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Abstracts of Original Contributions: 42nd Annual Scientific Session 
The American CoUege of Cardiology is pleased to announce that 
5,636 abstracts of original contributions were submitted to the 
Program Committee of the 42nd Annual Scientific Session. Space 
and time considerations this year aUowed the selection of 1,886. 
Each abstract was peer reviewed by a panel of graders; chosen 
abstracts are presented in either oral or poster format. 
The American CoUege of Cardiology thanks the thousands of 
abstract participants and the hundreds of category graders and 
701 Cardiac Reconstruction: Patient Support and Outcome 
Monday, March 15, 1993 
10:30 AM-Noon 
Anaheim Convention Center 
C-4 
701-1 
Impact of Intraoperative Echocardlography 
on Homograft Aortic Valve Surgery 
10:30 
William J Stewart, Linda Gillam, Annitta J Morehead, 
Ernesto E Salcedo, Allan L Klein, Carol Duffy, Gerald I 
Cohen, Harry M Lever, Joseph S Mikan, Lee H Ellison, 
Delos M Cosgrove: Hartford Hospital and Cleveland Clinic 
Intraoperative echocardiography (IOE) is an integral part of 
valve reconstruction surgery, but its role in homograft aortic 
valve replacement (HAVR) using cryopreserved human 
valves has not been well defined. We examined the utility of 
IOE in 86 pts (age 44±14, 69% males) undergoing HAVR, 
using transesophageal echo in 52 pts, epicardial echo in 20 
pts, and both in 14 pts. Pre-pump IOE was useful in defining 
aortic annulus diameter for sizing the homograft (difference 
between IOE measurement and valve size = 0.8 ± 1.1 mm) 
with only 5 pts showing more than 2 mm difference. Post•
pump IOE demonstrated normal homograft function and 0 to 
1+ AR (average 0.3 ± 0.4 on a scale of 4+) in 77 pts. In 10 pts 
(11.6%), post-pump IOE led to maJor alterations In 
management during the same thoracotomy: Significant AR 
in 6 pts led to a second pump run: for reVision of the 
homograft in 3, a St Jude AVR in 2, and a new homograft in 1 
pt. Aortic obstruction due to compression of the homograft in 
2 pts led to evacuation in 1 pt and a second pump run for a 
new homograft in 1 pt. An new post-HAVR MI diagnosed by 
intraoperative TEE in 1 pt led to CABG. In 1 pt, SAM and 
dynamic obstruction resolved with changes in therapy, 
precluding a potentially Inappropriate second pump run. 
CONCLUSION: In pts undergoing HAVR, IOE is useful pre•
pump to define native annuluF· diameter. Post-pump IOE 
defined suboptimal results in 12'):', allowing major changes In 
management. Intraoperative echocardlography should be an 
integral part of homograft implantation. 
chairmen for their efforts. 
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701-2 10:45 
Aortic Root Replac..ant with a Pulmonary Autograft 
Nicholas T. Kouchoukos, Victor G. Davila-Roman, Thomas L. 
Spray, Suzan F. Murphy, Johanna B. Perrillo. Washington 
University School of Medicine, St. Louis, Missouri 
Thirty patients (mean age = 31 yrs, range 8-47 years) had 
aortic root replacement with the autologous pulmonary root 
and replacement of the pulmonary root with a pulmonary 
allograft for aortic valve disease. Intraoperative 
transesophageal and postoperative transthoracic 
echocardiography at 3-6 month intervals were used to 
assess graft function. There were no operative or late 
deaths and no thromboembolic complications or episodes of 
infective endocarditis. The mean duration of follow up 
was 15 months (range 1-37). The mean echocardio•
graphically determined diameters (cm) of the autograft at 
the annulus, at the sinuses of Valsalva, and at the 
supravalvular ridge for 21 patients early postoperatively 
and at last follow up were 2.2 ± 0.4 vs 2.2 ± 0.4, 3.2 ± 
0.6 vs 3.3 ± 0.5, and 2.5 ± 0.4 vs 2.7 ± 0.4, 
respectively. Using Doppler color flow analysis, 21 
patients had no or trivial, 6 had mild, and no patients 
had moderate or greater incompetence of the autograft 
valve at last follow up. The mean peak valve velocity of 
the autograft at last follow up was 1.3 m/sec (upper limit 
of normal < 1.7 m/sec). One of the pulmonary allografts 
has moderate incompetence and one (in a 16 year old) 
required reoperation for stenosis of the pulmonary artery. 
The degree of incompetence of the autograft and allograft 
valves has not progressed over the length of follow up. 
Although the operative procedure is more complex than 
simple aortic valve replacement, it can be safely applied 
in selected younger patients with aortic valve disease. 
Intermediate term follow up indicates satisfactory 
function of pulmonary root autografts in the aortic 
position with no graft dilatation or progressive valvular 
incompetence for up to 37 months. 
18A ABSTRACTS 
701·3 11:00 
Postcardiotomy Shock: A Multicenter Evaluation of Treatment 
With the BVS SOOO® Bi·Ventricular Support System 
Robert Guyton, Jacques Schonberger, Peter Evens, G. Kimble 
Jett, Isaac Gielchinsky, Daniel Raess, Gus V1ahakes, Laman Gray, 
Jr., Stephen Woolley, William Piccione, Cecil Vaughn, Piet 
Boonstra, Mortimer Buckley for the Investigators Group 
Emory University, Atlanta, GA 
This prospective trial evaluated the safety and efficacy of a new 
pulsatile, temporary ventricular assist device, the BVS 5000. 
Patients were eligible for treatment if they were hemodynamically 
unstable despite maximal pharmacologic and IABP therapy, were 
free of concomitant complications, and were less than 6 hours 
from the first attempt to separate from cardiopulmonary bypass. 
Fifty five postcardiotomy patients were enrolled; 31 met all 
selection criteria and the remainder failed to meet criteria (n =15) 
or were not successfully supported (n=9). The BVS 5000 
effectively restored hemodynamics: Mean arterial pressure 
increased (77.1±B.O on-support vs. 50.1±15.3 mmHg pre-support, 
p=O.OOOl). Cardiac index increased (2.3±O.3 on-support vs. 
1.6±O.6 I/min/m2 pre-support, p=O.OO13). Left ventricular filling 
pressure decreased (11.9±4.5 on-support vs. 23.B±B.7 mmHg pre•
support, p=O.OO30). The most frequent complication was bleeding 
in 42 (76%) patients. Of the patients meeting all criteria, 17 (55%) 
were weaned from support and 9 (29%) were discharged. Survival 
was significantly influenced by pre-support cardiac arrest events. 
Su~val among patients not experiencing arrest was 47%. Eight 
patIents are long term survivors and were asymptomatic in NYHA 
class I or II at one year follow up. The BVS 5000 restored 
hemodynamics, permitted myocardial recovery and improved 
survival in a group of patients who would have otherwise died. 
701-4 11:15 
SuccessfuD Percutaneous Veno-arterial Assistance for Intractable Post•
Cardiotomy Low Output Syndrome: CIinicaJ ExperieoI:e in 19 Cases. 
Eric Epailly, Bertrand Mettauer, Arnaud Charpentier. Daniel Barrionuevo, Jean•
Claude Thiranos, F1'III1\fOis Levy, Jean Lonsdorfer, Jean-Georges Kretz, Bernard 
Eisenmann. Cardiovascular Surgery Dept. University Hospital Strasbourg France. 
From may 1990 to July 1992, we encountered 19 intractable post cardiotomy low 
output syndromes, despite intra aortic balloon pumping (lABP) and maximal 
inotropic support, among the 2024 cases of open heart surgery (OHS) during this 
time period. These 19 patients have been treated by a percutaneous vena-arterial 
assistance with membrane oxygenation as a temporary cardiopulmonary support 
(CPS) ; 7 CPS were initiated during cardiopuhnonary resuscitation. The initial 
OHS Was valvular in 3. coronary bypasa in 11, beart transplantation in 3, heart 
lung transplantation in 1 and puhnonary embolectomy in 1. The CPS lasted 31.3 
± 26.8 honn (3-100 bours) with a mean CPS output of 2.42 ± 0.8411min. As a 
resuk of CPS. the mean arterial pressure increased from 46 ± 12 to 81 ± 10 
mmHg, and urine output from 31 ± 20 to 178 ± 116 mllbour (all p<O.OS). Ten 
patients (S3 %) left the hospital alive, and presendy 7 (37 %)...., alive 19 ± 8.6 
month. (4-27) after OHS. TIuee discharged patients died : 1 at 3 months of 
intractable ventricular arrhythmias, 2 at 3 and 11 months of non cardiac causes. 
CPS was complicated by sepsis in 1 and severe limb ischemia in S. When 
comparing non survivors to aurvivors, no pre-op. parameters and only post-op. 
max. creatine kinase (+ 109 %) and post CPS urine output (- 46 %) were 
significantly different. The relative high incidence of limb ischemia led us to a 
succeasfuIl modification in Ibe canulation technique in order to reperfuse the distal 
arterial tree. 
We concWde that CPS in association with lABP can be used as a simple, easy, 
percutaneous long term assistance for reversal of post OHS low output syndrome, 
despite the lack of left ventricular venting; it can lesd to over SO % of short term, 
and close to 40 % of long term survival. 
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Analyais of Diastolic Function in Patients Submitted to 
Left Ventricular (LV) Patch Reconstruction for 
Postinfarction LV Aneurys. 
Marisa Di Donato, Anna Toso, Giuseppe Barlet.ta, Fabio 
Fantini, Michel Sabatier, Philip Rossi, Francoise 
Montiglio, Vincent Dor. Dept of Cardiology, University 
of Florence, Italy; cardiothoracic Center of Monaco, 
Monaco. 
LV reconstruction (LVR) by means of endovent"icular 
circular patch plasty(EVCPP) with synthetic or 
autologous patch might negatively influence LV diastolic 
function. Aim of this study was to analyze diastolic 
function in 20 pta (mean age SSi7) submitted to LVR with 
EVCPP for postinfarction LV aneurysm. Pts had complete 
hemodynamic study before and early after surgery. LV 
pressures were recorded simultaneously ,dth angiogr,'phy 
(RAO 30°; 50 f/s). HR was paced at lOa/min durin .. 
angiographies. Global pressure/volume and segmental 
pressure/length (P/L) loops for 45 segments identified 
by the centerline method were analy •. ed in basal and 
postop conditions. The results showed a significant 
increase in systolic function in 15/20 pts (E> from 
28tlO to 44±14, p<.001 and maximal elastance from 1.Ot.7 
to 1.6±.9,p<.02). In these pts PFR increased from 1.Bi.7 
to 2.S±.8,p<.OS and the constant t of pressurn decay 
decreased from 53±8 to 44±S;p<.Ol). After surgery,the 
analysis of P{L loops showed a reducticn of 
nonuniforn>ity of LV contraction and relaxation (less 
evident early systOliC shortening and early relaxation). 
Pts who showed no improvement in systolic func~ion 
showed no changes or a deterioration of diastnlic 
parameters. Thus, LVR with EVCPP affects diastolic 
function by improving relaxation and filling in the 
majority of pts: changes in diastolic parameters appear 
strictly rela~ed to changes in systoliC function. 
701·6 11:45 
Patency of Saphenous Vein BypaSi Grafts Following Elective 
Angiography: Preliminary Resulta From the POST CABG Clinical Trial 
Cart W. White. lucien Campeau. Genell Knatterud, Jeffrey Probstfield. and 
the POST CABG Oinical Trial Investigators, University 01 Minnesota, 
Minneapolis, MN 
Reports 01 the time-related patency of saphenous vein coronary bypass 
grafts (SVGs) are usually derived from studies In which angiography Is 
prompted by cilnlcal symptoms. Preliminary angiography data are avalable 
from 1253 patients enrolled In the NHLBI Post-Coronary ArttJry Bypass Graft 
(POST CABG) Oinlcal Trial. These patIents were clinically stable and met 
criterIa for enrollment In the POST CABG Olnical Trial, Including placement 
of al least two SVGs one to eleven years earlier, with at least one SVG 
patent at study angiography. Patients with recent cerdlac events, a strongly 
positive treadmill test, severa angina. heart faOure or other life-threatening 
Dlnesses were excluded. Enrolled patients who had undergone more than 
one CABG surgery are not Included In this analysis. The average age was 
61.1 years <.±. 7.3 years); 7.7% were woman. Of the 3,698 SVGs placed 
(defined by distal anastomosis), 87% were patent. Single SVGs constituted 
70% 01 the SVGs placed (overall patency, 86%). Of the 1116 complex SVGs 
(988 continuation grafts, 106 Y grafts; and 22 Y plus continuation grafts), 
89% were patent. 
Years from Surgery 1-3 4-6 7-11 
No. Patients 531 448 274 
SVGs Placed (mean.±, sci) 2.8.±, 0.9 3.0.±, 1.0 3.1 .±, 0.9 
All SVGs Patent, n(%) 380 (72) 305 (68) 179 (65) 
2. 1 SVGs Occluded, n(%) 151 (28) 143 (32) 95 (35) 
2. 2 SVGs Occluded, n(%) 27 (5) 38 (8) 22 (8) 
Study angiography wiD be repeated after the patiema complete four to five 
years of moderate or aggrassive Ilpid-lowering therapy and warfarin or 
placebo. In this unique population 01 selected stable patients, complete 
SVG patency was seen In more than two-thlrds of the patients; occlusion 01 
2. 2 SVGs was seen In < 10%. Overall patency rates were similar among 
SVG types. 
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702 Effects of Medication on Coronary Artery 
Lesions and Ischemia 
Monday, March 15, 1993 
10:30 AM-Noon 
Anaheim Convention Center 
B-1 
702·1 10:30 
Effed of Lovastatin Upon the Evolution of Coronary Atherosclerosis 
as Assessed By Serial Quantitative Coronary Arteriography 
David Waters, Lyall Higginson, Peter Gladstone, Brian Kimball, Michel 
Lemay, Jacques Lesp6rance for the CCAIT investigators. Montreal Heart 
Institute, University of Ottawa Heart Institute and The Toronto Hospital, 
Montreal, Ottawa and Toronto, Canada 
The Canadian Coronary Atherosclerosis Intervention Trial is a double•
blind, randomized, placebo-controlled trial to determine whether mono•
therapy with an HMG CoA reductase inhibitor retards the progression or 
facilitates regression of coronary atherosclerosis. In 3 participating centers 
331 pts s70 years old with diffuse but DOt necessarily severe coronary 
disease and a fasting serum cholesterol (C) between 5.7 and 7.S mmol/L 
were enrolled. Major exclusion criteria were previous coronary surgery, 
PTCA <6 months, ejection fraction <0.40, MI or unstable angina <6 
weeks, left main stenosis ~SO% and 3 vessel disease with a preseptal 
LAD stenosis ~ 70%. Basel ine characteristics of the lovastatin and placebo 
groups were similar. All pts received intensive dietary counselling. 
Lovastatin or placebo was begun at 20 mglday and was up-titrated to 40 
and SO mg during the first 16 weeks of the trial to attain a fasting LDL-C 
S 3.4 mmollL, a goal reached in 69% of lovastatin and 10% of placebo 
pts. Initial data analyses show that from baseline to 6 months, total and 
LDL-C both decreased by only 3 % in placebo pts, but total C decreased 
by 23% in lovastatin pts, from 6.4±0.9 to 4.9±0.7 mmol/L and LDL·C 
decreased by 30%, from 4.S±0.8 to 3.2±0.6 mmollL. Coronaryarterio•
graphy was repeated after 2 years, or earlier if required for symptoms, in 
299 pts (90%). All films were measured blindly (with respect to order and 
pt identity) using quantitative techniques. The primary endpoint, coronary 
change score, defined as the mean of the minimum lumen diameter changes 
of all lesions per pt, worsened by 0.09 mm in placebo pts and 0.05 mm in 
lovastatin pts (p < 0.02). The number of pts with regression was not 
significantly different, but progression only, progression ± regression and 
new coronary lesions were seen in fewer lovastatin pts (p < O.OS for each). 
Conclusion: Lovastatin slows the progression of coronary atherosclerosis. 
702·2 10:45 
Beta·blocken Enbance Coronary VaaoreacUve Reaponae to 
Acetylcholine in Patient. with Chronic Stable ADglna 
Hassan El-Tamtmt. Michae! Mansour, Thomas J. Wargovich, James 
A. HiU, Roger M. Mills, Christopher Nunn. James Kazakis, Jamie 
Conti, Carl. J. Peplne. Universily of FIDrlda. GainesviUe. FL. 
The effects of beta-blockers on coronary vasoreacttvlty to 
acetylcholine were Investigated during diagnostic coronary 
angiography tn 20 patients with stable angtna, positive exercise 
tests and coronary artery disease. Ten patients took no antl-angtnal 
therapy for at least 24 hrs (Group 1) while the other 10 patients 
(age and symptom matched) received 50 mg metoprolol twice dally 
(Group 2). After baseltne angiography. acetylcholtne was infused 
selectively Into the left coronary artery (Iml/mln for 2 mlns) at 
concentrations from 10-6 to 1O-4M Immediately followed by 
angiography after each dose. Changes In diameter(mrn) of non 
stenotic proximal and distal left anterior descending (LAD) and 
Circumflex (eX) segments were measured by computerized 
quantitative angiography (mean ±SEM). All patients showed a dose•
dependent constriction to acetylcholtne. 
Percent decrease In vessel diameter from Comparison 
baseltne to maximum acetylcholine dose: between Group 1& 2 
Gmlm.l.. Gm!mJl 01 D G2 
LAD PI"O%. -1l±4 (p<.Ol) -18±4 (p<.OOl) (p<.05) 
LAD dis. -7±4 (p<.06) -19±6 (p<.Ol) (p<.03) 
ex PI"O%. -4±2 (p<.04) -18±4 (p<.OO2) (p<.04) 
ex cU.. -1l±6 (p<.07) -25±6 (p<.OO8) (p<.03) 
The constrictor response observed In all segments of group 2 
patients was Significantly more than that observed In group I 
patients. 
Conclusion: Patients with stable angina who are receMng chroniC 
beta-blocker therapy exhibit exaggerated coronary vasoreactlvlty tn 
response to tntracoronary acetylcholine. These data suggest that 
beta-blockers may potentiate the muscarinic constrictive effect of 
acetylcholtne on coronary smooth muscle. 
ABSTRACTS 
702·3 11:00 
The Antithrombotic Efficacy or Nitroglycerin Patches in 
Coronary Patients 
Lucie L.-Lacoste, Rosa-Maria Lid6n, Jules V.T. Lam, Pierre TMroux. 
Montreal Heart Institute, Montreal, Canada 
Nitroglycerin (NTG) and nitrates are useful anti-ischemic drugs because 
they dilate coronary arteries, but whether they have further beneficial 
antithrombotic effects in humans is unclear. In a double-blind 
randomized trial, stable coronary patients receiving no medication were 
assigned to nitroglycerin patches (nitrodur, 0.6 mg) (n=l1) or to 
equivalent placebo patches (n= II). Platelet thrombus deposition onto 
aortic media and fresh whole blood platelet aggregation (amplitude•
ohms) to ADP (20 I'M) and thrombin (0.1S I'M) were measured at 
baseline and after 3 hrs in both groups. Mural thrombus deposition was 
assessed by drawing venous blood for 3 min over porcine aortic media 
placed in ex vivo flow chambers at 37·C at a shear rate of 996 sec··, 
and quantitated by morphometric analysis (J.I~. There were no 
significant difference in blood pressure or heart rate between groups. 
Results are shown below: 
~ Baseline-Ntg Nli Baseljne-Placebo ~ 
Deposition <I'M') 2.5±0.S 1.0±0.2* 2.4±0.4 1.6±0.4 
Aggregation: ADP 7.7±0.8 S.3±O.S*t 8.S± 1.0 8.1 ±0.9 
thrombin IS.6± 1.2 12.0± 1.2* 13.4±0.9 12.1 ± 1.4 
* P < O.OS vs baseline; t p < O.OS vs placebo. 
Conclusion: Three hours after application, nitrodur patches reduced 
platelet-thrombus deposition onto aortic media by greater than 50% and 
selectively inhibited whole blood platelet aggregation to thrombin and 
ADP. This antithrombotic effect of nitrodur patches may contribute 
additional benefits to patients with ischemic heart disease, by inhibiting 
platelet-thrombus formation. 
702·4 11:15 
ACE Inhlbltora Reduce Myocardial lachemla Through Modulation of 
lachemla·lnduced Catecholamine Activation. ExperIence with 
Perlndoprllat 
Louis Bartels, Willem J. Remme, Martin van dar Ent, Dick Knlijssan. 
Sticares Foundation, Rotterdam, The Netherlands. 
Recent data indicate that ACE inhibition may significantly affect the inci•
dence of unstable angina and Infarction. To _Iuate the underlying 
mechanisms for this, as yet unexplained, antiischemic affect, 25 un•
treated, normotensive pis with exerciS&-lnduced angina without heart 
failure underwent 2 identical, incremental pacing stress tasts, 45 min b&•
lore (Tl) and 15 min altar (T2) 0.5 mg Intravenous Perindoprilat (P) 
(n=14) or placebo (n=11), while fasting and supine for 1.5 hIS. Basaline 
clinical, hemodynamic and neurohumoral variables and changes during 
T1, were comparable in P and placebo, whereas they were reproducible 
during 12 in placebo. AI. baseline before T2, P had reduced arterial and 
coronary venous ACE and angiotesin II by 95% and 96% and by 67% 
and 47%, resp., without affects on arterial pressures, systemic resist•
ance or coronary flow. Maximal heart rata, conbactillty, relaxation and 
coronary hemodynamlca were similar during T1 and 12 In P. In contrast, 
during T2 LVSP, rate-pressure product and myocardial 0, consumption 
were 10%, 10% and 13% resp. less (p<.05 vs T1). P clearly reduced 
myocardial Ischemia, evidenced by less ST depression, LV filling pres•
sure post-pacing and anginal score (0.12 vs 0.18 mV, 14 vs 24 mmHg, 
and 5.5 vs 7.2, 12 vs T1 resp., all p<.05). Neurohormones did not 
change during pacing-Induced ischemia, except for arterial norepineph•
rine, which increased by 35% during n, accompanied by a 14% in•
crease In systemic resistance and arterial pressures (all p< .05). In con•
trast, changes in norepinephrine, systemiC resistance and arterial pres•
sures during T2 were prevented by P. Immediately altar 12, LVSP r. 
tumed to pre-pacing levels. Thus, ACE inhibition with parindoprilat r. 
suits In antiischamic effects, not through a direct coronary or systemiC 
vasodilator effacI or negative inotropic activity, but by modulating is•
chemia-induced catecholamine activation and secondary systemic vas0-




Beta Blocken Lower the Heart Rate Threshold ror ischemia During 
Ambulatory Monitoring 
Richard F. Davies, Margaret Herbert, Habibullah Habib~ W. Peter 
Klinke, Claude Nadeau, Denis C. Phaneuf, Serge Lepage, Pierre 
Dessain, Jennifer A. Buttars, CASIS Investigators. 
University of Ottawa Heart Institute, Ottawa, Ontario, CANADA. 
Objectives: To examine the effect of atenolol on the heart rate (HR) 
threshold for ischemia during 48 hr Holter monitoring (HM) 
Background: Previous studies show beta blockers can have a 
coronary vasoconstrictor effect. The importance of this to their effect 
on ischemia during HM is not known. 
Methods: Fifty patients previously showing ischemia on HM were 
studied. Patients underwent repeat HM on placebo(P) and atenolol(A) 
in a double blind, cross-over study. HR and ST segment data were 
recorded every 15 seconds. HR threshold for ST depression was 
determined for each episode by applying a linear regression model to 
these data during episode onset. The mean off- and on-drug threshold 
and the % time spent above the off-drug threshold was determined for 
each 48 hr HM. 
Results: The 32/50 patients showing ischemia during repeat HM 
had a median of 4.5 episodes and 30.6 minutes of ischemia on P, 
which were reduced to 2.0 and 6.3 minutes respectively by A (p< 0.01). 
The HR theshold for ST depression was lowered by A in all patients 
(p< 0.001). Treatment with A caused a reduction in % time above the 
off-drug HR threshold of 96% (from 17% to 0.6%, p< 0.001), while 
episode frequency and ischemia duration were reduced by 56% and 
79% respectively. 
Conclusion: In addition to reducing HR, A lowers the HR threshold 
for ST depression. As a result, the suppression of ischemia by A 
during HM is less than would be expected on the basis of HR 
reduction. These results suggest that coronary vasoconstriction may 
limit the effectiveness of A in suppressing ischemia during HM. 
702·6 11:45 
The Influence of Chronic Estrogen Replacement Therapy on the 
Acute Effects of Intravenous Ethinyl Estradiol on Coronary 
Artery Flow In Postmenopausal Women 
Steven E. Reis, Sean T. Gloth, Roger S. Blumenthal, Howard A. 
Zacur, Gary Gerstenblith, Jeffrey A. Brinker. Johns Hopkins 
University, Baltimore, MD. 
We have previously reported that the IV administration of ethinyl 
estradiol (EE) is associated with a significant increase in coronary 
blood flow and decrease in coronary vascular resistance (eVR) in 
postmenopausal women. However, the influence of chronic estrogen 
replacement therapy (ERT) on the coronary response to IV EE has 
not been reported. We therefore assessed coronary flow and 
coronary vascular resistance before and 15 minutes after IV 
administration of 35 mcg of ethinyl estradiol (EE) in (1) eleven 
postmenopausal women not taking chronic ERT, and (2) six 
postmenopausal women taking ERT. We assessed the average peak 
velocity (APV) of coronary blood flow using a doppler-tipped guide 
wire and coronary. cross-sectional area (CSA) using quantitative 
angiography and calculated a flow index (FI) by the equation, 
FI(mVmin)=APV*CSA*60. Coronary vascular resistance (eVR) was 
calculated by CVR=mean coronary pressuretFI. EE was not 
associated with Significant changes in mean coronary blood pressure 
or heart rate. FI and eVR responses to EE were: 
FI eVR 
ERl Pre-EE Post-EE I! ~ ~ I! 
73.1%12.8 91:Q;i7.3.04 2.12±.38 1.78±.35 .02 
+ 75.5±16.8 77.4±15.5 NS 1.99±.61 1.83±.55 NS 
Therefore, low-dose IV EE was associated with an acute increase in 
coronary FI and a decrease In eVR in postmenopausal women not 
taking chronic ERT which were not present in those taking chronic 
ERT. These data suggest that chronic ERT alters the kinetics of the 
acute coronary response to EE. 
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Histomorphometric Features Predict I·Year Outcome of 
Patients With Idiopathic Dilated Cardiomyopathy 
Considered at Low Priority for Heart Transplantation 
Francesco Pelliccia, Cinzla Cianfrocca, Giulia d'Amali, Paola Demucci, 
Antonio Nigrl, Denedetto Marino. Pietro Gallo. Dept. of Cardiac Surgery. 
and Dept. of Human Diopathology, University "La Sapienza", Rome, 
Italy 
Heart transplantation (H'D is gcnerally postponed until symptoms have 
become intolerable in those pts with idiopathic dilated cardiomyopathy 
(IDC) considered "too well" for the procedure. However, the shon-tcrm 
prognosis of this subset of pts has been poorly defined. Accordingly, we 
allempted to identify which clinical or histomorphomctric features at 
assessment for HT could predict the I-year outcome of 30 IDC patients 
with an ejection fraclionS25% and a stabilized clinical condition. who 
werc considercu at low priority for the proceuure. AIl pts were trt!utcd 
with Uigoxin. diuretics and vasodilators. During follow-up. 10 pts (Gr. A) 
showed a poor outcome: 2 dit:d suddenly and 8 had hemodynamic 
deterioration (4 underwent liT and 4 died from heart failure while on Ule 
waiting IiSI). The remaining 20 pIS (Gr. D) had a benign outcome. At 
assessment for HT, clinical and ECG features, as weIl as J.V uimension 
and ejection fraction were similar between the two groups. Converst:ly, 
Gr.A pts had higher LV end-diastolic pressure (2t±4 vs 18B mill Bg, 
p<O.03). as well as lowc:r cantiac indt:x (2±O.4 vs 2.4±0.4 I/min/m2, 
p«W2) and stroke volume index (25±6 vs 30±$ mIlm2, p<O.03), with 
respect to Gr.B pts. In addition, Gr.A had a lower myolibril votume 
fraction (8$.I±25 vs 905±2.6%. p<O.OOl), and a higher nuclear area 
(73±17 vs 48±11 Jl2, p<O.OOI), as compared with Or.B. Multivariate 
analysis selectt!u myofibril volume fraction (p<O.OOl) and IIuclear area 
(p<O.l105) as thc only independent predictors of a poor I-year outcomc. 
The combination of myotibril volume fractjol~H9% and nuclear art~a>50 
Jl2 was found in all Gr.A pts (sensitivity: 100%) but in only 2 Gr.B pts 
(specificity: 90'Yo). We concluuc that in IDC pts considereu at low 
priority for HT: (I) the I-year survival (67%) is lower than that currently 
t:xpecled with surgery; (2) hislomorphom<:lric f<:.lltures, i.e. tht: 
concurrency of a low myotibril volume fraction antl an increasl)(\ lllidear 
urea, predict the short-t<:rm outcome; (3) cndomyocartlial biopsy sh,lul;J 
be performed at asst:ssment for HT. as it reliably improves the 
rationalization of the timing of the proc~lure. 
703·2 
The Natural History of Incidentally Discovered, 
Asymptomatic Idiopathic Dilated Clrdio~pathy. 
10:45 
Margaret M. Redfield, Bernard J. Gersh, Kent R. Bailey, 
Richard J. Rodeheffer_ Mayo Clinic, Rochester, MN 
Recent studies have reported survival in postinfarcti.on 
patients (Pts) with asymptomatic left ventricular 
dysfunction (ALVD). The natural history of patients with 
incidentally discovered Idiopathic Dilated Cardiomyopathy 
(IDCM) and ALVD is unclear. Increasing utilization of 
noninvasive assessment of LV function has resulted in the 
recognition of Pts who have IDCM but who have never had 
symptoms of congestive heart failure (CHF). The current 
study identified Pts with IDCM first seen at the Mayo 
Clinic between the years 1976 and 1987 (n=218). Of 
these, 33 Pts had never had symptoms of or treatment for 
CHF and were identified after assessment of LV function 
for palpitations, atrial fibrillation, abnormal EKG or 
CXR, atypical chest pain, or embolic events. All 33 Pts 
were identified between 1980-87. The mean ejection 
fraction (EF) of 33il%. Serial assessment of EF at a 
mean of 3.7iO.4 yrs was available in 19 Pts, EF improved 
or remained stable in 12 Pts and deteriorated in 7 Pts. 
Survival was compared to Pts identified during a similar 
time period (1982-87) who were NYHA class I at their 
first visit but who had a history of symptoms of CHF and 
were already on therapy for CHF. 
Survival (%) ~ 7~ 1E 
ALVD (n=33) 1mmf ·EIlr 53TI0 
Class I (n-25) 100±0 83i8 54i13 
While the short-term prognosis for both groups is good 
and appears better than that recently reported for 
post infarction ALVD, Pts with asymptomatic IDCM do not 
live longer than class I IDCM Pts (p=.75) and have a 
similar poor long-term prognosis. 
lACC Vol. 21, No.2 
February 1993:21A 
703·3 
Immunosuppressive Treatment in Autoreactive Myocarditis•
Results from a Placebo-Controlled Trial. 
11:00 
Bernhard Maisch, Matthias Hcrzum, GUnther Hufnagel, Christian 
Hengstcnberg. Ute SchOnian; Alfonso Bittinger", Eckhardt GJ.Olsen**.Depts 
of Int Medicine-Cardiology &*Pathology, Philipps-University, Marburg. 
**Dept of Card. Path., Nal Heart Hospital, London. 
It is controversial if pts with myocarditis(M) benefit from 
immunosuppressive therapy. Patiellls & methods: We report the 
clinical(NYHA class), hemodynamic (improvement of LV-ejection 
fracdon(EF) ~5%), histological (only infiltrate(Int) +/- in HE-stainingl and 
irmnunohistological(IgG and complement (C3)-fixation by direct 
immunofluorescence test in the LV-biopsies) results of a controlled study 
including 38 pts randomized in 2 groups. Group 1 was treated with restraint 
of physical activity, optional ACE-inhibition .. digitalis & diuretics only. 
group 2 for 4 weeks with 2mg/kg/d azathioprin(A) and 1.25mg/kg/d 
prednisone(P) in addition. After tapering off O.85mg/kg/ A and 0.3 mg/kg/d P 
were given for 2 months. Only pts with an infiltrate and hemodynamic 
impainnent(EF <55% and cardiomegaly: LVEDVl >IOOmVm2) were 
included. Follow-up(FU) biopsies & hemodynamics were carried out after 3 
months.Results(data are given in %, *p<0.05; improv : improvement; = 
:unchanged; deter :detcriorated, Viro:viral etiology likely): 
Under treatment with A + P pts improved their NYHA-class and ejection 
fraction significantly. Binding of complement, IgG, IgA and IgM in the 
biopsy was significantly reduced between both groups. In both treatment 
anns an infiltrate, which was obligatory as entrance criterium, was seen only 
sporadically at follow-up irrespective of the treatment ann (21 vs 15%). In 
group ~(A+P) 4~ts and 2TOUD Hconventionall 5 Dts died or went to HTX. 
Follow-up: BiopsySerum NYHA-c1ass LV-ejection fraction 
Treatment Inf+ IgGtC3 Viro improy deter unch jmproydeter WJch 
conventional 21 95 42 21 21 68 15 26 59 
A + P 15 26* 36 53* 21 26* 47* 21 32 
ConclMsions: Under a combined therapy of A and P patients improved 
ejection fraction. NYHA classification and the degree of inununoglobulin and 
complement fixation in their biopsies. 
703·4 11:15 
Serological Evaluation of the Role of Enteroviral Infection In 
Idiopathic Dilated Cardiomyopathy: A Matched Case-Control 
Study 
Philip J Keeling, Andrzej lukaszyk, Nayanti Sodha. Alida lP Calorio, 
Sonia Bent. James F Mowbray, Michael J Davies, Jim C Booth, William J 
McKenna, St George's Hospital Medical School, london, UK. 
Previous studies have suggested that enteroviral serology is raised in 
patients with dilated cardiomyopathy (OCM), but have failed to assess 
matched controls. In this study, sera was assessed at diagnosis in 119 
consecutive patients with OCM, 86 matched and 94 unmatched controls 
for the presence of Coxsackie B virus-specific immunoglobulin M (CVB 
IgM) and enteroviral viral protein 1 (VP1), a marker of active infection. 
Patients with OCM (mean age 43 years, range 12-74) had symptoms lor 
34±45 months, 33 (28%) gave a history of a preceding acute viral illness 
and 15 (13%) had clinical (n=9) or biopsy features (<1=6) of myocarditis. At 
diagnosis 40 (34%) patients with OCM were positive for CVB IgM 
serology. Monotypic responses were frequent (34, 85 %) and were most 
commonly against serotypes B2 and B5, but demonstrated no clear 
seasonal peak. Of 60 patients with OCM. 25 (42%) had positive CVB IgM 
serology compared to 23 (27%) matched controls (p:NS) , and 5 (5%) 
unmatched controls (p=0.OOO1). Within the matched control group, 
positive CVB IgM serology was more common in the controls of 
seropositive patients than in seronegative patients (36% versus 20%, 
p:NS) and showed the same serotypic response as the index patient in 
31 % of cases. No association was observed in patients with OCM 
between the presence of positive eVB IgM serology and any clinical or 
histological feature. High levels of VPl were detected in 251111 (23%) 
patients with DCM compared to 14170 (20%) matched controls (p=NS). 
No association was observed between the presence of high levels of 
VP1 and any clinical or histological feature, or with positive eVB IgM 
serology. 
Conclusion: these results suggest that enterovirus is a common 
environmental pathogen and do not provide support for an etiological 
role of enteroviral infection in the pathogenesis of OCM. 
ABSTRACTS 
703·5 11:30 
Elimination of Cytomegalovirus DNA by Hyperimmunoglobulin 
Therapy in Active myocarditis and Dilated Heart Muscle Disease 
Bernhard Maisch, Ute SchOnian Department of Internal Medidne•
Cardiology, Philipps-University, Marburg. FRG 
Effective treatment and elimination of the causative pathogen in active 
myocarditis(M) and dilated cardiomyopathy(DC) disease has been an 
unresolved problem. We recently demonstrated that in patients with 
M and postmyocarditic heart muscle disease cytomegaiovirus(CMV)•
DNA was found in 1096 of cases as assessed by in situ hybridization. 
Since elimination of the possible viral pathogen was considered the 
most effective therapeutic regimen, CMV 
hyperinummoglobulin(Cytotect) was administered. Patients and 
methods: 15 pts(llm/4f) with DC(EF<5096, L VEDVl > 100 m/m') and 8 
pts(4m, 4f) with active M, who had \Uldergone heart catheterization 
and left ventricular endomyocardial biopsy (EMB) with a CMV•
positive probe were treated with 2ml/kg Cytotect i.v. on 3 alternate 
days. Hemodynamic; and EMB were repeated after 3 months. 
Results( *p<O.05 by chi-square analysis): 
No pts myocarditis dil. cardiomyo.patby 
CMV positive EMB before Cytotect 8 15 
CMV positive EMB after Cytotect 3* 4* 
Percent reduction of CMV-pos EMBs 62.596 73.396 
Central hemodynamics and NYHA dassification improved or 
remained \Ulchanged in all patients who eliminated CMV-DNA from 
their myocardiwn. The treatment was well tolerated, no serious side•
effects were observed. 
Conclusion: CMV hyperimm\Uloglobulin effectively eliminated CMV•
DNA from affected myocardiwn in patients with active myocarditis 
and dilated heart muscle disease thus offering a new therapeutical 
option in myocarditis and DCM associated with a cytomegalovirus 
infection of the heart. 
703·6 11:45 
Idiopathic Dilated Cardiomyopathy: No Serological Evidenca 
of Persistent Enterovirus Infection 
Philip J Keeling, Andrzej lukaszyk. Nayanti Sodha, Alida lP Caforio, 
Sonia Bent, James F Mowbray, Michael J Davies, Jim C Booth, William J 
McKenna, St George's Hospital Medical School, london, UK. 
Persistence of Coxsackie B virus-specific immunoglobulin M (CVB IgM) 
has been noted in dilated cardiomyopathy (OCM) but has not been 
assessed in a large number of patients. In this study, sera from 71 
patients with DCM were evaluated at diagnosis and during follow-up 
(mean duration 12.5 ±o8.8 months, range 1-48) for the presence of CVB 
IgM by reverse radioimmunoassay and for enteroviral capsular protein 
(VP1), a marker of active infection. At diagnosis 23 (32%) patients were 
positive for CVB IgM, and 14 of 68 (21%) had raised levels of VP1. 
Monotypic CVB IgM responses predominated (18, 78%) and were most 
frequently against serotypes 82 and B5. During follow-up, 18 patients 
lost their positive CVB IgM response and 47 episodes of seroconversion 
were observed in 31 patients, and these were transient in all but one 
patient A persistent CVB IgM response (>3 months) was documented in 
5 patients (mean duration 13.1 ±.7.8 months, range 3.9-25.2). This 
response was monotypic in 2 patients (B1, B5) and multitypic in 3 
patients (B4 and B5 in two, and B1, B2 and B5) and showed no 
association with any clinical or histological feature. levels of VPl also 
showed frequent changes during follow-up, levels normalising in 11, and 
becoming elevated in 16 patients. A persistent elevation of VP1 was 
observed in 6 patients (mean duration 18.8 ±o10.7 months, range 4.5-
s.:.5), but was not associated with any clinical or histological feature, or 
With CVB IgM responses. Similar findings were observed in patients 
treated with immunosuppressive drug therapy following cardiac 
transplantation (n-19). 
Conclusion: the low prevalence of persistent CVB IgM responses and 
high levels of VP1 in patients with OCM does not support the hypolhesis 
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704-1 10:30 
A new K+ Channel Opener YM934: hs Effect on the ATP· 
Sensitive K+ Channel In Cerdlac Myocytes and a pancreatic 
a-Cell LIne 
Mitsuhiko Yamada, Andre Terzlc, Ian Findlay, Arshad Jahangir, and 
Yoshihisa Kurachi. Mayo CRnie, Rochester, MN 55905 
YM934, an analog of 1emakaJim, relaxes smooth muscles and decreases 
cardiac contraction. We examined the effect of YM934 in guinea-pig cardiac 
myocytes and an insulin-secreting cell line, HIT T15, using whole-cell and 
single channel current measurements. In atrial and ventricular cells, YM934 
(Hooj1M) Induced a time-independent K+ current In a concentratlon•
dependent fashion (EC50 ~3 j1M) under the whole-cell voHage-clamp 
condftlon. The YM934-induced current was inhibited by gllbenclamlde (1 
j1M), a blocker of the ATP-sensftive K+ (KATP) channel. In cell-attached 
patches, YM934 activated a 90 pS KATP channel. In inslde-out patches in 
the presence of 1 mM ATP, YM934 increased the KATP channel activlly in a 
concentratlon-dependent manner (EC50 ~10 j1M). In the absence of YM934 
the haH-lnhibftlon of lhe KATP channel occurred at 20 j1M of intracellular ATP 
(ATPj), but in fts presence (100 j1M) 1 mM ATP was required for haH•
inhibition. In the ATP-tree internal solution, the KATP channel appeared and 
then spontaneously ran down. YM934 increased the channel activfty in the 
partial rundown state, but did not affect the channel in fts fully open state or 
atter complete rundown. After complete rundown, UDPj (3 mM) partially 
restored the channel activfty, which was further enhanced by YM934. In HIT 
T15 B-cells, YM934 did not affect KA TP channel activlly In excised patches in 
the presence or absence of ATPj nor In cell-attached membrane patches 
while diazoxide stimulated channel openings under each of these 
condftions. In conckJsion, YM934 primarily targets the KATP channel fOr fts 
pharmacological action. This effect appears to be tissue-specHic since 
YM934 activates the KATP channel in cardiac but not in HIT T15 cells. YM934 
activates the cardiac KA TP channel by decreasing the sensftivlly of the 
channel to ATPj and by Increasing the maximal response of the partially•
operative channel. 
704·2 10:45 
An External Binding Site for Class I Antiarrhythmic Drugs 
Robert Sheldon. Ela Thakore, University of Calgary. Alberta. Canada 
Recent electrophysiologic data suggest the presence of an external 
binding site for class I drugs. We tested this with [3HlBatrachotoxinin 
IBTXI which binds to sodium channels on freshly isolated cardiac 
myocytes. We determined whether the impermeant permanently 
charged quaternary amine aX222 blocked BTX binding. whether the 
imperrneant aminocation choline blocked aX222 effects. whether the 
cationic charge was needed. and finally whether the antiarrhythmic 
drug lidocaine interacted with the external site. aX222 inhibited BTX 
binding and Scatchard analysis revealed a competitive pattern: 
Control 
1.6mM aX222 
P. t test 
I'H] BTX Binding 
"". nM 
19 ± 15 
80 ± 39 
< 0.05 







0.29 ± 0.11 
2.3 ± 0.4 
65 ± 10 
Control 
Brnax. fmol 
20 ± 10 
22 ± 8 
> 0.05 
0.13 ± 0.11 
1.8 ± 0.8 





Conclusions: 11 Permanently charged aX222 binds to an external 
site associated with the sodium channel; 21 The cationic quarternary 
amine group is involved in the binding; and 31 Amphiphilic lidocaine 
does not interact significantly with this external site. 
704·3 
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11:00 
D-SotaIoI ElIhibits Slow 0fI'set Kinetics: Im~ 'or its 
AnIiIiIIriIIato EIIiaq 
JOrg Weirich, Nancy Dierkes, Hermann Antoni, Stefan H. Hohnloser·. 
Department of Physiology and "University Hospital, University of 
Freiburg, Germany 
Reverse use-dependence (RUD) is considered to limit the usefulness of 
class 3 antiarrhythmic drugs. D-Sotalol (dSo) has been demonstrated to 
exhibit RUD resulting in reduced prolongation of action potential duration 
(APD) at higher heart rates. However, the time course of decline of its 
class 3 action associated with sudden increases in heart rate (offset 
kinetics) have not been characterized. Thus, RUD and offset kinetics of 
dSo were examined in isolated guinea pig papillary muscles and their 
influence on ventricular fibrillation threshold (VFf) (Langendorff 
preparation) was evaluated. 
Results: dSo (SOI'M) prolonged APD at a stimulation rate of 30 bpm 
from 222± 10 ms to 293± 12 ms (p < 0.05) whereas this APD prolong•
ing effect was reduced at 180 bpm (159 ± 8 ms versus 189 ± 9 ms; 
p=ns). Upon suddenly switching the stimulation rate from 30 to 120 or 
180 bpm, the APD prolongation observed at 30 bpm disappeared 
exhibiting slow offset kinetics of 0.026 ± 0.001 (increase to 120 bpm) 
and 0.021 ± 0.004 (increase to 180 bpm) per beat. According to the 
RUD of dSo, the drug caused the VFT (as determined by single pulses) 
to increase only at a rate of 60 bpm (from 69±5 rnA to 92±6 rnA, P < 
0.05) but oot at 180 bpm (34±5 vs. 24±7 rnA, ns). When the VFT was 
determined at 60 bpm following a series of up to 12 extrasystoles at the 
closest coupling intervals possible, a similar dSo-induced VFT increase 
was still observed (lst3 vs. 35± 7 rnA, p < 0.05). This latter effect is 
well explained by the slow offset kinetics of the drug. 
Conclusion: The present study demonstrates for the first time that the 
RUD of a class 3 drug can be overcome in part by slow offset kinetics of 
the compound. This results in antifibrillatory efficacy even in the 
presence of salvos of very closely coulped extrasystoles. 
704·4 11:15 
Reversal of Cocaine-Induced Sodium Channel Blockade by 
Lidocaine 
Yonggao Wang, Robert J. Hariman, Jeffrey J. Grawe, 
Allison P. Winecoff, Eric K. Louie, King H. Hwang, 
Henry S. Loeb, Patrick J. Scanlon, Jerry L. Rauman, 
Hines VA Hospital and Loyola University, Maywood, 
Illinois 
Cardiac arrhythmia due to cocaine (C) toxicity is 
related to its ability to slow conduction through its Na 
channel blockade. Like C, lidocaine (L) has affinity for 
inactivated Na channels. However, unlike C which has 
slow on/slow off binding kinetics, L has fast on/fast 
off kinetics. Rased on the modulated receptor 
hypothesis, L may displace C from the Na channel 
receptors. Using standard microelectrode techniques, we 
tested the ability of L to reverse C-induced Na channel 
blockade in 7 canine papillary muscle preparations. 
During pacing at a cycle length (CL) of 1000 msec, C (30 
}JK) added to the perfusate (normal Tyrode, K•
concentration 4 roM) resulted in prolongation of action 
potential duration at 90% repolarization (APDso ) from 
308±l9 msec to 362±24 msec (p<0.01), and reduction of 
Vmax of phase 0 from 205±37 V/sec to 9l±21 V/sec 
(P<0.001). Addition of equimolar L to the C containing 
perfusate resulted in APD90 of 35l±30 msec (p<0.05 
compared to baseline, p-NS compared to C) and 
improvement of Vmax to l51±25 V/sec (P< 0.05 compared to 
baseline and C). No significant changes in resting 
membrane potential and overshoot were seen during 
perfusion with C or C and L. The restoration of Vmax by 
L was more prominent at shorter pacing CL than at longer 
CL (mean restoration 73~ at CL-60Omsec, 53~ at 
CL-lOOOmsec, and 27% at CL-200Omsec). L may prove to be 
an antidote for C-induced ventricular arrhythmias. 
JACC Vol. 21, No.2 
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704·5 11:30 
lidocaine is as Potent as Sodium Bicarbonate ill Reversillg Cocaine•
Induced Slowinz of Ventricular Condnaion. 
Allison P. Winecoff, Robert J. Hariman, Jeffrey J. Grawe, Yonggao 
Wang, Henry S. Loeb, Patrick J. Scanlon, Jerry L Bauman, Univelliity of 
minois, Chicago, IL and Hines VA Hospital and Loyola Univelliity, 
Maywood,IL 
We have previously shown that sodium bicarbonate (NaHCO,) revellies 
the effects of cocaine (C) on ventricular conduction. Based on 
modulated receptor concepts, lidocaine (L), like C, has the greatest 
affinity for inactivated sodium channels and may revellie C slowing of 
conduction through competitive binding. The effects of Land NaHCO, 
in revelliing C-induced electrocardiographic (ECG) changes were 
compared in isolated, Tyrode-perfused guinea pig hearts. C (30 pM) 
increased PR interval from 73 ±9 to 87 ±24 msec; QRS duration from 
21:2 to 39±6 msec; and QTc interval from 36(l±15 to 408±15 msec (p< 
0.01). Addition of equimolar L (n=8) to C containing perfusate 
decreased QRS to 29±3 msec (p< 0.01), a revellial of 59%. In other 
preparations a similar effect was not observed when equimolar quinidine 
(which has affmity for activated sodium channels) was added instead of 
L Addition of NaHCO, to increase pH of the perfusate from 7.33&1 
to 7.S2±0.1 (p< 0.01) in 8 other preparations decreased QRS to 30±6 
msec (p< 0.01), a 47% revelliaI. L decteased the prOlonged PR and QTc 
intervals due to C, but this did not reach significance. ECG intervals 
after C remained consistently prolonged over time in 4 control 
experiments. Conclusion: L revellies slowed ventricular conduction due 
to C. The magnitude of this effect is similar to that due to NaHCO,. 
These findings support the concept that agents with fast-onifast-ofC 
kinetics like L can revelliC the effects of drugs with slow-onJslow-off 
properties such as C through competitive inhibition at a single receptor 
site on the sodium channel 
704·6 11:45 
Attenuation of Arrhythmogenic Effects of Cocaine by a 
Dopaminergic Antagonist Schering 39166 
Paul A. Guse, Prapti M. Kanani, William M. Smith, Allen Barnett, 
Everett H. Ellinwood. Duke University Medical Ctr, Durham, 
NC; and Schering·Plough Corporation, Kenilworth, NJ. 
Schering 39166 is a dopamine 1 receptor antagonist that has been 
shown to suppress the central compulsive drug intake effect of 
cocaine in primates. Because the drug could be used during acute 
cocaine ingestion, this study examined the effect of administering 
Schering 39166 during cocaine induced cardiac toxicity. In 14 dogs 
anesthetized with isoflurane, aseptic cardiovascular testing was 
performed after pretreatment with either Schering 39166 10 mg/kg 
or placebo for 5 days. Cocaine HCI was infused (0.25 mg/kglmin) 
and ventricular refractory periods were determined during cathodal 
pacing (300 ms) in which a 10 rnA S2 pulse of 5 ms duration was 
used. After testing, the animals were allowed to recover and the 
treatments were crossed over. Five days later, refractory period 
measurements were repeated. In addition, fibrillation thresholds ± 
1 rnA were determined during ventricular pacing at 300 ms by 
delivering a 10 ms S2 shock during the T wave of the ECG. The 
refractory period increased by 10% after cocaine and by 11% after 
cocaine plus Schering 39166 (p=NS). The fibrillation threshold 
decreased by 11 % after cocaine alone. hut increased 11.3% in 
those animals receiving cocaine plus Schering 39166 (p<0.05). 
Schering 39166 does not potentiate cocaine's depressant action on 
the heart caused by sodium channel blockade. Schering 39166 may 
antagonize the arrhythmogenic action of cocaine, although it is not 
certain if this antagonism is related to dopamine receptor blockade. 
Thus, Schering 39166 has the potential to be an important drug in 
the treatment of cocaine abuse because of its dual action to block 
both acute toxicological and chronic addictive effects of cocaine. 
ABSTRACTS 
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705·1 10:30 
Response of Automatic Ventricular Tachycardia to 
Adenosine 
Bruce B. Lerman, Neal Lippman, Erica D. Engelstein. New 
York Hospital· Cornell Medical Center, New York, New York. 
In contrast to adenosine's efficacy in reentrant 
supraventricular tachycardia involving the AV node, only one 
form of ventricular tachycardia (VT) has been shown to be 
adenosine-sensitive, that due to cAMP·mediated triggered 
activity. This form of VT also terminates in response to 
verapamil, carotid sinus pressure (CSP), and Valsalva. The 
action of adenosine in this VT is related to its antiadrenergic 
myocardial effects (decreases cAMP). We have also shown 
that reentrant VT is insensitive to adenosine. The effects of 
adenosine on catecholaminHependent automatic VT have 
not, however, been previously studied. Four consecutive 
patients who met criteria for automatic VT (1. induced with 
isoproterenol, 2. non-inducible with programmed stimulation, 
and 3. suppressed with B-blockade) were tested with 
adenosine during VT (150-300 I1gJkg). Patients ranged in age 
from 9·59 years. Three patients had sustained monomorphic 
VT; the other had polymorphic VT (cycle lengths 270·480 
msec). At doses sufficient to cause AV block, adenosine had 
no effect on VT cycle length or duration in 3/4 patients and 
transiently suppressed (5 sec) VT in the remaining patient. 
Verapamil, CSP, and Valsalva had no effect on VT. 
Conclusions: 1) adenosine either transiently suppresses or 
has little effect on automatic VT, and 2) the response of 
catecholamine-dependent VT to adenosine may be 
mechanistically significant since it should differentiate cAMP•
mediated triggered activity from automatic VT. 
705·2 
Prognosis in Patients with Idiopathic Ventricular 
Tachycardia 
10:45 
Jaswinder Gill, Philip Keeling. David Ward, A John Camm. 
St George's Hospital Medical School, London, UK 
The prognosis of ventricular tachycardia (VT) associated with 
a normal heart (idiopathic VT) remains unclear. This study 
examines the outcome in a cohort of patients with idiopathic 
VT which has been prospectively followed. 
Methods: All patients were entered into the study on the 
basis of a documented episode of VT and no evidence of 
underlying myocardial disease on standard 12 lead 
electrocardiograph, chest x·ray, standard 2 dimensional 
echocardiography and coronary angiography. Patients also 
underwent detailed investigations including 
electrophysiological study, cardiac biopsies, signal averaged 
ECG and detailed right ventricular echocardiography. The 
majority of patients had left bundle branch block·like 
morphology VT. 
Results: Eighty four patients were entered (49 males, mean 
age 36.7 1: 13.7 years, 35 females, mean age 39.3 1: 12.6 
years) into the study and mean length of follow·up was 33.3 
1: 20.6 months (range 1-69 months). There have been 2 
deaths in this group, in one following surgery for incessant 
VT and the other sudden death. In both. the patient had 
evidence of myocardial abnormality at cardiac biopsy (severe 
fibrosis in one and mild fibrosis in the other). There have 
been no deaths, to date, in patients with normal cardiac 
biopsies. 
Conclusions: Patients with idiopathic ventricular tachycardia 
have a good prognosis. The only deaths recorded in this 
series have been in patients with abnormal cardiac histology 





Relation between complex slgnal-averaged electrocardiogram analysis 
and reauHs of endomyocardial biopsy In patients with ventricular 
tachycardia and no apparent heart dlsea .. 
Piotr Kulakowski, Jaswlnder GDI, Krzysztof Blaszyk, Marek Malik, Michael J. 
Davies, Oavkl E. Ward, A. John Camm. St. George's Hospital, London UK 
Abnormal endomyocardial biopsy (EB) may klentify pts with idiopathic 
ventricular tachycardia (VT) at risk of sudden death or developing 
symptomatic cardiomyopathy. Time domain (TO) analysis of the slgnal•
averaged ECG (SAECG) has been shown In one study to be helpful in 
predicting the results of EB but the value of combined TO and frequency 
domain analysis of SAECG has not yet been examined. This study, therefore, 
applied conventional TO SAECG and two new frequency domain techniques, 
spectral temporal mapping (STM) of the terminal ORS, and spectral 
turbulence analysis (ST A) of the whole ORS complex to 67 pts with YT and no 
apparent heart disease (normal ECG, 20 ECHO, and chest X-rays) . 
ReauHs: Abnormal EB was present In 25 (37%) pts. TO SAECG was abnormal 
In 13 (52%) pts with abnormal EB vs 4 (10%) with normal EB (p=0.OOO4), and 
all TO Indices were significantly different In both groups. Of the STM indices, 
only the value of normality factor In the composite lead was significantly lower 
In pts with abnormal vs normal EB (43±29% vs 63±3O'16, p=0.013). and It 
was < 30% in 11 (44%) pts with abnormal EB vs 5 (12%) with normal EB 
(p=O.OO7). The STA was abnormal (score 2-4) In 12 (48%) with abnormal vs 8 
(19%) pts with normal EB (p=O.026). The performance of SAECG methods for 
identification of ots with abnormal EB Is shown below: 
T025Hz TD40Hz STU STA Any abnormal 
Sensitivity 40% 52% 44% 4B% 72% 
Specificity 95% 90% 88% 81% 69% 
Positive PA 83% 76% 69% 60% 58% 
NegativePA 73% 76% 73% 72% 81% 
Overall PA 75% 76% 72% 69% 70% 
ConclUSion: TO SAECG identifies pts with idiopathic VT and abnormal EB 
with high specificity and predictive accuracy. and therefore. may be used as a 
non-invasive tool for identification of pts at risk of sudden death or presenting 
in early stages of cardiomyopathy. When TO analysis Is combined with 
frequency domain results, sensitivity Is improved but specificity Is lower. 
705-4 11:15 
anne BI:anch Reent:zy: A Medmnism of SUstained Wide 
~ Q:mpl.ex TadJycardia in ~ with no st:ruct:ural. 
Heart Disease. 
ZalJDen Blarx:k, M:hanmad Jazayeri, Jasbir Bra, Anwer 
Dlala, sanjay Deshpanie, Masood Akhtar. Sinai samaritan 
Medic:al. Center, Milwaukee, Wi.soa1sin. 
Illndle branch reentrant ventricular tadlycardia (lIER-W) 
oo:::urs not in:frecpent:l.y in patients (pts) with 
stI:uctural. heart disease. AIIrJn; the 46 pts with 
sustained lIER-W, all bIt three had underlyin; dilated 
caJ:di.anyopatby or valwlar disease. 'lbese three 
patients presented with cardiac arrest, sync:qle, or 
palpitatiClls am urD!J:wnt elec:trqilysiologic 
evaluaticn, ncninvasive am invasive diagnostic cardiac 
evaluatial. No evidence of heart disease was foorxi in 
any of these pts. rurlng sinls rll;ythm, surface EO:; 
showed inb:aventriall.ar CXlI1ductial delay am the IN 
interval was prolcn;ed in all 3 pts (90, 100, am 75 
IIEE!C) • D.Ir"in; ventriall.ar extrastiDul.atial, sustained 
lIER-W with left (3 pts) am right (1 pt) bm:ll.e brardl 
block (B8B) lIDl:liIOlogy was imuoed. ktivaticn sequeroe 
of the His bm:ll.e am right bm:ll.e duI"in3 W was 
diagnostic: of BBR-W in each pt. In 1 pt with prior Em 
doalmented spa1I:aneals tadlycardia the same armythmia 
was n:plicated in the laboratory. catheter ablaticn of 
the right bm:ll.e brardl suooessfully aIxIlished BBR in 
all pts. D.Ir"in; 24 mnth follow-up period, all pts were 
asyaptaDatic with OCIIplete right B8B al EO:;. 
crNCI.ImCllS: 1. Prolcn;ed His-PUzKinje CXlI1ductial 
manifestin;J as rat-13pE!cific intraventricular oc:muctial 
may exist as an isolated cardiac al:n:mDal.ity. 
2. SUstained ventricular tadlycardia due to BBR can 
occur in the absence of structural heart disease, bIt 
not in the absence of diseased His-PUzKinje system. 
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Role of Silent Ischemia in Patients with Idiopathic 
Ventricular Fibrillation 
Rene H. Peters, Eric F. Wever, Richard N. Hauer, Etienne O. 
Robles de Medina; University Hospital Utrecht, The Netherlands. 
Recently a high incidence of coronary artery spasm (CAS) 
has been reported in patients (pts) with ventricular fibrillation (VF) 
and absence of overt heart disease. However, all pts with CAS had 
non-critical coronary artery lesions. Identification of CAS is 
important for therapeutic and prognostic reasons. We studied 11 pts 
with idiopathic VF. Age 18 • 58, mean 38 years. All pts had a 
completely normal coronary angiogram (CAG) and none had 
angina. Incremental doses of ergonovine (up to 0.40 mg i.v.) were 
used to test for CAS during continuous ECG monitoring. All pts 
were off anti-arrhythmic and anti-ischemic drugs. Endpoints: 1) 
attainment of maximum dose of ergonovine, 2) recording of ST 
segment shifts (> lmm) in at least 2 corresponding leads of the 
12-1ead ECG. A positive response was achieved in only I pt, with 
ST segment elevation in leads n, III and aVF, unaccompanied by 
chest pain but in association with nonsustained polymorphic 
ventricular tachycardia episodes. No complications occurred. 
Conclusion: Our findings suggest a low incidence of silent 
ischemia due to CAS in pts with idiopathic VF and a completely 
normal CAG. Higher incidence in other reports may be due to 
some form of coronary artery disease as manifested by non-critica1 
lesions on CAG. Nevertheless all pts with idiopathic VF should 
have ergonovine testing. 
705·6 11:45 
Idiopathic Ventricular Fibrillation: a Clinical Dilemma 
Silvia G. Priori, Martin Borggrefe, A. John Camm, Richard 
W. Hauer. Helmut Klein. Karl H. Kuck. Peter J. Schwartz. 
Paul Touboul. Hein J.J. Wellens. 
Steering Committee of the U-CARE. 
Prognosis of sudden cardiac death among individuals 
without cardiac disease remains uncertain. Usually. these 
patients receive long term therapy of unproven efficacy. 
We analyzed the case reports published in the literature 
since 1959 using Medline data bank: 125 cases were 
reported. The age range was 9-79 years; 60% of episodes 
occurred in the age group 20-45 years. about 70% in men. 
Electrophysiologic study showed inducible ventricular 
fibrillation (VF) in 12%. ventricular tachycardia (VT) in 
35% and no inducibility in 53%. Therapy was given to 95% 
of patients (pts) and included antiarrhythmic drugs. 
beta-blockers, and the implantable defibrillator (ICD). 
At follow up (range 0.2-14 years) 12 pts had died 
suddenly or had a successful defibrillation by ICD. The 
overall recurrence of major arrhythmic events was 21%. 
These data show that idiopathic VF (IVF) has a high rate 
of recurrence and that prognosis is not benign. A 
worldwide registry of IVF (U-CARE: Unexplained Cardiac 
Arrest Registry of Europe) has been implemented. it is 
open to any center willing to participate. and it is 
expected to provide a definitive'answer on the prognosis 
and management of pts with IVF. 
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Effects of CaptoprU on Post Myocardial Infarction Physical 
Working Capacity· SAVE Ancillary Trial 
L. Howard Hartley, Greg C. Flaker, Frank J. Menapace Ir., Steven 
Goldman, Lofty L. Basta, Peggy Hamm, Gervasio A. Lamas, Marc 
A. Pfeffer. Brigham and Women's Hospital, Boston, MA 
The SAVE study reported improved survival and reduced incidence 
of nonfatal cardiovascular events in patients on Captopril with 
ejection fractions :s;40% and no evidence of clinical congestive 
heart failure after infarction(MI). We tested 166 SAVE subjects on 
graded cycle ergometers at 2-6 (T-I), 10-14 (T-2), and > 22 months 
(T-3) after MI. T-l values of ~ uptake were near normal (17 
ml-kg·l·min·I ), and were not different between Placebo (P) and 
Captopril (C) groups (mil minute, mean ± SO). 
T-l 1-2 1-3 
P 1403±513 (n=84) 1499±519 (n=73) 1469±530 (n=72) 
C 1353±559 (n=77) 1429±675 (n=65) 1472±531 (n=72) 
In both groups a significant increase occurred from T-I to T-2, but 
not thereafter. Neither absolute values nor changes from baseline 
were significantly different between P and C. ExerciSe time, peak 
work load, and anaerobic threshold showed similar patterns. 
Although the ejection fractions were almost identical in P and C, 
they were slightly higher than other SA VE subjects (33 % and 31 % ). 
Irrespective of therapy, ~ uptake was consistently lower in subjects 
who died compared to survivors (-26%, p<.OI). Although low 
working capacity is associated with higher mortality, exercise values 
did not improve with prolonged administration of Captopril in this 
subgroup of SAVE participants. 
706·2 10:45 
Do Patients With High Baseline Functional Capacity Benefit 
From Cardiac Rehabilitation and Exercise Programs? 
Carl I. Lavie, Richard V. Milani, Chris Boykin. Ochsner Heart and 
Vascular Institute, New Orleans, LA 
Numerous studies have documented the benefits of cardiac 
rehabilitation and exercise training following major cardiac events, 
although many experts feel that this therapy is indicated only for 
patients with poor baseline functional capacity. We assessed data, 
before and after phase II cardiac rehabilitation and exercise programs 
at 2 large teaching institutions to determine the benefits obtained in 
163 patients (Group I) with high baseline exercise capacity (~ 6 
METs, mean 8.8 ± 2.4 METs) compared with 124 patients (Group II) 
with low baseline functional capacity « 6 METs, mean 4.6 ± 0.8 
METs). Although exercise capacity increased by 21 % in Group I 
(peak 10.7 ± 3.1 METs; P < 0.001), the relative increase was much 
more marked (+ 49%; p < 0.0001 between groups) in Group II (peak 
6.8 ± 2.2 METs; p < 0.00(1). Both groups demonstrated statistically 
similar improvements in most coronary risk factors, including body 
mass index, percent body fat, total cholesterol, high-density 
lipoprotein cholesterol (HOL-C) and triglycerides. However, 
patients with hi&!l..baseline exercise capacity had significantly greater 
reductions in both low-density lipoprotein cholesterol [LDL-C] (-4% 
vs no change; p <0.05) andLDL-ClHDL-C (-10% vs -4%; p <0.04) 
compared to patients with low baseline functional capacity. 
Conclusions; I) Although patients with low baseline functional 
capacity gain the most regarding increasing exercise capacity 
following cardiac rehabilitation and exercise training, those with 
high baseline exercise capacity show more significant reductions in 
major lipid risk factors for coronary artery disease, including greater 
reductions in both LOL-C and LOL-C/HDL-C;2). These data 
demonstrate the marked benefits of cardiac rehabilitation and 
exercise training in patients with preserved exercise capacity and 




Training Level Comparison Study: Effects of 
High and Low Level Exercise Training on Left 
Ventricular Ejection Fraction in Subjects 
With coronary Artery Disease 
Gerald F.Fletcher, Albert Oberman, Navin 
G.Nanda, Barbara J.Fletcher, Jeannette Y.Lee, 
Sandra B. Dunbar, Emory University, Atlanta, 
GA; University of Alabama, Birmingham, AL 
The effect of exercise training level on left 
ventricular ejection fraction (EF) was tested 
by randomizing 198 sedentary males with coro•
nary artery disease (x=53.8 yrs age and 8 mo. 
post event) to high (HTR) (85% V02max) and low 
(LTR) (50% V02max) exercise training groups. 
Subjects exercised at prescribed levels for 
60 min, 3/wk X 1 yr. EF was determined by 20 
echocardiography in a subset (n=105) pre and 
immediately post (~54 sec) exercise testing 
at entry and at 1 year. Baseline resting EF 
ranged 22-65%. At one year, beneficial ef•
fects were seen in subjects with depressed 
baseline resting EF (~50%,n=23) compared with 
subjects with normal baseline resting EF 
(>50%,n=82). The depressed EF group increased 
pre EF from (x~SE) 37.5~4.31 to 41.3~2.33 
(p<.05) with LTR and from 43.2~2.4 to 45.13 
~2.40 (p<.05) with HTR. The depressed EF 
group also significantly increased change in 
pre to post exercise EF(1.80~.74 to 4.53~.9l, 
p=.Ol) with HTR. No improvement was seen in 
subjects with normal EF at baseline. We con•
clude that both high and low level exercise 
training confers a beneficial effect on left 
ventricular EF in patients with coronary 
artery disease and depressed resting EF. 
706·4 
Training Effect Transfer: Documentation In Long 
Distance Runners 
Gary J. Balady, Ravin Davidoff, Denise Fine, 
Anne Dempsey, Thomas J. Ryan 
Boston University Medical Center, Boston, MA 
11:15 
The ability to transfer training effect from chronic 
lower body exercise to upper body work requires further 
study. To evaluate whether this occurs, 12 highly 
trained long distance runners (R) were compared to 
9 wheelchair racers (V) and 10 healthy controls(C). 
All subjects were male,and were also age- and 
weight-matched. No runners had engaged in arm training. 
Each subject performed arm ergometry exercise testing 
to exhaustion using expired gas analysis. Peak exercise 
data are: 
11 R C 
1I0rkrate(watts) 129+18 115+24 84+13+ 
V02(ml/kg/min) 31+6 31+6* 25+7 1I0rkrate/HET 15+2** 13+3 12+3 
HR(bpm) 180+10 155+15* 166+17 
BP (mmHg) 177+14 159+16* 166+13 
02 pulse (ml/kg/beat) 17+4 20+3* 15+5 
+C vs R & 11; *R vs C;-**l1 vs-R & C 








Thus: runners ,show a transfer of training effect to arm 
work achieving a higher peak workrate and V02 than 
controls, but at a lower HR. This may be due in part to 
their observed greater exercise stroke volume 
(02 pulse). Despite reaching a similar peak V02, 
mechanical efficiency (workrate/HET) during arm 





Vall Stress Remains Normal In Highly Trained Athletes: 
A Comparison Of Vbeelchair Athletes And Distance 
Runners. 
Ravin Davidoff, Denise Fine, Anne L Dempsey, Thomas J 
Ryan, Gary J Balady. Boston University Medical Center, 
Boston, Massachusetts 
It has been shown that highly trained runners have 
chamber dilatation and increased wall thickness. It is 
not certain whether this response also occurs after 
long-term arm exercise training. To evaluate and 
compare morphologic and functional cardiac changes in 
competitive arm-trained and leg-trained athletes, 
resting echocardiograms were performed on 7 wheelchair 
racers(V), 10 long distance runners(R) and 8 age, sex 
and weight matched controls(C). The athletes had 
trained routinely for 10+4 years. The following 
results were obtained where LVEDV is LV end diastolic 
volume indexed to body surface area, LVEF is left 
ventricular ejection fraction and LVM/LBM is LV mass 
indexed to lean body mass. 
R V C P 
LVEDV(ml/m2) 61+12 56+11 50+10 * 0.05 
LVEF(%) 58+6 58+6 57+6 NS 
LV mass(gm/m2) 102+27 91+18 71+12 I 0.03 
LVM/LBM(gm/Kg) 2.9+.7 2.8+.7 2.1+.4 I 0.05 
Stress (dyn/cm2) 166+61 154+80 167+73 NS 
*c vs. R; tc vs. R &-\1; 
Conclusion: Vbeelchair athletes have increased LV 
volume and LV mass (indexed to height or lean body 
mass) compared to healthy controls, but not to the 
same degree as that of runners. Despite these changes 
in cardiac structure, resting wall stress remains 
normal. 
706-6 11:45 
Structural and Functional Characteristics of Winter 
Olympian's Heart 
M. Bally, B.W. Choi, B. Dennis, B. Emonnot, M. Lewintre, 
M. Contard, B. Bertrand, A. Pigot, J. Machecourt. 
Albertville Hospital, Albertville and University of 
Grenoble, Grenoble, France 
Previous studies have indicated that many trained 
athletes showed significant increase in left ventricular 
diastolic dimension (LVDd) and LV wall mass. We studied 
34 male winter olympians, age 18 to 40 yrs (27±6), with 
Doppler and echocardiography during and right after the 
olympic games. Measurement of ventricular septum (VS), 
LV posterior wall (LVPW) , LVDd, LV systolic dimension 
(LVDs), and fractional shortening (FS) on 4 ice skaters 
(IS), 5 bobsledders (BS), 9 cross country skiers (CS) 
and 16 downhill skiers (DS) were: (*P<O.OOI **p<0.02) 
VS(cm) LVPW(cm) LVDd(cm) LVDs(cm) FS(%) 
IS 1.07±O.1. O.94±O.2. 5.6±O.1 •• 3.8±O.2H 3l±3 
BS 1.35±0.1. 1.18±O.2. 4.9±0.4 •• 3.3±0.3 35±3 
CS 0.92±O.I. 0.09±0.1. 5.2±0.6 •• 3.5±0.5 34±5 
DS 1.05±O.2 1.05±0.1 4.9±O.4 3.2±O.4 34±6 
4/4 IS (100%) had LV dilatation, 5/5 BS (100%) had LV 
hypertrophy, 2/5 BS (40%) had septal hypertrophy (SH), 
3/9 CS (33%) and 1/16 DS (6%) had LV dilatation. 1/9 
CS(U%) and 3/16 DS (19%) had SH. None of the atheletes 
with LVH or SH had reversed E/A ratio (Emax V: O.94±0.2 
mis, Emax A: 0.37±0.1 Mis). Thus, athletes who used 
more of isometric contraction of upper torso and 
extremities showed significant LVH. LV dilatation was 
noticed in those who used more of isotonic exercise of 
lower extremities. Regardless of these structural and 
functional abnormalities, all athletes had normal 
systolic and diastolic function. 
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Chronic Norepinephrine Infu810n Lead8 to a 
Selective Decrease In the a3 lsoform of the 
a Subunit of the Myocardial Na+/K+ATPase. 
10:45 
Paul F. Kelly, Tai-Hwang M. Fan, Joseph M. Delehanty, 
Yoshio HimlJ'a, William B. Hood Jr., Helen 8am, Chang-seng 
Liang, University of Rochester MecflCal Center, Rochester, NY 
Plasma levels of norepinephrine (NE) are characteristically 
elevated in congested heart failure (CHF). To determine if 
high circulating NE contributes to the downregulation of the 
myocardial ouabain binding site and Na+A(+ ATPase activity 
that we observed in dogs with experimental CHF, we exposed 
mongrel dogs to 8 weeks of chronic exogenous NE utilizing 
subcutaneous osmotic pumps (n~). Compared to control 
animals (n~) receiving saline infusion, [3H]ouabain binding 
sites were decreased in the NE pump dogs by 33% (mean ± 
SO; 8.39 ± 1.44 vs. 5.57 ± 1.08 pmoleslmg, p< 0.(01). To 
further examine if this downregulation is specifIC to any of the 
three known a isofonns of the catalytic subunit of the Na+IK+ 
ATPase in the heart. we perfonned Western blot analysis 
using monoclonal antibodies specific to each of the three a 
isofonns. Vllhile there was no significant effects on the a1 
isoform, NE infusion resulted in a 37% reduction in the as 
isoform using videocIensitometry (mean ± SO; 00 value 642 ± 
34 vs. 464 ± 123, p< 0.05). There was no a2 detected in 
either group. The data indicate that chronic NE exposure 
laoos to a selective decrease in the oJ isofonn similar to the 
reduction in ouabain binding sites. These results suggest that 
high circulatng levels of NE may play an important role in the 
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Chronic Exposure to High Levels of Circulating 
Norepinephrine is Associated with Reduction in Cardiac 
Neuronal Norepinephrine Uptake 
11:00 
Joseph M. Delehanty, Yoshihiro Himura, William B. Hood Jr., 
Chang·seng Liang, University of Rochester, Rochester, N. Y. 
We have previously demonstrated abnormalities of 
norepinephrine (NE) uptake by cardiac sympathetic nerves in the 
failing ventricle in congestive heart failure. To investigate the role 
of high circulating NE in the development of these changes we 
administered NE via sub-cutaneously implanted osmotic 
minipumps. Control animals received vehicle. Eight weeks later, 
we measured left ventricular (LV) dP/dt (mmHglsec), mean aortic 
pressure (AoP, mmHg), LV to body weight (BW) ratio 
(grams/kg), arterial NE concentration ([NE] .. ng/ml) and the rate 
constant of neuronal uptake of NE <KN, sec·l ) as measured by 










4.S9± 1.55* O.36±O.02 
O.30±O.06* 1.01±O.2l 
* p<O.05 vs vehicle 
Thus, KN was reduced by NE at sub-hypertensive doses. These 
results suggest that chronic exposure to high circulating levels of 
NE may be responsible for abnormalities of neuronal uptake 
function independent of hemodynamic changes or cardiac 
hypertrophy. 
707·4 11:15 
Role of Angiotensin II Type I Receptor on the 
Development of Heart Failure In Rats. 
Toshio Nishikimi, Takashi Ohmura, Tomoko Tani, Hiroyuki 
Yamagishi! Shiro Yanagi, Minoru Yoshiyama, Iku Toda, 
Kaname AklOka, Masakazu Teragaki, Kazuhide Takeuchi, 
Tadanao Takeda. 
First Department of Internal Medicine, Osaka City 
University Medical School, Osaka, JAPAN 
To elucidate the role of angiotensin II type I receptor 
on the development of heart failure, we produced 
aortocaval fistula(AVF) rats, volume-overloaded heart 
failure model, and after 3 weeks treatment of new 
angiotensin II receptor antagonist(AIIA) by TCV-116(1 
mg/kg/day), we evaluated hemodynamics, heart weight, 
and degree of cardiac dilatation. AVF rats were 
produced by a our new technique, a simple and rapid 18 
gauge needle multipuncture method. We also compared the 
effect of AlIA with that of angiotensin converty enzyme 
inhibitor(ACEI), delapril(l giL drinking water). 
SHAM AVF rats 
n ace 0 8 ace 0 8 CEI 8 A IA 8 
MA mmHg l2l± l18±2 103±3*+ 107±5*+ 
Shunt Ratio(%) --- 55±4* 65±4* 57±4* 
LVW(g/kgBWl 2.09±.04 3.00i.13* 2.52±.15*+ 2.53i.II*+ 
RVW(g/kgBW 0.59i.01 0.93±.05* 0.77i.06*+ 0.80±.04*+ 
LVEDP(mmHg) 4±1 12±1* 8±1*+ 8±1*+ 
RAP (mmHg) I.Oi.4 5.0±.6* 2.3±1.4+ 3.8±.6* 
RVSP(mmHg) 33±1 58±6* 46±3*+ 50±2*+ 
LVEDVI 0.7St.07 2.25±.14* 1.70i.17*+ 1.67±.15*+ 
Values are Means ± SE, *p<0.05 vs SHAM, +p<0.05 vs 
placebo AVF, LVW:Left Ventricle Weight, RVW:Right 
Ventricle Weight! RAP:Right Atrial Pressure, RVSP:Right 
Ventricle Systollc Pressure, LVEDVI:Left Ventricular 
End-Diastolic Volume Index 
There were no differences in shunt ratio between the 3 
groups. AVF heart failure rats produced by our new 
method were characterized by higher heart weight, 
intracardiac pressure and LV dilatation. AlIA 
similarly improved these hemodynamics as well as ACEI 
did. These results suggest that AlIA is as effective as 
ACEI on heart failure, and that angiotenSin II type I 
receptor play an important role on the development of 
heart fail ure . 
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Platelet Angiotensin II Receptors in S- Congestive 
Heart Pailure 
Hillel S. Ribner, Mark J. Zucker. Newark Beth Israel 
Medical Center and UMDNJ-New Jersey Medical School, 
Newark, NJ 
The physiologic effects of a hormone cannot be 
appreciated until the properties of its receptor are 
known. Although the renin-angiotensin system (RAS) 
is thought to be activated in CHP, circulating 
concentrations (concn) of angiotensin II (All) correlate 
poorly with hemodynamic variables in the CHF population. 
The vasoconstrictive effects of All are mediated via 
specific AT-l receptors on vascular smooth muscle 
which have been shown to be analogous to the more 
accessible AT-l receptors on platelets. Accordingly, 
platelet All receptor binding capacity (Bmax) 
(molecules/platelet) and hormone affinity (Kd) were 
measured by l25-I-All ligand techniques in 10 normal 
controls and in 8 untreated CHP patients managed by 












Receptor characteristics and All concns were 
statistically identical in the two groups. Analysis 
was consistent with a single receptor species. 
CONCLUSIONS: Normal plasma All concn and normal 
receptor Bmax and Kd suggest that RAS activity is 
not enhanced in untreated CHF. The reported 
dissociation between All concns and hemodynamic 
parameters does not appear to be explained by 
alterations in ~II receptor characteristics. 
707·6 11:45 
Elevated Plasma Concentrations of Endogenous Ouabain 
are Associated with Decreased Neurohormonal Activation 
Stephen S. Gottlieb, Michelle Weinberg, Catherine M. Krichten. 
Amy Rogowski. John M. Hamlyn. University of Maryland School ot 
Medicine. Baltimore. MD. 
Plasma concentrations of endogenous ouabain (a recently 
identified endogenous inhibitor of Na+-K+ ATPase) are elevated in 
patients with congestive heart failure (CHF). Furthermore, the 
ouabain concentration reflects the severity of CHF, being inversely 
related to the cardiac index (Circulation. 1992; 86:420). However, 
cardiac glycosides are known to directly affect production of various 
neurohormones, and the interaction between endogenous ouabain and 
these neurohormones is unknown. We therefore assessed plasma 
renin activity (PRA, ng/ml/hr), plasma concentrations of ouabain 
(OUA, nM). Angiotensin-II (A-II, pg/ml), atrial natriuretic peptide 
(ANP, pg/ml), norepinephrine (PNE, pg/ml), and aldosterone (Aldo, 
ng/d!) and ejection fraction (EF, by nuclear ventriculography) in 15 
stable patients with CHF who had not received ACE inhibitors or 
digoxin for> 30 days. Patients were grouped according to ouabain 
concentration: NML = normal ouabain « 0.8 nM) & HIGH = 
ouabain> 0.8 nM, where * = 0 < 0.05. 
I lnTOUAIA-1I PRAIANPIPNEIAldol EF 1 
INML 181 0.31 46 7.2 1377 1 510 1 71 1 28 1 
rHIGHTn 3.3*1 11* 1.7126112921121241 
Patients with HIGH ouabain tended to have a lower EF, 
consistent with the previously reported relationship of ouabain and 
severity of CHF. Rather than demonstrating the expected elevated 
concentrations of other neurohormones. however, these patients with 
HIGH ouabain exhibited decreased activity of the renin-angiotensin 
system & tended to have lower PNE and ANP. 
The detection of less neurohonnonal activation in patients with 
elevated plasma concentrations of endogenous ouabain than in 
patients with normal ouabain concentrations suggests that endo•
genous ouabain may directly limit production and release of other 
neurohormones. 
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Role of Transesophaqeal Echocardioqraphy prior to 
cardioversion in patients with atrial fi))rillation. 
Marcus F. stoddard, Rita A. Lonqaker, University of 
Louisville, Louisville, Kentucky 
cardioversion (CV) of atrial fibrillation (AF) is 
associated with a small, but significant risk of 
systemic embolic events. Thus, prophylactic 
anticoagulation for 3 to 4 wks prior to CV is standard 
clinical practice. Transesophagealechocardiography 
(TEE) is an accurate method of detecting and excluding 
left atrial (IA) thrombus. We examined the hypothesis 
that TEE could be used to determine the need for 
anticoagulation prior to CV of AF. TEE was done in 82 
pts mean age 63 ± 12 yrs (27-86 yrs) scheduled for 
elective CV of AF. In 66 pts without IA thrombus on 
TEE, CVwas done without anticoagulation a mean of 2.5 
+ 5 days (range 0-14) after TEE. No embolic events 
occurred over 3 wks of follow-up. 5 pts without IA 
thrombus on TEE underwent CV without embolic events 
after 3 wks of prophylactic anticoagulation. In 11 pts 
with IA appendage thrombus on TEE, CV was delayed. In 
7 of these pts, a 2nd TEE demonstrated resolution of 
thrombus after 2-3 months of anticoagulation and CV 
was done without complications. In 4 pts, IA appendage 
thrombus persisted despite 2-6 months of 
anticoagulation and CV was deferred. 
conclusions; TEE appears useful in identifying pts 
with AF who may safely undergo CVwithout prophylactic 
anticoagulation. TEE identifies pts in need of 
anticoagulation prior to CV. TEE may expedite the 
management of pts with AF prior to cv. 
708·2 10:45 
Risk Factors for Atrial Thrombus and Stroke In 156 Patients 
Undergoing Electrical Cardioverslon: A Multicenter Transesophageal 
Echocardlograpbic Study. 
Ian W. Black, Richard A. Grimm. Warren F. Walsh. Allan L. Klein, 
William J. Stewart, Andrew P. Hopkins, Lincoln C.L. Lee. Cleveland 
Clinic Foundation, Obio and Prince Henry Hospital, Sydney, Australia. 
Transesophageal echocardiography (TEE) has been used to detect atrial 
thrombi in pts undergoing electrical cardioversion of atrial fibrillation or 
flutter. However, the risk factors for atrial thrombi and embolism in this 
group have not been defined. We prospectively assessed the TEE results 
(biplane 69%) and outcome in 156 pts, age 63 ± 11 years undergoing 
cardioversion of atrial fibrillation (n= 120) or flutter (n=36). 
Atrial thrombi were detected in 12 pts (8%), comprising 10 left atrial 
(LA) appendage thrombi and 2 right atrial appendage thrombi. Atrial 
thrombus was associated with LA smoke (11/12 (92%) vs 621144 (43%), 
p=O.OOI), moderate or severe left ventricular (LV) dysfunction (6/12 
(SO%) vs 26/144 (18%), p=0.OO8), and the absence of moderate or 
severe mitral regurgitation (1112 (8%) vs 50/144 (35%), p=O.06). Atrial 
thrombus was not significantly related to rbythm, LA dimension, or 
anticoagulation. 
Cardioversion was deferred in all 12 pts with atrial thrombi, 1 pt with 
severe LA smoke and 3 pts who reverted spontaneously; and was 
successful in 114/140 pts (81%). Stroke occurred 24 hours after 
successful cardioversion in 1 pt (O.7 %) with atrial fibrillation, LV 
dysfunction and LA smoke who was not anticoagulated. Repeat TEE 
showed a fresh LA appendage thrombus and severe LA smoke. 
Conclusions: Atrial thrombi are detected by TEE in 7% of pts with 
atrial arrhythmias undergoing cardioversion, and are associated with LA 
smoke, LV dysfunction, and the absence of mitral regurgitation. Stroke 
may occur in nonanticoagulated pts despite screening by TEE, 
suggesting de novo thrombus formation after cardioversion. 
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Transesophageal EchocardioP"llphy Before and DuriII, Direct 
Current Cardiovenion of Atrial Fibrillation: Evidence for 
"Atrial Stunnln&" as a Mechanism of Thromboembolic 
ComplicatioDs 
Diane Fatkin, Dennis Kuchar, Charles Thorburn, Michael Feneley 
St Vincent's Hospital, Sydney, N.S.W .• Australia 
Transesophageal echocardiography (TEE) was performed in 40 
patienta (pta) with atrial fibrillation prior to electrical cardioversion 
(CV). and in 9 of these pta, during CV, in order to determine 
potential mechanisms of thromboembolic complications of the CV 
procedure. In each case, the left atrium (LA) was inspected for 
evidence of thrombus, or spontaneous echo contraat (SEC). which was 
graded from 0 (nil) to 4+ (severe) by 2 independent observers. 
Cardioversion was not performed in 3 pta due to: LA thrombus in 1 
pt, and pharmacological reversion in 2 pta. After CV, 32/37 pta had 
immediate restoration of sinus rhythm. Prophylactic anticoagulation 
was received by 23 pta before, and 21 pta after the procedure. 
Thromboembolic complications (TIE) occurred in 4 pta, none of whom 
were therapeutically anticoagulated, from 24 hours to 7 days 
following CV. There was no evidence of LA thrombus on pre-CV TEE 
in any of the pts with TIE. Neither the presence of LA SEC (12 pts), 
or LA dilation (31 pta) on pre-CV TEE distinguished those pta who 
developed TIE and those who did not. In the 9 pta who Wlderwent 
simultaneous TEE during CV. 7 pts had no SEC pre-CV. In 5 of 
these patients, new SEC developed within 5-10 seconds of the 
electrical discharge, and in 2 pta, SEC did not develop. One pt with 
1+ SEC pre-CV developed 4+ SEC. One pt with 2+ SEC pre-CV was 
unchanged. The extent of SEC formation was associated with a 
variable degree and duration of impairment of atrial contraction and 
bradycardia induced by CV: "atrial stunning". 
Conclusions: The TEE detection of LA thrombus is important, but 
infrequent. The occurrence of TIE in the absence of demonstrable LA 
thrombus and the new development of SEC in association with the 
transient atrial dysfWlction caused by CV suggest that the CV 
procedure may promote thrombus formation, in which case all pts 
should be fully anticoagulated at the time of CV. 
708·4 11:15 
Return or Atrial Function Postcardioverslon: Comparison Between Left 
Atrial Appendaie and Left Atrial Cavity Function by Doppler 
Transesophageal EcbcM:ardIography 
Allan L. Klein, Richard A. Grimm, Ian W. Black, Alexander S. Bailey, Yvette 
M. McQueen. Gerald 1. Coben, Gregory L. Pearce, 1ames D. Maloney, Lon 
W. Castle. The Cleveland Clinic FoUlldation, Cleveland, Obio 
Mitral valve (MY) atrial (A) flow velocity by Doppler ecbocardiograpby, a 
measure of left atriaI cavity function, bas been shown to return after successful 
canlioversion. Recently, left atrial appendage (LAA) function bas been assessed 
using Doppler TEE; however, the relationship between the return of left atrial 
appendase function and left atrial cavity function bas not been described. We 
performed pulsed-Doppler TEE of the LAA, pulmonary vein (PV), and mitral 
valve (MY) inflow in 42 patienta (mean "Be 64 .±. 1 I years) with atrial 
fibrillation (n-28) and flutter (na 12) immediately post eardioversion. We 
measured the LAA forward atrial ("a') wave velocity, PV atrial reversal (AR), 
and mitral valve (MV) A flow VEL. 
Left Atria! ApDeDdaG 
".- wave 








Posl..:ardioversion, left atrial appendage function, as shown by the appendage 
"a' wave, returned in 32 (76~) oftbe 42 pta, while left atrial cavity function, 
as shown by PV AR and mitral valve A velOCity, was detected in 34 (81~) and 
36 (86~) of pta, respectively. In 6 pis (14~), there was no evidence of either 
LAA or LA cavity function. A significant correlation was noted between the 
peak LAA 'a" wave and mitral valve A VEL (r=0.55, p=O.OO(6). There was 
no difference in return of atrial function between atrial fibrillation and flutter. 
Conclusion: Post-cardioversion, LA cavity function returns immediately in 
86 ~ of pta, while LAA function returns in only 76 ~ of pta, providing a 
potential milieu for thromboembolism. 
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Left Atrial Appendage Blood Flow In Atrial Fibrillation: Hs 
Influence on Thrombus Development In Mitral Stenosis 
Esteban G. Torrecilla, Miguel A. Garcia-Fernandez, Daniel San Roman, 
Hector Bueno, Juan L. Delc8n. Hospital General 'Gregorio Maran6n', 
Madrid, Spain 
Left atrial appendage (LAA) function has been suggested as an 
important determinant on thrombus development within this structure. 
To funher assess the factors that influence LAA thrombus formation in 
mitral stenosis (MS), we performed a transesophageal 
echocardiographic study (TEE) in 66 consecutive patients (P) with MS 
and the LAA blood flow was tested by pulsed Doppler interrogation at 
the outlet of that structure. The presence of LAA thrombus and both left 
atrial and LAA sponfaneous echocardiographic contrast (LASC, LAASC) 
were studied in each P. LAA thrombi were found In 12 P (18.2"10) by 
TEE. In the 19 P in sinus rhythm a characteristic pattern of LAA flow was 
noted with biphasic flow waves of filling and emptying and in none of 
them a thrombus wHhin the LAA was detected by TEE. In 17 of the 47 P 
(36%) with atrial fibrillation a characteristic LAA outflow velocity pattern 
wHh rapid LAA emptying and filling flow waves was recorded (Gr A), 
whereas in the remaining 30 P no identHiable LAA flow was documented 
(Gr B). The incidences of LASC, LAASC and LAA thrombi as well as the 
anficoagulant status of the P in both Gr were as follows: 
GrA GrB p< 
LAA Thrombus 0 12 0.02 
LASC 6 27 0.001 
LAASC 9 28 0.01 
Anticoagulation 8 21 ns 
There were no signHicant dHferences between both Gr wHh regard to 
age, mitral valve area and left atrial size. Conclusion: our results indicate 
that in P with MS, two dHferent LAA flow patterns can be recorded in 
atrial fibrillation. P with atrial fibrillation and active, identifiable LAA flow 
within LAA showed a lower prevalence of spontaneous 
echocardiographic contrast with absence of LAA thrombus, suggesting 
the existence of minimal fibrillatory contractions with mechanical efficacy. 
708·6 11:45 
CbaJ'acterization of Left Atrial Appendage Flow by Fourier Analysis: 
Application to Patients witb Atrial Fibrillation and Flutter 
Ricbard A. Grimm, AJIan 1.. Klein, William J. Stewart, James D. Maloney, Ian 
W. Black, James D. Thomas. Cleveland Clinic Foundation, Cleveland, Ohio. 
Measurement of blood velocity within the left atrial appendage (LAA) bas 
recently become possible with transesophageal cchocardiography (TEE), but the 
proper characterization of LAA mechanical function in the fibrillating appendage 
i. unknown, despite its clear implication for embolic risk. To better characterize 
LAA function, we have employed Fourier spectral methods in patients with atrial 
fibrillation (AF) and atrial flutter (AFl). Methods: Using mono- and biplane TEE, 
pulsed Doppler recordings were obtained from I em inside the mouth of the LAA. 
Four-second datasets were digitized at 2 msec intervals and Fourier transformed to 
yield the velocity power spectrum from .2S Hz to SIlO Hz. After normalization for 
total power, spectra were compared for AF and AFl in the range 0 to SO Hz. 
Results: For 10 patients (S AF, S AFl) peak velocities were not significantly 
different (42 cm/sec), but spectral •. J,--------,---., 
patterns WOJe markedly different 
(Figure). AF patients diaplayed a '.J>. 
highly organized sinusoidal velocity 
pattern with a single dominant peak 
at 6.7±0.9 Hz, (mean±S.D.) but 
with significant subharmonic 
modulation at 1 - 2 Hz. SO" of 




spectral power wu between 6 and 8 .... 
-.II •• UI ..... 
.. -
Hz. Velocity in AFl patients was &..IJ"",,'n'biIf.~.80."",,:,:~~=---! 
much purer harmonically, ' II " JO 
diaplaying only peaks at 4.1 ±0.3 """"'91HzI 
Hz and 8.1 ±O. 7, with a small subharmonic at 2.1 ±O.I Hz. SO" of power was 
between 3.S and S.O with hisher and lower frequencies significantly suppresaed 
relative to AF patients. There wu no significant modulation of the AF velocity 
by the contraction of the ventricle. Conclusions: I) Left atrial Velocity shows 
organized contraction patterns, even in AF. 2) AF is characterized by a higher 
dominant frequency and increased spectral contamination than AFl. 3) Fourier 
analysis is a sensitive method to define frequency and regularity of contraction in 
the LAA and may be of help in defining LAA mecbanicaI function. 
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Favourable Outcome of Luminal Narrowing After Dilatation of 
Chronic Stent Restenosis Compared to Initial Stent Implantation 
Michael Haude, Raimund Erbel, Hassan Issa, Monika Herber, Jiirgen Meyer. 
2nd Medical Clinic, University Mainz, Mainz, Germany. 
Although the immediate post-procedural luminal gain is improved after 
intracoronary stenting the late luminal loss is more pronounced compared 
to PTCA. In order to investigate the results of initial gain and late loss after 
balloon dilatation of chronic stent restenosis (group AI we calculated 
minimal luminal diameter (MLDI before and after PlCA and at 6 months 
follow-up (FU) in 19 patients (ptsl by quantitative coronary angiography. 
Results (mean ± standard deviationl were compared to 105 pts with 
uncomplicated implantation of 112 Palmaz-Schatz stents (group BI and to 
33 pts with conventional PlCA (group CI who were matched for anamne•
stic, procedural and angiographic variables: 
initial gain: 
MLD(post Intervention) • 
3 MLD(pre Intervention 
late loss: 
MLO(post intervention) • 
MLO(6 months FU) 
3 
C v.,..ua A or B: p<O.001 B v .... u. A or C: p<O.01 




Thus, dilatation in chronic stent restenosis provides a similar initial luminal 
gain compared to the previous stenting procedure. In contrast to the 
stenting procedure late luminal loss was significantly lower in these pts 
suggesting a fibrointimal proliferation comparable to conventional PleA. 
709·2 10:45 
Clinical And Angiographic Outcomes or Native Coronary 
Stenting With Single Palmaz·SchatzTM(PS) Stents. Update 
or U.S. Multicenter Experience. 
Alexander Shaknovich, Scott M. Lieberman, Jeffery W. Moses 
Lenox Hill Hospital, Section of Cardiology, New York, NY. 
962 delivery attemplS of single PS stenlS in native coronaries of fJrSt 
953 consecutive pIS in U.S. Multicenter Trial resulted in successful 
stent delivery in 949 pIS (success rate 99.5%1 pt, 97.8%1 attempt). 
79.9% of pts were male. Mean age was 58.8 yrs (range: 31·88). In 
68.1 % of pIS, the target lesion represented a restenosis after prevo 
PTCA('s); the mean number of prevo PTCA's was l.81pt (range, 1-5). 
Mean target vessel diameter was 3.2mm. With current anti-coagulation 
protocol, acute «= 24hrs of implantation) stent thrombosis occurred in 
1 pt Subacute (>24hrs post implantation) stent thrombosis occurred in 
40/949 (4.2%) pIS, resulting in death (lpt) or non-fatal MI (12pts) or 
CABO with (2pts) or without MI (13pts) in 26/949 (2.7%) pts. 
Vascular complications required transfusions (22pts), surgical repair 
(46plS), or both (12pts) in 801949 (8.4%) pIS. Mean post-implantation 
hospital stay was 6.0 days. Non-consecutive angiographic follow-up 
(>= 4 mos after stenting or showing restenosis (RES» at mean of 8.7 
mos in 684/908(76%) eligible pIS showed RES at >=50% of luminal 
diameter in 27.0% and at >=70% of luminal diameter in 17.0% of pIS. 
In vessels >= 3.Omm in diameter, RES rate (>=50% of luminal 
diameter) for ~ lesions was 17.7% compared to 28.7% for prevo 
PTCA RES (p<.05). Of 145 (89%) pIS with stent RES for whom data 
on subsequent management are available, 27 (18.6%) were treated with 
re-PTCA, 70 (48.3%) with CABO, and 48 (33.1 %) medically. 
Implantation of a single PS stent resulted in freedom from major 
complications (MI, death, re-PTCA, CABO) related to PS stent at the 
time of angiographic follow-up in 77.2% of pIS. CONClliSIONS: 
1) Stenting of discrete native coronary artery stenoses with single PS 
stenlS on the current anticoagulation protocol remains a safe and 
effective treatment strategy, but requires a relatively extended post•
procedure hospital stay. 2) Apparent favorable impact ofPS stent on 
RES in pts with discrete ~ coronary stenoses in vessels >= 
3.0mm in diameter awaits corroboration in ongoing randomized trials. 
30A ABSTRACTS 
709·3 11:00 
Intracoronary Thrombosis Prior to Stenting: Impact on 
Angiographic Success and Clinical Outcome 
W Carter Grinstead, Albert E Raimer, David A Churchill, John T 
Hays, Neal S Kleiman, Jane Joseph, William D Voorhees, Neal Fearnot, 
Gary S Roubin, Barry S George, Cass Pinkerton, Spencer B King, for 
the Cook Stent Investigators, Baylor College of Medicine, Houston TX 
The presence of thrombus has been considered a relative 
contraindication to intracoronary stenting (IS). The importance of pre•
stent thrombosis (pST) was determined from a registry of SOO pts 
receiving Gianturco-Roubin flexible coil 20 mm stents for acute or 
threatened closure after PTCA. Angiographic evidence of PST was 
present in 139 pts (28 %). The PST group had a greater incidence of 
males (81% vs 66%), emergency cases (52% vs 37%) and stented 
bypass grafts (11 % vs 6%) than the no PST group (all P < .05), but age, 
ejection fraction, and incidence of multivessel disease were not different. 
All pts received heparin (PTT >2.5 x control), then Coumadin (PT 
>18 sec). Angiographic success «50% residual with TIMl grade ill 
flow) occurred in 96% of PST and 98% of no PST pts (p=NS). 
Immediate post stent thrombosis was detected in 12.2% of PST and 
7.5% of no PST pts (p=NS). In-hospital clinical success (no death, MI, 
or CABG) occurred in 83% of PST and 89% of no-PST pts with 
angiographically successful stent deployment (p=NS). Cumulative 
adverse clinical events at 6 month follow-up in all stented patients were 
not different between the two groups: 
Death, 
Group N Death CABG MI CABG or MI 
PST 139 5 (4%) 21 (15%) 10 (7%) 35 (25%) 
No PST 361 13 (4%) 60 Cl7%) 27 0%) 87 <24%) 
Thus, PST does not appear to significantly contribute to adverse clinical 
events following Gianturco-Roubin stent implantation and aggressive 
antithrombotic therapy. As such, PST per se should not be considered a 
contraindication to IS. 
709·4 11:15 
Clinical and Angiographic Results of the Pilot Phase of the Benestent Study 
Peter De Jaegere, Patrick W. Serruy', Ferdinand Kiemeneij, Marie A. Morel, 
Victor Legrand, Guy Heyndrickx, Bernard de Bruyne, Paul vande Heuvel, 
Frank vanden Brande, Pierre Matterne, Jean Bolland, Hans Bonnier, Serge 
Doucet, Jean Fajadet, Jean Marco, for the Benestent Study Group. 
The Benestent Study is a multicenter randomized study comparing stent 
implantation versus balloon angioplasty in pts with stable angina and a de novo 
lesion in a native coronary artery. Between June and December 1991, 60 
consecutive pts (40 male, mean age 57 ± 11 yrs) were randomized: 33 to 
PfCA and 27 to Palmaz-Schatz stent implantation. The baseline demographic 
and angiograpbic characteristics were similar in both groups. 
In I PTCA pt, a bail-out steht was implanted because of dissection. In 5 stent 
pts, the stent could not be implanted: 3 crossed over to PfCA, 1 to elective 
CABG aod 1 to medical therapy. The clinical events during hospital stay and 
follow-up were analyzed according to the intention to treat principle and ranked 
according to the highest category on a scale ranging from death (PfCA 0, stent 
1), CVA (PfCA I, stent 0), AMI (PfCA I, stent 2), bail-out stentlCABG 
(PTCA 5, stent 4), re-PfCA (PfCA 7, stent 1). The 6 mth event and symptom 
free survival was 67% after stent implantation and 54% after PTCA. 
A total· of 54 of the 58 pts (93%) treated had repeat angiography at 5.3 ± 1.9 
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The difterence in MLD at FU between stent and PlCA group was 0.28 mm 
(95% CI:-O.IS - 0.7). The incidence of restenosis according to the SO% OS 
criterion was 30% and 47% after stent implantation and PfCA, respectively. 
Conclusion: 1) nl~re is no difference in the occurrence of clinical events at 
follow-up between ster.1 impl3lltation and PTCA. 2) The incidence of restenosis 
was lower following stenting. These results have encouraged the investigators 
to proceed with the d~fi,J!e study. 
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Mid·Term Follow-up After Wiktor-Stent Implantation for 
Prevention of Restenosls 
W Burger, Tvd Krieken, P de Jaegere, M Bertrand, N Oanchin, 
J Dyckmans, M EI Gamal, J-J Goy, P Labrunnie, J Puel, W 
Rutsch, PW Serruys, R Uebis, M Vrolix, V Wiegand, G Kober. 
Leuven (B), Aachen, Berlin, Frankfurt, Gottingen, Homburg 
(0), Ulle, Nancy, Toulouse (F), Eindhoven, Rotterdam (NL), 
Lausanne (CH) for the European Wiktor-Stent Study Group. 
Elective implantation of a single Medtronic Wiktor stent was 
attempted for the prevention of restenosis in native coronary 
arteries of 119 patients. Previous restenosis had occurred 
once in 72 patients, twice in 39 patients, and three times in 8 
patients. Implantation was preceeded by conventional PTCA 
and was successful in 117/119 patients (98 %). The 
anticoagulation drug regimen consisted of dextran, heparin, 
aspirin, and coumarin. 
Acute stent occlusion occurred in 4/117 patients (3 %). 
Subacute stent occlusion developed between day 3 and day 
14 after implantation in 9/117 patients (8 %). This resulted in 
myocardial infarction in 4/4 patients after acute, and in 6/9 
patients after subacute stent occlusion, necessitating 
emergency bypass surgery in 2 patients (2 %). 1 patient (0.9 
%) died during the 6-month follow-up period (not stent 
related). Bleeding complications were encountered in 24/117 
implanted patients (21 %). While angiographic 6-month follow•
up, performed in 110/117 patients (94 %), revealed restenosis 
in 41 of 110 patients (37 %) (restenosis criterion: diameter 
stenosis >50 %), only 18 of these 41 patients showed clinical 
signs of restenosis. 
Conclusion: Clinical symptoms do not reliably indicate 
restenosis after stenting. The restenosis rate after implantation 
of the Wiktor stent seems to be similar to conventional repeat 
PTCA. Together with the high risk of acute and subacute stent 
closure. stenting is currently not recommended as a first step 
measure for the treatment of restenosis. 
709·6 11:45 
Restenosis and Long-Term outcome Following Successful 
Coronary stent Implantation 
Serge Doucet, Jean Marco, Jean-Baptiste Caillard, 
Gabriel Robert, Bernard Cassagneau, Jean Fajadet. 
Clinique Pasteur, Toulouse, France 
Between March 89 and January 92, 462 patients (pts) 
underwent success full Palmaz-Schatz coronary stent 
implantation. Angiographic follow-up obtained in 372 
pts (81%) and in 385 stented vessels at a mean of 147 
± 54 days (range : 28-339 days), showed overall 
restenosis rate of 23.4% (90/385 vessels) and 20% 
after single stent implantation. Multivariate analysis 
identified multiple stent implantation (p<O.OOOl) , 
final stent diameter :s 3.25 nun (p~0.0002), chronic 
total occlusion (p=0.0111), concentric lesion 
(p=0.0205) and unstable angina (p=0.0234) as predictor 
of restenosis. Stenting of de novo lesion was also a 
predictor of less restenosis rate (p=0.0152). 
Clinical follow-up was ·obtain in 440/462 pts (95%) at 
a mean of 18 ± 4 months (range: 6-36 months) and 317 
pts (72%) were event free. Major events occurred in 
123 pts (28%) : 99 pts (22.5%) had reintervention 
(CABG : 20%, PTCA : 80%), 10 pts (2.3%) had myocardial 
infarction and 14 pts (3.2%) died (8 pts or 1.8% from 
cardiac death). 
Conclusion : 
1) Angiographic restenosis rate after coronary 
stenting is low and seems lower compare to historical 
reported rates after PTCA. 
2) The two strongest independant predictors of 
restenosis after coronary stenting are multiple stent 
implantation and final stent diameter :s 3.25 mm. 
3) Long term clinical outcome is encouraging with more 
than 70% event-free pta at 18 months fOllOW-Up. 
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850·106 
Factors Influencing Outcome With Coronary Rotational 
Ablation: Multicenter Results 
Michael J. Cowley, David Warth, Patrick L. Whitlow, David 
Kipperman, Maurice Buchbinder. Medical College of Virginia, 
Richmond, VA 
In order to evaluate indications for coronary rotational 
ablation (PTCRA), we analyzed results in 1362 lesions in 1362 
patients treated with the Rotablator at 20 centers. Mean age was 
62 yrs, 72% were male, 40% had prior MI, 16% had prior 
bypass surgery (CABG), 41 % had unstable angina, and 64% 
had multivessel disease. Overall success rate was 95% 
(1291/1362). Univariate analysis by gender, age, extent of 
CAD, lesion location, prior CABG, and angiographic 
characteristics such as eccentricity, tortuosity, calcification, and 
stenosis length or severity showed no effect on procedure 
success rate. Complications included Q wave MI in 0.9%, non•
Q MI in 4.6%, urgent CABG in 2.1 %, and death in 0.8%. 
Analysis of angiographic characteristics showed that 
calcification, eccentricity, tortuosity, lesion length, and initial 
stenosis severity had no effect on rates of MI, urgent CABG, or 
death. Bifurcation lesions were associated with a higher rate of 
Q wave MI, (2.2% vs 0.6%, p< .05) and calcified lesions 
showed a trend for higher Q wave MI rate (1.5% vs 0.4%, 
p=.lO). Eccentric lesions showed a trend for higher urgent 
CABG rate (2.7% vs1.2%, p=.IO). 
Thus, procedure success with coronary rotational ablation is 
not affected by baseline clinical or angiographic factors. Major 
complications are infrequent and bifurcation lesion was the only 
angiographic factor identified as a predictor of complications 
with the Rotablator. 
850·107 
Lack of Graft Age Dependency for Success of Directional Coronary 
Atherectomy and PaImaz-Schab Stenting 
Alaa E. Abdelmeguid, Stephen G. Ellis, Patrick L. Whitlow. Raoul Bonan, 
Wanlin Yeh, Daniel Diver, Richard Schatz, Tomoaki Hinohara, Eric J. Topol, 
Donald S. Bairn and the NACI InvestigatolS. 
The Cleveland Clinic Foundation, Cleveland, Ohio 
To evaluate the results of directional coronary atherectomy (DCA), and Palmaz•
Schatz stenting (PSS) in revascularization of old (>36 months) and new (:>36 
months) saphenous vein grafts (SVG), we analyzed all patients in the NACI 
registry treated with these devices for SVG stenosis. Comparisons were made 
between old & new SVG within each device group. There were 117 PSSs in old 
& 21 in new SVG (106 & 18 patients, respectively). The respective numbelS for 
DCA were 110 & 28 lesions (94 & 23 patients). For each device, baseline 
characteristics including EF, unstable angina, multivessel disease and reason for 
revascularization were similar for old vs new SVG. Lesion morphology for old 
vs new SVG was also similar within each device (including diffuse disease, 
thrombus, eccentricity, vessel size and % stenosis before treatment). Within each 
device group, lesion success, device success and residual stenosis after treatment 
were similar for old vs new SVG. In hospital complication rates (death, Q-Ml and 
emergency CABG) were also similar for old vs new SVG within each device 
group. 6-week follow-up was reached in > 80% of patients, and 6-month follow 
up in >60%. Cumulative 6-month event rates were; 
Directional Atherectomv Palmaz-Schatz Stents 
Old New Old New 
N (patients)= 66 14 62 11 
Death 2% 14% 2% 0% 
MI 6% 14% 3% 0% 
Angina 50% 36% 39% 45% 
Repeat-revascularization 24% 21 % 16% 27% 
Conclusions; The preliminary results of this multicenter study of DCA and PSS 
suggest similar acute procedural results and acute complication rates for old vs 
new SVG. These results suggest that for SVG stenoses with similar morphologic 
characteristics, aging of the graft does not seem to increase the complication rate. 
These results appear to contrast with the significantly WOISC results with PTeA 
in old SVG, and are therefore encouraging. 
ABSTRACfS 
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A Quantitative Analysis or Factors Affecting Late Angiographic Outcome 
After Rotational Coronary Alherectomy 
Jeffrey J. Popma. Lowell F. Saller. Augusto D. Pichard, Kenneth M. Kent. YC 
Chuang, Gary S. Mintz. Alan J. Merritt. Micheal B. Keller, and Martin B. Leon. 
Washington Hospital Center, Washington. DC 
To identify the factors affecting late angiographic outcome after rotational 
coronary atherectomy, we followed 210 consecutive patients undergoing 
successful rotational atherectomy over an l8-month period. Clinical follow-up 
(FU) was obtained in 206 (98%) patients 8.6±4.3 months after the procedure and 
repeat arteriography was perfonned in 152 (72%) patients. Cineangiograms were 
reviewed using quantitative angiographic methods and minimal lumen diameters 
(MLD) and % diameter stenoses (%DS) were detennined from serial stodies. In 
112 (74%) lesions. adjunct balloon PTCA was perfonned. In these lesions. % 
stretch = [(mean diameter of the largest adjunct balloon - preMLD)/reference 
diameter] x 100 and % recoil = [{mean diameter of the largest adjunct balloon -
postMLD)lreference diameter] x 100. Acute gain was defined as the postMLD•
pre MLD. Late lumen loss was detennined from the postMLD - FU MLD. 
Restenosis was defined as ~ 50% stenosis at FU. After rotational atherectomy. 
%DS was reduced from 72±12% to 25111% (p < 0.(01) and MLD increased from 
0.67130 10m to 1.78±O.37 mm (p < O.OOl)(acute gain 1.11±O.39 mm). During the 
RJ period. recurrent symptoms developed in 95 (46%) patients: %DS increased to 
52±25%; MLD fell to 1.16±0.64 mm (late loss = 0.62±0.65 mm). Restenosis 
developed in 79 (52%) lesions; late loss was ~ 0.72 mOl in 60 (39%) lesions. 
Reference Diameter (mm) 
Pre % Diameter Stenosis 





















Late loss was directly related to postMLD (R = 0.285; p = 0.(01). Restenosis was 
not related to the residual %DS or postMLD. We conclude thai I) restenosis may 
develop after rotational atherectomy. related to the magnitude of early lesion 
stretch and recoil and 2) restenosis appears independent of the effects on residual 
lumen diameters noted in larger vessels. 
850-109 
Rotational Atherectomy for Aorto-Ostial and Branch•
Ostial lesions. 
Evelyne Goudreau, Michael J. Cowley, Germano 
DiSciascio, David DeBottis, George W. Vetrovec, Nagui 
Sabri. Medical College of Virginia, Richmond, VA 
Coronary angioplasty (PlCA) of ostial lesions is 
associated with a lower success rate and higher 
complication rate. We report our experience in 
treating 31 aorto-ostial and branch-ostial lesions 
using Rotational Atherectomy (RA). Success rate was 
97% (30/31 lesions) with reduction of stenosis from 
71% to 32% after RA alone. Adjunctive PlCA was used 
for 21 lesions (68%) and Atherectomy (DCA) for 3 
lesions (10%). RA-related complications included 1 
small non-Q infarction, 2 mild intimal dissections and 
1 occlusion with aneurysm formation. 
#lesions %PRE %Post RA 
Overa 11 31 71% 32% 
RA a lone 7 70% 35% 
RA + PlCA 21 70% 31% 
RA + DCA 3 81% 33% 
lesion characteristics* 
Aorto-ostial 6 77% 
Branch-ostial 25 70% 
De novo 18 73% 
Restenosis 13 69% 
Calcified 9 76% 
Noncalcified 22 69% 
Eccentric 21 70% 
Concentric 10 73% 






















Thus Rotational Atherectomy is a highly effective 
treatment for aorto-ostial and branch-ostial lesions. 





Directional Atherectomy For Treatment of Restenosls WHhln Coronary 
Stents: Anglographlc: And Histologic: Results 
Bradley H. Strauss. Robert J. van Suylen. VICtor A. Umans. Donald C. 
MacLeod. Jean Marco. Gregory C. Robertson. Bemard De Bruyne. Jean 
Renkin. Pim J. de Feyter. Patrick W. Serruys. Erasmus University. Rotterdam. 
Netherlands. 
To study the histo-pathological events alter coronary stenting and the 
efficacy of directional atherectomy for restenosis within a stented coronary 
segment. 9 patients (Pts)(10 procedures) underwent atherectomy 47-1179 
days post stanting. The immediate post atherectomy resuH was similar to the 
Initial resuH alter Slenting (2.31±O.38 mm vs 2.44±0.35 mm. p=NS). In 5 pts 
with follow-up 44-131 days post atherectomy. 3 pts had restenosis (DS>50%) 
requiring reintervention. 
The stent restenosis tissue was studied for presence of intimal hyperplasia. 
smooth muscle cell (SMC) phenotype. cell prolneration markers and cell 
density. A control (non-stented) group consisted of 13 patients who had 
restenosis tissue removed by atherectomy 14-597 days following PTCA. 
atherectomy or laser. Intimal hyperplasia was identified in 80% of stent 
specimens and in 77% in the control group. No unique tissue features could 
be attributed to a specific procedure. 8/8 stent specimens stained strongly for 
SMC specnic o-actin. In 3 stented pts (47-143 days post stenting). 75% of 
intimal cells had morphologic features of a contractile phenotype by electron 
microscopy. 6/S post stent samples and 5110 controls were exposed to anti•
PCNA antibody (prolnerating cell marker) and all were negative. AHhough 
large individual variability exists in the maximal cell density of the intimal 
hyperplasia. there was a trend toward a reduction in cell density over time. 
Conclusion: Atherectomy is safe to use for restenosis in coronary stents. with 
excellent initial resuHs, but restenosis still limits late effectiveness. Intimal 
hyperplasia is a non-specific response to injury regardless of device and 
accounts for 80% of cases of restenosis. SMC proliferation and phenotypic 
modulation towards a contractiie phenotype are early events and largely 
completed by the time of clinical presentation of restenosis. 
850-111 
Effects of ACE Inhibitors in Human Arteriosclerotic Lesions: Evidence 
From Cell Culture Studies With Atherectomy Specimens 
Gerhard Bauriedel, Jiirgen Heimerl, Petra Heidemann, Reinhard Kandolf, 
Berthold Hofling. Dept. of Internal Medicine I, University of Munich, FRG 
Animal models have shown that ACE inhibition results in a significant 
reduction of intimal hyperplasia following vascular injury. However, the 
underlying cytobiologic events are still poorly understood and it is 
questionable, whether these results are applicable to humans. The purpose 
of this study was to evaluate the effects of ACE inhibitors on human 
vascular smooth muscle cell (SMC) proliferation and migration. Coronary 
and peripheral plaque specimens were obtained from 67 patients treated 
by percutaneous atherectomy. SMCs were cultivated by explant 
outgrowth and enzymatic disaggregation, respectively. A retrospective 
study of cell culture and clinical data revealed that incidence of SMC 
outgrowth was not affected by patient medication such as aspirin, 
nitrates, ~-blockers, Ca-antagonists or antilipid drugs. However, plaque 
tissue originating from 10 patients previously treated with ACE inhibitors 
showed a significant (p<O.05) decrease of this parameter. To analyze basic 
cellular processes contribUting to tissue explant outgrowth, proliferation 
and migration of isolated SMCs were studied. SMC proliferative activity 
was assessed by growth curves quantitating population doubling rates 
(PDR). Addition of the ACE inhibitor benazeprilat (10" M - 10"' M) had no 
effect on SMC PDR. Concordantly, migration analysis performed with a 
standardized computer-assisted video system (Circulation 1992;85:554) 
did not reveal modulation of SMC migration velocity by benazeprilat at 
the concentrations indicated above. Parallel results were obtained for 
ramiprilat and trandolaprilat. 
Conclusion: Our data demonstrate that ACE inhibitors induce no direct 
effect on SMC proliferation and migration. As suggested by the apparent 
discrepancy between the two experimental models used, effects on the 
extracellular matrix may be postulated, with a subsequent stabilization of 
the local balance between cellular and non-rellular plaque components. To 
achieve anti-arteriosclerotic effects in patients, a standard ACE inhibitor 
dose may be sufficient, however, a pretreatment period seems to be 
necessary. 
850-112 
JACC Vol. 21, No.2 
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Directional Coronary Atherectomy In Patients With Recent 
Myocardial Infarction: A NACI Registry Report 
Ziyad M.B. Ghazzal, Tomoaki Hinohara, Neal A Scott, Donald 
S. Baim, Robert D. Satian, Nancy Fishman, Spencer B. King, 
III. Emory University of Cardiology, Atlanta, Georgia 
The use of directional coronary atherectomy (DCA) in patients 
with a recent myocardial infarction (MI) compared to patients 
who never suffered an MI has not been reported. Thus we 
analyzed two groups of patients from the NACI regis~. 
Group I consisted of 147 patients who suffered an MI (Q or 
non-Q wave) within 30 days prior to attempted treatment with 
DCA. Group II consisted of 438 patients attempted with DCA 
who never had an MI. Patients in Group I had a lower ejection 
fraction (49% vs 61 %, P <0.(01). Also, a thrombus was more 
often identified at baseline angiography in Group I (19 % vs 
5.5 %, P < 0.(01) but lesions were less often calcified than in 
Group II (9% vs 18%, p <0.05). Lesion ulceration and severity 
were more frequent reasons for DCA attempt in the group with 
MI cr' d fll! recent omVlIcations an success rates were as 0 ows: 
Grou I ...!iT01!I!lI uValue 
Dissection 1211]1 lleslOns 7. ~ ~eSlOns_"l.lS'!I <0.05 
Abr. Closure lSIl7 4.7% ~90 1.2% <0.05 
Embohzatio 4 7 .l.47D 4/4~l .8% NS 
QMI,CABl 
or Death 5/147pts 3.4% 51438 pts 1.1% NS 
C~mlcal 
Success 122/147 83% 387/438 88.4% <0.1 
In the group with recent MI, clinical success rate increased from 
77 % for DCA attempted 1-9 days post MI, to 90 % and 95 % 
when the procedure was8.erformed 10-19 days and 20-30 days 
post MI resJlectively (p= .07) Conclusion: (I) DCA in patients 
post recent MI achieves less favorable results than in non-MI 
patients (2) There is a trend of an improved success rate with 
Increasing time interval post MI. 
850-113 
Mechanisms of Luminal Enlargement from Directional 
Coronary Atherectomy: Vessel Stretching or Plaque 
Removal? 
Gregory A Braden, Michael A. Kutcher, Thomas R. Downes, 
Richard A Kerensky, David M. Herrington, The Bowman Gray 
School of Medicine, Winston-Salem, NC 
Although directional coronary atherectomy (DCA) removes 
atherosclerotic plaque, the relative contribution of tissue removal 
and vessel stretching to luminal gain remains unknown because 
previously the vessel wall could not be assessed both prior to and 
then following DCA Accordingly, using intracoronary 
ultrasound (ICUS) imaging, luminal area, vessel area, and plaque 
area were measured, both prior to and following successful DCA 
at the site of severe stenosis in 39 lesions from 37 patients. 
Luminal area increased from 2.33+0.04 mm2 to 6.58+0.30 mm2 
(p<O.OOOI). Plaque area decr~ed from 14.47±0.60 mm2 10 
10.96±0.57 mm2 (p<O.OOOI), accounting for 81 % of the luminal 
gain (atherectomy effect) while vessel area increased from 
16.78±0.60 mm2 to 17.52±0.62, mm2 (p<0.OO4). Luminal gain 
occurred solely from the plaque reduction in 22 (56%) lesions, 
from vessel stretching in 5 (13%) and a combination of both in 12 
(31%). Eccentric lesions by ICUS were more commonly 
associated with plaque reduction (p=0.06). 
Conclusion: Luminal enlargement from DCA occurs primarily 
from plaque reduction via a likely mechanism of actual tissue 
removal. Vessel stretching also occurs and is the sole mechanism 
in a minority of lesions. 
JACC Vol. 21, No.2 
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850-114 
Directional Coronary Atherectomy for the 
Treatment of Unstable Angina 
Gregory C. Robertson, Tomoaki Hinohara, James W. Vetter. 
Matthew It Selmon. Bruce J. McAuley, Dennis J. Sheehan, 
.Jacqueline H. Lee, Jeffrey P. Gress, John B. Simpson. Sequoia 
Hospital and the Pacifk Foundation for Cardiovascular 
Research, Redwood City, CA 
Thp. purpose of this study was to evaluate the outcome of 
directional c()ron .. ry atherectomy (DCA) among patients 
(pts) \"ith unstable angina (U/A) compared with pts with 
stable angina (S/<\). Consecutivl'!y, -157 pts for 552 primary 
ksions in native arteries treated by DCA were examined. Of 
these, 214 pts (47%) had a history of UI A; accelerating 51 %, 
new onset 40%. post lvIl 11 %, prolonged 26% and rest pain 
72%. The outcome of DCA was compared with 243 pts with 
S/A. 
S/A U/A pvalue 
DCA success 89% 85% n.s. 
OCA/JYI'CA success 96% 92% n.s. 
CABG 2.5% 5.6% 0.1 
Mi CK elevation 11.5% 18.7% 0.02 
Q. wave 0% 1.4% n.s. 
In hospital occlusion 0.7% 2.4% 0.2 
Among the type of UI A, accelerating angina and prolonged 
angina were associated with a poorer outcome: 
Success rate p CABG P 
Accelerating angina (+) 83% 8.7% 
Acceleratjnll aogiruU.:l 88% M. 2.5% 0.01 
Prolonged angina (+) 77% 11.1% 
Prolonged angjna 8 89% om 3.0% 0.01 
In conclUSion, the success rate of DCA was not significantly 
altered by the presence of UI A, however there was a higher 
incidence of CK elevation and a trend for higher CABG rate 
among U/ A pts, particularly for those with accelerating or 
prolonged angina, than among SI A pts, 
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851-84 
Efficacy of Coronary Stents in the Treatment of Refractory 
Rest.enosis Following Balloon Angiopiasty 
Michael Savage, David Fischman, Martin Leon, Richard Schatz, Paul 
Teirstein, Donald Bairn, Sharon Gebhardt, Stephen Ellis, Sheldon 
Goldberg. Jefferson Medical College, Philadelphia P A. 
The long-term effectiveness of balloon angioplasty is diminished when 
repeated PfCA procedures are required for recurrent restenosis. The 
goal of this multicenter study was to assess the utility of intracoronary 
stents in the management of restenosis refractory to conventional 
PfCA. The study population consisted of 40 consecutive patients 
treated by single Palmaz-Schatz stent implantation for lesions which 
recurred after 3 or more prior PfCA (mean 3.3 prior procedures). The 
major endpoints were angiographic restenosis at 6 months and clinical 
events at 1 year follow-up after stentplacement. There were 30 men and 
10 women with a mean age of 60 years (range 38 - 72). Vessel location 
included 15 left anterior descending, 8 left circumflex, and 17 right 
coronary arteries. Follow-up coronary angiography was performed in 
90% of patients (36 of 40) at a mean of 6.2 months, and quantitative 
coronary analysis was performed at a core laboratory. Angiographic 
restenosis (diameter stenosis ~ 50% ) occurred in 10 of 36 stented sites 
(28%). Clinical events at 1 year follow-up included 0 deaths, myocar•
dial infarction in I (2.5%) patient due to stent thrombosis, coronary 
bypass surgery in 2 (5%) patients, and repeat angioplasty in 4 (10%). 
85% of patients (34 of 40) remained free of any adverse clinical events 
1 year after stenting. Therefore, intracoronary stenting is effective in 




Lp(a) Correlates with Restenosis After PfCA. 
Bryan Donohue, David Lasorda, Esmond Barker, Richard Begg, Diane 
Vido, Francis Ergina, Dennis Incorvati, Tony Farah, Demetrious Sgoutas . 
Allegheny General Hospital, Medical College of Pennsylvania, Pittsburgb, 
PA. 
To evaluate the correlation between serum Lp(a) and restenosis after PfCA, 
fasting serum was prospectively obtained from 8S patients undergoing 
diagnostic catheterization within one to six months following successful 
PTCA. Patients on antihyperlipidemic medication were excluded. All 
cineangiographic measurements were made with electronic digital calipers. 
Restenosis was defmed as present if luminal di-.ter was >SO". The SS 
restenosis ( + RS) patients were similar to the 30 no restenosis (-RS) patients 
with regard to demographic and clinical features. The + RS group had a 
greater post-PTCA residual lesion (25.7") than did the -RS group (19.3 "), 
p=Ol. Mean values of the lipid analysis are displayed. 
-RS +RS p value 
Total Cholesterol 1965 187.2 NS 
HDL Cholesterol mgld! 30.7 31.1 NS 
Triglycerides mg/dl 166.S 191.8 NS 
Apo Al mg/dl 111.6 109.9 NS 
ApoB mgldl 132.8 127.8 NS 
Lp(a) mg/dl 14.8 39.2 0.001 
Using logistic regression analysis, only serum Lp(a) (p=O.04) and the 
degree of residual lesion post-PTCA (p=0.030) were independent predictoIll 
of restenosis. CONCLUSION: Increased serum Lp(a) strongly correlates 
with restenosis following PTCA. 
851-86 
An Intensive Poly-Pbannaceutical Approach to the Prevention or Restenosis: 
The Mevacor, Ace Inhibitor, Colchicine (BIG-MAC) Pilot Trial 
Mark S. Freed, Maureen A. Safian, Robert D. Safian, Denise E. Jones, William 
W. O'Neill, Cindy L. Grines, William Beaumont Hospital, Royal Oak, Michigan 
Restenosis trials involving sinilie-agent pharmacotherapy have failed to show a 
consistent, significant reduction in intimal thickening following PTCA. This may 
reflect the multi-mechanistic nature of restenosis. To determine patient (pt) 
tolerance and clinical efficacy of a combination of drullS directed at different 
mechanisms, we employed mevacor (2040mll bid) to lower cholesterol and impair 
DNA synthesis, enalapril (2.5mll bid) to block Angiotensin II stimulation of 
cellular proliferation and colchicine (0,6mg bid), an antimitotic agent which arrests 
cell division. Combination therapy was administered prior to PTCA (mean, 7.8 
days) and continued untit the lime of follow-up angiography (mean, S.l + 1.3 
mos). PTCA was performed in SO pis on 69 lesions located in the LAD (28"), 
LCX (31 %), RCA (38") and SVG (15"). Complex lesion morphology (Type 
B or C) was present in 71 ". Procedural success «SO" stenosis without death, 
MI or emergent CABG) was achieved in 96". Serum cholesterol levels decreased 
from 225±49 mg/dl at baseline to IS8±37 pre PTCA (p<O.OOl) and remained 
low at follow-up (179±37). Four (8") pts were not compliant with medications 
and I pt stopped mevacor due to liver function abnormalities. Quantitative 
analyses of lumen dimensions were performed using electronic calipers. 
Reference Minimum Lumen Vessel 
Segment (nun) Diameter (nun) Stenosis (") 
Baseline 2.62±0.68 0.7S±0.SO 71±17 
Post-PTCA 2.S8±0.S8 1. 87±0.S3 27±16 
Follow-up 2.89±0.86 I.S3±0.82 49±21 
Restenosls, deiine<i as an mcrease m lameter stenoSIS trom <JUlI> post-l' I l.OA 
to >SO" at follow-up, occurred in 47" of lesions. Using the Thoraxcenter II 
definition of > 0.72nun loss, the restenosis rate was 33 ". Conclusions: Although 
combined administration of mevacor, enaIapril and colchicine is well tolerated, 
angiographic restenosis rates do not appear to be favorably affected by this 




Initial Lesion Eccentricity Predicts Restenosis After Suceessful 
Coronary Angioplasty. 
Ezra Deutsch, Richard S. Gerber, Jack L. Manin, James A. Burke, 
Willam G. Combs, Michael Moran, Alfred A. Bove for the M-HEART 
Study Group. Temple University School of Medicine, Philadelphia, PA 
Lesion morphology directly impacts on the longterm success of 
coronary arterial remodelling after PTCA. To evaluate the contribution 
of initial lesion eccentricity to longterm outcome after successful 
PTCA, we examined quantitative angiographic data from 122 pts who 
were enrolled in a prospective, mullicenter restenosis trial. Each pt 
underwent elcelive follow-up angiography of the dilated artery at 6 
months unless clinically indicated repeat angiography was performed at 
an earlier time. Quantitalive coronary angiography was performed by 
our core laboratory. TIle eccentricity of the vessel wall at the site of 
stenosis was assessed from pre- and post-intervention and late 
angiograms using a computer-based edge detection system. Changes in 
the morphology of each side of the vessel wall were separately assessed 
based on changes in the standard deviation of the radius of curvature 
(SOC) averaged across the stenotic wne. An eccenlricity index (E) was 
generated from a ratio of the SOCs of the opposing vessel walls. This 
technique permits evaluation of lesion eccentricity independent of the 
course of the arterial segment in space. Restenosis (R;n=24) or no 
restenosis at 6 months (n=76), and early restenosis groups « 6 
months;n=22) were defined. Minimum luminal diameters (MLD) are 
expressed in mm. We observed: 
E Pre ELate MLD Pre MLD Post MLD Late 
No R 10.8 ± 1.8. 9.2 ± 2.5 0.5 ± .03 2.03± .07 1.86 ± .07+ 
R 33.7±17.4 2.4±0.4# 0.4±.07 1.88±.12 J.I3±.13 
EarlyR 16.6±8.4 5.1 ± 1.3 1.2±.08A 1.7l±.16" I.31±.1 
• p=.03 R vs No R;#p=.04 R vs Early R;Ap<.OOIEarly R vs R and No 
R;"p<.OS No R vs early R +p<.OOI No R vs R and Early R. 
Proximal arterial dimensions and stenosis lengths were similar in the 
three groups. Conclusions: Initial lesion eccentricity predisposes 10 
rcstenosis 6 months after successful PTCA. Restenosis occurs in a 
concentric fashion. Early restenosis was observed in patients with 
larger initial mean MLD and Significantly less acute gain post-PTCA. 
851-88 
Prevention of Restenosis after Percutaneous Transluminal 
Coronary Angioplasty by LDL-apheresis: LDL-apheresis Angio•
plasty Restenosis Trial (LART) 
Hiroyuki Daida, Hiroshi Yamaguchi, Hisashi Yokoi, Tatsuji Kanoh, 
Shizuo Ishiwata, Kenichi Kato, Hideo Nishikawa, Fumimaro Takatsu, 
Yasunori Kutsumi, Nobuhiro Yamada, Juntendo University and the 
LART Group, Tokyo, Japan 
A high lipoprotein(a) (Lp(a» level was indicated as a risk factor for 
restenosis (RS) after angioplasty. LDL-apheresis(LA) using a dextran 
sulfate cellulose column has been shown to be an effective method for 
reducing Lp(a) as well as LDL-cholesterollevel. To investigate the 
efficacy of LA on the prevention of RS, LA was performed in 54 pa•
tients 2 days before and 5 days after angioplasty. In 29 out of the 54 
patients, Pravastatin and Niceritrol were combined with LA (drug•
apheresis combined group). As a control, we evaluated the RS rates in 
the patilmts who did not receive LA (n=137, non-LA). RS was de•
fined as a recurrent luminal stenosis of more than 50% in a previously 
dilated segment 5 months after the procedure. Eighteen of the total 54 
patients (33.3%) showed RS on at least one site. In the drug-apheresis 
combined group, RS occurred in 9 out of 29 patients (31.0%). The RS 
rate in non-LA was 38%. RS rates were analyzed according to Lp(a) 
reduction rates and Lp(a) levels before LA. In 33 patients, whose 
Lp(a) levels were reduced by 50% or more, the RS rate was signifi•
cantly less than that observed in 21 cases with Lp(a) reduction rate 
less than 50% (21.4% vs 52.4%, p<O.OS). In the 33 patients, 20 pa•
tients whose Lp(a) levels before LA were greater than 30 mg/dl (high 
plasma Lp(a» had RS rate of 15.0%, while the RS rate of high plasma 
Lp(a) subjects in non-LA (n=43) were 48.8%(p<O.05). These results 
suggest that the sufficient reduction of plasrr,a Lp(a) is important 
factor determining the RS possibilities after angioplasty and LA is an 
effective method to prevent RS after angioplasty in high Lp(a) sub•
jects by reducing plasma Lp(a) level. 
851-89 
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EARLY DECREASES IN MINIMAL LUMEN DIAMETER AFTER PTCA 
ARE ASSOCIATED WITH HIGHER INCIDENCE OF LATE RESTENOSIS. 
Alfredo Rodriguez, Miguel Larribau, Omar Santaera, Ricardo Sarmiento, 
Nestor Perez Balino, John Newell, Igor Palacios. Anchorena Hospital, 
Buenos Aires and Massachusetts General Hospital. Boston, MA. 
The relationship between early (24 hours) changes in minimal lumen 
diameter (MLO) and late (6 months) restenosis was determined in 110 
consecutive patients (pt) who underwent successful PTCA of 126 lesions. 
MLO and percent diameter stenosis (OS) were measure by quantitative 
coronary cineangiography before PTCA, immediately post, 24 hours after 
and at 6.4±1.2 months after PTCA. 
Late restenosis, defined as ~ 50% stenosis at 6.4±1.2 months follow-up 
occured in 42 (33.3%) lesions. However, if 12 lesions with total occlusion 
identified at 24hours are excluded, late restenosis occured in 30 (26%) of 
the rest 114 lesions. From this later cohort of 114 lesions, the 30 lesions 
with late restenosis had a significantly greater decrease in MLO at 24 
hours than the 84 lesions without restenosis (-Q.3±0.06 mm vs -0.05±O.03 
mm, p<O.OOO1). The corresponding decrease in OS at 24 hours was also 
significantly greater in lesions with restenosis (-9.8±1.8% vs -1.9±0. 78%, 
Jl<O.OOOO5). 
Similar relationship between late restenosis and changes in MLO and OS at 
24 hours were present when the definition of restenosis of loss of 0.7 mm of 
the initial gain in MLD at follow up was used. With this definition 30 (26%) of 
the 114 lesions had late restenosis. They had a significantly greater 
decrease in MLO at 24 hours than lesions without restenosis (-Q.27±0.06 mm 
vs -0.06±O.03 mm, p<0.0016). The corresponding decrease in OS at 24 hours 
was also significantly greater in lesions with restenosis ((-8.7±1.8% vs 
-2.44±O.8%, P<O.OO3). 
Thus, decreases in MLO occuring during the first 24 hours after successful 
PTCA are associated with a significantly higher incidence of late 
restenosis. 
851-90 
Long-Term Histologic Patency After PTCA is Predicted by the 
Creation of a Greater Luminal Area Immediately After PTCA 
Andrew Farb, James B. Atkinson. Renu Virmani. Armed Forces Institute 
of Pathology. Washington, DC 
Angiographic measurement of lumen size after PICA has not been a gOOd 
predictor of late success or failure. This limitation may be due to 
inaccurate lumen assessment by angiography. To test the importance of 
true lumen Size and variability of neointima formation, morphometric 
measurements were made in 18 postmortem coronary arteries. from 16 
patients, that had undergone PTCA a mean of 73 weeks antemortem 





Acute Lumen Area= 
Neointima+Fmal Lumen 
The luminal area immediately 
following PICA (acute lumen 
area) was determined by the 
sum of the final lumen and 
neointima. A final lumen area 
>25% of the area enclosed by 
the internal elastic lamina 
(IEL) was considered a long•
term successful PTCA and 
S25% a failure. 
RI:il!.I.IS (Mean:l:SD): ~ EaiIl!re. 
Acute Lumen AreaIIEL (%) 47±Il 31±12 p<.OOI 
Plaque (mm2) 4.5±2.0 6.6±3.4 p=.05 
Neointima (mm2) 1.3±1.0 1.9±1.1 p=NS 
Plaque eccentricity did not affect outcome. The amount of neointima 
formation was not significantly different in successes and failures and was 
independent of plaque quantity or arterial size. Conclusion; Since 
neointima was not significantly different in successes and failures, the 
creation of a larger luminal opening immediately after PTCA, as a percent 
of the original lumen size, was the more important predictor of long-term 
patency. A strategy that can assess true lumen size as a function of arterial 
size (e.g .. intravascular ultrasound) may help predict long-term patency 
afterPTCA. 
JACC Vol. 21, No.2 
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851·91 
Pre-Angioplasty LaiOD Morpbology: A Case 01 Dimmwbing Etreet On 
Survival ? 
Donald F. FoniD. CharlOite L. Nelson. Laura H. GardneI-. Frank Harrell Jr .• David 
J. Frid. James E. Tcheng. Harry R. Phillips. m. Roben M. Califf. Daniel B. 
Marlt. Richard S. Stack. Duke University Medical Center. Durham. NC 
Baseline pre-angioplasty (PTCA) coronary lesion morphology bas been shown to 
predict short term adverse outcomes SIlCh as abrupt cloSllre and death, but there is 
little information about the value of these factors for predicting long·term 
outcomes. To examiDe the potential impact of baseline lesion morphology on 5 
year survival. 934 patients undergoiDg first-time PTCA to a native coronary 
anery were randomly chosen from a cohon of 2191 undergoiDg PTCA at our 
iDstirution between 4/1/86 and 6130/89. BaseliDe clinical variables and long-term 
annual follow-up information were prospectively entered iDto the Duke 
Cardiovascular Databank. Procedural and follow-up angiograms were reviewed 
by 2 experienced angiographers and iDdividual descriptors comprisiDg the 
AHN ACC Class were recorded. Inclusion of lesion descriptors iD previously 
described SIlrvival models determiDed by multiple logistic regression analysis 
revealed h ~II .. d de . [ teo owm2 m eoen nt prognostIc actors: 
Variable '12 p 
Ejection Fraction 30.4 0.0001 
Extent of CAD 19.6 0.0001 
History of CHF 7.8 0.005 
Age 7.9 0.005 
Comorbid Illness 8.7 0.003 
CliDical Presentation 6.8 0.009 
AHNACC Lesion CJass 0.15 0.69 
. . .. 
No iDdivldual lesIon descnptor compnsmg the AHNACC score contaiDed 
independent prognostic information usiDg either univariate or multi variable 
analysis. 
Conc\usioo: Once the short term consequences of PTCA become manifest. the 
contribution of lesion mosphology iD predicting long-term survival is far less 
imponant than routiDely collected clinical variables. We found no evidence of a 
significant association between long-term survival and baseliDe lesion 
morphology. 
851·92 
Acute Gain Predicts Late Loss After PTCA Independent of 
Proximal Arterial Dimension. 
Ezra Deutsch, James A. Burke, William G. Combs, Alfred A. Bove 
for the M-Heart Study Group 
Temple University School of Medicine, Philadelphia, PA 
We have previously observed that patients undergoing PTCA of 
lesions with minimum luminal diameters (MLD) < 0.5 mm have a 
significantly higher incidence of restenosis (R). To determine 
whether there is a relationship between a proximal reference arterial 
dimension (P), MLD, and the likelihood of restenosis, we examined 
quantitative angiographic data from 496 pts who were enrolled in a 
prospective, multicenter restenosis trial. Each pt underwent elective 
follow-up angiography of the dilated artery at 6 months unless 
clinically indicated repeat angiography was performed at an earlier 
time. Quantitative coronary angiography was performed by our 
core laboratory. Data are presented as mean ± sem, in mm. We 
observed: 
prePTCA MLD 0.59 ± .02 
post PTCA MLD 2.08 ± .03 
Follow-up MLD 1.46 ± .03 
P 2.86± .03 
Acute Gain 1.49 ± .03 
Late Loss 0.63 ± .04 
Net Gain 0.86 ± .04 
These serial changes in MLD were significant (p<.OOI). Regression 
analysis demonstrated a linear relationship between initial acute 
gain and subsequent late loss (R=O.49;p<.OOI). Larger acute gains 
were observed in pts with smaller MLDs (R=O.46;p<.OOI). 
However, there was no correlation between net gain and initial 
proximal dimension. Restenosis (>50% narrowing at PTCA site) 
occured in 43.7% of patients. Conclusions: Acute gain does predict 
late loss after successful PTCA. The extent of late loss is 
independent of proximal arterial diameter. The likelihood of 




RecoIl TWWIIy F_ HoIn at. Coronary Angloplally: a ComputarlDd 
Anglogrllphlc Study 
Jean-Marc I..abIanche on behalf of the FAC.T. 1nYeaIIgatcn. University of 
UIe. France 
It has been suggested !hal delayed eIaatIc racoI may contribute to the 
phenomeilOll of restenotlla !hal 0CCUI1I In some patients after initially 
SI.ICC888fU coronary angloplasly (PTCA). 
The FACT study Is a doubl&-bllnd randomized comparIeon of fraxiparlne, a 
1oN-moIecuIar weight heparin derivative, ___ placebo, administered 
sutIc:WneouaIy for 3 months In the pr8Y8I1IIon of restenoaIs after PTCA. 
Computerized anglographlc measurements with an edge detection program 
are performed In a core centre on anglograma obtained before, Just after, 
and at 3 months after the procedure. In addition, aM patients undergo, by 
protocol, a comoI angiogram 24 hours after PTCA. To minimize the effects 
of changes In vasomotor tone, Isosorbide dlnilrate (1 mg) Is given before 
each angiogram. In the IIrst 123 patients enrolled 138 segments were 
SI.ICC888fUIy dlated. 
Mean proxlmaI diameter (SEM) was 2.89 (+/- O.05)mm before PTCA, 2.90 
(+ /- 0.05) mm Just after PTCA and 2.96 (+ /- 0.05) mm 24 hours after PTCA. 
Mean distal control diameter was 2.66 (+ /- 0.05) mm before PTCA, 2.67 
(+ /- 0.05) nvn Just after PTCA, and 2.74 mm (+ /- 0.(6) 24 hours after PTCA. 
MInlmaI lumen diameter Increased from 0.81 (+ / - 0.03) mm to 1.75 (+ /-
0.04) nvn after PTCA (p < 0.(01). Mean minlmaIlumen diameter at 24 hours 
1.71 (+ / - 0.05) nvn was not sIgnlflcanlly different from ITINn diameter Just 
after PTCA. However, In the 19% of st8l10888!hal were eccentric (stenotic 
lumen appearing to lie In the outer quarter of the adjacent normal lumen In 
one view) before PTCA the change In minimal lumen diameter, ~.18 (+/-
0.07) nvn was sIgnificantly greater (p<0.01) than In stenoses (81%) !hal 
were concentric, 0.02 (+/- 0.03). Percent stenosis diameter was 37.7 (+/-
1.1) % after PTCA and 39.8 (+ / - 1.3) % at 24 hours (p < 0.02). 
The degree of recoI Is significantly greater In eccentric stenoses 24 hours 
after SI.ICC888fU angloplasly. However the mean severity of residual stenosis 
Irlcr'aaa. only marginally during thls time. Therefore delayed elastic recoil Is 
unlikely to play a significant role In restenosls after angIopIasly. 
851-94 
Using Clinical Outcomes To AS5ess New Interventional Dmas 
Paul C. Gordon, Richard E. Kuotz, Steve.n P. Friedrich, Robert N. Piana, 
Aaron D. Kuaelmass, C. Michael Gibson, Goorae Y. Paik, David J. Cohen, 
Joseph P. Carrozza, Donald S. Baim. Beth Israel Hospital, Boston, MA. 
Newer devicee for coronary interve.ntion tax traditiOlla/ evaluation techniques. 
High _ of onpognpbic follow-up are needed to reduce biu from incomplete 
ascertainment, but are difficult to obtain. It is thus altnctive to consider clinical 
follow-up u on alternative outcome. We therefore evaluated cUnical outcomes 
iD 566 (99") of 567 pts treated by directional atherectomy (DCA, n=275) or 
Palmaz-SCbatz stentinS (S, n=292), and compared them to angiographic data 
available iD 349 (79") of 443 successful procedures eligible for 6 month 
follow-up. Multivariable models related clinical outcomes [eve.nt free survival 
(death, MI, or revascularization; EFS), repeat revascularization of target vessel 
(RTV), early .:ve.nts < 8 months post-procedure (EEV)] or ongiognpbic data 
[follow-up " stenosis, (FU"), binary restenosis (BR)] /0 post-treatment 
diameter (PLD), diabetea (DM), or number of di-..ed coronaries (CADI). 
PLD (p-value) DM CADI 
Model Y!Ii M!!l!i l.lJIi M!!l!i l.lJIi M!!l!i 
EFS (eve.nt free) .17 .en7 <.001 .002 .001 <.001 
RTV (target revasc).OOS .001 .003 .001 .39 NS 
EEV (early eve.nts).OO6 .01 < .001 .002 .f17 NS 
FU" (" stenosis) <.001 <.001 .003 .003 .01 NS 
BR (binary resten) .002 .003 < .001 < .001.23 NS 
Anpograpbic e.ndpoints (FU" and BR), u well as clinical endpoiDts (RTV 
and EEV) were each associated with PLD ond DM, but DOl CAD#, by 
multivariable analysis. While EFS was associated with both DM ond CAD#, 
however, it was 110/ associated with PLD uotil adjustment for CAD# and DM. 
Multiple regression demonstrated EEV (p= .(03) and RTV (p= .001), but DOl 
overall EFS (p=.35) to be iadependent determinants ofBR or FU". 
CondlBiODS: 1) Anpognpbic endpoints (FU" or BR) are determined 
principally by PLD and DM, reflecting target vesael outcome. 2) Overall 
freedom from clinical eve.nts (EFS), however, is also determined by OM and 
CAD#, reflecting disease at other silea. 3) For clinical endpoiDts to parallel 
angiograpbic endpoints, EEV, RTV, or overall EFS adjusted for the iDcidence 
of DM ond CAD# must be used. 4) Clinical follow-up th.e.n constitutes an 




Which P.rt or the Anglographlc DI.meter Reduction After Balloon Dilation 
.. due to Intimal Hyperpl .... ? 
Mar1I Post, UeselOl van Erven, Evelyn VaIema, Mohamed Bentala, CorneIiua 
Bent, Heart Lung Institute, University Hospital Utrecht, Utrecht, The 
Netherlands. 
Intlmal hyperplasia OH) is considered to be a major detenninant cI 
restenosls. However, the quantitative contribution of IH to lumen reduction 
Is unclear. To assess this contribution, we compared angiographic lumen 
reduction with histologic IH. Twenty four non-atherosclerotic femoral arteries 
cI rabbits (fem) and 11 atherosclerotic iliac arteries of Yucatan micropigs 
(iliac) were balloon dilated using coronary angloplasty balloons with different 
balloon diameters (BO). Angiographlc diameters from postdilatlon (Opost, 1 (). 
20 min after dilation) and sacrifice (Osse, 3 and 4 wks after dilation for 
rabbits and mlcroplgs, respectively) angiograrns were measured at 8 levels 
per dilation site with a caliper. Elastlc recoil (Elrec) and restenosis (R) were 
denned as BO-Opost and Opost-Dsse, raspectively. Histologic processing 
Included pressure perfusion fixation, 8-16 sections per dilation site and an 
Elastin von Giesen stain. After digitlzatlon of the microscopic image, the 
circumference of the Internal elastlc lamina (IEL), the IEL-bounded area and 
lumen area were measured by planlmetry. The IH erea was converted into 
a mean IH thickness (IHth), assuming an annular configuration of IH. All 
tissue within the IEL-bounded area was defined as IH. In the Yucatan iliac 
arteries, this led to an overestimation since part of this neointima was In fact 
atherosclerosis. Oasplte this, the results are (mm, mean :I: sam): 
Opost Osac Elrec R IHth(2K) 
!em (24) 1.86:t0.04 1.34:t0.04 0.14:t0.04 0.52:t0.04 0.12%0.01' 
lilac (11) 2.77:1:0.29 2.14:t0.33 0.79:1:0.19 0.62:t0.31 O.29:to.oet 
'p<0.OO1, t p .. 0.019, compared with R. 
Thus, only 27-47% of anglographlc lumen reduction can be attributed to 
Intlmal hyperplasia TIssue shrinkage was minimized by pressure fixation and 
will affect these results only W neointlma and arterial wall show differential 
shrinkage. 
II Is concluded that both In the nonnal rabbll model and In the ather0-
sclerotic mlcroplg model, Intlmal hyperplasJa accounts for less than 50'!(, cI 
anglographic lumen reduction. Ills proposed that after balloon angloplasty, 
the major part of the diameter reduction is due to remodelling 01 the arterial 
waI. 
852 Cardiac Transplantation: Immunology and Rejection 
Monday, March 15, 1993 
Noon-2:00 PM 
Anaheim Convention Center 
Hall D 
Presentation Hour: 1:00 PM-2:00 PM 
852-8 
Ralatlonlhlp of Echo WIth Biopsy Following cardiac Transplantation 
In Pediatric Patients 
Nancy A. Ayras, Rlcaldo Pignatel., Jeffrey Towbin. G. Wesley Vick. III, O. 
Howard Frazier, J.TIrnothy Bricker. 
Baylor College of Medicine, HouSlon, Texas. 
Echocardlographically derived left ventricular filling and ejection indices 
have been advocated as markers 01 cardiac rejection status. The purpose 
of this study was to teSl the utUity of these indices in transplanted pediatric 
patients by comparing, in a prospective, blinded fashion, echo Indices with 
biopsy (bx) results. EIghteen cardiac transplant patients, ages 2 months to 
18 years, were evaluated by 78 serial echoes. AU echo evaluations began 
one month following transplantation. LV dimensions, posterior wall 
thickness (LVPW), LV mass (LVM) and shortening fraction (%SF) were 
evaluated by m-mode. MHraf inflow patterns were evaluated by Doppler 
and used to calculate Isovolumlc relaxation time (IVRn. peak mHral inllow 
(M1), and pressure haH-time (PH). Percent change (%ChB) from baseline 
echo and from most recent echo (%ChRI were also determined for all 
echo indices and compared to biopsy results. The biopsy (bx) resuHs were 
graded by the Texas Heart InstHute scale (1-10) for rejection. Non•
rejection (NR) patients (0-67) had a bx score of 1-5. Rejection (Rl was 












9.H 1 88±37 
Expressed as mean ± standard deviation 
Ml. fI:i CiBI 
IIOVsec) Imsec) Ilmsec) 
87±24 40±12 54±14 
117±28 28±10 4S±10 
No significant differences in the SF%. LVEO. LVPW and LVM were found 
between the patients with R bx when compared to NR bx. There was a 
trend towards higher bx scoras In patients wHh low PH and IVRT or high 
M1. However. PH, IVRT, and M1 were highly variable and did not 
statistically distinguish between R and NR. Neither o/oChB nor %ChR 
correlated significantly with bx score. 
CONCLUSION; Echo indices in pediatric cardia<: transplant patients 
poorly predict biopsy scores. Therapeutic intelVentlon for rejection in 
pediatric cardiac transplant patients should not be primarily based on 
echocardIographically derived left ventrlcualar filling and ejection indices. 
852-9 
JACC Vol. 21, No.2 
February 1993:36A 
SlgnHlcance of Mild ReJection Late After Cardiac Transplant In 
Patients With and Without Steroid Maintenance 
Jon A Kobasbigawa. Michael P. Gleeson, Lynne W. Stevenson, 
Jaime D. Moriguchi, Nobuyuki Kawata, Antoine S. Hage, Michele 
A Hamilton, Davis C. Drinkwater, Hillel Laks. UCLA Medical 
Center, Los Angeles, CA 
Mild rejection (rej) on endomyocardial biopsy within the first year 
after cardiac transplantation has been reported to progress to 
moderate rej in 25% of cases. The significance of mild rej in 
cardiac transplant pts > 1 year post-op with steroid maintenance 
(SM) and steroid-free maintenance (SFM) immunosuppression is 
not known. Therefore, we retrospectively reviewed 109 episodes 
of mild rej (ISHLT 1A or focal mild rej, 1B or diffuse mild rej) in 
83 pts > 1 yr post-op to assess outcome. Of these mild rej 
episodes, 35 occurred in 31 pts on SFM and 74 occurred in 52 pts 
on SM. The outcome of the untreated mild rej episodes was as 
follows: Cleared Persist mild Progressed to 
~ l2U.m rej at 4 wks moderate rej 
1A SFM 10 15 0 
SM 32 25 3 
1B SFM 9 1 0 
SM 7 7 3 
All persistent mild rej cleared by 4 mos without therapy. No mild 
rej progressed to moderate rej (ISHLT 3) in the SFM group 
compared to 6/74 (8%) in the SM group. Of note, 3/14 (21%) 
diffuse mild rej (1B) in the SM group progressed to moderate rej. 
Conclusion: Cardiac transplant pts on SFM > 1 yr post-op who 
develop mild rej do not appear to require reinstitution of steroids. 
For those pts requiring SM late after transplant who develop 
diffuse mild rej (ISHLT 1B) close follow-up and consideration to 
intensify immunosuppression is warranted. 
852-10 
Increased Mortality and Morbidity in Cytomegalovirus Mismatched 
Heart Transplant Recipients 
Paul A Mullins. Bojan Biocina. Anoop Chauhan. Jayan Parameshwar. 
Linda Sharples, John Wallwork. Tim Wreghitt, Peter M Schofield. 
Stephen R Large. Transplant Unit, Pap worth Hospital. Cambridge UK 
The importance of cytomegalovirus infection (CMV) after heart 
transplantation is unclear. We examined the morbidity and mortality in 
CMV mismatched heart transplant recipients in our programme. 
Between April 1986 and July 1991. 283 orthotopic heart transplants 
(Htx) were performed. All patients received triple immunosuppressive 
therapy Icyclosporine. azathioprine. prednisolone). Acute rejection 
episodes were treated with pulsed doses of intravenous methyl•
prednisolone. 36 patients died before discharge from hospital and were 
excluded from this study. The remaining 247 patients were divided in 
groups according to their donor (D) and recipient (R) preoperative CMV 
status: mismatched (R·/O +) n = 43. non-mismatched (all others) 
n = 204. There was no significant difference in donor or recipient 
variables. The 3 year actuarial survival was 69.7% SE 7.51 in 
mismatched group and 79.5% SE 3.17 in the non-mismatched group 
Ip<O.l). Infection related early deaths were more frequent in the 
mismatched group (1 year survival 90.5% SE 4.51) than in the non•
mismatched group (96.4% SE 1.31. p<0.05). Rejection and non-CMV 
infection rates were comparable. In the mismatched group 27 patients 
(62.9%) were readmitted to hospital. compared with 68 (33.3%) in 
the non-mismatched group group(p<O.OOOl). The number of 
readmissions per patient were higher in the mismatched group than 
the non-mismatched groups (2/patient vs 1.6B/patient) as well as 
mean length of stay 116.5 days vs 12.2 days. p<0.05). The number 
of additional hospital days post discharge were 24.211 000 patient 
days in mismatched patients compared to the non-mismatched group 
(6.6/1000 patient days. p<O.OOOl). There is increased risk of death 
from early infection. and higher morbidity in CMV mismatched heart 
transplant recipients in the medium and long term. CMV matching or 
the introduction of appropriate prophylaxis should be considered an 
important consideration for heart transplant recipients. 
JACC Vol. 21, No.2 
February 1993:37A 
852-11 
Myocardial Tissue Impedance during Rejection Episodes 
after Heart Transplantation 
Johannes Mueller. Henning Warnecke, Onnen Grauhan. Tatjana Cohnert. 
Robert PflIzmann. Roland Hetzer. German Heart Institute. Beilin. Germany 
Measurements 01 the myocardial tissue Impedance for alternating current 01 
different frequency can describe variations 01 the Ion level 01 Intra- and ex•
tracellular space. and the functional state 01 the cell membrane. The aim 01 
this study was to evaluate. ~ Impedance measurements can detect the 
inftammatory process 01 the myocardial tissue during ailograft rejection after 
heart transplantation. Impedance was measured by recording the voltage re•
sponse to a current step oIl0llA applied at myocardial screw-In electrodes. 
This method ailows to differentiate between Impedance changes 01 the 
intracellular space and cell membrane. and the extracellular space. 12 Beagle 
dogs were heterotopically neck heart transplanted. and immunosuppressed 
with cydosporlne and steroids. Impedance was measured twice daiy. Biopsy 
was pariorrned under sufficient immunosuppression and after reduction 01 
immunosuppression with consecutive mild and moderate rejection. All hearts 
showed a unHorrn Impedance decrease 01 the Intracellular space after opera•
tion. reaching a stable plateau after 4 to 5 days. Impedance vaiues then 
remained unchanged as long as rejection was absent. Biopsy findings of mild 
and moderate rejection were refiected by a statistically significant (p < 0.(05) 
Impedance increase 01 the intracellular space and the cell membrane of 13.2 
± 3.4% (mild rejection) and 27.6 ± 6.8% (moderate rejection). respectively. 
Sensitivity and specHlcIty were 100%. The Impedance changes 01 the ex•
tracellular space were less pronounced. An Increase 01 3.8 ± 1.6% in the 
course of mild rejection and 01 8.3 ± 2.7% during moderate rejection were 
statistically not significant. Impedance changes 01 the myocardium during 
rejection episodes are predominantly caused by changes in the intracellullar 
space. This seems to be the most specHic and sensitive electrophysiologic 
parameter for rejection. most appropriately refiecting the inflammatory chan•
ges 01 the myocardium. In this study Impedance recordings during rejection 
served as physical method. which was measuring the ion shift into the In•
tracellular space. and the consecutive cell swelling which is a known phen0-
menon 01 rejection processes. 
852-12 
Steroid· Free Immunosuppressive Treatment 
Increases Platelet Aggregation in Rats 
Pierre Desseigne, Michel de Lorgeril, Maryvonne Ciavatti, 
Pascale Boissonnat, Georges Dureau, Serge Renaud, Jacques 
Delaye. INSERM U 63 and Hopital Cardiologique, Lyon, 
France 
In a previous study, we showed that enhanced platelet 
aggregation (PA) is a major prognostic factor of long term 
survival after heart transplantation. The aim of this study was 
to test whether immunosuppression per se increases PA and 
whether other envirorunental factors (such as nutrition) are of 
significance. 
In a first study we compared ADP-induced PA in 18 Wistar 
rats after 2 months of triple immunosuppressive therapy (10 
mglkg/day Cyclosporin A, 2.S mglkg/day Azathioprin, and 1 
mglkg/day Prednisolone) to 18 control rats (C). In a second 
study Prednisolone was withdrawn. Each group was 
subdivided into 3 subgroups in relation to their diet: olive oil, 
butter, or sunflower (40% calories). 
~ In controls, PA was higher in olive oil and sunflower 
subgroups as compared to butter subgroup (39% and 53%, p= 
0.02 and 0.11 respectively). There was no' differences 
between treated subgroups, whatever the diet. When 
Prednisolone was maintained, PA decreased by 2S±7% 
(p=O,04) as compared to C, while PA increased by 33±13% 
(p=O,05) when Prednisolone was withdrawn. 
Thus, triple immunosuppressive therapy appears to decrease 
platelet aggregation response, wathever the diet These data 
suggest an interplay between platelet function and 
immunosuppression, and potential adverse consequences of 
steroids withdrawal in heart transplant recipients. 
ABSTRACTS 
852-13 
Deviations in Peripheral Blood T Cell Receptor Expression Predict 
Cardiac Allograft Rejection. 
John F Carlquist. Jeffrey L Anderson. Jay H Greenwood. 
M Elizabeth Hammond. Univ. of Utah and LDS Hospital. SLC. Utah. 
Allograft rejection is believed to be mediated by activated 
T-Iymphocytes. but frequencies of circulating T-cells have not been 
useful in predicting cardiac allograft rejection (REJ). We 
hypotheSized that aberrations in circulating T-ceil receptor (TCR) 
subfamilies might predict onset of REJ. Accordingly. we studied 
peripheral T ceil receptor (TCR) expression for 6 cardiac transplant 
recipients (for periods from 7-127 days) and for 5 normal subjects 
(over 30 days) by flow cytometry using monoclonal antibodies that 
recognize 6 TCR subfamilies. Changes in TCR expression were 
determined by comparing the number of cells expressing a 
particular TCR subfamily over one week intervals. Changes in cell 
numbers were expressed as ratios. Of 120 determinations for 
controls. 119 (99.2%) showed ratios falling between 2.0 (two-fold 
increase) and 0.5 (two-fold decrease). In contrast, for patients. 59 
of 246 ratios (23.9%) fell outside of this range (p<0.004. chi 
square). Correlation with histologic diagnoses indicated that 84.7% 
of the abnormal TCR ratios for patients occurred within two weeks 
of biopsy proven mild-severe rejection (p<0.001. 
R= 0.91 by linear regression). 
An overall agreement between I 
TCR subfamilies expressed a: 
on infiltrating T ceils on biopsy 
and peripheral TCR 
abnormalities was seen 
(p<0.05 chi square). Thus. 
changes of peripheral TCR 
expression predict rejection 
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Antibodies to T ceU Receptor (COO) Initiate Mononuclear Cell Binding 
to Arterial Endothelium. 
Alistair I. Fyfe, Judith A. Berliner, Linda L Derner, Davis C. 
Drinkwater, Hillel Laks, Lynne W. Stevenson. UCLA Medical Center, 
Los Angeles, CA. 
While antibodies to the T ceU receptor (TCR-CD3) like OKT3 are 
used for immunosuppression, binding to the TCR leads to enhanced 
LFA-l dependent adhesion to artificial surfaces. To detennine ifTCR 
binding would increase cardiac transplant recipient peripheral blood 
mononuclear ceU (PBMC) adhesion to confluent human aortic 
endothelial cells (HAEC), PBMC were incubated for 30 min with 
monoclonal CD3 or CD3 + CD18 antibody (Ab), prior to a 15 minute 
HAEC binding. Immuno-fluorescence was used to assess lymphocyte 
/monocyte proportions. 
PBMC adhesion increased 2-fold 
after anti-CD3 Ab preincubation. 
This was prevented by coincubation 
with anti-CD18 (p<0.OO5). CD3 Ab 
increased monocyte binding from 
11.7±1.5 to 14.S±1.6 
cells/HPF,(p<O.OS) The major 
increase was due to lymphocyte 
adhesion 3.4±0.6 to 14.8±6.7 
cells/HPF,p<O.OS. Anti CD18 Ab 
markedly reduced binding of both cell types. 
__ 0_ 
.-
Crosslinking of the TCR by anti-CD3 Ab causes acute adhesion of 
PBMC (particularly lymphocytes) to arterial endothelium (HAEC) 
using an CD (LFA-l) dependent mechanism. Increased PBMC 
adhesion after OKT3 may influence vessel waU function, and contribute 




Serial Asaeaament of Coronary Artery Intimal Thickening After 
Orthotopic Heart Tranaplantatlon: Relatlonahlp to Early Defective 
Endothelial Function 
Thomas Porter. JennWer A. Fields, Alan Cycan, Chauncey Crandal~ 
Anthony Minis/. PK Mohanty. McGuire VA Medical Center and Medical 
College of Virginia, Richmond. VA 
Abnormal endothelium-dependent coronary vascular responses have 
been reported within the first year after heart transplantation (Hl) prior to 
angiographic evidence of transplant coronary arteriopathy (TCA). Despite 
the evidence that angiographically normal vessels of HT patients often 
demonstrate significant TCA (manWested as intimal thickening) when 
examined at autopsy or by intravascular ultrasound (IVUS). the causal 
relationship between defective endothelial function and the development 
of TCA is unclear. Accordingly. we performed IVUS of the proximal and 
mid segments of angiographically normal LAD in 13 stable HT patients 1-
18 months following HT. and 5 age-matched control patients with 
angiographically normal coronary arteries (CA). In each case. CA area 
responses to incremental infusion of acetylcholine (ACH) (10" to 10" 
Molar) were assessed. In 5 of the HT patients. IVUS and incremental ACH 
infusions of the same vessels were repeated six months later to assess 
the effect of the early ACH response on intimal thickeness (11). IT was 
determined as {(lumen + intimal area)-lumen area/(Iumen+intimal area)}. 
Vasodllatory responses (VDR) to ACH on the early study were seen in 
7/13 (54%) HT patients and 4/5 (80%) controls (p<O.05). There was no 
correlation between fasting LDL (r=0.13) or time in months since HT 
(r=0.4O) and the early vascular responses to ACH. In the 5 serial studies. 
VDR to ACH at 6 months follow-up could not be predicted on the basis 
of the initial study response to ACH. Only the extent of IT of the LAD 
segment analyzed at either the early or follow-up study correlated with CA 
response to ACH (r=-O.87. p=.OOl). These results suggest that the 
development of TCA is unrelated to time since HT or plasma lipids. These 
data also imply that the extent of IT by IVUS is an important predictor of 
impaired endothelium-dependent responses in the coronary Circulation of 
HT recipients. 
852·16 
Decreased 8.-Adrenoceptor Density Despite Normal Hemo•
dynamics in Patients with Coronary Vasculopathy After 
Cardiac Transplantation 
Heiko von der Leyen, Markus Steinfath*, Andreas Hecht, Wilhelm 
Schmitz*, Hasso Scholz", Axel Haverich, Bernd Heublein, Paul R. 
Lichtlen. Medizinische Hochschule, Hannover, and, *UniversitalS•
Krankenhaus Eppendorf, Universitat Hamburg, Hamburg, FRG 
Coronary vasculopathy (CVP) has been found to be the most 
important form of chronic rejection after cardiac transplantation 
(CTx). Until now, changes of the 6-adrenergic system in pIS with 
CVP are not well characterized. Therefore, we determined total 6-
AR density (Bmax; fmoUmg prot) and 6\- and 6r subtype distribu•
tion in right ventricular biopsies taken from 10 pts with CVP. To 
elucidate changes characteristic for pts with CVP total 6-AR density 
and 6\- and liz-subtype distribution were additionally determined in 
10 pts without any signs of CVP. Both groups of pts did not differ 
with regard to age, donor-age, indication for Tx, post-transplanta•
tion time, hemodynamic values, catecholamine levels, and 
cyclosporin A levels. 8 prospective donor hearts served as control 
(Ctrl). Total Bmax (mean ± SEM) was assessed with (-)-(\25I)-iodo•
cyanopindolol. The selective 8\-AR antagonist CGP 20712A (300 
nmoUl) was used for determination of 6\/6r AR ratio. 
With CVP No CVP 
Total Bmax 51.9 ± 5.6 H 71.7 ± 4.6 
81 30.2 ± 2.9 *H++ 47.9 ± 4.1 
~ 21.7 ± 3.2 25.3 ± 1.8 ++ 
81/~ (%) 58.8/41.2·+ + + 66.6133.4 + + 
Control 
70.8 ± 7.1 
56.6 ± 4.2 
14.2 ± 2.4 
79.9/20.1 
.. p < 0.051 ** D < 0.001: vs. No CVP 
+ P < 0.05/ +.;. p < 0.011 + + + P < 0.001: vs. Control 
In pts with CVP total 6-AR density (B~ and the 8\-AR number 
were decreased as compared to pts WIthout CVP and Ctrl. The 
6\/lIz-AR ratio was decreased resulting in an increased relative 
proportion of lIz-AR density. It is suggested that pathological 
changes leading to coronary vasculopathy may also alter, at least in 
part, the 6-AR system. 
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Detection of CMV In Autopsy Speelmens of Cardiac 
Transplant Recipients by PCR: Implications of CMV 
Involvement In Graft Atherosclerosis 
Evan Skowronski, Arturo Mendoza, Brian Jaski, S Nehlsen•
Cannarella, Sidney Smith, Leonard Bailey. Loma Unda 
University Immunology Center, Loma Uncia, Ca, and the San 
Diego Cardiac Center, San Diego, Ca. 
In order to assess the presence of CMV in various tissues 
and its relevance to the development of graft atherosclerosis, 
38 paraffin embedded coronary artery specimens from 15 
cardiac transplant recipients surviving> 100 days were 
analyzed by PCR for CMV. Eight patients had known 
previous CMV exposure/infection, 7 did not. Of the 8 with 
prior CMV exposure, 3 (38%) died of graft atherosclerosis vs. 
4/7 (57%) without prior exposure. Only 2 coronary 
specimens were CMV + in a single patient who did not have 
evidence of graft atherosclerosis at autopsy. Other tissues 
tested (5 lung, 5 GI, 1 kidney) showed CMV + lung in one 
patient (patient with 2 CMV+ coronary specimens) and 
CMV + kidney, GI, and lung specimens in another patient. No 
specimens were CMV+ in the remaining 13 patients despite 
the presence of graft atherosclerosis or previous CMV 
exposure. 
CONCLUSION: Our data do not support the hypothesis that 
graft atherosclerosis is associated with latent CMV infection 
of the coronaries. Only 2 coronary specimens in this study 
were CMV +, but not in a patient with graft atherosclerosis. 
The role of CMV in the pathogenesis of graft atherosclerosis 
is unknown, but is possibly a modulation of the immune 
system via remote infection. 
852·18 
Vasodilator Response to Dipyridamole Assessed by 
Positron Emission Tomograpby (PET) is Impaired in 
Cardiac Transplants witb Early Coronary Disease. 
Sudhir S Kushwaha, Ranil de Silva, Luis I Araujo, Eldad 
Rechavia. Terry Jones. Adriaan A Lammensma. Andrew G 
MilChell. Altilio Maseri and Magdi H Yacoub. MRC Cyclotron & 
Cardiovascular Units. Hammersmith Hospital and Harefield 
Hospital, London. UK. 
In order to assess the degree to which coronary disease affects the 
resistance vessels in the transplanted hean, we studied 14 non•
rejecting cardiac allograft recipients (TXRs) with angiographically 
normal coronary arteries (N) and 11 TXRs with mild 3 vessel 
epicardial coronary disease (CAD), i.e. <40% reduction in vessel 
diameter. MBF (ml/min/g) was measured by PET using the 
previously validated 0-15 water technique, both at rest (R) and after 
intravenous dipyridamole (0. 0.6 mg/kg). Dipyridamole vasodilator 
response (DVR) was calculated as the ratio of D-MBF/R-MBF. 
Data are expressed as rnean±SEM. R-MBF was significantly higher 
in CAD than in N (1.59±O.l2 CAD vs 1.I6±O.07 N, p<O.OI), 
despite the rate-pressure product (RPP) in the groups being similar 
(11500±489 CAD vs 11255±766 N, p=NS). Absolute levels of 
MBF after D in CAD were significantly lower than in N (1.9O±O.16 
CAD vs 2.73±O.28 N, p=NS). RPP increased after D to a similar 
extent in both groups (l2057±520 CAD vs 12179±683 N, p=NS). 
DVR was significantly attenuated in CAD patients compared with N 
(1.50±0.26 vs 2.47±O.30). DVR was homogeneously distributed 
throughout the heart in both patient groups. In summary. the data 
suggest a dysregulation of the coronary resistance vessels even in 
the absence of flow limiting epicardial stenoses in TXRs with CAD, 
as evidenced by the higher R-MBF and the attenuated response to 
dipyridamole. The data suggest that in TXRs. resistance vessel 
function is altered at an early stage of the coronary disease process. 
JACC Vol. 21, No.2 
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Heart Transplant Recipient Mixed Lympbocyte Reaction Induces Sub•
Maximal Class II HLA on Donor Endotbeliu .... 
Alistair I. Fyfe, Mahamad Navab, Linda L. Derner, Lynne W. Stevenson. 
VCLA Medical Center, Los Angeles, CA. 
Human aortic endothelial cells (HAEC) may initiate a donor mixed 
lymphocyte reaction (MLR) with class II HLA induction. It has not been 
established whether cardiac transplant recipients (crxR) on 
immunosuppression mount a normal MLR, or if second exposure to 
donor derived endothelium in a MLR may hyper-induce class II HLA. 
MLR's were set up between 10" peripheral blood mononuclear ceUs 
(PBMC) from rn CTxR, and 6 donor specific HAEC or 91 third party 
HAEC. Eight third party HAEC were used for normal MLR's. The 
induction of Class II HLA on HAEC was determined using CEUSA. 
Maximal class II induction was achieved by culturing in the presence of 
200 V/ml interferon"), (IFN). 
MLR's using transplant PBMC 1.1 
induced class II significantly less than 11.4 
NORMAL; which induced class II 1.I..a 
HLA equal to IFN. Class II induction t 
was similar in MLR's where PBMC ~o .. 
had been previously exposed to donor ~ ::: • 
HAEC, (Tx-SP) compared to third I . 
party HAEC (Tx-NSP). iSO~.· 
PBMC from cardiac transplant ._._ .... 0_._ .... 
recipients on immunosuppression have 
reduced ability to induce class II HLA expression on donor vascular 
endothelium in a mixed lymphocyte reaction when compared to normal 
PBMC, despite prior invivo priming. This may be important in the 
chronic submaximal immune response aimed at aUograft endothelium 
implicated in the development of transplant vasculopathy. 
852·20 
Prolongation of Cardiac Allograft Survival in Rats With 
Transforming Growth Factor.HI 
G. Praveen Raju, Sheri E. Belland, Howard I. Eisen, University of 
Pennsylvania, Philadelphia, PA 
The endogenous growth factor, Transforming Growth Factor-Bl 
(TGF·BI), has been shown to inhibit T-cell proliferation as well as 
cellular expression of MHC Class I antigens and cell adhesion 
molecules in vitro. To determine if TGF-Bl can inhibit transplant 
rejection in vivo, 14 Lewis rats received Wistar Furth heterotopic 
abdominal cardiac allografts. Five Lewis rat transplant recipients 
were treated one day before surgery with 1 I!g TGF-Bl (i.v.) in 
media and constituted Experimental Group I. TGF-Bl was then 
administered to Experimental Group I for 14 days with a constant 
infusion at 0.5 ng/hr (12 ng/day TGF-BI) using a mini-osmotic 
pump placed in the peritoneal cavity at the time of transplantation. 
Experimental Group II consisted of four Lewis recipients which 
received ll!g TGF-Bl (i.v.) one day prior to surgery after which 
TGF-Bl was administered by constant infusion at 2.5 ng/hr (60 
ng/day TGF-Bll for 14 days after transplantation using a mini•
osmotic pump in the peritoneal cavity. Five Lewis recipients were 
treated with media alone and served as Controls. Controls 
received a constant infusion of media alone by the mini-osmotic 
pumps. Cardiac allograft function was assessed by palpation and 
grading of ventricular systole. The mean length of allograft 
survival (±SD) for TGF-Bl treated animals in Experimental Group 
1(12 ng/day) was 12.8 ± 1.1 days vs. 8.8 ± 1.1 days for Controls 
(p<O.OOl). For Experimental Group II (60 ng/day), allograft 
survival (±SD) was 16.3 ± 2.5 days (p<o.05 vs. Experimental 
Group I and p<O.Ol vs. Controls). Rejection was verified histo•
logically in all cases. We conclude that: 1) TGF-Bl in v'.!ry low 
doses appears to prolong cardiac allograft survival in vivo and; 2) 
the immunosuppressive effect of TGF-Bl is dose dependent. The 
immunosuppressive utility ofTGF-BI merits further investigation. 
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rolE CF 1l£ AmIAL <XNl'Iilll1l'ICti ro VENmIaJIAR FII.LIr-G IN HEAIJ..UP mT 
INlXE) S'mlFE. AN ECHX:.ARlI<rnAmIC EVAU.lATICti. 
De Picccli B., Rig:) F., ~oglio F., Raviele A., Di Pede F., Gaspa•
rini G., Piccolo E. Cardiac Lab. UItJertD IO ~enezia. Italy. 
In order tIl dltain rrcre details 00cut the ventrirular fillill!; 
~ irxU:ed by head LP tilt test (!UT: passive ~t positicn at 
roo fa: ro' a: mtil synptars develq:J!B'lt) , .... evaluated by 20 an:! 
Doppler edxJcardi.~ 10 pts wi It! ri.procU::ible syrcqJe ciJrirg !UT 
(€loI, 4F, !II39'l I3f!f' 32~ yrs) an:! 8 sex an:! age rratched central abjects 
(C) wilt! a neg;3tive test. The follClorirw; parareters abcut the t1o.o 
ventricles size an:! fillirl?; were calrulated: end-di.astolic area (EllA), 
fracticnal area d1a1ge (FAG), early (E) an:! late (A) diastolic peak 
mitral £100/ velocities an:! their ratio (E/A) , tIltal diastolic £100/ 
velocii;y time integral oornalized fOC' R-R interval. (~ OC' EllA 
(MI/EllA) • 
Resll. ts: ciJrirg the !iJase prec:ediJl! syrcqJe .... recorded in !UT 
positive pts, a progressive decrease of EllA, E, E/A, MI/VR-R, 
MI/EllA an:! 1rl in:::rease of FAG an:! A. At the crset of syrcqJe .... 
dltained the follClorirw; re&Jlts abcut left ventricle (LV): 
EDLVA FAG E/A ~ MI/EDLVA 
positive pts (%) -31+2 +15>3 +15+4 -45:!:,1O -26+8 
neg;3tive pts (%) -18+4 + 0.1 -191-2 -12~ +3+5 
p < 0,03 0,05 0,003 0,(04 O,<X6 
The re&Jlts 00cut rigtlt ventricle overJ.<wed LV Cl1E!S. By this re&Jlts 
.... twothize tllat the vig::Iro.s centracticn of ventricles dJrill!; passi•
ve Lprigj'lt positicn gives rise tIl a vB!i§3l reflex tllat causes 1rl abnpt 
fall of the previrusly Eri1a'x:ed atrial carpcnent of the ventrirular 
f~ an:! ~tly detennines a drcp of 'JVl'I even greater than 
the decrease of EllA. This ~ betwee'l the ventrirular fillirl?; 
an:! areas seers tIl be the nein factnr fOC' syrcqJe irducticn. 
853·65 
Relatlou,hlp Betweeu Left Veutrleular (LV) Dlalolle Stlffu ... ud 
Dlutolle Flow Wa •• Tru,.Issloulu a Pulsatile LV .odel 
Ramw G Pai, Ajit P Yoganathan, Cbris Toome, Carol Eberhardt, 
Pravin M Shah, VA Hospital and Loma Linda Vniv, Loma Linda, CA 
The transmitral 'A' wave is transmitted to lbe LV outflow tract 
(LVOT) as a flow wave being registered in L VOT as Ar wave. We have 
demonstrated in a previous clinical study that lbe A wave transit time to 
the LVOT (A-Ar interval) is dependent on LV late diastolic stiffness 
(,.-0.74,1><.001). Shorter A-Ar interval was associated wilb stiffer 
ventricles. This is consistent with lbe principles of Moens-Korteweg 
equation which relates pressure wave propagation in an elastic tube to 
the elastic properties of its wall. This in vitro study was undertaken to 
investigate the relationship between LV diastolic stiffness and lbe peak 
to peak and foot to foot transmission velocities of the transmitral flow 
wave in a pulsatile LV model. 
Thirty-two sets of experiments wilb varied ventricular stiffness 
were carried out wilb direct measurements of pressure and flow waves 
at mitral valve (MV) and L VOT. The overall LV diastolic stiffness, 
measured as the ratio of diastolic pressure to volume change, correlated 
highly with foot to foot transmission velocity of lbe flow wave (r-o.93. 
p<.ool) and to a slightly lesser degree with its peak to peak transmission 
velocity (r-o.87, p<.ool). The foot to foot transmission velocity of the 
pressure wave (range 150-598 cm/s) correlated both with foot to foot 
transmission velocity of the flow wave (range 141-591 cm/s; r-o.99) and 
peak to peak transmission velocity of the flow wave (range 136-591 
cm/s; r-o.81). 
CONCLUSIONS:ln an in vitro model (I) The transmission velocity of 
diastolic flow wave is a measure of LV diastolic stiffness. (2) The foot 
to foot transmission velocity of the flow wave correlates better wilb LV 
stiffness and lbe rate of pressure wave propagation than the peak to peak 




Diastolic PUDctiOl After IsoIeb:ic bercise In YOUICJ Diabetic Patieats iitb 
ADd litbout CoIplicatiOllS: BcIIo-Doppler 5tlIIy. 
Adriano M. Pellicelli, Joaquin Barba, Juan Cabanero, Sergio Mejia, ADa 
IlUellos, Alfredo Yoldi, Diego MartiDel-caJ:O. University Clillic of lavarra. 
PalploDa. SpaiD. 
TIle objective of tbe study vas to assess diastolic and systolic function ill 
young type I diabetic patients divided according to tbeir clinical characte•
ristics. Tlieoty-six diabetic patients (age 16-32 yrs.) were studied and 
divided into two grolql6: group I, lade up of 14 patients witbout diabetic 
coJplications and group II lade up of 12 patients witb diabetic coJplications 
(neuroautollOlic dysfunction, retinopatby and nepIlropatby). Ie perfol'led 
Doppler ecbocardiograpby deteninations of diastolic filling parueters and 
isovolUJetric relaxation tile (IVRT) at rest and after 3 lins. of isoaetric 
exercise. Groups I and II were coJpared to a control group of 20 heal tby 
subjects (age lS-31 yrs.). TIle following table shows tbe results of tbe 
bandgrip tests: 
Variable Gr.I P control p Gr. II 
E(CI/sec) 87.3±l7.4 IS 86.l±l7.S IS SO.'lt12.2 
A(CI/sec) 64.8±lS.3 <0.01 SO.S±7.4 <0.0001 82.1±1S.9 
E/A l.4±O.4 <0.02 U±O.3 <0.0001 l.L+O.2 
Area E(CI2) 13.6±3.8 IS 13.3±3.2 <0.02 10.6±2.9 
Area A(CI2) 6.4±1.3 <0.02 S.1±1.2 <0.0001 7.6±l.6 
AreaE/Total 0.7±O.07 IS 0.7±O.04 <0.0001 O.S±O.l 
Areal/Total 0.3±O.08 <0.03 0.2±O.04 <0.0001 0.4±O.OS 
IR'l'V/RR ill.Sm.1 <0.01 84.2±lS.4 <0.0001 123.4±27 .9 
conclusions: In group I diabetics, tbere already exists diastolic dysfunctioD 
inspite of tbe short duration of sickness and tbe absence of coJplications. 
At rest tIUs group bad a significant contribution of active ventricular 
filling over total filling which increases witb additional afterload. Group 
II diabetics bad greater contribution of active filling in basal conditions 
witb decrease of passive filling after exercise. They also shoVed decreased 
systolic and diastolic left ventricular diueters. These data support tbe 
possibility of an infiltrative Iyocardial process secondary to diabetes which 
lay cause ilpairaent of diastolic function. 
853·67 
M.ItnI fIDw Velocity ....... ud ~ Wedle rr-re ProYide 
~ P'rcJpoBtk InfCJnlllldoa ill I'IdeaP willi Iscbemic IIeIIrt Di8MR ad 
Left v ........ DysfuadioB 
Soccono Capomolla, Massimo Pozzoli, Franco Cobelli, Luigi Tavazzi.-Foad. 
CIinica del Lavoro.IRCCS, Pavia-Centro Medico Mooa.scano, IT AL Y 
In patients with left ventricular dysfunction a "rapid filling 
predominant" pattern of transmitral flow is generally associated 
with high left ventricular filling pressure, which is a marker of 
poor prognosis. To determine the relative prognostic values of 
transmitral flow pattern and mean pulmonary wedge pressure 
(PWP), 101 patients with ischemic heart disease and left 
ventricular systolic dysfunction (Ejection fraction < 40% ) were 
studied. All patients underwent right heart catheterization and 
complete two-dimensional and Doppler echocardiographic 
examination. Early (E) and late diastolic (A) peak flow velocities 
were measured from Doppler of mitral flow. Results:During a 
follow-up of 25 months(range: 12-48) cardiac events, defined as 
death, heart transplant and heart failure requiring hospitalization, 
occurred in 43 patients(42%). One year Kaplan-Meier event-free 
survival was: 50% and 91 % when EtA ratio was> I and~l 
respectively (p<O.OOI); 48% and 90% when PWP 
was> 18and~18 mmHg respectively (p<O.OOI). Cox 
proportional hazard models (including either invasive or echo•
Doppler hemodynamic variables) showed that NYHA functional 
class combined both with PWP and with EtA ratio provided the 
best estimate of risk: risk ratio(95%CL) =5.2(2.3-12.8) and 
4.3(1.8-10) respectively. 
COlIClusieBS: our data indicate that in patients with ischemic heart 
disease and systolic dysfunction, a "rapid filling predominant" 
pattern is associated with an adverse outcome. Doppler of mitral 
flow and PWP provide similar prognostic information. 
853·68 
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Noninvasive Measurement of Left Ventricular Relaxation In in 
Patients: Comparative Doppler and Catheterization Results. 
Roben S. Schwam.. Rick A. Nishimura. A. Jamil Tajik. David R. Holmes Jr. 
Mayo Clinic and Foundation. Rochester. MN 55905 
Left ventricular diastolic relaxation abnormalities may playa 
major role in the pathophysiology of heart failure. Diastolic function 
is generaIly best assessed invasively, by measuring the time constant 
of ventricular relaxation Tau (T). 
The purpose of this study was to determine if T could be 
accurately estimated noninvasively using doppler echocardiography. 
Tau was measured using high fidelity left ventricular pressure tracings 
and compared with values obtained from simultaneous continuous•
wave doppler signals in 25 patients with at least moderate mitral 
regurgitation. The mitral regurgitant velocity signals were digitized 
at 3 msec intervals and converted to left ventricular pressure by the 
modified Bernoulli equation and various methods to approximate left 
atrial pressure. Both invasive and doppler-derived measurements of 
T were obtained digitally using a semi-logarithmic model. 
The best correlation was found using the measured left atrial 
pressure added to the Doppler derived ventriculo-atrial gradient to 
reconstruct the LV pressure curve (r= .84, SEE= 15 msec). Adding 
a constant 20 mmHg to approximate left atrial pressure yielded a 
correlation of r=.63, SEE= 14 msec. 
Conclusion. Although doppler and catheter derived measures of 
relaxation are suboptimal, T may be estimated semi-quantitatively by 
noninvasive means using the descending limb of the doppler-derived 
mitral regurgitation velocity signal. The clinical impact of this method 
awaits further investigation. 
853·69 
Noninvasive Computation of Left Atrial Chamber 
Pressure·Dimension Relation in Patients With Mitral 
Regurgitation Using Doppler Echocardiography 
Karl Isaaz. Jean F Bruntz, Thiery Courtalon, Jean P Simon, Etienne 
Aliot. HopitaI Central, CHRU de Nancy, University of Nancy I, 
France. 
In patients with mitral regurgitation (MR), left atrial pressure (LAP) 
during systole may be written as: LAP = L VP - PO where L VP = 
left ventricular pressure and PO = atrio-ventricular pressure 
gradient In the absence of aonic disease, the time course of LV 
pressure during LV ejection can be estimated by the aonic pressure 
(AoP) so that LAP = AoP - PO. We studied 16 patients with mitral 
regurgitation (angio grade 2+ in 8 pts, grade 3+ in 5 pts and grade 
4+ in 3 pts; the etiology of MR was ischemic in 6 pts, rheumatic in 
3, myxomatous with chordal rupture in 2. dilated cardiomyopathy in 
5 pts). AoP was measured by a calibrated subclavian pulse tracing 
and recorded simultaneously with continuous wave Doppler PO. 
Instantaneous LA dimensions were recorded using digitized M•
mode echo. LA pressure-dimension relation from minimum-to end•
systolic LA pressure was analyzed using an exponential curve 
fitting: LAP = AebDimension where b is an index of LA stiffness. 
In 12 patients Doppler echo derived LAP values were compared to 
catheterization (Cath) capillary wedge pressure data. ~: In the 
12 patients with Cath, Doppler end-systolic LAP was linearly related 
to maximal capillary wedge pressure (r = 0.75, p=O.OO(8); a good 
linear correlation (r=0.92, p=O.OOOl) was found between the 
amplitude of the capillary "v" wave relative to the minimum pressure 
and the Doppler derived pressure difference: [end-systolic LAP•
minimal LAP]. In the 16 patients, b ranged from 0.6 to 10 with the 
highest values for rheumatic MR and MR with dilated 
cardiomyopathy. Ih!I.s: Left anium pressure-dimension relation may 
be studied noninvasively by Doppler echocardiography in patients 
with mitral regurgitation. This provides a method for noninvasive 
estimation of LA chamber stiffness. 
lACC Vol. 21, No.2 
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Influence of Rigid or Flexible MItral Annulopluty Ring on Mitral Annu•
lar DyIlll/llIc8: A Two-dImensional Echocardlographlc Study 
Yasuko Yamaura, Junichi Yoshikawa, Kiyoshi Yoshida, Takashl AIIasaka. 
Kobe General Hospital, Kobe, Japan 
This study was undertaken 10 observe lhe effect of rigid (Carpentier) and 
flexible (Duran) annuloplasty rings on dynamics of the mitral annulus in pa•
tients who had mitral valve repair for chronic mitral regurgitation secondary 
to degenerative disease of the mitral valve. Nineteen patients were studied 
by two-dimensional echocardiography. Seven had a Carpentier and twelve 
a Duran annuloplasty ring. The 
mitral leaflets and annular at- 4 
tachments were recorded from li" 
a view close to the standard ! 3 
apical four chamber view. The J 
transducer was rotated and re- .. 
cordings were made at 30· ro- i Z 
tational intervals around the .li 
circumference of the mitral 1 1 
valve annulus. To reconstruct I 
the annulus, diameters (or 
chords) from each rotational 
- _- Duran size 27 
- Duran size 29 
- Carpentier size 30 
-- Carpentier size 32 
interval were arranged around a reference point. Annular areas were plani•
metered. The annulus movement was reduced in all 7 patients with a Carpen•
tier ring. In aU 12 patients with a Duran ring, the annular area increased dur•
ing diastole and became maxirrum in late diastOle. There was presystolic fol•
lowed by systolic narrowing to a minimum in midsystole. The mean reduction 
area was 26.0 ± 4.5 %. This was signHicantly higher than the the mean reduc•
tion area of 2.4 ± 1.1 % for patients with a Carpentier ring (p<O.OOI). 
Conclusion: A flexible Duran annuloplasty ring is more physiological than a 
rigid Carpentier ring. 
853-71 
Value of Right and Left Ventricular Diastolic Parameters 
by Doppler Echo to Predict Cardiac Rejection after 
Transplantation 
Gong-Yuan Xie, Edward J. Morris, Melanie D. Mattson, Sharon C. 
Mahoney, Michael E. Sekela. Connie G. Taylor, William N. 
O'Conner, Mikel D. Smith. University of Kentucky, Lexington, KY 
This study prospectively evaluated RV and LV diastolic parameters by 
Doppler echo for the prediction of cardiac rejection after 
transplantation. Fifty Doppler echo and cardiac biopsy examinations 
were sequentially perfonned in 20 pts. Early filling (E) and atrial (A) 
velocities and deceleration time of E (01') were obtained from RV and 
LV inflow Doppler recordings respectively. LV isovolwnic relaxation 
time (IVR1') was measured as a time interval (msec) between the 
ending of aortic outflow and the beginning of mitral inflow by 
Doppler CW recordings from the apical5-chamber view. RV-IVRT 
was obtained as the time difference between hean rate matched CW 
and PW recordings of tricuspid regurgitation and pulmonic outflow, 
respectively. IVRT was corrected by hean rate to 60 beats/min. 
Biopsy findings were graded as: None(O), mild(l), moderate(ln and 
severe(lll) rejection. Results (Spearman rank correlation analysis): 
o I II III r p 
RV-IVRT 135±9 133±19 91±11 71±13 -0.55 0.002 
LV-IVRT 132±7 I 22±7 106±6 97±5 -0.45 0.004 
There was no relation between the severity of rejection and 
conventional Doppler filling indices (E, A, E/A, D1') from either RV 
or LV recordings. However, IVRT progressively shortens with 
worsening grade of cardiac rejection. RV-IVRT appears to be slightly 
better than LV -IVRT as a correlate of rejection severity. Only 1/11 
biopsies showing grade II-Ill rejection was associated with an RV•
IVRT> 110 msec. These data suggest that IVRT may be a useful 
noninvasive screening parameter to avoid repeated cardiac biopsy. 
ABSTRACTS 
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Pulmonary Venous Flow: Relation to Mitral Annular Motion 
John Jue, Ken Gin, Charles Pollick. Vancouver General Hospital, 
Vancouver, B.C. Canada 
Background: The contribution of mitral annular descent to 
pulmonary venous flow (PVF) has not been well documented. We 
hypothesize that depending on where annular motion is interrogated, 
descent of the base (ooB) as measured by a 20 directed M mode 
cursor has dHferential influences on PVF. 
Methods: 59 patients (mean age 50±11, 37 F, 22 M) in sinus 
rhythmn with no more than mild mitral regurgitation had ooB 
measured from the transthoracic 4 and 2 chamber views to obtain 4 
points of mitral annular excursion [medial (med), lateral (Iat), 
posterior (post) and anterior (ant)]. DoB was meesured as total 
e~ursion (TE) and atrial excursion (AE) in cms. 
TEff'.. I_~ 
if '-V AE Pulsed Doppler sampling of the right 
superior pulmonary vein from the apical 4 chamber view was used to 
obtain systolic and diastolic PVF velocities and their velocity time 
integrals. 
.Bul.Il1I;., There was a weak correlation of peak systolic PVF velocity 
to mad TE (r=O.28, p=0.03) and ant TE (r=0.35. p=0.OO7) but no 
correlation was seen with lat and post TE or with AE. Analysis of only 
patients ~40 years of age (n= 44) improved these correlations 
(r=0.39 and 0.42 for med TE and ant TE respectively). The 
correlation of systolic PVF velocity to the sum of the 4 pOints of 
annular interrogation also improved when only the older patients 
were considered (0.27 to 0.38). Diastolic PVF had no correlation to 
TEorAE. 
Conclysion: In patients with sinus rythmn, medial and anterior mitral 
annular descent, especially in the older patients. correlated best with 
systolic PVF. Previous failures to demonstrate a correlation of mitral 
annular motion to PVF may be due to the lack of recognition of 
regional dHferences of longitudinal muscle shortening in contributing 
to PVF. 
853·73 
A New Method to Determine DiastOliC Filling Volume 
Using Doppler Transmltral Flow and Mitral Valve 
Motion 
Shingo Kurokawa, Haruhiko Okuri, Ryuichi Kikawada. 
Kitasato University, Sagamihara, Japan 
41A 
The relative contributions of early and late diastolic filling to 
total Doppler transmitral flow patterns have been shown to vary 
in various cardiac diseases with left ventricular relaxation, 
stiffness and filling pressure. It is necessary to clarify a relation 
between filing velocity and filling volume. Therefore,we devised 
a method to calculate diastolic filling volume by analyzing of 
transmitral flow velocity and mitral valve motion, and validated 
our method in comparison with time(t)-volume(V) curve 
obtained from left ventriculography. Early diastOlic filling 
volume(EDFV) and late diastolic filling volume(LDFV) during 
atrial contraction were measured from t-V curve by reference to 
t-dV/dt curve invasively. A good correlation was found between 
Doppler and angiographic EDFV (r=0.93, p=0.0001, n .. 14), 
Doppler and angiographic LDFV (r=0.88, p..o.0001), and also 
between Doppler and angiographic EDFVILDFV (r=0.92, 
p..o.0001). 
> 80 > 3 ..,....----..,....--, ~ 70 ~  
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Conclusion: our method provides a volumetric evaluation of 
diastolic filling and may contribute a further understanding of 
left ventricular diastolic performance. 
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853·74 
Errect or Ldt and Right Lateral Decubitus Positions on 
Mitral Flow Pattern by Doppler Echocardiography in 
Congestive Heart Failure 
Kazuaki Tanabe, Yutaka Ishibashi, Tetsuro Ohta, Kazuaki 
Nakayama, Toshio Shimada, Rinji Murakami, Shigefumi Morioka, 
Katsutoshi Moriyama. Shimane Medical University, Izumo, Japan 
In this study we attempted to explain the increased dyspnea 
(trepopnea) which patients in congestive hean failure (CHF) have in 
the left lateral decubitus position using pulsed Doppler 
echocardiography. We recorded mitral flow velocity in II patients 
with CHF (PCWP~18mmHg, mean age 62) and in 10 normal 
subjects (mean age 53) in the left (LL) and right lateral (RL) 
decubitus positions. The Doppler mitral flow measurements included 
the peak early flow velocity (E; cm/sec), peak auial flow velocity (A; 
cm/sec), the E/A ratio and time-velocity integrals of each peak (TVI•
E, TVI-A; cm). In CHF there was a significant change in peak E in 
LL compared to RL. The E/A in LL was markedly higher than that in 
RL. The similar results were obtained on TVI-E, TVI-A and TV 1-
E/TVI-A. TVI·E+ TVl-A was larger in LL compared to RL. 
Normal CHF (/I: p<0.05 vs. LL) 
LL RL LL RL 
E 62±12 6O±13 71±26 53±24# 
A 57±12 55±15 44±22 50±24 





8.8±1.7 8.7±2.1 7.2±2.4 5.6±2.4# 
4.8±1.4 4.7±1.7 3.i'±1.7 4.2±1.9 
2.O±0.5 2.O±O.9 2.5±1.6 1.9±1.4# 
13.7+2.5 13.3+2.6 IO.9±3.1 9.9±2.4# 
Conclusion: These data suggest that patients with CHF have lower 
preload in RL compared to LL and may help to explain trepopnea. 
853-75 
Discordant Effects of ~ am Nitroprusside an 
Left Atrial CcIltril11tian to ventricular FillinI in 
Dogs with Olranic Heart Failure 
Tatsuji Keno, Bani N. sabbah, H:IWard RcsIIBn, M:.tlsin 
Alam, Sidney Goldstein. Henry Ford Heart am Vasrular 
Institute, Detroit, Midligan 
'lhe effects of intraverDlS dci:JUtamine (1XlB) (4 
m.:lqjkg/min) am nitroprusside (NIT) (3 m.:lqjkg/min) on 
left atrial (IA) oantribltian to LV fillirq was 
examined in 7 dogs with cilranic heart failure pr:oduced 
by sequential .intracaranary microembolizatians. '!he 
tiJDe-vel.ocity integral of the early rapid fillirq 
oc:.qx::llellt (Ei) and the IA ~ (Ai) of mitral 
inflow were measured usin;J Dq:Jpler ecbocardiogralily. 
'lhe ratio Ei/Ai, LV ejectian fraction, LV 
~lic wall stress (a), LV em-diastolic 
cilamber stiffness (S) ani IA dimensian (LAd) were 
measured at baseline (B) ani durirq steady state IXlB 
am NIT infusian. 
B IXlB B NIT 
LV EF (t) 26±1 40±5 t 25:t2 JJ±2 t 
a (glen) 86±J 106±4 § 8G:t5 52±5 § 
S (llIItiJ/ml) .27±.OJ .J6±.04 t .25:t.02 .18±.02 t 
LAd (en) J.l±.l J.4±.2 t J.l±.l 2. 7±.1 t 
Ei (en) 5.6±.4 6.5:t.J* 5.4±.4 6.2±.5* 
Ai (en) l.l±.l 1.0±.1 1.0±.1 1.4±.1 § 
Ei/Ai 5. 4± • .L.L.0±1.!lj 5.7±.l.........i..5:t.1!-
[*=P<.05; §=P<.02; t=P<.Ol far B vs. IXlB ar NIT] 
IXlB increased EF, a, s, :cAd am Ei/Ai. NIT increased 
EF mt: reduCled a, s, :cAd am Ei/Ai. a:n::lusian: '!he 
results iniicate that IXlB decreases IA oantrimtian to 
LV fillirq by inc::reasirq IA 't«lIitload (increased a, S) , 
whereas NIT increases IA oantimtian to LV fillin;J by 
decreasirq IA 't«lIitload. 
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854-22 
PET PredictloD 01 Tissue Viability iD Acute ID'aret PatieDts by 
SemiquaDtitative aDd QuaDtitative MeasuremeDts 0' Blood Flow, 
Oxidative aDd Glucose MetabolislB 
Johannes Czemin. Gerold Porenra, Janinc Krivokapich. Richard Brunken. Jan 
Tillisch. Michael Phelps. Heinrich Scbelbert. UCLA School of Medicine. Los 
Angeles. California 
To examine wbelber absolute measlRmenlS of blood flow (MBP). oxidative 
metabolism (It mono. min-I) and glucose utili7alion (MRGlc) are superior 10 
semiquantitative indices of metabolism relative 10 flow (match·M; mismatch· 
MM) for predicting functional recovCly of acutely injured myocardium, 11 
patienlS were studied 86±37 hours after an acute infarction (MI) using dynamic 
PET with previously validated IrlICer kinetic models for N· \3 ammonia, FOG 
and C-lI acetate. Segmental wall motion was assessed using 2D-echo on the 
day of PET and 100±33 days after the MI. There were 25 dysfunctional 
segments. Wall motion improved by I grade in 1(¥25 segmenlS (IMP; 40%) and 
remained unchanged in 15 (No-IMP; ~). MBF and II; mono were higher in 
IMP (O.69±20 vs 0.38±O.19 mVg/min and 0.062±O.OO7 vs 0.038±O.009 min•
I; p<O.OOI). while MRGlc was similar for both groups (0.34±0.15 vs 
0.28±O.l8 lUIIoIIg/min). Quantitative measuremenlS as weU as their normalized 
values (expressed in % of those in normal myocardium) were used 10 establish 
retrospectively the best threshold (TH) 10 discriminate IMP from NO-IMP. 
••••• ··:p<O.I.OOI.OOOI by),.2 
IMP NO·IMP 
1M true false true false 
MM·M·· 10 5 10 0 
K mODO'" 0.05 10 0 15 0 
MRGlc 0.25 7 8 8 2 
% MRGIc" 75% 10 5 10 0 
MBF' 0.45 10 6 9 0 
K mono and MBF were related linearly in IMP (y=O.028+0.023x:r=O.55; 
p<0.05) but were uncoupled in NO-IMP (y=0.06+0.0002x: p=NS). The 
uncoupling of oxidative metabolism from blood flow might be explained by an 
increase of oxygen extraction which might be a prerequisite 10 maintain acutely 
injured tissue viable. Thus, quantitative measuremenlS of MBF and MRGlc do 
not improve the high predictive accuracy of the MM-M. Conversely. 
quantitative indices of oxidative metabolism predict accurately the functional 
outcome of acutely injured myocardium. 
854·23 
Patient Characteristics, Electrocardiographic Findings 
and Prognosis of Suspected Myocardial Infarction Patients 
who Present with ST Depression 
Rai Shiang Lee, Stephen Cross, John Rawles, Kevin 
Jennings. Department of Academic Cardiology, Aberdeen 
Royal Infirmary, Scotland, UK 
Patients recruited into GISSI and ISIS-2 trials who 
presented with ST depression (STl) had a high mortality 
(16-19%). To determine the rea.ons for this and the 
diagnostic and prognostic value of the presenting 
electrocardiogram (ECG), we studied all patients with 
suspected acute myocardial infarction (AMI) who 
presented with STl during 1990. Of the 136 patients (84 
male, mean age (SD) 68 (11) years), 74 (54%, 48 male, 
age 68 (11) years) had confirmed infarction. Previous 
MI occurred in 73 (54%) patients. The severity (SEV) 
and the number of leads (L-dep) showing STl were helpful 
in diagnosing AMI (Sen=sensitivity, Spec=specificity): 
Sen Spec Sen Spec Sen Spec Sen Spec 
SEV > 3mm > 4mm > 5mm > 6nnn 
41 90 20 97 1'2 98 5- 100 
L-dep > 4 leads > 6 leads > 7 leads > 8 leads 
74 552 35 84 21 95 7 100 
Rine .anth's mortality: 22% for all patients and 28% for 
those with confirmed infarction (71% had previous MI). 
For presenting ECC: STL of 1 m - 8/72 (11%) died, >2 mm 
- 22/64 (34%) died; p <0.01. Number of leads showing ST 
L < 2 leads = 2/28 (7%) died, >3 leads = 28/108 (26%) 
died; p < 0.05. Patients with AMI subsequently excluded 
have a surprisinglY high mortality of 15% (48% had 
previous MI). concluSi1n: Patients with suspected AMI 
who presented with ST had a high mean age, a high 
incidence of previous MI and a poor prognosis. STl of 
>4 mm or in > 7 leads is high\y specific for the 
subsequently diagnosis of AMI. ST ~ of > 2 nnn or in > 3 
leads identified patients with poor prognosis. 
JACC Vol. 21, No.2 
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854-24 
Have Changes in the Management of Acute Myocardial Infarction 
Between 1980 and 1990 Reduced Late Arrhythmic Complications? 
David Radzik, Mario Talajic, Denis Roy, John T.Y. Hii, 
Bernard Thibault, Pierre Tht!roux, David Waters. Montreal Heart 
Institute, Montreal, Quebec, Canada 
To better understand the impact of aggressive management on the 
incidence of early and late arrhythmic complications of acute 
myocardial infarction (AMI), we compared the I·year follow·up of 
2 series of 100 consecutive pts admitted to our coronary care unit for 
AMI in 1980 and in 1990. Arrhythmic complications were divided into 
ventricular tachycardia or fibrillation (VTNF), syncope with inducible 
sustained VT, and sudden death. Time to admission was longer (l6±25 
vs 5±9 hrs, p=O.OOI) and the incidence of anterior MI was higher 
(40% vs 20%, p=0.(03) in the 1980 group compared to the 1990 
group. Early aggressive therapy was significantly more common in the 
1990 group: thrombolysis (57 vs 0 pts), IV nitroglycerin (80 vs 2 pts), 
IV heparin (87 vs 23 pts), PTCA (19 vs 0 pts). The number of pts 
treated with ,6·blockers (40 vs 40) and antiarrhythmic drugs (6 vs 5) 
was similar between groups but more pts in the 1990 group received 
aspirin (78 vs 2, p<O.OOI). Early VTNF was more common in the 
1990 group (17 vs 8, p=O.09), perhaps due to reperfusion or earlier in· 
hospital care. 














Conclusion: The dramatic changes in the management of acute MI over 
the past decade have resulted in a lower incidence of major late 
arrhythmic events. 
854·25 
QT Interval, a Strong Predictor for 1 Year Cardiac Death 
After Acute Myocardial Infarction In Patients Without 
Hospital Discharge Medication 
Staffan Ahove', Elisabeth Gilpin, John Ross Jr., 'Karolinska Institute, 
Cardiology, Huddinge HospHal, Stockholm, Sweden and Cardiology, 
UniversHy of CalHcmia, San Diego, CA. 
aT interval is known to be related to prognosis after AMI. but ns role in 
combination with other factors in defining risk groups has not been 
specified. 
We examined clinical characteristics and 1 year cardiac mortalHy in 
2089 hospHal survivors of AMI enrolled in a prospective collaborative 
study. In contrast to most other studies, there was no upper age limit for 
study entry. From a hospital discharge resting 12·lead ECG the aT interval 
was measured prospectively and corrected for heart rate (OTc). A 
rnuttivariate analySis was perlorrned using hospital discharge data: age, 
physical examination, medical therapy, ECG, LVEF and 24 hr Hotter 
monitoring. Ventricular arrhythmias were coded aocording to Lown. In 
order of importance age, LVEF, use of diuretics, complex ventricular 
arrhythmias and OTc were significant predictors for 1 year cardiac mortalHy, 
and yielded a sensitivHy of 77% and a specificHy of 73%. OTc was not 
signHicantly related to different types of ventricular arrhythmias, and 
correlated poorely to LVEF (coefficient ·.19). Patients who died within 1 
year had longer OTc compared to survivors (.43±.05 s vs .41±.04 s, 
p<.01). Because of medication and pacemaker therapy which influence 
OTc, a muttivariate analysis was perlorrned in patients (11=334) without 
such therapy using age, diureticS, discharge physical and ECG data. 
Ranked in order, OTc, bibasilar rales and ORS duration were of significant 
importance to predict 1 year outcome yielding a sensitivHy of 44% and 
specificHy of 81%. Patients who died wHhin one year (nz 22) had longer 
OTc than survivors (.44±.04 S VS .41±.04 S, p<.Ol). When the optimal OTc 
of .440 s was used as a cutoOff value, OTc alone yielded a sensitivHy of 
59% and a specificHy of 83% to predict 1 year total cardiac mortalHy. 
We conclude that OTc measurement is useful for assessi:1Q 1 year 
prognosis at hospital discharge after AM I especially in low risk patients 
without drug and pacemaker therapy. 
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854-26 
Long-Tara Results of a 12-Year Bxperience With Infarct 
Angioplaaty: COmplete Revaacularization Prior to 
Dilllllisaal IIaprogetI Lata Survival 
Donald R. Westerhausen, James O'Keefe, Barry D. 
Rutherford, Lee V. Giorgi, Thomas M. Shimshak, 
Geoffrey o. Hartzler, 
Mid America Heart Institute, Kansas City, MO 
Infarct angioplasty without thrombolytic therapy was 
performed in 900 consecutive patients between 1980 and 
1992. Mean age was 60 years, 21\ of pts were over age 
70, and 8\ presented with cardiogenic shock. Elapsed 
time from pain onset to angioplasty was 5.4 hours. 
Infarct vessel recanalization was achieved in 94\; 
overall in-hospital mortality wae 7.7\. Multivariate 
correlates of in-hospital mortality were cardiogenic 
shock, failed infarct PTCA, LVEF < 40\, 3-vesael 
disease, and age > 70 yrs. Multivariate correlates of 
late mortality (mean follow-up of 45 months) were 
shock, age > 70 yrs, LVEF < 40\, and incomplete 
revascularization at the time of-dismissal. ACTUARIAL 
SURVIVAL, !....z! ~ l...1!! 
Overall 95\ 85\ 77\ 
Shock 82\ 46\ 36\* 
Nonshock 96\ 87\ 79\ 
Age ~ 70 *p<.001 for 89\ 71\ 55\* 
Age ~ 70 each subgroup 97\ 84\ 71\ 
LVEF ~ 40 pair 88\ 73\ 66\* 
LVEF > 40 98\ 90\ 81\ 
Incomplete revascularization 91\ 80\ 71\* 
Complete revascularization 97\ 88\ 81\ 
CONCLUSIONS: Early and late mortality in pta 
undergoing infarct angioplasty was correlated with 
cardiogenic shock, age ~ 70, and LVEF ~ 40\. Complete 
revascularization prior to hospital dismissal was 
important to long-term survival. 
854·27 
The Prognosis in lIyOCardial Infarction in 
Relation to Sex. 
Bjorn W. Karlson, Marianne Hartford, Johan 
Herli tz . Division of Cardiology, Sahlgrenska 
Hospital, Goteborg, Sweden 
If there is a different prognosis in male and 
female infarct patients is under debate. Some 
studies have shown that female sex is an inde•
pendent risk factor, some have shown no dif•
ferences between the sexes. We have therefore 
studied differences, especially prognostic 
ones, between men and women in 921 consecutive 
infarct patients. 
Of the 921 patients 33% were women, whose 
median age was 7 years higher than for men 
(p<O.OOl). The women more often had a history 
of hypertension (p<O.OOl) and congestive heart 
failure (p<O. 001), and they more often 
developed acute congestive heart failure 
(p<0.05) . 
The in-hospital mortality was 19% for women 
and 12% for men (p<0.01). The one-year morta•
lity was 36% for women and 26% for men 
(p<O.Ol). However, female sex was not an 
independent risk factor for death in multi•
variate analysis. 
Conclusion: If women seem to have a worse 
prognosiS than men after myocardial infarc•
tion, the explanation is probably that the 
women are older. In Goteborg female sex is not 
an independent risk factor for death during 
one year after myocardial infarction. 
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854-28 
Iffect of captopril Therapy on Post MI outcome in 
Patients with and without a Patent Infarct•
Related Artery 
Gervasio Lamas, Greg Flaker, Gary Mitchell, 
Sidney Smith, Bernard Gersh, Jean L. Rouleau, 
Marc Pfeffer, Eugene Braunwald, for the 
SAVE Investigators. Brigham and Women's 
Hospital, Harvard Medical School. Boston, MA. 
The role of a patent infarct-related coronary 
artery (IRA) and of post-MI captopril (CAP) were 
studied in 750 patients (pts) in the SAVE trial 
who underwent catheterization up to 16 days post 
MI. EF was </=40% in all cases. Initially, 
519 (69%) had a patent IRA; after angio-
plasty and/or bypass, 616 pts (82%) had patent 
IRAs. Patients with patent IRAs had higher EF 
(patent v. occluded: 32+/-6 v. 30 +/-7; 
p<0.002), less mitral regurgitation (13% 
v. 29%, p<O.OOl), and a lower prevalence of 3 
vessel disease (18% v. 29%, p=0.02) than did 
occluded IRA pts. The incidence of a combined 
clinical endpoint (cardiovascular death, or 
severe heart failure, or recurrent MI, or EF 
deterioration) at 3.5 years' follow-up was 36.0% 
in the patent group and 50.7% in the occluded 
group (p=0.002). Multivariate analysis showed 
that both IRA patency (p=O. 003) and captopril 
therapy (p=0.002) independently improved patient 
outcome. 
IRA-PATENT IRA-OCCLUDED 
CAP no CAP CAP no CAP 
EVENT RATE% 32 41 43 59 
In conclusion, a patent IRA appears to exert an 
independent protective effect. Captopril is 
beneficial in post-MI pts with patent as well as 
occluded IRAs. 
854-29 
Prognostic Value of Neurohumoral Activation in 
Acute Myocardial Infarction 
Torbj0rn Omland. Torbj0rn Aarsland. Asbj0rn Aakvaag. 
Rolv Terje Lie. Kenneth Dickstein. Central Hospital 
in Rogaland. Norway 
Assessment of neurohumoral variables may provide an index 
of prognostic value in acute myocardial infarction (MI). 
The relationship between 1 year mortality and plasma 
levels of atrial natriuretic factor (ANF) and norepineph•
rine (NE) obtained on day 3 following MI was determined 
in 145 patients (age 58 (10) (SO) years). During the 
follow up period 17 patients died. Both ANF and NE were 
independently related to mortality (ANF: p=0.015; NE: 
p=0.003). The patients were stratified into two groups 
according to the median plasma concentration of ANF 
(30.3 pmol/l) and NE (2.29 nmol/l) for construction of 
Kaplan-Meier survival plots (figures). A significantly 
increased mortality rate was observed in patients with 
elevated ANF (p=0.0008). but not NE levels. 
. sao 
---- ANf, 30.3 pMol/l 
- AHF > 30.3 pmoV! 
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••• __ NOf1!pmlphnnt" l.29n.olll 
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0..,. 
These results suggest that ANF measurements in particular 
may provide valuable prognostic information in acute MI. 
while the predictive value of NE seems to be limited to 
patients with very high plasma levels. 
854-30 
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The Salutory Effecta of Captopril on 
aecurrent Myocardial Infarction: The 
SAVE Trial Experience. 
John D Rutherford, Marc A Pfeffer, Greg C 
Flaker, Bela B Hackman, Peter R Kowey, Henry S 
Miller, Lemuel A Moye, Jean L Rouleau, and 
Eugene Braunwald, for the SAVE Investigators, 
from the Department of Medicine, Brigham and 
Women's Hospital, Boston, MA. 
Survivors of MI are at increased risk for 
subsequent ischemic events. The purpose of this 
study was to determine the predictors of 
recurrent (Re) MI and to ascertain its impact on 
subsequent mortality. 
In the SAVE Trial 303 (14%) of the 2231 patients 
(pts) experienced at least one ReMI which was 
more likely to occur in pts with diabetes 
mellitus, hypertension and a higher prevalence 
of angina and functional disability prior to the 
index MI,P < 0.001. Importantly, ReMI was 
independent of LVEF. ReMI was associated with a 
sevenfold increase in the relative risk (RR) of 
death. Therapy with captopril reduced the RR of 
ReMI by 25%, P=O.015 and also reduced the RR of 
death after ReMI by 32%,P=O.029. 
In conclusion, a subset of post MI pts at higher 
risk for ReMI can be identified with simple 
clinical descriptors. Captopril therapy reduces 
the risk of development of ReM I and, of those 
who develop ReMI, captopril reduces subsequent 
mortality. In contrast to cardio-vascular death 
and severe heart failure ReMI was independent of 
LVEF suggesting the possibility that captopril 
could be useful in preventing ReMI in pts with 
maintained LV function. 
854-31 
Beneficial Effects of Late Angioplasty of the Infarct•
Related Coronary Artery on Subsequent Left Ventricular 
Remodeling After Acute Myocardial Infarction 
Wing-Hung Leung, Chu-Pak Lau, Cardiology Division, Department 
of Medicine, University of Hong Kong, Hong Kong 
The severity of residual stenosis of the infarct-related artery has been 
shown to be an important predictor of subsequent left ventricular 
(LV) remodeling after infarction. We evaluated 75 patients (pts) with 
first anterior myocardial infarction and significant disease only in the 
proximal left anterior descending coronary artery on subsequent 
arteriography perfonned 5-7 days after admission. All patients 
received immediate thrombolytic therapy (tPA). Severity of residual 
stenosis of the infarct-related artery was measured as minimum leison 
diameter (MLD) using qtiantitative coronary arteriography. Pts were 
divided into those with MLD ~1.5mm (0=26) or < 1.5mm (n=49). Pts 
with MLO < 1.5mm were randomized to receive angioplasty (PfCA) 
(n=25) or no PfCA (n=24) 5-7 days post-infarction_ LV volumes and 
ejection fraction (EF) were measured by echocardiograpby and 
radionuclide angiography respectively within 7 days after infarction 
and at 1 year. End-diastolic (EOV) and end-systolic (ESV) LV 
volumes were measured by 2-dimensional echocardiography and 
nonnalized to bo<I y surface area. 
At I year MLD ~1.5mm MLD<I.5mm 
follow-up NoPfCA PfCA 
(n=26) (n=24) (n=25) 
% ~EDV +4±5 +24±7* +7±4 
% ~ESV +2±3 +11 ±S* +4±2 
~EF(%) -l±3 -7±4* -2±2 
*p<O.OI vs. other groups (ANOVA); mean ± SO 
Conclusions: I) Pts with high grade residual stenosis (MLD 
< 1.5mm) of the infarct-related artery have more LV dilation and 
functional impairment than those with insignificant residual stenosis 
(MLD ~1.5mm). 2) Late mechanical reperfusion with angioplasty of 
tight residual stenosis of the infarct-related artery significantly 
reduces subsequent LV dilation and functional impairment 
JACC Vol. 21, No.2 
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854-32 
Late Reocdusion after Thrombolysis: Incidence and 
Consequences for Left Ventricular Recovery and Dilatation. 
Albert Meijer, Freek W.A. Verheugt, Christ I. Werter for the 
APRICOT investigators. Free University Hospital. Amsterdam, 
Interuniversity Cardiology Institute. The Netherlands. 
Reocclusion is a major problem after thrombolysis (T) for acute 
myocardial infarction (MI). In a prospective follow-up study of 300 
patients (pts) with a patent infarct artery (IA) at angiography (AG) 
<48 hours after T • second AG (AG2) \\'as done after 3 months in 
248 pts to evaluate IA patency. increase of ejection fraction (dLVEF) 
and subsequent LV dilatation (dV). MI was localized anteriorly in 





anterior 7+12 12+30' 
inferior 2+ 8 5+ 3 
all 4+10' 8+33· 







We conclude that after successful thrombolysis: 
1) Reocclusion occurs in 29% after 3 months. 2) Reocclusion 
precludes recovery of L VEF in anterior MI. 3) LV dilatation occurs 
independently of LVEF recovery and long-term IA patency. There•
fore. additional strategies are needed to prevent both reocclusion and 
subsequent dilatation. 
854-33 
ProlDostlc V.loe or ST,seameDt DepressloD 10 the Early Post. 
10rafttioD Period aad ReductioD hy Thrombolytic Therapy 
Alfred Cheng. Dan Shanit. Robert A Greenbawn 
Cardiovasadar Reoean:h Uait, Edgw_ GencraI Hoopital. Edgware. UK 
We prospectively studied !he iucidence and siguificance of transient. reversible 
ST-scgmcnt depression (fSlD) following acute myocanlial infarctioa (AMI) and 
!he results of thrombolytic !herapy on these changes. 127 patients (pis). 102 
(80%) males and 25 (20%) females. mean age 60%11 yR. wi!h AMI underwent 
24 boon of Holter monitoring immediately after admission 10 the Cardiac Care 
Unit. There were a total of 202 episodes of TSlD in 44 (35%) pIS. Of Ihcsc 44 
pIS. 34 (78%) bad ooIy paioless TSlD (137 episodes); 5 (11%) bad TSlD ooly 
accompanied by chest paia (21 episodes) and 5 pIS bad bo!h painless (39 
episodes) and painful (5 episodes) TSlD. Thirteen of the 23 (57%) patients wbo 
did not receive thrombolysis developed TSlD whereas 31 of 104 (30%) patients 
receiving thrombolysis developed TSlD (p<0.02). After 6 monlhs follow up. 
further cardiac events occurred in 35 of 44 (80%) pIS wi!h TSTD ooMp""'d wi!h 
35 of 83 (42%) of !hose wilhout TSlD (fable) (p<O.OOO4). The scusitivity of 
TSlD as a predictor of further cardiac events in the six moalhs following AMI 
was 49%. specificity was 81 % wi!h a predictive value of 75%. 
We condude chat silent TSTD is seven times more common chao TSTD 
accompanied by chest pain immediately following MIl Thrombolytic therapy 
almost balved !he incidence of TSTD. TSTD detected in the first 24 hours 
following AMI is a useful predictor of an inaeased incidence in cardiac events 
over !he following six moalhs. 
Table : , mootb clio leal outcome of palieDts with aad without 
ST ,seameDt depression 
ST.selmeDt No ST .segmeDt 
Sllalfleaaee Outcome depressloD depressloD 
n=44 0=83 
No complications 9(20%) 48(58%) !"'<l.0004 
Total cardiac events 35J80'lhl 35J42'lhl_ chi-SQUare 
Death or DOD-fatal 14(32%) 14(17%) p<0.05 
reinfarctioo 
Post-infarction or 20(46%) 21(25%) p<O.04 
unstable aoltina 
Ventriadar tachvcardia 12% 00% NS 
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855·50 
Lett Ventricular Functio. is not Altered by Transieat 
Ischemia in Man. 
Paolo Marzullo. Gianmario Sambuceti. Oberdan Parodi. Alessia 
Gimelli. Monica Bartoli. Danilo Neglia. Antonio L'Abbate. CNR 
Institute of Clinical Physiology. Pisa.Italy. 
To assess whether post-ischemic ventricular dysfunction (myocardial 
stunning) occurs in man following periods of ischemia. left 
ventricular systolic (ejection fraction. EF) and diastolic (peak filling 
rate. PFR) function was studied by radionuclide angiography in 52 
patients. Group I consisted of 15 patients studied before. during and 
after episodes of angina at rest. Twenty patients with stable effort 
angina were studied in the same way and constituted group 2. Group 
3 consisted of 17 patients studied immediately before and following 
coronary angioplasty. Medical therapy was discontinued 48 hours 
before the study in all patients except in those patients undergoing 
coronary angioplasty that were under Diltiazem I8Omgldaily. In all 
patients of group I and 2 EF declined more than 5% during ischemia; 
all patients of group 3 showed ST segment displacement and/or chest 
pain during angioplasty. Transient ischemia lasted for 134±48. 
155±20 and 120±60 seconds in the three groups. respectively. 
Control scans were performed 7±3 minutes and 20 minutes in 















Persistence of systolic or diastolic dysfunction was not observed in 
any of the 3 groups in the recovery phase of ischemia. 
In conclusion. transient ischemia in man did not re-produce the 
phenomenon of systolic and diastolic stunning observed in animal 
experiments. The duration of ischemia appears to be the most striking 
difference between animal and clinical data. Stunned myocardium 
should be investigated in different clinical models of more prolonged 
ischemia such as myocardial infarction and unstable angina. 
855-51 
Circadian Pattern of Ambulant Myocardial Ischemia in 
Asymptomatic and Minimally Symptomatic Patients With Coronary 
Artery Disease 
Prakash C. Deedwania. Carl J. Pepine. Peter F. Cohn. Robert S. 
Gibson. James A. Hill. Udho Thadani. Eileen Handberg. Alice 
Boyette. for the ASIST study group. VAMC/UCSF Fresno. CA 
Acute MI and sudden cardiac death show a circadian pattern. The 
increased density of transient ischemic events (TIEs) in the 
morning may trigger coronary events. Prior studies have evaluated 
relatively small number of patients (pts). Accordingly. we 
examined the circadian pattern of TIEs in 1.229 pts with 
asymptomatic or mildly symptomatic CAD by 48 hr ambulatory 
ECG (AECG) recordings. All pts had CAD. exercise-induced 
ischemia and were off antianginal drugs except NTG. During 
58.992 hours of AECG. 291 (24%) pts had =::2 TIEs (1 xl xl rule) 
or a single TIE =:: 5 min. A total of 1.137 TIEs were observed and 
accounted for 22.382 min of ischemia during AECG. Hourly 
comparison of frequency of ischemic events revealed that most 
TIEs (n = 86) occurred between 8 and 9 am with the longest 
duration (1.552 min) of ischemia between 9 and 10 am. To assess 
the circadian pattern of ischemia during the monitoring period. the 
AECG findings were evaluated in 4 six-hour time blocks: 
~ 6am-12om 12pm-6om 6om-12om 12am-6am 
Number 65±14 57±8 45±19 23±5 
Duration 1241 ± 258 1081 ± 139 907 ±390 500± 138 
The hourly frequency of TIEs was significantly (p < .001) different 
between 4 time blocks with the greatest number (389 TIEs) and 
longest duration (7,446 min) of TIEs seen during the period of 6am 
to noon. In summary. patients with CAD are at highest risk of 
developing TIEs between 8 and 10 a.m. The increased density of 
TIEs during this period might act as a trigger for coronary events 




Tbe Activity 01 Myocardial Ischemia Increases WitJa Plasma 
CIaoIesteroi 
Khether Raby, Thomas Andrews, Alan Yeung, Joan Barry, Gina 
Fantasia, Andrew Selwyn. 
Plasma lipids profoundly alter the biology of atherosclerotic 
lesions. To determine if elevations in plasma cholesterol (em.) 
are associated with increased activity of myocardial ischemia, we 
sampled em. at the time of 48 hour ambulatory monitoring off 
anti-anginal medications (em. lowering medications were 
unchanged) in 185 patients (YfS) with prior myocardial 
infarction, coronary artery disease on angiography, or abnormal 
thallium imaging who had ST depression (STD) on a graded 
exercise test. Presence of STD, number of episodes of sm, and 
total STD duration on monitoring were compared in YfS with 
em. levels of .s.200, 201-240, 241-280. and >280 mg/dI, 
respectively_ There were 149 men and 36 women, ages 42-83 
years (mean 63). Coronary anatomy was known in 89 YfS (48%) 
CBL (m&ldD ..s.liI!l ~IU-~ lli:lH 2l8Il 
No. of YfS 78 53 32 22 
STD present 41(43%) 25(47%) 24(75%)" 14(74%)" 
>6 episodes 6(8%) 3(6%) 7(21%)" 8(36%)" 
>J!l mimJt§ lZUS2f2) J(!i2f2) 2(ZB2f2)" ~ 
("=p<O.05 by ANOVA) 
Age, history of chest pain, exercise capacity, time to STD during 
exercise, and degree of coronary artery disease were evenly 
distnbuted in all 4 em. groups. In YfS with stable coronary 
artery disease, elevations in serum CHL are associated with 
increased activity of myocardial ischemia. 
855-53 
Is There a High Prevalence of Complex Plaque in Patients with Asymptomatic 
Cardiac Iscbemla? Qualitative and Quantitative Description of Coronary 
Anatomy in Patients in the ACIP Study 
Bany L. Sbaraf. David O. Williams, Robert P. McMahon, Joan Bany. Preben 
Bjerregaard, Richard F. Davies. A. David Goldberg. Michael Parks. Carl 1. Pepine. 
George Sopko and C. Richard Conti. For the ACIP Investigators. Rhode Island 
Hospital, Brown University. Providence. Rhode Island 
Asymptomatic cardiac iscbemia is associated with a higb risk fer an adverse 
outcome butlittie is known about the coronary anatomy of these patienlS (pIS). 
Prior to enrollment in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Swdy pIS 
with an abnormal exercise tolerance test and at least one asymptomatic episode of 
ischemia on a 48 bour atnbuIatcry ECG underwent coronary angiography to 
document the presence of coronary artery disease (>50% stellOsis in a major artery 
or branch). The coronary anatomy of 171 pIS enrolled was characterized both 
quantitatively (stenosis severity) and qualitatively (lesion complexity). In this 
preliminary analysis. the mean age was 61.5 years. 154 (90%) were male. 61 (36%) 
bad a history of prior MI. '11 (53%) bad a recent bistory of angina, and the majority 
(88.3%) had an ejection fraction >50% at study entry. 
Of the 171 pIS. 44 (26%) bad single vessel. 69 (40%) bad double vessel. and 58 
(34%) bad triple vessel disease. The worst stenosis per patient averaged 86.7 ± 
15.0% (S.D.) diameter reduction. Over half (56%) bad 3 or more lesions of 50% or 
greater. Over 'lJ3 (67%) of pIS bad a >50% stellosis in the proximal LAD. RCA. or 
LCX. Total occlusions were common in this population as 113 (33%) of pIS bad a 
100% stenosis with TIMI grade 0 flow. All but I of these pIS bad at least partial 
collateraIs. An additional 38 (22%) pIS bad abnormal flow (TIM! Grade I or 2) 
with a 95·99% stenosis. 
More than balf of the pIS (59%) had a suggestion of a complex plaque with 
possible ulcer. thrombus or irregular lesion contour. Defmite angiograpbic 
evidence for complex plaque was present in 15 (9%) pIS with ulcers and in 5 (3%) 
pIS with thrombus. 
We conclude that the majority of these pIS with asymptomatic atnbulatory iscbemia 
bave severe coronary artery disease and a significant percentage bave angiograpbic 
evidence of a complex plaque. Correlating anatomy with the extent of ischemia 
may clarify the mechanisms involved in asymptomatic cardiac ischemia and in the 
bigb risk for an adverse outcome. 
855-54 
JACC Vol. 21, No.2 
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"Clandestine Ischemia"1 Asymptomatic and Electrically 
Silent Myocardial Ischemia During Upright Leg Cycle 
Ergometry Vel'llWl Treadmill Exercl8e 
Kim' A. Williams, Linda A. Taillon, and James E. Carter, Jr. 
The University of Chicago, Chicago, 11. 
Background: The incidence of "clandestine" (asymptomatic 
and electrically silent but 8cintigraphically evident) myocardial 
ischemia was examined during treadmill and upright leg cycle 
ergometric studies of 39 patients. Metbodal All patients had 
angiographic coronary artery disease and reversible ischemia on 
both thallium-201 scintigraphy and first-pass radionuclide 
angiography. Exercise was performed to a similar double 
product for both tests. ResuJ.tB: Angina pectoris was signifi•
cantly more frequent with treadmill exercise than with leg 
cycling (11/39 VB. 2/39, p=0.OO79). The exercise ECG was inter•
pretable in 33 of the 39 patients; ischemic ST-eegment shifts of 
.. 0.1 mV horizontal or downs loping (or .. 0.15 mV upsloping) 
occurred in 17 (52%) of the treadmill studies, but in only 6 (18%) 
of the leg cycle studies (p=0.0025). Ischemia was evident by 
symptoms or ECG in 22 patients (56%) with treadmill testing, 
but in only 7 patients (18%) with leg cycling (p=0.OOO3). Those 
that developed symptomatic or ECG evident ischemia during leg 
cycling also did so with treadmill exercise. There were no 
significant differences between the exercise hemodynamic or 
scintigraphic variables of the 22 patients with ischemia manifest 
on treadmill and the 17 with clandestine ischemia. However, on 
multivariate regression analysis, previous coronary artery 
byp81!8 surgery (p=O.Ol) and myocardial infarction (p=0.05) were 
associated with the development of clandestine ischemia. 
Conciusiollll: Clandestine ischemia is a frequent occurrence 
during exercise testing of patients with reversible myocardial 
ischemia. The very high frequency of clandestine ischemia 
during upright leg cycle ergometry raises questions about the 
diagnostic criteria and/or utility of this mode of exercise testing, 
in absence of cardiac imaging, for the evaluation of patients with 
a high likelihood of (or known) ischemic heart disease. 
855-55 
The Unfavourable Prognosis of Silent Ischemia Can be 
Improved by Appropriate Therapy 
Peter Nikutta, Nicola Kurzrock, Victoria Delloch. Paul Wenzlaff, 
Dirk Hausmann, Werner G. Daniel, Paul R. Lichtlen, Hannover 
Medical School, Hannover, FRO. 
The presence of silent myocardial ischemia (SMI) during daily life 
is a marker of an unfavourable outcome and poor survival in patients 
(pts) with stable angina. Whether this prognosis remains worse than 
that of pts without SMI after therapeutic interventions is unknown. 
We therefore analyzed the clinical course of 190 pts with stable 
angina and coronary stenoses> 70% proven by angiography. In 103 
pts, a 48h Holter ECG recorded at the time of initial diagnostic 
revealed SMI, in the remaining 87 pts no SMI was present. On the 
basis of clinical and catheterization findings, pts were treated 
medically, surgically (CABG) or by angioplasty (PTCA). Holter 
results were not involved in therapeutic decision making. Pts were 
followed for 38 ± 12 months and cardiac events and additional 
therapeutic interventions were registered in the 3 treatment groups: 
Medical PTCA CABG 
SMI ± ± ± 
#pts 25 39 42 31 36 17 
Cardiac death 2 2 2 I 
Infarction 2 2 2 
PTCA 2 2 11 11 
CABG 13 56 2 
Kaplan-Meyer analysis for the time-dependent probability of survival 
showed no sign. differences between pts with and without pre•
treatment SMI; cardiac event rates and necessity for specific 
interventions were also comparable. The results indicate, that after 
appropriate therapy the initially impaired prognosis of SMI becomes 
markedly improved and is no longer different from that of pts 
without pre-treatment SMI. 
lACC Vol. 21, No.2 
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855·56 
Vasoconstriction as a Cause of Myocardial Ischeaia 
During Daily Life: COIparison of Albulatory Monitoring 
with Blood Flow Changes During Exercise "'Rubidillll 
Positron E.ission Ta.ography 
Arshed A. Quyyumi, James A. Arrighi, Jean G. Diodati, 
Jose A. Marin-Neto, Robert O. Bonow, Vasken Dilsizian, 
NHLBI, Bethesda, Maryland. 
Although myocardial ischemia occurring at low heart 
rates is considered to be due to vasoconstriction, 
quantitative blood flow dynamics in ischemic myocardial 
segments have not been measured. Using ~Rb positron 
emission tomography in 17 pts with stable coronary 
disease, we studied the relation between ~Rb uptake 
(RBU) (an estimate of myocardial blood flow) in the 
ischemic zones (IZ) during exercise (EX), and the 
characteristics of episodes of ST segment depression 
(STE) recorded during ambulatory monitoring. The ratio 
of EX to rest RBU (rest=100%) was quantitatively 
computed from regional RBU and corrected for arterial 
input function. In 12 of 17 pts, 117 STE (85% silent), 
lasting 4108 min were recorded. With EX, normal zone RBU 
increased by 80±30%. In 11 pts, there was an attenuated 
increase in RBU in the IZ (Group I), whereas in 6 pts, 
RBU was lower than at rest in the IZ (Group 2). 
* p<O.Ol, group 1 versus group2. 
~ ~ III at onset STE 
Group 1 130±20% 2.S±3.3 100±6 bpm 
Group 2 70±20% 4.2±3.1 92 ±S* bpm 
The HR at the onset of STE correlated with the change in 
IZ RBU with EX (R=0.62, P=0.02), indicating that pts 
with the lowest RBU in the IZ had the lowest HR 
threshold, and vice versa. Thus, pts who develop EX•
induced coronary vasoconstriction also have frequent 
ischemic episodes during daily life that occur at low 
HR, suggesting that low heart rate ischemia during 
ambulatory monitoring is secondary to vasoconstriction. 
855·57 
Electrocardiogram Variance Analysis for Detection of Myocardial 
Ischemia· a Comparison with Exercise Test In an Angiographically 
Documented High Prevalence Population 
Jacek Nowak, Christer Sylvan, Inger Hagerman, Olof Nyquist, Marco Vlan. Dept. of 
Medicine and Clinical Physiology, Karolinska Institute at Huddinge Hospital, S·141 86 
Huddinge, Sweden. 
Electrocardiogram variance analysis (V·ECG) is a new 22·lead resting ECG 
~edure for detection of coronary artery disease (CAD). The method measures 
Ischemia·induced variability of the depolarization phase. The analysis is pertormed 
on 220 cardiac cydesltead (sampling Ir. 4 kHz, fr. range 0.05 • 1500 Hz) and the phase•
locked electrical variability is presented as an electrical heterogeneity index (CAD-I, 
tang!! 1 - 150). 
This study compares the diagnostic accuracy of V·ECG with that of exercise stress 
test (bicycle elllometer, 10 W/min tamp) in 199 symptomatic patients evaluated with 
coronary angiogtaphy. Receiver opetating characteristic (ROC) curves were 
constructed for both methods by successive consideration of several cutrints 
{CAD~O to CAD~5 and ST -depression ~1 mm and ~ mm, respectively. 175 
patients with CAD (~O% luminal stenosis in 1 + major epicardial arteries) presented 
a mean CAD·I of 88±22 colr4lared to 70±21 in 24 patients with normal arteriograms 
(p<O.OI). V·ECG provided a stochastically significant (p<O.OI) discrimination (A) 
matched by exercise test only when the chest pain criterion (C) was added to ST· 
depression (S). At a cutpoint of CAD·I~70 (conresponding to S1' -depression ~1 mm 
and chest pain) V·ECG elicited significantly higher (p<O.OI) sensitiVity than exercise 
lest (79% vs. 48%). 
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Conclusion: V ·ECG is an efficient diagnostic method which compares favourably to 
exercise test for detection of CAD in a high prevalence population. II combined, the 
two methods identify 93', of angio-graphically documented CAD cases. 
ABSTRACTS 
855·58 
SILENT ISCHE"IA ON THE TREADmL IN OUTPATIENTS WITH PREVIOUS NYOCARDIAl 
INFARCTION: CLINICAL SIGNIFICANCE AND LONG-TERN PROGNOSIS. 
Gianni Casella, Pier Calillo Pavesi, Naurizio Nezzetti, Pietro Sangiorglo, 
Daniele Bracchetti. 
Cardiology Section - Ospedale Naggiore, Botogna ITALY 
In order to assess clinical/prognostic significance of exercise-induced 
silent ischeaia in out-patients late frol Iyocardial infarction IAN1), .e 
evaluated 7b9 consecutive patients (pts.) .ho under.ent frol ~/1/19B8 to 
10/111991 a sYlptol-lilited IBruce protocol) Treadlill test at least 1 yur 
after a Q .ave ANI and .hose clinical and exercise data .ere prospectively 
entered in the cOlputerized database used in our Insti tution, Frol this study 
population 3 different subgroups .ere retrospectively identified according to 
exercise results: Group 1 = pts •• ith silent e,ercise ST depression In:1~bl; 
Group 2 = pts .• ith sYlptolatic exercise ST depression (n:7~); Group 3 = pts. 
.ith negative test In:991. The lOin clinical and exercise test data, cardliC 
events and total lortality in the folloo-up .ere evaluated. 
Group 1 Group 2 Group 3 
15b pts. 7~ pts. 99 pts. 
Age Iyrs.): ~b.3~9.3 5b.9t1l ~b. ~:B.b NS 
Exercise tioe (sec): m~1~3 39~~173 b1B~152 (0.05 
HR/BP product (11000): 23.0~0.~ 19.7~0.4 25.8~0.5 (0.05 
Unstable angina In,I): 8 I~I 11 (14) 3 13) =0.005 
Reinfarction In,I): 2 11.31 b 18) 2 (2) =O.Olb 
PTCA/CABG In, %) : b 13.8) 13 (17) 3 (3) (0.001 
Death overall 12-yrs): 4 (2.~) ~ Ib.b) 1 III NS 
The Authors conclude that out-pts •• ith previous ANI .ith silent e,erClse•
induced ischeaa do have 100 risk of coronary events laverage annual lortality 
rat. 1.2%) and .hen cOlpared olth sYlptolatic they represent a subgroup .Ith 
inbraediate risk response in the broad spectrul of exercise-induced ischeaia. 
Furtherlore this study does not support the concept that silent exercise-indeced 
ischelia in pts. oith sYlptoaatic CAD has unique adverse prognostic 
consequences. 
855·59 
Does Spontaneous S)uolic Dysfunction at Rest Mean Episode IIf 
C"ronary I ;chemia in Angina Patients ? 
Hisashi Katayama. Hitoshi Yoshikawa. Yultihiko Momiyama. Susumu NakatIawa. 
Susumu Ui. Mitsuru Kimura. Taka;hi Hirolani. Katsuhiko Motegi. Tadashi 
Kameda. Tokyo Saiselkai Central Hospital. Tokyo. Japan 
The ambulatory functioning monitoring (VESn is capable of identifying epi•
sodes of ejection fraction (EF) fall at rest in patients with coronary anery disease 
(CAD). To investigale !he palhopbysiology of EF fait. \3 CAD patients who had 
critical stenosis on coronary arteriograms underwent continuous VEST monituring 
before and after surgical.., angioplasty revasculization (REV). While patients wore 
!he VEST and sa! quielly for 15 min. EF. end systolic volume (ESV). and end 
diastolic votume (EDV) were derived every 15 sec. All of an EF fall more than 3% 
for more than 30 sec were detected ifigure). then an EF fall more than 6% for more 
than I min was determined as a significant change (SC) of EF fall. lllere weno 8 
episodes of SC in 7 patients befvre REV, but none of SC was seen after REV. In 
each of all SC the rise of ESV was 
significantly grealer than the 
,te.ren.ent of EDV 111.0 ± ·U% vs 
2,4 ± 2.0% (I'Oth vailie'; are shown 
as a rano to EDV of previnus ~od). 
p = (:'(X>3 i. The duration of 
nonsigmflCanI change of EF falf in 
each of 6 patients not dell1Ol1~trating 
any SC was decreased significantly 
after REV [1.8 ± 1.0 min vs 0.25 ± 
0.39 min. p = 0.03). 
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We conclude that a spontaneous systolic dysfunction in conliooous VEST moni•
toring a! rest is a meaningful marker of an episode of coronary ischemia. fUllher· 
more a minor reduction of coronary flow seems one of etiologies of nonsignificant 




Silent Myocardial Ischaemia: The Role of Endorphins and 
Autonomic Function In Diabetics and the Elderly. 
Bradley Marchant, Kulasegaram Ranjadayalan, Robert 
Stevenson, Adam 0 Timmis. 
London Chest Hospital, London, United Kingdom 
Endorphins and autonomic function may playa role in silent 
myocardial ischaemia (SMI) but evidence has been 
conflicting. This study was designed to assess the separate 
role of endorphins and the autonomic nervous system in 
diabetic and non-diabetic patients with particular reference to 
age. 43 patients (13 diabetic) were randomised between 
naloxone and placebo in a double blind crossover fashion. 
Anginal perceptual threshold (APT), was measured during 
treadmill testing (time from 0.1 mV ST depression to onset of 
angina). 4Bhr Holter monitoring, autonomic function tests and 
somatic pain tests were performed. There was no significant 
difference between diabetic and non-diabetic patients with 
respect to exercise tests, Holter parameters or autonomic 
function. Endorphin inhibition with naloxone significantly 
reduced electrical pain tolerance (1.72±0.19 to 1.39±O.10 
mA, p=O.01), but did not affect APT (72± 16 to 61 ± 19 sec, 
p=NS). There was a tendency towards impaired autonomic 
function in 9 patients who did not experience angina on 
treadmill testing, but these patients were significantly older 
than 34 patients who developed angina on treadmill testing 
(6S.6± 1.6vs60.S± 1.7yrs, p<O.S).ln conclusion, endorphins 
do not appear to play an important role in SMI. Autonomic 
function tends to be impaired in patients without angina on 
treadmill testing, and this may be the mechanism of silent 
ischemia in elderly patients. 
855-61 
Design of the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study 
Genell L Knatterud. George Sopko, Nancy L Geller, Michael Proschan, 
PhIlp L Day, C. Richard ContI for the ACiP Investigators. Maryland 
Medical Research Insl~ute, BaltImore, MO 
The presence of asyrnptomatlc cardiac ischemia (ACI) on a 48-h0ur 
ambUatory electrocardiogram (AECG) In patients with stable coronary 
artery disease Is associated w~h an adverse prognosis. Currently, there 
Is a lack of knowledge as to the relative efficacy of different strategies 
to control ACI. With identification and control of ACI, the potential for 
reduction In morbId~ and mortaI~ Is substantial. Major objectives of 
AClP, an NHLBI-funded, multlcenter, International trial are to: a) 
compare the safety and efficacy of 3 randomly assigned strategies to 
suppress Ischemia; b) clarify Issues for a large trial, such as patient 
avaDabU~ for randomization, compliance with therapies, and estimates 
of fatal and non-fatal events. The 3 management strategies are (1) 
revascularlzation of all Important stenoses; (2) anglna-gulded therapy 
with incremental levels of anti-ischemic medication to relieve angina; 
and (3) angina plus AECG-guided therapy with incrernentallevels of anti•
ischemic medication to eliminate both angina and ischemia on AECG. 
In the two medical therapies, treatment for ACI is placebo-controlled and 
administered double-blind. Within each management strategy, patients 
are esslgned randomly to one of two medical regimens (atenolol 
followed by nifedlpine or dDtiazem followed by lsosorblde dlnitrate) 
unless one of the regimens Is specifically indicated or contraindicated. 
Six hundred patients sumble for revascularlzatlon, with positive stress 
tests and 2. 1 ACI on AECG wDl be recruited from 11 centers and 
followed for 2. 1 year. Patients are stratified by center and angina status 
or previous coronary surgery. The primary end point is elimination of 
ACI on AECG at 12 weeks. The presence of ischemia on the AECG at 
six months and one year, and the presence of arrhythmia on 48-hour 
AECGs wUI also be analyzed. Clinical £Nents (death, MI, occurrence of 
unstable angina, etc.) wi! be ascertained at the time of each follow-up 
visit As of September 4, 1992, 382 patients were enrolled. ACIP wUl 
assess the feaslbil~ of conducting a large-scale trial to determine 
whether amelioration of ACI reduces cardiovascular morbld~ and 
mortaI~. 
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856-38 
ECG Algorithm For Predicting Radlolrequency Ablation Site in 
Right-Sided Accessory Pathwaya 
Mayricjo Arruda, Xunzhang Wang, James H. McClelland, Karen J. 
Beckman, Lawrence Widman, H. Andrew Hazlitt, Ian Santoro, Ismaile 
Abdalla, Raed Sweidan, Anatjit Singh, Hiroshi Nakagawa, Kenzo Hirao, 
James Calame, Ralph Lazzara, Warren M. Jackman. 
University of Oklahoma Hea~h Sciences Center, Oklahoma C~, OK 
The purpose of this study was to determine if the site of successful 
radiofrequency ablation in patients (pts) with right-sided accessory 
pathways (APs) could be predicted by the morphology of the deHa wave 
(.0.) during sinus rhythm. Based on a correlation between the de~ wave 
pattem and site of successful ablation in 85 patients with a single 
antegrade conducting right-Sided AP, the Iollowing algorithm was devised. 
Results: These symbols are used to indicate delta wave morphology: +•
positive .0. . +=Isoelectric .0. . - =negative .0. ,-
.o.inAVF + ± -
.0. in II + + ± 
.o.inVl + ±,-
QRSaxis + -
Pattern A B C 0 E F 
Ablation Site Number 
Right anterolateral 6 5 0 0 1 0 0 
Rioht anterior 7 6 0 0 0 0 1 
Riltht anteroseolal 14 2 11 0 0 0 1 
Mid septal 4 0 0 4 0 0 0 
Right Q9steroseptal 38 0 3 2 5 2 26 
Richt oosterior 4 0 0 0 0 4 
Rioht DOsterolaterai 2 0 0 0 0 2 
Richt lateral 10 1 0 0 9 0 
ConclUSion: 1) An lsoelectnc or negatIVe .0. an V1 can be used to 
differentiate anteroseptal from right anterior APs. 2) A negative QRS axis 
can distinguish midseptal from anteroseptal APs. 3) A negative .0. in AVF 
identifies right posteroseptal APs. 
856-39 
Magnetocardiographic Mapping of Accessory Pathways 
Using a Multi-Channel Recording System 
Michael Oeff, Lars Hennig, Matthias Jereczek, *Martin Burghoff, 
*Konrad Brockmeier, *Roger Zimmermann, Rolf Schr()der, 
Cardiopulmonary Deptm., Klinikum Steglitz, Freie Universitllt 
Berlin and *Physikalisch-Technische Bundesanstalt, F.R. 
Germany 
To analyze the localization of ventricular preexcitation in space, 
its direction and its conduction velocity, a 3-dimensional 
magnetocardiographic mapping of the ventricular activation was 
performed in 22 patients with Wolff-Parkinson-White 
syndrome. 
This investigations were made in the Berlin Magnetically Shielded 
Room, which allowed an optimal shielding against environmental 
noise and had an intrinsic noise of 5-8 fT / -jHz. After the 
synchroneous recording of 37 precordial magnetocardiograms 
(MCG) using SQUIDs (Super Conducting Interference Devices) the 
progression of the equivalent current dipole (ECD) in space was 
calculated and projected into MR images. 
A variety of accessory pathway (AP) positions could be localized 
in the right and left free wall and the posteroseptal space, whose 
poSitions differed 1 - 2 em in space as compared to invasive 
localization according to electrophysiologic mapping or successful 
catheter ablation. The mean conduction velocity was 1.2 m/sec and 
thus comparable to that of invasive measurements. The abolishion 
of the delta wave after ajmaline infusion revealed the physiologic 
ventricular activation which was seen also beforehand at the end 
of fusion with the delta wave. In 3 patients with concealed AP in 
the surface ECG a short antegrade ventricular excitation was seen 
at the pOSition of the AP, which disappeared after ajmaline 
infusion. 
Conclusions: Magnetocardiographic 3-dimensional mapping using 
synchroneous multi-channel recordings allows the exact 
localization and the analysiS of ventricular preexcitation, which 
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856-40 
Late Block and Recurrence of Accessory Pathway 
Conduction Following Radiofreqency Catheter Ablation 
Xu Chen, Gerhard Hindricks, Stehphan Willems, Wilhem 
Haverkamp, Martin Borggrefe, Mohammad Shenasa, Gunter 
Breithardt. Dept. of Cardio!./ Angiol. and [nst. for Res. in 
Arteriosclerosis., University Hospital, Miinster, Germany 
Accessory pathway (AP) conduction may return after an acute 
successful radiofreqency (RF) ablation. [n contrast, late block of 
AP conduction has also been noted after an immediate 
unsuccessful ablation attempt. The purpose of this study is to 
prospective examine the factors that affect the return of AP 
conduction, and if a late block of the AP conduction can predict 
long-term efficacy. 
Acute block of AP conduction was achieved in 113 of 123 
consecutive pts (91%) following RF ablation. Late block of AP 
conduction was observed in another 5 pts (4%) 1 to 3 days 
following an unsuccessful ablation attempt in which only a 
transient block of AP (return of AP conduction during ablation 
procedure) was noted. AP conduction resumed in 10/113 pts 
(9%) following an acute successful ablation and in 4/5 pts 
(80%) with late block of the AP conduction during a mean 
follow up of 10±6 months (p<O,OI). AP conduction resumed at 
a median of 2 months, varying from 1 day to 13 months. Return 
of AP conduction occurred in 12 of 81 left sided APs (15%) and 
in 2 of 37 (5%) right sided APs (n.s.). Overall, in pts with return 
of AP conduction more ablation attempts and more RF pulses 
were needed. AP location, manifest vs concealed AP and 
repeating RF energy after an effective pulse did not predict AP 
conduction return. 
Thus, AP conduction returned in 9% of pts following immediate 
successful ablation. Late block of AP conduction following an 
immediate unsuccessful ablation attempt did not predict a long•
term efficacy in 80 % pts. 
856-41 
Pitfalls of Surface ECG Preexcitation Patterns Preceding and Fol•
lowing Radiofrequency Ablation in WPW Syndrome 
Christian Weiss, Riccardo Cappato, Karl H. Kuck. University Hospital 
Eppendorf, Germany 
Delta wave polarity provides information on the site of accessory 
pathway (AP) in most cases and may be a guide to catheter position•
ing during radiofrequency current (RFC) ablation procedures. In our 
experience, 7 (5%) out of 136 pts undergoing RFC ablation of mani•
fest APs exhibited a delta wave polarity which was not consistent with 
the AP location (Table; L, left; R, right; BBB, bundle branch block) . 
Location Delta wave polarity 
I II III aVF aVL VI V6 BBB 
I. L lat ± ± ± + ± L 
2. Llat ± + + ± no 
3. L postlat + ± + no 
4. Lpostlat + + + + no 
5. L postsept ± + ± + + no 
6. Rpostlat + ± + + + no 
7. Rantsep; + + ± + + R 
In pts 1 and 7, a BBB ipsilaterally to the AP location accounted for the 
anomalous delta wave polarity preablation. In pt 5 pseudo-preexcita•
lion (PPE) with an inferior-lead Q wave appeared after ablation of the 
AP, consistent with hypertrophic cardiomyopathy. A second PPE pat•
tern was found in another pt with the same delta wave polarity as 
before ablation, and no apparent cause. Conclusions: Discordance 
between delta wave polarity and AP anatomical location is rarely 
observed. When present, a bundle branch block ipsilaterally to the AP, 
or electrical displacement of ventricular activation secondary to 
organic heart disease are likely causes; in the latter case, a PPE can 
also be observed after ablation of the AP. 
ABSTRACTS 
856-42 
Preablatlon 50 kHz Impedance: a New Parameter for Assessing 
Myocardial Wall Contact Before Radiofrequency Catheter 
Ablation 
Ellen Hoffmann, Thomas Remp, Andrea Gerth, Snren Mattke, 
Gerhard Steinbeck. Medical Hospital I, U/uversity of Munich, 
Munich, FRG. 
In order to assess myocardial wall contact before radio frequency 
(RF) energy delivery, impedance was measured prior to 386 RF 
energy applications in 31 patients (12 ± 4) undergoing catheter 
ablation. Measurement of impedance with a frequency of 50 kHz was 
carried out before the actual energy delivery using a current of 2 
Microampere incorporated in a custom-made 500 kHz RF generator. 
Energy applications were stratified into three groups according to 50 
kHz preablation impedance: <1200 (n=150), 120-1300 (n=117), 
> 130 0 (n= 129). In this study significantly more impedance rises 
were observed in the group with high 50 kHz impedance (>130 Q) as 
compared to the group with low 50 kHz impedance «120Q)(15% vs. 
6%, p<O.05). In addition maximal power for energy applications with 
impedance rise was significantly higher for energy deliveries with 
low «120 Q) or average (120-130 Q) preablation impedance as 
compared to those with high (>130 0) 50 kHz impedance (p<O.05). 
For energy applications without impedance rise maximal power was 
similar regardless of 50 kHz impedance. 
Conclusions: High preablation 50 kHz impedance may reflect firm 
myocardial wall contact anJ is associated with a high incidence of 
impedance rise. Thus 50 kHz preablation impedance offers a new 
parameter for assessing myocardial wall contact before RF energy 
delivery and may help to increase safety and efficacy of RF-ablation. 
856-43 
Single-Catheter Approach to Radiofrequency Current Ablation 
of Right-Sided Accessory Pathways in Patients With WPW Syn•
drome 
Ralph U. Mletzko, Jurgen Siebels, Riccardo Cappato, Michael 
Schluter, Karl H. Kuck, University Hospital Eppendorf, Hamburg, 
Germany 
A single catheter approach to radiofrequency current (RFC) ablation 
of overt left-sided free wall accessory pathways (APs) has recently 
been introduced and shown to be effective and safe. 
The objective of this study was to establish whether this technique 
can be expanded to the ablation of right-sided APs. Eighteen pts 
with the WPW syndrome and a delta wave pattern indicative of an 
overt right-sided AP underwent attempts at RFC ablation via a single 
catheter introduced into the right ventricle; mapping was performed 
at the tricuspid anulus. Anatomical location of APs was anterolateral 
in 1, lateral in 2, posterior in 2, posteroseptal in 11 and midseptaJ in 
2 pts. The approach was compiet1y successful in 17 pts (94%). In 
the remaining patient, ablation of a posteroseptal AP was achieved 
by using the multiple-catheter technique. 
Compared to our previous experience with 40 right sided APs 
approached with multiple catheters, the present technique resulted 
in a shorter procedure duration (2.2±1.7 h vs 4.7±2.1 h, p<O.OOOl), a 
shorter median radiation exposure time (22 min vs 64 min, p<0.OO5), 
and a similar success rate (94% vs 88%, n.s.). 
In one patient, manifest preexcitation recurred over a right postero•
septal AP; definitive ablation was achieved in a repeat session with 
the same technique. 
Conclusion: The single-catheter approach to RFC ablation of overt 
right-sided APs is feasible, safe and efficacious in the majority of pts. 





Observations on Accessory Connections With Decremental Con. 
duction Properties During Radiofrequency Current Ablation 
Riccardo cappato, Joachim Hebe, Michael Schliiter, Sinan Giirsoy, 
Karl H. Kuck. University Hospital Eppendorf, Germany 
Six out of 355 consecutive pts referred for radiofrequency catheter 
(RFC) ablation of an accessory pathway (AP) showed antegrade 
decremental conduction during pre ablation EP study. In all cases the 
atrial insertion was located in the lateral area of the tricuspid annulus 
(TA). The ventricular insertion was in proximity of the right bundle 
branch in 5 pts (atriofascicular Mahaim fiber), and in the basal right 
ventricle in I pt (A V fiber). There was no retrograde conduction over 
any AP. A presumed AP potential could be recorded in 2 Mahaim 
fibers via endocardial mapping, and in the A V fiber via a right coro•
nary anery (RCA) catheter electrode. In the former, mapping along the 
T A allowed for continuous AP potential recording from the anterior to 
the lateral area, with an increasingly longer atrium·AP potential inter•
val. In all Mahaim fibers, manipulation of the mapping/ablation cath•
eter caused transient conduction block, and successful attempts at . 
RFCA were obtained at the ventricular, but not at the atrial aspect of 
TA. In the case with an A V fiber, RFC application resulted in success•
ful ablation at the AP-ventricle interface, as evidenced by the persis•
tence of an AP potential recorded from the RCA electrode catheter 
despite absence of preexcitation. Conclusions: 1) APs with antegrade 
decremental conduction appear to be mainly located in the right lateral 
TA. 2) Most such APs are Mahaim fibers. 3) Some Mahaim fibers 
may have a long, oblique course across the TA. 4) The ablation target 
site of these APs appears to be the endocardial breakthrough below the 
TA. 
856·45 
New Development of Defta Wavo In Patients After 
Electrophysiology Study·proven Single Concealed Bypass Trac:t8 
John M. Miller, Henry H. HSia, Alfred E. Buxton, David J. Callans 
Temple University and University 01 Pennsylvania, Philadelphia, PA 
Patients (PTS) without obvious preexcitation on the ECG may however 
manHest deka waves with atrial pacing during electrophysiologic study 
(EPS). We now report 5 PTS in whom deka waves were first observed 
weeks to months after detailed EPS had shown only concealed bypass 
tracts. The PTS were 3 men, 2 women, ages 14-48 yr (mean, 29), who 
had EPS for supraventricular tachycardia; ECG from that time, as well 
as all prior ECGs, showed no deka wave. Each PT had detailed EPS 
which demonstrated a single, concealed bypass trad; pacing from each 
atrium confirmed no preexcitation. All 5 PTS underwent ablative 
procedures (3 surgical, 2 catheter; 3 PTS had 2 pre-ablation studies). 
Four PTS manHested deka waves for the lirst time from 1.5-11 mo 
(mean 6.4 mol after concealed tract ablation, the other PT at the time of 
catheter ablation 
# EPSs before Concealed DeHa Wave Interval 
PT Sex Deka Seen· Path Location Location EPS->Deka 
1 M 3 left lateral anterior septal 11 mo 
2 F 5 left lateral left lateral 6wk 
3 M 4 right lateral left lateral 4mo 
4 M 1 left lateral left lateral --
5 F 2 right PQsterior right lateral 9mo 
·Includes ablatIOn and post-ablation studies 
In 2 PTS, the newly-observed delta wave appeared to be due to 
anterograde conduction over the same, previously-known ·concealed" 
tract; in the other 3 PTS, the delta waves suggested sites 01 
atrioventricular connection remote from the concealed tracts. Two PTS 
had EPS after the deHa wave appeared: in each, the anterograde 
relractory period was 260 rns and 1:1 atrioventricular conduction over 
the tract was S320 ms; one had preexcited tachycardia. The mechanism 
responsible for the appearance of delta waves alter EPS had shown no 
preexcijation is not clear, but these cases demonstrate that bypass tract 
conduction is eijher not consistent over time, or possibly that humans 
can acquirB anomalous, functioning atrioventricular connections alter 
birth. 
856·46 
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Evidence for Parasympathetic Denervation of the Sinus Node 
After Radiofrequency Modification of the A·V Node in 
Patients with A·V Nodal Reentry 
Ousan Kocovic, Julie Shea, Peter L. Friedman, Brigham and 
Women's Hospital, Boston, MA 
Persistent inappropriate sinus tachycardia (pIST) has been 
reported after radiofrequency ablation (RFA) of the fast pathway 
(FP) in patients with A-V nodal reentrant supraventricular 
tachycardia (A VNRT), The mechanism of PIST is uncertain, 
since RF A is performed at sites distant to the sinoatrial node 
(SAN). We evaluated heart rate variability (HRV) in 24-hour 
Holter monitor tapes recorded immediately after and during 
subsequent follow-up of 3 patients after RF A for A VNRT. Two 
patients had RFA of a slow pathway (SP); one patient had FP 
RFA. RFA was successful in all patients, rendering AVNRT 
non-inducible in the basal state and during isoprotemol infusion. 
In all 3 patients power spectrum analysis immediately after RFA 
revealed lack of high frequency components (0.15 to 1.0 Hz), 
indicative of parasympathetic denervation (PO). The values for 
percentage of differences between adjacent normal R-R intervals 
> 50 ms, computed over the entire 24 hour Holter monitor 
immediately after RFA (pNN50) were 0.5%,2.1 % and 3.6% for 
the 3 patients, with average heart rates for these patients of 86, 
79, and 97 beats/min respectively. Analysis of Holter tapes 3-6 
months after RFA revealed recovery of these abnormalities. We 
conclude the RFA in the region of the A-V node can result in PO 
of the SAN. Evidence of PO occurs after SP and FP ablation and 
may explain PIST, The prevalence and prognostic significance of 
altered HRV after RFA of the A-V node or of other regions in 
the heart are unknown. 
856·47 
Management of Primary Atrial Tachycardia with 
Radiofrequency Catheter Ablation 
Charles H. Machell, Charlotte K. Jutila, 
UNM/Lovelace Med Center, Albuquerque, New Mexico 
The efficacy of radio frequency (RF) catheter ab•
lation for definitive management of atrial 
tachycardia (AT) was investigated in five 
patients (PT). Two PT had reentrant AT in the 
right atrial appendage, one had sinus node re•
entry, and two had automatic AT, one with an 
associated cardiomyopathy. Each PT had failed 
antiarrhythmic therapy. The site of origin of 
atrial tachycardia was chosen based on the 
earliest activation site during tachycardia 
and/or by pace-mapping. A migratory approach to 
delivery of RF energy was used in which this 
site was selected for initiation of RF energy. 
The catheter was then moved 3-4 mm every 15 
seconds during continuous RF application for a 
total of 120 seconds to cover a circular region 
around the tachycardia site. A mean of 16 + 4 
applications of RF energy were required. AT-was 
eradicated in all patients. One PT had a 
recurrence three weeks after the initial 
ablation and was successfully treated with a 
second session. The PT with cardiomyopathy had 
an improvement in ejection fraction from 20\ to 
50% in the first month of followup. There were 
no complications. 
Conclusion: RF catheter ablation can be suc•
cessfully applied to PT with primary AT with a 
high success rate and a low risk of complicat•
ions. The mechanism of AT does not appear to be 
an important determinant of procedural success. 
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856·48 
RADIOFRBQUENCY CATHBTBR ABLATIO. FOR ATRIAL 
TACHYCARDIA 
John Kall, Brian Olshansky, Jeffrey Baerman, 
Douglas Kopp, Charles Kinder, David Wilber. 
Loyola University Medical Center, Maywood, IL. 
Experience with radio frequency (RF) catheter 
ablation (CA) for atrial tachycardia (AT) is 
limited. RF CA was attempted in 8 patients (pts) 
with AT (mean age 38±24 years). Ventricular 
function was impaired in 4 pts. In 7 pts, AT was 
refractory to medical therapy (3.5±1.7 drug 
failures). AT was incessant or nearly incessant 
in 6 pts; isoproterenol was required to initiate 
sustained AT in 2 pts. Endocardial mapping during 
AT identified a discrete right atrial site of 
earliest activation in 7/8 pts. RF lesions (22-40 
W, 20-30 secs/application) applied to atrial 
sites of earliest activation (18±12 lesions/pt, 
range 3-40) resulted in abolition of spontaneous 
AT in 5/8 (63%) and marked diminution of 
spontaneous AT (only brief runs of nonsustained 
AT on isoproterenol) in 2 pts. During a follow-up 
of 8.3±6.9 mos in these 7 pts, 3 had recurrent AT 
within 4 weeks after initial RF CA: in 1 pt, AT 
was suppressed with amiodarone; in 2 pts, AT was 
localized to a previous site of successful RF CA 
in 1 and to site remote from a previously 
successful RF CA site in 1. Repeat CA (including 
2 direct-current shocks in 1 pt) resulted in 
abolition of AT and no recurrent symptoms for ~14 
mos. RF CA was unsuccessful in 1 pt in which 
endocardial mapping identified multiple sites of 
early atrial activation. CONCLUSIONS: RF CA may 
be effective in treating AT in selected pts. 
Factors influencing procedural success and 
patient selection warrant further investigation. 
856·49 
Rate of Temperature Rise Increases with Power during 
Microwave Ablation 
Arun Gadhoke, N.A. Mark Estes III, Paul J. Wang. 
New England Medical Center, Boston, MA 
Prior studies have demonstrated that microwave (MW) ablation 
lesion size increases with power and temperature(TEMP). However, 
the effect of power on the rate of TEMP change has not been 
examined. Using sheep endocardium in vitro, we therefore 
measured the TEMP at the MW antenna-myocardial interface in 32 
lesions using a Luxtron TEMP probe during 30 seconds of ablation 
at 20-80 Watts(W) power. 
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Lesion dimension increases as power increases. The rate of TEMP 
rise is particularly rapid at high power, suggesting that TEMP 
monitoring during initial energy application is particularly important 
Adjusting the power based on TEMP during this phase may permit 
modulation of the degree of tissue destruction. 
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857·1 
<lIaqes In Flectrocardlogrblc AboormaIIdes In 60- to 92-Year-Old Male 
AlhIeta at »Year Follow-up 
Larry J. Mengelkoch, Marian C. Lirnacher, Michael L. Pollock, David T. 
lowenthal, J~ E. Graves, Michael Fagien, Donald H. Schmldt, Henry S. 
Miller, UnivelSity of Florida and v AMC, Gainesville, FL 
The prevalence of ECG abnormalities were determined in 19 senior 
athletes (runnelS/walkers) at 2O-yr follow-up. Electrocardiographic 
recordings during maxima1 treadmill exercise (GXO were compared from 
initial, 10-yr, and 2O-yr follow-up (T1,T2,T3), between 1971 &: 1992, and 
from 18 hr Holter IOOnitoring (HM) at T2 and 1'3. Subjects were age 60- to 
92-yr at T3 and had maintained regular aerobic training ~ 22 yr. Significant 
age-related changes occurred in low grade arrhythmias (premature atrial 
contractions, and ventricular arrhythmias, lown grades 1 and 2) during 
GXT, while the occurrence of major ECG abnormalities (ventricular 
conduction defects (YCO), ventricular tachycardia (yo, ST·segment 
depression) remained low, or were never present (left ventricular 
hypertrophy, nonspecific ST-T wave changes, significant Q waves). We 
observed that vr and YCO were not present in subjects < 60 yr age. 
Although occurrences of major ECG abnormalities were low, they persisted 
through follow-up in 50% to 100% of those subjects with the 
abnonnalities. The occurrence of ECG abnonnalities during HM was similar 
at T2 and 1'3. The prevalence of ECG abnormalities did not appear related 
to training intensity. 
The sensitivity of exercise testing to predict acute cardiac events 
(myocardial infarction, sudden cardiac death) during physical activity, in 
senior athletes, using ST-segmer.t depression or vr as markers, was poor 
(0/4-0%), as the cumulative incidence of acute cardiac events during 
physical activity was 0%. In summary these data suggest: 1) age related 
clunges in the occurrence of ECG abnonnalities are few and low grade in 
senior athletes who maintain long-term exercise. 2) habitual vigorous 
exercise and competition, in senior athletes, has low risk for acute cardiac 
events during moderate and strenuous physical activity. 
857·2 
Prediction of left Ventricular Hypertrophy From the Signal-Averaged 
Electrocardiogram 
lianmin Ma, John Turner, Vasu Goli, Don Parker, Udho Thadani 
University of Oklahoma, Oklahoma city, OK. 
To asses the usefulness of the signal-averaged electrocardiogram 
(SAECG) for detecting left ventricular hypertrophy (LVH) logistic 
regression equations were constructed to predict LVH (LVMI > 110 g/m' 
female; > 134 glm' male) based on echocardiographic left ventricular 
mass index in a learning series of 70 hypertensive patients 36 with LVH 
and 34 without LVH. SAECG and ECG were both recorded using current 
AHA recommendations in two groups of patients free of any conditions 
known to affect the SAECG. Models for both SAECG and ECG variables 
were developed. Maximum likelihood estimation revealed the best 
predictors of LVH to be the ORS duration in the X-lead (p~O.OOOl), 
integral of the vector ORS complex (p =0.0195), sex (p =0.0347) and 
weight (p =0.0236). While the best predictors in the ECG model were 
the ORS duration (p = 0.0289) and sum of the R wave voltage in AVL 
and S wave voltage in V3 (p = 0.0033). Receiver operating characteristic 
curves were constructed to asses the relative performance of SAECG 
and ECG models and for Cornell criteria for L VH in a prospective group 
of 74 hypertensive patients. As shown in the figure the SAECG model 
was superior to the ECG model (area 0.84 .• 
vs 0.70). Conclusion: 1) SAECG model U 
for predicting L VH is superior to the : 
standard 12 lead model for predicting ~ U 
LVH. 2) The initial performance of the S: 
SAECG model is promising enough to u 
subject the model to further studies to u 





Signal.Averaged Electrocardiograms in Ischemic 
Cardiomyopathy are not Predictive of Sudden Death 
Donna M. Mancini, Keith D. Aaronson, Michael B. Simson 
Hospital of the University of PeMsylvania, Philadelphia, PA 
An abnormal signal·averaged electrocardiogram (SAECG) has 
predictive value for future arrhythmic events in patients with c0ro•
nary artery disease and recent myocardial infarction. To investigate 
whether an abnormal SAECG could provide prognostic information 
in patients with ischemic cardiomyopathy, we prospectively 01>•
tained SAECGs in 92 patients with ischemic cardiomyopathy. 
Twelve-lead ECGs, nuclear ejection fractions (EF), hemodynamic 
measurements, and peak exercise oxygen consumption (VOV were 
also obtained. An abnormal SAECG was dermed as QRS duration 
:>120 msec, or root mean square of the last 40 ms <20 I1V, or dura•
tion under 40 I1V >38 msec at 2S Hz. Patients were divided into 3 
groups, those with a normal SAECG (N=20), an abnormal SAECG 
(N=38), and an underlying bundle branch block (N=34). Mean 
follow-up was 18 months. NYHA class, EF, peak V02, and car•
diac index were not statistically different between the three groups: 
lmIA tt ~ Cl. 
~ l1t (mI/kg/minl (L/min/m2L 
Nl SAECG 2.9tO.6 2lt6 ll.8t4.0 2.2tO.3 
Abnl SAECG 3.ltO.9 19±7 13.2±5.1 2.2±O.6 
BBB 3 .liO . 7 19t7 13 • 7t5 • 0 1. 9±O . 5 
Pulmonary capillary wedge pressure was significandy higher in 
patients with bundle branch block (BBB) (p<O.05). The incidence 
of sudden death episodes in patients with Nl SAECG, Abnl 
SAECG, and BBB was comparable (Nl SAECG: 4; Abnl SAECG: 
5; BBB: 7 episodes; NS). Urgent transplants and heart failure 
deaths occurred more frequendy in those patients with BBB (Nl 
SAECG: 3; Abnl SAECG: 6; BBB: 14 events; p<O.OI). 
In conclusion, SAECG CaMot predict sudden death in patients 
with ischemic cardiomyopathy probably due to the extensive nature 
of the disease and heterogeneity of causes of sudden death in this 
population. Mortality from heart failure is significandy greater in 
those patients with bundle branch block. 
857-4 
GTe Diapersion, Late Potential • .nd _rei .. EOQ in a 
Large F ... i ly With 'The RaIano WIrd Synchme 
walt .. Rhoden II'Id David 8emett. I'WIc:hest .. , EnglWld. 
Forty six IIlBTbers of a f ... ily with the AanIno Ward 
Synci-a'ne __ a studied. rtr.. f.,.i ly msrbers had died 
.uddenly before the aee of 20, following smtionel or 
physical stress. 
Nine s\A:ljeets had resting QTe prolCJr6lltion. Two patients 
had I'lCII"IMI resting QTe intervals but had stress ind.loed 
syncope. Two 811"~ents wid fOt.l" parents of affected 
individuals had I'IOI"ITW.I QTe int .. vals at rest. Three of 
tn.e subjects had QTe shortening on exereise. 'The 
r_ining three lengthened their QTe intervals with 
ex .. eis •• Two prolonged their QTe int .. val to such an 
extent that tha T wave fused with the suooeeciing P wave 
even at IIDdestly increased heart rates, a featlre shred 
by one of their cousins. Ei!otlt of the sixteen suff ..... 
wid carri .. s of the Ranano Ward ayncrane had late poten•
tials on siW1&l averaged eleetroerdi08ll"aphy (so.) 
ocnparecl with only one of the thirty nonn!ll subjects 
(3.~). !i~t of the sixteen suff .... s and erriers of 
the RCIIBI'lO Ward syncrane (so.) had marked QTe dispersion 
(defined as Max QTe-Hin QTe. -.red fran a twelve lead 
eleetroeardi0!J"8Il, of ",eat .. than 100ns) ocnpared with 
two of the thirty I'IOI"ITW.I subjects (6 •• ). 
F8Ili I ies carrying the RCIIBI'lO Ward gene can show a wide 
variety of eleetroeardiO!J"aphie abnormalities both at 
rest and on exercise. Parents with I'IOI"ITW.l resting QTe 
int .. vals ~ have children with the AanIno Ward Syn•
drane. Appropri.t. assessment of msrbers of a Rcrnano 
ward f8llily cannot be basad on resting QTe int.-val 
alone and should include ex .. eis. testing signal av .. -
aged aleetroeardiO!J"aphy WId llaUUl"alWlt of QTe disper•
sion. The finding of apparently nonn!ll elderly f8llily 
merrbers does not ~Iy that their lintl of the f.,.ily 
can be eliminated fran screening. 
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Prognostic Significance of Late PotenUal. In Patients with 
Coronary Artery Dlaea .. 
l'I1oITa HoI!nInl, Andra. Bumeist., l'I1oITa MeineItz 
AX St. Georg, II. Mad. KliI*, Ha'I1I:ug, GerIlllllTf 
406 pia. undergoing diaIJ108Iie caonary and left ventrlcUar angiogrllf*iy 
w •• studied proepeclNely bv siIJl8I lMII'aging ECG (SAE). Pta. with 
valvular heat diseaSe or with primary cardiomyopllttlv w •• excluded. SAE 
recordings w.. analyzed according to the method of Simson. Lat. 
~_ w •• dalacted In 4Q'406 pia. (12.1%). LP w •• pr8S8l't in 1/59 
pIS. (1.6%) with normal cardiac findings, in 22/218 pIS. (11%) with CAD 
wilhoU prior myocardal infarction and in 26/128 pIS. (20%) with CAD and 
prior myocardal infarction. OU'ing follow-up (23.2 ± 0.2 months) a cardiac 
8\/9rt (. either cardiac death or a cardlopUmonary resuseitalloo) OCCU'ed 
in 1£V406 pIS. (4.""). 
No evant Cardiac Event p-Value 
LVEDP [rnniig) 9.62:1:6.53 14.0 ± 1.09 0.005 
LVEF[%) 13.5:1: 15.3 SS.6±20.3 0.001 
QRS duration [ms) 102± 13 118±3O 0.026 
RMS40[uV] 44.9:1:34.9 28.2 ± 19.6 0.040 
LAS4O[ms) 30.9:1: 11.3 31.1 ± 14.1 0.024 
A cardiac 8II9rt OCCU'ed in 131356 pIS. (3.6%) wiIhcU LP and in 6149 pis. 
(12.2%) with LP (p • 0.(21). The presence of a LP predicted a cardiac 
8\/9rt with a sensitivity of 31.5% and a specificity of 88.2%. The incidence 
of a cardiac 811811 dU'ing follow-up was 1.2% for pIS. wiIhcU LP and 
EF>5O%, 6."" for pIS. with LP and EF>5O%, 11.2% for pIS. wiIhcU LP 
and EF<5O% and 19% for pIS. with LP and EF<5O%. 
Logistic regression analysis ldertified left ventrieul. ejection fraction and 
QRS-dU'aion in the SAE as independert predictors for the OCCU'80C8 of a 
cardiac 8II9rt dU'ing the fallON-UP periOd. 
857·6 
T_Vol .... IDIiepIIl of the Vector QRS fOr Improved Diapo8ia of Left 
V<IIIricuIar Hypertroplay 
Peter M. Obn. Mary J. Roman, Richard B. Devereux, Jeffrey S. Borec, Paul 
KIillfield. Comell Medical Center, New Yon:, NY. 
SWIdard BeG criteria have exhibited poor sensitivity for left venlriculat 
hypertrophy (LYH) II acceptable levels of specificity. However, LV maSs may 
be more cloaeJy related to the time-voltage inteerai of the SIIIIIIIII!d left 
ventriculat dipole than to QRS dUtaliOll or voltape that ate U8ed in staDdatd 
BeG criteria. To test the hypothesi. that the time-voltage inteerai of the QRS 
caD improve the identification of L VH, l2-Iead BeG.. orthollonal-lead 
signai-averapd BeG. IDII echocatdiograma were obtained in 43 patients with 
valwlu heart diseaselDll L VH IDII in 72 control subjects wi~ut L VH. L VH 
wu de~ by echocatdiognpbic criteria (LV mass :> 110 g/m in women IDII 
> 125 111m in men). Voltage of the QRS complex wu integrated over the 
total dutatioo of the QRS in leids X, Y IDII Z to calculate the maximal spatial 
time-voltap vector inteerai IDII to calculate horizontal. frontal IDII sagittal 
pi..... QRS inteerai" Usinll percentile estimatiOll, partitiODl with 98" 
specificity were derived for standard 12-lead and signai-avet8l1ed BeG criteria 
in the 72 normal subjects, IDII sensitivities of the. partitiODl were then 
compared in the 43 palienll with L VH. At matched specificity of 98". the 
56" (26/43) sensitivity of the time-voltage integral of the vector QRS complex 
in the horiz.ontal p1aDe WU sisnificaDtly bieber than the 28" sensitivity of 
Sokolow-Lyon voltage (p < 0.005), the 23" sensitivity of the Romhilt-Estea 
point score (p<O.OOI), the 26" sensitivity of Comell voltap (p<O.OOI), the 
40" sensitivity of the l2-lead sum of QRS volt&p (p<O.05), IDII the 33" 
sensitivity of QRS dUtaliOll alone (p < 0.(05). Sensitivity of the horizontal 
pi ..... vector wu also pealer than the 37" sensitivity of the time-voltage 
vector inteerai in either the frontal or sagittal pi ..... (each p<O.OI) IDII the 
44" sensitivity of the time-voltage integral of the maximal spatial vector 
complex calculated from all three orthogonal lelds (p < 0.05). Comparison of 
receiver opetatinll chancteristic curves confirmed that the superior performance 
of the horiz.ontal pi ..... time-voilige vector integral relative to standard IDII 
other signai-averqed criteria _ independent of partitioo valuo selection. 
These findings suglleat that UIIe of the time-voltap inteerai of the vector QRS 
caD improve the IICClUllCy of BeG methoda for the detection of L VH. 
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857-7 
Diabetes, Glucose Intolerance and Left 
ventricular Hypertropby in the Fra.inqhaa study 
William B. Kannel and Daniel Levy 
Boston University, Boston, MA 
Incidence of ECG-1eft ventricular hypertrophy 
(ECG-LVH) and its cardiovascular sequelae are 
examined in relation to diabetes based on 36 
years of follow-up of the original cohort. ECG•
LVH incidence was significantly related to an•
tecedent systolic blood pressure, serum choles•
terol, body mass index and glucose intolerance. 
Cigarette smoking was unrelated to LVH inci•
dence. Glucose intolerance was associated with 
increased incidence of ECG-LVH after adjusting 
for age, blood pressure and BMI. Diabetics with 
ECG-LVH compared to nondiabetics with ECG-LVH 
had a markedly greater risk of cardiovascular 
events. 
CARPIOVASCULAR EVENTS IN ECG-LYH FOR 
PIABETICS ys NON-DIABETICS 
Men 
Women 










Diabetes independently predisposes to ECG-LVH, 
and also greatly enhances the cardiovascular 
consequences of ECG-LVH. 
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858-34 
Afferent Nerve Stimulation Decreases Ventricular Arrhythmias 
Induced By Hypothalamic Stimulation In Rabbits 
Xiaohong Zhou, Patrick O. Wolf, William M. Smith and Raymond E. Idekar, 
Duke University Medical Center, Durham NC 
Dysfunction of the autonomic nervous system has been shown to be ass0-
ciated with sudden cardiac death. It has been shown that hypothalamic 
stimulation (hypo stim) can induce tachyarrhythmias in normal animal ven•
tricles. We tested the hypothesis that afferent nerve stimulation would 
decrease the Incidence of such arrhythmias by inhibition. The 
hypothalamus was electricaJly stimulated for 10 sec in anesthetized rab•
bits. In each rabbit, the hypothalamus was stimulated 6 times with a 10 
min interval between stimulation episodes. Six rabbits underwent the 6 
episodes of hypo stim alone (control group), while in another 6 rabbits the 
peroneal nerve was electrically stimulated 5 min after the second episode 
of hypo stim for 15 min (PN group). ECG, atrial and ventricular electro•
grams were recorded to monitor the heart rhythm and the number of ven•
tricular arrhythmic beats was determined after each episode of hypo stim. 
Hypo stim repeatedly Induced ventricular arrhythmias in the control group 
(see figure. Circle. 40 _ C.n".'9'0IIp 
mean value, bar = SO). J!! - PH ...... 
Peroneal nerve stimula. : • pc .• ' 
lion significantly reduced c:: 30 
the number of arrhythmic ·S 
beats Induced by hypo t 
stim. Thus, ventricular ~ 20 
arrhythmias can be '0 
repeatedly induced by ~ 
hypo stirn and the central .8 10 
nervous system induced ~ 
ventricular arrhythmias PH SUm 
can be reduced by stimu· 
lating peripheral nerves. 





Effect of Isoproterenol on Ventricular Fibrillation Wavefronts 
Mapped by S06 Closely Spaced Epicardial Electrodes 
Russell E. Hillsley, Edward V. Simpson, Dennis L. Rollins, Patrick D. 
Wolf, William M. Smith, Raymond E. Ideker, Duke University Medical 
Center, Durham, NC 
We tested the hypothesis that isoproterenol (ISO) increases organization 
during ventricular fibrillation by increasing the size of activation 
wavefronts. A plaque of 506 electrodes spaced 1 mm apart (22 x 23 mm) 
was sewn to the RV or LV in 6 pigs (25-30 kg). ISO (3-5 )Jog/min) 
shortened the effective refractory period (mean±std dev) 237±14 ms to 
213±14 ms (p<0.05) at an RV epicardial site. VF was induced by an 
extTastimulus. A control VF episode preceded each VF on ISO. Unipolar 
electrograms were recorded at a sampling rate of 2 kHz for 0.5 s at Is, ISs, 
and 30s after VF onset. Wavefronts were analyzed by animating the first 
derivative of the potentials. Electrodes with a fint derivative of potential 
more negative than ·1 voltls were assumed to be activated in that sample, 
and ;;,:5 contiguous electrodes meeting this criterion in the same sample 
defined a wavefront. Wavefronts were then counted and sorted by the 
maximum number of electrodes activated in one time sample: 5-29, 30-99, 
or <0100. 
MEAN NUMBER OF Acnv AnON W A VEFRONTS 
Control ISO 
5-29 30-99 ;;,:100 5-29 30-99 >100 
1 s 12.3 4.2 0.5 5.5 5.S 1.2 
15 s 10.7 3.8 0 7.7 4.7 0.7 
30s 8.5 4.0 0 5.8 4.0 0.2 
Sum 31.5 12.0 0.5 19.0 14.2 2.0 
The number of wavefronts was not significantly different for ISO and con•
trol. The distribution of wavefronts with ISO differed from control at Is 
and for the sum of all 3 time intervals (chi-square, p<0.05); ISO had 
larger activation wavefronts in both cases. Thus, ISO increases the size of 
wavefronts seen during early VF. This increase in organization may partly 
explain the lower defibrillation threshold with ISO. 
858-36 
Body surface mapping detects regional sympathetic 
imbalance in canine ventricular myocardium 
Mary L. Stanley, Harlan R. Grogin, Michael C. Chin, Ashutosh Goel, 
Michael W. Dae, Michael D. Lesh. University of California, San 
Francisco. 
Regional imbalances in myocardial sympathetic innervation cause dis•
perSion of repolarization and may be arrhythmogenic. We tested the 
hypothesis that body surface maps (BSM) could detect and localize dis•
parate ventricular repo1arization caused by sympathetic denervation. 
Regional denervation was created in 9 dogs (P) by local epica~dial phe•
nol application during left lateral thoracotomy. Six control (C) dogs re•
ceived left lateral thoracotomy and pericardiectomy only. Recordings 
were made from 64 leads on the anterior and lateral thorax, at constant 
heart rate, before and 1 wk after thoracotomy. QRST isoarea maps were 
constructed from the digitized BSM data. Repolarization gradient ( V) 
was defined as the difference between peak maximum and minimum on 
QRST area maps. The area of sympathetic denervation was confirmed 
by dual isotope imaging of excised hearts using 1-123 metaiodobenzyl•
guanidine (MIBG) and T1-201. MIBG/T1 functional maps were assessed 
for location and extent (%area) of denervation. 
Results: MIBG imaging confirmed denervation in the anterior left ven•
tricle corresponding to P painted areas. Mean extent of denervation in P 
dogs was 37 ± 8% vs 10.7 ± 3.4% for C dogs (P=.OOOI). In P dogs mean V 
increased from 113 to 260 m Vms (P=.OIS), consistent with an increase in 
dispersion of repolarization, whereas in C dogs the mean V did not Sig•
nificantly change (133 to 141 mVms). QRST isoarea BSMs of P dogs 
displayed a marked increase in the area of right sided negativity as 
compared to C dogs (P=.OOS), suggesting that repolarization abnormali•
ties induced by anterior denervation project to the right chest in dogs. 
Conclusions: BSM can detect regional differences in ventricular repolar•
ization caused by sympathetic imbalance and provide evidence for an 





Mapetic Resonance mu..mr of the Cardiac Atrioventricular 
Conduction Syatem 
Maria L. Aguirre, David J. Aziz, Arthur F. Gmitro, Anthony C. 
Caruso. Tucson Veterans Administration Medical Center, University 
of Arizona, Tucson, Arizona. 
The use of magnetic resonance imaging (MRI) for visualizing the 
cardiac atrioventricular conduction system has not previously been 
reported. We report the atrioventricular (AV) node and proximal 
bundle of His to be distinguishable from surrounding tissue using 
magnetic resonance imaging. Excised tissue blocks from seven canine 
hearts were studied with a 4.7 Tesla Broker Biospec system. Two 
millimeter thick slices were imaged through the region of the AV node 
and the bundle of His as well as the adjacent atrium and ventricle. 
These images were correlated with histological sections of these 
tissue samples. It was found in each case that the AV node 
represented a distinguishable structure in both T 1 and T2 weigh ted 
magnetic resonance images confirmed by histologic analysis. The AV 
node was most visible in the T2 weighted images. T2 decay times 
from the AV node were consistently longer than the T2 decay times 
from the atrium and ventricle. The AV node was distinguishable 
from the atrium with a mean p=0.03 for all seven hearts. The AV 
node was easily distinguishable from the ventricle in all seven hearts 
(p<O.OOOOOl). Conclusion: Magnetic resonance imaging can be used 
to visualize the canine AV node and proximal bundle of His in...Dtm. 
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859-76 
Predictive Value or Fast cr Coronary Artery Calcification as 
Compared to Angiograpby in Patients Under tbe Age or 50_ 
James A Fallavollita, Alan S. Brody, Krishna Kumar and 
John M. Canty, Jr., University at Buffalo, Buffalo, New York. 
Previous studies have demonstrated that the presence of 
coronary artery calcification assessed by fast cr is a sensitive 
predictor of angiographically significant coronary artery disease 
(CAD). Unfortunately, its specificity has been limited by the 
increasing prevalence of coronary artery calcification with age. 
Accordingly, we performed the present study to determine whether 
the specificity of fast cr was improved in patients under the age 
of 50. Patients undergoing coronary angiography for routine 
clinical indications underwent high resolution fast cr scanning 
(n=I08). Angiographic disease was defined as >50% diameter 
stenosis in one or more coronary arteries. Significant calcification 
was defmed as the presence of > 1 mm2 of density above 130 Hu. 
The mean age of the population was 43.5 ± 5.4 years with a prev•
alence of significant coronary artery disease of 54%. Of 58 patients 
with significant CAD, 9 had no calcium detected by fast cr 
resulting in a sensitivity of 84%. In 50 patients without significant 
CAD, 20 had calcium demonstrated by cr resulting in a specificity 
of 60%. Positive and negative predictive values to detect CAD 
using cr were 71% and 77% respectively. We conclude that in 
patients under the age of 50 1.) detection of coronary calcification 
with fast cr has a sensitivity and specificity comparable to many 
other noninvasive tests used to evaluate the presence of CAD and 
2.) although the specificity of cr in this age group is higher, the 
sensitivity for detecting anatomically significant CAD is lower than 
demonstrated in older populations. Because of this, caution should 
be exercised in using the absence of coronary calcification to "rule 
out" significant CAD in patients under the age of 50. 
859-77 
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Correlation Between Coronary Artery Cllciflcation A.M.sed by 
Ultrafast CT and Angiogriphicllly Ooeumented Coronlry Anery 
DiM .. 
Pierre P Leimgruber. Terrance P Judlll. Bryan E Fuhs. Fred K Viren. J 
Paul Shields. Spokane. WashingtOn 
Coronary anery calcification [CAC) indicates coronary atherosclerosis. 
To correlate the degree of CAC assessed by ultrafast CT and 
angiographically documented coronary anery disease [CAD) we 
evaluated angiograms of 96 patients [22 f. 74 m) between 33 and 87 
years of age who had CAC by UCT within 55 ± 11 days. 13 
patients had normal CAD [OVD). 12 had mild [< 50%) CAD [mVD). 34 
had single [2: 50%) vessel disease [1 VOl. 22 patients had 2VD and 
15 patients 3VD. Mean tOtal CAC Score and number of calcified 







OVD mVD lVD 2VD 3VD 
• p <0.05 •• p < 0.01 3VD vs 2.1.m.OVD 
Conclusion: Patients with 3VD had significantly higher coronary anery 
calcification scores and more calcified lesions. Considerable overlap 
exists in patients with less than 3VD or normal coronaries. CAC in 
patients with normal coronary angiograms may suggest earliest 
manifestation of CAD. 
859-78 
DOES CHOLESTEROL-LOWERING DRUG THERAPY IMPROVE 
EXERCISE-MEDIATED CORONARY VASOMOTION? 
Christian Seiler. Otto M. Hess, Martin Buechl, Thomas M. Suter. Hans P. 
Krayenbuehl. University Hospital. Cardiology B Pol 11. Zurich. Switzerland 
Animal studies have shown that the impaired endothelium-dependent 
vasodilation due to hypercholesterolemia can be reversed by lowering serum 
cholesterol. Vasomotion of angiographically normal coronary arteries in 15 
male patients (pts) w~h coronary artery disease (CAD) was evaluated at rest 
and during exercise at baseline (pre) and 4.3±2.3 months after PTCA (post) 
with or without cholesterol-lowering drug therapy. Luminal area change 
during exercise (delta-ex. % change compared to rest-100%) was 
determined by biplane quantitative coronary arteriography. Eight pts (age 
54±10yrs) with a total serum cholesterol of 5.98±1.48mmoVI served as 
control group (grl. no treatment); 7 pts (age 52±8yrs) with a cholesterol of 
6.89±1.31mmoVI were treated with bezafibrate 4OOmg/day (gr2). There was 
no difference between the two groups with regard to Clinical variables. 
hemodynamic parameters during exercise and exercise-workload. 
There was a signHicant, 
40 r • .o.53. no3O. poO.OO3 IJ grl. "'" inverse correlation between 
delta-ex and total cholesterol :.!! 
with all pre and post data pooled 0 
(figure). PIs in gr2 significantly X 20 
lowered their cholesterol (to I-\-f 
5.61±1.06mmolll. p-O.03 VS pre) ~ 
and improved delta-ex (from ...J 0 
0.7±9.9 to 9.3±7.3"1o. 1'-0.04 VS W 
pre) whereas these variables C 
remained unchanged in the 
controls (cholesterol 
6.00±1.19mmoVI. NS vs pre; 
delta-ex from 4.6±14.4 to 
6.3±7.6"1o. NS vs pre). 
• grl. post 




Conclysions· (1) Exercise-induced vasomotion of angiographically normal 
coronary arteries in pts with CAD is inversely related to serum cholesterol. 
(2) The decrease of serum cholesterol by drug therapy was accompanied by 
an improvement of the vasodilafory response during exercise. (3) Thus. 
lowering of cholesterol appears to have. in addition to the well-known 
antiatherosclerotic effect. a beneficial effect on coronary vasomotion during 
exercise in angiographically normal coronary arteries. 
JACC Vol. 21, No.2 
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859-79 
INFLUENCE OF SERUM CHOLESTEROL ON VASOMOTION OF 
ANGIOGRAPHICALL Y NORMAL CORONARY ARTERIES 
Christian Seiler, Otto M. Hess, Martin Buechi, Thomas M. Suter, Hans P. 
Krayenbuehl. University Hospital, Cardiology B Polll, Zurich, Switzerland 
Hypercholesterolemia impairs endothelium-dependent coronary vasodilation 
in the presence of and even before histologic evidence of atherosclerosis. It 
was hypothesized that exercise-induced vasomotion of normal coronary 
arteries is influenced by serum cholesterol (C). Thus, vasomotion of 
angiographically normal coronary arteries in 61 patients (pts) with CAD was 
evaluated at rest and during exercise. luminal area change during exercise 
(delta-ex, % change compared to rest.l00%) was determined by biplane 
quantitative coronary arteriography in three groups (gr): 14 pts with normal 
total serum C «5.2, mean 4.48mmolll, gr1), 23 pIS with slightly elevated C 
(5.2-6.5, mean 5.nmmoVI, gr2), and 24 pts with markedly elevated C (>6.5, 
mean 7.43mmoVI, gr3). Other risk factors such as positive family history, 
history of hypertension, smoking, obesity and diabetes did not differ in the 
three groups. 
The three groups did not differ with regard to clinical characteristics, 
exercise-workload and hemodynamic data measured during exercise. 
However, delta~x in normal vessels was significantly different between all 3 
groups (ANOVA, p<0.01): +31% (gr1), +18% (gr2) , +4% (gr3). Delta-ex in 
stenotic vessels did not differ between the groups: -5% (gr1), -13% (gr2), 
-12% (gr3). Delta-ex 01 the non-stenosed vessel correlated inversely with 
total C,lDl-C and with the ratio of total to HDl-C (ligures). 
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Conclusions' (1) Exercise-induced vasodilation of angiographically normal 
coronary arteries in pts with CAD correlates inversely with total cholesterol, 
lDl-cholesterol and with the ratio 01 total to HDl-cholesterol. (2) In the 
stenotic vessels, vasomotion during exercise does not appear to be 
intluenced by the actual serum cholesterol. 
859-80 
An Algorithm to Identify Patients at High Risk for a Contrast 
Reaction - When to use Nonionic Contrast 
William H. Malthai, Jr., Jane M. Krol, James E. Goin, William G. 
KussmaUl. John W. Hirshleld. Jr.. UMDNJ/Robert Wood Johnson 
Medical School at Camden. NJ and University of PA. Philadelphia 
No convenient method exists to identify patients at high risk 01 a 
contrast reaction during cardiac angiography who would get greatest 
benefit from use 01 a low osmolality. nonionic contrast agent. We 
have previously shown that such patients can be identified. but the 
formula to identify them. based on logarithmic regression. is complex 
and not clinically useful. We developed a simple algorithm defining 
high risk as anyone with a prior contrast agent reaction or with two of 
the following criteria: age> 65 yrs. lVEDP > 15 mmHg. or NYHA 
Class = IV. We have reported data from a prospective. double-blind 
study of 2246 consecutive patients randomized between low 
osmolality. nonionic contrast (lOCA) and high osmolality contrast 
(HOCA). To demonstrate the utility of this algorithm. we evaluated 
the outcome of cardiac angiography in a theoretical population of 
1000 patients with the same clinical characteristics and rates of 
adverse reactions to HOCA and lOCA as our study population. II 
LOCA were used in ali 1000 patients, the model predicts 29 adverse 
events. If lOCA were used selectively in high risk patients only and 
HOCA were used in the others. the model predicts 16 events in the 
317 patients who would receive lOCA and 13 events in the remaining 
patients who would receive HOCA. a total 01 29 events. If HOC A 
were used exclusively, the model predicts 45 events. Use of 100% 
lOCA would cost $216.000 lor contrast material. $74.209 lor the 
selective strategy. and $8400 for 100% HOCA use. 
Conclysjons: lOCA can be used selectively in high risk patients as 
identified by this Simple algorithm with no more adverse events and 
with significant cost savings when compared to exclusive use 01 
LOCA. Use 01 HOC A in all patients costs the least but leads to the 
most adverse events. 
ABSTRACTS 
859·81 
Mechanisms of Radiocontrast-Induced Nephropathy in 
Humans Undergoinll Arterial Angiography 
Kenneth B. Margulies, Linda 1. McKinley,lohn C. Burnett,lr. 
Mayo Clinic and Foundation, Rochester, MN 
Radiocontrast-induced nephropathy (RCIN). an acute decrease in renal 
function following administration of iodinated radiocontrast media, has 
emerged as the leading cause of hospital-acquired renal failure. Although 
recent animal studies have suggested that early renal hemodynamic 
effects, proximal tubule toxicity and the vasoconsttictor pepide endothelin 
(El') may participate in the pathophYSiology of RCIN, these mechanisms 
have not been evaluated in humans. Therefore. in a prospective study of 
64 patients with baseline renal dysfunction (creatinine> 1.Smgldl) 
undergoing aortic angiography. we measured creatinine clearance (CrCl) 
as a measure of glomerular filttation rate. urinary adenosine deaminase 
binding protein (ADBP) as a marker of proximal tubule injury, and 
plasma ET before and after aneriography. When RCIN was defined as a 
sustained 25 % reduction in etCl during the two days following the 
aortogram. 26.8% of patients developed RCIN. 
Patients with ReIN Patients without RCIN 
Time post-Contrast Q:Q. ADBP Q:Q. Mmf 
Baseline 4S±6 .06±.01 43±3 .06±.01 
0-12 hrs 34±4· .06±.01 40±3 .06±.01 
12-24 hrs 33±5· .09±.02· 40±3 .11±.02. 
24-36 hrs 28±4* .14±.04· 41±4 .lS±.02· 
36-48 hrs 32±6· .16±.06* 44±4 . 16±.02· 
(*p<O.OS vs. Baseline; OCI in m1/min; ADBP in standard units) 
The occurrance of RCIN was not associated with greater baseline renal 
dysfunction. However, ReIN is characterized by significant decreases in 
CtCl within the first 12 hours in patients who develop ReIN. Although 
ADBP increased follOwing radiocontrast. such increases occurred equally 
in those with and without ReIN. Following aonography, plasma ET 
increased from 12.2±1.3 to 19.6±4.48g1ml (p<O.OS) in patients with 
ReIN and to a lesser extent (lU±l. to 14.3±1.4, p<o.OS) in patients 
without ReIN. These studies support a role for early renal hemodynamic 
responses, but not proximal tubular injury, in the pathophysiology of 
ReIN in humans. Immediate increases in the renal vasoconsttictor ET 
may conttibute to these early renal hemodynamic responses. 
859-82 
II:i4l Iiddeme of l8Bl AI:t:Eq stEn:Bis in BJt:ieris with 
ClxtDKy AI:t:Eq IlisaeIse 
W:illian J. Jean, Issam Al-£itar, Diame L. 2Wicke, stevEn 
c_ R:rt, D::mld H. Sdl!ridt, Tanvir K. Bajw!, Ulivetsity of 
Wjsan;rin M:rliaU SdlCol. (M:C), Mllw:llJ<ee, WI 
Dl£pite a great interest in reral art.ay sterrs:Ls (FAS), 
the in::iden::E of Rl\S in p!tients (pts) with o::u:trlaIY ~ 
disease (CAD) has rd: beal v.ell da:u1a1ta:i. CNer a J1ina•
nmth pericx:l, 196 pts ~ UI'Den.lenI: o::u:trlaIY arg:i.o:;Jrcqi: 
l:a:aEe of c1ini.cally s J¥rte1 CAD ha:l rrutina 
n:nsel.e:::tive Ia'Bl. eire or digital s.i:JtI:ac:t:ia 
argi.ograply. 'nEre ~ 68 faJales an:i 128 nales with a 
na:m cqe of 63 :rears (~ 35-85). lIrgi.c:gJ:apliy 
signi.ficant CAD was present in 152 pts (78%) _ Of the total 
p!tient a::h:rt, 29 pts (15%) lB:l mild RAS (<50%), ard 36 
pts (18%) ha:l signi.ficant Rl\S C? 50%). In pts with CAD, 28 
pts (18%) ha:l mild RAS ard 33 pts (22%) lB:l signifiamt 
RAS. In pts with n:IC1Bl. o::u:trlaIY arteries, a1l. y thIee pts 
(7%) lB:l RAS. 'Ihirty-three pt:s (92%) with SE!IIere RAS ha:l 
a:n:x:mi.tant CAD. Of these 33 pts: 45% lB:l ~; 
30% lB:l ~l.ipi<Eni.a; 24% ha:l diaI:etes nellitus; 24% lB:l 
Ia'Bl. .irs.Iffici.a'x:¥ (c::rea.t.iniIE? 1.5); ani 51% ~ 
SIDkers. In cdli.ticn, it was n±si that 20/33 (61%) ha:l 
boo or mre of th! aI:oie listed clini.c::al pu:a!lEters. 
In exn::lusim, Rl\S is a fnqJent fWin;r in pts with 
signi.ficant CAD, p:!rt:iaJlar1y vh:n cXb!r risk fnar:s far 




ReplKement 01 Cine Film by Digital Angiography: 
Clinical Evaluation 01 a Real-Time Optical Storage System 
Tom H. Karson. Anthony De Franco. Daniel 1. Evans. David L. 
Brown. Raymond W. McIntyre. Kenneth A. Suzuki. Gerald 
Mitchelmore and Steven E. Nissen. Cleveland Clinic. Cleveland. OH 
Although digital angiography is widely employed during cardiac 
catheterization. the unavailability of a suitable storage medium has 
precluded replacement of cine film. A new algorithm. known as the 
10int Photographic Experts Group (JPEG). enables a high-degree of 
compression of digital images with little or no loss of image quality. 
We evaluated a new approach to digital archiving using real-time JPEG 
compression and random-access optical storage as a potential 
replacement for coronary cineangiography. The compression ratio was 
variable. averaging 10 to 1. The storage medium was 5.25 inch 
erasable optical disks with 650 MB capacity (25.000 images at 10: 1). 
A standard cine laboratory was employed without any special 
preparation and the operators were unaware of the data collection. The 
X-ray exposures averaged 19 ~frame in 7 inch mode. Three 
experienced ailgiographers evaluated 91 lesions in 20 patients by both 
cine and JPEG-compressed digital angiography and graded stenosis 
severity by both standard visual criteria and manual calipers. For 
lesions classifted by all observers. the mean visual stenosis was 62.8% 
for film and 62.3% for digital (p=NS by paired t-test). The mean 
caliper stenosis averaged 60.2% for film and 60.7% for digital 
(P=NS). The correlation coefficients for film and digital interpretation 
by visual and caliper measurements were close. r = 0.92 and 0.84. 
respectively. Interobserver variability was low and comparable for both 
film and JPEG-compressed digital angiography; the average standard 
deviation between observers was 7.2% for visual inter-pretation of film 
and 7.4% for digital (p=NS). Interobserver variability was similar for 
caliper measurements by both cine and digital. 8.3% and 8.4%. 
respectively (p=NS). Intraobserver correlations comparing ftlm and 
digital for individual observers were close, ranging from 
r =0.89 to 0.95. These data establish that JPEG-compressed digital 
coronary angiography is diagnostically equivalent to cineangiography 
and represents a suitable architecture for cine replacement 
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Direct and Autonomically Mediated Effects of Oral Quinidine on 
RRlQT Relation Following an Abrupt Increase in Heart Rate 
Riccardo Cappato, Paolo Alboni, Luciano Codeca, Gabriele Guardigli. 
Gian Enrico Antonioli, Arcisp. S. Anna, Ferrara, Italy 
The direct and autonomically mediated effects of oral quinidine (Q) 
on f"dte-related changes of QT interval were investigated following 
abrupt increase in heart rate in 15 pts with the atrial pacing technique. 
In the control study the QT interval was measured at six paced cycle 
lengths(6OO, 540, 500,460.430,400) both in the basal state (BS) and 
after autonomic blockade (AB) (propranolol 0.2 mg/kg and atropine 
0.04 mg/kg); oral Q was then administered at daily dosage of 1200 mg 
for 3-4 days, after which the QT duration was reassessed with the 
same method in a second study. Regression curves estimating the cor•
relation between pacing cycle length and QT duration were drawn for 
any pt during BS and after AB. both in the control study and at the 
steady state following Q administration. During the control study the 
mean slope of regression curve was lower after AB (0.14 ± 0.05) than 
in the basal state (0.27 ± 0.10, p < 0.05). Q exhibited a prominent, but 
opposite effect on the mean slope of the regression curves in BS (from 
0.27 ±O.IO to 0.20 ±0.07, p < 0.05) and after AB (from 0.14 ±0.05 to 
0.19 ± 0.05. p < 0.05), thus annulling the differences observed 
between the two states in the control study. Conclusions: In the range 
of cycle lengths between 400 and 600 msec, the prolongation of the 
QT interval induced by the direct electrophysiologic effect of Q 
increases as cycle length prolongs (reverse use dependence). Such 
effect may not be evident in basal conditions, due to interaction of Q•
related vagolytic activity with autonomic modulation. Reverse use 
dependence and autonomic activity on ventricular repolarization fol•
lowing abrupt increase in heart rate may favor a proarrhythmic effect 
of Q when given chronically. 
860-63 
JACC Vol. 21, No.2 
February 1993:56A 
Use-Dependent Postrepolarization Relractoriness: A New 
Mechanism by Which Class IA Antiarrhythmic Drugs 
Prevent Arrhythmia Inducibility 
Bettina S. Koller, Allen 1. Solomon, Pamela E. Karasik, Michael R. 
Franz. Georgetown University and V AMC, Washingtion, DC. 
Empirical testing of antiarrhythmic drug (AAD) efficacy, either by 
Holter or programmed electrical stimulation (PES), has provided little 
insight into the mechanism of AAD efficacy or failure. We tested the 
hypothesis that class IA efficacy is related to drug-induced 
postrepolarization refractoriness (PRR). In 32 patients with ventricular 
tachycardia (VT), we performed PES at two right ventricular sites with 
a monophasic action potential/pacing combination catheter which 
allows precise distinction between myocardial repolarization and 
excitability. Action potential duration at 90% repolarization (APD90). 
effective refractory period (ERP) and ERPI APD ratio at both sites, and 
the conduction delay (CD) between the two sites were determined 
during baseline and after IA AADs. Sustained VT was inducible in 22 
patients during baseline and was suppressed in 9 of these after IA 
AADs. In both baseline and treatment failure patients. VT induction 
occurred when extrastimulation (S2-S4) captured the myocardium 
ll.w:iI!i repolarization of the preceding action potential (ERPI APD ratio 
0.85±'05). Noninducible patients during S2-S4 did not have capture 
until repolarization was completed. i.e. they exhibited use-dependent 
PRR (ERP/APD ratio 1.05±O.8, p<O.05). Capture before complete 
repolarization in inducible patients was associated with CD relative 10 
S I which progressed with number of extrastimuli (cumulative CD = 
95±2l %). Post-drug noninducible patients with PRR had significantly 
less relative CD (l8±7 %). 
Conclusions: Patients responding to IA treatment Gudged by nonin•
ducibility of VT during PES) had greater PRR and less CD than VT 
patients at baseline study or during ineffective IA therapy. Determina•
tion of PRR by simultaneous measurements of ERP and APD might 
enhance prediction of AAD efficacy or failure in the individual patient 
860-96 
Negative Inotropic Drug .... d the Atrium - The Influence of Sotelol on 
Atrial Tr .... port 
Arthur Pollak, Ravi Saini, Rodney H. Falk. Boston City Hospital, Boston, 
MA 
Following DC cardioversion for atrial fibrillation (AF), the mitral Doppler 
A wave may be depressed, a feature attributed to delayed atrial 
mechanical recovery. Many patients (pt) receive antiarrhythmic (AA) 
drugs for AF. While these are known to have a negative inotropic effect 
on the ventricle, no data exist on their effect on atrial function. 
Therefore, to determine the effects on atrial function of sotalol, a type 
III AA drug with beta-blocking properties, 30 pt randomized pre•
cardioversion to sotalol 240-360 mg/day or placebo were studied. All 
had EF ~ 45%, and there was no difference in EF between the placebo 
and aotalol groups. Mitral inflow Doppler was performed within 24 hours 
of cardioversion. Peak A wave, atrial flow velocity integral (AFVI), and 
atrial flow velocity integralltotal flow velocity integral (AFVIITFVI) were 
significantly lower in sotalol pt. In contrast peak E wave, EFVI, 
EFVIITFVI and E wave deceleration time were similar in both groups. 
SotaloUN z 141 PtacebolN = 161 fJ!i!l!l 
A Wave(cm/s) 17.4.±.3.0 36.1.±.6.0 <0.02 
AFVl(cm) 1.5.±.0.3 3.9.±.0.8 <0.02 
E Wave(cm/s) 85.5.±. 4.3 l00.1.±.8.0 NS 
EFVl(cm) 12.6.±.0.8 16.3.±.2.1 NS 
(Values expressed as mean.±. SEM) 
The .. flow pattern differences persisted after correction for heart rate, 
which was significantly lower in the sotalol group (56 vs 69 bpm). 
Conclusions: Atrial contribution to LV filling is reduced by sotalol 
immediately after DC cardioversion. The absence of effect on ventricular 
function, E wave velocity and deceleration time suggests that this is due 
to a direct negative inotropic effect on the atrium. Thus, assessment of 
the significance of mitral Doppler parameters should take into account 
the possible role of AA drugs, particularly sotalol, on atrial function. 
JACC Vol. 21, No.2 
February 1993:57A 
860-97 
Effeets or at-adrenergic Stimulation on Human Sinus Node 
Automaticity 
Hirokazu Saitoh, Atsunobu Nomura, Motohisa Osaka, Norum Sasabe, 
Takeshi Ino, Hirotsugu Atarashi, Takao Katoh, Hiroshi Kishida, 
Hirokazu Hayakawa, Nippon Medical School, Tokyo, Japan 
It is known that the a I-adrenergic stimulation tends to suppress 
automaticity in adult canine cardiac Purkinje fibers and human atrium. 
On the other hand, al-adrenergic-induced acceleration of automaticity 
in neonatal canine cardiac Purkinje fibers and rabbit sinus node fibers 
are also reported. We examined the effects of ai-adrenergic 
stimulation on human sinus node automaticity. Forty-six patients (pts) 
of paroxysmal supraventricular tachycardia with normal sinus nodal 
function, aged 17 to 75 y.o., were included. After attaining total 
autonomic blockade with intravenous administration of atropine 0.04 
mg/kg and propranolol 0.2 mg/kg, phenylephrine O.4I'g1kglmin was 
infused for 5 min. Increased blood pressure (BP) and sinus heart rate 
(HR) with phenylephrine were designated as 4BPa and 4HRa 
respectively. Although phenylephrine significantly increased HR 
(4HRa= 16.0± 12.0 bpm, p < 0.01) among 14 pts under 30 y.o., 14 
pts over 50 y.o. did not show any acceleration of HR 
(4HRa=0.0±1.9 bpm) with phenylephrine. As a whole, 4HRa 
showed negative correlation with age (4HRa=2l-O.34xage, r=-O.56, 
p<O.OI). Phenylephrine significantly increased BP, however 4BPa 
did not correlate with 4HRa or with age. In conclusion, ai•
adrenergic stimulation accelerates sinus node automaticity in pts under 
30 y.o. independent of changes in BP. This effect diminished with 
age and developmental change of a I-adrenergic chronotropic response 
in human sinus node was suggested. 
860-98 
Comparlsoa of tbe Effects of ladapamlde Wltb 
Hydrocblorotblazlde, Nlfedlplae, Eaalaprll aad Ateaolol oa Left 
Veatrlcular Hypertropby la Hyperteasloa: A Double-Bliad 
Parallel Study 
Roxy Senior, Jean L. Imbs, Michel Bory, Bernard Denis, Faiez 
Zannad, Bruno Trimarco, Avijit Lahiri, Edward B. Raftery. A 
Multicentre Study. Northwick Park Hospital, Harrow, UK 
Left ventricular hypertropby (L VH) is associated witb a poor 
prognosis in hypertensive patients. L VH regression was assessed 
by echocardiography in 4 parallel double-blind studies in 149 
bypertensive patients treated witb either indapamide (IND), 
nifedipine (NIF), enalapril (ENL), atenolol (ATL) or 
hydrocblorathiazide (HCTZ). All bad diastolic blood pressure 
(DBP) between 95-IZOmmHg and increased left ventricular mass 
index (L VMI) as calculated by the Devereux method. After a 
Z week wash-out period the patients were randomly assigned to 
either IND (Z.5mg/d), HCTZ (Z5mg/d), NIF (40mg/d), ENL 




IND ZO IOZ.3±1.5 





Baseline 6 months 
151.40±6.3 IZ5. 70±4.6· 
14I.30±6.6 I35.60±8.3 
IND ZZ 100.4±0.6 89.3±1.8" 144.10±5.3 IZ5.10±4.3" 
NIF 19 103.6±1.2 9 I.3± 1.6 " 170.40±6.6 148.Z0±6.Z" 
IND 9 IOZ.89±I.71 87.44±Z.I I" 155.1 1±6.Z6 143.44±5.15· 
ENL 9 103.1 1±2.36 85.67± 1.96" 14Z.00±6.72 130.00±5.93" 
IND 17 IOZ.8Z±1.45 86.Z9±I.68" 146.18±5.06 I30.82±6.S4" 
ATL IZ IOZ.8Z±I.83 85.73±1.90" 156.67±8.36 142.92±10.Z8·" 
'P < 0.001 "'P < 0.01 
Conclusion: all drugs significantly reduced DBP and L VMI 
except HCTZ. Percentage of LV fractional shortening 
significantly improved with IND (p<.05) in the IND vs A TL 
group. Thus indapamide is as effective as nifedipine, enalapril 
and atenolol in reducing L VMI. 
ABSTRACTS 
860-99 
Haemodynamic IUId Hormonal Respoases to Central Sympathetic: BIoc:kade with 
CIooidine Separate two Subgroups of Patients with Autonomic Failure. 
! S Kooner·, W S Peart & C J Mathias. 
Clinical Cardiology Unit, Department of Medicine, Royal Postgraduate 
Medic:a1 School, London Wl2 ONN. Departmeat of Medicine, St Mary's 
Hospital Medic:aI School, Norfolk Place, London W2 lNY. 
The possible differences in the sympathetic lesion in two subgroups of 
patieats with primary autonomic failure (9 with multiple system atrophy,MSA; 6 
witb pure autonomic failure,PAF)were investigated by studyiag the 
haemodynamic and hormonal responses to central sympathetic blockade with 
c1onidine. 
Blood pressure(BP), beart rate(HR)(Sentron), digital skin blood flow 
(DSBF) (laser Doppler) and skin temperature (thermistors) were measured 
non-invasively before and after c1onidine(Zug/Kg). Blood samples were taken 
for measurementsof plasma noradrenaline (NORAD) and adrenaline 
(ADREN). 
Mean BP was higher in MSA (p < 0.05). After c1onidine, mean BP feU 
in MSA (12S.±.5 to 108.±.6 mmHg, p<O.05), butrose in PAF (104.±.4 to U9.±.3 
mmHg, p<O.05); HR feU in MSA p<O.05). Basal DSBF and temperature were 
lower in MSA (p < 0.05). After c1onidine, there was a rise in DSBF (O.74.±.O.14 to 
l.26.±.O.28 v, p<O.OS) and temperature (29.8.±.1.3 to 32.8.±.1.loC, p<O.05) in 
MSA alone. Basal digital skin vascularresistance (DSVR) was higher ia MSA 
compared to PAF(p<0.05)After c10nidine DSVR fell in MSA (Z08.±.46 to 
108.±.2S mmHg/v,p<O.OS),but rose in PAF (128,±,10 to 165.±.Z9,mmHg/v 
p<O.05).BasaI supine NORAD was higher (p<O.05),and feU after c10nidinein 
MSA (4S6.±.160 to 209.±.67 pg/ml,p<O.OS) but not in (PAF 7S.±.14 to 54.±.9 
pg/ml,ns). Plasma ADREN was lower in both groups. 
Clonidine lowered BP, DSVR and NORAD in MSA which is consistent 
with a faIl in residual sympathetic nervous activityMean BP, DSVR and NORAD 
were lower in PAF, with a rise in BP and DSVR after clonidine indicating 
extremely low residual sympathetic activity with alpha adrenoceptor 
supersensitivityThis indicates differences in site, nature and eXlent of the lesion 
in these subgroups of patients with sympathetic failure who have a similar degree 
of postural bypotension. 
860-100 
Can the Myocardial Blood Flow Response to Pharmacologic 
Vasodilation be Predicted by Systemic Hemodynamic Change.? 
Richard C. Brunken, Johannes Czemin, Sammy Chan, Alan Chan, 
Peter Milller, Heinrich R. Schelbert. UCLA School of Medicine, 
Los Angeles, CA. 
Although intravenous adenosine (AD) and dipyridamole (DIP) 
both alter heart rate (HR), systolic and diastolic blood pressure 
(SBP, DBP) and rate-pressure product (RPP), it is uncertain if 
observed systemic hemodynamic changes quantitatively reflect 
the efficacy and magnitude of the pharmacologic coronary 
vasodilation induced by these agents. In 46 normal men, rest and 
hyperemic (29 DIP, 17 AD) myocardial blood flows (MBP's) were 
quantitated using dynamic N-13 ammonia PET imaging and 
correlated with HR, SBP, DBP and RPP changes. Myocardial flow 
reserve (MFR) was calculated as the ratio of hyperemic/rest 
MBP's. For both AD and DIP, MFR's were unrelated to either 
absolute or relative changes in DBP or SBP. For DIP, MFR's were 
linearly related to relative changes in HR (MFR = 2.68 + 0.020 % A 
HR. p<0.02, SEE = 0.97), and absolute RPP changes (MFR = 2.62 + 
0.000250 A RPP), p<O.025, SEE = 0.98), relative RPP changes (MFR 
= 2.69 + 0.016 0 % A RPP, p<0.02, SEE = 0.95) and ratios of stress to 
rest RPP's (MFR = 0.87 + 1.62 0 RPP ratio, p<o.OO5, SEE = 0.93). In 
contrast, AD MFR's were unrelated to either absolute or relative 
HR and RPP changes. Thus, HR and RPP changes are not 
clinically helpful in gauging the MFR's induced by adenosine•
induced hyperemia. In contrast, the results suggest that the 
clinical efficacy of dipyridamole for inducing coronary 
vasodilation in men can be estimated from the associated changes 




Hemodynamic Actions or the Class III Antiarrhythmic 
Agent Sematilide HCI in Congestive Heart Failure. 
Stephen S. Gottlieb, Michelle Cines, Richard D. Patten, Catherine 
M. Krichten, Salvatore S. Lauria. University of Maryland School of 
Medicine, Baltimore, MD. 
Although class I antiarrhythmic agents consistently demonstrate 
adverse hemodynamic actions when tested in patients (pts) with se•
vere heart failure, the effects of class III agents are not known. We 
therefore sought to evaluate the hemodynamic actions of sematilide 
HCI, an antiarrhythmic agent with selective class III actions, in pts 
with NYHA class III & IV heart failure. At least 12 hrs after place•
ment of a Swan-Ganz catheter & radial arterial line, we administered 
intravenous sematilide HCI to 12 pts with an ejection fraction < 30%. 
3 pts received a loading dose of 11.25 mg followed by a I hr mainte•
nance infusion of 0.3 mg/min. 9 pts received a loading dose of 22.5 
mg followed by an infusion of 0.6 mg/min. Cardiac inde)( (CI, Vmin/ 
M2), mean arterial, LV filling & right atrial pressures (MAP, LVFP, 
& RAP, mmHg), heart rate (HR, bpm), systemic vascular resistance 
(SVR, dos-c), & QTc were measured before (PRE), after the loading 
dose (LOAD),& 30 & 60 minutes into the maintenance infusion. The 
ch f PRE . * d 0 05 E. ange rom are gIven, enotlng 0 < as com oared to PR 
OTc HR CI LVFP RAP MAP SVR 
PRE .41 89 1.99 23 9 93 1630 
&OAD +.01 ·2' +.03 ·0 ·1 +0 ·47 
630 +.04' - 6' - .09 - 0 - 1 + 1 +133 
660 + .04' - 6 ' -.07 - 0 - 0 +2 +82 
Sematihde HCI e)(erted Sl ni Icant electro h slOlo IC effec g p y g ts, 
with the QTc prolonging and HR decreasing. Nevertheless, at plasma 
concentrations similar to those seen after therapeutic oral dosing, 
there was no detectable hemodynamic response. 
In conclusion, in contrast to class I, II, and IV antiarrhythmic 
agents, sematilide HCI e)(erts no clinically important hemodynamic 
actions at doses which produce electrophysiologic effects. 
Determination as to whether this is a class characteristic depends 
upon investigation of other class 1II antiarrhythmic agents. 
860·102 
Additive Effects of Geafibrozil and Nicotinic Acid in 
the Treat.ent of Isolated Hypoalpbalipoproteinea1a 
Michael Zema, Patricia Ogilvie. Brookhaven Memorial 
Hospital Medical Center, Patchogue, New York 
Among patients (PTS) with angiographic CAD, 8-36% have 
HDL-C < 3Smg/dl as sole lipid abnormality. We have previ•
ously shown that both gemfibrozil (GEM) and nicotinic 
acid (NA) - given as mono therapy - are capable of rais•
ing HDL-G, lowering triglycerides (TRIG) and improving 
the lipid profile of such PTS. Thirteen non-smoking CAD 
PTS (12M, IF) age 60.3!11.lyr, of normal body wt (173!35 
Ib), with isolated low Apo Al and HDL-C (total-C-189.l! 
29.8mg/dl; other lipid values normal at baseline (BASE) 
as shown in table), who had been able to tolerate random•
ized mono therapy with either GEM(1200mg/24hr) or NA(l.S-
3.0g/24hr;mean dose 2.4g/24hr) were given combination Rx 
for 12-16 wk. 
BASE (mg/dl) GEM(mg/dl) NA(mg/dl) GEM+NA(mg/dl) 
LDL-C 13l.4!24.9 l19.6!2S.6 103.8t25.8 88.3t27.7 
HDL-C 34.8t6.8 39.9t7.4 47.0t8.2 SO.2t7.8 
LDL/HDL 3.88tl.00 3.l2tO.92 2.34tO.89 1.81tO.68 
TRIG l14.St38.8 80.7t39.9 88.6tS3.2 S8.4t20.2 
Apo B 88.3t23.0 74.7t16.9 6S.3t19.7 S4.1t13.8 
Apo Al l16.7t17.9 l22.3t14.2 129.St14.l l39.7t20.8 
ApoAl/B 1.40tO.42 1.69+0.31 2.l8tO.83 2.69tO.68 
p< 0.02 for all BASE VB GEM except Apo Al where p-NS 
p< 0.02 for all BASE vs NA except TRIG where p< O.OS 
p< 0.02 for all NA vs(GEM+NA)exceptAl(p-NS);HDL-C(p-0.09) 
p< O.OOSfor all GEM vs(GEM+NA) except TRIG where p< O.OS 
Conclusion: GEM and NA produce additive beneficial 
effects upon the lipid profile of PTS with isolated 
hypoalphalipoproteinemia. 
860·103 
JACC Vol. 21, No.2 
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Reoal Dy.function After Contra.t Media Attenuated by 
Blockade of tbe Adeno.ine Receptor. 
Richard Katholi, George Taylor, William McCann, W.T. 
Woods, Kelly Womack, Cyndi McCoy, H. Weston Moses, 
Prairie Education and Research cooperative, southern 
Illinois University, Springfield, Illinois 
We have previously shown the fall in creatinine 
clearance (CCR) after administration of intra-arterial 
constrast media is associated with increased intra-renal 
adenosine. This suggests that blockade of the adenosine 
receptor with theophylline may prevent contrast media 
nephrotoxicity. 
This was a double blind study of 40 patients with serum 
creatinine ~ 2.0 mg/dL who received 1) an ionic high 
osmolar contrast medium (HOCM; Hypaque) or a non ionic 
low osmolar contrast medium (LOCM; Isovue) during 
coronary angiography and 2) received pre-angiography 
oral theophylline (2. BB mg/kg) or placebo. Patients 
receiving ACE inhibitors, beta-adrenergic blockers, 
NSAIOS, digoxin, dipyridamole, allopurinol or xanthines 
were excluded. CCR and urinary adenosine were measured 
12 hours before and 12 hours after angiography. 
Age, baseline CCR, and dose (ml/kg) of contrast media 
were the same (P=NS) in all groups. After HOCM, CCR 
decreased by 39% ~ 5% (P<O.Ol) in placebo-treated 
patients (n=ll) and decreased by 21% + 4% (P<0.05) in 
theophylline pre-treated patients (n=9). After LOCM, 
CCR decreased by lB% ~ 4% (P<0.05) in placebo-treated 
patients (n=lO) but did not decrease «3% + 2%, P=NS) in 
theophylline pre-treated patients (n=lO)~ 
We conclude that patients receiving HOCM (Hypaque) had 
higher intrarenal adenosine levels, and some developed 
nephrotoxicity even after they received theophylline. 
Patients receiving LOCM (Isovue) and theophylline had 
low adenosine levels and no change in renal function. 
860·104 
Should Gender Dirrerences Guide Therapeutics 
Gerald A. Klassen, Pollen K. Yeung, Orlando R. Hung, 
P. Timothy Pollak, Katherine D. Barclay, Susan 1. Mosher. 
Dalhousie University, Halifax, NS, Canada 
Women arc rarely recruited into trials to test drug efficacy: therefon: 
gender differences in pharmacodynamics of commonly used 
cardiovascular drugs arc unknown. A survey of mortality of patients 
admitted for myocardial infarction in Halifax County demonstrated a 
2-fold greater mortality for women using calcium channel blockers. 
We performed a study on 21 healthy young volunteers (10 females, 
11 males) to measure their pharmacodynamic responses to diltiazem 
(0) 60 mg qid for 7 days. We measured intra-arterial blood pressure, 
heart rate, plasma adenosine (using stopping solution), D and its 
metabolites (after drug) at rest, during the fIrst 2 stages of a Bruce 
protocol and during a 20 minute recovery period before and after 
drug. Before D all measured values were similar at rest. During 
e)(ercise before D, diastolic pressures (Pd) wen: on average 10 mmHg 
lower in females and heart rate 9 beats faster (p < 0.01). After D at 
rest female systolic pressure (Ps) was 21 and Pd 13 mmHg lower 
than males. During e)(ercise Ps was 22 and Pd 12 mmHg lower in 
females than males. During recovery Ps was 18 and Pd 11 mmHg 
lower in females than males (all p < 0.01). Heart rate differences 
during exercise wen: similar. Plasma diltiazem concentration was the 
same in both groups (141 ngm/mI). Serum adenosine demonstrated a 
different response to e)(ercise in males and females, following D 
serum adenosine was increased more in females than in males during 
e)(ercise. These data demonstrate that following D a significantly 
diffen:nt blood pressure and adenosine response to e)(ercise occurs in 
females than males with both lower systolic and diastolic pressures 
but with a comparable decrease in heart rate. This represents a 
differential response of the Al receptor (heart rate) and the A2 receptor 
(vasodilation). The increased sensitivity of females to the blood 
pressure lowering effects of D (a known inhibitor of the adenosine 
transporter) may relate to a different mode of adenosine metabolism 
in women. Such gender differences in pharmacodynamics may have 
important therapeutic implications. 
JACC Vol. 21, No.2 
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860-105 
H.p.rin i. Cl •• r.d F •• t.r in Childr.n With 
Cong.nit.l H •• rt Di..... Th.n in Adult. 
Sophronia Turner-Gomes, Evan Nitschmann, Lee Benson, 
Patricia Burrows, Maureen Andrew. McMaster University, 
Hamilton, Ontario, Canada and University of Toronto, 
Toronto, Ontario, Canada 
In children with congenital heart disease (CHD) 
undergoing invasive procedures, standard heparin (SH) 
is invaluable for thrombosis prophylaxis and treatment. 
SH protocols in CHD are extrapolated from adult data. 
However, pharmacokinetic studies show that newborns and 
young animals have increased SH requirements compared 
to adults. We assessed SH pharmacokinetics in 17 CHD 
patients aged 2-15 years, during interventional 
catheterization - acyanotic (AC) (11), cyanotic (C) (6); 
and in normal adults (Ad) (10). Blood drawn before and 
1-60 minutes after an IV bolus (100-150 u/kg) of SH was 
measured for anti-Factor Xa activity (chromogenic). 
The data were analysed using ANOVA. 
~;tg!.lg Agi )l.d 1::1 Ilt1L2 II:J:IU 
AC 7.0 98.7 2.3 41.1** .88 
C 5.0 82.0 2.6* 30.5** .59 
Ad >20 112 1. 9* 55.3** 1.02 
[Results expressed as mean, *p<.Ol, **p<.OOl; 
Vd=Volume of distribution, Cl=Clearance, 
Btl/2= half-life, ATIII= antithrombin 1111 
Vd - Age important covariate (p<.Ol, age !,Vd 1). 
Mean Vd in all 3 groups was similar (p=NS). 
Cl - Age important covariate (p<.Ol, age !,Cl 1). 
Cl varied between the groups C>AC>Ad (p<.Ol C vs Ad) 
Btl/2 - C<AC<Ad (p<.OOl) 
ATIII - Low in C, normal in AC and Ad. 
Conclusion: SH half-life is less in CHD children than 
in adults, with further decrease in cyanotic CHD. 
Additional heparin +1- ATIII may enhance SH use in 
younger CHD and in cyanotic CHD patients. 
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861-118 
Endomyocardial Biopsy in Arrhythmogenic Right 
Ventricular Cardiomyopathy. 
Annalisa Angelini, Gaetano Thiene, Giovanni 
M. Boffa, Irene Calliari, Luciano Daliento, 
Andrea Nava. University of Padua, Italy. 
Using an imaging analyser system, 
histomorphometric parameters of myocytes (M), 
interstitium (I), fibrous tissue (FT), 
adiposis (A) were evaluated on endomyocardial 
biopsy (EMB) from 30 patients (pts) with 
arrhythmogenic right ventricular 
cardiomyopathy (ARVC), 29 pts with dilated 
cardiomyopathy (DC) and 30 control (C) pts. 
The percent area of M decreased from 
78.10+7.34 in C to 63.39+9.22 in DC (p<O.OS) 
and to 47.28+1S.01 in- ARVC (p<O.OI). FT 
increased from 8.10+3.89 in C to 21.80+9.29 
in DC (p<O.OS) and-to 24.60±11.37 in -ARVC 
(p<O.OS). A varied from 0.33±1.44 in C and 
0.07+0.31 in DC to 13.30+17.30 in ARVC 
(p<O:OS). A was a feature of-ARVC (67% of pts 
vs 6% of C and DC pts). Diagnostic values 
typifying ARVC, obtained by excluding any 
overlapping between confidence intervals in 
the three groups, were: M <44.9S%; FT 
>40.38%, and A >3.21%, with 67% sensitivity 
and 91.S3% specificity for at least one 
parameter. 
In conclusion, a significant difference 
between ARVC, DC and C exists in terms of 
amount of M, FT and A. Presence of A and FT 
exceeding 3.21% and 40.38% respectively 
should be considered highly suspect for ARVC 
in right ventricular EMB. 
ABSTRACfS 
861-119 
Increased Cardiac: Myocyte Gap Junctional Membrane Early in 
Renovasc:ular Hypertension. 
Nicholas S Peters, Federica del Monte, Kenneth T MacLeod, Colin R 
Green, Philip A Poole-Wilson, Nicholas 1 Severs. National Heart & 
Lung Institute and University College, London, UK. 
Ventricular hypertrophy in response to hypertension is associated with 
alterations in myocardial electrophysiology that can not be explained 
entirely by changes in the action potential. The purpose of this study 
was to investigate alterations in gap junction intercellular coupling in 
renovascular hypertension. 
The distribution and quantity of gap-junctional membrane was 
determined using a 2 kidney, 1 clip model in the guinea pig. At between 
3 and 5 weeks, the clipped animals(n=6) were hypertensive (blood 
pressure 141±5192±4 mmHg; mean±SEM) compared with controls 
(108 ±4/66± 3: p<O.OOl). The heartlbody weight ratio showed no 
significant alteration. Enzymatically·isolated ventricular myocytes were 
immunolabeled for the principle cardiac gap-junctional protein, 
connexin43. Laser scanning confocal microscopy was used to determine 
the volume and gap junctional area of 6 randomly-selected cardiac 
myocytes per animal. The cell volumes of the hypertensive animals were 
not significantly greater than controls (31422±2359 vs. 25764±1508 
1'm3: p=0.08). Although the pattern of gap junction distribution was 
normal, the junctional area was substantially increased in the myocytes 
from the hypertensive animals (l46±4 vs. 92±7 1'm2: p<O.OOl), and 
remained increased when expressed per myocyte volume 
(0.0049±O.OOO3 vs. 0.OO37±0.00041'm2/1'm3: p=O.03). 
This increase in connexin43 gap junctional membrane would be 
expected to enhance intercellular coupling, reducing myocardial 
resistivity. and contributing to the electrophysiologic changes that occur 
in the early phase of the myocardial hypertrophic response. 
861-120 
Does Nutritional Deficiency Play an Important 
Role in the Development of Alcohol-Induced 
Cardiomyopathy ? 
Charles Y Lui, Tatsuo Yoneyama, University of 
Virginia-Charlottesville & DVAMC-Salem, VA 
The biochemical mechanism involved in the 
pathogenesis of alcoholic cardiomyopathy (AC) 
has not been elucidated. Several clinical 
studies have demonstrated independently the 
serum selenium (Se) and vitamin E (vE) are 
decreased in chronic alcoholics. To test 
whether Se and/or vE deficiency (def) is a 
prerequisite for development of AC, 4 groups of 
adult Sprague-Dawley rats (10 each) were fed 25% 
v/v alcohol (alc) and either normal, Se def, vE 
def or Se/vE def diet for 50-69 weeks. Four 
non-alc control groups were included. Electron 
microscopy (EM) of left ventricles (LV) (two/gp) 
obtained at 23-34 weeks of feeding showed 
significant mitochondrial damages in the Se/vE 
def, alc-treated group only. Subsequently, alc 
was administered by gavage for 13 more weeks. 
EM of LV (two/gp) from the alc-treated animals 
showed characteristic changes of AC along with 
an increased HW/BW ratio (p < 0.02) in the Se/vE 
def, alc-treated group only. These data 
suggest, in addition to chronic alc consumption, 
both Se def and vE def are required for the 
development of AC. In the presence of reduced 
scavenging activities from Se-containing 
glutathione peroxidases def and vE def, the free 
radicals induced by chronic alc consumption are 
likely to be inadequately detoxified. This 
would lead to an increase in cardiac lipid 
peroxidation which in turn disrupt microsomal 




Beta Blocker Treatment of Murine Dilated Cardiomyopathy: 
Role of Intrinsic Sympathomimetic Activity 
Eric Gangbar, Fayez Dawood, John Asta, Jack Butany, Peter 
Liu. The Toronto Hospital, University of Toronto, Canada. 
To determine the role of intrinsic sympathomimetic activity 
(lSA) of beta blockade in heart failure, we compared the effects 
of acebutolol (selective beta blocker with ISA) with metoprolol 
(selective beta blocker without ISA) in a murine model of 
dilated cardiomyopathy. DBA/2 mice were inoculated with 
encephalomyocardltis virus and were randomized at 3 weeks to 
oral metoprolol (Met, 0.2 mg/g/day; n=8), acebutolol (Acb, 0.4 
mg/g/day; n=8) or placebo (n=7). The animals were sacrificed 
after 42 days of treatment, and the hearts were removed and 
perfused physiologically to assess the force-frequency response, 
and contractile response to graded doses of isopreterenol (Iso). 
The maximum force (F) generated at fixed freload, and the 
response to 0.12 ug/mJ of Iso are (mean.±.SEf> , p < 0.05): 
Placebo Metoprolol Acebutolol 
Max Pace F(g) 0.97.±.O.13 l.31.±.0.40 2.43.±..40· 
F(WO.12ug Iso(g)O.92.±.O.19 l.05.±.0.36 1.88.±..33· 
Overall there was si~nificantly higher contractile response at 
all pacing frequencies In the acehlltolol group. The acebutolol 
group also showed less myocardial necrosIs and fibrosis on 
patholo!,'Y by hoth qualitative and quantitatiw criteria. The 
levels of serum atrial natriuretic factor were also the lowest in 
the acebutolol group. There was a trend towards lower heart 
weights and lower heart/body weight ratio. 
We conclude that beta blocker with intrinsic sympathomimetic 
activity provided greater functional and structural protection in 
this model of cardiomyopathy following myocarditis, even when 
treated late during myopathy. The mechanism of this protection 
warrants further investigation, and may have important clinical 
implications. 
861-122 
High Energy Phosphate Matabollsm Is not Ralated to Saverlty of 
Machanlcal Dysfunction In Canine Tachypaced-Induced Haart Failure 
Peter S. Rahko, Michael P. Cinquegrani, Robert Wortmann. 
University of Wisconsin-Madison WI and Medical College of Wisconsin 
Milwaukee, WI 
Tachypacing is a well defined method of producing left ventricular 
dysfunction (LV DYSI. It has been previously shown that tachypacing 
may cause significant regional variation in LV DYS. The purpose of this 
study was to characterize high energy phosphate metabolism and 
determine its relationship to severity of LV DYS in this model. Eighteen 
dogs (weight 20-26 kgl were instrumented with a modified pacemaker 
and micromanometer catheters. Eleven were paced at 215-240 bpm 
over 3 weeks, 7 were controls. Using 2·0 echocardiography in the short 
axis view, the antero-septal and posterior-lateral walls were imaged and 
scored as normal (1 +1, hypokinetic (2+1 or akinetic (3+1. Myocardial 
muscle samples were then taken and flash frozen from both walls to 
asaess high energy phosphates. RESULTS: Comparing the LV DYS 
group to controls, there was a significant increase in LV end-diastolic 
pressure (27±7 vs 10±5 mm Hg, p<0.0011 and a decrease in peak 
+dP/dt (1035±77 vs 1882± 118 p<0.0011. All controls had normal 
wall motion. In the LV DYS group the antero-septal wall motion score 
was significantly better than the posterior·lateral region (1.4 ± 4 vs 
2.5±0.4, p<0.0021. High energy phosphete results: 
(rvnol/mg muscle except EC = 1/2 ADP+ ATP/AMP+ADP+ATPI. 
Controls In-71 LV DYS In-11l 
Ant. Sep. Post. Lat. Ant. Sep. Post. Lat. 
AMP 0.85±0.25 0.50±0.22 0.46±0.15 0.54±0.20 
ADP 1.49±0.27 1.04±0.13 1.10±0.18 0.98±0.22 
ATP 2.89±0.58 3.64±0.73 2.82±0.41 2.93±0.57 
NAD 0.64±0.10 0.49±0.03 0.61±0.10 0.57±0.06 
EC 0.78±0.03 0.80±0.05 0.77±0.03 0.79±0.05 
(p = NS for aliI 
CONCLUSION: High energy phosphate levels are not different from 
controls in areas of moderate or severe tachypaced induced LV DYS. 
These findings suggest withdrawal of regulatory influence controlling 
the coupling of mechanical and metabolic function in this model. 
861-123 
JACC Vol. 21, No.2 
February 1993:60A 
Decreased Inotropic but Preserved Relaxation Response to Phos•
phodiesterase Inhibitors in Myopathic Human Myocardium 
Erika Bruce, Judith K. Gwathmey, Bernard J. Ransil, John E. 
Markis, James P. Morgan. Harvard Medical School. Boston, MA 
The purpose of this study was to determine whether heart failure 
differentially affects the inotropic versus relaxation response to 
phosphodiesterase inhibitors (POEII in myocardium from patients 
with end-stage heart failure (CHF). Control (CI human hearts 
(n = 81 were obtained through the New England Regional Organ 
Bank; CHF hearts (n = 7) were obtained at the time of cardiac 
transplantation in Boston-area hospitals. 26 C and 15 CHF tra•
beculae carneae s 1 mm dia were placed in physiologic saline, 
2.5 mM Ca2+, and stretched to the length at which maximal iso•
metric force developed at 30 oC, 0.33 Hz. A subgroup was 
loaded with the Ca2 • indicator aequorin. Dose-response curves 
were determined for calcium (Ca2., and milrinone (MILl. Ca2+ 
from 2.5 to 16 mM produced equivalent increases of peak force 
(PFI in both C and CHF with no effect on relaxation. In contrast, 
10.1 to 10" M MIL increased PF in C by 190 ± 93% (p<0.051, 
but by only 7 ± 6% in CHF (p=nsl. Over the same range of 
doses, MIL decreased the time to 50% relaxation in both groups 
(289 to 275 ms in CHF, 245 to 200 ms in C; p<0.051; similar 
results were obtained with isobutylmethylxanthine. The POEI•
induced enhancement of relaxation was associated with a briefer 
Ca2• transient, suggesting enhanced resequestration by the sarco•
plasmic reticulum (SR). Since both the inotropic and relaxant 
effects of POEls are attributed to cAMP-dependent phosphoryla•
tion of the sarcolemma and SR, respectively, our results indicate 
relative preservation of the cAMP pool associated with the SR. 
Moreover, our results suggest that POEls may have a beneficial 
effect on relaxation in patients with end-stage heart failure, des•
pite an attenuated inotropic response. 
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862-115 
Mechanical Coupling of the Myocardium with Coronary Circulation 
J. Yasha Kresh, H. Frederick Frasch, Peter Walinsky, Abraham 
Noordergraaf. Stanley K. Brockman. Cardiothoracic Research, 
Hahnemann Univ. and Univ. of Pennsylvania, Philadelphia, PA. 
We tested the hypothesis that the systolic impediment to coronary 
inflow resides in the muscle fiber-interstitium-microvessel 
interface, functioning independently of the generated LV-chamber 
pressure (LVP). To examine the mechanical coupling function of 
the myocardium to the imbedded circulation. coronary flow (CBF•
mllminl - perfUSion pressure (CPP-mmHgl relations were studied 
in isolated, Krebs-Henseleit perfused, unloaded (LVP sO" Beating 
and ryanodine (5pMI Tetanized rabbit hearts (n=6). ~ 
fu!1!§1: CBF-CPP relation was linear (r> .991 in each case. The 
slope (resistancel of CBF-CPP (average ± SO) did not change 
(p>.41 with systolic-arrest. The heightened intramyocardial tissue 
pressure (lMP-mmHgl induced by the sustained systole in the 
Tetanized hearts, resulted in a similar (p> .2) mean·IMP to that 
generated in th!l Beating state, concurrent with an insignificant 
slope change (p> .2) in mean IMP-CPP relation. Zero flow (z.) 
pressures (CPP @ Z, and IMP @ z,) were minimally (p> .41 
affected by cardiac tetanization. 
CBF vs CPP IMP vs CPP 
Slope CPP@Z, r Slope IMP@l, r 
Beatinll 0.9±.2 3.5±2.6 0.94 O.7±0.1 7.5±4.6 0.96 
Teta.,iud 0.8±.2 4.9±2.5 0.90 0.6±0.1 7.9±3.6 0.9a 
Under these experimental conditions, similar microvascular 
resistance in beating and tetanized hearts revealed the dominant 
role of myocardial tissue forces, generated by phasic contraction 
or manifested by the induced tetanization (static contraction). The 
muscle tissue influence on the embedded vasculature is 
independent of LV-chamber pressure. Systolic flow impediment 
is princip:llly dependent on the active changes in tissue pressure 
("stiffness"). 
lACC Vol. 21, No.2 
February 1993:61A 
862-116 
New Method for Evaluation of Arterial 
Properties by Three- Element Windkessel 
Youngtack Shim, Ares Pasipoularides, Craig Straley, Thomas 
Hampton, Clarence Owen, James Davis, Donald Glower, Duke 
University, Durham, NC 
Evaluation of arterial properties is important for management of 
hypertension, arteriosclerosis and heart failure. However, previous 
methods of estimating the parameters of the three-element Wind•
kessel model (WM) of arterial function yield conflicting values of 
characteristic impedance (Z), total arterial resistance (R) and 
compliance (C). Accordingly, we developed a new integral method 
(1M) for estimating Z, Rand C using only time domain aortic 
pressure (AoP) and flow (Q) data during ejection and the governing 
differential equation (GDE) of WM. Ensemble averaged waveforms 
of micromanometric AoP and EMF Q were obtained from 8 dogs and 
used to compare the accuracy of the new method with existing ones 
based on monoexponential diastolic pressure decay (MOM) and on 
model input impedance equations (11M). The values obtained by 1M 
were as follows: Z=145±31(g/em'/s), R=4699±1133(g/em'I.) and C=3.7±O.6 
(em','/g). All these values did not differ significantly from maximum 
likelihood estimators by an independent least squares approach. 
However, they differed significantly from those given by the other 
methods (p<O.OI). 
,.
200m " AoP ~ IlO 
i" 100 Mt! 1M 
1M MOM lIM 
SE(AoP) 1.1±0.2 2.3±0.S 4.2±3.7 
(mmH.i 
~E(?? S.h1.4 9.S±3.S 9.9:tS.7 mils 
o 0.2 0.4( ... ) 
To mathematically identify the most accurate method, AoP and Q 
waveforms were reconstructed using Z, R and C values obtained by 
each method in the solution of the GDE of WM. Standard errors (SE) 
of reconstructed from ensemble averaged waveforms were 
invariably smallest by the new method. These results show the 
superiority of 1M (integral method) in estimating arterial properties. 
862-117 
N'lCotine Wrthdrawal Meets Myocardial Contractility 
Charles C. Elkins, James R. Stewart, Vanderbilt University, Nashville, 
Tennessee 
Nicotine is a positive inotropic agent that exerts direct and indirect effects on the 
myocardium. We tested the hypothesis that nicotine withdrawal leads to • 
transient depression in contractility using the i!! vitro contracting rat atrial strip 
model. LewisIBrown Norway rats received nicotine in their water to equal one 
ppd smokins for >6 weeks. Five experimental groups were studied. Group 1 
(control, n=20) was not fed nicotine. The other groups were studied at various 
times after nicotine withdrawal: group 2 (n= 12) immediately after withdrawal. 
group 3 (n= 12) 6 hours. group 4 (n= 16) 12 hours. and group 5 (n=20) 24 
hours. Baseline force. postrest augmented force (rest interval=45 sec.). 
postextrasystolic augmented force (PESAF) and Isoproterenol (IS0PROT) dose 
response (0.05 mcll added to hath) were evaluated. Data are reported as mg 
force/mg strip weight at 60 bpm. 
*=p<0.05 BASELINE POSTRESr PESAF ISOPROT 
Control 44.4±14 93.9±14 SO.O±lS 97.9±11 
o Hour 29.3±7" 77.0±13· 70.0±11 63.9±23· 
6 Hour 29. l± 9' 69.8±28" 60.5±26" 70.3±U· 
12 Hour 34.3±13· 7S.7±27" 7S.2±28 66.9±2S" 
24 Hour 34.9±13· 76.4±16" 77.0±25 70.SHl· 
Decreased contractile force was demonstrated in this model with the nadir at six 
hours in baseline. postrest and postextrasystolic augmented force. 
Post".trasystolic force returned to control by 12 hours. while Isoproterenol dose 
response. postrest and baseline force remained d.,..reased in all groups. 
Conclusion: Nicotine withdrawal leads to a decline in cardi"" contractility and 
an attenuated response to lsoprotereool. 
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710-1 2:00 
Transplant Coronary Disease Distribution and Lesion 
Characteristics: An Intracoronary Ultrasound Study 
Adrian Chenzbraun. Fausto J. Pinto. Tim Fischell. John S Schroeder. 
Hannah A. Valantine. Edwin L. Alderman • Richard L. Popp. 
Stanford University, Div Cardiovascular Medicine, Stanford, CA 
Transplant Coronary Artery Disease (CAD) is a major cause of 
morbidity in transplant hean recipients. Prior angiographic and 
pathologic studies show it to be an extensive and diffuse process. 
However. angiography has known limitations and pathologic data are 
based on patients with advanced disease. 70 cardiac transplant 
recipients. were studied with a 30 MHz 5 or 4.3 Fr.ultrasound 
catheter (CVlS. Inc.). during angiographic follow-up studies at 4±3 
yrs (range: 1-16) after transplant, The left main coronary artery (LM) 
was visualized in 15. the left anterior descending artery (LAD) in 64, 
the circumflex artery (LCX) in 14 of them; 26 pts had more than one 
vessel studied. One site/pt was studied in the LM. while the LAD and 
the LCX were divided into three segments with 1 to 3 sites. separated 
by >1 em. imaged in each segment, Mean intimal thickness (I'D and 
plaque characteristics were assessed for each site. A four class 
system, based on IT and percentage of vessel circumference involved 
was used to grade lesion severity; classes 3-4 represented significant 
IT. 43nO pts (62%) had significant IT in at least one segment, with 
distribution per vessel as follows: LM-9/lO. LAD-4U42, LCX-3/5. 
Two-thirds of the lesions were concentric. 13% showed calcification 
or fibrosis. In 9/43 pts (21 %) the lesions had a focal distribution. 
Class 3-4 IT was present in 49 of the 58 proximal segments visualised 
and in 32 of 50 mid and distal segments (84% vs 64%; p<O.OI). Lack 
of IT in the LM was associated with lack of IT in the more distal LAD 
segments. No difference in time from transplant was found between 
those with more diffuse IT and those with only proximal IT. 
Conclusion: In cardiac transplant recipients, intimal thickening, as 
seen with lCUS. is a diffuse and concentric process in 2/3 of the 
patients. However, in 1/3 of pts. intimal proliferation is limited to the 
proximal vessel and in 1/5 of pts. the lesions have a focal distribution. 
710·2 2:15 
III Intravascnlar IDtrasonnd Better 'Ibaa Quantitative COl'OIW)' 
ArterIography to Assess Cardiac Allograft ArterIopathy? 
Richard W. Lowry, Neal S. Kleiman, Albert E. Raimer, 1ames B. Young, 
Multi·Organ Transplant Center of The Methodist Hospital and Baylor 
College of Medicine, Houston, TX. 
Arteriography and intravasc:uIar u1trasonnd (IVUS) ha\'C been used to 
evaluate vessel lumen diameter (LD), area (LA), and arterial wall thickness 
(Wr) in patients following cardiac transplant, howe\'Cr no direct comparison 
of these techniques has been previously reported. To determine the 
usefulness of quantitative angiography (QA) to detect transplant-related CAD 
compared to IVUS, 25 patients underwent both procedures during routine 
follow-up (20 early, Slate). LD and lA measurements of proximal coronary 
artery segments using a 4.8F ultrasound catheter were compared with those 














Overall, LD and lA correlate closely between the 2 procedures for early 
(1.6 mo) and late (122 mo) follow-up patients (R2= .88). Also, wr 
measurements (intima + media) obtained by IVUS demonstrate significant 
differences between early and late follow-up. 
In summary: (1) This is the first report to directly compare QA and IVUS 
for evaluation of allograft arteriopathy; (2) QA determination of LD and lA 
ac:curately predicts IVUS measurements. (3) Because of the ability to more 
precisely characterize changes in coronary vessel shape and wall thickness, 
IVUS offers distinct advantages over routine coronary angiography and is 
probably the technique of choice to evaluate allograft arteriopathy. 
62A ABSTRACTS 
710-3 2:30 
Anatomic and Functional Correlates of Transplant Coronary Artl!l)' Dis•
ease: Comparison of Intracoronary Ultrasound and Stress Echocardiogra-
f!;.· M. Cohn, Robert L Wilensky, Patrick Bourdillon, Jacqueline A. O'Don•
nell, James Dillon, Harvey Feigenbaum. Krannert Institute of Cardiology, 
Indiaaa Univenity, Indianapolis, IN 46202 
Traosr,laot coronary artery disease (TCAD) is the leading cause of cardiac 
traosp ant related dea:th following the first post-transpIaot year, and it is difficult 
to diaJnole either clinically or angiographically. Intracoronary ultrasound 
(ICUS) bas become a prolDlsing new diagnostic method. Thus, 24 transplant 
recipients with a mean age of 48 years (range 25-66) underwent coronary 
angiography (ANGlO), ana Exercise Stress Ecllocardiography (EX-ECHO), in 
adaillon to ICUS to evaluate the prevalence, extent, and functional conse•
quences of TCAD (meao 3.3 years ~st-traosplaot, raoge Hi). Aogiograms 
were graded for luminal irregularoties and focal stenoses. EX-ECHO was 
abnonilal when worsening of wall motion or failure of wall motion to improve 
with exercise was present. ICUS utilized a 30MHz 4.3F ICUS catheter (23 
LAD, I circumflex) with 4 sites chosen in each vessel (Left Main, proximal, 
mid and distal arteries). Arteries were classified at each segment using the 
Stanford classification system based on maximal intimal thicIcness and degree of 
circumferential involvement (Class O-IV). 
Class 0- no measurable intimal layer by ICUS 
Class I(Minimal)- Intimal thickness <0.3mm1circumference < 180 
Class I!(Mild)- Intimal thickness >0.3mm1circumference > 180 
Class U1(Moderate)- Intimal thickness 0.3-O.5mm or > 0.5mm1circumference 
<180 
Class IV(Severe)- Intimal thickneas > I.Omm or >0.5mm1circumference > 180 
RESULTS: 
1) 20/24 patients had intimal thickening ~ Class II in their most severe loca•
tion; (2 Class II, 13 Class III and 5 Class IV). Four had Class I and none with 
ClassQ 
2) Of the 20 patients, 12 have diffuse intimal thickening defined ~2 contigu•
ous segments with Stanford Class ~ II, while 8 had focal intimal thickening. 
3) 8/2" ANGlO were normal; 5 of the 8 with Class IIClass II intimal thiclcen•
ing. 15116 ANGlO were abnormal with Class JIJIClass IV intimal thickening 
4 4124 EX-ECHO were abnormal- two with resting waIl motion abnormalities. br
ICUS
. 
5 EX-ECHO has 2591\ sensitivity aod 10091\ specificity in our population in 
~g~c'WK,~J~:US Stanford Class III or greater. 
I) Most patients ~ I year post-transplant exhibit significant intimal thickening 
which can be diffuse or focaJ. 
2) Patients with Class JIJIIV intimal thickening exhibit luminal irregularities on 
ANGlO, and thus are not angiographically silent. 
3) TCAD intimal proliferation does not lead to EX-ECHO abnormalities in the 
majority of cases m our population. 
710-4 2:45 
Progression of Transplant Coronary Artery DIsease by 
Intracoronary Ultrasound: Correlalion with Clinical 
Characteristics 
Fausto J. Pinto, Adrian Chenzbraun, Frederick G. SLGoar, Tim Fischell, 
Edwin L. Alderman, John S. Schroeder, Richard L. Popp, Hannah A. 
Valantine. Div of Cardiovasc Med, Stanford. CA 
Transplant coronary artery disease represents a significant cause of 
morbidity and monality in cardiac transplant recipients. Intracoronary 
ultrasound (lCUS) has recently been shown to be a sensitive method to 
slUd~ vessel wall morpholOgy. The progression of intimal thickening in 
canhac transplant recipients was studied by lCUS and correlated with 
several clinical-laboratory characteristics. Seventy pts w~ studied twice at 
a one year intelVal (mean age 47 yrs, mean 4.1 yrs after transplantation) 
corresponding to 189 coronary sites (2.7 sites/pt). Mean intimal thickness 
and an index of intimal thickness were calculated. A significant increase in 
intimal thickness (progression) by ICUS was defined as development of 
moderate (intimal layer 0.3 mm to 0.5 mm thick or greater than 0.5 mm 
involving less than 1800 of vessel circumference) or severe intimal 
thickening (intima greater than 0.5 mm involving more than 1 goo of vessel 
circwnfereru:e or thicker than 1.0 mm in any area of vessel circumference). 
The following results were ObselVed: 
Progression No Progression p 
(n=27) 0=43) 
Total No. Rejections 3.6±3.9 1.4±1.9 0.003 
No. Mod Rejections l.5±1.8 0.6±1.l O.oI5 
Donor age (years) 29±9 23±7 0.002 
Prednisone (mg/day) 16±8 1l±5 0.01 
Pulsed steroids (mg) 2566 839 0.01 
Cyclo dose (mg/day) 402±182 311±168 0.04 
Tryglicerides (mg/dl) 173±97 135±61 0.06 
In conclusion, the present study shows multiple factors are correlated with 
progression of intimal proliferation. The increased number of moderate and 
total myocardial rejection episodes and the correlation with steroids and 
cyclosporine strongly suggests rejection represents an important factor in 
the progression of graft coronary disease. 
710·5 
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3:00 
Angioscopic Surface Morphology of Early Allograft Coronary 
Artery Disease in Cardiac Transplant Recipients with 
Atherosclerosis Documented by Intravascular Ultrasound 
Hector O. Ventura, Ashit Jain, Tyrone J. Collins, Christopher J. 
White, Stephen R. Ramee, Frank W. Smart, Dwight D. Stapleton. 
Ochsner MedicallnstilUtions, New Orleans, LA 
Intravascular ultrasound is a sensitive method for detecting early 
allograft coronary anery disease, but does not provide detailed 
plaque surface morphology. To evaluate coronary surface 
morphology, we determined the plaque color (yellow vs white), 
contour (irregular vs smooth), and degree of stenosis (s50% vs 
~%) by coronary angioscopy in 26 cardiac transplant recipients 
with early allograft coronary artery disease after documenting its 
presence by intravascular ultrasound. Correlation between 
angioscopic surface morphology and the following variables was 
also performed: Time (years) post-transplantation, history of acute 
rejection, and serum lipids. Results as foIlows: 
PIS Years Cholesterol Smooch Irregular Stenosis>5O% 
Post TX (mg/dI) 
Yellow IS 2.7±O.2· 298±17· 9/15(60%) &'15(~) 7/15(47%)+ 
While 11 2.2±0.2 224±11 9/11(82%) 2/11(18%) 0/I1 (0%) 
• p = 0.05;+pooO.OOI 
Cardiac transplant recipients with yellow pigmented plaques had a 
higher serum cholesterol level and were more likely to have 
irregular contour and significant stenosis than patients with white 
plaque. In addition, yellow pigmented plaques occurred later after 
transplantation than white plaques. Plaque irregularity and degree 
of stenosis directly correlated with years post-transplantation 
(p=O.Ol). Conclusions; Coronary angioscopy demonstrates two 
types of coronary plaque surface morphologies (yellow and white in 
cardiac transplant recipients with early allograft coronary artery 
disease by intravascular ultrasound. These lesions may represent 
either two different types or different stages of allograft coronary 
disease in cardiac transplant recipients. 
710·6 3:15 
Prospective Coronary Angioscopy Assessment of Allograft 
Coronary Artery Disease in Cardiac Transplant Recipients 
Ashit Jain, Hector O. Ventura, Tyrone J. Collins, Stephen R. 
Ramee, Christopher J. White. Ochsner Clinic, New Orleans, LA 
A major cause of late morbidity and monality in human cardiac 
transplantation is allograft coronary artery disease. Recently, 
coronary intravascular imaging has been shown to be a sensitive 
method of detecting early changes in coronary anery surface 
morphology in cardiac transplant recipients. In order to 
prospectively evaluate the presence and progression of allograft 
coronary artery disease, percutaneous coronary angioscopy was 
performed at baseline and yearly in 20 cardiac transplant recipients. 
Coronary angioscopic findings were classified as follows: GRADE 
I=normal, GRADE II=plaque without stenosis, GRADE 
III=stenosis <50%, and GRADE IV=stenosis >50%. The mean age 
of cardiac transplant recipients was 43±2 years (range 22 to 61 
years), and the time since transplant was 2.9±0.2 years (range I to 5 
years). The coronary arteries imaged were LAD=14, CFX=5, 
RCA=21. Results: 
Grade I IT ill IV Mean Grade 
Baseline 5(25%) 11(55%) 3(15%) 1(5%) 2.1 ± 0.7 
Follow-up 0(0%) 11(55%) 6(30%) 3(15%) 2.St 0.6· 
·p:().OO5 
There was significant correlation between angioscopy grade and 
time since hean transplantation (p=0.OO8), and significant 
progression of allograft was detected with follow-up worsening in 
angioscopy grade (p=O.OO5). 
Allograft coronary anery disease as assessed by prospectiv( 
coronary angioscopy demonstrates yearly progression and is 
directly related to time after cardiac transplantation. In conclusion, 
coronary angioscopy will allow early detection and evaluation of 
therapeutic regimens to reduce this disease and possibly effect the 
natural history of allograft coronary artery disease. 
JACC Vol. 21, No.2 
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Superior Vasodilator Effect of Single Dose Nifedipine 
Compared to Captopril for Chronic Severe Aortic 
Regurgitation. 
Christian Rothlisberger. Thomas Wisenbaugh, Pinhas Sareli. 
Baragwanath Hospital, Johannesburg, South Africa. 
2:00 
In patients with severe aortic regurgitation (AR), short-term 
treatment with nifedipine has been shown to reduce systemic 
resistance and wedge pressure and increase cardiac output. 
However, because of less frequent side effects, vasodilator therapy 
with an angiotensin-converting enzyme inhibitor such as captopril 
may be preferable. The effects of a single dose of either nifedipine 
20mg or captopril 50mg were therefore compared at 
catheterization (L Y micromanometer) in 20 patients with severe, 
symptomatic AR. At 90 minutes mean arterial pressure was 
reduced comparably after both drugs (S6±15 to 76±IS mmHg for 
nifedipine vs 95±19 to 7S±IS forcaptopril, p=NS between groups 
by 2-way ANOYA), as was wedge pressure (l1±5 to 9±4 vs 13±9 
to 9±5 mmHg for captopril). However, systemic resistance was 
reduced more (p=.OI) after nifedipine than captopril (l549±46S to 
1067±291 dyn-sec-cm's vs 1632±559 to 1436±392). Heart rate 
declined after captopril (S4±14/min to 75±15, p=.OO2) but not after 
nifedipine (7S±13 to SO±I4). Forward stroke volume increased 
after nifedipine (5S±14 to 70±16ml, p<.OOI) but not captopril 
(5S±17 to 59±16ml). Thus, cardiac output increased after 
nifedipine (4.4±O.9 to 5.5±1.2 liters/min, p<.OOI) but decreased 
after captopril (4.S±1.2 to 4.3±1.0, p=.OO4). Angiographic ejection 
fraction did not significantly change after either drug (.50±.12 to 
.49±.12 for nifedipine and .49±.OS to .50±.OS for captopril). 
Regurgitant fraction declined (p=.OI) only in the nifedipine group 
(0.72± .05 to 0.64±.06 vs .69±.09 to .7l±.OS with captopril). 
Conclusion: While both drugs comparably decrease systemic 
arterial and pulmonary wedge pressure in severe AR, only 
nifedipine decreases regurgitant fraction, and increases stroke 
volume and cardiac output through potent vasodilation which 
offsets its reported negative inotropic effects. 
711·2 2:15 
Hemodynamic and Echo pronles at Rest and Peak Exercise Before and 
After Aortic Valve Replacement for Chronic Aortic Regurgitation 
David P. McLaughlin. Sunil Nath. Eric R. Powers. Patrick J. Commerford. 
ran J. Sarembock. University of Virginia Health Sciences Center. 
Charlottesville. VA. and Cardiac Clinic. University of Cape Town. South Africa 
PatienlS (pIS) with chronic aortic regurgitation (AR) commonly improve func•
tional starus following aortic valve replacement (AVR). The structural and 
physiologic basis for this improvement Is currently not well defined. We srudied 
22 pIS undergoing A VR for isolated. severe (4 + ) AR. All pIS were NYHA func•
tional class II-III. Echocardiography. supine rest (R) and exercise (Ex) 
hemodynamics. and radionuclide ventriculography were obtained at baseline. 10 
days and 6 mas postop. There were 3 postop deaths: S4% of pts were asympto•






























PCWP (mmHg) 32± 10 (25± S) 26± tOt 
CI 6.7±2.3 (6.3± 1.6) 7.0± 1.5 
SVR It ±4 13±4 
EF 45± 15 (65± 15) 66± 1St 
·p<O.OS baseline vs 10 days; t p<0.05 baseline vs 6 mas; 
( ) = equivalent workload attained at baseline. 
Only 2 pIS had an abnortnal LVEF at rest of <50% postop versus 8 pIS (42%) 
preop. p-0.03. 
In conclusion. 6 mas after successful AVR. there was: I) progressive 
normalization of LV end-diastolic dimension; 2) improved S)"tolic function with 
normalization of a reduced LVEF at rest in 75% of pIS; 3) normalization of 
L VEF response on exercise. but 4) continued postop elevation of PCWP on 
exercise. possibily reflecting a persistent abnortnality of diastolic function. 
ABSTRACTS 
711·3 2:30 
Angiographic Grading of Aortic Regurgitation Correlates 
Poorly With LV Size in Mixed Aortic Valve Disease 
Robert S. Lind, James M. Flynn, Bonnie H. Weiner. 
William H. Gaasch, Gerard P. Aurigemma U Mass Medical Center 
and Medical Center of Central Massachusetts, Worcester, MA 
LYdilatation uncommonly accompanies ~Titical AS despite signifi•
cant aortic regurgitation (AR) by angiogrJphy. This may occur 
because angiographic gnlding does not accurately reflect regurgitant 
volumes or because of a limited capacity of the LV to dilate in 
concentric LY hypertrophy (LVH). We therefore examined LY size 
and geometry in 64 consecutive pts undergoing cath and echo for 
severe calcific AS (mean AVA=.7 ± .2). AR was assessed by angio 
(0 to 4+) and with a mathematical model. L Y end diastolic and end 
systolic dimensions (EDD, ESD). diastolic relative wall thickness 
(RWf), fractional shortening (FS), and LV mass index (L YMI) were 
determined by echo and L Y end-diastolic pressure (EDP) by cath. 
Patients were free of focal wall motion abnormalities and SIgnificant 
MR; all had concentric LVH (mean RWT=.54) and normal FS. 
Dilatation (L VEDD>55 mm) was not seen despite ~3+ AR nor were 
there any significant differences in echo or hemodynamic parameters 
between pts with OIl + AR vs those with ~ 3+: 
AR fHunrcrirerial E.DQ ~ fill:[ ES. L VMI J..YfQf 
0-1+ (n- 57) 48 31 .54 .36 173.8 IS 
~3+ (n=7) 51 31 .49 .40 16S.5 21 
We then computed theoretical maximal regurgitant volume (RY) and 
fraction (RF), with regurgitant orifice area (ROA)= stenoticAYA by 
modifying the Gorlin equation where: RV=ROA*DFP*CVAP, at 
constant diastolic transaortic pressure gmdient (AP); diastolic filling 
period (DFP) was varied. Our model indicates that large RFs are 
mfluenced more heavily by heart rate (HR) than by ROA: 
AYAIROA (cm2) .6 ....R.. .L.Q U 
RF (hr-60) .35.41.47 .51 
RF (hr=9O) .13 .17 .20 .24 
In the 7 pts with> 3+ AR mean HR was 73 + 4 and AVA.7 +.04 
cm2, indicating ollly mild-moderate AR. Thus while it is poSSIble that 
concentric LYhypertrophy limits the potential for dilatation in mixed 
aortic valve disease, modeling data suggests that a more likely expla•
nation is that regurgitant volumeis overestimated by qualitative 
grading of AR. 
711·4 2:45 
Aortic and Hitral Regurgitation in Patients 
with Genetic Hucopolysaccharidosis 
Carl-F. Wippermann, Michael Beck, Dietmar Schranz, 
Ralph Huth, Herwig Stopfkuchen, Bodo-K. JUngst. 
University Children's Hospital Mainz; F.R.G. 
The Mucopolysaccharidosis (MPS) are inheredited diseases, 
which cause accumulation of Mucopolysaccharides in vario•
us organs including the myocardium and valvular tissue. 
The latter can be demonstrated by 2-D-echo. However, the 
frequency and degree of aortic and mitral regurgitation 
(AR and MR) in these patients (pts) remains unclear. 
Objectivea: Purpose of this study was to evaluate pts 
with MPS by color flow Doppler for AR and MR. Patients: 
62 pts were examined, aged 0.9 to 47.4 (mean 9.7) years. 
For subgroups see the table below. Methods: Color Dop•
pler studies were performed with a Toshiba SSH 140 syst•
em. MR and AR were graded as mild, moderate and severe 
(1-3+). Results: in 2 mentally retarded pts an adequate 
examination was not possible. The major results are lis•
ted in the table. 70% of all pts had either AR or MR. 
These are less co •• on in pts with MPS IV. 
MPS pts MR AR pts with 
tvoe No 1+ 2+ 3+ 1+ 2+ 3+ AR or MR 
IH 10 3 4 2 3 1 0 80% 
IS 4 1 3 0 3 1 0 100% 
II 10 4 3 0 4 2 1 80% 
III 20 7 1 0 3 2 1 65% 
IV 12 1 3 1 2 1 2 33% 
VI 4 0 3 0 0 0 1 100% 
Conclusion: MR and AR are common finding in pts with MPS. 
We conclude that pts with MPS should have regular color•





IIIprove_nt in the Diegnaah of Bioproathetic Valve 
Dysfunction by Tren.e.ophegeal lchocardiography 
Miguel Zabalgoitia, Cesar J. Herrera, Farooq A. 
Chaudhry, John H. Calhoon, David J. Mehlman, Robert A. 
O'Rourke. Univ of Texaa Hlth Sci Ctr, San Antonio, TIL 
To determine the value of transesophageal (TEE) vs. 
transthoracic echocardiography (TTE) in detecting 
etiology of bioprosthetic dysfunction, we studied 
prospectively 38 consecutive pts who underwent surgery. 
There were 57 pathologic findings in 38 bioprostheses: 
26 (45.6') flail cusps (FC), 13 (22.8') vegetations (V), 
4 (7.0') ab.ce •• es (A), 4 (7.0') dehiscences (D), and 
10 (17.5') stenose. (S). 
Sensitivity Specificity 
TTE TEE TTE TEE 
FC 54t lOOt 92, 96t 
V 39' 96t 85' 92t 
A 25t 97, 100% 94' 
D 25' lOOt lOOt lOOt 
In bioprosthetic .itra1 S, both TEE and TTE esti_ted 
valve area. However, in bioprosthetic aortic S, Doppler 
TTl calculated valve area in 4 of the 6 pta. In 2 pts 
with abnormally elevated flow velocities, the valve area 
could not be calculated because of inability to measure 
the LV outflow tract (LVOT) dimension. Convers.1y, TEE 
allowed LVOT measure .. nt in all 6 pta, but alignment of 
the continuous-wave Dopp1.r was not posaib1. in any of 
th •• e aortic S pta. 
In conclusion, in bioprostheses, TEE is the method 
of choice to det.ct FC, V, A, and D. Doppl.r TTE is 
irreplaceable in calculating prosthetic valve gradients 
and area., and coap1eaenta the 2D TEE i_ging in 
biopro.thetic S. In th.se pt., cardiac cath.terization 
can be restricted to coronary art.riography whenever it 
is dee .. d •••• ntial. 
711-6 3:15 
Spontan.ously Appearing Microbubbles Associated With 
Left Sided Mechanical Prosthellc Cardiac Valves Detected 
by Transesophageal Echocardlography: Importance of 
Dlfferentiallon From Valvular Masses 
David A. Orsinelli, Tomasz J. Pasierski, Anthony C. Pearson, 
The Ohio State UniverSity, Columbus, Ohio. 
During transesophageal echocardiography (TEE), we have noticed 
the presence of spontaneously appearing microbubbles (MBS) 
associated with mechanical prosthetic cardiac valves. These MBS 
appear as a shower of small «1 mm) highly mobile echoes moving 
from the leaflet or poppet into the left atrium or left ventricular 
outflow tract following valve closure. To further define this 
phenomenon, we reviewed 124 studies (33 of which had associated 
MBS) performed in 92 patients with at least one left sided 
mechanical valve. A total of 117 individual valves were studied, of 
which 25 (21%) had MBS. Abnormal valves were more likely than 
normal valves to have MBS (18/55, 33% versus 7/62, 11 %, 
p-.004). MBS were more frequently associated with mitral than 
aortic prostheses (19/60, 32% versus 6/57, 11%, p-.005). A 
total of 8/32 Medtronic Hall, 6/14 Bjork·Shiley, 6/9 SI. Jude, 
4/49 Starr-Edwards and one Duromedics valve were found to be 
associated with MBS. Of 27 disc valves in the mitral position, 15 
(56%) had MBS. We conclude that spontaneously appearing MBS 
associated with prosthetic cardiac valves are frequently observed 
during TEE. These MBS, which must be differentiated from 
thrombus or vegetations on the prosthesis, are found primarily in 
association with disc valves located in the mitral position. While 
more frequently found with abnormal prostheses, MBS may also be 
seen with structurally normal prosthetic valves. The clinical 
importance of these MBS and the mechanism(s) involved in causing 
them are unknown at the present time and warrant further 
evaluation. 
JACC Vol. 21, No.2 
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712·1 2:00 
BeneIIdai Effect or Estradiol 17·(1 on Exercise-Induced Myocardial 
lschemia in Women with Coronary Artery Disease. A Double Blind 
Randomized Placebo Controlled Study. 
Giuseppe M.C. Rosano; Piotr Ponikowski; Debbie Clarke; Philip A. Poole•
Wilson; Philip M. Sarrel and Peter Collins. 
National Heart & Lung Institute, London, United Kingdom. 
Estradiol 11..p has been shown to induce relaxation of isolated coronary 
arteries but its effect on myocardial ischemia has not been assessed. The 
aim of the present study was to evaluate the effect of sublingual estradiol 
11·{1 (SLE· I mg) on exercise-induced myocardial ischemia in 10 women 
(mean age 61 ± 1) with angina due to coronary artery disease. Patienll 
were randomized to receive either SLE or sublingual placebo (SP) 40 
minutes before a modified Bruce exercise test on day 1 and the opposite OD 
day 2. No difference was seen between a pre-study exercise test and PL. 
Plasma estradiol 11·{1levels were significantly higher after SLE when 
compared with SP (3396± 1316 VI 217±202 pmolll P<O (01) , 
Placebo Estradiol 
Resting SBP (mmHg) 147±24 133±24 
Resting RPP (beats/min x mmHg) 10291±2312 9814±209S 
Time to 1 mm ST depression (sec) 161±82 320±IS9 * 
Maximum ST depression (mm) 1.9±O.6 1.3±O.4 * 
Exercise time (sec) 307±109 431±14S* 
SBP = systolic blood pressure; RPP = rate pressure product; 
* = P<O.OS 
In conclusion, estradiol 11..p improves myocardial ischemia in women with 
coronary artery disease. This effect may be the consequence of a direct 
coronary vasodilation or of peripheral vasodilation or of a combination of 
the two mechanisms. 
712·2 2:15 
Coronary Vascular Reserve Is Reduced In DIabetic 
Patients WIth Anglographlcally Normal Coronary 
ArterIes. 
AlaIn Nltenberg, Paul Valensl, RegIs Sachs, Mustapha Dall, Jean•
Raymond Attal!. lNSERM U.2S I, CHU Xavler-Blchat, ParIs, France. 
Small-vessel coronary artery dIsease frequently occurs In diabetIcs. 
To evaluate the maximal area or coronary microcIrculation in 
dIabetIcs, coronary flow velOCity was measured using Intracoronary 
Doppler catheter before and after maximally vasodilatlng dose of 
papaverine in 7 nondiabetic controls and in 1 I diabetIcs. All patients 
had normal left ventrIcular angiography and coronary arteriography. 
Peak-to-resting coronary flow velocity ratio (P/R), and a minimal 
coronary vascular reSistance index (MCVRI) were used for coronary 














In diabetic patIents, P/R was lower than In control subjects, and 
MCVRI was higher. Results were similar In insulin-dependent (n-6) 
and nonlnsulln-dependent (n-S) patients. 
ConclusIon: these data provide evidence that coronary vascular 
reserve 15 reduced In dIabetiC patIents with normal left ventricular 
systolic function. This reciJctlon mll1t contrIbute to the progressive 
deterioratIon of left ventrIcular fl.l'1ctlon In dIabetIcs. 
JACC Vol. 21, No.2 
February 1993:65A 
712·3 2:30 
Elfecla of SerotonIn on Epicardial V_Is In Patients with 
MlcrovalCUilr Angina (Syndrome X) Ind Control PItIenta 
E~ P McFadden, ChrIstophe BaUl.., Jean-Marc lablanche, 
Graham Davtee, Altlio Masert, MichII E. Bartrand. 
UnIYerIky of IJIe, France. Catholic UnIYerIky, Rome, Italy. 
It '- been suggeated thai petIerta willi rnic:roIIaacUar angina have a 
regulatory defect In praerterlolar V8888II. Serotonin, an endogenous 
endothelJum.dependent dilator can cause IachemIa due to Intense 
distal coronary constrtctlon In patients with stable angina. 
We compared the effects of Intracoronary Infusion of graded d088l 
(1().6 through 1()..t molar) of serotonin with those of leoeorbIde dlnltrate 
(2 mg) a direct smooth muscle dlalor In consecutive women (n z 11), 
referred for further evaluation of rnIcroYascUar angina (stable angina, 
exerclaH1ducad ST depression (more than 1 mm). negative 
ergonovine tesll, previously documented normal coronary 
arteriograms) and In comol women (n • 6) without cheat pain referred 
for InvesIlgation of mitral valve dlseaae. 
Control vessel diameter did not change slgnlflcandy at Infused 
concentrationa of 10-6 or 1 ().5 molar. Control vessels tended to 
constrtd at 1()..t molar with maxlmal raductions <± SEM) of 10.4.± 4.7 
'" (p • 0.08), and 18.± 4.7% (p • 0.06) compared to baseline In 
proximal and distal segments. Paln or ST -shift did not occur. Vessels 
from Syndrome X patients developed diffuse dose-dependent 
constrtctIon willi maximal raductions of 36.3.± 5.7'" (p < 0.0001), and 
42.0.± 3.7 '" (p < 0.0001) compared to baseline In proximal and distal 
segmentI at 1 ()..t M. FIve developed angina with ECG changes In 2. 
ProxImIII (p < 0.005) and distal (p < 0.05) constriction to serotonin was 
markedly greater In syndrome X vessels than In control vessels, 
whereas the dlalor response to leoeorbIde dlnitrate was simMar. Thus. 
whIe serotonin infusion does not cause signlftcant constriction In 
control vessels,· It causes dose-dependent constrtctlon In smooth 
vesaels In paIienIs wIIh Syndrome X. 
AbnormII epicardial vasomotor reactivity may play a role In the 
pathophysiology of chest paln In paIienIs with microvascular angina. 
712·4 2:45 
Contribution of Endothelium·Derived Nitric Oxide to Coronary 
Arterial Compliance: An in Vivo Two-Dimensional Intravascular 
Ultrasound Study. 
Krishnankutty Sudhir, William L. Mullen, Dirk Hausmann, Peter 1. 
Fitzgerald, Paul G. Yack, Kanu Chatterjee. Cardiovascular Research 
institute, University of California, San Francisco, California. 
A decrease in epicardial coronary arterial compliance may precede the 
development of overt atherosclerosis. We have previously shown that 
nitroglycerin increases epicardial coronary artery compliance. 
Nitroglycerin induces vasodilation via conversion to nitric oxide (NO) 
in vascular smooth muscle. To directly assess the contribution of 
endogenous NO to coronary arterial compliance, we examined the effect 
of intracoronary NID-nitro-L-arginine methylester (L-NAME), an 
inhibitor of NO synthetase, and L-arginine, its natural substrate, on the 
circumflex artery In 6 anesthetized dogs. We also examined the effect of 
pharmacologically induced NO release on coronary compliance, using 
intracoronary acetylcholine. ECG-gated measurements of epicardial 
coronary lumen area were made by a blinded observer from images 
obtained using a 4.3F, 30 MHz intravascular ultrasound catheter. Aortic 
root pressure was continuously monitored, and neither mean arterial 
pressure nor pulse pressure changed with intracoronary drug 
administration. Compliance was assessed by the change in lumen area 
from end-systole to end-diastole (a-LA). Acetylcholine (lO-6M) 
increased end-diastoIic lumen area by 11.2±1.2% (p<O.Ol), and a-LA 
from 8.0±1.3% at baseline to 16.3±2.8% post-drug (p<O.02). L-NAME 
004M) decreased end-dlastolic lumen area by 6.1±1.1% (p<O.05), and 
decreased a-LA to 3.1±1.3% (p=O.03). End-diastolic lumen area and a-LA 
were both restored to baseline by L-ArgInine (104). Balloon denudation 
of the left anterior descending coronary artery also decreased a-LA in 
the denuded segment to 5.1±1.5% (p=O.08), but to a lesser degree than 
pharmacological blockade of NO release. Conclusion: Epicardial 
coronary artery compliance is modulated by both basal and induced 
release of endothelium-derived NO. The endothelial dysfunction that 
precedes overt atheroslerosis may thus decrease coronary arterial 
compliance, even prior to structural changes In the blood vessels. 
ABSTRACfS 
712·5 3:00 
Impairment or Acetylcholine-Induced Coronary 
Vasodilation In DIabetIc Patients wIth Anglographlcally 
Normal Coronary Arterles_ 
Alain Nitenberg, Paul Valensl, Regis Sachs, Boris Lormeau, Mustapha 
Oall, Eduardo Aptecar, Jean-Raymond Attall. INSERM U.2SI, CHU 
Xavier-Blchat, Paris, France. 
There Is IncreaSing evidence that endothelium-dependent vasodilation 
Is Impaired In both arterial and arteriolar vessels of diabetic 
patients. To evaluate coronary artery endothelial function in diabetic 
patients, coronary artery responses to stepwise infusion of 
acetylchol ine (I a-8M to I a-SM coronary estimated concentrations) 
were analyzed by quantitative angiography In II diabetic patients and 
in 6 nondiabetic control subjects. All patients had normal left 
ventricular function and coronary arteriography. Cholesterol. 
trlglycerlde~, hlgh- and low-density lipoproteins were within 
normal range In both groups. Vessel dimensions were measured on 4 
segments of left coronary artery in all patients. 
_140 .... Controls In diabetic patients. no change was 
:: .... Diabetes produced at I a-8 M and I a- 7 M. A 
,:512D progress Ive reduction in coronary 
!! dl ameter was produced at I a-6r1 
:ul00I--..:::;; .... ....I:,...-+-~'+-+ and la-SM. In control subjects, a 
;: dose-dependent coronary dl lat ion 
e was observed from I a- 8M to ~ eo I a-6 M, and no change at I a-SM. ... 
" 15 &0 p<O.OOI 
~ <DIabetiCS vs Controls) 
.. Base 10-8 10-7 10-6 10-5 lSON 
isosorblde dlnitrate (ISDN). 
There was no dl fference between 
Insulin-dependent (n=6) and 
nohlnsul In-dependent (naS) 
patients All segments dilated 
similarly after Intracoronary 
ConclusIon: This study indicates that a deficit of acetylchollne•
Induced endothelium-derived relaxation develops In both Insulln•
dependent and non insulin-dependent diabetic patients. 
712·6 3:15 
Effects of Intracoronary Adenosine on the Phasic Components 
of Coronary Flow Velocity In Right and Left Coronary Arteries 
During the Cardiac Cycle 
Steven E. Reis, Jon R. Aesar, Sean T. Gloth, Gary Gerstenblith, 
Jeffrey A Brinker. Johns Hopkins University, Baltimore, MD. 
The pattern of coronary artery blood flow (CBF) during the cardiac 
cycle is affected by Intra- and extravascular determinants. Since 
ventricular pressure and contractility are (1) extravascular 
determinants of coronary resistance and systolic flow impediment, 
and (2) markedly different in the right and left ventricles, we 
hypothesized that right (ACA) and left (LCA) coronary arterias should 
exhibit different patterns of now during the cardiac cycle. The effect 
of adenosine-Induced coronary hyperemia on phasic flow variation is 
also not known. We therefore assessed the patterns of coronary flow 
velocity in the ACA (n=10) and LCA (n=16) before (pre-A) and after 
(post-A) intracoronary infusion of 43 mcg of adenosine. A doppler•
tippod guide wire was used to assess the average diastolic (D) and 
systolic (S) peak velocity components of CBF. The ratio (A) of 0 to 
S was calculated. The results (mearl:tSE) are: 
LCA RCA 
~ f.2!!.:A 2 ~ f.2!!.:A Q 
o 40.2:1:6.2 77.9%10.6 <.001 26.3:4.8 46.1:4.8 .001 
S 25.0:3.7 57.5:8.3 <.001 27.2:5.9 49.7:7.2 .001 
A 1.66:.11 1.40:1:.05 .03 1.01:.06 0.97:.05 NS 
Before the adenosine Infusion, 0 and S were similar In the ACA 
whereas 0 predominated In the LCA. These findings were associated 
with a significant difference in A between the ACA and LCA (p<.001). 
Adenosine-Induced incre!lSes In 0 and S were similar in the ACA but 
S increased out of proportion to D In the LCA. The ratio remained 
Significantly different between the ACA and LCA after adenosine 
(p<.OO1). These data suggest that the RCA and LCA have dilferent 
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713-1 2:00 
The Optimal TIming of Internal C8rdloverslon Shocks for 
Ventricular Tachycardia 
Huagui G. U, Raymond Yee, Rahul Mehra, Paul DeGroot, 
George J. Klein, Ranjan K. Thakur, Carlos A. Morillo, H. 
William Stites. University Hospital, London, Ontario, Canada 
Synchronizing shocks to the ORS complex for transthoracic 
cardioversion of ventricular tachycardia (VT) is critical in 
preventing VT acceleration or ventricular fibrillation (VF) but 
the optimal timing of intemal cardioversion shocks is unknown. 
We compared the efficacy and safety of shocks synchronized 
to the aRS onset (aRSO) during VT with those delivered 100 
ms after aRS onset (aRS100) in patients with clinical VT 
undergoing implantable defibrillator lead testing. Transvenous 
defibrillation leads were positioned in the right ventricle apex 
(cathode), coronary sinus and superior vena cava. VT was 
repeatedly induced and sequential pulse shocks were given at 
stored energy settings from 22-0.6 J in a decremental protocol. 
The lowest successful test shock delivered energy was 
defined as the cardioversion threshold (CVT). The right 
ventricular electrogram was used to trigger the cardioverter 
with a time delay box to adjust shock timing relative to the 
earliest aRS onset during VT on surface leads 1, 2 or 3. 
Fourteen patients (aged 61±8 years; ejection fraction .2B±.04) 
had a single morphologic type of VT (morphology and rate) 
that was repeatedly inducible by programmed stimulation. 
(mean ± SO) aRSO aRS100 p value 
VT cycle length (ms) 348±18 350±21 NS 
CVT energy (J) 11.4±2.1 3.2±0.9 0.0015 
VT accelerationlVF 20/49(41"10) 6/52(12"10) <0.05 
Conclusion: Intemal cardioversion shocks delivered 100 ms 
into the aRS complex during VT are more effective and 
reduce the risk of subthreshold shocks causing VT 
acceleration or degeneration to VF. 
713·2 2:15 
Improved Defibrillation Efftcacy With a Simple Non-thol'llCotomy LNd 
Configuration 
Marco Zardini. Raymond Vee, Rahul Mehra, George Klein, Ranjan K. 
Thakur, Carlos A. Morillo, H. William Stites, University Hospital, London, 
Ontario, Canada 
A recent report by Bardy at aI indicated thet single pathway biphesic (BQ 
shocks delivered between a right ventricular electrode (RV) and the 
housing 01 an implantable defibrillator device(CAN) is an effective method 
of defibrillation. We prospectively compared the RV:CAN method with 
biphesic shocks between transvenous electrodes in the RV and superior 
v_ cava (RV:SVC) and sequential monophasic defibrillation using 3 
transvenous leads (NTL·Seq) tested intraoperatively at the time of 
deIilrillator implantation. MedIronic defibrillation leeds were positioned RV 
apex, SVC and coronary sinus. After completing NTL-Seq defibrillation 
testing to identify a lead configuration for implantation, a hollow 'dummy' 
device CAN was inserted into a subcutaneous pocket in the left 
infraclavicular region and the two biphasic defibrillation methods were 
tested. Asymmetric biphesic shocks (65% till) with the negative phase 
voltage equal to the trailing edge of the positive phese and separated by 
0.2 msec were delivered 10-12 sec after VF induction USing 60 Hz. Positive 
phese leading edge voltage levels tested were 500, 400, 300 or 200 V 
followed immediately by a rescue shock if it failed. The defibrillation 
threshold (OFT) was defllled as the lowest succassful first shock delivered 
energy (J). 
Seven Men and 2 women, aged 18-66 years, were studied. OFT energies 
and leading edge voltages were lower with RV:CAN Bi than with the 
RV:SVC Bi or best NTL-Seq tested at implant. 
(mean±SO) ~ p RY'CAN-Bj 
OFT energy (J) 16.0±4.4 .019 9.6±4.2 







In conclusion, biphesic shocks delivered between a single RV electrode 
and an ICO CAN improve defibrillation effICacy over standard biphesic 
shocks between two transvenous leads or sequential monophasic pulse 
defibrillation and ~ offers a potentially simpler lead system for implantable 
defibrillators. 
713·3 
JACC Vol. 21, No.2 
February 1993:66A 
2:30 
SIMPLICITY AND EFFICACY OF A SINGLE INCISION PECTORAL 
IMPLANT UNIPOLAR DEFIBRILLATION SYSTEM 
Gust H. Bardy, George Johnson, Jeanne E. Poole, G. Lee Dolack, Peter 1. 
Kudenchuk, Bradley Hofer, Rahul Mehra, Robin MitcheU. David Kelso. 
University of Washington, Seattle, WA 
This study examined prospectively and consecutively the efficacy of a new 
simplified, single incision pectorally implanted unipolar, single pathway 65% 
- - patients immediately prior to routine transvenous ri ~ tilt biphasic transvenous defibrillation system in 37 ,~ defibrillator implanl In the last nine patients, we also ._ compared the efficacy of this system to a slightly more - complicated one that utilized a third electrode in the . superior vena cava (SVC) for dual pathway pulsing in 
, a randomized prospective manner. The defibrillation 
sysIem for the primary unipolar method is shown to the left. 
The patient population consisted of 15 patients with ventricular fibriUation, 
13 with ventricular tachycardia, and 9 with both. The average EF of all pIS was 
O.4O±O.16, age is 57±1~ yrs (27-73), and 76% of pIS were male. CAD was 
present in 24/37 (65%), dilated cardiomyopathy in 6/37 (17%), long QT 
syndrome in 2137 (5%). right ventricular dysplasia in 1137 (3%), and primary 
electrical disease in 2 (5%) pts. 
The defibrillation threshold for the unipolar, single lead system for all 37 
patients was 9.4±5.9 J stored energy and 379±1l7 V leading edge voltage. The 
defibrillation threshold for the unipolar, single lead system in the last nine 
patients in whom a comparative study was perfonned happened to be less than 
the entire group. 6.7±4.4 J stored energy and 319±I02 V leading edge voltage. 
In this same group of nine patients, the use of a S VC electrode and dual pathway 
simultaneous pUlsing did not improve defibrillation efficacy. The defibrillation 
threshold for the more complicated dual pathway system was 6.9±4.1 1 stored 
energy and 325 ± 100 V leading edge voltage, p=O.83 and p=O.81, respectively. 
Conclusion: The unipolar single electrode defibrillation system is as easy to 
insert as a pacemaker and provides defibrillation at energies comparable to 
epicardial lead systems. The addition of a superior vena cava electrode does not 
enhance the system and increases complexity unnecessarily. 
713·4 2:45 
Symptoms end ECG-Documented Rhythm Preceding Spontaneoul Shocks 
in Patients With Implentsble Cardloverter Defibrillator (lCDI Therapy 
Wolfram Grimm', Belinda F. Aores, Francis E. Marchlinski, Philadelphia 
Heart Institute, Philadelphia, PA, 'Philipps-University Marburg, Germany. 
Symptoms and spontaneous shocks with documentation of the rhythm 
preceding the shock by Holter or telemetry monitoring or stored 
electrograms (EGI by the device were analyzed in 241 consecutive 
patients (ptsl with ICD therapy. Devices with EG storage capability 
(Ventritex Cadence I were implanted in 54 pts, and 187 pts received 
devices without EG storage capability. Criteria for rhythm diagnosis using 
stored EGs have been described. Symptoms preceding the shocks were 
classified as absent, mild (palpitations, mild dizziness), or severe 
(presyncope, syncope I. Shocks during sleep were excluded from analysis. 
Results: During follow·up of 24±20 months, 101 of 241 pts (42 %) 
received 1 or more ICD shocks documented by surface ECG or stored EG 
by the device. Sustained ventricular tachycardia or fibrillation (VT or VF) 
was documented in 67 of the 101 pts (66 %1 with ECG-documented 
shocks, nonsustained VT in 4 pts (4 %1, supraventricular tachyar•
rhythmias (SVTI in 41 pts (41 %), and normal sinus or pacemaker rhythm 
in 10 pts (10 %). No, mild, and severe symptoms preceded 1 or more 
spontaneous ICD shocks in 20 (30 %1, 33 (49 %1, and 27 (42 %1 of the 
67 pts with ECG-documented VT or VF, and in 23 (56 %), 16 (39 %), 
and 1 (2 %) of the 41 pts with ECG-documented SVT respectively. Three 
of the 4 pts with nonsustained VT had mild symptoms, and 1 pt with 
nonsustained VT had presyncope. None of the 10 pts with spurious 
discharges during normfrequent sinus or pacemaker rhythm had 
symptoms preceding the ICD shocks. Of note, 7 of the 101 pts (7 %1 
with ECG-documented shocks received one or more shocks for VT 
induced by antitachycardia pacing or by a shock for SVT ('ICO 
proarrhythmia·l. Two of the 7 pts with "ICD proarrhythmia' had mild 
symptoms, and 1 pt had severe symptoms preceding the shock. 
Conclusions: 11 most pts with either ECG·documented VTNF or a non•
VT NF rhythm preceding spontaneous ICD shocks have no or only mild 
symptoms preceding the shock, 2) although severe symptoms preceding 
ICD shocks suggest sustained VT or VF as the underlying rhythm, severe 
symptoms occasionally occur in patients with SVT, or nonsustained VT. 
JACC Vol. 21, No.2 
February 1993:67A 
713·5 3:00 
Troubleshooting Tiered Therapy Implantable Defibrillators with 
Continuous Telemetry to a New Holter Recording System. 
Charles Feldman, Walter Olson, Mark Hubelbank, David Kelso, 
Robin Mitchell, Gust Bardy. Brigham and Women's Hospital and 
University of Washington Medical Center. Boston, MA, Seattle, WA 
The memory and diagnostic capabilities of any of the new tiered 
therapy tachyarrhythmia devices is frequently inadequate for 
determining reasons for device dischar&e or recognizing suboptimal 
programming. We have developed a modified Holter monitoring 
system for continuous recording of the telemetered electrogram or 
marker channel output from a tiered therapy tachyarrhythmia device 
(Medtronic model 7217B). The modified Holter system (MortaraJ 
CardioData Pr4A) receives 175KHz telemetry from the implantable 
cardioverter defibrillator (ICD) using an antenna taped over the ICD 
implantation site. The telemetered signal is recorded on channel two 
of the monitor while a standard ECG lead II is recorded on channel 
one. Seventeen patients were monitored for signs of inappropriate 
lCD performance for 24-48 hours post implantation, just prior to 
hospital discharge. Ten patients (59%) had only normal ventricular 
sense markers. Four (24 % ) had appropriate VT or VF markers during 
self limiting ventricular arrhythmias. Three (18%) had minor 
oversensing, never leading to VT or VF treatment. In an additional 
three patients who had apparently received inappropriate ICD therapy, 
the modified Holter was able to identify a fractured lead system, the 
requirement for VT stability criterion, and patient misperception as 
problems, and to guide corrective action. We conclude that 
transmission of a telemetered lCD signal to a Holter monitoring 
system provides information critical to the management of patients 
with tiered therapy lCDs unavailable with any other technique 
including the device's own memory. 
713·6 3:15 
Efficacy, Safety and Long.term Follow·up of 
Nonthoracotomy Implantable Cardioverter Leads in 
Patients with Poor Left Ventricular Function 
John M. Herre, Robert C. Bernstein, Linette R. KIevan, Szabolcs 
Szentpetery, and Lenox O. Baker. Eastern Virginia Medical School 
and Sentera Norfolk General Hospital, Norfolk, VA. 
Prior reports of implantation of nonthoracotomy leads with 
automatic implantable cardioverter defibrillators (AICOs) have 
shown adequate defibrillation thresholds (DFTs) in 64% to 87% of 
patients (pts), with greater success in pts with good left ventricular 
ejection fractions (EF). We attempted implantation of the CPI 
ENDOTAK lead system in 63 pts, (51 male) ages 30-84, with EF 
10%-57% (mean 31% ± 10%). EF was less than 30% in 27 pts. 
OFT was 25] in 12 pts and ~ 20 ] in 44 pts. Adequate DFTs were 
obtained in 24 of 27 pts with EF < 30 (89%) and 32 of 36 pts with 
EF;a 30 (89%). Age, sex, EF, heart disease and functional class 
did not predict success. A single defibrillation lead with electrodes 
in the right ventricular apex and superior vena cava provided 
adequate DFTs in 21 pts; a subcutaneous patch was used in the 
remaining 35 successful implants. There were no operative deaths. 
Complications were pneumothorax (2 pts), infection (3 pts) and 
oversensing (l pt). Four implanted pts had unacceptable DFTs at 
re-study and required addition of a subcutaneous patch (n=2) or 
repositioning of the patch (n=2). Of the 7 pts with high DFTs, 2 
were treated medically, 3 underwent thoracotomy AICD patch 
implantation and 2 required both intrathoracic patches and the 
ENDOTAK lead. Implanted pts were followed .8 to 16.2 months 
(mean 7.9 ± 4.3 months). One-year sudden death survival was 
97% and overall survival was 91 % for the 56 implanted pts. 
CONCLUSIONS; 1) Using the ENDOTAK lead system, 
adequate DFTs can be obtained in 89% of pts regardless of EF. 2) 
Morbidity and mortality are low. 3) Long term results are 
comparable to thoracotomy patch leads used with AICD systems. 
4) In this study, clinical parameters cannot be used to predict 
ENDOT AK implantation. 
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Clinical Comparison of Cardiac EwnIs During Follow-up After a Non•
Ischemic Exercise Test Suggests Superiority of SPECT 11-201 Over 
Echocardiography. 
Timothy M. Bateman, James O'Keefe, Carrie Barnhart, Larry R. 
Handlin, Robert W. Ugon. Cardiovascular Consultants, Inc., Mid 
America Heart Institute, Kansas City, MO 
Prior comparisons of exercise echocardiography (Echo) and SPECT 
n-201 have focused on accuracy versus the coron8/y angiogram. 
In this study, we compared clinical outcome during follow-up after a 
nonischemic (NI) Echo or a NI TI-201 by retrospectively reViewing all 
405 and 546 patients respectively with NI exercise studies between 
6/90 and 6/92 in a large clir.ical cardiology practice. Groups were 
identical in age (58 yrs) and % of maximum predicted heart rate 
achieved (87%). Echo and n-201 were done for diagnostic reasons 
in 192 (47%) versus 324 (59%) patients (p<O.OOl) and in patients 
with known coronary artery disease (CAD) in 213 versus 222. Mean 
follow-up was 9.4 and 13.2 months respectively. There were a total 
of 38 cardiac events (cardiac death or myocardial infarction = 7, 
PTCA or CABG = 28, unstable angina = 3): 30 after NI echo and 8 
after NI TI-201 (p<O.OOl). Event-free survival was 93% vs 99% at 6 
months, 91 % vs 99% at 12 months, and 91 % vs 99% at 18 months 
(p<O.05 for all intervals). In diagnostic patients, event rates were 
similar: 0 vs 0.9%. However, in patients with known CAD, the event 
rate was 14.1 % after NI echo vs 2.2% (p<O.OOl) after NI TI-201. 
Event rates were significantly higher after NI Echo vs NI TI-201 in 
subgroups of patients post·infarction [16/111 (14%) vs 2/93 (2.1%») 
and within 6 months of PTCA [14/55 (25.5%) vs 3/131 (2.3%)] 
(p<O.Ol for both); but not in patients post-CABG [5/82 (6%) vs 2/72 
(2.7%)] (p=0.4). 
CONCLUSION: In patients with known CAD, a nonischemic SPECT 
n-201 scan more accurately predicts freedom from subsequent 
cardiac events than does a nonischemic exercise echocardiogram. 
714-2 
Increased Lung Uptake of Thalli .... 201: An Adverse 
Prognostic Finding That is Underestiaated by 
Techneti .... 991 Sesta.ibi 
2:15 
James A. Arrighi, Shakeel Uddin, Peter T. Katsiyiannis, 
Arshed A. Quyyumi, Robert O. Bonow, Stephen L. 
Bacharach, Vas ken Dilsizian, NHLBI, Bethesda, Maryland 
Increased lung/heart (L/H) ratio of thallium (TL) 
during exercise identifies coronary artery disease 
(CAD) pts at high risk for subsequent cardiac events. 
Recent studies indicate that the accuracy of Tc-99m 
sestamibi (SM) for detecting CAD is similar to that of 
TL. To determine whether SM also yields similar 
information to TL imaging with regard to L/H ratio, 42 
pts with chronic CAD and left ventricular (LV) 
dysfunction (mean ejection fraction (EF) 33:13%) 
underwent stress TL SPECT and same-day rest-stress SM 
SPECT studies. The rate-pressure product and duration 
of exercise were similar for TL and SM studies. 
Quantitative TL and SM L/H ratios were calculated from 
the anterior projections. Based on previously 
published data, L/H ratios >0.5 and >0.42 were 
considered abnormal for TL and SM, respectively. While 
TL L/H ratio was inversely correlated with LVEF at rest 
(r=-.46, p<O.Ol) and during exercise (r=-.44, p<O.Ol), 
there was no correlation of LVEF with SM L/H ratio. 
When TL and SM L/H ratios were compared, there was 
concordance in 25 of the 42 pts (60%), with 18 
identified as normal and 7 identified as abnormal. In 
the remaining 17 pts with discordance between TL and SM 
L/H ratios, 12 pts (71%) were identified as abnormal by 
TL but normal by SM. When the time period from tracer 
injection to imaging was matched in a subgroup of 22 
pts, the discordance in L/H ratio between TL and SM 
persisted. These data suggest that the adverse 
prognosis of pts with increased TL L/H ratio may be 




Prognostic Value of Dipyridamole Technetlum·99m Sestamlbl 
Myocardial Imaging In .. 300 Consecutive Patients With Stable 
Chest Pain 
Henry G. Stratmann, Beaver R. Tamesis, Liwa T. Younis, Marl< D. Wittry, 
Henry M. Goodgold, Bernard R. Chaitman, D. Douglas Miller, SI. Louis 
Veterans Administration Medical Center and Saint Louis Univers~y Medical 
Center, SI. Louis, Missouri. 
Dipyridamole thallium-201 myocardial imaging provides useful prognostic 
information in stable pts with known or suspected coronary artery disease 
(CAD). To determine whether similar information can be derived from 
technetium-99m sestamibi (MIBI) imaging, we evaluated 329 consecutive 
pts (315 men, age 65 ±9years) w~h stable chest pain consistent wfth angina 
pectoris using intravenous dipyridamole rest-stress MIBI tomography. 
Cijnical CAD risk factors and known CAD were also recorded. Follow-up 
(mean 9±3 months) was complete in 308 pts (94%). 42 pts had cardiac 
events (CE): unstable angina (n.16), nonfatal acute 1.11 (n.4), or cardiac 
death (n-22). Clinical and MIBI data were compared by univariate analysis in 
pts with and without events, and risk ratiOS (Cox model) determined for 
sjgoj!!cant (ps OS) yariables' 
~ QQ! 
No CE(n.26) ~ ~ 
History of CHF 44(17%) 14 (33%) .02 2.28' 
CAD by angiographyt 92(35%) 23 (55%) .02 2.14' 
Angina during test 23(9%) 10 (24%) .007 2.31' 
Abnormal MIBI Scan 190(71%) 41 (98%) .00007 13.99" 
Reversible MIBI Defect 104(39%) 20 (48%).40 NS 
Fixed MIBI Detect 134(50%) 29 (69%) .03 2.38'0 
Reversible and Fixed 9(3%) 8 (19%) .03 3.40'0 
o.psO 05' ".OsO 01 CHF. conoestjye heart failure t ~ 1 stenosis ~ SO% 
By muttivariate analysis, angina and an abnormal MIBI scan remained 
signfficant (ps.02). Of 26 pts wfth nonfatal 1.11 or cardiac death, CHF, angina, 
or an abnormal MIBI scan were univariate predictors of a later CE; by 
muttivariate analysis only CHF was signficant (psO.OS). 
We conclude that, as with thallium-201 imaging, an abnormal 
dipyridamole MIBI study provides independent prognostic information 
regarding risk of future cardiac events in patients wfth stable chest pain. 
714·4 
Prognosis of Patients with Isolated Fixed Tl-201 
Defects and No Prior Myocardial Infarction 
Kenneth A. Brown, Michaelanne Rowen, Eric Altland. 
University of Vermont, Burlington, Vermont 
2:45 
Contrary to early dogma, recent data has revealed that 
not all fixed Tl-20l defects (FD) seen on stress-2-4 hr 
redistribution (S-RD) imaging represent infarction, 
Some studies have suggested that up to 50% of 
myocardial segments showing FD on standard S-RD imaging 
will show RD after re-injection of Tl-20l or with 24-48 
hr imaging. Prior studies have shown that RD on 
standard imaging has strong predictive value for 
cardiac events while FD do not. The prognostic 
implications of the subgroup of FD on S-RD imaging that 
show RD only with re-injection or late imaging is 
unknown. To shed some inSight to this dilemma, we 
examined the outcome of 100 pts withoyt prior MI who 
had isolated FD on standard planar S-RD imaging. Such 
pts would be likely to show RD with re-injection or 24-
48 hr imaging. Cardiac events were defined as cardiac 
death, MI, or revascularization for unstable angina. 
Over a follow-up of 24±7 mo, only 1 patient developed a 
cardiac event (nonfatal MI) for an event rate of 
0.5%/yr. This low event rate was not significantly 
different from that of a contemporaneous group of 261 
pts with a normal exercise Tl-201 study (1.2%/yr). 
Conclysions: Pts with isolated FD on standard S-RD Tl-
201 imaging, even in the absence of prior MI, have a 
very benign prognosis. Although re-injection or late 
imaging may result in new RD and thus identify FD 
segments with viable myocardium, such defects are 
unlikely to have the same clinical significance as 
defects showing RD on standard 2-4 hr delayed imaging. 
714-5 
lACC Vol. 21, No.2 
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3:00 
Prognostic significance of a fixed thallium defect. 
Implications for reinjection. 
Monty M Bodenheimer, Frans JTh Wackers, Ronald G. Schwartz, Mary 
Brown and the Multicenter Myocardial Ischemia Research Group. Long 
Island Jewish Hospital, New Hyde Park, NY. 
Reinjection of 201-n at rest may detect viable myocardium in as many as 
50% of zones with a fixed defect on delayed imaging 2-4 hrs after exercise. 
However, the prognostic significance of this finding remains unclear. In 
a large prospective study of myocardial ischemia, 8% patients had exercise 
n tests 1-6 mos after an acute coronary event [acute infarct (MI)-70%; 
Unstable angina (UA)-3O%). n images were analyzed quantitatively using 
circumferential profiles with reference to a normal data base for both 
exercise and delayed images. FoUow up averaged 28 mos. The table 
shows that the likelihood of an event was similar in patients wbo bad 
normal n images or a rlXed defect. In contrast, reversible defects 
(REVERS) were associated witb an increased mortality. Interestingly, tbe 
likelihood of either noniatal MI (NFMI) or UA was not related to tbe 
thallium result. 
Death NFMI UA n=117 
n=22 n=51 (13%) 
n Results (2.5%) (5.7%) 
Normal n=311 3 (.96%) 18 (5.8%) 43 (13.8%) 
FIXed n=217 2 (.92%) 11 (5.1%) 21 (9.7%) 
REVERS n=368 17 (4.6%) 21 (5.7%) 46 (12.5%) 
Thus, either the prevalence of viable tissue in fixed defects was low in this 
patient population or, the prognostic value of detecting viable myocardium 
with n reinjection should be questioned. A prospective prognostic study 
in such patients appears appropriate. 
714·6 3:15 
Incremental and Independent Prognostic Value of Exercise 
SPECT Thallium Imaging in Coronary Artery Disease 
Abdulmassih S. I skandr ian , Shung C. Chae, Joseph Lemlek, 
Charles Stanberry, Valerie Wasserleben, Virginia Cave, 
Jaekyeong Heo. Philadelphia Heart Institute, 
Presbyterian Medical Center, Philadelphia, PA. 
Most previous prognostic thallium studies were done with 
planar imaging. This study examined the independent and 
incremental prognostic value of exercise (Ex) SPECT 
thallium imaging in 316 patients (pts) with coronary 
artery disease (CAD) defined by angiography (angio). 
During a mean follow-up of 28 months, 35 pts had hard 
events (death or myocardial infarction). 
Using Cox proportional hazards regression models, several 
clinical (gender); Ex (exercise workload); angio (extent 
of CAD and ejection fraction); and thallium variables 
(extent of total perfusion abnormality, extent of 
ischemic abnormality, and LV dilatation) were predictors 
of events. 
The global 1t were as follows; clinical-S.l, Ex-3.l, 
thallium-22.7, angio-14.8, clinical + Ex-7.4, clinical + 
Ex + thallium-33.S, clinical + Ex + angio-2S.0, clinical 
+ Ex + angio + thallium-33.7 (P < 0.01 vs clinical + Ex 
+ angio). 
The extent of the thallium perfusion abnormality had the 
highest single 1t value (14). Using life tabla analysis, 
pts with large perfusion abnormality had worse prognosis 
than those with no or mild abnormality (Kantel-Cox 
statistic-10.6, P < 0.001). 
Thus, Ex SPEcr thallium imaging provides independent and 
incremental prognostic information even when 
catheterization data are availeble. The extent of the 
perfusion abnormality is the single most important 
prognostic predictor. 
JACC Vol. 21, No.2 
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Effect of Alpha-l Adrenoceptor Subtypes on Susceptibil•
ity to Sudden Death: Alpha lA receptor antagonists 
protect againat Ventricular Fibrillation 
George E. Billman, Michael Lappi. 
The Ohio State University, Columbus, Ohio. 
The activation of adrenergic receptors during myocardial 
ischemia have been implicated in the development of ven•
tricular fibrillation (VF). Previous studies demonstra•
ted that alpha-l adrenoceptors contribute significantly 
in the development of malignant arrhythmias. Recent in 
vitro studies suggest that activation of specific alpha-
1 receptor subtypes (alpha-lA) can induce triggered ar•
rhythmias while a second receptor (alpha-lB) may de•
crease automaticity. If these receptor subtypes contri•
bute to VF in intact animals, then specific alpha-lA an•
tagonists should protect against these arrhythmias while 
alpha-lB antagonists could induce VF. To test this hy•
?othesis a 2 min coronary occlusion was made during the 
last minute of exercise in dogs with healed myocardial 
infarction. Seven dogs developed VF (susceptible) while 
5 did not (resistant). The alpha-lA antagonist WB 4101 
(2.0 mg/kg) prevented VF in 6 of 7 animals, while delay•
ing arrhythmia onset in the remaining animal. In con•
trast, the alpha-lB antagonist chloroethylclondine (2.0 
mg/kg) induced arrhythmias in the resistant animals (n= 
3). As a final test VF was induced in the resistant an•
imals (n=5) by the combination of cocaine during the ex•
ercise plus ischemia test. WB 4101 prevented cocaine•
induced VF in aIlS animals. These data demonstrate 
that specific alpha-l adrenoceptor SUbtypes are involved 
in the induction of VF reSUlting from either ischemia or 
cocaine. In particular, alpha-l A adrenoceptors (blocked 
by WB 4101) potentiate lethal arrhythmias which may 
result from afterdepolarizations and triggered activity. 
715·2 2:15 
Preservation of Sympathetic Innervation Followil1ll Late Reperfusion may 
Explain the Benefits of the ·Open Artery" 
Margaret A. Hood. Harold P. Pride. Douglas P. Zipes 
Klannert Institute of Cardiology. Indiana University School of Medic~. 
Indianapolis. Indiana 
We tested the bypothesis that less regional sympathetic denervation after myocardial 
infarction migbt belp explain the mechanism of reduced mortality found in patients 
with an 'open artery'. We studied 3 groups of open cbest neurally decentralized 
dogs 4-7 days after sham occlusion (groupl. n=4);occlusion ofa diagonal coronary 
artery and collaterals followed by reperfusion 6 hours later (group2. n=6); 
permanent diagonal coronary artery occlusion (group3. n=4). Sympathetic 
innervation was assessed by determining effective refractory period (ERP) 
shortening during supramaximal bilateral ansae subelaviae stimulation (SS) with 
unipolar "lunge electrodes placed at sites basal and apical to the infarct area. ERP 
shortening during norepinephrine infusion(O.Sl'gm/kg) established 
electrophysiologically normal myocardium. Nitro blue tetrazolium stain documented 
the presence of transmural infarction and that all test sites were outside the infarct 
area. Results: Basal ERPs shortened oquivalently in all 3 groups during SS and NE 
(p=O.063). However. SS shortened ERP less in group 3 (nonreperfused) than in 
groups I and 2 (p=O.OO9). while ERP shortening was the same for groups I and 
2 (p=O.134). ERP shortening was greater for each group during the NE than the 
SS (p<O.OOl) becaWiOO of the NE dose and this effect was greatest in group 3 
(p=O.OO9). 
J.ERP apical sites 
Treatment Group I (n=4) Group 2 (n=6) Group 3 (n=4) 
BAS 19.8±2.0 14.2±4.0 6.3±2.1 
NE 28.I±S.2 27.0±4.S 29.0±4.6 
t Test p=O.037 p=O.OO3 p=O.OO3 
Conclusion: Reduced ERP shortening during S5 and greater ERP shortening during 
NE in the apical region of the permanently occluded group is consistent with post 
infarction sympathetic denervation and supersensitivity. The ERP responses in the 
reperfused group were the same as in the sham group. Thus. late coronary artery 
reperfusion following infarction preserves sympathetic innervation and prevents 
autonomicbeterogeneity. Sucb cbanges could help prevent arrhythmia development 




Effects of Endothelin·l at Pathophysiological Concentrations on the 
Normal and Post-Ischemic Myocardium 
Julian Donckier. Oaude Hanet. Laurence Galanti. Liviu Stoleru. Henri 
Van Mechelen. Wataru Hayashida. Jean-Marie Ketelslegers. Hubert 
Pouleur. University of Louvain. Brussels. Belgium. 
To assess the effects of endothelin-I (ET-I) on myocardial function at 
plasma concentrations similar to those seen in myocardial infarction. hean 
failure or renal failure. IS conscious chronically instrumented dogs were 
studied. Global and regional (piezo-electric crystals) LV functions were 
studied during placebo or ET -I infusion (2.S nglkg.min for 120 min) 
under basal conditions. during a IO-min coronary occlusion (CO) and 
after reperfusion. Plasma ET -I (sampled with protease inhibitors) 
concentrations were detennined by radioimmunoassay after plasma 
extraction before. during and after CO. ET·I levels were unchanged with 
placebo (3.S±O.4. 3.9±0.9. 3.6±O.4 pg/ml. respectively) but reached 
pathophysiological ranges during ET-l infusion (32.3±2.7. 34.0±2.9. 
43.6±3.2 pg/ml). ET-I had no effect on hean rate. LV and aortic 
pressures or on percent shonening of the control LV segment before. 
during and after CO. Coronary flow in the LAD was also similar in both 
groups at baseline (20 vs 20 ml/min). during and after CO (at 90 min 
post-CO: 22 vs 23 ml/min with ET-I). ET·I. however. significantly 
depressed the function of the ischemic zone during reperfusion. 
Systolic Shortening Occlusion Recovery (min) 
(% of baseline) 60 90 110 
ET-I ischemic -7±9! 46±9*! 48±1O*! S2±10*! 
control 83±9 81tS 82±6 79±7 
Placebo ischemic -8±9! 77±7 78±8 83±7 
control 84±13 91±7 87±8 88±1O 
In conclusion. ET -\ at pathophysiological levels has no effect on the 
nonnal myocardium but depresses post-ischemic myocardial recovery. As 
coronary blood flow is not affected. an alteration in intracellular calcium 
handling (induced by ET -I) can be suspected. * p<0.05 ischemic ET-I 
vs ischemic placebo. !p<O.OS vs corresponding control. 
715·4 2:45 
Cytokines in Myocardial Infarction: Selective 
Induction of TNF, Soluble TNF Receptor and IL·l 
Receptor Antagonist. 
Roberto Latini. Marina Bianchi. Charles A. Dinarello, Giamila 
Fantuzzi, Claudio Fresco. Aldo P. Maggioni, Manuela Mengozzi, 
Salvatore Romano, Leland Shapiro. Pietro Ghezzi 
Mario Negri Institute. 20157 Milano/Cardiology Divisions 
Caserta. Magenta. Udine, Italy. and Tufts University-New 
England Medical Center. Boston, MA. 
There is a growing list of infective and inflammatory diseases 
where cytokines playa pathogenetic role. Recently, attention in 
the cytokine field was focused on endogenous inhibitors. 
We measured the levels of a-lheta. IL-6. IL-8 and TNF alpha 
(by ELISA) in patients thrombolyzed after acute myocardial 
infarction (AMI) of different severity and in 6 matched controls 
without AMI. In 6 out of 7 patients with severe AMI (Killip class 
at entry: 3 and 4). high plasma levels of TNF were detected 
(1.094±1.177 (SD) pg/ml, rangeI80-3.600). within 6-12 h of the 
infarction. No a-I. IL-6 or IT..-s « 50 pg/ml) were detected at 
any time poinL No TNF was detected in the group of II patients 
with uncomplicated AMI (Killip class at entry: I) and in the no•
AMI group. We also measured plasma levels of IL-I receptor 
antagonist (a· Ira) and soluble TNF receptor (TNFrs). by RIA. 
A marked elevation of a-Ira was found, with peak levels 
(4.766±2.953 pg/ml. range 1.900-8,5(0) observed within 6-24 h 
of AML Lower but detectable a-Ira peaks (l,271±1,270 pg/ml, 
range 570.4.1(0) were also observed in uncomplicated AMI. 
TNFsr levels were also elevated. although with varying kinetics. 
in AMI patients when compared with control or uncomplicated 
AMI patients. In conclusion, severe, but not uncomplicated AMI, 
followed by thrombolysis triggers a transient. but marked, 
increase in TNF; its pathogenetic role. and that of its endogenous 




Myocardial Protection After Heat Shock Pretreatment 
Correlates with the Degree of Prior Stress Protein Induction 
Matthew M Hutter. Richard E Sievers. Christopher L. Wo~e. 
University of Califomia. San Francisco. CA 
To test the hypothesis that the degree of protection from ischemic injury in 
heat shocked rats correlates with the degree of prior 72 KDa heat shock 
protein (HSP72) induction. rats pretreated with 40°C. 41°C. or 42°C of 
whole body hyperthermia followed by 24 hours of recovery and controls 
(n=6 in each group) were quantitatively assessed for the presence of 
myocardial HSP72 by optical densijometry of Western blots using a primary 
antibody that is specific for HSP72 and a tertiary antibody labeled with 
12510dine. Although rats heat shocked to 40°C had no induction of 
myocardial HSP72. rats heat shocked to 41°C and 42°C demonstrated a 
signfficantly increased amount of myocardial HSP72 compared to controls. 
Separate groups of rats. heat shocked to 40°C (n=6). 41°C (n=10). 42°C 
(n-7) and controls (n.19), were subjected to 35 minutes of left coronary 
artery occlusion and 120 minutes of reperfusion. Infarct size was assessed 
by TIC staining. Compared to control and 40°C rats. there was significant 
infarct size reduction in rats that were heat shocked to 41°C and 42°C. 
HSP72 ......... va o.v- ....... Shook Inlorct Size VI Deg_ 01 HHt Shock 
Control 400C .. , "C 4zoe 
These results suggest that the improved salvage after heat shock 
pretreatment may correlate with the amount of HSP72 induced prior to 
prolonged left coronary artery occlusion and reperfusion. 
715·6 3:15 
Deleterious Effects of 'the Lytic State on Recovery of 
Reperfused Myocardium 
James A. Goldstein, Michelle G. Butterfield, Timothy J. 
Shelton, Jeffrey E. Saffitz, Burton E. Sobel. Washington 
University, St. Louis, MO 
This study was designed to determine whether induction 
of a lytic state (plasminemia, fibrinogen depletion, etc) 
attenuates beneficial effects of recanalization on 
ischemic myocardium. Accordingly, we characterized RV 
function and histology I hr after recanalization 
following 1 hr of right coronary occlusion induced by 
angioplasty balloon inflation-deflation (group I, n - 6), 
pharmocologic lysis (Streptokinase 40,000 U) of a copper 
coil induced clot (group II, n - 6) or balloon occlusion 
with lytic state induced prior to deflation (group III, 
n - 6). Occlusion led to RV free wall (FV) dysfunction 
by echo (RVFV thickening group I 52 ± 8 to 1 ± 2%*, II 
47 ± 7 to -1.3 ± 0.4%* and It I 53 ± 11 to -3.0 ± 0.2*). 
In the absence of lytic state (group I), RVFV thickening 
improved with recanalization (1 ± 2 to 31 ± 7%*), RVFV 
diastolic thickness increased slightly (0.46 ± 0.04 to 
. 50 ± 0.06 cm, NS) and microscopy revealed minimal 
interstitial edema. However, recanalization induced by 
lysis (group II) led to increased RVFV thickness (0.51 ± 
0.09 to 1. 22 ± .21 cm*) and minimal recovery of RVFV 
thickening (-1.3 ± 0.4 to 7.1 ± 1.1%, NS). Microscopy 
demonstrated marked edema, hemorrhage, leukocyte 
infiltration, vascular plugging and contraction bands. 
Recanalization in the presence of lytic state (group III) 
also led to increased RVFV thickness (0.58 ± .1 to 0.99 
± .24*)and only slight improvement of RVFV thickening 
( - 3.0 ± 0.7 to 16 ± 7.3%, NS). Microscopy revealed 
marked edema and vascular plugging. Thus, the presence 
of a lytic state exerts adverse effects on recovery of 
ischemic myocardium subjected to reperfusion. (*P<0.5) 
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716·1 2:00 
Blood Pressure 1l'eatment Slows the Rate of Progression of Carotid Stenosis 
in Patients with Isolated Systolic Hypenension. 
Kim Sutton-'JYrrell, Lewis H. Kuller and Sidney K. Wolfson, Jr., University of 
Pittsburgh, Pittsburgh, PA 
Serial carotid duplex scans were performed on 107 individuals in the Systolic 
Hypenension in the Elderly Program (SHEP), and rates of progression and 
regression of carotid stenosis were observed. Prior to analysis of the data, 
changes in Doppler measures of blood flow velocity were used to ascenain 
progression: Progression was defined as the development of a 50% stenosis 
when one was not present on the initial scan or, if a stenosis was already 
present, funber reduction in the cross-sectional luminal diameter of approxi•
mately 10-20% or greater. Progression occurred in 20% (21/107) of panici•
pants and regression in 7% (81107). Progression was seen primarily in the 
internal carotid (15%), but was also observed in the external carotid (9%) and 
common carotid or carotid bulb (2%). When results were analyzed by SHEP 
treatment assignment, 30% of those randomized to placebo progressed while 
only 12% of tbose randomized to active blood pressure treatment progressed 
(p=.019). All 8 patients who showed regression were randomized to active 
treatment (p=.OO9). At baseline, tbose randomized to placebo were more likely 
to have ever smoked and were more likely to have a glucose ~ 120 mg/dL 
Those randomized to active treatment were more likely to be male. After 
controlling for age, sex, smoking and glucose, panicipants assigned to placebo 
remained 3 times more likely to show progression of disease tban those 
assigned to active treatment (p=.046). An HDL-3 level < 30 mg/dl was a,1so 
independently predictive of progression (p=.OO9). The most pronounced 
treatment effects were seen among those who had either an internal or external 
carotid stenosis at baseline. Among this group, 45% of participants randomized 
to placebo progressed compared to 19% of those randomized to active 
treatment (p=.036). This study provides strong evidence that treatment of 
systolic hypenension slows the progression of carotid anery stenosis. It is likely 
that this is at least pan of the reason for the reduction is stroke risk among 
SHEP panicipants randomized to active blood pressure treatment. 
716·2 
Regression and progression of coronary 
Artery Disease during Lipid Lowering 
Treatment. 
stellwaag M+, B Maisch+, J Schneider+, A 
steinmetz+, M Leschke*, BE strauer* , H 
Kaffarnik+. Department of Internal 
Medicine and Kardiology *Univ. DUsseldorf 
+Univ. Marburg FRG. 
We examined the effect of a lipid 
lowering treatment on the changes of the 
course of coronary artery disease 
(CAD).36 Patients with angiographically 
proven CAD and hyperlipidemia type 
IIa,IIb and IV were treated with a lipid 
lowering diet, fenofibrate 250mg per day 
and colestipol up to 20 g per day. After 
controlled therapy up to 4 years coronary 
angiography was repeated. By 
computerassisted quantification of the 
angiogramms three groups of patients were 
formed: group I-regression in CAD (n=3) , 
group II-no change in CAD (n=2l), group 
III-progression in CAD (n=12). Different 
responsiveness to the treatment was seen 
in the three groups with significant 
reduction of total cholesterol- and LDL•
levels in groups I and II: 
Group I II III 
Cholesterol 318/236 251/220* 257/238 
LDL 212/159 193/158* 202/184 
* p<0.05 before/after therapy (mg/dl) 
Conclusion: Effective lipid lowering 
therapy slowes down the progression and 
even leads to a regression of CAD. 
2:15 
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Errect or Triglyceride-rich Lipoproteins on Progression or Early 
Atherosclerotic: Lesions as Determined by Coronary Angiography in the 
MevinoHn (Lovastatin) AtherGSderosis Regression Study (MARS) 
Howard N. Hodis, Wendy J. Mack, Janice M. Pogoda, Pew Alaupovic, 
Linda C. Hemphill, David H. Blankeohom. 
University of Southern California School of Medicine, Los Angeles, CA 
and Oklahoma Medical Research Foundation, Oklahoma City, OK 
Accumulating evidence indicates that angiographic lesions less than 50 
percent diameter stenosis (%S) are likely to result in clinical events if they 
rapidly progress. Less clear are the risk factors for progression of these 
early lesions. Serial quantitative coronary angiograms in the Mevinolin 
Atherosclerosis Regression Study, a double-blinded, placebo-controlled, 
two-year coronary angiographic trial testing SO mg per day of lovastatin in 
270 men and women, demonstrated a multivariate correlation of on-trial 
apolipoprotein cm and total triglyceride (TG) levels with progression of 
early lesions in coronary artery segments < 15%S and 15-50%S at 
baseline, respectively. Progression of lesions in segments 2,50%S at 
baseline multivariately correlated with the ratio LDL-C/HDL-C. 
Furthermore, lesion progression was greater in subjects whose TG levels 
increased on-trial than in those whose levels decreased, irrespective of 
treatment group (Table). Segments 15-50%S at baseline demonstrated 
significant difference in change in mean %S (±S.D.) when subjects were 
divided. according to on-trial TG change (p < 0.03). Effect size (ES) 





+4.1±1.1 %S change + S.3±1.9%S change 0.07 0.62 
+ I.I±O.S + 3.1±0. 7 0.03 0.37 
-1.I±1.2 +O.S±I.S 0.41 0.27 
Conclusion: Progression of early atherosclerotic lesions in coronary artery 
segments < 15%S and is-50%S at baseline significantly correlates with 
triglyceride-rich lipoproteins, whereas, lesion progression in coronary 
artery segments 2,SO%S at baseline correlates with the LDL-C/HDL-C 
ratio. These results indicate the importance of reducing LDL-C and 
triglyceride levels in patients with established coronary artery disease. 
716·4 2:45 
Clinical Factors l\ssociated with Recurrent Myocardial 
Infarction in the Year FollONing a First Myocardial 
Infarction 
Ran Kornovski. Solanan Behar, for the SPRINT Study 
Group, Neufeld Cardiac Research Institute, Sheba 
Medical Center, Tel Hashomer, Israel 
Early identification of patients (pts) at risk for 
recurrent myocardial infarction (RMI) is crucial because 
of short and long term prognostic implications. To det•
ermine the clinical and historical predictors related to 
RMI we analysed 3695 pts with first MI included in the 
Secondary Prevention Reinfarction Israeli Nifedipine 
Trial (SPRINT) Registry. The 1-yr reinfarction incidence 
was 6.0% (220/3695). pts with RMI were slightly older 
(63.0 vs 60.8 yrs), and had a greater incidence of 
anterior infarction (56.8% vs 43.1%), congestive heart 
failure (23.7% vs 14.9%), prior angina (51.6% vs 40.5%), 
hypertension (47.4% vs 39.9%), diabetes mellitus (25.4% 
vs 19.1%), peripheral vascular disease (PVD) (11% vs 
5.3%) and were more often prescribed calcium antagonists 
(p<0.05 for each ccmparison) than pts free fran RMI. The 
independent clinical predictors for 1-yr RMI were (rela•
t i ve adjusted odds): prior angina (1.42), hypertension 
(1.29), diabetes (1.35), PVD (1.95) and anterior MI loc•
ation (1.58). pts with 0 to 4 of these variables had 
1-yr reinfarction rates of 3.8%, 4.7%, 5.7%, 10.6% and 
16.8% respectively (p<0.0001). pts with RMI had signifi•
cantly increased 1 and 5-yr mortality ccmpared to their 
reinfarction free counterparts (36.4% vs 5.3% and 57.3% 
vs 20.3%, p<0.001, respectively). By multiple regression 
analysis. RMI within one year after first MI emerged as 
a very powerful independent predictor for 5 yr mortality 
(RR=3.44). We concluded that clinical data obtained 
during hospitalization for a first MI could identify pts 
at risk for 1-yr reinfarction, which emerged as a strong 
independent predictor of long term prognosis. 
ABSTRACfS 
716·5 3:00 
PLAC·2: Effects of PravastatiD on Progression of Carotid 
Atherosclerosis and CUnicai Events 
Curt D. Furberg, John R. Crouse, Robert P. Byington, M. Gene 
Bond, Mark A. Espeland. 
Bowman Gray School of Medicine, Winston-Salem, NC 
PlAC·2 (Pravastatin, Lipids, and Atherosclerosis in the Carotids) 
is the first clinic:al trial with carotid atherosclerosis progression as 
an efficacy outcome. Eligibility criteria included low density 
lipoprotein (lDL) cholesterol between the 60th and 90th 
percentiles and documented coronary artery disease (CAD). CAD 
is associated with a high progression rate of carotid 
atherosclerosis. Patients were also required to have a plaque on 
the B-mode ultrasonogram of 2. l.3mm but < 4.5mm in at least 
one of 12 arterial wall segments. 151 patients (15% females) were 
randomly allocated to pravastatin (40 mg/day) or matched 
placebos. Baseline clinical characteristics and lipids in the two 
groups were similar. Mean age was 63 years and mean lDL 
cholesterol was 166 mg/dl. Each patient's 3-year progression of 
atherosclerosis was defined as the slope of the mean of the 
maximum intimal-medial thickness from 12 wall segments, as 
measured during the semi-annual ultrasound exam. 
The estimated annual progression rate in the placebo group was 
O.06mm per year. This double-blind trial is scheduled for 
termination December 31, 1992. To date, there have been 6 
deaths, 12 acute myocardial infarctions, 4 acute strokes, 10 
coronary artery by-passes, 8 PTCAs and 4 carotid 
endarterectomies. The effect of pravastatin on lipids, carotid 
atherosclerosis progression, and clinical events and procedures will 
be discussed. 
716·6 3:15 
A Com~ of Outcomes and Sample SUes Usi .. Lesion and Patient-Based 
Analyws of Coronary R~ Data: Results oftbe Familial Atberosclenlsia 
Trealmeol Study (FATS). 
C. Micbael Gibson, Bernard R.-. Lynn HiIlger. Uoyd D. Fisbet. B. Greg 
Brown. Beth IsneI Hospital, Bostoa MA. UDivenity of Washington. SeattJo. 
PreviouslY. the FATS study wu aaa1yzed by averasing together the change in 
percent stenosis (.1 %5) over 2.S years for all iesioaa ill each pal~1II (pi). We 
reaoaIyzed .1%5 in 1.034 iesioaa on • JH!T-/aiofl basi. using. General Linear 
Model with iDtraclass Correlation (GUMIC) !o 1) determine if multiple lesions 
in the same pt. proareosJregrest at ilIdq!endent riles when exposed to inlellse 
lipid-lowering therapy. 2) to delcra:i"" the effect of Vui0U8 coronary artery 
disease risk fleto.. WId uther cov~ on illdividual laion 
propessionl,.,..-iOO:. ,00 3) 10 compare sample sizes using lesion and pt. based 
aaa1y...". 120 t:r.I with opo B level. > 125 mg% were randomized to either 
COIIv~tiOlll:.l dJenlpy (CONV). lovastatin..:olestipol (LC). or Diacin..:olestipol 
(NC). ~ %5 in CONY (2.1 % worsening in .1 %5) differed significantly from LC 
(~. 7S% improvement) and NC (~.8S % improv_t. p-O.O(9) usingGUMIC. 
The correlation in .1 %5 among multiple lesioaa within the same pt. was low 
(r=O.D7. p=0.OO3). indicating thai multiple lesioaa in the same pt. progress or 
regress at independent riles. Baseline stenosis severity. a decrease in Apo B (or 
LOL) over tOO study period. and • decrease in systolic BP were indepeodoot 
predicton 01. benefit in .1%5 using GLIMIC (p<O.OOI). Lesion location was 
nota predictor of .1. %S. To detect. 3 ~ difference in the outcome variabl" .1 %5 
""tween treatment and control groups. (Le. the FAT5 outcome) 27 pts P"f 
treatment group would b.; required in a pl.-bas.ld analysis and 26 pts. in a lesion•
based aaa1y"is correcting for the correlation among lesions using GUMIC (80% 
power. a= O.OS). If the O.OSS mm difference between treatment an!! control 
groups in minillUlJn diameter is to be detect .... then 43 pts. would be required in 
• pt.-based analysis. and 38 pts. would be required in • lesion-based analysis 
using GUMIC. CoocItmons: When exposed to lipid lowering therapy multiple 
lesions progress or regress intkpendt!nlly in • given pI. Increased baseline disease 
severity. a decrease in Apo B. and • decrease in systolic blood pressure are 
important determinants of individual (rather than patient-based) lesion regression. 
Despite • larger number of data points available for analysis in a lesion-based 
approach. the results of the treatment effect are nearly identical to thai obtain<d 
when the data is aaa1yzed on a P"f-patient basis. The statistical power of these two 
methods is similar for .1 %5. but • small advantage exists for • lesion-bas.ld 
approach to tbe change in minimum diameter. 
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717-1 2:00 
Angloplasty vs Bypass-SUrgery In Patients with Multlvessel 
Disease: Re-Interventlons and Complications During 6 Months 
Follow-up 
Christian W. Hamm, Jacobus Reimers, Hans-JOrgen Rupprecht', 
Thomas Ischinger"' for the GAB.I. Study Group; Medical Clinic, Dept. of 
Cardiology, University of Hamburg, and 'University of Mainz, and "Div. 
of Cardiology, Klinikum Bogenhausen, Munich, Germany 
The German Angioplasty Bypass-Surgery Investigation (G.A.B.L) is a 
prospective randomized muHi-center trial to compare bypass surgery 
(CABG) and coronary angioplasty (PTCA) in patients (pts) w~h 
symptomatic muHivessel coronary disease. Pis were included, if complete 
revascularization was considered necessary and technically feasable in 
at least two major coronary vessels supplying different myocardial 
terr~ories. A total of 358 pts (58 ± 8 years, 16 % women) were rando•
mized by 8 clinical s~es to PTCA (n=179) or CABG (n=179). There was 
no difference in baseline characteristics as to risk factors, clinical status, 
prior myocardial infarction, angina CCS class, and number of stenoses in 
pts groups. Serious events during hospitalization were not dnferent 
(CABGIPTCA: death 3.2 vs 0.7%, myocardial infarction 9.6 vs 5.8%). 
CABG patients received 2.5 ± 0.6 grafts, PTCA was performed in 2.5 1: 
0.6 vessels. Delay from treatment to discharge was 21±2 vs 8 ± 2 
(p<0.001) days for CABG and PTCA. Freedom of angina at discharge 
was reached in 88.7 % of CABG and 82.2 % of PTCA pts (n.s.). During 6 
month follow-up (data from n=234 pts, n= 105 CABG; n= 129 PTCA) 2.8 
% pts (CABG) and 2.3 % pts (PTCA) suffered myocardial infarctions. but 
there were no deaths. Re- interventions were necessary in 6.7 % CABG 
(1.9 % re-CABG, 4.8 % PTCA) and in 46.5 % PTCA pts (21.7 % CABG, 
24.8 % re-PTCA) (p<0.001). At 6 months angina ecs class ~3 was pre•
sent in 6.7 % CABG and 5.4 % PTCA pts (n.s.). 
In conclUSion, for selected pts with muHivessel disease, PTCA and CABG 
appear to be equivalent treatment modalities as to safety and 6-months 
clinical outcome. The length of hospitalization is longer with CABG, 
whereas the rate of early re-interventions is higher with PTCA. 
717·2 2:15 
Corollary Bypaa. Vat .... ADqioplaaty in the Elderly 
Matthew B. Sutton, James O'Keefe, Ben D. McCallister, 
James L. Vacek, Jeffrey M. Piehler, Robert W. Ligon, 
Geoffrey O. Hartzler 
Mid America Heart Institute, Kansas City, MO 
The purpo.e of the current study was to compare the 
relative risks and benefits of coronary angioplasty 
(PTCA) and coronary artery bypass graft surgery (CABG) 
in patients ~ 70 yrs of age. A group of 195 
consecutive patients who underwent CABG in 1987-88 
were compared with a concurrent cohort of 195 PTCA pts 
who were matched for LV function, age, and gender. 
All baseline variables were similar except the 
incidence of multives.el disease, which was the 
dominant pathoanatomy in both groups, but was 
significantly more common in CABG (97') than PTCA 
(8n, p-.001). 
PTCA!n=195I CABG!n=195I p-value 
In-hospital death 2' 9' 0.007 
In-hospital stroke 0' 5' <0.001 
In-hospital infarct 1\ 6' 0.014 
Survival (1 yr) 84' 86' NS 
(5 yr) 62' 65' NS 
Event-free (1 yr) 76' 81\ 0.01 
(5 yr) 40' 59' 0.01 
Repeat CABG or PTCA 38' " <0.001 
Multivariate correlates of long-term survival were, 
LV function, prior CABG, L~d prior infarction. 
CONCLUSIONS, In this cohort over age 70, the early 
morbidity and mortality rates were higher in patients 
treated with CABG vs PTCA. Long-term survival was 
similar in the two groups, although the event-free 
survival and e.pecially freedom from repeat procedure. 
favored the CABG group. 
717·3 
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Correlation of Exercise Testing with Results of 
Quantitative Coronary Arteriography in the VA 
Study of Angioplasty Compared to Medicine (ACME) 
David C. Booth, Pamela M. Hartigan, Edward D. Folland, Alfred F. 
Parisi, ACME Investigators, Lexington V AMC, Lexington, KY 
A total of 212 patients with one-vessel disease and stable 
angina were randomized in the ACME Study to PTCA (105, 
49.5%) or Medicine (107, 51.5%) and bad both entry and 6-
month flu coronary arteriograpby to assess index lesions and 
exercise testing to assess functional status. Quantitative 
coronary arteriography (QCS Anrck) was available in 89 PTCA 
pts (84.7%) and 88 Medicine pts (82.2%). Linear regression 
analyses between duration of exercise at follow-up and, 
respectively, minimum lumen diameter (1'=.10) and % diameter 
stenosis (r=.09) revealed only a general correlation. In a 
separate analysis, exercise duration and double product (DP) 
were analyzed in PTCA and Medicine pts grouped in % diameter 
stenosis terciles defined as Progression, No Change (pts witb 
A % diameter stenosis less than 2 S.D. of the variability of Q/A 
method, S.D.=7.2%), and Improvement (Imp). Data are means. 
PTCA (n=87) Medicine (n=9l) 
Prog No Change Imp Prog No Change Imp 
n 6 38 43 10 n 9 
A % Sten 19.6 0.36 -28.9 22.5 0.74 -25.5 
A Ex Our 3.43 1.57 2.13 0.84 0.028 1.63 
P 0.06 0.0009 0.0002 0.04 0.28 0.077 
AD. P. 781.2 1936 1793 -655 -3957 1829 
P 0.36 0.03 0.11 0.68 0.0001 0.28 
In the PTCA group, exercise performance increased in pts with 
Improved lesion status, but also in pts with No Cbange or 
Progression (216 pts improved ex. duro by 9.2 and 6 min., 
respectively) and to a lesser extent in Medicine pts with 
Improved status. Thus, flu exercise performance improved in 
PTCA pts regardless of Q/A-derived geometric outcome of the 
index stenosis, and the expected close correlation of exercise 
duration and lesion geometry (severity) by linear regression 
was not found. 
717·4 2:45 
·Relatlonship Between Changes in Exercise Duration, Thatfium Perfusion 
Defect and Coronary Stenosis in Patients with Single Vessel Coronary 
Disease - Resutts from ACME Triar. 
Kodangudi Ramanathan, Pamela Hartigan, Charles Boucher, Edward 
Folland and AHred Parisi. V. A. Medical Center, Memphis, TN 
The purpose of the study was to compare changes in exerCise duration 
with changes in thallium perfusion defects and coronary stenosis. 227 
patients with single vessel coronary disease were randomized to receive 
either medical therapy (113) or PTCA (114). All patients underwent 
symptom limited maximal ETT with thal6um and coronary arteriography 
before and after 6 months of treatment. ExerCise duration (ED) was 
divided into three categories (Worse - Decrease in ED; Mild improvement 
• increase in duration 0 to 1.5 min, Marked improvement - greater than 
1.5 min. in ED). Thallium perfusion defects were quanified by a central 
core laboratory using a point score system (O.no uptake; 1 =some uptake 
2=normal uptake;Maxirnum 18 points, minimum 0). Changes in coronary 
stenosis were measured by catipers and expressed as %. 
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In the Medical group there was no change in coronary stenosis in any 
of the groups. Only marked improvement in exercise duration was 
accompanied by significant change in thallium defect. In PTCA however, 
both percent stenosis and thalUum defect improved significantly 
irrespective of improvement in exercise duration. Thus in patients 
following PTCA tha16um SCintigraphy appears to correlate better with 
changes in percent stenosis than exercise duration. 
JACC Vol. 21, No.2 
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717-5 3:00 
Piv. Year ComparIson of TripI. V •••• I 
R.va.cularization, Coronary Bypa.1 Surg.ry V.rlUI 
Balloon Angiopla.ty. 
Richard K. Myler, Richard E. Shaw, Peter A. Baciewicz, 
Joseph Rosennlum, Mary C. Murphy, Simon H. Stertzer, 
Alex Zapolanski, Laurel Leary, Jean Chan. San 
Francisco Heart Institute, Seton Medical Center, Daly 
City, CA 
During 1986-87, 77 con~e<:utive patients underwent 
triple vessel coronary angioplasty (TVPTCA) and lOS 
concurrent patients had triple vessel coronary bypass 
(TVCABG) treatment at the same institution. These 
groups wp.re taken from a total series in which 
patients with left main coronary artery diseaAP, 
stenotic valvular disease, prior bypass surgery or 
emergency procedures were excluded. The TVPTCA and 
TVCABG groups did not differ on distribution of 
gpnder, history of diabetes or hypertension, elevated 
cholesterol, history of myocardial infarction, anginal 
class, or left ventricular function. The TVCABG 
patients were significantly older (62 vs. 58; p<O.Ol). 
Five year followup was obtained in 75 (97%) of TVPTCA 
and 97 (92%) of TVCABG patients. Results were: 
TVPTCA TVCABG p-value 
Survival 90:7% 86.6% n.s. 
Angina Free 81.3% 85.6% n.s. 
Late MI 5.3% 4.1% n.s. 
Repeat Revascularization 56.0% 5.2% 0.0001 
Although certain patient subsets may by better served 
by a particular revascularization strategy, this 
analysis suggests that overall longterm outcome of 
triple vessel disease patients treated with coronary 
angioplasty or bypass surgery is quite similar. 
Patients having TVPTCA do require additional 
intervention to sustain these longterm results. 
717-6 3:15 
Completeness or Revascularlzatlon after Coronary Angloplasty and 
Coronary Surgery: Different Strategies, Different Results. 
William S. Weintraub, Spencer B. King III, Ellis L. Jones, Joseph M. Craver, 
John S. Douglas Jr, Douglas C. Morris, Henry A. Liberman, Robert A. 
Guyton. Divisions of Cardiology and Cardiothoracic Surgery, Emory University 
School of Medicine, Atlanta, Georgia. 
To compare the infJuence of completeness of revascularization (R) on long 
term results after coronary surgery (CABO) or coronary angioplasty (PTCA), 
all patients undergoing a fIrSt R procedure (RP) for two vessel coronary disease 
in 1984 and 1985 were foUewed, 98% complete, mean of 5 years. 5 year survival 
was 93% for PTCA and 89% for CABG (p=.l1). CABG patients were older, 
and had more severc disease. When adjusted for differcnces in baseline 
variables, there was no difference in survival. The 5 year event free survival was 
49% for PTCA and 77% for CABG (p< .0001), events defmed as death, 
myocardial infarction, or additional RP. Many more additional RP's occurred in 
the PTCA group. Effect of completeness of R: 
Incomplete R CompleteR P Value 
5 Year Survival 
PTCA 92% 93% NS 
CABG 68% 90% .0009 
5 Year Event Free Survival 
PTCA 48% 53% NS 
CABO 70% 78% NS 
Multivariate correlates of death for PTCA were congestive failure and older age 
(p< .05). Multivariate correlates of death for CABO were older age, congestive 
failure, prior myocardial infarction and incomplete R (p < .05). 71% of the 
additional RP's after PTCA were in patients with restenosis, and thus not due 
to incomplete R. CABO and PTCA use different strategies; surgeons bypass all 
lesions possible, PTCA operators dilate the most significant. Incomplete R 
after CABO is primarily related to ungraftable severe distal disease or 
infarction, tbus correlating with high mortality. Intomplete Rafter PTCA is 
more likely a strategic decision to not dilate milder stenosis or unapproachable 
total occlusions, thus not correlating with mortality. Thus, completeness of 
revascularization is of limited value in comparing therapeutic efficacy of the two 
procedures. 
718 Restenosis: Basic Mechanisms 
Monday, March 15, 1993 
2:00 PM-3:30 PM 





Smooth MUlde CeO ProUrentioa II Not the Domillut Cdlular Eveat In 
Relteaotlc Coroaary Atheredolll)' Speclmcn 
Edward O'Brien, Charles Alpers, Marina Ferguson, Doug\al Stewart, Nam 
Trau, Tomoaki Hinohara, John Simpson, Stephen Schwartz. Seattle, 
Washington 
Rcstenosis therapies have been based On the 8IIUIIIpIion that animal models, 
which show smooth muscle cclI proliferation occurring within the lint few days 
post arterial injwy, mimie the elinic:aJ problem. Littlo II kDown about the 
proliferation profile of human n:stcnotic lesiaDl. TIle purpose of tbiJ study is to 
use human coroll&J)" atherectolll)' tissue to determine if ratcnotic lesioDl 
display proliferation kinctics that resemble those of animal models. 
One hundred ratcnotic coroll&J)" athem:tomy tissue specimens were obtained 
from 93 patients, with a mean age +1- SD of 60 +1- 11 yn. 
Immunocytochemi5Uy for the proliferating ceU nuclear antigen (PeNA), a 
protein that shows increased expression in mitotic:aJly active cells, was used to 
gauge the proliferation profile of tissue. Seventy-three percent of specimens had 
no e\idence of proliferation, as reflected by PCNA labeling. This included 19 of 
30 specimeDl obtained within 2 IIIOS of the original coroll&J)" procedure. Those 
specimens that did display PCNA labeling were obtained over a broad 
restenotic time interval (e.g. 24 hn to 1 yr), and showccl only a modest number 
of positive cells per slide (typic:aJly <50 celis/slide). There was no obvious early 
peak in proliferative activity, as one would anticipate from animal studies. 
Those specimens that had PCNA positive cells had adjacent slides double 
labeled for PCNA and a cell-identity specific antibody (e.g. CD-68 for 
macrophages, anti·a-actin for smooth muscle cells, and ULEX for endothelial 
cells). Combining the double label results we found that the overall percentage 
of PCNA positive cells that were macrophages was 25"1 .. smooth muscle cells 
was 650/. and endothelial cells was 15"1 .. 
ConclusioDl: 1) Proliferation in ratcnotie coroll&J)" atberectomy specimens, as 
indicated by PCNA labeling, occun infrequently and at low levels. 2) The 
proliferating cells identified were not only smooth muscle cells, but also 
macrophagea and endothelial cells. These results suggest a divergence of 
information concerning the clinic:aJ and animal experimental lesions, and may 
help explain wby current approaches to ratcnosis therapy have been uniformly 
unsuccessful. 
718·2 2:15 
In Vivo Evidence that Efficiency of Arterial Gene 
Transfer is Related to and Augmented by Proliferative 
Activity of Vascular Wall Following Angioplasty 
Satoshi Takeshita. Dov Gal, Guy Leclerc, Jeffrey M. Isner. Tufts 
University School of Medicine, St. Elizabeth's Hospital, Boston, MA 
Anerial gene transfer post-angioplasty (PTA) represents a potential 
strategy to prevent restenosis. In vivo experiments to date, however, 
have been compromised by low transfection efficiency. Previous 
work in our laOOratory has shown, using an organ culture model in 
vitro, that transfection efficiency is proportional to the proliferative 
activity of vascular smooth muscle cells in the anerial wall. The 
purpose of this study was to investigate this relationship in 
atherosclerotic aneries in vivo. Percutaneous gene transfer was 
attempted in a total of 30 experimentally induced atherosclerotic 
external iliac aneries (EIA) of rabbits with a solution of plasmid 
containing the gene encoding firefly luciferase (pRSVLUC) and 
liposomes (Lipofectin). PTA was perfonned on one EIA of each 
rabbit Zero to 14 days post-PTA, a solution of DNA (10 ).Igltnl) and 
liposome (40 ).Ig/ml) was infused into the 2-cm-Iong portion of 
angioplastied EIA using a double balloon catheter for 30 minutes. 
Contralateral EIA of each rabbit was also transfected with an identical 
amount of DNA and liposome without preceding PTA. Luciferase 
activity (LUC) per transfected segment was measured 3 days 
following transfection. Transfection procedures were successfully 
perfonned in 29 of 30 EIA (96.7%) except one with total occulusion, 
and LUC was detectable in 24 of 29 (82.8%). Mean ratio of LUC 
(angioplastied EWnon-angioplastied EIA) signiflcantly increased 
from l.3±1.2 (day 0) to 14.4±8.0 (day 3-7, p<O.05), and then 
decreased to 3.3±1.9 (day 8-14), consistent with the time course of 
proliferative activity of atherosclerotic rabbit aneries post-PTA. 
Conclusions: 1) These in vivo findings confinn previous in vitro data 
indicating that vascular transfection efficiency is dependent upon 
proliferative activity of target vessel; and 2) suggest that transfection 




In Vivo Transfer of Antisense Cell Cycle Genes Using HV J 
Method Prevents Neointimal Hyperplasia in Balloon· 
Injured Rat Carotid Artery 
Ryuichi Morishita, Gary H. Gibbons, Kristin E. Ellison, Lu 
Zhang, Yasufumi Kaneda, Toshio Ogihara, Victor J. Dzau. 
Cardiovascular Research Center, Stanford University School of 
Medicine, Stanford, CA 
Restenosis after angioplasty involves many potential growth 
factors that promote the development of myointimal 
hyperplasia. Many of these growth factors activate common 
cellular pathways involving proteins that regulate cell cycle 
progression. In this study we tested the hypothesis that 
blockade of cell cycle gene expression utilizing antisense (AS) 
oligonucleotides would prevent myointimal hyperplasia after 
vascular injury. The feasibility of short-term luminal 
administration of AS oligomers was limited by rapid 
degradation. To enhance the efficacy of this strategy, AS 
oligomers were complexed with the viral protein coat of HVJ 
(hemagglutinating virus of Japan) and liposomes (3jLM final 
concentration). AS oligomers directed against cdc2 kinase and 
cyclin A were inculcated within the lumen of the balloon•
injured rat carotid artery for IS min. At 4 days after 
transfection, AS groups showed significantly lower DNA 
synthesis rate (BrdU labeling index) compared to control (C) 
and "sense" (S) oligomer groups (C: 21±3; S: 23±3; AS: 
lOti %). In addition, total vessel DNA content was lower in the 
AS than control groups (p<O.05). Preliminary data documents 
significant prevention of neointimal formation at 2 weeks after 
transfection compared to controls. 
Conclusion: In vivo transfer of AS cdc2 kinase and cyclin A 
reduced cell proliferation and neointima formation after balloon 
injury. This study demonstrates the feasibility of short-term 
luminal delivery of AS oligomers to prevent restenosis after 
angioplasty. 
718·4 2:45 
Successful Vascular Gene .Transfer Using a Hydrogel•
Coated Balloon Angioplasty Catheter 
Reimer Riessen. Hootan Rahimizadeh, Satoshi Takeshita, Dov Gal, 
James Barry, Jeffrey M. Isner. Tufts University School of 
Medicine, St. Elizabeth's Hospital, Boston, MA. 
Vascular gene transfer (VGT) has been previously performed with 
double-balloon (B) catheters, perforated Bs, and stents.We 
investigated whether VGT might be simplified by direct delivery of 
naked genetic material (neither liposomal nor retroviral delivery) 
from a standard, single-B catheter coated with hydrogel (H). 
Feasibility was tested in 3 stages using plasmid (pRSVLUC) 
endcoding for the luciferase (LUC) reporter gene applied to the H•
coating on angioplasty B surface. Stage 1 involved 5 experiments 
using scintillation counting to document that 35S-labeled LUC DNA 
(mtSEM=45±2mg) could be successfully applied to and maintained 
on the H-coated B. Stage 2 tested transfection efficiency in an 
organ culture model. LUC/H-coated B catheters were inserted into 
both rabbit carotid arteries and inflated to 8 atm for 30 or 5 min. 
Arteries were then immediately excised, incubated in organ culture 
for 3 days, and then assayed for LUC activity (in Turner light units 
(TLUj). Gene expression achieved with 5-min inflations (n=5, 
tissue wt=40±2mg, LUC=368±121 TLU) was not statistically 
different from that observed in arteries following 30-min inflations 
(n=5, tissue=44±4mg, LUC=154±60), (p=ns). In Stage 3, 
LUC/H-coated B catheters were tested in vivo. B inflation (8 atm) 
was performed in right carotid artery for 5 or I min, following 
which arteries were repaired. Three days later, transfected arteries 
were harvested and assayed for gene expression. In arteries inflated 
for 5 min (n=7, tissue=46±2mg) LUC=368±121 TLU; for I-min 
inflation (n=7,tissue=45±3mg), LUC=68±17 TLU (p=ns). 
Conclusions: 1. VGT can be performed successfully without 
liposomes or retroviral vectors using DNA applied to standard 
angioplasty B coated with H. 2. LUC activity was detected in all 
(24/24; 100%) transfected arteries. 3.Gene expression achieved in 
vivo was quantitatively similar to that achieved under optimized 
conditions in organ culture. 
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Time Course of Transforming Growth Factor-~ 1 
Expression in Human Arterial Restenosis 
Si~rid Nikol. Lawrence Weir, Marianne Kearney, Barry Sharaf, 
Christopher J. White, Gerald Zemel, Geoffrey Hartzler, Richard 
Stack, Guy Leclerc, Jeffrey M. Isner. Tufts University School of 
Medicine, Sl Elizabeth's Hospital, Boston, MA 
Transforming growth factor-beta-I (TGF-SI) is a multifunctional 
cytokine; there is abundant evidence that TGF-SI is the principal 
growth factor regulating proteoglycan synthesis in human blood 
vessels. Recent work has demonstrated that TGF-SI expression is 
significantly increased in human vascular restenosis lesions 
compared to primary lesions and non-atherosclerotic arteries. To 
further study the potential contribution of TGF-SI to restenosis, we 
sought to determine the time course of expression post-angioplasty 
of the TGF-SI gene. In situ hybridization was performed on tissue 
specimens obtained by directional atherectomy (DA) from 62 pts 
who had previously undergone angioplasty of native coronary (CA) 
or peripheral arteries and/or CA bypass grafts (CABG). TGF-SI 
gene expression was assessed by measurement of peri-nuclear silver 
grains, adjusted for background expression. The time interval 
between angioplasty and DA was I hr to 25 mo (m±SEM=5±4 mo) 
for all 62 pts, 5±4 mo for CA specimens, 8±5 mo for CABG 
specimens, and 7±3 months for peripheral arterial specimens. TOF•
SI mRNA expression remained persistently increased independent 
of the site from or time interval following which the specimen was 
obtained. For CABG specimens, TGF-SI expression was highest 
in specimens retreived from pts with multiple versus single episodes 
of restenosis (l6±5 vS.· 6±5 grains/nucleus, p<O.OI). TGF-SI 
expression did not correlate with pt age, sex, or known risk factors 
for CA disease. 
Conclusions: Persistently augmented expression of TGF-SI 
observed in present series of restenosis lesions supports the concept 
that TGF-SI influences non-cellular expansion of restenosis plaque 
due to continued production of extracellular matrix. Accordingly, 
TGF-SI may represent a suitable target at which to direct efforts to 
inhibit vascular restenosis. 
718-6 3:15 
Sequential Biopsy of Human Atheromata In Vivo: 
Longitudinal Analysis of Atheromatous Coronary 
Arterial Wall in 11 Patients Treated for Primary and 
Restenosis Lesions by Directional Atherectomy 
Jeffrey M Isner Marianne Kearney, Scott Bortman, J. Geoffrey 
Pickering, Reimer Riessen, Eric J. Topol for the CAVEAT 
Investigators, Sl Elizabeth's Hospital, Boston, MA. 
Pathologic analysis of human atheromata has until recently been 
limited to necropsy study of pts with fatal coronary artery disease 
(CAD). The advent of directional atherectomy (DA) permitted for the 
first time in vivo biopsy of a less selected pt population. To 
investigate whether pathologic observations collected by DA from 
pooled pt groups were reproduced in biopsies obtained from 
individual pts studied longitudinally, specimens from II pts 
undergoing DA for both primary (PRI) and restenosis (RE) CAD at 
the identical site were analyzed by light microscopy (LM), 
immunohistochemistry (IHC), and/or in situ hybridization (ISH). 
Interval from PRI to RE was 2-7 mo (m=4.7). PRI and RE 
specimens were distinguished principally on basis of cellularity (C): 
PRI were hypoC, while RE were hyperC in 10/11 pts; in I pt, both 
were hyperC. Neither PRI nor RE contained foam cells or 
cholesterol clefts in any of II pts. Thrombus was present in 3 PRI, 
and I RE, but never in both PRI and RE of same pI. Calcific 
deposits were seen in 2 PRI and 3 RE but never in both PRI and RE 
of same pl IHC consistently disclosed increased ratio of smooth 
muscle cells/macrophages in RE vs PRI. ISH disclosed that gene 
expression previously deduced from pooled pt groups was 
reproduced in pts studied longitudinally: human non-muscle myosin 
B (HNMM-B), transforming growth factor-~ I (TGF-~ I), and 
proliferating cell nuclear antigen (PCNA) showed augmented 
expression from PRI to RE. Conclusions: these findings I) establish 
evolution of histopathologic changes in individual pts studied 
sequentially in vivo, and 2) document longitudinally augmented 
gene expression of HNMM-B, TGF-~l, and PCNA in RE vs. PRI 
lesions of individually studied pts. 
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719·1 2:00 
Intracardlac Ultrasound and Dobutamlne Can Identify 
Stunned Myocardium In a Canine Model 
Charles R. McKay, Kirk Spencer, Peter Hanson, Steven 
DeJong, Robin Smith, Richard E. Kerber, University of Iowa, 
Iowa City, IA 
We have shown that intracardiac ultrasound (ICUS), a new 
imaging modality (10F, 10 mHz catheter in the left ventricle, LV) 
accurately determines myocardial risk areas. Our goal is now 
to demonstrate that in stunned myocardium wall motion 
abnormalities which are reversible using dobutamine (DOB) 
can be identified by ICUS. We compared the percent LV cross 
sectional area with ischemic wall motion abnormality (%WMA) 
by ICUS and transthoracic echo {lTE}. We documented 
changes in myocardial blood flow by radiolabeled 
microspheres (MBF, mljl00 gm/min). We studied 4 closed 
chest dogs at baseline (BASE), after 15 min of occlusion 
(CCC), during OCC with dobutamine (DOB, 5-10 meg/kg/min), 
after 30 min reperfusion (REP), and during REP+ DOB. 
.lIME ~ 
TIE %WMA 0 27+9* 
ICUS %WMA 0 40+5* 
MBF 157+87 41+16* 
RPP(X1000) 13+4 11 +4 
*=p<O.05 vs BASE by ANOVA 
OCC+ REP+ 
.QQB REP.QQJ 
19+9* 17+3* 5+6 
28+14* 32+16* 9+6 
36+15* 97+25 182+88 
17+4* 13+4 18+4* 
Mean %WMA by TIE and ICUS were similar at each time. DOB 
did not change %WMA during OCC, but decreased %WMA 
during REP. Thus, if MBF is near normal, the combination of 
ICUS and DOB can accurately identify the improved contraction 
of stunned myocardium. This combination warrants study 
during cardiac catheterization. 
719·2 2:15 
Differences In Spectral velocity and Volumetric Flow In 
Proximal and Distal Normal Human Coronary Arteries 
Elizabeth O. Ofill, Morton J. Kem, Jeanette A. St. Vrain, Bassam AI•
Joundl. Ramon Castello. Arthur J. Labovitz. Saint Louis University 
Medical Center. St. louis. Missourl. 
In order to evaluate the normal physiology of proximal and distal 
coronary arteries. we performed How velocity measurements with a 
12MHz Doppler-tipped angioplasty guidewire in 39 pts with 50 
angiographlcally normal arteries: LAD=23. Cire: 16. RCA= 11. 
Spectral Doppler velocity data were obtained in each proximal 
and distal coronary artery at baSeline (base) and following maximal 
hyperemia (HY) with 12ILg Intracoronary adenosine; velocity 
spectrum was digitized to compute flow velocity integral (FVI). 
Vessel diameter (D) was determined by quantitative angiography at 
the proximal and distal sites of flow velocity measurement. Cross 
sectional area (CSA) .. 1t(D/2)2. Coronary blood flow (CBF)= 
CSAxFVIxHR. Coronary vasodilator reserve (CVR)=HY/Base CBF 
RESULTS (mean ±SEl 'psO 0001 
Diameter FVI(cm) CBF(mlslmin) 
Lmm). ~ I:f:t aase. I:f:t 
Proximal 3.S±O.2* 2O±1.8 43 ±2.5 165±27* 407±94' 
Di!:tai 23±01 16±14 32±28 58±10 105±13 
Proximal and distal CVR were 2.6±O.1 and 2.3±O.9 respectively 
(p _ NS). CBF (proximal and distal) was not different in LAD. eirc. 
and RCA. 
Similarity of flow velocity in proximal and distal arteries despite 
higher proximal Hows is compatible with the branching model of 
coronary circulation where cross-sectional area and velocity are 
preserved through branching in the epicardial coronary arteries. 
This disparity between absolute blood How and flow velocity in 
proximal and distal coronary arteries must be considered in 
coronary Interventional studies. 
ABSTRACTS 75A 
719·3 2:30 
Non'Doppler, Angle Independent Color Flow Imaging From 
Intra-Vascular Ultrasound Images 
Joseph Kisslo. Sylvia Hubbard. Katherine B. Kisslo. Gregg E. 
Trahey. Duke University Medical Center, Durham. NC 
On the hypothesis that flow could be detected within an 
intravascular (IVUS) image (1M) a computer based system 
was developed. The system. currently configured. is based 
upon intravascular 1M previously collected from a Hewlett 
Packard Sonos 100 lVUS imaging device (at ~30 frames/sec) 
using 20 or 30 MHz catheters. 
During collection of 1M on videotape gains are increased 
slightly and gray scale maximized. Recorded images are then 
digitized (60 frames) by a frame grabber interfaced to a VAX. 
11/780 computer. A rectangular region of interest (ROI) is 
then operator selected measuring roughly 24mm in area 
Within the ROI a second smaller area is identified called a 
kernel. Kernel size is determined by the carrier frequency 
(1 wave length axially; 3 wave lengths in azimuth) and the 
speckle pattern is mapped within the kernel. Simply 
explained. the system then correlates the speckle pattern 
with patterns in the successive frame for "best fit". The 
one that correlates best indicates the direction and 
magnitude of motion (a vector describing velocity). After a 
velocity vector is determined. a color is assigned to the 
kernel and displayed within the ROI. This process is 
ongoing for many kernels in successive frames and results in 
a ROI filled with colors in a two'dimensional display of 
flow where direction is a different color and velocity is a 
different brightness (the palate is a two-dimensional color 
wheel where zero flow. the center. is the absence of 
color). Accordingly. flow determined by this system is 
unlike Doppler methods and is angle independent . 
These data indicate that the tools are available from 
lVUS 1M to add potentially useful descriptors to plaque 
morphology and size within diseased vessels. 
719·4 2:45 
au..,titation of Mitral Regurgitation using a Digital Color Doppler 
"Centerline" Flow Convergence Method: Validation in an Animal Model 
With Prolapse Type Mitral Regurgitation 
Takahiro Shiota, Izumi Yamada, Dag Teien, Michael Jones, Robin 
Shandas, David J. Sahn. Oregon Health Sciences Univ, Portland, OR 
Recently it has been suggested that flow volume through regurgitant 
orifices can be estimated by methods based on the axial "center-line" flow 
convergence IFC, velocitY acceleration proximal to the regurgitant orifice 
with accuracy independent of orifice size. The aim of this study was to 
validate the centerline FC method for mitral regurgitation IMR, caused by 
a flail mitral leaflet. Chronic MR due to a prolapsed valve was created 
surgically in 6 sheep and 3 to 5 stable hemodynamic states were obtained 
pharmacologically in each animal 124 hemodynamic states,. Maximal 20 
color Doppler lCD, FC area and CD MQ-mode images through the center 
of FC region were obtained with a Vingmed 750 scanner with velocities 
transferred into a microcomputer in digital format. The acceleration field 
was described by velocitY thresholds lx, m/sec' plotted against distance 
from the MR orifice Iy. cm) which had highly significant correlations using 
exponential function curves Iy 2 aell)",r z 0.93-0.99). True MR volume 
IMRV) was measured using mitral and aortic electromagnetic flow-
meters balanced against each other. '.0 
Severe MR resulted in rightward and 
upwardly shifted velocitY/distance 
curves and for the selected velocity 
ranges from 30 to 50 cm/sec. a clear ~ 
separation without any overlap was ~ '.0 
obtained between mild Iregurgitant a 
fraction < 20%), moderate 120-40%)! 
and severe MR I> 40%). This digital 
'-" y.l .• ·'OAI·O'· .. ' .-.. lit ..... 
!II. 0." 
FC centerline method based on 1'::.1.J~::::~~~~= 
multiple velocity-distance thresholds 0.' 
is applicable to even complex FC o. 0 
geometries such as those associated 





Qua.tltatl01 of Mitral Regurgltatl01 by Doppler 
Alplltude Weighted Mea. Velocity 
3:00 
Maurice E. Sarano, Alan M. Kaneshige, James B. Seward, 
A. Jamil Tajik. Mayo Clinic, Rochester, Minnesota. 
Doppler amplitude weighted mean velocity (AWMV) software 
remains a prototype, and its clinical usefulness has not 
been established. AWMV is proportional to the volume 
flow through non-stenotic valves and allows calculation 
of mitral regurgitant fraction (RF) as RF • (AWMV mitral 
- AWMV aortic)/AWMV mitral. In 60 patients (64 + 12 
years), 10 without regurgitation and 50 with pure, 
isolated mitral regurgitation, quantitation of mitral 
regurgitation was performed simultaneously using AWMV, 
quantitative Doppler (QDopp) and quantitative two•
dimensional Doppler echocardiography (Q2DE) using left 
ventricular volumes. In 16 patients, at least two 
Doppler gain levels were recorded for AWMV. With 
increasing gain, AWMV mitral integral increased (14.4 + 
3.9 vs. 10 + 4.2 P<O.OOOI) as well as aortic integral -
(10.1 ~ 2.B-vs. 6.7 ~ 2.5 P<O.OOOI), but RF remained 
u~changed (27 ~ 20 vs. 28 ~ 23S NS). In patients 
wlthout regurgltation, absolute value of RF was 9 + 8S 
for AWMV, 4 + 2S for QDopp, 4 + 3S for Q2DE. In -
patients with mitral regurgitation, there were good 
overall correlations for RF between AWMV and QDopp or 
Q2DE (R • 0.78, R • 0.76, respectively, P<O.OOOI). 
However, there was scattering of individual points and 
SEE was large (12S). 
We conclude that 1) AWMV integrals on each valve are 
gain dependent, but, for the same aortic and mitral 
gain settings, RF is not gain dependent; 2) calculated 
RF shows acceptable correlations between AWMV and QDopp 
or Q2DE; 3) although not providing the regurgitant 
volume, AWMV can be combined with QDopp or Q2DE to 
assess the severity of mitral regurgitation. 
719·6 3:15 
Measurement of Blood Flow Velocity 15 Feasible with 
Intravascular Ultrasound 
Mario Basic, Carolyn Kimme-Smith, Ersin Yigiter, 
Robert J. Siegel, UCLA School of Medicine, Cedars 
Sinal Medical Center, Los Angeles, CA 
Stagnant or slow moving blood cannot be reliably 
differentiated visually from thrombi with 
intravascular ultrasound (IVUS). Since this 
differentiation is diagnostically important, it was 
the purpose of our study to assess if tissue 
characterization parameters independent of backscatter 
amplitude could be used to intravascularly quantify 
blood velocity. Three sets of 64 A-lines of RF 
backscattered IVUS data were collected for a series of 
velocities and temperatures from canine blood pumped 
through human carotid arteries. Each A-1 ine was 
generated by a 20 MHz IVUS unit and digitized into 
1024 points at 100 MHz. Calibrated velocities varied 
from 0 to 25 cm/sec. Viscosity w~s altered by varying 
blood temperature from 15 to 370C. Two parameters 
were found useful to quantify blood velocity: JJ/,. of 
envelope detected ampli tudes and the full-width at 
tenth maximum (FWTH) of the frequency spectrum. We 
found that the FWTH increased with increasing velocity 
(r-.787,P<.OOI), while ~,vdecreased (r--.607, P<.OI). 
Velocity changes due to sampling position in the 
vessel and due to vi scos ity with temperature change 
were consistently reflected in FWTH and JJ/~ values. 
Conclusions: 1) Blood velocity can be reI lably 
estimated with intravascular B-mode ultrasound using 
digitized RF data and amplitude independent tissue 
characteri zat i on parameters and 2) These fi ndings 
indicate simultaneous intravascular ultrasound imaging 
and assessment of blood flow velocity is feaSible 
using a single catheter system. 
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863·62 
Pathological Background of Percutaneous Transluminal 
Coronary ADgioplasty for Chronic Total Coronary OCclusion 
Masayuki Katsuragawa, Hisayoshi Fujiwara, Masami Kiyamae, 
Shigetake Sasay .... Kyoto University, Kyoto, Japan 
The purpose of the study is to examine the histological•
angiographic correlation of chronic total coronary 
occlusion (CTOO) and to find the favorable angiographic 
feature and underlying histology of CTOO for percutaneous 
transluminal coronary angioplalty (PTCA). Ten autopsy 
hearts which showed CTOO on coronary angiography 
performed within 3 months before death were selected. The 
estimated duration of occlusion were all more than one 
year. At autopsy, postmortem-angiography was done and 
each heart was fixed with lOX formalin. OCcluded arteries 
were sectioned transversely and serially into slices of 
lOpa thickness. Ivery 5 slices were Itained in elastic 
van-Gieson and examined on a light microscope. Ten CTOOs 
were angiographically classified into tapering type (n=5) 
and abrupt type (n=5), or short occluded legment (il.5cm; 
n=7) and long occluded segment (>1.5cm; n=3). 
Histological examination of the serial sections showed 
that; 4 cases of tapering type with short occluded 
segment had small lumen recanalization (160-230pm in 
diameter) with surrounding loose fibrous tissue 
penetrating the occluded segment. Three cases of abrupt 
type with short occluded segment had no lumen 
recanalization, but loose fibrous tissue penetrated the 
occluded segment. In cases with long occluded segment (1 
of tapering and 2 of abrupt types) there was no 
recanalization, and loose fibrous tissue were dispersed 
in the occluded segment. 
Conclusion: CTOO of tapering type and/or with short 
occluded segment is favorable for PTCA, because small 
lumen recanalization and/or loose fibrous tissue 
penetrated the occluded segment and aight form a route 
for successful PTCA. 
863·63 
Coroaary AngIopIuty f1l Cbronk Total 0c:dusI0a: De ........... f1l 
Procedural S~ 
Kim H. Tan, Alfred N. Sulke, Nick A Taub, Elizabetb Watts and Edgar 
Sowton. Guy's Hospital, London. United Kingdom 
PTCA of chronic total occlusions is associated with relatively low success 
Tates. Oinical and angiographic determinants of procedural success were 
evaluated in 312 patients (mean age 55 years, range 31-79. 86% male) wbo 
underwent a first PTCA of chronic total occlusion (TIM! grade 0 or 1 
antegrade flow) between 1981 and 1992. Patients baving had a myocardial 
infarction within two weeks of PTCA were excluded. The median duration 
of occlusion was six months (range up to 156 months). Angiographic 
success was achieved in 61.2% with improved recent success rates (70% 
since 1990). Oinical success occurred in 60.9%. A major complication 
occurred in six patients (1.9%) with one death (0.3%) and five emergency 
CABG (1.6%). Complications were more common in patients with failed 
PTCA (p=O.03). Analysis of 27 clinical and angiographic variables showed 
that procedural success was significantly associated with angiograpbic 
variables and duration of occlusion. Procedural success rates were lower in 
patients with multivessel disease than those with Single vessel disease 
(53% versus (vs) 75%, p<O.OOl), in lesions occluded for >3 months than 
those s3 months (59% vs 74%, p<0.02). in vessels <3mm than those ;t 
3mm (48% vs 73%. p<0.OO(1), in occlusions without a tapered 
morpbology (43% vs 69%, p<0.OO1). in lesions with side branches (53% 
vs 69%. p<0.02). and in lesions with bridging collaterals (20% vs 70%. 
p<0.OO(1). Multivariate logistic regression analysis identified duration of 
occlusion (p=O.OO1). vessel diameter (p=O.OO3). presence of tapered 
morphology (p<0.OO1). and bridging collatera1s (p<0.OO1) as independent 
predictors of procedural success. A prediction model for success was 
formulated which bad a sensitivity of 80% and specificity of 71% 
(Jacknife estimates). Conclusion: Procedural success of PTCA of chronic 
total occlusions can be predicted from easily identifiable angiograpbic 
variables and alloWli beller patient selection. 
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863-64 
Beta Blockers With Direct Infarct ADgioplasty: 
Liability or U .. fu1 Adjunct? 
Khaldoun Sayed-Taha, Raffi Jrikorian, Dennis R. 
Breanahan, Robert W. Ligon, Timothy M. Bateman, 
Geoffrey O. Hartzler, James O'Keefe 
Mid America Heart Institute, Kansas City, MO 
B-blocker therapy (BB) has been shown to improve early 
outcome in acute MI when used as an adjunct to both 
conservative management and thrombolytic therapy. 
However, BB has been avoided in pt. undergoing direct 
infarct angioplaety due to theoretical concerns. We 
analyzed the effect. of BB or calcium antagonists (CA) 
in 169 consecutive pts who underwent infarct 
angioplasty without thrombolytic therapy in 1990-1991. 
All pte were routinely treated with aspirin and 
heparin. BB was utilized in 75 (44') pts, a CA was 
used in 82 (49\) pts. The BB and CA groups did not 
differ from .ach other or untreated pts with respect 
to age, sex, infarct location, or baseline LV 
function. 
BB !n-7S l 110 BB !n-94l p Value 
Desth 3 (4.0\) 10 (10.6\) .06 
Heart failure 4 (5.3\) 17 (18.1\) .017 
Serious dyarhythmias 7 (9.3\) 14 (14.9\) .39 
Total events 11 (14.1\) 28 (29.8\) .026 
Multivariate correlatea of in-hospital events 'included 
poor LV function (pc.OOl) and no BB (p=.02). Infarct 
artery reocclusion rates were similar in pts on BB 
(22\) and not on BB (17\,p=NS). In-hospital death 
(6.1\ vs 6.2\) and total events (22\ vs 23\) were 
similar in pts on and not on CA. 
CONCLUSIONS, BB therapy as an adjunct to direct 
infarct angioplasty reduced the incidence of serious 
early cardiac events. In contrast, CA appeared to 
have a neutral effect. 
863-65 
Platelet Activation During Coronary Interventions Detected by 
Measurement of Platelet-Derived Microparticles and 
Glycoprotein lib/ilia Expression on Platelets in Coronary 
Sinus Blood 
David A Tate, Arthur P. Bode, Darla liles, Timothy C. Nichols, 
Maureane Hoffman, Dougald Monroe, Gregory J. Dehmer, 
University of North Carolina at Chapel Hill and East Carolina 
University, Greenville, NC 
Detection of GP lIb/lia on the platelet surface and formation 
of platelet-derived membrane microparticIes (P-DMPs) may be 
independent indicators of platelet activation. Using flow 
cytometry, we assessed the number of P-DMPs (with rabbit 
antiserum specific for human platelet membranes) and the % of 
platelets binding fibrinogen (as a measure of acttvated lIb/lia 
expression) in coronary sinus blood from 8 patients who had 
successful coronary interventions. In separate control studies, 
neither the % of platelets binding fibrinogen (3.3± 1.6% vs. 3.9 
± 3.3%, p=0.6) nor P-DMPs (8.6± 12.4 x 106/ml vs. 6.3± 9.S x 
106/ml, p=0.14) were different in femoral vem blood from a 7 
ern sheath or the 110 ern sampling catheter, respectively. Also, 
comparing coronary sinus samples before and after coronary 
angiograpby, there was no change in P-DMPs (7.8± 12.2 x 
106/ml vs. 8.2±9.8 x 106/ml,'p=0.81) and a decrease in the % of 
platelets binding fibrinogen (5.8± 3.2 vs. 3.8± 2.9 p = O.OS). Thus, 
sampling via a long catheter and angiograJ>hy alone did not 
appear to activate platelets. In comparison, P-DMPs increased 
within 10 minutes after coronary interventions in 6 of 8 patients 
(23.0± 17.9 x 106/ml vs. 4S.0±28.7 x 106/ml, p=O.04) with the 
greatest increase (4-fold) seen after atherectomy. The % of 
platelets binding fibrinogen after coronary intervention also 
mcreased, but to a smaller degree. We conclude that variable 
degrees of platelet activation, measured by fibrinogen binding 
and platelet-derived microparticle production, are detected after 
coronary interventions. These findings may be related to the 
amount of endothelial trauma and plaque disruption produced 
by the techniques. 
ABSTRACfS 
863·66 
Myocardial Protection During Coronary Angioplasty with 
the Intracoronary Inrusion or a New Oxygenating 
Pernuorochemical 
Malcolm R. Bell, Robert D. Simari, Stuart T. Higano, Roben S. 
Schwartz, Steven J. Winter, Tom H. Goodin, Robert J. Kaufman, 
David R. Holmes Jr. Mayo Clinic, Rochester, MN. 
The myocardial protective effect of Angiosol, a new 
pertluorochemical with high oxygen carrying capacity, was studied in 
a closed chest canine model of acute ischemia. Thirteen anesthetized 
dogs (mean weight 24 kg) were randomly assigned to connul, 
intracoronary infusion (S4 ml/min) of oxygenated Angiosol (AO) and 
unoxygenated Angiosol (AU) during 3 sequential 90 sec balloon 
inflations in the left anterior descending coronary anery. Left 
ventricular peak (L VP), left ventricular end diastolic (L VEDP) and 
mean aortic (MAP) pressures were recorded with micromanometer-tip 
catheters at baseline and during balloon inflation (30, 60 and 90 sec). 
Left ventricular ejection fraction (EF) was obtained by angiography at 
baseline and during inflation at 90 sec. Lactate extraction (LEx) was 
determined from aortic and coronary sinus sampling prior to and 
following connul and AO inflations. Results (mean±SE): 
Baseline Inflation 
Connul N) AU Connul AD 
LVP Il0±5 1l0±5 113±3 101±3 I68±4* 
MAP 91±4 90±5 94±4 83±3 87±4 
LVEDP, 10±1 9±1 10±1 13±1 10±1* 
EF, % SI±4 Sl±3 S2±4 40±3 54±3* 






Pressures, mmHg. *P<O.OI for AO vs connul and AU (ANOVA) 
(Inflation pressure data represent mean of 30, 60 and 90 sec data) 
Conclusion: Intracoronary perfusion of AO preserves systolic 
ventricular function during coronary balloon inflations in this 
experimental model. There was no change in lactate extraction 
suggesting that ischemia may only be alleviated, not abolished. 
863-67 
Follow-up Exerel.. Function In PatIents Presenting WIth 
Cardlogenlc Shock and Acute Transmural Myocardial Infarction. 
Phillip L Laney, Louis J. Dell'ltaIia, S. Roland Brooks, R. Ronnie 
Harrell, James A. Sawyer, William P. Hood, Christopher E. Byard, 
Michael E. Pinson. The University of Alabama at Birmingham, 
Birmingham, Alabama and Flowers Hospital, Dothan, Alabama. 
We have previously . reported our experience using emergent 
percutaneous transluminal coronary angioplasty (PTCA) as primary 
treatment in patients presenting with acute transmural myocardial 
infarction (AMI). In this group of 303 consecutive patients, 52 
presented with cardiogenic shock defined as a systolic blood 
pressure <90 mmHg (mean .. 72 mmHg) after therapy with fluids, 
inotropic agents, or intraaortic balloon counterpulsation (n=34). 
There were 29 males and 23 females with a mean age of 63 years 
(range 33-82 years). Twenty-one patients had anterior and 31 
patients had inferior Ml's (mean peak CPK=4134). Emergent PTCA 
was successful in 49 patients with a mean time to vessel patency of 
4.1 hours. There were 10 in·hospital deaths (3 with unsuccessful 
PTCA) and 7 daaths in subsequent follow·up of 1-6 years. In the 
remaining 35 patients we performed semi-erect bicycle stress tests 
with simultaneous RVand LV radionuclide ventriculography and gas 
exchange analysis. Fifteen patients were not enrolled in the exercise 
study due to physical limitations (n=6). patient refusal (n=6), or 
Inability to be contacted (n=3). Mean resting LVEF (51±10%) and 
RVEF (48± 15%) changed to 48± 12% and 50± 10% during exercise. 
respectively. The mean exercise time was 450± 192 seconds and 
the mean maximal oxygen consumption was 583±161 ml 
Oo/min/m" (64±14% predicted). 
Conclusion: Emergency PTCA of patients presenting with AMI and 
cardiogenic shock results in low in-hospital mortality. In addition, 





Proc:edaral Cost aDd Be.diu of New IDterve.tlo.al Devices 
Charles L. Nino, Malt Freed, Lisa B1ankcnship, Cindy L. Grilles, William W. 
O'Neill. Robert D. Safian. William Beaumont Hospital, Royal Oak, MI. 
InfIX1ll8lion regarding benefits and costs of new intenentioDal devices will be 
required to define their role in percutaneous revascu1arizalion. Procedural cost daIa 
wen: assembled from consecutive patients submiued for single-vessel 
revascularizalion using high-speed mechanical rotational 8Iherectomy with the 
RotablalOr (ROTA, n=32), extraetion 8Iherectomy (TEC, n=25), excimer \aser 
angioplauy (ELCA. 0=26), and cooveotiona1 PTCA (0=103). Adjunctive PTCA 
was used in 84-96% of patients to further enlarge the lumen or to treat device•
related complications. The number of guiding catheters, guidewires. bum, cutters, 
\aser probes, and balloons wen: used b determinalion of equipment costs, based 
on manufacturer prices in 1992. 
Equipment PTCA ROTA TEe ELCA 
lIGuidecathelers 1.5 ± 0.9 2.1 ±1.6 2.2 ± 1.7 1.5 ± 0.7 
lIGuidwires 1.6 ± 1.6 2.3 ± I.S 2.7 ± 1.7 1.1 ± 0.4 
.PTCA balloons 1.4 ± 0.8 1.7 ± 0.8 1.3 + 0.6 2.1 ± 1.4 
llbumlcuuerslprobes 0 1.3 ± 0.5 1.2 ± 0.4 1.0 ± 0.2 
% PTCA used 100 84 96 92 
Cost ($) * 1350 ± 647 2577 ± 1302 2257 ± 844 2314 ± 745 
%Incremental cost @ 0 91 67 71 
*p<O.OOI compared to PTCA; @ Inaemental cost relative to PTCA 
In considering the efficacy of these devices compared to PTCA. we calculaled the 
ratio of the minima1lumen diameter to the diameter of the device (Mi.DID) as a 
measure of the relative lumen enlargement corrected for device size, the ratio of the 
diameter of the device to the diameter of the nonna1 reference segment (DI A), and 
the minimal1umen diameter nonna1ized for the rutal diameter of the balloon used 
(MLD/B): 
PTCA ROTA TEC ELCA 
MLD/D 0.71 ± 0.11 0.92 ± 0.16 * 0.73 ± 0.24 0.85 ±0.3O A 
DlA 1.05 ± 0.13 0.59 ± 0.17 * 0.63 ± 0.14 * 0.51 ± 0.11 • 
MLDIB 0.71 ± 0.11 0.86 ± 0.16· 0.69 ± 0.18 0.69 ± 0.20 
"p<O.05 compared to PTCA; *p<O.OOI compared to PTCA 
~: 1) Despite the inaemental costs and small diameters (low DlA) of 
ROTA and ELCA, the relative lumen enlargement after the device (Ml.DID) and 
after adjwx:tive PTCA (Mi.D/B) is greater than that for TEe or PTCA; and 2) 
Fwther acute and long-term studies of devices plus PTCA versus PTCA a10ne are 
needed to assess the safety, elflC8C}', and cost of new devices. 
863·69 
How Do You Back-up Multiple SimUltaDtoUS PTCA Procedures? 
James J. Ferguson, Ami1car Avendano, Barbara Reece, David Helfer, William 
Vaughn. St. Luke's Episcopal Hospital, Texas Heart Institute, Baylor CoDege 
of Medicine, Houston, TX 
At busy interventional centers, it can be difficult to coordinate surgical 
backup for multiple simultaneous PTCA procedures. We sought to determine 
the actual risk of two simultaneous cases requiring surgery, and to try and 
identify a group in whom multiple simultaneous PTCA procedures can be 
performed at low risk. We prospectively applied the AHA/ ACC A/B/C lesion 
classification system and an empiric low /mediumfhigh risk classification system 
(based OD patients' overaU clinical picture) to 1013 PTCA procedures over a 
Dine-mol!th period; 23 of these patieDts (2.3%) went directly from the 
catheterizatioD laboratory for emergency CABG. The incidence of emergency 
CABG by groups is shown below: 
I otal 
A 1/151 1/60 2/')33 
B 1/109 11/423 14/580 
4 7 7200 
4/303 15/559 23/1013 
We divided patients into low·risk (A + low B: 3/342-0.9%) and non·low risk 
(medfbigh B + C: ']fJ/671. 3.0%), and calculated, by group, the risk of 2 cases 
requiring OR backup at the same time as a function of the number of 
simultaneous PTCA procedures performed. 
IDcideDce or EmergeDC)' CABG (Rate per 1000 Patients) 
# simultaneous 
procedures Low Risk Non·low Risk Total 
2 0.05 0.84 0.49 
3 0.15 2.54 1.48 
4 031 5.09 2.% 
Conclusions: It is possible to identify a low·risk group of patients in whom 
multiple simultaneous procedures can be performed with a negligible risk of two 
cases requiring surgery at the same time. Single surgical backup for multiple 
simultaneous Don-low risk cases is associated with some degree of risk; some 
form of risk assessment should be incorporated into institutional algorithms for 
allocating surgical back-up in the setting of multiple simultaneous PTCA 
procedures. 
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864·70 
~ority of IJltraVa8aular Olt:naD1m4 onr ~ 
for tba Bvaluaticm of Blastic R8coil of l'ILlJIiaz-8cba 
8teIlts 
steven R. Bailey, stEplen Paige, John F. Hennecken 
university of Texas HSC, San J\Iltari.o, Texas 
Elastic recoil reR) of endcNascul.ar stents has been 
reported usi.n;J arqiography after oorcnu:y stent plaoement. 
Usi.n;J CXJIDined ;mp.ography (arqio) and :intravasc:ular 
ultrasaJrrj (lVUS), we prospectively evaluated the lIIIIOOnt 
of ER in a stmy utilizi.n;J Palmaz-sdlatz stents iDplante:i 
in the iliac arteries of oormal. flemish giant raI:tlits. 
19 stents were iDplantEd into the iliac arteries of 10 
raI:tli ts usi.n;J a 3. 0 ~ ballOCl"l :intravasc:ular ul traso.Jrrj 
i:maqi.n;J system (IV!.5). Argio and lVUS were perfonoed prior 
to and :inmediately after stent placement. Followup arqio 
and lVUS were also perfonoed at 4 halrs (N=ll) and 72 
halrs (N=8) for evaluatiCll of stent diameter. After 
sacrifice, each stent was reuDIIed fran the artety and 
stent diameter was measured usiIg a micraoeter (}fttlSD). 
'lhese measurements irrlicate that the diameter differeooe 
between actual and arqio J:an3ed fran 0 ~ up to • 6 ~. 
2.6:t05 2.&1Q.\ 2.&1Q.\ 
4Hr 2710.\ 2.&1Q.\ 2.&1Q.\ 
72Hr 2.6:tO.\ 29iO.I 2.&1Q.\ 
We oc:n::ll.De: 1) No elastic recoil of stents was 
observed when lVUS was <XIIpU'ed to actual measure:i 
diameters in this animal m:x:Iel.. 2) Argiograplic ass s.,elJt 
un:ierestiJDated stent diameter and may lead to an 
~iate diagmsis of stent recoil. 
864·71 
A COIDparlsoll of tile AIlgiolcopil: Coroury Surface MorpllololJ FoIIowiDg 
DirKtioDaJ AtIIerectomy witII BaIIooD AIIJiop1asty. 
Stephen R. Ramee. Christopher J. White, Tyrone J. Collins, Suresh P. Jain, Alvaro 
Escobar. Ochsner Medicallnstitutions, New Orleans, LA 
The angioscopic appearance of !be treated lesions in 20 CODSCCutive patients 
foDowing directional coronary 8Iherectomy (DCA) were oompared widt those of 
20 patients foDowing coronary balloon angioplasty (PTCA) to determine wbeIher 
there were differences in the surface morphology foUowing these two treatments. 
The two groups were maICbed for sex (16 1DCD,4 women), clinical SIatUS (UDStable 
angina=16, stable angina=3, acute infan:t=I), vessel location (LAD=13, LCx=2, 
RCA=2, SVG=3), and resIaIOSis (n=7). The presence of thrombus and dissection 













The DCA group was further subdivided into palients treated with DCA alone 
(n= 11) versus those wbo received PTCA+DCA (n=9). Both subgroups were 



















Despite theoretical differences in the mechanisms of PTCA IIId DCA, mgiosropy 
did not reveal any significant differences in the observed incidence of thrombus or 
dissection following cilbeo" treatmenlln particuJar,lesions treated with DCA were 
angioscopically characterized by marked surface irregularity rather than the 
smooth appearance typicaUy seen angiographicaUy. We COIIClude that there is no 
difference in the angioscopic surface morpbology after directional coronary 
athmctomy or balloon angioplasty. This rmding may 8CCOUDt for the similarity in 
previously reponed clinical results (primary success, complications, and restenosis 
rateS) in patients treated with these two percutaneous interventions. 
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864·72 
Post.procedural NonnaIization of Coronary Flow Dynamics 
FoUowing Successful Atherectomy, PTCA and Stenting: Analysis 
by Intracoronary Spectral Doppler 
Liwa Younis. Monon 1. Kern, Richard Bach, Thomas Donohue, 
Frank V. Aguirre, Carol Mechem, Marilyn Cauley, Trina Stonner. 
SI. Louis University, SI. Louis, MO 
Distal flow velocity is reduced beyond significant coronary stenoses 
with a proximal to distal flow velocity ratio of > 2 when trans•
lesional gradients exceed 30mmHg. To evaluate coronary flow 
dynamics in response to particular interventional techniques, spectral 
flow velocities. obtained with a 0.018" Doppler-tipped angioplasty 
(PTCA) flowire distal to the site of stenosis after successful 
atherectomy (ATH.n=6), PTCA (n=6), stent placement (n=6) and 
in 6 normal subjects, were compared. All 18 pis had left anterior 
descending stenoses (82±5%). There were no differences in clinical 
variables, heart rate or blood pressure among groups. Velocity 
variables were: DIA/SYS = peak diastolic to systolic velocity ratio; 
DFVi=diastolic flow velocity integral; MV=mean velocity; Px/Ds 
-proximal/distal velocity 
A TH Stent PTCA 
MV (cm/sec) 43±20 42±15 54±20 
DFVi (units) 20±6 15±6 1918 
DIA/SYS 2.3±1.0 1.8±0.9 1.7±0.5 
PxlDs l.l ±0.3 1.0±0.4 1.0±0.3 






There were no significant differences in flow dynamics after 
successful procedures, regardless of the technique applied or 
whether an elective or emergent procedure was performed. Success•
ful revascularization of coronary stenosis, in most cases, results in 
post-procedural coronary flow dynamics similar to normal patterns 
and independent of the procedure used or the acuteness of the 
intervention. 
864·73 
Angioscopic Versus Angiographic Detection of Thrombus and 
Dissection During Coronary Interventions 
Paul S. Teirstein, Richard A. Schatz, Allen D. Johnson, 
Nancy B. Korris, Krishna Rocha-Singh, Scott J. DeNardo. 
Scripps Clinic and Research Foundation, La Jolla, CA 
Simultaneous angioscopy (scope) and angiography (angio) 
findings were compared in 69 patients (pts) und,ergoing 
interventional cardiology procedures. The mean pt age was 
62± 9 yrs, anginal class was 1-9 pts, 11-7 pts, 111-25 
pts, and IV-28 pts. A total of 73 vessels (35 natives, 38 
vein grafts) were evaluated at 109 distinct procedural 
time points including: preintervention-23, post 
balloon-21, post stent-38, post atherectomy-4, post 
laser-l, post thrombolysis -1, and at stent follow-up-21. 
Thrombus (T) was observed on 43 occasions by scope, but 
only 13 occasions by angio. In four of these 13 cases, 
angio evidence of thrombus was not confirmed by scope and, 
in each case, scope provided an alternate explanation for 
the angio filling defect (i.e., large dissection, tissue 
frond, or bulky plaque). When compared to scope, the 
sensitivity of T detection by angio was 9/43 (20.9%) with 
a specificity of 62/66 (93.9%). 
Dissection (D) was observed on 36 occasions by scope and 
25 occasions by angio. When compared to scope, the 
sensitivity of D detection by angio was 18/36 (50%). In 7 
cases angio identified a small localized D where scope 
found no pathology, likely due to limitations in the 
scope's field of view within curved vessel segments. 
Summary: 1) Thrombus was often present during 
interventional procedures and was sigllificantly 
underestimated by angiography. 2) Nearly on" third of 
angiographic filling defects were falsely identified as 
thrombus by angiography. 3) Dissections were often 
underestimated by both angiography and angioscopy. 
Conslusions: 1) Angioscopy is superior to angiography 
for diagnosis of thrombus. 2) Angioscopy and angiography 
are complementary for diagnosis of dissection. 
ABSTRACTS 
864·74 
Evaluating PTCA by Intracoronary Doppler: 
The Confounding Effects of Resting Velocity. 
Richard L. Kirlceeide, H. Vernon Anderson, Oscar Rosales, Yvonne Stuart, 
Jacques Heibig, Richard W. Smalling, The University of Texas Medical School, 
Houston, Texas 
intracoronary Doppler can be used to assess the functional significance of 
coronary stenoses by m .... uring the maximum \0 restinS velocity ratio (VmNr). 
To evaluate the usefulness of this ratio, resting &lid maximal (post-adenosine) 
coronary velocity were measured in 22 patients undergoing I·vessel PTCA. Pre•
and post-PTCA VmNr was then compared to the ""'I""'Iive minimum lumen 
diameter of the stenosis (Dmin) as found by quantitative coronary arteriography. 
Dmin Vr Vm VmlVr VmlVrp 
I.53±.4O I.S3±.4O Pre 
J.84± .47 2.73± 1.2 Post 
NS <.001 P 
Despite the highly signiticant change in Dmin with PTCA, VmNr did not 
significantly change from its pre-PTCA value. This was due in pari to significant 
increases in Vr with PTCA, which paralieloJ the increases in Vm. Substituting 
the pre-PTCA Vr (Vrr) for th. Vr mea. .. red posI-PTCA, VmNrp was 
significantly relato<! to anglographic changes with PTCA. 
Cond .... ion: Resting flow vdocity increases significantly after PTCA and can 
obscure the functional improvement in stenosis severity when it is evaluated by 
the observed maximal to resting vdocity ratios. 
864·75 
First Experience With a new Combined Angioplasty· 
Ultrasound Catheter 
Dietmar H, Koschyk, Wolfram Terres, Christian W. Hamm. 
Medical Clinic, Dept. of Cardiology, University Hospital 
Hamburg, Germany 
A new combined angioplasty and intravascular ultrasound 
(IVUS) catheter (Oracle Micro®, Endosonics) was 
investigated for use in coronary arteries. The phased array 
ultrasound device is located proximal to the balloon on a 3.5 
French shaft. 
We tested this device in 17 pts (RCA n= 6; LAD n= 7; Cfx, n= 
2; vein-grafts n= 2) undergoing PTCA alone (n= 15) or PTCA 
following rotablation (n= 2). With intravascular ultrasound it 
was possible to visualize stenosis morphology before (in 9117 
pts) and after intervention (17/17). The IVUS probe occluded 
the vessel during passage through the stenosis before PTCA 
in 6/9 pts. PTCA could successfully be performed in all pts. 
Intimal dissection was detected in 3 pts by angiography and 
IVUS, in 3 additional pts by IVUS only. In one pt intima 
splitting was visualized only by IVUS. In another pt a small 
dissection line was found by angiography and could not be 
verified by IV US. There were no complications in any of the 
combined IVUS-PTCA procedures. 
Conclusion: The new combined PTCA and IVUS catheter 
offers a promising way to visualize stenosis morphology and 
PTCA results during the intervention at no major additional 
time costs or risks. 
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865·8 
Hepatic Venous Oxygen Saturation Monitoring for the 
Prediction of Acute Uver Dysfunction Early After Fontan 
Operation for Complex Cardiac Lesions 
Hiroshi Takano, Susumu Nakano, Yasuhisa Shimazaki, Keishi Kadoba. 
Nobuyuki Taenaka, Yoshiki Sawa, Hikaru Matsuda 
Osaka University Medical School, Osaka. Japan 
Acute liver dysfunction (ALD) is one of the critical complications early after 
Fontan operation (FO), particularly when the indication is extended to 
complex cardiac anomalies. In this clinical study, hepatic venous oxygen 
saturation (ShvoJ was monitored to predict ALD in 16 patients (pis), ages 
3-20 years (single ventricle-9; mitral atresia-2; tricuspid Blresia-3; pure 
pulmonary atresia-2) after FO. 
A blood sampling catheter was insened to the hepatic vein intraoperatively 
through right atrium, and Shvo. was monitored for 1-4 days. Mean Shvo. 
value (mShvoJ during the first 24 hours after FO was compared with 
subsequent postoperative liver function. 
mShvo. ranged from 5 to 65% with the average of 33%. mShvo. showed 
a signiflC8nl inverse logarithmic correlation with the maximum values in 
serum alanine aminotransferase (AL 1) within the first postoperative week 
(r=-O.83,p< 0.001), and all of 6 pts with mShvo. below 20% developed ALD 
with ALT>1,OOO utI. mShvo. also showed a significant linear correlation 
(n=B,r:O. 76,p<0.05) with anerial ketone body ratiO, an index of redox state 
in hepatic mitochondria Furthennore, there was a clear broken-line relation 
between mShvo. and mean anerial-hepatic venous lactate difference during 
the 24 hours, indicating that impairment of lactate metabolism in the liver 
staned to occur when mShvo. reduced below 20%. 
These resu~s indicated that marked low value in Shvo. as below 20% 
appeared to reflect the presence of hepatic tissue hypoxia developing ALD. 
Shvo. monitoring may be useful for the prediction of ALD in the 
postoperative management of critical pts undergoing FO. 
865·9 
Surxery FoUowiDtl BaIJooo DiJatioa vi Val ..... Aortic Steaosis Beyood 
lafmq 
Phillip Moore, Richanl Jonas, SlaDIoa B. Perry, James E. Lock, Joim F.Keaoe 
The IIo&ton CbiIdrm'. Hospital, IIo&ton M.8Il6Cbn_. 
Immediate JlWlieat reductioo following balJooo dilatioo (BD) of c:oogenital 
valvu IOItic -as (AS) beyoad infoDcy is lllisfactory in Ihe DIIjority of 
Jl8lieats. Aortic reprgilltioa (AR) is • kDowD complicatioo of Ihe proc:ecIure. 
With \IIIe of this relatively new tbenpeulic modality it is inevitable thalllUl'J"'Y 
will be ....,.,....,-y in aome palieats. 
From December 198410 October 1991, 126 palieats(pts) ace 110 44 yean; 
with c:oogeaital AS UDderweat BD without mortality. The immediate pieat 
reductioo was 55". To date 14 pabeats (pis) ore kDowD 10 have required post 
BD lIIlI'gery, without mortality. Two plS. required early repair of anterior 
mitral vllve leaflet tars. The other 12 (3 of whom bad • surgical valvotomy 
prior 10 BD) IIIIderwaIt aortic valve procedures 6 mooths 10 6 yean; after BD. 
The iDdicatiOll6 for lIIlI'gery were primarily aevere AR in 9, aevere recurrent 
AS in 1 and combined AS! AIl. in Ihe otber 2 plS. The sUrp)', II • Dumber of 
institutiOll6, coasisted of a prosIhesis iDsertioo in 4, autologous pulmonary 
valve transplant iD 2, bomograft placemeat iD 3 and commilllllJ'Olomy with tear 
plication in Ihe otber three plS. 
In c:oocIusioo, during Ihe past 8 yeus 10" of plS over ooe yell of age who 
IIIIderwaIt BD for AS have UDdergooe subaequeat aortic valve IIUI'J"'Y. The 
COIDIIIOIIeIlI indicatioo was severe AR. Althougb thi. AR was recognized 
immediately pool BD, DO patient required immediate 1IIlI'gery, the earliest beiDg 
6 mooths pool BD. In three Jl8lieats tear plicatioo and commissurotomy bas 
beeo sucx:essful with minima1 residual AS or AR. With experieace tear 
plicatioo and commissurotomy may become Ihe preferred procedure for IlI06I 
plS in whom BD results in signifiCIDt AR. 
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Preservation of Left Ventricular Function After 
Rapid Cooling and Cardioplegia 
John C. Lucke, J. Scott Kabas, Theodore C. Koutlas, 
Ross M. UngerJeider 
Duke University Medical Center, Durham, North Carolina 
Studies demonstrating a cooling injury in isolated neonatal 
hea~ (NH) ~ve been inconsisten~ with out clinical experi· 
ence 10 repamng complex congemtal heart lesions during 
profound hypotennia (PH) and circulatory arrest (CA). Fur· 
thermore, ifi.e effect of cardioplegia (CP) on rapidly cooled 
hearts remams unclear. The purpose of this study was to 
evaluate recovery of left ventricular function (L VF) after PH 
and CA (ischemia) using an in·vivo NH model. One week 
o!d piglets (n = 16) were rapidly cooled to 18°C using car•
dl?pulmon~ry bypass (C~B) and surface ice. During a 60 
mmute perlO~ of CA, ammals were randomized to CP (St. 
Thomas solution q 30 min) or control groups. LV pressure· 
volume data were obtained before CPB and after weaning 
from CPB with micro manometers and 20 epicardial 
ultrasonic crystals. The linear stroke work versus end•
diastolic volume relationship was used as a load insensitive 
measure ~f L VF. After CPB there was no significant systolic 
dy'sfunctlon (slope.l04er~s/ml) or post-ischemic diastolic 
dliatation (x·intercept-ml) In either group (p > .05 by paired-t 
test). 
SW(y)·EDV(x) Control(Pre/Post) CardioPlt'a(pre/post) 
Slope .656:1:.22/ .557± .37 .536:1:.25 .49Qt.32 
x·intercept .7± 1.1/1.6:1: 1.2 .Qt 1.7 1.9± 1.3 
~e~~ data d~mo~trate that rapid ~oolin~ to PH does not 
slgmflcantly Impair L VF follow1Og Ischenua in the in·vivo 
NH .. FU!1hermore, although cardiopl.e~ia was not detrimen· 
tal, It did not demonstrate an additive protective effect 
toward the recovery of L VF and may therefore be un•
necessary during CA at PH for neonatal patients. 
865·11 
PriJllary Repair of Tetralogy of ,.allot Guided by 
Echocardiography 
Giuseppe Santoro , Roberto Formigari,Duccio Di Carlo, 
Luciano Pasquini,Carlo Marcelletti,Giuseppe De Simone, 
Bruno Marino. 
Bambino Gesu Hospital, Rome, Italy 
Bidimensional, COlor-Doppler echocardiography (ECHO) is 
accepted as a safe diagnostic tool to guide the surgical 
treatment of certain heart defects; however. cardiac ca•
theterization and angiography (CC) is still considered 
mandatory for patients with Tetralogy of Fallot (TOF). 
Experience Over the years has resulted in good diagnostic 
correlation between these methods; thus, a policy was in•
troduced in our institution of primary repair of uncompl~ 
cated selected cases of TOF guided by ECHO alone. In the 
last five years 103 consecutive patients with TOF (mean 
age 23.9~22.6 mos, mean weight 10.9+5_6 Kg.) underwent 
repair; in 55 (53.4%) surgery was i~dicated by ECHO stu•
dy alone (Group I). In the remaining patients (48, 46.6% 
- Group II), associated malformations and/or coronary a•
nomalies were suspected on ECHO, and CC was added. The 
two diagnostic groups did not differ with respect to age 
and weight at surgery; type of repair and early results 
were also similar. Intraoperative assessment failed to 
show diagnostic errors in patients of Group I (0% false 
negative); CC and surgery excluded associated intracar•
diac and/or coronary anomalies in 37 patients of Group II 
(24.4% false positive by ECHO). Meticulous ECHO evalua•
tion proved adequate to select patients with uncomplica•
ted ~pe of primary repair, avoiding CC. 
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865·12 
Long Term Follow·up In Children and Adolescents 
With Left·sided Artificial Valves 
Margaret H. Schenck, William K. Vaughn, George 1. Reul, 
Martin P. O'Laughlin. Texas Children's Hospital, Houston, TX 
The pwposes of this study were to review left-sided artificial valve 
implantation in children and adolescents and to analyze the valve 
types versus complication incidence using various anticoagulation 
protocols. A retrospective study was done on 166 pts (mean age 
12 ± 4.6 yrs) who had undergone left-sided valve replacement at 
Texas Children's Hospital between 1uly, 1968 and August, 1991. 
Pts were followed from 6 months to 20.S yrs (mean 7.5 yrs) for a 
total of 1195 pt yrs. With 36% of the pts requiring replacement of 
an artificial valve, a total of 67 mitral valves (MV) and 159 aortic 
valves (A V) were reviewed. Of bioprosthetic valves, 74% of the 
MV and 72% of the A V were replaced at 5.6 yrs due to calcific 
degeneration. Thromboemboli (TE) occurred in these pts with an 
incidence of 1.7 per 100 pt yrs. The St. 1ude Medical (S1M) 
valve appeared superior to other mechanical valves, having an 
incidence of TE per 100 pt yrs of 2.8 versus 7 for AV and 4.8 
versus 14.9 for MV. Warfarin (WA) did not prevent TE in pts 
with S1M valves but was more effective than antiplatelet agents 
(APA) in TE prophylaxis. This effect was most noted in AV pts 
with S1M on W A followed up to 10.25 yrs who had an incidence 
of TE of 1.2 per 100 pt yrs. On APA, A V pts with S1M had a TE 
incidence of 2.9 per 100 pt yrs. Notably, the incidence of major 
bleeds (requiring hospitalization or blood transfusions) was 0.4 
per 100 pt yrs on WA or APA. One risk factor for development of 
TE in pts with S1M was a prior history of bioprosthetic valve 
implantation. Conclusion: In children or adolescence needing A V 
or MV replacement, the S1M is the artificial valve of choice, with 
the use of W A providing the best protective factor from 
thrombogenesis without an increased risk of major hemorrhage. 
Bioprosthetic valves provide no additive protection from TE and 
might potentiate TE risks with future valve reimplants. 
865·13 
Endocrinologic Changes As a Pl1Idictor of Effusions Following 
Bidirectional Glenn and Fontan Procedures 
Richard D. Mainwaring, John J. Lamberti, John W Moora Childran's 
Hospital, San Diago, CA 
Pleural effusions are a troublesome complication following Bidirectional 
Glenn (BDG) and Fontan procedure (FP). It was our hypotheSiS that 
effusions may be related to alterations in hormones which regulate fluid 
homeostasis. We made serial determinations (by radioimmunoassay) 
of ADH, Cortisol, Aldosterone, Angiotensin and Renin in patients 
undergoing BDG (n=12), FP (n=13) and in control patients (n=10) who 
underwent repair ofVSD. 
Distinctive hormonal response pattems emerged for the three groups. 
BDG had higher ADH and Aldosterone immediately after surgery as 
compared to controls (p<0.05), while FP had. higher ADH, Aldosterone, 
Renin and Angiotensin (p<0.05). None of these changes persisted by 
the fifth post-operabve day in patients without effusions. 
There were five patients (4 FP, 1 BDG) who developed effusions 
following surgery. These patients had a different endocrinologic pattern 
characterized by persistent elevation in Renin (28 ± 9 vs. 9 ± 5 nglmllhr, 
p<0.01) and Angiotensin (110 ± 33 vs 33 ± 14 nglL, p<0.01) on the fifth 
post-operative day compared to patients without effusions. There was 
one death (FP) in this saries and this patient had a marlledly abnormal 
hormone profile. 
These data demonstrate that patients who develop effusions following 
BDG and FP have significant alterations in their hormonal response. 
We speculate that the elevated Renin and AngiotenSin levels may have 
an etiologiC role or may facilitate the release of other humoral factors in 
the cause of the pleural effusions. 
ABSTRACTS 
865·14 
A New Surgical Approach lD IDfaDti with EblfelD'. Anomaly 
10seph Caspi, Michel Dbawi, David Roberson, Raid Abdullah, 
William Piccione, Hasan Najafi. The Heart Institute for 
Children and Rush Presbyterian-St.Luke's Medical Center, 
Chicago, n.. 
In symptomatic infants with Ebstein's anomaly(EA), surgical 
management is often complicated by the presence of right 
ventricular outflow u-act(RVOT) obstruction secondary to 
abnormal chordal attachment and decrease in the effective 
right ventricular(R V) volume due to severe displacement of 
the septal and posterior leaflet of tricuspid valve(TV). We 
descnbe a new surgical approach to these infants. It consists 
of (1) partial detachment of the anterior leaflet at the annulus 
with transection of abnormal chordae at RVOT, and 
reattachment of leaflet to annulus; (2) detachment of the 
displaced portion of the septal and posterior leaflet and 
augmentation with a piece of autologous pericardium; (3) 
reattachment of augmented leaflet to the anatomic 
atrioventricular junction without annular plication. Five infants, 
two with infracristal ventricular septal defect, age 5 wks-8 mos 
underwent the operation. There was no operative death. 
Two-dimensional echocardiogram with doppler flow at a 
follow up period 6-29 mas revealed no significant residual TV 
or RVOT stenosis. Two patients have mild regurgitation. The 
descnbed technique offers a safe and logical approach to 
infants with EA, and results in competent valve, enlarged RV 
cavity, and relief of RVOT obstruction. 
865·15 
Surgical Palliation of Univentricular Heart: Predictors of 
Outcome 
Robert L. Spicer, Karen C. Uzark, Richard D. Mainwaring, John J. 
Lamberti. 
Children's Hospital and Health Center, San Diego, California 
Since long-term survival of patients (pts) with univentricular (UV) 
heart is influenced by palliative intervention, we assessed predictors of 
outcome in 64 pts who had a hemi·Fontan (n=25) or bidirectional 
cavopulmonary shunt (n=39). PIs ranged from 2.5·195 months (m) of 
age (median 10 m) with 12 pts S 6 m old. Median pt weight was 7.3 kg 
(range, 3.9 - 37 kg). Mean pulmonary pressure (pp) was ~ IS mm Hg 
in 21 pts, and 4 pts had elevated ventricular end diastolic pressure (edp) 
> 12 mm Hg. Abnormalities of pulmonary artery (PA) architecture 
(arch) were present in 28 pts and the ratio of the combined diameters of 
the left and right PAs to that of the aortll at the diaphragm was less than 
1.8 in 13 pts. Fifteen pts had concomitant major cardiac surgery, (Camus 
- 4, Norwood - 4, VSD enlargement - 2, Mitral Valve replacement - I, 
Tricuspid Valve closure - 1, right ventricular outflow reconstruction - 3). 
Mean systemic oxygen saturation increased from 74% to 83.7% following 
palliation (p < .01). During the follow-up interval of 2-79 m (mean 24 
m), there have been 11 deaths - 3 early, 8 late (1 noncardiac). Actuarial 
survival (Kaplan-Meier) was 86% at one year, 80% at 2 years, and 74% 
at 3-5 years. Logistic regression analysis of potential predictors of 
survival revealed that PA arcb was the major predictor of outcome (33 % 
monality with abnormal PA arch vs 0% monality with normal PA arch), 
p < .01. Inclusion of age and pp or PA size in the model did not 
significantly improve predictive ability. No pt with elevated edp died. 
Early outcome was adversely affected by concomitant major cardiac 
surgery as well as abnormal PA arch. 
We conclude that effective palliation can be achieved in pts with UV 
heart despite young age andlor elevated pp and that avoidance or relief of 




Prim .. y Surgical Intervention for Complex Congenital 
He ... Disease in Newborns With Visceral Heterotaxy 
Markus K. Heinemann. Kathleen N. Fenton. Frank L. Hanley. 
Cerdlac SlSgery. The Chilcten's Hospital. Boston. MA 
Newborns with visceral heterotaxy often have complex cardiac 
maHormations: a univentricular heart in combination with anomalous 
pulmonary and systemic venous connections (APVC. ASVC). 
complete atriMentrlculer canal (CAVC). right ventricular outflow 
tract obstruction (RVOTO). or obstruction to the systemic output 
(OSYSO). 
Since 1981. 46 patients (ptS) were admitted within the fi"st 3 days of 
life. 8 were not operated because of severe nOl"l-CMdiac disease 
and died. In 38 pts (82.6%) ·complete palliation" was endeavored. 
i.e. alleviation of the most si!1lificant lesions. Kaplan-Meier analysiS 
showed a survival rate of 62% at 3 months and of 45% at 2 years 27 
potential rislc-factors for early mortality were analyzed statistically by 
univariate analysis andlor Chi-square test. The variables were 
demogaphic (age.weight). anatomic (a-/polysplenia. APVC withI-out 
obstruction. its SIte of connection. ASVC. CAVC withI-out valve 
reglS!jtation. ventricular morphology. RVOTO. pulmonary atresia. 
tranch pulmonll)' artery stenosis-BPAS. OSYSO) and slSgical 
(operation performed; use of cardiopulmonary bypass-CPS; 
incidence of reoparations). The analysis revealed only OSYSO 
(pooO.07) and ASVC (pooO.02) to be Significant nslc factors. Of the 
SlSgical variables. employing CPS (p=0.1) and performance of a 
shunt as a component of the fi'st operation (p=O.03) was associated 
with less early mortality. 
These data suggest that : 1. newborns with cardiac malformations in 
visceral heterotaxy are still a high-risk group: 2. a reliable. controlled 
SOISce of pulmonary blood supply by means of a prosthetic shunt 
improves the eventual ou1come; 3. an extensive and more definitive 
palhation in addition to a shunt. utilizing CPS to adctess obstructive 
lesions such as APVC and SPAS. does not increase mortality. 
865-17 
Three-Dimensional Surface Rendered MagnetiC 
Resonance Angiography for Assessment of Aneurysms 
After Dacron Patch Aortoplasty Repair of CoarctaUon 
W James Paries. Wlliam H Plauth. Scott Sheppard. Estelle Bank. John 
Vansant. Tomas Martin, Roderlc Pettigrew and Wliis Wiliams, Emory 
University School 01 Medicine, Allanta, GA 
Dacron patch aortoplasty (DPA) repair 01 coarctation of the aorta 
avoids sacrifice 01 Intercostal arteries and minimizes restenosis by elimi•
nation of circumferential suture lines. Aortic aneurysms detected on 
followup examination and I or sudden death from aortic rupture after 
DPA prompted us to abandon this operation and to tMlluate 39 patients 
known to have heel DPA between January. 1976 and the present. All 33 
IMng patients were Intervtewed and examined. Twenty-slx (26) were stUl 
followed at our Instltutlon. The ages 01 the 39 patients ranged from 10 
days to 14.5 years (mean 6.3 years) at time of DPA. There were 14 
females and 25 males. The aorta heel ruptured in 10 patients (26%). 6 01 
whom died from 9.4 months to 12.4 years (mean 8.1 years) after DPA. 
01 these ruptures. 8 occurred In the 14 females (57%). 3 01 whom were 
pregnant. Ten 01 the 14 females heel aneurysms (71%). compared to 11 
01 the 25 males (44%). Only 2 ruptures occurred in the 25 males (8%). 
Thr""imensional magnetic resonance angiography with surface 
rendering (3DMRA) was performed In 18 patients and conventional 
magnetic resonance Imaging (MRI) was performed in all 26 patients. 
MRI or 3DMRA defined aortic aneurysms in 9 01 the otherwise asymp•
tomatic 26 patients. Seven of the 9 underwent successful aneurysm 
resection; 2 await resection. Surgery was planned on the basis of 
3DMRA/MRI findings alone; no catheterization or contrast angiography 
was performed. Surgeons reported precise anatomic correlation 
between the 3DMRA and the operative findings in each case. 
3DMRA provides safe. rapid. non-invasive. radiation and contrast 
agent-free. high resolution Images of the entire thoracic aorta and 
adjacent structures. viewable by the surgeon from any desired perspec•
live. 3DMRA Is preferred aver angiography by surgeons in our institu•
tion as the definitive study prior to resection 01 aortic aneurysms. 
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Forward Flow il'on, Ventricle Suppresses Develop1l\ent of 
. (.j ~.c.t .. rdl Cilct,latlons after Cavo-pulmonary Shunt 
Hldekl Uemura, Toshikatsu Yagillara, FIlmio Yamamoto, 
Kyoid • .L Nis/!lgaki, OEBmU Matsuki, Yasunaru Kawashima, 
Natiollal Cardiovasculal Center, Osaka, JAPAN 
C'ht>rE: have been some reports about the development of 
collat.eral cirt:ul.ations (CC) after cava-pUlmonary shunt 
(CPS), which adversely affects future Fontan circula•
tion. Three types of CPS have been performed as 
follows, conventional Glenn's anastomosis (G-G) , bi•
directional CPS in patients with azygous connection 
(BD-G), and bidirectional CPS with forward flow (FF) 
from ventricle to pulmonary artery (PA) controlled by 
PA-banding or pulmonary valvotomy (BD/FF-G) . . They were 
t:ornpared from the view point of the postoperative 
development of CC such as systemic vein to systemic or 
portal veins (V-V), systemic arteries to PA excluding 
MAPCA (A-P), and pulmonary arterio-venous fistula 
(PAVF). They were studied by angiography and/or radio•
isotope scannings 0.2 - 5.2 (mean 1.8) years post•





No. V-V(%) A-P(%) PAVF(%) 
21 *7(41) 16(76)J O( O)J 
5 2(40) 3(60) 3(60)J 
8 3(38) 3(38) O( 0) 






" Seventeen patients were studied. 
All A-P in G-G were found at the side of operation. 
Thirteen of G-G and 5 of BD/FF-G underwent open heart 
surgery later such as Fontan operation or COlllllOn 
atria-ventricular valve replacement. cardiac return 
,peasured intraoperatively was 16 .. 74 (mean 33)% of pump 
flow in G-G, while 10-36 (mean 20)% in BD/FF-G. In 
cunclusion, development of CC except for V-V can be 
diminished by means of keeping FF from ventricle to PA. 
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Mufflplane Transesophageal Echocardlographic Examination of the 
Right Heart - Description Of Imaging Planes, Definfflon of 
Echocardiographlc Anatomy and Demonstration of Clinical Utility 
Abraham Schneider. Steven Schwartz. Natesa Pandian. Richard 
Tiemey. Joanne Zachistal. Tutts-New England Med Ctr. Boston. MA. 
Thorough examination of the right heart (RH) has generally remained 
difficult because of its complex geometry. Multiplane transesophageal 
echocardiography (MPTEE), which provides 0-1800 counterclockwise image 
plane rotation. (with 0'. conventional transverse plane and 900 longitudinal 
plane) has the potential to display the RH in a vast assembly of intermediate 
imaging planes. We examined (1) the echo anatomy observed as the 
imaging plane is steered thorough 1800 with the probe at different locations 
and (2) its clinical utility. After analyzing the MPTEE anatomy of RH in vitro. 
by correlating the MPTEE images and appropriately sectioned autopsied 
hearts. we explored the echo anatomy in vivo in 100 patients. The following 
are some of the intermediate views useful in the evaluation of right heart 
structures: TranseSQDhageal views: As the view offered at 0' may incom•
pletely visualize the RV in some pts. steering to 30-400 reveals more of the 
RV cavity and walls; 60-70' depicts the septal and antr TV leaflets. properly 
aligned for RV inflow spectral Doppler sampling and the RV outflow. Rota•
tion through 110'. here and at the aortic valve level. demonstrates a muhi•
tude of views of the interatrial septum.SVe and Ive. Gastroesophageal 
Junction views' Full extent of antr TV lealiet is seen at 30-S00; RV outflow at 
40· 70' and a large extent of the basilar antr and lateral RV Iree wall at 80-
100' ; Ive and coronary sinus on the L. sve on the R; septal and antr TV 
leaflets with chordae and pap muscles. and RA appendage well seen at 
100-120'. Transgastric views' RV inflow appears at 70' • true long-axis of RV 
including RV apex. post and ant TV leaflets at 110-1300. Pap muscles and 
chordae better seen at 130-150'. Proximal and distal transgastrict views. at 
60·90' and 0-30' respectively. allow examination of all 3 TV leaflets in short 
axis and RV outflow ina plane useful for both anatomiC and spectral Doppler 
examination. In 29 pts with RH pathology. many of these off-axis 
intermediate views were useful in delineating abnormalities such as TV 
vegetations. clots. RA tumors. RA clots. regional and globai RV dysfunc•
tion. atrial septal defects. tricuspid regurgitation. VSDs. and Ao-RV fistulae. 
We conclude that MPTEE uniquely demonstrates RH anatomy and struc•
tural relationships by offering images not readily available with other tech· 
niques and is a highly versatile clinical tool for examination of RH disorders. 
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Multlplane Transesophageal Echocardlography Provides More Precise 
Echo-Anatomical Definition and Functional Assessment 01 the Normal 
and Pathologic Mitral Valve and Its Apparatus 
Abraham Schneider. Steven Schwartz, Natesa Pandian, Tsui-Ueh Hsu, 
R Bojar. H Aastegar, D Payne. Tufts-New Engl Medical Center, Boston, MA. 
The anatomic and physiologic complexity 01 the mitral valve apparatus 
(MVA) creates the necessity for precise echo-anatomic correlation. Tnis is 
critical when TEE is being used to guide interventional/surgical therapy. We 
performed mUHiplane TEE (MPTEE) studies in 150 pts and attempted: to 
define the the unique views it offers, clarify standard TEE views. and to 
demonstrate how MPTEE improves our understanding of diseases of the 
MVA. Esophageal imaging in a transverse 4 chamber view, with the anterior 
MV leaflet (AML) on the left (Ll and the posterior MV leaflet (PML) on the 
right (A) is considered 00. As the beam is steered through 1 aOo, passing the 
vertical plane at 900. numerous unique views of the MVA are available. At 
35-45' more of the AML is seen to the L and just the anterolat scallop of the 
PML is seen on the right. When the beam steers to 60-90'. or a 2 chamber 
view, it will be nearly parallel to the commisures and only the PML may be 
seen. Its anterolat scallop is on the A. the posteromed on the L. and the 
middle scallop in the center. Intermediate views may place the middle PML 
scallop out of the imaging plane and the commisural PML scallops on the A 
and L appear as separate leaflets. At 110·1500, with the LV in its long axis, 
the AML is on the A and is seen in its greatest width. In 39 pts, MPTEE 
views at this level improved our ability to precisely localize and quantify 
eccentric MA jets, MV vegetations, coaptation problems and paravalvular 
fistulas. With transgastric imaging, the MV may be seen in SAX at 00 At 70· 
aD' the parallel array of anterior chords are visible at the bottom and the 
posterior strut chords fan out more obliquely from the top of the LV image. 
Improved visualization of the papillary muscles, particularly the multiple 
heads of the posterior. may be obtained at 95-125'. In 26 pts with MVA 
disease, these images enhance definition of subvalvular rheumatic disease, 
chordal vegetations, papillary muscle based masses, pap muscle or chordal 
infarction or rupture and broaden our appreciation of normal variants. 
Conclusion: With the ability to continuously steer the beam through a 
munitude of views from anyone imaging location, MPTEE provides superb 
echo-anatomic correlation of the MVA . It provides more rapid and accurate 
appreciation of the intricacies of the MVA in normal and disease states and 
its function, and offers the clinician or surgeon more precise direction on the 
appropriate mode of therapy. 
866-97 
Multiplane Transesophageal Echocardiography Enhances 
Diagnostic Capability in the Assessment of Simple and 
Complex Prosthetic Valve Dysfunction 
Steven Schwartz. Abraham Schneider. Nateso Pondion. Tsu~Lieh Hsu. 
George Gordon. Micheol England. 
Tufts - New England Medical Center, Boston, MaSSaChusetts. 
To evaluate the utility of muHiplane transesophageal echocardiography 
(MPTEE) in the evaluation of prosthetic valve (PV) dysfunction, we 
retrospectively analyzed 150 MPTEE studies performed with 4 different 
prototype probes. Each device consisted of a single transducer array that 
can be steered 1aO degrees. 35 PVs, 17 aortiC and 1a mitral, were 
evaluated in 2a pts. There were 20 mechanical (11 aortic, 9 mitral) and 15 
biologic (6 aortic, 9 mitral) PVs. Indications for MPTEE included suspected 
PV dysfunction, SBE and cardiogenic embolus. Findings: In all cases, 
visualization of PVs using MPTEE was excellent. Leaflets of the biologic 
PVs were well defined, as were the discs of the mechanical PVs. 26 of the 
PVs studied were normal and exhibited normal, trivial regurgitation. PV 
valve dysfunction was observed in 9 pts. Although PV pathology was 
evident at both 0 and 90 degrees of rotation, corresponding to the standard 
transverse and longitudinal planes, delineation of abnormal valve motion 
and regurgitant jets was enhanced by steering the uHrasound beam through 
the numerous intermediate planes provided by MPTEE. Specifically, in two 
cases of mechanical PV obstruction (1 aortiC and 1 mitral), MPTEE allowed 
easier detection of disc immobility and measurement Of flow velocity. In 
cases of para valvular regurgitation (3 aortic, 3 mitral) delineation of the 
precise site and size of the leak was best acco~lished using intermediate 
planes. The chaotiC motion of torn biologic mitral PV cusp and the coexisting 
eccentric regurgitant jet was defined. Additionally, complex problems such 
as aorto-right atrial fistula and aorto-right ventricular fistula (1 each) could be 
tracked in their full extent. Of these 9 cases with PV dysfunction, abnorma•
lities were confirmed at surgery in 7; 2 pts were treated medically. The ability 
to continuously direct the beam allowed for improved localization of patho•
logy, communication with the surgical team, and -mental 3D reconstruction•
of the abnormality. Conclusion: The ability to continuously steer the ultra· 
sound beam through the numerous intermediate imaging planes offered by 
mUHlplane TEE improves delineation of prosthetic valve abnormalities and 
enhances echocardiographic guidance of surgical repair. 
ABSTRACTS 
866-98 
Three-Dimensional Echocardiographic Imaging of the 
Fetal Heart: Method, Feasibility and Problems 
Gerold Marx. Noteso Pondion. David Fulton. Qi-Ling Coo, and Jose 
Azevedo. Tufts - New England Medical Center, Boston. Moss. 
83A 
Increasing interest in attempting to operate fetal cardiac disorders in utero 
point to a need tor a detailed assessment of fetal cardiac anatomy parti•
cularly to delineate complex cardiac malformations. Although 2-D echo of 
the fetus prollides important information, three-dimensional image of the 
fetal heart has the potential to offer supplementary information. We explored 
the feasibility ot 3-D echocardiography ot the fetal heart by applying a 
technology developed for transesophageal 3-D echocardiography. The 
device conSists of a 5 MHz, 64 element transducer mounted on a sliding 
carriage within a casing and an uHrasound image processing unit thaI yields 
conventional 2-D echo images and is capable of volume rendered 3-D 
reconstruction and 4·D display. We studied 3 selected patients. After 
ascertaining the fetal chest position in utter, the transducer probe was 
placed on the abdomen of the mother and positioned along the midline 
vector of the fetal heart. Sector images were acquired from the base of the 
heart proceeding to the cardiac apex at 1 mm increments with computer•
controlled transducer movement. Complete cardiac cycles were recorded at 
each' mm tomographic level. These were processed and displayed as a 
dynamic image of the heart. Although fetal movement led to two image 
acquiSition sequences in each patient, the average time for data collection 
was less than 10 minutes. The images were processed with depth coding 
and displayed in a number of 3·D orientations. Because data acquisition 
was gated not to the fetal EKG and respiration but to those of the mother, 
accurate 4-Dimensional display of the beating fetal hearts was not possible. 
Despite this problem, the 3-D echo tissue reconstructions showed a normal 
heart in one fetus, a single ventricle in the second patient and biventricular 
tumors in the third. These were consistent with the findings on 2-D echo. In 
addition to the 3-D display, we were also able to non-invasively section the 
hearl in many 3-D orientations and examine the pathology from a number of 
perspectives. We conclude that 3-D echocardiography of the fetal heart is 
clinically feasible and is likely to have practical application with dedicated 
fetal imaging probes and appropriate gating mechanisms. 
866-99 
Volume Calculations using Omniplane 
TransesophageaJ Echocardiography and Three 
Dimensiona' Reconstruction from Echo-CT 
Suzanne M. Rodkey, William J. Stewart, Berthold 
Klas, James D. Thomas Cleveland Clinic 
Although transesophageal echocardiography (TEE) 
appears promising for image acquisition for 3D 
reconstruction. the methodology and accuracy of this 
image registration process has not been validated. 
We imagedl7 fluid-filled balloons with Omniplane 
TEE (Hewlett-Packard) at 150 rotational intervals 
from 00 to 1800. The volume of each 150 section 
was calculated based on ellipsoid symmetry: volume 
= (4/3 x cavity area x b)112. where b equals half the 
minor axis length. Total volume equaled the sum of 
the individual sections_ The balloons' actual volumes 
determined by weight ranged from 41-1490 cc. 10 
balloons were also imaged using 3D reconstruction 
from TEE (Tomtec) and volumes calculated using the 
Simpson's rule. from parallel sections one mm in 
thickness. Results: Volumes calculated with 
Omniplane TEE correlated with the weight-derived 
volumes: y=_82 + 51.8. n=17, r=O_97. Echo-CI' volumes 
correlated well with weight-derived volumes: y= 
1.l0x -3.86. 1'=.99. Conclusion: As more sophisticated 
TEE imaging techniques are developed that provide 
easier registration of planar images, accurate three•
dimensional reconstruction becomes feasible. 
84A ABSTRACTS 
866-100 
Development of a New Image. Processing System for 
Echocardiography and Other Cardiac Imaging Systems; 
"Omnidirectional" and "Multidirectional" M·Mode Methods 
Yoshihisa SugimolO. 'IlIkami Furukawa, Mayumi Shilcano. Tuhin Haque. 
Masahiko Kinoshita, Shiga University of Medical Science. Ohtsu. Shiga, Japan 
~ have developed a new image-processing system 10 complement an M-mode echo•
cardiographical drawback that an origin of the M-mode is fixed 10 a ultraSOnic Ctystal 
in a transducer; cf. point A in fig. I. The system consists of an echocardiograph. a 
video recorder. a microcomputer with a video analog 10 digital convener and a 
printer. The software is described in i80286 assembly language. With "Omni•
directional" M-mode method one can position a cursor line ad lib. on a B-mode 
screen. e.g. line Be in fig. 1. The computer sequentially aligns the video data on the 
cursor line inlO a vertical line and synthesizes an M-mode record. With "Multi•
directional" M-mode one positions a center point of the left venuicle (LV) and 4 
cursor lines across the center point ad lib. on a B-mode screen of the parasternal 
short axis view. as shown in fig. 2. The computer synthesizes 4 M-mode records 
simultaneously. The "Omnidirectional" M-mode method is useful for LV 
measurements in case a correct measurement is not available. Using the "Multi•
directional" M-mode we have evaluated the unevenness of regional LV motion and 
thickening. These methods are applicable 10 other cardiac cine images. such as 
magnetic resonance imaging. cine cr and left ventriculogram. 
Ig. 2 Schemoollho __ 
Conclusion: the "Omnidirectional" and "Multidirectional" M-mode methods are 
epoch-making for analyses of cardiac imaging. 
866·101 
Acoustical QulDtification of Left ventricular Area 
is Hiqhly Pe •• ibl. DUrinq Tr.n ••• ophaq.al 
Bchocardioqraphy. 
Marcus F. Stoddard, David L. Keedy, University of 
Louisville, Louisville, Kentucky 
Acoustical quantification (AQ) usinq automatic 
endocardial border detection algorithms accurately 
measure left ventricular (LV) systolic function when 
applied to transthoracic 2-D echo (Tl'E). However, 
the feasibility of AQ may be limited durinq Tl'E. To 
determine the feasibility and accuracy of AQ applied 
to 2-D transesophagea1 echo (TEE), 38 consecutive 
adult pts were studied. AQ was performed from the 4-
chamber (4C) and papillary muscle short-axis (SAX) 
views with 1atera1-gain-compensation. AQ was 
feasible in 92% (35/38) and 95% (36/38) of pts from 
the SAX and 4C view, respectively. AQ-derived left 
ventricular areas at end-systole (ES) and end•
diastole (ED) compared to digitized 2-D areas did not 
differ (p=ns) • 
TABLE2 ~ TEE-SAX ~ ~ 
ES (em) 1l±5 10±5 22±8 22±8 
ED (em2) 16±6 15±6 30±7 29±7 
Excellent correlations were found between ES AQ-SAX 
vs TEE-SAX (r=0.98, p<0.0001, slope=l.O), EDAQ-SAX 
vs TEE-SAX (r=0.99, p<0.0001, slope=0.93), ES AQ-4C 
vsTEE-4C(r=0.97,p<0.0001,slope=0.97)andEDAQ-4C 
vs TEE-4C (r=0.90, p<O.OOOl, slope=0.80). 
CONCLUSION: AQ applied to 20 TEE is highly feasible 
and accurately measures LV end-diasto1ic and end•
systolic areas. 
866-102 
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Utility of On·Llne Automated Acoustic QuantifIcatIon In the EvaluatIon 
of Right VentrIcular Function: Comparison With Rapid Response Ther•
mistor catheter Measurement of RIght Ventricular EjectIon Fraction 
Abrahom Schneider. Steven Schwartz. Noteso Pandian. ~eorge 
Gordon. Michael England. Kenneth Warner. 
Tufts - New England Medical Center. Boston. Massachusetts. 
The unusual geometry of the right ventricle (RV) makes assessment of the 
systolic function of this chamber difficuh. There Is a need for a rapid. reUa•
ble. and reproducible method for serial assessment of RV function. This is 
particularly true of the cardiac surgery patient (pt) in the perioperative 
period. Acoustic quantification (AO) based on automated border detection of 
the RV endocardium allows for real-time monitoring of the fractional area 
change (FAC). We hypothesized that the FAC of the RV as measured by 
AO would correlate with the volumetric ejection fraction (EF). To assess this. 
we compared AQ FAC to %RV EF obtained with a previously vaUdated rapid 
response thermodilution catheter technique. Measurements of FAC were 
made using muHiplane and biplane TEE probes intraoperatively in 19 
consecutive pts. Care was taken to optimize overall gain. TGC. grey scale. 
and lateral gain control. In a majority of patients AQ measurements were 
recorded in the esophageal 4-chamber view before and atter cardiopul•
monary bypass. Simultaneous independent. bUnded measurements of the 
%RV EF were acquired from the catheter technique. Results: 57 AQ FAC 
and catheter RVEF determinations were made in 19 pts. The presence of 
atrial fibrillation excluded 2 pts from analysis. Optimal border detection by 
the AO method was achieved with minimal difficulty in 14/17 pts and 
satisfactory definition obtained in the other 3. The mean AO FAC was 40 ± 8 
%. The mean catheter RVEF was 41 ± 9%. For each individual 
measurement. the mean difference between the 2 methoas was 4 ± 5%. 
Regression analysis revealed a significant correfation (y-.67+12.7. r = 0.74. 
P < 0.0001) between FAC and EF. In our pts. presence of RV dysfunction 
and recognition of changes in RV function were reUably identified by AO 
FAC. Conclusion: The AQ derived RV FAC. as measured by TEE, correlates 
well with RVEF. It provides a new cUnically useful method for continuous 
assessment of RV systolic function. 
866·103 
Measurement of C.-dlac Output by Transesophageal Pulsed 
Doppler Echocardlography In Machanlcany Ventilated 
PatIents: ComparIson With Thennodflutfon. 
Phi llppe Estagnasle, I sabe lie Antony. Didier Dreyfuss. Kame 1 
DJeda"inl. Laurence Mler. Fran~ols Coste. Alain Nltenberg. Centre de 
Reanimation Medicale et INSERM U.2SI, HOpital LouiS Mourier, 
COlombes, France. 
Est I mati on Of card lac output (CO) by transesophagea I 
eChOcardiography (TEE) would be useful In Intensive care settings. A 
monoplane TEE mitral Inflow method of measuring CO with pulsed 
Doppler was developed in 10 consecut ive mechanically ventilated 
patients. No patient had more than mild mitral regurgitation as 
determined by color now mapping. Mitral valve area (MVA) was 
calculated as ltd2/4. where d represents the diameter of the mitral 
anulus at mid-diastole, obtained from the frontal 4-chamber view. 
CO was the product of MVA. time-velocity Integral of LV inflow from 
same site and heart rate. Thermodilution (T) and TEE measurements 
of CO were obtained simultaneously, both at end-expiration, and five 
:?I cycles were averaged In all 
:§ y = 0.79x + 1.48 patients. CO was determined 
:::12 r = 0_73 • after at least 3 different ~ therapeutic Interventions 
8 10 likely to modify it, (baseline. 
l;l 8 administration of flUidS, 
~ dobutamine, ventilation with 
U 6 positive end-expiratory 
pressure). A total of 37 ~ 4 measurements was obtained. 
'e Interobserver variability was 
o 7.Sr.. A significant correlation I was observed between T and TEE 
t- 0 2 4 6 8 10measurements (r- 0.73. 
Doppler C.-diac Output (I/min) p<O.OO I l. These results 
indicate that TEE could be a useful and reliable method of 
measurement and monitoring of canliac output In meChanically 
ventilated patients. 
JACC Vol. 21, No.2 
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866-104 
Automatic Endocardial Detection Applied to 
Transesophageal Echocardiography Accurately 
Characterizes ventricular Filling. 
Marcus F. stoddard, David L. Keedy, Rita A. Longaker, 
University of Louisville, Louisville, Kentucky 
Automatic endocardial border detection (ABO) 
accurately measures left ventricular systolic 
function using transthoracic 2-0 echo (Tl'E). However, 
ABO of Tl'E is frequently not feasible. Also, its 
accuracy in characterizing left ventricular filling 
is unknown. Thus, ABO of the left ventricle from the 
4-chamber view was done in 83 consecutive adult 
patients (pts) during transesophageal echo (TEE). 
After TEE, pulsed Doppler Tl'E of mitral velocities 
were done (apical 4-chamber/annulus level) . 
Results: ABO using lateral-gain-compensation was 
feasible in 80/83 (96% ) pts. pts were divided into 2 
groups with synchronous (n=53) and asynchronous 
(n=27) systolic wall motion (WM). In pts with 
synchronous WM, correlations were found between 
analogous ABO indexes vs. Doppler-derived peak early 
filling velocity (r=0.78, p<O.OOOl), peak early to 
atrial filling ratio (r=0.80, p<O.OOOl), percent 
atrial contribution to filling (r=0.80, p<O.OOOl) and 
deceleration rate of early filling (r=0.46, p<O.Ol). 
Despite asynchronous WM, correlations were found 
between ABO and Doppler-derived peak early filling 
velocity (r=0.60, p<O.OOl), peak early to peak atrial 
filling ratio (r=0.98, p<O.OOOl), percent atrial 
contribution (r=0.77, p<O.OOOl) anddecelerationrate 
(r=0.52, p<O.Ol). 
Conclusions: The ABO system accurately assesses the 
pattern of left ventricular filling in pts with 
synchronous and asynchronous wall motion. ABO appl ied 
to TEE is feasible in the majority of pts and should be 
a useful adjunct to TTE in the assessment of left 
ventricular filling. 
866-105 
&emIIutomatlc Algorithm for Three-Dimensional Reconstruction In 
Echocarclography Using Khoros11l for Data ProcessIng 
Marek BeIohlavek, VlIlayak Dull, Thomas M. Kinter, James F. Greenleaf, 
James B. Seward. 
Mayo Clinic and Mayo Foundation, Rochester, Minnesota 
Thr~imensional (3-~) display provides improved spatial perception (Ner 
standard two-dimensional images, however, 3-D recons1rUCtion of t0mo•
graphic ultrasonic images has been hampered by fractionated, job specific 
COIllJUter procedures and the need for significant operator interaction. 
We have developed a semiautomatic sequential COIllJUter algorithm for 3-D 
reconstruction of cardiovBSQJlar structures from transesophageal echocar· 
diographic images which employs Khoros 111, a software environment for 
research developed at the University of New Mexioo. It uses a visual 
programning tool (called Cantata) that provides an interface to the library of 
image processing and image analysis routines. We have upgraded these 
routines to a 3-D format and added several new routines written in C 
'-9Iage. 
Ow algorithm contains: 1) re-registration procedure that compensates a 
possible small translational motion of the transducer during date acquisition, 
2) data normalization allows the utilization the entire range of gray levels, 
3) speckle reduction program enhances images for easier segmentation, 4) 
segmentation employs U6eriluided thresholding (this is the only procedure 
that requires an operator input, i.e. the method is seniautomatic), 5) mor· 
phoIogic fitering correcIs possible small artifacts caused by segmentation, 
6) median fitering removes noise and smooths edges, 7) data oonversion 
rewranges cylindrical data to a rectangular 3-D viewing environment, and 
8) interpolation. The resulting 3-D volume is used as a mask (Ner the 
original unprocessed data set. Original backscatter texture is preserved. 
A 3-D volume display uses ANAL VZETM developed at Mayo Clinic, since 
3-D rendering is currently not available in Khoros TM . 
Individual steps of our method that is user friendly and logically unified will 
be explained and final 3-~ ultrasonic images will be demonstrated. 
In conclusion, we have developed an image processing technique that 
IIows 3-D image reconstruction of cardiovascular ultrasound tomographic 
images. 
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867-22 
A Novel Cbimeric HumanlMurine GPIIblIIIa Antiplatelet 
Antibody Enhances Thrombolysis in tbe Baboon 
Chikashi Kohmura, Herman K. Gold, Tsunehiro Yasuda, 
Mark A. Nedelman, Roben E. Holt, J. Luis Guerrero, 
Ik-Kyung Jang, John T. Fallon, Roben C. Leinbach, 
Harlan F. Weisman, Desire Collen. Massachusetts General 
Hospital, Boston, MA and Centocor, Inc., Malvern, PA 
Immunogenicity of the mtuine monoclonal antiplatelet antibody (7E3 
Fab) may hamper its widespread use. Chimeric 1£3 Fab (c7E3) 
consisting of human constant domains and murine variable regions 
specific for GPIlb/lIla platelet receptor has been shown to be less 
immunogenic. To determine whether c1£3 enhances thrombolysis, 
a baboon femOl"82 artery thrombosis model with superimposed high 
grade stenosis was developed. All animals were heparinized. Group 
A received c7E3 with n-PA 0.25 mg/kg boluses every 15 min until 
reperfusion (R) or up to 4 boluses. In group B aspirin replaced 
c7E3. Group C was the same as Group B except that 4 n-PA 
boluses were given regardless of reperfusion. Patency was 
monitored for two hours.Total time of vessel patency dtuing two 
hours (P) was calculated and bleeding time (BT) was measured. 
ADP-induced platelet aggregation was completely inhibited by c7E3 
from 54 ± 13% to 5 ± 8% (p<0.OO1). Results are mean ± SO: 
Group Agent n R Time to Total time BT at 2hr 
R (min) ofP (min) (min) 
A c7E3 6 6 25± 8* 92±6** 26±6~ 
B asp!r!n 6 6 51±17 14±17 4±1 
C aspmn 6 5 57±35 49±39 5±2 
* p=O.005 vs B, p=O.048 vs C. ** p<0.01 vs B, p=O.021 vs C. 
~ p<O.01 vs B and C. Rt-PA boluses for Groups A, B, and C 
were 2.2 ± 0.4 (SO), 3.5 ± 0.5, and 4.0 ± 0, respectively. 
Thus, c1£3 completely inhibits platelet aggregation, significantly 
reduces time to reperfusion and enhances anerial patency as 
compared to aspirin. 
867-23 
Modulation or Neutrophil Function in Vivo Utilitizing an 
Adenosine Receptor Antagonist: A Novel Therapy ror 
Myocardial Reperl'usion Injury 
Mervyn B. Forman, Carlos E. Velasco, Thomas W. Rigsby, 
Joao Vitola, Edwin K_ Jackson, John J. Murray. Vanderbilt 
University, Nashville, TN 
We previously demonstrated that administration of adenosine or 
adenosine ailalogues during the peri-~sion period 
significantly attenuated myocardial reperfuslon injury. To 
determine whether endogenous adenosine protects the 
myocardium from reperfusion injury, the effects of OPSPX (a 
compound that blockS both AI and Al receptors and is restricted 
to tile extracellular companment) on myocardial salvage were 
investi~ated in closed chest dogs under~oing 90 mins of LAD 
occlUSIOn and 72 hrs of reperfuSlon. AniInals randomly m:eived 
OPSPX (600mg;n=10) or an eguivalent volume of saline 
(control;n-Il) during the last 30 nuns of occlusion and first 
180 mins of reperfusion. Infarct size (AN) was determined 
histologically an(l expressed as a percentage of risk region (AR) 









ANlLV~%~ 10.8£ : 
*7.7±2.6 
Baseline predictors of infarct size were similar in both groups. 
Unexpectedly, DPSPX reduced, rather than au~mented, 
myocardial necrosis, and this was accompanied by a diminution 
of neutrophil infiltration into the AR. Since stimulation of AI 
receptors is known to enhance neutrophil chemotaxis, we 
examined the effects of DPSPX and DPCPX (a selective ~l 
antagonist) on FMLP-induced chemotaxis in vitro. Both OPSPx 
and OPCPX decreased the response of neutrophils to the 
chemoattractant FMLP by> 75 %. These studies suggest that 
blockade of AI receptor-mediated chemotaxis of neutrophil may 




Reftow Adequacy Alters Recovery After Stunning 
Steven F. Bolling. Larry Bies. University of Michigan, Ann Arbor. MI 
Following coronary occlusion. myocardial stunning depresses oxygen 
utilization efficiency (OP/MV02). as less won is developed per oxygen 
utilized. Also following coronary occlusion. reperfusion adequacy 
from angioplasty. surgery. etc. can vary widely. To study the effect of 
post-ischemic reperfusion pressure adequacy upon soon-term recovery 
after stunning. myocardial oxygen consumption (MV02. ml02/mg). 
oxygen extraction (02EX. mlO2/ml). developed pressure (OP. mmHg) 
and OP/MV02 (%mmHg/%ml02/mg) were measured before and 30 
min after either a 10. 20 or 45 min period of 370C stunning in 36 
isolated. retrograde-perfused rabbit heans. Hearts were re~rfused 
post-stun at 80 mmHg (baseline). 40 mmHg or 20 mmHg to s~ulate 
full. panial or minimal reperfusion. Results are shown at 30 mm after 
reperfusion (mean ± SO. * = p < .05 vs 80 mmHg 
W! DPIMY02 mEX. m:w 
PRE-STUN 97±5 100 72±7 68±5 
BI:OIllt:(mmU2l 
10 80 64±7 68 83±8 66±5 
min 40 62±IO 76 92±.3 57±,4 
stun 20 38±11* 79 96±.3* 3Q±8* 
20 80 72±5 73 85±9 68±6 
min 40 60±9 80 91±7 52±8 
stun 20 37±9* 71 96±.7* 36±.10* 
4S 80 46±9 50 74±.3 64±.12 
min 40 30±8 * 81 84±1l 26±.8 * 
stun 20 29±.10* 72 92±.16* 26±8 * 
Heans had depressed OP following all intervals of stun. significantly 
worse in those minimally reperfused. As expected. OP/MV02 was 
depressed from presnm. but equally maintained between groups. as the 
more "stunned" hearts compensated for a I~sser MV02 b~ upregullll:ing 
02EX. However. with inadequate reperfuslOn pressure this mechanism 
is overwhelmed. leaving inadequately reperfused stunned myoc~lum 
poorly functioning. at risk for more dam~ge and ~uppo~ attemptmg to 
acheive full reperfusion after all myocardial stunnmg episodes. 
867·25 
Direct Quentitative Analysis of Free Radical Production by Electron 
Paramagnetic Resonance Spectroscopy Following Primary Coronary 
Angioplasty in Acute Myocerdiallnfarction 
Ever Grech, Nicholas Dodd, Christopher Bellamy, Undsay Morrison, 
Raphael Perry, David Ramsdale. Department of Cardiology, The 
Cardiothoracic Centre, Uverpool L14 3PE, U.K. 
In animal models oxygen-derived free radicals have been found to be 
important mediators of reperfusion injury to ischaemic but viable 
myocardium. However in man there is no direct evidence of free 
radical production after restoration of coronary artery patency and 
there is uncertainty how animal models relate to human studies. We 
have used primary coronary angioplasty for acute MI as a model of 
acute reperfusion to assess direct free radical levels. Nine patients 
(mean age: 58.3 years, range 47-661 undergoing successful primary 
angioplasty for acute MI (3 LAD; 1 Intermed; 5 RCA) of less than 6 
hours duration (mean: 3.19 hours, range 2.1-5.0) had venous 
sampling using the spin trap a-phenyl N-tert-butyl nitrone. Samples 
were taken from the base of the right atrium/coronary sinus before 
angioplasty, and at timed intervals up to 24 hours, with more 
frequent sampling in the early period following recanalisation. Each 
sample was analysed by electron paramagnetic resonance 
spectroscopy. 
The pre-intervention mean free radical signal level lay above our 
control range (p<O.Ol I. This was followed by a marked increase soon 
after recanalisation reaching a peak at 2 Y, hours post recanalisation. 
Thereafter values declined gradually to 6 hours. A late increase in free 
radicals up to 24 hours were also observed and may have their origin 
from accumulating myocardial leukocyte infiltration. Relative to the 
baseline a significant increase was apparent at 15 minutes (p<O.Ol) 
and was maintained throughout the study period. 
Conclusion: This study provides the first direct and quantitative 
evidence of frae radical production during myocardial reperfusion in 
man, and support present concepts of free radical mediated 
reperfusion injury. Further studies with adjuvant pharmacological 
agents to modulate the extent of tissue injury are needed. 
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868-26 
The Electrocardiogra. does not Correlate with Throabin 
or Platelet Activity in patients with Either Unstable 
Angina or Hon-Q Wave Myocardial Infarction 
Richard Becker, Russell Tracy, Edwin Bovill, Jeanne 
Corrao, Stephen Baker, Kenneth Mann. Thrombosis Center, 
University of Massachusetts Medical School, Worcester, 
MA. 
The progression of stable to unstable coronary artery 
disease is determined by thrombus burden. For patients 
with unstable angina/non-Q wave MI, the 12-lead 
electrocardiogram (ECG) is the diagnostiC tool used most 
commonly in clinical decision making, including the need 
to perform coronary angiography or initiate thrombolytic 
therapy. To explore whether the ECG reliably reflects 
ongoing coronary thrombOSiS, plasma levels of thrombin•
anti thrombin complex (TAT) and fibrinopeptide A (FPA), 
markers of thrombin activity, and platelet activation 
(PA), determined by flow cytometry, were measured at 
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Yes 10 19.4±7.5+ 27.1±12.0 12.8±4.7 
No 26 9.3±2.8 11. 4±1. 8 9.8±3.0 
Collectively, patients with unstable angina/non-Q wave 
MI had heightened thrOmbin and platelet activity 
compared with controls (P<.004)*. However, these 
markers did not differ between the EeG groups (p>.05). 
Further, patients without ECG changes had increased 
thrombin activity compared with patients with either ST 
or T wave changes (p<.05)+. Thus, the ECG is not a 
sensitive measure of ongoing coronary thrombosis in 
patients with unstable angina/non-Q wave MI. 
868-27 
VERY EARLY SERIAL ELECTROCARDIOGRAPHY IN ACUTE 
MYOCARDIAL INFARCTION: CAN EARLY BE TOO SOON? 
Peter J. Kudenchuk, Timothy Dewhurst, Paul E, Utwin, Jenny S. 
Martin, Mark J. Wirkus, W. Douglas Weaver, for the MITI Project 
Investigators, University of Washington, Seattle. WA. 
Findings on the initial electrocardiogram (ECG) are pivotal 
in targeting patients (pts) with possible acute myocardial infarction 
(AMI) for early thrombolytic therapy (TT). However. if obtained 
prematurely there are concerns that ECG criteria for n may be 
subtle or undetectable. We therefore serially compared pre•
hospital versus initial hospital ECG findings in 2215 consecutive 
pts during a trial of pre-hospital n. Prehospital ECGs were taken 
by medics 62 ± 74 minutes after symptom onset; the first hospital 
ECG was obtained 41 ± 17 minutes later (or 103 ± 74 minutes 
after symptom onset). All ECG's were independently interpreted 
by 2 electrocardiographers who were not aware of pt data. 
Criteria for n were ST elevation ~.1 mV in ~2 contiguous leads in 
the absence of left bundle branch block or a ventricular rhythm. 
Of 737 pts with documented AMI, 447 (61%) were eligible 
for n on the pre-hospital ECG alone. and 424 (58%) on the first 
hospital ECG alone (p=NS). Criteria for n were present on both 
ECG's in 385 pts (52%). on neither ECG in 251 pts (34%), on the 
pre-hospital but not hospital ECG in 62 pts (8%). and on the 
hospital but not pre-hospital ECG in 39 pts (5%). Age, sex, 
cardiac history and time interval from symptom onset to ECGs did 
not correlate with whether either. neither or both pre-hospital and 
hospital ECGs met criteria for n. 
Candidates for n can be accurately identified by an ear1y 
ECG. Such an ear1y ECG infrequently obscures findings which 
merit n, even in the minority of pts with only evanescent ST 
elevation. 
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868·28 
AV Block and Right Ventricular Infarction: a 
Poorly Recognized Association in Acute 
Inferior Myocardial Infarction 
Roberto Bassan, Roberto GaInarski, Renata Macaciel, 
D:Jmi.ngos Labanca, Luis Antonio campos, Hans Dohmann. 
Procardiaco Hospital, Rio de Janeiro, Brazil. 
Studying 116 consecutive pts with acute inferior MI, AV 
block (AVB) was seen in 23 pts (2nd-degree= 6, 3rd-de•
gree=17) and RV-MI in 27 (by ECG only: 4, by 2-D Echo og 
ly: 7, by both= 16).57% of pts with AVB had RV-MI vs 
15% of pts without AVB (p<.OOl). Conversely, 48% of RV•
MI pts had AVB vs 11% of non RV-MI pts (p<.OOl). Early 
type AVB «6 h after MI onset) was seen in 12/13 pts 
with AVB associated with RV-MI and in 3/10 pts without 
RV-MI (p<.OO5). . 
with AVB Without AVB 
RV-MI no RV-MI RV-MI no RV-MI p 
Vagal SymptOOlS 69% 10% 43% 13% <.001 
Hypotension 85% 60% 50% 11% <.001 
Killip II-IV 23% 30% 7% 5% <.02 
Vent rate 44+10 55+12 <.05 
LVEF (Echo) (%) 64+17 63+14 64+15 69+17 NS 
Hospital death 0 30% 0 5% < .01 
Conclusions: 1) The 4-fold increased incidence of AVB in 
pts with inferior MI and RV-MI as compared to inferior 
MI without RV-MI indicates a strong association between 
AVB and RV-MI; 2) RV-MI is probably responsible for many 
AVB in inferior MI through the Bezold-Jarisch reflex; 
3) Hypotension comronly seen in AVB pts is IIDstly due to 
RV dysfunction and increased vagal tone and not to LV 
failure; 4) Late AVB (ischemia-related) is responsible 
for the higher mortality rate seen in AVB pts in acute 
inferior MI. 
868·29 
Incidence and Prognostic Significance of Complete 
Atrio·Ventricular Block in 11,483 Patients Treated 
with Reperfusion Therapy After Acute Myocardial 
Infarction in the GISSI·2 Trial. 
AIdo P Maggioni, M.Grazia Franzosi, Eugenio Santoro, Luigi 
Tavazzi, Gianni Tognoni on behalf of GISSI-2 Investigators, 
Milano, Italy. 
To investigate the rate of occurrence and the clinical implications 
of complete atrioventricular block (cAVB) in a large 
representative population of patients (pts) with acute myocardial 
infarction (AMO treated with reperfusion therapy, we analyzed 
the incidence of cA VB and the relationship between cA VB and 
15-day and 6-month monality in 11,483 pts with confirmed AMI 
randomized in the GISSI-2 trial within 6 hours from the onset of 
symptqms. Incidence of cA VB in the total population 
(n.1I,483), in pts with inferior (n.4,194) and with anterior AMI 
(n.4,163) was respectively 5.6%, 10.4% and 2.0%. Multivariate 
analysis adjusting for the main clinical-epidemiological variables 
showed that inferior site of AMI or a poor haemodynamic status 
at entry were the only independent risk factors to develop cA VB. 
15-day mortality was higher in pts with cAVB than in those 
without this complication: 20.1 % vs 8.1 % in the total population 
(2p 0.(01); 58.5% vs 12.3% in pts with anterior AMI (2p 
0.0001); 12.8% vs 4.5% in pts with inferior AMI (2p 0.001). 
Logistic regression models showed the independent prognostic 
significance of cA VB for 15-day mortality in the total population 
of pts (RRCox, 95%CI 1.98, 1.57-2.48) either of anterior 
(RRCox, 95%CI 3.66, 2.59-5.14) or of inferior site of AMI 
(RRCox, 95%CI 1.67, 1.15-2.44). Post-discharge to 6-month 
monality was not different between pts suffering or not cA VB in 
the course of the hospital phase (4.0% vs 3.5%). In conclusion 
the findings of this large population of thrombolyzed pts 




Significance of Intermittent ST Elevation in' Patients 
Receiving Thrombolytic Therapy 
Agha W Haider, David Hackett, Felicitta Andreotti, Charles Seydoux, 
Graham Davies, Attilio Maseri. Hammersmith Hospital, London, UK 
Rapid normalization of the elevated ST segment is predictive of 
infarct-related coronary artery (lRCA) patency in patients receiving 
thrombolytic treatment. However, it is not known if intermittent IRCA 
occlusion (defmed as <!2 episodes of ~1.5 mm ST elevation lasting 
~ 1 min on Holter monitoring or angiographic intermittent occlusion) 
predicts the response to thrombolytic therapy or 24hr patency. We 
studied 102 patients with WHO criteria of probable AMI treated with 
intravenous (IN) or intracoronary (IIC) thrombolytic drugs given 
within 6 hrs of the onset of symptoms (IIC streptokinase 5000· 
600000 IV in 45 patients, IN t-PA 0.30-0.60 MU/kg in 57 patients). 
Intermittency was seen in 26.5% (Group 1) and absent in 73.5% 
(Group 2) of patients. The IRCA patency rate (TIM! grade 2 or 3) in 
Groups I and 2 was 40.7% Vs 28% (p<o.ooOI) before thrombolytic 
therapy, 92.6% Vs 76% (p<0.0001) at 90 min and 86.4% Vs 72.5% 
(p<o.002) at 24hrs, respectively. In conclusion intermittent occlusion 
was associated with a higher pre-treatment patency rate and this 
advantage was maintained at 24 hours. 
868·31 
Failure of Post Infarction Exercise Testing to Predict 
Coronary Anatomy After Thrombolysis: Significance of 
Reciprocal ST Depression. 
Robert Stevenson, Kulasegaram Ranjadayalan, Robin H 
Roberts, Bradley G Marchant, Adam D Timmis. The London 
Chest Hospital, London, UK. 
Most 01 the data relating exercise test variables to angiographic findings 
after acute infarction predate the Introduction of thrombolytic therapy. We 
prospectively studied 202 patients with acute myocardial infarction treated 
by thrombolysis Who underwent early exercise testing and coronary 
aneriography. The infarct related anery (IRA) was patent in 69% 01 
patients. and 52% had multivessel disease. Exertlonal 5T depression 
occurred more frequently In m~ivessel disease (58% vs 44%, p<O.05), 
but its diagnostic value was too low to be clinically useful. It was an 
"isolated" finding in 46% of cases, but In the remainder It was "reciprocal" 
and associated with 5T elevation In the Infarct related leads. When only 
isolated 5T depression was considered (with reciprocal change classified 
as a negative response) the association with m~ivessel disease 
strengthened and both specificity (86% vs 56%) and predictive accuracy 
(72% vs 59%) increased, although sensitivity (33% vs 59%) diminished to 
a level that rendered the finding unhelpful as a screening criterion. 
Exertional 5T depression also faDed to identify patients with patency of the 
IRA, although the association 01 5T elevation with large Q wave infarcts 
probably accounted for the finding that reciprocal ST depression was 
more common in patients with nonpatency of the IRA (42% vs 21% 
p<O.Ol). Diminished exercise tolerance and blood pressure response 
were associated with both multlvessel disease and nonpatency of the IRA, 
but again the diagnostic value 01 these electrocardiographic, functional, 
and haemodynamic variables was much too low to be clinically useful. 
In conclusion, the trea<lmUI test early after myocardial Infarction faUs to 
identify the majority 01 patients with multivessel disease or patency of the 
IRA. and is therefore an unsatisfactory method for selecting patients for 




Non-Q Wave Myocardial Infarction Presenting With ST Segment 
Elevation: Evidence for Early Spontaneous Reperfusion 
William D. Keen, Michael P. Savage, David L. Fischman, 
Andrew Zalewski, Paul Walinsley, Sheldon Goldberg. 
Jefferson Medical College, Philadelphia, PA 
The goal of this study was to define the acute coronary anatomy of non•
Q wave MI presenting with ST segment elevation. Accordingly, we 
reviewed the angiographic fmclings of 66 consecutive patients present•
ing with ST elevation who underwent emergency cardiac catheteriza•
tion within 6 hours of symptom onset and without prior thrombolytic 
therapy. ST segment elevation was defined as ~ 1 rom ST elevation in 
at least 2 contiguous leads on the acute ECG. Patients were classified 
intoQ-wave M1 (QMI, n=56) or non-Q wave MI (NQM1, n=lO) groups 
based on the development of Q waves ~.04 sec prior to discharge. The 
2 groups were similar in termS of clinical characteristics, time to 
catheterization, frequency of single vessel disease, infarct related artery 
(IRA) location, and treatment. Thrombus was more common in the 
QMI group than in the NQMI group (86% vs. 40%, p=.OOI). Total 
occlusion of the IRA (TIMI 0 or I flow) was more common in the QMI 
group compared to the NQM1 group (93% vs. 40%, p=.OOOl). Thus, 
acute angiography demonstrated a patent IRA in 60% ofNQMI vs. only 
7% of QM1 (p=.OOOl). The mean peak CK level was significantly 
higher in the QMI group than in the NQM1 group (2620 vs. 698, p=.OI). 
In conclusion, very early angiography performed in acute non-QMI 
presenting with ST segment elevation demonstrates: (1) a patent IRA 
in the majority of patients despite the absence of thrombolytic therapy, 
and (2) a lower incidence of intraCOronary thrombus compared to acute 
QMI. These fmdings suggest that transient occlusion with spontaneous 
reperfusion occurs early in non-QM1 and is associated with myocardial 
salvage. 
868·33 
Cardiac Troponln T Measurementa are Higly Specific tor 
Myocardial Cell Damage 
Hugo A. Katus. Michael Simon. Marl<us Zorn, 'Thomas ScheffoId. AIwJIfNI 
Remppis, Joerg ZeheIein. Ekkehard Gruenig. Walter FMIhn 
University Hospital Heidelberg, FR-Gennany 
We have developed an assay kit for cardiac troponln T (cTnT) which has 
undergone multicenter evaluation of Its sensitivity, Its diagnostic time 
window. and 01 release kinetics 01 cTnT. 'The present study was designed 
to test In detail A) In VItro and B) clinical specHicity of this cTnT essay. A) 
In Immunoblot and binding assays monoclonal antibody (MAb) M7 is 
cardlospecific. whereas MAb 1Bl0 reveals 12% cross-reactivity with 
Ikeletal TnT. The combination of these 2 MAbs results In 0.5% eross•
reactivity 01 fie assay. However TnT adhering unspecifically to the well of 
the test tube Is detected by the labelled. erolsreactlve lBl0 MAb. B) 
Clinical Ipecificlty was tested in 12 volunteers after eccentric muscle 
exercise. 32 patients after orthopaedic lurgery. and 135 patients with 
a1evated total serum CK activity on admission. The specificity of CKMB 
activity (CKMBa). CKMB mass (CKMBm). and cTnT after exercise (48 
samples. CK 200-92000 lUll) was 44%. 58%. and 75%. cTnT was only 
elevated if CK >5000IU/l. After surgery (79 samples. CK 150-4300 lUll) 
the specificities of CKMBa. CKMBm and cTnT were 81 %. 98%. and 99%. 
In the 135 patients (223 samples) with a1evated CK on admission cardiac 
disease was excluded In 72 (53%). In these 72 patients specificity of 
CKMBa. CKMBm. and cTnT was 78%. 85%. and 92%. Definite myocar· 
dial cell damage was present in 17 of the 135 patients. In these 17 pa· 
tients sensitivity of CKMBa. CKMBm. and cTnT was 71%. 94% and 
100%. Thus although in clinical practice the TnT assay is not absolutely 
cardilHp8Cific. cTnT measurements are more specific than CKMB activity 
or CKMB mall determlnaIions. 
868·34 
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Improved Detection of Perl operative Myocardial 
Infarction With Cardiac Troponin I 
Jesse E Adams iii. Geza S Bodor, Victor G Davila-Roman. 
Gregorio A Sicard. Jack H Ladenson. and Allan S Jaffe. 
Washington University School of Medicine, St Louis. MO 
Perioperative myocardial infarction (MI) portends an ad•
verse prognosis after noncardiac surgery. However. the 
diagnosis of Mi during this period is difficult. ECG changes 
are common and some elevations of MB CK can be due to 
skeletal muscle damage. Measurement of cardiac troponin 
I (cTnl). a cardiac regulatory protein elevated in plasma for 
up to one week after MI. has been shown to have compa•
rable sensitivity to MB CK for the diagnosis of MI but not to 
be elevated in patients with acute or chronic skeletal mus•
cle injury. To determine whether cTnl can distinguish pa•
tients with increases in MB CK due to perioperative MI from 
those with increases due to skeletal muscle injury. 28 high•
risk patients undergoing vascular surgery procedures were 
studied prospectively. The development of new regional 
wall motion abnormalities between pre- and post-operative 
echocardiograms was considered diagnostic of MI. MB CK 
and cTnl concentrations were determined with ELISA as•
says based on specific monoclonal antibodies. Three of 
28 patients (10.7%) had perioperative infarctions; all had 
increases in cTnl and MB CK with rising and falling pat•
terns. No other patient had elevations in cTnl. Three addi•
tional patients (10.7%) had minor elevations of MB CK in 
the absence of new regional wall motion abnormalities. 
Thus. cTnl appeared to be as sensitive as MB CK but more 
specific. Measurement of cTnl should facilitate identifica•
tion of patients with perioperative MI following noncardiac 
surgery. 
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869·50 
EXERCISE TESTING AND 24-HOURS HOlTERMONITORING IN 
ASYMPTOMATIC MEN WITH FAMILIAR HYPERCHOLESTEROLEMIA. 
Mogens lytken larsen, Margaret Marley, Annebirthe Bo 
Hansen, Ida Rosenlund & Torben Haghfelt. Dept. of 
Cardiology B, Odense University Hospital, DENMARK. 
The prevalence of asymptomatic ST-segment depression 
(silent ischemia) during exercise testing has been esti•
mated to about 2-4% of the middle-aged male population. 
We wanted to investigate whether silent ischemia was 
more frequent in asymptomatic men with familar hypercho•
lesterolemia. Twentytwo men were consecutively referred 
to the lipid clinic because of elevated serum choleste•
rol and a family history of premature ischemic heart dis•
ease. They had been given dietary advice but not been 
treated with lipid-lowering drugs. Total cholesterol (T•
CHOl), HDl-CHOl and TG (triglyceride) was measure twice 
fasting. They all performed a graded maximal bicycle ex•
ercise test and were ST-segment Holtermonitored for 24 
hours. Mean age was 48 years (38-60 years). Mean T-CHOl 
was 8.7+0.7 mmol/l(+SD), HDl-CHOl 1.1+0.5 mmol/l, lDl•
CHOl (calculated) 6~1+1.1 mmol/l and TG 2.2+1.3 mmol/l. 
Mean body Index (BMI)-was 25.7 kg/m2. Work capacity was 
100% (60·125%) of the expected and ECGs at rest were nor•
mal. During exercise five men (22.4%) developed signifi•
cant ST-segment depression. During 24-hours Holtermonito•
ring two men had significant ST-segment depression with•
out symptoms. Both had had silent ischemia during exer•
cise testing. The five men with silent ischemia showed 
no differences from the total group regarding age, BMI 
or lipid levels. 
In conclusion exercise-induced silent ischemia was found 
more often in asymptomatic men with familiar hyperchole•
sterolemia than in random male population studies. Si•
lent ischemia during 24-hour Holtermonitoring was only 
seen in men who also had exercise·induced silent ischemia 
JACC Vol. 21, No.2 
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869·51 
PredictioD of EllteDt of Myocardial Viability: ComparisoD of 
PosltroD EmissloD Tomograpby Metabolic aDd Flow ImaglDg wltb 
Rest aDd Low Dose DobutamlDe Stress Ecboardiograpby 
Anne M. Hepner. David S. Bach. Kale Stafford. William F. ~SIroIIg. Markus 
Schwaiger University of Michigan Hospitals, and VA Medical Center, Ann 
Arbor,Ml 
Multiple modalities have been used 10 evalU8le Ihe alent of viable myocardium in 
patients with chronic ischemic heart disease and left ventricular dysfunction 
(L VD). The pwpose of our study was 10 determine Ihe amount of viable 
myocardium present in 11 patients with L VD due 10 chronic ischemia. 
Dobutamine Stress Echocanliography (DSE) involved baseline imaging followed 
by incremental infusions of dobutamine at 5, 10, 20, 3Omcg/kg/min in 3 minute 
stages. Images from 4 views (parastemallong and shon axis, 4 and 2 chamber) 
were acquired at each stage. Wall motion scores (WMS) and left ventricular 
ejection fraction were measured by a blinded observer in each of baseline (BL), low 
dose (LD)(5mcg), peak, and post images in each of Ihe 4 views. Viability was 
considered present if myocardium was full thickness and S hypoIdnetic at rest or 
increased in motion at LD dobutamine. Positron emission tomography (pEn 
studies were performed within 20 days with 20 mCi NI3 and 10 mCi 
f1uorodeoxyglucose (FOG) after oral glucose loading or intravenous insulin 
lherapy. PET images were analyzed by a blinded observer. A visual score of 1 
(normal tracer uptake) 10 4 (activity comparable to background) was given to each 
of 13 corresponding left ventricular segments (SEQ) by an observer blinded to the 
results of the DSE study. Viability was defined as a NI3 score of Sl. or an FOG 
score Sl. 
Modality Viable SEG Nonviable SEG .,Viable 
FOG 113 30 79 
NI3 How 100 43 70 
Rest Echo 95 48 66 
D~ ~ % ~ 
Each of the above modalities showed overall agreement with respect to percent 
total myocardiallissue viability. Of 49 akinetic segments, only 2 improved with 
the addition of LD dobutamine. 28 segments nonviable by DSE displayed 
evidence of tissue viability by PET/FDG, although 82., of these were viable by 
NI3 imaging alone.We conclude there is a high conc:mIance between rest function 
on DSE and PET imaging in Ihe prediction of Ihe amount of viable myocardium. 
DSE augmentation was of limited additional value when compared with rest echo 
or NI3 flow imaging alone. Discrepant findings between echo and PET in akinetic 
Jegments requires further evaJuatioo following revascularization. 
869·52 
COMPARISON OF DOBUTAMINE AND DIPYRIDAMOLE 
STRESS-ECHO WITH EXERCISE TEST FOR CORONARY 
ARTERY DISEASE DIAGNOSIS 
Luca Lanzarini, Raffaela Fetiveau, Arnaldo 
Poli, Antonio Mussini, Mario Previtali. Div. 
Cardiology, IRCCS-S.Matteo, Pavia, Italy. 
To compare the value of Dobutamine (DOB) and 
Dipyridamole (DIP) stress echocardiography 
(E) with bycicle Exercise Test (ET) in 
detecting coronary artery disease (CAD), 80 
pts,62 men, aged 53+/-8 yrs, with chest pain 
underwent in random order a DOB-E 
(incremental step of 5 mcg/kg/min per 3' up 
to 40 mcg/kg),a DIP-E (0.84 mg/kg in 10') and 
a maximal symptom-limited supine ET in the 
absence of treatment. A previous infarction 
was present in 15/80 pts (19%). The results 
are as follows: 
DOB-E DIP-E ET 
Specificity(n=23) 83%A 96%A 35% 
Sensitivity (n=57) 79%* 60% 68% 
l-vessel(n=24) 62% 33% 46% 
2-vessel(n=24) 91% 75% 79% 
3-vessel(n=9) 88% 88% 100% 
Diagnostic Accuracy 80%** 70% 58% 
A p<.OOl vs ET;* p<.05 vs DIP;** p<.Ol vs ET. 
Non-sustained ventricular arrhythmias 
developed more frequently with DOB than with 
DIP infusion (25 vs 2%). One pt prematurely 
stopped DOB for the occurrence of junctional 
rhythm with dizziness and hypotension. 
In conclusion: DOB-E and DIP-E have a 
higher specificity and diagnostic accuracy 
than ET; the higher sensitivity of DOB-E 
compared to DIP-E is due to a better 
detection of l-vessel disease. 
ABSTRACTS 
869·53 
Comparison Between Dobutamlne and Dlpyrldamol. 
Echocardlography In Detecting Viable Myocardium 
Perfused by a Critical Stenosis. 
Salvatore Pirelll, Wilma Crivellaro. Francesco Faletra. Livia Ruffini', 
Roberto Sara§. Manlio Cipriani, Antonio Pezzano, Claudio De Vita. 
luigi Campolo. Oberdan Parodi'. Department of Cardiology, 'C.N.R. 
Clinical Physiology Institute, Section of Milan, § Nuclear Medicine 
Service. Niguarda Hospital, Milan, "aly. 
Low dose Dobutamine stress echocardiography (DSE) (10 IIQIkglmin) 
and Dipyridamole echocardiography test (DET) (0,56 mglKg over 4 
min) were compared with resting Thallium-201 (TI) SPECT delayed 
Images as reference standard for the detection 01 viable myocardilm. 
Sixteen consecutive patients with previous anterior myocardial 
Infarction undergoing coronary angioplasty because of a severe 
isolated stenosis of left anterior descending coronary artery (lumen 
reduction >70%) were studied. A score Index ranging from 1 
(norrnokinesis) to 4 (dyskinesis) and a 14 segment model were used 
for DSE and DET. TI uptake. using a comparable segmental model, was 
measured and normalized to the peak activity. A segment was 
considered viable when resting dyssynergy showed an Improvement 
of 1 grade or more during DSE or DET and when TI activity was 50% or 
more 01 the maximum. Resting dyssynergies were observed In 
107/222 segments (48%). Quantitative TI detected viability in 51/107 
segments (48%). DSE correctly detected viable and necrotic areas in 
26 and 42/107 segments, respectively and DET in 17 and 48/107 
segments. respectively. Sensitivity, specHiclty and predictive accuracy 
01 DSE and DET were 51%, 75%,64 and 37%, 79%, 61%, 
respectively. Thus, In segments supplied by critically stenotic left 
anterior descendig coronary artery. DSE and DET provide moderate 
predictive accuracy in identification of myocardial Viability. DSE appears 
superior to DET in detecting potentially reversible dyssynergy. 
869·54 
Relation between the Increase of Left Ventriculaf 
Filling Pressure and the Extent of Ischemic 
Myocardium during Exercise In Patients with 
Coronary Artery Disease 
Akitada Ando, Mltsuhlro Yokota, Toshikazu Sobue, Yasuto Nishinaka, 
Mltsunori Iwase. Hiroshi Hayashi, Hidehiko Saito. The First Department of 
Internal Medicine, Nagoya University School of Medicine. Nagoya, Japan 
To assess what influence the extent of ischemic myocardium exerts on 
left ventricular filling pressure, 24 patients with ellon angina pectoris 
(group A) and 12 patients with old myocardial Infarction (group B) were 
studied. Hemodynamic parameters including pulmonary artery wedge 
pressure (PAWP) were measured with Swan-Ganz catheter at rest and 
during bicycle exercise, and Ischemic siZe at peak exercise was calculated 
using thallium-201 myocardial single photon emission computed 
tomography. PAWP increased from rest to peak exercise in both groups. 
There was a good linear correlation between PAWP and ischemic siZe (r. 
0.70, p < 0.001) in group A, but no relation between both In group B. 
_ 50 
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Conclusion: In acute reversible ischemia. the extent of ischemic 
myocardium Influences the degree of net global left ventricular diastolic 
dysfunction. On the contrary, the extent of infarcted myocardium dose 
not always affect the change in global left ventriCular diastolic function 
during exercise. This finding may Indicate that the compensation 
mechanism of nonischemic myocardium for ischemic myocardium during 





Arterial Compll8Dce was a Determinant or tile EJterc\se Capacity In 
Patients wltb Stable Angina - Flow Dynamic Analysis or a 
SreD~ C~ary Artery -
Hideki Watanabe, Sadanori Ohtsuka, Masaaki Kakihana, Ryuichi Ajisaka, lSuyosi 
Enomoto and Yasuro Sugishita 
University oflSukuba, Ibaraki, Japan 
We previously demonstrated that the decrease in anerial compliance was a great 
additional risk for the development of subendocardial ischemia in eases of coronary 
stenosis. A decrease in anerial compliance due to aneriosclerosis has been known in 
patients with coronary artery disease. The aim of this study was to clarify the 
effects of arterial compliance on coronary flow dynamics and exercise capacity of 
patients with stable angina. 
Coronary flow velocity (CFV) was measured in 10 patients (CAD group) with 
single vessel disease (50% to 90% coronary stenosis) of tbe left anterior descending 
coronary anery (LAD) and in 6 patients (control group) without coronary stenosis. 
A Doppler catheter was positioned at the proximal ponion of the LAD, and CFV 
was measured at rest and after an intracoronary injection of 6 ml of contrast material 
(Iopamidol). The peak to resting velocity ratio (PRVR) was calculated as an 
estimate of the coronary flow reserve. The time interval (fpv, time to peak 
velocity) between the dicrotic notch in aonic pressure and the peak of the diastolic 
CFV was measured as an estimate of early diastolic inflow. A bicycle ergometer 
exercise test W8'\ performed by the CAD group. and the end point of exercise was 
0.1 mV depression of ST segment. ExercLo;e ca;>acity (DPR, double product ratio) 
was expressed as a ratio of maxImal to resting double product (heart rate x systolic 
pressure). . 
The arterial compliance (ACo) and PRVR of tbe CAD group were significantly 
lower Ihan those of the control group (ACo; 1.35 ± 0.33 vs. 1.70 ± 0.35 
mlimmHg. p<O.05: PRVR; 1.6 ± 0.2 vs. 2.6 ± 0.5. p<O.Ol, CAD group vs. 
control group). The Tpv of the CAD group was prolonged (136 ± 42 vs. 62 ± 14 
msec, p<O.OOI, CAD group vs. control group) compared to the control group. In 
the CAD group, the PRVR and Tpv correlated well with anerial compliance 
(pRVR; r=O.75, p<O.Ol: Tpv; r=O.68, p<O.OOI). The DPR correlated well with the 
anerial compliance and PRVR (ACo; r=O.72, p<O.05: PRVR; r=O.75, p<O.05). 
However, there was no correlation between the extent of coronary stenosis and the 
DPR. In the control group, there were no correlations between anerial compliance, 
PRVR and Tpv. 
Conclusion: These results indicate that a decrease in anerial compliance affects 
the PRVR and Tpv of stenosed coronary anery cases, and that the extent of arterial 
compliance is a determinant of the exercise capacity in patients with stable angina. 
869·56 
Which Stress is Best? Exercise, Dobutamine, Dipyridamole 
and Pacing in an Animal Model 
Pamela R. Paulsen, Todd Pavek, Melanie Crampton, Roben J. 
Bache, Roben Boudreau, David C. Homans, University of 
Minnesota, Minneapolis. Minnesota 
Non· invasive detection of coronary artery disease relies on the 
ability of a sttess to shift the myocardial oxygen supply/demand 
balance sufficiently to provoke ischemia that is not apparent at 
rest This study tested the hypothesis that sttesses used to provoke 
ischemia differ in their effects on oxygen demand, blood flow and 
regional function. Seven chronically instrumented dogs were 
studied during exercise (EX), dobutamine 20 mcglkg/min (OB20), 
and 40 mcglkg/min (OB4O), dipyridamole 0.7mglkg (DIP) and 
rapid atrial pacing (RAP) while wall thickening(%Th), myocardial 
oxygen consumption (MV02), and myocardial blood flow were 
measured. Dogs were studied under control conditions and during 
partial inflation of a hydraulic occluder to create a critical stenosis. 
With no coronary stenosis (S·) MVD2 was greatest with EX (247 
vs 124 m1/min/mg control, p<O.05) whereas blood flow was 
greatest with DIP. Control %Th in the ischemic zone was 15.9 ± 
4.3%. Thickening during a stenosis was also normalized to 
thickening during the same intervention in the absence of a 
stenosis (S+/S). 
Re~ona1 Wall Thickening (%Th): Ultrasonic Microcrystals 
EX illUO ~ me RAf 
No stenosis (S·) 22±6 25±7 28±9 22±5 ll±5 
Stenosis (S+) 6±5 15±8 13±1O 10±5 2±8 
S+/S· (%) 24+19 54+28 43±30 45±27 19±61 
When function was analyzed as percent systolic wall thickening, 
DB20 caused the least dysfunction (p<O.05) whereas EX and RAP 
caused the most dysfunction. When thickening was nonnalized to 
the same intervention without stenosis (S+/S·), differences 
between interventions were less pronounced. Of the common 
sttess interventions, exercise appears to cause the most myocardial 
dysfunction. 
869·57 
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Prognostic Significance of Dipyridamole Tc·99m Sestamlbi SPECT 
Imaging for the Evaluation of Ischemic Heart Disease 
Carlo D. Santos-Ocampo, Steven D. Herman, Joseph R. McClellan, 
Carol Ewing Garber, Donna J. Cloutier, Gary V. Heller. MEllTlorial and 
Miriam Hospitals, Brown University School of Medicine, PawtUCket and 
Providence, Rhode Island 
While the prognostic value of dipyridamole (DIP) planar thaliiOOl-201 
Imaging is well established, no prognostic studies of DIP Tc-99m 
sestamibi (MIBI) SPECT inaging have been reported. Accordingly, the 
imaging resutts of 138 sequential, unselected patients (pis) referred for 
DIP MIBI SPECT studies were characterized as demonstrating ischemia 
(IS) or no IS. The presence or absence of IS was compared with 
slbsequent cardiac events during an average follow·up period of 8.5 
months. Events included cardiac death in 2 pis, M I in 2, admission for 
unstable angina pectoris in 2 and need for revascularization in 20. 
IS Present~ • EVENTS 
_ DNOEVENTS 
IS Absent I 
0~===;2O=====~~===;~==~~~ 
NUMBER OF PATIENTS 
Cardiac events occurred in 24164 PIS (38%) with IS and only 2f7 4 (30/0) 
with no IS (p<O.OOl). There was no cardiac death or MI in the no IS 
group. 
The 26 pis with events and 112 pis wilhout events were compared 
with regard to age, sex, history of diabetes mellitus, hypertension, prior 
MI, prior revascularization and the presence of IS on DIP MIB!. Only 
age (71 'IS 66 years, p<O.OO1) and the presence of IS (92% 'IS 36%, 
p<0.OO1) were significantly different between the groups. 
Conclusion: The presence of ischemia with dipyridamole Tc-99rn 
sestamibi SPECT inaging has prognostic value in predicting Mu'e 
cardiac events in patients referred for pharmacologic stress testing. 
869·58 
AbaeDce of AdeDoaiDe-IDduced Cheat PaiD 
FolloviDq DeDervatioD 
Barry D. Bertolet, Roger M. Mills, Jr., Luiz 
Belardinelli, James A. Hill. University of 
Florida Health Sciences center, Gainesville, FL 
The mechanism of angina-like chest pain induced 
by adenosine is unknown. Approximately 50% of 
patients receiving intravenous (IV) and nearly 
100% receiving intracoronary (IC) infusions of 
adenosine experience chest pain. In order to 
assess the contribution of cardiac afferent 
innervation to the sensation of this pain, 22 
orthotopic heart transplant recipients (20 men, 
2 women; mean age 52 years (range, 25-66); 
average 2.0 years post cardiac transplant 
(range, 1 week-6 years) were studied. 
Adenosine was administered either as a 2 mg IC 
bolus into the left anterior descending artery 
(N=ll), or as a continuous IV infusion (N=ll) 
titrated to systemic side effects (average dose 
100 ug/kg/min). 
RESULTS: No patient had obstructive coronary 
artery disease. Three patients developed heart 
block with IC adenosine. None of the remaining 
19 had ischemic ECG changes during adenosine 
infusion. Despite systemic effects (nausea=l, 
headache=2, flushing=2, 3rd degree AV block=3, 
dyspnea=14), only one patient experienced 
anginal-like chest pain, which occurred with 
transient heart block induced by IC adenosine. 
CONCLUSION: Adenosine-induced chest pain is 
cardiac in etiology, and intact cardiac 
afferent innervation is necessary for the 
transmission and sensation of this pain. 
JACC Vol. 21, No.2 
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869·59 
Impairment of the Hyperemic Response in Women With Syndrome X: 
Beneficial Effects of 17~·Estradiol 
Giuseppe M.C.Rosano, David C.Lindsay, Peter Collins, Philip M.Sarrei 
and Philip A. Poole-Wilson. National Heart & Lung Institute, London, 
United Kingdom. 
Many patients diagnosed with syndrome X (angina pectoris, positive 
exercise test, normal coronary arteries) are women in the menopausal or 
perimenopausal age group and have evidence of a widespread disturbance 
of vascular function. To evaluate the hyperemic response to ischaemia 20 
syndrome X (SX) women and 12 age and sex matched controls underwent 
repeated measurement of finger pulp blood flow by a laser Doppler 
velocimeter at rest, during and after five minute brachial artery occlusion. 
SX pts had an increased baseline (base) blood flow (expressed as the mV 
output of the apparatus) compared with controls before treatment (751 ±372 
vs 318±270mV, p<O.OS mean±SD) and a lower maximumlbaseline flow 
ratio after release of the blood pressure cuff (0.99 vs 3.8, p<O.OI). To 
evaluate the effects of oestrogen on the hyperemic response 10 of the SX 
women (mean age 55±6 years) and 10 sex and age matched controls were 
studied. The 10 SX pts underwent treatment for 2 months with 17{J•
estradiol patches (50-100 micograms/day). SX pts showed a higher base 
blood flow compared with controls before treatment (760±450 vs 270±226 
mV, p<O.OI) and a lower maximumlbaseline flow ratio during hyperemic 
response (1.06 vs 2.31, p<O.OOI). After treatment a significantly lower 
baseline (295±230 vs 760±450, p<0.(02) and a significant increase of 
maximumlbase ratio (2.07 vs 1.06, p<O.OOI) compared with pre·treatment 
were found. No significant differences in resting blood flow (295±230 vs 
270±226, p=NS) and hyperemic response maximumlbase ratio (2.07 vs 
2.31, p=NS) were found between patients and normal controls after 
oestrogen treatment. Thus, patients with SX have an increased baseline 
skin blood flow and this is responsible for their limited peripheral 
vasodilator reserve. Estrogen replacement therapy normalises peripheral 
blood flow in patients with SX the potential beneficial effects on coronary 
flow and symptoms have not yet been evaluated. 
869·60 
Role of Coronary Stenosis Reactivity In Variable Tbresbold 
Angina In Patients Witb Cbronic Stable Angina Pectoris 
Agha W Haider. Juan Carlos Kaski. Graham J Davies. Wagner I Pereira, Attilio 
Maseri. RPMS. Hammersmith Hospital. London. UK. 
Patients with chronic stable angina often have 'variable threshold angina' (effon 
angina with marl<edIy variable angina threshold). To assess the pathophysiologic 
mechanisms of variable threshold angina. we studied the history. 
electrocardiography and coronary anatomy of 104 patients (81 men, 23 women; age 
31·76 years) with chronic stable angina and angiograpbica11y documented coronary 
anery disease. 41 patients (39%) had effon angina with fixed angina threshold (a 
similar amount of exercise consistently and predictably producing angina). and 63 
(61%) variable threshold angina. Patients with variable threshold angina had more 
severe coronary anery disease (2·3 vessel disease 73% vs. 49%. p<O.02) and lower 
exercise capacity than patients with fIXed angina threshold (6.20 ± 2.6 vs. 7.34 ± 
2.45 METS. p<0.05). 'Dynamic coronary stenoses' (change in lumen diameter 
> 10% with nitrate and/or ergonovine) were found in 76% of patients with variable 
threshold angina and 36% with fixed angina threshold (p<O.05). Ambulatory 
electrocardiography demonstrated that the episodes of transient myocardial ischemia 
not preceded by an increased bean rate were more frequent in patients with variable 
threshold angina than in those with fixed angina threshold (83% vs. 42%. 
respectively. p<O.05). 
Thus potential for vasomotion at stenoitic site plays an imponant role in different 
clinical manifestations of chronic stable angina. Moreover. variable threshold 
angina is closely associated with dynamic stenosis and is more likely to become 
manifest in those with extensive coronary disease. 
ABSTRACTS 
869·61 
II Pain·discriminating Ability of Cortcx Evaluatcd 
by Pain Rclatcd Ccrcbral Potcntials a Factor for 
Thrcsholds of Anginal Pain? 
Naoki Moriai, Kenji Nakai, OJuichi Itoh, Junya Kamata 
Tomohisa Miyakawa, Kenichi Fukami and Katsuhiko 
Hiramori. lwate Medical University, Morioka, Japan 
Pain related cerebral potentials (PRPs) , a kind of 
somatosensory evoked potential, are considered to be an 
objective marker of the disc:rimination of pain. We studied 
the clinical significance of the PRPs for evaluating the 
thresholds of anginal pain. Subjects consisted of patients 
(mean age: 64.8 ± 8.0 years) with coronary artery disease, 
who revealed ischemic changes on exercise TI·201 
myocardial SPECT (ex. n·201 SPECT). The subjects were 
divided into two groups based on the presence (painful 
group: 16 patients) or absence (silent group: 20 patients) of 
chest pain during ex. TI·201 SPECT. The PRPs were 
recorded from Cz referred to a single ear lobe with the frontal 
lobe as ground during electric stimuli to the left middle 
finger. The PRPs in response to 30 stimuli of a constant 
intensity were averaged in one trial. The stimulus intensity 
was 0.4 mA for the first trial, and was raised in 0.4 rnA 
increments in serial order to a maximum of lOrnA on the last 
(25 th) trial. The stimulus intensity of the electric current at 
which the PRPs began to appear was defmed as the electric 
pain threshold (EPT). The values of the EPT were 3.44 ± 
I. 96 mA for the silent group, and 2.36 ± 0.81 rnA for the 
painful group (P < 0.05). Peak amplitude was as follows; 
painful group: 12.1 ± 5.7 J,lV V.S. silent group: 11.5 ± 4.9 
J,lV (N.S.). There was no significant difference in the peak 
latency (painful group: 315.1 ± 61.5 ms v.s. silent group: 
321.5 ± 70.3 ms). In conclusion, the pain·discriminating 
ability of the cortex evaluated by EPT may be one of the 
objective factors for determining thresholds of angina1 pain. 
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870·80 
Dispersion or "Rerractoriness" in patients with Ventricular 
Fibrillation in the chronic phase or Myocardial Infarction. 
Anand Ramdat Misier, Tobias Opthof, Jessica Vermeulen, Norbert van 
Heme!, Jo Defauw, Jacques de Bakker, Frans van Capelle and Michiel 
Janse. St Antonius Hospital, Nieuwegein ; University of Amsterdam and 
the Interuniversity Cardiology Institute, The Netherlands. 
Ventricular fibrillation (VF) intervals were measured during arrhythmic 
surgery in two groups of pts on cardiopulmonary bypass, at 
normothermia and at noninfarcted myocardium. One group of pts (VF 
group) had suffered circulatory arrest with documented VF. The other 
group of pts had experienced hemodynamically tolerable ventricular 
tachycardia (VT group). A grid of electrodes was used for simultaneous 
epicardial recording of VF intervals during 4 sec at 64 sites. VF was 
induced by premature stimulation. At each site the intervals between 
consecutive local depolarizations were measured. The average value, the 
so-called VF interval, is an index of local refractoriness. Dispersion of 
• refractoriness· was defined as the coefficient of variation ( SD * 
100/mean VF intervals at all sites in one heart). 
VF interval Coefficient of variation 
VT group (n=7) 136 ± 5.5 ms 1.55 ± 0.40 
VF group (n = 7) 129 ± 3.4 ms 3.63 ± 0.56* 
*p<0.01 
In conclusion' Dispersion in "refractoriness" is significantly larger in 
the VF group. This suggests that the amount of dispersion in 
"refractoriness" in the normal myocardium of patients with a chronic 




Site Speclfity of Ventricular Tachycardia Induction by 
Programmed Electrical Stimulation Is Related to Dispersion 
of Action Potential Duration 
Bettina S. Koller. Pamela E. Karasik. Allen J. Solomon. Michael R. 
Franz. Georgetown University and V AMC. Washington. DC 
Backamund' It is well app~ted that venuicular ~hyca.rma <':'11 
inducibility varies with the SIte of programmed electrical sumulabon 
(PES) but the mechanism underlying this site ~lCity. is ~o~ 
The purpose of this swdy was to ~t the hypo~ that SIte ~ty 
is related to disparate action potential durabons m the human ventncle. 
In 21 patients undergoing evaluation of vr inducibility. a monophasic 
action potential/pacing combination catheter was used to perform PES 
and to measure action potential duration (APD) and effective refractory 
period (ERP) simultaneously at two RV sites (ape~ and outflow tract). 
and the conduction delay (CD) between the two SItes. 
B.c.sW.Is; RV sites at which extrastimulation resulted in sustained vr 
(15126 sites) had shorter action pote~tial ~urations (22~.6±22.~ msec) 
than RV sites at which vr was not mduclble (11126 Sites) which had 
APDs of 246.0±21.1 msec (p<O.05). vr induction at sites with 
shorter APD was associated with marked conduction slowing; 
cumulative CD during repetitive extrastimulation (S2-S4) increased 
20.4 times when vr was inducible. which was significant greater than 
in non-inducible uials (cumulative CD increased 12.3 times. p<O.05). 
Conclusjons' Site specifity of vr i~duci~ility c8!l be expl~ed. by 
dispersion of APD. Stimulation at Sites With earlier repolanza~on 
might increase the likelihood of the propaga~n~ w~vefront ~ colli~e 
with sites not yet repolarized, while waves ongm~g from sites WI.th 
longer APD are It!Ss likely ~ encou.nter refractonness and result m 
functional block or conducuon slowmg. 
870-82 
"Tightness" of Extrastimulation Must Be Viewed Relative 
to Local Repolarization. . . 
Bettina S. Koller. Pamela E. Karasik, Allen J. Solomon. Michael R. 
Franz. Georgetown University and V AMC. Washington. DC 
Background. Inducibility of ventricular tachycardia (VT). by 
programmed stimulati~n increases. with the nU'!lbe~ of successive 
extrastimuli (ES) and IDversely WIth the couplmg IDtervai of ES. 
However. the mechanism underlying the increasing vr inducibility 
with more aggressive extrastimulation has never been demonstrated 
clinically. . 
Methods and usults. Using 2 monophasic action potentiallpac~g 
catheters for extrastimulation in 33 patients, we measured at 2 RV Sites 
simultaneously local action potential ~uration (API?), ~ffective 
refractory period (ERP) and ERPI APD rano, and condUCtion time (<;D 
between the 2 sites during repetitive ES (S2-S4) at the tightest coupling 
intervals resulting in vr. There was no significant difference in the 
cumulative coupling interval (S2-S4) between vr-inducing and 
noniducing trials (640.2±23.9 msec vs 648.6±19.9 msec, p = 0.15). 
However, the ERP/APD ratio during ES was significantly smaller 
(0.87:tO.II) at vr-inducing vs.noninducing sites (0.98±O.1; p<O.05). 
An ERPI APD ratio below 0.85 was associated with a cumulative cr 
increase of 129 % and 87% vr inducibility while an ERP/APD ratio of 
0.98:tO.09 and cumulative cr increase of only 22% was associated 
with II % vr inducibility (p<O.OI). 
Cnnclusjons. The ability to induce vr by ES does not depend on the 
absolute coupling intervals but rather on the proximity of ES to the 
preceding repolarization phase. Therefore,. "tightness." of ES ~ould be 
viewed in the context of simultaneous acbon potential recording. 
870-83 
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Presence of Earll-after Depolarizations in Patient With 
Congenital Long QT Syndrome 
Emmanuel Drouin, Chantal Gauthier, Flavien Charpentier, Jean C. 
Chevallier, Jean L. Michaud, Herve Le Marec. Laboratory of 
Cardiology UA-CNRS 1340. Nantes, France. 
Experimental and clinical evidences suggested that long QT syndrome 
(LQTS) could be due to early-after depol~on (EAD). In .order to 
test this hypothesis we used standard IDlCTOelectrode techruques to 
record transmembrane action potentials (AP) of posterior papillary 
muscle (PM) excised at the time of mitral valve replacemen~ fro~ a 
man with LQTS. The patient was a member of a large family wllh 
LQTS. Before surgery. ECG parameters were: heart rate: 55 
beats/min. QT : 600 msec. QTc : 574 msec, and a large U wave was 
present in the precordials leads. PM was superfused with Tyrode 
solution (37:tO,5°C, 95% 02-5% CO2) and stimulated at pacing cycle 
lengths of 1000 msec. We mapped the PM to look at AP 
characteristics. A large heterogeneity was found in the AP duration 
(APD). Some AP were short or normal (APD90%-300 msec) and 
others were very long (APD90% -620 msec) with a small phase 2 
EAD. Such heterogeneity was never present in PM excised from 
patients without LQTS (n=~) and EADs were. never seen: These resul!s 
are in agreement with preVIOUS MAP recordings and ~Ith hyp~thesls 
of abnormal cardiac substrate at the cellular level Involved In the 
repoIarization process in patients with LQTS. 
870-84 
Evidence of Unbalanced Autonomic Activity by Hourly Analysis 
of Heart Rate Variability in Sudden Cardiac Death Survivon 
Lii Fei. Mark Anderson, Demosthenes Katritsis. Carl 
Shakespeare, A John Camm. SI George's Hospital, London, UK 
Background: Although decreased 24-hour heart rate variability 
(HRV) has been shown to be associated with increased risk of 
sudden cardiac death (SCD), the predictive value of hourly HRy 
remains uncertain. ThIs study aims to study the hourly HRV In 
SCD survivors compared with normal subjects. 
Methods: Eight chnically healthy subjects (5 men and 3 women, 
aged 37:!: 12 years) and eIght patients with aborted SCD who were 
treated with implantable cardioverter-defibrillators (6 men and 2 
women, aged 40:t 14 years) underwent 2-channel 24-hour Holter 
monitoring. All subjects were in normal sinus rhythm and had 
normal A V conductIon. No patient was taking any antiarrhythmic 
drug. Spectral HR V was analyzed on a Marquette Holter analysis 
system and expressed as total (TF. 0.01-1.00 Hz), low (LF. 0.04-
0.15 Hz) and high (HF. 0.15-0.40 Hz) frequency components for 
each hour. Hourly mean heart rate (MHR) was also calculated 
from the same Holter tapes. 
Results: 
Normal SCD 
TF ~ms~ 52:t20 44:t 18" LF ms 34:t 13 29:t 13" 
HFWs) 19:tll 16:t 11' 
LF/ F 2.00:t0.49 2.16:t0.74· 
MHR (bpm) 73:t 14 78:t 12" 
• p < 0.05; •• p < 0.01 
Conclusions: The hourly TF, LF and HF components of HRV 
are si~ificantly lower, but the ratio of LF /HF and the MHR are 
signifIcantly higher in SCD survivors co~pared t~ normal 
subjects. These results support the hypo~h~sls that an .JDcreased 
sympathetic and/or decreased vagal actlVlty play an Important 
role in the development of SCD. 
JACC Vol. 21, No.2 
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870·85 
Spontaneous Mechanisms of Onset of Torsade-de-Pointes 
(TdP) in Patients with Acquired Prolonged Repolarization. 
Emanuela H Locati, Pierre Maisonblanche, Fernando Bozza, 
Patrice Dejode, Philippe Coumel. Dept of Medicine, Univ 
of Milan, Italy; Hop Lariboisiere, Paris, France. 
The spontaneous onset of TdPs was analyzed by digitized 
Holter recordings in 12 patients (67% females, age 67~18 
years) with acquired long repolarization (mean QTc 573~ 
57 msec). All ventricular arrhythmias (VA) were graded in 
3 classes: 1) Isolated beats (VPB, n-47147); 2) Salvos of 
2-4 beats (n-2003); 3) TdPs of ~ 5 beats (n-105). In each 
class. six variables (msec) were obtained from 10 minutes 
(MN-IO •• MN-l) and cycles (CL-IO •• CLO) preceding VA onset: 
Class MN(-10-2) MN-l CL(10-3) CL-2 CL-l CL-O 
PVBs 986~247 94~208 897~151 68~79 1104~225 613~81 
Salvos 1042~226 998~194 928~155 601~77 1232~249 637~72 
TdPs 1117~340 991~183 879~177 574~9 1303~181 64~86 
Short-long-short (CL-2,CL-l,CL-0) patterns preceded not 
only TdPs but also salvos and VPBs. By 2-way ANOVA, as 
CL-2 shortened (p<.005) and CL-l increased (p<.Ol) more 
complex VA occurred. Heart rate increased in the minute 
(MN-l) before VA onset (p<.Ol). By multiple regression. a 
set of 4 variables (CL(-10-3),CL-2,CL-l,CLO) had the best 
correlation with VA class (r2-.43,p< 0.005). By discrimi•
nant analysis these variables correctly classified 69% of 
VA (p<.OOl). In conclusion, oscillatory short-long-short 
patterns and heart rate increase preceded all arrhythmias 
in patients with acquired prolonged repolarization. Thus, 
preceding cycle lengths were quantitative determinants of 
the complexity of the following ventricular arrhythmias. 
870·86 
Three-Dimensional Poteotial Distribution Mapping for Rapid 
Localization of Canine and Human Ventricular Tacbycardia 
Chris K. Rokkas, Barry H. Branham, Richard B. Schuessler, Takashi 
Nitta, John P. Boineau, James 1.. Cox. Washington University, Barnes 
Hospital, St. Louis, MO. 
Activation time maps (A TMs) require extensive editing while potential 
distribution maps (PDMs) provide a rapid and accurate means for the 
precise localization of ventricular tachycardia (VT). PDMscorrelate 
with the concomitant activation sequence and can locaIize the site of 
reentry. Because maps displayed as fiat projections can be confusing 
and difficult to interpret, a realistic 3D model of the ventricles was 
created from a sequence of 2D magnetic resonance images of fixed 
hearts. Three-dimensional maps can be displayed as a movie of 
developing and receding potentials immediately after the data are 
collected and analyzed by a 25O-channel system. Real time rotation 
of the model with interactive display of endocardial and epicardial 
surfaces allows precise identification of the site of earliest 
breakthrough of the vr wavefronts. In a canine model of septal vr, 
15 morphologies were mapped in 12 dogs (CL - 210 ± 2 msec). 
Form·fitting endocardial and epicardial molds containing 250 unipolar 
electrodes were used to record potentials from the endocardial 
surfaces and the epicardium. Site of origin was on the left septal 
surface (n = 5), right septal surface (n .. 7), or intraseptal (n = 3). 
Successful ablation with radiofrequency energy delivered through the 
mapping electrodes conftrmed accurate localization of yr. In four 
patients undergoing surgery for vr, eight morphologies were mapped 
(CL = 340 ± 40 msec). In three patients, three morphologies 
originated from the left septum and one from the left free·wall all 
successfully ablated. A fourth patient had multiple macroreentrant 
morphologies. Three-dimensional PDMs accurately localized the site 
of earliest depolarization in both canine and human vr and correlated 
well with intraoperatively constructed 2D PDMs and ATMs. We 
conclude that 3D imaging provides realistic display of data and greatly 
improves the ability of PDMs to rapidly localize the site of origin of 
vr for the purpose of surgical ablation. 
ABSTRACTS 
870·87 
T Wave Alternans in Long QT Syndrome 
Wojciech Zareba, Arthur J. Moss, Jennifer L. Robinson, and LQTS 
Study Research Group. Universiry of Rochester Medical Center, 
Rochester, NY 
Twave altemans (TwA) is a rare ECG fmding usually seen in 
patients with QT prolongation. The aim of study was to evaluate the 
clinical significance of morphologic rypes of TwA, recorded in 30 
patients (2.5%) of 1193 patients with Long QT Syndrome (LQTS; 
QTc>O.44sec.) enrolled in the LQTS Multicenter Registry. Based 
on the magnitude of the bidirectional change in consecutive T waves 
on 12-lead ECG, TwA was categorized as mild (n=9) versus 
advanced (Adv.TwA; n=21). The pertinent clinical findings as well 
as cardiac death (CD), cardiac arrest (CA), and syncope (Sy) rates 
are as follows: 
Yariablcs MildlwA Adv IwA Il villllC 
Age (mean) 21 ±20 9± 10 .013 
<20yr 4(22%) 19 (90%) .006 
QTc (mean) 0.54±0.06 0.63±0.09 .008 
~0.60 1 (11%) 12 (57%) .024 
CD 0 3 (14%) ns 
CD orCA 0 10 (48%) .012 
CDorCAorSy 4 (44%) 17(81%) .045 
Conclusion: Advanced forms of T wave altemans are observed 
mainly in childhood in LQTS patients. Presence of advanced T 
wave altemans is strongly associated with longer QTc duration and 
higher event rates than in LQTS patients with mild forms of T wave 
altemans. 
870·88 
Beta-blockers Markedly Affect aT Dispersion During Exercise In 
Long aT Syndrome Patients. 
.E.IL.Z!JAQ, Katherine Timothy, Jolene Fox, G. Michael Vincent. 
Departments of Medicine, LOS Hospital and University of Utah 
Health Sciences Center, Salt Lake City, UT. 
In LOTS patients the degree of oTc dispersion (dis) may be an 
indicator of ventricular tachycardia (VT) risk and of antiarrhythmic 
drug efficacy. While beta-blockers (BB) reduce risk of VT in LOTS, 
oTc dis at rest is not different after BB. To further evaluate this 
apparent discrepancy, we examined BB effects on oTc dis on 12 
lead ECG during bicycle exercise (EX). 
MdmlIl: 9 LOTS and 6 normals (N) were studied before (0) and 
after Esmolol (BB). oTc dis (difference between the maximum 
(max) and minimum (min) oTc values) was calculated at each stage 
of EX and recovery (diagram). Statistical evaluation by Pearson's 
correlation for 0 vs BB administration at 15 minute EX are shown, 
except • are from t test comparison. 
BHY!t!: ~~,,-,cmox UTe min U~ c a,. 
u u.~ .... + u.\N"~X u .... u~ .. , + 0.OOZ3' 
BB 0.484·0.00307x 0.44 0.0474·0.00119x 
LOTS P < 0"",,-1 < u.0498 < 0.001 
0 0.429·0.00104x O.~ 0.019.·0.00108x 
N ~ ~~4. ~ ~' ••. 0.00108. 
P > 0.5 > 0.1 > 0.1 
LUTSvs N 0 < 0.001' < 0.001 < 0.001 
BB < 0.001' < 0.001 < 0.001 
x - mInutes IStage). .. 
Conclusions: oTc dis during EX .. 
markedly increased in LOTS and 
1-decreased in N. BB significantly I~ j .. -&. decreased oTc dis in LOTS during - .... EX, mainly by shortening oTc max - ... £.QT and partly by lengthening oTc ; -




Dispersion of Repolarization as a Marker to Predict 
Efficacy of Antiadrenergic Therapy 
Silvia G. Priori, Carlo Napolitano, Livia Diehl, Peter J. 
Schwartz. 
Depts of Medicine, Univ of Milan and Pavia, Italy 
Excessive dispersion of repolarization is considered as a 
contributing factor to QT interval prolongation in long 
QT syndrome (LQTS) patients (pts). However, it is unknown 
if the degree of dispersion correlates with the presence 
of ventricular tachyarrhythmias (VTA). We assessed QT 
dispersion in 12 leads ECG in 12 LQTS pts in whom syncope 
and cardiac arrest were not prevented by beta-blockade 
(BB), but were abolished after left cardiac sympathetic 
denervation (LCSD), and in 15 age matched controls. QTc 
dispersion was assessed as QTcmax-QTcmin (msec-!) and as 
the Variation Coefficient of QTc [(Standard Deviation! 




69 ~ 20 
171 + 40 * 
QTc Variation Coefficient 
5.3 + 1.9 
10.1 ~ 2.9 * 
LQTS LCSD 73 ~ 26 ** 5.1 ~ 1.9 ** 
*p< 0.0001 vs controls **p<0.005 vs pre LCSD 
Thus, high risk LQTS patients present excessive 
dispersion of repolarization. When VTA are prevented by 
successful LCSD, dispersion of repolarization b~comes 
comparable to that of the control group. QTc dispersion 
is an important marker of electrical instability in LQTS 
patients and can help in predicting therapeutic efficacy. 
870-90 
QTIItR Ilelatioasbip ill PostmyocardiaJ laIardioa I'IItiaIIs WIlllIIIId Without 
Life-'J'breaIeniDg Veatricular Arrb)'tIuDiM. 
Xavier Viiiolu, EduanI HOOII, Vicem Marti, Jooep CluiDdo, 
AnIooio Baytlo de Lama. 
Hospilal de Saul Peu, BaroeIoDa, SpaiD. 
We aMIyz.ed the QTIRR. iDlerval reIaIioaIbip ill 3 cliff ... poupo of 
poIiema(pta.). 14 poet-MI pta wiIb Suaioed VT or VF (Or.I), 20 poet_mi pta 
wiIbout VTNF IIIIIcbed for bueIioe c:bono<:teriotiOr.D} and 10 I..lIhy 
oubjecU (Or.Ill). QT and RR iDlerval -. durio& a 24 h Holler 
reconIiDc ill a dru& free _ ... uoed. Eocb '- ____ m!lolJ>otically 
uaq a DeW computer aJgoriIhm. M ..... QTc iaterval and QTIRR. reIatioaabip ---. 
Reoults: 








QTIRR. iaterval reIatiooship ill the 3 poupo ia ohown ill figure 1. Or.! QTIRR. 
reIatiooship is cliff ... from the other 2 poups. No difJereoceo axilla &IIIDIII 
poot-MI pta wiIbout vGriaalar anbythmiu and I..lIhy IUbjecU. 
Coociwlions: Pool•
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HEART RATE VARIABILITY AFTER VENTRICULAR 
PACING. CORRELATIONS WITH CLINICAL DATA. 
Beatrice Brembilla-Perrot, Daniel Beurrier, 
Arnaud Terrier de la Chaise 
CHU of Brabois 54500 Vandoeuvre FRANCE 
The purpose of the study was to report another 
method permitting to easely evaluate heart 
rate (HR) variability. HR was studied in 167 
patients during one minute following a 
ventricular pacing up to 200 beats.min. In 48 
patients without underlying heart disease the 
sinus rate was initially accelerated during 2 
to 5 seconds and then suddenly slowed. The 
mean decrease in HR was 36±18%. In patients 
with underlying heart disease the decrease in 
HR was smaller and in those with left 
ventricular ejection fraction <30% the mean 
decrease in HR was 24±17% (p<O.OOl). The 
injection of 2 mg atropine suppressed the 
variations in HR after ventricular pacing 
while oral betablockers did not alter 
significantly the changes in HR. The clinical 
history and the follow-up demonstrated that a 
mean decrease in HR~40% was found in patients 
younger than 40 years and/or in patients prone 
to an increased vagal tone. An decrease in HR 
<10% was associated with a bad prognosis : 12 
of 35 patients (34%) with decrease in HR <10% 
died from sudden cardiac death compared to 1 
of 125 with decrease in HR>10%. 
In conclusion HR variability may be evaluated 
after ventricular pacing. The principal 
mechanism was the increased vagal tone. Its 
decrease was correlated with a bad prognosis. 
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871·1 
Long-Term Dual Chamber Pacing Reduces Left Ventricular 
Mass in Patients With Obstructive Hypertrophic 
Cardiomyopathy. 
Nicolas Sadoul, Jean-P Simon, Jean-F Bruntz, Karl Isaaz, Christian 
de Chillou, Daniel Beurrier, Bernard Dodinot, Etienne Aliot. 
Depanment of Cardiology, University Hospital, Nancy, France. 
Obsrructive hypertrophic cardiomyopathy (OHCM) is characterized 
by the association of LV hypertrophy (L VH) with a left 
intraventricular systolic pressure gradient (lVSG). Recent studies 
have shown that long-term DC pacing reduces IVSG and relieves 
symptoms in pts with OHCM but its effects on L VH remain 
unknown. We prospectively studied the influence of long-term DC 
pacing on L VH quantitated by echo derived LV mass index (g/mIl2) 
in 10 pts (7 men, age 56± 18 yrs) with symptoms refractory to 
medical therapy. A-V delay was programmed to obtain maximum 
IVSG reduction measured by continuous wave Doppler. LV mass 
index and IVSG were measured before (DEI), 1 day after (DE2) and 
3-1 months (DE3) after pacemaker imp antation. Results: 
mmHg g/m2 ___ 
100 




•• ..JL • ..J 
LV mass Index .-" --•~D~E~I----~D~E-2----D~O~'--~ 
L NS .JL •• ...J 
L V mass reduction was related to a decrease in septum wall 
thickness with no change in cavity diameter. 
Conclusion: ollr study suggests that long-term DC pacing reduces 
L V mass in pts with OHCM, This decrease in left ventricular 
hypenrophy may be due to IVSG reduction induced by DC pacing 
leading to improved ventricular loading conditions. 
lACC Vol. 21, No.2 
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871·2 
Usefulness of Temporary Dual Chamber Pacing Before a Possible 
Pacemaker Implantation in Patients With Obstructive 
Cardiomyopathy 
Jean p.simon. Nicolas Sadoul. Christian de ChiJlou. Daniel Beurrier. 
Bernard Dodinot, Etienne Aliot. University Hospital. Nancy. France. 
In order to determine the possible benefit of a pacemaker (PM) 
implantation in patients (pis) with drug resistant obstructive hypertrophic 
cardiomyopathy (OHCM) and normal A V conduction. we studied the 
possible reduction in systolic gradient (SG) induced by temporary dual 
chamber (DC) pacing in 8 pts (4 men) (mean age ± SO = 57 ± 21). Two 
catheters were positionned in the right atrium and ventricle and were 
connected to an external DC PM. SO was determined by doppler 
echocardiography at various predetermined sensed atrioventricular delays 
(AVO) (=VAT pacing mode) which allowed complete right ventricular 
capLUre. Permanent PM was implanted if a 25% SO reduction was 
achieved. 
Results: SO was reduced in all but I pt (- -). The maximum SO reduction 
was obtained with a mean AVO of 55 ms. A further decrease in the A VD 






,--"-'--'-- pd."1 ------, 
: __ pd,ll_ -. • - - -DS - --
... - - - ..... 
AVD o ~ ______________________________________ (_-.) 
Baseline 100 70 SS 40 
Condusion. In drug resistant OHCM. temporary DC pacing with SO 
determination at various sensed AVO is a useful tesl to select pts in whom 
SO decreases with pacing and who hence could benefit from a PM 
implantation. 
871·3 
Cboice 0' Pacini Mode Arter Atrio-ventricular Conduction 
System Ablation for Refractory Atrial Fibrillation 
Andreana Siu, Daniel Bradley. Anne F. Chazouilleres. Michael D. Lesb. 
Melvin M. Sc:beinman. Jerry C. Oriffm. University of California, San 
Francisco. CA. 
A portion of patients undergoing A V conduction system ablation for 
~ auiaI fibrillatiOD/flllller have paroxysmal anltythmias. We 
prospectively studied 98 patients undergoing A V c:onductioo system ablation 
for refractory auiaI fibrillation in order to determine the proportion in which 
dual chamber (DC) pacing couJd be used and the loog-term success of that 
approach. A DC pacemaker was used in every palientllOl having a history of 
persistent anltythmia, and a single chamber (SC) pacemaker in the remainder. 
VVI/VVIR 
DDD/DDDR 
1/ of PIS. Age EF 
64 (65%) 64±15 52%±13% 







Only the mean follow-up period was significanlly different for 
patients receiving SC and DC pacemakers (p<O.OO I). There were two late 
complications requiring openuive revisioo in the SC group and one in the DC 
group. 
DDD DDDR DOl 
Discharge 15 4 2 







At the time of discharge. 94% (32/34) of patients were in a DC mode 
compared to 74% (25f34) after 17.4 mooths of follow-up. During follow-up. 
SO% (17 f34) of these patients required a change of pacing mode. All 5 with 
DOD pacemakers remained in DOD mode. Of 29 patients with a ODDR 
pacemaker. 20 (69%) remained in some DC mode and 9 (31%) were 
reprogrammed either to VVI or VVIR (7/9 for persistent auiaI fibrillation). 
Cooclusions: I) A third of our patients with refractory atrial 
fibrillation could be paced with dual chamber pacemaker and 2) most of them 
sustained some form of dual chamber pacing over 18 months. 3) The short 
term complication rates were similar to those for single chamber pacing. 4) 
Devices with exlellSive mode programmability are preferred since mode 
changes are frequent 
ABSTRACTS 
871·4 
A Unique New Pulse Generator Feature for Protecting 
Against Loss of Capture in Pacemaker· Dependent Patients 
with Bipolar Lead Fracture 
Jonathan F. Mauser. Thoma~ Risser, Gregory J. Bonavita. 
Carlos Cuello. Alan B.Wagshal. Shoei K.Stephen Huang. 
University of MassachusetL~ Medical Center. Worcester. MA. 
Sudden ventricular lead fracture with loss of capture can lead to 
tragic consequences in pacemaker-dependent (PD) patients. We 
recently encountered 2 PD patients (age 45 &78 years) with 
outer-coil fractures in their bipolar ventricular leads who averted 
potentially catastrophic outcomes through a new safety feature 
incorporated into their pulse generator (Intermedics Cosmos 11). 
Both patients were asymptomatic in A V sequential pacing; the 
malfunction was found during routine pacemaker evaluation. 
Application of the magnet resulted in symptomatic loss of 
ventricular capture. Telemetry revealed a markedly high bipolar 
lead impedance (>2.5 kohm) and normal unipolar lead impedance 
(400-600 ohms). Chest radiographs and intraoperative lead 
inspection confirmed the outer-coil fracture in the infraclavicular 
region of the ventricular lead. The leads were replaced with 
return of normal pacing. The pulse generator monitors the 
integrity of a hipolar lead hy constantly delivering the "Bipolar 
Lead Verilication Pulse" (BLVP) to the sensing amplilier. While 
in DDD mode a detected BLVP in the ventricular channel 
resulL~ in DOO unipolar pacing. while detection of the BL VP in 
the atrial channel results in VVI pacing. THEREFORE this 
unique feature may protect PD patients from symptomatic loss of 
ventricular output despite outer-coil fracture or inadvertent 
programming to hipolar polarity with an implanted unipolar lead. 
It also provides noninva~ive diagnosis of an outer-coil fracture of 
a bipolar lead hy pacing unipolar in a previously bipolar•
programmed pacing system. We feel this feature should be 
incorporated into all devices with programmable polarity. 
871·5 
Major Factors In Interventlonal Lead Extraction Techniques: 
Clinical experience with 1,122 Leads 
Heidi J. Smith. Neal E. Feamot, Charles L Byrd, Paul G. Colavita. 
Charles J. love, T. Duncan SeUers. Bruce L WUkoff 
MED Institute. West Lafayette. IN 
As an alternative 10 traction or open heart surgery tor removing Infected 
pacemaker leads. clinical experience using interventlonal18c:hniques to 
attempt extraction of 1.122 leads from 670 palienlS (ages 8 to 95, mean 
65 years) was evaluated. Procedures were performed by surgeons 
(38%) or cardiologislS (62%) at 132 institutions. Locking stylets and 
sheaths were used to remove leads via the Implantation vein (83%); 
maneuvering devices. retrieval baskets, and sheaths were used 
transfemorally (5%); both approaches were used In 12%. Indications 
were endocarditis/septicemia (11%). Infectionterosion (44%). pacemaker 
reoperation with lead problems (38%). and other (7%). Major factors 
Increasing success were. In order of effect: shorter Implant duration 
(P<.OO01). physician experience (P<.OOOl). and active fixation 
(P<.OOOl). Of 355 atrial, 766 ventricular. and 1 SVC (delbillator) leads 
implanted 0.2 to 264 months (mean 57. median 48). 86% were 
completely removed. 8% partially. and 6% not removed. For physicians 
who had done >20 procedures. 90% were completely removed. 9% 
partially. and 1% not removed; 97% were completely removed or 
removed except for the distal tip. No complications were reported for 
95% of patienlS. Major complications oa:urred in 2.1 % of palienlS (with 
0.6% death). These were: 5 hemothorax (0.7%.1 with highly calcified 
tissue. 1 death). 6 hemopericaldium (0.9%. 1 with h~1y caJcified tissue. 
1 death). 2 pulmonary embolism (0.3%, both deaths). and 1 atriotomy 
to remove a detached, migrating tip. Incidence of ~icaIions was not 
significantly affected by experience. Incidence of thoracotomy following 
failed or partial extraction was 2.2% elective and 1.3% emergent (1.1% 
and 1.5%. respectively. for physicians with >20 procedures). 
Conclusion: Wrth experience and proper patient selection. these 
techniques have a high success rate (higher for short implant duration 




Survival and Functional Independence After Penaanent 
Pacemaker in the Octogenerians and Nonagenarians: A 
Population-Based Study 
Win K. Shen, David L. Hayes, Stephen C •. Hanmi1l, Kent R. 
Bailey, David J. Ballard, Bernard J. Gersh. Mayo 
Clinic, Rochester, MN 
To determine the results of pacemaker (PM) therapy in 
the elderly, outcomes of all 157 pts>80 yrs from Olmsted 
County receiving PM for symptomatic bradycardia between 
1962-1988 were evaluated. There were 87 females and 70 
males. The mean age was 85.2 + 3.9 yrs, ranging from 
80-97 yrs. The median survivaT was 3.9 yrs (Kap1an•
Meier Methods). Observed survivals for pts with (I) 
and without (II) heart disease were compared to age and 
sex matched controls (Northcentral White Population 19:§:' 







Symptoms were e1iminatea or improved in 120 (76%). 
After PM, 70 (45%) were subsequently placed in nursing 
homes (NH). Dementia occurred in 46% Nrl pts and in 22% 
non-NH pts after PM. New cardiac or orthopedic disabil•
ities were not significantly different in NH or non-NH 
pts (p>.1). We conc 1 ude: (1) The normal re 1 at i ve sur•
vival in elderly without heart disease after PM is re•
assuring. The poor prognosis in pts with heart disease 
warrants careful evaluation of the indications and meth•
ods of pacing. (2) PM is effective in alleviating 
bradycardia-related symptoms in the elderly. (3) NH 
placement after PM implantation is a frequent occurrence. 
871·7 
The FlI"eet of Pulse Amplitude. Pulse Width, and Pacing 
Rates on Tnmsvenous Pacemaker Stimulation Impedance at 
Implantation 
Joseph V. Condon, Joseph P. Zbilut, Elizabeth Wimer, 
Annabelle S. Volgman, Joseph E. Panillo, Thomas A. 
Buckingham. Rush Medical College, Chicago, Dlinois. 
Currently there is no standard approach to the measurement of 
pacemaker lead impedance. To measure the effect on 
stimulation impedance, we studied varying pulse amplitudes, 
pulse widths, and pacing rates at the time of implantation. 
Impedance values were measured from 32 atrial and ventricular 
leads using a Medtronic model 5311 pacing system analyzer at 
the following pulse amplitude (PA) and pulse width (PW) 
settings: PA 5V PW 0.5 ms, PA 2.5V PW 0.5 ms, PA 5V PW 
2ms, PA 2.5V PW 2ms. Impedance values were measured at 
pacing rates of 80 or less and at a pacing rate of 100 bpm. 
Repeated measures analysis of variance showed no statistically 
significant difference in impedance values with variation of 
pulse amplitude or pulse width. Mean impedance in ohms was 
584 ± 102 at rates less than 80 bpm and 599 ± 111 at rate = 
100 bpm, p S 0.04. 
We conclude that rate, but not pulse amplitude and pulse width 
has a clinically important effect on pacemaker lead impedance. 
In clinical practice, lead impedance should be measured at a 
standard rate (Le. 100 bpm). 
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Effect or Wind and Cold on Exercise Capadty and Exen:ise-induc:ed 
Myoardial Ischemia in Stable Angina Patients 
Martin Juneau, Lucie Lariv6e, Micb~le de Guise, Mark Smilovitch, 
Jean Perrault, David Waters. Montreal Heart Institute, Montreal, Canada 
This study was undertaken to measure the effects of cold and wind, singly 
and in combination, on myocardial ischemic thresbold. Twelve patients 
with proven coronary disease, CCS class I or 2 angina and exercise•
induced angina and ST depression underwent 4 treadmill exercise tests in 
a randomized sequence using a Bruce protocol. Tests were performed off 
all anti-anginal medication at 20·C with and without a 15 mpb beadwind 
and at -S·C with and without wind. Temperature was controlled accurately 
in a specially designed cold room and wind was provided by a large fan. 
~ ~ zooC+wind £.C -8·C+wind 
Exercise duration (sec) 340±90 334±SO 323±SS 295±91*11 
Time to Imm lST (sec) 243±99 227±69 99±67* 171 ±65*t 
Time to angina (sec) 26H90 276±SO 251 ±SO 249±S9 
RPP at I mm lST x Ht' 19.3±4 IS.2±3 19.5i3 20.0±4 
Max RPP xlO' 22.7±2 22.0±5 23.3±5 23.0±3 
Max ST depression(mm) 2.0±0.7 2.0±0.7 2.0±0.S 2.0±0.6 
* pSO.OI vs 20·C, t p<O.OI vs 20·C+wind, :j: p<O.OI vs -S·C. 
Wind had no significant effects upon exercise endpoints at 20·C. Time to 
the onset of Imm ST depression was reduced by IS% in the cold (p <0.01) 
and by a further 14% with the addition of wind (p=NS). The addition of 
wind to cold further reduced total exercise duration (p < 0.0 I). Rate•
pressure product at the onset of ischemia and at peak exercise did not 
differ significantly among the 4 experimental conditions. 
Conclusion: In patients with stable angina, wind does not greatly influence 
exercise capacity or time to iscbemia at normal temperature. Exercise 
induces myocardial ischemia earlier in a cold environment and this 
reduction in exercise capacity is accentuated by wind. 
872·111 
Hemodynamic ComparllOn of the ACIP and Modified ACIP 
Veraus Bruce and COrnell Exercl.. Protocola 
Beaver Tamesis, Art Stelken, Sheila Byers, LesIee S'-, Uwa Younis, D. 
Douglas MUler, Bernard R. Cha~man, San louis UnIversIy, St. louis, MO 
The ACIP and modHied ACIP (MACIP) treadmill exercise protocols 
were developed to resul in a linear increase in workload b8Iween Slages 
in patients with coronary disease. The physiologic changes that occuned 
w~h ACIP and MACIP were co~ to the Bruce and ComeD protocols 
in 28 normal volunteers and 16 men with coronary disease. The exercise 
protocols were randomly assigned over two days. Gas exchange data 
were coUectad contillJOUSly with each test. In /lOnna! subjects. peak heart 
rate, sySlolic blood pressure, peak V02, minute ventilation. were similar 
for the four protocols tested with exercise time shortest tor the Bruce 
protocol compared to the ACIP, MACIP, and COmell protocols (10.2± 3.1, 
13.4 ± 4.9. 13.9 ± 4.S. and 1S.0 ± 4.2 millJles, respectively; p.:O.OO1). In 
normal subjects the difference between predicted and measured oxygen 
uptake was smallest for the ACIP protocol (37.0 ± 11.0 versus 35.8 ± 13.S 
rnl/mirVkg) and greatest for the Bruce protocol (41.1 ± 11.8 versus 36.7 ± 
1S.0 IllVrninIkg). In the patients with coronary disease, peak aerobic 
capacity was signHicantly less than for nonna! subjects (p.:O.OO1). The 
difference in predicted versus measured oxygen uptake in patients with 
coronary disease were greatest for Bruce (29.1 ± 7 ¥s. 22.6 ±S.7) and 
smallest for ACIP (26.9± 7.1 ¥S. 22.S ± 6.7). The ratio of oxygen uptake 
to work rate expressed as a slope was similar for the normal subjects. 
However, in the patients with coronary disease. the slope was 0.84 and 
0.83 for ACIP and MACIP versus 0.61 and 0.71 for the Bruce and Cornea 
protocols, respectively. Ischemic ST segment depression was detected 
in 93.8%, 87.S%, and 100% of patients with coronary disease using the 
ACIP, MACIP, and Bruce protocols. respectively. significantly greater than 
with the COmen protocol (64.S%; p..O.OS). The data Indicate that the 
ACIP and MACIP exercise protocols resuK In a Unear and moderate 
increase in workload resuKing in 6near increments in heart rate and 
oxygen consu~ion between stages with similar peak expired gas 
parameters and sensitivity in the detection of ischemic ST segment 
depression as the standartl Bruce protocol. 
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872·112 
Supine Exercise Induces Profound Hypotension in Patients with 
Autonomic Dysfunction 
Ragavendra R Baliga, Laura Watson and Christopher Mathias 
St MaI)"s Hospital Medical School and The National Hospital for 
Nervous Diseases, London, UK. 
To investisate the role of the sympathetic nervous system 
on haemodynanuc responses to exercise, we studied 7 patients 
with primary (pure) autonomic failure (P AF) and S normal 
subjects. All patients with PAF had postural hypotension and 
severe sympathetic failure on autononuc function tests. None had 
anginal symptoms. Measurements were made in the supine 
~sition before, during and after bicycle exercise at 3 workloads 
(25W, SOW and 7SW for 2 minutes at each stage). Blood pressure 
and heart rate responses were measured using an automated 
sphygmomanometer (Sentron) before and after each period of 
exercise and blood samples were taken for measurements of 
plasma noradrenaline (HPLC) from an indwelling venous 
cannula. 
Basal systolic and diastolic blood pressure was higher in 
PAF (lS2±.16 and 82±.11 nunHg) compared to normals (1l0±.8 
and 68±.9 mmHg, p<O.OS). After 7SW exercise SBP and DBP fell 
in PAF (122±.33 and 61±.17 nunHg, p<O.OS) but rose in normals 
(122±.10 and 73±.8 mmHg, p<O.OSi. Heart rate rose after 
exercise in PAF (67±.11 iO 90±.16 min· , f<O.oS) and in normals 
(71±.12 to 10l±.10 min- , p<O.OS). Basa plasma noradrenaline 
levels were lower in PAF and not increase after exercise (10S±.6S 
to 96±.S8 pg/ml, ns) unlike normals (194±.S3 to 490±.226 pg/rnl, 
p<O.OS). 
In PAF, unlike normals, exercise induces a profound fall in 
blood pressure even in the supine position. This is likely to result 
from sympathetic dysfunction alone and may be due to a relative 
lack of vasoconstriction in major regional (ie splanchnic) vascular 
beds. Sympathetic dysfunction may contribute to exercise induced 
hypotension during diagnostic exercise ECG stress testing. 
872·113 
PopaIaIima SeIec:tiqa -' Pab_ 01 tile IWIa. ~11111 lOr 
ec.-y MIrf 0-. 
I'd« M. Okin. Paul lCIiefioid. ComeIl Medical Caller. New YOIt. NY. 
Performaoce of abe Gem. ECO for abe ideatificatioll of corooary m•
(CAD) it hi,h1y depoodeml 011 popuIatiOll preval_ aDd _enty of CAD md 
011 multiple IOUI'CCI8 of bias in oeIectinl .w.jects md petialll for iDcIusiOll in 
clinical llUdies. To qIIIIltify abe effect of popuIatiOll oeIectiOll 011 test 
...wtivity. ipeCificity. md ovenll performuc:e of IIudard aDd heart rate (HR) 
Idjlllled ST IepICIIl clefn-i0ll criteria for !be delectiOll of CAD. lpeCificity 
was eumined in 212 clinically DotmallUbjects md oeporateIy in 31 patimll 
with DO oiJDifiCUlI CAD at lDaioanpby (OVCAD). aDd ...wtivity _ uaessed 
in 1S3 patieall with clinically liable IDpua aDd oepanICIy in 184 petialll with 
catbeterizatiOll provecl CAD. Selectioo of study popuIatiOll bad. marbd effect 
011 test perfOl1lllDCe: IIudard ECO criteria. abe aimple maanitude of ST 
depreaaiOll. abe STIHR index md tbe STIHR IIope ideatifiecl CAD with 
compuably hiab lpeCificities (94" to 97") in clinically Dotmal .w.jects. but 
with oiJDificontly Jower lpeCificities in patieall with OVCAD (similar values 
for all testa of68" to 77". p=O.OO2 to p-O.OOOI va ipeCificities in clinically 
DOrmaJ IIIbjecll). A1thouab lCIISitivity was oiJDifiCUltly Jower in patimll with 
liable anJina IhID in patimts with prOYCII CAD for IIudard criteria (54" vs 
70". p-O.OO4) aDd for tbe STIHR index (88" VI 95". p a O.04). there was 
DO oiJDifiCUlI difference in tbe poor ...wtivity of abe aimpJe ST depreaaion 
maanitude criteria (51" va 58". p-DS) or in tbe hiab ...wtivity oftbe STIHR 
lIope (93" v. 96". paDS). However. abe 51" to 70" test ...wtivities of 
IIudard criteria md aimple ST depressioo criteria -.. oiJDificantly Jower IhID 
!be 88" to 96" test ...wtivities oftbe STIHR index aDd tbe STIHR lIope both 
in patieall with clinical anJina md in patieall with provea CAD (p<O.OOI for 
all COmparilODS). Comparisoa of areas UDder receiver operatinJ c:bancteristic 
curves COGfirmed thai improvecl ovenll performauce of tbe ST IHR lIope md 
ST IHR index relative to aimple ST depressioa criteria was DOl dependeol on 
popuIatiOll oeIectioD. A1thouJb ...wtivity aDd ipeCificity of both IIIDdard md 
HR Idjlllled ST depressioa criteria vary with oeIectioD of popuIatiOIII used to 
_ test performaoce. lUpel'ior ovenll performuc:e of tbe ST IHR lIope md 
tbe ST IHR index relative to IIudard ST depressioa criteria is DOl • 
CCIIIIOIJII<IIC of patieal oeIectiOll in tbeIe clinically reievlDl popuIatiODS. 
ABSTRACfS 
872·114 
Diagnostic Accuracy of STlHeart Rate Slope 
Measurements Using Four Treadmill Exercise Protocols 
Beaver Iamcsjs. Martin Ast, Art Stclken. Sheila Byers. Bernard R. 
Chaitman. St Louis University. St. Louis, MO 
The ST/bean rale slope derived from linear regression ofbeart rale 
and SI segment ~ssion is reported to improve diagnostic 
accuracy of treadmill exercise testing. panicu1arly when die 
increment in worldoad between stages is gradual We tested a newly 
developed treadmill exercise protocol (Am). and a modiflC8lion 
using a slower walking speed (MACIP) to the Bruce and Cornell 
protocols to determine the sensitivity (Sens) and specificity (Spec) 
for the detection of ischemic SI segment depression ~ 0; 1 mV and 
SI/bean rate slope values of 1.0 m V /beat/mmute in n apparently 
healthy volunteers and 17 patients with documented coronary disease 
and exercise-induced ST segment depression ~ 0.1 mV on routine 
diagnostic testing. Each patient subsequently Wlderwent four 
el'erci se tests on two separate days in random order Results' 
sn ~ 0 I my SIIHR Slope ~ I 0 u\1tbeatlmjn 
Sens % Spec % Sens % Spec % 
ACIP 94 93 88 89 
MACIP 87 93 88 88 
Cornell 6S 89 82 8S 
Bruce 100 89 82 89 
In patients with coronary disease. the sensitivity and specificity 
of ACIP and MACIP were similar to the Bruce protocol using SI • 
and SI/bean rate slope criteria. The Cornell protocol was 
significantly less sensitive in detecting SI. (pea. OS) • but improved 
using ST/bean rate slope criteria. In the coronary disease grouP. 
there were 110 significant correlations between ST/bean slope to peak 
oxygen consumption. or ventilatory threshold, or V~ at the onset 
of SI segment depression ~ O. I m V. The data indicate that ST/bean 
rate slope measurements increase the sensitivity of the Cornell 
protocol. but do not improve the diagnostic 8CCUI'lICy of the ACIP. 
MACIP. and standard Bruce protocols. 
872·115 
•• avy I.o •• trio Ix.roi.. lohooar4ioqraphya A 
N.w M.thod for A ••••••• nt of L.ft v.ntricular 
Wall Motion Patt.rn. in Po.tmyooar4ial 
Infarotion Pati.nt •• Enrique Z. Fisman, Efraim 
Ben-Ari, Amos Pines, Yaacov Drory, Jacob 
Klein, Michael Motro, Jan J. Kellermann. Chaim 
Sheba Medical Center, Tel-Hashomer, Israel. 
The aims of this study were to determine the 
effects of heavy isometric exercise (HIE) on 
left ventricular (LV) wall motion (WM) 
patterns in postmyocardial infarction 
patients, and to compare HIE with dynamic 
exercise for competence in eliciting LV WM 
abnormalities at similar rate-pressure product 
(RPP). Echocardiography was performed in 48 
patients during supine bicycle ergometry and 
during dynamometer streching at 50% of maximal 
voluntary contraction. Systemic vascular 
resistance increased from 1490 to 1652 
dyn/s/cm (p<0.05) at HIE, and decreased from 
1080 to 665 (p<O.OOl) during dynamic exercise. 
WM abnormalities or new asynergy were induced 
by HIE in 126 segments, 110 of which (87%) 
showed significant stenosis of the perfusing 
coronary artery. Hypokinesia was the dominant 
pattern in the range of 76%-90% narrowing, and 
akinesia at 91%-100%. Sensitivity and 
predictive value in identifying specific 
vessel disease was similar for both types of 
exercise. In conclusion, HIE induces WM 
abnormalities of a severity concordant to the 
degree of coronary narrowing. HIE is similar 
to dynamic exercise for ability in identifying 
obstructions in a specific coronary vessel. 
Furthermore, when compared at near-equal RPP, 




The Influence of Peak Systolic Blood Pressure on ST•
Segnent Depression During Exercise in The Absence of 
Coronary Artery Disease 
Timothy F. Christian, Todd D. Miller, Kent R. Bailey, 
Raymond Gibbons. Mayo Clinic, Rochester, MN 
The purpose of this study was to examine the possible 
relationship between exercise systolic blood pressure 
(EXSBP) and significant ST depression (ST DEP)(> 1 mm) 
in the absence of coronary artery disease. All patients 
had a normal resting ECG and normal exercise thallium 
scans. Patients receiving digoxin were excluded. There 
were 1873 patients in the study group: 583 had> 1 mm ST 
DEP during exercise and 1290 had no significant-ST 
change. A separate analysis was done on patients not 
receiving antianginal medications. There was a highly 
significant correlation (p<O.OOOl) between ST DEP and 
EXSBP for both males (M)(n=923) and females (F)(n=950). 
EXSBP (mm Hg) % Pts ST DEP % Pts ST DEP (off meds) 
M F M F 
<200 12.4"2T."5" j/.U ~ 
200-219 35.3 35.2 38.6 35.9 
>220 37.0 30.0 45.7 44.4 
The strongest effect of EXSBP was on women with> 2 mm 
ST DEP (n=67): <200 mm Hg=5.3%, 200-219 mm Hg=11.0%, 
>220 mm Hg=14%. Multivariate analysis demonstrated that 
Gender, EXSBP, body surface area, and age to be 
independent but very weak predictors of ST DEP 
(R2=0.03). 
Conclusion: In the absence of coronary artery disease, 
patients with higher EXSBP are somewhat more likely to 
develop ST DEP, but this association is much too weak 
to be predictive in individual pts. 
872·117 
Rdatiaa of ltt:ot ad Eun:Ue DiIpeniml of hpoIarizIIimIlD IIae 
Prmr:ace ad &1aIt of eon-y AIt«y ~ 
Kevin Lax, Peter M. Okin, Paul Kligfield, ComeIl Medical Caller, 
New Yodc. New Yodc 
To _ Ibe bypothesis that simple ........,.. of dispenioo of npolarizalion 
might be related to !be preseDCe ad eeverity of c:oroauy artery m-se (CAD). 
we examined !be 8IaDdanI devWioo of !be mean l-point to T wave maximum 
intervols _ !be Vl·V6 preconIio1 Ieods (SD-50Tm) durina IreIdmiII 
ClIerciae in 92 clinically DOnDaI mal ad in 79 mea with liable aqina or 
catheterizltioo proved c:oroauy m-se. All DOnDaI lUbjecll ad 011 patients 
hid DOnDaI ft!8Iing BCGs. without prior infarctioo or buDdIe bnncb block. ad 
without ST segment depressioo, T wave inveniOll. or DOOBpeCific T wave 
flattenin,. In each cue, SD·SoTm was calcuIated from !be upriJbt pre-exerciae 
control tncing; in 12 DOnDaIad in 6 CAD patimts, SD-SoTm could DOl be 
calcuIated at peak. symptom-limited ClIerciae because of T wave flattening. 
The mean SD-SoTm in DOnDaI mea _ 10.4 .±.4.5 (8IaDdanI devWioo) msec 
at re&lad 9.0.±. 4.3 msec at peak ClIerciae (p<O.OOOI by pUree! t-test); by Ihe 
meIbod of pen:eotile ellimatioo. 95 lIi of DOnDaI IIUbjecll hid re&I ad ClIerciae 
vol_ of SD-SoTm of 18.1 ad 16.3 1IIIeC. respectively. The mean SD-SoTm 
in patients with CAD was 11.7 .±. S.6 IIIIeC at re&lad 14.S .±. 7.7 msec at peak 
ClIerciae (p < 0.01). Mean vol_ of SD-SoTm were lipificandy bi,ber in mea 
with CAD than in DOnDaIllUbjecll during ClIerciae (p<O.OOOI). but c1iffen:nces 
were less marIced at re&I (p=0.06). SD-SoTm vol_ ClIoeedin& Ihe 9SlIi vol_ 
in norma1 subjecll were fOUDd in 16l1i (13n9) of CAD mea at re&l1IId in 41 lIi 
(30m) of CAD mea at peak ClIercise. Amoog catheterized mea with CAD. 
abnormal vol_ of SD-SoTm were fouDd in 33l1i (7121) ad 79l1i (ISI19) of 
patients with three-vesseI CAD at re&I ad at peak ClIerciae, respectively. IDd 
exercise SD-SoTm idmtified 011 (SIS) patients with left main m-se. Similar 
fiDdinilS. but with c1iff_t mean ad partitiOIl Voluel, were fOUDd in • amoller 
IIUbgroup of women. These data defiDe DOnDaI vol_ for SD-50Tm during 
upriJbt treadmill ClIerciae in men; abDormaI SD-SoTm vol_ occur in • amoll 
proportion of men with CAD even at rest. but abnorma1 SD-SoTm during 
ClIerciae is more seositive for CAD, particularly wilen CAD is ClIleoIive. 
872·118 
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Superiority and Safety of Maximal Exercise 
Testing Early After Myocardial Infarction. 
Avanindra Jain, G. Hunter Myers, Peter M. Sapin, Robert 
O'Rourke. The University of Texas Health Science Center•
San Antonio, San Antonio, TX USA. 
A predischarge low level (HR<70% of age predicted) 
exercise treadmill test (ETT) is common for risk 
stratification after myocardial infarction (MI). To assess the 
added benefit and safety of early predischarge maximal 
ETT, we performed symptom limited ETTs (6.4±3.1 days) 
using a modified Bruce protocol in a consecutive group of 
150 pts (111 men and 39 women). The mean age was 
58±13 years. MI was Q-wave in 85 pts and non-Q in 65 
pts. Most pts (83%) achieved a HR >70% of predicted. 
Average exercise duration was 9.7;t4.2 min with the peak 
HR of 122±23 beats/min and peak systolic BP of 158:t31 
mmHg. No patient had infarct extension, sustained 
ventricular tachycardia or death. Chest pain developed in 
22 pts (13 with positive ETT). ETTs were positive in 34 pts 
(23%) (25 Q-wave and 9 non-Q-wave) at a HR<70% of 
predicted. A significantly more, 26 pts (9 Q-wave and 17 
non-Q-wave) had positive ETTs only after HR >70%. The 
incidence of positive tests among patients with Q and non•
Q-wave MI was the same (40%) at peak exercise. With the 
mean follow up of 15 months in 138 pts (92%) there were 
49 cardiac events. Of the patients with events only 16 had 
a positive test at low level but 29 pts (p<.001) had a 
positive test at peak exercise. Only 5/32 pts with negative 
exercise tests had events. Conclusion: Maximal ETTs 
early after MI appear to be safe and identify additional 
patients with ischemia who are at risk for cardiac events. 
872·119 
Comparison of Neural Network and Logistic Regression 
Algorithms for The Interpretation of Exercise 
Electrocardiography 
Sanjay Pati!, Anthony Morise. Robert Detrano, Marco Bobbio, 
George Diamond, Smai Hospital, Detroit, MI 
Using a neural network and logistic regression analysis, two 
probability algorithms for the exercise ECG were derived using 
912 patients l'l institutions) who underwent exercise ECG ana 
coronary ang1O.grapJly because of suspected coronary disease 
(prevalence 60%). These algorithms were applied to a separate 
set of 608 patients (prevalence 58%). Variables considereo were 
age, sex, symptoms, risk facto~ STand symptom response, and 
magnitude oT stress. Probability outputs were analyzed for 
discrimination by receiver operating cliaracteristic curve areas 
(~OCCA; 1.0 = ~rfect disCrimination) and for cahDra~on by 
X goodness-of-fit (if Xl = 0, perfect calibration and if X < 16. 
gooo calibration). 
All Men Women 
N 608 430 178 
Prevalence 58% 66% 39% 
Logistic Regression 
ROCCA 0.85 0.84 0.84 
Xl 9.8 6.6 9.1 
Neural Net 
ROCCA 0.84 0.83 0.82 
Xl 8.6 3.3 6.9 
F ratios all revealed no difference in calibration. Correlation of 
neural net and logistic regression outputs: r=0.81. p<O.OOOl. 
When applied to the same patients, both algorithms had 
equivalent accuracy, in both sexes. 
Conclusion: Because of their equivalent accuracy to logistic 
regression and their unique ability to learn to identify patterns 
based on past experience. neural networks may be more 
advantageous for applications to clinical decision making with 
exercise testing. 
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873-35 
Contrast Media induced Platelet DegranuJation is dose dependent. 
Nicolas Cbronos, Ulrich Sigwart, • Alison Goodall, Nigel Buller. The 
RoyaJ Brompton National Heart and Lung Hospital and .RoyaJ Free 
Hospital School of Medicine, London. 
Thromboembolic events are recognised as significant side effects of tbe 
use of non-ionic contrst media. Paradoxically contrast media also have 
significant anticoagulant properties in whole blood. To investigate 
whether tbe p1atelet degranulation occuring with non-ionic contrast 
media is concentration dependent we have performed dose n:sponse 
studies, varying the proportion of blood to contrast media to blood. 
Whole blood from normal volunteers was mixed with three different 
contrast media. Non-ionic (Omnipaque), ionic (Urografin) and low 
osmolar ionic (Hexabrix) contrast media were added to varying volumes 
of whole blood in proportions of (contrast media : blood) 1:1 to I: 10 to 
mimic tbe intracoronary concentration during angiography. These 
mixtures were incubated for I minute and tbe platelets were analysed 
for changes in tbe surface expression of two granule membrane 
antigens; namely GMPI40 oftbe alpha granule and GP53 oftbe 
lysosome using fluorochrome 1abelled anti.QMP 140 and anti.QP53 
antibodies and detected by a Cou1ter Epics II Flow Cytometer.At high 
concentrations of contrast media, I: I marked platelet degranu1ation 
occurred with Omnipaque, GMPI40 was expressed on 78.9±.6.0% 
(mean ± SEM) and GP53 on 42.8±5.2 % of platelets. Urograffin 
caused only 17.8±Q.25o/00fplatelets to express GMPI40 and 25.6±Q.35 
to express GP53. Hexabrix caused no degranu1ation as compared to a 
normal saline control. The differences were statistically significant 
(p<0.001). Despite dilution to concentrations less than seen within tbe 
coronary artery during angiography non-ionic contrast media 
(Omnipaque) cause significant platelet degranu1ation. This may explain 
tbe increased incidence of thromboembolic events seen when these 
agents are used. 
873-36 
The Stimulation of Glucose Utilization in Myocytes Via The 
Regulation of Fatty Acid Metabolism 
Salah Abdel-aleem, Xiaomin Li, Mark P. Anstadt, R Anthony Perez•
Tamayo, and James E. Lowe. 
Duke University Medical Center, Durham, NC 27710. 
Glucose loading during hypoxia or ischemia improves mechanical 
function on reoxygenation in cardiac muscle. Since the inhibition of 
fatty acid oxidation is accompained by stimulation of glucose utilization 
in the heart, this study was designed to investigate the mechanism (s) by 
which fatty acid blocking agents (FABAs) stimulate glucose utilization 
in the heart. The effects of FABAs on glucose uptake or pyruvate 
dehydrogenase (PDH), a key enzyme in the pathway of glucose 
oxidation, were studied in isolated rat myocytes. Glucose transport was 
determined by measuring the rate of uptake of [U- 14Cj-D•
deoxyglucose, whereas PDH activity was estimated by measuring the 
rate of oxidation of [2_14C] pyruvate in myocytes. 
The Rate of Glucose Uptake PDH Activiy 
Inhibitor (% of controll (% of con troll 
2-TDGA (SO}lM) 200± 4**(4) 145± 10* (3) 
2-BPA (80}lM) 187± 32* (4) 191± 7** (3) 
Etomoxir (SO}lM) 238± 88* (4) 172± 10** (3) 
4-BCA (JOOuM) 348±141* (3) 125± 5* (3) 
[2-TDGA: 2-tetradecylglycidic acid, 2-BPA: 2-bromopalmitic acid, 4-
BCA: 4-bromocrotonic acid; *p <0.05 & **p<O.OO5 of FABA vs 
control; ( ) no. of experiments j 
Each FABA significantly stimulated glucose uptake and PDH activity. 
These effects may be mediated through the regulation of acetyl-CoA, the 
end product of fatty acid oxidation, in response to the inhibition of fatty 
acids. These data suggest that FABAs may be beneficial during cardiac 
ischemia by facilitating glucose loading. 
ABSTRACTS 
873-37 
Dietary Fish Oil Supplementation Protects Against 
Myocardial Dysfunction and Arrhythmias Caused by 
Ischemia and Reperfusion in Isolated Rat Hearts 
Bai Chun Yang, Tom G.P. Saldcen, Wilmer W. Nichols, Jawabar 
LMehta 
University of Florida and V AMC, Gainesville, FL and University of 
Uppsala, Uppsala, Sweden 
Dietary supplementation with fish oil bas been shown to 
decrease monality after acute myocardial infarction, presumably by 
reducing arrhythmias. To determine the effect of fish oil on 
myocardial dysfunction and arrhythmias following ischemia and 
rcperfusion, 8 Sprague Dawley rats were fed a diet supplemented 
with fish oil (20% of fat) for 5 days. Nine control rats were fed 
butter-rich or ordinary diet. Myocardial content of long chain 
polyunsaturated fatty acids (PUFAs) and n-3 PUFAs increased 52% 
and 55%, respectively, and n-6 PUFAs decreased 42% (all P<O.OI). 
Hearts from both groups of rats were perfused on a LangendorfT 
apparatus, allowed to equilibrate, and then subjected to 15 min of 
global ischemia and 10 min of reperfusion. In control rat hearts, 
ischemia-reperfusion resulted in a marked decrease in cardiac 
contractile force (CCF, 90±7%), increase in coronary perfusion 
pressure (CPP, 68± 12%), fatal arrhythmia and release of creatine 
kinase (CK) in the coronary effiuents. Feeding the rats with fish oil 
significantly (P<0.05) protected against myocardial dysfunction 
induced by ischemia and reperfusion. The decrease in CCF was 
73±9% (vs 90±7% in control hearts), and the increase in CPP was 
35±7% (vs +68±12%). The CK release in coronary effiuent during 
rcperfusion was reduced by over 30% (P<O.O I) in the fISh oil-fed rat 
hearts. The frequency of fatal arrhythmias was 38% in fISh oil fed 
rat hearts compared to 78% in control rat hearts (P<O.OI). In 
addition, platelet aggregation in fISh oil-fed rats was inhibited (7±2% 
vs 63±16%, n-3, P<0.05). These results demonstrate that dietary 
supplementation with fish oil protects against myocardial dysfunction 
and injury as well as arrhythmias caused by ischemia and 
rcperfusion. 
873-38 
Inbalational Administration or Nitric Oxide to Dogs S .. bjected to 
MODOC rota line· Induced Pulmonary Injury 
Joseph R. VanCamp, Flavian M. Lupineui; Department of Surgery, Section of 
Thoracic Surgery, The University of Michigan, Ann ArlKr. Michigan 
Experimemal observations of the effects of inhalational nimc oxide (NO) on 
systemic and pulmonary vascular physiology have obtained inconsis1ent findings. 
Clinical reports of NO administration 10 reduce pulmonary vascular resistanee 
(PVR) without affecting systemic vascular resisJaDce (SVR) have shown more 
consis1enl, but necessarily less controlled, responses. Preliminary studies in litis 
laboratory failed 10 detect reproducible effects of inhaled NO on normal clogs. We 
hypothesized that these inconsistencies may be attributable to the use of animals 
without pulmonary vascular disease. Five adult mongrel dogs received 
monocrotaline 10 mglkg/d by intraperitoneal injection for thn:e consecutive days 
10 induce pulmonary vascular injury. Prior 10 monocrocaline adminisuation and 1 
month after monocrotaline, hemodynamic measurements were made with the 
animals under general anesthesia Each animal was mechanically ventilated with 
an FiO:! of 21 % and 10%, and inhaled NO was given at 0 10 120 ppm. Cardiac 
output (CO), SVR, PVR, and pO:z were recorded. Results: 
Pre-Monocrotaline Posl-Monocrolaline 
Fi02 NO pO:z CO SVR PVR pO:z CO SVR PVR 
ppm mmHg l/min U U mmHg l/min U U 
21% o 83 7.8 21.6 1.8 85 6.6 24.1 2.2 
21% 30 79 7.4 22.6 1.9 79 7.2 22.8 1.9 
21% 60 81 7.3 23.7 1.9 84 7.3 21.9" 1.9" 
21% 120 86 7.5 22.7 1.7 90 7.0 22.7 1.8" 
10% 0 31 7.9 25.0 2.2 32 7.6 24.5 2.7 
10% 30 27 7.6 22.5 2.0 30 7.1 25.1 2.3 
10% 60 28 7.6 22.3 2.0 31 7.2 24.2 2.2" 
10% 120 29 7.6 24.4 2.0 32 7.0 25.7 2.0* 
• p < 0.05 vs. 0 ppm at same FlO:! 
These data show that inhalational administration of NO had little effect on clogs 
with uninjured lungs under normoxic conditions or with a moderate degree of 
hypoxia. Following monocrotaline-induced pulmonary injury, however, 
inhalational adminisuation of NO consistently decreased PVR with little or no 





Nitrate Tolerance and Alina in Isolated Rat Aorta 
Philippe Unger, Guy Berkenboom, Dmitri BrCkine, Jeanine 
Fontaine. Erasme Hospital, Free University of Brussels, Belgium. 
Not all patients seem to be prone at a same extent to nitrate 
tolerance but the predictive factors are unknown. To assess whether 
nitrate tolerance is age-related at the vascular level, isometric 
tension was studied in aortic rings isolated from 8 week-, 12 and 18 
month-old male Wistar rats. Deendothe1ia1ized rings wen: incubated 
in Krebs physiologic buffer at 37°C, and exposed to nitroglycerin 
(NTG) 10 11M for 30 min whereas adjacent rings (without NTG 
preexposure) served as control.Thereafter, dose-response curves to 
NTG or Sin I (a direct activator of soluble guanylate cyclase) were 
constructed on KCI- or phenylephrine (phe) - induced contractions. 
The difference between the area under the dose-response curves of 
NTG-treatcd and that of control ring (MUC) was assessed (mean ± 
S.E.M.): 
MUC 8 weeks 12 months 18 months 
NTG relaxation 79±2S (n=II) 96±3S (n=7) IS0±20' (n=10) 
KCL-contractcd 
Sinl relaxation -24±28 (n=6) -1l±3S (n=S) 26±23 (n=8) 
KCL-contractcd 
NTG relaxation 96±18 (n=7) 247±4S·· (0=5) 
phe-contractcd 
.p < 0.05 vs 8 weeks, •• p < 0.01 vs 8 weeks 
These data indicate that the extent of nitrate tolerance is larger when 
aortas are isolated from older rats, independently of the contractile 
agent used; this alteration does not appear to involve desensitiz.ation 
of guanylate cyclase. 
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874·40 
Concentrations and Molecular Forms of Plasma and 
Myocardial Endotbelin in Human Coneestive Heart 
Failure 
Chi-Ming Wei, Denise M. Heublein, Oru1rej Lisy, Amir Lerman, 
Richard 1. Rodeheffer, Richard C. Daly, Christopher O. A. 
McGregor, 10hn C. Burnett Jr., Mayo Clinic and Foundation, 
Rochester, MN 
While recent investigations repon the elevation of plasma 
endothelin (El) in congestive hean failure (CHF), it remams unclear 
if this elevation is that of the biologically active peptide ET -I or of its 
precursor Big-ET. Further, it is unclear if such elevation is associated 
with increased myocardial ET as it is known that high affinity cardiac 
receptors and coronary endothelial ET production exist in the normal 
heart. The present study was designed to investigate concentrations 
and molecular forms of ET in plasma and cardiac tissue in normal 
subjects and CHF patients with NYHA Class I-IV using 
radioimmunoassay, gel penneation chromatography (OPC) and 
immunohistochemical staining (lHCS). Plasma ET was increased 
only in Class III and IV CHF (8.7±1.1 and 20.9±3.4 pg/ml, p<.OS) 
when compared to normals (6.S±O.6 pg/ml) and NYHA Class I and 
II (6.2±0.6 and 6.7±O.7 pg/ml) . OPC demonstrated that 
immunoreactive plasma ET was ET-l in normals but both mature ET· 
1 and the precursor Big-ET in severe CHF were present in severe 
CHF. Cardiac tissue concentrations of immunoreactive ET revealed 
ET presence in normal anial tissue which was maintained in severe 
CHF (20±4 vs 21±4 pg/ml). OPC revealed that the molecular form 
of cardiac ET was ET-l in both normal and CHF subjects. IHCS 
revealed markedly strong immunostaining in both normal and failing 
myocardium which was nOI different between the two groups. The 
current studies suppon the conclusion that elevation of plasma ET is a 
marker for moderate and severe CHF but not asymptomatic or mild 
beart failure and that this elevation represents both active ET-l and the 
lesser biologically active Big-ET. These studies also suggest the 
cardiac tissue activity of ET remains unaltered in CHF and that this 
activity is that of the active mature ET-I which is known to mediate 
vasoconstriction and mitogenesis. 
874·41 
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Decreued p.-Adreaergic Receptor mRNA Level. CoRdate With 
Decreued P. Receptor Density ia the Failiag Bum .. Heart. 
Michael R Bristow, Wayne Minobe, J David Port, Philip E Ray, Arthur M 
Feldman 
University of Colorado Health Sciences Center, Denver, CO 
We have previously reported that II, receptor (II,R) density is cIecreased ia 
failing human myocardium and thai norepinephrine induces down-regulation 
of II,R and II.R mRNA levels in cultured heart cells. In the rurrent study we 
characterize the quantitative PCR (QPCR) method for measurement of II,R 
mRNA in human myocardium and compare the II,R and II.R mRNA levels in 
nonfailing (NFl and failing (F) human left ventricles (LV). Using an in vitro 
transcribed full-length II.R mRNA, the QPCR assay was sensitive to 16 
zeplomoles (10-2' mole) and retained colinear amplification efficiency with an 
RNA internal standard up to 16 attomoles (10"" mole). Since II,R mRNA is 
the product of an intronless gene, poly-A selection was required to obtain 
mRNA that was free of genomic DNA. Utilizins samples from NF hearts 
removed from organ donors and F hearts from subjects with end-stage 
idiopathic dilated cardiomyopathy, a poly-A enriched RNA was extracted and 
II.R mRNA was measured, as was II,R density. 
II,RmRNA 
II,R density (molecules x 107/ 
!fm2!l!!!gl I!I!mRNA) 
NF 97.3:0 10.8 2.32:0 1.0 
<n-6) 
F 18.4:0 1.9· 1.62 :00.6 
<n-6) 
• p<O.OOOI vs. NF 
When F II.R mRNA were expressed as a percentage of their corresponding NF 
II,R mRNA control group. the F levels averaged 35% below (p=O.OO26) the 
levels of the NF group. 
Coaclulioa: II, receptor mRNA levels appear to be lower in subjects with 
marked II, receptor down-regulation. These data suggest that one element 
responsible for the down-regulation of cardiac II. receptors is the steady-state 
level of II, receptor mRNA. 
874·42 
Analysts of the Prevalence of 7 Cardtac ttyostn 
Heavy Chatn Gene ttutattons In 13 italian Fammes 
with Hypertrophic Cardiomyopathy 
Domenico Coviello, Pllolo Spirito, Nicolettll Bobolll, Roberto 
Bertorelli, Cerlo VecchiO, Christine E. Seidmlln, Roberto 
RIlYllzzolo. Istltuto di Biologill e Genetice, University of 
Genoll, Divisione di Cllrdiologie, Ospedllli Gellierll, Genoll, 
Itely, lind HeNerd Medicel School, Boston, MA 
fIlmiliel hypertrophic cllnUomyopllthy (HCM) is II genetlclllly 
heterogeneous disellse. In II preylous study, 7 mutllUons In 
the ~-cllrdillc myOSin hellYY chllin gene were found to be 
responsible for HCM in 12 of 25 fllmilies. We eXllmined 13 
IteHlln fllmilles with HCM for the presence of these 7 
mutetlons. Genomic DNA wes amplified by PCR using sets 
of primers flanking the regions where these mutlltlons hlld 
been preyiously identified. For the detection of 6 of the 7 
mutations, direct restriction enzyme digestion WIlS used, 
since these mutlltions led to crelltion or Ilbolition of II 
restriction site. For the detection of the remllining 
mutlltlon, PCR - Primer Introduced Restriction Anlllysis 
(PCR-PIRA) WIlS used. Posltiye controls for ellch of these 7 
mutlltions were alwllYs included in the restriction anlllyses. 
None of these 7 previously Identified mutlltions WIlS 
responsible for HCM in our 13 Italian fllmilies. In addition, 
none of these mutations WIlS identified In 10 other plltients 
with HCM In whom documentlltion of the fllmililll 
tnmsmission of the disellse WIlS not IlYllilllble. Thus, our 
results suggest these 7 mutlltions lire uncommon in Itlllilln 
plltlents with HCM. 
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874·43 
LoDg-term Metoprolol Therapy IDcIURl Myocardial Jl-AdreeerPc 
Receptor DeDlity Relative to Placebo CODtroll 
Michael R Bristow, E. Michael Gilbert, Stephanie Olsen, Patti Lanabee, Dale 
G. RenJund, John B. O'ConneD 
University of Colorado Health Sciences Center, Denver, Colorado 
The selective ~1 blocking ageDt mctoprolol has been reported to increase 
myocardial ~ adrenergic rec:eptor density in \llla)DtroDed clinical trials. In a 
32·patient substudy of the MOe (Metoprolol in DiIaIed Cardiomyopathy) 
multi(;enter clinical trial, we compared myocardial ~ adrenergic receptor 
density measured by endomyocardial biopsy in subjects treated with metoprolol 
or placebo. Baseline ~ rec:eptor density, receptor density at six months, and the 
change from baseline are given in the table below. Also given are ejection 
fraction data. The mean dose of mctoprolol was 125 mglday. Results ± SEM: 
.1~ ... .1CSNE 
~ fm2!lmg U'm! .1EF 
mctoprolol +23.9· +189· +0.063 
n=16 *11.1 *106 ±O.021 
placebo -1.9 ·S65 +0.055 
n=16 %5.2 %250 ±O.023 
·p<O.05 
CoaclusioD: In this placebo-controDed substudy, metoprolol increased P 
~tor density relative to placebo. Since coronary sinus NE values increased 
in the metoprolol group in relation to placebo and the EF changes were not 
di1ferent in the two groups, this effect is likely due to either receptor blockade 
of norepinephrine or direct rec:eptor·regulating effects of metoprolol. 
874·44 
Localization Of A Functional Autoimmune Epltope On 
The Muscarinic Acetylcholine Receptor·2 In Patients 
WHh Idiopathic Dilated cardiomyopathy 
Wang·Xiong Fu. Yvonne Magnusson, Claes·Hakan Bergh, Jan Ake 
Wljeqvist, Finn Waagstein, Ake Hjalmarson, Johan Hoebeke. 
GOteborg, Swed~n 
A peptide corresponding to the sequence 169·193 of the second 
extracellular loop of the human muscarinic receptor·2 was used as 
an antigen in an enzyme immunoassay to screen sera from 
patients with idiopathic dilated cardiomyopathy (n- 36) and healthy 
blood donors (n. 40). The sera from 14 patients with dilated 
cardiomyopathy (38.8 "10) and 3 healthy blood donors (1.5 "10) 
recognized the muscarinic receptor peptide at dilutions varying 
from 1: 20 to 1 :160 in an enzyme ·Iinked immunoabsorbent assay. 
Affinity purified autoantibodies from positive sera of patients with 
dilated cardiomyopathy recognized on the electrotransferred 
protein of rat ventricular membrane a major band with a molecular 
weight of about 80 KOa. Incubation of autoantibodies with rat 
myocardial membrane resulted not only in a decrease in the 
number of radioligand binding sites, but also in an increase In 
dissociation constants in a concentration·dependent manner. 
Moreover, preincubation with the antagonist atropine abolished 
the Inhibitory effect of autoantibodies on the receptor of rat 
ventricular membrane whereas the agonist carbachol appeared to 
have no effect on the activity of the autoantibodies. 
Conclusion: these data define a subgroup of patients with 
idiopathic dilated cardiomyopathy who have in their sera 
autoantibodies against the second extracellular loop of the 
muscarinic receptor·2. These autoantibodies interfere with the 
ligand binding function of the muscarinic receptor. 
ABSTRACfS 
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875·45 
Chronic Heart Failure in the Community - Prevalence and 
Validity of Diagnosis in Primary Care 
Nigel M. Wheeldon, Thomas M. MacDonald, Christopher J. 
Flucker, Alexander D. McKendrick, Denis G. McDevitt, Allan 
D. Struthers • 
Department of Clinical Pharmacology and Medicines 
Monitoring (MEMO) Unit, Ninewells Hospital and Medical 
School, Dundee, Scotland, UK. 
The aim of the present study was to determine by 
echocardiography the prevalence of left ventricular (LV) 
systolic dysfunction in the community and assess the 
validity of this diagnosis in primary care. Prescribing data 
captured by MEMO from a single practice population of 
12,012 persons, identified a total of 149 patients taking 
loop diuretics for a presumed diagnosis of cardiac failure. 
78 patients (30 males) from this group underwent 
2-dimensional and Doppler echocardiography to assess LV 
dimensions, LV systolic and diastolic function, and the 
presence of associated valvular disease. 
Only 32 (41 %) patients being treated for cardiac failure had 
objective echocardiographic evidence of impaired LV 
systolic function. This occurred in 63% of male but in only 
27% of female treated patients. 91 % of all patients however 
had reversal of the transmitral early:late diastolic filling 
ratio«1.2) in keeping with an impairment of diastolic 
relaxation. In summary, the estimated prevalence of true LV 
systolic dysfunction was 0.84% whereas 1.6% of the 
population received loop diuretics for this indication. 
False-positive diagnosis occurred in 47% of patients and was 
more likely in females (73%) than in males (37%). 
This data has important therapeutic implications since 
ACE-inhibitors are only of proven benefit in those patients 
with LV systolic dysfunction, and on clinical grounds 59% of 
patients would have received these drugs inappropriately. 
Echocardiography is therefore an essential early step in the 
management of patients with presumed cardiac failure. 
875·46 
The Progression from Hypertension to Overt Heart Failure. 
Daniel Levy, Kalon K.L. Ho, Martin G. Larson, William B. Kannel. 
Framingham Heart Study, Framingham, MA 
During the first 36 years offollow-up of 5 I 87 subjects of the 
Framingham Heart Study and 12 years of follow-up of 4079 
participants in the Framingham Offspring Study who were free of 
congestive heart failure (CHF) upon study entry, there were 652 
incidence cases of CHF. Cases were nearly equally divided between 
men and women; the mean age at time of CHF was 69 in men and 
74 in women. Antecedent hypertension was present in 482 cases 
(74%). Myocardial infiIrction (MI) was present in 37% ofCHF 
cases; left ventricular hypertrophy (LVH) was present in 27%. 
Hypertensive subjects were at tripled risk for developing 
CHF compared with those who were normotensive (age·stratified 
hazards ratio [HR 1 in men 3.13, 95% confidence intervals [CIl 
2.45,4.00; HR in women 3.07, 95% CI 2.32,4.05). The increased 
risk for CHF associated with hypertension was true both for those 
with a history of coronary heart disease and those without. 
Hypertension was also associated with increased risk for the 
development ofLVH (HR 3.80,95% CI 2.92,4.95 in men; HR 5.93, 
95% CI 4.22,8.41 in women) and MI (HR 1.79,95% CI 1.53,2.10 
in men; HR 2.68,95% CI 2.07,3.47 in women). Among 
hypertensive subjects, MI (HR 6.03,95% CI 4.61,7.87 in men; HR 
7.03,95% CI 5.28, 9.35 in women) and L VH (HR 4.12,95% CI 
3.08, 5.52 in men; HR 3.29,95% CI 2.43,4.45 in women) further 
increased risk for CHF. 
Hypertension figures prominently in the pathogenesis of 
CHF. Only a minority of hypertensive patients who develop CHF 
have had MI; diastolic LV dysfunction likely plays an important role 




Anatoaic and ECG Indications of Left ventricular 
Hypertrophy and Risk of cardiac Failure 
william B_ Kannel and Daniel Levy 
Boston University school of Medicine, Boston, MA 
Left ventricular hypertrophy (LVH) is a prominent 
feature of cardiac failure (CHF)_ Risk of CHF is 
examined in relation to anatomical (x-ray and 
echocardiogram) and ECG evidence of LVH in the 
Framingham Study. OVer 34 years of follow-up 298 
men and 298 women had initial episodes of CHF. 
Risk of CHF increased 3-5 fold when either ECG or 
anatomical versions of LVH appeared in either 
normotensives or hypertensives. ECHO-LVH was 
present in 61% of men and 56% of women who devel•
oped CHF. Risk of CHF increased la-fold in those 
with LV mass/height exceeding 150 gms/meter com•
pared to those with under 100 gms/meter. CHF 
incidence increased progressively with LV mass 
with no critical value delineating compensatory 
from pathological LVH. 
Anatomic and ECG evidence of LVH each 
contributed to CHF incidence, those with both at 
substantially greater risk than those with either 
alone. 
Age-Adjusted Biennial Incidence*of CHF By LVH 
X-Ray LVH Absent X-Ray LVH Present 
ECG-LVH 
Absent 
~ ~ HM ~ 
3 2 16 17 
Present 17 16 128 83 
"Incidence per 1000 
Evaluation of hypertensive or coronary candidates 
for CHF should have both ECG and ECHO or x-ray 
exam for LVH. 
875-48 
I.pact of Atrial Fibrillation (AF) on IIortality, Strokea, 
and Iach .. ic .. enta in Studiea of Left Ventricular 
DyafUDction (SOLVO) Patienta 
Kevin M. McIntyre, Salim YUBuf, Barry Greenberg, James 
Mathew, Lara Ekelund, Patricia Woods and Tamara Pinkett, 
for the SaLVO Investigators 
Brockton/West Roxbury VA Medical Center, West Roxbury, 
MA, Harvard Medical School, Boston, MA 
We studied the influence of atrial fibrillation (AF) on 
prognosis among 6,796 patients with EF ~3s entered into 
SOLVO and followed for an average of 40 months. Results 
are presented below without and after adjustment for 
ejection fraction, New York Heart Association Functional 
class. age. and use of druas: 
Event Ratea Unadjusted Adjusted 
AF No AF Odds Odds 
n=419 n=6378 Ratios Ratios 
Total Mortality 34.6 23.0 1. 40** 1.12 
Heart Failure, 
Death or 
Hospitalization 45.1 33.1 1.28 1.03 
Total Stroke 6.0 3.4 1. 78** 1.69* 
Total Myocardial 
Infarction (MI) 2.9 10.9 0.35*** 0.37** 
unstable Angina fOAl 6.9 15.1 0.42*** 0.50*** 
* p<0.05; ** p<0.01; p<O.OOl 
Although AF was associated in univariate analysiS with 
increased risk of death and hospitalizations, these 
associations were not significant after adjusting for 
other prognostic factors. However, even after 
adjustment, AF significantly increased the risk of 
strokes. Surpri.ingly, there was a strong and highly 
significant lower incidence of MI and UA that persisted 
after statistical adjust .... nt.. This new finding requires 
confirmation in other atudies. 
875-49 
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Len Ventricular Thrombus, Stroke and Mortality in Congestive 
Heart Failure: Two-year Prospective Follow-up 
Stuart O. Katz, Paul Marantz, Luigi Biasucci. Guillaume Jondeau. 
Kevin Lee. Claudia Brennan. Mark Goldberger. Albert Einstein 
College of Medicine Bronx. NY and Columbia University. College 
of Physicians and Surgeons. New York, NY 
To determine the risk of cerebral thromboembolism (non•
hemorrhagic stroke and transient ischemic attack (TIA)) and 
mortality in ambulatory patients with congestive heart failure. 
(CHF). 264 patients (mean age 62±11. mean ejection fraction 
27±8%) attending an outpatient CHF clinic were prospectively 
followed for a mean duration of 24±9 months. In addition. two•
dimensional echocardiographic (20 echo) studies. which were 
performed for clinical indications other than previous 
thromboembolism in 109 patients. were analyzed to relate the 
presence of LV thrombus to subsequent outcome. Six strokes and 3 
TIA's occurred during the follow-up period. yielding an incidence of 
cerebral thromboembolism for all 264 patients of 1.7 events per 100 
patient-years of follow-up. Patients with 20 echo had more severe 
CHF (NYHA class 2.6±Q.8 vs. 2.l±Q.8. p<.OJ) than patients without 
20 echo. and had greater risk of stroke and TlA (2.4 vs. 1.4 events 
per 100 patient-years of • p<.OI) and greater mortality (21.3 vs. 5.5 
deaths per 100 patient-years. p<.01). LV thrombus. i.e .• an echo•
dense mass adjacent to the LV wall but distinct from the 
endocardium. was detected in 54 patients (50%) of the 109 patients 
with 20 echo. The presence of LV thrombus was associated with a 
greater risk of stroke (5.3 vs. 0 events per 100 patient-years of 
follow-up. p=O.03) and was an independent predictor of mortality 
(relative risk 2.2. 95% C.l. 1.1-4.6. p<.03) in a Cox proportional 
hazards model that included age. ejection fraction and functional 
class. In conclusion. stroke and TIA occur relatively infrequently in 
ambulatory patients with CHF during a mean two-year follow-up. In 
patients referred for 20 echo studies. LV thrombus was highly 
prevalent and was associated with increased risk of thromboembolic 
events and mortality. 
875-76 
Len Ventricular Tbrombi in Dilated Cardiomyopathy; 
Course Following Diagnosis and Anticoagulation 
Cham S. Nandra, Candace O. Dick, Charles A. Herzog. Richard W. 
Asinger. Hennepin County Medical Center. Minneapolis. Minnesota 
The association of left ventricular thrombus (L VT) and systemic 
embolus in dilated cardiomyopathy (DCM) is controversial. Over a 
80-month period. we performed echocardiography on 10.159 
patients and 97 had left ventricular thrombi. Of these. 19 had non•
ischemic OCM: 13 had no significant coronary disease by 
angiography. 2 by autopsy. 2 by exercise thallium, and 2 were less 
than 25 years of age. All 19 had dilated left ventricles with decreased 
global systolic performance and no regional wall motion 
abnormalities. Oinical indications for the initial echocardiogram 
showing L VT were: left ventricular function - 10. systemic embolic 
source - 6. pericardial effusion - 2. and to rule out intracardiac 
thrombus prior to cardioversion - 1. 
Thirteen patients had follow-up echocardiography performed at 
least one month following initial L VT detection-mean follow-up 
14 ± 14 months (range 2-51 months). Twelve of these 13 were 
anticoagulated and 11 showed thrombus resolution. L VT persisted 
over a follow-up period of 113 days in the only non-anticoagulated 
patient. The average prothrombin time (PT) for anticoagulated 
patients was 18.7 ± 2.9 seconds. A single systemic embolic event 
occurred in an anticoagulated patient whose PT was 12.5 sec. with a 
control of 12.0 sec. at the time of the event 
We conclude: 1) A significant number of patients with L VT have 
non-ischemic DCM. and many of these present following a systemic 
embolic event, 2) L VT associated with DCM frequently resolve with 
anticoagulation. 3) Embolic events are unusual in adequately 
anticoagulared DCM patients with L VT. 
JACC Vol. 21, No.2 
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875-77 
Maximal FUnctional capacity in Patients with 
Cardiomyopathy due to Chagas' Disease ·wi thout 
congestive Heart Failure. 
Charles Mady, Antonio C. P. Barretto, Ricardo 
Nacruth, Evandro T. Mesquita, Giovanni 
Bellotti, Fulvio Pileggi. Heart Institute, 
univ. of Sao Paulo, Sao Paulo, Brazil. 
We studied 38 male persons, divided in 2 
groups: Group 1 constituted by 20 sedentary 
normal persons, aged 20-42 years (32.9±6.1), 
and Group 2 by 18 patients age 19-40 years 
(29.2±5.6) without symptoms or signs of heart 
failure, with positive reactions to Chagas' 
disease, electrocardiographic alterations 
suggestive of chagasic cardiomyopathy, and 
normal ejection fraction at the 
echocardiography. 
The 2 groups were submi tted to maximal 
functional capaci ty, obtaining values of 
maxima! 0lygen consumption (V02max in 
ml.kg- .min- ) and 02-pulse index (P02max in 
ml/beat) . Group means were compared by 
t test. 
We found statistically significant difference 
between Group 1 (V02max 37.0+5.5 and P02max 
15.1±2.5) and Group 2 (vo~max 24.3+4.3 and 
P02max 10.5±1.4) (p = 0.0001). 
Thus, cardiac function in Group 2 is clearly 
compromised, though no symptoms or signs were 
detectable, and no echocardiographic 
alterations present. However, the deficit was 
sufficient to reduce maximal functional 
capacity significantly below the normal group. 
875-78 
Diabetes in the SOLVD Registry: an Independent 
Predictor of Morbidity and Mortality 
Daniel M. Shindler, Tamara L. Pinkett, John B. 
Kostis, Miguel A. Quinones, Bertram Pitt, Salim 
Yusuf, for the SOLVD investigators. 
Data on patients with left ventricular 
dysfunction (LVD) in the Studies of Left 
ventricular Dysfunction (SOLVD) Registry were 
analyzed to assess the impact of diabetes (DM) 
on patients with ejection fractions of 45% or 
less. DM patients were older: 64.0+/-9.92 vs. 
61.5+/-12.56 (p=O.OOOl). 
At the time of enrollment into the Registry 
DM patients had a higher incidence of: 
hypertension: 816 of 1377 (59.3%) vs. 1752 of 
4585 (38.2%) (p<O.OOOl); hypertensive heart 
disease: 638 of 1339 (47.6%) vs. 1324 of 4447 
(29.8%) (p<O.OOOl); pulmonary edema: 384 of 
1217 (31.6%) vs. 986 of 4145 (23.8%) 
(p<O.OOOl); and angina: 885 of 1377 (64.3%) vs. 
2641 of 4528 (58.3%) (p<O.OOl). 
During one year followup DM patients had 
higher mortality: 261 of 1425 (18.3%) vs. 640 
of 4654 (13.8%) (p<O.OOl). Multiple regression 
analysis using age, sex, ejection fraction, 
race, primary etiology of LVD, and DM, 
identified DM as an independent predictor of 
mortality (p=0.0018) and hospitalization 
(p=O.OOOl). 
Thus, diabetes is a significant independent 
predictor of morbidity and mortality in 
patients with ejection fractions of 45% or 
less. These findings have important prognostic 
and therapeutic implications in patients with 
combined LVD and DM. 
ABSTRACfS 
875-79 
Can Clinical and Hemodynamic Parameters Identify CHF 
Patients With Viable Myocardium? 
Johannes Czemin, Alan Chan, Peter Miiller, Richard Brunken, 
Janine Krivokapich, Lynne Stevenson, Michael Phelps, Heinrich 
Schelbert. UCLA School of Medicine. Los Angeles, CA. 
Blood flow-metabolism imaging with N-13 ammonia (NH3), F-
18 deoxyglucose (FOG) and PET can identify reversible 
myocardial dysfunction in patients with poor left ventricular 
function. To determine if clinical or hemodynamic parameters 
can also identify heart failure patients (CHF) who might benefit 
from revascularization, 28 patients (age: 54±10, 23m, 5f) with 
matched perfusion-metabolism deff.{:ts <Concordant reduction of 
NH3 and FIX.; activity) and 29 patients (age: 56±9; 25 m, 4f) with 
mismatched defects (FIX.;-NH3 > 2SD above the mean in >10% 
of the entire myocardium) were analyzed. Perfusion defects were 
similar in extent (44±18 and 39±23%, p=NS) but more severe in 
patients with mismatches (36±15 vs 24tll%, p<O.Ol). Both 
groups had similar histories of bypass surgery, previous 
myocardial infarction, duration of heart failure (lill5 vs 19±21 
months), NYHA functional class (3.3±O.6 vs 3.0±0.8) and angina 
(l.70±1.3 vs 1.45±1.4) and had similar hemodynamic 
characteristics. Echocardiographic left ventricular ejection 
fraction (28±13 vs 26±11 %), left ventricular diameter (69±10 vs 
67±8mm), and mitral regurgitation (l.7±O.8 vs 1.5 ± 0.8) did not 
differ between the two groups. Pulmonary arterial systolic blood 
pressure (42±20 vs 46±20 mmHg), pulmonary capillary wedge 
pressure (21±12 vs 22 ±to mmHg) as well as cardiac output 
(4.4±1.4 vs 4.3±1.3) were similar. Thus, PET provides unique 
information on tissue viability while clinical and hemodynamic 
parameters fail to identify patients with potentially reversible 
contractile dysfunction. 
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876-92 
On-Scene Restoration of Spontaneous 
Circulation: The Key Predictor of Survival 
from Out-of-Hospital Cardiac Arrest 
Paul E. Pepe, Kay T. Kimball, Marni J. 
Bonnin, Peter S. Clark, Baylor College of 
Medicine, Houston, TX 
We conducted an 18 month prospective study to 
document that on-scene restoration of 
spontaneous circulation (ROSC) (Le., prior 
to hospital transport) is the most predictive 
factor for survival to hospital discharge 
after out-of-hospital cardiac arrest. Other 
variables studied included age; sex; 
presenting ECG rhythm; witness status; as 
well as time to initiation of basic CPR, 
paramedic arrival and ROSC. Stepwi~e 
logistic analysis was used to evaluate the 
relative prognostic value of each of these 
variables. Of 1,322 consecutive unmonitored 
scene arrests, 370 patients achieved on-scene 
ROSC, 23% of whom survived. Of the 952 
without on-scene ROSC, only six survived. 
However, all six were readily-identified as 
those with persistent ventricular 
fibrillation (VF). The step-wise analysis 
revealed that in predicting survival, the 
odds ratio (OR) for on-scene ROSC was 35:1, 
10:1 for VF, 4:1 for witnessed cases and 2:1 
for bystander CPR. For those with witnessed 
VF receiving bystander CPR, survival was 50% 
if on-scene ROSC was achieved. ConclUSion: 
on-scene ROSC is, by far, the strongest 
predictor of survival, and, except for those 
with refractory VF, failure to achieve it is 
an absolute predictor of non-survival in 




The Hlath Costs or In-Hospital Cardiopullnonary Rsuscitation 
Mark C. Thel, Christopber M. O'Connor, Gordon P. Keeler, Daniel B. 
Mark. Duke University Medical Center, Durbam, North Carolina. 
Cardiopulmonary resuscitation (CPR) Is performed in up to 4O'JIi of 
hospitalized patients who die. In order to undentand tbe COS1S 
~ciated witb undergoing CPR, we examined IS I consecutive patients 
wbo bad a cardiopulmonary arrest from June of 1990 to January of 
1992 on tbe general medical and IlUJical wards. Arrests in tbe 
intensive care units (lCUs) and emerleDC)' room were excluded. The 
median age was 6S yn (27 - 100), S6'J1i of tbe patients were male. 
Eighty-five patients (S6'J1i) bad return of spoDWIeOUS circulation and 
were transferred to an Intensive Care Unit (ICU). Only eight patients 
(5 'JIi) were discharged from tbe hospital and 6 were capable of 
independent living after discharge. The post arrest hospital stay of tbe 
as patients was 421 days, 357 ICU days and 64 days on a general 
ward. 
The approximate tota1 bospital cost for patients witb return of 
spontaneous circulation after CPR was $1,016,900. The approximate 
average cost of total resuscitation effort per patient discharged alive was 
$127, 112. 
In conclusion, tbe tota1 cost of in-bospital CPR outside tbe ICU is 
high given tbe limited survival rate. Improved resuscitation guidelines 
and techniques are needed to malte tbe use of CPR in leoeral hospital 
wards more cost effective. 
876-94 
a.hoapital1&atlon in SurviTOra of Out-of-Roapital 
Ventricular Fibrillation: 2e.ulta Fro. the CASCADE 
Study 
Charles Maynard, Judy L. Powell, Ellen Graham-Renfroe, 
Alfred P. Hallstrom, H. Leon Gr.ene, CASCADE 
Inve.tlgators. Harborview Medical Center, University 
of Washington, Seattle, VA 
Since 1984, 228 pta reauacitated from out-of•
hospital VF were randoaized to receive either 
.. iodarone (AKIO) or conventional (CONV) 
antiarrhythaic drug therapy. Eight pts initially 
died; 220 (96') were discharged allve after study 
enroll.ant. During followup, 145 pta (66') were 
hospitalized a total of 450 tl.as (range 1-15) for 
both cardlac (82') and non-cardiac (18') reasons. The 
average nuaber of rehospitalizationa per year was 
1 . 1 ± 2 . 1 for AKIO and 1.2 ± 2 . 0 for CONV pts (p-.74). 
By actuarial analysis, 50, of aurviving pts were 
rehospitalized in the year after .tudy enrollment. 
Cox analysia indicated that basellne CHF class 
(p-.029), baseline EF (p-.045), and referral from 
outlying hospitals (p-.05l) were predictive of first 
rehospitalization. Presence of an t.plantable 
defibrillator was not a.sociated with 
rehospitalization. The reasons for first 
rehospitalizstion following enroll .. nt were non•
cardiac (19'), ventricular tachycardia (5'), CHF 
(13,), angina (10'), procedure-related (23'), drug•
related (15'), and other (15t). 
Concluaiona: Rehospitalization is a common 
occurrence for VF survivors, and i8 particularly 
frequent in patients with CHF. 
876-106 
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Cardiac Catheterizatioa in Tradilioaal aDd Noattaditioaa\ Laboratory 
Setlinl" 
Eric B. Lieberman, J. Kevin HurilOn, Mickey Peoples, Laura Gardner, 
Tbomu Trahey, Daniel Mark, Tbomu M. Bashore. 
Duke Unlvenlty Medical Center, Durbam, NC. 
Recent AHA! ACC ,uidelines bave established two Ievell of Ielection 
criteria for cardiac catheterization (cath) bued oa local availability of 
cardiac sur,ical backup (sur,). We eumined the impact of sur,ical 
backup and ICreellini criteria on consecutive patient populationl 
Itudied in 4lettinp: the inpatient lab with sur,ical backup (lnpt-Sur,), 
the inpatient lab without sur,ical backup (lnpt-No Sur,), the outpatient 
(Outpt) and the mobile (Mobile) lenin,s. 
RESULTS: IAPI-Sm, IAps-Np Sm. 
n· 31S3 673 
Mean age (yean) 62 63 
CHF (FC >2) ,.. ~ 
Unstable an,ina 48% 44% 
L VEF< 0.40 23% 11% 
EZlttU of corOlUJry disttut: 
None 26% 33% 
3 vessel 28% 20% 
Left main 6% 3% 
PriorPTCA 16% S% 












None 9~ 9,.. 9,.. 9,.. 
Sipificanl 0.4% 0.3% 0.1% 0.1% 
As expected, pIS studied in the laboratory with sur,ical backup bad 
more licnificant disease and bi,ber complication rates. AHA!ACC 
I'Ildelines created similar low ria populations in nutplS and in mobile 
lettin,s. In the fixed laboratory without sur, backup, pIS bad more 
severe CAD and unstable presentationl tban expected following these 
l'Iidelines, yet complication rates were low. Thus cath guidelines based 
on availability of surgical backup do not renect current practice and 
may be unnecessarily restrictive in the fixed laboratory setting. 
876-107 
PaIterDS ofPTCA alld CABG Ulilllf in Alfli Medicaft Patients: 1987-1990 
Lawrence H. Muhlbaier. Marek Ancukiewicz, Eliz.abeth R. Delong. 
S. Raben Collins. James G. JoUis, David B. Pryor. Duke University Medical 
Center. Dm1Iam. North Carolina 
The patternS of utilization of PTCA in the qed Medicare population wi!b 
ischemic hean disease show msrked variability across the United Swes (US) 
from 1987·1990. a1d1ough the causes are uncenain. Using !be Medicare claims 
daIa. we obtained qe. race. and sex adjusted USl8e wes for PTCA and CABG as 
first revascularizalion within 6 months of diagnostic catheterization. For the SO 
ewes. the 2Sth!sotbnSth pm:entiles of llI/eS per 100 for PTCA were '87: 
14/18121. '88: 19/21/2.5. '89: 18123/2.5. and '90: 23126129. and for CABO were 
'81: 28/30132, '88: 25/28(31. '89: 23/2.5m.and'90: 24/26m. UseofPTCAas 
tim revascularization increased more rapidly in the WCSI and central US than the 
_and had achieved higher rates by 1990 (rllure). RaIes ofCABG showed 
c:orreIpOIIding reductions over the SIne time period. 
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February 1993:105A 
876·108 
Outpatient versus In·hospltal Queuing for LIft Ualn Coronary Artery 
Bypall Grafting: A Coat·Effectlveneu Analysis 
John B Wong, Joni R Beshansley, Hany P Selker, Robert Bojar, 
Stephen G Peuker. New England Medical Center, Tulls University School 
01 Medicine, Boston, MA 
Patients with stenosis of the left main artery ara, in general, treated by 
coronary artery bypass surgery, but tha optimal timing 01 surgery in the 
management of these patients following cardiac catheterizetion has not 
been determined. Specifically, applying decision analysis to data from the 
literature and actual variable costs and clinical data from patients at New 
England Medical Center, we examined the cost-effectiveness 01 keeping 
patients with left main coronary artery disease and stable angina 
hospitalized until their bypass surgery is performed, compared to 
discharging and readmitting the patients for their surgery. 
Our decision analysis considers duration 01 time waiting in-hospital and 
out of hospital, the likelihood 01 a cardiac event (myocardial infarction or 
sudden death) during that tima, the consequences 01 the cardiac event 
(death or emergent surgery), operative mortality, long-term prognosis and 
costs. In 1989-90, stable patients with left main disease at New England 
Medical Center (11=47) had surgery performed on average 3 days after 
catheterization W they remained hospitalized but 22 days after 
catheterization W they were discharged and readmitted. In our decision 
enalysis, staying in the hospital produces a longer IWe expectancy but is 
more expensive; continued hospitalization costs $13,000 per additionallffe 
year gained. Indeed, the cost-effectiveness for continued hospitalization 
falls below the 'popular' threshold willingness to pay of $50,000 per 
additional IHe year gained H discharge delays surgery by 4 days or more. 
Our resutts are sensitive to variation in the cost of a day spent in the 
hospital waiting for surgery but are relatively unaffected by wide variation 
in nearly all other parameters. If the cost of waiting is $100 per day, then 
all patients should remain hospitalized. If the cost is $1000 per day, then 
patients should remain hospitalized only if discharge would delay surgery 
by more than 9 days. 
In the absence 01 effective prioritization of out-patient queues, our 
analysis supports the practice of keeping patients with stable angina and 
left main stenosis hospitalized while waiting for bypass surgery. 
876·109 
Proc:eduraI SkiI1s in Prac:ticio& CardiolQlists: It. JteyeUDa Surre, 
Robert S. Wigton. Linda L. Blank. Thomas O. Tipi'. Departmeat of MediciDe. 
University of Nebraska College of Medicine. Omaha ad !be Americaa Board 
of Intemal Medicine. Philadelphia. PA 
As part of the Clinical Privileps Project of the Americaa Collep of 
Physicians. we lWVeyed a nodom eamplo of 1000 cardiolocista reprdiDa 
which of 55 proced\ll"08 they perform in tbeir pr8CIice. For 14 procecIIII"08 used 
in !be diaposis and/or treaImeIlI of cardiovascular m-. we asked what 
traininl wu needed to altaiD competeDce ad in what ICUiD8 they 1amed the 
procedure. We aulyzed 637 completed lWVeYI (63"). Tbe median 
respoadeot wu 46 yean old. pduated from medical achool in 1970. ad 
apeot 60 hrs.lwee1c in patient cue: 95" were Board certified in cardiololY' 
On averaee. respondents performed 24 cardiolOlY proc:edurea in pr8CIice. A 
pealer Dumber of proced\ll"08 were performed by Iboole wbo _ Board 
certified. wotked loop hours. pduated more recently. ad worked in a 
desipaled cardiology JIOIIp. Of the 14 dialDD"'ic or thenpeutic procedurea 
for which we asked about trainina. over balf the respoodeDts 1amed two or 
more of these in pnctice. Of Ibeae. rouahly balf were leamed without forma1 
trainin.: for example. of the 43" who leamed eodomyocudial biopsy in 
pr8CIice. 43" aid they leamed it 011 tbeir own; for Swan Gaoz c:aIbeIer 
placement. 56" leamed it 011 their DWD; Holter moaitor iDterpretatiOll. 83"; 
I.V. thrombolysis. 78". ad Err. 6"'. Thus. cardiolocista perform a wide 
variety of proced\ll"08. recolllllllllld CODSidenble experieace to ,aiD competency. 
and lIIIIIy leam proced\ll"08 in pnctice without formal traiDiDJ. on- resuJlI 
are important in plaoDiol educatioaa1 curricula for IUbapecialty trainina. 
establisbiD. credentia1in1l IIaIIdards within bospitals. aDd cletermiDiDl 
requirements for Board certificatioo ad recertification. For JIIUPOSCS of 
comparison with pl"ICticine canlioloaists. we also lWVoyed all cardiology 
training program dirocton (125) to glean tbeir estimates of !be Dumber of times 




EyalualiDa the Clinical Competeace 01 CardIaIop T.w-: rr-. 
Results and Ramifications lor the Future 
Linda L Blank. Melvin D. CbeitliD. AmericaD Boud of InIenIal Medicine. 
Philadelphia. PA. ad Uoivenity of Ca1iforDia, Sa FIIIICiIco. CA 
In 1987. the ABlM developed ad impl-'8d the aiDical Competeace 
Program for Cardiovascular DiIeuo to ~ the certiIicaIioII proc.a by 
cIofiDin, IIaDdanIs for certificatiOll, providiDa JUicIeIio. for III1ICIuriDa 
evaluation 1)'_ within traiDiDJ proarIIIII. ad JIIODIIIIiDI better 
KCO\ID!ability. For certificatiOll. cIiDical competeDce ia cIofined as • __ of 
compooenll eaaentia1 in !be pr8CIice of cardiolOlY: clinical judc-t. medical 
kDowledle. clinical 1kilIs. hlllllUlistic qualitiea. profeaaioaal a1titudea ad 
bebavior. proVisioo of medical cue. coatiDuiDa ICholanhip ad mora1 ad 
ethical bebavior in the clinicallCUiD8. From 1987·1992. !be Boud viaited all 
accredited cardiololY traiDiDJ proarIIIII (225) at Ieut _ to review tbeit 
evaluatioo 1)'_. The proc.a iDc1uded pte-viait 1WVeYI. iDIerviewI with 
program ditectors. IeIected fxulty ad au-. ad exlllllive I8Viewa of 
IraiDee filea iDcludiDe procedural lop. Aaa1y.ea of the daIa coDectecI from 
225 programa traiDiDJ 2310 fellow. Ihow IhIt 100" of the au- had tbeir 
clinical competence evaluated. primarily by multiple oo.v.Doaa. Evaluaton 
included IIlbspeciaity chiefs (88"). 1tteadiD, faculty (96") • .vIJuatioo 
committees (73"). ~or fellow. (12"). resideotl (11") ad _ (9"). 
Documentatioo wu IUbstaotiated in 93" of !be proarama. predomiDateIy by 
evaluation forms. Problem fellow. allO are identified throup the .vIJuation 
I)'stem: 31" of the proarams reported -viDa problem felIowa. In Idditioa, 
a stroDI COrrelatiOD was foUlld between program ditectors· ntiDp of uam-' 
clinical competeDce and their performance on !be 1991 cardiololY eumiDalion. 
These findinp indicate IhIt the evaluation I)'IIem worltI well in uaeasinll 
physician competeDce. UDdencorea !be profeaiolll' 8CCOUIIIIbility to !be 
public. ad may letVe as a model to verify phyliciao competency in 
coajUllclioo with recertification. 
876·121 
Secular chan,es ID tbe treatmeDt of DDcompllcated acute 
myocardial infarctloD bet weeD 1987 and 1992. 
Louise Pilote. Mark A. Hlatky. 
Stanford University School of MediclDe. Stanford. California 
Objectives: To examine secular changes in practice patterns for 
the treatmeDt of uncomplicated myocardial infarction. 
Study subjects: Cardiologists from both community and 
university settings in the United States who answered a mail 
survey in 1987 (n-379) and in 1992 (n-292). 
Methods: Comparisons of Questions common to both surveys. 
Results: Respondents reported an increase in the use of 
thrombolytic therapy between 1987 and 1992 (from 12% to 
60%). and a decrease in length of hospital stays (9 to 7 days). 
Use of some cardiac drugs in hospital increased. iDcluding beta•
blockers (intravenous by 17% of physicians to 75%. oral 78% to 
96%) intravenous heparin (12% to 75%). and aspirin (63% to 
99%). The use of nitrates. calcium blockers aDd digitalis 
remained constant while that of antiarrythmics decreased (31% 
to 20%). Discharge medications changed little between 1987 
and 1992. except for a marked decrease in use of persantiDe 
(24% to 6%) and calcium blockers (42% to 28%). Procedures use 
also changed considera bly during this period. with an increased 
use of thallium scintigraphy (30% to 42%) and coronary 
angiography (28% to 56%). and a decreased use of Holter 
monitoring (49% to 27%) and radionuclide ventriculography 
(30% to 17%). 
CODclusioD: Care of American patients with uncomplicated 
acute myocardial infarction has become more aggressive over 




Prognostic Significance of serial exercise TbaUIUm StUdies 
Hari P. Chaliki, Todd D. Miller, Timothy F. Clvistian, Kent R. Bailey, 
Raymond J. Gibbons, Mayo Clinic, Rochester, MN. 
The value of serial exercise tests for following patients(pts) with 
coronary artery disease(CAD) Is not clear (class IIlndicaIion as per ACClIoJoiA 
guideHnes). 222 medically treated pts(192M, 3OF, 61±9 yrs) underwent 2 
exercise thallium(TI) studies separated by at least 6 months without an 
Intervening cardiaC event. During median follow-up of 36 months after the 2nd 
exercise Tl study, there were 22 hard cardiaC events ( 10 cardiaC deaths, 12 
non fatal myocardial Infarctions) and 22 late(> 3 months after 2nd Tl) 
revascularizations (19 for progressive angina requiring hospitalization). 
Worsening exercise performance between the two Tl studies was 
prospectively defined by the following variables: (A) Worsening net serial post 
stress TI score; (B) Worsening nat serial delayed Tl score; (C) Worsening 
serial 6 Tl score (6 - delayed • post), (0) Tl defect in a new vessel 
distribution at the 2nd study; (E) More ST segment depression; (F) Lower 
exercise duration; (G) Combination of variables (A) and (E); (H) Combination 
of variables (A) and (F). 
None of the variables predicted pts at risk of cardiaC death or 
myocardial infarction. The following variables were associated with outcome 
( univariate Cox proportional hazards analysis) when late revascularizations 
were also Included as events. 
Variable PIs wHh PIs wtthout :t. f Events 
events !l!!!l!! %p\s 
Variable 
N-44(%) N-178(%) (+) (.) 
F 16(36) 40(22) 4.6 0.03 29 17 
G 6(14) 7(4) 10.0 0.002 46 18 
H 11(25) 21 (12) 5.4 0.02 34 17 
CONCLUSION: Although worsening serial exercise Tl performance was 
associated wKh overall outcome, its inability to predict hard events and its 
limited predictive value for overall events suggest that routine serial exercise 
Tltesting Is not indicated in pts with CAD. 
876·123 
Ecbocardiograpbic Services: How They are Used by 
Different Health Insurance Companies 
Rami Gal, James Kubota, Joseph Sarnoski, Donald H. 
Schmidt, University of Wisconsin Medical School, 
Milwaukee, WI 
Commercial health insurance (CHI) companies reimburse 
retrospectively on a per procedure or per visit 
basis. In contrast, many health maintenance 
organizations (HMO) provide capitation fees such that 
a fixed sum of money is paid prospectively to 
reimburse a provider for all studies and visits that 
may be necessary for a given period of time. In 
order to evaluate the cost effectiveness of these two 
methods regarding echocardiographic services, we 
compared the reasons for referral with the final 
diagnoses in 2,353 outpatients. Of these patients, 
1,297 had CHI while 1,056 were covered under an HMO. 
The female distribution was (CHItfHMOt) 62.6/58.7 
(p-NS) , and the mean age was 49.7/47.3 (p<.Ol). 
Among the reasons for study, a combination of murmur, 
rule out mitral valve prolapse, and palpitations 
accounted for 41.3/62.8 (P<.0001) of cases. The 
final "echocardiographic diagnoses were: normal 
12.3/28.7 (p<.OOOl) , reduced left ventricular 
function 10.7/6.3 (p<.001), left atrial enlargement 
13.8/3.9 (p<.OOOl) , moderate or severe mitral 
regurgitation (Grade ~2/4) 10.8/6.3 (P<.0001), aortic 
stenosis 4.8/2.2 (P<.001), pericardial effusion 
5.3/1.1 (p<.OOOl). 
We conclude that the referral criteria for 
echocardiographic services for patients covered by an 
HMO may be more liberal than for patients with CHI. 
This may explain the higher normalcy rate and lower 
Significant abnormal results among the HMO patients. 
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720·1 
OutCOle of Pregnancy in Forty Nolen With Ebstein's 
Anomaly 
Heidi M. Connolly, Carole A. Warnes 
Mayo Clinic, Rochester, MN 
4:00 
In order to define the outcome of pregnancy in 
women with Ebstein's anomaly (EA), we reviewed data on 
40 such women who have had pregnancies and were seen at 
the Mayo Clinic between 1982-92. There were 18 patients 
(pts) with an ASD or patent foramen ovale (PFO) at the 
time of pregnancy, of whom 15 were cyanosed. There 
were 97 pregnancies with 75 live births (77%). Eight 
pts had 9 successful pregnancies after cardiac repair. 
Of the 19 spontaneously unsuccessful pregnancies, 5 
occurred in 3 pts with prior cardiac repair, and 12 in 
6 pts with an ASD or PFO, 5 of whom were cyanosed, One 
miscarriage occurred in a pt with mild EA and another 
in a pt with severe EA with prior ASD repair. There 
were 3 therapeutic abortions. Sixty-seven deliveries 
(89%) were vaginal and 8 (11%) by cesarean section. 
There were 20 premature births (27%), 12 occurred in 6 
cyanosed pts. Prematurity and miscarriage was as 
frequent in acyanotics as cyanotics (10/25 vs 7/15). 
Of the available birthweights, the mean for 32 
offspring of 12 cyanosed pts was 2.6 kg, compared to 
3.0 kg for 29 offspring of 15 acyanotic pts (p=.004). 
No serious maternal cardiovascular complications 
occurred; including no life-threatening arrhythmias, 
cardiac failure, endocarditis, or stroke. There was a 
7% (5/75) incidence of congenital cardiac anomalies in 
the offspring; 1 bicuspid aortic valve, 1 congenital 
aortic stenOSiS, 1 pulmonary atresia, and 2 VSDs which 
spontaneously closed. 
Conclusion: Pregnancy in pts with EA is well 
tolerated but carries an increased risk of fetal loss, 
prematurity, and cardiac anomalies in the offspring. 
720·2 4:15 
Ou~ of Pregnane)' in Wc.en With Transposi tion of 
the Great Arteries After the Mustard Operation 
Nigel J Wilson, Patricia M Clarkson, A Louise Calder, 
Robyn A North, John M Neutze. Departments of 
Cardiology, Green Lane Hospital and Obstetrics, 
National Women's Hospital, Auckland, New Zealand 
The current maternal risks of pregnancy after atrial 
repair (Mustard or Senning operation) for 
transposition of the great arteries (TGA), and the 
risks for the offspring are unknown. TWenty-three 
women > 15 years with TGA and intact ventricular 
septua who had a Mustard operation were reviewed. Nine 
women have had 14 pregnancies. Their age at operation 
was 2-41 (median 20) months. Mean age at pregnancy was 
23 (range 19-27) years. 
There were 7 live births, 2 spontaneous abortions, 
1 intrauterine death at 23 weeks and 4 (gestation 
22-40 weeks) await delivery. All women were free from 
cardiac symptoms prior to pregnancy. None had 
important baffle obstruction or leak or pulmonary 
stenosis. None developed cardiac symptoms or signs of 
heart failure during pregnancy despite the occurrence 
of pregnancy induced hypertension in 3. The 7 infants 
born live between 35 and 41 weeks gestation had no 
signs of congenital heart disease. TWo of 4 awaiting 
delivery have normal fetal echocardiograms (2 not yet 
scanned) • 
Conclusion: Pregnancy in women with TGA who have no 
8ajor associated lesions or complications after 
Mustard operation is well tolerated. 
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720·3 4:30 
A Second Generation Study of 417 Probands 
with Congenital Heart Defects and their 822 
Children 
Ruth Whittemore, Xavier Caste11grande, James A. 
Wells. Yale University, New Haven, Connecticut 
Do mothers with congenital heart defects (CHD) 
have a greater chance of having an affected 
child than fathers with CHD? Exclusive of 
families with genetic syndromes, 228 mothers 
with CHD and 189 affected fathers and their 
respective 406 and 416 children were examined. 
The maternal study was prospective from 
pregnancy through the child's first three 
years. The paternal study included a complete 
reevaluation of the father and examination of 
all his progeny. Echocardiograms and other 
extensive tests were performed as indicated. 
The total incidence of CHD in these children 
was 13.4% (110/822); 11.8% in the maternal 
study, 14.9% in the paternal study. The 
difference was not statistically significant. 
Concordance was 44%. In the 5% of our 
probands who had a sibling with CHD, 42% 
(20/46) of their progeny were affected, (58% 
concordance). The incidence of congenital 
heart defects among the progeny of affected 
probands without genetic syndromes nor other 
family history was 10.7% (approximately 1/2 
mildly affected). Therefore a careful family 
history is most important before counselling 
such families concerning the potential risk 
of recurrence in a child. 
720·4 4:45 
The Natural History of Ebltein·. Anomaly from Fetal to Adult Life 
David Celermajer. Janice Till. Seamus Cullen. Vas Vassilikos. John 
Deanfield. Hospital for Sick Children. London. England. 
In order to examine the natural history of Ebstein'S anomaly (EAI in the 
era of cross-sectional echocardiography (echol. we reviewed 220 cases 
of EA; 21 presenting in fetal life, 88 as neonates. 23 as infants (1 
month to 2 years. yl. 65 IS children (2·18y) and 23 IS adults (18-71yl. 
Duration of follow up was 3 months to 30y (mean 8y). The commonest 
mode of presentation was Ibnormal routine prenatal scan for fetuses 
(86%1. cyanosis for neonates (73%). heart failure for infants (40%1. 
incidental murmur for children (66%) and arrhythmia for adults (50%). 
The earlier the presentation. the higher the incidence of associated 
cardiac defects. most commonly pulmonary stenosis or atresia (fetal 
52%, neonatal 49%. infants 48%, children 17%. adults 4%. p<0.05). 
In contrast. pre-excitation or arrhythmia were more frequent in those 
presenting later in life (fetal 10%. neonatal 10%. infants 17%. children 
35%. adults 65%. p<0.05). 
Outcome was poor in the fetus and neonate. Of 21 fetuses. there 
were 8 terminations. 4 intra-uterine and 6 post-natal deaths and 3 
survivors (1 year survival 19%). Of 88 neonates. 32 died during follow 
up (5 year survival 65%1. Deaths were mainly due to hemodynamic 
deterioration (17132. 53%1. perioperative (9/32. 28%) or late sudden 
death (5132. 16%). Outcome was best predicted by an echo grade of 
severity. Older age at presentation was associated with a bener 
prognosis (5 year survival of infants 78%. children 95% and adults 
86 % I. and the major cause of morbidity was recurrent arrhythmia. 
85% of survivors are in NYHA class I, and 70% are on no medical 
therapy. 79/220 (36%1 patients had surgery (palliation in 32. tricuspid 
valve [TVI surgery in 30 and other open heart in 17). Perioperative 
mortality of TV surgery was 515 (100%) in children <2y of age at 
operation. and 5/25 (20%) in those >2y (p<0.05). 
In EA. the earlier the presentation. the worse the prognosis. largely 
due to hemodynamic problems and poor surgical outcome in neonates 
and infants. In children and adults with EA. incidental finding and 
arrhythmia are common modes of presentation and the long term 
outcome is superior. 
ABSTRACTS 107A 
720-5 5:00 
In::ilBlce In! Ri.Bt FId.trs fer latE ~ arter FCJTtm Procecb"e 
Paolo Gu::cicne, Cla.i:lia Ca1Cblu::i, R:lberto Fonnigari, AcIriaxl Carotti, 
Fabrizio Ilrag:>, Pietro Rag::nese, Carlo /IBrcelletti. 
Qspedale BaTbim Ges), 1tJJe, Italy 
In:iden:::e am ria< factors for late ~ after FCI1tal (F) were 
!mlyzed in'lO SJIVivors. Mea1 age at F was 5.5 yrs (1-19), rrean foll~ 
q:J was 3.2 yrs (2-14). apraventrirular ~ (SVA) were irx:lu:led 
CI1ly if h:lspi talizatiCl1 or dla1ge of 1:herei{Iy was required, veltrirular 
~ (VA) if of l.a!I!1 class 2 or I!Dre at rc:utine EXXl. DiaglOStie 
gro.ps: 23 triOJSpid atresia (3$), 23 cb.tl1&-in1et left veltricle (33 
%), 24 a:nplex fams of U1ive1trirular heart (34%). Types of F: 35 (m 
%) atricpJlrrmary carectiCl1, 26 (m) total ~~
ry canectiCl1, 9 (13i6) atriOve1trirular canectiCl1. N::l late deaths 0::•
o..nTed. Eleven pts (l!l11\l had late SVA. Actl.larial. enalysis etnIecI ~, 
79%, OCJ% of pts free fran SVA 1, 3 am 5 yrs after F. Iot.lltivariate ala•
lysis of ria< factors far SVA was performed, irx:lLr:Iing ~e grcq> 
sex, age am weiglt at F, pre am p:stqleIative rrean p..ilirrnary artery 
ax:! LV Eni-diastolie presQ.I['e, p..ilirrnary artery !I18tmrf, precperative 
i.rcreased or decreased p..ilirrnary blood flClll, previCIJS palliatiCl1, t;ype 
of F, presence of precperative ~as, pre am p:str.perative ~ 
mie AV valve reg..u"gitatiCl1, need of recperatiCl1 after F. Need of reqle•
ratiCl1 am precperati ve uorestrieted p..ilirrnary blood flew were identif.!:, 
eel as ria< factors (P(O.C1S) for late SVA after F. BidirectiCl18l ~ 
IlO18I'!f mastarDsis had protective effect (p¢l.C1S) probably dJe to red.!•
ced atrial wall distensiCl1. Three asynptaratic pts had late VA (nulti•
form FVCs 2 pts am c:<qllets 1 pt). Cc:n::lusiCl1: - SVA are the rrost fre•
q,Blt ~as after F; -recperatiCl1 am precperative l.l1reStrieted 
p..ilirrnary blood flClll are ria< factors; - bidirectiCl18l CCM:p..llm:nary 
mastarDsis is related to a l.Cl!Ier irx:iden:::e of late SVA; - VA are rare 
am wi ttn.rt clinical relella1ce. 
720·6 5:15 
Benefits and Potential Risks of Atrial Antitachycardia Pacing After 
Repair of Congenital Heart Disease 
Larry A. Rhodes, J. Philip Saul, Walter J. Gamble, Edward P. Walsh. 
Children's Hospital, BoS\{)n, MA and WVa Univ Hasp, Morgantown. WVa 
Fourteen pts (ages 4.6 to 31.9 yrs, m= 12.8) with a history of atrial 
reentry tachycardia following repair of complex congenital heart disease (7 
single ventricle, 5 TGA, 2 CAVC) have undergone placement of an atrial 
antitachycardia pacer (lntenach II) as an addition to, or substitute for. 
existing therapy. During 0.5 to 51 months prior to implant, 14/14 patients 
required 45 cardioversions (17 DC and 28 paced). Also, all patients were 
treated with chronic medical therapy: 14 digoxin, 6 Class lao 1 flecainide, 
4 beta-blockers, and 2 sotalol. During 4 to 30 mas (m= 13.4) of follow-up, 
8 pts have had 103 recurrences of tachycardia detected either clinically or 
by the pacemaker. All but 6 episodes in 5 pts have been convened 
successfully by the pacemaker. Four episodes in 3 of these pts have 
required DC cardioversion. The other 2 episodes in 2 patients resulted in 
sudden death (see below). Due to concern over even brief rapid AV node 
conduction, or failure of the pacer to terminate either induced or 
spontaneous tachycardia. 12 pts were continued on medical rx after pacing: 
8 dig. 2 Class la, I flecainide, 3 beta-blocker and 2 sotalol. 
Complications have included false sensing in 3 pts leading to 
inappropriate inhibition of pacing, and 2 sudden deaths. In one pt, death 
occured during intense activity while wearing a Holter, which shOwed 
multiple attempts to terminate the tachycardia, with subsequent tachycardia 
acceleration. and eventual ventricular tachycardia and fibrillation. In the 
other pI, death also occurred during activity. Post mortem pacer 
interrogation revealed tachycardia detection and apparently successful 
termination in both cases, but was otherwise unremarlalble. 
Conclusion: Antitachycardia pacers in pts with atrial reentry tachycardia 
following surgery for complex congenital bean disease are effective in 
decreasing other therapeutic modalities. However, the risk of rapid A-V 
conduction from resistant or accelerated atrial tachycardia still exists under 
different autonomic states than that in which pacer testing is perfonned. 
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Abnormal Endothelium-Dependent Vascular Relaxation in 
Patients With Hypercholesterolemia is Not Modified by 
Increased Availability of Substrate for Nitric Oxide Production 
Philip R. Casino, Crescence M. Kilcoyne, Arsbed A. Quyyumi, 
Stephen E. Epstein, Julio A. Panza. NHLBI, Bethesda, MD. 
Patients with bypercbolesterolemia (HC) have a depressed 
endothelium-mediated vasodilator response to acetylcholine (Ach) , 
which is at least partly due to impaired endothelial release of nitric 
oxide (NO). To determine whether this abnormal endothelium•
dependent response of He pts is due to reduced availability of 
substrate for NO synthesis, we studied the effect of L-arginine (40 
"moUmin) , the natural precursor of NO , on the response to Ach 
(7.S, IS, 30 "g/min) and to sodium nitroprusside (SNP; 0.8, 1.6,3.2 
"g/min), a direct smooth muscle dilator, in 12 He pts (6 male; age 
S2±9 years) and 12 controls (7 male; age 49± 7 years). Drugs were 
infused into the brachial artery and forearm blood flow (mUminll00 
ml volume) was measured by strain gauge plethysmography. The 
vasodilator response to Ach was depressed in He patients compared 
to controls (max flow 6.8±4 vs lS.7±6; p<O.Ol). L-arginine 
augmented the response to Acb in controls (max flow increased from 
lS.7±6 to 21.4±8; p<O.OOI) but did not significantly modify the 
response to Ach in He pts (max flow 6.8±4 vs. 8.4±S; p=NS). L•
arginine did not modify the response to SNP in He pts or controls. 
D-arginine did not change the response to Ach in either group. Thus, 
the augmentation in endothelium-dependent vasodilation normally 
observed with increased aVailability of NO substrate is absent in 
peripheral resistance vessels of He pts. This indicates that the 
abnormal endothelium-dependent vasodilation of these patients is not 
due to decreased NO substrate, and further suggests a defect in the 
synthesis, release, or breakdown of nitric oxide. 
721-2 4:15 
Absence of Upld Effects on Coronary Flow Response to the 
Endothelial-Independent Vasodilator Adenosine 
Steven E. Reis, Sean T. Gloth, Roger S. Blumenthal, Gary 
Gerslenblith, Jeffrey A. Brinker. Johns Hopkins University, 
Baltimore, MD. 
Studies have demonstrated t~t abnormal lipid profiles and the 
presence of coronary atherosclerosis are associated with abnormal 
coronary constriction in response to the endothelial-dependent 
vasodilator acetylcholine. However, it is not known whether these 
clinical parameters are associated with coronary vasomotor 
response to the endothelial-independent vasodilator adenosine. 
We therefore assessed coronary blood flow in 33 patients before 
and after intracoronary infusion of 430 mcg of adenosine and 
correlated the adenosine flow response (AFR) with lipid profile 
(total, LDL, & HDL cholesterol, trigiycerides, apoA-1 & B, Lp(a)) and 
percent stenosis of the study artery (PCT). Flow (F) was assessed 
by the equation, F=APV*CSA*60, where APV is the average peak 
velocity of coronary flow measured by a doppler-tipped guide wire 
and CSA is the coronary cross-sectional area determined by 
quantitative angiography. AFR was determined by the ratio of F 
after adenosine to F before adenosine. The 33 patients had AFR 
(mean:SE) of 2.5Ch.22 and PCT (range) of 0-77.6. The lipid 
profile of the study patients was (range, mg/dQ: total cholesterol 
156-312, LDL84-231 , HDL 17-76, triglycerides 51-480, aP0A-1115-
243, apoS 87-215, and Lp(a) 0-138. Unear regression analysis 
revealed that the only factor significantly associated with AFR was 
PCT (AFR=-.02*PCT +2.94, r=-.48, 1><.01). Therefore, the severity 
of coronary stenosis but nolthe lipid profile is a significant correlate 
of coronary flow response to the endothelial-independent 
vasodilator adenosine. This suggests that lipid levels are not 
asSOciated with coronary smooth muscle function. 
JACC Vol. 21, No.2 
February 1993: 108A 
721·3 4:30 
Comparison of Coronary Artery Vasoconstriction to Intra•
coronary Injection of Acetylcholine and Ergonovine 
Maleate. 
Shozo Sueda, Yutaka Hayashi, Takashi Tsuruoka, Atsushi 
Kanaya, Tadao Uraoka. 
Kita Ishikai Hospital, Ozu City, Japan. 
In attenps to identify patients with vasospastic anginct 
pectoris (VSA), erogonovine maleate (RM) and recently, 
acetylcholine (ACh) have been used to provoke coronary 
vasospasm. It is unclear whether coronary artery 
response of ACh and EloI were identical or not. We studied 
50 patients with selective intracoronary injection of 
both 1ICh and EloI. ACh was perforned in incremental doses 
of 20, 50 and 1001'9 into the 1CA and of 20 and 50 1'9 
into the RCA. continuously, EM was perforned total 
doses of 32-64 1'9 into the 1CA and of 20-40 1'9 into the 
RCA. 
In 16 of 50 patients, spasm induced after injection of 
ACh or EloI. ACh induced spasm in 12 of 16 patients. 22 
(46%) of 48 vessels(segmental(s):5, diffuse(d):17). EloI 
induced spasm in 14 of 16 patients, 20(42%) of 48 vessels 
(s:10, d:l0). Configurations of spasm were nearly the 
same in the identical vessels. ACh induced no spasm in 
6 vessels, documenting total obstruction by EM. 
In conclusion, intracoronary injection of both ACh and 
EM are useful and reliable lrethods to document coronary 
artery spasm in patients with VSA. Diagnosing of VSA, 
if ACh induced no spasm, additional intracoronary 
injection of EloI should be perforned. 
721-4 4:45 
Blev.ted Triqlycerides aDd Low BDL Promote 
Bndotheli.l Dysfunction in Subjects with Boraal 
Total Chol.sterol 
Frederick E. Kuhn, Emile R. Mohler, Kathleen 
Reagan, Charles E. Rackley. 
Georgetown University, Washington, DC 
Recent data suggests that both elevated tri•
glycerides and low HOL are risk factors for 
coronary artery disease. While elevated total 
cholesterol has been associated with human 
coronary endothelial dysfunction and abnormal 
vascular reactivity, the relationship between 
triglycerides, HOL, and coronary endothelial 
function is unknown. We therefore assessed the 
response of coronary artery diameter to the 
intracoronary infusion of graded concentrations 
of the endothelium-dependent vasodilator 
acetylcholine in 24 subjects with normal total 
cholesterol levels (181±27 mg/dl). A direct 
correlation was observed between HDL levels 
(r=O.60, p<O.Ol) and normal vasodilatory re•
sponse to acetylcholine. In contrast, trigly•
cerides were associated with an abnormal 
vasoconstrictive response (r-.44, p<o.OS) to 
acetylcholine. No relationship was noted between 
total cholesterol or LDL and vasoreactivity in 
this group with normal total cholesterol. 
Conclusion: Elevated triglycerides and low HDL 
promote coronary endothelial dysfunction. Since 
endothelial dysfunction is thought to precede 
atherosclerotic coronary artery disease, 
subjects with elevated triglycerides or low HDL 
may be at increased risk of developing coronary 
artery disease despite having normal total 
cholesterol levels. 
JACC Vol. 21, No.2 
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721·5 5:00 
Variable Responses of Coronary and Collateral Circulation 
to Intracoronary Injection of Nitroglycerin In Patients With 
Effort Angina 
Kazuto Yamanishi, Masatoshi Fujita, Kunihisa Miwa, Moriaki 
Inoko. Toyama Medical and Pharmaceutical University, 
Toyama, Japan 
To assess direct effects of nitroglycerin (NTG) on coronary and 
collateral circulation (CC), 26 patients with effort angina, but 
without prior myocardial infarction were investigated. The rapid 
atrial pacing was repeated with the same pacing rate to induce 
myocardial ischemia before and after an intracoronary injection 
of 5Of.1g of NTG. In 14 patients with a patent ischemia-related 
coronary artery (IRCA) (Group A), NTG was injected into IRCA. 
In 12 patients with a totally obstructed IRCA (Group B), NTG 
was injected into a major donor artery of the well-developed 
CC. The administration of NTG caused no changes in hemo•
dynamic indexes. In 9 of 14 Group A patients, the extent of 
ST -segment depression remained unchanged despite the 
pretreatment of NTG (0.15±O.04 (SO) mY to 0.13±{l.05 mY, 
P=NS). In the remaining 5 patients of Group A, it was marked•
ly improved from a basal value of 0.1 St<l.05 mY to 0.01-+{).02 
mY with NTG (P<0.01). In 12 Group B patients, 0.14±Q.05 mY 
of basal ST -segment depression was consistently ameliorated 
to 0.04±O.04 mY after NTG pretreatment (p<0.01). These 
changes by the intracoronary injection of NTG were 
accompanied by a preferential dilatation of recipient arteries of 
CC (18.7% in donor arteries vs. 32.7% in recipient arteries, 
P<0.05). Conclusions (1) the contribution of the dynamic 
stenosis of IRCA to effort angina differs largely among patients 
and (2) CC responds effectively to the intracoronary injection of 
NTG in all patients with the well-developed CC. 
721·6 5:15 
Detection of Hibematine Myocardium Durine Cardiac Catheterization 
by Enomnone Administration 
Gian Luigi Morgagni, Enrico Pomarici, Claudio Simoni, Giuseppe 
Fiorentini, Maurizio Conilli, Franco Rusticali. Dpt. of Cardiology, G.B. 
Morgagni Hospital, Forli, Italy 
We tested the hypothesis that Enoximone (E) might be accurate io detecting 
hibernating myocardium duriog cardiac catheterization (catb); indeed it may 
relax vascular smooth muscle cells (unloading rightlleft ventricle and 
dilatin$ coronary I\Tteries) with concurrent stimulation of systolic calcium 
influx m myocardial cells (positive iootropic action).Accordingly, 34 anginal 
pts (mean age 55) were prospectively evaluated before and a&r myocardial 
revascularization (REV), assessiog wall motion (by angiography) as well as 
perfusion changes ( by rest·iojected TbalJium 201 imaging ) elicited by E 
administration (0.75 mglkg i.v. io 10 mio). Wall motion was.malyzed with 
the aid of computer techniques; from the center of left ventricle 36 equally 
spaced radii were drawn to iotersect the endocardial outlioes for end•
diastolic and end-systolic images, thus dividing images io 36 areas: the mean 
area change of wall motion abnormalities (A WM) was obtained from the 
sum of systolic fractional area change (%) divided by the number of A WM. 
At baselioe all pts had, at the same time, A WM and defects (0), but, 
followiog E administration, 22 pts exhibited significant changes (Groupl: 
mean area change 44 ± 19 vs 22 ± II % p < 0.001; 22122 D improved or 
disappeared), whereas 12 did not (Group2: mean area change 17 ± 8 vs 16 ± 
8 % p--ns; 12112 D persisted). None of the pts experienced untowards 
effects (myocardial ischemia, ventricular tachicardia) during or after E; 
heart rate and aortic pressure showed only slight changes (± 7%).After 
REV, neither AWM (byechocardiography) nor D were detected io Groupl; 
conversely, io Goup2, 2112 AWM improved and 6/12 D disappeared. We 
conclude that: (1) sensitivity of E io detecting hibernating myocardium io 
anginal pts is high (22 out of 24 pts whose AWM reverted followiog REV; 
91%) as well as its specificity (10 out of 12 pts whose AWM did not 
reverted after REV; 83%), thus E should be taken ioto account for this 
target; (2) its administration during catb is easy and safe. Further studies 
are necessary to compare this new test with those more widely used so far 
(nytroglicerin or dobutarnioe). 
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722·1 4:00 
Efficacy of Chimeric Fab Fragment 7E3 (c7E31 verl!us Aspirin 
and Heparin for the Prevention of Carotid Thrombosis In a 
Non-Human Primate 
William E. Rote, Mark A. Nedelman', Dun-Xue Mu, Peter J. Manley, Harlan 
Weisman', 'Mark R. Cunningham, Benedict R. Lucchesi. Department of 
Pharmacology, University of Michigan Medical School, Ann Arbor, MI; 
'Cenlocor, Malvern, PA 
This study examined the relative abilities of c7E3, a GPllblllla antagonist, 
aspirin (ASA), heparin (HEP), or ASA + HEP to prevent carotid artery 
thrombosis in Cynomolgus monkeys. Animals were treated whh saline 
(no:6, Group I), ASA (25 mglkg p.o., daily for 3 days; n-6; Group II), HEP 
(100 Ulkg i.v. + infusion adjusted to maintain APlT @ 2-3X baseline, n=6, 
Group III), HEP + ASA (n=6, Group IV), or c7E3 (0.10 mgikg i.v., n=7, 
Group V, 0.15 mglkg i.v., n=6, Group VI, 0.20 mgikg i.v., n-6, Group VII, 
0.25 mglkg i.v., n-6, Group VIII). Monkeys were anesthetized and 
thrombus formation via 
Incidence of OcclUSion electrolytic stimulation of the 
Group RCA LCA endothelium in the right carotid 
I. Saline 616 616 
II. ASA 616 616 
III. HEP 516 616 
IV. HEP + ASA 616 516 
V. c7E3: 0.10 mglkg 4n 7n 
VI. c7E3: 0.15 mglkg 216' 416 
VII. c7E3: 0.20 mglkg 0/6' 1/5' 
VIII. c7E3: 0.25 mg/kg 116' 0/6' 
• p<O.05, FIShel's Exact vs Group I 
artery (RCA) was initiated 15 
min after drug administration 
and continued for 180 min. 
Stimulation of the left carotid 
artery (LCA) began 210 min 
after drug administration. 
Platelet aggregation, whole 
blood cell counts, APTT, blood 
pressure, heart rate and carotid 
artery flow velocity were 
monitored continuously. Heart 
rate, blood pressure, and platelet count were not affected. c7E3 inhibhed 
ex vivo platelet aggregation, increased bleeding time, decreased thrombus 
weight and increased time to occlusion in a dose-dependent manner. All 
other treatments failed to attenuate occlusive thrombus formation. 
Conclusions: In an acute model of arterial vessel wall injury, c7E3 
prevented throrrbus formation in Cynomolgus monkeys while HEP, ASA, 
or a corrbination of the two, failed to prevent thrombotic occlusion. 
722·2 4:15 
Urokinase ActIvatIon or Surface-Locallzed Endothelial Cell 
F1brlnolya18 Is Regulated by Thrombin 
109A 
VlVek K. Varma, James M, Parks, Xin-Nong U, Jay C. Koons, John, 
R. Grammer, Francois M. Booyse, University of AIabarna at 
Birmingham, Birmingham, AL 
Normal hemostasis 18 maintained by an Interplay between the 
coagulation and fibrinolytic systems. The endothelial cell (EC) 
urokinase (u-PA) receptor (u-PAR) plays an Important role In the 
localization and receptor-mediated activation of EC-bound 
plasminogen (Pmg) and hence, surface-localized fibrinolysis. 
Thrombin rapidly « 30 min) reduces (20-80%) the specific binding 
of '''I_labeled u-PA to u-PAR In subcultured (passage 2-4) human 
umbilic:al vein ECs (from -140,000 to -110,000 site8/celQ, In human 
aortic ECs (from -250,000 to -150,000 site8/celQ, and In porcine 
aortic ECs (from -60,000 to -18,000 s1tes/ceIQ, as compared to 
untreated controls. After 24 hr incubation of thrombin treated EC 
cultures in 10% FCS/M199 medium, the '''I-labeled u-PA ligand 
binding was restored to control (no thrombin) levels. The decrease 
In u-PA binding Is paralleled by a concomitant decrease (-50%) In 
surface-localized plasmin generation, as measured by a fluorometric 
substrate (Val-Leu-Lys-AFC) assay for plasmin. Preliminary results 
suggest that the apparent decrease In '.1-IabeIed u-PA ligand 
binding may be due to thrombln-mediated secretion of u-PA which 
Increases endogenous receptor occupancy of u-PAR, and thereby 
decreases u-PAR available for '""J.Iabe1ed u-PA. The release of 
plasminogen activator lnhibltor-1 by thrombin may account for the 
decrease seen in fibrinolytic actMty. These results demonstrate a 
novel interrelationship between the coagulation and fibrinolytic 
systems, and suggest that thrombin can acutely enhance Its 




Is Reactivation of Unstable Angina Following Disc:ontinuation of 
Heparin Associated with De~ Antithrombin m Plasma Activity? 
Rosa-Maria Lid6n, Pierre lMroux, Marta Gbitescu. Montreal Heart 
InstiDlte, Montreal, Canada 
To determine wbetl1er low plasma antithrombin-III activity (AT-III) could 
playa role in reactivation of unstable angina (VA), 49 pts bad serial 
determinations of plasma AT-III, activated partial thromboplastin time 
(aP1T) and heparin levels before heparin administration, daily for up to 12 
days (mean 7.6±4.2 days) on an infusion titrated to the aPTr and 4 hrs 
after its discontinuation. AT-III was measured with a chromogenic 
substrate. During treatment, aPTr and heparin levels remained within the 
therapeutic range, as shown in the table. AT-III fell by 3.3±27% at the 
onset of heparin administration (p<0.01) but remained stable thereafter 
with no further decrease. Values returned promptly to control 4 hrs after 
discontinuation of heparin. No pt had depletion by more than 20%, which 
could have been associated with a prothrombotic state. 
Before Heparin infusion After 

















Heparin 0.07 0.41 t O.44t O.44t 
(IV/mI) ±0.12 ±0.36 ±0.42 ±0.27 













Conclusion: Heparin treatment is associated with a small, early decrease 
in AT -III plasma activity with prompt return to control following 
discontinuation of heparin. Any prothrombotic state that occurs following 
heparin withdrawal must be related to another mechanism. 
722·4 4:45 
ADP and ThrombOxane A, Are Important Mediatora of Cyclic Flow 
Variations in Nonhuman Primate Arterle. 
Sheng·Kun Vao, Janice McNatt, Kexin Cui, L MaicimUian Buja, Jean·Pierre 
Maltrand, James T. Willerson, Texas Heart Institute and UT Medical School, 
Houston, TX, Sanofi Recherche, France 
ADP, thromboxane A, and serotonin are Important mediators of platelet 
aggregation and cyclic flow variations In stenosed and endothelium·injured 
canine coronary arteries. This study was designed to test the hypothesis 
that ADP, thromboxane A" and serotonin are also involved in mediating 
platelet aggregation and cyclic flow variations in nonhuman primates. Five 
anesthetized, open-chest baboons were studied with their blood flow 
velocities In coronary and femoral arteries monitored by pulsed Doppler flow 
probes placed around the arteries. Cyclic flow variations were established by 
mechanically injuring the endothelium of the arteries and narrowing the 
arteries with extemal constrictors. Sixty minutes after the establishment of 
cyclic flow variations, clopidogrel, a combined inhibitor of platelet 
aggregation induced by ADP. thromboxane A2 and serotonin, was given 
intravenously at 10·20 mg/kg bolus plus 2.5 mg/kg/hour continuous 
infusion. The treatment resulted in abolition of cyclic flow variations In the 
coronary and femoral arteries of all 5 baboons (frequency of cyclic flow 
variations = O/hour versus 14/hour at baseline, p<O,OOl) . Then epinephrine 
was infused intravenously up to an average dose of 2.2 l'9/kg/minute. No 
cyclic flow variations were restored in etther coronary or femoral arteries of 
any of the 5 baboons. Ex vivo studies demonstrated a dose-dependent 
platelet aggregation induced by ADP and U46619, a thromboxane A2 
mimetic, but not by serotonin before clopidogrel treatment. The ADp·induced 
platelet aggregation was completely inhibited and U46619·lnduced platelet 
aggregation was signHicantly diminished after clopidogrel treatment. Thus, 
clopidogrel is effective in eliminating cyclic flow variations in stenosed and 
endothelium·injured coronary and femoral arteries of nonhuman primates 
probably due to its ability to antagonize ADP and thromboxane A;s platelet 
proaggregatory effect. 
lACC Vol. 21, No.2 
February 1993:110A 
722·5 
meet of Fis. 011 oa TIIrombus, Smoodl Muscle Ceu 
ProUfel'8tioa, aJld Neolatimal 'I'IIIckeaiag After Deep Arterial 
blJury by BaUooa DlJatatioa Ia Pigs. 
Mark W.l Webster, Valentin Fuster, Diane E. Grill, Holly B. 
Lamb, Robert Enger, Steve Krage, Curt Grabeau, Juan J. 
Badimon, James H. Cl!esebro, Mayo Oinic, Rochester, MN. 
The effect of dietary fish oil supplementati3n o¥ 1251_ 
labeled fibrinogen deposition (molCcules xl 01 /em ), 
neointimal and medial ceq proliferation (CP, % of total cells), 
and neointimal area (rom ) was determined in pigs with deep 
(tear into the media) carotid arterial injury. Treated pigs were 
given Max-EPA (4OOmglkg/day) started 3 weeks before and 
continued until sacrifice 2 weeks after dilation. All animals 
were given antithrombin therapy with hirudin (1mg/kglh) for 
48 hours after angioplasty and iododeoxyuridine (SOmglkglday) 
for 2 days before sacrifice to label dividing nucle~ which were 
detected with a double-antibody, immunohistochemical 
technique. Results are mean:l:SEM in deeply injured 
segments. 
Control Fish Oil p 
P~n W 9 ~ 
Fibrinogen 281:1:62 466:1:343 NS 
Neointimal CP 30:1:7 21:1:2 NS 
Medial CP 15:1:3 9:1:1 0.04 
Neointimal area 0.47:1:0.07 0.47:1:0.06 NS 
mean aPTI x48h 2.30:1:0.05 2.38:1:0.10 NS 
Dietary fish oil had a borderline effect on cell proliferation 
in the arterial media. Thrombus formation (measured by 
fibrinogen deposition) and neointimal thickening and CP were 
not reduced. Thus fish oil does not appear promising for 
reducing neointima formation. These results may explain the 





Clot-bound Thrombin is Better Inactivated by Low 
Molecular Weight Oermatan Sulfate Than by Heparin 
Giovanni Melandri, Franco Semprini, Nicoletta Candiotti, 
Vittorio CerVi, Angelo Branzi, Bruno Magnani. Institute 
of Cardiology, University of Bologna, Italy 
Clot-bound thrombin is relatively protected from inhibi•
tion by heparin (HEP)-antithrombin III (ATIII) and may 
be responsible for ongoing coronary thrombosis despite 
the treatment. Low molecular weight dermatan sulfate(LOS) 
catalyzes thrombin-heparin cofactor II (HCII) complex 
formation and inhibits thrombus growth in animal experi•
ments. In this study we compared the ability of HEP and 
LOS to block the fibrinopeptide A (FPA) release by fluid•
phase thrombin (0.4 nM)(FT) and thrombin incorporated in 
plasma derived fibrin clots (CT). Increasing concentra•
tions of HEP and LOS resulted in progressively lower FPA 
release. However CT was inactivated more effectively by 
LOS than by HEP. For APTT ratios between 1.5 and 2.5 the 
residual FT activity was 11+/-7% with HEP and 8+/-6% with 
LDS(p=NS). CT residual activity was 52+/-20% for HEP and 
22+/-16% for LOS(p<.0001). Even with HEP levels ~0.3 U/ml 
it was not possible to inhibit CT activity below 30%.The 
same result could be obtained by adding small doses of 
LDS and HEP in presence of lower APTT levels(56+/-7 vs 
111+/-32 sec; p (.0001) • 
Thus,fibrin interference with the catalytic action of HEP 
on thrombin-AT III complex formation is considerably 
stronger than the interference with the catalytic action 
of LOS on thrombin-HCII complex formation. 
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Are Bete Blocke,. Prosyncopel Medlclltions? 
4:00 
Shawn Killam, Robert Sheldon, Calgary General Hospital, Alberta, 
Calgary, Canada 
Our goal was to determine if clinical history or tilt table variables 
predicted the risk of recurrent syncope following a positive tilt table 
test. Accordingly we fOllowed 102 syncope pts after a positive tilt 
table test for 1-1036 d, mean 308 d, median 240 d. Of 102 patients 
with a positive test, 46 pts received empiric drug therapy and 56 pts 
did not. They were similar with regard to gender (39 vs 41 % male), 
number of preceding syncopal spells (median 6 vs 4), duration of 
preceding symptoms (median 24 vs 12 months), and frequency of 
preceding syncope spells (mean 0.7 vs 0.5 syncopal spells/month I 
but treated pts were older (45 ± 22 y vs 35 ± 17 y, p = .01). 
Effects on actuarial syncope-free survival were assessed by the 
Wilcoxon test. Age, gender, and test symptoms (presyncope vs 
syncope) were not risk factors for recurrent syncope. Several risk 
factors were identified, including use of beta-blockers. Effects of 
beta-blockers on syncope-tree survival in total population and high 
risk groups were: 
POPULATION 
All patients 
1 yr Syncope-free survival 
~ 5 spells in past 
~ 1 2 months history 
> 1 spell/month in past 
< 1 spell/month in past 












Each risk factor also predicted syncope in the pts treated with beta•
blockers: 
1 yr Syncope-free survival in pts on beta-blockers 
RISK FACTOR HIGH RISK LOW RISK p 
~ 5 spells in past 0.34 0.76 .006 
~ 12 months history 0.39 0.76 .012 
> 0.3 spells/month 0.33 0.81 .019 
Conclusions: 1) Historical factors predict recurrent syncope; 2) Beta 
blockade predisposes to recurrent syncope; 3) This effect occurs in 
all high risk groups. 
723-2 4:15 
A Placebo Controlled Trial of Intravenous and Oral 
Disopyramide for Prevention of Neurally Mediated 
Syncope Induced by Head-up Tilt 
Carlos A. MorillO, James W. Leitch, Raymond Yee, George J. 
Klein, University Hospital, London, Ontario, Canada. 
Recent uncontrolled trials have suggested that disopyramide 
(Diso) may be an effective therapy in patients (pts) with neurally 
mediated syncope (NMS). We conducted a double blind, 
randomized trial comparing IV Diso with placebo (P) in 22 
consecutive pts with a history of 2 or more episodes of NMS. 
Two consecutive positive HUT were required to be eligible for 
this trial. The primary end point was prevention of syncope or 
presyncope provoked by head-up tilt (HUT). Overall. HUT was 
positive in 12 of 16 pts (75%) receiving IV P, and 12 of 20 (60%) 
receiving IV Diso (p=0.55). If NMS persisted after being 
randomized to the first treatment, pis were crossed-over to the 
alternative intervention. Fifteen of 22 pis completed cross-over 
on the IV arm of the study. HUT was positive in 13 pis (87%) in 
the P arm, and 12 pis (80%) receiving IV Diso (p=O.50). Of the 
15 pis, 9 were initially randomized to P and 6 to IV Diso. HUT 
was positive in all initially randomized studies. Subsequent 
cross-over to IV Diso or P was completed by 9 and 6 pts, 
respectively. HUT was positive in 6 (67%) receiving Diso and 4 
(67%) assigned to P. Eleven pts subsequently received oral 
Diso 200 mg qid or P during one week in a randomized cross•
over fashion. HUT was positive in only 2 pts (18%) taking P and 
in 3 (27%) taking P (p=O.54). 
Conclusions: Intravenous Diso was ineffective for prevention of 
NMS provoked by HUT. No significant difference was observed 
during oral therapy with Diso. There was a striking decrease in 
the incidence of positive tilt tests over time regardless of 
intervention. These findings discourage the use of HUT as the 




~ (F NImX;LYQ:RIN NU5ICll IlJIID{; tEAI).Up Tn..T FCJ! 'lJ£ 
DI!GC5IS (F VPS:N~ SYI'«XFE, 
AntaUo Raviele, GiaYJi Gasparini, Fnn::esco Di Pede, Carlo Menozzi§, 
Michele Brijpoleo , Maurizio Dinel.li*, Paolo Al.bcI1i*, Eligio Piccolo. 
Divisioo of Cardiolcgy, llltlerto I lb3pital, Msst:re-Venioe, Italy, 
§ Divisioo of Cardiology,S, tom1a tuNa lb3pital, Reggio Emilia,Italy 
° Divisioo of CardiCll.cgy, lb3pital of~, Italy, 
* Divisioo of Cardialcgy, lb3pital of Cerrto-FerT8r8, Italy, 
In the preeert; stu::\Y ..., assesse1 the value of nitrcW-ycerin infusioo 
olI'irl> ~t tilt as a new test to 1ZIIEI9< the neurally-<nediated 
<rigin of ot:ileNise U'leICPl.ainerl syrxxpe, To this p..JrpCBl 4) pts wi til 
syrxxpe of Inietennined na1lJre (17 lIBles, IIISl age If7 yrs) an 25 
asynptXJletic age-natd!ed centrol s..i>jects wi til IleI1J9.ti ve baseline 
~ tilt (roo for ED min) lnlerwent Inliher til~ test ~ 
ni trcW-ycerin infusioo. 'Ihe protoool of the ni trcW-ycerin test 
cx:misted of a naxinun of 5 ru:cessi ve stages of 5-min &.pine pesi tioo 
plus 1O-rnin OOO~iglt tilt at prcwessively inc:reas~ infusioo rate 
(initial rate of 1.72 ~ witil s.iJee!pnt :in:::ra'o9nts of O.ffi 
)lI!!Kg/Inlr £Nery stage). Paritive respc:n;e to nitrcW-ycerin test was 
cief"iMd as the develq:ment of syrxxpe ~ by the pt as similar 
to its clinical spells in asoociatioo wi til 9.lCXlen an lIBrl<ed 
twot:amoo an braqycardia. 
'lWenty-ooe pts (53%) and 2 oc.rrtnll s..i>ject:s (~) had a pcsi ti ve 
respc:n;e to the nitroglycerin test, In no case the test was 
intern.pted becaJse ~ intolera-x:e, 'Ihe pcsitive rate, specificit;y 
an prediCtive a:o..n-acy of the nitroglycerin test were 53%, 92% and 
Oi'fo respectively, 
In caclusioo ni trcW-ycerin infusioo ~ tpI'iglt pa;b.Ire _ to 
be a useful. tool for the ~ of vasovag;il rE9::tioo in pts wi til 
previCJ.lSly urlefined syrxxpe anllel1J9.tive baseline ~ tilt test. 
723-4 4:45 
Acute Beta Blockade Attenuates Reduction in Left Ventricular Volume 
CBUHd by tha Head-Up THt Test 
Eugene A. Nwosu. Peter S. Rahko, Peter Hanson, E. Wayne Grogan Jr., 
Cardiology Section, University of Wisconsin Medical School, Madison WI 
We have previously shown that the head-up tilt test (HUT), when 
combined with graded isoproterenol (ISO) infusion, is frequently positive 
in healthy adults and moreover, that a positive response is associated 
with a high incidence of LV cavity obliteration (CAVOB) caused by a 
Significant reduction in LV end-diastolic (EDV) and end-systolic (ESV) 
volumes. This study was perfonned to determine whether acute beta 
blockade prevents the positive response to HUT in such subjects and if 
so, whether this beneficial response is associated with an attenuation 
in the reduction of LV volumes and the development of CAVOB. Five 
male SUbjects (ages 28·37) had HUT on no drug (NO), 5 Jig/min ISO and 
5 Jig/min ISO + acute bolus esmolol (ESMOI. Two-dimensional Doppler 
echocardiography was perfonned supine at baseline and during 80" HUT 
either after 10 minutes of HUT or at the time of symptoms to evaluate 
EDV, ESV, ejection fraction (EF) and for the presence of CAVOB. 
Results: (Mean ± SO, • =p<0.05 vs baseline and· =p<0.05 vs HUT•
ISO by ANOVA repeated measures). 
Bese/ine HUT -NO ~ HUT-ESMO 
EDV (mil 93±25 58±22'· 43±15' 5S±1S'· 
ESV (mil 34±13 1S±6" 7±4' 1S±3'· 
EF (%) 64±6 69±6 83±S' 65±11 
CAVOB 0/5 0/5 5/5- 0/5 
In all five subjects HUT was positive (syncope or presyncope with 
systolic BP < 90 mm Hg or heart rate < 60 bpm) during ISO but negative 
during no drug and ISO + esmolol. Conclusions: Beta blockade 
attenuates the further reduction in EDV and ESV and the CAVOB caused 
by ISO during HUT. Attenuation of these effects by beta blockade is 
associated with prevention of the clinically positive response of HUT to 
ISO. These findings support the hypothesis that neurocardiogenic 




High Power, Low Frequency H .. rt Rate Chenges During Presyncope 
Elicited by ',oprotereno/-nt Table Testing 
Robert Sheldon, Ken Riff, Calgary General Hospital, Alberta, Canada 
and Medtronic, Minneapolis, Minnesota 
Hemorrhage in dogs causes marked 0.05 Hz heart rate 
oscillations, suggesting that these oscillations might be seen in human 
syncope. We report marked changes in heart rate variability which 
occur during presyncope elicited by isoproterenol (lSO)-headup tilt 
IHUT) table testing. 35 patients with recurrent syncope underwent 
ISO-HUT, which consisted of 4 stages: I, 5 min drug-free supine; II, 
5-10 min drug-free HUT; III, 5 min ISO 5mcg/min supine; IV, 10 min 
ISO 5mcg/min HUT or until syncope. 17 pts. had a negative test and 
18 pts. had a positive test ending in syncope In & 9) or presyncope 
N = 9). Marked low frequency lapprox. 0.05 Hz) heart rate changes 
were seen during stage IV in 16/18 positive ISO-HUT and only 6117 
negative ISO-HUT Ip = 0.002, Fisher's Exact" Heart rate variability 





p, t test 
Power Ibpm'/Hz) in Stage 
-L _1_1 _ --.J!L __ IV_ ~ 
27±29 37±29 16±12 74±134 .098 
33 ± 25 49 ± 35 41 ± 33 322 ± 298 < .001 
NS NS .005 .006 
Thus positive tests have a great increase in heart rate varibility. 
The increase in power was due to an incr .. se in low frequency 
power: 
TEST 
Mean Power Frequency Ix10" Hz) 
in Stage 
~ _1- .....1l- --.J!L ~ ~ 
Negative 63±33 44±20 83±60 87±48 .001 
Positive 64±22 47±18 75±37 46±19 <.001 
p, t test NS NS NS .003 
Thus presyncope during ISO-HUT is associated with the 
appearance of high amplitude, low frequency changes in heart rate. 
These changes may be due to baroreceptor activation. 
723-6 5:15 
AutoDomic Neural ModulatioD of Atrlo-Vntricular CODductiOD 
Time ia Humaas Studied by Spectral ADalysis 
Giandomenico Nollo. Maurizio Del Greco. Flavia Ravelli. Giorgio Speranza. 
Marcello DiserUJri. IRST l'mIlO. 0spedaIe Civile Rovemo. Italy 
To investigate die influences of die autonomic uervous system (ANS) on atria•
venlricular c:ooduclion in humans. die spontaneous fluctualions of die AR intervals 
were studied and COIIIfJIIR'd 10 those of die AA interval 
~ Ten minutes of surface ECG and oesopbageaI eIccIrogram from 10 healthy 
subjeclS in supine position and during 60" tilt. were recorded. The A-wave and R•
wave fiducial poinlS were automatically measured respectively on die oesophageal 
and on die surface ECG (sampling rate: I KHz). The AA and AR interval series 
bave been characterized by swistical parameters both in time and frequency 
domains. 
~ The mean values of AA and AR interva1s before tilt were 932.2 and 134.6 
msec. During tih a signiflCallt (p<O.OOOI) decrease in the mean cycle length 
«AA>= 717.9 msec). bul no signiflCalll reduction of die AR mean values (<AR>= 
133.6 msec) was documented. AA specua showed a power density distribution 
concenuated in 2 main bands: low frequency: (LF) 0.04~.12 Hz. high frequency: 
(HF) 0.IS~.4 Hz. The AR specua were similarly characterized by LF and HF 
bands. Whereas the AA PSD shows an LF power inaease and HF power deaease 
during till (p<O.OS). die AR PSD shows a decrease of die power contents in both 
LF and HF bands (p<O.OS). 
RRPSD RRPSD ARPSD ARPSD 
LFpow. HFpow. LFpow. HFpow. 
!n.u·l !n.u·l !n.u·l !n.u·l 
BeforeTdt 0.34 ± 0.16 0.24 ± 0.15 0.26 ± 0.12 0.23 ± 0.15 
During Till 0.56 ± 0.25 0.09 ± 0.08 0.15 ± 0.15 0.15 ± 0.07 
Conclusion: The study of AR interval variability seems 10 provide useful 
parameters 10 evaluate the influence of the ANS on the AV node. Particularly. 
spectral analysis during till revealed a differenlialed influences of die ANS on AA 
and AR imervaIs indicating a predominance of die vagaJ rone on AV conduclion. 
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724 Detection of Myocardial Ischemia by Magnetic 
Resonance Imaging/Spectroscopy 
Monday, March 15, 1993 
4:00 PM-5:30 PM 
Anaheim Convention Center 
C-2 
724-1 4:00 
Myocardial Metabolic Responses to High Workload: Is There 
Evidence for Demand Ischemia? 
Barry M. Massie, Gregory G. Schwartz, Jorge Garcia, Sean 
Steinman, Judith Wisneski, Michael Weiner, Twyman Owens. 
VAMC and Univ. of California, San Francisco, CA. 
The purpose of this study was to determine if physiologic 
increases in myocardial 0, demand are accompanied by metabolic 
evidence of LV ischemia in the absence of coronary stenosis. In 
10 open-chest swine, regional anterior LV blood flow, oxygen 
consumption (MVO,), lactate release (by "C-Iactate dilution), and 
high energy phosphates (by subendocardially weighted 3lp_NMR) 
were measured. MVO, increased from 5.1.±0.5 "moUg-min in the 
control state to 7.0.±0.6 with aortic constriction (CONST), 
11.5.±1.1 with dobutamine infusion at 15 "g/kg-min (DOB), and 
14.9.±1.2 with combined DOB+ CONST. With increased LV work 
and MVO" the phosphocreatine/ATP ratio (pCr/ATP) fell and 
lactate release increased from control (Fig 1). These changes 
were associated with decreasing subendocardia1lsubepicardial 
(ENDO/EPI) blood flow ratio, despite increases in absolute 
subendocardial blood flow up to 3 times control during 
DOB+CONST (Fig 2). 
, 5r---::":"':=-=,."....,=,,--~'O .• _ 
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This constellation of metabolic and blood flow findings is 
consistent with the occurrence of myocardial ischemia under 
conditions of high LV workload. 
724·2 4:15 
Effect of Adenosine on Recovery of Phosphorus 
Metabolites In Acute Myocardlallschemla-Reperfuslon : 
In Vivo 3'p MR Spectroscopic Assessment in Cats 
Tae-Hwan Lim. Seong Wook Park. Pyung Hwan Park. Dong-Man Seo. 
Tae-Keun Lee. Mi-Young Kim. Chi-Woong Mun 
Asan Medical Center. UniversHy of Ulsan. Seoul. Korea 
Effect of adenosine on the recovery of high energy phosphorus 
metabolHes during the reperfusion period following 90 minutes of left 
anterior descending artery ligation was assessed by 31p MR 
spectroscopy in 13 cats (8 : control grouP. 5 : adenosine group). In 
adenosine group 0.2 mglkgfmin of adenosine was Infused intravenously 
for 90 minutes. The experiments were performed on a 4.7 T/30 em 
Biospec MRS/MRI system (8ruker. SwitZerland) and the MR signals 
were obtained by using a 1.5 em diameter sized doubly tuned surface 
coil. The size of the spectral peaks was measured by area integration 
method. In adenOSine group significant recoveries of PCr (p < 0.001) 
and ATP (p < 0.001) peaks were occurred during the reperfusion 
periodS. whereas only PCr peak showed statistically significant recovery 
(p < 0.001) in control group. The recovery of per peak was more 
pronounced in adenosine group than in control group (p < 0.05). 
.. '" .. 1M ...... 
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Conclusion: 31P MRS can be used for in-vivo assessment of the 
changes of high energy phosphorus metabolites concerning acute 
myocardial ischemia and reperfusion. Adenosine infusion irT1>roves the 
recovery of ATP and PCr during the reperfusion period following acute 
ischemia. 
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724-3 
Detection of Myocardial Ischemia by ·P-Magnetic 
Resonance Spectroscopy During Hand-Grip Exercise 
"IlIkahiro Yabe,Kenichi Mitsunami.Mamoru Obda,Shigeru Endoh, 
Hiroshi Miwa, lbshiro lnubushi,Masahiko Kinoshita. 
Shiga University of Medical Scicnce.Otsu)apan 
4:30 
The purpose of this study is to invesligaJe whelher the hand-grip exercise resting 
with "P-MR 5pCCtroscopy(MRS) is useful in the evaluation of myocardial 
ischemia. The subjects were 27 patients with severe slellOSis of either the left 
anterior discending or the left main coronary artery(~75%),and 11 normal 
controls (C). Patients were divided into two groups by exercise thalium-
201 ("'11)scintigraphy. reversible '''11 defect group (RD(+»)and fllted '''11 defect 
group(RD{-». Examinations were peformed using a GE Medical SyslCms 
1.5T(SIGNA). Subjects lay supine in the magnet,and performed hand-grip 
exercise at a cycle of once in every 2 cardiac cycles with 30% of maximal 
force.Spectra were spatiaUy localized to the anterior and apical region of the I~ft 
ventricle with depth-resolved surface-coil spectroscopy (DRESS).Spectrai 
acquisition was gated once per 2 cardiac cycle~ at end-systole using ECG. "P 
NMR spectra wm collected before and dwing band-grip exercise,and cooect::d for 
the sawration factor.At rest,ANOV A revcaled .ignifieant differences among the 
three groups of the mean (±SD) ratio of phosphocreatine(T'Cr) to adenosine 
triphosphale(ATP){based on (J -ATP resonance) in the left ventricular wall 
(p<O.05).The PCr/ATP ratio signifiClllltly decreased from 1.56±0.19 at rest to 
0.94±0.27 dwing exercise (p<O.OOI) in RD(+) group (n=15). HoweverJn RDO 
group(n=12).the ratio did DOt change significantly dwing hand-grip exercise (1.18 
±0.28 at rest versu.. 1.I2±0.24 during).Likewise,the ratio did DOl change in 
group C(n=l1)(I.80±0.28 at rest versus 1.84±0.26 during). 
Conclusion: Only in RD(+) group.the PCr/ATP ratio was signifiamlly changed 
by the exercise. These results suggest that the hand .grip excrrise testing with 
"P-MRS is a sensitive method for detection of the myocardial ischemia. 
724-4 4:45 
Prevention of [Na+]i Accumulation and 
MYOCardi!~ stunning by Amiloride 
---a Na NMR Spectroscopic Study--•
Takashi Konishi, Isao Morii, Masato Watanuki 
Shigetake Sasayama, Toshirou Inubushi 
Kyoto University and Shiga College of Medical 
Science, Kyoto and Shiga, Japan 
[AIM] To know the role of [Na+]i accumUlation 
during ischemia in myocardial stunning, we 
examined effects of amiloride (Na+-H+ 
exchange inhibitor) on [Na+]i and cardiac 
function during ischemia and reperfusion 
(20min each). 
[METHOD] [Na+]i of an isolated pel/used rat 
heart was measured with Na N~R 
spectroscopy. NMR Shift reagent D~(TTHA) -
was used to separate [Na+Ji from [Na ]0. To 
examine the role of Na+-H exchange in [Na+]i 
accumulation, inhibitor of Na+-H+exchange 
(amiloride 0.5mH) was added to the perfusate. 
[RESULTS][Na+]i(~) EDP(mmHg) DP(mmHg) 
~ A!!!.i ~ Ami ~ Ami 
PreI 100 100 7±1 6±1 83±4 87±4 
I 165±10* 122±8 39±4 44±5 0 0 
Rep 121±7* 85±ll 42±5* 15±1 33±6* 81±6 
EDP=end-diastolic pressure, DP=developed 
pressure, Con=control group, Ami=amiloride 
group, I=ischemia, Rep=reperfusion, *=p<0.05 
[Na+]i was lower during ischemia in Ami than 
in Con. Furthermore, at the end of 
reperfusion [Na+]i and EDP were lower in Ami 
than in Con and DP was greater in Ami than in 
Con. 
[CONCLUSION] We concluded that amiloride 
prevented [Na +] i accumulation and improved 




Dipyridamole Stress MapetIc: R_lDee Myocardial Perfusiolllmaging 
aad Magnelic Resoaance Veatrlcu\op"aplly ill die Al8elismeal 01 Coro•
ury Artery Disease. 
Adam Cerel. George HanneU. Masoor Kama1esh. Paul Finn. Richard TeUo. 
Thomas Hill. Stanley Lewis. New England Deaconess Hospital and Institute 
for Prevention of Cardiovascular Disease. Harvard Medical School. Boston. 
Massachusetts. 
Conventional Magnetic Resonance Imaging (MRI) perfusion and 
angiographic techniques lack sensitivity for detecting significant coronary 
anery disease (CAD) when used in resting patients. We evaluated the use 
dipyridamole stress for increasing the accuracy of MR perfusion imaging 
combined with waU motion analysis from MR ventriculography. To our 
knowledge this technique has not been reported previously. 
12 patients with angiographically documented significant CAD were 
examined using a IT superconducling MR imager (Siemens. Iselin NJ). 
Perfusion was assessed using a fast TI 1IJIbo..000h pulse sequence (TRfI"E 
12ms/5ms. matrix 64xl28) dwing injection of Gadolinium-DTPA (O.04mmoV 
kg). Ventricular function was assessed using multip1anar time of flight cine 
MR angiography. Perfusion imaging and ventriculography were performed in 
identical positions before and after injection of dipyridamole (0.56mg/kg). 
MR perfusion and angiographic images were read blind and the information 
combined to indicate areas of fIXed and reversible abnormality. Comparison 
was made with Thallium-Tc99MJSestamibi scintigraphy. using the same 
stress period. Examination time was usually less than 50 minutes. 
Pre and post-stress images were obtained in II patients. one developed 
severe angina after receiving persantine requiring reversal. In 9/1 I the 
combined MR imaging agreed with the scintigraphy in identifying fIXed or 
stress related areas of abnormal function. In I patient there was disagreement 
on the distribution of perfusion abnorma1ities. In the other patient with a 
documented non Q wave myocardial infarction scintigraphy was normal 
(therefore possibly a false negative) but MR identified inferior hypokinesia 
and a reversible perfusion defect. 
Combined stress MR ventriculography and perfusion imaging is feasible 
and early results indicate that the information quality may be at least as good 
as that gained from scintigraphy, Advantages eompared with non-invasive 
alternatives make this a potentia1y valuable technique for assessing CAD and 
worthy of further investigation. 
724-6 5:15 
113A 
la Vlyo Qaaat1ficalloa 0' Anle Myocardial la'ard Size: 
Comparlsoa 0' Malutic KetoaaDce I.allal Studies wltll 
Eazy ... llc ladlces ftI Myocardial Necrosis 
Eduard R. Holman. J. PeI.er W. YID Joobergen. Paul R.M. van Dijkman. 
Arnoud YID tier LIane. Albert de ROllI and Emsl E. YID del Will. University 
Hospital Leiden; 1nIeruni-.ily CanIioIoKY InstiIute d TIle NedIc:dands. 
PlII"pose: To __ the poteDtial d ill Yi~ GlIIolinium (GcI)-DTP A-eabaneed 
magneIic resonance imqina (MRI) ill qUllllifyiDa myoc:anlial iDfarct size ill pItieIIts 
with acute m)'OC8ldial infarcIioa (AMI). 
Meillocls: CIrdiIc MRI was pcrlonned ill 2A fIIIieDIs wiIbiD 3 to 7 days (_ 
".3) after 0IIIel 01 AMI. Nine Tl-wiabled Ibort-uia imIaea (tbiclaJesl-lOmm. 
TR-RR-intervll. TEa30 IDS) _ obIaiDed 20 min after admiDiJ1ratioa of Gd•
DTPA (0.15 mmollkg bw intravenously). Areas with increued signal inteDsily on 
MR images were coosidered to be infartIcd. MRl infarct size was deII:nnined using 
the Simpson's rule and compared willi infarct size calculated from cumulative release 
at 72 h of aIpha-hydroxybulyrlllC dchyckogenase (HBDH) in plasma «Qn00.0410q 
body weight) /152) and with peak CK-MB levels. Both MRI and HBDH-cak:ulated 
enzymatic infarct size were exp-essed in g. CK-MB was expressed in J.IIIl. 
Results: Infarct size quantified using Gd-DTPA enhanced MRI showed an 
excellent agreement with Ihe HBDH-calculaled enzymatie infarct size (left panel of 
Ihe figure). MRI infarct size correlated well with peak CK-MB plasma levels (right 
pmeI of the figure). 
10 
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MRI infUtt Iiu (&> MRI infant IUe (&) 
Note that the line of idcndity (dashed line) d the left figure fllb within the 95% 
ClOIIftdcnce inta"vaI. 
Coaclusioa: Gd-DTPA enhanced MRI IIIows ICCUIIIe delaminatioo of infarct 
Iize in patients within 1 week after onset 01 AMI. 
114A ABSTRACTS 
725 Controlled Clinical Trials in Heart Failure I: 
Beta-Blockers 
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Anaheim Convention Center 
C-5 
725-1 4:00 
Double.Blind, Placebo·Controlled Study or the Long·Term 
Efficacy of Carvedilol in Patients with Severe Heart 
Failure Treated With Converting-Enzyme Inhibitors 
Henry Krum, Brian Schwartz, Jonathan Sackner-Bernstein, Joshua 
Penn, Rochelle L. Goldsmith, Marrick L. Kukin, Norma Medina, 
Madeline Yushak, Milton Packer. . Division of Circulatory 
Physiology, Columbia University, College of Physicians & Surgeons 
and Mt Sinai School of Medicine, New York, NY 
Previous studies of beta-blockade in heart failure (CHF) enrolled 
pri~a?IY mildly impaired pIS who were not taking convertiog-enzyme 
mhlbllors (ACEI). To evaluate the efficacy of beta-blockers in 
advanced CHF, we conducted a double-blind. placebo-controlled study 
of the alpha/beta-blocker, carvedilol (CRV), in 32 CHF pts taking 
ACEI (mean EF = 15%), most of whom had class IIUIV symptoms. 
PIS were assigned (double-blind, 2:1 randomization) to receive CRY 
(25 mg BID, n=22) or placebo (PBD, n=IO) for 14 weeks, while 
background therapy with digoxin, diuretics and ACEI remained 
constant Invasive hemodynamic and noninvasive functional variables 
were measured at the start and end of the study. Hemodynamic 
changes in the PBD and CRY groups after 14 weeks are shown below: 
MlF ASVI ~ ~ 6MAP MlR ASVR 
Carvedilol +5.6* +11.7* -8.9* -5.3* -14.2* -21.5* 481* 
where • = P < 0.05 (pBD vs CRY); EF = ejection fraction (%); SVI = 
stroke volume index (mVm2); PWP = pulmonary wedge pressure; RAP 
= right atrial pressure; MAP = mean arterial pressure (mmHg); HR = 
heart rate (min· I); SVR = systemic vascular resistance (dyn-s-cm-5). 
Compared with PBD, pts treated with CRY had a substantial 
improvement in cardiac performance (t EF & SVI and .!. PWP, RAP & 
SVR) associated with the expected.!. HR. Clinically, pts treated with 
CRY showed an improvement in NYHA class (-0.9 on CRY vs +0.4 
on PBD) and an t in distance traversed during a 6-min walk (+16.2 m 
on CRY vs -27.4 m on PBD, both P < 0.005 (CRV vs PBD). 
In conclusion, carvedilol produces hemodynamic and clinical 
benefits in pts with severe CHF treated with ACE inhibitors. 
725-2 4:15 
CarvedUol Improves Symptoms and Left Ventricular 
Function In Patients with Congestive Heart Failure Due 
to Ischemic or Idiopathic Dilated Cardiomyopathy. 
Stephanie L Olsen, Edward M. Gilbert, Dale G. Renlund, Patrice C. 
Mealey, David O. Taylor, A. Kirk Volkman and Michael R. Bristow, 
Universily of Utah Division of Cardiology, Salt Lake Cily, Utah. 
Carvedilol is a B-blocker with vasodilator activity that may 
improve symptoms and hemodynamics in heart failure. We 
evaluated carvedilol therapy in a randomized, placebo-controlled 
study of 54 patients (pts) with congestive heart failure due to 
either idiopathic (41 pts) or ischemic dilated cardiomyopathy (13 
pts). Entry criteria were NYHA Class II-III heart failure 
symptoms and a LVEF < 0.35. All pts tolerated a one week challenge 
of carvedllol 3.125 mg bid and were randomly assigned to receive 
carvedilol or placebo in a 3:2 ratio. Study drug was titrated over 
one month from an initial dose of 6.25 mg bid to a maximum dose of 
25 mg bid (for pls<75 kg) or 50 mg bid (for pts>75 kg) and then 
continued for 3 additional months. 
Findings (mean:!: SEM): 
Carvedilol (n-34) Placebo 
~!IIW ~
LVEF: .20 ± .01 .31±.02·t .19±.02 
HR (beats/min): 88 ± 3 68 ± 3·t 83 ± 3 
PA (mm Hg): 28 ± 2 23 ± 2·t 25 ± 3 
PCWP (mm Hg): 17 ± 2 13 ± l·t 14 ± 2 
CI (Umin/m2): 2.2 ± .1 2.4 ± .It 2.2 ± .1 
LVSWI(gm m/m2): 25:!: 2 38 ± 3't 26 ± 2 
NYHACIass: 2.5 ± .1 2.0 ± .1·t 2.4 ± .1 
Symptom Score: 4.7 ±.6 2.6 ± .4t 4.1 ± .6 




84 ± 3 
25 ± 2 
15 ± 2 
2.2:!: .1 
27 ± 3 
2.1 ± .2 
3.8:!: .8 
Both ischemic and idiopathic cardiomyopathy pts responded to 
carvedilol. Only one pt did not tolerate chronic carvedilol therapy. 
CONCLUSION: Carvedilol is well tolerated and improves both 
symptoms and cardiac function in pts with either ischemic or 
idiopathic cardiomyopathy. 
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725-3 4:30 
Effect, of Acute and Chronic Carveclilol on Relltlng and Exercl .. 
Hemodynamics of Patienll with idiopathic Cardiomyopathy 
Marco Metra, AntoniO O'Aloia, Gaia Panina, Matilde Nardi, Raffaele 
Giubbini, Uvlo Dei Cas. Chair of Cardiology, University of Brescia; Italy. 
The effects of the bela blocker and alphal antagonist carvedilol (C) 
were evaluated in 20 patients with idiopathic dilated cardiomyopathy 
(IOC) randomized (double blind) to either placebo (PI) or C. Each pi 
was studied by cardiopulmonary exercise (ex) testing with Swan-Ganz 
catheterization both acutely and chronically. In the acute study, pts 
were evaluated before (B Ae) and 3 hs after drug ingestion (Ae). They 
were then evaluated, after 6 months of chronic therapy, 12 hs after last 
drug ingestion (B Ch) and 3 hs after its readministration (Ch). C was 
administered at the dose of 12.5 mgs in the acute study and titrated up 
to 25 mgs bid chronically. LV Ejection Fraction (EF) was evaluated by 
MUGA before and after chronic therapy. No significant change oc•
curred after P; data of pts on C are summarized in the table. 
BAc Ac BCh Ch 
~ HR B4.±.15 75.±.7· 67.±.11··· 62.±.8··· 
MAP 87.±.11 83.±.11 85.±.12 89.±.10 
CI 2.2.±.0.5 1 .8.±.O.3 2.S'±'O.~. 2.2.±.O.~. 
SVI 27.±.6 24.±.4. 40.±.IQ.. 34.±.1~ •• 
PWP 17.±.7 12.±.7 10.±.S 10.±.4 
fH!s HR 148.±.IS 127.±.7·· 125.±.11·· 116.±.8··· 
~ MAP lD4.±.12 102.±.15 105.±.15. l00.±.9 • 
CI 4.9.±.1.3 4.4,±,1.4 5. 7 .±.2.~ • 5.2.±.1.1l.. 
SVI 34.±.10 3S.±.13. 46.±.17 ••• 46.±.17 ••• 
PWP 44.±.13 39.±.12 3O.±.11 27.±.10 
V02 IS.±.3 14.±.3 16.±.3 15.±.3 
(HR = Heart Rate; MAP = Mean Arterial Pressure; CI .. Cardiac Index; 
SVI.. Stroke Volume Index; PWP., Pulmonary Wedge Pressure; 
• = p < .05; .... p < .01: ..... p < .001 vs PI and B Ac). EF increased from 
19.±.7 to 28.±.14% after Ch C therapy (p< .001). Thus, C significantly 
improves both resting and ex hemodynamics of pts with IOC. 
725-4 4:45 
Heart Failure with Known Coronary Artery Disease: 
Comparison of Changes in Ejection Fraction with Beta•
Blocker and Placebo. 
Susan K. Bennett, Michael L. Fisher, Catherine Krichten, Richard 
D. Patten, Nancy L. Greenberg, Stephen S. Gottlieb. University of 
Maryland School of Medicine, Baltimore, MD. 
In dilated cardiomyopathy (DCM), reversal of left ventricular 
dysfunction is uncommon, particularly for patients (pts) with 
coronary anery disease (CAD). Most previous repons indicating 
that beta-blockers tend to increase (t) ejection fraction (EF) in DCM 
have !lQ1 compared this pattern of outcome with placebo. Concern 
that even low dose beta-blocker might worsen hean failure (tCHF) 
and EF persists. In 50 DCM-CAD pts randomly assigned to either 
titrated metoprolol or placebo. baseline EF was 23±8 in both groups. 
40 pts completed 6 months of study therapy with an overall median 
change ( t,. ) in EF of +3. With metoprolol EF increased (+5±6) 
while mean EF did not change (0±6) with placebo (p<O.05). 16 pts 
completing placebo were then given metoprolol for 6 months 
(crossover). Pts were divided according to t,. EF or occurrence of a 
co mplication. 
EFt~ 3 EF=±2 EF.!.~3 tCHFor 
Death 
Metoprolol (n=25) 12 8 2 --r 
Placebo (n=25) 7 5 6 7 
Crossover (n=16) II 4 0 I 
nfavorable outcomes t,. EF -3 or more iCHF or dealh w U ( , ) ere 
more frequent with placebo (p<O.05). Marked tEF (~+8) was seen 
in 35% of metoprolol treated pts (8/25 randomized and 6/16 
crossover), but in only one (4%) of the placebo pts (p<O.05). 
Titrated low dose beta-blocker can be safely initiated in DCM-CAD 
with reduced (rather than increased) likelihood of tCHF. The 
observed increases in EF suggest the potential for marked 
reversibility in more pts with DCM-CAD than previously recognized. 
JACC Vol. 21, No.2 
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725·5 5:00 
Effect of Long Term a·Blockade with Metoprolol on 
Exercise Tolerance In Patients with Idiopathic Dilated 
Cardiomyopathy. 
Edward M. Gilbert, Frank G. Yanowitz, Jeffrey L. Anderson, John B. 
O'Connell and Michael R. Bristow, University of Utah Salt Lake ~,~~ , 
Pre~ious studies of exercise capacity in Idiopathic dilated 
cardIOmyopathy have suggested that maximal exercise is increased 
by the a·blocker metoprolol (M). However, in these studies, peak 
oxygen consumption (V02) was not directly measured and M was 
administered at a low dose that did not reduce maximal exercise 
h~art rate. Therefore, we studied the effects of chronic therapy 
with moderate doses of M on exercise tolerance in participants in 
the international trial "Metoprolol in Dilated Cardiomyopathy" 
Twenty-seven patie~ts with idiopathic dilated cardiomyopathy, 
symptomallc heart failure and a LV ejection fraction e 0.40 were 
randomized to receive M or placebo. Study drug was started at a 
daily dose of 10 mg and titrated upwards as tolerated to a target 
dose of 150 mg/day. Exercise tolerance was measured at baseline 
and 6 months using a modified Naughton protocol with expired gas 
analysis for V02 measurement. Mean M dose was 130 ± 7 mglday. 
Findings (mean ± SEM, 'peO.05 vs baseline): 
Metoprolol (n=14) Placebo (n=13) 
~ 6...mQ. ~ §.J]]Q. 
rest HR (blmin): 87±4 72±3' 95±6 89±5 
max ex HR (blmin): 155±8 132±6' 160±9 157±7 
max ex time (secs): 522±60 536±60 450±73 521±61 
V02 (ml 02/kg/min): 19.3±1.4 19.3±1.6 18.0±1.5 18.9:t5.1 
max ex = maximal exercise, HR - heart rate 
NYHA functional class improved with M but not with placebo. 
Conclusions: When administered at a dose that is sufficient to 
~wer maximal exercise heart rate, chronic M therapy does not 
Increase maximal exercise in idiopathic dilated cardiomyopathy. 
~hus, our ob.served improvements in heart failure symptoms are 
likely due to Improvements in submaximal exercise capacity. 
725·6 5:15 
Do II-blocking Agents Improve Left Ventricular Fuctioa in Subjects with 
bchemic Dilated Cardiomyopathy! 
Michel White, E. Michael. Gilbert, Jeffrey A. AIIdenon, John B. O'Connell, 
Stephanie Olsen, Dale G. Renlund, Michael R Bristow 
University of Colorado Health Sciences Center, Denver, Colorado 
Based on results in at least six plac:ebo-controlled clinical trials, it is now 
accepted that ~ blocker treatment improves left ventricular function in subjects 
with idiopathic dilated cardiomyopathy (\DC). However, the effect of~· 
blocking agents on LV function in subjects with the most common kind of 
dilated cardiomyopathy, that due to ischemic causes (lSCDC), is much less 
certain. Previous studies have randomized only small numbers of ISCDC 
patients, and the available data are in conflict with regard to a significant 
improvement in LV function. Over the past seven years our group has 
randomized 167 subjects with heart failure from either IDC or ISCDC into four 
placebo-controlled clinical trials using three different ~-blocking agents: 
metoprolol, bucindolol, and carvedilol. The study durations have ranged from 
three to six months. 125 subjects have had IDC, and 42 ISCDC. Because of the 
uncertainty of the ISCDC response in ~ blockade, we performed a meta•
analysis of the effects of ~ blocker therapy in !DC versus ISCDC. The 
percentage of subjects tolerating initial ~-blocker challenge was 96.8% for IDC 
and 97.6% for ISCDC, while the percent completing the ~ blocker arms of the 
various trials was respectively 92.70/. and 96.2% (P=NS). Results ±SEM are 
given for patients treated by ~ blocker as change from baseline values for 
continuous variables, or as percent of subjects demonstrating an L VEF of ~.05 
vs. subjects not meeting this L VEF critcrion or dropping out of the study from 
heart failure molbidity or monaIity (responder/DOn-responder) 
T)1>e aLVEf a LV.OO 
(D) (%) (tm) 
JDC +IO·· t -0.34 
(0-69) .1.0 ±O.09 
ISCDC +4.7" -0.34" 
(0-28) .1.2 ±O.l4 
• p<O.05 VI. rcopcdi .. pIocdx> _ 
t p<O.Ol ... ISCDC 
aExHR aRllHR aswi R~' 
IBPM) (BPM) (In>mIM'l 
-:19.6" -16.5" +13.1-,1 66.2"·1 
<2.6 .1.8 <2.2 
-34.2" -16.0" +6.2" 40.7" 
.5.2 <2.7 .1.9 
. Conclusions: (I) Subjects with ISCDC demonstrate improved LV function 
wben treated with ~-blocking agents. (2) This degree of improvement is 
quantitatively less than for IDC subjects. 
ABSTRACTS 
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Intracellular Sodium as a Marker of Adenosine Mediated 
"Preconditioning" Protection of Iscbemic Myocardium 
Mary Osbakken, Danning Zltang, Tamas Ivanics 
University of Pennsylvania, Philadelphia, PA 
Shon episodes of "preconditioning" ischemia as a means to protect the 
hean against more prolonged ischemia is a documented physiological 
phenomenon. However, the mechanism(s) by which "precondition•
ing" produces its protective effects is (are) not well understood. One 
proposed mediator for the protective effect on the my~ is adenosine 
release and metabolism. To explore this hypothesis, 23Na nuclear 
ma~etic resonance (NMR) spectroscopy was used to monitor myocyte 
sodIUm (Nai) transpon response (used as a marker of the ischemic 
event) to prolonged ischemia and subsequent reperfusion. 
Measurem~nts were made on isolated cardiac myocytes pretreated in 
the followmg ways: 1) 3 consecutive episodes of 10 min ischemia/I5 
min recovery (ISCH/REC) considered to be ischemic "precondition•
ing" (N=3); 2) 3 consecutive episodes of 10 min supetfusion with 
adenosine (ADO, IO-6M)/15 min superfusion without ADO 
(ADO~C), considered to be ADO "preconditioning" (N=2); 3) 
superfuslOn with an ADO receptor antagonist, 8 S04-phenyltheo•
phylline (8SPT, 10 or 300 11m) for 60 min followed by 3 episodes of 
ISCH/REC (n=4); 4) superfusion with the ADO uptake inhibitor, 
dypyridamole (DYP, 10 11m) followed by 3 episodes of ISCH/REC 
(N=2). Exposure of myocytes to prolonged 60 min ischemia/60 min 
recovery after ISCH/REC or ADO "preconditioning" was associated 
with similar increases in Nai, which were significantly lower than thOSt 
found in myocytes not exposed to either type of "preconditioning" 
(CON, N=3): Maximum %Change Nai during prolonged ischemia: 
CON=300%; ISCH/REC=200%; ADO/REC=180%. Pretreatment 
with 8SPT or DYP prior to "preconditioning" ISCH/REC or ADO did 
not prevent the protective effects of either type of "preconditioning" on 
prolonged ischemia: both doses of 8SPT=180%; DYP=185%. These 
data indicate that ADO may mediate some "preconditioning" protection 
and that ADO effects are not necessarily mediated by ADO interaction 
with purinergic receptors or by ADO uptake by the cell. 
726·2 
Altered [Na,K).ATPase Function Contributes to 
"Preconditioning" Protection of Ischemic Myocytes 
Judy Chung, Tamas Ivanics, Danning Zhang, 
Mary Osbakken 
University of Pennsylvania, Philadelphia, PA 
4:15 
"Preconditioning" protection of the ischemic myocardium is a docu•
mented physiological phenomenon whose mechanism is not completely 
understood. To detennine whether altered [Na,K]-A TPase function 
contributes to "preconditioning" protection of ischemic myocytes, the 
following study was done. Isolated cardiac myocytes were superfused 
with ouabain (OUA, 10 1J.1ll) for 10 min followed by 15 min of super•
fusion without OUA. This regimen (OUA/REC) was repeated X3, 
after which myocytes were subjected to prolonged ischemia (60 min) 
followed by 60 min re-superfusion (Prolonged ISCH/REC). A second 
set of myocytes was exposed to the more traditional ischemic "precon•
ditioning" which consisted of 3 episodes of 10 min ischemia followed 
by 15 min re-superfusion (lSCH/REC), before exposure to Prolonged 
ISCH/REC. A third set of myocytes not exposed to either "precondi•
tioning" regimen, acting as the control (CON), was also exposed to 
Prolonged ISCH/REC. The effects of ischemia on myocyte intracellu•
lar sodium (Nai, mM) were monitored with 23Na Nuclear Magnetic 
Resonance (NMR) spectroscopy. Myocytes pretreated with OUNREC 
and ISCH/REC had smaller increases in Naj during prolonged 
ischemia, and more rapid and full recovery of Nai upon re-superfusion 
than myocytes subjected to prolonged ischemia without either 
pretreatment, ThlllU. These data suggest that "preconditioning" 
protection of the ischemic myocardium is associated with altered 
[Na,K]-ATPase function which may stabilize membrane function and 
intracellular calcium transpon. 
TABLE 1: Nai Response During Prolonged Ischemia: * P< 0.05 CON 
versus OUA and Isch groups . 




mM ~ mM ~ roM ~ 
32.5±t.9 3t.7±7.4 29.4±7.8 
89±7 175±19 63±13* 122±31 * 64±15* 11 5±25 * 
36±2.5 12.5±2 35.5±5 8.8±O.9* 29.5±12 1.3±O.S* 
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726·3 4:30 
Role or Adenosine Receptor Subtypes ill Preconditioning. 
Robert S. Walsh, Steven C. Richards, Guang S. Liu, Michael V. 
Cohen, James M. Downey. Univ. of South Alabama, Mobile, AL 
Preconditioning (PC) the heart with a brief period of ischemia 
protects it against infarction from a subsequent ischemic insult. 
We tested whether adenosine is the trigger of PC and deter· 
mined which receptor subtype is involved. Infarcts were pro•
duced in isolated buffer·perfused rabbit hearts by 30 min 
regional ischemia (Rl), followed by 120 min reperfusion. PC was 
achieved with 5 min global ischemia followed by 10 min 
reperfusion before the 30 min RI. Agonist groups experienced 
5 min of drug infusion then 10 min washout preceding the 30 
min RI. Infarct size was determined by staining with tetrazolium. 
32.1 ± 1.5% of the ischemic zone infarcted in control hearts vs 
8.9±2.3% in PC indicating that PC did protect. 2'phenylamino•
adenosine (500 nM), an A2<-selective agonist, failed to protect 
(26.8±3.9% infarction) as did the A:z.- agonist CGS 21680 at 20 
nM (18.4±5.4% infarction). The AI-selective agonist 2-chloro•
N6'cyclopentyladenosine (CCPA) (200 nM) protected with only 
6.5±4.8% infarction. The AI·selective antagonist DPCPX (200 
nM) blocked the protection from CCPA with resulting 
33.9±6.5% infarction. The less selective AI antagonist, 
8-sulfophenyl theophylline (SPT) at 50 J'M blocked PC 
(33.6±2.8% infarction). Hence, neither A:z.· nor A2<·selective 
agonists could induce PC and therefore, these agents cannot be 
PC's trigger. Only occupancy of the AI receptor with either 
exogenous agonists or ischemia·produced endogenous adenosine 
could trigger PC and that protection was blocked with the At 
antagonist. We conclude that endogenous adenosine does trigger 
PC through the AI receptor. 
726·4 4:45 
AdenoslDe Improves Recoftl')' Of Post·1scbemIc CanIlac FIIDdIon VIa Its 
At Receptor In the Isolated, Globally bchemk, WorIdn& Rat Heart. 
Ramiah Subramanian, Lisa Triemstra, Frank KoIodgie, Andrew Farb, Renu 
VItD1ani. Armed Forces Institute of Pathology, Washington, D.C. 
Adenosine has been sbOWll to imprO\'C post-ischemic reoovery of cardiac 
function and reduce infarct size in animal models of regional ischemia. 
Adenosine', protecti~ action is thought to be mediated mostly via i15 Al 
receptor. How.:~r, the relationship of aden05ine receptors in the global 
ischemia model ha~ not been 5tUdied. We tested the effect of adenosine in 
the isolated, perfused, working rat heart model with global ischemia. 
Cardiac Output (CO) and dP /ell were assessed after 20 min. stabilization 
(Pre I) and after 20 min. reperfusion (p05t R) which followed 20 min. of 
sustained global ischemia. Hearts were randomly assigned to 3 groups 
(n=6 for each group): I. Adenosine alone, n. Adenosine + SPT {8-(p•
sulpbophenyl) theopbylliDe - an Al receptor antagonist}. Aden05ine and 
SPT were infused (1 IIg/min.) iDlo the left atrial canula 3 min. prior to 
reperfusion (R). m. Untreated (control) group. 
Results: Mean • SEM 
Group CO' dP/eII CK# 
Prel P05tR Prel P05tR Prel P05tR 
I 66.4 52.6" 4200.500 39OO.soo" rT.6 6lt21f 
n 55.4 24.10 3400.600 1200.500 43.11 187.78 
m 74.12 2lt8 4300:700 1100.700 51118 16lt39 
Abbr: Pre I = Prior to induction of Ischemia, Post R = End of 
Reperfusion. 
·co in ml/min, #CK in UjL. 
"I ys II, (p = 0.01) and m, (p = 0.04); "I ys n (p - 0.009) and 
I YS III (p - 0.02); <) YS n and 1 YS m, (p - 0.04). 
The eJIlent of ischemia, IS measured by post-ischemic release of lactate 
dehydrogenase, and CK were simiJar in the 3 groups. CO and dP / dt 
aignificantJy improved post-ischemia after infusion of aden05ine; and was 
reversed by the addition of the AI receptor blocker SPT. 
Coaclusloa: Aden05ine induced cardiac protection against ischemic injury is 
mediated via its AI receptor in the globally ischemic isolated working rat 
heart. 
lACC Vol. 21, No.2 
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726·5 
ROLE OF ADENOSINE RECEYI'OR AGONISTS ON 
MYOCARDIAL REPERFUSION INJURY IN RABBITS: 
IMPORTANCE OF LIDOCAINE. 
John G. Kingma Jr., Denis Simard, Jacques R. Rouleau. 
Laval University, Ste-Foy (Quebec), Canada. 
5:00 
Adenosine (ADO) modulates reperfusion injuryi however, its 
efficacy may be limited in the absence .of conconutant lidocaine 
(LIDO) treatment. We tested whether ADO, or ADO receptor 
agonists were cardioprotective in the absence of LIDO in hearts 
w~thout .corol!ary co!lateral flow. Rab~its (n =50) underwent 30 
nun reglonallschemta and 3 h reperfuslon and were randomized 
to 4 groups: saline (CON)' ADO (0.01 mg/min), the ADO A2-receptor agonist CGS 21680 (0.01 mg/min); or the AI-receptor 
agonist, cyclopentyladenosine (CPA; 0.001 mg/min). Drugs 
were infuSed mtravenously for 65 min starting 5 min before 
coronary reperfusion. Area of necrosis (AN) and area at risk 
(AR) were determined using tetrazolium staining and 
autoradiography, respectively. AN was normalized to AR. 
Data are mean±SEM; ANOVA with Duncan's multiple range 
test was used to determine significant differences between 
groups; *pSO.05. 
CON ADO CGS CPA 
AN/AR (%) 46±4 45±6 29±4* 48±6 
Cardiac hemodynamics and ARlLV (ANOVA' p=0.22) were 
not different between experimental groups. ' 
Conclusions: ANI AR was reduced (ANOVA; pSO.05) with the 
ADO A2-receptor a~onist, CGS 21680 without LIDO; however, 
ADO and CPA Without LIDO did not limit tissue necrosis. 
These data support the concept that different mechanisms are 
involved in ADO receptor-mediated cardioprotection in this 
experimental preparation of ischemia-reperfusion injury. 
726·6 5:15 
Mechanism of Early Diastolic Dysfunction During Acute Myocardial 
Ischemia 
Richard P. Shannon. Kazuo Komamura, Tadashi Ihara. Thomas A. 
Patrick, Stephen F. Vatner, Dept. of Medicine. Harvard Medical School 
and New England Regional Primate Research Center. Southborough MA 
Controversy exists as to whether contractile or relaxation processes are 
more sens~ive to the imposition of an ischemic insuH. Accordingly. we 
studied 5 conscious dogs. chronically instrumented wHh left circumflex 
coronary artery occluders, dimenSion crystals in the non-ischemic (NZ) 
and ischemic (IZ) zones to measure wall thickening (WT) and left 
ventricular pressure gauges to measure isovolumic relaxation time 
constant. TAU. during the first 15 beats following the abrupt onset of 
occlusion. Within 4 beats, IZ end systolic WT fell by 0.3I±O.08 mm from 
15.67:t0.95 (p<0.05). This was associated with simuHaneous increases 
NZ end systolic WT (+O.15±O.02 mmfrom 13.67±O.89 mm). However.tau 
was not signfficanliy prolonged until the 7th beat (+2.1±O.4 ms from 
20.5±O.5 ms. p<O.05) when there was signHicant post-systolic WT 
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Notably. despite greater impairment in IZ WT (oO.12±O.16 mm. p<0.05) 
and persistent hyperfunction in the NZ (+O.15±O.03mm) as occlusion 
progressed (1 min). TAU returned to baseline as NZ post-systolic WT 
decreased (Figure). Thus. the earliest changes in isovolumic relaxation are 
a consequence of post-systolic WT in NZ rather than ischemia. per se. 
JACC Vol. 21, No.2 
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727·1 4:00 
Clinical Results of Percutaneous Ultrasound 
Angioplasty in 50 Patients with 55 Peripheral Arterial 
Lesions 
Robert J. Siegel, Peter Gaines, John Crew, Anthony Don 
Michael, Henry Nita, Wolfgang Steffen, Ann Proctor, 
David C. Cumberland, Cedars-Sinai Medical Center, los 
Angeles, CA and Northern General Hospital, Sheffield, 
England 
In this clinical trial of percutaneous ultrasound 
angiop1asty on 55 arterial lesions in 50 patients, the 
ultrasound ablation system had a frequency of 19.5 
KHz. We used 2m - 3l11li ball tip probes and a 3mm 
developed over-the-wire probe to treat 44 femoral, 8 
pop1 itea1 and 3 tibial peroneal lesions. Eighteen 
vessels (33%) had calcific lesions. Thirty-five of 40 
occ 1 us ions, 0.5 - to 28 em long, mean 7.0 ± 5.7 em 
were recanalized (88%). In the 50 patent arteries, 
the stenosis fell from 95 ± 12% to 50 ± 15% after 
ultrasound and to 10 ± 8% after adjunctive balloon 
angiop1asty. USing a recently developed over-the-wire 
system (n-18) the stenosis fell from 98 ± 5% to 40 ± 
22%. The residual stenosis post adjunctive balloon 
angioplasty in this series was 2±2% (p<O.OOl). No 
arteri a 1 di ssect ions or perforat ions occurred wi th 
the-over-the- wire probe. No embol i or vasospasm 
occurred, but vasodilation was noted after ultrasound 
ablation. At 24h ASI's increased by 0.19 ± 0.17, 
(0.07 - 0.50). Six to 12 month clinical follow-up and 
ASI on 23 cases with ultrasound and adjunctive balloon 
angiop1asty is indicative of restenosis in 6 cases 
(26%). 
Conclusions: Our findings indicate therapeutic 
intravascular ultrasound is 1) safe, 2) recanalizes 
calcific and non-calcific arterial occlusions, 3) 
reduces arterial stenoses and causes vasodilation 
during arterial recanalization. 
727-2 4:15 
Initial Human Experience wHh Cutting Balloon Angioplasty 
Peter Barath, Volker Wiegand*, Kristina Unterberg*, Hok Chong 
Leong, David Schmidt, James S. Forrester. Cedars-Sinai Medical 
Center. Los Angeles; *Georg-August Univeraity, Goettingen, Germany. 
We have demonstrated In pig and human cadaver coronary arteries 
that blades mounted on the aurface of a PTCA balloon (cutting 
balloon) produce longitudinal, radially directed endovascular surgical 
InCisions. The actual dilatation occura at the expense of the InciSions, 
sparing the Integrity of the Interinclslonal segments. The aQ!! of this 
Initial study was to demonstrate the safety and efficacy of cutting and 
dilating diseased human coronary arteries In vivo. M!!!!l!!!!i We have 
dilated 8 type A and 12 type B lesions (ACC/AHA) In 20 patients wHh a 
single Inflation of 4-6 atm for 60 seconds. Quantitative angiography 
wHh automated edge detection was performed pre and post PTCA. 
~ average referenCtl artery diameter was 3.23 mm (2.2-4.3 mm), 
average diameter stenosis 86% (~98%). The cutting balloons were 
undersized by an average of 0.38 mm (11.7e%). The average post 
PTCA artery diameter wa. 2.73 mm (lin average of 15.47% residual 
diameter stellosls). A single Inflation of the cutting balloon dilated the 
stenotic segments to the exact nominal diameter of the balloon In 14 
cases (70%) while in 6 cases, the vessel diameter remained belOW the 
nominal diameter of the balloon by an average of 8% (3-16%). The 
angiographic appearance of the dilated segments was smooth but 
hazy. The cutting balloon successfully dilated two lesions resistant to 
conventional angloplasty. We used adjunctive conventional balloon 
dilatation in 5 cases where the residual stenosis was greater than 30% 
and In 2 cases, to predilele subtotal occlusions. There were two 
complications not directly related to the cutting and dilating 
procedure: 1) a contrast jet from a faulty balloon Induced a minor 
dissection and 2) a reoccluslon 4 houra after an adjunctive balloon 
dilatation. None of the patienta dilated successfully wHh cutting 
balloon has have recurring chest pain 2-5 months after the procedure. 
Conclusions: 1) Cutting balloon effectively dilates high grade type A 
and B lesions wHh low Inflation pressure and short Inflation time and 
2) There were not complications directly related to the cutting and 
dilating procedure. 
ABSTRACfS 117 A 
727-3 4:30 
LOCAL HEPARIN DELIVERY WITH A HYDROGEL-COATED 
PTCA BALLOON CATHETER INHIBITS PLATELET "[)EPENDENT 
THROMBOSIS 
Gilberto L. Nunes, Stephen R. Hanson, Spencer B. King, Ronald 
A. Sahatjian, James J. Barry, Neal A. Scott. Division of 
Cardiology, Emory University, Atlanta, GA. 
SystemiC heparin therapy is ineffective in the prevention of acute 
closure after PTCA. Platelet-dependent thrombus fonnation in 
experimental models of thrombosis is also refractory to 
conventional doses of systemic heparin. To evaluate the efficacy 
of local heparin delivery on thrombus tonnation, we used a 
hydrogel-coated PTCA balloon catheter in a swine model of arterial 
thrombosis. Thombogenic Dacron grafts were interposed in chronic 
arteriovenous shunts in pigs. Autologous platelets were previously 
labeled with l11lndium. After a short (15 min) period of graft 
thrombus fonnation, the hydrogel-coated balloon was dip-coated 
with heparin (10,000 U/ml) and inflated at the thrombus for 15 min. 
The balloon was then withdrawn and flow re-established. Platelet 
deposition was quantitated by gamma camera imaging. 
Platelet Deposition (x1 ()8) 
30 min §QJnin 
coated balloon + heparin 
(n=6) 
0.5:!: .03* 0.7:!: .06* 0.6 :!:.04* 
coated balloon + saline (n=5) 2.6:!: .06 3.5:!: .08 4.5:!: .08 
regular balloon + heparin 4.8:!: .13 5.5:!: .2 7.3:!: .37 
(n=4) 
regular balloon + saline (n=6) 1.9:!: .03 4.3:!: .1 4.6:!: .1 
* = p<0.05 
An intravenous dose of heparin (100 Ulkg) was ineffective in 
inhibiting thrombus fonnation in the same model. We conclude 
that local therapy with heparin using a hydrogel-coated balloon 
catheter provides sustained inhibition of platelet-dependent 
thrombosis. 
727-4 4:45 
Feasibility And Efficiency of a New High Pressure PTCA Catheter Also 
Capable of Simultaneous Local DJ1II! De6very at Low Pressure 
Mun K. Hong. Moshe D. Mehlman. Andrew Farb. Renu ViJmani. Barbara V. 
HOWard. Keum S. Pad;. James J. Barry. Manin B.' Leon. Washington Hospital 
Center. Washington. D.C. 
Local drug delivery at the site of angioplas'y may reduce the frequency of early 
thrombosis and chronic restenosis. A new high pressure PTCA catheter (up to 15 
atmospheres) with intramural channels containing exterior pores for local drug 
delivery from a proximal infusion pon independent from the balloon inflation pon 
was developed. The advantages of this unique catheter design are: (I) uncoupling 
the high therapeutic balloon inflation pressure from the low pressure desirable for 
local drug delivery. thereby permitting simultaneous PTCA and local drug 
delivery ; and (2) avoiding high pressure jet effects. which cause focal tissue 
injury. Feasibility: After inflating the balloon to 6 atmospheres for one minute 
(balloon:anery= 1.8). 2 ml of methylene blue was simultaneously infused into a 
freshly expianted canine peripheral anery at 2 atmospheres. Visually there were 
no jet stream effects and histology confumed methylene blue staining in the inner 
third of the media. Under these same conditions. 2 ml of horseradish peroxidase 
(\ 0 mglml) was infused into the iliac aneries of rabbits (balloon:anery = 1.24; 
mean infusion time = 36 seconds). Immunoperoxidase staining of the petfusion 
fixed aneries revealed reaction products involving the full thickness of the media 
in 2 of 3 rabbits. Histology showed stretch of the vessel wall by the balloon 
without evidence of medial dissection. Delivery efficiency: Under the same 
conditions. 2 ml of W-heparin (1 uCi; specific activity = 0.57 mCi/mg heparin) 
was infused into freshly expianted canine anerial walls at 2 or 4 atmospheres (n = 
7: mean infusion time - 17 seconds; balloon:anery - 1.35). Light microscopy 
again showed no jet stream effects. Each 1.0 em segment contained mean 
radioactivity equivalent to 22·37% of the delivered radioactivity whereas the 
cOlltrol segments had only background level of radioactivity. 
We conclude tbat: (I) it is feasible to deliver drugs locally at 2 atmospheres 
without jet streams while performing high pressure PTCA simultaneously with the 
same catheter: (2) local infusion with this catheter result in drug delivery to the 
media: and (3) the efficiency of local drug delivery ranged from 22% to 37%. 
1I8A ABSTRACTS 
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LocaIized InIramuraI Delivery Of Heparin DuriDg Balloon ADgiopIasty: A 
New Technique Using HepariJHAlatecI BallOOIII And Active Diffusion 
Daniel B. Fram, Thomas A. Aretz, Joseph F. Mitchel, Michael A. Azrin, 
Linda D. Gillam, Raymond G. McKay 
Hartford Hospital, University of Connecticut, Hartford, CT 
Previous work by our laboratory has documented the efficacy of localized 
drug..<Jelivery during balloon angioplasty using standard balloon catheters 
which are coated with a hydrogel polymer into which various agents can be 
adsorbed. Balloon inflation against the arterial intimal surface results in 
active diffusion of agents from the polymer into the vessel wall. To assess 
the efficacy of this technique in the localized intramural delivery of heparin 
during arterial angioplasty, in-vitro halloon angioplasty was performed in 
14 porcine peripheral arterial segments using balloons coated with 
flouresceinated heparin. Balloons were coated with either a thin hydrogel 
layer (5 microns) or a thick layer (20 microns). Inflations were performed 
with a balloon vessel ratio of 1.2, at a pressure of 8 atm, and for a duration 
of 90 or 300 seconds. Post angioplasty, all specimens were examined 
grossly under a Woods Lamp and then stained to determine the presence of 
heparin and the depth of penetration. Depth of penetration was 
semi quantified as extending into the inner 113 (rank score I), middle 113 
(rank score 2) or outer 1/3 (rank score 3) of the arterial wall. 
RESULTS: Heparin was deposited in the arterial wall in all specimens. 
Mean average depth of penetration was 1.4±0.7 and mean maximal depth 
of penetration was 1.9±0.9. Penetration extended to the inner 1/3 of the 
arterial wall in 6 specimens (43%), the middle 113 in 3 specimens (21%) 
and the outer 113 in 4 specimens (29%). There was no significant 
difference in the depth of penetration betwen the 90 and 300 second group 
or between the thick and thin coated balloons. 
CONCLUSIONS: Localized intramural delivery of heparin is possible with 
the use of hydrogel-coated balloons. Duration of balloon inflation and 
quantity of heparin loaded on the halloon does not significantly influence 
the depth of penetration into the arterial wall. 
727·6 5:15 
Mechanism of Fluid Transfer Into the Arterial Wall From a 
Porous Balloon (PB): Scanning Electron and Light 
Microscope Study Using CollOIdal Gold Marker 
Keith A. Robinson, Steven R. Sig~an, Joel E. Schneider, 
Edward C. Santoian Gustavo D. CIpolla, Norman Tarazol!a, 
Spencer B. King III. 'Division of Cardiology, Emory Umverslty 
School of MedIcine, Atlanta, GA 
Local delivery of therapeutic agents is a potential means to 
decrease restenosis after balloon angioplasty. Concerns with 
local delivery devices include the efficacy of substanc~ 
delivery and the induction of additional tissue dam~ge by ~U1d 
jets. The purpose .of this study was. to determIDe, uSIDg 
scanning electron mIcroscopy (SEM) WIth backscatter electron 
(BSE) imaging as well as light microscopy, the nature of fl~ld 
delivery and extent of inj~ry to swine coronary art~nes WIth 
fibrotic intimal lesions, uSIDg a PB catheter. CollOIdal gold 
(2ml, 0.01 % solution of IO or 30 nm parti~les) was.perfuse~ at 
2 or 4 ATM into 14 swine coronary artenes ID whIch preV1o~s 
balloon injury had induced an eccent.ric intimal hyperplastIc 
lesion. SEM with BSE revealed mlcroaggregates of go!d 
marker (lOO-l50um diameter, verifie~ by X-ray mia:oana!ysls) 
associated primarily with focal craterlike areas of mlDor ttssue 
disruption formed by fluid jets from the catheter pores. A 
random pattern of less intense BSE signal was also observed 
Light microscopy of silver-enhanced thick sections 
demonstrated the marker near the luminal surface and at the 
interface between the media and neointima Tissue damage 
was restricted to endothelial loss; there was no evidence of 
medial injury. Conclusion: SEM with BSE imaging 
demonstrated that the PB delivered gold marker in a focal 
pattern due to fluid jets. These jets may be integral to the 
mechanism of fluid delivery; at these pressures and volumes 
overall tissue damage is minimal. 
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728·1 4:00 
Intravascular Ultrasound Comparison of De Novo and RestenoDc Coronary 
Artery Lesions 
Gary S. Mintz. Philippe C. Douek. Roben F. Bonner. Kenneth M. Kent. Augusto 
O. Pichard. Lowell F. SaUer. Martin B. Leon. Washington Hospital Center. 
Washington. DC 
If reSlenosis is predominantly the result of intimal hyperplasia. then plaque mass 
should be greater in restenotic than in de novo lesions and plaque composition 
should favor the accumulation of myointimal tissue in restenotic lesions. To test 
this hypothesis. we used a comprehensive intravascular ultrasound (IVUS) 
imaging system {25MHz rotating transducer. 3.9F monorail imaging sheath. 
motorized transducer pullback at 0.5mm/sec. 2-0 and 3-D display and 
quantification} to study 71 target lesions (28 LAD. 17 LeX. 26 RCA) prior to 
transcatheter therapy. Pre-intervention external elastic membrane (EEM). lumen. 
and plaque+media (P+M) cross-sectior.aI areas (CSA) and arcs of calcium and 
dense fibrous tissue were measured at the target lesion and at a proximal reference 
site. 
Lesion EEM CSA 
Lesion/Reference EEM 
Lesion P+M CSA 
Lesion/Reference p+ M 
Target lesion calcium # (%) 
Arc of calcium n 
Arc of calcium + fibrosis n 
























Thus. there is less atherosclerotic plaque (lesion P+M CSA) in restenotic than in 
de novo coronary anery target lesions even when normalized for a proximal 
reference site. Conversely. the frequency and amount of noncompliant plaque 
elements (calcium and dense fibrous tissue) are greater in restenOlic lesions. We 
conclude: Intimal hyperplasia (which should cause both increased total plaque 
mass and softer plaque components and. therefore. proponionately less 
calcification and fibrosis) may not be the dominant factor in restenotic lesions. 
AlternativelY. chronic recoil to the original lesion geometry caused by extensive 
noncomplia~t plaque elements may playa greater role than has been appreciated 
previously. 
728·2 4:15 
Disaepancies Between Angiographic and Intravascular Ultrasound 
Appearance of Coronary Lesions Undergoing Intervention. A Report of 
Phase I of the "GUIDE" trial. The GUIDE Trial Investigators 
University of California, San Francisco and Stanford University, CA 
The GUIDE Trial (Guidance by Ultrasound Imaging for Decision 
Endpoints) is a 12 center, prospective study of the utility of intravascular 
ultrasound (US) imaging in PTCA and directional coronary atherectomy 
(DCA). Phase I has enrolled 93 patients to date and this report 
documents the first 76 patients analyzed by both the angiographic (AN) 
and ultrasound (US) core facUities. Among 82 lesions in 76 patients 
studied (53 PTCA and 29 DCA), interpretable pre-intervention US images 
within the lesion were obtained in 38% and post-interventionaJ images in 
96%. 
Quantitative AN analysiS revealed that mean diameter stenosis within 
the target lesion decreased from 81 % to 18% post intervention. Residual 
stenosis by US (measured as the ratio of neolumen to vessel area), 
however, was 41 %. In the reference segment, chosen as a "normal" vessel 
by AN, the mean stenosis measured by US was 37%. Dissections were seen 
in 33/82 (40%) of lesions by US and 15/82 (19%) of lesions by AN. Lesion 
calcification was seen in 48 cases (58%) by US and 22 cases (26%) by AN. 
In 15/22 AN calcifications, a minimum calcium arc of 1800 was seen on US 
cross-section. Of 23 lesions with a calcium arc less than 90° by US, only 
one was detected on AN. Lesion eccentricity was also underestimated by 
AN compared to the US eccentricity ratio (ER ~ ratio of thinnest to 
thickest plaque depth). Lesions were concentric by US if the ER ? 0.5. 
The average US ER in lesions judged eccentric by AN was 0.23. Thus only 
lesions with a high degree of US eccentricity were called eccentric by 
AN. To date, no centers have been reported any in-hospital 
complications following the use of catheter-based US. 
Conclusion: These results suggest that US gives a more detailed 
representation of plaque morphology than AN, and may provide more 
accurate guidance for catheter-based interventions. 
JACC Vol. 21, No.2 
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728-3 4:30 
Coronary Endothelial Function and Vascular Structure in 
Cardiac Transplant Recipients 
Fausto I. Pinto. Adrian OIenzbraun. Helmut Drexler. Richard L. 
Popp, Edwin L. Alderman.Tim Fischell. Div of Cardiovasc Med. 
Stanford. CA 
Intracoronary ultrasound (lCUS) allows the study of vascular wall 
structure in great detail, and has been shown to be a sensitive method 
to detect angiographically silent intimal proliferation. However. the 
correlation of vascular morphology with endothelial function is not 
clear. The vasomotor response of epicardial coronary arteries to 
acetylcholine (Ach) was assessed by changes in coronary artery 
diameter. measured by quantitative angiography; microcirculation 
was studied by determination of coronary blood flow using a 0.014 
or om 8 in. Doppler flow wire and cross sectional area. Ach was 
infused in 15 cardiac transplant recipients via a 3.6 Fr. infusion 
catheter into the LAD (l(}8. 1(}7. 1(}6 M). Endothelium-mediated. 
flow-dependent dilation (FDD) was determined by analyzing the 
proximal LAD exposed to increased flow but not to Ach. The same 
coronary segments were studied with a 30 MHz 4.3 Fr. ultrasound 
catheter (CVIS. Inc.). Intimal thickness (IT) was quantified by an 
intimal index (intimal area divided by intimal and lumen area). FDD 
of the proximal LAD ranged from +2 to +16% and was inversely 
related to IT (r=O.62. p<0.05, n=l1). Five of 6 distal LAD 
segments with no intimal thickening by lCUS constricted in response 
to Ach, ranging from -1.5% to -32%. The Ach-induced increase in 
blood flow (range: 10% to 265% increase from baseline). reflecting 
endothelium-dependent dilation of the coronary microvasculature. 
was predominantly impaired in patients late after transplantation but 
no correlation was observed with intimal thickness of epicardial 
coronary arteries. 
In conclusion. endothelial dysfunction of epicardial coronary arteries 
may precede structural alterations as identified by lCUS. OIanges in 
coronary microvasculature occur with time after transplantation, 
regardless of the extent of intimal thickness. The ability of epicardial 
coronary arteries to dilate in response to increased flow is related to 
the degree of intimal proliferation. 
728-4 4:45 
Impaired Distensibility of Human Coronary Artery In 
Angiographlcaily Normal Site : In Vivo Assessment 
With Simultaneous Intracoronary Ultrasound and 
Intracoronary Pressure 
Satoshi Nakatani, Masakazu Yamagishi, Jun Tamai, Akito 
Kawaguchi, Chikao Yutani, Kunio Miyatake. 
National Cardiovascular Center. Suita, Osaka, Japan 
Impaired distensibility of a vessel is a feature of 
atherosclerosis. Coronary artery distensibility (CD) was 
assessed precisely with simultaneous measurements of 
coronary luminal area and intracoronary pressure in 
angiographically normal coronary arteries in 12 patients 
(mean age 57 yrs). Coronary luminal area was measured 
with a 4.3F, 30MHz intracoronary ultrasound imaging 
catheter inserted from the femoral artery and intracoronary 
pressure was measured with a 2F micromanometer-tipped 
catheter inserted from the other femoral artery. CD was 
obtained as the ratio of luminal area change to intracoronary 
pressure change during a cardiac cycle after intracoronary 
injection of 500 Ilg nitroglycerin. Thickness of intima-media 
complex, defined as the distance between the intimal leading 
edge and the adventitial leading edge, was measured as an 
index of atherosclerosis. Extreme eccentric lesions were 
excluded from the analySiS. Thus, measurements were done 
in 10 sites of left main coronary arteries and 10 sites of 
proximal left anterior descending coronary arteries. Results: 
Thickness of intima-media complex ranged from 0.38 to 
1.15mm, suggesting existence of various grades of 
atherosclerosis. There was a significant inverse correlation 
between CD and thickness of intima-media complex (r=-
0.78). Conclusion: Coronary distensibility was dependent on 
the severity of occult atherosclerosis and may be impaired 
even in angiographically normal coronary arteries. 
ABSTRACTS 
728-5 5:00 
Three-dimensional Reconstruction Enhances tbe Utility or Intravascular 
Ultrasound during Transcatbeter Therapeutic Procedures 
Gary S. Mintz. Augusto D. Pichard, Kenneth M. Kent, Lowell F. Saller, Satwnino 
P. Javier. Martin B. Leon. Washington Hospital Center, Washington, DC 
To assess the utility of 3-D NUS image reconstruction in the setting of mulli· 
device transcatheter therapy (TCf) for CAD, we configured a comprehensive 
lVUS imaging system [25MHz roIating ttansducer, 3.9F monorail imaging sheath, 
motorized nansducer pUllback at O.5rnm/sec. cath-lab integrated displays of axial 
2·0 and 3-0 images, and quantification of vessel wall, lumen, and plaque 
volumes}. Axial 2·D and 3-D images aided in extrapolating measurements of 
deeper aneriaJ structures shadowed by superficial plaque calcium (Ca"). Pre•
intervention imaging (n=l90) influenced TCT therapy by (I) detecting unusual 
lesion morphology (eg. thrombus, true or false aneurysms), (2) quantifying axiaJ 
lesion severity and its relationship to branch points or vessel ostia. and (3) 
detennining the presence, distribution. and extent of Ca". Used in comparison to 
subsequent post·intervention imaging. it was valuable in assessing mechanisms of 
TCT. Post-intervention imaging: (I) Rotational atherectomy (RA, n=66) 
produced a smooth. cylindrical lumen in calcified plaque, preferential Ca·· 
ablation. and minimal tissue disruption or vessel expansion except after adjunct 
balloon angioplasty (PTCA). (2) Excimer laser angioplasty (ELCA, n=29). used 
mostly after guidewire recanalization of total occlusions, produced multiple small 
and large. superficial and deep dissection planes (primarily in fibrocalcific plaque) 
with occasional evidence of ea·· ablation. especially at edges of Ca" deposits. (3) 
Directional atherectomy (DCA, n=57) resulted in tissue removal opposite or 
adjacent to. but not involving Ca" except as adjunct to RA or ELCA. 3-D lVUS 
lumen volume increase after DCA averaged 3.4 times the measured retrieved 
tissue volume. but only 1.6 times the 3·0 lVUS measured decrease in plaque 
volume: both of these were significantly less than the atherectomy effect suggested 
by planar image slice analysis alone. (4) 3-D slent geometry (n=57) was recreated 
with focal stent compression by fibrocalcific plaque and occasional non-unifonn 
axial and radial stent expansion. (5) PTCA (n=18) caused aneriaJ dissection at the 
junction of Ca·· and non·Ca·· plaque. Plaque mass was preserved. Anerial 
expansion occurred in all pts, even in the face of aneriaJ dissection. When paired 
with post·intervention imaging. follow-up imaging (n=ll) showed patterns of 
disease progression and restenosis. sometimes more focal and other times more 
diffuse. than that of original lesion morphology. We conclude: As an aid to 
selecting and assessing TCT device therapy. 3-D lVUS imaging provides unique 




Accurate displacement sensing device provides reproducible 
intravascular ultrasound images 
Elma J. Gussenhoven. Wenguang li. Aad v. d. Lugt, Marco J.L. v. 
Strijen, Claudia M.M. Stigler. Salem H.K. The. Frans v. Egmond. 
Willem P.T.M. Mali. Nicolaas Born. 
Thoraxcenter. Erasmus University Rotterdam, the University Hospital 
utrecht and the Interuniversity Cardiology Institute. The Netherlands. 
The need for accurate positioning of an intravascular ultrasound 
(lVUS) catheter resulted in the development of a dedicated 
displacement sensing device that provides instantaneous information 
about the catheter position on a videoscreen. The displacement sensor 
device consists of two parts: a sensing unit through which the 
catheter is pushed or pulled. and a registration part which converts 
the linear movement into an electronic signal. The electronic signal, 
which indicates the displacement of the catheter in steps of 0.1 mm. 
is mixed on-line with the videoscreen information. The accuracy of 
this device has been tested in-vitro. using 11 pressurized arterial 
specimens (l coronary and 4 iliac arteries) with atherosclerosis. From 
each specimen the free lumen area from 3 pull-back series were 
determined over a mean distance of 18.4 mm with increments of 0.5 
mm. A total of 1261 cross-sections were analyzed. 
ResuIts:The mean paired difference was -0.15 ± 0.8 mm2 between 
the first and second pull-back (p<0.01). and was -0.29 ± 1.3 mm2 
between the first and third pull-back (p<0.01). The cross correlation 
showed that only one pull-back had ~. position shifting of 0.5 mm and 
no other position mismatching was found in the rest of the data. 
Conclusion: the displacement sensing device provides accurate 
reproducible images. This device used in humans may prove to be a 
unique tool to accurately compare IVUS images before and after 
intervention and to compare IVUS images with angiography. 
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729-1 4:00 
The SympatbovagaJ Balance Duriaa Ina'8DentaJ Tilt 
Muiume BooIsma, cas A. Swcane, Harm H. van Bolhuis, Volkert Manger Cats, 
Albert V.G. Bruscbke 
University HOIpital, 1.Aid<:D, The Nelberlands 
Heart rate (HR) and the percealage low-lrequency beat! rate variability (LF) are 
both iDdexes of the syDIP8Ibov.,a1 balance. HR is stable, covers nearly the whole 
range of autoDomic 8IaIes betweaI complete iDactivity and vigorous exercise, but 
ueods calibraliOll, "0. due to individual differences in intrinsic beat! rate. LF is 
aoisy, bas DIOII of its dyoamic& betweaI rest and mild exercise, but is calibrated, 
ranging from 0 (vqal precIominaDce) to 100 (sympathetic predominance). To 
determine if LF can be used to calibrate HR, we studied the LF -HR relatioa with 
bead-up tilt (HUT). 
Twenty bealthy males (mean±SD age 2S.5H.2 years) _ subjected to 
incremental HUT. This procedure gradually increases the sympatbovagal balance 
by incremental unloading of the cardiopulmonary baroreceptors. Tilting angles (0-
10-20-3040-45-50-55-60-65-70-75-80°) were maintained during 6 minutes. 
Sessions _ ohorted at any subjective or objective sign of discomfort or 
presyncope. During sessions, we recorded the ECG (Marquette Holter recorder), 
arterial blood pressure (D)'DIIIIIIIp), and respiratory rate (thoracic impedance). LF 
was computed by multiplying the quotient of the 0.07.().14 and the 0.07.().4O Hz 
spectral powers by 100. 
HR increased consistently with the tiltiog angle. iDcIividuailinear regressions of LF 
011 HR yielded: Intercept Slope (s) Correlation 
Mean±SD -37 ± 53 J.5 ± 0.8 0.81 ± 0.13 
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729·2 
CGDClusion: 
LF ciwlges proportiODally with 
HR during incremental HUT. 
1bi. reinforces the significance of 
LF and HR as iDdexes of the 
.ympathovagal balance. By 
regression, LF can be used to 
individually calibrate HR. 
4:15 
Spectral .... ysis 01 heart rate YWialIility does .at predict occurreace or 
IYJICOPe OD tilt tatIng 
Dennis L. Kuchar, Harry PIaIl, MusIafa Karamanoglu. Charles TIKxbum. 
Cardiology DeparllMlII. SI Villcelll'S Hospi/IJI. Sydney. AMStraiia. 
PaticnIs wid! rec:unent syncope may have abnormal aulalOmic responses 
manifest as bradycardia or a vasodepressor response. Tilt resting induces a 
SIrong ortbostatic slimulus whicb bas been shown to IUIIIIISk a susceptability to 
vasovagally-medicated syncope. 
Variability of the RR iDtavaJ is lintcd to respiratory and blood pressure 
fluctuations and reflects autonomic cardiac inputs. Power spectrum analysis 
(PSA) is a Fourier tnmSform analysis of RR intervals represented as a 
frequency distributim with distinct parasympathetic (Hi. 0.15-0.40 Hz) and 
sympathetic (Lo. 0.06-0.10 Hz) frequency peaks. We studied PSA wbilst 
supine. standing and following atropine in 35 consecutive patients with 
rec:unent syncope who Wlderwent tilt resting. This was to detennine whether 
PSA could differentiale patients with or without tilt-induced (vasovagal) 
syncope. Results are expressed in tenns of die ratio of LoIHi power for those 
with or without tilt-iDduced syncope. 
Syncqle (0= 1 0) 
No syncope (0=25) 
~ 
1.3 :!; 0.7 







Both standing and IIIOpine lead 10 an in=ase in LoIHi ratio (p=O.OOI) 
reflecting a relative increase in sympathetic activity and parasympathetic 
withdrawal. However. there was DO difference in the response of die ~ 
ratio in patients wid! syncope. compared wid! those without tilt-induced 
syncope 8l rest nor in their response to standing or atropine (p=O.6). 
Conclusion: Delemlinalion of autonomic activity using ECG specual analysis 
does not identify patients with tilt-iDduced syncope. 
JACC Vol. 21, No.2 
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729·3 4:30 
Ab.ence of Tachycardia Durin9 Tilt Teat 
Predicts Failure of Therapy With Beta Blockers 
in Patient. with Neurocardioqenic Syncope 
Jonathan Leor. Zeev Roth.tein. Zvi Vered. 
Eli.a.r Kaplinaky. S.adar Trusan. Michael 
Eldar. Heart Institute. Tel-Ha.hoser. Iarael. 
Not all pt. with neurocardioqenic syncope (NCS) 
respond to a-blocker •• To deter.ine whether 
diff.rence. in h.art rate (SR) r •• pon.e to 3-
.tage isopr.terenol (0.3.5 scg/sin up to 10 
.in) h.ad-up tilt t •• t (BUTT) ar. correlated 
with drug efficacy. 28 con.ecutive pts with NCS 
and po.itive (+) BUTT were .valuated. Gr I: 20 
pt. with ba.eline BR of 70:!;15 d.v.loped sinu. 
tachycardia (129:!;13, range 105-150) during BUTT 
.her.a. 8 pt.: Gr II with ba •• line SR of 69:!;13 
did not (79:!;12. rang. 59-92; p<0.01). The 
group. "ere g.nerally cosparabl •• All pt. were 
.tart.d with S-blocker. (propranolol, setopro-
101); 15 pt. w.r. r.challenged during a-block•
ad •• Pta with re-NCS and +re-BUTT during thera•
py with ~block.r. w.r •• witch.d to disopyra•
.ide. aff.ct of drugs on the incidence of NCS 
and re-HUTT during 12:!;6 sonth. are .hown below: 
-= __ --:-_______ .:,P:-":r::o"'p~r_"an~otC>t ... _~!opyrllsjde __ 
Event re-NCS +r.-BUTT r.-NCS +re-HUTT 
Gr I 0/20 0/10 NP *** 
Gr II 5/8 * 5/5 ** 0/5 1/5 
Total 5/28 5/15 0/5 1/5 
* p<0.01 ** p<0.05 *** HP-not perfors.d 
CoDcluaian: In pt. with HCS. absence of tachy•
cardia during BUTT predict. therapy failure 
with ~block.ra. Th •• e pt ••••• to ben.fit from 
di.opyra.ide. 
729·4 4:45 
Differential Response to Phenylephrine in 
Patients with Neurocardiogenic Syncope •• 
Marilyn M. Cox. Aurelio Duran. Raul Jimenez. 
Lynn Pringle, Agustin Castellanos, Robert J. 
Myerburg, University of Miami, Miami, FL. 
Thirty-three patients (pts) with unexplained 
syncope or near-syncope and positive (+) head•
up tilt tests (HUT) underwent repeat testing 
with IV phenylephrine (PHENYL) and then IV 
propranolol (PROP). A 2ug/kg bolus of PHENYL 
followed by a 10ug/min infusion increased 
systolic blood pressure (BP) from 119±17mmHg 
to 147±21, (p=.0001) and decreased heart rate 
(HR) from 84±17/min to 56±10 (p=.0001); and 
19/33 (58%) pts had a beneficial HUT response 
to PHENYL, becoming HUT (-). There were no 
differences in supine BP and HR between PHENYL 
responders and non-responders in the drug-free 
state or during PHENYL. After washout, all 
pts received PROP, and during repeat HUT 31/33 
(94%) became (-). 18/19 (95%) of PHENYL 
responders and 13/14 (93%) of non-responders 
became HUT(-) after PROP. However, PHENYL 
responders had a significantly lower supine 
systolic BP after PROP than did PHENYL non•
responders (114±17mmHg vs 126±17, p=.04). 
suggesting lower inherent alpha-adrenergic 
tone. In conclusion, the differential 
response to PHENYL suggests that blunted 
peripheral vasoconstriction is not a uniform 
pathophysiological mechanism in pts with 
neurocardiogenic syncope. The paradoxical 
response to PROP in PHENYL responders suggests 
that PROP unmasks a lower baseline alpha•
adrenergic activity in the PHENYL-responder 
group. 
JACC Vol. 21, No.2 
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729·5 5:00 
Do PaUentl with Neurally Mediated Syncope have Elevated 
Vagal Tone? 
James F Sneddon, Yaver Bashlr, Francis Murgalroyd, Phillip J Keeling, 
David E Ward, A John Carnm. St. George's Hospital, London, UK. 
The vasovagal reaction consists of both resistance vessel vasodllalion and 
bradycardia due largely to sympalhetic withdrawal and Increased vagal 
activity respectively. We have studied parasympathetic function In patients 
wHh neurally mediated syncope (NMS) using both heart rate variability 
(HRV) analysis as a measure of tonic activtty and baroreceptor sensitivity 
(BRS) to assess maximal vagal reserve. Temporal and spectral indices of 
HRV were computed from 24 hour Holter recordings of 24 patients wtth tilt 
induced NMS and an age matched control group of 24 patients in whom 45 
minute 600 tilt tests were negative. None of the patients had evidence of 
important structural heart disease, diabetes or neuropathy. Power spectral 
plots were quantHied into low frequency (0.04-0.15 Hz) and high frequency 
(0.1S-0.40 Hz) bandwidths reflecting predominantly sympathetic and vagal 
components respectively. BRS was determined using bolus injection of 
phenylephrine. 
:amlX![ill Mllil~U[II~ HM.S ~ Sj9Cjjj"ilC"1I 
MeanRR(ms) 820 ± S094 811 ± S0107 p-O.77 
50(ms) 147 ± S033 142 ± S046 pK O.67 
PNNSO(%) 14.7 ± 5014 13.4 ± S013 p-0.75 
S~CI[ill MlliI~U[II~ 
Bandwidth 
O.OH.OHz (ms) 47.7 ± S023.9 42.1 ± S014.7 p=0.34 
0.04-0.1SHz (ms) 30.7 ± S016.3 27.2 ± 5010,4 p-0.38 
0.1S-0.4Hz (ms) 18.6 ± 5012.8 1S.S ± S07.6 p-0.31 
ail[Q[fl"flI:l19[ SflCSIII)(tt~ 
BRS (mSlmmHg) 1S.7 ± 5013.3 14.0 ± 5011.7 p-0.74 
In conclusion; there is no evidence that patients with tilt induced NMS have 
chronically augmented vagal tone. Similarly assessment of vagal tone is of 
uttle diagnostic value in patients wHh suspected NMS. 
729·6 5:15 
Alteration of Regional Left Ventricular Function in 
Relationship to Vasovagal Syncope on Head up Tilting 
Amar Singh, Joseph Galvin, Diane Lombardo, Arthur 
Portnow, Steven Fein, Bettye Briggs, Dan Mead, Karen 
Anthony. 
Albany Medical College and VA Medical Center, Albany, NY 
To detennine the nature and significance of morphological 
changes to the left-ventricle in the genesis of malignant 
vasovagal syncope (MVS), 2-Dimensional echocardiography 
was perfonned in the supine and head up tilt (HUT) 
positions in patients with syncope of unknown origin. 
fourteen (14) patients (Group I) developed hypotenSion, 
bradycardia and altered levels of consciousness on HUT (9 
requiring isoproterenol infusion). All patients demon•
strated increased contractility of the left ventricle, 10 
with cavity obliteration. Regional wall motion abnonnal•
ities were noted in all patients consisting of systolic 
bulging of the basal posterior wall in 13 patients and 
apical bulging in 1 patient. The changes occurred soon 
after HUT and preceded contractile changes of the 
ventricle. fifteen patients (Group II) failed to develop 
syncope on HUT despite isoproterenol infusion. An 
increase in contractile function was noted in 13 patients 
with cavity obliteration in 8 patients. Basal posterior 
wall bulging was present in only 1 patient. Compared to 
Group I, Group II patients tended to be older and were 
more likely to be taking vasodilation medications as a 
potential cause of syncope. 
Conclusion: Activation of both pressure and stretch 
receptors of the left ventricle appear to be involved in 
the genesis of MVS, with the latter mechanism possibly 
being of greater importance. 
ABSTRACTS 
730 Outcome and Complications Following Adult 
Cardiac Surgery 
Tuesday, March 16, 1993 
8:30 AM-10:00 AM 
Anaheim Convention Center 
C·2 
730·1 8:30 
Improvement or Post Cardiopulmonary Bypass (CPB) Pulmonary Function 
by Inhibition or Platelet Activating Factor (PAF) 
Kenton Zehr, Roben Poston, Paul Lee, Peter Cho, A Marc Gillinov, Kay 
Utholf, Jerry Winkelstein, AlIvie Herskowitz, Duke Cameron. 
The Johns Hopkins Medical Institutions, Baltimore, MD 21205 
121A 
CPB produces a diffuse inflammatory reaction which may injure multiple 
organs and complicate cardiac surgical procedures. In this study, a PAF 
competitive inhibitor (HUL-412) was used in a porcine model of CPB as a 
potential means to ameliorate post-CPB pulmonary injury. 12 pigs (35-40 kg) 
underwent CPB at 28° C for 2 hrs, followed by 2 hrs observation. Group I 
(n-6) received HUL-412 IV (3 mg/kg loading dose and 2 mg/kglhr continuous 
infusion) staning pre-stemotomy. Group II (n=6) received saline vehicle. 
PAF inhibition was confirmed ex vivo by platelet aggregometry. Peak airway 
pressure, pulmonary anerial pressure, left atrial pressure, and anerial blood 
gases were measured; flow cytometry evaluated surface expression of adhesion 
molecule subunit CD18 on circulating neutrophils. Pulmonary function was 
significantly improved in Group I. Dynamic compliance in Group I was 
91±12% of baseline 15 min post-CPB versus 44±4% in Group II (p<.OS by 
ANOVA). PaO, and post-CPB pulmonary vascular resistance (PVR) were 
also significantly hacuer.m, G.r,' oup I: 
O. ON .''-2 PULMONARY VASCULAR RESISTANCE 
f: ~ ~~  'I: ;Ff~ }= H-t-1 1:: 
I~ ~ 
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CD18 upregulation increased £imilarly in the 2 groups during CPB (I: 
32±14.S% I'S II: 3O±IS%) and after 2 hrs reperfusion (1: 83±19.S% vs II: 
121±lS.5%). This study demonstrates that PAF inhibition 1) decreases PVR, 
increases PaO" and improves lung compliance after CPB but 2) does not 
exen ilS effect by modifying up regulation of neutrophil adhesion molecule 
receptors. PAF inhibition may have clinical applicability in amelioration of 
organ damage after CPB. 
730·2 8:45 
Neurologic Events and Neuropsychological Function after Warm vs 
Cold Cardiopulmonary Bypass: A Prospective Randomized Trial in 
Patients Undergoing Elective Coronary Bypass Surgery 
Christina T. Mora, Martha B. Henson, William S. Weintraub, Tomas D. Martin, 
Joseph M. Craver, John P. Gott, James G. Ramsay, Robert A. Guyton. 
Department of Anesthesiology, Divisions of Cardiology and Cardiothoracic 
Surgery, Emory University School of Medicine, Atlanta, GA. 
While Hypothermia during cardiopulmonary bypass (CPB) may confer cerebral 
protection, normothermic CPB with warm blood cardioplegia may provide 
superior myocardial protection. To compare normo- ~3sD C) versus 
hypothermic (980 C) CPB, 1001 elective coronary bypass surgery (CABG) 
patients were randomized in a prospective c1inical trial, with endpoints death, 
myocardial infarction and neurological events. A subset of 147 patients 
underwent detailed neuropsychological testing preoperatively, at 7-10 days, and 
at 4-6 weeks. Results: 
N Death 
Warm 493 1.0% 










•• p < .02. Neurologic events included perioperative (Peri-Op) strokes, late in•
hospital strokes and encephalopathy. Neuropsychological tests assessed 
concentration, coordination, learning and memory. Scores: 
Time CPB Digit Span Coordination Learning 
Pre-Op Warm 13±4 114±S4 U±3 
Cold 14±4 109±4S U±4 
7-10 Days Warm 13±3 137±62 9±4 
Cold 14±4 U7±S2 8±3 
4-6 Weeks Warm 14±4 104±48 13±4 
Cold 16±S· 98±48 U±4 
.p < .05. Little difference in neuropsychometric function was noted; thus, the 
incidence of major neurologic events and overall neuropsychometric function do 
not necessarily correlate. In elective CABG surgery, warm blood cardioplegia 
with normothermic CPB showed no benefit in myocardial protection, and 
resulted in an increase in stroke. 
122A ABSTRACfS 
730·3 9:00 
Predictors and Prevention or Arrhythmias Following Coronary 
Artery Bypass Surgery 
Michael R. Gold, Patrick T. O'Gara, Mortimer 1. Buckley, 
Roman W. DeSanctis. University of Maryland, Baltimore, MD 
and Massachusetts General Hospital, Boston, MA 
Arrhythmias are common following coronary artery bypass surgery 
(CABS). Given the morbidity and costs associated with 
postoperative arrhythmias, we studied the predictors of these 
arrhythmias in 100 pts who were part of a randomized trial of 
procainamide (proc). Atrial fibrillation (AF) and ventricular 
tachycardia (VT) were detected and quantified by telemetry and 
Holter monitoring. AF developed in 32% of pts while VT ~ 3 
beats) occurred in 11 %. The duration of postoperative 
hospitalization was prolonged in pts with arrhythmias (11.6±0.7 
days vs 7.9±0.3 days, p< .01). Multivariate analysis of 16 
demographic, hemodynamic and operative factors identified age as 
the only predictor of AF and ejection fraction (EF) as the only 
predictor of VT: AF occurred in 36% of pts > 55 years old, but 
only in 13% ~ 55 years (p< .05); VT developed in 39% of pts 
with EF < 50% but only in 3% with EF L 50% (p<.01). With 
regard to arrhythmia prevention, AF was reduced in pts receiving 
postoperative digoxin (14% vs 43%, p< .05) or beta blockers (8% 
vs 38%, p< .05). VT was reduced only in those receiving Proc 
(2% vs 20%, p< .05). In pts with therapeutic serum Proc levels 
~ 4.0 mg/dl), there was a significant reduction in the incidences 
of both AF (13% vs 38%, p< .05) and VT (0% vs 20%,p< .01). 
Conclusions: Postoperative arrhythmias prolong hospitalization 
following CABS. Age and EF can be used to identify pts at high 
risk for AF and VT. Appropriate prophylactic therapy to such pts 
will reduce arrhythmias by about 80%. 
730·4 9:15 
The Impact of Aprotinin l1li Coronary Artery Bypass Graft Patency 
Glenn W. Laub, S. MlII"Ilidlw"lll, Robert ClanCY. Jerome B. Riebman, Chao 
0-, Milk S. AdlriDs, William A. ADderson, Javier Femmdez, Deborah 
IIkowski, Bridget Bailey, IIId LYJID B. McGrath. 
Deborah Heart &: l.uDg CenIeI", BI'OWDS Mills. NJ 080IS USA 
Aprotinin bas been shown to reduce postoperative bleeding cd 
InDsfusion requirements usociated witb coronary artery bypass ,..rung 
(CABO). ODe COIICetIl witb its use, however, is that it may have a deleterious 
effect on graft pateocy because it promotes bemo8tasis. Forty-five patients 
lI1Idergoing CABO were emolled in a prospective, ~. double blind trial 
of high dose IpIOtinin (4 - 6 1 10' kallikrein inhibitory uuits) to determine tbe 
effect of this agent on postoperative bleeding, InDsfusion requirements, reoaI 
fuDction. cd graft pateacy. The lllUdy group was comprised of thirty-two 
patients who UDderwent technically adequate ultrafast CT IICaIIS 6-8 weeks 
postoperatively to determine graft pateacy. Thirteen patients were DOt included 
in this malysil because they bad ID inadequate SCID (S), refused follow-up (6) 
or expired (2). 16 patients received high dose IpIOtinin (AG = Aprotinin Group) 
cd 16 received placebos (00 = Control Group). 
Results: Demographic cd operative descriptors were similar between 
AG cd 00. Postoperative mediastinal cd chest tube drainage in the AG was 
fignificmtly less IbID that in tbe 00 (722 vs 1540 mls [p = 0.0006)) cd tbe 
melD InDsfusion requirements were less, but this did DOt reach fignificmce (97 
vs 125 mls [p=0.16)). Ultrafast CT IICaIIS revealed 3S of 4O .... fts placed in the 
AG were patent, while aU 38 pafts placed in the placebo group were patent 
(87.S vs lOO'lli, p=0.03). There was DO difference in the incidence of 
myocan:lial infarction. reoaI dysfuDction or bemoglobin level at discharge between 
the groups, or evidence of other thrombotic complications. 
Cooclusions: We cooclude that high dose IpIOtinin is efficacious in 
reducing bemorrbage after coronary artery bypass parting. However, its routine 
use sbould be IppI08Ched cautiously due to its possible adverse effects 00 graft 
pateocy. 
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730·5 9:30 
Clinical Predictors of Renal Insufficiency After Cardiac Surgery: 
A Prospective AnalysiS of 1200 Patients 
Victor G. Davila-Roman. Benico Barzilai. Suzan F. Murphy, Thomas 
H. Wareing. Bill B. Daily. Nicholas T. Kouchoukos. Washington 
University. SI. Louis, MO 
Atherosclerosis (Ath) of the Ascending Aorta (AscAo) has been 
associated with atheroemboli to the brain. the kidneys and other 
organs after cardiac surgery. In order to determine the relative 
significance of AscAo Ath in the development of postoperative renal 
insufficiency, perioperative variables known to affect renal function 
were evaluated prospectively in 1200 consecutive patients (age >50) 
undergoing cardiac surgery. Severity of Ath was determined 
intraoperatively by ultrasonic evaluation of the AscAo; postoperative 
low output state was defmed as cardiac index <2 & infusion of 
inotropes >24 hrs. Preoperative LV function was determined by the 
angiographic wall motion score. Patients with normal preoperative 
creatinine levels «1.5mg/dl), n=976. were analyzed. An increase in 
creatinine of >50% over baseline at days 1 & 6 was considered 
abnormal. 
V ARlABLE p value (day 1) p value (day 6) 
AscAo Ath 0.02 0.0004 
Low Output 0.04 <0.0001 
Cross-clamp time 0.15 0.50 
Bypass time 0.32 0.31 
LV Function 0.34 0.02 
Age 0.98 0.004 
Gender 1.00 0.11 
Results of the univariate analysis are shown. Multivariate analysis 
performed for the data at day 6 revealed that low output state and 
AscAo Ath were independently related (p<O.OOOOl) to postoperative 
renal failure. The preoperative LV score approached significance 
(p=O.062). Thus. atherosclerosis of the ascending aorta and 
postoperative low output state are significant risk factors for the 
development of postoperative renal insufficiency. 
730·6 9:45 
Atrial Arrbythmiaa After Cardiac Surgical Proc::edures: An Updated 
Eumination of Risk FadOrs 
Lawrence L Creswell, Michael Rosenbloom, Richard B. Schuessler. 
and James L. Cox. Washington University School of Medicine, Barnes 
Hospital. St. Louis, Missouri 
Atrial arrhythmias (AA) after cardiac surgical procedures are 
common. From January 1. 1986. to December 31. 1991,4.507 patients 
underwent cardiac surgical procedures requiring cardiopulmonary 
bypass. Postoperatively, patients were monitored continuously by 
telemetry until discharged. For 3.983 patients (88.4%) in normal sinus 
rhythm preoperatively, the incidence of AA (atrial fibrillation, atrial 
flutter. or paroxysmal atrial tachycardia) requiring treatment, by type 
































CABG/MVR 66 63.6% CABG/carotid 31 38.7% 
endart. 
For all patients considered collectively, the risk factors associated with 
increased postoperative AA (p < 0.05 by multivariate logistic 
regression) included: increasing age, number of previous myocardial 
infarctions. preoperative use of digoxin, history of rheumatic heart 
disease, chronic obstructive pulmonary disease, and increasing aortic 
cross-clamp time. Risk factors varied. however. for particular 
operative procedures. The relatively high incidence of postoperative 
AA reflects the use of intensive monitoring for these arrhythmias in 
this series. Therefore. these data provide a more accurate baseline for 
prospective, randomized trials of various therapeutic modalities 
designed to decrease the incidence of post-cardiac surgery atrial 
arrhythmias. 
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Dual Chamber Pacing Relieves Outflow Tract Obstruction 
and Improves Symptoms in Hypertropbic Cardiomyopathy 
Patients Despite Pre-Existing Left Bundle Branch Block 
Dorothea McAreavey, Dorothy Tripodi, Neal Epstein, and 
Uimeh Fananapazir. NIH, Bethesda MD 
In hypertrophic cardiomyopathy (HeM). atrial-synchronized 
right ventricular (DOD) pacing relieves outflow tract (LVOT) 
obstructiort. The pattern of ventricular activation duriog pacing 
resembles LBBB. A putative mechanism for the therapeutic result 
is alteration in the pattern of septal activation! contraction. 
To determine whether a similar therapeutic benefit can be 
achieved in obstructive HeM pts with pre-existing LBBB, 15 pts 
received a DOD device for relief of LVOT obstruction. Three pts 
had failed previous LV septal myectomy. All had drug-refractory 
symptoms and were in NYHA functional classes III or IV. 
Cardiac catheterization was performed at baseline and after 
3.4±O.7 months of DOD pacing. The NYHA class improved 
from 3.0±O.4 at baseline to 1.6±O.6 following chronic DOD 
pacing (p<O.OI). The hemodynamic changes due to ODD pacing 
were: Follow Up 
a .. elln. bbb Sinu. 
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Thus. pre-existing LBBB does not preclude obstructive HeM pts 
from deriving benefit from DDD pacing. The reduction in LVOT 
obstruction in these pts is probably due to asynchronous LV 
contraction wave induced by pacing spreading towards the LVOT. 
731·2 8:45 
The l-Dimeusional EchocardioKl"aphic Spectrum of Hypertrophic 
Cardiomyopathy Due to Myosin Heavy Chain Geue Mutations 
Scott D. Solomon, Simonetta Wolff, Hugh Watkins, Patricia C. Come. 
Paul M. Ridker. Christine E. Seidman, Richard T. Lee, Brigham and 
Women's Hospital, Boston, MA 
To dcfiDe the 2-dimensi0ll3l ecbocardiographic spedrWn of familial 
hypertrophic cardiomyopathy (FHC) due to mutatiOllS in the myosin 
heavy chain gene. we analyzed ecbocardiognuns from 69 affected and 
unaffected adult members of 10 fiunilies with FHC. Left veuIricular wall 
thicJcness was measured at 10 separate locatiOllS. Systolic aDterior 
motion of the mitral valve (SAM), right ventricular hypertrophy (R VH). 
left ventricular morphology and location of hypertrophy were evaluated 
independently by three observers without knowledge of the genetic 
diagnoses. Maximal wall thickness ranged from 11 to 40 nun (r= 23.8 
:I: 8.2) in the genetically confirmed FHC group. c:anpared with a range 
of 7 to 16 nun (r = 1 1.1 :I: 1.9) in genetic:ally 1IOIl-af£ected &miIy 
members. Septal to free wall ratio ranged from .86 to 3.57 ( I" = 1.75 :I: 
.57) in the FHC group compared with a range of .66 to 1.8 (I" = 1.1 :I: 
2.1) in unaffected members. RVH was present in 25% of the FHC group 
compared with 6% of the control group. SAM (both leaflet and cbordal) 
was present in 56% of the FHC group and IIOIIC of the control group. 
76% of pts in the FHC group had hypertrophy predccninantly of the 
anterior septum. Reverse septal curvature was present in 80"1. of 
patients with FHC with IIOnnaJ veuIricular morpboIogy in 20"10. 
Maximal wall thickness. septallfree-wall ratio. concentricity, SAM, end· 
systolic volume and reverse septal curvature were univariate predictors 
of FHC in fiunilies with known myosin JDUtations; maximal wall 
thickness remained the best predictor in a multiple 10gistic regression 
model. CODclusioD: The ecbocardiographic spedrWn of FHC due to 
mutations in the myosin heavy chain geae is broad and multiple 
echocardiographic criteria an: aecessary for diagDOsis. 
ABSTRACTS 123A 
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Progression of Hypertrophic Into Dilated Cordiomyopothy in F riedreich's Ataxia: a 
Follow-up Study 
Franco Casazza, Franco Ferrari, Angelo Copozi, Roberto lAottioli, 
Corrado Piane, Mario Morpurgo. 
Department of Cardiology. S. Carlo Hospital, lAilon, Italy 
From 1969 to 1992, we examined 81 patients (pts) with carefully defined 
Friedreich's Ataxia (FA). 61 of them (30 males and 31 femoles, mean 0ge 19 
years at the beginning of the study) hod clinical, Ecg and Echo follow- up (mean 
periods were 76 months for clinical and Ecg follow-up and 60 months for Echo 
follow-up). At the first echo examination, a left ventricular hypertrophy of 
variable degree and extent, with normal LV function was observed in 48 pts 
(75%). Repeated Echo examinations in the hypertrophic pts provided 
documental evidence of the progressive thinning of the interventricular septum 
and/or posterior wall of the LV in 5 pts. At the some time the LV wall motion 
decreased and the L VEDD and L VESD increased so that the final Echo picture 
was very similar to that of a dilated cardiomyopathy. The mean final EF was 
33% and the mortality rate was 60%. A sixth patient's Echo evolved from a 
mildly hypertrophic to a severely hypakinetic and enlarged LV (EF 19%) after a 
period of rapid atrial fibrillation. Once the synus rylhm was restored, the LV 
dimension and function come bock to normal within a few months. In all first 5 
pts the shift to a dilated. hypofunctional and thinned LV was associated to a 
progressive loss of electrical forces at Ecg and a final onset of abnormal D 
waves mainly in the Inferior and lateral leads. In the sixth case, the DRS pattern 
did not change. 
ill ~ our data support the passibility for some pts with FA to evolve 
froin on initially hypertrophic into a dilated and severely hypokinetic LV These 
~.:, hove a poor prognosis. 
731·4 9:15 
Predictors and PrognosIS of Left Ventricular Dilatation In 
Patients with Hypertrophic Cardiomyopathy 
laura A. Corr. Jule French. Cella M. Oakley, Petros NlhoyamopouIos. 
Oepartrnelt d Medicine. Cardiology Unl, HammersmIth HospItal and RPMS. 
london, United KIngdom. 
A subgroup d patIerU willi hypertrophic Cllldiomyoplllhy (HeM) may 
develop progressive left ventrIc:Uar (LV) dlatatlon asaocIated willi reduced 
systolic contractlon. To determine the prognosis d these patlerts and to see 
whether they could be distinguished at presentation. _ lltUdied 114 patIerCs 
willi HCM followed echocardiographically In our Ir1stItI*I eMIl" the past 10 
years. We identified & distinct subgroup d 5 patIerU (4.4%) who showed a 
fall In fractional shortening (-1U4%) va -1.±1%. p<O.Ol). and Incraa8ed LV 
diastolic (13.4.±2.5 va O.8.±O.3 mm. p<O.Ol) and systolic dimensions 
(16.~2.4 va 1.~O.4 mm. p<O.Ol) compared with the remaining 109 
patients. None had slgnlflcant mitral regurgitation. The non-dlaled patients 
had a small. slgnlflcant Increase In wall thickness CMII" the period d follow-up; 
In contrast, the subgroup who dlated showed progressive thinning of the 
ventricUar septum (-7.8.±2.3 va 1.~O.4 mm, p<O.05) and posterior LV wall 
( .... O.±2.2 va O.7.±O.3 mm. p<O.05). All the patients who dialed were 88II8r8Iy 
symptomatic. Four d the 5 (80%) were awaiting Cllldiac transplarUtlon or 
died d progressive heart falure; In contrast, 2 d the remaining 109 patients 
(2%) died suddenly (p<O.OOI). The dlflerenc:es between the groups were not 
related to length d follow up (4.1.±O.8 va 3.7.±O.2 yrs) or age (32.~ 7.3 VB 
45.~ 1.5 yrs). ComparIng the baseline echocardlographlc data d the two 
groups at the time of presentation. patients who dlated were found to have 
had thicker walls (ventrIc:Uar septum: 27.±5 va 21.±O.6 mm; posterior wall: 
15.±4 VB I~O.2 mm) and a slgnlficanlly greater LV mass (639.±169 g VB 
373.±15 g, p<O.OOI) but there were no dlflerances In LV diastolic (4U5 va 
43.;tO.6 mm) or systolic dimensions (~4 va 25.±O.6 mm). left atrial size 
(3&,±5 VB 41.± 1 mm) or fractional shortening (3&,±5 va 41.± 1%). 
Progressive LV dlatatlon and impaired systolic function occtJTed In 4.4% d 
patlerts with HCM and was asaocIated willi I8'IIfII"8 symptomatic heart falure 
and a very poor prognosis. Patielta who pr.n willi markedly Incraa8ed LV 




Importance of Resting and Early Exercise Stroke Volume as 
• Determinant of Exercise Capacity in Symptomatic Non•
Obstructive Hypertrophic Cardiomyopathy. 
David M. Gilligan, B. William Cboi, Julio A. Panza, Vasken 
Dilsizian, Lameb Fananapazir, Richard O. Cannon, Ill. 
NHLBI, Bethesda, MD. 
Exercise capacity is frequently reduced in symptomatic patients 
with non-obstructive bypertrophic cardiomyopathy (HCM) and bas 
been attributed to an impaired cardiac output response. To 
investigate the role of stroke volume as a determinant of exercise 
capacity, we studied 22 symptomatic patients with non-obstructive 
HCM, 13 male, aged 39± 14 years (mean±SD), using invasive 
hemodynamic measurements at rest and during graded semi-erect 
bicycle exercise (25 watt increments every 2 mins), radionuclide 
ventriculograpby and ecbocardiograpby. 
Exercise capacity ranged from 50 to 175 (96±36) watts. Stroke 
volume index (SVI, mllbeatim,) ranged from 22 to 67 (42± 12) at 
rest and was a modest predictor of exercise capacity (r= .56, 
p= < .01). There was no correlation between rest SVI and LV 
ejection fraction (r=-.09), peak LV filling rate (r= .02) or the 
maximum LV wall thickness (r=.09). Of note, SVI in early 
exercise (25 watts) was a mucb stronger predictor of exercise 
capacity (r= .78, p< .(01) because of changes in SVI from rest, 
whicb included a fall of ~ 10% in 9 patients. SVI at peak exercise 
(42±13) was little changed from SVI at rest and accounted for a 
strong correlation between peak cardiac index and exercise capacity 
(r=.70, p< .(01). In conclusion, limited stroke volume at rest and 
especially during early exercise is a major determinant of reduced 
exercise capacity in symptomatic, non-obstructive HCM patients 
and appears to be independent of resting systolic function and 
diastolic filling as well as the magnitude of LV bypertropby. 
731·6 9:45 
X-LInked DIlated CardI~opathy Due to Dystro•
phinopathy WIthout Apparent Skeletal Myopathy 
Antonello Ganau, *Francesco Muntoni, Luciana 
Cuccuru, Giuseppina Arvedi, **Maria A. Melis, 
Giuseppe Realdi. Clinical MedIcine, Sassari; 
'Children Neuropsychiatry, and **Pediatrics, 
Cagliarl, Italy. 
We studied the relatives of a 23-year-old male 
index patient with severe idiopathic dilated 
cardiomyopathy, elevated serum creatine kinase 
(CK) levels,and a farr.ily history of two mater•
nal uncles deceased for dilated cardiomyopa•
thy. He had no clinical or electromyographic 
evidence for skeletal myopathy or neuromuscu•
lar disease, but muscle immunocytochemical 
study by anti-dystrophin antibodies revealed a 
mild dystrophinopathy. Eighteen family members 
were evaluated by clinical examination, CK 
measurements, electrocardiogram (EKG), echo•
cardiogram (ECHO), rest and exercise radionu•
elide angiography (RNA), and genetiC study to 
look for deletions of the dystrophin gene. 
Three brothers and one cousin of the proband 
showed elevated CK levels, deep Q waves on 
EKG, global or regional ECHO ventricular hypo•
kinesis, and abnormal RNA ejection fraction, 
ir. the absence of appreciable muscle weakness. 
PNA analysis revealed that proband and affect•
ed relatives had a large deletion involving 
the muscle promoter region and the first exon 
of the dystrophin gene. 
Conclusion: an unusual deletion in the S' 
region of the dystrophir. gene may result in 
typical X-linked dilated cardiomyopathy with•
out skeletal muscle weakness. This abnormality 
should be searched in patients with primary 
dilated cardiomyopathy and elevated CK levels 
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Endoth"!.1 Dysfunction Is ... Early EVlnt in Chldrln with FamII!.I 
Hyperc:hol.sterol.mia 
Keld Sorensen, David Celermajer, Jacqui Robinson, Odette Thomas, 
June Uoyd, John Betteridge. Geoffrey H.tc:her, John Deanfield. The 
Hospital for Sick Children, london, England. 
Familial hypercholesterolemia (FH) is .ssociated with .arly development 
of coronary atharosclerosis, but the age 8t which this process is first 
detectable is not known. Because endothelial dysfunction is an early 
event in .therogenesis, we .ssessed whether endothelial dysfunction 
occurs in large systemic arteries of children with FH; 29 children aged 
7-17 ye.rs (mean 11) with FH (hypercholesterolemia, an affected first 
degree relative .nd normal triglyceride level; 27 heterozygotes and 2 
homozygotes) were studied. Vascular responses were compared to 
data from 24 healthy children aged 6-15 vear. (mean 11.6). In the FH 
group total plasma cholesterol ranged from 212 to 770 mgldl (mean 
317). in the control group from 115 to 205 mgldl (mean 161). All were 
prescribed lipid·lowering diet and 12 were taking lipid-lowering agents 
(7 cholestyramine. 5 HMG CoA reductase inhibitors [for homozygotes 
and older childrenll. 
Using high resolution ultrasound the diameter of the superficial femoral 
artery was measured at rest, in response to reactive hyperemia (with 
flow increase causing flow mediated endothelium dependent dilatation) 
and after sublingual glyceryltrinitrate (GTN, causing endothelium 
independent vasodilation). 
Baseline vessel size and percentage reactive hyperemia were similar in 
both groups (5.0 vs 4.8 mm, 395 vs 418%, p>0.051. Flow mediated 
dilatation (FMP) was observed in the control children (7.7 ± 3.7%, range 
0.0 to 12.5). but was impaired or absent in the FH children (1.2 ± 2.2%, 
range 0.0 to 5.8, p < 0.0001). There was no relationship between 
cholesterol level and the degree of impairment of FMD in the FH children 
(r=O.Ol, p=0.91. GTN mediated dilatation was similar in both groups 
(11.9±4.4% vs 9.7±4.3%, p=0.07). 
Endothelial dysfunction therefore occurs in children with FH as young 
as 7 years of age. This non-invasive method will allow serial study to 
determine whether these early abnormalities in vascular physiology can 
be reversed with effective cholesterol lowering treatment. 
732·2 8:45 
Arginine Prevents Atherogenesis in the Coronary Artery of 
the Hypercholesterolemic Rabbit 
Bing-yin Wang, Alan H. Singer, Philip S. Tsao, Helmut Drexler, 
Jon Kosek, John P. Cooke. Stanford University, Stanford, CA 
Endothelium-derived nitric oxide (NO) is derived from L•
arginine. This potent endogenous vasodilator also inhibits platelet 
aggregation and monocyte adherence, key events in athero•
genesis. Hypercbolesterolemia reduces endothelial NO activity, 
and we postulate that this contributes to atherogenesis. The fol•
lOwing study was designed to test the hypothesis that chronic oral 
supplementation of dietary arginine would provide a sustained 
elevation of NO activity and thereby inhibit atherogenesis. 
38 male New Zealand White rabbits were fed nonnal chow 
(N), 1 % cholesterol chow (e), or 1 % cbolesterol chow with di•
etary arginine (A) or methionine (M) supplementation to increase 
tbeir intake of these amino acids sixfold. After 10 weeks of the 
dietary interventions the left main and left anterior descending 
coronary arteries were harvested for histomorphometry. 
Serum cholesterol measurements were elevated to the same 
degree in groups receiving the 1 % cholesterol diet (643±33, 
687±50, 595±19 mgldl in C, A, M respectively; p=NS). Plasma 
arginine levels were doubled in the A group (from 0.13±O.02 to 
0.24±O.05; p<0.05), and unchanged in the other groups. IntimaV 
medial ratios were 0, 0.004, 0.83,* 0.99;* N, A, C, M respective•
ly; *=significantly different from N, p<O.05). 
Conclusion: Dietary supplements of L-arginine prevent intimal 
tbickening in the coronary artery of hypercholesterolemic rabbits. 
This anti-atherogenic effect is not due to an alteration in serum 
cholesterol, or caloric or nitrogen balance. The data are consistent 
with the hypothesis that NO has anti-atherogenic properties. 
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732-3 9:00 
Circulating Endothelin During Acetylcholine Induced Coronary 
Vasoconstriction In Hypercholesterolemic Pigs. 
Amir Lennan. Mark WI. Webster. James H. Chesebro. Valentin 
Fuster. John C. Burnett Jr. Massachusetts General Hospital. Boston. 
MA and Mayo Clinic. Rochester. MN 
The endothelium possesses the ability to regulate vascular tone by 
the release of vasodilator and vasoconstrictor factors among them 
the potent vasoconstrictor and mitogenic peptide endothelin (ET). 
Hypercholesterlemia is associated with abnormal endothelial 
dependent coronary constriction to acetylcholine (Ach). The current 
study was designed to test the hypothesis that Ach-mediated 
coronary vasoconstriction is associated with elevated plasma ET. 
Fourteen minipigs were randomly allocated to a normal diet (Gr I. 
n=6) and to a 4% cholesterol diet (Gr 2. n=8), for 4 months. 
Increasing concentration of Ach (10-6-10-4 M) were sequentially 
infused at 0.8 mUmin x 3 min into the left anterior descending artery 
and arterial blood samples for ET were drawn at baseline (B) and at 
peak Ach infusion concentration (ET Ach). ,lntracoronary Ach 
infusion resulted in a significant coronary vasoconstriction in Gr 2 
(4% Chol). 
Nonnal diet 4% Chol diet 
Chol. mgldl 7S±4 244±38 * 
ET (8) pglml 8.2±1.4 J3.S±l.S* 
ET (Ach) pglmJ 29.4±5.0 6S6.4±117*t 
*p<O.OS vs. Normal diet. tp<O.OS vs. Baseline (B). 
This study demonstrates that 4% Chol diet for 4 months resulted in 
elevated plasma ET concentrations. Furthennore. in response to 
intracoronary Ach infusion further elevation of plasma ET was 
observed and was associated with coronary vasoconstriction. This 
study suggests a role for ET as a marker and/or participant in the 
endothelial dysfunction associated with hypercholesterolemia. 
732-4 
Impairad Endothelial Function Occurs in the Systemic Arteries of 
Ch~dr.n with Homozygous Homocyatinuria but not in their 
Heterozygous Parenti 
9:15 
David Celermajer. Keld Sorensen. Michael Ryalls. James Leonard. John 
Deanfield. Hospital for Sick Children. London. England. 
Homocystinuria (HC) is strongly associated with premature vascular 
disease in homozygotes. and even heterozygotes have been shown to 
be at increased risk from early atherosclarosis associated with 
hyperhomocystinemia. Because endothalial dysfunction is an early 
event in atheroganesis. we aimed to assess whether HC affects 
endothelial function in systemic arteries. We therefore studied non•
invasively the superficial femoral arteries of 6 and the brachial arteries 
of 3 children aged 4-17 (mean 11) years with homozygous HC. and the 
brachial arteries of 12 parents aged 33-49 (mean 41) years (obligate 
heterozygotes). Each subject was matched with 2 controls of similar 
age. sex. smoking history. cholesterol level and vessel size. Using high 
resolution ultrasound. vessel diameter was measured at rest. during 
reactive hyperemia (with flow increase causing endothelium dependent 
dilation) and after sublingual glyceryl trinitrate (GTN. an endothelium 
independent vasodilator). 
Flow mediated dilation (FMD) was observed in the control children 
(9 ± 0.6%. range 6-14) but was impaired or absent in the HC children 
(2.S±0.7%. range 0-7. p<0.001). In contrast GTN mediated dilation 
was similar in both groups (16 ± 2% v 13 ± 1 %. p =NS). In each case 
H C was due to cystathionine synthase deficiency. and total plasma 
homocystine concentrations (free and bound' were 38-1 04pMII (normal 
7-19' at the time of study. In the parents with heterozygous HC. both 
FMD and GTN responses (7 ± 1 %. 17 ± 2% respectively' were similar to 
control values (8± 1 %. 20± 1 %. p=NS'. Baseline flow and degree of 
reactive hyperemia (Doppler estimated' were similar in the HC and 
control groups. 
Children with homozygous HC as young as 4 years of age have 
impaired endothelial function in systemic arteries representing an early 
event in their premature vascular disease. Endothelial function is 
however preserved in adults who are heterozygous for this condition. 
ABSTRACfS 
732-5 9:30 
C-type Natriuretic Peptide Enhances Canine Corooary Blood Flow. 
R. Scott Wright, Lawrence L. Aarhus, John C. Burnett Jr., Wayne L. Miller. 
Mayo Clinic. Rochester, Minnesota 
C-type natriuretic peptide(CNP) is acardiac peptide with structural homology 
to atrial (ANP) and brain-type (BNP) natriuretic peptides. In contrast to ANP 
and BNP. CNP is of endothelial cell origin and iIui1m is a potent vasodilator 
associated with the production of cGMP. The action of CNP on the coronary 
circulation has not been reported to date. This study was designed to 
detennine the ~ effect of CNP on the canine coronary circulation. 
Intracoronary (left circumflex) CNP was infused in five pentobarbital 
anesthetized dogs in two step-wise concentrations (5 and 20 ng/k.glmin) for 
tbiny minutes each. 
~ ~ ~ 
CBF 56.4±21 73.1±19' 96.1±3I' 
CO 1.92&2 1.82&23 1.71&2 
+dP/dt 2641±256 2999±281 2786±259 
CVR I. 75±0. 5 1.47&4 1.41&5 
MAP 92±8.8 97±13.2 101±1O.8 
SVR 49.7±7.0 52.3±3.4 58.3±3.3 
CS-Lactate 0.93&33 1.05&43 1.08&45 
Data are Mean±SEM, coronary blood flow (CBF, mlhnin), cardiac output 
(CO, Umin), left ventricular contractility (+Dpldt, mmHglsec), coronary 
vascular resistance (CVR, Wood U), mean arterial pressure (MAP, mmhg), 
systemic vascular resistance (SVR, Wood U) and coronary sinus lactate (CS), 
·=p<0.05 vs baseline. 
These data demonstrate for the flTSt time that the newly described endothelial 
cell peptide CNP increases CBF in a dose-dependent manner independent of 
alterations in cardiac or systemic hemodynamics and suppon the role of CNP 
as a functionally important, endotbelial-derived coronary vasodilator. 
732-6 9:45 
Anti-Platelet Effect of Dietary L-Arginine, the NO Precursor 
Philip S. Tsao. Alan H. Singer. Minoru Ohno. Aaron V. Kaplan. 
Lawrence L.-K. Leung. JQhn P. Cooke. Stanford University. 
Stanford, CA 
We have recently found that NO-dependent vasodilation can be 
restored in hypercholesterolemic rabbits by chronic dietary sup•
plements of L-arginine. the NO precursor. This is associated with 
a striking reduction in atherogenesis. We now propose that an 
anti-platelet effect of dietary L-arginine may playa role in this 
anti-atherogenic effect. 
Platelets are capable of producing nitric oxide (NO) through 
the L-arginine:NO synthase pathway. The purpose of this study 
was to determine if platelet aggregation was affected by chronic 
oral administration of L-arginine in hypercholesterolemic 
animals. Male NZW rabbits were fed: nonnal chow (N). 1 % 
cholesterol diet (C). or I % cholesterol diet with L-arginine: 
2.2S% in water (A). After 10 weeks cholesterol levels were 
equally increased in (C) and (A) animals whereas plasma arginine 
levels were doubled in the (A) group. There was no difference in 
maximum aggregation initiated by ADP (lOOI1M) between 
washed platelets from (N) (l00±1l U) and (C) animals (91±I3 
U). However. platelet aggregation to ADP was significantly 
decreased in A animals (48±13 U. p<O.OS). The NO synthase 
inhibitor NGmonomethyl-L-arginine reversed the effect of dietary 
L-arginine. Furthermore. cGMP levels in aggregating platelets 
from arginine-treated animals (4.6±1.l pmoVmg pro) were signifi•
cantly higher than the other groups (N: 2.I±O.9 pmoVmg pro. C: 
I.S±O.3 pmoVmg pro, p<O.OS). 
Conclusion: Chronic dietary supplementation of L-arginine. the 
precursor of endogeneous NO. in hypercholesterolemic rabbits 
decreases platelet aggregation and increases stimulated cGMP 
levels. This may have important therapeutic implications for 
atherogenesis and thrombosis. 
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733·1 8:30 
Prospective Evaluation of Four Nonthoracotomy Lead Configurations Using 
Single and Simultaneous Shocks 
Roman T. Pachulski, Robert B. Kleiman, Belinda T. Flores, Francis E. 
Marchlinski, Hospital of the University of Pennsylvania, Philadelphia, PA 
During defibrillator implantation in 19 patients we prospectively evaluated 
the efficecy of 4 nonthoracotomy lead (NTL) configurations in each patient. 
The Medtronic NTl system included a right ventricular (RV) endocardial 
lead, a lead in the suparior vena cava (SVC;n=12) or coronary sinus 
(CS;n= 7) and an adutt size (87.5cm2) defibrillator paddle (DP) overlying 
the intended de (left anterior axillary line from 4'" to 8'" intercostal space) 
of subcutaneous patch lead implantation. NTl configuration adequacy was 
defined as 3/4 successful defibrillations at energies of 518 joules. NTl 
configuration consisted of Single (2 lead) or simultaneous dual (3 lead) 
pathway as indicated: 
PATHWAY/CATHODE 
Single (CS or SVCj/RVA 
Dual (CS or SVC & DP)/RVA 
Dual (CS or SVC & RVA)/DP 












Ten patients failed all 4 NTl configurations and only 2 patients had 2 
different succesful NTl configurations (RVA or CS or SVC as cathode). 
Conclusion: With this NTl system a statistically significant difference in 
defibrillation adequacy was identified between the 4 lead configurations 
tested. Single pathway shocks uniformly failed to produce adequate 
defibrillation. The success of the simultaneous dual pathway NTl 
configurations was about 50% with the most successes with RVA or CS or 
SVC as cathode. 
733·2 8:45 
Non-Thoracotomy Tr8l1svenoul Leads 8I1d Programmable Implantable 
Cerdioverter Defibrillators: Technique, Morbidity 8I1d Outcome 
Rajesh S. Suri, Javier R. Woscoboinik, James D. Maloney, Marcelo E. 
Helguera, Jeanne M. Shewchik, Victor A. Morant, Lon W. Castle. 
The Cleveland Clinic Foundation. Cleveland, Ohio. 
Transvenous lead systems and multi-programmable devices with pac•
ing, cardioversion and defibrillation capability were investigated in 40 
patients (p). A non-thoracotomy lead implantable cardioverter defibrilla•
tor (NTl-ICD) with triple electrodes, comprising of two transvenous 
leads and a subcutaneous patch (SO) was used. Ventricular fibrillation 
termination with three shocks ~ 18 J in I of 3 configurations (single, 
simultaneous or sequential) permitted implantation. ~: Forty p. 
(31 males and 9 females), age 63.±. I I years, EF% 30.±. I 1, and 32 
with previous open heart surgery were selected. Six p. were excluded 
due to high defibrillation threshold (DFTI, and I due to an unsuspected 
SVC thrombosis. Thirty three p. (82.5%1 received NTl-ICDs. Compli•
cations included 4 lead dislodgements, 2 infections requiring explant, I 
-r-----------~ ·IL ______________ ~_.~ __  _____ 
o 1 2 3 4'61'910 
11WE{ ... ) 
hematoma overlying SO 
needing evacuation, and 2 
deaths from CHF. Hospital 
stay ranged from 2 to 9 
days. Cumulative 164 
month/po follow-up revealed 
no p. death due to device 
malfunction. Twenty- nine of 
33 (87.9 %1 successful NTl•
ICD implants continue to 
have functioning systems 
and 16 p. have used the de•
vice during follow-up. Conc/usions: I - An overall 82.5% implant suc•
cess was observed in our series. 2- lead dislodgement, a potential 
complication, can be overcome changing pulse wave configuration to a 
single pathway non-invasively. 3- High OFT using this protocol is 
definitive limitation. 4- A direct comparison of NTl-ICDs with epicardial 
systems using this protocol is necessary to compare overall outcome. 
733·3 
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9:00 
Implantable Daflbrlllators With Antltachycardla Pacing 
Reduca the Number of Shocks In Cardiac Arrest Patients 
Who Have Inducible Sustained Ventricular Tachycardia 
Raman L. Mitra, Henry H. Hsia, Bruce G. Hook, David J. Callans, 
Belinda T. Flores, John M. Miller, Mark E. Josephson, Francis E. 
Marchlinski. Hospital of the Uriversity of Pennsylvaria and Presbyterian 
Medeal Center, Philadelphia, Pennsylvaria 
The value/role of antitachycardia pacing (A TP) incorporated in iflll/antable 
defibrillators (ICD) has only recently been addressed in patients presenting 
with cardiac arrest. We reviewed our experience with ATP in 28 
consecutive patients who presented with cardiac arrest requiring 
emergent shock therapy between 10189 and 3192. All patients underwent 
programmed stirnJlation prior to ICD implant to determine Inducibility of 
sustained VT. ArrhythlTic events after !CD ifill/ant and efficacy of ATP was 
assessed from stored diagnostic information in the lCD, ECG documented 
recordings or both. The mean duration of tollow up is 16 months. 
, of Patients 
Total.. ....................... . 
Response to Programmed Stimulation 
PMVTINSVTlNoVT Sustained Yr(±AAA) 
11 17 
Effective A TP demonstrated 
post implant.. ............ . 
ATP activated .......... .. 
VT during follow-up .... . 
ATP delivered .......... . 
Any effective ATP ...... . 













AM-antiarrhythlTic agents, N.A.-non appficable,·uniform morphology 
In the 5 pts (4 receiving AM) with effective ATP, 19127 VT episodes were 
successfully terminated without a shock. 2 of these 5 patients accounted 
for the 8 episodes of ATP failure. 
Conclusions: 1) Inducible uniform sustained VT (with or without AM) 
favors selection of an ICO with ATP 2) lC~'s capable of ATP greatly reduce 
the number of shocks in this subgroup of cardiac arrest patients 3) Cardiac 
arrest patients without inducible sustained VT have a low frequency of VT 
recurrence. 
733·4 9:15 
Incidence of Sudden Cardiac Death in Patients vi th 
Sustained Ventricular Arrhytbaias Treated vith 
Antiarrhytbaics versus I.plantable Defibrillator. Role 
of Left Ventricular Function. 
John H. Ip, Stephen L. Vinters, Jorge Cemunas, Arisan 
Ergin, Elena Pe, J Anthony Gomes. Hount Sinai Hedical 
Center, New York, NY. 
The optimal management of patients with sustained 
ventricular arrhythmias (VA) remains controversial. Ve 
prospectively followed 216 patients with inducible VA 
for a lIean follow-up period of 38+14 .onths. Group 
(Gp) 1 (69) patients received electrophysiologic (EP) 
guided antiarrhythmic agents (AA). Gp 2 (87) patients 
received amiodarone. Gp 3 (60) patients underwent 
cardiovertor defibrillator (ICD) illplantation. Gp 3 
patients ei ther failed AA or were intolerant of the 
side effects. The mean age of the patients was 58+12 
and the mean ejection fraction (EF) was 31+12%. The 
age and the EF were not statistically different among 
the gps although more patients presented with sudden 
cardiac death (SO) in Gp 3 (38%) than in Gp 2 (22%) 
and Gp 3 (8%). The actuarial incidence of new or 
recurren t SO in the follow-up period in each gp as 
stratified according to the EF were as follows: 
ISO (%) EF>30 
EFOO 






Conclusions: Patients with sustained VA and EF>30% 
treated with EP-guided therapy or amiodarone appear to 
be at low risk of SO. However, patients with EF(30%, 
even wi th their arrhythmia suppressed, continued to 
have a high risk of new or recurrent SO. ICD should be 
considered as first line therapy in this subset of 
patients. 
JACC Vol. 21, No.2 
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733-5 9:30 
Cardioverter..[)efibrillator Therapy in a High-Risk Subgroup 
of Patients with Arrhythrnogenic Right Ventricular Disease 
Thomas Wichter, Michael Block, Dirk BOcker, Martin Borggrefe and 
Gunter Breithardt. Department of Cardiology and Angiology, 
University Hospital ofMiinster, Germany 
Clinical data and outcome of II pts. with arrhythmogenic right 
ventricular disease (ARVD) who underwent implantation of a 
cardioverter-defibrillator (lCD) were analyzed and compared to 47 
ARVD pts. treated by catheter ablation (ABL; n=IO) or EP-guided 
serial drug testing (n=37). All 58 pts. had documented spontaneous 
sustained VT and inducible VT during EP-study. However, VT 
induction was not reproducible in 5 pts. 
8/47 pts. (17"10) treated with drugs or ABL had previously 
survived cardiac arrest. During follow-up (34±23 months) on treatment 
considered effective, 6 of 47 pts. (\3%) had nonfatal VT recurrences 
after 32±24 months (cycle lengths: 360±79 ms). One pt. with 
progressive ARVD died suddenly 3 months after successful ABL. 
9/11 pts. (82%) undergoing lCD implantation had previously 
survived cardiac arrest. Indication for lCD was either drug 
refractoriness (n=5), non-reproducible VTNF induction (n=5) or side 
effects of an otherwise effective drug (n=I). In 5/10 pts. with 
transvenous lCD systems, ~ positions of the RV lead had to be tested 
intraoperatively to achive adequate sensing and pacing. During follow•
up (l1±6 months), no pt. died. 6 of II pts. (54%) had VT recurrences 
after 3±4 months. All 66 episodes were terminated by antitachycardia 
pacing (n=50 in 4 pts.; cycle lengths: 335±38 ms) or by primary 
cardioversion (n=\6 in 4 pts.; cycle lengths: 293±\9 ms). In 4/6 pts. 
with VT recurrences, VT rate was >200/min. 
Thus, in pts. with ARVD a diagnostic electrophysiologic approach 
selects pts. at low risk of sudden cardiac death after successful serial 
drug testing or catheter ablation. In pts. in whom EP-guided therapy 
has failed or is not applicable due to non-reproducible VT induction, 
life-threatening VT recurrences are frequent. lCD therapy is safe and 
effective in terminating these arrhythmias and and may improve the 
long-term prognosis in this high-risk subgroup of pts. 
733-6 9:45 
PREDICTION OF ELECTROPHYSIOLOGIC STUDY RESULTS IN PATIENTS 
TREATED WITH AMIODARONE 
Kevtn J. Ferrick, Sard~ Singh, Sao G. Kim, James A. Roth, John D. Fisher. 
Montellore Medical Center, Bronx. New York 
Identification ot effective antiarrhythmic therapy (MT) In patients (pts) with 
sustained vent~r tachycardia (VT) using electrophyslologlc studies (EPS) 
Is often time consuming. Hospital length 01 stay could be shortened for these 
PIs H ineffective MT could be predicted by previous EPS. Therefore, we 
reviewed the resUts 01 serial EPS In SO pts with sustained VT to assess H 
resl4ts during amlodarone could be predicted by prior response to M T with 
a type IA agent. Group mean age was 53,:!: 11 yrs, 40 pIS were male. 
Sustained VT was Induced at baseline In all pts, mean ejection fraction for the 
group was 0.36,:!: 17. Partial cure (PC) by EPS was defined as well tolerated 
VT, drug slowed to a rate <1SO bprn with BP 290mm Hg. 
VT not inducible on amlodarone 
PC only with amlodarone 
PC only with IA 
PC with both amlodarone and IA 







2 of 3 pts with noninduclble VT during arnlodarone showed marked VT slowing 
during IA MT. 20 pts died during follow-up (mean=37,:!:29 months): 10 
deaths were sudden. 16 of 18 pts with recurrent VT during follow-up laDed to 
meet PC criteria during EPS on amlodarone. 
CONCLUSION: 1) Mortality In pts treated with amlodarone Is substantial. 
2) EPS resl4ts during IA M T predicted amlodarone response in 76% of 
patients. 3) Rather than proceeding to amlodarone, pts who lal to meet PC 
criteria with other MT should be considered for non-pharmacologlc therapy. 
734 New Innovations in leD Design 
Tuesday, March 16, 1993 
8:30 AM-1O:00 AM 





Defibrillation Using SequeatlaJ PaIsiDg: Importance of Phue Reversal 
127A 
Paul A. Guse, Ellen Dixon-Tulloch, Ned D. Danieley, William M. Smith, 
Raymond E. Ideker. Duke University Medical Center, Durham, NC. 
Sequential pulsing of shocks for internal defibrillation has been shown to 
lower defibrillation thresholds (OFTs) by increasing the distribution of p0-
tential gradients throughout the heart. However, waveforms that incorpor•
ate phase reversal (i.e., bidirectional pathways) also improve DFTs. The 
purpose of this study was to determine if phase reversal is important for 
the efficacy of sequential pulsing. In 9 pigs, defibrillation catheters were 
placed in the right ventricle (RY) and the superior vena cava (SVC). A 
mesh electrode (4.2 cm2) was sutured to the LV apex (A) and a 42 cm2 R2 
cutaneous patcb electrode (P) was placed on the left thorax. The following 
configurations were tested as listed in the table: a 3/3/3/3 ms (each phase = 
3 ms) quadraphasic (lA) and a 4/4/4 ms triphasic (2A) waveform that used 
sequential shocks of the same polarity; a 3/3/3/3 ms sequential biphasic 
waveform (lB) that reversed shock polarity during the second and fourth 
phases; and a 4/4/4 ms triphasic waveform (2B) that reversed polarity dur•
ing the third phase. All waveforms were generated from a single capaci•
tor defibrillator. DFTs were determined with an upldown technique, and 
ex.pre~ as total joules ± SEM. The DFTs from monophasic configur-
allOns \ lA,2A) were comJ'l'red to those that used phase reversal (lB,2B). 
TnIe Phase 1 Phase 2 Pbase 3 Pbase 4 Waveform DFT 
lA RV-P A-SVC RV-P A-SVC ~ 17.9±1 J' 
lB RV-P P-RV A-SVC SVC-A ~ 6.2+.4 J 
2A RV-P A-SVC RV+A-P+SVC ~ 19.7±1 1* 
2B RV-P A-SVC P+SVC-RV+A ~ 6.0±.4 J 
The sequentIal configuratlons that employed phase reversal were much 
more effective ( •• P< .GO(1) than those that used all monophasic shocks. 
Both monopbasic and bidirectional waveforms produce the same distribu•
tion of potential gradient in the heart. Therefore, the use of sequential 
pulsing with waveforms that use phase reversal substantially reduces the 
DFT by requiring less potential gradient necessary for defibrillation. 
734-2 8:45 
Ventricular Arrhythmia IdentHlcatlon by Electrogram Pattern Analysis 
Bruce L. Wilkoff, David A. Igel, Sergio L. Pinski, Michael Firstenberg, 
Loo W. Castle. The Cleveland Clinic FOUDdation, Cleve1and, Ohio. 
Tiered ICD devices must extract infonnation from myocardial electrograms 
(EGM's) to deliver specific therapy appropriate to the type of ventricular 
tacbyarrltythmia. lCD's presently use only tachycardia rate to distinguish 
arrltythmias, but physicians often _igb multiple factors (e.g. reguJarity, 
morphology, hemodynamics) when making therapeutic decisions. Multiple EGM 
parameters were calculated to identify unique parameter patterns specific to 
Ventricular Fibrillation (VF), Ventricular Flutter (VFL), Polymorphic Ventricular 
Tachycardia (PVJ) & Monomorphic Ventricular Tachycardia (MVI). 
METHODS: Ventricular tacbyarrbytbmia episodes (n-94) were recorded and 
digitized during lCD implantation from surface leaJ I, a bipolar sensing lead and 
the shocking electrodes. Anbythmias were categorized as VF, VFL, PVT or MVT 
by CODSeIISUS of 2 electropbysiologists. EGM's were computer analyzed for 6 
parameters: Mean Cycle Length (MCL), Cycle Length Variability (CL V), Cycle 
length Standard Deviation (CLSD), Amplitude Variability (A V), Slew Rate (SR) 
& Slew Rate Variability (SRV). Parameters were analyzed individually by 
ANOV A and in combinations by an Artificial Neural Networlc. 
ANOVA TEST OF SENSING LEAD PARAMETERS 
" P 00001 b ANOVA R <. ~v 
"MCL "CLV CLSD "AV SR "SRV 
(ms) (ms) 
MVT 328 153 SO 130 47 288 
PVT 256 203 SO 280 42 558 
VFL 231 172 40 205 45 412 
VF 217 228 49 329 37 576 
Ventricular tachyarrltythmias demonstrated statistical 
differences in rate & other EGM parameters. When these parameters (e.g. CLV, 
AV, SRV) were analyzed by Artificial Neural Network, MVT & VF were always 
correctly identified. VF was the false positive diagnosis when VFL or PVT was 
misclassified. This produces a safe endpoint for tiered ICD therapy. 
128A ABSTRACTS 
734-3 9:00 
Abrupt~t Algorithm EnlwIces Discrimination of Sinus Tachycardia 
From Ventricular Tachycardia by Tiered-Therapy Antianhythmic Devices 
Charles Swerdlow, Cathy Luckett. Cedars-Sinai Medical Center and Daniel 
Freeman Memorial Hospital, Los Angeles, CA. 
We evaluated an abrupt-<mgel (AO) algorithm for distinguishing sinus 
tachycardia from VT in 38 pts with a tiered-therapy antiarrhythmic device 
(Medtronic PCD). AO was fu)fi))ed if an RR interval was less than a 
programmed percent of the mean of 4 previous intervals lind the second 
and/or third interval preceeding the test interval exceeded the "Tachycardia 
Detection Interval (TO!)." Detection of VT required 12 to 16 consecutive 
intervals < TOI after AO was fulfilled. AO was reset by 2 consecutive 
intervals ~ TOI, but not 1 interval. In treadmill exercise, AO = 97% 
prevented detection of sinus acceleration in all 21 pts tested (peak sinus rate 
143;)3 bpm). False detection occurred in 5 pts who had single PVCS as si•
nus rate accelerated through the TOI. Example (TOI = 500 InS): 
Interval (InS) sa; 500 350 650 495 490 485 480 
~ ~ ~ 00 00 00 00 00 00 
VTCount 0 0 1 0 1 2 3 4 
It was prevented by AO = 87% in 3 pts, 84% in 4 pts and 72% in all 5 pts. 
During follow-up, false detection was studied in 10 pts with ventricular 
fibrillation, but not VT, using AO = 84%, and VT therapy "off." Detection 
occurred in 7 pts' with a median frequency of 5.7/month at TOI = 500 ms 
and 43/rnonth at TOI = 600 InS. Treadmill testing did not reliably identify 
pts with false detection. The PCD stores 20 intervals prior to the last "VT' 
event In 25 sets of intervals, the reason for detection was a single PVCS as 
sinus rate accelerated through the TOI in 9, other in 3, and indeterminate in 
11 (AO fulfilled prior to the first of 20 intervals). True detection was studied 
in the remaining 28 pts with AO = 87% and TOI based on VT rate. In 412 
pt-months, 399 episodes were identified as VT and treated successfully. 
Only 1 symptomatic VT was rejected by AO (hemodynamically stable VT 
with cycle length initially> TOI of 500 InS, followed by acceleration < TO!). 
Conclusions: AO = 87% permits detection of VT and prevents detection of 
sinus acceleration. But even with AO = 84%, detection may be caused by 
PVCS as sinus tachycardia accelerates through the TOI. 
734-4 9:15 
Change in the Amplitude of Endocardial Electrograms 
Following Defibri11ator Discharge: 
Comparison of Two Lead Systems 
Werner Jung. Matthias Manz, Dietrich Pfeiffer, Jiirgen Tebben•
jobanns, Susanne Spehl, Thorsten Lewalter, Rainer Moosdorf*, 
Berndt Uideritz, Depts. of Cardiology and ·Cardiovascular 
Surgery, University of Bonn, Germany 
Failure of redetection of ventricular fibrillation (VF) has been 
demonstrated in patients (pts) using an integrated sensing/pa•
cing/defibrillating lead. The purpose of this prospective study 
was to compare the effects of defibrillator shocks applied via 2 
different integrated leads (Endotak model 0062 and (072) on 
the endocardial electrogram amplitudes (EEAs) in 32 pts. The 
distance between the distal sense/pace tip and the distal defi•
brillating coil is 6mm in the model 0062 and 12mm in the mo•
del 0072. At implant, EEAs were recorded prior to each shock 
application, during initial VF, during redetection of VF and at 
intervals of 5, 10, 20, 30, 60 and 120 seconds following each 
shock delivery. The following EEAs(mV) were obtained for the 
2 integrated lead models 0062 and 0072: 
At baseline sinus rhythm: 11.6+/-5.4 vs 11.3+/-3.3; during 
initial VF: 7.0+ /-2.4 vs 8.6+ /-3.8·; during redetection of VF: 
3.3+ /-1.8 vs 7.9+ /-2.5···; post-shock sinus rhythm Ss: 2.8+ /-
1.9 vs 7.2+ /-1.7··; lOs: 4.5+ /-2.9 vs 9.1 + /-2.9"; 205: 6.4+ /-3.9 
vs 11.4+ /-3.8·'; 30s: 8.0+ /-4.5 vs 11.2+ /-3.4'; 60s: 10.4+ /-4.4 
vs 11.5+ /-3.4; 
(·p<O.OS, ··p<O.Ol, ···p<O.OOl). 
Conclusions: These findings demonstrate a substantial improve•
. ment in redetection of VF using a new integrated lead with a 
greater distance between the distal sense/pace tip and the distal 
defibrillating coil. 
734-5 
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Feasibility of Reducing Implantable Cardioverter-Defibrillator 
Pulse Generator Output With Endocardial Defibrillation Leads 
Sanjeev Saksena, Ryszard B. Krol, Ramesh Raju. Eastern Heart 
Institute, Passaic, New Jersey 
Endocardial [ENDO] defibrillation lead systems have higher defib•
rillation thresholds [DFf] than epicardial systems & implantable 
cardioverter-defibrillator [JCD] pulse generators presently' deliver 
2.30J shocks at maximum output. We examined the feasibility of 
using ICD pulse generators with lower maximum shock outputs for 
ENDO lead systems in 16 patients with inducible sustained 
ventricular flutter(n =4)/fibrillation(n = 12) [VF]. 2 defibrillation 
catheter electrodes were positioned in the RV & SVC. Thoracic 
patch electrodes were placed at 3 sites (apical, pectoral & lateral). 
OFT testing was performed. 15, 10 & 5J bidirectional simultaneous 
biphasic shocks were delivered across 3 different triple electrode 
configurations (RV[ -]/SVC & patch[ +]) after inducing VF. ~: 
percent efficacy for VF reversion at the preset energy levels for each 
electrode configuration was: 
1oo.,-I------_---c==-tt ~ 751 //~/_~1 
c . / ~~>/ 
C 50;' ./.~ APICAL ~ I . ~...... LATERAL 
5 25~~ ~/- ...... - PECTORAL • 0~1---------~ 
5J 10J 15J 
BIPHASIC SHOCK ENERGY 
Mean OFf for lateral configuration was 8.5±3.2J(n= 10) & percent 
efficacy was significantly higher than the 2 other configurations at 
10J(p < .02). With the optimal electrode configuration all patients 
could be reverted at ~15J & 81 % at 10J. Conclusion: Reducing 
maximum lCD pulse generator shock output to 25J can maintain a 
2.10J safety margin with this approach & permit pectoral generator 
implant with ENDO defibrillation leads. 
734-6 9:45 
The Single Endocardial Lead Configuration for ICD•
Implantation: Biphasic Versus Monophasic Waveform 
Rudolf Ruppel, Jurgen Siebels, Michael A.E. Schneider, Karl•
Heinz Kuck, University Hospital Eppendorf, Hamburg, Germany 
In 25 consecutive patients (pts) a transvenous lead system 
consisting of one endocardial lead with a unidirectional current 
pathway for defibrillation between a distal spring electrode in 
the right ventricular apex (RVAP) and a proximal spring elec•
trode in the vena cava superior (VCS) ( CPI, Endotak C) was 
tested. In 14 pts (group A, EF 42 ± 17 %) monophasic wave•
form pulses and in 11 pts (group B, EF 33 ± 14 %, n.s.) 
biphasic waveform pulses were used for defibrillation. There 
were no differences in mean age, treatment with amiodarone or 
cardiac disease between the two groups. In group A 8114 pts 
(57 %) had a defibrillation threshold (OFT):S 20 J (16 ± 5). Five 
of them had a OFT = 20 J. In the first three cases for reasons 
of security a sUbcutaneus patch electrode (SO) was added 
resulting in a 5 to 10 J reduction of OFT. Six pts in group A with 
high OFT (> 20 J) achieved a sufficient OFT when the SO was 
implanted additionally. In group Ball 11 pts (100%, P < 0.001) 
had a OFT:s 20 J (10 ± 5, P < 0.05) and the endocardial lead 
was implanted without SO electrode. Discharges due to spon•
taneous arrhythmias were effective using the single lead sys•
tem in 100% during follow up (2 - 15 months). 
Conclusion: An endocardial single lead configuration with a uni•
directional current pathway between a spring electrode in the 
VCS and another in the RVAP is effective in 57 % using a 
monophasic pulse. The efficacy can be increased to 100% with 
a biphasic waveform. These preliminary data suggest that the 
single endocardial lead is the treatment of choice for ICO 
implantation with biphasic pulses. 
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735-1 8:30 
The Value of PET for Predicting Improvement In Heart Failure 
Symptoms In Patients with Coronary Artery DIsease and Severe Left 
Ventricular Dysfunction 
Marcelo Di Carli. Sandeep Khanna. Michael Davidson. Greg Harris. 
RIchard Brunken. Johannes Czemin. Freny Mody. Carl Hoh. Lynne 
Stevenson. Hillel Laks. Randall Hawkins. Michael Phelps. Heinrich R. 
Schelbert, Jamshld Maddahl. UCLA School of Medicine. Los Angeles. 
California. 
TIle value of PET assessment of myocardial viability for predicting 
improvement in heart failure symptoms (HF) after revascularization 
(REV) vs medical therapy (MRx) was studied in 72 patients with coronary 
artery disease and severe left ventricular (LV) dysfunction (mean EF= 
2S±6). Resting 13NH3 and glucose loaded FDG PET images were 
acquired and then reoriented into short and long axis slices. The 13NH3 
and FDG patterns were assessed in each of 20 LV segments and the extent 
and severity of perfusion defect and mismatch (perfuSion defect with 
enhanced FOG uptake) were expressed as percent of the LV. Thirty six 
patients underwent REV and the remaining 36 underwent MRx. All 
patients were followed-up for an average of 13.6 months. Severity of HF 
was graded at the time of PET and during follow-up using the NYHA 
functional classification. Improvement in HF was considered significant if 
a patient with an initial functional class of III or IV improved to II or 
became asymptomatic. Cox model analyses of 14 variables showed that 
presence of mismatch (p=0.003). age (p=0.02) and the combination of 
mismatch and REV (p=O.OO2) were the only predictors of improvement in 
HF during follow-up. After REV. HF improved in 17121 patients (81%) 
with mismatch but oniy in 41IS (27%) without mismatch. Following MRx. 
HF improved in 4/10 (40%) patients with mismatch and in 7127 (26%) 
without mismatch. Of note. the degree of symptom improvement post 
REV related to the extent of mismatch; 80% (8/10) of patients with 
mismatch involving ~O% of the LV became asymptomatic. while only 
38% (SIB) of patients with <20% mismatch became asymptomatic. In 
conclusion. In patients with coronary artery disease and severe LV 
dysfunction the PET pattern of mismatch is a significnat predictor of 
improvement in HF following REV and the degree of improvement 
appears to be related to the extent of PET mismatch. 
735-2 8:45 
Quantltatlv. Evaluation Of Cardiac Sympathetic Neuronal 
Function FOllowing Cocaln. Exposura By Positron Emlllion 
Tomography 
Pierre G. Melon. Timothy R. DeGrado. Ngoc Nguyen. Thomas J. 
Mangner. Gary D. Hutchins. Donald M. Wieland. Markus Schwaiger. 
University of Michigan Medical Center. Ann Arbor. Michigan. 
The cardiac toxlctty of cocaine Is linked to Its action on the sympathetic 
nerve terminals. In order to evaluate the effects of a single injection of 
hydrochloride cocaine (2 mg/kg) on the sympathetic neuronal function of 
the heart. we studied 10 anesthetized dogs using dynamic positron 
emission tomography and the catecholamine analogue. carbone-11 
hydroxyephedrine ( C-11 HED). Myocardial retention of C-11 HED (RH). 
determined as the ratio of the tissue radioactivity over the integral of the 
arterial blood radioactivity. was used as an Index of neuronal 
catecholamine uptake. RH was determined prior cocaine in each dog and 
5 min ( group I. 5 dogs) or 148 min (group II • Sdogs) aIIer cocaine 
Injection. During the study. the heart rate and the aortic blood pressure 
were monitored and the myocardial blood flow (MBF) measured with 
microspheres. The resutts are as follows ( 'p < 0.001 versus before 
cocaine, t p < 0.04 versus before cocaine): 
before cocaine aIIer cocaine 
RH group I 0.256±0.058 0.056±0.010· (min-1) 
group II 0.252±0.042 0.183±0.048t 
Heart rate 140±21 137±22 (bpm) 
Systolic pressure 130±18 130±21 (mmHg) 
Diastolic pressure 94±15 95±17 
MBF 0.85±O.26 0.88±O.25 (rMirVg) 
Heart rate. aortiC blood pressure and myocardial blood flow did not 
significantly change following cocaine exposure at the selected dose. 
However. cocaine resulted in homogeneous reduction of RH by 80%. At 
148 min after cocaine. RH was still slgn~lcantly reduced (27"10) suggesting 
prolonged effects of a small dose of cocaine on the sympathetic nerve 
terminals. Posttron emiSSion tomography in COmbination with C-11 HED 
provides non-invasive and sensitive means to objectively define cardiac 




Residual Coronary Vasodilating Capability Despite 
Reduction in Resting Myocardial Blood Flow in 
Collateral Dependent Myocardium 
Gianmario Sambuceti. Assuero Giorgetti. Paolo Marzullo, Danilo 
Neglia, Mario Marzilli. Giacomo Puccini. Sonia Di Sacco. Oberdan 
Parodi. CNR Institute of Clinical Physiology, Pisa, Italy. 
It has been demonstrated that the myocardium downstream a 
coronary occlusion is hypoperfused at baseline; however, the 
persistence of a residual vasodilating capability in these regions has 
not been fully elucidated. Aim of this study was to determine 
whether collateral dependent myocardium preserves a residual 
coronruy tone or is maximally vasodilated at rest. To this purpose. 
11 patients with stable angina. no previous myocardial infarction, 
positive exercise stress test and isolated occlusion of the left anterior 
descending (LAD. n=9) or left circumflex (LCX, n=2) coronary 
artery. were evaluated. in the absence of any medical therapy. 
Myocardial blood flow (MBF) was measured, by means of dynamic 
positron emi~sion tomography and nitrogen-13 Ammonia. both at 
baseline and after Lv. dipyridamole (0.56 mgIKg over 4 min). The 
anterior and the postero-laterdl walls were considered as the LAD 
and the LCX distribution territory. respectively. MBFs in the 
collateral dependent regions were compared with MBF values 
obtained in 13 normal subjects evaluated according to the same 
protocol. At rest. MBF to the collateral dependent myocardium was 
significantly reduced with respect to normal subjects (0.56±.08 vs 
1.07±.2 ml/min/g. p<O.OI); 10/11 patients showed MBF values 
below the mean - 2 standard deviations of normal subjects. 
Dipyridamole increased MBF to 0.83±0.3 mVmin/g. p<O.OI vs 
resting values. An increase in MBF >15% was observed in 8/11 
patients. Average coronary reserve (dipyridamole/resting MBF) was 
l.S3±.S3. 
These data indicate that collateral dependent myocardium maintains 
a residual coronary tone despite resting hypoperfusion. 
735-4 9:15 
En-eets of Fasting on the Incidence of Blood Flow Metabolism 
Mismatches In Chronic CAD Patients 
Alan Chan. Johannes Czemin. RIchard Brunken. Yong Choi. Janine 
Krivokapich. Heinrich R. Scheiber!. UCLA School of Medicine. Los 
Angeles.CA 
Augmented F-IS deoxyglucose (FDG) uptake relative to blood flow 
(MBF) indicates potential reversibility of myocardial contractile 
dysfunction. Because different protocols are used for metabolic 
imaging we examined the effect of different dietary states on the blood 
flow metabolism mismatch pattern in 14 chronic CAD patients. 
Glucose metabolism (MRGlc) was measured with FOG after oral 
glucose (loog. L) and again during fasting (F). MBF was quantified 
with IV N-13 ammonia. Plasma glucose and insulin levels averaged 
103±46 mg% and 22±37mcU/mi during fasting and IS8±36 mg% and 
70±51mcU/ml after glucose loading (p<0.01 for both). MRGIc in 
normal myocardium increased from 0.14±0.08 til,: 
0.S8±O.16I1IDol/g/min from F to L (p<O.OOOI). Polar mapping of the 
N-13 ammonia and FDG studies and comparison to a normal database 
uncovered 24 matches and 8 mismatches after glucose loading. Of the 
24 matches. 14 (S8%) converted to mismatches in the fasted state. In 
contrast. all 8 mismatches in the glucose loaded state remained 
mismatches in the fasted state. Absolute and relative MBF (0.6OfO.27 
vs. 0.44±0.16 ml/min/g and 60±30 vs SI±20%» and MRGlc 
(0.43±O.l7 vs. 0.3S±O.l2I1IDol/g/min ) were similar in segments with 
fixed and in those with convening mismatches. However. relative to 
normal myocardium. MRGlc after glucose loading was significantly 
higher in fixed than in convening mismatches (0.82±O.22 vs 
0.S9±O.14%; p<O.OS). Thus. the mismatch pattern is observed more 
frequently in the fasted than in the glucose-loaded state. Moreover. 
only 8/22 mismatched segments (36%) observed in the fasted state 
persisted while the remaining 14/22 converted to matched defects after 
glucose loading. These two types of mismatches cannot be 
discriminated by quantitative measurements of MBF and absolute 
MRGlc while normalized glucose utilization rates after glucose loading 
are significantiy higher in fixed mismatches. Although mismatches 
noted only after fasting suggest the presence of some ischemic 
myocardium. it is uncertain if its amount is sufficient to result in 




Carbon·ll Hydroxyephedrlne Aaae •• ment Of Cardiac 
Sympathetic Neuronal Function In Chronic Cocaine U.er. 
Pierre G. Melon, Carol J. Boyer, Stephanie McVey", Thomas J. Mangner, 
Donald M. Wieland, Markus Schwaiger. 
Universny 01 Michigan Medical Center and School of Nursing", Ann Arbor, 
Michigan. 
Cardiotoxicity of cocaine has been reported In chronic cocaine users. 
Potential mechanism for cocaine-Induced adverse cardiac events 
includes sympathetic neuronal dysfunction. The aim of this study was to 
evaluate the cardiac sympathetic neuronal function of active chronic 
cocaine abusers using dynamic poshron emission tomography and the 
catecholamine analog, carbon-ll hydroxyephedrine (C-l1 HED). 
Myocardial retention of C-ll HED, determined as the ratio of the tissue 
radioactivity over the integral of the ventricular blood radioactivny, was 
used as an index of catecholamine neuronal uptake. We studied S 
women using cocaine for a mean period of 4.6±I.S years. All of them 
reported the use of cocaine wnhin 16±13 hours and had posnive urine 
test for cocaine at the time of the study. Myocardial blood flow Imaging 
performed wnh 20 mCi N-13 ammonia, confirmed absence of previous 
myocardial infarction. On the resliced short axis images obtained after 
injection of 20mCi C-ll HED, regions of Interest were defined on 
proximal, mid and distal planes to determine regional retention of C-ll 
HED. Cocaine users resutts were compared to 6 female normal controls. 
The results are as foilow ("p<O.OS versus control, tp<0.02 versus 
proximal, §pcO.002 versus distal): 
region of interest IlCl2XirDa1 mk1 dis1aI 
Cocaine users 0.107±0.0IS" 0.112±0.019" 0.109±0.022 
Control 0.130±0.017 0.140±0.016t§ 0.121±0.0IS 
As compared to control, C-Il HED retention in cocaine users was 
significantly decreased in proximal and mid myocardial regions. One 
patient revealed a regional decrease of HED uptake in the Inferior wall in 
the absence of flow abnormalities. Thus, catecholamine uptake by cardiac 
sympathetic nerve terminals is decreased in active chronic cocaine users 
which may refiect neuronal damage or alteration of uptake I mechanism. 
posnron emission tomography allows for non-invasive assessment of 
acute and chronic effects of cocaine on the human heart. 
735·6 9:45 
Beta adrenoceptor number and function are unaltered In 
Itunned myocardium : An In vivo Itudy uSing poSitron 
amlllion tomography. 
Ranil de Silva, Yoshikazu Tamura, Aldra Takahashi, M. Murakami, Iwao 
Kanno, Yuklhiko Ono, Altilio Maseri and Hiclehiro lida. Research Institute 
for Brain & Blood Vessels, Akita, Japan. 
To Investigate the integfny of the beta adrenergic system in stunned 
myocerdium, S open-chest anesthetized mongrel dogs underwent ten S 
min LAD occlusions and 10 min reperfusion, with a final 90 min 
reperfusion. Stunned regions (S) were identified as asynergic segments 
on 2D-echocardiography (ECHO). Regions with normal wall motion were 
used as controls (C). In 4 animals, myocardial oxygen consumption 
(MMR02, mVminlg) and blood flow (MBF, mVmlnlg) were measured 
nonlnvasively by positron emission tomography using the previously 
validated lS02 inhalation and H2150 infusion techniques, respectively, 
both at rest and after infusion of isoprenaline (ISO) (0. 1 IIOIkglmin). No 
signHicant differences between C and S were observed for both resting 
MBF (O.S5±O.11 v 1.02±O.17, mean±SEM) and MMR02 (0.15±0.03 v 
O.IS±O.OS). After ISO, MBF (1.29±0.20 v 1.30±0.13) and MMR02 
(0.30±0.07 v O.33±O.06) increased similarly In both C and S, and were 
associated with similar levels of hypercontractilny in C and S assessed by 
ECHO. Absence of tissue necrosis in S was confirmed by post-mortem 
TTC staining and by the perfuSable tissue index (PTI) being close to 
unny (0.98±O.02). In the other 4 animals, the hearts were removed after 
the final reperfusion period and beta adrenoceptor density (Bmax , 
fmoVmg protein) and affinny (Ke!, pM) were measured in C and S by 125-
iodocyanopindolol binding to refined myocardial membrane 
preparations. Both Bmax (114±16 v 136±21) and Ke! (117±19 v 123±19) 
were similar in C and S, respectively. In CQnclyslon : 1) both resting 
MM R02 and MBF are preserved in stunned regions despite depressed 
contractile function; 2) beta adrenoceptor density is unchanged in 
stunned myocerdium; 3) stunned myocerdium has a normal metabolic 
and contractile reserve in response to beta adrenergic stimulation, 
suggesting that the beta adrenergic signal transduction pathways are 
unimpaired. These data provide an In vivo demonstration of the integrity 
of the beta adrenergic system in stunned myocardium. 
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Converting.Enzyme Inhibitors 
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736·1 8:30 
USE OF EKALAPRIL FOLLOWDfG ACO'l'E 1IY00000nL 
IIIFARC'l'IOIf 
John Kjekshus, The Consensus II Study Group, 
Rikshospitalet, University of Oslo, Norway. 
6,090 patients with acute myocardial 
infarction (AMI) were randomized to 
intravenous enalaprilat followed by oral 
enalapril, or placebo, and treated for 6 
months. No requirement for left ventricular 
dysfunction was made. A history of heart 
failure (HF) prior to the index AMI was 
present in 6.1% of patients; 23.5% had a 
prior AMI. There was no difference in overall 
mortality, enalapril 11.0% vs, placebo 10.2%, 
(p=0.26), but a significant benefit with 
respect to development of heart failure 
(HF), enalapril 27.2%, placebo 30.3% 
(p<0.007). Reduction of risk was 10.3%, 95% 
.conf idence interval of 2.9 to 17.2%. Fewer 
enalapril patients had roentgenographic 
evidence of HF (4.1% vs. 5.5%, p=0.02) and 
cardiac enlargement (29.9% vs. 34%, p < 
0.001). Less patients in the enalapril group 
discontinued the ~tudy due to the need for 
open label angiotensin converting enzyme 
inhibitor to treat heart failure (2.6% vs_ 
3.6%, p=0.2). The benefit of enalapril on 
the development of symptomatic HF was similar 
in patients with or without prior MI or 
evidence of HF prior to the index MI. Early 
enalapril reduced the incidence of 
development of symptomatic heart failure 
after AMI in a population not selected for 
the presence of left ventricular dysfunction. 
736·2 8:45 
Errect or Captopril on Ventricular Arrhythmias and 
Sudden Death in Patients with Left Ventricular 
Dysrunction After Myocardial Infarction: SAVE Trial_ 
Milton Packer. Jean-Lucien Rouleau. Lemuel A. Moy~. Jacques R 
Rouleau, Victoria Bernstein. Thomas E. Cuddy. Sandra Lewis. Bruce 
A. Sussex. Francois Sestier. Steven Goldman. Kirk Jacobson. 
Gervasio A. Lamas. John McCans. Otelio S. Randall. John H. 
Wertheimer. Barry R Davis. Eugene Braunwald. Marc A. Pfeffer. 
Columbia Univ. College of Physicians & Surgeons. New York. NY 
Previous multicenter uials have suggested that convertiog-enzyme 
(ACE) inhibitors have no effect on venuicular arrhythmias and sudden 
death and that these drugs .I. mortality solely by .I. death from 
progressive heart failure. This issue was re-evaluated in the SAVE 
Trial. a study of 2231 pts with LV dysfunction following myocardial 
infarction who were tteat.ed with captopril (CPT) or placebo (PBO) for 
42 ± IO months. CPT .I. all-cause mortality by 19%. P = 0.019. 
All deaths in the SAVE Trial were reviewed blindly by a Mortality 
Committee using prospectively dermed criteria and without knowledge 
of the treatment assignment. CPT.I. the risk of sudden death by 19%. 
an effect that was similar in magnitude to the .I. in all-cause mortality 
(.I. 19%) and the .I. in cardiovascular mortality (.I. 21 %). 
To assess the effect of CPT on venuicular arrhythmias. Holter 
recordings were performed in 553 pts at randomization and after 3 
months. I year and 2 years. At randomization. a similar proportion of 
pts in the PBO and CPT groups had VT (11.7% and 11.4%. respect•
ively). and the prevalence of VT remained similar in the 2 groups after 
3 months. However. during long-term follow-up. whereas the 
prevalence of pts with VT tended to t in the PBO group (15.2% after 
I year and 14.9% after 2 years). the prevalence of pts with VT 
decreased in the CPT group (8.6% after I year [P = 0.033] and 8.8% 
after 2 years [P = 0.071]. even though more high risk pts were alive at 
these time points in the CPT group than in the PBO group. 
In contrast to previous experience with ACE inhibitors. CPT 
exens favorable and parallel effects on venuicular arrhythmias and 
sudden death in pts with post-infarction LV dysfunction. 
lACC Vol. 21, No.2 
February 1993:131A 
736·3 9:00 
Comparison of Left Ventricular Remodeling and Effects of 
Enalapril in Patients With Ischemic Versus Non·lschemic 
Etiology for Systolic Dysfunction 
Marvin A. Konstam. Marvin W. Kronenberg, Michel F. Rousseau, 
James E. Udelson, Jacques Melin, Jeanne Metherall, Lori Kilcoyne, 
Debra Kinan, Dawn Stewart, Tonya R. Edens, Noreen Dolan, Sylvie 
Ahn, Salim Yusuf, Hubert Pouleur, for the SOLVD Investigators, 
Tufts University, Boston, MA. 
Prior studies of LV remodeling have included only pts with ischemic 
etiology or have combined ischemic and non·ischemic pts. We 
examined serial radionuclide LV end-diastolic (ED) volumes (V), end•
systolic (ES) V and EF in 12S pts with EF ~ 3S%, enrolled in SOL VD 
Treatment (symptomatic) and Prevention (asymptomatic) Trials, 
randomized to placebo or ena1april, 2.5-20 mg/day. Unexpectedly, we 
found strong interaction (p<0.OO2) among a) treatment effect, b) 
symptom status (nial), and c) etiology (ischemic vs non-ischemic). 
Changes in LV measurements and treatment response differed by 
etiology. One-vr cbange from baseline (mean ± SD): 
Asymptomatic pts ~ (n=7S) Non-ischemic (n=12) 
~.EniIlmIDl ~ ~ 
EDV (ml/m2): .8±20 .1±20 JI6±28* J13±22 
ESV (ml/m2): .6±21 JI±16 J22±22** J23±20* 
JI+S t2+4 t9+10** t11+8** ~(n=29) NOD-ischemic (n=9) 
~ EImlDIlril ~ ~ 
EF(%): 
Symptomatic pts 
EDV(ml/m2): t6± 16 J6±2l .37 ±SI* J40± 17**## 
ESV (ml/m2): tS + 14 J8 + 17 t34 + 37* J37 + 14**## 
EF(%): 0±6 t3±S J3±5 .S±-6# 
*p<o.OS, **<0.01 vs Ischemic; #p<O.OS, ##<0.0001 vs placebo 
Conclusions: I) Asymptomatic pts with non-ischemic etiology for low 
EF showed spontaneous improvement in LVV and EF. 2) Among 
symptomatic pts, those with non-ischemic etiology showed more rapid 
progression of LV dilatation and greater benefit from enalapril than 
ischemic pts. 3) Progression of LV remodeling and drug effects may 
not be equivalent in pts with ischemic and non-ischemic etiologies. 
736·4 9:15 
Kffect of Knalapril OD the Kaercise a.spon.e 
of SOLVO l'atients With Left Ventricular 
Dysfunction and Mild SymptOIU 
Douglas K. Stewart, Chang-seng Liang, Thierry H. 
LeJemtel, Kevin M. McIntyre, Philip C. Kirlin, H. 
Thomas Robertson, Park Willis III, Peter Held and 
Mark McBride for the SOLVD Investigators, University 
of Washington Medical School, Seattle, Washington. 
It is unknown whether the beneficial effects of 
angiotensin-converting enzyme inhibition on exercise 
capacity in patients with left ventricular 
dysfunction extend to patients with minimal symptoms. 
Treadmill exercise capacity was examined in 164 SOLVD 
Prevention Arm patients with an ejection fraction of 
S35% and no requirement of digitalis preparations or 
diuretics for treatment of heart failure randomly 
assigned to either treatment (enalapril {RK) or 
placebo {PI)). Using repeated measures analysis 
adjusted for clinic, age, NYHA class, gender and 
baseline exercise measurements, peak V02 and time to 
anaerobic threshold significantly improved at one 
year in the enalapril group. 
~ &nalaptil ~ 
Exercise time (min) 
1 year 13.51 14.65 0.10 
Peak V02 (ml/min) 
1 year 1473 1627 0.01 
AT Time (sec) 
1 year 535 607 0.03 
AT V02 (ml/min) 
1 year 1166 1293 0.06 
ABSTRACI'S 
736·5 9:30 
Mild SyBtollc DyBfunct1.a1 (BP>35') I BIUIel..1ne 
0vu::actar:1Jrt, .AM 'Dwmpeort:i C Raapal188 in VHaPl'1 
P. carson, G. Johnson, R Fletcher, J. Cohn, and ']he 
VA Coop. Stu:iy Group, washington, D.C., Minneapolis MN. 
Previous heart failure (HF) trials have fcx:used on 
patients (pts) with ejection fraction (EF)~35% ~le 
pts with EF>35% have been less ~ll stlXlied. Fran 
VHeFl' I and II, ~ evaluated the baseline 
characteristics, annual JJDrtality rate (AMR), and also 
cx:rtpll'ed the respoose to therapy using Hydralazine 
Isosorbide Dinitrate (H-I) vs. Plaoei:x> (PI) in VHeFl' I 
and H-I vs. Enalapril (E) in VHeFl' II for EF <35% and 
EF >35%. Baseline characteristics differed (p.<.Ol) in 
the follCMing: VHeFl' I VHeFl' II 
~35%(n=422) >35%(n=172) ~35%(n=554) >35% (n=218) 
Max V02 14.413.9 15.913.7 13.413.4 14.5±3.6 Sys/BP 117.4+16.7 130.8+19.1 123.4+16.1 133.7+17.3 
CT ratio 53.8+6.2 51.2+6.1 53.4+6.0 50.9+5.7 
EF 23.~6.6 46.1~9.9 23.4±6.8 43.2~6.7 
Fbdftn(%) 34 53 42 56 
Fbdftn = histozy of hypertension 
']he AMR W!lS 20.7 ~35% vs 10.2 >35% in VHeFl' I; 14.7 
~35% vs 7.8 >35% in VHeFl' II. Vascx!ilator therapy 
resulted in the follOOng JJDrtality rates (*P<. 05 ) : 
VHeFl' I H-I PI P VHeFl' II H-I E P 
AMR~35% 16.8 21.8 .07 ~35% 15.7 13.8 .29 
>35% 9.4 9.5 .96 >35% 9.9 5.7 .035* 
131A 
By nechani.sm, sOOden death W!lS lower in E c:atpaIed to 
H-I (P<.Ol) in pts with EF>35% in VHeFl' II. Conclusion: 
Pts with EF >35% are characterized by a nme fJ:eqUE!llt 
hypertensive history, less exercise ilIpai.nIen.t and 
smaller hearts. 'lhey have decreased mortality cx:rtpll'ed 
to EF~35% and a~ to exhibit better prognosis on E 
than on H-I. Converting enzyme inhibitors may be 
effective in prolonging life in patients with heart 
failure and only mild systolic dysfunction. 
736·6 9:45 
The Effects of ACE. Inhibitor Withdrawal in Patients With 
Congestive Heart Failure: A Multicenter, Randomized, 
Controlled Study 
Peter W. Pflugfelder, Michael G. Baird, Melvin J. Tonkon, Robert 
DiBianco, Andrew C. G. Uprichard, Robert M. Singer, Bertram Pitt, 
on behalf of the Quinapril Heart Failure Trial Investigators. 
Abrupt withdrawal of ACE-inhibitors from patients (pts) with heart 
failure (HP) has been suspected of causing major cardiac events 
(Konstam et al, JACC 1992;19:216A). This was evaluated in 204 
pts, NYHA class n-III, EF S3S%, on diuretics ± digoxin. After 8 
weeks of single blind quinapril (Q), pts underwent baseline treadmill 
exercise testing (ET). After 3 weekly ETs within 60 sees, pts were 
randomized either to continuing Q or placebo (P). Endpoints 
included ET changes from baseline and withdrawals due to 
worsening HF. 
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The median change in ET was +3 and ·16 sees for Q and P 
respectively (p=0.0 16). There was no precipitous deterioration or 
significant increase in early adverse events (1-4 weeks), rather a 
steady worsening of HF. Thus, ACE-inhibitor withdrawal is 
usociated with progressive cardiac deterioration beginning at 
approximately 4 weeks. 
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Comparison or Resource Utilization and Estimated 
Cumulative Cost Over 5 Years After Coronary Surgery or 
Coronary AIIgioplasly in Patients With 'IWo Vessel Coronary 
Disease 
William S. Weintraub, Patrick Mauldin, Susan Oilbert, Spencer B. 
King m Division of Cardiology, Emory University School of 
Medicine, Economics Department, Emory Univenity, AlIanta GA 
To study differences in resource utilization after PTCA or coronary 
surgery (CABG), in patients with two vessel coronary artery disease, 
371 PTCA and 416 CABG from 1984 and 1985 with complete 
followup to 5 years were analyzed. 5 year risk adjusted survival was 
93% for both groups. All hospitalizations for myocardial infarction 
(MI), catheterization, additional PTCA or CABG were recorded. 
Costs were estimated from published figures, using 1984-1985 
estimates. 5 year mean additional events with range and tota1 
cumulative costs: 
ue 
PTCAs 0.356 (0-5) 0.005 (0-1) <.0001 
CABGs 0.129 (0-2) 0.002 (0-1) <.0001 
MIs 0.110 (0-3) O.on «()'2) NS 
Catheterizations 1.10 «()'11) 0.284 «()'7) <.0001 
Cost S19,305:!: 13,674 S24,I82:!:3,671 <.0001 
More procedures were utilized in the PTCA group. Sensitivity 
analysis on costs was performed. 30000 ....... ---------, 
The figure displays total 2SOOO ....... StlllO .......... ·· 
cumulative cost estimates over 5 ............................ . 
years using low, mid and high 20000 
estimates for costs. While the 15000 
non· randomized population and 
difficulty in making cost estimates 10000 
limit definitive conclusions, the SOOO Cost (S) 
cost of PTCA rises relative to 
CABG over time is additional 
resources are used. o 2 
737·2 
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8:45 
Evaluation ror Gender Bla. In the Post·Exerclse Test 
Manaaement or Outpatients With Suspected Coronary Artery 
Disease 
Anthony Manse, H. Paul Singh, Robert Duva~ West Virginia 
University, Morgantown, WV 
We evaluated for the presence of gender bias in the ~-exercise 
(Ex) test management of 2070 consecutive outpatients (926 
women) with sUspecte4 coroIWy artery disease IUn at our 
institution between 1981·1991. Using a previ~ derived 
logistic regression algorithm (age, sex, symptoms, di8betes, Sf 
r~nse, magnitude of exercise, exercise symptoms, thallium 
results), the probabilities of coronlU)' disease for each patient 
followmg all ExECGs and 662 thallium studies were calculated. 
Men and women were grouped according to both ~t.ExECG 
and final ~ttest probability and then respective com ared 
concerning % usage of thallium testing farrowing and 
coronary an~ography (CADg) following all testing. RESULTS: 
Overall % tIlamum usage: men 24% and women 42% (1)<0.001). 
When grouped by decife of pos!.ExECG probability, there were 
gender related differences m % thallium usage on!>' in the 3 
lowest deciles (range 0-30%). In each of these deciles, women 
had higher % usage of thallium testing (p<O.OI). Overall % 
CADg usage: men 21% and women 24% (j>NS). When grouped 
by decile of final ~ probability, there was a progressive 
increase in % usage of CADg with eacn decile, but there were no 
differences noted between men and women in this respect (XZ 
goodness-of·fit: F ratio = 15.9/12.9 ., 1.22; pNS). Concemmg 
the time periods 1981·1986 (n.,1010) and Ig86-!991 (n=I06O), 
overall % thallium usage increased' (22% to 41%; p<O.OOI). 
However, the gender related differences noted above were 
unchanged. Likewise, there were no significant differences in 
gender related % usage of CADg between the 2 time periods. 
CONCLUSION: These results are Dot consistent with an 
inappropriately lower usage of post·ExECG diagnostic testing in 
women. However, there were gender related differences in % 
thallium usage that continued Clespite adjustments for clinical 
and ExECG (lata. 
lACC Vol. 21, No. 2 
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737·3 9:00 
Outcome or Coroaary Bypus Reopel1ltioa la Womea 
Steven Khan. Sharon Nessim. Richanl Gray. Keta Hodgson. Debra Scarlala, Aurelio 
Chaux. Jack MatIoff. Cedars-Sinai Medical Center. Los Angeles. CA 
Purpose: To detennine the results of caonary artery bypass (CAB) reoperation 
(Reap) in women. we analyzed risk factors and oulComes in 2.849 (643 women and 
2,206 men) consecutive patients undcr&oing CAB between 1986 and 1991. 
Resulu: ~eops comprised only 8.6% of the Operative Mortality (%) 
surgenes m WOOlen compared 10 16.!1% of 
lUCgeries in men. Reop women were 
younger than those undergoing flnt (Opl) 
CAB (R~.S vs OpI-71.2 )'0. p.().04) 
whereas theM was 110 difference in the ages 
of males (Re0p-66.8 VI Op I ~.6 )'0. 
p.().82). SigniflC8lltly more Reop women 
had UllSlable angina (R~86% vs Opl· 
70%, P-<tOI) while chronic stable angina 
was more common in Opl women (R~ 
7% vs OpI-2S%. 1'=0.002). Though similar 
n 
Gender 
o First Op It Reop 
proportions of Opl women (8%) and Opl (5%) and Reap (5%) males had had a 
failed PICA at this admission. none of the Reap females had had a prior failed 
PTCA ~.02 for Reap vs Opl females). When outcomes were analyzed. there 
were no differences in length of haspital stay or in in·hospital death rates (Reop-7% 
vs Op I ·7%.1'= 1.00) between Reap and Opl women. In contrast. the in-hospital death 
rate was signiflcantly higher for male Reap than Opl (Reop-8% vs OpI·3%. 
P<O.OOOI). Life table analysis demonSlr1lled similar survival in Reop and Opl 
women at I (R~89'J1, vsOpI·88%)and S years (R~8O% vs OpI-78%. 1'=0.92). 
Survival was Significantly beuer in the male Opl patients than Reap (Reop-86% vs 
OpI·93% at I year. 1'=0.00(1). 
CoDclusioa: The short and long term resullS of reoperation in women are similar 10 
initial CAB in women and as good as reoperation in men. Although the monality 
rate of women undergoing fIrSt CAB is higher than that of men. the monality rdte 
of f11Sl and reap women and reap men were all similar. Although it has been 
suggested that women undergoing flnt CAB have a higher m<Xtality rolle. our results 
suggest that the outlier in m<Xtality rates is the low m<Xtality rate of men undergoing 
first CAB. 
737·4 
Caapari.on of Woaen Und.rgoing MUltipl. V •••• l 
a.va.cularization with Coronary Iypa •• Surg.ry or 
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9:15 
Richard E. Shaw, Joseph Rosenblum, Richard K. Hyler, 
Simon H. Stertzer, Hary C. Hurphy, Heidi N. Hansell, 
Alex Zapolanski, Colman Ryan, Laurel Leary, Jean Chan . 
San Francilco Heart Institute, Seton Medical Center, 
Daly City, CA 
To etudy longterm outcome for women undergoing 
coronary reva8cularization, 221 patients having 
coronary bypass (CABG) and 191 having .ultivessel 
coronary angioplasty (PTCA) at the eame institution 
were analyzed. Women compdsed 18.3% (N-35) of the 
PTCA group and 21.7% (N-48) of the CASG group. Women 
having PTCA were more likely to have a hiltory of dia•
bet.es (28.6% vs. 9.0%; p<. 001) compared to men under· 
going PTCA. Women undergoing CABG were more likely to 
have diabetes (39.6% VB. 15.6%; p<.OOI), hypertension 
(77.1% V8. 61.3%; p<.05) and were older (64t8 vs. 
61t9; p<.05) than CABG men. Comparing PTCA and CABG 
women , CABG wom@n had more triple veaael dieease 
(60.5% vs . 17.1%; p< . OOOl) and were older (p<.05). 
Women in both groups had a higher rate of in.hospital 
death compared to men (5.7% V8. 0.0% in PTCA and 8.3% 
vs. 1.7% in CABG; p<.05) from either group. Five year 
followup for 99% of PTCA and 94% of CABG patients 
thowed that PTCA and CABG women did not differ from 
ea~h other in RUTvival, but both women groups had 
,ignificantly lover survival rates than men (PTCA 
women vs. men: 79% vs. 92%; p<.05; CABG women VI. men: 
76% V8 .. 90%; p<. 05). In slIIIID&ry , regardless of 
r.vascularization strategy, women undergoing treatment 
for multiveaRel coronary diseaee appear to be at 
higher risk for early and late adverte .vents compared 
to men. 
JACC Vol. 21, No.2 
February 1993:133A 
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Quality of Life Measures Predict Long-term Mortality in Coronary 
Disease Independently of Disease Severity 
Daniel B. Mark, Charlotte Nelson, Elizabeth Delong, Mark A. 
Hlatky, Donald Fortin, Donald Glower, James Jollis, Robert M. 
Califf,David B. Pryor Duke University Medical Center, Durham, 
NC 
Quality of life (OOL) is increasingly being regarded as an important 
endpoint in coronary disease (CAD) patients (pts) when mortality 
differences cannot be detected. However, OOL is generally 
considered to be a function of disease severity rather than a separate 
clinical domain. To evaluate the relationship between one important 
aspect of OOL, functional status, and CAD mortality, we 
prospectively studied 3932 pts with significant (z.75% stenosis) CAD 
referred to Duke for dx catheterization (cath). All pts had a detailed 
OOL assessment at the time of cath (baseline) including the 12-item 
Duke Activity Status Index (DASI) to assess functional status and 
all pts were followed at 3-6 mos, at 1 year and annUally (mean 
follow-up interval 3.4 yrs). During follow-up, 510 pts died. Cox 
model analysis showed that baseline DASI was a strong predictor of 
long-term mortality (p<.0001) and that this relationship was 
independent of important covariates including age, sex, number of 
diseased vessels and ejection fraction. Each one-item decrease in the 
number of activitiespts could do without difficulty (out of 12) 
increased the pts mortality risk by 14%. 
Thus, functional status is not only an important secondary outcome 
in CAD pts, it is also an independent determinant of the risk of 
mortality. Our results suggest that assessment of functional status 
should become a routine part of the clinical evaluations of pts with 
CAD. 
737·6 9:45 
Importance of MOnitoring Cardiac Catheterization Complications for 
the Bntire 24 Hour Period After the Procedure 
Thomas M. Bashore, Mickey Peoples, Bric B. Lieberman, J. Kevin 
Harrison, Richard Wawrzynski, Laura Gardner, Daniel Mark. 
Duke University Medical Center, Durham, NC 
While acute complications following diagnostic cardiac catheteriza•
tion (cath) have been well defined, there are little prospectively 
collected data regarding complications at 24 hours in a variety of 
laboratory settings. The issue is especially important in the outpatient 
and mobile cath environment. To address the need for monitoring of 
complication rates at 24 hours an ongoing prospective study inciuded 
982 inpatient (inpt), 493 outpt and 280 mobile cath pts that were 
followed for 24 hours. Most adverse events were minor and of nn 
consequence. Significant acute events included death, prolonged 
Ischemia with BCG changes, cardiogenic shock, pulmonary edema, 
sustained hypotension, ventricular fibrillation, need for intubation, 
transient ischemic attack, TIA, stroke, and large hematoma. "Following 
cath" implies a complication observed between the time of the acute 








Total 80(8.1%) 21(4.3%) 3(1.1%) 
Acute 42(4.3%) 8(\.6%) 1(0.4%) 
Following Cath 38(3.8%) 13(2.6%) 2(0.8%) 
Of a total of 104 significant cardiac events that occurred, 53 required 
24 hour monitoring to detect. These included TIA, stroke with 
residual, large hematoma, pseudoaneurysm, A V fistula or a major bleed 
requiring transfusion. 
Since vascular injury in particular may present late following cardiac 
cath, it is important in the establishment of quality assurance programs 
that prospectively collected cardiac catheterization complication rates 
include data that are obtained both acutely and at 24 hours following 
the procedure. 
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The Innuence or Pre-Intervention Intravascnlar Ultrasound Imaging on 
Subsequent TralISCIItbeter Treatment Strategies 
Augusto D. Pichard, Gary S. Mintz, Lowen F. Satler, Kennelh M. Kent, Jeffrey J. 
Popma. Julie A. Kovach, Martin B. Leon. Washington Hospital Center, 
Washington, DC 
Aldtough intravascular ultrasound (lVUS) imaging provides useful paIhoanatomic 
insights. Ihe clinical utility of IVUS as a determinant of tran5calheter Iherapy 
(Ten strategies is poorly dermed. To assess Ihe impact of pre-intervention IYUS 
on subsequent TCT. 190 patients wilh symptomatic CAD were studied (168 native 
coronaries and 22 saphenous vein grafts) eilher prior to planned TCT (86%) or to 
beller evaluate lesion severity for possible TCT (14%). IVUS was perfonned 
using a comprehensive imaging system {25MHz rotating transducer. 3.9F 
monorail imaging sheath. motorized transducer pullback at O.5mm/sec. 2-D and 3-
D display I and images were immediately analyzed for quantitative factors (lesion 
and reference vessel areas and diameters. % area steDOsis, and lenglh) and 
qualitative lesion morphology (eccentricity and plaque composition). Combined 
time for IVUS set-up, calheter placement, and multiple imaging sequences was <5 
minutes. In 14 patients (8.3%), pre-intervention IYUS was unsuccessful due to 
vessel tonuosity or lesion severity. Apart from transient ischemia. IYUS-related 
complications occurred in 2 patients (1.1%): dissection in I and Ihrombus in 
anolher. Of Ihe first 90 patients studied. pre-intervention IVUS was the 
detennining factor in changing subsequent TCT in 24 (26.7%): whereas in Ihe last 
90 patients, TCT strategy was modified in 46 (51.1%). Unplanned TCT was 
influenced by quantitative assessment of lesion severity. and planned TCT was 
revised Iar@ely due 10 qualitative assessment of plague composition. 
First 90 Patients Last 90 Patients 
n(%) n(%) 
Unplanned TCT: (lesion severity) 10 (11.1) 11 (12.2) 
Planned TCT: (plaque composition) 
10 device selection 6 (6.7) 23 (25.6) 
l!. device selection 8 (8.9) 12 (13.3) 
Imponantly. the presence. extent. and location of target lesion calcification (seen 
in >70% of lesions) frequently influenced device selection. 
We conclude: Pre-intervention IYUS assessment of target lesions (I) can 
be performed rapidly and safely in >90% of patients, (2) commonly modifies 
subsequent TCT strategies, especially in lite setting of unsuspected lesion•
associated calcium, and (3) bas progressively greater impact on TCT strategy with 
increasing operator experience. 
738-2 8:45 
Quantitative Angioscopy: a New Method for Measunment of 
Luminal Dimensions by Use of a "Lightwire" 
J. Richard Spears, Syed J. Raza, Mahmood Ali, Gayathri S. lyer, 
Wai-Pung Cheong, Richard J. Crilly. Wayne State University School 
of Medicine, Detroit, Ml. 
Although angioscopy permits direct visualization of the arterial 
lumen, assessment of luminal dimensions is unreliable because of 
variation in magnification with lens-object distance and ambiguity 
associated with identification of corresponding points about the 
circumference of a given discrete cross-section. Therefore, we 
developed a new method for quantitation of luminal dimensions 
during angioscopy. A transverse ring of fiberoptically transmitted 
laser light is emitted from a guidewire at a known distance from the 
distal end of an angioscope, and discrete cross-sections of interest are 
observed as the ring of light is reflected from the luminal surface. To 
determine the accuracy and reproducibility of the method, caliper 
measurement of the diameter of the light ring image (<50 mW at 
488/515 nm), obtained on 
angioscopic video recordings d 4 
(Baxter) of cylindrical phantom ~ 
vessels of known dimensions, i: 
was perfonned by 3 observers on 5 -_E 3 
occasions. As shown in the E 
figure, measurement of true ! 
luminal diameter with this .,.1 
method was accurate to within 
,.1_-0.12 
,z.o .... 
65 ± 35 microns (± 1 s.d.) over a 1 
clinically relevant range (1-4 • 
mm). The mean coefficient of :1 1+£---.----___ .., 
1 variation was 6 'lb. 2 3 T .... die_tor (mm) 
In conclusion, by use of the Iightwire method, luminal dimensions can 
be measured in trilro with a high degree of accuracy and 




Angioscopy of Coronary Stents at Follow-up 
Paul S. Teirstein, Richard A. Schatz, Krishna J. Rocha•
Singh, Scott J. DeNardo, Nancy Morris, Robert Strumpf, and 
Richard R. Heuser. Scripps Clinic and Research Foundation, 
La Jolla, CA 
Coronary angioscopy was performed in 23 pts undergoing 
angiographic follow-up (FU) after Palmaz-Schatz stent 
implantation. Stents were placed in 12 native vessels and 
11 vein grafts. Mean time from stent placement was 7 ± 7 
months. Twenty stented vessels were examined at 1 month to 
2-1/2 yr FU (LATE FU), and 3 stented vessels were examined 
at 1 day to 4 week FU (EARLY FU). All pts were studied 
electively; none in the setting of subacute' thrombosis. 
By angiography, 6 vessels demonstrated no restenosis (0-
10% diameter stenosis), 11 had moderate renarrowing (11-
50% stenosis), and 6 had restenosis (>50% stenosis). 
Stents were fully visible in 5/6 pts with no restenosis. 
Visible stent struts were indistinguishable from the 
angioscopic appearance of freshly implanted stents. Stent 
struts were not visualized in any of the 6 pts with 
restenosis and the stented region was completely covered 
with smooth, white tissue. In one pt with restenosis at 2-
1/2 yr FU, the stent was not visualized until successful 
balloon redilatation, whereupon stent struts emerged and 
were clearly visible. Stent struts were partially visable 
(some stent struts were exposed and some covered) in all 
11 pts with moderate renarrowing. 
Small quantities of patchy mural thrombus surrounded 
some stent struts in one EARLY FU and three LATE FU pts. 
Conclusions: 1) Macroscopic covering of stent struts at 
FU was associated with angiographic restenosis. In vessels 
with no restenosis, most stents were fully visible; in 
restenotic vessels, stents were entirely covered and 
obscured from angioscopic view; in vessels with moderate 
renarrowing some struts were visible and some were 
covered. 2) Minimal thrombus surrounding stent struts was 
infrequently observed. 
738·4 9:15 
Impact of Intravascular Ultrasound on Device Selection and End-point 
Assessment of Interventions: Phase I of the GUIDE TriaL 
TIte GUIDE Trial Investigators. University of California, San Francisco 
and Stanford University, CA 
The GUIDE Trial (Guidance by Ultrasound Imaging for Decision 
Endpoints) is a multicenter, prospective study of the usefulness of 
intracoronary ultrasound imaging (JCU) in PTCA and directional 
atherectomY' (DCA). In phase I of the trial, time-based data recording is 
used to track the operator's decisions during the intervention. 
Angiography (ANG) and lCU assessments are made "on-line" at points 
during the case where the operator is selecting a catheter or evaluating a 
potential end-point. Eighty-two cases with complete time-based data 
forms were analyzed at the core lCU and ANG laboratories. There were 
no major complications associated with imaging in any of the cases. 
Spasm was reported in 3/82 (4%) cases requiring an additional 
administration of nitroglycerin. 
Change in assessment: In 56 cases (68%) operators reported that lesion 
characteristics seen with ICU were discrepant from or additional to the 
impression from the ANG. Unanticipated findings included: 
calcification within the target lesion in 29/56 cases; significant 
eccentricity in 22/56; and dissection (14/56), of which 4 were judged to be 
severe. 
Chan~e in thera~y: Overall, changes in therapeutic approach were 
documented in 39 cases (48%). Detection of Significant dissection led to 
perfusion balloon placement in 7 cases. Lumen caliber which was 
significantly smaller by ICU than by ANG resulted in balloon upsizing in 
19 cases. Detection of significant calcium at the luminal border during 
pre-DCA imaging led to the decision to abandon DCA for PTCA in 9 cases. 
Significant residual plaque not appreciated by ANG led to upsizing of 
DCA devices in 5 cases. Localization of plaque in an area other than 
predicted by ANG resulted in a change in device orientation in 6 cases. 
Conclusion: Current ICU technology provides detailed information about 
plaque morphology which leads to a Change in therapy in 
approximately 50% of cases. 
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Initial Clinical Experience with a Novel Low·ProfIle Integrated Coronary 
Ultrasound-Angloplasty catheter: Impllcetlons for Routine Use 
Gregg W. Stone, Fred SI. Goar, Melissa A. Klette, Thomas J. Linnemeier. 
The CardiovaSQJlar Institute of EI Camino, EI Camino Hospital, Mountain 
View, CA, and Northside Cardiology, St. Vincent's Hospital,lndianapolis,lN 
Intra-arterial uttrasound (US) imaging has shown promise as a complement 
to angiography during interventional coronary procedures. Present US de•
vices have thus far been limHed by large profile design, or the necessity to 
exchange for a dedicated imaging catheter wHhout dilatation capability. We 
report the inHial experience wHh a novel low-profile integrated ultrasound•
angioplasty (US-PTCA) catheter (Enclosonics Oracle Micro"'), consisting of 
a 64 element dynamic aperture array for US imaging located just proximal to 
a 2.0·3.5 mm polyethylene balloon, mounted on a 3.5F shaft. 
Forty-four pts (mean age 62.9 yrs, 71% male) underwent PTCA of 
65 lesions in 51 vessels. Twenty-four pts (55%) had muttivessel disease, 10 
(23%) had diabetes, 17 (39%) had prior myocardial infarction (MI), and 12 
(27%) had unstable angina. US·PTCA was attempted in 57 lesions (86%); 
US·PTCA was not pertormed in the remaining 8 lesions for lack of a proper 
size US-PTCA catheter (n=5), distal, tortuous disease (n=2), or atherectomy 
(DCA) pertormed (n=I). Forty-one (72%) of the US-PTCA stenoses were in 
the mid or distal coronary tree. Procedural success rate was 100% wHh no 
major complications (death, bypass surgery or MI.) Balloon angioplasty was 
successful in 56 (98.2%) lesions; adjunctive DCA was successful in 1 
(1.8%) ostial LAD stenoSis. 
Adequate US images were obtained with 55 of 60 (92%) catheters. 
Sign~icant independent morphologic information was obtained from US not 
present by angiography in 26 (46%) of 57 lesions (more .extensive disease 
(n=18) or calc~ication (n=8), signHicant reference stenosIs (n=6), leSion re•
solved wHhout dilatation (n=I), less disease by ultrasound (n=I), other 
(n=2). (More than 1 finding allowed per lesion}). More importantly, US imag•
ing altered the dilatation strategy in 17 (30%) of stenoses (greater number 
of inflations or pressure used (n=6), decision to upsize (n=7) or not to upsize 
(n=3), decision to dilate (n=2) or not to dilate (n=2) a bordertine lesion, ofher 
(n=4». 
Conclusions: Combined PTCA wHh US imaging can be pertormed 
wHh a high success rate and minimal complications using a new low-profile 
integrated US·PTCA catheter. Adjunctive ultrasound imaging contributes 
significant morphologic information in nearty 50% of lesions, and may alter 
the dilatation strategy in 30% of stenoses. 
738·6 9:45 
Initial in Vivo Human and in Vitro Use or a Combined 
Laser Ablation and Ultrasound Imaging Device 
Andreas Kreis, Willibald Maier-Rudolph, Iiirgen Hug, Heinrich 
Duda. Hilde Fritsch-Zrenner+·, Heinrich Htifler+*, Peter Huppert·, 
Claus Claussen, Werner Rudolph. Gennan Heart Center, Munich; 
·lnst. of Radiology, Univ. Tiibingen, ··lnst. of Pathology, Techn. 
Univ. Munich, Gennany 
To explore the feasi~ility and potential. of ~ newly~developed 
integrated laser ablauon and ultrasound Imagmg deVIce, a 3.5F 
Endosonics ultrasound catheter (lVUS) was incorporated in the lumen 
of a 9F excimer laser (L) catheter (Technolas 308 run, 55 mI) with 
160 circularly-orientated lOOj1 fibers for the in vitro use in post 
mortem human common iliac and superf. fem. arteries. A total of 20 
lesions were created in nonnal areas and in areas with different 
degrees of atherosclerotic disease by coaxial laser energy delivery in a 
saline bath. For in vivo use in 4 pts with high-grade stenoses of the 
superf. fem. or ext. iliac artery, a 4.8F Diasonics ultrasound catheter 
was integrated in the lumen of a 9F laser catheter (Candela Corp. ~ 
run, 1.44 I1s, 10 Hz) with 17 circular 1501.l fibers (Ceram .Opucs, 
Bonn). After laser application in vivo, mean stenosis reductton was 
from 84±8% to 47±1O% as detennined by angiography. No 
complications were associated with the use of the newley-developed 
system. In vivo, the intennittent use of the IVUS-imaging system 
during the interruption of laser energy deliyery, immedia~ly showed 
the location of the ablated area and the arterial wall composlUon at that 
site. In vitro, the lesions visualized by IVUS were compared with the 
corresponding histological sections stained with VanGieson. The site 
of the ablated areas shown by histology were all recognized by the 
UIVUS device. Vacuolisation of the arterial wall next to ablated areas 
were identified as an echo free space by the IVUS, overestimating the 
true amount of ablated material. 
We conclude that the integrated combination of laser ablation and 
inttavascular ultrasound is feasible in humans in the peripheral 
circulation and that IVUS may overestimate the effects of laser 
application. 
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739-1 8:30 
Patent Foramen Ovale: Characteristics of the Atrial Septum Associated 
With an Increased Risk for Paradoxical Embolism 
Dirk Hausmann, Andreas Miigge, Peter Nikutta, Werner G. Daniel. 
Hannover Medical School, Hannover, Germany. 
Due to high prevalence in the normal population, the clinical significance 
of a patent foramen ovale (PFO) remains unclear even in patients (pts) 
with otherwise unexplained systemic embolism. We studied 78 pts (48 
m, 30 f; age 46±8 years) with PFO proven by transesophageal echocardia•
graphy (TEE; right-ta-Ieft contrast shunting through the atrial septum 
after Valsalva). No pt had valvular or myocardial disease or atrial fibril•
lation. Pts were classified into 3 subgroups. Gr. A: In 21 PFO-pts with 
unexplained ischemic events (13 stroke, 3 TIA, 5 peripheral embolism), 
additional findings suggested that paradoxical embolism had occurred: 
A thrombus lodged in the atrial septum (n=2), concomitant pulmonary 
embolism (n=7). deep venous thrombosis (n=5), chronic venous insuf•
ficiency (n=5), or unequivocal Valsalva maneuver immediately prior to 
the ischemic event (n=2). l:iLlL In 30 PFO-pts with unexplained 
ischemic events (19 stroke, 6 TIA, 5 peripheral embolism), no further 
evidence for paradoxical embolism was found. Gr. C: In 27PFO-pts, no 
ischemic events had occurred. TEE images were evaluated for presence 
of severe right-tOoleft atrial shunting (contrast opacification of ~ 50% of 
the left atrium), of wide PFO opening ~ 5 mm), or for presence of atrial 
septal aneurysm ~15 mm bulging of the atrial septum); the incidence of 
these features in Gr. A, B and C were: 
~Wli~~~ 
Severe contrast shunt 71 % 20 % 4 % p<.00l p<.OOI 
Wide PFO opening 86 % 37 % 11 % p<.01 p<.OOI 
Atrial septal aneurysm 29 % 30 % 7 % n.s. n.s. 
Conclusion: Assessing only the presence of a PFO by TEE is not suffident 
in patients with ischemic events and suspected paradoxical embolism. 
Since severe right-tOoleft shunting and wide PFO opening are associated 
with an increased risk for paradoxical embolism, PFO evaluation by 
transesophageal echocardiography should include these features. 
739·2 8:45 
As .... ment of the Clinical IeleYanc. of Potent Foramen 
Ovate in Young Strok. Patients and Normals by Simul· 
taneous Transesophagaal Contrast Echocardiography and 
Transcranlal Contrast Doppler 5onography 
Frank P. Job, E. Bernd Ringelstein·, Yvonne Grafen, Fronk A. 
Flochskampf, Andreas Stockmanns· Christopher Doherty·, Christian 
lehmann, Peter Hanrath (FACq 
Medical CliniC I and Deportment of Neurology·; RWTH Aachen, FRG 
In 74 young stroke patients (pis) (34.3 ± 10.1 years) and 60 oge 
matched healthy controls ("norm", 31.3 ±8.9 years) simultoneovs 
tranresophageal contrast echocardiography Ie TEE) and transcranial 
contrast Doppler sonography of the mid cerebral arteries (eTC D) ~ 
performed to compare the prevalences of patent foramen OVdle (PFOI 
in both groups. According 10 stroke etiology slroke pts _re 
subdivided in unclarified ("unci"; n-44) and clarified ("clar"; n-33) 
cases in whom a probable source of embolism had been identified. 
Right to left shunls were scored by c TCD results as minimal (1·10 
spikes), intermediate (11-50 spikes) or massi ... (>50 spikes). With a 
prevalence of 56 % significanlly (p<0,05) more PFO were discovered 
in "unci" versus 30 % in "clar" and 39 % in "norm". By cTCD scoring 
it was shown that positive findings in the 'norm" and "clar" _re 
mosdy minimal shunts (71 %) versus only 6 % in "unci" . Massive 
shunts _re signilicanlly more frequent In "unci" 168 %) than in "clar". 
Concordance of c TEE and c TCD was 100 % in cases with intermediate 
or massive shunts versus 81 % in cases scored minimal. 
Conclusion: cTEE and cTCD are equipotent to detect non trivial PFO. 
Nan trivial PFO is more frequent in "unci" SU9gesling on etiological 
role in young slroke pis. 
ABSTRACTS 
739·3 9:00 
How Reliable is Transcranial Doppler Ultrasound in the 
Assessment of Patent Foramen Ovate? 
Peter Nikutta, Manfred Schneider, Dirk Hausmann, Gunther Claus, 
Sebastian M. Schellong, Andreas Miigge, Henning KUhn, Werner 
G. Daniel, Hannover Medical School, Hannover, Germany 
Previous studies suggested that transcraniaI Doppler ultrasound 
(TCD) is an alternative technique to contrast echocardiography (CE) 
for the detection of patent foramen ovale (PFO). We therefore 
studied prospectively 35 consecutive patients (pts) without additional 
atrial septal abnormalities for presence or absence of PFO. All 
patients were first examined by transesophageal (TE) CE using 3 
different contrast agents in all cases: agitated saline (SAL), 
oxypolygelatine solution (OPO) and SHU-454 were administered 
i.v. in a random sequence. Following the TE-CE study, all pts 
underwent a TCD examination analyzing spectral Doppler signals of 
the left or right middle cerebral artery after application of SAL, 
OPO and SHU in a random order. TCD and TE-CE studies were 
performed during normal breathing and Valsalva maneuver and by 
2 different operators blinded to the results of the previous 
examination. Results: Due to insufficient TCD signals in 1 pt, TE•
CE and TCD findings could be compared in 34 pts. PFO was 
detected by TE-CE in 11 pts and there were no differences between 
SAL, OPO and SHU. In contrast, SAL-TCD detected an 
unequivocal right-to-Ieft shunt in 13 pts, OPO-TCD in 23 pts and 
SHU-TCD in 13 pts. Compared to TE-CE, SAL-, OPO- and SHU•
TCD-studies were falsely negative for PFO in 1, 0 and 1 cases 
respectively. Conclusion: These data indicate that PFO diagnosis by 
TCD is associated with a clinically relevant insufficient accuracy 
when compared to TE-CE. This is primarily due to false positive 
TCD results based on transpulmonary passage of the injected 
contrast agent. This lung passage of contrast particles varies 
dependent on the contrast material used. Thus, TCD is a non•
reliable tool for diagnosing PFO. 
739·4 9:15 
Identification of Interatrial Communication In Patients 
with Elevated Right Atrial Pressure Using Surface and 
Transesophageal Contrast Echocardiography 
Howard C Dittrich, Hugh A McCann, William W Wilson, Mark M 
Mitchell, Stuart W Jamieson, William R Auger, Kenneth M Moser 
University of California, San Diego 
Contrast echocardiography using transesophageal (TEE) Imaging is 
superior to surface imaging for detecting interatrial 
communications (lAC) in patients with unexplained stroke. It is 
not known how these two techniques compare in patients with 
pulmonary hypertension and elevated right atrial pressure where 
a transeptal pressure gradient may enhance right to left flow. We 
therefore evaluated 36 patients with thromboembolic pulmonary 
hypertension (pulmonary artery systolic pressure 78±25 mm Hg 
[mean ± SO]) and elevated right atrial pressure, (12±5 mm Hg) 
undergoing pulmonary thromboendarterectomy, where surgical 
inspection of the interatrial septum was compared with blinded 
readings of surface echo and TEE using agitated saline. Surface 
studies were performed during quiet breathing and with Val salva 
while TEE was performed in surgery, during both assisted 
ventilation and with artificially elevated right atrial pressure 
(20±7 mm Hg). At surgery, 16 (44%) patients had lAC of 
varying size and location. Sensitivity for lAC by surface was 63% 
while specificity was 95%. TEE sensitivity was 56% with 
specificity of 95%. Using combined surface and TEE. the 
sensitivity was 69% with a specificity of 95%. 4 of 5 false 
negative studies occurred in patients with lAC of 1 mm. The 
overall predictive accuracy for either technique alone or combined 
was similar at 78·83%. Thus, in patients with pulmonary 
hypertension and elevated right atrial pressure. where the 
frequency of lAC is very high, detection of right to left shunts by 
contrast echo is excellent unless the lAC is very small. Further, 
surface or TEE contrast echocardiography are equivalent in this 




The Effect of Positive End Expiratory Pressure on 
cardiopulmonary Shunt in Patients With Patent For .. en 
Ovale 
Bibiana Cujec, Petr Polasek, David Johnson. University 
of Saskatchewan, Saskatoon, Canada 
Poaitive end expiratory pressure (PEEP) is used to 
decrease high inspired oxygen concentrations (Fi02 ) in 
mechanically ventilated patients with respiratory 
failure. Patients with patent foramen ovale (PFO) may 
not improve alveolar to arterial oxygen difference (A•
a02 mmHg) or intrapulmonary shunt (Qs/Qt) with PEEP 
because of increased intracardiac right to left shunt. 
Forty-five patients ventilated with Fi02 ~ .5 and PEEP ~ 
5 em H20 had a transesophageal echocardiogram with 
diagnosis of PFO by saline contrast. Qs/Qt was meaaured 
from the arterial and central venous oxygen content 
differences while on Fi02 1.0. "denotes p < 0.05 
comparing PEEP 0 versus PEEP 10. 
A-a02 A-a02 QS/Qt Qs/Qt 
PEEP a PEEP 10 PEEP a PEEP 10 
PYO (-) 442 .:!; S9 39S.:!; 110".32 .:!; .14 .26.:!; .1S" 
PYO (+) 502 .:!; 69 507.:!; 67 .2S.:!; .OS .29 .:!; .04 
In the PFO (-) group (N=39), A-a02 and Qs/Qt decreaaed 
after addition of 10 em H20 PEEP by 45 .:!; 69 mmHg and .05 ± .06% respectively. In the PFO (+) group (N=6), A-s02 
and Qs/Qt increased after addition of 10 em H20 PEEP by 
5 ± 33 mmHg and .01 ± .03\ respectively. Moreover, Qs/Qt 
increased after applying 10 em H20 PEEP in 5 of the 6 PFO 
(+) group but only in 5 of the 39 PFO (-) group (p < 
0.01) . 
Conclusion: PFO can be found in 14% of respiratory 
failure patients and in these patients PEEP does not 
improve oxygenation. An increase in Qs/Qt after addition 
of PEEP can be attributed to PFO in 50\ (5/10) of 
patients. 
739·6 9:45 
Assessment of Transpulmonary Passage of Echo-Contrast 
Agents by Transesophageal Bchocardiograpbic Spectral 
Doppler Analysis - Differences of Contrast Agents 
Peter Nilrutta, Gunther Claus, Dirk Hausmann, Andreas Miigge, 
Jost Niedermeyer, Henning KUhn, Werner G. Daniel, Hannover 
Medical School, Hannover, Germany 
Intravenous application of echocardiograpbic (E) contrast (CON) 
agents has become an accepted tool for diagnosis of cardiac shunt 
lesions and various CON materials are in use. Little information, 
however, is available concerning the question if the commonly used 
right heart CON agents are able to partially cross the pulmonary 
capillary bed and appear in the left atrium. This question may be of 
clinical relevance in patients (pts) where a right-to-Ieft shunt has to 
be excluded. We studied 42 consecutive conscious pis without 
pulmonary diseases or atrial septal defect by ttansesophageal (TE) E 
prospectively. Spectral Doppler curves were recorded in the left 
upper pulmonary vein (LUPV) before and after i. v. administration 
of agitated saline (SAL), oxypolygeiatine (OXY) and SHU-454 
injected in a blinded sequence. Wben CON appeared in the LUPV, 
Doppler curves showed a typical signal distUJbance. Results: 
Contrast appearance in the LUPV could be documented in 19 (45%) 
pts after SAL, in 26 (62%) pts after OXY and in 13 (31 %) pts after 
SHU injection. 
Conclusion: The results document that all three most commonly 
used right heart CON agents in E at least partially cross the 
capillary bed and appear in the arterial circulation. This has to be 
taken into consideration in right-to-Ieft shunt diagnosis by non· 
imaging techniques such as transcranial Doppler ultrasound. 
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740·1 8:30 
Hirudin Reduces Reoccluslon Compared to Heparin Following 
Thrombolysis In Acute Myocardial Infarction: Results of the TIMI 5 Trial 
ChrIstopher P. Cannon, Carolyn H. Mccabe. TImothy D. Henry, Wlilam J. 
Rogers, Marc Schweiger, Robert S. Gibson, Jeffrey L Anderson, DavId O. 
Wiliams, Eugene Braunwald for the TIMI 5 Investigators, Boston MA 
Hirudin Is a direct thrombin inhibitor that has been shown In experimental 
models to enhance thrombolysis and reduce raoccIusion. The TIMI 5 Trial Is 
a randomized. operHabeI dose-ranglng trial 01 recombinant desUfalohlrudin 
(CGP-39393, 'hirudin") versus heparin given In conjunction with front-loaded 
tP A and aspirin to 214 patients with acute MI. Patients received either hirudin, 
as a boIus{B) followed by a constant infusion ~NF) at 1 014 doses (0.15 B 
[mg/kg) + O.05INF [mg/kg/h), 0.1 B + 0.1INF, 0.3 B + 0.1INF, or 0.6 B + 
0.2 INF) or heparin (5000U B + 1000U/h INF, adjusted fNery 12 hours to 
maintain an Am 01 65-90 seconds). Patients underwent angiography at 90 
mins and 18-36 hours W patent at 90 mlns. 
HEPARIN HIRUDIN 
II! Min!!!! Angil! AU 0.051NF 0.20 INF 
No. of pts 80 134 48 26 
TIMI Flow <3 41% 32% 29% 27% 
TIMI Flow 2 or 3 79% 83% 86% 88% 
11:::111 HI!l.![ Angll! 
No. of pts 60 105 37 22 
TIMI Flow <3 25% 14%+ 14% 14% 
TIMI Flow 2 or 3 93% 99%* 100% 100% 
Reocclusion 7% 1%* 0% 0% 
Reoccluslon or ST, 18% 8%+ 12% 4% 
Spontaneous 
Hemorrhage 3% 3% 1% 0% 
P<O.05, +p-O.09 companng nlrudln across all doses versus nepann 
Conclusion: In this pDot study, hirudin appears to have advantages over 
heparin as adjunctive therapy to t-PA and aspirin for the treatment 01 acute MI. 
Hirudin was effective in preventing reoccluslon without an Increase in the rate 
of spontaneous hemorrhage. Hirudin Is a promising agent in the treatment of 
acute MI and Its evaluation in larger numbers of patients Is warranted. 
740·2 8:45 
Factors Limiting Effective Heparinization Following Throm•
bolysis for Acute Myocardiallnrarction: Interim Fmdings from 
the t-PA-Heparin Duration Trial 
Frank V. Aguirre, Diane Werth, C. V. Gudipati, Wes Pedersen, 
Marc Lewen, N. Kent Wise, Mahesh Changlani, Bassam Al-Joundi, 
Michael Flynn, Trina Stonner, Morton J. Kern, Bernard Chaitrnan. 
St. Louis University, St. Louis, MO 
Recent studies have demonstrated that effective systemic hepariniza· 
tion (HEP) enhances infarct artery patency following thrombolysis 
with rt-PA. Pt characteristics associated with ineffective anticoagUla•
tion during the initial 24 hrs following rt-PA were analyzed in an 
interim analysis of the multicenter, randomized t-PA-Heparin 
Duration Trial. This trial will determine the optimal duration of 
HEP following rt-PA for acute myocardial infarction (AMI). 108 pts 
presenting $ 6 hrs of AMI received an accelerated, weight-adjusted 
dose of rt·PA ($ lOOmg) followed by 24 or 72 hrs of IV HEP 
(5,000 IU IV bolus, 1,000 IU/hr) and adjusted to maintain aPTT 
between 65·90 seconds. Mean aPT[ (seconds±SD) was determined 
at 3 time intervals: 6-S hrs (SI.4±46.9), 12-14 hrs (78.5±40.5), 24 
hrs <6S 5+ 29. 7) after study entry 
% Patients Wjth aPTT ~ 65 Seconds 
Time Interval 6-Shrs ~ ~ 
Weight <SO kg (n=45) 77.S 67.4 65.1 
Weight ~SO kg (n=63) 34.9 42.6 36.2 
P value 0001 002 o.oOS 
Age, race, smoking history, site or extent of infarction failed to 
characterize the ability to achieve effective HEP. In conclusion, 
effective HEP is difficult to achieve during the initial 24 hrs after 
AMI, especially in heavier weight (~SOkg) pts. The data suggest 
that weight-adjusted heparin dosing may be required following 
thrombolysis for AMI. 
JACC Vol. 21, No.2 
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Is Endogenous Fibrinolysis I.paired In Acute Coronary 
Syndromes? 
Mark K. Urman, Prediman K. Shah. Cedars· Sinai Medical 
Center and UCLA School of Medicine, Los Angeles, CA. 
Acute coronary syndromes of unstable angina (UA) and 
acute myocardial infarction (AMI) result from plaque 
fissure followed by coronary thrombosis which tends 
to be transiently occlusive in UA and persistently 
occlusive in AMI. To determine whether impaired 
endogenous fibrinolysis plays a role in 
predisposition to persistent coronary occlusion, 99 
patients with coronary artery disease were studied. 
Circulating level of the rapid inhibitor of 
endogenous tissue plasminogen activator, plasminogen 
activator inhibitor·I (PAl), was measured using a 
sensitive and specific assay. Results are (mean ± 
standard deviation). 
Stable Unstable 
N .... ~ ~ 
PA1-I(u/ml).. 11.2±8.5 12.3±8.7 





The patients in the three groups were comparable with 
respect to age and gender. Conclusion: PAI-I levels 
are significantly higher in AMI compared to pts with 
stable and unstable angina suggesting that impaired 
fibrinolysis may contribute to persistently occlusive 
coronary thrombosis in AMI. 
740·4 9:15 
Comparison of the Effectiveness of Intravenous Heparin, 
Intravenous rt·PA, and Intracoronary Urokinase for Treatment 
of Intracoronary Thrombus 
George R. McKendall, Mark S. Bennan, Barry L. Sharaf, Brent Lee, 
David O. Williams. Rhode Island Hospital, Brown University, 
Providence, RI 
Although intracoronary thrombus (lCT) is a frequent fmding in 
patients with unstable coronary syndromes, little data exist regarding 
its optimal management To compare the effectiveness of three 
current therapies for ICf we evaluated 38 consecutive patients (pts) 
who received jntrayenous (IV) heparin (11 pts, over an average of 
5.3 days), or IY n-PA followed by heparin (18 pts, average dose 72 
mg), or jntracoronary urokinase (9 pts, IC UK, average dose 642,850 
units). Response to therapy was judged according to an angiographic 
thrombus score (TS), flow grade (FO) and stenosis severity and 
graded as full, partial, none, or worse. 
Response Heparin n-PA ICUK 
0=11 0-18 0=2 
Full 1(9.1%) 12 (66.7%) 1(11.1%) 
Partial 3 (27.3%) 3 (16.7%) 5 (55.6%) 
None 4 (36.4%) 2(11.1%) 2 (22.2%) 
Worse 3 (27.3%) 1 (5.6%) 1 (11.1%) 
Improvement was more commonly observed among patients treated 
with either IV rt-PA or IC UK, although full improvement was 
essentially limited to those treated with n-PA(p<.05). Average 
stenosis severity decreased by 7.0% with n-PA but increased with 
both heparin (3.9%) and IC UK (4.4%) (p= .08). We conclude that of 
the treatments studied, IV n-PA and IC UK appear superior to 
heparin for eliminating ICT and more complete thrombolysis may be 
achieved by IV n-PA. 
ABSTRACTS 
740·5 9:30 
Suboptimal RespoDse To Flud Dose Subcutaneous He""riD Aller 
Thrombolytic Therapy 
Nigel J Trudgill, Andonis G Violaris, Linda Rowlands, Julian Gunn, Stephen 
Campbell. Cardiology Department, Northern General Hospital, Sheffield, UK 
The large thrombolytic trials have allocated patients to fIXed dose 
subcutaneous (sc) heparin with no monitoring of coagulation parameters. We 
hypothesized that heparin's apparent lack of benefit and increased 
baemorrhagic complications in these trials may be the result of inappropriate 
anticoagulation. 
Anticoagulation parameters (AP1T and Heparin levels) were measured six 
hourly OD 10 AMI patients treated with streptokinase (SK) and subsequently 
sc heparin (l2,SOOu bd, at Bam and 8pm). Samples were taken on da)~ 1.4,5, 
and 6 after SK There was marked variation in both AP1T and heparin levels. 
A representative period (day 4) is shown below with the therapeutic range 
(APTf 65·112, heparin 0.3-0.7) delineated by dashed lines. 
The results indicate marked individual variation in response to the currently 
advocated dose of heparin, with many patients inadequately anticoagulated 
and an Ob\10US diurnal variation. This has important implications when 
considering the benefits and haemorrhagic complications from fIXed dose sc 
heparin therapy following thrombolysis. 
740·6 9:45 
137A 
Thrombin InhIbition Is More Closely Related to FIT than to Heparin 
Level after Thrombolysis and Heparin Therapy 
Edwin G. Bovill, Christopher B. Granger, Allan Ross, Costas Lambrew, 
Richard Becker, Gordon Keeler, Russell P. Tracy. University of Vermont, 
BurlingtOn, VT 
In the GUSTO Trial, patients with acute myocardial infarction are being 
randomized to one of four arms: streptokinase (SK), acceIer-ated t-PA, or 
t-PA + SK, each with intravenous (IV) heparin or SK with subcutaneous 
heparin. IV heparin is dosed at 5,000 units (u) bolus, then 1,000 ulhour 
and adjusted to keep the P'IT 60-85 seconds. In order to determine the 
correlation of thrombin inhibition to the heparin level and P'IT, blood was 
sampled from 63 patients at 5 centers into two different anticoagulants 
(3.8% Na Citrate and EDTAlPPACKlAprotinin) at 12 and 24 hrs after 
thrombolytic therapy. These blood samples were assayed for P'IT, heparin 
level (anti-Xa) and the concentration of the prothrombin derived activation 
peptide, Fragment 1.2 (F1.2), as a measure of In vivo thrombin fonnation. 
At 24 hours, the heparin level was below the "therapeutic· range of 0.2~.4 
u1ml in 47% of patients. P'IT correlated better with heparin level at 24 
hours (r=0.79) than at 12 hours (r=0.62). The correlations (r) of F1.2 to 
P'IT and heparin levels were: 
P'IT 
Heparin level 








Thus, in the first day after thrombolytic therapy, thrombin inhibition, as 
reflected in F1.2 levels, appears to be more closely associated with PTT 
than with heparin level, perhaps in part, due to the proteolytic effects of the 
fibrinolytic state on the hemostatic system. The P'IT, rather than heparin 
dose or level, may be a more imponant indicator of thrombin inhibition 
during the first 12-24 hrs following thrombolytic therapy. 
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877·22 
Ten Year FoUowup or Patients Undergoing Coronary AngIoplasty In 
the Year 1981 
Wi1liam S. Weintraub, Spencer B. King III, John S. Douglas Jr. Emory 
University School of Medicine, Atlanta GA 
Long term outcome in the 41:1 patients undergoing PTCA ill 1981 was 
evaluated. Age was 54:!: 10, TT% were male, 5.6% bad diabetes, 30% 
hypertension, 46% class m·IV angina. 22% previous myocardial infarction, 
1.2% congestive failure, 11.5% multivcssel coronary disease, and ejection 
fraction 65:!: 9. The proximal left anterior descending was dilated in 63%. 
Diameter stenosis before PTCA was 72:1:15 and 33±21 post PTCA. There 
were no in·hospital deaths, 2.1% 0 wave myocardial infarction and 10.3% 
emergent coronary surgery. 10 year foDowup is 90% complete. Multivariate 
determinants of 10 year survival were older age « 60 years !17 ± .01 V5 ~ 
.8l:!:.O6, p<.OOl) and vessels diseased (1 vessel .92:!:.01 V5 multivcssel 
.81:!:.06, pE.OO4). Angina was present in 24% 10 years. FoDowup events on 
left (from top 1: Survival, 2: Ml frcc Survival, 3: Mland CABG frcc survival, 
4: MI, CABG and PTCA frcc survival) and on right survival by age (from 
top 1: < 60, 2: ~): 
1 r:::::::::====::::l 
0.8 :=:--~ 0.9 0.6 Freedonr • 0.8 
0.4 From 0.7 Events 
0.2 0.6 
0 0.5 
0 2 4 6 8 10 o 2 4 6 8 10 
Cardiac events continued to occur throughout the followup period, despite 
mostly 1 vessel disease patients. Over time age and severity of disease are 
more important risk factors for death than details of the angioplasty 
procedure. 
877·23 
MuItivessel Coronary Angioplasty: Five- to Ten·year Follow·up 
Claude Le Feuvre, Raoul Bonan, Jacques Lesperance, 
Jacques Crepeau, Gilles C6t6, Pierre de Guise. Montreal Heart 
Institute, Montreal, Quebec, Canada 
Among 1937 patients (pts) undergoing coronary angioplasty (PTCA) 
until 1986, 203 (10.4%) underwent multivessel angioplasty during a 
single procedure, defined as PTCA of 2 or 3 of the 3 major coronary 
arteries. Primary success was obtained in 449 (91 %) of 494 
attempted segments. Myocardial infarction occurred in 13 pts 
(6.4%), non-Q in 8, without in-hospital death. Urgent coronary 
artery bypass surgery (CAB G) was needed in 3 (1.4%). 
Follow-up (FU) was obtained in 195 pts (96%). Pre-PTCA, 126 pts 
(62%) were in class ill or IV of CCS and after 71 ±23 months, 62% 
were angina free and 22 % were in class I. Death occurred in 14 pts 
and non-fatal myocardial infarction in 18. Restenosis (R) was 
diagnosed in 96 pts (60%) and in 37% of dilated lesions. Repeated 
revascularization procedures for R and/or disease progression were 
performed in 92 pts (47%) during FU. The event-free survival rates 
at 7 years in terms of freedom from CABG, rePTCA, or both, were 
81 %, 71 %, and 53% respectively. Survival rate and cardiac event· 
free survival at 7 years were 91 % and 85 % respectively. Baseline 
ejection fraction is the only independent predictor of cardiac death 
(p<O.OOI) and the number of baseline insignificant coronary lesions 
( < 50 %) in non-dilated sites is the only independent predictor of a 
second revascularization for disease progression (p < 0.02). 
Single-procedure multivessel angioplasty can be a safe and effective 
initial therapy in selected pts with multi vessel disease with favorable 
long-term outcome. 
877·24 
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Outcome and Complications 01 500 Consecutive Chronic 
Total Occlusion Coronary Angloplastles 
Emmanuel Haine, Philip Urban, Pierre·Andre Dorsaz, Bemhard Meier. 
Cardiology Center, University Hospital, Geneva, Switzerland 
In 500 consecutive angioplasty procedures for chronic (>24 hours) total 
coronary occlusion, the angiographic success rate was 70%, with a 
residual stenosis of 24±10%. A total of 17 patients (3%) experienced one 
or more of the following events: Q·wave infarcts (5/1%), emergent bypass 
surgery (5/1%). or death (10/2%). 
01 the 5 Q·wave infarcts, none was due to a reocclusion of the recanafized 
segment but 3 were related to the revascularization attempt (1 left main 
stem dissection. 2 sidebranch occlusions). The other 2 were related to 
additional Sites in multivessel procedures. Of the 5 emergent bypass 
operations, 2 were needed for left main dissection, 2 for extensive 
dissection distal to the recanalized site, and 1 for aortic dissection. No 
death was due to a reocclusion at the recanalized Site since 4 occurred in 
patients with preexisting cardiogenic shock, 2 patients died from left main 
dissection, 2 cardiac deaths without prexisting shock were sudden and 
occurred in patients with multivessel procedure, 1 patient died from an 
anaphylactoid reaction to a protamine bolus, andl from septicemia. 
In addition, 16 patients (3%) presented a minor creatine kinase elevation 
(mean peak value < 2x normal) related to sidebranch loss (6), distal 
dissection severing collateral inflow (5), isoembolization (3). and acute 
occlusion in multivessel procedures (2). Predictive factors of 
complications were: unstable symptoms (58% vs 31%'), recent 
incomplete infarct (18% vs 6%'). multivessel procedure (9% vs 2%'), 
intraluminal thrombus (25% vs 7%") and sidebranch involvement (18% vs 
3% '). Predictive factors of success were: mean symptom duration (days) 
(12 vs 31")' mean occlusion duration (days) (11 vs 21'). unstable 
symptoms (40% vs 26%,,) and l·vessel disease (69% vs 47%'). The 
major in·hospital benefit of successful recanalization was a reduced need 
for bypass surgery (0.3% vs 15% in case of failed procedure"') with a 
98% uneventful in·hospital course (vs 80% in case of failure"). 
We conclude that angioplasty for chronic total coronary occlusion is a 
valuable and relatively safe technique for nonsurgical revascularization. 
Major complications occur but are not due to a reocclusion at the 
recanalized Site. ' p< 0.05, .. p< 0.025, "'p<0.01 
877·25 
c.:.parbon of HellUlta and Late Follow-up of PTCA in 
Patienta with varying Riak .. actor a 
Thomas M, Shimshak, Lee v. Giorgi, Warren L. Johnson, 
David R. McCOnahay, Barry D. Rutherford, Robert w. 
Ligon, Geoffrey o. Hart&ler. Mid America Heart 
Inatitute, IAnaaa City, MO 
We have previoualy identified an increased PTCA 
complication rate associated with age > 70 yrs, left 
ventricular ejection fraction < 40\, three vessel CAD 
and unatable angina. Betwee~ 1980 and 12/91 we 
performed 11,663 PTCAa including 3486 procedureB in 
pta with no riak factora (29.9\), 8002 with 1,2 or 3 
riak factora (60.6') and 175 (1.5') in pta with 4 risk 
factora. compariaon of the procedural results, 
complications and long-term follow-up are summarized 
below. 'Riak Factor a 






Mean t~ (mos) 
MI (\) 




95 95 94 
0.9 1.5 2.0 
1.4 1.5 1.7 
.1l 1,14 10,9 
56.8 47.7 24.5 
7.3 10.1 9.4 
13.8 7.7 6.2 




1-yr (') 98,3 93.6 62.1 <.0001 
5-yr (') 93.7 82.4 35.0 <.0001 
Concluaiona: 1) PSR waB high for all 3 groups; 2) The 
"high riak" group had higher procedural MI and 
mortality; 3) rePTCA and CABG were frequently 
required; 4) survival at 1 and 5 yrs was significantly 
better in the low and intermediate risk groups. 
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877-26 
COMPARISON 0 .. OUTCOME 0.. PTCA lUfI) COROllARY SURGERY FOR 
LESIONS 0 .. TIlE LEFT AllTERIOR DESCBNDINQ COROllARY AltftRY 
James Cameron, Nithi Mahanonda, COn Aroney, John Hayes, 
Paul McEniery, Michael Gardner, JH Nicholas Bett. 
Prince Charles Hospital, Brisbane, Australia 
We compared outcome for 389 consecutive patients (pts) 
undergoing initial revascularization for lesions of the 
Left Anterior Descending Coronary Artery (LAO) by 
either PTCA (n-275) or CA8G (n-114) from 1987 to 1989 
inclusive. PTCA and CABG pts were similar in age (54.4 
yrs VB 55.7 yrs), aex, risk factor profile, anginal 
class (Canadian Class 3.1 vs 3.2), prior MI, lesion 
morphology, 1e.ion site ie proximal vs mid/distal, and 
left ventricular ejection fraction (65.4\ vs 62.2\). 
CABG pts underwent Left Internal Mammary Artery graft 
in 98 pts (86\). PTCA had primary success in 93\, and 
was complicated by MI in 4\ and urgent CABG in 2.5\. 
Follow-up data (99\ complete) was obtained at a mean 
3.0 years (range 1.5-5.2 years) post procedure by 
survey, including York Quality of Life Questionnaire. 
Endpoints were mortality (early= <1 month IEl;late= 
>1month ILl), myocardial infarction (MI), recurrent 
chest pain (RECURR.CP), repeat revaacularization 
procedure either PTCA or CABG (RPT.REVASC), and quality 
of life index score (Rosser Index score) (QUAL.INDEX). 
RESULTS: PTCA (n"'275) CABG (n=114) p value 
MORTALITY IEl 0 (0\) 1 (0.9\) p=ns 
MORTALITY ILl 6 (2.2\) 4 (3.5\) p=ns 
MI 14 (5.1%) 2 (1.6\) p=ns 
RECURR.CP 110 (40\) 13 (11.4\) p<0.0001 
RPT.REVASC 92 (33.5\) 1 (0.9\) p<0.0001 
QUAL. INDEX 0.98/1.00 0.98/1.00 p=ns 
CONCLUSION: Both procedures result in excellent 
survival and quality of life for pts undergoing 
revascularization for LAD lesions, but PTCA pta require 
more frequent repeat revascularization to achieve this. 
877-27 
Short and Long Term Outcome of PTeA ., 




Hideo Tarnai, Kinzo Ueda, Yung-sheng Hsu, Seiichiro Motohara, 
Hiromu Uehata. Shiga Medicai Center for Adult Diseases, Moriyama, 
Japan 
In order to determine the outcome of PTCA to unprotected left main 
coronary artery, we reviewed our experience. 01 25 patients(pts) 
undergoing angioplasty, the mean age was 67±12, 76% were male, 
12% were acute myocardial infarction(AMI). 36% were age~75, 20% 
had LVEF<40%, 16% were after CABG. Totally 44 PTCAs were 
done including repeat PTeAs for restenosis and mean percent 
narrowing was 72 :t12% Conventional balloon dilatation was done in 
21 procedures. autopArf:Jsion balloon was used in 11 procedures, 
pumr., assis!ed coronary hE-moperiusion was done in 12 procadurt-s 
and ;ntfaao,1ic b.1!IOfln pumping was usea in 2.7 procedures. Follow•
liP angiography was done 2 and 4 mos. following PTeA. Mean 
follow-up duration was 28 mos.(3-72). PTCA success was defined 
as more 'har. 20% dec:rea$C in % narrowing and less than 50% 
residual stenosis witnout major cornplicatior. and restenosis was 
definad as a 50% loss of gain achieved by angioplasty. 1) Short 
term: Initial success rate was 95%, monalny was 4%, AMI was 4% 
and there was no emergency CABG. Mean residual stenosis was 
27 ±15%. 2) Long term: Restenosis occured in 46%, AMI was 
4% and re-PTCA was procedured in 11 pts. There was no late 
death and CABG. All events occured within 6 mos. after PTCA. 
Conclusion: 1) Initial success rate of PTeA to unprotected left main 
coronary artery is very high, 2) majol complications are !are and 




Initial am I.alg-TeIIII Fol.lcw-up in Patients 'l'leated 
with BieIget£y cardiopl1111'1'!1!ry Bypass: 'Dle Natialal. 
Registry Experience 
Paul A. OVerlie, Robert A. Vogel, Fayaz A. Shawl, 
William W_ O'Neill, Michael R. Mooney, Sidney C. Slnith, 
Jr., Simoo Stertzer Methodist/St. Mary Hospitals, 
Lul::bock, Texas 
238 coosecutive patients (pts) have been treated with 
emergency cardiopulJronary bypass (CPa) since 1986. 
Diagnoses included acute MI with arrest (n=61), P'It:A 
failure with arrest (n=62), cardiogenic shock unrespon•
sive to pressors (n=57), post oorooary bypass arrest 
(n=8), pu1mnary emboli (n=10) am other (n=40). 
198/238 (83%) pts survived initially; 81/238 (34%) pts 
survived an:j were discharged :improved. 
Follow-up data are available on 56 of the 81 survivors 
(69%) for 1-56 mooths (average 28_4 mooths)_ '!his 
daronstrates 98% 1 year survivors (n=47), 96% 2 year 
survivors (n=46) an:j 95% 3 year survivors (n=45). 
'!he remaining 8 survivors have been treated within the 
past year. filly 3/56 (5%) patients expired. 
In pts where flow on CPB was established in <20 minutes, 
81/169 (48%) survived, discharged improved. 46 of the 
81 (57%) were treated with emergency cardiac surgery. 
Long tenn survivors by category included 9 post MI 
arrest (17%), 14 P'It:A failures with arrest (26%), 
26 cardiogenic shock (49%), 1 pu1mnary embolus (2%), 
an:j 3 other (6%). 3 pts expired •. 
Emergency CPB in pts with hanodynamic collapse allows 
imnediate an:j loog-tenn survival. Results have improved 
with increased experience. 
877-29 
'Tandem Lesion' Coronary Angioplasty: Acute and Long-Term 
Results 
Kim H. Tan, Alfred N. Sulke, Elizabeth Watts, Sheila Karani and 
Edgar Sowton. Guy's Hospital, London, United Kingdom 
Little data is available regarding the acute success, complication rates 
and long-tenn follow-up of tandem lesion PTCA. This study evaluates 
the outcome of 102 consecutive patients (mean age 54 years, 78% men) 
who underwent tandem lesion PTCA of the left anterior descending 
artery (204 lesions) between 1981 and 1991. Patients with prior CABG, 
PTCA or disease in other vessels were excluded. Twenty-six patients . 
(25.5%) had a previous MI and 19 patients (18.6%) had an ejection 
fraction of <45%. Sixty-eight patients (66.7%) suffered grade IIIIIV 
angina before the procedure. PTCA was done as an emergency for 
unstable angina in 11 patients (10.8%). Primary angiographic success 
was achieved for both tandem lesions in 96 patients (94.1 %) and 195 
lesions (95.6%). Only the proximal lesion was dilated in three patients. 
Clinical success was achieved in 91 patients (89.2%). A significant, 
complication occurred in 5 patients (4.9%). All had a non-fatal Q-wave 
MI. There were no procedural deaths. The median duration of follow-up! 
was 46±32 months ranging up to 122 months. During the follow-up 
period, two patients died due to fatal Ml and two suffered non-fatal MI. i 
Eighteen patients required a second revascularization procedure; 7 had a ' 
repeat PTCA, 6 underwent elective CABG and 5 underwent both PTCA 
and CABG. The cumulative probability of survival for all 102 patients 
was 98.8% (SE 1.2%) and 97.5% (SE 1.7%) at one and five years, 
respectively. The cumulative event free survival rates (freedom from 
death, MI, CABG and PTCA) at 1 and 5 years were 79_2% (SE 4.9%) 
and 72.1 % (SE 6.7%) respectively. At census, of the 100 survivors, 62 
patients were asymptomatic and only 7 suffered grade IIIIIV angina 
(p < 0.001). Conclusion: Tandem lesion PTCA of the LAD artery can 
be performed with a high primary success rate, low incidence of 
complication and excellent long-term outcome. 
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877·30 
ChlractM'latlon of Angllll Type Prldlctl Clinical RetpOn .. to PTCA 
Maher M. Rabah. Mark Freed. Staven C. Ajlunl. Cindy L Grlnes. 'Wlllam W. 
O·Nell. Milam Beaumont HoapItaI. Royal Oak. Michigan 
Patients pr_ntlng with typical angina. atypical angina. or noncardlac chest 
pain (CP) have been reported to have significant coronary disease In 
approximately 90%. 50%. and 15%. respectively. It Is uncertain whether the 
lesIon(s) Identlllad by angiography are directly responsible for the pt's 
symptoms ~ CP. or a coincidental finding. It Is also uncertain whether the 
type ~ balloon Inflation pain (SIP) during PTCA or tha character ~ CP on 
initial avaIuallon has any predictive value for restenosIs. In a group ~ 297 
patients Undergoing PTCA ~ a 'presumed' culprit lesion. we characterized 
BIP and compared tt with their presenting symptoms. 
Pr_ntlng 
symptoms 
typical (n = 215) 










Phone follow-up at 6 months demonstrated InttlaJ symptomatic Improvement 
post PTCA In 187/215 (87%) 01 pIS wtth typical angina versus 33/82 (46%) 
~ pta with atypical angina (p < 0.0001). Saventy-elghl pIS had recath for 
recurrent symptoms and restenosis was pr_nt In 49. Among pts who 
und_ent cath for recurrent symptoms. no differences In restenosls rates 
were observed In pts with BIP similar and dlsslmlar to recurrent symptoms 
(68% VS 54%. P = NS). 01 pts having recurrent symptoms similar to their 
InttlaJ angina. restenosls occurred In 47/65 (72%) versus 2/11 (18%) In pts 
presenting with symptoms different than their InttlaJ angina (p < 0.0001). The 
sensttlvtty and speclflctty for restenosls In pts pr_ntlng wtth recurrent typical 
angina Is 97% and 61 %. respectively with an overall predictive accuracy of 
74%. Conclullons: 1) In pta with atypical CPo the likelihood 01 a 'presumed' 
culprit lesion being responsible for a pt's presenting complaint Is low and 
symptomatic Improvement post PTCA occurs Infrequently; 2) Recurrent 
symptoms typical 01 angina are highly sensttlve for restenosls; howaver. 
further characterization 01 the pain which occurs during balloon Inflation 
appears to be of limited value. 
877·31 
The Influence of Chest 'afn Seyerity on Late Reperfusion 
Benefft Durfng Acute ~ocardfal Infarctfon 
Timothy F. Christian, Raymond J. Gibbons, Jack Daley, 
David R. Holmes, Jr., Bernard J. Gersh. Mayo Clinic, 
Rochester, Minnesota 
The purpose of this study was to determine if patients 
with severe chest pain (SEV CP) have a better response 
to late reperfusion (> 6 hrs) compared to those without 
SEV CPo Sixty-nine patients with acute myocardial in•
farction underwent direct PTCA (48 < 6 hrs, 21 > 6 hrs). 
All patients had ST elevation at PTCA. Chest paTn was 
graded 0 (none) to 3 (severe) prior to PTCA. Tc-99m-ses•
tamiDi was injected prior to PTCA to determine area at 
risk (AAR), and again at diScharge (infarct size) with 
tomographic imaging performed 1-6 hrs later. Perfusion 
defect size was quantitated using previously described 
techniques and expressed as a % of the LV (AAR=35 t 20% 
LV, infarct size=17 t 17% LV). Salvage index, (the 
proportion of area at risk salvaged) was calculated by 
(AAR-infarct size)/AAR and varied by CP SEV in those 
with late PTCA 
C.P. < 6 hrs (n) > 6 hrs (n) p 
Nonsevere (0-2) 0.62 ± 0.35(37) ~3E t 0.29(14) n:nJ 
Severe (3) 0.62 t 0.39(11) 0.63 t 0.30(7) NS 
CP SEV was an independent determinant of infarct size 
after adjustment for AAR in patients with PTCA > 6 hrs 
(p=0.04) but not < 6 hrs (p=0.35). -
Conclusion: 1) Patients with severe chest pain and ST 
elevation who present after 6 hours from CP onset have a 
greater benefit from reperfusion therapy than those with 
mild or moderate symptoms who present late. 2) The 
reduced but measurable salvage that occurred in patients 
presenting> 6 hrs without severe chest pain suggests 
that other factors may also determine benefit in late 
therapy. 
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P.rcutaneous C.rdlopulmonary Bypa •• Support.d Coron.ry 
Anglopla.ty In S.vlr.ly D.pr .... d L.ft V.ntricullr Function. 
FIyaz A. Shawl. Sandeep Bajaj. Michlel J. Domanski. Sus.n Hoff. 
InterventJonal C.rdiology. Washington AdventJst Hospital. Takoma 
Park. Maryland 
New onset Ischemia from coronary di .... e In a .. oclatlon wlth .e•
verely depres .. d left ventricular function results In high mortality. 
Few reports exist on coron.ry englopllaty (CA) or lurgical rlv •• • 
cularizatJon (CVGI in patlenta (ptsl with left ventricular ejection 
fraction (LVEFI sO.25. Historically. ICuta results have been poor 
with both forms of therapy. Percutaneous cardiopulmonary support 
(PCPSI .1I0ws dilations of multiple crltlc.1 lesions without hemody•
namic collapse. We report data on 103 consecutive pts (91 males. 
mean age 68:1:9 yrs (range 44-871 with LVEF sO.25 who under•
went PCPS-CA between 1988 and 1991. Atty-nine (57%1 pts 
were in functional class IV Ind 44 (43%1 pta were in class III; 72 
(70%1 pts had unstable angina; 48 (46%1 pts ware declared Inop•
.rable; 99 (96%1 pta had 3 vessel diaea .. (VOl. Eighteen (17%1 
pts had previous CVG and 57 (55%1 pts had only 1 patent vessel 
(PVI including 7 grafts. Mean LVEF waaI9.5:1:3.5 (range 11·251. 
A total of 224 lesions in 195 vessels were attempted with proce•
dural success In 101 (98%1 pts. Asystole occurred in 4 pts during 
the procedure. Mean PCPS tim. wa, 47:1:20 minutes (range 13-
120 minI. Major complications occurred In 3 pts (2 deaths. 1 Mil 
and 6 pts died prior to discharge (3 congestive heart failure (CHFI. 
2 arrhythmias (ARI]. Out of 95 survivors follow·up Is available in 
84 over a period of mean 23:1: 13 months. Clinical recurrence oc•
curred in 20 (23%1 pts of which 14 (17%1 had restenosis and 6 
(7%1 had new lesions. These were treated with PCPS-CA in 12 
pts & CVG in 4 pts. of which 2 died post-operativelv. To date. 
24 pts have died (3 from non-cardiac causes. 4 from CHF. 3 acute 
MI. 4 AR. and 10 suddenl. and 16 of 24 (75%1 pts who died had 
only 1 PV. Survival at 36 months was 61%. 43 (71%) pts are in 
functional class I and 16 (26%) pts are In class II. Thus. PCPS-CA 
is a viable revascularization option in the treatment of this subgroup. 
877·33 
PTCA in Patients with Severely Depressed Ventricular Func:tion 
Klaus Rey=!' Bcmhard KuDkcl, Sicgbcrt HaetiDger, Rolf GIIISSCl, Kurt 
Bachmann 
Department of IDtcmaI Mcdicinc n, UDiversity of ErlaDgen, Federal Republic 
ofGcrmany 
Amoag ncarly 2000 COIIICCUtM YfCA-paticDlS 42 (36 m, 6 f; mean age 60 .1. 11 
,an) had cjcctioa fradioas ~35% (mean 30.1.5%). 34 paticDlS (pts) suffered 
&<.a IIIIStabic and 8 from stable ...gina. All had previous myocardial infardioa 
ad of these 23 had recent myocardial infarction. 4 had prior coroowy bypass 
IIIfFl'Y and 1 had UDdcrgODC ucury&mcctomy. 31 of 42 (. 74%) pta had 
aultJpJc vesscI disease (stcllOlC& > 50%). 
Successful proczdure was achieved in 35 of 42 pis (. 83%). The \csion-rdatcd 
_ rate of YfCA was 89%, of recanaJi7!!rio1l 60%. 6 proczdurea -.e 
aultJpJc \'CSSe1 YfCA. Major complicariOIlS OCCUlTed in 2 of 42 pis (1 
ayocardial infarction, 1 emergency bypass operation). The in-hospital mortality 
_2,4%. 
Follow-up angiography was performed in 22 pIS and showed re&teno6el in 9 
cuca. All pis underwent repeat c:oronary angioplasty, of these 1 pt had 
poItproczdural myocardial infarction. The ejection fractioD had meaawlailc 
IigDiIicantIy improwd from 29.1.5% to 36.1.7%. 
CiaicaI follow-up after 19.±,1S moaths (2-53 mo.) _ available in 39 of 40 JIll, 
wIao were discharged from hospital without major complicatiollS. 29 pta were 
free of ugina or anginal class n, 1 had • late cardiac: transplant. 5 pis had died 
rI. _diac: and 1 of DODC8l'diac: causes. 
nu.. YfCA in paticnt5 with IC\'Cfcly depressed ventricular function &bows 
acceptable KUIc results which are comparable to those of routine angioplasty, 
aitiptioo of left ~ dysfunction and continued symptomatic 
improvement can be ac:hicved. However the late outc:ome is significantly 'MlI'IC 
thu in patieDts with normal \cIt ventricular function. 
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878·8 
De EIectrophysiologic meets of Preoperative Amiodaroae After 
Cardiac 1'raDspIautation 
Christopher D. Scott, John H. Dark, Janet M. McComb. Freeman Hospital, 
Newcastle upon TyDc, United Kingdom. 
The unusually large volume of distribution and long elimination half life of 
amiodarone result in persistence of its effects 1011& lifter discontinuation of 
therapy. Preoperative amiodarone therapy may therefore affect the 
transplanted human heart. The e1ectropbysiologic effects of amiodarone 
were examined in S transplant recipients who bad received the drug 
preoperatively. 13 recipients who did not receive amiodarone were studied 
as controls. Each underwent seria1 e1ectropbysiologic studies at 1,2,3,6 and 
12 weeks lifter transplantation. The spontaneous cycle length (SCL) , 
corrected maximal sinus node recovery time (CSNRT) and longest atrial 
pacing cycle \ength resulting in Wenckebach AV block (WCL) were 
measured usinC standard techniques. 
Results: 3 recipients were not in sinus rlIythm at week I, none had received 
amiodarone. They ue not included in the analyses of sinus node function. 
SCL (ms) Week 1 2 3 6 12 
No amiodarone 749± 12S 720±68 710±6S 694±10S 687±97 
Amiodarone 849±100 831±74 818±129 856±101 782±107 
Significance p=NS p=O.OI p=O.04 p=0.02 p=NS 
SNRT (msec): 
No amiodarone 296±64 
Amiodarone 366±SO 
Significance p = NS 
WCL (msec) 
No amiodarone 393 ±46 
Amiodarone S02±134 



















Conclusion: These results ue consistent with redistribution of amiodarone 
from extracardiac stores to the transplanted heart. Between 2 and 6 weeks 
lifter transplantation sinus and A V node function ue significantly depressed 
in recipients who received amiodarone when compiled with controls. 
878·9 
Increase in Cyclosporine Levels due to Amiodarone Therapy after Heart 
.... d Heart-Lung Transplantation 
Jun Egami, Paul A Mullins, Filipo Mamprin, A Chauhan, Stephen R 
Large, J Wallwork, Peter M Schofield. Transplant Unit, Papworth 
Hospital, Cambridge, United Kingdom. 
Rapid atrial flutter and fibrillation may cause significant problems after 
heart and heart-lung transplantation. They may be often refractory to 
Digoxin or Verapamil therapy. Amiodarone is a Class III anti•
arrhythmic drug with negligible negative inotropic effects which may 
be used in this situation. From September 1989 to 31 May 1992 we 
treated 11 patients (8 patients heart transplantation, 3 patients heart•
lung transplantation) who had resistant atrial tachycardia were treated 
by oral Amiodarone hydrochloride therapy. Ten patients had atrial 
flutter with or without atrial fibrillation and one heart transplant patient 
had atrial fibrillation alone. In all patients, following the institution of 
Amiodarone therapy, the level of Cyclosporine increased within a 
week. Despite the reduction in dose of Cyclosporine during this 
period, the serum creatinine and blood urea level rose significantly. 
(cyc-cyclosporine) 
Before After p Value 
Amiodarone Amiodarone 
Cyc level 440 ± 161 480 ± 192 n.s. 
Cyc dose/day 572 ± 201 491 ± 193 < 0.04 
Cyc dose/kg/day 8.5 ± 4.1 7.4 ± 4.6 < 0.04 
BUN mmol/I 13.6 ± 3.6 17.7 ± 6.5 < 0.03 
Serum creatinine 157 ± 28 216 ± 153 < 0.04 
pmol/I 
Conclusion: Close vigilance and a reduction in the dose of 
Cyclosporine is necessary to keep nephrotoxicity to a minimum when 
used in conjunction with Amiodarone. 
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878·10 
Effects of Pravastatin for Hypercholesterolemia in Cardiac 
Transplant Recipients 
Jon A Kobashigawa, Erica D. Brownfield, Lynne W. Stevenson, 
Michael P. Gleeson, Jaime D. Moriguchi, Nobuyuki Kawata, 
Michele A Hamilton, Antoine S. Hage, Roxella Minkley, Johanna 
Salamandra, Shelly Ruzevich, Davis C. Drinkwater, Hillel Laks. 
UClA Medical Center, Los Angeles, CA 
The use of pravastatin, a new hydrophilic HMG-CoA reductase 
inhibitor to lower cholesterol (Chol) after cardiac transplantation 
has been limited by concern for side effects such as the rhabdo•
myolysis reported in cardiac transplant patients receiving the lipo•
philic HMG·CoA reductase inhibitor, lovastatin. To determine the 
safety and efficacy of pravastatin after cardiac transplantation, 44 
patients with Chol > 200 mg/dl were immediately treated with 20 
mgt day pravastatin for 3 mos. 
Mean Total LDL HDL 
Chol (m&/dl) ChQl ChQl 
Baseline 281 ±. 45 169 ±. 37 54 ±. 16 
Pravastatin -230 ±. 52 -138 ±. 31 45 ±. 10 
(3 mos) -p <0.05 
CPK 
am 
93 ±. 70 
99 ±. 70 
Total and LDL Chol were both lowered by 18% at 3 mos without 
CPK elevation. HDL Chol at 3 mos was lower but not statistically 
significant. Triglycerides were unchanged (213 ±. 98 mg/dl 
baseline to 213 ±. 123 mg/dl at 3 mos). Eight patients have had 
pravastatin dose increased to 40 mg/day with further Chol 
lowering and without CPK elevation. 
Conclusion: Pravastatin at 20 and 40 mg/day appears effective 
and safe to treat hypercholesterolemia in cardiac transplant 
patients. 
878·11 
Enbanced Glucose Metabolism in Non.rejecting Cardiac 
Transplants Assessed by Positron Emission Tomograpby • 
Eldad Rechayia, Ranil de Silva. Luis I Araujo. Sudhir S Kushwaha, Terry 
Jones, Attilio Maseri and Magdi H Yacoub. MRC Cyclotron and Cardio•
vascular Units, Hammersmith Hospital and Harefield Hospital. London, U.K. 
To assess the relationship between cardiac perfusion. metabolism and work 
after bean transplantation, resting 18FDG uptake rate (FOGU. s-I) and regional 
myocardia! blood flow (rMBF, m!.min,l.g.l) were measured in 10 non-rejecting 
orthotopic cardiac transplants (Tx) with angiographically nonnal coronary 
arteries and 5 bealthy male volunteers (NY) using PET imaging. AU subjects 
were studied after an overnight fast. The scanning protocol comprised a 
transmission scan (tissue density), C1S0 (blood pool), H2 1S0 (rMBF) and 
18FDG (FDGU) emission scans. Images of extravascular tissue density were 
produced by subtracting the blood pool from the transmission scan after 
nonnalization of the 1arter for tissue density as reponed previously. These 
images of cardiac anatomy were used to position tissue regions of interest 
(ROIs) in the anterior, lateral, inferior and septal walls. ROls in the left atrium 
were identified on the blood pool scans. AU ROl's were projected onto the 
dynamic H21S0 and 18FDG data sets to generate myocardia! and arterial time•
activity curves for each tracer. rMBF was calculated using a previously validated 
method. FDGU was calculated using a previously reponed Simplified integral 
approach. HR and BP were measured for calculation of rate-pressure prodUCI 
(RPP). an index of cardiac work. Data are presented as mean±SD and compared 
using an unpaired Studentt test with pSO.05 (0) considered significant FDGU 
was unifonnly distributed in both Tx and NY as evidenced by intra-subjecl 
regional variabilities of 15±8% and l4±!O%, respectively. rMBF was similarly 
evenly distributed. Mean data for the whole bean are given as no regional 
differences were identified. 
FDGU (xlO-4 ) rMBF RPP 
Tx (8=10) 4.31±2.65 1.1 4±O. 3 11740±2830 
NV (n=5) 1.66±O.77 0 O.8S±O.2 0 8320±151O 0 
In Tx. FDGU was 160% higher than in NV. whereas rMBF and RPP were 
similarly increased by only 34% and 4 I %. respectively. consistent with 
physiological coupling of cardiac work and rMBF. These data suggest either a 
decreased efficiency of glucose utilization in Tx or that factors. such as raised 
plasma calecholamines. stimulate FOGU independently of cardiac work in the 
cluooicaUy denervated transplanted bean. 
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878·12 
Dietary DehydroepianclrosteroDe (DHEA) Inhibits Graft AtterioIderosis in 
Rabbit Heterotopic CardiIIc AUOJRfts 
David E. TolmlD, DIDD& E. JoImson, Joim E. Nestler, Cynthia AlIen, Andrew S. 
Wechsler, Michael L. H_. Medical College of VirJiDia, RiduDoad, VirJiDia· 
DHEA bas been Ihown to inhibit the development of arterioocleroois in animal 
models. The protective mechanism remains 1IIIkoown. We evaluated the effect of 
dietary DHEA oa the development of cardiac graft arteriooclerosis (CGA) ill the 
rabbit heterotopic IrIIIsplaDt model immlll106Upp.--ed with cyclooporine. Poot•
operatively, recipients were randomized into 4 groups (n=9/group) differiDg by 
dietary IUpplement. Group 1 _ fed plain rabbit chow, Group 2, .S" DHEA, 
Group 3, .S" cholesterol (Chol), Group 4, .S" ChoI+.S" DHEA. Rabbits were 
IIICrificed at 4, 8, IIId 12 weeks. CGA _ quantified utilizing digital morphometric 
ODaIysis. A mean of 4S ± 3 v~. were measured per heart. Mean percent llenosis 
of each heart was calculated IIId the inhibitory effect of DHEA on ('AlA ill the 
presence IIld ab6ence of Chol IUppIementat.ion _ determined. There was no 
significant difference in Chol levels or rejection scoring ~ groups at each 
time point (data not shown). Mean IIICrifice ImlIII DHEA levels were significantly 
: elevated in those groups with DHEA supplement compared to controls: Group 2 
8.4±1.4 ng/m! vs Group 1 0.39 ±.!16 ng/m! (p< .00(1); Group 4 26.06±8.3 ng/m! 
vs Group 3 0.3S±0.1 ng/m! (p<.OOS). At 8 weeks DHEA significantly reduced 
mean percent slePosis of allografts in rabbits fed cbol free IIId cboIsupplemented 
diet. At 12 weeks DHEA significantly reduced mean percent sIeOO6is of allografts 
878·13 
• p< .05 vS Ploln 
t p( .05 .s Chol 
in rabbits fed chol free 
diet. There _ a trend 
towards reduced CGA 
in group 4 at 12 weeks. 
We conclude that 
DHEA significantly 
reduces severity of 
CGA in chol and chol•
free environments 
without reducing gnft 
tolerance. Dietary 
DHEA may extend long 
term gnft survival. 
F1aIJ Tricuspid Leaflet after Multiple Biopsies Following Orthotopic Cardiac 
Transplantation: Echocardiovaphic and Hemodynamic Con-elation 
Paul A. Tucker, Bing Sheng Jin, Carlos M. Gaos, Brano Radovancevic, O.H. 
Frazier, Susan WlIansky. Texas Heart Institute, Houston, TX 
Flail tricuspid leaflet has been reported as a complication of 
endomyocardial biopsy (EMB) following orthotopic heart transplantation 
(OUT). 
From January 1991 to August 1992, all echocardiograms of patients 
status posl OHT were evaluated for the presence of flail tricuspid leaflet and 
tricuspid regurgitation. After their identification, hemodynamic traeings done 
at or near the time of the moot recent diagnostic echo were reviewed. 
One hundred sixty-six post -transplant patients underwent 
echocardiographyat THI from January 1991 to August 1992. Thirteen patients 
(7.8%; 12 M, 1 F) were identified as having flail tricuspid leaflet. The mean 
duration from OHT was 4S months (range: 2-87 months). The mean number 
of biopsies performed per patient with a flail leaflet was 16.1 (range: 7·27). 
The mean severity of TR by echo was grade 3/4. Four patients were 
identified with severe TR (grade 4/4). 
The mean right atrial .yo wave by cath was 15 mm Hg (range: 6-26 
mm Hg). The 4 patients with severe TR by eeho afl had right atrial "V" waves 
by catheterization of ~ 20 rom Hg. No patient with eeho TR of grade 3 or less 
had a "YO wave greater than 20 mm Hg. Correlation between echo and 
hemodynamic assessment of TR severity was good (r= .8667). Mean systolic 
pulmonary artery pressure was 29 rom Hg (range: 22 to 50 mm Hg). 
One hundred ninety biopsy reports were available on the 209 biopsies 
performed in the above 13 patients (91%). Ot;e hundred one biopsies were 
performed from the internal jugular approach and 89 from the femoral vein. 
One of the 13 patients had afl biopsies performed from the internal jugular; 2 
patients e,eh bad all but t biopsy performed from the femoral vein. 
Conclusion: F1aiJ tricuspid leaflet is not an uncommon complication 
of multiple endomyocardial biopsies. Echocardiographic assessment of TR 
severity correlates weD with hemodynamic measurements. There appears to be 
DO association between the access site used for EMB and subsequent 
development of this complication. The cliniea1 significance of flail tricuspid 
leaflet in tbis population is yet to be determined. 
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Hurt Tl1In.plantatlon for Treatment of ChIIg •• ' Heart Disease. 
Reactivation of Trypanosoma cruzl Infection 
Edimar Bocchi. Giovanni Bellotti, David Uip. Jorge KalU, Maria Higuchi, 
Noedir Stolf, Adib Jatene, Fulvio PUeggi. Hean Institute, sao PalJlo 
University, Brazil 
Chagas'disease(CD) Is a systemic infection and main etiology of 
cardiomyopathy(CM) in South America. The rate of reactivation of T. Cruzj 
Infection, rejection, treated infection, clinical events and survival were 
Investigated In 12 pts (20±30 years old) who underwent hean 
transplantation (HT) for treatment of CD cardiomyopathy. The monitoring 
for CD included detection of parasites (culture, xenodiagnosis, mouse 
Inoculation, blood smears and leukocyte concentrate examination) and 
serologic tests ( complement fixation. hemagglutination. 
Immunofluorescence assays). Cyclosporine(4± 1.6mg/kg/day), 
azathioprine (2±0.5mg/kglday), and prednisone(0.1'{).2 mg/kg/day) use 
was the comestone of maintenance immunosuppressive therapy. Results: 
The mean follow-up was 22±30 months(m)(2-81 m) and the survival was 
75% at 4m, 47% at 8m and remained so. Five pis developed neaplasias 
that contributed for the deaths. The mean LV election fraction determined 
using echocardiography, were respectivelly at 6,12,24 and 36 months: 
81 ±2%, 83±4%, n±12% and 76±6%. The surviving pts have good quality 
of life. The linearized rate in the first year for T. cruzi infection reactivation 
was 1.9 episodes and for symptomatic clinical reactivation was 0.5 
episodes. Signs and symptoms of clinical reactivation included fever, 
subcutaneous nodule, myocarditis and hepatomegaly. Five pts developed 
CD myocarditis with transient worsening of LV function and were 
sucessfully treated with benznldazole. The actuarial freedom from T.cruzi 
infection reactivation was 60%, 34% and 23% at 1,6 and 12m of follow-up_ 
Detection of parasites and increase of hemagglutination titers were found 
during the reactivation episodes. The first year linearized rates for treated 
infection and degree of rejection ;e 3A were 3.4 and 1.6 episodes 
respectivelly. Thus, HT for CD may be associated with a long-term 
follow-up and good quality of life, in spite of frequent reactivation of T.cruzi 
infection and myocarditis. 
878·15 
Left Ventricular Remodeling after Orthotopic Cardiac Tl1Insplantation 
Wichll T. Vigneswaran, Richard J. Rodeheffer, Jerome F. Breen, Christopher 
GA McGregor, John A. Rumberger, Mayo Olnlc and Foundation, Rochester, 
MN 
Following onhotoplc heart transplantation (OHT) numerous adjustments 
occur In the recipien!"s clrculation; In tum, these changes should be 
anticipated to produce adaptations in the transplanted hean's physiology and 
morphology. However, little Is known regarding quantitative changes in LV 
chamber volumes and muscle mass (LVM) subsequent to OHT. To quantify 
adjustments In LV size, mass and function we performed Cine CT scans In 
patients at various times follOWing OHT (n = 15 at l-month, n = 10 at 3-months, 
n= 11 at 12-months, n=4 at 24-months). No patient had evidence of rejection 
or clinical deterioration at the time of any individual scan. Results for LVEDV 
(end-diastolic volume), LVM and the ratio of LVEDV fLVM ry /M) during the 
first 12-months following OHT are shown graphically below (mean±SEM, • 
= p<.05 versus 1-month). Ejection fraction (LVEF) remained unchanged 
(69±2% (l-month) vs. 65±2% (12-months)), p=NS). 
ConClusions: Significant increases in LVEDV occur during the first year after 
OHT accompanied initially by a slight decrease (p= NS) In LVM at 3-months 
with little or additional change by 12-months; meanwhUe LVEF remains 










progressively during this time 
period, but Is subnormal at l-month 
and within normal limits by 12-
0.1 months. Umited data from 4 
0.7 i patients suggests V /M continues to 
0.1: be within the normal range at 24· 
0.5 : months. These observations are ~ ....... -----t1 0.4~ consistent with normalization of 
~• O.l ~ overall wall tension. Progressive LV 0.2 ~ remodeling following OHT, unlike D. , that seen with cardiomyopathy or 
0.0 after infarction where V fM Is well 
o I 4 • • 10 11 
lim_ trem T .... pt.nt (mo.lIIa) 
above normal, appears to be 
physiologically appropriate. 
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878·16 
Discrepancy Between Pre and Post Transplant Diagnosis of 
Idiopathic Dilated Cardiomyopathy. 
Guillermo Bortman, Miguel Sellanes, Dale S. Odell, W. Steves 
Ring, Maria Teresa Olivari. University of Texas Southwestern 
and St. Paul Medical Center, Dallas, Texas. 
At least 40% of heart transplants (lIT) are performed in 
patients with pre-Hf diagnosis of idiopathic dilated 
cardiomyopathy (IDCM). It is unknown whether histologic 
examination at explant confirms it. In 89 consecutive Hf 
patients (72 M, 17 F, mean age 51 yrs., age range 15-68) pre 
and post Hf diagnosis were compared. Pre Hf coronary 
angiogram and endomyocardial biopsy were performed only if 
clinically indicated. Diagnosis pre Hf was: ischemic 
CM(ICM)=48 patients, IDCM=32, rheumatic heart 
disease = 1, post-partum CM=I, restrictive CM=2, adriamycin 
CM=I, alcoholic CM=4. At explant, all 49 ICM patients had 
severe CAD. IDCM was confirmed in only 11/32 (34%); 9/32 
(28% ) were found to have hypertrophic DCM, 4/32 
myocarditis (none had pre Hf biopsy) and 8/32 (25%) 
moderate to severe CAD. CAD was found in 3/4 patients with 
diagnosis of alcoholic CM. Coronary angiogram was done 
prior to Hf in only 5111 patients with clinically unsuspected 
CAD and showed no in 3 or mild CAD in 2 patients. These 
data show 100% concordance in pre and post Hf diagnosis in 
patients with IeM, but discrepancy in 65% of patients with 
IDCM, suggesting IDCM is overly diagnosed. High incidence 
of CAD suggests angiography should be performed in all 
patients with dilated CM, even when ischemic etiology is not 
clinically suspected, since alternative surgery to Hf may be 
appropriate. The data also suggests that biopsy should be 
performed in all cases of DCM of unknown etiology. 
878-17 
Lack of Inotropic Supersensitivity to p-Adrenergic 
Receptor Stimulation Late After Cardiac 
Transplantation in Han 
Joel S. Landzberg, John D. Parker, Diane F. Gauthier, 
Wilson S. Colucci. Brigham and Women's Hospital, 
Boston, MA 
In animals, denervation is associated with an increase 
in myocardial p-adrenergic receptor (BAR) density and 
inotropic supersensitivity to BAR stimulation. 
However. in patients following cardiac transplantation 
(TX), the chronotropic response to BAR stimulation is 
reduced, as are the density of BAR and the adenylate 
cyclase response in myocardial tissue. The goal of 
this study was to determine whether the inotropic 
response to BAR stimulation is altered after TX. To 
avoid potentially confounding effects of reflex 
mechanisms, dobutamine (DOB) was infused into the left 
main coronary artery of 9 stable patients 12 or more 
months after cardiac TX, and 8 normal subjects 
previously studied. Intracoronary DOB was infused at 
5, 12.5 and 25 mcg/min. At baseline, left ventricular 
+dP/dt was similar in the two groups. Shown are the 
percent change in +dP/dt over baseline (±SEM): 
nQlLJ. DOB 12. 5 DOB 25 
Post-TX 23±7 68±17 75±11 
Normals 24j:4 54±18 82±11 
p ~ ~ ~ 
Conclusion: Late following cardiac TX in man, the 
positive inotropic response to BAR stimulation is 
similar to ~hat in normal subjects with regard to both 
sensitivity and maximal amplitude of response. The 
lack of BAR super sensitivity in man may reflect re•
innervation late after TX, the effects of immuno•
suppressive therapy and/or other fundamental 
differences from animal models of denervation. 
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878·18 
Regulatory Role of Intracellular Calcium in 
Gregg's Phenomenon 
Shoji Kojima, Shao T. Wu, William W. Parmley, Joan Wikman•
Coffelt University of California San Francisco, San Francisco, CA 
Intracellular calcium ([Ca2+]i) has been proposed to playa key 
regulatory role in the regulation of myocardial contraction and 
energy production by coronary perfusion (Gregg's phenomenon). 
We approached this issue by evaluating beat to beat changes in 
[Ca2+]i induced by changes in perfusion pressure in isovolumic 
perfused rat hearts. [Ca2+]i was assessed with a surface fluorometry 
technique in Indo 1-AM-loaded hearts. Perfusion pressure in a range 
of 50 - 140 em H2O modulated the systolic, diastolic, and amplitude 
of Indo 1 fluorescence ratio (FR == [Ca2+]i) in a linear fashion in the 
presence of2 (e) or4 roM (0) perfusate calcium (Figure 1, n=6). 
There was a good linear correlation between left ventricular 
developed pressure (DP) and the systolic FR, that was common to 
both perfusate calcium concentrations (Figure 2). Changes in FR 
were rapid and concordant with rapid changes in left ventricular 
pressure. FR was also correlated with oxygen consumption. Left 
ventricular end-diastolic wall thickness, measured by 2-D 
echocardiography. paralleled perfusion pressure and showed a good 
correlation with FR. Diastolic myocardial c-AMP and In [pCr]IIPi] 
had no direct relationship to [Ca2+]i or cardiac function. 




sb sb 1io 140 O~ o.ls o~ 
Perfusion pressure (em H2O) Systolic FR 
Conclusions: Coronary perfusion regulates [Ca2+ ]i, that in tum 
regulates mechanical function and associated oxygen consumption. 
Myocardial stretch may be a regulatory mechanism of [Ca2+]i. 
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879·72 
Role of Three-Dimensional Valve Angle on Calculation of Regurgitant 
Volume by the Proximal lsoveloclty Surface Area Method In Clinicel 
Valvular Regurgitation 
Shiro Yarnachika. Edward G. Cape, Devang Savani, Jankhana Desai, 
Cheryl L Reid, Julius M. Gardin. University of CaIWomia, Irvine, CalWomia 
and ChUdren's Hospital, University of Pittsburgh, Pennsytvania 
The color Doppler proximal isoIIelocity surface area (PISA) method is 
known to be accurate In calculating volume flow across a J!!m!i!!: orifice. 
Clinically, however, cardiac valves are non-Dlanar. To define the role of 
three-dimensional (3D) valve angle on PISA calculation of regurgitant 
stroke volume (REG SV), we evaluated patients (pis) with native mitral, 
aortic and tricuspid regurgitation (MR,AR and TR) using two orthogonal 
views. ~ REG SV by PISA was calculated in 88 REG lesions. 
Valve angles were measured In two orthogonal views (8,,82) for each 
lesion-apical 4 chamber (ch) and 2ch for MR, apical 4ch and RV Inftow 
for TR, apical 5ch and apical long axis for AR- and averaged (8m), REG 
SV was corrected for valve angle by multiplying MeQ:. for MR based 
on 3-D model for bileaftet valves and !1-lcos6/2)) for AR or TR (3-D 
conical angle assumption for trileaflet valves). The % error in REG SV due 
to faUure to angle correct was calculated as: (uncorrected REG SV -
corrected REG SV)/uncorrected REG SV x 100.~ Table shows the 
mean±SD and (range) for 8 (in degrees) from two orthogonal views. 
MRln:52) TRln:24) ARln=12) 
8., 202±18(160-230) 193±11 (180-220) 214±2O(190-260) 
8 2 193±17(160-22O) 189±10(170-210) 212±21 (180-240) 
8 m 197±16(168-225) 191±10(180-215) 216±17(185-235) 
1) FaUure to use angle correction was responsible, on average, for 
underestimation of REG SV by 9% in MR, 10% in TR, and 31% in AR. 2) 
In absence of 3-D angle correction, prevalence of pts with % error> 10% 
was 44% in MR and 37% In TR, but 82% in AR. Conclusion' 3D angle 
correction from two orthogonal views is important for calculating REG SV 
by PISA. Angle correction is especially important for AR due to 1) the 
conical geometry which prcxluces a greater correction factor for a given 
angle and. 2) greater deviation from planar geometry than in MR or TR. 
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879·73 
Effect of Mitral Regurghant Jets on Pulmon.ry Venoua Row Velocity 
p.ttama: In Vitro Experiments 
Juliana Paik, Marianne R. Depp, Takahiro Shiota, Katsufumi Mizushige, 
Robin Shandas, David J. Sahn, Anthony N. DeMaria, Univ of Calif, San 
Diego, CA, and Oregon Health Sciences Univ, Portland, OR 
The pulmonary venous flow (PVF) velocity pattern obtained on Doppler 
echo may be useful in assessing diastolic LV function and can provide 
information about the severity of mitral regurgitation (MR). To study the 
effect of MR on PVF, we built a rigid in-vitro model of the left atrium (LA) 
with variable outflow resistance. The (3.5 m/sec) MR jet was produced by 
a pulsatile pump through a 2.5 mm diameter orifice while the PVF was 
driven either by a continuous pump or by gravity. Four different pattems 
of PVF and MR simulating the MR jet aimed toward or away from an 
upper or lower pulmonary vein were examined. We also varied systolic LA 
chamber 'V' wave pressure (10, 30, and 50 mmHg) and baseline PVF 
VELs between 30 and 80 cm/sec. The MR velocity, MR volume (VOLl 
(approximately 20% of forward output), and 'heart rate' were kept 
constant. PVF was examined with a pulsed wave sample VOL placed 2.0 
cm inside the PV. At an LA chamber 'V' wave pressure of 10 mmHg 
there was negligible change in PVF VEL due to MR. As LA pressure was 
increased, the deceleration in PVF was significantly greater (42% at 
30mm and 58% at 50 mmHg) for bott, pump and gravity-driven PVF 
(p<O.OOOl). The diminution of systolic PVF VEL due to MR was greater 
at lower (p<O.OOOl) than that at higher initial PVF VEL. Reversal of the 
PVF due to MR was observed only with low VEL gravity-driven PVF, low 
LA compliance and high LA 'V' wave pressure (50 mmHg). In all four 
combinations of PVF and MR jet directions, the MR jet caused similar 
decreases in PVF VEL which did not differ statistically. Our study suggests 
that forces which act counter to the suction of blood into the LA, and RV 
driving pressure, including LA ambient pressure, LA to PV gradient, and 
the volume and pressure burden of MR had a greater influence on PVF 
than direct interactions between the PVF and the MR jet. 
879·74 
Chenge. in Systolic Pulmonary Venous Blood Row in Chronic Mitral 
Regurgitation: Validation of Quantitative Application. in an Animal Model 
Dag Teien, Takahiro Shiota, Michael Jones, Izumi Yamada, David J. Sahn. 
Oregon Health Sciences Univ, Portland, OR 
Systolic pulmonary venous (PVI blood flow is influenced by atrial filling 
and compliance, ventricular outPut and by the presence of mitral 
regurgitation. The quantitative severity of the regurgitant volume itself is 
difficult to judge in clinical examinations. In this study we examined the 
influence of regurgitant volume on PV blood flow patterns in an animal 
model with quantifiable mitral regurgitation. Six sheep with chronic mitral 
regurgitation produced by prior surgery to create chordal damage were 
examined. At reoperation the heart was exposed and epicardial 
echocardiography was performed. PV blood flow wa'~e-forms were 
recorded by pulsed Doppler under color flow Doppler guidance using a 
Vingmed 750 scanner. The systolic inflow to the left atrium was 
expressed as a fraction of the total inflow velocity time integral (VTII. 
Flows across the aortic and mitral valves were recorded by 
electromagnetic flowmeters balanced against each other. Pressures in the 
left ventricle and left atrium were measured directly with high fidelity 
manometer tipped catheters. Preload and afterload were systematically 
manipulated resulting in 24 stable hemodynamic states. Simple logarithmic 
correlation between the regurgitant volume and the size of a negative PV 
inflow velocity time integral (VTII during systole was good (r : 0.84, SEE 
: 4.0 cclbeatI. By stepwise linear regression anelysis with PV negative 
systolic VTI as a dependent parameter compared to the regurgitant 
volume, fractional shortening, v-wave size, systemic vascular resistance 
and left ventricular systolic pressure, only contributions from v-wave size 
and regurgitant volume (r : 0.801 reached statistical significance in 
determining PV negative systolic flow. Evaluation of systolic pulmonary 
venous blood flow VTI can give valuable information helpful in estimating 
the regurgitant volume in mitral regurgitation. 
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Which Physical Factors Detenline Mitral Regurgitation Jet 
Area in the Clinical Setting? 
J Miguel Rivera, Pieter M Vandervoort, Donato Mele, J 
Antonio Vazquez de Prada, Arthur E Weyman, James D Thomas. 
Massachusetts General Hospital, Boston, MA, and Cleveland 
Clinic Foundation, Cleveland, OH 
It is cOlllllOnly held that color jet area closely 
corresponds to regurgitant fraction in mitral 
regurgitation (MR). To investigate whether other recently 
available phYSical parameters significantly affect 
displayed jet area, we analyzed data from 43 MR patients. 
All were in sinus rhythm and were divided into those with 
free jets (FJ, Group I, n-15) and those with impinging 
wall jets (IJ, Group 2, n-28). Jet measurements included 
mean jet area (MJA) (average of four chamber, long axis, 
and short axis areas) and MJA/MLA, where MLA is the mean 
left atrial area. These were correlated with the 
following factors: 1) peak flow rate (Q.) determined by 
identifying a proximal contour velocity v. at a radius r 
from the regurgitant orifice as Q. - 2.r2v ; 2) effective 
regurgitant orifice area (ROA) given by Q:Jvo' where Vo is the peak MR velocity from continous-wave 50ppler (CW); 3) 
momentum (M) giYen by Q vo; and 4) regurgitant fraction 
(RF) assessed by pulsed ~oppler mitral and aortic forward 
flow. RESULTS: In Group I, MJA correlated best with 
momentum (r=0.86, p<O.OOI), followed by Qo (rz O.84, p<O.OOI), ROA (r-0.78, p< 0.01), and RF (r=0.74, p< 0.01). 
MJA/MLA showed fair correlation with Q. (r-0.66), ROA 
(r-0.62), M (r-0.64) and RF (r-0.61). In Group 2, r<0.50 
was observed for all MJA and MJA/MLA correlations. 
CONCLUSIONS: 1) New clinically available parameters such 
as Qo' ROA, and M influence the size of displayed 
regurgitant jets more than RF. 2) Better correlation is 
obtained without normalizing jet area by LA size. 3) Jet 
impingement renders jet area measurements almost useless. 
879·92 
The Effective Area of a Stenotic Orifice Depends Critically on Inlet 
Geometry: Digital Doppler Analysis of a Pulsatile In Vitro Model 
Neil Greenberg, B.S., Kimerly A. Powell, Ph.D., Pieter Vandervoort, 
M.D., William J. Stewart, M.D., F.A.C.C., James D. Thomas, M.D., 
F.A.C.C., Cleveland Clinic Foundation, Cleveland, Ohio. 
The functional significance of a restrictive orifice depends not 
only on its cross-sectional area but also on the detailed geometry leading 
into it. To detennine the practical importance of this issue in the 
Doppler echocardiographic assessment of valvular stenosis, we studied 
reversible, pulsatile flow through a restrictive orifice with an 
asymmetric inlet geometry: a 6° tapered inlet for flow in one direction 
away from the transducer and an abrupt, 90° reduction in cross•
sectional area for opposing flow. Forward and reverse stroke volume 
(SV) were fIXed and the peak velocity was adjusted by varying the cycle 
length. Peak orifice velocity was obtained by continuous wave Doppler 
and the time-velocity histogram stored to optical disc. The velocity 
profiles (v(t» were traeked by hand-tracing and digital edge detection. 
Velocity through the tapered (v,) and abrupt (v.) geometries were 
compared by paired t-test. Results: For velocities between 40 and 400 
cm/sec, velocity through the abrupt and tapered orifices were closely 
correlated (r>0.98). However, velocities were Significantly 
(p < 0.0001) higher through the abrupt orifice (va = 2S6±27 em/sec, 
mean±S.D.) than through the tapered one (vt = 211 ±23 em/sec). On 
average, v, was 16% lower than v., implying an effective orifice area 
(BOA) 20 % larger than for the abrupt geometry despite identical 
physical orifices. BOA increased by 22 % across the velocity range for 
both geometries. Conclusions: 1) In pulsatile flow, a tapered geometry 
is associated with significantly larger effective orifice area. 2) BOA is 
smaller at low velocities, presumedly reflecting viscous effects. 3) lnJet 
geometry should be considered when relating anatomic to functional 
orifice area. 
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Effective Regurgitant Orifice Area Calculated by Proximal 
Flow Convergence Method for Estimating Severity of Mitral 
Regurgitation in Patients 
Chunguang Chen, Pieter M Vandervoort, Dietmar Koschyk, 
Soeren Heik, Arthur E Weyman, Christian Hamm. University 
Hospi tal Hamburg, FRG & Massachusetts General Hospi ta 1, 
Boston, HA 
Recent studies have suggested that effective mitral 
regurgitant orifice area (MRA) can be calculated using 
color Doppler proximal convergent flow region (PCF). To 
test this in patients (pts), we studied 37 pts with mitral 
regurgitation (MR). The maximal accelerating flow rate 
proximal to MR orifice (Max AFR) was calculated using 2-D 
color Doppler flow mapping assuming hemispherical shape of 
PCF. Maximal velocity (V) through MR orifice was obtained 
from continuous wave Doppler MR profile. MRA by PCF was 
calculated using max AFR/max V. MRA by PCF was then 
compared to angiographic severity of MR and MRA derived 
from stroke regurgitant volume/systolic time/max V/max to 
mean flow ratio, where stroke volume was measured using 
combination of M-mode, 2-D and pulse wave Doppler 
echocardiography. RESULTS; Correlation between MRA by PCF 
(y) and MRA by the combined method (x) was y-I.16x -0.09, 
r - 0.94, SEE - 0.19 cm2• There was no significant 
difference between MRA by PFC (0.83±0.69 cm2) and by the 
combined method (0.79±0.57 cm2, p-NS). Relation between 
angiographic severity of MR and MRA by PCF was: 
MR angi? I II III IV 
MRA (cm) 0.06±0.03 0.27±0.07 0.52±0.14 1.5±0.59 
MRA by PCF greater than 0.65 cm2 estimated MR IV in 13/11 
pts, while only 2/10 pts with MR III had a MRA > 0.65 cm 
(peO.OOI). CONCLUSIONS; I) calculation of mitral 
regurgi tant orifice area us i ng proximal flow convergent 
region is feasible and relatively accurate in clinical 
settings and can be used to estimate angiographic severity 
of mitral regurgitation. 
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880·94 
Role of Trans esophageal Echocardioqraphy in Cardiac 
Donor Screening. 
Marcus F. Stoddard, Rita A. Longaker, University of 
Louisville, Louisville, Kentucky 
Transthoracic echocardiography (TTE) has played a 
useful role in screening of cardiac donors. However, 
TTE may be suboptimal in such pts on ventilators. The 
role of transesophageal echo (TEE) for cardiac donor 
screening is unknown. We compared the potential 
benefit of TEE added to TTE in 23 (15M/SF) 
consecutive brain-dead pts mean age 30 ± 9 yrs (16-44 
yrs) being considered as cardiac donors. TTE was 
done inunediately before or after TEE. 'ITE was 
technically difficult in 7/23 (30%) pts. TEE 
eliminated the need for cardiac catheterization in 
these 7 pts. TEE was abnormal in 5 of these 7 pts and 
demonstrated left ventricular wall motion 
abnormalities (n=4) and valvular heart disease 
(n=l). These 5 pts were eliminated as potential 
donors. In 16 pts with technically adequate 'ITE, TEE 
and TTE findings agreed and demonstrated normal 
studies in 14 pts and left ventricular wall motion 
abnormalities in 2 pts. Overall 7 pts were 
eliminated as cardiac donors on the basis of TEE 
(n=7) and/or TTE (n=2). Intraoperative and/or 
autopsy was confirmatory of TEE findings. 15/16 
(94%) of cardiac recipients survived surgery and were 
discharged. 1 pt died of acute rejection. 
Conclusions: TEE is a useful adjunct to 'ITE in the 
screening of donors and eliminates the need for 
cardiac catheterization in approximately 1/3 of pts 
assessed by TTE. 
ABSTRACfS 
880·95 
Ihould ~raDsesophaqeal loho be Perforaed 
aoutiDely iD liDqle LWlCJ ~raDaplaJIt 
caDdihtea'l 
Miguel Zabalgoitia, Len J. SCUderi, Steven R. 
Bailey, Mary Garcia, Teresa R. Cronin, John H. 
Calhoon, J. Kent Trinkle. univeraity of Texas 
Health Science Center, San Antonio, TX. 
We have previously shown that aatisfactory 
Doppler transthoracic echo ('1"l'E) in single 
lung transplant (SLT) pts is possible in only 
46t due to poor acoustic windows. Trans•
esophageal echo (TEE) may overco.e thes. 
limitations but worseninq hypoxemia during TEE 
is a concern. . Thus, 28 SLT candidates (men 
17, women 11; mean age 48±6 yeara) underwent 
biplane TEE and TTE. Feasibility of LV seg•
mental wall motion (SWM), mUral regurgitation 
(MR), R. L intracardiac shuntinq by contrast 
echo, RV wall thickne.s (Th), and systolic PA 
pressures by tricuspid regurgitant equation 
4~+10 were compared between TTl and TEE. 
F E A SIB I LIT Y 
OVerall LY SWM MR RY Th R.. L PA 
TTE 50t 33' 33' 5o, 33' 17' 
TEE 100' 100' 100' 100' 100' 50' 
Significant R • L shuntinq explained PAt 
pressures in 2 pt. by TEE. O2 saturation (on 
100' O2) remained unchanged before and during 
TEE (91' ~ 89', p NS). 
In conclusion, biplane TEE in SLT candidates 
A) i. f.asible and safe despite hypoxemia; B) 
should be performed routinely because it 
provides important information not available 
by TTE and C) helps in exclUding cardiac 
causes of pulmonary hypertension. 
880·96 
Multiplane Transesophageal Echocardiography Enhances 
Visualization of Pulmonary Artery Lobar Branches and 
Chronic Thrombus in Pulmonary Hypertension 
Howard C. Dittrich, William Auger, Stuan Jamieson, Kenneth M. 
Moser. University of California, San Diego 
Although single-plane transesophageal echocardiography (TEE) has 
been used to successfully visualize chronic thrombus in the main 
pulmonary amry (p A) branches, this technique has been limited by 
false positives in the right main PA and the inability to deflne lobar 
vessels, the site of most chronic thrombus. We therefore 
performed TEE in 7 patients with chronic thromboembolic 
pulmonary hypenension (systolic PA pressure = 89±13 rom Hg, 
[meaniSD]) undergoing surgery to resect PA thrombus. TEE 
results were compared with preoperative PA angiography and 
flndings at surgery. Images were obtained at the time of surgery 
with an Omniplane® (Hewlett-Packard) 5 MHz TEE transducer. In 
5 cases, suspected thrombus in the right main PA, seen in the 
transverse (0 degree) plane, was excluded by multiplane imaging. 
Additionally, thrombi in the right and left main PA were seen in 2 
cases with imaging between the transverse and longitudinal (90 
degrees) planes. The origins of the right upper, middle and lower 
lobe vessels were seen in 62% (13/21) with the right lower lobe 
seen in all patients. In only one case was a lobar vessel on the right 
seen well in the transverse plane. 81% (17/21) of the origins of the 
lingula, left upper and lower lobes were visualized with only 5 seen 
using the transverse plane. 43 of the 56 possible left and right main 
and lobar branches were visualized. Of these, 23 (53%) were 
considered interpretable for thrombus. Concordance between TEE 
and surgery/angiography in these 23 was 91 % (21/23). Inability to 
interpret for thrombus occurred most often in the lingula and left 
lower lobes where the ultrasound beam was often parallel to the 
course of the vessel. Thus, multiplane TEE appears to enhance the 
ability to distinguish PA thrombus from artifact, allows for 
visualization of lobar vessels and therefore improves the ability of 




Transnasal Introduction of TransCBsophageal 
Pediatric Echocardlography Probe for Adult 
Critically III Patients Monitoring : Feasibility and 
Advantages. 
Bruno Valtier, Olivier Dubourg, Alexandre Duguet, 
Guillaume Jondeau, Jean·Claude Dib, Jean-Pierre 
Bourdarias, Franc;ois Jardin. 
Medical Intensive Care Unit, Ambroise PARE University 
hospital, 92104 Boulogne, France. 
New pediatric transCBsophageal echocardiography probes 
(PTE B) may allow nasal introduction in adults. We 
evaluated the feasibility of this technic in 12 sedated, 
ventilated, critically ill patients (age range: 55±15 y.o.) in 
whom classical oral introduction would have required the 
use of laryngoscope. 
We used a 5 Mhz PTEB connected to a SONOS 1500 
(Hewlett Packard@). The probe could be nasally introduced 
in 11 patients. In one patient nasal introduction was 
impossible because of nasal malformation. Introduction of 
the probe was always easy, time delay for obtention of good 
quality images being lower than 5 minutes in all cases 
without need of laryngoscope. No adverse effect were 
notified. In contrast to what is observed with classic 
tranCBsophageal echocardiography, the probe could be 
kept in stable position for at least one hour in all patients (up 
to four hours), allowing continuous left ventricular (LV) and 
right venticular (RV) monitoring without any complication 
and further complication for the patient. 
We concluded that transnasal insertion of PTEB is then 
possible in adult critically ill patients. Introduction is easy. It 
should allow continuous and prolonged RV and LV 
monitoring. 
880·98 
Application of a Pediatric Biplane Truaeaophaaea1 
EchocardlogtaphJc Probe to Adult Patlents 
Toshlro Aokl. Katsu Takenaka. Fumlyoshl Watanabe. Wataru 
Amano. Jun·lch! Suzuki. Tsutomu Igarashi. Makoto Sonoda. 
Yuepeng Wang. University of Tokyo. Tokyo. Japan 
To assess the clinical utility of a pediatriC biplane 
transesophageal echo probe In adults. 12 adult patients (mean 
age=65 yrs) In sinus rhythm were examined by both a pediatric 
probe (tip dlameter=7mm) and an adult probe (tip 
dlameter=12mm). ComparISons were made between the two 
probes regarding difficulty In insertion. B-mode Image of LV 
long-axis view. LV short-axis view (transgastrlc). atrial septum. 
descending aorta and left coronary artery. pulsed Doppler 
recordings of the pulmonary venous and mitral flow velocities. 
and color-Doppler signal of mitral regurgitation (MR). Insertion 
was easy In 10 patients (83%) with a pediatric probe and In 7 
(58%) with an adult probe. The numbers of the patients In whom 
quality of the Image was acce~table were as follows; 
LV long-axis view 5(42'" 9(75%) 
LV short·axis view 0(0%) 121100%) 
Atrtal Septum 10(83%) 12(100%) 
Descending aorta 12(100%) 12(100%) 
Coronary artery 2(17%) 11(92%) 
Pulmonary venous flow 11(92%) 12(100%) 
Mitral flow 8(67%) 11(92%) 
MR was detected bY color Doppler In 4 patients bY a pediatriC 
probe and In 7 patients by an adult probe. Color signal area of 
MR was smaller by a pediatric probe than by an adult probe 
(0.6±1.0 vs 2.8±3.9 cm2 ; p<O.01). Long-axiS Image of the 
descending aorta was inclined more by a pediatric probe than by 
an adult probe (19±12 vs 5±70 ). Conclusions: Quality of B-mode 
Images and Doppler signals more than about 4 em In depth by a 
pediatric probe was not acceptable and a contact of the probe 
with the esophageal wall was Incomplete without a balloon. 
However. a pediatric probe was easy to tnsert. less unpleasant to 
patients. and prOVIded satisfactory Images of near-fleld targets 
such as the descending aorta and pulmonary venous flow. 
880·99 
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The Identification of Intra-Cardiac and Intra·Pulmonary Shunts in 
Patients with End-stage 6ver Disease by the Use of Contrast Echo 
Galal M. Ziady, Victor Scott, S Chandra Bose Reddy, A DeWolf, 
Irving Paradis and Maureen Martin, University of Pittsburgh, 
Pittsburgh, PA 
Arterial 0. desaturation is known to occur in ptS with end-stage liver 
disease. Right to left shunting of blood is incriminated as the cause of 
that condition. Agiwed saline injection is used to produce bubbles that 
are easily seen on Echo and it does DOt cross the lung barrier because 
of their large size, and its appearance in the left heart will be due to 
intra-cardiac and/or intrapulmonary shunts. We performed 2D Echo 
associated with injection of 10 ml of agiwed bacteriostatic saline 
solution in 16 pts with end-stage liver disease and evidence of arterial 
0. desaturation. The injection was carried out through a floating 
pulmonary catheter into the following sites respectively. Site 1 = 
main pulmonary artery (MPA); site 2 = right pulmonary artery (RPA) 
and site 3 = left pulmonary artery (LP A). Transthoracic echo (ITE) 
was carried in all Pts and additional transesophageal echo (TEE) was 
carried out in 10 pts. Bubbles visualization site was left atrium in all 
16 pts and in both right pulmonary veins (RPV) and left pulmonary 
veins (LPV) respectively in the 10 pts who had additional TEE. 
RESULTS: injection of contrast in MPA, RPA, and LPA revealed 
positive contrast appearance in LA in 14 out of 16, 8 out of 16 and 6 
out of 16 pts respectively. In the remaining 2 pts injection in a 
peripheral arm vein revealed right-left shunt at atrial level through a 
palent foramen ovaie. In the 10 pts who had TEE selective 
visualization of contrast was observed in RPV in 6 pts and LPV in 4 
pts. Conclusion' Contrast echo is useful to identify right to left 
shunting in pts with atrial O2 desaturation in end-stage liver disease. 
The selective injection of agitated saline could identify further the site 
of right-left shunting whether inter-atrial, or inlra-pulmonary affecting 
either the right or left lung. 
880·100 
Detection of CaD:li.ovasallar Stults by T.ransescphagea 
Ec:hocanliograp in Patients with lb!!xplained Pul•
IOOIliIl:y Hypertension 
wei-Jan Chen,Jin-Jer Chen,Shen-Chang Lin,Juey-Jen Hwang, 
wen-Pin Lien.National Taiwan University &>Spital, Taipei, 
Taiwan,R.O.C. 
The pJrpOSe of this stuiy was to validate the useful•
ness of transeso~eal ecOOcardiograph;y(TEE) in the 
assessment of caniiovascular stnmts in patients with 
unexplained p.1lmonary qypertension(PH). 'IWenty-tt.u 
aiult patients with ItI docunented ~ echocardiogra~y 
were studied (16F,6M;20 to 70 y/o). All were exanined 
~ transthoracic(Tl'E) and transeSOIfulgeal echocardio•
grapqy(TEE). Tl'E denanstrated the ventricular septal 
defect in 2 patients (muscular type in 1 and per:imen•
branc:us type in the other). TEE dEmJnstrated the atrial 
septal defect in 6 patients (secundun type in 5 and 
pr:imun type in 1) and the patent ductus arteriosus 
in 6 patients, which were not found ~ Tl'E. The ven•
tricular septal defect denanstrated ~ Tl'E were also 
found ~ TEE. Patients with a ventricular septal defect 
were also associated with a patent ductus arteriOSUS. 
Irnoog 12 patients with cardiovascular leSions, 8 
patients displayed a pattern of bidirectional shunt, 3 
a p.1re left-to-right stnmt and the rsnaining 1 a pure 
right-to-left shunt. All of the caniiovascular defects 
could be oonfiImed by passage of the catheter across 
the defect at caniiac catheterization. 
In light of ItI, transthoracic identification of cani•
iovascular stnmts is difficult because of the low 
velocity across the defect. In this stuiy, we fim 
that TEE is superior to Tl'E in detecting am local•
izing caniiovascular malfoImations in patients with 
ItI. 
JACC Vol. 21, No.2 
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880·101 
Tra .. ie.t Systemic Hypotusio. as a Major Mec .... i' .. 
Responsible lor latraoperative Myocardial IK"emla ia Gneral 
Surgery: a Transesophageal Ecbocardiographic Study. 
Michaela Koz8lcovll. Carlo Palombo. Alessandro DistanlC. Antonio L' AbbalC. 1st 
Department of Medicine. Prague. CS ans C.N.R. InstibJlC of Clinical Physiology, 
Pisa, Italy 
Transient intraoperative (10) myocardial ischemia (MI) is known to increase the risk 
of 10 and postoperlItive cardiac complications. The role of 10 hypocensiOll (Hypo-) 
in inducing ll'ansient 10 MI during general surgery is not yet well established. Aim 
of this study was to investigalC incidence and possible mechanisms of 
hypotension-related 10 MI in pIS without previous myocardial infarction undergoing 
major abdominal surgery. To this aim, in 59 pts (M:F:18:41, mean age 54.1±14.8 
years) without regional wall motion abnormalities (RWMA) on basal, 
Il'anSthoracic, 2-D echo, continuous 10 monitoring of LV kinesis was performed by 
ll'ansesophageal echocardiography (1eE), using a monoplane phased-array probe 
(Hew leu-Packard SYSIelll). Simulraneous automatic BP and HR was )X'Ovided, with 
measurements done every 5 min. Significant 10 Hypo- was considered to occur 
when sudden 10 decrease of systolic BP by more than 25%, compared to the 
)RCeding value, was delCcred. 
~: the incidence of ll'ansient 10 RWMA in the overall group was 41 % (24/59 
pIS). 10 Hypo- , with average decrease of systolic and diastolic BP by 33.2±7% and 
28±16%, respectively, occurred in 17/59 pts (29%), and incidence of ll'ansient 
RWMA in this subgroup was 71 % (12/17 pts). Incidence of 10 RWMA within pts 
without sudden 10 Hypo- was 29% (12/42 pts, p<.01 compared to pts with 10 
Hypo-). PIS with and without 10 hypo- were comparable for age, type of surgery, 
preoperative systolic BP. prevalence of hypertension or CAD, preoperative 
abnormalities 011 basal and stress ECG and Echo-, while 10 Hypo- had significantly 
higher incidence (p<.01) in females (16/17) and was associalCd with a lower 
intraoperative income of the fluids «750 ml/h) (p<.05). PIS with and wilbout 
ll'ansient RWMA associalCd to transient 10 Hypo- did not differ in mean decrease of 
systolic and/or diastolic BP, but in duration of Hypo- (l9.9±11.7 vs 6.2±2.8 min, 
p<.02) and in response of HR to Hypo- (I1HR: +28.8±24.2 vs +18.4±16.5 bpm, 
p<.05). Cpnclusipns: sudden 10 hypocension is associalCd with higher incidence of 
RWMA and seems to be related to 10 hypovolemia and female sex. Its duration, 
nue !han its degree, and the extent of tachyCllldic response, repesent major factors 
responsible for 10 development of RWMA, and possibly myocardial ischemia. 
880·102 
FrequeDC)' a.d expla.atioD or raise Deeatlve dlal.osls or aortic 
dissectloD b)' aortolraph), aDd tra.sesophaleal echocardlolraph),. 
Ramesh Bansal, Krishnaswamy Chandrasekaraa, Kaliprasad Ayala, Kraig 
Wangsnes. Loma Linda University, Loma Linda, CA and Hahnemann 
University, Philadelphia, PA. 
Patients with the DeBakey types I and II (Stanford type A) aortic 
dissection (AD) usually require immediate surgery, whereas patients with 
type III (Stanford type B) AD can be treated medically. Any diagnostic 
technique, therefore, should provide information regarding the ~resence 
and type of AD. Aortography and transesophageal echocardlography 
(TEE) have been used for the diagnosis of AD. These techniques may be 
associated with false negative findings. Previous studies have reported 
on the sensitivity of aortography and TEE in diagnosing AD but there is 
lack of information regarding the reasons for false negative test fiDdings. 
ObJecthe: This retrospective study was designed to define possible 
explanations for false negative diagnosis of AD by TEE or aortography 
in a large number of patients undergoing both tests. 
Methods: From 1988 to 1992, 6S consecutive patients with AD 
underwent both aortography and TEE. Diagnosis of AD was confirmed 
by either surgery or computed tomography (CT) in all patients. 
Results: 17 of 65 patients showed discrepancies between aortography and 
TEE. There were 2 patients with false uegative biplane TEE (sensitivity 
63/65 or 97%). Both patients had well localized type II AD (one 
confirmed by surgery and one by CT) confined to the inner margin of the 
upper third segment of the ascending aorta (1 male, both 79 years old). 
There were IS patients with false negative aortograms (sensitivity 50/65 
or 77%). There were S males and the mean age was 59 years (range 24-
80). Of these IS patients, 7 had type 1(6 confirmed atsurgerY,1 by CT); 
I type II (confirmed at surgery); and 7 type III (confirmed by CT in all). 
Completely thrombosed false lumen was felt to be the explanation of false 
negative aortogram in 13/1S patients (7 type III, I type II and S type I). 
In 2 patients with type I AD, the aortogram was negative probably 
because of nearly equal flows in both lumens. 
CODclusloDs: J) TEE is an excellent screening tool for AD. Small type 
II AD can, however, be missed. 2) The principal reason for false 
negative aortogram is thrombosed false lumen. 
ABSTRACTS 
880·103 
Direct Cardiac Compression Generates Systemic Blood Flow 
During Cardiopulmonary Resuscitation: Evidence Against the 
Thoracic Pump 
Alastair C.H. Pell, PelCr Bloomfield, Colin E. Robertson, Ursula M. GuI)" 
David J. Steedman, George R. Sutberland. 
Royal Infirmary, Edinburgh, UnilCd Kingdom 
The mechanisms responsible for generating systemic blood flow during closed 
chest cardiopulmonary resuscitation (CPR) were investigated in 18 pMients 
presenting in cardiac arrest. Compression of the heart chambers and patterns of 
blood flow were determined using transesopbageal ecbocardiography within 30 
minutes of the onset of the cardiac arrest. Stemal depression resullCd in -.-ked 
compression of the right atrium (RA) and the right ventricle (RV), and was 
ICCOmpanied by tricuspid regurgitation and antegrade pulmonary artery (P A) 
flow. Left atrial (LA) compression resulted in retrolfBde pulmonary vein (PV) 
flow, whilst left ventricular (LV) compression was most prominent at the base 
of the beart and resulted in flow through the aortic valve. Turbulence within the 
LV outflow tract in 5 patients suggeslCd that displacement of the interventricular 
leptum and compression of the aortic root caused obstruction to flow. Sternal 
release resullCd in immediate filling of the RA and RV from the vena caVIe and 
coronary sinus, and there was retrograde PA flow. Antegrade PV flow with LA 
aad LV filling occurred during this phase. Transmitral filling of the LV occurred 
immediately on sternal release and no LV filling tonk place during stemaI 
compression. Mitral valve (MV) motion was complex throughout both phases of 
CPR. The initial motion during both sternal depression and release comprised 
leaflet separation. This was followed by partial coaptation. Despite incomplete 
MV closure, mitral incompelCnce occurred in only 2 pis. indicating that cardiac 
compression resulted in equivalent increases in LA and LV pressure. 
Accordingly, competence of the MV was not essential for generation of effective 
forward flow. 
Conclusion: during CPR the LA and LV behave as a single chamber, 
compression of which generates systemic blood flow. The thoracic pump model 
i. incompatible witb the presence of retrograde PV flow during stemaI 
depression. Ejection of blood from the LV may be limited by a combination of 
inodequate LV compression and outflow tract obstruction. 
880·104 
Trans-telephonic EchocardiollJ'Bphy: A One Year Experience in a 
Regional Tertiary Pediatric Care Center. 
Walter Sobczyk, M.D., Robert Solinger, M.D., Allan Rees, M.D., 
Francisco Elbl, M.D., University of Louisville, School of Medicine. 
Recent technical advances have made trans-telephonic 
echocardiography (trans-echo) practical. Digital images may be 
stored and transmitted as either real-time cine-loops or still frames, 
and in full, split, or quad-screen formats. All imaging modalities 
including color flow Doppler may be transmitted. Our institution 
has developed a regional network of transmission centers and 
reviewed our initial experience to determine: 1) if trans-echo gave 
an accurate diagnostic impression compared to subsequent videotape 
review; and 2) does trims-echo lead to appropriate clinical 
management (i.e. transfer to a tertiary center vs. continued care 
and follow-up at the regional referral site). To date we have 
successfully evaluated 90 trans-echoes with the following final 
diagnoses: 49 normals, 15 PDAs, 10 VSDs, and 16 miscellaneous 
diagnoses including 2 valvar PS, 1 TOF, 1 VSD with interrupted 
arch, and 1 DORV with CoA Seventy-nine of the 90 trans-echoes 
(88%) gave an accurate diagnostic impression. Nearly all of the 11 
inaccurate impressions were due to the seleetion and transmission of 
insufficient information. None of these inaccurate impressions 
have led to an increase in patient morbidity. Only 2 of the 90 trans· 
echoes (2%) led to an inappropriate clinical decision in which 
transfer to our institution was delayed until a final correct diagnosis 
was made by videotape review. Neither patient suffered increased 
morbidity due to the delay. We conclude that trans-echo can 
successfully help manage pediatric patients with suspected heart 




Accentuated Impact or Acull T.mpollld. on PllllIe PullIIOf1Iry 
Venoul Flow Following IntrlYIftOUI Volum. Intullon 
Eric K louie, Robert J. Hariman, Yonggao Wang, Mlng H. Hwang, Henry 
S. Loeb, Patrick J. Scanlon, Loyola Untverslty Medical Center, Maywood, 
IL and Veterans Administration Hospital, Hines, IL 
LBft upper pulmonary vein low velocities In systole (pVa) and diastole 
(PVd) were recorded by transesophageal Doppler echocardlography In 
10 chloralose anesthetiZed open chest dogs. Measuremants were 
performed during brief periods of auspended respiration during atrial 
pacing at a constant rate. The dogs wera studied st a low right atrial 
pressure (RAP-O mmHg) and following I.v. saline infusion to raise RAP 
to 4 mmHg. Both before and after I.v. saline infusion, tamponade was 
reversibly Induced by Increnentallntraparlcardlal saline Infuslon followed 
by withdrawal 01 the saline from the parlcardlal sac. Perlcardlal pressure 
(PP) was monitored during the Intraparlcardlallnfuslon and withdrawal 01 
fluid. In the low RAP state as PP rosa from -3.;t.3 to 4.;t. 1 mmHg, cardiac 
output (CO) fell (2.1.;t.0.2 to 1.2..±.0.3 IImln, p<.OOI) and mean aortic 
pressure (AP) fell (120..±.16 to 59..±.28 mmHg, p<.OOI). At. the onset 01 
tamponade (defined as the point during Intraparlcardlallnfuslon when PP 
exceeded RAP), PVa did not change slgnlflcanUy from baseline (40..±.29 
v.40..±.32 cm/a). PVd, however, exhibited a downward trend (40..±.15 v. 
31..±.12 em/a, pa.l1) and the ratio PVa/PVd exhibited an upward trend 
(1.2..±.1.0 v. 1.5..±.1.1, p=.36). After Inlravenous volume InfUsion reversible 
tamponade was egeln Induced resulting In an Increass In PP (1..±.3 to 9..±.3 
mmHg), a fall In CO (2.6..±.0.6 to 1.2..±.0.71/mln, p<.OOI) and a leilin AP 
(137..±.33 to 53..±.18 mmHg, p<.OOI). In the volume replete state the onset 
01 tamponede (again defined as the point during Intraparlcardlallnfuslon 
when PP exceeded RAP) Induced by Intraperlcardlallnfuslon coincided 
with e downward trend In PVs (42..±.15 to 35..±.12 cm/s, p=.IO) end a 
slgnlflcant decrease In PVd (34.;t.ll to 18..±.16 cm/s, p<.02) resulting In 
a significant Increass In PVs/PVd (1.4..±.0.7 v. 2.6..±.1.1, p<.OO5) at the 
onset 01 tamponede. Conclu.lon.: The decrease In PVd and the 
increase In PVs/PVd reflects en alteration In pulmonary venous retum 
and left atrial filling at the onset 01 tamponede physlology. Though these 
changes are evident In the low RAP state, they are markedly accentuated 
In the volume replete state following Intravenous Infusion es the left and 
right sides 01 the heart compete to fill In the limited perlcardlal space. 
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881·62 
Admission Hypomagnesemia Does not Predict an 
Untoward Course in Patients with Acute Myocardial 
Infarction 
John E. Madias, Ketan Sheth, Mubashar A. Choudry, 
Samin Sharma, David O. Berger, Nicolaos E. Madias, 
Mount Sinai and Tufts University Schools of Medicine, 
New York, NY, and Boston, MA 
Hypomagnesemia (Mg" ( 1.7mg/dL) is a frequent 
finding in patients admitted with acute myocardial 
infarction, but its association with hypokalemia, 
prior diuretic therapy or arrythmias is contro•
versial. To investigate this further, we prospec•
tively evaluated 509 consecutive patients admitted 
with myocardial infarction. The 126 patients (24. 
8\ of total) with hypomagnesemia (1.48 0.16) (x ± 
SD), were not different from the 383 patients with 
normal Mg" (1.96 ± 0.26) in age (62 ± 14 vs 64 ± 
13 years), sex (M/F) (86/40 vs 274/109) admission 
K' (4.1 ± 0.7 vs 4.2 ± 0.6 mEq/L), heavy alcohol 
use (12.7\ vs 9.4\), digitalis use (11.9% vs 10.2%), 
previous myocardial infarction (24.6\ vs 29.8\), 
hypertension (54.0' vs 49.9%), diabetes (22.2% vs 
24.0\), angina (33.3\ vs 40.2\), smoking (61.9% vs 
53.5%), peak MB-CK (227 ± 239 vs 241 ± 271 lUlL), 
Killip's class (18/24/1212 vs 266/70/37/8), frequent 
PVCs (18.3% vs 13.1%), ventricular tachycardia (19.0% 
vs 14.9%), ventricular fibrillation (15.1\ vs 13.6\), 
cardiac mortality (15.9% vs 15.1\) and total mor•
tality (19.9\ vs 18.3%), but differed in prior 
diuretic therapy (32.5\ vs 22.7\, P<0.03). Thus, 
admission hypomagnesemia is found in ~ of patients 
with acute myocardial infarction, is more frequent 
with prior diuretic therapy, but is not associated 
with hypokalemia, higher incidence of arrhythmias 
or worse in-hospital course. 
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881·63 
Impact of ResiOD uuI Ha.pital Si7.e OD Variation in Mortality ReICll 
AmOD. PatieDti With Acute Myocardial WU'Ction 
William J. Freoch, William J. Rogen for the National Rqpmy ofMycx:ardial 
Infarction Investipton, Harbor·UCLA Medical Ccuter, TOrrBllCC, California 
Thrombolytic therapy RdIlQel mortality in patienll with acute mycx:ardial 
infarction. It is IIDkDOWD, however, if variatioDl in mortality ralel exist by 
region audlor hospital D. The purpoee of this study wu to review data 
oollected by the National Registry ofMycx:ardial Infarction in 91,000 patients 
with acute mycx:ardial infarction treated in 5SO hOlpitaia throughout the 
United Stalel. Univariate analyaia wu perfol'lllCld aftct Itratifying patient data 
into 8 regioDl and by age, _, and uae of thrombolytic therapy (IT) for IInall 
«200), medium (201-400) and large (>400 beds) hospitaia. Overall, patienll 
receiving thrombolytic therapy (rt·PAl had the Io_t mortality nte (5.6 VI 
13.8%, p<.05) with relatively IInall differences by region or hospital D. 
However, marked variation in mortality ralel oc:x:umd among patients not 
receiving thrombolytic therapy. Mortality rates: ·Hi, ··Low; A, B, C p<.OI. 
Small Medium Large 
&sUm &.JJ: n &.JJ: n &.JJ: n 
West 13.1 5.2 13.8 5.S 9.7" 5.1" 
Southwest 16.1· 6.9' 16.8' 4.4" 12.7 6.6 
South 12.7 S.S 13.6 6.3' 14.9 6.4 
Southeast IS.6 S.S 13.6 5.0 14.6 S.7 
Midwest 13.8 2.9'· 12.9'· 5.6 12.8 6.2 
Greet Lakes IS.6 4.5 15.5 6.1 14.1 5.1·· 
Mid Atlantic 13.8 4.9 14.2 5.1 12.9 7.1· 
Northeast ll.!...u W U ill· jJ 
Mean 13.9" S.O" 14.3· 5.S· 13.4c S.9c 
CDnclulion: Uae of thrombolytic therapy is IIIIOCiated with improved 
survival after myocardial infarction and minimizca differences in mortality 
among regiODl and hOlpitaia. Further study is warranted to Cltplain 
differences in mortality among patients not receiving thrombolytic therapy. 
881·64 
The Absence of 24 Hour Interventional 
Facilities Has an Adverse Affect on prognosis 
of Patients with Acute Myocardial Infarction 
Praveer Jain, Samir Pancholy, Christopher 
Mallavarapu, Amir Malik, Humayun Mirza, John 
P. Oervan, Peter F. Cohn. SUNY Health 
Sciences Center, Stony Brook, NY 
Although the role of early intervention «7 
days) in selected patients (pts) with acute 
myocardial infarction (AMI) is well 
established, many pts fail to undergo inter•
ventional procedures. A limiting factor may 
be available facilities. To study this, we 
compared the care and outcome (mean follow-up 
1.2 yrs) of pts with AMI treated at a 
hospital without 24 hr interventional cath 
lab facilities (H-l) and one with such 
facilities (H-2) between 1/89-12/90. Logistic 
regression revealed age, Killip Class and 
ejection fraction were significant positive 
predictors of mortality while early cath 
and/or angioplasty (PTCA) were significant 
negative predictors of mortality. At H-l 
only 28/95 pts had early cath and only 4/95 
had early PTCA while at H-2 the figures were 
80/172 and 39/172 respectively, both p<.Ol 
compared to H-li at 1 yr 32/95 pts at H-l 
were dead compared to 30/172 at H-2 (p<.003). 
Thus, 24 hr availability for early inter•
vention is an important factor in prognosis 
after AMI and absence of such facilities may 
have an adverse effect on prognosis. 
JACC Vol. 21, No.2 
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881-65 
Influence or a New Critical Coronary Care Unit Upon 
Treatment Practices and Morbidity in Unstable Angina 
Anne M. Kudelka, Rajat Prakash, Kevin Maquiling, Joseph E. 
Parrillo, James E. Calvin, Rush Medical College, Chicago, n.. 
To determine the effects of opening a 34 bed critical coronary care 
unit (CCCU) upon treatment practices for unstable angina (VA), 
forty-two consecutive patients (group 1) admitted to Rush•
Presbyterian-St. Luke's Medical Center 6 months before and 40 
patients (group 2) admitted 6 months after opening the CCCU were 
studied. Only 2 patients in group 1 were admitted to a 
multidisciplinary ICU and 30 patients in group 2 were admitted to 
CCCU. UA was diagnosed by the presence of prolonged or 
increased frequency of visceral chest pain in the absence of both 
CK elevation (twice the upper limits of normal) in the first 24 h 
and new q waves on 12 lead ECG. The groups were comparable 
in baseline characteristics other than age (group I, 66.9 ± 10.9 Y 
vs. group 2, 60.8 ± 11.0 y, P < .014) and sex (males 32.6% in 
group 1 vs. 75 % in group 2 p < .005). The use of Heparin 
(H, 47.5% vs. 18.6%, p <.02), nitroglycerin (N, 27.5% vs. 
7.0. %, P < .01) and coronary revascu1arization (42.5% vs. 8.0%, 
P < .03) was increased in group 2. However, complications 
(myocardial infarction, recurrent ischemia, heart failure or 
malignant ventricular arrhythmia) were reduced in group 2 (51.2% 
vs. 10%, P < .0009). Discriminant analysis revealed that the 
reduction in complications was explained only by the use ofN, H, 
and revascu1arization (standardized coefficients = .5036, 
P = .0316; .48653, p = .0041; .6251, p = .0059; respectively). 
Conclusion: Increasing critical cardiac care resources was 
associated with higher utilization of therapeutic interventions and a 
lower incidence of major complications in UA. 
881-66 
Predictors of Revascularization In a Multicenter Registry of Patients 
with Unstable Angina and Non-Q Wave Infarction 
William J. Rogers. Daniel J. Diver. Catherine M. Kells. James B. 
Nasmith. J. Wayne Warnica. Bruce Thompson. and Carolyn H. 
McCabe for the Thrombolysis in Myocardial Ischemia (TIMI-3) 
Registry Investigators. U. of Alabama Med Ctr. Birmingham. AL. 
To essess clinical variables predictive of revascularization 
(bypass surgery or coronary angioplasty) among patients admitted 
with unstable angina or non-Q wave MI. univariate and multivariate 
analyses were performed on 1257 patients with complete data 
enrolled in the Thrombolysis in Myocardial Ischemia ITIMI-3) 
Registry at 14 medical centers. Of the 1257 patients. 425 (34%) 
were revascularized within 6 wk of initial hospitalization. 
Revascularization rates varied significantly according to the age. 
gender and race of the patients (p < 0.001). The lowest 
revascularization rate was 13% among black females> age 75 
and the highest 53% among white males ~ age 75. Revasculari•
zation was more likely among patients with MI within the previous 
21 days (16% vs 6%) and among patients with non-Q wave MI 
(45%) than unstable angina (32%)(p = .002). Univariate analysis 
also showed more frequent revascularization (p < .01) among 
patients presenting with rest. exertional. accelerating or prolonged 
(> 20 min) angina as well as among patients requiring cardiac 
medication within the prior week (nitrates. beta blockers. calcium 
channel blockers. espirin. ACE inhibitors or heparin). Multiple 
logistic regreSSion showed that revascularization was more likelv 
to be employed in patients with non-Q wave MI (odds ratio (OR) 
2.2, recent MI (OR 2.6). rest angina (OR 1.6). use of beta blockers 
(OR 1.6) or aspirin (OR 1.6) and less likely to be employed in 
blacks (OR 0.4). females (OR 0.6) or patients> age 75 (OR 0.6). 
Thus. among patients presenting with unstable angina or non-Q 
MI. the likelihood of revascularization is highly variable but is 
related to simple demographic and c)inical variables. 
ABSTRACfS 
881-67 
Can Coronary Angiography Predict tbe Site of a 
Subsequent Myocardial Infarction ? 
Mitsuisa Yoshiaura, Hikaru Sato, Hironobu Tateishi, 
Takuji Kawagoe, Masaharu Ishihara, Yuji Muraoka. 
Hirosbiaa City Hospital. Hiroshiaa, Japan 
To assess whether coronary angiography could predict 
the site of a subsequent ayocardial infarction (MI), 
66 pts who had obtained two coronary angiograas were 
studied. The first coronary angiography was performed 
29±34 months before the MI. The indication for the 
first angiography was angina pectoris in 22 pts (Gr-1) 
and reperfusion therapy for acute NI in 44 pts (Gr-2). 
Results: 00 In Gr-1: 5 pt~ suffered froa MI within one 
month of the initial angiography. All 5 (100%) MI 
developed from the stenosis ~75%. In contrast, out of 
17 pts who suffered from MI beyond one aonth, MI 
occurred at the stenosis ~75% in only 1 (6%) pts 
(p(O_OI). ~ In Gr-2: Within one month of the initial 
angiography, MI recurred in 14 pts. Eleven (79%) NI 
developed from the stenosis ~75% and the same site as 
the previous infarct related lesion. In contrast. out 
of 30 pts who suffered froa recurrent MI beyond one 
month, MI developed from the stenosis f75% on the 
initial angiograa in only 5 (17%) pts (p(O.OI) and 
from the saae site in only 2 (7%) pts (pCO_05). 
Conclusion: p) Assessment of the angiographic severity 
of coronary stenosis might be adequate to predict the 
site of subsequent MI within one aonth but inadequate 
beyond one aonth. ~ The incidence of reinfarction at 
the saae site aight be low beyond one aonth_ 
881-68 
Ischemic Preconditioning: Prodrcmal Angina 
Luits Myocardial Infarct Size 
Filippo Ottani, Marcello Galvani, Donatella 
Ferrini, Gian Luigi Morgagni, Andrea Pettini, 
Francesco Sorbello, Franco Rusticali 
Divisione di Cardiologia,Forli',Italy 
To investigate whether new onset prodromal 
«24 hrs) angina is the clinical correlate 
of ischemic preconditining, we studied 25 
patients with a first anterior myocardial 
infarction treated with thrombolysis. All 
patients had early reperfusion (time to peak 
CK-MB ~15 hrs plus ~50' reduction of ST 
segment elevation at the end of rt-PA), 
infarct artery patency, and no evidence of 
collaterals at 3 week angiography. Infarct 
size was evaluated by peak CK-MB and dividing 
the left ventricle, with a computer-assisted 
method, in 36 se~ents and calculating the 
number of hypokinet~c segments (HS). Severity 
of hypokinesia was evaluated usin9 percent 
mean area change (MAC) of HS, obta~ned from 
the sum of percent area change of each HS 
divided by the number of HS. Area at risk 
was defined as the amount of myocardium 
beyond the infarct-related stenosis. 
Angina +VE Angina -VE 
Cn-13) Cn=12) 
Time to rt-PA(min) 75±21 81t19 NS 
Peak CK-MB(U/L) 210t129 69t22 <.001 
Area at Risk(n.HS) 15t4 13t4 NS 
Infarct Size(n.HS) 11t7 4t3 <.004 
MACC') 19±11 10t8 <.05 
In conclusion, despite a similar area at risk, 
~atients with prodromal angina have a smaller 
~nfarct size, and a lesser extent of 





Does Chronic Ischemic Preconditioning Umlt Infarct Size In 
Patients Treated with Flbrlnolytlcs for Acute Myocardial 
Infarction? 
Labros A Karagounis, Jeffrey L Anderson, Lewis C Becker and the 
TEAM-3 Investigators, University of Utah, LOS Hospital, Salt Lake 
City, Utah. 
Ischemic preconditioning has been shown to protect against ischemic 
insults in animal models. To investigate if ischemic preconditioning 
operates in humans, we compared lell ventricular functional indices 
between patients (pt) with (ANG, n=84) and without a history of 
angina (NO ANG, n=183) who suffered a first acute myocardial 
infarction (MI) and in whom fibrinolytic therapy (IV APSAC, 30 U/5 
min, n=132 or t-PA,100 rngl3 hr, n=135) was initiated early (~hr) from 
symptom onset in conjunction with aspirin and heparin. There was no 
difference between ANG and NO ANG groups in terms of age (X±SD, 
60±11 vs 57±10 p=0.12), gender distribution (males, 71.4% vs 
77.0%, p=0.32), anterior MI (36.9% vs 36%, p=0.89), time lapsed 
from symptom onset to therapy initiation (2.7±1.0 vs 2.7±O.8 hr , 
p=0.76), pre-therapy rST elevation (1.0HO.7 vs 1.18±0.9 mV, 
p=0.26) and grade 3 flow of the Infarct related artery at 24 hours 
(72.2% vs 76%, p=0.51). The discharge (D/C) and 1 month (mol 
global (EF) and regional radionuclide left ventricular ejection fraction EF 
(reg EF) were used as indices of lell ventricular function. Analysis of 
the radionuclide studies was performed in a central laboratory blind to 
pt outcomes. Analysis of variance was used to compare the two 
groups after adjustment for ~N~ effect !APSAC vs t-PA). 
X±SD ""OANG ~
Baseline EF 54.4±12.3 54.8±12.0 0.82 
Reg EF 37.6±17.1 392±17.6 0.52 
DIC EF 52.2±12.3 53.8±11.0 0.39 
D/Creg EF 38.2±19.7 41.3±16.9 0.30 
Me EF 52.9±13.6 53.1±11.6 0.97 
Me reg EF 38.0±19.9 4O.3±19.0 0.55 
Conclusions: We found no evidence to suggest that preconditioning in 
the form of clinical angina confers protection against ischemic injury 
during MI treated with fibrinolytic therapy in humans. 
881·70 
Established 8·blockade reduces infarct size 
in acute myocardial infarction 
Knud Landmark. Petter Urdal, Michael Abdelnoor, Ullev!1 
University Hospital, Oslo. NOIway 
Four hundred and eighteen patients (pIS) (mean age 66.2 years) 
admitted with acute myocardial infarction (AMI) were evaluated to 
see if ongoing B-blocker treatment (BB+) at the onset of chest pain 
had beneficial effects on infarct size as judged from peak creatine 
kinase (CKmax) activity. In this analysis we have also taken into 
consideration confounders such as previously diagnosed coronary 
hean disease (CHD). thrombolytic therapy (Thr) during AMI, 
hypenension (HTN) and the age of the patient. In the different 
groups we found: 
CKnwx (mean ± I standard deviation. VI/) 
fu... lifL-
BB 1072±781u (n=63) 1486±1107 (n=355) 
CHD 117O:t924*u (n=220) 1704±1159 (n=198) 
1lrr 2071±1311*** (n=87) 1244±914 (n=331) 
**p<O.OI. u*p<O.OOl 
Thus. BB+ and CHD+ pts had significantly lower CKmax than had 
BB- and CHD- pIS. and Thr+ pIS had significantly higher CKmax 
values than had Thr-pts. In addition. age decreased CKmax 
(p<O.OO 1) whereas lITN did not affect this parameter. 8-blocker 
treatment was more common in CHD+ pIS and in hypertensives 
than in CHD- pts and nonnotensives (p<O.Ol and 0.05. 
respectively). 
After adjusting for confounding effects of CHD+. Thr+. age and 
lITN. B-blocker treatment still significantly (p<O.03) reduced 
CKmax. To quantify this reduction, in the patients with the largest 
infarcts (CK max> 1977 Ull. the 75% quartile) and using a logistic 
model. we found that use of B-blocker reduced the incidence of 
large infarcts by 58% (odd ratio (OR) =0.42; 95% CI(O.l8-O.94». 
Conclusion: This study shows that when controlling for 
confounders. 8-blocker treatment at the onset of AMI reduces 
infarct size as well as the incidence of large infarcts as judged by 
CKmax. 
881-71 
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Multinational Study of the Effect of Acadesine on Major 
Cardiovascular Outca.es Associated with CABG Surgery -
Europe/Canada Perioperative Ischeaia Research Group 
The effect of acadesine (AICA riboside) on the incidence 
of perioperative myocardial infarction (PMI) and other 
adverse cardiovascular outcomes of CABG surgery has been 
studied in a major multinational collaborative trial. 
Acadesine (A) is a purine nucleoside adenosine regulat•
ing agent (ARA) which enhances local myocardial adeno•
sine concentration selectively, i.e. only during is•
chemia and only in the ischemic region. In animal models 
of cardioplegic arrest A has been shown to improve car•
diac functional recovery. In a preliminary study of 116 
patients, treatment with A has been reported to be as•
sociated with a 64% reduction in the incidence of PMI 
after CABG surgery. In the present study, therefore, 
the efficacy of A on the incidence of PMI and major CV 
outcomes were assessed in 831 patients undergoing CABG 
surgery at 25 centers in the Netherlands, Germany, Nor•
way, Sweden, UK, France, Belgium and Canada. Patients 
were randomly allocated to treatment with placebo (P) or 
A 0.1 mg/kg/min by IV infusion starting 15 minutes be•
fore anesthetic induction and continued for 7 hours. A 
(5 ug/ml) was also added to cardioplegia solution in 
group A. Anesthesia was standardized, hemodynamics were 
carefully controlled and surgery was performed USing 
standard bypass techniques. A 12 lead ECG was obtained 
preoperatively (control), on post-operative days 0,1,2, 
3,5 and discharge. CK-MB isoenzyme levels were obtained 
at frequent intervals for 60 hours postoperatively. ECGs 
and CK-MB levels were centrally analyzed by blinded ob•
servers. Other adverse CV outcomes evaluated were car•
diac death, heart failure, serious arrhythmias and 
stroke. Results of intervention with A on the incidence 
of these adverse CV outcomes will be presented and 
their clinical significance discussed. 
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882-50 
Early Ambulatlon 130 minutes) After Cardiac Catheterization 
UsIng the Collagen Plug. Efficacy ond Follow-Up Comporlng 
Two Dlfferenf Plug Dosages In 660 Cases_ 
S. Silber, C. Haentsch, N. Seidel, H. MOhling, Kardiologische 
Gemeinschaftspraxis, Dr. MOiler Hospital, Munich, Germany 
Outpatient cardiac catheterization (cath) using the femoral 
approach is usually performed with 5F sheaths and ambulation 
aller appro 4 hours. Purpose of this study was to investigate 
whether immediate hemostasis (hst) using a newly developed 
collagen plug may reduce the time to ambulation and to deter•
mine possible side effects. 
660 consecutive outpatients were randomly assigned to either 
2 plugs or 1 plug. Efficacy was graded as A (immediate hst), B 
(acceptable hst) and C (no hst). PIs with A and B were ambu•
lated 30 minutes after plug. FollOW up (next day, 1 and 4 weeks) 
included history, physical findings and duplex ultrasound of the 
puncture site. Results (% of pts): 









normal 70% 88% 
little local swelling 27% 12% 
severe local swelling 3% 
No intravascular deployment, major bleeding complications or 
pseudoaneurysms occurred. 
Conclusions: The collagen plug effectively allows ambulation 
30 minutes after diagnostic cath in most patients. 1 plug is as 
safe as 2 plugs. Because of fewer side effects, 1 plug should be 
preferred. 
lACC Vol. 21, No.2 
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882-51 
Safaty and Efficacy of Randomized. Single Blind Nilrogiycwin vs. Ditiazem 
Infusion In Patiants With Sevare Unstabla Angina 
Mitchell W. Krucoff. Sharon T. Sawchak, Cynthia Graen. Nancy M. 
Wilderman. Habib Komari. Karen S. Pieper, James E. Pope. William E. 
Boden. Duke Medical Center. Durham. NC. 
To test the safety and afficacy of IV diltiazem (DILn va. stsndard IV 
nitroglycerin (TNG) therapy. 56 pts. with both rest angina and raversible 
ST 88gmant changes on oral medication were randomized to addition of 
TNG or OIL T. TNG infusion was 100 ug/min; OIL Twas boIused 10 mg + 5 
mg with infusion at 5-1 0 mglhr. Infusions were titrated down to avoid 
BP < 100 or up for angina. Safety endpoints were: HR < 50 (BRADY); 
BP<90 (HYPO); heart failure (CHF); heart block (BLOCK); other 
intolerance (OTHER). Efficacy endpoints (during infusion) were: death; MI 
(2X CPK); urgent CABG or PTCA; transient ischemic epsisodes (TIE); and 
total ischemic burden (TIB). TIE (as > 100 uV ST deviation lasting > 60 
seconds) and TlB (as summated 12-lead ST deviation over the duration of 
all TIE) were determined from blinded analysis of continuous 12-1ead ST 
segment monitoring for a median 30.4 hrs. Results (all as , of pts): 
Qryg BRADY.t:!XfQ Q:jf ~ OTHER AN:!.. 
TNG 10 15 0 0 11 20 
OIL T 7 0 1 1 8 15 
Qryg DEATH MI CABGtpTCA I!f AN:!.. 
TNG 0 1 18 11 23 
OIL T 0 6 16 15 23 
Quantified 12-lead TlB (as uVmin) was: 
Qryg Mean + SO Median (25th. 75th '!bile) ~ 
TNG 2250.±.4917 0 (0. 249) 0-19.173 
DILT 4551.±. 9359 457 (0,5181) 0-36,333 
No differences reached significance. although the trend in TlB and MI were 
noteworthy. Thus, relative to TNG in pts. with severe unstable angina: 
1) combined OIL T bolus and infusion appears safe but 2) appears to be 
less effective in stabilizing the duration and severity of transient ischemia 
at the doses used in this trial. 
882-52 
Effect of L-Arginine, the Substrate for Nitric Oxide, on 
Endotheliu.-Oependent Vasodilation of the Coronary 
Microvasculature 
Arshed A. Quyyumi, Nader Dakak, David Gilligan, 
Jean G. Diodati, Julio A. Panza, Richard O. Cannon III, 
NHLBI, Bethesda, MD. 
We have previously demonstrated that L-arginine (l-Arg), 
the substrate for nitric oxide synthesis, can enhance 
acetylcholine (Ach)-induced endothelium-tendo) dependent 
dilation of the peripheral vasculature. To examine 
whether L-arg improves endo-dependent dilation of the 
coronary vasculature, we studied 20 pts, 11 with chest 
pain and normal coronary arteries (CPNCA), and 9 with 
coronary artery disease (25 to 70% stenosis). 
Incrementa 1 concentrat ions of Ach (l0''M to IO"M) were 
infused into the left main (ic), and blood flow was 
derived from Doppler flow velocity and coronary diameter 
measurements. The 2 highest concentrations of Ach were 
re-infused after ic L-Arg (I60 #M/min) infusion. 
* =P<0.05 compared to baseline. 
S change in Coronary vascular resistance with Ach 
Baseline ~ 
CPNCA -43±28 -55±23* 
Coronary artery disease -38±22 -47±2I* 
Resting flow and endo-independent flow reserve with 
adenosine were unchanged after l-Arg. However, the 
dilation in response to Ach was enhanced with l-Arg in 
both groups. IN CPNCA pts, there was an inverse 
correlation between the response to Ach at baseline and 
the improvement with L-Arg (r=-0.55, p<O.OI), implying 
that pts with depressed dilator response to Ach, that is 
those with endo dysfunction,had a greater response to 
L-Arg, and vice versa. Thus, limitation of nitric oxide 
substrate may account for the endo dysfunction in some 
pts with CPNCA and in coronary artery disease. 
ABSTRACfS 15lA 
882-53 
Low Hortali ty Among Patients in whom the 
Suspicion of Acute Myocardial Infarction was 
Ruled out if Beta-blockers were Prescribed at 
Discharge_ 
Johan Herlitz, Bjorn W.Karlson, Axe Hjalmarson 
Division of Cardiology, Sahlgrenska Hospital, 
Goteborg, Sweden 
Background: Previous studies have shown that 
beta-blockers improve prognosis after develop•
ment of acute myocardial infarction (AMI). 
Whether they will affect the prognosis in 
patients in whom AMI was not confirmed has not 
been shown. Purpose: To relate the prognosiS 
among patients in whom AMI was not confirmed 
to prescription of beta-blockers at discharge. 
Methods: Consecutive patients admitted to one 
single hospital due to suspected AMI but in 
whom the diagnosis could not be confirmed who 
were discharged alive were prospectively 
followed for one year. Results: 
Beta-blockers prescribed at discharge 
YES NO P 
n=637 n=806 
Age (years;mean±SEM) 67±0.5 69±0.5 <0.001 
Previous history of (%) 
Myocardial infarction 42 26 <0.001 
Angina pectoris 70 48 <0.001 
HypertenSion 46 25 <0.001 
Congestive heart failure 21 34 <0.001 
One-year mortality (%) 6 16 <0.001* 
* p-value corrected for difference at baseline 
Conclusion: Among patients hospitalized due to 
suspected AMI but in whom the diagnosiS was 
not confirmed, prescription of beta-blockers 
at discharge was associated with a low one•
year mortality. 
882-54 
Complete Coronary RevascularlzaUon Is Associated With A 
Lower Risk Of Ventricular Arrhythmias In Patients With 
Implantable DefIbrillators. 
Lewis L. Horvitz, Joseph F. Pietrolungo, Lon Castle, Richard 
Trohman. James D. Maloney. 
Cleveland Clinic Foundation, Cleveland, Ohio. 
To detennine the influence of complete revascularization on patients 
with lethal ventricular arrhythmias and an implantable defibrillator 
(ICD), we studied survival and appropriate shock-free survival in 234 
coronary patients who received an iflllIantabie defibrillator (ICD) lor 
hemodynamically unstable ventricular tachycardia or sudden 
arrhythmic death. 
Results: At the time of or before their ICD implant, 122 ICD patients 
underwent complete revascularization (R), and 112 were left 
incompletely revascularized (with less than TIMIIiI flow in at least 
one major epicardial artery). Appropriate shock-free survival is 
superior in the complete revascularizion group (p = 0.0006). Ejection 
fraction (EF) is an independent predictor of appropriate shock-free 
survival with the Cox proportional hazards model (p = 0.006). 
Adjusting for EF, appropriate shock-free survival in the complete 
revascularizion group remains superior to the incomplete group 
(p = 0.007). Survival is similar between the two groups. 
Kaplan-Meier Appropriate Shock-Free Survival 
12 roo 24 roo 36 mo 48 roo EF 
COlllliete R 70.3% 53.2% 50.4% 44.8% 32.8 ±9.3 
Incomplete R 49.7"10 27.3% 24.0% 24.0% 29.8 ±7.4 
Conclusions: 1. Patients receiving complete revascularization have 
improved shock-free SUrvival, independent of EF. 
2. These data further support the benefit of restoring coronary blood 
flow in patients with ventricular arrhythmias. 
3. Prospective studies are needed to further define the role of 
revascularization in patients with lethal ventricular arrhythmias. 
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882·55 
FEW COMPLICATIONS OF CORONARY ANGlO· 
GRAPHY IN CLlNICALl.Y STABLE PATIENTS 
William J Stewart, Lucien Campeau, Ann Hickey, Irvin 
Goldenberg, Alan Herd, Norma Lynn Fox, Carl W White, for 
Post CABG Clinical Trial Investigators, Cleveland,OH 
Most reports of the frequency of complications of 
diagnostic coronary angiography (CATH) have included 
large numbers of acutely ill patients, whose instability may 
have contributed to periprocedural complications. In the 
recruitment phase of the NHLBI·funded Post·Coronary Artery 
Bypas$ Graft (Post·CABG) intervention trial, CATH was 
performed at 7 different clinical centers in 1532 stable 
patients who had no recent clinical cardiovascular events, 
severe angina, heart failure, or other disease associated with 
potentially reduced survival. All patients (61.4 ± 7.5 yrs old, 
8.5% women) had undergone CABG a mean of 4.8 ± 2.6 
years earlier (average 3.0 veins and 0.5 arterial graftslpt). All 
had selective native coronary artery and graft opacification 
and left ventriculography. 
RESULTS: Only 12 (0.8%) serious complications 
were noted within 24 hours of CATH, including 3 strokes and 
9 vascular trauma events requiring surgical repair. There 
were no deaths or myocardial infarctions. Minor 
complications occurred in 33 patients (2.2%) involving 2 
transient ischemic attacks, 1 episode of minor gastrointestinal 
bleeding, 2 anginal chest pain, 2 dye reactions, 10 minor 
vascular trauma, and 16 arrhythmias (including 7 ventricular 
fibrillations). 
CONCLUSIONS: Truly elective CATH not driven by 
clinical events in stable coronary patients following bypass 
surgery is associated with a lower incidence of serious 
cardiovascular complications than has previously been 
reported. 
882·56 
Rapid Angiograpbic Coronary Artery Stenosis 
Progression in Patients Witb Iscbemic Heart Disease 
Juan Carlos Kaski, Demos Katritsis, Lijia Chen, Michael Chester. 
Cardiological Sciences Dept. St George's Hospital, London, UK. 
The incidence and clinical and angiographic fcaMes of rapid (within 
1 year of flTst evaluation) coronary stenosis progression was studied 
in 92 consecutive patients (pts) (77 men, 15 women) with angina 
and documented coronary artery disease. 61 pts presented with 
chronic stable angina and 31 with unstable angina, whicb stabilized 
following conventional drug therapy. All pts underwent coronary 
arteriography at study entry and follow up (8.0±3.2 months after 
first examination), preceding elective coronary angioplasty or by· 
pass grafting (66 pts), or owing to the development of an acute 
coronary syndrome (26 pts). Progression was assessed in 196 
stenoses by means of computerized coronary arteriography (CAAS). 
Stenoses were classified as smooth (smooth edges; 124 stenoses 
(63%» and complex (overhanging edges, irregular borders; 72 
stenoses (37%». Of the 196 stenoses, 116 (59%) were <50% and 80 
(41 %) ~50%. Stenosis progression was defmed as >30% increase in 
severity of a previous stenosis or progression to total occlusion. On 
average, diameter (mm) of complex stenoses decreased from 
1.54+0.45 to 1.25+0.69, wbilst that of smooth stenoses decreased 
from 1.67+0.53 to 1.58±O.54 (p=O.OOl). Progression occurred in 
20 of 78 (26%) complex and 7 of 124 (6%) smooth lesions 
p<O.OOI). Total coronary occlusion developed in 13 complex and 2 
smooth stenoses. Acute coronary events developed in 26 pts (28%), 
which were associated with progression of complex stenoses in 14 
pts and of smooth stenoses in 4 pts. In 8 (31 %) of the 26 pts the 
acute event developed in the absence of stenosis progression. Acute 
events were more frequent amongst pts who presented with unstable 
angina compared with those with stable angina (17!31 (58%) vs 9/61 
(15%); p<O.OOI). The results of this study indicate that rapid 
stenosis progression is a rather common phenomenon. It occurs 
more frequently in pts with complex lesions who present with 
unstable angina, in spite of stabilization with medical treatment Our 
findings may have clinical and pathogenetic implications. 
882·57 
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Medical and Surgical Tberapy for Left Main Equivalent 
Coronary Artery Disease: Long Term CASS Experience 
Eugene A. Caracciolo, George C. Kaiser, Hartzell Schaff, Herman 
A. Taylor, George Sopko, Kathryn Davis, Bernard R. Cbaitman, for 
the CASS Investigators, St. Louis, Missouri 
Left main equivalent (LMEQ) coronary disease was defined in CASS 
as combined proximal left anterior descending and proximal left 
circumflex coronary disease > 70%. The 13 yr cumulative survival 
of 1,368 pts with LMEQ coronary disease enrolled in the CASS 
registry was 29% for 423 pts treated with medical therapy (MT) and 
52% for 945 pts who had coronary artery bypass grafting (CABG) 
(p<O.OOl). The median survival for the MT and CABG group was 
5.8 and 13.3 yrs, respectively. Analysis ofLMEQ registry pts 
showed a significant survival benefit in favor of CABG with 
subgroup stratification based on age, Canadian heart angina class, 
right coronary artery disease, and left ventricular ejection fraction 
(LVEF) (p<O.OOI). The median survival in 348 pts with LVEF 
< 50% for the MT and CABG groups was 3.9 and 11.4 yrs, 
respectively. In 618 pts with an LVEF> 50%, the median survival 
was 11.1 and 14.3 yrs for the MT and CABG groups, respectively. 
In the CASS randomized trial of pts < 65 yrs of age with mild or no 
angina and a L VEF > 0.35, 48 pts had LMEQ coronary disease. An 
additional 83 pts met entry criteria but were not randomized 
(randomizable). The randomized and randomizable pts account for 
10% of the total LMEQ pts in CASS. CABG did not confer a long· 
term survival benefit for the randomized or randomizable LMEQ pts 
when the baseline L VEF was > 50% (P::{).76 for the randomized 
group, p = 0.85 for the randomizable group). Presently, > 50% of 
the randomized and randomizable pts are alive after 13·15 yrs of 
follow·up. 
In conclusion, CABG improves survival in the majority of pts 
with LMEQ coronary disease but does not improve long-term 
survival in pts < 65 yrs of age with mild or no angina, and an L VEF 
> 50% that meet CASS entry criteria. 
882·58 
Improved Decision Makin& for Coronary Interventions: Com· 
parison of Intracoronary Lesion Flow Dynamics VersUs ischemIc 
Stress Testing 
Thomas Donohue, Morton I. Kern, D. Douglas Miller, Richard 
Bach, Arthur J. Labovitz, Bernard R. Chaitman, Eugene Caracciolo, 
Frank V. Aguirre. 51. Louis University, St. Louis, MO 
Stress testing with perfusion imaging is routinely used for determin•
ing the significance of coronary artery stenoses. Using a 0.018" 
Doppler guidewire, a ratio of proximal/distal total Velocity integrals 
(flow ratio) of < 1. 7 has been shown to correlate with insignificant 
( < 20mmHg) translesional gradients. To determine the functional 
Significance of coronary artery stenoses, 49 patients had intracoro•
nary translesional flow and pressure gradients measured and 
underwent stress testing with thallium·201 or Tc·99m sestaMmI. 
Total flow velocity integrals were detennined both proximal and 
distal to coronan' stenoses. 
Flow Ratio 
Stress Test < 1 7 ~ 1 .7 % Stenosis Concordance 
I Normal (n=23) 22 1 54±14 96% 
IT Abnormal (n=26) 15 11 68±15 42% 
Normal perfusion stress testing is 96 % concordant (22123) with 
normal basal coronary flow. Of the 26 patients with abnormal stress 
tests, 11 (42 %) had abnormal flow ratios with significant transle· 
sional gradients (43±29mmHg) and angiographically severe lesions 
(78± 10%). Of the remaining 15 patients with abnormal stress tests 
but normal flow ratios, 14 had inSignificant gradients (10±8mmHg) 
and angiographically intermediate stenoses (60±10%). These 
patients did not undergo coronary angioplasty. 
Therefore, translesional flow dynamics are strongly predictive of 
epicardial lesion significance and can be useful in assessing angio•
graphically intermediate stenoses with abnormal perfusion imaging 
that may not require coronary intervention. 
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Colnpllrable AnJlKhemIc EtIIc8cy of Proplony\-L.camltl.. and 
Dlltlaam • A Novel Metabolic Approach to lacllemla 
Louis Bartels, WUIem J. Remme, Dick KruljsMn, Klaas HoMwda. 
Sticeras Foundation, RoIIerdam, The Ntlher1and •. 
PropIony~L-camlline (PLC) administered Intravenously acutely reduces 
myocardial ischemia by raatoring 1schemIa-IndUClld cardiac L-camlline 
loss. Consequently, It Improvea aaroblc mtItaboIism through pyruvat. 
acetate conversion and anhances mitochondrial A TP transport. To wall.!•
alii long-term antIlschemlc elllcacy, 46 unIr8at8d pis with liable, axer•
c:is&-Inducecl angina r1IC8ived PLC and Olltiazem (0) In a randomized, 
dcu~blind, crossover study. After a 2 wk washout phase of anti-ang~ 
nal medication and a 2 wk singl.blind placebo period, 23 pis r1IC8ived 
500 mg PLC tiel for 6 wks and 23 pis 0 (60 mg tid for 3 wks followed by 
120 mg tid for 3 wk.), CfOIIing over to the other InIatrnant after 1 wk 
wuhout. Pta with > 2 anginal attackaIwk during the placebo period and 
angina and ~0.1 mV ST-deprasaion (Sl) during upright bicycle axercise 
teating (10 Watt/min Increment) and <15% variation '*-1 2 baseline 
exercise I8Its __ Included. ThIW pis on PLC (2 prograasivll angina, 1 
v.getativll complaints) and 2 pts on 0 (1 heart failure, 1 stomach oom•
plaints) dilcontinued. Both InIatments resulted In comparable exercise 
duration (582± 238 sec and 588±229 sec, PLC and 0 rasp., X±SO) and 
time to 0.1 mV ST (436±259 sec and 465±244 sec, rasp.). PLC similarly 
incr8aaed time to 0.1 mV ST In comparison with baseline [20% VI 28""", 
(0)), and redUClld ST at maximal axercise (23% VI 35% (0), both p<O.05 
VI baseline). MOlllOVer, anginal attacks __ redUClld by 70% (PLC) and 
57% (0), wt... nitroglycerin oonaumption cIec:reued by 57% (PLC) 
and 70% (0). Thus, both PLC and (high-dcse) D reduce myocardial ls•
chemia In a similar fuhlon. Ita, In addition, PLC II as effective as 0 In 
decrllasing anginal attack. and II well tolerated, this novel metabolic 
approach to ischemia warrants further development. 
882·60 
Antlanglnal Effects of Captopril In Hypertensive Patients 
David B. Cross, Gregory M. Scalia. Constantine N. Aroney, John J. Atherton. 
J.H. Nicholas Bett. John T. Rivers. Peter J.O. Stride, and Geoffrey W. Holt. 
Royal Brisbane Hospital, Brisbane, Australia. 
Recent large studies of angiotensin converting enzyme inhibitors In patients 
with left ventricular dysfunction have demonstrated an Important reduction 
In ischemic events. The mechanism of this effect is uncertain. We 
examined the antlanginal effects of captopril SOmg b.i.d. and those of 
verapamll 160mg b.l.d. in 22 hypertensive patients (16 male. age 62 :!: 6 
years) in a double-blind crossover study. After withdrawal of all antlanginal 
therapy for 2-6 weeks. two symptom limHed treadmill exercise tests and a 
1 day angina diary were obtained. More than 1mm of ST segment 
depression on the second baseline study was required for inclusion. The 
exercise test and diary were repeated at the end of each 6 week treatment 
period. Both agents produced similar reductions in blood pressure. 
Baseline c.ptaprll 2p V.,..,..,..II 2p 
Q!m 
Eplsodes/Wk 4.1 :I; 1.3 2.4:1; 1.1 .02 2.6:!: 1.1 .04 
ISDN/Wk 4.3:1; 1.5 2.5:!: 1.4 .03 2.8:!: 1.4 .06 
Totai pain/Wk (min)' 5 (0-15) 0(0-5) .01 0(0-3) .02 
Stress teat 
Time lmm ST ~(min)' 4 (3-6) 5.5 (3.5-10) .02 7.5 (5-NR~ .01 
Duration (minI 7.0:!: 0.5 1.4:!: 0.6 .16 8.0 :!: 0.7 .01 
Maximum ST ~ (mm 1.9:!: 0.2 1.1:!: 0.2 .09 1.4:!: 0.6 .01 
Double product" 269 ± 11 255:!: 12 .14 253:!: 14 .14 
[wk = week; ISDN = lsosorbide dinkrate; ST ~ = ST depression; Results 
mean ± SEM or median (interquartile range)'; • NR = lmm not reached; 
• x100 bpm.mmHg) Results for captopril were not Significantly different to 
verapamil except time to lmm ST depression (p=0.05). 
Conclusions: Captopril has a Significant antlanglnal effect In patients with 
hypertension. This benefit was manifested by reduced angina frequency 
and by Increased ischemic threshold on stress testing. 
ABSTRACTS 
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Possible Role of Magnesium Deficiency for Alcohol•
Induced Variant Angina 
Kunihisa Miwa, Akihiko 19awa, Masatoshi FUjita, Toyama 
Med. & Pharm. Univ., Toyama, Japan 
Alcohol Is a known precipitating factor for anginal attacks in 
patients with variant angina. Because urinary magnesium 
(Mg) excretion is known to be accerelated after alcohol 
drinking, Mg deficienay may be responsible for alcohol•
related anginal attacks. In order to elucidate the possible role 
of magnesium defiCiency in the pathogenesis of the alcohol•
related anginal attacks, 10 patients with variant angina who 
had a positive relation between anginal attacks and alcohol 
Intake (Group A), the 11 patients without the relation (Group 
B) and 8 control subjects (Group C) were studied for 
estimating 24-hour Mg retention of Intravenously 
administered low dose Mg (0.1 mM/kg). A 24-hour Mg 
retention of 6Ot8% (mean±SEM) in Group A was Significantly 
higher than 40±8% in Group B (p<0.05) and 26t5% in Group C 
(p<0.01). There was no significant difference in 24-hour Mg 
retention between the latter 2 groups. intravenous infusion of 
Mg (0.27 mM/kg) over 30 min completely suppressed the 
occurrence of hyperventilation-induced anginal attacks after 
alcohol intake in 4 (50%) of additional 8 patients with variant 
angina and alcohol-related attacks in all of whom anginal 
attacks had been induced by hyperventilation on the next day 
of alcohol intake. Habitual drinking was noted in 16 (89%) of 
the 18 patients with alcohol-related attacks. 
Conclusion: Mg loading test revealed the remarkable Mg 
deficiency in patients with variant angina and alcohol-related 
attacks, suggesting that alcohol-induced Mg deficiency play 
an important role in the pathogenesiS of these attacks. 
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883·81 
Implantable Cardiovartor-Oeflbrlilator Therapy: How Important II 
Age In the Selection Procell 
Anwer Dhala. Zalman Blanck. Alfred Anderson. Kathl Axtell. Sanjay Desh•
pande. Boaz Avitali. Mohammed Jazayerl. Jasblr Sra. Masood Akhtar. Sinai 
Samaritan Medic:al Center. Milwaukee. Wisconsin 
The Impact on long tenn survival of pts treated with the Implantable 
cardiovertor-deflbrlilator (ICO) remains debatable. This Is speclaDy relevant 
In the older population In whom the prognosis of coronary anery disease 
(CAD) is reponedly worse. We therefore compared the survival of pts with 
CAD under 70 years of age. mean age 60.3 yrs. SO 6.5 (Group 1. 250 pts) 
with those over 10. mean age 73.7 yrs. SO 3.3 (Group 2. 99 pts) to assess 
if ICO benefk persists with increasing age. Both groups were comparable 
with respect to sex distribution. ejection fraction. NYHA functional class. 
presenting arrhythmia, concomHant surgery, prior myocardial Infarction, 
and frequency of appropriate shocks. 
RESULTS: 39 pts in Group 1 (SCD 12, nonsudden cardiac 15 and noncar•
dlac 12) and 25 pts In Group 2 (SCD 2. cardiac 14 and noncardlac 9) died 
during a mean follow-up of 3.0 yrs and 2.2 yrs In the two groups respectively. 
Actuarial total survival from yrs 1-5 was 0.94.0.90.0.86.0.82 and 0.74 for 
Grollp 1. and was 0.85.0.80.0.70.0.65 and 0.51 for Group 2 (p < 0.002). The 
p value was < 0.01 when only nonsudden cardiac survival was compared 
and wes not slgnWlcant when sudden cardiac survival wes compared. 
Using a multivariate analysiS to identify which of the factors listed above 
were associated Independently with mortality. the relative risk was 2. 18.1.96 
and 1.63 for age greater then 10. non Q 1.41 and sustained VT on presenta•
tion. respectively. Within Group 1. when pts were subdivided Into those 
below 60 yrs and 60 to 69, age was not significantly related to mortality. 
CONCWSION: 1. Age greater than 10 yrs adversely affects outcome. 2. 
Projection of survival data from a younger population may result In an 




Haemodynamlc Deterioration During leD Implant: Preoperative 
Identification or High Risk Patients 
Uwe Dorwarth, SOren Mattke, Ellen Hoffmann, Heidi Rhode, 
Bernhard Kemkes, Peter Tassani, Gerhard Steinbeck. University of 
Munich, Munich, FRO. 
Implantation of defibri1lator systems requires consequent testing of 
defibrillation threshold (OFl) to ensure the efficacy of the system. 
However, perioperative haemodynamic deterioration and pump 
failure were observed earlier. 
To investigate the influence of OFT testing on cardiac function we 
measured haemodynamic parameters with a Swan-Ganz catheter 
peri- and postoperatively in 28 consecutive patients wih a 
transvenouslsubcutaneous approach. A mean of 5±2 episodes of 
ventricular fibri1lation were induced with an overall ischaernic time 
of 99±52s. At the end of the procedure patients with an ejection 
fraction (EF) < 30% showed a significant impainnent of cardiac 
index (1.8;tO.4 vs 2.3;tO.6 lImin1m2 before testing). Left ventricular 
function of patients with a preoperative EF ~ 30% was not 
significantly changed (2.4±O.5 vs 2.4±0.6 lImin1m2 before testing). 
Patients in group one had an EF of 23±5%, in group two EF was 
58±17%. The two groups did not differ with respect to the number of 
testing episodes, ischaernic time or OFT. ~uring a postoperative 
observation period of 1152.6 hours cardiac index recovered in all 
patients, one patient with severe compromised ventricular function 
needed dopamine infusion. 
Conclusion: Patients with a preoperative EF < 30% carry a high risk 
of perioperative haemodynamic deterioration. For these patients we 
recommend a close perioperative haemodynamic monitoring and a 
highly restricted OFT testing regime. 
883·83 
Do Patients With Implantable Defibrillators Live Longer? 
Oir1c. BOeker, MO, Michael Block, MO, Frank Isbruch, MD, Dietmar 
Wtetllolt. MO, Dieter Hammel, MD·, Martin Borggrefe. MO, 
Gunter Breithardt, MO, FACC 
Dep. of Cardiology. Dep.of C8rdiothoracic SUrgery" and lnst. for Res. 
ArterIOsClerosis. WestflliSChe-Wilhelms-Universitlt. MOnster. Germany 
Bac:kground: Implantation of automatic cardioverter~lators (ICO) is 
reported to abort sudden cardiac death due to malignant tachyarrhythmias. 
Method. and mults: Between OctOber 1e89 and 1992 107 patient were 
screened for implantation of 3rd generation implantable defibrillators (ICO) 
combined with andocardialleads. Mean age was 56:1: 16 years, mean EF 
was 40:1: 15%. 
Sudden death, surgical mortality, non-sudden arrhythmia related death 
(death Within 24 hours after an arrhythmic event despite initial termination 
of the alThythmia by the ICO), total arrhythmia related death (inctuding 
surgical mortality, sudden death, and non sudden arrhythmia related 
death), and total cardiac death were compared to \he occurrenca of fast 
ventricular lachyarrhythmias (M. > 240 bpm), assuming that most fast 
sustained VT would have been fatal without treatment by the ICO. T achy· 
cardias occurring within 1 week after operation were excluded from analy•
sis. 
Successful defibrillation with endocardial leads was achieved in 99 pa•
tients, 8 patients recaived epicardial leads. Surgical mortality was 2.7 'II. in 
atl patients and 1.0 'II. In \hose patients who qualified for andocardial leads. 
DurIng the follow-up of 12 :I: 8 months actuarial survival rates free of 
events were 100%, 100%. and 100% at 6. 12. and 18 months. respec•
lively, for sudden death; 97%, 97%, and 97% at 8, 12, and 18 months, re•
spectively. for total arrhythmia related death; and 95%, 95%, and 95% at 
6, 12. and 18 months. respectively, for total cardiac death. whel"llas only 
83%,74%, and 69%. respectively, were free of fast VT after 8. 12. and 18 
months and only 59%, 49%, and 40%. respectlvely. were free of any ven•
triCUtartachyarrhythmia after 8. 12, and 18 months. 
Conc:tulion: The outcome of patients treated With ICDs and endocardial 
defibrillation leads Is exceHent. For many patients this treatment most 
probably is lifesaving. Non-sudden arrhythmia related death is a rare find•
ing. 
883·84 
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Pradictors of Total Arrhythmic Mortality and Total Mortality 
in 241 Patients With Implantable Cardioverter Defibrillator 
Wolfram Grimm', Belinda F. Flores, Francis E. Marchlinski, Philadelphia 
Heart Institute, Philadelphia, PA, 'Philipps-University Marburg, Germany. 
To determine predictors of total arrhythmic and total mortality, 241 
consecutive ICD patients were followed for 26 ± 22 months· after ICD 
implant (intention to treat). Total arrhythmic mortality (n = 19) was 
defined as suddan (death < 1 h after onset of symptoms or unwitnessed, 
n = 1 7) or tachyarrhythmic/nonsudden (death associated with sustained 
VT or VF persisting or recurring over a time period ~ 1 h before death, 
n = 2). TOUlI mortality (n = 73) was defined as death from any cause 
including perioperative mortality (n = 8). Univariate and multivariate 
comparison of the Kaplan-Meier curves for both, total arrhythmic and total 
mortality. was performed using Cox proprotional hazards analysis for the 
following variables: age, gender, ejection fraction (EFt. response to 
programmed stimulation, coronary bypass grafting and antiarrhythmic 
drugs at implant. and occurrence of spontaneous shocks during follow-up. 
Results: The actuarial incidence of total arrhythmic mortality was 3, 
11, and 17 %, and the incidence of total mortality was ", 38, and 43 
% at 1, 3, and 5 years of follow-up respectively. EF s 30 % was the 
only independent predictor of both, total arrhythmic and total mortality 
after ICD implant: the estimated 5 year incidence of total mortality was 
53 % for pts with an EF s 30 % compared to 37 % for patients with an 
EF > 30 % (p = .003). Treatment with class I antiarrhythmics at implant 
was also independently associated with a higher total mortality (p = .03) 
but not with a higher total arrhythmic mortality. None of the remaining 
variables including age, gender, heart disease, coronary bypass grafting 
preceding ICD implant, and occurrence of spontaneous shocks during 
follow-up was predictive for total arrhythmic or total mortality. 
Conclusions: Although low ejection fraction is an independent predictor 
for both, total arrhythmic and total mortality after ICD implantation, the 
analyzed clinical characteristics do not allow for accurate prediction of 
outcome in this selected patient population. The efficacy of ICD therapy 
in sudden cardiac death prevention is confirmed by the finding that 
patients with and without spontaneous shocks during follow-up have 
similar low actuarial Jotal arrhythmic death rates. 
883·85 
Survival ADa lysis 0' a Titred Therapy Device: A valtabllity 0' 
Additional Therapy at No Compromise of Morbidity, Mortality, 
or SuddeD Death Survival 
Galen VanWyhe for !he US VENTAX® PRx® In\'eSligalor Group,lowa Heart 
Center, Des Moines, lA. 
To assess lIIe impact of newer therapy options available in !be CPI 
VENT AX PRx system, a IIOIICOIICIlfmIt cohort Sllldy was performed comparing 
Ibis tiered therapy device to !he VENTAK P. Patient popuIaIion demographics 
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VENT AX PRx patients were significantly older. predominantly male, bad lower 
L VEF. and more VT than !he VENT AX P group. There was 110 statistical 
difference in lIIe opemlive mortality raIeS in !he VENTAX PRx patients (4.S%) 
and VENTAX P patients (2.7%, p > 0.05). The lOla! c:ardiac death rate was 
significantly higher for die VENTAX PRx group compared 10 !he VENTAX P 
group (10.3% and 4.7%, ~tively, p < 0.05). 'Ibis may be due 10 !he lower 
L VEF and greater age of VENT AX PRx patients compared to VENT AX P 
patients. There were, however, no slalistical differences in one year survival 
rates between VENTAK PRx and VENTAK P for sudden dealll (99.4% and 
98.6%, respectively) or a11-guse mortality (84.3% and 90.7%, respectively). 
CONCLUSION' The availability of additional therapy options does nOl 
adversely affect morbidity, mortality or sudden dea!b survival at one year of 
patients implanted willi die VENT AX PRx. 
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Antitachycardia Therapy Use in Patients Implanted With Third· 
Generation Cardioverter·Defibrillators With Epicardial or 
Endocardial Leads 
Sanjeev Saksena, Ryszard B. Krol, Karleen Hanna, Ramesh Raju, 
Theofilos Kolettis, Raj Kaushik. Eastern Heart Inst, Passaic, NJ 
Ventricular tachycardia & fibrillation [VT/VF) recurrence rates are 
reported to exacerbate immediately after cardioverter/defibrillator 
[lCD) insertion using epicardial [EPI] lead systems. We examined 
the in-hospital, short- & long-term VTIVF recurrence rates in ICD 
pts with EPI leads & compared it to pts with endocardial [ENDO) 
leads. The use of antitachycardia therapies in third-generation ICD 
recipients having tachycardia event data storage was also analyzed. 
41 pts, mean age 61 yrs, 36 men & 5 women, with cardiac disease, 
mean LV ejection fraction 30% were followed for 1-34 mos after 
Medtronic 7216A/7217B ICD insertion with EPI (23 pts) or ENDO 
(18 pts) leads. Recurrent VT/VF was validated by clinical & stored 
event data. ~: Duration of followup was 18±9 mos for EPI 
leads to 9±7 mos for ENDO leads (p< .002). The incidence of 
VTIVF events requiring ICD therapy for the lead systems was: 
76 1'oINCIDENCE(VT/VF EVENTS) 
25 
O~--------------------~ 
IMPLANT EARlY LATE 
FOI.J.OWUP PERIOD 
Conclusions: 1) The incidence of recurrent VT/VF at ICD implant 
is not influenced by surgical implant technique. 2) Long-term inci•
dence of third-generation ICD use is comparable to early utiliza•
tion of this therapy during this followup period for both lead 
systems. 
883·87 
Comparison of Two Different Nonthoracotomy 
Cardioverter-Defibrillator Systems: 
Analysis of 74 Patients at One Center 
Ross Brooks, Brian A. McGovern, Hasan Garan, Jeremy 
B. Ruskin; Cardiac Unit, Massachusetts General 
Hospital, Boston MA 
The CPI "Indotak" and Medtronic "Tran8vene" 
nonthoracotomy implantable cardioverter•
defibrillator (ICD) systems were compared in 74 
patients. The two patient groups were aimilar with 
respect to age, gender, body aize, extent of heart 
diseaae, heart aize, and left ventricular 
dysfunction. A Indotak nonthoracotomy 100 Bystem 
was Buccessfully implanted in 17/24 patients (71\) 
while a Transvene system was successfully implanted 
in 36/50 patients (72'). Selected implant 
characteristics are Bhown in the table: 
Succ History OFT RW Pac Res Lead 
Rate MVT (J) (mV) Th(V) ohms Dislog 
Endotak 71\ 4/24 16.8 13 .55 431 0\ 
Transvene 72\ 23/50· 17.4 14 .77+ 555+ 14\ 
• p<O.Ol, + p<0.0003 (Indotak vs Transvene) 
Conclysions: (1) The rate of 8uccessful 
nonthoracotomy implantation of the two systems in 
Bimilar patient groups is comparable, (2) Selection 
of a particular Bystem is mainly determined by 
features of the ICD (e. g., desirability of 
antitachycardia pacing), rather than because of 
differences in efficacy, (3) Lead disruptions 
appear more problematic with the Transvene system. 
ABSTRACTS 
883·88 
Factors Associated With Successful 
Nonthoracotomy Cardioverter-Defibrillator 
Implantation: Analysis of 74 Patients at 
One Institution 
Roa. Brooks, HaBan Garan, John Newell, GUB J. 
Vlahakes, David Torchiana, Brian McGovern, Jeremy 
N. Ruskin, MassachusettB General Hospital, Boston 
MA 
A nonthoracotomy (BTL) approach was initially 
attempted in 74 consecutive patients (pts) and 
Buccessfully implanted in 54/74 (73\). In 10/54 
pts (19\) with an BTL, • transvenous electrode 
(TE) alone was used, while in 44/54 pts (81\), a 
TE was used in conjunction with a Bubcutaneous 
patch. Despite testing multiple BTL 
configurations, 20 pts required thoracotomy' (T). 
Twelve of 20 pts received a "hybrid" system 
consisting of one LV epicardial patch (EP) in 
conjunction with two TE, 6/20 pts required two EP, 
while in 2/20 pts, two EP in conjunction with one 
TE were necessary. Univariate predictors of 
successful BTL implantation included: a smaller 
cardiac Bize on a PA chest x-ray (P<O.OOOl), a 
smaller chest x-ray cardiothoracic (CT) ratio, 
(p<O.OOl), female gender (p<0.003), and shorter 
height (P<O.Ol), whereas left ventricular ejection 
fraction and echocardiographic LV size were not 
predictive. Conclusions: (1) A BTL ICD system can 
be implanted in most pta, (2) Relationships 
between body habitus and the heart are important 
in determining the Buccess of BTL Bystems, whereas 
indices of cardiac function may be less important. 
883·89 
Has Antiarrhythmic Drug Use Declined in Patients 
Receiving Implantable Cardiovertor Defibrillators 
(ICDs)? 
Robert E. Sperry, Bruce S. StaInbler, Alan Cycan, Mark A. Wood, 
Susan Kaye, Kenneth A. Ellenbogen. McGuire V A Medical Center 
and Medical College of Virginia, Richmond, Virginia 
We hypothesized that expanded indications and increasing use of 
leDs along with limited efficacy of antiarrhythmic drugs would 
decrease antiarrhythmic drug use in patients with ventricular 
tachycardia and fibrillation. We retrospectively examined overall 
and class specific (lA, m, lC, n, Ill) antiarrhythmic drug use from 
data derived from the CPI-VENTAKK database (Models 1500-
1600). This comprised 25,450 patients in the 5 year period from 
1987 (2055) to 1991 (8170). The overall antiarrhythmic drug use 
was evaluated with respect to the clinical variables: age, coronary 
artery disease (CAD), ejection fraction(EF), and sex. Multivariate 
analysis compared changes in overall antiarrhythmic drug use to the 
clinical variables and to time. In addition, each antiarrhythmic 
drug class use was evaluated with respect to time. 
~: A significant decrease in overall antiarrhythmic drug use 
(p=.OOOI) over time was found independent of the clinical 
variables of age, CAD, EF, and sex (p=NS). Changes in overall 
antiarrhythmic drug use decreased from 62% (1987) to 24% 
(1991). All classes of antiarrhythmic agents except class n showed 
a reduction in use (p < 0.05) during the study period. 
Conclusions: Use of antiarrhythmic drugs before lCD implantation 
has significantly decreased over the previous 5 year. The reduction 
1)fantiarrhythmic drug use was seen with all drug classes except 




Defibrmatloa Tllrealaolds Ia Noa·tlloracoto.,. Denbrillator 
Patleats recelvlal A.locIaroae 
John Prodafikas. Paul J. Wlllg. AnIOllis MaDoIis. Laurie BUllS. Carol Colbum. 
Deborah Cliff. ArlIn GadboIce. NA Mark EsIes m. 
New EnsJand Medical Center. BosIoo. MA 
Beause II1IiodIIronc (AMlO) may iIIcreage defibriJJalion lhrcsholds (DFI's) in 
paIieIIIs wi1b dxncotomy dcfibriJJalln (lCDs). we bypocbesized !hat amiodarone 
might also iIIc:eae DFI's in paDenlS with IIOMilancotlXay Jcad (NlL) ICDs. 
We dlercfcn eumined DFI's obcained in 57 JlllientS(pcs) receiving die 
Tclec:lIOOics EnganI N'IL ICD. DFI'I wae defiaed as die Jowest energy wbich 
always \elminalcd VF. In Iddilion. 2 or men VF inductions IIId a faiI\D'e 10 
Calven VF allII energy less than the DFI' (unless the DFI' was 16 J or less) 
w= required. In die 46 paIicnts meeting this aiteria. we fOUDd !hat sender. age. 
and type of Ian di3ease were aa sigaiflCllltly difftJ'CIIt in AMlO pts compared 
10 non-AMIO pts. DFI's wae significandy bigher in the AMlO JroUP{mean 







However. 1hcrc was 110 significant diffcmx:es in DFI' bIscd on the type of heart 
disease. IF. lender. presenting arrhythmia. and ejcc:Don fnl:1ion. AMlO was a 
dclenninant of DFI' independent of theIc wriablcs. Since drug-f= DFI's may be 
bigh in a significant number af N'IL ICD pts.dIe poIeI1lia1 al AMlO 10 increase 
DFTs in theae pts may be particuJar:iy imponant c1iniW1y. 
883·91 
co.preben.ive Ivaluation of DafillriUator. 
And ll .. u.citative· Sbook. (CIDnS) StudYI 
.urvival and Incidenoe of Appropriate .book 
in 'atient. witb and witbout Siqnifioant LV 
Dy.fwactioll. 
CEDARS Investigators 
Cedars-Sinai Medical Center, Los Angeles, CA 
It i. often argued that implanted 
defibrillators (ICD) do not add benefit 
independent of LVEF to the survivors of 
sudden death. To answer this question, we 
compared the incidence of appropriate shock 
and survival rate between patients (pts) 
with LVEF<0.35 (n-214) and the remaining 
(n-238) in 452 consecutive initial ICD 
recipients. The first yr fOllow-up events 
were: 
LVEF<0.35 LVEF>-0.35 P 
(n-214) (n-238) 
Appr. shock 97 (45\) 64 (27\) <0.001 
Inappr. shock 15 (7\) 27 (11%) NS 
Indeterminate 14 (7\) 14 (6\) NS 
~I! ~bl!!;k aa '41~l mm~l <Q,Ql 
Actual Survival 195/214(91\) 227/238(95%) NS 
Projected . 108/214(50\) 159/238(67\) <0.01 
CONCLUSIONS: Pts with LVEF<0.35 have 
significantly higher incidence of 
appropriate shock, but the actual survival 
is compatible with the pta whose LVEF>-0.35 
within the first yr. This implies that ICD 
improve survival rate by appropriate shock. 
JACC Vol. 21, No.2 
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884·1 
Can vagal and sympathetic effects on heart nte be assessed by spectral 
analysis or respiratory sinus arrhythmia (RSA)? 
Bengt Ablad. Jan Axcnborg, Jan-Arne BjOrkman. Gunnar Olsson and Ingrid 
Sutherland. AsIra HAssle AB, MOlndal. S wcdcn. 
In anC5lhetized pigs (chloralosc-saffan) on artificial respiralion (15 cyclcslmin) 
willi denervated rightllellale ganglion. we recorded heart rate (HR) responses 
10 graded elcclrical efferent nerve stirnulation (Symp. stirn.) in Series 1 (11=5) 
willi intact vagal nerves. and in Series 2 (n-8) with bilalcral cervical vagolOmy. 
in which artifICial RSA was induced by phasic dcclrical stirnulation of the 
efferent right vagal nerve (Vag. stirn.) in expiration. By means afpower 
~Iysis ~ respiration synchronous R-R interval variability 
(.JHFR-R and HFR-R/meanR-R i.e.CCV.cfAmJCatdioI 
1991;67:199) and HR variability (.JHF iIR) were determined. Representative 
results: 
Series I. Endogenous RSA 
Vag. Symp. HR .JHFR-R .JHFHR crv 
stim.(Hz) stim.(Hz) (bpm) (mscc) (bpm) (%) 
o 105 7.6 1.4 1.3 
0.5 138 6.0 1.9 1.4 
1.0 170 4.7 2.3 1.3 
1.5 187 4.2 2.5 1.3 
Series 2. Artificial RSA 
0 0 229 0 0 0 
0.4 0 203 6.3 4.3 2.1 
0.6 0 194 9.4 5.9 3.0 
1.0 0 178 14.5 7.7 4.3 
1.0 0.25 192 13.1 8.0 4.2 
1.0 0.5 215 12.6 9.3 4.3 
1.0 1.0 229 11.6 10.1 4.4 
884·2 
ThrH-Dimensional Return Map: 
CllangeofHR 








A Method for Quantification of Heart Rate Variability 
Ruy S. Moraes. Ellen A. Fertin, Carisi A. Polanczyk, Gabriel Grossman. 
Marco Wainsteln, Lenda A. Zaslavsky, Jorge P Ribeiro. 
Cardiology Division, Hospital de Clinicas.UFRGS, PorID Alegre. RS, Brazil. 
TwtHlimenaional retum maps ha'o<e been uted for qualitative analy5is of 
24-hOur heart rate variability. To objectively quantify heart rate variability, 
avoiding lupenmp05ition of points which may hide pattems of variability, a 
modified 3-dimenaional return map WIIS d~ped using as axes RRn 
VWIU5 [(RRn+1)-{RRn)) Yersus counts obtained from 24-hour 
electrocardiograms. To _Iu.le the capacity 01 this method to deiect 
aUlDnomic dyafunction. 3-dimensional retum maps of 10 patients with 
diabetic autonomic neuropathy, 12 diabetic patients without neuropathy. 
and 12 age- and sex-matched normals _ns compared. For each map, a 
set of variabin which quantify hart rate variability WII$ calculated and a 
normalized index computed. Repr-mtive 3-dirnensional retum maDS: 
NonnII DIabetIc ~ropa1hy 
The normalized index lot heart rate variability _a significantly dltlerent 
among diabetic patients with autonomiC neuropathy (43!.7). patients 
without neuropathy (122:!:20). and normals (1~:!:1Ij) (ANOVA PeO.01). and 
COIIWialild significantly (r=O. n, PeO.01) with time domain Indices such as 
RR andarel deYiation for 5 min epochs. Thus, the quantification of heart 
rate variability by 3-dimensional retum mapa can identify patients with 
autonomic neuropathy, IWuiting in an objective index which correlates with 
time domain indices. (Suppclllild by CNPq and FINEP) 
JACC Vol. 21, No.2 
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884·3 
Specificity of Head·Up Tilt: Effectll of Degree of 
Tilt and IsoprotereDOl Infusion 
Andrea Natale, Jasbir Sra. Boaz Avitllil. Anwer Dhala. 
Sanjay Deshpande. Mohammad Jazayeri. Abdul Wase. 
Mita Sheth. Masood Akhtar. 
Sinai Samaritan Medical Center. Milwaukee. WI 
The specificity of the head-up tilt test (HUT) may vary 
significantly as a function of the degree of tilt and 
isoproterenol (ISO) infusion. Forty-five normal 
volunteers with no history of neurocardiogenic syncope 
were subjected to HUT using 60. 70 or 80 degree tilt 
for 20 minutes. The degree of tilt was assigned in a 
random fashion. All the subjects had HUT at baseline 
(BAS) and during ISO infusion. ISO was started at 
lmcg/min and increased to achieve at least 20% increase 
in heart rate. Blood pressure was continuously 
monitored using an intra-arterial cannula. The groups 
did not differ with respect to mean age (HUT 600 34±9 
years; HUT 700 35±14 years; HUT 800 35±7.S years) 
and sex. 
The number of patients with positive HUT at varying 
degrees of tilt at baseline and ISO is shown below: 
HUT 600 HUT 700 HUT 800 
BAS 1/15 (7') 2/15 (13\) 2/15 (13%) 
ISO 0/15 0/15 3/15 (20%) 
Total 1/15 (7') 2/15 (13\) 4/15*(27%) 
* one patient had positive HUT at baseline and ISO. 
These results suggest that 1) HUT test provides an 
adequate specificity for assessment of patients with 
unexplained syncope; 2) HUT 800 results in higher 
incidence of false positives; 3) At tilt levels of 60 
and 70 degrees the specificity of HUT does not appear 
to be affected by isoproterenol infusion. 
884·4 
The Integrity and Frequency Response of the Carotid 
Baroceptor Heart-rate Reflex. Comparison Between Sinus 
Rhythm and Atrial Fibrillation 
Stephen Cross*. Hai Shiang Lee*, Kevin Jennings*, John 
Rawles**. Department of Academic Cardiology*, Aberdeen 
Royal Infirmary, and Department of Medicine & 
Therapeutics**, University of Aberdeen, Scotland, UK 
To investigate whether the baroreflex is operational 
in atrial fibrillation, and in what way it differs from 
that in sinus rhythm, we have studied 5 patients with 
this arrhythmia, aged 44-70 years. Their heart rate 
responses to neck suction were compared with those from 
20 healthy controls in sinus rhythm, aged 17-70 years. 
Cyclical suction (-40 mmHg) at 14 different 
frequencies (0.004-0.56 Hz) was applied to the neck by 
means of a moulded lead collar; respiration, synchronised 
with a sine wave of 0.23 Hz, was continued throughout 
neck-suction. 
By means of multiple regression analysis, the 
amplitude of the heart-rate response to cyclical suction 
over a range of frequencies was obtained, from which a 
frequency-response curve for the baroreflex was derived. 
The averaged frequency-response curve from patients 
with atrial fibrillation was similarly shaped to that 
from the control subjects in sinus rhythm. Maximum 
responses were in the region of 0.06-0.16 Hz, with 
attenuation of the responses at higher and lower 
frequencies. 
Conclusion The baroreflex is operational in atrial 




Respiratory Cycle Length Modulates the Relationship 
Between High Frequency Component of Heart Variability 
and Cardiac Vagal Tone 
Junlchlro Hayano. Seljl Mukai, Relko Hori. Aklra Yamada, Takao Fujlnaml. 
Nagoya CIty University, Nagoya, Japan 
Although the amplkude of high frequency (HF) component 01 heart rate 
variabilky has been used as an Index 01 cardiac vagal tone, k Is also 
affected by the pattem 01 respiration. The HF amplitude has reported to 
Increase with Increased cycle length 01 breathing (CLJ and with paced 
breathing Itself (PB). However, k Is not clear If these phenomena appears 
through the changes In cardiac vagal tone associating with the respiration 
pattems. The effects of Clg and PB on mean RR Interval under beta· 
blockage (Intravenous propranolol, 0.2 mg/kg) as well as on the HF 
amplkude were examined In 7 heakhy male subjects. Neither CL" nor PB 
at individual spontaneous Clg affected mean RR Interval under B· 
blockage, although the HF amplitude Increased with CL" (p<O.OOl). 









II 3 4 5 II 
a.a 
Conclusion: the Clg modulates the relationship between the HF amplitude 
and cardiac vagal tone during supine and tilt. This effect should be 
factored in the assessment 01 cardiac vagal tone by the HF amplttude of 
heart rate variabllky. 
884·6 
Abnormal Autonomic Control or the Cardiovascular System in Patients 
with Syndrome X 
Giuseppe M.C. Rosano, Piotr Ponikowski, Stamatis Adamopoulos, Andrew 
1.S. Coats, Philip A. Poole-Wilson, luan Carlos Kaski. National Heart &. 
Lung Institute and St George's Hospital, London, United Kingdom 
The aim of the present study was to assess the autonomic control of the 
cardiovascular system in 26 patients (pts) with syndrome X (SX) and in 20 
healthy sex and age matched controls (CO). Autonomic tone was 
investigated by means of the analysis of heart rate variability. Mean heart 
rate was similar in SX and CO. PIS with SX showed significantly lower 
values of sdRR and pNNSO (126.4±22 vs 149±43, p<O.OS; 6.3±4 vs 
l1.2±7,p<0.05; respectively). PIS and CO were allocated into 2 croups 
according to the median RR duration: SXl and COl with high and SX2 
and C02 with low mean heart rate 
SXl SX2 COl CO2 
n 13 13 10 10 
mRR (ms) 716±44 876±7 785±57 891±48 
sdRR (ms) 113±17* 139±20 136±32 162±SO 
rMSSD (ms) 20.7±3** 32.4±8 31.3±10 33.7±11 
pNN50 (%) 3±l** 9.6±5 9.9±7 12.5±8 
HF (ms2) 84±33** 226± 119 205+169 267±185 
LF (ms") 336± 134** 645±329 691±502 696±505 
= p<U.U:l, •• p<U.UI comparee to ;).lU, CUI, CU:l 
The circadian pattern ofLF and HF was similar in SX and CO. However. 
SX 1 pts showed significantly lower values of LF and HF throughout the 
day compared to the other 3 groups. 
In conclusion pts with SX and increased mean heart rate have an impaired 
autoDOmic control of cardiovascular function (predominantly a depressed 
parasympathetic activity). This autoDOmic dysfunction appears to persist 
throughout the 24 hours. 
158A ABSTRACTS 
884-7 
Circadian Variation of •• art Rate Variability: A 
CO.parati.e Study •• tween Sbort and Long Tar.' Spectral 
Analyoio 
Ovidio Costa, p.Lago, A.P.Recha, M.J.Carvalho, 
J.Freitas, J.Puig, A.Brandao and Falcao Freitas. 
Hospital S. Joao. Porto. 
Matematica Aplicada. Universidade do Porto. Portugal. 
Mean hourly parameters obtained from all beats (long 
series) were compared with those obtained from a 
stationary sample of 512 beats extracted each hour 
(short ser ies) in 9 heal thy subjects. Low frequency 
(LF) and high frequency (HF) spectral components, and 
time domain indices, such as proportion of RR that 
exceeds 50 me (PNN50) and standard deviation (Std_RR) 
were calculated. The LF, HF and LF/HF evaluated by the 
two methods were not found statistically different, 
whereas significant differences were found between 
Std_RR and PNNSO. In both short and long series good 
correlation was found between LF and Std RR and between 
HF and PNN50. Figs 1 and 2 show, in both sequences, the 
rIsing of LF/HF around 8 a.m. 
LF/HF LF/HF 
long~ft~ 
[J 'Ul! I j ;11J 
j J '. JJUUJ ljy 
7he results suggest that 24 hour heart rate variability 
calculated by spectral analysis can be obtained using a 
single stationary series of 512 beats in each hour, 
with a great advantage over the evaluation of the mean 
<hourly parameters. 
884-34 
Spectral Analysis or Heart Rate Variability in End-Stage 
Renal Desease: Evidence ror Altered Cardiac Autonomic 
Control 
Gilllcario Strata, U go Umbruno, Antonio Oi Vincenzo, Enrico Montagnani, 
Robeno Palla, Mario Mariani. 
Istiblto di Cardiologia, Clinica Medica n, University of Pisa, Italy. 
Uremic patients under dialysis treatment may show clinical evidence of a 
peripberal neuropathy, althougb the involvement of autonomic cardiac 
innervation bas not been clearly proved yet We used the spectral analysis of 
heart rate (HR) variability to assess the sympatbo-vagal influences on HR in 
24 uremic pts under dialysis treatment (group A) and 12 healthy subjects used 
IS control (group B). ECG recordings obtained both, at rest and during 
tilting, were digitized and analyzed to obtain the power spectrum of HR 
variability. Tbe low-frequency (LF) band (0.05-0.18 Hz) and the 
high-frequency (HF) band (0.18-0.35 Hz) of power spectrum were considered 
IS III index of sympathetic and vagal activities respectively. 
Results: LF and HF band at rest were markedly reduced in group A with 
respect 10 group B, werheas the LF/HF ratio was similar in the two groups. 
During tilting, the physiologic increase of LF band and LF/HF ratio was 
absent in group A (see table; 0: p<O.OOI group A vs group B; *: p< om 


















The reduction of power spectrum in patients of group A was significantly 
correlated to serum creatinine levels (LF+HF vs serum creatinine: r .. -
0.724, p<O.OOI). 
Conclusions: HR spectral analysis in uremic patients is highly consistent 
with a dysfUllCtiOll of both, simpathetic and parasimpathetic cardiac fibers. 
The entity of sucb pbenomenon seems related 10 the severity of renal failure. 
884-35 
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Reproducibility of TIlDe Domain Measurement of Cardiac 
Parasympathetic Activity from Ambulatory FJectrocardiograms 
James Nolan, Andrew D. Flapan, Nicholas E. Goodfield, Peter 
Bloomfield, James M. Neilson, David J. Ewing. Department of 
Cardiology, Royal Infinnary, Edinburgh, UK 
Heart rate variability analysis is commonly used in the non-invasive 
assessment of autonomic function. There is limited data on the 
stability of such measurements over time. We have developed a 
time domain technique for the assessment of cardiac 
parasympathetic activity from 24 hour ambulatory 
electrocardiograms by counting the number of times each successive 
RR interval exceeds the preceding RR interval by >50 ms. Short 
and long term reproducibility of the technique was assessed by 
obtaining repeated ambulatory electrocardiograms in 19 normal 
subjects aged 44±13 years at an interval of 13±9 day, 74 patients 
with documented cardiac disease at an interval of 14±!3 days, 
28 diabetics at an interval of 29± 11 days and 18 diabetics at an 
interval of 19S!24 days. Count rates were log transformed and the 
results investigated by analysis of variance; intraclass correlation 
coefficients (ICC) and the coefficients of repeatability (COR) were 
calculated and used to assess reproducibility. 
RESULTS 
Bor.al Cardiac Diabetics Diabetics 
Subjects Disease (29 days) (195 days) 
ICC 0.97 0.94 0.91 0.86 
COR 0.212 0.402 0.614 0.870 
These results indicate that this technique is highly 
reproducible in the short term in normal subjects and patients 
with cardiac disease or diabetes. Reproducibility remains good for 
up to 6 months in diabetics. The limits of biological variability are 
narrow, and it is thus able to detect small temporal variations in 
cardiac parasympathetic activity due to changes in disease state or 
therapeutic intervention. These results compare favourably with 
published figures for other frequency or time domain techniques of 
beart rate variability analysis. 
884-36 
Effect of Hyperbaric Condition on Heart Rate Variability 
Hirokazu Nagayoshi, Akira Kurita, Yasuhiro Okamoto, Bonpei 
Takase, Takayuki Miyake, Masahiro Hukuda, Hideki Milani, 
Toshihiko Nishioka, Hiroyuki Hikita, Akimi Uehata, Haruo 
Nakamura, National Defense Medical College, Saitama, Japan 
Heart rate variability (HR V) is said to reflect the autonomic nerve 
tone. As several factors are known to affect HRV, we investigated the 
physiological effects of HRV under severe byperbaric conditions. 
Well-lI1Iined six male divers (average age: 32±5 years) participated in 
a saturation diving experiment in an experimental chamber and 
simulated depth of 400 meters of sea water (400 MSW). The 
atmosphere absolute (ATA) pressure was 1 AT A on day I, after 
which, from day 1 to 4, the AT A pressure was compressed to 41 AT A 
(at 400 MSW), and from day 5 to day II, the pressure was kept at this 
compression. From day 12 onwards, the AT A pressure was gradually 
decompressed until a normal AT A pressure was reached on day 29. 
Holter ECG monitoring was conducted from 23:00 to 05:00 every day. 
The mean heart rate was measured. The time domain of SD was 
determined by mean of all S-minute standard deviation of normal R-R 
interval for 24 hours. By spectral analysis Jow frequency (LF; 0.04-
0.15 Hz) and high frequency (HF; 0.15-0.40 Hz) were measured. 
Results are shown below. 
AT A Mean HR (bpm) SD (ms) 
Day 1 1 56±3 SI±lO 
Day 4 41 54±8 114±2I* 
Day 11 41 58±2 9I±I2 
Day 28 2 58±4 83±9 











Conclusion: These results suggest that the HRV is influenced by the 
physiological condition adequately, since it changed significantl: 
during the start of compression state and, then returned to the basal 
values. Thus, HRV measurement has proven to be useful in detecting 
physiological adaptation. 
JACC Vol. 21, No.2 
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884·37 
Effects or metoprolol and diltiuem on spectnJ and noa-spedraI heart 
rate variability parameten in patientS With stable qina pectoris IWng 
24-hour holters 
B.T.H. van Dooren, A.I. van Boven, I. Brouwer, I. Haaksma, I.W. 
Viersma, K.I. Ue. Dept. of Cardiology, University of Groningen, 
Groningen, The Netherlands. 
We studied the effects of metoprolol(M,CR 200mg) and diltiazem 
(D,6Omg qid) on Don-spectral and spectral Heart Rate Variability (HRV) 
parameters in 105 24 hour Holter ECGs. Ten patients (9 males; mean age 
59.5 ± 9.8 yrs) with stable angina pectoris were monitored in. randomized 
double- blind CrDSS-over intervenllon lrial, with • 2 week IIIOIIOtherapy 
period of either M (28 Holters), or D (28 Holters), colIIPIred to 49 Holters 
of 2 baseline periods. Tukey-HSD t-test and ANOVA were used for 
statistical analYSIS. 
Results: On M there were significantly higher values of mean RR, SD and 
pNNSO compared to baseline. On D ooly mean RR valucs were higher. No 
effect of medication was found for sd RR, SDANN and rMSSD. Spectrsl 
parameters were analysed for 24-hour, 8.00-15.00, 16.00-23.00, 24.00-
7.00, and 8.00-23.00 hour averages. Twenty-four-bour averages of total 
power, HF, and LF were Dot significantly different regarding treatment 
group, nor were 8.00-15.00 and 8.00-23.00 hour averages. However, on M 
the 16.00-23.00 hour averages showed significantly higher HF and total 
power values with a comparable effect at 24.00-7.00 bra., hut DOW 011 both 
Dand M. 
Speotral HAV parameter • 
• ~ ~ • hoOura perIOd. 
Cnndusion.<: Both M and D ameliorate HR V parameters and have influence 
on its circadian pattern. An early morning inforcement of parasympathetic 
activity (reflected by HF) by both drugs could he beneficial in the 
prevention of sudden cardiac death. 
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Training Level Comparison Study: Comparison of Two 
Exercise Echocardiography Methods for Determining 
Left Ventricular Ejection Fraction 
Mary Ellen Sweeney, Gerald F_ Fletcher, Albert Oberman, 
Navin Nanda, Stephen 0_ Clements, Barbara J. Fletcher, 
Sandra B. Dunbar, Jeannette Y. Lee. 
Emory University, Atlanta, Georgia; University of 
Alabama, Birmingham, Alabama 
Exercise echocardiographic ejection fraction (EEF) 
is an established method of determining left ventricular 
function. To determine if peak exercise EEF performed 
it < 54 seconds after maximal treadmill testing (1M) is 
comparable to peak EEF performed at immediate termina•
tion of supine leg ergometry (SLE) in subjects with 
coronary artery disease, 198 men (X 54 ! 8 yrs) were 
studied. All were stratified by baseline ejection 
fraction, > or i 50%. EEF was performed in left 
lateral decubitus position using both SLE and 1M on 
alternate days in random sequence. EEF was done using 
continuous 2D color Doppler during SLE and with 20 
and M-mode irrmediately post 1M (x 34.2 ! 19.8 sec)_ 
EEF was calculated using standard methods. Results 
(% x ± SE): 
N EEF 1M EEF SLE P Value 
All Subjects 142 59.5 ± 1.0 58.8 ± 1.0 ~
Baseline> 50% 99 66_6 ± 0_6 66.3 ± 0.6 0.94 
Baseline < 50% 43 44.0 ± 1_1 45.0 ± 1.5 0_24 
Paired-t-tests revealed no differences in peak EEF 
between SLE and 1M. We conclude that peak EEF done 
< 54 seconds after 1M is equivalent to peak EEF done 
at immediate termination of SLE in subjects with 
coronary artery disease. 
ABSTRACTS 
885-111 
Can Exercise Testing Localize IschemIa In Single Vessel Coronary 
Artery Disease? 
Michael Rodriguez, Jeffrey Froning, Victor F. Froellcher, 
Long Beach VA Medical Center, Long Beach, CA 
Objective: To evaluate whether 5T measurements in exercise testing 
can localize ischemia in single vessel CAD. a retrospective analysis of 
digital exercise ECG data on 103 men who had undergone exercise testing 
and coronary angiography was performed. CAD was defined as ~70% 
stenosis, 103 patients had single vessel CAD. None were receiving 
digoxin, had a previous CABG, or exhibited LBBB, LVH, or 5T depression 
on their resting ECG. Analysis was performed using averaging and 
measurement software at rest and at each 30 seconds through exercise 
and recovery in leads II. V2, and Vs. Discriminant function analysis (DFA) 
was used to analyze over 50 clinical and exercise test variables in order to 
localize ischemia in single vessel CAD. A discriminant function score 
(DF5) was developed to predict isolated right CAD (RCA). Receiver 
operator characteristic (ROC) curves were generated. 
Vessel 
RCA (45 men) 
LAD (40 men) 
LCX (18 men) 
5T Measurements 
DF5 = .5(time product of recovery ST 
depression in lead II) -.5(maximum 
exercise ST slope In lead II) 
Recovery ST -Integral In lead V 2 
No Predictive ST Measurements 
=.65 
=.61 
DFA identified recovery and exercise ST measurements to predict 
isolated RCA and Left Anterior Descending (LAD) disease. None of the 5T 
measurements predicted isolated Left Circumflex (LCX) disease. 
Conclusion: Exercise testing can predict Isolated RCA and LAD disease 
but not LCX disease. Recovery and exercise ST measurements in lead II 
are needed for optimum localization of isolated RCA disease. while 
recovery 5T measurements in V 2 are needed for localization of isolated 
LAD disease. 5T measurements currently cannot localize isolated LCX 
disease. 
885·112 
Inlraesophageal pH Monitoring as an AdjuncI 10 Exercise 
Stress Testing (EST) in Chest Pain (CP) Patients 
Dennis A. Tighe, David M. Kastenberg. Susan Georgeson, Pradeep Nayak, 
Ras Sheth, Deborah Fleischer, Donald O. Castell. Jefferson Medical 
College and The Graduate Hospital, Philadelphia, PA 
CP is a common presenting co~laint. The evaluation of CP ollen begins 
with an EST supplemented by nuclear perfusion agents. In many cases the 
EST is within normal limits leaving doubt as to the etiology of CPo 
Gastroesophageal reflux (GER) is recognized as a common cause of 
unexplained chest pain. We first studied the effect of graded exercise 
testing in healthy subjects (11 F, 9M; x age 24) without CP to establish 
standard values for GER during treadmill exercise. An antimony pH probe 
was placed 5 cm proximal to the manometric lower esophageal sphincter 
and reflux episodes were defined by convention as pH <4. The patients 
were exercised using the Bruce protocol with a taroet of 80-90% of age 
predicted maximal heart rate. Standard endpoints were employed for 
termination of exercise and the EST was considered positive if 
conventional ECG criteria for ischemia or nuclear scan evidence of 
redistribution was present. The study was divided into three periods: 1) 
exercise, 2) time immediately preceeding exercise (control), and 3) rest 
period following exercise (rest). All subjects achieved ~ 85% of age 
predicted maximal heart rate and there was no positive EST. Using an 
identical protocol we then evaluated 53 consecutive CP patients (23 F, 30 
M; x age 54) referred for EST. 44% achieved target heart rate and all but 
three tests utilized nuclear perfusion agents. 26% (14/53) of CP patients 
had a positive EST. Overall, 25% (13153) of CP patients had a positive pH 
study for GER. GER was present in 14% (2/14) with a positive EST and in 
28% (11/39) with a negative EST. This is significantly higher than the 5% 
incidence of GER found in healthy subjects exercised on a treadmill (p < 
0.05). 
Conclusions: 1) In CP patients with a negative EST, evidence of GER is 
common; 2) GER frequency is much greater in CP patients with a negative 
EST than in those with a positive EST; 3) Intraesophageal pH monitoring is 





Interacticz of BKercise-IDduced Myocardial IPcb-ia aDd 
Bchooardiographic Left Vetricular Mass in ftedictinq 
00r0IIaly Heart DisMse BYaDts: 'ftIe J'nIDingtwa Heart 
Study 
Michael S. lauer, Peter M. akin, Keaven M. Amerscn, ani 
Daniel IsNy. FramiI'gham Heart study. FramiI'gham, Mass. 
Previ~ investigatia'lS involvin;, subjects of the 
~ Heart study have shown that exercise 
treadmill test- (BTl') doalmented myocardial. isdJemi.a, as 
assessed by the exercise related c:ilan;Je in ST-segment 
depressioo divided by the dlan;Je in heart rate (Sl'/HR), 
am ec:hcx:al:tliograIilic left ventricular IIBSS namalized 
for height (LVM,IHt), are predictors of COI:'a1aI'Y heart 
disease (QID) events. To determine 104lether Sl'/HR am 
IMVHt together provide additive pL0JuJstic 
signific:aJ'De, a restricted pcpUatioo of 3109 lIISIiJers of 
the Offsprin;, study 1rbJ were free of QID, ~ BTl' 
(Bruce ProtoJol), ani had ted'l!'li.cally ader:pate 
edlocardiograms at the same examinatioo, were stulle:i 
and folla./ed for 4.3 years. LVM was estilDated usin;, the 
Fenn O:lnvention. '!he man age was 43.3±10 years. D.lrin;, 
follOlrMlp there were 65 irx::ident QID events. In 
univariate analyses, significant predictors of QID 
irx::lu1a:l Sl'/HR (dri-square[CliISQ]=14.13, P=O.OO02), 
LVM,IHt (CHISQ=19.79, P=O.OOOl), and the product (1roD) 
of Sl'/HR and LVM,IHt (CHISQ=35.38, P<O.OOOl). After 
adjustirg for age ani sex in OJX prqx>rtiooal hazards 
analyses, neither Sl'/HR (CHISQ=3.354, P=O.067) oor 
IMVHt (CHISQ=O. 93, P=O. 33) remained in::lepen:ient 
predictors of am in this restricted pcpUatioo. '!he 
interactioo teIlII 1roD, however, remained an in::lepen:ient 
pre:tictor (Q!ISQ=4.80, P=O.029) of am. In Cla'lClusion, 
CXJJi:>inin;J BTl' and edlocardiograJ;hlc data in this healthy 
pcpUatioo provided additive progoostic informatioo. 
885·114 
DIe II8l.atiCllSbip ~ ~ Left 
V8lltricular ~ aDd BKerciae 'l'aIrt.iDg ~ 
in tbe J'rNringtwa Heart 8t:uI!J 
Michael S. lauer, Peter M. akin, Keaven M. Amerscn, ani 
bmi.el. 1.ENy. FramiI'gham Heart study. ~, Mass. 
Because ec:bJc:ardi.ogrc left ventricular hyperb:qiIy 
(VJH) has been shown to be an iJdepeuEiIlt predi.ctar of 
c::ardi.ovascul risk pemaps due to in::re8sed myccardial. 
isc:tlemia, 10Ie studied 3109 subjects of the ~
Heart study free of clinical cardi.avascular disease with 
bath exercise treadmill testin;J (BTl') ani edIoamtio•
grapty at the same exami.natioo. El'1's (Bruce ProtoJol) 
were tenninated upal attai.rment of an age-predic:ted 
heart rate or syuptans. El'1's were positive if there was 
at least 1 ]lID of horizaltal or dcwnslcpin;, Sl' segment 
depressioo 80 msec:s after the J-point (st:.aniard+) or if 
the c:ban;Je in Sl' depressioo divided by the exercise 
heart rate c:ban;Je exceeded 1.6 microvoltsjbeatsjmin 
(Sl'jHR+). Peak double product (PDP) was l'ICIted. left 
ventriOllar IIBSS (nIH) was estilDated usin;, the Fenn 
0:lnveI1t.ic:n ani was namalized by height (bt). Sex•
specific criteria for VJH were used. Results of 
lmivariate analyses: 
Para!Ieter VJH Absent INH Present ~ 
st:.aniard+ 406/2789 (15%) 51/320 (16%) 0.509 
Sl'jHR+ 216/2789 (8%) 40/320 (13%) 0.003 
PDP 2852~4634 2999~5126 0.0001 
After adjustirg for age Sl'jHR+ was no lcn;JeI' related to 
VJH (P=O.08) or to LVM/ht (P=O.89). After adjustirg for 
age, sex, I:xldy IIBSS index, restirg SSP, ani use of anti•
hypertensive medicatia'lS in IIIlltivariate linear regres•
sioo analyses, PDP remained iJdepentJ.y ani positively 
related to INR (1"=.0083). In cxn::l.usioo, the relatic:n•
ship between VJH ani Sl'jHR+ is laIgel.y ocnfCAlJ'ded by 
age. VJH is associated with a higher exercise PDP, 
lohlcil reflects increased myocardial. ax:ygen CXIlSUIIPI:ial. 
885·115 
JACC Vol. 21, No.2 
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Accuracy of Hultivariate Exercise Score for 
Coronary Disease Diagnosis! Comparison with 
Exercise Echocardiography and HIBI-SPECT. 
Thomas Harwick,Anne-H O'Hondt,Annie R Robert, 
TJhierry Baudhu1n,Jacques A Hel1n,William Wyns, 
ean-H Detry. Univ of Louvain,Brussels.Belg1Um 
A multivariate exercise score (ES) incorp•
orating exercise parameters additional to sT 
segment analysis (ST) has been shown to exceed 
the accuracy of ST alone in the diagnosis of 
coronary disease (CAD). The aim of this study 
was to Qompare ES with exercise echo (EE) and 
HIBI-SPECT 1n 88 unselected pt with interpret•
able ECG' and no infarction. undergoing angio•
graphy (CAD defined by >501 stenosis). 
Exercise was performed using a standard bi•
cycle protocol (lncrements Qf 20W/min), during 
ECG and echo monitoring. HIBI was inJected at 
peak stress, with SPECT 2h later and rest HIBI 
1maging on another day. Positive ST results 
were eefined bI LO.1mV ST depression. The ES 
(previously va idated) was calculated fro. 
exercise capacity. peak heartrate (HR). ST/HR 
d
slope, and angina as well as ST. Ischemia was 
ef1ned by a stress-induced HIBI defect. and 
by a new wall motion abnormality by EE. 
In 59 pts with significant CAD, the sensit•
ivity of EE (90%) die not differ significantly 
from HIBI (78%) or EE (76%). However! ST (63%) 
was less sens1tive than EE (p<O.O ). In pts 
with 1-vessel CAD. the sensit1vity of EE was 
86%, significantly greater than for ST (32%, 
p<O.OOl)t but not significantly different from 
ES (71%, or HIBI (64%) whiCh were also more 
sens1tive than ST. The specificity of ES (66%) 
did not differ from HIBI or EE (both 69%)~ or 
ST alone (79%). The accuracy of E5 was ,4%, 
not signif1cantly different fro. KIBI (74%), 
EE (83%}, or 5T alone (68%). COnCt~'10n The lower sensltivity of ST (p<O.Ol 
vs may be enhanced by use of ES (p=Ns). ES 
is the opt1mal non-imaging stress approach. 
885·116 
Increased left Vent:ri.allar Mass, in the AI:I:IeID! of ]!X]; 
UIH is Associated with Sl' Depressia'l DlrinJ Exercise 
Richard H. Smith, Barbara IePetri-8chlegel., Rctilin !t>isa, 
El:iith Flaster ani Richard M. stein;Iart. SUNY at 
statyBrook am Winthrcp-University Hospital, Mineola NY. 
Em LVH is a cause of false positive exercise (EX) tests 
(ElCl'). Because the Em is insensitive for VJH relative to 
echocardiograpiy(ECH», 10Ie hyp:rt:hes~ that in::reased 
left ventriOllar IIBSS index(LVMI, gmjm") by mr:>. in 
the absence of Em INR, wtUld be associated with Sl' 
depression (SID) durin;, EX. Ten pts wittnzt Em INH 1rbJ 
had a positive Em ElCl' durin;, evaluatioo for JUl"'Cardi.ac 
dlest pain were identified(GP1). All GPl pts had a lOii 
clinical likelihood for CAD am namal EX thallil.m\ 
scans. Six other pts matdled with GPl pts for clinical 
presentatioo, baseline Em ani EX thallil.m\ results I::ut 
1rbJ had noImal Em Elcr's served as a CCIltrol groop(GP2). 
GPl and GP2 pts had interpretable Em Elcr's withcut lmcMl 
causes for false positive SID durin;, EX. Em ElCl' was 
positive if there was 2:1 ]lID horiza'ltal or dcwnslcpin;, S'ID 
.08 sec. after the J pt ani negative if there was <.5mn 
SID at 2: 85% MRlR. GPl and GP2 pts had mr:> within 7 
days of the irdex ElCl'. mr:> INMJ: was calculated usin;, 
the FenrH::ube method by an ci:lserver masked to clinical, 
Em, and ElCl' data. GrCllp data are mean±1SD. 
Jlqe Male HlN ImP PBP EX!llR tMRIR LVMI 
GPl n=10 69.1 7 8 140 190 6.7 96.1 119.4 
±8.6 ±17 ±25 ±1.6 ±9.6 ±31.7 
GP2 n=6 62.3 3 3 137 177 7.2 94.2 84.0 
±11.2 ± 9 ±31 ±2.4 ±7.4 ±11.8 
P value NS NS NS NS NS NS NS <.01 
HIN=t w/ hx hypertension: ImP ani PBP=Rest ani Peak EX 
systolic BP (IIIIB;J): EXIllR=EX chlratioo (minutes). 
'!he ally significant difference between GPl am GP2 was 
a higher LVMI in GPl than GP2. Conclusion: lJx:reased LVMI 
in the absence of Em LVH is associated with EX SID. 
lACC Vol. 21, No.2 
February 1993:161A 
885·117 
Doe. Left Ventrlcullr Hypertrophy (LVH) Evident Only by 
Echocardlogrsphy Intarlere With ECG Stre •• Test Interpretation 
Srlnlvas N. Paranandl, Fredric J. Pashkow, Lata Paranandl, Emesto E. 
Salcedo, The Cleveland Clinic Foundation, Cleveland, OH 
The diagnostic accuracy of exercise ECG test compared to 
Exercise Thallium test for evaluation of Ischemia in 86 patients wtth 
LVH documented by echocardiogram (LV mass Index..a 100 g/m 2 for 
females and ..a 131 g/m2 for males) but no changes of LVH on the 
baseline ECG (defined by a score of ..s. 4 using Estes-Rornhllt scoring 
system) was examined. All (64 males, 22 females) had an exercise thallium 
test and none had ST segment changes on baseline ECG. The mean 
ltSD) LV mass Index for males was 161.7lt26.8) and 124.8lt23.2) for 
females. Resutts of ECG component (EC) were compared to the thallium 
component (TL). 
RESULTS: Of the 86 patients, 8 were positive and 52 were negative on 
both EC and TL; 21 were posttive on EC and negative on TL; and 5 were 
negative on EC and positive on TL This constitutes a sensttivlty of 62% 
(95%CI: 51-72) and a specificity of 71% (95%CI: 62061); a posttive 
predictive value of 28% (95%CI: 18-37) and a negative predictive value of 
91% (95%CI: 85-97); a false negative rate of 38% (95%CI: 28-49) and a 
false posttive rate of 29% (95%CI: 19-38). 
CONCLUSION: TL used as the reference standard, ttself has a reported 
sensltivtty of 84% and specHlclty of 86% on average, compared to coronary 
angiography. Considering this,the sensttivlly (62%) and specHiclty (71 %) 
achieved by EC compared to TL In this study maybe actually Inflated. 
These data suggest that the presence of LVH by echocardiographlc cmeria 
alone leads to confounding interpretation of ECG stress test. 
885·118 
Blunted Heart Rate Response Predicts Sudden Death In Heart 
Failure 
Jeff S. Eaton, Lynne W. Stevenson, Mary A. Woo, Virginia Lem, 
William G. Stevenson. UCLA Medical Center, Los Angeles, CA. 
Sudden death in heart failure (HF) has been related to 
abnormalities of autonomic tone, which may influence heart rate 
response to exercise. For 97 pts who were alive with HF or had 
died suddenly, records were reviewed to determine heart rate 
(HR) increase during maximal bicycle exercise. The median HR 
increase of 50 bpm defined Gp I (50 pts with HR increase> 50 
bpm) and Gp 2 (47 ptswith <50 bpm increase). Average EF was 
24% in Gp I and 19% in Gp 2 (NS). Peak 02 consumption was 
higher in Gp I (17 vs 
13 ml/kglmin, p<0.05). 
There were 4 sudden 
deaths in Gp I 
compared to 20 in Gp J 
141 
"*Change HR<50 
2 (p=0.OO2), with 2.yr .~ 80 
actuarial survival 87% ~ 
compared to 62%. The 40 
exercise HR response '# 20 
can be easily measured ..... Change HR > 
°O.'--6::---:1:-::-2-1:-::-8-24~::"'30:---36-.:.J and used to identify heart failure pts at 
high risk for sudden Time in Months 
death. While reflecting 
reduced functional capacity, blunted HR response may directly 
relate to the degree of chronically reduced parasympathetic and 
elevated sympathetic tone at rest in severe heart failure. 
ABSTRACTS 
885·119 
Absence of Trace MB Creatine Kinase Release 
Following Stress-Induced Myocardial Ischemia 
Robert Hamburg, Mario S. Verani, John J. Mahmarian and Peter R. 
Puleo. Baylor College of Medicine, Houston, Texas 
161A 
Plasma MB creatine kinase (CK) is the "gold standard" for detecting 
myocardial necrosis. However, animal studies have demonstrated CK 
release after reversible ischemia (RI) without necrosis, and a recent 
study in humans revealed the release of troponin in patients with 
unstable angina. We recently developed an assay for the two MB CK 
subfonns, sensitive to 0.5 unitslliter. The assay detects infarction 
within 5 hours of onset, and is sometimes abnormal in unstable 
angina. To detennine whether RI provoked during exercise or 
phannacologic stress testing releases trace quantities of CK, plasma 
MB2 and MBI subfonns were measured in 295 consecutive patients 
before, and 4-6 hours after treadmill (n=260) or dobutamine (n=35) 
stress. Thallium imaging (Thai), perfonned immediately after stress 
and again in 4 to 6 hours if the post-stress study was abnonnal, 
demonstrated thallium redistribution compatible with RI in 63 (24%) 
treadmill-stressed patients and 12 (34%) dobutamine·stressed patients. 
Treadmill Dobutamine 
Time of MB SamDle MB2u1l MBflllI MB2u1l MBluIl 
Baseline Dre-stress .2±.1 .2±.2 .2±.2 .2±.2 
4-6 hr: no Thai RI .2±.1 .2±.1 .2±.2 .2±.2 
4-6 hr: RI bv Thai .2±.1 .2±.2 .3±.2 .3±.2 
Mean Thai defect SIZe (% of left ventricle) among paoents WIth RI was 
14% (range 3-71) for treadmill stress and 22% (range 4·47) for 
dobutamine stress. Only I patient had abnormal plasma MB2 CK 
(> 1.0 U/L) before or after stress (a treadmill·stressed patient with 
elevated MB2 both pre-and post· stress; no RI); no patient had an 
increase of more than 0.3 U/L in plasma MB2 or MB 1. We conclude 
that no detectable release of MB CK occurs during exercise- or 
pharmacologic-induced RI, even when a very sensitive assay is 
employed. Thus, MB2 release in unstable angina is due either to 
subclinical necrosis or RI significantly more severe than that achieved 
by exercise or phannacologic stress testing. 
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886·38 
Efficiency of Arterial Transfection Determined by 
Complementary Assay Techniques: Measurement of 
Human Growth Hormone Levels Combined with 
Immunostaining In Vitro and In Vivo. 
Dou~las W. Losordo. Geoffrey Pickering, Satoshi Takeshita, 
Jaclyn Jekanowski, Jeffrey M. Isner, Tufts University School of 
Medicine, St. Elizabeth's Hospital, Boston, MA. 
We postulated that transfection(Tn) with a gene encoding a secreted 
marker protein, with direct assay of protein production, would 
pennit a more accurate assessment of transfection efficiency than can 
be achieved using typical intracellular markers proteins. We 
transfected(Td) rabbit vascular smooth muscle (VSM) cells in 
cu!ture(C) by incubating sub-confluent cells overnight with a 
solution of 5j.J.g of the PXOH5 plasmid (encoding for human 
growth hormone (hGH)) and 20j.J.l ofliposome (Lipofectin®). hOH 
concentration in the C broth was measured before daily exchange of 
the medium. When hOH concentration peaked, the cells were fixed 
and stained using a monoclonal antibody for hGH. The peak 
concentration of hOH in the C medium was 77 .25 nglml in 5ml of 
medium giving a total production of hGH of 386ng!24hrs. Survey 
of the immunostained cells revealed that 0.89% of cells in the dish 
were staining positive for hOH in a total population of cells of 
3.57x105; Thus, the calculated number of Td cells was 3173. 
Production of hOH was therefore determined to be 5.05xI0·3ng 
h~H! Td cell/hr. In vivo Tn of rabbit anenes was then performed 
uSIDg ~e same plasmid. Assay for hOH in vivo was perfonned by 
sampling blood from the Td artery. A tourniquet was used to isolate 
the Td central ear artery from the systemic circulation for 10 min 
before sampling, allowing the secreted protein to accumulate. On 
day 5 se~m hOH le,;,els were 0.35. nglml (m; range 0.1-1.0 nglml, 
n=9). USIDg the prevIously detemuned rate of hOH production per 
Td cell the total number of Td VSM cells was calculated to be 
209/Td artery. Conclusion' Although in vivo liposome mediated Tn 
res~!ts. in a s~all n.umber of Td c~lls, these cells are capable of 
achieVlDg phySIOlOgiC levels of proteID production. 
162A ABSTRACTS 
886·39 
Angiotensin II Stimulates the Sodium-Hydrogen Antlport 
In P.-fused Heart 
Andrew A. Grace, James C. Metcalfe, Peter L. Weissberg, 
Jamie I. Vandenberg Departments of Clinical Medicine and 
Biochemistry, University of Cambridge, United Kingdom 
Angiotensin II (All) bas been shown to stimulate both the Na+ -H+ BDliport 
and Na+IHCO)- co-transport in non-cardiac mammalian preparations. In 
the bear! promotioo of Na+ influx by these mechanisms could contribute to 
a positive iootropic effect, increase myocardial damage following 
reperfusion and promote cardiac cell growth. We have examined the effect 
of All on the Na+-H+ antiport and HC03--influx during the recovery of 
pH; after NH4Cl prepulse (IOmM, 1000ns) in the isovolumic Langendorff•
perfused ferret beart. Hearts, paced at 1Hz, were perfused at constant flow 
(5-6mLg-I min· l) with either HC03--solution at300C (PH 7.42-7.44) or 
nominally HC03--free (HEPES) solution. Intracellular pH (pHi) was 
estimated using 3lP-NMR spectroscopy. All 10-7 M was added directly to 
the buffer solutions. The Na+ -H+ antiport was inhibited by 5-(N-ethyl-N•
i80propyl)-ami!oride (ElPA), I}JM. Net acid efflux rates (JH, mmol L-I 
min-I) at pHi 6.90 were calculated: JI-FIIi.dpHi I dt (iii, intrinsic 
intracellular buffering capacity calculated as 4[Nl4+1i/4pHi: fIi (H<D3-) 
= 5Ot4mmol L-I; iii (HEPES) = 37±2mmol L-I); dpHi I dtcalculated 





I. ± . 
0.8± 0.3 (7) 
1.0± 0.2 (5) 
33 
100 
All stimulates both the Na+ -H+ antiport and external Na+ and HC03-•
dependent acid extrusion in this system. Botb mechanisms increase Na + 
influx and could cootribute to the observed effects of All on the beart. 
Na+ influx may be enhanced via these mechanisms in conditions 
associated with high circulating AJIlevels promoting cell damage and 
cellular bypertrophy. 
886·40 
Different Responses of Subendocardial Function and 
Biochemistry to Isoproterenol and Forskolin After Coronary 
Artery Reperfusion in Conscious Dogs 
Kaname Kiuchi, You-Tang Shen, Stephen F. Vatner, and Dorothy E. 
Vatner, Dept of Medicine, Harvard Med School, New England Reg 
Primate Research Ctr, Southborough, MA 
While it is known that coronary artery occlusion and reperfusion alter 
B-adrenergic receptor-adenylyl cyclase coupling, it is unclear whether 
this is associated with impaired regional subendocardial (ENDO) 
responses to sympathomimetic amines. To study this, regional wall 
thickening in normal (N) and ischemic (J) ENDO and epicardial layers 
was correlated with B-adrenergic receptor-adenylyl cyclase coupling in 
chronically-instrumented, conscious dogs. After 45 min coronary artery 
occlusion followed by 45 min reperfusion, isoproterenol (O.lpglkg;lmin, 
n=5) infusion increased % wall thickening in I-ENDO more than in N· 
ENDO, whereas forskolin (25nmol/kg;lmin, n=5) elicited the opposite 
effect (Table, • p.:O.05 from N-ENDO). In cardiac sarcolemmal 
preparations total Jl.adrenergic receptor density (fmol/mg) was depressed 
in I-ENDO, however, the % high affinity state of B-adrenergic receptors 
in I-ENDO was increased (Table). Adenylyl cyclase activity was 
depressed by similar amounts (25 to 35%) in I·ENDO compared to N· 
ENDO in both isoproterenol and forskolin groups_ Except for Jl. 
adrenergic receptor down-regulation, there were neither biochemical nor 




o/r Wall Thickening B·Adrenergic Receptors 
TZ!!l High Affinity 
N-ENDO 7.2±O.6 70~7 51:9 
I-ENDO 12.6±1.2" 45~5" 85~6' 
N-ENDO 7.7~1.l 89~7 55~8 
I-ENDO 3.8~O.9" 61:4" 83~9" 
Thus, the increased number of high affinity B-adrenergic receptors in I· 
ENDO compensated for down-regulation of total B-adrenergic receptor 
density and reduced adenylyl cyclase activity and results in enhanced 
I-ENDO function to isoproterenol after coronary artery reperfusion in 
conscious dogs. In contrast, functional responses to forskolin, which are 
not mediated by the B·receptor, were actually depressed. 
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Repld Aldoaterone Action on the Na+/H+·Antiport of V .. cu•
ler Smooth Muacle Cella: A New Pethwey of Steroid Action 
Michael Christ, Kathrin Douwes, Karl Theisen, Martin Wehling. University 
of Munich. Munich, Gennany 
In the classical model of steroid action, steroids bind to intraoellular recep_ 
lors, which act as ligand·dependent transcription factors modulating gene 
expresSion. In addition to these genomic steroid effects there is ina-e•
asing evidence lor rapid nongenomic steroid actions in various cell sy•
stems and, recently, lor rapid aldosterone (ALDO) effects on the Na+/H+•
antiport 01 human mononuclear leukocytes (HML). The aim 01 the present 
study was to Investigate rapid, nongenomic ALDO effects on the Na+/H+· 
antiport of rat vasaJlar smooth muscle ceMs (VSMC). 
VSMC from Sprague Dawley rat aorta were obtained enzymatically and 
cultured in Ham FI2IWaymouth MB 752 medium supplemented with lOOk 
letal calf serum. Initial rates of 22Na+-uptake were measured in the 
presence of ouabain (ImM) and bumetanide (O.lmM) with and without 
lII1IiIoride, aldosterone, cortisol or canrenone atter Intracellular acidification 
by preincubation in Na-Iree media. VSMC were cultured in serum-free 
medium 24 hours belore experiments. Basic 22Na+·inllux in VSMC was 
16,3 ± 1,1 nmollmg proteinlmin (mean ± STD, n=9) and was significantly 
stimulated to 20,1 : 2,8 nmol/mg protein/min (n=9, P<O.05) 5 minutes 
atter ALDO Incubation. These Is thought to rellect the activation 01 the 
III1Illoride-sensltive Na+/H+·antiport. HaH maximal effects were seen at 
about 0.05nM ALDO. 22Na+·uptake was stimulated by cortisol and other 
glucocorticoids at about 1000 fold higher concentrations. Canrenone, a 
specific antagonist 01 classical ALDO action, was not able to decrease 
ALDO ellects up to 100 fold excess concentralions. These are the first 
dala which demonstrate rapid nongenomic aldosterone effects on 
sodium transport 01 VSMC, but not lor cortisol or canrenone. 
These findings perfectly match the functional data on Na<-IH+-anliport st~ 
mulation in HML. Hall maximal effects were seen at concentrations in the 
range 01 plasma ALDO levels, thus indicating a possible physiological role 
of ALDO in regulation of vascular tone. They could also be the base lor 
the development 01 new strategies in antagonism of in the plasma memo 
brane localized ALDO receptors with potential cardiovascular relevance. 
From a teleological standpoint 01 view these mechanisms could be the 
base lor a physiological meaning 01 rapid POStural changes in plasma aIdo· 
sterone levels. 
886·42 
Novel Peptide Designed To Compete For Calcium Binding Sites 
W. Thomas Woods, Jr., e.G. Woods, R_ leBoeuf, K. Bost, lE. 
Blaylock, H.e. Van Der Heyde. Prairie Education and Research 
Cooperative, Univ. of AL at Binningham, and Southern Illinois 
Univ. School of Medicine, P.O. Box 19420, Springfield, Illinois 
62794. 
Protein binding sites with affinity for Ca++ regulate many contractile 
and electrophysiologic events in cardiac myocytes. In this study we 
tested effects of a peptide Ca++ analog. 
Amino acid sequences in Ca++·binding domains of the troponin 
superfamily of proteins reveal consistent patterns of hydropathicity_ 
Two octapeptides were constructed with amino acids at the CaH_ 
coordinating positions having hydropathicity values opposite those 
at the same positions in calmodulin CaH-binding site ID. The 
peptides competitively inhibited CaH.binding to high affinity Ca++•
binding sites (III and IV) on highly purified Troponin e. The 
octapeptides (lxlO-6 mol.!l.) were administered to isolated, arterially 
perfused canine right atria. Developed tension was decreased by 50 
+/- 10%; passive tension was not affected. Removal of peptides 
from the perfusate completely reversed this effect within 90 minutes. 
These responses were quantatively similar to those obseTlled when 
[Ca++] was lowered to 10-4 mol.!l. or CaH channel blocking agents 
wers added (verapamil, 100 micrograms/milliliter or Mn++, 10-4 
mol./I.). We conclude that peptides with hydropathicity profiles 
anticomplimentary to those of Ca++-coordinating sites have Ca++ 
mimetic effects. 
Ca++-like peptides with modifiable affinities may provide novel 
phannacologic approaches to control of cardiac cell function. 
JACC Vol. 21, No.2 
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Arginine Vasopressin DownrqWates N.¥ATPase Gene 
Expression in Vascular Smooth Muscle Cells 
Prakash R. Tirupattur, Jeffrey L. Ram, James R. Sowers, Wayne State 
University, Detroit, MI 
Coatractile responses induced by Arginine Vasopressin (A VP) in vascuIar 
smooth muscle c:ells (VSMC) bave been sbowa to be poteaIiated by inbibition 
ofNa+K+ATPase activity. In the present study, we investigated potentia1 
molecular mechanisms of A VP induced cootraction in VSMC, using Reverse 
Transcription·Polymerase Chain Reaction (RT ·PCR) techniques. Smooth 
muscle cells (a70) grown to confluence, made quiescmt for 16 brs, were 
incubated with A VP (I11M01) for 2 brs and total RNA extracted. RT ·PCR of 
mRNA generated a 335 base pair sequence of both at and ~ subunits of 
the Na+K+ ATPase gene. Southern blots of PCR products hybridized to at 
and ~ specific oIigoprobes revealed bands for both at and ~ (brain) and 
only at (kidney). Restriction enzyme digestion with Hpa n (cuts only at) 
showed a digested band hybridizing to only the at probe, confirming 
specificity of the probes. 
A VP caused an inbibition of the ~ subunit of the Na+K+ ATPase gene 
ttanscription at 2 hrs (n=4). A time course experiment showed a bipbasic 
response with the effect peaking at 2 brs and decreased inbibition at 6 hrs. 
Under similar conditions, A VP had 110 effect on at gene ttanscription. Thus 
at served as an intemaI standard to compare cbanges in ~ mRNA levels. 
This is'the first reported demoostration of isoform specific modulation of 
Na+K+ATPase gene expression by AVP in YaSCU!artissue.lnhibition of 
Na+K+ ATPase pump function would increase [Na+);, trigger the Na+Ca++ 
exchanger to pump in Ca-, and coosequentIy increase YaSCU!artooe. We 
believe this phenomenon could be one potentia1 mechanism by which A VP 
mediates cootractile responses in VSMC. 
886·44 
FosB mRNA Levels Increase In Response to a 
Hypertrophic but not a Proliferative Stimulus In 
Cultured Pulmonary Arterial Smooth Muscle Cells. 
Abraham Rothman, Branden Wolner. University of California, 
San Diego, CA 
Remodeling of the pulmonary vascular tree in pulmonary 
hypertension is associated with smooth muscle cell hypertrophy 
and proliferation. The stimuli and signaling pathways for these 
processes are not well understood. We used a previously•
characterized cloned rat pulmonary arterial smooth muscle cell 
line to study the effects of thrombin and platelet-derived growth 
factor (PDGF) on cellular growth and immediate-early gene 
expression. Thrombin (1 Ulml) caused a 55% ± 46% (n=18, 
P<0.0005) increase in protein/cell but no change in cell number 
(hypertrophy). PDGF (2.5 ng/ml) stimulated cellular 
proliferation (cell doubling in 4-5 days) but no change in 
protein/cell. Both thrombin and PDGF induced egr-1, c-fos, junB, 
c-jun, and fra-1 mRNAs within 15 minutes, peaking at 30-60 
minutes (average increase 4-5 fold over control serum-deprived 
cells) and returning to baseline within 4 hours. Neither agent 
affected junO mRNA levels. In contrast, thrombin caused an 8 fold 
increase in fos-S mRNA (n=11, P<0.0005) at 60 minutes, while 
PDGF did not alter low baseline fos-B mRNA levels (n=12). 
Pretreatment with 1 ~M thapsigargin (to deplete intracellular 
calcium stores) and 5 mM EGTA (to chelate extracellular calcium) 
attenuated the fosB mRNA response to thrombin by 79% and 80%, 
respectively. 
In summary, thrombin, a hypertrophic agent, but not PDGF, a 
proliferative agent, causes a significant increase in fosS mRNA 
levels in cultured pulmonary arterial smooth muscle cells. The 
induction of fosB mRNA by thrombin appears to require both 
intracellular and extracellular calcium. Whether fosB induction is 
necessary or exclusive for pulmonary arterial smooth muscle cell 
hypertrophy remains to be elucidated. 
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Higb Level RSV·Luc:iferase Expression Following Direct 
DNA Injection Into Iscbemic/Reperfused Myocardium. 
Howard M. Prentice, Robert A. lOaner, Yuwei u., Laurie NCW111811 BDd Lany 
KccIes.lnstitute for Genetic Medicine, Ilcpar\meDt of BiocbemisIry 4 MoIecuIIIr 
Biology, and Department of Medicine, University of Soulhem California BDd 
Hospital of Good Samaritan, Los Angeles, CA 
Reva'sible iscbemic injury is III8l'kecI by a1teraliOllB in ce11u1ar permeability II1II 
cardiac metabolism that IR dependent upon time of occlusion. It is kDowD that 
an injected solution of DNA can be liken up by bealtby cardiac myoc:ytea in 
vivo but it bas not been deIamined wbetber ischemica11y injlll!ld myoc:yta IR 
capable of lllking up and expressing genes eocoded in the eltogeuous DNA. In 
Ibis study we have applied a rat coronary occlusion model 10 detamine wIIeIber 
iojcclcd DNA can be iDror)xnIcd into cells IIICI eXJRSSCd by ~
(I/R) heart and if so to what degRe. Rats were subjecled to IS min coronary oc•
clusion followed by reperfusion. This duration of iscbemia does not CIIIIIC cell 
deaIh. The Rous san:oma virus (RSV)-Iucifnae gene c:oasII'UCt (SO j!g) wu in•
jected into the left ventricle immedialcly below the occlusion at IS min. of 
repafusion. Two randomized groups of animals were injcclcd in Ibis _ and 
saaificed 7 days later. The mean peak lucifnae activities (m) for cecluded II1II 
IIOIHlCCluded groups fell into 4 main ca/epies as sbown in the Table. 
Luc:iferase Expression In Iscbemic/Reperfused Venus 















Ten rats in the I/R group and nine rats in the aon-ischcmic group ~ sig•
nificant amounts of lucifmse. These data demOlllllate high level eXJnSSion of 
RSV -Iucifmse from DNA injected into rat heart fo11owing a mild ilChemic 
injury. Levels of lucifcrase activity in iscbemic heart were comparable to diose 
obtained witb normal tissue. Thus foreign genes can be transferred by diJeet 
injection into I/R myocanlium and I1'IIISCribed from a IIIOIIg viral prtlIIIOfa". We 
lie clllTeDtly examining a1lelations in DNA uptake that IR dependent upon 
severity of ischemic injury. Experiments of Ibis lIatUIe open the way for tbe 
investigation of direct DNA transfer and FIIC Ibmpy in models of ilcbcmia. 
886·46 
Type Ilnterleukin-I receptor is expressed iD myocardium 
Jose A. AJeman-Gomez. Niall S. Colwell. Jose R. Rosado. Jeffrey N. Rottman. 
George S. Schreiner. Louis G. Lange Ill, Jewish Hospital at Washington Uni•
versity Medical Center. SI. Louis. MO 
Recent findings suggest that IL-t may mediate some of the hemodynamic ef•
fects associated With round-cell myocarditis. However the mechanisms under•
lying IL-t signal transduction in the myocardium are lUlknOWD. We found that 
IL-t (fl) displayed sarurable and specific binding to a homogenous pq>u!ation 
of cultured rat neonatal carwocytes (myocytes). The affinity of binding was 
snnilar to thai found for the fibroblast IL-I receptor, suggesting that this or a 
similar receptor might be present in cardiocytes. A Type ) (fibroblastic) IL-l 
IeCeptor complementary probe also hybridized wilh carWocyte RNA. Two 
oligonucleotide primers derived from the 5' and 3' untranslated regions of !he 
human dermal fibroblast IL-J receptor cDNA sequence were used to amplify 
reverse-transcnbed total human heart mRNA. A single band was produced. 
which was subcloned and sequenced. and found to be identical wilh the Type I 
IL-\ receptor. Taken together these data suggest that cardiac myocytes express 
the Type I IL·t receptor. and that this receptor could mediate the interaCtion of 





Upregulation of IGF , IGF -Receptor and Late Growth Related 
Genes in Left and Rigbt Ventricular Myocytes Acutely After 
Myocardial Infarction in Rats 
Krzysztof Reiss, Leonar~ G. Meggs, Peng Li, Giorgio Olivetti, 
Joseph M. Capasso and Plero Anversa 
New York Medical College, Valhalla, NY 
To determine the effects of acute myocardial infarction on the 
expression of insulin-like growth factor 1 (IGF ) and insulin-like 
growth facto~l recepto~s (lGF-lR).on the survIving myocytes of 
the left and ~ght ventnc.le.s, large mfarcts were produced in rats 
and the anImals sacnflced 2 days later. Hemodynamic 
m~urements d~umented .that coronary occlusion was associated 
WIth left ventncular failure and severe right ventricular 
dysfunction. By employing reverse transcriptase polymerase chain 
reaction (RTPCR) a low level of expression of IGF-IR mRNA was 
~etec~ in myocytes from sham-operated rats. Acute myocardial 
mfarctlon was found to enhance by nearly 2-fold the message for 
IGF-l~ in viable myocytes biventricularly. Moreover,IGF 
mRNA .mcreased 4.3-fold and 9.~-fold in left and right myocytes: 
respectively. In order to estabhsh whether the upregulation of 
IGF1 and IGF-IR with infarction was coupled with induction of late growth related genes, which are known to be implicated in 
DNA replication and mitotic division, proliferating cell nuclear 
antigen (PCNA) and histone-H3 expression was assessed by 
Northern blot and RTPCR. The level of expression of PCNA 
mRNA was found to be increased 3.9-fold and 2.4-fold in left and 
right myocytes from infarcted hearts. Corresponding increments in 
histo~e-~ mRNA were 2S.S-fold and S.3-fold. However, PCNA 
protem as detected by immuno-peroxidase staining was restricted 
to a limited number of myocyte nuclei adjacent to the necrotic 
myocardium of the left ventricle. In conclusion, acute myocardial 
infarction is associated with enhanced expression of IGF 1 and IGF•
lR on stressed myocytes and this phenomenon may activate genes 
essential for DNA synthesis and myocyte cellular hyperplasia. 
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887·48 
lntracoronary Doxonablcln, but not IDtraeoronary Verapamll, 
Improves Recovery of Postlscbemk: Function 
Steven Smart, JoEl Schultz, Kiran ~ar, David Warltier. Medical 
College of Wisconsin, Milwaukee, Wisconsin 
High dose doxorubicin inhibits release of Ca from the SR and 
verapamil inhibits Ca influx via sarcolemmal Ca channels. To 
determine whether inhibition of Ca release from the SR is a more 
effective strategy than inhibition of sarcolemmal Ca influx for 
accelerating recovery of postischemic myocardium, 23 open chest 
dogs undergoing a IS minute occlusion (0) of the proximal left 
anterior descending (LAD) artery and 3 hours of reperfusion (R) 
were randomized to 3 treatment protocols. The intracoronary 
catheter was inserted into the LAD via a side branch. The treatment 
protocols were SI dextrose (C, n=8), doxorubicin SO mg over 20 
min before 0 (D, n-8), and verapamil S.S mg over 7S min from 30 
min before 0 to 30 min after R (y, n=7). Hemodynamics were 
monitored along with systolic shortenin~ (sonomicrometers) and 
regional myocardial blood flow (radiolabeled microspheres). 
Hemodynamics were similar in all groups. Blood flow in D animals 
was similar to C before occlusion (0.89±0.14 mlImin1gm) and at 30 
min (0.56±0.07) after reperfusion. In V animals, blood flow was 
significantly higher (p<O.OS) before 0 (1.76±0.36) and at 30 min 
after reperfusion (2.12±0.44). During 0 and at ISO min of R, 
blood flow in all groups was similar to C (0.02±0.01 and 
0.67±0.07, respectively). Systolic shortening was (mean±SEM): 




16±1 16±1 -7±1 -1±2 -2±2 
15±2 11±2 -10±2 O±l IH2* 
15±1 1±2* ·Hl -HI H2 
*p<0.01 vs C 
The mechanisms of D and V were ckarly different u V was a much 
more potent negative inotropic agent and increased coronary blood 
flow. While V did not improve postischemic function, systolic 
shortening almost completely recovered in D animals by 3 hrs after 
R. Altered hemodynamics did not account for the improved 
function. Inhibition of SR release of Ca may be the better strategy. 
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Pyruvate Protects Hearts From Peroxide-Induced Free 
Radical Injury 
Laurey Steinke, LuHeng Han, and Laurence W. V. DeBoer. 
University of Nebraska Medical Center, Omaha, NE 
Pyruvate provides significant protection to hearts when 
supplied . d~ng i&<:h~.ia anc1/o~ during reperfusion following 
myocardiallscheUllc Injury. This effect hu been attributed to 
several biochemical mechanisms such as alteration of the 
NAD/N~H ratio ~d stimulation of pyruva~e dehydrogenase. 
ScavengIng free radicals may be an alternative mechanism of 
action s~ce w~ ~ave shown pyruvate administration during 
reperfuslOn ehmInates 80% of free radical generation as 
measured by ESR. To pursue this mechanism of protection 
ap~ fr~ the many factors of global ischemia and reperfusion, 
we Investigated the effects of pyruvate in a model of oxidative 
stress. Isolated rat hearts were perfused with Krebs·Henseleit 
buffer at 37°C. Oxidant stress from H202 (360 J.i.M) resulted in 
a progressive decline in mechanical function to 67±3% of 
baseline over 7 minutes of infusion (pSO.OI VS. baseline). 
During oxidative stress creatine kinase and lactate 
dehydrogenase were not released from the heart. Dysfunction 
was reversed by infusion of epinephrine. Pyruvate (2 mM). 
when supplied during the oxidative stress, completely prevented 
the peroxide· induced fall in mechanical function and the release 
of p~es. M?re~ver, when pyruvate was supplied prior to, but 
not dunng, oXIdative stress, mechanical function fell only 15% 
(pg).02 vs. no pyruvate). 
These results demonstrate: 1) the protection by pyruvate 
from free radical damage is a major mechanism of the 
accelerated recovery from ischemia, apart from any metabolic 
effects, 2) pyruvate may provide an effect like 
"preconditioning" against oxygen-derived free radical injury. 
887·76 
Acidosis during Prolonged (24 Hour) Preservation of Rat 
Hearts Increases Benefit of University of Wisconsin Solution 
LuHeng Han, Laurey Steinke and Laurence W. V. DeBoer. 
University of Nebraska Medical Center, Omaha, NE 
Current methods limit the duration of heart preservation to 
approximately six hours. Many advantages would be seen if this 
time limit could be extended. University of Wisconsin solution 
(UWS) is a high potassium, lactobionate buffered, glutathione 
and hydroxyethylstarch formula effective in liver, pancreas and 
kidney preservation. UWS is designed as an intracellular 
solution. We hypothesized that alteration of intracellular pH 
might optimize hypothennic cardiac preservation. Since C02 
freely perfuses into the cardiomyocyte altering intracellular jlH. 
UWS was either oxygenated with pure 02 or a 97-3% 02/C02 
mixture. Rat hearts were isolated and arrested with the 
preservation solution and continuously perfused at 4°C for 24 h, 
then reperfused at 37°C for 30 min. Effects of preservation 
were determined by meuuring enzyme release (creatine kinase, 
IU/!) into the perfusate, A TP after 30 min of reperfusion, and 
functional recovery (FR (%) = rate x pressure product after 
preservation I rate x pressure product of control x 1 (0). 
SOLUTION FR (15 min) 
25±7 
39±6 






02 UWS (n=lO) 
02-C02UWS (n=9) 
*=p<.01. 
A TP content did not differ between groups. Intracellular pH, 
measured by phosphate shift using NMR, at 4°C was driven 
acidotic as C02 was added to UWS. Histology qualitatively 
confirmed improved organ preservation. 
Conclusion: the addition of C02 during continuous 
hypothermic perfusion of UWS improves anatomical, 
mechanical and biochemical preservation. 
JACC Vol. 21, No.2 
February 1993:165A 
887·77 
Inotropic Stimulation in Right Ventricular Ischemia 
Clifford Greyson, Jorge Garcia. Sean Steinman. Michael W. Weiner. Barry M. 
Massie. Gregory G. Schwartz; University of California, San Francisco. CA 
This study determined 1) whether inotropic stimulation during experimental ischem· 
ia of the RV free wall (RVFW) enhances global RV systolic function by stimu1ating 
the ischemic RVFW as opposed to non·ischemic regions of the heart; and 2) whether 
inolropic stimulation during ischemia produces deleterious effects on RVFW energy 
metabolism. In 12 open-chest pigs. measurements of global RV systolic function 
(dP/dt_) and regional RVFW systolic function (segment sbortening). phosphocrea•
tine to A TP ratio (pcr/A TP. by IIp NMR). blood flow and lactate consumption were 
made during 4 conditions: 1) control (CI1.); 2) infusion of dobutamine at 7.5Il8f1cg•
min (DOB); 3) after 60 min of moderate RVFW ischemia (lSC. mean RVFW blood 
flow = 52% of control»; and 4) ischemia plus dobutamine (I+D). 
Global RV Systolic Function RegIonal RV Systolic Function 
1-
2000CU fi2'0~ ~f1000 c§~ 1.0 ...,-
"\:3 ~ §. 0 CTL DOB ISC 1+0 M,e. 0.0 CTL DOB ISC 1+0 
~ '2 1'0R~V Lactate Uptake 
_.~ -r 
§'. 0.5 
.!? ~~ 0.0 
lil.a. -0.5 
..J -1.0 CTL DOB ISC 1+0 
During I+D. global RV systolic function exceeded the control level. while regional 
RVFW systolic function remained severely depressed. implying that dobutamine 
primarily stimulates non-ischemic myocardium. Surprisingly. the RVFW PCr/ATP 
ratio did not decline during ISC (despite lactate production). possibly due to reduced 
energy demand and/or increased energy production via anaerobic metabolism. 
During I+D. neither the Per/ATP ratio nor lactate production in the ischemic RVFW 
was significantly different from ISC. Thus. during I+D dobutamine did not 
significantly stimulate contractile function in the RVFW. nor did it produce 
deleterious effects on R VFW energy metabolism. 
887·78 
Ischemia Induces a ReversIble Incr.... In Rat Myocardial 
Peripheral Type Benzodlazeplne Recaptors (PBRs). 
Ranil de Silva. Ann Sanders. Ralph Myers. Paolo G Camici. Michael J 
Curtis'. Giovanni E Mann'. MRC Cyclotron Unit. Hammersmith Hospital 
and King's College'. London. UK. 
High densities of PBRs in the heart have been demonstrated previously 
and pharmacological evidence suggests that PBRs exert an inhibitory 
modulatory effect on L-type calcium channel function. Given the role of 
calcium in ischemia (IS) and reperfusion (R) induced injury. cardiac PBRs 
were measured using the specific PBR ligand (3H)PKII19S (PK) in 
anesthetized rats which underwent 30 min IS. by snare occlusion of the 
left coronary artery. followed by S min or 30 min R. The success of 
reperfusion was confirmed by infusion of disulphine blue dye. Sham•
operated controls (SH) were also studied. Regional and transmural 
distribution of PBRs were assessed by autoradiography in unfixed 20!1m 
myocardial sections. PK uptake (pmoVmg tissue) was measured in 
subendocardial (EN DO) and subepicardial (EPI) anterolateral (AL) 
myocardium. since in lesioned animals. the risk area was always in AL as 
confirmed by glycogen depletion on Periodic Acid Schiff staining. Data 
are expressed as mean±SD. Data were analyzed using an one way 
analysiS of variance and specifiC differences were identified using a 
Student t-test with Bonferroni inequality adjustment. 
SH n=3 IS n=5 SR n=3 30R (n=4) 
ALEPI 0.12+0.04 0.18:t0.04§ O.I7±O.OS!! 0.10±0.02t 
ALENDO 0.06±0.03 0.09:t0.02§ 0.11±0.06§ 0.09+0.02' 
ALendo:epi 0.S2+0.12 0.SI+0.09 0.71±0.43 0.94±0.21' 
. '(§P<O.OS vs SH. tp<O.OI vs IS.SR. p<0.01 vs SH. ,p<O.OI vs IS.SH) . 
In SH. PK uptake in EPI was higher than in ENDO. Absolute levels of 
PBRs were elevated in all regions in IS and SR compared to SH. but the 
ENDO:EPI ratio was unchanged. After 30 min R. PBRs had completely 
normalized in EPI. thus eliminating the transmural gradient of PBRs. In 
conclusion. these preliminary data indicate that acute IS produces a 
transmural increase in PBRs which partially reverses on R. It is 
hypothesized that the upregulation of PBRs during ischaemia may serve 
as an endogenous mechanism to protect the heart from tissue necrosis 
which ()t'..QIrs as a resuft of ischemia-induced calcium overload. 
ABSTRACfS 165A 
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Metabolical Intervention Modifies Myocardial 
Stunning: Evaluation with Dichloroacetate(DCA) 
Ryuji Nohara, Kazumi Okuda, Shinji Ono, 
Hirofumi Kambara, Shigetake Sasayama 
Kyoto University, Kyoto, JAPAN 
Metabolic contribution to ischemic stunning was 
evaluated in open chest dogs with DCA(lOO~/kg, 
bolus), which stimulates pyruvate dehydroge-
nase. Ten minutes occlusion (Occ) of the left 
anterior descending coronary artery (LAD) was 
followed by reperfusion (Rep) for 90 minutes, 
and 2nd Occ-Rep was repeated there after in 2 
groups: DCA(D: S dogs) and control (C: S dogs) 
group. Regional wall motion (WM) was serially 
evaluated with echocardiography and blood 
samples were obtained from LAD and great cardi-
ac vein for metabolites. 88mTc-pyrophosphate 
(PYP) uptake was also assessed as a marker of 
cellular injury (ischemic/normal region). After 
90 minutes of 2nd Rep, D group showed better 
recovery in WM than C (81.2+22.9% : S2.3+11.7%, 
P<O.Ol), and smaller reduction of lactate ex•
traction (Ex) and free fatty acid-Ex and larger 
glucose-Ex than C (during the onset of 2nd 
ischemia to IS min of Rep, p<O.OS), although 
myocardial flow and pH decreased in both D and 
C without a difference. Furthermore, D group 
showed a significant suppression of 88mTc_PYP 
uptake ratiO than C ( 0_99+0.06 : 1.18+0.01. 
p<O.OS). Thus, DCA modifies myocardial-metab-
olism and improves recovery of stunning from 
ischemia without changing pH and flow after 
Rep, probably through mechanism related to 
.88mTc_PYP uptake. 
887·80 
Decrea.lng Membrane Potential by Hlgh·KCI Cardlo· 
plegla Causes Depletion of Hlgh·Energy Phosphate •• 
Michael Horn, Stefan Neubauer. JOrgen VolI, Stephanie HOgel. Klaus 
Schnackerz. Georg Ert!. Departments of Medicine and Physiological 
Chemistry. WOrzburg University, FRG 
High-KCI-Cardioplegia (K+-C) decreases the membrane potential 
(AE) and. due to opening of Ca++-channels, causes intracellular 
Ca++-overload; this mimicks ischemic injury without reductions in 
flow. substrate and 02 delivery. Isolated. isovolumic rat hearts 
were perfused with Krebs-Henseleit (KH) buffer at constant flow. 
Hearts were subjected to control (KCI.4.7mM; AE - -90 mV). S6 
min of K+-C (buffer KCI 30. 70, 90 or 110 mM corresponding to 
AE of -40. -I B. -11 and -6 mY) and recovery at normal IKCI) 
(Re-KH) (n-S per group). Performance (LVDP) recovered to 
72±3, 6B±9. 67±7 and 40±B %. respectively. ATP and creatine 
phosphate (CP) (mM) were measured every 7 min by 31 P-NMR: 
IKCI) Control 24.S# S2.S# Re-KH 
30 ATP 9.6±0.4 9.2±0.7 9.7±0.7 B.6±0.S' 
a:> 13.4±0.4 14.7±0.3 1S.1±0.4' 12.3±0.S' 
70 ATP 10.0±0.9 9.4±0.7 9.2tO.S S.4±0.3' 
a:> 14.1±0.7 11.6±0.9' 11.6±1.1" 11.9±0.3' 
90 ATP 10.4±0.6 7.4±1.1' S.4±0.7' S.2±0.S' 
a:> 13.7±1.0 9.9±1.4' 6.BtO.9" 9.4±1.0" 
110 ATP 10.3±0.2 S.1±0.7' 4.0±0.B' 2.B±0.S' 
a:> 12.4±0.S 7.4t1.4" 3.0±0.S' 4.4±0.S· 
#min of high KCI-perfusion. "p<O.OS vs. control 
The high-KCI effect was concentration-dependent and not an all-or•
none phenomenon. Conclusion: This model of Ca++ overload causes 
depletion of high-energy phosphates and reduced post-cardioplegic 
performanca in spite of normal flow, oxygen and substrate delivery 
and zero work. 
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888-106 
LDL-Cholesterol And LDUHDL Ratio Correlate With 
Progression in Existing Lesions but not With New Lesion 
Formation 
Peter Nilrutta, Stefan Jost, Birgitt Wiese, Jaap Deckers, Wolf 
Raffienbeul, Paul G. Hugenholrz, Paul R. Lichtlen and the INTACT 
Group, Hannover Medical School, Hannover, FRG. 
In several epidemiologic studies, morbidity and mortality from 
coronary disease (CAD) was increased with high LDL-Cholesterol 
(C) and low HDL-C. However, only little is known concerning the 
influence of LDL-C and HDL-C on angiographic progression of 
CAD. Therefore, we analyzed the progression rate of existing and 
new lesions in 115 INTACT patients (pts), who had repeated 
standardized coronary angiograms at an interval of 3 years and 
recurrent LDL-C and HDL-C determinations once a year. Cine 
films were analyzed using an automated contour detection system 
(CAAS). An increase in percent diameter reduction 2..20% in 
existing plaques (PRO) and the formation of new lesions 2..20% 
(NL) in initially normal segments was considered as progression. 
The follOwing correlations between PRO, NL and LDL-C, HDL-C 
and LDLlHDL ratio were found (p=Spearman's rank correlation): 
PRO pos ne~ p 
# pts 32 83 
LDL-C (mg/dl) 180.5 155.4 0.028 
HDL-C (mg/dl) 37.7 42.8 n.s. 
LDLlHDL 5.76 4.32 0.034 
NL pas nel: P 
# pts 50 65 
LDL-C (mg/dl) 158.5 164.9 n.s. 
HDL-C (mg/dl) 37.7 42.8 n.s. 
LDLlHDL 5.18 4.37 n.s. 
Conclusion: Increasing LDL-C and LDLlHDL ratio were 
associated with subsequent growth of existing plaques, but did not 
account significantly for the initialisation of new lesions. 
888-107 
Reduction or Carotid Artery Intima-Media Thickness With lipid 
Lowering Therapies: A Comparison or Two Clinical Trials 
Wendy J. Mack, Howard N. Hodis, Janice M. Pogoda, Donald W. 
Crawford, Robert H. Selzer, Chao-ran Liu, Dieter M. Kramsch, Petar 
Alaupovic, David H. BlanJcenbom. 
l.Jniversity of Southern California School of Medicine, Los Angeles, CA 
and OJclahoma Medical Research Foundation, OJdahoma City, OK 
Intima-media thicJcness (lM1) of the distal common carotid artery is a 
measure of early atherosclerosis proven at autopsy and used by 
cardiovascular epidemiologists. We examined the effect of two different 
lipid-lowering regimens: (I) colestipol-niacin versus placebo from the 
Cholesterol Lowering Atherosclerosis Study (CLAS), and (2) lovastatin 
versus placebo from the Mevinolin (Lovastatin) Atherosclerosis Regression 
Study (MARS). We compared a matched popuhtion of male nonsmokers, 
aged 40-59, with prior coronary artery bypass surgery and identical 
atherosclerosis risk factors for both trials. We sampled 78 CLAS subjects 
(39 colestipol-niacin, 39 placebo) and 30 MARS subjects (1510vastatin, 15 
placebo) with baseline and two-year carotid image-processed ultrasound 
data. For CLAS, the average ± SD two year change in IMT was 
-0.05±0.06 mm (colestipol-niacin) and +0.04±0.06 mm (placebo) 
(p<O.OOOI). MARS two-year IMT change was -0.06±0.11 mm 
(lovastatin) and +0.07±0.07 mm (placebo) (p=0.0006). In CLAS, 
independent correlates of IMT change were on-trial levels of HDL-C with 
higher values correlated with thinning of IMT and LDL-C with higher 
values correlated with thickening of IMT (total R2=0.24). In MARS, 
higher apolipoprotein C-IIl ratios, a measure of HDL-C metabolism, 
correlated with thinning of IMT and LDL-C with higher values correlated 
with thickening of IMT (total R2=0.68). 
Conclusion: Two independent lipid-lowering regimens, colestipol-niacin 
and lovastatin, tested in suhjects from two randomized clinical trials with 
matched risk factors, comparably reduced carotid arterial IMT. Higher 
LOL-C values increased IMT in both trials. Higher HDL-C levels and 
apolipoprotein CIIl in HOL-C reduced IMT in both trials. 
888-108 
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Upoprotein Lplal is en Important Risk Factor In Intermittent Claudication: 
Evaluation of Retrospective end Prospective Datil In 2440 Men. 
Bernard Cantin. Sital Moorjani. Gilles R. Dagenais and Paul·J. Lupien. 
Upid Research Center. Laval University Medical Center and Qullbec Hea" 
Institute. Qullbec. Canada. 
In an ongoing study of cardiovascular risk factors. plasma lipids and 
apolipoprotein lapo) measurements were performed in 2440 men aged 
45-75 years in 1986. Intermittent claudication was recorded in 93 men 
retrospectively IR) from 1973 and in 22 men prospectively IP) until 1990. 
In the retrospective study. the mean concentrations of cholesterol IC). 
LDL -C and apoB were similar in both intermittent claudication and 
unaffected groups; whereas the differences in HDL-C and apoA-1 were 
significant. Mean Lpla) values were significantly elevated in the 
intermittent claudication group as compared to unaffected subjects 1408 
mgldl vs 334 mgldl; p<0.05). In the prospective study. the differences 
were however significant for all the variables between the unaffected and 
intermittent claudication groups. The mean values for \.pIa) in the 
unaffected and intermittent claudication groups were 331 mgldl and 680 
mgldl. respectively Ip<O.OO1). Maximum likelihood analysis was 
performed to evaluate the risk ratio according to quintiles of each 
variable. The variables included in the model along with \.pIa) were total 
cholesterol. HDL-C. apoB. apoA·I. systolic pressure. smoking habits and 











The risk ratios for \.pIa) in quintiles 2.3.4.5 of the retrospective study are 
1.4.2.2. 1.3.2.2 and in the prospective study 1.3. 5.1. 5.2. 9.4. These 
results suggest that \.pIa) is an important risk factor for claudication. 
888-109 
Lp(a) is inaeased in Acute Coronary Syndromes but is not 
predictive or the severity of Coronary Atherosclerosis. 
Paolo Spallarossa, Claudio Brunelli, Luca Corsiglia, Cristina Barbara, 
Carlo Pastorini, Stefano Bertolini, Paola Masturzo, Pasquale Lantieri, 
Salvatore Caponnetto. Dept. of Cardiology and Internal Medicine, 
University of Genova, Italy. 
Lipoprotein(a) [Lp(a)] levels were investigated in 365 patients 
submitted to coronary angiography with these diagnosis: Stable Angina 
(SA, n= 159), Unstable Angina (UA, 0=99), Acute Myocardial 
Infarction (AMI, n=45) and 110 Ischemic Heart Disease (110 IHO, 
n=62). Angiograms were evaluated for presence of significant 
(L 70%) Coronary Artery Disease (CAD +), number of vessel 
diseased (V), and Score Severity Index, i. e. sum of all stenosis 
percentage values present in the major branches. Lp(a) and clinical 
diagnosis: Lp(a) was higher in IHD (40±34) than in ooIHD (27±26) 
(p< .01). Comparing subgroups, UA (53±37) and AMI(45±36) were 
higher than oolHD (p<0.01); SA (30±29) was similar to noIHO, but 
lower than UA (p < .05). At multivariate analysis Lp(a) was the best 
discriminant among SA, UA, and AMI; also smoJcing and HDL were 
significant. Lp(a) and CAD+: Blood levels were 28±27 in CAD+ 
and 41±36 in CAD-. Discriminant analysis showed that besides old 
MI, HDL, smoking, gender and cholesterol, also Lp(a) significantly 
and indepeodently discriminated between CAD+ and CAD-. Lp(a) 
and severity or CAD: At univariate analysis Lp(a) correlated with V 
(r=0.14, p< .01), but not with Score (r=O.09; NS) These correlations 
were of less magnitude than those of HDL, LDL and triglicerides, and 
greater than those of cholesterol. In multivariate analysis Lp(a) was 
excluded from the model. Conclusions: the present study documents 
that high Lp(a) levels are associated with the occurence of acute 
coronary syndromes but not with the extent of CAD 
JACC Vol. 21, No.2 
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888·120 
Importance of Plasma Apolipoproteln B In Coronary Artery Disease: 
Evidence from retrospective and prospective findings In 2440 men 
Sital Moorjani. Bemard Cantin. Gilles R. Dagenais and Paul-J. Lupien. 
Upid Research Center. Laval University Medical Center and O"'bec Heart 
Institute. Oullbec. Canada 
In an ongoing coronary artery disease (CADI risk factor study. plasma 
lipid and apolipoprotein (apol measurements were performed in 2440 men 
aged 45-75 years in 1986. The occurence of a first CAD event. angina 
or myocardial infarction was recorded in 253 men (10.4%1 
retrospectively (RI from 1973 and prospectively (PI in 91 men since 
1986. In the retrospective evaluation. the mean concentrations of 
cholesterol (CI. LDL-C and lipoprotein Lp(al were not significantly 
different between the non-CAD and CAD. whereas the mean 
concentrations of apoB. apoA-1 and HDL-C were significantly different 
(p<0.051. In the prospective evaluation. the concentrations of all the 
above variables were significantly different between non-CAD and CAD. 
In the retrospective study the mean concentration of apoB for CAD and 
non-CAD were 124:1: 31 mgldl and 118:1: 31 mg/dl. respectively 
(p<O.OO1). In the prospective study. the values were 130:1:31 mgldl 
and 116:1: 30 mg/dl. respectively (p < 0.0011. Maximum likelihood analysis 
was performed to evaluate the risk ratio according to quintiles for each 

















The risk ratios for apoB in quintiles 2,3,4,5 in the retrospective study are 
1.7. 2.1, 2.0, 1.9 and in the prospective study 2.3, 2.7, 2.8, 4.2. These 
results clearly demonstrate that apoB is the single most powerful variable 
in both retrospective and prospective evaluation of CAD risk in this 
cohort. 
888·121 
Relation of Lipoprotein Levels to the Presence, Extent, 
and Severity of Coronary Artery Disease 
Heinz Drexel, Franz W. Amann, Katharina Rentsch, Reto Candinas, 
Antonia Luethy, Christian Neuenschwander, Ferenc Follath. 
University Hospital. Zuerich. Switzerland 
We determined the relation of lipoprotein levels to angiographic 
characteristics of coronary atherosclerosis. Of 443 consecutive 
patients (368 men and 75 women), 338 had significant coronary 
lesions (>50% obstruction) and 105 had nOL We quantified coronary 
artery disease in terms of presence, extent (i.e. number of significant 
lesions), and severity (i.e. size of a lesion). These characteristics 
were then related to cholesterol and triglyceride levels (determined 
enzymatically) in plasma, HDL, HDL2, HDL3 (prepared by a dual 
precipitation procedure), and lDL as well as to plasma levels of 
apolipoproteins A-I and B. 
OIolesterol fiaclion OIaracterislic of coronary anery disease 
Presence Extent Severity 
p values" p valuesll p values1 
Men (N:368) 
LDL N.S. 0.047 N.S. 
HDL2 0.0001 0.0003 0.032 
HDL3 0.015 0.0013 0.046 
Women (N:75) 
LDL N.S. N.S. N.S. 
HDL2 0.023 0.018 0.019 
HDL3 N.S N.S. N.S. 
• two-tailed t-teSt II simple regression analysis; 1 KruskaI-Wallis teSt 
In men, HDL2, HDL3, and lDL cholesterol proved independently 
correlated to the extent of disease. Triglyceride and apolipoprotein 
levels had no additional predictive power. We conclude that HDL2 
cholesterol shows a strong and consistent correlation with presence, 
extent, and severity of coronary atherosclerosis whereas the 
correlation of LDL cholesterol is less consistent. 
ABSTRACfS 
888·122 
The relationship between the apolipoprotein-B100 mutation at codon 
3500 and risk of coronary artery disease in the Utah population 
Erwin H. Ludwig, Ann Allen, linda C Morrison, Hiram W. 
Marshall, Jeffrey L Anderson, R.H. Ward 
University of Utah and the LOS Hospital, SaIt Lake Oty, Utah 
Familial defective binding of apolipoprotein-B100 (FOB) to the low 
density lipoprotein receptor has been established as a cause of 
moderate to severe hypercholesterolemia. To date, only one 
mutation in the apolipoprotein-B gene has been identified as a cause 
of FOB: A G to A transition in codon 3500, which results in an 
amino add change of Arg to Gin. We have detennined the 
frequency of this mutation in an angiographicalJy defined sample of 
Utah cases and controls using polymerase chain reaction to amplify 
genomic DNA, followed by restriction enzyme digestion. Two oUI 
of 411 cases (> 60% stenosis of the coronary arteries) were found ' 
to have the Arg to Gin mutation, while none were found in 383 
controls «10% stenosis of the coronary arteries). 
In conjunction with other studies, this data suggests that the 
mutation at codon 3500 of apo-B causes 0.5% to 2.0% of coronary 
artery disease in individuals of Northern European descent. 
We have also traced this mutation in one family of 33 members, of 
which 19 have the mutation. In one of the four nuclear families in 
this kindred, the occurrence of the Arg to Gin mutation is not 
consistently associated with an elevation of total cholesterol or LDL 
cholesterol, suggesting other modifying factors may be present in 
this family. In the rest of the kindred, the mutation shows a more 
consistent association with total cholesterol and LDL cholesterol. 
Haplotype analysis revealed that this mutation occurs on the same 
chromosome which has been previously described, indicating the 
spread of this mutation is due to founder effect. 
888·123 
167A 
Apparent Variation of VLDL Triglrceride/Cboleaterol .. tio 
Influencea the LDL Value Obtained br CAlculation 
Eric T. Foasel. Beth Iarael Hoapital, Boaton, MA 
It hae become apparent that a practical direct measure•
ment of LDL is needed in a number of clinical aituations. 
The p-quant ultracentrifugation baeed method, which is 
the source of the LDL data used for developing NCEP risk 
categories, ie too difficult to use in routine practice. 
Recently, a number of inveatigatora have ahewn that LDL 
can be _asured directly by NHR apectroscopy and that 
results equivalent to those obtained from the p-quant 
mea.urement can be obtained. The widely uaed calculated 
method for obtaining the value of LDL aaaums. a conatant 
ratio of triglyceride to cholesterol in VLDL aa well. We 
have calculated thi. ratio based on LDL and HDL values 
obtained from both p-quant and NHR data in 288 patients 
and normal controls, and found it to be widely variable 
with means and ranges of 5.36; 0-27 and 4.50; 0-22, 
respectively. Approximately 65' of the values fall 
between 3 and 8. From this finding it is apparent that 
calculated LDL could result in mi8clasaification of a 
patient into the wrong risk category. We tested this in 
the 288 individuals as described above. Riak categories 
are: LDL of <130 mqjdl - normal; 130-160 mqjdl -
borderline; and >160 mqjdl - high risk. Of the 288, 87 
had p-quant LDL values of 115 mqjdl or higher, placing 
them near or in the increaaed ri.k category. Of these 
87, 27 (31') were aa8igned to the wrong risk category by 
calculated LDL. When the 17 8ubject8 with triglyceride 
values of 190 mqjdl or higher were eliminated from this 
group, 26 of the remaining 70 (37') were aSSigned to the 
wrong risk category. We also analyzed the 84 of the 288 
subjects with total cholesterol of 200 mgjdl or higher. 
Of these 84, 24 (28') were as.igned to the wrong risk 
group by calculated LDL using the p-quant LDL values as 
the gold standard. In both the high cholesterol and high 
triglyceride groups, the values of LDL obtained by NMR 
spectroscopy correctly classified all aubjects into the 
proper riek group. We conclude that calculated LDL 
values are sufficiently inaccurate to lead to wrong risk 
classifications in a substantial fraction (28-37'1 of 
those atudied. The source of this diacrepancy may be the 
variable triglyceride/chole.terol found in VLDL. 
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741-1 10:30 
Orthotopic Heart TraasplaDtatloa: CI1DIcaI EsperIeDce With a New 
Technique 
Lawrence S.C. Czer, Alfredo Trento, Carlos Blanche, Peter Barath, Dan 
Admon, Deborah Harasty, Michele DeRobertis, Jack M. MatIoff, Cedars· 
Sinai Medical Center, Los Angeles, CA 
Orthotopic beart transplantation (OHT) is usually performed with a bi· 
atrial anastomosis, but this technique causes sinus node dysfunction in many 
patients and atrial enlargement in nearly all. We desaibe our clinical 
experience with a new OHT technique which utilizes bi-caval and pulmonary 
venous anastomoses, potentiaIly avoiding sinus node injury and ensuring 
normal atrial size and function. 
Methods: In 50 consecutive pts having OHT between 9/W and 8/92, the old 
(hiatriaI) technique was used in 26 pis, and the new technique in 24. Old and 
new technique pts were similar in prcop age (55.±.10 vs 56.±.8 yrs), NYHA 
class (69% vs 71% class IV), LV ejection fraction (18.±.5% vs 18.±.5%), 
myopathy (69% vs 67% ischemic), pulmonary vascular resistance (3.5.±.2.6 vs 
2.!\..±.1.6 units), and donor age (29.±.9 vs 25.±.9 yrs)(aII p=NS). lschemic time 
was longer with the new technique (139.±.36 vs 160.±.32 miD, old vs new; 
p= .03). Followup was shorter with the new technique. 
Results: Symptomatic bradycardia requiring pacemaker insertion occurred 
in 35%(9) of old technique pis, and in none of the new pts (p< .05). Postop 
residual mitral regurgitation (MR) grade by echocardiograpby was lower in 
the new Pts (15.±.1.l vs 0.7.±.0.8, old vs new; p=.03), and the tricuspid 
regurgitation (TR) grade was also lower (2.3.±.0.9 vs 1.4..±.0.6, old vs new; 
p=.OO6). Caval stenosis occurred in 1 new pt (4%) and required operative 
patch repair. Early (30 d and 6 month) survival rates were 96% and 88% in 
the old pts, and 100% and 100% in the new (p=NS). 
Conclusions: OHT with bicaval and pulmonary venous anastomosis takes 
longer to perform but significantly reduces the occurrence of postop 
bradycardia and tbe need for permanent pacemaker insertion. Postop 
residual MR and TR are reduced, perhaps due to less distortion of the atria. 
Caval stenosis is an infrequent complication. Early survival is excellent but 
more followup is needed. 
741-2 10:45 
Cyclosporine Associated Hypertension: Angiotensin II 
Blockade Suppresses Circulating Levels of Atrial 
Natriuretic Factor 
Martha Grogan, Margaret A. Lloyd, Sharon M. Sandberg, 
Terry J. Opgenorth, Brooks S. Edwards, Mayo Clinic, 
Rochester, MN and Abbott laboratories, Abbott Park, IL 
Cyc10sporine (CYClO) administration results in sodium 
retention and activation of the renin-angiotensin system 
(RAAS), both of which may contribute to CYClO associated 
hypertension. In vitro angiotensin II (All) may be a 
secretagogue for atrial natriuretic factor (ANF), an 
important count-regulatory natriuretic hormone. The 
effects of All blockade on ANF and CYClO induced sodium 
retention were assessea in 2 groups of anesthetized dogs. 
Gr.l (n=5) received CYClO (2Omg/kg/day, p.o.). Gr.2 
(n=5) received CYClO and the All receptor antagonist 
(AS09BS, Abbott laboratories) O.lmg/kg/day, p.o. All 
blockade was confirmed by challenge with All. The 
responses to lO~ saline volume expansion (VE) are 
reported below: 
MAP Urine Flow UNaV ANF 
(nmHg) (m1/min) <ilEq/min) (pg/mll 
Gr. 1 143t12 6.Stl.6 S04t206 l03t24 
Gr. 2 122±lO 4.0tl.O 467±lO8* 49±12* 
(* p<O.05 Gr.l vs Gr.2, UNaVcurinary sodium excretion) 
In Gr. 1 there was activation of the RAAS and 
hypertension; the hypertension was attenuated by All 
blockade. During VE, atrial pressure rose similarly in 
both groups, however All blockade attenuated the increase 
in ANF and bluntea the natriuretic response to VE. In 
vivo, All may be an imporant secretagogue for ANF, a-•
hormone critical for the regulation of sodium 
homeostasis. 
741-3 
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11:00 
Diastolic Dys'unctiOD Ia CydosporiDe Iadaced Hypertension: 
DirrereDctl Ia Heart Versus Liver Traa.plant Recipients . 
Andrew P. Rccs, Daniel T. Fontenot, Hector O. Ventura, Carl J. Lavie, Daniel 
H. Hayes, Mark M. Cassidy. Ochsner Medical Institutions. New Orleans, LA 
Since the advent of eyclosporine, hypertension has been highly prevalcm in the 
orpn tmnsplant population. To cvaIuate cardiac adaptation 10 eycIosporine induced 
bypenension, we compared 10 bypertensive heart transplant ru:ipients (HTRs) 
without evidence of allograft rejection and 10 hypcn.cnsive liver transplant 
ru:ip!ents (LTRs) 10 a control group of 10 lIOf1I\otensive palicnts (ClRs) matched 
for body mass index (mean 28±6 kg/m2), Transplant recipicDts were matched for 
age (mean 49±ll yQrS), intcrvaI since transplantatioll (mean 15:t4 mos), and 
immunosuppressive drug regimen. Indices of systolic and diastolic function were 
measured using Doppler echocardiographic examinatioll. Hemodynamic indices 
were confumed in HTRs by invasive monitoring. There were no statistically 
significant differences between HTRs, L TRs, and ClRs in cardiac output (m~<II1 
5.8±1.I Llmin), ejectioll fraction (mean 62±7'1», right IIIriaI pressure (mean 7±2 
mmHg), or bean rate (mean 77±12 bpm). AdditionaIly, there was no statislicall} 
signiflC&Dt difference between HTRs and LTRs in mean .-teriaI pressure (mean 
107±13). Echocardiograph cxaminatioo revealed: 
End-diastolic: LV mass Ewave A wave FlA Deceleration 
dimensioa (em (guI) (mls) (mls) ratio time (msec) 
CTRs 4.3 ±.3 217 .h.1 .St.1 1.6±.4 188 ±i3 
HTRs 4.S±.4 182 .8± .2 .4±.1 1.9± 5 175 ± 32 
LTRs 4.7±.3 197 .h.2 .8±.2" 1.1 ± .4" 225 +46" 
° p SlgmflC&Dt 8t 95% for L TRs vs. HTRs 
In comparison to ClRs and HTRs, L TRs had diminished E! A ralios and 
prolonged deceleration times indicative of greater diastolic dysfunction due lO 
relaxation abnormality. As 8 group, HTRs had preserved left ventricular dia~LOlic 
function. Conclusion: Despite 110 significant differences in left vemricular 
structure, preload, afterload, or systolic fUnctioll, HTRs with cyclosporinc 
induced hypertension exhibit less diastolic dysfunction than L TRs. Potential 
mechanisms for this might include: 1) younger age of the donor hean, 2) cardiac 
denervation, and 3) variations in antihypertenSive regimen. 
741-4 11:15 
Early TroulII CydosporlD Levels do Not I.nueace Tile Rate of 
SubiequeDt Acute Cardilc Rejection 
Stephen HJennison, Aaron G.Wcsp, MicbaeI A Graham, Lawrence R McBride, 
LcsIie W.Miller. 5t Louis University Medical Center, 5t Louis, Missouri. 
Cyclosporin (CsA) is the primary immWlosuppressive drug used by cardiac 
transplant centers. Its advcne effects 011 renaI functioll in the early postop period are 
aa:epIed by many because of a fear of acute rejection (Rej); others administct ALG or 
OKTI (l]) fir 7-10 days in placeofCsA, believing that less dian "thcnpeutic· CsA 
levels cannot block graft sensitization. A retrospeCtive review was performed in 
patients (pis) woo had received 110 II to evaluate the influence of various trough 
(11br post-do8e) CsA levels in the fust wccIt 011 subsequent rateS 01 Rej over the 
next M days. 
70 consecutive pts received IOmglkg i.v. solumedrol intraoperatively, and then a 
Jndnisone taper from l.Omg/kgld, deacased by 5mg/d 10 O.3mg/kgld, then gradually 
to O.lmglkg/d by 3 months. Azathioprine was given 81 1-2mgs,lkg/day. Pts were 
groopcd (A-D) according 10 their mean trough CsA levels by TDX assay in the fust 
7 postoperative days. Rej was treated for grade 3A or more by ISIR.T aituia, using 
only an i.v steroid pulse 81 IOmgs,lkg for 3 days. PI age. sex, etiology, and UNOS 
status were not signiflC8lltly different between groups. The rate of Rej is expressed 
below as the p~r gf rei5 per pt month of fgllow-up CReis!Pt Mg fu\ 
Group(Gp) Gp sA Level CsA dose CreatipipeCugD> Reis!Pt Mo Fu 
Day Q-7 Q-7CO) 0 7 Q-28 Q-S4 
A(n=6) <75 4.18±1.45 1.5 2.1 0.33 0.16 
(mS f1) ("47.2±12.2) 
B (0=5) 75-100 4.7S±1.8S 1.3 1.2 0.20 0.13 
(m3 /2) (OW.6±7.5) 
C (0=33) 100-1S0 4.17±1.71 1.1 1.2 0.36 0.15 
(m26PJ (OI21.6±13.4) 
D (n=26) > 1 50 3.15±1.44 1.3 1.2 0.50 0.24 
Cm24 ntf2) rI8! 2t325) 
Abbrev: Gp=group;m=maIe,f=femaIe;("')=mean±1 standard deviation;G.=mean CsA 
CppcJu5jm: Low trough CsA levels in the fust 7 postoperative days do not predict 
a higher rate of Rej in the fust 3 months, and may inadequately reflect the 
immllllOStlPlRSsive cff"IC8CY of the drug. Reduced CsA llllding doses and Ioo.\u early 
trough levels may be acceptable in pts with known compromised preaperative renaI 
function, without necessarily requiring the addition 01 lymphocyte depleting agents. 
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741·5 11:30 
Optimal Lipid Lowering Tberapy After Heart Transplantation: 
a 12 Montb Randomized Trial 
Peter W. Pflugfelder, Rita Oskalns, Laszlo Rudas, Murray W. Huff, 
William J. Kostuk. University Hospital, London, Ontario, Canada. 
Hyperlipidemia, a common problem after cardiac transplantation 
(TP), may be important in the genesis and progression of allograft 
coronary artery disease. To determine optimal therapy for this 
problem, 48 patients with hyperlipidemia 35±20 mo after TP were 
randomized to therapy with cholestyramine (C) 4g bid (n=18), 
gemfibrozil (G) 600 mg bid (n=17), or simvastatin (S) 10 mg od 
(n=13). All patients also received detailed dietary counselling. 
Immunosuppressive therapy was comparable in all 3 groups 
throughout the study. To date, 22/48 patients have been followed 12 
mo on original therapy. At 3 mo, 3 patients in group Chad 
discontinued therapy because of side effects (mainly GI), as had 2 in 
group G. By 12 mo 9 patients in group C and 4 in group G had 
discontinued therapy because of side effects. No patient in group S 
withdrew because of side effects. 
Cholestyramine Gemfibrozil Simvastatin 
Baseline Total·C 7.2±1.2 6.8±1.0 6.8±O.5 
3 mo Total·C 6.1±1.5t 6.6±0.9 5.2±1.0.t 
6 mo Total-C 6.8±1.1 6.5±1.1 5.0±0.7 .. t 
12 mo Total-C 6.4±O.3 6.6±1.3 5.0±1.1.t 
means±SD; Total-C.tota1 cholesterol (mmoVL); *p-O.05 vs gemfibrozil, °Op<O.OS 
Vllemfibrozil and cholestyramine, tJKO.Ql vs baseline. 
In the first 3 mo of treatment, serum triglyceride levels were reduced 
significantly in group G (2.9±1.3 to 2.0±1.l, p<O.OOOI), but not with 
other therapy. High density lipoprotein cholesterol levels were not 
affected significantly by any therapy. No biochemical abnormalities 
resulted from any therapy and specifically, neither G or S were 
associated with clinical or biochemical evidence of myositis. No 
therapy caused significant alterations in cyclosporine blood levels. 
We conclude that of the 3 therapies studied, simvastatin is the most 
efficacious and well tolerated lipid lowering treatment for patients 
after cardiac transplantation. 
741·6 11:45 
Hypercholesterolemia in tbe First Year Post Cardiac Transplant 
is Related to Transplant Coronary Arteriopatby Despite 
SubRquentLowering 
Jon A Kobashigawa, Erica D. Brownfield, Lynne W. Stevenson, 
Jaime D. Moriguchi, Michele A Hamilton, Antoine S. Hage, 
Nobuyuki Kawata, Roxella Minkley, Johanna Salamandra, Shelly 
Ruzevich, Davis C. Drinkwater, Hillel l..aks. UCLA Medical 
Center, Los Angeles, CA 
The treatment of hypercholesterolemia and the development of 
cardiac transplant coronary arteriopathy (TCA) is unknown. We 
reviewed 150 pts > 1 yr post cardiac transplant to assess the 
impact of treating hypercholesterolemia on TCA incidence. The 
first yr cholesterol (Chol) level was obtained by averaging levels 
at 3, 6, 12 mos post-op and then recording levels yearly. Most pts 
were treated with diet and low dose lovastatin for Chol > 200 
mg/dl after 1 yr post-op. Between 1 and 5 yrs post-op, 32 pts 
developed TCA (10 at 1 yr, 7 at 2 yrs, 15 at £ 3 yrs) and were 
found to have a higher first year Chollevel ("p<0.05) compared 
to the 118 pts without TCA After treatment of hypercholesterol· 
emia, subsequent Chollevels in 2nd/3rd post-op yrs were reduced 
by 16/18% in TCA groups and 12/17% in no TCA groups. At 1 
yr, average prednisone dose and number of pts placed on 
lovastatin for both groups were similar. 
Ay& Chol Av& Chol at 
..N.. in..ln.n 2nd yr 3rd yr 
TCA 31 257 .±. 54" 215 .±. 44 210.±. 50 
No TCA 118 235 .±. 52 206.±. 46 196.±. 41 
Conclusion: First yr hypercholesterolemia appears associated with 
the development of TCA despite Chollowering after the first yr 
post cardiac transplant surgery. Treatment of hypercholesterol•
emia immediate post-op may decrease TCA incidence. 
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742·1 10:30 
One Year Follow·Up of Antltacbycardla Pacini and Low 
Energy Cardioverslon In a Third Generation Implantable 
Defibrillator 
John M. Herre for the the US VENTAK® PRx® Investigator Group. 
Eastern Virginia Medical School and Sentera Norfolk General Hospital. 
Norfolk. VA. 
Antitachycardia pacing (A TP) and low energy cardioversion (LEC) 
terminate many episodes of sustained monomorphic ventricular 
tachycardia (VT). Two hundred and sixty patients were implanted with a 
CPI-PRx pulse generator. Patients were age 63.9 ± 11.1 year, 86.5% 
male. with ejection fraction 31.2% ± 12.4%. Spontaneous or inducible 
sustained vr was documented prior to implant in 227 patients. After 
successful testing ~ I sustained vr termination). A TP was used in 125 
of 249 patients tested. LEC ~ 25J) was used in 34 of 61 patients tested. 
Conversion (C) of spontaneous sustained vr events (E) by heart rate 







1 CI# E ('I) 
358/413 (86.7%) 
2206/2346 (94.0%) 








Patients with spontaneous sustained vr in an ATP or LEC zone were 
examined using actuarial analysis to examine ATP and LEC conversion 
(C) and nonconversion (NC): 










Conclusions; I) In sustained vr patients, ATP is useful in 
approximately 50%. 2) When testing is successful. 90% episodes can be 
terminated by ATP. 3) At 12 months. 86% of ATPpatierus will have ~ I 
ATP failure requiring shocks. 4) LEC has lower failure rate than ATP 
and. unlike A TP. is useful for sustained vr > 2OOImin. 
742·2 10:45 
comprehensive Bvaluation of Defi))rillators 
And Resuscitative Shock (CBDARS) Study: 
Multivariate ADalysis of Predictors of Barly 
Appropriate Shock 
CEDARS Investigators 
Cedars-Sinai Medical Center, Los Angeles, CA 
To optimize patient selection for implantable 
defibrillators (ICD), an index to predict 
individual probability of receiving an 
appropriate shock is needed. Therefore, we 
followed up 468 consecutive patients from 9 
centers with AICD for a period of one year. 
Of these, 9 died within one month, 3 units 
were explanted, and 4 pts were lost to follow 
up. Of the remaining 452 pts, 30 (7%) died, 
and 231 had shocks (161 were appropriate by 
predefined criteria; 42 inappropriate and 28 
were indeterminate). 20 variables (clinical, 
ECG, LVEF, EP induced VT /VF, surgery, 
discharge drugs, etc.) were entered into a 
mUltivariate logistic regression model. A 
probability index for appropriate shock 
within the first year was developed with a 














CONCLUSION: By accurately indentifying pts 
who are not likely to have an appropriate 
shock wi thin the next one year, physicians 
can triage survivors of VT/VF to ICD or drug 





Interval-Stability Criteria Enhance Disaimlnation of AtrW Fibrillation 
From Ventricuw Tachycardia by Tiered-Therapy Antiarrhythmic Devices 
Charles Swerdlow, Cathy Luckett. Cedars-Sinai Medical Center and Daniel 
Freeman Memorial Hospital, Los Angeles, CA. 
We evaluated interval-stability (IS) criteria for distinguishing atrial 
fibrillation (AF) from VT in 42 pts with a tiered-therapy antiarrhythmic 
device (Medtronic peD). VT was detected if consecutive RR intervals equal 
to the "Number of Intervals to Detect (NID)" varied from each of the 3 
previous intervals by less than the IS criterion and were shorter than the 
'Tachycardia-Detection Interval." At electrophysiologic study, true detection 
was evaluated in the 35 pIS with indudble VT using IS a 40 ms and NID = 
12 or 16. All 152 episodes of induced, sustained VT were detected. IS 
delayed detection of VT more than 5 sec in only 1 pi. False detection of AF 
was studied in 13 plS,4 with chronic AF and 9 with induced, sustained AF. 
Initially, the wea\cest criteria were set (NID = 8, IS =100 ms). We increased 
NID and decreased IS systematica\ly until detection did not occur for 5 min. 
The ventricular rate in AF was increased by isoproterenol (2 - 61lg/min), 
and the process was repeated. The maximum ventricular rate was 159±11 
bpm. The table shows the number of pts (n) with detection at each setting 
and the corresponding mean ventricular rate (bpm). 
lsi r-~~==m=s~ __ ~~==m=s~ __ ~~~m=s~ __ ~M~m~s __ ~l~OO~m~s-, 
lill2 n.Rm n.Rm n .Rm n.Rm n.Rm 
8 2 154 5 141 11 134 13 121 13 113 
U 1 161 3 157 7 140 12 126 13 118 
16 0 1 172 5 151 12 136 13 123 
For follow-up, IS was set to ~ ms and NID to 12 or 16. During 562 pl•
months, 399 episodes were detected as VT and treated successfully. No pi 
had symptomatic, undetected VT because of IS. In addition 10 lhe 4 pIS wilh 
chronic AF, 6 pts had paroxysmal AF during follow-up. None had therapy 
for documenled or suspected AF. Conclusions: With IS = 40 ms and NID 
.. 12 or 16, spontaneous or induced VT is delected reliably, and AF is 
rejected al electrophysiologic study. Use of these crileria may diminish the 
incidence of inappropriate therapies for AF. 
742-4 11:15 
Stability of Defibrillation Threshold Greater than 
20 Joules with Nonthoracotomy Lead Systea 
Andrea Natale, Jasbir Sra, Boaz Avitall, Anwer Dhala, 
Sanjay Deshpande, Mohammad Jazayeri, Kathi Axtell, 
Abdul Wase, Mita Sheth, Masood Akhtar. 
Sinai Samaritan Medical Center, Milwaukee, WI 
The stability of defibrillation threshold (DFT) in 
patients (pts) with nonthoracotomy lead system and DFT 
~ 20 joules has not been evaluated. To ensure future 
efficacy, we measured stability of DFT over time in 26 
pts receiving a nonthoracotomy lead system (NTL) with 
high DFT (~ 20 joules) at implant. The mean age was 
62±11 years (21 male, 5 female). Twenty-four pts had 
coronary artery disease, 1 dilated cardiomyopathy and 1 
valvular disease. The mean ejection fraction was 
35'±13. DFT was determined at implant (I), before 
discharge (D), 1,6, and 12 months post-implantation. 
The mean DFT was as follows: 
DFX' I DFX' D DFX' 1 
n 26 26 26 
joules 22±2 23±3 22±3 







At implant DFT ranged from 20 to 26 joules. Increase in 
DFT of 6 and 8 joules was observed only in two pts at 
discharge and was attributed to small displacement of 
the coronary sinus catheter. In both pts DFT remained 
stable during subsequent testing. 
Conclusion: 1. In pts with DFT equal to or higher than 
20 joules, significant changes in DFTs were not seen 
during short term follow-up using NTL systems. 
2. The stability of the DFT should not be a limiting 
factor in the implantation of NTL system in pts with 
high DFX'. 
JACC Vol. 21, No.2 
February 1993: 170A 
742·5 11:30 
Influence of Honer, exercise Performance Ind Ventrlcullr Function on 
Outcome Ifter Defibrlilltor Impllnt: A Multlvarllte Analysis 
James A. Roth, Gina Wang, Simie B. Platt, Soo G. Kim, John D. Fisher, KevIn 
J. Ferrick, Jay N. Gross, Richard Brodman, Seymour Furman. Montefiore 
Medical Center/Albert Einstein College 01 Medicine, Bronx. New YOII< 
DespIte Its efflcacy In abOltlng sudden death, patients receMng an ICC 
continue to experience I substantial cardiac monaIlty. The factors influencing 
Ulimate outcome In these patients remain Incompletely understood. 
Therefore, survtval free oItotai cardiac death was analyzed In 107 pts followed 
Ifter ICC implantation. Twenty six baseline variables reflecting 24 hour Holter 
recording, exercise testing, left ventricular function, functional class, 
concomitant revascularizatlon, age, sex and undertylng cardiac disease were 
evaluated. Median followup was 20 months. The Cox proportional hazards 
model was used to identify univariate predictors 01 cardiac death which were 
then Included In a stepwise multivariate analysis. Dichotomous or continuous 
representations 01 variables were selected to optimize fit In the univariate 
analysis. Significant unlvarlates were: Exercise maximum blood pressure (BP) 
(p=.04S) and BP Rise < = 20rnmHg (p=0.02), Holter VPB/hr (p=0.002) and 
> 1 VT Run/24 hours (p = 0.0009) , Election Fractlon (EF) < 0.30 (p=0.049) 
and NYHA aass (p=0.03) Multivariate analYSis yielded: 
Yariable D Yalue Hlzard 195% Cll 
> 1 VT Run/24 hrs O.OOOS S.98 (2.20-16.27) 
BP Rise <= 20mmHg 0.01 3.88 (1.31-11.S1) 
EF < 0 30 O.08(NS) 2.86 (Q 92- 8.90) 
Total cardiac syrylva! Including Implant related mortality was: 
Group 12mo. 24m0l *01 .IDOI 8Omos 
All patients (N= 107) .91.84.75.66 .S9 
< = 1 VT Run/24hr (N =65) .95 .90 .87 .87 .81 
> 1 VT Ryn124hr (N-391 .84 .72 .53 .33 22 
Conclusions: Nonsustalned VT on baseline Holter Is a potent Independent 
predictor oItotai cardiac monaIlty which persists despite the presence 01 
effective ICC therapy. Functional reserve as assessed by exercise BP 
response provides addttional prognostic data not encompassed by the EF. 
742·6 
. Complications of Third·Generation Defibrillators Using 
Endocardial or Epicardial Leads: A Multicenter Study 
11:45 
Sanjeev Saksena, Valerie Sakun, L. Brent Mitchell, Michael 
Lehmann, The PCD Investigators and Participating Institutions 
Complications of third-generation implantable defibrillator devices 
[ICDs] which permit nonthoracotomy implant, programmable 
detection & tiered pacing/shock therapy are not defined. 751 patients 
with ventricular tachyarrhythmias implanted with Medtronic 7216/ 
7217 ICDs with either epicardial [EPI] or endocardial {ENDO] lead 
systems were followed for 0-22 mos totaling 6205 device mos. 
~: ENDO & EPI patients were comparable for age, sex, 
coronary artery disease, LV ejection fraction & prior drug trials. 
Prior sudden death was more frequent (p< .(01) & followup shorter 
(4.5 vs 11 mos,p< .(01) in ENDO patients compared to EPI 
patients. VVI pacing & sensing parameters were comparable but loss 
of capture & undersensing were more frequent in EPI than ENDO 
patients (2.8% vs 0.3%). ENDO patients used 3-lead systems & 
bidirectional shocks (p < .00 1) more often than EPI patients. 
Complications ~ EEl 
Perioperative Mortality (%) 0.3 --p< .001-- 5.5 
Ineffective Therapy (%) 0.9 0.7 
Inappropriate Therapy (%) 0 1.4 
Pace/Sense (%) 0.3 --p< .05-- 3.7 
Infection (%) 3.2 3.2 
Leadrelated(%) 9.7 --p<.05-- 2.5 
Generator related (%) 0.6 1.4 
There were no deaths from ENDO lead dislodgement but 2 EPI 
deaths were ICD related. Overall complication rates did not differ 
but potential adverse clinical events were less frequent with ENDO 
than EPI leads (p=.007). Conclusion: ENDO leads use more 
complex configurations yet reduce leo perioperative risk 
complications relating to ICD pacing/sensing. Careful ENDO lead 
fixation is needed for long-term system reliability. 
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743-1 10:30 
THE EFFECT OF LONG TERM AMIOOARONE THERAPY ON 
THYROID FUNCTION. Leesar, M.A., Kerjn. N.Z., 
Marian. M.J .• Faitel. K .• Narala. C. Sinai Hospital 
and Wayne State University. Detroit, MI 
We evaluated the effects of low-dose (LO) 
amiodarone (A) on the thyroid function in 101 pts 
(54 with VT and 47 with atrial fibrillation). 
treated with an average oral loading of 670:t102 
mg/day and a maintenance of 275:t102 mg/day. The 
mean age was 66:t9 yrs and were followed for 37:t27 
months. Thyroid dysfunction (TO) assessed by T •• T3• TSH developed 1n 15 pts (14.8'). 8 had 
hypothyroidism (HP)(7.9') and 7 hyperthyroidism 
(HT)(6.9'). No statistical differences were found 
between euthroids and TOs pts with respect to age. 
gender. wei ght. A and OE-A leve 1 s. A dose or 
duration of therapy (P=NSl. HP developed after 
26.0:t26.4 months. while HT after 41. 7:t13.2 month. 
yielding a difference in the total dose of A to 
147:t112 g for HP vs 284:t97 g for HT (P=0.02). 6/8 
HP pt and 4/7 HT had biochemical abnormalities 
alone. without clinical manifestation. All cases of 
clinical HT were transient and responded to dose 
reduction. The biochemical abnormalities of either 
HP or HT changed on 1 y after about 2 months of 
therapy on a lower A dose. ' 
We conclYde: 1) LOA produces mild TO in 14.8' of 
patients; 2) Most HP patients have biochemical 
changes and no treatment was reQui red; 3) The HT 
cases were mild and responded to dose adjustment; 4) 
The HP developed earlier and received a lower total 
dose of A; 5) No variables predicted the development 
of TO. 
743-2 10:45 
Propafenone: determinants of Its beta-blocking effect during chronic 
treatment In extensive oxldisers • 
Giuseppe Boriani. Alessandro Capucci. FACC. FESC. *Enrico 
Strocchi. Andrea Santarelli. Mauro Biffi. Bruno Magnani, FESC. 
Institute of Cardiology and *Dept. of Clinical Pharmacology, University 
of Bologna. IllIly. 
Alms of this study were to evaluate whether a beta-blocking effect can 
be clinically significant during propafenone (PF) treatment even in 
subjects with normal oxidative metabolism (>90% of Caucasians) and to 
identify eventual kinetic determinants of such an effect. Eleven patients. 
classified as extensive oxidisers of debrisoquine, with stable premature 
ventricular contractions (> 1 OOIbour) were studied by Holter monitoring 
in basal condition and after 14 days of treatment with PF 300 mg tid. 
Moreover a complete pharmacoklnetlc assessment with serial plasma 
samples for PF and 5-hydroxy-propafeDOne (5-0H-PF) determination 
was performed during wash-<lUt. 
Results: A mean reduction in either maximum heart rate (HR max) (-7.1 
%) or mean heart rate (HR mean)(4.2%) was observed during treatment 
with PF but its extent varied within the patients population from 0 to 
17%. The degree of HR slowing was related to PF area under curve 
(AUC) (r=O.72. p<O.02 for HR max; r=O.71, p<O.02 for HR mean) as 
well as to PF concentrations at steady state (Css)(r=O.81. p<0.005 for 
HR max; r=O.75, p<O.Ol for HR mean) without significant relationships 
with 5-0H-PF levels or with age. HR max percentage reduction during 
therapy resulted significant in comparison to basal values only in the daily 
hours (-8.1 %, p<O.(05). thus suggesting a beta-blocking effect, and was 
again related to PF AUC (r=0.70, p<0.02) and to PF Css (r=O.78, 
p<O.(05). A strict relationship between oxidative metabolism, evaluated 
by debrisoquine hydroxylation, and PF metabolism was observed 
(r=O.98,p<O.001). 
In conclusion: a beta-blocking effect during PF treatment at 300 mg tid 
can be detected even by Holter monitoring performed during daily 
activity; however the extent of such an effect varies widely, depending 
on PF plasma levels. The degree of oxidative metabolism. appears 
therefore a major determinant of the clinical beta-blocking effect of PF. 
ABSTRACfS 
743·3 11:00 
Flecalnide, Mexiletine and PropMenone: QRS width In Hollar Eco. 
Georg Schmidt, Petra Barthel, Heinz Kreuzberg, Horst Herb, Kurt Ulm, 
Albert SchOmig 
I. Medizinische K1inik dar Technischen U1iversitat MOnchen, 
Zentrum fOr NichUineare Oynamik in der Kardiologie, Gennany. 
I71A 
The incidence of proarrhythmic events during treatment with class-I ... tiarr· 
hythmic drugs is believed to correlate with the extent of sodium channel 
blockade. which among other things depends on heart rate. 
In this study, infonnation on the frequency dependence of sodium channel 
block was obtained by assessing the ORS width in Holter ECGs. 20 patients 
with CHO 01' IDC and> 10 VPCskI were included into ... open ao&S"ilVSr study. 
Each patient received Flecainide (100mg b.i.d.), Mexilatine (2OOmg !.i.d.) and 
Propafenone (3OOmg t.i.d.) fOl' 1 week in a randomise<! order. The trough drug 
plasma concentrations were in the therapeutic range. The treatment periods 
were separated by wash out periods of 3 days. 
Holter tapes were recorded before the first application and at the end 01 each 
treatment period. The tapes were digitised with a sampling rate of 1 kHz per 
channel. By means of a computer program developed in our institution. the 
ORS complexes were classHiad according to the length of the preceding RR 
interval, divided into different heart rate classes (increment 1Ohnin), and-lifter 
averaging of 50 beats in each class - ORS width was assessed. 
At control, no significant changes of the ORS width were observed. On 
Mexiletine, ORS widened by 3 % at 50 bprn plus IKlditional3 % at 110 bpm. On 
Propafenone these figJes were 8 % pkJs 5 % InI on FIecairide 10 % plus 10% 
(see figure) 
L>QRS 
['l6 ----1 Fleealnide 10 ~ Propafenone 
5 I 1 - Mexllet.ine t-. -, ] Cont:rol 
--:r 1 o 
59 69 79 89 99 109 bpm 
In summary, Aecainide, Mexiletine and Propafenone do vary with respect to 
the rate dependent increase of ORS width. This might contribute to a differing 
proarrhythmic potential of these drugs. 
743·4 11:15 
A controlled study on efficacy IIIId safety of a single oral loading dose 
of propafenone or Oecalnlde In converting recent onset atrial 
ObrUlation to sinus rhythm. 
Alessandro Capucci, FACC, FESC, Giuseppe BorianI. *Gian Lulgi Botto. 
*Carnillo Falcone, °Ida Rubino, **Tiziano Lenzi. "Giuseppe Trisolino. 
°Mario Sanguinetti, Bruno Magnani, FESC. Institute of Cardiology. 
University of Bologna; *Dept. of Cardiology, Fatebenefratelli Hosp. 
Erba (CO); °Dept. of Cardiology, Civ. Hosp. Lugo (RA); **Dept.of 
Urgency. S.Orsola Hosp. Bologna. Italy. 
A population of 145 patients with recent onset « 2 weeks) atrial 
fibrillation (AF) was randomly treated with placebo (PLA) or with a 
single oral loading dose of propafenone (PFN) (600 mg) or flecainlde 
(300 mg). The 3 groups (PLA = 61 pts. PFN = 43 pts. FLE = 41 pts) were 
comparable as to age, gender, etiology, duration of AF, left atrial 
dimensions. 
All the patients were In NYHA fUnctional class S 2. Holter monitoring 
and serial ECG tracings were performed. Resumption of sinus rhythm 
(SR) within 3 and 8 hours after the oral loading dose was considered as 
aiterion of efficacy. 
Results: 
Coversion to SR 
Within 3 hours 
Within 8 hours 
*p < 0.001 vs PLA 
PLA (0= 61) PFN (n= 43) 
8 (13%) 21 (49%)· 
17 (28%) 32 (74%)* 
FLE (0= 41) 
23 (56%)* 
33 (80%)* 
Mean conversion times to SR did DOt differ significantly among the 3 
groups (pLA= 247±134 min, PFN= 192±127 min,FLE= 175±120 min). 
Pbases of atrial flutter before SR were observed in 4 pts of each group 
but in only 2 cases, both treated with FLE, 1: 1 atrioventricular conduction 
ensued. Pauses > 2 sec at conversion to SR occurred in 5 cases treated 
with FLE, 3 cases treated with PLA and 1 case treated with PFN. 
Conclusions: FLE and PFN at a single oral loading dose are promptly 
efficacious in converting recent onset AF to SR in a group of patients 
without left ventricular dysfunction. The clinical uselfulness of class I C 
drugs administration. however.can be limited by the possible onset of 
atrial flutter with I: 1 atrioventricular conduction even in resting condition. 
172A ABSTRACTS 
743·5 11:30 
Verapamll for the Suppres.lon of IdiopathiC Ventricular Tachycardia 
of Left Bundle Branch Block-Llke Morphology 
Jaswlnder Gill. Krzysztof Blaszyk. David Ward. A John Camm. 
St George's Hospital Medical School. london. UK. 
This study examines the efficacy of verapemll for the suppression of 
idiopathic ventricular tachycardia (VT) of left bundle branch block-like 
morphology. Forty-two patients (mean age 36.2..:!:.12.1 years. 20 males) 
with VT. without any underlying cardiac abnonnallty on clinical 
examination and non-Invasive investigation. were studied. The Inducibility 
of the clinical VT was examined by treadmill exercise testing. 
programmed ventricular stimulation (PYS) In a drug-frae state. In 27 
patients. VT was Inducible by exercise testing. In 20 by PVS and 23 
patients had evidence of VT on Holter monitoring. Following baseline 
testing. patients were treated with verepemll120 mg thrice dally for at 
least 5 half lives for the drug to load before evaluation. 
Re.ults: 
VT suooressed VT exacerbated 
HolterVT 14 4 
Ex VT 15 (+5 pertial) 0 
PVS VT 10 3 






In patients with a pertial response to verepemil treatment. rete of the VT 
was unaffected (baseline: 355 (SO 72). verapamil treatment 338 (SO 61) 
ms). although the duration of the arrhythmia was reduced. No patient with 
Holter response to verapamil had VT with a superior axis. but otherwise 
there were no differences between responders and non-responders to 
verapamil. 
Conclusions: Idiopathic VT of left bundle branch block-like morphology 
can be suppressed in approximately 213 of petients by verepamil. Some 
patients demonstrates a pro-arrhythmic effect with verapemil treatment. 
In petients with a partial response. the rate of VT is unaffected. Yerapemll 
should be considered for the treatment of Idiopethic VT of right 
ventricular origin. 
743·6 11:45 
Usefulness of VerapamiJ in Preventing Upright Tilt Induced 
(Vasovagally-Mediated) Hypotension and Bradycardia. 
Douglas A. Wolfe, Blair P. Grubb, Peter N. Temesy-Armos, 
Daniela Samoil, Daniel J. Kosinski, and Pamela S. Brewster. 
Medical College of Ohio. Departmelll of Medicine. Toledo, Ohio. 
Upright tilt testing is a recognized method of evaluating patients 
(pts.) with vasovagal syncope. The underlying pathology is thought to 
be an inappropriate Bezold-Jarisch reflex resulting in a paradoxical 
response to sympathetic stimulation. Cardiac mechanoreceptor stimu•
lation results in the diminution of efferent sympathetic tone and a 
marked rise in vagal tone with hypotension and bradycardia In sus•
ceptible pts. syncope occurs. Paradoxical cerebral vasoconstriction has 
been demonstrated by transcraniaI Doppler during vasovagal syncope. 
Beta blockers have been shown to be efficacious probably by a nega•
tive inotropic effect. The hypothesis for this study was that verapamil 
will also be effective because of its negative inotropism. Oral verapa•
mil was administered to one patient (240 mg/day) and intravenous 
verapamil (7.S to IS mg) was administered to 9 pts. with vasovagal 
syncope provoked by upright tilt testing. In 7 of 10 pts. vasovagal 
syncope demonstrated by a positive upright tilt test became negative 
with verapamil. In 2 of the remaining 3 pts. the symptoms and signs of 
vagotonia diminished. Standing time increased by at least 100% in 8 
pts .. Conclusion: calcium channel blockade may be an effective treal•
ment modality in pts. susceptible to vasovagal syncope. Verapamil 
may prevent the Bezold-Jarisch reflex and syncope in the following 
manner: 1) Cardiac mechanoreceptor activation is inhibited through 
negative inotropic and negative chronotropic effects; 2) Paradoxical 
cerebral vasoconstriction which occurs during vasovagal syncope and 
described at our institution may be attenuated by the vasodilatory effect 
of verapamil; and 3) Calcium channel inhibition of verapamil may alter 
Ibe cerebral iscbemic threshold, 
IIIacIIDl lmuIIIIl 
A~. ~:?' TiIIII I::r;!:w 
/a ,-V.IIII 
4S±1 21±S .001 
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744·1 10:30 
Radiofrequency Current Ablation of Accessory Pathways in 
Ebstein's Anomaly 
Riccardo Cappato, Joachim Hebe, Christian Weill, Michael SchlUter, 
Karl H. Kuck. University Hospital Eppendorf, Germany 
Six (3 f, 3 m; 26 ± 16 yrs) of 355 symptomatic pts referred for radio•
frequency current (RFC) ablation of an accessory pathway (AP) had 
underlying Ebstein's anomaly. Two pts had 1 AP, 3 had 2 APs and I 
pt had 4 APs. All APs were located on the right side of the heart (4 
posteroseptal, 4 posterior, 2 posterolateral, 1 anterolateral and I ante•
roseptal); 10 APs were manifest and 2 concealed. All pts exhibited a 
preexcitation pattern; concomitant right intraventricular conduction 
delay was observed in all but I case. Four antidromic and 9 onho•
dromic tachycardias were induced during EP study. Mapping for AP 
location was performed with the ablation catheter; in 3 cases, addi•
tional epicardial right coronary artery (RCA) mapping was used. 
Ablation failed in the first 2 pts, but successfully abolished all 9 APs 
in the last 4 pts. A higher number of RFC applications (18 ± 13 vs 6 ± 
3, p < 0.0 I) was required to ablate the 7 APs located in the posterior 
area than the 2 ~Ps located in the anterior area. Two sessions were 
required in I pt with 2 APs, and 3 sessions in the pt with 4 APs. The 
major difficulties encountered while mapping the posterior tricuspid 
annulus (T A) were: its anatomical displacement towards the right ven•
tricle; a wide, late ($ 40 msec after the offset of surface QRS) compo•
nent of the local ventricular potential, resembling retrograde atrial 
activation during onhodromic tachycardia; poor definition of atrial 
potentials by RCA mapping. Conclusions: In Ebstein's anomaly, I) 
RFC ablation of APs is safe and in most cases efficacious; 2) anatomi•
cal displacement of TA, unusual patterns of local electrical activation 
and the frequent occurrence of mUltiple APs account for procedural 
difficulties; 3) RCA mapping does not appear to be helpful. 
744-2 10:45 
Catheter Ablation of Left Free Wall Accessory Pathways: 
Evaluation of an Abbreviated Protocol. 
H. William St~es. Ranjan K. Thakur, George J. Klein, Raymond Vee 
University Hospital, London, Ontario, Canada 
Ablation of left free wall accessory pathways (AP) using an abbreviated 
protocol with one catheter has been shown to be feasible. To evaluate this 
strategy, we prospectively compared a traditional diagnostic protocol 
followed by ablation to an abbreviated one. Twenty-five consecutive 
patients with ECG criteria of lFW AP were randomized to one 01 2 groups. 
Group 1 underwent 4 catheter diagnostic (Diag) study consisting of 
anterograde and retrograde incremental pacing and refractory pariod 
delennination et 2 cycle lengths (Cl). Group 2 had cathaters in coronary 
sinus and right ventricle, and went directly to ablation after incremental 
pacing. 
Group 1 Group 2 P 
N 13 12 
Age (yrs) 29.4± 15.9 28.3:1; 13.4 0.42 
Diag Auro (min) 9.0± 5.6 5.6:1; 3.4 0.04 
Ablation Auro (min) 28.1 :1;17.2 33.5±27.1 0.27 
Total Auro (min) 37.1 :1;18.9 39.1 ± 28.6 0.42 
Total Time (min) 206 :1;48.8 205 ± 71.1 0.48 
II of Ablations 6.5:1; 5.8 6.3:1; 4.9 0.46 
All patients underwent auccessful ablation via trans-septal or retrograde 
aortic approach. Dual AV Node pathways were noted in 3 Group 1 
patients, with inducibla AVNRT in 1. Three patients had muHipie APs: 1 in 
Group 1 and 2 in Group 2. Three patients in Group 2 required add~ional 
catheters due to diagnostic complexities. 
CONCLUSIONS: 
1. Abbreviated protocol does not save time or diminish ftuoroscopy 
exposure. 
2. Diagnostic complexities may necessitate addHional catheter placement 
with an abbreviated protocol. 
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Recognition and Catheter Ablation of Epicardial 
Accessory Pathways 
Jonathan 1. Langberg, John D. Hummel, K. Ching. Man, Vic ken 
Vorperian, Brian D. Williamson, Steven J. Kalbfleisch, S. Adam 
Strickberger and Fred Morady, University of Michigan Medical 
Center, Ann Arbor, MI 
Pathologic studies have shown that some accessory pathways 
(AP) traverse the atrioventricular groove subepicardially. The 
purpose of this study was to characterize these AP' s ~nd. to 
describe the results of radiofrequency (RF) energy applicanon 
within the coronary sinus (CS). Since April 1992, 60 pts with 
AP's located in the posteroseptal region (n = 14) or left free-wall (n 
= 46) have undergone RF ablation. 7/60 pts (12%) failed to have 
their AP ablated from the endocardium. 5 of these 7 pIS appeared 
to have epicardial AP's. These were characterized by CS 
electrograms with high-amplitude AP potentials (0.58 ± 0.3 mV) 
that were larger than the atrial or ventricular electrograms (.19 ± 
.11 and .35 ± .18 mY, respectively). 3 of these epicardial AP's 
were located in the left posteroseptal region, within or near the 
insertion of the posterior interventricular vein and 2 were ~ ~e left 
anterolateral region. RF (31 ± 8 watts for 17 ± 10 secs) wlthm the 
CS or the posterior imerventricular vein successfully eliminated all 
of the AP's. There were no complications and post-ablation 
echocardiograms showed no pericardial effusion. 
Conclusions: 1) Approximately .10%. of left free-waH ~nd 
posteroseptal AP's may be subepicardial. 2) If effecl1ve 
endocardial target sites cannot be identified, th.en the CS should. be 
explored for sites with very .Iar~e AP pot~nnals. ~) RF applied 
within the CS or the postenor mterventncular vem eff:cl1~ely 
ablates epicardial AP's. 4) Although there were no comphcanons 
in this small series, further study is required to determine the safety 
of this approach. 
744·4 11:15 
Effect of Radlofrequency Catheter Ablation of Accessory Pathways on 
Inducibility of Atrial FlbrillaUonIFlutter 
Hiroshi Nakagawa Karen Beckman, James McClelland, Xunzhang Wang, 
Kenzo Hirao, Mauricio Arruda, Ian Santoro, Jess Oren, H. Andrew Hazlitt, 
Ismalle Abdalla, Anantjtt Singh, Raed Sweidan, Lawrence Widman, Ralph 
Lazzara, Warren Jackman. Universtty 01 Oklahoma HeaHh Sciences Center 
and DVAMC, Oklahoma Ctty, OK 
The high Incidence 01 atrial fibrillatiorVflutler (AFF) in patients (Pts) wtth 
WPW syndrome decreases or Is eliminated after successful surgical ablation 
01 the accessory pathway (AP). ThIs observation has led some investigators 
to postulate a direct relationship between the presence 01 an AP and AFF, 
due to AV reentrant tachycardia or conduction delay wtthin a network of 
fibers comprising the AP. The purpose of this study was to determine 
whether RF ablation 01 AP eliminates the induclbiltty 01 sustained ~60 
seconds) AFF. 80 pts (age 33 ± 15 yrs) were studied. 29180 pts (36%) had 
a previous documented episode 01 AFF (clinical AFF). APs were located on 
the left (l) In 39, right (R) in 12, anteroseptaJ (AS) in 3, posteroseptal (PS) 
in 21, or muttlple locations (Ml) In 5 pts. Programmed stimulation was 
performed before and >30 minutes after ablation, including decremental 
atrial pacing to cycle length 200 msec, single and double atrial extrastimuli 
to atrial refractoriness at two atrial pacing cycle lengths, and decremental 
~entricular pacing to cycle length 200 msec or V-A block. RESULTS: 
Sustained AFF was Induced In 2&'29 pts (96%) with clinical AFF vs 39151 
~s JZ.6%.1 without clinical AFF 3lTe-ablation~O.05~ 
L R AS PS ML Total 
AFF induced 33139 9112 al3 1&'21 415 67/80 
i..2!:e-ablation (84%) ~~ ~100~ J.85~ (80~ l83°& 
AFFinduced 32/39 7/12 al3 10121 215 54180 
[post-ablation (82%) (58%) (100%) l47~ ~40%) (67%) 
ns ns ns IKO.Q1 ns I p<O.OS .. 
CONCLUSIONS: 1 )Sustamed AFF was induced In the majOrity of pts wtth 
APs. but the inductJiltty was higher in pts with clinical AFF. 2)RF ablation 
Significantly decreased the induclbUtty 01 sustained AFF only in pIs w~h 




Effective Temperatures at sites of Atrial 
Insertion Accessory pathway Ablation 
11:30 
Cynthia M. Tracy, Hans J. Moore, Allen J. 
Solomon, Jean T. Barbey, Ross D. Fletcher. 
Georgetown University Hospital and VA Medical 
Center, Washington, D.C. 
Ablative effects of radiofrequency (RF) energy 
delivery have been attributed to heat and 
duration of energy delivery. Short energy 
application times to accessory pathway (AP) 
interruption have been described. We sought 
to characterize the relation between 
temperature and AP interruption in patients 
undergoing atrial insertion AP ablation 
utilizing a thermistor catheter. Fourteen 
consecutive patients underwent successful 
ablation of 16 AP's. Seventy-eight RF 
deliveries (4.9±4.0 per AP) with a mean time 
to effect of 2.77±4.1S seconds were made_ The 
initial set power and mean temperature 
achieved were not different at successful vs 
unsuccessful sites (26.4±7.6 vs 22.8±7.l Watts 
and S3.4±5.9 vs 51.1±8.8·C). At the time of 
interruption of AP conduction, the mean 
temperature was only 47.24±10.2S"C. The 
majority of pathways (56%) showed an effect at 
<1 second and <4S·C_ A substantial minority 
(19%) showed an effect at <O.S sec and <40·C. 
Conclusions: 1) initial interruption of AP 
conduction by RF energy occurs at low 
temperatures and short durations of energy 
delivery, 2) this may be due to electrotonic 
interruption of AP conduction and longer 
energy deliveries may be needed to ensure 
tissue necrosis thus preventing recurrence. 
744·6 11:45 
173A 
The Split·Tip Electrode Catheter. Improvement in Accessory 
Pathway Potential Recording 
Karl H. Kuck, Michael Schluter. University Hospital Eppendorf, Ger•
many 
The recording of accessory pathway (AP) activation potentials at the 
ventricular insertion of left-sided APs is associated with a high suc•
cess rate of catheter ablation. To improve the recording quality of AP 
potentials and facilitate the differentiation from local atrial (A) and 
ventricular (V) potentials, a new tip electrode split into two halves 
along the length of a 7-French catheter (EP Technology) was 
designed. The length of either half is 4 mm and interelectrode distance 
is 0.5 mm. Located 2 mm proximal to the split electrode tip is a I-mm 
ring electrode. This electrode configuration allows for 4 different 
bipolar recordings: between the 2 tip electrodes (new configuration), 
between either tip electrode and the ring electrode, and between the tip 
electrodes connected and the ring electrode (conventional configura•
tion). A comparison between either type of bipolar recording was per•
formed in 10 pts with an overt left free-wall AP. In all pIS, an AP 
potential could be recorded from the left ventricle during sinus rhythm 
with the conventional configuration, but in 8/10 pIS it fused with the 
local V potential. In contrast, using the new configuration the AP 
potential was always clearly seperated from the local A as well as the 
local V potential (AP-V: 28 ± 8 msec) due to a reduction in width of 
the latter (25 ± 4 msec versus 53 ± 18 msec, p < 0.05). Bipolar record•
ings from either half of the tip electrode versus the ring electrode 
revealed in 6 pts that the AP potential could only be recorded from 
one, but not the other tip electrode. Conclusions: The split electrode 
configuration allows for easy and unambiguous recording of AP 
potentials at the left V insertion site. This should further improve the 
mapping quality during catheter ablation procedures. 
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745·1 
ST Segment depressIon durIng Dipyridamole Infusion 
Is a marker for severe coronary artery disease. 
David W, Frazier, Raymond J. Gibbons; 
Mayo Clinic, ROChester, Minnesota 
The significance of ECG and hemodynamic changes during 
dipyridamole <DIP) InfUSion aM their relation to underlying 
CAD severity remains uncertain. 246 patients were studied 
who had interpretable ECGs during DIP Thallium <T1l SPECT 
imaging, cardiac catheterization within 3 mas, and met 
exclusion criteria of no prior CABG or PTCA within 6 mos, 
73 (30~) developed )-1 mm ST depression (+STd) during 
DIP infusion, Multiple variables were significantly 
aSSOCiated with -STd: Hempdynamic (all p ( 0,05) - higher 
rest systol ic BP 2nd rate pressure product <RPP); higher 
peak heart rate (HR), SBP and RPP; and increase In HR and 
RPP; II analysis (all p ( 0,003) - increased extent of Tl 
redistribution <RD) and increased Tl defect at stress, total 
amount of RD. Increased Tl pulmonary uptake, and severe 
chest pain during 01 P Infusion; Mglographjc (p=O,OOO 1 )•








" of Diseased Vessels 
o 1 2 3/l M 
1 9 18 45 
28 61 49 35 
The positive predictive value of STd was 99~ for CAD and 
62~ for LM13V CAD, After adjustment for number of 
diseased vessels; increased extent and total amount of RD 
were Independent predictors of -STd (p (E 0,004), 
ConclUSions: ST segment depression during DIP Infusion is 
strongly aSSOCiated with (1) increased number of diseased 
vessels, (2) LM13V CAD, and (3) Increased Thallium RD 
10:30 
745·2 10:45 
Dipyridamole Induced ST .segment Depression II a Highly Specific 
M.rker of Coronary Art.ry Di ..... 
Karanbir 5. Grewal, Eugene F. Uretz, Amjad Ali, Joseph E. Parrillo, 
John T. Barron. Rush Heart Institute, Rush Medical College, 
Chicago, Illinois. 
To evaluate the significance of 5T -segment depression for detection 
of coronary artery disease (CADI in patients undergoing 
dipyridamole thallium stress testing we studied 213 consecutive 
patients, CAD was defined angiographically as ~ 70% stenosis. 
17 (8%1 patients developed 5T depression. Patients with versus 
without 5T depression (~O, 1 mVI were more likely to have ~ 70% 
stenosis in an .picardial artery (100% vs47%; p < 0.0061 or even 
in two or more epicardial arteries (73% vs 16%; p < 0.00051. 5T•
segment depression was also more frequent in patients with 
reversible thallium defects (82% vs 31 %; p < 0.00011. 
Dipyridamole induced a greater increase in heart rate (24 ± 10 vs 
16 ± 10 bpm; p < 0.0011 and rate-pressure product (3.9 ± 2.7 x 
10' vs 2.6 ± 2.5 x 10'; p < 0.051 in patients with 5T depression. 
Patients with 5T depression were more frequently on nitrates (71 % 
VI 39%; p < 0.021, beta-blockers (47% vs 22%; p < 0.051, or had 
chest pain during the study (71 VI 15%; p < 0.00011. The 
sensitivity .nd specifICity of 5T depression for detection of 
significant CAD are 42% and 100%, respectively. whereas for 
detection of multivessel disease they are 62% and 90% 
respectively. By contrast. thallium scintigraphy has a sensitivity of 
85 % and specifICity of 47% for detection of significant CA D. Even 
though the presence of a reversible thallium perfusion defect was 
a univariate predictor of CAD, on multivariate analYSis it was not 
found to be an independent predictor of CAD. On multivariate 
analysis. change in heart rate and rate-pressure product were 
significant predictors of ST depression. and ST depression was an 
independent predictor of CAD. Thus. ST-segment depression during 
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Electrocardiographic Changes, During 
Infusion as a Predictor of Myocardial 
Erik S, Marshall, Joel S. Raichlen, Dennis A. Tighe, Katharine M. 
Breuninger. Edward K. Chung. Thomas Jefferson University. 
Philadelphia, PA 
To assess the utility of ECG changes during adenosine infusion, 
550 consecutive patients who underwent adenosine perfusion 
imaging (140 meg/kg/min x 6 min with injection of thallium or 
sestamibi at 3 min) were evaluated for ~ 1 mm horizontal or 
downs loping ST segment depression (STdepr). Myocardial ischemia 
was defined as the presence of any reversible perfusion defect. 
Patients with LBBB or ventricular paced rhythm (n = 33) were 
excluded, STdepr developed in 82 patients (15.9%). The frequency 
of STdepr was similar in palients wilh normal scans and those wilh 
fixed defects (9.4% vs 8.1%. P ~ NS), STdepr occurred in 58/242 
patienls with ischemia (senSitivity = 24.0%) and in only 24/275 
patients (8.7%) without ischemia (specificity = 91.3%) (p < 
.001), The positive predictive accuracy of STdepr was 70.7%, 
with a negalive predictive accuracy of 57.7%. These statislics 
were not significantly altered by eliminating 155 patients who 
received digoxin or had LVH by ECG. The presence of chest pain 
during adenosine infusion occurred with equal frequency in palients 
with and wilhout ischemia (32.0% vs 33.0%. P = NS). and did not 
affect the predictive accuracy of ECG changes. Adenosine infusion 
caused a fall in blood pressure, a rise in heart rate, and an increase 
in rate·pressure product in most patients, Patients with STdepr 
averaged higher heart rales during infusion (99.6 ±. 12.2 vs 89.4 
±. 14.8 bpm, p < .001), but no difference in rate-pressure product 
or diastolic blood pressure. We conclude that the presence of 
STdepr during adenosine infusion is a predictor of myocardial 
ischemia. Although ECG changes are insensitive markers of 
ischemia, they are highly specific and have a high predictive 
accuracy for the presence of myocardial ischemia, 
745·4 11:15 
How Reliable is Dobutamine Stress ECG for the Diagnosis of 
Coronary Disease ? A Receiver Operating Curve Analysis of ST 
Segment Changes 
Georges Mairesse, Thomas Marwick, Anne-Marie D'Hondt, William 
Wijns, Martine De Kock, Jacques Melin, Jean-Marie Detty. University 
of Louvain Medical School, Brussels, Belgium 
In patients (pts) unable to exercise maximally, the exercise ECG is often 
replaced by pharmacologic stressors, usually combined with cardiac 
imaging. The purpose of this study was to determine the optimal criteria 
and accuracy of dobutamine (Db) stress ECG for the diagnosis of 
coronary disease (CAD) in routine practice. One hundred thirty-three pts 
(age 57 ±9y, 99 males) with interpretable ECG and without prior 
infarction were studied at the time of angiography. A standard Db stress 
protocol (5 to 4Omcg/kg/min) was used, with endpoints : attainment of 
peak dose (n = 101), severe ischemia (n = 25) or intolerable side-effects 
(n=7). ECG leads X, Y and Z were filtered and recorded digitally at the 
end of each stage. Using> 50% diameter stenoses to define CAD, various 
criteria of ST segment depression (from 0-2nun) were used to create 
receiver operating curves (ROC) at 0,20,40,60 and 80 msec after the J 
point. Additional ROC were created for ST segment changes relative to 
baseline ECG. U sing conventional criteria (~I nun horiwntal or 
downsloping ST depression (6Omsec after the J point), sensitivity (SENS) 
(n=87) was 17%, specificity (SPEC) 96%, and accuracy (ACC) 43%. 
The optimal ROC was observed using relative ST depression ~0.5nun at 
80 msec after J point. 
ST change -1,2 -I -0,8 -0,6 ~,5 -0,4 -0,2 
SENS (%) 7 8 16 30 36 44 56 
SPEC (%) 100 98 93 89 85 74 57 
ACC (%) 39 39 42 50 52 54 56 
Clinical criteria did not enhance the accuracy of ST analysis, Thus, 
the accuracy of Db ECG alone in an unselected population is unacceptably 
low, even after optimization of diagnostic criteria by ROC analysis. 
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Dobutamlne Streas Echocardlography: Hemodynamic Corre•
lates and Physiologic Basis of Wall Thickening Abnormality 
Elizabeth O. OIiIi. Jeanette A. St. Vrain. John A. Standeven. Frederick A. 
Dressler. Bhugol Chandel. Henry M. Goodgold. Mark G. Barnett. Ramon 
Castello. Dennis Anthonis. Arthur J. LabovitZ. Saint Louis University 
Medical Center. St. Louis. Missouri. 
Although Dooutamlne (Dobut) stress echocardiography (echo) Is 
increasingly used as a pharmacologic stress technique In the diagnosis of 
coronary artery disease. there is limited data on the hemodynamic and 
physiologic correlates of Dobut induced functional abnormality. 
Using a model of critical circumflex stenosis. we studied 10 anesthetized 
open-chest mongrel dogs. Doppler ultrasonic flow probes around the 
proximal aorta. left circumflex (CIRC) and left anterior descending (LAO) 
recorded cardiac output and coronary blood flow (CBF) continuously. 
Subendocardial (endo) and subepicardial (epi) regional myocardial blood 
flow (RBF) was measured by radiolabeled microspheres. Continuous 
epicardial two-dimensional (20) echo was performed; the LV short axis was 
divided into 6 matched segments for wall thickening (WT) and RBF. 
Flow parameters. RBF and WT were performed at baseline and following 
intravenous Dobut (1511'1icst1q¥min x 10 min). Results (mean ± SO): 
co CBF (nilmin) EndoIEpi 20Echo WT (%) 
!Llminl J:<IBC......1.A12.. elRC LAD ~ ~ 
Base 1.8±0.8 31±15 26±13 1.04±0.33 1.11±0.13 37±15 51±22 
Dobut 5.0±2.0 76±44 68±36 0.64±0.13 0.96±0.15 42±32 128±64 
P 0.001 0.01 0.005 0.02 NS NS 0.02 
Heart rate Increased signHicantly with Dobut (122 to 205 blmin. p< 0.01). 
Dobut resulted In 150% Increase in epi and normally perfused endo flow; 
CIRC perfused endo increased only 38% with Dobut. The lower endo/epi 
ratio in CIRC distribution was associated with a lack of increase in WT on 20 
echo. 
Thus. functional abnormalities cilring Dobut consists of a lack of increase 
in WT of stenosed bed coupled with hypercontractility of normal segments; 
regional heterogeneity in myocardial blood flow is due to a lack of increase 
in endo flow to stenosed bed despite increased cardiac output and CBF. 
745·6 11:45 
Does Hypotension During Dobutamine Stress Echocardiography 
Correlate with Anatomic or Functional Cardiac Impairment? 
Eric B. Lieberman. Sheila K. Heinle. Marek Ancukiewicz. Sondra 
Myers, Joseph A. Kisslo, Thomas M. Bashore. 
Duke University Medical Center, Durham, NC 
While hypotension during exercise stress testing correlates with the 
presence of extensive coronary artery disease (CAD); the factors 
associated with hypotension during dobutamine stress echocardiography 
(DSE) are unknown. The purpose of this study is to examine the 
association of dobutamine induced hypotension with various clinical, 
angiographic, and eChocardiographic parameters. 
85 pts with a history of prior PTCA underwent cardiac 
catheterization and DSE on the same day as part of an ongoing study of 
restenosis 6 months after PTCA. Dobutamine was infused in stepwise 
increments to a maximum rate of 30 mcg/kg/min. Systemic arterial 
blood pressure (BP) was measured at each increment. Coronary 
arteriograms were analyzed by quantitative techniques and significant 
CAD was defined as luminal diameter narrowing ~ 50%. 
Results: 18 pts (21%) sustained a fall in systolic BP ~ 20mmHg during 
DSE. Of these 18 pts, 6 (33%) had an abnormal DSE and 8 pts (44%) 
had significant CAD, (6 with PTCA restenosis). Qass 2 or 3 congestive 
heart failure (p=.OI) and digoxin therapy (p=.03) were univariate 
predictors of dobutamine induced hypotension. Female gender was of 
borderline significance (p=.06). Qinical variables not predictive of 
hypotension include age, recent angina, prior myocardial infarction, 
coronary artery hypass grafting, use of beta blockers, calcium channel 
blockers, or chronic nitrates. Catheterization variables un associated 
with dobutamine induced hypotension include ejection fraction, PTCA 
restenosis, and the extent or severity of CAD. The development of DSE 
or ECG abnormalities was also unassociated with the development of 
hypotension. 
Conclusions: Dobutamine induced hypotension during stress 
echocardiography is not associated with functionally or anatomically 
significant CAD, but it is noted most frequently in patients with 
symptoms of congestive heart failure. 
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746·1 10:30 
Variation in Cardiac Catheterization (CATH) and Survival 
Following Acute Myocardial Infarction (AMI) in the VA 
Steven M. Wright, Eric D. Peterson, Jennifer Daley, 
George E. Thibault, Brockton/W. Roxbury VAMC, Boston, MA 
This study examines utilization of cardiac 
catheterization and survival following AMI in a large 
cohort of VA users under age 65. Using an administrative 
database, a longitudinal record of medical care in the VA 
was constructed for 15,732 males discharged with the 
diagnosis of AMI from 1/88-3/90. Mean age for the cohort 
waa 56.3 years. 
The CATH rate within 90 days of AMI was 39\. In s 
logistic regression model lower age, less severe illness, 
and fewer comorbidities correlated with increased 
likelihood for CATH. Patients admitted for AMI to 
hospitals with CATH labs were more likely to receive 
CATH, adjusted OR 2.73 (95\ CI 2.51-2.96). CATH rates 
show large variation across geographic regions, adjusted 
high/low OR 1.6S (CI 1.49-1.91). 
Thirty and 365-day mortality was 10.4\ and IS.9\ 
respectively. Significant patient predictors of 
increased mortality were increased age, congestive heart 
failure, anterior AMI, and increased number of 
comorbidities. The presence of a CATH lab at index 
hospitalization was an independent predictor of survival 
at 1 year, adjusted OR 1.41 (CI 1.24-1.60). No 
geographic differences in one year survival were found 
after casemix adjustment. 
This study represents the largest national report on 
utilization of cardiac catheterization and survival 
following AMI in middle-aged males. Within the VA 
system, there are large institutional and regional 
variations in CATH rates following AMI. Survival across 
regions is constant despite differences in procedure 
rates, but institutional factors may influence survival. 
746·2 10:45 
Lack of en Independent Bffect of Gender on Short and 
Long-Term Mortality in Patients Treated With Direct 
Angiaplasty for Acute III 
Donald R. Westerhausen, James O'Keefe, Barry D. 
Rutherford, Lee V. Giorgi, Thomas M. Shimshak, 
Geoffrey O. Hartzler, 
Mid America Heart Institute, Kansas City, Me 
The purpose of this study was to determine whether 
gender exerted an independent effect on the safety and 
efficacy of direct infarct angioplasty without 
antecedent thrombolytic therapy in 900 consecutive 
patients enrolled between 11/S0 and 1/92. The study 
was comprised of 255 females (28\) and 645 males 
(72\). Women were significantly older (65 yrs versus 
59 yrs, p<.OOl), more likely to be diabetic (lS\ vs 
11\, p=.005), and have prior MI (36\ vs 28\, p=.02). 
Other baseline variables were similar. successful 
PTCA of the infarct artery was achieved in 94\ in both 
women and men. In-hospital mortality was 10.7\ for 
women and 6.5\ for men (p=.05). Logistic regression 
analysis identified age ~ 70 years, cardiogenic shock, 
three vessel disease, baseline EF ~ 40\, anterior 
infarction, and failed angioplasty, ~ female gender 
as variables associated with in-hospital mortality. 
Late follow-up (mean of 45 months) was performed on 
hospital survivors and revealed similar actuarial 
survival rates in women and men (1 year = 94\ vs 95\, 
7 years 74\ and 77\ respectively, p=.16). 
CONCLUSIONS: Although in-hospital mortality with 
infarct angioplasty was higher in women than men, this 
was due to baseline differences between the genders. 
Long-term survival was similar in both groups. 
Therefore, gender should not influence the decision to 
proceed with infarct angioplasty in patients suffering 
an acute myocardial infarction. 
176A ABSTRACfS 
746-3 11:00 
Two- and Three-Yaar RHUIli of the Thrombolysis In Myocardial 
Infarction (TIMI) Phaaa " Clinical Trial 
Michael L Temn, David O. WIlliams, Neal KIelman, James WIIlerson, 
HUtrud Mueller, Patrice Desvignes-Nlckens, Sandra A. Forman, Genell 
L Knatterud, and Eugene Braunwald for the nMllnvestigators. Maryland 
Medical Research Instttute, BaItlmore, Maryland. 
In nMI II 3,339 patients were randomly assigned to management 
according to etther an Invaslve or a conservative strategy after 
Intravenous recombinant tissue type plasminogen activator (n-PA) for 
acute myocardial Infarction. After two years of follow-up, there was no 
difference In monaltty between the Invasive (8.9%) and conservative 
(8.7%) strategy patients (p=O.84). Among 2,174 patients enrolled three 
years before the end of TIMI II follow-up, there was no difference In 
monaltty between the invasive end conservative strategy patients 
(p=0.72). 
Monaitty (%) 
Follow-up Invaslve Conservative All 
6 Weeks 6.3 5.0 5.6 
1 Year 8.2 8.3 8.2 
2 Years 9.7 9.3 9.5 
3 Years 11.5 11.0 11.2 
In this cohon, monaItty In the second year from study entry was 
1.3% and In the third year 1.7%. Low mortaltty In the second year and 
third year was consistently observed in a variety of patient groups (e.g., 
men and women). In nMI II, both Invasive and conservative strategies 
resulted In slmBar favorable outcomes after two and three years of 
follow-up. 
746-4 11:15 
Lons Term Mortality ot Aoute Myocardial Intarotion With 
and Without Cardiao Catheterization in Men and Women 
John B. [oetia, Alan C. Wilaon, Patrioe Gregory, lora 
M. eoagrove, Tins Cui, Anu Ch1rala, [enneth O'DoveI tor 
MIDAS, lIMDIJ-Robert Wood JohDllon Medical School, lew 
Brunawiok, IJ 
WOllen with aoute lIYocardial intarotion (AMI) are leaa 
likely to have invuive prooedurea. However, whether 
thia leada to advarae lons teJ'll outoomea ia Wlknown. 
We ex8ll1Ded 5 year IIOrtality in all lien (1=25,031) and 
WOllen (II: 17,333) who were hoapi talized wi th a diagnoe1s 
ot AMI in the atate ot lew Jersey in the yeara 1986-87. 
Cardiao oatheterization (CC) wu pertormed in 12' ot 
women and 17' ot men, PTCA in 1.06 and 2.10 and CABG in 
2.52 end 1.7 reapeotively (p(O.OOOl). 
Standardized death rate ot AMI w .. 22' at 6 .antha, 28' 
at 1 year, 36' at 2 yeara, 38' at 3 yeare, and __ , at 5 
yeara. Overall only men appeared to derive a 
I1gD1t1oant (p(0.05) lons tel'll benetit trOll an inv .. ive 
lI8Ilas_ent atratesr. In MIl, up to ase 75, oardiao 
oatheterization w .... aociated with lower 10DS term 
IIOrtality adjuated tor ase, oompl1oationa, oOllOrbidity, 
raoe, inauranoe type and hoapital type. In women, the 
inv .. 1ve atratesr tended to be .. aociated with higher 
aortall ty • MEN WCIIEN 
,,- Ase Group RR P( RR P( 
_5-59 0.17 0.01 0.90 0.48 
60-14 0.88 0.02 1.16 0.03 
15-89 1.08 0.29 1.36 0.01 
RR:Relative Biak by hazard rate. 
CODoluaion: V_ with AMI have 
higher lons ter. IIOrtality and 
1 - darive leaa benefit troll an 
o iov .. l'Ie lI8D&8-t atratesr than 
III. 113..,"'",I1121116I11l2,," men. 'IiIIIo __ 
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Rand_bed Trial of Prillary PTCA va ~olytic 
Therapy in Acute IIyocardial IIlfarctiOll (PAIa) - Siz 
IIcmth Pollowup 
Kevin F. Browne, Cindy Grines, William O'Neill, Watson 
Clinic, Lakeland, FL and Beaumont Hospital, Royal oak, 
HI 
PAMI randomized 395 pts at 12 sites with AMI who 
presented within 12 hours of symptom onset to either 
primary PTCA or tPA therapy. No significant difference 
was found in mortality or HOGA IF during the ~ndex 
hospitalization. Persistent or unstable ischemia, 
nonprotocol PTCA, and CNS bleeds occurred significantly 
more frequently in the tPA group. Six month followup 
was performed at all sites to determine if clinical 
outcane differed between treatment groups. Table I 
lists the clinical status of the pts at 6 months post 
AMI. 
~ PTCA It! !;l!lt. III 
# of pts enrolled 195 (100) 200 (100) 
Alive at 6 months 177 (91) 170 ( 85) 
Dead at 6 months 7 (3.6) 15 (7.5) 
Lost to followup 11 (5.6) 15 (7.5! 
Pta followed at 6 months 179 ( 92) 172 ( 86) 
Recurrent chest pain .5/179 (25) 53/172 (31! 
CHF 14/179 (7.8) 16/172 (9.3! 
Any interim event 57/179 (32) 51/172 (30! 
New HI 3/179 (1.7) 6/172 (3.5! 
Recatheterization 48/179 (27) 37/172 (22) 
Reocclusion of IRA 3/U (6.2) 4/37 (ll! 
Restenosis by cath 23/.8 (U) 20/37 (54! 
Repeat PTCA of IRA 20/48 (.2) 23/37 (62) * 
PTCA of different artery 13/179 (7.3) 12/172 (7.0) 
CASG 12 (6.7) 6 (3.5) 
* p K 0.06 
Conclusion: Clinical outcane at 6 months _B the same 
for ptB with acute HI treated within 12 hrB of symptoms 
either with primary PTCA or tPA. Both treatments 
should be routinely considered as initial therapy in 
reperfuBion etrategies for AMI. 
746-6 11:45 
Follow-up Cost and Other Economic Outcomes in Patients Treated 
with Direcl Angioplasty For Acute Myocardial Infarction 
Daniel B. Mark, Bruce Brodie, Russell Ivanhoe, George Taylor,James 
O'Keefe, Linda Davidson-Ray,David Knight, Robert Califf, Duke 
University Medical Center, Durham, NC 
To elucidate the follow-up economic consequences associated with 
the use of direct angioplasty (PTCA) for acute myocardial infarction 
(MI), we prospectively studied 217 consecutive patients (pts) enrolled 
in the multicenter Primary Angioplasty Registry (PAR). Mean age 
was 58±12 (range 29 to 86), 76% were male and 40% had an anterior 
MI. Hospital and 6 month mortality rates were 3.7% and 6% 
respectively. All pts had dx catheterization at baseline; 85% had 
PTCA alone, 3% had CABG alone and 8% had both prior to 
discharge. Among hospital survivors, 30% were rehospitalized for 
cardiac reasons during the 6 month follow-up; 7% had> 1 cardiac 
rehospitalization. Follow-up dx cath he fore 6 months wa- performed 
in 25%. During follow-up,3% required CABG and 21% required 
rePTCA. Baseline (BL) and foliow-up(F IU) costs (not charges) were: 
X±SI2 l!Wliin 
BL Hospital Costs $12,772 ± 8,548 $10,171 
BL MD Fees $ 5,522 ± 2,570 $ 4,804 
FlU Hospital Costs $ 3,563 ± 6,543 $ 0 
F/UMD Fees $ 1,144± 2,426 $ 0 
Of the 113 pts working pre-MI, 78% were working at 6 months; of 
these, 24% were working fewer hours or doing less strenuous work. 
27% of the 208 surviving pts had a decrease in monthly income at 6 
months relative to pre-MI levels. Comparison of these results with 
corresponding data from the TAMI 5 trial of thrombolytic rx and 
PTCA revealed equivalent costs and other economic outcomes. 
Thus, despite a high rate of angiographic restenosis, economic 
outcomes after direct PTCA rx for acute MI are quite comparable to 
those reported for thrombolytic strategies. 
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C-5 
747·1 10:30 
1& Coronary SteotiDa for Acute or Tbreateued Closure. Temporary BaiI-Out 
Dmce or Dermitin Therapy? 
Min, W. U'" SubocIh K. Apwal. Adam D. Caanoo. Luc BilodeIU. Sriram S. 
lyer. Jamee A. Heam. Lury S. Dean. William A. Buley. Gary S. Roubin. 
Division of Canliovaacu1ar Dw.ao. Uaivenity of Alabama at Birminaham. 
BinJIiDaIwn, Alabama 
Due to !be poIIIItiaJ problem of thromboIia and ilchemic complications after 
IleDtiDa. it bas bMI ara-J that c:orooary _ mould be II8ed only .. a "bridge 
to _aery" followina acute(AC) or tbreateoed(TC) ciOllW"e. Recent atwIies bave 
aboWII that IIeDt diameter < 3mm, preaeIlce of reoidual diseection or fillin, defect 
were 3 indepeDdent predictora of IleDt thrombosis. Therefore. we &D&lyzed the 
relatiOlllhip of IleDt thromboIia and its complications and preaeIlce of these 
predictors. We divided 240 (228 patients) coasec:utive IleDtiDa procedures intJ 
tIuee aroups by !be preaeIlce of DOD. (0). any on. (1). and any two or more (ll or 
Ill) of these 3 predictors. Of these. 44 were IleDted for AC. defined as TIMI 0 
or 1 flow. and 196 were IleDted for TC. defined .. I or more of the following: 
~SO" residual lleDosis. di88eclion ~15mm and/or exn-Iuminal CODtnst, or 
anama and/or EKG chanaes. Procedural myocardial infarction (Ml) was defined 
.. MI 0CCIIITina within 2 days after IleDtiD,. Late MI was defined as MI 
occurrina more than 2 days after IleDtiDg. Th. incidence of IIeDt thrombosis and 
ischemic complications within 30 days of IleDtiD, were as follows: 
Predidon 0(0=92) 1(0=116) norm (0=32) p 
Thrombosis I" 8" 28" 0.0001 
Procedural MI 11" 12" 25" NS 
Late MI 2!Ii 3% 16" 0.005 
Repeat PTCA 3" 9" 4'" 0.001 
CABG 31 35 91 NS 
CoIIdusiollS: The risk of late ilchemic events is low when 3.Omm or larger stents 
are II8ed or when amaller diameter IleDts produce optimal angiogrsphic results. 
Under these circumstances IleDtiDg may be coasidered as definitive therapy. The 
preaeIlce of IIIboptimal results in less than 3.Omm IleDts warrants close 
lIW"Veillance and poeoibl. referral to bypass lIW"gery. 
747-2 10:45 
Improving the Results ~ Ball-Out Coronary Stenllng After Falled 
Balloon Angloplasty 
Philip Urban, Emmanuel Haine. Vitali Verine. Vivek K. Mehan, 
Pierre-Andre Dorsaz. Josiane Favre, Bernhard Meier. Cardiology 
Center. University Hospital. Geneva. Switzerland 
Stent implantation can be a valuable alternative to emergent bypass 
surgery to treat established or threatening abrupt closure following 
coronary balloon angioplasty. To evaluale several sequentially 
introduced changes in our practice of bail-out coronary stent 
implantation since april 1988. we compared the first and second balf of 
our single center experience (72 procedures = 3.4% of all angioplasty 
procedures). During the same period 13 patients (0.6 %) underwent 
emergent CABG for failed angioplasty without prior stent implantation 
attempt (0.5% during the first and 0.7% during the second period. NS . 
First 36 Last 36 
Technical success 35 97%) 34 94%) NS 
Death 13% 2 6% NS 
Emergent or elective CABG 4 11% 2 6% NS 
wave infarction 5 14% I 3% NS 
Stent thrombosis 6 17% 2 6% NS 
CK above 2 x normal 16 44% 6 17%) 0<0.02 
Significant bleedinl! 10 28% 5 14% NS 
Hosoital stav davs 12+ 11 8+5 0<0.05 
TIMI 0 flow at implantation 23 64%) 10 (28%) 0<0.001 
Balloon-exnandable stent 19 53%) 36 (100%) 1)(0.001 
Self -expandigg stent 17 47%) 0(0%) 0<0.001 
6 French euidine catheter 00%) 4 (11%) 0(0.05 
Collagen plug hemostasis 00%) 26(72%) IXO.OOI 
nle WIde use of bail-out coronary stenling IS assocIated WIth a low 
requirement for emergent CABG. Our current practice of earlier stent 
implantation after a poor angioplasty result (to prevent rather than 
reverse abrupt total occlusion). together with use of balloon•
expandable stents. small diameter catheters. and improved local 




Projected Cost Savings for Coronary Stenting Instead of Emergency 
CABG for Acute Closure Complicating PTCA 
Edgar D. Charles, Subodh K. Agrawal, Adam D. Cannon, Larry S. Dean, 
William A. Baxley, Gary S. Roubin. Division of Cardiovascular Disease, 
University of Alabama, Binningham, Alabama 
There are approximately 300,000 coronary angioplasty procedures 
perfonned annually in the United States. Aeute closure (AC) of the treated 
arteries occurs on average in 5% of patients and 40% (or 2% of total 
PTCAs) of these need emergency coronary bypass surgery (ECABG). A 
recent multicenter stent study (Cook Registry) has shown that acute closure 
can be manage effectively by coronary stenting (S), reducing ECABG to 
3.2% in the stented patients. S increases cost over PTCA because of 
increased hospital stay. We studied the projected economic impact of 
stenting in the management of AC in the United States. Two models were 
characterized: model A; conventional PTCA with 2% receiving ECABG for 
AC, Model B: PTCA with 2% receiving S for AC and 0.16% of all receiving 
ECABG for failed S. Hospital records, finance charges of patients treated at 
our institution between Oct. 89 and Feb. 92 were reviewed to detennine 
cost for PTCA only, PTCA + Sand ECABG . The above data were used to 
project the total cost of 300,000 PTCAs in the conventional model (A) where 
40% AC was treated by ECABG and a stenting model where acute closure 
treated by S instead of ECABG (model B). The individual patient cost for 
PTCA, PTCA + Sand ECABG were $8061:1: 6150 (N=167), $13787:1:7858 
(N=88), $39310 :I: 286179 (N=11) respectively. The projected costs and 
savings for 300,000 PTCAs with presumed 5% incidence of acute closure in 
the two models were as follows: 
Model A Model B Projected $ 
$ Cost !millionsl $ Cost !millionsl Savinas !millionsl 
PTCA 2.418.3 2,369.9 
PTCA+ S 82.7 
ECABG 235.9 7.S 
Total 2,654.2 2,460.2 194.0 
Conclusion: A strategy of coronary stenting for AC as altemative to 
ECABG may offer substantial savings. 
747-4 11:15 
Predictors of Coronary Lumen Narrowing After Emergency 
Placement of Palmaz-Schatz Stents 
Franz-Josef Neumann, Adnan Kastrati, Katherina SchAfer, Rainer Dietz', 
Wolfgang Kabler", Albert SchOmig. I. Med. Klinik lU MOnchen.-d (j Innere 
Medizin III Heidelberg, Germany 
The change in minimal luminal diameter (MLD) after coronary interventions 
reflects the amount of neointimal hyperplasia as a response to vessel wall 
injury. Using quant~ative angiography, we evaluated the factors correlating 
with this process in patients (pts) with single Palmaz-Schatzstent implantation 
because of large occlusive dissections after PTCA. 120 out '* the 130 eligible 
pts (92 %) had follow-up angiography at a median of 185 days after stenting 
(S). Lumen gain was defined as the difference between MLD immediately 
after S and that before PTCA and lumen loss as the reduction in MLD from 
immediately after S to follow-up. At 6 months a lumen loss of 0.95 ± o.n 
nm was verified. that was independent of sex, type of angina and prior 
PTCA. MLD before PTCA. lesion length, balloon size and lumen gain were 
also tested for correlation w~h lumen loss by means of stepwise regression 
analysis. The only significant variables were lumen gain (p = 0.005) and 
length of the lesion (p = 0.02). Linear regression showed a positive relation 
w~h lumen loss for these variables. 
e 3 
.5.2 
Lumen gain (mm) 
e 3 -r---,!!I:6!--.....-----, 
.5.2 
10 20 30 40 
Lesion length (mm) 
Since for both increased lesion length and IUlnen gain a greater extent of 
injury is assumed to occur during the procedure, our findings comply w"h 
those of experimental studies suggesting that the amount of neointimal 




Acute and Long· Term Results of Coronary Stenting for Complex 
Intimal Dissections Following Balloon Angioplasty 
David Fischman, Michael Savage, Martin Leon, Richard Schatz, 
Richard Heuser, Sheldon Goldberg. Jefferson Medical College, 
Philadelphia, PA 
The goal of this study was to assess the effect of Palmaz·Schatz stents 
on complex dissection. Qualitative and quantitative coronary analysis 
by a core laboratory was performed in 495 patients at baseline, after 
balloon angioplasty, after stent placement, and at 6 month follow-up. 
Intimal dissections were graded as follows: 0, none; I, simple (intralu•
minallinear defect or extraluminal cap); II, complex (nonlinear defect 
or occlusive flap). After balloon PTCA, 158 of 495 lesions (32%) 
demonstrated intimal dissection (98 simple, 60 complex). Anatomic 
features predictive ofpost-PTCA complex dissection included eccen•
tricity, plaque ulceration, and longer length. Mean diameter stenosis 
(%DS) was as follows: 
Grade Baseline Post-PTCA Post-SteD! 
o 75±14 48±16* 16±12 
I 75±1l 47±16* 16±12 
II 79±14 62±19 16±12 





While baseline stenosis was comparable for the 3 groups, post-PTCA 
%DS was significantly more severe in association with complex 
dissection; nevenheless, the immediate and long-term results of stenting 
were not affected by the presence of a complex dissection beforehand. 
Complex dissections improved by stenting in all patients, with com•
plete resolution in 70%. In conclusion: 1) Intracoronary stenting is 
effective in the management of complex dissections resulting from 
PTCA; 2) The presence of a complex dissection does not adversely 
influence the efficacy of stenting; 3) This benefit is maintained at late 
follow-up. 
747·6 11:45 
Ie 1I8ceDt Myocardial Infarction a IfOrae setting for 
COroaary 8teDt x.plantation ? 
Jean Marco, Jean-Baptiste Caillard, Serge Doucet, 
Bernard caaaagneau, Gabriel Robert, Jean Pajadet. 
Clinique Pasteur, Toulouse, Prance 
Of 565 patients (pts) undergoing coronary atenting 
from March 1989 to August 1992, 36 (6.4\) had atenting 
after a recent « 15 days) myocardial infarction (MI). 
There were 33 males, 3 females, _an age 60.4 :!: 8.6 
years (range I 39-72 years). Bleven pts had an 
anterior MI, 11 ptB an inferior MI, 3 pta a lateral MI 
and 11 pts a non Q wave MI, 18 pts were treated by 
thrombolyais and 6 had direct PTCA :s 4 hours after 
onaet of aymptom. LVII' was 52.6 :!: 10.8' (range 
20.70\), and 60\ had multivessel disease. The delay 
between acute MI and atenting procedure was 6.7 :!: 4.2 
days (range: 0-15 days). AmOng the 37 stented vessels 
(17 LAD, 7 LeX, 7 RCA and 6 vein grafts) 31 were 
responsible of the HI. A total of 40 stents was 
implanted with mean final diameter of 3.56 :!: 0.44 mm 
(2.9-4.5 II1II). Indications for stenting were elective 
in 19 pts (53\) and to improve unaatiafactory post 
PTCA reBult in 17 pts (47\). Procedural auccess was 
obtained in all pta. Sub-acute thrombosis in the first 
month occurred in 2 pts (5.6'). Angiographic follow-up 
(134.7 :!: 43.4 days, range' 47-207 daya) obtained in 
21 lesions of the 20/28 (71') eligible pts at 6 months 
follow-up ahowed reBtenosiB ( ~ 50\ diameter stenosis) 
in 4 lesions (19') and 4 pts (20'). 
ConcluBion I 1) Stent implantation can be carried out 
with high Bucceaa and low complication rates after 
recent HI. 2) Low restenosis rate (20') waB achevied 
in thi. small population and S88mS to be similar than 
the u8ual .tent re.tenoBis rate obtained after 
Palmaz-Schatz coronary etenting. 
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Inhibition of Injury-Induced Intimal Thickening in the Rat Carotid 
Artery by a Recombinant Cytotoxin Specific for the Epidermal 
Growth Factor Receptor , 
J Geoffrey Pjckerin~, Dov Gal, Patricia Bacha, Jean C. Nichols, 
John Hogan, Jaclynn Jekanowski, Lawrence Weir, Jeffrey M. 
Isner, Tufts University School of Medicine, St. Elizabeth's 
Hospital, Boston, MA and Seragen Inc., Hopkinton, MA 
Proliferation of smooth muscle cells (SMC) is a fundamental 
feature of restenosis and targeted delivery of SMC toxins may 
represent a therapeutic approach. DAB389EGF is a fusion protein 
expressed by a gene in which the sequences for the receptor•
binding domain of diphtheria toxin have been replaced by those 
encoding human epidermal growth factor (EGF). We have 
previously demonstrated that DAB31!9EGF is a potent cytotoxin for 
human SMCs in culture. The purpose of these studies was to 
determine if DAB389EGF could influence lesion formation in vivo. 
The left carotid anery of 19 rats was injured by balloon catheter 
denudation. In two rats, the expression of EGF binding sites 
within the lesion was documented by incubating the excised anery 
with 12SI-labeled EGF and studying sections by autoradiography. 
Binding sites were prominent within the lesion, particularly at the 
luminal edge. Rats were then exposed to daily intravenous 
injections of either DAB389EGF or saline and sacrificed 7 or 10 
days after balloon injury. Arteries were fixed in situ at physiologic 
pressure and the neointimal area was determined by morphometry. 
Of the rats exposed to fusion toxin and sacrificed at 7 days, 3/8 had 
no evidence of intimal thickening vs mild thickening (0.057±.047 
mml) in all (n=3) of the control rats. Rats exposed to cytotoxin and 
sacrificed at 10 days (n=3) showed mild intimal thickening; 
neointimal area (0.048±.020 mml) was, however, significantly less 
than that in the 10-day control rats (n:3) (0.102±.OO4 mml, 
p<0.05). Conclusion: These findings document in vivo that 
therapy with the fusion toxin DAB389EGF can reduce the extent of 
intimal thickening following balloon angioplasty and may therefore 
be of value in preventing restenosis. 
748·2 10:45 
Time Course of Human Growth Hormone Secretion 
Following Arterial Gene Transfer: A Model for Vascular 
Gene Therapy 
Satoshi Takeshita. Douglas W. Losordo, Guy Leclerc, J. Geoffrey 
Pickering, Jeffrey M. Isner. Tufts University School of Medicine, SI. 
Elizabeth's Hospital, Boston, MA 
Site specific secretion of therapeutic protein following arterial gene 
transfer, such as anticoagulant or antiproliferative protein, may be a 
potential approach to the treatll1ent of atherosclerotic vascular disease. 
The pwpose of this study was: 1) to determine the time course of 
foreign gene product secreted from anerial wall following gene 
transfer; and 2) to compare the efffect of different promoters on 
vascular transfection. Rabbit arterial strips were transfected in vitro 
with two different plasmids containing the gene encoding human 
growth hormone (hGH): pXGHS having the mouse metallothionein-1 
promoter (mMT-1), and pRSVGH having the Rous Sarcoma Virus 
promoter (RSV). All transfections were performed using 20 I1g of 
DNA and 80 I1g of liposome (Lipofectin) in 2 m1 of reduced serum 
media for 30 minutes. Transfected aneries were cultured for up to 21 
days, and the atnount of hGH secretion was measured in serial 
fashion. For those aneries transfected with pXGHS, ZnS04 was 
added to the culture media to induce mMT-1 promoter. Regarding the 
aneries transfected with pXGHS, hGH could be detected within 24 
hrs post-transfection; maximum production was observed at day 3 
(1.45 ± 0.44 ng/ml/day) and was detectable for up to 14 days. 
Immunostain with monoclonal antibody to hGH revealed that <1 % of 
cells were successfully transfected with pXGHS. In contrast, the 
amount of hGH secreted from aneries transfected with pRSVGH was 
<0.5 ng/ml/day, significantly lower than that measured with pXGHS 
(p<O.05). Conclusions: 1) hGH is secreted from anerial cells as early 
as 24 hrs post-transfection, and for up to 14 days; 2) levels of protein 
secreted are disproponionately favorable relative to low % cells 
transfected; 3) gene expression manifested by site specific secretion of 
hGH is promoter dependent, with mMT-1 promoter being superior to 
RSV promoter in this vascular transfection model. 
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Local Infusion of Anglopeptln Into the Angloplasty Site 
Inhibits Neolntlmal Development after Overstretch Balloon 
Injury In a Swine Model of Restenosls 
Edward C. Santoian, Michael B. Gravanis, Norman Tarazona, 
Joel E. Schneider, Gustavo Cipolla, Charles A. Dennis, 
Spencer B. King III, Emory University School of Medicine, 
Atlanta, GA and Deborah Heart and Lung Center, Browns Mills, 
NJ 
Angiopeptin (AP) administered systemically has been shown to 
decrease intimal hyperplasia (IH) in swine. The purpose of this 
study was to determine whether local infusion of AP directly 
into the injured arterial wall using a porous balloon (PB) 
catheter would alter the development of IH in swine coronary 
arteries 14 days after balloon injury (BI). Fourteen swine 
underwent oversized (25-35%) coronary angioplasty in the left 
anterior descending and circumflex arteries. Four pigs(LOCAL) 
received only local AP (1 OOug/kg) into the BI site at the time of 
injury and 4 additional pigs (SYSTEMIC/SALINE) received local 
saline infusion into the BI site combined with systemic (AP 
100ug/kg/day in 2 divided doses SO) for 14 days. Both 
treatment groups were compared to control animals receiving 
no therapy after BI. Animals were sacrificed at 14 days and the 
intimal area (IA), luminal area (LA), the maximal intimal 
thickness (MIT) and residual lumen (RL) were determined 
using a morphometry program. 
Group (n=yessels) RLCLAlLA+IA) 
Control (12) .70±.OS 
AP LOCAL(S) .S1±.09· 
AP SYSTEMIC/SALlNE(4) .S5±.OS· 





Conclusions 1) Local infusion of AP after BI inhibited the 
development of IH 14 days later. The beneficial effects of 
systemic AP therapy were greater than local AP therapy alone. 
748·4 11:15 
Biodegradable aDd Biostable Polymers May Both Cause Vigorous 
IDf1ammatory Responses WIlen Implanted in the Porcine Coronary Artery 
A. Michael Lincoff, Willem 1. van der Giessen, Robert S. Schwartz, Heleen M.· 
M. van Beusekom, Patrick W. Serruys, David R. Holmes, Jr., Stephen G. Ellis, 
Eric J. Topol. The Cleveland Clinic Foundation, Cleveland, OH, Thoraxcenter, 
ROI1erdam, The Netherlands, Mayo Clinic and Foundation, Rochester, MN. 
We have previously reported that biodegndable poIymera, potential vebicles 
for local dru8 delivery following PTCA, may evoke a _ere inflammatory 
reaction following experimental placement in !be coronary artery. To investigate 
wbetber such adverse response is due to !be products and biological mechanisms 
of biodegradation or to !be presence of polymer per Be, 3 different biodegradable 
[polyorthoester (POE), polycaprolactone (PCL), and polyethylene 
oxide/polybutylene terephtbalate (pEO/PBTP)) and 3 bioslable [polyurethane 
(PUR), silicone (SIL), and polyethylene terephtbalate (PET») polymers were 
implanted in porcine coronary arteries. Polymer strips were deployed as 3-5 mil 
thick films cast longitudinally over 90" of !be circumferential surface of coil wire 
stents; polymer-coated stents were sized appropriately to 2.5-4.0 mm arterial 
segments to minimize overexpansion injury (neointima\ thickening over 
appropriately.sized control stent wires is typically 0.06-0.18 mm in this model). 
Histologic examination 30 d after implantation showed asymmetric neointimal 
thickening (Neothickness) concentrated at the polymer-ooated side of each stent. 
Biodegradable Polymers Biostable Polymers 
Polymer n NeoTbickness Polymer n NeoTbickness 
POE 1.62mm PUR 8 1.12 mm 
PCL 6 0.94 mm SIL 6 1.59 mm 
PEO/PBTP \0 0.63 mm PET 8 0.42mm 
Strips of POE, PCL, PUR, and SIL evoked extensive fibromuscular 
proliferation, multinucleated giant cell formation, mononuclear and eosinophilic 
cell infiltration, and medial necrosis with lysis of elastic laminae; more modest 
smooth muscle cell proliferation 0CCIImld adjacent to PEOIPBTP and PET 
samples. Thus, while some biodegradable polymers may induce considerable 
inflammatory reaction within !be coronary artery, bioslable polymers are nol 
necessarily biologically inert; observed adverse tissue response may be due 10 
properties of both biodegradation /IIId the parent polymer compounds. 
ABSTRACTS 
748·5 11:30 
Local DeUvery of DeJllllllethasone ror Prevention of Neointimal Pi-oUr .... tion 
After BaDoon Injury In lb. Rat Carotid Model 
AugustoE Villa, Luis A Guzman, Gersbon Golomb. RobertJ uvy, EricJTopol. The 
Cleveland Clinic Foundation, Cleveland. OH. 
TOdelermine if chrooic Ioca1 adventitial delivery of dexamethasone (Ox) decreases 
neointima\ proliferation after balloon injlD)', silicone poIymers.(SP) containing 5% 
and 0.5% of Ox were implanted. 
In 3 groups ofS(ngue-Dawley I"8IS weighing 350-4SO g,IODx 5%, II Ox 0.5% 
and 10 Placebo SP (15 mm in length) were implanted around the left common carotid 
artery (LCCA) foUowing dendothelializalion with a 2 Fr balloon catheter. In a founh 
group (81"81S), a placebo SP was implanted wilhoUl balloon dendotbe\ialization. Dx 
serum levels were obtained 24 hours and 21 days after SP implantation. After 21 days 
I"8IS were sacrificed and sections from 3 ronsecutive segments of the LCCA covered 
with SP, and I segmenl nol covered by the SP were analyzed. Morpbometric and 
histologic analysis of all LCCA was performed using a Bioquant program. 
The amount ofDx contained in theDx 5% and Ox 0.5% SPwas 2.74 ± 0.13 and 
0.28 ± 0.03 mg, respectively (p=O.OOOI). The Ox serum levels 24 h after SP 
implantation were \372 ± 526 and 452 ± 440 ngldl , respectively (p=O.O\). Three 
weeks later were 535 ± 127 and 233 ± 75 ngldl, respectively (pdl.OOI). 
There was no neointima formation in any of the 8 LCCA from the group with 
placebo SP and no balloon dendotbelialization. MorpbOOletric analysis of the other 
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CWlClllsion" I) Wrnpping around tbecommon carotid artery with silicone polymer.;, 
by itself. did not stimulate neointima\ prolifemtion al 3 weeks. 2) Activity of the drug 
eluting polymer was chiefly. but DOl exclusively Site-specific. 3) Chronic local 
adventitialdeliveryofdexametbasoneal2dilferenldoses,mark.edlyinhibilsneointimal 
proliferatioo after balloon inj ID)'. 
748·6 11:45 
Differential Arterial Response to Stents in a Porcine 
Coronary Model; Exogenous Fibrin vs Polyurethane vs 
Polyethylene Terephthalate 
179A 
David R. Holmes, William D. EdwaIds, Allan R. Camrud, Michael A. 
Jorgenson, Roben S. Schwanz, Mayo Foundation, Roch.ester, MN 
Various configurations and types of polymers have been studied as 
alternatives to metallic coronary stents for scaffolding of anerial 
dissections and local drug delivery. However, initial results in a 
porcine coronary model have been disappointing with marked 
neointimal thickening, foreign body reactions with multinucleated 
giant cells, and extensive des1I"IIction of local anerial struct\D"eS as a 
result of inflammation. Other substances or biopolymers are needed. 
Fibrin has been considered since it is pan of the natural healing 
process, is biodegradable, and has excellent viscoelastic mechanical 
propenies and can incorporate microcapsules for drug delivery. To 
assess the potential role of exogenous fibrin as an alternative 
biopolymer, we compared a circumferential fibrin sleeve coated coil 
wire stent, with a balloon expandable complete polyethylene 
terephthalate (PET) stent and a coil wire stent which was 
circumferentially coated with polyurethane (PU) in porcine coronary 
aneries. At 4 wks following implantation, animals were euthanized 
and stented segments analyzed. 
Noofstents 
Complete occlusion of 
stented segment 
Diameter stenosis <75% 

















Conclusion: Exogenous fibrin sleeves were associated with markedly 
less vessel occlusion and less severe stent stenosis compared to PET 
and PU. The foreign body reaction seen with PET and PU was 
markedly less with exogenous fibrin. Exogenous fibrin is a promising 
alternative for polymeric stenting. 
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749·1 10:30 
11I ...... DlmenIIonII EchocIrcIIognIphic DetermInation of VentI'Ic&Ur 
Volume: CamperIIon of 111,... I_gin" Technlquea 
Thomas C. Gerber, David A. Foley, Marek BeIohlavek, Jamee B. Seward, 
James F. Greenleaf 
Mayo Clinic end Mayo Foundation, Rochester, MN 
The accuracy of volume determination was compared for 3 different three•
dimensional (3D) imaging techniquas using water-filed balloons (B) IW1d 
excised dog hearts (LV). 
e B's end 6 LV'. were acanned in a watertank with a 5 MHz transasophageal 
imaging probe. B volumes ranged from 30 - 120 mi. Water-filed balloons 
distended the LV'. to 50 - 100 ml during fixalion but were removed before 
imaging. Pullback scans were obtained by linear translation of the probe in 
1 mm increments while imaging in the transverse plane. Rotational scans 
were 8<XIuired by rotation of a variable plane transducer at 3' increments. 
"Fan-like" scans were obtained by rotation of the probe around its long axis 
at 1.8' increments with a stepper device while imaging in the longitudinal 
plane. The images were digitized end analyzed using commercial and 
aISIom image processing software. The cavities were segmented using 
In lIUIomatic border detection algorithm (B's) or by manual tracing (LV's). 
30 volumetric casts were reconstructed from the segmented tomographic 
images. The voxels within the cests were oounted. Voxel oounts were 
converted into absolute volumes using calibration marks on the ultrasound 
imllles and cc moared to the actual volumes by linear rearession analY!;i$. 
Balloons Hearts 
Method r SEE [mI] r SEE [mI) 
Pulback 0.9981 2.7 0.9903 3.0 
Rotation 0.9967 3.7 0.9943 2.6 
"Fan-like" 0.9971 3.3 0.9572 7.1 . Conclusions: Pullback, rotational and "lan-llke scans produce accurate 
volume determinations. Image segmentation as well as interpolation during 
dale conversion and 3D-reconslrUclion may introduce errors wIich seem 
to be largest for "fIIl..fike" scans. 
749·2 10:45 
Quantification of Left Ventricular Volumes by Automated Three•
Dimensional Echocardiography Using a Computer·Controlied 
Tomographic Ultrasound Prabe: In Vitro Validation 
Jose Azevedo. Qi-Ling Cao. No1esa Pandian. Steven Schwartz and 
Berthold Klas. . 
Tufts - New England Medical Center. Boston. Massachusetts. 
Recently a new tomographic 3-Dimensional echocardiographic 
system has been developed tho1 provides not only volume rendered 
tissue 3-D reconstructions and 4-D Image display but also is capable 
Of providing measures of left ventricular VOlume and function. In this 
study we examined the reliability of its quantitative approach in 
estimating LV volume. 12 canine hearts (S with symmetric and 4 with 
asymmetric ventricles) w~re fixed In a wo1er-bo1h and Imaged by the 
tomographic probe. In this device a 5 MHz. 64 element transducer is 
mounted on a sliding carriage and encased within an endoscope. 
The prObe is Interfaced to a ultrasound unit which has 3-D recons•
truction capabilities. The transducer assembly is moved 01 1 mm 
intervols with computer control. allowing acquisition of numerous 
parallel slices of the left ventricle and the heart. Following data 
acquisition. a 3-D reconstruction is performed. For LV volume esti•
mo1ion. volume ot sequential tomographic LV slices is measured and 
the total LV volume calculo1ed by a modified Simpson's equo1ion (y). 
We compared the LV VOlumes thus deriVed to actual absolute volu•
mes measured by filling the chamber with saline (x). The data were 
collected independently and blindly. Results: 3-D reconstruction ot 
the LV was possible tor all hearts. The mean LV volume by 3-D echo 
was 20. 7± 16 and the mean volume measured with saline was 21.S± 14; 
The correlation between the methods was y= 1.11x-3.56. r= .99. 
p<.OOOl. There was no over or underestimo1ion of LV volumes by 3-D 
echo. In addition to providing accuro1e LV volumes. sections of 3-D 
images corresponded in shape and size to analogous anatomiC 
sections. We conclude that this tomographic 3-D echocardiographic 
approach provides reliable estimates of LV volumes and thus a 
foundation for quanmative clinical application. 
749·3 
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1bree-dbnenslonal EcbocardiOlJ'llphy: In Vivo Measurement of 
Left Ventricular Mass In Humans 
Andrew M. Keller, Aasha S. Gopal, Eve M. Gerasimou, Richard 
Rigling, Donald L. King. Columbia University, New York, NY and 
Danbury Hospital, Danbury cr. 
Current echocardiographic methods of determining LV mass are 
limited by geometric usumptions. To improve accuracy by 
eliminating these assumptions we have developed a three dimensional 
echocardiographic technique (3DE) which uses a polyhedral surface 
reconstruction algorithm for myocardial mass determination. We have 
previously reported that 3DE is an extremely accurate method for 
measuring LV mass in vitro. Thus, the purpose of this investigation 
was to determine the accuracy of 30E {or measuring LV mass in 
vivo by comparison to LV end-diastolic mass measured with spin•
echo cardiac magnetic resonance imaging (MRI) in a cohort of 
normal subjects. 15 healthy volunteers (7 males, 8 females, age 23-
41, BSA 1.38-2.17 ml) were imaged by both 3DE and MRI. For 
30E, LV mass was determined at end-systole (30E-SYS) and at end•
diastole (30E-DIA). There was a low inter-observer variability for 
each technique (30E-SYS r = 0.96, standard error of the estimate 
(SEE) = 6.84 gm, 30E-DIA r = 0.90, SEE = 8.80 gm, and MRI 
r = 0.99, SEE = 4.07 gm). The regression of LV mass determined 
by 30E against MRI demonstrated: 
r SEE Regression Equation 
30E-SYS 0.92 9.24 gm 30E = (0.87) (MRI) + 10.3 
30E-DIA 0.89 10.6 gm 30E - (0.81) (MRI) + 11.6 
oncluslons: 30E accuratel' aetermmes LV mass when com Y pared 
to MRI in normal subjects. Moreover, 30E-SYS is superior to 30E•
DIA. 
749-4 11:15 
Simulation of Intraoperative 3·Dimensional Visualization of 
Cardiac Structures In Pre-Operative 3·Dlmensional and 4-
Dimensional Transesophageal Echocardlograms Acquired 
Using a Computerized Tamographlc Imaging Prabe 
Jose Azevedo. Qi-Ling Cao. Natesa Pandian. Navin C. Nanda. Steven 
Schwartz. Abraham Schneider. Michael Krauss. Bemard Mumm and 
Berthold Klas. 
Tufts - New England Medical Center. Boston. Moss. and UAB. AL. 
We have previously demonstrated the clinical feasibility of 4-<1imensional 
echocardiography that yielded volume-rendered tissue reconstruction of the 
heart. If this approach could provide 3-D appearances of intracardiac struc•
tures before a heart COuld be opened, it would be of valuable help in plan•
ning surgery. In this study of 24 aduH patients with a variety of cardiac dis•
orders, we explored the potential of pre-operative 3-D visualization of intra•
operative scenarios. A specially designed tomographic phased array sndo 
scopic imaging probe was used to acquire parallel (at 1 mm intervals) 
images of the heart aided by computer controlled movement of the transdu•
cer within the endoscope. Processed with a dedicated 4-D sottware, volume 
rendered 3-D images of the heart were obtained and viewed in a dynamic 
mode (4-0). We explored various means of sectioning the heart in alpha, 
beta and gamma axes. Starting from short-axis orientation, rotation of the 
cuHing plane by 3.3±2 units in alpha, 99%8 in beta and 20±9 in gamma yield•
ed 4-chamber type 4·D images: rotating the sectioning plane by 100i13 units 
in alpha, 2±5 in beta and 101±4 in gamma delivered 2-chamber type 4-D 
images; with rotations by 95±5 units in alpha, 37±18 in beta and 95±6 in 
gamma, the left heart could be viewed in 4-D in long-axis. In all these 4-D 
images, the valves and chambers could be seen in their whole span. In 
addition, we were able to section the heart in a number of orientations that 
yielded 3-D and 4-D images of the heart as if a cardiotomy was done and 
the chamber and the valve viewed intraoperatively. Mitral. tricuspid and 
aortic valves could be visualized both from above and below. Ukewise we 
were able to display interatrial and interventricular septae from the sides and 
in other orientations. Stenotic and regurgitant valves, LV aneurysms, and 
regional and global LV dysfunction were all recognizable in the 4-D images. 
We conclude that 3-D and 4-D echocardiography is a clinically feasible 
technique; 3-D images simulating intraoperative visualization provided by 
this technique has the potential to aid in surgical planning. 
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749·5 11:30 
Quantitative Three-Dimensional Reconstruction of Myocardial 
Perfusion Defects by Contrast Echo: In Vivo Validation 
Leng Jiang, J. Antonio Vazquez de Prada. J. Luis Guerrero, 
Mark D. Handschumacher, Mark G. Hibberd, Tracy Svizzero, 
Michael H. Picard. Arthur E. Weyman, Robert A. Levine, Mass. 
General Hospital, Boston, MA 
Appreciating the 3-dimensional (3D) spatial extent of myocardial 
perfusion defects (MPDs) outlined by myocardial contrast echo 
could help quantify myocardium at risk of infarction. Typical 
evaluation of MPDs is currently based on individual 20 echo 
short -axis views and is therefore limited in evatuatm~ the 
3-dimensional size of the defect, which often varies In 
ClrculriferenUal extent at different levels and is difficult to evaluate 
at the apex. The purpose of this study, therefore, was to 
demonstrate the feasibili of 3D reconstruction of MPlYs in vivo 
an to v I te Us ~uantitative accuracy. system t at 
automabCatly com loes 2D lITIages and their locations was applied 
to reconstruct 10 beating canine hearts from intersecting long-
and short-axis views during aortic/left main injection of agitated 
saline after ligation of varying portions of the left anterior 
descending or circumflex arteries. Endocardial. epicardial and 
contrast borders were traced at end-diastole. The masses (volume 
x density) of non-perfused, normally perfused (NLP) and total LV 
myocardium by 3DE were compared to the actual weights of 
corresponding muscle delineated by Evans blue injection. 
RESULTS: In all instances, coherent 3D reconstructions 
reflected the size (25-105 gm) and distribution of MPDs: 
Mass Regression Line r SE~~m) lY 
1JPD y-I.O xOO4.4 .98 . 
NLP y=l.l x-4.4 .99 5.7 
Total y= I.03x-4.2 .99 3.5 
CONCLUSION: ~uantitative volumetric 
reconstruction of PDs can be achlevea 
m VIVO to assess myocardiat area at 
~spite the often irregular shape 
and distribution of the defect. 
749·6 11:45 
Spatially Correct Three Dimensional Reconstruction of 
Intracoronary Ultrasound: Further Validation and Initial 
Patient Studies 
James 1.. Evans, Kok-Hwee Ng, Michael J. Vonesh, David A 
Cusick, Ralph E. Morales, Carl 1.. Tommaso, Sheridan N. Meyers, 
Sanford 1. Roth, Barry 1.. Kramer, David D. McPherson. 
Northwestern University, Chicago, IL 
We previously presented a method of spatiaUy correct three 
dimensional reconstruction (3DR) of intravascular ultrasound data 
(IVUS) using biplane digital cinefluoriJscopy. To validate this 
technique, coronary arteries in 8 calf hearts were imaged with a 30 
MHz IVUS catheter (Cardiovascular Imaging Systems). Using the 
previously described algorithm, spatiany correct 3DR volume 
renderings were made and compared to histology (HISTO) and 
angiography. We evaluated lumen area, lumen diameter, lumen 
volume, and total volume (wall and lumen), and found good 
correlations. RESULTS: n tlon Lumen Area mm2 30R IVUS ~sl'O + 1.0 
Lumen Oistance mm 3DR IVUS=0.9 HlSTO - 0.6 
Lumen Volume mm3 30R IVUS=1.0 HlSTO - 4.1 





C1inical data was then conected online in 6 patients (7 saphenous 
vein grafts, 5 coronary arteries) for spatially correct 3DR. Data was 
easily obtained and added less than 4 minutes to the IVUS study. 
Lumen geometry was similar to angiography. Wan geometry was 
completely outlined in all cases. H respirations and movement were 
not suspended, marked distortion of the 3DR occurred (3/12 
~Is) that would not have been noted with linear puUback 3DR 
techniques. 
Spatially correct three dimensional reconstruction is cIinicany 
feasible, accurate, overcomes problems using linear 3DR in the 
coronary bed and should anow for true evaluation of atherosclerotic 
coronary geometry. 
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750·1 10:30 
The Value of P·Wave Signal-Averaged ECG For PredictiDg Atrial 
Fibri11atioD After Open Hrart Surgery: A Prospective Study 
Steven Zelenkofske, Mark Gelemt, Shing-Chiu Wong, Edith Menchavez 
and Jonathan S. Steinberg. St. Luke's-Roosevelt Hospital Ceoter and 
Columbia University, New York, NY. 
Previously we have described a method of signal-averaged (SA) p-wave 
analysis that differentiated patients with a history of atrial fibrillation 
(AF) from matched controls, however prospective studies are lacking. 
We hypothesized that the p-wave SAECG is valuable in predicting AF 
in the postoperative open heart patient. Signal-averaging was performed 
using an orthogonal lead system with the QRS as trigger and the p-wave 
as template. The p-wave complexes of the three bipolar leads were 
combined into a vector composite and total p-wave duration was 
measured after filtering with the least squares fit filter (lOOms window). 
A standard ECG p-wave duration was also measured. A total of 86 
patients were enrolled preoperatively and observed for AF up to 10 days 
after open heart surgery. Twenty-two patients (26 %) developed AF 
3.4±2.1 days after surgery. 
..AE ~ p-value 
N 22 64 
Age (YRS) 66±17 66±9 (NS) 
Sex (MIF) 17/5 52112 (NS) 
CABGNalve Replacement 18/4 54110 (NS) 
Previous MI 4(18%) 8(11 %) (NS) 
Standard P-Wave Duration(ms) 92±23 79±8 (NS) 
Filtered P-Wave Duration(ms) 153±17 135±44 (p<0.05) 
A SA p-wave duration of ~155ms provided excellent specificity (84 %) 
and maximal positive predictive accuracy (48 %), whereas a cutpoint of 
~ I40ms yielded the best sensitivity (17 %) and maximaJ negative 
predictive accuracy (85%). CONCLUSION: The duration of the SA 
filtered p-wave is an accurate predictor of AF following open heart 
surgery, and can be used to guide therapeutic interventions. 
750·2 10:45 
Spectral Temporal Mapping of the P wave In IDbJects with and 
without parosysmal atrial nbrlll.tlon. 
Janis M. Paylos, Beatriz Cordero, Esteban L6pez de SA, Carlos Saenz de la 
Calzada. Hospital "12 de Octubre". Madrid. Spain. 
The clinical usefulness and the study protocols of the spectral analysis of signal 
averaged P waves are not yet stablisbed, and the reports about this issue are 
IC8Ilty. The Objective of this study was to determine if the energy spectrum 
analysis of the atrial myocardium allows to differentiate patients in sinus rhythm 
with documented episodes of paroxysmal atrial fibrillation (PAP) from normal 
IlUbjects. 
We otudied 42 subjects, 21 with AF and without other heart disease (16 male,S 
female, 58±IS.7 mean age), and 21 normal subjects as controls (13 male, S 
female. 48.1±28.7 mean age). A SO mS window length was studied on the PR 
intaval, 60 mS backward from the end of the P wave and 20 mS forward from 
this point within the isoelectric Ta segment. Fast Fourier Transform (FFI) 
analysis was performed applying 8 4-Term Blaclanan-Hmris (B-H) and Hanning 
window functions and fFf magnitudes and also the energy distribution betw .... 0 
to SOHz and its logarithmic Oog)transformations were compared. It was also 
compared the relative cootribution of ftequencies between 20 to SOHz to those 
between 0 to SOHz. in X, Y, Z orthogonal electrocardiographic (ECG) leads. 
Results: 
Hanning Window Lad Hz AF Control p 
Magnitude Ratio X ~ 559.5±432.7 1837.7±2294.4 <0.02 
1..02 Area Ratio X 1.413±O.413 1.982±0.71 <0.003 
80H Window Lad Hz AF Control p 
Area Ratio Z 425.5±549.3 994.±1l41.9 <0.05 
Magnitude Ratio X 10-25 34OO.7±3305.4 7389.2±7732.5 <0.04 
Magnitude Ratio X ~ 206.9±188.9 1025.9± 1300.5 <0.007 
Log Area Ratio X 1.I86±O.448 1.833±O.738 <0.002 
l..oI! Magnitude Ratio X ~ 2.09±O.539 2.57I±O.789 <0.03 
ThUl: The spectral analysis of the P wave from patients with PAF sbowed 
significant less energy content (2540Hz) on the ECG leads facing the posterior 
I0Il postero-Iateral atrial myocardium, where zones of slow conduction and blocks 




.onlnvaslve Estllatlon of Sino-Atrial Conduction Tile br 
P 'ave-Triggered Signal-Averaged Electrocardiogral 
Ei ichiro Tsujilura. Masatake Fukunni. Masabaru Ohlori. 
Takahisa Yanda. Nobubiko Kondob. Yasusbi Abe. Nagahiro 
Nishikawa. Noritake Hoki. Division of Cardiology. 
Osaka Prefectural Hospi tal. Osaka. Japan. 
To deterline whether sino-atrial conduction tile (SACT) 
could be estilated noninvasively by P lave-triggered 
signal-averaged electrocardiogral(SAE). 15 patients(7 
,itb sick sinus syndrole(SSS). 8 controls witb 
atrioventricular block or ventricular tachycardia and 
norlal sinus node function) were studied. Tbe signals 
obtained frOI the standard VI. V2. V3 precordial leads 
lere alplified up to 1# Vici and ,ere converted analogue 
to digital at a snpling rate of 1KHz. Thereafter. the 
data 'ere passed tbrough a digital bandpass filter of 
2Bz(6dB/oct)-20Hz(18dB/oct) using personal cOlputer. Un•
til pre-P potential ,as detected. the signal was 
averaged(usually 200 or lore) witb tbe P-.ave triggering 
tecbniQue. Pre-P signal was observed in all patients. in 
such a shape as sinus node electrogral directly recorded 
tbrough a catbeter. Pre-P potential duration(Pre-PO) .as 
leasured as an interval frol the beginning of the pre-P 
signal to the onset of the filtered P .ave in SAE and 
was cOlpared to indirect SACT(N) by the Narula's lethod 
at tbe electrophysiological study. There was a good cor•
relation between tbel (r=O. 89. p(O. 001. SACT(N)=0.78tPre•
PO+19.3). Furtherlore. the cOlparison of Pre-PO bet.een 
SSS and control groups revealed that Pre-POs of SSS .ere 
significantly (pC 001l longer (10 •. 3± 10. 61s) than that 
in control (70. 5± 12. 21S). In conclusion. this new lethod 
would be useful for tbe noninvasive estilation of SACT 
as an alternative approacb tbat is lucb silpler and 
safer than the conventional invasive letbod. 
750-4 11:15 
A Neural Network System for Automatic Detection of Atrial 
Fibrillation. 
David Cubanski, David Cyganski, Mark Hubelbank, Elliott Antman, 
Charles Feldman, Brigham & Women's Hospital and Worcester 
Polytechnic Institute, Boston, MA. 
Because atrial fibrillation (AF) is difficult to quantify, most 
studies of AF simply document its presence or absence and do not 
provide measurements of the amount of paroxysmal AF. To 
overcome this limitation of existing systems and permit continuous 
quantitation of paroxysmal AF, a neural network system has been 
developed that is able to distinguish atrial fibrillation from other 
supraventricular arrhythmias in ambulatory electrocarciiograms 
(AECGs). The classification algorithm relies on preprocessing by 
a well. validated, automated AECG analysis system 
(CardioDatalMortara MK 5) to screen out artifact and ventricular 
premature beats. It employs both R-R interval information and an 
analysis of baseline morphology, using the morphological 
characteristics of the non-QRS portions of the waveform. 
When applied to a library of 28868 validated 10 second segments 
of AF and 14102 ten second segments of other, potentially 
confusing supraventricular rhythm disturbances, the system correctly 
characterized 23807 episodes of AF (sensitivity = 82.5%) and 
correctly characterized 13610 episodes without AF (specificity 
96.5%). Actual performance on typical AECGs would be 
considerably better, as our statistics quantify the performance of the 
algorithm when applied specifically to isolated sections of AECG 
tapes which are difficult to classify by traditional means. 
This method makes it possible to reliably detect paroxysmal AF 
and may provide a hitherto unavailable method for quantifying AF 
on AECG, leading to more efficient evaluation of potential 
treatments. 
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Frequency of Asymptomatic Arrhythmias in 
Patients with symptomatic Paroxysmal Atrial 
Fibrillation and Paroxysmal supraventricular 
Tachycardia 
Richard L. Page, William E. 
Walter K. Clair, Elizabeth A. 
Edward L.C. Pritchett, Duke 




We evaluated the frequency of asymptomatic 
paroxysmal atrial fibrillation (PAF) and 
paroxysmal supraventricular tachycardia 
(PSVT) in 22 antiarrhythmic drug-free 
patients with a history of symptomatic PAF 
or PSVT previously documented with trans•
telephonic ECG monitor (TTEM). During a 29d 
stUdy period, five 24-hour continuous 
ambulatory ECGs were recorded (l/wk) to 
detect asymptomatic PAF or PSVT lasting > 30 
sec; patients carried TTEM to record 
symptomatic PAF and PSVT. Results: In 8 
patients with PAF, there were 25 
asymptomatic events in 5 days of monitoring 
and 12 symptomatic events in 29 days. Mean 
intensi ties of PAF, expressed as a point 
estimate of events/100d/patient (95% 
confidence interval) were significantly 
different: 62 (40,87) for asymptomatic PAF 
and 5 (3,9) for symptomatic PAF (p<O.Ol). 
In contrast, the 14 patients with PSVT had 
o asymptomatic and 30 symptomatic events, 
with mean intensities of 0 (0,5) and 7 
(5,11), respectively (p=0.02). Conclusions: 
In contrast to patients with PSVT, patients 
with PAF have more frequent asymptomatic 
than symptomatic arrhythmias. 
750·6 11:45 
ECG Criteria for Right Atrial Enlargement are Insensitive 
When Tested by Quantitative 20 Echocardlography 
Jeffrey O. Kaplan, Tom Evans, Elyse Foster, Nelson B. Schiller. 
University of California, San Francisco, California 
The sensitivity of ECG criteria for right atrial enlargement (RAE) 
are not precisely known. Previous studies have concluded that aRS 
patterns in the right precordial leads are more accurate in detecting 
RAE than traditional P-wave criteria. To determine the sensitivity of 
recognized ECG abnormalities associated with RAE, and to identify 
new criteria(,), we retrospectively studied' 100 randomly selected 
pts with RAE by quantitative 20 echocardiography (echo) and 
compared them to 15 matched normal controls (C). ECG's were 
available for all subjects within 3 months of the echo. Atrial 
fibrillation was present in 46% of pts and 83% had moderate or 
severe right ventricular enlargement (RVE) by echo. Using a single•
plane area-length algorithm from the apical 4-chamber view. right 
atrial (RA) volume for pts was 132.0 ± 76.6 ml vs 24.8 ± 4.5 ml 
for C (mean ± SO) (p<.01). ECG criteria for RAE were then analyzed 
for sensitivity and compared to C by the unpaired t-test: 
ECG Criteria RAE C p-value 
P in lead 11 > 0.25 mV and P-axis > 700 4% 0% <.01 
Positive P in V1 or V2 > 0.15 mV 14% 0% <.01 
aRS amplitude (ORSA) in V1 < 0.6mV 42% 20% .98 
Ratio of ORSA in V2N1 > 3 1 4 % 6% .54 
O-wave in V1 or V2 (without infarct) 38% 0% <.01 
"Right axis deviation 33% 0% <.01 
"RR' in V1 or Y2 (without LYH or LBBBI 56% 0% < 01 
Conclysions: Most previously identified ECG criteria for RAE are 
either insensitive or are not significantly different from C ECG's. 0-
waves in V1 or V2 or, as new criteria, right axis deviation or RR' in 
V1 or V2, are relatively sensitive indicators for RAE, likely due to 
associated RVE. 
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Experimental Atrial Fibrillation: Evidence for a Focal 
Mechanism 
Carlos A. Morillo, George J. Klein, Douglas L. Jones. University Hospital & 
Tha John P. Robarts Research Institute, University d Western Ontario, 
London, Ontario, Canada 
Chronic rapid ventricular pacing has been used as a model to induce 
ventricular myopathy. We hypothasized that chronic rapid atrial pacing 
(RAP) would lead to an atrial myopathy that would yield. a model of 
sustained atrial fibrillation (SAF). A trensvenous lead was Inserted and 
placed at the right atrial appendage in 22 dogs. Atrial vulnerability, 
assessed by the extrastimulus and burst pacing techniques, was 
parformed before and after 6 weeks of continuous RAP at 400 beat~ per 
minute. Two dimensional echocardiography (2DE) was performed In 11 
dogs to assess tha effects d RAP on atrial size. Ten quadripolar epicardial 
electrodes were surgically attached to tha right atrium (RA) an<! left ~tri~m 
(LA). Tha local fibrillatory cycle length was measured at each stte. BlBtnal 
enlargement after 6 weeks of RAP was documented by 20E: LA (7.8 ± 1 
cm2 vs 11.3 ± 1 cm2), and RA (4.3± 0.7 cm2 vs 7.2 ± 1.3 cm2). SAF was 
not inducible at the baseline study. After 6 weeks of continuous RAP, 
SAF was induced in 18 dogs (82%), nonsustained atrial fibrillation (AF) 
was documented in 2 (9%). Spontaneous occurrence of SAF after pacing 
was also observed in 4 dogs (18%). Effective refractory period measured 
at 2 sites in tha right atria was shortened significantly after pacing (147 ±11 
msec vs 123± 12 msec poc 0.001). Mean AF cycle length was significantly 
shorter in the LA 81 ± 8 msec compared to the RA 94 ± 9 msec (p-c0.05). 
An area in the posterior LA consistently had highar local fibrillatory rate 
than othar atrial segments. Cryoablation of this "high frequency" area was 
attempted in 11 dogs. AF cycle length was significantly prolonged from 
81 ±8 msecto 132 ± 10 msec intha LA and from 94±9 msec to 136± 11 
msec in the RA (pocO.001). SAF could no longer be induced after 
cryoablation in 9/11 dogs (82%), insteed, nonsustained atrial flutter was 
induced in tha majority of dogs. 
Conclusions: 1) Chronic RAP was consistently associated with biatrial 
myopathy and marked changes in atrial vulnerability, yielding a 
reproducible model of SAF. 2) The mechanism of atrial fibrillation in this 
model may be due to a rapid atrial focus localized to tha posterior LA. 
751-2 10:45 
Activation Patterns During Tennination of Clockwise and 
CountercloCkwise Circus Movement Atrial Flutter by Cryothennal 
Technique in Dogs With Sterile Pericarditis 
Nidal Isber, Mark Restivo, Hua Yang, Edward B. Caref, William B. Gough, 
NabiJ EI-Sherif, SUNY Health Science and VA Medical Centers, Brooklyn, NY 
We have shown that atrial flutter in dogs with sterile pericarditis is commonly 
due to a single loop reentrant circuit in the lower right atrium comprised of a 
functional or functionallanatomical obstacle and a slow zone of conduction (SZ) 
between the central obstacle and the AV ring. We analyzed the high resolution 
(1.5 mm) activation patterns during epicardial cooling of the SZ with an Np 
cooled probe in 8 dogs (6 with clockwise [CW) reentrant circuit, 2 with both a 
CW and counterclockwise [CCW) reentrant circuit around the same pathway). 
In all 8 dogs, cooling the narrow isthmus at the infero-posterior part of the SZ 
between the central obstacle and the A V ring terminated the reentrant circuit, 
while cooling outside this area failed to terminate the reentrant circuit. Both CW 
and CCW reentrant circuits could be terminated from the same site within the 
SZ. Cooling resulted in slowing of conduction in the SZ (55 ± 15 DIS) in both 
CW and CCW reentrant circuits. In CW reentrant circuits, a characteristic shott•
long cycle length pattern always immediately preceded the termination of the 
reentrant circuit. After constant or slight oscillation of cycle length (5 ± 3 DIS), 
significant shottening of one cycle length (25 ± 10 DIS) occurred followed by 
significant lengthening of the last cycle length (35 ± 20 DIS). The sbotter cycle 
caused marked slo\\ing of conduction in the SZ, shifting the recovery of 
excitability of the SZ rightward relative to the normal zone. Thus conduction 
block occurred within the SZ. On the other hand, in CCW reentrant circuits 
conduction block occurred abruptly at the distal border of the SZ and without 
significant cycle length alternation. Our data strongly suggests: I) the postero•
inferior part of the epicardial SZ is the critical site for the termination of atrial 
flutter in this experimental model; 2) cooling-induced interruption of CW 
reentrant circuits is due to decremental and/or dissociated conduction in the SZ 
while interruption of CCW reentrant circuits could be due to lengthening of 
refractoriness and/or decreased excitability at the border of the SZ; 3) because 
the atrial myocardium behaves electrophysiologically as a two-dimensional 
surface, the results of this study can help to guide the endocardial electrode 
catheter ablative technique for treatment of clinical atrial flutter. 
ABSTRACfS 183A 
751-3 11:00 
A New, Reliable Atrial Fibrillation Model With a Olnlcal Counterpart 
Jose Ortiz Masaki Igarashi, Xavier Gonzalez, Nancy J. Johnson, Albert 
L. Waldo, 'Case Western Reserve University, Cleveland, OH. ' 
Previous models of atrial fibrillation (AF) have been unreliable, difficult 
to make or had no clinical counterpart. We developed a reliable, reproduc•
ible, and easy to create model which resembles AF seen in patients in the 
first days following open heart surgery. This report describes and charac•
terizes the AF model in 12 dogs with sterile pericarditis. After creating 
pericarditis, studies were done in the conscious state on postop days 1-4. 
Then on postop day 4, using standard techniques, the heart was exposed 
and a mapping system was used to record 190 unipolar electrograms simul•
taneously from the right and/or left atrium (RA, LA) with ECG lead II. 
AF induction was attempted first by programmed atrial stimulation (SlS:; 
SlSzS3) and then by rapid atrial pacing for ~ 20 beats from selected sites 
at selected cycle lengths (eL). Sustained AF (sAF) (AF ~ S min) was indu•
ced 67 times in 12 dogs (~4/dog); 9 following SlS2S3(mean CL 300/107/80 
ms), and S8 following rapid pacing (mean CL SOt3 ms). sAF was induced 
in 12/12 dogs on days I and 2, and 9/12 dogs on day 3. On day 4, only 
brief episodes of AF were induced in 3 dogs, and sAF in 3. The sAF epi•
sodes lasted a mean of 29±3 min (11-62 min). sAF on days I and 2 lasted 
longer (mean 36±4 min) than on day 3 (mean 18±4 min, p<.OI). 19 epi•
sodes of sAF lasting 12.7±2 min were mapped and activation maps were 
drawn using sequential time windows of 110 ms. During AF, 1-4 activa•
tion wave fronts (A WF) were observed in the RA (from 4 different direc•
tions). The LA had 1-3 AWF. Activation patterns consisted of fusion (S 
episodes), bifurcation (9 episodes), and block (S episodes) of the AWF, 
with activation patterns commonly repeating (at least once/6 cycles). In 
40% of the maps, the RA and LA were each activated by a single, broad 
A WF. Non-stable reentrant circuits were observed only in the RA free 
wall and lasted from 2-4 beats. No ectopic foci were seen. Conclusions: I) 
This sAF model is reliable and reproducible, providing an in vivo model 
with a clinical counterpart; 2) the time course of the pericarditis and the 
aggressiveness of the pacing protocol are critical for induction of sAF; 3) 
sAF of ~ S min duration always continued for at least II min, providing 
a predictable (6 min) window during which interventions (e.g., antiarrhy•
thmic drugs or devices) can be tested; 4) all maps demonstrated 1-4 simul•
taneous wave fronts in the RA or the LA with frequent repetitive activa•
tion patterns and activation of either atrium by single, broad wave fronts. 
751-4 11:15 
Comparative Mechanisms of Antiarrhythmic Action in 
Experimental Atrial Fibrillation - The Importance of Use•
Dependent Effects on Refractoriness 
Gerald W. Bourne, Jinjun Wang, Zhiguo Wang, Christine 
Villemaire, Mario Talajic, Stanley Nattel. Montreal Hean Institute. 
Montreal, Quebec, Canada 
A variety of antiarrhythmic drugs have been used to treat atrial 
fibrillation (AF), but their mechanism of action remains poorly 
understood. To evaluate potential mechanisms by wh1ch 
antiarrhythmic agents terminate AF, a 112-electrode atrial mappmg 
system was used to study the effects of drugs in class la 
(procainamide, PA), Ic (propafenone, PF) and 3 (sotalol, S). Vagal 
stimulation (VS) at a functionally fixed level was used to penmt the 
induction and maintenance of stable sustained AF in 
morphine/chloralose anesthetized dogs. Clinical loading doses of PA 
(12.5 mg/kg) and PF (2 mg/kg) convened AF in 12/12 (100%) and 
7/8 (88%) dogs, respectively. A clinical dose of S (2 mg/kg), in 
contrast, convened 2/8 (25 %) dogs, while a higher dose (6 mg/kg) 
convened 8/8. Drug effects on refractoriness (ERP) and conduction 
were measured at stable plasma concentrations during maintenance 
infusions. All drugs increased ERP in the presence of VS (figure) but 
S's effect showed strong reverse use-
dependence, in contrast to PA with 200~" •. ~/" 
none and PF with positive use- "160 
-d S '\ . dependence. PA, PF and high ose E 
increased wavelength at rapid rates, c.. 120 ~ 
enlarging reentry circuits and reducing ~ . .... 1 .. 
their number until AF could no longer eo '-6--6--_-. 
be sustained. Conclusions: 1) PA, PF '0 '--__ ~_~_ 
and S tenninate experimental AF by 20e JOO 400 
increasing ERP and wavelength; BCL (ms) 
2) Reverse use-dependence limits the efficacy of S for AF 
tennination while positive use-dependence contributes to that of PF. 
184A ABSTRACTS 
751·5 11:30 
Atrial Fibrillation Induced by Vagal stimulation 
of Atrial Flutter: Insights from aD ADimal Model 
Yusef Haj-Darwish, Jeffrey M Baerman, John G 
Kall, David Euler, Robert Hariman, David J 
Wilber, Brian Olshansky. Loyola University 
Medical Center, Maywood, IL 
We hypothesized that degeneration of atrial 
flutter to atrial fibrillation (AF) is 
associated with functional changes in the atrial 
flutter reentrant circuit. Five dogs underwent 
surgery to create sterile pericarditis. Right 
atrial epicardial free-wall activation was 
determined by 56-point simultaneous recordings 
over a 2 x 4 cm area. Atrial flutter (cycle 
length = 127±8 ms) was induced reproducibly in 
all dogs. supramaximal vagal stimUlation 
initiated AF from atrial flutter (but never from 
sinus rhythm) in the dogs. There was a mean of 
4 (range 2-7) AF episodes per animal. Initiation 
of AF was associated with beat-to-beat changes 
in the atrial activation pattern. In atrial 
flutter, coincident with vagal stimUlation: 1. 
atrial conduction accelerated, 2. fractionation 
of the activation wave front occurred and 3. 
activation developed across previous lines of 
block. Activation wavelets then varied beat-to•
beat. Vagal stimUlation also shortened the 
atrial monophasic action potentials from 119.5 
ms to 60.5 ms pacing at 120 ms(p<0.0001). 
CONCLUSION: During vagal stimUlation of atrial 
flutter, AF initiation was associated with 
acceleration of conduction velocity and 
fractionation of the atrial flutter reentry 
circuit. This mechanism of initiation of AF may 
apply to other conditions causing AF. 
751·6 11:45 
Early Afterdepolarizations in Human Atrium. 
Hakim Benamer, Jean-Paul Couetil, Christophe Acar, 
Michele Portoghese, Louis Guize, Thomas Lavergne, 
Pierre Peronneau, Jean·Yves Le Heuzey. INSERM U 256 
and Dept of Cardiology, Broussais Hospital, Paris, France 
Early afterdepolarizations (EADs) have been described in 
Purkinje and ventricular cells, but never in atrial fibers. 
The morphology of some human atrial cell action 
potentials are similar to those of Purkinje fibers, with a 
notch and a plateau. The aim of our study was to 
investigate the possibility of EAD induction in human 
atrium. We studied, by the microelectrode tecjmique, 10 
preparations of human atrium, !lsing low rates of 
stimulation and superfusions of Cesium (2mMolll) or sea 
anemon toxin ATX II (10.7 M). The preparations were 
driven at 60, 12 and 21mn at control and after superfusion 
of Cesium (n=5) and ATX II (n=5). No EAD was observed 
at control. The values of action potential durations at 90% 
of repolarization were the following: 
Rate Control Cesium Increase p 
(beats/mn) (ms±SD) (ms±SD) (%) 
ill 285±75 352±95 2A NS 
12 373±79 415190 11 NS 
2 475±170 563±185 19 NS 
Rate Control ATX II Increase p 
ill 24l±54 338±81 40 <.01 
12 291±4O 476±50 64 <.01 
2 409±82 646:!:236 58 <.05 
We observed EADs and triggered activity in 3/5 cells of the 
ATX II group but in only 115 cell of the Cesium group. 
In conclusion EADs can be induced in human atrium. It 
could be in'volved in the genesis of some atrial 
arrhythmias. 
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Effect of EBtm:I:ial. 1H! en ~ ~ After Billa:n 
Artedal. InjIy :in Ratbits 
MIrcll9 Ibell, S!t:ifh A!Dtta, M:Irie ~, ~ RaINill. ~ 
UIi.W!'.'Si.ty Mrlical. <l:!nI:eI: 
(M;r til! last fBI years tiEre IllS \:an ~ epidsnio1ogi.ca data 
thIt ~ tnBtIIl!nt IXttEctS ~ a:rcmry artery disease. In 
~ stulies of ~ a::cel.etata:i ath!rorlemri.s til! Uge 
of ~ sigd.ficaltly <B:reass:l :int::iJJB1. ~. TIEse stulies 
{n1l1XErl til to ~ til! effect of ~ en ~
~  1Bl.1a:n arter::ial. :injIy :in IIBle rctiJi.ts. ~ 
sep![Bte 1I'B1yses of :int::iJJB1. !Dllifemt:i.cn W!!:e E!Ipl.o}ej, til! first tIleS 
QJXIiIm!tty talaIsJre :int::iJJB1. ~. 'lh! send III!IBl!:eS 
~ :.. ~ :iu:n:p:r:at:im :into sn:xxh cells as III :irIEx of ~ 
 
MLpcII"t:x::i.c rata: Jnfi:arEml. Acrta C:m!m Ilia;: EXt:erml Ilia;: 
Ortrol 18.6:t2.1 17.J:!: 1.6 72.7± 2.2 
EBtm:I:ial. 17-ii 5.7± 1.2* 7.Q!: 0.9* 7.'l:!:. 1.1* 
'L*{P<O.OJl) IIE'Bl ± san data: ~ :int::iJJB1. ~ 
"If -'D1}midire data: Jnfi:arEml. Acrta 
Ortrol 617 ± 76 ~
EBtm:I:ial. 1H! lJ2. ± 47 ~ INA* 
*(P<0.01) IIE'Bl ± !BII 
Int:inBl. ~ ~ sigd.ficaltly <B:reass:l :in all ~ ar:<B3 
:in til! IIlinBLs r:e:Ei.~ EBt:mtial. 1 H cipi.aBte 1<D..W\<g/day as 
axq:mai to <XJ1trols. 
'lhis stuly clearly Sn5 thIt ~ sigd.ficaltly cEcreases 
~~ :in IIBle rctiJi.ts f~ 1Bl.1a:n :injIy 1ni 
thIt aE of til! lIBhrIisIB fer this <Ecrease is dJt:ajmf ~ 
:irhibi.t:i.cn of :int::iJJB1. sn:xxh aill rroJ i feratim. 
889·23 
~ Irhihi.t:i.cn of ~ ~ Fbl1.OOrg Billa:n 
~of~ Arteries:in Ral:f:ri.ts 
MIrcll9Ibell, Micteel.!da!s, M'Ity W:llfe, M:Irie ~, Ieter RaINill. 
~ta.n UIi.v. ~., ~ D.C., Ihmn-Q:ay UIi.v. Wimtm•
Sl1.an N::. 
Olrr:Ettly a wilE talJ! of drugs are ~ evah.atal to l.aoier tI:E 
h:igl iIJ:UEnE of r:est:in:s:is 1JIi.dl oo:mpni.es p![UItaID.IS t:r<mhmiml 
arcmr.y~. S:iIn! ITBV jlltients are ~, 
plasm l.:ipial1lBY roqmnise til! eff:i.ca:y of t:IEe! drugs. A {X'OIIis:iIll 
~ :in clinical trials is ~, III ~ 1m1.og of 
9:l1Btc6tat:in lrith a higlly li{x:PIili.c teJJ1Iiml. 'lh! IXJIBltial 
:inI:.em::t:i.c !:etlan ~ 1ni ~ en :irhibi.t:i.cn 
of~ ~ ~ evalmted:in a ~
rctiJi.t m:xEl of arteria11Bl.1a:n catil!ter :injIy. 'lh! ~ 
~~.as evalmted ~ nrqh:netty 1ni E!lqrE!SBi as 
area of :int::iJJB1. ~ / total. ~ area x 1rot. Serun IU.,IlL, 
dnl.est:erol, VUL 1ni nIL ~ all elevated ~ til! 0.5% dDlesterol. 
diet 1ni W!!:e rot affocted ~ ~. 
EXte:ml. Ilia;: C:m!m Ilia;: 
antIOl- 2B.4 ±S.B 17.at 2.0 
~ 15.0 ± 1.6* 9.4 ± 2.3* 
*(PCO.01) 1IIBl±lBn 
Acrta 
16.6 ± 1.4 
8.7 ± 1.6* 
In tI:Ese ~ IIlinBLs ~ ~day 
~y reim:l ~ ~ ~ III <M!ragi! of 47'!. 
:in til! :infrareml a:rta, til! CIlIIIIIl 1ni ext:enBl. iliac arteries. 
TIEse exp!dnalI:s irrlicate tIBt elevated serun l.:ipial cb rot 
:interfere lrith til! eff:i.ca:y of~. 1'1.Irth!r, ~
d::es rot sigd.ficaltly affe:t serun J..4qrot.iEre. 
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889-24 
PathologIcal Effecta of Balloon Xe-Hg Flaah Lamp IrradIatIon aa 
Photodynamic Therapy for the Praventlon of Restenosla 
Takayukl Asahara, Mikio Usui, Tadashl Amemiya, Hiroyukl Rakue, Yasuhisa 
Ok., Hiromori Shiraishi, Tomitugu Kalo, Yuichi Nailo, Chiharu lbuklyama,; 
Tokyo Medical College, Japan 
Photodynamic therapy (POT), which can destroy the prolHerating cells, 
was proved to prevent restenosis in vivo. The purpose of this study is to 
evaluate POT effects by diffusing balloon irradiation of flash lamp. POT 
was performed wtth abdominal aortas of every 5 rabbtts of immediately(OD), 
3days(3D), lweek(1W) 2weeks(2W) and 3weeks(3W) after balloon injury. 
An Irradiation was 24J110mrn2 Hg-Xe flash lamp light through a quartz fiber 
wtth a balloon diffusing tip. A photosensttizer of Hematoporphyrin Derwatlves 
(5mg1kg) was administered intravenously 24 hours before irradiation. All 
rabbHs were killed 4 weeks after balloon injury, investigated histologically 
wHh H-E, EVG stain and PCNA immunohistochemistry. The resuHs were 
expressed by the intima: media area ratio (IAlMA). lW POT was the most 
effective (IMIMA .0.94±0.34). POT sHes revealed marked cell necrosis and 
less proliferation almost around the cavity. Especially in most cases of lW, 
severe and extensive media cell necrosis were [result) IAIMA 
observed wtth the least intimal thickness. The control 2.S6±0.65 
sttes of 2W noted moderate media and intima OD-PDT 2.17±0.64 
3D-POT 1.78±0.58 
cell necrosis, while the 3W had less media 1W-PDT 0.94±0.34 
and more intima cell necrosis. conclusion; (1) 
1 W POT resuMed the most effective suppression 
2W-PDT 1.11±0.41 
3W-PDT 1.64±0.62 
of intimal prolHeratlon, but 2W or 3W POT remained less necrotic changes 
In media on Ihis restenosis model. Long term pathological changes must 
be examined. (2) POT using a balloon diffusing tip and flash lamp irradiation 
would be an useful therapy of restenosis. 
889-25 
Suppression or Intimal ProllCeratlon after Balloon An&loplasty 
with Local Beta irradiation In Rabbits 
Arie Shefer, Neal L. Eigler, Iames S. Whiting and Frank I. Litvack, 
Cedars-Sinai Medical Center, Los Angeles, California. 
We studied the effects of locally delivered ionozing radiation (R) on 
the proliferative response to balloon overstretching injury (I), The 
injury model was balloon angioplasty (1.5 mm diameter for 10 min 
at 6 atm) -of the central artery of the ear of NZW rabbit. (N =50, 
100 arteries). R was delivered as hi~h energy beta from a sealed sfO 
source in a single dose (skin dose of 900 rad) after a scheduled time 
delay from I. The proliferative response was measured at 14 days as 
the ratio of neointimal to media cross sectional areas (I:M) from 
histologic cross sections of intact and injured arterial segments. 
~ N I;M C!lmPllri~D :«ilh C!lm,lmi~D :«ilh 
lklax DQD-l[IlIlIlil~ 
D!lDlIilI ill1Cril:~ lIilil~ ill1Cril:~ 
0 10 0.21±0.22 p=.06 p<O.05 
1 d 12 0.19±O.14 n.s. p<O.05 
2d 12 O.OHO.13 n.s. p<O.05 
3d 23 O.14±O.11 n.s. p<O.05 
7d 12 O.32±O.27 p<O.02 n.s. 
I:M in normal arteries (N=31) was O.05±O.09 and O.38±O.31 in 
non-irradiated dilated segments. 
Conclusion; Irradiation with single dose of beta radiation effectively 
suppresses the proliferative response after balloon angioplasty in the 
rabbit. The optimal timing for the irradiation treatment is the second 
day, but immediate irradiation is also effective. A second protocol 
using a porcine coronary injury model with transluminal intravascu•
lar irradiation is ongoing. 
ABSTRACTS 
889-26 
Meet of ID-Sltu Polymeric HIruJoa Releue OD ResteDo8Is FollowiDg BaIIooII 
AIIgiopIasty iD tile Atllel'OlClerotk: Rabbit. 
Luis A Guzman. Augusto E Villa, Gmhat Golomb, Robert Levy, Joseph Furst. 
Eric J Topol. Cleveland Clinic Foundation. Cleveland. Ohio 
The purpose of this study was to detennine if hiJulog, a synthetic direct thrombin 
inhibitor agent. delivered locally into the vessel waD coukI decrease neointimal 
proliferation following balloon angioplasty (BA) in atherosclerotic rabbits. 
Previous in-vitro release studies using silicone rubber matrix with 6 % hiJulog 
showed an initial 12 hours burst phase, followed by a constant 20 ug/cm2 
matrix/day drug release for more than 30 days. In these studies, hirulog's 
anticoagulant activity was maintained after matrix incorporation and heat or 
gamma irradiation sterilization. Each rabbit underwent bilateral focal femoral 
anery injury by air desiccation, followed by an atherogenic diet (I % cholesterol 
and 6% peanut oil) for 28 days. On day 28. after a baseline P1T was obtained, 
silicone rubber polymers coated hiJulog or placebo were randomly implanted 
around both femoral arteries. BiJatel'al femoral BA was performed with a 2.S 
mm balloon, following a standard protocol of 3 inflations at 6 atmospheres each 
during 60 sec. After this procedure. the cholesterol diet was discontinued. and 21 
days later a follow-up angiogram was performed immediately prior to sacrifICe. 
In-vivo fIXation was done with 10% fonnaldehyde. The implanted polymers 
contained a mean of 12 ± 2 mg of Hirulog. The PTT prior to polymer 
implantation was 21 ± 9 sec. and 19 ± S sec 24 boon after (p<0.2). Twenty two 
arteries (10 in the Hirulog group and 12 in the placebo group). were available for 
quantitative JIIOIPhometric analysis 
HIruIot Placebo P value 
IDtiml.lume. area (mm2) 1.34±.S8 1.29±.33 <0.8 
LameD area (mm2) 0.73±OS7 0.8S±O.3S <0.6 
IDtimai area (mm2) 0.6I±O.26 O.44±O.29 <0.2 
Ipt!mHDm:¥£!lPD (%) 42±18 34±18 <0 Ill! 
Thus, although systemic hirudin has been shown 10 be effective in this same 
atherosclerotic rabbit model. local delivery of hirulog at high concentration into 
the vessel wall via a periadventitial polymer did not decrease neointimal 
IIOliferatioo. 
889·27 
EnhInI:ed Localization and Retention of Micropartldes Followi,. Intra•
mural Delivery into Atherosclerotic Arteries usi ... New Delivery Cathe•
ter 
Robert 1:.. Wilensky, Keitb L. Marcb, Irmina Gradus-Pizlo, Donald S. 
Scbauwecker, David R. Hathaway. Krannert Institute of CardiololY, Depts. 
of Medicine and RadiololY, Ind. Univ. 5cb. of Med. and R.L. Roudebush 
VAMC, Indianapolis, IN. 
The local application of hiBb concentrations of a,ents capable of modulatinll 
vucu1ar responses including smooth muscle proltferation, via a porous local 
drull delivery catheter, offers. potential therapeutic approacb to reducinll 
restenosi. wbile minimizinll undesirable systemic effects. We bave recently 
demonstrated the catheter-mediated delivery of microparlicles into the vascu•
lar wall; such an approacb could be employed for release of active allents 
over prolonlled time periods. To further defme the localization &lid distribu•
tion of microparticles injected radially into a vascular wall, we have utilized 
lIamD1a countmg and scintigraphy immediately and at 1 week followinll deliv•
ery of '''Ce-Iabelled 10 I' latex microspberes (2 ce, 6 atm) into atherosclerotic 
rabbit femoral arteries followinll angioplasty. Delivery was accomplished by 
catheters witb porous balloons alone (PS, n-Il) or porous balloons support•
ed by a mechanical infrastructure (PS/MI, n-7) a1lowinll for differentiation 
of inflation and infusion. Initial delivery into the vascular wall, perivascular 
tissue, tissue distal to the infusion site, and systemic cin:ulation were evalu•
ated, as was the retention of microparticles at each site. Both PS and PS/MI 
resulted in localization of a majority of particles in the vascular and perivascu•
lar tissue near the infusion site, witb PS yielding 85.5.±.I1.S% (range 75-
100%) and PS/MI yielding 99.9.±.0.38% (range 99-100%) in tbat region 
(p < 0.005). The remainder of particles were present in tissues distal to the 
infusion site. There was no evidence of radiographic dissection in lilly animal. 
Virtually all particles (>99%) were retained locally for the 7 day period. 
Particles in tbe arterial wall (neointima + media) and perivascular tissue 
(adventitia) were separately quantitated following necropsy; this revealed 
0.09.±.0.04% (PS) or 0.13.±.0.04% (PS/MI) to be present witbin tbe wall, 
with the majority located in the immediate perivascular space. Repeat scintig•
raphy after 7 days demonstrated persistence of > 95 % of initial radioactivity 
in the rellion of delivery. In conclusion, local delivery utilizinll a porous 
balloon modified by a mechanical infrastructure results in enhanced, predict•
able localization and decreased downstreaming of microparticles; with a 
substantial fraction found in the perivascular tissue both in,tially and after I 
week. Delivery of active biodegradable microparticles by the modified 
porous balloon catheter is a promisinll approach to local therapy of the vascu•




Transforming Growth Factor·8 Mediates Extracellular 
Matrix Accumulation in Experimental Atherosclerosis 
Ronald D. Jenkins, Elizabeth O. Palmer, John E. Lassetter, Nancy A. 
Noble, and Wayne A. Border. University of Utah School of Medicine, 
Salt Lake City, Utah. 
To demonstrate the acute and Iong·term role of transforming 
growth factor-B (TGF-B) in the mediation of extracellular matrix 
production in a hypercholesterolemic balloon-injured animal 
model, we evaluated the appearance and distribution of TGF-B and 
fibronectin-EDA (extra domain-A, a matrix protein preferentially 
induced by TGF-B) in rabbit aorta following balloon endothelial 
denudation. Rabbits on a hypercholesterolemic diet (mean serum 
cholesterol 1289 mg/dl) underwent Fogarty balloon injury to the 
distal aorta. Angiographic, in-vivo intravascular ultrasound 
(IVUS) and histologic study was done at .5, I, 2, 3, 6, 8, 12, and 
24 weeks on one control and two injured sites in each of two 
animals for each follow-up time. Peroxidase stains were done for 
TGF-B and fibronectin-EDA using mouse monoclonal antibodies. 
TGF·B protein was evident at 7 days in the media immediately 
below the internal elastic lamina, and in the developing neointima. 
Maximal intensity of TGF-B staining in the neointima was evident 
between two and three weeks, but dropped off markedly beween 12 
and 24 weeks. Neointimal thickness peaked at 308 ~ at 8 weeks 
when the high cholesterol diet was discontinued. The appearance 
and distribution of fibronectin-EDA paralleled that of TGF-B with 
trace activity at 3 days, mild activity at 7 days and peak staining 
intensity between 3 and 6 weeks. Staining for fibronectin-EDA 
diminished markedly between 12 and 24 weeks. These data are 
consistent with a central role for TGF-B in the mediation of matrix 
accumulation following vascular injury in the presence of 
hypercholesterolemia. 
889·29 
Qumtitatioo of Ozidativa Produat rOlWStioo by 
Rautrophila After PICA. 
Antonino llazzone, Stefano de Servi, Federica llarsieo, 
Iolanda "azzuochelli, Giovanni Ricevuti, Davide 
Paaotti, Giuseppe Specchia. IRCCS S.lIatteo Hospital, 
Pavia, Italy 
Activated neutrophils (PllNs) my generate 02 radicals, 
like hydroqen peroxide (8202), IIhich haw dit'ect 
cytotozic effect and IIIIIY destroy endothelial calls. 
I ntt'acellular oxidation of nonfluorescent 
dichlot'ofluoreacain diacetate to highly fluorescent 
dichlorofluoreacein providee a quantitativa assay of 
8202 fot'lllStion by activated PIINs. T .. nty pts undat'llent 
successful PTCA for single ves .. l disease: 10 had 
unstable angina (OA) defined as Braunwald Class II-IIIB 
and 10 pts had stable exertional angina (SA). 
Bepat'inized blood samples .. re taken ft'om a periphat'al 
vein before PTCA, immediately post-PTCA, 4 hoUt's and 24 
hoUt's thereafter. Results at'e exPt'esaed as mean channel 
fluorescenes: *= p<O. 05 va pre-PTCA 
pre-PTCA post-PTCA 4 h 24 h 
OA <10 pt.) 4Ot9 28t7 * 23t4* 46tl1 
SA <10 pts) 38t7 44t8 37t5 43t6 
A lo .. r generation by PI'INs of 8202 occUt'red 
immediately after PTCA and 4 hoUt's thereafter only in 
pts 8ith OA, suggesting that PI'INs had been activated, 
releasing 8202, during the procedure. Sines 02 t'adicals 
genet'ation is implicated in the pathogenesis of 
restenosis, this finding my exPlain the higher 
restenosis rate ob .. 1:'V8d in pts 8ith OA. 
889·30 
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Direct Gene Transfer into the Coronary Arteries of Intad 
Animals via Infusion Balloon Catheters: Comparison of 
Canine and Porcine Model Systems 
Wojciech Mazur. Mir-Nadir Ali. James P. Finnigan. Daryl G. Schulz. Douglas 
M. Cromeens. George P. Rodgers. Robert Roberts. Albert E. Raizner. Brent A. 
French. Baylor CoDege of Medicine. Houston. TX 
The problem of resrenosis following coronary angioplasty may be amenable to 
treatment by somatic ceO gene therapy provided that effICient and reliable methods 
of gene transfer can be developed. We therefore assessed the ability of a perforated 
balloon delivery system (WOlinsky Infusion Catheter [WIC). USCI. Billerica. 
MA) to deliver luciferase reporter genes to the coronary arteries of two popular 
large animal models. Direct gene transfer has been reported in canine coronary 
arteries using similar percutaneous porous baUoon catheters. but the superiority of 
porcine models of restenosis led us to compare gene transfer efficiencies in the dog 
versus the pig. In addition. we sought to investigate the effects of delivery 
volume and pressure upon transfection effiCiency in vivo. In our study. 50 Ilg of 
reporter vector DNA (pRSVL) was complexed with ISO Ilg of Lipofectin (BRL) 
and diluted to either 4 or 8 mls with Opti-MEM I (BRL). Under fluoroscopy. 
these volumes were infused into the RCA. LAD. and LCX arteries of 4 Hanford 
miniature swine and 4 mongrel dogs using oversized WICs (balloon/artery ratio of 
I.I to 1.3) and pressures of either 4 or 8 atm. Levels of reporter gene activity 
were determined 3 days following catheterization uSlDg a Monolight 2010 
luminometer (Analytical Luminescence Laboratory. San Diego. CAl calibrated 
with certified luciferase standards. Luciferase activity corresponding to ;a 6 
femtograms (fg) protein was detected in 22 of 24 arteries (92%) with a mean of 
275 fg luciferase recovered per infused artery. The results of varying the DNA 
concentrations and balloon pressures in the two species are shown below. where 





55 ± 78 
4m!l8atm 
311 ± 460 
648± 1173 
Thus. the transfection efficiencies obtained in porcine coronaries were similar to 
those obtained in canine coronaries. and higher levels of gene expression were 
obtained in both species when low volume/high pressure (4ml/8atm) delivery 
conditions were substituted for high volume/low pressure (8mV4atm) conditions. 
889·31 
The Efficiency of Lipofectin-Mediated Gene Transfer into Porcine 
and Human Coronary Smooth Muscle Cells is Dramatically 
Improved by the InnuenZ8 Virus Hemagglntinin Antigen 
Wojciech Mazur. James P. Finnigan. Robert Roberts. Albert E. Raimer, Brent A. 
French. Baylor College of Medicine. Houston. TX 
Our laboratory and others have quantitated the expression of luciferase reporter 
genes following Lipofectin-mediated gene transfer into the coronary arteries of 
intact animals via infusion balloon catheters. Unfortunately. the picogram levels 
of recombinant gene product which can be obtained by these methods fall far short 
of attaining physiological Significance. Limited gene transfer effiCiency is thus a 
major obstacle in the development of somatic cell gene therapies directed against 
restenosis. We have therefore examined the effect of the influenza virus 
hemagglutinin antigen (HA) upon the efficiency of Lipofectin-mediated gene 
transfer using cultured porcine and human coronary smooth muscle ceDs (SMCs) 
as in vitro models. We hypothesized that the fusogenic properties of HA should 
enable plasmid·based expression vectors to escape from the lysosomal pathway 
and thus increase the frequency of nuclear uptake and expression. Coronary SMCs 
obtained from explanted porcine and human hearts were cultured in DMEM with 
10% FBS. Transfections were performed during the 1st or 2nd passage utilizing 
1.67 Ilg of luciferase reporter vector (PRSVL) and 5 Ilg of Lipofectin (BRL. 
Gaithersburg. MIl) per 35mm culture dish. Purified HA (in the amounts indicated 
below) was added to the Lipofectin-DNA complexes and the SMCs were treated 
for 24 hrs in Opti-MEM I (BRL). The Iipofection media was then replaced with 
DMEM/FBS and the cells cultured an additional 2 days until harvest. Levels of 
reporter gene activity were determined on a Monolight2010 luminorneter (ALL. 
San Diego. CAl calibrated with certified luciferase standards. The picograms of 
active luciferase recovered per plate (pg Luc) are reported below with the standard 
deviation (SO). the number of plates (n). and the effICiency of transfection relative 
to parallel transfections performed with no HA (Rei Eff). 
I---Pm:ine SMCs---l ~--Hurnan SMCs----I 
Maa.lIA.. n 01 Luc (SOl Rel.Efi n 01 Luc (SOl Rd.aC[ 
No HA: 4 2.24 (1.31) 1.0 4 0.011 (0.015) I 
400 ng: 4 11.01 (3.07) 4.9 3 1.400 (0.038) 127 
600 ng: 4 20.34 (2.82) 9.1 2 6.942 (0.066) 631 
800 ng: 4 10.15 (3.0S) 4.5 4 0.314 (0.299) 29 
Thus the efficiency of Iipofection into porcine and human coronary SMCs can be 
significantly increased by the addition of HA. although some cytotoxicity was 
observed aI 800 ng/plate. Additional studies will be required to determine if HA 
can also increase the efftciency of Lipofectin·mediated direct gene transfer in vivo. 
JACC Vol. 21, No.2 
February 1993:187A 
889-32 
Immunhistochemical localization of bFGF in ArterIo•
sclerotic Intimal Tissue Specimens Obtained by Directional 
Atherectomy 
Peter Gonschiorl , Andreas Nerlich2, Susanne Dreher2, Inngard 
Wiest2, Brigitte Mackl, Erwin Schleicher3, Berthold Hollingl 
lMed. Dept. I, Klinikum GorBhadem; 2Inst. for Pathology, Univ. of 
Munich; 3 Inst. for Diabetes Research, Munich; FRG 
The basic fibroblast growth factor (bFGF) is one of the most potent 
growth factors for mesenchymal cells. Its role in arteriosclerotic intimal 
cell proliferation has already been a matter of discussion, although the 
results are inconsistent until now. 
We analyzed the immunohistochemical distribution of bFGF using a 
polyclonal antibody (Oncogene Sci.) and the avidin-biotin method on 
15 formalin fixed and paraffin-embedded intimal tissue specimen 
obtained by directional atherectomy. The specifity of the immuno•
staining had been tested using various normal tissues and negative 
controls. 
The intimal tissue areas were divided up into highly cellular (hc) and 
low cellular (lc) fields. In hc areas we observed an extensive positive, 
cell associated bFGF labelling of the proliferating intimal cells 
comprising almost all cells present. In contrast, in Ie areas only very 
few cells demonstrated a positive staining for bFGF. As internal 
control. the staining for bFGF bound to the subendothelial basement 
membrane was equally well pressent in both conditions. 
Our results thus provide evidence for the presence of enhanced amounts 
of bFGF in highly cellular, proliferating intimal tissue areas, thus 
emphasizing the importance of bFGF in the pathogenesis of restenotic 
intimal thickening. 
Supported by Sander Stiftung 90.026.2 and Deutsche Forschung 
Gemeinschaft 107611-2) 
889-33 
Differential Expression of Nonmuscle Myosin lIB 
mRNA In Atherosclerosis: Use of Quantitative PCR 
to analyze Gene Expression In Speclmens Obtained by 
Directional A therectomy. 
Lawrence Weir Dongfen Chen, I.Geoffrey Pickering, Kenneth 
Rosenfield, Douglas Losordo, Christopher White, Richard 
Stack, Ieffrey M. Isner. Tufts University School of Medicine, 
St Elizabeth's Hospital, Boston MA 
Previous attempts to measure differential mRNA expression in 
small tissue samples obtained by atherectomy have generally been 
limited to in situ hybridization. The usually small yield of RNA 
from these samples precludes the use of Northern blots or 
nuclease analysis on a regular basis. Observations using in situ 
hybridization have indicated the involvement of nonmuscle 
myosin in the development of atherosclerosis and restenosis after 
balloon angioplasty In order to obtain more quantitative data 
concerning this hypothesis we have used the polymerase chain 
reaction (PeR). We have isolated RNA from a total of 25 patients 
undergoing percutaneous atherectomy (16 primary lesions and 9 
restenosis lesions, including peripheral and coronary) and have 
used PeR to detect messenger RNA for nonmuscle myosin 
heavy chain lIB (NMMHC-IIB). In each case 0.5 Ilg of RNA 
was reverse transcribed and 1120 of the resultant cDNA subjected 
to PeR using specific primers in the presence of 32P-labelled 
dCTP. PCR products were separated on agarose gels and 
quantified by autoradiography and densitometry. RNA was 
demonstrated to be undegraded by PeR for cytoplasmic and 
smooth muscle actin. Content of mRNA for NMMHC-IIB 
(expressed as molecules x 106 per 0.51lg) was as follows: 
Primary - 0.015 to 37.8, mean 7.274 ±2.477 (SEM) ; Restenotic 
- 0.20 to 22.76, mean 10.222 ±3.102 (SEM). High content of 
NMMHC-IIB in primary lesions appeared to correlate with the 
degree of cellularity of the lesion as observed microscopically. 
The wide range of NMMHC-IIB expression both in primary and 
restenotic lesions may reflect important differences in 
fundamental growth properties. 
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889-59 
Immunohistologic Human Macrophage Typing 10 Biopsies from 
Directional Coronary Atherectomy 
Peter Gonscbior, Andreas Nerlich2, Brigitte Mack. Irmgard Wiest2• Berthold 
Htifling 
Moo. Dept I. K1inikum GroShadem, 2 lost. of Pathology. Univ. of Munich 
Invasion of macrophages and proliferation of smooth muscle cells might be 
important factors 10 tha development of arteriosclerosis. New monoclonal 
antibodies enable characterization of macrophages with various markers 
characteristic for acute (ai), intermediate (iml). late (Ii) and chronic 
inflammatory processes (ci) in arteriosclerotic tissue. Therefore, histochemical 
analysiS with monoclonal anti-bodies BMA27IEIO (ai); BMA 311 (imi); BMA 
25F9 (Ii) and BMA 16/1 (ci) were performed using cryosectioos (24j.un) of 
biopsies obtained by directional atherectomy (26 samples from 17 patients). 
Analysis included 44 primary lesions (PL) and 12 restenosis (RS). Digital 
bistomorphometry was used for quantification (mean±S.D.). The lesiOns 
consisted quantitatively of 84% intima and 16% media. 32% of the intimal 
area was comprised of low cellularity and 68% of high cellularity and foam•
cells. In the intima 52% of the cells were detected as macrophages. 96% of 
these cells also showed fibroblastic characteristics with the expression of 
prolylhydroxylase. While 40% of cells positive for macrophage marker also 
expressed (X-SMC actin, typical foam cells were negative for (X-actin. 
Marker RS-he RS-Ic Pl.-he Pl.-Ic 
BMA271EiO 10% 0% 1.7% 0.4% 
BMA3II 7.6% 0% 27% 12.4% 
BMA25F9 13.7% 100% 83% 4.4% 
BMA 1611 1% 0% 35% 4% 
he: high cellular; Ic: low cellular; % expressed per total macrophages 
In human arteriosclerotic lesions a transformation of cells from monocytic and 
myofibroblastic origin to cells with macrophage marker can be found. 
Furthermore, chronic and intermediate inflammatory processes playa key role 
in progressive arteriosclerosis. Ongoing inflammatory processes seem to 
enhance development of arteriosclerosis and imply the potential benefits of an 
antiinflammatory therapy. (supported by Sander Stiftung 90.026.2 and 
Deutsche Forschung GemeiDSChaft 107611-2) 
889-60 
Severe Congenital Platelet Adhesion and Aggregation Defects 
(6-8torage Pool Diseasel Modestly Reduce Neointimal 
Thickness After Coronary Injury In a Porcine Restanosls Model 
Roben S. Schwanz. William D. Edwards, EJW Bowie. William L. Nichols. 
A/lan R. Cumrw, Michael A. Jorgenson. David R. Holmes Jr. 
Mayo Oink' and FOllndaJion. Rochester, MN 55905 
Platelet adhesion and aggregation after coronary artery injury 
may playa major role in restenosis. To test the role of adhesion and 
aggregation on ncointimal formation, pigs with congenital &.Storage 
Pool Disease (o-SPD) were studied. Patients and pigs with this 
condition manifest abnormalities of dense granule ADP and serotonin 
secretion, causing severe, platelet-induced clinical bleeding 
syndromes. 
The effects of &'SPD on neointimal thickness following 
severely oversized coronary stent injury were studied in 12 pigs (26 
lesions) with &'SPD, and in 9 normal control (C) pigs (21 lesions). 
Animals were sacriticed at 28 days. Mean neointimal thicknesses 
(N!) for each lesion were microscopically measured, and controlled 
for mean arterial inj lIry. Linear regression modelling compared the 
injury-thickness relations for control vs. &'SPD pigs as shown. Mean 
neointimal thickJlt'sses were. 71 ± .4mm and .47 ±.2 mm respectively. 
Conclusion: Despite marked 
defects of platelet adhesion and 
aggregation, neointimal 
thickness was reduced only 
modestly in the o-SPD pigs. 
Potent inhibition of platelet 
aggregation may not completely 
solve to the restenosis problem. 
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889·61 
Method or Application or Local High Dose Heparin During Balloon 
Angloplasty 
Mohammad U. Sheriff. Vikram Khetpal. J. Richard Spears. 
Wayne State University School of Medicine. Detroit. MI. 
Local application of heparin by transfer of a film of the drug from 
the balloon surface to the luminal surface allows use of a maximum 
heparin concentration without risk of barotrauma. However. 
premature loss of heparin needs to be prevented and the transfer 
efficiency needs to be defined. Accordingly. we studied. ill vitro. the 
effect of the use of either a hydrogel coating or a sheath on the 
washout rate of heparin from angioplasty balloons. Tritium labeled 
heparin (3000 U at 120.000 U/cc) was air-dried on the surface of the 
deflated balloons (either with or without a Mansfield hydrogel coating 
or protected within a sheath) which were then subjected to a 
continuous flow of fresh normal saline at 6Occ/min in a 3 mm lumen. 
and radioactivity was measured in the washout every 10 sec. for 5 
min. ~ Without the use of a sheath. the residual % heparin 
remaining on the balloon surface was < 1 % after I min .• although 
use of a 100 .•.•••.•.•••.•.•••.•••••.•.•••••.•••.• 
hydrogel \, "-lIIIlloonwtthlnShMth 
coating delayed 110 
~~_30ass~~~~:l. 10 \ -- :ra:::'::'-::lo>lcIod) 
In contrast. with J; 40 . \:--.-- Hydtogollllllioon 
the use of a! \, ~" 
sheath. the loss .,. 1 20 "s" 
of heparin was l a 's .. 
only 3 % at S a 20 40 10 30CI 
minutes. The ill Tlmo I-I 
vitro transfer 
of heperin from the balloon surface to the injured porcine aorta ( 6 -
8%) was independent of both balloon type and temperature (2S°C. 
90°C) used during application. 
Conclusion: Application of local heparin therapy by transfer of a 
heparin film mounted on the balloon surface requires use of a 
protective sheath to prevent premature drug dissolution. 
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890·6 
T~eal EcbocardiOlll'llPhy (TEE) Predicts RIght Ventricular (RV) 
Dysfuactioa FoUowiDa Implantation or the Left Ventricular Assist Device 
(LVAD) • 
Robert M. Savo .... Jamee D. Thomas. Carol I. Duffy. William J. Stewart. Allan 
L. Klein. EtDeIIo E. Salcedo. Kareo B. Jamee. Normall J. Starr. Thomas Higgins. 
Patrick M. McCarthy and the LVAD STUDY GROUP. Cleveland Clinic 
FoundatiOll. Cleveland Ohio 
DetermiDaliOll of lOYere ript ventricular dysfuDction is • oecessity following 
LV AD implaotatioa to _ the oeod for biventricular mechanical support. To 
allow the immediate evaluatiOIl of RV function. we have used intraoperative TEE 
to guide tho iaertiOIl of the LV AD which coosists of • pneumatically driven 
pulsatile pump with an LV apical cannula for blood drainage and an ascending 
aortic graft for blood return. Those devices were implanted in 5 males (ase 49~ I) 
with either end slap dilated (2) or ischemic (3) cardiomyopathies who bad ript 
ventricular ejectiOIl frac:tiOIl (REF) catheters. intraoperative TEes with RV 
Acoustic Quantification (RVAQ). and Doppler RV dp/dt based 00 meosurement of 
the tricuspid regursillDt jet. RESULTS: After LV AD implaotatioo. TEE 
demoostrated an improvement in RVAQ frac:tiooaI area shortening from 28.1" 
.±. 8.a to 40.1" .±. 5.2" (p .!i,0.OO1). The RVAQ diastolic area decreased by 
16.0". and right atrial area decreased by 26.6". Pre and post implantatioo 
RVAQF correlated well with the REF (r =0.89) . Ooe patient bad acute RV 
failure despite an increased REF because of 3 + TR detected by TEE. This patient 
further illustrates tho ability of the TEE RVAQ to DOl only detect RV failure, but 
to define its etiology in the settioll of an improved REF. Severe RV dysfunctioo 
was detected preoperalively in two patients as indicated by " RVAQ area 
change/diastolic area (D AI~iast> of 15.6 and 26.2. Those values corresponded 
respectively to a RVEF of'" and I'" • a Doppler dP/dt of 235 and 423 mm 
HI/sec. and. traospuImooary gradient (Mean PA - LA pressure) of 35 and 21 mm 
Hg. Both patieo,. respooded to RV inotropic support and afterload reduction with 
amrioooo. isuprel. andlor prostsglaodin derivatives with increased RVEF. 
RVAQF. and decreased TR postoperatively. These patients have undergone 
succ:essful orthotopic heart transplantation without the oeed for right ventricular 
mechanical support. CONCLUSIONS: I)TEE cao quantify RV function pre and 
post LV AD implantatioo. 2)TEE is critical in defiDiol the etiology of RV 
dysfuDction after LV AD iosertiOIl. 
890·7 
JACe Vol. 21. No.2 
February 1993:188A 
Exercise Training with an Implantable Ventricular Assist 
Device 
Fredric Pashkow. Charles Walters. Gordon Blackburn. 
Patrick McCarthy. 
The Cleveland Clinic Foundation. Cleveland. OhIo 
Patients waiting lor heart transplant (Tx) on lnotropes and/or Intraaortlc 
baloon pump become severa/y decondItIoned. An inplantable lett ventrfc· 
u1ar assist device (LVAD, HeartMateTl') now exists that adjusts and contin•
uously displays heart (pump) rate (PA) and now (cerdlac outpuI). We 
undertook a physical activity program In lour consecutive patients racelvlng 
the LV AD. Our experience with these patients is summarized In the table. 
1.t SeuIon PA Flow APE Distance Speed 



























Mean change 35.5 2.75 
SD:I: 9.1 6.40 































Most patients showed an Increase In PA and now lrom I8SIto exercise. 
Changes in peroelved exertion (APE), speed and distance suggest exer•
cise improvement. Patient 112 was transplanted only 13 days alter the Initial 
session accounting lor the tower performance. fVs, IItIIe as 14 sessions may 
rasu/t in reconditioning. 
Conclusion: Moderate intensity aerobic activity is a practical additional ther•
apy that can be performed in LV AD patients without exerdse complica•
tiON. Exerdse training provtdes an opportunity to obseMi exerdse capa•
bility in L VAD supported patients and may allow reconditioning belora Tx. 
890·8 
Rehabilitative Potential of Ch~onic Mechanical 
Ci~culatory Support: Bffect 00 Po.t-T~an.plant 
Boapitaliaation Tiae 
stephen Winowich, Robert L. Kormo., Carla J. Capretta, 
John M. P~i.ta., Sriniva. Murali, Barry P. Uretsky, 
Bartley P. Griffith. University of Pittsburgh 
Artificial Heart Program, Pittsburgh, PA. 
UNOS status I patients awaiting cardiac transplantation 
(CTX) are prone to deconditioning, malnutrition, and 
subtle end-organ damage as the donor waiting period 
increases. The efficacy of short-term mechanical circu•
latory support (MCS) in providing acute salvage of a 
deteriorating CTX candidate is well accepted while the 
benefits of long-term support have yet to be appreciat•
ed. Fifteen left ventricular assist device (LVAD) re•
cipients were supported for> 2 weeks (range 15-226 
days) and 3 were discharged to an outpatient facility 
for 5-131 days. All were discharged following CTX with 
a one year survival of 90\. Patients were grouped ac•
cording to level of participation in a cardiac reha•
bilitation (CR) program after LVAD implant. Grp 1(N-5), 
no active partiCipation, Grp 2(N-4), low intensity CR, 
Grp 3(N-6), rigorous CR. Pre-transplant factors and 
time to hospital discharge following CTX are shown 
below 
Group 1 Group 2 Group 3 
Pre-CTX 
BUN/BUDcr 
11.8/0.8/0.6 18.3/0.6/0.9 16.5/0.6/1.1 
Pre-CTX 0, Not Appll.- 11.8 14.3 
Con9um~tion cable (ml/min/kg) (ml/min/kg) 
Implant Du- 31.8 Days 96.8 Days 147.0 Days 
ration 
Time To o is- 58.4 Days 42.0 Days 28.7 Days 
charge 
Extended pe riods of MCS allows CTX candidates to recov 
er from the effecta of chronic heart failure and im•
plant surgery and to participate more actively in CR 
allowing for earlier discharge from hospital after 
subsequent CTX. 
JACC Vol. 21, No.2 
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890·9 
Is Intra-aortic Balloon Pumpinq More Bffective 
in Cardioqenic Shock due to Isch .. ic 
cardioayopathy Than Idiopathic cardioayopathy? 
Alan M. Rosenbaum, Srinivas Murali, Barry F. 
Uretsky, University of Pittsburgh, PA. 
The mechanisms for efficacy of intra-aortic 
balloon (lAB) pumping in ischemic 
cardiomyopathy (ISCM) and idiopathic 
cardiomyopathy (IDCM) may be different. To 
determine if lAB is more effective in 
cardiogenic shock due to ISCM, we compared the 
effects of lAB on hemodynamics, renal, and 
hepatic function and clinical outcome in 26 
IDCM and 16 ISCM NYHA Class IV pts awaiting 
transplantation (TX). Data prior to lAB were 
comparable in the 2 groups. Percent change in 
data after lAB insertion (obtained just prior 
to termination of lAB) are shown. 
Mean systemic pressure 
Mean pulmonary pressure 
Pulmonary wedge pressure 
Cardiac index 
Urine volume 


















AST - serum aspartate aminotransferase. 
Vascular complications (19% IDCM, 19% ISCM) 









Death or need for additional mechanical 
support occurred in 38%(10/26) of IDCM and 44% 
(7/16) of ISCM pts. Conclusion: lAB produces 
comparable salutary effects with similar 
clinical outcome in both IDCM and ISCM pts 
awaiting TX. 
890·10 
Use or Gradual Exercise Protocol Demonstrates Improved 
Exercise Capacity After Heart Transplant. 
Maria Teresa Olivari, Clyde W. Yancy, Randall 1.. Rosenblatt, 
W. Steves Ring. University of Texas Southwestern and St. Paul 
Medical Center, Dallas, Texas. 
Exercise tolerance (ExT) has been shown to improve but not 
normalize after heart transplant (HT) due to reduced max heart 
rate (HR) and stroke volume(SV). We hypothesized that reduced 
ExT may be due to use of Ex protocols that do not allow time for 
appropriate increase in HR and oxygen consumption (V02) at 
each workload. To test this hypothesis, 11 patients (age 55 ± 10, 
15 ± 9 months post HT) underwent cardiopulmonary stress 
testing using both standard Naughton (protocol A) and 
individualized NaUghton (B), in which workload was changed only 
when steady V02 and HR were achieved. Results: mean ± SO. 
A B 
Exercise duration, sec 714 + 161 1082 + 355* 
Time to AT, sec. 522 +" 152 928 +-4390 
Peak HR, b/min 133 ± 18 (77) 138 ± 16 (SO) 0 
Peak V02, mI/kg/min 22 ± 4 (74) 23 ± 5 (77) 
RQ at peak 1.08 ± .13 1.02 ± .09 
Peak 02 pulse, mI/b 14.4 ± 3.9 (92) 14.1 ± 3.8 (90) 
Peak VE, Vmin 79 ± 25 (83) 80 ± 29 (84) 
V02 at AT, mI/kg/min 18 + 6 22 + 40 
Workload/V02 9.1 ±. 3.3 12.4 ± 6.2 0 
AT ... anaerobic threshold, RQ = VC02/V02, VE = ventilation; 
value in ( ) = % of max predicted value; *p< 0.01, 0p< 0.05. 
These data show increased ExT, normal peak SV, increased 
anaerobic threshold in spite of reduced max HR post HT when 
gradual protocols are used and suggest that alternative exercise 
protocols should be used in testing ExT post HT. 
ABSTRACfS 
890·11 
Donor And Recipient Atrial Synchronization Improves The 
Hemodynamic Prolile After Heart Transplantation 
James McClur1<en, Barbara Todd, Terry Sullivan, Ileana Plna, Alfred Bove, 
Valluvan Jeevanandam. Temple University, Philadelphia, PA 
Atrio-ventricular synchrony has been shown to be an Important compo•
nent in maintaining cardiac output at a given state of lnotropy. particularly at 
heart rates of 60-100 beats par minute. AHhough the AV node in trans•
planted hearts Is normal allowing for A V synchrony between the donor 
atrium and ventricle, the donor and recipient atria are not synchronized. 
Therefore the contribution of the hypertrophied and enlarged recipient 
atrium to atrial systole Is lost In patients undergoing orthotopic heart 
transplantation who are in sinus rhythm preoperatively. This project Is 
designed to investigate the effects of recipient and donor atrial 
synchronization on hemodynamics at a fixed heart rate and stable level of 
inotropy. 
Six heart transplant recipients who were In sinus rhythm preoperatively 
had bipolar temporary electrodes placed on the native and donor right atria 
and on the right ventricle during transplantation. Hemodynamics were 
measured between 2 to 3 days after transplant when the patients were on 
less than 2.6 jJgIkglmln dopamine (for renal perfusion) and had intrinsic 
heart rates of less than 100 beats per minute (bpm). Patients were paced 
aHematlvely (100 bpm) with the donor atrium only (mode 1) or with both 
native and donor atria in synchrony (mode 2). 10 minutes was allowed 
between mode adjustments for hemodynamic stabilization. 
Patients studied: N=7, male, no previous heart surgery, native atrium in 
sinus rhythm, standard orthotopic heart transplanation technique. Mode 1: 
blood pressure (BP) systolic 128%22 mmHg, BP diastOliC 78:7 mmHg, 
central venous (CVP) 13:05 mmHg, pulmonary artery systolic (PAS) 33:7 
mmHg, pulmonary artery diastolic (PAD) 13:05 mmHg, pulmonary capillary 
wedge (PCWP) 12:3 mmHg, cardiac Index (CI) 3.2:10.5 Uminlm2. Mode 2: 
BPsystolic 130:t20, BP diastOliC 84:5, CVP 8%2 " PAS 34:6, PAD 1Ii:t4, 
PCWP 16:4 " CI 4.0:10.5 •.• Statistically significant difference at p<O.05 
between mode 1 and mode 2. 
Synchronized atrial pacing Increases myocardial performance by 
augmenting ventricular filling through the use of the native atria. This Is 
reflected by a lower CVP, a higher PCWP and increase in CI of 200/ •. This 
mode of pacing might be beneficial in pateints with: decreased Immediate 
donor heart function, right sided failure or with undersized donor organs. 
890·12 
189A 
Influence of the Gap Junction Protein Connexln 43 over 
Arrhythmias after Heart Transplantation. 
Johannes Mueller, Rolf Dermietzel, Andreas Hofer, Manfred 
Hummel, Susanne Hempel, Tatjana Cohnert, Martin Fuhl, Ro•
land Hetzer. German Heart Institute, Berlin, Germany. 
Rejection after heart transplantation leads to different electrophy· 
siological disorders, but very frequently to arrhythmias. The aim 
of this study was to find out whether connexin 43, the cardiac 
gap junction protein, has an importance for the generation of 
arrhythmias. Western blot analysis of 19 endomyocardial biopsy 
specimens of 18 heart transplanted patients was performed in 
order to investigate the expression of connexin 43. The investi· 
gator was not aware of the clinical presence of arrhythmias. 
Reduced connexin 43 levels were found in 6 biopsy specimens 
from 6 patients, who had at least mild rejection (3/6 mild, 3/6 
moderate). Only these 6 patients had clinically evident arrhyth•
mias. The data also revealed that all 13 remaining biopsy speci· 
mens with a normal connexin 43 level were from 12 patients wit•
hout arrhythmias although 8 of these 12 patients showed histo•
logical rejection (6/12 mild, 2/12 moderate). All patients with 
arrhythmias had a reduction of connexin 43 levels of varying 
grades in their corresponding endomyocardial biopsies. Obvio•
usly rejection does not only affect the known compartments as 
intracellular space and membrane function but also connexin 43 
levels. It seems that there is no correlation between the histolo•
gical grade of rejection and reduction in connexin 43. Thus it 
must be presumed that antibody-mediated rejection, which 
cannot be diagnozed histologically, may diminish connexin 43 
levels. This phenomenon may explain the occurrence of arrhyth•
mias even during mild rejection after heart transplantation. 
190A ABSTRACTS 
890·13 
Nucleoside Transport Inhibitor Protects the Cardiac Explant 
During Hypothermic Storage via Adenosine Al·receptors 
Xiaoping Yang, Qingyan 2'1tu, Melinda. A. Claydon, George. L. Hicks, 
Ir., and Tingchung Wang, Department of Surgery, University of 
Rochester, Rochester, NY 
It has been postulated that loss of adenine nucleosides during ischemia 
affects the regeneration of adenine nucleotides and limits the recovery of 
function during reperfusion. In this study, we test the hypothesis that 
inhibition of nucleoside transport during long·term hypothermic cardiac 
storage preserves myocardial adenosine (ADO), which can react with 
ADO receptors or replete A TP, thus protects heart function and viability. 
Isolated rat hearts (n = 5/group) were flushed with a cardioplegic 
solution containing 0, 0.01, 0.2, 0.5, 2, 5, 10, 50, and 100 nM S-(p•
nitrobenzyl)-6-thioinosine (NBMPR), an nucleoside transport inhibitor, 
and stored at O"C for 9 hours. Recovery of function was assessed by 
working reperfusion. Function of the unstored hearts (n = 14, 
means±SE) including heart rate (HR, 297±11 beats/min), aortic flow 
(AF, 56.4±1.3 ml/min), coronary flow (CF, 23.0±1.l ml/min), and 
cardiac output (CO=AF-K::F, 79.4±2.1 ml/min) served as controls. HR 
in all groups returned to normal after reperfusion. Recovery of other 
hemodynamic function in untreated hearts was: AF, 56%; CF. 54%; CO. 
55% of the control. NBMPR improved functional recovery in a dose•
dependent manner. The optimal dose was 5 nM. which boosted the 
recovery to AF, 78%; CF, 74%; CO, 77% of control (p < 0.05 vs no•
NBMPR hearts). NBMPR (5 nM) also significantly elevated both end•
storage myocardial ADO content (0.08 vs 0.04 ~moVg dry) and ADP 
levels (10.0 vs 7.3 ~moVg dry) over untreated hearts. Thus by 
inhibiting nucleoside transport during hypothermic storage, NBMPR 
prevented ADO loss, conserved myocardial adenine nucleotides. and 
enhanced cardiac preservation. ADO AI-receptor antagonist, 1.3-
dipropyl-8-cyclopentyl-xanthine (0.1 nM), significantly reduced the 
recovery of the 5 nM NBMPR hearts to AF, 63%; CF. 58%; and CO, 
62% of the control suggesting that the protection by NBMPR may be 
mediated via the stimulation of ADO A I-receptors. 
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891·14 
Outca.e of the Various Indications for Fetal 
Echocardiography 
Michael J. Cooper, Marlene A. Enderlein, Claude L. Rog~ 
Harold Tarnoff. Kaiser Permanente Medical Centers, 
Vallejo and San Francisco, CA 
Indications for fetal echocardiography (FE) include 
conditions which potentially increase the risk for 
congenital heart disease (CHD) in the fetus. We 
evaluated the outcome for each indication in reference 
to the yield of true-positive (T+) studies for CHD as 
well as false-negative (F-) studies. We did 901 FE on 
745 fetuses. Of these, 670 had postnatal confirmation 
for presence or absence of CHD on the basis of cardiac 
consultation, echocardiography, normal physical 
examination for at least the first 2 months of life, or 
by autopsy for aborted fetuses and stillborn infants. 
Indication Number T+ FE % Detected F- FE 
Previous child 
withCHD 173 0.6 5 
Parent with CHD 43 2.3 1 
Maternal exposure 
to teratogen 32 0 0 0 
Diabetic mother 187 2 1.0 5 
Suspect arrhythmia 
on exam or 
obstetric 
ultrasound (OU) ll7 5 4.3 
Abnormal heart 
suspected on OU 16 9 56.0 
Fetal abnormality 
on amniocentesis 
or OU 102 5 4.9 2 
Total 670 23 3.4 15 
The 15 F- FE included 12 small ventricular septal 
defects, 2 patent ductus arteriosus, and 1 small atrial 
septal defect. A prior OU su~gesting CHD gave bt far the highest yield of T+ stud~es on subsequent F • OU is 
a preferred screening tool that ~enerally should be 
employed before the more definit ve FE. 
891·15 
To ee or Not to ee e Ventricular Septal Defect 
lACC Vol. 21, No.2 
February 1993:190A 
Joseph D. Orie, Deborah L. Flotta, Frederick S. Sherman. 
Magee Women's Hospital, University of Pittsburgh, 
Pittsburgh, Pennsylvania 
Spontaneous closure of ventricular septal defects (VSD) 
is well described in infants and is reported to be as 
high as forty-three percent. The natural history of a 
VSD identified ill ~ and its impact on the fetal 
heart has not been well documented in a prospective 
study. From January 1991 to August 1992, 498 patients 
underwent fetal echocardiography at Magee Women's 
Hospital. All patients were referred for being at risk 
for offspring with congenital heart disease. A VSD as 
a single cardiac lesion was detected in 21 fetuses 
(4.2%). VSD's associated with other complex ~ongenital 
abnormalities were excluded. The gestational age at 
diagnosis was 18 to 27 weeks. After detection of the 
VSD, the fetuses were prospectively studied with serial 
sonograms in 4-6 week intervals, and when possible. 
after birth. Spontaneous closure occurred in 15 of the 
21 fetuses (71%). At birth, 6 patients had VSD's. No 
other cardiac abnormalities were detected with the 
exception of a coarctation in one infant. Closure of 
the VSD was confirmed in the remaining 15 patients by 
echocardiogram in 11 and by clinical examination in 4. 
Conclusion: The presence of a simple VSD does not 
contribute to fetal morbidity and mortality. 
Spontaneous closure of isolated fetal VSD's is higher 
than that in infants. Frequent fetal follow up is not 
necessary. Parental anxiety ~an be minimized since the 
closure rate is high. 
891·16 
Asplenla Syndrome: Analysis of Embryology In 519 cases. 
Colin K. Phoon and Catherine A. Neill. Division of Pediatric 
Cardiology, Johns Hopkins Hospital, Baltimore, MD. 
Asplenia syndrome is characterized by complex congenital heart 
defects (CHDs), asplenia, and abdominal heterotaxy. To determine 
the embryological origin of asplenia syndrome, we reviewed 32 
necropsy cases at our hospital and reanalyzed 487 published cases 
for associated congenital defects (cardiac and noncardiac). The 
most common CHDs were atrial septal defects (93%), common 
atrioventricular canals (91%), and conotruncal anomalies (73%). 
After analyzing the stages at which intact structures develop, we 
hypothesized that most defects likely originate at Horizon (H-) XIIl•
XIV; patients averaged 3.0 H-XIII and 1.5 H-XIV CHDs each. Earlier 
and later defects occurred less frequently in a near-Gausslan 
distribution. Extracardiac anomalies also exhibited a developmental 
spectrum. Asplenia, a sine qua non, originates at or before H-XIIl. 
Abnormal lung lobation occurred in 80% of cases, with right 
isomerism most common; pulmonary asymmetry also originates at 
or before H-XIIl. Abdominal heterotaxy occurred in 72% of cases, 
but with extended developmental processes, their origins are 
unclear. Anomalies olthe genitourinary, musculoskeletal, endocrine, 
and nervous systems develop later (typically H-XV to H·XXIII) and 
occur with much less frequency ( < 15%). We conclude that asplenia 
syndrome is a local developmental disturbance in laterality which 
occurs primarily at apprOximately H·XIIl; developmental 
disturbances of later Horizons occur less frequently. 
JACC Vol. 21, No.2 
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891·17 
Na + Pump Demity and the Mitogenic Respome of Immature 
C:-nine Vascular Smooth Muscle Cells in Primary Culture 
Timothy F. Feltes, Charles L. Seidel, Iulius C. Allen. Baylor 
College of Medicine, Houston, TX. 
Variable onset of adult canine vascular smooth muscle cell 
(VSMC) proliferation (coronary artery·CA delayed vs saphenous 
vein·SV, pulmonary artery·PA) is linked to the cycling of cell 
sodium content (Na + i) and number of Na + IK + ATPase (Na + 
pump) si!e5. We ~easured.cell num.ber, Na+i and Na+ pump 
number m enzymatically dispersed Immature « 14 d) canine 
CA·, PA· and ~V·VSMCs and studied them through confluence. 
There was no difference in onset of proliferation in CA·,PA· or 
SV·VSMCs (ANOVA). Na+j peaked by day 1 in culture 
(+29%, p =.22) and returned to baseline levels by day 3. Na+ 
pump number (comparable to adult VSMCs at day 1) increased 
14% (p=.31) by day 6. While qualitatively similar to previously 
reported adult canine data, the increase in Na + and Na + pump 
number were greatly attenuated in the immature canine. Cell 
volume (CV) was measured at day 1 in immature and adult CA·, 
PA· and SV-VSMCs. CV was less in all immature vs adult 
VSMCs but achieved significance only in the CA- (.53 vs 1.79 
pUcell,p < .05). Thus, Na + pump density was greater in the 
Immature vs adult CA-VSMC. 
In summary and in contrast to the adult, immature canine CA·, 
PA- and .SV-VSMCs demonstrate a common mitogenic response 
charactenzed by an attenuated Na + peak and rapid proliferation. 
!his sif!1ilarity may relate to a higher density of Na + pump sites 
m the Immature VSMC. The physiologic significance of the 
maturational reduction in Na + pump density that occurs in the 
CA-VSMC remains to be determined. 
891·18 
THE HEMODYNAMIC EFFECT!i or MATERNAL INDOMETHACIN AND 
A fl-SYMPATHOMlMETlC AGENT ON THE FETUS AND THE 
NEWBORN: A RANDOMIZED STUDY 
Marianne Eroncn, ErIdd Pesonen, Eric lvar WaUgren, Millo Hallman 
Children's Hospital, Universily of Helsinki, Finland 
To study die effect of anlenatal indomethacin (n=46) or nylidrine (n=38) IreabDenl 
on the fetal and neonatal hemodynamics, 84 pregnant women with Ihn:alened 
pn:maturc birth belween 22.9 and 34.0 weeks 'gestation, and 94 of their offspring, 
born at 24.7 10 41.6 weeks of gestation, were studied by Doppler echocardiography. 
Both syslolic and diaslolic velocities in the ductus iocn:ased after administration of 
indomethacin and exceeded the corresponding velocities in the fetuses of nylidrin 
JrOUP (p=(l.OOOI). Ductal CODBlriction occurred in 42 of 49 fetuses treated with 
indomethacin (86%) and in 54 of 69 .rudie. performed during indomethacin 
_ (78%). Incidence of tricuspid valve regurgitation was 22 %. In the nylidrin 
"""" III no time in any fetus was there evidence of ductal constriction or tricuspid 
iosufficieocy A significanl increase in systolic (1'='0.54. p=O.OOOI) .and diastolic 
vdocitics (r=O.46.p=O.OOO!) with advancing gestational age was demonstrated in the 
indomethacin group (Fig.!). A less marked relationship was seen in systolic 
(r=O.3S.p=O.04), but not in diastolic velocities (r=O.02.p=O.93) in the nylidrin group 
(F1 •. 2). Postnatally, in infants bom al or before 35 weeks'gestation incidences of 
.pcataDeoua closun: of ductus or need for indomethacin closure were identical in 
boIh study groupe (p>O.I). However, ductal reopening occWTed more frequendy "'1« indomethacin (17%) than after nvlidrin (0%) administration (p=O.04). _:== .. muw. _ ...... • 'Ylfoucvs,oan . .... :.~~~ ................................. . 
I' 
I-- .... .. 
I" , ..... 
• .. • • • • It '. If • • • • .. 
amATlQNA.L AGI (WUKI) QUTA11CNA&. AGE (WEEKI) 
Coocluailllll: Fetal ductuJ becomes more reactive 10 indomethacin with increasing 
JCIIaIioaalagc. Prenata1 CXJlOlure 10 indaDcth8cin docs not decn:aac the need for 
PPA treabOCnl in premarun: infanta. However, ductal reopeninll may occur in 
JlRIDIIIUrC infanta afl« IOIIIcrDaI ;ndomcthacin treaImaIL 
ABSTRACTS 
891·19 
Sarcoplasmic Reticulum (SR) Blockade has Limited 
Effects on LV Contractility in the Newborn Pig Heart. 
Robert I.M. Klautz. David F. Teitel. Cardiovascular Research 
Institute, University of California, San Francisco. 
Blockade of SR function in the adult heart by ryanodine causes 
profound global depression of systolic LV performance. We 
hypoth~sized that the newborn heart may be less affected by 
ryanodlOe because of SR immaturity. Since intact SR function can 
~st ~ demonstrated by an intact force-frequency relationship. we 
IOv~stIgated ':he ~ffect of ryanodine on baseline contractility and 
dunng stepwise IOcreases 10 heart rate (HR) using relationships 
derived from early systolic (dP/dtmax-end-diastolic volume 
relationship •. or ~EDVR) and late systolic (end-systolic pressure•
volume relatIonshIp. or ESPVR) events. In 8 anesthetized newborn 
piglets. we placed micromanometric and conductance catheters in the 
LV, a balloon occlusion catheter into the upper inferior vena cava 
(IVC) and a pacing catheter into the right atrium by percutaneous 
techniques. We generated PV loops during IYC occlusion at control 
heart rates and at 4-5 stepwise increases generated by atrial pacing. 
We repeated the measurements after ryanodine, 10 J.lg!kg. which 
acutely decreased dP/dtmax to 37% of baseline. For our indices of 
contractility. we calculated the slopes of the dPEDVR and ESPVR 
from the PV loops obtained during IVC occlusion at each hem rate. 
By multiple regression analysis coded for HR effects and animal 
variability, we found that the dPEDVR and ESPVR demonstrated 
both an intact force-frequency relationship at baseline and a marked 
decrease after ryanodine (HR coefficient for dPEDVR decreased from 
2.41±0.21 to 0.64±0.08 mrnHg'sec-1'ml-I'beat-1; for ESPVR it 
decreased from 0.55±0.01 to 0.30±0.02 mmHg.ml-1·beat- I). 
However, whereas ryanodine markedly decreased the control slope of 
the dPEDVR (from 165±89 to 38±21 mmHg'sec-1'ml-1) it did not 
change the control slo~ of the ESPVR (l0.4±4.4 at baseline versus 
10.6513.2 mmHg'ml- after ryanodine). Thus. although the rate of 
pressure generation is markedly decreased by SR blockade. elastance 
at end-systole is not. suggesting that SR function is less important to 
global systolic performance in the newborn than in the adult heart 
891·20 
The Effect of Veno-arterial Extracorporeal Membrane 
Oxygenation on the Left Ventricular Systolic Function of 
Swine 
Irving Shen. Fiona H. Levy. Craig R. Vocelka, Hiroji Akimoto, 
Robert Thomas. P. Pearl O'Rourke. and Edward D. Verrier. 
University of Washington. Seattle. WA 
Veno-arterial extracorporea! membrane oxygenation (VA•
ECMO) is an effective modality of pulmonary support for neonates 
with respiratory failure. It is now being used as a means of 
temporary cardiac support for pediatric patients with cardiovascular 
compromise or following the repair of complex congenital cardiac 
defects. Echocardiography has demonstrated a significant and 
prolonged decrease in left ventricular (LV) function during ECMO 
support for neonatal respiratory failure. This dysfunction has been 
attributed to ECMO although the exact cause remains unknown. We 
studied the effect of ECMO on LV systolic function in an animal 
model. Three 7-9 kg anesthetized farm piglets underwent median 
sternotomy and placement of minor axis LV sonomicrometry 
crystals and LV ffi1cromanometer. V A ECMO was then initiated and 
maintained for six hours at an extracorporeal flow rate set at 50% of 
the measured pre-ECMO cardiac output. The preload recruitable 









*Slope is expressed as lIP erg/crrJ3. 







Left ventricular systolic function was not significantly depressed 
d~n.g or after ECMO. We conclude that exposure to an ECMO 
CITCUlt alone does not cause cardiac dysfunction as measured by a 
load insensitive method. 
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892·92 
Serial Quantitative Angiography and Intracoronary Ultrasound: 
Do Angiographic Measurements Match Morphology? 
Fausto S. Pinto, Adrian Chenzbraun. Shao·ZOu Gao, Frederick G. 
SlGoar, TIDl Fiscbell, Edwin L. Alderman, Hannah A. Valantine, John S. 
Schroeder, Richard L. Popp. Div of Cardiovasc Med, Stanford, CA 
Serial quantitative coronary angiography (QCA) has been used as an 
endpoint in clinical trials of atheroma progression/regression. 
Intracoronary ultraSOund (ICUS) provides measurements of both intimal 
thickness and lumen diameter. In order to assess QCA in detection of 
atheroma change, 90 coronaI)' sites in 35 cardiac transplant recipients (2.6 
sites /pt) were studied twice by QCA and ICUS at a I year interval, under 
identical conditions of nitrate administration. lCUS catheter location in 
serial studies was verified by angiographic position in relation to branch 
vessels. Luminal area (LA) and area of lumen plus intima (IL) were 
measured at each site. Mean intimal thickness and an index of intimal 
thickness were calculated (IL-LAJIL). There was no significant correlation 
between the change (~) in mean QCA lumen diameter (- O.16±O.29 mm) 
versus ~ in ICUS mean intimal thickness (0.03±O.14 mm; r=O.06, 
p=O.15). A QCA ~ in mean diameter >-0.2 mm and lCUS ~ in the index 
of intimal thickness >10% defmed progression (P) or no progression 
(NoP). In 23 PIS (65%) there was concordance ofQCA and ICUS: 
In conclusion, comparative observations with serial ICUS and QCA 
suggest changes in angiographically measured luminal dimensions do not 
consistently reflect changes in coronary vascular disease, porentially due to 
vessel wall compensation. Serial ICUS provides complimentary 
information to serial quantitative angiography for monitoring progression of 
coroDaI)' artery disease. 
892·93 
Effect of Disease Chronicity on Atherosclerotic Wall 
Morphology by Intravascular Ultrasound: Insights 
into the Natural History of Coronary Artery Disease 
Steven E. Nissen, Masakazu Yamagishi, E. Murat Tuzcu, 
Anthony De Franco, Joseph M. Sutton and Stephen G. Ellis 
The Cleveland Clinic Foundation, Cleveland. OH 
Intravascular ultrasound can detect and quantify the morphology of 
coronary atherosclerotic lesions in vivo. This study was designed to 
evaluate the natural history of atherosclerotic coronaI)' disease in 
patients stratified according to duration of CAD symptoms. Ultra•
sound was performed at 231 sites in 95 patients catheterized for chest 
pain, using a 20 MHz, 3.5 or 5.5 F multi-element array or a new 30 
MHz, 3.5 F mechanical ultrasound device. The duration of CAD 
symptoms ranged from <I week to >20 years (mean 3.7 years). 
Intravascular images were digitized and classified using previously 
reported 95% confidence values obtained in a group of 19 normal 
subjects for the intimal leading edge (<0.28 mm) and subadjacent 
sonolucent zone (<0.24 mm). Calcification was defined as dense 
plaques not penetrated by ultrasound. At 137 sites in 59 patients with 
<5 years disease chronicity, 21 % of sites were abnormal by angio•
graphy and 62% were atherosclerotic by ultrasound. At 94 sites in 36 
patit:nts with> 5 years duration of symptoms, 37% of examined sites 
were abnormal by angiography and 88% were abnormal by 
ultrasound. For the 36 patients with longer disease chronicity, the 
dominant morphology was a thickened leading-edge (mean 0.38 mm) 
and a less thickened sonolucent zone (mean 0.30 mm). For the 59 
patients with shorter symptom duration, the prevalent lesion was a 
thickened sono-Iucent zone (mean 0.32 mm) with a less thickened 
leading-edge (mean 0.26 mm). These differences were significant at p 
s: .01. For 22 patients with very recent onset «3 months), differences 
were more striking. mean sonolucent zone, 0.38 mm, mean leading 
edge, 0.27 mm. Calcification was more prevalent in long-standing 
CAD (29%). than recent onset (12%), ~.Ol. These data demonstrate 
significant differences in lesion morphology with increasing disease 
chronicity. These fmdings may explain differences in behavior of 
acute vs. chronic CAD and permit identification of vulnerable plaques. 
892·94 
JACC Vol. 21, No.2 
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From which Segment of the Artery Is this IVUS Cross Section? Two Methods 
for Locnlizatlon: Fluoroscopy nnd Displacement Transducer. 
Gerard Pasterkamp, Mark J. Post, 'Willem P. Mali, "Nicolaas Bom, Cornelius 
Borst. Heart Lung Institute, 'Department of Radiology, University Hospital 
Utrecht, Utrecht:'Erasmus University, Rotterdam, The Netherlands. 
Exad localization of the intravascular ultrasound (IVUS) catheter tip is 
mandatory for 3D interpretation of the artery. We lirst localized the catheter 
tip OD fluoroscopy with reference to a radiopaque ruler. Secondly, we tested a 
newly developed device, the Displacement Transducer (DT), which records 
every 0.1 mm the catheter is conducted through the device. In 10 patients who 
underwent baDooD angioplasty of the femoral artery, we performed two IVUS 
pull-back maneuvres over 10 cm. For each puD-back maneuvre, the luminal 
cross sectional area was measured and plotted as a function of position (area 
fundion, left figure). 
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The distance between two measurements was 25 mm for the ruler method 
(n-8) and 2 mm for the DT (n=2). For the ruler, in 718 cases the cross 
correlation function of the two area functions revealed the highest correlation 
coefficient (r) at lag=O, indicating a shift of less than 25 mm. In one case the 
highe~t r was found at lag=2 (right figure). The maximal r ranged from 0.717 
to 0.950. For the DT, the highest r was found at lag = O. r = 0.943 and r = 0.939, 
indicating a shift of less than 2 mm. In one patient we measured the cross 
sectional area every 0.2 mm with reference to the DT. The highest r was 
found at lag = 0, r = 0.945. Conclusion: fluoroscopic localization of the IVUS 
catheter can be accurate to within 2S mm. The Displacement Transducer 
promises to be a very accurate device for catheter localisation not subjected to 
parallax. For lVUS follow up, the unique pattern of the area function may be 
used to match two subsequent examinations. 
892-95 
Angiographic Changes (Dotter etTect) Produced by 
Intravascular Ultrasound Imaging 
Fernando Alfonso, Carlos Macaya, Javier Goicolea, Andres Iniguez, 
Rosa Hernandez, Juan Castillo, Jose Zamorano, Pedro Zarco. 
Hospital Clinico. Madrid. Spain. 
Intravascular ultrasound imaging (IVUS) has been used to evaluate 
the results of coronary angioplasty (CA) but the angiographic 
effects of an IVUS study before CA are unknown. Accordingly, we 
prospectively studied the feasibility and the potential angiographic 
changes produced by lVUS before CA. The study group included 
30 lesions (L) in 29 patients (P) (age 61±9 years, 5 female). 
Reason for CA was unstable angina in 21 P and stable angina in 
8. Before IVUS, 0.2 mg of intracoronary nitroglycerin was 
administered and 2 orthogonal angiographic views were selected. 
IVUS was performed with a 4.8F mechanical transducer (20 MHz) 
using a monorail system. The lVUS catheter was gently advanced 
to the L which was crossed only when no resistance was found. 
In 17 L (57%) the lVUS transducer (radiopaque) could be exactly 
located at the L site, whereas in 13 L only the catheter tip could 
be advanced to a wedge position in the target L. Angiographic L 
characteristics could not predict the feasibility of the rvus study. 
Then, the catheter was withdrawn and the same angiographic views 
were repeated. No complications resulted from lVUS. Results of 
quantitative angiographic analysis were the following: 
Minimal luminal diameter (rom) 
Stenosis (%) 
·p<O.Ol 
Before lVUS After lVUS 
O.84±o.2 1.16±o.3· 
70.7±IO 59.8±ll· 
Thus, lVUS study of severe coronary L, using currently available 
technology, is safe but not feasible in all P. IVUS induces 
significant angiographic changes consitent with plaque remodelling, 
that should be considered when interpreting ultrasound images. 
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892-96 
Tissue Weight MeasuremenlS Underestimate" Atberec:tomy Efrec:t" Arter 
Diredional Coronary Atherec:tomy: An IDtravascular Ultrasound Study 
Fadi A. Matar. Gary S. Mintz. Andrew Farb. Kenneth M. Kent. Julie A. Kovach. 
Augusto O. Pichard. Lowen F. Saller. Jeffrey J. Popma. Martin B. Leon. 
Washington Hospital Center. Washington. DC 
Measurement of tissue weight (1W) from directional coronary atherectomy (DCA) 
specimens has been used to assess the relative contributions of atherectomy (Le. 
tissue removal) and angioplasty remodeling to lumen enlargement after DCA 
procedures. To determine if intravascular ultrasound (IVUS) measurements of 
plaque volume provide a simpler and more accurate method of assessing 
atherectomy effect. we fust performed in vitro validation studies fOllowed by 
comparison of the TW atherectomy index vs an IVUS atherectomy index in 
patients undergoing DCA. In vitro validation: Thirteen necropsy coronary 
arteries (4 normal. 6 mild disease. 3 severe disease) were fixed. imaged by lVUS 
within 18 hours of death. and analyzed using video planimetry techniques. Plaque 
volume measurements from 2-0 IVUS cross-sectional image slices obtained at 
Imm axial intervals were compared with a similar analysis of histology sections. 
IVUS plaque volume (l34.0±94.8mml ) strongly correlated with histology plaque 
volume (187.4±128.9mml • r.=O.96. p<O.OOI). DCA study: Of 26 patients in 
whom pre-DCA and post-DCA IVUS imaging was performed. reliable IVUS 
measurements of plaque and lumen volumes were obtained in 17. An atherectomy 
index [TW oc d lVUS plaque volume/d IVUS lumen volume] was calculated. and 
indices using both TW (plaque density=lmg/mm) and IVUS determinations of 
plague volume were compared. 
lVUS TW P 
d plaque volume (mm) 19.4±11.I 9.1±4.3 <.001 
atherectomy index 0.6I±O.30 0.35±O.24 <.001 
Using quantitative coronary angiography techniques to calculate d lumen volume. 
TW-angiography atherectomy index (the existing standard for quantifying 
atherectomy effect) was 0.4O±O.21. similar to the TW-lVUS atherectomy index 
(p=NS). We conclude: (I) lVUS derived plaque volume measurements in vitro 
strongly correlate with histology-based techniques; (2) pre- and post- DCA lVUS 
imaging is a simple and reliable method to determine atherectomy index in most 
patients (without significant lesion calcium). and (3) compared with lVUS. TW 
assessments of plaque volume consistently underestimate atherectomy index after 
DCA. These differences may be partially explained by in situ tissue loss or 
dessication of tissue prior to weighing and may have important implications in 
assessing DCA results. 
892-97 
Transvenous Ultrasound Imaging: A New Method for 
Observing Acute Coronary Artery Thrombosis Without Direct 
Arterial Cannulation 
Mark G. Hibberd. Leng Jiang. Mark D. Handschumacher. J. Luis 
Guerrero. Arthur E. Weyman. Robert A. Levine. Massachusetts 
General Hospilal. Boston. MA 
Recent studies have demonstrated the ability of intmvascular 
ultrasound (IVUS) to evaluate arterial thrombosis. However. the 
use of an intra-arterial catheter may affect the process under 
investigation by disruption of in situ thrombus or direct 
endothelial injury. Transvenous imaging from a concomitant 
vein. in contrast. can potenttally Vlsuahze thrombi without direct 
arterial cannulation. The purpose of this study. therefore. was to 
explore the ability of transvenous ultrasound imaging to display 
the process of acute arterial thrombosis and reperfusion. Cross•
sectional images of 12 thrombi in 6 canine circumflex coronary 
arteries were obtained by advancing a 4.3F. 30 MHz IVUS 
catheter into the coronary sinus. A validated model of acute 
arterial thrombosis was used and verified by subsequent clot 
recovery. Simultaneous ultrasound images and coronary flow 
measurements were obtained during thrombus formation and 
following mechanical or thrombolytic reperfusion. RESULTS: I) 
In all instances. thrombosis produced a striking increase in 
luminal echo intensity (4.1: I.p<O.OOI). returning to baseline 
with clot disruption. 2) Following r-tPA thrombolysis. cycles of 
spontaneous reocclusion and recanalization were observed by 
ultrasound. in parallel with changes in coronary flow. 3) Blood 
stasis produced by mechanical compression produced similar 
intensity increases but with distinct swirling of the luminal 
echoes. CONCLUSIONS: Transvenous ultrasound imaging 
rovides a new method for stud In the rocesses of acute 
coronlit t rom oStS an repe USlon Wit out trect artenaJ 
cannuaiion or contrast In,ectlon. It could. therefore. be valuable 




Villdltlon of IntrlcorOl1lry Ullr .. ound Defined Pllque Compoaillon: 
COITelatlon with Hlltologlc Samples Obtllned During Dlrectlol1ll 
Atherec:tomy 
Qalser Rasheed. Randeep Suneja. James Anderson. John McS. Hodgson. 
University Hospitals 01 Cleveland and Case Western R9S81V8 University. 
Cleveland. Ohio 
Plaque composition Is known to affect Interventlonal device performance 
during coronary Interventions. Thus. proper device choice requires knowtedge 
of plaque composnlon. Intracoronary ultrasound (ICUS) may allow such 
characterization but has not been validated In patients. Directional coronary 
atherectomy (DCA) provides a unique opportunity to validate ICUS defined 
plaque composition using histology. ICUS was performed before and after 
DCA In 40 patients. Lesions (or when possible to Identify. the atherectomized 
tissue) were classified as ll2fl (homogeneous echoes less dense than the 
adventitia). ~ (>900 arc of bright echoes with acoustic shadowing). or 
mixed (mixture of echodenslty with or without acoustic shadowing) Histologic 
samples were evaluated for elastosis and calcification (known determinants of 
ultrasonic backscatter). Samples were classified as~ (minor elastOSis but 
no calcification). ~ (moderate to heavy elastosis ± minor calcification). or 

















X2 = 47.53 
P<O.OOl 
Of the 6 histologiC type 2 lesions classified as soft by ICUS. 3 had 
m1crocalciflcations which were not appreciable on the ICUS Images. We 
conclude that increased echogeniclty 01 atherosclerotic coronary lesions 
correlates with Increased deposition of elastin and calcium In the plaque. Thus. 
ICUS imaging allows accurate characterization of the basic histologic 
composition of atherosclerotic lesions in patients. Such Information may prove 
useful in defining interventlonal device strategy. 
892-99 
Intravascular Ultrasound Detects SignirtalDt Progresssion of Atberosclerosis 
Soon aIler Transcatbeter Therapy 
Julie A. Kovach. Gary S. Mintz. Augusto O. Pichard, Kenneth M. Kent. Lowell F. 
Saller. Jeffrey J. Popma. Martin B. Leon. Washington Hospital Center. 
Washington. DC 
Because intravascular ultrasound (IVUS) sensitively detects the presence and 
magnitude of atherosclerosis in angiographically normal coronary arteries. it is 
uniquely suited to evaluate disease progression. Therefore. we used a 
comprehensive lVUS imaging system (25 MHz rotating transducer. 3.9F monorail 
imaging sheath. mOlorized transducer pullback at O.Smm/sec. 2-0 and 3-D display 
and quantification I 10 study 21 arteries (I left main. 6 LAD. 2 LCX. 7 RCA. 5 
SVG) in 20 pts (15 males; ages 58±12 years; IS with hypercholesterolemia) 
immediately after transcatheter therapy (TCT: 3 balloon. 3 excimer laser 
angioplasty: 6 directional. 6 rotational atherectomy; 3 stents) and at follow-up 
4.1±2.4 months later. We imaged all vessels from beyond the target lesion to the 
aono-ostial junction and .compared external elastic membrane (EEM). lumen. and 
plaque+media (P+M) cross-sectional areas (CSA) and % CSA narrowing 
(CSN=P+MJEEM) of paired post-TCT and follow-up image slices at the lesion 
site and at5 sites 5. 10. 15.20. and 25 mm proximal to the lesion. 
post TCT P+M' CSN follow-up P+M' CSN 'P 
lesion site 16.5±4.9 mm1 77% 16.4±3.0 mml 82% NS 
5 mm Il.lli.O mm1 60% 11.5±4.9 mm1 67% NS 
10 mm 9.00.3 mm1 47% 9.1±3.4 mml 51% NS 
15 mm 1O.3±5.3 mm1 48% 11.6±5.8 mm1 57% .047 
20 mm lO.m.8 mm1 50% 12.l±5.4 mm1 57% .031 
25 mm 9.2±3.9 mm1 48% 10.4+5.9 mm1 57% .II 
Overall. there was an 11.5% increase in P+M CSA at sites ~15 mm proximal 10 
the target lesion. Proximal progression did not correlate with restenosis. plaque 
composition. calcification (average calcium arc of 89' at the lesion sites and 8' at 
remote sites). or patient related variables. 
We conclude: Serial lVUS studies may detect small. but significant amounts of 
disease progression within 6 months at sites (I) not affected by TCT and (2) 
without angiographic changes in lumen dimensions. These findings have 
imponant implications in plaMing future studies directed at influencing the 
progression of coconary atherosclerosis. 
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892·100 
Characteristic Flow Dynamlca of Internal Mammary Art.ry 
Grafts; COmparison with Saphenoua Vein Grafts 
Takashi Akasaka. Junichi Yoshikawa. Kiyoshi Yoshida. Masahiro Shakudo. 
Takeshi Hozum. Tsutomu Takagi. Kobe General Hosp~al. Kobe. Japan 
To investigate lhe flow dynamics of coronary artery bypass grafts (CABG). 
phasic flow veloc~ patterns of CABG to the left anterior descending artery 
were analyzed using a 20 MHz Doppler catheter in 8 patients (pts) with internal 
mammary artery grafts (IMA) and 7 pts with saphenous vein grafts (SVG). 
Systolic and diastolic peak velocities (SPV. DPV) and time velocity integrals 
(SVI. DVll of the graft flow were measured in the proximal. mid and distal 
portion (PRX. MID. DST) of CABG. Flow volume (FV) of the CABG were 
calculated from SVI+DVI (TV I) and diameters 01 the CABG. Smau arterial 
branches (BRC) were seen lrom the PRX to MID 01 IMA. and phasic flow 
velocity patterns of the biggest ones 01 these branches was recorded in 4 of 8 
pis with IMA. The same parameters were also obtained in these recordings. 
Resu~s are shown as mean ±sd ('*poe.05. *.poe.Ol): 
SPV DPV SPVIDPV SVt DYI SVVTYt FV 
(em's) (em's) (em) (em) (mllmln) 
IMA: PAX 41±7T1 41±1?"! 1.0i±0.3511 8±'11'8±~ 0.35tO.07~ 65±20, 
laD 31±8 ..I * 411i18J 0.7O±O.211-' * ~ * 18±4 * 0.26±O.OSJ * 55±26' 
DST 2ti5-1 54±8 0.541O.16.J G±I-' 21±..,! 0.2110.0..-1 47±1:.J 
BAC 40±5 1&1:4 2.38±O.21 8±1 e±2 1.24±O.08 lli4 
SVG:PRX 12±5 221:10 0.5310.10 3±1 lli4 0.24±O.03 66±22 
laD 10±4 II±t O.53±O.10 3±1 8±4 0.2410.03 e6±28 
DST 10±4 lti1 0.5410.17 211 8±4 0.2310.05 66±32 
Spy. DPV. SVI and DVI in each portion were signdicantly greater in IMA than 
those in SVG (poe.Ol) . While aH parameters in SVG did not vary in each portion. 
Spy. SVI and FV decreased and DPV and DVI increased signdicantly as the 
pos_ional change lrom the PRX to the DST in IMA. SPVIDPV and SVIITVI in 
the PRX of IMA were signdicantly greater than those in the other portions. In 
conclusion. higher peak veloc~ies and greater time velocity integrals in systole 
and diastOle. and the positional change of the FV and the systolic/diastolic ratio 
of peak veloc~ies and time veloc~ integrals are the characteristics 01 the IMA 
flow. These would be affected by the size and the llow 01 branches of 1M A. 
892·101 
Intravascular Ultrasound and Angioscopic Imaging ot 
Saphenous Vein Grafts After Coronary Artery Bypass 
Grafting Compared With Histopathological Findings 
Nobuyuki Komiyama. Shigemoto Nakanishi. Shinichiro Nishiyama. Toshiya 
Kobayashi. Katsuo Fuse. Akira Seki. Tcranomon Hospital. Tokyo. Japan 
We applied both intravascular u~rasound (IVUS) imaging and percutaneous 
transluminal angioscopy (PTAS) to assess the structural changes of SVGs 
after surgery and compared them with the histopathological findings. 
(1) In vivO study' Six SVGs of 6 cases within 6 months after surgery (group 
E) and ten SVGs of 9 cases 4.5 to 8 years after surgery (group L) were 
examined by IVUS and PTAS. IVUS images were generated using a 4.3 Fr. 
ultrasound imaging catheter (CVIS) and PT AS images were obtained using 
a 0.7mm in diameter angioliberscopic catheter. (2) In vitro study' Three 
SVGs 01 3 cases 8 years after operation, which were taken out at 
reoperation. and one new saphenous vein were examined in vitro by IVUS 
and PTAS and in subsequent histopathological study . .BuWao...(I) In group 
E. IVUS images demonstrated an echogenic single-layered appearance and 
PTAS showed a smooth and whitish surface structure in all of SVG vessel 
walls. In group L. IVUS revealed a triple ·layered appearance in the 
angiographically normal sites. which conSisted of inner and outer echogenic 
layers and a medial echo lucent layer. In their sites, PTAS showed the 
relatively smooth and whitish surface. and in the angiographically narrowed 
lesions, it revealed yellow atheromatous plaques with the Iriable surface or 
ulcerations with thrombi. (2; In three SVGs, the pathological study revealed 
remarkable fibrous proliferation in intima as well as in media and adventitia 
at the sites 01 a triple-layered appearance in IVUS. At the lesion where a 
projected yellow plaque was demonstrated by PTAS. a lipid·rich 
atheromatous plaque was revealed pathologically and a homogeneous echo 
image 01 the plaque without the layer structure was obtained in IVUS. In the 
new vein without fibrous prolileration. a single·layered appearance in IVUS 
and the smooth and white surface in PTAS were demonstrated. 
tonclusion; The triple' layered appearance of SVGs in IVUS was 
suggested to be caused by the fibrous proliferation and thickening in intima 
and adventitia. The application of both IVUS and PTAS could clarify the 
structural changes in SVGs after operation and the mechanisms in vivo. 
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Effect of Lesion Location on Coronary Plaque Morphotogy: Impllcetions 
for Irrterverrtional Therapy 
Qaiser Rasheed. John McB. Hodgson. University Hospitals of Cleveland and 
Case Western Reserve University. Cleveland. Ohio 
Selection and subsequent success of coronary interventional devices may 
depend greatly on the composition and location of the plaque to be treated. 
Previous autopsy data suggest that lesions in distal coronary artery segments 
have a higher prevalence of fibrocalcWic plaque than those fOUnd proximally. 
We sought to validate this concept in patients using intracoronary ultrasound 
(ICUS) imaging. Images of severe atherosclerotic lesions were obtained from 
s~es cJ intervention in 125 patients. Lesions were classified as ~ (n: 81) 
H they were located In the proximal segments (AHA classification) of the LAD. 
LCX. or flrst two sections of the RCA. All other lesions were classified as.ru§!i! 
(n = 44) . Based on ICUS imaging. lesions were classified as ~ (homogeneous 
echoes less dense than advent~la) or Ma1 (bright echoes with or without 











*P<O.OO5 VS DISTAL 
n DIAMETER SOFT HARD 
43 3.5.0.6 67% 33% 
4 3.2.0,2 25% 75% 
30 3.2.0.4 70% 30%" 
21 3.2.0.4 24% 76% 
8 3.4.0.5 75% 25% 
19 3.1t0.5 58% 42% 
81 3.4.0.5* 69% 31%" 
44 3.2.0.5 39% 6t% 
There was no significant difference between the two groups with respect to 
mean age. gender. anginal type (stable vs unstable). or prevalence of risk 
factors. We conclude that coronary stenosiS in the distal segments are more 
likely to be hard as compared to those in lhe proximal segments. This occurs 
desptte simRarvessei size. This observed difference in plaque morphology may 
have implications for device selection lor treatment of specWic lesions and may 
allow selection of devices such as rotational atherectomy for hard lesions or 
directional atherectomy for soft lesions. Clinical trials assessing this strategy 
appear warranted. 
892·103 
Plaque MorphOlogy In Acute Coronary Syndromes: N.w 
Insights from Intravaacular Ultrasound 
Sabino R. TOlTe. Samin K. Sharma. Douglas H. Israel. Or1ancIino Almeida. 
Martin E. Goldman. John A. Ambrose. Louis E. Teichholz. Mount Sinai 
Medical Certer. New York. New York. 
Pathologic. angiograpttic. and angioscopic studies have demonstrated 
that atherosclerotic plaque rupture w~h subsequent thrombosis is the 
predominant pathogenic mechanism In acute coronary syndromes 
(ACS). The ruptured plaque often has an eccentric soft lipid pool within 
the intima which tends to rupture at a concentrated stress point. 
Intravascular uHrasound (IV US) is a unique imaging modality which 
provides real-time cross-sectional vascular images and can accurately 
define plaque morphology. Information regarding IVUS determined 
plaque morphology in ACS has been limited. ~ To determine 
plaque morphology by IVUS in ACS. ~ IV US was performed in 28 
culpr~ stenoses trom 28 patients (age 59±09; male-24) during PTCA . 
IVUS definitions: soft plaque (SP) • homogeneous echolucent image; 
fibrous plaque (FP) - increased 
echogenecity; and calcified 
plaque (CP) • bright echoes with 
shadowing. Unstable angina (UA. 
n-16) implied accelerated 
symptoms or rest angina while 
stable angina (SA. n.12) implied 
the absence of same. B.uWlL 
SP were seen more Irequently in 
UA (75% vs. 25%. p •. 02). FP 
were seen more frequently in SA 
(58% vs. 12.5%. 1>-.02). CP SP FP CP 
were evenly distributed (17% VS. NUS Lelion Morphology 
12.5%. p-NS) (see figure) . 
Conclysjon' Plaque morphology by IVUS correlates well w~h the anginal 
syndrome. Soft plaques are seen significantly more frequently with 
unstable angina while fibrous plaques are seen significantly more 
frequently with stable angina. Too few calcdied plaques were identified in 
this study to draw any conclusions. Further study 01 the utility of IVUS in 
identifying plaque morphology is warranted. 
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893-50 
Angloscoplc Differentiation of Culprit Lesions In Unstable Versus 
Stable Coronary Artery Disease 
Richard W. Nesto, Michael A. Sassower, Karen S. Manzo, Christine M. 
Byrnes, Stephan E. Friedl, James E. Muller, George S. Abela, Institute lor 
Prevention of Cardiovascular Disease, Cardiovascular Division, Deaconess 
Hospnal, Harvard Medical School, Boston, MA 
The presence and degree of coronary plaque rupture and thrombo•
sis is thought to be the distinguishing feature between stable and unstable 
coronary disease (CAD). Evidence supporting this observation is, however, 
largely indirect and drawn from enher angiographic or autopsy studies. 
Direct imaging wnh intracoronary angioscopy may allow precise in vivo 
characterization of culpnt lesions in CAD. 
Methods: We studied culpnt coronary lesions in 35 patients 
utilizing a new angioscope wnh a moveable liberoptic bundle which enables 
complete scanning of the pre-stenotic, stenotic, and post·stenotic regions. 
Ten of the patients had stable angina (SA), t 2 unstable angina (UA), 6 
non·Q·wave intarction (NQMI), and 7 Q·wave MI (QMI). Culpnt lesions 
were separated into 3 categories: SmoothlwMe = smooth, nondisrupted, 
predominantly wMe surface wnhout thrombus; Irregular/yellow = irregular, 
lobulated, nondisrupted, yellow surface wnhout thrombus; and Disrupted/red 
= irregular, disrupted (intimal fissure +/. ulcer), red surface +/- thrombus. 
Stenosis seventy was similar among the 3 groups. Angioscopic images 
were categorized wnhout knowledge of the clinical condnion. 
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SmoothlwMe lesions underlie SA while disrupted/red lesions 
predominate in QMI. Lesions in UA and NQMI exhiM a wide range of 
angioscopic features. summary: Angioscopy provides differentiation of 
culpnt lesions that may have important implications regarding mechanisms 
causing acute CAD and individualization of therapy. 
893-51 
A Comparison ot Unstable Angina and Stable Angina Lesion 
Morphology Using Percutaneous Coronary Angloscopy 
Christopher J, Wh~e, Stephen R. Ramee, Tyrone J. Collins, Suresh P. 
Jain, Alvaro Escobar. Ochsner Clinic, New Orleans, LA. 
Percutaneous coronary angioscopy was performed in 68 patients 
undergoing single vessel balloon angioplasty (PTCA). Unstable angina 
(UA) was present in 54 patients (rest pain. 14, accelerated angina. 22, 
and post-MI angina. 18), and stable angina (SA) pectoris was present in 14 
patients. The undisturbed lesion was imaged without crossing the 
stenosis prior to PTCA in 51 patients (40 UA and 11 SA). Following PTCA 
the angioscope was advanced across the dilated stenosis and the entire 
lesion including the distal and proximal segments were imaged in all 68 
patients. Lesion morphologies observed included plaque color 
(pigmented or white), surface texture of the plaque (rough or smooth), 
dissection, and intraluminal thrombus. The resuHs of angioscopy before 







'23 (57%)' 26 (65%) 
1 ( 9%) 2 (18%) 
UA (n-54) 36 (66%)' 47 (87%) 
SA (n.14) 3 (21%) 12 (86%) 
•• p S 0.01 vs. SA ". P • 0.02 vs. SA 
Of particular interest are the pre-PTCA images of the undisturbed lesions 
which revealed the increased incidence of intracoronary thrombus and 
evidence of plaque rupture (dissection) in the UA lesions compared to the 
SA lesions. There was a marked difference in the pre-PTCA appearance of 
the plaque texture between UA and SA lesions. A rough plaque surface 
was present in 30/40 (75%) UA lesions versus only 219 (18%) SA lesions 
(p <0.01). The high incidence of dissections and disrupted plaques 
present in both SA and UA lesions after PTCA reflects the injury to the 
vessel wall secondary to balloon dilation. The increased frequency of 
intracoronary thrombi seen in both groups after PTCA may have been 
related to the more extensive angioscopic examination performed, 
including the distal segment of the vessel which was not accessible before 
PTCA. These in vivo findings are conSistent with post-mortem studies 
suggesting that the pathophysiology responsible for the occurrence of UA 
is plaque rupture and thrombus formation. 
ABSTRACTS 
893-52 
Plaque Morphology Underlying Occlusive Thrombus in 
Acute Myocardial Infaraction As Encountered Using 
Percutaneous Angioscopy 
Kiyoshi Inoue, Keichi Kuwaki, Hidenobu Ochiai, Yoshio 
Mukaiyma. Cardiovascular Disease Center, Tokyo Metropolitan 
Police Hospital, Japan_ 
The characteristics of intraluminal morphology of the infarct related 
artery (IRA) seen after thrombolytic recanalization in patients with 
acute myocardial infarction (AMI) has been an important predictor 
concerning the mechanism of occlusion as well as the likelihood of 
subsequent reocclusion. Therefore, we angioscopically examined the 
27 IRA sites in AMI patients immediately after in whom more than 
TMI grade 2 thrombolytic recanalization was achieved by i.v. t-PA. 
Atheromatous plaque alone (11 %), thrombus alone (7 %), or 
atheromatous plaque and thrombus (74%) were encountered at 
these IRA sites. 
Among 10 cases in whom T1MI grade 3 reperfusion was 
achieved,complete lysis, in terms of angioscopy i.e. thorough 
dislodging of intraluminal thrombus leaving only trivial amounts 
of mural thrombi and thus totally uncovering atheromatous plaque, 
which if existed, was only observed in 5 cases, while the other S 
cases in this group showed angioscopicafly incomplete 
thrombolysis, i.e. atheromatous plaque partially covered by the 
residual un lysed thrombus. 
Similarly, the other 17 cases, in whom T1MI grade 2 recanalization 
was obtained, were of angioscopically incom plete lysis. 
The atheroma plaques seen by angioscopy were classified 
progressively into stages I-V based on their morphological 
characteristics and frequencies. Stage I and II henign atheromatous 
plaque was observed in only 18%, while Stage III-V malignant 
atheromatous plaque was observed in 72% of this group. The Stages 
111-V plaques in comparison with Stage I and II plaques had 
specific morphology ie. stemmed masses with undulation more or less 
endotherial disruptions on its surface and lipoidosis in the gullies 
(Stage III and IV), and also had stemming and tearing (Stage V)_ 
Stages III-V seemed to be linked developmentalll)'. 
In conclusion, malignant atheroma frequently exists at the infarct 
related coronary artery in patients with acute myocardial infarction. 
Since such atheroma appears extremely rupture prone, this presence 
should also be considered in the selection of all therapeutic regimen 
for acute myocardial infarction_ 
893-53 
Pathogenesis of Throabotic Occlusion in 
Infarct-Related Coronary Artery_ 
195A 
Koh Arakawa, Kyouichi Mizuno, Toshio Shibuya, 
Hirokuni Etuda, Hirotugu Tabata, Kimio Satomura, 
Kazushige Isojima, Akira Kurita, Haruo Nakamura. 
National Defense Medical College, Saitama,JAPAN 
To prove the hypothesis that the rupture of ath•
eromatous plaque is fundamental of thrombotic 
vessel occlusion in acute myocardial infarction, 
percutaneous trans luminal coronary angioscopy 
was performed immediately after thrombolysis 
and/or within 4 weeks after thrombolysis_ 
Of the angioscopic findings, presence of mural 
thrombus, plaque color (yellow/white) and irre•
gularity of vessel wall (ulceration) were 
evaluated in 26 lesions. 
Results: thrombus yellow plaque ulceration 
88% 77% 69% 
Ulcerated plaque was not clear in cases of 19%, 
because high grade residual thrombus mostly 
covered the arterial lumen of culprit lesion 
after thrombolysis. In cases of 12% (3 of 26), 
not only the ulceration of yellow plaque but 
also thrombus were not detected after thrombo•
lysis. Furthermore, vasospasm was provoked 
after intracoronary administration of 
acetylcholine in those 2 cases_ 
Conclusions: Our angioscopic findings supported 
that the rupture of lipid rich plaque played an 
important role of thrombus formation in most 
cases of acute myocardial infarction, but in 




Histological Characteristic. of Tissue Excl.ed During 
Directional Coronary AtllerlCtomy In Patients with Stable and 
Unatable Angina Pectoris 
Javier Escaned. Robert J. van Suylen. Victor A. Umana. Donald C. 
Macleod. Marcel de Jong. Fred T. Bosman. Pim J. de Feyter. Patrick W. 
Serruys. Thoraxcenter. Erasmus University. Rotterdam. The Netherlands. 
We report on the histopathological charactertstics of directional coronary 
atherectomy specimens obtained in patients with stable (SAP) and 
LIlStable (UAP) angina peeloris. TIssue samples were obtained from 93 
consecutive procedures performed in 48 SAP (52%) and 45 UAP (48%) 
patients. HistopathologicaJ study was performed by two observers blinded 
to the clinical history. The presence of neointimal hyperplasia (NH). fibrous 
tissue. cholesterol clefts. necrotic debris. calcium depositS. macrophages. 
thrombus. internal elastic lamina. media or adventitia were recorded. Clinical 
variables considered included age. sex. previous MI. previous intervention. 
and coronary risk factors. In UAP patients angiographic morphology was 
classified as complex if overhanging luminal edges. multiple irregularities or 
persisting staining was noted. The presence of 2 of the variables listed 












Complex anglographic morphology was recorded in 17 (37%) UAP 
patients. but only 6 (35%) of them contained thrombus. The presence of 
NH correlated strongly willi a history of previous coronary intervention 
(17/24 'IS 14169. P=O.OOO1). NH without previouS intervention (11=14) bore 
no relation willi SAP or UAP but was observed in younger patients (5H12 
'IS 59:1:10 years. P=O.017). 
Cordusions: UAP was associated with more thrombQ\:ic and calcific plaques 
than SAP. There was no relation between thrombus and complex 
angiOgaphic morphology. NH was found not only in restenottc but also In 
prinary lesions at younger paIienIs presenting wiltl either UAP or SAP. 
893-55 
Unstable Angina Treated ~th Laser Angioplasty 
Eduardo de Marchena, Stephen Mallon. On Topaz, William Groh. 
Peter B. Kumik. Peter Y. Lai. Chae Moon. Douglas R. Murphy•
Chutorian. University of Miami School of Medicine. Miami. Florida 
In vitro studies suggest that holmium laser can ablate both 
atherosclerotic plaque and thrombus. thereby having potential benefit 
in the management of unstable angina. To study the effects of 
holmium laser coronary angioplasty in the treatment of unstable 
angina, 209 patients (mean age 61 years) with 219 coronary l~sions 
were treated. Pulsed holmium laser energy at 5 Hem was delivered 
through a 1.4. 1.5 or 1.7mm flexible laser catheter placed over a 
guidewire. Most cases required adjunctive balloon angioplasty. 
Results: Mean lesion length was 11.6 mm. Mean % stenosis was 
90.1 % prior to laser treatment. The laser catheter recanalized 190 
(87%) lesions using a mean of 129 laser pulses (25 seconds). Mean 
% stenosis was reduced to 59.2% post-laser. Procedure success 
(~O% residual stenosis and the absence of myocardial infarction. 
emergency coronary surgery or death) was achieved in 210 ~96'1'0) 
cases after adjunctive balloon angioplasty. Final mean % stenosIs was 
23.8%. Complications were as follows: 
(n= 219 lesions) 
Dissection 6.8% Perforation 1.4% 
Recurrent thrombosis 3.7% Distal emboli 0% 
Q-wave MI 0.9% Non-Q-wave MI 1.8% 
Bypass surgery 3.2% Death 0% 
At six months. angiography performed in 67 cases showed ~a~eter 
stenosis ~O% in 38 (56.7%) cases. >50% but gO% stenosIs to 13 
(19.4%) cases. and >70% stensosis in 16 (24%) cases. 
Conclusions: Coronary lesions associated with unstable angina can 
be successfully treated in the acute setting with the combined approach 
of holmium laser energy and balloon angioplasty. Follow up studies 
showed acccptable results in a series of predominantly complex 
lesions. 
893-56 
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Is Intracoronary Stenting Safe in Unstable Angina? 
Steven A. Malosky. Jane Krol. John W. Hirshfeld. Jr .• and 
Howard C. Herrmann 
University of Pennsylvania, Philadelphia, PA 
PTCA performed in patients with unstable angina has increased 
complication and restenosis rates compared to stable angina. To 
determine whether intracoronary stenting is similarly associated with 
a poorer outcome in unstable angina. we reviewed the results. 
complications. and outcome of 118 consecutive patients receiving 
Palmaz-Schatz stents. Patients were divided into 3 groups based on 
clinical status at the time of stenting: group I had stable angina. 
group II had unstable angina (rest pain despite treatment). and group 
III received emergent bailout stents following failed PTCA. Stents 
were successfully deployed in 93% with the following differences 
between groups (*p<o.05 vs group I. #p<o.05 group III vs II): 
Group: I II ill 
N 57 48 13 
Age (yrs) 57±10 62±10* 56±9 
MI. CABG. or death 1(2%) 3(6%) 6(46%)*# 
Subacute thrombosis 2% 4% 31%*# 
Restenosis (>50%) 29% 26% 50% 
There were no significant differences between groups with 
respect to prior MI. prior CABG. severity of CAD. vessel stented. or 
# of stents placed. Mean angina class in group II (unstable) patients 
improved to 1.5±1.0 and 77% were free of angina at 6 months. 
Overall clinical success with successful stent placement. no 
complications. and no angina at 6 months was achieved in 85% of 
group I patients and 82% of group II (p=NS). 
Conclusions: 1) Unlike conventional PTCA. intracoronary 
stenting in the setting of unstable angina has similar complication. 
restenosis. and overall success rates compared to stenting in stable 
angina. 2) Stenting performed under emergent bailout conditions is 
associated with an increased rate of major complications. 
893-57 
Padentl with Unstable Anlina and Prior Bypass Graltina Have 
Higher Rate! or Death and RehospitaUzadon: Resultl or the 1'3 
Registry. 
Neal S. Kleiman. H. Vernon Anderson. Bruce Thompson. Pierre 
Theroux. William Rogers. Carolyn McCabe. Eugene Braunwald, for the 
T3R Investigators. Baylor College of Medicine. Houston. Texas 
Previous studies have suggested lower short term morbidity and 
mortality for patienta with acute ischemia who have had prior coronary 
bypass graft surgery (CABO). To validate this observation in a large 
prospectively followed cohort of patients hospitalized with unstable 
angina or non-Q wave myocardial infarction (MI). we examinined 
patienta enrolled in Ihe 1'3 registry. Of 1954 patienta, 309 (16") had 
prior CABO at 5.7±4.6 years previously. Patienta with and without 
prior CABO had a similar mean age and frequency of non-Q wave MI. 
but patienta wilh prior CABO were more likely to be male (64" VI 
46"*), white (82" VI S3"*), have prior MI (64" VI 38"*); and have 
received aspirin within the precedina 24 hours (60" va 4a *) or 
antiischemic drugs during the past week (83" vs 71" *) (*P < .001 all 
comparisons). During hospitalization. the likelihood of undergoing 
coronary arteriography or angioplasty was similar, but patients with 
prior CABO were more likely to receive heparin or intravenous 
nitroglycerin (65" VI S6" +.41" VI 32" + respectively. +p=0.(03). 
Aftet hospital discharge. recurrent ischemia occurred equally in both 
grouP. but there was a trend toward more frequent death or MI. (S" vs 
3") in patienta wilh prior CABO. By 6 weeks. death or MI occurred 
more frequently (10" vs 6". p=O.Ol). and rehospitalization for cardiac 
reasons was more common (19" VI 14". p< .01) in this group as well. 
By multiple logistic regression, prior CABO predicted death or MI wilh 
an odds ratio of l.S9 (9S"CI 0.99-2.54). We conclude: despite more 
aggressive medical management, patienta with acute ischemia who have 
had prior CABO constitute a higher than average risk group and may 
merit even more aggressive management. 
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893-58 
Clinical Outcome Based on a Probability Index for Non-invasive 
Detection of Reperfuslon 
E. Magnus Ohman. Robert H. Christenson. Robert M. Califf. Mijcheil W. 
Krucoff. Kristina Sigmon. Kirby Quintero. Barry S. George. Stephen G. 
Ellis. Eric J. Topol. for the TAMI Study group. Duke University Medical 
Center. Durham. North Carolina 
Non-invasive detection of reperfusion is possible using a logistic 
regression model of CK-MB slope and clinical variables to generate 
probabilijies ("Rescue" Index; RI) for identifying pts who have failed to 
restore patency after thrombolytic therapy (TT). To evaluate the clinical 
outcome in pts wijh different RI. we examined 97 pts receiving n and 
acute angiography (CATH) at a median (25th. 75th percentile) 137 (94. 
184) minutes after starting n. PIs who had failed to restore patency after 
n underwent rescue PTCA. The RI was calculated from the slope of CK•
MB change. chest pain prior to CATH. and time from chest pain to 
receiving n. PIs were categorized by having a low RI (median 0.05; 
n:31). medium RI (median 0.17; n:34). and high RI (median 0.52; n:32). 
Combined clinical endpoint (CCE: death. reinfarction. ischemia. heart 
failure) and folloW-Up (FlU) outcomes were: 
~ lmLBI M.ed..B..l I::iighlll 
Patency Acute 100% 79% 47% p<O.OOI 
Patency FlU 100% 96% 93% 
EF at FlU 0.53 0.54 0.53 
Death 7''10 9% 0 
CCE 26% 35% 31% 
Thus. a low "rescue" index is associated wijh high early and 
sustained patency rate. Patients wijh high "rescue" index have lower 
patency acutely but after rescue PTCA similar high patency can be 
achieved at follow-up. Patients wijh either high or low "rescue" index can 
have similar clinical outcomes ~ rescue PTCA is used. Selective use of a 
probabilijy index for detecting thrombolytic failures may aid in decision 
making regarding acute CATH and rescue PTCA. 
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894-62 
The Effect of Losartan, an Angiotensin II 
Antagonist, on Viral Myocarditis in Mice 
Minoru Araki, Tsugiyasu Kanda, Susumu Imai, 
Tadashi Suzuki, Kazuhiko Murata. 2nd Dept. 
Internal Medicine, Gunma UniverSity, 
Maebashi, Japan 
Angiotensin-converting enzyme inhibitors 
reportedly reduce the inflammation of 
myocarditis. We evaluated the efficacy of an 
angiotensin II antagonist, losartan, on viral 
myocarditis in mice at different doses. 
Losartan, 2.5 mg/kg/day (L-1, n=7), 25 mg/kg/ 
day (L-2, n=7), 125 mg/kg/day (L-3, n=7) and 
captopril 7.5 mg/kg/day lC, n=7) were 
administered in DBA2 mice orally from days 7 
to 21 after encephalomyocarditis virus (500 
pfu/mouse) inoculation. Control mice were 
infected but treated (CONT, n~9). 
HW HW/BW Histologic score 
(mg) (1/1000) I Necrosis 
CONT 158+33 8.2+0.9 2.3+0.4 2.4+0.5 
L-1 166+31 9.6+0.8 2.5+0.5 2.5+0.4 
L-2 128+29 8.4+0.7 2.2+0.8 2.1+0.9 
L-3 91~19** 6.3+0.7** 1.9+0.5* 1.8+0.6* 
C 95+ 9** 7.0+0.6* 1.6+0.5** 1.5+0.6** 
I: Inflammation, HW:Heart WeIght, BW:Body 
Weight, *p<.05, **p<.01 vs. CONT. 
Conclusion: Only high dose of losartan ( 125 
mg/kg/day) was effective as captopril in 
treating acute viral myocarditis in mice in 
accord with the reduction of cardiac 
inflammation and necrosis. 
ABSTRACTS 197A 
894-63 
Incidence, Clinical Significance and Clinical 
Predictors of sustained ventriCUlar Arrhythmias 
Associated with Biopsy-Documented Myocarditis 
John Kall, Gayle L. Winters, David Wilber, Brian 
Olshansky, Jeffrey Baerman, Douglas Kopp, Maria 
Rosa costanzo-Nordin, Patrick J. Scanlon. Loyola 
University Medical Center, Maywood, IL. 
The clinical courses of 20 patients (pts) with 
biopsy-documented myocarditis (M) were reviewed. 
M was acute (symptom onset S4 weeks before 
histologic diagnosis) in 18 pts. Mean age was 
33±17 years. Biopsy findings (using the Dallas 
criteria) included: lymphocytic M (focal or 
multifocal-13 pts, diffuse-4 pts), giant cell M 
(2 pts), and idiopathic granUlomatous M (1 pt). 
Sustained ventricular arrhythmias (SVA) developed 
in 6/20 pts (30%) : sustained monomorphic 
ventricular tachycardia (VT) in 3 pts and 
ventricular fibrillation in 3 pts. Mean time from 
presentation to initial SVA was 1. 7±1. 9 days 
(range 0-4 days). Multiple clinical, hemodynamic, 
and histologic variables were examined and only 
extensive M on biopsy predicted SVA (P=0.01). 
Within the first week, 2/6 pts with SVA died (1 
VT, 1 heart failure). One of 4 surviving pts had 
recurrent SVA and received an implantable 
defibrillator. The remaining 3 pts received no 
antiarrhythmic treatment and have remained free 
of recurrent SVA. During a mean follow-up of 
47±23 months, no other pts had recurrent SVA. For 
all pts, SVA was not a significant predictor of 
total mortality or cardiac transplantation. 
CONCLUSIONS: In pts with M: 1) SVA may occur in 
up to 30% of pts; 2) SVA are associated with 
biopsy evidence of extensive M; 3) SVA are not 
necessarily associated with adverse outcome. 
894-64 
ENDOTHELIUM DEPENDENT CORONARY VASOMOTION IS 
ABNORMAL IN PATIENTS WITH CHAGAS HEART DISEASE 
Frank W. Torres. Harry Acquatella, Jose Condado, Robert Dinsmore. and 
Igor F Palacios. Centro Medico. Caracas, Venezuela and the Massachusetts 
General Hospital. Boston, MA. 
In patients (pt) with Chagas heart disease (ChD) angina like chest pain and 
acute myocardial infarction occur with normal coronary arteries. In addition 
segmental wall motion abnormalities including left ventricular apical 
aneurysm frequent occur in ChD. Therefore, we assessed endothelium 
dependent coronary vasodilation by infusing both acetylcholine (Ach) (10-8 M 
to 10-6 M) and adenosine (AD) (10" M) into the left anterior descending 
(LAD) of 9 pis with ChD with angiographically normal coronary arteries. 
There were 5 males and 4 females with a mean age 43 ± 4 years (mean ± 
SEM) and mean LVEF of 39 ± 5%. Eight pt had left ventricular apical 
aneurysm and 1 (acute Chagas) had anteroapical akinesis. Coronary blood 
flow (CBF) was measured using a Doppler flow velocity catheter placed in 
the LAD and quantitative coronary angiography. An impairment of the 
coronary microvasculature was demonstrated in pt with ChD by a reduction 
in CBF of -41.2 ± 12.8% (p < 0.03) by the infusin of Ach at10~ M. and by a 
blunted increase in CBF of 114.6 ± 65% by the infUSion of AD at 10-4 M. 
COiTlOI. .......... , ,.. ... 
ACUTLQICUIl IfOIaIffMTJOII fIQ 
In conclusion pt with ChD have an 
abnormality of the coronary 
microvasculature as reflected in 
both Ach induced marked 
vasoconstrittion and decrease in 
CBF and a blunted response to 
AD. This abnormality of coronary 
vascular reactivity may playa role 
in both their chest pain syndrome 
and in the development of their 




Delay and Saapling Error Are the Reasons For 
Low Endo~ocardial Biopsy Detection of 
Myocarditis 
Marc A. Silver, Yuqui GUO, Trevor Law, Midwest 
Center for Heart Failure, Midwest Heart 
Research Foundation, Lombard, IL 
Biopsy sampling of the endomyocardium is 
useful in many diseases includin9 myocarditis. 
Reported detection of myocard~tis (M) via 
endomyocardial biopsy has varied but recent 
reports indicate that detection remains below 
10% in a group of patients suspected of having 
inflammatory heart disease. To evaluate the 
localization and the time course of the 
inflammatory foci, we used a murine Coxsackie 
B3 model of M. Eighty-two (82) mice were 
intraperitoneally infected with CB3 virus and 
groups were sacrificed at 7, 14 and 21 days 
post infection. ventricular slices were 
examined to determine the presence or absence 
of inflammation and its localization within 
both ventricles and the ventricular septum. 
Of 82 animals, 44 had M and 8 had epicardial 
inflammation only (52 (63%». Thirty (37%) 
had neither myocard~al nor epicardial foci of 
inflammation. The total number of foci was 
2,838 with 2,101 (74%) being present in the 7 
day animals, 468 (16.5%) present at day 14 and 
269 (9.5%) present at day 21. The total 
number of foci present in the left vs 
subendocardium was 15 (0.5%) and in the right 
vs subendocardium was 113 (4%). The total 
number of foci present in the subendocardium 
of the vs at day 21 was 9 (3.3%). Therefore, 
in experimental M, most of the inflammation is 
present early after infection; additionally, 
less than 5% of the inflammatory foci are in 
areas amenable to endomyocardial biopsy 
sampling. 
894·66 
1b1 Have Histopathological T,pea of Myocardial Fibrosis 
a Close Relation to the Effectiveness of ft-Blocker 
Therap1 for Dilated Cardioayopathy? 
Ei ichiro Tsuj imura. Masatake Fukunaai. Masaharu Ohmori. 
Katsuoli l.akura. Kazuaki Kuaagai. Takahisa Yamada. 
Nobubiko Kondoh. Tetsuo Minnino. Yasushi Abe. Nagahiro 
Nishikawa. Noritake Hoki Division'of Cardiology. Osaka 
Prefectural Hospi tal. Osaka. Japan 
We have recently reported that the effectiveness of 
long-terl ft -blocker therapy in patients(pts) with di•
lated cardiolyopathy (OeM) could be predicted from the 
fibrosis type in endolyocardial biopsy specimens. To 
clarify .hy the effectiveness of ft -blocker therapy for 
DCM depends on the fibrosis type. hemodynamic 
parneters and plasaa norepinephrine level (NE) during 
sy.ptol-limited supine bicycle ergo.etry .ith Swan-Ganz 
catheter technique .ere compared between 12 DCM pts 
lith interfascicular (IF) type of fibrosis and 12 DCM 
pts with intercellular (Ie) type utched for the ex•
tent of fibrosis measured by the point counting method 
(11. 5± 7.1 vs. II. 5± 7. H). At rest. there .ere no 
signi ficant differences in heart rate. blood pressure. 
cardiac index. pulmonary capi Ilary pressure and NE be•
tween the two types. Ho,ever. at the end of exercise. 
cardiac index (6.1±1.5 vs. 4,9±1.3 I/.in/m~ p<O.05) 
us higher and NE (O.64±O.33 vs. 1.20±O.72 ng/ml. 
p<0.05) was lo,er in Ie than IF group. This finding 
laS cOlpatible ,ith evidence that /3 -adrenergic recep•
tor density of the peripheral IYlpocytes was higher in 
Ie than IF (1922± 575 vs. 1088± 313 sites/cell. 
p<O.Ol). These results indicate that the cardiac func•
tion in IF group ,auld be modulated by /3 -adrenergic 
systea lore than that in IC group in terms of the 
do.n-regulated condition of /3-receptor. This implies 
that the effectiveness of /3 -blocker therapy in IF 
group light be related to up-regulat ion of /3 -receptor. 
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Left Atrial Myopathy In Idiopathic Dilated Cardiomyopathy 
Filippos Triposkiadis, Christos Pitsavos, Athanasios Trikas, 
Harisios Boudoulas, Pavios Toutouzas. The Ohio State 
University, Division of Cardiology, Columbus, Ohio, USA and 
University of Athens, Greece 
Whether left atrial (LA) systolic dysfunction in dilated 
cardiomyopathy (DC) is secondary to LA dilation due to left 
ventricular dysfunction and/or to atrial involvement in the 
myopathic process is not known. 
LA volumes M: maximal, mitral valve (MY) opening; at onset 
of LA systole (P wave on the electrocardiogram); and minimal 
(MV closure) were measured echocardiographically using the 
biplane area·length method in 14 patients (pts) with dilated 
cardiomyopathy (DC), 20 pts with aortic stenosis (AS) and 10 
normal controls (NL). LA active emptying fraction (AEF) = LAV 
onset of LA systole ·LAV minimai/LAVonset of LA systole, was 
used as an index of LA systolic function. 
Heart rate, and left ventricular end·diastolic pressure were 
similar between AS and DC. LA maximal V was similar in AS 
and DC but greater (p<0.OO1) than NL (DC 8O±25, AS 75±26, 
NL 46± 12). AEF was inversely related to LAV at onset of atria! 
06 AEF systole both in AS and DC; 






eoC.,.-o.19 however, AEF was lower in 
DC compared to AS (Fig). 
Conclusion. LA dysfunc•
tion in DC cannot be 
explained on the basis of 
atrial dilation per sa, 
suggesting atrial involve-
o 20 40 60 80 100 120 140 ment in the myopathic 
LAV • onset systole /cm l) process. 
894·68 
Adenosine Deaminase Activity in Pericardia! Aspirates 
: Diagnostic Significance in Tuberculous Pericarditis 
Kwang Kon Koh, Min Joon Choi, Chul Ho Cho, Chul lu Lee, 
loon Mee Kim, Sang Kyoon Cho, Sam Soo Kim, Inha University 
Hospital, Kyunggi-do, Korea 
BlICkgrolllld. It is difficult to establish a definitive bacteriological 
diagnosis of tuberculous pericarditis(TP). Adenosine 
deaminase(ADA) activity in the cell mediated immune response to 
Mycobacterium tuberculosis is elevated in perieardial fluid. 
Methods GIld IlnIIIts. We measured ADA activity by colorimetric 
methods of Guisti in fluid obtained at the time of pericardial 
aspiration in 20 patients(pts) with pericardial effusion(PE). Pts were 
included in a prospective protocol from August, 1991 to July, 1992. 
Pts were grouped as follows: Group I • 6 pts with TP confirmed by 
bacteriologic culture or histology of pericardial biopsy; Group II • 4 
pts with clinically suspected; Group III • 3 pts with lung cancer or 
chronic nonspecific pericarditis; Group IV • 7 control pts without 
pericardial disease 
I) In group I, the ADA activity wlluignificantly higher( 117±7 lUI 
L) than in group III(25±41U1L) or group IV(20±9 lUlL). 
(p<0.05) 
2) There was no significant difference between ADA acitivity in 
group 1(117±7 lUlL) and that in group 1l(107±6 lUlL). 
3) If the cut-off value of ADA activity is 45 lUlL, the sensitivity is 
88% and the specificity is 100% in the diagnosis ofTP. 
COllclllSiollJ. Elevated ADA activity more than 45 lUlL in PE is of 
great value in the diagnosis ofTP, particularly when the results of 
other laboratory tests are negative. 
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894·69 
Effects of NKH477, Water Soluble Forskolin Derivative, 
on Mechanoenergetics in Human Diseased Heart 
Masuki Mori, Motoshi Takeuchi, Hideyuki Takaoka, 
Yoshihiko Hayashi, Mitsuhiro Yokoyama 
Kobe University School of Medicine, Kobe, Japan 
The positive inottopic and vasodilatory actions of NKH477 have been 
demonstrated in vitto and in animal heans. However, the effects of 
this agent on human hean have not been investigated. The aim of this 
study was to compare the effects of NKH477 on human diseased 
hean with those of dobutamine. To this end, we examined variably 
loaded left ventricular (LV) pressure· volume loops before and after 
the administration of NKH477 (0.5 ~g I kg I min, iv) and dobutamine 
(3 ~g I kg I min, iv) with using conductance catheter and inferior vena 
caval occlusion in 6 patients. We measured Emu (the slope of end•
systolic pressure-volume relation), Tau (the time constant of LV 
pressure decay), Ea (effective anerial elastance), SW (stroke work) 
and PV A (pressure volume area circumscribed by the end-systolic 
pressure-volume line, the end-diastolic pressure-volume curve and the 
systolic segment of the pressure-volume trajectory) as the indices of 
L V contractility, relaxation, afterload, external work and total 
mechanical energy, respectively. NKH477 increased Emu (3.5 to 5.3 
mmHg I mil m2) and decreased Tau (88.4 to 55.2 msec) to the same 
extent as dobutamine (3.5 to 5.1 mmHg I mil m2, 88.4 to 68.2 msec, 
respectively). Ea decreased with NKH477 (3.5 to 3.1 mmHg I ml ) 
but not altered with dobutamine. As a result, NKH477 improved Ea I 
Emu, ventricular-anerial (V-A) coupling, and SW I PVA, work 
efficiency, more than dobutamine [1.1 to 0.7 vs 1.1 to 0.8 p < 0.05, 
0.67 to 0.77 vs 0.67 to 0.73 p < 0.05, respectively). These results 
indicated that NKH477 imprOVed V-A coupling and work efficiency 
more than dobutamine because of reduction of afterload. despite of the 
comparable inotropic and lusitropic effects with two agents. Thus, 
NKH477 may have a potential advantage to be an alternative agent to 
dobutamine owing to its more vasodilatory effects on human diseased 
hean. 
894·104 
Do the Indications for Perfonnilll Endomyocardial Biopsy Predict Biopsy 
Results? 
D. Michael Unks, Charles Steenbergen, Michael S. Cuffe, Charles B. McCants, 
Jr., Gordon P. Keeler, Christopber M. O'Connor, Duke Univenity, Durham, NC 
Despite the limited sensitivity of endomyocardial biopsy (EMB) for diagnosing 
various myocardial disease states, the performance of EMB continues in many 
institutions. We therefore performed a detailed review of the initial EMB IIDd in•
bospital course in 183 patients, to determine the yield of biopsy based on the 
predominllDt clinical reasons for performiog the procedure. Patients undergoing 
EMB for monitoring post-cardiac transplantation or following chemotherapy were 
not included. Indications for biopsy were subdivided into primary and secondary 
(wben appropriate) groups for eacb patient, based on the clinical scenario IIDd 
chart documentation. 
Results: Primary reasons for performiog EMB included unexplained CHF andlor 
LV dysfunction (71 %), possible amyloidosis (9%), possible myocarditis (7%), 
unexplained arrhythmia (4%). peripartum cardiomyopathy (3%). possible 
sarcoidosis (2%). and other (4%). Possible myocarditis was a primary or 
secondary indication in 22%. and amyloidosis in 13%. of the total population. 
Pathology findings were classified as nonspecific (68%), mild T-Iympbocyte 
infiltrates (23%). amyloidosis (7%). myocarditis (1.5%), IIDd other (0.5%). 
Three patients bad insufficient tis.""e for interpretation. The majority of patients 
with unexplained CHF IIDdlor LV dysfunction (as the primary indication) bad 
nonspecific fIDdings on biopsy. with a sensitivity of 68%. specificity of 55%, and 
predictive value of 77%. Possible myocarditis as a primary or secondary 
indication bad a sensitivity of 24%, specificity of 76%, and predictive value of 
23% for detecting mild T -Iympbocyte infiltrates and myocarditis on biopsy. 
Finally, possible amyloidosis as a primary or secondary indication bad a 
sensitivity of 38 %. specificity of 98%, and predictive value of 75% for detecting 
cardiac amyloidosis. 
Concl~ion: Nonspecific EMB findings are found in the majority of patients with 
unexplained CHF IIDd/or LV dysfunction. Allbougb Ibe absence of a clinical 
suspicion of myocarditis was reasonaby specific in identifying patients without T•
cell infiltrates and myocarditis. tbe presence of this suspicion was not sensitive 
nor predictive in detecting these changes. The absence of clinically suspected 
cardiac amyloidosis was bigbly specific in identifying patients without patbologic 
evidence of cardiac amyloidosis. 
ABSTRACTS 
894·105 
Comparison or Myocardial T·Lymphocyte Infiltrates and Myofibril 
Loss to Various CUnical and Hemodynamic: Parameten 
D. Michael URb, Charles Steenbergen, W. Ross Stevens, Gordon P. 
Keeler, Charles B. McCants, Jr., Christopher M. O'Connor, 
Duke University Medical Center, Durham, NC 
In order to examine the possible relationship between myocardial T•
lymphocyte infiltrates (TLI), myofibril loss (MFL), and various clinical 
and hemodynamic parameters, the prospectively collected clinical 
characteristics of 379 consecutive patients undergoing endomyocardial 
biopsy (EMB) from 7/84-12/91 were compared to biopsy findings. 
Patients receiving EMB for monitoring post-.:ardiac transplantation or 
following systemic chemotherapy were not included. A significant TLI 
was defined as an average of > 2 T -cells observed per higb power (200X) 
field, using monoclonal immunoperoxidase staining. MFL was 
determined on examination of myocardial ultrastructure by electron 
microscopy. The mean patient age was 47+1-17 years (range 10-90). 
The majority of patients were male (56%) and caucasian (64%). Over 
80% of patients had symptoms of CHF. Of these, 56% had duration of 
symptoms <3 months and 69% were NYHA class m or IV. The mean 
left ventricular ejection fraction (L VEF) was 31 +1-15% (range 4-84). By 
pathology, 23% of patients had TLI and 71% had MFL. 
CI inical parameters (age, sex, race, duration of CHF, severity of CHF), 
presence of significant coronary disease, L VEF, and hemodynamic 
measurements were not significantly different between patients with or 
without TLI. In contrast, patients with MFD had a significantly lower 
LVEF (29+/-14% vs. 34+1-16%, p=0.026) and cardiac index (2.6+1-
0.8 Ilminlm' vs. 2.9+1-1.1 Ilminlm', p=0.025). 
In conclusion, patients with TLI do not have significant differences in 
baseline clinical and hemodynamic parameters as compared to those 
without TLI. Patients with MFL have decreased LV systol ic function. as 
evidenced by their significantly lower LVEF and cardiac index. The 
impact of MFL, and other biopsy features, on patient prognosis is 
currently being evaluated. 
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895-70 
Present Incidence and Characteristics of Infective Endocarditis 
Christine Selton-Suty, Fran<;ois Delahaye, Veronique Goulet 
Flore Lacassin, Rene Ecochard, Bruno Hoen, Serge Brian<;oI\ 
Jerome Etienne, Catherine Leport. CHU Brabois Nancy France 
In order to determine the present incidence, and the 
demographic, clinical, microbiological, and evolutive characte•
ristics of infective endocarditis (IE), a comprehensive survey 
was conducted between November 1st, 1990 and October 31st, 
1991, in three French regions, in which all cardiologists, and all 
hospital departments of cardiology, infectious diseases, internal 
medicine and cardiovascular surgery were contacted. According 
to the Von Reyn criteria modified by echocardiography, 410 
cases of certain, probable, or possible IE were collected. 
Overall incidence of IE was 24 cases / million : 32 cases / 
million males and 16 cases / million females. 31 % of IE were 
considered as certain, 53% as probable, and 16% as possible. 
Age was 56 ± 19 years ; 65% were males. There was no 
previously known heart disease in 141 pts (34%), valvular heart 
disease in 138 pts (34%), non valvular heart disease in 42 pts 
(10%) and valvular prosthesis in 89 pts (22%) in whom 24 cases 
occurring less than one year after valvular prosthesis surgery. 
Portal of entry was dental in 26%, digestive in 13%, iatrogemc 
in 9%, cutaneous in 5%, urinary in 4%; 19 pts (5.2%) were drug 
abusers. The causal germ was evidenced in 89%, Staphylococcus 
in 22% (S. aureus: more than 3/4 of Staphylococcus), 
Streptococcus in 59% (non groupable: 26% ; group D: 23%). 
Yeasts were found in only 2 pts. 
IE was mitral in 39%, aortic in 37%, mitral and aortic in 
13%, tricuspid in 6%. At 1 month after diagnosis, 17% had been 
operated on, and 12% had died; at two months, 25% had been 
operated on, and 16% had died. 
Compared to a previous French study carried out in 1983, 
IE remains frequent and severe, in spite of the diffusion of 
prophylaxis recommandations. Interestingly, and contrary to 
what has been observed in the US, there was no evidence of an 




Batural. Hi.tory of veqetatio_ 
in SUcoe •• tully ~reate4 Ba4ocarditi. 
Oiidrlc VIlille, Mal:it Nidorf 
Arthur E. Weyman, Mi.dlael H. Picani 
MassadDJsetts Generallbspital, Bcsta1, MA 
In infectious endocarditis (IE), initial vegetatien size 
is a marker of progoosis. It is unclear if there are 
consistent ~ in vegetatien size durin} successful 
medical treatment ani whether ~ in size relate to 
progrxsis. In a 1<>-year database, we searched all patients 
woo met strict criteria: proven native valve IE with a 
vegetatien clearly visualized by ec:bx:ardi~ at the 
cnset of treatment, successful ncn-surgical treatment, 
follOiH.lp ec:bx:ardiogram after at least 3 weeks of 
treatment. Vegetatien dimensicns were measured ani a 
c:ilaJ'l3e of 4 !lin was considered significant. Results: 28 
patients were identified ani 36 vegetaticns were 
visualized, en 30 diseased valves. EVolutien of vegetatien 
size between first ani secon::i ec:bx:ardiograms (mean 
interval 45 ± 18 days) was as follows: 
Aortic Mitral TriOlSpid Total 
In::rease 1 3 1 5 
No c:ilaJ'l3e 4 6 4 14 
Decrease 1 2 3 6 
Di.saaleararoe ~ :i ~ 11 
Total 8 16 12 36 
QUy cne late a::mplicatien was oot:ed: stroke in a patient 
with a lllitral vegetatien of increasin} size. In additien 
7 patients \II'Xlezwent elective valve replacement after a 
a::mplete ocurse of antibiotic treatment, withrut signif•
icant treni in vegetatien E!IIOlutien. It is cxn:::luded that 
even durin} successful treatment of IE, IOOSt vegetations 
~ ani c:ilaJ'l3es in their size vary greatly. In spite 
of this variability, late gmlications are rare. 
895·72 
Influence of ischemic site in detennining acute mitral regurgitation: study 
during Pl'CA. 
A. Lombardo, L.M. Biasucci, R. Mongiardo, M. Mazzari, F. Pennestrl, E. 
Rossi, A. Costalung., M. Testa, G. A1ecce, F. Loperfido. Cardiology Institute, 
Catholic University, Rome (Italy). 
10 order to assess the relation between acute MR, coronary vessel occluded and 
regional or global myocardial function, we studied by color Doppler 
echocardiography (CD) 28 pts with single-vessel coronary artery disease, aged 
56.±.1l yrs, before and during coronary angioplasty (PTCA). Artery occlusion, 
collateral circulation, basal CD MR> I + and presence of segmental left 
ventricular (LV) dyssynergy were criteria of exclusion. LV EF was 2,50% in all 
pts. There were II left anterior descending (LAD), 9 circumflex (CX) and 8 right 
coronary artery (RCA) PTCA. Before (B) and during Pl'CA (occlusion time: 30 
to 120 sec; pressure: 4 to 10 atm), new or worsened CD MR, EF, regional wall 
motion (WM) changes and WM score index (WMSI) were evaluated by apical 
approach. To assess WMSI the following scale on 9 segments LV model waa 
used:-I, 0, 1,2, aa dys-, a-, hypo-kinesis and norntal, respectively. 
Results: MR (pts) WMSI EF (%) 
B PTCA B PTCA B PTCA 
LAD 2 2" 2.0,±,0.1 1.6.±.0.2§ 55.±.5 46.±.5§ 
CX 6"· 2.0.±.0.1 l.7±0.2§ 55±4 49.±.5§ 
RCA 0 0 1.9+0.1 1.6.±.0.2§§ 52.±.4 47±5§§ 
·:p<O.OOOI, §: p <0.001 and §§: <0.005 vs B 
-unchanged MR; .. 5 new MR and I worsened MR. 
During PTCA, no pt with neW MR showed mitral valve prolapse nor significant 
mitral annular diameter increase. Lateral dyssynergy was induced in 6 pts 
during CX PTCA and in 1 pt during RCA PTCA (p=0.03). All 6 patients with 
CX dilatation and PTCA-related MR developed lateral dyssynergy vs none of 
the 3 without MR (p=0.02). WM changes and MR disappeared at balloon 
deflation. No pts developed symptoms related to MR. 
In conclusion, in single-vessel disease model, during short periods of coronary 
artery occlusion: I) reversible acute MR often occurs only during transient 
occlusion of the CX: 2) acute MR is related more to the site of ischemic zone, 
and in particular to specific dyssynergy of the lateral LV wall, than to global 
WM worsening. 
895·73 
JACC Vol. 21, No.2 
February 1993:200A 
Coronary Artery Size In Mitral Regurgitation Before and 
After Valve Surgery 
Giuseppe Vassalli, Otto N. Krogmann, Otto M. Hess, Marko Turina, 
Hans P. Krayenbuehl_ University Hospital. Zurich. Switzerland. 
Coronary artery size and its relation to myocardial hypertrophy has 
not been evaluated In patients with mitral regurgitation. Cross•
sectional area (CSA; mm2) of the proximal left (LCA _ left anterior 
descending and circumflex coronary artery) and right coronary 
artery (RCA) was determined by quantitative arteriography In 10 
controls (C) and 10 patients with chronic mitral regurgitation and 
normal coronary arteries before (preop) and 28±IS months after 
(postop) successful valve surgery. 
n EDV LMM EF LCA-CSA RCA-CSA 
C 10139 119 64 14.0 8.8 
Preop 10 349** 2S7" 62 26.S** 12.7 * 
PostOD 10 217* 205· 51* 229* 11.7 
EDV-end-diastolic volume (ml); LMM-LV muscle mass (g); EF•
ejection fraction (0/0)_ * - p<O.OS; ** - p<O.OOI vs C. 
20 y.0.04x+2.4 40 y .. 0.09x+3.4 
f. 0_84 f .. 0.88 
P c 0.001 P < 0.001 
n .. 30 I n=30 
oc 
• MRpreop 




o 100 200 300 400 0 100 200 300 400 
LMM (9) LMM (9) 
Conclusions: Left and right coronary artery size increases 
proportionally to LV muscle mass in patients with mitral 
regurgitation. After surgery both coronary artery size and LV 
muscle mass decrease but do not normalize. 
895·74 
Location or Left Atrial Thrombi (Appendage vs Cavity) is Dependent 
on Underlying Cardiac Disease. 
Ian W. Black, William J. Stewart, Warreo F. Walsh, Allan L. Klein, 
Andrew P. Hopkins, Carol I. Duffy, Lincoln C.L. Lee, Gerald I. 
Cohen, Harry M. Lever, Emesto E. Salcedo. Cleveland Clinic 
Foundation, Ohio and Prince Henry Hospital, Sydney, Australia. 
Left atrial (LA) thrombi may occur in different locations and by different 
mechanisms. From 5,022 consecutive transesophageal echocardiographic 
studies at 2 centers, we identified 100 LA thrombi in 94 pts. Thrombi 
in the LA appendage (n=67) and in the main LA cavity (n=33) were 
compared. All 94 pts had either atrial fibrillation (AF) (n=81, 86%), 
mitral valve disease (n=58, 62%) or LV systolic dysfunction (n=26, 
28%). 
Mitral Valve Disease 
AF (Non-Valvular) 
AF (Total) 
LA Dimension (mm) 
LV Dysfunction 
LA Appendage LA Cavity 
n=67 n=33 
33(49%) 30(91%) 
32 (48%) 2 (6%) 
61 (91 %) 25 (76%) 
54±11 6O±11 







Thirty-two (94%) of the 34 LA thrombi in pts with non-valvular AF 
were located in the LA appendage. Thirty (91 %) of the 33 LA cavity 
thrombi were associated with mitral valve disease. LA appendage and 
cavity thrombi were similar in pt age, frequency of LA spontaneous echo 
contrast and frequency of significant mitral regurgitation. 
Conclusions: Non-valvular AF. mitral valve disease and LV dysfunction 
are associated with LA thrombi in different locations, suggesting 
different mechanisms of thrombogenesis. LA cavity thrombi are 
associated with mitral valve disease and with more left atrial dilatation, 
while LA appendage thrombi are associated with non-valvular AF. 
JACC Vol. 21, No.2 
February 1993:201A 
895·75 
Does the Acquisition of MItrII Regurgitation Reduce ThrombogenIC 
Risk Factors? A Controlled Study. 
Dylmttr Rittoo. George R Sutherland. Peter Cume. Thomas RD Shaw. 
Westem General Hospital. Edinburgh. UK 
Left atrial spontaneous echo contrast (LASEC) has been shown to be a 
marker for increased risk of thromboembolism. To investigate whether 
mttral regurgttatlon (MR) had any influence on LASEC. transthoracic and 
transoesophageal echocardlography (TEE) were performed immediately 
before and 24 hours after mitral balloon valvotomy (MBV). Before MBV 
(n: 72) all patients except one. had etther mild or no MR. Mean mttral 
valve area (planimetry) was 1.1 ± 0.4 em'. mean left atrial pressure 25 
± 7 mmHg. transmttral gradient 12 ± 9 mmHg. cardiac output 3.7 ± 1.1 
I/min. and left atrial volume (determined by precordial echo using ellipse 
method) 94 ± 48 mi. LASEC was detected by TEE in all patients in atrial 
flbrillation (n: 54) but In only 4 of the 18 patients in sinus rhythm (p < 
0.(01). The patient wtth significant MR (3+) had mild LASEC. Eleven 
patients had thrombus in the left atrium; all were in AF and had dense 
LASEC. Multivariate analysis showed AF to be the only Independent 
predictor of LASEC. After MBV (n: 60). mean valve area and cardiac 
output increased by 55% and 16% whilst mean gradient and volume 
decreased by 50% and 17% respectively. LASEC was unaltered in all 
but 7 patients; 6 of the latter had an increase in grade of MR. SignHlcant 
MR (> 2 +) developed in 7 patients. 4 in SR (no LASEC before MBV) 
and 3 in AF. LASEC disappeared in 2 of the latter 3 patients In AF and 
was reduced in density in the third. Three of the 4 patients in SR wtth 
LASEC developed mild MR after MBV; LASEC disappeared In 2 and was 
reduced in density in the other. LASEC was unchanged in the fourth 
patient in SR who had no MR either before or after MBV. LASEC 
appeared less dense in one other patient in AF who reverted 
spontaneously to SR after MBV. 
Conclusions: This controlled study demonstrates that acute MR 
influences the presence and degree of intensity of LASEC in patients 
with mitral stenosis. Mild MR may clear LASEC in patients in SR 
whereas MR of at least moderate severtty Is required to exert the same 
effect In patients in AF. 
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896·42 
Comprehens;ve Eva 1 uati on of Defi brillators And 
Resuscitative Shocks (CEDARS) Study: Does Atrial 
Fibrillation Increase the Incidence of Inappropriate 
Shock by Implanted Defibrillators? 
CEDARS Investigators 
Cedars-Sinai Medical Center, Los Angeles, CA 
It is unknown whether or not atrial fibrillation (AF) 
increased the i nci dence of inappropriate shock by 
implanted defibrillators (ICD). We followed up 452 
consecutive initial ICD reCipients from 9 centers for 
a period of 1 year. 120 pts had a hi story of AF, 46 
pts had AF at the time of ICD implantation and 286 pts 
had neither. Pts with AF were more 1 ikely to receive 
antiarrhythmic agents and/or Digoxin [131/166(79%) in 
AF group(Grp) vs. 189/286(66%) in No AF Grp P<O.Ol]. 
The incidence of ICD inappropriate shock based on ECG 
documentation (n=10) or by history only (n=61) are 
shown in Table 1. 
Table 1. Incidence of Inappropriate Shock 
ECG Documentation By History Only 
AF Grp(166) 8/166(5%) 42/166(25%) 
No AF Grp(286) 2/286(1%) 19/286(7%) 
P <0.01 <0.001 
The result were independent to LV function.(Table 2.) 
Table 2. Incidence of Inappropriate Shock 
AF Grp(166) 
No AF Grp(286) 
P 




CONCLUSIONS: Presence of AF (either by history or by 
ECG) increased the inc i dence of i nappropri ate ICD 
shock, regardless of LV function, however pts with AF 




Atrial Eleclrophyslologlc Patterns of Patients with Lone Paroxysmal 
AIr! a; Fibrillation. 
Alessandro Capuccl FACC, Giuseppe Boriani, Mauro Biffi, flavia 
Ravelli", Giandomenlco Nollo", Andrea Santarelli, Bruno Magnani. 
Institute of Cardiology, Unlversity of Bologna, *IRST, Trento. Italy. 
We performed an electrophysiologic study in 20 consecutive patients 
with lone paroxysmal attial fibrillation (LP AF) to evaluate the pattern 
of atrial fibrillation (AF) inducibility and we compared the atrial 
electrophysiologic findings with a group of 10 consecutive patients with 
oormal atria. Three quadripolar catheters (0.5 cm interelectrode distance) 
were placed in high right attium, proxymal His bundle recording site and 
coronary sinus. All the parameters were evalualed at 3 cycle lengths (CL) 
(600, 500 and 400 IDS). Forty-two episodes lasting > 1 min of attial 
fibrillation were recorded. All the 20 patients were inducible with only I 
extrastimulus.; control patients were oot inducible. 
AF 
C 








a. 600 (ms) 500 (IDS) 
7±20 16±29 
4±7 3±6 
40tH ••• 37±15 ••• 
10±9 7±8 
193±23 •• 190±24 • 
231±36 231±42 











Legend: ••• p< 0.001; •• P < 0.05; • p < 0.01; AF= attial fibrillation; C= control. 
AERP/AfRP= attial effectivelfWlCtionai refrnctory period. ~ difference among 3 
attial sites. A 4 A2 value> 45 IDS and a MIA2 > 25 ms were invariably 
associated with AF induction. In conclusion. in patients with LP AF a 
shorter attial refractoriness was a constant finding at every CL meanwhile 
single AF episode discharge was more related to dispersion of conduction 
among the 3 atrial sites above a critical value. Therefore an intraatrial 
conduction delay evoked by a short coupled single extrastimulus may be 
the trigger mechanism leading to fibrillation in an attium with a favourable 
electrophysyologic substratum, as shown by short atrial refractoriness. 
896·44 
Prophylactic Treatment After 
Electroconversion of Atrial Fibrillation in 
Patients After Cardiac Surqery - a Controlled 




371 patients (pts) (235 women,136 men) after 
cardiac surgery were randomized after 
succesful electroconversion of atrial 
fibrillation to quinidine (7B pts),verapamil 
( 6 B pts), amiodarone (56 pts), propafenon ( 43 
pts), digoxin (70 pts) or control group (56 
ptS) .After one year sinus rythm was still 
present in 43% reciving quinidine, 43% 
reciving verapamil,40% receiving 
amiodarone,38% receiving propafenon,22% 
receiving digoxin, 20% in the untreated group 
and after two years in 14%,11%,20%,10%,0% and 
0% = respectively. The treatment was 
discontinued because of side effects in 13% 
of pts in the quinidine group, B% of pts in 
the amiodarone group,4% of pts in the 
verapamil group and 5% in the propafenon 
group,There were two sudden deaths, probably 
related to proarythmia: one in quinidine and 
one in amiodarone group. 
Conclusion:Quinidine,verapamil,amiodarone and 
propafenon compared with control group are 
significantly (p<0.05 after one year) more 
effective in preventing reccurence of the 
arrythmia.There are not significant 
differences between quinidine, verapamil, 





Factors Determining Conversion of Difficult·to·Treat Atrial 
Fibrillation and Flutter on Oral Amiodarone 
AT. Marcel Gosselink, Harry J.G.M. Crijns, Hans Hillege, 
Kong I. Lie. Thoraxcenter, Groningen, The Netherlands. 
Oral amiodarone (AM) may be effective for conversion of 
atrial fibrillation (AF) and flutter (AFL). To determine 
factors associated with conversion on oral AM, 126 patients 
(pts) with chronic AF (101 pts) or AFL were studied. Pts 
were considered difficult-to-treat: mean AF / AFL duration 
was 43±32 months, and all pts had undergone at least 1 
electrical cardioversion (ECV) previously (median 2). In 
anticipation of ECV, pts were loaded with 600 mg of AM 
daily for 30±3 days (mean total dose 18±2 g). At the end of 
this period, 20 pts (15%, all having AF) had sinus rhythm 
(SR), whereas in 106 pts the arrhythmia persisted (AF / AFL): 
SR AF/AFL 
(n=20) (n= 106) 
AFL (pts)' 0 25 
AF / AFL duration (mts) • 41 ± 8 65: 10 
AM serum level (~g/ml)' 2.3±0.5 1.9:t0.5 .. 
DfA serum • .level (~g/ml) 1.5 ±0.9 1.1 ±0.3 
p<O.Ol, p<O.OOl; DEA = desethyl-amiodarone 
Analysed multivariately, only DEA serum level (p < 0.001) 
and arrhythmia duration (p<O.Ol) maintained significance. 
DEA serum level, apparently a more important determinant 
of conversion than AM serum level, seems to follow AM 
level in time. In conclusion, oral AM is only moderately 
efficacious in converting long-standing AF and fails to 
convert AFL A prolonged loading period to obtain higher 
DEA levels may enhance efficacy and obviate ECV. 
896·76 
Effect of Cardioversion on Functional Capacity in Chronic 
Atrial Fibrillation: A Study Using a Control Group of 
Patients Maintaining Atrial Fibrillation 
AT. Marcel Gosselink, Harry J.G.M. Crijns, Stan AJ. Van 
Den Broek, Kong I. Lie. Thoraxcenter, Groningen, The 
Netherlands. 
To investigate the effect of restoration of sinus rhythm (SR) 
on functional capacity in atrial fibrillation (AF) patients (pts), 
we assessed peak oxygen consumption (V02) and NYHA 
class before and 1 month after cardioversion l CV) in 63 pts 
with chronic AF. To determine peak V02, pts underwent 
treadmill exercise testing using gas exchange analysis. Peak 
VOZ of pts in SR after 1 month (SR-1 month, n=37) and pts 
haVIng a relapse of AF after 1 month (AF-I month, n=26) 





Peak V02 (mVmin/kg) 
.--p<O.05--•
-.--p-~- --
·p<O.OS G;c 1 
5-- :/ i 
OL " ~~ J 
SR-I man A -I month 
• bet()(e cardiovelsion mlI atter cardloversion 
In pts in SR after 1 
month, peak V0 2 
improved from 21.4±6 
to 23.7±6 rnI/min/kg 
(+11%), and NYHA 
class from 1.8±0.7 to 
1.4±0.5. In contrast, no 
changes occurred in pts 
having AF after 1 
month. Improvement of 
peak V02 in pts having 
SR after 1 month, was 
not correlated with 
baseline peak V02. 
Conclusion: restoration of SR improves functional capacity in 
AF irrespective of baseline peak V02 or NYHA class. 
Therefore, both pts with high and low functional status may 
benefit from cardioversion. 
896·77 
JACC Vol. 21, No.2 
February 1993:202A 
Changes in Atrial Dimensions After Cardioversion of Atrial 
Fibrillation: Role of Mitral Valve Disease 
AT. Marcel Gosselink, Harry J.G.M. Crijns, Hans P. Harner, 
Kong I. Lie. Thoraxcenter, Groningen, The Netherlands. 
Both atrial fibrillation (AF) and mitral valve disease (MVD) 
may cause atrial enlargement. To investigate the effect of 
restoration of sinus rhythm (SR) on echocardiographic left 
atrial (LA) and right atrial (RA) dimension, we studied 28 
chronic AF (mean arrhythmia duration 38±53 months) 
patients (pts) with (n= 10) and without (n= 18) MVD, before 
and 6 months after cardioversion (CV). Atrial dimensions 
were obtained from apical 4-chamber (long-axis and 
transverse (T) diameter) and parasternal «P), LA only) view. 
LA and RA (assuming P=T) volume were then calculated. 
Non-Mitral Va/'Ie OIsease 
Conclusion: restoration of sinus rhythm in pts with long•
standing AF is associated with a decrease of LA and RA 
volume. This holds also for pts with MVD, although LA 
volume in MVD pts remains significantly larger than in pts 
without MVD. Thus, CV may prevent adverse clinical effects 
associated with atrial enlargement in AF, irrespective of the 
presence of MVD. 
896·78 
Dual·Chamber Pacing Reduces the Risk of Recurrent 
Atrial Fibrillation 
Sharon C. Reimold, Gervasio A. Lamas, Catherine O. Cantillon, 
Elliott M. Antman, Brigham and Women's Hospital, Boston, 
MA. 
Dual chamber pacing (DOD) has been reported in 
retrospective studies to prevent recurrences of atrial fibrillation. 
To investigate whether pacing mode influences the maintenance 
of sinus rhythm we prospectively studied 214 patients (188 
Nonpaced, 10 VVI, and 16 DOD), who had previously failed 
therapy with 2±1 type I agents. Pacemakers had been placed for 
symptomatic bradycardia that developed during prior drug 
therapy or during current treatment with sotalol (SOT) or 
propafenone (pPFN) for recurrent symptomatic atrial fibrillation. 
Baseline features and the proportion in sinus rhythm at 6 months 
are shown below: 
Nonpaced YYI oou .12 
Age (yrs) 61 67 71 <0.01 
% Male 47% 10% 75% <0.01 
LA (em) 4.6 4.5 4.5 NS 
EF (%) 58% 62% 60% NS 
CAF:PAF 94: 94 3 : 7 8: 8 NS 
PPFN:SOT 116: 72 7 : 3 7:9 NS 
% SR 55% 40% 80% <0.02 
(CAF=ehronic atrial fibrillation; P AF=paroxysmal atrial 
fibrillation; SR=sinus rhythm) 
A Cox proportional hazards model showed DDD pacing to be the 
only significant predictor of maintenance of sinus rhythm (Odds 
ratio for atrial fibrillation 0.22; p<O.02) 
Ilws;, 1) When therapy to suppress atrial fibrillation causes 
bradycardia, DOD pacing is preferred. 2) VVI pacing increases 
the risk of atrial fibrillation and may be worse than no pacing. 3) 
A larger scale clinical trial of various pacing modes now appears 
indicated to define the contribution of pacing in maintenance of 
sinus rhythm without suppressive antiarrhythmic therapy 
JACC Vol. 21, No.2 
February 1993:203A 
896·79 
Amiodarone is Highly Effective in Maintaining NSR In 
Refractory Atrial Fibrillation/Flutter 
Sung Chun, Philip Sager, William Stevenson, Koonlawee 
Nademanee, Holly Middlekauff, Bramah Singh. 
West LA VAMC & UCLA Med Ctrs, Los Angeles, CA. 
To determine the efficacy and safety of amiodarone (AMIO) 
to maintain NSR in pts with ili 1.00 
refractory atrial fibrillation or z 
flutter (AF/FL), we evaluated ~ 0." 
AMIO Rx (277 ± 102 mg/d) in 91 ~ 
pts (chronic AF/FL in 44 and ~ 0.00 
paroxysmal in 47; mean age li! 0.40 
59 ± 13 yrs) who failed to ~ 0.20 
maintain NSR during 2.3 ± 1.4 gJ 
previous drug trials. g: 0.00 0'-~~2~3~~4 ~5~6 
The probability of remaining in FOLLOW UP (YRS) 
NSR was linear over the 6 yr "-------------' 
period (r=0.98, p< .001). The actuarial rate of maintenance 
of sinus rhythm (after 1 month loading) at 1,2, and 5 yrs, 
was 0.87, 0.80, and 0.57. 21 pts with arrhythmia 
recurrence had their AMIO dose increased, and after a mean 
follow up of 2.3 yrs, 76% remained in NSR. 
Predictors of AF/FL recurrence were paroxysmal AF/FL 
(45% recurrence vs 11 % in chronic pts, p < .001) and 
increased LA (46mm vs 40mm, p< .03), but not LVEF, age, 
cardiac diagnosis, or # previous drug trials. The actuarial rate 
of withdrawal for side effects at 1, 2, and 5 yrs was 0.06, 
0.12 and 0.27, the most common being skin (5.5%). thyroid 
(3.3%) toxicity or pulmonary fibrosis (3.3%; none fatal). 
CONCLUSION: AMIO has a high rate of long term efficacy 
in maintaining sinus rhythm in pts with refractory AF/FL and 
a relatively low incidence of side effects necessitating 
withdrawal. 
896·80 
Augmented Increase In Sympathetic Activity during Tread· 
mill Exercise In WPW patients with Atrial Fibrillation. 
Toshihiro Honda, Kazuya Hayasaki, Takashi Honda, Osamu Doi, 
Saiseikai Kumamoto Hospital, Kumamoto Japan 
The mechanisms of the onset of paroxysmal atrial fibrillation 
(P-AF) in patients with WPW is unknown. To evaluate the contri•
bution of sympathetic activity on the onset of P-AF, we measured 
plasma norepinephrine (NE) with electrocardiogram during 
symptom-limited treadmill exercise test (TAT). 
In 10 control subjects, NE increased to 1.46 ± 0.63 ng/ml dur•
ing TRT, while heart rate (HR) increased to 157 ± 19 beats/min. 
In 23 patients with WPW, NE and HR increased to 2,59 + 2.10 ngl 
ml and 153 ± 19 beats/min, respectively. In 10 patients with AF 
out of 23, NE increased to 3.71 ± 2.74 ng/ml during TRT. The 
value at a max exercise was significantly higher than that of con•
trol subjects or WPW patients without P-AF (p<0.05). In 5 of 10 
patients with P-AF, NE during TRT increased over 3.35 ng/ml, a 
value of mean ± 3SD of control group. Atrial premature contrac•
tions (APCs) frequently occurred in proportion to the increase in 
NE during TRT. The exercise induced APCs decreased after pre•
medication of 0.2 mg/kg of propranolol. Oral a-blocker de•
creased the appearance of P-AF from 1.5 ± 0.8 to 0.4 ± 0.8 1 
patienVyr (p<0.01). The augmented sympathetic activity was 
considered to be one of the important mechanisms of the onset of 
P-AF in WPW patients. 
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Falue fII. AIIUl Size ta Pralid Jl.ecarr_ fII. Alrid 
Filtril1ati_ After S.ccessfwl Cu:dioftrsioa: Aa 
~~
David B. Truitte, Elaine M. Olmstead, Gerald T. O'Connor, 
Jonathan F. Plehn, Dartmouth-Hitchcock Medical Center, 
Lebanon, NH 
The value of echocardiographic (echo) atrial dimension 
assessment in the prediction of sinus rhythm (SR) maintenance 
after cardioversion of atrial fibrillation (AF) is controversial. 
The accuracy of echo left atrial volume (LA V) determination 
using the modified biplane Simpson's formula has recently been 
validated by nuclear magnetic resonance imaging. In a 
prospective study of 100 patients (mean age 67 years, range 26-
91) undergoing cardioversion we evaluated the association of 
LA V as well as standard echo parameters with maintenance of 
sinus rhythm. Over an average followup of 212 days (range 5-
794) 28 patients (31 %) had recurrent AF. 
Analysis of the 90 patients successfully converted to SR 
(68% medically. 32% electrically) using a Cox proportional 
hazards model with age and sex included as covariates indicated 
that AF duration alone was significantly associated with 
recurrent AF (t=3.01, P=0.003). However none of the 
echo cardiographic parameters including LA V (t=0.894, 
P=0.374), LA area (t=1.795 , P=0.076), M-mode LA dimension 
(t=1.772, P=0.080), monoplane right atrial volume (t=0.768, 
P=0.445) and area (t=1.320, P=0.191), LV ejection fraction 
(t=0.741, P=0.461) or LV mass (t=1.914, P=0.062) achieved 
statistical significance as predictive instruments of SR 
maintenance. 
Conclusion: Neither LA V nor standard echo parameters 
are predictive of recurrent AF in patients successfully 
cardioverted. These data suggest that the routine use of 
echocardiography prior to cardioversion may not be indicated. 
896·82 
The Effects of Digoxin in Patients with Paroxysmal Atrial 
Fibrillation: Analysis of Holter Data from the CRAFT-1 
Trial 
Francis D. Murgatroyd, Baiyan Xie, Sheila M. Gibson, David E. Ward, 
Marek Malik, A. John Camm, for the Controlled Randomized Atrial 
Fibrillation Trial Investigators. St George's Hospital Medical School, 
London, England. 
The effects of digoxin on the frequency of episodes of paroxysmal atrial 
fibrillation (AF), and on the heart rate in sinus rhythm (SR) and AF have 
not been established. We analysed 24-hour Holter recordings from 31 
patients (18 men and 13 women) partiCipating in CRAFT-1, a multicentre, 
double-blind, placebo-controlled crossover trial of digoxin in paroxysmal 
AF. All recordings were made after a loading/washout phase of 7-14 days. 
Digoxin dosing was based on estimated creatinine clearance: the mean 
digoxin dose was 325 (sd 69)1'9, and the mean digoxin level was 0.86 (sd 
0.26) ngli. 
Placebo (sd) Digoxin (sd) p 
Amount of AF (min) 5153 (13212) 4427 (9241) 0.817 
No. of episodes of AF 19.1 (33.9) 12.5 (22.7) 0.256 
Mean AF episode duration 3097 (11815) 946 (3523) 0.348 
(min) 
Min. Heart Rate in SR 46.1 (7.8) 43.2 (8.7) 0.038 
Mean Heart Rate in SR 76.6 (9.5) 73.6 (10.8) 0.055 
Mean Heart Rate in AF 123.1 (25.4) 125.4 (25.8) 0.921 
Max. Heart Rate in AF 229.4l61.7) 207.9 (45.3) 0.092 
No significant reduction in the frequency or amount of AF was detected. 
Although the heart rate in sinus rhythm was reduced, the mean heart rate 
in AF appeared unchanged. However, there was a (rend towards a 
reduction in the maximum heart rate during AF: this may affect the degree 
of symptoms caused. 
204A ABSTRACTS 
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Can Heart Rate Control in Atrial Fibrillation! Atrial Flutter be 
TItrated With an Intravenous Diltiazem Maintenance Infusion? 
Kenneth A. Ellenbogen, Frank P. Cardello, Virgil C. Dias, William E. 
Strauss. Medical College of Virginia/McGuire V A Medical Center, 
Richmond, VA. 
Initial treatment for atrial fibrillation/atrial flutter, the most common 
arrhythmia for which patients are hospitalized, includes slowing of the 
heart rate with calcium channel blocker, beta-blocker or digoxin. N 
diltiazem has recently been shown to be safe and effective in the acute 
treatment of atrial fibrillation/ atrial flutter. We determined if maintenance 
infusion of N diltiazem given in stepwise increments (5 to 15 mg./hr) to 
78 patients with atrial fibrillation/atrial flutter (heart rate ~ 120 bpm) 
could maintain heart rate reduction after response to bolus. Response was 
defined as ~ 209' decrease in heart rate from baseline, heart rate < 100 

















70% to 89% 
36% to 59% 
57% to 79% 
669' to 85% 
For the 3 infusion rates studied, mean (±SD) baseline heart rate of 
144± 14 bpm was reduced by 25± 16%, 26± 14%, 30± 15%, 37± 11 %, 
and 39± 11 % at infusion hours 1,2,4, 8 and 10, respectively. By the 
end of the infusion, 14178 (18%) patients had converted to sinus rhythm. 
There were no untoward adverse events. 
Conclusion; The 5, 10, and 15 mglhr infusion rates of N diltiazem are 
safe and effective in reducing rapid heart rate in atrial fibrillation/atrial 
flutter. Ventricular response during atrial fibrillation/flutter can be titrated 
with increasing doses of N diltiazem. 
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Myocardial (Mgl+)i·Regulation: Mechanisms and Intracellular 
COlICentratioDs Measured .... ith Mgl+.Selective Microelectrode •• 
Robert Gass~r, Experimental Cardiology, Dept .of Medicine, University of GIlIZ, 
Austria; Richard D. VtW8han·JOII~S, University Laboratory of Physiology, 
University of Oxford, OX I 3PT, U.K. 
In heart die mechanisms that regulate die levels of free ionised Mg2+ «Mg2+)j) 
an: not well understood. This has primarily been due 10 technical difficulties 
associated with accurately measuring (Mg2+)i. In the sheep Purkinje fibre we 
applied a new design of Mg2+ ·selective microelectrode using the liquid Mg2+. 
selective cocktail ETH 5214 with greatly improved Mg2+.sensitivity. The 
stability, voltage·uniformity and selectivity over other ions was tested and showed 
satisfactory results. Resting (Mg2+) in 3 I sheep Purkinje fibres assessed with 
the3e microelectrodes amounted to 0.96 ± 0.04 mM. Varying extracellular Mg2+ 
level! between 0 and 8 mM produced no signiflC8llt change in measured (Mg2+)i' 
Similarly varying extracellular Ca2+ between 0 and 2.5 mM did not influence 
(Mg2+)i.Changes of extracellular as well as intracellular pH (PHi has been varied 
between 7.4 and 6.9) had no effect on (Mg2+)i.Furthennore, die theory of a 
reversible Na+ /Mg2+ .exchange mechanism was tested. Removing Na+ 0 
consistently produced a small rise in (Mg2+)i. This rise did not originate from an 
exr.ernaJ site because it could also be seen in the absence of Mg2+ o. In addition. 
1his rise of (Mg2+)i was not secondary to Ca2+ -entry upon Na+ o·removal since it 
occured also in the absence of Ca2+ o. Conversely, maximally elevated (Ca2+)j 
provoked by Na+ ·removal in the presence of 10.5 mM sttophanthidin did not 
produce a larger rise in (Mg2+)i than Na+ 0 removal in the absence of 
suophanthidin. Osmotic shock was produced by adding various concentrations of 
sucrose up to 80 mM to the external solution without osmotic compensation. 
Such an osmotic shock caused a measured rise of (Mg2+)i of similar magnitude as 
the rise observed upon removal of external Na+ .We conclude that in the sheep 
cardiac Purkinje fibre (Mg2+)i is not regulated via a reversible Na+ /Mg2+ • 
exchange mechanism although a unidirectional Na+ o·dependent Mg2+ ·efflux 
cannot be excluded. The apparent rise of (Mg2+)i seen upon Na+ o·removal is 
possibly a mixture of different factors such as osmotic shock and the effect on 
Mg2+ ·selective microelectrode of organic Na+ ·substiwl.eS. 
897·2 
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The Role of Intracellular Ca Released from the 
Sarcoplasmic Reticulum in Positive Chronotropy during 8 
Receptor Stimulation in the Rabbit Sinus Node 
Tadayoshi Hata, Takeshi Noda, Qianmin Tao, Masao Nishimura·, 
Yoshio Watanabe, Fujita Health University, Aichi, and Teikyo 
University, Tokyo·, Japan 
To evaluate the physiological role of intracellular Ca released from the 
sarcoplasmic reticulum (SR) in regulating sinus node automaticity 
during 8 receptor stimulation, action potential recording, and voltage 
clamp experiments were conducted on small preparations (0.2xO.2xO.l 
mm) of the rabbit sinus node, Selective 8 receptor agonist isoproterenol 
(ISP) increased spontaneous firing frequency (SFF), action potential 
amplitude, maximal rate of depolarization and rate of phase 4 
depolarization in a concentration dependent manner (1·100 oM). When 
Ca· induced Ca release channel was blocked by 1 11M ryanodine, SFF 
was decreased by 9.4±3.6% mainly due to the inhibition of late phase 4 
depolarization. Action potential amplitude and duration were increased 
(n=6). Conversely, the addition of 100 nM ISP after ryanodine 
superfusion longer than 10 min resulted in a further decrease in SFF by 
9.2±4.6% (p<O.05, n=6). ISP·induced increase in SFF was reversed 
by ryanodine within 1 min. Voltage clamp experiments using double 
micro-electrode techniques revealed that 100 nM ISP increased Ca 
current (Ie,) by 28.5±5.8 and 48.9±7.4%, and delayed rectifying K 
current (lK) by 12.3±4.1 and 48.6±9.2% in the absence and presence 
of 111M ryanodine, respectively. A marked increase in IK by ISP in the 
presence of ryanodine resulted mainly from an increase in its slow 
componenL In contrast, ryanodine alone decreased Ie. by 12.3±3.7% 
and I K by 8.1±2.3% without affecting their gating kinetics. These 
results suggest that I) 8 receptor activation exens a positive 
chronotropic action only when Ca release function of SR is intact, 2) 
this positive chronotropy is caused by an increase in Ie., 3) negative 
chronotropy by ISP in the presence of ryanodine is attributed to a 
marked increase in IK, and hence, 4) sinus node automaticity is 
controlled by a complex interplay of Ie. and IK conductances, both 
regulated by intracellular Ca released from SR. 
897·3 
Beneficial Effa:ts of Nisoldipine on Recovery of Ventricular 
Relaxation and Intracellular Calcium after Global Ischemia 
Ivo Amende. Lisa Bentivegna, James P. Morgan. Beth Israel 
HO~'Pital, Boston MA 
We studied the effects of the Ca2 -!antagonist nisoldipine (N IS) 
on the relationship between diastolic intracellular calcium 
([Ca2 "1i ) and LV relaxation during reperfusion recovery after 
global ischemia on a beat· to-beat basis. Nine isovolumic 
coronary-perfused ferret hearts were made globally ischemic for 
3 min and reperfused for 10 min. Ischemia and reperfusion were 
repeated during perfusion containing 10.8 M NIS. From LV 
developed pressure, time to 50 % pressure decline (T50%P) was 
obtained. leal +Ii was determined with the bioluminescent 
protein aequorin. Results (%change from control; *p <0.05 vs 
control; lIP <0.05 vs reperfusion without NIS) are: 
REPERFUSION 
TIME(min) I 3 10 
[Ca2 '1i (%) +32* +16* +1 
T50%P (%) +57* +38* +3* 
REPERFUSION + NIS 
I 3 10 
+ 14# +2# +3 
+46*# +31*# +1* 
Diastolic [Ca2 "1i was significantly elevated during reperfusion 
and associated with delayed LV relaxation. NIS reduced the rise. 
in diastolic [Ca2 "1i during early reperfusion. which correlates 
with improved relaxation. 
Data indicate that NIS ameliorates the ICa2 "1i overload and 
lessens diastolic dysfunction during reperfusion recovery. 
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Role of Cell Calciu. Overload in Production of Ische.ic 
Ventricular Fibrillation : Influence of Calciu. Channel 
Activators and Inhibitors. 
Jean F. Aupetit, *Ouadiri Timour, *Joseph Loufoua. 
Hani Ghobrial, *Jean P. larbre. *Georges Faucon. 
St-Joseph Hospital *Med. Pharmacal. Department. 
CI. Bernard University. 69373 Lyon Cedex 08 France. 
Production of ventricular fibrillation (VF) induced 
by ischemia was studied after 10 min iv infusion 
of a calcium channel activator (8ay K 8644 2.5~g/kg/mn) 
and after 5 min iv infusion of a calcium channel 
inhibitor (diltiaze. 0.5 mg/kg) in anesthetized open•
chest pigs. Ischemia was produced by temporary 
complete occlusion of the left anterior descending 
coronary artery under ventricular pacing at a constant 
high rate (180 bpm). Production of VF "as assessed 
by time to fibrillation (TF). IF "as calculated from 
occlusion of the vessel to the appearance of VF. 
Conduction time (eT) and monophasic action potential 
(MAP) were recorded in the ventricular contractile 
fibres. At the same time dP/dtmax in the left ve~tricle 
and blood pressure (BP) in a carotid artery were 
measured. IF was reduced by about 40 % by Bay K 8644 
and returned to its control values within 20 min. 
On the other hand TF was increased 5 to 6 times after 
diltiazem infusion, even 25 ruin later. These variations 
in TF were not associated with changes in CT or MAP 
duration out of the ischemic periods. A significant 
increase in ~P/dt max and BP was observed under the 
effect of Bay K B644, contrary to diltiazem. 
Conclusion Enhancement and prevention of intra•
cellular calcium overload by 8ay K 8644 and diltiazem 
respectively proved that calcium overload is the 
main determinant of ischemic VF. 
897-5 
Magnesium Reduces Cardiac Glycoside Toxicity in Human 
Myocardium 
Robert H.G. Schwinger. Rainer Uhlmann. Michael Bohm. Erland 
Erdmann. Medizinische Klinik I der Universitiit Miinchen. Klinikum 
GroBhadern. SOOO Miinchen 70. Germany 
The present study aimed to examine the effect of Mg2 + on 
inotropic and toxic actions of ouabain (OUA) in human 
myocardium. QUA concentration·dependently increased 
isometric force of contraction (FOC) in electrically driven human 
right auricular trabeculae (AUT. nonfailing. no cardiac glycoside 
treatment). The maximal positive inotropic effect (IE) of QUA 
(5.9±0.9 mN. 1 mM Mg2+) was preserved after increasing 
Mg2+ from 1 to 2 mM (5.8±0.9 mN). Time until toxic effects 
(arrhythmias. contracture) occurred after QUA (0.1 pmolll) was 
significantly longer with 2 mM Mg2+ compared to 1 mM Mg2+. 
In AUT the FQC increased with increasing frequency (0.5-3 Hz) 
of stimulation (l.S mM Ca2+: 2Hz 146±S% basal). The force•
frequency·relationship (FFR) becomes negative after elevation of 
extracellular Ca2 +. Mg2 + was effective to restore the normal 
FFR in the presence of enhanced Ca2 + (2.4 mM Ca2 + • 2 mM 
Mg2 +; 2 Hz: 145 ± 16% basal). The receptor·density (Bmax:NF 
14.1 ±O.S pmollmg protein. NYHA IV 11.2±O.5 pmol/mg 
protein) and affinity measured by 3H·ouabain binding was not 
different in nonfailing and failing (heart transplants. NYHA IV) 
hearts. Mg2 + increased concentration·dependently the affinity of 
3H·QUA to its receptor. In conclusion: (1) Mg2 + acts directly on 
human myocardium to diminish QUA·induced toxicity. but 
preserves the maximal positive IE of QUA; (2) the antagonistic 
action of Mg2 + is not due to a reduced receptor·binding of 
cardiac glycosides. but may be due to Ca2 + ·antagonistic 
properties of Mg2 + . 
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ABSTRACTS 
Coronary Endothelial Function and t-PA, PAI-. 
Release During Exercise 
Hirolaka Napslima. Yukio Tsurumi. Kenichiro Ichikawa. AlSushi Takagi. 
TsUbl!U Suzuki. Megumu Kanno. MasaIDmo Honda. Saiehi Hoseda. 
ilinda Memorial Tohoku Cardiovascular Medical C .... r. Fukushima. Japan and 
The Heart Institute of Japan. Tokyo Wemen·. Medical CoDege. Tokyo. Japan 
To evaluate coronary endothelial function. we investigated association 
be~n vasomotor response ci angiographicaDy nonnal corooary ar1eries to 
acetyk:holine(Ach). an endolhelitm-dependent vasodilaIDr. and exerci.e-induced 
re~e of tissue plasminogen activator(t-PA) arIi plasminogen activator 
inhibitor-l(PAI-l) from endolhelialceDs. 
We meaued diameter changes d left anterior descending coronary arteries 
p-cxU:ed by in1raCOronary acetyk:holine(50"g) wilh videodensitometric analy.is 
in 30 patienlS with angiographically nmnal coronary arteries. In the same 
.ubjects. "" performed trea<knill exercise !£sIS (Bruce protocol) and measured 
venous ~PA. PAl-I. and epinephrine(EPI) at rest and peak exercise (85% of 
maximal heart rate). 
The vasomokr response to Ach (ran\llO: +13% diIalation - -47% constriction) 
was lhought to ref1ectcorooary endolhelial function since all arteries were dilated 
by intracoronary isosorbide dinitrate. an endothe1ium·independent vasodilat>r. 
Moreover. ceronat)' vasomok>r response was associated with both &r .. PA/AEPI 
and APAI-IiAEPI provoked by .. ercise (p=O.005. p=O.03. respectively). 
These resullS sug\llO.t lhal coronary endolhelial function is impaired in lhose 
wilh sy.1emic endolhelial dysfunction assessed by release of t-PA and PAI-l 
dtring exercise even when atherosclerotic changes are not de~talie with 
angiography. 
898-85 
Relationship Between Early Plasma Atrial Natriuretic 
Factor levels and Exercise Performance After Acute 
Myocardial Infarction 
Torbjorn Omland, Vernon V5 Bonarjee, Asbjorn Aakvaag, 
Torbjorn Aarsland, Kenneth Dickstein. Central Hospital 
in Rogaland, Norway 
The hypothesis that early plasma atrial natriuretic 
factor (ANF) levels are related to subsequent functional 
capacity in patients with acute myocardial infarction 
(MI) was tested in 90 male patients (age 66 (10) (SO) 
years). ANF determination was obtained on day 3 and 
exercise testing on an upright bicycle ergometer to 
symptomatic endpOints was performed 1 and 6 months after 
MI. A weak, but Significant inverse relationship between 
day 3 plasma ANF levels and exercise duration was 
observed (1 month: r=-O.274, p=O.012; 6 months: r=-O.35B 
p=O.OOl). In the subgroup of patients without effort 
related myocardial ischemia, the relationship was closer 
(figures). 
1 Month 6 Months 
800 800 
n- 36 D"" Jl 
600 .' '. r--S33 600 ,..-60S p- 001 ~.' Exercise ~ DuratioD 400 .. . . ~o ." .. fucoDcllJ ..... .. . " .. . . 
200 200 
0 0 
0 20 ~ 60 '0 0 20 .. 60 10 
ANF (pmol/U ANF (pmoVIl 
This finding suggests that in male patients early plasma 
ANF values are predictive of subsequent exercise capac•
ity post MI. The relationship seems to be especially 




Physiologic Responses to Morning and Evening Exer1lon: implICations 
for Triggering of Cardiovascular Disease 
AKredo H. Jimenez, Xianghong Chen, Harold S. Solomon, Geoffrey H. 
Tofler, James E. Muller. Institute for Prevention of Cardiovascular Disease, 
Cardiovascular Division, Deaconess Hosp~al, Harvard Medical School, 
Boston, MA 
The frequency of onset of myocardial infarction and stroke is now 
well.oocumented to increase during the hours after awakening. Since 
these data suggest that disease onset could be triggered by extemal 
stressors, recogn~ion of the moming period of increased risk has led to 
concem about the safety of exertion at this time of day. 
To determine whether the time of day influenced the hemodynamic 
and hemostatic responses to exercise, we compared isometric exercise 
(handgrip) in the moming (9 am) versus the evening (6:30 pm) in 15 
subjecls w~h mild hypertension. Fibrinolytic potential (euglobulin clot lysis 
time [ECl1] and plasminogen aclivator inhib~or [PAl] antigen) and systolic 
arterial pressure (SAP) were measured following handgrip (HOG) at 30% 
maximum for 3 minutes. Values are mean :I; SEM; • = p < 0.05 for 
adjacent values. 
EClT(minl PAI(ng/mll SAP (mmHg} 
Rest HOG Rest HOG Rest HDG 
AM 364!45 • 312:t44 18:1;5 19:t;6 131:1;4 • 161:1;5 . . . . . 
PM 220:1;33 • 176:1;27 10:1;2 11:1;2 141:1;5 • 176:1;5 
Isometric exercise produced similar fibrinolytic and hemodynamic 
responses in the moming and evening. The lower fibrinolytic potential 
(higher ECl T and PAl levels) noted in the moming both before and after 
stress is consistent w~h a greater absolute risk of infarction at this time of 
day. However, considering the overall beneficial effects of exercise, the low 
absolute risk of an event during exercise, and the lack of an adverse 
moming response to exercise in the present study, there is currently no 
reason to caution patients to avoid moming exercise. 
898·87 
Influence of the Autonomic Nervous System on 
Atrioventricular Conduction during Exercise in Patients 
with Chronic Atrial Flutter. 
Balazs M. Szab6, Harry ],G.M, Crijns, K,I. Lie. University of 
Groningen, The Netherlands 
In a retrospective study 15 exercise stress testing ECG 
recordings of patients (pts) with chronic atrial flutter (AFL) 
were analyzed, On 6 recordings 1: 1 atrioventricular conduction 
(A VC) was observed, Comparing those with and without rapid 
A VC, a significant difference in resting cycle length (CL) (262 
ms vs. 234 ms) and change of CL during exercise (5,16 % vs, 
3.86 %) was observed (fig.), Analysis of these recordings by 
type of medication showed no difference in resting CL between 
pts using digoxin (CL 247 
ms) and those without 
digoxin (CL 244 ms) with 
a lower increase of CL 
during exercise 
:m.llfl.a.!lm] 
11 AV:: dUnnj 0lIElCSe 
D> 
L----L-l ,., I I I (2.48± 1.94 vs. 
6.05±5,05%) in pts using 
digoxin, 
Conclusion: Pts 
with long resting AFL CL 
and an enhanced increase 
of CL during exercise are 
Dl 
"" 
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!6t.!n:! Pl:Bk.exer~ ~ 
at risk of developing rapid A VC, The above changes are 
caused by the exercise-induced decreased vagal and increased 
sympathetic tone, Vagotonic treatment of pts with AFL causes 
not only slowing of A V -conduction, but it also reduces the 
increase of AFL CL during exercise, thus preventing rapid 
AVC, 
898·88 
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Differential Effects of Coronary Bypass Surgery in Men 
and Vo.en Based on Exercise Testing 
Donald A. Yeiner, Thomas J. Ryan, Lori Parsons, Lloyd 
D. Fisher, Bernard R. Chaitman, L, Thomas Sheffield, 
Felix E. Tristani, and The CASS Investigators. Boston 
University Medical Center, Boston, MA. 
To evaluate the long term effects of coronary 
bypass surgery in men and women based on exercise 
testing (ETT), we compared the ETT results of 3086 men 
and 747 women from the CASS registry. The patients 
were divided into 3 groups based on the degree of ST 
depression (~) and the final exercise stage (FS) 
achieved: Grp 1 (high risk) = > 1mm ST ~, FS <1; Grp 2 
(intermediate risk) = ~1mm ST I, FS > 1 or no-ST +, FS 
< 1; and Grp 3 (low risk) ~ no ST *, FS > 3, Sixteen 
year survival, based on ETT groups, ranged from 48 to 
74% in men and from 58 to 91% in women (p<0.001), 
Twelve year survival (%) of surgical and medical 
treatment in men and women, based on ETT groups, were: 
MEN YOMEN 
Surg Ked Surg Ked 
N%N%N%N): 
Grp 1 (high risk) 348 68 205 57* 66 56 82 72* 
Grp 2 (intermediate) 574 75 855 75 35 85 241 88 
Grp 3 (low risk) 146 78 958 82 9 67 311 95* 
*p<0.05, surgical vs. medical 
The major benefits of surgery in group 1 men 
occurred in 3-vessel CAD. By contrast, no angiographic 
or ETT subset of women showed enhanced survival after 
surgery. 
Ye conclude that ETT is helpful in assessing the 
long term survival in men and women. However, only in 
men could ETT identify a high risk subset whose 
survival was enhanced by coronary bypass surgery. 
898·89 
Prognostic Value of Exercise Echocardlography After 
Aortic Valve Replacement: Long-term Follow·up 
Uwa Younis, Frederick A. Dressler, Jeanette A. 51. Vrain. TImothy J, 
Martin. Ramon Castello. Arthur Stelken. Arthur J, Labovitz, Saint 
louis University Medical Center, SI. Louis, Missouri. 
Aortic valve replacement (AVR) is associated with significant 
improvement in mortality in pts with significant aortic valve disease; 
however. the impact of surgery on functional capacity is not well 
known, To evaluate the prognostic information contained in 
exercise (EX) Doppler echocardiography (ECHO) after AVR, 81 pts 
(mean age = 56±16) had preoperative rest and rest & post EX 
ECHO at 6 months post-operatively, During 17±8 monthS of follow•
up, 17 pts worsened their functional capacity by one or more NYHA 
functional class (G1), while 64 pts had improvement (G2), There 
were no differences in age, sex, extent of coronary artery disease. 
size and type of prosthetiC valve used. resting left ventricu lar 
ejection fraction (LVEF), or Doppler variables, At 6 months, rest & 
EX ECHO showed: 
EX Duration (sec) 
METS 
lVMI (g/m2) 
Increase EX EF 
!Jl 
375 ± 222 
5,3 ± 32 
143 ± 60 
53"10 
!:a2 
481 ± 162 
7,1 ± 2,6 
112 ± 31 
82"10 






Univariate analysis of 36 clinical. EX and ECHO variables selected 
functional class at 6 months (p<O,OOl), EX duration (p<0.002), 
LVMI regression (p<0,02). increase lVEF > 5"10 with EX (p<0.01) as 
predictors of improved functional class, Therefore. post-operative 
EX ECHO after AVR can identify pts in whom functional capacity 
may remain limited after successful intervention, 
lACC Vol. 21, No.2 
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Comparison of Thallium Kinetics in Normal Subjects During 
Exercise, Adenoaine, Dipyridamole, and Dobutamine Stress 
Jaetae Lee, Shung C. Chae, Kyubo Lee, Jaekyeong Heo, 
Abdulmassih S. I skandr ian , Kyungpook National University 
Hospital, Taegu, South Korea, and Philadelphia Heart 
Institute, Presbyterian Medical Center, Philadelphia, PA 
This study examined the initial thallium uptake and 
washout (W/O) in 15 normal volunteers who underwent 
serial stress testing during exercise (Ex), adenosine 
(ADEN) , dipyridamole (DIP) , and dobutamine (DOB) 
infusion. Planar images were obtained after initial 
thallium injection and four hours later. Count densities 
(counts per pixel) were derived from myocardial (M), 
hepatic (H), and lung (L) regions of interest. The 
results are shown in table. 
Els t.!mi ill ~ 
M 410 :t 54 510 :t 96* 504 :t 113* 544 :t 81* 
LIM Ratio (') 27 :t 5 39 :t 7* 41 :t 8* 35 :t 4* 
HIM Ratio (') 27 :t 5 89 :t 16* 95 :t 19* 97 :t 15* 
M-W/O (') 50 :t 4 40 :t 7t 40 :t 9t 45 :t 8 
L-W/O (') 32 :t 7 39 :t 5t 42 :t 5t 35 :t 6 
H-W/O(t) -12 :t 24 56 :t 7* 60 :t 7* 57 :t 10* 
* - P < 0.001 and t - P < 0.05 
Thus, myocardial thallium concentration is higher during 
pharmacologic than exercise testing, reflecting a higher 
coronary blood flow. However, the myocardial W/O is 
lower, probably due to the greater degree of hepatic W/O. 
Further, the lung and hepatic uptake and W/O are 
different between the types of stress testing suggesting 
the need for specific normal files for each type of 
stress when quantitative analysis is used. 
899-91 
Safety of Dipyridamole Testing: Preliminary Results in 43,000 
Patients 
Jean Lette on behalf of the Multicenter Dipyridamole Safety Study. 
Montreal Heart Institute, Montreal, Quebec, Canada 
Data was collected retrospectively from 43,697 patients who 
underwent dipyridamole imaging in 30 Nuclear Cardiology labora•
tories in 9 countries to determine the incidence of major adverse 
reactions during the test. The dose of dipyridamole infused was 
0.56 mglkg in 37,889 pts, 0.74 mg/kg in 3,827 pts, 0.84 mg/kg in 
1,981 pts. 
There were a total of 29 (0.07%) major adverse events, including: 
1- cardiac deaths: 4 (0.009% or 1110,(00) 
2- non-fatal myocardial infarctions: 10 (0.02% or 1/4,(00) 
3- malignant (but reversible) ventricular arrhythmias: 4 (0.009% or 
1110, (00) 
4- transient cerebral ischemic attacks (*): 8 (0.02% or 1/6, (00) 
5- strokes: 1(0.002 % or 1/40, (00) 
6- severe bronchospasm requiring intubation: 1 
7- acute severe allergic reactions to dipyridamole: 1 (fatal) 
8- acute severe allergic reactions to aminophylline: none 
9- others 
. massive fatal pulmonary embolism: 1 (0.002 % or 1140, (00) 
. severe bradyarrhythmia requiring cardiac massage: 1 
Unstable angina requiring hospitalization and/or coronary 
revascularization, and reversible pulmonary edema were uncommon, 
and not included as study end points because of the subjectivity 
related to the definition of these conditions. The variability in the 
complication rate from one center to another is low, suggesting that 
the detection and reporting of events was done with a similar degree 
of accuracy. 
Conclusion: The risk of dipyridamole appears to be very low and 
similar to that which would be expected from exercise testing in a 
comparable population of patients. 
(*) with dysphasia and/or motor defect 
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899-110 
Dipyridamole Sestamlbl Myocardial Imaging For Cardiac Risk 
Assessment Before Nonvascular Surgery: Does Every 
Operation Demand a Preoperative Stress Study? 
Henry G. Stratmann, Beaver R. Tamesis, Liwa T. Younis, Mark D. Wittry, 
Robert D. Wiens, Bernard R. Chaijman, D. Douglas Miller. 51. Louis Veterans 
Administration Medical Center and Saint Louis Universijy Medical Center, 
51. Louis, Missouri. 
Stress thallium-201 myocardial imaging is frequently combined with 
clinical evaluation to assess the risk of perioperative cardiac events (CE) in 
pts having nonvascular surgery. The prognostic value of dipyridamole 
technetium-99m SestaMIBI (MIBI) tomography has not been established in 
this setting. We performed same-day rest-stress dipyridamole MIBI studies 
in 131 consecutive pts (129 men, age 67±8 years) who were unable to 
exercise < 3 mos before nonvascular surgery. 60 pts (Group I) had "major" 
procedures (intraabdominal surgery, Ihoracotomy, limb amputation, etc.), 
and 71 (Group II) had "minor" procedures (transurethral prostate resection, 
hemiorrhaphy, etc.). Resuns of MIBI testing were available for preoperative 
risk management; only 1 Group I pt had coronary revascularization before 
nonvascular surgery. 5 Group I pts (8%) had CE--unstable angina in 2, and 
cardiac death in 3. There were no CE in Group II pts. Selected preoperalive 
clinical and MIBI imaging dala in the 2 groups are compared below: 
Group I ~
NoCE(n=551 ~ (n=71) 
GoldmanClass~ II 50 (91%) 5 (100%) 71 (100%) 
CAD by angiography' 18 (32%) 1 (20%) 21 (30%) 
MI History/ECG Q waves 20 (36%) 2 (40%) 25 (35%) 
Abnormal MIBI scan 27 (49%) 4 (80%) 53 (75%) 
Reversible MIBI defect 14 (25%) 2 (40%) 26 (37%) 
Fixed MIBI defect 17 (31%) 4(80%j 39 (55%) 
Reversible and fixed defects 4 (7%) 2 (40%) 11 (16%) 
• >1 stenosis >50%' "=p<.05 versus Group I pts wtthout CEo 
We conclude that, wijh the exception of a fixed MIBI defect predicting CE 
in "major" nonvascular surgery pts, the prognostic value of preoperative MIBI 
imaging in low-moderate CAD risk pts undergoing nonvascular surgery is 
limrted, especially in "minor" surgery piS where very low cardiac event rates 
reduce the predictive power of preoperative CAD screening. 
899-111 
ST Segment depressIon durIng AdenosIne 
InfusIon Is a marker for severe coronary 
artery dIsease. 
David W. Frazier, Jack R. Daley, Donald L. Johnston, 
RaymondJ Gibbons; 
Mayo Clinic, Rochester, Minnesota 
The Significance of ECG and hemodynamic changes during 
Adenosine (AD) infusion and their relation to underlying CAD 
severity and clinical variables remains uncertain. 56 patients 
were studied who had interpretable ECGs during AD Thallium 
(TD SPECT imaging, cardiac catheterization within 3 mos, and 
met exclusion criteria of no prior CABG or PTCA within 6 mos. 
11 (20%) developed >-1 mm ST depression (+STd) during 
AD infUSion. Multiple variables were significantly aSSOCiated 
with +STd: Hemodynamic (all p < 0.04) - higher rest rate 
pressure product (RPP), and higher peak heart rate (HR) and 
RPP; II analysis (all p < 0.02) - increased extent and total 
amount of Tl redistribution mD). and Increased Tl perfusion 
defect at stress; AoQioQraphjc significant LM or 3V CAD 








It of Diseased Vessels 
o 1 2 :WM 
o 1 4 6 
4 14 20 7 
The positive predIctive value of STd was 100% for any CAD 
and 55% for LM13V CAD. After adjustment for number of 
diseased vessels; Increased stress Tl perfusion defect was an 
independent predictor of +STd (p=O.OOO 1). 
Conclustons: ST segment depression during Adenosine 
infusIon is strongly aSSOCiated with (1) Increased number of 
diseased vessels, (2) LM13V CAD, and (3) Increased stress 
Thallium perfusion defect. 
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899·112 
Intravenous adenosine fails to increase coronary blood flow as 
consistently as dipyridamole or dobutamine 
Cart W. Christensen, Michelle A. Rieder, Cynthia S. Lessila, Yue-Hua 
Shen, Donald H. Schmidt, University of Wisconsin, Sinai Samaritan 
Medical Center, Milwaukee, WI 
Dipyridamole (DIP) is often used as a coronary vasodilator in patients 
who are intolerant of exercise stress. DIP acts primarily by blocking the 
uptake of adenosine (ADN) in the cell and thus prevents its rapid 
breakdown. Because of this action, IV ADN has been proposed as a 
comparable pharmacologic stress inducing agent for evaluating 
coronary reserve and coronary artery disease in patients. We 
compared IV ADN (140llg/kg/min), IV DIP (0.58mg/kgl4min) and IV 
dobutamine [(DOB) 6119/kg/min)J in dogs (n=14) for their ability to 
maximize coronary blood flow (CBF) as measured by Xenon-133 (XE) 
washout, microspheres (115) and electromagnetic flow probe (EMF). 
We measured heart rate, diastoliC coronary perfusion pressure (PPd), 
and the percent of positive responses (%POS). 
BSLN IVADN IV DIP IVDOB 
EMF (mllminll00gm) 64±4 80±9* 131±18"# 11219"# 
liS (mllmin/l00gm) 58±4 62±6 108±14"# 102±6"# 
XE (mllminll00gm) 47±3 60±6* 93±10"# 90±7* 
Heart rate (bpm) 116±3* 113±4' 107±4*' 138±4* 
PPd (mmHg) 87±5 75±6' 55±3*' 111±5* 
%POS 0 66 100# 100# 
*p<0.05 vs. BSLN #p<0.05 vs. IV ADN 'p<0.05 vs. IV DOB 
In this model (1) IV ADN is not as effective as IV DIP or IV DOB in 
increasing CBF; (2) IV ADN was significantly less consistent increasing 
CBF than either DIP or DOB; (3) the greater increase in CBF with IV 
DIP occurred in the presence of a greater decrease in PPd than was 
observed with IV ADN; (4) IV DOB was as effective as IV DIP in 
maximizing CBF. The data suggest that due to the inconSistency of IV 
ADN to increase CBF it is not a good agent for clinical use in 
diagnosing coronary flow reserve. 
899·113 
Comparison of Simultaneous Dobutamine Tc-99m Sestamibi Imaging 
and Echocardiography in Patients with Reactive Airways Disease 
Steven D. Herman, Joseph R. McClellan, Carlo D. Santos-Ocampo, 
Candace M. McNulty, Carol Ewing Garber, Donna J. Cloutier, Alan W. 
Ahlberg, Debra E. Messinger, Linda J. Saint Laurent, Gary V. Heller. 
Memorial Hospital, Brown University, Pawtucket, Rhode Island. 
To compare the utility of dobutamine sestamibi SPECT imaging (OS) 
and dobutamine echocardiography (DE) for the detection of ischemia in 
patients (pts) with reactive airways disease, 27 pts on bronchodilators 
(19 females, mean age 63 years [range 45-811) underwent simultaneous 
OS and DE. Dobutamine was infused in 3 min stages to a maximum of 
30 IIg1kglmin. OS and DE were assessed by separate investigators 
without knowledge of patient identity for evidence of dobutamine•
induced normalizing perfusion detects or wall motion abnormalities. 
Heart rate increased from 83±16 to 131±22 (p<O.OOOl) and heart rate•
blood presslM'e product from 11,27312564 to 19,10914296 (p<O.OOOl). 
Ischemic SoT segments ~lmV) occurred in 3 pts and chest pain in 6. 
Side effects included hypotension (a fall of >20 mmHG) in 3, dyspnea in 
1, increased ectopic atrial activity in 11, increased ventricular premature 
comptexes in 9, and non-sustained ventricular tachycardia in 2. 
OS images were adequate for interpretation in all pIS and identified 
ischemia in 12 (440/0). DE was adequate in 16 pts (590/0), and 
inadequate in 11 (41%, partially interpretable in 6 and uninterpretable 
in 5). DE identified ischemia in 3 pts (11%). Comparisons between DE 
and OS results revealed: 
DE Qualitv Ischemia on DE Ischemia on OS Concordance 
Adequate 3/16 4/16 15/16 (94%) 
Inadequate 0/11 8/11 3/11(27%) 
Concordance varied with the adequacy of the echocardiogram obtained. 
Conclusions: Dobutamine sestamibi SPECT imaging and dobutamine 
echocardiography compare favorably for the evaluation of myocardial 
ischemia in patients with reactive airways disease when adequate 
echocardiograms are obtainable. However, dobutamine sestamibi 
SPECT imaging frequently can identify ischemia in those patients who 
have inadequate echocardiograms. 
899·114 
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SPECT Tc-99. Se.tamibi Imaging During Adenoaine Induced 
coronary Hypere.ia 
Marc reece, Ira Wolmer, Shung Chae, Jaekyeong Heo, 
Valerie Wasserleben, Virginia Cave, Abdulmassih S. 
Iskandrian. Philadelphie Heart Institute, Presbyterian 
Medical Center, Philadelphia, PA. 
It is not clear whether the lower extraction fraction of 
sestamibi than thallium affects the diagnostic accuracy 
of sestamibi during adenosine induced coronary hyperemia. 
This study, therefore, exaained the results of SPEcr 
sestamibi imaging during adenosine infusion. There were 
101 patients (pts) with coronary artery disease (CAD) (~ 
50' diameter stenosis) of 1 or more of the major 
arteries, and 31 pts with either normal angiograms (n-13) 
or low pretest probability of CAD. There was an increase 
in heart rete (72 t 12 vs. 87 t 16 bpm, P < 0.0001), and 
a decrease in systolic blood pressure (139 t 21 vs. 131 
:t 20 mmHg, P < 0.001) during adenosine infusion. The 
SPECr images were abnormal in 83 pts with CAD 
(specificity-82,), and normal in 25 pts with no CAD 
(normalcy rate-8l,). The sensitivity was 69\ in the 35 
pts with l-vessel CAD, and 89% in 66 pts with multi•
vessel CAD. In pts with l-vessel disease, the \ stenosis 
was 81 :t 18 in pts with abnormal, and 75 :t 20 in pts with 
normal images (P-NS). The size of the perfUSion 
abnormality was 16 :t 12 in pts with l-vessel disease, and 
23 :t 10 in pts with multi-vessel disease (P < 0.05). 
There was a correlation between the presence and nature 
of perfusion defects, and wall motion by contrast 
ventriculography in 71% of segments (P < 0.05). Thus, 
SPEC! sestamibi imaging is highly sensitive in pts with 
multi-vessel CAD. The low extraction fraction at high 
coronary flow. rates may explain the lower sensitivity in 
pts with l-vessel CAD, especially those with mild 
stenosis. 
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900·34 
Va.a80tar Con.ideratian. in the Choice of Contra.t 
Media 
David S. Mark., John A. Osborne, Kenneth S. Himmel, 
Joseph A. Vita. Harvard University, Boston MA_ 
There is considerable controversy regarding the 
relative advantages of non-ionic and low-osmolar 
contrast media for cardiac catheterization. In 
particular, the vasomotor effects of these agents 
are not well defined. We investigated the vasomotor 
response. ot isolated ring. of rabbit aorta 
preconstricted with norepinephrine to ionic high 
osmolar (IHO), ionic low osmolar (ILO) and non-ionic 
100 a ICN1C HIGH os_ low osmolar (NLO) contrast 
• NON-IONIC LOW OSIIOIAA media. IHO and ILO contrast 
_ v OSWOlAA ""T-o produced greater, dose-
~ '0 ,,- related relaxation than NLO 
~ 0 (ANOVA p<0_05). IHO and ILO ~ sa / contrast also produced 
1 greater relaxation than high•S ht:::==e osmolar control (mannitol ~.. 6 ....-:i:;-' 1690 meq/L) (p<0.05). i,~ ~:~O:~lef~!ct t~~ t~~d~:~~~t~~ 
responses, suggesting a 
10 ,. direct effect of these agents 
PERCafl\QJJIII[ on vascular smooth muscle. 
Thus, ionic contrasts are more potent vasodilators 
than non-ionic contrast by virtue of ionic, but not 
osmolar properties. This mechanism ia endothelium 
independent. When the object of catheterization is 
a careful assessment of vasomotion, e.g- evaluation 
ot coronary spasm or during quantitative 
angiography, non-ionic (and not simply low osmolar) 
contrast may be a more appropriate choice. 
lACC Vol. 21, No.2 
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900·35 
Structural Analysis of Tillue-type Plasminogen 
Activator (t-PA) Receptor Mediated Internalization 
and Degradation by Human Smooth Muscle and 
Endothelial Cells 
Stephen R. Grobmyer, Alice Kuo, Shunichiro Okada, Margaret 
Orishimo, Douglas B. Cines, Elliot S. Barnathan, University of 
Pennsylvania School of Medicine, Philadelphia, PA 
Smooth muscle cells (SMC) synthesize t-PA mainly after 
vascular injury, while endothelial cells synthesize, secrete and 
bind t-PA, particularly after vascular occlusion. Since little is 
known about the interaction of t-PA with SMC, we studied the 
binding of labeled t-PA to passaged, confluent layers of human 
SMC explanted from human aorta, coronary artery, and umbilical 
vein. Binding was rapid, specific, and saturable. Analysis of SMC 
Iysates after binding at 4°C revealed formation of labeled SDS•
stable complexes with plasminogen activator inhibitor· 1 (PAI•
l). To assess whether SMC internalized and degraded bound t·PA, 
SMC were incubated with labeled t-PA (0.2 j.1g1ml, n=6) at 4° C 
for 2 hrs, and then warmed to 37° C for 4 hrs. SMC internalized 
and degraded 67±6% of specifically bound t-PA as measured by 
trichloroacetic acid soluble counts in the supernatants. 
Degradation was inhibited >90% by monesin (100j.1M) or 
chloroquine (2 mM). When labeled t-PA was added at 37'C, 
degradation at 4 hrs was inhibited 94±2% by unlabeled t-PA 
(n-5), 79±4% by active site blocked t-PA (n-5), 68%±S% 
(n=4) by a variant t-PA missing the finger and epidermal growth 
factor domains and carbohydrate at amino acid 117, and 36±4% 
(n-3) by this variant with the active site blocked (all at 100 
fold molar excess), while excess mannose, galactose, EACA, and 
ovalbumin had no effect. Degradation of labeled t-PA or 
t-PAlPAI-1 complexes by SMC was nearly completely inhibited 
by recombinant receptor-associated protein (100nM), a protein 
known to inhibit internalization of protease-inhibitor complexes 
via the a2 macroglobulin receptor (a2MR). By contrast, human 
umbilical vein endothelial cells degraded only 6±1% (n=3) of 
bound t-PA (0.2 I1gJml) over 4 hrs. These stUdies suggest that 
t-PA binds to SMC-associated PAl-I and gets internalized at least 
in part via the a2MR and that several t-PA domains may 
contribute to its ultimate recognition by SMC t-PA receptors. 
900·36 
A TP Sensitive Potassium Channel Plays an Important Role 
in Maintenance of Arteriolar Dilation Distal to A Severe 
Coronary Artery Stenosis 
Michael Gilson, Daniel Levine and Henry Gewirtz. Rhode Island 
Hospital and Brown University, Providence, Rhode Island 
Recent evidence indicates that metabolic mediators such as adenosine 
play only a limited role in maintenance of baseline arteriolar dilation 
distal to a severe coronary artery stenosis (CAS) and that other factors 
(eg; myogenic mechanism) playa more important role. This study 
tests the hypothesis that an A 1P sensitive potassium channel also 
contributes importantly. Studies were performed in 9 pigs prepared 
with a severe CAS (80% DIA reduction) in the left anterior descending 
(LAD) coronary artery: Hemodynamics and regional myocardial blood 
now (RMBF) were measured at control and after 5 min of infusion of 
glibenclamide (GLB; K channel blocker) at 0.1 and then at 0.5 
mg/kg/min distal to CAS. Results (mean±SD) were as follows: Heart 
rate (lmin) and mean arterial pressure (mmHg) were unchanged versus 
control (l32±15 and 118±19, respectively) during the study. 
Zone: Control 
RMBF(mVminlg) 
GLB (0.1) GLB (0.5) 
Stenosis 
Endo 1.38 ± 0.27t 1.23 ± 0.34 0.94 ± 0.35 (**,+) 
Epi 1.58 ± 0.50 1.40 ± 0.40 1.04 ± 0.41 (**,+) 
Circumnex 
Endo 2.16 ± 1.34 1.85 ± 0.62 1.58 ± 0.70 
Epi 1.84 ± 0.92 1.72±0.61 1.40 ± 0.63 (*) 
*=P<0.05 vs Control; **=P<O.OI vs Control; +=P<O.05 vs GLB 
(0.1); t=P<O.05 vs Circumflex Endo 
Accordingly, the data indicate in the setting of a severe CAS that an 
A TP sensitive potassium channel plays an important role in 
maintaining baseline arteriolar dilation distal to the stenosis. 
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900-37 
Maximizing Gene Transfer Into Vascular Smooth Muscle 
Cells 
Yi Shi, lJ.xin Jiang, David J. Hall, Howard G. Hutchinson, AI K. Fard, 
Andrew Zalewski. Thomas Jefferson Universiy, Philadelphia, PA. 
Manipulation of gene expression by gene transfer into vascular 
smooth muscle cells (SMC) may offer insights into pathomechanisms 
of cardiovascular disease and provide new therapeutic tools. 
However, a low level of gene expression using non-virus mediated 
gene transfer significantly limits its application. Therefore, the goal 
of this study was to define the proper expression vector and to 
optimize the condition for gene transfer in human and porCine SMC. 
The luciferase (Iuc) gene was inserted into different expression 
vectors containing various promoter/enhancer and the efficiency of 
gene transfection was assessed measuring luc activity. pCEP-luc 
containing human CMV 
promoter provided the 
highest gene expression 
pCEP-Iuc transfer Into human SUC 
30T:~----~~----------'" 
luposOmeJONA 0:1 UposomeJONA 1:1 in human and porcine ..!! SMC (30 and 400 ng/ ~ 106 cells, respective- "'~ 20 UposomeJONA 2:1 UposomaiDNA 3:1 
Iy). The maximal luc 2' 
expression was obtained ! 10 
after 6 hours of l 
transfectlon. The effi--g 
ciency of gene transfer...l 0 ~_ .............. -. __ ............ 
was dependent on DNA 
concentration and lipo•
some/DNA ratio (Fig.). 
0.5 1.0 2.5 
DNA I'9fWeg 
5.0 
In conclusion: I. the pCEP-luc expression vector provides a 
high level of gene expression in human and porcine SMC. 2. the 
efficiency of gene transfection is critically affected by DNA and 
liposome contents. 3. these data provide the basis for using gene 
transfer in manipulation of gene expression in vascular SMC. 
900-38 
Na+,H+ Exchange Inhibition Suppresses Neolntlma 
Formation After Arterial Injury in the Rat 
Roger Kranzhofer, Eberhard von Hodenberg, Wolfgang 
Kabler, JOrgen Metz·, Johannes Schirmer, Albert SchOmig, 
Depts. of Cardiology and *Anatomy, University of Heidelberg 
Neointimal thickening after vessel wall trauma results from 
migration and proliferation of smooth muscle cells from the 
tunica media. Smooth muscle cell proliferation is initiated by 
growth factors. The proliferative response to growth factors is 
thought to be mediated by Na+,H+ exchange. In this study the 
effect of the Na+,H+ exchange inhibitors 3-methylsulfonyl-4-
piperidino-benzoyl guanidine (Hoe 694) and 5-(N-ethyl-N-iso•
propyl)amiloride (EIPA) on neointima formation in the rat 
carotid artery after balloon injury was investigated. Cross•
sectional plaque area and DNA content of the vessel wall 
were quantified 14 d after ballooning. Hoe 694 (3x5, 3x15, 
and 3x30 mg/kg body weightld i.p. over 14 d) dose•
dependently reduced plaque area up to 61% and DNA 
content up to 60%. The latter finding indicates a true 
antiproliferative effect of the compound. The structurally un•
related Na+,H+ exchange inhibitor EIPA had comparable 
inhibitory effects on plaque area and DNA content. On the 
other hand, 3-methylsulfonyl-6-piperidino-benzoyl guanidine, 
a position isomer of Hoe 694 lacking Na+,H+ exchange 
blocking properties, did not suppress neointima formation. 
These findings indicate that the inhibitory effect of Hoe 694 
and EIPA on neointima formation is due to Na+,H+ exchange 
blockade. 
Conclusion: The data suggest an important role of Na+,H+ 
exchange for smooth muscle cell proliferation in vivo after 
vascular injury. Na+,H+ exchange may be a potential target 
for new antiproliferative strategies in vascular disease. 
210A ABSTRACTS 
900·39 
Inhihitioll Of Platelet Arterial Thrombosis On Severely Injured Vessel Wan 
by a Thrombin SpecifIC Syntbetic Peptide 
BadimoD JJ, Weng D, Fuster V, and Badimon L. Cardiovascular Biology 
Resean:b. Cardiac Vnit. Massachusetts General HospitaL Boston, MA. 
Thrombin seems to have a key role in platelet arterial tbrombosis 
triggered by severe vessel wall injury (SVI). We have tested tbe 
antitbrombotic effect or a synthetic peptide with bigh amnily ror thrombin 
and oral bioavailabilily (DUP.714, D.phe.pro-boro-arginin hydrochloride 
acid. DuPont Merck) on: A) whole blood platelet aggregation to ADP (1·20 
jJ.M). collagen (0.5·5 ILg) aDd thrombin (0.2·5 V); B) PRP.aggregation to 
ADP (1·5 ILM) and collagen (0.5·3 ug); and C); a nowing blood in vivo 
porcine model or arterial thrombosis. The effect or DVP·714 (bolus plus 
inrusion) was studied in now conditions mimicking patent SVI (P·SVI) (shear 
rate 21251) and mildly stenotic SVI (S·SVI) (shear rate 1690 s·l)io 
beparinizedanimals (SO Vlkg + SO Vlkg/hour; APTT ratio = 2). Thrombus 
build up was measured by autologous radioisotopic platelet labeling. 
RESULTS: Collagen. and ADP·induced platelet aggregation in both, whole 
blood and PRP, was not modirled by DVP·714; however, tbrombin·induced 
aggregation was totally abolisbed. Platelet·tbrombus rormation, expressed 
as platelets (xl06/cm2) deposited on P·SVI (N=12) and S·SVI (N=12) was 
signirlClnt/y inhibited (Op< 0.05). 
None 
PSVI 67±6 
SS", 203m 1 
0.1 mg/kg 0.2 mg/kg 
t Q 6 mIlk! 
80±6 
24+'3" 
+ 06 mgJlkg 
36±2" 
117+7" 
In this study, DVP· 714 bas been tested as an antiplatelet agent; 
however, tbis specific tbrombin inhibitor is obviously a strong anticoagulant 
(Thrombin time and APTT were significantly prolonged by DVP·714). 
Our results show tbat acute platelet·tbrombus rormation in 
conditions mimicking severe arterial injury, in both patent and mildly 
stenotic vessels, is Significantly reduced by tbrombin inbibition witb DVP· 
714. 
900-40 
Chronic Intrapericardial Basic Fibroblast Growth 
Factor Induces Myocardial Neovascularization in an 
Ischemic Rabbit Model 
Charles Landau, Alice K. Jacobs, David P. Faxon, Thomas J. 
Ryan. Christian C. Haudenschild. 
Boston University Medical Center. Boston. MA. 
Fibroblast growth factors (FGF) have well recognized 
angiogenic properties. but their ability to promote myocardial 
neovascularization has not been demonstrated. To study this 
phenomenon. ischemia was produced in a rabbit model by 
rapidly inducing left ventricular hypertrophy (LVH) with 
intravenous (IV) Angiotensin II (AlI) for one week. Basic 
human FGF (bFGF) was then infused into the intrapericardial 
(IP) space using an osmotic pump for 6 • 28 days. mean 24. 
The control groups received IP bFGF only. IV All only. or IV 
All and IP Albumin (Alb). Bovine Alb. a foreign protein. 
acted as a nonspecific inflammatory agent. 
The hearts were serially sectioned following perfusion 
fixation. and were examined histologically. A neovascular 
response score (NRS) was assigned to each heart in blinded 
fashion on a 0 to 2 scale indicating no. minimal. or marked 
increases in subepicardial vascularity. 
Group n NBS p ys N All only 
IP bFGF + IV All 7 1.9 <0.003 
IP bFGF 5 104 <0.02 
IP Alb + IV All 7 1.3 <0.03 
IV All Only 5 0.2 
p ys IP Alb±N All 
<0.10 
NS 
In conclusion. IP bFGF combined with IV All in this model 
leads to new myocardial vessel formation in excess to that seen 
with IV All alone. We also noted a trend towards increased 
vascularity in All treated hearts exposed to IP bFGF compared 
to the nonspecific reaction seen with IP Alb(NRS of 1.9 vs 1.3). 
This trend suggests that bFGF may be useful in promoting 
myocardial angiogenesis in an ischemic milieu. and warrants 
further study. 
900·41 
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Beat·la-Beal Variability of the Hyperemic Coronary Pressure/Flow Velocity 
Relation in Patients without Significant Coronary Stenoses. 
Carto Di Mario. Nicolas Meneveau. Robert Gil, Plm J. de Feyter. Sipke 
Strlkwerda, Peter de Jaegere. HAkan Emanuelsson. Jos Roelandt. Patrick w. 
Serruys. 
Thoraxcenter. Erasmus University. Rotterdam. The Nethertands. 
In an animal model of coronary stenosis the Instantaneous hyperamlc 
pressure/flow slope index showed a high correlation with the stenosis severlly 
aver a broad range of aortiC pressures. 
In this study the feasibility of this method was tested In humans using a 12 
MHz Doppler guidewire Introduced into the proximal coronary artery. The 
study population Included 33 patients (31 arteries with <30% OS In 27 CAD 
patients and 8 normal arteries In 6 cardiac transplant recipients). 
~: The Instantaneous peak flow velocity (Vel), automatically detected 
after· spectral analysis of the Doppler signal. and the proximal coronary 
pressure. measured through the guiding catheter, were continuously recorded 
after papaverine 12 mg I.c. A clear Doppler envelope. allowing a reliable 
detection of peak Vel during diastole, was obtained In 31/39 cases (79%). 
Unear regreSSion analysis was used to assess the slope (cm'S" fIlmHg") of 
the pressure/Vel relation in 4 consecutive beats (from peak diastolic VIlA to the 
more rapid flow velocity decrease due to myocardial contraction). Beat-ta-beat 
variability (VAR.) was defined as FLOW VELOCITY (cm/s) 
the ratio of SO to the average -i -.-----------~-
of the four m~asure~~:~~~~g., ::: 1 ,/, II. 
MEAN 0.90 1.86 50 
y. 2.56x -107 ~ 
~SO 0.06 0.84 o +--__ ----A0-e-R-TIC PRESSURE 
VAP.. 5% 14% o 35 70 105 mmHg 
Conclusion: The instantaneous pressure/Vel relation could be studied In 
conscious humans in the catheterization laboratory In most cases. Durtng 
consecutive sinus beats at maximal hyperemia the relation between diastolic 
pressure and Vel was linear and a low beat-ta-beat variability in the slope of 
the regression equation was observed. 
90046 
Visualization of the Intima of Atherosclerotic Arteries Using 
Rhodamine·Labelled F ... ·2 Fragments 
Mark Wolfe, Nina Braunwald, Akimi Uehata, Ian Meredith. Todd 
Anderson. Charles Ditlow. Francis Chen, Andrew Selwyn, Helmut 
Rennke. Peter Ganz, Brigham & Women's Hospital. Boston, MA 
An antigenic site selectively expressed in the thickened intima of 
atherosclerotic arteries of humans and rabbits has been identified 
and mouse chimeric IgG antibody to the site has been constructed 
(Vasocor Inc.). The purpose of the present study was to detennine 
whether labelling of the antibody with a fluorescent tag would 
allow selective visualization of the atherosclerotic intima, an 
approach which could be exploited for laser ablation. F ..,'2 
fragments of the antibody were prepared by pepsin digestion and 
conjugated with rhodamine. Atherosclerosis was induced in the 
rabbit aorta by a hypercholesterolemic diet (predominantly a 
macrophage lesion) or by a combination of balloon injury and 
hypercholesterolemia (mixed smooth muscle cell and macrophage 
lesion). Frozen sections of aortae stained with the Rhodamine·F.b'2 
demonstrated intense fluorescent staining confined to the diseased 
intima of atherosclerotic arteries (in both types of lesions) while 
control arteries were entirely negative. Isolated aortae segments 
exposed to Rhodamine·F.b'2 demonstrated immunofluorescent 
staining of the luminal portion of the thickened intima during 1·24 
hours of exposure. Thus antibodies directed at atherosclerosis· 
associated antigens can be utilized as delivery agents. In the 
present study. this novel approach of selectively labeling 
atherosclerotic lesions with immunofluorescent markers may allow 
ablation of diseased regions by laser while minimizing damage to 
the nonnal vessel. 
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Possible Causes of a Defective Fibrinolytic System in Young 
Patients with Coronary Artery Disease 
Senta GraE, 'Renate Beckmann, Giinter Christ, Alexander Geppert, Fritz 
Kaindl, 'Bernd R. Binder and Kurt Huber. Departments of Cardiology 
and 'Clin. Exp. Physiology, University of Yienna, Austria. 
We determined in 42 patients (pts) with angiographically proven 
coronary artery disease (CAD; m/f=31/1l; age~21-47) the plas~a levels 
of tissue plasminogen activator (t-PA, anttgen and actlVlty) and 
plasminogen activator inhibitor-l (PAl-I; antigen and actlvtty) at basal 
conditions and after venous occlusion (YO) as well as before and after 
physical stress test. Furthermore, we determined plasma levels of 
lipoprotein a (Lp(a)), cholesterol, triglycerides, hematocrit and platelet 
count at basal conditions. The data obtained from CAD pis were compared 
to those from 16 age and sex-matched healthy controls. Mean PAI-l 
activity levels before YO were significantly elevated in pts as compared 
to controls (9.4±0.5 vs. 3.5±O.3 IU/mI; p< O.Ol). After YO, mean PAI-l 
activity decreased to a similar extent in both groups. In contrast, mean t•
PA activity levels were not significantly different between the groups 
before YO, while in both groups an increase of t-PA actlvtty could be 
demonstrated due to YO. However, following individual courses of t-PA 
after VO in 31% of controls and in 61% of pts no significant increase of t•
PA acti~ity after VO could be demonstrated (p<O.Ol). Mean antigen 
levels of PAI-l and t-PA exhibited a similar behavIOur as the respective 
activity levels. The reaction of mean fibrinolytic parameters on physical 
stress test was not significantly different between the study groups. Lp(a) 
mean plasma levels were within the normal range for controls (J6O±47) 
but significantly elevated in pts (426±90), in whom Lp(a) levels were 
elevated above normal in 57%. Positive correlations could be calculated 
for Lp(a} vs. platelet count (r=0.59, p=O.Ot), and for PAI-l activity vs. 
cholesterol (r=0.65, p:O.OOl), triglycerides (r=0.57, p= 0.OO2), or PAI-l 
antigen (r=0.52, p=O.OS) levels, respectively. 
Conclusion: a defective fibrinolytic system due to elevated basal PAl-] 
and Lp(a) plasma levels and to a diminished top A release after a 
thrombotic stimulus might be important factors for the development of 
CAD in young pis. 
90048 
Chlorpromazine Plus Aspirin but not Aspirin Prevents Epinephrine or 
Shear Induced Platelet Thrombus Formation in Stenosed Carotid 
Arteries of Monkeys 
John D. Folts, James W. Jefferson, Departments of Medicine and 
Psychiatry, University of Wisconsin, Madison, WI 
Aspirin (ASA) is widely used as an antiplatelet agent (AA) to 
prevem arterial thrombosis and reocclusion after thrombolysis or 
angioplasty in stenosed arteries. However, animal and human 
platelets inhibited with ASA can be reactivated with physiologic 
amounts of Epinephrine (EI, or increased shear forces applied to 
platelets by severe stenoses (Circ 83(61:3-14, 1991 I. In 15 
anesthetized monkeys (M), fixed carotid artery stenosis (75% 
diameter reductionl with imimal damage was produced and blood 
flow measured with EMF probe. Cyclical flow reductions (CFRsI 
occurred due to periodic acute platelet thrombus formation (APTFI 
followed by embolization to the brain. CFRs in stenosed human 
coronary arteries can cause unstable angina and in cerebral arteries 
can cause transient ischemic attacks, which can progress to 
myocardial infarction or stroke. In 5 M CFRs were abolished with 5 
mg/kg of ASA given IV but were renewed in 4 of the 5 M with the 
infusion of E 0.2 pg/kg/min given for 30 min or when the stenosis 
was increased to 90% which produces higher shear forces which 
activate platelets in the lumen. Ie 5 M, CFRs were abolished with 
chlorpromazine (CPZI (Thorazine I, 0.6 mg/kg IV, and the CFRs were 
not renewed by an E infusion or increased stenosis. In 5 M CFRs 
were abolished with ASA, 5 mg/kg plus CPZ, 0.4 mg/kg and CFRs 
were not renewed by E infusion or increased stenosis. Low dose CPZ 
may complement ASA treatment and prevent APTF and ischemia 
producing CFRs since CPZ: Is a modest alpha adrenergic receptor 
antagonist; inhibits the calcium calmodulin complex and light-chain 
myosin kinase activity needed for platelet shape change and 
subsequent exposure of platelet fibrinogen receptors. Periodically 
elevated E and/or acute increases in the amount of stenosis due to 
plaque rupture are common in patients, and ASA alone would not 
protect against these conditions. 
ABSTRACTS 
900-49 
Human Thrombin Receptor Actlvallng Pepllde-Induced Prollferallon of 
Cultured Vascular Smootb MUlde Cells Is Spedes Specific 
Coleen A. McNamara. Ian 1. Sarembock, Lawrence W. Gimple, 
lobn W. Fenton II, Shaun R. Coughlin, Gary K. Owens, 
Dep15. of Medicine and Physiology, University of Virginia, Charlottesville, 
VA; Wadswortb Center for Laboratories and Research, New York State Dept. 
of Health, Albany, NY; Dept. of Medicine and Cardiovascular Research 
Institute, University of California. San Francisco. CA 
211A 
Thrombin stimulates proliferation of cultured vascular smooth muscle cells 
(VSMC) by a proteolytically activated receptor. The amino acid sequence of 
the tethered ligand generated by thrombin-induced cleavage of i15 receptor 
varies across species. To determine if the 14 amino acid human thrombin 
receptor activating peptide (huTRAP-14) shows species specificity in 
stimulating proliferation of cultured VSMC, the responses of rat, bovine, and 
rabbit VSMC to buTRAP were evaluated. VSMC from rat. bovine. and rabbit 
were grown to confluence, growth arrested in a defined serum free medium 
(SFM), and stimulated with increasing concentrations of human II-thrombin, 
DlP-II-thrombin, and huTRAP-14 for 48 hours. S I'Ci/mL of )H-thymidine 
was added to the cultures at 24 hours and the cells were harvested at 48 hours 
for determination of 3H-thymidine incorporation. Human II-thrombin was a 
potent mitogen for VSMC in all three species. DlP-II-thrombin was not 
mitogenic for YSMC.in any of the three species evaluated, demonstrating that 
the active proteolytic site of thrombin is required for thrombin-induced 
mitogenesis in all three. The huTRAP-14 was as efficacious as II-thrombin in 
stimulating mitogenesis in rat VSMC, however it was not mitogenic for rabbit 
or bovine YSMC. These data demonstrate that while human II-thrombin 
stimulates mitogenesis in the three species of VSMC by a proteolytic 
mechanism, the resultant tethered ligand may be species specific. This has 
important implications for the development and evaluation of specific thrombin 
receptor inhibitors. 
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901·106 
Bleeding and ThrolDoembolis. on Anticoagulation: 
A Population Based Study in Rochester, Minnesota 
Michael J. Gitter, Thomas M. Jaeger, Marc D. 
Silverstein, Tanya M. Petterson, Bernard J. Gersh, 
Mayo Clinic, Rochester, MN 
Randomized trials reporting low risks of anticoagulation 
(A/C) for non-rheumatic a.fib often exclude the elderly 
and may not apply to the population at large undergoing 
A/C for a variety of clinical indications. Therefore 
this population based study was designed to address out•
come of chronic A/C in Rochester, MN, residents ini•
tiating warfarin for >4 weeks duration from 9/1/B7 to 
12/31/89. All bleeding complications were classified as 
minor or major using the bleeding severity index, and 
thromboembolic events were classified as major if they 
were fatal or life threatening. There were 261 pts with 
incident courses of A/C (52% male, 61% > age 65, 31% > 
age 75) with 221 pt-yrs of warfarin exposure. The 10-
indications for A/C were a.fib (11%), DVT (39%), 
stroke/TIA (21%), CAD/cardiomyopathy (15%), and other 
cardiovascular indications (14%). The cumulative inci•
dence of major thromboembolic event at 1, 3, 12, and 
24 months was 1.6%, 1.6%, 3.1%, and 4.8% and for major 
bleed was 1.6%, 3.3%, 5.3%, and 10.6%. In multivariate 
analyses, (1) malignancy significantly predicted major 
bleed and (2) malignancy & PUD significantly predicted 
combined major & minor bleed. Neither age, sex, a.fib, 
history GI bleed, PUD, alcohol abuse, HTN, stroke, nor 
Charlson comorbidity index were significantly associated 
with major bleed. 
Conclusion: Our study is unique because it is 
populatlon based, includes a large number of elderly, 
and all indications for A/C. Only malignancy predicted 
a major bleed. Advanced age is not a contraindication 
for A/e therapy. 
212A ABSTRACTS 
901-107 
Endunoce Exercile Tninio, Au,mentl Diutolic FiIlin, at 
Reat and Durin, Exercile in Healthy Older and Y ouo, Malel. 
WC Levy, MD Cerqueira, m Abrasa, RS Schwartz, Jll StraIIOa, SeaItle V AMC 
ODd University of Washinitoa. SeaItle, WA 
Diastolic fil1ina at rest ill markedly altered with advancin ... e. Whether 
exercise training can improve diastolic filling at rest or durina exerciJe in healthy 
older or }'OWII males II1II not I.n determined. 
Peak early fal1ina rate ODd peak atrial fillin. rate (PEFR and P AFR in 
mVslM2), were measured usin. radionuclide ventriculo ........ (20ms1frame) 
acquired at rest and durina supine bicycle exercise in 13 older ( .. e 60-82) ODd II 
YOUDI (ap 24-32) rigorously ocreened healthy males before and after 6 months of 
exercise tra.inin.. Before training the PEFR was S3 % lower in the older IfOIIP 
(older 86±8 vs you.,. 184±13 mVslM2, 1""0.0001) while the peak atrial filling 
rates was 31% higbtr (older 85±6 vs young 65±10 mVslM2, p-0.07). The 
single peak fiUinS rate (SPFR) during peak exercise was 33% lower in the older 
group (older 379±20 vs young 566±33 mVslM2, p<O.OOOI). The maximal 
oxygen consumption (V02 Max) before exercise training correlated with the 
resting PEFR ( ... 0.78, p<O.ooO I) and the peak exercise SPFR ( ... 0.70, 
p<O.OOOI). 
Six months of intensive endurance exercise training increased V~ Max by 
21 % in the older group and 17% in the young (ANOVA • training 1""0.0001, 
young/older p-n.s.). Left ventricular mass index increased in both groups (+5% 
older, + 10% young, training p=0.002, young/older pailS). Training increased the 
resting PEFR by +25% in the older group and +8% in the young group (training 
paO.Q2, young/older pan.s.) and decreased the PAFR by S% in the older group 
while increasing by 9% in the young (Older/young· paO.13). Training also 
increased the SPFR during peak exercise by +21 % in the older group ODd +9% in 
the young group (training 1'"'0.0004, young/older pan.s.). 
Mean ±SE Rest PEFR Rest PAFR Peak Exercise SPFR 
Pre Post Pre Post Pre Post 
Older 86±8 106±8 85±6 7UIO 379±20 458±42 
YOUJI, 184±13 199±18 65±10 78±6 566±33 617±35 
Healthy older males have reduced early diastolic fiUing at rest and during 
exercise. Exercise training enhance. early diastolic fiUine at rest ODd during 
exercise in both the old and the young. The training induced augmentation of 
early diastolic fiUing at rest ODd during exercise may be an important adaptation 
by which training leads to an increased exercise stroke volume and cardia<: output. 
901-108 
Carotid Artery ~try and Left Ventricular Mass: The 
Cardiovascular Health Study (CHS) Vivienne-E Smith, 
Richard A Kronma1, Joseph F Polak, Julius M Gardin, Teri 
A Mano1io On behalf of the CHS Collaborating Investiga•
tors 
The Cardiovascular Health Study (CHS) is a five year 
longitudinal study of cardiovascular risk in a cohort of 
free living persons age ~ 65 yrs. To further elucidate 
the relationship of great vessel structure to LV mass in 
the elderly, we examined the correlations of internal (I) 
and cOllll1On (C) carotid artery (CA) diameter and wall 
thickness with LV dimensions and mass measured by ultra•
sound in 3409 CHS participants. A full stepwise regres•
sion model including relevant confounding variables 
identified several key physiometric, hemodynamic and other 
CV risk predictors which, with maximum CCA diameter and 
wall thickness were independently related to LV mass. 
These were weight, gender, BP, antihypertensive drug use, 
major coronary disease by history or ECG, HDL, trig1ycer•
ides and factor VII. Of note, fCA (but not lCA) diameter 
and wall thickness were significantly related to LV mass 
even after adjustment for weight and gender (partial r=.16 
p<.0001 for CCA diameter and .07 p<.0005 for CCA wall 
thickness). As expected, systo1 ic BP was strongly related 
to both CCA diameter and LV diasto1 ic dimension. We 
speculate that the observed relation of CCA wall thickness 
to LV mass which is due only partly to the blood pressure, 
may also be a consequence of the thickened, inelastic 
arterial wall acting to augment impedance to LV ejection. 
If so, conduit artery wall thickening could, byexacerbat•
ing LVH, constitute yet another important risk for adverse 
cardiovascular outcome. 
901-109 
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Left Ventricular Isovolumic Relaxation is not 
Responsible for Reduced Early Diastolic Fill•
ing With Aging 
Tetsu Yamakado, Chikaya Oomichi, Takahiro 
Oonishi, Mitsugu Maeda, Masaki Takeuchi, 
Takeshi Nakano. The First Department of In•
ternal MediCine, Mie University, Tsu, Japan 
It has been well known that left ventricular 
(LV) early diastolic filling (EDF) is 
decreased with aging. To test the hypothesis 
that it is associated with impaired relaxa•
tion with aging, we analysed simultaneous 
biplane left ventriculograms (LVG) and high 
fidelity LV pressures (P) (tip manometer) in 
38 subjects (20-77 years) with normal coro•
nary arteries and LV functions. LV volume (V) 
curves were derived from frame-by-frame trac•
ings of LVG in 27 subjects. LVEDF was 
assessed by the peak filling rate (PFR) of LV 
volume. Relaxation was assessed by the time 
constant (T) of isovolumic LVP decay. 
Results. The PFR decreased significantly with 
aging (r=-0.75), and inversely related to 
atrial contribution. But the T did not corre•
lated with aging (r=0.04, ns) and PFR 
(r=O. 004, ns). Ej ection fraction, LVEDP and 
LV walll thickness, which are maj or deter•
minants of the T and PFR, were not also sig•
nificantly affected by aging. 
Conclusion. LV isovolumic relaxation is not 
essentially impaired at least until seventh 
decades in man. Age-related decrease in LVEDF 
seems not to be associated with LV isovolumic 
relaxation. 
901-115 
Implantation of the Automatic Defibrillator System in 
Elderly and Younger Patients: Comparative Results 
Antonis S. Manolis, Hassan Rastegar, Paul 1. Wang, N. A. Mark 
Estes m, TuftslNew England Medical Center, Boston, MA 
The automatic cardiovener defibrillator (lCD) system was 
implanted in 85 elderly pIS aged ~ 65 (mean:72 ± 5 years) and 86 
younger pts < 65 (mean: 56 ± 7 years) for drug-refractory 
ventricular tachycardia (Vl) (108 pts) or fibrillation (VF) (63 pts). 
The ejection fraction (31 ± 11 % vs 34 ± 14%), type of arrhythmia 
(VT in 68% vs 58%), number of failed drugs (3.2 ±.l.5 vs 3.5 ± 
1.3) and the defibrillation threshold (12 ± 5 vs 11 ± 6 joules) were 
similar in the 2 groups. Elderly pIS more often had coronary anery 
disease (96% vs 80%) and underwent concomitant surgery 
(coronary bypass and/or subendocardial resection) (67% vs 49%) 
(p < 0.05). Perioperative monality was 7% in the elderly and 1 % 
in the younger (p<0.05), with all 7 deaths (3 from cardiogenic 
shock, 1 from VF, 1 from sepsis, and 2 from ischemic bowel 
necrosis) unrelated to ICD implantation. Complications were 
similar in the 2 groups (20% in each group). In follow-up of 18 ± 
13 mos for the elderly and 19 ± 15 mos for the younger pts, 1 
sudden and 5 nonsudden deaths occurred in each group. Nonfatal 
VT recurrences (19 in the elderly and 27 in the younger) were 
successfully managed by the ICD. 
We conclude that when compared to younger pIS receiving the 
lCD, elderly pts 1) have a higher surgical monality not directly 
related to the ICD and a higher need for concomitant surgery, 2) 
have similar complications, 3) have equivalent benefit in prevention 
of sudden cardiac death. 
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901-116 
Clinical and prognostic Implications for 
Arrhythmia in the Old Old: The Bronz Longi•
tudinal Aging study 
Mark Heiman, Alex Karpenos, steven Greenberg, 
Jeremy Nadelmann, William Frishman, The Albert 
Einstein College of Medicine, Bronx, NY. 
Functional ambulatory subjects (n=423, aged 75-
85 yrs) underwent baseline and annual Holter 
ECG exams with up to 9 yrs of clinical follow 
up. The presence and absence of supraventric•
ular and ventricular arrhythmias and heart 
block were related to the incident rates of 
death, myocardial infarction (MI), cerebrovasc•
ular accident (evA), and dementia. Arrhythmias 
of various types were prevalent in the study 
cohort. Subjects with non-sustained ventric•
ular tachycardia at baseline had higher 
incident rates of MI and death compared to 
those with minimal or absent ectopy (p<0.05), 
specifically if associated with left ventric•
ular hypertrophy. Subjects with AV block and 
bradycardia (RR <60 bpm) at baseline had higher 
incident rates of evA and multi-infarct 
dementia (p<0.05). Episodes of atrial fibrill•
ation and paroxysmal supraventricular tachycar•
dia at baseline were not associated with 
adverse clinical outcomes. Analysis of serial 
Holters did not show any relationship between 
the development of new brady- or tachyarrhyth•
mias and increased rates of death, MI, evA and 
dementia. Arrhythmias found on ambulatory ECG 
~onitoring can identify elderly subjects at 
risk for cardiovascular mortality and 
morbidity. However, serial exams to identify 
new arrhythmias provide no additional 
prognostic information. 
901·117 
An Aggressive, Multidisciplinary, Nonphanaacologic 
Treatlent Strategy I_proves Quality of Life (QOL) in 
Elderly Congestive Heart Failure (CHF) Patients 
Michael W. Rich, Valerie Beckham, Carol Wittenberg. 
Jewish Hospital at Washington Univ., St. Louis, HO 
Psycho soc ia 1 factors often play a promi nent role in 
perceived QOL in elderly patients with chronic illness. 
We randomly assigned 126 PTS (mean age 79±6 yrs, 67% 
female, 64% white, mean NYHA class 2.4±l.1) hospital•
ized with CHF to a multidiscipl inary nonpharmacological 
intervention consisting of intensive patient education, 
medication analysis, early discharge planning, and 
aggressi ve post-di scharge followup, or to standard 
care. QOL was assessed at randomization and 3 mo. post•
discharge using the Chronic Heart Failure Questionnaire 
(Guyatt, J Gen Intern Med 1989;4:101), a 20-item in•
strument with 4 subscales: dyspnea, fatigue, emotional 
function, and environmental mastery. 
RESULTS: At baseline, there were no differences between 
the control (N=59) and treatment (N=67) groups with 
respect to total score or any of the subscores. At 3 
mos. followup mean changes from baseline scores were: 
Control Treatment R 
Total score +11.3 +22.1 .001 
Dyspnea + 3.8 + 6.8 .013 
Fatigue + 2.7 + 5.4 .010 
Emotional Function + 1.9 + 5.6 .001 
Envi ronmenta 1 Mastery + 2.9 + 4.4 .096 
Thus, improvements in QOL with the study intervention 
were twice as great as with conventional care. 
CONCLUSION: An aggressive, multidisciplinary, nonphar•
macologic treatment strategy in elderly CHF PTS results 
in significant improvements in QOL. 
ABSTRACTS 
901-118 
Should the Elderly be Resuscitated? 
Kim H. Tan, Alfred N. SuHre, Richard A. Cooke and Alex Norris. 
Guy's Hospital, London, United Kingdom 
213A 
This study evaluates the success rate of cardiopulmonary resuscitation 
(CPR) at a district general hospital and aims to identify factors that may 
influence outcome. One hundred and forty-eight patients underwent CPR 
between Jan 1, 1990, and December 31, 1990, at the William Harvey 
Hospital, Kent. Their case notes and resuscitation notes were reviewed 
retrospectively and long-term follow-up obtained for those who survived. 
The main outcome measures were long-term survival as judged by 
discharge from hospital, vital status and level of dependence at the time 
of census. Of 148 patients, 47 (31.8%) survived initially but only 14 
(9.5 %) survived to hospital discharge. Advanced age did not affect long•
term survival after CPR. There was no significant difference in the 
discharge rate between those above and those below 70 years of age 
(p=0.15, 95% Confidence Interval (CI)= -16% to 2%). However, the 
underlying disease and the presenting arrhythmia were both major 
determinants of survival. Patients with asystole and electromechanical 
dissociation had a poorer survival rate compared to those with ventricular 
tachycardia or fibrillation (p<O.OOOI, 95% CI= 11% to 42%). Those 
with multiple trauma, terminal or incurable disease were associated with 
poorer prognosis. The site of resuscitation was also a predictor of 
outcome with the best discharge rate from coronary care unit 
(p<O.OOOI, 95% CI= 9% to 40%). Of the 14 patients that were 
discharged, 10 were more than 70 years old and all had underlying 
pathology that was associated with a good prognosis. The mean duration 
of follow-up was 6.9 months (SD=3.4) and ranged from 3 to 12 
months. At the time of analysis 13 were alive and leading an independent 
existence. Conclusion: Advanced age is not an important determinant of 
outcome after CPR. The decision whether to subject a patient to CPR 
should not be based on age and should take into account the underlying 
disease, its associated prognosis and patient's level of dependence. 
901·119 
Glucosellnsulin Ratio: Age Related Differences and 
Response to Exercise 
William F. Graettinger, David H. Smith, Joel M. Neutel, 
Michael A. Weber. DVA Medical Center, Long Beach, CA 
and University of California, Irvine, CA 
Insulin has been recently demonstrated to be a potential 
myocardial growth factor and the insulin/glucose ratio (IG) an' 
index of insulin resistance and therefore, excess circulating 
insulin. To evaluate the effects of age on IG and its response 
to exercise, we studied 163 male subjects (age 19-73) with 
conventional BP, 24-hr automated BP monitoring, treadmill, 
and resting echocardiography. Blood for glucose and insulin 
was drawn before and immediately after exercise in 150 
subjects. Subjects were separated into younger age « 45yrs) 
group (YG, n=88) and older age (:;: 45yrs) group (OG, n=75). 
Conventional and 24-hr BP were greater in the OG (144/95 vs 
132/90 and 134/83 vs 127177 mmHg, p<0.005). Max exercise 
DBP was also greater in the OG (96±12 vs 85±13 mmHg, 
p<0.001). Max exercise HR and double product were less 
(157±18 vs 174±15 bpm and 3.2±.5 X103 vs 3.5±.45 X103, 
p<0.005). DBP fell less with exercise in the OG. 
Insulin/glucose ratio tended to be greater at rest in OG and 
was significantly greater immediately post exercise. LV wall 
thickness was greater in the OG (2.17±.20 vs 2.11±.22 cm, 
p=0.5). LV dimension was similar in both groups but the 
extent of hypertrophy in relation to chamber size (2*pw/lvd) 
was greater in the OG (0.42±.05 vs 0.40±.05, p<0.02). LV 
mass Index was similar in both groups. Therefore, aging is 
associated with increased BP at rest and exercise with 
reduced maximal exercise heart rate. The increase in IG 
seen with maximal exercise may also occur with less 
strenuous daily exertion. The resultant relative increase in 
insulin may be in part responsible for the observed 
myocardial hypertrophy in older male subjects. 
214A ABSTRACTS 
901·120 
PredIctors or Long-tenn Survival In EIderty Patients 
Undergoing Open Heart Surgery 
Syed Irian Shah, Colin Meyerowitz, Herman MovsowJtz. Jeffrey Bruss, 
Alhanassios Manginas, John Bell-Thomson, Morris Kader, Larry Jacobs. Alben 
Einstein Medical Center, Philadelphia, PA 
One hundred patients (pis) over the age 0/ 75 who underwent open heart 
surgery at our institution between 1987-1989 were followed to determine long•
term survival. n pts underwent coronary artery bypass surgery(CABG), 10 pts 
valve replacement, 9 pts both CABG and valve replacement and 4 pts other 
cardiac procedures. Patients were followed for a mean 0/35 ± 8.9 months 
(range 26.6 - 62.1 months). Major In-hospital morbIdity(MAJMORB) was 
defined as the presence 0/ intrathoracic bleeding requiring reoperatlon, stroke, 
myocardial Infarction, Ilfethreatenlng arrhy1hmias, pneumonia, pulmonary 
emboli, prolonged intUbation, surgical gastrointestinal complications, renal 
faBure requiring dialysis or septicemia. Multiple logistic regression analysis 0/ 
22 perI-operative clinical variables identifIed predictors 0/ mortality as' 
VARIABLE n Odds Ratio 95%CI MULTIVARIATE..!!.. 
MAJMORB 37 4.3 1.8 - 10.3 0.004 
IMAgraft 17 0.08 0.01 - 0.6 0.027 
(IMA-Internal mammary artery, n-. SURVNAL 
number 0/ patients, a = confidence r-----------, 
intBMll). Conclusion:l) Elderly pts 1~0\IBWJ.SUAV1VAI. _ NOIIClIalfTY 
(n = 100) undergoing cardiac surgery. YORIIIDITY .... 
have 1,3,5 year postoperative survival 
rates 0/ 75%,67%,58%. 2) PIs (n=63) ;i. 
with an uncomplicated in-hospital 2: ~' 
n_. 
course have 1,3,5 year survival rates of ~ ... ___ n - 100 
86%,78%,71%. 3) Pls(n= 17) under- ~ so-. ---'--------~-;.-3i: _____ _ 
going IMA bypass surgery have 1,3,5 30'1',"---------
year survival rates 0/ 100%,100%,89%. 0 2 3 4 5 
4) The presence 0/ MAJMORB is an YEARS 
independent predictor 0/ increased early llate mortality. 5) The use 0/ IMA 
grafts in elderly pts undergoing CABG predicts excellent early llate survival. 
901·121 
Directional Coronary Atherectomy Can Be Successfully 
Performed in the E1derty 
Herman MovsowJtz. Alhanassios Manglnas, Colin Meyerowitz, Sri Kothapall, 
Jeffery Bruss, Gary Ledley, Morris Koder, Fred Nakhjavan, Shahrlar 
Yazdanlar. Albert Einstein Medical Center, Philadelphia, PA. 
The restJIs 0/ directional coronary atherectomy (DCA) performed in 237 
consecutive patients (266 lesions) were analyzed retrospectively to determine 
the effect 0/ age on clinical outcome. 11 patients in whom the ostium could 
not be engaged, and 30 patients who underwent ·rescue DCA" were 
excluded. Patients were grouped according to age. 
Age (years) <55 




Emergency CABG 3.3% 
Abrupt closure 0% 
There was no statistically 
significant difference between the 
age groups (table). 
Conclusions: 
1) Success rates and major 
complications are not 
significantly different between the 
age groups. 
2) There is a non-statistlcal trend 
towards decreased success and 
increased ischemic 
complications in the elderly. 
5IH;5 66-75 :>75 
68 62 34 
n.9% n.4% 70.6% 
0% 3.2% 0% 
0% 8.1% 8.8% 
7.4% 4.8% 2.9% 




55 - 65 56 - 75 ~ 75 
3) Groin complications are significantly more common in the elderly 
(graph). 
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EIJ"Jcacy and Safety of Rotational Coronary Atherectomy in Elderly Patients 
Kenneth D. Henson. Jeffrey J. Popma. Martin B. Leon. Kenneth M. Kent. Lowell 
F. Saller. Gary S. Mintz. Michael B. Keller, Regina Deible, Augusto D. Pichard. 
Washington Hospital Center. Washington. D.C. 
Balloon PTCA in elderly patients has been associated with diminished procedural 
success rates. due to the frequent presence of unfavorable lesion characteristics. 
To determine whether rotational atherectomy is a useful alternative to balloon 
PTCA in elderly patients with complex lesion subsets. we reviewed Our experience 
in 412 patients (463 lesions). One hundred fony-three patients (165) lesions were 
~70 years of age. Procedural success was defined as <50% residual stenosis 
without death. CABG or Q-wave MI. Cineangiograms were analyzed using 
qUalitative morphologic and quantitative angiographic methods. Records were 
reviewed for periprocedural complications and clinical follow up was obtained 
prospectively by telephone interview at I. 3. 6. and 12 months. 
< 70 years 70-79 years ~ 80 years 
N=269 N= 136 N=29 
Bend~45(%) 28 31 34 
Calciwn Mild/Mod (%) 59 57 62 
Severe (%) 15 26 24 
Ostial Location (%) 22 21 31 
Eccentric (%) 76 76 66 
Pre Minimal Diameter (mm) 0.63±O.32 O.7I±O.35 0.75±O.43 
Post Minimal Diameter (mm) 1.80±0.42 1.75±O.41 1.75±QJ7 
Final % Diam Stenosis (%) 26±14 26±14 26±13 
Procedural Success (%) 95.1 96 88 
Death/MllCABG (%) 0.7/0.4/3.0 0.0/0.9/0.0 0.0/4.2/4.2 
Evenl·free survival (%) 84 87 7i 
Conclusjnns: I) Rotational atherectomy can be performed in the elderly with the 
same high procedural success rates seen in younger patients. 2) Despite 
procedural success, major complications tend to occur more frequently in patients 
over the age of 80. 3) The effectiveness of rotational atherectomy in complex 
lesions. especially lesions containing calcium. may make it the procedure of 
choice for many elderly patients. 
901·123 
Doee Augmentation Index Provide a Charllderizlltlon of Vaec:uler 
Propertl .. Independent of Ventricular Propertiee? 
Amit Nussbacher. Peter V. Vaitkevicius, Jerome L Flag. DMiei Burkhoff. 
Steven P. SctUman, Gay Gerstenblith. Jeenette Wright. EctNard G. Lakata. 
GerontoJogv Research Career ,NIA,NIH, Johns Hopkins HospitaI,Baltimore MD 
The ability to assess vascular properties quartitevely yet noninvasively is 
critical for several aspects 0/ aging and hypertensive carciovascular research. 
The Augmentation Index (AI) has been proposed as such a measure and has 
been shown to correlate with vascular stiffening which occurs with aging and 
hypertension. AI is believed to index the magnitude 0/ aortic pressure 
augmentation restJIing from weve reflections (WR), which, in turn, varies with 
vascular stiffness. However, since the aortic pressure wave contour varies 
with the timing as well as magnitude 0/ WR, we hypothesized that AI can be 
affected I7f changes in the speed 0/ ventricular contraction in addition to 
vascular properties. To test this, AI was determined noninvasively from carotid 
pressure waves registered I7f applanation tonometry in 13 healthy volunteers 
before and invnediately alter maximal treadmill exerCise. The time from the 
fool 0/ the pressure rise to the arrival 0/ WR (TWA), to the dicrotic notch 
(LVET, an index 0/ the speed 0/ ventricular contraction) and to peak aortic 
pressure (PP) were also determined (results in mean :0 standard deviation), 
REST POST-EXERCISE P value 
AI 14.2:09.8 -2.2:011.7 <0.001 
TWR(ms) 118:022 90:027 0.017 
PP (ma) 190:0 41 91 :0 36 <0.001 
LVET (ms) 327 :0 19 244 :0 30 <0.001 
AI rest, WR arrived before PP (TWA < PP) arlCI AI assumed positive values. 
With exerCise, 1WR decreased slightly (28 ms) while the speed 0/ ventricular 
contraction increased substantially (as indexed by an 83 ms decrease in 
L VEl). As a restJI 0/ the marked speeding 0/ ventricular contraction and 
despite a mild increase in WR speed, 1WR and PP became very close alter 
exercise. Consequent to this change in relative timing 0/ WR arlCI ventricular 
contraction, AI decreased substantially and even took negative values in 6 
0/ the 13 subjects in which 1WR came after PP. Thus, AI can be affected I7f 
the speed 0/ ventricular contraction. Since ventricular dynamics vary 
substartially with aging and hypertension, interpretation 0/ char1ges in AI 
should take into account .!2Q!!:l vascular and ventricular properties. 
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752-1 2:00 
Coronary Blood Flow Velocity Profiles In Aortic Stenosis and 
the Effect of valve Replacement 
Antoinette Kenny, Michael Sutlers, Christopher A. Wisbey, Leonard M. 
Shapiro, Papworth Hospnal, Cambridge, U.K. 
Myocardial ischemia in aortic stenosis (AS) is believed to be due 10 
reduced coronary vascular reserve secondary 10 left ventricular 
hypertrophy. Aortic valve replacement (AVR), however, improves 
symptoms of angina even in the presence of persistent left ventricular 
hypertrophy and other mechanisms of ischemia may therefore be 
implicated. The distal left anterior descending coronary artery may be 
imaged and coronary blood flow (CBF) velocijy profiles measured using 
high frequency transthoracic echocardiography/Doppler. In this study we 
use this non-invasive technique to examine resting CBF velocijy profiles 
before and after AVR in patients wijh pure AS and angiographically normal 
coronary arteries. 
Ten patients (Smale, 4 female, mean age 68 years, range 50-82) were 
studied the day prior to and 1 week following AVR. Peak aortic valve 
gradient ranged from 48 to l30mmHg, mean 8S. Heart rate, blood 
pressure and peak systolic and diastolic forward flow velocijies were not 
sign~icantly changed following AVA. However, reversed coronary flow in 
early systole, mean velocijy 20.S±3.6cm/s. was seen in S patients before 
AVR. The interval from the initiation of Ihe QRS complex to the onset of 
the forward systolic component of CBF was significantly longer before 
AVR (pre, 0.17±0.02sec; post, 0.08±0.01sec. p<O.OOl by Hest). The 
timing of onset of the diastolic component of CBF was unaffected (pre, 
O.48±.OSsec; post, 0.42±.05 sec). The time from onset of diastolic flow 
to peak diastolic velocity was, however, sign~icantly longer prior to AVR 
(pre, 0.15±.02sec; post O.07±.Olsec, p<O.OOl by t-test). 
Conclusion. This is the first study to examine CBF in AS under non•
invasive, physiological conditions. CBF velocities were characterized by 
reversed earty systolic flow, a delay in onset of forward systolic flow and in 
attainment of peak diastolic velocity. The reversal of these abnormalities 
follwing AVR may be the result of reduced ventricular wall stress and 
increased aortiC root systolic pressure and may contribute to the relief of 
angina when left ventricular hypertrophy persists. 
752-2 2:15 
Accumulation of T-Iymphocytes and Expression of Interleukin-
2 receptors in Non-rheumatic Stenotic Aortic Valva. 
Margareta C. Olsson, Carl-Iohan Dalsgaard, Anders N. 
Haegerstrand, Ian C. Nilsson, Marten Rosenqvist, Lars E. Ryden 
Karolinska Hospital and Karolinska Institute, Sweden 
Non-rheumatic valvuJar aortic stenosis (AS) is the most common 
adult valvular heart disease.The biological processes involved are 
still poorly understood.ln this study cell-specific antibodies were 
used to identify immunocompetent cells . 
Metbods:Tricuspid stenotic aortic valves were obtained from 19 
patients undergoing surgery for non-rheumatic valvular AS. Nine 
tricuspid control valves were collected at autopsies.The valves were 
fixed in formaldehyde, cryosectioned and stained with antibodies 
against fibroblasts(anti-Vim), endothelial cells (Factor VIII-related 
antigen), macrophages (Mac-I), T-Iymphocytes (CD 6), and inter•
leukin-2(IL-2)- receptors (CD 25). A subset of valves were snap 
frozen and analyzed with antibodies against T-helper cells (CD4) 
and cytotoxic T-cells (CD 8). 
Results: The stenotic valves were characterized by a basal 
accumulation of calcium deposits and by a cell-rich subendothelial 
thickening. Most cells in the subendothelial connective tissue were 
fibroblasts. T-Iymphocytes appeared to be the most common cell 
type in the vicinity of the calcium deposits. and were also found 
close to the endothelial lining of the valves. Analyzes of the T-cell 
population demonstrated that T-helper cells were more frequent 
than cytotoxic T -cells. Expression of IL-2- receptors occurred at the 
similar location as the T-Iymphocytes .Control valves lacked a sub•
endothelial thickening and contained only a few cells reacting with 
antibodies against lymphocytes and macrophages. 
Conclusion:The presence of activated T-Iymphocytes in tricuspid 
stenotic valves suggests the possibility of immunological 
mechanisms involved in the etiology of the non-rheumatic AS. 
ABSTRACTS 215A 
752-3 2:30 
Usefulness of Contrast Enhanced Doppler Echocardiography 
for the Evaluation of Aortic Valve Disease. Initial Results 
of an European Multicenter Study 
Joachim Neudert. George Sutherland, Helen von Bibra. Harald Becher. 
Petros Nihoyannopoulos for the Levovist Cardiac Working Group. 
Munich FRG. Edinburg UK. Munich FRG. Bonn FRG. London UK. 
A poor signal to noise ratio in continuous wave Doppler recordings may 
impede calculation of peak gradient in aortic stenosis. The 
transpulmonary. saccharide-based contrast agent. SHU S08A (S). has 
been shown to enhance left heart Doppler signals after intravenous 
administration. We have therefore evaluated the clinical role of this 
transpulmonary contrast enhancement technique in the assessment of 
aortic valve disease. 21 patients referred for evaluation of suspected 
aortic stenosis (AS) had multiplaneDoppler echocardiographic 
examination before and for 10 min. after the intravenous administration 
of 16 ml S 200 mglml and 10 ml 200 or 300 mglml. The video 
recordings were analyzed by two independent observers. 
There were unequivocal Doppler envelopes in the unenhanced antegrade 
aortic now curves in 7/21 patients. In these, beat to beat analysis did not 
reveal any change of peak velocity due to contrast enhancement. In the 
remaining 14 patients. intravenous S improved the Doppler envelope. so 
that peak gradients couJd be calculated with certainty. Their values 
increased by 8 - 52 mm Hg (p<O.OI). if compared to the unenhanced 
Doppler calculation. and showed an improved correlation with 
catheterization derived gradients. Color Doppler enhancement by S 
provided better visualization and semiquantitative assessment of aortic 
regurgitant jets in 15/21 patients. Contrast enhancement brought about 
better definition of enddiastolic now velocities in the respective spectral 
Doppler recordings in those patients with mixed aortic valve disease. 
Heart rate and blood pressure remained unchanged. 
Conclusion: SHU S08A achieves significant enhancement of both 
spectral and color Doppler modalities. thus improving the quantification 
of the peak velocity gradient in aortic stenosis and allowing better 
defmition of site of origin and extension of aortic regurgitant jets in 
patients with low quality Doppler signals. 
752-4 2:45 
Does Percutaneous Balloon Valvuloplasty have a Role in Patients With 
cardlogenic Shock and Critical Aortic Stenosis? 
Pedro R. Moreno, Ik-Kyung Jang, Igor F. Palacios. Cardiac Unit, 
Massachusetts General Hospital, Harvard Medical School. Boston, MA. 
From 380 patients (pt) undergoing Percutaneous aortic valvuloplasty (PA V) 
at the Massachusetts General Hospital, we identified 18 pts (10 women and 
8 men) with cardiogenic shock (systolic blood pressure <90 mmHg, cardiac 
index < 2.0 Uminlm2 and urinary output <0.5 mUk!Vhr). The mean age was 
75±9 yr and mean LVEF was 29±16%. All pts had major associated medical 
problems. Single balloon PAY was used (17 retrogade and 1 antegrade). 
Results: 
Mean Gradient (mmHg): 
Cardiac Index (Uminlm2): 












With PAY there were 2 vascular complications, 1 0 pts ruled in for non Q•
wave myocardial infarction (3 of them with normal coronary arteriogram), 
one had a cerebrovascular accident.. In-hospital mortality was 50% .. Two 
pts died during PAVand seven pts died within 8±6 days from multiorgan 
failure. Among the 9 pts (50%) who left the hospital, three were in NYHA 
class I-II at 8± 5 months, 3 underwent aortic valve replacement (AVR), 
one had a repeat PAV and two died at 2 and 4 months post PAY. 
ConclUSion: 1 ) Cardiogenic shock in patients with AS and other major 
medical problems is associated with high mortality, despite successful PAY. 
2) PAV can be performed as a rescue life-saving bridge procedure to AVR. 
216A ABSTRACTS 
752·5 3:00 
Exercise Doppler·Hemodynamics May Predict Symptom Onset 
in Valvular Aortic Stenoai. 
Catherine H. Otto, Ian G. Burwash, Alan S. Pearlman, 
Carolyn J. Gardner, Nancy L. Healy, Rebecca Schwaegler. 
University of Washington, Seattle, WA. 
We hypothesized that, in valvular aortic stenosis 
(AS), symptom onset can be predicted from the failure 
of functional valve area (AVA) to increase with exer•
cise. Bruce protocol treadmill exercise was performed 
in 51 asymptomatic AS patients (age 64±15 yrs, 35, 
female) with immmediate pre- and post-exercise Doppler•
echo recordings of transaortic jet velocity and stroke 
volume (SV). No serious complications occurred. 
With exercise, increases were seen in blood pressure 
(144/80 to 165181 mmHg, p<.OOl), heart rate (70±14 to 
146±27 bpm, p<.OOl), AS-jet velocity (3.7±0.8 to 4.2± 
1.0 mis, p<.OOl), mean gradient (32±16 to 42±20 mmHg, 
p<.OOl), maximum flow rate (444±131 to 537±200 mIls, 
p<.OOl), cardiac output (6.8±2.0 to 13.1+5.7 Llmin, 
p<.OOl), and AVA (1.3±0.6 to 1.5±0.7 cm~ p-.005). 
SV decreased slightly (101±34 to 90±31 ml, p-.OOl). 
Subjects with an exercise increase in AVA ~0.2 cm2 
(Group A) vs >0.2 cm2 (Group B), were not different in 
age, gender, SV, cardiac output, AVA at rest, or exer•
cise duration. However, Group A had a higher resting 
jet velocity (3.9±0.8 vs 3.3±O.7 mis, p-.007), and mean 
gradient (37±17 vs 25±13 mmHg, p-.Ol). With exercise, 
the increase in cardiac output (4.8±3.1 vs 8.9±4.6 
Llmin, p<.OOl), and maximum flow rate (58±84 vs 153±92 
mlls, p<.OOl) was blunted, and SV fell (-2l±20 vs +6±16 
ml, p<.001). At a mean follow-up of 5 months, symptoms 
requiring valve replacement developed in 6/32 (19') 
Group A and 0/19 (0') Group B subjects (p-.04). 
We conclude that inability to increase volume flow 
rate adequately with exercise may predict symptom onset 
in AS, possibly due to increased valve "rigidity". 
752·6 3:15 
A Histologic Study on the Conduction System in 
Patients with Calcific Aortic Stenosis 
Shin-ichiro Ohkawa. Chizuko Watanabe. Yuji Ito. 
Masaya Sugiura. *Donald B Hackel 
Tokyo Metropolitan Institute of Gerontology, 
Tokyo. Japan. *Duke Univ Med Center. Durham. NC 
A histologic study using serial sections of the 
conduction system was performed in 10 cases of 
calcific AS(5 M. 5 F;mean 80 yrs). espeCially 
to elucidate the relationship between atrioven•
tricular block(AVB) and the calcification in 
the conduction system. ECG showed 2nd degree 
AVB in 1. advanced (Ad) AVB in 2. complete(C) 
.AVB in 2. SSS in 3. AF in 4. LBBB in 1. and 
RBBB in 1. All escape beats of Ad/C AVB showed 
wide QRS complexes. Five cases including 4 AVB 
had calcification extended from the sinus of 
Valsalva to the ventricular septum. The SAN 
showed marked fibrosis in 2. and the main site 
of lesion in 2 cases of Ad/C AVB was located in 
the common bundle and bilateral bundles(BB). In 
the remaining 2 cases of Ad/C AVB. lesions were 
located in the branching His and both fascicles 
of the left bundle(LB). In 3 cases of AVB the 
branching His and both fascicles of the LB were 
destroyed by a large calcification at the 
summit portion of the ventricular septum. The 
remaining 1 showed idiopathic fibrosis of the 
BB. Cases of LBBB or RBBB showed lesion of each 
corresponding bundle. In conclusion. the main 
lesion in cases with AVB caused by calcific AS 
was located in the branching His bundle and the 
LB. which is more distal to that in cases of 
AVB caused by mitral annural calcification. 
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753·1 2:00 
Comparison of Quality of Life Outcomes FoUowing Coronary 
Angioplasty, Coronary Bypass Surgery and Medicine 
Daniel B. Mark, Charlotte Nelson, Elizabeth Delong, Donald Fortin, 
David B. Pryor, Richard S. Stack, Robert H. Jones, Robert M. Califf, 
Harry R. Phillips,IlI, Mark A. Hlatky, Duke University Medical Center, 
Durham, NC 
Because most angioplasty (PTCA) patients (pts) are low risk, a 
large survival benefit is unlikely and much interest has focused on the 
quality of life effects of the procedure. As part of our on-going 
program to study the cost effectiveness of PTCA relative to medicine 
(Me d) and bypass surgery (CABG), we prospectively studied 3932 
patients who had significant (-,!75% stenosis) coronary disease by 
catheterization (cath) at Duke. Of these, 845 underwent PTCA and 
1506 underwent CABG within60 days of cath, while 1581 were treated 
with initial Med rx. The PTCA pts were younger than CABG or Med 
(median age 60 vs 63 and 62), had less heart failure (7% vs 13% and 
17%), more I vessel disease (65% vs 9% and 48%), less 3 vessel disease 
(9% vs 58% and 21%), and better left ventricular function (median EF 
56 vs 53 and 51). Quality of life was measured at baseline (pre-rx),at 
3 to 6 mas, at one year and annually using a battery of instruments 
including the 12 item Duke ActivityStatus Index (DASI) (range 0 to 
60). At baseline, PTCA pts were more functional than CABG or Med 
pts (DASI 22.4 vs 17.3 and 18.7). Over the first year after rx adjusted 
for baseline DASI, improvement in PTCA pts was about twice that of 
Med (DASI change from baseline 8.19 vs 3.58) (p=<.OOOI) and was 
equivalent to CABG (9.26) (p=O.I). The improvement in PTCA 
functional status relative to Med remained significant even after 
adjusting for baseline imbalances in rx groups and differential mortality 
rates. 
Thus, our study shows a significant improvement in functional 
status over 1 year with PTCA relative to Med, equivalent in magnitude 
to that seen with CABG. 
753·2 2:15 
Women with Angina Pectoris Report Less Pain than Men 
at Similar Levels of Ischemia During Exercise. An 
Interim Report from APSIS, 
Lennan Forslund, Claes Held, Inge Bjorkander, Paul Hjemdahl*, 
Nina Rehnqvist. Dept of Med. Danderyd Hospital and Dept of Clin. 
Phannacol*. Karolinska Hospital. Sweden 
In a single-center, prospective and randomized angina pectoris study 
(APSIS; Angina frognosis Study In Stockhom) the preset number of 
patients (790) have now (Aug 1992) been included. Treatment codes 
will be broken in January 1994 thereby reaching a follow-up of 2400 
p~tient years. Study medications are either verapamil (120-240 mg 
bId) or metoprolol (100-200 mg once daily). In this report 612 pa•
tients (172 women) have been studied. Mean age was ~±7 years for 
both genders. Resting hean rate (HR) (65±11 vs 66±11 bpm; ns) and 
systolic blood pressure (SBP) (143±20 vs 143±20 mm Hg; ns) were 
equal. On exercise testing, men performed 128±22 and women 
96±24 W (p<O.OOI) (Wmax). HR at Wmax was higher for women 
(138±22 vs 131±22 bpm; p< 0.001), SBP was lower (176±26 vs 
I 85±30 mm Hg; p< 0.001) but median plasma norepinephrine values 
were identical, 2.1 for men and 2.3 for women at rest, 10.8 and 10.7 
nM respectively after work. During exercise, women had shorter time 
to I mm ST-depression (404 vs 658 s; p< 0.001) but there was no 
difference in time to chest pain (533 vs 578 s; ns). This means that 
women, at the same level of ischemia, have less symptoms compared 
with men. Twenty women either suffered a myocardial infarction 
(n=6) or had a coronary angiogram for clinical reasons. Women with 
negative angiograms (n=8) had similar time to chest pain as those 
with documented coronary disease (228±114 vs 240±162 s; ns) but 
developed ST -depression later (3~±162 vs 222±96 s; p< 0.05). The 
amount of silent ischemia was equal in women with or without docu•
mented atherosclerotic coronary disease. 
Conclusion: Women have similar sympathetic activation as men but 
less symptoms at comparable levels of ischemia during exercise. 
Women with nonna! angiograms experienced pain at the same level as 
those with documented coronary disease but ST-depression appeared 
later. Silent ischemia was similar in both groups of women. 
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Long· Term Physical Training and Left Ventricular Remodeling Aller 
Anterior Myocardial Infarction: Final Results From the EAMI Study. 
Pantaleo Giannuzzi. Pier Luigi Temporelli. Marinella Gallone. Ugo Co~. 
Alessandro Imparato. Luigi Sala. Claudio Malinveml. Carlo Schweiger. 
Amerigo Giordano and luigi Tavazzl. on behalf of the EAMI Study Group. 
Veruno Medical Center - Cardiology Department. Veruno. Italy 
Aim 01 this multicenter randomized study was to Investigate the effects 01 e 
6-month exercise training program on LV function and remodeling after 
anterior myocardial Infarction (MI). A total of 130 consecU1ive pts with first 
anterior Q-wave MI. In I-II NYHA class. were evaluated for possible 
enrollment. Twenty-seven pts were excluded because of severe exertlonal 
scintigraphic Ischemia or resting EF <25%. The remaining 103 enrolled pis 
(53.±. 9 yrs) were studied 4-8 weeks after the acU1e episode and 6 months 
later by 2D-ECHO at rest and upright symptom-limtted bicycle ergometric 
teS!. At entry. pts were randomly allocated to physical training (T = 52 pts) or 
control (C=51 pts). Global endocardial surface area (ESA). LV volumes and 
ejection fraction (EF). the extent of abnormal wall motion (WMA%). of 
regional dilatation (RD%) and the shape distortion Index (DISTQ were 
analyzed. After 6 months. a slgnHlcant (p<0.01) increase In work capacity 
(4596.±.1246 to 5508.±.1335 KPMjmln) and in lactic anaerobic threshold 
(46.±.13 to 6O.±.14 Walls) was observed only in T. In~ial ESA. end.<fiastollc 
volume (EDV). EF. WMA%. RD% and DISTI were similar and they did not 
change after 6 months In both groups. However. pts wtth .!5,40%EF had 
greater (p<0.01) EDV and WMA% wtth marked DISTI at entry and showed 
further (p<0.01) deterioration after 6 months both in C and In T (EDVmljm2: 
77.±.14 to 85.±.17ln C. 74.±.11 to 77.±.15 In T; RD%: 46.±.18 to 58.±.22 In C. 
41.±.13 to 44.±.19 in T; DISTI: 0.2.±.0.08 to 0.23.±.0.09 In C. 0.18.±.0.07 to 
0.20.±.0.09 In D. These variables did not change In pts wtth >40%EF. 
In conclusion. pIS wtth poor LV function 1-2 months after anterior MI are 
prone to further global and regional LV dilatation. Nevertheless. long-term 
physical training Induces pos~lve results In terms of both peripheral effects 
and work capacity and does not appear to be responsible for this 
increasing late ventricular deterioration. 
753·4 2:45 
Workplace-Related Mental Stress as a Cause of Myocardial 
Ischemia· Comparison With Treadmill·lnduced Ischemia In Pilots 
Using Sophisticated Flight Simulators 
Andrew J. Doorey, Bany S. Denenberg, Peter H. Stone, 
Tracy J. Hanna, Jack N. Newman, Richard Friedman, Vidya V. Sagar, 
The Med. Center of Delaware and Flight Safety Intemational, 
Newark, DE, Brigham and Women's Hospital and Harvard Medical 
School, Boston. MA, State University of NY, Stony Brook, NY 
The induction of myocardial ischemia by workplace-related mental 
stress has been difficult to assess due to the lack of an appropriate 
model and imaging agent. We used a sophisticated full motion (FAA 
Phase C) flight simulator to create a realistic (widely accepted in the 
aviation industry), reproducible model of mental stress during a flight 
segment complicated by severe weather and multiple aircraft system 
failures. Injection of Tcllll-Sestamibi (which has minimal redistribution) 
at pealk mental stress allowed nuclear imaging at a later time. 
Comparisons were made with treadmill tests in airline pilots with 
known coronary artery disease and reversible thallium defects. 
Arousal during the aviation stress was confirmed by heart rate, blood 
pressure and skin impedance measurements. 
Maximal ST depression (mm) 
Regional Sestamibi uptalke 







Conclusion: Workplace-related mental stress causes myocardial 
ischemia that differs in extent from that produced by treadmill 
exercise. Realistic simulation may be useful to study cardiac risk in 
patients subjected to mental stress. 
ABSTRACTS 
753·5 3:00 
Detrimental Effects of Smoking on the Prognosis in 
Variant Angina-Accurate Assessment of Smoking 
Status by Urinary Cotlnine Measurement 
Kunihisa Miwa, Yuko Miyagi, Akihiko 19awa, Masatoshi Fujita. 
Toyama Med. & Pharm, Univ., Toyama, Japan 
Self-reports may underestimate the prevalence of Cigarette 
smoking during a forced or unwilling education for smoking 
cessation. In order to determine the effects of smoking 
cessation on the prognosis, 48 patients with variant angina 
who discharged after the complete disappearance of attacks 
by medical treatment with calcium blockers were advised to 
stop smoking and followed-up. The current smoking status 
was evaluated by both self-reports and a biochemical marker, 
urinary cotinine measured by 1251-cotinine radioimmunoassay 
(>50 ng/ml as smokers), The prevalence of smokers by 
urinary cotinine (3 months: 27 %, 1 year: 28%) was 
underestimated by self-reports (3 months: 8%, 1 year: 13%). 
Although the self-reported smoking status failed to correlate 
significantly with the presence of anginal attacks during the 
last 3 months, the accurate smoking status by the urinary 
cotinine measurement significantly (p<0.05) correlated with it 
(3 months; smokers: 62%, nonsmokers: 29%, 1 year; 
smokers: 38%, nonsmokers 9%). The prevalence rate of the 
presence of anginal attacks during the first 3 months was 
significantly (p<0.05) higher in the patients who continued 
smoking (8/13, 62%) than in the quitters (5/24, 21%) 
according to the classification using urinary cotinine assay. 
Conclusion: smoking significantly worsened the prognosiS of 
variant angina even during a relatively short follow-up period. 
The benefit of smoking cessation may be underestimated by 
the misclassification of smoking status by self-reports. 
753·6 3:15 
217A 
Validation of a Gender-Based Scoring System For Coronary 
Disease Detection and Risk Stratification In 840 Consecutive 
Patients: A Method for Improving Health Care Delivery 
Leslee J. Shaw. James C. Romels. Deborah J. Kargl. Liwa T. Younis. 
Bernard R. Chattman. D. Douglas Miller. Saint Louis University Medical 
Center. SI. Louis. Missouri. 
The recent demonstration of significant differences In diagnostic test 
utilization and revascularization rates between men and women wijh known 
coronary artery disease (CAD) suggests that gender-specilic guidelines are 
needed to correct for potential systematic gender bias In the evaluation of 
pts with suspected CAD. A stepwise logistic regression analysis of 21 
clinical. rest and stress ECG and thallium-201 myocardial perfusion imaging 
variables In 840 consecutive pts (men=449. women-391) aged 45-65 yrs 
wa~ used to determine the relative risk (RR) of cardiac death (n=17 pts). 
myocardial infarction (n=26 pts) and slgnHlcant (~70% diameter stenosis) 
CAD during 24±7 mos of follow-up. RR ranged from "low" for hypertension 
or stress-induced angina (RR=2). to "moderate·· for congestive heart failure 
(RR=4) and stress-Induced ST depression (RR:6 In men). and "high" for 
fixed or reversible thallium-201 defects (RR=15 in women; RR=20 in men). 
A 55-point maximum scoring system weighted according to RR. and receiver 
operating characteristic (ROC) curves were developed for men and women 
(ROC r2=0.80;p<0.001 for both). The annualized gender-specific CAD 
inci:lence rates based total raw scores are gjyen belOw· . 
Total CAP Incidence (per yr) 
~ Mm!nL Women (n) 
<5 1.S% (324) 2.4% (270) 
moderate 5-15 4.5% (55) 5.9% (59) 
hid! >15 236%(70) 213%(61) 
Scoring system sensltivijy=90% and posijlve predictive value=98% lor 
men and women; specificlty=72% for men and 78% for women. Mean 
scores were greater in men (23 ±14 vs. 5±9) and In women (18±13 vs. 6±S) 
who developed angiographic CAD or cardiac events (p<O.OOI for both). 
We conclude that this gender-specific risk-weighted scoring system 
accurately discriminates male and female patient subsets at low. moderate or 
high risk for CAD anellor cardiac events. A gender-based risk stratHlcation 
schema should be implemented in patients wijh suspected CAD. 
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Th. Effect of Wlllfirin on Prev .. enc. of Stroke in Patients With S.v". 
Heart Failur •. 
Rodney H. Falk, Arthur Pollak, P.K. Tandon & Milton Packer, for the 
PROMISE Investigators Boston City Hospital, Boston MA 
Patients with congestive heart failure (CHA due to systolic dysfunction 
are believed to be at an increased risk of thromboembolic stroke although 
the value of anticoagulation ia uncertain. We determined the incidence 
of stroke and the benefits of anticoagulation in CHF by retrospectively 
examining data from 1088 patients (pt), mean age 64 yrs, with 
persistent class 3 or 4 CHF despite standard therapy who were enrolled 
in a multicenter trial of oral mUrinone (PROMISE trial). All had ejection 
fraction (EF).s.35% with mean EF of 21.±.7%. Warfarin was prescribed 
at entry in 324 pt (29.7%) and antiplatelet drugs in 573 pt (52.6%). At 
a median follow-up of 6.1 months, 22 pt (2%) had had a stroke, for an 
annualized incidence of 3.5%. The etiology of CHF (ischemic vS non•
ischemic) did not predict stroke risk but EF .s.20% was associated with 
increased prevalence of stroke which was significantly reduced by 
warfarin use. 
Stroke prevalence at 6.1 month median follow-up 
WARFARIN 
ISCHEMIC 2/153 (1.3%) 
NON -ISCHEMIC 11171 (0.6%) 
EF> 20% 21143 (1.4%) 











In contrast to warfarin, aspirin therapy showed no benefit in stroke 
prevention. W. condude that pt with EF.s. 20% & class 3-4 CHF are at 
high risk of straka (3.3% at 6 months) and that this risk is markedly 
reduced by warfarin but not by anti-platelet agents. Although these data 
support the usa of warfarin in CHF and very low EF a prospective trial is 
warranted to determine the risk-benefit ratio of long-term 
anticoagulation. 
754-2 2:15 
Is Patent Pora.en Ovale A Risk Pactor Por Stroke? 
Daniel Fisher, Edvard A. Fisher, Jacqueline B. Budd, 
Stacey Rosen, Martin E. Goldman, Mount Sinai Medical 
Center, Nev York, New York. 
Patent forallen ovale (PFO) is present in 10-35% of 
people and has been reported to be an important risk 
factor for cardia-embolic cerebrovascular disease 
(evA), especially in young people. Vhile contrast 
transthoracic echo has been used to detect PFO, 
contrast transesophageal echo (TEE) has a greater 
sensitivity. Therefore, to determine if PFO is a real 
risk factor for evA we reviewed 1000 consecutive TEEs 
performed with contrast and color Doppler for the 
presence of PFO and other evA risk factors including 
atrial septal aneurys. (ASA) , aortic plaque, atrial 
fibrillation (Afib), and "atrial smoke" and/or 
thro.bi. Vhile imaging with mono or biplane TEE, 
multiple injections of agitated saline were injected 
during cough or val salva to detect flow through a PFO. 
There were 482 males and 518 females, mean age 60 : 17 
years (range 11-93 yrs) (*.p'.OOOI t.p'.003) 
N CVA ASA AGE Afib Smoke 
PFO 94 34 IF 58.8 lr ar 
NO PFO 906 352 54 60.5 83 193 
PFO was found in 9.4% of all patients and in equal 
proportion in all age groups divided by decade. 
Contrast TEE had a much higher detection rate than 
color alone. Importantly, there was no greater 
incidence of PFO in patients with evA or in males vs 
females. Also, there was a very strong correlation 
between the presence of ASA with PFO (p<.OOOl). Thus, 
PFO detected by TEE, frequently seen with ASA, is seen 
in all age groups and does not in itself present a 
risk factor for evA. The association of PFO with 
peripheral thro.bosis and evA needs further study. 
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Detection of Prosthetic Valve Strands by Transesophageal 
Echocardiography: Clinical Significance in Patients With 
Suspected Cardiac Source of Embolus 
David A. Orsinelli, Anthony C. Pearson. The Ohio State University, 
Columbus, Ohio. 
Transesophageal echocardiography (TEE) is frequently employed in 
the assessment of patients with prosthetic valves who have had a 
stroke, TIA or arterial embolus as well as in patients with suspected 
prosthetic valve dysfunction (PVD). The significance of highly 
mobile, linear echodense structures (strands) seen on the prosthetic 
valve sewing ring remains controversial. We therefore reviewed our 
experience in 80 patients (91 total studies) with prosthetic valves 
undergoing TEE for the evaluation of suspected PVD or a suspected 
cardiac source of embolus (CSE) and compared the presence of 
strands in these two patient populations. Patients who underwent TEE 
for suspected prosthetic valve endocarditis were excluded. Of the 65 
studies performed to evaluate PVD, 8 (12%) had prosthetic valve 
strands. In contrast, of the 26 studies performed to evaluate a eSE, 
prosthetic valve strands were found in 18 (69%), p=.OOO 1. Of the 8 
studies with no prosthetic valve strands, 5 had other abnormal 
findings that have been associated with systemic emboli: spontaneous 
left atrial contrast (3), atrial septal defect (2), left atrial thrombus (1). 
Two patients with strands underwent valve replacement for repeated 
embolic events. There was surgical confirmation of thrombus in both 
specimens. A third patient had strands noted on his mitral prosthesis 
following a TIA despite a therapeutic prothrombin time. Dipyridamole 
was added and a follow-up TEE demonstrated a normal prosthesis, 
with resolution of the strands. We conclude that in patients with a 
prosthetic cardiac valve, strands are found significantly more often in 
patients with a suspected CSE than in patients being evaluated for 
PVD. Most likely, these strands indica!:: an abnormal valve with 
thrombus, fibrin or pannus formation and a high potential for systemic 
embolization. In patients with apparently normal valves, TEE may 
detect other potential cardiac sources of emboli and thus may alter 
patient~gemenL 
754-4 2:45 
Usefulness of Early Echocardiography in the Decision Making in Massive 
Pulmonary Embolism 
Franco Casazza. Fabrizio Centonze. Maurizio Marzegalli. Mariangela ChiriCO. 
Corrado Piane, Mario Morpurgo 
Department of Cardiology. S. Carlo Hospital. Milan, Italy 
In a lifethreatening situation like Massive Pulmonary Embolism (MPE), it's 
mandatory to make a correct diagnosis as soon as possible in order to start 
the appropriate treatment. In the last 4 years 40 pts underwent 20 echo Within 
6 hours (75% within 2h) from the onset of symptoms. The diagnOSIs of PE 
was assessed on the basis of Angiopneumography (APC). Lung Perfusion 
Imaging (LPI) and autopsy. All the pts had clinical. hemodinamic or 
morphologic signs of MPE; 65% of them received thrombolltic therapy. Echo 
preceded APC or LPI in all cases. Parasternal Long Axis view (PSLA), Apical 4 
Chamber (AP4C) and Subcostal 4 Chamber view (SC4C) were used for 
calculation of RVEDD. LVEDD and their rotio. and for the analysIs· of the 
Interventricular septum (iVS) motion. All data were compared, In each echo 
view. With parameters obtained in 40 healthy subjects. A color gUided 
continuous wove doppler was performed in 10 pts. By pooling the results from 
the three echo Views, 39/40 pts showed abnormoi findings the RVEDD/LVEDD 
was the most sensibve parameter of Acute Cor Pulmonale (ACP), being 
increased in 95% of cases. The only pt who failed to show echa signs of ACP 
suffered a dilated cardiomyopathy causing a severe dilation and hypokineSia oi 
the LV. Other (wo pts with previous mitral incompetence had ;Gcreased 
RVEDD/LVEDD during the acute phase that reverted to the picture of LV volume 
overload in the intermediate phase. An abnormal diastolic leftward shift of Ihe 
IVS was detected in 76%, more often I~ the AP4C View (92%) A mild to 
moderate trrcuspld regurgitation was seen In 100% With a mean VD-AO 
pressure gradlent=37mmHg. ill ~ very early echo seems to plOy a 
mOjor role in the diagnosis and management in MPE, especiallv when APG 0' 
LPI cannot be quickly performed. 
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The Optimal Management of Patients With Suspected Pulmonary 
Embolism: A Decision Analysis. 
William B. Hillegass, Anna N. A. Tosteson, Lee Goldman, C, Seth 
Landefeld, Thomas H. Lee. Brigham and Women's Hospital, Boston, MA. 
To determine the optimal management of patients with suspected 
pulmonary embolism (PE), we used published data to perform a decision 
analysis comparing the four month quality· adjusted survival that would be 
expected from five strategies: 1) observation (OBS); 2) empiric 
anticoagulation (AC); 3) pulmonary angiography followed by initiation of 
anticoagulation ifPE were detected (ANG·AC); 4) pulmonary angiography 
followed by placement of an inferior vena caval fliter if PE were detected 
(ANG·FILT); and 5) empiric placement of an inferior vena caval ftIter 
(FILT). A patient's noninvasive probability of PE (P[PEJ) was determined 
from clinical assessment, lung scan, and lower extremity noninvasive test. 
A patient's bleeding risk can be estimated from a validated prediction 
model. 
Results: Patients should be observed only when the P[PE] is < 1-4% by 
noninvasive assessment. If P[PE] is >80%, empiric AC or FILT are 
appropriate, depending on the patient's risk for bleeding from AC, When 
four month bleeding risk is > 14%, FILT is superior to AC, If P[PE] is 
5-80% after noninvasive testing, ANG·AC or ANG·FILT are the best 
strategies unless the patient's risk of bleeding complications is < 5%. In 
patients with intermediate P[PE] after clinical and lung scan assessments, 
a negative lower extremity noninvasive testing (LENT) was not sufficiently 
sensitive for PE to reduce P[PE] below the 1-4% threshold at which 
observation would be the optimal strategy. 
Conclusion: The optimal use of ANG, AC, and FILT can be determined 
for individual patients based on the clinical assessment of their probability 
of pulmonary embolism and major bleeding risk. In patients with an 
intermediate/indeterminant lung scan result, a negative LENT does not 
appear to reduce P[PE] to a level at which OBS is appropriate. 
754-6 3:15 
Bedside aPTT Monitoring' A Convenient, Rapid, and 
Accurate Assessment of Systemic Anticoagulation in 
Heparinized Patients 
Richard Becker, Jay Cyr, Jeanne Corrao, Steven Ball, Joel 
Gore. Thrombosis Center, University of Massachusetts 
Medical School, worcester, MA. 
Patients with thromboembolic disease and acute coronary 
syndromes are known to benefit from systemic 
anticoagulation (AC) with heparin. Of concern, however, 
clinical studies have shown that AC is rarely achieved 
rapidly and many times is not maintained at a therapeutic 
level. Prolonged laboratory turnaround time of the 
activated partial thromboplastin time (aPTT), a test used 
commonly to assess AC, may contribute to this problem. 
Accordingly, we assessed the adequacy of AC in 120 
heparinized patients in the Coronary Care Unit using a 
hand-held bedside device that determines aPTT with a drop 
of whole blood from a capillary (finger stick), venous, or 
arterial sample. From the same blood sample (5 ml), aPTT 
also was determined using a standard laboratory assay. A 
total of l52 aPTT's were performed. The bedside device 
provided a reliable (r=O.83) aPTT within 3 minutes. In 
contrast, the laboratory aPTT was delayed on average 134 
minutes (range 35 to 280 minutes). The average time from 
blood draw to laboratory acquisition was 44 minutes, while 
90 minutes were required for sample processing and 
performance of the aPTT. Subtherapeutic aPTT values «60 
seconds) were documented in 2l% of patients in the first 
24 hours of heparin therapy. Thus, bedside aPTT monitoring 
provides a convenient, rapid, and accurate assessment of 
AC in heparinized patients. The potential impact of this 
new technology on clinical outcome among patients with 
acute myocardial infarction receiving thrombolytic therapy 
is currently being evaluated in the GUSTO trial. 
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Changes in Ventricular Myocardial Gap Junction Distribution 
in Man throughout Childhood. 
Nicholas S Peters, Nicholas J Severs, Christopher Lincoln, 
Magdi Yacoub, Colin R Green. National Heart & Lung 
Institute, and University College London, England. 
From birth there is a > IO-foldincrease in ventricular mass, but 
the duration of ventricular depolarization increases by only 
20%. Gap junctions are a major determinant of electrical 
propagation velocity, and the purpose of this study was to map 
age-related changes in distribution of the principle cardiac gap•
junctional protein, connexin43 (Cx43). Immunolocalization of 
Cx43 gap junctions using laser scanning confocal microscopy, 
and electron microscopy were performed on ventricular 
myocardium from 20 surgical patients (age: neonate - 15 yrs). 
In the neonate, immunolabeled Cx43 is distributed in a 
punctate pattern over the entire surface of the ventricular 
myocytes. With advancing age, the gap-junctional label 
becomes increasingly distributed in the cell terminals which lie 
transverse to the long axis of the myocytes; that is, tending 
towards the adult distribution of gap junctions in the 
intercalated disks. The proportion of label in the transverse 
terminals showed a linear increase with age (R=0.89,p<0.OOI), 
reaching the adult pattern at about 6 years of age. Electron 
microscopy confirmed the changing pattern of intercellular gap•
junctional contacts. 
These postnatal developmental changes of gap junction 
distribution would be expected to alter the patterns of 
intercellular coupling and the nature of impulse propagation, 
and may explain the increasing myocardial conduction velocities 
during this period. 
755-2 2:15 
Ventricular Dilatation Increases the Potential ror Tachycardia Acceleration 
in Reentry Ventricular Tachycardia 
Michael I. Reiter. Zoltan Zeteloki, Lucas Boersma, Charles I.H. Kirchoff. and 
Maurits A. A11essie. University of Colorado Health Sciences Center, Denver. 
Colorado and University of Limburg, Maastricht. The Netherlands. 
Ventricular tacbycardia (VT) occurs frequently in patients with congestive 
heart failure and VT acceleration is often observed during therapeutic 
interventions in these patients. We examined VT acceleration during a study 
of the interaction of ventricular dilatation and d·Sotalol (d-S) in a model of 
reentry VT. 
Methods: Thin epicardial layers of anisotropic myocardium were created in 
Langendorff p<rfused rabbit left ventricles (LV) by a cryoprocedure. A fluid•
fillod. latex balloon was secured within the LV in order to dilate the ventricle. 
Sustainod reentrant VT. around a central cryolesion. was induced by rapid 
pacing in all preparations (n = 7). Mapping was performed through 248 
epicardial electrodes. Single premature beats (4 x threshold). introduced 
within the reentry circuit. were used to define the excitable gap (EG). 
Results: Dilatation did not influence stable VT cycle length (CL). EG which 
averaged 47 'IIi of VT cycle length (CL) in the undilated LV. was increased by 
dilatation (to 52 'IIi of VT CL; p < 0.05). 
During rapid pacing to induce or tenninate VT in this model. VT acceleration 
was observod more frequently in the dilated LV (7 episodes out of 19 attempts 
in 5 of7 preparations) than in tbe undilated LV (0 episodes in 15 attempts; p 
< 0.05). VT acceleration was due to the development of double-wave reentry 
(DWR; two successive waves traveling in the same circuit in the same 
direction). d·S which narrowod EG prevented VT acceleration (2 episodes in 
36 attempts; p < 0.05 compared to dilatod LV in the absence of d·S) and 
DWR. 
Most episodes of DWR were transient and spontaneously converted to stable, 
slower single wave VT. On occasion. stable DWR was observed to convert to 
single wave reentry only after removal of volume from the dilated LV, with 
block of I wave. 
Conclusion: VT acceleration in the dilated beart may be related to a widening 





DiffermtW Effect ollJche~ on Monophasic Action Potentials in 
Canine Ventric:ulM Epicardium and Endocm:llum 
Subramaniam Krishnan, Thomas G. Trouton, Hasan Garan, Jeremy 
N. Ruskin. Massachusetts General Hospital, Boston MA. 
2:30 
Myocardial ischemia in vivo is known to exert a differential effect 
on the e1ectrophysiology of canine ventricular subepicardium (EPn 
and subendocardium (ENOO). We examined the effects of 15 
minutes occlusion of the left anterior descending coronary artery on 
the monophasic action potential (MAP) in canine ventricular EPI 
and ENOO in vivo (n .. 11). At baseline, the MAPs in EPI and 
ENOO showed the following characteristics, respectively: 
activation time 23 ± (SO) 12 msec, 4 ± 6 msec; upstroke time 16 ± 6 
msec, 18± 11 msec;amplitude31 ± 12 mY, 28± 8 mV; 90% MAP 
duration (MAPOejo) 243 ± 47 msec, 2SS ± 3S msec. After 5-7 minutes 
of ischemia maximal changes in MAP morphology were observed. 
In ENOO, activation time was delayed to 11 ± 10 msec (compared 
with baseline, p<0.05), upstroke time increased to 39 ± 29 msec 
(p<0.0l) and amplitude decreased to 20 ± 5.3 mV (p<0.005). In EPI, 
there was a marked delay in activation time to 54 ± 14 msec 
(compared with baseline, p<0.00l), upstroke time was slowed to 
100 ± 4S msec (p<O.OOOI) and amplitude decreased to 7.6 ± 2.7 mV 
(p<O.OOOl). Non-significant reductions in MAPD90 were observed in 
both tissues. After 3-5 minutes of coronary occlusion, discontinuous 
conduction was seen in EPI but not in ENOO, and was manifested by 
step delays. After 6-7 minutes of coronary occlusion severe 
depression in electrical responsiveness occasionally resulted in 
complete electrical quiescence in EPI but not in ENOO. The 
ischemia-induced depression of electrical responsiveness in EPI 
displayed a tachycardia-dependence and was most severe during 
ventricular fibrillation. In conclusion. ischemia-induced electrical 
changes which occur in the canine ventricle are heterogeneous and 
are more marked in subepicardium than in subendocardium. MAP 
recordings are a sensitive method of studying these changes. 
755·4 2:45 
Studies of Collision of W .. e Fronts - Implications for Undentandinl 
Double Potentials Recorded In Reentrant Rhythms 
Jose Ortiz, Anand Murthi, Xavier Gonzalez, Albert L. Waldo, Case 
Western Reserve University, Cleveland, OH. 
Double potentials (DPs), defined as 2 deflections separated by an isoelect•
ric interval, are frequently recorded during reentrant tachycardias. They 
are thought to represent block at the center of the reentrant circuit, with 
each potential reflecting activation of the reentrant wave front on each 
side of the central area of block. However, the cause of the DPs has not 
been elucidated. We tested the hypothesis that centripetal wavelets from 
the circulating reentrant wave front can sequentially bombard the central 
area of block and cause DPs. ~: We studied 6 dogs, 4 with sterile 
pericarditis (SP) and 2 with normal hearts. In order to obtain collision of 
wave fronts, simultaneous rapid pacing was performed from opposite dir•
ections [from the right atrial appendage (RAA) and the inferior vena cava 
(IVC») beginning at a CL of 200 ms, with 10 ms decrements until 2:1 atrial 
capture at one or both sites developed. Studies were performed using a 
multisite mapping system which recorded from a high spatial resolution 
190 electrode array placed in the center of the right atrial free wall 
(RAFW). The interelectrode distance was 1.2 mm perpendicularly and 1.7 
mm diagonally. Results: Pacing at CL of 200-150 ms produced collision of 
the 2 opposite wave fronts simultaneously in the center of the RAFW with 
absence of DPs and presence of positive deflections in the unipolar elec•
trograms recorded along the line of collision. However, at shorter pacing 
CLs, after collision of the wave fronts during the first 1-3 beats, unequal 
slowing of conduction resulted in sequential collision of wave fronts not 
with each other, but with an area of refractoriness, resulting on recorded 
double potentials. This occurred at longer CLs in the SP hearts (mean 130 
ms) than the normal hearts (mean 110 ms). The difference in activation 
time at the line of refractory block was ~ 50 ms, allowing the DPs to be 
seen clearly on the electrograms. Each potential reflected activation time 
of the two opposite wave fronts just before each blocked. The "true" acti•
vation potential showed the maximum negative slope (-dv/dt) when the 
monopolar recordings were analyzed. No DPs were recorded when pacing 
at same range of CLs from only a single site. DPs in this model were 
similar in morphology and behavior (they reflected the activation time on 
each side of the block) as DPs found along the line of functional block 
during atrial flutter (AFL) in the SP model. Conclusion: These data 
support the hypothesis Ihat DPs in reentrant rhythms like AFL in the can•
ine SP model most likely reflect sequential collision of centripetal wave 
fronts along a "line of functional block" due to refractoriness. 
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Measurement of Cardiac Transmeabrane Current in Vivo, 
a Novel Karker of LDeal Activation 
Francis X. Witkowski, Katherine M. Kavanagh, Patricia 
A. Penkoske, Robert Plonsey*. University of Alberta, 
Edmonton, Canada and *Duke University, Durham, North 
Carolina. 
The inwardly directed component of transmembrane 
cardiac current (1m) during normal activation is 
known to be predominantly a Na+ mediated current with 
a duration determined from patch clamp studies of 
around I msec. We have developed a remarkably simple 
in vivo technique, using an extracellular 
electrogram recording array with cellular dimensions to 
estimate the extracellular image of 1m' Five-element 
electrode arrays incorporating 75pm diameter Ag 
electrodes with center-to-center distances of 2l0~m 
initially were verified to provide spatially sufficient 
samples for voltage gradient determinations. 1m was 
estimated from the derivative of the magnitude of this 
voltage gradient. Recordings from 57 epicardial RV 
and LV sites in 7 open-chest anesthetized dogs were 
obtained. The duration (mean±SD) for the inward 
transmembrane current component at 25% of the maximum 
value - 0.45 ± 0.22 msec. The difference between 
local activation time determined from the intrinsic 
deflection of the central unipolar site of the array 
and the minimal dIm/dt -0.001 ± 0.06 msec. 
Additionally, KCl induced membrane potential depression 
in vivo, in the absence of ischemia clearly 
demonstrated a transition from normally Na+ mediated 
activ~tions to either severely depressed Na+ mediated 
or Ca + mediated activations. 
Conclusion: a new approach to local cardiac activation 
determination has been developed and verified that 
additionally provides, for the first time, insight into 
the responsible underlying ionic mechanisms. 
755·6 3:15 
A Large Region of Membrane Hyperpolarization Near the 
Cathode During Stlmulatlon In Arterially Perfused Rabbit Heart. 
Slephen B. Knisley, Bruce C. Hill, Raymond E. Ideker, Duke Univ., Durham, 
NC and Resean:h Institute, Palo Alto Medical Foundalion, Palo Alto, CA 
Knowledge 01 the effect 01 a shock on the transmembrane potential (TM) is 
crucial for underslanding myocardial stimulation and defibrillation. We used 
TM-sensitive dye fluorescence recordings, immune to shock anifacts, to 
investigate TM during shock pulses on the left ventricle of anerially-pertused 
isolated rabbit heans at 370 C. The heans were given 20 mM diacetyl 
monoxime to eliminate contraction anifacts In the recordings and were 
endocardially prefrozen to produce a thin layer of viable epicardial tissue. In 5 
hearts a stimulation (5) electrode consisting of 16 100x200 micron chlorided 
Ag terminals in an 8 mm-Iong Dne perpendicular to the myofibers was used 
and a laser scanning system recorded transmembrane dye fluorescence 
during 6-20 vo~ S from 64 spots in a 9x9 mm region beside and beginning 1 
mm from the S electrode. In 2 other heans a 25 micron point 5 electrode with 
1-2 rnA S was used and a fluorescence microscope recorded transmembrane 
dye fluorescence from 60 micron-diameter spots at the 5 electrode. and 0.5 
mm and 1 mm away from the electrode in the direction approximately along 
the myofibers. In all heans the S retum electrode was a 2 cm2 sponge on the 
oppoSite side of the heart. RESULTS: The fluorescence microscope 
revealed that a cathodal point S produced positive TM changes within 60 
microns of the S electrode, as expected near a cathode, yet it produced 
smaller negative TM changes 1 mm away from the electrode. In the scanned 
hearts. 40% of spots 1 mm from the S line underwent positive TM changes 
during the cathodal S pulse while a large fraction, 0.60±0.29, of the scanned 
region underwent negative TM changes. The negative TM changes occurred 
from 2.4t1.0 mm to as far as 9 mm from the S electrode, were largest 4.3±1.0 
mm from the 5 electrode, and for 20 volt 5 had magnitudes as large as the 
action potential phase zero depolarization produced by distal pacing. With 
both scanner and microscope, switching the S to an anode reversed the 
directions of the TM changes at a given recording spot. Thus depolarization 
occurs near an S electrode during a cathodal pulse as expected yet a large 
region of hyperpolarization occurs just a few mm away. These TM changes 
near and away from an S electrode may playa role in producing the voltage•
dependent membrane responses that lead to stimulation and defibrillation. 
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756·1 2:00 
Sequential Teboroxlme Imaging for the Detection of 
Subtotal Coronary Occlusion and Reperfuslon. 
Louis I. Heller. Bemard J. Villegas, Bonnie H. Weiner. Brenda A. 
McSherry, Seth T. Dahlberg, Lawrence I. Laifer, Edward D. 
Folland. Jeffrey A. Leppo. Univ of Massachusetts. Worcester MA. 
A noninvasive real time technique to serially evaluate myocardial 
perfusion in patients receiving thrombolytic therapy for acute 
myocardial infarction is needed. Prior investigations have 
demonstrated that sequential planar imaging with teboroxime 
(tebo) can rapidly detect total occlusion and reperfusion and 
identify the totally occluded vessel. In order to assess the ability of 
this technique to differentiate subtotal occlusions from 
reperfusion we studied 7 patients undergoing elective PTCA of a 
major coronary artery. Tebo scans were acquired during balloon 
inflation with an RX Perfusion Catheter"'. Average peak blood flow 
velocity (APV) was measured in the distal vessel with a doppler 
FIoWire®. Equivalent views were repeated one hour following 
successful PTCA. The APV increased from 10.7±9.0 cm/sec during 
balloon inflation to 32±12 em/sec following successful PTCA 
(p=0.002). There was a direct linear relationship between the 
LAO occlusion scan defect/normal zone count/pixel ratios (ct/pix) 
and the APV during inflation (r=0.89;p=O.007). The mean 
number of defects decreased significantly from 4.7±1.1 during 
balloon inflation to 0.28±0.7S following reperfusion 
(p=O.OOOS). The ct/pix was lS% lower during inflation than 
following reperfusion (p<O.OS). Overall the scans correctly 
identified the subtotally occluded artery in 617 subjects. The scan 
was 100% accurate for distinguishing the LAD (n=4) from the 
LCX or RCA (n=3). This is the first clinical study to suggest that 
(1) there is a direct linear relationship between defect intensity 
and coronary artery blood flow velocity during subtotal occlusion 
and (2) sequential planar imaging with teboroxime can identify a 
subtotally occluded coronary artery and quickly confirm 
reperfusion in real time. 
756·2 2:15 
Nitroglycerin Before Reinjection of ThaJllum-201 Enhances 
Detection of Reversible Hypoperfuslon via Collateral Blood 
Flow: A Randomized, Double Blind, Parallel, Placebo•
Controlled Trial 
Rafael Medrano, John J. Mahmarlan, Marlo S. Verani, Baylor 
College of Medicine, Houston, Texas 
We investigated whether nitroglycerin (NTG) administration prior 
to thallium-201 reinjection (RI) enhances detection of defect 
reversibility (REV) and whether this is dependent on collateral 
flow. Sixty-eight pts (60 male, S female, mean age 62±9.7 yrs) 
with angioQraphicaily proven coronary artery disease were 
prospectiveI'( randomized to a double blind parallel, placebo•
controlled trial. Prior myocardial infarction was present in 45 
(66%) pts. All pts had persistent defects on 4 hr post-exercise 
redistribution thallium tomograms and were then randomly 
assigned to receive 1 mCi of thallium-201 after administration of 
either O.S mg sublingual NTG or placebo, with repeat imaging 5 
min later. 
Total perfusion defect size and extent of REV were 
computer-quantified and similar at baseline and 4 hr 
redistribution in pts with or without collaterals and in those who 
received NTG or placebo. The overall mean extent of REV was 
greater following RI than at 4 hr redistribution (13 vs 10%, 
p=0.OO1). Pts who had no collaterals and received NTG, as 
well as those who had collaterals but didn't receive NTG, did not 
have enhanced REV after RI. However, a significant increase in 
the extent of REV following RI was noted for the subgroup of pts 
(n=2O) who had collaterals and received NTG, compared to 4 
hr redIstribution images (16 vs 11%, respectively, p<0.01). In 
this subgroup, 11 of 20 pts had a > 50% increase In the extent 
of REV follOwing RI, of which 10 (91%) had a total or nearly total 
coronary occlusion with distal collateral circulation. 
In conclusion, NTG administration before RI of thallium-
201 enhances the detection of REV, but only in areas perfused 
by highly stenotic and/or occluded arteries supplied with 
collateral blood flow. 
ABSTRACTS 221A 
756-3 2:30 
Improvement of Resting 99mTc-Sestamibi Myocardial 
Uptake by Acute Nitroglycerin Administration 
Michele Galli. Claudio Marcassa. Pedro Silva. Orazio Zoccarato. 
Riccardo Campini. Fondazione Clinic a del Lavoro. Verono (NO). 
Italy. 
Sestamibi uptake and retention reflect cellular integrity; however 
some myocardial segments showing reduced tracer uptake at rest 
may consist of viable though hypoperfused myocardium. In order to 
differentiate scarred tissue from viable segments with resting 
hypoperfusion, we assessed if regional Sestamibi myocardial 
distribution at rest could be influenced by nitroglycerin (TNG) 
administration before the tracer injection. Twenty pts (54±8 years; 
previous MI documented in 18 pts; mean LVEF 48%±15%) showing 
Sestamibi uptake defects at resting SPET images repeated the 
scintigraphic study 2-6 days later, assuming TNG (0.4-0.8 mg 
sublingually) before the tracer injection. Resting and post-TNG scans 
were acquired 120-150 min after Sestamibi injection. The size of the 
tracer uptake defect was quantified by integrating the hypoperfused 
area under the lower nonnallimit (mean-2 SD) from circumferential 
profiles in 3 short-axis slices. In 10 pts the reproducibility of the 
method was assessed (r=0.988). 
After TNG. the mean defect area Significantly decreased (4899±836 
vs 4071±708; p<0.05). The post-TNG defect size was reduced 
beyond the reproducibility limits in 13 pts (Group I; 5242± 1066 vs 
3570±838, p<O.OOI) and was unchanged/increased in 7 (Group 2; 
4511±1384 vs 4985±1370, p<0.05); resting Sestamibi defect size 
was comparable between the two Groups. The Sestamibi defects 
bound to improve following TNG were associated with 
corresponding regional wall motion abnonnalities in 11/13 Group I 
pts. In 16/20 pts the coronary angiography was available: the 
defect-related vessel was occluded in 8/11 Group I pts and in 1/5 
Group 2 pts. 
In conclusion, the administration of TNG before resting Sestamibi 
injection may improve the detection of residual viability in 
hypoperfused regions. 
756·4 2:45 
Simultaneous Assessment Of Myocardial Perfusion and 
Ventricular Function By Adenoslne-Sestamlbl Cardiac 
Imaging 
Marla G. Koutelou, Tony Chin, Gerald W. Guidry, John J. 
Mahmarlan, Mario S. Verani. Baylor College of Medicine, 
Houston, Texas 
The association of adenosine and Tc-99m sestamibi imaging 
has not been previously reported. Accordingly, we performed 
single-photon tomography (SPECT) and first-pass radionuclide 
angiography in 120 pts (61 females, 59 males, mean age 64 ± 12 
yrs) undergoing adenosine-sestamibi cardiac imaging. SPECT 
Images were quantified by computer-derived polar plots 
compared to a normal adenosine-sestamibi data bank. 
Radionuclide angiography was performed on a Scinticor 
multicrystal gamma camera with computer determination of left 
ventricular volumes, ejection fraction (EF) and cardiac output 
(CO). Fifty-three pts also underwent coronary angiography at a 
median interval of 1 day from the adenosine-sestamibi study. 
Adenosine SPECT was abnormal in 36 of 42 pts with 
~50% coronary stenosis (sensitivity 86%) and normal in 9 of 12 
pts with normal coronary arteries (specificity 75%). In the total 
patient cohort, adenosine increased CO from 6.5±7 to 7.2±7.1 
I!min (p=O.OOOS). The increase in CO was exclusively due to 
increase in heart rate (from 76± 15 to 93± 18 beats/min, 
p=0.OOO1) as there were no changes in end-diastOlic volume, 
end-systolic volume or EF. Furthermore, pts with and without 
transient perfusion defects had similar increases in cardiac 
output. Yet, EF did not change during adenosine infusion, even 
in pts with transient defects. Of 35 pts with reversible perfusion 
defects, only 7 (20%) developed wall motion deterioration 
during adenosine infusion. Adenosine-sestamibi SPECT is an 
accurate test for detection of coronary artery disease. 
However, in our patient cohort, wall motion deterioration during 
adenosine infusion occurred infrequently on first-pass 
radionuclide angioQraphy, rendering the latter technique 
unsuitable for detection of coronary artery disease. 
222A ABSTRACTS 
756-5 3:00 
Frequency of Reversible Resting Hypopertuslon In Patients 
Undergoing Rest TI-201/Stress Tc-99m sestamlbl Separate 
Acquisition Dual Isotope Myocardial Perfusion SPEeT. 
Hosen Kiat, Yolanda Biasio, Fan Ping Wang, John Friedman, Guido 
Germano, Ken Van Train, Daniel S. Berman. Cedars-Sinai Medical 
Center, L.A., CA. 
In comparison to rest/stress Tc-sestamibi (Tc) SPECT, separate 
acquisition rest TI-201 (TI)/stress Tc dual isotope myocardial 
perfusion SPECT (DIMPS) offers the potential of detecting reversible 
resting hypoperfusion (RRH) through the performance of 
redistribution TI SPECT. This study assessed the frequency of RRH 
in 86 consecutive pis (prior MI, n=60) who underwent DIMPS with 
late TI redistribution imaging. Rest TI (2.5·3.5 mCi) SPECT was 
followed by stress Tc (20-30mCi), and Tc SPEeT 30 mins post•
stress. Redistribution TI SPEeT was performed 18-72 hrs later 
without TI reinjection. SPEeT images were divided into 20 
segments (segs) and scored using a 5 point system (O=nl, 4=absent 
uptake, a score of ~2=defect). Tc defects were categorized as 
reversible (DIMPS-REV) and nonreversible based on comparison 
with the rest TI. All pts had ~2 nonreversible defects by DIMPS. The 
nonreversible defects were further evaluated for RRH by 
comparison of rest TI to late TI. Of the 1720 segs in 86 pts, 
787(46%) segs had stress defects, of which 256 (33%) were 
DIMPS-REV. Of the 531 nonreversible stress defects, 145(27%) had 
RRH: 25% of the nonreversible defects in the MI pts (101/406) had 
RRH vs. 35%(44/125) in no MI pts (p=.03). For pts and individual 
coronary territories to have RRH, ~ segs with RRH were required. 
For pts, 37(43%) pts had RRH, with 15/86(17%) pts having only 
RRH without DIMPS-REV. RRH was present in 12%(30/258) 
coronary territories which did not have DIMPS-REV: 16 territories 
had 2 segs, 13 had 3-4 segs, and 1 had ~5 segs with RRH. 
Conclusion: RRH is common in pis undergoing DIMPS. Since TI 
redistribution imaging identified RRH in 17% of pts and 12% of 
coronary territories without reversibility by rest and stress studies 
alone, these findings are of potential clinical significance. 
756-6 3:15 
Comparison of Planar and SPECT Tc-99m Tetrofosmin 
Myocardial Imaging 
Jaekyeong Heo, David Cassel, Virginia Cave, Valerie 
Wasserleben, Abdulmassih S. Iskandrian. Philadelphia 
Heart Institute, Presbyterian Medical Center, 
Philadelphia, PA. 
Tc-99m tetrofosmin is a new technetium-labeled myocardial 
perfusion imaging agent. This study compared the.results 
of planar and SPECT imaging, in 26 patients (pts) who 
underwent I day exercise-rest protocol. The exercise 
study was done with 7-8 mCi, and the rest study with 21-
24 mCi. Images were obtained 15-30 minutes after 
injection. 
The images were abnormal in 20 of 23 pts with CAD by 
SPECT, and 19 by planar (P:NS). They were normal in the 
3 pts with no CAD by both methods. The images were 
divided into 5 segments/pt by both planar and SPECT. 
There were 58 segments with perfusion defects (PO) by 
SPECT, and 50 by planar (P:NS); and 47 (36%) reversible 
by SPECT, and 35 (27%) by planar (P:NS). 
There were 32 diseased arteries in the 19 pts with 
coronary angiography. Perfusion defects were present in 
21 territories (66%) by SPECT, and 19 (59%) by planar 
(P:NS). There was agreement between planar and SPECT in 
116 of 130 segments (87%) (P <0.003). The SPECT images 
were of better quality than planar. The lung-to•
myocardium count density ratio was similar regardless of 
presence and extent of CAD or perfusion defects. 
Thus, both planar and SPECT imaging are feasible with Tc-
99m tetrofosmin. The results are comparable, though with 
SPECT slightly more total and ischemic defects are 
detected, and image quality is better. The lung 
tetrofosmin uptake is similar in pts with and without 
perfusion defects. 
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757·1 2:00 
Nitric-Oxide Mediated Negative Inotropic Bffect 
of IL-6 as a Mecbanism of stunned Myocardiua 
Mitchell S. Finkel, Rosemary A. Hoffman, Carmine 
V. Oddis, Timothy D. Jacob" Li Shen, Richard L. 
Simmons, Brack G. Hattler, University of 
Pittsburgh Medical Center, Pittsburgh, PA 
Pro-inflammatory cytokines are synthesized and 
released locally by macrophages and leukocytes 
in response to injury. Reperfusion of ischemic 
myocardium is associated with infiltration by 
leukocytes and macrophages that may be 
responsible for a transient depression of 
myocardial contractility ("stunned" myocardium). 
Myocardial stunning frequently occurs following 
cardiopulmonary bypass (CPB) and may complicate 
successful recovery from cardiac surgery. We 
found selectively elevated levels of !L-6 
(1,800-4,000 units/ml) in bronchoalveolar lavage 
from patients following CPB. IL-6 decreased 
tension in isolated hamster papillary muscles to 
55 ~ 5% of baseline at 3,200 units/ml (n=6). 
The negative inotropic effect of IL-6 was 
completely blocked by L-NMMA (NO synthase 
inhibitor) (n=6). L-Arginine (precursor for NO) 
overcame the L-NMMA inhibition and decreased 
tension to 35 ~ 3% of baseline in the presence 
of IL-6 (1,000 units/ml) (n=6). IL-6 raised 
nitrate/nitrite levels in the muscle bath from 
7.2 ~ 0.8 to 14.3 ~ 1.3~M (n=6). These effects 
were unchanged by chemically denuding the 
endocardial endothelium (n=6). IL-6 similarly 
decreased tension generated by pectinate muscles 
removed from patients at the time of CPB. We 
conclude: (1)IL-6 is a negati'Te inotrope in 
hamster and human heart. (2) Mammalian 
myocardium produces NO. (3) IL-6 may mediate its 
negative inotropic effect through NO. (4) IL-6 
may play a role in myocardial stunning following 
CPB. 
757-2 2:15 
Reduced Na,K-ATPase Density in Left Ventricular Myocardium With 
Pacing Induced Heart Failure 
Thomas A. Schmidt. Jim S. Larsen, 'Richard P. Shannon, 'Kazuo 
Komamura. 'Dorothy E. Vatner, 'Stephen F. Vatner. Keld KjdJsen 
Department of Medicine B, Rigshospitalet. University of Copenhagen. 
Denmark and 'New England Regional Primate Research C!. ter. 
Harvard Medical School, Southborough, MA, USA 
Due to the importance of myocardial Na.K-A TPase for development of 
arrhytmias. Ca·handling and digoxin treatment. our objective was to 
evaluate regulation of left ventricular (LV) Na,K·ATPase de:1'ity in 
heart failure induced by sustained. rapid cardiac pacing. Samp!t: .. 'J the 
LV were obtained from 10 dogs exposed to ventricular pacing co' 240 
beats/ min for 3 to 4 weeks and 8 sham operated controls. Na.K-A TPase 
was quantified with high recovery using vanadate facilitated lH_o ,,,bain 
binding to intact samples. Paced dogs developed clinical signs 0) Ileart 
failure. which was characterized by a 257% increase in LV end-d;,' ,tolic 
pressure and a 46% decrease in LV dP /dt (p < 0.001) without 
significant change in LV mass (p > 0.10) compared with controls Na,K•
ATPase concentration was reduced by 16% (p < 0.05). Evalual'on of 
lH·ouabain binding kinetics revealed no significant difference h:l"een 
myocardium from paced and control dogs: Equilibrium hOiding 
conditions were obtained after similar incubation time; Nonsl_ :'~ific 
uptake and retention of lH-ouabain was 0.9 - 0.8% of total upta, , and 
retention; Apparent dissociation constant (KD) was 6.5 - 6.6 .< )(l" 
mol/I; Loss of specifically bound lH-ouabain during washout at a °C 
occurred with a half-life time (T~) of 120 . 121 h. Total lH-o.',lhain 
binding site density was (means :i: SEM) 1I!O :i: 56 and 13'" ~ 6il 
pmol/g wet weight or 1>.54 :!: 0.43 and 10.05 :!: 0.52) pmol/mf. nrotein 
(p < 0.05). in myocardium from paced (n = 10) and control (.; = 8) 
dogs. The reduced Na.K·A TPase density supports the conce! I ,.,f a 
relationship between Na.K-A TPase and contractility and ,~ of 
pathophysiologial importance in heart failure. 
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757·3 
Myocardl8l Met8boIlIm In HIberMIIng Pig H..,. 
2:30 
A. James lJedIke, Sritta Renstrom, and Stephen H. Nellis. UniVersity of 
WISCOIlSin, Madlson, WI 
The purpose of this study was to characterize metabolic behavior In 
hibernating (HIS) myocardium and to test whether these functions are 
principally aerobic or eneerobic. Intact HIS heans (n .. 8) were prepared by 
modestly restricting maximum phasic COI'OI18IY now velocity by 50% in the 
anterior descending (lAD) circulation for four days. HIS hearts were 
compared with SHAM (n-7) heans CN8I a flnal60-min peIfusion trial during 
extracorporeal perfusion in bOth groups in which LAD pump flows (HIS:4.7 
• 0.3 VI SHAM:6.4 • 0.5 mI min" g dry wI", p<O.OO9) were determined by 
matching venous O. saturations in the LAD circulation before and after 
coronary cannulations (22 VI 26%. NS). Flow differences were explained 
largely because heart weight was greater in HIS heans (208 • 6 VI 145 • 
3 g wet WI, p<O.OOl). [U-"C) palmitate (43 i£VanimaJ) and [S-'H) glucose 
(76 i£VanlmaJ) were infused into the LAD circulation CN8I the 6<Hnin 
perfusion trial (1.6 x 10' and 2.9 x 10' dpm/min. respectively) to measure 
falty acid oxidation (FA OX) and exogenous glucose utilization (GLUC un. 
respectively. Rates of lactate extraction (EX1) were also measured. 
Substrate levels of FA (0.36 • 0.03 jATlO//mO and GLUC (6.0 • 0.3 jATlO//mQ 
in whOle blood perfusate were comparable between groups. Expectedly, 
systolic shortening was more reducedlrom initial values in HIS (46%) than 
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As a group. there was no net evidence of lactate production in HIS hearts 
and the decreasecI rates of exogenous laCtate EXT probably reflected the 
much greater rates of glycolySis In this group. These data Indicate that 
metabolism during chronic hibernation in this experimental. large animal 
preparation remains primarily aerobic in pattern bIA with a shift In substrates 
toward the usually less preferred utUizaIion of glucose. 
757·4 2:45 
Butanedione Monoxime Prevents Diastolic Contracture in Prolonged No•
Flow Ischemia Without Preserving ATP 
Paul C. Gordon, Takatoshi Mochizuki, Elien O. Weinberg, Judith K. 
Gwathmey, Beverly H. Loreli, Harvard·Thorndike Laboratory, Beth Israel 
Hospital, Boston, MA 
2·3 butanedione monoxime (BOM) actS at myofibrils to reduce the 
sensitivity of the myofibrils to Ca" and to inhibit force development. In 
isolated, isovolumic rabbit hearts loaded with the Ca" ·fluorescent probe 
indo l·AM (n = 5). 20 mM BOM reversibly eliminates cardiac contrac· 
tions with a minimal « 20%) reduction in the amplitude of Ca" 
transients. To investigate the effects of BOM on contractile function and 
high energy phosphate metabolism during normothermic ischemia, 
isolated, isovolumic rabbit hearts (37') were subjected to 35 minutes of 
zero·flow ischemia and 15 minutes of reperfusion with BOM 20 mM (or 
vehicle) infused 1 minute prior and 1 minute post· ischemia, and at a rate 
of .1 mllmin during ischemia. At baseline, after a 30·minute perfusion 
of uxygenated buffer containing 1.4 mM Ca", LVSP (116.:t, 3 mmHg), 
LVEOP (12.1 .:t, .3 mmHg) , CPP (73 .:t, 3 mmHg), and coronary flow 
(38+2 m1!min) were similar in comrol (c. n = 10) and BOM (n ~ 10) 
perfused hearts. At end· ischemia, BOM completely prevented LV diastolic 
contracture (9.1 .:t, 1.0 vs 32.3.:t, 3.9 mmHg, BOM vs C, P <.05). This 
effect was not associated with a Jilierence in magnitude of ATP or 
creatine phosphate depletion in BDM vs C. With reperfusion, there was 
only a 25% recovery of developed pressure relative to baseline in both 
groups with no difference in the recovery of high energy phosphates. 
Conclusion: BDM attenuates diastolic contracture caused by prolonged no· 
flow ischemia, possibly by inhibiting rigor cross· bridge formation during 
ischemic Ca" overload and ATP depletion. However, BOM fails to 




Dillociited Recovery of pHI end Contraction 
Following Acid Loading In Pertueed Heart 
Andrew A. Grace. James C. Metcalfe. Peter L Weissberg, 
Jamie I. Vandenberg Departments of CUnical Medicine and 
Biochemistry, University of Cambridge, United Kingdom 
223A 
3:00 
Reduction in both myofibrillar calcium sensitivity and maximal calcium•
activated force contribute to the decline in contraction due to myocardial 
ischaemia and could also underlie stunning. To test the hypothesis that 
acidosis per se may contribute to stunning we have investigated the 
relationship between the recovery of intracellular pH (pHi> and left 
ventricular developed pressure (L VDP) after an isolated proton load in 
the isovolumic Langendorff-perfused ferret heart. Intracellular acidosis 
was induced by Nl4CI exposure (lOmM. IOmin). pHi was estimated 
using 31p NMR spectroscopy. 7.2 N Cl 
Recovery of pHi (.) and LVDP 
(a;%baseline) from hearts (n=6) 
perfused with nominally HC03--free 
(HEPES. 5mM) buffer paced at 1Hz. 
t o.S(recovery) (mins): pHi = 
43201.0; LVDP 12.2202.0 (p<O.05). 
Changes in LVDP closely follow 
those in pHi during NH4CI exposure 
but after washout of NH3 recovery of 
LVDP is significantly delayed 
compared to pHi. [ATP]. [PCr] and 
[Pi) showed no significant changes 
throughout and an independent 
effect of N14+ has been excluded by 
the absence of adverse effects during 
prolonged exposure. Intracellular 





o Time (min) 30 
and our findings therefore suggest that delayed contractile recovery is 
due to reduced myofibrillar calcium sensitivity. Intracellular acidosis 
therefore independently leads to delayed recovery of contraction and by 
inference is likely to be a component of early post-ischaemic ventricular 
dysfunction (stunning). 
757·6 3:15 
Nicotine Selectively Exacerbates Contractile Dysfunction of Postischemic 
Stunned Myocardium in a Canine Model of Angina 
Karin Przyldenk. Heart Institute, Hospital of the Good Samaritan and 
University of Southern California, los Angeles CA. 
Numerous studies have demonstrated that high doses of nicotine have 
deleterious effects on cardiovascular function. In contrast, the effects of 
clinically relevant concentrations of nicotine have received little attention, 
and, surprisingly, the effects of nicotine in the setting of transient ischemia/ 
reperfusion are unknown. To determine whether nicotine, at a dose 
corresponding to that absorbed during inhalation of 1 cigarette, would alter 
the recovery of contractile function in a canine model of angina, 26 
anesthetized dogs underwent 15 min of coronary occlusion (CO) and 3h of 
reperfusion (R). Nine dogs received nicotine (80 I'g/kg IV) before CO; 8 
received nicotine at 1 h after R; and 9 controls received saline. All groups 
were equally ischemic during CO: endocardial blood flow (assessed by 
radiolabeled microspheres) was 0.07.:t,0.02, 0.06.:t,0.03 and 0.1O.:t,0.02 
ml/min/g (p= NS). Segment shortening (SS: assessed by sonomicrometry) 
in the ischernic/reperfused myocardium was: 
Baseline CO 1 h PostR 3h PostR 
Control 100% ·16+6% 54.:t,6% 50.:t,4% 
Nicotine PreeO 100% ·18+4% 29.:t,10%* 23.:t,6%** 
Nicotine PostR 100% ·23-:;:-10% 42+11% 6+13%·· .. 
(*p<0.05 and "p<O.Ol \IS. C-;;ntrol; "p~0.02 \IS 1h PostR) 
As expected, 55 in control animals was depressed or stunned, averaging 50-
54% of baseline' throughout reflow. Nicotine given PreeO did not 
exacerbate dyskinesis during occlusion. However, S5 following reperfusion 
was more severely depressed in the Nicotine PreeO group than in controls, 
recovering to only 23-29% of baseline. Furthermore, nicotine given at 1 h 
postR caused a marked deterioration in 55, from 42% before injection, to 
6% at 3h postR. This dose of nicotine did not, however, alter heart rate or 
arterial pressure, and did not impair contractile function in normally 
perfused myocardium [55 in nonischemic tissue was maintained at 90-110% 
of baseline in all 3 groups). Thus, a single dose of nicotine, given before 
occlusion or after reflow, selectively exacerbated contractile dysfunction of 
postischemic stunned myocardium in this canine model of angina. 
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The Errect of Late Tbrombolytic Tberapy on Left Ventricular 
Function follo,,'lnll Acute Myocardial Infarction. 
2:00 
Christopher D. Morgan, Judith S. Hochman, Raben J. Burns, Michael R. 
Freeman, Jonathan S. Steinberg. Pierre Theroux, Eric J. Topol, Paul W. Armstrong 
for the LATE Ancillary Investigators. University of Toronto, Toronto, Canada and 
St Luke's-Roosevelt Hospital Centre, New York. 
On Sept. 3, 1992 the Late Assessment of Thrombolytic Efficacy (LATE) trial 
reponed a monality reduction when thrombolytic therapy was administered 6 - s12 
hours, but not >12 - 24 hours, following symptom onset in acute myocardial 
infarction (MI). Left ventricular function and cavity size were evaluated serially in 
an ancillary study to LATE to provide insight into potential mechanisms of benefit. 
In the LATE trial 5700 eligible patienL', from 13 countries, presenting 6-24 
hours following symptom onset of MI were randomly assigned to treatment with 
tissue plasminogen activator (tPA) or placebo. Consecuti,'e LATE patients [rom 14 
coliaborating iru,titutions underwent radionuclide ventriCulography at hospital 
discharge and again 3t6-months fcr determination of left ventricular end-,ystolic 
(ESV) and end-diastolic (EDV) volumes, global (GEF) anct infarct r<gtOt:al ejection 
fraction (REf) and the presence of aneurysm, This ancillary study was limited to 
patients with STelevauon amI/or new Q-waves 0" qualifying ECG. 
One hundred and sixty two patients. 80';< male. mean age t± SE) = 58.6±1.2 
years, were enmlled between 09/89 and 05/92. Infarct location was anterior in 3oc< 
and time to treatment 15.2 ±O.6 hours; the ,remment groups were well bol"ncca 'ar 
b.<eline characteristics. The results nfhospital disch,rge "tudtes orJy, performea at 
median 7 days post-treatment, are "hown ([I=number ef patients): 
tPA6-sPhrs tPA >P-24hrs ~ 
ESV (mIs) 8O.h:l1.2 [17] 81.1:1:7.1 [43: 80.5:63 [54J 
EDV (mIs) 152.l:t12.2 [17] /50.1:1:7.7 [43] 147.2:1:8.0 [54J 
GEF(%) 49.1%2.8 [22] 48.3%1.8 [53] 4.'!.0%1.6 [681 
REF (%) 513%4.0 [20] 46.4%2.7 [421 49.7:2.4 [531 
Aneurysm(%) 39% 38% 31% 
When compared to placebo, thmmbolYlic therapy did not result in a sigr.lficant 
improvement in LV volwnes or function, whether gtven 6-~12 hours, or later, 
roilowing MI symptoms. ThLOS the monality benefits observed in tbe LATE trial do 
not appear to be mediated by early myocardial salvage. The potential effects of late 
thrombolytic tberap), on infarct r.ealing and remodelling will be evall!3too when 6-
month results are available (November. 1992) and will be presented. 
758·2 2:15 
Correlation Between MetabOlism And Function In 
Reperfused Myocardial Infarction 
Pierre G. Melon, Rodney J. Hicks, Victor Kalil. Edwin WoHe, Eric J. Topol, 
Gary D. Hutchins, Marlws Schwaiger. 
University of Michigan Medical Center, Ann Arbor. Michigan. 
We studied 9 patients to assess regional myocardial oxidative and 
glucose metabolism 4±2 days and 6±3 months after myocardial infarction 
reperfused with early thrombolysis or mechanical revascularization using 
posHron emission tomography (PET) wHh C-ll Acetate (Ac) and 18-FOG. 
LVEF and regional wall motion (RWM) were determined by radionuclide 
ventriculography at the time of both PET. Regional myocardial blood flow 
and oxidative metabolism were determined using relative uptake early 
after injection and clearance rate of C-ll Ac, respectively. Regional 
glucose utilization (MGU) was assessed using Patlak approach. C-ll Ac 
and 18-FDG data were displayed on polar maps of identical format. Using 
thresholds of relative uptake of 20% and 50%, 3 regions, with 
normal(>50%), moderately reduced (20-50%)and reduced «20%) blood 
flow. were defined and applied to the corresponding metabolic maps. 
Average value of C-ll Ac relative uptake and clearance rate as well as 
glucose utilization was calculated for each of the 3 regions. Resuns are as 
follow ("p<0.02 versus earty. t p<0.03 versus early) 
Ac Uptake(%) Ac Clearance (1/min 10-3) MGU(tJITlOle/minlg) 
tegjoO$ earN !ale earN !ale earN late 
<20% 17±2 33±10" 17±9 33±7" 0.08±0.07 0.13±0.17 
20-50%39±4 55±11t 35±6 48±12t 0.26±0.13 0.27±0.15 
>50% 73±3 73±4 64±11 58±10 0.43±0.28 0.39±0.21 
L VEF was closely correlated with the extent of perfusion abnormality 
(area of map <50%) an did not improve over time. Twenty four segments 
with impaired systolic function were identrried in the infarct territory at the 
time of initial PET. Ten demonstrated improvement in function at time of 
fOllOW-Up. C-l1 Ac initial uptake increased in all the myocardial segments 
at follow-up. C-l1 Ac clearance and MGU only Signrricantly increased in 
segments with improvement of function. Thus. successful 
revascularization after myocardial infarction resulted in partial 
improvement of blood flow and oxidative metabolism in infarct territory 
without signrricant improvemenf of global ventricular function. Recovery 
of regional systolic function was correlated to improvement of regional 
oxidative and glucose metabolism. 
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Clploprll During ThrombolylQ in Myocardial infarction: I 3 months 
follow up 
Wlek H. van Gist, J. Herre KIngma, for the CATS InvestIgators group. 
CATS coordination center, Sl Antonius Hospital, Nieuwegein, and 
University of Gronlngen. The Netherlands 
Captoprl reduces myocardial Injury upon ischemia and reperiuslon in in•
farcted animals. However, the clinical value of converting enzyme inhi•
bition during the first 24 hrs in acute myocardial infarction Is disputed. In 
CATS (Captopril And Thrombolysis Study), 298 patients with a first ante•
rior myocardial Infarction (AMI), treated with streptokinase (S) were ran•
domlzed to either oral captoprl (C) or placebo (P) at the end of the S in•
fusion. Initial dose was 6.25 mg (given 210%76 min after symptoms of 
AMI) and increased to 25 mg tid In the first 48 hrs. Primary endpoints 
were LV -end diastolic (EDVl) and systolic volume Index (ESVI) assessed 
by biplane echocardiography, occurrence of single and repetitive ventri•
c~ar arrhythmias rJA) assessed by 24 hr ambulatory ECG monitoring at 
admission, predischarge and after 3 months, and neurohumoral changes 
during first 5 days.Secondary endpoints were among others HBDH (Q72) 
estimated infarct size, Incidence of heart failure and coronary events. 
RESULTS: First dose hypotension occurred in 7% after C vs 1,3% in 
P(ns). There was only a moderate Increase in EDVI and ESVl, 6.14mljml 
and 4.9 mjrna In all patients resp. after 3 months. Although C treated 
patients had consistently lower volumes no significant differences could 
be detected. VA in the acute phase were 18% lower in C treated patients 
when compared to placebo. Noradrenaline leveis on C decreased signifi•
cantly after 1 hr. HBDH infarct size was 1Q15.215 after C and 137S.319 
after P(P=O.07).ln large infarcts(HBDH>II00) infarct size decreased signi•
ficandy.Reponed Incidence of heart faNure feil from 24% to 15% (p<O.OS). 
CONCLUSION: C does not inftuence EDVI or ESVI in first AMI patients 
treated with streptokinase at 3 months. In accordance with experimental 
data VA tend to diminish on C durfng the first 12 hrs after thrombolysis, 
paralleiled by a signifICant decrease in NA leveis and reduced enzymatic 
Infarct size In large infarcts. These findings suggests that the beneficial 
effects of ACE inhibition during the first 3 months after AMI may be 
atributed to other effects than remodeiling alone. 
758-4 2:45 
Reperfusion Ventric.J!ar Fibrillation in Tbrombolyzed Patients with 
Acute Coronary Inrarction : the EMIP Experience. 
Jean-Pierre BOISSEL. Alain CASTAIGNE(*), Catherine MERCIER, Alain 
LEIZOROVICZ and the EMIP Research Group 
Unite de Pharmacologie Clinique, H6pital Neuro-Cardiologique, Lyon, 
France; (*) H6pital Henri Mondor, Creteil, France. 
EMIP was a multicenter randomized, double-blind, controlled comparison 
of pre-hospital thrombolysis and in-hospital thrombolysis, with anisueplase 
(APSAC 30 mg); 2,750 patients (pts) were randomly allocated in the 
ambulance to receive first APSAC (A) in the ambulance then a matched 
placebo (P) when arrived in the coronary ward in the hospital (NP group) ; 
2,719 were allocated to receive first a matched placebo in the ambulance 
then APSAC in the hospital (PIA group). The ambulances were staffed with 
a physician uained to emergency medecine and 10 reading ECG. 
Occurrence of VF was recorded according to the time before or after 
randomization (rand.) (1 5t injection of A or Pl. before or after arrival at the 
hospital. before or after the second injection of P or A. Deaths within 30 
days for those with> I VF during the period are given in brackets. 
W Qatients with VF NP PIA Q(YB 
Pre·hospital Before rand. (lst inj.) 42 (10) 36 (13) 0.6 
After rand (1st inj.) 69 (211 44 (131 0.02 
In-hospital Before 2nd Inj. 34 (3) 40 (8) 0.45 
After 2nd inj. 100 (281 145 (451 0.002 
Ever 171 (62) 191 (79) 0.2 
Immediately after administration of A, either in the ambulance or in the 
hospital, there was significantly. more VFs than after administration of P. 
This supports that reperfusion VF does exist in acute myocardial infarction 
in humans. The delay between rand. (or 1st injection) and 2nd injection 
median was 55 minutes. The risk of reperfusion VF did not increase with 
time and was not affected by the care environment (1.6 pre-hospital after 
the I st injection as comparoo 10 1.45 in hospital, after the 2nd injection). 
There was an excess of deaths correlated with the excess of VFs after active 
treatment. 
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The EfFects or Thrombolytic Therapy Administered 6-24 boun AI'Ier 
Myocardial Inrarction on the Signal-Averaged ECG: Results or a 
Multicenter Randomized Trial 
3:00 
Ionathan S. Steinbere, Iudith S. Hochman, Christopher D. Morgan, Paul 
Dorian, Pierre Theroux, Eric I. Topol, Paul W. Armstrong and LATE 
Ancillary Investipton. St. Luke's-Roosevelt Hospital Center and Columbia 
Univenity, New Yorlt, NY and Univenity of Toronto, Toronto, Canada. 
Abnormalitiee of the signal-averaged (SA) ECG, in particular the filtered Q 
RS (IQRS), predict sudden cardiac deeth after MI. It is unclear, however, if 
the SAECG is favonbly altered by thrombolytic therapy. We report the first 
prospective, randomized, placelxKontrolled study that tested this hypothesis. 
In Late Assessment of Thrombolytic Efficacy (LATE), patients (PTS) 
presenting 6-24 houn after MI onset received placebo (PLAC) or rt-PA. On 
9/3/92, LATE reported a 27 'Ai mortality reduction (p=0.03) in PTS treated 
with rt-PA 6-12 hn, but not 12-24 hn, after symptom onset. 28S PTS at 23 
centen were enrolled in this LATE SAECG ancillary study. PTS were 61.±1 
yean and 8O'Ai male, and treated IS.±O.S houn post-MI (31 'Ai at 6-12 hn). 
PLAC (N=I46) and rt-PA (N= 139) groups were well balanced for baseline 
chancteristics. The SAECG was recorded 1l.±2 days post-MI with 3 
orthogonallesds and analyzed as a bidirectional filtered (4G-2S0 Hz) vector 
complex. Three SAECG measurements were made: total QRS duntion 
(fQRS), and terminal voltsge (V40) and duration (LAS). Results: 
Placebo 1l-~A!6-IZblll 1l-~A(lH4brsl 
N 146 43 96 
fQRS (ms) 108.±1 103.±1* 106.±1 
V40 (JiV) 26.±2 24.±3 28.±2 
LAS (ms) 38.±1 38.±2 3S.±1 
'"p=0.04 vs PLAC. CONCLUSIONS: There was a small but significant 
improvement in the IQRS (the most potent SAECG risk variable) after 
thrombolytic therapy administered 6-12 hn after MI. These results support 
the hypothesis that improved electrical stsbility may contribute to the 
mortslity reduction 3SSOCiated with late thrombolytic therapy. 
758·6 3:15 
Coronary Artery Reperfuslon Reduces Mortality 
Independent of the AttenuaUon of Late VentrIcular 
Remodeling In the Rat. 
Chu-M1n Klm, Janice M. Pfeffer, Marc A. Pfeffer 
H8Ivard Medical School and Brigham and Women's Hospital, Boston, MA 
Left ventricular (LV) volume (VOl) Is a major predictor of mortality following 
myocardial infarction (MI). In the rat with MI (coronary artery ligation) the 
extent of LV anlargernenlls a time- and Infarct sIz. dependent process. To 
detennlne whether coronary reperfuslon I sll~not release (R) at 45 and 90 
mini would Inftuence LV dilation, passive LV pressure-volume relations were 
obtained 7 weeks pOSl-M11n control (C;n a 30), R45'(n=34), R90'(n=33) and 
permanent occlusion (PO; n-38). Endocardial (Endo) MI size was 
comparable (40%) In all MI groups. WIth decreasing time to reperfuslon, 
proportlonately more epicardium (EpI) was spered and less LV dUatlon 
occurred. The mortality rate by 7 weeks pOSl-M1 was markedly reduced to 
the same extent In both 45 and 90 min reperfuslon groups, being only 1 /3 
that 0/ the PO group. 
Endo Epi VOL Mortality 
PO 4Oj:3 29j:2 2.25j:0.l0 71/112 (63.4%) 
R90' 41 j:2 2Oj:3* 2.09j:0.l0 10/45 (22.2%)* 
R45' 39j:2 10j:2* 1.97j:0.06* 10/47 (21.3%)* 
Meanj:SEM. *P<O.025 VS PO; VOL(mI/kg) at 20 mmHg; Endo and Epi MI 
size In %. For C MI, VOL - 1.46±0.04 mI/kg. 
Early (R45') reperfuslon salvaged epicardium, attenuated LV enlargement. 
and Improved survival. Although delayed (R90') reperfuslon had only an 
Intermediate effect on salvaging epicardium and attenuating LV enlargement, 
survival was stili comparable to that of early reperfuslon. 
We conclude that LV dDatlon Is attenuated In proportion to the salvage of 
eplcerdlum, but that mortality Is reduced by reperfusion Independent of Its 
effect on LV volume. These results suggest that other, stUI unrecognized, 
consequences of reperfuslon play a major roie In the Improvement of 
survival. 
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759·1 2:00 
The Significance Of Total Cholesterol And Lipid 
Fractions As Predictors For Coronary Artery Disease 
In Mlddl.Aged Women 
Alfred J. Anderson, Robert C. Brickner, Richard J. 
Battlola, Joseph J. Barborlak, SI. Luke's Medical 
Center, Milwaukee, WI 
To evaluate the relationship between lipid levels and coronary 
artery disease (CAD) in non-diabetic middle-aged women (ages 
35-54), three groups were compared: 1) Symptomatic women 
w~h signnicant CAD on coronary angiography (CA)(N = 85), 2) 
Symptomatic women with no signnicant CAD on CA (N = 120), and 
a control group of asymptomatic women not undergoing CA (N = 
87). 
~ ~ ~ Q.AO. 
Chol (mgldl) 223 215" 233 
HDL S5.8"# 51,3" 44,S 
TG 93"# 13S" 170 
LDL 139" 13S" 155 
ChollHDL 3,S"# 4,5" 5.S 
LDUHDL 2.3"# 2.9" 3.8 
Age (years) 46.7 47,3 48.4 
p<.05. "vs CAD. #VS No CAD 
Total cholesterol did not differ between the control group and 
those with CAD, whereas HDL-choi., triglycerides (TG), LDL-choi., 
and both cholesterol ratiOS differed significantly between these 
groups. Even after controlling for standard CAD risk factors and 
lipid fractions by multivariate analYSis, choVHDL and TG remained 
independent predictors for CAD. Also, total choi. and all lipid 
fractions dnfered significantly between symptomatic patients 
without CAD and those w~h CAD. Our lindings indicate that in 
middle-aged women total cholesterol does not predict CAD well 
and that choVHDL ratiO is the best predictor of CAD. Thus. current 
NCEP guidelines calling for a total cholesterol level as the initial 
step in screening for CAD risk factors is inadequate, 
759·2 2:15 
Differential Estrogen Receptor Expression in the 
Coronary Arteries of Pre· and Post·Menopausal 
Women: Possible Role in the Pathogenesis of 
Atherosclerosis. 
DouKlas W, Losordo Marianne Kearney, Jeffrey M. Isner, Tufts 
University School of Medicine, St. Elizabeth's Hospital, Boston, 
MA. 
The relative protection from coronary atherosclerosis conferred to 
most pre-menopausal females is well documented. The precise 
mechanism of this protection, however, has not been clarified. We 
postulated that estrogen may exert a direct effect on the arterial wall 
and the estrogen receptor (ER) would, therefore, be expressed in 
the coronary artery (C A) wall. We examined normal and 
atherosclerotic CA specimens obtained post-mortem from pre- and 
post-menopausal females. Using a monoclonal antibody 
immunohistochemical stain, we then determined the presence or 
absence of the ER. In pre-menopausal females ER expression was 
NL AlH detected in 5/6 normal arteries but was absent 
from the CA wall in atherosclerotic arteries (0/2 
PRE cases). In post-menopausal females with 5POS OPOS 
lNEG 2 NEG normal CA evidence of ER expression was 
found in all but one (4/5) of patients studied. In 
POST CA specimens from post-menopausal females 4POS 2POS 
lNEG 3 NEG with atherosclerosis, expression of the ER was 
variable with 2/5 arteries staining positive. 
Conclusions' 1) Pre-menopausal women with normal CA 
demonstrate ER expression within the intima and media in a 
majority of cases while those with atherosclerosis do not show 
evidence of ER expression; 2) The protection of premenopausal 
women from coronary atherosclerosis may be mediated by direct E 
effects on the anerial wall; 3) Post-menopausal women with normal 
CA also show a preponderance of ER expression in the CA wall 




Sex-specific Effects of Upoprotein (a) on the Risk of Coronary Artery 
Disease 
Patrice S. Corneli, Lily Wu, Hiram W. Marshall, Labros Karagounis, 
Ann Allen, Jeffrey L. Anderson, R.H. Ward, University of Utah and 
LOS Hospital, Salt Lake Oty, Utah 
Ouring a study of premature coronary artery disease, 
lipoprotein (a) [Lpa(a») concentrations were determined for 
angiographically-defined case and control patients using 
standardised methods. Patients included 444 cases with >60% 
stenosis of some major vessel and 404 controls with <10% stenosis 
in every major vessel. All patients were of northern European 
descent and lived within 100 miles of Salt Lake Oty, Utah. Lp(a) 
concentrations were compared between cases and controls using 
non-parametric methods because the distribution of Lp(a) levels 
departed substantially from normality and power transformations 
did not normalize the data. As expected, Wilcoxon rank-sum tests 
revealed significantly higher Lp(a) levels among males cases 
compared to male controls (p«0.00l). Males with Lp(a) levels in the 
upper quartile were more likely to have coronary artery disease than 
those with lower concentrations (p«0.001, OR=2.34, 95% CJ=(1.43, 
3.86». When compared males in the lower quartile, the odds ratio 
increased to 3.74 (p«0.001, 95% 0=(2.09, 6.67». However, when 
females cases were compared to female controls, there was no 
evidence that Lp(a) levels were higher in cases (Wilcoxon rank sum 
test,p=0.19; upper quartile test, p=O.06). Further, even when the more 
stringent comparison between upper and lower quartiles was made, 
there was no Significant difference in risk of disease (p=O.32, 
OR=1.40, 95%CJ=(O.73, 2.70». These results suggest that, contrary to 
the commonly observed situation in males, Lp(a) concentrations do 




Fffi1al~ Gender Predicts Survival From Out-of-Hospital Resuscitation. 
Nisha C Chandra, Alan D. Guerci, Ellen Fine, and Jdfrey Krischer. Johns 
Hopkins Med Inst, Baltimore, MD 
Rec~nt studies have identified that women have a worse prognosis than men, 
following myocardial infarction or revascularization. To study the effects of 
gend« on outcome following out-of-hospital cardiopUlmonary resuscitation 
(CPR) 415 non-tr.uma patients (295 men, 120 women) with cardiac arrest were 
studied. All underwent out-of-hospital resuscitation with conventional CPR and 
IS I. 36 %, survived to hospital admission. Of these survivors, 100 (34%) were 
men vs 51 (43%) women (p NS). However, only 47% of men and 41 % women 
admitted to hospital survived to hospital discharge(p NS). 
Examination of population characteristics revealed that, women did not differ 
from men in the proportion with a witnessed arrest (75% vs 81 %), those in 
whom CPR was initiated within 5 minutes (33% vs 28%) or those 
endotracheaJly intubated within 5 minutes (52% vs 60%). However, compared 
to men, women undergoing CPR were more likely to be> 75 yrs old (43% vs 
23%, p < 0.001), less likely to have ischemia as the primary cause of arrest 
(63 \Ii vs 75 %, p < 0.01), and less likely to have ventricular 
tibrillation/ventricular tachycardia (VFIVT) on ECG as the primary arrest 
rhythm (40% vs 61 %, p < 0.001). However, in patients with VFIVT, survival 
to hospital admission was similar, (24/48 women 50% vs. 70/180 men 39% p 
NS) though only 13/24 women, 54% vs. 37170 men, 53% survived to hospital 
discharge (p NS). Survival to hospital admission was signiticantly highor in 
women < 60 yrs of age 17/29,59% vs 24/87 men 28% (p < 0.004) though 
only 4/17 (24%) women vs 11/24 (46%) men survived to hospital discharge (p 
NS). A multivanate analysis incorponding gender, age, primary cause of arrest, 
ECG reading on arrival, witnessed arrest, race, time till CPR, minutes until 
intubation. and laymen CPR, identitied gendor as a favorable prognostic factor 
for survival to hospital admission, but not for survival to discharge. 
Thus, this study shows that women with out of hospital cardiac arrest are more 
likely to be older and less likely than men to have VFIVT. Marc women < 60 
yrs of age survive to hospital admission. Though overall survival for out of 
hospital CPR is similar for men and women, multivariate analysis identifies 
female gender as a favorable prognostic factor for survival to hospital admission. 
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Profile or an Outpatient Population Witb Cbronic Stable 
Angina in tbe 1990's: Tbe Dominance or Women, Aged and 
Rest Angina 
Carl J. Pepine, Jonathan Abrams, James Morris, Ronald Marks, 
Stephen Scheidt and Eileen Handberg for the TIDES Investigators, 
University of Florida, Coordinating Center, Gainesville, FL 
Characteristics of patients with chronic stable angina are 
changing as the US population ages, coronary anery disease death 
rates decrease, and newer diagnostic and therapeutic techniques 
emerge. To assess these characteristics a large cohort of patients 
with chronic stable angina was examined. Between September 
and November 1990, 5,125 outpatients were enrolled by 
approximately 1,200 primary care physicians. Diagnosis was based 
upon history supported by coronary angiography, myocardial 
infarction, and/or abnonnal exercise test. The mean age was 69 yrs 
and 53% were women. Their age (71 yrs) was significantly older 
than the men (67 yrs, p<O.OOOl). Phannacotherapy was used by 
71 % at baseline, 46% took calcium antagonists, 45%•
nitroglycerin, 36% - diuretics or other antihypertensives, 25% -
beta blockers, 18% - digitalis and 14% - ACE inhibitors. History of 
hypertension was present in 58%, hypercholesterolemia in 34%, 
hean failure in 25%, diabetes in 23%, arrhythmias in 21 %, and 
revascularization in 13%. Only 3% of the patients assessed their 
overall feeling of well being at entry as excellent, 35% good, 50% 
fair, and 12% poor. Median anginal frequency was 7 episodes/mo 
(lOth &90th percentiles were 2 and 30 episodes/mo respectively). 
There was a strong association (p<O.OOOI) between anginal 
frequency and perception of overall feeling of well being at 
baseline. Interestingly although angina with physical activity was 
present in 90% of patients 47% reported angina at rest, 25% 
noted angina during sleep and 35% dwing mental stress. 
Conclusions: Contemporary outpatients with angina are 
dominated by women and aged who also have a high frequency of 
associated illness, These characteristics and the high prevalence of 
angina at rest are at variance with perceptions based upon older 
data. 
759·6 3:15 
Are Women Lea Likely to Recein Thrombolysis ror Acute Myocardial 
Inrarction? 
Authon: I. Jaime Caw, Judith A. O'Brien, Iearme Holden-Wiltse, 
Ioseph S. Alpert·, Stuart C. Hartz, U.S. Thrombolysis Study Investigaton; 
Medical Research International, Burlinatoa, MA, "University of M.....,h_ 
Medical Center, Won:ester, MA 
A sex bias in the managemeat of coronary artery diseaso bas been alleged in 
several recent articles, but their credibility is nx1uced by limited control for 
potential major coofounden. We have collected compreheoaive data on 
interventions for AMI and 011 potentia1 major coofOllllders in a nationwide 
thrombolysis study of efficacy and safety of thrombolysis in actual clinical 
practice. Of consecutive patients presenting with AMI at 70 hospitals between 
September 1990 to March 1992, all those receiving thrombolysis and a 1/3 sample 
of those not receiving it were enrolled and extensive data on medical history, 
presentation, hospital cour.;e and in-hospital outcomes were obtained. Of the 2818 
patients enrolled. 30 % were females, 40 % of whom received a thrombolytic agent 
compared to 54% of males, (RR=O.74, 95% CI=0.69-O.80). Moreover, 38% 
of females had coronary bypass graft surgery or percutaneous transluminal 
coronary angiop1asty compared to 48% of males, (RR=0.8I, 95% CI=0.73-
0.89). Exclusion of patients presenting with known contraindications to 
thrombolysis and those presenting to the hospital more than 5 hoWl! after the onset 
of chest pain. did not alter this relationship for thrombolysis (RR=O.84, 95% 
CI=0.79-O.89). When examined by age. this sex difference persisted at nearly 
all ages, but was most strilting in patients under 50 years (RR=0.77, 95% 
CI=0.65-O.93) and over 79 years (RR=0.89, 95% CI=0.42-O.89). Control for 
other potential confounders, such as severity of heart disease did not eliminate this 
difference in treatment. However, when examined by diagnostic features of the 
presentation. the sex difference was observed only among patients without an 
anterior AMI or those without • cardiac history. Indeed,. probability model 
based on these data, indicates that a 45 year old woman with no cardiac history 
presenting with chest pain but ECG findings not typical of an anterior AMI is 
33 % less likely than a comparable male to receive thrombolysis. Conclusion: In 
actual practice in the U.S., women, particniarly those at the extremes of age and 
with • less typical presentation. are less likely than men to receive thrombolysis. 
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Baseline Cbaracteristics and Procedural Outcomes In 
Tbe Canadian Coronary Atberectomy Trial 
Allan G. Adelman for The CCAT Investigators 
Toronto Hospital and Mount Sinai Hospital, Toronto, CANADA 
To help determine the appropriate role of directional coronary atherectomy 
(DCA), randomized, controlled comparisons with PTCA are required. The 
Canadian Coronary Atherectomy Trial (CCA T) is a randomized study of DCA 
and PTCA for de· novo lesions in the proximal one-third of the LAD. The 
primary outcome is 6 month angiographic restenosis, assessed quantitatively. 
274 patients were enrolled between July191 and Augustl92 at 9 Canadian 
centres. Standardized peri-procedural medical and heparin regimens were 
used. The study population represents 19% of all LAD procedures during the 
study. Data presented is for the first 236 patients. Angiographic success (AS): 
final stenosis < 50%; procedural success: AS without urgent CABG, Ml or 
death within 24 hours of procedure. P<0.05 considered significant. 
Ba",line characteristics DCA (n=121\ PTCA (n=115) P value 
Gender (% male) 80 87 NS 
Age (mean .±. S.D.) 57.8.±. 103 54.8.±. 10.2 0.03 
Diabetes (%) 18 17 NS 
Prior MI (%) 39 39 NS 
Unstable angina (%) 41 51 NS 
LV ejection fraction .:s. 40% (%) 7 5 NS 
Multivessel disease (%) 28 19 NS 
Procedural Outcomes DCA(%) PTCA(%) P value 
Angiographic success (AS) 99 96 0.3 
AS with randomized technique 82 94 0.005 
Urgent CABG 1 3 0.15 
Myocardial infarction (1 0; 9 non-OJ 4 4 NS 
Procedural mortality 0 0 NS 
Procedural success 96 95 NS 
Thus, for lesions of the proximal LAD, complication rates are low and 
ultimate success rates high for both techniques, although failure of the primary 
technique occurs more often with DCA. Angiographic follow-up is underway 
(98% of 116 patients to date) and will be completed in February, 1993. 
760-2 2:15 
Transcatbeter Device Synergy: Preliminary Experience witb Adjunct 
Directional Atberectomy following Rotational Atberectomy in Treating 
CalcirlC Corooary Artery Disease 
Augusto D. Pichard. Gary S. Mintz. Kenneth M. Kent, LoweD F. SaUer. Jeffrey J. 
Popma, Martin B. Leon. Washington Hospital Center. Washington, DC 
High-speed rotational coronary atherectomy (RA) combined with adjunct balloon 
angiopJasty (PICA) often results in a >30% [mal diameter stenosis (DS) in large 
vessels. Conversely. directional atherectomy (DCA) achieves a greater minimum 
lumen diameter (MLD) in large vessels. but is limited by its inability to cut lesion•
associated calcium. Therefore. to optimize procedural outcome in larger calcified 
vessels. we combined RA and adjunct DCA in 10 pts (7 males: ages 62.5±9 yrs: 2 
left main. S LAD. 1 LCX, 2 RCA) and assessed the results with quantitative 
coronary aneriography {QCA: measurement of MLD and % DS} and sequential 
intravascular ultrasound (IVUS) measurement of external elastic membrane 
(EEM). lumen. and plaque+media (p+M) cross-sectional areas (CSA). % CSA 
narrowing (CSN=P+M/EEM), and arc of calcium before RA. after RA. and after 
adjunct DCA. 
pre RA POSt RA post DCA ANOV A 
EEM CSA (mm2) 20A±2.3 21.1±2.3 22.3±2.9 NS 
Lumen CSA (mm2) I.S±O.S 4A±1.0 7.7±1.2 <.001 
P+M CSA (mm2) 18.9±2.3 16.8±2.8 IS.8±3.0 .017 
% CSN 93±3 70±7 64±5 <.001 
Arc of calcium 271±92' 210±120' 163±122' <.001 
% DS 78±IS SO±I7 17±11 <.001 
MLD (mm) 0.67±OAI 1.48±OA8 2.50±0.28 <.001 
Retrieved tissue weight after adjunct DCA averaged 9.8mg and frequently 
contained calcium elements. Compared to 10 pts (matched for vessel size and arc 
of target lesion calcium) treated with RA and adjunct PTCA. adjunct DCA 
resulted in a significantly larger residual lumen CSA and MLD. a smaller residual 
% CSN and % DS. and less residual plaque and calcium. !VUS imaging showed a 
circular lumen after RA which became asymmetric and irregular with distinct cul~ 
into heavily calcified plaque after adjunct DCA. 
We conclude: RA and DCA have a synergistic effect in the treatment of 
heavily calcified coronary artery target lesions in larger vessels. Pretreatment with 
RA renders the calcium more susceptible to DCA while adjunct DCA results in a 
better acute procedural result than adjunct PTCA. 
ABSTRACTS 
760-3 2:30 
"Salvage" PTCA After New Device Interventions 
Roben D. SafllUl, Marl< Freed, Anne Lichtenberg, Melissa May, Nadine Jwan, 
Michelle Strzelecki, Nancy Corbell, Cindy L. Grines, William W. O'Neill. 
William Beawnont Hospital, Royal Oak, MI 
PTCA is often used after new device interventions to further enlarge the lumen 
and to manage device-relared comp1ications (salvage PTCA). Studies which repon 
the [mal incidence of complications (after the device foUowed by PTCA) could 
potentially mask the risks of new devices. We examined the incidence of 
angiographic complications (in a patient subgroup at high risk for PTCA) 
immediately after excimer Jaser (ELCA), Rotablator (ROTA), and extraction 
atherectomy (rEg and after device + PTCA (as % of aD lesions treated): 
Angiographic ELCA 1EC-SVG TEC-native ROTA 
complication 0=136 0=163 0=190 0=116 
Sidebranch occlusion 0.8 0 2.8 1.8 
Distal embolization 1.6 10.0 /.1 0.9 
No-reflow 0.8 10.0 /.1 6.1 
Abruplclosure 8.8 3.9 11.5 11.2 
Perforation 4.8 0 2.2 0 
New/persistent clot 1.8 16.0 1.6 3.6 
Other 0 0 2.8 16.5-
Total 18.6 39.9 23.1 40.1 
Successful Salvage by PTCA (with or without other medical therapy) 
% of total lesions 16.2 25.9 15.2 37.2 
% of all complications 87.1 65.1 65.8 92.7 
Clinical complications 
Death 2.1 2.5 3.1 0.9 
CABG 3.6 0 2.6 1.8 
Q-MI 1.4 3.7 4.7 4.4 
non-Q-MI 2.8 2.S 0 2.7 
Vascular repair 1.4 1.2 /.1 2.7 
Transfusion 5.1 6.1 5.8 7.2 
St.roIce 0 2.4 /.1 0.9 
-severe vasospasm 
~: I) Angiographic complications frequently occur after new device 
interventions (18-40% of lesions in this study), particularly in lesions felt to be at 
high risk for PTCA alone; 2) PTCA can successfully salvage 65-93% of device•
related complications, resulting in an acceptable overall incidence of clinical 
complications: 3) SlIldies of new devices which only report the [mal incidence of 
complications may underestimate the risks of new device interventions. 
760-4 2:45 
Cost-EffectiveDesI of DirectioDai Atberectomy, Steoting, and Conventional 
Angioplasty In Single-Vessel Disease: A Decision-Analytic Model 
David J. Cobea, Ricbard E. Kuntz, Steven P. Freidricb, Paul C. Gordoa, Jeffrey 
A. Breall, Kalon K. Ho, Milton C. Weinstein, Donald S. Baim. Harvard•
Thorndike Laboratory, Betb Israel Hospital and Harvard School of Public 
Health, Boston MA 
We have previously demonstrated tbat Palmaz-Scbatz steDting (S) is 
reasonably cost-effective over a wide range of conditions for coronary lesions 
amenable In either S or angioplasty (PTCA). Directional coronary atberectomy 
(DCA), bowever, is frequently also feasible, and may influence the Incremental 
cost-effectiveness (CE) of alternative therapies. To address the long-term CE of 
both DCA and S we developed a decision model incorporating four potential 
revascularization strategies for single-vessel CAD: (I) Initial PTCA; (2) Initial 
S; and (3) Initial DCA; all patients with symptomatic resteoosis were assumed to 
undergo up to 3 subsequent PTCA's and tben elective CABG. In strategy 4, 
initial DCA was followed by S if restenosis developed. Follow-up costs and 
quality-adjusted years of future life (QAL Y) were incorporated in the model. 
Baseline assumptions (derived from published data) included the probabilites of: 
failure to dilate (PTCA-4O/ .. DCA-2O/ .. S-2%); emergency bypass surgery 
(PTCA-2O/.. DCA-I'll.. S~.5%); and angiographic resteoosis (pREST) 
(pRESTPTCA=4O'Y .. pRESTocA=30"/ .. pRESTs=20"1o). The initial costs (Co) of 
revascularization were derived at our institution and included: Con-cA =$S200, 
CoocA =$5800, Cos=S7900, and CoCABG=S20,OOO. 
The baseline analysis demonstrated that initial PTCA was both more 
expensive and less effective than DCA. While initial S was I!igh!!y more 
effective than DCA, its incremental CE (SI30,OOO/QALy) was relatively higb. 
Sensitivity analysis demonstrated tbat tbe major determinants of CE were 
pREST and Co. At a spending threshold of S40,OOO/QAL Y (similar to the CE 
of treating mild hypertension), initial DCA was preferred over S or PTCA as 
long as: pRESTocA<37%; pRESTs>14%; and Cos>S7600. Strategy 4, 
reserving S for post-DCA restenosis, was also potentially cost-effective 
(Incremental CE of S42,OOO/QAL Y). Only if pRESTPTCA were < 31%, would 
PTCA alone become tbe preferred strategy. 
In conclusion: For lesions amenable to PTCA, S, or DCA, neitber initial S 
nor PTCA are cost-effective alternatives In initial DCA. S, however, is still 




Clinical and Angiograpbic Predictors or Procedural Outcome After 
Rotational Coronary Atherectomy in Complex Lesions 
Jeffrey J. Popma. Lowell F. Satler. Augusto D. Pichard. Kenneth M. Kent. Ya 
Chien Chuang. Gary S. Mintz. Alan J. Merritt. and Martin B. Leon. Washington 
Hospital Center. Washington. OC 
While rotational coronary atherectomy has demonstrated benefit in patients with 
complex anatomy. the precise clinical and angiographic predictors of procedural 
outcome remain poorly defined. To lend insight into these factors. we reviewed 
the procedural results after rotational atherectomy in 526 patients (707 lesions) 
using detailed hospital chan audit and cineangiographic review using qualitative 
morphologic and quantitative angiographic methods. Unfavorable lesion anatomy 
included calcification (72%). eccenbicity (67%). angulation ~ 450 (29%). and 
length ~ 10 mm (20%). Angiographic failure (> 50% final diameter stenosis) 
occurred in 3.3% lesions. Procedural failure (angiographic failure or death. Q•
wave MI. or CABG) developed in 4.9% procedures. Major and minor (abrupt 
closure. recurrent ischemia. repeat PTCA) complications occurred in 6.7% 
patients. 
Angiographic Failure 









De Novo Lesion 




























Importantly. high rates of overall procedural success were obtained even in these 
complex lesion subsets (lesion calcium. 94.9%; eccenbicity. 94.1 %: length ~ 10 
mm. 94.7%: de novo lesions. 93.9%; angulation ~ 450. 90.6%). We cOIIClude that 
I) high rates of procedural success are obtained after rotational atherectomy in 
complex lesion subsets and 2) minor complications after rotational atherectomy 
are related to certain clinical and angiographic factors present at the time of the 
procedure. 
760-6 3:15 
Distal Embolization After Transluminal Extraction Catheter Treatment of 
Sapbenous Vein Graft Lesions 
Mun K. Hong. Jeffrey J. Popma. Martin B. Leon. Kenneth M. Kent Lowell F. 
SaUer. Augusto D. Pichard. Washington Hospital Center. Washington_ D.C. 
Tbe transluminal extraction catheter (TEC) is an important new therapy for 
lesions with significant thrombus burden. However_ angioplasty with TEC. 
especially in degenerated saphenous vein grafts (SVG) with thrombi. may be 
associated with distaJ embolization (DE). To examine the factors conbibuting to 
DE and the effect of DE on procedural outcome. we reviewed the hospital 
records and analyzed cineangiograms (using qualitative and quantitative 
techniques) from 76 SVGs undergoing TEC atherectomy. DE was defined as 
TIMI 0 or I flow in the distaJ vessel following the procedure and associated with 
chest pain or EKG changes. Procedure success was defined as <50% final 
diameter stenosis and the absence of in-hospital major complications (death. M!. 
or CABG). Angiographic thrombus was present when prominent intraluminal 
filling defects were identified. DE occurred in 10 patients (14%); only 2 had DE 
after TEC and the majority were associated with post-TEC adjunctive halloon 
angioplasty . 
Mean Age (yrs.) 
SVG age (mos.) 
Thrombus (%) 
Adjunctive Balloon (%) 
Procedural Success (%) 
Complications (%) 
MI/CABG/Death (%) 



















The DE patients were treated with intragraft urokinase (9/10). PTCA (10/10). 
and/or clot extraction (3/10). resulting in mean final TIM! flow of 2.8. We 
conclude that: (I) TEC in SVGs with thrombi results in frequent DE (30%). 
largely atbibuted to subsequent adjunct PTCA: (2) DE in these patients was 
associated with frequent procedural complications. including mortaJity: and (3) 
new strategies for treatment of large thrombi in SVGs. which avoid adjunct 
PTCA and favor increased thrombus removal. are required to minimize DE and 
improve procedural success. 
JACC Vol. 21, No.2 
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Coronary Artery Disease 
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A-1O 
761-1 2:00 
Left Ventricular Thrombus After Myocardial 
Infarction: Risk Stratification and Rationale 
for Anticoagulant Management by Doppler Echo. 
Jan van Dantzig, Ben Delemarre, Hans Bot, Cees 
A. Visser. Academic Medical Center, Amsterdam, 
The Netherlands. 
Arterial embolisation of left ventricular 
thrombus after myocardial infarction (MI) may 
be prevented by oral anticoagulants (OAC) , 
which however introduce a bleeding risk. We 
examined the utility of (Doppler-assessed) LV 
spatial flow for OAC management in MI. Normal 
flow was simultaneous apical and basal inflow 
and discontinuous apical flow, by pulsed 
Doppler, 2Dcolor and color-M-mode. Echo was 
performed at admission, at discharge and 9 mo. 
of follow-up. Pts with abnormal flow at admis•
sion were placed on OAe, the others were not. 
Presently, 74 pts have been enrolled, with 284 
pt-months of follow-up in 67 pts. 








TOTAL 17 50 
sensitivity 94', specificity 86' 
positive predictive value 70 , 
negative predictive value 98 ,. 
23 
44 
Thus, Doppler LV flow stratifies pts with MI 
according to their risk of LV thrombus and 
hence, provides a rationale for OAC management 
to prevent cardiogenic embolism in MI. 
761-2 2:15 
Acute Wall Motion Score al an Ear1y Predictor of Left Ventricullr 
Dilltlon and Mortality after First Anterior Infarction ..... ted with 
Thrombolysll 
Kathinka H. Peels. Jan-Henk E. Dambrtnk. WIek H. van Gist. J. Herre 
Kingma, on behalf of the CATS investigators group. Catharina zlekenhuls, 
Eindhoven. The Netheriands 
In 284/298 patients (pis) (95%) with first anterior Infarction. treated with 
I.v. streptokinase. a wall motion score (WMS) was assessed with echocar•
diography (E) within 12 hours (E-l). WMS was based on 16 segments. 
assigning 1 to normo-, 2 to hypo., 3 to 11-, 4 to dyskinesia. The sum 
divided by the # of segments readable provided the WMSlndex (WMSI). 
In 1171298 pts (39%) enddlastollc and endsystollc volumeindex (EDVI, 
ESVI) could be computed serially on E-l and after 3 months (E-2). using 
the modified (biplane) Simpson's rule. During a follow-up of 517 ± 161 days 
24 pis died, these pts had significant higher WMSi on E-l than survivors 
(2. 16±O,28 vs 1.8\±O,41. p<O,OOI). 
Serial changes In volumes In the first 3 months' 
+LVEDVI ml/mI +LVESVI ml/mI #pts 
WMSi ~ 2 1.8:12,7 1.5:8.7 n 
WMSI > 2 11.9±16.0 
, 
7.2:11.9' 40 
& mean Changes±stanoaro O8VllltiOn OIIIWeen t-l ana t:-2; 
'~ p<O.OOI 
We conclude that In the acute phase of myocardial infarction, treated wtth 
thrombolysis, pts prone to dlate can readHy be identified using regional 
evaluation (WMSI) and that this acute WMSI Is a good predictor on 
mortality. 
JACC Vol. 21, No.2 
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761·3 2:30 
Tbe Errects of Coronary Angioplasty on Regional Coroaary Flow 
Reserve Evaluated by Positron Emission Tomography: 
Noninvasive Assessment by Dipyridamole Echocardiograpby 
Gianmario Sambuceti, Eugenio Picano, Fabio Lauanzi, Obenlan Parodi, Mario 
Marzilli, Alessandro Distante, Antonio L'Abbate. Institute of Clinical 
Physiology, CNR, Pisa, Italy 
Aim of this study was 10 assess whclber the physiological beocfit 011 regional 
flow reserve determined by coronary angioplasly can be mirrored by varialions in 
dipyridamole-echocardiography ICSt (DET) respoose. QuantitatiOll of regional 
myocardial blood flow was obtained by Positron Emission Tomography 
measurements of I3N·Ammonia arterial input function and left ventricular 
myocardial tissue COIIcenuation at control and afrer dipyridamole (0.56 mglkg over 
4'); regional coronary flow reserve was measured as DipyridamoleIBaseline 
myocardial blood flow. In DET (with dipyridamole infusiOll up 10 0.84 mglkg 
over 10'), two parameters were evaluated: the dipyridamole time (i.e., the time 
from onset of dipyridamole infusion to obvious dyssynergy) and the Wall Motion 
Score Index (derived by summation of individual segment scores, ranging from I, 
normal, 10 4, dyskinetic in an II segment model of the left ventricle). Both PET 
evaluation of regional flow reserve and DET were performed off therapy I 10 5 
days before and again afrer a successful PTCA in 7 patients with single vessel 
disease (left anrerior descending in 4, left circumflex in 3). The coronary stenosis 
(cornpurer-assisted assessment) went from 84±17 (mean ±SD) before 10 12±10% 
after PTCA (p<.0l). The flow reserve in the risk region went from 1.76±.73 
before to 2.7'H..67 afrer PTCA (p<.01); dipyridamole myocardial blood flow 
increased afrer PTCA from 1.l±46 to 2.3'H.l.l ml/min/g(p<.OI). DET was 
positive in 7{7 before and On afrer PTCA (p<.01). Following PTCA, the increase 
in maximal myocardial blood flow in the jeopardized myocardium was correlated 
10 variations in dipyridamole-time (r=.83, p<.05), not 10 variations in Wall 
Motion Score Index at peak dipyridamole (r=.02, p=ns).Simiiarly, the 
improvement in regional coronary reserve was better correlated 10 variations in 
dipyridamole time (r=.67) than 10 variations in WMSI (r=.OI, p=ns). 
We conclude that the physiologic beocfit induced by coronary angioplasly can be 
noninvasively derected and quantified in an objective, simple and exercise 
independent manner on the basis on the presence as well as timing of 
dipyridamole indoced dyssynergy. 
761·4 2:45 
Arbutamine. a New Agent for Diagnosing Coronary Artery 
Disease: Comparison with Exercise Testing 
L. E. Ginzton. M.D .• FACC. C. Appleton. M.D .• FACC. S. Mohiuddin. 
M.D .• FACC. P. E. Pool. M.D .• FACC. W. Robertson. M.D .• FACC. 
D. Bach. M.D .• G. Ismail. M.D .• W. Armstrong. M.D .• FACC. Harbor· 
UCLA Medical Center. Torrance. CA. & the Arbutamine Study Group 
Arbutamine (Ab) is a new. short·acting beta-agonist intended for 
pharmacologic stress testing. It increases heart rate (HR), LV 
contractility and systolic blood pressure (SP). We compared the 
ability of Ab and symptom-limited exercise (ex) to provoke ECG and 
2D-echo (echo) signs of ischemia in 45 patients (pts) with coronary 
artery disease (CAD). Ab was infused in up to 4. 8-min steps of 0.1. 
0.2. 0.3 and 0.4 mcglkg/min. Ischemia on ECG (n = 45) was 
defined as ~ 1 mm ST change from baseline. By stress echo (n = 
34). presence of CAD was defined as a wall motion abnonnality 
(WMA) at rest or stress. and ischemia as a stress-induced or 
worsening of rest WMA. Ab and ex increased HR 54± 17 vs. 72±20 
bpm (p < 0.0001) and SP by 31 ± 13 vs. 50± 19 mmHg (p < 0.0001). 
Ab and ex had no serious adverse events or clinically significant 
arrhythmias; transient hypotension occurred in 5 Ab pts. 
Angina ECG Echo Echo 
Ischemia Ischemia CAD 
Ab 51%(23/45) 58%(26145) 88%(29/33) 97%(32/33) 
Ex 24%(11/45) 53%(24145) 79%(27134) 91%(31134) 
p = 0.003 p = ns p = ns p = ns 
CONCLUSION: In this study. despite a lower HR and SP. 
arbutamine was as effective as exercise in provoking clinical. ECG 
and echo ischemia, and therefore is a promising alternative to 
exercise for diagnosing CAD. 
ABSTRACTS 
761·5 
Identfffcatfon Of Multfvessel Dfsease By Exercfse 
Echocard1ography: Correlatfon wfth Angfography 
Veronique L. Roger, Patricia A. Pellikka, Jae K. 
Oh, Mary Ann Capps, Barbara A. Nichols, A. Jamil 
Tajik. Mayo Clinic and Foundation, Rochester, MN 
3:00 
The ability of exercise echocardiography (ExE) to 
identify multi vessel coronary artery disease (CAD) and 
its incremental value in addition to clinical and 
exercise test data has not yet been documented. We 
reviewed 150 consecutive pts (120 men, age 63 + 11) who 
underwent treadmill ExE and coronary angiography 
(Cor A) without prior revascularization; 86 had 
multivessel CAD (2 or 3 vessels with stenosis> 50%). 
ExE reviewers were blinded to the results of Cor A; the 
motion of the 16 left ventricular segments was 
evaluated at rest and post exercise; the segments were 
classified into the 3 coronary artery distributions as 
recommended by the American Society of 
Echocardiography. 
The following variables were significantly related 
to the presence of multivessel CAD: history of 
myocardial infarction, positive exercise ECG, exercise 
rate pressure product, achieved percent of functional 
aerobic capacity, magnitude of ST segment depression, 
number of abnormal myocardial segments, and number of 
abnormal coronary distributions post exercise. Multiple 
logistic regression identified the following variables 
as independent predictors (p<0.05) of multivessel CAD: 
history of myocardial infarction, positive exercise 
ECG, exercise rate-pressure product, number of abnormal 
coronary distributions. 
Conclusion: echocardiography adds independent 
information to clinical and exercise test variables 
significantly improving the identification of 
multivessel CAD. 
761·6 3:15 
Identification of Coronary Artery Stenoses and Post•
Stenotic Blood Flow Patterns by Epicardial Echo/Doppler 
AntOinette Kenny, Michael Sutters, Leonard M. Shapiro. Papworth 
Hosp~al, CarTtlridge, U.K. 
Epicardial echo/Doppler (EE) of the coronary arteries has the potential to 
provide anatomical and functional intormation. The large size of standard 
transducers has hindered imaging on the beating heart and prevented 
full exploitation of this technique. Miniaturization of transducer 
technology may, by overcoming problems of restricted access. fuHil this 
potential. We used a miniature Vingmed 6.SMHz transducer, measuring 
11 X 40mm. to image and assess coronary blood flow velocities across 
proximal LAD stenoses in 10 patients undergoing coronary artery bypass 
grafting. Imaging was performed prior to bypass when the patient was 
hemodynamically stable. All patients had >90% proximal LAD stenoses 
on angiography. Stenoses were identified by EE as dense echogenic 
masses in the LAD lumen. In 7 the stenoses were calcific and cast large 
acoustic shadows. Coronary blood flow velocities across stenoses were 
assessed by placing a pulsed Doppler sample proximal to and just 
downstream from the stenOSis. Systolic (S) and diastolic (D) maximum 





Pre-stenOSis Post-stenosis Hest 
.20(.05) .60(.07) p:O.OO4 
.14(.03) .37(.04) p:O.OO3 
.41(.05) .33(.05) p:O.36 
.29(.05) 23(.04) p:O.33 
Post-stenotic flow velocities were characterized by a significant rise in the 
systolic component. This may be secondary to a decrease in systolic 
coronary artery cofTllression by the myocardium due to ischemia. 
Conclusion: This is the first study using EE to both image and measure 
blood flow velocity profiles in the coronary arteries. Stenoses were 
identified and post-stenotic blood flow disturbances in vivo defined. 
Intraoperative use of this technique may determine the hemodynamic 
significance of coronary stenoses. Further studies to characterize flow 
across different degrees and types of stenoses are required. 
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902·62 
All ACTs Are Not Created Equal 
JamesJ. Ferguson. St Luke's Episcopal Hospital, Texas Heart Institute, Baylor 
College of Medicine, HoustOD, TX 
The activated c:oaguIation timc (ACf) is frequently used to assess 
anticoagulation status in the catheterization laboratory for intervcntional 
procedures. A target ACT of 300 seconds (based an older cardiopulmonary 
bypass literature) is often cited as the 'standard' toward which anticoagulant 
therapy should be directed. Two brands of automated coagulation timers arc 
in general clinical usage: HcmoTec and Hemochron. These two systems use 
entirely different measurement techniques. We sought to directly compare 
these two systems to determine whether HcmoTec and Hemochron ACTs can 
be used interchangeably and whether simiIar target ACTs should be used with 
both systems in patients undergoing PTCA. 
We obtained a total of 260 paired simultaneous Hemochron and 
HemoTec ACT measurements in 91 PTCA patients enrolled in a randomized 
controlled trial of a platelet 
glycoprotein lIb/IlIa 
receploc antagonist; 198 
measurements were obtained HemoTec 
after the administration of ACT 
heparin in the catheterization 
laboratory. In general, the 
Hemochron ACT cxcccd the 
HemoTec ACT by 28 .±. 
30%, with considerable 
individual va:iation, as shown. 
'",' ..•... 
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Hemochron ACT 
The results of applying an arbitrary 300 second 'targer value to the 198 
post heparin measurements are shown below. 
Hemochron ACT 
<300 >300 [P<0.OO(1) 
HemoTee <300 I 17 78 
ACT ~ 300 0 103 
ConclnsiODl: HemoTec and Hemochron ACT measurements cannot be used 
interchangeably. In general, Hemochron measurements are significantly higher, 
with wide individual variation. A HemoTec ACT of 300 seconds does not imply 
the same degre of anticoagulation as a 300 second Hemochron ACT. There are 
a large number of patients with 'adequatc' anticoagulation on a Hemochron 
machine, but 'inadequate' anticoagulation on a HemoTec machine. 
902·63 
Pre-Procedural Anti-coagulation does not 
Reduce Anqioplasty Heparin Requirements 
Roger S. Blumenthal, Vicki J. Coombs, Jeffrey 
A. Brinker, Johns Hopkins Hospital, 
Baltimore, Maryland. 
To determine whether continuous pre•
procedural heparin influences the need for 
anti-coagulation during PTCA, we compared 
heparin requirements in 133 patients 
therapeutically anti-coagulated after 
continuous heparinization for ~ 12 hours with 
110 patients not pretreated with IV heparin. 
An activated clotting time (ACT) ~ 300 
seconds was used as a measure of optimal 
anti-coagulation throughout the procedure. 
Patients pretreated with heparin had 
significantly higher pre-procedural ACT 
(163±32 vs. l26±13 seconds, p<O.OOl) and PTT 
measurements (46±15 vs. 25±3 seconds, 
p<O.OOl). Only 41% of the patients pre•
treated with heparin achieved an initial 
therapeutic ACT with > 10,000 units of 
additional heparin, and the total heparin 
required to maintain an ACT ~300 seconds 
during the procedure was similar between the 
two groups (11, 55l±3, 181 vs. 12, l36±2, 575, 
p=NS). Thus, pre-treatment with heparin does 
not significantly reduce total heparin 
requirements, and these patients should 
receive the same initial heparin regimen as 
patients not pretreated with IV heparin. 
JACC Vol. 21, No.2 
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902·64 
Increued CompUcatioDS After Prolonged versus Bolu8 Iotracoronary 
Thrombolysis with Urokinase (UK) 
Daniel Evans, Josepb M. Sutton, Eric J. Topol and Stephen G. Ellis 
The Cleveland CUnic Foundation, Cleveland, Ohio 
To assess Ihc merilS of two distinct strategies of inlrllCOrOnary thrombolysis, 88 
consecutive pts wilh angiograpbically delermined thrombus were treated wilh either 
bolus (BL) (0=73) or prolonged (PRL) (0=14) intrncoronary UK. There were no 
differences in age, sex, total occlusion, acule MI. mean pressure, or Ihc shock at !be 
time of Ihcrapy betwcco Ihc BL versus PRL cohorts respectively. Target vessel 
lerritory, ACC/AHA lesion ciassifJCalion and multivessel disease were also similar. 
CIot severity was scored as follows: 0) no thrombus; TIMI 3 flow, I) thrombus wilh 
<.50% obstruction; TIMI 3 flow, 2) thrombus wilh subtotal 50 to 99% obstruction; 
TIMI3 flow, 3) thrombus wilh TIMI I or 2 flow, and 4=thromhus wilh complele 
obstruction; TIMI 0 or I flow. There were no differences in Ihc pretreatment clot 
score (2.8±O.9 BL v 2.9±1.3 PRL p=NS), and Ihe thrombolytic results were similar 
(post-UK clot score 2.I±O.9 BL vs 1.79±1.2 PRL; p=NS). PTCA was performed 
more often after BL (86%) compared wilh PRL.(50%; p=O.OO2), however Ihe final 
postinterven-tional clot scores were also similar (0.42±O.9 BL v 0.5± 1.2 PRL 
p=NS) Despite Ihe comparablc benefit derived from bolh strategies, Ihe 
compUcation !ale using a weighted event score syslem was bigher arler prolonged 
infusion. 
DoIIII Prolonged D • 
PaticnlS (n) 73 14 
Total Dose (lU) 
infusion Ttme (00) 0.5 ± 0.5 8.5 ± 8.0 0.0001 
EveDt Weighted Scon 
Overall evcnt score 2.4 ± 2.1 4.5 ± 2.0 0.002 
Fever I 1(1.4%) 0 NS 
Hypotension 2 2 (3%) 1(7%) NS 
Hematoma 3 5 (7%) 1(7%) NS 
Bleed; DO Transfusion 3 7 (10%) 6 (43%) 0.001 
Bleed wilh Transfusion 4 9 (12%) 2 (14%) NS 
MI(non-Q) 6 4(5%) 3(21%) 0.04 
MI (Q-wave) 7 2 (3%) 3 (21 %) 0.006 
CVA 8 0 0 NS 
De.alh !O 0 0 NS 
Thus, Ihcre were no differences wilh respect to Iherapeutic success wilh BL 
versus PRL adminislralion of UK, however the complication !ale proved higher 
after PRL infusion, wilh a bigher bleeding !ale and more frequent MI. 
902·65 
Intrac:oronary Inrusion o( Urokinase ror Angiograpbic Thrombus: 
Comparison or ProIoaged Versus Burst Infusion 
Judson S Million, Steven J Ya1rubov, Mark S Gonzalez, David Engleman, 
Nathan H Kander, Richard J Candela, Barry S Geol"ge, Anthony T OIapekia. 
Riverside Methodist Hospital, Columbus, Obio. 
Iotracoronary (IC) thrombus imparts a heightened cballenge to coronary 
artery intervention. Chemical thrombolysis appears to improve PTCA 
angiographic and clinical outcome when IC thrombus is suspected. From Jan 
1,1990 to Janl, 1992 we compared two groups of pIS receiving IC uroldnasc 
(UK) cither prior to or follOwing PrCA. Group I (40 pIS.) received burst IC 
UK (500,000.1,000,000 units over 30 min). Group 2 (106 pIS.) received 
prolonged IC UK by pcrtiJsion catbetez (mean infusion duration =20.1 hrs; 
mean dosage 2,200,00 .units). Angiograpbic results were made by 2 
independent observers. Angiographic thrombus was quantitated designating 
thrombus = I, bazimess,.2, and definite fitUng defect .. 3. 
QUIIIII.l. Qmsm.l 
Thrombus Score 
Pre-UK 2.5 2.8 
Post·UK 2.4 
Pen:cnt Stenosis 
p=NS 2.2 p<.03 
Pre-PTCA 94.1 95.3 
Post-PTCA 28.5 19.3 p=NS 
Distal Embolization 1()CJ, 10.4% p=NS 
CVA 0 I p=NS 
Deaths 0 2 p=NS 
ER-CABG I 2 p=NS 
CONo.USJQN Continuous prolonged IC UK decreases angiographic 
visualization of thrombus moreso than burst infusion. Comparable clinical 
and post-PTCA results were attained with these two mcthods of IC UK 
infusion. Allilough distal emboUzation is frequent. the clinical adverse event 
rate is very rare. Thercfocc either techiniquc of IC UK infusion may be 
adjunctivc benefit to PTCA in this bigh-risk subset of patients. 
JACC Vol. 21, No.2 
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902·66 
Prolonged Continuous InrlL'lion 01 Urokinase Through an Intrac:oronary 
Perrusion Catbeter Following PTCA: Clinical and Angiograpbic 
Outcome 
David Engleman, Steven J Yakubov, Mark S Gonzales. Nathan H Kander. 
Ricbard J Candela. Barry S George. Anthony T Cbapekis. Riverside 
Methodist Hospital. Columbus. Ohio. 
An insdequate angiograpbic result complicated by features of thrombus 
following PTCA defmes a group of patients(pts.) at high-risk for abrupt 
closure(AC) and emergency CABG. Prolonged continuous inlracoronary 
(IC) urokinase (UK) appears to be of benefit prior to PTCA in those pts 
suspected 10 have IC or sapbenous vein graft thrombus. Of 106 pts who had 
received continuous IC UK infusion (22.4 brs. mean length of infusion), 20 
pts with abnormal TlMl flow post-PTCA due to suspected IC thrombus 
\lllden>ent this therapy. TlMl flow, residual thrombus and residual sleOOsis 
were graded by 2 independent observers on initial angiography and upon 
completion of UK infusion (mean duration 20.1 brs.). Angiographic 
thrombus was quantitated designating no thrombus a score oil, haziness a 












No pts had major bleeding complications. none required emergency CABG. 
and there were no abrupt closures. (AC). 10 pts required repeat PTCA. 
CONCLUSION Prolonged continuous UK infusion after PTCA was 
associated with a significant improvement in angiographic coronary blood 
flow in those pts with abnormal coronary flow following PTCA thought 
secondary 10 thrombus. However, angiographic visualization of thrombus 
nor post-PTCA percent sleOOsis were altered by IC UK infusion. Post-PTCA 
infusion of UK may help improve the clinical outcome in this high-risk group 
of pts. decreasing the need for emergency CABG and AC. 
902·67 
Routine Use of Collagen to Seal the Femoral Artery Puncture Site After 
Percutaneous Transluminal Coronary Angioplasty in Fully Anticoagulated 
Patients; a Clinical Evaluation 
Els M. Nagtegaal, Martin J. Schalij, Beert Buis 
Department of Cardiology, University Hospital Leiden, The Netherlands. 
Immediate hemostasis of the femoral artery puncture site is difficult to 
achieve in fully anti-coagulated patients immediately after percutaneous 
transluminal coronary angioplasty (PTCA). The introduction of 
collageneous sealing plugs (pure bovine collagen) enables the immediate 
removal of the arterial sheath in fully anticoagulated patients. This 
procedure was evaluated in a group of 1 80 consecutive patients of which 
80 patients were treated with the collagen plug. In the treated patients 
the sheath was removed immediately after the procedure whereas in the 
non-treated group the sheath was removed after 6 hours. In all patients 
an 8 fr. arterial sheath was used and all were treated with heparin during 
the procedure (2 times 7500 Uti i.a.). Hemostasis was achieved within 
5 minutes in all treated patients compared to 1 5 minutes in the non•
treated group. With the exception of 5 procedure related false aneurysms 
no serious complication were encounterd. The results are summarized in 
the following table 
treated group non-treated group 
N 80 sd 100 sd 
Immobilization 
period (hours) 9°1 (540) 1914 (336 ) p <0.005 
Hemoglobin bef.mmolll 8.9 (0.8) 8.8 (0.8) NS 
aft.mmolll 8.2 (1.2) 7.7 (1.0) p <0.05 
Hematoma 5 9 NS 
False Aneurysm 1 4 NS 
Blood transfusion 0 0 N S 
Other complications 0 0 NS 
Conclusion: Routine application of collagen plugs to seal the femoral 
artery puncture site is safe and results in a more than 50% reduction of 
the immobilization period after a PTCA procedure. 
ABSTRACTS 
902·68 
A Randomized Evaluation of Arterial Puncture Sit. 
Closure by Collagen (Vasoseal). 
Edoardo Camenzind, Marianne Grossholz. Dominique 
Didier, Philip Urban, Bernhard Meier. 
University Hospital. Geneva, Switzerland 
Ninety·five patients with coronary angioplasty (PTCA) 
through 7 French (F) catheters or 6F catheters with 
intravenous heparin for >12 hours (h) were randomly 
assigned to delayed sheath removal with manual 
compression (MC) or immediate local application of bovine 
collagen (Vasoseal: V) for puncture site closure. The group 
V was divided into V1 (Vasoseal applied according to depth 
measurement) and V2 (no measurement). All had a 
pressure dreSSing applied for >6h. The local status was 
assessed clinically and by Duplex sonography. Criteria of 
evaluation were: hematoma (presence and diameter) and 
other vascular complications (C). 
N Hematoma (em) False Venous TotalC 
0 <10 10-20 >20 Aneurysm Thrombus 
Me 47 29 10 8 0 3 0 21 
V 48 25 11 8 4 3 1 27 
Vl 17 8 4 3 2 1 0 10 
V2 31 17 7 5 2 2 1 17 
(No statistically significant difference among groups) 
Puncture site closure with Vasoseal is attractive for time 
efficiency. However, it does not seem to reduce bleeding 
complications irrespective of whether used with or without 
prior depth measurement. 
902·105 
The HeIoostatic PUncture Closure Device causes OI11y 
TaIporary Echo Doppler Cllim;j"es in Flow and SIlrraUDdiJlq 
Tissue: A Three Months Follow-up 
H de swart, L Dijkman, L Hofstra*, F Bar, V van Cl!1nen, 
J Tordoir* arrl PJJ Wellens_ Departrrent of cardiology 
arrl Vascular SUrgery*, Academic Hospital Maastridlt, 
'!he NetherlaOOs_ 
'!he herrostatic p.mcture closure device (HPCD, Kensey 
Nash co.), which anchors in the arterial lumen has 
been proven to be an efficacious tool to achieve 
immediate herostasis an::l to shorten 1I"Obilization time 
after arterial catheterization. Echo doppler data, 
however, shCMed charges in flow spectrum arrl arterial 
wall integrity. '!he 3 tronths follow-up of 47 patients 
(pts) is rep:lrted. In these pts echo dewIer studies 
were nade before arrl 1, 7, 30, arrl 90 days after 
placement. 31 ptg were nale, 16 female; mean age was 
56 arrl 60 respectively. At insertion the APIT was 279 
± 67 seconds (normal 24-34 seconds); mean time to 
herostasis was 1.3 ± 2_1 minutes. ptg were ambJ.lated 
after 7.2 ± 5.3 hours. 
Results: 
PRE 1 DAY 7 DAYS 30 DAYS 90 DAYS 
NUMBER OF PATIEm'S 47 41 42 40 43 
SMALL HEM!\TCt1A «2 ~) 0 27 36 17 2 \ 
u.RGE HEM!\TCt1A (2-5 ~) 0 5 0 0 0 \ 
OEFEeI' ARI'ERIAL WALL 35 90 74 52 26 \ 
FI.Qi OIsruRBIINCES 63 72 71 65 58 \ 
PEAK FI.Qi VElDCITY 92 107 100 95 99 an/a 
~lusions: Ultrasourd data derronstrate only 
temporary changes in arterial flow patterns, arterial 
wall integrity, arrl peak flow velocity. 'Iherefore, 
anchoring of the HPCD in the arterial lumen is safe. 
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903·69 
Predicton of Late Clinical Outcome After New Device AngiopJasty 
Lowell F. Satler. Jeffrey J. Popma. Augusto D. Pichard. Kenneth M. Kent. Ya 
Chien Chuang. Gary S. Mintz. Alan J Merritt, Michael B. Keller. and Martin B. 
Leon. Washington Hospital Center. Washington. DC 
New device angiopJasty may provide its advantage over standard balloon methods 
by minimizing the residual % diameter stenosis immediately after the procedure. 
although the correlation between early angiographic results and late clinical 
outcome has not been previously demonstrated. To examine the factors affecting 
late clinical outcome in patients undergoing new device angiopJasty. we followed 
a cohort of 957 patients after successful angioplasty « 50% diameter stenosis and 
no death. MI. or repeat revascuJarization within 14 days) using directional (N 
=187). rotational (N=495). or extraction (N=59) alherectomy. balloon expandable 
stenling (N=137). or excimer laser angioplasty (N=79). Cineangiograms were 
reviewed using qualitative morphologic and quantitative angiographic methods. 
Pre-procedural lesion morphology included lesion eccentricity (65%). calcification 
(44%). ostial location (22%). length ~ 10 mm (22%). angulation (21%). and 
location in degenerated grafts (6%). F'tna1 diameter stenosis was 19±15%. Event•
free survival (freedom from death. Q-wave MI. and lesion-related 
revascularization) was 71 % 8±6 months after new device angiorJasty. Predictors 
of late cardiac events were obtained using multivariate Cox regression analysis. 
95% confidence intervals (CI) are provided. 
Risk Ratio 95%CI p Value 
Unstable Angina 1.66 1.28-2.16 <0.001 
Diabetes Mellitus 1.45 1.12-1.88 <0.01 
Ostial Location 1.39 1.05-1.85 <0.05 
Ulceration 0.53 0.15-1.0 <0.05 
Reference Diameter (mm) 0.78 0.63-0.97 <0.05 
F'ma1 % Diameter Stenosis 5.46 2.29-13.01 <0.001 
Late outcome was not significantly influence~ by a prior history of restenosis or 
device selection. Wt cOM/lldt tJuIt I) late clinical outcome is favorable after new 
device angiopJasty and related to certain preprocedural clinical and angiographic 
factors and 2) while late clinical outcome is affected by vessel size. the most 
important independent predictor of late outcome is the residual % diameter 
stenOSis immediately after the procedure. 
903·70 
New Device Angioplasty of Left Main Coronary Lesions: Angiograpbic and 
Clinical Insigbts 
S. Chiu Wong. Augusto D. Picbard. Lowell F. Satter. Kennelh M. Kent. Jeffrey J. 
Popma. Martin B. Leon. Washington Hospital Center. Washington. D.C. 
PTCA treatment of left main (LM) coronary stenoses is often avoided due to less 
favorable pucedural outcome and a higber recurrence frequency. To determine if 
lesion-specific new device angiopJasty (NDA) improves acute and long-term 
results. angiographic (QCA) and clinical data were analyzed from 54 patients 
with LM stenoses who underwent5S NDA procedures (Rotlblator 39. ELCA II. 
DVI 6. and TEC 2) usually followed by adjunct PTCA (SI%). PWlltlLtswII 
ClumuU,isms: 70% male. '.VEP 4O.9±12.7%. 96% "protected" LM. 93% 
calcified. 79% eccentric. lesion length 4.4±3.0mm. reference diameter 
2.8....+{).5mm. pre-treatment minimum lumen diameter (MLD) O.S±O.4mm and pre•
treatment percent diameter stenosis 7l±14%. ResuUs: Final MLD improved to 
2.I±O.5mm and percent diameter stenosis was reduced to 28±12%. Overall 
procedure success (final percent diameter stenosis <50% without majOr 
complications) was 94%. Complktlliolls: Major - no in-hospital deaths or Q•
wave MI. and 1 urgentCABG(1.7%). Other-I non-Q MI. and no abrupt closure 
or distal emholization. FolloW-lip: (9.0±5.0 months): Late angiograms were 
obtained in 36 patients (62% of cohort) and restenosis (~O% diameter stenosis) 
was present in 18 (50%). Late events included 2 deaths. 9 elective CABG. and 4 
repeat PTCA. Event free survival (no major complications or repeat intervention) 
was 55%. QCA Filldillgs: To explore the possible differences in the 
mechanisms of lumen enlargement after NDA in LM vs non-LM. stretch 
(%)=[(mean final balloon diameter - pre MLD)/reference diameter xlOO]. and 
recoil (%) = [(mean final balloon diameter - post MLD)/reference diameter 
xlOO)were calculated in IS LM and compared with 434 non-LM stenoses. In LM 
vs non-LM lesions. stretch was 63±20% vs 79±23% (p:O.007) and recoil was 
17±11% vs 25±17% (p=O.05). We c:onclude that: NDA in protected LM lesions 
(I) can be achieved safely with high initial procedural success: (2) angiogrnphic 
restenosis and event-free survival are approximately 50% in the first year of 
follow-up: and (3) stretch and recoil post-NDA is less in LM than in non-LM 
lesions_ Thus. persistent lesion rigidity of LM stenoses still limits final MLD 
after NDA indicating a need for more effective future therapies to improve 
angiogrnphic results. 
903·71 
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CPK-WB Elevation After Angioplasty of Saphenous Vein Grafts 
Dory B. Altmann, Jeffrey J_ Popma. Moo K. Hong. Lowell F. Satler. Auguslo D. 
Pichard. Kenneth M. Kent, Martin B. Leon. Washington Hospital Center. 
Washington. D.C. 
Because of saphenous vein graft (SVG) friability. the risk of microemholization and 
CPK-MB elevation alter angioplasty may be substantial. We measured CPK-MB 
serially for 24 hrs in 239 patients after standard balloon angioplasty (PTCA). 
directional (DCA) and extraction (TEC) atherectomy. and intragraft stenting 
(STENl). CPK-MB elevation was defined as CPK-MB > 5 X normal. Procedural 
success was defined as <50 % residual _is without death, emergent CABG or 
Qwave MI. Results included: 
PTCA DCA TEC STENT 
N=85 N=35 N=46 N-73 
Graft age (ma;) 79±49 77±40 79±44 99±53 
De novo lesion ( %) 79 82 82 48 
Graft degmeralion 31 18 66 25 
Angiograpbic thrombus (%) 20 6 34 0 
Length (mm) 7.2±6.4 5.6±4.2 7.8±4.3 7.6±3.9 
Procedural success 91 94 87 99 
CPK-MB elevation (%) 19 17 20 15 
DeathlQwMIICABG 11010 31013 7/412 1/010 
By logistic regression. predictive factors for CPK-MB elevation included 
angiographic thrombus (odds ratio = 3.57. 95% CI: 1.55-8.22. p < 0.005) and 
increased reference vessel diameter (odds ratio = 1.64; 95% CI: 1.05-2.57/mm. p< 
0.05). Notably. angioplasty device was not predictive. 74% of cases ofCPK-MB 
elevation occurred with procedural success and without acute closure. These were 
defined as microembolization. Patients with microembolization were more likely 
than those without to bave post-procedure chest pain (52 vs 22%. p:O.OOI) and 
ischemic EKG changes (23 vs 8%. p<0.05). We conclude that CPK-MB 
elevation I) is common after SVG angioplasty regardless of the device employed. 2) 
is associated with SVG thrombus and increased vessel size. 3) generally occurs in 
otherwise >'UCcessful procedures and thus is probably due to microembolization. and 
4) is frequently associated with post-procedure chest pain and EKG changes. 
903·72 
Are Significant Residual Stenoses Arter Laser and Atberedomy 
Due to Ineffective Tissue AblatioDiRemoval. Elastic Recoil or 
Small Device Size? 
Mark Freed, Anne Lichtenberg. Melissa May, Nadine Juran.Cindy L_ Grines, 
William W. O'Neill. Raben D. Safl8D. William Beaumont Hospital, Royal Oak, 
MI 
Signifx:ant residual stenoses are commonly observed after initial therapy with 
many new laser and atherectomy devices. It is UDknown whether these residual 
stenoses are due to ineffective tissue ablation/removal IX' to use of undersized 
devices. To determine the relative contribution of these factors. the minimal lumen 
diameter (MLD). % stenosis. and normal reference artery diameter (A) were 
measured immediately after extraction (TEC. 11=353) and high speed rotational 
(ROTA, 11=116) atherectomy; excimer 1aser(ELCA, 11=136); and PTCA (n=9I). 
The ratio of MLD after the device to the device diameter (0. in mm) (MLD/D) is 
a measure of the relative diameter achieved, normalized fir device size. The device 
to artery ratio (O/A) is the ratio of the diameter of the device size (0) to the 
normal reference artery diameter (A) and is a measure of appropriate device sizing. 
An MLD/D ratio= I implies that the minimal diameter achieved was 100% of the 
device diameter (i.e. no elastic recoil). and an MLD/D<I implies the presence of 
elastic recoil andIlX' vasospasm_ 
Device D (mm) %Stenosis MLD/D 
TEC 2-2.5 60 ± 21@ 0.73 ±0.24 
ROTA 1.25-225 54 ± 23@ 0.92 ±0.16@ 
ELCA 1.3-2.0 61 ± 18@ 0.85 ±O.30" 
PTCA 2.0-4.0 26+ 12 0.71 ±O.ll 





1.05 ± 0.13 
In conclusion: I) Significant residual stensoses occur commonly after laser 
angioplasty and atherectomy, and are due 10 the use of undersized devices (low D/A 
ratio). rather than ineffective tissue removal/ablation (low MLD/D ratio); 2) When 
corrected fir device size. Rotablator and ELCA provide greater relative lumen 
enlargement (higher MLD/D) than TEC or PTCA; 3) The relative lumen 
enlargement (MLD/D) and the extent of elastic recoil after TEC atherectomy are 
similar to those after PTCA; 4) The MLD/D and D/A ratios are useful for 
understanding the mechanisms underlying signiflC3llt residual stenoses after new 
device interventions and for comparing devices independent of device size .. 
JACC Vol. 21, No.2 
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903·73 
A Lesion·Specific Approacb to New Device Tberapy in Ostial 
Lesions 
Walter C. Brogan. Jeffrey J. Popma. Augusto D. Pichard. Kenneth M. Kent. 
Lowell F. Satler. Gary S. Mintz. Michael B. Keller. Martin B. Leon. Washington 
Hospital Center. Washington. D.C. 
Procedural results after balloon PTCA of ostial lesions may be limited due to 
lesion rigidity and elasticity as well as frequent recurrence. To evaluate the efficacy 
of new device therapy in this lesion subset. we reviewed the procedure outcome of 
198 patients (205 lesions) undergoing new device angioplasty of ostial stenoses 
(left anterior descending [N=67]. left circumflex [N=27]. right coronary [N=55] 
arteries and saphenous vein grafts [SVG. N=48]) using atherectomy (directional 
[DCA]. rotational [ROTO]. extraction [TEe]). intracoronary stenting (STENT). 
and excimer laser angioplasty (ELCA). Specific device selection was based on 
lesion characterisitcs (e.g. vessel sizellocation. angulation. calcification). 
Procedural success «50% residual stenosis with no death. Q·wave MI. or CABG) 
was obtained from hospital chart review. Cineangiograms were reviewed using 
qualitative morphologic and quantitative angiographic methods. Adjunct balloon 
PTCA was used in 145 (71%) lesions due to residual stenosis or angiographic 
complications. Results included: 
DCA ROTO TEC STENT ELCA 
N=58 N=IOI N=19 N=ll N=16 
Reference Diam(mm) 3.2±0.7 2.6±0.5 3.2±O.5 2.7±0.5 2.7±0.5 
Lesion Calcium (%) 14 72 21 0 0 
SVG LocaIion (%) 38 2 58 91 19 
Prior Restenosis (%) 21 14 21 64 13 
Angulation ~ 450 5 27 16 0 6 
Final % Stenosis 13 23 24 12 28 
Procedure Success (%) 97 97 95 91 94 
DeatM)WMJICABG 010/1 01012 01010 0/010 0/0/1 
Angiographic follow·up in 71 pts (39% of eligible) indicated restenosis <2,50% 
diameter stenosis) in 52%. The 12 month event·free survival (freedom from death. 
QWMI. CABG or rePTCA) was 64%. We conclude that employing a lesion· 
specific approach with multiple new angioplasty devices to treat ostial lesions 
results in (I) high procedure success (97%) with reduced final diameter % stenosis 
(2Q±15). and few major complications (2.1%) and (2) despite encouraging initial 
results. frequent recurrence remains an important limitation. 
903·74 
Late Clinical Outcome After New Device Angioplasty in Women 
Kenneth D. Henson, Jeffrey J. Popma, Lowell F. Satler, Kenneth M. Kent, 
Augusto D. Pichard, Anb N. Campbell. Theresa Bucher, Alan J. Merritt, Martin 
B. Leon. Washington Hospital Center, Washington, D.C. 
Conventional balloon angioplasty in female patients has been associated with an 
increased mortality and a higher incidence of complications. The application of 
new interventional devices based on specific lesion morphology may help 
surmount these limitations in procedural outcome in women. We report our 
experience with \014 coronary interventions (752 males1262 females) using 
directional (DCA), rotational (ROTa), and extraction (TEC) atherectomy. 
excimer laser (ELCA), balloon expandable stents (STENT) and balloon 
angioplasty (POBA). !!k!!w!£. Cineangiograms were analyzed using qualitative 
morphologic and quantitative angiographic methods. Procedural success was 
defined as a residual stenosis less than 50% without major complications (Death, 
Qwave MI, emergent CABG). Event free survival was defined as the absence of 
major complications or repeat PTCA. Clinical follow up was available for an 
average of ·8.2±6.2 months. 
Results: Females Males p Value 
Age 66.289±\O.588 61.650±10.841 0.001 
ReferenceVessel Diam(mm) 2.516±O.529 2.684±.632 0.001 
Diabetes 33 24 0.002 
Recent MI (%) 18 12 0.013 
Lesion Calcium (%) 53 40 0.001 
Multivessel Disease (%) 65 72 0.033 
DCAlROTO/STENTlElCA 16/56/11/8/3/5 I 9/461 14/snl6 
/TEC/POBA (%) 
Stenosis Diam Post (mm) 2.0\3±.478 2.155±O.597 0.001 
% Stenosis Post 21±13 20±\3 0.332 
Procedural Success (%) 93.1 94.1 0.490 
Event Free Survival (%) 73.7 70.3 0.307 
We conclude that: I) Clinical and angiographic features differed significantly 
between women and men. 2) Despite these differences, procedural success rates 
and late outcomes did not vary with gender. 3) This differs from results 
previously reported with ballon angioplasty and indicates that a lesion specific 
approach using new interventional devices may be superior for female patients. 
ABSTRACfS 
903·75 
Determinants 01 Luminal Improvement Arter New Device 
Angioplasty in Complex Lesion Subsets 
Walter C. Brogan. Jeffrey J. Popma. lowell F. Satler. Augusto D. Pichard. 
Kenneth M. Kent. Ya Chien Chuang, Michael B. KeUer. Martin B. leon. 
Washington Hospital Center. Washington. D.C. 
New device angioplasty has been associated with improved lumen diameters 
compared with balloon PTCA. To defme the mechanism of benefit on finaI lumen 
diameters. we analyzed the cineangiograms of 1186 lesions after new device 
angioplasty (directional [DCA] and rotational [ROTO] atherectomy. intracoronary 
stenling [STENT] and excimer laser angioplasty [ElCA]). Adverse lesion 
characteristics included calcification (53%). eccentricity (66%) and angulation 
(25%). Acute gain was defIned as fmallumen diameter (MLD) • pre MLD. In 884 
(76%) lesions. adjunct balloon PTCA was performed: % lesion stretch = [(mean 
diameter of the largest adjunct balloon - preMLD)/reference diameter] x 100; % 
recoil = [(mean diameter of the largest adjunct balloon· postMLD)/reference 
diameter] x 100. 
DCA ROTa 
N=265 N=728 
Final % Stenosis 14±15t 24±14 
Final MLD (mm) 2.5±0.6 1.8±O.4 
Acute Gain (mm) 1.6±O.6t U±0.5 
% Adjunct PTCA 44 85 
% Stretch 81±21 76±22 
% Recoil 18+16t 24+15 

















Acute gain was indirectly related to recoil (R = 0.374: p < 0.001). Independent 
predictors of acute gain included DCA and STENT (R = 0.399. P < 0.001). total 
occlusion (dR = 0.041. p < 0.001). left coronary artery (dR = 0.013. P < 0.001). 
angulation < 45° (dR = 0.006. p < 0.01) and thrombus (dR = 0.004. P < 0.05). 
Independent predictors of lower recoil included DCA and STENT (R = 0.208. P < 
0.001). calcification (dR = 0.051. P < 0.005). and eccentricity (dR = 0.027. P < 
0.0 I). We conclude that in complex lesion subsets (1) DCA and STENT 
(compared with ROTa and ELCA) result in greater final MLD and acute gain and 
lower final % stenosis. (2) DCA and STENT exert their beneficial effect on lumen 
dimensions in part by reducing elastic recoil. and (3) acute gain and recoil after 
ROTa and ELCA may be similar to that historically demonstrated after balloon 
PTCA in less complex lesions. 
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904·13 
Magnetic Rc!ommce Flow Mapping in Aortic Coarctation: 
A new Techniques aDd A new Concept 
Raad H Mohiaddin, Philip J Kilner, Simon Rees, Donald B Longmore. 
Royal Brompton National Heart & Lung Hospital, London UK 
A non·invasive method of assessing the haemodynamic significance of 
aortic coarctation is highly desirable. We have used magnetic 
resonance (MR) imaging with cine velocity mapping to compare curves 
of volume flow in the ascending and descending thoracic aorta in 
thirty·nine patients with coarctation and in tweleve healthy volunteers. 
In each, we displayed aortic anatomy and measured volume flow at 16 
stages through the cardiac cycle in a plane transecting the ascending 
aorta and the descending thoracic aorta about 5·1Omm distal to the 
coarctation. Peak velocity was measured in the plane of the 
coarctation jet and compared with that measured by Doppler 
echocardiograpby. Whereas cardiac output and the flow curves in the 
ascending aorta of patients and healthy controls were not significantly 
different, the following parameters related to flow in the descending 
aorta did show significant differences between the two groups: peak 
volume flow, which in patients was 10.6±5.3 Vmin (mean±SD) and 
in controls was 19.6±4.7 Vmin (P< 0.(01), time-averaged flow, which 
in patients was 2.5 ±0.9 Vmin and in controls was 3.9± 1.1 Vmin (P < 
0.05) and the descending/ascending aortic flow ratio, which in patients 
was 0.47±0.19 and in controls was 0.64±0.08 (P< 0.05). These 
parameters correlate well with the severity of aortic narrowing. MR 
peak jet velocity is comparable with that measured by Doppler 
echocardiograpby (r=O.96). These differences are most likely related 
to resistance to flow imposed by the coarctation, and could represent 





Non-Atherosclerotic Coronary Artery Disease 
and Sudden Death in the Young. 
Domenico Corrado, Gaetano Thiene, Patrizia 
Cocco, Carla Frescura. University of Padua, 
Italy. 
Postmortem study was conducted in 144 
consecutive victims of sudden cardiovascular 
death (SO) in youth (~35 years). Coronary 
artery disease (CAD) was found in 54 cases, 
18 of which (33.3%) were non-atherosclerotic 
in nature. 
Congenital coronary artery anomalies were 
present in 13 pts: deep intramyocardial 
course in 6, origin from the wrong S1nus in 
4, and ostial valve-like obstruction in 3. SO 
was the first manifestation of the disease in 
8, while the remaining 5 pts had a history of 
palpitationsand/or syncope with ECG 
recording of ventricular arrhythmias; none 
had reported angina pectoris. SO was related 
to physical exercise in 6 cases. Stress 
testing, available in 2 pts, failed to show 
any effort dependent ST-T abnormalities. 
Acquired, non-atherosclerotic CAD was found 
in 5 pts and consisted of spontaneous coro•
nary dissection in 3, and coronaritis in 2. 
In conclusion: 1) one third of juvenile 
coronary SO were non-atherosclerotic in 
nature; 2) congenital coronary artery 
anomalies were the most prevalent form; 3) 
despite absence of overt ischemic symptoms 
and Signs, these anomalies should be 
suspected in young patients with ventricular 
arrhythmias. 
904-15 
Detection and Quantification of the Cardiac Severity of 
Hereditary Fatty Acid Oxidation Deficiency by Positron 
e.ission TOIOgraphy 
Daniel P. Kelly, Nancy J. Mendelsohn, Burton E. Sobel, 
Steven R. Bergmann 
Washington University, St. Louis, MO 
Genetic defects in fatty acid oxidation are manifest by 
variable phenotypic expression of cardiomyopathy and 
sometimes sudden cardiac death. Unfortunately, 
convent i ona 1 assays of plasma enzyme act i v i ties do not 
define the extent of cardiac involvement. Accordingly, to 
define phenotypic expression of long-chain acyl-CoA 
dehydrogenase (LCAD) deficiency in myocardium, we 
evaluated 5 LCAD-deficient patients (ages 9-30 yr) and 9 
controls (ages 8-41 yr) by cardiac positr?r. emission 
tomography (PET) with "C-palmitate and C-acetate. 
Clearance (k,) of palmitate from the heart was 
significantly slowed in patients compared with controls 
(.025 t .012 vs .061 t .033 min'" p < .05) consistent 
with decreased long-chain fatty acid oxidation in 
myocardium. The clinical severity of the LCAD syndrome 
correl ated with the magnitude of pro 1 ongat ion of 
clearance. In normal children, the ratio of clearance of 
palmitate to clearance of "C-acetate, a substrate cleared 
from myocardi um in proport i on to the rate of overall 
oxidative metabolism, exceeded that in adults (k, 
palmitate/k, acetate· .95 t .07 vs .62 t .07, p < .01). 
The age-dependent differences demonstrated in the 
fractional contribution of fatty acid oxidation to overall 
oxidative metabolism in the heart may explain the relative 
predominance of cardiac manifestations of LeAD deficiency 
early in life. Our results indicate that cardiac PET can: 
1) detect genetically determined deficiencies in fatty 
acid oxidation; 2) quantify their phenotypic severity; and 
3) delineate age-dependent differences in functional 
consequences of the deficiency in the heart. 
904-16 
JACC Vol. 21, No, 2 
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Pul.onary Artery Rypertenaion Produced by Partial 
LiaatiOD of a Pul-.ry Artery Branch ill Juvenile Doaa 
Vijaya G. Seshadri, Jay S. Chandar, Made1een S. Mas, 
Amelia Escobar, Henry Gelband. Univ. of Miami, Miami, FL 
Significant unilateral pulmonary artery branch (PAB) 
stenosis results in contralateral PA hypertension (PAB). 
While PA pressure (PAP) acutely rises, then normalizes 
after total ligation (TL) of a PAB in the adult, little 
is known about the effect of TL or partial ligation 
(PL), particularly in the young. To study these 
effects, 10 juvenile dogs were subjected to either TL 
(n=5) or 50 percent (%) PL (n=5) of left pulmonary 
artery during pentobarbital anesthesia and mechanical 
ventilation. PAP, aortic pressure (AP) and cardiac 
output (CO), were recorded for 2 hra. 
Results: % 6 in mean and systolic PAP after TL & PL of 





15' - 30' 45' 60'. 90'. 120'. 
13~1.8 22~2.2 29! 4.0 30~5.4. 33~ 5.8. 38~3.6. 
9+4.5 14+2.7 28+12.0 34+9.0 35+10.0 38+8.0 
9+6.3 9+6.3 13+ 2.7 8+2.2 4+ 3.1 5+3.1 
15~6.7 12~6.7 21~ 4.5 10~6.3 11~ 6.7 14~3.5 
PL resulted in a significant rise in mean and systoliC 
PAP by 60' (p < 0.03) which was sustained at 120' (p < 
0.02), TL resulted in no significant 6 as reported in 
the adult. CO, AP and diastolic PAP remained unchanged 
in both groups. We conclude that in juvenile dogs, 1) 
PL of a PAB results in PAB that is acutely sustained, 2) 
TL produced no such effect. This suggests that in the 
pediatric age group a partially occluded PAB is of 
greater significance than total occlusion. The possible 
mechanism responsible for PAH, whether local 
intrapulmonary neural reflex or sustained humoral 
response, requires further investigation in the acute 
and chronic state. 
904-17 
Cardiac Abnormalities in Sudden Unexpected Death in the Young 
Julia Steinberger, Russell V. Lucas Jr, Jesse E. Edwards, 
Jack L. Titus. United Hospital, SL Paul, MN, and the University of 
Minnesota, Minneapolis, MN 
The heartS of 70 patients less than 21 years of age who suffered 
sudden unexpected death were reviewed. The cardiac findings in the 
70 patients were compared to those in 68 age matched controls who 
did not die suddenly but who had known cardiac disease (60 
ventricular septal defect, 8 myocarditis). Both study and control 
patients were divided into those less than age 1 year and age 1 - 21 
years. Cardiac abnormalities were present in 13 (65%) of 20 patients 
less than 1 year of age (group 1) and in 40 (80%) of 50 patients ages 1 
- 21 years (group 2). The abnormalities differed between the 2 groups 
(Table). 
Sudden Unexpected Death 0-1 yrs (20 PIS) 1-21 yrs (50 pts) 
Coronary Anerial Anomaly 10(50%) 12(24%) 
Ectopic aortic origin 2 4 
Acute angle aortic origin 3 2 
Both of the above 4 6 
Ostial stenosis I 0 
Myocarditis 0 14(28%) 
Hypertrophic cardiomyopathy 1(5%) 6(12%) 
Other cardiac abnormality 2(10%) 8(16%) 
No cardiac abnormality 7(35%) 10(20%) 
In 20 infants « 1 year of age) sudden unexpected death was 
associated with coronary arterial anomalies in 10 (50%); of these 10. 
five had had a preliminary diagnosis of sudden infant death 
syndrome. Conclusions: 1) Sudden unexpected death in the young 
commonly may be related to cardiac abnormalities which differ in 
type between infants and older patients. 2) In infants. coronary arterial 
anomalies were most common. 3) In the age group 1-21 years, the 
most common cardiac abnormalities in order of frequency were 
myocarditis. coronary arterial anomalies, and hypertrophic 
cardiomyopathy. 
JACC Vol. 21, No.2 
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904·18 
Morphology or Bicomrnissura1 Aortic Valve in Children and Adolescents 
Susan M. Jameson, Hilary Morris Simonds, Kathy J. Jenkins, Steven D. Colan, 
Stephen P. Sanders, Children's Hospital, Boston, MA OlliS. 
The morphology of a bicommissural aortic valve (BA V) might 
influence the ,",verity of valve dysfunction and the incidence of coarctation. 
Therefore, we evaluated valve morphology using 2-D echo in 551 patients ages 
Id - 21 yrs (mean 7.3±9.2 yrs) and BSA 0.1 - 2.1 M2 (mean 0.9±0.55 M2) 
with BA V who had not undergone surgical or catheter intervention previously 
and who were examined between 1986 and 1991. The 2-D echos were 
reviewed to determine which commissure was absent or underdeveloped, 
presence of stenosis (> 20 mm Hg) and regurgitation (mild or more) by 
Doppler, and the presence of coarctation. 
Aortic valve disease andlor coarctation was the sole or dominanllesion 
in 450 of the 551 patients. The other 101 patients had another significant 
cardiac lesion and are not considered further. The commissure between the 
right and left coronary leaflets (R-L) was absent or underdeveloped in 293 
patients (65.1 %), between the right and non-coronary leaflets (R-N) in 155 
patients (34.5%) and between the left and non-coronary leaflets (L-N) in 2 
patients (0 4 %) 
R-L R-N L-N p (R-LvsR-N 
Patients 293 155 2 
Stenosis 118 (40%) 110 (71 %) 1 (50%) <0.00001 
Regurgitation 49(17%) 54 (35%) 0 =0.00001 
Coarctation 158 (54%) 16 (10%) 1(50%) <0.00001 
Absence of the R-L commissure was twice as common as absence of 
the R-N commissure while the L-N commissure was almost always present. 
Aortic stenosis and regurgitation were more common with absence of the R-N 
commissure but coarctation was overwhelmingly associated with absence of the 
R-L commissure. 
904·22 
Clinical Profile and Prognosis of Hypertrophic 
Cardiomyopathy in the Pediatric Age Group. 
Salvatore Pipitme,Calogero Carp3rato,Mn-ia A.Iaccrla,Giovmni Giu:!ice, 
Giuseppe Centineo, Velio Sperenjeo .CGpedale Casa del Sole Palenro,I talia. 
Between JInJIII'Y 1978 and Decarber 1932 ~c cardi<ll\YOP8tl"\Y(OC) 
was di~ by means~e=ardi~ m or angiocardi~ in 34 
patiente(pts) ~ ti1an 14 years{y).Of these 18 -..me less tha11 
rrcnths{m).OC of I<:n::wl etiology ,children of diabetic rroti1ers and pte wi·it! 
cardia:: defecte ~sociated with rig)lt or left ventricular ~
-..me excluded.<h a:inissiao, 9 pte -..me syrrptaratic rut aoly 1 had C<XJgf:•
stive heart failure(CllF).Of the raraining e:i.gi1t,5 had noclerate cycrnsis, 
2 had sustained supravmtricular ta:±\ycardia and 1 had angina.Follow-up 
averaged 6.6 y(range: 1m-16y).All pte -..me evaluated clinically and Em 
and echx:ardi~ -..me performed regularly at intervals of 6-12 m 
interval.1Wenty-frur Iu.Jrs Holter rrcni tor'illg was performed ao 4 diffe•
rent occasiaos in 19 pte and 6 pte l.II1derwent repeated ~oc catheteriza•
ti on. to:> pte devclq:ed CllF.Three pte dioo a <n! day old necm.te SOQ1 
after ocin:i.ssiao for intractable CllF and 2 Sl.I<tiJnly a't 4 m and 9 Y later. 
Of the 18 necm.tes,either carplete(:pte) or s:igJifica"1t regressiao(IC\:lB) 
of the ventricular ~ \\W oOOerved within the first 2 years of 
life.Severe ventricular antvtmi~ (l.oIon class 3°-4°)-..me rrostly seen in 
pte older tha110 years (4!5) • 
Ccr1clusiao:the rrortality and CllF for OC are uoccr.m:n in the first year of 
life(2!18).In this age groJp the progoosis is rather bmigl chJe to the 
possible CCIlplete and or S:igJifica1t regressiao of the ventricular ljypeI>•
trqijy oOOerved in WI' series .1herefore,HC seen in the first year of life 
is ramer different fran OC in older age with regprd.to ventricular h,y•
pertrop-(y in term of severity and involverra-tt of the ventricular rrass, 
CllF,sulden death, ventricular arrIlyttrni~ and FEflIiliarity. 
ABSTRACfS 
904·23 
Von Wlllebrand Factor in the Bleeding Diathesis of 
Adult Congenital Heart Disease 
Mary C. Territo. Michael H. Rosove. Joseph K. Pertoff. Joel Mooke. 
UCLA School cA MediCine. Los Angeles. California 
Despite the potential role of a decrease In or loss of large von 
Willebrand muItimefIC forms (LVWMF) in the bleeding diathesis of 
congenital heart dlsease (CHD) especially cyanotic. studies hove 
been few. llmited In scope. and have not considered 3 major 
variables - the pIlMeI'lCe or absence or cyanosis and erythrocytosis. 
the effect of turbulent blood flow. and of pulmonary vascular 
disease (PVD). We focused on these variables in a prospective 
study of the von Willebrand factor in 71 unoperated patients 
recruited from the UCLA Adult Congenital Heart Disease Center 
Registry. Method" Ages ranged from 20 to 71 years (mean 37). 
Hematologic evaluation included analysis of LVWMF (2D 
immunoelectrophoresis) in addition to blood and platelet counts. 
bleeding time. prothrombin time (PT). activated partial 
thromboplastin time (pm. erythropoietin level. ristocetin cofactor 
and von Willebrand antigen levels. Turbulent blood flow was based 
upon echo/Doppler criteria. bIYII.I; Turbulent flow was present in 
16/27 acyanotic and 13/44 cyanotic patients. PVD was present in 
24/44 cyanotic and 5/27 acyanotic patients. There were significant 
reductions in or loss of LVWMF in 44/71 patients (62%). more 
frequently in cyanotic vs. acyanotic (77% vs. 34%. peO.Oll. and with 
turbulent vs. nonturbulent blood flow (70% vs. 46%. p<O.Oll. but 
equally frequent in cyanotic or acyanotic PVD patients (79% vs. 80%. 
p<O.Ol). Two cyanotic patients with reduced LVWMF normalized 
postoperatively. Overt bleeding (skin. gingiva. epistaxis. hemoptysiS. 
g.i.. heavy menses) occurred in 36% of cyanotic patients especially 
those with reduced VS normal LVWMF (20/44 VS 5/27) and higher 
hematocrit and erythropOietin levels. but did not correlate with 
platelet count. bleeding time. PT. PIT. ristocetin cofactor or von 
Willebrand antigen levels. The type of bleeding (except hemoptysis) 
was simiiar to that of inherited von Willebrand disease. Conclysion' 
Our data appreciably extend preliminary evidence that an 
acquired disorder of LVWMF may contribute significantly to 
hemostatiC defects in CHD patients. espeCially cyanotic patients 
with PVD or turbulent blood flow. 
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905·98 
235A 
Improved Assessment of Left Ventricular Volumes and Func•
tion by Contrast Echocardiography 
Herbert Dittmann, Volker Doernberger, Eva Razwan, Ludger 
Seipel; Department of Cardiology, University of Tuebin•
gen, Germany 
Studies have shown that an intravenous injection of soni•
cated albumin (Albunex) improves left ventricular endo•
cardial border definition on echocardiography. In this 
study we hypothesized that Albunex could improve twodi•
mensional echocardiographic assessment of left ventricu•
lar volumes, ejection fraction and regional wall motion. 
In 30 adult patients without shunts apical two and four 
chamber views were performed before, during and immedi•
ately after intravenous injection of Albunex (2 doses of 
9 ml). In comparison to biplane cineangiography echo car•
diographic left ventricular EDV, ESV, EF and regional 
wall motion were determined for beats without and with 
echocontrast opacification. For regional wall motion 
analysis the left ventricle was divided into 9 segments. 
Each segment was classified as hyper-, normo, hypo-, a•
and dyskinetic. The correlations between cineangiography 

























Without echocontrast regional wall motion was correctly 
assessed in 221 of 270 segments (82 %) and with echocon•
trast in 239 segments (89 %, p < 0.03). 
Conclusions: Intravenous injection of Albunex considera•
bly improves echocardiographic assessment of left ventri•




Respiratory Bffects on Variables Measured by 
Diqitized M-mode Bchocardioqraphy. 
Gunnar Norgard, Harald vik-Mo. Dep. of Clinical 
Physiology, Haukeland Hospital, Bergen, Norway. 
To assess possible factors affecting the 
variability of digitized M-mode 
echocardiograms, the influence of respiration 
and the variability due to different beats and 
observers were analyzed in 11 healthy subjects 
and 11 patients with repaired tetralogy of 
Fa1lot. Left ventricular end-diastolic 
dimension (LVEDD) decreased from end-expiration 
to end-inspiration in the healthy subjects, but 
not in the patients. The maximal rate of 
dimension change decreased in both healthy 
subjects and patients from end-expiration to 
end-inspiration (p<0.03). The coefficient of 
variation (CV%) for differences due to 
respiration(resp), beat (3 vs 5), intra-, 
inter- and long-term (one year apart) observer 
variability in the patients are summarized: 
Resp Beat Intra Inter llln;J-term 
EDD 4.0 0.4 1.6 4.3 5.2 
ESD 7.7 1.4 4.9 4.7 8.6 
PFR 15.7 3.4 14.5 9.9 10.8 
PER 16.8 2.6 14.1 10.4 12.0 
FS 8.6 1.7 5.9 8.4 7.7 
Conclusion: To obtain optimal technique for 
analysis of digitized LV M-mode echocardiograms 
in serial patient studies, the number of 
observers should be kept at a minimum and at 
least 3 beats at end-expiration should be used. 
905·100 
Clinical Feasibility of Two Dimensional 
Echocardlographlc Automatic Boundary Detection 
for Evaluation of Left Ventricular Function In 68 
Consecutive Patients 
Alan O. Waggoner, James G. Miller, Julio E. Perez, 
Washington University, St. Louis, MO 
Two dimensional echocardiographic imaging (20) with 
automatic boundary detection (ABO) provides instantaneous 
quantification of left ventricular (LV) function. To define its 
clinical application for visualization of the blood·boundary 
(endocardial) interface of the LV from different views we 
performed standard 20 and ABO with lateral gain 
compensation in 68 nonselected, consecutive patients. From 
each view: short axis (SAX). apical 4 and 2 chamber (C) the 
LV was divided into 6 wall segments. There were 46 patients 
with normal LV wall motion and 22 had wall motion 
abnormalities. The average time required to perform ABO 
was 375 sec (range: 180·780). 
Possible # Yisyalization 
view Patients Segments By 20 By ABO 
SAX 53 (78%) 318 305 (96%) 284 (89%) 
4C 63 (93%) 378 353 (93%) 324 (86%) 
2C 58 (85%) 348 306 (88%) 280 (82%) 
ABO detected LV endocardial/blood borders in a!1 6 
segments in each view in 73%, 72% and 72% concordant 
with adequate 20 imaging. Discrepancies between 20 and 
ABO were usually in the SAX inferior and lateral, 4C lateral 
and 2C anterior segments Thus ABO is clinically applicable, 
with better yield in apical views, does not add excessive time 
for analysis and provides comparable visualization of LV 
segments if acceptable conventional 20 images are 
obtained. 
905·101 
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Three-Di.anslona1 Echocardiography Improves In Vivo 
Quantltatlon of left Ventricular Volume 
Samuel C Siu, Robert A Levine, Song W Xle, Mark 0 
Handschumacher, Arthur E Weyman, Michael H Picard. 
Massachusetts General Hospital, Boston, MA. 
Current 2-dimensiona1 quantitative echocardiographic (20E) 
methods require images from standardized imaging planes 
and calculate LV volume (vol) by assuming LV geometry. 
Three-dimensional echocardiography (JOE) can quantitate LV 
vol without geometric assumptions, yet its incremental 
accuracy in vivo Is unproven. Using a model in which 
instantaneous LV vol can be directly measured, the beating 
LV in 10 dogs was imaged in 10ng- and short-axis planes 
using an automated 30E method which integrates spatial and 
imaging data. LV vol and EF were then calculated by a 
surfacing algorithm that takes advantage of the full 30 
data set. LV vol and EF were also calculated from standard 
20E images using cy1inder-hemie11ipsoid (Bullet) and 
biplane Simpson's methods. Systolic and diastolic images 
were obtained at 84 different vols (4-85 cc) and in 
conditions where LV shape was altered by either coronary 
occlusion or RV vol overload. Correlation coefficient and 
error (A; mean±SO) between calculated and true values (vol 
and EF) were computed. Results: All methods correlated 
well with actual vol (r=0.91- 0.98) and EF (r=0.80- 0.96) 
although JOE had lower SEE and error than 20E methods. 
Volume Ejection Fraction 
ill.Lill. Avo 1 (cc) ill.OO. illW. 
3DE J.6 -0.8±J.6 5.6 -0.3±5.9 
Bullet 9.1 -O.J±9.6 * 7.7 7.7±8.5 * 
Simpson's 7.8 -7.6±8.0 * 6.8 6.8±12.2 * 
* p<O.OOI between each method and JOE 
Conclusions: In the in vivo setting, JOE provides the best 
agreement with actual vol and EF without the need for 
standardized imaging planes or geometric assumptions. 
905·102 
Critical Appraisal 01 EchocardiolJ'llphic Measuremenu 01 Left 
Atrial Size 
Oiane Fatkin, Michael Feneley. 
St. Vincent's Hospital, Sydney, NSW, Australia. 
Methods of measuring left; atrial (LA) size by M-mode (LA·M) and 
20-eehocardiography (2D-E) were compared in 200 patients with 
atrial fibrillation. LA diameters were measured in 3 planes in 20-E 
views: 01-antero-posterior in parasternal long axis (PLA), 02-
mediolaterai in parasternal short axis (PSAl, 03-superoinferior in 
apical 4-chamber (A4C). LA area was estimated by planimetry in 3 
planes: A1·PLA, A2-PSA, A3-A4C. LA volumes were calculated 
using various geometrical models: sphere (41!1'3.(Olt.l)"), ellipse 
(41!1'3·01·02·03/8), cylinder (A2.03), "bullet" (5/6·A2.03), 
biplane area-length (8/311: . A3·A1JD3). Linear regression analysis 
did not indicate any significant influence of LA size, indexed by A2, 
on LA shape, indicated by the ratios 02ID1 (r=0.07) and 03ID1 
(r=0.19), so that geometrical models can be applied validly to assess 
LA volume. Linear regression coefficients (r) between 20·E 
dimensions (y·axis) and LA volume models (x·axis) were: 
SPHERE(01) ELLIPSE CYLINDER BULLET BIPLANE 
LA·M 0.85 0.83 0.82 0.82 0.60 
01 0.96 0.88 0.85 0.85 0.66 
02 0.66 0.87 0.86 0.86 0_62 
03 0.70 0.86 0.86 0.86 0.61 
A1 0.56 0.57 0.56 0.56 0.93 
A2 0.86 0.94 0.97 0.97 0.69 
A3 0.69 0.84 0.83 0.83 0.71 
Correlations with the biplane model were poor. Good correlations 
with the sphere model were obtained only for the single dimension 
used to derive the volume, indicating that the model was poor. All 
LA diameters and LA-M correlated well with LA volume derived from 
the ellipse, cylinder and bullet models, but correlations were best for 
A2, even when not a volume parameter. Thus, although valid, the 
use of complex LA volume algorithms is not necessary: single LA 
dimensions provide a good index of LA size, but A2 is preferable. 
JACC Vol. 21, No.2 
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905·103 
Aortic Valve Replacement with Stentless Porcine Xeno 
grafts : Early Echocardiographic Assessment 
Luigi Meloni, Alessandro Ricchi, Emiliano Cirio, Giorgio 
M. Aru, Valentino Martelli, Donald Ross, Angelo Cherchi. 
Institute of Cardiology and Division of Cardiac Surgery, 
Cagliari, Italy and London, U.K. 
Stentless porcine xenografts (SPX) implanted in aortic 
position have potential hemodynamic advantages compared 
to traditional prostheses. 16 patients (pts), 9 M, 7 F, 
aged 20 to 80 years (mean 57), who underwent aortic valve 
replacement with SPX, were studied with 20 and Doppler 
echocardiography to assess prosthesis hemodynamics. 
Valve size was 21 mm (n=2), 22 mm (n=3), 23 mm (n=l), 24 
mm (n=3), 25 mm (n=4), 26 mm (n=3). A Doppler study was 
performed before hospital discharge in all pts and 8 mon 
ths postoperatively in 10 pts. Peak (PG) and mean gra -
dient (MG), valve area (VA), and valve area index (VAl) 





DISCHARGE(n=16) DISCHARGE(n=lO) FOLLO~P(n=lO) 
17.8 + 6.7 17.3 + 5 16.4 + 9.8 
10.3 +" 4.7 10.3 +" 3.5 9.1 +" 4.8 
1.66 +" 0.5 1.83 +" 0.2 1.73 +" 0.3 
0.56 +" 0.07 0.58 +" 0.07 0.57 +" 0.1 
At discharge mild central aortic regurgitation (AR) was 
detected in 9/16 pts. One pt showed a mild paravalvular 
leak. After 8 months central AR disappeared in 2 pts and 
the paravalvular leak did not change. 
Our study indicates that SPX have satisfactory hemodyna 
mic characteristics. Long term follow-up will be requi -
red to confirm these preliminary findings. 
905·104 
Homografts of the Aortic Valve: Preoperative Sizing and Post•
operative FoUow·up by Two-dimensional Echocardiography. 
Daniel Raphai!~ Jean Rubay, Thomas Marwick, Jean· Louis 
Vanoverschelde, Jacques Cosyns. University of Louvain, Brussels, 
Belgium. 
Accurate preoperative measurement of aortic root size is mandatory 
for appropriate selection of the size of aortic valve homografts. The 
aim of this study was to determine the ability of two-dimensional 
echocardiography (2D echo) to accurately predict aortic root size in 
32 patients (pts) scheduled for aortic valve replacement with an 
homograft. 2D echo measurements were obtained from the left 
parasternal window by use of zoomed cine-loop images. 2D echo 
aortic root size (22.4 ± 3.2 mm) correlated closely with in-vivo 
surgical measurements (24.1 ± 2.9 mm) (r=O.95, p<O.OOI). The 
surgical measurements could be predicted within 1 mm in 26 pts and 
within 2 mm in 6 pts by the equation [anatomic size = (echo size x 
0.84) + 5.3]. The size of the aortic root obtained with 2D echo was 
used to select the size of the homograft (21.5 ± 1.9 mm) and was 
compatible with the in vivo size of the aortic root in each case. 
Postoperative echocardiographic follow-up was obtained in each 
patient. At predischarge, mild centrovalvular aortic regurgitation was 
present in 10 pts (32%). One patient had moderate paravalvular 
leakage, requiring reintervention. With Doppler, peak transvalvular 
pressure difference across the homograft never exceeded 3 a mm Hg 
(\ 8 ± 7 mm Hg) and the calculated homograft area averaged 1. 7 ± 
0.3 cm'. 
Conclusions: Echocardiography allows accurate quantification of 
aortic root size and is presently the best available technique for 
predicting preoperatively homograft size in patients undergoing 
aortic valve replacement. 
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906·24 
High !'.U Mortality in Women: Gender or Age? 
NishaC. ChandrA. WilliamJ. Rogers, A1anJ. Tiefenbl1lllJl, WilliamJ. French, 
Jud M. Gore, for the National Registry of Myocardial Infarction Registry 
Investigators, Baltimore, MO 
To determine whether the high mortality of myocardial infarction (MI) in 
females was a consequence of older age, data from the National Registry of 
Myocardial [nfarction for 65.806 pis were examined. Pis received rtP A or no 
thrombolytic therapy (T.T.) Of 46,527 pis not treated with thrombolytic therapy 
59.9% were male; and substantially more females than males were> 70 yrs 
old. 61.9% vs 39.2% (p < 0.(01). 
Of 19.279 pts treated with rtPA, 73.5% were males. Even in this population, 
females Were more likely to be > 70yrsofage (31.9% vs 16.9%.p < 0.(01). 
The distribution of anterior MI in males and females treated with thrombolytic 
therAPY was sinular (38%). Of all males treated, 72% vs 66% females were 
treated within 0-4 hrs of chest pain onset and in-hospital mortality in these pis 
was 4% vs 7.7% respcctivdy (both p < .(01). In this group. mean age (±SE) 
was 58 ± 0.1 yrs for males vs 63.5 ± 0.2 yrs for females (p < 0.(01). In 
contrast. mortality was higher for both males (5.1 %) and females (10.6%) 
treated> 4 hrs after chest pain onset (all p < 0.05). Mean age in these pis 
was 59 ± 0.2 yrs for males and 64.5 ± 0.3 yrs for females. 
Pecoent in-hospital mortality by age (yrs) and mean age per group is noted 
bdow. 
< 50 50-69 2...1.Q Mean age (Xrs) 
No T.T. male (I) 3.4 8.5 18.8 65.3 ± 0.1 (A) 
No T. T. female (2) 5.7 11.2 21.6 72.0 ± 0.1 (B) 
rtPA male (3) 1.7 3.8 11.4 58.3 ± 0.1 (C) 
rtPA female (4) 2.9 5.8 15.5 63.8 ± 0.2 (0) 
P < .05 for (1) vs (2). (3) vs (4). (I) vs (3), (2) vs (4) for similar ages. 
P S .001 for (A) vs (B), (C) vs (0), (A) vs (C), (B) vs (0). 
These data suggest that in both males and females with MI. mortality increases 
with age and that WOllkn with MI are more likely to be > 70 yrs old. 
Irrespective of treatment however, even for similar age groups females have a 
higher mortality than males from MI. 
906·25 
A Higher Rate of Prior Cardiovascular Disease 
Contributes to the Higher Case Fatality of Women after 
Myocardial Infarction 
Bruno Ridolfo, Konrad D Jamrozik, Michael ST Hobbs, 
Richard W Parsons, Robyn J Broadhurst, Peter L 
Thompson. Department of Public Health, University of 
western Australia and Department of Cardiovascular 
Medicine, Sir Charles Gairdner Hospital, Perth, 
western Australia. 
A higher case fatality in females than males after 
myocardial infarction (MI) is well recognised but 
poorly understood. We studied 3066 patients aged 25-64 
with MI who were admitted to hospital during the Perth 
MONICA Project 1984-1988. Case fatality at 28 days in 
the 2497 males was 12.6% and 23.0% in the 569 females. 
The females were three years older (57 vs 54 years 
p<0.0001). There were more females with a history of 
exertional angina, treated hypertension, cardiac 
failure or diabetes mellitus, and more females on 
cardio-active drugs prior to infarction. Although the 
females had serum enzyme and electrocardiographic 
evidence of less extensive myocardial necrosis, they 
developed a higher frequency of cardiogenic shock, 
cardiac failure, pulmonary oedema, atrial fibrillation 
and ventricular fibrillation. On logistic regression 
the unadjusted odds ratio for 28 day case fatality for 
females vs males was 2.07 (95% CI 1.54-2.60) and 1.97 
(1.35-2.86) when adjusted for age, past history and 
clinical status. 
Conclusion: The higher rate of pre-infarction 
cardiovascular disease is an important reason for poor 
outcome after myocardial infarction in females but 





Comparative Utility Of Immediate Exercise Testing in Men 
and Women Presenting to the Emergency Room With Chest 
Pain 
W.R. Lewis, E.A. Amsterdam. 
University of California, Davis 
Presentation of coronary artery disease can differ in men (M) 
and women (W) and this may lead to gender bias in 
management of patients (pts) presenting to the emergency 
room with chest pain. We have utilized immediate exercise 
treadmill testing (lET) to assess low risk pts hospitalized to 
rule out myocardial infarction. 82 pts (42 M, age 48 yr [37-
69); 40 W, age 51 yr [29-88)) underwent symptom-limited 
lET within 24 hr of admission (median < 1 hr) and before 
creatine kinase and MB data. There were no adverse 
effects with lET. 54 (66%)pts (74% of M, 58% of W) had 
negative lET (heart rate [HR) ~ 85% of age-predicted 
maximum [PM)). 18 (22%) pts (14% of M, 30% of W) had 
non-diagnostic lET (negative but HR <85% of PM). 10 
(12%) pts (12% of M, 13% of W) had positive (pas) lET. 
Further evaluation (angiography or stress scintigraphy) of 
8/10 pts with pas lET revealed 3 true pas (2 M, 1 W, HR on 
lET :s 65% of PM) and 5 false pas (2 M, 3 W, HR ~ 92% 
of PM). Of 55 (65%) pts (29 M, 26 W) with negative or 
non-diagnostic lET followed for 6 mas, 1 W died from 
noncoronary causes. No pt has had a coronary event. 
Thus, equal numbers of M and W received lET and it had 
similar utility in M and W for confirming low clinical risk and 
identifying pts with CAD. lET is useful in both sexes and 
our experience reflects no sex bias in pt selection for lET. 
906·27 
Gender Bias in Management of Myocardial Infarction: 
Prevalence and Relevance to Outcome 
Bruno Ridolfo, Konrad D Jamrozik, Michael ST Hobbs, 
Richard W Parsons, Robyn J Broadhurst, Peter L 
Thompson. Department of Public Health, University of 
Western Australia and Department of Cardiovascular 
Medicine, Sir Charles Gairdner Hospital, Perth, 
Western Australia. 
We examined the patterns of management and possible 
gender bias in 3066 patients, age 25-64, admitted to 
Perth hospitals with myocardial infarction (MI) 
between 1984-1988. More males than females (91.5 vs 
86.6' p<0.005) were admitted to intensive or coronary 
care units, but the difference was not significant 
after adjustment for clinical status. There were more 
males treated with thrombolytic therapy (17.0' vs 
11.8' p<0.005), an odds ratio (OR) on logistiC 
regreSSion analysis of 0.67 (95' eI 0.50-0.90); after 
adjustement for clinical status the OR was 0.31 
(0.18-0.56). There were no differences in coronary 
angiography in hospital (17.4' vs 16.0') nor in 
coronary artery bypass surgery in hospital (3.4' vs 
3.0'). At the time of discharge from hospital there 
were more males than females booked for exercise 
testing (42.6' vs 32.1' p<0.005) and coronary 
angiography (20.3' vs 12.6' p<0.005) but no 
differences in the bookings for coronary surgery (2.7' 
vs 2.7') or angioplasty (2.2' vs 1.1'). After 
correction fo clinical status the differences in 
management did not affect outcome at 28 days. 
ConclUSions: (1) Significantly fewer female patients 
were treated with thrombolytic therapy, (2) The rate 
of coronary revascularization was Similar in males and 
females, (3) The differences in management were not 
sufficient to affect outcome. 
906-28 
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Hypertriglyceridemia: an Independent Predictor for Acute 
Coronary Events and Angiographic Stenosis Progression 
Lijia Chen, Michael Chester, Demos Katritsis, Juan Carlos Kaski. 
Cardiological Sciences Dept, St George's Hospital, London, UK. 
Hypertriglyceridemia is associated with cardiac events and myocardial 
infarction (MI). The association between fasting plasma triglycerides 
and acute coronary events and angiographic new total coronary 
occlusion (TCO) was studied in 165 consecutive male patients (pts) 
with documented coronary artery disease (CAD) (>50% lumen 
diameter reduction in at least 1 vessel). 63 (38%), 67 (41 %), and 35 
(21 %) pts had 1,2, and 3 vessel disease, respectively, and 70 (42%) 
pts had a previous MI. Pts were followed regularly after diagnostic 
coronary angiography and underwent repeat catheterization prior to 
CABG or PTCA within 3 years (lOA±7.0 months) of first 
angiogram. In addition to fasting triglyceride and total cholesterol 
plasma levels we assessed: pts age, the time interval between 
angiograms, history of MI, number of diseased vessels, family 
history, smoking, hypertension and diabetes. Acute coronary events 
(unstable angina or MI) occurred in 37 (22%) pts, of whom 14 (38%) 
developed TCO. "Silent" TCO (without clinical events) was seen in a 
further 9 pts. Univariate analysis showed that mean triglyceride levels 
(mmoVl) were significantly higher in pts with acute events than in 
those without (3.0±2.1 vs 2.0±0.9, p<O.OOI), and in pts with TCO 
than in those without (3.5±2.3 vs 2.0±1.0, p<O.OOl). Mean total 
cholesterol levels (mmoVl) were also higher in pts with TCO than in 
those without (7.0±1.5 vs 6.3±1.2, p=O.03), but were similar in pts 
with and pts without coronary events (6.6±1.5 vs 6A±1.2, p=OA). 
Multiple regression analysis showed that hypertriglyceridemia was the 
only independent predictor for both acute events (p<O.OOl) and TOC 
(p=0.02). In 51 pts, in whom HDL cholesterol was also measured, 
hypertriglyceridemia was also the strongest predictor for acute events 
and TCO (p=O.04 and p=O.06, multivariate analysis). 
Conclusion.This study suggests that in CAD pts 
hypertriglyceridemia is an independent predictor for acute coronary 
events and total coronary occlusion. Our results may explain findings 
of recent epidemiological studies. 
906·29 
Unexplained Gender Differences in Clinical SyllptOM of 
Acute Myocardial Infarction 
Stefan N. Willich, Hannelore Lowel, Michael Lewis, 
Richard Arntz, Frauke Schubert, Rolf Schroder, TRIMM 
Study Group, Klinikum Steglitz, Free University of 
Berlin, Germany 
The clinical symptoms of acute MI were determined in 
1082 consecutive pts (741 male, 61±10 years) of a 
population based study. using a standardized interview 
13±5 days after MI. 
Symptoms 





































The frequency of symptoms was similar In stratified 
subgroups of pts defl ned wi th respect to gender and 
age, smoking, history of diabetes, cardiac medication, 
or prodromal symptoms. MI I oca 11 zatl on was simi 1 ar In 
male and female pts. 
Concl uslon: Female pts with acute MI ex perl enced neck 
and shoul der pain. nausea, vomitl ng, and dyspnea more 
frequently than males. These gender differences in 
clinical symptoms of MI could not be accounted for by 
pts or MI characteristics. 
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906·30 
Evolution of Lp(a), and Apolipoproteins B and A·I after 
Acute Myocardial Infarction 
Man800r Husain, Robert A. Hegele, Philip W. Connelly, 
Paul W. Armstrong, University of Toronto, Toronto, Canada 
Little is known concerning the behaviour of lipoprotein (a) 
[Lp(a)], apolipoprotein [apo] B, and apoA·I in the early hoU1'8 
following acute myocardial infarction [AMI]. We have previously 
found Lp(a), apoB, and apoA·I to be unchanged following unstable 
angina [UA]; however tissue plasminogen activator [tPA] in thia 
population produced a decline in Lp(a) and apoB but ~ in apoA·1. 
Accordingly, we studied these biochemical variables in 19 AMI 
patients who were part of a randomized placebo [pI] (n=7) controlled 
trial oftPA(n=12). Sequential lipoprotein data (mean±SEM, Lp(a) 
in mgldL, apoB and A-I in gIL) after AMI are shown. 
TIME (hIS) 0 12 48 192 
lp(a)-pI 26.S±7.3 29.6±7.S 19.5±5.S· 36.7±7.3· 
Lp(a)-IPA 23.9±2.6 24.3±4.2 20.2±3.S 32.3±4.6 
apeB-pI 1.35±O.19 1.12±O.16 O.S9±O.17 1.35±O.22 
apeB-tPA 1.39±O.12 1.24±O.19 I.OS±O.IS 1.32±O.t4 
apeAI-pI 1.31±O.12 1.1S±O.10 1. 19±O.07 1.10±0.oi 
apoAI·tPA I.S0±0.OS 1.37±O.12 1.41±O.OS 1.28±O.OS· 
•• Different from all other time points by Duncan's Test p.<O.OS 
We conclude that: (1) Lp(a) and apoB levels fall significantly in 
AMI patients but do so in a manner different from that previously 
described in UA. (2) At 192 bra post-AMI, Lp(a) levels rebound 
significantly above baseline. (3) ApoA-I, the main structural protein 
ofHDL, falls significantly at 192 hoU1'8 post·AMI. (4) In contrast to 
UA, the exogenous adminstration oftPAin AMI had no direct effect 
on these apolipoprotein phenomena. 
906·31 
Family History for Myocardial Infarction and Biocbemical 
Markers of Tbrombosis in Patients Witb Acnte Myocardial 
Infarction : a Case-Control Study. 
Licia Iacoviello·, MariaCaria Roncaglioni-, Concetta Amore·, Rosa Maria 
Marfisi·, Antonio Celardo·, Alessandro Nobili", Maria Grazia Franzosi', 
Giorgio Feruglio·, Gianni Tognoni-, Attilio MaseriA, Maria Benedetta Donati·, 
on behalf of G1SSI-EFRJM Investigators. ·Consorzio Mario Negri Sud, Santa 
Maria Imbaro;Mario Negri InsL, Milano, • Clinical Res. InsL, Udine, ACardiol. 
Div., Catholic Univ., Roma , Italy. 
A farnily history of myocardial infarction (Ml) bas been associared with the risk 
of COOlnary bean disease. We studied a series of thrombosis markers in a group 
of patients selected from a cobart of 916 patients affected by MI from the G1SSI-
2 swdy population. A family history of MI was defmed as the presence of at 
least two fIlS! degree relatives affected by MI before 65 years. Following a case•
control swdy, 79 patients with a family history of MI (F+) were matched with 
MI patients with no family history of MI (F-), according to sex, age, time of the 
event and CCU of admission. Blood collection could be performed at I months 
after the acute phase foUowing MI in 16 pairs of such patients (11M, 5 F, 59±8 
yr, means ±SO). Two patients with protein C activity levels below 60 % were 
found in the F+ group. The number of patients with t-PA antigen levels below 
the 25 th percentile of the normal distribution of the value was 7 and I, 
respectively, in the two groups (p<O.02, Fisher's test). In addition, the mean 
levels of t-PA antigen in the F + group were significantly lower than in the F•
group (7.5±4.4 vs 1I.1±3.5 ng/mI, t=·2.6, p<O.02). No difference was found in 
the distribution of fibrinogen, factor VII, factor vm, vWF, protein C, protein S, 
AT m, HC II, PAl-I, Iipoprolein (a) and sulphurated arninoacids. In the F+ 
group, the age was negatively correlated with the number of the relatives affected 
(r=-O.55, p<O.03 Pearson Correlation Coefficient) and Lp(a) was positively 
correlated with PAI-I levels (r=0.50, p<O.05) but negatively with HDL•
cholesterol (r=.{).53, p<O.03), while t-PA was positively correlated with vWF 
(r=O.60, p<O.OI). The application of a case-control stralegy to a progressively 
selected population can aUow the identification of associations between family 
history of MI and abnorma1ities in hemostatic factolS. The genetic determinant 
of protein C deficiencyand/or lower t-PA levels will be further investigated 
swdying the families of patients selected by the above criteria. 
ABSTRACfS 
906·32 
Prognostic Significance of Diabetes Mellitus 
in Patients with Acute Myocardial Infarction. 
IIIIplicatioD8 for Throabolytic Therapy 
Gabriel I. Barbash, Harvey D. White, Michaela 
Madan, Frans Van der Werf, for the 
Investigators of the International rt-PA/STK 
Mortality Trial 
Adverse risk factors and a hypercoagulable 
state may adversely affect the outcome of 
thrombolytic therapy in diabetics. There 
were 883 pts of which 160 received insulin 
and 8172 without diabetes. Diabetics had 
worse baseline profile: they were older (64± 
10 vs. 62±11, p<O.OOOI), had more previous 
infarc- tions (26.6% vs. 18%, p<O.OOI), 
antecedent angina (58% vs. 45%, P < 0.0001), 
and Killip >1 at entry (23% vs. 18%, p< 
0.0001). The rate of strokes were similar in 
non-diabetic and diabetic pts. Hospital and 
6-month mortality were highest among 160 
diabetics on insulin therapy (16.9% and 
23.1%), intermediate in diabetics not on 
insulin therapy (11.8% , 17.8%) and lowest in 
non diabetics (7.5%' 10.7%), p<0.0001. Less 
than 5 yrs diabetes duration was associated 
with similar hospital mortality as in non-dia 
betics. Five yrs and >10 yrs duration were 
associated with a relative mortality risk of 
1.38 and 1.99 respectively. The lowest mor•
tality among diabetics was observed among pts 
allocated to the streptokinase and heparin 
arm as compared to the streptokinase but no 
heparin arm (9.8% vs. 16.1%, p<0.05). Throm•
bolytic therapy reduces mortality and can be 
safely administered in diabetic patients with 
no increased risk of stroke or bleeding. 
906·33 
Do Patients with Dlabet.. MaUHu. Differ From Nondiabetic 
Patlants with Prolonged Myocardial Ischemia? 
Jay C. Koons, Quinton H. Dickerson, Edwin L Bradley, and William 
J. Rogers, Alabama Registry of Myocardial Ischemia Investigators, 
University of Alabama Medical Center, Birmingham, Alabama. 
Diabetes mellitus is a common predisposing risk factor for 
myocardial ischemia, yet few reports have studied the outcome of 
diabetics with acute myocardial ischemia. To assess differences in 
the presentation, management and outcome of diabetics with 
prolonged ischemic chest pain, data from 1012 pts admitted to 
CCU's with 2 30 min chest pain during 1990-1992 were analyzed. 
Of the 1012 pts, 222 were diabetic (22%). Diabetics were older (64 
versus 60 yrs.) , more often female (51% vs 29%) and more 
frequently black (25% vs 11%) (p< .00(1). Diabetics more often had 
prior angina (66% vs 50%), prior MI (39% vs 29%), CHF (18% vs B%) 
stroke (10% vs 4%), peripheral vascular disease (17% vs 7%), 
hypertension (73% vs 43%), and renal disease (9% vs 5%) (p<.05). 
Diabetics had a greater incidence of pulmonary edema (10% vs 2%), 
sinus tachycardia (22% vs 11%) and thrombolytic exclusion criteria 
(p<.005); but similar rates of CPK -confirmed MI and ST elevation 
as non-diabetics, (59% vs 62% and 52% vs 53%, respectively). 
However, diabetics less often received thrombolytic therapy (21% vs 
32%), and PTCA (19% vs 25%); but had a greater likelihood of 
recurrent myocardial ischemia (23% vs 17%), CHF (22% vs 10%) 
and death (10% vs 6%) (p<.05). Differences in the frequency of 
receiving thrombolytic therapy or PTCA, and having CHF, death or 
recurrent ischemia were not present in multivariate analysis. 
Thus, in this registry of prolonged ischemic pain, diabetics 
reported more risk factors for adverse outcome, and were more 
acutely ill on presentation. These differences likely accounted for 
diabetics receiving less PTCA or thrombolytic therapy, and having 
a higher incidence of death, CHF and recurrent ischemia. 
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907·50 
Mitral Valve Repair Versus Replacement in 
Children With Rheumatic Heart Disease. 
Charles A. Dietl, Alberto R. Torres, Rene G. 
Favaloro. 
Geisinger Medical Center, Danville, PA (USA), 
and Hospital Guemes, Buenos Aires (Argentina). 
Between September 1980 and August 1988, a 
total of 52 patients (pts), aged 8 to 17 years 
(mean 13.8 years), underwent surgery for se•
vere mitral stenosis and/or regurgitation, of 
rheumatic etiology. Three groups are consi•
dered: group A, 17 pts who had mitral commis•
surotomy; group B, 18 pts who underwent mitral 
valve repair; group C, 17 pts who required 
mitral valve replacement (MVR). Concomitant 
aortic valve replacement (AVR) was done in 8 
pts (1,2 and 5 in groups A,B,C respectively). 
A DeVega tricuspid annuloplasty (TA) was also 
performed in 10 pts (3, 2 and 5 in groups A,B, 
C respectively). The average preoperative NYHA 
functional class (FC) was 3.1, 3.0 and 3.4, in 
groups A,B,C, respectively. There was only 1 
early death, in a pt in group C. Follow-up 
ranged from 36 to 132 months (mean 79.0 m.). 
There were no late deaths in any group. Seven 
pts required reoperation (MVR) between 3 and 7 
years (average 4.3 years) after the initial 
surgery: 2 in group A for restenosis, 4 in 
group B for recurrent insufficiency, and 1 in 
group C for endocarditis. The average post•
operative FC was 1.4, 1.9 and 1.4 for groups 
A,B,C, respectively. In summary, mitral valve 
surgery in children with rheumatic heart di•
sease is very rewarding, even if valve 
replacement is required. 
907·51 
Natural History of Mitral Valve Prolap.e. Alfredo 
Zuppiroli, Michael Rinaldi, Randi Kramer·Fox, Silvia 
Favilli, Mary J. Roman, Richard R. Devereux. Cornell 
Medical Center, New York, N.Y. 
To assess the rate of complications and predictors of 
them in patients (pts) with mitral valve prolapse (MVP) 
we followed 303 subjects with echocardiographic MVP 
enrolled in a prospective study of MVP that began in 
1979 for a mean of 101 months. The subjects' ages were 
42±lS years; 214 of 303 (7lt) were women; 217 (72t) had 
clinically recognized MVP and 86 (28t) were detected in 
family studies. During the period of follow·up, 11 pts 
(0.4/100 subject years) required mitral valve surgery, 6 
suffered cardiac death (0.2/100 subject·years), 7 
developed neurologic ischemia (0.3/100 subject-years) 
and 2 (0.1/100 subject-years) developed infective 
endocarditis. The overall rate of fatal and non-fatal 
complications (1/100 patient-years) varied significantly 
in relation to demographic variables, being higher in 
men than women (odds ratio [OR]-2.9, p<0.02), in 
subjects >4S than ~4S (OR-4.3, p-0.002) , in clinically•
recognized patients than affected family members 
(OR-4.5, p-o.03) and in the IS with than in the 288 
without a holosystolic murmur (OR-ll.3. p-o.0002) and 
lower in those with an audible midsystolic click 
(OR-o.20, p<0.002). These results indicate that the 
risk of morbid and mortal complications of MVP a) is 
lower than previously suggested (2t/year or 2%/year or 
higher in other series); b) is higher in men, older pts 
and pts with holosystolic murmurs; and c) may be only 
about one-quarter as high in unselected individuals with 
MVP (approximated by our family members) as in MVP pts 
referred to university hospitals. 
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907·52 
Altered PulI1101111J'y VeaOUl Flow iD PatieD" Wltll Mitral Regurptatloa is 
Pressure Related and IndepeDdeDt IJI Regurgitant Jet DirectioL 
Michel A. Galjee. Albert C. van Rossum, Ouo Kamp, Frans C. Visser. Free 
University Hospital. AmsIenIam. The Netbcrlands. 
Pulmonary venous flow (PVF) measured in the left upper puInloIwy vein by 
transesophageal echocardiography (TEE) is altered in pis with mitral regurgilali-
011 (MR.). It remains questionable whether altered PVF correIaIes with left aIriaI 
pressure and whether left upper PVF is representalive, irrespective of the direc•
tion of the regurgitant jet. Magnetic resonance velocity mapping (MR. VM) can 
detennine the jet direction and quantify phasic velocity in each of the pulmonary 
veins. Hence. TEE and MRVM was done in 31 pis with MR, of whom 17 
underwent cardiac cathelerizalioo. In 14 pis with severe MR, graded by ventticu•
lognphy and echocardiography, reversed endsystoli<: PVF by TEE was measu•
red. In 12 pis this was confllDled in right and left pulmonary veins by MRVM 
irrespective of the regurgitant jet direction. In 2 pis revellied endsytslOlic PVF 
was only measured in one of the pulmonaJy veins. In the 17 pis with moderate 
MR. revened flow did DOl occur. Endsystolic PVF (y) measured by MRVM was 
invenely COITCIaIed with mean wedge pressure and the V·wave, y=30-1.9x (r=-
0.83) IDII Y"24-I.3x (~.72) n:spcctivcly (:ICC fillft I and 2). 
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COKIuIoa: The endsysIoIic PVF com:IaIes highly willi left atrial pressure. 
ReVCllied PVF is indicative of severe MR. PVF measured in the left upper 
pulmonary vein is in 94% of the cases representalivc of the flow paItem in all 
pulmonary veins. 
907-53 
Counterflowing Wall Jets are Relatively Longer than 
Central Jets .. Implications for Regurgitant Jets Opposed 
by Atrial Inflow: In Vitro Studies 
Randall Y. Grimes, Peter G. Walker, Joanne Hopmeyer, Ajit P. 
Y oganathan, Robert A. Levine, Georgia Institute of Technology, 
Atlanta,GA and Mass. General Hospital, Boston, MA 
Jet size remains the clinical Doppler standard of regurgitant severity 
assessment. This assessment has recently been modified to recognize 
the fact that jets adhering to chamber walls are smaller than free jets in 
views perpendicular to those walls. It is unknown, whether the kIWIl 
of wall jets is curtailed by momentum losses relative to comparable free 
jets. Since length is physiologically determined, in part. by the balance 
of jet now and opposing atrial intlow (countertlow), the interaction of 
counternow on wall vs free jets was simulated jn vitro. Methods: 
Steady jet tlows of I to 6 mls were driven through circular orifices of 
1.6 - 3.2 mm in diameter into a 5 cm diameter cylindrical chamber 
containing countertlows of 10 to 32 cmls. Jets of constant momentum 
(t1ow rate x velocity) were sequentially exposed to countert1ows of 
increasing momentum. Jet penetration length was measured by 
t1uorescent dye visualization in 10 videoframes to average out turbulent 
tluctuations. Results: Jet length (L-cm) varied directly with the ratio 
of jet to countert1ow momentum (X=Mj/Mc), but wall jets were 
unjformly lont;er than central jets of the same momentum in 
coyntertlow yp to 40'k for jets of hit:h momentum Me I I 
For wall jets Lw = 10 + 5.310g(X), r = 0.98, and ~ ~ ~ ~ ~ , , 
for central jets Lc = 7.1 + 4.2Iog(X), r =0.98. 
Conclusion: Wall jets penetrate further into the 
receiving chamber 'than central jets of the same 
momentum: they are opposed by countert1ow on 
only half of their surt'ace and therefore encounter 
less friction than central jets. This may help explain 
why eccentric regurgitant jets have a different 
relationship between jet size and lesion severity and 
are more likely to extend into the pulmonary veins 
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907·54 
Do B-Receptor Blockers (BB) I.prove Exercise Tolerance 
in Patients .ith Tight Mitral Stenosis (MS)? 
Jai Patel, Robin Dyer, Abdul Mitha. University of Natal 
and Wentworth Hospital, Durban, South Africa. 
This study was designed to evaluate objectively the 
effect of 88 on cardiopulmonary exercise performance 
(CPEP) in 19 symptomatic (NYHA class II or III) pts 
(F=16, M=3; mean age = 28 years) with isolated tight MS, 
in sinus rhythm, referred for percutaneous mitral val· 
votomy (PMV). A 88 (acebutalol 400 mg or atenolol 100 
mg daily) or matching placebo (PLA) were given for one 
week each in a randomized, double blind crossover 
fashion. Exercise (EX) to exhaustion on a treadmill 
with real-time gas exchange analysis was performed 6 
times over 4 weeks. CPEP was also performed within one 
week after PMV (MVA increase from O,9~O,2 to l,7~O,3 c~. 
Results: Peak YD. Rest HR Peak HR MY EX-T 
1. 8aseline 17,3~3,3 82~11 171~12 44.!.10 9,l~l,8 
2. PLA 17,8~2,9 78~9 173.!.8 46~13 9,4..:.1,8 
3. 88 15,6~3,l 63~10* 135.!.22* 38~14 8,8.:.1,7 
4. Post PMV 22,9.!.5,l# 76.!.13 165~23 51~15U 12,5~2,l# 
(VO, = 0, consumption, ml/kg; HR = heart rate, 
beats/min; MV = minute ventilation llmin; T = time; min) 
*p<O,05 versus 1 and 2. #p<O,05 versus I, 2 and 3. 
For those pts with peak HR i130/min on 88, baseline 
peak YO, was 17,5~4,O compared to 14,O~3,2 ml/kg on 88. 
Those pts with peak HR ~131/min, the result was 
18,O~2,4 and 17,2.!.2,4 ml/kg (NS). Thus 88 therapy 
had no effect on CPEP or exercise duration; in fact, 
it may produce an adverse effect when there is adequate 
8-blockade. PMV resulted in a significant improvement 
in all parameters of exercise performance. 
907·55 
Effects of pntloacl and aftarload augmentatIOn on mitral regurgitant 
yolume : A clinICal study using Doppler color proximal Isoyeloclty 
surface area method 
Kazuhiro Nishigami, Kazuya Hayasaki, Junichi Yoshikawa. Kiyoshi 
Yoshida. Division of Cardiology. Saiseikai Kumamoto Hospital. Kumamoto 
and department of Cardiology. Kobe General Hospital. Kobe Japan 
Mitral regurgitant volume can be determined by a regurgitant orifICe area. 
rl9lrgilant velocity and regurgitant period. We examined effects of 
preload augmentation by a legs ralsig maneuver (LRM) and afterload 
augmentation by a cold pressor test (CPT) on mitral regurgitant volume 
(RO). mean regurgitant orifice area (m-ROA), mean regurgitant velocity (m•
RV) and regurgitant period (RP) in 10 patients with mitral regurgitation 
using Doppler color proximal Isovelocity surface area (PISA) method. 
RO was calculated as PISA X Isovelocity X RP. PISA is given by: 2Ia'. 
where r is mean systolic aliasing radii calculated from color overfayed M•
mode images. m-ROA was calculated as RO divided by the time velocity 
integral of the regurgitant jet (measured by continous wave Doppler). m•
RV was obtained from continuous wave Doppler and RP obtained from 






















Thus. preload augmentation induces an increase in mitral regurgitant 
volume due to an increase in regurgitant orifice area. while afterload 
augmentation inc:Iuces an increase in mitral regurgitant volume due to an 
increase in both regurgitant orifice area and regurgitant velocity. 
ABSTRACTS 241A 
907·56 
Contrast Enhanced Doppler Echocardiography improves the 
transthoracic Evaluation of Mitral Regurgitation. 
Initial Results of an European Multicenter Study. 
Helen von Bibra. Oeorge Sutherland, Joachim Neudert, Harald Becher 
Petros Nihoyannopoulos, for the Levovist Cardiac Working Oroup. 
Munich FRO, Edinburgh UK, Munich FRO, BOM FRO, London UK. 
The evaluation of mitral regurgitation (MR) by transthoracic Doppler 
echocardiography may be limited.The transpulmonary contrast agent, 
SHU 508A (S), has been shown lO enhance left hean Doppler signals 
after intravenous administration.We tested the clinical role of this 
transpulmonary contrast enhancement technique for the evaluation of MR 
in 31 patients. All patients had Doppler echocardiographic examinations 
in apical and parasternal views before and during the intravenous 
administration of 16 ml S 200 mglml and 10 m1200 or 300 mglml. A 
randomly selected subgroup of patients had an additional transesophagea1 
study (TEE). The video recordings were analyzed by two independent 
observers. 
Contrast enhancement of color Doppler resulted in increased left atrial jet 
area (increase range 100 - 350%) (p<O.OOI). Enhanced jet area compared 
favorably with jet area measured at TEE. Continuous Doppler recordings 
of the MR jet had clear envelopes prior to S in 7/31 patients. In these. 
beat lO beat analysis did not reveal any change of peak velocity due lO 
contrast enhancement In the remaining 24 patients, intravenous S 
improved the Doppler envelope, so that dpldt and peak gradient could be 
calculated with confidence. In pulsed Doppler recordings of the 
pulmonary venous flow from the right superior pulmonary vein, contrast 
enhancement increased the signailO noise ratio and provided quantitative 
analysis in 27 patients. Wavefonns and peak velocities were similar to 
those obtained at TEE. 
Conciusian: SHU 508A achieves imponant enhancement of both spectral 
and color Doppler modalities. Thus it adds diagnostic confidence to the 
evaluation of the valvular defect and cardiac functional response and may 
obviate the need for TEE. 
907·57 
Estimation of the Severity of Mitral Regurgitation Volume from Invasive 
Pressure Measurements Obtained During Cardiac Catheterization: Potential 
for a Nonangiographic Grading Method Studied in an Animal Model with 
Quantifiable Chronic MR 
Dag Teien. Takahiro Shiota. Izumi Yamada. Michael Jones, David J. Sahn. 
Oregon Health Sciences Univ, Portland. OR 
In clinical studies of patients with mitral regurgitation it is often difficult 
to systematically estimate severity. Regurgitant volume (reg voll is 
dependent on several factors: the size of the regurgitant orifice. the 
pressure difference between the left ventricle and left atrium, left atrial 
compliance, left ventricular function and systemic vascular resistance. 
The size of the left atrial v-wave is dependent on the reg vol and left atrial 
compliance. Systolic blood pressure is influenced by the reg vol and the 
systemic resistance. The ratio of v-wave sizei1eft ventricular systolic 
pressure incorporates a number of these parameters. Our aim in this study 
was to investigate tne relationship between this ratio and the volume of 
mitral regurgitation. Six sheep with mitral regurgitation previously created 
by chordal damage were studied. Left atrial and ventricular pressures were 
recorded by manometer tipped catheters. Electromagnetic flow meters 
were positioned on the aorta and at the mitral annulus level and were 
balanced against each other allowing measurements of the reg vol 
directly. Systematic manipulation of preload and afterload resulted in 24 
hemodynamic states available for evaluation. A good correlation between 
the v-wave/LVP ratio and the reg vol was found (r = 0.77, SEE = 4.3 
cclbeatl over a wide range of regurgitant volumes 1.8 to 27.3 cclbeat and 
regurgitant fractions 8 to 54%. The ratio of the v-wave and the left 
ventricular systolic pressure gives a reasonably good estimate of the reg 
vol and is easily determined from invasive catheterization measurements 
wherein it may be complementary to angiographic estimates. An 
advantage compared to angiography is that the method facilitates 
evaluation of reg vol even during exercise. Further, we believe this method 
could be extended so as to be based on pulmonary capillary wedge and 
LV pressure data. 
242A ABSTRACTS 
907·58 
Left Ventricular Shape Deformation and Mitral Valve 
Prolapse in Chronic Pulmonary Hypertension 
Katharine O. Burleson, Daniel G. Blanchard, Howard C. Dittrich. 
University of California, San Diego 
Mitral valve prolapse (MVP) has been described in patients with 
right ventricular pressure or volume overload. The frequency of 
this phenomenon and its relationship to left ventricular shape and 
mitral valve annulus size, as well as its reversibility in chronic 
pulmonary hypertension, are poorly understood. We therefore 
evaluated 51 consecutive patients undergoing surgery for chronic 
pulmonary artery (PA) thromboembolic pulmonary hypertension. 
Echocardiographic features including interventricular septal 
position, as measured by an eccentricity index, and several mitral 
valve annulus dimensions were evaluated. The PA systolic 
pressure for all patients was 82±21 mm Hg (mean±SD) 
preoperatively. Twelve patients (23.5%) had MVP before 
surgery which resolved in 10 postoperatively. In addition, 1 
patient whose pulmonary hypertension improved little, developed 
MVP postoperatively. Those patients with MVP had a greater PA 
pressure preoperatively than those without (88±23 vs 79±21 
mm Hg, NS). The eccentricity index for those patients with MVP 
(1.68±O.2) was greater than for those with no MVP (1.53±O.37) 
but this difference was not significant. No significant differences 
were noted between groups with and without MVP according to all 
mitral annulus dimensions. Postoperatively, eccentricity index 
decreased significantly in both those with and without MVP 
(1.29±O.18 and 1.20±O.15, respectively) as did PA systolic 
pressure (62±22 and 42±13 mm Hg, respectively). The 
frequency of MVP in chronic pulmonary hypertension is high and 
is noted particularly in those patients with the most severe 
pulmonary hypertension. It appears that deformation of the left 
ventricle is associated with MVP and that reduction of pulmonary 




Juvenile Sudden Death in 
Prolapse. 
Domenico Corrado, Gaetano 




of Padua, Italy. 
We studied 144 consecutive cases of sudden 
cardiovascular death (SO) in young people 
(~35 years). SO was attributed to mitral 
valve prolapse (MVP) in 14 (10%), 9 females 
and 5 males, aged 14 to 35 years (mean 22.7). 
Four males had Marfan syndrome. In 11 cases 
SO occurred at rest (2 during pregnancy). MVP 
was diagnosed during life in 5 patients, 3 of 
whom had reported palpitations; ventricular 
arrhythmias were recorded in only 1 case. 
Post-mortem examination revealed elongated, 
thick and "floppy" ballooned mitral valve 
leaflets, with marked myxoid degeneration. 
Cardiomegaly due to mitral regurgitation was 
observed in 5 cases (mild in 3 and moderate 
in 2). MVP in 10 cases (71%) was associated 
with one or more minor histologiC 
abnormalities consisting of: invasive fatty 
replacement of infundibulum, apex or 
posterolateral right ventricular free wall in 
7 cases; left ventricular myocardial disarray 
(without hypertrophy) in 2, lymphocytic 
infiltrates in 1, foetal dispersion of 
specialized atrioventricular junction and 
fasciculo-ventricular Mahaim fibers in 2. In 
conclusion, most MVP young victims were 
asymptomatiC females without mitral 
regurgitation. MVP was frequently associated 
with silent but potentially arrhythmogenic 
histologic substrates. 
907·60 
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Mitral Valve Prolapse and Risk Factors for 
Severe Mitral Regurgitation and Valve Surgery 
Rampaul G. Singh, Roger Capucci, Mary J. Roman, 
Jeffrey S. Borer, Clare Hochreiter, Richard B. 
Devereux. Cornell Medical Center, New York, NY. 
A minority of indiviuals with mitral valve 
prolapse (MVP) develop severe mitral 
regurgitation (MR) and ultimately require 
corrective surgery. To elucidate which MVP 
subjects are at greatest risk for the 
development of severe MR 117 individuals with 
isolated MVP were compared to 54 patients with 
MVP and severe MR. Patients with MVP and 
severe MR were more likely to be male, older, 
overweight, and had higher unmedicated systolic 
and diastolic blood pressures. At baseline, 
patients with MVP and severe MR who underwent 
mitral valve (MV) surgery were older and more 
obese compared to those not requiring surgery. 
Gender and blood pressure did not predict the 
need for surgery once severe MR was present. 
Among patients undergoing surgery for pure, 
severe MR at New York Hospital and in the 
literature, 50% had MVP; of these patients 58% 
were male. Analysis of these data and national 
data from the National Center for Health 
Statistics yielded cumulative likelihoods of MY 
surgery among MYP subjects of 1/37 for men and 
1/93 for women by age 64. In conclusion, 
overweight and higher blood pressure, in 
addition to the previously-defined risk factors 
of male gender and older age, increase the risk 
of severe MR and MV surgery among individuals 
with MVP. Correction of overweight and blood 
pressure elevation may be of value in subjects 
with MVP who have MR or severe valve deformity. 
907·61 
Evaluation of Coronary Flow Reserve in Patients 
with Mitral Valve Prolapse, Positive Exercise 
Test and Normal Coronary Arteries 
CoItu Tenlolouril. Mtchld Kyrlakldel. SpillOi Kuu. Dlmlll'll TouaouliJ, 
CharaJambo. Kuatltlu, Jolm GlaiatOi. Pavio. TOUlouzu. Hlppotratlon 
HOIpital, Athena Uni-aty Medlc:aI ScbooI. AtbenI, Greece. 
We 11Ud1ec112 patlenll (pIJ).4 maJea md 8 femaJea, lCei 3()..46 yean, with 
ecbocardlocraphlcally doc:umenled mitral valve prol&ple (MVP) and cllnlc:aI 
IUlPidon 01 coronary artery dIIeue (CAD) bued on a hlItory 01 chest pain (6 
pll), angina.Jlke paiII (2 pII). a positive exerdle IIIeII EKG (all pll) and a 
focally poIitIve thaiIIum-20111Ie11 perfusion IC8IlIliD& (3 pal who wee Rimed 
for cardI&C catheteriza!l0II and found 10 have normal coronary uterieI. In aD 
pll, coronary now relerve (CFR) wu calculated succes.slvely for the left 
antertcr descendioc (l.AD). left dn:umfIex (LeA). and r\dIl (RCA) coronary 
mertel by !Ile8SIIIiD& the mean now velocity at bueIIne and after maximal 
hyperemia with intt&COrOnary papaverine II.Iinc the subleiealve intraA:oronary 
Doppler catheter. Normal CFR wu ddIned u a ratio 01 mean hyperemic 10 
mean basdlne Dow velocity 35:1 on the buIJ oI@t&oIourlaboratory. AD pII 
(100%) had normal CFR in all three coronary merle. with no slgnlflcanl 
dllferencet amonc the uterieI tested. Mean valuel ±SO 01 CRF were 4.7±O5 
(ranee 3.9-55) for the LAD. 4.6:1:0.4 (ranee 4.1-S.3) Cor the LCA and 45:1:0.4 
(ranee 3.8-S.0) for the RCA. CRF In any « 111_ lItertes did nol dllfer &mD1I& 
patlenll sublets delineated by the pattern « clInic:al manlCeIIa!IoDi. 
In conclusion our findlnp demon.strate that an inadequate regional CRF doeJ 
DOl accounl Cor the clinical manlCeIIa!IODl «CAD and poIitIve exerd.re tesIIln 
pII with MVP and normal coronary arteries. 
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3:00 PM-5:00 PM 
Anaheim Convention Center 
Hall D 
Presentation Hour: 3:00 PM-4:00 PM 
908-80 
A Controlled Trial of Amiodarone vs Metoprolol in Post-Myocardial 
Infarction Patients with Ventricular Ectopic Activity: Three-year 
Follow-up 
F Navarro·Lopez. J Cosin. J Guindo. J Marrugat. A Bayes de Luna 
and the SSSD Investigators. Barcelona. Spain. 
Starting in 1987. a multicenter trial was conducted to examine the 
efficacy of low dose amiodarone to prevent death and sudden death 
in post·MI patients with depressed left ventricular ejection fraction 
(LVEF ~ 45%1 and frequent or complex ventricular arrhythmias 
!.~3 VPD/h. pairs or runsl. Patients with LVEF 20-45 % (Group I. 
n = 3681. were randomized 10 to 90 days after the MI to amiodaro•
ne. 200 mgr/day (n = 1151. to metoprolol. 100·200 mgr/day 
(n = 1301 or to no antiarrhythmic treatment. Patients with L VEF 
< 20% (Group II. n = 261 were randomized to amiodarone or to 
control group. To test the arrhythmia suppression hypothesis 
treatment was monitored by serial Holter studies. 
After three·year follow·up. mortality of patients given amiodarone 
(3.5% .±. 4.2 SEM) was significantly lower than that of patients 
given metoprolol (15.4%.±.3.5. p = 0.007). but was no different from 
controls (7.7.±.2.5). Holter monitoring revealed that amiodarone as 
well as metoprolol induced a significant decline in average heart rate. 
but only amiodarone was associated with a highly significant 
reduction in VPD ( 53·65% arrhythmia suppression after one and 6 
months vs 24·25% under metoprolol and 24·33 % in controls. 
p < 0.000051. suggesting that the more favorable risk/benefit radio 
of amiodarone may be related to its superior antiarrhythmic ability. 
Cox's regression analysis confirmed that suppression of repetitive 
forms and lowering of the heart rate were independent predictors of 
survival (p..; 0.0041. In contrast. the higher mortality of amiodarone 
treated patients of Group II (p = 0.021 rises concern about the safety 
of its use in patients with markedly depressed LV function. 
Conclusion: amiodarone showed a more favorable risk/benefit ratio 
than metoprolol suggesting a beneficial effect on survival. which 
was associated with. significant ventricular arrhythmia supression. 
908-81 
Is '!here a Relatjmship Bebeen Ejectial Fracti.cn and 
M:>rlciziDe tbrta1ity in the 0Ud1ac Arzbyt:hnia ~
sim. Trial (CAST) 
Robert A. Chahine, Joel Morganroth, J. 'Iharas Bigger, 
Jr., Alfred Hallstrom, . for the CAST Investigators, 
University of Miani, Miani, FL. 
M:>ricizine (KlR) liaS coopared to placebo (POO) in post 
myocardial infarction patients (ptsl with ventricular 
ectopy in a 2;.eek blinded titration phase and long 
term. 
tbrtali ty fran Iot)R during the 2-week acute eKposure was 
2.6% (17 of 665 pts) vs 0.5% for PBO (3 of 660 ptsl 
(p<.Ol) , a result contraI)' to the safe and possibly 
l:eneficial trend noted with KlR in CAST r. Analysis of 
KlR mortality in relation to baseline left ventricular 
ejection fraction (EF) shCJloed MJR ITOrtality of 3.7% vs 
0.4% for PBO with Risk Ratio (RR) of 9.1 in pts with EF 
~ .30 conpared to KlR ITOrtality of 1.8% vs 0.5% for PBO 
with RR of 3.7 in pts with EF > .30. In the long term 
study, analysis of the effect of baseline EF on total 
cardiac ITOrtali ty liaS as follows: 
EF No. of Pts. TCM Relative 
KlR POO KlR POO Risk 
< .20 4T 30 13(32%) 3(10%) 3.2 
.20-.29 167 149 26 (16%) 23 (15%) 1.07 
.30-.39 269 290 19 (7%) 21 (7%) 0.98 
.40-.55 104 105 6 (6%) 5 (5%) 1.21 
KlR is associated with a higher cardiac lTOrtality vs 
PBO in pts with EF < .20, rut not in pts with higher EF. 
However, the prooability of the 00served occurring by 
chance is at least p = .12 (Bonferroni correction for 
multiple conparisons). ']:hus, further study is needed to 
confinn any Significant relationship between low EF and 
KlR nortality. Nevertheless, in view of the above noted 
trends, caution should be used, particularly during a•
cute exposure, if KlR is prescribed to pts with low EF. 
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908-82 
Influence of Dipyridamole-Induced Myocardial Ischemia 
on the Result of Programmed Electrical Stimulation in 
Patients With Recurrent Sustained Ventricular Tachy•
cardia 
Carsten J. Brockhoff, Christoph A. Nienaber. Wolfgang Duckeck, 
Joachim Hebe. Karl·Heinz Kuck, Department of Cardiology, 
University Hospital Eppendorf. Hamburg, Germany 
TO determine the influence of myocardial ischemia on the 
inducibility of sustained ventricular tachycardia (VT), 17 Patients 
(16 m, 1 f, age 62±8 years) with angiographically documented 
coronary artery disease and a history of recurrent sustained VT un· 
derwent both dipyridamole (dipy. 0.14 mglkg/min) TI·201 SPECT 
imaging with TI·201 reinjection and programmed right ventricular 
electrostimulation (PES. 1·3 extra-stimuli at a basal cycle length of 
510 msec). PES was repeated under infusion of the same dose of 
dipy to match the conditions at TI·201 SPECT imaging. Inducibility 
was defined as "enhanced", if sustained VT occurred under dipy. 
but not at baseline PES; in all other cases it was considered as 
"not enhanced". 
Results: 











All 3 Patients with enhanced inducibility of sustained VT under 
dipy had evidence of myocardial ischemia. Conversely, 11/14 
Patients without enhanced inducibility had no redistribution of 
TI-201. 
Conclusion: Myocardial ischemia may facilitate the induction of 
sustained VT in patients with coronary artery disease. Thus, the 
sensitivity of PES for the identification of patients at risk for sus•
tained VT is probably increased by simultaneous administration of 
dipyridamole. 
908-83 
Amiodarone Is Not Sare For Advanced Heart Failure Patients Witb A 
History or Torsades De Pointes 
Holly R. Middlekauff, William G. Stevenson, Leslie A. Saxon, UClA 
Medical Center, Los Angeles, CA 
Arniodarone is generally believed to be safe in patients with torsades 
de pointes due to Class I drugs, but safety in advanced heart failure 
patients with torsade de pointe on Class I drugs is unknown. To assess 
amiodarone safety and efficacy in heart failure patients with prior 
torsade de pointes, we detennined incidence of torsade de pointes 
history in 170 advanced heart failure patients (left ventricular ejection 
fraction 20 ± 7%) treated with amiodarone, and compared sudden 
death incidence in those with and without torsade de pointes history. 
RESULTS: Of 170 heart SUDDEN DEATH 
failure patients treated .. 100,,----___ _ 
with amiodarone, 9 (5%) B 80 
~~s~o;r:nd~l: ict~: e 80 
Heart failure patients t 40 
with and without prior ~ 20 P' 0.00\ 
torsade de pointes had 8 00 20 40 80 80 100 120 140 180 
similar left ventricular DAYS 
ejection fractions (20 ± 7% vs 21 ± 6%,p=NS), atrial fibrillation (44% 
vs 27%,p=NS), prior cardiac arrest other than TdP (22% vs 15%, 
p=NS), coronary artery disease (66% vs 53%,p=NS), ACE inhibition 
(33% vs 57%, p=NS) and hemodynamics. Five of 9 torsade de pointes 
patients died suddenly within 5 months. Actuarial sudden death free 
survival on amiodarone was significantly worse in patients with torsade 
de pointes history compared to patients with no torsade de pointes 
history (32% vs 92%, P < 0.001). CONCLUSIONS: In advanced heart 
failure, torsade de pointes from Class I drugs identifies heart failure 
patients at high risk for amiodarone proarrhythmia or inefficacy. 
244A ABSTRACTS 
908·84 
The Effects of Ibutilide Applied to the Epicardium on 
Defibrillation Threshold 
Jonathan J. Langberg, Thomas Underwood, Marsha Gallagher, 
Vinod Labhasetwar and Roben Levy, University of Michigan 
Medical Center, Ann Arbor, MI 
The utility of direct epicardial administration of Ibutilide•
fumarate for reduction of defibrillation threshold (OFf) was 
investigated in 8 open chest dogs. Standard defibrillation 
electrodes (l4cm2) were placed over the right and left ventricles. 
Test shocks were applied in a random sequence to determine 
baseline OFf. A polyurethane sustained-release matrix (1.5 x 1.5 
cm) containing 6 mg Ibutilide was applied to the anterior left 
ventricle. The estimated dose delivered over 2 hrs was 0.025 
mg/kg. There were no changes in heart rate or arterial pressure. 
The energy associated with an 80% pro.bability of sl!ccessful 
defibrillation (OFf 80) decreased from 15 Joules at baseline to 3.9 
joules after epicardial Ibutilide. OFf 90 decreased from> 20 
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Conclusion: Small doses of Ibutilide applied to the epicardium 
cause a 4-fold decrease in OFf. Epicardial administration of this 
potent Class III agent may preserve therapeutic effects and 
minimize potential systemic side effects. 
908·85 
New Clinical Index for Predictl.e Efficacy of Antiarrhythmic Dra. 
Therapy for Ventricular Tachycardias 
Randy A. Lieberman, Jose Ortiz, Lee A. Biblo, Nancy J. Johnson, 
Mark D. Carlson, Albert L. Waldo. Case Western Reserve Univenity, 
Cleveland, OH. 
In 107 consecutive patients (pts) with 200 episodes of induced 
monomorphic ventricular tachycardia (MMVT), we tested the hypo•
thesis that antiarrhythmic drugs (AA) has a different efficacy in pts 
whose inducible MMVT is preceded by ~ 3 initial beats (transitional 
beats) with a different QRS complex morphology (polymorphic [PM] 
VTonset) compared to a non-PMVT onset «3 transitional beats). Pts 
presented with cardiac arrest (N-16), syncope (N=26), sustained 
MMVT (N=52), and symptomatic nonsustained VT (N-IO). Eighty•
eight pts had significant coronary artery disease, 15 had nonischemic 
cardiomyopathy, and 4 had congenital heart disease. Using a standard 
EPS protocol, programmed ventricular stimulation with up to 3 
estrastimuli (ExSt) were introduced from either the right ventricular 
apex or outflow tract. Pts were then tested on serial antiarrhythmic 
drugs. AA were termed effective if MMVT was noninducible (AA+), 
or ineffective if MMVT induced (AA-). 
~ 
Baseline Indices (mean) 
# ExSt 
Coupling interval of last ExSt 
Cycle length of MMVT 

















Of note, serial EPS-guided AA therapy demonstrated a significant 
lack of efficacy with ~ 3 transitional beats (II/58 pts) compared to < 
3 transitional beats (19/44 pts) (p < 0.001). Conclusion; Induced 
MMVT preceded by < 3 PMVT beats suggests a relatively high 
efficacy for EPS-guided antiarrhythmic therapy. 
908·86 
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R8IPOf188 to Sotalol PredIcts the Response to Amlodarone During 
s.rt.1 Drug Testing In Patients With Ufe-threatenlng Ventrlcu .. 
T.chyarrhythmlu and Coronary Artery 01 ..... 
Antoni Martlnez-Rublo, Mohammad Shenaaa, Martin Borggrefe, ThomaI 
Wlchter, Xu Chen and GOnter Breltl'lardt. University Hospltsl of MOllIter, 
MOnIter, Germany 
The long half life and long steady state of Amlodarone (A) hampers It 
VllIues In serial drug testing. The aim of the study was to Investigate If the 
response to Sotalol (S) can predict the response to A as assessed by 
pro(p"ammed ventricular stimulation (PVS) In 32 pts with coronary artery 
d ..... and documented recurrent sustained ventricular tachycardia (VT) 
or fibrillation (VF). PVS was performed using up to three extrastlmull 
during sinus rhythm and drive cycle lengths of 600, 500, 430 and 370 me 
at rI~ ventricular apex and outflow tract 
DurIng control, VT and 'IF were Induced in 30 pts (93.8%) and In 2 pts 
(6.2%), respectively. The Induced VT had a cycle length (CL) of 303.2 .±. 
62.8 InS (mean .±. SO) and the right ventricular effective refractory period 
(ERP) during Sl-$l = 500 InS was 222.5.±. 12.6 rns. After S (160 mg BID 
or TID for at least 5 days), VT remained Inducible In 24 pts (75%) wher_ 
norHUstalned VT was Inducible In 7 (21.9%) of the pts. The mean CL of 
the Induced VT and of the ERP were prolonged to 350.1 .±. 76.1 me and 
256.3 .±. 21.9 rns after S (p<.OOl). Following A, sustained and non•
austaJnec:I VT were Inducible In 2S pts (78.1%) and In 7 pts (21.9%), 
respectively. The mean CL of the Induced VT and of the ERP were 
prolonged to 352.9.±. 84.2 rns and 246.9.±. 18.5 rns) after A (p<.OOl 
compared to baseline study, n.s compared to sotalol). Thus, during PVS, 
concordant results (effective or not effective drug) were observed 
betwa.I S and A In 28 patients (87.5%). We conclude that 1) the effects 
of S and A on the CL of the Induced VT and on the ERP were similar, 2) VT 
suppression by A can be predicted from Its response to S. Using this 
approach, patients who would not respond to A can be detected early, 
and therefore long hospItslizatlon period for loading dose and 
subeequently wash out of amiodarone for other non-pharmacoIog 
Imerventlonl may be avoided. 
908·87 
Influence of Quinidine and Amlodarone on the Rate•
Dependent Shortening of Refractoriness as Measured 
Clinically. 
Agustin Pastor, Angel Arena!, JesUs Almendra!, Jose Ormaetxe, 
Julian Villacastin, Jesus Martinez, Juan L. Delean. Hospital 
General Gregorio Mara116n. Madrid, Spain. 
It is well known that the effective refractory period (ERP) duration 
is rate-dependent. Antiarrythmic drugs can prolong ERP, but recent 
experimental data suggest a 'reverse' rate-dependent effect for 
some of them. To evaluate the clinical expression of these 
phenomena, we studied 25 patients on the baseline (8), on 
quinidine (0, mean serum level: 3.2±1 microgr/ml) and on 
amiodarone (A, mean dose: 16±6 gr, over a mean loading time of 20 
± 8 days). The ERP was measured during right ventricular apical 
stimulation after 8 paced beats at cycle lengths of 600 ms (CL.-
600) and 400 ms (CL.-400). The ERP was longer at CL-600 than 
at CL.-400 (J)<Q.001) on 8, 0 and A. 
ERP at CL-6oo 














%-Shortenlng:Difference between ERP at CL-6oo and at CL-400 
normalized for ERP at CL -600. 
'Yo-Shortening on 8 was smaller than on 0 (p<0.03). No 
statistically significant difference was found betweeen 'Yo•
shortening on 8 and on A (p:NS). 
Conclusions: 1) Neither A nor 0 prevent the rate-dependent 
shortening of ERP. 2) A prolongs ERP duration more than Qat 
faster rates. 3) The physiologic rate-dependent shortening of ERP 
is significantly exaggerated by 0 but not by A. Our clinical data 
are in accordance with experimental data of less 'reverse use•
dependence" effect on the ERP for A than for O. 
JACC Vol. 21, No.2 
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908-88 
Elecuophysiologie Effects or MS-551, A New Class ill Agent: 
Comparison with Sotalol 
Luyi Sen. Guanggen Cui. Yoshihide Sakaguchi. Jonnalagedda S. M. 
Sarma, Bramah N. Singh. VAMCI West LA and UCLA School of 
Medicine. Los Angeles, CA 
MS-SSI (MS) is a new selective blocker of the delayed rectifier K+ 
channel. To elucidate its electrophysiologic effects in rim, the EKG. 
endocardial and epicardial monophasic action potential duration (APD). 
left and right ventricular pressures (L VP and R VP) were measured 
simultaneously in pentobarbital anesthetized open-chest dogs. Complete 
heart block was produced by the injection of 37" formaldehyde into the 
His bundle. Intravenous MS produced prolongation of APD immediately 
after start of infusion reaching plateau at 10 min. MS 1 mg/lcg caused 
73±8" and 28±S" increase in APD .. and QTc at basic cycle length 
(BCL) of 700 msec (n=S, p < 0.01). This effect was 1.9 fold more than 
that at same concentration of sotalol (n=S, p < 0.01). MS significantly 
shifted the dose-response curve for '00 • MS'" 
ventricular ERP prolongation to the 0 ..... 
_ 80 f..-~_I r 
left compared with sotalol. The Ec", J /T j !~T~. J 
was O.S±O.1 and 1.2±0.2 mg/Kg for • 60 j~. 
MS and sotalol, respectively ~.o: ~~'?-~ 
(p<0.0S). At 2 mgllcg sotalol, EAD '~' V/ 
was induced in 2/5 dogs and triggered ~ 20 1 ¢/ 
.. ¢/ 
activity in 115 dogs, but not at 0.5 0 1/IfI!'-~~~~~ 
mgllcg MS which caused same 0 '0 20 " " 50 60 
increment in APD. At 2 mgllcg MS. 
EAD and triggered activity, and 
torsades de pointes were induced by 60 
stimuli at 200 msec CL in every dog, 
which was similar 4 mgllcg sotaJol (4/5 
torsades de pointes, liS sustained VT). 
The idioventricular rate and L VP were 
reduced significantly by sotaJol, not by 
MS. Conclusion: MS is more potent in 
prolonging APD and ERP with a lower 
tendency for pro-arrhythmia. 
Timc:(",,") 
908-89 
Differential Electrophysiologic Actions of Beta-Adrenergic 
Stimulation on Sotalol and Quinidine In Humans 
Philip Sager, Rafique Ahmed, Mahnaz Behboodikhah, Christopher 
Follmer, Clara Pruitt, Bramah Singh. West LA VAMC/UCLA,LA, CA. 
The effects of beta-adrenergic stimulation on the 
electrophysiologic actions of quinidine (OUIN; n = 11)' a Class I 
agent, or sotalol (SOT; n =9), a selective Class III a ent with beta•
blocking activity were examined in 
humans. EPS was performed at drug-free '10 
baseline; during OUIN or SOT Rx; and 
during isoproterenol (lSOP; 35ng/(kg' min)) ~ "" 
infusion while on drug Rx. The::; 
monophasic action potential duration 
(APD), RV ERP, and ORS duration were 
measured during steady state RV pacing. 
ISOP decreased the sinus cycle length C'ICt.E LIJOGTH ( .... ) 
to a greater degree during OUIN Rx (36%; 1--------1 
793 to 506ms, p<.OOl) than during SOT '10 v::: 
(10%; 1058 to 949ms, p<.Ol). During 
OUIN Rx, ISOP reduced the APD and ERP l'lO 
to baseline drug-free values. Despite the : t:::::T' 
I I h ::; ,<0 • significant reduction in sinus cyc e engt > r 
It: •• SOT"'-OL 
during ISOP in pts recieving SOT, ISOP did v 0 'O!/ISOP 
not alter SOT-induced APD and ERP 220 I .p<.05 ~ ~T~~;~ 
prolongation, and both remained 
significantly increased above baseline. 
"'" .,. 
CYCL£ LENGTH (1M) 
ISOP reduced VT cycle length in OUIN pts (360 to 297ms, p< .05) 
but not in SOT pts (329 to 316ms, p = ns). ISOP did not affect 
ORS duration or VERP/APD ratio. 
CONCLUSION: During ISOP, OUIN's effects on refractoriness 
and repolarization were completely nullified without effects on 
conduction and VT rate increased. In contrast, SOT's effects on 
refractoriness, repolarization and VT rate were unaltered. Beta•




Differing Frequency-Dependent Effects of Lidocaine{Lidlo Disapyr3lide(Dis). 
and Aprindine(Apr) on QRS Duration Studied in Patients with IlIIlanted Pa.i. 
UsI". Signal-Averaged ECG 
Jcnt Kook Lee. Chiei Takanaka. TSuYoshi SugiyalU. llauto Haruna. llaltoto 
Nonokawa. TSuYoshi llachii. and Seitaro Yabe. 
~tsu Medical Center. llalalatsu. JIII3II 
It has been eXJ)erilentally delOnstrated that class I ant iarrhytt.lc atenlt 
exIIlbit different kinetic prOPerty with regard to sodil. channel blocki".; Lid 
Is fISt kinetic with predlllinant affinity to inactivated channels. while Dis I. 
slow kinetic with affinity to OPen channels and Apr is slow kinetic vith 
affinity to inactivated channels. The ain of the study are to investigate 
frequency dependent effects of these three agents in vivo and their interactim 
when used in combination. For this purpose QRS duration vas leasured IS .. 
indicator of conduction velocity at various pacing rates in WI lOde. T1It 
signal-averaged ECG vas used for the objective deter.inat ion of QRS CCIIPlex. 
Single adiinistratjm: 
Rate (PPI1) 70 
Lid (1l119/kg) 0.7±2.1 
Dis (1l1!1/kg) 9.2±5.6 






















SloW of Dis & Lid 9.516.5 11.5±8.0 9.9±10.5 13.3±10.2 14.8±11.4 15.9113.7 
Dis+L id 6.5±3.30 7.616.1 8.6±5.8 10.316.7 12.8±7.4 15.4±12.7 
SloW of Apr & Lid 14.0±5.9 16.916.6 16.618.5 19.4±10.1 21.0±9.1 25.0±19.6 
AIIr+Lid 9.6±3.4* 12.4±5.3H13.616.2 14.816.1. 17.1±5.0 2O.7±16.Dtt 
Values are S increase in QRS dura! ion frill the predrug control at the ,. 
paci". rate. SUI indicates algebraic addition of S increase in QRS duration 
dll'i". the single treatlilent of each drug. (lean±S.D.; n=7 for rate 170. n=11 
for others; • p<O.05 ... P(O.01 cOIIIared to algebraic SloW) 
~: 1) Lid increased QRS durat ion at rates lIOI'e than 130pPl. 2) Dis 
produced IIlIlOtonouS increase in QRS duration. 3) Apr increased QRS duration in 
the frequency dependent fashion frill lover rate. 4) Effects of cai>ined 
adlinistration of Lid tended to be additive vith Dis and reductive vith A/It. 
The. findings are in line vith reported eXJ)erilliental observations. 
908-91 
Changes in Ventricular Excitability During Pharmacological Unloading 
of the Failing Heart: Contrasting EHects of Nltroprusaide and Captopril. 
Yaver Bashir, James F Sneddon, Spencer C Heald, Jaswinder S Gill, 
Guy A Haywood, A John Camm. St George's Hospital, London, U.K. 
Patients with Impaired LV function are susceptible to ventricular arrhythmias 
and sudden death. During long-term therapy cK cardiac failure, ACE 
Inhibitors have been shown to reduce the Incidence 01 sudden death 
compared to direct vasodilators: however, the effects cK these agents on the 
electrophysiology of the failing heart are unknown. We compared the 
changes in cardiac excitability produced by sodium nitroprusside (SNP) and 
captopril (CAPT) In 8 pts with impaired LV function (EF < 0.40) in a 
randomized crossover study with a 48-72 hrs washout period. A Franz 
combination catheter was used to record a monophasic action potential 
(MAP) signal from the Interventricular septum during constant atrial pacing: 
local refractoriness and latency were determined by a single extrastimulus 
technique. SNP or CAPT were administered Intravenously w~h dose•
adjustment to achieve a stable reduction In peak systolic pressures 01 
approximately 15%. Steady-state electrophysiologlc measurements were 
made before and after pharmacological unloading. Results are given as 
mean (SEM) change from baseline w~h corresponding p value:-


























Conclusion: Despite producing equivalent reductions In loading, CAPT 
prolonged whereas SNP shortened ventricular refractoriness (p < 0.01. 
CAPT vs SNP). Ne~her drug altered latency. This difference may reflect a 
complex Interplay of mechanoeiectric, neuro-hormonal and direct 
electro physiologic effects. 
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909-1 
Ventricular Dilatation Decreases the Antiarrhytlunic Effects of 
d-Sotalol in Reentry Ventricular Tachycardia 
Miclael l. Reiter. Zoltan Zetelaki. Lucas Boersma. CbarI .. l.H. Kirchoff. and 
Maurits A. A1lessie. University of Colorado Health Sciences Center. Denver, 
Colorado and University of Limburg. Maastricht, The Netherlands. 
Antiarrhythmic therapy of ventricular tachycardia (V1) is associated with 
decreased efficacy and increased proarrhythmia in patients with congestive heart 
failure (CHF). We hypothesized that the reduced efficacy of antiarrhythmic 
agents in CHF could be due to the electrophysiologic effects of ventricular 
dilatation. We examined, in a model of reentry VT. the influence of ventricular 
dilatation 00 VT cycle length (CL) and excitable gap (EG) during treatment with 
d-Sotalol (d-S). 
Methods: Thin epicardial layers of anisotropic myocardium were created in 
Langendorff perfused rabbit left ventricles (LV) by a cryoprocedure. A fluid•
filled. latex balloon was secured within the LV in order to dilate the LV (by 
adding 1.25 mI). Sustained reentrant VT. around a central cryolesion. was 
induced by rapid pacing in all preparations (n = 7). Epicardial mapping of VT 
was performed using 248 electrodes. Single premature beats (4 x threshold). 
introduced at 4 sites within the reentry circuit. were used to define EG (EG = 
VT CL - effective refractory period). 
Control d-Sotalol (10 mgIL) 
VT CL (ms) EG (ms) VT CL (ms) EG (ms) 
SV 190.±.14 9 I.±.9 197.±.13+ 7S.±.7+ 
+ 1.25 mI 193.±.IS 102.±.9* 200.±.14 92.±.9* 
Abbreviations: SV = starting volume. • indicates p < O.OS compared to SV. 
+ indicates p < O.OS compared to control. 
Results: A 1.25 mI increase in LV volume. because of decreased refractoriness. 
widened EG 12% (range S-29%; p < 0.05). d-S (final concentration 10 mgIL) 
narrowed EG 18% (range 7-29%; p < 0.05) in the undilated LV. The effect of 
d-S was significantly less in the dilated LV. narrowing EG only 9% (p NS). 
Changes in minimum gap within the circuit were proportionally similar. A 
higher level of d-S (20 mg/L) did not further narrow EG in the undilated or 
dilated LV. 
Conclusion: The lack of efficacy of drug treatment for VT in CHF may be due 
to consequences of ventricular dilatation because of both a widening of the initial 
EG and a decrease in the gap narrowing effects of these agents. 
909-2 
Cycle Length Oscillations During Ventricular Tachycardia: 
Assessment of the Effects of Procainamide 
Michael S. Hanna, Robert B. Kleiman, Meir Shinnat, Mark E. 
Josephson. Lawrence H Frame and Robert DePaola. University of 
Pennsylvania School of Medicine, Philadelphia, P A. 
Cycle length oscillations (CLOs) have been described in ex vivo preparations 
of reentrant tachycardias where they have demonstrated nonlinear or chaotic 
dynaJDic:a. CLOs have also been dcscnDed during human ventricular 
tachycardia (V1) particularly in the selling of anti-arrhythmic drug therapy. 
Although these CLOs have hecn attribured to drug effects on refractoriness, 
DO systematic clinical investigationa have been undertaken previously. In 
order to characterize CLOs on a beat to beat basis and to investigate their 
behavior in a clinical setting, we developed a computerized digital 
acquisition system that permits the highly accurate measurement (~.5 ms) 
and recording of large numbers of CLOs. The technique was applied to 6 
patients who had inducible sustained uniform VT both before and after 
procainamide (P) infusion. Measurements wen: made from a local right 
ventricular electrogram at the time of EP study. REsuLTS: Approximately 
45.000 heats of VT wen: anaIyzed. Mean VT cycle length increased from 
308 IDS to 442 IDS (p<O.OI) after P; ERP increased from 225 IDS to 255 IDS 
(p<O.OI). Nonparamctric analysis of variance revealed DO significant 
difference in the magnitude of CLOs after P when compared with control. 
However. serial assessment ofrandomncss by the method ofWaid-Wolfowitz 
was highly significant (p<O.OOOOI). suggesting an ordered, non-random 
structure of CLOs both in controls and after P. AJternans ("period two") 
behavior made up a large component of this structure, such behavior often 
characterizes non-linear systems. In conclusion, 1) CLOs may be precisely 
recorded using a computerized digital acquisition system; 2) P did not 
increasc: the magnitude of CLOs during VT. suggesting its primary effect is 
on conduction velocity. rather than on interval dependent conduction delay; 
3) CLOs during VT demonstrate an ordered, non-random strucrure. This 
methodology may help to characterize the dynamic behavior of tachycardias 
and the mechanisms by which drugs ntodulate this behavior, and may 
provide insights into the higher structure of CLOs. 
909-3 
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Direct Quantification of Apparent Binding Indlce. 
from Quinidine-Induced In VI'Io Conduction Delay In 
Canine Myocardium 
Frank N. Haugland, Susan B. Johnson. Douglas L Packer, Mayo 
Foundation. Rochester. MN. 
Direct characterization of use-dependent drug action in 'Iivo has 
been impeded by the absence of a means of quantifying 
antiarrhythmic drug effect under physiologic conditions. To 
develop a quantitative description of quinidine (aUIN)-induced 
conduction delay (CD) in 'Iivo. canine ventricular activation times 
were examined with an epicardial mapping technique. USing a 
novel approach that equally weights CD recorded at each of 56 
recording sites. normalized aUiN CD (slope of au IN CD vs control 
CD for each electrode) was determined for each pulse of a 12 sec 
train at inter-stimulus intervals (151) ranging from 750 to 300 
ms. With repetitive stimulation, a mono-exponential increase in 
CD was observed. the rates of which were both frequency•
dependent and a linear function of the interpulse recovery 
interval. tr (151 - APD90). Steady state aUIN CD was also 
linearly related to an exponential function of tr and 
interpulserecovery rates. The frequency-dependeht properties of 
OUIN. expressed in terms of CD. were characterized by 
apparent binding and unbinding rates of k. c 6.6±3.5x106M·1S·t. 
la-68±30s·1 for activated. and kr=18±13x103M-1s·1. 
Ir-0.63±0.23s·1 for resting states (ND 8). These in vivo binding 
rates were similar to values previously derived from canifle 
tissue in 'Iitro, although ~ suggests faster au IN unbinding in vivo. 
These findings represent the first complete quantitative 
description of use-dependent aUIN CD in vivo and provide a firm 
basis for characterizing antiarrhythmic drug action under 
physiologic and pathologic conditions in Ihe intact heart. 
909-4 
A Quantitative Analysis of Use-Dependent Conduction 
Delay Applicable to the Setting of Rapid Physiologic 
Heart Rate. 
Frank N. Haugland. Susan B. Johnson. Douglas L. Packer, Mayo 
Foundation. Rochester, MN. 
A direct quantitative assessment of the acquisition of and 
recovery from use-dependent antiarrhythmic drug binding ; n 
V;'IO is potentially limited by rapid underlying heart rates, 
particularly for drugs with long recovery time constants. We 
therefore sought to validate the prediction from a two-state 
binding model of quinidine (OUIN)-channel interaction that 
identical quantitative indices of aUIN binding may be derived 
from changes in use-dependent block produced by either abrupt 
increases or decreases in stimulation rales. aUlN·induced 
conduction delay (aCD) in intact canine myocardium (n-8) was 
examined with a 56 bipolar epicardial electrode mapping 
technique during pulse train stimulation. The change in OCD 
with a decrease in interstimulus interval (151) (1000 to 600, 
450 and 300 ms) or increase in 151 (300 to 600. 750 and 
1000 ms) was an exponential function of pulse number. As 
predicted. the overall drug uptake rates derived by decreaSing 
151 (A') and increasing 151 (RA') were linear functions of the 
interpulse recovery interval. tr A'aAata+Artr and 
RA·=RAata+RArtr. respectively. From this. the activated 
(A •• RA.) and resting (AroRA,) binding rates describing the 
frequency dependent properties of OUiN for both pulse protocols 
were equivalent: Aa-120±50 vs. RAa-98±96, A,-•• 74±.30 vs. 
R).,-.79±.36 sec·1. These experiments suggest pulse protocols 
and analytical methods which could be applied readily to obtain 
similar quantitative information under constraints of increased 
intrinsic heart rates in man. 
JACC Vol. 21, No.2 
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909-5 
Use of a Redialigend Assay for the Class I Drug Receptor to Predict 
Clinical Activity of Drug Metabolite. 
Robert Sheldon, Leslie Wilson, Ela Thakore, Henry Duff, University 
of Calgary, Alberta, Canada 
Class I antiarrhytlvnic drug metabolites may complicate therapy. We 
wished to determine whether a comparison of reported metabolite 
clinical senITI concentrations (SC) and metabolite IC .. from an in 
l!i1m radioligand assay for the drug receptor predicts whether 
metabolites are active clinically. The radioligland was 
[3H[8atrachotoxinin, which binds to sodium channels on freshly 
isolated rat cardiac myocytes. Previously we showed that class I 
drugs bind to the receptor with In (SC)= ·0.58+0.76 In (lC",,). 
Predicted serun concentrations were derived from this equation and 
metabolite IC .. values. 
Probably Inactjve 

















































A ratio of predictedlknown serum concentration < 5 accurately 
identified 515 active metabolites and rejected 616 inactive 
metabolites (p = 0.001). Thus a simple in l!i1m assay predicts the 
clinical activity of class I drug metabolites. 
909-6 
A Mathematical Model Predidli Adenosine's Rate-Dependent 
Efficacy in Experimental A V Reentrant Tachycardia 
Mohsen Nayebpour, Jacques Billette, Farid Amellal, Stanley Nattel. 
University of Montreal, Montreal, Quebec. Canada 
We have shown that adenosine (Ado) modifies the rate-dependent 
properties (RDP) governing the response of the AV node (A VN) to 
changes in heart rate.. causing tachycardia-dependent A V nodal 
depression. The purpose of the present study was to determine whether 
these actions contribute to the suppression of experimental A V reentrant 
tachycardia (A VRT) by Ado. Selective pacing and modelling techniques 
were used to record and quantify A VN RDP (recovery, facilitation, and 
fatigue) in isolated. superfused rabbit heart preparations, and a sensing 
and pacing circuit was used to mimic a retrograde bypass tract and 
produce AVRT. ~: Ado at 2 dose levels (Ado 1, 100 J.lM; Ado 
2. 300 J.lM) increased A VN refractoriness (A VERP) and AH interval. 
Increases in A VERP tend to suppress A VRT. while those in AH make 
AVRT more likely by increasing AVRT cycle length (T). The 
minimum wavelength for reentry divided by pathlength equals 
A VERP/T, and must be < 1 for A VRT to be sustained. Ado increased 
A VERPIT in a dose- and rate-dependent way (Figure). A mathematical 
model (MM) based on Ado 1.1 Ado 1 
effects on RDP accounted well 1.0 / 
for changes in AVERPIT. and 09 -MM 
predicted the ability of Ado to I- 0.8 
suppress AVRT by causing;;: 0.7 
A VERP/T > 1. Ado increased ffi 0.6 
the slope of A VERP/T vs rate ~ 0.5 
(Figure). and its efficacy in 0.4 
suppressing A VRT increased with 0.3 
increased tachycardia rate. 0.2+---,.--.,.---..,....---, 
Conclusion: 1) Ado's rate-depen- 100 150 200 250 300 
dent effects are important in A VRT Tachycardia Rate (beats/min) 
suppression; 2) Ado's efficacy increases with faster A VRT rate; 3) Ado 
effects on the determinants and suppression of A VRT are well•
predicted by the mathematical model. 
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909·7 
Lidocaine Terminates Reentry by Causing Fixed Conduction 
Block Regardless of the Initial Excitable Gap 
Hailing Fel. Dina R. Yazmajian. Christopher J. Damm. Dennis C. Lin. 
Lawrence H. Frame, University ofPennsylvannia, Philadelphia, PA. 
We have reported that d-sotalol, by increasing ERP. could terminate reentry 
but only when the excitable gap was short. We hypothesized that lidocaine 
would terminate reentry by producing fixed conduction block (FCB) due to 
decrease excitability at a vulnerable site regardless of the excitable gap. We 
used 6 adjustable reentry preparations in which the canine atrial tricuspid ring 
is cut and reconnected electrically by sensing activation on one side of the cut 
and pacing the other after an adjustable delay ( Temp.= 34°). A long delay 
results in a long cycle length and excitable gap during reentry. Decreasing the 
delay decreases cycle length and excitable gap, and causes oscillatory 
termination of reentry. We recorded from 10 approximately equidistant 
unipolar electrodes and measured monophasic action potential duration (APD) 
at 90% repolarization at the the major site of variable conduction and block in 
the ring. We used a lidocaine concentration of 3 mg/L in all 6 experiments. In 
all experiments. lidocaine initially terminated reentry by 1) Increasing ERP at 
the site of slowest conduction and 2) increasing cycle length oscillation as the 
reentrant impulse encountered a steeper portion of the conduction curve. 
However In 5 of 6 experiments after a mean of 35 minutes. lidocaine caused 
FCB which prevented reentry at all delays. FCB always occurred at the site of 
slowest conduction during control which was located just anteriorly to the 
septum where the supravalvular lamina is the narrowest. FCB could be 
transiently reversed by a bolus of acetylcholine which suggested cell 
depolarization at the site of FCB. It also resolved with washout of lidocaine. 
In these 5 experiments,lldocaine significantly increased cycle length 15:1:10% 
prior to FCB and 64% of the increase occurred at the site of slowest 
conduction. APD at this site was surprisingly increased 28:1:14 ms (from 
144:1:10 DIS in control). In the one experiment in which drug did not produce 
FCB. lidocaine slightly decteased APD at the site of block. cycle lengths 
increased only 4%-6% and conduction was slowed uniformly around the 
circuit 
Conclusion: Although lidocaine could terminate reentry by increasing 
refractoriness. It usually caused fixed conduction block which prevented all 
reentry regardless of the excitable gap. Fixed conduction block always 
occurred at the same anatomic site. 
909·8 
Antiarrhythmic and Electrophysiological Effects of the 
Class III Agent DoCetilide in a Canine Model of Reentrant 
Arrhythmias 
Thomas Hilhel. Friedrich Knollmann. Thorsten Beyer. 
Cl:lus Schmitt. Johannes Brachmann. 
Dept. of Cardiology. University of Heidelberg. Germany 
Dofetilide(DOF) is a new se1ecti ve class III antiarrhythmic drug. The 
dose-dependent electrophysiological effecL~ of DOF on inducible ven•
tricular tachycardia (VT) were determined by programmed electrical 
stimulation (PES). 15 conscious dogs were studied 4 to 8 days after 
proximal ligation of the LAD. The dogs were studied at different days 
using two cumulative doses of DOF (5 and 10 ~g/kg (n=12) and 20 
and 40 ~g/kg (n=15) i.v. ). respectively. Sustained ventricular 
tachycardias (Sus-VT) were induced during control PES in 53% and 
nonsustained VT (NVn in 13% of the dogs. Antiarrhythmic efficacy 
(AE) was delined as suppression of Sus-VT following administration 
of DOF. Spontam:ous PVBs were more prominent in 5 dogs after 
intravenous administration of 20 and 40~g/kg DOF. 
Results are shown as percentage changes compared to control. *=p < 
n.os control vs DOF. SCL= sinus cycle length. QT300= QT interval 
during atrial pacing at 300ms interval length. ERP330/250= 
ventricular ERP at 330ms/250ms cycle length. AE-Sus-VT = 
suppression of Sus-VT . 
Do~ge SCL 
DOF 5!lg/kg +8% 
DOF 5+ lO!lg/kg +9% 

















The results dt:monstralt: a potent dose-dependent class III action on 
inducihle arrhythmias at higher doses. In dogs dofetilide significantly 
slows heart rate at higher lloses. The incidence of clinical 
proarrhythmic dfect~ remains to he determined. 
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909·9 
Comparison of Class m Agents in a Canine Model of 
Proarrhythmia 
Lewis V. Buchanan, *Glenn G. Kabell, and John K. Gibson, The 
Upjohn Company, Kalamazoo, MI, and '"The University of 
Nebraska Medical Center, Omaha NE. 
Polymorphic ventricular tachycardia is occasionally observed in 
patients following the administration of class ill antiarrhythmic 
agents. We compared the class ill agents sematilide, clofilium, d· 
8Otalol and two new agents under clinical development, ibutilide 
and artilide for proarrhythmic effects in dogs with bradycardia 
following catheter ablation of the AV node, and CXt stimulation with 
5J,Lg1kg1min methoxamine. Although the overall incidence of 
proarrhythmia was similar for each agent, differences in the 
frequency of polymorphic (PVT) and monomorphic ventricular 
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ibutilide artllide sematilide clofilium d-sotalol 
Development of PVT or MVT was associated with significant 
increases in QT interval and right ventricular monophasic action 
potential duration. PVT and MVT could be suppressed by 
overdrive pacing, or magnesium sulfate. PVT but not MVT was 
suppressed by pinacidil. We conclude that under conditions created 
in this study, the agents tested prolong action potential duration 
and have an equal proarrhythmic potential. 
909·10 
Acute Effect of T 3 on Single Inward Rectifier Potassium 
Channel 
Yoshihide Sakaguchi, Luyi Sen. 
V AMC and UCLA School of Medicine, Los Angel .. , CA 
Thyroid hormones are important modulators of cardiac arrhythm, 
However, the effect on cardiac ionic channell II ltill unknown. To 
evaluate the acute effect of T. (3,5,3'-triiode-t.·thyroninel on Inward 
rectifier potassium channel (1.,1, single channel currents were recorded 
in cell-attached patches with 150 mM K+ in the pipette In guinea-pig 
ventricular myocytes. 10" M T. increased channel open probabDity (Pol 
from 77.6±7.7 to 88.2±6.7 % at resting potential (RPI 
(n= 10.p<0.00011 and from 56.4% 13.5 to 78.6±7.6 %.t RP-40mY 
(n = 12.p < 0.00011. The unitary amplitude, time constant of open and 
fast-closed time were not changed. At RP-40 mY, the increment In Po 
was significantly larger than that at RP (p<O.Oll. T. shortened 
duration of interburst from 536 ± 356 to 153 % 65 rnsec (p < 0.OO511/1d 
time constant of slow-closed time from 633%447 to 224% 134 rnsec 
(p<0.011 at RP-40 mV. The burst behavior at RP-40 mY wal not 
changed. SimUar results were obtained at RP. To further elucidate detail 
mechanism, we assumed 3 states model (C,OOC • ..01 and calculated 
each rate constant at RP-40 mV. 
Control 2.84% 1.88 33.2%9.2 






C k", C !. 0 
, k_, 2 a 8
' and C2 moan two cloood __ •• ; p<0.01 
means one open ,tete. 
Conclusion:1) T. enhanced I., with increment In Po, Which mainl, 
resulted from shortening of interburst-duration without change of burst 
behavior, with voltage dependent manner. 21 Shortening of interburst· 
duration is due to acceleration of the transition from C, to C. state. 
909·11 
JACC Vol. 21, No.2 
February 1993:248A 
Early Afterdepolarizations Fonnation: Correlation Between Phase Plane 
Trajectory, Action Potential, and Membrane Currents in Cardiac: 
Myocytes 
Mohamed Boutjdir, Mark Restivo, Yansheng Wei, Nabil EI-Sherif, 
SUNYIHSC and V.A Medical Centers, Brooklyn, NY 
Early afterdepolarizations (EADs) are among the mechanisms proposed to 
cause ventricular arrhythmias. Sea anemone toxin, (A TXII) was used to 
study the formation of EADs in rat ventricular myocytes. Phase plane 
analysis of action potentials (AP) and membrane currents were studied using 
patch clamp techniques. Phase plane was generated by plotting membrane 
potential versus the first temporal derivative of membrane potential (dV Idt). 
Under current clamp conditions, A TXII (40 nM) consistently prolonged AP 
and induced EADs. EADs developed at plateau voltage between -10 mV and 
-40 mY. Ca channel blockers, (verapamil 10 J"M & cobalt 2 mM), and the 
sarcoplasmic reticulum modulator, ryanodine (1 I'M), did not antagonize 
ATXII effects. Tetrodotoxin 0.3 J"M, lidocaine 40 J"M, and rapid stimulation 
shortened AP and suppressed EADs. Under voltage clamp mode, isochronal 
membrane currents tlowing at or later than 100 msec after test pulse were 
analyzed. In presence of ATXII, all the isochronal I-V curves showed an 
inward current carried by Na which was more prominent between -40 m V 
and 0 m V. Phase plane trajectory of the AP obtained with A TXII showed an 
oscillatory behavior corresponding to EAD range of potential. Within this 
range, the isochronal I-V curves were shown to cross the zero current axis. 
A TXII-induced current at 100 msec isochrone, activated at potential negative 
to.{j() mY, peaked around -20 mV and reversed at +40 mY. Isochrone I-V 
curves obtained after lidocaine superfusion resembled those of the control. 
These results suggest that, in this model, neither sarcolemmal L-type Ca 
current nor sarcoplasmic reticulum Ca release play a significant role in the 
EADs genesis. EADs are generated by a voltage-dependent balance between 
a markedly prolonged tirne-dependent Na inward current and outward 
current (s) occurring within the voltage plateau range of the AP rather than 
reactivation of Ca current. 
909·12 
Arrhythmogenic Role of Purkinje Fiber-Papillary 
Muscle Junctional Cells 
Zhen-Yuan Li, Yi-Han Wang, Joel Kupersmith 
Michigan State University, East Lansing, MI 
To examine the role of the Purkinje fiber (PF) -
papillary muscle (PM) Junctional Cells (J) in 
arrhythmogenises we studied 25 canine preparations 
superfused in Tyrode's with ethylenediamine 
tetraacetate (EDTA) (4.5-5.0 mM), known to induce 
early afterdepolarizations and triggered activations 
(TAs). Three Action Potentials (APs) and extra•
cellular electro grams were simultaneously recorded 
in terminal PF, PM and J at a same limited junctional 
site (1-2 mm2) using standard techniques. EDTA 
prolonged AP duration (APD) in PF after which 
secondary plateaus developed only in J at membrane 
potentials of -63.5 + 7.6 mY. TAs arose from these 
secondary plateaus and had earliest recorded 
activations in J. Tetrodotoxin (3-9 x 10-7M) and 
verapamil (10-6M) suppressed TAs. In 6 preparations 
in which J sites were excised, impulses did not 
conduct from PF to PM but impulse arising in PM 
could conduct in a retrograde direction. EDTA•
induced TAs with earliest activation in J that were 
observed prior to excision did not occur afterwards. 
Thus J site is an important site of origin of TAs 
induced by EDTA. Mechanism appears to be via 
electrotonic transmission of current from the longer 
APs in PF causing secondary plateaus and automaticity 
in J. This effect may be facilitated by the known 
high membrane resistance of J. 
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910·92 
Sympathetic Cardiac Dysinnervation in Patients with Rig~t 
Venbicular Outflow Tract Tachycardia and Arrhythmogemc 
Right Venbicular Disease. 
Thomas Wichter, Gerhard Hindricks, Hartmut Lerch*, Peter 
Bartenstein*, Martin Borggrefe, Ottmar Schober* and <;Ji!.nter 
Breithardt. Departments of Cardiology and Nuclear Medicme*, 
University Hospital ofMiinster, Germany. 
In arrhythmogenic right ventricular disease (ARVD), ventri~ar 
tachycardia (VT) induction is often triggered by physI~al exercise, 
mental stress or catecholamine infusion during EP·testtng whereas 
arrhythmia suppression can frequently be achieved by drug regimen 
including anti·adrenergic ag~nts. This indicates a. possible. role of the 
sympathetic nervous system 10 the arrhythmogenesls ofVT 10 ARVD. 
We therefore performed I·123·MIBG·scintigraphy in 25 pts. 
with ARVD and right ventricular outflow tract vr (RVO-VT) 
noninducible by EP·study in order to analyze the presence, extent and 
location of impaired sympathetic cardiac innervation .. MIBG upt~e 
was estimated semiquantitavely using the bull's eye VIew and settmg 
the maximum uptake to 100%. Abnormal I·123·MIBG uptake was 
defined as an uptake of less than 2 SD in a sector when compared to 
the control group. The results were compared with 7 pts. without 
evidence of cardiac disease. Additional Thallium·20 I·SPECr was 
performed in all pts. and excluded perfusion defects which might cause 
false positive results ofI·123·MIGB·scintigraphy. 
In 21 of 25 pts. (84) a localized abnormal reduction uptake of 
I·123·MIBG was demonstrated. In 20 pts. it was located in the basal 
and posteroseptal regions and adjacent posterior. sectors of th~ bull's 
eye view (P<0,01 compared to control) whereas Isolated antenor ~d 
lateral regions of the left ventriclar wall showed abnormal uptake 10 
only I pt.. No focus of enhanced sympathetic activity was observec;t. 
Thus, I· I 23·MIBG·scintigraphy demonstated. regIOnal 
sympathetic dysinnervation of basal posteroseptal myocardium close to 
the RVO in ARVD pts. with RVO-VT. These findings provide new 
insights to the mechanisms of RVO-VT and have implications for the 
diagnostic management and therapeutic considerations. 
910·93 
The Effect of Gating on Perfusion Defect Size and 
Severity Measured by TOIOgraphic I_aging 
Timothy F. Christian, Thomas Behrenbeck, Paul Rogers, 
Raymond J. Gibbons. Mayo Clinic, Rochester, Minnesota 
The purpose of this study was to examine the effect of 
cardiac motion on myocardial perfusion imaging during 
and after acute myocardial infarction. Tc-99m-sestamibi 
was injected in 17 patients (10 anterior, 7 inferior) 
acutely (prior to reperfusion therapy for acute 
myocardial infarction) and in 10 of these patients at 
hospital discharge. Tomographic images were acquired in 
gated (8 images per cycle gated to the R-wave of the 
ECG) and nongated format 1-6 hours after injection, and 
defect size was measured as a percent of the LV from 5 
short axis slices with a 60~ threshold program using 
previously described methods. Defect severity was 
measured as the lowest ratio of minimall maximal counts 
of the 5 slices from the acute image. There was a close 
correlation between gated and ungated defect size 
(acute: r=0.92, final: r=0.94, both p<O.OOOl), but there 
were differences: 
Ungated Gated 
Acute Defect (XLV) 32 ± 16 36 ± 19 
Final Defect (~lV) 10 ± 11 16 ± 13 0.002 
Acute - Final (~LV) 20 t 16 18 t 16 0.03 
Severity 0.32 t 0.13 0.28 ± 0.11 0.05 
Conclusion: 1) ungated imaging underestimates defect 
size and severity compared to gated imaging. This effect 
is the reverse of what would be expected on the basis of 
partial volume effects. 2) Ungated imaging provides 
slightly but significantly larger estimates of the 
change in defect size, or myocardial salvage. 
ABSTRACfS 
910·94 
Natural History or Serial Intrahospital 
Quantitative Planar Tc·99m Sestamibi Imaging 
Following Thrombolytic Therapy for Acute 
Myocardial Infarction 
Frans J. Th. Wackers. Christopher P. Cannon. Michael 
McMahon. Barry L. Zaret and TIMI Invesligalors. Yale 
Univ .• New Haven Cf 
In the course of TIMI 4 and TIMI 5 quantitative planar 
Tc-99m Sestamibi imaging was performed 18-36 hrs after 
thrombolYlic and anti thrombotic therapies for acule 
myocardial infarclion and again at hospilal disch~rge .. 
Thus far. Sestamibi imaging data have been acquired 1D 
188 patients (piS): 114 in TIM! 4. 74. in TIMI 5. D~fect size 
was quantified using circumferential count profiles a.nd 
normal data base. A difference >30% between two studies 
was considered significant based upon previous data . 
Ninety-nine/188 pts (53%) had no change and 71/188 
(38%) had a decrease >30% in defect size. Eighleen/188 
pts (9%) had a > 30% increase in defecl size. fulfilling the 
image criterion for reocclusion/reinfarction. Four ~ts 
with clinical reinfarction had no change on senal 
quantilative Seslamibi imaging. . 
Thus. on serial Sestamibi imaging after thrombolytic 
therapy for acute infarction a conlinuing decrease in 
defect size is seen commonly ( in approximately one•
third of pts), possibly due to recovery of regional wall 
motion after stunning. A clinically silent increase in 
defect size. consistent with reinfarction or reocclusion 
was detected in one-tenth of pts. 
These data suggest that silent late intrahospilal 
reocclusion/ reinfarction may be detected by serial 
Sestamibi imaging. This indicates that. in addilion 10 
early assesment of reperfusion. there is a pOlential role 
for Seslamibi imaging later after thrombolytic therapy. 
910·95 
249A 
Quantitative Detectioo of Right Ventricular Perfusioo 
Defects in Tec:tmeti.uzr99m Sestamibi ~ lD1ages 
Mark I. Travin, Robert D. Malkin, carol E. Garber, Debra 
E. M:!ssinger, Derma J. Cloutier, Gary V. Heller. Roger 
Williams and Memorial Hospitals, Brown University School 
of Medicine, Providence, Rhode Island. 
'lb enhance detection of right ventricular (RV) perfu•
sion defects in Tc-99m sestamibi SPECT images, a quan•
titative method of analysis was developed and evaluated. 
Exercise stress sestamibi images of 22 patients (pts) 
having a <: 5% likelihood of CAD (nl) and of 34 pts who 
had undergone cardiac catheterization were revie<Ned.. The 
images were qualitatively assessed for the presence of 
an RV perfusi:Jn defect (QUAL +). Quanti tati ve analysis 
consisted of masking all but the RV in the reconstructed 
transverse images, followed by reorientation based on RV 
axes. RV polar coordinate It'apS were constructed. Values 
were obtained for 10 points along each of 5 concentric 
nor:malized count profile curves within the It'ap, yielding 
50 sectors. A quantitative RV defect (QUANT +) was de•
fined as .>5 contiguous sectors >2.5 SO below means 0b•
tained fran analysis of the images of the 22 nl pts. The 
presence of an RV defect was related to a ~70% stenosis 
in the proximal or mid right coronary artery (RCA +). 
N QUAL + (%) QUANT + (%) P 
RC.\ + is 8 (53) 11 (73) Ns 
RCA - 19 2 (11) 3 (16) NS 
The QUANT technique had a 73% sensitivity and 84% speci•
ficity in identifying R~ +, yielding a diagnostic accu•
racy of 79%. 9 of 11 (82%) pts wit~ a severe (~90%) RCA 
stenosis had QUANI' +. 
CONCLUSIOO: A quantitative method to detect RV perfusion 
defects in Tc-99m sestamibi SPEL"'I' images has been con•
firmed. TIle presence of such a defect is strongly asso•
ciated with a proximal or mid RCA stenosis. 
250A ABSTRACTS 
910·96 
Acute Myocardial Infarctio. With and Without ST Seglent 
Elevation: Differences in Acute Perfusion 
John R. Daley, Timothy F. Christian, Kirk N. Garratt, 
Raymond J. Gibbons. Mayo Clinic, Rochester, MN 
The purpose of this study was to examine differences 
between patients with acute myocardial infarction (MI) 
with ST elevation (ST t) and patients with acute MI 
without ST elevation. The study group consisted of 118 
patients with acute MI who had acute tomographic imaging 
with Tc-99m-sestamibi and subsequent angiography during 
the acute hospitalization. Collateral flow was assessed 
angiographically by the Rentrop classification. Residual 
(collateral) flow to the infarct zone was also assessed 
noninvasively from the depth of the sestamibi profile 
curve (nadir), using previously described techniques. 
Myocardium at risk (MAR) was quantitated as previously 
described, and expressed as % LV. 
ST t 







22 ± 16 
<0.0001 
Nadir 
0.27 ± 0.12 







The difference in the nadir remained significant 
(p=0.02) even after adjustment for MAR. In patients with 
right coronary or left anterior descending coronary 
artery infarcts, angiographic collaterals tended to be 
more likely in patients without ST elevation, but this 
did not achieve significance (p=O.14). 
Conclusions: Patients with acute MI without ST elevation 
are: (1) more likely to have left circumflex infarcts, 
(2) have less MAR, and (3) have less severe perfusion 
defects consistent with greater residual (collateral) 
flow to the infarct zone. 
910·97 
LV FJection Fraction Derived From Gated Tomography Using 
Tc·99m·Seatamibi Myocardial PerfWlion Image Inversion: A 
Comparl8on with First-PUB Radionuclide Angiography 
Kim A Williama, Linda A Taillon, and Jam"" M. Draho. The 
U nivereity of Chicago, Chicago, IL. 
Backp-ound: A new technique for determination of radio nuclide 
LV ejection fraction from 8-frame gated single photon emi8eion 
computed tomographic (GSPECT) Tc-99m-Seotamibi perfUllion imag"" 
wao evaluated in 70 patients. Methoo..: Myocardial perfUllion image 
invereion (MPH), deriv"" simulated blood pool information from the LV 
chamber by reversing the image count matrix in GSPECT mid· 
ventricular horizontal and vertical long am slic"". MPH ejection 
fractioM were obtained with a combination firet and second derivative 
automated edge detection algorithm (ao employed with gated blood pool 
imaging), without the Ul!e of any background subtraction. MPH wao 
compared with f11'llt-p""" radio nuclide angiography (RNA) obtained on 
the eame day or within 24 houre of GSPECT in 35 patient. with LV 
dysfunction and 35 patient. with normal LV function defined by RNA 
Results: Automated edge detection with MPH wao accomplished in all 
patients, including 14 patient. with severe perfUllion defect.. GSPECT 
MPH ejection fractioM were slightly but significantly lower than the 
RNA ejection fractioM (45.5% YO. 49.5% for RNA, p<.Ol), coMistent 
with the effect of the lower GSPECT framing rate. However, excellent 
Group n r Regreaaion linear correlation be-
All tient. 70 .84 0.99'RNA-.04 tween MPH and ~A 
pa. wao found for the enhre Abno~l wall motion 37 .86 1.15·RNA-.ll group of 70 patient., ao 
PerfUl!llon defect. 42 .87 0.96·RNA-.05 wellao in the suboet. of 
Rating arrhythmias 48 .87 1.04·RNA-.05 patient. with abnormal 
resting regional wall 
motion on RNA, strees perfUllion defect., and resting atrial and/or ven•
tricular arrhythmiao noted during data acquisition (see Table). When 
• tudi ... were procesoed a second time, the technique'. reproducibility 
wao excellent (mean intraobeerver variability = 2.8%, r=.97 and inter· 
oboerver variability = 3.0%, r=.93). ConclWlloDB: Automated LV 
ejection fractioM can be obtained from GSPECT Tc-99m-Seotamibi 
images UlIing this new MPH technique. This simple computer 
algorithm giv"" reproducible result. which correlate well with RNA, 
even in the preeence of perfUllion defect., resting arrhythmiao, and 
regional wall motion abnormalities. 
910·106 
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ImmedIate Thalllum·201 Relnjectlon:a Novel TIme· 
savIng Approach In the Detection of MyocardIal Viability. 
Ernst E.Van der Wall, Serthe L.F.Van Eck-Smit, Aaf F.M.Kuijper, 
Ernest K.J.Pauwels, Albert V.G.Sruschke, University Hospital 
Leiden. The Netherlands. 
The potential of immediate reinjection of thallium(TI) following 
post-exercise imaging to assess myocardial viability was studied in 
120 consecutive patients(pts) suspected for CAD. Immediately 
following 3·view planar TI exercise scintigraphy (75 MBq Lv.) a 
second dose of TI(35 MSq Lv.)was administered. Image·acquisition 
was repeated after 1 h(lmReinj) and 3 hour redistribution (Red). On 
each set of TI images 8 segments(sgm) were analyzed. Exercise TI 
defects were seen in 322 sgm, of which 223(69%) showed 
reversibility, 96 sgm(30%) persisted, and 3 sgm(l%) showed 
reverse redistribution at ImReinj. At Red. an additional 12 sgm 
(4%) showed reversible ischemia whereas 47 sgm(16%) showed 
reverse redistribution. Twenty-five pts(21%) showed normal TI 
uptake at exercise, and 95 pts(79%) showed perfusion defects. 















ConclUSion: the new protocol streamlines the reinjection approach by 
eliminating the need for 3 hour Red imaging and by diminishing 
reverse redistribution. ImReinj imaging offers a time·saving and 
patient-convenient approach in the detection of myocardial viability. 
910·107 
Myocardial VIability Detected by f.18-DeoxygluCOS&-Tc-99m-Sestamlbl 
Ouallsotope Single Photon Emission Tomography (SPECT) 
Hans-Peter Stoll, Nicoia Hellwig, Cem Ozbek, Erich Oberhausen·, Hermann 
Schieffer; Division of Cardiology, Medical Clinic; • Division of Nucl. Medicine; 
University Hospital. Homburg/Saar; F.R.G. 
Purpose: The detection of preserved glucose metabolism in hypoperfused dys•
functional myocardium with fluorine-1 !kJeoxyglucose (FOG) and positron 
emission tomography (PET) was shown to be highly predictive for functional 
recov9fY after revascularization. Unfortunately, the use of the technique is re•
stricted to PET centers and thus not available for the majority of patients (pts), 
which are to be revascularized. In order to make perfusion-metabolism imaging 
suitable for widespread use, we developed a gamma camera technique. 
Methods: A Siemens Rota-1 camera with an especially constructed 511-l<eV 
collimator was used. Dual isotope SPECT was performed with Tc-99m-Sesta•
mibi (MISI) as perfusion agent and FOG as marker of metabolism. The F-18 
downscatter into the Tc-99m energy window was compensated by subtraction 
of scatter images recorded with 2 additional energy windows. By this, planar 
full width at hal! maximum is 14.7 mm for F-18 and 12.6 mm for Tc-99m. 
40 pts (EF:46%+/-16) with wall motion abnormalities at rest were investigated 
after oral glucose loading. 10 pts were excluded because of low glucose uptake. 
Coronary angiography with contrast ventriculography was performed 2-7 days 
prior to FOG-MISI imaging. Wall motion (wm) of 9 segments (seg)lheart was 
analyzed visually by 2 independent observers and graded into 8 classes. FOG 
and MISI short axis sliCes were evaluated visually and by computerized analy•
sis with 12 sectoral regions of interest /slice. Matched and mismatched defects 
were determined by comparison of the scintigraphic data with a database es•
tablished with 9 pts with normal left ventricular function (EF: 63 % +/- 6%). 
Results: Wm was abnormal in 142 of 270 seg. 87% of 38 mildly hypokinetic 
seg were normal, 80/0 had mismatches, 5% had matches. 24 severely hypoki•
netic seg were normal in 67%,120/0 had mismatched, 21% matched defects . 
44% of 75 akinetic seg showed matched defects, 27% mismatched defects and 
29% were normal. 5 dyskinetic seg did not reach statistical levels. 
Conclusion: FOG-MIBI dual isotope SPECT delivers tomographic images with 
a spatial resolution suitable for clinical use. The statisticai data of the present 
study are v9fY similar to the results of preceeding FOG-PET investigations. By 
this, widespread clinical use remote from PET centers should be possible. 
lACC Vol. 21, No.2 
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910·108 
Is 99mTc·sestamibi Scintigraphy a Marker or Viability ? 
Comparison to Thallium·20t Scan and Postoperative 
Recovery or Function. 
Paolo Marzullo. Gianmario Sambuceti. Alessia Gimelli, Barbara 
Reisenhofer, Monica Bartoli, Alessandro Distante. Oberdan Parodi. 
CNR Institute Clinical Physiology. Pisa, Italy. 
To investigate whether 99mTc-sestamibi (99mTc-S) could be used as a 
viability tracer we studied 14 patients (13 male, I female, mean age 
55±7 yrs. range 35 to 64) with postinfarction wall motion 
abnormalities. Rest 99mTc-S studies were performed by planar 
technique and compared with rest injected. delayed (4 hours) 20111. All 
background-subtracted images were quantified using circumferential 
activity profile analysis. The limit for normal/abnormal uptake was set 
at 2.5 SD below mean uptake of normal subjects for each tracer. In 73 
dyssynergic regions identified by echocardiography, 99mTc-S and 
201T! showed concordant results in 59 segments. Forty segments 
showed normal and 19 abnormal percent activity. Follow-up 
echocardiography showed increased contractility in 85% of normal and 
in 10% of abnormal segments, respectively. Fourteen segments, or 
19%. showed 99mTc-S / 20111 mismatch. Eight out of 9 segments with 
normal 99mTc_S / abnormal 20lTI did not improve following 
revascularization. All 5 segments with abnormal 99mTc-S but normal 
20111 activity showed postoperative improvement of regional wall 
motion. Segments of these "mismatch" groups showed similar degree 
of occluded vessel and collateral circulation while a more severe 
impairment of regional wall motion was detected in segments with 
abnormal lOIT\. Overall. 99mTc-S and 20111 correctly identified 71 % 
and 87% of viable and 70% and 89% of necrotic segments. 
respectively. 
In patients with left ventricular dysfunction. 201 Tl scintigraphy 
represents the first-choice radioisotopic approach to detect residual 
viability. The finding of a "reverse" mismatch (normal 99mTc-S / 
abnormal 201TI) in necrotic segments confirms that perfusion data 
alone cannot accurately distinguish viable myocardium. 
910·121 
Pulmonary ECG Gated Acquisition: A New Diagnostic 
Tool in Nuclear Cardiology 
Lino M. Gon~ves, Maria F. Botelho, Htima P. Pacheco, Cristina 
A. Santos, 1.1. Pedroso de Lima, Luis A. Providencia. University 
Hospital, Medical School, Coimbra, Protugal. 
ECG R-wave synchronized acquisition of 9911l'fc blood activity to a Gamma 
Camera-<:omputer System. is a method currently used in cardiology to study the 
heart function. This methodology is based on the detection and analysis of the 
periodic variations of the local labeled blood activity, during the cardiac cycle. at 
pixel level using Fourier analysis (De Lima et al.1986). In the pulmonary 
circulation blood volume variations occur during the cardiac cycle which are 
correlated with pressure variation in the pulmonary trunk. If a relationship between 
the pulsatile flow and the local blood activity variations is demonstated. the 
detection and quantification of systemic-pulmonary shunts in the lung circulation 
i. possible. For fbis purpose a full home made software was developed. The set of 
~ containing the counts accumulated on each pixel. for successive cardiac 
cycles. allows to obtain activity/time curves. parametric amplitude and phase 
images. and phase histograms, which inform about the pulsatile pulmonary 
circulation and allows the calculation of an amplitude ratio which is the 
quantitative parameter to assess the shunt flow. To validate the proposed technique 
systemic-pulmonary shunts from the ascending aorta to the pulmonary trunk were 
implanted in ten mongrel dogs. After introduction of a Swan-Ganz catheter in the 
pulmnonary trunk the flow of the shunt was evaluated using thermodilution by 
subtnlcting the pulmonary flow after and before the shunt's implantation. Linear 
regression between the values obtained by the proposed method (A) and ~ 
obIaiuod by thermodilution (B) shows a r-= 0.918 with p= 0.0002. 
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Myocardial Perfusion Imaging with Tetrofosmin: 
Comparison Between a One and a Two Day Protocol 
Simon Braat, Brigitte Leclerq, Roland Itti, Avijit Lahiri, 
Pierre Rigo, Academic Hospital Maastricht, Holland. 
Since there is no evidence of myocardial redistribution 
after injection of Tetrofosmin [TJ. two separate injec•
tions are needed in order to differentiate scar from 
ischemia. Fifty patients [ptsl with suspected coronary 
artery disease were evaluated with the following proto•
col. The first day at rest, 5 minutes images, anterior, 
left lateral, left anterior oblique 40° and 70° were 
obtained 30 minutes after the injection of 8 mCi of T. 
Two days later an exercise and rest study were perfor•
med. At peak exercise 8 mCi of T was injected and 30 
minutes later the same images were recorded as on 
day one. Four hours after the first injection, 24 mCi T 
was injected and again 30 minutes later the same 
images were recorded. Qualitative and qllantitative 
comparisons between the one and two day protocol 
were performed by three observers. Forty-six pts were 
identical, 8 normal, 15 ischemia, [ 9 in the inferior wall 
I and 23 had a necrotic area, [ 11 in the inferior wall I. 
In 4 pts the one day protocol showed ischemia, [ apex 
1, inferior wall 2 and lateral wall 1 J. while the 2 day 
protocol showed necrosis in these areas. Normal to 
abnormal wall ratios were the same in both groups. In 
conclusion when using T a one day protocol can be 
used, however, the interpretation of the inferior wall 
should be made with caution. 
910·123 
Are Tc99m Teboroxime 
Myocardial Perfusion 
Stress/Rest Images? 
Milena J. Henzlova, 
Sinai Medical Center, 
Stress/Wash-out 
Images as Useful as 
Josef Machac, Mount 
New York, NY 
The utility of Tc99m Teboroxime (TEBO) 
differential wash-out for detection of 
myocardial viability was tested after 
pharmacological stress in 53 patients 
(27M/26F, mean age 68+10 years). Adenosine 
was infused for 5 min,-up to 170 meg/kg/min, 
a 24 mCi dose of TEBO was injected at 4.5 
min. Single headed SPECT camera was used 
for 4 minute, continuous, counterclockwise, 
circular acquisition of STRESS and WASH-OUT 
images. REST images were obtained after a 
second TEBO dose (26 mCi) 15 min later. In 
each patient, 7 myocardial segments were 
evaluated for presence of reversible or 
fixed perfusion defects. STRESS/WASH-OUT 
and STRESS/REST images were compared. There 
were 103 mild, 32 moderate and 58 severe 
defects on the STRESS images: 36% (37/103) 
of mild defects improved on the WASH-OUT 
images, 44% (45/103) on the REST images 
(p=O.Ol), 44% of the moderate (14/32) and 
40% (23/58) of the severe defects improved 
identically on the WASH-OUT and REST images 
(p>0.05). 
Thus, TEBO WASH-OUT images contain all the 
diagnostic information in most abnormal 
segments. The REST images reveal viability 
in additional 8% of segments with mild 
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911-34 
Overcoming Early Nitrate Tolerance with Escalating Oral Dose 
of lsosorbide Dinitrate in Chronic Heart Failure 
Anil Mehra, Enrique Ostrzega, Avraham Shotan, Janet 
Vasquez-Johnson, Uri Elkayam. USC School of Medicine, Los 
Angeles, CA 
Frequent fixed dosing of oral isosorbide dinitrate (ISDN) has 
been associated with early development of tolerance and 
important attenuation of hemodynamic effect. In order to 
assess ability of dose increase to overcome tolerance to ISDN, 
we compared hemodynamic effects of escalating dose (40, SO 
and 120 mg) to fIXed dose (62±37 mg) given q 6 hours in 2 
comparable groups of 11 pts with chronic heart failure (CHF). 
Right atrial (RA), mean pulmonary arterial (PA) and 
pulmonary artery wedge (PAW) pressures in mmHg were 
measured 2 hours after administration of 3 consecutive doses 
given every 6 hours and were as follows: ("p<0.05 vs BL): 
Time RA PA PAW 
.Q1rs) EIX..Q ES.C....Q EIX...Q ~ f1X..D ESC..U 
BL 13±5 IO±6 34±6 37±9 24±6 23±9 
2 9±4" 6±4" 29±7 2S±9" 15±6" 14±9" 
S 1O±4 5±4" 27±6" 29±S" 16±6" 15±S" 
H .lQ:U ~ ~ 2n±2.:. .l2..±.l ~ 
SUMMARY: Initial ISDN effect on RA, PA and PAW is 
significantly attenuated during the study with fixed dose but not 
with escalating dose. 
CONCLUSION: Early development of nitrate tolerance to 
fIXed dose ISDN given q 6 hours can be overcome by the use of 
escalating dose. Escalating dose may therefore be superior to 
fixed dose in the treatment of pts with CHF. 
911·35 
Nitroglycerin Patches Reduce the Extent of Jeopardized 
Myocardium: Results of a Double Blind Placebo-Controlled 
Trial Using QuantHative Exercise Thalllum-201 Tomography 
John J. Mahmarian, Hugo Morales-Ballejo, Nancy L Fenimore, 
Marilyn J. Francis, Roberto Casareto, Mario S. Verani, Craig M. 
Pratt. Baylor College of Medicine, Houston, Texas 
We prospectively studied 40 pts (33 males, 7 females, mean age 
58 % 7.8 yrs) with an~iographically documented coronary artery 
disease, stable angina and no prior myocardial infarction to 
determine whether nitroglycerin petches (NP) (0.4 mg/hr; 12 
hours on/off) could reduce the extent of jeopardized 
myocardium (EJM) during treadmill exercise as assessed by 
quantitative thallium-201 tom~raphy. All pts performed a 
symptom-limited treadmill exercise at baseline (study 1) and a 
second treadmill to an identical workload after several days of 
randomized double-blind administration of placebo (Pl) (n = 19) 
or NP (n=21) (study 2). The EJM was computer-quantified 
blinded to treatment and displayed as a percent of the left 
ventricle with reversible hypoperiusion on polar maps. Baseline 
characteristics in NP and Pl pts were similar. The mean 
baseline EJM was 17.5± 12.9% for Pl vs 24.2± 11.4% for NP pts 
(p=.05). The mean EJM decreased from study no study 2 by 
only 1.8±6% in Pl and 8.9±11% in NP pts (p=.02). Also, 7/21 
(33%) NP vs only 1/19 (5%) Pl pts had an absolute ~10% 
decrease in EJM from study 1 to study 2 (p=.03). The observed 
larger reduction in EJM on NP occurred despite similar exercise 
heart rates (138± 15 vs 138± 17 bpm), and insignificant (p>0.08) 
decreases in systolic blood pressure (170± 17 vs 160± 19 
mmHg) and rate-pressure product (23585 ± 3387 vs 
22172±4510) from study 1 to 2, respectively. Summary: These 
data are the first to document that NP significantly reduces the 
EJM as determined by quantitative exercise thallium 
tom~raphy. The reduction in EJM by NP at comparable 
exercise duration, heart rate and blood pressure suggests the 
mechanism responsible for this change is an improvement in 
myocardial blood flow. 
911-36 
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Differ.rt;1al. Toler_ to tt. ~ Iffecta of 
litrogl7'DU'in in IIMrt 'ailure PatiAlota_ 
Stefano Ghio, Arnsldo Poli, Ksurizio Ferrario, Roberto 
"arioni, Carlo Campana, Antonio "uaain1. IRCCS S.Kstteo 
Boapital, Pavia, Italy. 
It ia still unImoIm whether the ti_ cour.. of 
devwlopaent of nitroglycerin (NTG) tolerance is similar 
in different vascular bada of heart failure (SF) pts. 
Accordill91y, 20 SF pts undel:'1Mtnt a 24 hour NTG infuaion 
followed by a bolua M-acetylcyateine administration 
(MAC, 59 iv>. RiCJht atrial pressure (RAP, indicativw of 
vwnoua NTG effects), systemc (SYR) and pulmonary (PVR) 
vaacular resistance .. re evaluated under control 
conditione, at peak NTG titration, at 24h and after 
MAC. Blood samples were drawn for plaaas renin activity 
(PRA) and hematocrit (Htc). Tolerance was defined as a 
>2OX loss af acute effects. At 24h, 12/20 pts developed 
vanoua tolerance (VT), 7/20 arterial (AT) and 6/20 
pullDOnary tolerance; NTG action was not attenuated on 
SIIR and PVR but the acute effecta on RAP were 60X 
reduced (p<.Ol). MAC partially revwrwed tolerance in VT 
and AT pts (both p<.O!5) without potentiatill9 NTG action 
in non tolerant pta. PRA activity increawed IDOstly in 
VT pta (+4!5X, p<.Ol) and in AT pts (+2!5X, MS) without 
chall9ill9 in non tolerant pts. Htc decreawed in all pts. 
In concluaion, our data show that in SF pts: 1 ) 
suacaptibility to MTG tolerance is higher in the venoua 
than in systemic or pullDOnary arteriolar Circulation; 
2) tolerance is uaociated with an inc~ in PRA and 
ia only partially reversed by MAC administration. 
911·37 
Effects of Placebo on Anginal Symptoms and Objective Parameters 
of Ischemia: Implications For Clinical Trials With Antianginal Drugs 
Prakash C. Deedwania, Enrique V. Carbajal, VAMC/UCSF School 
of Medicine, Fresno, CA, USA 
Therapeutic efficacy of antianginal drugs is evaluated primarily by 
improvement in exercise (Ex) test findings and anginal attack (AA) 
rate. In this study, we evaluated the effects of placebo (PL) on AA 
rate and Ex performance in 3B patients with stable angina and 
reproducible ischemia on Ex. These parameters were compared 
during two separate placebo periods (PL, and PL.) 2 and 3 weeks 
long at the beginning and end of two 7-week long antianginal drug 
treatment phases. All antianginal drugs except sublingual NTG 
were discontinued before PL,. A record of anginal attacks was 
kept and treadmill exercise test was performed at end of each 
treatment phase. 
Results: Findings (mean ± SO) for AA, and Ex parameters 
including time (T) to angina, total Ex time, T to ischemia (min) and 
double product (HR X SBP X 10·') at rest and peak Ex are shown: 
I...Ansi.!:li LIQla! I.SIl. HRxBPIRESD HRxBPIEX) ~ 
Pl, 5.B±3 7.9±3 6.2±3 9.B±2 21.4±6 12±15 
PL, 7.4±3 9.2±3 7.4±3 9.5±2 21.4±5 7±12 
• p <.005 <.001 <.01 NS NS <.01 
( • = significance level for difference between Pl, and Pl,' 
Compared to PL" all of the Ex parameters and AA rate improved 
significantly during PL •. Similar double product at rest and Ex 
during PL, and PL. shows a comparable workload achieved during 
Ex and thus rule out any drug carryover effect. Summary: These 
results show that treatment with placebo improves AA rate and Ex 
parameters. Because of such improvement with PL the therapeutic 
efficacy of antianginal drugs should be evaluated based on net 
improvement beyond that observed in the parallel placebo group. 
JACC Vol. 21, No.2 
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911·38 
Anti-ischemic Effects of Amlodipine in Patients with Stable 
Coronary Artery Disease and Ischemia During Daily Ufe 
Prakash C. Deedwania. for the amlodipine study group 
UCSFNAMC Fresno. CA 
Amlodipine is a new calcium channel blocker with a long half life 
(> 40 hours). In this study we evaluated the anti-ischemic effects 
of amlodipine in patients (pts) with stable angina and proven 
diagnosis of CAD. All pts had evidence of exercise-induced 
ischemia. The study protocol consisted of an initial placebo phase. 
followed by an 8-wk single blind administration of amlodipine 5-10 
mg once daily. and a final 4-wk double blind randomized phase 
comparing placebo versus amlodipine. Holter monitoring (HM) was 
performed for 48 hr at the end of each phase. All HM tapes were 
analyzed at a central core laboratory in a blinded fashion. A total 
of 56 pts had technically adequate HM data for evaluation. During 
the initial placebo phase 40 pts had one or more transient ischemic 
episodes (TIEs) defined as ~ 1 mm ST' lasting more than 1 minute 
and separated from another event by at least 1 minute. Average 
number of TIEs at baseline was 4.4 (range 1 to 23). There was a 
significant reduction in the mean number of TIEs (from 4.4 to 2.5. 
p< .005) during amlodipine administration. At baseline. the mean 
duration of TIEs was 127 mini 24 hrs and was reduced to 81 mini 
24 hrs on amlodipine (p = .07). During the final double-blind phase 
of the study the patients randomized to receive amlodipine 
continued to show beneficial anti-ischemic effects (2.9 vs 2.1 
TIEs). In contrast. patients assigned to placebo showed an increase 
in ischemic activity (2.2 vs 3.9 TIEs). There was a significant 
(p = 0.0 1 by ANOVA) difference between the effects of amlodipine 
and placebo on ischemic index at end of the double blind phase. 
Conclusion: Amlodipine given once daily is an effective anti•
ischemic drug as demonstrated by a significant decrease in 
ischemic events and total ischemic burden during daily life. 
911-39 
ChroaIc Beta·Blockade revena Diastolic Dysfuctloa iD Patleats With S,. __ X 
Gabriele Fragasso, Giuseppe Pim:tti, Mauro Carlino, Stefano Gerosa, 
Antonella Fedele, Orazio Carandente, Enrico Rossetti, Sergio Cbierchia. H S 
Raffaele, Milano, Italy. 
In 23 normotensive patients (17 females, mean age 5.s..±9 yrs) with angina, 
positive exercise test, normal coronary arteries and no inducible spasm (SX). 
we assessed diastolic function by Doppler-derived transmitral Dow pattern 
analysis at rest and following exercise. PIS were studied off therapy and after a 
7 day treatment period with Atenolol (A 1'). The same protocol was per•
formed in 13 controls (C) (9 males, 43..16 yrs) with no evidence for cardiac 
disease. Measurements included peak early (E) and late (A) filling velocities 
and their ratio (E/ A), total time/velocity integral (TV) and % of atrial 
contribution (AC) to LV filling. SX pts showed diastolic dysfunction as shown 
by inversion of the E/ A ratio and a greater AC. However, these parameters 
did not deteriorate any further at peak exercise in spite of the presence of 
significant ST segment depression. AT completely prevented exercise-induced 
ST segment changes in 18 pts and significantly improved resting diastolic 
dysfunction in a1l23 pis. Resting parameters were as follows: 
E/A E A TV AC HR 
Sx basal 0.9 63 73 18.7 39 79 
atenolol 1.2 75 63 22.0 29 56 
C basal 1.4 83 61 ']f).7 26 78 
ateno\ol 1.7 85 52 23.1 21 56 
Therefore, diastolic function appears impaired in Sx, through mechanisms 
that remain obscure. The mechanism by which AT improves diastole in these 
pts could be related to a reduction in myocardial 02 consumption with a 
consequent improvement of LV relaxation. The latter effect was probably 
unrelated to prolongation of diastole since C, althoOlgb exibiting a similar 
prolongation in diastolic time intervals, showed no change in peak velocities. 
ABSTRACTS 
911-40 
Differing Effects of Bepridil Versus Propranolol on Exercise Induced 
Wall Motion Abnormalities in Patients With Stable Angina 
Enrique V. Carbajal. Vishnu R. Bobba. Prakash C. Deedwania. 
UCSF School of Medicine. Fresno. CA. 
Bepridil (B, 400mg/day). a recently approved calcium channel 
blocker was compared to propranolol (P. 320mgl day) for its 
antianginal effects and ability to improve exercise (Ex) induced LV 
wall motion abnormalities (WMA) in 12 male pts with stable angina 
and Ex-induced ischemia. In this randomized double·blind, placebo· 
controlled. crossover study. global and regional LV ejection 
fractions were measured at rest and during Ex by radionuclide 
angiocardiography during B, P, and placebo. Treatment consisted 
of 2 placebo (1 wk) and 2 active therapy (7 wk) periods. Angina 
frequency, sublingual nitroglycerin use and Ex test parameters 
(total time, time to angina, time to 1 mm ST l) were compared. 
Results: Both bepridil and propranolol showed significant and 
similar improvement in angina frequency and Ex test parameters 
compared to placebo. The resting LV ejection fraction was 55 ± 
5% on placebo, 54 ± 4% on Band 53 ± 4% on P (p=ns). At 
peak exercise all patients showed one or more areas of WMA. 
Compared to propranolol. treatment with bepridil was associated 
with a significant improvement in total work capacity (381 vs 527 
kpm, p< .05). The LV ejection fraction increased to 56 ± 4% with 
bepridil but no improvement was seen during P treatment. The 
exercise induced WMA and regional ejection fractions improved 
with bepridil compared to both placebo and P. 
Conclusion: Although both bepridil and propranolol had similar 
antianginal efficacy, only bepridil produced improvement in 
ischemia-induced left ventricular dysfunction and total work 
capacity. These results emphasize the need for critical evaluation 
of the entire spectrum of pharmacologic properties of various 
classes of anti anginal drugs. 
911·41 
Infusion of a Chimeric Monoclonal Fab Fragment (e7E3) Against Platelet 
Glycoprotein UB·filA Potently Inhibits Platelet Aggregation But Does 
Not AlTect In Vivo Platelet Survival 
Joseph Sweeney, Stein Holme, Andrew Heaton, Harlan Weisman. Pamela 
Whitley, Kathleen Baraclcman, Denise O'Donnell, John Herre. Departments 
of Medicine and Pathology, Eastern Virginia Medical School and American 
Red Cross, Norfolk, Virginia 
The ability to prevent platelet aggregation using monoclonal antibodies 
(MoAb) directed against the major fibrinogen receptor (glycoprotein IIB·lIlA) 
would seem a useful therapeutic strategy, but the effect of such MoAb on the 
subsequent survival of SUrface-coated platelets is unknown. c7E3 is a 
chimeric monoclonal Fab fragment which recognizes an epitope on GplIB•
lIlA. preventing fibrinogen binding and results in a transient inhibition of 
platelet aggregation. After informed consent, 17 clinically stable patients, 
angiogr.phically proven to have ~ 70% stenosis in one or more major 
coronary artery, were randomized to receive either c7E3 or a placebo given 
by bolus IV (0.25 mglkg) followed by IV infusion (I0l'gimin) for 12 hours. 
III[ndium-o.ine-labeled platelets were infused within I hour prior to c7E3 
infusion. Subsequent samples for platelet survival were drawn daily for 7 
days and on Day 10. Post-7E3 infusion samples confirmed complete 
inhibition of aggregation to ADP in drug-treated patients and lack of effect in 
placebo-tr ... ted patients. Platelet survival was analyzed using various 
mathematical models. 
Survival (hours) 
Mathe- c7E3-treated Placebo-treated 
lIUItical Mean ± ISD Mean ± ISO 
Model ~ (n=6) Prob. 
Lin ... r function 237 ± 19 230 ± 15 >0.05 
Multiple hit 2[8 ± 31 204 ± 35 >0.05 
Weighted mean 210 ± 39 189 ± 40 >0.05 
Conclusions: Administration of c7E3 by IV boills and 12-hour continuous 




Inhibition of Platelet Aggregation With a Sustained 
Infusion of 1«-852 in Stable Coronary Artery Disease 
James D. Rossen, Theresa Palabrica, Carl Tommaso, Asma 
Ghannam, Debbie Panebianco, Sol I. Rajfer, Frederic L. 
Sax. Univ. of Iowa, Iowa City, LA, Tufts-New Engl. Med. 
Ctr., Boston, MA, Northwestern Univ. Med. School, 
Chicago, IL, and Merck Research Labs, West Point, PA 
MK-852 (MK) is a novel heptapeptide antagonist of 
fibrinogen binding to the platelet membrane receptor GP 
lIb/IlIa. 24 patients (pts) with stable coronary artery 
disease (CAD), stratified by aspirin (A) usage, received 
either MK or placebo (P), as a loading infusion of 
l~g/kg/min x 30 minutes immediately followed by a 
maintenance infusion of 0.33~g/kg/min x 5.5 hrs. Per•
cent platelet aggregation (PA) was measured by change 
in light transmission (LT) after addition of 2~ ADP. 
LT and bleeding times (BT) were measured at baseline (B) 
and for 24 hrs following drug initiation. X inhibition 
of PA (IPA) was calculated as 10Ox(LT(B)-LT(timepoint» 
/LT(B). BT extension was calculated as BT(6 hrs)/BT(B). 
Mean X IPA and the BT extension from B were as follows: 
--L -M1L ~ MKtA AlU AlLM~ 
(n-4) (n=6) (n=7) (n=7) (n=l1) (n=13) 
X IPA (30-illin) 24 6ot# -2 381'1 8 48tH 
X IPA (6-hrs) 13 53f# -13 42t# -4 481'# 
X IPA (8-hra) 22 7 1 18 9 13 
BT extension 1.2 1.7 1.3 2.5t# 1.2# 2.1# 
t p ~ 0.05 vs. P # p ~ 0.05 VB. B 
MK-852 was well tolerated with no significant bleeding 
or thrombocytopenia reported. From this study of pts 
with stable CAD, we conclude that a sustained infusion 
of MK maintains inhibition of ADP-induced PA during the 
infusion period and increases BT; these effects reverse 
rapidly on discontinuation of MK. Therefore, MK-852 may 
be useful in inhibiting platelet aggregation associated 
with acute coronary ischemic syndromes. 
911·43 
Improved Metabolic and Hemodynamic Function With a 
New Buffering Agent for Cardiac Arrest 
Robert M. Bersln, Clifford Williams. The Sanger Clinic 
and Heineman Medical Research Center, Charlotte, NC 
Sodium dichloroacetate (DCA) improves lactic acidosis by 
stimulation of pyruvate dehydrogenase. Sodium carbonate buffers 
H+ and improves the' blood pH without net generation of C02. A 
combination of these two agents was developed to optimally treat 
hypoxic lactic acidosis (HLA) and cardiac arrest. HLA was induced 
by having intubated, anesthetized dogs breathe a mixture of 4% 
02196% N2. Dogs with HLA were then treated with either 
NaHC03 or DCAlCarb at 2.5 mmoVkg IV, with measurements of 
mean arterial pressure (MAP), cardiac index (CI in mVminlkg), 
regional 02 consumption and lactate metabolism. After 30 min of 
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Systemic 02 consumption did not fall with DCAlCarb 
administration (5.2 v. 5.3 ml 02/Kg/min, p=NS). Oxygen•
hemoglobin binding decreased with DCAlCarb faCilitating oxygen 
unloading (P50 31.6 v. 30.9, p<.05), even though the blood pH 
rose and 2,3-DPG fell (from 4.36 to 3.35 ~mollml, p<.OI). Blood 
lactate concentrations fell dramatically, whereas net lactate 
production persisted with NaHC03. 
Conclusions: In dogs with HLA, DCAlCarb improves the arterial 
blood gases without the generation of C02 and with beneficial effects 
on 02 consumption and lactate production. Cardiovascular 
performance improves as a result. However, with NaHC03, C02 
generation is significant. Lactate production increases, renecting 
increased anaerobic metabolism and depression of cardiovascular 
function. DCAlCarb thus appears to be superior to NaHC03 in the 
therapy of HLA. 
911·44 
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SODfUM BICARBONATE AND RESUSCrrATION OUTCOME DURING 
I~OSPITAL CARDIAC ARREST 
Jeffrey B Sack Michael B. Kesselbrenner, Richard Gerber, Vinod Gupta 
UniYelSity of California Los Angeles Medical Center, Los Angeles, CA and 
Seton HaM UniYelSity School of Graduate Medical Education, Paterson, NJ 
The use of sodium bicarbonate (NaHCOa> during cardiopulmonary 
resuscitation (CPR) has recently come under re-ilxamination. The 
administration of NaHC03 has been shown to contribute to intramyocardial 
acidosis. We prospectively studied 84 in-hospital CPR's in an effort to 
determine the effect of the current recommendations for the use of 
NaHC03 on resuscitation outcome. 29 patients received an initial dose of 
NaHC03 of 1 meqlkg intravenously (NaHC03 group). Subsequent doses 
were at the discretion of the code team leader. 55 Patients received no 
NaHC03 (C group). All other aspects of the resuscitation attempt were in 
accordance with current AHA guidelines. The dosage of all resuscitation 
medications was recorded. Retum of spontaneous circulation (ROse) was 
definad by the presence of a palpable pulse and systolic BP > 80 mmHg > 
3 minutes. Patients were followad to hospital discharge. There were 36 
males and 48 females with a mean age of 62 years. There were no 
significant differences in baseline demographic, hemodynamic, electrolyte, 
or arterial blood gas values between the NaHC03 and C groups. The 
mechanism of cardiac arrest was similar in both the NaHC03 and C 
groups. 98Ofo of arrests were witnessed. The mean time from cardiac arrest 
to start of CPR was 1 minute 40 seconds. The overall rate of ROse was 
46%. There was no significant difference in ROse rates between the 
NaHC03 group and C group (12129 vs 27/55). There was no significant 
difference in 24 hour survival (5129 VS 16155) or survival to hospital 
discharge (0129 vs 2155) between the NaHC03 and C groups, respectively. 
We conclude that the administration of NaHC03 during CPR as is 
currently recommended does not improve ROse or survival to hospital 
discharge from in-hospital cardiac arrest. The benefit of NaHC03 during in•
hospital cardiac arrest may be outweighed by worsening of intracellular 
acidosis, especially when mean times from cardiac arrest to start of CPR 
are sheri. 
911·45 
The Importance of Epinephrine Administration Frequency on Outcome of 
PatienlS Undergoi .. In-Hospital Cardiopulmonary Resuscitation 
Mark C. Thel, Gordon P. Keeter, Karen Pieper, Christopher M. O'Connor. 
Duke University Medical Center, Durham, North Carolina 
The dose of epinephriDe used in resuscitatinl patients who experienced 
cardiopulmonary arrest bu been examined carefully and remains 
controversial. To determine the role of epinepbriDe on ouIA:ome of patients 
undergoing in-bospilal cardiac arrest, we examined IS 1 consecutive codes 
that occurred from June of 1990 to January of 1992. 
The median ale of patients was 6S years with S6 \IIi of the patients of male 
gender. The initial rhythm was asystole (3S \IIi), EMD (25 \IIi), ventricular 
fibrillation (2Hi), bradycardia/complete heart block (lO\IIi), and ventricular 
blchycardia (7 \IIi). Retum of spontaneous circulation (ROSC) occurred in 
56 \IIi of patients and the resuscitation score of 4 occurred in 5 \IIi of patients 
(1 - survival < I hour, 2 - survival> 1 hour hut < 1 day, 3 - survival> 1 
day but in-bospilal death, 4 - discharged and survived). 
Fifteen baseline and treatment candidate variables were examined to 
determine the independent predictors of ROSe and resuscitation score. 
Using logistic regression analysis, independent predictors of ROSe were: 
Variable Chi Square p Value 
1. Epi dose number 10.0 .002 
2. Lower maximum epi 9.8 .002 
dose 
3. Epi dose frequency 9.1 .003 
4. Not post surgical 6.3 .01 
S. Cardiology Service 4.0 .04 
In addition, the independent predictors of a higher resuscitation score were 
number of epi doses (x' - IS.S,p = O.OOOI)and DOt post surgical, (x' = 
1O.2,p = 0.001). ImjlOrtantly, age, sex, and duration of code were not 
determinants of the above outcome measures. 
In conclusion, the frequency of epinephrine administration and the number 
of doses are more important than the maximal dose of epinephriDe in 
determining ROSe or a favorable resuscitation score. 
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912-46 
Myocaxdf.al 5aJ:o:"tl1NDIc Reticul\D Fur¥:ticn in the 
DevelqIIIent and Recovery frail Heart Failure 
Peter J. O'Brien, Goroon W. MJe, C. Robert CIJry, 
Etienne Grima, Paul W. ADnstrong. Un1v. of Glelph, 
Q.\elph, and Un1v. of Toronto, Toronto, Ontario, canada 
Myocardial sarcoplasmic reticulum (SR) function was 
assessed in dogs at various stages of and recovery 
fran heart failure (HF). Dogs were paced (250 beats/ 
min) for 1 week (wk) to early HF (HFe, n=8); 4.l± 1.2 
wk to severe HF (HFs, n=7); or to severe HF followed 
by 4 wk of recovery (REX::, n=7). 11 nonnal. dogs served 
as controls (Cl'L). Maxinun SR channel and p.mp activit•
ies (awtnax, RK'max) were deteDnined fran ca uptake 
of isolated SR using ryanod1ne to fully open and close 
the channel. Data (x±5D) for p!lronary wedge pressure 
(POi, nm Hg) and cardiac outplt (CD, l/min) prior to 
sacrifice; net ca uptake in the native state (UPr), 
awtnax, PlMPmax (all in nM/s); and ratio of awtnax 
to RK'max (OWl/fUoIP) are stom. * p<.05 vs Cl'L. 
POi CD UPr awtnax RK'max OWl/fUoIP 
CTL 9±1 4.6±1.1 l6±3 l2±2 27±4 0.46±Q.03 
HFe 19±3* 2.4±Q.5* 22±5* 8±2* 27±5 0.3l±Q.05* 
HFs 28+4* 2.7+1.4* 17+3 8+2* 23+2* 0.35+0.12* 
REX:: 11~2 3.9~1.4 l5~2 9~3* 22~3* 0.42~.11 
In early HF, reduced awtnax was associated with 
increased UPr and decreased OWl/fUoIP. At severe !iF, 
RK'max was reduced with noIlllal UPr. At recovery, POi 
and CD returned to notmal but LV relaxation time cons•
tant remained prolonged (23±4 vs l7±6 IllS at CTL, p< 
.05): this was associated with persistent reduced 
awtnax and RK'max. 'lbese data iOOicate a dynamic 
response of UPr, SR channel and p.mp function to pac•
ing. At recovery, ca cycling ranains depressed which 
may account for the persistent diastolic dysfunction. 
912-47 
Cyclic AMP Independent Abnormalities in the Rat 
Ischemic Heart Failure Model 
Thomas P. Stuver, William B. Hood, Jr., Univer•
sity of Rochester Medical Center, Rochester, NY 
We previously showed diminished inotropic re•
sponses to isoproterenol in uninfarcted poste•
rior papillary muscles (PPM) of rats with ante•
rior wall infarct size (IS) comprising ~30' of 
the left ventricle (LV), despite absence of B•
receptor downregulation. To determine if this 
is due to a post-cyclase defect, we gave the 
cAMP analogue dibutyryl cAMP (dbcAMP) to PPM 
contractin~ isometrically at 0.2 Hz in a muscle 
bath at 28 C. Baseline rate of change of ten•
sion (dT/dt) and time to peak tension (TPT) in 
shams were 38±16 g/sec/mm and 138±14 msec, re•
spectively, and did not differ in infarcted 
rats. Changes in dT/dt and TPT with increasing 
concentrations of dbcAMP were (mean±SD): 
dT/dt db cAMP (M) 
(g/s/mm2 ) n 1x10·~ 3xlO·5 lxlO·4 3x10·4 
shams 12 3±3 6±4 10±7 l8±9 
15<30' LV 16 3±4 6!6 10±8 14±8 






shams 12 -6±14 -16±7 -29±9 -45±15 -57±16 
15<30' LV 16 -3±3 -10±10 -21±16 -34±16 -53±15 
IS~30' LV 13 -2±7 -5±7* -13±6* -29±14*-42±8 
*p<0.05, vs. shams and IS <30' LV 
No abnorma1itias were noted in measures of re•
laxation. The findings are similar to those we 
noted with isoproterenol stimulation. Thus, the 
impaired response to B agonists is due at least 
in part to a defect in post-cyclase mechanisms. 
ABSTRACfS 
912-48 
Dahl Salt-Sensitive Rat is a New Model of Congestive 
Heart Failure 
Moriaki Inoko, Yasuki Kihara, Shigetake Sasayama. 
Toyama Medical & Pharmaceutical University, Toyama, Japan 
To investigate whether Dahl salt-sensitive (OS) rats, which 
develop high blood pressure when exposed to a high-salt 
diet, are an useful model of heart failure, we placed 6-week•
old OS(n=12) and Dahl salt-resistant (DR) rats (n=12) on an 
8% NaCI diet and performed trans-thoracic echocardiography 
at various times thereafter. OS rats presented concentric LV 
hypertrophy at 11 weeks, mild impairment of LV wall motion 
at 15 weeks, and, finally, maked LV dilatation with severe 
hypokinesis at 15-20 weeks. During the final stage, all OS 
rats died with labored respiration, pulmonary congestion, 
pleural effusion and ascites, which were confirmed by 
subsequent pathological examinations. In contrast, DR rats 
did not show any of these findings. The serum creatinine 
level remained within normal range in both groups. The end•
systolic pressure-diameter curve of failing OS rats (n=5) 
showed a shift to right with a less steep slope than that of 
age-matched DR rats (n=5). We conclude that the OS rat is a 
rapidly-developing and reproducible model of congestive 
heart failure, in which the transition from compensatory LV 
hypertrophy to obvious LV failure can be observed. 
OS DR 
Dmm FS '" PW mm Dmm FS '" PW mm 6WK 4.8±0.3 51±6 1.4±0.1 5.0±0.4 49±4 1.5±!>.1 
llWK 5.8±0.4 46±5 2.l±0.3* 6.l±0.5 45±4 1.6±0.1 
15WK 7.2±0.8 40±7 2.0±0.2* 7.1±0.6 41±6 1.7:!:0.2 
failing 9.9±0.2* 28±3* 1.6±0.1* 7.3±0.3 4l±4 1.8±0.1 
Mean±SD. *P<O.O vs DR. D=LV end-diastolic diameter 
FS=fractional shortening, PW=posterior wall thickness. 
912-49 
Chronic ACE Inhibition Improves Left Ventricular Diastolic 
Function in Rats With Post-Infarction Heart Failure. 
Sheldon E. Litwin, Sarah E. Katz, James P. Morgan, Pamela S. Douglas. The 
Harvard-Thorndike Laboralory of Beth Israel Hospital. Bostoo, MA. 
Pathological remodeling of the left ventricle (LV) and impaired LV systolic 
function are believed 10 contribute 10 heart failure after myocardial infarction 
(MI). Both of these aboormalities are partially corrected by chronic angiolealsin 
converting enzyme inhibition (ACEI). To evaluate diastolic function after MI 
and 10 determiae the effects of ACEI on LV diastolic function, _ studied I"IIs 
that UDderwent sham surgery (n= 17) or MI induced by left coronary artery 
ligation (n= 19). One week after large MI (> 40 " LV) I"IIs were randomized 
10 placebo (n~ 11), or capIoprii (Cap. n-8) 2 gIL in the drinking water. Six 
weeks after suraery we recorded transthoracic 2-D short axis echoes at the 
midventricular level using_ 7.0 MHz transducer, and pulsed-wave Doppler 
speclIa at the tips of the mitral leaflets for early (E) and atrial (A) LV filling 
velocities. Hemodynamics were recorded within 48 houn of the 
echocardioKJ"IDI. Data are mean.±.SEM. LVEDP=LV end-diastolic pressure 
(mmHg); LVCA=LV diastolic cavity area (mm'); FAC=fractioaal area 
change ("); DeceI=E wave deceleration(mls'). *p < O.OS vs sham, #p < 
O.OS vs MI. 
Sham 
MI 
LVEDP LVCA FAC E A DeceI 
6±l 
27±3* 
6S±3 4S.±.3 74±3 34±1 1l±1 
89±3* 2S±3* l00±4* 18±S* 26±3* 
MI Cap 13±21* n±slI* 26±3* 82±SII 32±SII IS±21 
ColiC!ilSions: 1. Large MI m ihe rat causes LV dllatalton, systolic dysfllDCllon 
and the development of _ ·restrictive- LV filling pattern with increased E, 
decreased A, and npid deceleration of early filling; 2. Chronic ACE 
inhibition, instituted 1 week after large MI .-.lts in normalization of LV 
diastolic filling. 3. Although S weeks of treatment limits LV dilatation, 
systolic function is not significandy improved. Thus. improvement of diastolic 
function may contribute 10 the beneficial effects of ACE inhibition after MI and 




Arterial Remodeling after Myocardial Infarction 
in Rats: Effects of Captopril 
Mohamed A. Gaballa. Thomas E. Raya. and Steven Goldman 
University of Arizona Heart Center. VA Medical Center. Tucson. 
AZ. 
We examined arterial remodeling and effects of captopril on rats 
with chronic heart failure (CHA produced by ligation of the 
coronary artery. Starting 3 weeks post myocardial infarction (Mil. 
sham and CHF rats were treated with captopril (2g/l drinking· 
waterl or placebo for 3 weeks. CHF was defined as infarct size 
>40% and end-diastolic pressure >25 mmHg. Arterial 
remodeling was defined by alterations in the passive elastic 
properties. geometry. and the morphology of large arteries. The 
passive elastic propertiel were measured in-vivo in intact 
segments of carotid arteriel. The passive pressure-volume data 
were expressed in terms of a two-dimensional strain-energy 
function with four coefficients (C.a,.a2. and a41. Significant 
differences were dfmed al P < 0.05. Results: C increased in CHF 
(5.6 + 0.2 VI 3.9 + 0.1 mmHgl. ACE-inhibition decreased C in 
sha';-and CHF (2-:3.±.G2 and 4.7 .±.0.1 mmHg respectivelyl. The 
values for a,.a2. and a4 were lower in CHF (2.5.±.0.1. 
0.44.±.0.1. and 0.17.±.0.01 vs 4.2.±.0.1. 0.81.±.0.03. and 
0.31.±.0.OS respectivelyl. Captopril increased these coefficients 
in CHF (2.7.±.0.07. 0.54.±.0.05. and 0.18.±.0.01 respectivelyl. 
Aortic diamat ... decreased (3.21.±.0.19 vs 3.37.±.0.28 mml and 
collagen area density increased in CHF (153092.±.11352 vs 
96427.±.S6601. Captopril decreases collagen area density in 
Sham and CHF (97502.±.11845 and 102192.±.27022 
respectivelyl. Conclusions: 11 arterial remodeling defined by 
alterations in the passive elastic properties and morphology of 
large arteries occurs in heart failure; 21 some of these alterations 
were reversed by captopril. 
912·77 
Myocyte DNA Synthesis with Aging: Correlation with 
Ventricular Loading in Rats 
Joseph M. Capasso, Silvia Bruno, Peng Li, Xun Zhang, Zbigniew 
Danynkiewicz, Giorgio Olivetti and Piero Anversa 
Department of Medicine, New York Medical College, Valhalla, 
NY 
To determine whether the detrimental mechanical and anatomical 
changes which occur biventricularly with aging are associated with 
activation of DNA synthesis, the fractions of left and right 
ventricular myocytes which enter the cell cycle and undergo DNA 
replication were determined by flow cytometric analysis and these 
results correlated with the changes in myocardial loading in male 
Fischer rats at 4, 12, 20, and 29 months of age. These age groups 
were chosen since they represent, respectively, young adult, fully 
mature adult, aged and senescent stages in the lifespan of this 
animal model. Heart weight increased significantly With age and 
this growth adaptation was associated with the development of left 
ventricular failure and right ventricular dysfunction. These 
phenomena were coupled with marked elevations in diastolic wall 
stress and increases in the percentage of myocyte nuclei in S+G2M 
in both ventricles. Linear regression analyses revealed a direct 
correlation between the fraction of myocytes which entered the cell 
cycle and diastolic pressure and wall stress. An inverse relation 
was found between the quantity of myocyte nuclei in S+G2.M and 
+dP/dt and systolic wall stress. Thus, the depreSSion of 
hemodynamic performance coupled with alterations in the loading 
conditions contribute, at least in part, to increase DNA synthesis in 
cardiac myocytes with age. . 
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Atn::Irmal. Size and NImi:ler of Mit:oc:baldria in 
~um of Dogs with Olralic Heart Failure 
Bani N. 5aI:tlah, victor G. Sharov, Tatsuji Kale, 
Michael I.esc:h, Sidney Goldstein. Henry Ford Heart 
and vascular Institute, Detroit, Michlgan 
~ high-energy ~te cxntent may be 
dec:reased in dIralic heart failure (OIF) and may 
play a role in the prcgressicn of LV dysfurx:ticn in 
this disease state. In the present study, we 
examined the l'IlIIIber and size of mit:oc:baldria (MIT) 
in the myocardium of 12 dogs with OIF produced by 
III1l.tiple sequential intracarooary mic::roembolizaticn 
(LV ejecticn fracticn 22±2'). MIT size and !'LlIIIber 
were quantified usinJ transmissicn e1ec:trcn 
mic:roscx:py. Tissue specbDens were ran:Icmly selected 
frcm eacb of 3 myocardial regicns (LV, TN and 
sepblm) for analysis. For eacb viable ~' 
a stan::lard area of 100 square sarcx:meres ( ) was 
used to obtain an average MIT size ( ) and 
!'LlIIIber. ClaIpIrisals were made with values obtained 
frcm hearts of 9 normal dogs. 
Size NUmber Size NUmber 
(I'r) (/100.) (I'r) (/100.) 
LV 0.76±Q.05 59±4 O. 5Q±O. 02** 95±6** 
TN 0.68±O.02 66±4 0.52±O.04 89±4** 
Sepb.a O.84±O.07 66±2 O. 58±O. 05* 85±6* 
[ .... Ps. 01; **"'1'<. 001 relative to cx:rrt:rol J 
'lhe results in:licate that an increased lUlIDber and 
decreased size of MIT are present in the heart of 
dogs with OIF caused by loss of viable myocardium. 
Whether these chan;!es are a direct result of 
ClCIJIlellSCltory cellular hype:t:tJ:oplY or a Cla'lSeqIleIr8 
of a defect in the farmaticn of new MIT in the 
~ of OIF, remains urxletermined. 
912·79 
Hydraulic Conductivity of Large Arteries in 
Heart Failure Rats: Effects of Captopril 
Mohamed A. Gaballa. Thomas E. Raya. and Steven Goldman 
University of Arizona Heart Center. VA Medical Center. 
Tucson. AZ. 
This study was designed to measure the hydraulic 
conductivity (Lp) in large arteries in rats with chronic heart 
failure (CHFI and to study the effect of ACE-inhibitor 
(captoprill on Lp. Lp is a measure of fluid intake in the arterial 
wall. We studied 4 treatment groups; sham. CHF. 
sham/captopril. CHF/captopril. Heart failure was produced by 
coronary artery ligation. Starting three weeks post myocardial 
infarction. sham and CHF rats were treated with captopril 
(2g11 drinking waterl for three weeks. Large infarction was 
visually verified at the end of the experiment. Lp of the total 
carotid arterial wall was calculated as the ratio of the fluid 
filtration and the fluid pressure gradient (net hydrostatic and 
osmotic) across the wall and Lp was measured at pressure of 
100 mmHg. Results: Lp is increased in CHF (5.356.±.0.SS vs. 
2.53.±.0.52x10-S cm/sec. mmHg). ACE-inhibition with 
captopril decreases Lp in Sham and CHF rats (2.312.±.0.23 
CHF treated and 2.304.±.0.S24 x1 O-S cm/sec. mmHg. 
respectively). Conclusions: Lp is abnormal in this model of 
heart failure and captopril partially restore it toward normal. 
While captopril decrease Lp in both CHF and sham. these 
effects are more pronounced in CHF. 
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913·109 
Angiotensin I Converting Enzyme Gene Aa a Candidate Gene 
Contributing to Human Essential Hypertension 
Nobuyukl Ohmichl. Naoharu Iwal. Yasuyukl Nakamura. Kenichi Mttsunami. and 
Masahlko KinoshHa. The 1st Dept. of Int.Med .• Shiga Universtty of Medical 
Science. Ohfsu. Shiga. Japan 
Angiotensin I converting enzyme(ACE) gene has been recently Implicated as 
a candidate gene contributing to the hypertension of Spontaneously 
Hypertensive Rat.one of the genetic rat model for human essential 
hypertension. The purpose of the present study is to investigate whether the 
gene for ACE may contribute to one of the subgroups of human essential 
hypertension. A 287bp insertion! deletion polymorphism in the intron 16 can 
be detected by polymerase chain reactlon(PCR). In which one allele will give 
190bp or 490bp fragment. Thus.three types of genetic polymorphism can be 
detected In this locus. namely 490bp homozygous(LL). 190bp 
homozygous(SS). and heterozygous for 190bp and 490bp fragment(LS). A 
correlation between the genotype of the ACE and blood pressure was 
examined by utilizing this PCR polymorphism In 106 human subject> • 












ANOVA ( one way) revealed that the genotype of the ACE gene has a 
capactty to intluence the systolic ( p-o.o44) and the diastolic ( p-0.042 ) blood 
pressure value. The present resuHs strongly suggest that the gene for ACE 01 
the ACE locus may contribute to the human essential hypertension. Further 
study to identify a subgroup of essential hypertensives. in which the ACE 
gene or locus is strongfy involved in the genesis of hypertension. will be 
required. 
913·110 
A Prospective Study to Evaluate the Effects of Extra Corporeal 
Shock Wave lithotripsy (ESWl) on Blood Pressure (BP), Renal 
Fooction (RF) and Glomerular Filtration (GFR). 
Jeremy J. Hammond. Jan Raffaele. Neil liddel. Austin E. Doyle. 
Anthony Costello. lohn Amerena. St. Vincent's Hospital. 
Melbourne. Australia. 
Although ESWl is widely used. its side effects are poorly 
documented. Retrospective reports suggest an incidence of 
hypertension (HT) between 4% and 8% after ESWl. but no 
prospective data is available. Therefore a prospective study of 
ESWl on BP and RF was commenced in 1991. BPs are taken 
in triplicate using standardized techniques by a single observer at 
24 hours pre and post ESWl. and at 10 days, 3 months, 6 
months. 12 months then yearly for 5 years. RF is measured by 
urea and creatinine, and eFR by Tc99DTPA. Control readings 
are made on patients undergoing treatment for stones in the mid 
and lower ureter, thus not undergoing ESWl to the kidney. 97 
patients with renal stones underwent ESWl. Of 67 without prior 
HT 7 showed a significant rise in BP (defined as ;;.. 20/1 0 
mmHg) at 24 hours, of whom 2 exceeded 140/90. 30 patients 
had prior HT of whom 4 showed a rise in BP of ~ 20/10 
mmHg. At 3 months 9 of 22 patients without prior HT showed 
a significant rise in BP. as did 5 of 17 with prior HT. The 
results at 6 months are 3 out of 1 2 and 2 out of 10 
respectively. No patients in the control group have shown a rise 
in BP. At 24 hours eFR was reduced by 10% in the kidney 
treated by ESWl, in 5% of the patients studied. No change in 
urea or creatinine was seen. 
Conclusion: These data indicate that approximately 10% of 
patients show a rise in BP at 24 hours following ESWl. At 3 
and 6 months, between 20 and 30% of patients have significant 
increases in BP. eFR was adversely affected at 24 hours in 
some patients. Further prospective observations are required to 
confirm these findings, however this study indicates the need to 
carefully follow BP after ESWl. 
ABSTRACfS 
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A I'rmIl7 AbD.wJl1q cI Platelet FIn:t:J.aJ in ~; 
~ Wltil 0 Imibitim 
Iam1l F Isl1m. t:avid Bereford, Michael Hart, David G Beevers, 
Departments of Cardiolc&v, Haamtolc&v ani Medicine, ~ I'oBd 
Iblpital, Binn:IngIan, lhited Kingdan. 
257A 
The in-vivo platelet release reactial, represented by plaslB Beta 
Thronbogl.ot:clin (B-TO). is krncl to be raised in essential twPer•
tensial. It is un::leer whether this is a pr~ or seccn:lary 
!iJeoonen<:n, ie whether l\ypertensial affecte this reactial directly 
or :In:lirectly by other meclEnisIEI such as derangenent of sane cceg•
ulatial factors or via vascular ermthelial d¥sf'unctial. Platelet 
functial was studied using plaslB B-TO levela ani ex-vivo platelet 
aggregatial in resp:r1Se to PJP, Adrenalin, Arachidcnic Acid, 
Ristocetin arrl Collagen in 10 patients with I.Iltreated un:arplicated 
essential hypertensial ani then ale IIDIth after Enalapril. l~ 
daily. Fran tre coogulatial factors we studied Fibrirogen arrl 
Factor XII activities, as well as Factor VIIIC activity which t~trer 
with PCE levela. renect vascular ermthelial cell tuIrover. The 
median systolic pressure dr<::wed fron Hi5 to l45mtfg (p<O.Ol) arrl 
median diastolic pressure fron 103 to 9&mtIg (pCO. 01) • Fibrirqen 
arrl Factor XII activities were narnel. before treatllEnt with no 
sighificant changes after EhalaprU trerapy. The levels of PCE 
ani Factor VIllC activity were high llOl1IBl (median 32U/L arrl 
105U/ ell) ; they fell after treatllEnt (median laJ/L ani 9QI/ ell 
respectively) but this trern was not significant. PlasIB B-TO 
fell fron a median of 70 to 49ng/ml after Enalapril. therapy 
(M.04). Platelet sensitivity to PJP, Adrenalin, Arachidcnic 
Acid, Ristocetin ani Collagen was not significantly clrmged. 
We CalClule that llI1CCI1lllicated essential l\ypertensial may prlnBrily 
affect platelet functial arrl that the l.niJrovEllBlt which occut'S 
wi th Enalapril. is not due to a drug-effect producing platelet 
rxn-reactivity, ie unlike Aspirin therapy nCJrnBl.ly associsted with 
reduced sensitivity to Ristocetin. This rnay also irrlicate a 







Neutrophil. &le.ate 'ulmonary 
1le.i.tance 
Geraci, Shinobu Kitsukawa, Robert E. 
Uniformed Services University, Bethesda, HD 
Pulmonary hypertension in systemic inflammatory 
states has been attributed in part to the action of 
activated neutrophils (NP). Evidence for this has 
been largely indirect, based on study of NP-depleted 
animals. Seeking direct evidence, we activated NP ~ 
~ and studied their effect on pulmonary vascular 
resistance (PVR) when reintroduced in~. In 14 
pigs, peripheral blood NP were isolated and incubated 
with 6 mM Ca·· and either an activator (10 nM phorbo1 
myristate acetate [PMA], total dose-33 ng; n-7) or a 
control salt solution (vehicle, n-7), then washed and 
resuspended. First, a small aliquot of cells (1 x 106 
NP) was injected into the pulmonary artery of the 
open-chested donor pig, and hemodynamics monitored for 
90 min. Next, pigs received a large aliquot of cells 
(1-3 x 108 NP) and 90 min monitoring. Finally, pigs 
were given the total amount of PMA used ~ ~ (33 
ng), to control for any passive "drug carrier" effect 
of the cell injectate. Maximum increase (from pre•
injection baseline) in PVR (4PYRmax) following each 
intervention was measured in Wood units (means±SE): 
I1Pva.a• PHA-incubated YAh' c1 .. -
incubated li2 
1. 0 x 10 6 celh 6.1 ± 1.1 1.7 ± .60 
1-3 x 108 cells 10.8 ± 2.7 2.9 ± .56 
PHA no cells 0.18 ± .07 0.80 ± .26 
Activated (PMA-incubated) NP induced marked elevation 
of PVR across a wide range of cell doses; vehicle•
incubated control cells caused only minimal elevation, 
while the effects of activator alone were negligible. 
Our data demonstrate directly the pulmonary 
vasoconstricting effects of NP activation. 
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913·113 
Role of Nitric Oxide in the Endothelium-Mediated Vasodilation 
to Substance P in Normotensive and Hypertensive Humans 
Julio A. Panza, Philip R. Casino, Crescence M. Kilcoyne, Arshed A. 
Quyyumi, Stephen E. Epstein. NHLBI, Bethesda, Maryland. 
We have shown that patients with essential hypertension have a 
reduced vasodilator response to substance P (Subs Pl. However, the 
mechanisms that mediate the vasodilator effect of Subs P have not 
been studied in humans. To determine the contribution of 
endothelium-derived nitric oxide to Subs P-induced vasodilation in 
normotensive and hypertensive humans, we studied the vascular 
response to Subs P during combined infusion of either dextrose 5 % 
or N"-monomethyl-L-arginine (L-NMMA; 4I'mollmin), an antagonist 
of the endothelial synthesis of nitric oxide, in 8 normals (4 male; age 
49±9 years) and in 8 hypertensive patients (6 male; age 50± 12 
years). Drugs were infused into the brachial artery and forearm blood 
flow (mIImin1l00 m1) was measured by strain gauge 
plethysmography. The vasodilator response to Subs P was depressed 
in hypertensive patients compared to normals (max flow 8.8±4 vs. 
13.9±4; p<O.04). L-NMMA significantly blunted the response to 
Subs P in normals (max flow fell from 13.9H to 9.5±2; p<O.OO4), 
and in hypertensive patients (max flow fell from 8.8H to 7.6H; 
p<O.03). However, after infusion of L-NMMA, there was no 
significant difference in the response to Subs P between patients and 
normals (max flow 7.6±4 vs. 9.5±2, respectively; p=NS). These 
findings demonstrate that the vasodilator effect of Subs P in humans 
is at least partly mediated by endothelium-derived nitric oxide. The 
equalization in the response to Subs P after inhibition of the synthesis 
of nitric oxide indicates that the impaired response to Subs P of 
hypertensive patients is related to a defect in the endothelial synthesis 
or release of nitric oxide. 
913·114 
Angiotensin COftYertilll Enzyme Inhibition PreveDls V oIl1111e-O"fer\oad 
Left and Rigbt Veutricular Hypertropby 
Joseph S. Janicki, "- Kabour. Jeffrey R. Heneaar. and BeaIriz B. 
Matsubua 
Univenity of MiS8OUri. Columbia, MO 
AngiolalaiD convertin, eazyme (ACE) iDhibitioo bas been shown to prevent 
left ventricular hypertrophy secoodary to suprareaal abdominal IOrta 
constrictioo and renovucular hypertensioo. To _ whethet the 
antihypertrophic effect of ACE iDhibitioo i. the result of normalizing 
angiotensin U plasma levels. Jisinopril (ACE!. 20 mg/kg/day) wu given to 
6 male, Sprague-Dawley rats (360 I) ODe day prior to and for 3 weeks after 
the creatloo of an infrareaaI abdominal artery-inferior vena cava fistula. 
This model of biventricular volume overload and hypertrophy is not 
accompanied by an increase in plssma angiotensin U. Age and sex mslched 
rats without (SHAM. n=6) and with (UNTREATED. n=6) fistula received 
no tteatment. All rats were sacrificed three weeks after initiatioo of the 
fistula at which time blood pressure (BP). body weight (BW.G) and left 
(L VW) and right (R VW) ventricular weights were obtained. At sacrifice. 
mean BP in the three poupa wu similar. Other results are ss foUows (*= 
P<O.03 VerBIII UNTREATED): 
GROUP SHAM UNTREATED ACE! 
BW 400±25 410±40 4OS±10 
LVW/BW. mgl, 2.2±0.1- 3.2±0.4 2.4±0.4* 
RVW/BW. mg/l 0.6±0.1* 1.0±0.1 0.7±0.1* 
As can be _. ACE iDhibitioo prevenred the biventricular hypertrophy 
_ in this model of volume overlOlid. Therefore. the anti-hypertrophic 
properties of ACE iDhibitioo is not related to its ability to normaJiz.c 
circu\atinl angiotensin U level •• 
913·115 
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The Ability of Low and Higb Dose Angiotensin Converting Enzyme 
Inhibition to Prevent Angiotensin n Related Myocyte Necrosis. 
Ameer Kabour • Jeffrey R. Henegar and Joseph S. Janicki. 
University of MiS8OUri. Columbia Missouri 
In renovucular hypertensioo (RHT). angiotensin converting eazyme (ACE) 
iDhibitiOll prevents ventricular hypertrophy regardless of its ability to control 
blood pressure. However. it is not known if the angiotensin U (AIJ) related 
myocyte necrosis can also be prevenredby ACE iDhibitioo without 
normaIizatioo of blood pressure. To study this hypothesis. RHT wu 
created by coostricting the abdominal IOrts and the right renal artery in 10 
Sprague-Dawley rats (250-300g). One day prior to and 14 days after RHT. 
three rats received high dose (20 mg/kg/day) Jisinopril (Group I). three 
received low dose (2.5 mg/kg/day) Iisinopril (Group U). and four received 
no Jisinopril (Group IU). At sacrifice (day 14 of RHTl. BP. body weight 
(BW) and left (L VW) and right (R VW) ventricular weights were obtsined. 
Formalin fixed cardiac tissue wu examined for myocyte necrosis and when 
necrotic areas (NA) were present. their number (#) and size (smaU 
(Sm)<O.04 m. Medium (Md) 0.04-<l.09 mm'. and Large (Lg» 0.09 
mm') were determined. The results are ss follows; 
GROUP I II III 
Mean BP. mmHI 79 116 122 
(LVW+RVW)/BW. mg/g 2.35 2.66 3.43 
# NAlHesrt 2.3 1.3 9.5 
Sm. NAlHesrt 1.6 0.6 2.5 
Md. NAlHesrt 0.7 0.7 4.8 
Lg. NAlHesrt 0 0 2.2 
'\S can De seen. bOtb low ana bJ2b <loses 01 lISIDO nl Markelll ' re<luce<I lbe g p y
number and size of the necrotic areas. Thus ACE inhibition. with or 
without normaIizatioo of blood pressure. is cardioprotective against AU•
related myocyte necrosis. 
913·116 
Blunted Atrial Natriuretic Peptide Response to 
Angiotensin II Infusion in Nonmodulating 
Essential Hypertension. 
Riccardo Leonetti Luparini, Claudio Ferri, 
Antonio Porzano, Giovanni B. Desideri, Anna 
santucci, Francesco Balsano. Institute of I 
Clinica Medica, University of Rome, Italy. 
To evaluate the Atrial Natriuretic Peptide 
(ANP) response to Angiotensin II (All) in 
nonmodulating hypertension, 31 essential 
hypertensive males received a graded All 
infusion (1.0 ng/kg/min and 3.0 ng/kg/min for 
30' each) on a low NaCI intake (10 mEq of 
NaCI/day). Patients were subdivided in low 
renin (n.S), nonmodulating (n.ll) and 
modulating (n.12) hypertensives. Baseline ANP 
was higher (p<O.OS) in low renin patients 
(S3.2±S.7 pg/ml) than in modulators (34.S±14 
pg/ml) and nonmodulators (32.1±S.6 pg/ml). All 
increased plasma ANP in low renin (90.1±S.S 
pg/ml at 60 min, p<O.Ol) and modulating 
patients (66.3±10.0 pg/ml at 60 min, p<O.OS), 
but not in nonmodulators (4S.4±14.3 pg/ml at 60 
min, n.s.). After S days on a high NaCI intake 
(210 mEq of NaCI/day) plasma ANP increased in 
modulating (67.1±7.6 pg/ml; p<O.Ol), 
nonmodulating (6S.S±21.1 pg/ml; p<O.Ol), and 
low renin patients (SS.1±12.4 pg/ml p<O.OOl). 
However, when the All infusion was repeated 
plasma ANP did not increase in nonmodulators. 
Conclusion: nonmodulators' failed to increase 
ANP levels during angiotensin II infusion, 
suggesting their sodium retaining tendency may 
reflect an impaired ANP responsiveness. The 
normal ANP response to high NaCI intake 
indicate the defect in ANP regulation is 
confined to the All-induced ANP secretion. 
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AngioteDsia-U Inducea Differential ChaDges In The lnDcrvaled and DeDervated 
Limbs 01 PatieDts with Unilateral Brachial Plexus Injury. 
~ S Kooner·, R Birch, W S Peart & C J Mathias. 
Clinical Cardiology Unit, Department of Medicine, Royal Postgraduate 
Medical School, London W12 ONN. Department of Medicine, St Mary's 
Hospilal Medical School, Norfolk Place, London W2 lNY. 
We investigated the contribution of neurogenic and direct vascular 
effects in the pressor action of angiOlensin.U (A· II), in S patients with unilateral 
brachial plexus injury (ULBPI) before and after cenlral sympathetic blockade 
with clonidine. 
BP and heart rate (HR)(Sentron), stroke distance (SD) and cardiac 
index (CI)(continuous wave Doppler) were made non-invasively. Simultaneous 
measurements of digital skin blood flow (DSBF) (laser Doppler) were made in 
the innervated and sympathetically denervated limbs of patients with ULBPI; A 
reduction in digital blood flow is a sensitive marker of sympathetically mediated 
vasoconstriction (Pickering GW, Heart, 16, l1S-13S, 1933). A-II was infused for 
6 min at each of 4 doses (0.001, 0.002, O.OOS & 0,01 ug/Kg/min) before and after 
clonidine(2ug/Kg,i/v). There was a dose related rise in BP after A-II. There 
was no difference in dose response curves to A-II before (3.±.2, 4.±.3, S.±.3 & 
1S.±.3%, respectively) and after (2.±.2, 4.±.2, S.±.2 & 16.±.2 %) c1onidine. The 
pressor response to A-II was due to a rise in systemic vascular resistance as HR, 
SD and CI were unchanged. A-II induced digital skin vasoconstriction in the 
innervated (10.±.6, 3S.±.S, 61.±.17 & 85.±.16 %, P <O.OS) but not in the denervated 
limb (1.±.4, -6.±.9, -S.±.l1 & -6.±.14 %, ns). After clonidine, vasoconstriction did 
nOl occur in response to A·II in the innervated (-2.±.2. 1.±.6, 9.±.9 & 2O.±.11 %,ns) 
or the denervated limb (-6.±.9, 1.±.9, S.±.l1 & 10.±.11 %, ns). 
We conclude that the ability of angiOlensin-n to increase blood pressure 
after central sympathetic blockade with c10nidine is due to its direct vascular 
effects. Digital skin vasoconstriction however is due to a centrally induced 
increase in sympathetic nervous activity as it can be inhibited by clonidine and 
does nOl occur in the denervated limb. 
913-118 
Effed of Alltlhypertell.lve Tralmellt With CalclulD antaaoDlsts or ACE 
Inhlblton 011 Clrcacll .. Heart Kale Varlablll17. a. EvaJaaled by Power 
Spectral ADaIysIa 
Damiano RirzoDi, Maria Loreaza MuiesaD, Maurmo CasteUano, Roberto 
Zulli, Giorgio Bettoai, Eazo POtteri, Earico Agabiti-ROICi. Cattedra di 
Mediciaa Interaa, UaM:rsity 01 Brescia, Italy. 
Power spectral analysia (SA) 01 heart rate (HR) may provide useful 
informatioa about cardiac neural activity. A.bI 01 this study was to evaluate 
indl=s 01 cardiac sympalhctk and parasympathetic: activity, as assessed by SA 
01 HR, in hypertensive patieata (H pta) belore and after antihypertensive 
treatment In 14 H pta (12 males, 2 females, age range 33-61) and in 7 
normOlensive subjects (4 males, 3 females, at: range 32-52) a 24 hour ECG 
Holler monitoring was performed in basal o,.nditions; the examiaation was 
repeated after 6 months 01 therapy with N'tfed:pine (NIF) (n = 7) or Enalapril 
(EN) (D-7), giveD in a random order, in H pta. Sequeaces 01 512 R-R intervals 
were takeD for the evaluatioa of SA (&x-Jenkina method); absolute and 
Dormalized power spectral density (PSD) of the peak at 0.10 Hz (low 
frequency peak: LF) and at 0.25 Hz (high frequeacy peak: HF) as well as their 
ratio (possible index of sympathovagal interaction: SVI) were calculated. In 
basal cODclltlOII.: SVI was significantly decreased from daytime to night-time 
in normOlensives (3.4.±.2.S w.2.43.±.l, p<O.OS), while no change was observed 
in H pta (S.08.±.7.9 vs. 8.7.±.6.06). After treatmeDt: in all H pts a reduction of 
SVI during night·time in respect to basal values (-4.97.±.7.3, p<O.OS) was 
observed. SVI during night-time was significantly reduced with bOIh NIF and 
EN (-5.7.±.5.9, p<O.OS and -3.8.±.S.5, p<0.05, (o:spectively), while SVI during 
daytime was slightly increased (+ 1.8.±.5.S) during NIP Ircatment, and 
significantly reduced (-3.5.±.5.35, p<O.OS) Luring EN treatment (p<O.OS 
betw=D Ircatmcnts). Systolic and diastolic an :riaI pressure (SAP and DAP) 
as well as LV mass index (L VM1) were ~caaIIy reduced with bOIh 
Irealments (SAP and DAP: NIP: from 146/,,'l.±.20/12 to 134/92.±.lS/9 mm 
Hs, p<O.ool; EN: from lSO/102.±.18/10 to 1 O/94.±.lS/1 mm Hs, p<O.OOl; 
Lw.p: NIP: from 117.±.29 to 107.±.22 p<0.05: EN: from 129.±.64 to 112.±.30 
g/m p<O.OS)." CODduiOll: long term lrealm.:nt with NIP or EN seems to be 
able to restore an impaired daytime to night-time SVI modulation in H pis. 
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913-119 
Disparate Vascular and Pressor Respoll5Cs to Angiotensin·II after 
Sympathetic Blockade in Conscious Rabbits. Separation of Peripheral and 
CenIraI Aqioos of Aagiotensin-u, • 
JS Krouer , CN May, WS Peart and CJ Mathias. Clinical Cardiology Unit, 
DepartmeDt of Medicine, Royal Postgraduate Medical School, London W12 
ONN. St Mary's Hospital Medical School, London W2 lNY. UK 
The rise in blood pressure after acute intraveDous (IV) administration 
of angiOlensin-U (A-U) is thought to be due to a combinatioD of its direct action 
on vascular smooth muscle and its indirect effects resulting in iDcreased 
sympathetic nervous activity. To investigate tbe relative importance or these 
effects in the pressor actiOD of A-II, we Sludied the effect of IV A-U (0.001, 0.Q1 
& 0.05 mcg/Kg/min) on mean arterial pressure (MAP), heart rate (HR) 
cutaneous ear blood flow (EBF) and plasma noradrenaliDe (PNA) levels in 
conscious rabbits, before and after inhibition of ceDtral sympathetic outflow, with 
IV (15mcg/Kg) aDd intracisterDaI (IC,1mcg/Kg) c10nidine and ganglionic 
blockade with IV pentolinium (lSmg/Kg). 
Clonidine (IV and IC) and pentolinium (IV) lowered MAP, cutaneous ear 
vascular resistance (EVR) and PNA HR fell after clonidine (IC, IV) but rose 
after pentolinium. After A-II, there was a dose-related increase in MAP (O.S.±.2. 
12.±.3 & 34.±.4 mmHg) which was not reduced by IV c10nidine (2.±.1, lS.±.3 & 
36.±.4 mmHg). Similar responses occurred after IC c1llnidine and IV 
pentolinium. A-II did nOl alter HR significantly before or after clonidine (IV or 
IC) or pentolinium. A-II induced a dose-related fall in EBF and rise in EVR 
(2.±.6, 61.±.22 & 1n.±.7S mmHg/v) which was prevented by IV c10nidine (0.6.±.1, 
10.±.7 & 22.±.13 mmHg/v). Similar responses occurred after IC c10nidine and IV 
pentolinium. After A-II, there was a fall in ear, but not back or rectal 
temperature. A-II did nOl influence temperature at any site after clonidine (IV 
or IC) or pentoliaium. PNA fell after A-II and plasma adrenaline levels were 
unchanged. 
We conclude tbat in conscious rabbits, IV A-II causes cutaneous ear 
vasoconstriction, by a centrally mediated increase in sympathetic nervous 
activity, which is abolished by c10nidine (IV and IC) and pentolinium. This is in 
conlraSl to the acute pressor effect of A-n, which results from its direct vascular 
effects and is not dependent on ceDtral or ganglionic stimulation of the 
sympathetic nervous system. 
913·120 
Postprandial Hypotension In Tetraplegits 
Ragavendra R. Bahgal. Ammlll B. Catzl , Deborah J. Shortl. Hans L. Frankel 
I, Chnslopher JMalhias2-
INationai Spinal Injuries Centre. Ayelsbury and 2St Mary's Hospilal Medical 
School. London. UK 
Some palients wllh aUlonomic failure experience an exacerbation of their 
symptoms of poslural hypolension after food. We have IDvestigated the effects 
of a liquid meal (66g carbohydrate. ~2 g fal, 18g protein) on supine blood 
pressure and heart rate in 6 complete tetraplegif..'S with postural hypotenSion. 5 
paraplegics (low spinal cord leSIon) with no poslural hypotension ser\'ed as 
controls. All subjects were sludied after a S hour fasl and were supine for al 
least 30 mmutes before measurements were made. None of them had angina. 
Non invasive measurements of heart rale and blood pressure (Sentron) were 
made al baseline and IS min. 30minutes and 40 minutes after food. Blood 
samples for plasma adrenaline were laken through an IDlravenous cannula 
simullaneously. 
Telraplegics had lower basal systolic BP. hean rale and plasma noradrenaline 
levels (l19:t.7 mm Hg, 59±,4 bealSlmin and 91±.38 pglml) as compared 10 
controls (133±.13 mm Hg. 83:t.1~ bealSlminule and 323±.124 pglml. p<O.05). 
There was no difference in the basal diaslolic BP in lhe Iwo groups (72:;t8 vs 
72±,9 mm Hg). After Ihe meal there was a fall in BP in telraplegics (i03±.5/ 
S7±.3. 108±,7/ 58±,5 and 107±.13 / 56±. 6 mm Hg al 15,30 and 40 min 
respectively. P<O.OS for each change) wilh no change in BP in controls 
(127±.IS / 67±.S. 129:t,23 I 70:±,7. 13 I±.I I nO:±,I3 mm Hg at 15,30 and 40 
min respectively, ns). There was no significanl change in heart rates in both 
the groups. After food there was no sigruficanl change in plasma noradrenaline 
levels in IClrapiegics whereas in controls there was a significanl elevation after 
food (to 439:t,149 pg/ml at 15 min. p<O.05). 
Conclusion: Telraplegics Ihus have postprandial fall in supine blood pressure 
which is nOl accompanied by an increase in plasma noradrenaline levels seen in 
conlrols . This fall in blood pressure. e"en in lhe supine posilion would be 
expected 10 won;en the effects of poslural hypotension in these patients. 
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Plasma Endothelin-l is Related to Pulmonary Blood Flow 
Irrespective of Pulmonary Artery Pressures 
Julie A. Vincent, Robert D. Ross, Joseph Kassab, Julie 
M. Hsu, William W. Pinsky, Children's Hospital of 
Michigan, Wayne State School of Medicine, Detroit, 
Michigan 
Endothelin-l (ET-l), a potent vasoconstrictor peptide, 
recently was shown to be elevated in children with 
pulmonary hypertension associated with congenital heart 
defects. To evaluate the effect of pulmonary blood flow 
on ET-l concentrations, 5ml blood samples were obtained 
peripherally at cardiac catheterization from 35 pts, 
ages 0.13-17 (median 2) years. Plasma was extracted and 
ET-l measured by radioimmunoassay. Patients were 
divided into 2 groups based on the presence (Gp A) or 
absence (Gp B) of increased pulmonary blood flow (Qp:Qs 
~ 1.5:1). When the 13 pts (37%) in Gp A were compared 
to the 22 pts (63%) in Gp B there were no significant 
differences in age, cardiac index, or pulmonary and 
systemic resistances. ET-l concentrations were 
significantly higher in Gp A pts (median 3.25, range 0-
16.5 vs median 0, range 0-6.35 pg/ml; p $ 0.05). 
Pulmonary blood flow and pulmonary artery pressures 
(PAP) were also higher in Gp A pts (p s 0.01). However, 
when the 7 pts in Gp A with elevated PAP were compared 
to the 6 pts in Gp A with normal PAP their ET-l 
concentrations were no different (4.4 ± 4.3 vs 4.0 ± 6.4 
pg/ml). Conclusions: 1) Plasma ET-l is elevated in 
patients with increased pulmonary blood flow as in those 
with pulmonary hypertension. 2) It appears that this 
increase in ET-l occurs with increased pulmonary flow 
irrespective of pulmonary artery pressure. 
762·2 4:15 
BaU_ palmOIWJ Yalve dllaliOD ror crlllcal palmOlW7 steaosil Ia tile 
DeOaate 
Anna M Colli, John F Keaae, Staaton B Peny, James E Lock, Children's 
Hospital, Bo&toa, Mass 
Although isolated case reports and small series of patients (pta) haw 
demollllrated the feasibility of balloon pulmonary YaIw dilation (BPVD) in 
aeoaates, the frequeac:y of death, procedure failure and morbidity remain ill 
defined. From 1985 to 1992, all 34 aeoaates (age 1-29 days, mean 7.9) with 
critical PS underweat attempted BPVD. No antegrade flow was detected in 2 
pta. Eighteea pts were OD POEl iafuaion at the time of cardiac catheterization 
(Ce). Weight was 3.6.±.0.5 Kg (range 2.8-S.0), annulus size was 6.8.±.1 mm( 4.8-
8.5). Approach was from the femoral vein in 33. 
Results The systolic ejection gradieDt at CC was estimated at 62.6.±.34.3 mmHg 
«()'110) pre BPVD and 24.4.±.19.9 mm Hg «().8S) post BPVD. The RV /LV 
pressure ratio was > 1 in all but 1 Deonate pre BPVD and fell to 0.8.±.0.3 (0.4-
1.3). The ballOOll/annulus size ratio was bctwcca1.0 and 1.6 in 32/34 Deoaates 
(mean1.2.±.0.2). 
Morbidity There were no procedural deaths. Two deaths occurred following 
diiltioa: the ODC neonate with shock and RV /L V ratio < 1.0 prediiltion died of 
Decrotizing enterocolitis and sepsis 7 hours post dilatioa; a secoad DCoaate 
(with dysplastic val'll and unsuccessful dilation) died at later operation.There 
were four technique related complicatioas: 1 pt had myocardial perforatioa 
requiring pericardiocentesis,another developed iliac vein occlusion with ballooa 
passage, one required streptokiaasc for pulse loss, another developed staph 
aureus endocarditis. Repeat ballooD valvuloplasty was required in S /34 pta 
(14%),3 days to 16 months Iater,in 2 pIS with hypop1astic annulus, 2 with 
dysplastic va1ves and the pt with vascular access problems. Two pts required 
surgery for residual PS, with the ODe death DOted abow. 
Followup Thirtytwo pIS haw beeD followed for 32.3.±.24.5 months(l-9l). All arc 
well and their gradieDt(mean 21 .±.13 DUD Hg.rangc S-SS),estimated by Doppler, 
has remained stable or decreased. 
Coaclusloaa BPVD is feasible in all acoaates, although hypop1astic or 
dysp1astic valves may require multiple procedures. Care and ~pr~d ballooas 
are required to decrease the incidence of access related complicauoas and 
procedure related infcctioa. 
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Catheter Closure of Multiple Venlricular Septal Deleds With 
T~eal Echoau-diop-apb Guidance 
Mary E. van der Velde, Stepbea P. Sanden, StsDIoa B. Perry, Jolm P. 
Keane, JUDeII E. Lock_ Childrca'. Hospital, Booton, Massachuaetta. 
PrcIimiaary cxperieace sugaeoted that na-opbaacaJ echo (TEE) 
!Dipl be _ful durin, catheter closure of ventricular septal defecta (VSDs). 
We reviewed tile resulta of TEE imagin, of intraventricular umbrcllaa, 
focusin, 011 I) _I of device arm positioa, 2) distance from valvar 
sInIctureII prior to device rel_, and 3) preseao:e of pcri-umbrella Ieab and 
IIdditioaa1 defecta after rel_. 
Forty clamshell devices were placed in 26 patienta usia, TEE 
gaidaace (21 muscular VSDs, 14 postoperative patch IIIIIrJiD VSDs, 2 post. 
infudioa VSDs, 2 left ventricle (LV) to ript atrium (RA) shUDta, and 1 
f--..t VSD patch). Tbirty-tJix of 40 devices were well-viSlll!iz.ed (all 8 
arms localized); 2 were imapd indistinctly, and 2 were DOl well-imaged. 
Four c1amsbell. were adjacent (within 2-S mm) to IOmc valve leaflets but 
did DOl cause AR. No device placement caused AV valve insufficiency. 
Ma1a1iJllllll'llI of tile apical muacular septum was di8JDOSed ia 3 patienta. 
Residual flow was abaeal in 4/40, trivial or small ia 12. sigaificantly reduced 
in 10, and was difficult to quantify accurately ia 13. Device embolization 
with operatiD, room retrieval occurred ia I patient. Preseoce and &IIIOIIIIt of 
residual flow correlated sIroIIllly with angiolfllPhy. Because of reduced 
contrut load, in 10 patienta TEE allowed multiple (2-3) umbrellas to be 
placed ia tile ventricular septum durin, a single catheterizatiOD. TEE also 
allowed other iaterventiona1 procedures (2 patent foramca ovale devices. an 
LV outflow tract steat. pulmoaary artery dilatioa and steat placement) to be 
performed ia S patienta. No TEE-asaociated morbidity was observed. 
We COIIClude that TEE durinll transcathcter VSD closure provides 
excellent loca1izatioa of individual device arms with respect to tile septum 
and other intracardiac structures more readily than fluoroscopy and 
anciolfllPhy. TEE reduces contrut require_tao thereby allowinll multiple 
iDterventiODa1 procedures durinll a siagle catheterizatiOD. TEE seems 
indicated during catheter VSD closure when I) VSD. arc adjacent to valve 
ti_, or 2) multiple defecl closurco arc anticipated. 
762·4 4:45 
International Experience With Atrial Septal Defect Occlusion 
With The Buttoned Device 
E. B. Sideris, P. S. Rao, T. R. Lloyd, R. H. Beekman, A. M. Worms, G. 
Hausdorf, C. Rey, F. Sourlon, J. Losay, E. Onorato, J. Haddad. 
Athenian Institute of Pediatric Cardiology, Athens, Greece, and 
University of Wisconsin Medical School, Madison, WI 
During a 4-year-perlod ending August 1992, 105 transcatheter atrial 
septal defect (AS 0) occlusions have been performed with the 
buttoned device by the American and European investigators. The age 
of the patient varied between 0.5 and 76 years, and the stretched 
ASO diameter between 5 to 25 mm. The ASOs were closed with 25 to 
50 mm devices delivered via 8-F (96 patients) or 9-F (9 patients) 
sheaths. Eight patients were adults whose defects were closed to 
prevent recurrence of cerebrovascular accidents secondary to 
paradoxical embolism. In the remaining patients, the ASO was closed 
to treat the left-to-rlght shunt. The ASOs were effectively occluded as 
demonstrated by: 1) decrease in pulmonary-to-systemic flow ratio from 
2.1 :t 0.6 (mean :t SO) to 1.04 :to. 1 by oximetry; 2) normalized 52 and 
disappearance of the diastOlic murmur by auscultation; and 3) 
improvement in right ventricular (RV) volume overload by 
echocardlogram. However, trivial shunts could be detected by color 
Doppler flow studies in 30 of 90 (33%) patients in whom such 
information is available. Complications included unbuttoning in 8 and 
whole device embolization in 1. All 9 patients remained stable and 
retrieval of the device and surgical closure of the ASO were 
accomplished without complication in 7 patients. Transcatheter 
retrieval was used in the remaining 2 patients. Follow-up information is 
available in all but the last 5 patients. The follow-up duration varied 
between 1 month and 3 years (median - 6 months). Clinical 
examination did not reveal signs of atrial shunts. Chest x-rays did not 
show wire fractures or displacement of the device. The size of the RV 
decreased and paradoxical septal motion returned to normal. Color 
Doppler studies revealed either complete disappearance of the 
previously demonstrated shunts or further diminution in their size. No 
recurrence of paradoxical embolism was observed in the adult patients. 
Conclusion: These data indicate that transcatheter occlusion of the 
ASOs with the buttoned device is effective and safe. Complications 
are infrequent and may improve with experience. 
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Intracardiac .tent iaplantation to relie.e au.cular 
and non-au.cular ob.truction. 
Stanton B. Perry and Jame. B. Lock 
Obstructions due to ventricular myocardium do not 
respond to conventional balloon dilation and attempted 
surgical relief often fail •• We report intracardiac 
implantation of stents (Palmaz, Johnson & Johnson) to 
relieve muscular (n-6) and non-muacular (n-4) 
obstructions in 10 patients (pts). Pts ranged in age 
from 6 months to 16 years (6.8:4.6 yrs). Surgical 
relief had been attempted in 8 and all were either 
inoperable or felt to be high-riak surgical 
candidate.. In 6 of 10 pt. the obstruction was within 
the myocardium. In 5, there wa. ob.truction to left 
ventricular outflow: restictive VSD in 2 (1 Rastelli 
and 1 Fontan), a subaortic conus in 1, subpulmonary 
atenoai. in an I-TGA in 1 and steno.i. at the 
venticular end of a LV to descending aorta conduit in 
1. The other patient had tetaloqy of Fallot with 
subpulmonary stenosis. In 4 of 10 pta, the stenoaia 
was non-muacular but the stent was positioned with the 
proximal end in the muscular portion of the right 
ventricular outlfow tract (RVOT). 
ae.ult.. Overall, the diameter of the narrowest area 
was increased from 4.5:1.4 to 10.8:2.0 mm (increase 
ranged from 67 to 250\). The peak .ystolic ejection 
gradient decreased from 74:31 to 20:10 mm Hg. There 
were no significant procedural complications. 
Follow up. During follow up of 10.8:6.2 months, 3 RVOT 
stents (an articulated renal, a 12 and a 30 mm iliac) 
fractured. Both iliac stents had been dilated with 
high pressure balloons. Of these, 1 has been 
successfully restented and 1 underwent surgery. 
otherwise, there has been no evidence of restenosia. 
Pts are maintained on coumadin or aspirin with no 
clots or strokes. There have been 2 deaths, neither 
related directly to the stent. 
Conclu.ion.. Stent implantation can effectively 
relieve intracardiac obstructions. Further follow up 
is required to determine the incidence and cause. of 
stent fracture. 
762·6 5:15 
Two-Dimensional and Doppler Ultrasound Evaluation of 
Femoral Arteries in Infants After Cardiac Catheterization 
Keith C. KOCiS, A. Rebecca Snider, Roger P. Vermilion, Robert H. 
Beekman, University of Michigan, Ann Arbor, MI 
To determine if femoral artery injury occurs after cardiac 
catheterization in infants under 1 yr of age, 28 infants (6.9%3 mas, 
6.4%2.2 kg) underwent two-dimensional, pulsed and color Doppler 
ultrasound exams of the common (CFA), superficial (SFA), and 
deep (DFA) femoral arteries. Infants with previous femoral artery 
cannulation and aortic coarctation were excluded from the study. At 
cardiac cath, pts were randomized to receive a sheathed or non•
sheathed arterial catheter and systemic heparinization was used. 
Ultrasound exams were performed before cath in 28 infants and 24 
hrs after cath in 20 infants using a 128 element 7 MHz linear array 
transducer. Pulsatility index (PI) was calculated as (maximum -
minimum velocity) I mean velOCity. After cath, 6 pts (30%) had 
obstruction (OBST) of the CFA as evidenced by flow disturbances 
on color Doppler exam, abnormal pulsed Doppler tracings in the 
CFA and SFA (absent or continuous forward flow), retrograde flow 
on I D I . h DFA d d P' co or oppler In t e , an ecreased Is. 
Pre Post (No OBSn Post (OBSn 
n 28 14 6 
CFA 7.9±3.2 9.0±2.8 2.1±O.2' 
SFA 11.8±8.0 9.6±4.3 2.1±O.S' . P <0.01 repeat measure.s analysIS of vanance 
Post-cath in the pis with obstruction, the PI of the non-cannulated 
leg did not differ from the PI's of both legs of the pre-cath pts or the 
post-cath pts with no obstruction. 'CFA obstruction occurred in 3 pts 
with sheathed and 3 pts with non·sheathed arterial catheters. Thus, 
femoral artery injury occurs frequently in infants <1 yr of age 
undergoing cardiac cath. Two·dimensional and Doppler ultrasound 
examination of the femoral arteries is useful for identifying these 
arterial complications. 
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Abnormal Early Diastolic Left Ventricular Subendocardial Function 
in Syndrome X 
Michael Y Henein. Giuseppe M C Rosano. Richard Underwood. 
Philip A Poole-Wilson. Derek G Gibson. The Royal Brompton 
National Heart and Lung Hospital. London, UK. 
The function of the long axis of the left ventricle. representing that 
of the subendocardium. is frequently abnormal in patients with 
coronary artery disease. These disturbances are early diastolic 
(ED) in timing and normalised by successful PTCA. Their possible 
occurrence in syndrome X was assessed in 20 pts (age 57 ± 7 yrs) 
with chest pain, positive exercise test, and normal coronary 
arteriograms. 20 directed M-modes of LV transverse and long 
axis. and Doppler transmitral flow velocities were recorded at rest 
and digitised. The onset of ED long axis lengthening was delayed 
by > 90 ms in 9 pts, its peak velocity reduced to < 4 cm.s-l in 8, 
and A wave amplitude increased to >45% total in 7 , the 95% 
confidence limits from 21 normals, age 51 ± 11 yrs. Thallium 
scans, independently reported, showed reversible defects in 8 pts, 
5 definite and 3 probable. ED disturbances were present in all 
these 8 pts, compared with 3 of 11 with normal thallium scan 
(p<O.OO1), reduced ED velocity (p<O.OO1) being slightly more 
specific than delayed onset of lengthening (p<0.002). A wave 
amplitude (p<O.ll) failed to discriminate and EtA ratio was 
normal in all. 
Thus: ED subendocardial function may be abnormal at rest in 
patients with syndrome X, particularly when thallium scan shows 
reversible ischemia. We suggest that these early diastolic 
disturbances compromise coronary flow during stress, when 
diastolic time is shortened, leading to reversible perfusion 
abnormalities. 
763·2 4:15 
R .. lonal LV Diastolic Function and Myocardial Structure In 
Coronary Artery Disease 
Otto N. Krogmann, Juerg Traber. Otto M. Hess, Markus Jakob, Hans P. 
Krayenbuehl. UniversHy HospHal. Zurich. SwHzenand 
Global and regional diastolic functiori was assessed from simuHaneous 
biplane angiography and high-fidelity pressure measurements in 16 patients 
(pis) with either normal (C. n-7) or stenotic coronary arteries (CAD. n-13). 
Pts wHh CAD were studied before and 6 months after successful coronary 
revascularization (n-7). Regional ejection fraction (REF) was evaluated at 
rest (r) and during supine bicycle exercise (ex) using a radial axis system wHh 
6 different sectors in the right and left anterior oblique projection. From the 
behaviour of the regional ejection fraction during exercise a normo- (r: 47"10. 
ex: 48%. NS) and a hypokinetic segment (r: S2%, ex: 30%. p<0,05) were 
defined (C: r: 41%. ex 55%; p<O.OS). Global (pressure-volume) and regional 
(pressure-area) chamber stiffness were assessed by an elastic model wHh 
shifting asymptote. Transmural LV biopsies were taken at surgery in the 
norma- and hypokinetic region. InterstHial fibrosis and muscle fiber diameter 
were evaluated by morphometry. 
The constant of global chamber stiffness (l/mvm2) increased during ex from 
0.05 to 0.09 in C. from O.OS to 0.10 in preoperative pts with CAD and from 
0.06 to 0.08 in postoperative pts (all NS; no d~ference between groups). 




Myocardial structure showed muscle fiber hypertrophy (normo-: 30 11. hypo•
kinetic regions: 28 11; NS; norm :s: 2311) as well as increased interstHial fibrosis 
(norrno-: 16%, hypokinetic regions: 21%. p<O.OS; norm :S:10%). 
Thus. in patients with CAD regional diastolic stiffness is increased during 
exercise in the ischemic but not in the regions supplied by nonstenosed 
arteries. DespHe profound aHerations in myocardial structure regional chan•
ges in diastolic function are reversible after successful revascularization. 
262A ABSTRACfS 
763·3 4:30 
Impairment of Regional Relaxation and Filling In the 
Angina-free Period In Patients with Vasospastic Angina 
Noboru Ishikawa. Toshiaki Kumada. Masashi Kambayashi. Wataru 
Hayashida. Michiyo Noda. Fujimasa Kohno. Chuichi Kawai. Shigetake 
Sasayama. 
Kyoto University. Kyoto. Japan 
To study diastolic function in the left ventricular region which is rendered to 
be ischemic by coronary spasm. cardiac catheterization and left ventricular 
cineangiography (Millar's catheter) were performed in the angina-free 
period in 13 patients w~h spasm of the left anterior descending coronary 
artery alone (spasm group) and in 11 normal subjects. The left ventricular 
silhouette (right anterior oblique view) was divided into 8 areas by one long 
axis at 4 equal intervals. Regional wall stress (a: Janz's method) in 2 mid•
anterior (ANT) and 2·mid inferior (INF) areas were computed. Global left 
ventricular function in the spasm group was normal except for the 
decreased peak filling rate and left ventricular relaxation (p<0.05: vs 
normal subjects). In ANT. lime constant of left ventricular regional wa. 
stress decline during isovolumic relaxation and regional peak filling rate 
(normalized by end-diastolic area) were significantly impaired in the spasm 
group compared to those in normal subjects (the former: 43t11 vs 34t5 
msec. the latter: 2.3tO.8 vs 3.2t0.7 1/sec. both p<0.01). In addftion. in 
ANT regional peak filling rate negatively correlated to the time constant in 
spasm group (r=O.55. p<0.05. S,..---------~ 
figure). 
Conclusion: in vasospastic 
angina. not only global but j .. 
regional filling was decreased_ 
even in the angina-free period. the ; 3 
decreased regional filling which I 
was found in the side where 'I 2 
spasm occurred and was related .; 
to the impairment of regional l 1 
relaxation. 
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Lat. Rttecta ot cardiomyoplaaty on Lett 
ventricular Diastolic pilling. 
Giovanni Bellotti, Alvaro Moraes, Edimar 
Bocchi, Siquemituzo Arie, Luis Felipe 
Moreira, Adib Jatene, Fulvio pileggi. Heart 
Institute of University of Sao Paulo, Brazil. 
The effects of cardiomyoplasty (CMP) on LV 
diastolic filling were studied in 8 pts (45±7 
yrs) submitted with success to CMP for 
treatment of refractory heart failure. The 
pts were submitted to simUltaneous Echo•
Doppler-Hemodynamic (tip catheter) studies 
12±1 months after CMP with stimUlator ON and 
OFF (24 hours OFF). End diastolic pressure 
(EDP) , pressure/volume relation, mitral flow 
velocities and mitral annulus area (from 2D•
echo, assuming a eliptical shape and a linear 
variation from end-systole to end-diastole) 
were obtained. Subsequently, chamber 
stiffness (Kp), early peak flow (EPF), first 
derivative of EPF (dF/dT), deceleration time 
of EPF (DT), and flow areas during rapid 
filling (ARF) and atrial contraction (AC) 
were analyzed: 
OFF ON P 
EDP-mmHg 27.1±2.8 17.6±1.7 .019 
Kp-mmHg/cm 120±31 52±11 .017 
EPF-ml/s 231±20 217±21 .022 
dF/dT-ml/s2 4.27±.41 3.28±.57 .010 
DT-s 163±28 116±26 .001 
ARF-ml 105±15 75±12 .004 
AC-ml 39+4 88+9 .001 
In these pts, CMP -significantly changed the 
pattern of LV diastolic filling by decreasing 
chamber stiffness of the failing heart. 
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Inftuence 01 Filling on Left Ventricular Diastolic Pr ... ure-Volume 
ReiMion During Pacing-Induced I.chemla In Doga 
Hideo Shintani. Stanton A. Glantz 
University d California, San Francisco. San Francisco. CA 
The mechanism d the reversible upward shift d left ventricular diastolic 
pressure-volume relation during pacing-induced ischemia has not been fully 
explained. To test the hypotheSis that stretch 01 the ischemic myocardium 
due to filling affects the upward shift, we investigated the end-diastolic 
pressure-volume relation (EOPVR) defined by both filling and non-filling 
beals using our in situ volume clamp model in 10 dogs. After implantation 
d a modified Bjork-Shiley valve to prevent filling during diastole. we 
inserted Millar and conductance catheters into the left ventricle and plotted 
EOPVR points in filling and non-filling beats and calculated isovoIumic 
relaxation time constant (r J and a ratio 01 total diastolic lime to time 
constant ~r J. After baseline measurement. left anterior descending and 
circumflex coronary arteries were constricted. reducing the flow by 42%. 
Next, the right atrium was paced at 1.5 times the resting heart rate for 3 
minutes. The changes in hemodynamics. r _ and tJr. were analyzed by 
multiple linear regression implementation 01 a repeated measures ANOVA 
with dummy variables that accounted for pacing. stenosis. pacing-induced 
ischemia and differences between dogs (change±SE). Pacing-induced 
ischemia shifted and EOPVR in filling beats upward compared to the 
EOPVR d the normal filling heart. while the end-<liastolic points for non•
filling beats during pacing-induced ischemia fell on the control EOPVR. 
Increase in r _ with ischemia was not large enough to explain the upward 
shift throughout diastole. Left ventricular filling ~ was necessary for 
the upward shift 01 the diastolic pressure volume curves during pacing•
induced ischemia, suggesting that the active force developed during 
diastole induced by stretch-activation in the ischemic myocardium during 






EOP (mmHg) EDV (mQ r. (msec) 
11±1' 126±2 52±2 
-3+1 2+3 5+4 
1+1 ·1+3 2+3 








Catecholamine-Induced Early Relaxation is Counteracted by 
Cardiac Muscle Lengthening 
Puneet Mohan. Walter 1. Paulus, Stanislas U. Sys 
University of Antwerp. Antwerp. Belgium 
Deficient acceleration of LV relaxation during exercise after 
cardiac transplantation was recently suggested to be due to an 
interaction between utilization of LV preload reserve and a 
deficient response of LV relaxation to catecholamines. We 
analysed this possible interaction in isolated cat papillary muscle 
(n= 11, Krebs-Ringer. [Ca2+] 1.25, 2.5, 5 mmol/l, 35°C). Isometric 
twitches were obtained at different muscle lengths (mean:t S.E.: 
87.9:tO.8 to 103.0:tO.2 % of optimal muscle length or Imax). prior 
to and after addition of B-agonist isoproterenol (ISO:3x1o-7 
mmol/l). Since an increase in muscle length prolongs twitch 
duration. attempt was made to find the increase in muscle length 
required to counteract the twitch shortening effect of ISO. 
Results: The positive inotropic effect of ISO was independent of 
muscle length. It was most pronounced at [Ca2+] = 1.25 mmol/l 
where. averaged for muscle length. active tension increased by 
22.3±2.4 mN/mm2 and peak rate of rise of tension by 274:t31 
mN/mm2/s. ISO shortened twitch duration by 6.1 :to.7 % for time 
to peak active tension (tAT) and by 6.6±O.6 % for time to half 
relaxation (tHR). This reduction was independent of muscle 
length or [CaH ]. However this twitch shortening effect of ISO Was 
abolished by only a small increase in muscle length; this increase 
was +2.6±O.4 %lmax for tAT and +3.5±O.5 %lmax for tHR. 
Conclusion: A small increase in cardiac papillary muscle length 
counteracts catecholamine-induced improvement of relaxation. 
Thus. at the myocardial level. LV preload reserve utilization 
during exercise may explain the deficient acceleration of LV 
relaxation in the transplanted heart. 
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Patent Foramen Ovale in Young Patients With Stroke or 
Transient Ischemic Attack is an Incidental Finding by 
Transesophageal Echocardiography 
M. Elizabeth Brickner. Daniel B. Friedman, Carlos G. Cigarroa. 
Arvella Peters. Mannil Abraham. Micki Lacker. and Paul A. 
Graybum. 
UT Southwestern and V A Medical Centers. Dallas. TX. 
Patent foramen ovale (PFO) is often detected by transesophageal 
echocardiography (TEE) in patients with stroke (CV A) or transient 
ischemic attack (TIA). Accordingly. some physicians recommend that 
TEE be routinely employed in the evaluation of young patients with 
CV A or TIA to detect PFO as a potential source of cardiac embolism. 
We performed TEE in 60 young patients (mean age 34 yrs. range 17-
45) with unexplained CV A or TIA. None of these patients had clinical 
evidence of cardiovascular disease as determined by history. physical 
examination. ECG or chest X-ray. TEE was also performed in 54 
young normal volunteers with no evidence of cardiac disease and no 
history of neurologic symptoms (mean age 35 yrs. range of 23-45). 
Doppler color flow mapping of the interatrial septum was performed 
in all subjects at rest and during maneuvers (cough and Valsalva). 
Contrast echocardiography using agitated saline was also performed in 
all subjects. both at rest and during maneuvers. PFO was identified in 
13/60 patients with CV A/TIA (22%) and in 11/54 normal volunteers 
(22%) (p=O.9). There was no difference between groups in the size 
of the defect on color flow imaging. nor was there a difference in the 
prevalence of right-to-Ieft flow at rest or during maneuvers. Atrial 
septal aneurysms were detected in 3 patients (5%) with CV A/TIA but 
in none of the normal volunteers (p = 0.28). No other cardiac 
findings were detected by TEE in any subject In conclusion. PFO is 
an incidental finding in young patients with unexplained CV A!TIA. 
Routine TEE is of limited value in the evaluation of unexplained stroke 
or transient ischemic attack in young patients who have no clinical 
evidence of cardiovascular disease. 
764-2 4:15 
The Effect of Tran .. sophageal Echocardlographlc (TEE) 
Findings on Clinical Management In Suspected Cardiac 
Source of Embolus (CSE) 
George M. Klchura. Saad Bitar. Andrea Conversano. David L. 
Kemp. Fred Dressler. Ramon Castello. Arthur J. Labovltz. Saint 
Louis University Medical Center. St Louis. Missouri 
TEE has emerged as an Important technique for detecting potential 
CSE. However. the influence of TEE on clinical management is 
unknown. To determine the effect of TEE on clinical management. 
we reviewed the charts of 100 In-pts ( aged 61±15 years) with 
suspected embolic events. Presenting events were cerebro•
vascular accidents (CVA) In 63 PIS. transient ischemic attacks (TIA) 
In 27 PIS. and peripheral embolism in 10 pIS. Pt characteristics were 
56% male. 6 % had mitral valve prosthesis. 26% were in atrial 
fibrillation. 46% had hypertenSion. 25% diabetes. 16% prior stroke. 
and 16% had significant ipsilateral carotid disease by duplex scan. 
In 12 pIS (12%). coumadin therapy was initiated (despite relative 
contraindlcations to anticoagulation) because of left atrial thrombus 
(7%) none of which were seen by transthoracic echocardiography 
(TIE). left ventricular (LV) thrombus (1%). mobile aortic thrombus 
(1%). spontaneous LA contrast with LV dysfunction (1%). atrial 
septal aneurysm (1%). and severe LV dysfunction (1%) not 
appreciated on TIe. A normal TEE changed management in 9 
pIS. (9%). Heparin or coumadin was discontinued in 7 pts (7%) and 
coumadin was not started in 2 pis (2%). Surgery was performed in 
2 pIS (2%). for removal of bi-atrial thrombi and closure of patent 
foramen ovale (PFO) (1%). and removal of mitral valve vegetation 
(1%). Thus. in 24% of pIS evaluated for CSE. the TEE findings led 
to a change in management Of the changes influenced by TEE. 9 
(38%) resulted in the cessation and 13 (54%) in the initiation of 
medical therapy. Surgical intervention occurred after TEE in 2 
(8%). Thus. TEE findings frequently alter clinical management in 
patients with suspected CSE. 
ABSTRACTS 
764-3 
Lonq-Tera Follow-up of Transesophaqeal 
Echocardioqraphic Indicators for Stroke 
4:30 
Frances DeRook, Keith Comess, Kirk Beach, 
Nancy Lytle, Gregory Albers. 
University of Washington, Seattle, WA. and 
stanford University, stanford CA. 
121 consecutive patients (mean age 60) 
presenting with acute stroke or transient 
ischemic attack (TIA) were prospectively 
studied by transesophageal echocardiography 
(TEE) and fOllowed for an average of 18 
months (9 to 30 months) by chart review to 
identify recurrent events of either TIA or 
stroke. 13 patients (11%) had recurrent 
events on conventional therapy: 
2 atrial septal aneurysm (ASA), no shunt: 
3 ASA and inter-atrial shunt: 
1 left atrial thrombus: 
1 left atrial thrombus with ASA: 
1 left ventricular hypertrophy and mitral 
regurgitation: 
1 protruding plaque on the ascending aorta: 
4 no "high risk" TEE findings. 
CONCLUSION: 5/28 (18%) of patients 
presenting with ASA had recurrent events, 
compared to 4/65 (6%) of patients with 
other "high risk" findings and 4/28 (14%) 
with no "high risk" TEE findings. The risk 
of subsequent stroke associated with 
cardiac findings must be re-examined. 
764-4 4:45 
Increase in Transesopbageal Echocardiograms for Cardiac 
Source of Emboli Has Not Diminished Positive Yield 
Richard I. Weinstein, Mary W. Hawke, David C. Rubin. Gary D. 
Plotnick. University of Maryland, Baltimore, Maryland 
Transesophageal echocardiography (TEE) has been shown to 
increase the sensitivity of identifying cardiac source of emboli 
(SOE) over transthoracic echocardiography (TIE). Over the past 
three years. our institution has noted a marked increase in the 
number of TEEs being performed to evaluate for SOE. presumably 
as referring neurologists become more cognizant of the data. We 
analyzed TEE over a 3-year period to determine the percentage 
requested to identify potential SOE and the percentage of those 
studies that were positive (+) (i.e., identified a source not found 
on TTE). 
89-90 90-91 91-92 P 
# TEE 175 216 170 
SOE Indication 28 (16%) 69 (32%) 72 (42%) <.01 
+ Studies 9 (32%) 21 (30)% 21 (29%) NS 
We conclude that despite a marked increase in TEEs performed for 
SOE. the percent of these studies in which a SOE is identified has 
not changed. Therefore. the increase in number of TEEs 




Complex Arteriosclerotic Disease of the Aortic Arch 
Indicating Elevated Risk for Embolism: A Transesophageal 
Echocardlographic Study. 
Rolf M~usch, Ulrich Stierle, Abdohamld Sheikhzadeh. Cardiology, Medical 
University of Luebeck, Germany. 
In order to relate arteriosclerotic disease (AD) of the aortic arch to the risk of 
embolic complications we studied 177 patients (pts) prospectively by trans•
esophageal echocardiography. AD was classified as absent (0), mild 0) ~h 
Intima thickening, moderate (II) w~h sessile atheromas extending less than 
5 mm into the lumen and complex (ilia) w~h atheromas protruding 5 mm and 
more, partly w~h pedunculated componenls (lIIb). The incidence of embolism 
was related to the extent and location of AD and compared to 70 pts ~hout 
AD: 
aortic arch: descending aorta: 
AD-grade 0 I II III I II III 
no.ofpts 70 59 37 11 63 30 12 
embolism (%) 21 (30) 29 (49) 16 (43) 7(64) 31 (49) 16 (53) 5 (42) 
no embolism 49 30 19 4 32 14 7 
p-value <.05 n.S. <.005 <.05 n.S. n.s. 
In complex AD (III) of the aortic arch central embolism occured in 4 pts, peri•
pheral in 2 pts and one had both within 2 weeks. 4 of 5 pIS (80%) wnh AD IIIb 
had embolic events and in none of them other sources of embolism were de•
tected. LogistiC regression analysis revealed complex AD of the aortic arch 
(III) as independenl predictor for embolism (p < .005). Other predictive va•
riables in the model used were the presence of valve prosthesis and thrombi. 
We conclude, that In contrast to the descending aorta complex AD of the 
aortic arch plays a distinct role as risk factor for embolism. It is a potential 
source of cerebral as well as peripheral embolism. 
764·6 5:15 
Use or Transesopbageal Ecbocardiograpby to Predict Patients 
at Risk of the Fat Embolism Syndrome FoUowing Traumatic 
Injuries 
Alastair C.H. Pell, John F. Keating, James Christie, George R. Suther\lIIII. 
Royal Infirmary, Edinburgh, United Kingdom 
To determine whether traDsesophageaJ echocardiography (TEE) is of value to 
predict the development of the fat embolism syndrome (FES) following tnwma 
we studied 24 patieots undergoing surgical treatment of long bone froclllnll 
(mean injury severity score 9; range 4-24). Intraoperative TEE was uaed to 
detect embolic material appearing within the right heart chambers during SIIl"pIy 
II1II the results were correlated with the subsequent development of FES 
(hypoxia, neurological dysfunction, petechial rasb). Three categories were 
defined based on echocardiographic characteristics, Group I: minimal or no 
evidence of embolism (n= 14); Group II: moderate quantities of ecbogenic 
material comprising small masses l-lO mm diameter (n=6); Group III: large 
quantities of echogenic material comprising multiple small masses 1-10 mm 
diameter and large discrete emboli 1-8 cm diameter (n=4). Intramedullary 
reaming and nailing were commonly associated with tbe appearance of embolic 
material within the right atrium, but there was no correlation between severity 
of embolism and age, fracture type, or time since injury. The postoperative 
course in 21/24 pts was uncomplicated, bowever 3 pts in Group III developed 
clinical evidence of FES. TEE demonstrated massive intraoperative embolism in 
1 pt, with the development of right ventricular dilatation and severe tricuspid 
incompeteoce that precipitated paradoxical embolism through a patent fo~ 
ovale. Fully established FES developed in this pt and multiorgan microvascular 
fat deposition was demonstrated at autopsy. 
Conclusion: these results suggest that TEE might be used to predict patieota at 
risk of FES following surgical treatment of long bone injuries. Paradoxical 
embolism of fat through a patent foramen oval. is a possible mechanism 
responsible for the systemic features of FES. 
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Determination of the Site for Catheter Ablation Based on 
Termination of Ventricular Tachycerdia by a Non·Propagated 
Stimulus: Results of the Long· Term Follow·up Period 
Morio Shoda, Hiroshi Kasanuki, Saloshi Ohnishi, Jun Umemura, Saichi 
Hosoda. The Heart Institute of Japan, Tokyo Women's Medical College, 
Tokyo, Japan. 
Catheter ablation has become an accepted technique for the treatment of 
refractory tachyarrhythmias. However, its clinical outcome for ventricular 
tachycardia (vn is disappointing because of a low success rate. One of the 
keys to successful catheW ablation for VT is to identify the site crrtical to the 
perpetuation of arrhythmias by precise catheter mapping. We performed 
catheter ablation on 33 consecutive patients with refractory sustained VT. 
To determine the site of ablation, we tried to identify the site where the 
paced-QRS complex was identical to the VT-QRS complex with presystolic 
potentials which w~re recorded during VT. A single extrastimulus was given 
to the sHe by SU'::~3ssively scanning over a wnole cycle of VT until the VT 
was terminated. In 8 out of 33 patients (5 arrhy!hmogenic right ventricular 
dysplasia, 2 old myocardial infarction and 1 tetralogy of Fallot), sustained VT 
was terminated by a mn-propagated extrastimulus which only IO.:lked like a 
spike discontinuing the VTon surfac~ electrocard:ogram. This 
phenomenon should occur when a stimulus excites a part of the slow 
conduction zone (Sel) which is essential for reentry, and furthermore, both 
the wavefront of excitalion is blocked orthodromtcaliy and collides 
antidromically with the wavefront of VT inside the SCZ. Aller determining 
the site for ablation. DC shock (mean energy was 79.01:34.5 joule) was 
delivered to eliminate the VT using a standard defibrillator. In all 8 patients, 
the ablation procedure was successful, and no VT was inducible in 
electrop/lysiologic testing performed more than 2 weeks atter ablation. No 
complications related to the ablation procedure occurred. DUI ing the long•
term follow-up period (mean: 21.9"±:12.4 months). no VT recurred 
spontaneously. We concllJde that refraciory VT can be eliminated 
oermanently by ablating at the site where VT is terminated by a non•
propagated stimulus. 
765·2 4:15 
Relation.hip Bet.... the .fficacy of RadiofrequeDCY 
CAtheter Ablation &lid Site of Ori9ia of Idiopathic 
Veatricular Tachycardia 
Hugh Calkin., steven J. Kalbfleisch, Rafel Bl-Atas.i, 
Jonathan J. Langberg, Fred Morady 
Oniver.ity of Michigan Medical Center, Ann Arbor Michigan 
The purpo.e of thi. .tudy waR to determine the 
relation.hip bet_n the eite of origin of idiopathic 
ventricular tachycardia and the efficacy of 
radiofrequency catheter ablation. Bighteen consecutive 
patient. «SF, 13M, mean age 41±13 years) with 20 distinct 
type. of ventricular tachycardia underwent one or more 
attempt. at catheter ablation u.ing radio frequency 
energy. The mean ventricular tachycardia cycle length waR 
318 + 51 msec (range 260-430 msec). site. for 
radiofrequency energy delivery were .elected on the basi. 
of pace mapping. A follow-up electrophy.ioloqy te.t was 
performed 1 to 3 month. after the ablation procedure. 
Result.: Radiofrequency catheter ablation was Buccessful 
in .liminating each of the 10 ventricular tachycardiaa 
originating from the right v.ntricular outflow tract and 
was .ucc •• sful in .liminating 5 of 10 v.ntricular 
tachycardia. which originated from oth.r eit •• in the left 
or right v.ntricle. Th.r. were no complications. Th. 
duration of ablation •••• ion waR ahort.r (73 ± 17 V8 142 
+ 75 min, paO. 03), the frequ.ncy of id.ntifying a site 
r.sulting in an id.ntical pac. map high.r (10/10 vs 5/10, 
P < 0.01), and the .fficacy of cath.t.r ablation waa 
higher (10/10 v. 5/10, P < 0.01) for v.ntricular 
tachycardia. ari.ing in the right v.ntricular outflow 
tract compared to ventricular tachycardias arising in 
other location.. Conclu.ion1 Radiofrequ.ncy cath.ter 
ablation of idiopathic ventricular tachycardia i. aafe and 
effective. However, the efficacy of the procedure is 
dependent on the .ite of origin of the ventricular 
tachycardia, with the efficacy being greater for 
ventricular tachycardias arising in the outflow tract of 
the right ventricle than for v.ntricular tachycardias 
ari.ing in other location. 
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How to Select the Site for Successful Catheter Ablation of Idio•
pathic Ventricular Tachycardia Using Radiofrequency Energy 
Jeep L.R.M. Smeets, Luz-Maria Rodriguez, Jacques Metzger, 
Arnd Weide, Louis Constantinou, Hein J.J. Wellens. Academic 
Hospital Maastricht, The Netherlands 
In patients with a structurally normal heart and normal coronary 
arteries ventricular tachycardias (VT) can originate in both 
ventricles. Although the arrhythmia mechanism is often unknown 
catheter ablation of idiopathic VT's is possible. In the present study 
we investigated which criteria can be used for selecting the proper 
site to apply radio frequency energy. 
In a consecutive group of 13 pts (5 males, 8 females, mean age 
40±12 years) with documented idiopathic VT's an attempt was 
made to treat the VT by RF catheter ablation. VT originated in the 
left ventricle in 5 pts, and in the right ventricle in 8 pts. 
Because VT could reproducibly be initiated in only 7/13 pts data on 
endocardial activation mapping during VT were available in 7 pts. 
The earliest detected endocardial activation site preceded the QRS 
activation in the simultaneously recorded 12 lead electrocardiogram 
by IS to 60 msec (mean 27±17 msec). Pacemapping was per•
formed in 10 pts and identified the successful ablation site if the 
electrocardiogram during stimulation was similar to the spontaneous 
VT in 2!. 10 leads. A mean of 9±5 RF applications were given. 
No recurrences were observed. 
Conclusions: I) Successful RF catheter ablation is possible if the 
earliest endocardial activation site precedes the 12 lead surface 
ECG by 15-60 msec 2) Inability to induce VT frequently necessi•
tates pacemapping. The correct ablation site requires a paced QRS 
morphology equal to the spontaneous VT in 10 or more electro•
cardiographic leads. 
765·4 4:45 
Temperature·Guided Radiofrequency Catheter Ablation 
Using Very Large Distal Electrodes 
Jonathan 1. Langberg, Marsha Gallagher. S. Adam Strickberger, 
University of Michigan Medical Center, Ann Arbor, MI 
Studies ill vitro suggest that radiofrequency (RF) lesion size is 
determined by the temperature and surface area of the electrode•
tissue interface. The purpose of this study was to compare lesions 
made with very large distal electrodes (8 French, 8 and 12 mm in 
length) to those made by a conventional RF ablation catheter (distal 
electrode 8 French, 4 mm in length) heated to the same 
temperature. Each catheter had a thermistor at the tip. RF energy 
(500 KHz) was supplied by a generator that continuously 
monitored temperature and produced up to 100 W. In 10 closed· 
chest dogs, each of the 3 ablation catheters were positioned against 
the left ventricular endocardium and RF was applied at a power 
sufficient to heat to 80°C for 60 secs. Resultant lesion volume was 







Power Required to 
Produce 80°C (W) 
IS±7 
46 ± IS* 
62 ± 32* 
Maximal lesion 
Depth (mm) 
6 ± 1.2 
11 ± 2.4* 





465 ± 22S* 
*p < 0.001 vs. 4 mm 
Conclusions: I) Large-tipped RF ablation catheters require 
more power to achieve the same steady· state temperature. 2) An 8 
mm distal electrode is capable of producing lesions 4 times as large 
as a conventional 4 mm electrode. 3) Lesions produced by a 12 
mm electrode are smaller than those produced by an 8 mm 
electrode, probably because of inconsistent proximal contact. 4) 




Both Tachycardias Originating in Right or Left Ventricle in 
Patients Without Overt Heart Disease Can Be Cured by 
Catbeter Ablation Using Radiofrequency Energy 
265A 
Joep L.R.M. Smeets, Luz-Maria Rodriguez, Jacques Metzger, 
Arnd Weide, Louis Con stantinou , Hein J.J. Wellens. Academic 
Hospital Maastricht, The Netherlands 
Ventricular tachycardias (VT) in patients (pts) without underlying 
heart disease can originate in the right or in the left ventricle. 
Electrocardiographic documentation of idiopathic VT in 61 pts 
revealed a right bundle branch block morphology, suggesting a 
septal or left sided origin, in 22 pts; a left bundle branch block 
morphology, indicating a right ventricular origin was present in 39 
pts. Because 13 pts remained symptomatic despite treatment with 
several antiarrhythmic drugs an attempt was made to treat the 
arrhythmias with catheter ablation using radiofrequency energy 
(RF). 
Results: Detailed activation mapping or pace mapping in 5 right 
bundle branch VT showed a site of origin in the mid infero septum 
of the left ventricle in 4, and in an apico-septal segment of the left 
ventricle in I pt. The site of origin in the right ventricle during left 
bundle branch block VT were septum (6 pts) or the free wall 
(n =2) of the right ventricular outflow tract. RF energy (40 Watts 
during 30 seconds) was applied 8±4 times in the left, and 1O±7 
times in the right ventricle. During follow-up (mean 4.2 +2.2 for 
left, 3.8 +2.4 for right ventricular VT) no recurrences occurred. 
There were no complications. 
Conclusions: Catheter ablation using RF energy can successfully 
treat VT originating in the right or in the left ventricle in the 
absence of overt heart disease and should be considered as an 
alternative to treatment with antiarrhythmic drugs. 
765·6 
Electrode Panels: A New Design for Radiofrequency 
Ablation Catheters? 
Paul J. Wang, Peter W. Groeneveld, Arun Gadboke, 
5:15 
N.A. Mark Estes m. New England Medical Center, Boston, MA 
Prior studies examining the role of electrode length for radiofrequency 
(RF) ablation demonstrated the superiority of the 4mm tip electrode 
catheters used in current practice. Further increases in electrode 
surface area results in a decreased current density and a greater 
proportion of the catheter not in contact with the myocardium, 
producing a smaller RF lesion size. We hypothesized that dividing 
the catheter electrode into 3 electrically iso1atcd panels might permit 
one to use a longer electrode, thus creating a longer lesion with greater 
surface area and volume, while increasing the percentage of electrode 
in contact with the myocardium. Using an in vitro sheep 
endocardium model we compared 5 and 10 mm electrodes divided 
circumferentially into thirds. Using each catheter, 30 second lesions 
were created. The highest power which reliably failed to result in an 
impedance rise was used: 7.9±1.5 and 14.1±3.2 Watts, for the Smm 
and IOnnn catheters, respectively. 
t Jt .. ;. 1-
CATIiETER LENGTH WIDTH J)EPTH VOLUME 
5mm 7 .I±O. 7 3.S±O.6 2.S±O.S S4.3±IS.1 
IOmm 10 S±O 8* 3 6±O 4** 2 1±O,St 70.W7 Ott 
·pSl.QQQl. ··p-NS. tpSl,OS. ttpSl.03 
These studies demonstrate that RF using electrode panels is capable of 
creating lesions of increased length and surface area. RF using such 
a system may have increased success in the ablation of ventricular 
tacbycardia. 
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766·1 4:00 
Pressure Gradient Does Not Explain Leftward Shift of the 
Interventricular Septum in Acute Right Ventricular Hypertension 
Louis J Oetl'ltaIia, H Ross Singleton, Leslie Coghlan, Douglas J. 
Pearce, Gerald G BlaCkwell, Gerald M Pohosl The University of 
Alabama at BIrmIngham. 
Due to its compiex geometry, right ventricular (RV) function has 
been difllcult to assess using standard imaging modalities. The 
purpose of the present study was to optimally assess RV function in 
response to acute increases in afterload. We recorded high·fidelity 
right ventricular (RV) and left ventricular (LV) pressure (P) during 
cine-magnetic resonance imaging (Cine·MR) before and after acute 
pulmonary embolus (PE) in six aneathetized, intact dogs. Three•
dimensional (3-D) renderings of the RV were obtained from serial 
short axis slices in addition to curvature of the RV free wall (FW) and 
interventricular septum (IVS) using a software program developed in 
our laboratory. After PE, at end·systole RV systolic P increased (27 
.±. 2 to 43.±. 8 mmHg, p<O.05) as LV systolic P decreased (97.±. 17 
to 76 .±. 3 mmHg, p<O.05). At control, 3-D images of the RV 
demonstrated a crascent-shaped chamber formed by the RV free 
wall (RVFW) and the convexity of the interventricular. septum. (IVS) 
toward the RV cavity producing a narrow angle at the Intersection of 
the RVFW and IVS. After PE, at end-systole the IVS was shifted 
toward the LV in spite of LVP being higher than RVP in each dog. 
RV chamber size increased by the following mechanisms: 1) RVFW 
became spherically dilated, 2) the angles of the RVFW-IVS 
attachment points increased, and 3) the curvature of the IVS 
decreased on the RV and LV sides. We conciude that pressure 
gradient alone does not predict position of the IVS at end·systole 
after acute RV hypertension. Our 3-D reconstructions suggest 
longitudinal as well as transverse forces operating in determining the 
mechanism of leftward shift of the IVS after acute RV hypertension. 
766·2 4:15 
MRI.Tagglng Meaaurements of Impaired Regional LV·Mldwall 
Contractility Correlate with Histopathology In Hypertrophic 
Obstructive Cardiomyopathy 
Aichard D. White. Harry M. Lever. Daniel J. Murphy. Norman B. Aatliff. 
Kandace Kottke-Marchant. Eliot A. Aosenkranz. Bruce W. Lytle. Delos M. 
Cosgrove III. Cleveland CUnic Foundation. Cleveland. OH. 
Questions remain regarding the relationships between myocardial 
contraction 01 the Left Ventricle [LV]. histologic abnormalities of the LV 
myocardium. and patient prognoSis in the setting of Hypertrophic 
Obstructive CardioMyopathy [HOCM). Aegional [A) LV-midwall contractmty 
in HOCM was assessed with dynamic MAl myocardial-tagging (SPAMM). On 
dynamic image-~ (1~-phaSe) 01 systole ~t the L.V s':lOrt-ax~asal-1/3. 
equatorial changes In distance between grid-tagging IntersectIOn points 
within the LV mldwall were attributed to contraction of circumferential 
myofibers. To measure A-LV-midwall contractility. values of decreasing 
distance [D) between such points from End-Diastole [ED) to End-Systole 
[ES) in the Septal [S) and Lateral [L) walls were applied to a modified 
equation for Mean Midwall Velocity [MMV) of circumferential fiber [cf) 
shortening with correction [c) for cycle length and ED dimension: 
AMMVcfc • [(EOO • ESD) x 1000) + (It x MidS:L diameter)) + [ET + vA-A); 
LV Ejection TII1'ie [ET] was time to greatest 0 decrease minuS 50 msec (pre•
ejection phase) W no mitral regurgitation. Normal [N) (N_7: 20-38 YO) and 
HOCM (N-11: 8-76 YO) groups were studied; all HOCM patients had S•
myectomy for outflow obstruction <14 days after MAl. Myectomy samples 
were blindly graded (O.none to 3-severe) for both myocardial disarray and 
fibrosis. AMMVcfc values (circlsec) in the HOCM group were signWicantly 
less (p<0.01) than in the N group for both S (Mean: 1.2;tO.6 vs 4.2%1.1) 
and L (Mean: 2.9 ;to.6 vs 4.6 .to.6) walls; the HOCM group also had 
significantly depressed contractility of the S- vs L·wall. AMMVcfc in th~ S•
wan correlated significantly (p<0.01) with disarray ( r. ·0.67) and fibroSI~ (r. 
-0.52) grades. Thus. MAl-tagging can noninvasively locate and quantitate 
in HOCM impaired A-LV ·midwall contractility. which is directly related to 
severity 01 characteristic histopathologic changes thought to intluence 
patient prognoSis. 
766·3 
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ReSional Left Ventricular Diastolic Wall Motion A_sement 
UsinS Magnetic Resonance Velocity Mapptns: A Comparison Of 
Coronary Artery Disease With Controls. 
Stefan P Karwatowski, Raad H Mohiaddin, Guang Z Yang, David 
N Firmin, Richard S Underwood, Donald B Longmore. Royal 
Brompton National Heart and Lung Hospital London U.K. 
Current non invasive techniques for assessment of diastolic 
function focus on global measures. Long axis ventricular wall 
motion is an early marker for ischaemic heart disease (IHD). We 
have used cine magnetic resonance velocity mapping to study 
regional long axis diastolic ventricular wall motion. 
Eighteen normal subjects(10 male) and twenty one patien~ with 
IHD (17 male, 13 with a previous infarct) were studied off cardiac 
medication. Magnetic resonance cine velocity information was 
acquired through a basal short axis plane. This short axis ring was 
divided into 16 sectors and velocity time curves constructed. The 
peak early diastolic wall velocity during early diastole was 
identified and maximum and minimum velocities were 
measured. These were used to give a range of velocities 
standardised to the peak velocity. 
The mean velocity in rom/s (comparison with control values) are 
as follows. 
Max Min Range 
Control 100 52 50 
Angina 78(p=(l.06) 29(p=(l.04) 62(p=O.6) 
Infarct 71 (p=(l.02) 13(p=O.02) 84(p=O.02) 
In normal subjects, peak wall velocities were greater in early 
diastole than in systole, posterior wall velocities were cor.sistently 
the highest and peak velocity decreased with age. 
Magnetic resonance velocity mapping of long axis ventricular wall 
motion provides unique regional information not available with 
other techniques. It can detect resting abnormalities of diastolic 
regional long axis wall motion in patients with IHD. 
766·4 4:45 
NOD·IaVllSive Assessmeat 01 CorGIUU'Y Artery BypMS Graft FlIIletioa by 
MagDetic Resoaaace Flow Velocity MappiDl-
Michel A. Galjee. Albert C. van Rossum. Teddo DoesburB. Mart B. M. Hcf•
man. Free University Hospital. Amsterdam, The NeIherIands. 
True assessment of coronary aria)' bypass graft (CABG) function requires 
quantitatioa of graft flow. Allhough oororu.y angiography is the standard. it is ac 
best only a semi-ijuantitative method. Magnetic resonance velocity mappins 
(MRVF) offen the poIeIItial to characterize and quantita/e flow non-invasiveiy. 
The aim of this study was to investiga/c the feasibility of chanlcterizing and 
quantitatins flow in venous CABG by MRVM. 
MetIIocII: Twelve patients with 17 angiographically paIt:Dt grafts underwent 
MRVM within I week of oororu.y angiography. MRVM was perfooned with 
patients in prone position on a mattass wilh a built·in surface coil, in order 10 
reduce respiration artifacts and enhance the signal-IO-noise ratio and spatial 
resolution. In-plane resolution was 1.5 x 1.1 mm>. Velocity maps were obtained 
ac consecutive steps of SO msec throughout the cardiac cycle in multiple imaging 
planes. Peak velocities were measured, and volume flow was calculated by 
integrating average velocity x graft·area over the cardiac"cycle. 
Results: Imaging and velocity mapping of grafts to the LAD and CX coronary 
artery was best perfcrmed in a sagittal plane through the main pulmonary artery 
and in ttansverse planes above the aortic root. Imaging and velocity mapping of 
grafts to the RCA were best perfonned in a transverse plane aI the right atrial 
level Graft flow wu chaiacterized by a biphasic pattern with a fust peak in 
systole and a second peak in diastole. Generally. flow was highest in diastole. 
Average peak velocity was 14 :t 7 cm/sec (range 5-34). Average volume flow 
was 95 :t 60 ml/min (range 29-241). Imaging lime varied between 45 and 75 
minutes. 
Coaclusioa: CABG flow can he DOII-invasively chaiacterized and measured by 
magnetic resonance velocity mapping techniques. Generally. flow in the grafts is 
biphasic wilh predooIinant Dow in diastole. The method may become of value as 
a screening procedure for CABO function in postoperative pain syndromes. in 
late graft SIeIIOSis. or u an Indicala' of graft patency before oororu.y angiograp•
hy. 
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Can Noninvasive Quantification or Coronary Calcification with 
Fast cr Detect Early Coronary Atherosclerosis? 
Krishna Kumar, James A. Fallavollita, Alan S. Brody and 
John M. Canty, Jr., University at Buffalo, Buffalo, New York 
Although detection of coronary calcification by fast cr is a 
sensitive way to demonstrate the presence of anatomically 
significant coronary artery disease, its utility in defining early, 
clinically insignificant mural narrowing of the coronary arteries has 
not been determined. Accordingly, we assessed coronary 
calcification in 101 patients without anatomically significant stenosis 
undergoing coronary angiography for routine clinical indications. 
Patients in whom angiography demonstrated smooth, luminally 
normal arteries were compared to those with clinically insignificant 
coronary atherosclerosis (i.e., no diameter stenosis greater than 
50%). We maximized sensitivity by using a calcium score of 1 to 
define a positive cr study. The population ranged from 26 to 79 
years (mean 54 :t 12). The prevalence of mural atherosclerosis 
was 47%. In patients with angiographically insignificant disease, 
30 of 47 had calcium detected by cr vs 14 of 54 luminally normal 
patients. Thus, the sensitivity of cr to detect early mural 
atherosclerosis was 64% while the specificity to define luminally 
normal coronary arteries was 74%. Hypercholesterolemia (>200 
mg/dl) had a similar sensitivity (68%) but the specificity was lower 
(46%). These data indicate that 1.) the sensitivity of cr coronary 
calcification to detect early preclinical atherosclerosis is lower than 
that previously reported in populations with anatomically significant 
disease or clinical symptomatology and 2.) the sensitivity of cr is 
no better than hypercholesterolemia alone. Thus, current algorithms 
to quantify calcium may need to be refined if fast cr screening is 
to be helpful in identifying patients warranting aggressive risk factor 
modification at an early stage of coronary disease. 
766·6 5:15 
Automatic Left Ventricular Cavity Boundary 
Detection from Ultrafast CT Serial Images Using 
an Adaptive Graph Searching Procedure 
Elie Mousseaux, Nathalie Bastide, Alain Hennent, Philippe Oumee, 
Pierre Perronneau, Jean-Claude Gaux. INSERM (U 256) & 
Cardiovascular Radiology Depan, Hapital Broussais, Paris, France 
A new totally computerized method to automatically identify 
endocardial borders was applied in serial, short-axis UFcr images 
(n=156) of 6 patients (2 mid-LV series of 13 images per patient). 
Endocardial areas calculated from computer-derived borders (Auto) 
were compared with areas from two manual tracing (Ml & 
M2).The segmentation method based on a graph searching 
principles optimizes both local and global detection of borders by 
minimising a cost function taking into account: - a data fidelity 
criterion based on bath grey levels and gradient values, - a prior 
constraint grounded on the density of local maximal gradients, - a 
dynamic constraint on the cost function variation along the cardiac 
cycle. The algorithm is characterized by: - direct processing of 
pixels in order to avoid image resampling, - fast search procedure 
which only examinates a reduced number of pixels selected by the 
cost function, - the absence of any geometrical or'temporal 
smoothness constraint in order to obtain reliable wall motion 
details. Results: 
In all !56Ima&es slope r 
Ml vs M2 0.99 0.99 
Ml vs Auto 1.04 0.99 




mean * (%) 
0.50 
3.56 
Ml vs M2 0.99 0.97 6.31 2.11 
0.94-1.07 0.94-0.99 3.12-11.87 4.46-11.72 
M! vsAuto 1.00 0.98 6.53 3.54 
0.95-1.04 0.97-0.99 4.46-11.72 -1.32-13.75 
Without any correction by the operator, very close correspondence 
between computer-derived areas and observer tracing areas was 
obtained and variability was nearly similar to the intra observer 
variability. These data suggest the feasibility of automated 
endocardial edge detection in UFCT images. 
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767·1 4:00 
Modulatlnl Erretls or Experimental Congestive Failure Upon the 
Potent Cardiorenal Attions or Brain Natriuretic Peptide 
Alfredo L. Clavell, Andrew J. Stingo, Lawrence L. Aarbus and Jobn C. Bumctl, 
Jr. Mayo Clinic and Foundation, Rocbcsler, MN. 
Brain natriuretic peptide (BNP) shares strucwra1 and fWICtiooai similarities 10 
atrial natriuretic peptide (ANP). BNP, like ANP, is of cardiac origin and 
cirtulating concenllations &Ie increased in congestive heart failure (CHF). Recent 
studies conflict willi regard 10 llIe biological activity of BNP in CHF. The 
present study was designed 10 further defme llIe cardio-renal actions of 
systemically infused BNP (50 ng/k~min) in the presence and absence of llIoracic 
inferior vena cava constriction (TIVCC) for eight days. This model is 
characterized by reductions of cardiac outpul (1.8±O.2 VI. 3.0±0.2 Vrnin; P < 
0.05) and activation of plasma renin activity (7.l3±1.40 vs. 2.32±0.87 
n~ml/hr; P < 0.05) mimicking CHF but in llIe absence of chronk elevations of 
ANPorBNP. 
CONTROL TIYCC 
Baseline BNP Baseline BNP 
MAP 118tS 99±2* 1I0±5 74tS*t 
GFR 18.3±1.9 35.5±3.8* 13.9±2. 7 12.3±2.3t 
RBF 148±14 200±23* 16S±33 144±16 
UNaV 6O.8±17.2 482.8±44.9* 1.3±O.4t 1.2±O.2t 
PcGMP 5.2±1.6 44.6±S.2* 3.9±0.4 39.l±4.7* 
UcGMP 242±53 366O±801* 271±83 1337±314*t 
Values &Ie means ± SE; ns6 TIVCC dogs; n-S Control dogs. MAP 
(mmHg), mean anerial pressure; GPR (mVrnin), glomerular filtration rate; RBF 
(ml/min), renal blood flow; UNaV <lic<Vmin), urinary sodiwn excretion; PcGMP 
(pmol/ml), plasma cGMP;UcGMP (pmol/min), urinary excretion of cyclic 
GMP. °P < 0.05 vs baseline, tP < O.OS vs Control. 
This study demonstrates that BNP has potent vasoactive and renal 
hemodynamic and natriuretic actions willi marked activation of llIe second 
messenger plasma and urinary cGMP. In chronic TIVCC llIe renal actions were 
absent willi marked attenuation of llIe urinary cGMP response in contrast 10 the 
vasoactive actions which were enhanced willi preserved activation of plasma 
cGMP. In conclusion, TIVCC is characterized by renal but nOI systemic 
hyporesponsiveness 10 BNP supporting a differential receptor and/or post•
receptor regulation of the biological actions of BNP in congestive failure. 
767·2 4:15 
A, B, and C· Type Natriuretic Peptide. in Human Heart Failure 
Chi.Ming Wei, Denise M. Heublein, Linda J. McKinley, Mark A. Perrella, 
Amir Lennan, Richard J. Rodeheffcr, Pai C. Kao, Christopher G. A. McGregor, 
William D. Edwards, Hartzell V. Schaff, and John C. BumeuJr., Mayo Clinic 
and Foundation, Rochester, MN 
Alrial (ANP), brain (BNP) and C-lype natriuretic peptides (CNP) are structurally 
homologous cardiovascular peptides which regulaJe plasma volwne and vascular 
lOne. The control of llIeso peptides in congestive heart failure (CHF) remains 
unclear. The p-esent study was designed 10 characterize the plasma 
concenllations, cirtulating and cardiac tissue molecular forms and the presenc;e or 
absence of ventril:uIar peptide in nonnaI subjects (n~), mild (New York Heart 
Association. NYHA Class 1/lI, 0=20) and severe (NYHA Class III/IV, .,.,20) 
CHF patients. RadioimmUllOllSS8Y and gel permeation chromalOgraphy were 
used 10 characterize plasma and atrial tissue conccnllations and molecular fams, 
and immunohistochemical staining (IHCS) was used 10 characterized the presence 
or absence of ventricular peptide staining in normal and CHF beans. 
Plasma lpglml> Cardiac TiSSue lpg/l00m1 liMuel 
ANP BNP CNP ANP BNP CNP 
Normal 20±7 17±6 13±2 S21±28 291±771 2S±4, 
Mild CHF 68±12* 19±3, J1±21 239±26* 735±2J1"1 73±13°, 
Severe CHF 2Q9±48*t 42±7°tt 12m 462±32t 2028±289*tt 62±!O°, 
Mean±SEM; °p<.05 vs normal, tp<.OS vs mild CHF, 'p<.OS vs ANP. 
In vemricular tissue, IHCS wining was present for all three peptides in normal 
subjects and W"oIS markedly enhanced in CHF. The plasma molecular form of 
ANP in nonnaI subjects was a'ANP while in severe CHF it was B-ANP. The 
predominant molecular forms of plasma BNP and CNP in normal and CHF 
subjects were the mature BNP·32 and CNP·22. The predominant tissue 
isoforms in CHF patients were B-ANP, BNP-32 and CNP·S3, revealing a switch 
in the CNP isotype from plasma. This study demonstrates the isolared elevation 
of ANP in mild CHF supporting ilS role as a marker for mild CHF while BNP 
elevation may be a marker for severe CHF. The greater increase in plasma ANP 
than BNP in severe CHF despite greater tissue concentrations of BNP support an 
alteration in BNP processing and/or release. The absence of elevation of the 
potent vasoactive peptide CNP may represent a relative deficiency in CHF. 
These studies support a differential regulation of A. B, and CNP cirtulating 




Captopril Reverses Progressive Abnormalities in EDRF 
Activity in Chronic Heart Failure. 
Barry Greenberg, Keith Perkins, Michael Ontkean, 
Richard Gay. Oregon Health Sciences University, 
Portland, Oregon 
We sought to determine if changes in EDRF activity that 
occur in chronic heart failure (CHF) are progressive and 
whether they could be reversed by captopril, an 
angiotensin-converting enzyme inhibitor. CHF was 
produced in Sprague·Dawley rats by ligating the left 
coronary artery. After 10 weeks, rats were randomized to 
sacrifice (CHFIO : n = 10) or 10 further weeks with either 
no therapy (CHF20 ; n = 6) or 2 g/liter H20 of captopril 
(C H F capt ; n = 10). EC50 values for relaxation to 
acetylcholine (ACh ; ·logM) in isolated pulmonary artery 
segments was 6.44 ± 0.14 in sham-operated rats (n = 5) and 
was significantly increased to 5.91 ± 0.26 in CHF10 rats 
and 4.59 ± 0.41 in CHF20 rats. Maximal relaxation to ACh 
was significantly reduced in both CHF groups. In 
contrast, the EC50 value and maximal relaxation were 
essentially normalized in CHFcapt rats. Basal EDRF 
activity (measured as the increase in force when 
preconstricted arteries were exposed to hemoglobin) 
demonstrated a similar step-wise reduction in CHFIO and 
CHF20 rats and normalization in the CHFcapt group. 
Thus, in an experimental model of CHF, agonist induced 
and basal EDRF activity are progressively diminished. 
Captopril treatment can reverse the process and this 
property may contribute to its clinical efficacy as a 
vasodilator in patients with CHF. 
767·4 4:45 
Pre.enatloa or Iadothellum-DepeDdeDt Re,poDse. to Sub.taa« P 
la Idiopathic Dilated Cardiomyopathy 
Diana R Holdright, Debbie Clarke, Philip A Poole-Wilson, Kim M 
Fox, Peter Collins. Royal Brompton National Heart &; Lung Hospi•
tal, London, UK. 
Attenuation of acetylcholine-induced coronary arterial dilation has 
been reported in patients with idiopathic dilated cardiomyopathy 
and in aoimal models. To determioe whether thit represeots a 
specific muscarinic receptor abnormality or is part of a more 
generalised defect, we compared the responses to intracoronary sub•
stance P in 9 patients with idiopathic dilated cardiomyopathy and 
angiographically oormal coronary arteries (DCM) and 9 controls 
[(Con), atypical chest pain, negative exercise test and angiographi•
cally normal epicardial coronary arteries). Endothelium-dependent 
responses to intracoronary substance P (SP) 5, 10 &; 25 pmol/min 
were assessed using an intracoronary Doppler probe to measure 
coronary blood flow velocity and quantitative angiography to, deter•
mine epicardial coronary artery area. Flow (area x velocity) was 
calculated prior to drug infusion and at peak response to give a 
flow ratio (peak:baseline). 
Coronary flow reserve measured with papaverine was 3.310.5 
(DCM, mean tSEM) and 3.610.4 (Con, p-NS DCM vs Con). 
'Yo area locrease Flow ratio 
DCM COD DCM Coa 
SP 5 29.2±8.7% 24.2±9.0% !.S1O.1 1.510.1 
SP 10 37.7±14.0% 50.0±7.9% 1.810.2 2.2±o.2 
SP 25 43.7±12.0% 56.0±IO.l% 2.110.2 2.8±O.4 
There were no significant differences between DCM and Con 
patients in epicardial coronary artery area and coronary flow 
responses to substance P 5, 10 &; 25 pmol/min. 
These results indicate that endothelium-dependent responses to 
substance P are preserved in DCM. Reports of impaired acetyl•
choline responses indicate either a specific endothelial cell mus•
carinic receptor defect and/or a heightened smooth muscle cell 
response. 
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Augmented Lymphoklne Production In a Moderate 
Heart Failure Population. 
Edward M Gilbert, Mark A Munger, Barbara Johnson, Ina J Amber, 
Gregory J Stoddard,. Unlvers"yof Utah. Sa. Lake C"y, Utah. 
Anhough tissue necrosiS factor (TNF-a) is elevated in severe heart 
failure (HF), the ellect of moderate HF on circulating Iymphokines 
has not been described. Therefore. we measured arterial (ART) 
and coronary sinus (CS) interleukin (IL) concentrations ofIL-la, IL-
2. receptors. IL·6 and TNF-a in 51 NYHA FC IJ.lV patients. ART IL-
2. concentrations were compared to 48 control (C) subjects. 
Characteristics of HF population were etiology: 35 idiopathic 
dilated cardiomyopathy and 16 coronary artery disease. LV 
ejection fraction of 22±1.4% (x±SEM), cardiac index of 2,2±O,1 
literSlminlm2, wedge 14.9±1.5 mmHg and peak 02 consumption 
of 17.9±LO mVminlkg. 
FINDINGS: Lymphokine Concentrations (pg/ml)' p&05 HF YS C, 
IL-l L-2. IL-6 TNFa 
HF C 
ART 269±144 767±117' 409±25 147±24 6.4±6.4 
CS 308±163 738±97 140±23 6.0±3,3 
Arterial concentrations are elevated in HF vs histOrical controls in 
IL-la, and IL·6, with no change noted in TNF·a. There were no 
significant gradients between ART and CS for IL·la, IL·2. , IL-6, 
and TNF-a. Lymphokine concentrations did not diller significantly 
by etiology of HF. LV ejection fraction and peak 02 consumption 
significantly correlated with IL·6 and IL-la, respectively. while no 
cardiac parameters correlate w"h IL·2,. or TNF-a. 
CONCLUSION: 1) Lymphokine production is activated in a 
moderate HF population. 2) The heart does not appear to be the 




Cytokln. Antagonists Circulat. In the Blood of Patients 
with Advanced Congestive Heart Failur. 
John J. Smith, Lee Shapiro, Noreen A. Dolan, Lori M. Kilcoyne, 
James E. Udelson, Deeb N. Salem, Marvin A. Konstam and Charles A. 
Dinarello. 
Tufts Univ. School of MedJNew England Medical Center, Boston. MA. 
Previous Investigations have suggested that some patients with 
advanced congestive heart failure (CHF) have elevated levels of 
circulating inflammatory cytokines. We hypothesize that regulatory 
peptides (cytoklne antagonists) also circulate in elevated quantities 
in the blood of patients with CHF. We assayed fasting plasma from 20 
patients with NYHA class IV CHF with specific and sensitive 
radioimmunoassays for Tumor Necrosis Factor binding protein-l 
(TBP-l) and Interleukin 1 receptor antagonist protein (IRAP). 
These data were compared to a group of age and sex-matched patients 
with coronary artery disease (CAD) but without signs or symptoms 
of CHF (C) (n-20) and a population of control subjects without heart 
disease (N) (n-14). Of the patients with CHF, 790/. had ischemic 
cardiomyopathy, 79% were on therapy which included converting 
enzyme inhibitors, digoxin and diuretics; 35% had a body mass S the 
25th percentile for height and weight. 
CYTO E E KIN L VELS IN pgJrnl. MEAN (SEM) 
IRAP lBP·1 
CHI' I C ~ N CHI' 1 C 1 N 
395 (53) It89 (34) 1202 (6) 699 (86) 1664 (93) .1197 (t5) 
J;:o.oo2 P=NS 




ConclUSions: IRAP and TBP-1 levels are Increased In patients with 
advanced CHF. TBp·1 levels are also elevated in patients with CAD 
without CHF. In view of the increased levels of these antagonists, 
caution must be employed In interpreting the physiological 
significance of observed increases in pro-inflammatory cytokines in 
patients with CHF. 
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768-1 4:00 
CbiaMric 7E3 Antiplatelet Aldibody Filii f... TnUIIaIt 01 IlIIndaIy 
U ....... ADaiM: A l'III:ebo-CoDtr PIlot Stud, 
SimooaI ML, v.do BIIIIIIl M, HoomIje JeA, de PeytK P, Zijlllla P, HeyDdricb 
0, v.do Wieball, De BellO D, RIIIICII W, Wa- HP, Sc:baible TP, cIeac. 
MI., ~, R-.Iam, n. NedIerIauda, Cea/oc:or, IDe., Malvem, PA, 
USA, IIId .... EuJup.a CoopenIive Study Group. 
PDaII widllIIIIIabIe qiDa in IpiIo of exteuive a.Iical tbanpy, i.e., refnctOIy 
lIIIIIabIe qiDa (UA), lie It hiP riIIt for c1evolopiq tbrombotic compIkaIiou 
foIIowiD8 PTCA. To evaluIte ~ poteat pIaIeIet iDbibitioll could !educe 
1M. compIkaIiou, 60 pItiaa willa UA _ nuadomi.7Jed to _ willa 
placebo (Pb) 01" clIiJmric 7B3 Pib (e7B3), ID lIItibody fnameat wbicll bIocb .... 
platelet Jlycoproteia (OP) IlbIIIIa receptor IIIIi poteatly iDbibita pIat.eIet 
aappIioL AU pItiaa, 44 maleIlIId 16 femIIee, .. 38-73, hid qiDa willa 
dyDamic Eoo chana- in spite of thenpy with bepuiD. upiria IIIIi DilroalyceriD; 
11 pItiaa hid iDfarctioD in .... pIeI:ediua 7 days. AfW lII8ioJnphy, e7B3 
iIIfuaQ (1l-30, 0.25 IIIJIka injectioll + 10 I'almill iIIfuaQ) 01" I'll (1l-30)_ 
IIarted IIIIi CClIIIimtecl for 16-24 boun 1IIlIil aec:oad maiopaphy IIIIi PTCA. 
M--u of platelet fuuctioa cIemoaatntecl > 90" bIoc:bde of GPllblllIa 
receptorIlIIIi >90" reductiaG of eJt "'WI platelet agreptioIl (to ADp) duriDJ 
e7B3 iDfuaic-. AU poIieatI wen followed duriDJ hoopitalialioD ror ....".... 
i.:Jaemia (p.m IIIIi Eoo chaua-) IIIIi for .... 0CC\ImIIICe of IIIIj« _ 
(iDcludiq deIIh, myocardial iDfucIica, urpat PTCAICABG) before, duriDJ 01" 
foIIowiD8 PTCA. 
Wet, IImIl: MiDor bleediD& (maiDly puIICIuIe site) occurred in 10 e7B3 IIIIi 
6 I'll pmiIIIIL TrIIIIfusioa _ requinld in 3 e7B3 IIIIi 2 I'll pIIIieaIL 
EfIicIq RmII: III hoopital, • total of 12 ID1Ijor evente occurred in 6 (20") of 
.... I'll paIieDIa, iDcludiq 1 deIIh, 4 iIlfan:t8, IIIIi 6 urpat PTCAICABG 
procedunL Ill .... e7B3 pItiaa, oaty 1 eveat (aa infan:t) occurred ill 1 (3") of 
.... pmiIIIIL Recum:at i8chemia occurred ill 6 I'll poIieatI, COIIIpIIIeIi to 2 e7B3 
pmiIIIIL ADaioJlllPby tbowecl improved TIMI flow in S I'll IIId 6 e7B3 paIieaIa 
IIId wonmiaa of flow in 3 I'll poIieatI, but in ~ of .... e7B3 paIieaIa. 
CGnelllRIID' CombiIled thenpy with e7B3, bepariD. IIIIi upiria appean .... 
n- pilot llUdy r.uIta, a1tbouJh lIaIUtica11y DOt aiJDifiaat, IIIIppOIt .... aotioIl 
daIt effecIive bIocbcIe of platelet GPIlbIIIIa· receptorI em !educe myocarWa1 
iIlfan:IiGa IIId facilillte PTCA in pItiaa with refnctOIy lIIIIIabIe qiDa. 
768-2 4:15 
Flow Cytometry: A new and specific method for a.sessing 
platelet activity in patients with unstable angina and 
Qon-Q wave Myocardial Infarction 
Richard Becker, Russell Tracy, Edwin Bovill, Joel Gore, 
Steven Ball, Kenneth Hann, Kenneth Ault. Thrombosis 
Center, University of Massachusetts Medical School, 
Worcester, MA. 
Accumulating evidence suggests that platelet activity is 
increased in patients with atherosclerotic coronary heart 
disease, especially those experiencing unstable angina or 
myocardial infarction. Previous methods for assessing 
platelet activity have been indirect, and quantitation has 
been difficult, precluding their use in the clinical 
arena. A promiSing new method is flow cytometry, which 
uses monoclonal antibodies spec'ific for a glycoprotein 
marker of platelet activation (GMP-140/P-selectin) 
expressed on the membrane surface following a-granule 
release. Using this technique, 24 samples obtained on 
different days from 9 normal individuals were analyzed. 
All samples with one exception showed quantitative 
platelet activation <7\, while 75\ of samples showed 
activation <3\. In a preliminary study of 19 patients 
with unstable angina or non-Q-wave myocardial infarction 
participating in the TIMI 3 Trial, baseline samples were 
collected within 24 hours of ischemic chest pain (mean, 
S hours). Overall (mean) platelet activation was 10.6\ 
(range 1.3-29.9%) (P<.Ol vs controls). Fifteen of 19 
patients (79%) had activation >3\, and 12 (63\) exceeded 
7\ activation. Seven patients (37\) were found to have 
baseline platelet activation >10\. Thus, flow cytometry 
represents a new, specific, and previously undescribed 
method for assessing platelet activity in patients with 
acute coronary syndromes. Future work will correlate 
platelet activity over time using this technique with 
treatment response and clinical outcome in a larger 
patient cohort participating in TIM I 3. 
ABSTRACTS 
768-3 
Aspirin Inhibition or Platelet Thrombosis in Nonnal Men: 
<>met Gf Antitbrombotie Action and the Erred of Shear Rate 
269A 
4:30 
Josepb Hung, Jules Y.T. Lam, Lucie L.-Lacoste, lean-Gilles Latour, 
David Waters. Montreal Heart Institute, Montreal, Canada 
Cumulative small aspirin (ASA) dosages will provide an antithrombotic 
effect after a few days by near complete inhibition of platelet thromboxane 
A, production. However a rapid antithrombotic effect of ASA is desirable 
in acute myocardial infarction and unstable angina. The onset of 
antithrombotic action and the effect of a bigh sbear rate (wbich would 
occur at the site of a coronary stenosis) on the antithrombotic action of a 
bigher dose of ASA was studied in 9 normal men wbo took 650 mg soluble 
ASA. Platelet thrombus deposition (PO) was studied by flowing venous 
blood from the subjects over porcine aortic media (simulating deep vessel 
injury) placed. in cylindrical flow cbambers. The flow chambers were 
designed to produce sbear rates (SR) of 754 and 2546 sec". PO on vessel 
wall was planimetered and measurements were made before (Ctrl) and II 
I, 10 and 24 brs after ASA. The following decreases in PD (uM'/cm') 
were observed: 
~ Platelet Thrombus Deposition 
~ ~ 
Ctrl IS.3±2.7 21.8±4.2 
I hr IS.H2.3 17.4±2.2 
10 brs 14.6±2.4 14.9±2.6* 
24 brs 12.4±2.4 11.3±2.6* 
mean±SEM; * ANOVA p<O.OS vs Ctrl 
Thus, initial bigh dose oral aspirin significantly inhibits PD on injured 
vessel wall wben the sbear rate is bigh as occurs at the site of a coronary 
stenosis. However the onset of its antithrombotic effect may be delayed for 
some bours after the initial dose. 
768-4 4:45 
Doul. BliDd Jlalldoaise4 Trial of a proatac:yclin 
sparing Aapirin Woraulation in a.at Angina aDd 
.on-Q .av. Infarction 
Marc Cohen, Gareth Parry, Jan Xiong, Philip 
AdiUlS, Douglas ChaJlberlain, Keith Fox, Iwona 
Wieczorek, Ruth McBride, James Chesebro, Janet 
strain, Valentin Fuster, for ATACS. Hahnemann 
University Hospital, Philadelphia, Pa. 
More patients (pts) are presenting with 
unstable angina (U/A) or non-Q wave MI while on 
aspirin (ASA). In these prior ASA failures, we 
tested a stronger anti-thrombotic (A-T) regimen 
ASA + anticoagulation (AC). Also, a new ASA 
foraulation was used. Controlled release (CR) 
ASA acetylates platelets in the entero•
hepatic circulation but doesn't reach the 
systemic circulation thereby preserving 
endothelial prostacyclin synthesis. 144 pts 
were randomized to either CR ASA or conven•
tional ASA 75 ~ daily. All pts also received 
heparin (APTT 2 X control) followed by warfarin 
(INR 2-3) and anti-anginal drugs. Trial therapy 
was begun in the emergency room and continued 
for 3 months. Primary end points, recurrent 
angina (Rec Ang), myocardial infarction (MI), 
and death, analyzed by intention to treat were: 
Rec Ang MI Death Total 
CR-ASA 19\ 3\ 7\ 29\ 
conv ASA 25\ 4\ 0\ 29\ 
26 of the 42 (62\) recurrent ischemic events 
occurred in < 7 days. Conclusions: There is a 
significant rate of failure of maximal A-T 
therapy in prior ASA users with UIA or non-Q 
MI. Prostacyclin sparing ASA offers no clinical 
benefit over conventional A-T therapy. This may 
be explained by the high early event rate. 
270A ABSTRACTS 
768·5 5:00 
Unstable Angina Developing in Patients on Chronic 
Aspirin Therapy is Associated With an Increased Risk of 
Early Adverse Cardiae Events 
Kamyar Haghani, Prediman K. Shah, Bojan Cercek. 
Cedars·Sinai Medical Center and UCLA School of Medicine, 
Los Angeles, California 
Patients who develop unstable angina on chronic 
antiplatelet therapy with aspirin (ASA) may have a 
higher risk for adverse cardiac events. We studied 100 
consecutive patients admitted with unstable angina. 
Patients with chronic ASA (n=57) were comparable to 
those who were not (n=43) with respect to hypertension 
(40% vs 56%), smoking (35% in both groups), elevated 
cholesterol (19% vs 26%), EKG changes with pain (46% vs 
44%), coronary angiography (11% vs 12% with 3 vessel 
disease, jeopardy score 5.55 vs 4.59) and inhospital 
medical therapy (89% vs 91% received ASA/heparin, 83% vs 
89% Ca/beta blockers). 
Results: During hospital stay (6±S days) there were no 
deaths in either group. The cumulative rate of recurrent 
an9ina (Rec AP), infarction (MI), angioplasty (PTCA) and 
bypass surgery (CABG) was higher in patients with 
chronic ASA therapy (63%) compared to those not on 
chronic ASA (30%, p< 0.05). 
During 6·months follow·up after discharge, 2 (3%) of 
patients with chronic ASA and 3 (7%) of patients not on 
chronic ASA died (NS). There was also no difference in 
cumulative rate of other events, 35% in patients with 
chronic ASA had either Rec AP or positive stress test, 
sustained HI or underwent PTCA or CABG, compared to 23% 
in patients not on chronic ASA (NS). 
Conclusjon: Patients who develop unstable angina while 
on chronic ASA therapy are at higher risk of developing 
adverse cardiac events during initial hospital stay 
compared to those not on chronic ASA therapy. After 
discharge, the cumulative event rate at 6 months is 
similar in the two groups. 
768·6 5:15 
combination ADtithroabotiG Therapy aeduce. 
aecurrent I.Gh_ia in Un.tallle ADqina aDd .on-Q 
Wave InfUGtio. 
Marc Cohen, Gareth Parry, Jan Xiong, Philip 
AdillllS, Douglas Chamberlain, Keith FOx, Iwona 
Wieczorek, Ruth McBride, James Chesebro, Janet 
strain, Gilead Lancaster, Valentin Fuster, for 
ATACS. Hahneaann University Hospital, 
Philadelphia, Pa. 
Aim: To compare combination anti-thrombotic (A•
T) therapy with aspirin (ASA) + anticoagulation 
(AC), versus ASA alone in patients (pts) with 
rest unstable angina (n-160) or non-Q wave 
myocardial infarction (MI) (n-54) in non-prior 
ASA users. 105 pts were randomized to ASA 
(162.5 mq load + 75 mq daily), + heparin (APTT 
2 X control) followed by warfarin (INR 2-3). 
109 pts were randomized to ASA alone. Anti•
anginal and trial therapy were bequn in the 
emergency room and continued for 3 months. 
Primary end points were, recurrent angina (Rec 
Ang), myocardial infarction (MI), and death. At 
14 days, there was a significant reduction in 
total ischemic events in the combination group 
vs ASA alone, 13' vs 25', p-.002. At 90 days, 
events were; 
Rec Ang MI Death Total 
ASA+AC 11' 6' 2' 19' 
ASA 18' 8' 2' 28' p-0.10. 
Conclusion: Combination anti-thrombotic therapy 
with ASA+AC significantly reduces recurrent 
ischemic events in the early phase of unstable 
angina and non-Q wave MI. 
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769·1 4:00 
Effect of Mild Mitral Regurqitation on Post MI 
Death; Effect of captopril Therapy 
Gervasio Lamas, Greq Flaker, Gary Mitchell, 
Sidney Smith, Bernard Gersh, Joseph Alpert, 
Randall Zusman, Dale Adler, Ha Dinh, Eugene 
Braunwald, Marc Pfeffer, for the SAVE 
Investigators. Brigham and Women's Hospital, 
Harvard Medical School. Boston MA. 
The prognostic significance of mitral 
regurgitation (MR) and the effect of captopril 
(CAP) therapy were evaluated in 513 SAVE patients 
(pts) who underwent left ventriculography up to 
16 days post MI (pre-randomization). All pts had 
EF~40%. MR was absent in 421 (82.1%), 1+ in 69 
(13.5%), 2+ in 22 (4.3%), 3+ in 1 (0.2%), and 4+ 
in O. EF averaged 32% in pts with and without 
MR. However, MR pts had greater end systolic 
volumes (143+/-63 v. 110 +/-47 ml p<O.Ol), and 
end diastolic volumes (237 +/-92 v. 188+/-72 ml 
p<0.01); more spherical LVs (systolic sphericity: 
32%+/-10 v. 28 +/-7 p<0.01); and a higher 
incidence of 3 vessel disease (29% v. 18% 
p<0.01). After 3.5 years follow-up, 44.6% of MR 
pts and 28.0% of pts without MR had cardiac 
death, severe heart failure, or recurrent MI 
(p=0.002). Multivariate analysis showed MR to be 
a predictor of post MI cardiac death (odds 
ratio): 2.43, p<O.Ol) independent of EF, LV 
volumes, and extent of coronary disease. CAP 
therapy post MI reduced cardiac death or 
morbidity both in pts with and without MR by 
similar proportions (by 26% and 25% in pts with 
and without MR). In conclusion, MR, even when 
mild, is a strong predictor for post MI cardiac 
death and morbidity. CAP benefit is similar for 
pts with and without MR. 
769·2 4:15 
N·tenninal Proatrial Natriuretic Factor (PRO·ANF) • A 
Uniquely Powerful Predictor of Long Term Outcome After 
Myocardial Infarction 
Christian Hall, Jean L Rouleau, Marc Klein, Bruce Sussex, 
Milton Packer, Gervasio A. lamas, Francois Sestier, Stephen S. 
Gottlieb, Marc A. Pfeffer for the SAVE Study. University of 
Oslo, Oslo, Norway 
After myocardial infarction (MI), elevation of atrial peptide (ANF) 
has been associated with poor prognosis. However, when left 
ventricular ejection fraction (LVEF) and other clinical variables 
are included, the importance of ANF is reduced. Because of its 
longer halflife and stability, PRO·ANF may be a better integrator 
of atrial peptide secretion than ANF itself. In order to test 
whether PRO-ANF was of more prognostic value than ANF, 
plasma concentrations of both were measured in 249 patients 
in the SAVE study 3 -16 days after MI and related to prognosis. 
The correlation between ANF and PRO·ANF levels was only 
0.42, p < 0.001. A multivariate model which included age, 
gender, prior MI, hypertension, diabetes, use of thrombolytics 
and LVEF was constructed to predict subsequent cardiovascular 
mortality or the development of severe heart failure. When 
PRO-ANF was added to this model, it was found to be 1!!g 
most powerful independent predictor of these events (Wald 
Chi·Square = 22.3, p< 0.001). When ANF itself was added, it 
was less userJI (Wald Chi·Square = 4.1, p< 0.04). 
We conclude that in patients with lVEF s 40%, but no overt 
heart failure post MI, PRO-ANF is the most powerful indepen. 
dent predictor of cardiovascular mortality or the development 
of severe heart failure, more so than ANF itself. 
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769·3 4:30 
First Q Wave and Non·Q Wave Myocardial Infarction: 
Ischemic Test Results and Outcome. 
Wojciech Zareba, Arthur 1. Moss. Richard F. Raubertas, W. 
Jackson Hall, and the Multicenter Myocardial Ischemia Study 
Group, University of Rochester Medical Center, Rochester, NY 
The aim of this study was to compare ischemic test findings and 
event rates in patients with first Q wave (QMI; n=363) and non-Q 
wave (NQMI; n=186) myocardial infarction (MI). The following 
ischemic tests were performed at enrollment 1-6 months (mean 2.7 
months) after MI: rest ECG (RECG), exercise ECG (ExECG), 
ambulatory ECG (AECG), and stress thallium scintigraphy (STS). 
Frequency of ST depression on RECG and AECG was similar in 
QMI and NQMI patients. ExECG showed more ischemia 
(p=O.003) in NQMI (33%) than QMI (19%), but the reverse was 
true for STS (NQMI 34% versus QMI 46%; p=O.OI). During mean 
26 month follow-up, Cox regression modeling of QMI:NQMI 
adjusted for baseline clinical variables revealed similar cardiac event 
rates (cardiac death, nonfatal MI, or unstable angina, whichever 
comes first): Hazard Ratio QMI:NQMI = 0.90; 95% C.L 0.58-1.39; 
ns. The unadjusted event rates were also similar (QMI-15%, 
NQMI= 17%; p=ns). Results of ischemic tests, added to this 
adjusted model (one at a time) did not show any significant 
difference in prognostic value of ischemic tests between QMI and 
NQMI. 
Conclusion: 1) During 2-year follow-up after a first MI, cardiac 
event rates are similar in patients with QMI and NQMI. 
2) Prognostic value of ischemic tests is not different in QMI and 
NQMI patients, even though ExECG and STS show different 
frequencies of ischemia in these infarct types. 
769·4 4:45 
Gend .. Differences between Patlentl with Acute MI, Non Q.Wave.MI, 
and Unatable Angina. Resuns from TIMI II and T3B 
Carolyn H. McCabe, Mary Jane Prior, TIe Fraullnl, Richard Becker, Judith S. 
Hochman, Catherine Kells. Peter Stone, Christopher P. Cannon, Eugene 
Braunwaid, for the TIMI Ii and T3B Investigators, Brigham and Women's 
Hospital, Boston, MA 
Res~ from TIMI Ii and other large thromboiytic triais have shown that 
women (F) present with acute MI (AMI) lass often than men (M), and have 
a worse prognosis in all age groups. To determine if this ratio and outcome 
are similar in non O·wave MI (NOMI) and unstabie angina (UA), the data on 
1245 pts enrolled in the T3B Trial were examined. Analysis 01 baseiine 
characteristics reveaied that F compared to M, were significantiy older (61 
vs. 58 yrs), were more likely to have hypertension (56% vs 35%) or to have 
never smoked (42% vs 24%) ail P < 0.01. Of the 612 pts assigned to the 
Invasive strategy who had angiography, F were less likely to have multlvessel 
CAD (37% vs 45%, p=O.06) but had a simBar revascularization rate. Of the 
628 pts assigned to the COI1S8MItlve strategy, F underwent fewer 
revasculartzation procedures than M (40% VS 51%, P < 0.01). In contrast to 
previous AMI studies, gender was found l!2l to be a correlate 01 death, MI 
or ischemia by logistic regression anaiysls. Comparisons 01 outcome from 
TIMI II and T3B are given below: 
AMI N=3339 NOMI N=403 UA N=842 
F M F M F M 
Ratio 01 F to M 1 : 4.6* 1 : 2.7* 1 : 1.7* 
·p<O.Ol ail 3 grps 
% PIs with Death/ 15.9 9.5 16.4 13.7 8.1 9.0 
MI at 6wks Ip<O.Ol] INS] INS] 
hus, In companson to men, women: 1) const~ute a slgn~icantiy larger 
fraction 01 pts with UA than NOMI or AMI, 2) have lass multlvessei CAD, 
3) undergo symptom driven revascularization less frequentiy, and 4) have a 
worse outcome in AMI than was observed in NOMI or UA aithough power 
was limited for these comparisons. These findings are Important to the 
understanding at the natural history at CAD in women. 
ABSTRACTS 
769·5 
Prediction of Death after Myocardial Infarction 
with RR Variability Calculated from 2 to IS-Minute ECGs 
J. Thomas Bigger Jr., Joseph L Fleiss, Linda M. Rolnitzky, 
Richard C. Steinman, Columbia University, New York, NY. 
5:00 
RR variability calculated for a 240br period predicts time to death 
after myocardial infarction (MI). Parasympathetic and 
sympathetic nervous activity can be quantified from recordings as 
short as 2 to 5 min. It is not known whether RR variability 
calculated from brief ECG recordings can predict time to death 
and mechanism of death after MI. We studied 715 patients 2 
weeks after MI to test the hypothesis that power spectral 
measures of RR variability calculated from 2 to 15 min of RR 
interval data will predict all-cause mortality or arrhythmic death. 
Four frequency domain measures were calculated from spectral 
analysis of RR intervals for a 240br interval and for one 15, 10, 5, 
and 2-min segment selected at random during the day and for one 
15,10,5, and 2·min segment at night: (1) 0.0033 to <0.04 Hz, 
very low frequency (VLF) power; (2) 0.04 to <0.15 Hz, low 
frequency (IF) power (3) 0.15 to 0.40 Hz, high frequency (HF) 
power; and (4) the LF jHF ratio. Mean power spectral values 
calculated from 5 to 15 min periods during the day and night were 
similar to values computed with a full 24 hrs of data. Currelations 
between values computed from short segments and those 
calculated from 24 hrs of data were strong (r ~ 0.75). Patients 
with low values for RR variability calculated over short segments 
were 2 to 4 times as likely to die over a mean follow·up of 31 
months as patients with high values. 
Conclusion. Power spectral measures of RR Variability calculated 
from 2 to IS-min ECG recordings are remarkably similar to those 
calculated over 240br and are excellent predictors of all-cause 
mortality and arrhythmic death. 
769·6 5:15 
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Refractory Unstable Angina is Associated with Persistently 
Elevated Plasma Levels of Endothelin 
Iwonl Wjeqorek• Keith Fox, Christopher Ludlam, William 
Haynes, David Webb. 
CardiOvascular Research Unit, University 01 Edinburgh, UK 
Endothelin (ET) is an endothelium·derived peptide that is a potent 
vasoconsttictor in man. Plasma ET concentrations are increased in 
congestive heart failure and acute myocardial infarction (AMI). In 
contrast, in chronic stable angina, ET has been found to be nonna!. 
Elevated ET levels in acute coronary symptoms are associated with 
markers of a hypercoagulable state. 
We have measured ET levels in 14 patients presenting with 
refractory unstable angina (ECG change, unresponsive to heparin, 
ASA, nitrates) and in 17 healthy controls. Nine patients developed 
cardiac events (AMI, recurrent angina ± PTCNCABG) during 9 
weeks of follow·up, while five remained event·free. Presentation ET 
levels were significantly elevated in the patients compared with 
controls (7.80±0.29 vs 5.29 pg/ml, p<O.OOl) and remained elevated 
at 9 weeks (8.35±O.68 vs 5.29±1.29 pg/ml, p<O.OOI). Levels of ET in 
those who subsequently developed cardiac events were significantly 
higher both at presentation (6.52±O.4S vs 8.011±O.29, p<O.OS) and at 
9 weeks (S.9O±O.33 vs 8.72±O.78, p<O.OI). 
This study demonstrated persistently elevated levels of ET in 
patients with unstable angina. This may support the concept of 
endothelial activation in this condition. The finding that ET levels 
were elevated in patients who developed cardiac events may provide 
means of identifying individuals who are at greater risk. 
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Long Term Results or Coronary Angioplasty in Patients 
Younger Than 40 Years: a to-Year Follow-up Study. 
Philippe Buffet, Bruno Colasante, Nicolas Danchin, Yves 
Juilli~re, Christine Selton-Suty, Luc Feldmann, Joseph 
Anconina, Pierre Y. Marie, Fran~is Cherrier. Cardiology A 
and B, Nancy-France 
The aim of this study was to determine the potential long term 
benefit of PTCA in very young pts < 40 years. From 1980 to 
1991 140 pts < 40years (Mean age : 34±3 years, 132 men) 
unde'rwent FTCA Presence of risk factors was : smoking: 83%, 
hypercholesterolemia : 62%, heredity : 37%, hypertension : 
16% and diabetes : 3%. Before PTCA, 28% of -the pts had 
unstable angina, 44% had a history of prior MI, 76% had 1-
vessel disease and mean L VEF was 64 ± 10%. Primary success 
was 86% (79% before 1986 (n=66) versus 92% since 1986 
(n=74), p=O.02). Complicattons were 9 ~ (6.5%), 8 
emergency CABG (5.7%) and no death. During follow-up 
(mean = 6±3 years), 39 (28%) pts had re-PTCA for restenoslS 
(all < 6 mths post-P'fCA),13 had elective CABG (11 for 
restenosis, 1 for failed PTCA and 1 for progression of CAD on 
the other. vessels), 12 had PTCA on a new site (mean ~e = 
4.9±2.4 years), 4 died and 6 had non fatal MI. Among SUrvIvOrs, 
88% were free of angina and 76% still had antianginal drugs. In 
this young population, return to th,e same wor~ was.76%, return 
to work with a change of occupatton or part tIme Job was 15% 
and 6% did not return to work. Long term SUrvIval (Kapl.an•
Meier method) was 97±3% at 10 years. The event-free SUrvIval 
(without MI, elective CABG or re-PTCA on a new site) was 
91±6% at 1 year and 71± 12% at 10 years. 
In pts < 40 years, PTCA yields excellent very lon$ term 
results, provided the eventualio/, of repeat procedures d~nng the 
first mths is accepted. In addition, PTCA for progression on a 
new site is not unusual after several years. 
770·2 
Gender Differences in Patients Undergoing Coronary 
Revascularization: A Report fr_ the Bypass 
Angioplasty Revascularization Investigation (BAlI) 
Trial 
4:15 
Alice ~. Jacobs, Sheryl ~lsey, Allan Rosen, Bernard 
Chaitman, David P. Faxon, Thomas J. Ryan, htherine 
Detre and the BARI Investigators. Boston University 
Hedical Center, Boston, KA 
To examine the profile of women (i) currently under•
going coronary revascularization (REV) in comparison 
to .en (H), we evaluated 1829 patients randomized to 
PTCA or CABG in BARI, of whom 27X were i. 
Hen n-1340 iomen n-489 p value 
Age (years) 60.5 64.0 <0.01 
Age >65 years (X) 35 49 <0.01 
CHF (X) 7 13 <0.01 
Hypertension (X) 42 68 <0.01 
Diabetes (X) 20 38 <0.01 
Hypercholesterolemia (X) 40 54 <0.01 
LVEF <0.50 (X) 23 21 <0.44 
i were less likely than H to present within 1 year of 
symptom onset (48 vs 56X, p<O.Ol), were taking more 
anti anginal therapy (nitrates: 70 VI 64X, p<0.05; 
calcium blocker: 81 vs 73X, p<O.Ol), and were more 
unstable (67 vs 61X, p<0.05), but had an extent of 
multivessel disease similar to H. V received the 
same number of total grafts but fewer internal 
mammary artery grafts 72 vs 85%, p<O.Ol). These 
findings are the same even after adjustment for age 
difference between V and H. These data suggest that 
prior to REV, i are-treated more aggressively with 
medication and perhaps for longer than H. When they 
do undergo REV, V have a higher risk profile and are 
more unstable but surprisingly, have a similar extent 
of disease and preserved left ventricular function. 
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Gender Differences In Coronary Angloplasty: Results 
of 5,000 Consecutive Cases 
Anita Z. Arnold, Matthew J. Mick, Conrad Simpfendorfer 
Cleveland Clinic Foundation, Cleveland, Ohio 
To determine if differences between women and men associated 
with angioplasty (PTCA) were related to gender or size, we 
studied 5,000 consecutive patients (1274 women, 3726 men) 
and assessed baseline variables, and early and late outcome. 
Variables studied were age, hypertension (HTN), diabetes 
mellitus (OM), heart failure, hyperlipidemia, history of M I, 
prior PTCA or bypass surgery, familial coronary disease, 
Canadian Heart ClaSSification (CHC), extent of disease, and left 
ventricular (LV) function. After identifying factors associated 
with a poor outcome, correction was made for body surface area 
(eSA). Procedural morbidity and mortality were analyzed. 
Follow-up assessed overall and event-free survival (freedom 
from MI. repeat PTCA, bypass surgery and death). Compared to 
men, women were older (p< 0.0001), had a higher prevalence 
of OM (p<O.OOOI), familial coronary disease (p=0.002), HTN 
(p<O.OOI), prior MI (p=0.004), and worse LV function (p= 
0.012). While men had Similar extents of disease, women had 
more unstable angina and CHC III or IV (p< 0.0001). Success 
rates were similar (93.7% women, 93.1 % men) yet women had 
higher procedural mortality (1.1 % women, 0.32% men, 
p=O.OOI).Corrected for eSA, this relationship did not hold true 
and women had no greater risk than men. Follow up was complete 
in 97.4% of pts(mean 4 :t 2 yrs). Event-free survival was 
better in women. even after correcting for eSA. 
Conclusion: Women are not at higher risk for procedure 
related mortality when compared with men. Event-free 
survival in women surpasses that of men. The "gender 
difference' favors women on long-term follow-up. 
770-4 4:45 
Angioplasty in Patients With Severe Left Ventrieular Dysfunetion. 
an Analysis or Immediate and Long-Term Survival 
Edward F. Terrien, Noah Siegel, Christopher T. Bajzer, Sylvia 
Puchrowicz, R. Thomas Catlin, William W_ O'Neill, William Beaumont 
Hospital, Royal Oak, Michigan. 
Severe left ventricular dysfunction and multivessel coronary artery disease 
are associated poor long-term survival Little data exists on the impact 
of PTCA in this patient group. To gain insight into procedural risks and 
subsequent events, an analysis of n patients - with ejection fractions of 
35% or less - treated with PTCA was conducted. 
Results: Patients were foUowed for a mean of 19.3 months. (Range 8.5 
to 403 months). PTCA was associated with an 11% hospital mortality 
and a 30% mortality at 29 months (Mean Survival TlDIe). Survivors and 
nonsurvivors exhibited no significant differences in age, sex, risk factors, 
comorbid diseases, number of diseased vessels, lesion morphology, or 
incidence of total occlusions. Significant differences were as follows: 
Survivors Non-Survivors P Value 
Mean Ejection Fraction 30.4 25.6 .004 
Angina Class 3 or 4 71% 89% .01 
Hospital Stay (days) 7.1 15.4 .005 
ICU Stay (days) 1.3 5.7 .~ 
Incomplete Revascularization 82% 82% NS 
Conclusions: Increased severity of ventricular dysfunction and anginal 
class, but not completeness of revascularization, are associated with a 
worse long-term prognosis. These predictors may aid in patient selection 
for percutaneous revascularization. 
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Analysis of Early and Late Results of Left Ventricular 
Function After Direct Angioplasty for Acute Myocardial 
Infarction: Role of the Patent Artery 
Luiz Mattos, Ibraim Pinto, Luiz Tanajura, Aurea Chaves, 
Marinella Centemero, Fausto Feres, Manoel Cano, Galo 
Maldonado, Amanda Sousa, J. Eduardo Sousa. Institute 
Dante Pazzanese, Sao Paulo, Brazil 
Early and late results of LV function were analysed in 
75 pts who underwent sucessfull direct PTCA within 24 
hrs of AMI. All pts had a LV angiogram before PTCA and 
at the hospital discharge (early: mean • 9 days). 
Twenty three of this pts, with patent arteries in 
hospital period, had a late angiogrsphy (late: mean -
12 months). The end points were the arterial patency 
and its relation to LV function, measured by end 
dyastolic (EDV) , end systolic (ESV) volumes and the 




Patent IRA (69 pts) 





98±39 82t.36 < 0.002 
arly Reocclusion(6 





















Late Reocclusion(3 pts) 
* pre vs 
+ pre vs 
Pre PTCA Early Late 
36:13 43;1;6* 38±7+ 
167±63 149t.44* 162t.35+ 
2 * 95 0+ 
Conclusions: Pts with patent arteries have an immediate 
gain in LV function that is sustained lately, however a 
continuous decreasing in EDV/ESV indicates that PTCA 
may benefit LV remodeling. Reocclusion avoids such 
recovery. 
770·6 5:15 
Cb .... ct ... i.tic •• 114 Long bra oatc.,... of Diabetic P.ti.nt. 
P .... eating fo.. CoroD • .., ADgiopl •• ty 
W. L •• Bail.y, Donald R. W.st.rhau •• n, Ba .. ry D. Ruth.rford, 
D.vid R. HcConahay, W.r ... n John_on, L •• V. Giorgi, Thoma. 
H. Shim.h.ck, Rob.rt W. Ligon and G.offr.y O. Hartzl.r, 
Hid Ame .. ica H.art In.titut., KanIa. City, HO. 
W. analyz.d the clinical characteristic_, acut. and long 
term outcome. of 2043 pati.nt. with .ith.r in.ulin or non•
in.ulin d.pend.nt diab.t •• mellitus (DH) presenting to a 
sin'll. c.nt.r for co .. onary angiopla.ty betwe.n 1980 and 
1992. A control group (C) of 10,178 patients without 






























Despite aimilar leaion _ucc •• _ rates, hospital staya were 
.lightly prolonged for the DH group. Long term survival, 
ev.nt free survival and freedom from revascularization were 
all advers.ly .ffected (P < 0.0001) by the presence of DH. 
Ev",F,.. "rYlw' 
I.~'-• - ......... - C · .. -~-~-~.~ .. 
• OIl · ., ..... 
'-
I.~ · .. , ......... -.. 
• .. _ ... _ ... -!_-_.-.. 
· .
t ••• 
Furth.r aubgroup analy.i. found little diff.r.nc. in 
clinical charact.ri.tic., acut. or long t.rm outcom •• when 
.ep.r.ting pati.nta into in.ulin v.r.u. non-inlulin 
r.quiring diab.tica. 
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771·1 4:00 
Progno.tic Signific.nc. of SAlCG Aft.r Thrombolyai. in 
Acut. Hyoc.rdi.l Inf.rction (CAST Sub.tudy) 
Pablo D.n •• , Nabil Il-Sh.rif, Rich.rd K.tz, Rob.rt 
C.pon., Georg. Wy •• and Robin R.ynold.-H •• rtle fo .. the 
Cardi.c Arrhythmi. Supp ..... ion T .. i.l (CAST) 
Inv •• tig.tor •• 
Thromboly.ia/r.v •• cularh.tion (T) during the •• rly 
ph ••• of .n .cut. myoc.rdi.l infarction (MI) h •• b.en 
.hewn to improve progno.i.. Th. time-domain .n.ly.i. 
of the .ign.l av.r.ged .l.ctroc.rdiogram (SAlCG) i. a 
.trong, ind.pend.nt pr.dictor of arrhythmic .vent. 
(arrhythmic d.ath/cardiac arr •• t, AI) following .n HI. 
To d.t.rmin. wh.th.r the progno.tic .ignificanc. of an 
abnormal SAlCG (QRSD-40Hz ~120 m.) ia influ.nc.d by T 
we compar.d the AI of pati.nt. with and without T in 
the CAST-SAlCG .ub.tudy. Information waa av.ilabl. in 
788 patient., the .v ... ag. follow up wa. 9.9 ± 3.2 
month. and AI occur .. ed in 33 pati.nt. (4.2'). Th. 
pr.val.nc. of abnormal SAlCG wa. 9.4\ (34 of 362 
p.ti.nta) in pati.nta with T .nd 15.3' (65 of 426 
pati.nt.) in tho •• without T (p <0.02). Th. AI rat. 
for patient. with and without T in r.lation to the 










In conclulion in pati.nta with an acut. HI: 1) The u •• 
of T 11 allociated with • lignificantly d.cr ••• ed 
pr.val.nc. of abnormal SAlCG. 2) Th. u •• of T and • 
normal SAlCG port.nd an .xc.ll.nt progno.i •• 3) An 
abnormal SAlCG i. pr.dictiv. of .n incr •••• d incid.nc. 
of AI in pati.nt. with and without T. Thu., T doe. not 
.ff.ct the progno.tic .ignific.nc. of SAlCG. 
771·2 4:15 
Early Reperfusion in Acute Myocardial Infarction Diminis· 
hes Changes in the ORS Complex 
Paul G. Voiders, Pierre J. Hoppener, Frits W. Bar, 
Frank Vermeer. Department of Cardiology, Academic 
Hospital Maastricht, The Netherlands 
It is well known that a sudden decrease of ST·segment 
elevation is a sign of reperfusion. The effect of 
thrombolysis on CRS configuration is less clear. 
Therefore, quantitative analysis was performed on the 
changes of the ORS complex in patients with myocardial 
infarction (MI) receiving thrombolytic treatment within 4 h 
after onset of symptoms. Coronary angiography was 
performed at 90 min and at 24-36 h after start of 
thrombolytic treatment. Patients with TIMI grade 3 flow 
on both angiograms formed the Reperfusion Group (REP: 
n = 191). The Non·Reperfusion Group (NON·REP, n =46) 
consisted of patients with TIMI grade 0 or 1 flow on both 
angiograms. ECGs were recorded on admission (ECG1) 
and after the first angiogram (ECG2). The sum of O·wave 
amplitude in mm (IO; 1 mm = 0.1 mV) of the infarct·rela· 
ted leads and the Selvester ORS score were calculated for 
both ECGs. 
Results: Values in REP and NON-REP in ECG1 were for 
IO: 12.1 vs 17.7; and ORS score: 2.7 vs 3.2. Significant 
differences between REP and NON·REP (p < .05) were 
found for IO in ECG2: 19.7 vs 27.2; and for ORS score 
in ECG2: 4.2 vs 5.9. 
Conclusions: 1) Reperfusion in acute MI results in signi· 
ficantly lower IC and CRS score. 2) In addition to ST•
segment analysis, ORS analysis may be useful to evaluate 




Automatic: aTc Lenghtening measured in Holter ECG .s • Marker of 
Litethre.tening Arrhytmi.1 in Postmyocardial Infarction Patients. 
Eduard Homs. Xavier Villola •• Josep Guindo. Vicens Marti. Olga Guri. 
Antonio Bay •• de Luna. Hospital de Sant Pau. Barcelona. Spain. 
Dynamic aTc interval measured on Holter ECG seems to be a reliable 
method for risk assessment of life-threatening ventricular arrhytmias 
in postmyocardial infarction patients I PM I PI as we have previous 
reported. However because of manual measurements are time•
consuming. we determined the value of automatic aTc measurement 
from Holter ECG using a computer algorithm we have recently 
designed in order to identify PMIP prone to develop malignant 
ventricular arrhytmias IMVAI. We automatically measured aTc 
interval beat to beat from data recorded on a 24h ICR Holter system 
6201 in 3 groups of patients. Group I: 14 PMIP Imean age 56 ± 16 
and mean ejection fraction 42 ±4%1 with sustained VT 18ptsl or VF 
16ptsl during follow-up. Group II: 20 PMIP without MVA and matched 
for baseline characteristics to group I. Group III: 10 healthy subjects 
without heart disease as a control group and matched for age and sex 
to previous groups. All patients were not undertaking drugs known to 
influence aT interval before undergoing Holter ECG. 
RESULTS: 
Groups Mean aTc Pts with peaks 
Imsecl of aTc>500msec 















1.-PMIP who developed MVA exhibited a longer aTc and presented 
peaks of aTc above 500msec. 
2.-Automatic aTc measurement from Holter ECG is now available and 
feasible. thus may be a reliable method to stratify PMIP at high risk 
of arrhytmic events. although further studies in larger series of 
patients should be made to assess our preliminary results. 
771·4 4:45 
Late Potentials are Predictive of Ventricular Remodeling Following 
Myocardial Infarction 
Azfar G Zaman, John L Morris, John H Smyllie, J Campbell Cowan. 
The General Infirmary at Leeds, UK. 
The occurrence of late potentials (LP) following acute MI is related 
to patency of the infarct related artery, an established determinant of 
ventricular remodeling. A prospective study was undertaken to assess 
the value of LP in predicting change in infarct segment length and 
global ventricular remodeling. 
We studied 36 patients with a first anterior MI. Apical 2 and 4-
chamber long axis views were recorded by 2D Echo within 12 hours 
of admission and at 6 weeks. Infarct segment length (ISL) was 
assessed as the length of the hypokinetic zone, over which contraction 
was reduced by more than two SD in comparison with normal 
controls. This was compared with total perimeter length (TPL). 
Signal-averaged ECG was recorded (40-250 Hz, bidirectional filter) 
and LP were present if 2 of 3 standard criteria were met 
(QRS~114ms, RMSt40 <20/.lV LASD>38ms). 
--Day l-- -Day 42-
(cm±SEM) TPL ISL TPL ISL 
LPpos(n=lO) 17.9±0.7 9.8±1.0 21.4±2.2 9.0±1.2. 
LPneg(n=26) 18.5±0.4 9.4±0.6 18.2±0.7 5.8±0.5* 
*p<O.OOI day 1 to 42; .p<0.03, LP pos v LP neg 
LP negative patients showed a significant reduction in ISL at 6 weeks. 
This may represent recovery of stunned myocardium. LP positive 
patients showed no reduction in ISL and a trend towards increase in 
global ventricular dimensions. The presence of LP on day I is 
predictive of poor recovery in the infarct zone and adverse ventricular 
remodeling. 
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"Idiopathic· Severe Ventricular Arrhythmias in Young 
Patients: Ventricular Late Potentials as Initial manife= 
station of OrganiC Heart Disease 
Antonio Nobile, Andrea Frustaci, Paolo Zeppilli, Andrea 
Spampinato, Pietro Santarelli, Sandro Montenero, Paolo 
Zecchi, Fulvio Bellocci. 
Catholic University Rome, Italy 
We analized the presence of ventricular late potentials 
(LP) in young pts with apparently idiopathic severe ven= 
tricular arrhythmias and its relation with the presence 
of organic heart disease (OHD). We studied 34 pts, 19 men 
and 15 women, mean age 21 + 9 years, with apparently 
idiopathic severe ventricuiar arrhythmias (non sustained 
ventricular tachycardia in 28 and sustained ventricular 
tachycardia in 6). 
In all pts non invasive evaluation was not diagnostic for 
OHD, however LP obtained by Signal averaged ECG were pre= 
sent in 18 pts. All pts underwent cardiac catheterization 
and endomyocardial biopsy that revealed OHD in 21 pts: 
arrhythmogenic right ventricular dysplasia (ARVD) in 11 
pts, myocarditis (M) in 7 and idiopathic dilated cardio= 
myopathy (IDCMP) in 3 pts. All 18 pts with LP had OHD: 11 
had ARVD, 4 M and 3 IDCMP. In 3 pts with OHD (M) LP were 
negative. LP sensitivity was 85%, speCificity 100%, posi= 
tive predictive value 100% and negative predictive value 
81%. 
In conclusion, in young pts with apparently idiopathic 
severe ventricular arrhythmias, the presence of LP sug= 
gests an arrhythmogenic substrate due to an OHD (mainly 
ARVD, M or IDCMP) and warrants further diagnostic investi= 
gations_ 
771·6 
Elect:rq;ilysiologic signifi.came of New Q waves in 
Ric:#Jt PrecaI:di.aJ. Em Isads Followin:] Ri.cpt anne 
Ablatiat 
5:15 
AnI;er Illala, Banjay Deshparrje, Zalmen Blanclt, Abdul 
waR, Mita Sheth, Mctlamad Jazayeri, Jasbir Bra, Boaz 
Avitall, Masood Akhtar. Sinai Samaritan Medical 
Oent:er, Milwaukee, Wisccnsin 
Right bmdle brardl block (RBBB) in the absence of any 
cxn:::anitant intraventricular cx:nructial delay (IVa) 
or myoc:ardial. infarctial does rot alter the initial 
portial of ~ OCIIpleJC. However, the effect of RBBB 
al the ~ 0'lSet: with pre-existent IVa) has never been 
systematically stmied. TwentyfCllr patients (pts) 
uniergoin} tJ:ansc:atheter ablatial of RB for cardiac 
anhythmias fann the basis of this report. Nate of 
these pts had Q waves in Em leads Vl-V2. However, 
bmDediately p:lSt RB ablatial, in additial to the newly 
develqlEd RBBB, 8/12 pts with pre-existin} n::n;pec:ific 
IVa) exhibited new Q waves in Vl-V2. 'lhe mean HV 
interval was 66.3 IIBeC preablatial ani increased to 
99.2 IIBeC postablatial. cardiac enzymeS were rot 
diagmstic for aalte myocardial infarctial. 'lhe 
remainiIq 12 pts with J'X) IVa) prior to the prooedure 
did nat develop any Q wave. HV inteIvals in these pts 
were noDDal at baseline ani showed J'X) significant 
dIan:Je postablatial(fran 47.5 IIBeC to 50.2 1IBeC). 
a:NCIllSICI'l: In pts with preexist:in; IVa), develc:ptent 
of RBBB can produce a pseu:b-anteroseptal infarctial 
pattern. 'lhis is likely due to RBBB UlJlllISk.in:J 
cx:nructial delay ancJ,Ior block in the septal divisial 
of the lett bJncU.e. Reoognitial of this possibility is 
iqxlrtant for prqler Em intetpretatial to avoid 
lIIisdiagoosis of anteroseptal myocardial infarctial in 
pts with IVa). 
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772-1 8:30 
Ventricular Voluaa by Echocardiographic Autoaated Border 
Detection: On-line Calculation Without Loss of Accuracy 
Richard L. Morrissey, Samuel C. Siu, J. Luis Guerrero, 
Arthur E. Weyman, Michael H. Picard, 
Massachusetts General Hospital, Boston, MA 
Automated boundary detection (ABO) with echocardiography 
(echo) offers the potential of rapid, on-line calculation 
of cardiac dimensions and areas. To test whether ABO 
accurately quantitates LV volumes, an ABO algorithm was 
examined which detected LV long axis length and orthogonal 
diameters in an apical view and then util ized modified 
single plane Simpson's method for instantaneous volume 
calculation. Using a beating canine heart model in which 
actual LV volumes were measured continuously with an intra•
cavitary balloon connected to an extra-cardiac reservoir, 
39 volume stages were assessed (7 to 92 cc). At each 
stage, echo images were obtained and ABO volume calculated. 
Subsequently, for each volume stage standard LV images were 
manually traced and volumes calculated by both single plane 
(S) and biplane (B) Simpson's method. True LV volume was 
directly compared to on-line ABO and off-line echo values. 
RESULTS: On-line ABO volumes correlated with true volumes 
(y-.66x + 1.4; r-.91, p<O.OOI, SEE-8.6cc) with a consistent 
underestimation (mean-16.7±12.7cc). This underestimation 
was not significantly different than that for off-line 
volumes (S mean-12.S±12.9 cc, B mean-IO.2±6.7cc) and 
reflected the difficulty in obtaining a true long axis 
length in the canine heart from the apical 4 chamber view. 
CONCLUSIONS: In this experimental model, LV volume can be 
rapidly assessed by this new ABO algorithm with an accuracy 
gg!!il to offline methods. Deviations from true volume 
reflect the dependency on an image which accurately records 
the LV long axis. Recording LV volume in real time by ABO 
may improve the serial, noninvasive assessment of 
interventions on LV volume and rapid EF determination. 
772-2 8:45 
Automated, On-Line Determination of Left Ventricular Volumes and 
Ejection Fraction by Acoustic Quantification: (1) In Vitro Validation, (2) 
In Vivo COmparison With Radlonucllde Method In Patients, (3) ExamI•
nation of Factors Influencing Its Accuracy, and (4) Clinical Application 
Qi-ling Coo. Jose Azevedo. Howard Snapper. Steven Schwartz. 
James Udelson and Natesa Pandian 
Tufts - New England Medical Center. Boston. Massachusetts. 
A new acoustic quantification (AO) approach has been developed to derive 
LV volumes and ejection fraction (%EF) on-line from automated border ex•
traction (ABO) based on integrated backscatter analysiS. The method invol•
ves measurements of instantaneous LV cavity area in apical views and on•
line volume derivation using muniple disc method. In this study we exami· 
ned: its reliability by in vitro and in vivo validation lests, the factors influen•
cing its accuracy. and its clinical applicability. First. we imaged 25 symmelric 
and asymmetric canine hearts in vitro in a water bath. derived LV volumes 
by AO (y) and compared Ihem with actual absolute volumes measured wilh 
saline filling of the ventricles (x). Then. we studied 20 pts with normal and 
abnormal ventricles by AQ (y) who underwent simultaneous radio nuclide 
MUGA scans (x) to compare the end-diastolic and end-systolic LV volumes 
(LVVO and LVVS) and %EF. Following this, AQ functional measurements 
were applied to 64 pts with a variety of cardiac disorders to study the effects 
of Changes in gain. TGC. lateral gain, and imaging plane. Results: Irl..illm 
correlation: y=I.01x-.58. r=.99, p<.OOI. In vivo validation: AQ measurements 
were possible in 19/20 pIS. AQ vs MUGA correlation: for LVVD: .82Xi'51, 
r=.80, p<.OOI; for LVVS: . 98XT24. r-.90, p<.004; for %EF: .67XTI3. r=.92. 
p<.OOI. While optimum technical controls yielded reliable data, increased 
gain underestimated LVVD by 55±190/0 and overestimated %EF by 39±280/0; 
Low gain overestimated LVVD by 55±26 and underestimated %EF by 36±11. 
Lack or inappropriate use of lateral gain over or underestimated the %EF by 
12±10% (p<.OOI for all comparisons). Inappropriate TGC and imaging 
planes led to errors in AQ estimation of volumes and %EF. When optimum 
technical controls ",ere used, presence of LV dysfunction could be recogni•
zed in 30 of 64 pts and also was reproducible. Conclusion: Automated AQ 
provides reliable measurements of LV volumes and ejection fraction on-line 
in patients and is a major step in quantitative echocardiography to identify 
abnormal ventricles and recognize changes in LV function over time. Major 
errors can result with inappropriate use of technical controls but they can be 
easilv corrected and octimized with care in the use of AQ. 
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Intracavitary Echocardiography: In-Vivo Wall Motion and 
Perfusion Analysis of the Heart. 
J. Peter Longabau~, S~an~ey A. Gall, Jr., Eric Lilly, Mark 
Tedder, Suad !small, Hldel Utsunomiya, Peter Smith Joseph 
Kisslo. Duke University Medical Center, Durham, NC 
. To ~ther investigate the utility of catheter-based two•
dtm~nslonal e~ho to detect LV wall motion (WM) and myo•
cardial perfusion (PER), 11 dogs and 6 pigs underwent left 
~eart catheterization with a 9 French 12.5 MHz ultrasound 
tmaging catheter (some also with 6.5 French catheters using 
a new h~gh f!ame ~ate s~tem, Hewlett Packard Sonos 100). 
Short ~ mid-papillary tmages were obtained in all cases. 
Translen.t ~ abnormalities were induced by temporary 
~o.ron.ary hgatlons (30 seconds) or by intra-coronary/aortic 
mject~ons of macrobubbles, reversed by pharmacologic after•
load mcre~e. Changes were observed by two independent 
?bserver~ m four wall segments: septum, anterior, poster•
Ior and intenor walls. Analysis of 716 wall se~ents 
showed 260 WM changes (interobserver variability 1.1 %). 
For. P.ER an.alysis,. hum~ albumin microspheres (AJbunex) 
w.ere ~Ject~d mto either nght or left coronary arteries. 
SIXty mjectlons were made and scored by 2 independent ob•
servers by percent LV circumference with contrast uptake. 
There w~ .10~% agreement between observers in scoring. 
F?I'the,r, mje~tlons were made into the left main coronary 
With either clrcu~ex .or left anterior descending occlud-
e~ .. Th~ PER terntones of. each artery could be easily 
dlStmgulshed. In all cases, tmages from the new high 
frame rate sYS.tem were superior to the older, lower frame 
rate system With regards to dynamic range and resolution. 
These data indicate that intracardiac ultrasound has 
potential use in def~ing L VWM abnormalities and regional 
~ER of ~he myocardium. Such fmdings indicate that 
~tracar~tac ultrasound may play a role in patient 
diagnosIS and/or monitoring therapy in the future. 
772-4 9:15 
Colorized Wall Motion Analysis to Detect and Correct r or 
Translatioa Dnriag Upright Bicycle Stress Echocardiography 
John R. Bates, Douglas S. Segar, Thomas Ryan, Stephen G. Sawada, 
Geoffrey N. Fitch, Harvey Feigenbaum, Krannert Institute of 
Cardiology, Indiana University, Indianapolis, IN 
275A 
Cardiac translation may complicate the assessment of regiooal wall 
motion. Using a new technique, colorized wall motion analysis, we 
determined the frequency of, and corrected for, translation in 21 
subjects without obstructive coronary disease or resting wall motion 
abnormalities during upright bicycle stress echocardiography. Each 
study was displayed in an 8 cell digital cine loop format and consisted 
of 4 rest, 4 post, and 2 peak images (total 210 images). The ventricular 
walls at end-diastole were colorized blue and displayed in cell 1 of the 
loop, serving as the reference cell onto which were superimposed 
subsequent systolic cells (colorized red). Translation was considered 
present if the mitral annulus moved parallel to the plane of the mitral 
valve in the reference cell and was present in 3 of 84 (3.6%) rest, 31 of 
84 (36.9%) post, and 31 of 42 (73.8%) peak images. Translation was 
noted most frequently in the apical views (58.7% of 4-chamber, 39.7% 
of 2-chamber views). Translation was then corrected by shifting 
systolic cells relative to the reference cell using the mitral annulus 
(apical views) or the junction of the inferior septum and the right 
ventricular free wall (short-axis views) as landmarks. After correction 
for translation, wall motion was considered normal if a red rim 
(systole) moved toward the center of the ventricular cavity beyond the 
blue reference border (end-diastole). In 60 of 65 (92.3%) corrected 
studies, wall motion was normal. In the remaining 5, capturing errors 
(3), and poor image quality (2), accounted for the abnormalities. 
CODclnsioas: 1) Cardiac translation occurs frequently during and 
immediately after exercise and is most prominent in apical 
echocardiographic views. 2) Colorized wall motion analysis facilitates 
detection and provides a means to correct for translation. 3) Proper 
digital image capturing and adequate image quality are necessary to 
utilize the colorized wall motion analysis technique. 
276A ABSTRACTS 
772-5 9:30 
Myocardlll Imlglng by Colour Doppler CodlCl Velocity Mlpplng -
A New Method lor the A.-ment of Myocanflll Connctliity 
Francisco J GileIl-Peris, Kal W E Groundstroem, George R Suthe~and, 
Michael J Stewart, Lynn N Fenn, Carmel M Moran, Norman McDlcken. 
Departments of Cardiology and Medical Physics, Edinburgh, UK. 
Colour Doppler coded velocity mapping of the myocardium theoretically 
has the potential to assess regional myocardial contractile function. A serIee 
of In vttro studies has confirmed that this technique can identify both overall 
wall motion and dlff~ng velocities of contraction of muscle groups wtthln 
the myocardial wall. To determine what clinical applications this new 
technique may have we performed a series of studies with 2 main areas of 
Interest: 1) to compare and contrast the ability of this new technique wtth 
2-D Imaging In detecting abnormalities of regional wall motion and 2) to 
study intra-mural colour encoded myocardial fibre velocities as a possible 
measure of myocardial Viability. 81 clinical studies were carried out (53 
precordial; 28 transoesophageal) Including 24 normals, 7 with ischaemlc 
heart disease, 11 with left heart obstruction and 39 with miscellaneous 
lesions. Images were obtained using conventional ultrasound equipment 
which had been modified In such a manner that colour Doppler myocardial 
echoes were of a similar magnitude to those normally obtained from blood. 
Software modifications permitted a narrow low velocity range to be mapped 
(0-3cm.s-1), providing greater velocity measurment sensitivity. Acceleration 
and variance maps were used In Image acquisition. 
Results: 1) Images obtained by both 2-D imaging and modified colour 
Doppler (with 2-D Imaging suppressed) were virtually Identical in their 
degree of Imparted morphologic detail. 2) ModHied colour Doppler images 
of regional wall motion similar to those obtained by 2-D imaging could be 
obtained In all patients. 3) Colour Doppler Imaging of the heart in post 
Infarction patients, could differentiate normal from Infarcted segments. 4) 
A range of velocities within the myocardial wall could be recorded in every 
patient. These were different In patients with a) Ischaemia/Infarction, b) 
normal motion and c) hypercontractlle states. 
Conclusion: Colour Doppler imaging of the myocardium Is potentially a 
useful new clinical tool to assess global, regional and Intra·mural myocardial 
function. Frame-rates are comparable to those currently used In stress-echo 
studies. Colour coding allowed the identfflcatlon and quantitative 
assessment of abnormalities In myocardial contraction. From this 
experience, we believe that this technique can distinguish between 
Ischaernlc trana-mural and partial wall thickness myocardial abnormalities. 
772-6 
Diminished Amplitude of Cyclic Variation of Ultrasonic 
Integrated Backscatter With Adenosine Infusion Due to 
Alterations of Intramyocan:llal Blood Volume 
Thomas Behrenbeck, David A. Foley, A. Jamil Tajik, 
Michael K. O'Connor, and Erik L Rilman 
Mayo Clinic and Mayo Foundation, Rochester, MN 
9:45 
Carciac cycle-dependent variation of myocarcial ultrasonic integrated 
backscatter is in part due to alterations in the concentration of ultra•
sound scatterers with systolic wall thickening. Since blood reflects 
ultrasound less intensely than muscle, we postulated that increases 
in end ciastolic myocarcial blood volume induced by adenosine would 
be accompanied by decreases in cyclic variation of integrated back•
scatter due to greater "dilution" of scatterers by blood at end ciastole 
(ED) than at end systole (ES). 
Methods: Continuous measurements of integrated backscatter in 
the LV posterior wall were made with a modified 20 imaging system 
in eight intact anesthetized mongrel dogs at baseline and during 
the infusion of adenosine (0.75 mg/kgImin). Heart rate and blood 
pressure were maintained constant with right atrial pacing (120 bpm) 
and mechanical control of aftertoad. Cyclic variation of integrated 
baclQ;catter was calculated as the difference between the backscat•
ter amplitudes at ED and ES. Radiolabelled 15 pm microspheres 
were injected into the LA during separate adenosine infusions. Dogs 
were then imaged at base6ne and during adenosine infusion with 
a Triad SPECT scanner using respiratory and EGG gating. Blood 
volume to muscle mass ratios (BVIMMs) were calculated from image 
brightnesses at ED and ES. 
Results: The cyclic variation of integrated backscatter decreased by 
O.83±O.48 dB (p.:O.001) during adenosine infusion. The ED BVIMM 
ratio increased by 5% during adenosine infusion, while the ES 
BVIMM increased only 3.1% (p.:O.01). 
Conclusions: 1. Cycnc variation of integrated backscatter is atten•
uated by adenosine induced vasodilatation. 2. The attenuation is 
related to increased ED BVIMM causing "dilution" of the myocarcial 
scatterers. 
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Superiority of Bedside Partial Thrombopl .. t1D Time to Acllnted 
ClottiDI Time ID CODtrolllDI HepartD ADticoalulatioD 
Jonathan S. Reiner, Karin S. Coyne, CODOI' F. Lundergan. Ciro Berdeguez. Donald 
S. Karcher, Allan M. Ross, Gcorll" Wasbingtoo University, Washington, DC 
Heparin anticoagulation is utilized durin, and after interventiooal cardiac 
C81heterization ~urea, as an adjllllCt 10 fibrin specific agenlJ in patients with 
acute myocardial infarction. as well as in the settings of deep vein thrombosis and 
pulmonary embolus. While some investigaton feel that that a plasma heparin 
level (H) in the ran,e 0.2 - 0.4 1U/m1 refleclJ effective anticoagulation, the 
activated partiallhromboplastio time (aPI1) has become the most popular c1inical 
method for monitorin, heparin therapy. There is, however, often a substantial 
delay inherent in the processilll and retrieval of the aPTI' as performed by the 
hospital Iaboralory. To examine more expeditious methods of adjustina heparin 
therapy, we compared 2 devices designed 10 assess the level of anticoagulation at 
the bedside. We measured the activated clotting time (ACf) utilizing the 
Hcmochron device, the aPTI' utilizing the Ciba-Cornin, Biotrad: 512 device 
(BPIT), as well as the laboratory determined aPTI' (LPTf), and H in 100 
heparinized, non-lytic patienlJ. The BPIT correlated well with the LPTf (r : 
.87). The ACf did nol correlate as well with LP'IT (r = .60) or BPIT (r = .68). 
In the sub-therapeutic (0 - .2 IU/mI) and therapeutic range of H. the ACf did nol 
com:late at all with LPTf or H. Only ACf values> 225 s were predictive of 
LPTf levels> 60 s, however. ACf values below 225 s were obtained in patients 
with sub-therapeutic, therapeutic. and supra-therapeutic aPTI' levels (see plot). 
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Conclusion: The BPIT correlates well with the LP'IT. 1be ACf. however, does 
not correlate well with LPTf or H and cannot reliably predict aPTI' or H in the 
therapeutic or sub-therapeutic ranll". 
773-2 8:45 
Heparia Neutralizatioa by Platelet-Ricb Coroaary Thrombi: 
Poteatial Role of Platelet Factor" 
Daniel T. Eitzman and William P. Fay. University of Michigan, 
Ann Arbor, MI 
Heparin is routinely utilized in the treatment of acute coronary 
syndromes. However, hirudin, a direct-acting thrombin inhibitor, 
may be superior to heparin in the prevention of platelet-rich 
thrombus formation. To test the hypothesis that platelet-rich 
thrombi exhibit potent heparin-neutralizing capacity, the effects of 
extracts prepared from porcine, platelet-rich coronary thrombi were 
studied in an in vitro clotting assay (activated partial thromboplastin 
time, APTT). Thrombus extracts markedly attenuated the capacity 
of heparin to prolong the APTT, with extracts derived from 0.25 
ilL of thrombus shortening the APTT by approximately 20 sec. 
The mean heparin-neutra1izing capacity of thrombi (n=3) was 30 
heparin u/mL of thrombus. In contrast, coronary thrombus 
extracts had no inhibitory effect on the capacity of hirudin to 
prolong the APTT. The heparin-neutralizing activity of thrombus 
extracts adsorbed completely to heparin a~arose at physiologic 
(0.15 M) NaCI concentration. Sequential Incubation of heparin 
agarose with 0.4, O.S, and 1.4 M NaCI resulted in recovery of 
heparin-neutralizing activity in the 1.4 M NaCI eluate. These 
results suggested that platelet factor 4 (PF4), a heparin-binding 
protein present in a-granules, may mediate the inhibition of heparin 
by platelet-rich thrombi. Consistent with this hypothesis, an anti•
PF4 monoclonal antibody that blocks binding of human (but not 
porcine) PF4 to heparin markedly inhibited the heparin-neutralizing 
activity of human platelet Iysates. These results suggest that the 
immediate environment of a platelet-rich coronary thrombus may 
significantly inhibit the anticoagulant potency of heparin. but not 
hirudin. This differential effect may be mediated to a substantial 
degree by high local concentrations of PF4, and could represent a 
previously unrecognized mechanism for the potential superiority of 
hirudin over heparin as an anticoagulant. 
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773·3 9:00 
Combination of Platelet Fibrinogen Receptor Antagonkt and 
Direct Thrombin Inhibitor at Low Doses Markedly Improves 
Thrombolysis. 
Francesca A. Nicolini, Phil Lee, Joseph Furst, Kandice Marchant. 
Eric J. Topol. Cleveland Clinic Foundation, Cleveland, Ohio. 
With different mechanisms of anti-thrombotic action, it is possible that low 
doses of IIbIUla receptOr and thrombin antagonists may be additive or 
synergistic. In thls study, 16 mongrel dogs with electrically-induced occlusive 
coronary thrombus were given rt-PA (1 mg/kg over 20 min) alone (n=7), or 
together with either Integrelin, a novel KGD-peplide with specific affinity for 
the membrane platelet fibrinogen receptors (5 Ilg/kg/min for 90 min) (n=3). 
hirudin, a direct antithrombin agent (20 Ilg/kg/min for 90 min) (n=3), or with 
low doses of both (lntegrelin 2.51lg/kg/min+hirudin 10 Ilg/kg/min for 90 min) 
(n=3). Reperfusion rate was 71% in rt-PA alone and 100% in each other group 
(p=ns). After thrombolysis, dogs were observed for 2 hrs; there was no 
difference in time to thrombolysis among the 4 groups. however the duration 
of reperfusion was significantly lower in rt-PA alone treated dogs (p<0.02). 
Quality of thrombolysis was analyzed taking in account the magnitude of 
restored coronary blood flow during the reperfusion time. Restored coronary 
blood flow was <!; its baseline value for 6±2 min in rt-PA alone. 24±7 min in rt•
PA+integrelin (p<0.05 vs rt-PA alone). 25±4 min in rt-PA+hirudin (p<O.05 vs 
rt-PA alone) and 120i0 min in rt-PA+integrelin and hirudin treated dogs 
(p<O.02 vs all other treatments). Reocclusion occurred in 80% of dogs 
r~vingrt-PAalone,in33%ofrt-PA+integrelinaswellasrt-PA+hirudin.and 
in noneofrt-PA+integrelin and hirudin treated dogs (p< 0.05 vs rt-PA alone). 
Residual thrombus was 8.0±3.0 mg (p<0.0l vs all other treatments). 0.8±1.0. 
1.1±1.0 and 0.5±O.9 mg in rt-PAalone, rt-PA+integrelin. rt-PA+hirudin and rt•
P A+integrelin and hirudin treated dogs. respecti vely. Thus. these data indicate 
that either integrelln or hirudin potentiates rt-PA mediated thrombolysis. 
Moreover, the combination of both integrelin and hirudin at low doses with 
rt-PA further improves the quality and extent of thrombolysis. 
773·4 9:15 
Oxygen Free Radicals May Contribute to the Activation of Platelets by 
Platelet·Activatlng Factor 
Sheng-Kun Yao, Judy C. Obet. James J. Ferguson, H. Vernon Anderson, L 
Maximilian Buja. James T. Willerson. Texas Heart Instttute and University 01 
Texas Medical School, Houston, Texas 
Platelet-activatlng lactor is an Important mediator 01 platelet aggregation and 
cydlc ftow variations In stenosed and endothelium injured canine coronary 
arteries. We tested the hypothesis that platelet-activating lactor Induces 
platelet aggregation and cydlc ftow variations through the production 01 
oxygen free radicals. Ten anesthetized, open-chest dogs were studied wtth 
coronary blood ftow veloc~les monttored by pulsed Doppler ftow probes 
placed around the arteries. In 5 dogs, cydlc ftow variations were induced by 
mechanically Injuring the endothelium and externally narrOWing the artery. 
BN50730, a platelet-activating lactor receptor antagonist, was administered 
at 5 mg/kg Intravenously and abolished cyclic ftow variations In 4 (80%) 
dogs. Then, hydrogen peroxide was given directly into the coronary artery 
at 1.5 mg/minute and restored cyclic ftow variations In all 4 dogs. In another 
5 dogs. cydlc ftow variations were induced by Intracoronary infusion 01 
platelet-activatlng lactor. An antioxidant enzyme, catalase, was infused (2 
mg/kg + 2 mg/kg/hour, I.v.) and abolished the platelet-activating lactor 
induced cyclic ftow variations In all 5 dogs. In v~ro, platelet-activating lactor 
induced platelet aggregation in a dose-dependent manner before treatment 
with catalase. A significant inhibttion of the platelet-activating lactor-induced 
platelet aggregation was observed after catalase treatment. Thus, platelet•
activating lactor plays a role In mediating platelet aggregation and cydic flow 
variations and oxygen free radicals may be involved in platelet-activating 
lactor-induced platelet aggregation and cydlc ftow variations in this 
experimental animal model. 
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773·5 9:30 
Nitroglycerin Inhibits Re-occlusion After ThrombolYSis 
Steven W. Werns, William E. Rote, James H. Davis, and Benedict R. 
LucchesL University of Michigan Medical School, Ann Arbor, MI. 
Nitroglycerin (NTG) inhibits platelet aggregration in vitro, but its 
effect on thrombosis in vivo is controversial. This study assessed 
NTG's effect on re-occlusion after thrombolYSis. Canine carotid 
arteries were instrumented with a flow probe, stenosis, infusion line 
and electrode. A thrombus was induced by a 300 I1A current; APSAC 
0.05 Ulkg was injected proximal to the thrombus 30 min after 
occlusion. After APSAC, NTG (l I1glkglmin, i.a., n= 7) or vehicle 
(n=6) was infused proximal to the thrombus for 3 hours. 
Re-occlusion occurred in 217 NTG dogs and 6/6 vehicle dogs 
(p<O.05). NTG inhibited ex vivo platelet aggregation (%) to 20 ).1M 
ADP and 0.65 mM arachidonate (AA): 
~ f[I:·~IG l....Hmu: ~ Hlm[s 
V 65±8 62±4 65±3 
NTG 72±3 34±9* 36±10* 
..AA... 
V 68±S 72±4 66±S 
NTG 68±9 54±7* 45±10* 





















Thus, local infusion of NTG reduced the frequency of re-occlusion 
after thrombolysis and exerted systemic effects on platelet 
aggregation. The results suggest that NTG may inhibit re-occlusion 
after coronary thrombolysis in patients with myocardial infarction. 
773·6 9:45 
Sodium Nitroprusside an EDRF Congener Inhibits Platelet Mediated 
Thrombosis In Stenosed Canine Coronary Arteries by Elevating 
Platelet CycUc GMP 
Joshua D. Rovin, Jonathan S. Stamler, Joseph Loscalzo, John D. 
Folts, UniverSity of Wisconsin Medical School, Madison. WI and 
Harvard University Medical School, Boston, MA 
Sodium nitroprusside (SNPI, an EDRF congener, elevates platelet 
cGMP levels and inhibits platelet activity in vitro. However, the 
mechanism of platelet inhibition by SNP is not well established in 
vivo. In our model of mechanically stenosed canine coronary arteries 
(MSCAI with intimal damage, periodic acute platelet thrombus 
fonnation occurs producing myocardial ischemia followed by 
embolization causing cyclic flow reductions (CFRsI in coronary blood 
flow. SNP was given to 12 dogs (01 with MSCA; CFRs were 
abolished in all D at 4.1 ±2.9 Jig/kg/min (m±s.d.). Platelet cGMP 
levels were 3.4± 1.4 pmoles/1oa platelets at control. and increased 
to 5.7 ± 2.6 (p < .01) when CFRs were abolished. When CFRs 
returned 5-25 minutes after the SNP infusion had been stopped, 
platelet cGMP levels declined to 5.1 ± 2.4 (p< .02). In an additional 4 
D a 150 mg/kg bolus of N-acetylcysteine (NAC) was given I.V. after 
the CFRs had returned and the cGMP levels had nonnalized. CFRs 
were again abolished with a concomitant increase of cGMP to 
11.9 ± 4.0. These 0 were followed for an additional 35::1: 5 min until 
CFRs returned at which time platelet cGMP levels were 4.5±3.5. A 
SNP infusion was initiated again at half the dose previously needed to 
abolish CFRs. In all 4 D CFRs were abolished by which time platelet 
cGMP levels were elevated to 8.6±2.9. These data demonstrate: 1) 
SNP induced reversible elevations in intraplatelet cGMP in vivo; 2) 
these cGMP levels correlate reproducibly with the presence or 
absence of CFRs; and 3) NAC potentiates the effect of SNP on cGMP 
levels in platelets. These data SUppOIt the notion that cGMP is 
mechanistically associated with and is a marker for the inhibition of in 
vivo platelet function by a nitric oxide or EDRF-lik.e molecule. 
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Physiology of Retrograde Cardioplegia Delivery: Co.parison 
vith Anterograde Cardioplegia Delivery vith Respect to 
lIyocardial Cooling and Nutrient Plov 
Flordeliza Villanueva, William Spotnitz, William Glasheen. 
Sanjiv Raul. University of Virginia, Charlottesville, VA 
Although retrograde cardioplegia (RC) is being in•
creasingly used in clinical practice, its physiology is 
unclear. Since the microvascular architecture of the coro•
nary venous system is different from the arterial system, 
we hypothesized that myocardial cooling and nutrient flow 
would also be different during RC compared to anterograde 
cardioplegia (AC) delivery. Accordingly, AC and RC were 
given to 2 groups of 7 dogs each at the same flow rates 
(0.2-1.4 ml/min/gm). Cardioplegia flow (CF) was measured 
with a calibrated roller pump, microvascular flow (HF) to 
vessels ~11~ was measured using radiolabeled microspheres, 
and nutrient flow was measured by calculating the first•
pass extraction fraction of Tl-201 & Tc-99m. While CF~HF 
for AC, HF underestimated CF by 68% during RC. Similarly, 
for the same flow rates and same degree of myocardial 
cooling, first-pass extraction fractions of Tl-201 & Tc-
99m were significantly less during RC compared to AC. 
Extraction of Tl-201 was l-exp«-O.OOII/x) for AC and 1-
exp(-0.00026/x) for RC, while that of Tc-99m was l-exp(-
0.00061/x) for AC and l-exp(-0.OOOIS- 4 /x) for RC. This 
underestimation persisted despite adjusting for micro•
sphere loss. Despite these discrepancies between AC & RC, 
however, the degree of ventricular cooling was similar for 
AC & RC at the same flov rates. 
We conclude that HP and nutrient flow are significantly 
lower at the same flow rates during RC compared to AC. 
Hyocardial cooling, however, is similar using both 
approaches. The clinical benefits of RC may, therefore, 
be related to efficient myocardial cooling and substrate 
replenishment may be better achieved at the same flow 
rates and myocardial temperatures with AC rather than RC. 
774·2 8:45 
coaprehensive Bvaluation of Defillrillator. 
And Resu.cita.tive Shocks (CBDARS) Study: 
Doe. Conco.itant Revascularization Surgery 
Affect the Incidence of Recurrence in 
Survival of Sudden Death? 
CEDARS Investigators 
Cedars-Sinai Medical Center, Los Angeles, CA 
Clinicians often question the wisdom of 
implanted defibrillator (ICD) in patients 
(pts) who have had one or more episodes of 
sudden death or VT, if these pts also have 
concomitant critical ischemic heart disease 
which can be revascularized. They argue 
that correction of ischemia alone is 
sufficient to prevent recurrence of sudden 
death. To answer this question, we compared 
mortality and the incidence of appropriate 
shock during 1 yr follow-up between 210 pts 
who had ICD (GrpA) and 123 pts who had 
revascularization in addition to ICD(GrpB). 
Appropriate shock was 40% in GrpA and 34% in 
GrpB(p=NS). Similar incidence of appropriate 
shock was documented regardless of whether 
or not pts had a history of frequent (2 or 
more) VT/VF episodes. Total mortality was 
also similar (8.6% in GrpA vs. 5% in GrpB 
p=NS). The results were independent of LV 
function since LVEF in both Grps was 
comparable (.36 vs .. 33 p=NS). 
CONCLUSIONS: 1) In pts with ischemic heart 
disease, ventricular arrhythmias which may 
cause sudden death recur even after bypass 
surgery. 2) concomitant ICD implantation is 
therefore, warranted in such pts in addition 
to revascularization surgery. 
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Diastolic Dysfunction leeediately After Cardiac 
Surgery: Utility of Transesopbageal Echocardiograpby 
Patrice A HcKenney, Ravin Davidoff, Lisa A Hendes, 
Gilbert P Connelly, Gabriel S Aldea, Richard J Shemin, 
Carl S Apstein, Boston University Hedical Center, 
Boston, MA. 
Diastolic function is a more sensitive measure of 
myocardial preservation than systolic function. We thus 
used simultaneous hemodynamic monitoring and 
transesophageal echocardiography (TEE) to analyze the 
diastolic function of 10 pts prior to and immediately 
after elective CABG. LV end diastolic areas (EDAREA) at 
the mid-papillary level pre and immediately post CABG 
were analyzed at a comparable pulmonary capillary wedge 
pressure (PCWP). Systolic function was assessed by LV 
fractional area change (FAC). Hitral inflow Doppler 
profile assessment included deceleration time (OT). 
PreCABG PostCABG p 
N 10 10 
EDAREA(ce2) 14.6+0.9 11.9+1.2 0.0001 
PCWP( •• Bg) 14.4~0.6 13.9~1.0 NS 
FAC(%) 63.7~3.1 66.S~4.1 NS 
OT(sec) 0.16~0.01 0.08~0.01 0.0001 
No pt developed systolic dysfunction or nev wall 
motion abnormalities. Worsening of diastolic function, 
as evidenced by an average 19% decrease in LV EDAREA at 
a comparable PCWP, occurred in all 10 pts after CABG. 
Hitral OT fell in all pts, confirming the presence of 
abnormal LV relaxation. These changes were not 
attributable to tachycardia. 
Conclusions: In the immediate post CABG period 
diastolic dysfunction is very common, and thus PCWP 
does not accurately reflect LV volume and adequacy of 
preload. TEE is important to assess volume status and 
guide therapy immediately post CABG. 
774·4 9:15 
Intraoperati ve Isoproterenol-Dependent Indu•
cibility of Ventricular Tachycardia 
Alberto Interian Jr, Hooshang Solooki, 
Marilyn M. Cox, Deborah K. Cooper, Orlando 
Garcia, Michael Barron, George M. Palatianos, 
Agustin Castellanos, Robert J. Myerburg. Uni•
versity of Miami Medical Center, Miami, FL 
The inability to induce VT intra-operatively 
(intra-op) during antiarrhythmic surgery ob•
viates the benefit of intra-op mapping. We 
tested the hypothesis that intra-op isopro•
terenol (iso) enhances intra-op inducibility 
among 27 patients (pts) with clinical and 
laboratory-induced (ind) sustained mono•
morphic VT. Nine of 27 pts (33%) were not 
ind initially and received intra-op iso 
boluses in 1 ug increments, (4.4 ± 2.3 ug). 
with repeat intra-op PES, 7/9 pts (78%) 
became ind into their clinical arrhythmia 
allowing for successful mapping in 21/27 pts 
(78%) • In four pts mapping was aborted 
secondary to technical reasons. Four pts died 
perioperatively (15%) all of non-arrhythmic 
deaths. Post-op PES revealed 3 (17%) induc•
ible pts in the non-iso group, 2 of whom had 
not been mapped. During follow-up (20 ± 13 
mos), 1/21 (5%) mapped vs 2/6 (33%) non•
mapped pts had arrhythmic recurrences and 3 
died of non-arrhythmic deaths. All 7 pts of 
the intra-op iso-dependent group remained 
free of events. Thus, intra-op mapping 
decreases arrhythmia recurrence and iso 
facilitates intra-op inducibility by overcom•
ing operative electrophysiologic changes. 
This permits successful mapping and long-term 
survival in a greater percent of pts. 
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774-5 
Hypothermia Does Not Affect Myocardial Oxygen 
Consumption Per Beat in the Isolated Canine Heart 
9:30 
Jose P. Garcia, Chee Lim, William H. Gaasch, David 
Rhodes, Shukri F. Khuri. West Roxbury VA Medical 
Center, Harvard Medical School, Boston, MA., The Medical 
Center of Central Massachusetts, Worcester, MA 
To assess the effect of hypothermia on the energy 
demands of the heart, we examined the relationship 
between myocardial oxygen consumption (KYO,) and the 
left ventricular pressure-volume area (PVA) in 10 
isolated dog hearts. Each heart was studied in a blood 
perfused apparatus with cross circulation from a support 
dog. KYO, and PYA were measured in the empty beating and 
working states at 37C and 27C. A contractility index 
(~.) was derived from the slope of the systolic 
pressure-volume relation. Cooling the myocardium by 10C 
resulted in a decrease in heart rate from 120 to 79±7 
BPM, p<0.001. At 37C, the KYO, in the empty and working 
states was 0.030±0.07 and 0.045±0.017 ml O,/beat/lOO gms 
respectively; at 27C, the corresponding values were 
0.034±0.11 and 0.047±0.013 ml O,/beat/100 gms, both 
p=NS. ~. changed minimally from 4.9±2.0 to 5.2±2.1 mm 
Hg/ml(p=NS). The inverse slope of the KYO,-PVA relation 
(dimensionless) which reflects myofibrillar efficiency 
did not change significantly (0.40±0.19 to 0.38±0.15). 
Hypothermia does not alter per-beat myocardial oxygen 
consumption and does not improve myofibrillar 
efficiency. Thus, in the beating heart, beneficial 
effects of hypothermia during cardiac surgery cannot be 
explained on the basis of a decrease in energy demand 
per beat. 
774-6 9:45 
Mechanisms of Microvascular Endothelial Dysfunction 
Following Cardiopulmonary Bypass and Ischemic Arrest 
Frank Sellke, Ronald Weintraub, Frederick Schoen, Robert Thurer, 
Tajammul Shaflque, Robert lohnson. Beth Israel Hosp., Boston, MA 
Ischemic arrest during cardiopulmonary bypass may alter the 
reactivity of coronaI)' microvessels. To examine the cause, pigs were 
placed on cardiopulmonaI)' bypass. Hearts were arrested for 1 hour 
with crystalloid cardioplegic solution (CRT cP, 2S mEq/I KQ, n=12) 
or CRT CP containing superoxide dismutase (SOD, n=6), and then 
repcrfused for I hour. Additional hearts were arrested with CRT CP 
but not reperfused (n=S). Non-instrumented pigs (n=8) were used as 
controls. Selected hearts from the CRT CP group were perfused-fIxed 
at 90 mrnHg with Karnovsky's solution following reperfusion. 
CoroOaI)' microarteries were examined i.!l.xil!:Q with video microscopy 
during application of the endothelium-dependent (ED) vasodilators 
adenosine diphosphate (ADP) or calcium ionophore A23187 (CI), the 
endothelium-independent (EI) agent Na nitroprusside (SNP), or the 
thromboxane A2 analog (U46619). Responses are % relaxation of the 
acetylcholine induced precontraction, or % contraction (-) of the 
baseline diameter (for U46619). Mean±SEM. *=p<O.OS vs CRT CPo 
.Ym!.m (n) ADP (10 uM) CI (10 uM) U46619 (1 uM> 
CRTCP 8 43±9 40±7 -Sl±4 
SODCP 6 79±2* 8S±S* -41 ±S 
CONTROL 8 90 ± 3* 90 ± 3* -42 ± 4* 
No difference in EI relaxation to SNP was evident in any of the 
groups, while ED relaxation was impaired and constriction to U46619 
was enhanced following ischemic cardioplegia and reperfusion. ED 
relaxations to ADP and CI following cardioplegia without reperfusion 
were slightly impaired. Superoxide dismutase signifIcantly preserved 
ED relaxation. No endothelial injury was evident on electron 
microscopy, although moderate mononuclear leukocyte-endothelium 
adherence was present in the microcirculation. Therefore, ischemic 
cardioplegia-reperfusion induced endothelial dysfunction is at least 
partially mediated by prolonged exposure to hyperkalemia, and to the 
generation of oxygen-derived free radicals, likely of leukocyte origin. 
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Can Echocardlographlc Hemodynamic Measurements Replace 
Right Heart Catheterization To Assess the Hemodynamic 
Status of Critically III Patients? 
Salim E Pabaatj, Roxann Rokey, Jose M Rivera, Pirzada Majid 
Baylor College of Medicine, Houston, Texas. 
Noninvasive estimation of left ventricular filling pressure (LVEP) and 
cardiac index (GI) using Doppler echocardiography (DE) correlates well with 
invasive measurements. However, the utility of DE compared to right heart 
catheterization (GATH) for planning therapy in acutely ill patients remains to 
be defined. Accordingly, 42 patients (age 54.07 ± 13.96 years) admitted 
to intensive care units requiring GATH were studied prospectively during 
55 encounters. Serial studies were assessed in 12 patients. LVEP (mitral 
inflow; multiple regression analysis equation) and GI (LV outflow) were 
independently obtained by DE and GATH. A cardiac index (GI) of <2.2 
Uminlm2 or LVEP ~ 15 mm Hg were considered abnormal. Patients were 
placed into hemodynamic subgroups: GROUP I: Normal CI and LVEP; 
GROUP II: Normal GI; abnormal LVEP; GROUP III: Abnormal GI; normal 
LVEP; GROUP IV: Abnormal GI and LVEP. BuuIll: LVEP and GI by DE 
and GATH were similar (19.6 ± 7.8 mm Hg vs 18.9± 7.5 mm Hg; and 
3.16± 1.13Uminlm2 vs 3.12± 1.13Uminlm2, respectively) and correlated 
well with each other (LVEP, r=0.73; GI, r=O.89). Patients in each 
hemodynamic group are shown: 
CAlli 
GROUP I II III IV 
I 15 1 0 0 
0 II 2 27 0 0 
E III 0 0 1 0 
IV 0 0 0 9 
The three disagreements between DE and GATH were from minor 
differences in LVEP «5mm Hg). These disagreements resulted in no 
serious therapy errors. DE accurately tracked hemodynamic parameters 
serially in 11/12 patients. We conclude that the left heart hemodynamic 
status of critically ill patients is adequately assessed using DE and that 
therapeutic plans can be based upon these findings. Since Doppler 
echocardiography can be readily acquired, it appears to be an ideal tool for 
the rapid assessment of hemodynamic parameters in critically ill patients 
when right heart catheterization is delayed but immediate therapy is 
required. 
775·2 
Evaluad ... 01 Echocardlography as a Meaas to 
Noolavasively Assess the Fra.o.k-Starllog Reladoashlp. 
8:45 
Diane A. Zippricb, Oarence H. Owen, Oeveland W. Lewis, James W. DaYis, 
Donald D. Glower, Duke University, Durham, NC 
The Frank-Starling relationship between left ventricular (L Y) stroke work 
(SW) and end-diastolic volume (EDY) has been shown to be a reproducible, 
and load-insensitive measure of inotropic state. However, its usefulness in 
the clinical setting has been limited by difficulty obtaining accurate, non•
invasive measures of LV volumes and pressure. In 8 conscious dogs, we com· 
pared noninvasive and invasive means of determining the Frank-Starling rela•
tionship. The noninvasive model related echocardiographic stroke work area 
(SWA) to echocardiographic end-diastolic LV minor axis cross sectional area 
(EDA). SWA was the product of cuff systolic pressure (PSP) and the dif•
ference between EDA and end-systolic area. The invasive model related 
sonomicrometric SW (the integral of LV pressure and sonomicrometric 
volume) to EDV. After autonomic blockade, preload was varied by transient 
vena caval occlusion, inotropic state was varied with intravenous calcium 
(CA), and afterload was varied by intravenous infusion of nitroprusside (NP) 
or phenylephrine (PH). The noninvasive (SWA vs EDA) and invasive (SW 
vs EDV) Frank-Starling relationships during varied preload were highly 
linear (mean r=0.98) with slopes and x-intercepts as shown below (mean 
± SEM, ·p<O.05 versus control). 
Control CA NP PH 
Noninvasjye Slope (mmHg) 81±7 1.22±15* 84±9 97±9 
X-intercept (cm2) -O.5±0.9 -O.5±1.3 1.2t0.4 -O.7±O.8 
~ Slope (mmHg) 85± 8 112± 14* 9<t±: 11 107± 20 
X-intercept (ml) lost 19 89± 15 ll5± 21 109± 24 
Both noninvasive and invasive relationship slopes were sensitive to the in· 
otropic state. Neither the x·intercepts nor the slopes were related to after•
load by multivariate analysis. Thus, the Frank-Starling relationship calcu•
lated from noninvasive measurements of cardiac dimensions and peripheral 
arterial pressure reflects inotropic state, is preload independent, is relatively 
afterload insensitive, and may be a useful means of assessing inotropic state 
in clinical settings. 
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Bchocardioqraphy in the preclinical Detection 
of Pulaonary Hypertension in Sickle Cell 
an .. ia. Laddeus L. sutton, Jannet F. Lewis, 
Oswaldo Castro. Howard University, 
Washington, D.C. 
Pulmonary hypertension (PH) in pts with 
sickle cell anemia (SSA) is a poorly 
characterized complication. To determine 
whether echocardiography may be useful for 
presymptomatic detection of PH, we reviewed 
studies of 60 consecutive pts with SSA. 
Patients ranged from 19 to 61 years (mean 
32); 55' were men. Findings are as follows: 
pulmonary hypertension 
present absent p 
Number of pts 12 48 --
Age (years) 37±13 31±9 NS 
Gender (M:F) 8:4 25:23 0.03 
HCT (g/dl)* 27±5 26±5 NS 
EF(')* 57±15 61±8 NS 
Symptoms (') 58 27 0.04 -*HCT-hematocrlt, EF=ejectlon fractlon 
Over a followup of 5-49 months (mean 22), 
9 patients died: 5/12 (46') with PH and 4/48 
(8') without; p<0.01. In conclusion, 
pulmonary hypertension is detected in about 
20' of pts with sickle cell anemia referred 
for echocardiography and is associated with 
particularly poor survival. Importantly, 
cardiac symptoms are absent in >40' of such 
pts. Echocardioqraphy appears to be indicated 
for detection of the preclinical 
(asymptomatic) stage of this complication. 
775·4 9:15 
Freqaeace ud SIplIIcaace Of Aalte Global Left Veatrlcular D,sfuactloa 
(LVD) III H_ IJDmDDodeIIcIeacy VIrus (81V) IDfectloa. 
S. De Castro, G.d'Amati·, P.GaIIo·, P .santopadrc, P.Giannantoni, D.Cartooi 
and G.Migliau. Dept of Internal. Medic:iDe, University "La Sapieaza" Rome, 
'Dept Experimental Medic:iDe, L'AquiJa University. Italy. 
We describe the frequcnce, clinical evolution and pathological findinp of acute 
global L VD in HIV + patients. Between January 1988 and June 1992, 'NC 
prospectively studied with serial echocardiography 136 HIV + patients (mean 
age : 33.79 + I· SD 0.65; range 19-(1) without cardiovascular symptoms at 
admission. Patients 'NCre divided into 3 groups: 1) anti·HIV + asymptomatic 
(n = 15; 11% ); 2) Aids related complex (ARC) (n = 28; 20% ); 3) AIDS (n 
= 93; 69% ). Clinical diagnosis of global L VD was based on the foUawing 
criteria: 1) Acute heart failure (m·IV NHY A); 2) Echocardiographic findinp 
of: i) diffused YIlntricular bypokinesia, as shown by a decreased left ventricular 
ejection fraction; ii) normaJ or s1igbtly increased left ventricular end·diastolic 
diameter and parietal thickness. 
During a mean foUowup period of 415.15 days (+1· SD 282.75; range 17·1392) 7 
AIDS patients (5.1%) sho'NCd clinical and ecbocardiographic findinp of global 
L VD: 6 of these (85%) died of congestive beart failure. The mean survival time 
from the onset of symptoms was 41 days (range 20-54 days). Necropsy was 
performed in 5 cases. It sho'NCd acute Jimpbocytic myocarditis in 3, cryptococcal 
myocarditis in 1 and interstitial edema and fibrosis in 1 case. In thc last patient 
LVD was reYllrsible with treatment. We conclude that: 1) thc clinical course of 
HIV infection can be complicated by acute global L VD; in our study this finding 
occured only in AIDS patients. 2) although the frequencc of acute global L VD in 
HIV + patients is low (5.1%), it raises to 7.5% if'NC consider only the cnd·stage 
of the disease (AIDS). 3) in our study, acute global L VD was fatal in 85% of 
cases. Acute myocarditis was the main pathological finding at autopsy. 
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A New, Simple and Accurate Method for Calculating Ejection 
Fraction by Doppler Echocardiography 
Danielle Dion, Jean G. Dumesnil, Quebec Heart Institute, Quebec, 
Canada 
Echocardiographic methods for calculating ejection fraction are 
often time consuming and have pitfalls in patients with regional 
left ventricular (LV) asynergy. In this study, we evaluated a new 
method based on the Doppler calculation of LV stroke volume in 
LV outflow tract divided by LV diastolic volume calculated by 
Teichholz's formula. Theoretically, this method should not be 
influenced by the pitfalls associated with the distortions of LV 
geometry that can occur during systole. Two known methods 
(Quinones and single-plane area length) were also used and the 
results were compared with radionuclide angiography (RNA) done 
within 24 hours. Included were 60 consecutive patients (43M, 
l7F, mean age 66) of whom 33 had previous myocardial infarct 
and regional asynergy, lO chronic pulmonary disease, 6 aortic 
valve disease, 4 hypertension and 7 miscellaneous other diseases. 
No patient had more than mild mitral regurgitation (MR) and 2 
patients were excluded because of inadequate tracings. Correlations 
of echo methods with RNA were: single·plane area length r = 
0.88, Quinones r = 0.88, and new Doppler method r = 0.92. 
Correlations between measurements done by two observers in 12 
cases were: single-plane area length r = 0.85, Quinones r = 
0.88, and new Doppler method r = 0.97. This new and simple 
Doppler method for calculating ejection fraction is thus simple, 
accurate and reproducible provided there is no significant MR. In 
this unselected group of patients of whom many had regional 
asynergy, it was superior to other currently used methods. 
775·6 9:45 
Left Ventricular Volume/Man By M-mode Echocardiography: 
Evaluation Of The Geometric Assumptions Using Ultrafast CT 
Richard Marcus, Richard Coulden. Sanjeev Shroff. Lynn Weinert, 
Jim Bednarz. Martin Lipton. Roberto Lang. Univ. of Chicago. IL 
Calculation by M·mode echo of LV volume (EDV·M) and mass 
(L VM-M) is premised upon the geometric assumptions that the 
LV is a complete ellipse with major axis dimension (L) twice that 
of the minor axis (DI and with parallel epi· and endocardial 
surfaces. EDV and LVM determined by ultrafast CT (CT) are not 
influenced by geometric factors. LV geomotry is highly variable 
and comparative necropsy data on the validity of EDV·M and 
LVM·M are conflicting. In 15 subjects without regionalassymetry 
we used ultrafast CT and 2D echo to examine the accuracy of 
EDV·M and LVM-M and the assumptions inherent to their 
computation. R_uJts: (1) Mean EDV·M and EDV·CT values were 
similar (183::147 cc vs 159::60). but the 95% confidence 
limits for their difference were extremely large (:: 109 cc). (2) 
LID was less than 2 in all cases (mean 1.56::.18. p< .001). (3) 
Using measured values for L obtained by 2D·echo. EDV·M and 
EDV·CT could be not be reconciled in 12/15 subjects (80%1. 
indicating that the endocardial LV surface rarely approximates a 
complete ellipse. (4) Computer simulations showed ellipsoidal 
geometry to be inappropriate even when allowance was made for 
the full range of possible truncations. (5) M-mode overestimated 
epicardial volume in all 15 subjects. even when EDV·M was 
smaller. suggesting that endo- and epicardial surfaces are not 
parallel. (6) Predictably. LVM-M was 32% higher than LVM·CT 
(246::59 vs 187::62 g. p=.01), with wide 95% confidence 
limits (:: 80 g). ConclusiOlJ$: EDV·M and LVM·M calculations are 
based on a series of invalid geometric assumptions that result in 
overestimation of LV mass and inaccurate volume data in a high 
proportion of individual subjects. 
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Prevalence of Slow A V Nodal Pathway Potentials in Patients Without A V 
Nodal Reentrant Tachycardia 
H Andrew HazliU, Karen J. Beclanan. James H. McClellaod. Xunzhang Wang, 
Mauricio Arruda. Ian SanlOro, Ismaile Abdalla, Anantjit Singh. Raed Sweidan, 
Hiroshi Nakagawa. Kenzo HiJao, Ralph Lazzara, Warren M. Jaclanan. Univ. of 
Oklahoma Health Sciences Center aod DVAMC, Oklahoma City, OK 
A discrete poIeIItiaI (A~ representing activation of the atrial end of the slow 
A V nodal pathway is consistently =orded in the posteroseptal right atrium 
(between the coronary sinus ostium and tricuspid annulus) in pts with A V nodal 
reentrant tachycardia (A VNRT). During rettograde conduction over the slow 
A V nodal pathway, Asp p=eeds earliest atrial activation aod can be dissociated 
from the local atrial potential by atrial extrastimuli. Whether the Asp potential is 
unique 10 patienlS with A VNRT is unknown. The purpose of this stUdy was to 
determine the prevalence of the Asp potential in a group of 145 patienlS 
undergoing accessory pathway ablation whose presenting arrflythmia was not 
A VNRT. Asp was recorded after accessory pathway ablation in 143/145 pts 
(99%). After ablation, evidence for antegrade conduction over the slow A V 
nodal pathway ~5Oms increase in A·H or atrial echo complexes during atrial 
stimulation) was found in 1021145 pts (70%) aod evidence for rettograde 
conduction over the slow AV nodal pathway(earliest atrial activation in posterior 
septum with preceding Asp) was found in 55/145 pIS (38%) (figure). Rettograde 
conduction occurred exclusively over the slow AV nodal pathway in 17/145 pts 
(12%). 119/145 pIS (82%) had either antegrade or rettograde slow pathway 
conduction. A V nodal reentrant ec . ho complexes were induced m 61/145 pts 
(42%) and sustained AVNRT 
was induced in 13/61 pIS. 
Conclusions: An Asp potential 
and slow A V nodal pathway 
conduction (antegrade or 
retrograde) are routinely present 
in pIS with accessory pathways. 
These findings suggest that Asp 
and slow AV nodal pathway 
conduction are commonly 
present in pIS without A VNRT 
and may be a normal finding. 
776·2 







Shortening of Refractoriness of the Fast Pathway: A 
Direct Effect of Slow Pathway Ablation In AV Node 
Reentry 
Andrea Natale, George J. Klein, Raymond Yee, Ranjan K. 
Thakur, University Hospital, London, Ontario, Canada 
Shortening of the anterograde refractory (ERP) of the fast 
pathway (FP) has been reported after radiofrequency (RF) of 
the slow pathway (SP). We hypothesized that ERP shortening 
may be related to autonomic changes, possibly catecholamine 
release, as a result of ablation. To test this, 10 consecutive 
patients with AV node reentry undergoing SP ablation were 
given autonomic blockade before the ablation procedure. This 
was achieved by intravenous atropine, .03 mg/Kg and 
propranolol .15 mg/Kg. This was supplemented by half the 
initial dose after successful ablation of SP prior to the final 
study. A control group of 10 patients underwent the protocol 
without autonomic blockade. Shortening of the ERP of the FP 
was observed in the control group (·18 ± 59 ms) (mean ± SO) 
after ablation. Prior to ablation autonomic blockade did not 
alter the ERP of either the fast pathway (296 ± 22 versus 295 
± 19) or the slow pathway (263 ± 37 versus 276 ± 36). 
Autonomic blOCkade obscured dual pathway physiology in 2 
patients and brought it out in another 2 without dual pathway 
physiology initially. Slow pathway ablation shortened ERP of 
the fast pathway (-20 ± 50 ms) in spite of autonomic blockade. 
We conclude: 
1. Autonomic blockade has a "balanced" effect on both the 
fast and slow pathway. 
2. Autonomic blockade may obscure dual pathway 
physiology if present or bring It out if absent. 
3. Shortening of the ERP of the fast pathway following slow 
pathway ablation is not mediated by autonomic changes. 
ABSTRACTS 281A 
776·3 9:00 
SPECTRUM OF ATRIOVENTRICULAR NODAL REENTRY 
David J Wilber, Douglas P Kopp, Brian Olshansky, 
John G Kall, Neil Lippman, Bruce B Lerman. 
Loyola University Medical Center, Maywood IL, 
Cornell Medical Center, New York, NY 
One current model of atrioventricular nodal 
reentrant tachycardia (AVNRT) postulates an 
anteriorly directed fast pathway and a poster•
iorly directed slow pathway. To examine the 
general applicability of this model, we analyzed 
conduction intervals and the site of earliest 
retrograde atrial activation (POST - coronary 
sinus os; ANT = low septal right atrium) during 
108 distinct forms of sustained AVNRT in 95 
patients (pts). HA times were defined as fast 
(0-100 ms), intermediate (INTMD; 101-200 ms), or 
slow (> 200 ms). AH times were defined as fast 
(0-200 ms) or slow (> 200 ms). Multiple forms of 
AVNRT were observed in 11 pts. 
ANTEGRADE/ N (%) ATRIAL BXIT AH/RA 
RETROGRADE ANT POST (mean±SDI 
slow/fast 85 (79%) 80 5 6.27±3;18 
slow/intmd 7 (6%) 3 4 1.89±0.39 
slow/slow 2 (2%) 0 2 0.99±0.13 
fast/fast 1 (1%) 1 0 1.60 
fast/intmd 3 (3%) 2 1 0.98±0.18 
fast/slow 10 (9%) 3 7 0.40±0.10 
CONCLUSIONS: Multiple functional pathways are 
manifest in AVNRT. Retrograde pathways may exit 
either anteriorly or posteriorly, and appear to 
segregate into three groups based on retrograde 
conduction times. Such heterogeneity is not 
consistent with a simple antegrade/fast retro•
grade/slow model. Recognition of this complex 
physiology may facilitate directed ablation of 
AVNRT, particularly the less common forms. 
776·4 9:15 
Llmltatlonl To The Concept Of Ollereet AV Nodll PathwaYI 
Bruce G. Hook, David J. Callans, Raman L. Mitra, Kevin M. Monohan, 
Claudio D. Schuger, Marl< E. Josephson, Hosp. Univ. PA, Philadelphia 
PA and Beth Israel Hosp, Boston MA. 
Successful slow or fast pathway ablation for AV nodal reentry 
tachycardia (AVNRT) may occur In areas distant from their stated 
locations, suggesting that these ·pathways· may not be discreet 
struclures. We performed detailed catheter mapping of the AV node 
region In 6 pts with AVNRT to determine whether local atrial 
activation was consistent with sequential spread from a single AV 
nodal exit. Bipolar electrograms were recorded from a decapolar 
catheter (2·5 mm Interelectrode distance) positioned along the 
tendon of Todaro with the distal pole recording the largest His and the 
proximal pole at or Just above the level of the coronary sinus (CS) 
os. A 2nd decapolar catheter was placed In the CS with Ihe proximal 
pole at the os. A mapping catheter was placed In the region of the slow 
pathway (SP), with the distal electode at the level of the CS along the 
tricuspid annulus. Atrial activation was recorded during AVNRT 
(mean 380 ma) and ventricular pacing (VP, 400 ms). Mean atrial 
activation times (ms) are given below, normalized to the distal HBE: 
HBED 2 3 4 HBEP CSOS 2 3 4 dis SP 
'lIP 0 1 6 15 23 15 23 32 33 35 28 
A'IHrr 0 1 5 7 1 2 24 25 30 32 38 1 8 
During VP and AVNRT atrial activation along the tendon of Todaro was 
rapid, with the lime from HBED·HBE4 (2·4 cm distance) ~15 ms in 
5/6 pts. Of note, atrial activation time from HBED·HBEP was faster 
(range:1·52 ms) In AVNRT compared to VP in 516 pts. 
In summary, atrial activation along the lendon of Todaro: 1) Is 
nearly simultaneous during VP and AVNRT, implying 1.1 broad 
wavefront of activation rather than sequential activation from a 
discreet pathway, 2) Is more rapid during AVNRT than VP, 
suggesting different patterns of activation Ihrough the AV node during 
different Iypes of retrograde conduction. Perhaps the concept of a 
discreet retrograde fast AV nodal pathway should be reconsidered. 
282A ABSTRACTS 
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Association Between Atrioventricular Nodal 
Reentrant Tachycardia and Inducible Atrial Flutter. 
Steven 1. Kalbfleisch, Rafael EI-Atassi, Hugh Calkins. 
Jonathan J. Langberg, Fred Morady, University of Michigan. 
Ann Arbor, MI. 
Th~ purpose of t/'js study was to evaluate the inducibility of 
atrial tlutter (AA) in patients with atrioventricular nodal 
reentrant tachycardia (A VNRT) and to detennine the effect of 
radio frequency ablation of the slow pathway of A VNRT on the 
inducibility of AA. 91 patients were prospectively evaluated 
using a standardized atrial pacing protocol. The high right 
atrium was paced using a 25 beat drive train, 1.5 second 
intertrain pause, 10 rnA pulse amplitude and 2 msec pulse 
duration with pacing from cycle lengths of 250 msec to 100 
msec in 10 msec decrements. Pacing was perfonned twice at 
each cycle length. Three groups of paticnts were analyzed: 42 
patients with inducible AVNRT, 13 with a history of 
documentell AA and 36 control patienl~ without A VNRT or a 
history of AA. A subgroup of 34 patients with AVNRT who 
underwent successful (RF) ablation of the siow A V nodal 
pathway underwcnt atrial pacing again after ahlation. AFI was 
inducible more frequently in patients with A VNRT (88%) and 
those with a history of AFi (92%) than in control patienl~ 
(36%) (p ,., 0.0001). There was no differt!nce in the 
inducibility or duration of atrial flutter before and after RF 
ablation of AVNRT. The mean atrial tlutter cycle length before 
ablation (206 ± 22 msec) was not different than after ablation 
(196 ± 20 ms) (P=NS). 
Conclusions. 1) There is a strong association between 
inducible A VNRT and inducible AA, suggesting that there may 
be a common area of perinodal atrium participating in the two 
tachycardia circuits. 2) Radiofrequency ablation of the slow 
pathway of the A V nodal reentrant tachycardia circuit does nol 




Facilit:ltion or Anterograde Conduction FoUowinl Preconditioning 
Impulses in the Human Atrioventricular Node 
Stephen Keirn. Todor Mazgalev. Robert KinD. Kevin Rist. PaIrick Tchou. 
University of Piusburgh. Pittsburgh PA 
Fncilit:ltioll of AV nodal (A VN) conduction has been suggested to be 
independent of preconditioning stimuli in man although animal studies have 
suggested a dependence. We studied this phenomenon in the normal human 
A VN during clinical electrophysiologic study. Atropine was administered to 
prevent vagal1y mediated changes in A VN conduction. An aui:Il pacing 
sequence with two extra stimuli was used (AI-A2·A3. see insert). FoUowing 
20 beats :11400 ms (AI). prelllalure conditioning beats :II 3 different Al-A2 
intervals were utilized. The diastolic period after e:x:h Al-A2 was scanned 
with an A3. A VN conduction time of A3 (A3-ID) was prolonged in 
conventional fashion when ploued against the H2-A3 intervals (see figure). 
However. :II comparable H2-ID intervals the shortest Al·A2 resulted in 
shortened A3-ID by as much as 4S ms over values seen:ll the longest Al-A2 
(see figure). In addition the facilit:lted conduction was always preceded by 
a longer A2-A3 interval. Conclusion: Facilit:ltion of A VN conduction is 
demonstrabte in the human A VN and is sim ilar to thal demonstrated in 
animal models. 
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Early Post·lnfaret As ...... nt of lIyocardial Viability 
Using Rest-Redistribution Thallium Scintigrapby 
Carl T.LD.boy, Howard P.Grill, Jerome E.Granato, Judith 
E.Orie, Angel R.Flores, Douglas S.Scbulman. The 
Allegheny Campus of Th. lI.dical College of PA, 
Pittsburgh, PA 
In order to determine if rest-r.distribution (RR) 
tballiua scintigraphy (TL) could predict 1I)'0cardial 
viability vithin the infarct zon., 24 patients 
presenting vith acut. 1I)'0cardial infarction vere studied 
vith early (2.5±1.3 days) RR TL. Using 4 vievs/patient, 
viability va. defined aa initial infarct zone TL uptake 
>501 (normal zone-1001) or redistribution (>301 increase 
in count. on delayed vs initial images) (Group 1, n-12). 
Patients vith severe RR TL defects vithout 
redistribution vere classified as non-viable (Group II, 
n-12). Viability vas confirmed using vall motion scores 
of tbe infarct zone assessed by radionuclide or contrast 
ventriculography (5 point scale,-l-dyskinesia, 3-normal) 
and 7 day low level exerci.e(ETT) TL vitb reinjection. 
Initial resting infarct zone counts vere (lIean±SE) 44±21 
in Group 1 va 30±11 in Group II, p<O.OOOl, and increased 
on delayed imaging only in Group I. to 53±2I,p<0.0001. 
Infarct related artery patency vas 1001 in Group I vs 
661 in Group II, p-O.6. Viability vas confirmed in all 
patients in Group 1 by tbe presence of normal, or at 
worst .Udly hypokinetic vall motion in tbe infarct 
zone (score , 2.l0±Q.2). In Group II, vall motion ranged 
from severe hypokinesis to dyskinesia (score 0.42±0.3. 
p<0.0001 vs Group I). Of tbe 9 patients in Group II vbo 
bad 7 day ETT TL, tber. vas no improve.ent in infarct 
zone counts compar.d to RR TL (28±1 va 29±21) and no 
eVidence of increased count. after reinjection, (28±1 va 
27±2I). Thus, RR TL is able to predict residual 
.yocardial viability and may be useful in directing 
furtber interventionsl tberapy early post-infarction. 
777·2 8:45 
Predictive Value of Tc·99m·Sestamibl Tomographic 
ImaiiDI at Rest for Myocardial Viability ID 
HlbernatiDg Myocardium 
Jean C. Maublant, Bernard CitroD, Janusz Lipiecki, Daniele 
Mestas, Patrick Bailly, ADDie Veyre, Charles de Riberolles, 
Jean Ponsonnaille. Centre Hospitalier Regional and Centre 
Jean Perrin, University of Clermont-Ferrand, France 
The predictive value of Tc-99m-sestamibi uptake in 
hibernating myocardium for functional recovery after 
revascularisation (revasc.) was investigated in 18 patients 
by rest single photon emission computed tomography 
(SPECT). All patients showed at contrast angiography an 
abnormal segmental wall motion (SWM) and a critical 
coronary artery stenosis without infarction in the 
correspondiDg territory. SPECT studies were performed one 
week before revISe. and 3 months later. A control contrast 
angiogram was also performed 3 months later. Of the 25 
hibernating segments, 20 (80%) were showing a decreased 
uptake at the initial SPECT study, of which 11 were mild and 
9 severe. After revase., sestamibi uptake improved in 15 
segments (60%) (in 8 of the mild initial defects and in 7 of 
the severe initial defects) and SWM improved in 19 
segments (78%). All segments with scintigraphic 
improvement also improved at angiography. In the 16 
hibernating segments either with normal uptake or with a 
mild defect at initial SPECT, post-revISe. SWM improved in 
11 (69%) and sestamibi uptake in 8 (50%). In the 9 segments 
with a severe sestamibi defect at initial SPECT, SWM 
improved after revasc. in 8 (89%) and sestamibi uptake 
improved in 7 segments (78%). 
It is concluded that, in hibernating myocardium, (a) a rest 
sestamibi decreased uptake is very often reversible after 
revISe., (b) the degree of sestamibi uptake at rest seems to 
be poorly predictive of post-revase. functional recovery. 
lACC Vol. 21, No.2 
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777·3 9:00 
Impact of 201Thalllum Reinjection Imaging to Identify 
Myocardial Viability After Vasodilation-Redistribution 
SPECT 
Christoph A. Nienaber, Jens de la Aoche", Heike Camarius, 
Aicardo Montz", Departments of Cardiology and Nuclear 
Medicine", University Hospital Eppendorf, Hamburg, FAG 
To delennine the diagnostic Impact of reinjection 201T1 imaging 
after vasodilation-redistribution 201T1 scans, 56 patients with 
chronic coronary artery disease and resting wall motion 
abnormalities underwent biphasic Dipyridamole (0.6 mglkg/min) 
redistribution (AD) imaging with reinjection (AI) 201T1 imaging. 
Aelative 201T1 uptake was semiquantitatively measured by 
circumferential profile analysis of 4 short axis slices. All patients 
were subjected to repeat angiography after coronary 
revascularisation (6 ACVB; 50 PTCA) to assess improvement of 
wall motion as a gold standard for myocardial viability. Patients 
were stratified according to results of AD and AI 201T1 uptake and 
correlated to contractile recovery after revascularisation. 
Res ults: AD+ AD-/AI+ I AD-IRI+ AD~/AI-
(>20%·) (<20%') 
viable: 38[68] 6[11] -- 1(2) 
non viable: 5[9] - 11[20] --
r> or A< 20% relative increase in 201T1 uptake) 
[Numbers denote patients; numbers in brackets are percentages) 
Conclusions: 1.) A relative increase of >20% with 201T1 AI 
compared to 201T1 AD is indicative of viability in akinetic 
myocardium (sensitivity 100%). 2.) Aelative 201TI uptake <20% 
with AI versus AD imaging identified 11 of 12 patients with "fixed 
defects" at AD and no contractile recovery. 3.) A threshold of at 
least 20% relative increase in 201T1 uptake with AI is necessary to 
predict viability from AI 201T1 imaging. 
777·4 9:15 
Comparison of Rest/Stress and Delayed Reinjection TI· 
201 SPECT Imaging for Detecting Ischemic Myocardium 
A. Cahid Cive1ek, Mehmet Ozguven, Samuel Sostn:, Henry N.Wagner, lr .• 
Lewis C. Becker. 11K: Johns Hopkins Medical Institutions, Baltimore, MD 
Thallium-201 reinjection has been reported to improve the detection of 
ischemic myocardium but may still not reflect the full extent of 
ischemia. We have therefore prospectively compared this technique to 
rest/stress TI·20l (Tl) SPECT imaging in 42 randomly selected 
patients with coronary disease. Thirty six patients had a recent 
catheterization. Each patient had a stress study, a delayed reinjection 
study (1 mCi Tll5 minutes prior to delayed imaging) and a rest study 
48 hours later. The anterior, lateral, inferior and septal walls in the 
short axis and the apical region in the long axis were evaluated for TI 
activity. The 210 walls (630 segments) were visually scored by 2 
observers as 0: normal, I: equivocal, 2: moderate, 3: severe reduction 
of TI activity. Perfusion defects were considered present when the 
stress score was ~. Defects on delayed reinjection or rest images 
were called reversible or nonreversible if their scores were <2 or ~, 
respectively. The table below shows the percent of walls classified as 
normal or having reversible or nonreversible defects for the stress•
delayed reinjection and stress-rest study comparisons (difference in 
distribution p<O.OOOI). 
Stress-Delayed Reinjection Rest - Stress 
Reversible 13% (28 walls) 33% (69 walls) 
Nonreversible 48% (100 walls) 28% (59 walls) 
Normal 39% (82 walls) 39% (82 walls) 
Of the nonreversible defects on reinjection, 41 % became reversible on 
rest studies. Of the 42 patients, rest studies correctly identified II 
patients with reversible defects missed on delayed reinjection. In 9 
patients with reversible and nonreversible defects, rest studies showed 
additional ischemia compared to delayed reinjection. Thus, in patients 
with known CAD, significantly more ischemia is detected by paired 
rest/stress TI-201 imaging studies than by a stress/delayed reinjection 
protocol. The rest/stress imaging protocol. employing two separate 
injections of tracer, appears to represent the optimal means for 
detection of potentially ischemic myocardium. 
ABSTRACTS 
777·5 
Detection of Myocardial Viability: Sestaaibi 
Overestiaates Necrosis eo.pared with Thalliua 
Alan M. Taylor II and Michael E. Merhige, State 
University of New York at Buffalo, Buffalo, NY 
9:30 
The potassium analogue, 20l-Thallium (Tl) undergoes 
myocardial redistribution, reflecting cell membrane 
function in addition to perfusion; thus it may be more 
accurate in identifying viable tissue than the 
nonredistributing flow tracer, 99m Tc Sestamibi (Sesta). 
Tl uptake (at least 50% of peak myocardial activity) in 
hypoperfused segments correlates with the presence of 
tissue viability as recently demonstrated by F-18 
fluorodeoxyglucose uptake using positron emission 
tomography. This study directly compared Sesta and Tl 
imaging in the same patients in detecting myocardial 
viability. 
283A 
Thirty-two patients who demonstrated severe, fixed Sesta 
defects using a two-day treadmill exercise/rest imaging 
protocol were subsequently imaged with Tl, 24 hours after 
injection of 2.5 mCi at rest. A triple crystal camera 
and SPECT technique were used, and all studies were 
performed within one week of Sesta imaging. Of 167 
segments with severe, stress induced Sesta defects which 
failed to improve at rest and were therefore classified 
as infarcted, 87 (52%) demonstrated Tl uptake on 24 hour 
redistribution scintigraphy, compatible with preserved 
myocardial viability. This discordance affected 14/32 
(44%) patients. 
Conclusion: Severe Sestamibi defects seen on rest 
imaging markedly underestimate the presence of viable 
myocardium as compared to 24 hour Thallium 
redistribution scintigraphy. 
777·6 9:45 
Technetium·99m methoxy·isobutyl·isonitriles as a Tracer of Myo•
cardial Viability? A Quantitative Comparison With F·18 Fluoro•
deoxyglucose in 100 Patients With Coronary Artery Disease 
Juergen vom Dahl, Carsten Altehoefer~ ~aik Biedermann, Rainer 
Uebls, Udalrich Buell, Peter Hanrath, university of Aachen, Ger•
many 
Technetium-99m methoxy-isobutyl-isonitriles (MIBI) in combina•
tion with single photon emission computed tomography has proven 
to be a perfUsion tracer with~i diagnostic accuracy' for identifi•
cation und localization of si . cant coronary artery ilisease. Posi•
tron emission tomography PET) with F-18 fluoro-deoxygiucose 
(FOG) provides a sensitive approach for detection of viab1e tissue 
m the presence of reduced myocardial perfusion and function. To 
evaluate the relationshij! between severity of MIBI defects and 
FDG-uptake, resting MIBI studies in 100 consecutive patients (86 
male, 57 ± 8 years, 89 with previous myocardial infarction) were 
c~I!lPared with data acquired in the same patients with FDG and 
PET. All patients had coronary artery~isease and regional my'o•
cardial dysfunction by angiography. MIBI and FDG uptake of the 
left ventricular my'ocardium was evaluated using a cornPuterized 
analysis approach for 24 regions (polar la!get format). The region 
of maximal MIBI uptake was set as 100 % for both oata sets and 
regional uptake was normalized to this reference region. MIBI up•
take of < 50 % in at least 2 adjacent regions was classified as ([e•
feet. FOG uptake > 70 % of the reference region was defined as 
I h h ld~ d . bT ower t res 0 or preserve V1a lit}', 
MIBI uptake / % <20 20-29 30-39 40-49 
r~~o~~atients I 33/18 87/38 159/65 265/87 V1a Ie 0) 9/11 21/29 25/41 37/47 
Regression analysis of all 544 regions with a MIBI defect revealed 
a significant but weak correlation between MIBI and FOG uptake 
(r = 0.36, P < 0.0(1». 
Conclusion: There is a relationship between the severity of resting 
MIBI defects and the amount of V1able myocardium in regions witli 
reduced MIBI uptake. However;.,even in regions with severe MIBI 
defects « 30 % uptake), FDv imaginR Identifies a substantial 
proportion of ischemically compromizeabut viable myocardium, 
which might benefit from revascUlarization. 
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778-1 
Impelreel Force-Tention-R .. tIonahip In the Felli", Human 
MyOCllrclum 
8:30 
Robert H.G. Schwinger, Michael ~hm, Andrea Koch, Rainer 
Uhlmann, Ingo Morano', Johann C. Ruegg' and Erland Erdmam. 
Medizinische Klinik I der Universitlit Munchen, and 
'Physiologisches Institut II der Universitlit Heidelberg, Germany 
There is evidence that the failing human left ventricle in vivo 
subjected to additional preload is unable to utilize the Frank•
Starling mechanism. The present study aimed to examine the 
length-tension relationship (L TR) in electrically driven papillary 
muscle strips (PAP) as well as in skinned fiber preparations (SFP) 
from nonfailing (NF, donor hearts, n = 6) and terminally failing 
human hearts (NYHA IV, heart transplants, n = 26). Only in NF, 
force of contraction as well as peak rate of tension rise and 
decay increased in PAP following an increase of preload (PRL) 
(PAL: 20 mN NF: 204±16 %basal = 1.7±0.2 mN, NYHA IV 
121 ± 6 % basal = 1.7 ± O. 1 mN). There was no difference in 
resting tension, muscle length, cross sectional area or fibrous 
tissue between NF and NYHA IV. The L TR in SFP was similar in 
NF and NYHA IV. The Ca2 +-sensitivity (Ca2 +-S) in SFP from 
NYHA IV was significantly higher compared to NF (p < 0.0~j). 
After stretching (20% above slack condition) a significant 
increase in Ca2 +-S (mean EC50 1.43 vs. 1.91 pM) occurred in 
NF but not in NYHA IV (0.94 vs. 1.07 pM). Prestimulation with 
ouabein (OUA, 0.2 pM) or OUA plus the Na+-channel activator 
BDF 9148 (0.Q1 pM) restored the L TR in PAP of NYHA IV (PRL: 
20 mN: OUA +201 ±24 %; OUA+BDF 198±33 %baslll FOC). 
It is concluded that (1) pharmacological interventions may 
rastore the normal L TR in NYHA IV; (2) the impaired L TR in 
NYHA IV may be mainly due to alterations in intracellular Ca2 +•
handling rather than due to failure of the contractile apparatus. 
778-2 8:45 
How Much 0081 Adrenergic Tone Support the Failing Heart? 
Masayoshi Nagatsu. Michlel R. Zile, Gilberto DeFreyte, Blasa A. 
Carabello. Medical University of SC and the Gazes Resaarch Inst., 
Charleston, SC 
The ,-adrenergic system (BAS) provides ~ support for the 
failing heart. However, the magnitude of this support is unknown 
yet important in assasling the effects of diseasa and therapy on 
ioUinaik. contractility (C). To address this issue we studied the 
effects of '-blockade on C in the failing and non-failing heart. 
C indices were studied on (On) and off (Off) '-blockade (,8B) at 
baseline and after severe chronic mitral regurgitation had produced 
left ventricular dysfunction (LVD). 
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NE .. norepinephrine, EPI- epinephrine, EESVR = slope of the end•
ejection stress volume relationship, K = end-systolic stiffness 
constant. 
Conclusion: In the normal heart /IB did not decrease C. In LVe, 
C Off appeared normal in the presence of increased 
catecholamines. However /IB uncovered nearly a 50% reduction 
in C. Thus, the BAS is powerful in supporting C and may obscure 
a large intrinsic C reduction. 
778-3 
JACC Vol. 21, No.2 
February 1993:284A 
9:00 
Coatracllle Propertl.. 01 Hypertrophic and Non-Hypertrophic 
H .... Ventricular Myocytu. 
Federica del Monte, Sian E Harding, Giuseppe MC Rosano, Philip A 
Poole-Wilson. National Heart & Lung Institute; London; U.K. 
W. investigated the presence of cellular abnormalities in humaa 
myocytel from hypertrophied and non hypertrophied left and right 
ventricles, separating the tissue from the cellular aspects of the 
diseue. We also evaluated whether the changes observed in the 
myocyte function in the late failing phase are related to failure or 
they are present in an earlier non failing phase of the disease. 
Myocytes were electrically stimulated (0.2 Hz) at 320C and 
contraction amplitude and velocity were measured from a video-edge 
detection system. Patients were divided on the bases of the presence 
(HT) or absence (non-HT) of hypertrophy based on large left 
ventricular posterior wall thickness on ECHO for the left ventricle 
and known conditions of hypertrophy for both left & right ventricles. 
A further comparison was made within the two groups with respect 
to the degree of failure as indicated by the NYHA functional class 
(II-III vs IV). In the left ventricle no differences between myocytes 
from HT and non-HT group were seen for the contractile response to 
maximum Ca++ and ~ adrenergic agonist stimulation with 
isoprenaline. The velocity of contraction (TIP) and particularly of 
relaxation (RSO) in maximum Ca++ was slower in the HT vs non-HT 
group (Ca-rTP 0.37± 0.03 n-12 non-HT vs 0.47 ± 0.1 n-20 HT 
p<O.OS and Ca*RSO 0.17 ± 0.01 n-12 non-HT vs 0.28 ± 0.07 n-20 
p<0.02 HT,mean ± sem, n-patients). No differences between the same 
srouPi were observed in the right ventricle with respect to any of the 
contractile parameters. Comparing patients with similar degree of 
nOD-end stage failure (NYHA II-III) the differences in relaxation 
velocities in high calcium was still apparent between HT and 
non-HT. Systolic and particularly diastolic function is impaired in 
hypertrophied myocyteS, and this does not appear to be directly 
related to the severity of failure. 
778-4 9:15 
Effects of Metoprolol on Ventricular Function 
in Rats with Myocardial Infarction 
Wen-Jin Cherng, William B. Hood, Jr., Chang•
seng Liang, Univ. of Rochester, Rochester, NY 
Beta blocking agents (BBL) have been used to 
treat congestive heart failure (CHF) in pa•
tients, To study the effects of BBL in experi•
mental CHF, we measured left ventricular (LV) 
function in anesthetized rats with (+BBL) and 
without (-BBL) metoprolol treatment (2 mg/L in 
drinking water) for 3 weeks following left 
coronary ligation or sham operation. Infarct 
size (IS) was measured postmortem and rats were 
divided into those with IS<30'LV and ~30'LV, LV 
function was measured as the slope of the in•
crease in systolic vs. diastolic pressure 
following a 5 J.lg/kg bolus of phenylephrine 




n -BBL n +BBL 
! 11~,9 II 11~.O 
7 11.9±2.3 8 12.1±1.4 
9 3.3tO.3* 8 5.5±1.4* 
*p<O.05 vs. sham and IS<30'LV 
In muscle bath preparations the uninfarcted LV 
posterior papillary muscle (PPM) from shams and 
rats with IS<30'LV showed a dose-related in•
crease in rate of tension development with 
isoproterenol (ISO) stimulation, but this 
response was abolished in both control and 
metoprolol-treated rats with IS~30'LV. 
Conclusion: Ventricular function is impaired in 
rats with large infarcts, and PPM from these 
hearts showed impaired ISO responses in vitro. 
Neither defect was improved by BBL. Thii'i';"""Tn 
the absence of physiologic responses to BBL 
suggesting B-receptor upregulation, the results 
support the concept that the impaired response 
to ISO is due to a post-receptor defect. 
JACC Vol. 21, No.2 
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778·5 9:30 
Myocardial Nitric oxide aegulate. 
Na+/ca++ Exchanger 
Mitchell S. Finkel, Timothy R. Billiar, 
Li shen, carmine V. Oddis, O. H. Mayer, 
J. R. Lancaster, Brack G. Hattler, 
Richard L. Simmons, University of 
Pittsburgh Medical center, Pittsburgh, PA 
We and others have recently demonstrated 
that mammalian myocardium produces nitric 
oxide (NO) that functions as an 
endogenous, reversible negative inotrope. 
We now propose a novel mechanism by which 
endogenous NO regulates myocardial 
contractility. L-NMMA (known inhibitor 
of NO synthesis) reversed the negative 
force-frequency relationship (negative 
staircase effect) in isolated hamster 
papillary muscles (p <.01iANOVAiN=6). 
L-NMMA also completely blocked the 
positive inotropic effect of amiloride 
(known regulator of Na+/Ca++ exchanger 
(p <.01iANOVAiN=6), while not altering 
the inotropic effects of Bay K 8644 
(sarcolemmal, L-type calcium channel 
regulator) (EC~o = 9±O.3 vs. 9± 0.5 x 10-
7 ~1) or ryanod~ne (regulator of SR 
calcium release channel) (ICS9 = 1±0.1 vs. 2±0. 8 x 10-7 M). These f ~ndings 
implicate myocardial NO in the 
ph¥siologic regulation of the cardiac 
Na /ca++ exchanger. Thus, myocardial NO 
may playa critical role in calcium 
homeostasis and diastolic function in 
normal and diseased hearts. 
778·6 
Is Cocai.e-Ilduced Myocardial Dysfu.dio •• Direct Effect or 
Due to I.creased Will Stress? 
9:45 
Prabodh M. Mehta, Terry A. Grainger, Valerie J.Lynn, Robert M. Lust, 
Charles Clark, Assad Movahed, and Stanley R. Jolly, East Carolina 
University, Greenville, NC. 
To determine whether alterations in left ventricular (LV) function 
following cocaine (C) are due to reduced myocardial contractility 
or changes in loading conditions, we examined LV function in 30 
conscious, mOIphine-sedated dogs. Echocardiography (2-0E) provided LV 
fractional shortening (FS%) and calculation of end-systolic wall stress 
f/cm2 (WS). Radionuclide angiography for LV ejection fiaction (EF) was 
also performed. Saline or C 10, 30 or 100 Ilglkglmin was infused for 90 
min with ECG and arterial pressure monitoring. Arterial pressure rose 
over the 4 hr period in all 4 groups but saline and C 10 had no apparent 
hemodynamic effects. C 30 and C 100 acutely increased arterial pressure 
and heart rate but decreased EF from O.64±O.06 to 0.45±O.08 (mean ±SO) 
and 0.65±O.10 to 0.46±O.II, respectively. Additionally, C 100 decreased 
FS from 36±9 to 23±12O/o. However, C30 and ClOO also increased WS 
from 42±IS to 65±II, and 37±15 to 90±33 f/cm2, respectively. The figure 
shows the regression line for all baseline points and 95% confidence 
~ intervals. Squares represent values following saline infusion, while triangles represent values post-C 100. • • If- Values after C 100 tilll on the same .... line as baseline and post saline. Post-C .. FS values are displaced downward due • _ to increased WS. In addition, 
alteration ofafterload with phenylephrine (6Ilglkg) and sodium 
nitroprusside (10 Ilglkg) before and during infusion of C 100 showed 
similar WS to FS regression lines. CODclusloD: Ejection phase indices of 
LV function were reduced by C but effects were attributable to increased 
WS rather than reduced myocardial contractility. 
ABSTRACfS 
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779-1 
lleduced Heart lla te 
Volunteers Destined 
Ronaldo S. Kayuga, 
Frances O·Connor. 
NIH, &altimore, KD 
8:30 
Variability in Apparently lIealthy 
to Develop a Coronary Event 
Jerome L. Fleg, C. T. Arrington, 
Gerontology Research Center. NlA, 
Although it is well established that patients with 
clinical heart disease have restricted heart rate 
variability (HRV) , it is unknown whether HRV is reduced 
in apparently healthy subjects with latent coronary 
artery disease. To test this hypothesis we measured 
resting BCG R-R interval variations in 29 asymptomatic 
male volunteers eged 61.8 ± 11.2 years, free of clinical 
heart disease, who developed a coronary event (CE), 
Le., myocardial infarction or sudden cardiac death, 
within the next 2 years. For comparison, R-ll intervals 
were measured in 58 age·matched controls (C) who 
remained event free for 12.7 ± 6.5 years after the index 
ECG. The mean R·R interval (RR), standard deviation of 
Il·R (S~), the difference between minimum and maximum 
R-R (MAX·MIN), all measured in msec, and the ratio of 
minimum to maximum R-R (MINIMAX), are compared below in 
the 2 groups over a mean of 22.1 ± 2.6 beats. Values 




















Thus, asymptomatic subjects destined to develop acute 
myocardial infarction or sudden cardiac death 
demonstrate reduced HRV compared to healthy age-matched 
controls despite similar heart rates. These findings 
suggest that HRV criteria based on the resting ECG might 
be developed to identify a subset of apparently healthy 
individuals at high risk for future coronary events. 
779·2 8:45 
Abnormal Autonomic Balance in Chronic Cocaine Use: Evidence for 
Persistent Excessive Sympathetic Stimulation 
William M. Bailey. Koonlawee Nademanee. Olivia V. Adair. Mary F. Brin. 
Jill M. DiPasquale. Amy Dungao. Tara Pearson. Denver General Hospital. 
Denver. CO. 
The acute adverse effects of cocaine are partly mediated 
through a surge in catecholamines. Studies in chronic animal models 
have demonstrated altered autonomic balance. To investigate the 
hypothesis that chronic cocaine use in humans alters autonomic 
balance. we studied the autonomic balance of 29 chronic cocaine users 
(CCUI during the withdrawal period (mean age 33.9. last use 5.6 days) 
compared to 12 
controls by 24hr. Z. HOUR $P(C'TRAl. IIL.OI tlf IlIEI'tr RAIt:: '<MRWWIlY 
power spectrum 
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12/12 controls. as expected. and only 9129 CCU exhibited circadian 
rhythm. a diurnal increase in sympathetic low frequency tone (p<0.051. 
All CCU showed a marked increase in 24 hr. sympathetic low trequency 
tone. with nocturnal excess. as compared to controls. Parasympathetic 
high frequency tone was unaltered. 
This persistent increase in the level of sympathetic low 
frequency tone and lingering adrlJnergic stimulation in CCU may playa 
role in the long term adverse effects of the drug. It may also help to 




Heart Rate Variability: Is It Really Reproducible? 
Mina W. Ahmed, Michael Suleiman, Feng Zhang, Jerry S. Weiss, Diederik Van 
Hoogenhuyze, MicheUe Parker, DooaJd H. Singer, James E. RoscnIhaI 
Northwestern University Medical School, Chicago, Ulinois 
The reproducibility (Re) of heart late variability (HRV) bas been SIudied for sbon 
periods of time in young subjects. Time and frequency domain HRV indices of 
vagal tone are considered highly reproducible. Since the age-related decline in 
autonomic function might be expected to affect HR V, we examined the Re of HRV 
in 30 elderly subjects (23 females), ages 62 to 81 yean (mean 71.1 ± 5.2). Except 
for 3 subjects who had hypenension and were taking nifedipine, aU were healthy 
and taking DO medications. 24-hour Holter recordings were performed at an 
interval of 28.4 ± 1.5 months. No interval change occurred in the clinical status. 
Time and frequency domain indices measured were: SD (average of the SIatIdard 
deviation of 5 minute RR intervalS), SDNN (SD of the 24 hour RR intervals), 
pNN50 (percentage of adjacent RR intervals >5Oms apart), rMSSD (root mean 
square of the successive RR cycle interval difference), very low (VLF,O.017-O.OS 
Hz), low (LF, 0.05-0.15 Hz), high (lIF, 0.15-0.35 Hz) frequency bands (ms2) and 
LF/HF ratio (l :H). Results are shown as mean ± SD and remained unchan~ed after 
Day 1 Day 2 r pvalue ICC·· 
RR· 865 +118 866±105 .88 <{).OOOI .88 
SO" 46.9 +13.3 46.7±16.8 .79 <{).OOOI .78 
SDNN· 133.1±29.6 130.7±26.8 .79 <{).OOOI .79 
IlNN5O(%) 6.3±6.3 6.9+8.6 .70 <{).OOOI .68 
rMSSO" 29.2 ±13.3 31.7+18.2 .75 <{).OOOI .75 
VLFt 8.9 ± 5.4 7.4 + 4.7 .79 <{).OOOI .75 
LFt 7.1 + 5.4 6.9 + 9.9 .29 <{).22 :u, 
lIFt 2.6±2.1 3.1 +4.9 .40 <{).08 .40 
L:H 3.4 +2.7 3.4± 2.3 .78 <{).OOOI .78 
• • l •• [ ms, tms, Jnuaclass Correlation Coeffectent between Days 1 and 2) 
log transformation of frequency data for skewness. Conclusions: In healthy elderly 
subjects over a 2 year period: I) Re for time domain variables and VLF is 
exceUent; 2) LF and HF show poor Re, which is in conuast with previous reports 
in younger subjects over shorter intervals; 3) L:H, thought to be a better 
representative of autonomic tone, bas excellent Re. Thus, over a period of 2 yean, 
time domain variables and L:H provide a stable measure of heart late variability in 
bealthy elderly subjects with unchanged clinical status. 
779·4 9:15 
The Effect of Pindolol end Lebelelol on Heart Rete Verlebility In Normal 
Subjects 
Phytlis K Stein, Brooke M. Conger, Raben E. K1eiger, Jewish Hospital at 
Washington University, S1. louis, MO 
Use of atenolol, which Increases heen rate variability (HRV), Is associated 
with Improved prognosis after MI. We Investigated the effect of pindolol (5 
mg BID), a beta-blocker with instrinsic sympathomimetic activity (ISA), and 
labetalol (100 mg BID), a combined alpha- and beta-blocker, on HRV in 
normal subjects (22-37 yrs, 5M, 5F) In a ~y per arm, double-blind, 
placebo-controlled crossover study. On day 4 of each arm, a 24 hour 
Holter recording was obtained and analyzed for time and frequency domain 
Indices of HRV. Neither drug affected average HR. Although labetalol 
caused a significant reduction of maximum HR, It did not significantly affect 
any measure 01 HRV. Pindolol significantly decreased maximum HR, 
Increased minimum HR, and caused a significant decrease In the standard 
deviation of normal R-R intervals (SDNN) and the average over each 5 min 
interval of the standard deviations of N-Ns (SDNNIDX). There was also a 
trend to decreased high frequency spectral poIIVer (HFP), a measure 01 
vagal tone. 
PLACEBQ L,ABETA!.QL flNDQLQL 
MaxHR 137:1:22 124:1:18" " 116:1:16 
MinHR 43:1:7 45:1:7 " 48:1:10 
SDNN 164:1:45 156:1:30 123:1:42" 
SDNNIDX 139:1:47 128:1:27 97:1:27" 
In HFP 6.09:1:.69 6.07±.62 5.56:1:.981 
significantly d_ from placebo R<.05 • R.-.067 
Thus, labetalol desp~e its antihypenensive effects does not decrease 
HRV, whUe pindolol does decrease HRV. The ISA of 01 pindolol may be 
panly responsible for the decrease In HRV. This may explain why the 
improved survival associated with atenolol has not been seen with beta· 
blockers with ISA. 
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779·5 9:30 
Heart Rate Variability: Cycle Length Dependency Of Power Spectrum 
George Monir, Dan J. Fintel, Jerry S. Weiss, Feng Zhang, X. Nader 
Sahyouni, James E. Rosenthal, Nonhwestem University, Chicago,lL 
Power spectral analysis of heart rate variability, a non-invasive measure of 
cardiac sympathetic/parasympathetic activity, is a powerful independent 
predictor of sudden arrhythmic cardiac death (SeD). However, rmdings 
of healthy subjects with abnonna!ly low heart rate Variability values, and 
patients with overt heart disease with much higher than expected values 
would appear to detract from clinical utility. To test the hypothesis that 
power spectral analysis of heart rate Variability and its differences between 
nonna! subjects and patients with heart disease are cycle length (CL) 
dependent, we computed on 24 hour Holter recordings low (.05-.15 Hz) 
and high frequency (.15-.35 Hz) power (LF and HF respectively) in 19 
survivors of SCD (ventricular fibrillation or sustained ventricular 
tachycardia) who were inducible by programmed electric stimulation (age 
38-75, ~),and 20 age-matched normal subjects (age 4()..81. 55). Foreach 
consecutive 5 min period we computed the U (ms), LF and HF (ms2j 
values. For each subject, 5 min periods with comparable IT were grouped 
into consecutive lOOms bins, and mean values were computed: 
C~mo) eoo 7tIO 800 800 
LF I HF LF 1 HF LF' 1 HF' LF' 1 HF' -7.8.7.,122.2.1 10.7082122.1.5 13.5.8.513.4.2.3 15.8 0 8.0 14.6.3.3 SCD 2.6 • 3.5 1 .97> .911 4.1.5.511.4.1.7 2.7.3.31.79> .8 3.1.3211.1.1.0 
• p<.05 by ANOVA between nonna! and SeD; group mean ± SD (ms2) . 
Thus, significant differences between nonna! and seD subjects in the LF 
and HF spectra of heart rate variability existed only at longer cr.. These 
data suggest that CI. should be considered as an important variable in the 
interpretation of power spectral indices of heart rate variability and that 
comparisons between individuals and groups should be perfonned at 
similar, particularly longer, mean cycle length. 
779·6 
Heart Rate Variability and Patient Outcome in Advanced 
Heart Failure 
Bemhard Frey, Thomas Binder, Harald Teufelsbauer, Michael Wone, 
Gottfried Heinz, Herwig Schmidinger, Richard Pacher, Heinz Weber. 
Department of Cardiology, University of Vienna, Austria 
9:45 
Heart rate variability is evolving as a noninvasive tool for evaluation of 
autonomic dysfunction in patients wHh heart failure. Its relation to patient 
oucome, however, has not yet been assessed. 
The present prospective study coTlllrised 58 patients wHh advanced 
hilart failure and sinus rhythm (age 48±1 I years, I I CAD, 47 PDC, 
NYHASIII, plasma Na 140±6 mvaVl, LVEF 11±4 %) in whom heart rate 
variabilHy was analyzed in the time and frequency domain. At the time of 
Hoher recording all patients were clinically stable on digHalis, captopril 
and furosemide. None of the patients was on catecholamines, PGEI or 
POE inhibitors. 
There were 8 deaths wHhin 6 months (Group A), while 42 patients 
stayed alive during a follow·up period of 14±8 months (Group B). The 2 
groups did not differ wHh respect to hemodynamic measures (PCP 
26±6 vs. 20±9 mmHg, ns; CI 2.2±0.7 vs. 2.7± 0.8 VmiTVm2, ns; group A 
vs. group B) or captopril dose (74±1 12 vs. 61±48 mgldaY,ns; group A 
vs. group B). However, patients wHh poor outcome required significantly 
more diuretics (111±63 vs 50±54 mg lurosemidelday, p:.004, group A 
vs group B). The data lrom 8 patients who underwent cardiac 
transplantation were excluded from analysis. 
Group sdRR (ms) SDANN (ms) SO (ms) LF (ms) 
A 44±17 38±14 18±11 6±6 
B 111±40 101±46 49±25 20±12 
0:V;i.Je 00001 00001 00004 0 0006 
cutoff value 70 ms 55 ms 35 ms 15 ms 
sensitivity 100% 88% 88% 88% 
specificity 87% 87% 65% 31% 
Conclusion:These data suggest that heart rate variabilHy is associated 
with patient outcome in advanced hean failure independent of 
hemodynamic measures. Furthermore, sd RR and SDANN have a high 
predictive value in discriminating patients wHh poor outcome. 
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780·1 8:30 
Imp~ired Left Ven~ricular Function Due to Ischemia in Hyper•
tensIve PatIents wIth Normal Coronary Angiogram. 
Ingomar-Werner Franz, Ulrich Tonnesmann, Dieter Erb, Wehra•
wald-Clinic, Todtmoos, Germany 
Objective and patie~ts: In 12 hypertensive patients (group I; 
aged 53.:!:. 4 yrs) wIth ST-segment depression during exercise 
and concomi~ant angina pectoris but normal ~oronary angio•
grams and wIthout LVH (LVMI 89.3 + 18 g/m ) left ventricular 
function at rest and during exercise was studied by cardiac 
catheterization and compared with 12 hypertensives with CAD 
(group 2; aged 56 + 5 yrs) and 12 hypertensives without ST•
segl"gent depression (group 3; aged 56 + 7 yrs, LVMI 125 + 40 
g/m ) after discontinuation of all cardiac medications. Results: 
PCWP ~as normal at rest .(6.5 .:!:. 4; 6.9.:!:. 2; 9.4.:!:. 4 mm ~
respectIvely) and pathologIcally increasea at 75 watts only in 
group I and 2 (30.2 + 6 mm Hg; 31.5 + 5 mm Hg, respectively) 
but not in group 3 (18.5 .:!:. 3 mm Hg; p < 0.001). Repeated mea•
surements ?ur.i~g exercise 30 mi~ after 10 mg nifedipine orally 
showed a sIgnIfIcant and nearly mdentical fall in MAP (149 + 
15 to 137 .:!:. 15; 143.:!:. 17 to 134 + 20; 145 + 20 to 137 + 20 mm 
Hg, respectively; p < 0.01). TPRlp < o.olrand increase in CI 
(p < o.or) and unchanged HR x SBP in all groups, however sign. 
differences and decreases of PCWP (group I: to 17.7.:!:. 5 nmf-g, 
- 41.4 %; group 2: to 24.3 .:!:. 6 mm Hg, -22.9 % -p <0.01; group 
3: to 13.8 .:!:. 4, -25.4 %, P < 0.05) with concomitant reduction in 
ST -segment depression and anginal symptoms (p < 0.05) in group 
I and 2 (-43.7 % an~ -36 %, ~espectively). Conclusions: ST -seg•
ment ~e~resslon durmg exercIse ECG with concomitant angina 
p~ctOrtS IS not a. false-positive finding in hypertensive patients 
wIth .normal angl~rams but demonstrates myocardial ischemia 
also m patIents wIthout LVH (preferentially in females) and is 
mainly caused by functional changes of the coronary vascular 
bed as pump function is improved after nifedipine. 
780·2 8:45 
Stress lOtTI Scintigraphy Predicts Cardiovascular Morbidity in 
Asymptomatic Hypertensive Men with Multiple Risk Factors. 
Susan Ammon, Julio F. Tubau, Jadwiga Szlachcic, James Tom, 
Barry M. Massie. V AMC and University of California, San 
Francisco, CA 
Coronary artery disease (CAD) is the most frequent cause of 
morbidity and mortality in hypertensive patients (PTS). 
Therefore, we prospectively evaluated 225 asymptomatic men 
~ 40 yrs of age by performing exercise allTI scintigraphy, 48 hr 
ambulatory ECG and M-mode echo 5 days off treatment. PTS 
were followed 2-58 mos (mean 30 mos), during which 30 PTS 
experienced 22 cardiac events (3 deaths, 4 non-fatal MIs, 15 new 
angina) and 12 other cardiovascular (CV) events (6 strokes, 2 
TrAs, and 4 worsening renal function). By Cox proportional 
hazard analysis, a reversible >JITI defect, ECG LVH, >2mm ST 
, on exercise ECG, resting ECG ST-T abnormalities and systolic 
BP> I~ mmHg were significant univariate dichotomous predictors 
of cardIac or total CV events. By multivariate analysis only 
reversible >JITI (Risk Ratio 4.9, p=.OO3) and >2mm ST , (RR 
~i8, p=.05) remained significant predictors for cardiac events; 
TI (RR 8.1, p<.OOOI) and ECG LVH (RR 5.1, p=.OO5) were 
multivariate predictors for total CV events. The flB,ure below 
illustrates the prognostic importance of a reversible TI defect. 
Neither echo LV mass or I.. CVEVENTS 
ambulatory ECG were 
significant predictors of 
morbidity in this 
population. These 
findings indicate that 
scintigraphic evidence of 
myocardial ischemia is a 
powerflll indicator of 
subsequent CV morbidity 








Bffect of Blood Pressure Reduction on Coronary Plow 
Reserve in Essential Hypertension 
Joseph A. Diamond, Josef Hachac, Hilena Henzlova, Haria 
Ardeljan, Arlene Travis, Craig Vilkenfeld, Kevin L. 
Hartin, Lawrence R. Krakoff, Robert A. Phillips. Hount 
Sinai School of Hedicine, New York, New York. 
Coronary flow reserve (CPR) is blunted in untreated 
essential hypertension. The effect of sustained blood 
pressure (BP) reduction on CPR needs to be understood. 
Therefore, we examined the relation between B~ 
reduction and CFR in 20 untreated hypertensive mel'l 
wi thout evidence of epicardial CAD. Coronary perfusioll 
was evalua ted at baseline and af ter maximal coronary 
vasodilatation with adenosine using split-dose 
quantitative thallium-201 imaging. The ratio of count~ 
during maximum coronary vasodilation by adenosin~ 
divided by baseline counts in the anterior wall define1 
the CFR, a method validated with microspheres in dogs, 
After a month of medical therapy, all patients had> 1') 
mm Hg decrease in diastolic BP. As shown below, -CF~ 
varied in relation to A systolic BP, p value <0.01. ' 
A Systolic BP (mm Hg) 
Increase (n=4) 
Decrease 1-30 mm Hg (n=11) 












CPR improved only in the group wi th a 1 to 30 mm Hg 
reduction in systolic BP. Regression analysis suggested 
a U-curve relation between A systolic BP and ACFR. 
Conclusion: There is an optimal range of systolic BP 
reduction in which CPR improves. These results suggest 
that excessive sustained reduction of systolic BP may 
be detrimental during treatment of hypertension. 
780·4 9:15 
287A 
Transient ECG Abnormalities During Increased Metabolic Demand 
and Dipyridamole Inrusion Identify Dirferent Patterns of 
Myocardial Perfusion in Hypertensive Patients 
Carlo Palombo. Danilo Neglia, Gianmario Sambuceti, Claudio MaraboIIi. AnIDDio 
L' Abbale, Oberdan Parodi. CNR [nstitule of Clinical Physiology, Pisa, Italy. 
Whether transient ECG abnormalities (AECG) during stress are associated 10 
abnormalilies in myocardial blood flow (MBF) in patients wilb arterial 
hypenension (AlI) is still unsetted. Aim of Ibis study was 10 evaluare the possible 
role of transient ST· T segment depressiOn ( ~ 0.1 m V compared 10 basal) durinl 
increased metabolic demand and pharmacologically induced ca'OIlaI)' vasodi1atioo IS 
markers of impaired myocardial perlusion in AH. Mean and regional MBF were 
measured by 13-Ammonia and dynamic PET in 20 untreated pts wilb AH (10 
without and 10 with concentric left ventricular hypertrophy) and in 12 age-mardled 
normOlensive controls (C), all with angiographically normal coronary arteries, 
basally and after respectively maximal atrial pacing (AP) and dipyridamole i.Y. 
(Dipy: 0.56 mg/Kg/4 min). Mean MBF in AH was similar 10 C basally, but 
significantly lower during AP (1.6±.39 vs 2.2±.73 ml/min/g. p<.02) and Dipy•
(2.3±.98 vs 3.8±.86 ml/min/g, p<.OOI). [n AH, ~CG occurred in 10 [lIS only 
during AP (ECG.I), in 4 pts also afler Dipy (ECG·[I), while in 6 pts ECG was 
negative (ECG·). Mean MBF in ECG-, ECG·[ and ECG·II was respectively .8s±'1, 
1.1±.2 and 1.2±.2 basally (p<.OI), and 1.53±.2, 1.86±.3, 2.1±.2 after Dipy· 
(p<.01). A similar behavior was observed for regional MBF (septal, anterior and 
postero·laleral walls). Mean coronary resistance (CR) in ECG·, ECG·I and ECG-II 
was 152±22, 118±29 and 99±13 mmHg/mllmin/g basally (p=.01), and SI±S, 
66±11 and 56±7 (p<.OO5) after Dipy·. Coronary reserve (Dipy/Basal MBF) WlS 
similar in the three groups. No significant differences between ECG·, ECQ.I and 
ECG-U were found for basal BP, age (53±5, 53±9 and 51±3 years) and LV mass 
index (162±41, I 66±68, 130±25 g/sqm), while basal HR was 59±7, 71±8 and 
77±14 bpm, respectively (p<.05 for ECG-ll vs ECG·). This study confirms a 
significant reduction of coronary reserve in AH and shows that, in these patients, 
lIansient ECG abnormalities during increased metabolic demand and dipyridamole 
infusion appear 10 be unrelated 10 LV hypertrophy and 10 have incremental value in 
identifying patients with significantly lower basal and minimum CR, IOgether with 
higher basal HR and possibly myocardial oxygen consumption. Thus, ECG 
changes during multiple stresses seem to represent possible markers of MBF 
maldistribution due 10 "functional" more than "structural" abnormalities. 
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780·5 9:30 
Quantitative Adenosine-Thalliu. Perfusion I.aging For 
Assessing Coronary Flow Reserve in Arterial 
Hypertension 
Joseph A. Diamond, Josef Machac, Milena Henzlova, Haria 
Ardeljan, Arlene Travis, Craig lIilkenfeld, Kevin L. 
Martin, Lawrence R. Krakoff, Robert A. Phillips. Mount 
Sinai School of Medicine, New York, New York. 
Invasi ve techniques and positron emission tomography 
have 'shown that coronary flow reserve (CFR) is reduced 
in left ventricular hypertrophy (LVH). In humans we 
assessed the relation between LV mass and CFR using a 
new non-invasive method, quantitative adenosine 
thallium perfusion imaging, which we have recently 
validated by microspheres in a dog model. LV mass was 
determined by 2-D directed H-mode echocardiography in 
18 untreated hypertensive men (age = 48+7) without 
evidence of epicardial CAD. CFR was quantified by 
split-dose thallium-201 perfusion imaging. The ratio of 
counts during maximum coronary vasodilation by 
adenosine infusion divided by baseline counts defined 
CFR. CFR was detected (ratio >1.0) in the septal and 
anterior walls in all patients as shown: 
Mean+ s.d. Range 
CFR, Anterior wall 1.5~0.3 1.1 to 2.1 
CFR, Septal wall 1.7!0.3 1.1 to 2.2 
CFR in the anterior and septal walls was inversely 
related to LV mass (r = -0.61, p<O.Ol, r 3 -0.50, 
p<0.03, respectively). LVH was present in 67% of 
patients in the lower one-half range of CFR but in only 
22% of patients in the upper one-half (p.0.05). 
Conclusion: This study confirms that CFR is reduced in 
hypertensive patients with LVH. This new non-invasive 
method for determining CFR may be used to identify 
patients at risk for abnormal coronary perfusion and is 
sui table for serial measuremen ts to assess the effec t 
of treatment on CFR. 
780·6 9:45 
Coronary autoregulation in left ventricular 
hypertro~hy: comparison of eccentric and 
concentr~c hypertro~hy. 
Alvise Polese, N~coletta De Cesare, Anna 
Apostolo, Sergio Cozzi" Corrado Carbucicchio, 
Maurizio Guazz~. Inst~tute of Card~ology, 
Hospital "L. Sacco", University of Milan, Italy. 
In left ventricular hypertrophy (LVH) , lower 
threshold of the relationship coronary flow(CF)/ 
perfusion pressure (PP) is shifted upward and 
autoregulation may be exhausted at higher, PP 
values, still within physiological ranges. S~nce 
it is unknown if this is applied also to enlarged 
LV, when the ventricular mass(LVM) is augmented 
because of diameters and not because of increased 
parie~al thickness, we evaluated CF (thermo•
dilut~on) ~n base l~ne, and dur~ng gradual 
reduction of PP obtained through scaled doses of 
nitroprusside(0.65.5mcg/kg/min) ilv.. 6 
normotensives with normal LVM (l26g/m) (group 
1), 7 ?ypertensives with increased LVM 
(178+24g/m) and concentric LVH (H/R>0.45) (group 
2) and 5 hypertensives with similar LVH, but 
normal parietal thickness (H/R< 0.40), and 
increased diameters (group 3) were stud~ed. A 
previous coronary angiography had ruled out 
significant stenosis in all pts. In group 1 CF 
was 139~11ml/min in baseline, increased sl~ghtly 
at the beginning of n~tropruss~de ~nfus~on and 
was still similar to the basal one at 65 mmHg of 
PP.In grou~ 2 CF was 188~17 ml/min in base line 
(p<.OOl) w~thout significant change until PP of 
90 mmHg. Below this value, CF resulted dependent 
on PP In group 3 CF was 144~12 ml/min(NS) in 
baseline; autoregulation resulted exhausted at 
only 105 mmHg and further reductions of CF 
occurred during subsequent decrease of PP. Thus 
in LV enlargement w~th normal par~etal th~ckness: 
l)basal CF is not increased and, therefore, ~s 
reduced if normalized to LVM; 2) coronary 
autoregolatory capacity is even more lowered than 
in concentric LVH. 
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781·1 8:30 
Lesion Morphology and Outcome After Laser Angioplasty, 
A Prospective Evaluation: Excimer Laser Coronary 
Angioplasty Registry (ELCA) 
David R. Holmes, John F. Bresnahan, Malcolm R. Bell, Frank 
Litvak, for the ELCA Registry, Mayo Clinic, Rochester, MN 
Lesion morphology has been found to affect outcome with 
conventional PTCA. The relationship between morphology and 
outcome with ELCA remains uncertain. To assess this, the influence 
of lesion morphology on the acute outcome of excimer laser 
angioplasty and characteristics were prospectively coded prior to 
ELCA in 1,067 patients and 1,179 lesions. The modified ACCIAHA 
morphology code of A,B I,B2 and C was used. Of the 1179 lesions 
treated. 7% were A, 15% were Bl, 48% were B2 and 30% were C. 
Procedural success was defmed as final residual stenosis ~O%; 
ELCA technical success defined as stenosis reduction ~% or a 
lumen after ELCA ~ ablation area of fiber. Outcome was: 
# lesions 
ELCA tech success (%) 













Bl B2 C 
180 563 358 
91 87 84 

















Procedural success for specific lesion characteristics were I) length 
>20 mm - 90%, 2) bifurcation - 85%, 3) lesion calcification - 8~91" 4) 
chronic total occlusion - 90%, 5) eccentric lesions - 90%, 6) OStial 
location - 90%, 7) thrombus in lesion - 91 %, 8) unprotected side 
branch - 89%, 9) friable vein graft - 97%. . 
Recent experience with ELCA is characterized by a high proporn,?n of 
complex lesion morphology. Success rates are excellent trrespectlve 
of specific lesion type even with high risk lesions and complication 
rates are low. 
781·2 
The'Novel Directional Laser Catheter: Multicenter 
Angiographic Core Lab Analysis 
8:45 
Ziyad M.B. Ghazzal, Martin B. Leon Arie Shefer David R. 
Holmes Jr., Frank Litvack, Au,gusto b. Pichard, Donald A. 
Rothbaum, Tsvi Goldenber,g, Spencer B. King, III. Emory 
University, Division of Cardiology, Atlanta, Georgia 
Lesions that are moderately to highly eccentric have the 
potential for a higher complication rate when attempted with 
balloon angioplas~ alone. Such lesions may become more 
favorable when t1ie plaque volume is reduced with newer 
devices such as the Dlfectional Laser Catheter (DLC). This 
over the wire system contains eccentrically arranged excimer 
laser fibers tliat can be selectively oriented to face the 
e~centric plague, and a~' thil;t prote"ts the opposite wl!ll 
SIX -one leSIOns from -e~lit pattents attemp.ted with DL~ at five centers were s udled in a central angiographic 
core lab. Cine frames were optically ma&!lifielf, A to 0 
converted and entered into a computer for oetailed analysis 
using computer assisted visual edge detection. Lesion 
distnbution was as follows: Left Mam 10%, LAD 33%, RCA 
27%, Cx 21 %, SVG 9%. Mean vessel diameter was 
2.8+0.6mm. Twenty-five lesions were calcified and 15 
lesiOns were at or in the immediate vicinity of branch points. 
Mean length was 6.2+3.2mm. Mean eccentricity index (EI) 
was 29+ n % (A lesiOii with an EI of 0% is concentric, wbile 
for an extremely eccentric lesion, the EI approaches 50 %). 
Thirty-two lesions (53%) had an EI >30%. The mean 
diameter stenosis for all attempted lesions was reduced from 
72+11 % to 41+22% post laser to 24+20% post balloon. 
Five lesions coulil not be crossed with m::;c. One such lesion 
could not be crossed with a balloon. Eleven lesions were 
complicated by a dissection after laser or balloon treatment 
The majority however, were non-flow limiting. Three 
patients required emergency CABG. Laser success was 
achieved in 84% and procedure success without major 
complications was p'ossIble in 92 %. Conclusion: Early 
experience with DLC suggests that it may be effective 
acutely for the treatment Of moderately to severely eccentric 
lesions and bifurcation lesions in small to medium diameter 
vessels. Long term follow-up is ongoing. 
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781·3 9:00 
Improved Efficacy and Salety Using Small Highly EfTlCient Excimer Laser 
Catheters in Complex Lesion Morphologies 
Martin B. Leon. Kenneth D. Henson. Augusto D. Pichardo Lowell F. Saller. 
Jeffrey J. Popma. Michael B. Keller. Ann Greenberg. Tsvi Goldenberg. Kenneth 
M. Kent. Washington Hospital Center. Washington. D.C. 
Previously. operator technique favored the use of excimer laser catheters (LC) 
closely matched to vessel dimensions. lower energy densities (35-5OmJ/mm2). and 
multiple passes across the lesion site. For the past 12 months. we have tested a 
smaller (I.3mm). more efficient (ie. less dead space) LC capable of higher energy 
densities (SO-65mJ/mm2) using a single pass technique combined with adjunct 
PTCA. We compared quantitative coronary angiography and chart review from 
our earlier experience using larger LC (1.6 and 2.Omm. n=51 lesions) with our 
recent experience using the I.3mm LC+ PTCA (n=1I3 lesions). Procedure 
success was defined as a residual % diameter stenosis (OS) <50% without major 
complications (death. Q-wave MI. urgent CABG). 
I.3mm LC Larger LC p value 
energy density (mJ/mrn2) 58.9±6.2 45.3±8.1 .04 
reference diameter (mm) 2.4±.4 2.6±.6 .005 
lesion length (mrn) 15.1±9.9 8.3±6.4 .001 
lumen diameter: pre/final (mm) .26±.33/1.64±.50 .62±.35/1.72±.60 .001/05 
% OS: pre/linal (%) 90± 12132± 19 76±14/34±18 .001/05 
bifurcations/occlusions (%) 21144 6114 .02{.001 
procedural success (%) 91 86 ns 
majorcomplications(%) 5.3 7.4 ns 
Importantly. in the last 40 lesions treated with the I.3mm LC. a new "cobra-head" 
catheter design was used with even less dead space and radial dispersion of laser 
light to facilitate lesion crossing and tissue ablation. 
In conclusion: There has been an evolution in laser angioplasty favoring the 
treatment of smaller vessels with more severe stenoses and additional complex 
morphologic features (e.g. diffuse disease. bifurcation lesions. and total 
occlusions). The use of smaller more efficient laser catheter designs combined 
with PTCA has improved procedure success (>90%) and reduced major 
complications (-5%) in these more complex lesions. We postulate that efficient 
tissue ablation of the superficial fibrocalcific plaque components (1) improves 
lesion compliance faCilitating subsequent PTCA and (2) reduces unwanted 
acoustic shock wave effects which may cause deep vessel wall injury. 
781·4 9:15 
QuantItative Anglographlc ResuIts After Coronary Exclmer Laser 
Angloplasty: the European RegIStry 
Jan Kvasnicka. Andreas Baumbach. Eckart Fleck, Karl R. Karsch, Helmut 
Oswald, Het1)ert J. Geschwlnd. Henri Mondor Hospital, Universtty of Paris 
XII, Creteil, France, for the European Study Group for Coronary Excimer 
Laser Angioplasty 
From January 1991 to August 1992 350 lesions in 343 patients were 
submitted to coronary excimer laser angioplasty in 14 European centers. 
The excimer laser was coupled into 1.4, 1.7 or 2.0 mm muttHiber wire-guided 
catheters. Lesions included 210 LAD, 54 LCx, 70 RCA, 4 protected LM and 
12 grafts. There were 2% type A, 19% type B1, 58% type B2 and 21% type 
C lesions. Ouantitative data were calculated using an automated edge 
detection system. Prior to the measurements, point-spread function, 
pincushion distortion and calibration factors had been determined in each 
interventional cardiology unit. These values were used for individual 
correction on each angiogram. The minimal luminal diameter, the reference 
diameter and the percent diameter stenosis were measured before. 
immediately after, at 24 hours after the procedure. A 6 month follow-up was 
available for 35 patients. The procedure success rate defined as a <50% 
final stenoSis (with or wtthout additional PTCA) was achieved in 85%, 48 
patients (14%) could be left on stand-alone laser therapy. There were 51 
failures (15%). Complications included spasm (12%), dissection (24%), 
acute closure (9%) and perforation (2%). There were 6 (2%) deaths, 10 (3%) 
AMI and 10 (3%) emergency CABG. The minimal luminal diametllr 
increased from 0.7±0.4mm to 1.3±0.6mm (p<O.OOl) after laser irradiation 
and to 1.8±0.5mm (p<O.OOl) after balloon dilatation corresponding to a 
percent diameter stenosis reduction from 79±12% to 55±18% and 38±13% 
after laser and balloon angioplasty, respectively. There was no signHicant 
change in the reference diameter after either laser or balloon angioplasty 
(3. 1 ±O.7mm, 3.0±0.6mm and 3.0±0.7mm before, after laser and after balloon 
angioplasty, respectively). At 24 hour follow-up the minimal luminal diameter 
decreased slightly from 1.8±0.5mm to 1.7±0.6mm. Laser stand-alone 
therapy resutted in a percent diameter stenosis reduction from 76±11% to 
42±12% (p<O.OOl) which was maintained at early follow-up. The late follow•
up results showed a percent stenosis diameter of 63±21% and 48±17% for 
laser stand-alone and laser+balloon, respectively. 
Conclusions: 1. Coronary excimer laser angioplasty alone results in a 
sign~lcant increase in minimal luminal diameter. 2. The increase is not great 




Laser Thrombolysis in Acute Myocardial Infarction 
Kenton W. Gregory, Peter C. Block, William D. Knopf, Lisa A. 
Buckley, & Christopher U. Cates, St Vincent Hospital, 
Portland, OR & St Joseph Hospital, Atlanta GA. 
We studied the safety and feasibility of selective laser 
thrombolysis (L 1') of coronary artery thrombi in 16 patients 
with acute myocardial infarction (AMI). A pulsed dye laser 
emitted 1.0 Ils duration pulses (3 Hz) at 480 nm, a wavelength 
highly absorbed by thrombus and minimally absorbed by vessel 
wall constituents. Laser energy was delivered via flowing, 
fluid-core light guides using radiographic contrast (Angiovist) 
as the core fluid with 0.3 or 0.5 cc/s flow rates. Patient 
inclusion criteria were AMI with ST elevation in <!: 2 EKG 
leads, ongoing ischemia, contta-indications or failure of 
fibrinolytic drugs and coronary thrombi by angiography. 240-
600 laser pulses between 60-75 mJ per pulse were delivered. 
LT removed thrombi in 15/16 patients and mean TIMI grade 
coronary flow increased from 0.7 to 2.4. All patients then 
underwent adjunctive PTCA or atherectomy. Mean stenosis 
decreased from 99% pre-treatment to 80% after laser to 24% 
after adjunctive therapy. Procedural success (residual stenosis ~ 
50% and ~ TIMI grade 2 flow) was achieved in 15116 patients 
(94%). No perforations were observed. There were no acute 
vessel closures, recurrent infarctions or deaths during 
hospitalization. We conclude that selective laser thrombolysis 
may be a feasible and safe method of removing coronary artery 
thrombi in acute myocardial infarction. 
781·6 9:45 
Excimer Laser Anglopluty of Aorta-Ostial Stenosis In 175 Patients: 
Acute and Follow-Up ResuIts and Core Lab Analysis. 
Barry S. Weinstock, Neal L Eigler, Frank Lttvack and the ELCA 
Investigators 
Cedars-Sinai Medical Center, Los Angeles. CA 
We performed core lab morphologic (MA) and quantHatlve analysis (OeA) 
on 175 pts following excimer laser coronary angioplasty (ELCA) of aorto•
ostial stenosis (LM 11.4%, RCA 62.3%, vein graft 26.3%). Stenoses were 
eccentric 10%, calcified 19%, thrombus 6%, TIMI flow < 2 11 %. Procedural 
success « 50% residual stenosis wtthout major -complication) was 
documented In 86%. 66% of patients had adjunctive PlCA. Major 
complications included death 0.6%, OMI 1.2%, in-hospital CABG 2.3%, 
perforation 0.6%, acute occlusion 0.6%. Six month angiographic follow-up 












No MA characteristics predicted primary success or complication. 
Angiographic restenosls (> 50% diameter) occurred In 39% of patients and 
32% of RCA lesions. Adverse clinical events at six month follow-up in 149 
eligible patients Included death 2.7%, MI 1.3%, CABG 4.7%, repeat 
intervention 12.1%, cumulative events t7.4%. There was a trend for 
restenosis when residual stenosis was >30% (50% vs 22%, p< .05), 
residual stenotic diameter <2.0 mm (48% vs 33%), and lnabilny to create 
channel of catheter ablation diameter with ELCA (57% vs 37%). 
Conclusions: (1) OCA of pts having ELCA for aorto-ostial stenosis confirms 
a high primary success rate, (2) Major complications are infrequent and 
are not predicted by lesion morphology, and (3) Restenosis, especially for 
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914-16 
Does The Speed Of Balloon Deflation Affect The 
Complication Rate Of Coronary Angioplasty 
Christopher 1. Foster, Robert Teskey, Catherine Kells, Nancy 
Fitzgerald, Kim Foshay, Cathy Peck, Blair O'Neill. Victoria 
General Hospital, Halifax, Nova Scotia, Canada 
Introduction: Coronary angioplasty (PTCA) balloon deflation is 
traditionally performed rapidly. It was hypothesized that altering the 
rate of deflation might cause different shear forces on the arterial 
wall therefore altering the incidence of arterial dissection. This 
should affect the complication rate. 
Design and Methods: 200 sequentially dilated coronary artery 
stenoses were randomized to fast or slow balloon deflation. The 
speed of deflation was controlled by the rate that negative pressure 
was applied, using an inflation device. Data were obtained from all 
patients on the variables that are known to affect the complication 
rate. The coronary angiograms were reported blind for the presence 
or absence of arterial intimal dissection and its extent was graded 
using the N.H.L.B.I. classification (A-F). 
~: The stenosis was dilated in 188 cases (!OI slow and 87 
fast deflation). Lesion variables were similar in both groups other 
than stenosis length, with more long stenoses in the fast deflation 
group (P=O.05). There was no significant ditTerence in the 
incidence of minor (A-B) dissections, however the slow deflation 
group had significantly more severe dissections (C-F) (20 vs 5; 
P=0.013). 
Conclusjon: Slow PTCA balloon deflation is associated with a 
higher incidence of severe arterial intimal dissections. Possible 
explanations are: I. increased turbulence and high velocity flow 
around the balloon during deflation or II. movement of the partly 
deflated balloon down the artery, by arterial pressure, while it is in 
partial contact with the arterial wall. Either of these would increase 
shear forces favoring propagation of small tears. 
914-17 
Prolonged Dilatation Improves Initial Results During PTCA of 
Complex Coronary Stenoses: Results From A Randomized 
Trial 
Dean 1. Kereiakes, Merril L Knudtson, E. Magnus Ohman, 
Thomas M. Broderick, Jean-Francois Marquis, Paul A Gurbel, 
James E. Tcheng. Paul Owens, Michael H. Sketch, Jr. for the 
PBC Study Group, Christ Hospital, Cincinnati, OH. 
To evaluate the potential benefit of jrolonged (PROL) 
inflation (diI) compared with standar shorter duration 
(STAND) diI of complex coronary stenoses, we analyzed 
angiograpbic and procedural success by lesion mo~hology from 
the randomized perfusion balloon catheter (PBC) trial. PBC 
was used to dilate a single stenosis in 478 pts. After PBC was in 
place, patients were randomized to STAND dil (up to 4 diI of 1 
min each) or PROL dil (up to 2 dil of 15 min each) in phase 1. 
If residual stenosis was > 50% following phase 1, further dil as 
necessary were done in phase 2. Angiograpbic success (visual 
stenosis .s.50%) was read by a core laooratory. The median 
(25th, 75th percentile) number of STAND diI was 2 (2,4) and 
PROL diI was 1 (1.2). Angiograpbic success rates and 95% 
confidence intervals (CI) by lesion morphology (ACC/ AHA) in 
phase 1 were: 
Morpholo&)' SIAN!:2 (CI) fRill. (CI) 
Lesion Type A (0:92) 98% 194,102) 94% 187,101) 
Lesion Type B1(n:I92) 93% 87,98) 96% 93,1(0) 
Lesion Type B2 (n:129) 91% 84,97) 97% 93,101) 
Irregular, Ulcerated, 
Thrombus(n:1l4) 88% (80,96) 98% (95,102) 
Eccentric (n:29O) 92% (87,96) 97% (94,100) 
Gradual prolonged dilatation was associated with improved 
angiograpbic outcome in patients with complex stenosis 
morphology (B.2' irre/.tlllar, ulcerated, thrombus, eccentric). 
Influence of PKOL dil on restenosis rates in these subsets 
awaits definition. 
914-18 
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Over-the-wire vs Fixed Wire PTCA Systems: 
Comparison of Procedural Variables In a Multicenter 
Randomized Trial 
Blair J. O'Neill, Robert Feldman. Joan Creighton. Nancy 
Fitzgerald, Sammie Palmer. Christopher J. Foster, Catherine M. 
Kells. Robert J. Teskey. Brian N. Corbett. Robert G. Macdonald. 
Munroe Regional Hospital, Ocala, Florida. New Brunswick 
Heart Center, Saint John. New Brunswick, Canada, Victoria 
General Hospital, Halifax. Nova Scotia Canada 
Fixed wire (FW) systems are generally considered easier to use 
than over-the-wire (OW) coronary angioplasty (CA) balloon 
catheters. Although less time is required to prepare a FW 
system, there is no data concerning the relative procedural 
variables. As part of a randomized trial comparing the 2 
systems, we prospectively evaluated procedural variables. Out 
of 1,513 patients (pts) undergoing CA at 3 centers between 
19/06/90 and 10/04/91, a total of 643 lesions in 602 pts (40% of 
total) met predefined inclusion and exclusion criteria. Of these, 
327 were randomized to FW and 316 to OW. Baseline 
demographic and lesional characteristics were similar. The 
start of the procedure was taken as time of wire exit from guide. 
Procedural variables (mean±SD) were as follows: 
FW OW P 
total procedure time (min) 21±23 21 ±18 NS 
total fluroscopy time (min) 6.7±7.4 7.1±6.3 NS 
time to cross lesion (secs) 200±372 233±388 NS 
total contrast usage (cc) 89±76 84±61 NS 
number of cine runs 5.9±3.1 6.3±3.4 NS 
number of balloon inflations 3.1±1.8 3.1±1.8 NS 
% stenosis pre 81±9 80±6 NS 
% stenosis post 28±15 28±16 NS 
Thus, despite differences in design and operation of the 2 
systems there were no differences in procedural variables. 
914-22 
Use of the GUdewire Improves Recanalization Rates of Resistant Total 
Cororuiry Artery Stenoses 
Mark S. Freed. James E. Boatman, Noah Siegel, Robert D. Safian, 
William W. O'Neill, Cindy L. Grines, William Beaumont Hospital, Royal 
Oak, Michigan 
The Glidewire is comprised of an elastic titanium-nickel alloy core and a 
hydrophilic polymer-coated polyurethane cover which imparts extreme 
flexibility, pushability, kink-resistance and decreased surface tension when 
wet. The distal 3 cm of wire are soft and flexible to facilitate atraumatic 
passage during crossing attempts. The Glidewire has been shown to be of 
value in negotiating severe vessel tortuosity during extracoronary 
angiography and in crossing complex, high-grade peripheral occlusions 
during angioplasty. To determine its role in revascularization of coronary 
stenoses, the Glidewire (0.018") was used to treat 71 lesions which failed 
conventional guidewire crossing (59 total and 12 subtotal occlusions). 
Lesion locations included the RCA (35%), LCX or OM (35%), and LAD 
or diagonal (30%). 
Total Subtotal 
Occlusion Occlusion Overall 
No. lesions 59 12 71 
Successful lesion crossing 32(54%) 10(83%) 42(59%) 
Successful PTCA 23(39%) 9(75%) 32(45%) 
« 50% residual stenosis) 
Coron arte dissection was evident u n case comoletlon ID 15/42 ary ry po P 
(36%) successfully crossed occlusions, but no coronary artery perforations 
uccurred. Conclusion: Use of the Glidewire increased the success rate of 
PTCA for total and subtotal occlusions which could not be crossed with 
conventional guidewires. 
lACC Vol. 21, No.2 
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914-23 
Effects of Angloplasty Balloon Material and Lesion 
Characteristics on the Incidence of Coronary 
Dissection in 2150 dilated Lesions. 
Erwin Raymenants. Suman Bhandari. Francis Stammen. Ivan De 
Scheerder. Walter Desmet. Jan Piessens. University Hospital. 
Leuven. Belgium. 
Conflicting results have recently been reported about compliant 
balloon materials as a possible culprit for coronary dissections. A 
commonly proposed explanation is the possibility of excessive "dog•
boning" at higher inflation pressures with overstretching of the 
normal artery adjacent to the lesion. 
In order to solve this issue we analyzed a series of 2150 coronary 
lesions dilated at our institution between January 1. 1991 and June 
30. 1992. with three different balloon materials. All lesions dilated 
with a plastomer 300 low compliance balloon (LCB lesions. n=863). 
were compared with lesions dilated with a polyethylene 600 
intermediate compliance balloon (ICB lesions. n=688). and with 
lesions dilated with a polyolefin copolymer highly compliant balloon 
(HCB lesions. n=599). To account for the possible selection bias of 
higher risk lesions to certain types of balloon catheters. the clinical. 
angiographic and periprocedural characteristics were compared 
between the three groups and stepwise linear discriminant analysiS 
was performed to relate all possible risk factors to the incidence of 
dissection. 
RESULTS: Angiographic dissection rates were 4.3% for LCB lesions. 
5.1% for ICB lesions and 3.7% for HCB lesions (p=NS). Baseline 
characteristics and procedural variables were similar among the 
three groups. while lesion complexity (expressed as % B2 and C type 
lesions) was significantly lower in ICB lesions. compared to LCB and 
HCB lesions (34% vs 45% and 47% respectively. p< 0.001). 
Stepwise linear discriminant analysis revealed that not balloon 
material but lesion location in bend. lesion length. presence of tandem 
lesion and patient age were multivariate predictors of dissection. 
CONCLUSION: Our data demonstrate that lesion characteristics but 
not balloon materials are important predictors of dissection. 
914-24 
A Third Coronary Anglopillty Procedur •• EIfICtlvl and Saf. treatm.nt 
for a Second RestenosIs 
Christophe Bauters, J~ Lablanche. Eugene P. Me Fadden. Fabric. 
Leroy. Phllppe QuandaIIe. Michel E. Bertrand. University 01 LIIe. France 
ConIIIctIng data have been published regarding the risk 01 Immediate 
compIlcaIIon8 and the Iongtenn rate 01 reslenosls when a third angloplasty 
Is performed for a second reslenosia. The dlscr8jl8llCies In reported 
reslenosis ratee may reftecl varying ratee 01 angiograpNc foIlO'N-up. We 
performed quantJIaIlve coronary anglographlc measurements 01 stenosis 
severity In 100 consecutive patients who undlllMlll a thlrd angloplasty 
procedure for two successlv. reslenoses at the same site. Mean age was 
56.± 9 yeers. 86'11. were male. Procedural success was obtained In 97 
patients : 3 patients had uncomplicated failure (residual stenosis >50%). 
There were no major compllcatlons (deeth. bypasa surgery. myocardial 
1nfarcIion). 
AnglograpNc foIIO'N-up was parfonned In 87% 01 patients ; the 
reslenosis rate (defined as the recurrence 01 > 50% stenosis at follO'N up by 
quanIiIatIYe coronary analysis) was 39%. Two varlablee were associated 
wtth a high risk 01 recurrent reslenosla : the presence 01 
hypercholesterolemia and a short Interval since the second angloplasty 
(reslenosla rate 72% If the Interval ..s 3 months va 30% If the interal > 3 
months (p <0.001). 
A thlrd angIopIasty may be performed on the same coronary segment 
wtth a ION risk 01 complication and a risk 01 reslenosis simlar to that of a 
first procedure. In salecled patients with a second restenosis. a further 
balloon angioplasly Is an elfectJve and safe therapeutic option compared to 
some 01 the IlM8I" technologies such as stantlng which have been 
suggested as alternatives. 
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Stenting the Infarct Related Arta-y Within 1S Days or the Acute Event: 
Immediate and Long Term Outmme Using the Flexible Metallic Coil Stent 
Sriram S. Iyer. Luc Bilodeau. Adam D. CaDDon. Subodh K. Agrawal, David A. 
Cox, J. Michael Pub. James A. Hearn. Wi1Iiam A. Baxley, Larry S. Dean. Gary 
S. Roubin. University of Alabama II Birmingham, Birminaham. Alabama 
Between 11189 and 8/92. 46 pati ... ts(pIs)(33 males, _ age 58± lOy) received 
59 flexible coil stenlS to stabilize ICIIIe closure (TIMI flow 0 or 1; 13 pts) and 
threatened closure (> 50" luminal diameter compromise with ongoing ischemia; 
33 pIS) complicatina PTCA. performed 0-15 days (Mean: 6±4d) following an 
..:ute myocardial infarction (2Oq;2600nq). T ... pts had ICIIIe evolving MI defined 
by ongoing chest pain with ST aegmeo! elevation. Five pts were in cardiogeDic 
shock and meaD L YEF was 43 ± 9". 
Prolonged intnroronary urokinase infusion after Blenting was used in 7/46 pis; 
5 pts with acute evolving MI received intnroronary urokinase. Stenting was 
angiographically succeosful «50" lumen compromise with TIMI ill flow) in 
45(98") patienls. 
Whereas 3110(30") pis with ICIIIe evolving MY developed BIen! thrombosis, only 
2 of the remaining 36(6") pIS had Blent thrombosis. Of the 7 pts who received 
intnroronary urokinase. only 1 patient had Blent thrombosis. All 5 pis with &tent 
thrombosis had successful repeal PTCA. No patient required emergency CABG. 
All 4(9 %) in hospital deaths were in cardiogenic shock at the time of their PTCA. 
Of the 6 (lq, Snonq) late MI's(> 2 days post stenting). 4(lq. 3nonq) weco a result 
of stent thrombosis. Clinical success (angiographic success. no qMI, CABO or 
death) was achieved in 41pls (89"). Angiographic follow up at a meaD interval 
of 4.S±2 mos was available in 28/38(74%) eligible pis; 15(54%) had restenosis; 
13(87") had succeosful repeal PTCA without complications. Clinical follow up 
data was avai1able for all 42 hospital survivors. At. meaD interval of 11 ± 8 mos. 
41 pIS were alive (I late death). Three patienls required CABO. Of the remaining 
38 patienls, 30 were asymptomatic and no patient sustained • myocardial 
infarction. 
CONCLUSIONS: 1) Stenting in patients with an evolving myocardial infarction 
carries with it • significanUy higher risk of Blent thrombosis. 2) Prolonged 
intnroronary urokinase infusion after stenting should be sIrongly considered in 
these patients. 3) Although restenosi. is common. results of repeal PTCA are 
... couraging and 4) Survival and event free data are favorable. 
915-65 
Can Preemptive Stenting tmprove The Outcome Of Acute Closure? 
Subodh K. Agrawal, Ming W Liu, James A. Hearn. Adam D. Cannon, Luc 
Bilodeau. Sriram S. Iyer, Larry S. Dean. William A. Baxley. Gary S. 
Roubin. Division of Cardiovascular Disease. University of Alabama, 
Birmingham, Alabama 
Threatened and acute closure represent two consecutive stages in the 
formation of unstable lesions after PTCA. Despite prompt opening of 
acutely closed arteries after coronary angioplasty, there is a high incidence 
of myocardial infarction (MI). To reduce this high MI rate we developed a 
strategy of stenting arteries prior to a significant reduction in coronary blood 
flow (acute closure). We analyzed 228 consecutive patients undergoing 240 
procedures for indications of threatened closure (n= 196) or acute closure 
(n=44). with balloon expandable. stainless steel stents (Cook. Inc.). 
Threatened closure was defined as 1 or more of the following: ~50% 
residual stenosis. dissection ~15mm and/or extra-luminal contrast. or 
angina and/or EKG changes. Acute closure was defined as TIMI 0 or 1 flow. 
There was no difference in clinical (age, sex. history of MI, angina class. 
mutlivessel disease) or angiographic characteristics (lesion class or length, 
pre PTCA % stenosis) between the groups. The significant post stent 
angiographic characteristics and ischemic complications within 30 days of 
stenting were: 











q wave MI 3% 11% 
thrombosis 7% 11 % 
repeat PTCA 11 % 18% 
CABG 4% 5% 









The incidence of MI increased 2.7 fold once acute 
established. 
closure was 
Conclusion: Even transient and reversible acute closure complicating 
PTCA is associated with a higher incidence of myocardial infarction 
compared to threatened closure .. Strategic stenting during threatened 
closure may reduce morbidity associated with acute closure. 
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SteatiD9 a. aD Adjunct to Balloon &agiopla.tJ for 
.ecanali .. tioD of TotallJ OCcluded Corollary Arterie., 
Clinic.l aDd ADgiogr.phic Pollowup. 
Luc Bilodeau. Sriram S. Iy.r. Adam D. cannon. Subodh K. 
Agraw.l. Larry S. Dean. J ..... A. Bearn. Hing W. Liu. 
William A. Baxl.y. Gary S. Roubin. Univer.ity of Alabama 
.t Birmingham. Birmingham. Alabama 
From November 89 to July 92 •• 6 flexible coil .tent. were 
.ucce •• fully placed in 37 pt. following recan.liz.tion of 
tot.lly occluded native coronary arterie.. Indications 
for .t.nting were di •• ection with threaten.d closure in 35 
pta(95') and elective to pre •• nt r •• teno.ia in 2 pta(5'). 
Tot.l occlusion. ware les. than 2 weeks old in 15 pta(40') 
including 5 acute HI. gr •• t.r than 2 we.ks but l •• a than 
2 montha old in 14 pt.(38') and older than 2 montha in 8 
pt.(22'). Stent. were 2.5mm di .... t.r in 46'. 3mm in 43'. 
3.5mm in 3' and 4.0 in 8'. Hultiple at.nta were placed in 
9 pt. (24\). Prolonged intr.coronary urokina.e infu.ion 
.ft.r .tenting w •• u.ed in 8 pt.(22'). 
Th.re were 3 (I w.ve. 5 non-Q w.ve HI (22') and 2 in•
ho.pit.l de.th. from cardiog.nic .hock. All the (I wave 
Hla. 2 of the 5 non-(I w.v. Hla and both fataliti •• were 
•• en in pt. with .cut. HI. St.nt thrombo.ia d.v.loped in 
6 pta(l"), .11 6 und.rwent .ucc.s.ful r.peat angioplaaty. 
Angiogr.phic followup w ••• v.ilabl. in 30 of 33(91')pts 
who h.d complet.d 6 montha followup. Re.t.no.i.. as 
def ined by ~50' diamet.r atenoaia. was obaerved in 17 
pta(S7\). A r.current tot.l occluaion was found in 6 
pta(20'). During clinical followup. available or all pts. 
8 pta h.d r.curr.nt angina (23') and 2 had myocardial 
infarction (") • Of thea. 17 re.tenotic pta. 14 h.d 
.ucce •• ful repeat PTCA. 1 w.. tre.ted _dically .ft.r 
f.iled PTCA and 2 underwent CABG without PTCA .ttempt. 
COHCLUSIOII Us. of the st.nt for threat.ned clo.ur. after 
recanaliz.tion of totally occlud.d coron.ry artery 
produces satisf.ctory results. Stsnting in total 
occlu.ion. is ••• oci.ted with a high.r riak of .cute 
thrombo.is. Re.teno.i. r.te. .ppear comparabl. to 
recan.liz.tion with b.lloon angiopl.aty .lon •• 
915-67 
-.rly 0Iltcc.e aDd I!lCicleDce of lIarteDoau ill .1actiYa 
vs DOll .lactiva Coronary stantiDg 
Serg. Douc.t. J.an-Bapti.t. C.Ulard. J.an Faj.d.t. 
Bernard cassagn.au. Gabriel Robert. J.an Marco. 
Cliniqu. Pa.teur. Toulou ••• Franc •• 
Coronary .t.nting has be.n proposed for two different 
purposes : r.duction of reat.noaia rate and correction 
of un.ati.factory po.t PTCA r.sult. The aim of this 
atudy was to compare early outcome and r •• t.nosi. rate 
of P.lmaz-Schatz .t.nt(S) implantation in those 
.lective (I) and non el.ctive (HI) indication.. Data 
ware analy.ed from par.ll.l conaecutive •• riea of 3S5 
I pt. and 210 HI pt.. I and HI population. did not 
diff.r in t.rm of g.nder. age. .ymptoms. native 
.t.nted v •••• l •• Hore I (P<0.01) pt. had pr.vioua PTCA 
and CABG. aingle v .... l di •••• e. chronic total 
coronary occlu.ion. .t.nt di .... t.r > 3.25 mm. .ingl. 
at.nt implantation and vein graft .t.nting. larly 
outcome and re.t.noai. were aa follows 
S clo.ur. CS 28 day.) C') I 
Single S clo.ur. CS 28 daya) 
Recanalization w/o HI (') : 
HI C') : 
CABG C') I 
Death C') , 
6 monthB F.U. angio Cn/') , 
Re.t.noBia rate C') , 





















251/83 124/76 na 
21.7 27.5 ns 
19.7 20.0 ns 
Conclu.ion I 1) I .tent implantation i. followed by a 
lower incidence of .t.nt cloBur.. 2) Single .tent 
re.t.noai. rate C20') is .imilar in both group. and 
._a lower than u.ual poat PTCA rate. 
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Comparison of Oulalme After CoiJn. Slotted Tube Stainless Steel Coronary 
Stellt Implantation to Prevent Restenosis - Les!IcIm from • Single Group 
Experience 
Step""" G. Ellis, Peter N. Verloe, David W.M. Muller. The Clevebud Clinic 
FOUDdatiOD, Cleveland, OH 
To gain insight into performance CbaracteristiC8 of stainless steel coronary stents 
that might COIIfer clinical benefit, delivery success and 6 month clinical and 
angiogrophic (angio) outcomes were analyzed for 98 consecutive patients stented 
for the indication to prevent resteoosis. Palmaz-Schatz (PS) slotted tube stents were 
used except when they were unavailable or could not be placed, in which case 
Gianturco-Roubin (GR) coil stents were used. AIl dimensional measurements were 
made at a core laboratory. 
Palmaz-Schatz (p -78) Gjanturw-Roubjn en - 20> .l!.. 
Demor.rlBl.h;-cs 
Male gender (%) 71 75 
Age (yrs) 59±10 56±13 
Prior restenosis (%) 75 85 
Normal diameter (mm) 3.2±.6 3.4±.8 
Saphenous vein graft C%) 26 20 
T~nI 
Pre-stent % stenosis 73±12 7HI6 
Multiple steots (%) 7 0 
Balloon artery ratio 1.0J±.12 1.12±.09 p=O.OO4 
Post_t % stenosis IS±II 3H2 p=0.OO7 
Failed delivery (%) 13 0 p=0.07 
Outcome 
Angio FlU (% elig) 96 87 
Restenosis (angio) 26 55 p=0.12 
Late loss (mm) 0.82±.78 0.8S±.93 
Restenosis (clinical) 27 61 p=O.04 
Thus, this coil design is somewhat easier to place, but has more early recoil and 
thus less dimeosional pill despite larger delivery balloons. As used in this series, 
this appear> to translate into higher rates of restenosis despite similar dimensional 
loss over time. 
915-69 
Influence of Angiographic Lesion Characteristics on Early 
Complication Rates After Palmaz-Schatz Stent1ng 
Krishna J. Rocha-Singh, David L. Fischman, Michael P. 
Savage, Sheldon Goldberg, Paul S. Teirstein, Richard A. 
Schatz. Scripps Clinic and Research Foundation, La Jolla, 
California, USA. 
Major ischemic complications rise in proportion to 
angiographic lesion complexity following balloon 
angioplasty. However, the correlation between complication 
rate and lesion characteristics following coronary 
stenting is undefined. Therefore, the relationship between 
angiographica1ly defined lesion characteristics and major 
complications (subacute stent thrombosis (SAT), myocardial 
infarction (MI), bypass surgery (CABG) , death) occurring 
within 30 days after successful Palmaz-Schatz stent 
deployment was investigated. 
A total of 658 target lesions (557 native, 101 saphenous 
vein grafts) in 622 pts were assessed by a core 
angiographic laboratory. Each lesion was classified as 
simple (S), intermediate (I) or complex (C) based on the 
follOWing angiographic characteristics: 
S(46.8%): Discrete (slO mm) and/or eccentric. 
1(18.4%): Length 10-20 mm and/or calcium, 
thrombus, ~45° angulation present. 
C(34.8'): Length >20 mm and/or ulcerated. 
Lesion types were matched against complications occurring 
























Conclusion: Angiographic lesion severity is not 
associated with a proportional increase in complications 
after successful Palmaz-Schatz stent deployment. 
JACC Vol. 21, No.2 
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915-70 
One year clinical and angiographic follow-up after 
Palmaz-Schatz stent Implantation 
Takeshi Kimura, Hideyuki Nosaka, Masakiyo Nobuyoshi 
Kokura Memorial Hospital, Kitakyushu, 802, Japan 
From June 1990 to July 1991, single Palmaz-Schatz stent 
implantation was performed in 109 patients (113 lesions). 
Delivery success (residual diameter stenosis < 50%) was 
achieved in 106 patients (109 lesions). Clinical follow-up 
data at 1 year were obtained in all patients. 
Freedom from death. 95% 
death, MI. CABG. 94% 
death. 1.11, CABG, PlCA (stent site). 83% 
death. 1.11, CABG. any PlCA. 71% 
Early(3 to 6 months)follow-up angiography (FUA)was 
performed in 107 lesions (98%). Angiographic restenosis was 
documented in 14 lesions (13%). Repeat PTCA was 
successfully performed in 1 0 lesions. Late (1 year) FUA was 
available in 86 lesions (79%). "New· restenosis was 
documented only in 3 lesions (3.6%) and one year cumulative 
restenosis rate was 18%. Quantitative angiographic results 
in 86 lesions with one year FUA (caliper measurement) were 
as follows. 
Minimal Stenosis % Diameter 
Diameter Stenosis 
Pre O.8±O.5mm n±13% 
Post 3.0±0.5mm 13±10% 
Early FUA 2.4±O.6mm NS 28±13% NS 
Late FUA 2.3±O.6mm -' 30±15% ~ 
In conclusion, stenosis exacerbation between 6 months 
and 1 year after Palmaz-Schatz stent implantation was a rare 
phenomenon and one year clinical and angiographic outcome 
was acceptable after this procedure. 
915-71 
SALVAGE OF mROMBOTICALLY OCCLUDED BYPASS 
GRAFI'S WIm PROLONGED INFUSION OF UROKINASE AND 
CORONARY STENTING 
Alexander A Stratienko, Paul S. Teirstein, Martin B. Leon, Richard 
A Schatz. Scripps Ginic & Research Foundation, La Jolla, CA 
Prolonged infusion of urokinase (UK) into thromboticaJly occluded 
saphenous vein grafts (SVG) has been shown to produce 
recanalization, though long-term patency is unknown. Deployment 
of a Palmaz-Schatz'N stent (PSS) to SVG stenoses produces excellent 
short-term results with good restenosis expectations. 
In a consecutive series of patients presenting with unstable angina, 
5 occluded SVG (mean age 8.2 :t 3.9 yrs) were recanalized using UK 
followed by deployment of one or more Palmaz-Schatz'N stent(s) at 
the residual stenoses. Medical treatment of all patients after stenting 
conformed to normal stent protocol. Four of 5 SVG were found to 
be patent after UK (mean duration 25.6 :t 12.6 h, mean dose 
119,000 U/h) with residual stenoses between 50% and 95%. The 
remaining graft had decreased thrombus burden and was easily 
opened with conventional balloon angioplasty. A total of 13 PSS 
were deployed with no residual stenosis at any lesion. There was no 
peri-procedural myocardial infarction and one significant vascular 
access site hemorrhage requiring blood transfusion. There was no 
acute nor subacute PSS closure. 
At angiographic follow-up (5.6 :t 2.3 mos). 3 of 5 grafts remained 
widely patent with no more than 11 % diameter stenosis at any PSS. 
The remaining 2 SVG exhibited restenosis with 90% and 87% 
diameter stenosis within a single PSS each. Only patients with 
angiographic restenosis reported angina. 
In conclusion, based upon this small pilot series. thrombotically 
occluded SVG can be safely salvaged using prolonged infusion of UK 
followed by deployment of PSS without stent thrombosis and with 
promising long-term patency. 
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915-72 
Strecker Coronary Stent: Initial Multicenter 
Experience 
Richard R. Heuser, Jeffrey A. Brinker, Bonnie H. 
Weiner for the Strecker Stent Investigators; 
Arizona Heart Institute & Foundation, Phoenix, 
AZ 
The Streckerm stent, a flexible, balloon•
expandable, woven tantalum endoprosthesis, has 
been proposed as an optional treatment for post•
angioplasty restenosis, saphenous vein graft 
stenosis and failed angioplasty. 
Forty-nine patients had 55 stents placed for 
the following indications: restenosis 21 
(43%); bypass graft stenosis - 23 (47%); and 
dissection - 5 (10%). The 3.0 mm stent was used 
in 21 cases and the 3.5 mm device in the 
remaining 34 implantations. 
Acute angiographic success rate was 100%. 
Three patients (6%) had stent thrombosis, 2 
acutely « 24 hrs) and one at 4 days. No stent•
related myocardial infarction occurred in any 
patient except those with thrombosis. The 
overall clinical success rate (angiographic 
success and no death, MI, or CABG) was 84%. 
In those patients discharged free of major 
complications and evaluated at 3 months, the 
clinical restenosis rate was 22%. Two patients 
wi th restenosis underwent surgery; all others 
underwent successful repeat PTCA. No patient 
wi th the 3.5 mm stent has had thrombosis or 
restenosis. 
In this limited and early experience, the 
Strecker stent was easily implantable, and the 
results with the large< model are encouraging. 
915-73 
8alJoon-Expandable Slent Size Versus inflation Pressure: Tbe 
Streeker Experience 
Marlc A. Thompson, Jeffrey A. Brinker, Richard R. Heuser, Bonnie H. Weiner. 
Kathy Hess. Allan M. Ross, Jerome Segal. The George Washington University 
Quantitative Analysis Core Laboratory for the Stteclr.er Stent Inveatigaton 
Balloon-expandable Stalts bave been WiCd cffcclively in the _t eX coronary 
stenoses. The Strecker stent is a 3.0 or 3.5 mm continnous loop, knitted 
tantalum wire. balloon-expandable stent mounted on a minimally compliant 
(PE) balloon whose nominal diameter is 0.5 mm larger than the deployed stalt. 
Stent sizing has frequently been accomplished by mounting a stent on a balloon 
whose nominal inflated diameter is 0.5 mm larger than the deployed ltent in 
order to compensate for lominal enaoacbment by the stent and immediate stalt 
recoil. Recommended balloon inflation for .tent deployment is 8 A 1M. 
Additional inflations at higher pressures are employed at the disttetion of the 
investigator. Stent diameter following each balloon inflation and deflatioo at 
various pressures was measured in two views by quantitative mgiographic 
automated edge delcclion (QCA) in 32 patients unda'going Stteclr.er sterll 
placement. These data were then compared 10 Stteclr.er stents measmed by optical 
comparator following balloon inflation and deflation at various inflation 
pressures in a 37°C water bath. Results with standard error bars are shown 
below. 
s. PATIENT STENT INF!.A TlONS 
... 19 .. 19 
WATERBA11I 
2.·ol-~F-!=:!.:!!.~-1 ----- 2. 9 to 11 12 
AN AN 
Conclusion: Strecker stent size increasea predictably in vitro with increasing 
balloon inflation pressure. When measmed by QCA in patients, however, stent 
size is smaller and appears less dependent on inflation pressure than in vitro. 
This disaepancy may be due 10 compressive vascular fon:eli in vivo or inherent 
variability in the QCA process. 
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915-74 
Thro.bin-.arkers for the 
Manage.ent after Bailout 
Co.parison of TAT and F 1+2 
Anticoagulation 
Stenting 
Dietrich C. Gulba, Gunther Claus, Markus 
Sosada, Martin Friedrich, Martin Bergfeld, 
Bernd Heublein, Paul R. Lichtlen. Hannover 
Medical School, Hannover, Germany 
It has been reportet, that both thrombin•
markers (TM) TAT and F 1+2 successfully 
identify the hazzard of reocclusion after 
coronary interventions (borderline values 
(bl) 6 ug/l and 1.2 ug/l respectively). 
Patients (pts) with bailout stenting (BS) 
are particularly prone to early thrombotic 
occlusion. Over a 10 days observation time, 
TAT and F 1+2 were compared in their 
potential to orient the anticoagulation 
therapy on in a series of 54 consecutive 
pts with BS by twice daily measurement. 
Heparin was adjusted if both TM exceeded 
the bl or if either TM exceeded 150% of 
the bl. TAT values were above bl in 34 
measurements (7%) in 27 pts (50%), F 1+2 
were elevated above bl in 44 measurements 
(9%) in 28 pts (52%). Both TM were elevated 
in 16 measurements (3%) in 12 pts (22%), 
15 times out of which both were above 150% 
bl (94%). In 11 more measurements (2%) 
in 8 pts (15%) either TAT (n=3) or F 1+2 
(n 5) were increased above bl. None of 
the pts experienced acute Stent thrombosis. 
Conclusion: Both TM are equally suitable 
for the gUidance of the anticoagulation 
management after BS. Intervention limits, 
however, should be increased to 150% of 
those previously described. 
915-75 
De Novo Lesions Have a Lower Restenosis Rate Post Stent 
Placement: A Mechanistic Explanation 
S. Chiu Wong. Jeffrey J. Popma. Y. C. Chuang. Walter C. Brogan. 
Kenneth M. Kent. Lowell F. Satler, Augusto D. Pichard. Richard A. 
Schatz, David Fishman. Michael Savage. Martin B. Leon. 
Washington Hospital Center. Washington, DC 
A larger initial post-stent minimal lumen diameter (MLD) and a 
lower late lumen loss may both contribute to reduced restenosis in 
stent patients. To determine the mechanism(s) of lower restenosis in 
patients after placement of a single Palmaz-Schatz stent in native 
coronary arteries, we analyzed 316 consecutive paired angiograms 
(lOS de novo and 20S prior PTCA) from a core angiographic 
laboratory using quantitative techniques and qualitative assessment 
of lesion morphology. Serial angiographic studies revealed: 
Reference Vessel Diam (mm) 
Preprocedure MLD (mm) 
Post Stent MLD (mm) 
Follow-up MLD (mm) 



















Independent predictors for a larger post-procedural minimal 
lumen diameter included complex morphology (R = 0.193. p<O.OOI) 
and de novo lesions (R = 0.142. P < 0.05). Although late lumen loss 
correlated with post stent MLD (R = 0.284. P < 0.001). no lesion•
related factors were predictive of its magnitude. Independent 
negative predictors for restenosis included de novo lesions (odds 
ratio 2.23. 95% CI = 1.12-3.5S) and a larger post stent MLD (odds 
ratio 0.53. 95% CI = 0.30-0.94). 
We conclude that de novo lesions and lesions with a larger post•
stent MLD independently predict a lower restenosis rate. Based on 
these findings. an aggressive approach to maximize final post-stent 
MLD should be emphasized in all stent patients. 
916 Pediatric Electrophysiology 
Wednesday. March 17, 1993 
9:00 AM-I 1:00 AM 
Anaheim Convention Center 
Hall 0 
Presentation Hour: 9:00 AM-IO:00 AM 
916-8 
Management of Supraventricular Tachycardia In Infants 
Steven N. Welndling, Edward P. Walsh, J. Philp Saul. 
ChIldren's HospItal, Boston, MA 
JACC Vol. 21, No.2 
February 1993:294A 
To detennlne the efficacy of medical management of SVT In Infants, we 
retrospectively reviewed the clinical outcome of chldren treated for SVT at 
our institution. The study group consisted of 83 Infants who underwent 
initial esophageal EP testing between 8/87 and 12/91. The SVT 
mechanism Involved an accessory pathway (AP) In 57, AV node reentry 
(AVNR) In 13, and primary atrial tachycardia (AT) In 13. Therapeutic 
success was defined as clinical freedom from SVT. Data are presented In 
the table as # patients successfully treated / # Infants tried on the 
treatment 















Medical therapy was successful In 89% with an AP, 100% with AVNR, and 
92% with AT. No treatment was given to 1 Infant with an AP with no clinical 
recurrence. Initial therapy for WPW with B-blockers was effective in 47%. 
Primary treatment with digoxin was successful In 55% of Infants with a 
concealed pathway. Treatment with digoxin and/or B-blocker was 
successful In 60% with an AP, and 61% overall. Following lalure of multiple 
medical regimens, radiofrequency (RF) ablation was successful In treating 
SVT in 5 Infants with an AP and 1 with an ectopic atrial tachycardia. 
These data suggest that SVT Is either controlled with relatively benign 
pharmacologic therapy, or lals to recur spontaneously, In up to 60% of 
Infants with SVT. More aggressive drug therapy or RF ablation are rarely 
needed for AVNR, but are required In occasional cases Involving an AI' or 
AT. 
916-9 
Comparison of the Benefits and Costs of Therapies for 
Pediatric Patients with the Wolff-Parkinson-White 
Syndrome 
Joyce C. Pressley, Ronald J. Kanter, Eric N. Prystowsky, James 
E. Lowe, J. Marcus Wharton, Duke University Medical Center, 
Durham, NC 
This study examined the outcome of 181 consecutive 
pediatric pts (age 0 to 18 yrs) with electrophysioiogically•
documented Wolff-Parkinson-White CNPW) syndrome. Sixteen 
pts were treated with radiofrequency (RF) catheter ablation, 119 
with surgical (SUR), ablation, 36 with pharmacological (MED) 
therapy alone, and 10 required no therapy. Follow-up status was 
obtained for 87% of pts (mean 7.6±.5.4 yrs). The majority of pts 
(86%) initially receiving no therapy and 7% of pts initially on MED 
were off MEO's and had not had ablation at mean follow-up 
6.4±.5.3 yrs and 8.0±.4.8 yrs, respectively. 
When analyzed in their final treatment categories, the majority 
of pts in all treatment groups experienced significant improve•
ment as assessed by a decreased frequency of arrhythmic 
symptoms (100% for RF, 95% SUR, and 95% MEO), increased 
activity levels (69"A., 74%, and 71%), and fewer hospitalizations 
(92%, 91% and 100%), respectively. When both initial and 
annual recurrent costs for each therapy were projected for a pt 
with a life expectancy of 70 yrs, lifetime SUR cost was 2.5 times 
that of lifetime RF costs and MEO costs ranged between 2 to 7 
times that of RF. 
Conclusion: After crossover, the remaining MED population 
demonstrates effective arrhythmia control. However, RF pro•
vides arrhythmia control similar to SUR and the highly selected 
MEO group at significantly lower projected life-time cost than 
either SUR or MEO. 
JACC Vol. 21, No.2 
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916·10 
Esmolol Withdrawal During Esmolol Tilt Testing is Superior 
Alternative to Isoproterenol for Noninvasive Provocative Testing 
of Syncope in the Young 
Marc Ovadia, David Thoele. Univ of AZ. Tucson; Univ of n... Chicago. 
Evaluation of recurrent syncope in the young is frequently complicated 
by coexisting heart disease or arrhythmias and conduction system dis•
ease. Isoproterenol provocation (lp) may not detect some types of syn•
cope and may not predict fi-blocker (fiB) response. Other disadvantages 
of Jp are arrhythmia and worsened outflow obstruction or ischemia, as 
well as false positives. We hypothesized that (1) esmolol withdrawal· 
EW (acute discontinuation of fiB during tilt, i.e., fiB withdrawal during 
tilt) is physiologically equivalent to Jp 35 provocative test for syncope 
and (2) if esmolol E prevent syncope then fiB may improve symptoms. 
17 pts 7-35 y.o. (m=14) had unexplained recurrent syncope orpresyn•
cope. 5 had structural heart disease (3 operated), 7 had arrhythmias or 
conduction system disease. Each pI. had 3-5 tilt tests (6QO) lasting up to 
49 min each: (1) 1-2 baseline tilts, (2) esmolol tilt (500 Ilg/kg then 
50 Ilg/kglmin), (3) esmolol withdrawal tilt (tilt test after esmolol 
acutely stopped) and (4) isoproterenol tilt if tests 1-3 negative and Jp 
not contraindicated. A positive test recreated symptoms of syncope or 
pre syncope in association with hypotension or bradycardia. 11 had a 
positive test and 6 had negative tests. Of the II positives, 8 were initial•
ly hypotensive and 3 bradycardic. In 9 a baseline test was positive, in 9 
E & EW were positive with 2 where E & EW were positive and base•
line negative. 0/6 isoproterenol tilts were positive (lp added no sensitivi•
ty to E & EW). E & EW predicted benefit from fiB in 5.Treatment 
was fiB (5), Na/FIorinef (5) and DDDR pacemaker (1); the 6 with nega•
tive tests had further workup. E & EW testing accurately predicted re•
sponse to fiB. We conclude (1) E & EW testing predicts fiB response. 
(2) Esmolol withdrawal tilt testing is superior to isoproterenol for pro•
vocative testing of syncope in children and may be safer. 
916·11 
Long Term Course of Children and Young Adults with 
Congenital Complete Heart Block 
Parvin C Dorostkar, Gerald A Serwer, Sarah LeRoy, Macdonald 
Dick, II. Univ. of MI, Ann Arbor, MI. 
To evaluate the long term prognosis in regard to pacemaker need 
and longevity of children and young adults with congenital complete 
heart block (CCHB), we reviewed the records of 58 consecutive pts 
followed at the Univ of MI. There were 21 males and 37 females 
followed from 1 to 23 yrs. 14/58 had structural heart disease (SHD) 
other than an isolated secundum ASD. There were 8 deaths with 6 
having SHD. Deaths in those with SHD occurred from 1 day to 2.0 
yrs., mean .53 yrs. Death was due to congestive heart failure (CHF) 
in all. Those with no SHD died suddenly at 16.9 and 0.1 yrs. Ven•
tricular fibrillation was confirmed in the younger pI. Only the older pt 
had a pacemaker. 31/58 (53%) underwent pacemaker implantation 
(13/14 with SHD, 18/44 without SHD) for CHF (n=18), excessive fa•
tigue with routine activities (n=4), syncope (n=4), ventricular ectopy 
(n=3), or heart rate < 30/min without symptoms (n=2). All pts with 
SHD underwent pacemaker implantation or died by 1 yr except 2 
who underwent implant at 7 and 11 yrs. Actuarial analysis of pts 
without SHD showed the incidence of pacemaker implantation to be 
14±5 (SE)% by 6 mos, 26±7% by 5 yrs, 47±9% by 13.5 yrs and 
74±13% by 20 yrs. Evaluation of intrinsic heart rate in both paced 
and non paced pts showed no change with time. Children with 
CCHB have a high incidence of pacemaker implantation by young 
adulthood. Those with SHD are highly likely to require pacemaker 
implantation by 12 mos of age and exhibit a high mortality (6/14). 
Those without SHD show a lower but still significant incidence of 
pacemaker need and a lower but significant mortality (2144). Close 
long term follow-up of all pts with CCHB is required as the incidence 
of pacemaker need shows a steady progression with the most com•
mon reason being development of congestive heart failure. 
ABSTRACTS 
916·12 
Effect of Adenosine on Accessory Pathway Conduction in Children 
Parvin C. Dorostkar, Macdonald Dick, II, Gerald A. Serwer. C.S. Mott 
Children's Hosp~al, Univers~y of Michigan Medical Center, Ann Arbor. 
Michigan 
Several authors have demonstrated partial antegrade penetration of the 
accessory connection (AC) in patients (pts.) with concealed accessory 
pathways. We postulated that ff partial penetration of the AC does occur, 
atrioventricular (A V) nodal block would lead to an increase in conduction 
across the AC, ff present, and thus unmask concealed WoHf·Parkinson•
Wh~e syndrome. To test this hypothesis, we administered adenosine to 6 
pts. w~h supraventricular tachycardia prior to radiofrequency (RF) 
ablation. All pts. were male, w~h a mean age of 10.8 years. One pI. had 
manifest preexc~ation (P). The ACs were left lateral in location in 4 pts., 
right posteroseptal in 1, right freewall in 1; and 1 pI. demonstrated 2 ACs 
(1 in the right posteroseptal region, 1 in the right freewall). Adenosine was 
given as a bolus at a mean dose of 218 meg/kg (range 160-310 mcg/kg). 
The one pI. w~h P demonstrated minimal increase in QRS duration (150· 
160 msec) during adenosine infusion, primarily due to maximal preexci•
tation during atrial pacing prior to RF ablation. During atrial pacing (mean 
cycle length 617 msec, range 500-800 msec) , adenosine produced 
complete AV block in 4 of 5 pts without P. and first degree block in the 
remaining pt., w~hout appearance of P. AV block was observed w~hin a 
mean 10.4 sec (range 3-14 sec), lasting a mean of 4.4 sec (range 3-6 
sec). Adenosine infusion during ventricular pacing at a mean cycle length 
of 553 msec (range 440-800 msec) produced complete retrograde block 
in 3 of 6 pts. Ventriculoatrial (VA) conduction time did not change (pre•
mean VA time 144 msec, post 138 msec) in the remaining 3 patients. 
Following RF ablation, the response of VA conduction to adenosine was 
studied in 3 pts.; complete retrograde block occurred in all 3 pts. We 
conclude that adenosine does not unmask antegrade conduction across a 
concealed AC in children. Manifest pathways may exhib~ increased P 
following adenosine. Following RF ablation, adenosine may be useful in 




Results of ~c study in 180 adldrm With Syncope 
Seshadri Balaji, Paul C. Oslizlok, Mary C. Allen, 
Cllri.stqlher L. case, Paul C. Gillette. Sruth carolina 
Children's Heart Center, Olarlest.cn, Sruth carolina 
Bet10Ieen NaIl 1986 and AIl;J 1992, 180 dlildren with I'lODIIal 
hearts (63 male, 117 female: age 4-20 years, median 13) 
undeIwent autcn:mic stI.Xiy (ANS) for unexplained syn:::q:lE! 
(SE). '!he ANS protocol :i1x:lu::Jed tilt testin;J, carotid 
s:inJs DBSSage, divi.rr;J reflex, Valsalva, and graded dose 
respc:I'lSe to injectiat of Isq>rotereool and 1bany1e¢rine. 
In tilt + patients, the type of respc:I'lSe was classified 
into vasodepreSsor (hypotensiat ani tadlycardia) in 41 
(34.5%): cardioinhibitory (asystole> 5 sees) in 7 (5.5%) 
ani miJan (hypotensiat ani bradyamtia) in 72 (60%). 
Carotid hypersensitivity was fcum in 4. 
TreatJoent with flWrooortisale ani salt (F&s) was started 
in 116/120 tilt + patients. At follow up (1-65 lIP, mean 
25), 82 (72%) had no further syn:::q:lE!' 15 (13.5%) were 
inpraved (~ 2 SE'.jm) ani 19 (16.5%) were 1.I!lCilan}ed. Of 
the last, 17 were treated with P blockade, with 
resolutiat of SE in 14. Five (0.04%) patients had excess 
weight gain/headadle at F&S ani elected to stet> medical 
therapy. Pacemakers were inplanted in 4/1 CIS patients. 
the other 3 qlted for F&s. cne patient had recurrent pre 
SE despite paci.rr;J and needed a&iitiatal. F&s. 
On::lusiCl'l: Tilt ani carotid DBSSage were the CI'lly 
clinically useful IIIlIIlOalVeI'S duri.rr;J ANS. F&S prc:wided 
effective cx:nt:rol of SE in the majority, and P blockade 
was adequate in the rest. ANS helps to guide the 
managanent of dlildren with recurrent SE. 
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916·14 
INTRAVENOUS AKIODARORB FOR LIPE-THREATENING 
TACKYARRJIYTB](IAB III YOUIIG PATIBIITS 
James C. Perry, Timothy K. Knilans, Dianne 
Marlow, Susan Denfield, Arnold L. Fenrich, 
Richard A. Friedman. Houston, TX and 
Cincinnati, OH 
Oral amiodarone (AMIO) therapy has been useful 
for problematic arrhythmias in children. AMIO 
pharmacokinetics with the oral route often 
preclude its use in acute settings. Intra•
venous (IV) AMIO was given to 10 patients 
(pts) , mean age 6.8 years, for ventricular 
tachycardia (VT) in 7 pts, atrial tachycardia 
(AT) in 1, junctional tachycardia (JET) in 1 
and AT, JET, VT in 1. Surgery for congenital 
heart defects was performed previously in 6 
pts. 2 pts had hamartomas causing VT. All pts 
had failed standard IV therapies and 
cardioversion. 6/10 pts had complete 
resolution of arrhythmia with IV AMIO: 4/7 VT, 
1/1 AT and 1/1 post-op JET. IV AMIO was not 
successful in 2 pts with VT due to hamartomas, 
but slowed VT in 1 allowing successful 
surgical cure. AMIO loading was given as 1 
mg/kg aliquots. Average IV load at the time of 
effect was 4.8 mg/kg. 4 pts had mild 
hypotension during loading, corrected with 
volume. IV AMIO at 10 mg/kg/day infusion was 
continued an average of 3 days. 4/10 pts died, 
all of non-arrhythmic causes and not 
attributable to IV AMIO. Summary: IV AMIO was 
well-tolerated in all pts. Post-op VT, JET and 
AT were very responsive. Use of IV AMIO in 
acute, post-op tachycardias can be lifesaving 
in many pts when standard IV therapies fail. 
916·15 
Atypical Forma Of Supraventricular Tachycardia due to 
Atrioventricular Nodal Reentry In Children Following 
Radlofrequency Modification of Slow Pathway Conduction 
Michael J Silka, Jack !<ron, Jeanny K Park, Blair 0 Halperin, 
John H McAnulty. Oregon Health Sciences University, Portland 
There is timited data regarding the electrophysiology of 
atrioventricular nodal reentrant tachycardia (AVNRT) during 
childhood and adolescence. However, with the development 
of radiofrequency (RF) catheter ablation, new insights have 
been reported regarding the anatomic and functional bases of 
AVNRT. This study reports "atypical" forms of inducible AVNRT 
observed in 7 of 9 young pts fOllowing RF ablation in the area of 
slow pathway conduction (between the coronary sinus os and 
posteromedial tricuspid annulus). Pts were ages 6-17 years 
(mean 12.7.± 3), referred tor RF ablation as an alternative to 
chronic antiarrhythmic treatment. 
Conventional slow·fast AVNRT was inducible in each pt 
(retrograde fast pathway conduction) prior to the initial 
application of RF current. The mean ~cIe length of AVNRT 
was 33O.± 60 msec. Following the initial applications of RF 
current to the area of slow pathway conduction, 5 pts 
demonstrated fast·slow AVNRT (mean cycle length 44D.± 52 
msec) which had not been identified prior to RF ablation. 4 
patients also demonstrated AV dissociation during AVNRT, with 
2:1 AV conduction, which was converted to 1:1 AV conduction 
following programmed ventricular stimulation. 
No pt had inducible AVNRTfoliowing additional RF 
current applications to the area of slow pathway conduction. 
There were no significant changes in antegrade fast pathway 
conduction; however, 3 pts had complete absence of 
retrograde VA conduction following ablation of the slow 
pathway. 
These findings suggest additional complexity regarding 
the mechanism and substrete of AVNRT in young pts. RF 
ablation may selectively modify the capability of slow pathway 
fibers to conduct antegracle and retrograde. 
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917·62 
Improving Accuracy of Continuity Equation In Estimation of 
Stenosis Severity In Coronary Arteries Using Doppler Catheters 
Scott J. Denardo, Lawrence Talbot, Victor K. Hargrave, Paul G. Yock. 
University of Califomia, San Francisco, CA 
Estimation of the severity of coronary artery stenoses by Doppler catheters 
(Des) using the continuity equation requires measuring mean velocities. 
according to fluid physics. However, several factors (e.g., inhomogeneous 
distribution of beam power) make determination of mean velocity using Des 
inaccurate. The peak velocity can be accurately measured but the relationship 
between the peak velocity and mean velocity varies based on location within a 
stenosis. This varying relationship may account for the systematic errors that 
have been demonstrated in animal models and human studies. We 
hypothesized that the continuity equation will not accurately estimate stenosis 
severity using the peak velocity measured in the entry region of a stenosis but 
becomes more accurate for measurements made within the stenosis where 
the flow becomes more fully developed and a stable relationship between 
peak velocity and mean velocity occurs. 
To test our hypothesis, we constructed a scaled-up model of coronary flow 
using an optically clear cylindrical test section in which we placed axisymmetric 
stenoses ranging from 20% to 90% (eSA). The fluid flow rate was adjusted to 
achieve Reynolds numbers of 200 • 400, spanning the physiologic range for 
coronary flow. A custom-designed DC with an end-mounted transducer and 
guidewire was placed centrally within the test section. DC peak velocity data 
was collected upstream and at intervals within each stenosis at each Reynolds 
number. The ratio of peak velocity measured upstream to each stenosis to 
that measured within the stenosis was then calculated (vp,ufvp,s), corrected to 
provide a stenosis fraction, and compared to the known stenosis severity (5). 
~: The linear regression comparing the ratio of peak velocities, using 
the peak velocity measured in the proximal entry region of each stenosis. to 
the known stenosis severity differed significantiy from the line of unity: 
5 - 0.92[1 - (vp.uivp.s)] + 0.14 (r - 0.99; p < 0.001). 
Using the peak velocity measured three test section radii within the stenoses 
resulted in a regreSSion line that did not differ from the line of unity: 
5 - 0.99[1 - (vp.uivp,s)] + 0.05 (r - 0.99; p > 0.05). 
Conclysions: The continuity equation using the ratio of peak velocities 
measured by DCs is more accurate in the estimate of stenosis severity if 
measurements of peak velocity are made within the stenosis where the flow is 
more fully developed. These results may help explain the systematic errors 
that have been encountered previously in animal models and human studies. 
917·63 
The innuence of the driving pressure on the turbulent 
jet area is a direct consequence of nuid mechanics. 
Eric Brochet, Bertrand Connier, Benoit Diebold, Annie Delouche, 
Jean-Paul Rinaldi, Philippe Delouche, Pierre Peronneau, INSERM 
U 256, Hopital Broussais, Paris, France. 
The relationship between color Doppler jet area and driving pressure 
has been reported in several studies but, so far, the respective role 
of ultrasound Doppler technics and of fluid mechanics has not been 
precisely studied. For that purpose, a series of experiments has 
been conducted on an in vitro pulsatile model (orifice diameter (0) = 
4.4 to 11.3 mm, peak velocity = 3 to 5 m/s) using high fidelity laser 
Doppler velocimetry. Velocities (V) were collected together with 
their coordinates (x,y). Longitudinal and transverse velocity profiles 
were analysed at peak ejection. The results demonstrated that (i) the 
lenght (L) of the central laminar core is proponional to D and inde· 
pendant of V (L = 3.8 D, r = .98), (ii) the centerline turbulent velo•
city decay is hyperbolic (V(x,y) = V(O,O). 3.8 . D, r = .97) and (iii) 
the transverse velocity profiles in the turbulent area are gaussi~ and 
follow a nonnal distribution: log [V(x,O)N(x,y)] = 25 (y/x) ,r = 
.94, as expected according to momentum equation. The combina•
tion of these fonnula allow to calculate all the velocities in the 
turbulent area [V(x,y) = V(O,O). 3.8. D/x 101\.25(y/x)2] and to 
calculate the Turbulent lsovelocity Surface Area (TISA) det~n~ 
as ~ is given by regular color Doppler: TISA = K . V(O,O) . D . 
Va ,where Va is the V corresponding to aliasing and K a constant. 
TISA is proponional (a) to the dimensions of the orifice times the 
pressure gradient or (b) to the volumic flow times the square root of 
the pressure gradient. 
In conclusion, the influence of the driving pressure on color 
Doppler jet area is a direct consequence of fluid dynamics in the 
turbulent area. Corrections according to the initial velocity or flow 
measurements in the central laminar core could overcome this 
limitation. 
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917-98 
Automatic Tracking of Etbocardiograpbic Regions of Interest 
Improves Contrast Enbancement Data Distorted by 
Translocation Artifacts. 
Victor Mor-Avi, So1ange Akselrod, Daniel David 
Tel Aviv University, Tel Aviv and Meir General Hospital, Kfar Saba, Israel 
Myocardial regions of interest tend to change their location due to 
respiratory translocation of the heart An automatic tracking algorithm was 
developed to enable the frame-by-frame tracking of regions of interest, so as 
to allow reliable acquisition of contrast enhancement data free of 
translocation related noise. The algorithm is based upon pattern recognition 
of distinct details (templates) repeatedly and reproducibly appearing 
throughout the entire series of images. The validity and accuracy of the 
developed algorithm were tested using computer simulation and 
experimental data in three stages. (I) Six regions of interest within the 
coordinate system of the frame were selected. A single short axis image was 
randomly shifted in both x and y directions. The videointensity in each 
region was determined with and without the application of the tracking 
algorithm. Image shifting caused marked fluctuations in videomtensity 
measured without tracking in all regions of intereSt, completely abolished by 
the tracking algorithm. (2) This protocol was repeated under increasing 
levels of random noise (SNR 10 down to 2) dispersed throughout the entire 
image. The tracking algorithm reduced the combined effect of translocation 
and nOise to levels below the simulated noise. (3) Following the validation of 
the algorithm using simulated noise and translocation, its accuracy was 
tested in 8 series of images obtained during experimental contrast injection 
(AJbunex). The steady state, pre- and post-injection portions of the contrast 
enhancement curves were examined. The tracking algorithm significantly 
reduced the translocation related variations in videointensity (p<0.025). 
Thus, automatic tracking of echocardiographic regions of interest improves 
contrast enhancement data distorted by translocation artifacts. The 
application of this algorithm. can markedly enhance the reliability of 
myocardial blood flow assessment based upon contrast echocardiography. 
917-99 
Peak Emptying and Peak Filling Rates Derived From 
Automatic Border Detection Ecbocardiograpby: 
Comparison Witb Cineventriculograpby 
Peter M. Sapin. Gungyuan Xie, Mikel O.Smith, Oi Ling Kwan. 
Annette C. Cater, Steven K. Souther, Steven K. Reed. S. Tariq 
Shahab, Anthony N. DeMaria, University of Kentucky. Lexington. 
KY 
A recently developed echocardiographic automatic border detection 
system (ABO) displays throughout the cardiac cycle the instantaneous 
rate of change of left ventricular (LV) cross-sectional area. However. 
peak emptying rate (EMPT) and early diastolic peak filling rate (FILL) 
by this technique have not been compared to rates derived by other 
methods. Therefore we performed ABO echo (short axis [SAX] and 
apical 4 chamber [A4C) views) within 45 minutes of 
cineventriculography (CINE) in 33 patients undergoing cardiac 
catheterization. Frame-by-frame LV volumes were computed from 
RAO ventriculograms (30 frames/sec) using a summation-of-discs 
method. The CINE EMPT and FILL rates were measured from 
smoothed CINE volume-time plots and were compared to rates 
measured from the ABO graphics display (average of 3-5 beats). 
Rates were expressed as both an absolute value, (cc/sec or cm2/sec) 
and in relation to left ventricular size (end-diastolic volumes or areas 
per second). 
Correlations (r values) between ABO echo and CINE 
EMPT FilL EMPT FILL 
~ (CC1sec ys c~ 1E0YIsec ys EOMec) 
SAX .68** .69** .49** .50** 
A4C .27 .33* .46** .37* 
**= p<O.OJ *=p<O.05 
CONcLUSIONS: Instantaneous filling and emptying rates frOm ABO 
echo correlate with rates from CINE. The SAX view appears to yield 
better results than the A4C view. The relationship is not improved 
when rates are normalized to end diastolic volume and area, probably 
because of an imperfect correlation between ABO and CINE 
measurements of LV size. 
ABSTRACTS 
917-100 
The TImings of Left Ventricular Diastolic Filling In Patients 
with Hypertrophic Cardiomyopathy Having a Normal 
Transmital Flow Velocity: a Study by Real-time Acoustic 
Quantification. 
Masahiro Shakudo, Junichi Yoshikawa, Kiyoshi Yoshida, T alcashi Akasaka, 
T oshikazu Yagi. Kobe General HospicII. Kobe, japan. 
Recently acoustic quantification (AQ) using automatic border detection has 
been incorporated into a standard echoc.ardiographic equipment. which 
produces a real-time numerical display of the values of left ventricular (l V) 
volumes. A time-volume curve generated by AQ is comparable to that from 
cineangiography. To evaluate the usefulness of AQ in the clinical setting. we 
perfonned echocardiography with AQ on 10 nonnaI volunteerS as control 
and 13 consecutive patients with HCM having a normal transmitral velocity; 
AlE < 1.0 and deceleration time of E-wave < 250 msec. Real-time l V volumes 
by AQ were obtained with the Simpson's rule (discs method) in the apical 2 
chamber view as a time serial numerical data set. The serial raw data were 
smoothed using a Fourier filter technique. Then. a time-volume curve, it's I 51 
derivative and 2nd derivative curves were plotted from the smoothed data. 
The timing of end systole (ES). peek filling rate (PFR) and end of rapid filling 
were measured. and the time to PFR (T -PRF) and the duration of rapid filling 
(D-RF) were cakulated as the times from ES. lhe timing of PFR was recog•
nized as a relative maximum point of the first deriv.ltive curve in early dias•
tole. The timing of end of rapid filling was detenTlined as a relative minimum 
point of the 2nd derivative curve next to the timing of PFR. The T -PRF and 
the D-RF in HCM are 98±30 msec and 1 .. 9±37 msec respectively and those 
of control are 1-4O±30 msec and 238±7 msec respectively. In both T-PFR and 
D-RF. the value in HCM were significantly shorter than those in control 
(p<O.OS and p<O.OOOI respectively). 
Conclusions: In patients with HCM, diastolic properties of l V are abnonnal 
even if nonnal transmitral flow velocities are seen. Real-time acoustic quanti•
fication is useful to assess the global pattern of the left ventricular filling. 
917-101 
Acoustic Quantification Clarifies Doppler LV Fllllni Patterns 
In Patients with Len Ventricular Hypertrophy 
Adrian Chenzbraun. Fausto J Pinto. Shawn Popylisen, Ingela ScImittger. 
Richard L Popp. Stanford University. Div CardiovascuIar Medicine. 
Stanford. CA 
Acoustic quantification (AQ) technology provides on-line tracking of the 
endocardial borders. The value of the resulting LV area change waveform 
for diastolic function assessment has been recently reported. Abnormal 
relaxation is considered present in patients with significant L VB. LV filling 
patterns were studied by AQ and DoppJerin 16 pIS.with LVB: bypenropltic 
cardiomyopathy-So aortic SIeIIOSis-4 and aneriaJ hypel1eDsioo-4: Five of 16 
pts bad an E/A mitral flow velocity ratio <1. Amon& the other II patients, 
Doppler patterns were apparently normal in 8 and nondiagnostic in 3. 
Sixteen healthy subjects with normal 20 and Doppler studies constituted the 
control population. A significant difference between the between pts and 
controls was found for 3 diastolic indices obtained from the AQ waveform: 
% of total area change at the end of rapid filling (RFC). mean slope of rapid 
filling segment (RFS) and peak rate of area change (PRAC) during rapid 
filling. When the II patients with normal or lIOII-diagnosliC Doppler patterns 
were compared with the control population. the AQ diastolic indices 
remained significantly different from controls and similar to those with 
E/A>I: 
Conclusion: Abnormal LV filling patterns are demonstrated by AQ in 
patients with L VB. These abnormalities are seen even when a DOrmal or 
DOndiagnostic Doppler pattern is present This suggests this technique is 
useful in identifying impaired relaxation in the presence of a 




End-Systolic Pressure - Area Relation: A Noninvallvely 
Accessible Index of Regional Myocardial Contractility 
Roberto Lang, James Bednarz, Lynn Weinert, Beth Balasia, 
Claudia Korcarz, Richard Marcus. Univ of Chicago. Chicago, IL. 
The end-systolic pressure - volume (ESP-V) relation has been 
used as a load-independent index of global myocardial 
contractility. Clinical application of this index has been hampered 
by tha need for invasive techniques to access left ventricular (LV) 
pressure-volume data. The recently developed backscatter 
system for automated endocardial border detection (ABO) 
provides on-line measurements of LV cavity areas in selected 
planes. In this study ABO was applied to short axis 20-echo 
tomographic slices of the LV at the mid-papillary level to provide 
on-line measurements of LV cavity area. 
Simultaneous recordings of calibrated 
subclavian pulse tracings (SPT) were 
used to obtain end-systolic central 
arterial pressures. In 7 normal sub•
jects end-systolic pressure and area 
1:\ j /•
~-~ -, . . .. . 
LV Area (cm2) 
(A) data were acquired over a wide range of loads generated by 
methoxamine infusion at baseline (BSL) and during inotropic 
stimulation with dobutamine. ESP-A relations, determined by 
regression analysis, were linear at baseline (r = .96 ± .05) and 
during dobutamine (r = .93 ± .06). The response of the ESP-A 
relation to dobutamine parallelled the well-documented effects of 
inotropic stimulation on the ESP-V relation i.e., leftward shift 
and increased slope (21 ± 12 vs 33 ± 13 mmHg/cm2, p< .01). 
Conclusions: Simultaneous ABO and SPT can be used to 
determine the ESP-A relation noninvasively. This two-dimensional 
(regional) analog of the ESP-V relation, may be a useful load 
independent index for on-line serial assessment of regional 
myocardial contractility in the clinical environment. 
917-103 
Assessment of Age-Dependent Change. of Aortic DistensibUity With • 
New Acoustic Quantification System 
Thomas C. Gerber, David A. Foley, James F. Greenleaf, A. Jamil Tajik, 
James B/Seward. Mayo Clinic and Mayo Foundation; Rochester, MN 
Age-dependent changes of aortic diameter and compliance have been 
demonstrated with angiographic, echocardiographic, and computer tomo•
graphic techniques. The aim of the study was to investigate the feasibility 
of assessing morphologic and functional changes of the thoracic IIOrta 
using a recently released acoustic quantification (AO) package during 
transesophageal echocardiography (TEE). Methods: 22 patients (16 men, 
6 women; age 59.9 ± 12.8 yrs) were examined. TEE images of the aorta 
were analyzed using the AO package which provides real-time mea•
surement of aortic cross-sectional area. Peak and nadir of the area curve 
were chosen as systolic (sA) and diastolic (dA) areas. Systolic (sBP) and 
diastolic (dBP) blood pressure were measured from the arm immediately 
before and after data aquisition. toP was calculated as sBP - dBP. Aortic 
distensibility (AoDis) was calculated as ([sA - dAlldA) I toP. An estimate 
for lortic compliance (AoComp) was calculated as (sA - dA) I toP. 
Results: 
dA" vs. Aile AoDis' vs. Aile AoComp. vs. Aile 
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Conclusions: AO measurements were useful for determining aortic cross•
sectional area, aortic distensibility and aortic compliance. Age-related 
differences in these parameters were identified. AO may be a convenient 
tool for assessment of clinically useful variables in vessel morphology and 
function. 
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917-104 
Effect of Adjacent Boundary Layer Formation on the Proximal Row 
Convergence Region: Comparison of Color Doppler Row Mapping With 
Theoretical and Gold Standard Velocity Measurement Techniques 
Dorian Liepmann, Robin Shandas, Douglas Dommermuth, David J. 
Sahn. Science Applications Int'l and Oregon Health Sciences Univ, 
Portland, OR 
To enhance our understanding of the dynamics of flow convergence 
(FC), we simulated physiologiC flows theoretically, by solving the 
Navier-Stokes equations using a new time-dependent 3-0 algorithm, 
and compared results to in-vitro velocity measurements of pulsatile FC 
flows using digital image particle velocimetry (DPIV) and to color 
Doppler studies (CDFM) from a Vingmed 750 system which provides 
direct digital velocity assignments. Since FC regions encountered 
clinically may develop adjacent to walls or ,'alves we used models with 
and without adjacent surfaces to explore the influence of boundary 
layer formation on the FC region. For all flows without adjacent surfac•
es, symmetrical isovelocity contours were obtained on theoretical and 
DPIV Data 
~ 
in-vitro measurements, leading to good agree•
ment between actual and calculated flow rates 
for isovelocities > 1 orifice diameter proximal 
to the orifice when flows were calculated using 
a hemispheric FC formula. In the presence of 
adjacent surfaces, the simple FC method could 
no longer accurately calculate flow rate be•
cause secondary backward flows associated 
with boundary layers violate the mass conser•
vation principle underlying the FC method. Our 
studies explain the significant CDFM overesti•
mation of actual flow rate in many flow geome•
tries. Also, compared to the DPIV and theoreti•
cal results, the CDFM studies showed poor low 
velocity sensitivity precluding the easy recogni•
tion of boundary layer effects which must be 
taken into account before the FC method can 
be more generally applied clinically. 
Dig~al Uttrasound 
917-105 
Estimation of Regurgitant Row Rate Using Center-Line Velocity Profiles 
From Digital Color Doppler: Application to Orifices of Different Sizes and 
Shapes 
Takahiro Shiota, Dag Teien, You-Bin Dang, Robin Shandas, David J. Sahn. 
Oregon Health Sciences Univ, Portland, OR 
Recently it has been suggested that flow rate through an orifice can be 
estimated by methods which assess the axial • center-line' flow velocity 
profile in the proximal flow convergence zone. To test whether color M-O 
Doppler acceleration data could be used to develop a nomogram for the 
estimation of flow rate regardless of orifice size or shape, we applied this 
method using digital data derived from color Doppler M-mode images 
transferred from a Vingmed 750 scanner into a Macintosh computer. In 
a constant flow model, we studied 4 circular orifices with diameters 2.0, 
3.8, 5.5 and 10 mm, two rectangular orifices with orifice area of 0.24 
cm2 with major to minor axis ratios of 4: 1 and 8: 1 and an oval orifice with 
orifice area of 0.24 cm2 and major to minor axis ratio of 2: 1 at flow rates 
1.7 to 6.5 IImin. Digitally determined flow velocities at discrete positions 
along the center-line of the acceleration field (increment: 0.4 mm) were 
plotted against distance from the orifice. A clear separation of flow 
acceleration profiles for three different flow rate ranges was observed 
independent of orifice size for the 
circular orifices. Asymmetry of the 
orifice shape resulted in a slight 
leftward shift of the flow velocity I u 
acceleration profile. However, when 
the profiles for different ranges of i 
flow rates were analyzed, clear i 
separation was found irrespective of 
orifice size and shape. Since various 
il 
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.. +++t: • ••••••• n. " ., sizes and shapes of regurgitant 
orifices are encountered clinically, 
the simplicity of this method for the 
estimation of the severity of re•
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gurgitation may be important and it should be more generally applicable 
than methods which use a single alias. 
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918·92 
Patterns of Lett Ventricular Hypertrophy in 
Familial Hypertrophic Cardiomyopathy in 18 
French Families 
Olivier Dubourg. Alain Hagege. Richard Isnard. Michel 
Desnos. Andre Sacrez. Jean B Bouhour. Marc Ferriere. 
Alain Millaire. Laurence Faure. Ketty Schwartz. Michel 
Komajda. Hopital A Pare. Boulogne-Billancourt. France. 
An echocardiographic study was performed, as a part of 
genetic study. in 250 subjects (40.1±18.3 y.o.) of 18 
families in which at least 3 members were affected by 
hypertrophic cardiomyopathy (HCM). Diagnostic criteria 
were 1) left ventricular diastolic wall thickness (L VOW) ~ 
13 mm 2) septal-to-posterior wall thickness ratio (IVSIPW) 















According to Maron's classification : 6% of affected were 
type I. 30% type II. 58% type III. 6% type IV. In affected 
individuals. mitral systolic anterior motion (SAM) was 
complete (mitral leaflet - septum contact) in 5%. 
incomplete in 47%. and absent in 48%. 
Conclusion Asymetrical HCM involving both septum 
and LV anterior free wall was the most common form in the 
present study. However. obstruction was uncommon. 
Apical or concentric forms were very rare. 
918-93 
A Combined EcboDoppler and Hemodynamic Assessment of 
Ventricular Filling in Patients Witb Left Ventricular Hypertropby 
Due to Aortic Stenosis 
Craig S. Keighley, Stephen P.F. Gordon, Beverly H. Lorell, Steven P. Friedrich. 
Pamela S. Douglas, Beth Israel Hospital. BoSlOn, MA. 
Left ventricular (LV) filling parameters are complexly reIaIed to left atrial (LA) and 
LV pressures, with higher LA pressure thought to increase rapid venlricular filling 
(E) due to a higher early LA-LV driving pressure gradient, and higher LV end 
diastolic pressure (L VEDP) thought to decrease late filling (A) due to a reduction in 
the LA·L V gradient during atrial systole.To study this relationship. simultaneous 
pulmonary capillary wedge pressure (pcWP). L VEDP. and LV inflow Doppler 
were performed in 6 patients with LV hypertrophy due to aortic stenosis (5 maIe:1 
female. 74±.6 years. valve area 0.7±.0.2 cm2). Measurements were repeated 
following modest reduction in preload using intnlCoronary infusion of enalaprila1. 
Taking all data points together. higher PCWP (and thus LA pressure) was closely 
related to higher E velocity and more rapid dece1era1ion, highe.- E/A ratio. and lower 
atrial filling fraction (all r ~ 0.68). Higher L VEDP was closely related to higher E 
and E/A ratio. and lowe.- atrial filling fraction (all r ~ 0.69). 
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Conclusions Within this group of patients with LV hypertrophy. higher PCWP 
(LA pressure) was associated with higher E. probably due to higher early LA·LV 
gradient, consistent wilh the pseudonormalization of LV ftIling pattern that has 
been reported in this situation. Higher L VEDP was also associated wilh a higher 
E, but by a different mechanism: through narrowing of the late diastolic LA·L V 
gradient and a shift in filling to early diastole. Thus. hemodynamic events in both 
early and late diastole may affect LV rapid ftIling velocity. 
ABSTRACfS 
918-94 
As~tric Septal Bypertrophy(ASB): Induction by 
Angiotensin II(AlI) but not by Phenylephrine 
Ravin Davidoff, Ann L Dempsey, Soeun Ngoy, Frederick J 
Schoen, Carl S Apstein. Boston University and Harvard 
Hedical School, Boston, HA 
Ve have previously shown that exogenously infused All 
rapidly induces LVB with ASH in the rabbit. To assess 
whether this response is specific to All rather than a 
non specific response in the rabbit to pressor-induced 
increase in BP, we randomized 30 rabbits to 1 week of 
continuous IV All, IV phenylephrine(PE) or control(C). 
Echocardiograms were performed with a 7.5 KHz 
transdur.er. BP ~ peak systolic BP, IVS ~ inter•
ventricular septum, PV ~ posterior wall, LV is autopsy 
LV mass. A subgroup of treated animals were matched 







C All PE 
9 10 11 
123+4.0 * 152+5.1 148+7.6 
0.16;.01 t 0.31;.04 0.22;.04 
1.0~.04 + 1.67~.19 1.15~.10 
3.54;.17 $ 4.33~.21 x 3.86~.26 
LV(gm) - 4.33~.21 x 4.31;.28(n=7) 
IVS:PV 1.67;.19 T 1.18;.12(n=7) 
* C vs AII,PE p=.Ol t C-vs AIl p •• 002~ vs PEeNS 
+ C vs All p-.003,vs PE.NS $ C vs All p •• OO6, vs PEeNS 
x All vs PE P = NS TAIl vs PE p_.045 
Conclusion: In the entire treated group, All and PE 
caused similar increases in BP; after 1 week of IV 
infusion, All but not PE resulted in a significant 
increase in LV mass. However in the entire treated 
group, or when matched for equal LVB(>3.3gm), only All 
caused ASH. This supports the hypothesis that the 
renin angiotensin system may be important in certain 
forms of hypertrophic cardiomyopathy. 
918-95 
Echocardiographic Assessment of Left Ventricular 
Structure and Function in Subjects with Borderl ine 
Isolated Systolic Hypertension: 
The Framingham Heart Study 
Alex Sagie, Emelia J. Benjamin, Maurizio Galderisi, 
Deborah L. Fuller, Jane C. Evans, Martin G. Larson, 
Brigi tta Lehman, Dani e 1 Levy. Frami ngham Heart Study, 
Framingham, MA 
The purpose of the present study was to examine the 
association of borderline isolated systolic hypertension 
(ISH)(defined as systol ic blood pressure (BP) between 
140-159 mmHg and diastolic BP < 90 mmHg) with LV 
structure and function. Ninety one healthy members of the 
Framingham Heart Study (mean age 76) with borderline ISH, 
were examined by Doppler echocardiography and compared 
with 130 normotensive subjects (BP<140/90mmHg). 
Borderl ine ISH was the most common form of untreated 
hypertension in this elderly population. The groups 
differed in mean systolic BP (147 ± 6 vs 125 ± 9) and 
mean diastolic BP (76 ± 7 vs 70 ± 7 mmHg). Sum of LV wall 
thickness was higher in the hypertensive group than in 
the normotensive subjects (20.3 ± 2 vs 19.4 ± 2 mm; 
P=0.003). No differences were detected in LV internal 
dimensions or systolic function. Peak velocity E wave and 
ratio of peak E to A wave were low~r in the borderline 
ISH group (40 vs 44 cm/sec P= 0.03 and 0.69 vs 0.76 P= 
0.01). There was no significant correlation between LV 
mass index and the majority of the Doppler indices. 
Conclusions: Elderly subjects with borderline ISH have 
normal LV systolic function, mildly increased LV mass and 
impaired diastolic function compared with normotensive 
subjects. The observed changes in LV diastolic function 
appear to be unrelated to LV mass and may result from the 




SbouJd ~by Be Perfonned in Individual Patients to AIsess 
L VB Jlearession? - Test·Retest Reliability of EcbcJcardioIrapby For 
~tofLVMus 
John S. Goudieoer, Sue V. Livlllllood, Patricia S. Meyer, GeoraeloWn 
Univenity Medical Ceater, WaaIUnJton, DC 
To determiDe 1eoI-_ liability of 2-D taraeted M·mode echo for LV Mass 
(1. VM) -.elllOllt in a multicenter trial and its relation to study quality, echoes 
done off antihypert<mive drua. in 74 patieDts with studies adequate for 
_t of LV mass (77'JO of 96 pts adequate) were repeated 6±8 day. 
apart by the same technician and u1truonocraph at II centers after training to 
IltaDdardiz.e echo technique. Echoes were measured by ODe eXper1eDced 
ecbocardia,raphy core Jab reeder and coded 1-4 usin& specific criteria for 
technical adequacy for L VM measurement; pde I - interpretable to pde 4 
- excelleDt. lDtnoboerver (r-.93, p< .(01) and inleroboerver (r-.91, p<.OOI) 
variability was established. Average L VM did DOl differ betweeD studies 
(323± 82 VI. 320 ± 77, pNS); ~ measurements were highly correlated 
(r=.83, p < .(01). Of the echo componentsuaed in LVM calculations, test-retest 
correlation was higher for aeptal thiclcness (r=.89, p<.OOI) than LV diastolic 
dimeasion (r=.85, p<.OOI), or poaterior WIll thickness (r=.80, p< .001). The 
95" confidence limits for LVM and LVM index (I) were 75 g and 36 glm-, 
respectively, equivalent to or exceeding predicted maximum L VM and L VMI 
recressioa of 78 I and 21 11m- determined from published meta-analyses of 
_t studies. There were DO intercenter differences (ANOV A, pNS) in " 
LVMI error or in coded echo quality (av 2.S± 1.5). However, echo grades 1-2 
had greater " LVMI error (18±l1") than andes 3-4 (12±9", p=.04). 
lDtertest error for components of L VM measurement was greatest with posterior 
wall (H7'JO) ODd least with LV diastolic dimension (4±3"). 
Conclusions: I) EVeD under optimal circumstaDces, interstudy variability in L VM 
-.elllOllt precludes its use in individual patients to assess effects of therapy 
011 L VM; 2) the stability of L VM measurelllOllt i. affected by echo quality even 
within the rIOle of 'readability'; and 3) multicenter test·retest reliability ofLVM 
should be considered in power eatimates during the design of clinical trials of 
antihypertensive therapy. 
918·97 
RCI1'CSlIOD or HyperteDsive Myocardial Hypertrop.y Does Not 
Arrect UltrasoDlc Myocardial Reflectivity: a Tiuue 
C.aracterlzatioD Study 
Guido Gigli, Fabio LatIanzi, AIcssandra R. t.uc.ini, Eugenio Piano, Ricca'do 
Zunino, Alessandro Mazwisi, Mario lanncui, Alessandro Dislante. C.diology 
Division, RapaJlo Hospital and CNR, Institute of Clinical Physiology, Pisa, 
Italy. 
Ultrasonic backscatter of myocardial walls is dirccUy related to the 
morphometrically or biochemically evaluated collaJen content in man, and 
hypertenSive paticmts show a normaJ paum! of quantilalively asaessed u1lr8SODic 
backscaucr, evcm in presence of left ventricuW hypenropby (1. VH). Whether the 
pharmacologically induced regression of LVH in hypertensive patients is 
accompanied by a disproporlionale increase of relative connective tissue content 
is presently not known. Aim of this study was to assess the effects of the 
regression of LVH on the quantitatively eValua/ed myocardial reOcctivity in 
esscmtial hypertensives. We evaluated 19 mild to moderaIe esscmliaJ hypertensives, 
wilb echocardiographically assessed L VH, before and after 8 months of effective 
.. tihypertllllSive therapy wilb enalapriJ 10 to 20 mg once daily, associated wilb 
diuretics and/or calciwn-antagooists in 6 patients to achieve an optimal blood 
pressure conlrOl. Wilb an echo proIOtype implemcmted in our lnSIitulC, an OIl-line 
radio frequency analysis was performed to obtain quantitative operator independent 
measurements of the integrated baclr.scaUer signal of the vcmlricular septum and 
the posterior wall. The integrated values of the radio frequency signal of 
myocardial walls wcze normalized for that of the pericardiaJ inlaface and expessed 
in percent (integrated backscatter index. IBI). In comparison wilb baseline, 
hypertensives showed, after therapy, a signifICant decrease of mean blood pressure 
(121±10 vs 104±10 mmHg, p<.001) , LV mass index (l40±33 vs 129±35 
gr/m2, p<.01), septal (1.491.24 vs J.36±.20 em, p<.01) and posterior wall 
thiclr.ness (J.32±.I6 vs 1.191.14 em, p<.OI). However, ml values were similar at 
baseline and after therapy for both the septum (19110 vs 23±8%, P-JIS) and the 
posterior wall (l0±4 vs 11±3%, ))=lIS). We conclude that .. tihyperlCltsive therapy 
wilb enalapril does not increase myocardial reOectivity allbougb inducing a 
regression of L VH. This may suggest that, in keeping wilb experimental daIa, the 
regression of hypertrophy is achieved by this drul through a proportionate 
regression of the myocite and connective tissue component. 
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919·25 
The Effects or Ramipril on Early Left Ventricular Remodeling 
in the Dog are Dose· Dependent 
Kenneth M. McDonald, Michael D. Garr, Gary S. Francis, Jay N. 
Cohn, University of Minnesota, Minneapolis, MN 
We have previously reported that high-dose convening enzyme 
inhibition (CEI) blocks left ventricular (LV) remodeling in a 
canine model of discrete myocardial damage. CEI also has been 
shown to prevent left ventricular hypertrophy and cause regression 
of established left ventricular hypertrophy in doses that do not 
affect blood pressure. It is possible therefore, that the effects of 
CEI on left ventricular remodeling are independent of the 
hypotensive effect of these agents. To test this hypothesis. adult 
mongrel dogs (21±2 kg) were assigned randomly to a non•
hypotensive dose of ramipril (R I: 1.25 mg BID: n=6); a blood 
pressure-lowering dose of ramipril (R2: 10 mg BID; n=6) or no 
therapy (C; n=7). These interventions were initiated 36 hrs after 
myocardial damage was induced by transmyocardial direct-current 
shock. Left ventricular mass (L VM) and volume (L VV) were 
measured by magnetic resonance imaging at baseline and 4 weeks. 
Mean arterial pressure (MAP) was recorded at these time 
periods 
Baseline 4 Weeks 
LVM LVV MAP LVM LVV MAP 
(gm) (mil (mmH~) (~m) (m)) (mmH~) 
C 87±4 69±5 90±4 JOI±5* 78±4* 89±2 
RI 87±5 61±4 94±5 98±5* 70±4* 95±5 
R2 89±6 66±4 87±2 85±5t 64±6t 77±5*t 
*pSO,Q5 with Baseline. tpSO.Q5 with C. (C=Contro)) 
Therefore, a non-hypotensive dose of ramipril fails to prevent left 
ventricular remodeling in dogs with discrete myocardial damage. 
Ramipril in doses that lower blood pressure block ventricular 
remodeling. The influence of CEI on ventricular remodeling may 
be highly dependent on the type of model and the use of a dose that 
lowers systemic blood pressure. 
919·26 
Late Throabolysis With Alteplase r.proves 
Left Ventricular Ejection Fraction at 1 Month 
After Myocardial Infarction - a Double Blind, 
Placebo Controlled study 
Victor Gil, Ana Antunes, Ant6nio Ventosa, Joio Korais, 
Alleo Skene, Ricardo Seabra-Gomes, on behalf on the 
Portuguese Cooperative Group on Ventricular Function 
of the LATE Study, Lisboa, Portugal 
Objective: To determine whether late thrombolysis 
with alteplase affects radionuclide left ventricular 
ejection fraction (LVEF) at 1 month post myocardial 
infarction. 
Methods: Radionuclide gated ventriculography was 
performed 1 month after HI in a group of 103 patients, 
randomized to alteplase 100mg over 3 hours (49 p) or 
placebo (54 p) 6-24 hours from onset of symptoms of 
acute HI. Global and five regional segments (antero•
lateral. apical, septal, inferior and postero-lateral) 
ejection fraction were determined. 
Results: Mean age was 58 (range: 20-78) years and 83% 
of the patients were male. Infarct localization was 
anterior in 76.5% and inferior in 23.5% of the 
patients. Alteplase and placebo groups were similar 
regarding age, sex, infarct site, risk factors 
(hypertension, diabetes mellitus, smoking, 
hypercholesterolemia), previous angina, previous HI, 
HYRA and Killip classes were also similar between the 
two groups. 
Global LVEF was 5.5% better on alteplase group. 
Regional wall motion was also better on alteplase 
group, mainly in septal region. 
alleplase 
placebo 
Global' anHat apical inferior septal" post-lat 
48.7 49.0 43.7 47.8 42.5 49.8 
43.2 44.3 35.5 41.3 34.9 47.8 
(* p-0.028 ** p-0.026 ) 
Conclusion: Late thrombolysis 6 to 24 hours from onset 
of symptoms of myocardial infarction improves left 
ventricular global and regional ejection fraction at 
1 month after HI. 
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919·27 
Benefits of Late Coronary Artery Reperfusion on 
Infarct Expansion Evolve as a Wave-Front Over 
Time 
lmad A Alhaddad, Ishral Hakim, Jessica L. Garno, Raman D. Arora, 
Edward J. Brown Jr. 
Nassau County Medical Center, East Meadow, NY 
Late coronary artery reperfusion will decrease infarct expansion even 
w~hout infarct size reduction. Our purpose was to define the time lim~s of 
late reperfusion's benef~s. Rats were randomized into one of 4 groups: 
Group f: permanent left coronary artery occlusion (perm.); Group 2: 2 
hrs. of occlusion followed by repertusion (2hrsR.); Group 3: 8 hrs. of 
occlusion followed by reperfusion (8hrsR.): Group 4: 16 hrs of occlusion 
followed by reperfusion (16hrsR.). Two weeks after acute myocardial 
infarction. the rats were anesthetized, hemodynamic measurements 
were obtained and the hearts were fixed at a constant end-diastolic 
pressure then, sectioned and photographed for morphometric analysis. 
Infarct and septal thickness were measured along radians passing 
through the center of each left ventricular section. Expansion was 
graded from O=no expansion to 4=severe expansion by three blinded 
observers. Resutts follow w~h mean +/- SEM. 
Perm. 2hrsR. BhrsR. 16 hrsR. 
(n=ll) (0=12) (0=13) (0=12) 
Expansion (0-4) 3.2+/-0.2 1.4+1-0.3" 2.2+/-0.2" 2.9+/-0.2 
Intarct thickness (mm) 0.3+/-0.1 0.8+/-0.1" 0.6+/-0.1"+ 0.5+/-0.1 
Septal thickness (mm) 2.4+/-0.2 2.3+1-0.2 2.1+/-0.1 2.3+/-o.t 
"p<.05 vs Perm. +p<.05 vs 2hrsR. 
In rats, late repertuSion benef~ infarct shape by preventing infarct 
thinning'and expansion up 10 8hrs. after infarction. However, benef~s 
diminish w~h time and are not observed when reperfusion is performed 
16 hrs. after intarction. 
919-28 
ContrIbutIon of CardIac AngIotensIn II to VentrIcular 
RemodelIng In Rats WIth MyocardIal InfarctIon 
Hiroyuki Yamagishi, *Shokei Kim, Toshio Nishikimi, 
Shiro Yanagi, Minoru Yoshiyama, Iku Toda, Kaname Akioka, 
Masakazu Teragaki, Kazuhide Takeuchi, Tadanao Takeda. 
First Department of Internal Medicine and *Department of 
Pharmacology, Osaka City University Medical School, 
Osaka, JAPAN 
To examine the contribution of ventricle-derived angio•
tensin II (Ang II) to ventricular remodeling, we 
compared the effects of 3-week treatments with a new 
nonpeptide Ang II type 1 (AT,) receptor antagonist, TCV-
116 (lmg/kg/day, p.o.), and those with an angiotensin 
converting enzyme inhibitor, delapril (100mg/kg/day ~.o.), on hemodynamics and ventricular Ang II content~ 
1n rats with myocardial infarction(MI). Ventricular and 
plasma Ang II levels were measured by reverse phase HPLC 
combined with specifiC RIA. TCV-116 treatment decreased 
right and left ventricular weight, mean aortic pressure 
and left ventricular end-diastolic pressure and volume 
significantly, being similar to the effects of delapril 
treatment. Ventricular (pg/g tissue) and plasma (pg/ml) 
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Values are meantSEM. *p<0.05 vs. untreated rats with MI, 
1I~<0.05 VB. LV of untreated sham-operated rats RV 
r1ght ventricle; LV, left ventricle. " 
~ng II contents in the infarcted scar were Significantly 
1ncreased. TCV-116 as well as delapril decreased 
ventricular Ang II contents of rats with MI, but did not 
plasma Ang II le~els. ~oncluBion:Ventricle-derived Ang 
II rather than c1rculat1ng Ang II playa central role in 
the devel9pment of ~entricular re~odeling after MI. AT, 
receptor 1S respons1ble for ventr1cular remodeling. 
ABSTRACTS 
919·29 
EARLY BENEmS OF LATE CORONARY REPERFUSION ON 
REDUCING MYOCARDIAL INFARCT EXPANSION; ECHO FINDINGS 
AND ULTRASI'RUCTURAL BASIS 
R. Hahn, S. C. Wong, Elliot Brown, All ... Mogtader, Marianne Legato, 
1udith S. Hochman 
51. Luke'slRooseveit Hospital Center and Columbia University 
New York, N.Y. 
The early effects of late reperfusion 011 infarct expansion were studied by 
electron microscopy (EM) and echocardiography in a rat model of extensive 
tranBmuni MI which mimics findings in patients with tnmsmunI MI. 16 nts 
underwent left coronuy artety (CA) ligation and 9 late reperfusion (2-3hrs). 
LV short axis diameter (0) measured from uninfarcted septum to infarcted LV 
free walland MI wall thickness were measured aerially 011 echo. Functional 
infarct expansion occurred rapidly after CA ligation, with increased LV 
diameter (p<0.01)* and MI ZDIle wall thinning (p<.OOW: 
PreMI 1m P-MI lS'p-MI 6Q'p-MI 120'p-MI 
LVD(mm) S.7±.8" 7.4±.9· 7.6±1.0" 7.6±.S' 7.6±1.2" 
MI WalI(mm) 2.3±.4+ 1.7±.4+ 1.7±.4+ l.S±.4+ 1.6±.2+ 
Im=immediate p=post Rep=reperfusion '=minutes (* , + pre vs p-MI) 
By 30 minutes following late reperfusion, functional expansion was markedly 
decreased, with decreased LV diameter (p<0.00S)- and reversal of MI wall 
thinning (p < .00 1)++ to baseline values. These shape changes were independent 
of salvage and return of function as the MI zone remained akinetic and 
pathology confirmed necrosis. (-, + + pre Rep vs p-Rep) 
PreMI pre Rep 1m p-Rep 3O'p-Rep 9O'p-Rep 
LVD(mm) S.9±.9 7.8±l.CJ 7.0±.8 S.8±1.3- 6.0±.cr 
MI WalI(mm) 2.3±.S 1.S±.3++ 1.9±.4 2.3±.2++ 2.3±.S++ 
EM showed striking intracellular edema, mitochondrial vacuoJization and 
contraction bands in the late reperfusion group only. I bands suggesting stretch 
were prominent in the non-reperfusion samples. 
Functional expansion with MI zone thinning and LV dilation occun BOon after 
CA ligation. This is revened early after late reperfusion by myocardial 
contracture in the MI zone resulting in increased diastolic thickness of the MI 
zone and reduction in LV size to near baseline values. These early changes 
may explain the long term benefits of late reperfusioo on LV remodelling. 
919·30 
A Gradient In Function Between Non-Infarcted Adjacent and 
Remote Regions Characterizes Post·lnfarct Remodeling 
Christopher M. Kramer, Joao A.C. Ulna Victor A. Ferrari, Mario Uanaras, 
Barbara Tallant, Leon Axel, Nathaniel Reichek. Univ. of PA, Phila., PA. 
Global changes in LV architecture after MI have previously been attribu1ed 
to diastolic volume overload. However, LV remodeling may also be medi•
ated by regional differences in myocardial function during systole. Seven 
sheep were studied after transmural anteroapical MI produced by coronary 
ligation. MagnetiC resonance tissue tagging by Spatial Modulation of Mag· 
netization was performed at baseline, 1 and 6 weeks, and 6 months after 
MI. Measurements of LV mass. volume, and end-diastolic wall thickness 
were obtained. Circumferential (CR) and longitudinal (LN) intramyocardial 
segment shortening (%5) in subendocardium and subepicardium were 
measured in infarcted and in non-infarcted adjacent and remote regions as 
defined by histopathology. Changes in LV volume and mass were: 
~~ ~~&!Qxu 
Volume (mI) 42:t6 41:t4 57:tS"§ 94:t10"§# <0.0001 
Mass (g) 5S:t6 66:t4 77:tS" 100:t3"§# <0.0001 
p<O.05 by Scheffe subtesting, " vs. baseline, § vs. 1 week, # vs. 8 weeks. 
End-diastolic wall thickness did not change over the 6 months post-infarc•
tion in the adjacent or remote regions. but fell from 9±1mm to 6±1 mm in 
the infarcted region (p<O.OS). Changes in CR subendocardial %5 were: 
~~~~&!Qxu 
Remote 19:t1% 17:t3% 20:t1% 19:t2% NS 
Adjacent 23:t1% 8:t2%"§ 13:t2%"§ 12:t2%"§ <0.0001 
Infarcted 23:t1% 6:t1%"§ 4:t1%"§# 4:t1%"§# <0.0001 
Anova D NS <f). 01 <0.0001 <f). DO 1 
p<O.05 by Scheffe subtesting. " vs. baseline, § vs. remote, # VB adjacent. 
Improved %S in the adjacent region relative to the infarcted region was 
noted after 1 week. However, a gradient in function between adjacent and 
remote regions was present up to 6 months. Similarly, in the LN plane, a 
gradient in subendocardial %5 between adjacent and remote regions 
remained at 6 months (10:t2% vs. 16:t1%, p<O.OS) despite improved adja•
cenl region function after one week post-MI. Parallel changes occurred in 
the subepicardium in both planes. In conclusion, during remodeling, LV 
dilatation and eccentric hypertrophy are associated with initial depression 
and later improvement in adjacent region function, but a gradient in func•




In VIVO Assessment of Left Ventricular Remodeling after Myocardial 
Infarction by Digital Contrast Angiography in the Rat 
Shiro Ono, Valmik Bhargava, Michael I. Miyamoto, Marco Guazzi, 
Robert Duerr, Howard A. Rockman, John Ross, Jr. 
UniversitY of California, San Diego, School of Medicine, La Jolla, CA 
To assess ventricular function in the intact closed-chest rat, we have 
developed an angiographic technique of contrast ventriculography and 
applied it to study models of non-transmural (NTMI and transmural (TMI 
myocardial infarction. NTM infarction was produced by 45 minutes of 
left coronary artery occlusion followed by reperfusion. Angiographic studies 
were performed 4 weeks after surgery in 28 rats (sham = II, NTM = 8, TM 
= 91. Under anesthesia, angiographic images were acquired on videotape 
by fluoroscopy following injection of 0.7 ml of contrast into the jugular 
vein in 30° RAO and 60° LAO projections. Levophase left ventricular 
(LVI interlaced images were digitized and regions of interest (ROil defined 
over the LV and background (BKGI. Video-densitY curves were created 
using field-by- field subtraction of LV ROI from corresponding BKG ROI. 
l V ejection fraction (EFI was calculated by computer densitometric 
analysis (DMI from the maximal (end diastolel and minimal (end systole I 
values.l Vend-diastolic volumes (EDVI, end systolic volumes (ESVI and 
EF also were obtained from traced biplane images using the area-length 
(All method after grid correction for magnification. Inter-observer 
correlations for EDV and ESV were 0.95 and 0.98, respectively. The 
correlation between EF by OM and Al methods was 0.92. 
~ ~ ff~& ff~~ 




0.34:1:0.06 0.10:1:0.03 70:1:5 67:1:5 
0.53:1:0.05' 0.25:1:0.04' 53:1:7, 50:1:10, 
0.68:1:0.15" 0.41:1:0.11" 40:1:5" 37:1:9" 
, p<O.OI vs. sham; # p<0.02 vs. NTM 
Thus, compared to sham, increased l VEDV and decreased EF were 
detected in NTM infarction, and these values became more abnormal 
with TM infarction, demonstrating functional effects of reperfusion. These 
techniques show a beneficial effect of reperfusion on l V function and 
remodeling, and provide the first quantitative angiographic cardiac 
visualization in vivo in rats, an approach which can be applied to other 
disease models. 
919·32 
Barly Left veDtricular RaDodeliDq after ~ 
IDfaroticm in Cl.~ Dogs. 
R. stefan Kiesz, IlI:tJert A. O'Rcurite, Gregory L. Freeman, 
UIHSC ani Al.MII1IH, San Antc:nio, TX 
SUrvival after MI depends on left ventrirular (IN) 
fun::tiCll, whi.ct1 is adversely affected by c:haIIiJer 
dilatation. To assess patterns of IN shape chi!In;Je whidl 
ocx::ur after MI we stuiied 6 dogs instIumented with IN 
manc:meters and 3 diameter gauges before and for 4 weeks 
after flow prd:le verified acute ruff occlusion of the 
ciro.Jmflex oorcnazy arteIy. Data were d:1tai.ned after 
sedation and autcn:mic blockade, at 0CIlStant heart rates. 
All dogs had a biplasic respa1SE!, with an acute riqrt:ward 
shift of the pressure-
volume loop present at 
24 hr post MI: en:l•
systolic volume (Ves) 
irx:reased to 149.5±13.2% 
(P<O.OOl). '!his was 
follaoed by a gndJal 
JIDVE!IIleIlt of the loop to 
the left, with J'IODIIal. or 
reduced Ves by day 14. 
For the grrup Ves was 
91.l±20.9 of baseline at 
day 14 (p=ns). No fur-
ther c:ilarges ocx:urred by 
"':"~u0J''''T tOO j- • /' , {- .. 1 1 , ' 11:" \ i 
£I" i I 
wao~./ 
It 0 --.. .. .. . 
week 4. At necrcp;y the infarcts involved 28±4% of the 
IN. We CXIDCl.1D: MI causes a biplasic shape c::tlange of 
the LV. 'lherapy designed to affect LV rem:x:lel.in;J sbruld 
be institute:l early to be JOOSt effective. 
919·33 
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Circulating RAA System and Hypotensive Response 
to Increasing Doses of ACE-inhibitor in 
Patients with Acute Myocardial Infarction. 
Claudio Borghi, Stefano Boschi,oGiovanni 
Melandri, Stefano Bacchelli, Daniela Degli 
Esposti, Ettore Ambrosioni, °Bruno Magnani. 
Inst.of Internal Medicine & oOInst. of 
Cardiology-University of Bologna, Bologna-Italy. 
In order to assess the importance of 
circulating RAA system in the hypotensive 
response to ACE-inhibitors in patients with 
acute myocardial infarction (A.M.I.),the 
pressor and humoral responses to increasing 
doses of zofenopril calcium (Z) have been 
evaluated in 20 patients with A.M. I. according 
to a double blind, randomized, placebo-controlled 
design. Patients were studied by measuring 
every 12 hours: blood pressure (BP),% ACE•
inhibition (%ACEI),active plasma renin (AR) and 
plasma aldosterone (PA) ,while Z dose was 
doubled every 48 hours from 7_5 to 30 mg/die. 
Mean BP %ACEI AR PA 
P Z P Z P Z PZ 
BAS. 99 101 11 13 98 102 
7.5mg 97 94 0 7 59° 12 17 0 100 63° 
15mg 95 86° 0 6 75° 0 9 33 00 72 0 36°0 
30mg 94 92* 5 91* 10 47* 52 67* 
0,00 P<_05,.005 vs BAS_;* p<.05 vs 15 mg. 
ACE activity is inhibited by Z in a dose 
dependent fashion. The BP decrease with 7.5 mg 
of Z was partially abolished by the dose of 30 
mg which also sharply raised A.R. and partially 
restored the PA levels. We suggest that in 
patients with A.M.I_ the circulating RAA system 
can modulate blood pressure levelS despite an 
effective blockade of ACE activity. 
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920·50 
Troponln T • a Marker for Myocardial Injury After 
Defibrillation Threshold Testing DurllJg ICD Implantation 
Christoph Stell brink. Friedrich A SchOndube • Klaus-Peter Kunze, Georg 
HaJtem, ,t.1lchaela Reitz, ROdiger Kock +, tlelmut Grelling +, Bruno J. 
Messmer , Peter Hanrath. Medical Clinic I, Depanment of Thoracic and 
Cardiovascular Surgery and + Institute for Clinical Chemistry and 
Pathobiochemlstry, RWTH Aachen. Germany. 
To study the extent of myocardial injury after defibrillation threshold (OFT) 
testing during impiantation of an Impiantable cardlovener /defibrillator (ICD) 
we measured Troponin T (1T), creatin kinase (CI<) and CK-MB 0, 3, 6 hours 
and 1 to 7 days after ICDI In 18 pts (17 m, 1 f, 61.±.9 years). Left ventricular 
ejection fraction (LV -EF) wes determined before and 1 week after ICDI by 
radionuclide ventriculography. Surgical approach was subcutaneous/ 
transvenous In 17 pts and transvenous In 1 pI. The mean number of delivered 
shocks was 7.4.±.2.S, mean cumulative energy (CE) was 180.±.74 Joules (J) 
and mean cumulative duration of ventricular fibrillation (VF) was 107.±.45 s. 
Results: After OFT testing CK rose from 3B.±.12 to 141.±.20 Ufl 
(p<0.05); n rose from O.04.±.O.02 to 0.98.±.0.33 (p<O.OS). CK-MB showed 
detectable increase only in 9/18 pts. n correlated with VF duration and CE: 





, • n' '8 
°o----~~'oor---,~,,--~~-, 
Vf durallon (s) 
.,TT Ing/ml) 
r·0.68 
P • O.OOB 
o~~~ __ ~~-r~n~.~'~B~~ 
o I~ 200 2SO 
Energy IJ) 
There was no correlation of CK release with VF duration or CEo LV-EF 
remained unaltered (40.±.13%->40.±.11%) 
Conclusions: 1) After OFT testing there is significant increase of n 
and CK where n Is more sensitive than CK-MB. 2) Only n release correlates 
with VF duration or CE IndiCating non~speclficic CK Increase caused by 
muscle trauma. 3) LV-EF was not influenced by OFT testing. 
JACC Vol. 21, No.2 
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920-51 
Late Complications of Third Generation Implantable 
Ca rdl overter-Oeflbrllla tors. 
Sean S. 0 Nunain, Thomas G. Trouton, Marc Roelke, You Ho 
Kim, Guillermo E. Sosa-Suarez, Hasan Garan, Ross Brooks, 
Brian McGovern, Jeremy N. Ruskin, Massachusetts General 
Hospital, Boston, MA. 
Between September 1989 and August 1992 one hundred and 
thirty nine patients underwent implantation of a tiered•
therapy implantable cardioverter-defibrillator (ICD). Pulse 
generators from three different manufacturers were used. In 
37 patients a complete non-thoracotomy lead system was 
employed. Of these 139 patients, 19 % have experienced late 
post-operative lCD-related problems. Fourteen patients have 
required system revision within 13 (mean 3.9 ±. (SO) 3.7) 
months of surgery. Reasons for revision were: spurious shocks 
due to electrode fractures (3) or electrode adaptor 
malfunction (1); failure of endocardial rate-sensing 
electrodes (3); superior vena cava or right ventricular coil 
migration (4); failure to correct tachyarrhythmias due to a 
post· implant rise in defibrillation threshold (2) or pulse 
generator failure (1). In addition one of these patients 
required system removal for infection after revision of an 
endocardial lead. Eleven patients have received inappropriate 
countershocks for atrial fibrillation with a rapid ventricular 
response or sinus tachycardia. In two of these patients 
inappropriate anti·tachycardia pacing for atrial fibrillation 
induced ventricular tachycardia which was terminated by ICD 
countershocks. Two further patients received shocks in sinus 
rhythm· one because of autogain induced oversensing following 
ICD backup pacing and a second because of mechanically 
Induced lead noise from a redundant rate sensing lead. 
CONCLUSION· Despite advances in ICD technology a Significant 
proportion of patients continue to experience mechanical 
complications or receive inappropriate shocks for 
tachycardias of supraventricular origin. 
920-52 
Efficacy of Thoracoscopic and Laparoscopic Patch Placement for 
Defibrillation 
Gregory A. Buser, Andrew H. Foster, Robert W. Bailey, John L flowers, 
Thomas R. Scott, Mark J. Krasna, Michael R. Gold. University of 
Maryland, Baltimore, MD 
Nonthoracotomy lead systems are being developed to reduce the 
morbidity associated with cardioverter defibrillator implantations. 
However, total endocardial lead systems are frequently unable to provide 
satisfactory defibrillation thresholds. To provide an alternate, minimalIy•
invasive approach, we have examined the defibrillation characteristics of 
patches inserted by thoracoscopic (THOR) and laparoscopic (LAP) 
techniques in nine closed-chest pigs. Patches were redesigned to 
accomodate trocar insertion, allow complete unfurling. and permit stapler 
reapplication in the left hemithorax. These were placed onto the 
pericardium over the base of the left ventricle (THOR) and against the 
diaphragm opposite the inferior surface of the heart (LAP). A spring coil 
electrode was positioned in the right ventricle (RV) to serve as the anode. 
Serial testing (up-<lown method) was performed using biphasic 
waveforms to determine the energies associated with 50% (ED5O) and 







Single lung ventilation and intraperitoneal insufflation were well•
tolerated during patch placement. Autopsy examination revealed no 
evidence of damage to pericardium or to diaphragm after repeated (>30) 
defibrillation tests. 
Conclusions: Thoracoscopic and laparoscopic defibrillator patch 
implantation is feasible, effective and safe. Defibrillation thresholds are 
lower with thoracoscopic extrapericardialleft ventricular patch than with 




Successful Implantation of Cardioverter•
Defibrillator Systems in Patients with 
Elevated Defibrillation Thresholds 
Ross Brooks, David Torchiana, Gus J. Vlahakas, 
Brian A. McGovern, Jeremy N. Ruskin, Hasan Garan 
MO; Massachusetts General Hospital, Boston, HA 
High defibrillation thresholds are an uncommon, 
although challenging problem confronting 
physician's implanting internal cardioverter•
defibrillator (ICD) systems. Eighteen patients (age 
• 6l±9 years), with advanced cardiac disease and 
high defibrillation thresholds (>25 Joules) at the 
time of initial implantation using a two electrode 
system were successfully managed with a three 
(n=16) or four (n=2) electrode configuration. A 
mean of 6±4 electrode configurations were tested 
per patient before the final configuration was 
selected. The mean final defibrillation threshold 
was 19.±4 Joules, (p<O.OOOl). A total of 11 
different final electrode configurations were used 
in the 18 study patients. One patient died three 
days after implantation. The remaining 17 patients 
are alive a mean of 7.6 months post-implantation. 
Six patients (33\) have received appropriate leo 
therapy during the follow-up period. Conclusion: 
Patients with high initial defibrillation 
thresholds can be successfully managed when a third 
or fourth defibrillation electrode is used, and if 
enough electrode configurations are tested after 
incorporation of the additional electrode(s). 
920-54 
Implantable Cardioverter-Defibrillator Shocks Do Not Convert 
Atrial Fibrillation to Sinus Rhythm 
Marc Roelke, Thomas G. Trouton, Sean S. O'Nunain, Hasan 
Garan, Brian A. McGovern, Jeremy N. Ruskin. Massachusetts 
General Hospital. Boston, MA. 
Traditional therapy for atrial fibrillation (AF) includes 
electrical cardioversion. Implantable Cardioverter-Defibrillators 
(leDs) deliver a countershock when the ventricular response 
(VR) during AF exceeds the programmed detection rate. The 
availability of stored intracardiac electrograms (ICEG) in fourth 
generation !CDs provides insight into whether !CD 
countershocks are effective for cardioverting AF to sinus 
rhythm. 
Forty-four consecutive patients (34M,10F), mean age 60 years 
04-84 years), had the Ventritex Cadence~ !CD with right and 
left ventricular patches implanted via thoracotomy. This device 
stores three 30 second recordings of ICEGs during arrhythmia 
detection and therapy. These 44 patients had 320 stored events, 
of which 39 were episodes of AF. AF was recognized by 
irregularly irregular cycle lengths, with a uniform ICEG 
morphology throughout the stored period. 
In 5 cases therapy was aborted when the VR no longer met 
rate criteria. ATP was applied as first line therapy in 23 cases; 
therapy was aborted in 10 of these but 13 received CV /D after 
failed ATP. In 11 cases, CV /D was the initial therapy. In total. 
CV /D was applied during AF in 24 cases. In no instance was 
sinus rhythm restored. 
We conclude that with ICD shocks applied via epicardial 




Incidence and Clinical Significance of Muhlple Consecutive 
High Energy Discharges In Patients with Implanted 
Cardloverter Defibrillator 
Julian Villacastin. Jesus Almendral. Angel Arenal. Agustin Pastor. Hector 
Bueno. Jesus Martinez-Alday. Francisco Jimenez. Olga Medina. Juan L 
Delcan. Hospital Gregorio Marall6n. Madrid. Spain. 
In patients with implantable cardioVerter defibrillators (ICD). appropriate 
Shocks. atthough effective. seem to be a marker for a worse prognosis. 
Objective: to asses the incidence and prognostic significance of the 
difficulty to defibrillate the heart represented by the occurrence of 
appropriate (associated with syncope or a documented ventricular 
arrhythmia) muttiple consecutive (> 1 therapy for a single epiSode) high 
energy discharges (AMCD). Forty-two consecutive patients that survived 
implantation of ICD. were followed for 22±18 months. Ten (24%) had 
AMCD. 11 had appropriate single discharges (ASD). and 21 had no 
appropriate discharges (No D). 
AMCD (n- 10) ASD (11= 11) No D (11=21) P 
Age 63±13 56±14 55±9 ns 
Male Sex 7 10 19 ns 
Heart DiSease 10 11 16 <0.06 
Failed AAD 2±1.5 2±1 0.8±0.3 <0.01 
AAD post ICD 4 2 4 ns 
EF(%) 27.5±12 41±16 48±16 <0.005 
Mortality 6 1 1 <0.005 
AAD post ICD: antiarrhythmic drogs after the ICD implantation. EF: 
ejection fraction. Failed AAD: number of failed antiarrhythmic drogs. 
No differences were found among groups in follow-up duration. type Clr 
number of clinical or induced arrhythmias. defibrillation thresholds (at 
implantation) or programmed ICD rate cutoff. Death was arrhythmic in 5 
patients. Logrank analysis showed a statistically significant difference in 
the outcome of the 3 groups. Despite univariate dif1erences in EF. 
logistic regression analysis identified AMCD as the only independent 
predictor of mortality during follow-up. Conclusion: In patients with ICD. 
the occurrence of AMCD is common and aSSOCiated with a poor clinical 
outcome. Some of this patients may require heart transplantation. 
920·56 
Implanting Patches OutSide the Pericardium Protects Against 
High Energy Shock·lnduced Damage to Sympathetic Nerves 
Makoto Ho. Harald P. Pride. Douglas P. Zipes 
Krannert Institute of Cardiology. Indianapolis. Indiana 
High energy shocks delivered to the epicardial surface of the heart attenuate 
sympathetic responsiveness. We tested whether extra pericardial patches 
reduce sympathetic damage by comparing the effects of shocks delivered 
over patches sutured to the inside (group 1. n=5) or outside of the 
pericardium (group 2. n-5) in the dogs. Truncated exponential shocks of 25-
35 J were given synchronized to· the R wave during sinus rhythm. In group 1. 
shocks reduced the shortening of ventricular effective refractory period 
(ERP) produced by bilateral ansae subclaviae stimulation (55) by 54% (20 rns 
to 9 ms) at 5 of 15 sites apical to the patches and by 54 % (20 ms to 9 ms) at 3 
6f 10 sites beneath the patches. High energy shocks shifted the 55 
frequency-ERP response curves downward and to the right at sites apical to 
and beneath the patches. In group 2. no apical test sites showed reduction 
by ~ 50 % of the SS-induced ERP shortening. and shocks did not affect the 
SS frequency-ERP response curves. ERP response at sites basal to the 
patches was unchanged in both groups 1 and 2. Shocks of 0.8-1 J delivered 
over patches sutured to the inside of the pericardium did not shift the SS 
frequency-ERP response curves. Ventricular weight (VW. 187±39 vs. 
171±34 g). delivered energy (0.17±0.04 vs. 0.19±0.05 J/gVW). and peak 
current (0.0710.02 vs. 0.06±0.01 amp/gVW) were the same in group 1 
compared with group 2. SS frequency-ERP response curves at apical test 
sites are as follows: 
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These resuHs suggest that shocks delivered to the heart via patches outside 
the pericardium protect against shock-induced sympathetic damage and may 
prevent attenuation of sympathetic function after cardioversion and 
defibrillation. 
920·57 
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High Energy DC Shocks Delivered to the Epicardial Surface of 
the Heart Attenuate Sympathetic Responsiveness 
Makoto hO. Harald P. Pride. Douglas P. Zipes 
Krannert Institute of Cardiology. Indianapolis. IN 
To test whether shocks delivered directly to the heart impair sympathetic 
responsiveness. truncated exponential shocks were delivered through 
implantable patches sutured to the inside of the pericardium in dogs. Shocks 
of 28-34 J were synchronized to the R wave during sinus rhythm and 
shortening of ventricular effective refractory period (ERP) during bilateral 
ansae subclaviae stimulation (55) was measured for 3 hours afterward in 6 
dogs. Shocks reduced the 55-induced ERP shortening by 61% (17 ms to 7 
rns) at 6 of 18 snes apical to the patches and by 60% (19 ms to 7 rns) at 3 of 12 
sites beneath the patches 15 min after shock delivery. While SS 
responsiveness gradually recovered during the 3-hour period. ERP 
shortening was still diminished by 60 % (21 ms to 8 ms) at 5 of 18 apical sites 
and by 50 % (20 ms to 10 ms) at 1 of 12 sites beneath the patches 3 hours 
after shock. ERP shortening at sites basal to the patches was unchanged 
before and atter shock. Shocks of 0.8-1.0 J did not shift SS frequency-ERP 
response curves in 5 dogs. Shocks did not affect norepinephrine-ERP dose 
response curves. indicating normal myocardial responsiveness. The time 
course of SS-induced ERP shortening was as follows: 
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These results suggest that defibrillating shocks delivered directly to the 
epicardial surface damage efferent sympathetic nerves and heterogeneously 
attenuate ERP shortening in response to 55 beneath and apical to the patch 
site for at least 3 hours after the shock. Such 55 attenuation could affect 
both mechanical and electrophysiological cardiac function after cardioversion 
and defibrillation. 
920·58 
Ethanol Increases the Defibrillation Threshold In Patients 
with Implantable Defibrillators 
Huagui G. Li, Ranjan K. Thakur, Marco Zardini, Carlos A. 
Morillo, H. William Stites, Raymond Yee, George J. Klein. 
University Hospital. London. Ontario. Canada 
While alcohol drinking has been shown to induce cardiac 
arrhythmias and cardiomyopathy. the effect of alcohol on 
defibrillation efficacy in patients with implantable cardioverter· 
defibrillators (ICO) is unknown_ We measured the defibrillation 
threshold (OFT) in 7 men (age 19-78,46 ± 16 years) with ICO 
devices before and after intravenous alcohol dose suffiCient to 
achieve a serum ethanol level of 80 mg/dL. Underlying heart 
disease was ischemiC heart disease (n=4), dilated 
cardiomyopathy (n=2) and primary ventricular fibrillation (n:1). 
OFT was defined as the lowest effective first shock energy of a 
sequential pulse shock delivered from the ICO 15 seconds 
after the induction of ventricular fibrillation by AC current. The 
mean serum ethanol level following a loading dose and 
maintenance infusion was 136.6±18.9 mg/dL. OFT increased 
from 13.3 ± 2.0 J at the baseline to 16_1 ± 1.3 J, p<0.05) 
during ethanol infusion. There was no significant change in 
systolic or diastolic blood pressure during alcohol infusion 
accompanying the change in OFT (103 ± 4164 ± 9 vs 10H 
7/67 ± 10 mmHg. p=NS). 
Conclusion: Acute alcohol intake appears to be associated 
with a small but significant increase in the minimum 
defibrillation energy requirement in ICO patients. 
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920·59 
Adenosine Mediated Increase In Transmyocardlal 
Defibrillation Threshold Is Attenuated by Heptanol 
Erica O. Engelstein, Bruce B. Lerman, Cornell University 
Medical Center, New York, NY. 
We have shown that adenosine increases transthoracic 
defibrillation threshold (OFT) through its antiadrenergic 
effects. We hypothesized that one potential mechanism for 
adenosine's effects is to antagonize the facilatory effects of 
catecholamines on cell·to·cell coupling. Adenosine 
(3001l9/kg/min) was infused in combination with the 
adenosine uptake inhibitor dipyridamole (0.25mg/kg) and 
isoproterenol (S·10Ilg/min) in 10 mongrel dogs. Adenosine 
increased transmyocardlal (epicardial patch electrodes) OFT 
by 85 % from 1 0.3±2.5 to 19.1 i3.9 J (mean±SE, p<0.05). The 
effect of adenosine on OFT was then compared with that of 
heptanol, an aliphatic alcohol known to inhibit cellular 
coupling. Heptanol was administered by retrograde coronary 
sinus perfusion to avoid systemic effects. The effects of 
heptanol on OFT were similar to adenosine's. Heptanol 
increased OFT from 8.1 ±2.9 (control) to 14.4±4.4 J (heptanol), 
whereas adenosine increased OFT from 9.S±2.8 (control) to 
17.3i4.3 J (adenosine). Furthermore, in dogs pretreated with 
heptanol, adenosine caused no further increase in OFT. 
Conclusions: 1) adenosine increases transmyocardial OFT 
by > 80 %, 2) parallel changes in OFT are produced by 
cellular uncoupling due to heptanol, and 3) cellular 
uncoupling abolishes adenosine mediated increase in OFT. 
These data suggest that adenosine may increase OFT in part 
by antagonizing the effects of catecholamines on cellular 
coupling. 
920·60 
Prolongation of Refractoriness and Action Potential 
Duration by Monophasic and Blphaslc Stimuli In Man 
James P. Daubert, Robert A. Sorrentino, Joyce C. Pressley, 
Ruth A. Greenfield, Mark E. Hamer, Richard L Page, J. Marcus 
Wharton, Duke University Medical Center, Durham, NC 
The effect of subthreshold conditioning stimulus (Sc) wave•
form on effective refractory period prolongation (ERP-P) in 
humans is not known. In 8 pts undergoing electrC?physiologic 
studies, the effect on ERP·P of a 6 ms monophaSIC (M) or 3-3 
ms biphasic (B) Sc was determined. Baseline ERP was 
determined after 8 S1's at pacing cycle lengths of 600 or 500 
ms using 2 ms M S1 and S2 pulses at twice diastolicthreshold. 
ERP was redetermined after 2,10, and 20 mA M and B Sc's 
were given either 40 ms (M40, 840) or 100 ms (M1oo, B1oo) 
earlier than baseline ERP. S 1, Sc and S2 were delivered to the 
RV from the same pacing poles of a monophasic action 
potential (MAP) catheter. MAP durations at 90% repolarization 
(MAPD90) were measured adjusting for offsets as needed. 
ERP-P (means in ms) was plotted vs Sc (mA) for the 4 
combinations of Sc waveforms and timings: 
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ERP-P was greater for larger Sc (p=0.05) and for M40 or 840 
vs M100 or B100 (p=O.02). However, ERP-P was not signlfi· 
cantly different for M va B at any stimuius intensity (p=C.7). 
For M40at 2,10, and 20 mA, MAPD90 for the S1-Sc activation 
compared to S1 was prolonged by 1 O.±.24 , 38.±.20, and 21.±.36 
ms and for B40 by 12.±.14, 56.±.90, and 56.±.82 ms, respec· 
tively. Conclusions: Although B may be more effective than 
M for defibrillation in humans, this appears unrelated to 
waveform differences in prolonging ERP. 
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920·61 
Postoperative Exacerbation Of Ventricular Arrhythmias Is 
Rare After Nonthoracotomy Defibrillator Implantation 
Julie Ling, Gina Wang, Soo G. Kim, John D. Fisher, James A. 
Roth, Kevin J. Ferrick, Jay Gross, Richard Brodman, Seymour 
Furman. Montefiore Medical Center, Bronx, New York 
Ventricular arrhythmias during postoperative period after ICD 
implantation was compared between 36 pts treated with 
transvenous ICDs and 52 pts treated with thoracotomy ICDs. Pts 
who had concomitant surgery such as coronary bypass were 
excluded from the study. Postoperatively, one pt in thoracotomy 
group had incessant VT with eventual death. Multiple re•
currences of sustained VT in pts who had been stable pre•
operatively were noted in 8 pts in thorl:lcotomy group, and in 2 
pts in transvenous group. Frequen, and fast non sustained VT 
requiring additional antiarrhythmic therapy (unstable non· 
sustained VT) was noted in 2 pts in thoracotomy group, and 
none in transvenous group. Therefore, 11 (21%) of 52 pts with 
thoracotomy ICD had clinically significant worsening of ven· 
tricular arrhythmias (incessant VT in 1, multiple sustained VT in 
8, and unstable nonsustained VT in 2), while only two of 36 
patients with transvenous ICD did. In the remaining clinically 
stable pts (41 pts in thoracotomy group, 34 in transvenous 
group) a 7-fold increase in frequency of VPCs was noted in 15 
(37%) of 41 pts in thoracotomy group, and only in 2 (5.9%) of 34 
pts in nonthoracotomy group. 
Conclusions: Postoperative exacerbation of ventricular arrhy•
thmias, occasionally noted after thoracotomy ICD implantation, 
is rare after transvenous ICD implantation. 
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921·34 
Probability or De6brUlation Success and Incidence or Postshock Arrbythmias 
as a Function or Sbock Strength 
Adam W. Cales, Joseph J. Souza, Russell E. Hillsley, Pabid D. Wolf, W'J11iam M. 
Smilb. Raymond E.ldeker, Duke University, Durham, NC. 
It is thought that increasing defibrillation shock strength increases the probability of 
successful defibrillation (PS). To detennine the voltage above which increasing die 
S1I'erIgth of monophasic and biphasic shocks is no longer advantageous. we studied 
the etTeclS of high voltage defibrillatioo shocks in 6 pigs. A defibril\ating ca!he1Cr 
was placed in the right ventricle, and a 114 cm2 cutaneous patch was placed on !he 
left Iaterallborax. Five selS of 10 ms monophasic and S/5 ms single-capacitor 
biphasic shocks wilb leading edge 
volrages of 200, 400. 600. 800 and '00
10
',00 e"""" ~: ~s... pp!. 990 vollS (approximately 2.3 J to 59 1) -- -
were tested (tolal of 50 shocks to each 
animal). For 4 minutes after each 
shock, ECG and aneriaI pressure 
traces were recorded every minute for 1: ".0 
30 seconds. The postshock arrhylb- l 
mias (PSA), shown in the figure as a .... 0 
percentage of successful shocks. were 
subdivided into bradyarrhylbmias 20.0 ' 
(BRADy) (AV block and asystole), n ~ h 
supraventricular tachycardias (SVT) n i u •. U 
(excluding sinus tachycardia), and 0.0":;: _ ... 100 ... 
venlricular tachycardias (VT). voltage 
For monophasic shocks, PS and PSA increased wilb higher volrage shocks. Success 
ranged from 0% at 200 V to 90% at 990 V. There was no incidence of BRADY or 
SVT at 200, 400 and 600 V. BRADY occurred in 37% of successful shocks at 990 
V and Ibe occurrence of SVT was 30% at 990 V. Sustained VT occurred twice at 
990 V. For biphasic shocks. PSA increased wilb higher voltage shocks, but PS 
peaked at 97% for the 600, 800 and 990 V shocks. The incidence of BRADY in· 
creased from 8% at 400 V to 40% at 990 V. SVT increased from 7% at 600 V to 
17'1> at 990 V. Allbough PSA occurred at lower S1l'erlgths for biphasics than for 
monophasics. Ibe difference between PS and PSA was always higher for biphasics. 
We conclude for Ibe catheter-patch electrode configuration that increasing Ibe shock 
strength does not always improve PS and may increase Ibe incidence of PSA. 
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921·42 
Predicting the Potential Gradient Field in Veulricular Fibrillation From 
Sbocks Given in Paced Rhythm 
Salim F. Idriss, Patrick D. Wolf, Sharon B. Melnick, William M. Smith, 
Raymond E. Ideker, Duke University, Durham,NC. 
The myocardial potential gradient is a parameter that has been linked to 
successful defibrination. Prediction of the potential gradient field far shocks 
given in ventricular fibrination from fields created by lower strength shocks 
given in paced rhythm (PR) could anow estimation of the shock ItTength 
necessary to defibrinate. This would reduce the number of VF episodes and 
the number of high strength shocks delivered during defibrination threshold 
determination. The purpose of this study was to determine if potential gra. 
dients measured during shocks delivered in PR can be used to predict poten•
tial gradients in VF. Defibrination electrodes were sewn on the LV apex 
and the right atrium of 6 pigs. Five shocks of SO-4OO volts were deliveled in 
PR fonowed by three DFf determinations using an up-down protocol. The 
sequence was repeated for a total of 5 PR shock sets and 4 DFf shock sets. 
The potential gradient was measured for each shock delivered in PR and VF 
at 40 epicardial sites using tripolar button electrodes and a 128 channel map•
ping system. Regression of potential gradient on transcardiac peak current 
was performed for each PR shock set at each button site. For shocks 
delivered in VF, the potential gradients at each button were then estimated, 
The potential gradient varied linearly with peak current in PR 
(r-.96±.11, mean±sd). But, there was an unexpected significant overesti•
mation of the potential gradient in VF (error=·2.19±7.7 Volt/em, p<.OO1. 
nc 1749.errora measured-predicted, mean absolute error=S.O Volt/em). To 
adjust for the overestimation, a prediction correction equation was gen•
erated using linear regression of measured on predicted values (slope-. 76. 
p<.OO1; intercept=3.26,p<.OO1). Using the correction equation. new 
predicted potential gradients were generated without average overestimation 
(newerror= 0.0±6.9 Volt/em, mean absolute error= 4.4 Volt/em). 
For transcardiac shocks of similar strength, the potential gradient was 
lower in VF than in PRo Changes in cardiac geometry andlor ventricular 
blood volume during VF could account for these results. Empiric correction 
for the differences in the potential gradient field between PR and VF, for 
the electrode configuration used in this study, improved prediction of the 
,potential gradients in VF from shocks given in PRo 
921·43 
Cardiac Vein Electrode Locations for Transvenous Atrial 
Defibrillation 
Gregory Ayers, Marina Dina, Darrell Wagner, Paul Kreyenbagen, 
Susan Bernard, Clif Alferness, InControl Inc., Redmond, W A 
Low energy transvenous atrial defibrillation provides an alternative 
for the treatment of atrial fibrillation (AF) in the conscious patient 
We compared atrial defibrillation thresholds for shocks delivered 
between a catheter electrode in the right atrial appendage and in four 
locations in the great cardiac vein or coronary sinus: anterior 
descending vein (ADV), under the left atrial appendage (LAA), at 
the obtuse margin (OM), and in the coronary sinus (CS). Both 
electrodes were 6 em long coils on a 6 Fr. mapping catheter. 
In 7 adult sheep (61 ± 4 kg), thresholds were determined for each 
location. Following induction of AF with rapid atrial pacing, 
thresholds were determined starting at 80V, incrementing the 
intensity by IOV until AF was terminated. AF was re-initiated and 
20 shocks were delivered at this intensity to determine the percent 
success. If greater than 10% success was not achieved, the shock 
intensity was incremented by IOV and percent success was again 
determined. The intensity that achieved greater that 10% success 
was the threshold. Shown are the mean and standard deviations for 
the thresholds. In 3 animals thresholds could not be obtained for the 
CS location. For statistical analysis the highest unsuccessful 
intensities (all >300V, 3.41) were used for these 3 CS thresholds. 
Loca on AD LAA M 
oItage V I ± 6 I 7 ± I 16 ± 1 
Ene (J) 0.7± 0.4 0.6 ± 0.2 1.4 ± 2.1 
e thresholds were slgni Ican y igher than rom the other 
three locations (p<O.05). The remaining three locations were not 
significantly different from each other (p>O.1) although ~he. OM 
location had a higher mean threshold and greater vanablhty. 
Conclusjons: I) ADV and LAA locations are superior, 2) OM 
location may be less optimal due to a higher mean and incre~ed 
variability of the thresh!>ld. and 3) in some cases, .the CS l?Ca~on 
may be inappropriate for low energy trans venous atnal defibrillatton. 
921·44 
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Subcutaneoul Array Electrode Dramatically Reducel 
Defibrillation Strength Requlramentl Compared to 
Catheter Alone In Pigi 
Stephen J. Hahn, Roger W. Dahl, John E. Heil, Susan A. Kaye, Yayun 
Un and Douglas J. Lang; Tachyarrhythmia Research, CPI, St. Paul, 
MN. 
Endocardial lead systems for use with implantable defibrillators have 
rapidly gained acceptance due to their proven clinical efficacy, ease of 
inplantation and reduction of post-i~lant morbidity. However, such 
systems have not been suitable for every patient due to high 
defibrillation strength requirements (DSR). In such cases, • has been 
common to augment the endocardial system wKh a subcutaneous 
patch. We have developed a new subartaneous array lead for use in 
conjunction with an endocardial system which has previously been 
shown to significantly lower DSR compared to a catheterlpatch 
system. In this study DSR's were co~ared for catheter alone vs 
catheter/array in pigS (n-6, 40-45 kg). Catheter electrodes (3.9 cm2) 
were placed in the RV apex and RAlSVC junction. Three 17 em 
ribbon wires were positioned subaJtaneously between the 3rd and 
6th intercostal spaces and centered on the left thorax, Shocks were 
delivered in two configurations 1) RV-RAlSVC or 2) RV-RAlSVC + 
Array. 15 biphasic, single capacitor shocks (60/40, SO% tilt) were 
delivered in each configuration using an up/down protocol. 
Conversion data were used to construct dose response aJrYes for 
Energy , Peak Voltage and Peak Current. 
RESULTS; Energy, Peak Voltage, and Peak Current at 50% 
probability of success were (mean±SD): 
~ Peak Voltage 
1) Catheter Alone 32.3±4.7 631±29 
peak Current 
12.2±1.6 
11.3±3.0 2) Catheter / Array 12.S7±3.7 374±49 
Energy and Voltage were statistically signHicant at the p..03 level 
using the Wilcoxon signed-rank test. 
CONCLUSIONS; The new subcutaneous array electrode 
dramatically reduced DSR's co~ared to catheter alone. The array is 
fast and simple to i~lant and will be signHicantly more comfortable for 
the patient. The Catheter/Array reduced defibrillation energies by a 
factor of 3.0+0.4 and voltages by a factor of 2.3±1.3, 
921·45 
Mechanisms of Spontaneous Defibrillation in tbe Rabbit 
Heart. 
P. Jacob Varghese, Paris P. Bransford, Oscar H. Tovar, Kevin B. 
Milne, Janice L. Jones, Georgetown University, V A Medical Center, 
and George Washington University, Washington, D.C. 
Internal defibrillator testing revealed a higher incidence of 
spontaneous ventricular defibrillation (SD) in humans than expected. 
Knowledge of SD mechanisms and effects of drugs on its occurrence 
may improve clinical treatment ECG morphology suggests similar SO 
mechanisms in human and rabbit hearts. Therefore, we examined SO 
in the isolated rabbit heart which, due to its smaller size, has a greater 
incidence of SD and in which detailed mechanisms can be examined. 
We examined patterns of activation sequence and action potential 
characteristics during sustained fibrillation and preceding SO. 
Perfusate was modified Krebs-Henseleit solution (Ko=4.0 mM, 
37°C). Ventricular fibrillation (VF) was induced with I sec 60 Hz to 
epicardial patch electrodes. Sustained VF was terminated through the 
patch electrodes. Monophasic action potentials (MAP) and epicardial 
electrograms were monitored. Spontaneous defibrillation was defined 
as conversion to sinus rhythm after 3 sec of VF. Cycle length (CL). 
action potential duration (APD), and synchronization (SYN) of endo•
and epicardial MAP's (measured as activation time difference) during 
VF, the ftrst two beats of altered rhythm preceding SD (N+2), and the 





VF N+2 N-2 
8U 4 89 ± 5 (P<O.02) IOU 4 (P< 0.001) 
81 ± 4 68 ± 3 (P<O.OOI) 84 ± 4 (P=NS) 
1 ± 0 0.75 ± (P<O.OOI) 0.79 ± 0.02 (P< 0.001) 
16 ± 4 23.6 ± (P=NS) 10 ± 4 (P=NS) 
These results show an abrupt change from VF patterns to 
tachyarrhythrnia rhythm with diastole (APD/CL<I). Therefore SYN 
improves leading to longer reentry loops as shown by the prolonged 
cycle length before conversion. 
lACC Vol. 21, No.2 
February 1993:307A 
921-46 
An In-Vitro Model of Electrical Defibrillation 
Robert J. Sweeney, Robert M. Gill, Philip R. Reid, Ully Research 
Laboratories Division, Eli Ully and Company, Indianapolis, IN 
We studied electrical defibrillation using a one-dimensional tissue 
bath model. Thin strips (3 em x 1 cm) of epicardial tissue were ob•
tained from canine RV and super-perfused with Tyrode's at 37° C in a 
slightly larger tissue bath. The long walls of the bath were Ag-AgCI 
electrodes across which 5 ms rectangular shocks were delivered. The 
strip was electrically paced (200 msec intervals) at one end and 
cellular impalements were maintained in the center (cell 1) and at 
the other end (cell 2) using glass micro-electrodes. Shocks were 
delivered at selected times aiter the last pacing stimulus and were 
electronically controlled to produce minimum artifact and the desired 
voltage gradient at cell 1 . Shown are superimposed tracings of the 
simultaneously recorded action potentials (AP) from both cells with 
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With no shock, the last pacing activation is seen reaching cell 1 and 
then cell 2 about 35 msec later. All shocks extended cell 1 AP but 
were too early in the cell 2 AP to extend it significantly. A 2 V/em 
shock directly excited tissue closer to the pacing site and produced a 
new activation which is seen passing cell 1 and then cell 2. A 3 V/cm 
shock produced greater AP extension in cell 1 and also produced a new 
activation which is seen developing near cell 1 and passing cell 2. 
Stronger shocks produced even greater AP extension and failed to 
produce new activations. The direct observation that weak, but not 
strong, shocks produce new activations strongly supports the concept 
that AP extenSion by the shock contributes to defibrillation. 
921·47 
Accuracy of Defibrillation Efficacy Estimates From Upper 
Limit of Vulnerability Step-down Testing 
Robert A. Malkin, Joseph J. Souza and Raymond E. Ideker, Duke Uni•
versity Medical Center, Durham, NC 
Since a significant correlation between the upper limit of vulnerability 
(ULV) using the step-down approach and the defibrillation threshold 
has been reported, we examined if ULV step-down measurements were 
an effective means of estimating defibrillation efficacy. In 10 pigs, 2 ULV 
step-down sequences were obtained by pacing at 250 ms intervals from 
an electrode pair in the RV apex and then delivering shocks at the peak 
of the T wave, starting at 500V and decreasing the stimulus strength 
in 20V steps until fibrillation was induced. The ED 50, ED80 and ED90 
(the voltage which defibrillates 50%, 80% and 90% of the time) were 
obtained from logistic regression on 50 or more defibrillation attempts. 
Shocks were symmetric, biphasic, 11 ms pulses delivered between an 
electrode in the RV apex (the cathode) and an electrode in the SVC 
and a cutaneous patch (the anodes). Two ULV step-down based es•
timators were examined for the ED50, ED80 and ED90: (1) ULVstp 
- the average of the lowest voltages which did not induce fibrillation 
during the two ULV step· down sequences, and (2) BLUE - the linear 
regression, ULVstp based estimator which minimizes the rms error. 
ED 50 ED80 ED90 
population mean (voits) 336 391 422 
ULVstp, ED corr. coef. 0.613 0.581 0.511 
pop. stand. dev. (volts) 44.4 54.6 66.4 
rms error (volts) ULVstp 51.0 56.0 82.5 
rIns error (volts) BLUE 32.9 42.0 54.2 
If the populatIOn mean IS used as the estimate for all subjects, the rms 
error is the population standard deviation. Therefore, the ULVstp is 
not an effective estimator of defibrillation efficacy, since the population 
mean yields consistently lower rms errors. The correlation coefficients 
suggest that a linear estimator can be based on ULVstp. However, the 
BLUE shows that this estimator performs only somewhat better than 
the population mean. We conclude that simple, linear ULV step-down 
techniques cannot be used to accurately estimate defibrillation efficacy. 
ABSTRACTS 
921·48 
Dietary Hypomagnesemia Enhances Epinephrine mediated 
Decrease in Defibrillation Threshold in Pigs. 
P. Srivastava, P.J. Varghese, R. O'Donnell, 
George Washington University, Washington, D.C. 
Hypokalemia is known to alter catecholamine mediated 
excitability of the heart. Effect of Magnesium deficiency (MgD) 
on Defibrillation Threshold (On) is unknown. We studied the 
effect of MgD on OFT with and without Epinephrine (E) in 
closed chest pig model. Seven controls (C) and 7 MgD pigs 
(serum Mg levels < 1.3 meq/l) produced by Mg ++ free diet for 
4 weeks were studied. Pigs were anaesthetized by 
intravenous Pentobarbital. A 7 em braided mesh tip catheter 
electrode was placed at RV Apex (cathode) and large 
subcutaneous patch (CPI) positioned at the point of maximum 
cardiac impulse (anode). After 20 sec of ventricular fibrillation, 
defibrillation was achieved using 8 msec monophasictruncat•
ed trapezoid shocks at different energy levels in random 
fashion. OFT so curves were obtained in C and MgD pigs 
before and aiter E infusion using logistic regression analysis. 
E infusion was titrated to keep the blood pressure, twice the 
Baseline (B). 
BDFTso 
Post E DFTso 
% Change 
(Q) (n=7) 
37.5± 9.5 J 
25.6 ± 10.3 J 
31.7 
MgO (n=7) J=Joules 
36.6± 6.5 J 
13.4 ± 3.4 J 
63.4 p=<0.OO3 
Conclusion: Lowering of OFT with E infusion is markedly 
enhanced in presence of MgD. This may be due to the effect 
of MgD on cardiac excitability and may have clinical signifi•
cance. 
921·49 
Optimal Capacitance Value For A Parallel·Series DefIbrillator 
307A 
Gregory P. Walcott, Dennis L. Rollins, William M. Smith, Raymond 
E. Ideker Duke Univ. Medical Center, Durham, N.C. 
Previous work has shown that a biphasic waveform created by 
switching two capacitors from parallel to series between phases defi•
brillates with a lower leading edge voltage (LEV), peak voltage 
(PV), and total delivered energy (TDE) than a single capacitor 
biphasic waveform of the same phase durations. This study was 
designed to test the defibrillation efficacy of two parallel-series capa•
citor systems. 
Six open-chested swine, approx. 25 kg, were studied. Two epicar•
dial patches, 22 cm2 and 20 cm2 were sewn to the R.V. outflow tract 
and the L. V. freewall. Two parallel-series capacitor systems, a 300:75 
... f and 150:37.5 ... f, were used which produces a waveform where 
phase 2 LEV was twice phase 1 trailing edge voltage (TEV). Nine 
waveforms were examined: 4:0 ms, 4:2, 4:4, 6:0, 6:3, 6:6, 8:0, 8:4, 
8:8. Defibrillation thresholds (OFT) were determined using an 
up/down technique with a final step size of 10 V. 
The 300:75 fl.f system defibrillated at a significantly lower LEV 
(all p's < .05) than the 150:37.5 fl.f sytem across the series of 
waveforms. The 150:37.5 ... f system defibrillated at a lower TOE 
than did the 3OO:75 ... f. All the biphasic waveforms difibrillated at 
lower LEV and TOE than either of the monophasic waveform series 
tested. The waveforms with the second phase 112 the period of phase 
1 defibrillated with a lower LEV and TOE than the biphasic 
waveforms with both phases of equal duration. The 150 ... f capacitor 
system required a lower charging energy than did the 300 ... f capaci•
tor system. The biphasic waveforms required less charging energy 
than did the monophasic waveforms; the waveforms with the second 
phase 112 of the first phase required a lower charging energy than did 
the waveforms with equal phase periods. 
These results suggest that the optimal system among the ones 
tested here is one which uses a 150:37.5 fI. parallel-series capacitor 
system to create a biphasic waveform with the second phase 112 the 
period of the first phase; TDE for these waveforms Was 2.0 ::.6 J. 
308A ABSTRACTS 
921-76 
Subpectoral laplantation of • Cardiovertor•
Defi brilla tor CoIIbined Vi tb a Nonepieardial Lead 
Systea: A Novel Approach. 
John B. Ip, Jorge Camunas, Davendra Mehta, Elena Pe, J 
Anthony Gomes. Mount Sinai Medical Center, New York NY. 
The current nonepicardial implantable cardiovertor•
defibrillator (ICD) systems are investigational and are 
not available for general use. Ve studied the efficacy 
of a nonepicardial ICD system using FDA- approved 
transvenous leads and patch in 10 consecutive patients 
who were candidates for ICD therapy. The mean ejection 
fraction was 29+8%. The system consisted of a 8F 
bipolar endocardial lead (Cardiac Pacemaker Inc (CPI) 
BT-I0) posi tioned in the right ventricular apex for 
rate sensing; a llF spring coil electrode (CPI, C-lO) 
was positioned in the superior vena cava and the right 
atrium. A large patch (CPI, L67) was placed 
submuscularly at the anterolateral chest wall near the 
cardiac apex via a submammary incision. All patients 
underwent at least 3 defibrillation tests at 20J or 
less. Eight patients (BO%) had satisfactory thresholds 
with the mean energy requirement of ll.5+3J. Two 
patients (20%) had threshold >20J and required 
epicardial placement of the patch via a limited lateral 
thoracotomy. All generators (CPI-l600) were placed 
subpectorally in the lateral chest wall via the same 
submammary incision. The mean hospital stay of patients 
was 3.5 days. No migration of the generators was noted 
during follow up. 
Conclusions. Ve concluded that subpectoral implantation 
of ICD combined with a nonepicardial system using 
FDA-approved components appears to be feasible and well 
tolerated. Excellent defibrillation thresholds were 
achieved in BO% of patients. Easy transition into an 
epicardial system could be done wi th a small lateral 
thoracotomy if necessary. 
921-77 
First Experience with a new Biphaslc 
cardioverter Defibrillator System 
Hans-J. Trappe, Olaf Conrad-Weber, Hans-G. 
Fieguth, Thorsten Wahlers, Birgit Kileblock, 
Helmut Klein, Paul R. Lichtlen. Uni versi ty 
Hospital Hannover, Germany 
We studied the new cardioverter defibrillator 
(ICO) Ventak P 2 with biphasic (B) waveforms 
(W) in 17 patients (pts) with ventricular 
tachycardia (VT) or fibrillation (VF). ICD 
implantation was performed in all pts with a 
bidirectional transvenous lead system 
(Endotak, CPI). Thirteen pts had coronary 
disease and 4 pts dilated cardiomyopathy. The 
mean LV ejection fraction was 30±12%. Intra•
operatively, defibrillation threshold (OFT) 
testing was performed with monophasic (M) W 
shocks in 9 pts (G 1) and BW in B pts (G 2). 
Results: In all pts with BW, mean OFT was 520 
Joule, whereas OFT with MW was 30 Joule in 3 
pts. OFT was significantly lower with BW both 
in induced VT and VF: 
OFT-MW OFT-BW P 
VF 1B±10 Joule 10±B Joule <.05 
VT 12±10 Joule B±6 Joule <.05 
During the mean follow-up of B±2 months no pts 
died, 13 pts had ICD discharges (76%). 
Conclusions: ICD with BW leads to lower DFTs 
compared to MW. Therefore, BW should be used 
in the future, particularly in pts with poor 
LV function. 
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Relationship between L-Arginine Metabolism and 
Exercise-Induced Hemodynamic Alterations in Coronary 
Vasculature 
Yasuto Nishinaka, Toshikazu Sobue, Mitsunori Iwase, Masahilo 
Ubi, Satoru Sugiyama, Mitsuhiro Yokota, Hidehiko Saito, Takayuki 
Ozawa. University of Nagoya, Nagoya 466, Japan 
Endothelium-derived relaxing factors (EDRF) induce coronary 
vasodilation and these disturbances might lead to ischemic heart 
disease. L-Arginine is the precurser of nitric oxide, one of the EDRF, 
and its metabolism might play an important role in regulating 
coronary vasculature and other hemodynamics. To clarify the 
relationship between L-arginine metabolism and hemodynamics, we 
investigated the effects of exercise on the alterations of L-arginine 
metabolism and hemodynamics in coronary vasculature. Sixteen 
patients with stable effons angina pectoris underwent multigrade 
bicycle ergometer exercise tests. Arterial blood pressure, pulmonary 
artery wedge pressure, and coronary sinus blood flow were 
measured. Samples of arterial blood and coronary sinus blood were 
obtained at rest, peak exercise, and 6 min after exercise, respectively. 
Coronary vascular resistance significantly decreased during exercise 
(from 1.08 ± 0.10 to 0.71 ± 0.09 mmHglmVmin, p<O.Ol). Arterial 
systolic blood pressure, pulmonary artery wedge pressure, and L•
arginine uptake in coronary vasculature were increased significantly 
by exercise (from 130 ± 6 to 174 ± 7 mmHg, p<O.OI, from 4 ± 1 to 
22 ± 3 mmHg, p<O.OI, and from 337 ± 457 to 1075 ± 824 
nmol/min, p<O.OI, respectively). Funhermore, a significant 
correlation was observed between the decrease of coronary vascular 
resistance and the increase of L-arginine uptake in coronary 
vasculature (r=O.69, p<O.Ol), and the increase of L-arginine uptake 
in coronary vasculature was inversely related to the increase of 
pulmonary artery wedge pressure (r=-0.57, p<O.05). These results 
suggest that changes in L-arginine metabolism might be associated 
with coronary vascular regulation and hemodynamics. Clinical 
application of L-arginine to coronary vascular disease might be 
expected. 
922-91 
Effect of the Exercise Capacity on Determination 
of Anaerobic Threshold in Cardiac Patients 
Hiroaki Kitaoka, Takao Yoshioka, Yoshiaki Okano, Hiroshi Takaki, 
Jun Tarnai, Norifumi Nakanishi, Kazuo Haze, Katuro Shimomura 
National Cardiovascular Center, Suita, Osaka, Japan 
An aerobic threshold (AT) is not necessarily determined even in the 
healthy subjects (HS). The aim of this study is to show the percentage 
of determination of AT in patients with cardiac disease (CD), and to 
clarify the factors which affects the detection of AT. 396 CD (263 
males, 133 females) and 70 HS (44,26) were studied. Each subject 
performed a symptom-limited ramp (15 watt/min) exercise test on a 
cycle ergometer in a sitting position. V02, VC02 and VE were 
determined by respiromonitor. Three curves during exercise (v-slope, 
VE/V02, ventilatory exchange ratio (R» were separately analyzed to 
determine AT. Each curve was marked by six experienced reviewers 
according to the clearness of recognition of AT point as follows; 1 ) 
Points of all reviewers were in perfect agreement: 2, 2) 3 or more 
reviewer's points were in agreement: 1, 3) 3 or more reviewers did 
not agree or could not decide the point: O. Therefore, the most clear 
AT point was given 6 points. We decided a point as AT in each 
patient whose total score was more than 4. Results: The acquired 
points in each curve were as follows; v-slope (2=66.9%, 1=:6.6%, 
0=26.5%), VE/V02 (2=:65.9%, 1=:9.1%,0=:25.0%), R (2=71.0%, 
1=9.1%,0=19.9%). The subjects whose total score over 4 points in 
CD and HS were 287 (72.4%) and 49 (70%). There were no signifi•
cant difference between them. The ratio to detect AT in CD whose 
peak VOz was more than 1000 ml/min (81,5%) was significantly 
greater than those with peak V02 less than 1000 mVmin (66.3%). 
Conclusion: 1) In about three fourth patients with cardiac disease, AT 
could be determined by expiratory gas analysis. 2) The detection ratio 
of AT were not different among v-slope, VE/V02 and R. 3) The 
reduction in peak V02 might obscure the detection of AT point. 
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922-110 
l5dMmic Threshold During Steady-State Activity and Relation to Anaerobic 
Tbreshold in Patients with Coronary Artery Disease 
Mark Smilovitch, Michele de Guise, Mutin Juneau. Montreal Heart Institute, 
Montreal, Canada 
To investigate the mechanism of exercise-induced ischemia, we compared 
pbysiologic variables (HR, BP, 0, uptake) and time 10 the onset of ischemia 
during incremental exercise and submaximal steady-stale exercise. Twelve pts 
(mean age 57 ± 7 yrs) with documented coronary di_ and exerciae-induced 
ischemia completed a symplom-Iimited incremental test using a modified NaughloD 
protocol, foUowed by I steady-state test during which pts walked on the treadmill 
with a O· slope for 20 min atl speed adjusted 10 maintain HR 10 beats/min lower 
than HR at the onset of ischemia during the first test. Tbe tests were performed 
at the same time of day, and were separated by a mean of 4±3 days (range 1-12). 
Ischemic threshold was defined as the onset of I DUD ST depression. Anaerobic 
tbresbold (An was determined ooninvasively by 0, and CO, analysis using the V•
slope method. All pts displayed exercise-induced ischemia during the incremental 
test; 6 also showed exercise-induced ischemia during the ateady-state test, at a 
lower HR (102± 13 vs 114± 17, p=0.OO2) and rate-pressure product (15,753 
±2,411 vs 18,683±3,212, p=0.OO7) compared 10 the incremental test. Time 10 
the onset of ischemia did oot differ significantly betw_ the 2 tests. CompariSOD 
of pts with and without ischemia during steady-state activity indicates that those 
with ischemia were exercising at significantly higher 'II> of the VQ,max, 
representing an intensity of exercise above the AT: 
bcbania (0=6) No isc:bemia (0=6) P 
Mean VO, ('II> VQ,max) 78±32 48±9 =0.05 
Mean VO, ('II> An 159±83 82±6 <0.05 
CondoNoO: Exercise-induced ischemia can occur during submaximal steady-state 
activity at a significantly lower HR and rate-pressure product than during an 
incremental test. Duration of exercise was oot a determining faclor. Intensity of 
exercise above the anaerobic tbresbold appears 10 be an important determinant of 
the ischemic tbresbold during steady-state activity in coronary patients. 
922-111 
Is Availability of L-Arginine, the Substrate for Nitric Oxide 
Synthesis, Rate-Limiting for Exercise-Induced Vasodilation in 
Humans '! 
David M. Gilligan, Julio A. Panza, Crescence M. Kilcoyne, 
Arshed A. Quyyumi. NHLBI, Bethesda, MD. 
We have found that inhibition of endothelial nitric oxide (NO) 
synthesis by N" monomethyl-L-arginine reduces exercise-induced 
vasodilation in the human forearm, indicating that NO contributes 
to exercise vasodilation. Availability of L-arginine, the substrate 
for NO synthesis, is rate-limiting for the endothelium-dependent 
vasodilator response to acetylcholine. Therefore, to determine if 
availability of L-arginine is rate-limiting for exercise-induced 
vasodilation, 10 normal subjects (5 male, age 41 ±9 years) 
performed forearm exercise during infusions of 5% dextrose, L•
arginine (40j.lmol/ml) and D-arginine (an isomer which is not a 
substrate for NO synthesis). Drugs were infused via the brachial 
artery. Exercise (EX) was intermittent handgrip at 15%, 30% and 
45 % of maximum grip strength. Forearm blood flow was measured 
by strain gauge plethysmography and forearm vascular resistance 
(mmHg/ml' .min·'.IOOml volume") was deriVed. Neither L nor D•
arginine affected resting resistance. The EX resistance results were 
(mean±SD): 
EX 15% EX 30% EX 45% 
5% dextrose 13.6±6.9 7.7±4.l 4.8±2.l 
L-arginine 12.7±3.8 7.2±3.4 4.6±2.0 
D-arginine 12.6±4.3 7.4±3.5 4.8±2.3 
Infusion of L-arginine did not affect the vasodilator response to 
exercise. These results indicate that availability of L-arginine, the 
substrate for endothelial production of NO, is not rate-limiting for 
exercise-induced vasodilation in humans. 
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922-112 
Response of Plasma L .Arginine Concentration to 
Exercise·lnduced Hemodynamic Alterations 
Yasuto Nishinaka, Toshikazu Sobue, Mitsunori Iwase, Masahiko 
Ukai, Satoru Sugiyama, Mitsuhiro Yokota, Hidehiko Saito, 
TakayulO Ozawa 
University of Nagoya, Nagoya 466, Japan 
L-Arginine is the precurser of nitric oxide, one of the 
endothelium-derived relaxing factors, and its metabolism might play 
an important role in regulating blood pressure and other 
hemodynamics. To clarify the response of plasma L-arginine 
concentration to hemodynamics, we investigated the effects of 
exercise on the alterations of plasma L-arginine concentration. 
Twenty patients with stable efforts angina pectoris underwent 
multigrade bicycle ergometer exercise tests. Arterial blood pressure 
and pulmonary artery wedge pressure were measured and samples of 
arterial blood were obtained at rest, peak exercise, and 6 min after 
exercise, respectively. Arterial systolic blood pressure, pulmonary 
artery wedge pressure, and plasma L-arginine concentration were 
increased significantly by exercise (from 133 ± 5 to 180 ± 8 mmHg, 
p<O.Ol, from 5 ± I to 20 ± 2 mmHg, p<o.Ol, and from 87 ± 5 to 93 
± 5 mg/dl, p<O.OI respectively). Furthermore, a significant 
correlation was observed between the increase of arterial systolic 
blood pressure and the increase of plasma L-arginine concentration 
(r=0.71, p<O.OI), and the increase of plasma L-arginine 
concentration was inversely related to the increase of pulmonary 
artery wedge pressure (r=-0.6O, p<0.05). However, no significant 
correlation was observed between the increase of plasma L-arginine 
concentration and cardiac output or systemic vascular resistance. 
These results suggest that plasma L-arginine concentration responds 
to the increase of arterial blood pressure. Changes in L-arginine 
metabolism associated with exercise alleviate exercise-induced 
hemodynamic alterations. 
922·113 
Does Exercise During Pharmacologic Vasodilation Increase 
Hyperemic Myocardial Blood Flow? 
Peter MUller, Johannes Czemin, Yong Choi, Anatole Kim, Denis 
Buxton, Egbert Nitzsche, Karl Sun, Michael E. Phelps, Heinrich 
R. Schelbert, UCLA School of Medicine. Los Angeles, CA 
To test the hypothesis that exercise during pharmacologically 
induced coronary vasodilation enhances the hyperemic 
response, we quantified myocardial blood flow (MBF) with N-13 
ammonia and PET in 11 normal volunteers (21±3 years) at 
baseline, 1 hr later during N adenosine (AD 140 mg/kg/min) 
and again 1 hr later during IV adenosine (140 mg/kg/min) plus 
supine bicycle exercise (AD+EX, 125 watts). An additional 9 
normal volunteers (age 31±13) were studied at baseline and twice 
















MBF in the 9 control subjects was similar during both AD 
infusions (2.6±O.5 vs. 2.S'±O.9 mi/min/g; p=NS). Tachyphylaxis 
to AD was therefore unlikely to account for the lower MBF and 
flow reserve (MFR) during AD+EX. While exercise increased 
mean arterial and, thus, coronary perfusion pressure (BP) during 
coronary vasodilation, its effect 'on MBF was possibly offset by the 
higher heart rates with shortening of the diastole and an increase 
in contractility with greater vasocompression and, thus higher 
coronary resistance. We conclude that supplementation of 
pharmacologic stress by exercise fails to increase hyperemic MBF. 
The results indicate the possibility to study noninvasively 
coronary circulatory physiology in human myocardium. 
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922·114 
Effects of Flecainide on Heart Rate and Ventricular 
Conduction Responses to Exercise Testing in Patients 
W;thout Structural Heart O;sease 
Jian·An Wang, Chu-Pak lau, Yau-Ting Tai, Bi-Zhen Wu. 
Division of Cardiology, Department of Medicine, Queen Mary 
Hospital, University of Hong Kong, Hong Kong. 
The effects of flecainide(F) on heart rate and ventricular 
conduction during exercise testing were investigated in 24 
patients (age, 47±11 year) with paroxysmal 
supraventricular tachyarrhythmias, who had normal cardiac 
structure and sinus node function. Paired treadmill 
exercise tests using the Bruce protocol were performed 
after I week of treatment with F (200mg/day) or placebo in 
a double blind, randomized design. Exercise test was 
termi nated because of fatigue in all subjects. At all 
stages of exercise, F significantly reduced sinus rate 
(see figure) and double product (P<O.OS) compared with 
placebo, but not at rest. Tt:e drug did not significantly 
change resting and exercise systolic blood pressures, and 
exercise duration. F-induced QRS prolongation ranged from 
BI±II msec at rest to 97±14 msec at peak exercise 
(P<O.OI). Complete and incomplete right bundle branch 
block developed in 2 pat i ents ......... 
during exercise on F but not • OJ •• 'uc_ . ~~ad~~a~~~~l~:~~~!~ T~!m~!~~c~~~~ ~':: 
in exercise heart rate and double = .. ~ 20 product represents the decrease - • 
in myocardial oxygen consumption ExrACI~ LEVEL 
during exercise. The effect of F 1,._ r ....... u , .• _ ttl 
should be considered when we :.~.l"=" -::-;;:~~: ,.•
conduct exercise testing in patients on F. Exercise 
accentuates the F-induced QRS prolongation and may cause 
conduction disturbance in right bundle branch in these 
relatively normal SUbjects. 
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923-1 
Clinical Significance of Silent Cerebral Infarction in Patients 
with Atrial Fibrillation 
Wataru Sasaki, Akihiko Kanazawa, Kazuhiko Maki, Mikio Noguchi, 
Hajime Kimura. MamOEu Miura 
Akita Kumiai Hospital and Akita University, Akita, Japan 
We previously reported by using brain cr scan that asymptomatic patients 
(pts) with atrial fibrillation (AI) had high incidence of silent small cerebral 
infarction (SCI) probably due to thromboembolism. But we don't know whether 
SCI in Pts with Af predicts increased risk for future stroke. To elucidate the 
clinical significance of SCI and promotive factors of stroke in Pts with Af, 97 
consecutive Pts with Af who had had no evidence of stroke at entry were 
followed for 5 years. At entry time, each Pts underwent brain cr scan and other 
cardiac evaluation. 
Five years after entry, 86 Pts (47 ntaIe, av.age 63.5±9.6 yrs at entry) with Af 
were analyzed, excluding 2 Pts with cerebral hemorrhage and 9 Pts with other 
death except stroke. The incidence of SCI was 52% (45 Pts) at entry. The stroke 
probably due to new thromboembolism occurred in 27% (23 Pts) for 5 years 
and 87% (20 Pts) of these strOkes originated from Pts with SCI. In comparison 
between Pts with SCI and Pts without SCI,the occurrence of stroke was signifi. 
cantly higher in Pts with SCI (44% vs 7%, p<0.01). The parameters of blood 
pressure, age, hematocrit and duration of Af at entry were nOl Significantly 
different between Pts with suoke and Pts without stroke. However, the occur· 
rence of strOke was Significantly higher in Pts medicated with diuretic than in 
those without diuretic (36% vs 18%, p<O.05). 
We conclude that SCI in Pts with Af may be a sign of increaced risk for future 
stroke and that diuretic medication to Pts with Af may promote cerebral throm· 
boembolism. 
923·2 
JACC Vol. 21, No.2 
February 1993:31OA 
Evaluation of Relation Between Atrial Septal Aneurysm 
and Cerebrovascular Embolism. 
E. Chammas. L. Goullard. A. Millaire. V. Taverne. 
G. Deklunder. Y. Houdas. 
Hopital Cardiologique. CHU. Lille. France. 
An atrial septal aneurysm (ASA) was diagnosed in 51 
(7 %) of 735 pts referred for Transesophageal echo•
cardiography. 
Among the 735 pts. 184 were referred for evaluation of 
a cerebrovascular embolism (CVE. group 1) and 551 for 
other reasons (group 2). In the grp 1. 31 pts (16.8 %) 
have an ASA versus 20 pts (3,6 %) in the grp 2 
(p<O.OOI). All pts with ASA had contrast echocardio•
graphy ; this test was positive in 68 % of pts with 
ASA and CVE (grp A) and 76 % in pts with ASA without 
CVE (grp B. ns). In grp A, 16 pts/31 have another 
source of embolism such as atrial fibrillation (6). 
cervical lesions compatible with the stroke (3). 
paradoxical embolism (2). antibodies against phospho•
lipids (1). isolated mitral prolapse (2). St Jude 
aortic prosthesis with ineffectual anticoagulation (1) 
and 1 case of aortic dissection responsible for 
peripheric ischemia. In 15 pts/31 no cause has been 
found. The prevalence of ASA was significantly 
(p = 0.01) greater in pts with CVE (15/184) than in pts 
without CVE (20/551). In this series: 16 pts have an 
anticoagulant therapy. 18 an anti platelet therapy, 1 
operated and 16 without treatment. 
It is concluded that isolated ASA is a real source of 
embolism ; the follow up of these pts will allow the 
determination of the best therapeutic option. 
923·3 
Mitral Requrqitation Decreases Risk of 
Throaboembolis. in Atrial Fibrillation•
Associated Left Atrial Bnlarq .. ent 
Joseph L. Blackshear, Lesly A. Pearce, Richard 
W. Asinger for the SPAF Investigators 
Mayo Clinic - Jacksonville, Jacksonville, FL 
Transesophageal echo/Doppler data suggest that 
mitral regurgitation (MR) is associated with a 
reduced prevalence of left atrial (LA) 
thrombi. We tested the hypothesis that the 
presence of MR would also be associated with a 
reduced risk of thromboembolic events in 
patients with atrial fibrillation (AF) and LA 
enlargement. Echo and Doppler data were 
available in 478/568 placebo-treated patients 
with nonrheumatic AF followed for 1.3 years in 
the SPAF I Study. In persons with LA > 2.5 
cm/m2 MR was associated with a 60% reduction 
in thromboembolic events (RR = 0.4, 95% CI = 

















After adjustment for individual clinical risk 
factors, MR in the presence of LA > 2.5 cm/m2 
reduced the risk for thromboembolic events by 
70% (RR = 0.3, 9S% CI 0.1-0.9; p = 0.03). MR 
appears to reduce the risk of thromboembolic 
events in nonrheumatic AF patients with LA 
enlargement. Conversely, patients with AF and 
LA enlargement without MR are at exceptional 
risk for thromboembolic events. 
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923-4 
Thrombin Activation In Dilated Cardiomyopathy 
Simon C Jung, Robert L Wilensky, Jack Zeller, Steve Sawada 
Krannert Instrtute of Cardiology, Indiana University Medical Center. 
Indianapolis, IN. 
In patients with dilated cardiomyopathy, those with severe left 
ventricular(LV) dilation and reduced systolic function are at greatest 
risk for thrombus formation. Additionally, those with nonischemic 
cardiomyopathy (OCM) may have increased thrombin activation 
compared to those with ischemic cardiomyopathy (lsCM). Urinary 
fibrinopeptide A (FPA) levels were obtained from 30 patients 
with IsCM and OCM to investigate thrombin activation. 
Echocardiographic measurements of LV end-diastolic diameter 
(LVdO) and fractional area change (FAC) were obtained. We 
compared FPA levels in patients with IsCM and OCM and in 
those with severe (LVdD>6.0cm) and moderate (LVdO<:S.Ocm) 
LV dilation. No patient had an intraventricular thrombus or serum 
creatinine (Cr) >2mg/dl. FPA levels greater than S.Ong/mg Cr 
were considered elevated. 
Of patients with elevated FPA levels, LVdO did not differ from 
patients with normal FPA levels. However, FAC was 0.18±O.08 
and 0.26±O.10 in elevated and normal FPA groups, respectively, 
(p<0.05). 
Seventeen patients had OCM and 13 had IsCM. FPA levels 
were elevated in 5/13 (38%) patients with IsCM and 9/17 (53%) 
with OCM (p::NS). Mean FPA levels were similar in IsCM and 
OCM groups (S.76±1.39 and 7.56±1.15ng/mg Cr, respectively, 
p=O.SS). 
Mean FP A levels were not significantly increased in severe LV 
dilation in comparison to moderate LV dilation (7.5±1.2 and 
S.6±1.7nglmg Cr, respectively, p=O.S9). 
In conclusion, patients with IsCM and DCM have similar incidence 
of thrombin activation. The severity of LV dilation was not 
correlated with evidence of thrombin activation. Patients with 
thrombin activation have more severely reduced systolic function. 
923-5 
Non-invasive evaluation of carotid atherosclerosis in 
patients with hypersensitive carotid sinus syndrom 
loannis Kallikazaros, Eleftherios Tsiamis, Christodoulos 
Stefanadis, Manolis Skoubourdis, Filippos Triposkiadis, loannis 
Vassiliadis, loannis Gialafos, Paul Toutouzas. 
Division of Cardiology, Athens University, Greece 
The purpose of this prospective study was to evaluate with 
echocardiography the incidence and the extent of carotid 
atherosclerosis (CA) , especially in the carotid sinus region in 
patients with hypersensitive carotid sinus syndrom (HCSS). 
Fifteen patients (10 men and 5 women, age 56:!: 10 years, range 
56-76 years) with clinically and electrophysiologically 
documented HCSS were studied. Of these, 14 had right sided 
hypersensitivity and 1 left sided. In 13 patients HCSS was of 
cardioinhibitory type and in 2 of mixed type. Atherosclerotic 
lesions in the common carotids and their branches were 
assessed with combined two-dimensional and pulsed Doppler 
echocardiography (Duplex technique). Based on the degree of 
luminal stenosis the following categories of CA were determined: 
A=O%, B=1-15%, C=16-49%, 0=50-79%, E=80-99%, F=total 
occlusion. CA was present in 11 out of 15 patients (73.3%) 
whose CA category was: B: n=2, C: n=5, 0: n=2, E: n=2. The 
CA category in the 13 patients with cardioinhibitory HCSS type 
was: B: n=2, C: n=3, 0: n=2, E: n=2. The 2 patients with 
mixed type HCSS were in class C. In 8 out of the 11 patients 
(72.7%) with CA, atherosclerotic lesions were also found in the 
region of carotid sinuses. 
Conclusion: in 73.3% of patients with hypersensitive carotid 
sinus significant atherosclerotic lesions in the carotid arteries 
and the hypersensitive carotid sinuses are observed. 
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923-6 
A Dose-Ranging Study of rt-PA for the Thrombolytic Therepy of Deep Vein 
Thrombosis: Results of a Multicenter Trial 
Erhard Seifried. Rainer Zimmermann. Wolfgang Schramm. Erich Bluhmki, 
Walter Haarmann, Departments of Internal Medicine. Universities of Ulm 
and MOnchen. Rehabilitation Hospital. Heidelberg and Dr.Karl Thomae 
GmbH, BiberachIR., Germany 
To assess clinical effects and the dose-response relationship of rt-PA in the 
thrombolytic therapy of deep vein thrombosis (DVT), 164 patients (pts) 
aged 18-60 were randomly allocated to intravenous liv) doses of 0.75 
(group I. 27 pts). 0.5 (group II, 27 pts), 0.375 (group III. 54 pts) and 
0.25mg/kg rt-PA (group IV, 56 pts) for 7d; concomitant iv heparin was 
given to maintain aPTT within therapeutic range. Study endpoints were 
phlebographic vessel status on day 4 and lor 7 and side-effects. Success 
was defined as complete or partial recanalization. failure as minor or no 
thrombus alteration. 8Ieeding events were recorded only when they neces•
sitated interruption of therapy. Results: 
rt-PA dose Recanalization 1%) Marder score Bleeding 
mg/kg/day complete partial pre-lysis post-lysis events (%) 
0.75 29 25 23±8 16±8 44 
0.5 23 35 28±11 20± 12 26 
0.375 15 49 22±9 16±9 15 
0.25 9 58 26±9 21 ± 12 8 
Differences between pre- and post-lYSIS Marder score values were 6tatlstl•
cally significant (p <0.001) for all groups. no significant change of fibrino•
gen-levels were observed. One bleeding on d8 was fatal; no fatal or serio•
US pulmonary embolism or cerebral hemorrhage was observed. 
Conclusions: In the doses applied. rt-PA is a highly fibrin selective thera•
peutic agent and leads to complete or partial recanalisation in 54-68% of 
DVT opts. No important change of success rate was observed with increa•
sing doses. The rate of side effects seems to be dose-dependent. As the 
investigated therapy regimens were not superior to established strategies, 
new concepts remain to be examined. A promising new approach could be 
the loco-regional lysis with rt-PA which will be investigated in near future. 
923-7 
Leg Perfusion During Exercise Using Tc99m Sestamlbl: Findings 
In Patients with Occlusive Vascular Disease 
L. Samuel Wann, Charles Hellman, Gerald Dorros; St. Luke's Medical 
Center, Milwaukee, Wisconsin 
Functional evaluation of the ITlJscular perfusion of the lower 
extremnies is i~rtant for accurate diagnosis and appropriate 
intervention in patients with occlusive peripheral arterial disease 
(PAD). We injected 30 mCi of Tc99m sestamibi IV during maximal 
treadmill exercise in 37 patients who subsequently had arteriography 
for PAD. Subsequent anteroposterior scintigrams showed excellent 
resolution of individual muscle groups. Quantitative (mean pixel 
intensity) and semi-quantitative (visual) analysis of the images 
compared favorably with arteriographic findings of greater than 70% 
stenosis: 
Ouantitative Semiquantitative 
T C F T C F 
True Pos. 24 35 45 28 41 43 
False Pos. 5 8 11 0 0 2 
True Neg. 23 13 8 27 21 18 
False Neg. 22 17 5 19 11 6 
Sensit. % 52 67 90 60 79 88 
SpecH. % 82 62 42 100 100 90 
KEY: T-thigh C-caH F-foot 
We conclude: Tc99m sestamibi perfusion imaging of the legs can 
demonstrate relevant areas of hypoperfusion during exercise in 
patients with PAD. 
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923-35 
Evaluation of Endothellum.oependent Vasodilation In the 
Human Femoral Circulation with Intra-Arterial Doppler: 
Impairment by Hypercholesterolemia 
Helgi Oskarsson, James D. Rossen, Brook D. Scott, Robert L. Minor 
Jr., Michael D. Winniford. Univ. of Iowa and VAMC, Iowa City, IA 
Repeated assessment of endothelium-<lependent vasodilation 
(EDV) in the coronary circulation is logistically difficult. To explore 
the study of endothelial function in a more easily accessible vascular 
bed, we extended the use of intra-arterial Doppler catheter flow 
veloCity measurements to assess the effect of hypercholesterolemia 
on EDV in the leg. Changes in femoral artery blood flow velocity 
(0/06 FFV) were measured with a 3F Doppler catheter inserted via 
the contralateral femoral artery at control and during intra-arterial 
infusion of saline, acetylcholine (ACH, 0.2-200 I19/min), and a 
maximally dilating dose of adenosine in 17 patients. Fasting total 
cholesterol (TC, mg/dl) was <220 in 9 patients (Low TC, 
TC=188±5, mean±sem, age 48±3 yrs) and was >220 in 8 patients 
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There was no significant difference in the responses to adenosine. 
Conclusions: Endothelium-<lependent vasodilation in the femoral 
circulation can be assessed using Doppler catheter methodology 
and is impaired in hypercholesterolemia. Measurement of EDV in the 
leg using this or other less invasive methods may simplify repeated 
assessment of endothelial function during medical interventions. 
923-36 
Augmentation by HYperlipidemia of Plas.inogen Activator 
Inhibitor Type-l Expression in Walls of Injured Vessels 
Hirofumi Sawa, Satoshi Fujii, Burton E. Sobel. Washington 
University, St. Louis, Missouri 
Plasminogen activator inhibitor type-l (PAl-I) attenuates 
fibrinolysis and may impair vascular remodel ing after 
injury thereby contributing to atherogenesis or resteno•
sis. This study was performed to determine whether hyper•
lipidemia induced by cholesterol plus peanut oil feeding, 
a regimen atherogenic in rabbits, increases local PAI-I 
gene expression in response to aortic endothelial injury 
induced with polyethylene tubing over 8 weeks (n • 31). 
Hyperlipidemia, with or without injury increased plasma 
PAl-I activity only modestly (15.9 ± 7.6 (SO) arbitrary 
units (AU)/ml vs 5.7 ± 4.1 in controls). However, injury 
plus hyperlipidemia induced increases in aortic PAI-l mRNA 
expression (1.9 fold over control, Northern blots) in 
neointimal endothelial cells (positive for Factor VIII and 
thrombomodulin by immunocytochemistry), in de-differenti•
ated vascular smooth muscle cells (positive for embryonic 
myosin heavy chain), and in macrophages (positive for RAH-
11) as shown by in situ hybridization (n • 10). The in•
creased PAI-l gene expression was paralleled by co-local•
ization of PAI-l protein. Neither vitronectin (Vn), known 
to stabilize PAl-I, nor Vn mRNA increased in liver. How•
ever, marked accumulation of the Vn protein occurred in 
aorta of hyperlipidemic animals with or without vascular 
injury (5 fold over control, Western blots) in subendothe•
lial fibrotic tissue as shown by immunocytochemistry. In 
addition, Vn mRNA, detected by in situ hybridization, in•
creased in the neointima. Thus, vascular injury augments 
PAI-l and Vn gene expression locally, particularly when 
hyperlipidemia is present. The increases in both may po•
tentiate accumulation of extracellular matrix and thereby 
accelerate atherosclerosis. 
923-37 
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The Clinical Consequences of Penetrating Aortic Ulcer 
(Aortic Intramural He.at~) 
Peter C. Spittell, William D. Edwards, Anthony W. 
Stanson, Peter C. Pairolero 
Mayo Clinic, Rochester, Minnesota 
Penetrating aortic ulcer (PAU) is clinically similar to 
distal (Type III) aortic dissection (DAD). The distinc•
tion is important, as the natural history of PAU is not 
well-defined. 56 patients (pts) (35 men and 21 women) 
with PAU proven by computed tomography (CT), aorto•
graphy (AOR), surgery, and/or autopsy are the basis of 
this report. Their mean age was 71 years (range 52-88 
years). 47 pts (84%) had hypertension, 26 pts (46%) had 
an associated abdominal aortic aneurysm (AAA). 41 pts 
(73%) presented with acute chest pain, while 12 pts 
(21%) were asymptomatic and 3 pts (5%) died suddenly. 
Of the 19 pts (36%) treated medically, 14 (74%) survived 
to hospital discharge. Repeat CT scans (mean 9 months) 
were performed in 8 pts. In 4, the intramural hematoma 
(1M) resolved but there was localized aortic dilatation 
at the site of PAU, 34 pts (64%) underwent surgery; 
6 pts (18%) died in-hospital, 28 pts (82%) survived to 
hospital discharge. 6 pts (18%) treated surgically 
developed paraplegia postoperatively. Pathologic exami•
nation of surgical and autopsy material revealed 1M in 
19 pts (60%), pseudoaneurysm in 7 pts (22%), saccular 
aneurysm in 3 pts (9%) and transmural aortic rupture in 
3 pts (9%). 
Conclusions: (1) Despite the similar presentation of 
PAU and DAD, there are important differences in the 
clinical outcome, (2) Pts with PAU have an increased 
incidence of AAA, (3) PAU may result in formation of an 
1M, pseudoaneurysm, saccular aneurysm or transmural 
aortic rupture, (4) Definitive diagnosis of PAU with CT 
or ADR is essential, and (5) selection of medical or 
surgical therapy of PAU should be individualized. 
923-38 
RATE AND MANAGEMENT OF PALMAZ SCHATZ STENT 
THROMBOSES IN PERIPHERAL ARTERIAL APPLICATION. 
A SINGLE CENTER EXPERIENCE CONCERNING 357 STENTS IN 268 
PATIENTS. 
Max Amor. Michel Henry. Gerard Ethevenot. Isabelle Henry. Mohamed 
Allaoui. Claude Amicabile. Richard Beron. Essey Clinic. Nancy, France. 
Among 268 symptomatic patients (232 male. 36 female. mean age 63 to.7 
years). having 357 Balloon Expandable Palmaz-Schatz stents (BEIS) (183 
BEISl148 iliac arteries. 162 BEIS/108 femoro-popliteal arteries. 12 
BEISl12 femoro-popliteal grafts). and followed during a mean period of 20 
to.5 months (range 1-38 months). 21 patients (8%) (18 male, 3 female) 
had a stent thrombosiS (S.T) (6 iliac. 13 femoro-popliteal. 2 by-pass 
stenoses). All pts received anticoagulant therapy and aspirin in the first 
three months and aspirin thereafter. 
13/21 S.T (62%) occured in the first 15 days after BEIS placement. 3/21 
S.T (14%) between 3 weeks and 2 months and 5121 S.T (24%) after the 
3rd month.The rate of S.T is significantly higher in stented femoro-popliteal 
arteries than in stented iliac arteries (12% vs 4% p<0.02); in case of 
muHiple stents (9 5.T/66 pts) than in case of single stents (12 S.T1202 pts) 
( p<0.05). in stented occlusions (15 S.T 1 55 pts) than in stented stenoses 
(6 5.T1213 pts) (p<0.001). and in stenosed by-passes than In stenosed iliac 
arteries (16% vs 1.5% p<0.04). The rate of S.T increases along the 
superficial femoral (SFA) and popliteal (POP) arteries (Upper 113 SFA : 1 
S.T/22 pts. Mid 113 SFA : 5 S.T/47 pts, Lower 113 SFA : 5 S.TI29 pts. POP 
: 3 S.T/10 pts). In our serie the rate of S.T is not Significantly influenced by 
diabetes or the runoff status. 15 out of 16 S.T occuring before day 60 were 
successfully recanalized percutaneously (PTA and/or local thrombolysis 
and/or Fogarty) and 4 out of 5 S.T occuring after the third month were 
unsuccessfully recanalized and required surgery (p<0.01). Among all 
successfully recanalized pts. only 2 pts reslenosed requiring a third PTA 
during the time of follow-up. 
Conclusion : Stent thrombosis is more frequent In femoro-popliteal 
stented arteries. In recanalized occlusions wrapped by BEIS and in 
muHipie stents. Recanalization of stent thrombosis could be successfully 
attempted within a three month delay following placement. Stent 
thrombosis after this delay should be surgically treated if necessary. 
lACC Vol. 21, No.2 
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923·39 
Chronic Pentoxirylline Administration Results in 
Endothelium Dependent, Cyclooxygenase 
Dependent Vasodilatation 
Cheol H. Kim, Virginia M. MiJler, Sharon M. Sandberg, 
Brooks S. Edwards, Mayo Oinic and Foundation, Rochester, 
Minnesota 
Pentoxifylline (frenta1®;Pentox) has been utilized in the 
treatment of claudication based on its ability to increase red 
blood ceJl deformation. We hypothesized that Pentox treatment 
would enhance the production of vasodilatory prostaglandins. 
Experiments were designed to determine whether chronic 
treatment with Pentox alters endothelium-dependent 
relaxation. Control dogs (N=7) and dogs treated with Pentox 
400mg bid p.o. for 10 days (N=4) were studied. The femoral 
arteries were suspended in organ chambers for the 
measurement of isometric force. 
In rings contracted with norepinephrine or prostaglandin F2 a, 
endothelium-dependent relaxations to acetylcholine occurred at 
a significantly lower concentration in arteries of Pentox•
treated dogs than in control dogs (-logED.so; 8.2±0.! vs 
7.8±O.JM, p<O.OI). This difference was eliminated by 
indomethacin (ID-SM). The threshold for relaxations to 
arachidonic acid occurred at a significantly lower concentration 
in arteries with endothelium from Pentox-treated dogs 
compared to control dogs (-logED.tO; 7.3±O.7 vs S.7±O.3M 
respectively, p<O.05) 
These results suggest that chronic treatment with 
pentoxifyJline enhances relaxation of canine femoral arteries 
by an endothelium-dependent mechanism which requires the 
metabolism of arachidonic acid. 
923·40 
GeDder DirrereDces ID CliDical Marken ADd 
Dipyridamole-Thallium ImaglDg ID the PredlctloD of 
Perioperative Cardiac EveDts After Vascular Surgery 
Ming Hui Chen. Gilbezt D11alien, John B. Newell, Raben C. Hendell, 
Jeffrey A. Leppo and Kim A. Eagle. Univ. of Mass. Medical Cenler, 
Worcester, MA and Massachuseus General Hospital, Boswn, MA 
To compare the effects of gender 00 the va1ue oi clinical markers and 
p-eoperative dipyridarnole-thaIliwn imaging (DTHAL) in predicting 
perioperative cardiac complications (MJ or deaIh), we swdied 571 
patients (380 males, 187 women) prior to aortic or peripheIal vascular 
surgery (PV ASC). Clinical markers were assessed by chart !eview. AU 
patients underwenl DTHAL prior to surgery; DTHAL was analyzed for 
fixed defects (FIX), !evezsible defects (REV), and iscbemic EKG 
changes (DEKG). 
Univariate predictors of cardiac events (CARD) for men were hisIory 
(hx) of angina, Iu CHF, FIX and REV. DEKG, and Q wave on 
baseline EKG (all p<O.lO). Predictors for women were diabeIes, 
angina. Iu MI, FIX and REV, and PV ASC(a11 p<O.IO). Univariate 
predictors were then included in logistic regressioo analyses. 
Multivariate predictors for CARD and odds ratios are displayed in the 
table. Odds ratios for variables that are IWt jredictive oi CARD al 
pSO.OS are lisled as NP. 
CHF QW AVE ANGINA PV ASC DEKG REV FIX 
Men 2.8 2.6 NP NP S.2 3.9 NP 
Women NP NP 4.5 6.9 NP 5.5 NP 
All 23 NP NP NP 3.4 3.9 2.1 
CONCLUSIONS: Clinical predictors of CARD vary according to 
gender: hx CHF and Q waves were especially useful in men. whereas 
hx angina and peripheral surgical sile were more predictive in women. 
Stress test variables also vary in predictive power. REV was predictive 
of CARD in males and females. DEKG were not predictive in women, 
consislenl with prior observation that stress-induced ST segment 
depression is a less useful marlcer of cardiac risk in females. Therefore 
p-eopemtive cardiac assessmenl of patients should take into IICCOUIII 
these gender differences. 
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923·41 
NEW NONINVASIVE CRITERIA FOR IDENTIFICATION OF 
SEVERE SUPERFICIAL FEMORAL ARTERY DISEASE IN 
PATIENTS WITH INTERHITTANT CLAUDICATION 
J.Philip A.Binton,John R. Nelson,Janice L.Melton 
The California Vascular Institute, Fresno, CA 
Limitations in noninvasive measurements including 
ankle/arm index (AAI) in identifying patients 
(pts) with severe superficial femoral artery 
(SFA) disease has prompted evaluation of new 
criteria. Magnetic resonance flowmetry (KRF) 
evaluates perfusion of lower extremities in pts 
with intermittant claudication (IC). Individual 
artery performance (lAP) has recently been 
developed to measure flow (F) in SFA. We 
evaluated new HRF-IAP criteria:Thigh (T)F S70 
cc/min(T-F ~70),SFA-F~40 cc per minute(SFA-F~40) 
The HRF-IAP data from 72T's of 36 pts with normal 
AAI (Group 1 (Gr1» and no IC were compared to 
data from 21 T's of 16 pts (Gr2) with 
angiographic severe SFA disease (>70% stenosis) 
with abnormal AAI «1.0) and IC and no inflow 
disease.The MRF-IAP Data is as follows: .p<O.Ol 
T-F SFA-F 
Gr1 97±19}- 59:13}-
Gr2 52:14· 22;1:12· 
The diagnostic yield in detecting severe disease 
in SFA is shown: Predictive 
Sensitivity Specificity Value 
SF~-F ~40 0.91 0.96 0.86 
T-F ~70 0.91 0.97 0.91 
Conclusion: a SFA-F S40 and T-F S70 are highly 
clinically useful parameters in identifying pts 
with severe SFA disease. 
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924·78 
Renln-Anglotenaln Activation Preced.. Other Neurohumoral 
Stimulation and LNda to Syatemlc Vaaoconatrlctlon In Untruted, 
Aaymptomatlc L..ft Ventricular Dyafunctlon and lachemlc CIU'CI1o•
myopathy 
Louis Bartels, Martin van dar Ent, Dick Kruijssen, WIllem J. Remme. 
Sticares Foundation, Rotterdam. The NetheI1ands. 
Although recent evidence indicates that patients with uymptomatic 18ft 
ventricular dysfunction (L VO) as a resutt of ischemic cardiomyopathy, 
may exhibit significant systemic neurohumoral activation, it Is uncertain 
whether the renin-angiotenSin system is involved in pIS not on diuretic: 
thenlpy. As, also, the hemodynamic aspects of neuroendocrine activa•
tion in untreated asymptomatic LVD are unknown. n nonnotensive pIS 
with coronary artery disease, without signs of heart failure, _e studied 
after an ovemight fast, without premedication and cardiac therapy wlth•
held for 24-72 hIS. Impaired LV function (ejection fraction <45%) was 
present in 16 pts (ejection fraction 29±3%, x±SEM) , none of whom ,. 
ceived diuretics (I). In the remaining 61 pts, LV ejection fraction was 
55±1% (N). Both groups were comparable as to age and sex. In the su•
pine resting state, contractility and relaxation were significantly reduced 
in I. LV dP/dt pos, Vmax and LV dP/dt neg were 24%, 24% and 28"" 
less in I than in N, rasp. Also, LV filling pressure was increased in I 
(17±1 mmHg va 13±1 mmHg (N). p<O.05) and cardiac and stroke 
index 15% and 18"", less in I (p<O.05 vs N). Although arterial pressures 
were comparable, systemic vascular resistance was 17% higher in I than 
in N (p<.05). Also, in I, arterial and coronary venous renin activity was 
increased, 29.9±12 nmol/l!h and 17.5±3.6 nmoWh va 10.5±1.4 
nmol/llh and 10.3±1.1 nmoI/IIh. rasp., I va N (p<O.05). In contrast, ar•
terial and coronary venous angiotensin II, norepinephrine, epinephrine 
and dopamine ieYeis and cardiac neurohumoral balances were compa•
rable in both groups. Thus, in untreated asymptomatic LV dysfunction in 
patients with ischemic cardiomyopathy, systemic renin activity increases 
at an early stage. resulting in systemic vasoconstriction before changes 




Effect of Early Converting Enzyme Inhibition on 
Neurohumoral Activation in Acute Myocardial Infarction 
Torbjern Omland, Torbjern Aarsland, Asbjern Aakvaag, 
Kenneth Dickstein. Central Hospital in Rogaland, Norway 
The effect of enalapril administered acutely on neuro•
humoral activation in acute myocardial infarction (MI) 
was investigated in a randomized double-blind study 
comprising 145 patients (age 66.9 (10.7) (SO) years; 
72.4% males). Plasma levels of atrial natriuretic factor 
(ANF) and norepinephrine (NE) prior to randomization and 
on day 3 post MI were determined. No significant between 
group differences in day 3 plasma ANF or NE levels were 
observed in the general MI patient population. In the 
subgroup of patients with heart failure (HF) (i.e. 
basilar rales or peripheral edema requiring diuretic 
therapy) during the 6 months follow up period (n=44), 
a significant attenuation of the day 3 plasma ANF. but 
not NE response was observed in the enalapril group. 
(Table: mean (SEM}) 
Day 3 
No HF ANF (pmol/l) 
NE (nmol/l) 
















These results suggest that enalapril therapy is 
associated with a reduction in early plasma ANF levels 
in patients with acute MI and subsequent HF, compatible 
with decreased atrial pressures in the acute phase. 
Further, the effect of enalapril on the neurohumoral 
response in acute MI may depend on the degree of initial 
neurohumoral activation. 
924-80 
EfIact of EnaJapriI on Plasma Norepinephme in Patients wit! Congestive 
Heart Falure 
Claude R. Benedict, Gary Francis, David Johnstone, Brent Shelton, Spencer 
Kubo, Philip Kirlin, John Nicklas, Chang-Seng Liang, Marvin A Konstam, 
BarrY Greenberg, Selim Yusuf for SOLVO Investigators, University of Texas 
Medical School, Houston, Texas. 
In the SOLVO treatment trial (1i) [patients with left ventricular ejection 
fraction (lVEF) .:35% and symptoms of congestive heart failure (CHF)], 
enalaprU (Eng decreased mortality. In contrast, in the SOLVO prevention 
trial (PT) (patients with L VEF .:35% and no symptoms of CHF) Enl failed to 
demonstrate a reduction in mortality. In a subset of patients enrolled in the 
TT (n .. '25) and PT (n=325), we examined the effect of Enl on plasma 
norepinephrine (PNE) at entry into study (Bsg, at 4 months and at 1 year 
and compared the changes to the placebo (Pic) group. In all these patients 
PNE levels were available at entry, 4 months and 1 year. During follow up 
Enl significantly decreased PNE levels in the TT patients but not in PT 
patients. Enl had the greatest lowering effect in patients with highest PNE 
220D 1 III PlACEBO .. ENALAPRIL 
- SLOPE for PlACEBO 









at Bsi. The slope of 
the finear relationship 
between PNE at entry 
and PNE at 1 year was 
0.84 for Pic group and 
0.07 for the Enl group 
(p .. O.OO2) (Fig). This 
suggests that long 
term treatment with 
Enl decreases sympa•
thetic activity 
especially in those 
with greatest baseline 
activation. This finding 
Is likely to be linked to 
the clinical benefit of 
o o'-----.o~o---.~OO---,-.'2~OO ACE inhibition in pat-
Baseline PNE (pgjml) ients with heart failure. 
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The Jl-Blocking Agents Mewprolol and Can'edilol Affect Cardiac 
Adrenergic Drive Differently in Subjects With Heart Faihare From 
Idiopathic Dilated Cardiomyopatby 
Michael R Bristow, Stephanie Olsen, Patti Larrabee, E. Michael Gilbert 
University of Colorado Healtb Scieaces Center, Denver, Colorado 
We bave previously reported that the ~ blockerlvasodilator carvedilol (C) 
decreases cardiac adrenergic drive in subjects witb idiopathic dilated myopatbY 
(IDC). 1D concurrently nmning placebo controlled trials of the ~, selective ~ 
blocking agent metoprolol (M) and C, we compared effects of these two agents 
on cardiac adrenergic drive. M data were geneIated in a substudy of the 
Metoprolol in Dilated Cardiomyopatby (MDC) multicenter clinical trial. 
Subjects were treated witb C for four months, and witb M for six months. A 
comparable degree of ~ blockade was accomplished by M (mean dose 131 
mglday) and C (mean dose 81 mglday) as assessed by reduction in maximal 
heart rate during exercise (M = -23:<S BPM, C = -26:<3 BPM). Results :<SEM 
are as follows. NE=norepinephrine, CS=alronary sinus, EF=ejection fraction. 
A CS-Art. 
A VenousNE ACSNE NE 
Group J!&im! l!W!!! l!W!!! ill: 
M +ISS +771 ~ +0.081 
n=16 :<58 :<147 ±211 ±O.027 
C -33· -ISS··I -1471 +0.1161 
n=22 :<42 :<48 :<77 ±O.02 
• p < O.OS vs. metoprolol 
t p < O.OS vs. respective placebo controls 
For CS NE, relative to placebo coDtrols carvedilol produced a significant 
decrease, while metopro)o) produced a significant increase. 
COIIc:lusiooL 1D !DC the ~ blockerlvasodilator carvedilollowers cardiac 
adrenergic drive, while the ~, selective, DOD-vasodilator compound metoprolol 
does not. These divergent results are likely due to direct effects of metoprolol 
on DOrepinephrine clearance. 
924-82 
PathophysiologiCal Role of Endogenous Atrial Natriuretic Peptide in 
Severe Congestive Heart Failure 
Atsuyuki Wada, Toshiyuki Kanamori, Yukiharu Maeda, Takayoshi 
Tsutamoto, Masahiko Kinoshna, Shiga University of Medical Science, 
Otsu, Japan. 
To evaluate the pathophysiologiCal role of endogenous alrial natriuretic 
peptide (ANP) in congestive heart failure (CHF) ,we used HS-142-1 
(HS) , a specific guanylyl cyclase Unked ANP receptor inhib~or. HS 
compet~ively and selectively inhib~ed ANP binding to its guanylyl 
cyclase containing receptor and blocked cyclic guanosine 
monophosphate (cGMP) production elic~ed by ANp.we assessed the 
hemodynamic, renal, and neurohumoral responses to endogenous 
ANP in severe CHF produced by rapid chronic ventriaJlar pacing in 
clogs (n=6). 
#cGMP PCWP MAP CO #ALD #PRA #U-Na 






13.8 9.0 103.4 3.02 77 1.3 
30.9 22.6 87.6 1.65 303 8.2 35.3 
22.3 23.8 93.4 1.52 486 11.3 19.0 
13.2 24.7 96.4 1.70 608 11.9 13.1 
9.0 25.3 97.9 1.66 711 13.7 7.24 
# P<0.05 (ANOVA) 
Though plasma cGM P is thought to be a useful biologiCal marlier of AN P 
activity, HS signniCantly decreased cGM P by 71 % to the low level of 
the pre- pacing state. Thus,HS completely blocked endogenous ANP 
activity, as occurs in absence of CHF. Hemodynamic parameters, such 
as pulmonary capillary wedge pressure (PCWP) and mean arterial 
pressure (MAP) and cardiac output (C 0) were not statistiCally affected, 
while plasma renin activity (PRA) and aldosterone (ALD) secretion were 
signniCantly increased. The urinary excretion of Na (U-Na) signniCanlly 
decreased. These changes were not observed in the control dogs. 
We conclude that endogenous ANP in severe CHF mainly contributes 
to renin -aldosterone suppression and Na excretion, but its regulation 
of hemodynamicS is attenuated. 
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Atrial Natriuretic Factor (ANF) Modulates 
Receptor-Mediated cAMP-Dependent Responses in 
canine Pulmonary Artery During Heart Failure 
Rajarnrna Mathew, Hatim A. Omar, Michael H. 
Gewitz, Thomas H. Hintze, Michael S. Wolin. 
New York Medical College, Valhalla, New York. 
We have previously demonstrated that during 
pacing-induced congestive heart failure (CHF), 
canine pulmonary arteries (PA) demonstrate 
attenuation of receptor-mediated cN1P•
dependent relaxation responses (>50% reduction 
in relaxation to isoproterenol [ISO] and 
arachidonic acid [AA]). During CHF plasma ANF 
levels are known to be increased. Since atrial 
appendages are the main source of ANF and ANF 
is negatively coupled to adenylate cyclase, we 
evaluated the effect of ANF depletion on 
relaxation responses in PA from dogs with CHF 
who had undergone atrial appendectomy (ATR 
APP) for comparison with the control (Cl and 
CHF' (non A:!:~ APP) groups. _~ela~3tion responses 
to ISO (10 Ml and AA (10 -10 M) were 
restored to normal during CHF in ATR APP 
gr~gp. For example, the relaxation of 49~5% to 
10 M ISO in C (n=8) was reduced to 21+5% in 
CHF (n=7) (P<0.05) but relaxation of 49+16% 
was observed in ASR APP (n=5). Relaxation 
responses for 10- M AA were as follows, 71+5% 
(C, n=6), 20+8% (CHF, n=7) (P<0.05) and 83i5% 
(ATR APP, n=5). -
Conclusion: altered receptor-mediated cAMP•
dependent relaxation responses in PA during 
congestive heart failure appear to be modulated 
by circulating ANF levels. 
924·84 
Modulating Action of Circulating Atrial Natriuretic Peptide 
and Blockade of Clearance Receptor on Circulating Brain 
Natriuretic Peptide and C·type Natriuretic Peptide 
Roland R. Brandt, R. Scott Wright, Lawrence L. Aarhus, John A. 
Lewicki, John C. Burnett, Jr., Mayo Clinic and Poundation, 
Rochester. MN. and Scios Inc .• Mountain View. CA 
Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), 
and C·type natriuretic peptide (CNP) belong to a family of peptides 
which share structural homology and pharmacologic activities. While 
studies in vitro suggest comparable interaction of these peptides with 
the biologically silent clearance (C) receptor. interactions with the C•
receptor in vivo remain undefined. We investigated whether elevated 
circulating ANP produced by exogenous ANP administration (10 
nglkg/min Lv.) to mimic pathophysiologic concentrations as observed 
in mild congestive heart failure (CHF) would modulate endogenous 
BNP and CNP plasma concentrations by interference with the C•
receptor and additional C-receptor blockade with a ring-deleted 
analogue of ANP (C-ANP4-23, O.ljJ.g/kg/min i.v.) would demonstrate 
further plasma alterations. A group of control dogs was compared with 
dogs in mild CHF produced by 10 days of rapid ventricular pacing. All 
data are expressed as mean±SEM. n=S in each group: 
Baseline ANP i Y C-ANP~ 
ANP Control 38±12 146±17* 236±32*t 
[pg/mll CHP 230±52, 408±40*, S28±51*~ 
BNP Control 10.0±O.5 12.2±O.9 10.1±0.7 
[pg/mll CHF 10.6±0.8 10.8±O.S 9.1±0.8 
CNP Control 10.8±2.3 11.S±1.2 12.0±1.7 
[Pg/mll CHP 11.S±1.6 13.1±2.9 13.3±1.8 
·p<O.OS vs baseline. tp<O.OS vs ANP Lv .• ,p<O.OS vs control 
These results demonstrate in the presence and absence of mild 
CHP: 1. Circulating ANP but not BNP or CNP are increased during 
ANP infusion. 2. C-ANP4-23 administration further increases ANP but 
not BNP or CNP. We conclude that the C-receptor in states associated 
with pathophysiologic concentrations of ANP does not serve to control 
basal BNP or CNP but selectively regulates circulating ANP. 
ABSTRACTS 
924-85 
Conge.ti~ Heart 'ailure i. Characterise. by .,.te.tc 
Zadothelia ActiTatioa 
Amir Lerman, Denise M. Heublein, John C. Burnett, Jr., 
Richard J. Rodeheffer. Mayo Clinic, Rochester, MN 
Endothelin (ET) is s vasoconstrictor peptide 
detectable in human plasma which we have previously 
reported to be increased in chronic human congestive 
heart failure (CHF), a state of excessive 
vasoconstriction. Recent studies have suggested 
that there is increased ET secretion in pulmonary 
hypertension, and ET has been detected in ventricular 
myocardium. Therefore, we sought to determine if the 
increased circulating ET in CHF is due to a secretary 
site in the central cardiopulmonary circulstion or if 
ET elevation is generalized throughout the circulation. 
In 70 patients undergoing catheterization we 
simultaneously measured plasma ET (pg/ml) in the 
femoral vein (FV), pulmonary artery (PA), pulmonary 
capillary wedge (PCW) position, and femoral artery 
(FA). There were no significant differences between 
ET concentrations at these anatomic sites: FV-9.2±0.5, 
PA-9.3±0.4, PCW-9.4±0.5, and FA-9.5±0.5 pg/ml. The 
linear correlation between ETFA snd PCW pressure was 
significant (r-0.29, p-O.Ol), as was that between ETFA 
and right atrial pressure (r-0.30, p-O.Ol). 
These data show no regional anstomic variations in 
plasma ET concentrations in the central circulation and 
support the concept of a generalized systemic 
activation of ET in chronic human CHF. This activation 
is associated with s modest positive relationship 
between cardiac filling pressures and plssma ET. 
924·86 
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The Role of Cyclic Guanosine Monophosphate In the 
Regulation of Endothelln·1 Production In Patients with Heart 
Failure 
Takayoshi Tsutamoto. Atsuyuki Wada. Yukiharu Maeda. Masahiko 
KinosMa. Shiga University of Medical Science. Otsu. Japan. 
Atrial natriuretic peptide (ANP) and nHric oxide decrease endothelin(ET)-1 
production by increasing intracellular cyclic guanosine monophosphate 
(cGMP) levels in v_roo Both plasma cGMP and ET-1 levels are known to be 
elevated in patients with chronic heart failure (CHF). Therefore. to 
determine whether enoogenous cGMP regulates the ET-1 production in 
the pulmonary vascular beds of patients with CHF. we measured plasma 
cGMP and ET-1 levels using blood samples obtained from the main 
pulmonary artery (PA) and pulmonary capillary wedge region (PC) of 
patients wHh CHF (NYHA Class n -IV; 11><58). Plasma cGMP and ET-1 
levels in the PC were significantly higher than those in the PA (cGMP:10.3 
vs 7.2 pmoVml. p<0.001; ET-1 : 4.6 vs 3.2 pglml. p<O.001). suggesting 
that both cGMP and ET-1 are produced in the pulmonary vascular beds. 
The production of cGMP [(PC-PAl cGMPxcardiac output] was correlated 
wHh the extraction of ANP [(PA-PC) ANPXcardiac output]. In addition. 
there was a significant positive correlation between cGMP production and 
ET-1 production [(PC-PAl ET-1 xcardiac output] in the pulmonary vascular 
beds ('Y=0.81. p<O.001), and the ET-1 production was significantly 
correlated with pulmonary vascular resistance ('Y=O.80. p<O.001). 
Moreover. exogenous ANP infusion did not change the plasma ET-1 level 
(from 3.7 to 3.8 pglml) in spHe of the increase of plasma cGMP level (from 
11 to 33 pmoVml. p<O.01) in 7 patients with CHF. 
Conclusion: these results indicate that both cGMP and ET-1 are produced 
in the pulmonary vascular beds and that neither ANP nor cGMP is a major 
factor in the regulation of ET-1 production in patients wHh CHF. 
316A ABSTRACTS 
924-87 
Intense Forearm Training Improves Vascular Endothelium Function 
in Patients with Congestive Heart Failure 
Jeannette L Yuen, Rachel Bijou, Marie Galvao, Paola Levato, Thierry H 
LeJemtel. Albert Einstein College of Medicine, Bronx, NY 
Physical conditioning improves conductance in the trained skeletal muscle 
vasculature. The vascular endothelium plays an important role in the 
regulation of flow-mediated vasodilatation and in coordinating the behavior 
of various vascular beds. Accordingly, forearm blood flow (FBF) responses 
to the intra-arterial administration of an endothelium-(iependent vasodilator. 
acetylcholine(Ach)Ia".IO·~)andanendothelium-independentvasodilator, 
nitroglycerin«NTG)\()'7,1a"M) were measured in the brachial artery of six 
non-edematous patients with Class III congestive heart failure (CHF) (mean 
EF 25%) before and after training. The training protocol consists of 4-
week hand-grip exercises daily for 2 hours of the non-(iominant forearm. 
The FBF responses to drug infusions were measured by venous occlusion 
plethysmography (ml/min./IOOmI). Responses to Ach and NTG were 
expressed as percentage change from rest blood flow. 
Results: Pre-training Post-training 
NTG 10',7 1.52+0.20 1.87+0.13 p=ns 
NTG ta" 2.50±0JO 3.20±0.30 p=ns 
Ach Ia" 1.39j:0.16 2.35,tO.04* 
Ach \0,5 3.10,t0.50 6.6O,tO.80** 
~.05. **p<O.02 
Maximum hand-grip strength improved from pre-training of 23±1.2kg to 
post-training of 27±I.7kg (p<0.05). Changes in forearm circumference 
(pre-training: 24;tO.5cm. post-training: 24J,tO.7cm) and in peak reactive 
hyperemia (pre-training: 42±4.7 m1/min./100m1. post-training: 41.3±5.5 
ml/min./IOOmI) did not achieve statistical significance. 
Conclusion: While FBF reponses to Ach improved with training, there is 
no change observed in FBF with nitroglycerin. Thus. intense physical 
conditioning tends to reverse the depressed vascular endothelial function in 
patients with severe CHF. 
924-88 
Pulmonary Va,cular Reactivity to Acetylcholine In ChroniC Heart 
Failure: Influence of Thromboxane Inhibition 
Thomas R. Porter. Alan Cyean, JennWer A. Fields, Cynthia Bagley. PK 
Mohanty. McGuire VAMC and Medical College of VA. Richmond, VA 
In experimental animals and humans with heart failure (HF) pulmonary 
artery (PA) responses to acetylcholine (ACH) has been shown to be 
tone dependent. The mechanisms for endothelium mediated 
vasodilation or vasoconstriCtion in pulmonary circulation is unclear. 
Animal studies suggest that vasoconstrictor responses in PA may be 
modulated by ACH induced PA thromboxane synthesis. Accordingly, 
we assessed pulmonary vascular responses by determining PA area 
changes (using 20 MHz intravascular u~rasound) to direct infuSions of 
ACH 10" M before and after inhibition of endothelium dependent 
relaxation (EOR) with methylene blue (MB) in 12 pis with chronic heart 
failure (CHF) (6 with normal PA pressure [HFNLPAJ, 6 with secondary 
pulmonary hypertension [HFPHJ) and 5 age matched controls(C) with 
normal left ventricular systolic function and normal PA pressures. PA 
area responses to ACH/MB were repeated in combination with 
Indomethacin(l) in order to determine n vasoconstrictor responses are 
mediated by thromboxane pathway. The resu~s are summarized in the 




PA-Area Responses (% ro 
ACH/MB' Indomethacin/ACH-MB2 
-11.0±S.1* 8.0±7.6* 
2.0 ±4.2 -3.0±3.4 
-O.S±2.2 -O.6±3.9 
, % change from MB alone • % change from MB/ACH 
No signnicant PA area changes to infusions of ACH. MB or I alone in 
any group were seen. Signnicant reversal of ACH induced PA con•
striction efter inhibition of EOR was seen after thromboxane inhibition 
from indomethacin in HFNLPA but not HFPH or C. These resu~s 
suggest that EORF plays a major role irt the maintenance of normal PA 
pressure in treated heart failure and that the tone dependent constrictor 
responses to ACH in pulmonary artery is mediated by thromboxane. 
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Increased Blood Levels of Erythropoietin in Severe Congestive 
Heart Failure. 
Massimo Volpe, Oistina Tritto, U go Testa', Speranza RubatIu, Angela 
Mirante. Roberto Martucci·, Tma Rao, AIessandro FMele. Cesare Peschle·, 
Mario Condorelli Dept of Internal Medicine, UniversitA Federico II, Napoli 
and "Dept. of HematolOgy and Oncology. Istituto Superiore di SanitA, Roma, 
ITALY. 
The kidney and its related hormonal systems play an important role in 
heart failure (CHF). However. the behaviour of erythropoietin (EPO) in 
CHF is unknown. The aim of this srudy was to assess the levels of 
circulating EPO in human CHF. For this purpose, plasma EPO levels were 
measured by EUSA technique in patients with CHF (n=66) and in normal 
controls (C) (n=35). Patients with CHF were divided according to NYHA 
class. Plasma EPO. serum creatinine (Crea) and hemoglobin (Hb) levels 




C 35 1.8±O.2 1:t().02 
NYHA I 24 1.5:t().2 1±o.D3 
NYHA II 14 4.8±1 * l±o.06 
NYHA m 18 8.4±3** 1.1:t().07 
NYHA IV \0 87.0±45** 1.1:t().08 








Plasma EPO levels were inversely correlated with radionuclide ejection 
fraction in CHF (1'=-0.381. n=36. p<O.025). These data demonstrate that 
plasma EPO levels progressively increase in patients with heart failure, 
independently from anemia and renal dysfunction. This increase is 
particularly pronounced in the advanced stages of the disease. These data 
indicate that EPO is a marker of severity in CHF and may suggest an 
involvement of EPO in the compensatory mechanisms that are activated 
in the advanced stages of heart failure. 
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925-106 
Hypolipidemic Effects of FUib Oil Compared to Maize Oil in 
Hyperlipidemic Patients 
Johannes M. Hartog. Ad van Tol*, los M.1. Lamers·, Leon ]. van 
Woerkens, Picter D. Verdouw, ]05 R.T.C. Roelandt. Thoraxcenter and 
*Biochemistry I, Erasmus University, Academic Hospital Dijkzigt, 
Rotterdam, The Netherldands. 
The habitual ingestion of fish is assumed to lower the incidence of 
coronary heart disease. It has been shown that the n-3 polyunsaturated 
fatty acids (PUFA's) eicosapentaeooic acid (EPA) and docosahexaenoic 
acid (DHA) decrease the rate of synthesis of the very low desnity 
lipoproteins (VLDL) and thereby reduce the plasmaleve)s oftriglycerides 
(TG) and cholesterol (CHOL). 
In the present double-blind cross-over srudy in 16 male patients (mean 
54 years and 84 kg) the effects of a daily dose of 20 g capsulated fish 
oil (6 g EPA and 4 g DBA) and 20 g maize oil (15 g linoleic acid), each 
for a period of 6 weeks, were compared. 
The plasmalipidlevels during fish oil consumption compared to those 
during maize oil consumption were as follwowed: TG 2.5 mM vs 3.7 
mM (p < 0.05), total-CHOL 7.6 mM vs 8.3 mM (p < 0.05), VLDL•
CHOL 0.8 mM vs 1.1 mM (p < 0.05), LDL-CHOL 5.8 mM vs 6.1 
mM, HDL-CHOL 1.0 mM vs 1.0 mM and phospholipids (PL) 3.7 mM 
vs 4.4 mM (p < 0.05). 
It is shown in this srudy that fish oil consumption lowers the 
plasmalipidlevels by reducing the levels of VLDL. It is likely that the 
changes in the other lipoproteins are secondary effects. The fall in 
plasma PL (-16 %) together with the decrease in total-CHOL (-8 %) may 
reflect changes in lipoprotein composition. 
It is postulated that the changes in the chemical composition of the 
lipoproteins may influence the atherogenity or anti-atherogenity of these 
lipoproteins. These effects will par1ially explain the anti-atherosclerotic 
effect of fish consumption. 
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925·107 
Characterisation and Follow-up of Patients With Chest Pain and 
Normal Coronary Arteries. 
Ann K Sullivan, Diana R Holdright, Christine A Wright, Jane L 
Sparrow, Kim M Fox. Royal Brompton National Heart & Lung 
Hospital, London, UK. 
We identified 138 men and women from all 886 patients presenting 
with chest pain between 1987 and 1991 to one unit who were sub•
sequently found to have normal coronary arteries at coronary ar•
teriography, with follow-up to present day (mean follow-up 2.5 yrs, 
range 0.1-5.3 yrs). 
The group comprised 83 women (representing 41% of all women 
investigated for chest pain) and 55 men (9% of all men). Mean age 
was significantly greater in women (54.2±9.3 yrs vs 47.6±9.8 yrs, 
p<O.OO 1). Men were significantly more likely to have a smoking his•
tory (p<0.005) but less likely to have a history of hypertension 
(p<0.05) compared with women. There was no difference in the 
prevalence of other cardiac risk factors. Exercise testing was positive 
in 29% of women compared to only 2% of men. 
At follow-up a high proportion of patients continue to experience 
chest pain (91 pts, 73%), of whom 36 patients (40%) remain on 
anti-anginal medication and 18 patients (20%) have required 
hospitalisation for chest pain. There was one sudden death and no 
myocardial infarctions. 
Of patients referred with chest pain women were more likely to 
have normal coronary arteries. Compared with men, a high propor•
tion of women had a positive exercise test in the absence of coronary 
artery disease. Despite the reassurance of a normal coronary ar•
teriogram, morbidity remains high in these patients. 
925·108 
The Effect of Macrophage Scavenger Receptor Polymorphisms on 
Coronary Artery Disease 
Unda C. Morrison, Mitsuru Emi, Jonathan Byrd, Hiram W. Marshall, 
Jeffrey L. Anderson, R H. Ward, University of Utah and LOS 
Hospital, Salt Lake City, Utah 
Macrophage scavenger receptors play a role in the deposition of 
cholesterol in atherosclerotic plaques. Cloning of the human 
macrophage receptor has yielded 2 clones which detect 
polymorphisms. Oone SRcDNA(H), a 1.2kb cDNA fragment detects 
a two allele polymorphism with BamHJ digested genomic DNA, and 
a four allele polymorphism with Mspl, while clone SRgenHd.9.0 
detects a two allele HindlII polymorphism. To determine whether 
these markers were associated with the presence of coronary artery 
disease (CAD), we screened a series (n=703) of patients who had 
undergone coronary angiography. Presence (n=362) or absence 
(n=341) of disease was determined by blinded assessment of 
coronary angiograrns with presence of disease being defined as 
>60% stenosis of any major branch, and absence of disease defined 
as <10% stenosis. The frequencies of the Mspl alleles were 0.762, 
0.157, 0.069, 0.012. The BamHJ and HindIIl allele frequencies were 
0.748,0.252 and 0.804, 0.1% respectively. All three loci were found 
to be in Hardy Weinberg equilibrium. Contingency chi-square 
analysis indicated that none of these polymorphisms were 
associated with an increased risk of CAD. Also, after adjusting for 
disease status, the different genotypes at this locus displayed nearly 
identical lipid profiles. Hence, despite the fundamental role played 
by the macrophage scavenger receptor in cholesterol deposition, 
genetic variability at this locus neither influences lipid levels nor risk 
of CAD in populations of Northern European descent. 
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925·109 
Black/White Differences in Baseline Characteristics of PatieDts in the Bypass 
Angioplasty RevascularizatioD Investigation (BAR I) Thai aDd Registry 
Kim Sutton-1Yrrell, William Rogers, Nicholas Koucboukos, AllaD RoseD aDd 
tbe BARI Investigators, University of Pittsburgh, Pittsburgh, PA 
BARI is designed to determine tbe relative efficacy of aD initial strategy of 
bypass surgery vs angioplasty for selected patients witb multivessel coroDary 
disease. Of tbe 3,841 patients enrolled into the BARI trial and registry, 194 
(5%) were Black and 3551 (92%) were White. PeroeDt of Black patients 
differed by site, ranging from 0% to 27%. Blacks were significaDtly younger 
tban Whites (mean age 60 vs 62, P < .05), and a bigher proponion of Blacks 
were female (38% vs 26%, P < .01). With respect to past medical history, 
Blacks had more CHF (13% vs. 6%, P < .01), diabetes (42% vs 22%, P < .01), 
and hypertension (73% vs 47%, P < .01), and major Q waves were more often 
found on their baseline EKG (23% vs 17%, P < .05). Mean weigbt was bigher 
among Blacks, (84 Kg vs 81 Kg, P < .05), and tbey were more likely than 
Whites 10 have ever smoked (78% vs 69%, P < .01). Blacks bad a significantly 
bigher median HDL cbolesterol (36 vs 39, P < .05) but tbere were DO 
significant differences with respect to total cbolesterol, Cbolesterol/HDL ratio, 
or fasting triglyoeride levels. 36% of Whites were OD low cholesterol diets 
compared to 25% of Blacks (p < .01). Blacks were more likely thaD Whites to 
rate their own health as fair or poor (35% vs 26%, P < .05). With respect to 
angiographic characteristics, Blacks were more likely than Whites to bave triple 
vessel disease (47% vs 38%, P < .05) and Blacks bad a bigher mean number of 
significant lesions (3.8 vs 3.4, P < .01). Mean ejection fraction for Blacks was 
.59 compared to. 61 for Whites (p < .01). These differences persisted after 
controlling for age and sex. For patients who underwent PTCA, Blacks were 
more likely 10 have staged procedures and 10 have total occlusions attempted. 
However, after controIling for variation in site practioe, age and gender, no 
Significant difference in PTCA procedure strategy was found. For patieDts who 
underwent CABG, Wbites were more likely tban blacks to have internal 
mammary grafts (85% vs 68%, P < .01). After controIling for age and variation 
in site practices, this difference remained significant for women but not men. 
In conclusion, Blacks entered into BARI had a more severe risk factor profile 
than Whites and had more severe disease. Black women received IMA grafts 
less frequently, but no other revascularization procedurr tlifferences were found. 
925·115 
InDuence of Postmenopausal Hormone Replacement on the Upld Profile: 
The Framingham Offspring Study 
Sonya M. Vaziri, Jane C. Evans, Martin G. Larson, Peter W F. WIlson 
Framingham, MA 
Favorable aherations of plasma LDL-cholesterol (LDL-C) and HDL•
cholesterol (HDL-C) levels secondary to postmenopausal estrogeD therapy 
appear to partially mediate the cardioprotective eflects of replacement 
estrogen. Altbough the influence of oral conjugated equine estrogens 
(premarin) on tbe lipid profile bas been widely studied, less is known of the 
effects of commonly prescribed combined therapy (premarin and 
medroxyprogesterone acetate (provera». Among eligible female subjects in 
the Framingham Offspring Study (exclusions (n = 73) for ~70 years, use of 
lipid-lowering agents, triglycerides > 500 mg/dl. or unavailable menopausal 
or hormone usage data), there were 52 users of premarin alone, 28 users of 
premarin and provera, and ssg nonusers. The adjusted lipid means (all in 
mg/dL) among Nonusers, Premarin only, and Combined PremarinjProvera 
groups, respectively, were 56.9, 62.5 [p<O.OI), and 62.9 [p<0.05) for HDL-C. 
The anaJagous means for apolipoprotein AJ were 160.0, lBO.l[p<O.OOl), and 
181.7 [P<O.Ol); for LDL-C, adjusted means were 145.6, 143.8, and 
129.7[p<0.05). We found no significant differences in levels of total 
cholestero~ triglycerides, very low density lipoprotein cholesterol or 
apolipoprotein B between users of hormone therapy and nonusers. All 
statistical comparisons were made to the referent DODuser group. The models 
were adjusted for age, body mass index, alcohol intake, current smoking, beta 
blocking ageDts and diuretic therapy. 
Conclusion: In this cross-sectional ana\ysis, the addition of 
medroxyprogesterone acetate (provera) to postmenopausal oral conjugated 
equine estrogen therapy is associated with little difference in total blood 
cholesterol levels, but favorable effects on HDL-C and LDL-C fractions. 
Measurement of lipid fractions is needed to assess the impact of hormonal 
replacement therapy on lipids, and provera supplementation does not appear 
to adversely affect the estrogen-induced alterations. 
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925·116 
Grapeseed Oil, A Natural Agent Which Raises Serum HDL Levels. 
David T. Nash, Stephen D. Nash, State University of New York Health 
Science Center at Syracuse, William D. Grant, Department of Family 
Medicine, State University of New York Health Science Center at Syracuse, 
Syracuse, New York. 
Grapeseed Oil (GSO) has been produced in Europe for hundreds of years as 
an edible oil, a byproduct of wine production. GSO contains 75% linoleic 
acid, 15% oleic acid, 6% pabnitic acid, 3% stearic acid, and 1 % linolenic 
acid. We stodied the effect of GSO on HDL levels in a sample of 56 men 
and women all of whom had an initial HDL reading or <4Omg% (fasting 
blood samples.) All subjects had been on a lipid modified diet for more than 
three months prior to enrollment and gave informed consent to participate. 
Subjects were instructed to use up to 45 ml of GSO in their daily diet as a 
substitute for their usual oil. Fasting blood tests were performed at baseline 
and after three weeks' use of GSO. No significant changes in this time period 
were noted for subjects' total cholesterol, triglycerides, or weight 
measurements. However, statistically significant changes were noted for 
levels of High Density Lipoprotein cholesterol (HDL), an increase in mean 
values from 31.6mg% to 35.6mg% [t=5.79, p< .001, 95%CI 1.87 to 5.241, 
and for levels of Low Density Lipoprotein cholesterol (LDL), a decrease in 
mean values from 146mg% to 136mg% [t=·2.7I, p<.OOI, 95%CI ·2.84 to 
22.56). The total cholesterollHDL ratio was reduced 15.6%, and the 
LDLIHDL ratio was reduced by 15.3%. The use of Grapeseed Oil in the 
daily diet appears to improve both HDL and LDL levels during a sbort term 
treatment period in weigbt stable subjects with initially low HDL levels. 
925·117 
Prospective study of Risk Pactora for Pulmonary 
Bmboliaa in Wo.en 
Samuel Z. Goldhaber, Meir J. Staapfer, JoAnn E. 
Manson, Graham A. Colditz, Walter C. Willett, 
Frank E. Speizer, Charles H. Hennekens. Brigham 
and Women's Hospital, Harvard Medical School, 
Boston, MA 
To evaluate risk factors for pulmonary 
embolism (PE) in women, we identified 190 
incident cases of PE du;ring 1,332,785 person•
years of observation in the Nurses Health Study 
from 1976-1988. We validated the biennial 
questionnaires by reviewing medical records, and 
we required reports of high probability lung 
scans or positive pulmonary angiograms for 
confirmation. Women with prior cancer or heart 
disease were excluded. After adjusting for age 
and other coronary risk factors in a 
multivariate model, we found that compared with 
lean women, obese women (Quetelet's index >29.0) 
had a relative risk (RR) of 2.53 (95% Cl, 1.60-
4.00) for PE. However, lower levels of 
Quetelet's index were not associated with PE. 
Heavy smokers (>25 cigarettes/day) compared with 
nonsmokers had a RR of 1.66 (95% Cl, 1.08-2.56). 
Women with self-reported hypertension had a RR 
of 1.64 (95% Cl, 1.17-2.30). Neither self 
reported diagnoses of hypercholesterolemia (RR 
1.19 [95% Cl, 0.72-1.97]) nor diabetes mellitus 
(RR 1.40 [95% Cl, 0.74-2.62]) were risk factors 
for PE. ThUS, marked obesity, heavy cigarette 
smoking, and hypertension appear to predispose 
to PE in women. Control of these risk factors 
in women may decrease the risks of PE as well as 
coronary heart disease. 
925·118 
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Social Factors and Depression Mter Myocardial Infarction 
Nancy Frasure-Smith, F~ois Lesperance, Mario Talajic. 
Montreal Heart Institute, Montreal, Quebec, Canada 
While recent studies have linked low income and social isolation with 
increased mortality after myocardial infarction (MI), the mechanisms 
are unclear. Because post-MI symptoms of depression are also 
associated with excess cardiac events, we hypothesized that the 
increased mortality risk of low income and socially isolated pts may 
be mediated by a greater tendency to depression. We interviewed 
358 pts (280 men; 78 women) aged 24 to 88 (mean 58.2 yrs) I week 
post·MI. 24.3 % had a previous MI. PIS responded to the 21·item 
Beck Depression Inventory (BDI) and provided information about 
income and social network. PIS were classified into 4 income 
groups: < $12,000 (n=57); $12,000 to $23,999 (n=101); $24,000 
to $35,999 (n=llO) and $36,000 or more (n=9O). Overall 21.5% 
said they had no close friends. Analysis of variance was used to 
assess the relationships among income, having a close friend, and 
B 01 score after controlling for age and gender. 
Results: The lower the pt's income the higher the mean BOI score 
(from low to high income: 11.0±1.2, 8.3±0.8, 7.7±0.7, 6.0±0.6; 
p=.02). Further, 49.1% of the pis in the lowest income group had 
BOI scores of 10 or more indicating some degree of depression. 
Only 21.1 % of those with incomes> $36,000 had BOI scores in this 
range. PIS without friends had higher mean BOI scores (9.6±1.2) 
than those with friends (7.5 ±0.4; p= .02). Interactions were not 
significant. In addition, history of previous MI was not associated 
with income, friends, or BOI score. 
Conclusions: It appears that both low income and social isolation are 
associated with depressive symptomatology after MI, supporting the 
view that psychological status may mediate between social factors 
and post-MI outcome. 
925·119 
Outcome Analysis of a 10 Year Experience with Mitral Stenosis 
Patients to define the Need for Valve Repair 
Naltoli Neuburger.Thomas Santucci, Vari<.ey Mathew, Christopher 
Kubicki, Jeffrey A. Stahl. The Jamaica Hospital, Queens, New Yori<. 
Because 30% of patients in recent mitral valve valvuloplasty series only 
had NYHA Class 2 symptoms we tabulated our 10 year experience 
with mild Mitral Stenosis eMS) patients. 3 out of the 34 MS patients 
were NYHA Class 4 at presentation and required prompt repair. The 
remaining 31 consisted of 9 patients (Group 1) who presented status 
post mitral commissurotomy (Me) and 22 patients who had no previous 
heart surgery {Group 2). Group 1 suffered no major clinical sequelae 
during the study period. Three group 2 mortalities were due to 
myocardial infarction, prostate cancer, and lung cancer. Group 2 
morbidity conSisted of 1 breast cancer, 1 CABG for angina, 1 aortic 
valve replacement without MC, 1 Me, and 4 major CVA's that preceded 
the diagnosis of MS. Only the 2 valve operations occurred in patients 
under the age of 60. The table summarizes the meaned data with the 









Mu M_ Vetocily 
1.7(0.3) 
1.7(0.3) 
Conclusions: 1. Progression of mild MS in the middle aged and elderly 
adult to higher levels of impainnent is rare. 2. The greatest threat 
to mild MS patients is the failure to diagnose MS and prevent major 
CVA's. 3. The remaining morbidity in mild MS is due almost entirely to 
diseases unrelated to MS. This is especially true in the elderly. 4. If 
these findings can be confinned in larger series over longer periods of 
observation it will be difficult to justify mechanical repair of the mitral 
valve in mild MS, especially in the elderly. 
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925·120 
Early Manifestations of Coronary Atherosc:lllra.ia In Trauma VICtims 
Determined at Autopsy 
S. Abraham Joseph, Douglas Ackerman, J. David Talley, John 
Johnstone, Joel K. Kupersmith, Cardiovascular Div. U of Louisville, 
Louisville, KY 
To determine the incidence of coronary atherosclerosis (CAS) in the 
young «35 yrs), paIhoIogiceJ examinations were performed on the 
coronary arteries of 111 pis who died from non-cardiac trauma. The 
degree of CAS was determined by histological score (Grades I·IV) and 
computerized planimetry. The pts were predominantly male (86%), 
wMe (86%), with a mean age of 26:t6 years. Prevalent risk factors in 
a comparable population were tobacco use and a family history of CAS. 
Results: Signs of CAS were seen in 78.3% of the total population with 
i!: 50% narrowing in 20.7% and i!: 75% narrowing in 9%. Except for 
heart weight being significantly lower in the group with more severe 
involvement (p<O.OOOl), no demographic or anatorniceJ features 
separated the two groups. 
DEMOGRAPHICS OF GROUPS WITH MILD «50%) vs. SIGNIFICANT 
DISEASE (>50%) BY CROSS-SECTIONAL AREA (CSA) 
< 5O%CSA >50%CSA p Value 
Sex (M/F) 53/64 (82.8%) 20/23 (86.9%) 0.98 (ris) 
Age (yrs:t 1 SO) 27:t5.4 25.6:t5.5 0.14 (ns) 
Race (W/oIher) 55/64 (85.9%) 21/23 (91.1%) 0.96 (ns) 
BSA(m'} 1.9:t0.5 1.8:t0.5 0.43 (ns) 
Heart WI (G/m'j 208.36:t78.1 340.1 :t67.9 <0.0001 
ConcluslOl1a: l.~ remature l,;Al) IS p reV8Jent ana 01 Similar rrequency 
as noted following earlier historical studies done alter the Korean War 
emphasizing the need for aggressive risk factor modification in the 
young. 2. The presence of left main or significant two and three vessel 
disease existed in 20% of this young population who would be at 
significant risk for a cardiac event aI a young age. 
925·121 
Evaluation of Phosphodiesterase inhibitors In Chronlc Heart Failure, Using an 
Effect Model Approach In Addition to Usual Mela-Analysls Methods 
Patrice Nony, Jean-Pierre Boissel, Alain L.etzorovicz, Michel Uevre, Margaret Haugh. 
Brigitte de Breyne, Samir Fareh. 
C~nical Pharmacology Unit, Cardiovascular HOSpital, Lyon, France 
We propose the use of a singie regression eHect model as a complement to the 
techniques of meta-analysis, to improve the definition of the benefiVrisk ratio of 
phosphodiesterase inhibitors (PO is) in clvonic heart laiiure (CHF), 
Methods: eight randomized placel»controlled trials of POI involving 1 !¥J7 patients 
were selected. ReSUlts, in terms of mortality data, were calcuiated using the mean· 
difference,logarithm of the odds-ratio, Cochran, Mantel·Haensze/ and Peto methods. 
in addition, a weighted straight~ine regression analysis was performed, each trial being 
characterized by the mortality rate in the treated group (response variable, y axis) and 
the mortality rate in the control group (predictor variable, x axis). The weight was equal 
to the opposite of the variance. We tested the inearity of the model and compared the 
regression tine to the bissector line 6.e. the null therapeutic eHect). 
Results: all meta·analytical methods gave resuits showing significant increased mortatity 
under POI compared with placebo (odds ratio: 1.42; 95% CI: 1.1 to 1.8). From the 
regression model (r • 0.81; p • 0.002), POis do not seem to have any intrinsic bJxic 
eHect 6ntercept not different from 0, p = 0.17), and no toxicity·threshold based on the 
mortality rate under placebo seems to have been observed: 
mortality rata 
unclar patmant 0.2 ':u.Y;: ,./ y . ' 
.,1' .. ' 
0.1 ",--
, . 
o 1;/ Int.rven~on 
1/ better 
o 0.1 0.2 
mortality rate 
uncler ptacebo 
Conclusion: Despite some iimitations of the statistical methods used. our results 
confirm that POi h!rapy significantly increases mortality (about 40%) in CHF patients. 
whatever the severity of the disease (i.e. the mortality rate under placebo) . 
ABSTRACTS 
925·122 
BDL Chola.tarol I. the Sole Predictor of 
Angiographically Hormal Coronary Arterie. 
Heather O'Connor, Stan Castor, Hendrick Brown, 
Kevin F. Browne, Watson Clinic, Lakeland, FL 
319A 
A case control study utilizing 88 matched pt pairs, 
having previously undergone cardiac catheterization, 
were examined to determine if total cholesterol, 
triglycerides, high density lipoprotein (HDL) and low 
density lipoprotein (LDL) predict the absence or 
presence of coronary artery disease (CAD) at coronary 
arteriography. Pts were classified as normal if all 
coronary vessels were smooth in contour with no 
irregularity suggesting plaque. Matched pts were 
obtained from the PTCA database collected during the 
same time period. All abnormal pts had undergone at 
least one PTCA. The pairs were matched for race, sex, 
family history of CAD, cigarette smoking, diabetes, 
hypertension, and obesity. All pts had fasting lipid 
profiles performed on the day of angiography. None of 
the pts were receiving medications that would affect 
lipid levels. Table I demonstrates the group mean :I: SO 
total cholesterol, triglyceride, HDL and LDL levels of 







* P < 0.001 
I!mY.L 
Coronary Arterie. 
209 ± 46 
157 ± 90 
45 ± 14 
135 ± 40 
5 ± 1.6 
3.1 ± 1.2 
AbnOrmal 
Coronary Arterie. 
222 ± 49 
184 ± 120 
38 ± 11 * 
145± 44 
6.2 ± 2.2 * 
4.1±1.8* 
In conclusion, utilizing coronary angiography to assess 
the presence of CAD, normal populations significantly 
differ from diseased populations only in their HDL 
levels. Routine measurement of HDL as part of 
cholesterol screening may add significant information 
to risk stratification. 
925·123 
Comorbidity Index Predicts Survival in Severe Heart Failure 
Keith D. Aaronson, Kar Wong, J. Sanford Schwanz, Donna M. 
Mancini. Hospital of the UniveJ1)ity of Pennsylvania, Philadelphia, 
PA 
The impact of comorbid illness in patients with seve~ ~eart 
failure has not been determined. We evaluated the predictive value 
of a comorbidity index originally derived from consecutive 
admissions to a general medical service (Charlson et al. J Chronic 
Dis 1987; 40: 373-383) in 423 patients (325 male, 98 female; 292 
white, 114 black, 17 other) referred for evaluation of severe heart 
failure (age: 52.5±12.7; LVEF: 20.7±9.4; NYHA class 3.0±1.0 
(mean±S.D.). Comoribidty data was prospectively obtained 
(history of myocardial infarction, peripheral vascular dis,ease, 
cerebrovascular disease, dementia. chronic pulmonary disease, 
peptic ulcer disease, liver disease, diabetes, hemiplegia, renal 
insufficieny, non-hematologic primary tumor.leukelIDa, 
lymphoma, liver disease, metastatic solid rumor,. AIDS) and 
compiled into weighted comorbidity scores. Patients were 
prospectively followed for survival, with urgent transplant 
considered equivalent to death and elective transplant rreated as a 
censored observation. Survival estimates were computed by the 
Kaplan-Meier method for four grouped strata of comorbidity 
scores. Survival differences between strata were tested by log•
rank and Wilcoxon tests. Results: Overall I-year survival was 
67±2% with a mean survival of 990 ±42 days. Survival for the 
comorbidity strata was as follows: 
Comorbldlly # of patients 1-yr survlV:il Mean survival 
score %(±S.E) (days) 
I 1.;7 74±4% 1213:+-71 
2,3 2jl Mt3% !s/\J:!:4~ 
4,5 41 6U±!S% Itll 122 
6 14 55+14 457±99 
Survival was Significantly different between comorbidity strata 
by both the log-rank and Wilcoxon teSls( both p<.OO1). In 
conclusion, an easily obtained index of comorbidity provides. 
useful prognostic infonnation in patients with severe heart faIlure. 
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782 Role of Transesophageal Echo in Intraoperative 
Decision-Making 
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782-1 10:30 
Utility of Transesophageal Echocardiography in 
Patients Undergoing Myocardial Revascularization. 
Barry D. Bergquist, Wayne H. Bellows, Nelson B. Schiller, 
Dennis T. Mangano, Jacqueline M. Leung. 
University of California, San Francisco 
To determine how transesophageal echocardiography 
(TEE) guides intraoperative decision-making during coronary 
anery bypass surgery (CABO), we studied the performance of 
five community-based, full-time cardiac, anesthesiologists 
during 33 CABO procedures, All patients had radial artery and 
pulmonary artery lines and were monitored with biplane TEE, 
Anesthetic management was not controlled by study protocol; 
immediately following each intervention (therapeutic or 
surgical), the anesthesiologist was asked to determine how 
real-time TEE influenced the therapy, which single monitor 
was most influential, and why each therapy was initiated, 
Of the 271 interventions, TEE was the single most 
important guiding factor in 73 (27%), Interventions 
involving fluid administration contributed to 136/271 (50%) 
cases, TEE was the most important monitor influencing fluid 
administration in 34 instances (25%), versus the pulmonary 
artery catheter in 16 (12%), TEE was the single most 
important monitor in guiding other therapies as follows: 
vasopressors or inotropes-(3/43=7%), depth of anesthesla•
(5/41=12%), and anti-ischemic therapy-(5/16=31 %). In 2/33 
(6%) patients, critical surgical interventions (repair of graft 
which kinked during sternal wiring; retrograde cardioplegia 
(CP) used instead of antegrade CP due to previously 
unrecognized aortic insufficiency) were made solely on the 
basis of TEE. 
In conclusion, TEE is frequently influential in guiding 
decision making in CABO surgery (7-31%), More importantly, 
it may guide critical surgical interventions, 
782-2 10:45 
TranselOphageal Echocardlography In Patients Undergoing Valvular 
Surgery and Thoracn-Abdomlnal Aortic Aneurysm Repairs: Experience 
In 200 Consecutive Patients 
Harold K Doerr, Hazim Safi, Gerald M, Lawrie, Joseph S, Caselli, Jimmy F. 
Howell, Rafael Espada, Mlquel A. Quli'lones, WUliam A. Zoghbi, Baylor 
College of Medicine, Houston, Texas. 
The application of echocardlographlc techniques In the operating room has 
significantly Impacted on the planning and the assessment of Immediate 
results of the surgical Intervention, We reviewed our experience In the first 
200 intraoperative transesophageal echocardlograms (TEE) performed for 
assistance In valve surgery or aonic aneurysm repair In 119 males, 81 
females (mean age 58.±.11 yrs). The distribution of the 200 TEE's was as 
follows: 83 m~raI valve surgery, 64 aortic valve replacement, 46 aortic 
aneurysm repair and 7 tricuspid valve surgery, Of the 83 mitral valve 
surgery, 45 were mitral valve repairs, 28 replacements and 10 repeat 
replacements, Of the 45 patients who underwent mitral valve repair, TEE 
prior to surgery influenced planning of the procedure in 12/45 pts: In 7, 
mitral valve repair was attempted as opposed to the scheduled 
replacement, all of which were successful; in 2, the repair was deemed not 
feasible and mitral valve replacement was performed; In 3 pts, the repair 
scheduled as part of another operation was deemed not necessary, Three 
pts following mitral valve repair had Significant residual regurgitation and 
underwent mitral valve replacement. Of the 38 pts with m~ral valve 
replacement, TEE revealed an unsuspected atrial septal defect in one 
patient, a thrombus on the mitral valve in another and a new wall motion 
abnormality In one patient Of the 64 pts with aortic valve replacement, 
TEE assisted the surgeon In locating abscess formation in one pt and 
helped define a sinus of valsalva to RV fistula in another. One patient had a 
s1gnlflcant paravalvular leak postoperatively that required a repeat surgery, 
In the 46 pts with thoraco-abdominal aneurysm repair, TEE helped further 
define the aneurysm prior to the operation In six pts, and influenced the 
decision to use a composite graft rather than a single graft in three, In one 
patient, an ejection fraction of 20% was unsuspected and the surgery was 
held untU hemodynamics could be improved. 
In conclusion: An overall Impact of TEE In planning valvular or 
thoracoabdominal surgery was seen In 16% 01 pts, Although Infrequent 
(4%), Important residual abnormalities were detected and corrected in the 
same setting obviating the need for reoperation. 
782-3 
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11:00 
The Usefulness 01 Intraoperative Transesophageal 
Echocardiography In Adult Congenital Heart Disease 
Ariane J, Morelli, John S. Child. Susheela Songwan. Hillel 
Laks. UCLA School of Medicine. Los Angeles. Califomia 
It is generally assumed that intraoperative transesophageal 
echocardiography (lTEE) is important in the assessment of 
operated congenital heart disease (CHD), To determine the 
role of this procedure in adults with CHD. we analyzed the 
contribution of ITEE to preoperative. Intraoperative and 
postoperative management, Methods' Between 1990 and 
1992,42 iTEE's were performed by a congenital cardiologist at 
our institution, Of these. 38 were biplane and 4 were single 
plane, An intraoperative pre and postintervention study was 
performed during each ITEE, These were compared to 
preoperative and postoperative diagnostic transthoracic (TTE) 
and angiographic studies. iiIWll; !TEE was performed during 
42 operations in 41 patients, mean age 29±.11 yrs (range 16 to 
55), The surgical interventions involved right or left ventricular 
outflow tract lesions in 25. atrioventricular valves in 8. shunts in 
7, and cavopulmonary anastomosis in 2, The !TEE accurately 
assessed the operative result in all 42 studies, In 19 or 42 
studies one or more of the following contributions were made 
by the ITEE: (1) the preintervention ITEE. clarified or detected 
unsuspected lesions in 15 studies; (2) the intraoperative 
management was altered as a result of a finding in the 
postintervention ITEE in 5 patients; (3) in 15 of 36 patients. 
where the first postdischorge TIE was available for review. 
anatomic or hemodynamic information was obtained during 
postintervention ITEE. that could not be evaluated by TIE, 
Conclysions' ITEE accurately assessed the operative result in 
all cases of adult congenital cardiac surgery, The !TEE made 
a unique contribution to preoperative anatomy. 
intraoperative management or postoperative residuae in 
olmost 50% of patients who had the procedure, 
782-4 11:15 
Does Intraoperative Echocardiography Prevent the Develop•
ment of Tricuspid Regurgitation During Longterm Follow-up for 
Tricuspid Valve Repair Surgery? 
Allan L. Klein, Sami J; Azzam, William J. Stewart, Emesto E. Saleedo, 
Harry M. Lever, Gerald I. Cohen, Carol I. Duffy, Delos M, Cosgrove, 
The Cleveland Clinic Foundation, Cleveland, Ohio 
Intraoperative echocardiography has been widely used in asBessing and 
guiding mitral, aortic and tricuspid valve repair surgery. The effect of 
intraoperative echo on the longterm follow-up of tricuspid valve repair 
. surgery has not been well described. We studied 195 pts (59 M, mean 
age 60 .±,10 yrs) who underwent TV repair surgery from Dec 1986 to Feb 
1992, and had echocardiographic follow-up at a mean interval of 129 
days. One hundred sixty-four pts (84%) had transthoracic echo mE), 27 
(14%) had transesophageal echocardiography (TEE) and 1TE, and 4 
(2%) had TEE alone, One hundred thirtY-Beven pts (70%) had an 
intraoperative post-pump echo study, while 58 (30%) had no 
intraoperative study, Echocardiographic failure of TV rep was defined as 
significant 3+ or 4+ tricuspid regurgitation (TR) or TR 2 grades or 
higher than the preop echo. Of the pts who had intraoperative studies, 
12 (9%) required a 2nd pump, of which 5 (4%) were for significant TR, 
In follow-up, 19 (14%) of these pts had late failure at mean interval of 
109 days. Of the remaining 58 pts with no post-pump echo, 10 (17%) 









n = 19 
Follow-Up 
Total n = 137 
FaHure Rate 
14% 
Conclusions: 1) Recurrence ofTR after TV repair is common (14-17%), 
2) Intraoperative echocardiography is an excellent tool for detection of 
early TV repair failure (4%), but does not prevent the development of 
late echocardiographic failure (14-17%), 
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782-5 11:30 
Evaluation of Hypertrophic Cardi~yopatby by 
Intraoperative Transesophageal Echocardiography 
William K. Freeman, Hartzell V. Schaff, Jae K. Oh, 
Gordon K. Danielson. Mayo Clinic, Rochester, MN 
Intraoperative transesophageal echocardiography (1-0 TEE) 
was performed in 36 patients (Pts) undergoing septal 
myectomy (SM) for hypertrophic obstructive cardiomyopathy 
(HOCM). The mechanism of associated mitral regurgitation 
(MR) was systolic anterior motion (SAM) in 25 (70%) Pts, 
SAM + mitral valve prolapse in 14%, SAM + flail posterior 
mitral leaflet in 8%, and calcific mitral disease in 8%. 
Seven of the 11 (64%) Pts with a mechanism of MR other 
than SAM alone underwent a mitral valve procedure. 
After initial SM, grade 3-4 residual MR due to SAM was 
found by 1-0 TEE in 3 (8.3%) Pts, prompting a second 
surgical procedure. Residual MR and LV outflow tract 
(LVOT) gradient were evaluated by transthoracic echo•
cardiography (TTE) in 33 Pts prior to hospital discharge. 




75 ± 40 2.6 ± 1. 0 
p<O.OOOl p<O. 05 
14±ll 1.3±0.9 
p=0.08 p=0.3 
Predischarae TIE 19 ± 18 1.0 ± 0.6 
Mlld to mo erate resldual SAM was detected by 1-0 TEE 
in 21 (58%) Pts after SM (mean LVOT gradient 17 ± 14 
mmHg), 12 (33%) Pts had residual SAM evident on pre•
discharge TIE (mean LVOT gradient 28 ± 19 mmHg). 
Conclusions: (1) A mechanism other than SAM alone is 
responsible for MR in 30% of Pts undergoing SM for HOCM, 
two-thirds of whom require concomitant mitral valve 
surgery, (2) MR due to SAM alone significantly improves 
after SM, but grade 3-4 MR persists in 8% of Pts after 
initial SM, (3) Residual SAM detected by 1-0 TEE afterSM 
resolves in 43% of Pts by the time of predischarge TIE. 
782-6 11:45 
Transesophageal Echocardiography (TEE) Is Indiaated in the 
Placement of the Implantable Left Ventricular Assist Device 
Robert M. Savage, Carol I. Duffy, James D. Thomas, William J. 
Stewart, Ian W. Black, Michael L1cina, Karen B. James, Michael 
O'Conner, Patrick M. McCarthy, and the LVAD Study Group. The 
Cleveland Clinic Foundation, Cleveland, Ohio 
Left ventricular assist devices (LV AD) are indicated in a growing 
number of patients with end stage heart failure as a prolonged bridge to 
transplant. TEE has been used extensively in the OR, but has had 
I imited use in intra-operative LV AD placement and functional 
assessment. We implanted 5 devices which consisted of a pneumatically 
driven pulsatile pump with an LV apical cannula for blood removal and 
an ascending aortic graft for blood return. These devices were 
implanted in 5 males (mean age 54, range 49-61) with either end stage 
dilated (2) or ischemic (3) cardiomyopathy who had intraoperative TEEs 
done pre- and post -placement. 
RESULTS: Post LVAD implant, TEE demonstrated unrestricted apical 
conduit flow which was asynchronous with heart contraction. Aortic 
regurgitation was detected in 3 patients preoperatively and, in one, 
increased following LV AD placement resulting in a 25 % increase in 
pump flow compared to right ventricular cardiac output. Trivial AR was 
detected following implantation in the other 2 patients. Pre-LV AD 
implant, only TEE (vs. transthoracic) was useful in diagnosing an LV 
mural thrombus and a patent foramen ovale (PFO) which was repaired, 
thus preventing a potential significant right to left shunt andlor 
paradoxical emboli. 
CONCLUSIONS: TEE has a significant application in LV AD 
implantation, not only for chamber assessment and cannulae flow, but 
also for detecting the presence of PFOs or aortic regurgitation, 
conditions that may alter hemodynamics in LV AD recipients. 
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Ciprooteae for Reotenosi.s Revisited: Quantitative ADalysia of ADliosnms 
Albert E 1Wznet. lay HolJman, 101m AbukbaIiI, Doaald Demke for the 
Ciprolllalc Inv~, Baylor CoJlese of Medicine, Houston TX 
In a previous tria1 of ciprolllalc (C), a atable cWo, of JIIOIbICYclin, 
adminisIered intncoroIwy for 15 miD before PTCA aDd iDlravfllOUliy for 48 
Ius after PTCA, C WII ahown to have IiJDifiCUII clinical beaefit. In !bat 
pbcebo coolrollecl tria1, 311 pta _ raudomiz.ecI. 'Ihe C pta (D -157) !wi 
IianificantJy fewer advene clinical ev_ (repeat PTCA, CABO, M1 or dea!h) 
in 6 moo of follow-up (23" va 39" for the pbcebo pta, p=.O(4). AnIliollIl'Phic 
__ of re&taIo8ia sbowecI a tnIId in favor of die C puup. However, the 
anaiollIl'Phic __ were made by vimaI intetpretatioa aDd coacluaiOJlS 
repn:Ilna a beacfit in recluciDll reIImo8ia _ tbonfore equivocal. 
ConIequentJy, lID attempt WII made to reIroIIpectively retrieve alI available 
lIDaiollfUllB and perform qumtitative c:oronaty anaioanphy (QCA) uaiDa CAAS, 
a st.mdardized, automated ecI,e detectioa I)'IIIem. QCA WII doae in 104 C pts 
aDd 107 placebo pta, representiDa 83" and 88" of the pta who bad complete 
(pre-PTCA, post-PTCA and follow-up) arterioaraphic llUdiea, napectively. 
There were DO lipificant differenc:a in minimum 1_ diameter (MLD) pI&•
PTCA (!MIlD'±' SE) (0.96 .±. 0.04 VI 0.98 .±. 0.04 mm) 011 post-PTCA (2.26 .±. 
0.07 ,VI 2.33 .±. 0.06), or percent diameter IIeoo8ia pre-PTCA (70.5 .±. 0,93 vs 
70.7.±. LOS") or post PTCA (27.1 .±. 1.35 VI 27.15 .±. 1.21) for C or placebo 
pta, napectively (p - NS for alI compariaoaI). Two' cumal defiDitioas of 
re&taIo8ia wen 1abulatecI: 
~ lIal!Il bIilIQ 
ChalIce in MLD from 
post PTCA to follow- 0.32 .±. 0.07 OS7 .±. 0.08 0.025 
up(mm) 
~SO" diamet!lr 
..,0Bis at follow-up 271104 (26") 411107 (38") 0.OS5 
(") 
Thus, C appean to IianificantJy 1_ reoteDoois u meuuted by QCA. lbeae 
data are c:ooconlant with clinical benefits previoII8ly report.ecI. As such, 
ciproalale warrants coaaidentioa u adjllDCtive I:nlatmeI1t for the provmtioa of 
re&taIo8ia in PTCA. 
783-2 10:45 
"Moderale" ResleDosis Has a Favorable Natural Histor, 
Steven P. Friedrich. Richard E. Kuntz, Paul C. Gordon, Gilbert A. Leidig, 
Clifford J. Berger, David J. Cohen, C. Michael Gibson. Robert F. Fishman. 
Joseph P. Carrozza. DooaId S. Bairn. Beth Israel Hospital, Harvard Medical 
School, BasIon, MA 
Luminal narrowing at 6 month angiography is normally distributed. 
DicholOl\lous restenosis definitions traditionally fall within the region of 
lftOurate stenosis, where !he ability to delennine !he need for subsequent 
revascularizatioo is poor. We thus compared the clinical OUlCOCIle (follow-up 4 
to 44 mooths) of pIS with moderate (ModR: stenosis 40-70%) and miflimal 
(MinR: stenosis <40%) angiographic "restcnosisw after directional coronary 
atbeccctomy or Palmaz-Schatz stcnting. At foDow-up angiography performed in 
441 pts (77%) by 8 months after their procedwe, ModR was present in 78 pts. 
33 (43%) of !he pIS underwent repeat revascularization prior to 8 months for 
symptoms or positive exercise test. The remaining 4S non-revascularized pts 
(ModR-) were compared with 2iJ7 MinR pts who bad nOl been revascularized 
within the rust 8 months of !heir index procedwe (MinR-). Although Logrank 
analysis of !he Kaplan-Meier estimates of event-free survival (death, MI, or 
revascularization) showed Significant differences between the overall MinR and 
ModR groups (p<O.OI), there was /10 differeflce ~lWeefl MinR- and ModR•
(p=O.93). 
]~:~«~ 
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CODclusloDs: I) Fewer than balf of pIS with moderate stenosis at 
angiograpbic foDow-up require revascularization by 8 months. 2) The remaining 
moderate restcnosis patients (without symptoms or exercise test positivity) have 
a subsequent natural history similar to milder lesions, and can be managed 
conservatively. 3) Binary definitions of restenosis are limited by the failure to 
make this distinction adequately. 
322A ABSTRACTS 
783-3 11:00 
Interaction of Human Plaque Smooth Muscle Cells With 
Extracellular Matrix Components: Expression of Cell Surface 
Proteins With Relation to Cellular Locomotion 
Gerhard Bauriedel, Judith Johnson, Petra Heidemann, 
Jiirgen Heimerl, Marcel Strauss, Brigitte Mack, Berthold Holling, 
Gerd Riethmiiller, Dept. Int. Med. I and Inst. Immunology, 
University of Munich, FRG 
Interaction of the cell surface with extracellular matrix components 
affects functional cellular activities. In atherogenesis and restenosis, 
migration of smooth muscle cells (SMCs) may be regulated by 
SMC/substrate interactions. In SMCs cultured from human 
atherectomy tissue of 12 coronary lesions, the distribution pattern of 
SMC surface proteins including integrins and other adhesion 
molecules (AM) was analyzed by immunofluorescence microscopy: 
AM Antigen Expression C8sesITnt.AJ 
Collagen (C) Receptor CD49b +++ 12112 
Laminin (L) Receptor CD49f 11/12 
Fibronectin (F) Receptor CD4ge ++ 12/12 
Thrombospondin Receptor CD36 + 5/10 
Cultured SMCs and histological sections of the same vascular 
segment exhibited a comparable AM distribution pattern. Receptors 
for C and F were typically expressed, whereas those for L could not 
be detected. To study and quantitate migratory activity of cultured 
SMCs, a standardized motion analysis system (Circulation 
1992;85:554) was used. Imitating the in vivo environment of SMCs by 
coating culture dishes with specific matrix components (5 !lg/cm'), 
C and F significantly reduced SMC migratory activity by 28% 
and 33%, respectively, whereas the same parameter was increased 
by 120% for SMCs cultured on laminin. 
In summary, human plaque SMC migratory activity can be reduced 
by specific extracellular matrix components with the prerequisite of 
corresponding SMC surface receptors. By means of a local site•
specific delivery, this phenomenon may be a promising therapeutic 
principle to antagonize SMC migration in human plaque formation. 
783-4 11:15 
Early "Restenosis" at 
Coronary Angioplasty. 
Patients. 
24 Hours Following Successful 
A Prospective Study in 1000 
Thierry Carcos, Xavier Favereau, Corrado Tamburino, 
Harcel Toussaint, Gerard Souffrant. Centre Hedico-
Chirurgical Parly-Grand Chesnay, Le Chesnay, France. 
Repeat coronary angiography was prospectively performed 
24 hours following successful coronary angioplasty 
(PTCA) in 1000 consecutive patients (1352 lesions) in 
order to determine the incidence of early "restenosis". 
Diameter stenosis (DS) was measured on-line using quan•
titative digital angiography immediately after and 24 h 
after PTCA. 
Hean DS increased from 17 + 13 % tmmediately after PTCA 
to 25 + 18 % at 24 h. Co;onary angiography at 24 h 
showed-significant "restenosis" (DS ~ 50:0 in 105 
lesions (7.8 % of lesions, 10.5 % of patie~ts), inclu•
ding total occlusion in 24 lesions (1.8 7. of lesions, 
2.4 % of patients). 
Predictors of early "restenosis" were moderate or 
severe dissection after PTCA (restenosis rate was 
20.7 % when present vs 6.3 % when absent, p < 0.0001), 
DS ~ 30 % after PTCA (14.8 vs 6.1 %, p < 0.0001), total 
occlusion before PTCA (13.3 vs 7.3 %, p < 0.05), and 
fp~ale gender (11.6 vs 7.0 %, p < 0.05). 
Early "restenosis" was treated with repeat PTCA using 
long inflations (54.4 % of lesions), stent implantation 
(7.6 %l, emergency CABG (1.9 %), elective CABG (1.9 %), 
or medical treatment (36.2 X). 
Repeat coronary angiography at 24 hours after PTCA may 
detect early "restenosis" or failure of the procedure. 
Repeat PTCA may be considered in some patients in order 
to improve long-term results. 
783-5 
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PARK: the fost ~ngioplasty Hestenosis Ketanserin trial. 
Serruys PW .. Klein W .. Rutsch w.. Heyndrickx G .. Emanuelsson H., Ball S.G., 
Wijns W., Schroeder E., Leibermann H., Eichhorn E., Wilierson J.T., Khaja F., 
Alexander R.W .. Baim D., Gool R. van, Melkert R. 
Thoraxcenter. Rotterdam, The Netherlands. 
Janssen Research Foundation, Beerse, Belgium. 
Background. Ketanserin is a serotonin S2-receptor antagonist which inhibits 
platelet activation and vasoconstriction induced by serotonin as well as its 
mitogenic effect on vascular smooth muscle cells. 
Methods. We have conducted a randomized. double blind. placebo-controlled 
trial to assess the effect of ketanserin in restenosis prevention after PleA. 
Patients (pts) received either ketanserin (loading dose 40 mg 1 hr before 
PlCA. maintenance dose 40 mg bid for 6 months) or matched placebo. In 
addition, all pts received aspirin for 6 months. Coronary angiograms before 
PlCA, after PTCA and at 6 months were quantitatively analyzed. 
R .. ults. 658 pts were entered into the intention to treat analysis. The primary 
clinical end point of the study was the occurrence between PlCA and 6 
months of anyone of the following: cardiac death, myocardial infarction, the 
need for repeat angioplasty or bypass surgery. It also included the need for 
revascularization actuated by findings at 6 months follow-up angiography. The 
primary clinical endpoint was reached by 92 (28%) pts in the Ketanserin group 
and 104 (32%) in the placebo group (RR: 0.89; 95% CI: 0.70,1.13; p=O.33). 
For the per-protocol analysis, quantitative angiography at post-PTCA and 
foIlow·up was available in 513 pts who complied with the treatment regimen 
(ketanserin 240. control 273). The mean difference in minimal lumen diameter 
between post-PTCA and follow-up angiogram (primary angiographic end 
point) was -0.30 ± 0.49 mm in the ketanserin group and -0.24 ± 0.50 mm in 
the control group (difference -0.06 mm; 95% CI: -0.15, 0.03; p=0.18). 
Conclusion. Ketanserin at the dose administered in this trial failed to reduce 
the loss in minimal lumen diameter during follow-up after PTCA and did not 
significantly improve the clinical outcome. 
783-6 11:45 
Restenosis After PTCA Affects the Entire Yessel Segment Dilated. 
David P Foley. Walter R Hermans, Wolfgang Rutsch, Hakan Emanuelsson. 
Nicolas Danchin, William Wijns, Francois Chappuis. Patrick W Serruys. for the 
MERCATOR group. 
The aim of this study was to examine the extent of luminal renarrowing after 
successful coronary balloon angioplasty, using quantitative angiography, in the 
search for new insight into the phenomenon of restenosis. The study 
population comprised all 653 patients (n8 lesions) In the MERCATOR trial. 
who had angiographic follow·up (94%). Minimal Luminal Diameter(MLD), 
Vessel Size (interpolated reference diameter· Rem.mm), Lesion Length 
(LL.mm) , Plaque Area (PA,mm"j. and Balloon Inflated Vessel Segment 
·(BIYS,ie. mean diameter(mm) of the entire segment dilated) were measured 
using an automated edge detection technique. Restenosis was defined 
according to two fundamentally disparate categorical criteria: 1) 'OSS of 
l!O.72mm" in MLD during follow·up(n= 128, restenosis rate 20%) identifying 
a signfficant deterioration in luminal diameter during follow uP. 2)'>50% OS' 
at follow up(fup.n=231. restenosis rate 35%) which is based on physiological 
principles. Students t·tests were used to identify differences in change(Cl) from 
post BA to fup (fup - post) between 'restenotic' and -non-restenotic- lesions. 
/LOSS>0.72MM): Rest Nonrest 'p' />50% DS):Rest NonRest 'p' 
ClMLD ·1.14 -0.09 <.001 -0.75 -0.07 <.001 
ClRem - 0.17 +0.06 <.001 +0.04 +0.01 .46 
ClBIYS - 0.70 +0.04 <.001 - 0.34 +0.02 <.001 
ClLL +0.96 +0.20 <.001 +o.n +0.11 <.001 
ClPA +3.62 +0.84 <.001 +3.33 +0.44 <.001 
Gain MLD +1.06 +0.70 <.001 +0.80 +0.75 .23 
Gain BIVS +0.37 +0.19 <.001 +0.28 +0.21 .11 
Both criteria identify 'restenotic'lesioris as undergoing greater deterioration not 
only in MLD but also in length and plaque area, as well as the entire segment 
dilated, compared with non-restenotic lesions. The 'oss~_72mm' criterium also 
reveals narrowing of the reference diameter and a greater associated gain In 
MLO and the dilated segment(BIVS) at Intervention, among restenotic lesions. 
Conclusion: The restenosis process. when deffned as significant ~ In 
lesion severity, affects the entire segmem dilated and Is associated with greater 
galn at Intervention. perhaps implying greater Injury sustained In these lesions. 
JACC Vol. 21, No.2 
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Residual Patency of the Arterial Duct After Surgical Ugation 
N Zucker, SA Qureshi, EJ Baker, PB Deverall, M Tynan 
The Department of Paediatric Cardiology and Cardiac Surgery,Guy's 
Hospital, London, U.K. 
The true incidence of residual ductal patency after surgical ligation 
has not been accurately defined, because the follow-up assessment 
generally has been based on auscultatory findings, Auscultation has 
been shown to be unreliable in identifying residual ductal patency, 
whereas, colour Doppler echocardiography is a sensitive technique, 
We have evaluated 65 patients who had undergone arterial duct 
ligation at Guy's Hospital between January 1978 and December 
1991, 
The evaluation included clinical assessment and Doppler 
echocardiographic examination, There were 23 boys and 42 girls, 
The mean (±1SDl age at surgery was 29±31 months (range 2 
weeks to 11 years, and the mean weight at surgery was 11 ±7.6 kg 
(range 0,7 kg to 21.3 kg), The mean age at Doppler evaluation was 
111 ±58 months (range 5 weeks to 21 years) and the mean time 
from surgery to follow-up Doppler evaluation was 80±46 months 
(range 1 month to 13 years), 
':our patients had been born prematurely and had duct ligation soon 
after birth, 
Results: 
Twelve (18%) patients had residual patency of the arterial duct 
demonstrated by colour Doppler echocardiography, in whom three 
(4,6%) had continuous murmurs on auscultation, Seven of these 
patients had typical Doppler continuous flow and one had high 
velocity systolic flow pattern, In 4 patients the pulsed and continuous•
wave Doppler could not detect the small residual leak shown by the 
colour Doppler, There was no association between residual patency 
and the age at surgery,the weight at surgery, or the follow-up 
interval. 
Conclusion: 
Despite previously widely held belief that surgical ligation of arterial 
ducts results in complete occlusion, we have found that there is a 
significant incidence of residual patency of the duct after surgery, 
784-2 10:45 
Additive Effect of Adenosine Infusion and Leukocyte Depletion on 
Recovery After Hypothermic Ischemia in Neonatal Lamb Hearts 
Fumikazu Nomura, Mitsuru Aoki, Joseph M. Forbess, John E. Mayer 
Jr. 
Cardiovascular Surgery, Children's Hospital, Boston, MA 
Experimentally, both leukocyte depletion (LD) and adenosine (ADO) 
infusion during reperfusion (Rep) improve the recovery of neonatal 
lamb hearts after hypothermic ischemia. ADO inhibits leukocyte 
function, but also dilates coronary arteries, is an ATP precursor. and 
blocks inward calcium currents. To determine if the ADO effect was 
due only to leukocyte inhibition, 32 isolated, blood perfused neonatal 
lamb hearts were subjected to 2 hrs of 15 C cardioplegic ischemia, 
Group ADO received 350 uM ADO during the first 20 min of Rep, 
Leukocytes were removed (Sepacell filtration) prior to Rep in group 
LD. Group ADO/LD received both ADO and LD. Controls (C) had no 
Rep interventions. At 30 min of Rep, measurements of LV developed 
pressure (DP), dp/dt, and L VEDP (all with an LV halloon at fixed 
volume), coronary blood flow (CBF) and oxygen consumption (V02) 
were maue. Results are given as o/r recovery of preischemic values. 
(*,#,$=p<.05 vs control, LD, ADO groups) 
~llUlg Il DP Wgg~l -mgllLl;!1 L.V!;;!;;!l! !;;;BF VQ2 
C 8 73.2 67.7 61.4 120 157 75.4 
ADO 8 99.3*# 95.0*# 78.7*# 75,6*# 184 136* 
ADO/LD 8 106*# 106*# 77.6*# 77.5*# 263*#$ 199*#$ 
LI:! 8 8~.1* 12 ~* 2:1.4 12Q 12Q 112* 
The results show that Rep with LD blood and ADO infusion during 
Rep have additive effects on the recovery of neonatal hearts anu 




Spontaneous Plasma Ollioatlcm and Depletion of AntioxIdant 
capacity In YounD Children After cardiopulmonary Bypass 
Lee A. Pyles, James E. Fortney, John J. Kudlak, William H. Raley, Christana 
Lock, Anthony P. Fumari, Martha D. Mullet, Robert A. Gustafson, Stanley 
Einzig, Dept. of Pediatrics and Surgery, West Virginia U., Morgantown, WV 
We describe the use of two in vitro tests to characterize the ability of 
plasma to combat oxidative damage during cardiac bypass for congenttal 
heart surgery in 16 pediatric pts: age 1 d.- 18.9 ys., avg 4.9:t5.7y. (std dev). 
First, a test of plasma radical antioxidant power (TRAP) measured chain 
breaking or secondary antioxidant capacity of plasma to prevent oxidation of 
~noleic acid in vitro. Oxgyen radicals were generated in a cell by hydrolysis 01 
the azide bond of 2, 2'azo-bis-(2-amidino-propane)-HCI (ASAP). Plasma 
TRAP capac~y was determined by t~rating oxygen consumption inhibition 
time against that of a known amount of a water-soluble vHamin E analog in 
the oxygen electrode cell. Secondly, overall ability of plasma to prevent lipid 
peroxidation was assessed by a classiC test of plasma inhib~ion of 
malondialdehyde (MDA) formation in a beef brain homogenate, Blood wi's 
placed into Na Heparin tubes and immediately spun at -4. C. and plasma 
separated and frozen at -70· C, from samples obtained Immediately prior to 
and following bypass and upon arrival in PICU. 
TRAP capac~y at baseline was 0.78±O.18 nmoVL plasma and was founcj to 
be totally depleted following bypass in 11 of 16 pts, all less than 5.5 y.o, 
Five pts ages 5.7-18,9 y.o. showed a residual capac~y post-bypass or in 
PICU which was 0.18±0.08 nmoVL plasma decreased from their preop 
values, The avg, in vitro rate of oxygen consumption was 0.59±O.16% 
02/min pre-op and 3.11±1.8% 02/min post-op, Suprisingly, post bypass 
plasma of the 11 young pts was able to produce spontaneoys in vitro 
oxidation of linoleic acid prior to add~ion of the radical generator, ASAP. The 
reaction could be slowed but not stopped w~h desferoxamine added both 
at the time of the sample draw or the assay. Superoxide dismutase and 
catalase showed no effect alone or in combination, Beef brain MDA 
formation was lim~ed by plasma to 10.8±16.6"1o production of control value 
pre-op vs. 52.8±28.9% post-op :p<0.001, and 58±22% at recovery: 
p<0,001, paired t-test), 
Thus, cardiac bypass presents a profound stress to the antioxidant system 
which can not be attenuated w~h iron chelation or SOD/Catalase, The partial 
effect of desferoxamine and lack of effect of SOD/Catalase suggests 
Fenton mediated OH radical production. These assays provide a means to 
test efficacy of oxygen radical scavengers in future studies. 
784-4 11:15 
Rapid Two-Stage Arterial Switch Operation: Acquisition or Left Ventricular 
Mass after Pulmonary Artery Banding in Infants. 
Christine Boutin, Steven D Colan, Stephen P Sanders, Gil Wemovsky, Suzanne 
M Mone, Richard A Jonas. Children's Hospital, Boston, MA. 
Banding of the pulmonary artery (PAB) in preparation for uterial switch 
operation (ASO) in patients with transposition of the great arteries (TGA) 
represents a unique model of acute LV pressure overload in hUllllDS. In order to 
determine the rate, magnitude, and determinants of LV hypertrophy (L VH) and 
the effect on LV function, serial echocardiographic exams were performed as 
often as every 12 hours on 26 patients with TGA who bad a rapid 2-stage ASO 
(that is, PAB followed by ASO 1-2 weeks later), LV mass, volume and ejection 
fraction (EF) were obtained from each 20 echo using a biplane Simpson's rule 
algorithm, Cardiac catheterization data prior to P AB and again prior to ASO were 
reviewed. 
The meao age at PAB was O,4±O.3 yrs, weight - S.6±2,2 kg. The 
mean interval between PAB and ASO was 9±4 days. The LV:RV pressure ratio 
prior to PAB was O.S±O.1 and increased to 1.0±O.2 prior to ASO. The mean !Ii 
increase in LV mass from PAB to ASO was 96±66!Ii, 9S!Ii nf which was 
achieved in the first 7 days. The average rate of L VH for the eatire period was 
O.06±O.04 gm/hr, and was O.19±O.2S gmlbr during tbe interval from PAB to 
attainment of maximum LV mass. The most rapid rate of L VH was aeen by day 2, 
with an expon~ntial fall thereafter, approaching zero by day 7, EF was 
significantly reduced by 12 hours after PAB, but mean values returned to pre-PAB 
levels by 3.5 to 7 days after banding. The rate of LVH correlated directly with 
patient body surface arell (p=O.02) and EF prior to PAB (p-O.03), but not to 
patient age (p=O,60), Although there was a weak inverse relation between rate of 
LVH and both pre-PAB LV mass and RV:LV pressure ratio, these were not 
statistically significant. 
Conclusion: In infants with TGA, • doubling of LV mass can he achieved 
in 1 week after PAB, with only minor further hypertrophy thereafter. Age, 
relative LV pressure, and absolute LV mass do not bave a major impact on the 
rate of hypertrophy, although patient size and preoperative function do. Function 




Pulmonary Artery Growth Patterns Following the 
Bidirectional Glenn Procedure 
Alan M. Mendelsohn. Edward L. Bove. Flavian M. Lupinetti. 
Oennis C. Crowley. Robert H. Beekman. University of Michigan. 
Ann Arbor. MI 
The effect of the bidirectional Glenn (BOG) shunt on pulmonary 
artery (p A) growth in the univentricular heart was investigated. 
Between 10/89 and 11,91.20 consecutive pts (age at BOG 17±3 rno; 
mean±SE) underwent serial hemodynamic and angiographic 
evaluations prior to and 19±.2 mo post BOG. Right BOG were 
performed in 15 pts. left BOG in 2 pts. and bilateral BOG in 3 pts. 
At BOG. patch angioplasty of the contralateral PA was performed in 
2 patients. Angiographic PA diameter ipsilateral to the BOG was 
unchanged (7.7±O.5 vs S.2±O.6 mm. p=O.27). however contralateral 
PA diameter decreased from 7.5±0.6 to 5.S±0.4 mm after BOG 
(p<O.OI). Nakata index of total PA cross·sectional diameter 
decreased 36% (2S1±40 to 179±19 mm2/M2• p<O.OI). and was 
associated with a decrease in total pulmonary blood flow (4.4±O.5 to 
2.l±0.1 L/min/M2• p<O.OI) and a decrease in mean PA pressure 
(lS±2 to 1l±1 mmHg. p<O.Ol). By multiple linear regression 
analysis. the decrease in Nakata index was directly related to the 
Nakata index prior to BOG (r=O.SS). but was unrelated to the 
increase in BSA or duration of follow·up. Ventricular end-diastolic 
pressure decreased following BOG from 9.0±0.5 to 7.0±0.4 mmHg 
(p=O.05). but there was no change in pulmonary resistance (2.6±0.4 
vs 2.4±0.4). effective pulmonary flow (l.S±0.2 vs 2.l±0.1 
lJmin/M2) or arterial oxygen saturation (7S±2% vs SI±I%). At 
subsequent Fontan. two pts required stent implantation for 
hypoplasia of the PA contralateral to BOG. We conclude that PA 
diameter contralateral to the BOG and the Nakata index decrease 
following BOG. which may have imponant implications for 
subsequent therapeutic intervention. 
784·6 11:45 
The Non-fenestrated Faltan: Hospital Course and outcane 
Frank lng, carlos M:lntoya, Daphne Hsu, Jan Quaegebeur, 
Welton Gersony. Columbia University, New York, New York 
Recent reports indicate the fenestrated Fontan (FF) 
operation is advantageous in the early post-op period 
when ~ to earlier non-fenestratEd(NFF) cases at 
the same institution. Forty-eight consecutive patients 
I.lIldenlent NFF operations I:lebIeen 2/90 and 6/92. Pre'-op 
hem:xl:ynamic data; hospital course, and autcane \\'erE! 
evaluated. Paraneters irivestigated include age of opera•
tion, duration of intubation(INT), lCU stay (lCU) , total 
hospital stay(lDSP), rn.mi:ler of inotropic agents(~#) 
and duration (~D), duratial of chest tubes (Cl'), pleural 
effusions (PE), and failures (F) due to death or Fontan 
1:akedcMn. 
Pre-op hsrodynamic data: (Irean mn Hg) 
N RAP PAP lAP Em' PVR PAsteoosis 
Columbia 4B 4.9 14.2 6.1 B.O 1.2 16/47(34%) 
Boston** 66 NA 15.2 7.8 NA 1.8 29/66(44%) 




Age mr rcu lDSP ~# lNJ-D Cl' PE F 
Columbia 6.6y 1.6 6.7 14.5 2 3 5.6 14.5 5/48 
Boston** 5.4y 2* 4* 14.4 NA 2* NA 13.6 3/66 
Other post-op OCIlPlicatialS included: significant 
arrhythmias 13/ 4B (27%) and thranboembolic events 3/48 
(6%). Seventeen patients require1 24 additional pr0ce•
dures to drain effusions. 
This data suggest that early post-op results for NFF 
often may not be significantly different fran those 
reported in the li teratilre for FF cases. We ccmclude 
that prospective stu:iies of these two foDIIS of manage•
nent including risk factor assessnent are necessary to 
further clarify this question. 
** Circulation,1991 (abstract), * Circulation,1990 
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785·1 10:30 
Somatic Pain Threshold and Reactive Hyperemia in Autonomic 
Diabetic Neuropathy and Silent Myocardial Ischemia 
A.Hartmann, B.Schlottog, G.Kober, B.Reschke, E.Jungmann, 
P.-H.Althoff, M.Kaltenbach. Depts. of Cardiology and 
Endocrinology, J.W.Goethe-University Medical Center, 
Frankfurt, Germany 
In 31 patients (p.) with coronary artery disease 
(autonomic neuropathy n = 1 1, diabetes without neuropathy 
n = 10, silent myocardial ischemia without diabetes n = 10 ) 
difference in somatic pain threshold and plethysmographically 
determined reactive hyperemia induced by forearm skelettal 
muscle ischemia was investigated. 
There was no difference in reactive hyperemia after 
passive maximum forearm ischemia in the three groups 
indicating identical vascular reactivity. After symptom·limited 
ischemic work however, reactive hyperemia was significantly 
higher in p. with silent myocardial ischemia as compared to 
the diabetic p. Exercise time was longer in p. with silent 
myocardial ischemia (153 ± 51 sec) as in p. with diabetic 
neuropathy (139 ± 45 sec) and diabetics without neuropathy 
(120±45 sec). Pain as a cause of termination of symptom· 
limited ischemic forearm exercise occurred less frequently in p. 
with diabetic neuropathy (2/11) and patients with silent 
myocardial ischemia (3/10) as compared to p. with diabetes 
without neuropathy (9/1 0) . 
In conclusion, p. with silent myocardial ischemia have a 
higher ischemic tolerance in the working forearm as compared 
to diabetic p. with and without neuropathy. In p. with 
neuropathy ischemic pain occurs less frequently at the same 
ischemic work level as in diabetics without neuropathy. 
Diabetic neuropathy appears to facilitate the occurrence of 
silent myocardial ischemia. The data presented here suggest 
that there is a quantitative difference in ischemic tolerance 
between p. with silent myocardial ischemia and p. with 
diabetic neuropathy. 
785·2 10:45 
Spinal Cord Stimulation in Pacing.Induced Angina 
Pectoris 
Clas Mannheimer, Finn Waagstein, Tore Eliasson. Clas HAkan Berg. Bert 
Andersson, Lars-Erik Augustinsson. HAkan Emanuelsson. University of 
GOteborg. Sweden 
In order to investigate the effects of spinal cord stimulation (SCS). 20 
patients with severe angina pectoris due to coronary artery disease 
underwent right-sided catheterization with atrial pacing via a catheter in 
the coronary sinus. Blood samples were drawn simultaneously from the 
coronary sinus and a peripheral artery for lactate analysis. Patients were 
paced to symptoms of angina in a control session (C). to comparable heart 
rate with SCS (PI) and, in the absence of anginal pain at PI' funher to 
anginal pain during SCS (P2). All patients had previously had a spinal 




















--- **. - --*._-
136±65 124±63 145±55 
---**-- --*._-
19±11 16±9 19£1 
---**-- --**--
SCS seems to have aruianginal and antiischemic effects in coronary artery 
disease. The antiischemic effect seems to be secondary to a decrease in 
myocardial oxygen consumption. Furthermore. ischemia during SCS 
treaunent gives rise to anginal pain and the treaunent does not conceal 
symptoms of myocardial ischemia. 
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785·3 11:00 
Central Modulation of Pain perception in 
Patients with Silent Myocardial Ischemia 
Anatoly Langer, Paul O'Connor. St. Michael's Hospital, Toronto, Canada 
Patients with silent ischemia (SI) have a higher pain threshold (PT) 
which is thought to be related to altered central pain modulation. 
However, the evidence for greater 6-endorphin levels and the response 
to naloxone to alter pain perception remains controversial. Accordingly, 
we studied PT (maximal tolerable electrical forearm skin stimulation, 
mAl in 30 male pts (age S7±9 yrs, i±SD) with angiographic coronary 
disease (~SO% stenosis, d artery); I S had stable angina (SA), symptomatic 
positive (~.1 mY STI) exercise test (+GXT) and no SI (~.1 mY ST!, ~I 
min) on 48 hr Holter monitoring and IS were asymptomatic including 
+GXT and had SI on Holter monitoring. 
SA and SI groups wer~ similar in demographic and clinical 
characteristics, including angiographic extent of CAD. Measurement of 
PT was made at baseline and after placebo and naloxone administered in 
a double blind, random sequence: 
BauIlJa llm.lI2 ~ 
(mA) (mA) (mA) 
SA (n-IS) 13±4 I1±S 12±4 
SI (n~ 15) 17±S· 13±4+ 13±3+ 
·p<0.05 SA vs SI, +p-O.07 vs SI Baseline, fp-O.13 vs SI Baseline 
The peripheral perception was similar between SA and SI groups in 
measurements of upper limb nerve conduction velocities (median nerve: 
54±2 vs 56±4 misec, P-O.9) and somatosensory evoked potential latencies 
(Erb's point - cervical column interval: 4.0±0.9 vs 3.9±0.S msec, P-O.7; 
central conduction time: 6.1±0.7 vs 6.1±0.5 msec, P-O.8). 
We conclude that patients with SI have a higher pain threshold as 
evidenced by baseline values. The lack of difference in peripheral pain 
perception points to altered central pain modulation as does the similar 
decrease in pain threshold after placebo and naloxone. However, the 
mechanism of this phenomenon is unlikely to be mediated by higher /3-
endorphin levels alone but rather by more complex cerebral responses 
which were not addressed in this study. 
785-4 11:15 
Mechanisms or Silent Myocardial Ischemia in Type I Diabetic and 
Nondiabetic Patients 
Hiroyuki Hikita, Akira Kurita, Bonpei Takase, Hirokazu Nagayoshi, 
Toshihiko Nishioka, Hideki Milani, Akimi Uehata, Kimio Satomura, 
Kyoichi Mizuno, Haruo Nakamura. National Defense Medical 
College, Saitama, Japan. 
Previous studies support a role of beta-endorphin (FD), pain threshold 
(Pr) and cardiac autonomic tone in silent myocardial ischemia (SMI). 
Although SM! are frequently found in patients (pts) with diabetes 
mellitus (OM), differences of mechanism in SMI between OM pts and 
nondiabetic (NoOM) pts have not been well documented. Therefore, 
we investigated the exercise treadmill testing (ETT) and 24-hour 
ambulatory ECG monitoring (AECG) in 120 pts (20 with type 1 DM 
and 100 without OM, age;62±10 years) with coronary artery disease 
(CAD) and with well reproducible exercise-induced ischemia PIS were 
divided into 3 groups according to previous thallium imaging and 
symptoms during Err:Group 1 (G 1); 20 OM pts with SMI, Group 2 
(G 2); 52 NoOM pts with SM!, Group 3 (03);48 NoOM pts with 
painful ischemia. At rest (R) and immediately after Err (Ex), plasma 
ED level was determined with RIA and Pr was measured with 
electrical skin stimulation testing on the forearm. In the AECO, the 
mean of the standard deviations of all normal sinus RR intervals 
during successive S-minute recording periods over 24 hours (SOl) was 
analyzed as an index of heart rate variability. The results are shown 
below. The other data from Err were similar among 3 groups. 
EDCR lEx) Pr(R lEx) SD!(msec) 
01 6:t2 18%2# 1.7±O.3 12.0±0.2# 33±9$ 
02 8±3 1 13±7#* 1.5±O.5 11.8±O.5# 47±7 
o 3 8:1:3 19±5# l.l±O.5t 1 1.3±O.7t 50:!: 10 
(Mean±SO, FD;pglml, Pr;mA, # p<O.05 Ex vs. R, *p<O.05 02 vs. 
01,3, t p<O.05 03 vs. 01,2, $ p<O.OI 01 vs. 02,3) Conclusion: ED 
is related to the pathogenesis of SM! in NoDM pts with CAD whereas 
SM! in OM is associated with the decreased SOl reflecting autonomic 
nerve dysfunction. Thus, the underling pathophysiologic mechanisms 
of SM! are different in these two entities. 
ABSTRACfS 
785·5 11:30 
Mechanisms of Angina: Interaction ofischemic and Perceptual 
Variables. 
Bradley Marchant, Kulasegaram Ranjadayalan, Robert 
Stevenson, Peter Kopelman, Adam D Timmis. London Chest 
Hospital, London, United Kingdom 
The mechanism of silent myocardial ischemia (SMI) is poorly 
understood due partly to a lack of a simple quantitative 
measure. The purpose of this study was to evaluate the 
relationship between SMI on 48hr Holter monitoring and 
anginal perceptual threshold (APT, the time from 0.1mV ST 
depression to angina on treadmill testing) and to investigate 
mechanisms of SMI. 43 untreated patients with stable angina 
and a positive stress test were studied, of whom 34 experienced 
angina on the treadmill (Group A) and 9 did not (Group B). 
Group A had a lower exercise tolerance (322 ± 22 v 461 ± 55 
sec, p < 0.05) and more extensive coronary disease. In group A 
the ratio of silent to total ischemia on Holter monitoring was 
lower (0.65±O.07 v 0.99±0.01, p<0.005) and correlated 
positively with the APT (r=0.5,p<0.02), patients with a longer 
APT having a higher proportion of SMI. Within patient 
comparison of painful and silent ischemic episodes on Holter 
monitoring showed that painful episodes lasted longer 
(12.0±4.6 v 2.1 ±O.4 mins, p<O.02) and were associated with a 
greater increase in heart rate (26±3 v 13±4%, p<O.OI). 
In conclusion, myocardial ischemia is associated with pain when 
it is prolonged, and associated with a greater increase in heart 
rate, suggesting that a critical mass of ischemic myocardium 
may be necessary to stimulate pain. However, the threshold at 
which angina is experienced varies between patients, and the 
APT provides a useful measure of this variation. 
785·6 11:45 
Observation of Sleep Apnea in Patients With Coronary 
Artery Disease and Their Clinical Significance 
Osamu Tateishi, Izumi Nishimuta, Kyouko Ogihara, Shin•
ichiro Obata, Tetsuya Nagamori, Yoshibumi Hihara, 
Akiko Fujita, Takayuki Nagata, Shuichiro Fujimoto, 
Tetsuo Okamura, Jikei University, Tokyo, Japan 
The clinical significance of sleep apnea syndrome 
(SAS) in patients with coronary artery disease was 
observed. One-hundred thirty five recordings of 
electrocardiograms and respiratory wave-forms were 
obtained in 71 patients with coronary artery disease 
(male 68, female 3, age 55±10 years) with a 24 hours 
ambulatory monitoring recorder (FUKUDA SM28, IR28). 
SAS was defined when apneic episodes (ceasing of abdom•
inal wall movements for at least 10 seconds) occurred 
more than 30 times during sleep. 
SAS (+) 
EF ~ 50 4/8 (50%) 







The values of ejection fraction were less and the 
cardiac events (sudden death, ventricular tachycardia 
and new onset chest pain) were more prone to occur in 
patients with SAS than in those with Non-SAS. 
Conclusion: Patients with SAS are high risk patients 
for occurring cardiac events. 
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786-1 10:30 
Evidence for Motogenlc Effects 01 Platelet-Derived Growth Factor A 
and B Expressed In Human Vascular Smooth Muscle Cells 
Ralf Koster, Ulrich Windstetter, Peter Oberfuhr, Gunter Hofmann, 
Gerhard Bauriedel, Berthold Holling. Depts. of Intamal Medicine and 
Surgery, University of Munich, FRG 
Proliferation and migration of vascular smooth muscle cells (SMCs) are 
key events in atherogenesis. It is known that PDGF stimulates both of 
these processes in a paraerine fashion, whereas autocrine stimulation 
has only been shown for proliferation. The aim of our study was to 
investigate the influence of PDGF expression in SMCs on the migratory 
activity of these cells. The SMCs assayed were cuHivated from vascular 
tissues of 23 patients. Cellular motility was analyzed by a computer•
assisted motion analysis system. PDGF-A and PDGF-B mRNA levels 
were determined by quantitative Polymerase Chain Reaction (PCR) 
following reverse transcription. Cells derived from arteriosclerotic lesions 
produced a 1.6 fold increase of PDGF-A (1)-0.0321) and a 4.5 fold 
increase of PDGF-B (1)-0.0090) compared with those from normal 
vessels. The migratory velocity (range: 17.6-42.6 iJ.ITl/h) was independent 
of PDGF-A and PDGF-B mRNA expression. A signifICant correlation 
between levels of PDGF-A and PDGF-B mRNA and the degree of direc•
tional changes of SMCs on the covered track (k1inokinesis) was found: 
.-.... '" ·r-=~"-------", 
D .•.•••••••• _ ••••• _______ • __ ••• ___ •• _._.~L._ .. _. 
'········I~:= I" .. ~~---~-+-~~~~ - - ---- .. -c..... .. ,., .... ~MIAt 
.................•.•.• D. .. ...,. ....................•...•... ~ .. 
------•c..- ........... -....,..u.I 
Conclusion: PDGF-A and PDGF-B mRNA expression is significantly 
correlated to positive klinokinesis without affecting migratory velocity 
(chemokinesis). This finding reflects enhanced random motility of SMCs. 
Besides its known mitogenic effects we present evidence that PDGF may 
act as an autocrine motogen in SMCs. 
786-2 10:45 
Inhibition of Smooth Muscle Cell Migration and 
Proliferation by P-Cyclodextrin Tetradecasulfate. 
Shunichiro Okada, Ewa Hozakowska, Sally H. Zigmond, Paul B. Weisz, 
Elliot S. Barnathan. University of Pennsylvania. Philadelphia, PA 
One of the control points in the development of intimal hyperplasia is 
the migration of vascular smooth muscle cells (SMC) from the media 
to the intima with subsequent proliferation in the intima. Heparin 
and p-cyclodextrin tetradecasulfate (PCDT), a synthetic analog, have 
been demonstrated to be effective in limiting intimal hyperplasia 
after experimental vascular injury. We compared the effect of PCDT 
or heparin (72 h) on: A) SMC proliferation using a quantitative 
cellular protein assay and 3H-thymidine incorporation and B) 
migration using a linear under-agarose assay with time-lapse video 
microscopy. In cultured human coronary artery SMC (Fig A), we 
demonstrated a dose dependent inhibition of proliferation for ~CDT 
(91±5% inhibition, 10 mg/ml, n=3) and for heparin (83±8%, 10 
mg/ml, n=3, ±SEM). 3H-thymidine incorporation was similarly 
reduced by both drugs in cultured rabbit aortic SMC. Migration of 
both rabbit (Fig B) and human SMC was significantly inhibited by 
both compounds as well. Thus, PCDT and heparin may be effective 
agents in inhibiting intimal hyperplasia by limiting both 
proliferation and migration. 
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Onset of Transforming Growth Factor-B Mediated Matrix 
Production Following Arterial Balloon Injury 
Elizabeth O. Palmer, Robert C. Krall, Nancy A. Noble, Wayne A. 
Border, and Ronald D. Jenkins. UniverSity of Utah School of 
Medicine, Salt Lake City, Utah. 
Transforming growth factor-B (TGF-B) is a cy10kine which 
mediates extracellular matrix production in response to tissue 
injury. To demonstrate the onset of TGF-B activity and 
extracellular matrix production following arterial injury, we 
evaluated the appearance and distribution of TGF-B and fibronectin•
EDA (extra-domain A, a matrix product preferentially induced by 
TGF-B) in rabbit aorta following balloon injury. Twelve 34 Kg 
New Zealand white rabbits were subjected to Fogarty balloon 
stripping of the terminal aorta. Two rabbits each were sacrificed at 
0, 2, 4, 6, 8, and 10 days following balloon injury. After 
perfusing the aorta with cold phosphate-buffered saline, sections of 
both injured and non-injured aorta were placed in formalin for 
histochemical analysis. Peroxidase stains were done for TGF-B and 
fibronectin·EDA using mouse monoclonal antibodies. Trivial 
subintimal TGF-B staining was evident by 2 days. By 4 days, TGF•
B activity was mild in the subintima, and intense in the scant 
neointima, which progressively thickened through the 10th day. 
The staining for TGF-B remained moderate in the subintima and 
intense in the neointima through day 10. The appearance and 
distribution of fibronectin-EDA paralleled that of TGF-B, being 
mild in the subintima and intense in the neointima by day 4. By day 
6, subintimal staining was moderate and neointimal staining 
remained intense which continued through day 10. These data 
suggest that TGF-B is directly related to extracellular matrix 
production following balloon injury with TGF-B protein and 
associated matrix products distributed primarily in the neointima 
and subintima . 
786·4 11:15 
Lesion Composition Determines Compeasatory Vessel Wall Responses and 
Plaque Accumulation in Native Coronary Artery Stenoses: An Intravascular 
Ultrasound Study 
Gary S. Mintz, Robert F. Bonner. Philippe C. Douek. Kenneth M. Kent. Augusto 
D. Pichard. Lowell F. Satler. Manin B. Leon. Washington Hospital Center. 
Washington. DC 
To assess the relationship of lesion composition to plaque burden and vessel wall 
geometry at focal coronary artery stenoses. we studied 71 pts before transcatheter 
therapy using a comprehensive intravascular ultrasound (IVUS) imaging system 
{25MHz rotating transducer. 3.9F monorail imaging sheath. motorized transducer 
pullback at O.5mm/sec. 2-D and 3-D display and quantification I. Lesion site 
measurements of external elastic membrane (EEM) and plaque+media (p+M) 
cross-sectional areas (CSA) were compared to an angiographically normal 
proximal reference (ref) site. Predominant lesion composition was categorized as 
soft. fibrotic. and deep or superficial calcific (Ca++. circumferential arc > 135°). 
Lesion EEM CSA (rrun2) 
RefEEM CSA (mm2) 
Ratio 
Lesion P+M CSA (mm2) 
Ref P+M CSA (mm2) 
Ratio 
Soft Fibrotic Deep Ca++ SuperfICial 
(n=24) (n=16) ( 0=14) Ca ++ (n=17) 
23.0±5.S 20.6±7.2 14.S±4.2 13.7±3.7 
IS.5±4.5 19.5±7.3 l4.5±5.5 IS.3±3.7 
1.3±O.2 l.1±O.l l.1±O.3 O.75±O.1 
2I.S±6.0 19.3±7.2 13.5±4.2 l2.3±3.S 
1O.0±3.6 1O.9±3.9 8.6±4.3 11.5±3.1 
2.5+ 1.7 1.9±O.6 1.7±O.5 l.1±O.4 
Plaque composition depends. in part. on vessel size: deep Ca++ occurs more 
commonly in smaller arteries. More importantly. lesion composition effects vessel 
wall responses to plaque accumulation. Reference sites have significant plaque 
burden (average P+M= 10.3 mm2). but little Ca++ and dense fibrous tissue 
(combined arc=46°) allowing compensatory EEM enlargement. Similarly. lesion 
site soft plaque accumulation allows. but eventually outstrips compensatory 
dilatation to result in lumen compromise (lesion:reference EEM= 1.3: 1. 
P+M=2.5:1). The constraining influences of dense fibrous tissue and deep Ca·· 
limits lesion site compensation (lesion:reference EEM=l.1:l.1): and. therefore. a 
smaller plaque burden causes lumen compromise. Lesions with superficial Ca·· 
show failed compensation (Iesion:reference EEM=O.75: I): lumen compromise 
occurs with no increased plaque mass compared to the reference site. 
We conclude: Despite similar angiographic appearances of focal stenoses. IVUS 
reveals striking differences in patterns of plaque accumulation and compensatory 
dilatation that vary with differences in lesion composition. 
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786-5 11:30 
Inhibition of Porcine Vascular Smooth Muscle Cell 
Proliferation Using c-myc Antisense Oligonucleotides 
Howard G. Hutchinson, Vi Shi, Annie M. Peter, Andrew Zalewski, 
Jefferson Medical College, Philadelphia, Pa. 
Present treatments for the prevention of restenosis 
following angioplasty have been disappointing neceSSitating a 
search for newer molecular based therapies. Previously, we 
reported successful inhibition of human vascular smooth muscle 
cell (VSMC) proliferation using antisense oligonucleotides 
(oligomers) complimentary to the translation initiation region of 
the human c-myc protooncogene. Since further testing of the c•
myc antisense approach requires careful selection of an 
appropriate animal model, we first tested the effect of 15-mer 
phosphorothioate oligomers complimentary to the human c-myc 
gene on porcine VSMC growth. Antisense oligomer concentrations 
of 8 to 121!M markedly reduced the growth rates of porcine VSMC 
compared to sense treated cells (p < 0.001). Growth inhibition 
was 80 to 100 % on day 1 with significant Inhibition of 60 to 93% 
maintained through 4 days of culture. No cell toxicity was 
observed at these concentrations. In addition, cellular uptake 
studies using 32p labelled oligonucleotides verified intracellular 
accumulation of oligomers beginning at 1 hour of exposure. 
In conclusion, 1. activation of the c-myc gene plays an 
important role in both human and porcine VSMC proliferation, 2. 
the growth-inhibitory effect of c-myc antisense oligomers in 
porcine VSMC provides a strong rationale to study the c-myc 
antisense approach for the prevention of coronary restenosis in a 
porcine model. 
786·6 
Autoc:rine Production of Platelet-Derived Growth Factor Regulates 
Thrombin-Induced Smooth MllKle Cell Mitogenesis 
11:45 
George A. Stouffer. Ian J. Sarembock, Coleen A. McNamara, Gary K. Owens. 
University of Virginia Health Sciences Center, Cbarlottesville, VA 
Thrombin bas been implicated in mediating restenosis following angioplasty in 
animal models. Studies in vitro have shown tbat thrombin i. a potent mitogen for 
vascular smooth muscle cells (SMC) and that this effect is mediated via activation 
of a receptor belonging to the seven fransmembrane. G-protein coupled 
superfamily. However, studies in fibroblasts demonstrated that inhibition of 
tyrosine phosphorylation blocked thrombin-induced mitogene5is. suggesting a 
potential role for autocrine production of secondary growth factors. To explore 
this question. SMC derived from Sprague-Dawley rats were grown to con fluency . 
growth arrested and treated with .. -thrombin (10 nM) or vebicle. At prescribed 
time points. 3H-thymidine incorporation was determhled or conditioned media 
(CM) was harvested. Results demonstrated that treatment with thrombin was 
associated with an increase in non-hirudin inhibitable mitogenic activity in CM 
from thrombin treated SMC (Thr CM) beginning approximately 12 hours after 
treatment. This activity was totally inhibited by treatment with neutralizing 
antibodies to PDGF-AA and PDGF-AA levels were increased in Thr CM as 
demonstrated by radioreceptor bioassay. Treatment with exogenous PDGF-AA 
was mitogenic and cotreatment with thrombin and PDGF-AA resulted in a 
mitogenic response equivalent to that induced by thrombin alone. Further studies 
examined the effect of exogenous PDGF-AA on kinetics of thrombin-induced 
mitogenesis. Addition of hirudin at any time from 0 to 12 bours after treatment 
with thrombin totally inhibited thrombin-induced mitogenesis. However. addition 
of hirudin to SMC 4 hours after treatment with both thrombin and PDGF-AA 
only partially inhibited thrombin effects. Tbese results demonstrate that 
thrombin-induced mitogenesis was mediated, in part, by SMC autocrine secretion 
ofPDGF-AA. 
ABSTRACfS 
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Inducibility of Ventricular A1rhythmias at Baseline Electrophysiologic 
Study in Cardiac Arrest Survivors 
Thomas C. Trouton, Anne C. Powell, Subramaniam Krishnan, John Newell, 
Brian A. McGovern, Hasan Caran, Jeremy N. Ruskin, Massachusetts 
General Hospital, Boston, MA. 
In a retrospective analysis of 331 survivors of out-of-hospital cardiac 
arrest inducibility of ventricular arrhythmias at baseline 
electrophysiologic study (EPS) was examined. 228 patients (69%) had 
inducible sustained ventricular arrhythmias (1) and 103 patients (31 %) 
had no inducible sustained ventricular arrhythmias (NI). The diagnoses 
in NI compared with I were, respectively: coronary artery disease (553% 
versus 79.4%), cardiomyopathy (15.5% versus 11.8%), valvular heart 
disease (8.7% versus 7.0%), congenital heart disease (2.9% versus 0.9%) 
and structurally normal heart (11.7% versus 0.9%). Vasospasm and 
myocardial bridge accounted for a further 5.9% of NI. Compared with I 
pts, NI pts were younger (mean age 54 ±. (SEM)1.6 years versus 58 ±. 0.8 
years, p=O.OO5) and had higher left ventricular ejection fractions at 
baseline (47 ±. 2% versus 38 ± 1.1 %, p<O.OOl). An implantible cardioverter•
defibrillator (lCO) was placed in 51/103 NI (49.5%) and in 99/228 I 
(43.4%). During a mean follow-up of 41 ±. 1.9 months 75/228 (32.9%) I pis 
died compared with 17/103 06.5%) NI pts. Survival free from cardiac 
death at 1 and 3 years was 92.1 % and 84.2% respectively for I pts and 
95.2% and 93.2% for NI pts. Multivariate analysis revealed no 
independent predictors of sudden death in NI pts; only age and 
antiarrhythmic drug use at the time of cardiac arrest predicted total 
mortality. Neither left ventricular ejection fraction nor the absence of an 
ICO predicted cardiac or total mortality in NI pts. 
Conclusions: Cardiac arrest survivors with no inducible ventricular 
arrhythmias at baseline EPS constitute a younger, more heterogeneous 
group with better left ventricular function and a more favourable prognOSiS 
than those with inducible arrhythmiaS. Standard predictors of mortality 
are not useful in managing NI patients. 
787·2 10:45 
ReappraIsal of Programmed VeDtricular StlmDlatioD la Idlopatblc 
Dilated Cardlomyopatby with or without Docu· .eDted SustalDed 
VeDtricular Arrbytbmias In 154 Patients 
Xu Chen, Micbael Block, Stehpban Willems, Antonio Martinez•
Rubio, Gerbard Hindricks, Wilbelm Haverkamp, Dirk Borcker, 
Mohammad Sbenasa, Martin Borggrefe, Gunter Breithardt. Dept. of 
Cardiol.! Angiol. and Inst. for Res. in Arterioscler, University 
bospital, Munster, Germany 
Tbe role of programmed ventricular stimulation (PVS) in patients 
(pts) at bigh risk of sudden death (SO) related to idiopatbic dilated 
cardiomyopathy (OeM) is still controversial. Tbe possible reason is 
tbat most study series are too small or only a few pts bad 
documented sustained ventricular tacbycardia (dsVT). PVS was 
performed in 154 pts with DCM. Tbe indication for PVS were dsVT 
(n=61) or VF (n=37), syncope (n=27), non-sustained VT (n=26) and 
palpitations (n=3). Using up to 3 extrastimuli, sustained VT were 
induced in 54/98 pts (55%) with and in 18/56 pts (32%) witbout 
dsVT /VF (p<O.OI). An effective drug regimen was obtained in 31 pts 
(20%) by serial drug testing. An implantable cardioverter 
defibrillator (lCO) was implanted in 35 pts. At a mean follow-up of 
30±15 months , tbere were 16 SO (including 5 aborted SO). SO 
occurred in 14 of 98 pts (14%) witb dsVT /VF compared to 2 of 56 
pts (4%) without dsVTiVF (p<0.05). In 66 pts with dsVT/VF but 
without implantation of an lCD, tbere were 10 SO in 33 pts (30%) 
without inducible sustained VT /VF, and 3 SO in 33 pts (10%) with 
inducible sustained VT /VF (p<O.05). Only one of tbe 32 pts (391) 
with dsVT /VF who were treated witb lCD died suddenly. Discharges 
of the ICO were observed in 63% pts during 18 ± 11 months of 
follow-up. 
Conclusion: sustained VT is induced more frequently in DCM pts 
with dsVT tban in those without dsVT. The efficacy of 
antiarrbytbmic tberapy is limited in a small subgroup of pIS with 
documented but not inducible VT have a high risk of SO. ICD may 
improve tbe prognosis of tbese bigh risk pIS. 
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Reproducibility Of Electrophyslologlc Study Results During AntIarrhythmic 
Therapy For Ventricular Arrhythmia, Unreleted To COI'ONIry O ... ee 
Kevin J. Ferrick, Michael Maher, James A. Roth, Soo G. Kim, John O. Fisher. 
Montellore Medical Center, Bronx. New York 
Although electrophysiologlc studies (EPS) are commonly used to assess 
antiarrhythmic drug (MO) efficacy In patients with ventricUar arrhythmias, the 
reproducibility 01 these studies during therapy has not been estabiished In 
patients without coronary disease. We, therefore, performed repeat EPS 
during MO therapy deemed effective or partially effective on the basis 01 a 
single EPS In 60 patients to assess the reproducibllty 01 drug effect. Patients 
with a history 01 myocardial Infarction, angina, or ECG evidence 01 MI, were 
exciuded from analysis. All patients had sustained ventricular arrhythmias 
induced during Inttial control state EPS (VT In 55 pis, VF in 5 pis). The group 
had a mean age 01 48.± 18 years, 41 patients were men. The mean ejection 
fraction for the group was 46.± 22%. The mean rate 01 vet1lricUar tachycardia 
induced at the time 01 Inttial study was 260.± 64 bpm. ConfIrmation 01 EPS 
resutts was performed within 48 hours 01 EPS during MO therapy deemed 
either effective or partially effective (VT rate slowed to < 150 bpm associated 
with a biood pressure 290mm Hg). 
~ 47 01 60 patients (78%) exhlbtted concordant rasUts during 
confirmation EPS. Sustained VT was Induced in 18% patients during MO 
therapy felt to be effective on the basis 01 a single EPS. 
CONCLUSIONS: 1) EPS rasUts during MO therapy exhibtt significant day-to•
day variability. 2) Sustained VT can be Induced In a substantial number of 
patients on a regimen deemed effective on the besis 01 a single EPS. 3) Con•
firmation EPS should be considered In patients In whom arrhythmia recurrence 
could be IWe threatening. 
787-4 11:15 
I, "Noncllnicar' Induced Ventricular Tachycardia. Clinical Problem 
Anwer Ohala, Sanjay Deshpande, Ancirea Natale, Mb Sheth, Mohammad 
Jazayeri, Jasbir Sra, Boaz AvIIaI, Masood Akhtar. Sinai Samarftan Medical 
Center, Milwaukee, Wisconsin 
Induction of so called nonciinical ventricliartachycardia (VT) is 01 frequent 
occurence during electrophysioioglc studies (EPS). The ciinical relevance 
of these Induced but nonciinical arrhythmias are unclear. In 25 pis present•
Ing with ventricuiar tachyarrhythmias, we documented 90 spontaneous VT 
racurrancas (VT -Recurrence) electrocardiographically thai occured during 
a mean foilow-up 01 2.65 years (majority in the drug !rae state) and 
compared the morphologies obtalned to that 01 the Inttial cilnical tachycar•
dia (VT -Index) and the induced VT (VT -EPS). 
RESULTS: 38 different morphologies were noted during recurrences. In 7 
pts the VT -Index. VT -EPS and VT -Recurrence were simHBr, In 5 VT -Index 
and VT -Recurrence were simHBr, and conversly in 8 VT - EPS and VT -Recur•
renee were slmlar. In 9 pis, VT -Recurrence was dflerent from VT -Index 
and VT -EPS. Multiple morphologies were seen during EPS In 9 patients, 4 
01 whom had mlitiple morphologies during foilow-up. However, 4 pts who 
had only a single VT-EPS morphology, had multiple morphologies during 
VT-R. 
CONCLUSION: 1) Induced VT frequently presents as ciinical VT. 2) When 
multiple morphologies are Induced multiple morphologies are frequently 
seen during recurrences. 3) VT -R morphologies not seen during VT ~ and 
VT -EPS are not uncommon. Successful prevention of VT racurrencas would 
require effective control of induced VT. 
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Truncated Serial Drug Stimulation Protocols 
Kay Limit the Interpretation of BSVEK 
Stephen L. Winters, Donald Rubenstein, John 
lp, Oaniel Goldman, John S. Banas, Jr., 
Pankaj Patel, J. Anthony Gomes. Morristown 
Memorial Hospital, Morristown, NJ and The 
Mount Sinai School of Medicine, New York, NY. 
The programmed ventricular stimUlation (PES) 
protocols used to assess serial drug stUdies 
(SOS) in ESVEM were not extended beyond the 
degree of aggressiveness at baseline. To 
assess if this may represent a limitation, we 
reviewed the results of PES in 54 consecutive 
patients who had induction of sustained 
ventricular tachycardia (VTi) in 1 or more 
SOS. The PES protocol used at SOS was similar 
to that in ESVEM except for use of the 
following even if not used at the baseline 
study: a shorter basic drive (BO); a second 
site (ST); a second or third extrastimulus 
(XS); burst stimUlation (B); closer S1S2 
coupling intervals (CI). Results: PES was 
performed in 87 SOS until either non 
pharmacologic therapy was chosen or 
suppression was documented. Extension of the 
PES protocol was required for VTi in 39 (45%) 
of these as follows: BO-19 (49%); ST-12 
(31%); XS-2 (6%); B-1 (2%); CI-5 (13%). Two 
or more additional variables were needed in 
11 (13%) SOS. A more aggressive PES protocol 
was required for VTi in 31 (57%) patients. 
Conclusion: The lack of extension of the 
baseline protocol used in ESVEM to more 
rigorous PES at serial drug testing may be a 
substantial limitation of the study. 
787-6 1l:45 
IafJ __ fIla TbinI Exb dimul .. ill Dd'iDiD& mcdiYe Dna 'lbrnpy 
duriD& SaW EIedropb~ Tadiac 
David E, Mann, Patricia A, Kelly, Cbarles E. Fuenzaiida, William M. 
Bailey, Michael J. Reiter, University of Colorado Health Sciences Center, 
Denver CO_ 
Although the use or 3 t:"trastimuJi (ES) to induce sustained ventrladar 
tachycardia (sus VT) dW"ina baseline e1ectrophysiologic testing is well•
established, the use or 3 ES dW"ina drug restudies in patients in whom only 
1 or :z ES are needed to reproducibly induce sus VT in the baseline stale is 
controversial_ To assess the impact of using 3 ES in these patients on 
predictiOIti or drug efficacy, we reviewed all baseline and oraJ drug 
e1ectrophysiologic tests perfonned during the last :z years and analyzed 
patients who had reproducibly inducible sus VT in the baseline stale and 
underwent serial drug testing_ There. were 181 tests, 69 control and IU 
during oral drug therapy, perfonned on 69 patients, whose presentation was 
sus VT (4l), sudden death (U), syncope (11), noJmJStained VT (4)_ In aU 
studies 3 ES at :z right ventricular sites were used, We analyzed drug 
efficacy using this protocol, and compared it to drug efficacy if stimulation 
had been halted arter using :z ES during drug testing in patients in whom 
sus VT waS reproducibly induced with 1 or :z ES in the baseline stale. 
In the baseline state, SUS VT was reproducibly inducible with I or :z ES in 
38 (55%) patients_ In this group or patients, 6 (16%) bad no inducible sus 
VT on a drug during restudy using 3 ES. H stimulation on drug had been 
limited to:z ES in this group, IS (39%) would have had no inducible sus VT 
on a drug (p < 0.05). In the whole group or 69 patients, the nlDllber of 
responders would have increased rrom 18 (U%) using 3 ES to 27 (39'1» 
using the:Z ES protocol (p NS), VT morphology on drug ... similar 
whether VT was induced by 3 ES or by 1 or :z ES but VT cycle length was 
shorter when VT was induced by 3 ES on drug Verswi 1 or :z ES (303.±.15 
ms vs 385.±.15 ms, p <0.01)_ Thus, many patients undergoing 
e1ectrophysiologic testing ror ventricular arrbytlunias bave inducible sus VT 
with 1 or :z ES in the baseline stale. Using 3 ES in these patients dW"ina 
drug restudies significantly decreases the nlDllber or patients in whom sus 
VT becomes noninducible. Whether using 3 ES improves or worsens the 
predictive value or serial drug testing in these patients cannot be answered 
rrom this study. 
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BDh&Dced UtUiaatioa of tha Fraak-Itarliag IlecbaJli .. 
Augaaata Stroka Volu.a Duriag S.erciae ia Patieata With 
.. vere Left Veatricular I,atolic DyafuactioD 
Martin J. Sullivan, Frederick R. CObb, Polly Beare, 
Matthew Flynn, Jim Kennedy, Kenneth G. Morrie, Michael B. 
Higginbotham, Duke & VA Medical centera and Duke center 
for Living, Durham, HC 
In order to e.amine the role of diastolic left ventricu•
lar (LV) performance on atroke volume (SV) control during 
exerciae in patient. (PTS) with LV ayetolic dyafunction 
and chronic heart failure (CHP) , we performed ..... imal 
(MAX) upright bicycle exerci.e (EX) in 56 PTS and 18 age•
matched normals (NLS). Meaaurementa at upright reat (R) 
and during MAX EX included cardiac output (00, l/min), 
(direct Pick), SV (ml/beat), LV ejection fraction (LVlP, 
'), oxygen conaumption (Ve:" ml) and pulmonary wedge 
pressure (PWP, I11III Hg). From aimultanaoua LVIP and SV data 
LV end-diastolic volume (EDV, ml) and end-sy.tolic volume 
(ESV, ml) were calculated. The re.ulta are aa follows, 









ill I!l& ill IIld 
4.0* 4.6 9.0*f l5.1f 
47* 64 67*f 95f 
9* 3 19* 11f 
22* 65 24* 75f 
234* 98 312*f l28f 
l8S* 34 243* f 33 










Although PWP waa higher in PTS va NLS at MAX, the 
t.PWP/!J.LYEDV from R to MAX waa no different in PTS va NLS, 
auggeating similar LV compliance changes with e.erciae. 
Thus, in PTS with CHP 1) increase. in SV during EX are 
important in augmenting CO, 2) increases in SV are due 
primarily to enhanced utili&ation of the Prank-Starling 
mechanism, as LYEP did not increase in PTS, and 3) LV 
compliance during EX, as indicated by the LV preaaure/ 
volume relationship ia normal in CHP. Thus diaatolic LV 
function plays a major role in determining SV during EX 
and possibly EX tolerance in PTS with CRP due to LV 
ayatolic dysfunction. 
788·2 10:45 
Relation Betweea Exercise Tolenmce and Left Ventricular DiIIstoIic FiIIiIIg in 
I'IItieDts wid! Ischemic Heart Disease and Systolic Dysfunction 
Musimo Pozzoli. Soccorso CapomoUa.Giorgio Riccudi. FI"IIICO Cobelli, LuiBi 
Tavazzi. Fondazione Clinica del Lavoro. IRCCS. Pavia • Centro Medico 
MODIeoCaDO; ITALY 
Left ventricular diastolic abnonnalities may influence exercise 
tolerance in patients with left ventricular dysfunction. We evaluated 
the relationship of left ventricular filling pattern and left ventricular 
filling pressure at rest to peak oxygen uptake during exercise 
(pY02) in 80 patients with ischemic heart disease and left 
ventricular systolic dysfunction (EF < 40%). Patients uderwent a 
cardiopulmonary exercise test during right heart catheterization, 
and two-dimensional and Doppler ecbocardiographic examination 
(simultaneous in 48 patients). Patients were divided into two 
groups according to the Doppler mitral flow velocity pattern: 
Group 1(E/ A ratio < I) and Group 2 (EI A ratio> I). 
RESULTS pV02 PWP EF C I SVI 
tdtqJm2 maIg. JlIllinlm2 ailm2 
Groupl 15+4 12+4 32+6 2.7+.5 37+6 
Group2 10+4 24+7 30+6 2.6+.4 34+6 
P < 001 .001 lIB lIB lIB 
During exercise, patients in Group I increased SVI (from 37+6 to 
43+9 m11m2, p<O.OOl), while SVI failed to increase in Group 2 
(from 34+6 to 34+6 ml/m2, ns). pY02 was correlated with PWP 
(r=-O.55,p<O.OOl) and E/A (r=-45,p<O.OOl), but not with any 
invasive or noninvasive indices of systolic function at rest. 
Conclusions: in patients with a comparable degree of systolic 
dysfunction, those with EI A> I filling pattern have a reduced 
exercise tolerance. In these patients, the high PWP at rest and the 
failure of increasing SVI during exercise suggest that a reduced 
preload reserve may playa role in limiting exercise tolerance 
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Chronotropic Incompetence DurlnQ lxerel .. In Patients WIth Seve,. 
Left Ventricular Dyafunctlon 
David S. Hamer. Bruce L. Wilkoff, Gordon G. Blackburn. Lori A. 
Alexander. The Cleveland Clinic Foundation. Cleveland. OH 
Normal subjects demonstrate a linear relationship wHh Percent Heart Rate 
Reserve (%HRR). defined as (HRstage-HRrest) I {(22~Age) - HRrestj x 
100 and Percent Metabolic Reserve (%MR). defined as (METSstage•
METSrest) I (METSpeak-METSrest) x 100. This relationship is tenned the 
Metabolic Chronotropic Response (MCR) and was assessed during 
cardiopulmonary exercise testing wHh METS calculated from measured 
oxygen consumption in 12 patients under evaluation for cardiomyoplasty 
(LVEF=24±B%. Age=54.5±14.0 yrs. METSpeak.4.93±1.22 with 
range=3.46·7.37 METS) . Forty-eight control subjects with normal LV 
function. no ischemia and no cardiac medications were also tested by 
cardiopulmonary exercise testing wHh METS calculated from measured 
oxygen consumption (Age--47.4±6.3 yra. METSpeak • 9.05±2.02 with 
range = 5.14-13.14 METS). 
RESULTS: The average HRrest (±SEM) for the LV dysfunction group was 
95.6±4.5 BPM compared to 73.6±1.9 BPM for the control group 
(p<0.0001). HRpeak was 143.3±6.3 BPM (expected=165 BPM) compared 
to 174±1.2 BPM (expected=173 BPM) for the control group (p-<0.OO01). As 
previously described in nonnal subtwts. the MCR was strongly linear 
(r=.95) and was described by %HAR ~ «0.99) x MR) - 3.48. Un ear 
regression analysis of the MCR in the LV dysfunction patients also 
demonstrated a linear relationship (r=.75) between %HRR and %MR. and 
was described by the formula %HRR .. «0.67) x MR) + 2.71. The 
reduction in MCR slope of 0.32 (p<0.005) was significant and was related 
to the elevation in resting heart rate and failure to reach the age predicted 
maximal heart rate. 
CONCLUSION: The chronotropic response 0/ subjects wHh severely 
impaired LV function is significantly aHered from normals and characterized 
by: elevated HRrest. reduced HRpeak and a reduced slope of the MCR 
relationship. AHhough clear1y linear in normals. the MeR in subjects wHh 
LV dysfunction contains a significant nonlinear con,>enent. 
788·4 11:15 
Onset Of Regional Anaerobic Muscle MetabolIsm DurIng Exercise Does 
Not Explain Reduced Systemic Anaerobic Threshold In Heart Failure 
Sarah A. Samaan. Milton V. Icenogle, Robert A. Robergs, Tracee L. 
Hudson. Eiichi Fukushima, and Michael H. Crawford. V A Medical 
Center, University of New Mexico, and Lovelace Medical Foundation. 
Albuquerque, NM 
Heart failure patients (HF) have limited exercise capacity characterized 
by low peak exercise oxygen consumption and reduced systemic 
anaerobic threshold. Recent data from HF, using forearm exercise as a 
model, demonstrated peripheral muscle abnormalities which are thought 
to contribute to limited exercise capacity and early lactate (La) 
accumulation. Two possible mechanisms which could account for early 
lactate accumulation are: I) a low regional anaerobic threshold (AT) for 
lactate production in exercising skeletal muscle, or 2) abnormal 
production and/or clearance of lactate after the muscle AT is reached. 
Using 31-phosphorus magnetic resonance spectroscopy (31-P MRS), we 
have previously shown in normal (NL) subjects that the muscle AT 
during forearm exercise (marked by onset of rising La efflux) 
corresponds to aD inflection in the rise of muscle inorganic-phosphate•
to-phosphocreatine ratio (Pi/PCr). To test if skeletal muscle AT is low in 
HF, 9 HF (EF 25-40%) and 9 NL subjects did incremental wrist flexion 
exercise during 3IP-MRS with simultaneous arterialized and deep 
antecubital venous blood sampling. The change in La level from the 
exercising muscle was calculated using arterial-venous differences. The 
workloads at which Pi/PCr inflections occurred were determined bv 
fitting the data to a two line regression model. There was a line;r 
relationship between the workloads precipitating La release and the 
inflection in Pi/PCr in HF and NL subjects (R=0.86.p<0.05). The mean 
workload for the inflection in the rise of Pi/PCr in HF was 0.37±0.07 W 
and not significantly different from NL (0.37±0.14 W). The workload at 
which La release increased was also not different between HF and NL 
(O.39±0.10 and 0.35±0.12 W. respectively). Thus, the peripheral muscle 
A T is the same in HF and NL. indicating that abnormal production 
and/or clearance of lactate after the muscle threshold is reached is the 
likely mechanism of low systemic AT in HF. 
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Tailored Exercise Protocol in Heart Failure 
Studies 
Hilsry F. Marlow, Martin Griffiths, Paula J 
Slater, Michael K. Davies, Surinder J. Virk, 
Department of Cardiovascular Medicine, 
Queen Elizabeth Hospital, Birmingham, England. 
Exercise improvement is a measure of efficacy 
for therapeutic interventions in heart failure. 
Most studies use a standard exercise protocol, 
whether treadmill or bicycle ergometer. 
Patients' exercise capacity varies widely, need•
ing large numbers to show significant treat•
ment differences. We thus compared two bicycle 
ergometer protocols, a fixed load and a variable 
incremental load, where the increments were 
tailored to each individual to stop symptom•
limited exercise in 5 min (range 4-6 min). Ten 
patients, mean age 61 (range 46 to 78), mean EF 
22% (range 12 to 33), in stable NYHA Class II -
III completed both protocols in one afternoon on 
three occasions separated by at least 1 week. 
Results for exercise duration [sees] (mean ± SO, 
variance, range) were 
Fixed load(n - 30) Variable load(n - 30) 
876±326 106552 195-1200 330±124 15257 180-648 
We conclude that in comparative efficacy studies 
where exercise is a primary end-point, an exer•
cise protocol in which loads are tailored to the 
exercise capacity of each individual, produces 
lower variance (p<O.Ol) in exercise duration and 
numbers of patients required will therefore be 
substantially reduced. This has important impli•
cations for the design of heart failure studies. 
11:30 
788·6 11:45 
L..eII Ventricular Function During Submaximal Exercise Following 
Maximal Exercise Testing 
Carl Foster, Thomas Gaeckle, Steven C. Port, Donald H. Schmidt, 
Sinai Samaritan Medical Center, Milwaukee, WI 
Exercise radionuciide ventricular function studias (ExRNA) are 
technically difficult if performed at peak Ex because of patient 
motion artifact. Previous studies have shown the left ventricular 
ejection fraction (LVEF) increases abruptly Immediately following 
cessation of exercise or reductions in workload. Another strategy 
for reducing motion Is to image during submaximal (-75%) Ex 2-3 
minutes following peak Ex (POS1), allowing both an optimal exercise 
study and, potentially, representative LV imaging. To examine the 
value of POST, we studied 22 pts during cycie ergometer (CE) and 
treadmill (TOM) Ex at both peak Ex and POST using first pass RNA 
with a multicrystal gamma camera. Two TOM Ex studieS were not 
tec:mically adequate at peak Ex. Combining the CE and TOM studies, 
we fcundthal HR (147 ± 24vs 142 ± 23 b!min), SBP (181 ± 23vs 174 
± 24 mmHg), HR x SBP (26.8 ± 5.9 VS 25.1 ± 5.9), LVEF (56 ± 14 VS 
60 ± 13%) and wall motion score (6=normaI) (5.1 ± 1.3 VS 5.4 ± 0.9) 
were all significantly (p < 0.05) different peak Ex vs POST. The 
overall ciinical impression of the ExRNA study was different in 
3/22 patients, with abnormal findings at peak EX and normal 
findings POST. The results suggest that the augmentation of left 
ventricular function that occurs immediately following stopping EX 
or reduction in exercise load persists at least 2-3 minutes POST 
and may lead to underestimation of the magnitude of abnormalities 
of ventricular function evident during peak Ex. 
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Primary Angloplasty Is the Preferred Therapy for Women and 
the Elderly with Acute Myocardial Infarction • Results of the 
PrImary Angloplasty In Myocardial Infarction (PAMI) Trial 
Gregg W. Stone, Cindy L. Grines, Ronald Vlietstra, Michel 
Vandormael, Donald ~othbaum, James O'Keefe, Paul Overlie, Brian 
Donohue, Noah Chelliah, Mellisa May, Sylvia Puchrowicz-Ochocki, 
William W. O'Neill. William Beaumont Hospital, Royal Oak, MI 
The optimal management of myocardial infarction (MI) in women and 
the elderly remains controversial. To address this issue, 395 pts pre•
senting within 12 hours of acute MI at 12 centers were prospectively 
randomized to treatment with tPA followed by intervention only for 
spontaneous or inducible ischemia (n=200) or primary angioplasty 
(PTCA) without antecedent thrombolysis (n=195). 107 pts (27%) 
were female, and 150 pts (38%) were 2,65 years of age. Endpoints 
examined included in-hospital mortality, recurrent ischemic events 
and stroke. Demographic characteristiCS were similar between pts 
treated with tPA and PTCA. 
PTCA was successful in 96.3% of men and 100% of women 
(p=NS). Similarly, PTCA was equally successful in pis <65 years and 
2,65 years of age (97.3% vs. 96.7%, p=NS). Adverse ciinical events 
were as follows: 
789·2 10:45 
Outcome of Patients Managed with Primary PTCA varsul Lytic Therapy 
in e Multicenter Registry 
William J. Rogers, Larry S. Dean, Paul B. Moore, Sheila L. Burgard, Edwin 
L. Bradley for the Alabama Registry of Myocardial Ischemia Investigators. 
Univ of Alabama Medical Center, Birmingham, AL. 
To assess the relative merits of primary PTCA and thrombolytic therapy 
in myocardial infarction, patients (pts) with 2, 30 min of chest pain within 
the prior 12 h were entered into a prospeetive registry during 1990-92 at 
12 tertiary care hospitals. Of 519 pts with 2, 0.1 mV ST elevation in 2,2 
leads, 107 received primary PTCA and 125 lytic therapv within 6 h of 
admission. Interval from pain onset to hospital evaluation was 147 min 
in the PTCA group vs 119 min in the lytic therapy group (p = 0.081. 
Interval from pain onset to primary PTCA averaged 248 min, whereas 
interval from pain onset to lytic therapy averaged 184 min (p = 0.0006). 
Patients in the PTCA and lytic therapy groups were remarkablv similar 
with regard to age, sex, race, prior MI, prior CVA, and admission physical 
exam. Primary PTCA was successful in at least one vessel in 88%. During 
hospitalization, 5.7% of the PTCA group were transfused compared to 
17.7% of the lytic therapy group (p = 0.0051. Stroke occurred in 0.9% 
of the PTCA group and 0.0% of the lytic therapy group. Of the PTCA 
group 9.4% died in-hospital versus 3.2% of the lytic therapy group (p = 
0.015). Combined death/reinfarction was noted in 15.0% of the PTCA 
group versus 4.8% of the lytic therapy group (p = 0.007). To account 
for baseline differences between the primary PTCA and lytic therapy 
groups, multivariate logistic analysis was performed. Both hospital 
mortality (p = 0.035) and the combination of hospital death and 
reinfaretion (p K 0.007) were found to be more common among pts with 
primary PTCA. Furthermore, in a subgroup of 197 pts treated ~ 6 hr of 
pain onset, hospital death and death/reinfaretion were also more common 
when the treatment was primary PTCA (p < 0.03,0.002, respectively). 
This prospective registry shows that pts undergoing primary PTCA for 
AMI: (11 are remarkably similar on presentation to those being managed 
with lytic therapy but are treated later after symptom onset; (2) have 
successful PTCA in 88%; (3) have less need for blood transfusion; but (4) 
have higher hospital mortality and a higher rate of hospital 
death/reinfaretion than those managed with lytic therapy. 
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Primary Angloplasty Reduces In-Hospital Mortality and Molbldlty In 
Acute Anterior Myocardial Infarction - Results of the Prtmary 
Angloplasty In Myocardlallntarctlon (PAMI) Trial 
Gregg w. Stone, Cindy L. Grines, Kevin F. Browne, Jean Marco, Donald 
Rothbaum, Geoffrey O. Hartzler, Paul Overtie, Brian Donohue, Noah 
Chelliah, Michelle Strzelecki, Sylvia Puchrowicz-Ochocki, William W. O'Neill. 
William Beaumont Hospital, Royal Oak, MI 
Observational series have demonstrated that primary infarct angio•
plasty(PTCA) can be pertormed with a high success rate and low in-hospital 
morbidity and mortality. However, it has been suggested that PTCA 
reperfusion of inferior myocardial infarction (MI) may paradoxically resutt in 
sudden clinical deterioration. To determine the safety and efficacy of 
different reperfusion strategies in anterior and inferior MI, 395 pts presenting 
within 12 hours of acute MI at 12 centers were prospectively randomized to 
treatment with tPA followed by intervention only for spontaneous or in•
ducible ischemia (n-2oo) or primary PTCA without antecedent throrrilolysis 
(0=195). The mean age was 60 years (range 29-85 years); 288 pts (73%) 
were male. MI location was anterior in 138 pts (35%) and non-anterior in 
257 pts (65%). Endpoints examined included in-hospital death, ventricular 
!i)rillation (VF), recurrent ischemia and stroke (CVA). 
Maior adverse clinical events were as follows: 
Anterior Non-anterlor 
tPA PTCA p tPA PTCA p 
(n=67) (0=71) (0=133) (n=124) 
Death 11.9% 1.4% .01 3.7% 3.2% NS 
VF 1.5% 1.4% NS 1.5% 9.7% .011 
Ischemia 28.4% 11.3% .01 27.8% 9.7% .0002 
eVA 6.0% 0% .037 2.2% 0% NS 
Conclusions: Compared to tPA followed by conservative care, pri•
mary PTCA in pts with anterior MI resutts in improved in-hospital survival 
and a reduced rate of stroke. In pis with inferior MI, though the incidence of 
VF is increased after primary PTCA compared to conventional tPA therapy, 
in-hospital survival and incidence of stroke are similar. Primary PTCA offers 
the additional advantage of a marXed reduction in the rate of recurrent is· 
chemic events, independent of infarct location. 
789-4 11:15 
PrImary Percutaneous Translumlnal Coronary Angloplasty Versus 
Recombinant Tissue-type Plasminogen Activator In Acute 
Myocardial Infarction: Evidence Suggesting Thallium-201 Defect is 
Similar, but More Reveralble Ischemia Occurs With Recombinant 
Tissue-Type Plasminogen Activator 
Marcus A. DeWood, The Heart Institute of Spokane, Deaconess and 
Sacred Heart Medical Centers, Spokane, WA 
Reversible ischemia following myocardial infarction is frequently 
measured by stress/redistribution thallium-201 studies. To define the 
extent of defect and reversibility in patients randomized to primary 
percutaneous transluminal coronary angioplasty (PTCA) or recombinant 
tissue-type plasminogen activator (rt-PA). we studied 40 patients at 7 to 
10 days post myocardial infarction. To determine the extent of defect (in 
percent) in the area of myocardial infarction, polar maps were constructed 
using stress/redistribution images taken at 6.3 ±. 0.2 mmtpixel in the 
region supplied by the infarctvessel. The percent defect (D) at stress (ST) 
and redistribution was measured and reversibility was calculated. 
Baseline "'''IllS' It-PA IN,,19) 
Age (Years) 58 ±.1 1 
Male (Percent) 74% 
Global Ejection Fraction (%) 53 ±. 13 
LV End Diastolic Pressure (mmHg) 21 ±. 04 
Collaterals 21 % 
BIILIIIli 
Extent of Defect (%) 
Reversibility (ST - D) 
53;1:07 
16;1:08 











NS 55±. 05 
.15 04;1:12 
Conclusion: The extent of defect is similar but there is a strong trend 
suggesting more reversibile ischemia is present in rt-PA treated patients 
but not in the PTCA group. 
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Immediate and One Year Outcome Following Direct 
Angioplasty Versus Thrombolytic Therapy for Acute 
Myocardial Infarction 
Jenny S. Martin, Paul E. Utwin, Daniel A. Waxman, Alfred P. 
Hallstrom, W. Douglas Weaver, for the MITI Project Investigators, 
University of Washington, Seattle, WA. 
To compare outcomes in AMI patients who receive direct 
PTCA vs. thrombolytic therapy, a computer program was 
developed to optimally match clinical characteristics in 314 AMI 
patients receiving direct angioplasty (PTCA) to 773 AMI patients 
receiving thrombolytic therapy (TT). This resulted in 225 pairs 
matched for sex, race, presence of clinical shock on admission, 
ECG location of MI, history of prior MI and CHF, age (±3 yrs), and 
symptom duration (±2 hrs). 
Patients treated by direct PTCA had similar mortality and rates 
of new congestive failure and recurrent infarction. Direct PTCA 
patients were much less likely to develop spontaneous recurrent 
chest pain prior to discharge (18% YS 27%, p=0.03). 
All patients were followed for one yeaf to determine the need 
for readmission or death. One year mortality rates were 11 % for 
those receiving direct PTCA compared to 8% in those who 
receiving thrombolysis. ApprOximately a third of both treatment 
groups were readmitted for cardiac problems and 26% and 20% of 
patients, respectively, had a catheterization procedure during 
follow-up. 
We conclude that outcome is similar for AMI patients treated 
initially by direct PTCA and thrombolytic therapy with the 
exception of fewer episodes of recurrent chest pain. The need for 
rehospitalization and incidence of significant events in the year 
following hospitalization is also similar. 
789-6 11:45 
Acute Outcome After Primary Angloplasty In Myocardlallntarctlon -
The Primary Angloplasty In MyocardlallntarctlOn (PAMI) Trial 
Gregg W. Stone, Cindy L. Grines, Kevin F. Browne, Jean Marco, Donald 
Rothbaum, James O'Keefe, Paul Overtie, Brian Donohue, Noah Chelliah, 
Michelle Strzelecki, Sylvia PuchrowicZ-Ochocki, Gerald C. TImmis, William 
W. O'Neill. William Beaumont Hospital, Royal Oak, MI 
Previous single center studies of primary angioplasty (PTCA) in myocardial 
infarction (1.41) have been Hmited by their applicability only to the parent insti•
Mion and lack of rigorous quality control. To further define the role of PTCA 
in MI, 195 pis presenting within 12 hours of MI at 12 centers who were ran•
domized to primary PTCA wHhout antecedent thrombolysis were prospec•
tively evaluated. Patient charts, EKGs and cineangiograms were reviewed 
by independent study monitors. 
All pts assigned 10 PTCA underwent acute angiography. Twenty pts 
(10%) were excluded after angiography for <70% stenosis (n=8), small 
vessel-left occluded (n=I), patent-asymptomatic (n.l), presence of large 
thrombus-given IC lytic (0=1), and high risk features for PTCA-referred for 
bypass (n=9). Angioplasty was performed in 175 (90%) of the 195 pts 
assigned to PTCA. Success was achieved in 170 pts (97.1%) and partial 
success (restoration of flow wHh >50% stenosis) in 4 pis (2.3%); PTCA was 
unsuccessful in 1 pt (0.6%). Thus, by "intention to treat analySiS", 193 of 
195 pts (99%) randomized to PTCA achieved a patent infarct vessel. 
In-hospital adverse events were as follows: 
Death Recunent Stroke 
IschemIa 
All DIs n:195 2.6% 10.8% 0% 
Anterior MI (n:71) 1.4% 11.3% 0% 
Non-Anterior MI (":124) 3.2% DzNS 9.7%D=NS 0% 
Age <70 years (n:125) 1.9% 10.8% 0% 
Age ~70 years (n:70) 5.3%p:NS 7.9%p=NS 0% 
Male (n:I45) 2.1% 8.2% 0% 
Female In:5()) 4.0%DzNS 16.0%D=NS 0% 
Conclyslons. Management of MI with urgent angiography followed 
by triage to primary angioplasty, urgent bypass or medical therapy resutted 
in patency of the intarct vessel in 193 of 195 pts (99%), low In-hospital mor•
tality (2.6%), clinical stability (recurrent ischemia in only 10.3%). and no 
strokes. In-hospital outcome was favorable in pts known to be at high risk 
post-MI, including women, the elderly, and anterior MI. 
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Three-Dimensional Echocardiography Can Accurately Measure 
Left Ventricular Mass: In Vivo and In Vitro Validation 
Donato Mele, Leng Jiang, Mark O. Hancischumacher, Samuel C. 
Siu, Pieter M. Vandervoort, Gus J. Vlahakes, J. Luis Guerrero, 
Michael H. Picard, Tracy Svizzero, Arthur E. Weyman, Robert 
A. Levine. Mass. General Hospital, Boston, MA 
Documenting progression of left ventricular hypertrophy (LVH) 
and its regression with antihypertensive therapy ideally requires a 
technique that can measure small differences in LV mass. Widely 
used methods based on wall thickness (WTh) are limited because 
localized trabeculations and oblique views can exaggerate the 
appearance of LVH on M-mode or 20 echo scans in a variable 
manner from study to study, and their accuracy may vary with 
altered LV geometry in ischemic or valvular disease. The 
purpose of this study. therefore, was to validate the ability of 3-
dimensional echo (30E reconstruction to ev81uate LV mass 
WIt out ~eometnc assumptions. e system us aCI nates in 
VIVO app lcatlon by automatIcally combining 20 echo images with 
their spatial locations. It was applied to reconstruct the LV from 
intersecting views in 6 beating canine hearts. subsequently 
weighed. and 10 excised hearts. Endocardial and epicardial 
borders were traced at end-diastole and contained volumes 
calculated by a surfacing algorithm that uses the full 30 data sel. 
Both the corresponding 30 mass and predictions of a standard 
WTh method were compared to actual weights. RESULTS: 
30E successfully reproduced LV shape and mass (52-276 gm). 
which agreed well with actual values: y= 1.0x-5.4. r=.99. 
SEE=2 gm (1.5% of the mean). Although the WTh method 
correlated well with actual values (r= .97), its standard error was 
considerably higher (14.6 vs 2.0 gm. p< .01), as was the mean 
difference between its predicted and actual values (9.6,:: 14.2 gm 
vs -2.4+2.3 gm. p<.OOOI). CONCLUSION: LV mass can be 
accurat~ measured b~ 30E with a small standard error 
compar to methOds asea on mdlvldu81 Wfh v81ues. 30E 
should improve our ability to evaluate progression of LVH and its 
regression with treatment of hypertension. 
790-2 10:45 
Myocardial Fibrosis In Hypertensive Patients with Cardiac 
Hypertrophy: Assessment Using Endomyocardial Biopsy 
Scott E. Campbell. Karl T. Weber. Wolfgang Motz. Hans P. 
Krayenbuehl. University of Missouri. Columbia. MO; Heinrich•
Heine-University of Dusseldorf. Dusseldorf. Germany; University 
Hospital. Zurich. Switzerland 
Postmortem studies in the hypertrophied human myocardium 
found in hypertensive heart disease suggest that interstitial 
fibrosis represents an important component of structural 
remodeling and which. in animal studies. has proven a major 
determinant of myocardial stiffness. To determine if such an 
abnormal fibrous tissue response was present antemortem. we 
utilized endomyocardial biopsy specimens and picrosirius red 
staining in patients with established hypertension (mean arterial 
pressure 115 ± 4 mm Hg) and left ventricular hypertrophy (free 
wall thickness> 12 mm). Collagen volume fraction (CVF. %) 
was determined by videodensitometry in these patients and 
compared to CVF found in biopsied control tissue obtained from 
donors at the time of cardiac transplantation. We found both 
interstitial and perivascular fibrosis in biopsies from hypertensive 
patients. Microscopic scars were also occasionally found in 
tissue from these patients. Control myocardial tissue exhibited 
histologically normal fibrillar collagen. Hypertensive patients had 
significantly increased CVF. i.e. 4.0 ± 0.5 (p < 0.03) without 
scars and 5.0 ± 0.7 (p < 0.009) including microscopic scars. 
compared to 1.8 ± 0.5 for control patients. 'Thus. myocardial 
collagen is significantly increased in patients with hypertension 
and hypertrophy which may lead to systolic and diastolic 
dysfunction over time. Antemortem endomyocardial biopsies 
may prove useful in assessing the extent of myocardial fibrosis 
and in determining efficacy of interventional therapy. 
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Structural Characteristics of Left Ventricular Hypertrophy 
(L VH) Show Dissimilar Functional Correlates 
Oagnovar Aristizabal. Federico Soria, Edward O. Frohlich, Franz H. 
Messerli. Ochsner Medical Institutions. New Orleans. LA 
L VH in hypenension ~y be concentric (C) or eccentric (E) and may 
not be relate4 completely to pressure or volume overload. To deter•
mine whether other myocardial factors may be important: fractional 
fiber shonening (FS) and end systolic wall stress (ESWS) were deter•
mined in 85 hypenensive pIS., 20 with C. 15 with E and 50 without 
L VH. all having similar demographic and arterial pressure levels. All 
were studied with 2-0 guided M-mode echocardiography and were 
treated with ACE inhibitors (n=27) or calcium antagonislS (n=58) for 
8-12 weeks. Before therapy (Rx) there was no correlation between 
FS and ESWS in Col VH; however. this relationship was significant 
in E-LVH and non-LVH pIS. After treatment the C·LVH bacame 
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Thus. E-LVH provides a more appropiale functional response for the 
hemodynamic overload in bypen.ension than C-LVH and Rx normal•
izes this relationship. 
790-4 11:15 
"Ibe meet of Chaoges ID Blood Pressure IUId Left Ventricular Mass IDduced 
by TrealmeDt OD Ventricular AlTbythmlu ID Eueatlal Hyperteulon. 
Maria Lorenza Muicsan, Roberto Zulli, Da-.4iauo Rizzoui, Silvia Calebich, 
Mario Malerba, Enzo Porten Enrico Apbi:i-Rosel Cancdra di Mediciua 
Intema, Ulli\oersity of Brescia, Italy. 
"In csseDIiaJ bypertensM patients (EHP) a reduction of left VCDlricuIar 
hypertrophy (LVH) during autibyperteusM tr~.atmeul can IcacIto a decrease 
oC ~ntricuIar ectopic beats (VEB). Aim of ow study was to evaluate the effect 
oC changes in blood pressure (BP) and in L VH on the number and se~rity of 
VEB. ThereCore, 19 EHP (4 without LVH,:zt.,; and 2F, 15 with LVH,UM and 
3F) (age range 34-62 yrs) were studied in basaJ coDditions, after 6 moDlhs oC 
effecti~ antihypertensM treatment (n= 12 dibydropyridinic Ca-antagoDists, 
n -7 ACE-inhibitors) and after withdrawal oC treatment Cor 20 days. At each 
phase of the study, all EHP uuderwent the following procedures: 24 hours 
ECG monitoring (Hoker), 24 hours non-invasi~ BP ambulatory monitoring 
and ecbocardiograpbic examination (M-mode, 2D guided). meet oflreatment. 
BP was significantly reduced in every patieDt. ID EHP without L VH DO change 
in LV mass or in BEV was obsef\'ed. ID 8 EHP with L VH a reduction of L VH 
(from 151.;t27 to 116.;t20 g/m2, p<.01) as well as of BEV (from 46.;t7 to 
15.;t36 BEV {24brs) and eDd-systolic stress (ESS)(from 65.;t14 to 51.;t1O 
dynesl!f / au • p < .OS) was observed, while in .he remaining 7 EHP DO change 
in LV mass index (from 159.;t39to 143.;t33 S/m2, NS), BEV (from 448+ 1092 
to 206.;t382 BEV/24brs) and ESS (from 79.;t:~ to 66+17 dynesl!f/au2) was 
recorded. meet of trealmeDt withdrawal. BP ,eturned to pretreatmeul values. 
ID EHP without L VH there was DO change in LV mass and BEV in respect to 
basaJ coDditions. ID EHP with L VH and n JUctioD of LV mass significant 
increases of BEV (from 46.;t7 to 238+201 B oV/24brs, p<.OS) and of ESS 
(from 65.;t14 to 84.;t18 dynes 1ft /aur: p<.O~ I were recorded. ID EHP with 
L VH and no change in LV mass, no significa~t change of BEV and of ESS 
was observd. 10 csscntial hypertensM patients with reduction of L VH there 
was a significant correlatioD betweeD changes oC BEV Dumber and of ESS both 
during therapy (r-O.89, p<.OO1) and after treatmeDt withdrawal (r = 0.63, 
p<O.OS). In conelusloa: The results of this study suggest that the number and 
severity of ~DtricuIar arrbythmias are related to changes in afterload (ESS) 
more than to changes in left ~DtriCUIar mass. 
JACC Vol. 21, No.2 
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Mechanisms for Increased Mortality With Increased Left 
Ventricular Mass (LVM) Among Mild Hypertensives: The 
Treatment of Mild Hypertension Study (TOMHS) 
Ronald J. Prineas, Philip A. Liebson, Gregory A. Grandits. Richard S. 
Crow. Pentii M. RautahaJju. Richard H. Grimm. for the TOMHS Research 
Group. University of Miami. Miami. Florida 
L VM predicts higher mortality. independently of blood pressure (BP) by 
imprecisely defined mechanisms. These mechanisms have been 
speculative. Possible mechanisms were examined in TOMHS. TOMHS is 
a randomized trial among 902 men and women. aged 45 to 69 years. with 
average baseline BP of 140m mmHg comparing active drug trealIDent with 
placebo. All received nutritional counseling. Ventricular Premature 
Complexes (VPC) and ST -T depression were recorded on 24-hour 
ambulatory mOnitoring at baseline. 3 months. 12 months and annually for a 
total of 4 years. as was M·Mode echocardiography (ECHO). A stepwise 
Cox regression analysis for the occurrence of frequent VPC (~IO/hr) or 
ischemic episodes (J-depression <! lOOuV with horizontal or downsloping 
ST for 60 seconds or longer) for those free of these abnormalities at 
baseline was carried out including age. race. sex. SBP. physical activity. 
smoking. alcohol. Na+ excretion, stratum (on or off antihypertensive drugs 
at baseline). body mass index. serum K + • ECHO/L VM as possible 
predictors. and for predicting incident VPC only. ST·T depression was 
added as an independent variable. For men. only L VM and urinary Na+ 
were significant predictors of incident VPC; for women. only age was a 
significant independent predictor of incident VPC. Incident ischemia was 
predicted by serum K + in men and by L VM in women. These results 
indicate that increased L VM is associated with increased incidence of 
frequent VPCs in men and with increased incidence of ischemic episodes in 
women and may thus be possible mechanisms for the increased mortality 
associated with increased L VM. 
790·6 11:45 
Altered Heart Rate Variability and its 
Circadian Rhythm in Left Ventricular 
Hypertrophy 
Reynaldo F. Mulingtapang, Simon Chakko, Heikki 
V. Huikuri, Kenneth M. Kessler, Barry J. 
Materson, Robert J. Myerburg, V.A. Medical 
center and University of Miami, Miami. FL 
Both heart rate variability (HRV) and LV hyper•
trophy (LVH) are independent cardiovascular 
risk factors. HRV was measured by 24 hr Holter 
monitoring in 22 patients (Pts) with 
uncomplicated hypertension, echocardiographic 
LVH, and no coronary disease by stress thallium 
or angiography and compared to 11 age matched 
normal controls. Mean 24 hr R-R intervals were 
similar (825±43 vs 868±115 ms, p=NS). 
Difference between sleep (11pm-7am) and awake 
(9am-9pm) mean R-R interval was lower among Pts 
(73±33 vs 263±63 ms, p< 0.0001). Mean 24 hr 
standard deviation of R-R intervals (55+6.3 vs 
93±11, p<0.0001) and the percent of difference 
between successive R-R intervals that exceed 50 
ms (PNN50) were also lower among Pts (6.8±7.1 
vs 13.6±8.9, p<0.002). Spectral analysis of 
hourly 10 minute segments showed that power in 
the 0.15-0.40 Hz range was lower among the Pts 
during all hours. Among controls, power in the 
0.04-0.15 Hz range increased during day and 
decreased at night and PNN50 increased during 
the day and decreased at night; this circadian 
rhythm was bl unted among Pts. Thus in 
hypertensive Pts with LVH, HRV is decreased 
with a withdrawal of parasympathetic tone and 
the circadian rhythm of sympathetic/para•
sympathetic tone is altered. 
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PTCA, Directional Atherectomy and Coronary Artery Bypass 
Surgery in Cardiac Transplant Patients: Multicenter Findin'gs 
Austin A Halle, Germano DiSciascio, Robert F. Wilson, 
Edward K Massin, Robert C. Bourge, Neil S. Kleiman, 
Chauncey C. Crandall, Ross A Davies, Robert B. Wray, 
Michael L Stadius, Thomas R. Aversano, Maryl R. Johnson, 
Spencer H. Kubo, Leslie W. Miller, Gustavo Rincon, 
Susan G. Fisher, Michael J. Cowley, George W. Vetrovec. 
Loyola University Medical Center, Maywood, Dlinois 
Medical College of Virginia, Richmond, Virginia 
To assess the outcome of revascularization in cardiac 
transplant (CT) patients (pts) 11 medical centers 
retrospectively analyzed their complete experience with 
angioplasty (PTCA), directional atherectomy (DCA), and 
bypass surgery (CABG). 57 pts had PTCA of 62 lesions 
47.±.29 mos post-CT. In-hospital mortality (HOSP MORT) 
was 2/57(4%). 6 pts are alive with <6mos follow-up. Of 49 
pts with 2:,6mos follow-up 31(63%) are alive at 22.±.12mos. 
There were 10 deaths and 8 repeat CT. Of 24 pts with distal 
arteriopathy, survival without repeat CT was 13/24(54%) 
compared to 14/16(88%) in pts without distal arteriopathy 
(p<.03). 
DCA was performed on 8 lesions in 8 pts 52.±.12 mos post•
CT. HOSP MORT was 2/8(25%). At 5.±.4 mos follow-up 6 
pts are alive; 2 had later PTCA 
Elective CABG was done in 6 pts 50.±.31 mos post-CT. 
HOSP MORT was 4/6(67%) due to bleeding and/or heart 
failure. Two pts remain alive 5 and 21 mos post-CABG. 
In summary, PTCA in cardiac transplant pts is associated 
with acceptable survival in the absence of distal arteriopathy. 
Assessment of DCA and CABG is limited by the small cohort. 
791-2 
Effects of Serotonin on Coronary Vessels of Cardiac Transplant 
Recipients 
Guy Berkenboom, Philippe Dequenne, Philippe Unger, Alex Lipski, 
Martine Antoine. Jean-Louis Le Clerc, Georges Primo. Erasme 
Hospital. Free University of Brussels, Belgium. 
10:45 
Serotonin (5Hr) constricts coronary arteries with endothelial (E) 
dysfunction. In order to detect early graft artery disease, the 
responses to intracoronary 5HT were studied 6 weeks (group A. 9 
patients) and I year (group B, II patients) after transplantation (Ix). 
No patient had evidence of rejection and all had angiographically 
normal coronary arteries. 5HT in increasing doses (I flg/min, I 0 
flg/min, 20 flg/min for 2.5 min each) was infused into the coronarY 
circulation. Diameters of proximal, middle and distal segments w;re 
measured by quantitative angiography. In the distal part of the 
vessels (where the 5HT effects were the most pronounced) the 
diameters in % of base line were as follows : 
Control 5HT Iflg 5HT 10flg 5HT 20flg ISDN 
mm % % % % 
Group A 2.3±0.1 81±4·· 69±7· 62±5· J16±4 
Group B 2.3±0.2 105±2 98±4 86±4 121±2 
•• P < 0.01, • < 0.05 vs B, ISDN = isosorbide dinitrate (2 mg) 
Among 33 segments of group B, 21 diI:ued at I flg of 5HT and 
constricted at 20flg of 5HT; while in group A even at Iflg 5HT, 
almost all the segments (26 among 27) constricted (p < 0.001 vs B). 
The 2 groups were similar with regard to plasma cholesterol, blood 
pressure, age of the donors and inununosuppressive therapy, except 
cyclosporin doses which were higher in group A. Thus, abnormal 
response to 5HT commonly occurs in Tx patients and unexpectedly, 
mainly in the early weeks after Tx. This could be related to Tx 
procedure and/or an immune process not detectable by standard 




IS TRANSPLANT CORONARY DISEASE DETECTED BY QCA 
ASSOCIATED WITH CHANGES IN MYOCARDIAL RESERVE? 
Brian Jaski, Mark van Unden, Aggie Balk, Sipke Strikwerda, Pim de Feyter, 
Marcel vd Brand, Patrick Serruys. Sen Diego Cardiac Center, Sen Diego 
and Thoraxcenter, Rotterdam, The Netherlands. 
T ransplent coronary disease is a diffuse arteriopalhy-polentially 
involving the coronary microvasculature-thai can be monitored by 
quantitative coronary angiography (OCA) of major epicardial vessels. The 
physiologic significance of these changes, however, is uncertain. 
Therefore, 91 patlents without local angiographic stenosis > 5O'Jb 
underwent initial evaluation 1 month to 5 years after cardiac transplent with 
1 year foIIowup (FlU). QCA (post·NTG) and atrial pacing to matched 
maximum heart rate were performed with measurement of LV pressure 
(SYS,EDP) and pressure-derived parameters (+dP/d1, Vmax, Tau) by tip 
manometry. Mean coronary segment diameter (mn±SE) decreased 30 ± 
11 microns (733 segments, p<.05). Transplentdala (mn±SD) shown with 
67% range in 57 normaJ edults: 
N = 91 HR LVSYS 
REST-INIT 93±12 129+17 
REST-FlU 92+12 133+20 
NI 67% 68-80 114-170 
Max-INIT 144±21 123±18 
Max-FlU 144+21 128+17 








2225±522 70±16 38±8 
2352+512 74+14 38±8 
1800-3200 63-96 
Even in FlU of 2 subsets of patlents (a: 1 month initial study group 
N=22, 182 segments, OCA decrease 58 ± 25 microns, p < .05; b: > 220 
micron aCA decrease in patlent mean segment diameter at FlU group, 
N=14), LVEDP, Tau, +dP/d1, and Vmax remained similar to initial study. 
Conclysion: Despite detectable decreases in coronary artery size by 
QCA. no deterioration in LV systolic or diastolic function at rest or during 
maximal peeing oould be identified in this group of patlents nor in high risk 
subgroups (a,b). In the absence of savere local stenosas, decreases in 
cardiac transplent epicardial vessel size do not seem to be associated with 
changes in the coronary microvasculature sufficient to result in a decrease 
in left ventricular function as assassed by atrial pacing stress testing. 
791·4 11:15 
Antibodies to Vascular Smootb Muscle and Endotbelium after Cardiac 
Transplantation 
Alistair I. Fyfe, Nazzi Mojibi, Jon A. Kobashigawa, linda L. Demer, 
Davis C. Drinkwater, Hillel Laks, Lynne W. Stevenson, UCLA School 
of Medicine, Los Angeles, CA. 
The development of antibodies to endothelial ceUs after cardiac 
transplantation has been associated with transplant vasculopathy. We 
assayed 120 serum from 81 cardiac transplant recipients (CI'X) for 
antibodies (IgA, IgG & IgM) to endothelial cells (EC-A, EC-G, EC-M) 
or vascular smooth muscle cells (SMC-A, SMC-G, SMC-M) by CELISA. 
Because the use of ABO incompatible targets in previous assays suggest 
that some antibodies may be directed to ABO antigens, blood type 0 
EC and SMC were grown to confluence and fixed in 96 well plates. A 
1:25 dilution of serum was added for 2 hours followed by a 1:5000 anti 
IgA, IgG or IgM antibody. Results are expressed in arbitary units and 
compared to pooled normal human serum (PHS). 
"p<0.OO5 EC-A EC-G EC-M 
PHS (15) 344±81 299±5fi199±138 
CTx (120) 266± 106" 267 ±81472± 185 
SMC-A SMC-G SMC-M 
165±19 185±19 268±52 
162±27 177±35 32O± 71' 
In 38 CTx sera anti SMC antibodies were detected (>2 S.D. above 
normal); 8 IgA, 6 IgG, & 24 IgM. In 26 C1X sera anti EC antibodies, 
were detected; 4 IgA, 7 IgG, & 15 IgM. Conversely, in 26 CTx sera anti 
EC-IgA levels were >2 S.D. below normal. 
We document for the first time the presence of anti-SMC antibodies 
after CTx; predominantly IgM. We confirm the presence of anti EC 
antibodies, not due to ABO antigens. 19A antibodies which are thought 
to be protective, are significantly reduced in CI'X recipients. Differing 
antibody profiles directed at vascular wall cells after CTx may influence 
the development of transplant vasculopathy. 
791·5 
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Cyclosporine Impairs Release of Endothelium-Derived Relaxing 
Factor in Epicardial and Resistance Coronary Arteries: In Vivo Studies 
with Intravascular Two-Dimensional and Doppler Ultrasound. 
Krishnankutty Sudhir, John S. MacGregor, Teresa DeMarco, Mukesh 
Gupta, Paul G. Yock, Kanu Chatterjee. Cardiovascular Research 
Institute, University of California, San Francisco, CA. 
Coronary artery disease is the major limitation to long term allograft 
survival after heart transplantation. Cyclosporine A (CyA) is said to 
impair release of endothelium-derived relaxing factor (EDRF) in 
noncoronary beds. We hypothesized that CyA might induce coronary 
endothelial dysfunction, and thus contribute to accelerated coronary 
vasculopathy post-transplantation. We examined the effect of 
intracoronary acetylcholine (ACh) and nitroglycerin in 6 anesthetized 
dogs, before and after acute CyA administration (3mg/kg IV over 30 
mins). To directly assess the effect of Cy A on nitric oxide (NO) release, 
we examined the pre- and post-CyA response to intracoronary NW_ 
nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO 
synthetase, and L-arginine (L-Arg), the natural substrate of this 
enzyme. Flow velocity was measured with a 0.014" Doppler wire to 
assess resistance vessel responses, and epicardial coronary lumen area 
was simultaneously measured with a 4.3F, 30 MHz imaging catheter 
inserted over the Doppler wire. ACh (lO-6M) increased flow velocity 
(mainly determined by resistance vessels) by 84±30% pre-Cy A, but only 
22±99C post CyA (p<o.01). The epicardial vasodilator response to ACh 
(l0-6M) was also impaired (Pre-Cy A: 9±2% change in lumen area, post•
CyA: 2±1 %, p<0.02). Vasodilation with nitroglycerin (lOOl1g) was 
unchanged by CyA. Epicardial vasoconstriction with L-NAME (lo4M) 
was reduced by CyA (Pre: 7±1, Post: 1±3%, p<O.05) but L-Arg (104M) 
had no effect, suggesting decreased NO release, but not via competitive 
inhibition of NO synthetase. This study shows that CyA acutely 
impairs release of EDRF in both conductance and resistance coronary 
arteries, and provides direct evidence for decreased epicardial NO 
release following Cy A. Coronary endothelial dysfunction induced by 
CyA may participate in post-transplant vasculopathy. 
791·6 11:45 
Nitroglycerin-Induced Coronary Vasodilation in Heart Transplant 
Patients is Impaired by Intimal Thickening 
Dirk Hausmann, Andreas Miigge, Peter J. Fitzgerald, Paul G. Yock, 
Werner G. Daniel. Hannover Medical School, Hannover, Gennany and 
University of California, San Francisco, CA. 
Previous studies have suggested that in heart transplant patients intimal 
thickening does not affect coronary vasodiJatory responce to nitroglycerin 
(NTG). In 12 transplant patients (1-5 years post transplant) with 
angiographically normal coronaries, we studied vasoreactivity of the 
circumflex and left anterior descending artery using high-frequency 
(30MHz) intravascular ultrasound (IVU5) during routine cardiac 
catheterization. In 9/24 (38%) coronary segments, morphology of the 
intima was considered as normal (thickness <200 J.Im); in 15 (62%) 
segments, concentric (n= 11) or eccentric (n=4) wall thickening (maximal 
thickness> 250 J.Im) was detected by IVUS. Time following transplant was 
11 40 longer for diseased vs. non-diseased 
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sodilation after 100 J.1l intracoronary 
NTG was attenuated in segments 
with thickenened vs. non-thickened 
intima (. p<.01). Vasodilatory re•
sponce to NTG was more attenuated 
in concentric vs. eccentric lesions (+ 
16±.2 vs. + 23±.3 %; p<.05). In eccen•
tric lesions, increase in the length of 
the normal segment was greater 
60 120 180 than for the diseased (+ 5±.2 vs. + 
Time after NTG (sec) 14±.3 %; p<.05). 
Conclusion: In heart transplant patients, coronary vascuIopathy detected 
only by IVUS is associated with functional impairment of vasoreactivity. 
NTG-induced vasodilation is preserved in coronary segments without 
intimal thickening. 
JACC Vol. 21, No.2 
February 1993:335A 
792 New Developments in Contrast Echocardiography 
Wednesday, March 17, 1993 
10:30 AM-Noon 
Anaheim Convention Center 
A-IO 
792·1 10:30 
Effect of Pressure on Persistence 
of Echocardiographic Contrast Agents 
Cedric Yuille, Mark Nidorf, Richard L. Morrissey, 
Arthur E. Weyman, Michael H. Picard. 
Massachusetts General Hospital, Boston, MA. 
Assessment of the intensity of echocardiographic contrast 
(EC) for quantitation of blood flow requires an 
understanding of the variables affecting bubble survival. 
To determine the' effect of pressure on EC agents, 
a) AlbunexR, b) LevovistR, c) agitated AngiovistR and 
d) agitated saline were exposed to different constant 
pressures in vitro. Contrast intensity was recorded by 
echocardiography and measured each second following 
injection. Normalized curves of the EC intensity over 
time were constructed for the average of 5 injections at 
pressures of 0, 50, 100, 150, and 200 mmHg. Except for 
saline (graph d), contrast intensity half time was 
significantly altered by pressure (p<O.Ol). 
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Thus the rate of disappearance of EC depends on pressure. 
This result has significant implications for any attempt 
to quantify perfusion using contrast echocardiography. 
792·2 10:45 
Colour Doppler Mapping of the Myocardium Following IntrII·venous 
Injection of a Transpulmonary Echo ContrllBt Agent (SH U 508A) • 
A New Technique to Evaluate Regional Myocardial Perfusion? 
Michael J Stewart, Carmel M Moran, Kaj W E Groundstroem, Lynn N Fenn, 
George R Sutherland. University of Edinburgh, Edinburgh, U.K. 
Myocardial two-dimensional contrast echocardiography using direct 
intracoronary injection of sonnlcated contrast media can allow a semi· 
quantitative evaluation of regional myocardial perfusion but the widespread 
clinical applications of this technique are limtted. Although the Introduction 
of stable, transpulmonary ultrasonic contrast media offers the potential for 
myocardial perfusion imaging following intra·venous injection, inttial results 
have been disappointing due to 2·0 image ultrasound attenuation. In 
addttion, current 2·0 ultrasound instruments lack a linear grey scale for 
proceSSing the amplttude of contrast reflected echoes. By comparison, 
colour Doppler flow detection is much less influenced by intervening tissues. 
Moreover, colour Doppler signal strength is enhanced by the presence of 
contrast material wtthin the insonnated region of interest. We have therefore 
adapted a standard ultrasound machine by changing the colour Doppler 
software to image myocardial motion by excluding Doppler information from 
the blood pool. This is achieved by bypassing the clutter filter and 
interrogating a narrow low velocity range (0·3 cm.s·'). Two new colour 
maps were specifically developed for image acquisition from contrast 
enhanced myocardium - i) Energy, Ii) Veloctty. Initial clinical studies were 
carried out in 11 patients wtth cardiac lesions but no ischaemic heart 
disease. Multiplane imaging of the left ventricular myocardium was carried 
out using 2·0, M-mode, two dimensional colour Doppler and M-mode colour 
Doppler modalities. Images were acquired immediately before and for 10 
minutes after LV. injection of 3.2g of a transpulmonary contrast agent (SH 
U SOBA). Images were recorded on video-tape and on digital quad screen 
format to allow subsequent side-by-side comparison. Pre· and post•
contrast images were then compared by 2 independent observers who 
scored relative signal strength. A visually·appreciable contrast related effect 
on myocardial signal strength was apparent in 5/11 studies. This was best 
appreciated on M·mode colour Doppler using the energy map. 
Conclusion: Wtth suitable modification of standard Doppler equipment, an 
increase In Doppler signal strength can be detected in the left ventricular 
myocardium following LV. Injection of SH U 508A. These inttial clinical 
studies would suggest that this new technique has the potential to allow the 
non·lnvasive detection of regional myocardial perfusion. 
ABSTRACTS 
792·3 
Transthoracic Display of Pulmonary Venous Flow is 
Improved by the I.V. Injection of SHU 508A. 
Initial Results of an European Multicenter Study. 
335A 
11:00 
Harald Becher Helen von Bibra, Petros Nihoyannopoulos, Joachim 
Neuden, George Sutherland for the Levovist Cardiac Working Group. 
Bonn FRG, Munich FRG, London UK, Munich FRG, Edinburgh UK 
The display and quantification of pulmonary venous (PV) flow by pulsed 
Doppler (PD) and color Doppler (CD) is limited in adult patients. 
Improved Doppler sensitivity of left atrial flow detection has been shown 
with contrast enhancement To test the hypothesis, that lV injection of 
the transpulmonary contrast agent, SHU 508A (S), would allow 
clinically useful transthoracic evaluation of PV flow in the right upper 
pulmonary vein, 43 patients with valvular or ischemic heart disease were 
studied before and after injection of 16 ml S (200 mglml). Recordings 
were stored on video tape and analyzed by two independent observers. 
CD and PD signal intensity was graded using a visual score system from 
o (none) to 5 (too strong). 
Baseline CD and PD signals were poor (score <2) in 36/43 patients. 
After S, adequate CD flow signals (score >2) were recorded in 40 
patients (p<O.O I) and could be detected up to 3 em extracardiac from the 
vein orifice. The enhanced CD signals of the right superior pulmonary 
vein facilitated the alignment of the beam for the PD recording. Thus, PD 
recordings had clear envelopes and allowed quantitative analysis in 38/43 
patients. Shadowing from mechanical mitral valve prothesis appeared to 
be the main problem precluding satisfactory PV imaging in the 
remainders.l2 patients also underwent transesophageal 
echocardiography and PV flow velocity patterns recorded during this 
procedure compared well with the contrast enhanced image.Thus, 
contrast enhancement provided imponant information for the evaluation 
of LV diastolic function and mitral regurgitation. 
Conclusion: lntravenous SHU 508A improves transthoracic CD and PD 
imaging of PV flow.This simple and safe technique will obviate 
transesophageal recordings of PV flow in adult patients and facilitate 
further studies of its diagnostic and monitoring value. 
792·4 11:15 
Efficacy and Safety of SHU 508A for Doppler Contrast 
Enhancement in the Left Heart . 
Initial Results of an European Multicenter Study. 
Michael Stewart, Helen von Bibra, Petros Nihoyannopoulos, Joachim 
Neudert, Harald Becher for the Levovist Cardiac Working Group. 
Edinburg UK, Munich FRG, Bonn FRG, London UK, Munich FRG 
Doppler echocardiographic examination of the left heart is not universally 
successful but may be improved by the use of ultrasonic contrast 
media.We have therefore evaluated the clinical role of contrast enhanced 
Doppler, using the transpulmonary contrast agent. SHU 508A (S). 63 
patients referred for the assessment of mitral regurgitation (MR n=31), 
aortic stenosis (AS n=21), aonic regurgitation (AR n=4) and pulmonary 
venous flow (PV n=4) underwent a Doppler study before and for 10 min 
after the IV administration of S (16 ml of 200 mglml and 10 ml of 200 or 
300 mg Iml), recorded on videotape which was later assessed by two 
independent observers. All patients had a physical examination, routine 
blood tests and an electrocardiogram prior to, I h and 24 h after the study, 
Administration of S was well tolerated with no adverse effects and no 
change in beart rate, blood pressure and laboratory values. Maximal 
increase in color flow Doppler signal intensity in the left heart lasted from 
10-60 s with decreasing effects for up to 360 s. Enhanced color Doppler 
display of regurgitant jets, providing imponant additional information, 
was seen in 39/42 patients, The continuous wave Doppler envelope 
improved in all retrograde and antegrade jets but Doppler peak velocity 
was not altered by injection of S in patients with satisfactory baseline 
studies. However, Doppler contrast enhancement did result in 
measurement of higher peak gradients (p<o.Ol) in 14 patients with AS 
who had vague precontrast velocity envelopes, with improved correlation 
to invasive pressure measurements. Similarly, the pulsed Doppler 
envelopes of PV flow improved after S, allowing quantitative analysis in 
33 patients with poor quality recordings prior to contrast. 
Conclusion: SHU 508A is a safe LV contrast agent which achieves 
significant enhancement of both spectral and color Doppler modalities, 
improving the quantitative assessment of aortic stenosis and pulmonary 
venous flow, and improving the definition of site of origin and extension 
of regurgitant jets. This simple technique may obviate the need for TEE. 
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792·5 11:30 
Fenwral Venous Conlnlsl Uelivery Enhances Tnlnstllenoclc Ec:hocaniiOlnlphic 
Detection or Palenl Fordmen Ovale 
Dr. Ken Gin, Dr. Charles Pollick, Vancouver General Hospita~ Vancouver, BC 
Background; Although precordial contrast echocardiography is widely used to 
diagnose patent foramen ovale(PFO), this method is limited by poor sensitivity. 
Previously, investigalOrs demonstrated enhanced detection of atrial defects by 
the dye dilution technique following contrast delivery into the inferior vena cava 
rather than the superior vena cava. We postulated that femoral venous contrast 
delivery, because of streaming, might enhance precordial echocardiographic 
detection of PFO. 
l!kl!uuI: Transthoracic contrast exams were performed on a randomly selected 
group of 70 patients (without prior history of cerebral or systemic embolus) 
undergoing cardiac catheterization. Paired contrast injections (lOee 
D5W /O.25ee air) were administered from an upper extremity vein and a femoral 
vein in each paticnt during spontaneous respiration, cough, and Valsalva 
maneuvers. Studies were interpreted by an experienced echocardiographer 
blinded to the sequence and site of injections. Positive studies were 
semiquantitatively graded from + 1 (minimal left ventricular opacilication) to +4 
(intense left ventricular opacilication). The effect of left atrial pressure(lAP) 
ctIn sensitivity of contrast echocardiography for detection of PFO was evaluated. 
Comparison of catheterization and echocardiographic assessment of PFO was 
performed in 21 subjects. 
.Rn!!!ill PFO was detected signilicantly more often duriog femoral venous 
contrast delivery as compared to upper extremity contrast delivery [23/70 
patients (prevalence 33%) vs. 9/70 patients (prevalence 13%) p<O.OOIJ. The 
intensity of left ventricular opacilication was also greater during femoral vein 
contrast injection. The presence of increased lAP did not adversely effect the 
sensitivity of this tcchnique for detection of PFO [Group I: Normal lAP vs. 
Group II: Increased lAP; 5/17 patients (prevalence 29%) vs. 9/30 patients 
(prevalence 30%) p=O.795\. Precordial echocardiography combined with 
femoral contrast delivery was signilicantly more sensitive tban cardiac 
catheterization for assessment of PFO (8/21 patients vs. 2/21 patients; p<O.05). 
Condusinn; Femoral venous contra~t delivery signilicantly enhances the ability 
of precordial contrast echocardiography to diagnose PFO. Physiologic patency 
of the foramen ovale is more common (prevalence 33%) than previously 
documented. 
792·6 11:45 
Myocardial Contra.t Echoca,diography (MeEI: What May Be Considered 
an Abnormal Perfusion in Humans 
Fernando Morcerf, Carlos Alberto Mendonca, Guilherme Paulino, Flavio 
Cure, Antonio Carlos Nogueira, Wanderley Quarte Pereira, Edson Sandoval 
Peixoto, Pierre Labrunie. 
Hospital Procardiaco, Rio de Janeiro, Brazil 
There has not been a large series of MCE in humans, under routine 
coronary angiography, to testify what may be considered an abnormal 
perfusion. 310 MCE studies were performed in 277 pts who had coronary 
angiography. 1 84 pts were selected because they had a technically 
satisfactory MCE and were divided in group CORO (117 pts) if there was 
a coronary obstruction = or > 75% in one or more artery, and in group 
NORMAL (67 pts) if there was no, or < 75% obstruction. Two ml of 
sonicated Pielograf 76% was injected into the left main and right coronary 
arteries during simultaneously performed 20 short-axis parasternal echo 
at the pap. muscles level. LV walls were divided in 6 segments: anterior 
and posterior IV septum, anterior, antero-Iateral, postero·lateral and 
posterior walls. There was superposition of segments perfused by both left 
and right coronaries in 26% (311117) in CORO and in no occasion in 
NORMAL (0/67) (p<0.051. The pattern of appearance of the contrast in 
the myocardium had a detay between segments perfused by the same 
coronary in 18% (21/117) in CORO and was simultaneous in NORMAL (01 
67) (p<0.05). The contrast appeared in the endocardial layer of the LV 
wall initially and spread to the meso and epicardial layers lately in 38 % (451 
117) in CORO and had a simultaneous appearance in all three layers in 
NORMAL (0/671 (p<0.05). One or more segments remained without 
opacification after injection in both coronaries in 21 % (251117) in CORO 
and none in NORMAL (0/671 (p < 0.05). At least one of the above perfusion 
abnormalities was found in 71 % (83/117) of the pts in CORO. Time from 
injection to contrast appearance, peak contrast intensity and time of 
contrast washout were visually extremely variable between cases with 
same degree of stenose and also between two different injections in the 
same artery of a Single pt. There was no complication. Thus, MCE is a safe 
procedure. The abnormal perfUSion pattern as found in MCE is shown in 
a large number of humans under routine investigation for chest pain. Signs 
of abnormal perfusion described in ani"als under laboratory experiments 
may not be useful for humans under routine conditions. 
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926·1 
Coronary arterial histological response to the self 
expandable Nitinoil stent. 
Rafael Beyar, Rona Shofti, Ehud Grenedier. Mordechai Beyar. Haim 
Lichtig, Daniel Mordechowttz and Walter Markiewicz. The Rambam 
Medical Center and the Technion, Ha~a, Israel. 
A seK-expandable Nitinoil coil stent showing pseudoelasticity at 
transttion from room to body temperature continues to apply radial 
pressure below nominal diameter. We sought to investigate the long term 
histological response of coronary arteries to this stent. In a total of '6 
dogs in which a 3 mm stent (length=12 mm) was implanted 
transcutaneously (2.7±OA mm aneries; 12-LCx; 4·LAD) follow up was 
obtained at '·2 weeks (n=2), 1 month (n=4). 3 months (n=4). 6 months 
(n=4) and 1 year(n=2). All dogs were treated with Aspirin (80 mg/day) 
and Coumadine (2.5 mg/day) up to 1 month. At the end 01 the follow up 
the dogs were sacrificed and the stented arterial segment studied 
histologically. Histological cross sections were obtained every 1 to 3 mm 
along the stented segment (3-6 sections per case), in each the intimal 
thickness measured at 8 points, circumferentially. Outward stent pressure 
compressing the internal elastic membrane and tunica media 
were present in most cases. INTIMAL RESPONSE VS TIME 
Intimal hyperplasia with smooth "0 rj -~-~-~--r--'---""" 
muscle proliferation and ~ 300 n= t6 
mononuclear infihrates started :il 250 AV(SD) 
at 2 weeks. was most apparent U 
at 3 and 6 months and was % 200 
milder at 12 months. Mean ~ 150 
intimal thickness as a function ~ '00 
of time is shown in Figure. Note ~ I 
that intimal thickness increased ;: '0 Lr --1~L.I:~l..£=-,"=..l::<:i2<L-l 
up to 3 months and tended to ° ° H W ,. 3 • 6. ". 
decrease at 1 year. TIME AFTER IMPLANT 
Conclusion: the Nitinoil seH expandable stent provokes a moderate cellular 
proliferative response which reaches its maximum in 3 months and may 
partially regress in 1 year. 
926·2 
Quantitati.e Ifutopatbologic Analysis of the Vascular Itespome to Heparin 
Coati,. of the Cordis Stent 
James P. Zidar, Rcou Virmani, Stepbco c. Culp, Robert P. Bauman, Hugh A. 
Wells, Jr., Roger S. Gammon, Gregory D. Chapman, John D. Jackman, Jr., 
Harry R. Phillips, Ricbard S. Stack. Armed Forces Institute of Pathology and 
Duke Univenity, Durham, NC 
Several metallic """'Is are currently under investigation to address 
resIeDosis sod $Cute closure post-angioplasty. To cbarscterize the effects of a 
monolayer of heparin hooded to • flexible tantalum ",,",t (Cordis CoIp), 32 
b8lIooo-expandable 3.0 mm """'Is were deployed in a paited study in ooronary 
uteries of 16 dogs (16 heparinized(H) sod 161101theparinize stenls). Each 
dog received an H or NH """'I in either the left circumflex or left anterior 
desaoding coronary Ulery. Histopathologic analysis was performed following 
perfu:;ion fixation II 100 mm Hg II 14 days (D=9) or 28 days (D=7). 
Quantitative analysis was obtained using planimetry from projected ligbt 
microscopic images. The mean area(mm') of the intimal sod medial Iayen;, and 
the area of the """'ted sod proximal DOD-steoted arterial hUDCOS for the H and NH 
groups are presented as mean ± standard deviation. 
14day H (n =9) 
14day NH (n =9) 
28day H (n=1) 
28day NH (0=1) 
Media (nun') IDIima (nun') Stalled Lumen 
(nun') 
.88 i .12 1.06 i .85 4.26 i 1.18 
.88 i .11 .86 i .46 4.47 i .85 
.14 i .18 .83 i .24 3.89 i 1.15 




2.24 i .83 
1.99 i .57 
2.26 i .62 
2.59 i .86 
No differences were Doted by quantitative analysis between the media, 
intima or the """'ted 1\IIIIeII """'" for the H sod NH """'ted groups II 14 or 28 
days. Enlargemenl of the """'ted segment, when compared with the adjacent 
proximal DODStcoted vessel was presenl in all animals II 14 or 28 days, and 
suggests this """'t design did DOt recoil from the time of deployment. No 
significant quantitative histologic changes were obseJved betweeo H and NH 
"""'Is. Therefore, it woold appear bistoIogicalJy that the arterial reaction to H and 
NH tantalum """'Is was simiJar in this animal model. 
JACC Vol. 21, No.2 
February 1993:337A 
926"3 
Safety and Efficacy of Extended Urokinase Infusion PIU8 Stent 
Deployment for Saphenou8 Vein Graft Disease 
Scott J. Denardo. Richard A. Schatz, Nancy B. Morris, Krishna J. Rocha· 
Singh, Guy P. CurtiS, David S. Rubenson, Paul S. Tairstein. Scripps Clinic 
and Research Foundation, La Jolla, CA 
The risk of subacute stent thrombosis, a serious but uncommon complication 
with the Palmaz·Schatz stent, may be increased following stent deployment 
into saphenous vein grafts (SVGs) obstructed by thrombus in addition to 
atherosclerosiS. Combination therapy using extended urokinase (UK) 
infusion plus stent deployment may minimize any increased risk. To evaluate 
the safety and efficacy of extended urokinase infusion plus stent 
deployment in SVGs obstructed by both thrombus and atherosclerosis, 22 
patients (pIS) (mean age 62.3 ± 8.5 yrs; 86.4% male) were studied 
retrospectively. Prior to intervention, 16 pIS were anginal class IV, 5 were 
class III and 1 was class II. The mean obstruction from both thrombus and 
atherosclerosis was 86.9 ± 14.4%. Seven vessels were 100% occluded. 
Mean TIMI flow was 1.3 ± 1.1. UK was infused over a median duration of 20.3 
hrs. The median rate of infusion was 48,000 UnilSihr through a guiding 
catheter and 51,000 Unitslhr through a sub-selective catheter. The median 
total dose of UK was 2.2 ± 0.6 million Units. UK was infused prior to stent 
deployment in 18 pIS and following deployment in 4 pts. 
~: Repeat angiography following completion of both interventions was 
performed in 20 pts. The residual stenosis was 0% (caliper) in all SVGs. No 
thrombus was evident in any SVG. Mean TIMI flow increased to 2.7 ± 0.6. No 
pt had subacute thrombosis, a a wave myocardial infarction (MI), emergency 
bypass surgery or death. Eight pIS (36.4%) had non-a wave MI (mean CK 
535), 1 pt had a femoral artery pseudoaneurysm complicated by 
retroperitoneal hemorrhage requiring surgical repair and 2 pIS had significant 
femoral hematomas. These latter 3 pIS (13.6%) required blood transfusions. 
The fibrinogen level following completion of UK infusion was 292 ± 72 mg/d!. 
At follow·up (mean 5 ± 3 months), 15 pIS were anginal class I or II. Each of 
the 7 pts who were class III or IV had repeat angiography and 3 had restenosis 
requiring repeat revascularizabon. There were no late Mis or cardiovascular 
deaths. 
Conclusipns: Extended UK infusion plus stent deployment in SVGs 
obstructed by both thrombus and atherosclerOSis was highly successful at 
early follow-up and was not complicated by subacute thrombosis or 
excessive bleeding. However, non·a wave MI was not uncommon, probably 
due to distal embolization of thrombus or debris. 
926"4 
ProloDgad IDtracoronary Urokina.e coapl"'Dt~9 PTCA. 
Luc Bilodeau, Sriram S. Iyer, Adam D. Cannon, Sucodh K. 
Agrawal, Larry S. Dean, James A. Hearn, King W. Liu, 
William A. Baxley, Gary S. Roubin, Univeraity of Alabama 
at Birmingham, Birmingham, Alabama 
Prolonged intracoronary urokinase infusion was used in 67 
patient. during angiopla.ty. Indicationl for UK uee were 
myocardial infarction related native artery filled with 
clot or totally occluded in lS pta(27'l, aaphenous vein 
grafts diaeaae in 33 pta(49\l and acute or subacute stent 
thrombosi8 in 16 pts(24'l. UK infusion was initisted 
following &ngiopl •• ty if • filling defect lugge.tive of 
thrombul wa •• een on the post PTCA angiogram. UK was 
delivered locally through an intracoronary perfusion 
catheter with lide holes at e rate varying from SO,OOO 
O/hr to 200,000 O/hr. After 6 to 30 hours, repeat 
angiogram wal obtained and a PTCA procedure repeated if 
needed. Mean age of the patient population was 59.9±10 
year.;73' ware male. Prior KI in the related territory 
was ob.erved in 47 pts (70') with Q wave. present in 24 
(36'). A bolus of UK ranging from 100,000 to 750,000 units 
was given in 36 pt .. (54'). The dose of UK used as a 
continuous infuaion was 1,S63,000±1,362,000 unit. over a 
mean duration of 17. 7±7. 2 hours. UK success def ined by 
improvement of TIKI flow, and/or decrease in length of 
filling defect, and/or improvement of lumen narrOWing was 
obtained in 46 patients(69'). Procedural success defined 
as final angiogram showing luminal narrowing <SO, with 
TIKI III flow was .een in 54 pta(Sl'). Repeat PTCA after 
OK had to be performed in 26 patient.(39'l. On 11 of the 
13 failure.(SS'), the distal bed of the involved artery 
could not be visualized. Transfulion ~2 units was required 
from 10 patients(lS\l. KQ KI occurred in 29 pts(43\l and 
Q wave in B pta(12'l. 11 of these ware aeen in the Betting 
of recanalization of an acute KI. An9iographic dbtal 
-.bolhation during the procedure occurred in 2B ptl(42'). 
3 patient. n .. ded a third PTCA and one required CASG 
because of reocclusion (6'). CONCLUSION. Prolonged 
intracoronary UK improves primary luccess in PTCA 
procedurel complicated by the presence of thrombu8. Non-Q 
wave KI and distal embolization occur frequently and poor 
distal runoff on pre-OK angiogram. appear to predict 
failure of thi. procedure. 
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926"5 
Thermal Alteration of Cardiac TISSUe By CooducOOn is NOD-UDiform.: The 
CoDCept of Cardiac "Heat SiDks" 
Daniel B. Fram, Thomas A. Aretz, Joseph F. Mitchel, Linda D. Gillam, 
Raymond G. McKay 
Hartford Hospital, UDiversity of Connecticut, Hartford, cr. 
Previous investigations by our laboratory on the efficacy of radiofrequency 
thermal balloon angioplasty and thermal balloon coronary sinus ablation 
have documented specific histological effects of conductive heating on 
cardiac tissue. To-ilate, in-vivo radiofrequency heating has been assessed 
in 86 porcine peripheral arteries, 35 porcine coronary arteries, 20 porcine 
coronary sinuses, and 13 dog coronary sinuses. For all specimens, heat was 
circumferentially transferred to cardiac tissue by conduction from a 
radiofrequency-heated balloon that was inflated either in a coronary artery 
or a coronary sinus. Balloon temperatures ranged from 40· to 100·C, and 
heating duration ranged from 10 to 80 seconds. RESULTS: In almost all 
specimens, there was some evidence of oon-circumferential and non•
uniform thermal alteration of cardiac tissue. Heat-induced cellular necrosis 
was particularly non-uniform with circumferential cross-sections in a given 
specimem showing a depth of necrosis ranging from as little as 20 microns 
to greater than 200 microns. In some cross-sections, an entire quadrant was 
necrosis free, while the remaining three quadrants all demonstrated heat•
induced cell death. This inhomogeneity of response could not be explained 
either by the technique of radiofrequency heating of intraballoon fluid, nor 
by varying thermal properties of different types of local tissue. The most 
obvious explanation for varying thermal responses was the presence of 
small blood vessels which acted as • cardiac heat sinks· and provided 
convective heat loss to ameliorate thermal damage. A common histological 
pattern seen in many specimems consisted of an island of viable tissue 
surrounding a small blood vessel located completely within a zone of 
thermal necrosis. Branch side vessels similarly provided other examples of 
heat sink convective heat loss. CONCLUSION: Thermal conduction heating 
of cardiac tissue results in a non-uniform pattern of histological effects in 
part related to vascular "beat sinks" wbich provide convective beat loss. 
926"6 
Usa of a Vascular Hamostatlc Device for Immadlate Shaath 
Ramoval and Early Ambulatlon Following Parcutaneous 
Translumlnal Coronary Angloplasty. 
Hany H. GDbs, Geoffrey W. Bergman, ThomasJ. Molloy, Artur M. Spokojny, 
Peter A. Shaftel, Susan T. Hosat, Usa A. Berra, Timothy A. Sanborn. New 
York Hospital- Cornall Medical Center, New York, NY. 
A novel vascular hemostatic device (VHD) may allow immediate sheath 
removal during full anticoagulation and earlier ambulation following 
percutaneous transluminal coronary angioplasty (PTeA). Therefore 127 
patients (pts) were randomized to either immediate sheath removal on fuU 
enticosgulation using a VHD (73 pts) or to standard sheath removal by 
arterial compression (C) the morning following PTCA efter discontinuation 
of heparin (54 pts). VHD pts were fully anticoagulated (mean ACT 342 sacs) 
at the time of sheath removal and remained on fuU anticoagulation overnight 
as w~h C pts. The mean hemostasis times and times to ambulation were as 
follows: 
Hemostasis time (mins) 
PTCA to ambulation (hrs) 










There were no vascular complications in either group requiring surgical 
intervention. Bleeding from the arterial puncture site requiring transfusion 
occurred in 1 (0.02%) C pts vs. 0 VHD pts. The incidence of significant 
hematomas (>2 cm) was similar in the VHD and C pts (6.S% and 7.4% 
respectively, p = NS). 
Conclysion' The use of VHD for immediate sheath removal during full 
anticoagulation following PTCA is safe and effective and significantly 
reduces the time to petient ambulation. This device may allow earlier 
hospital discherge and reduced costs aftar PTCA. 
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926·7 
Catheter Delivered Therapeutic Ultrasound RecanaHzes 
Thrombotically Occluded Canine Coronary Arteries 
Wolfgang Steffen, Huai luo, Henry Nita, James 
Passafaro, Michael C. Fishbein, Gerald Maurer, Robert 
J. Siegel, Cedars Sinai Medical Center, los Angeles. 
We have demonstrated that catheter del ivered 
therapeutic ultrasound recanalizes peripheral arterial 
occlusions. In this study we evaluated the safety and 
efficacy of a prototype coronary ultrasound probe (SF 
percutaneous over the wire catheter, 1.7 mm ball tip) 
to recanalize acute thrombotic coronary occlusions in 
7 dogs. A selective coronary infusion catheter was 
introduced in the left coronary artery with a 
guidewire protruding 2 cm into the arterial lumen. 
Thrombotic occlusion was induced by electrical injury 
(3 volts for 45 minutes). Angiography confirmed a 3 to 
5 cm long occlusion in all cases. The ultrasound probe 
(USP) (19.5 KHz; 25 w at acoustic horn) was advanced 
over a 0.016 in guidewire to the occlusion. After 2 to 
5 min the activated USP recanal ized 5/7 of the total 
occlusions. Attempts to recanalize the same occlusion 
with an unactivated ultrasound probe failed, excluding 
the Dotter effect as the recanal ization mechanism. 
After recanalization EKG ST segment elevation resolved 
and angi ography demonstrated a patent 1 umen with no 
angiographic evidence of residual thrombi or distal 
embol i. Two dogs died in ventricular fibrillation 
before recanalization was completed. Histology 
revealed no acoustic but mild mechanical injury and 
non- occlusive residual mural thrombi. 
Conclusions: Catheter del ivered ultrasound has the 
potent i al for recanal i zing acute thrombotic coronary 
occlusions and might serve as an alternative or 
adjunctive method for the treatment of acute 
myocardial infarction. 
926·8 
Initial Experience of Unipolar Radlo·Frequency Hot 
Balloon Angloplasty for Ball·Out from Abrupt Coronary 
Closure after Conventional Balloon Angioplasty 
Shigeru Saito, Hidekazu Ami, Kunikane Kim, Naoto Aoki, Shutaro 
Satake·. Shonan Kamakura Hospital and ·Yokohama Red Cross 
Hospital, Kamakura and ·Yokohama, Japan 
Abrupt coronary closure after conventional balloon coronary 
angioplasty (PTCA) is still a big problem. Angioplasty with a new 
type of radio-frequency hot balloon (RF-balloon) was applied to 9 
patients who had abrupt coronary closure (4 cases) or threatened 
closure with severe intimal dissection (5 cases) after PTCA. This 
RF-baUoon includes an intetgrated unipolar electrode and thermistor. 
The radio-frequency current of 13.56 MHz (25 to 30 Watts) is 
applied between the plate electrode attached on the patient's body 
surface and heats the vessel wall of the coronary artery directly by 
the unique dielectric heating mechanism. The balloon temperature 
can be easily controlled by changing the applied energy. The mean 
maximum balloon temperature was 65 degree Centigrade, inflation 
pressure 5.2 atmospheres and total inflation time 133 seconds. Mean 
diameter stenosis was 91.8%8.5% before PTCA, 70.8%31.4% after 
PTCA and before RF-balloon angioplasty and 28.G!:16.4% after 
RF-balloon angioplasty (P<O.Ol). Bail-out from coronary closure 
was successful in all patients without any major complication. 
Angiographic restenosis was noted in 5 of 7 patients (71 %) during 
the mean follow up period of 3.2 months, all of whom were 
successfully treated by repeat PTCA. 
Conclusion:(1 )Abrupt coronary closure or threatened closure with 
severe intimal dissection after PTCA can be successfully treated by 
RF-balloon angioplasty. (2)The determination of optimum balloon 
temperature will be necessary for decreasing the current relatively 
high restenosis rate. 
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Coronary Remodelling With Low Stress Angloplasty at 60 ·C vs 
Conventional Angioplasty in Man: Analysis of Changes in 
Plaque Eccentricity. 
Jack L Martin, Ezra Deutsch, Raymond G McKay, Daniel B Fram, 
Blair] O'Neill, Serge Makowski, Alfred ABove. 
Temple University, Philadelphia, PA 
Physiologic low stress angioplasty at 60 ·C (PLOSA) is a new 
technique which employs the simultaneous application of heat and 
a minimal distending pressure to reduce atherosclerotic arterial 
stenoses. To compare the coronary arterial remodelling which 
occurs with PLOSA and conventional PTCA, the eccentricity of the 
vessel wall at the site of stenosis was assessed from pre- and post•
intervention angiograms using a computer-based edge detection 
system. Changes in the morphology of each side of the vessel wall 
were seperately assessed based on changes in the standard deviation 
of the radius of curvature (SOC) averaged across the stenotic zone. 
An eccentricity index (E) was generated from a ratio of the SOCs of 
the opposing vessel walls. This technique permits evaluation of 
lesion .eccentricity independent of the course of the arterial segment 
in space. 22 native coronary stenoses treated with PLOSA were 
compared with 35 lesions matched for location and anerial 
diameter that were treated with PTCA. Data (x ± sem) include the 
delta SOC of the wall with the greatest initial SOC. 
delta SpC E...llR E.JlQSl 
PLOSA 40.3 ± 19.3 13.1 ± 0.9 2.1 ± 0.3 
PTCA 3.6 ± 1.9 4.6 ± 0.8 4.2 ± 0.8 
P value <.02 ns <.05 
Lesions were significantly less eccentric after PLOSA. The more 
diseased wall with the greatest SOC pre-intervention changed 
significantly more towards paralleling the vessel midline with 
PLOSA. CONCLUSIONS: The acute coronary remodelling process 
is different in PLOSA than in conventional PTCA. PLOSA results in 
more concentric dilatation with facilitated remodelling of regions 
with greater plaque burden. 
926-10 
Prolonged Intra-Graft Urokinase with a lin Infuaion 
Wire: r-praved Short Tera Results 
P.E. Cundey, Jr., M.K. Edwards, R.R. Whitlock, T. Scott 
Key, D.E. Tummillo, P.E. Cundey, III 
University Hospital. Augusta. Ga. 
Patients with symptomatic,· partially occluded aorta•
coronary saphenous vein grafts remain a treatment 
dilemma. Direct balloon angioplasty is frequently 
complicated by distal embolization and further 
complicated by early re-stenosis. Prolonged intra-graft 
urokinase infusion was carried out in 23 consecutive 
patients with a new multi-side hole infusion wire. All 
patients were symptomatic with progressive or unstable 
angina. Average graft age was 8 years. Average 
urokinase infusion was 2,186.000 over 18 to 24 hours. 
Adjunctive PTCA was performed in 9 patients. 
TIMI grade flow improvement was as follows: 
GRAFT AGE 
0-3 years N-3 3/3 
4-7 years N-6 5/6 
8-16 years N-14 14/14 
This study suggests that many. partially occluded 
symptomatic vein grafts contain significant thrombus. 
Debulking thrombus with prolonged intra-graft urokinase 
infusion through a multi-side hole infusion catheter 
results in improved TIMI flow. Adjunctive PTCA carried 
out in 9 patients was without complication. 
Short term clinical follow-up in 23 patients revealed 
symptomatic improvement in all and improved exercise 
time in 21/23 (91%). Average follow-up time was 2 
months (12 month to 2 weeks). 
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926·11 
Transcatheter Closure of Patent Ductus 
Arteriosus in Adults. 
Mario Carminati, Phlipp Bonhoeffer, Adele Borghi, 
Eustaquio Onorato. Department of Cardiology, Ospedali 
Riuniti, Bergamo, Italy. 
The effectiveness of transcatheter closure of patent 
ductus arteriosus (PDA) in adults is not well defined. 
From October 1990 to June 1992, 17 patients (15 females 
and 2 males; mean age 42 years, range 19-62 years) 
underwent PDA closure with Rashkind double umbrella 
device. The NYHA functional class was I in 8, II in 4, III 
in 3, IV in 2; cronic atrial fibrillation was present in 3; 3 
had recanalization of a previously surgically ligated 
duct. At catheterization the minimal diameter of PDA 
varied from 3 to 9 mm; a significant pulmonary 
hypertension (mean pulmonary pressure > 30 mmHg) 
was recorded in 5; calcifications were present in 7. 
~. In all but one patient a 17 mm umbrella was 
used: a complete closure was achieved in 13. A residual 
shunt remained in 4, trivial in I, significant in 3; 2 of 
~ese also developed hemolysis and were sent. to surgery, 
m the latter the shunt was completely abolished after 
implantation of a second 17 mm device 16 months later. 
A significant improvement of clinical conditions was 
achieved in all the symptomatic patients. 
Conclusion. Transcatheter closure of PDA in adults is 
feasible, even in presence of calcifications and/or 
pulmonary hypertension; taking into account the 
significant surgical risk, PDA umbrella closure should 
be considered the first choice procedure in this group of 
patients. 
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927·12 
Visual Angiographic Beadings are Kore Predictive of 
a Successful One Year OUtcoae Than Quantitative 
Angiographic leadings (NHLBI PTCA legistry) 
David P Faxon, Robert Vogel, Vanlin Yeh, Alice I 
Jacobs, Katherine Detre and the NHLBI PTCA Investi•
gations. Boston University Kedical Center, Boston, KA 
Visual assessment of the angiographic results of PTCA 
is less reliable and more biased than quantitative 
angiographic readings (QCA). However, neither has been 
evaluated as a means of predicting long-term outcome. 
From 10 sites participating in the 1985-86 NHLBI PTCA 
registry, 393 patients (573 lesions) had blinded QCA 
performed at a core laboratory. Patients were 
classified as having a successful one year outcome 
(ClinS) if they survived without an HI or bypass 
surgery and were asymptomatic. Success occurred in 
63.4% (67.9% excluding in-hospital events). 
Angiographic success (AngS) was defined as a 20% change 
in stenosis in none, some or all attempted lesions. 
Reading AngS % %ClinS Odds Ratio 
Visual* None 3 25 
QCA 
Partial 9 47 
Total 88 66 
None 28 58 
4.16 
6.72 
Partial 19 55 .73 




Other degrees of % change in stenosis showed similar 
differences while other QCA measurements were less 
predictive. 
In conclusion, the AngS is related to a favorable one 
year outcome. However, visual assessment was more 
predictive of ClinS than QCA. Frame selection with QCA 
and the integration of additional iformation into the 
visual reading may account for these differences. 
ABSTRACTS 
927·13 
Consistency of Assessment 01 Eligibility for Multivessel 
Revascularlzatlon by Physicians Enrolling In the Bypess 
Angioplasty Revascularlzation Investigation 
E. Magnus Ohman, Sheryl F. Kelsey, Stephen R. Wisniewski, Kerry L. 
Lee, Edwin L. Alderman, Robert M. Califf, lor the BARI Study group. 
Duke University Medical Center, Durham, North Carolina 
To evaluate the consistency lor eligibility in the BARI study, we periormed 
a substudy whele 25 PTCA operators (0) from 14 BARI sites evaluated 
clinical details and coronary angiograms in 72 clinically su~able patients 
(pts) from another s~e (S). Of the 72 pts, 38 (53%) were actually 
randomized while 34 (47%) pts were angiographically excluded. In all but 
one case PTCA 0 reviewed 8 records and angiograms on 2 occasions on 
average 8.3 months apart. There were 199 readings representing muHiple 
readings by the same S and 181 readings representing muHiple readings 
by a specifiC PTCA O. During each reading session the PTCA 0 
assessed his/her willingness to perform PTCA or CABG (scale 0-10; O=not 
willing and 10=ideal) and whether pts were sunable for randomization. 
MuHiple observer Kappa statistics were calculated. PIs were deemed 
su~able lor randomization in 253 (65%) readings and unsu~able in 139 
(35%). For pts deemed su~able lor BARI, the median willingness to 
perform PTCA was 8 and lor CABG 8. For pts not sunable the willingness 
lor CABG was 8, but only 2 for PTCA. The agreement on su~abil~y for 
BARI among PTCA 0 and S was: 
Intraobserver 
Intras~e (inter & intraobserver) 














Thus, agreement on selection of patients lor randomization in 
BARI differed significantly across different s~es and operators. The 
agreement in an individual inst~ution and operator was better, but 
considerable variability remains apparent. Factors affecting decision 
making for muHivessel revascularization need to be defined. 
927·14 
339A 
Predictability of Major Adverse Cardiac Events After Balloon Angioplasty 
From Clinical Data and Quantitative and Qualitative Anglographic Analysis. 
David P Foley, Walter R Hermans, Benno J Rensing, Patrick W Serruys. 
Thoraxcenter. Erasmus University, Rotterdam, Netherlands. 
Major procedural and in-hospital Adverse Cardiac Events (MACE) (death, 
myocardial infarction, need for re-intervention or coronary artery bypass graft 
surgery) occur in 2-10% of all patients undergoing coronary balloon 
angioplasty (BA). This study examines the predictability of these events from 
dinlcal characteristics and baseline and post-BA quantitative and qualitative 
lesion morphology In 1452 patients treated by BA In two European multicenter 
dinical trials. All cinefilms were analyzed in a core laboratory (automated edge 
detection technique-CAAS) for lumen dimensions, lesion length, plaque area, 
symmetry, roughrress, curvature, as well as for qualitative features of: pre•
PTCA lesion location (vessel and segment), lesion type (AHA/ACC and 
modified Ambrose classffication), location at/in/near a branch point or in a 
curve > 45°, calcKication and presence of thrombus or dissection (NHLBI 
classifICation), by 2 "blinded" experienced observers. 69 patients (5%) 
experienced MACE and were randomly matched 1:3 with those who did not. 
In stepwise logistiC regression, of 42 variables examined, the following with 
odds ratio> 2 and lower 95% confidence Interval> 1, were predictive 01 MACE 
Variables MACE/pts pos MACE/pts neg Odds 
Retained in LA lor variable for variable RatiO (95% CI) 
DISSECTION 46/1 I I 18/153 5.39 (2.90·10.0) 
UNSTABLE ANGINA 29/69 39/206 3.11 (1.72·5.61) 
BEND> 45° 31/86 35/180 2.34 (1.31-4.15) 
TYPE "C"LESION 14/36 40/172 2.10 (1.08-6.01) 
Conclusion: It is not possible to predict the occurrence of major adverse 
cardiac events during or after coronary balloon angioplasty from pre•
Interventional lesion morphological characteristics, even using quantitative 
angiographic assessment. Angiographically visible dissection Immediately after 
angloplasty was, perhaps not surprisingly, the strongest predictor 01 the 
occurrence of major adverse cardiac events. The only pre-procedurai variables 
predictive of subsequent major adverse cardiac events were unstable angina, 
lesion location in a bend > 45° and type C lesion. 
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927·15 
Angiograpbic r'redidors of the Immediate Outeome of ConIaary Balloon 
Angioplasty. Tboraxcent.er bperieace 1991·1992. 
DooaId C. MaoLeod, Arthur Mus, Ron van Dombur'J, Mucel VAIl den Brand, 
Patrick W. Serruys, Pim J. de Feyter. Thoraxceocer, RoIIerdam, the Netherlands. 
Between July 1991 and July 1992, 552 patients received conventional balloon 
angioplasty for 772 coroaary lesions during 617 procedures. The population (age 
6O±1J yrs) of 391(71") men and 161(29") women underwent single lesion 
dilallltion in 487(80") of procedures, multi-lesion single vessel in 61(9") and 
multi-vessel in 69(11"). Lesions were graded lICCOrding to the original and 
modified ACC! AHA classifications. Also, "functional" occlusions (TIMI I) were 
Doted. Table I gives lesion success rates and failure rates due to immediate 
complicatiol1S (abrupt occlusion, surgery, death) by classification. 
Table 1. A B BI B2 C 
tota1 n 164 569 323 246 39 
IIICCesS 94.5" 88.8" 90.4" 86.6" 56.4" 
failure 1.2" 3.7" 5.3" 1.6" 12.8" 
success/faIlure rates for A, B, Bl and B2 leslODS were Dot SlgruhcanUy different, 
whereas C I""ions differed from all others (p< 0.0001, X, lest). Univariale analysis 
reveal"" 5 lIIIgiograpbic features associated with procedural failure (Table 2). 
Table 2. feature odds ratio (95" Cl) 
> I vessel disease 1.7 (1.1-2.8) 
calcification 
length > 20mm 
occlusion > 3 mth 





"functional" occlusion 2.1 (1.2-3.7) 
For successful outcome, mu1tlvanate analYSIS revealed iIiat tile comblDalion of 
«CeIlIricity + irregularity + angle 45-90° was not significantly different from 
conanlricity + smooth + angle <90°, while calcijiC4lion + length> 20mm + 
"functional" occlusion strongly predicted failure. 
Conclusion Specific angiograpbic features, not broad lesion categories, are useful 
in anticipating the immediate outcome of coronary balloon angioplasty. 
927-16 
Increased Incidence of Progression of Coronary 
Stenosis In Lesions Proximal to the Site of Previous 
Percutaneous Translumlnal Coronary Angloplasty 
Tomoya Onodera. Aki nori Teki zawa, Kazuhi ro Yamamoto. 
Terumoto Fukuchi. Masahiko Kimura. Hiroyuki FukitB. 
Ry uzo Nawade. Tadash i Mi k ami. Sh i z uok a Ci ty Hospi•
tel, Shizuoka, Japan 
Progression of stenosis proximal to a percutaneous 
transluminal coronary angioplasty (PTCA) site can be 
a serious complication of PTCA. The purpose of the 
present study was to determine whether the progres•
sion may be attributable to a PTCA procedure and to 
assess predisposing factors to the progression. 
Coronary angiography at PTCA and at follow-up 139±62 
days after PTCA was reviewed in 302 consecutive 
patients (367 PTCA lesions). Progression of stenosis 
wes defined as a ~20~ decrease in luminal diameter 
with >60~ stenosis in diameter at the follow-up 
study~ Progression of stenosis proximal to the PTCA 
site was noted in 10 lesions of the 367 vessels with 
PTCA (2.7~). Progression of stenosis in proximal 
segments of 539 non-di lated coronary arteries was 
noted only in 2 vessels (O.4~; p(O.Ol compared with 
vessels with PTCA). Progression of stenosis proximal 
to the PTCA site was seen only in lesions with ~2~ 
stenosis prior to PTCA (10/60 vessels, 16.6~) and 
was not observed in vessels without ~20~ stenosis 
(01307 vessels; p(O.Oll. 
ConclUSion: Progression of stenosis proximal to the 
PTCA site appears to be infrequent in vessels with•
out prior stenosis. However, progression often 
occurs in vessels with prior lesions and is likely 
to be related to the PTCA procedure. Indication for 
PTCA should be carefully assessed in vessels with 
proximal lasions. 
927-17 
JACC Vol. 21, No.2 
February 1993:340A 
Higb Fidelity Translesioaal Pressure Gradients DwiDg PfCA • CorrelatioD 
With Quantitative COI'OIUIry Angiograpby 
HAkan Emanuelsson, Carl Lamm·, Michal Dohnal, Pattick W. Senuys·· 
Division of Cardiology and ·Division of Thoracic Radiology, Sahlgrenska 
Hospital, Goieborg, Sweden, ·"TboraxceDter, Rotterdam, The Nedlerlands. 
A fiber optic sensor on a 0.018" guide wire (Pressure Guide""') was used 10 
measure the tranSSter\otic pressure gradient in 30 patients undergoing !'TCA and 
with lesions suitable fCI quantitative coronary angiograpbic (QCA) assessmenL 
The aim of the study was to correlale pressure gradients with QCA parameters. 
After 125 Jlg of nitroglycerin i.c., multiple angiographic views were taken of 
the lesion. The Pressure Guide TN was then positioned distal 10 the stenosis and 
die pressure gradients were recorded before and after !'TCA. 
There was a significant correlation between mean pressure gradients and 
minimal luminal diameter (r = 0.67: p<O.OOI) and minimal luminal cross•
sectional area (MLCA: r = -0.63; p<O.OOl). With a measured gradient of > 15 mm 
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In conclusion, a statistically signiflCanl relationship was fOlUld between 
stenosis pressure gradients and angiographic parameters in lesions without 
compJicaaed morphology. The information from pressure gradient measurement 
may be of panicular value in intermediately severe lesions or in stenoses where 
the angiographic assessment otherwise is difficulL 
927·18 
Mechanisms of COronary Vasoconstriction After Successful Single 
AngiopJasty Of the Left Anterior Descending Artery, 
Clro Indo"l, Federico Ptsclone, Giovanni Espostto, Antonio Rapaociuolo, 
AntonGiulio Maione, Nicolino Espostto, Giuseppe Gargiulo, Massimo 
ChiariellO. Divis. of Cardiology, Naples, ITALY. 
To assess the effect of balloon angioplasty (PTCA) on coronary vasomotion 
and the role of neuro-hormonal systems, we prospectively studied 22 
patients (pts) wHh single left anterior descending artery stenosiS (LAO). The 
only therapy allowed before the study was aspirin and/or heparin. 
QuantHative angiography was performed in the control state, 5 min. and 15 
min. after PTCA. In 6 pts we Infused (before the PTCA) 1.5 mg of 
phentolamine (an a-adrenoceptor antagonist agent) through the balloon 
catheter. The basal coronary diameter, distal to the balloon dilation, was 
2.5±O.9 before PTCA, 2.3±Q.7 (pcO.01, by AN OVA) after 5 min., and 
2.1±O.6 mm (pcO.01) after 15 min .. A signHicant vasoconstriction was 
present also In the circumflex control segments. The pretreatment with (X•
adrenergic blockade prevents the PTCA-induced coronary vasoconstriction 
distal to a dilated segment (2.0j;O.3 
mm Vs 2.2j;O.5, NS,). The coronary 
sinus and aortic norepinephrine levels 
Increased (from 335±225 to 481±294 
pglml, pcO.01 and from 243±165 to 
487±272 pglml, pcO.01, respectively). 
Thus, after single LAO PTCA a 
coronary vasoconstriction routinely 
occurs distal to the sHe of balloon 
dilation and in the circumflex coronary 
artery not manipulated by balloon 
catheter and tt is abolished by i.e. 
phentolamine. Finally, LAD PTCA 
induces an Increase in coronary sinus 
and aortic norepinephrine levels. 




Thus, after successful PTCA an Important s~hetic activation occurs 
that may cause coronary vasoconstriction not only distal to a dilated 
segment. 
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927·19 
Enhanced Vasospastic Activity to Acetylcholine of the Coronary 
Arteries Undergoing Previous Balloon Angioplasty 
Hazime Kirigaya, Tadanori Aizawa, Ken Ogasawara, Hiroshi Sato. 
Kazuyuki Nagashima, Masafumi Onoda. Kazuhiko Ogawa. Akihisa 
Yabe. Kazuzo Kato. The Cardiovascular Institute. Tokyo. Japan 
To examine the vasospastic activity of the coronary arteries undergoing 
previous balloon angioplasty. we completed the acetylcholine(ACH) 
provocative test at the diagnostic catheterization in 147 consecutive pts. 
All pts (124 males and 23 females. mean age 58) underwent successful 
elective PTCA and had follow-up angiography 1 to 6 month ( mean 
duration 3.6 mon.) after the procedure. Sixty-two pts had a history of 
prior myocardial infarction and 43 pts had multi-vessel coronary artery 
disease. PTCA was performed to 96 left anterior descending arteries. 
33 left circumflex arteries and 47 right coronary arteries. After control 
right and left coronary angiograms were obtained, incremental doses of 
ACH (25Ilg. 50llg. lOOllg) were injected into the right and left 
coronary arteries over 1 min. Spasm was defined as transient total or 
subtotal occlusion of the coronary artery and restenosis was defined as 
coronary luminal stenosis >50%. The incidence of coronary spasm of 
the arteries undergoing angioplasty was 44%. Angiographical 
restenosis was revealed in 59 pts (40%). There was no correlation 
between the occurrence of coronary spasm and the presence of 
restenosis. There were also no correlation between the occurrence of 
spasm and a history of myocardial infarction or a number of diseased 
coronary arteries. The maximal doses of injected ACH was smaller in 
pts with positive evidence of spasm than in pts with negative evidence 
of spasm (55±27Ilg vs 82±28Ilg. respectively. p<O.Ol). In pts with 
single vessel coronary artery disease. the incidence of spasm of the 
contralateral artery. i.e. the artery not having angioplasty. was lower 
than that of the artery undergoing angioplasty (22% vs 
46%.respectively. p<O.OI). Thus. the data suggest that the coronary 
artery undergoing previous angioplasty has enhanced vasospastic 
activity to ACH. 
927·20 
Effects of lntracoronary Ketanserin in Proximal 
and Distal Segments Post Angioplasty 
DlmJtriI TouaoullJ*. CoItal TeotolouriJ. Theodoroa ApoatolopouiOi. Pavlo, 
T_. *HammonmIIh HOIpItaI, RPMS Loodon, IIId HIppotradoD HOIpItaI, 
AIIIalI UDI-my MedIcII ScbooI. AIhaIa. Greece. 
PreYlOG. nudie. have c1emon.tratecl the c1evelopment of dina! coronary 
VUOCOIWIctlon poIt coronary aopopIasly (nCA). To __ wb«ber IOIOIODIo 
recepror anta&onilta prevent !be diltal coronary artery vUO<:ODJtrlctlon. we 
compared the etrCCll of the Intncoronary (I.e.) IDfuIIon or 1111& tetansertn (52· 
ICI'OtoIIcfiIc anU&OOist) In ancIopapblc.ny DOrIIIIII proxlmallllcl cII&taI oecmenu 
(In coronary Ye&&d& Whlwttbout PTCA·Ie&lon) immediately poJt PTCA. U&in& 
qDlDUllllve coronary ancIocraPby (CAAS 1)'IlaD) we evaIDIIecI the elfCCll or I.e. 
tetaDIeriD admIniJIraUon on c:oronary dIameten (proximal. cII&ta1 ancI COI'OIIIIry 
1IaIOIeI) ID 8 palicnll (7 male. 1 fcma1e; DICIIl lie 54:16 )all) WIth IlabIe ancIDa 
who l8Id<nieDt PTCA. AU palicnll were receIvID& upIrIn IIId c:aIc:Inm 1I&IC0DI&t& 
ancI were fully beperiDlzecl cIurIoc the proc:edme. 
Nonna! coronary veueI.I (1lCD0I1s diameter reduction SSO% ancI w1thODl PTCA•
leliDD) were DOt II&olficaoUy cllffcrent before anel after I.e. teIao&erID (proximal 
1C&JIICD1I3.0±0.26 and 3.05:t024 mm; cII&taI oecmenu 1~l:tO.07111e11~l±O.06 mm 
relpCCllvely (PONS». Furthermore coronary veach Iociuclln& PTCA-le&Ioo &bowed 
IlgnlllcanUy distal dIIaIatIon wr Lt. tc:taD&CriD admInIsIraIioo (proximal oecmenu 
2.93:tO.16 anel3.03:tO.17 mm (PONS); cII&taI &qmeIIt& 1.39:tO.08 ancI1.66±O.11 mm 
(mean dIllWlon 19:tS%. p<O.05). C<JrODatY __ l.98:tO.D9 ancI227:tO.lS mm 
(PONS) before IIId oftcr teuDIorID re&peCIIveIy). 
1'beIe IIDdIn&I ~est that IntncoroDary IDI'uIIoD d tetansertn JIOIl PTCA _ 
cII&taI to PTCA-Ie&loo vuodIlatatIon. Therefore &a'OtODIn may pert1dpatc In the 
cll&tal1O PTCA-Ie&lon vuOCODllricUon by way d 52-1C1OlOD<r11c mec:hanI&m&. 
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928·22 
CABG RESULTS IN PATIENTS WITH EFs s...30%: 
The Importance of the LIMA Graft for Long-term Survival and 
Implications for Transplantation. 
Richard Gates. Steven Barthel, Hillel Laks, Davis Drinkwater. 
Gerald Buckberg, Robert Williamson. Jr. & Lynne Stevenson. 
UCLA Medical Center. Los Angeles, California 
Between 1986 and 199 I sixty-one p.tlients with EFs !>. 30% (mean 
23.7, range 12.5·30) underwent elective CABG without 
associated procedures. There were 4 early deaths (6.6%) and 13 
late deaths (21.3%) with a mean follow-up of 30.7 months 
(range 4-64). Mean age was 63.4 (range 44-82) and mean 
NYHA class was 2.9 +/- 0.5. Eleven (18%) were redo procedures. 
Angina was present in 58 (95%) and CHF in 48 (79%). Mean 
grafts placed were 3.6 +/- 1.0. with 2 I in-situ LIMA grafts. In 
survivors. the mean change in EF was +7.5% (P $. .05) and the 
mean change in NYHA class was +1.2 (P !>. .05). Eighty-two % 
were free of angina and 36% no longer required medications 
to treat CHF. Multivariate analysis revealed no predictors of 
early death. however, there was a trend toward increased 
death in patients with an EF of < 20% (2 of JO vs. 2 of 51). 
Similar analysis revealed thal for long·term survival. the use 
of a LIMA graft was a positive predictor (P !>. .05). while an EF of 
< 20% was a negative predictor (P !>. .05). There was also a 
negative survival trend in patients with EFs that did not 
improve post-op. however. this did not achieve statistical 
significance. Actuarial survival for all patients (n=61) was 
76% at 2 years and 61 % at 4 years. for patients with EFs 
between 20% and 30% and a LIMA graft (n=20) it was 83% at 2 
years and al 4 years. For patients with EFs < 20% and no LIMA 
graft (n=8) actuarial survival was 34% at 2 years and 17% at 4 
years. Cone/usion' In patients with EFs between 20% and 30%. 
the use of a LIMA graft during CABG surgery improves long· 
term survival and affords good long-term results. However. 
for patients with EFs < 20% in whom no LIMA graft is planned. 
results are very poor and transplantation should be 
considered. 
928·23 
Intermediate-term Results aner Aortic Valve Replacement (A VR) with 
Cryopreserved Pulmonary Allografts 
Wolfgang Konertz, Peter Hamann, Michael Weyand, Ehud Schwammeothal, 
Giinter Breithardt, Hans H. Scheid. 
Departments of Cardiac Surgery and Cardiology, University Muenster. 
Germany 
Experimental as wen as clinical data support the finding that the pulmonary 
valve can act satisfactorily as systemic semilunar valve. This prompted us to 
investigate the use of cryopreserved pulmonary allografts as aortic valve 
substitutes. 
From January 1990 to December 1991 eighty-three patients (pts.) received 
allograft aortic valve replacements, 70 of them with cryopreserved pulmonary 
anografts. 15 pts. suffering from native or prosthetic valve endocarditis were 
included. Ages ranged from 15 to 71 yrs. 51 pts. received primary isolated A YR 
and 23 required additional measures or Redo·A YR. All operations were 
performed with normothermic bypass and cold cardioplegic arrest. Additional 
operative measures were mitral valve reconstruction in 10, ACBG in 6. and 
aortic root replacement in 2 pts. Followup is maintained with visits to the 
outpatient clinic and echocardiographic assessment of the valve status every 
three months during the first yr. and every six months thereafter. 
Actuarial survival was 95 % at I yr. and 93 % at 2 yrs. Tbree valves had to be 
removed. One intraoperatively due to erroneous sizing. two other two and four 
montbs postoperatively in presence of ongoing endocarditis. 
Follow-up of the patients is near complete with a total of 298 echo 
investigations. Trace Or minimal regurgitation without hemodynamic relevance 
is a frequent echocardiographic finding. In no case, however, a deterioration of 
tbe valve could be observed during the follow· up, which is now up to 30 months. 
No thromboembolic events have been observed in 1354 patient's months. The 
majority of patients is currently in NYHA functional class I. 
The early results with pulmonary allografts have shown to be comparable to 
aortic allografts. Even in patients with acute native or prosthetic valve 
endocarditis the use of a cryopreserved pulmonary allograft valve has shown DO 
adverse effects. Thus, we continue to implant cryopreserved pulmonary 
allografts in aortic position. The longtcrm function of the valve, however, has to 




Initial Experience with Removal of Protruding Atheroma 
from the Aortic Arch: Diagnosis by Transesopbageal 
Echo, Operative Technique, & Follow.up 
Alfred T. Culliford, Paul A. Tunick, Edward S. Katz, 
Itzhak Kronzon, Aubrey C. Galloway, Greg H. Ribakove, 
Rick A. Esposito, Frank C. Spencer. 
New York University Medical Center, New York, NY 
Previously we reported that protruding atheromas 
(ATH) of the aortic arch (AA) detected by 
transesophageal echo cardiography (TEE) are associated 
with spontaneous cerebral and peripheral emboli. We 
have also shown that the presence of ATH predicts stroke 
during heart surgery, which is due to embolization. In 
order to prevent these debilitating events, we performed 
operative removal of ATH in 12 pts. 5 pts had TEE because 
of spontaneous cerebral and peripheral emboli; 7 pts had 
TEE during previously planned heart surgery. In all pts, 
TEE showed ATH, frequently with mobile components 
(superimposed clot). Arterial cannulation was distal to 
the left carotid in 9, femoral in 2, and in the ascending 
aorta in 1, to avoid ATH.With tympanic membrane 
temperature at 15°, and circulatory arrest, the AA was 
opened and ATH gently debrided. One pt died of aortic 
dissection, and 1 had postoperative confusion which 
cleared, and a small parietal infarct on CT scan. The 11 
survivors were followed for 1.5 to 24 (mean 12) months. 
There was 1 death (sudden) at 8 months, and 1 peripheral 
embolus (toes) at 3 months. There were no cerebral 
emboli. Anti-platelet drugs or warfarin was used in all 
patients. 
. Conclusion: Surgical removal of ATH of the AA is an 
option in pts with severe embolic symptoms, and it should 
also be considered if ATH are discovered with 
intraoperative TEE. 
928·25 
Atherosclerosis of the Ascending Aorta: Intraoperative 
Comparison of Two Ultrasound Techniques to Assess Its Severity. 
Kenneth J. Phillips, Victor G. Davila-Roman, Benico Barzilai, 
Thomas H. Wareing. Bill B. Daily. Rosa M. Davila. Nicholas T. 
Kouchoukos. Washington University, SI. Louis. Missouri 
Atherosclerosis (Ath) of the Ascending Aorta (AscAo) is an important 
predictor of postoperative stroke in patients undergoing cardiac 
surgery. Regions with Ath should be identified before cardiac surgery 
to avoid manipulation and prevent atheroembolism. To determine 
which ultrasonic technique bener defines Ath. intraoperative biplane 
transesophageal echocardiograpby (TEE. 5 MHz) and direct scanning 
of the AscAo was performed with a 7 MHz linear transducer in 44 
consecutive patients (age >50 years) undergoing cardiac surgery. The 
AscAo was divided into proximal and distal segments. and severity of 
Ath was graded on a 4 point scale (normal. mild, moderate. & 
severe). Two independent observers reviewed both studies in random 
order; both were blinded to the patients identification and clinical 
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Statistical analysis reveals that the relationship between the twO 
techniques was poor (IC = 0.13). Pathologic confirmation was 
obtained in the 3 patients with severe Ath. which in each case was 
underestimated by TEE. but correctly identified with the linear 
ultrasound technique. Thus. biplane TEE significantly underestimates 
the severity of Ath of the AscAo. particularly in the distal segment. 
Identification of severe Ath of the AscAo is best achieved 
intraoperatively by the use of a linear ultrasound probe placed directly 
over this vessel. 
928·26 
Coronary Artery Bypass Grafting in Patients with 
Eod Stage Renal Disease on Dialysis Therapy 
JACC Vol. 21, No.2 
February 1993:342A 
CIareoce H. Owen, Robin G. Cummings. Timothy L. Sell. Steve 1. Schwab. 
Robert H. Iones. Donald D. Glower. Duke University Medical Center. 
Durham, NC 
The role of corooary artery bypass araftina (CABO) in patieDts willi CIId llaJe 
renal disease (ESRD) remains to be clearly defmed. We retroapec:tively 
reviewed the experience at our instituti ... of CABO in 21 patieDts willi ESRD 
... dialysis lIIerapy prior operation. Age at the time of IWJerY was 60± 12 
yean. and patieats bad 3.4± I.S comorbid diseases other than toroIW)' artery 
and renal disease. Mean CHA angina class was 3.7 ±0.6 with IS of 21 
patiOllts described as class IV. Myocardial infarction was documented prior to 
operation in 14 patients. and S were talcea to surgery for UDJIable. post-infarct 
angina. Five patients required preoperative intra...ortic balloon counterpulsa•
tion for symptom control. Coronary angiography demonstrated an average of 
2.6±0.6 diseased vessels. with 14 of 21 patients diagnosed with significant 3-
vessel disease and 2 willi left main stenosis > so!!>. Mean ejection friction 
was SO±13!!> (range 26-79!!>. n=20). and no patients had evidense of 
significant valvular disease. The number of bypass grafts pllced averaged 
3.J± 1.3 and included internal mammary artery grafts in 12 patieats. There 
were 2 in.oospital deaths (within 30 days of CABG) and 8 major complications 
including exploration for bleeding (2 patients). pneumonia (2 patients), 
catheter-related peritonitis (2 patients), pUlmonary failure (1 patient). and 
mediastinitis (1 patient). Intensive care and total hospital days following 
CABG averaged 3.3± 1.9 and 14.3±9.4 days. respectively. Symptomatic 
improvement was observed in all hospital survivors. and overall functional 
status assessed using the Kamofsky Performance Scale was improved from 
36 ± 16!!> preoperatively to 63 ± 23!!> at the time of hospital discharge or death 
(p< .(01). Long term follow up was obtained for all 19 hospital llUVivon; IDd 
averaged 24 ± 29 months (range 1-96 months). Product-Limit survival 
estimates derived from these data were 87 ± 9!!> and 46 ± 14!!> at 1 and 2 yean. 
respectively. willi a medilD survival following CABO of 23.7 months. There•
fore, CABO may be performed in selected patients with ESRD on dialysis willi 
increased but acceptable peri operative rislr.. resulting in exce1leat symptomatic 
relief. However, 1000g term survival following CABG in this patient popula•
tion is limited. 
928·27 
The Five Year Survival Analysis of a New Bloprosthesls: 
The Perlcarbon® 
Alix Nguyen Van-Cao, Krystof Kucharsky, Une Veyssie, Bouchaib 
Faris, Philippe Menasche. Gerard Bloch, Annand Piwnica. HlIpital 
Lariboisi~re. Paris, France. 
Pericarbon® bioprostheses have two sheets of pericardium with a 
turbostratic carbon coating of the non-biological surfaces. A beller 
resistance to mechanical stress is presumed. The 5 year survival 
analysiS of this new bioprosthesis is reported. 
One-hundred and twenty-eight patients with a mean age of 64.6 
±14.6 yrs (range 23 - 85) were operated on. Sixty-eight were male. 
Sixteen had previous cardiac surgery and 11 had preoperative 
endocarditis. Twenty-three patients had coronary heart disease and 
coronary bypass grafts were perfonned in 16 cases. Ninety-eight 
valves were implanted in the aortic position and 37 in the mitral 
position. From 1985 to 1991. 21 deaths, 7 reoperations. 6 valve•
related endocarditis and 9 thromboembOUc events occurred. Three 
structural deteriorations and 2 non-structural dysfunctions were 
operated on. 
Al 5 years, a 81% probability of survival was observed with 74% 
and 87% as 95% confidence limit (Cl) intervals. The 5- year probability 
of being free from structural deterioration was 97% (Cl: 91-99%), from 
related structural failure 98% (Cl:94-99%), from endocarditis 94%(Cl: 
88-97%), from thromboembolic events 87% (Cl:77-93%), from 
reoperations 94%(Cl:88-97%), from any event 65% (Cl:55-73%). 
Using a log-rank test the mitral valves had a lower probabiUty of 
being free from reoperation (p<O.OI5) and non-structural dysfunction 
(p<O.031). 
The preoperative NYHA status was the most significant factor of 
survival by Cox regression analysis. 
The survival analysis of the Pericarbon® co~res well with that of 
other bioprostheses. 
JACC Vol. 21, No.2 
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928-28 
Impact of AortIc DIssectloa oa Morbidity Ia Patients with the Marfan 
Syacirome 
Harry R. Aldrich, Robert L Labarre, Mary J. Roman, Randi Kramer-Fox, 
Mariane Spitzer, Richard B. Devereux, The New York H06pital-Comell 
Medical Center NY, NY 
Surgical intervention bas been beneficial to patients with the Marian 
syndrome, but late complications may occur at the level of aortic composite 
grafts and throughout the aorta. This study was undertaken to compare rates 
of long-term morbidity in Marfan patients who had initia1 aortic dissection or 
had elective composite grafting. We report on the long-term followup of 39 
Marfan patients who have had elective composite aortic graft surgery or 
aortic dissection prior to their initial surgery who have been evaluated at 
NYH-CUMC since 1984. 
The patient population consists of 26 men and 13 women, whose mean age 
was 35 years (range 17-69 years). The mean follow-up time was 57 months 
from the date of operation and 44 months from the first post -operative visit 
at NYH-CUMC. 28 patients had elective composite graft surgery. One 
patient died perioperatively, and 5 of the other r7 required a second operative 
procedure for complications involving the composite graft, including 
perivalvular leakage into the native aorta (2), pseudoaneurysm or partiaI 
dehiscence of a coronary anastom06is site (2), and infective endocarditis (1). 
One of the r7 elective surgical survivors died 39 months after surgery due to 
heart failure. 11 patients had initia1 aortic dissection prior to composite graft 
surgery, involving the ascending aorta in 8 and the distaJ aorta in 3. One of 
the 11 patients died 26 months after her initial operation during a subsequent 
thoracic aortic repair. 5 of 8 patients (63%) who had ascending aortic 
dissection prior to composite grafting required subsequent distaJ surgery 
versus 2 of r7 (7%) with elective composite graft surgery (p<0.01). 
Subsequent complications occur frequently in Marfan patients who require 
initial surgery for aortic dissection (9.5% /year), but also occur in patients 
who undergo elective composite grafting (1.5% /year). Thus, elective surgery 
before aortic dissection reduces but does not entirely eIiminate long-term 
morbidity in patients with the Marfan syndrome. 
928-29 
Functional CapacIty FollowIng Aortic Valve Replacement 
(AVR):Determlnates of Poor ExercIse Tolerance In 
Women. 
Frederick A. Dressler, Liwa Younis, Jeanette A. St. Vrain, Ramon 
Castello, Lawrence R. McBride, Arthur J. Labovitz 
St. Louis University Medical Center, St. Louis, Missouri 
The purpose of AVR is not only to prolong life but also to improve 
functional capaCity. This is especially true in pts with preserved left 
ventricular (LV) function. In order to assess the determinates of 
exercise capacity following AVR, 79 pts with good LV function pre•
operatively were studied prospectively. They received clinical and 
echocardiographic evaluations before and 6 months after surgery. 
At 6 months, they also received symptom-limited treadmill exercise 
tests. The pts were divided into those with low ($3 METS), moderate 
(3-5 METS) (Mod), and good (>5 METS) exercise tolerance. Of the 
52 men, only 4 (8%) were in the low exercise group whereas, of the 
27 women, 9 (33%) achieved S3 METS (p<0.001). Pre-operative 
characteristics of the 3 functional groups of women were compared: 
Group (METSl ./Y;L. ~ ~ 19-21mmAVR 
Low ($3) 63±17 47 (44%)' 47±9 9 (100%) 
Mod «3>5) 59±11 1 (11%) 54±9 6 (67%) 
Good (~5) 50±13 0 (0%, 49±15 4 (44%, 
'p<0.05, poor vs mod; "p<0.05, poor vs good; "'p<0.05, mod vs good 
AI:aortic insufficiency; MR:mrtral regurgrtation; MS:mrtral stenosiS. 
The 3 groups were similar in baseline LV ejection fraction (EFl· 
Although no significant difference in mean age was seen, pts >70 
years old were more frequently in the lowest functional group. A 
greater number of women with low (100%) and moderate (67%) 
capacity received a 19-21 mm AVA compared to the good functional 
group (44%). Thus, in pts with NL LVEF pre-operatively, poor 
functional capacity following AVA is mainly limited to women. The 
factors associated with poor functional capacity in women are 
(1) age >70 and (2) small (19-21mm) prosthetiC size. 
ABSTRACTS 
928·30 
Influence of Coronary Endarterectomy on Long•
Term outcome After coronary Bypass Surgery. 
Gerald M. Lawrie, Michael E. DeBakey, Nan R_ 
Earle, Baylor College of Medicine, The 
Methodist Hospital, Houston, TX 
Increasing numbers of pts with distal, 
diffuse coronary disease are being referred 
tor coronary bypass (CAB). Over a 20 year 
period 2985 pts had isolated CAB (I) while 
216 had CAB and coronary endarterectomies (E) 
of one or more vessels. Mean age was: I 55 
± 9 yrs, E 55 ± 9 (P=NS). There were more 
males in E: 93% vs 83% of I (P < 0.05). 
More E had previous MI - 79% vs 63% (P < 
0.05). The E pts had more 3 vessel (50% vs 
40%) & left main disease (16% vs 11%) & less 
1 vessel disease (7% vs 20%) (P < 0_05). 
More E pts had poor preop LV function: 29% 
vs 19%. Perioperative mortality was 7% for E 
and 5% for I (P< 0.06). At 10 yrs, survival 
(Kaplan-Meier) was 55% for E & 63% for I. 
39% and 4H at 15 yrs (p<0.05). Angina 
relief or improvement at 10 yrs was 72% (E), 
83~ I, at 15 yrs 84%, 87% (P=NS). Freedom 
from reoperation at 10 years was 85,2% for E 
& 84.3% for I and at 15 yrs. 78%, 70% (P = 
NS). Graft patency at 10 yrs was for E 44% & 
I 58% (p<0.05). Thus, despite less favorable 
baseline characteristics, E has provided good 
long-term clinical results similar to I 
except for a small difference in survival 
which may be due to worse baseline 
characteristics. E 8x~ends the indications 
for CAB in pts with diffuse CAD involving 1 
or more vessels. 
928-31 
343A 
Bilateral vs. Sing!e Internal Mammary Artery (IMA) Grafting 
for Left Main Coronary Artery Occlusion 
Masaki Otaki, Robert M. Lust, Yo" S" SIUI, Terry O. Norton,Palli A. Spence, and 
W. RtJIIdo/ph Chitwood, Jr. Eas1 Carolina Umversitj", Greenville. NC 
The flow capacity of lIIl internal mammary ar.ery graft remains unclear, as are the 
co!lSf".quenct'-s of grafts perfusing in competition with each other. Ten dogs (19.3 ± 
2.2 kg) underwent coronary amry bypass grafting through a left thoracotomy, off 
pump, using a Mef local occlusion to perform the anastomosis. Dogs were random•
ly lISsigned to rcci~ve either a .ingle left IMA graft to the circumflex coronary 
artery (CFX). or bilateral IMA grafts. with additiorul1 placement of the right IMA 
to the left anterior descending coronary artery (LAO). After the grafts were placed, 
the left main coronary artery was ligated. Elcctromagnetic flows were obtained in 
the proximal and distal LAD and CFX in both groups before grafting (Control) and 
after grafting. IMA flow in sit" WllS also measured before rotation from the ch~t 
wall. These values are expressed as mean ± SD, and are SUI11IIIl!tized below. 
Flow (mlimin) 
prox LAD dist LAD prcx CFX dlst CFX 
CO:lll-01 48.4± 6.2 31.7 ± 6.7 50.1 ± 10.4 38.6 ± 8.1 
Single 48.3 ± 9.5 30.2±6.0 SO.I ± J5.t 38.4 ± 8.9 
Bilateral 15.3 ± 5.8 32.1:: 7.6 15.9± 10.9 36.7± 7.5 
Total teft vcntrir.uiar ilow requirements were satisfied equally well by either single 
(116.7 ± 11.6) or bilateral (total, 116.8 :t 9.6 divided as LIMA, 55.9 ± 7.4; RIMA 
60.9 ± 12.0) gral'.ing. Grafting produced bila!ezal flow in the native artery from the 
point of graft insertion. When two grafts were placed, competiti>e flow in the 
proximal regions of t-oth native vessels was noted, although basal flow require•
ments were maintltined. When individual grafts were occluded i~ the bilaterally 
grafted system, the remaining graft it!lmediately rccruited the additional t1ow, 
demonstrating that either right or left IMA can support flow d~.mands 5-6 times 
higher than in sit" chest wall flow (RIMA, 21.9 ± 3.1; 22.3 ± 4.9). Thes.: data 
suggest that in this canine model, single 1MA grafts can suppon the entire /low 
requirements of the left ventTic\e. Assuming DO intervening stenosis is present in 
the native system, bilateral IMA grafting may provide a margin of safety, but Wider 
resting con~_,tiOllS, provides no perfu:;;on advantages ov~r single IM.A grafts. 
344A ABSTRACTS 
928·32 
A.rlnone Enh.nce. latera.. M •••• ry Artery 
Gr.ft Blood flow 
George V. Lctaou. Wea X. Liu. Roben S. D. HiggiaI, lUID A. 
Sanchez, Spyrol Coadol, Robena HiDe., 101m C. Baldwia 
Yale Uaiversity, New Ravea, Connecticut 
Whea iao&ropic .uppon i. required for wcaniag from 
cardiopulmonary bypus, the vuoconltrictive effects of 
iaotropes .uch II epiaephriae on internal mammary artery 
(lMA) Jraft blood flow are potentially deleterioUi. Amrinone 
hu potent iaotropic and vuoclilatory propenies. We 
postulated that these vuodilatory propenie. would make 
amrinone superior to epinephrine when IMA grafts have 
been used to bypu. coronary artery lesions. 
Methods: A canine right bean bypass model WII used in 
which the left IMA WII anastomosed to a proximally ligated 
left anterior descending artery. IMA blood flow wu 
meuured under bueline conditions and during intravenous 
infusions of either amrinone or epinephrine in 7 animals. 
Each animal served u its 0..... control. The perc:eatage 
increase over bueline blood flow wu calculated, and 
significance of difference between baseline and treated IMA 
blood flows wu calculated using the paired t test. 
Rrnllu.: High (0. JO mcg/kg/min) and low (0.02 
mcg/kg/min) dose epinephrine produced no change in IMA 
blood flow from bueline. However, there WII a significant 
increase in IMA blood flow over baseline with high (20 
mcg/kg/min) and low (5 mcg/kg/min) dose amrinone; 36% 
and 19%, respectively. There wu also I lisnificant increue 
in dP/dt with high and low dose amrinone. 
Conclusions: Amrinone lignificantly iacreues IMA graft 
blood flow at high and low dosages. Epinephrine does not. 
Amrinone may have an important role in the care of 
patients with IMA grafta. 
928·33 
Late Endothelial Function of Free and Pedicled Internal 
Mammary Artery Grafts 
Sudhir Kushwaha, Mahmud Bustami, Samad Tadjkarimi, 
Andrew Mitchell, Charles Ilsley, Magdi Yacoub, NHLI and 
Harefield Hospital, Harefield, Middlesex, England. 
We examined endothelial function and maximum dilatory 
ability of free (F) and pedicled (P) IMA grafts by 
comparing the response to the endothelial dependent 
vasodilator substance P (SP) and isosorbide dinitrate 
(ISDN) infused into the grafts of 2 groups of patients 
undergoing routine follow-up of 5 weeks to 5 years after 
surgery. SP was infused selectively into F or P grafts 
following coronary angiography. Each dose of SP was 
infused for 2 minutes followed by an angiogram. 
Following the SP infusion, ISDN (Img/ml) was infused 
for 2 minutes followed by a final angiogram. Changes 
in diameter were measured using quantitative arteriog•
raphy; % diameter change ! SEM for each dose of SP and 
ISDN are shown as well as the p values. 
SP dose Saline 
1.4 2.8 5.6 11.2 22.4 ISDN 
pmol/min. 
p(n=7)0 0.HO.7 3.9!0.6 6.l!1.1 8.0n.5 8.7n.8 10.7!!.1 
F(n=8)0 2. HI. 6 6.8!2.0 5.9!2.1 8.2:!:2.9 8.8:!:2.3 9.7:!:2.4 
p va1.0 0.3 0.2 0.9 0.9 0.9 0.7 
Maximum endothelial and nitrate dependent vasodilation 
was not significantly different between the 2 groups. 
It is concluded that late endothelial function is 
preserved in both the free and pedicled IMA. This could 
have important implications with regard to their 
performance. 
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929·34 
Detedion of atherosclerotic lesions in the descending 
portion of the left coronary artery by transthoracic high 
frequency echocardiographlc. 
FrIlllCC800 Falelra MD. Manlio Cipriani MD. Roberto Como MD. Giovanni Cali 
MD. Silvia Cantoni MD. GianBattista Daozi MD. and Antonio Pewmo MD. 
• A. De Gmperis· Cardiology Department Niguarda-Ca' Granda • Milan. Italy 
BackgrouDd ud objec:tiYes Whit lbe uewly available translboracic high 
frequeocy (up to 9 MHz ) anoular array ec:bocardiograpbic transduccn (HfE) it is 
DOW possible to achieve an axial resolution of 0.2 mm up to a 4-6 an depth. The 
distal part of lbe left descending coronary artery (dllx::A) is embedded in lbe 
intaventricular sulcus 2-4 an from the thoracic wall. Tbc:r'Cfore the vessel is wdl 
wbitin the focal ume of HFE and accessible to ultrasound imaging. This study was 
designed to assess the ability of HFE to detect atherosclerotic lesions in the dLDCA. 
Metbods Thirty consecutive patients wilb suspected coronary artery disease 
underwent two-dimensional echocardiograpbic examination 24-96 hours before 
coronary angiography. The dUlCA was arbitrarily divided into a mid segment (the 
portion of the coronary vessd anbedded in the anterior interventricular sulcus) and 
an apical segment (the portion turning around the cardiac apex into the posterior 
intaventricular sulcus). 
Results The mid segment was imaged in 24 and the apical segment in 25 of 30 
patients (49/60 segments examined=82%). Comparison with lbe corresponding 
angiograpbic segments indicated that a correct ecbocardiograpbic diagnosis of 
significant stenosis was made in II of 12 segments. There weu no false positive 
results. Thus the sensitivity and specificity of high-frequency transthoracic 
ecbocardiograpby in detecting significant stenosis in the imaged segments were 92 
and 100% respectivdy. When inadequate studies (1lof 60 segments) were included in 
the analysis. sensitivity was 78% and specificity 80%. 
Conclusion In our study population HFE proved to be able to identify significant 
coronary stenosis in the distal portion of the dLDCA in the majority of patients. 
Since complanentary information such as status of lbe arterial wall. presence of 
calcific plaques and circumferential extension of atherosclerotic Ie ions. were 
obtained by HFE. it is cooceivable that in the near future HFE could be used as a 
saeening tool in selected patients. 
929·35 
Noninvasive Assessment of Left Internal Mammary Artery (LIMA) 
Graft Patency Using Duplex Doppler Eehocardlography from Supra· 
clavICular Fossa 
Tsutomu Takagi. Junichi Yoshikawa. Kiyoshi Yoshida. Takashi Akasaka. 
Masahiro Shakudo. Kenji Maeda. Kobe General Hospital, Kobe. Japan 
To elarify the usefulness of duplex Doppler echocardiography from supra•
clavicular fossa for the assessment of left internal rnalTVl18ry artery (LIMA) 
graft patency. we studied 56 consecutive patients who underwent routine 
postoperative angiography. Using supraclavicular duplex Doppler 
echocardiography. LIMA graft flow was recorded in 55 (980/0) of 56 
patients. Systolic peak velocny (SPV). systolic time velocity integral (SI). 
diastolic peak velocny (OPV). diastolic time velocity integral (01). the 
diastolic to systolic peak velocity ratio (OPV I Spy). and diastolic fraction 
(01/01+81) were measured in 55 patients. The patients were divided 
into two groups according to quantkative angiographic data: group A (n 
~ 10) with sign~icant stenosis (>75% diameter stenosis) in LIMA graft. 
and group B (n ~ 45) without sign~icant stenoSiS. Results: 
SPV OPV SI 01 OPV I SPY 011 01+51 
(em/sec) (em/sec) (em) (em) 
group A 44.fr+-27.0· 12.S:t9.S' 7.6!5.8· 4.4±3.7 0.29±O.12·· 0.37±O.13" 
aroup B 26.3+'24 22.4±'0.2 4.5+-2.9 8.8+8.9 0.93±O.40 0.64+0.09 
... 0 0 
:;~- ... 




• P < 0.05 ••• P < 0.001 vs group B 
Diastolic fraction (011 01+81) less than 
0.5 predicted significant LIMA graft sten· 
osis (>75%) by angiography with a sen•
snivily and specificity of 90% ahd , 00"10. 
respectively . 
In conclusion. duplex Doppler echocar· 
diography from supraclavicular fossa is a 
0.0' "':--'; .. ;--.. ;-~ .. ;;;-"'; .. ;;;-7., .. ;;;-, reliable method for the noninvasive as-
.. ~ Of.- GRAFT sessment of LIMA graft patency. 
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929-36 
Evaluation of Left Internal Mammary Artery. Left Anterior Descending 
Coronary Artery Bypass Graft Patency by Subclavian Echo-doppler Duplex 
Bernard GLA IT , Philippe VEAU, Yves SENTOU. Centre Cardiologique du 
Nord, Saint-Denis, France 
From june 90 to december 91, 53 patients (pts) 46 males, mean age 58,2 years, 
have been investigated prospectively with subclavian echo-doppler duplex (EDD) 
of proximal internal mammary arteries (IMA) and selective IMA arteriography 
before and after left IMA - left anterior descending coronary artery bypass graft 
for obstructive coronary lesions. Ultrasonic exploration (US) was performed 
mean 6 days before and mean 10 days after bypass surgery, lMA aneriography 
mean 12 days after. All the data were available for 50 pts. US data, systolic peak 
(SP) diastolic peak velocily (DP), ratio SPIDP, mean IMA blood flow were 
correlated with angiography IMA graft patency. For 150 normal IMA the velocity 
curves were "muscular" with a great systolic wave, for 46 patent IMA grafts were 
"coronary" with decreased SP, increased DP and large diastolic wave, for 3 non 
patent grafts remanied muscular, and for I patent graft with large per surgical 
anterior myocardial infarction were in between. The difference is significant 
between normailMA and patent lMA graf~ between patent and non patent IMA 
graft, and not significant between norrnailMA and not patent graft,. 
normallMA patent grafts non patent grafts 
(n-JSO) (n:46) (n;3) 
SPcrn/sec 95± 20 p <0,002 4818 p < 0,002 9O± 18 
DPcrn/sec lOt 8 p < 0,002 58± 10 p <0,002 1517 
SPIDP p < 0,002 0,9 p<O,OO2 
Flowml/sec 36 ± 4 p< 0,005 84± 5 p< 0,005 38±6 
Conclusion : The subclavian EDD of lMA is a non invasive technique easily 
performed (feasability 96 %). The accuracy of EDD to predict patency of IMA•
LAD bypass graft is hight (sensibility 98 %, specificity 75 %), EDD is an 
acceptable technique to select pts for selective IMA arteriography control. 
929-37 
Ultrasound Assessment of Brachial Artery 
Endothelium Dependent Vasoactivity as a Means 
for Diagnosing coronary Artery Di.ea.e. 
Robert A. Vogel, Peter V. vaitkevicius, Gary 
D. Plotnick, University of Maryland, 
Baltimore, Maryland. 
Patients with coronary artery disease (CAD) 
have been shown to have abnormal coronary and 
peripheral artery endothelium-dependent vaso•
activity. To determine whether this finding 
could be used to non-invasively diagnose CAD, 
we measured brachial artery percent diameter 
change (%DA) immediately following 4 minutes 
of ipsilateral blood pressure cuff arterial 
occlusion induced hyperemic dilatation (HYPER•
OIL) and during up to 4 minutes of contra•
lateral ice-water hand submersion (COLD-PRES). 
Ten normal individuals (NLS) and 5 CAD 
patients were evaluated using 7.5 mHz crystal 
long-axis ultrasound. In response to HYPER•
OIL, NLS had a mean 12.7±12.7 %DA, whereas CAD 
patients had a 3.34±5.23 %DA (P=0.14). In 
response to COLD-PRES, NLS had a mean 5.4 ± 
9.3 %DA, whereas CAD patients had a -9.9±9 %DA 
(P<O.Ol). The HYPER-OIL response was 90% 
specific and 80% sensitive and the COLD-PRES 
response was 80% specific and 100% sensitive. 
Responses to HYPER-OIL and COLD-PRES in NLS 
tended to be inversely correlated suggesting 
variation in basal tone. To correct for this, 
the mean response of the two stimuli was 
evaluated. The mean response was 100% 
specific and 80% sensitive (P<0.003). These 
data suggest that CAD may be diagnosed using 




ECHOCARDIOGRAPHIC EVALUATION OF DDD PACING IN DILATED 
CARDIOMYOPATHY AND IN NORMAL LEFT VENTRICULAR FUNCTION 
W.D. Ren, E.Hrovatin, L. Sparacino , G.L.Nicoloai, F. Zardo , 
N, Meneguzzo, E. Cervesato, D. Zanuttini. 
Cardi ologi a-ARC , Ospedale Civile, Pordenone, Italy. 
By using 2D and Pulsed Doppler Echocardiography diastolic 
filling parameters (DF) {mitral valve opening (S-MVO); 
closure (S-MVC); diastolic filling time (DT» cardiac 
output (CO) and ejection fraction (EF) were evaluated in 
2 selected groups of patients (pts) with normal left ven•
tricular function (NLVF) (9 pts, mean age 63 yrs) and di•
lated cardiomyopathy (DCM) (7 pts, mean age 65 yrs). All 
pts were treated with DDD pacing. All parameters were ob•
tained during DDD pacing st different heart rate (HR) and 
after modifing AV Delay intervals (AVD~150-250 DIS), and 
the pacing to VVI. 
RESULTS: In both groups with NLVF and DCM with DDD pacing, 
at basal HR, all DF parameters were longer at AVD 150 as 
compared to AVD 250 DIS {DT 6.7:1:2 VB 7.7:1:2 DIS (DCM) and 
B_5~3vs 11.013 DIS (NLVF». CO and EF improved at rest 
during DDD pacing mode at AVD 150 DIS VB 250 DIS (CD=5,18±1 
vs 4.94±1 Ilmin (DCM) and 4.81:1:2 VB 4.28±1 I/min). At ma•
ximal HR, DT was longer at AVD 250 DIS in all pts {DT=6.2 
±2 VB 5.71±1 (DCM) and 6.6±1 vs 6.011 (NLVF); only in DCM 
CO was greater at AVD 250 DIS (6.41:1:2 vs 6.39±2 l/min). 
CO was greater in all pts with DDD as compared to VVI 
pacing mode. 
CONCLUSION: Optimization of AV delay interval has to be 
achieved in each pts with DDD pacing, in particular in 
cases with DCM. 
929-39 
Differentiation of Partial and Complete Aortic Arch 
Obstruction in Neonates by Pulsed Doppler Velocity 
Profiles in the Proximal Arch. 
Narayanswami Sreeram, Kevin Walsh, Mark Jackson, Royal Liverpool 
Children's Hospital, Liverpool, England, 
In 36 consecutive neonates (age < 28 days) with suspected aortic 
arch obstruction, two-dimensional image·guided pulsed Doppler 
(PWD) recordings were obtained from the transverse arch proximal 
to the obstruction, and blind continuous wave Doppler (CWO) 
interrogation of the descending aorta was also performed from the 
suprasternal notch, The diagnoses (confirmed at surgery in all) were 
preductal coarctation (21 patients), postductal coarctation (6 
patients), interrupted aortic arch (5 patients), and arch atresia (4 
patients), Using CWO, a high velocity jet (>2.2m/sec) was recorded 
in 13 patients, Of these, 4 had preductal and 6 postductal 
coarctation, The remaining 3 patients had arch atresia or interruption, 
By PWD, a prominent diastolic flow signal into the descending aorta 
was recorded in the proximal arch in all patients with coarctation 
(pre- or postductal). This diastolic flow signal was absent in patients 
with interruption or arch atresia, and represents either (a) a diastolic 
coarctation gradient or (b) diastolic steal by the duct or collateral 
vessels. The peak velocity and area of this diastolic signal also clearly 
distinguished neonates with coarctation from normals (p<O,Ol), 
Conclusions: In neonates with arch obstruction, ductal patency often 
precludes the development of a large pressure drop across the 
obstruction. Conversely, a high velocity CWO signal may be recorded 
from a restrictive duct in patients with arch atresia or interruption, In 
conjunction with two-dimensional imaging, PWD velocity profiles in 




Utility of Echocardiographically-Directed 
Endomyocardial Biopsies in Patients with 
Cardiomyopathy 
Wes R. Pedersen, Irvin F. Goldenberg, Jeanne Olson, 
Joan Curran, Charles Jorgensen, Tammy Krause, Terry 
Plourde, Susanne K. Roeller, Marc R. Pritzker 
Kinneapolis Heart Institute & Abbott Northwestern 
Hospital, Kpls, KN 
Percutaneous endomyocardial biopsy (EHB) remains the 
standard technique for the diagnosis of myocardial 
disease. Traditionally, EHB has been performed in the 
cardiac catheterization laboratory using fluoroscopy. 
Echocardiographically-guided endomyocardial biopsy 
(EGEHB) has offered a less expensive alternative 
without radiation exposure. In addition, echo•
cardiography displays more precisely the relationship 
between the bioptome and endomyocardial surface, 
allowing for more diffuse endomyocardial sampling. 
Our objective in this ongoing prospective study was to 
determine whether EGEHB could be used as successfully 
and safely in cardiomyopathic pts as we had previously 
demonstrated in our transplant population. Previously 
cardiomyopathic patients have been felt to be at 
higher risk for complications than transplant pts. We 
performed 76 EGEHBs without fluoroscopy from 4/89 to 
6/92 on 69 nontransplant pts. All procedures were 
performed successfully without complications. 
Advantages included a cost reduction of 
$700/procedure, absence of radiation exposure, more 
diffuse myocardial sampling, and the generation of 
clinically useful supplemental echocardiographic 
information. Thus, we found EGEHBs for the evaluation 
of myocardial disease to be a useful, safe, and 
cost-effective alternative to fluoroscopically•
directed biopsy. 
929-41 
Accuracy of Cardiac Output Calculations by Color Doppler 
and Multigate Spectral Doppler Echocardiography 
Herbert Dittmann, Manfred Strunz*, Xiangchen Wu**, Jochen 
fischer**, Peter Schwarzmann**, Ludger Seipel. Department 
of Cardiology, University of Tuebingen, *Institute of 
Aero- and Gasdynamics, **Institute of Physical Electro•
nics, University of Stuttgart, Germany 
We evaluated the accuracies of cardiac output measure•
ments by multigate spectral Doppler and color Doppler 
echocardiography. In a flow model flows with flat and 
parabolic velocity profiles were simulated. Flow rate 
ranged between 4.1 and 22.1 I/min. Spatial flow veloci•
ties were calculated by multigate spectral Doppler echo•
cardiography using a fast Fourier transform analysis in 
10 gates distributed equally across the vessel diameter 
and by color Doppler echocardiography over the entire 
cross sectional vessel area using an autocorrelation 
technique. Flow rates were calculated from average spa•
tial velocities and flow areas. Color Doppler measure•
ments correlated well with absolut flow rates for flat 
(r = 0.98, SEE = 1.5 I/min) and parabolic velocity pro•
files (r = 0.98, SEE = 1.2 I/min). B~t color Doppler 
underestimated actual flows with parabolic profiles by 
13.7 % (p < 0.00001). Independent of flow profiles the 
correlation between multigate spectral Doppler measure•
ments and actual flow rates was strong without system•
atic error (r = 0.98, SEE = 1.2 I/min). 
Conclusions: By multigate spectral Doppler echocardiogra•
phy flow rates can be exactly measured independent of 
velocity profiles. Underestimation of volumetric flows 
with parabolic profiles by color Doppler echocardiography 
resul~s from insufficient detection of low flow veloci•
ties near the vessel wall. 
929-42 
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Accuracy of Different Doppler Transducers Assessed by 
a new laser Calibrated Flow Device 
Soeren C.W. Heik, Pieter Vandervoort, Christian W. Hamm, 
Wolfgang Kupper, James D. Thomas, Massachusetts General 
Hospital, Boston and University Clinic Hamburg, Germany 
To investigate the accuracy of different Doppler probes of every 
day clinical use we compared Doppler velocity measurements of 19 
transducers in 8 echomachines of S different manufacturers. We 
measured peak velocities ranging from 50 to 500 cm/s using PW 
and CW Doppler in a new laser calibrated flow device with 
pulsatile flow (Echocal, Dynatek). From PW Doppler spectra 
modal and peak velocities were obtained, where as for CW Doppler, 
the peak velocity was 
measured. Measurements 
were performed by two 
independent blinded 
observers. 
Results (table): Modal PW 
measurements were most 
accurat, mean deviation 
Overall accuracv (n= 19) 
Mode % Diff. %Sd 
CW +5.8 ±B.2 
PW-modal +0.2 ±S 
PW-Deak +12 ±8 
from g i v e n ve I oc i t y + 3 0 t::l::l=-:::i;l:iiiIfLE:;;;;;;;;;;;;:r:::t 
being only 0.2%. In CW 
mode range of difference 
was significantly higher 
(-5 to +29 %). In CW 
mode overestimation in 





highest at low velocities -1 50 Velocity crn/s 500 (graph). 
Conclusions: 
Measuring modal PW velocity is mandatory to obtain accuracy in 
PW mode. In CW Doppler the range of differences was wider and 
there was overestimation in all machines at lower velocities. We 
observed no difference in accuracy between older and newer 
transducers and echocardiographs. 
929-43 
Application of a Semi-Automated MuHipiane Imaging Transducer to 
Transthoracic Echoeardiogrophy Makes Transthoracic Examination 
Easier and Faster, And Yields New Imaging Planes· A New Direction 
in Transthoracic Echoeardiography 
Natesa Pandian. Qi-Ung Coo. Marjory Caldeira. Joanne Zachistal. 
Janet Simonetti. Kenneth Taylor and Steven Schwartz. 
Tufts - New England Medical Center. Boston. Massachusetts. 
Optimum pertormance of transthoracic echocardiography (TTE) requires 
appropriate positioning. angulation and rotation of the transducer at every 
acoustic window. A good examination is often time-consuming and requires 
considerable skill. To explore the notion that a multiplane (MP) probe could 
enhance TTE as it does in transesophageal echo (TEE), we used a 513.7 
MHz MPTEE probe as a TTE device. In 20 pts, we placed the MP probe 
(OmniPlane. H·P) at the parasternal, apical, subcostal and supraSlemalloca•
tions and pertormed 2-D echo, spectral Doppler and color Doppler studies. 
At each site, imaging was started with a standard (STD) view (eg. long-axis 
in the parasternal window). Maintaining probe stability, the transducer array 
was then electronically rotated from 0 to 180· acquiring not only the STD 
views but also many intermediate views. Then. with minor adjustments in 
probe angle in 4 directions. MPTTE images were recorded. Similar proce•
dure was repealed at all available acoustic windows. Resuhs: MPTTE 
yielded all the previously described conventional TTE views from every Site. 
Once optimum acoustic window and starting view were defined, rest of the 
STD views from that site became easily available as the imaging plane was 
steered through 180· with the touch of a button. The exanination was faster 
and easier. In addition, a number of new imaging planes. not easily available 
by usual approaches in TTE, could be recorded. Some of them are: SAX 
view of RV outllow, pulm valve, and tricuspid valve, SAX and LAX images of 
thoracic aorta over greater lenglhs, RV outllow view from the apex, visuali•
zation 01 the atrial and ventricular septae in many orientations, detailed dis· 
play 01 submitral apparatus in longitudinally and better visualization 01 SVC 
and pulm veins. Alignment of CW Doppler beam was relatively easier and 
abnormal jets on color Doppler were better appreciated. We were able to 
define valvular abnormalities, septal defects and regional ventricular dys· 
function better. We conclude that a muhifrequency, mUhiplane transducer, if 
designed for TTE, will make TTE easier. faster and more versatile providing 
many new imaging plans. In addition, n could provide an important step in 
the development of transthoracic three-dimensional echocardiography. 
JACC Vol. 21, No.2 
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929·44 
Three·Dlmenslonal Echocardlographlc Evaluation of the Left Ventricle 
In Patients With Ischemic Heart Disease and, In Vitro and In Vivo 
Validation of Its Quantitative Ability to Assess Ventricular Volumes and 
Ejection Fraction· A Simple and Reliable Approach 
Jose Azevedo. Qi'Ling Coo. Natesa Pandian. Howard Snapper. 
Steven Schwartz. James Udelson. Bjom Angelsen and Janet Simonetti. 
Tufts· New England Medical Center. Boston. Massachusetts. 
As myocardial stunning and ventricular remodeling assume increa•
sing therapeutic implications in ischemic heart disease (IHD). defining 
the ventricular geometry and function in greater detail becomes 
important. We have previously shown the feasibility of 3-D recon· 
struction in a clinical setting. In this study. we explored the reliability of 
quontitative data derived from 3-D reconstructions of the LV cavity 
from 2-D echo. The approach we employed involved digital collec•
tion of 3 or 6 apical orthogonal views. semiautomatiC border extrac•
tion and 3-D reconstruction and 4-D display using a specially deve•
loped software. Such 4-D data also provide LV volumes and ejection 
fraction (EF). First. we correlated the volumes from 3-D data (y) of 15 
autopsied hearts (symmetriC and asymmetric ventricles imaged in 
water both) to actual volume measurements acquired with saline 
filling of the LV (x). Next. we used this approach in 15 pts (with normal 
and abnormal ventricles) to obtain end-diastOliC and end-systolic 
volumes (LWD and LWS). and EF (y) and compared them with data 
from simultaneous radionuclide MUGA scanning (x). Finally we appl•
ied the 4-D method to 50 pts with IHD. Results: The in vitro correlation 
for LVV is y=92x+2.95. r=.98. p<.(XJ1. In vivo correlations with MUGA 
were: for LVVD: y= 1.23x+32. r=.77. p<.Ol: for L VVS: y= l.46x+ 13. r=.88. 
p<.OOl: for %EF: y=.86x-.16. r=.93. p<.OOl. When applied 50 pts. 4-D 
echo derived volumes and %EF were able to identify LV dysfunction in 
21 pts. In addition. 4-D echo displayed the ventricular shope. geo•
metry. regional motion and change in global shope and size in a 
dynamic mode. and could be viewed from a number of orientations. 
Cardiac imaging. border extraction. 4-D display and derivation of 
quantitative data all could be performed in on easy and fast manner. 
Conclusion: 3-D and 4-D echocardiographic analysis of the LV is 
clinically feasible and it provides data of therapeutic importance. 
929·45 
Myocardial Contra.t Echocardiography (MCE): Safaty And Normal 
Perfusion Pattem in Hurnens 
Fernando Morcerf, Armando Cantisano, Flavia Salek, Susan Souto, Mario 
Salles Neto, Paulo Sergio Oliveira, Ronaldo Villela. 
Hospital Procardiaco, Rio de Janeiro, Brazil 
31 0 MCE studies were performed in 277 PIS who had coronary angiography. 
67 pts were selected because have normal or < 75 % stenosed artery, and 
a technically satisfactory MCE. The right coronary artery was dominant 
(RDI in 60 pts and the left (LDI in 7 pts. Two ml of sonicated Pielograf 76% 
was injected into the left main and right coronary arteries during 
simultanaously performed 20 short-axis parasternal echocardiogram at 
the papillary muscles level. The left ventricular walls were divided in 6 
segments: anterior IV septum (AS). posterior IV septum (PS). anterior (A). 
antero-Iateral (AL), postero-Iateral (PL) and posterior (P) walls. An 
injection into the left main coronary artery opacified 100% (65/65) of the 
AS, A, and AL segments regardless of the coronary dominance, 97% (621 
64) of the PLsegment (RD= 55/60,92% and LO= 7n, 100%). 16% (91 
56) ofthe P segment (RO: 4/60, 7% and LO= 5n, 71 %) and 18% (101 
55) of the PS segment (RD = 5/60,8% and LD = 5n, 71 %). An injection 
in the right coronary artery opacified 0% (0/671 of the AS, A and AL 
segments regardless of the coronary dominance, 3% (2/67) of the PL 
segment (RD= 2/60, 3% and LD= on, 0%). 79% (53/671 of the P 
segment (RD= 51/60,85% and LD= 2n, 28%) and 76% (51/67) ofthe 
PS segment (RD= 49/60, 82% and LO= 2n, 28%1. The antero-Iateral 
papillary muscle was perfused by the left coronary in 98% of the time (581 
59) and the postero-medial papillary muscle by the right coronary in 70% 
(41159) depending on the dominance (RD= 40/52,77% and LD= In, 
14%1. There was no superposition of perfusion area between left and 
right coronaries. The pattern of appearance of the contrast in the 
myocardium was a simultaneous opacification of all involved segments, 
with no delay between segments. The contrast appeared in the epi, meso 
and endocardial layers of the LV wall simultaneous)y. In no occasion one 
segment remained without opacification after injection in both coronaries. 
Time from injection to contrast appearance, peak contrast intensity and 
time of contrast washout were visually extremely variable between cases 
and also between two different injections in the same artery of a single 
case. There was no complication. Thus, MCE is a safe procedure. The 
normal perfusion pattern is shown in a large number of humans. 
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930·57 
Tiae to Treataent with rt-PA. I.pact on Mortality and 
Morbidity 
Joel M Gore, Nisha C Chandra, William J French, William 
J Rogers and Alan J Tiefenbrunn For the National 
Registry of Myocardial Infarction (NRMI) Investigators, 
Worcester, MA. 
To determine the impact of time to treatment with 
thrombolytic therapy on in-hospital mortality among 
patients (P) with acute myocardial infarction (MI), data 
from the IIRMI were examined. 17,011 P were treated with 
rt-PA. Time to treatment was analyzed as <6 hours (H), 
6-12 Hand >12 H. 
Tiae to Treat.ent (rt-PA) 
<6H 6-12H >12H p. 
N 14304 1560 1147 
Males' 75 70 68 <.001 
Age (Mean) 59.5 60.1 60.6 NS 
Mortality \ (in-hospital) 5.0 6.4 7.9 <_001 
Major Bleeding 2.6 2.6 2.4 NS 
Stroke 0.6 0.6 0.6 NS 
IV Heparin 98.7 98.7 98.7 NS 
Recurrent MI 3 . 0 3.0 5. 1 NS 
Rupture/EMD 0.5 0.5 1.0 <.05 
.p compares <6H to >12H treatment groups 
Male mortality was. <6 H (Nz l0507) 4.0\, 6-12 H (N=1072) 
5.0\ and >12 H (N=775) 6.8\. Female mortality was. <6 
H (N=3518) 8.0\, 6-12 H (N=463) 9.7\ and >12 H (N=381) 
10.3\. For each time period mortality was significantly 
higher in females (p <.001). 
In conclusion, among P with MI, in-hospital mortality 
increases progressively as treatment is delayed. The 
incidence of rupture/EMD increases Significantly when 
treatment is initiated >12 H. Our findings etress the 
importance of early diagnosis and treatment of men and 
women with MI. 
930·58 
Cost Comparison of Primary Angioplaaty Veraua 
Thrombolytic Therapy for Acute Myocardial Infarction 
Todd Eckleberg, Ronald E. Vlietstra, Alan S. Brenner, 
Cindy L. Grines, William W. O'Neill, Kevin F. Browne, 
Watson Clinic, Lakeland, FL 
Concern about the potential increased cost of primary 
angioplasty (PTCA) in acute myocardial infarction (AMI) 
has limited the application of this effective 
technique. Patient costs were compared for PTCA and 
thrombolytic therapy using tissue plasminogen activator 
(tPA) in patients who were enrolled in the Primary 
Angioplasty in Myocardial Infarction (PAMI) study at 
one site. Fifty-three patients were randomized over an 
18 month period and all received their assigned 
therapy. Of the 26 patients who were randomized to 
tPA, 10 had subsequent PTCA, 3 had coronary artery 
bypass surgery (CABG) , and 2 died. Of the 27 patients 
who were randomized to PTCA, 2 received intracoronary 
urokinase, 2 had CABG and 1 died. Bach patient's 
complete hospitalization and physician bills for the 
AMI admission were collected and divided into 12 
different charge categories. 
Mean t SO Chargee ($) for PTCA and tPA Patients 
Categories PICA tpA 
Cath lab Physician 3211 ± 1591 1548 ± 1557· 
Cath lab Hospital 8729 ± 3711 4033 ± 4433· 
Lytic Orugs 78 ± 283 5386 ± 1260· 
Other Orugs 2033 ± 1377 1837 ± 1238 
CABG 490 ± 1768 1148 ± 3197 
Miscellaneous 4352 ± 1252 4153 ± 1473 
Room/Telemetry 803 ± 593 1090 ± 1026 
Intensive Care Unit 3643 ± 1648 3499 ± 1417 
Lab/Films 2203 ± 1060 2240 ± 1016 
Total Hospital 22330 ± 7388 23388 ± 9373 
Total Physician 5070 ± 2420 4329 ± 2954 
Total Charges 27400 ± 9204 27716 ± 12095 
• P < 0.01 for tPA vs PTCA 
Conclusions: Primary PTCA or tPA therapy for patients 





A Thrombolytic Predictive Instrument for Emergency AMI Treatment 
Harry P. Selker, John L. Griffith, Joni R. Besbansky, Cbristopber H. Schmid, Robert 
M Califf, Ralph B. D' Agostino, Michael M Laks, Kerry L. Lee, Charles Maynard, 
Galen S. Wagner, W. Douglas Weaver, New England Medical Ceoterrrufts Univ, 
Boston, MA. Duke Univ, Durham, NC, Univ ofW A, Seattle, UCLA·Harbor Medical 
Center, Los Angeles 
Benefit of Ihrombolytic dlerapy (TI) fer AMI depends 011 llIPidly treating 
appropriate patients and avoiding those at high risk fir complications. We developed 
a Thrombolytic Predictive Instrument (1P1) to facililate this in EMS and ED settings. 
The TPl's component predictive multivariate regressions were developed using data 
on 5,033 subjects from Western Washington Streptokinase, MI Triage and 
Intervention (MlTI), Thrombolysis and Angioplasry in MI (T AMI), and AIHD 
Predictive Instrument Trials, and die Duke CCU Databank, including lead-by-lead 
ECG data and detailed data 011 stroke and cardiac arrest patients. All receiver•
operating characteristic (ROC) curve areas were above 0.8 and matches of predicted 
and observed outcomes for important patient groups were excellenL 
The TP! is printed on !he ECG to aid clinicians' real-time Tf use. Upon 
presentation, die TPl's required variables are entered into die cardiograph (time from 
chest pain onset, age, weight, lITN and diabetes histOry) and acquired automatically 
(rate, QRS, ST, and T measures), generating predictions of Tf impact I) 3O-day 
m~ity if given Tf vs if not; 2) I-year mortality if given Tf vs if not; 3) cardiac 
arrest if given Tf vs if not; 4) Tf-relatcd major bleed; and 5) hemorrhagic stroke. 
The TP! should optimize Tf outcomes by identifying patients likely to benefit and 
unlikely to suffer seriotts complications, and by facilitating early Tf administration. 
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930-60 
Consequences 01 TIMI Grade 2 n 3 Flow at !III Minutes Following 
Thrombolysis 
C. Michael Gibeoo, Christopher P. CaoDoa, Robert N. Pian&, Jeftiey A. Bre&ll, 
Stacy F. Davis, Kathleen A. Maher, Margaret FJatley, Vicki Davis, Daniel J. 
Diver, Donald S. Baim for the TIM! 4 Study Group, Brigham &< WOIllOll'S IDd 
Beth Israel Hospitals, Harvwd Medical School, Boston MA. 
While TIM! flow pades 2 ODd 3 at 90 minutes both indicate patency of the infarct 
related artery, the clinical significance ODd lDaiOgraphiC oulcome of TIM! 2 flow 
(partial perfusioo), a relatively frequeut OCCIIn'eIIce following thrombolytic 
therapy, is DOt well defined. To __ whether arteri ... with TIM! grade 2 flow 
at 90 minutes following thrombolysis are more likely to noocclude IbID arteries 
with TIM! 3 flow grade, paired lDaiOgrams were IDIIlyzed in • blinded fashion 
from die 154 of 210 (73%) patieots wi!h acute M! eorolled iD!he TIM! 4 trial 
who achieved TIM! 2 or 3 flow at 90 minutes. Patieots received eilher APSAC, 
froot 10lded t-PA, or APSAC + tPA iD additioo to aspirin ODd full dose IV 
beparin 
No. Reocclusioo TIM! grade 3 flow 
PIs 18-36 hrs at 18-36 hrs 
TIMI 2 Flow 90 MiD. 60 9 (15%)" 21 (35%)* 
TIM! 3 Flow 90 MiD. 98 5 (5%) 78 (80%) 
·p<O.OI, *p<O.OO()J by Chi' compatulg the rate oflDgtographic nooccluslon or 
achievement of TIMI 3 flow at 18-36 hrs for TIM! 2 VI TIM! 3 flow at 90 min. 
Conclusions: I) Patients with TIM! grade 2 flow at 90 minutes were more likely 
to n:occlude at 18-36 hrs compared to patieots with TIM! grlde 3 flow. 2) Only 
ooe-third of patieots wi!h TIM! grade 2 flow at 90 minutes achieve TIM! Grade 
3 flow by 18-36 hours. 3) Early noocclusioo ODd failure to achieve full reperfusion 
may explain iD part wby patieots with TIM! grade 2 flow bave beeo shown to 
experience inadequate myocsrdial salvage, comparable to that of patieots with 
TIM! grade 0 or I flow. 4) TIM! grade 2 flow i. associated with unfavorsble 
IDgiogrsphic oulcomes which may be of clinical significance. Whether further 
early interveotion will improve late angiogrsphic and clinical outcomes needs 
additional study. 
930-61 
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Does an Allergic-Type Reaction to Streptokinase or Anlstreplase 
Affect Patency Status Following Thrombolysis for Acute 
Myocardial Infarction? 
Mi\luel A Gomez, Labros A Karagounis, Jeffrey L Anderson, 
University 01 Utah, LOS Hospital, Salt Lake City, Utah. 
Failed thrombolysis occurs in a signilicant number 01 patients who 
receive Streptokinase (SK) and anistreplase (APSAC) lor acute 
myocardial inlarction. Drug inhibition by neutralizing antibodies has 
been proposed as a possible mechanism. Obtaining pretreatment 
levels 01 antistreptokinase antibodies could lead to unacceptable 
delays. Identification 01 simple bedside clinical markers such as signs 
01 an allergic-type reaction (AR) which could identify patients at 
Increased risk lor lailure to reperfuse would be more ideal since they 
would not delay treatment, be less expensive and could identily 
patients who would warrant closer observation and consideration lor 
further intervention. To evaluate this hypothesis, we reviewed the 
TEAM-l, 2 and 3 databases lor all patients who received IV SK (1.5 
MUIh, n=182) or APSAC (30 Ul5min, n=472) and compared inlarct•
related artery (IRA) patency in patients who had an AR (n=59) with 
those who did not (NAR, n:595). Patients with ~ 1 signs 01 lever, 
chills, rash, pruritus or edema were classilied as AR. The 2 groups 
were similar for age, sex, inlarct site, IRA and time to therapy. 
Patency was determined at 90 min (TEAM-l,2) and at 24 h (TEAM-
2,3) and graded on a scale 01 0 to 3 according to TIMI criteria. 
Patency results: 
TlMI Gr: 0 2 3 
hr NAR%(n) 7(29) 3(10) 11 (42) 79(307) 
Thus, patency s a us tS no a verse y a ec e In pa lents who 
develop an AA following SK or APSAC administration lor myocardial 
inlarction. Patients who develop these AR are just as likely to 
achieve total reperfusion (TIMI 2+3) at 90 min (69% AR vs 67% 
NAR) and at 24 hr (93% AR vs 90% NAR).These observations may 
have implications lor the mechanisms and clinical signilicance of 
these AR: eg, that patients with AR do not necessarily require 
greater consideration lor 'rescue' Interventions. 
930-62 
Do Pati.ata with Inferior Infarction aenefit 
fro. Throabolyaia? Influenoe on the Evolution 
of Siguifioant Mitral aevurqitation. 
Jonathan Leor, Micha S. Feinberq, Zvi Vered, 
Hanoch Hod, Elieaer Kaplinaky, Ori Goldbourt, 
S.adar Truman. Michael Motro_ aeart Institute. 
Sheba Medical Center, Tel-Hashomer, Israel_ 
We proapectively studied 104 consecutive pts 
Hith firat inferior myocardial infarction 
(IMI). Thrombolysis Has administered to 55 pta 
[Gr I) 3.2±2.1 hours SO after onset of aymptoms 
Hhile 49 pta [Gr II) Here treated "conserva•
tively". EchO-Doppler color floH iaaqinq (CFI) 
Has done at 24 hra (T-1); 7-10 days (T-2); and 
at 28-30 daya (T-3)_ Siqnificant mitral requr•
gitation (SMR) Haa defined as aoderate or 
severe MR. There Has no aiqnificant difference 
in baseline clinical characteriatics betHeen 
qroup •. By aultivariate analyaia. independent 
correlates a.sociated Hith the occurrence of 
SMR Mere: female qender [odds ratio (OR) • 5.3, 
90t confidence interval (CI) • 1.8-15.5) heart 
failure (OR. 7.7; 90t CI • 2.2-26.9) and com•
plete AV block (OR. 5_8; 90t CI • 1.2-27_0)_ 
Compared Hith Or II. Gr I pta exhibited marked 
reduction in the incidence of SMR at 24 hra 
[16_3 vs 3.6t; OR • 0.12; 90t • CI 0.02-0_67); 
at 7-10 days [24_5 vs 10_9t; OR • 0_32; 90t 
C1 • 0.11-0.921 and at 28-30 daya [15_0 vs 7.4 
OR • 0_22; 90t CI • 0_13-1_601. Five pta in Gr 
II developed aevere MR Hhile none in Gr I 
.hoHed thia complication. 
Concluaiona: throabolytic therapy is associated 
with reduced incidence of SMR in the early poat 
infarction period_ Our results further support 
the use of thrombolysis in pts Hith IMI. 
JACC Vol. 21, No.2 
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National Registry of MyocarViallnfarc:tion INRMI): What Have We Leamed 
From the First 100.000 Patients? 
William J. Rogers. Nisha C. Chandra. Joel M. Gore for the NRMI 
Investigators. Univ. of Alabama Medical Center. Birmingham. Alabama. 
In order to assess current treatment practices and olJtcomes for acute 
myocardial infarction (AMII in the U.S .• 96.990 patients with validated 
AMI were enrolled in an ongoing national registry at 750 hospitals from 
9/90 to 8/92. Mean age was 64 yr. 64% were male. and mean time from 
onset of chest pain to hospital presentation was 5.2 hr (median 2.2 hrl. 
Pharmacologic therapy utilized included: rt-PA (26%1. other thrombolytics 
(13%). IV heparin (68%1. aspirin (67%1. IV NTG (58%). IV beta blockers 
(8.8%). oral beta blockers (30%1. and calcium channel blockers (40%1. 
Invasive procedures were commonly employed: coronary arteriography 
(58%). PTCA (22%1. CABG (12%1. Length of hospitalization averaged 
10.2 d (median 8.0 dl. and overall hospital mortalitY was 10.8%. 
There were 25.706 patients treated with rt-PA. Major reasons cited 
for not utilizing rt-PA were advanced age (21 %1. presentation> 6 hours 
after pain onset (31 %1. lack of ST elevation on baseline ECG (40%) and 
perceived contraindications (25%1. Of the patients treated with rt-PA. 
chest pain had been ongoing for a median of 1.5 hr prior to hospital 
presentation. and a median of 1.0 hours elapsed prior to initiating rt-PA. 
In 26% of patients. rt-PA was initiated in the CCU. rather than in the 
Emergency Department. "Front-loaded" dosing of rt-PA (100 mg over 90 
min) had been employed in 24% of all rt-PA recipients enrolled as of 8/92 
and in 32 % of those enrolled since 11/91. Adjunctive IV heparin therapy 
was used in 98% of rt-PA recipients. though. surprisingly, aspirin was 
administered in only 81 %. In a (non-randomized and non-adjusted I 
comparison of rt-PA recipients and all other registry patients. there was 
more frequent use of invasive procedures in the rt-PA group. more 
bleeding complications and peri-MI arrhythmias, but lower hospital 
mortalitY (5.5% versus 12.8%1-
The National Registry of Myocardial Infarction is a valuable resource 
for tracking the utilization of current therapies for AMI. discerning 
temporal trends. and documenting outcome. Furthermore, comparison of 
global registry data with that of individual centers can be useful in 
detecting and improving suboptimal management of AMI. 
930-64 
Acute Myocardial Infarction in Patients with Previous Coronary Bypass 
Surgery: Association of Complex Anatomy and Lower Reperfusion Rates 
with Poor Long-Term Survival 
Paul E. Nathan, Michael H. Sketch JR., Donald F. Fortin, Joseph A. Puma, Laura 
Gardner, Charlotte Nelson, Richard S. Stack, Robert M. catiff. 
Duke University Medical Center. Durliam. North Carolina 
In order to provide insight into treatment approaches fix- patients (pis) with acute 
myocardial infarction (AMI) after coronary artery bypass (CABG). we enrolled 
2061 pts into a protocol of inunediate angiography for AMI belWeen 3/86 and 
7f9(). The 86 patients with previous CABG more frequelllly had 3-vessel disease. 
bean failure (CHF). and were more often male than patients without previous 
CABG. The infarct related artery could not be identified in 18% of patients with 
previous CABG compared with 3% of pts without previous CABG. When 
thrombolytic therapy was given prior to angiography. reperfusion occurred in only 
47% of previous CABO pts compared with 65% of pts without previous CABG. 
Although early survival was equivalent. the tmadjusted late monaJity was higher 




Age (yrs) (med) S9 S9 
Male % 75 8S 
EF(med) 47 45 
CHF% 8 15 
3-VD% 21 53 
IRA Unlrnown. % 3 18 
Reperfused (%) 65 47 
Conclusion: Patients with AMI after CABG have more coronary disease, more 
CHF. more difficult infarct aneries to identify. and lower reperfusion rates. These 
factors appear to be associated with a worse long-term survival. 
ABSTRACTS 
930-65 
Cyclic Change. in Coronary Row: Underlying Dis ... e. R .. utt of Therapy. 
or Both? 
Mitchell W. Krucoff. Kathleen M. Trollinger, Rolf F. Veldkamp, Cynthia 
Green, Nancy M. Wilderman. Jill Ryan. Sharon T. Sawchak. James E. 
Pope. Robert M. Califf. Duke Medical Center. Durham. NC. 
349A 
Cyclic changes in infarct artery flow may reflect aither disequilibrium of 
endothelial homeostasis, the result of partially effective therapy, or both. 
If spontaneous patency changes prior to therapy uniquely identified 
patienta with ongoing cyclic flow. then endogenous influences would be 
implicated. We reviewed 10,080 hours of continuous 12-1ead ST 
segment monitoring from 280 pts. treated early in infarction with tPA, IV 
heparin, and aspirin, 60 of whom were monitored for > 15 min. prior to 
therapy. As we have previously correlated, ST recovery of > 50% was 
taken as evidence of reperfusion, and ST re-elevation of > 150uV .. 
evidence of re-occlusion. Change from ST recovery to re-elevation or vice 
versa was taken as a patency 'transition (TRANSI.' Spontaneous 
reperfusion was defined as L 1 TRANS prior to onset of tPA. Cyclic flow 
was defined as L4 TRANS over the period monitored (median 36 hrsl. 
Evidence of cyclic flow was seen in 102 of the 280 pta. (36%1, with a 
median of 6 TRANS (range 4-221 each. Of the 60 pta. monitored prior 
to tPA. 21 (35%1 had evidence of spontaneous reperfusion. Of these 
21, only 9 (43%1 had cyclic flow over the entire monitored period. Of 
the 39 pts. monitored but with no TRANS prior to tPA, 13 (33%) evolved 
cyclic flow following tPA. Thus, 35% of pta have evidence of 
spontaneous reperfusion prior to therapy. and 36% of pta. have evidence 
of cyclic flow changes following therapy. Despite aimilarities in 
incidence, the actual pts. in each population are different, suggesting that 
cyclic changes in coronary flow represent both the .pontaneous 
pathophysiology and a superimposed response to therapy. 
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931-76 
Acute Results end 2 Year Follovup After Inoue'Balloon 
Mitral Valvotomy in 550 Patients 
Ted Feldman. John D. Carroll. Howard C. Herrmann. 
Jeffrey M. Isner. Thomas M. Bashore. David Holmes. 
Gerald Dorros. Donald A. Rothbaum. Augusto Pichardo 
Larry S. Dean and the N. American Inoue Investigators. 
The University of Chicago • Chicago Illinois 
Inoue balloon mitral valvotomy (BMV) was performed 
in 550 petients. Mean age was 53± 14 yrs and 84% were 
female. Mitral valve area increased from 1.0+ 0.3 to 
1.8±0.6 cm2 (figure) (P<.001). BMV was succe;sful 
(area >1.5 cm2 or area increase >50%, no major 
complications) in 417/550 (76%). Insufficient increase 
in area occurred in 16%. and failure to cross the 
valve in 3%. Hospital death (n-4). hospital MVR 
(n-13), ~3+(n-27). or cardiac perforation requiring 
pericardiocentesis (n-4) occurred in 9.4%. 
PA LA Mean 
Mean Mean Gradient 
(mmHg) (mmHg) (mmHg) 
Pre BMV 33±13 24±8 l3±6 
Post BMV 29±12* l8±7* 6±3* 
*=p<0.001 vs Pre 
Mean NYHA class was 
2.9±0.7 pre BMV. and 1.4± 
0.6 at 1 and 2 yrs. Over 
80% of patients were 
improved by ~l NYHA class 
at 1 and 2 yrs. 
Conclusions: Balloon 





4. S±l. 3* 
....... 
and with an acceptable rate of complications using the 
Inoue catheter. Sustained hemodynamic and symptomatic 
improvement is seen in the majority after 2 yrs. 
350A ABSTRACTS 
931·77 
Factors Determining Late SuCCfSS After Mitral Balloon 
Valvuloplasty: A Multivariate Study 
Manuel Pan, Enrique Herrulndez, Miguel Romero, Francisco Melim, 
Djordje Pavlovic, Jos4! A. Cabrera, Elfas Romo, Alfonso Medina, Jos~ 
Suarez de Lezo. Reina Sofia Hospital, C6rdoba and Pino Hospital, Las 
Palmas, Spain. 
Mitral balloon valVUlotomy (MBY) has proven to be an effective 
method for the treattnent of patients with mitral steoosis. Although 
factors determining an optimal immediate result are well known, there 
is little information regarding factors influencing late success after the 
procedure. We analyzed 350 patients treated by MBV who were 
clinically followed between 3 months and 6 years. The mean age was 
46± 12 years. At least I echo-doppler study was obtained in 298 
patients, 28± 14 months after. Hemodynamic re-evaluations were 
performed in 65 patients after 23 ± 8 months. Late success was defined 
as the patient being in functional class I-II and free of major events 
(death, restenosis or valve surgery). Restenosis was defined as the loss 
of 50 % of initial gain in terms of valve area, confirmed always 
hemodynamically. At a mean follow-up time of 38± 15 months, 296 
patients (85 %) remain in functional class I-II without surgery or need for 
an increment in medical treatment. The 5-year Kaplan-Meyer survival 
rate was 94± 1 %, while restenosis, valve surgery and major event-free 
probability were 90±3%, 91 ±2% and 85±2% respectively. The 
multivariate study (Cox-regression model) identified as the only 
independent factors of late success the presence of sinus rhythm 
(p < 0.001; relative risle =4.26) and the absence of calcium at fluoroscopy 
(p<0.003; relative risle=3.06). 
Conclusions: The best results 5 years after MBV were observed 
in patients with non calcified valve and sinus rhythm (estimated major 
event-free probability=96%). On the contrary, the presence of atrial 
fibrillation and valve calcification before treattnent determined an event•
free probability of 60%. 
931-78 
Sinus Conversion Improved Exercise Capacity in Patients 
With Kitral Stenosis and Atrial Fibrillation Who 
Underwent Balloon Kitral Valvuloplasty. 
Jun Tarnai, Satoshi Yasuda, Takao· Yoshioka, Seiki Nagata, 
Hiroshi Takaki, Kunio Miyatake. 
National Cardiovascular Center, Suita, Osaka, JAPAN. 
Impact of sinus conversion (SC) on exercise capacity 
was investigated in consecutive 3Z patients with mitral 
stenosis and atrial fibrillation who underwent balloon 
mitral valvuloplasty (BMV). Peak oxygen uptake (PVOZ) 
was measured by symptom-limited exercise test with 
respiratory gas analysis. Mean mitral pressure gradient 
and LV stroke volume at rest were obtained by echo•
Doppler methods. Atrial filling fraction of mitral flow 
velocity profile after SC was calculated as an index of 
left atrial activity. These examinations were repeated 
before BMV, 4 days after BMV, 5 days after electrical 
cardioversion and 3-5 months after BMV. 
RESULTS: Mitral v~lve area increased from l.l±O.3 (mean± 
SD) to 1.9±0.4cm. Although mitral pressure gradient 
significantly decreased days after BMV from 8.3±3.Z to 
4.6±l.ZmmHg (P<O.OI), PVOZ did not improve (19.5±4.4 to 
20.1+4. Oml/min/kg). SC was obtained in 17 patients and 
it i;creased both LV stroke volume (57+22 to 75+28ml, P< 
0.01) and PVOZ (21.4±4.1 to 23.4±5.Oml/min/kg,-P<0.01). The increase 1n PV02 was correlated with the amplitude 
of atrial filling fraction in mitral flow velocity 
profile after SC (R=0.62, P<O.Ol). Sinus rhythm and 
improved PVOZ were preserved 3-5 months after SC in 15 
of these patients (PV02:Z3.7±4.7ml/min/kg). In patients 
with persistent atrial fibrillation, PVOZ did not 
improve even months after BMV (18.9±4.2ml/min/kg). 
CONCLUSION: SC by electrical cardioversion is clinically 
valuable therapy in patients with mitral stenosis and 
atrial fibrillation who underwent BMV. 
931·79 
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The risles of embolism during percutaneous mitral 
commissurotomy. 
A.Vahanian. G.Ghanem. P.L Michel, B.Cormier. J.Elias. 
O.Nallet, E.Dadez. J.Acar : Tenon Hospital. Paris - F. 
The risles of embolism (E) after percutaneous mitral 
commissurotomy (PMC) were assessed in 920 patients (pts). 
Their mean age was 43±.15 years (13-86). 277 (30%) were in 
atrial fibrillation (AF). 218 (24%) had calcified valves. and 
98 (11%) had had E more than two months before PMC. No 
left atrial thrombosis was shown by echocardiography 
prior to PMC. Pts with AF or prior E received at least 2 
months of full oral anticoagulation before PMC. A two 
balloon technique (2B) was used in 600 pts and Inoue's 
technique (I) in 320. All pts received 4000 IV IV Heparin 
during PMC. and then sub-cutaneous Heparin for 24 hours. 
Thirty pts (3.3% of the total series) suffered E during PMC. 
E was coronary (C) in location in 22 pIS (72%) (right C : 21. 
left main C : I). cerebral in 2. and both cerebral and C in 6. 
Twenty-seven E (90%) lasted only a few minutes. They 
were probably attributable to gas because they occurred on 
balloon rupture with 2B (n=21) or immediately after balloon 
deflation with I (n=6). with transient consequences. and 
location in the right C. 
They were lasting clinical effects in only 3 pts (.4% of the 
total series) : 2 pts had mild neurological deficits (1 
cerebral. I peripheral). and I pt. who had E in the left main 
C. had myocardial infarction despite PTCA and thrombolytic 
treatment. and secondarely died. 
In conclusion : I) E is infrequent during PMC providing 
steps are tuen to prevent its occurrence ; 2) it is usually 
without lasting clinical effects ; 3) it is often due to gas on 
balloon rupture with 2B. 
931·80 
Restenosis after successful percutaneous mitral 
commissurotomy. _ 
A.Vahanian. B.lung, J.Elias. B.Cormier, G.Ghanem. 
P.L Michel. J.Acar : Tenon Hospital. Paris - France. 
The characteristics of restenosis (R) were assessed in 405 
patients (pts) who had undergone successful percutaneous 
mitral commissurotomy (PMC)(final valve area > 1.5 cm2 
without regurgitation > 2/4). 
Their mean age was 43±.13 years (12-83). Ninety-six (24 %) 
had pliable valves without severe subvalvular disease (Grl). 
214 (53%) had extensive subvalvular disease (Grll) , and 95 
(23%) had calcified valves (Grill). After PMC. valve area 
(VA) increased from 1.l±..2 to 2±..3 cm2 (p<.OOI) as assessed by 
2D Echo. 
Follow-up (FU) echocardiographic examination was 
performed 21±.13 months (5-60) after PMC. R was defined as 
a loss greater than 50% of the initial gain and a FU V A < 1.5 
cm2. 
R occurred in 38 pIS on average 25±.14 months (6-52) after 
PMC. The actuarial rate of R was 18% at 42 months. The 
occurrence of R was related to valve anatomy : 3% in Grl. 
20% in GrII. 23% in GrllI (p<.02). 
Eighteen pts with R had recurrent symptoms (S). 
representing an actuarial rate of 13% at 42 months. They 
underwent furtber treatment 2R±.J5 months after PMC 
(6-54) : re-PMC in 5 pts with favourable anatomy (final VA 
1.9±..2 cm2). valve replacement in II. surgical commissuro•
tomy in 2. 
We conclude that after successful PMC I) the occurrence 
of R. and particularly R with S, is low. 2) Valve anatomy is a 
predictor of R. 3) re-PMC is a viable procedure in selected 
pts when R gives rise to S. 
JACC Vol. 21, No.2 
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931·81 
Percutaneous Mitral Valvoto.y (PMV) During Pregnancy 
Using Inoue Balloon Technique 
Jai Patel, Abdul Mitha, Farouk Hassen, Nalin Patel, 
Rajendran Naidu, Sivabakiyam Chetty, Reventheran Pillay. 
University of Natal/Wentworth Hospital, Durban,S Africa. 
Reports of successful PMV during pregnancy have been 
published. However with the need for fluoroscopy, 
potential harm to the fetus cannot be entirely ruled out. 
The need to perform the procedure with short fluoroscopy 
duration exists. we performed PMV in 24 symptomatic 
pregnant patients (~VHA class III or IV) with tight 
pliable mitral stenosis (MS). Mean gestation age was 
30 weeks (range 26-35 weeks). Two pts were in pulmonary 
edema and the procedure was performed as an emergency. 
All pts had a trial of diuretic therapy and 21 were also 
on atenolol (100 mg per day). The results as follows: 
The mean diastolic mitral gradient decreased from 18~6 
to 6,O~3 mmHg (p<O,OOl) and the mitral valve area , 
(pressure t time) increased from O,8~O,3 to l,7~O,4 cm 
(p<O,OOl). Immediate symptomatlc improvement occurred 
in all pts. Fluoroscopy time (FT): Full hemodynamic 
measurements before and after PMV was performed in first 
2 pts only. For next 17 pts, after having performed LV 
angiography (30· RAO - to help determine level of atrial 
puncture) transseptal was performed followed by valvoto•
my. The average FT for these 19 pts was 9,2~3,3 min. 
For the last 5 pts, no angiography was performed. 
The average fluoroscopy time in these 5 pts was 3,2 min 
(range 2,5 - 5,4 min). Except for 1 pt who developed 
3+ MR, there were no other serious complications. 
All pts delivered healthy infants at term. 
Thus PMV can be performed with safety in pregnancy with 
the Inoue balloon. Furthermore the risk to the fetus can 
be minimized as this technique allows the procedure to be 
completed with short FT. 
931·82 
Right Ventricular Function Before and After Balloon Mitral 
Valvuloplasty. . . 
Wolfram Burger, Gisbert Kober, Martin Kaltenbach, Rainer 
Schrader. Department of Cardiology, University Hospital, 
Frankfurt, Germany. 
To evaluate the effect of balloon mitral valvuloplasty on right 
ventricular function, we investigated 11 consecutive patients 
(age 22 to 64 years) with rheumatic mitral stenosis. All patients 
had sinus rhy1hm and were in functional class II or III 
according to the New York Heart Association. Hemodynamics 
and right ventricular (RV) volumes were determined one day 
before and after valvuloplasty (Inoue technique) .at rest and 
during supine bicycle exercise (50 Watt) with a new 
thermodilution Swan·Ganz catheter. 
Mitral valve area (Doppler echocardiography) increased from 
1.1 ±0.2 to 2.0±0.4 CfTl2 (p<0.005). Mean pulmonary artery 
pressure (PAPm) was reduced at rest from 37±16 to 22±8 
mmHg (p<O.OO3) and during exercise from 67±17 to 52±15 
mmHg (p<0.005). Cardiac index increased both at rest (from 
3.3±0.6 to 3.7±0.7 Umin/m2, p<0.05) and during exercise 
(4.6±0.8 to 6.2±0.9 Umin/!ll2, p<0.(03). While RV end•
diastolic volume remained unchanged, stroke volume index 
increased at rest from 40±9 to 48±8 mllm2 and during 
exercise from 35±8 to 51 ±6 mllm2 (both p<0.(03). RV 
ejection fraction (EF) increased at rest from 36±11 to 46±4 % 
(p<0.02) and during e~ercise fr~m 28±9 to ~1:t;9 % 
(p<O.OO3). Linear regression analysIs revealed a Significant 
correlation between PAPm and RVEF (p = 0.003, R=-0.601) 
and between stroke volume index and RVEF (p=0.OO1, 
R=O.655). 
Conclusions: Mitral valvuloplasty causes an immediate 
improvement of AV function. This oc:curs predomina~tly due 
to an increase of stroke volume and IS probably mediated by 
a reduction in AV afterload. 
ABSTRACTS 351A 
931·83 
Results ot Percutaneous Balloon Mitral Valvoto.y in 
Patients with Left Atrial Spontaneous Echo Contrast 
Wing-Hing Chow, Tsun-Cheung Chow, Alex Yip, ling-Loong 
Cheung, John Li, Tak-Hing 15e. Dept of Medicine, 
Grantham Hospital, Hong long 
To determine whether the presence of left atrial 
spontaneous echo contrast (LASBC) influences outcomes of 
percutaneous balloon lIitral valvotollY (PBHV), the 
results of this technique were co.pared in 52 
consecutive patients (pts) with (gp I) and 67 without 
(gp II) such ecbocardiograpbic finding. Pts in gp I were 
older (45+11 vs 40+11 yrs, p<0.05), proportionally IIOre 
lIale (37 vs 19\, p<O.OS), lIore sYilptOllatic (NYUA>II: 65 
vs 6\, p<O.OOIl, had history of ellbolisll (27 vs 0\, 
p<O.OOIl and atrial fibrillation (75 vs 6\, p<O.OOll 
IIOre frequently. The left atriu. (5.7!0.9 vs 4.S!0.6 cm, 
p<O.OOll was larger and echocardiograpbic score (9.0!1.8 
vs 6.2+1. 2, p<O. OOll also higher in gp I pts. Before 
PBHV, iii tral valve area (HYA) , IIi tral gradient, left 
atrial pressure, cardiac output (CO) were sillilar in 
both gps althougb lIean pulmonary artery pressure (mPAP) 
was slightly higher (36.8~14.3 vs 31.6~10.1 11m 8g, 
p<O.OS) in gp I pts. After PBHV, final HVA (1.81!0.38 vs 
2.21+0.55 c1l2, p<O.OOll, absolute increase in HVA 
(0.92+0.32 vs 1.14+0.47 cm2, p<O.OOl), CO (3.64~0.9S vs 
4.17+0.89 Llmin, p<O.OOS) were lower and IIPAP (26.2!11.3 
vs ii. 8+7.1 _Hg, p<O. 05) was higher in gp I pts. PBHV 
success - (HVA increase>50\ without cOllplications) was 
similar in both gps. An-optimal result (HVA~1.5 cm2) was 
found less frequently (85 vs 100\, p<O.OOI) in gp I pts. 
Embolic complications during the procedure were not 
encountered in both gps. In conclusion, pts with lIitral 
stenosis and LASBC .ay successfully undergo PBHV without 
cOIiPlications notably embolism, but they have more 
severe IIi tral valve disease and experience suboptimal 
results more often than pts without LASEC. 
931·84 
Effect of Prazosin Therapy on the Outcome of Acute 
Rheumatic Mitral Valvulitis 
Sherif S. Tawfik. Abdelgawad Sheisha, Magdi Ahulkheir, Samiha Mohareb, 
Mohamed Hafez. Salah Hawas 
The contribution of systemic pressure 1raUIIIa 10 the pathogenesis of permanent 
valvular damage following acute Jbeumatic carditis was investigated Ihrough 
a double-hlinded, COIIuolled therapeutic trial of the afterload reducing agent, 
prazosin. Forty-six patients. ages 4-14 years. with first 8IIaCI< of acute 
meumatic mitral valvulitis were randomized 10 receive conventional rbeumatic 
carditis tbetapy or conventional tberapy plus prazosin. Echo-DoppIcr-derived 
mitral regurgitant fractioo (RF) was obtained before initialing and 6 months 
after oompletioo of tbetapy. The mitral regurgitant murmur disappeared in 
65% of patients in the prazosin group and those with residual mitral 
insufficiency bad a mean RF of 8.6 ± 12% in comparison with 22% and 30 ± 






Conclusion: the addition of prazosin 10 conventional thernpy of acute rbeumatic 
carditis signiflC8Ddy Rduced the illddence and severity of residual mitral 
insufficiency. This supports OW' hypothesis that systemic pressure exerts a 




Reduction in Mitral Valve Regurgitant Area Secondary to Left 
Ventricular Remodeling: A Mechanism for Improvement of 
Mitral Regurgitation Mediated by Vasodilator Therapy 
Anil Mehra, Avraham Sbotan, David Kawanishi, Enrique 
Ostrzega, Janet Vasquez-Johnson, Uri Elkayam. USC School 
of Medicine, Los Angeles, CA 
A reduction of mitral valve regurgitant area (MRA) due to 
change in left ventricular volume has been shown in animal 
experimentation. We evaluated the feasibility to decrease MRA 
and thus to improve mitral regurgitation (MR) by reduction of 
left ventricular volume with nitroglycerin (NTG) in 12 pts with 
chronic, non-rheumatic MR who were in normal sinus rhythm. 
NTG was titrated to reduce pulmonary artery wedge pressure 
~30%. Left ventricular end-diastolic volume (LVEDV), V•
wave, mitral regurgitant volume (MRV), mitral regurgitant 
fraction (MRF) and MRA in these pts at baseline (BL) and 
during NTG were as follows: 
LVEDV V-wave MRV MRF MRA 
(rnl) (rnmHg) (ml) (%) (cm2) 
BL 235± 104 43±20 80±53 33± 16 0.71±035 
NTG 199±82 16±12 55±55 25±20 050±0.40 
P <0.01 <0.001 <0.01 <0.05 <0.05 
CONCLUSION: Remodeling of the left ventricle through 
reduction of its end-diastolic volume by direct venodilation with 
NTG results in a significant decrease in mitral valve regurgitant 
area in pts with chronic MR. This mechanism contributes to a 
substantial improvement in mitral valve regurgitation. 
931-86 
Effects olDobatamtne IDfusloD CII1 Mitral RefaIaltatlaa 
Makoto Sonoda. Katsu Takenaka. Jun-Ichl Suzukl. Wataru 
Amano. Tsutomu Igarashi. Fumiyosht Watanabe. Toshiro 
Aold. Yuepeng Wang. 
Un1vers1ty of Tokyo. Tokyo. Japan 
Color-coded Doppler S1gnal area of mUral regurgitation 
has been reported to be proportional to mitral regurgitant flow 
multiplled by regurgitant jet veloc1ty. To evaluate the effects of 
dobutamlne infuslon On mitral regurgitatiOn. 18 patients with 
mUral regurgttation were studied by phonocardiography. 
echocardlography. and Doppler ultrasound before and durtng 
dobutamlne infusion (0.02-0.03mg/ kg/m1O). Mitral regurgi•
tation was due to mitral valve prolapse 10 8 patients. rheumatic 
change 10 6 and dllated cardiomyopathy 10 4. Durtng 
dobutamlne infUSion. heart rate (77 to 1OIbpm). systol1c blood 
pressure (117 to 14ImmHg). peak mitral regurgitant jet velocity 
(4.4 to 5.lm/sec). 10tenslty of mitral regurgitant murmur (to 
184% of that before dobutamlne infusion) lnCreased (p<O.05).left 
ventricular systollc dlmenslon (36 to 33mm). color-Doppler 
mitral regurgitant Signal area (618 to 364 mm2) and color•
Doppler mitral regurgitant Signal area divided by mitral 
regurgitant jet velOCity (an 10dex of mitral regurgitant flow per 
beat) (176 to 9Omm2 /m/sec) decreased (p<0.05). and left 
ventricular dlastollc dlmenslon (54 to 53mm) and total (forward 
and backward) left ventricular stroke volume (103 to 102 ml) 
showed no change (p>O.05). 
Conclusions 1) Dobutamlne decreased mitral regurgitant 
flow per beat regardless of the etiology the regurgitation. which 
was probably due to the decrease 10 systol1c left ventrtcular sJze 
and mitral anular diameter. 2) Although total left ventricular 
stroke volume was unchanged. dobutamlne effectively 10creased 
forward left ventricular stroke volume by decreaSing backward 
regurgitation. 3) Mitral regurgitant murmur became louder 
despite the decrease 10 mitral regurgitation. indicating the 
uselessness of phonocardography In the grading of the severity 
of mitral regurgitation. 
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932-87 
Impact of the Implantable Defibrillator in Hypertrophic 
Cardiomyopathy Patients at High Risk for Sudden Death 
Dorothy Tripodi, Dorothea McAreavey, Neal D. Epstein, and 
Lameh Fananapazir. NIH, Bethesda, Maryland .. 
The incidence of sudden cardiac death (SCD) is 3 to 5 fold 
higher (6-10% annual mortality) in the following subgroups of pts 
with hypertrophic cardiomyopathy (HCM): 1) pts with a history 
of cardiac arrest or syncope, 2) ventricular lachycardia (VT) on 
Holter, 3) sustained VT induced at electrophysiologic study 
(EPS), 4) a family history (FH) of premature SCD in 22 first 
degree relatives, and 5) young age at presentation. To study the 
ability of the implantable defibrillator (AICD) to improve 
prognosis in HCM pts at high risk for SCD, AICD was implanted 
in 31 pts (20 males; mean age, 33±19 yrs, range 10-68 yrs). 
Clinical presentation and prevalence of VT on Holter, VT induced 
at EPS, myocardial ischemia (MI) detected by exercise thallium 
scintigraphy, and LV outflow obstruction (OT Obs) were: 
PreseDla.timl N. HQlter VT laduced YI .Ml 0I..Qba 
CA 21 7 17 2 2 
Syncope 3 2 3 0 1 
Presyncope 4 2 3 0 2 
EH !2fSCO J 2 J !l 1 
Total 31 13(41%) 26 (84%) 2 (6%) 6 (19%) 
During a mean follow-up of 33±.17 months (range, 88 months), 
10 pts received appropriate AICD shocks (discharges following 
impaired consciousness). Mean time interval to first shock was 
10±17 months. Although the 2-yr cardiac event-rate was very 
high (36%), there were no deaths during follow up. We conclude 
that AICD is highly effective in preventing SCD in high risk 
HCM pts identified by non-invasive and invasive risk assessment. 
932-88 
Evaluation of Mitral Regurgitation in Hypertrophic 
Cardiomyopathy A Study With Transesophageal 
Echocardiography 
Nobuo Fukuda. Takashi Oki. Arata fuchi. 
Tomotsugu Tabata. Koichi Kiyoshige. Takashi 
Fujimoto. Masato Tanimoto. Kazuyo Manabe. 
Susumu Ito. 
Tokushima University. Tokushima. Japan 
To clarify the mechanisms and timing of mitral 
regurgitation (MR) in hypertrophic cardiomyopathy 
(HCM), transthoracic (rTE) and transesophageal (TEE) 
echocardiography were performed in 40 patients with 
HCM. including 25 with asymmetric septal hypertrophy 
(ASH) and 15 with apical hypertrophy (APH). and 20 
normal subjects. Color Doppler signal of MR was 
detected in 39 of 40 (9&%) of HCM by TEE, but in 23 of 
40 (58%) by TTE. MR in HCM was generated by following 
mechanisms: (1) anterior mitral valve prolapse (MYP), 
which was observed in 7 of 25 with ASH and 2 of 15 
with APH. (2) posterior MYP. which was in 6 of 15 with 
APH and 3 of 25 with ASH, (3) abnormal coaptation due 
to systolic anterior motion (SAM) of mitral complex. 
which was in 13 of 25 with ASH, (4) abnormal coapta•
tion due to thickening of anterior MY, which was in 7 
of 10 with ASH having significant pressure gradient in 
left ventricular outflow tract, (5) mitral annulus 
calcification, which was in 2 of 25 With ASH. 
Concerning timing of MR by TEE. pansystolic MR was 
seen in 24 of 40 (60%) with HCM, and early systolic MR 
was in high incidences (67%) in patients with APH. SAM 
and thickening of MY played important roles in mid•
systolic and early systolic MR. respectively. 
Conclusion : Mechanisms and timing of MR in HCM were 
determined by localization of left ventricular 
hypertrophy. spatial imbalance of mitral complex and 
thickening of mitral valve. 
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932·89 
Venturi Force. Fall to Produce Systolic Anterior 
Motion of the Mitral Valve In Upper Septal 
Hypertrophy 
Ehud Schwammenthal, Cedric Vuille, Arthur E. Weyman. 
Robert A. Levine. Massachusetts General Hospital, Boston. 
MA 
Isolated upper septal hypertrophy (US H), primary or 
secondary to left ventricular pressure overload, frequently 
results in elevated outflow tract velocities. Thus, US H 
constitutes a unique natural model to address. the question 
whether Venturi forces alone created by high velocities can 
produce systolic anterior motion of the mitral valve (SAM) as 
commonly postulated in hypertrophic cardiomyopathy. 
Results: Out of 45 consecutively examined patients with 
USH by echocardiographic criteria, 20 patients had elevated 
outflow tract velocities (exceeding the upper normal value of 
1.2 m/s) as assessed by Doppler echocardiography. The 
velocities ranged from 1.30 to 4.80 m/s (1.94 :I: 0.97 m/s) 
corresponding to a potential anteriorly directed lift pressure of 
7 to 92 mm Hg (19 :t 22 mm Hg). Despite the substantially 
elevated outflow tract velocities no classic obstructive SAM 
was observed. Three patients had nonobstructive trivial distal 
leaflet and/or chordal SAM. All three had· mitral leaflet 
elongation (anterior leaflet: 3.1 cm, 3.3 cm, 2.9 cm; posterior 
leaflet: 2.2 cm, 2.0 cm, 1.7 cm) beyond the previously reported 
upper normal limits, providing abnormal mitral leaflet mobility. 
ConclUSion: Venturi forces (elevated outflow tract velocities 
up to 4.8 m/s) alone do not produce SAM as long as normal 
mitral leaflet length, normal position of the papillary muscles 
and thus appropriate tethering of the mitral valve are 
preserved. 
932·90 
Mechanism of Mitral Regurgitation in Hypertrophic 
Cardiomyopathy: Competition Between the Systolic Anterior 
Motion of the Posterior Leaflet and Its Restraint 
Ehud Schwammenthal, Shengqiu He, Joanne Hopmeyer, Ajit P. 
Yoganathan, Arthur E. Weyman, Robert A. Levine. Mass. General 
Hospital, Boston, MA; Georgia Institute cj Technology, Allanta. GA 
Systolic anterior motion of the mitral valve (SAM) causes subaortic 
obsIrudlon and mitral regurgitation (MR). The degree of SAM and MA 
are theretore dosely related in the individual case. Clinically, however, 
great i:t'~indiVidyal differences in the degree of MA have been 
observ or comparable degrees of SAM. These differences may 
relate to observed variations in leaftet length that could impair the 
ability of the posterior leaftet to follow the anteriorly·moving anterior 
leaflet (partiapate in SAM) and coapt effectively with it. We therefore 
studied the effect of SAM on MA is yitro for three different mitral valve 
geOmetrieli prOduced by surgica manipulation of exasea porcine 
valves. SAM was varied by changing the degree of anterior and 
superior displacement of the papillary muscles at a steady now rate of 
lSlhnin. Results: Elongating both mitralleaftets (A) caused MR to 
inaease from 0.21 Ihnin with mild SAM to 0.30 lImin with severe SAM. 
Elongating the anterior leaflet alone (8) caused MR to increase from 
0.10 to 1.1 Ihnln at the same driving pressures. Elongating the anterior 
leaflet plus chordal shortening to further limit posterior leaflet excursiOn 
(C) caused substantial MA (2.3 IImin) even with mild SAM which 
inaeased to 9.0 lImin with severe SAM. 
~L~L%  LV, 
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932·91 
Chronotropic Incompetence In Hypertrophic Cardiomyopathy 
and Its Associadon With impaired Exercise Capacity 
Alistair K B Slade. Philip J Keeling. Carl F Shakespeare. Peter J 
Counihan. William J McKenna. St George's Hospital Medical 
School. London, UK. 
l1te major determinants of exercise intolerance in hypertrophic 
cardiomyopathy (HCM) remain uncenain. Recent reports on the 
association of chronotropic incompetence (CI) and exercise 
capacity in sinoatrial disease and systolic heart failure have 
provoked interest in CI. To determine the prevalence of CI in HCM 
and its relationship to exercise capacity we analysed the 
chronotropic response at maximal and during submaximal exercise 
in 131 consecutive patients with HCM. All patients underwent 
simultaneous respiratory gas analysis and all achieved anaerobic 
threshold [mean respiratory quotient l.07]. All patients were in 
sinus rhythm and no patient was taking beta blockers, calcium 
antagonists or digoxin. No patient had evidence of exercise induced 
ischaemia 
CI was observed in 49/131 (37%) patients. during exercise. CI at 
submaximal exercise strongly correlated with CI at maximal 
exercise [R=O.82. p=O.OOOIJ. CI was associated with impaired 
exercise capacity [6.6 vs 8.6 peak Mets (p=O.OOOl). 63% vs 75% 
percentage predicted maximal ~ consumption (p=O.002)]. Patients 
with CI had reduced maximum left ventricular hypertrophy 
[22.2mm vs 25.7mm (p=O.025)]. Other echocardiographic variables 
(left atrial .size. fractional shortening. end·diastolic and end·systolic 
dimensions and presence of total systolic anterior motion of the 
mitral valve) showed no significant difference between the two 
groups. 
Conclusion: CI is common in patients with HCM and its presence 
is associated with significant impairment of exercise capacity. 
Further studies are warranted to determine the mechanisms of CI in 
HCM and whether correction of chronotropic response with rate•
adaptive pacing might improve exercise tolerance. 
932·110 
Autonomic Nervous Activity In Patients with Dilated and 
Hypertrophic Cardiomyopathy 
Kohsuke Ajiki. Yuji Murakawa. Atsuko Miwa-Yanagisawa, 
Masahiro Usui, Takeshi Yamashita, Naokl Qikawa, Hiroshi Inoue. 
The 2nd Department of Internal Medicine, Tokyo University 
Hospital, Tokyo, Japan 
To characterize changes in autonomic nervous activity of patients 
with cardiomyopathy during daily life, heart rate variability was 
determined with fast Fourier transform in 14 patients with. dilated 
cardiomyopathy (DCM) without overt heart failure, 15 with 
hypertrophic cardiomyopathy (HCM), and 16 age- and sex•
matched control subjects. Low frequency power (LF; .00-.lSHz) 
and high frequency power (HF; .lS·.S0Hz) during night and 
daytime were calculated and the lit component was removed by 
coarse-gralning spectral analysis. Log( H F}, an index of 
parasympathetic activity, was significantly lower, and 
Iog(LF/HF), an index of sympathetic activity, was significantly 
higher in DCM. Log(HF) had a strong positive correlation 
(night: r •. 64, p<.OS; daytime: r •. 60, p<.OS) and Iog(LF/HF} 
had an Inverse correlation (night: r.-.60, p<.OS; daytime: r. 
-.70, p<.Ol) with ejection fraction in DCM. In HCM, lower 
Iog(HF) and higher log(LF/HF} were recognized only during the 
night, and these changes were independent of the degree of 
myocardial hypertrophy determined with echocardiogram. 
[Night) Control DCM HCM 
Iog(HF} 2.12±,0.60 1.BB±,0.71· 1.7B±,O.S4· 






1.12±.0.S7· I.S3±.0 .52 
0.93±.0.39· 0.B1±,0.27 
• p<O.OS vs. control 
In conclusion, in DCM patients, parasympathetic activity decreases 
and sympathetic activity increases along with impairment 





Thalllum·201 Myocardial Scintigraphic Changes during 
50· month Follow.up Period in P_atients with 
Hypertrophic Cardiomyopathy 
Marcomi Hamada, Makoto Suzuki, Masayuki Takezaki, Hiroshi 
Matsuoka, Yuji Shigematsu, Takumi Sumimoto, Kunio Hiwada. 
Ehime University School of Medicine, Ehime, Japan. 
To estimate the change of myocardial characteristics during the long•
term follow-up in patients with hypertrophic cardiomyopathy 
(HCM), thallium-201 (TI) myocardial scintigraphy was performed 
every one year in 26 HCM (mean age 53:t:14 yrs). The TI tomograms 
were quantified with use of computerized two-dimensional polar 
(bull's eye) maps. The pixels with count activity>2SD below the 
mean count activity were color-coded as the region of defect extent 
(DE), and the DEJ'total count activity ratio was calculated as DE score 
(%). Total t2-lead QRS amplitude (~QRS) on electrocardiogram and 
echocardiographic enu-diastplic dimension were measured using the 
initial and the latest recordings. The mean follow-up penod was 
52.6±9.8 months in scintigraphy, 71.4:t:25.5 months in 
electrocardiopgraphy and 68.0:t:26.5 months in echocardiography. 
respectively. 
The mean DE score changed from 28:t:24% to 58:t:38% (p<O.OI). 
In 17 patients (65%), DE score changed more than 30%. Myocardial 
segments with diminished uptake of TI were observed mainly in 
interventricular septum and apex. IQRS decreased from 34.8:t:9.8 
mV to 23.8:t:9.8mV (p<O.Ol). Lert ventricular end-diastolic 
dimension changed from 41.8:t:5.6 mm to 47.8:t:7.2 mm (P«J.Ol). 
During the follow-up period, 6 patients progressed from typical 
HCM to dilated cardiomyopathy-like features. 
Conclusion: In many patients with HCM myocardial ischemia or 
necrosis occurs gradually, and dilated cardiomyopathy-like features 
seem to be one of the natural course of HCM. 
932·112 
Safety of Radiofrequency Catheter Atrio-Ventricular Node 
Ablation in Patients with Existing Permanent Pacemaker 
Antbony C. Chang, Dorothea McAreavey, Dorothy Tripodi, and 
Lameh Fananapazir. NIH, Bethesda, MD 
Successful radiofrequency (RF) ablation of the atrio-ventricular 
node (A VN) necessitates temporary pacing (TP) prior to insertion 
of permanent pacemaker (PP). Implantation of the PP prior to RF 
ablation would reduce the risks and inconvenience of TP. We 
studied the safety of RF A VN ablation in 21 hypertrophic cardio•
myopathy (HCM) pts (13 males, age 52±16 yrs) with existing PP. 
Indications for A VN ablation were: drug-refractory atrial 
fibrillation in 17 pts and short PR interval preventing ventricular 
pre-excitation by DDD pacemaker implanted for relief of LV 
outflow obstruction in 4 pts. Nine pts had DDD (Synchrony II in 
5, Elite in 3, and Synergist in 1 pt) and 12 pts had VVI devices 
(Solus in 6, Sensolog III in ~, Activitrax in I, and Synergist in I 
pt). During ablation, all PP were set to VVI at 50 bpm. The 
ablation catheter was manipulated under fluoroscope to avoid 
disturbance of the PP leads and the tip was kept > 1 cm away 
from the leads. Six pts had PP implanted prior to the A VN 
ablation during the same session. The power applied was 25-50 
Watts for a duration of 15-60 sees. A V block was achieved in all 
21 pts but required 36±39 applications/pt and 23.1±32.7 minlpt). 
No TP was required in any of the pts. In 1 pt, RF ablation 
consistently caused reversion to magnet rate. In all other pts, 
interrogation of PP after ablation showed no immediate change of 
lead or pulse generator function. At 14±12 weeks follow-up, all 
PP were functioning normally without significant change of pacing 
parameters from baseline. Thus, RF ablation of A VN in pts with 
existing PP can be performed safely, and implantation of a PP 
prior to A VN RF ablation avoids the need for TP. 
932·113 
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Assessment of the Diagnostic Value of Head·Up Tilt 
Testing in the Evaluation of Syncope in Patients with 
Hypertrophic Cardiomyopathy 
James F Sneddon, Anne C O'Donoghue, Carol Page, Peter J 
Counihan, William J McKenna. Sl George's Hospital. London, UK 
Syncope is a common and frequently difficult clinical problem in 
patients with hypertrophic cardiomyopathy (HCM) and may have 
hemodynamic or arrhythmic aetiologies. Head-up tilt (HUT) testing is 
of proven value in the identification of patients with neurally mediated 
syncope (NMS) in subjects with recurrent syncope and structurally 
normal hearts. The purpose of this study was to examine the value of 
HUT in elucidating the cause of syncope in HCM. 30 patients with 
echocardiographically confirmed HCM underwent HUT at 6Cf for a 
maximum of 45 minutes. 13 Pts had unexplained recurrent syncope, 7 
had syncope with a documented arrhythmic cause and 10 gave no 
history of syncope. A po~itive tilt test was defined as loss of 
consciousness or a fall in systolic blood pressure to < 65 mmHg. 
Results 
Tut Unexplained Arrhythmic No 
Result Syncope (n-13) Syncope (n=]) Syncope(n-lQ) 
+ve 4 0 6 
·ve 9 7 4 
In those with positive tests 6 Pts showed cardioinhibitory responses 
with the minimum heart rate <60bpm and the minimum mean arterial 
pressure in all positive tests was 51.4±13mmHg. 
Conclusion. Tilt testing may be of value in establishing the cause of 
syncope in patients with HCM but the high rate of positive tests in 
patients with no history of syncope severely compromises the 
specificity of the test 
932·114 
Ventricular Pre-excitation is Highly Effective Therapy for 
Elderly Patients with Obstructive Hypertrophic 
Cudiomyopathy and Symptoms Refractory to Medication 
Dorothea McAreavey and Lameh Fananapazir. NIH, Bethesda MD 
Elderly pts with obstructive hypertrophic cardiomyopathy 
(OHCM) often have drug-refractory symptoms. In this subgroup, 
septal myectomy for relief of LV outflow obstruction is associated 
with high mortality rates (about 16%). We explored the ability of 
dual chamber (DDD) pacing to improve symptoms in 22 elderly 
pts with OHCM and drug-refractory symptoms: mean age 
69.9±4.7 yrs, (range 65-77). At baseline, the NYHA class was 
3.3±0.5, 16 pts had pulmonary artery (PA) hypertension (mean 
PA >20 mmHg) and all pts had LV outflow tract (LVOT) 
gradients > 30 mmHg at rest or > 50 mmHg with provocation. 
Twenty pts were in sinus rhythm and thus received dual chamber 
(DDD) pacemakers for relief of LVOT obstruction. Two pts had 
chronic atrial fibrillation and were treated with radiofrequency 
ablation of the A V node plus insertion of a VVIR pacemaker to 
smooth heart rate and to permit RV pre-excitation. During a mean 
follow up of 15±7 months, 2 pts died (one year survival, 70%). 
The NYHA class of the remainder has improved significantly 
(1.7±0.5, p<O.OI). In addition, the mean number of cardiac 
drugs prescribed reduced from 2.0±0.8 to 1.1±0.9 (p<0.001). 
The hemodynamic benefits of DDD pacing were as shown: 
Mean PA (mmHg) 
PA Capillary wedge (mmHg) 
LVOT gradient (mmHg) 
Cardiac Output (llmin) 
~ Follow Up p 
30±8 24±11 <0.001 
19±9 12±8 <0.001 
103±50 43±46 <:0.01 
3.9±1.5 3.9±1.5 >0.05 
Thus, in elderly pts with OHCM, pacing ± radiofrequency A V 
node ablation allows clinical and hemodynamic improvement when 
conventional treatment has failed. 
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933·46 
Local Slimulua Kesponae Latency I. the Main Contributor to Conduction 
TIme Increase During PrezruohHe Slimulation In the Human Atrium 
Michael R. Franz, Bettina Koller, Allen J. Solomon, Ross O. Fletcher. 
Georgetown University and V AMC, Washington. OC. 
Current electrophysiologic pacing and recording techniques cannot 
accurately differentiate between local stimulus response latency (LL) 
and conduction time (en of the propagated response. This limitation is 
due to Interference between electrical stimulus artefact (5) and local 
response as well as to the usually large spacing between pacing and 
recording electrodes. To evaluate the respective changes in LL and CT 
during premature stimulation, two monophasic action potential (MAP) 
recording/pacing combination catheters with interelectrode distance of 
<2mm were placed at the high right atrium and low atrial septum, 
respectively, and pacing was performed at either site. LL was measured 
as the interval between 5 and the upstroke of the local MAP, and CT 
was measured as the interval between local and remote MAP upstrokes. 
During regular pacing, 5 was. superimposed onto the upstroke of the 
local MAP recording; i.e. LL was zero. With extrastimulation (52) at 
successively decreasing coupling intervals, there was a progressive 
separation between 52 and the local 
MAP upstroke (LL) while CT 
between the elicited MAP and the 
i remote MAP remained essentially 
!. unchanged during the entire range of 
premature stimulation. The figure 
shows LL and CT as a function of 
proximity (interval between 5 and 
.. _I .... <-_I ERr); (SO not shown). 
Conclusion:;: 1) LL is negligible during late coupling intervals but 
increases dramatically when extrastimulation approaches the 
preceding repolarization phase; 2) LL, not CT, seems responsible for the 
greater functional than effective refractory period during premature 
stimulation; 3) LL during premature stimulation curbs the targeted 
response interval; 4) LL must be considered in pace mapping for accurate 
comparison of CT before pacing with that during pacing. 
933·47 
A Double·Blind Parallel Placebo Controlled 
Trial of Cibenzoline for Treatment of 
Supraventricular Tachyarrhythmias After 
Cardiac Surgery 
Jacky F. Ollitrault, Laurent E. Quilliet, Florence S. Scheck, 
Bernard A. Lelong, Genevieve B. Jarry, Alain J. Richard, 
Louis J. Guize. Broussais Hospital, Paris, France 
The antiarrhythmic efficacy of a single intravenous dose of 
cibeDzoline (C) versus placebo (P) was assessed in 86 
patients (77.9 % males) aged 62.1±.0,9 years (25 to 75) who 
developed supraventricular tachyarrhythmias (SVT) 2 to 21 
days after cardiac surgery. PIS were entered into the study if 
the arrhythmia had persisted for at least 30 minutes with a 
ventricular cate of more than 120 bpm. Pts were randomized 
to C (n = 43) given as a. bolus of 1.2 mglkg over 2 minutes or 
P (n=43). Efficacy (conversion to sinus rhythm or slowing of 
ventricular rate below 100 bpm ) was assessed by continuous 
electrocardiographic recording over 30 minutes. 
SVT were atrial fibfillation (n=56). atrial flutter (n=21). 
atrial tachycardia (n=8) and junctionnal tachycardia (n=I). 
C was effective in 13 (30 %) pts (9 converted and 4 
controlled) compared to 3 (6.9 % ) ptS with P (2 converted 
and I controlled). p<0.05. In the non-reverted patients 
ventricular rate was significantly lower in C (129 ±.. 4 bpm) 
compared to P (138 ±. 4 bpm), p<0.05. 
QRS duration was prolonged in C (112.3±.5.3 ms) compared to 
P (S1.4±.3.5 ms), p<O.O I.Nine pts in C demonstrated adverse 
effects : Mild hypotension (n = 7), right bundle branch block 
(n=I), moderate increase of ventricular rate and increase of 
QRS duration from 120 to 200 ms (n=I). There were no serious 
adverse effects. Conclusion : C is a safe and effective 
treatment for recent onset postoperative SVT. 
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933·48 
EIectropIlyoiGlop: meeD 01 Cllroa1e RapId Atrial p.., ... 
Mark Tedder. Mark P. Allatadt, San jay S. Hcp. Micbael J. Stooningloll. 
Amiran Sh. Revishvili.lames E. Lowe [)t'."" Uoivenity Medieal Center, Durbam. North Carolina 
SupravenlricuIar ladIycardia-iDduced alteraliOllJ in the cardiJH: conduction system 
~. poorly. understood. To determine the clectropbysiologic effects of cbrooic rapid 
alnal pactD., 20 colony bred hounds were divided into 2 groups. Ten sham•
operated animals (Sham) wen: compared to 10 animals paced from the right atrial 
appendage at 190 bpm for 3 months (Paced). EJectrophysioiogic studies (EPS) were 
performed at initial (PRE) and sacrifice (poST) thoracotomies using a bipolar His 
catheter, high right atrial pacing and recording wires. and programmed stimulation 
(cycle leagth=300 mICe). The Paced group also underwent EPS following atropine 
(0.04 mglkg) (Atrop) lmd atropiDo/propnmolol (0.2 mglkg) (Atrop .. Prop). RcsullJ 
for the Paced group an: shown as mean ± SEM (msec). 
~ flSi!I A!l!lI! Atroo .. Prop 
fBf~fImfQ[[~~flW~ 
Sa. 460±33398±24 502±31370±12t 430±26306±14t S41±21 531±12 
SNRT 532±3248S±19 577±43 45O±1s* 496±31383±IS* 638±26 614±15 
AU 73±5 64±4 79±4 56±3t 7GB 52±3t 85±4 !Kl±3 
HV 33±1 32±2 32±2 37±lt 32±2 37±lt 33±2 37±2t 
fRP 238±8 237±6 269±3 217±3t 246±4 209±3t 176;:5 269±4 
SCL=sinus cycle length. SNRT=sinus node recovery time. AH=atrial-His interval. 
HV=His-vcntricuJar interval. FRP=funclional recovery period of the AV node 
* P < 0.05. t p < 0.01 vs PRE, Paired t-test 
The Paced group exhibited significant alterations in both SA and A V nodal 
function which penisted following parasympathetic blockade. howcver resolved 
with comp/e~ autonomic blockade. These data show: I) the cardiac conduction 
system adapIJ to chronic rapid atrial pacing by enhancing SA nodal automaticity. 
and A V nodal conduction and refractoriness. while prolonging intraventricular 
cooduction; 2) the extrinsic (autonomic) effects of chronic rapid atrial pacing on the 
SA and AV nodes predominate and appear to be sympathetically mediated; 3) 
chronic rapid atrial pacing appears to have no significant effect on intrinsic 
(inherent) SA and AV nodal function; and 4) the prolonged HV intervals suggest a 
modification in the His-Puririnje system. 
933·49 
FAST-SLOW ATRIOVENTRICULAR NODAL REBNTRY: 
ANTERIOR VERSUS POSTERIOR RETROGRADB PATHWAYS 
David J Wilber, John G Kall, Brian Olshansky, 
Douglas Kopp, Neil Lippman, Bruce B Lerman. 
Loyola University Medical Center, Maywood IL, 
Cornell Medical Center, New York, NY 
Of 95 patients (pts) with sustained atrioven•
tricular nodal reentrant tachycardia (AVNRT), 9 
(9%) had fast-slow (FS) tachycardia, defined as 
AH/HA intervals < 1. Retrograde atrial 
activation was earliest at the His bundle (HB) 
in 2 pts (anterior FS), at or near the coronary 
sinus (CS) os in 6 pts (posterior FS), and one 
pt had both forms: anterior FS posterior FS 
cycle lengtb (ms) 353±45 36l±33 
HA interval (ms) 265+49 255+30 
P vave (II, III, Avr) + (3/3) - (7/7) 
In anterior FS, HB activation preceded the CS by 
25-35 ms; in posterior FS, CS activation 
preceded HB by 25-40 ms. In 2/3 pts with induced 
anterior FS, spontaneous episodes with similar p 
wave morphologies were documented. Alternative 
mechanisms were excluded by dissociation of all 
atrial (HB and CS os) and ventricular electro•
grams from the tachycardia. Radiofrequency 
ablation using a posterior approach eliminated 
posterior FS AVNRT in all pts, but failed to 
eliminate anterior FS AVNRT in any pt. 
Conclusions: Anterior FS AVNRT is a previously 
uncharacterized tachycardia that has unique 
electrocardiographic features and does not 
respond to a posteriorly directed ablation 
approach. This tachycardia should be considered 
in the differential diagnosis of long RP 




The Errects 01 Atrial Pacing on the "Slow Pathway 
Potential" in patients with AV Nodal Reentry 
Tachycardia. 
John Hummel, Ching Man, Vick Vorperian, Brian Williamson, 
Steven Kalbfleisch, S. Adam Strickberger, Fred Morady. 
Jonathan Langberg, University of Michigan, Ann Arbor. MI. 
Target site electrograms during radiofrequency catheter ablation 
(RF) of the slow A V nodal pathway have high frequency 
components inscribed after the initial component of the atrial 
electrogram. To better define the origin of these "slow pathway 
potentials" right atrial and left atrial (coronary sinus) pacing at 
cycle lengths of 500 and 300 msec was performed while 
recording target site electrograms in 8 pts undergoing RF of 
A VNRT. The degree of fractionation of the atrial electrogram 
(AEGM) was quantitated as the number of local peaks in the 
signal and the duration of the signal. AEGM's at baseline were 
compared to AEGM's after successful RF and to smallest 
AEGM values during leCror right atrial pacing. Results: 
B.sellne Post RF Pacing SOO Pacing 300 
Duration (IDS) 77+/-15 75+/-16 *52+/-17 *52+/-14 
# of Peaks 5.5+/-1 5.6+/-1 *3.0+/-1 "'3.0+1-1 
·p<O.OI vs. baseline 
In 7/8 patients ihere was a \S.46 msec difference in AEGM 
width, pacing from the right atrium compared to the left atrium. 
Conclusion: 1) Fractionation of the target site AEGM does 
not change after successful RF of the slow pathway. 2) 
Fractionation of the AEGM is a direction-dependent 
phenomenon suggesting that it is due to anisotropic conduction 
and not a discrete slow pathway potential. 
933·51 
Role of AccellOry Pathway location, Intrlventrlcular Conduction 
Defectl and Stimulating Site In the Development of Ventricular Fusion 
During EntrllnmeDt of Orthodromic Reciprocating Techycardlal 
Jose Ormaexte, Jesus Almendral, Angel Arenal, Agustin Pastor, Juli4n 
Vllacastin, Juan L. Delc8n, Hospital G. Gregorio Mara/\6n, Madrid, Spain. 
Entrainment with fusion (E+F) is sometimes observed with ventricular 
stiroolatlon during circus movement tachycartlias. To analyze the relative 
role of accessory pathway location (APL), stiroolating site (SS) and 
Intraventricular conduction time In the development of E+F during 
orthodromic reciprocating tachycartllas, we studied 41 situations of 
tachycal'tlla and stimulation, In 33 patients, divided Into 4 groups (A to D), 
as defined in the table. Definitions: entrainment: transient acceleration Of 
all atrial and ventricular reoortllngs to the pacing rate. E+F: a surface ORS 
morphology during entrainment that is constant and different from that of 
stiroolatlon without tachycardia. Entrainment could be demonstrated 
during all 41 situations, but E+F in only 25 (see table). 
n APL SS QRS CL E+F 
A 12 Septal RV narrow 318 12 
e 17 LFW RV narrow 321 1 
C 4 LFW RV LIVCD 371 4 
o 8 LFW L V narrow 332 8 
LFW: /eft free Wall. LlVCD: /eft intraventricular conduction dsfects. CL: 
mean tachycanla cycle length (ms). 
E+F with RV stiroolation in narrow ORS tachycartllas was always seen H 
AP was septal and very rare K it was in the LFW (p<.01 comparing A and 
B). In tachycadias with a LFW AP the demonstration of E+F usually 
required LV stimulation or LIVCD (p<0.01 comparing C&D with B). 
Conclullons: 1. Fusion can be observed during entrainment of 
orthodromic reciprocating tachycardias. It depends on conduction time 
from SS to AP Insertion relative to intraventricular conduction time during 
tachycal'tlla. and therefore develops K the former is short (RV stimulation 
with septal AP or LV stimulation with LFW AP) or the latter long (L1VCD in 
LFW AP). 2. Factors other than stiroolatlon proximal or distal to the area 
of slow conductIOn can influence ability to observe E+F. 3. Analysis Of 
ORS during entralnment can help to localiZe AP. 
933·52 
JACC Vol. 21, No.2 
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Detection of Poatero-septal Kant Pathways by Comparison 
of Vantrlculo-Atrtal Intervall During aual and Apical Right 
Ventricular Stimulation 
Jesus Martinez-Alday, Jose Ormaetxe. Jesus Almendral. Agustin 
Pastor, Julian Villacastin. Angel Arena!, Juan L Deican. Hospital General 
Gregorio Maranon. Madrid. Spain. 
The detection of concealed postero-septal Kent pathways can be 
difficuR H tachycartlias are unsustained, or the ventrlculo-atrial intervals 
(VAl) non diagnostic. Hypothesis: H VA conduction proceeds over a 
postero-septal Kent pathway the VAl during stimulation from right 
ventricular posterobasal s~es (VAI-RVB) will be shorter than from apical 
sites (VAI·RVA); with normal VA conduction the VAI-RVA may be 
shorter than the VAI-Rve due to an earfier invasion Of the HiS-Pur1<inje 
system. We performed prospectively 28 studies in 24 patients: 9 (group 
A) with VA conduction over a postero-septal Kent pathway (recogniZed 
because ventricular stimulation: 1 was performed during tachycardia 
producing entrainment, or 2: produced an atrial activation sequence 
identical to the tachycardia sequence and unmodHied by ATP) and 17 
controls w~h VA conduction over the normal conduction system (group 
e); 2 patients were studied pre and post-ablation. RVA and Rve pacing 
were performed at identical CYCle lengths on each case. The VAl (in ms, 
see Table) were measured from the stiroolus artHact to the same stable 
atrial reference on each case. 
VAI·RVA 
Group A 207±37 
Group e 172±42 
pvalue NS 









All group A patients had a RV NRVe ratio > 1, and 16117 group e 
patients had a RVA/RVe ratio s1. 
Conclusions: A shorter VAl w~h RVe stimulation than with RVA 
stimulation strongly suggests the presence of a concealed postero•
septal Kent pathway in cases w~h concentric retrograde atrial activation. 
This can be clinically useful in the absence of sustained tachycartlia, 
after ablation procedures, or for the detection of multiple Kent 
pathways. 
933·53 
Palpitations Occur Frequently Following Radiofrequency 
Ablation for Supraventricular Tachycardia, but Do Not Predict 
Pathway Recurrence 
David E. Mann, Patricia A. Kelly, Stuart W. Adler, Charles E. 
Fuenzalida, Michael J. Reiter, University of Colorado Health 
Sciences Center, Denver, CO 
Radiofrequency ablation (RfA) of extranodal pathways is an 
effective treatment for supraventricular tachycardia (SVT), but 
late recurrences of pathway conduction do occur. To determine if 
recurrence of palpitations (palps) post-RfA predicts late pathway 
recurrence, we interviewed 73 patients who were at least 4 weeks 
status-post successful RfA of an accessory pathway (40 overt, II 
concealed) or a slow pathway (22) for A V nodal reentrant 
tachycardia. 44173 (60%) patients repor;,ed palps post-RCA. 
28173 (38%) patients had Jliilps lasting -10 sees. and/or felt 
their palps represented recurrent SVT (major palps). The other 
16 patients described palps consistent with premature 
contractions. Repeat electrophysiologic testing was performed 
three months post-RfA in 48 patients (66%), including 31 patients 
with palps (21 with major palps). Seven patients (\0%) had 
recurrent pathway conduction on repeat testing: one had no 
palps prior to restudy, 6 had major palps suggestive of their 
previous SVT. One patient with major palps did not have 
pathway recurrence on restudy, but did have inducible sustained 
atrial tachycardia. Thus 14121 (67%) patients with major palps 
who were restudied had no pathway recurrence or inducible 
arrhythmia to explain their symptoms. Of the 29 patients not 
restudied, 19 refused restudy, the other 10 have been followed for 
less than 3 months, and none of these 29 has had documented 
recurrent SVT or overt pathway conduction by electrocardiogram. 
Conclusions: I) Palps, includmg palps reminiscent of pre-RfA 
symptoms, are common post-RfA. 2) Palps do not predict 
pathway recurrence. 3) Routine restudy is necessary to document 
long-term success of RfA. 
JACC Vol. 21, No.2 
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933·54 
Catheter Cryoablation under the Mitral Annulus: A New 
Method of Accessory Pathway Ablation? 
Paul J. Wang, Mark AronovilZ, Frederick 1. Schoen, 
Arun Gadhoke, N.A. Mark Estes ill. 
New England Medical Center, Boston, MA 
Because cryoablation is so successful in the intraOperative treattnent 
of cardiac arrhythmias, we hypothesized that catheter cryoablation of 
accessory pathways might be feasible using a ventricular approach to 
the mitta! annulus. Therefore, in 4 closed-chest dogs, we advanced a 
flexible 13 French cryoablation catheter from the carotid artery to the 
left ventricle. fluoroscopy and atrial and ventricular electrograms 
from the ablation catheter tip were used to position the catheter under 
the mitta! annulus. A single cryoablation lesion was made for 5 
minutes at -60 degrees Centigrade. The animals were studied again 
11 to 28 days after the ablation. Coronary arteriography and cardiac 
venography were performed at baseline and at follow-up. One 
animal exhibited transient eircumflex artery spastn during freezing, 
resolving completely with intracoronary nitroglycerin. In all animals 
there was no change in the coronary arteriograms or cardiac 
venograms at follow-up. Left ventriculograms were normal in all 
animals. In the first 2 animals, lesions were present in the left 
ventricular tissue away from the A-V groove. As we learned to 
more accurately position the catheter, in the next 2 animals we were 
able to ablate in the A-V groove itself. Histologically these lesions 
were characterized by regions of hemorrhagic myocardial and fat 
necrosis with early healing fibrosis, extending from the endocardium 
into most of the A-V groove, without damage to the mitta! valve. 
These preliminary data are the first demonstration that catheter 
cryoablation from under the mitta! annulus may be feasible, 
providing a new potential method for the ablation of accessory 
pathways. In addition, reversible cooling via the cryoablation 
catheter may provide a unique means of mapping accessory pathway 
location, potentially obviating the multiple ablative lesions which 
currently may be required. 
933·55 
Microwave Catheter Ablation of the Canine 
Atria-Ventricular Junction 
James C. Lin, Yujin Wang, Yonggao Wang, 
Roben J. Hariman, University of Illinois, 
Chicago, ll. and Hines V A Hospital, Hines, ll.. 
Previous studies have shown the feasibility of ablating the atrio•
ventricular junction with microwave catheter antennas. However, 
precise placement of the catheter antenna's tip relative to the bundle 
of His is difficult with the stiff-necked catheter antennas. We 
developed a new catheter antenna geometry that provided a 9F, 
flexible, and curved tip. Microwave catheter ablation of the Atrio•
ventricular junction was tested in 8 dogs, with an average weight of 
28 kg, to evaluate the performance of the new design. Under 
fluoroscopic guidance, the tip of the catheter antenna was advanced 
to the heart via either right femoral vein or right common carotid 
artery or both. The same catheter antenna was used to localize the 
His bundle by recording His bundle potential bipolarly. Then, a 
shon burst of 2450 MHz microwave energy was delivered to the 
atrio-ventricular junction. Complete atrio-ventricular block was 
induced in 4 dogs using the femoral approach and in another 4 dogs 
using the carotid approach. The treatment consisted of 4 ± 3 
applications of 40 watts of MW energy in 8 ± I s (320 :t 40 J per 
application). Conclustions: The new design of microwave catheter 
antennas allows easier maneuver of the catheter for localization and 
ablation of the atrio-ventricular junction. Microwave ablation of the 




Angioscopic Visualization of Right Heart Structure in Dog. Using A 
Balloon TIpped Fiberoptic Endoscope 
Chien-Suu KIlO, Osamu Fujimura, Cheryl A. Koch 
University of Kentucky, Lexington, KY 
Fiberoptic endoscope is widely used in GI, GU & respirato/y systems. InHiated 
by one of us (OF), we have designed a system for cardiac use consisting of a 
thin wall flexible tube capped with an inflatable balloon. A fiberoptic endoscope 
is fitted inside this tUbe. By placing this angioscoplc system(ANGIS) 
intracardially & inflating the balloon wHh 5-10 ml saline, the balloon dispels 
blood allowing visualization of endocardiac(ENO) structure(STT) without 
requiring saline ftushing. We tested ANGIS in 8 anesthtized closed chest dogs 
for: 1) feasibility of in vivo visualization of END STT of right heart(RH), 2) 
placing of ablation(AB) electrode (EL) in coronary sinus(CS) or its vicinity under 
direct vision for lesion generation by radiofrequency(RF) energy, 3) 
hemodynamic effects of a baIl0Gll(5-20ml) plac-ed in RH. ANGIS is introduced 
via femoral vein, AB EL via intemal jugular or femoral vein under ftuoroscopic 
guidance. Cardiac output(CO) is measured by thermodilution method. We 
found that 1) CS orifice is easily located, 2) END STT, e.g. tricuspid leaflets, 
fossa ovale, A orV trabeculae, PUrkinjie network, chordae and papillary muscle 
are clearly visible, 3) placement of AS EL in CS or its vicinity can be guided 
under direct vision and fine adjustment in EL posi-tion within mm distance can 
be achieved. Lesion & coagulum formation during delivery of RF energy can 
be seen. Balloon inflation caused following changes: 
_Balloon in RA __ Balloon in RV_ _Balloon in RVOT_ 
Volume B P CO(Um) Volume B P CO(Um) Volume B P CO(Um) 
o mI 1391103 4.2 0 mI 123186 4.4 0 mI 132190 4.9 
5 mI 136/100 4.2 5 mI 126189 4.4 5 mI 131/90 5.0 
10m1 133198 3.9 10m1 122185 4.2 10ml 108172 4.1 
20m! 119188 3.4 20ml 118/80 3.8 20m1 93164 2.2 
We conclude that END STT can be visualized via percutaneous approach us•
ing our ANGIS and placemenVpositioning of EL in CS or its vicinity for RF AB 
can be done under direct vision with no or minimal hemodynamic effects. 
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934-115 
Thrombolytic Therapy in Patient. With Cheat pain 
and NondiapoRic EIectroc:ardiosrama 
William J. French, David A. Wilson, Marko Blagotic, Julie ZaJacc, 
Michael M. Lab, Harbor-UCLA Medical Center, Torrance, California 
Thrombolytic apl5 reduce mortality in patientS with acute myocardial 
infarction. However, eligibility requircmcnl5 for II3C of thrombolytic agenl5 
restrict usage to patienl5 with chest pain :t 30 minutes and a diagnostic 
eIcctrocardiogram (ECG) for acute myocardial infarction (AMI) with ST 
elevation :t hnm in 2 or more leads with or without ST depression. It is 
unknown if paticnl5 with chest pain and nondiagnoatic EOO's (ST elevation 
$ Imm) evolve ST elevation and become potential candidates for thrombolytic 
therapy. The purpose of this study was to evaluate patienl5 with chest pain 
and initial nondiagnostic ECG to determine if ST elevation :t Imm developed 
while paticnl5 were still candidates for thrombolytic therapy. Serial ECG's 
were evaluated in SS consecutive patients who had received rt-PA. There were 
62 maIcs and 23 females with a mean aF S9 ~ 2.S years. The ECG was 
diagnostic of an acute myocardial infarction with ST elevation in 73 patienl5 
(anterior 36, inferior 37), and nondiagn08tic in 12 patients. Mean hean rate 
was 90 % IS bpm in patienl5 with a diagnostic ECG and SO % 28 bpm in 
paticnl5 with a nondiagn08tic EeG (p> .OS). A diagnostic ECG evolved in 9 
or 75"10 of patienl5 who presented with an initial nondiagnostic ECG within 
a mean 47 min, range 4 to 91 min. There were S maIcs and 4 females with 
mean age 54 % I I yean, hean rate 68 % S bpm (p< .OS) and ST elevation 
present in anterior (3) or inferior (6) leads who all received rt-PA (M % SO). 
Summary: Initial nondiagnostic ECG's evolved ST elevation in 7S% of 
patienl5 with suspected AMI. Serial ECG's identified more patients with acute 
myocardial infarction eligible for thrombolytic therapy. 
Concluaioa: Serial electrocardiograms for at least 2 hours arc required to 
detect paticnl5 eligible for thrombolytic therapy with initial nondiagnostic 
electrocardiograms. A prospective study is indicated in patienl5 with chest 
pain and nondiagn08tic ECG's who haYe not received thrombolytic therapy. 
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934·116 
Relat(onship Between the QT Interval and the RR 
Interval During 24·Hours Holter ECG Recordings In 
Patients With Long QT Syndrome 
Tetsuro Emori. Tohru Ohe. Naohiko Aihara. Takashi Kurita. 
Wataru Shimizu. Shiro Kamakura. Katsuro Shimomura, 
National Cardiovascular Center. Osaka. Japan 
To clarify the relationship between the OT interval and the RR 
interval during daily life. a computer algorithm of automatic OT 
measurement for 24·hours Holter ECG recordings was 
developed. The algorithm defined the interval from the 0 wave 
to the peak of the T wave as the OTp interval. Patients with 
congenital long OT syndrome (CLOT). patients with torsades 
de pointes induced by class la antiarrhythmic drugs (laTdP). 
and normal persons (ContrOl) were studied using the 
algorithm. The following variables were compared among 3 
groups: 1) correlation coefficient of the linear relationship 
between the OTp interval and the RR interval in 24-hours: r 
(OTp/RR) • 2) coefficient variation of the corrected OTp interval 






N rIOTplAR)+SP CVlQIc)+SPI%} 
7 O.62±O.2S* B.2±3.3* 
B O.71±o.2S* 6.6±3.4* 
9 O.94±o.03 3.7±O.7 
*p<O.OS V.s. Control. N= number of patients 
Conclusion: 1) The computer algorithm of automatic OT 
measurement for 24-hours Holter ECG recordings is an useful 
method to evaluate the relationship between the OT interval 
and the RR interval. 2) Both CLOT and laTdP have low r 
(OTp/RR) and high CV (OTc) compared to Control. indicating 
increased dispersion of the OTc interval. 3) These findings 
suggest both CLOT and laTdP have common underlying 
ventricular repolarization abnormalities. 
934-117 
Prognosis of Patients with an AbnoZ'llaI 
Dobutaaine Stress-Reho 
Mohammad Kamran, stephen Teague, Robert 
Finkelhor, Neal Dawson, Robert Bahler. 
MetroHealth Medical center, Cleveland, Ohio 
An abnormal dobutamine stress echocardiogram 
(DSE) has a high sensitivity for severe 
coronary artery disease. To determine the 
ability of a positive test to predict 
cardiovascular outcomes, we followed 207 
patients who had a DSE to assess chest pain or 
peri operative risk. Patients were 
followed an average of 267±172 days. 
Dobutamine was infused in increments of 10 
ug/kg/mih up to 40 ug/kg/min or appearance of 
new wall motion abnormality(NWMA), systolic BP 
>220 mmHg, diasto~ic BP >110 mmHg or fall in 
systolic BP >10 mmHg from baseline. Standard 
echocardiographic views were recorded during 
the last minute of each 5 minute infusion 
stage. Segmental LV wall motion during stress 
was compared to baseline using a quad screen 
display. Only stress induced NWMA was 
considered an abnormal test. Sixteen of 59 
(27%) patients with NWMA died versus 5 of 148 
(3%) without NWMA (p<O.OOl). Other univariate 
predictors of death (p<O.Ol) were prior 
myocardial infarction, age, stress induced 
hypotension and being hospitalized. A NWMA 
was shown by Cox proportional hazard analysis 
to identify a population at significantly 
higher risk of death (p=O .03) when adjusted 
for the above covariates. 
We conclude, a NWMA in patients referred for 
DSE identifies a subgroup at high risk of 
cardiovascular mortality. 
934·118 
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Inappropriate Sinus Tachycardia after Radiofrequency 
Ablation of AV Nodal Tachycardia. Incidence and Clinical 
Significance. 
Vassilis Skeberis, Frank Simonis. Erik Andries, Pedro 
Brugada. Cardiovascular Center, O.L.V. Hospital, Aalst. 
Belgium. 
Recently, it has been suggested that inappropriate sinus 
tachycardia can occur in up to 40% of patients after 
radiofrequency ablation of AV nodal tachycardia. We 
prospectively studied this complication in our series of 62 
patients who underwent radiofrequency ablation for AV 
nodal tachycardia. From them. only 5 (8%) presented 
inappropriate sinus tachycardia (2 men, 3 women. 
median 28 years of ag'11. Inappropriate sinus tachycardia 
had rates between 120-1 50 beats/min. The mean number 
of radiofrequency applications in these patients was 3, 
with energy levels of 30-38 watts during 20 seconds. 
Inappropriate sinus tachycardia persisted from 2 hours to 
4 days and disappeared spontaneously in 4 of them 
without any treatment. The tachycardia persisted for 2 
months in the fifth patient. Therapy with beta-blockers 
was given to her fot that period. 
Conclusions : The incidence of inappropriate sinus 
tachycardia after radiofrequency ablation of AV nodal 
tachycardia is very low (8%)' and only rarely requires 
tremporal treatment. 
934·119 
Are lMIat Racordera uaeful aDd. coat Bffective in the 
oiagnoaia of PalpitatioDa, Preayncope, and syncope? 
Richard I. Fogel, Christine R. Gest, Joseph J. Evana, 
Eric N. pryatowaky, Indiana Heart Inatitute, 
Indianapolie, IN 
Event recorders (SR) are frequently used to diagnose 
(OX) the etiology of palpitationa (palp), pre syncope 
(presyn), and syncope (ayn) although their utility and 
cost effactivena8s (CE) are unclear. We proapectively 
investigated thia issue in 201 pta given an ER for palp 
(n-123), presyn (n-33), or ayn (n~45). continuoua loop 
SR waa used in 124 pta with short lasting symptoms or 
8yn without prodrome; hand held ER was given to 77 
other patients. Positive Ox was typical symptoms with 
arrhythmia (Sx+A) or during ainua rhythm (Sx-A). CB 
waa calculated as coat/Ox using the medicare 
reimbursement of $1'9/~nth of ER. of 123 pts with 
palp monitored for 5.1 mean wks, OX was positive in 
18/28 (62.) pta with heart disease (HO) (llSX+A;7SX-A), 
and in 6~/95 (68.) with no BD (39SX+A;26SX-A). SX+A 
were 28 aupraventricular tachycardiaa (SVT) and 22 
ventricular arrhythmia. CB for ox was $282 ($336 BD, 
$267 BD). of 33 pta with presyn monitored for 5.' mean 
wks, OX waa positive in 13/21 (62.) with no BD 
(5SX+A;8SX-A), but in only 2/12 (17%) with BD 
(lSx+A;lSX-A). SX+A were. SVTa and 2 brady•
arrhythmias. CB for Ox was $.43 ($89. BD, $220 no HO). 
of 45 pta with syn monitored for 6 .• 4 mean wka, Ox was 
poaitive in only 1/13 (8%) with BD (lSx-A), and in 6/32 
(19') with no BD (3sx+A;3Sx-A). All 3 SX+A were SYT, 
CE for OX waa $1533 ($3778 BD, $1153 no BD). we 
conclude that event recorders: 1) are useful and CE in 
pts with palp and in pta with preayn and no BD, and 
should be the initial ox teat in theae pta. 2) are of 
minimal· use and le.a CE in pta with sync. 
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935·106 
'I.'he Indapeadct Proguaatic Value of AcIlte II;rocardial 
Perfusion I.ag1ng With Tecbaet1u.-99a Seataaibi in the 
Dlargeaq S- Me8eeet4; of Patiaata With Cbeet Pain 
Thomas C. Hilton, Randall C. Thompson, Hugh Williams, 
Robert Saylors, Holly Fulmer, Stephen A. Stowers. St. 
Luke's Hospital, Jacksonville, Florida. 
Standard clinical and ECG variables have lim! ted 
prognostic accuracy in the emergency room (ER) 
assessment of patients with angina. To see if acute 
~ocardial perfusion imaging with ,Technetium-99m 
Sestamibi (Tc-99m) would provide additional independent 
prognostic significance, we injected 10-30 mCi Tc-99m in 
acutely symptomatic ER patients (n=90) with typical 
angina (chest pain score > 4 on a validated chest pain 
questionnaire) and a n~rmal or nondiagnostic ECG. 
Patients were excluded if there was a history of 
previous ~ocardial infarction (MI) or if the ECG was 
diagnostic of ischemia or previous MI. Cardiac events 
(CE's) were defined as cardiac death, nonfatal 
~ocardial infarction, or the need for acute coronary 
intervention (angioplasty or surgery). 
No CE's occurred in 62 patients with normal scans. 
All CE's (n=16) occurred in the 28 patients with an 
abnormal scan (0. vs. 54., p=.OOO1). Univariate 
predictors (p ~ .05) of CE's were: chest pain score, 
number of risk factors, use of anti-anginal drugs, 
abnormal ECG, and an abnormal Tc-99m scan. Multiple 
regression analysis identified an abnormal Tc-99m 
perfusion scan as the only·independent predictor of CE's 
(p=.0001). 
Acute Tc-99m imaging appears to be extremely 
sensitive (1~) and highly specifiC (83.) in the 
prediction of CE's in ER patients with typical angina 
and a nondiagnostic ECG. Low risk patients may be 
candidates for early hospital. discharge. 
935·107 
Lung Uptake of Tc9g.·Sestamibi: Relationship To 
Clinical, Exercise, Hemodynamic, and Left Ventricular 
Function Variables 
Madhumita Saha, Todd Farrand, Kenneth A. Brown. 
University of Vermont, Burlington, Vermont. 
To examine determinants of lung uptake of ggm Tc· 
Sestamibi (MIBI) on exercise myocardial perfUSion 
imaging studies, MIBI scans in 67 patients were 
reviewed. All patients underwent both rest 
echocardiography and a standard one day rest· stress 
MIBI planar imaging protocol. USing the anterior 
projections of the stress images obtained one hour 
after MIBI injection, regions of interest over peak 
activities of the heart and left lung were selected for 
computation of 1ung/he.art (l/H) ratio. Using 
multivariate regression analysiS, l/H ratio was 
related to clinical (age, sex, prior MI), exercise/ 
hemodynamic (peak heart rate, blood pressure. exercise 
duration, EKG changes), MIBI criteria (presence and 
extent of perfUSion defects). and echo left ventricular 
(lV) function score. We found no significant 
relationship of l/H ratio to any clinical, exercise, 
hemodynamic, perfUSion, or LV function variable. No 
significant difference in l/H ratio was found in 
patients with normal vs abnormal lV function (0.39±0.08 
vs 0.39±0.08), presence vs absence of prior MI 
(0.39±0.09 vs 0.39±0.08), and presence vs absence of 
coronary disease (0.40±0.09 vs 0.38±0.08). 
Conclusions: Unlike tha11ium-20I. lung uptake of MIBI 
is not related to indices of exercise. lV dysfunction, 
or perfusion abnormalities. Thus. MIBI lung uptake 
does not appear to have the same clinical Significance 
as Tl-201 lung activity. 
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935·108 
Enhancement 01 prognostic Abllhy 01 Thalllum·201 Myocardial 
Perfusion Scintigraphy by Addition of Left Ventricular Functional 
Intormatlon 
Walter Palmas, Timothy A. Denton, Daniel S. Berman, George A. 
Diamond. Cedars-Sinai Medical Center, Los AngeleS, CA. 
To assess the incremental prognostic value of left ventricular functional 
information when added to myocardial perfusion scintigraphy we studied 
596 pts (417 M, age 56±10) with suspected coronary artery disease 
(CAD) who had both a stress (treadmill exercise)/redistribution planar 
thallium scintigraphy(TI) and rest/exercise radionuclide angiography 
(RNA) within 90 days without change in symptomatic status. Multiple 
logistic regression analysis was used to produce models tor prediction of 
cardiac events (CE. cardiac death or MI or CABG>60 days after testing). 
For every model the clinical variables (age, sex, symptom classification) 
and exercise variables (duration of exercise, magnitude of ST 
depression, ST slope, peak heart rate) were considered as prior 
information. RNA variables included: rest/peak exercise ejection fraction 
(EF), degree of worst wall motion abnormalities (WMA) at peak exercise. 
For TI we included the degree·of worst stress perfusion defect. 
Mean follow-up was 5.3%.1.4 years. Twenty pIS (3.3%) were lost to 
follow-up, and 30 underwent CABG within 60 days after testing and were 
eliminated from the study. In the remaining group there were 34 CE (6 
cardiac deaths, 6 MI and 22 late revascularizations). The increment in 
prognostic information in a stepwise addition of scintigraphic data, as 














Conclusion: Functional information provided by exercise RNA 
significantly improved the prognostic accuracy of planar thallium 
scintigraphy. This was achieved by the addition of peak exercise EF, and 
was further enhanced when exercise WMA were considered. These 
findings suggest a degree of independent value of functional and 
perfusion .variables for the prognostic assessment of CAD. 
935·109 
Identific.tion of High I.hk Women With Left !fain or 
Thr •• -V •••• l Di ••••• U.ing St.pwi •• Diacr1ainant Analy.i. 
of Exercise SPECT Thallium Imaging 
Shung Chae, Jaekyeong Heo, Debbie Johnson. Kathleen 
McClain, David Cass.l, Abdulmassih S. Iskandrian. 
Philadelphia Heart Ins titut., Presbyterian Medical 
Center, Philadelphia, PA. 
This study examined the ability of exercise single-photon 
emission computerized tomography (SPECT) thallium imaging 
in identifying high risk women with sever. left main or 
3-vessel disease (3 VD) using stepwise discriminant 
analysis. There were 243 women of whom 58 had left main 
or 3 VD (Group 1), and 185 had either no coronary artery 
disease (CAD) (N-80), I-vessel CAD (N-62), or 2·vessel 
CAD (N-43) (Group 2). 
Women in Group 1 were older (65 va 61 years, P < 0.03); 
had lower exercise KETS (5.3 vs 6.2, P < 0.02); lower 
exercise heart rate (1.22 vs 132 bpm, P < 0.004); more 
prevalence of diabetes mellitus (31' vs 14', P < 0.0003); 
more thallium abnormality (84' vs 51t, P < 0.001); more 
multi vessel thallium abnormality (SSt vs 20t, P < 
0.0001); more increa.sed lung thallium uptake (3It vs 
11t, P < 0.01), but no difference in S-T depression. 
Using multivariate analysis. only multi vessel thallium 
abnormality (F-43) , and exercise heart rate (F-6) were 
independent predictors of severe disease. Using a model 
based on these two variables, the women were divided into 
3 groups; 99 had 9t, 70 had 23', and 74 had 45' 
prevalence of left main or 3 VD (P < 0.0001). Thus, high 
risk women with severe left main or 3 VD can be 
identified by exercise SPECT thallium imaging. The 
perfusion data are significantly more important than the 
clinical and treadmill exercise data. 
360A ABSTRACfS 
935·120 
Independent Prognostic Value of Lift Ventricular Transient Ischemic 
Dilation In Dipyridamole-Thallium 201 Perfusion Scintigraphy: a 
Multiple Logistic Regression Analysis 
Walter Palmas, Hosen Kiat, John Friedman, Phillip Hofman, Daniel S. 
Berman. Cedars-Sinai Medical Center, Los Angeles, CA. 
Transient ischemic dilation (TID) of the ielt ventricle during stress 
myocardial perfusion scintigraphy correlates with severe and extensive 
CAD. However, whether it adds sign~icant prognostic information to 
clinical, ECG and perfusion variables is unknown. Therefore, we studied 
405 consecutive pts who had dipyridamole stress-planar thallium 201 
myocardial perfusion studies. Thirteen pis were lost to follow-up and 18 
were eliminated from the study due to early « 60 days after testing) 
coronary artery by-pass surgery (CABG) (naI2) or angioplasty (PTCA) 
(n-6). There were 374 pts in the final group (age.65.6 .t. 12.7, 
males.210). Scintigraphic images were read using a 4 point score 
(Oanorrnal, 3-severe defect) and dividing the heart in IS segments. Any 
study with at least one segment scored 2.2 was considered abnormal. 
ReversibUity (REV) was defi~ as the presence of any of the following 
score combinations (stress/redistribution): 311, 310, 211, 210. Scores from 
all segments were added to obtain a summed stress score (SSS) and a 
summed redistribution score (SRS). TID was visually estimated as 
Oaabsent, I-probable or 2-definite. Length of follow-up was 529 ±. 206 
days. There were 23 cardiac events (CE): II cardiac deaths, 4 non-fatal 
AMI, 8 late revascularization procedures. After consideration of multiple 
clinical, ECG and perfUSion variables, a stepwise multiple logistic 
regression model was built including only those seiected by univariate 
analysis: gender, history of CABG or PTCA, degree of ST segment 
depression, abnormal scan, fixed defect, REV, number of reversible 
segments, SSS and SRS. Then, a second model was generated by 
addition of TID information. For both models, REV was the most 
significant predictor of CE (p<O.OOOI), whereas a history of PTCA was 
predictive (p-0.03) initially, but lost sign~icance after considering TID. TID 
was an independent predictor of CE (p<O.OI), with an odds ratio of 3.26 
(95% CI-I.15-9.29) of CE, after compensating for all other variables. 
Conclusion: Stepwise multiple logistic regression analysis showed that 
pts with REV were at highest risk of CEo Presence of TID further 
increased that risk, suggesting that inclusion of TID information might 
improve the prognostic accuracy of pharmacologic stress myocardial 
perfusion scintigraphy. 
935·121 
Progno.tic Value of Adeno.tne SPECT Thallium Imaging 
Ira Wolmer, Stam Lerakis, Valerie Wasserleben, Virginia 
Cave, Jaekyeong Heo, Abdulmassih S. Iskandrian. 
Philadelphia Heart Institute, Presbyterian Medical 
Center, Philadelphia, PA. 
This study examined the prognostic value of SPECT 
thallium imaging during adenosine-induced coronary 
hyperemia (140 ~g/kg/min for 6 minutes) in patients (pts) 
with angiographically documented coronary artery disease 
(CAD)_ Of the 290 pts with angiographic evidence of CAD 
who had adenosine thallium imaging, 147 underwent early 
revascularization (angioplasty or bypass surgery). The 
remaining 143 pta were treated medically. There were 87 
men and 56 women aged 64 t 10 years. There were 34 pts 
with Q-wave myocardial infarction, 61 with I-vessel CAD, 
37 with 2-vessel CAD, and 45 with 3-vessel CAD. During 
adenosine infusion, 26 pts had SoT segment depreSSion. 
During a mean follow-up of 18 t 10 months, 11 pts had 
cardiac events (death or nonfatal acute myocardial 
infarction). Using uni- and multivariate survival 
analysis, only the extent of abnormality (number of 
segments with perfUSion defects), and the presence of a 
multivessel thallium abnormality (MVTA) were predictors 
of events. Extent abnormality was 9.8 t 5.2 in those 
with events, and 6.3 t 5.3 in those without events (P < 
0.04). MVTA score was 2.3 t 0.8 in those with events, 
and 1.4 t 0.9 in those without events (P < 0.005). Using 
actuarial survival analysis, the event free survival was 
worse in pts with large defects or MVTA (Mantel-Cox 
statistic-4, P < 0.04). Angiographic severity of CAD was 
not a predictor of events. Thus, in medically treated 
pts with angiographic CAD, adenosine SPECT thallium 
imaging provides important prognostic information; the 
extent of perfusion abnormality and the presence of a 
MVTA identify pts at high risk irrespective of the 
angiographic severity of CAD. 
935·122 
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ne Pr'(III1Itic y .... II ExlRise Te-'" .... SPECT. SinglH>t:f 
PrItKIt.llter Recent Yyscar~ InIlRtien : C __ en ,. Otller 
Test w. dIIiti es. 
NII'lZil R. Petix, Stefano Gabbani, Gabriele. lo4ercuccl, Giovami ic«di, Luigi 
Lawn, Roberto Ten:Ii, Stefano [)j lo4erco, Me3sino Siveslri, ,6Iberto 1!4-=m1ii, 
Lall'o Papi. Depeltment 01 c.diology , Pescla, and DeJ*lment 01 Necleer 
l!4edici"le, Pnto,llly. 
We compered the reWive pro~osIic .... u. 01 rooimeI S)IIlplom limied exercise 
electrocerdio,aphy Ie!! (EET),ligh dose diP'!'idsnoie-echocerdio~hy te!! 
(DEl: 2D-Echo morilomg dlftlg diP'!'idamoie irtusion up to 0.8<1 mg/Kg over 
10') and exercise Tc-99m hlBI SPECT, silgle-day protocol, n 164 pls ~er recent 
myocardial irterttion (hIlnnge 10--40 ..,,)A pts 'o'ere folwed up for 20.6 
months for the OCClifenc. 01 herd (HI cerdiel: everts (CE) (cerdiel: d~h, 
myocardial reirterttion) and soft (S) CE (midUlil angi'la, late CABG or PTCA > 60 
.." p03He*lg).Clieria ot poslMy'o'ere: for EEl, an ST selJllent shift > 1.0 
mVoI from baseline; for DEl, a ne-w lJ8nsient regional ~ergy absent n the 
baseline eXllllli'*ion ;forSPECT, a ~ ortotal reversible de/ect. There .".ere 14 
HCEand 66 S CE in the folw Up.Mlong 14 pis 'o4Ih HCE ,SPECT _ positive 
(+)n ovmI pts; EET,DET and-SPECT_ p~n 12 pls(8~,..m1e EEl 
andDET_negelive(-in ony2 pts( 14"1. Frequencydislribliion otHand S CE 
'o'er' : 
EEl DEl SPECT 
+ + + 
N- 96 68 90 14 68 96 
HCE 2" 1'" 2" 1~ 0" 15" 
SCE 2~ 5~ 2" 6~ 24" 5~ 
PICE 31" 14" 2~ 1'" 24" 6~ 
Reger*tgloHCE, EEl shwed X2=10.4 111'"0.001), DEl X2=8.4 Ip=O.OM) and 
SPECT X2=9.0 (p=0.003) ,'o4Iholi sj~1Cerlt iMerence bet....een three tests; 
reger*tgto SCE,EEl shwed X2=10.1 (p=O.OOI),DEl X2= 34,5 (p=O.OOI) and 
SPECT X2=12,3 (p=O.OOI).The lIMriaIe analysis identried .. motion score 
ndex (an iI'lteped semiq~etive measll'e 01 eJotent and severity <:I the 
dyss'll'lerg'1l III peel: diP'!'idsnole(f=80.3;p=O.OOI) and peel: rate pressll'e 
prodw dlftlg EEl(f= 14.8; p=O.OOI)asthemost pwert~ pro~03tic prediclon 
<:I SPECT peremelers (reversible pertusion defects).h conclusion n pis 'o4Ih 
recent hlthe positMyot EEl orDEl orSPECT cerl prediclH CE; the p~ ot 
DEl cerl be the most important pro~osIic prediclon ot S CE ; SPECT has the 
most ligher semiMy for dectelilg residUlil ischenia, ..m1e regerdi1g to rel&ive 
pro~osIic .... ue SPECT seem have the S8fIlesemiMy ot the otherte!!s. 
935·123 
Prognostlc Value or Ejection Fraction Chau&e with Exercise In Stable 
Patients with 3-Vessel Coronary Disease 
Phyllis Supino, Jeffrey S. Borer, Frank Braegelmann, James WaIlis, Gregory 
ChIouverakis, Edmund M. Herrold, Jason Spector, Cornell Medical Center, 
New York, NY 
Ejection fraction(EF) measurement with radionuclide cineangiography 
(RNCA) during exercise(ex) provides prognostic information in pts with 
stable coronary artery disease(CAD). However, the prognostic importance of 
RNCA is unclear in the pt subgroup with severe CAD, often considered 
surgical candidates based on anatomy alone. Therefore we determined time 
to cardiac events (death or nonfatal MI) an!llate surgical(S) procedures 
(CABG or PTCA) among 94 consecutive patients with 3-vessel(v) CAD 
(:t.50% stenosis) studied by RNCA within 1 year of catheterization who had 
preserved (~ 30%) EF at rest(r). During followup (av 9.1,02.1 yrs for 31 
non-event/non-S pts) initial events included 6 known cardiac deaths and 15 
nonfatal MI; 35 pts had CABG and 3 had PTCA without event. The av 
annual risk(AAR) for non-S cardiac events was 9.1 % for pts whose EF fell 
with ex at least 8% (AEF.:-8%) \'S. 3% for pis with AEF 0 to -7% \'S. 1% 
for pts with AEF>O (p<.02, across all 3 grps, log rank test), yielding 8 yr 
event rates of 53%, 18%, and 7%, respectively. Similarly, the AAR for late S 
was 13.9% for pis with AEF.:-8% \'S. 7.9% for pis with AEF 0 to -7% vs. 
1.9% for pts with AEF>O% (p<.05, across all 3 grps, log rank test). Thus 
pts with AEF .:-8% were at greatest ril.k for both DODoS cardiac evcnts and 
late S. Neither clinic:a1 variables, EF.X' EF r blood pressure, heart rate, ex 
duration or ex load were significantly related to outcome. However, 
angiographic Gensini score was related to cardiac events (p < .002) and was 
marginally related to S (p< .09). Stepwise multivariate Cox regression analysis 
showed that both AEF and Gensini score independently predicted non-S 
cardiac events, with AEF strongly improving the prediction (p< .01); AEF 
alone predicted S (p< .02). Thus RNCA AEF provides independent 
information about prognosis in patients with 3v CAD and preserved LV 
function; pts with AEF>O have excellent prognosis without CABG. 
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936-66 
The Effect of Aspirin on the Expression of Neoaatips OD the Platelet 
Surface Membraae ia Respoue to Physiolopcal Aaoaista. 
Nicolas Cbronos, *Dam:a Wi1soa, * AIi80D H.Goodall, Ulrich Sigwart, 
Nigel Buller. Royal Bromptoa Natioaa1 Heart and Luag Hospital and * 
Royal Free Hospital School of Medicine, Loodoa, Uaited Kingdom. 
Aspirin is widely used as an anti-platelet ageat ia the treatement of 
cardiovascular disease. It inhibits platelet fuactiOll by irreversibly 
acetylating cyclooxygezwe and thus blockiag the productioa of 
thromboxane A2 and prostacyclia. Platelet functioa was analysed by a 
whole blood flow cytometric technique that detects activation-specific 
marlcers 011 the platelet surliIce. Platelets activated by weak agoaists such 
as ADP develop a coaformatioaa1 change ia the glycoproteia (GP)IIb-IDa 
complex exposiDg the binding site for fibrinogen (fgn). Stroag agoaists 
such as thrombia cause degranuJatioa and translocatiOll of granu1e 
membnme proteias GP53 and GMPl40 to the platelet surliIce. These aeo•
antigens can be detected with Specific, fluorochrome Iabe11ed antibodies. 
Veaous blood samples (n=IO) from normal male donors were taken prior to, 
and after 4 days of aspirin (300mg/day) and stimu1ated withADP (10.7 to 
iO-SM) and thrombin (0.025 to 0.4 unitslml). There were no significant 
differences (p>O.05) in the expression ofbound fgn, GP53 or GMP140 in 
response to ADP or thrombin. Expressioa of all three activatiOll antigens 
011 unstimulated platelets was also una.ffectM by aspirin t=tment. This 
indicates that neither fibrinogen binding nor degranulatiOll of platelets ~ 
affected by aspirin, suggesting that the release of cyclooxygezwe 
independent platelet contents such as growth fiIctors may not be inhibited. 
This bas important implications for anti-platelet therapy used during 
coronary intervention in which vascular barotrauma may cause activatiOll 
of platelets with release of procoagulant molecules and growth fiIctors. 
Growth fiIctor stimulatiOll of the smooth muscle cells within the PTCA 
damaged arteria1 wall will continue despite the use of aspirin. 
936-67 
Detection of Chlamydia PneumDlliu in Coronary Atherectomy 
Specimens 
Edward R. O'Brien, Lee Ann Campbell, Cho-chou Kuo, Douglas 
K. Stewart, Earl P. Benditt, 1. Thomas Grayston. University of 
Washington, Seattle, Washington 
Chlamydia pneumoniae strain TW AR is an intracellular, gram•
negative bacteria and respiratory pathogen. Previous work has 
documented an association between C. pneumoniae antibody titers 
and evidence of coronary atherosclerosis. Accordingly, we sought 
to detect C. pneumoniae in coronary atherectomy tissue using 
immunocytochemistry as well as the polymerase chain reaction 
(PCR). 
Eight patients with symptomatic CAD (mean age +/- SD=S7 +/- 8 
yr), underwent directioiw coronary atherectomy of 7 native 
coronary arteries (I restenotic and 6 primary lesions) and 1 primary 
lesion of a saphenous venous bypass graft. In formalin fixed tissue, 
the Chlamydia genus-specific antibody CF-2 identified Chlamydia in 
5 of 8 specimens. The CF-2 labeled cells appeared in areas that 
labeled for the macrophage specific antibody CD-68 on adjacent 
sections. Similarly, PCR demonstrated TWAR specific DNA in 5 of 
8 specimens. 
Conclusions: I) C. pneumoniae can be detected in symptomatic 
coronary artery lesions, 2) TW AR appeared to localize in plaque 
macrophages. Although the role of TW AR in these lesions remains 
speculative, there are important potential implications due to the 
widespread prevalence of C. pneumoniae infection and its favorable 
response to antibiotic therapy. 
ABSTRACTS 
936-68 
Antiplatelet Effects of Endotheliw.-Derived Relaxing 
Factor in the Coronary and Peripheral Circulations 
361A 
Jean G. Diodati, Nabeen Hussain, Nader Dakak, Richard O. 
Cannon III, Arshed A. Quyyumi, NHLBI, Bethesda, MD 
Luminal release of endothelium-derived relaxing factor 
(EDRF) produces platelet inhibition in vitro. We 
studied the role of in vivo EDRF release on platelet 
aggregation (PA) in the peripheral and coronary 
circulations of patients with non-significant coronary 
artery disease «50% narrowing). We measured PA in 8 
pts, using ex vivo whole blood impedfnce aggregometry in 
response to collagen 1-5 #g/ml at 37 C. In the 
peripheral Circulation, measurements were made 
simultaneously in femoral arterial and venous blood at 
baseline, after a 2-min infusion of 145 #g/min 
acetylcholine (Ach), an endothelium-dependent dilator, 
and after 15 mins of rtcovery. In the same pts, 
measurements were made simultaneously in the coronary 
sinus (C5) and aorta at baseline, after a 2-min infusion 
of Ach (96 #g/min), and after 15 mins of recovery. Ach 
was infused in femoral artery or the left main coronary 
artery, and flow was calculated from Doppler velocity 
measurements. Ach produced a reversible increase in 
flow in the leg (+IZ0±3S%; p<O.OI) that was accompanied 
by inhibition of PA in the vein (-Z7±IZ%; p=O.OS). In 
contrast, in the same pts, while Ach produced a similar 
increase in flow in the coronary circulation (+IS1±2S%; 
p<O.OI), there was no significant change in C5 PA 
(+27±17%; p=N5). Thus, EDRF release with Ach inhibits 
platelet function in the peripheral but not the coronary 
vasculature despite similar endothelium-dependent 
vasodilation in both beds. This suggests that the 
inhibitory effects of EDRF seen in the peripheral 
circulation are counterbalanced by other pro-aggregatory 
factors in the coronary circulation. 
936-69 
The Role of Adenosine In MetaboliC Control of 
Coronary Blood Flow In Humans 
James D. Rossen, Helgi Oskarsson, Robert L. Minor, Jr., 
Charlotte L. Talman, Michael D. Winniford. The University of 
Iowa and Veterans Affairs Medical Center, Iowa City, Iowa 
The role of adenosine (ADO) in the control of coronary blood 
flow is controversial, and few human data are availabfe. To 
assess the role of ADO in metabolic coronary vasoregulation 
during increased myocardial oxygen demand, the effect of 
ADO receptor blockade with aminophylline (AM) on the 
coronary flow response to rapid atrial pacing stress was 
determined in 15 patients during cardiac catheterization. 
Identical pacing protocols (rate 80±8 to 125±9 bpm) were 
performed before (CON) and after AM, S mg/kg IV over 10 
min. The extent of ADO receptor blockade was assessed by 
measurement of the coronary flow response to graded intra•
coronary ADO infusions before and after AM in 7 patients. 
Changes in coronary blood flow velocity (~CFV) were mea•
sured with a 3F Doppler catheter, and an index of change in 
coronary resistance (CVRI) was calculated. 
~: (mean±SD), • p<.001 vs CON, t p<.01 vs CON 





CON AM CON AM 
84±48 21±31" 0.57±.11 0.8S±.15· 
130±39 59±51· O.45±.OS O.S7±.17t 
Atrial Pacing 2S±14 24±10 0.80±.09 0.8H.OS 
Conclysion: AM substantially decreased ADO-induced 
coronary vasodilation, but did not impair vasodilation occur•
ring with pacing stress. This sUQgests that ADO is not essen•
tial for coronary vasoregulalion In response 10 increases in 
myocardial oxygen demand due 10 tachycardia in humans. 
362A ABSTRACTS 
936·70 
Cytotoxic Effects of a Heparin-Binding (HB) Chimeric Toxin 
(HB-Transforming Growth Factor a-Pst!uilomo1UlJ Exotoxin) 
on Vascular Smooth Muscle Cells (SMC) 
Ya-Min Fu, Enrique A. Mesri, Zu-Xi Yu, Ira Pastan, Stephen E. 
Epstein, NHLBI, Bethesda, MD 
SMC proliferation and migration is the dominant mechanism for 
restenosis after angioplasty. These SMCs overexpress growth•
modulating cell surface receptors. We have attempted to exploit 
this by using genetically engineered molecules designed to 
specifically target and kilJ these celJs. Thus, the chimeric toxin 
created by genetically fusing TGFa (targets the EGF receptor) to 
Pseudomonas exotoxin (PE) (mutated to render its cell binding 
domain non-functional) selectively killed rapidly proliferating 
SMCs. Recently, a heparin-binding EGF-like growth factor (HP•
EGF) has been identified. The HB domain enhances the molecule's 
mitogenic activity for SMC, an effect due to heparan sulfate 
molecules present on the surface of SMCs. We therefore designed 
a new chimeric toxin,HB-TGFa-PE'"KDEL, having both a heparin 
binding and an EGFR binding function. As in our prior study, the 
toxin selectively killed rapidly proliferating vs quiescent SMCs 
(p<O.025). Importantly, the HB domain increased the molecule's 
cytotoxicity compared with that of TGF-a-PE'"KDEL (at I ng/ml, 
leucine uptake = 21 vs 47%; p<O.OOI), an effect significantly 
decreased by exogenously added heparin. Thus, a heparin-binding 
domain increases the SMC cytotoxicity of the TGFa-fusion toxin, 
an effect that might contribute to the succe51>ful in vivo use of this 
molecule. 
936·71 
Does Tbrombin Activation following Tbrombolysis occur 
Systemically or Intracoronarily? 
Albert Meijer, C. Erik Hack, Freek W.A. Verbeugt. Free University 
Hospital and Central Lab. of the Netherlands Red Cross Blood 
Transfusion Service. Amsterdam, The Netherlands 
Continuing thrombin activation (T A) after coronary thrombolysis 
bas been related to failed thrombolysis and reocclusion. The site of 
in vivo TA. however. is unclear. To study whether TA occurs either 
systemically or int:racoronarily. we compared thrombin-antithrombin•
ill (TAT) levels in arterial (ART) and coronary sinus (CS) blood 
with those in venous samples (VEN) in 13 patients (pts) undergoing 
cardiac catheterization 30+ 17 hours (hrs) after treatment with 1.Sx 10" 
U of intravenous (iv) streptokinase (SK) followed by iv heparin. 
Inferior caval vein (VCI) samples served as controls. The infarct 
artery (lA) was occluded in S pts and patent in 8. Normal TAT level 
in healthy volunteers was t.67,iO.83 ug/L. 
Pts VEN VCI ART SC 
all 22+13' 14+12 19+IS 12+8' 
lA_patent 26±IS' 16+1S . 21±17 12+8' 
IA.occluded IS± 8 1 it. 8 16±3 It±9 
'VEN vs SC: p<O.OS; 'YEN vs SC: p<O.Ol. 
We conclude that: 1) SC-TAT levels were not higher than ART•
TAT and VEN-TAT levels, supporting the concept of systemic and 
not exclusively coronary thrombin activation following coronary 
thrombolysis. 2) At 30±17 hrs after SK, TAT levels are still eleva•
ted. indicating ongoing thrombotic activity despite iv heparin. 
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936·72 
Increase in Monocyte Procoagulant Activity (PCA) in 
Unstable Angina (UA), Compared to Stable Angina and 
Coronary Angiopl asty 
Ben Agraou, Brigitte Jude, Eugene McFadden, Philippe 
Asseman, Christophe Bauters, Alain Cosson. Hopital 
Cardiologique, Li lle,France. 
Monocyte PCA was investigated in peripheral blood from 
33 patients with UA (2-24 H after the pain onset, mean 
11 H). 23 patients with stable angina, 22 patients 
undergoing coronary angioplasty (PTCA) and 34 control 
subjects. Mononuclear cells were isolated by gradient 
centrifugation and incubated for 16 H with or without 
stimulation by endotoxi~, and PCA was estimated on lysed 
cell suspensions by a chromogenic tissue factor assay. 
In the UA group, stimulated and non-stimulated monocytes 
exhibited a higher PCA level than in control, stable 
angina or pre-PTCA patients (p<O.Ol). In the PTCA group, 
no increase in monocyte' PCA was detected either just 
after or 2H30 post PTCA. 
peA leves Control Stable Unstable Before End 2H30 mU FT/lO Angina Angina PTCA of after 
cells PTCA PTCA 
Incubation 57 55 859 84 83 86 
-endotoxin t.45 ;t41 t696 t77 ±69 ;78 
Incubati on 1257 1080 2733 1281 1183 1213 
+Endotoxin t790 ±482 t1588 t519 ±602 ;t650 
Conclusion: Increased syst('mic PCA in UA and not after 
PTCA suggests that in UA, activation of monocytes by a 
process unrelated to actue plaque injury may promote 
thronbogenes is, 
936-73 
Heparin Effectively Inhibits Streptokinase-Induced Thrombin 
Generation in Patients With Acute Myocardial Infarction. 
Christiane Col-De Beys, Edith Lavenne-Pardonge, Agnes Legrand•
Monsieur, Myriam Vanderlinden, Jean Renkin, Jacques Col. 
University of Louvain Medical School, Brussels, Belgium. 
The thrombotic ocx:lusion of the coronary artery in acute myocardial 
infarction (AMI) implies fibrin formation which can be evidenced 
on the increased circulatory levels of fibrinopeptide A. This peptide 
was reported to increase during streptokinase (SK) infusion 
suggesting that thrombolysis may trigger thrombin (lIa) activation. 
Whether increased IIa generation is the mechanism for the 
procoagulant effect of SK was investigated in 73 patients (pts) with 
AMI s 6 hours (hrs) randomly assigned in a double blind 
administration of heparin 10,000 IV bolus followed by 1,000 IV/hr 
(H=39) or placebo (P=34), ~ pts receiving intravenous SK 1,5 MU 
and aspirin 200 mg. lIa generation was assessed by plasma 
concentrations of prothrombin activation Fl+2 peptides and 
thrombin-antithrombin III (TAT) complexes. 
F1+2 (run/I) Baseline 3 hrs 24 hrs 
H 1.73±,.97 ns 1.82±.68 * 1.l2±.64 * 
ns ns 
P 1./i6±.88 * 2.53±,1.0 * 1.26+.47 * 
SK promotes IIa generation in AMI, which- can be entirely 
prevented by H. Similarly, TAT did not change at 3 hrs in H (from 
15±,21 to 1B±15 }lg/L, NS) but did in P (from 14±19 to 24±21 }lg/I, 
p=O.04). Interestingly, levels of Fl+2 and TAT returned to normal 
at 24 hrs, regardless of H use. Thus, the procoaguiant effect of SK 
resulted from increased ria generation during the SK infusion and 
could be prevented by H conjunct to SK. 
*p<0.01 vs baseline; **p<0.01 between groups 
Normal range Fl+2: 0.44-1.11 run/I; TAT: 1.0-4.1 }lg/1. 
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936-74 
Uposomal Prostaglandin Et Prevents Cyclic Flow V.riation. in Stenosed 
.nd Endothelium-Injured Canine Coronary Arteries 
James T. WUlerson. Sheng-Kun Yao. Janice McNatt. Kexin Cui. H. Vernon 
Anderson. Chris Swensen. Mar\( Ostro. L MaximUlan Buia, Texas Heart 
Institute and University of Texas Medical School. Houston. TX. The Uposome 
Co .. Princeton. New Jersey 
Prostaglandin El Is a potent vasodilator with antl·inflammatory and 
anti platelet effects. We tested the hypothesis that prostaglandin E 1 prevents 
platelet aggregation associated cyclic flow variations(CFVs) In severely 
stenosed and endothellum·lnjured canine coronary arteries. Sixteen 
anesthetiZed. open-chest dogs were studied. CFVs were Induced by placing 
an external constrictor around the left anterior descending coronary artery 
(lAO) at the site where the endothelium was mechanically Injured. The blood 
flow velocity In the LAD was monttored by a pulsed Doppler flow probe 
posttioned on the artery. Sixty minutes after the establishment of CFVs. llpo•
somal prostaglandin El. a stable formulation of prostaglandin El. was given 
to 12 dogs at Incremental ddses of 0.25. 0.5. 1. 2 I'Q/kg intravenously and 
abolished CFVsln 8 (67%) of them. Control treatment wtth free prostaglandin 
Et In 4 dogs did not abolish CFVs in any of them. After the abol~1on of CFVs 
by llposomal prostaglandin El. epinephrine was infused intravenously and 
restored CFVs In 7 of 7 dogs at a dose of 6.6 ± 1.611Q/minute. Platelet count 
decreased from 310.000 ± 16.000 /mm3 before llposornal prostaglandin E1 
treatment to 241.000 ± 29.000 /mm3 at the time CFVs were abolished or 
when the highest dose of llposomal prostaglandin E 1 has been given 
(p<0.05). Ex vivo platelet aggregation Induced by collagen was inhibited by 
llposornai prostaglandin E1 treatment. Activated clotting times. prothrombin 
times and partial thromboplastin times were not significantly affected by the 
treatment. Thus. liposomal prostaglandin E 1 treatment is effective In 
abolishing cyclic flow variations in severely stenosed and endothelium•
Injured canine coronary arteries. 
936-75 
Calcification in Human Coronary Atherosclerosis is Specifically 
Associated With Osteopontin. a Bone Matrix Protein 
Ronald T. Ingram. Lorraine A. Fitzpatrick. William D. Edwards. Roben L. 
Frye. Larry W. Fisher!. Robert S. Schwartz. tNational Institutes of Health. 
Bethesda. MD 20892. and Mayo Foundation. Rochester. MN 55905 
Calcification is a prominent feature of coronary atherosclerosis. To 
delineate the mechanism of calcification, human coronary artery 
sections were stained for osteopontin (OP), a phosphorylated 
glycoprotein responsible for calcification in normal bone. 
We examined 48 coronary artery segments (14 normal and 34 
atherosclerotic) obtained at autopsy from 7 patients with known 
coronary artery disease. In undecalcified sections using Goldner's 
stain, calcification was diffuse in all plaques. Chemical composition 
of calcified sites was found to be hydroxyapatite (Caro(P04MOH)2), 
the major inorganic component of bone, by energy-dispersive x-ray 
microanalysis. Immunohistochemistry for (OP) indicated intense, 
highly specific staining in the outer margins of all plaques at each 
calcification front; diffuse staining was evident within the plaque. 
Arterial segments free of atheroma and sections treated with 

















Conclusions: Calcification within human atherosclerotic plaques is 
identical to normal bone (crystalline hydroxyapatite). Osteopontin. a 
protein responsible for bone calcitication. exhibits high speciticity for 




Hum.n Smooth Muscl. C.II Outgrowth Is Iner •••• d In 
Cultur.d Coronary Ath.r.ctomy Sp.clm.ns Containing 
Org.nlslng Thrombus 
Javier Escaned. Marcel de Jong. Donald C. Macleod. VIctor A. Umans. 
Robert J. van SuyIen. Bradley H. Strauss. Fred T. Bosman. Pim J. de 
Feyter. Patrick W. Serruys. Thoraxcenter. Erasmus University. Rotterdam. 
The Nelherfands. 
The aim of this study was to investigate the relationship between the clinical 
and histopathoi0gicai substrate of tiSSue retrieved during directional 
coronary atherectomy and the proliferative and migratory potential of 
smOOCh muscfe ceRs (SMC) as judged from successful outgowth during cell 
culture (CC). 
M.etruIdll: CC was attempted in tissue samples from 98 consecutive 
atherectomy procedIres. Samples were examined macroscopically. divided 
In two and separatfy subjected to CC and histopatholOgical study. the latter 
performed by two obserVers bUnded to clinical data CC was performed 
USing an explant technique. In-vitro SMC outgrowth was related to clinical 
(age. sex. coronary syndrome. previOUS MI. previous intervention. risk 
factors) and histological variables (presence of neointlmal hyperplasia. 
connective tissue. cholesterol clefts. necrotic debris. calcium deposits. 
macrophages. thrombus. internal elastic lamina. media or advertitia). 
BMiIlIa: Successful SMC outgrowth occurred In samples from 43 of 98 
patients (44%). Outgrowth was not Influenced by any of the variables listed 
above with the exception of organising thrombus: outgrowth was 
.successful in 8110 (80%) and failed in 35/88 (40%) samples with and 
without organising thrombus respectively (p = 0.03). 
Conc!ysjoos: The presence Of organising thrombus in the retrieved tissue 
facHitates SMC outgrowth. This enhanced proliferative and/or migratory 
potential of SMC in thrombotic plaques may be relevant to the development 
01 neoirtinal proliferation In acute syndromes or after coronary intervention. 
936-93 
VITAMIN D3 TOGE1lIER WITH DIFFERENT CYl'OKINES 
INDUCES TIlE DIFFERENTIATION FROM MONOCYTES 
TO MACROPHAGES 
E.Peste~ S.Oenger, M.Hautmann, M.Forster, W.Kiibler, E.von 
Hodenberg, Med. Univ.-Klinik Heidelberg, Germany 
Monocytes(MO)/Macropbages(MA) are known to play a 
major role in atherogenesIS. MO migrate into the 
subendothelial space, differentiate to MA and become foam 
cells. We studied the effect of Vitamin 03 (Vit.03) alone, 
Vit.03 together with different cytokines (IL-l, IL-6, PDGF, 
FGF, M-CSF and others) and conditioned medium (CM) from 
buman smooth muscfe cells (SMC) to induce MA•
differentiation. Characterisation of MO/MA-differentiation 
was performed "r. immunofluorescent techniques with specific 
monoclonal antibodies. MO differentiated to MA after 
incubation with CM. Cells cultivated in serum-free medium 
(SF), without the addition of any cytokines or preincubation 
with SMC, did not differentiate at all. VIT.03 was adde~to 
SF-medium us~ different concentrations, ran~ng from 10- M 
to l0"11lM. lO" M concentration of Vit.03 mduced a MA•
differentiation in about 70% of the cells. Analysis of SMCs 
showed mRNA-cxpression for a-Hydoxylase, tbe enzyme tbat 
forms the active metabolite of VIT.03. Known SMC secretory 
products were tested together with VIT.03. IL-l, IL-6, PDGF 
and M-CSF together witb VIT.03 induced a MA•
differentiation in about 99% of the cells and had a maximum 
effect after 9 days of cultivation. Cytokines alone were 
markedly less effective in inducing differentiation. We 
therefore hypothesize that SMC release active VIT. D3, wbicb 
induces MA-differentiation to~ether with known secretory 
products of SMC. This mecbarusm may be important in foam 
cell formation and atherogenesis. 
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937·94 
Localization of Proliferating Cell Nuclear Antigen in 
Cardiac Myocytes of Human Hearts in End·Stage Failure 
Federico Quaini°, Elena CigolaO, Costanza LagrastaO, Roberto 
Riccio, Gloria Saccanio, Giorgio Olivetti°, Eugenio Quaini·, 
Cristiano Rossi·, Joseph, M. Capasso#, Fiero Anversa# 
°Dept of Pathology, University of Parma, Italy, ·De Gasperi 
Center of Cardiac Surgery, Niguarda, Milan, Italy and # Dept 
of Medicine, New York Medical College, NY. 
Myocyte cellular hyperplasia has been claimed to occur in 
humans when extreme degrees of cardiac hypertrophy are 
present. Moreover, this phenomenon has been postulated in 
association with severe cardiac decompensation and failure. 
Therefore, specimens from human hearts with terminal failure 
were obtained and the expression of the Proliferating Cell 
Nuclear Antigen (PCNA) evaluated by immunoperoxydase 
technique. Atria and ventricular tissue from 4 patients with 
dilated cardiomyopathy (11 biopsies) and in 2 patients with 
ischemic cardiomyopathy (8 biopsies) were studied. Finally, 
myocardial samples were also obtained from a patient who 
died 2 days after a large myocardial infarct. Specimens were 
fixed in formalin, embedde(l in paraffin and sections stained 
with a monoclonal antibody to PCNA. In 68% of the biopsies 
a large number of myocyte nuclei expressed PCNA. 
Furthermore, endothelial, smooth muscle and fibroblast 
nuclei were positively labeled. In the material collected at the 
autopsy, myocyte nuclei were found to be labeled as well. 
Moreover, the immunoreactive product was restricted to the 
tissue adjacent to the necrotic myocardium. In conclusion, 
congestive heart failure in humans appears to be coupled with 
the expression of PCNA, a gene which is considered essential 
for DNA synthesis initiation and cell proliferation. 
937·95 
Coronary Vascular Reserve is Substantially Reduced in Dilated 
Cardiomyopatby Independently from tbe Presence or Absence of 
Coronary artery Disease 
Jeannette L Yuen. Jiajia Wu. Michele Nanna, Biagio Oliva. 
Zhanqing Shen. Michael Schwarz, Ioel A Strom. Thierry H 
LeJemtel. Alben Einstein College of Medicine, Bronx. NY. 
The etiology of dilated cardiomyopathy (OeM) is classified as 
ischemic or non· ischemic depending on the presence or absence of 
coronary artery disease (CAD) (lesions~75%). However. to what 
extent coronary vascular reserve (CVR) is affected by the dilated left 
ventricle independently from the presence or absence of CAD is 
unclear. Accordingly, coronary blood flow velocity was non•
invasively measured in the proximal left anterior descending artery 
(LAD) by transesophag~ Echo-Doppler (TED). CVR was 
estimated from the ratio of peak and mean diastolic LAD flow 
velocity at baseline and after IV dipyridamole in 24 patients (pts) 
with DCM. LAD was visualized in 22 pts and quality spectral 
display was obtained in IS (63%). Eight of the 15 pts were free of 
CAD, while all 7 with CAD had double· or triple-vessel disease. 
Results: Compared to a normal CVR of 3.2±Q.9, both groups of pts 
with DCM with and without CAD have substantially reduced CVR 
of 1.3±Q.3 and 1.9±Q.4 respectively (p<O.02). There is a substantial 
overlap in CVR in 8 of IS pts with and without CAD. Their ratios 
range between 1.3 to 2. 
Conclusion: Thus CVR is significantly depressed in patients with 
DCM regardless of the presence or absence of CAD. The substantial 
overlap of CVR in patients with and without CAD indicates that 
depressed CVR is an integral component of DCM. 
937·96 
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Increased Airway Irritability in Chronic Heart Failure 
Assessed by Renex Sensitivity to Capsaicin. 
Simon W Davies, Sally L Jordan, Nozhat B Chaudry, David 
P Lipkin. The Royal Free Hospital, London UK 
Abnormal sensitivity of the airways may contribute to 
symptoms in chronic heart failure (CHF): for example, there 
is bronchial hyper-reactivity (increased broncho-constriction 
to inhaled methacholine) in CHF. We have assessed the 
rapidly-adapting and J-receptors using the selective stimulant 
alpha-capsaicin !o provoke cough. 
The cough response to inhalation of metered doses of 
capsaicin was studied in 10 patients with CHF (NYHA II-III) 
not receiving ACE inhibitors, and in 10 controls. There was 
no history of pulmonary·disease or atopy, and lung function 
(FEY l , FYC, DLco' ~) was >70% predicted normal values. 
Deep inspiration through a mouthpiece actuated the delivery 
of 6.25 nmoles of nebulised capsaicin in saline (O.02ml, mass 
median diameter 4)1m). The number of distinct coughs was 
noted, and each subject was tested 4 times in succession. 
The mean number of coughs was 3.5 - 10 (median 6.1) in 
CHF and 0 - 5.75 (median 3.9) in controls (p<O.Ol, Mann•
Whitney). Increased cough reflex to inhaled irritants in CHF 
may reflect abnormal sensitisation of pulmonary airway 
receptors, contributing to the dry cough of CHF and perhaps 
to other symptoms such as dyspnoea. 
937·97 
MUKu18r Plralysll Ind Sedition Oecr8l.. 02 Consumption and 
Improve HemodYlllmlclln Ventil8ted Patients With Severe Hllrt FIUura. 
Andrea Rubboll, Thomas Oraghi, Charles Vanderwarff. Paul A. Sobotka. 
Loyola University Medical Center. Maywood, IL 
In acute pulmonary edema the respiratory muscle blood now and the work 
01 breathing are elevated. To evaluate H paralysis and sedation. as observed 
In experimental models. are capable 01 decreasing 02 consumption and 
favorably Influencing the hemodynamics, we studied 7 patients with severe 
stable heart faNure (HF) requiring mechanical ventilation wtth Swan-Ganz 
hemodynamic monitoring. Each patient underwent three different modes 01 
ventilatory support. each carried on for 60 min: assist control (AC). 
synchronized Intennittent mandatory ventilation wtth pressure support 
(SIMV) and volume control with paralysis (IV infusion of atracurlum) and 
sedation wtth morphlna (VC-P). Hemodynamic and ventilatory parameters 
were collected at the end of each mode 01 ventilation. Heart rate (HR). 
systemic (BP) and pulmonary artery (PA) pressures, pulmonary artery wedge 
pressure (PAWP) as well as stroke volume (SV). systemic vascular resistance 
(SVR) and central venous pressure (CVP) were obtained. 02 consumption 
(V0i and CO2 production (VC02) and basal metabolic energy expendtture 
(MEt:) as well as peak airway pressure (PAP) and static compliance (SC) 
were also measured. The results were (meant SO): 
AC SIMV VC-P 
HR (bpm) 97:1: 18 96!: 19 86:1: 19* 
PA (mmHg) 32:1:9 32:1:9 29t9* 
BP (mmHg) 7Bt9 76t13 691:9* 
VO (ml/mln) 227:1:43 2231:45 195:1:28* 
vc62 (ml/mln) 199t36 202:1:2 181:1:33 
MEE (Kcal/day) 1586:1:297 1617:1:248 13741:207* 
*=p<O.05 VC-P vs AC and VC·P vs SIMV 
No difference was found for PAWP, CVP. SV. SVR, PAP and SC. 
Conclusion: In severe HF requiring mechanical ventilation, muscular paralysis 
and sedation with morphine favorably influences the hemodynamics (by 
reducing HR, PA and BP) and reduces V02 and VC02 as well as MEE. This 
may be clinically valuable In patients with severely reduced cardiopulmonary 
reserve. 
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937·98 
ReproducibilitJ •• d EtloloU of tile Dluna! Variability i. Plasma 
Potasaiu. uvell i. Patie.1S witll CO.latin Heart Failure 
Alicia Williams, Barry Bieske, DonaJd Giacherio, Harpaul Bajw&, Karen Stemmer, 
Monica WaidJcy, Sunil Du. Charles MooIe, Morton Brown, 101m Nicklu 
TIle Univasity of Michigan. Ann Arbor, ML 
We haw previously shown 1baI plasma poIlISSium lewis (K) in patients with heart 
failure vary widely in a diurnal panem. To determine the reproducibility of 
individual diurnal paaems and possible causes of K variability, we measured houriy 
K 0_ 2 consecUliw 24 hr periods in 7 pes with stable CHF receiving oral ioop 
diurcIic:s and in 4 • matclIed healthy controls and correlated K with plasma levels 
of norepinephrine, epinephrine, and insulin. Repeated measures ANOV A 
cIemoIIsInIed I highly significant correlation between individual diurnal variations in 
K during tile first and second 24 h periods (p < 0.(01). There was no difference in 
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Plasma ncrepincphrine leveis correlated with K (r • 0.29. P < 0.01). Insulin and 
epinepbrine leveis were DOl correlated with K. We conclude that I) K varies in a 
reproducible diurnal paIIem, 2) A diurnal K p8IICm can be demonstl3lCd in both heart 
failure patients receiving diuretics and in nonnaI controls, 3) Norepinephrine levels 
may be reiated 10 diurnal changes in K but 4) Insulin and epinephrine levels do not 
correIaIe with diumaI changes in K. 
937·99 
Effect or Portable Oxygen Therapy on Symptoms and 
Walking Capacity in Chronic Heart Failure 
L Restrick, SW Davies, L Noone, JA Wedzicha, R Balcon. 
The London Chest Hospital. London V.K. 
The mechanism of limitation of exercise capacity in chronic 
heart failure is not known. Portable oxygen markedly 
improves symptoms and exercise capacity in some patients 
with chronic hypoxic lung disease, and hyperoxia increases 
exercise capacity slightly in normal subjects. We have . 
assessed the effects of portable oxygen therapy during 
corridor walking tests in 12 patients aged 28 • 74 (median 
64.5) with chronic heart failure in NYHA class III without 
pulmonary disease. Baseline 6-minute walk distance was 90 • 
450m (median 250m) with oxygen saturation by oximetry 
falling from 85 • 99% (95%) at rest to a minimum of 77· 
99% (91%) on exercise: Endurance walks were 19· 2690m 
(275m) with oxygen saturation (Sa02) falling from 88 • 97% 
(95%) to 72 . 97% (90%). 
Oxygen at 2L/min increased resting Sa02 to 90 • 100 
(97%), p<O.Ol. During 6·minute walks portable oxygen at 
2L/min did not change the distance walked, the minimum 
Sa02 , or dyspnoea rated by visual analogue scale and Borg 
scale. During endurance walks, portable oxygen at 41/min 
(but not at 2L/min) increased the minimum Sa02 from 72 . 
97% (90%) to 85 . 97% (95%), p<O.02, but dyspnoea ratings 
and the distance walked were unchanged. 
It appears tha, the levels of portable oxygen supplementation 
which are routinely available in practice do not lead to 
worthwhile improvements in chronic heart failure. 
ABSTRACTS 
937·100 
The Effects of zaprinast, a Type V Phospho•
diestera.e InhiJ:litor, in a Canine Kodel of 
Dilated cardiomyopathy 
Henry H. Holzgrefe, Michael 3. Child, Susan A. 
Fennell, and Michael 3. Antonaccio 
Bristol-Myers Squibb Co. princeton, N3. 
Congestive heart failure subsequent to dilated 
cardiomyopathy is accompanied by an increase in 
plasma ANF. As the effects of ANF are mediated 
by cGMP, we examined the effects of Zaprinast, 
a Type V cGMP phosphodiesterase (POE) inhibit•
or, in a canine model of dilated cardio•
myopathy (OCM) produced by rapid ventricular 
pacing. progression of OCM was documented by 20 
echocardiography. When LV ejection fraction had 
declined to < 35'. and LVEOP was > 20 mmHg, 
Zaprinast was administered as a 30 min infusion 
at 10 (n=4) or 30 (n=4) ~g/kg/min. Hemodynamic, 
hormonal, and renal function were monitored for 
4 hours post drug. At both doses systolic pres•
sure was rapidly decreased by 30 mmHg, with no 
reflex increase in heart rate or cardiac 
output. At the termination of the infusion, 
pressures returned to predrug levels, demon•
strating dose dependency in the time to rec•
overy (30 vs 180 min, 10 vs 30 ~g/kg). GFR 
increased in the 30 ~g/kg group (71±7 vs 
104±12, 0 vs 120 min, p<0.06). Cumulative UNa 
excretion increased similarly in both groups 
(24,287 (10 ~g) and 22,736 (30 ~g) ~eq/4 hr vs 
8137 ~eq/4 hr (vehicle), p<0.05, in the absence 
of any increase in UcGMP excretion. These data 
suggest that Type V POE inhibition augments 
natriuresis in OCM by an undescribed, non-ANF, 
cGMP independent mechanism. 
937·101 
IIIotropic Ac&. of OPC 18790 ill tile boIated FailiIIllIIId Noafaililll 
BllllluBean 
Robert L. RodeD. Kelli O. Mitchusson, Lisa SkerI, Michael R. Bristow 
University of Colorado Health Sciences Center, Denver, Colorado 
OPC 18790 is a quinolinone inotropi<: agent in Phase II development for 
treatment of heart failure. We examined the effects of 18790 in isolated right 
veotricular myocardium (RVM) from hearts of organ donors (oonfailing, NF) 
and subjects with end stage heart failure undergoing transplantation (failing, 
F). Results were comparcd to other relevant inotropic agents including the 
vasodiIaIor/inotrope flosequinan (FLSQ), the Na channel agonist BOF9148, the 
phosphodiesterase inhibitors enoximooe (ENOX) and milrinone (MIL), and the 
~ agonist isoproterenol (ISO). Results are shown as changes from baseline in 







































Additiooa1ly, we investigated the potential mechanism by which ope IS790 
exerts its inotropic dfect by measuring the contractile response of R VM in 
preparations that had been forskolio pretreated to increase cAMP production. 
In separate experiments, under conditions of forskolin pretreatment. the 
response to 18790 was significandy potentiated from 71.5:1: 21.6 to 165:1: 27.4 
(p<O.05). 
Coaclusiou: OPC 18790 is a positive inotrope in human myocardium and 





Is Oral Magnesium Replacement Antiarrhythmic in 
Patients with Congestive Heart Failure? 
Stephen S. Gottlieb. Michael L. Fisher. Catherine Krichten. Richard 
D. Patten. Michael Pressel. Jeffrey Brackett. University of Maryland 
School of Medicine. Baltimore. MD. 
Intravenous magnesium decreases the frequency of ventricular 
ectopic activity. but the antiarrhythmic effect of chronic oral 
replacement has not been well evaluated. Since patients with heart 
failure often experience magnesium depletion & frequent ventricular 
arrhythmias. we randomized 40 patients with serum Mg ~ 2.0 mg/dl 
and heart failure to receive placebo (PLA) or MgCI2 (128 mg of Mg 
po tid. or as tolerated). 24 hour ambulatory electrocardiographic 
recordings were obtained to measure frequencl of premature 
ventricular contractions (PVC. hr I). couplets (hr ). & ventricular 
tachycardia (VT. day-I) before (Pre) & after (Rx) 8 weeks of 
treatment. 
Mean serum Mg decre:tsed .01 mg/dl after PLA administration. 
and increased .08 mg/dl after Mg therapy (p=NS). The 2 groups did 
not differ regarding changes in arrhythmia frequency. PVC frequency 
decreased by 28 ± 36 after PLA & 67 ± 51 after Mg. couplet frequen•
cy decreased by 4 ± 9 after PLA & 20 ± 14 after Mg. & VT episodes 
increased by 15 ± 18 after PLA & decreased 27 ±18 after Mg. 
The graph shows PVC-Pre & 
PVC-Rx for each patient (Mg indi•
cated by +. PLA by • ).There was 
no difference in the response of the 
2 groups. PVC decreased >80% in 
only 2 Mg & 4 PLA patients. 
10 4 _-----..,. 
In conclusion. chronic Mg 
replacement does not markedly 
decrease the frequency of VT. 
10 0 couplets or PVC or increase serum 
100101102103104 MginCHFpatients. Whether oral 
PVC· Pre Mg administration repletes Mg 
stores or improves survival still needs to be evaluated. 
937·103 
Circadian Pattern of Heart Rate Variability After Physical 
Training in Congestive Heart Failure. 
Piotr Pooikowski. Stamatis Adamopoulos. Elena Cerquetani, Giuseppe 
M.C.Rosano,Massimo Piepoli, Andrew J.S.Coats. John Radcliffe 
Hospital,Oxford and National Heart &. Lung Institute, London.U.K. 
We evaluated the effect of physical training on the circadian pattem of 
heart rate variability (HRV) in patients with chronic heart 
failure(CHF). We studied 12 males with stable, moderate to severe 
CHF of ischemic origin in a randomized,cross-over controlled trial of 
bicycle exercise training (20 mins x 5 days per week at 60·8096 of 
max HR). HRV was derived from 24 hour ECG recordings and 
measured by both: time-domain measures (SDRR,pNNSO,rMSSD) and 
frequency-domain measures (low and high frequency·LF, HF). To 
assess the circadian pattem of HRV, LF and HF were calculated for 
each hour. 
After physical training we found increased values of rMSSD, 
pNNSO,HF and decreased LF:HF ratio ( 21±13ms vs 17±7ms, 4±8'l6 
vs2±3'l6, 107±214ms2 vs S1±S9ms2, 3.8±2.1 vs 4.7±2.4 
respectively,all differences-p<O.OS). These changes are seen during 
different times of the day with preserved circadian variation(table). 
LF power(ms2) HF power(ms2) 
time before after before after 
training training training training . 
lam-7am 393±448 S22±707 87±140 169±34l'" 
7am-lom 184t267 36S±716* 89±217 146±344* 
lorn-7om 119±119 138±142 29±19 8S±197. 
7Drrtlam 232±280 266±31S* 83±227 123±2S7* 
mean±SD are given; *·p<O.OS before vs after training. 
We conclude that physical training can improve both time and 
frequency·domain measures of HRV in CHF with preservation of the 
circadian pattem. These changes may lessen the predisposition to 
ventricular arrhythmias in CHF. 
937·104 
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Thiaaine Supple.mts I.prove Left Ventricular Function 
in Patients with Chronic Ueart Failure. 
Ilan Shimon, Hanna Seligmann, Zvi Vered, Adam Steinmetz, 
Shlomo Almog, Hillel Halkin, David Ezra. Sheba Medical 
Center, Tel-Aviv University, Israel. 
I~e have described thiamine deficiency in patients with 
congestive heart failure (CUF), receiving furosemide 
therapy. In a double blind study we assessed the effect 
of thiamine repletion on thiamine status and left 
ventricular ejection fraction (LVEF), in patients with 
CHF. Changes were determined by the erythrocyte 
thiamine-pyrophosphate effect (TPPE, normal 0\-15\), and 
echocardiographic LVEF. Twenty patients with CUF were 
randomized to 1 week of in-hospital IV therapy, thiamine 
200 mg/day (n=10) or placebo (n=10), all previous drugs 
being continued. All patients of both groups then 
received oral thiamin~, 200 mg!day as outpatientR for 6 
weeks. Baseline values were (mE'iln!fi.D.): age 7h12 ?.,d 
72±8 years; LVEF 0.2910.12 and 0.27<0.10; NYHA class 
2.5.0.6 and 2.610.8; TPPE 1317, and 16110\ for thiamine 
and plilcebo groups, resvectively. ~esults were: 
£'ilseline l after: 1 week,I..'! ~",ceks,pO thiamine 
TPPE TPPE LVEF TPPE LVEF 
ill ill (.. change).L'U (\ change) 
Thiamine 1317 613** +24.3149.2 312** +31. 21j8. 7'· 
Placebo 16110 171~ +12.6132.6 505** +24.8.28.2" 
(* p<0.05, •• P<O.OI, both vs. baseline). 
TPPE decreased after 1 week of IV thiamine, but not 
placebo. LVEF increased 2-fold as compared with placebo 
at 1 week (N.S.). After 6 more weeks of oral thiamine in 
both groups, mean TPPE was low in all patients and LVEF 
was increased by 28133\ above baseline (p<0.005). 
Conclusion: thiamine repletion improves left ventricular 
function and biochemical evidence of thiamine deficiency 
in patients with CHF. 
937·105 
Is Chronic Heart Failure an Insulin-resistant State? 
Jouko Rames, MD and Malkku Laakso, MD. Department of Medicine, 
Kuopio Univ8lSity Hospital, Kuopio, Finland 
Patients with hypertension, obesity or type II diabetes mellitus 
have a decrease in insulin (I) mediated glucose uptake and, 
consequenUy, an increase in plasma (P) .concentrations of C•
peptide (C) and I. This insulin resistance is associated with 
decreased skeletal muscle blood flow (SMBF). Chronic heart 
failure (CHF) is another disorder associated with diminished 
5MBF. We have tested the hypothesis that I resistance might 
also exist in patients with CHF, by determining P concentrations 
of C and I in 21 patients with new-onset untreated CHF, and in 
43 age-matched healthy control subjects, all aged 45-74 years. 
Fasting blood glucose (FBG) and P levels of atrial natriuretic 
peptide (ANP), epinephrine (E), norepinephrine (NE), and P renin 
activity (RA) were also assessed. The follOwing results were 
observed: 
Control CHF oatients 
FBG (mmoVl) 4.3±0.1 4.5±0.2 
C (nmoVl) 0.51±0.03 0.73:1:0.07-
I (mUll) 8.8±0.7 12.2:1:1.7 
ANP (pg/ml) 49:1:4 177:1:37-
E (nmoVl) 0.33:1:0.04 0.47:1:0.07' 
NE (nmoVl) 2.09:1:0.13 2.76:1:0.27' 
RA (ng/mllh) 2.38:1:0.22 2.25:1:0.32 
(Mesn:tSE. • fJ<O.05, - 1'<0.001, Mann-Whitney test) 
In addition to ANP, E, and NE also C and I levels were increased 
in CHF patients. In the patient group, C remained elevated after 
adjustment for body mass index and history of hypertenSion. 
Thus, CHF is associated with high C, which is in accordance with 
the hypothesis that CHF is an insulin-resistant state. 
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793-1 
Echocardiographic Diagnosis of Intramural Coronary Artery WI 
Transposition of the Great Arteries 
2:00 
Luciano Pasquini, Ira A. Parness, Steven D. Colan, Philip J. Spevak, 
Mary van der Velde, John E. Mayer, Stephen P. Sanders, Children's 
Hospital, Boston, MA 02115 
A n intramural coronary artery is an uncommon but significant factor 
for transfer of the coronary arteries as part of the arterial switch 
operation for transposition of the great arteries (TGAI. Because 
preoperative diagnosis is advantageous, we investigated the reliability 
of 2-D echo for detecting this coronary artery panern. 
All 435 infants with TGA who underwent 20 echo 'and primary 
surgical repair at this institution between 1/87 and 6/92 were 
identified and the 2-D echo, surgical and autopsy reports reviewed. An 
intramural coronary artery was identified at surgery or autopsy in 27 
patients (6.2%1. Twenty of the 27 intramural arteries were correctly 
diagnosed prospectively by 2·0 echo (left coronary artery in 12 of 16 
patients, left anterior descending artery in 5 of 7 patients and right 
coronary artery in 3 of 4 patientsl, with 2 false positive diagnoses 
(sensitivity 74%, specificity 99.5%1. 
Two major diagnostic criteria were identified: 1 I origin of a 
coronary artery from the contralateral septal sinus of Valslava, near 
the usually intercoronary commissure; and 21 detection of a coronary 
artery coursing between the arterial roots within the posterior aortic 
wall creating a 'double border' appearance. Retrospective review of 
the cases using these criteria identified 26 of the 27 intramural arteries 
with no false positive diagnoses. In one patient, an intramural right 
coronary artery which arose from the appropriate (rightl septal sinus of 
Valsalva could not be detected even in retrospect. 
During the first 2 112 years of the study 6 of 10 intramural arteries 
were diagnosed correctly (60%1 while during the last 3 years 14 of 17 
intramural arteries were correctly diagnosed (83%1. 
We conclude that 2·0 echo is an extremely promising technique for 
detecting an intramural coronary artery in TGA. Caref~1 application of 
the criteria identified should continue to improve diagnostic accuracy. 
793-2 2:15 
la Vitro Studies olVeatricular Septal Defect Flow Uslag ProDmaI Isoveloclty 
Surface Area ADalysis 
Gerard I. Boyle, IOSAS A. Ettedgui, Robert A. Levine, Edward G. Cape. 
University of Pittsburgh, Children's Hospital, Pittsburgh, PA 
Studies of valvular regurgitation using color Doppler images of a proximal 
isovelocity surface area (PISA) to calculate orifice flow rate have assumed 1) 
conservation of mass (continuity) between the PISA and orifice and 2) 
symmetry of the PISA. ~ is likely to hold in the case of a VSD. where 
systolic ejection IIllIa interact with converging VSD flow in the outflow tract. 
PISA images are however readily Qbtained in patients with VSDs and should 
be useful for Quantifying these flows. We therefore developed an iIu:ilm 
model to examine the effects of ambient conditions on the PISA calculation 
of VSD flow. Variable VSD diameters (5-10 mm) allowed sbunt flow 
between left and right ventricles. Pulmonary and systemic pressures and mitral 
inflow were varied independently to produce a range of cardiac outputs and 
pbysiologic pulmonary to systemic flow ratios (Op/O. = 1:1 to 6:1) consistent 
with comparable clinical data. PISA images were obtained for VSD velocities 
of 150-590 em/s and aortic outflow (AD) velocities of 0-250 em/s, (0 em/s to 
test the basic PISA calculation with no cross-flow). Results: The PISA 
estimation of flow when compared to Op - O. feU into two groups. With VSD 
flows in the physiologic range (velocities 150-590 em/s), PISA overestimated 
Op - o. (10-110%) although correlation was good (r=.96). in agreement with 
reported clinical studies. When AD was increased to simulate high output 
states (up to 250 em/s) along with VSD velocities, PISA closely estimated 
actual flows (Y=.92X+9.78 (mils). r=.95). Conduslons: These .iI!...!ilm 
studies explain clinical reports showing overestimated shunt flow by PISA. 
They also point out that the degree of overestimation is related to the strength 
of AD. Fluid dynamically. failure of the continuity equation to take into 
account AO leads to an overestimation of VSD now in the physiologic range. 
Increased distortion of the PISA with increased AD counteracts this effect and 
produces a range in which agreement is found. These quantitative ilI...!ilI!! 
studies suggest modifications of the basic PISA approach for the VSD setting, 
which will ultimately lead to clinically useful markers of shunt flow. 
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793-3 2:30 
Crossno" Augments Color Doppler Jet Area - Implications 
for the Assessment of Atrial Septal Defects:ln Vitro Studies 
Randall Y. Grimes. Edward G. Cape. Peter G. Walker. Ajit P. 
Yoganathan. Robert A. Levine. Georgia Institute of Technology. 
Atlanta. GA. Children's Hospital of Pittsburgh. Pittsburgh. PA. Mass. 
General Hospital. Boston. MA 
Color Doppler jet area (CJA) is in wide use clinically as an index of the 
severity of jet forming lesions and has been suggested as a marker of 
atrial septal defect (ASD) shunt flow. When jets enter a chamber of 
stationary fluid. jet area ~ a function of jet momentum (t1ow rate x 
velocity). However. bulk atrial blood flow. in transit from the caval 
veins to the ventricle. is perpendicular to ASD jet trajectory. TIle. 
hypothesis that this peJllendicular now (crossflow) Can deflect the jet 
and chan~e its size Was tested in vitro. Jets were injected through a 4.8 
mm diameter orifice into a cylindrical chamber 5 em in diameter. 
At a constant orifice velocity and flow rate. the velocity of a 
crossnowing field was varied from 10 to 30 cmls and the jets imaged 
by Doppler color now mapping to simulate the apical4-chamber view. 
Results: For relatively low ratios of jet to erossflow momentum 
(X=Mj/Mc). simulating low-velocity ASD flow. the jet was deflected 
from its initial trajectory. as seen clinically (deflection angle = 9 -
241ogX. r = 0.99). and jet area was considerably augmented by the 
crossflow. As the ratio of jet to crossflow momentum increased. both 
det1ection and area augmentation decreased. resembling high-velocity 
ASD t1ows. For example. as crosstlow velocity increased from 10 to 
30 cm/s. a 0.66 mls jets area increased from 3.2 to 7.1 cm2 while the 
area of a 1.3 mls jet. of higher momentum. 
increased less from 5.1 to 6.S cm2. Conclusion: 
Jet area may be increased by atrial cross flow thu: 
potentially obscuring the relationship between jet 
size and lesion severity in detlected jets. The 
prominence of this effect increases as je 
momentum decreases and jet detlection increases. 
Thus. paradoxically. low momentum ASD jets may 
appear larger and more severe than higher t + t t t t t 
momentum jets of greater flow rate. CROSS FLOW 
793-4 2:45 
Three-Dimensional Reconstruction and 4-Dlmensional Display 
of the Changes in left Ventricular Size. Shape and Geometry In 
Children With RighI Ventricular Pressure and Volume Overload 
and in Post-Operative Senning/Mustard Patients 
Gerald Marx. Jose Azevedo. Qi-Ling Coo. David Fulton. Barbara 
Romero and Natesa Pandian. 
Tufts - New England Medical Center. Boston, Massachusetts 
Detailed assessment of deformed left ventricles in the setting of 
significant RV pressure or volume overload and following Senn•
ing/Mustard Surgery has remained difficult by 2-D echocardiography. 
Recently a 3-D reconstruction capability that could be applied to 
conventional 2-D echo derived images has been developed. This 
offers an opportunity to study the left ventricle in pathologiC states. 
We employed this 3-D reconstruction approach to evaluate the 
changes in LV in 34 children with RV pressure or volume overload 
(RV OLD) (9 Ps with ASD.9 pts with VSD, 6 pts with AV canal, 4 pts 
with Tetralogy of Fallot. 3 pts with PDA and 3 pts with other complex 
congenital cardiac abnormalities; age 6.2±2 yrs). and in 11 children 
after Senning/Mustard surgery (age 7±3 yrs). In addition 20 age•
matched normal children were examined as well. In all subjects. 3 or 
6 orthogonal apical 2DE views were digitally collected. LV borders 
semi·automatically derived and 3-D and 4-0 reconstructions were 
performed using specially designed software. This previously 
validated method yields not only 3-D reconstructions but also 4-0 
display. While a symmetric and uniformly contracting LV was seen in 
the normal population. the 4-0 display in both groups of patients 
depicted the dynamic deformations of the LV chamber in different 
formats demonstrating the adverse influence of septal dysfunction 
and reduced LV size on its overall function. Data collection. proces•
sing and 3-D reconstruction all could be accomplished within a few 
minutes after the echocardiographic examination. We conclude that 
this easily performed three-dimensional echocardiographic method 
provides a new approach to study the chamber in LV geometry in 
congenital heart disease and the effects of surgical procedures. 
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793·5 3:00 
Three-Dimensional Echocardiography: In Vivo Validation for 
Right Ventricular Free Wall Mass As an Index of Hypertrophy 
Leng Jiang, J. Antonio Vazquez de Prada, Mark O. 
Handschumacher, J. Luis Guererro, Gus J. Vlahakes, Mary Etta 
King, Arthur E. Weyman, Robert A. Levine, Mass. General 
Hospital, Boston, MA 
Right ventricular free wall (RVFW) thickness has been used as an 
index of RV hypertrophy (RVH). Its value is limited, however, 
because the RV may increase its mass by dilating without increased 
thickness; and because trabeculations and oblique views can 
exaggerate the appearance of RVH in individual M-mode and 20 
scans. The purpose of this study was therefore to validate the 
abilit of 3-dimensional echo 30E) to reconstruct the RVFW and 
etermme Its mass m VIVO usm~ a system t at automatlca y 
combmes 2DE Images With their spatial locations. This system 
was applied to 12 beating canine hearts to reconstruct the RVFW 
in intersecting views. Endocardial and epicardial borders were 
traced at end-diastole, and the contained volume calculated by a 
surfacing algorithm that takes advantage of the full 3D data set. 
The corresponding mass was compared to actual weights of the 
excised RVFWs which ranged from 15.5 - 78 gm. Thickness of the 
sinus (body) and outflow RVFW were also measured by 20E and 
the best functional fit to predict mass obtained. RESULTS: 30E 
successfully reproduced RVFW shape and mass, which agreed well 
with actual values: y = O.94x + 1.1, r = 0.99, SEE = 2.6 gm 
(5.7% o{ the mean). 3D predictions were significantly better than 
those derived from 20E thicknesses (p < .01), with a variance 6.5 
times smaller by 3~. CONCLUSION: Despite the irregular 
crescentic shape of the RV and variability in thickness related to 
20E views. RVFW mass can be accurately measured by 3D echo 
in vivo. This should Improve our ablhty to eviiluate the presence 
and progression of RVH in patients with heart disease. 
793·6 3:15 
Transthoracic Three- and Four- Dimensional Echacardiography In 
Children and Adults Using a Computerized Tomographic Ultrasound 
Probe: Gray level Gradienl Shading Enhances Ihe Recognition of 
Inlra-cardiac structures and Congenital Hearl Defects 
Q~Ung Coo. Jose Azevedo. Gerold Marx. David Fulton. Berthold Klas. 
Bernard Mumm. Michael Krauss. Barbara Romero. Frances 
Andruszkiewlcz. Susan Aylaian and Natesa Pandian. 
Tufts - New England Medical Center. Boston. Massachusetts. 
We have previously shown the feasibility of transthoracic 3·0 and 4·0 
echocardiography in infants and children. In this study, we explored the 
clinical application 01 newly developed gray level gradient shading technique 
to process and display Ihe 3·D studies. We studied 17 patients (Age 2 day 
old infant to 20 yr old adutt) with a variety of congenital heart defects. A 5 
MHz. 64 element transducer mounted on a sliding Carriage was fixed on the 
chest over the heart or in the subcostal region. This was interfaced to an 
uttrasound imaging console with 3·D and 4·D capabilities. From parallel 2·D 
images acquired at 1 mm intervals (1 cardiac cycle each mm. gated to EKG 
and respiration. data acquisition time less than 3 minutes) by computer· 
controlled transducer movement. volume rendered 3·D and 4·D recons· 
tructions were performed. 2 processing approaches were employed: the 
previOUSly available depth coding (distance shading) technique and a newly 
developed gray level gradient shading technique. These processing tech· 
niques which could be performed within an hour of each study allowed us to 
recognize abnormalities such as atrial septal defects (in one case pre- and 
post- Raskind procedure), ventricular septal defects. RV mass. single ven•
tricle, truncus arteriosus, A·V canal defect. Ebsteins anamoly. and stenotic 
valves. Atthough these disorders could be recognized on the depth coded 
(distance shading) 4·D images. the definition of the abnormalities were 
better in the images processed with gray level gradient shading. From the 4· 
D images. 2·D images could be derived in any desired plane using tri·linear 
interpolation. This ability allowed us to view the cardiac structures in imaging 
planes not available by conventional2·D echocardiography. The heart could 
also be sectioned in 3·D and the intracardiac structures visualized in 4·D in 
a variety of planes. The newly developed 4·D software required less pro•
cessing time compared to previous methods. We conclude that transthoracic 
4·D echocardiography can be used clinically both in infants. children, and 
aduhs; the decreased time requirement for 3-~ and 4·0 processing makes 
the clinical applicability more practical. 
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794-1 2:00 
I.c:n;J-'l'erm CkI'It:irI.DlS Prcstacyt:lin Treatment Inprcves 
survival in PrilIIary PUlJII::rlary Hypertension 
RdJyn J. Barst, Lewis J. Rubin, Michael. D. !i::Gocn, 
Fd;Jar J. caldwell, walker A. I.c:n;J. CoIUDilia 
university, New York, NY ard a:Jrroughs Wellcxme Co., 
Researdl 'l'ri.arqle Parle, NC. 
We prospectively ran:bnized 25 patients (N'iHA 
Class III ard IV) with severe pril1lary pulJIr:lnaIy 
hypertension (Pm) who had failed conventional therapy 
(CT) to receive either oontinuous intravenous 
prostacyclin (rot, n=11) or CT (n=14) for 8 weeks 
(1987-1989) • All2patients 10Iere then given the c:¢ion 
to receive oontinuous rot indefinitely, 'lhree 
patients in the CT grrup adt 1 patient in the rot2 grrup died durin) the 8 week ranianized pericxi. All 
10 of the smvivin) Ril2 patients ard 8 of the 11 
smvivin) CT patients elected l~tem rot 
treatment. Five of 19 patients died while receiv~ 
rot2 (smvival 27 ± 4 IOOS; median 28 IOOS) while all 6 patients died who had never received Ril 
(smvival 6 ± 8 IOOS, median 2 IOOS) (Kaplan-Mei~ 
smvival analysis p<.0002) , 'lhe 1, 3 ard 5 year 
smvival rates of rot treated patients 10Iere 89%, 
72%, ard 61% c:x:mpared ~ a 17% one year smvival for 
the CT treated patients (P<.001) ard 64%, 40% ard 24% 
for N'iHA Class III ard IV patients entered into the 
NIH Registry on pm (p<_02). Eight patients 
UOOer.Ient transplantation, all of wb:m 10Iere receivin) 
~l2~ Mean duration of Ri!to,~tment prior to 
o:ansplantation was 17 ± 9 IOOS ( . 15 IOOS). 
We oonclude that l~-tem oontinuoos Ril 
therapy ilIproves smvival in severe pm ard may ~ 
particularly useful as a palliative bridge to 
transplantation. 
794·2 2:15 
Nitric <hide is a Selective Pubnonary Vasodilator in Patients with 
Pubnoll8rJ Vascular Disease 
Barbara A. Cockrill, Robert Kacmarek, B. Taylor Thompson, Michael A. 
Fifer, Watrf!IJ. A. Zapol, Man: J. Semigran. Massachusetts General Hospital 
and Harvard Medical School, Boston MA. 
Response to high doe calcium channel btocker (CCB) therapy is correlated 
with improved survival in patients with primary puJmooary hypertension. The 
effectiveness of CCB therapy may be limited by its negative inotropic effects 
and systemic arterial vasodilation. Nitric oxide (NO), an active component of 
endothelium derived relauot factor, has been reported to be • selective 
pulmonary vasodilator when inhaled. Because it is rapidly bound to 
bemoglobin and inactivated, inhaled NO should have no myocardial or 
systemic effects. In order to assess the effects of inhaled NO and CCB therapy 
on pulmonary hemodynamics and right ventricular contractility, we studied 7 
patients (4 male, 3 female, age 48± 16 yrs, meao±SEM) with pulmonary 
hypertension unrelated to left heart failure. While patients were breathing 
100% ~, measurements were taken at baseline, during NO inhalation, during 
IV nitroprusside titrated to a systolic arteriaJ pressure of 90 mmHg (NTP, doe 
289 ± 7S "g/min) and after sublingual nifedipioe (NIF, dose 23 ± J.8 mg) 
administration. Mean PA pressure (PA, mmHg), pulmonary vascular 
resistance (PVR, dyoo-sec/cmS), mean systemic arterial pressure (MAP), 
micromaoometer RV end-<liastolic pressure (RVEDP),and RV dP/dt ala 
developed pressure of IS mmHll (dP/dtDPIS, mmHg/sec), were: 
fA fYR MAE ~ ~ 
Baseline SS±4 899 ±I 46 107±8 11±2 472±30 
NO 46±4* 679±132* 107±9 9±2* 433±18 
NTP 48±4* 726±8S 80±8* 6±1* 47S±20 
N1F S3±3 822±121 96±10* 11±2 411±27* 
(*P < 0.05 vs baseline) 
Cardi"" output (CO) was unchanged on NO, NTP and N1F compared with 
baseline. Conclusions: (I) NO decreases PA and PVR without decreasing 
MAP or altering dP/dtDPIS. (2) NTP decreases PA, but its utility is limited 
by. fall in MAP. (3) NIF decreases RV dP/dtDPIS, consistent with a 
negative inotropic effect. 
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794·3 2:30 
Octreotide (SMS 201-995) Prevents Superior Mesenteric Artery 
Va.w1ila'atjoo and POS!.Prandia1 HypoteasWn in Human Autonomic Failure. 
I S Kooner , R Baliga , W S Peart, R Bannister & C J Mathias. 
Clinical Cardiology Unit, Department of Medicine, Royal Postgraduate 
Medical School, London. St Mary's Hospital Medical Schoo~ London. UK 
We bave studied the bacmoclynamic responses to a liquid meal in S patients 
with primary autonomic failure before and after Octreotidc (SMS 201·995), the 
somatostatin analogue, which inhibits the release of gastrointestinal peptides. 
S~ects Wl:re studied while supine, in a temperature controlled laboratory 
(23.±.1 C), after a 12 hr fast. Saline placebo (O.5ml) or Octreotidc (SOug) was 
injected subcutaneously 30 min before a balanced liquid meal (66g carbohydrate, 
22g fat and 1Sg protein), and measurements were made for 60 min. Blood 
pressure (BP) and heart rate (HR)(Sentron), cardiac index (CI, continuous wave 
Doppler ultrasound, Exerdop), forearm blood flow (FBF, strain gauge 
plethysmography), digital (thumb) skin microvascular flow (LOF, laser Doppler 
flowmetry, Periflux, PF2b) were measured non·invasively. Superior mesenteric 
artery blood flow (SMABF) waS measured by a real time sector scanner and 
pulsed Doppler flowmeter (Ultramarlc S A TL, 5 MHz pbased array transducer). 
The study had ethical approval. Data are presented as means.±. s.e.m. ANOVA 
and 't'tcsls were used in data analysis. p<0.05 was considered significant. 
After placebo and the meal, MAP fell (I22.±.S to 99.±.9 mmHg. p < 0.05). 
SMABF rose (0.41.±..05 to 0.743.±.-148 l/min, p <0.05) and superior mesenteric 
artery vascular resistance (SMA VR) fell (371.±.94 to 167.±.33 units, p<0.05). 
There were no other baemodynamic changes. After Octreotide, there was a 
transient rise in MAP (US.±.6 to 135.±.S mmHg, p<0.05). SMABF fell 
(0.497.±..03 to 0.40.±.-03 I/min,p<O.05) and SMA VR rose (240.±.19 to 370.±.26 
unils,p < 0.05). There was no change in HR, CI, FBF and LOF. After Octreotide, 
food ingestion did not change MAP (127.±.7 to 125.±.9 mmHg), SMABF 
(0.373.±..04 to 0.323.±..04 l/min), SMA VR (352.±.19 to 386.±.31 units) or other 
baemodynamic parameters. 
We conclude that in AF patients, food ingestion increases SMABF and 
reduces SMA VR which probably contributes to the fall in blood pressure 
especially as there is no compensatory rise in HR,CI, and FVR, as observed in 
normal man. Octreotide prevents superior mesenteric artery vasodilatation and 
post· prandial hypotension, probably through inbibiting tbe release of 
vasodiIatatory gastrointestinal peptides. 
794·4 2:45 
Monosodium Glutamate Increases Vascular Tone and 
Potentiates the Vasoconstrictor Effect of Norepinephrine: 
Potential Mechanism of Vasospasm 
Bai Cbun Yang. Paulette Mehta, Phillip Behrens, Iawallar L. Mehta 
University of Florida and VA Medical Center, Gainesville, FL 
Monosodium glutamate (MSG) consumption has been 
reported to provoke asthma and headache. These effects of MSG 
have been attn'buted to smooth muscle constriction. To determine the 
direct effect of MSG on vascular tone, rat aortic rings with intact 
endothelium (endo+) and others with disrupted endothelium (endo·) 
were exposed to MSG (lO's to 10- 1 M) in an organ bath. MSG 
caused a concentration-dependent contraction of vascular rings, more 
pronounced in endo- than in endo+ rings (maximal tension 
0.16±O.0.3 and 0.93±0.14 g/mg, respectively, P<0.05, n-6). The 
contractile response to MSG in endo- rings occurred in two phases, 
an initial « 1 0 sec) mild and sustained contraction and a second 
delayed (at 10 min) marked contraction mimicking spasm. Pre•
treatment of endo+ rings with MSG (10.3 M) potentiated the 
subsequent contractile effect of norepinephrine (NE). Pretreatment of 
endo+ rings with NE also resulted in marked contraction in response 
to MSG. In MSG·treated endo+ rings, the acetylcholine-induced 
relaxation was decreased by 15±2%. The vasoconstrictor effects of 
MSG were not blocked by the TxAz receptor antagonist SQ 29548 
(Io-SM) or the serotonin receptor antagonist LY 53857 (lO-s M), but 
were attenuated by the glutamine receptor antagonist ketamine HCI 
(10-3 M). Ketamine also blocked the potentiation of the effects of 
NE by MSG. The decrease in acetylcholine. mediated relaxation 
suggests that MSG may decrease the relea5C'/activity of endothelium· 
derived relaxing factor, and thereby potentiate the vasoconstrictor 
effects ofNE. The direct potent contractile effects ofMSG in endo•
rings suggest glutamine receptor activation following exposure of 
vascular smooth muscle to MSG. Thus, intake oftarge amounts of 
MSG by susceptible individuals (those with endothelial dysfunction 
or high catecholamine levels) may result in vasospasm. 
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EFFECTS OF COCAINE ON CAROTID ARTERY REACTIVITY IN 
YORKSHIRE SWINE AFTER BALLOON VASCULAR INJURY: AN IN 
VIVO AND IN VITRO STUDY. 
Boris 0 Nu/IeZ, Lin Miao. Joseph P. Carrozza, James Ross, Steven Gladstone, 
William Grossman, Donald S. Bairn, James P. Morgan. 
Harvard· Thorndike Laboratory Beth Israel Hopital, BoslOn, MA and Tufts 
University, School of Veterinary Medicine, North Grafton, MA.. 
The usc of cocaine has been increasingly associaled with iscbemic and hemonaghic 
strokes. Although the exact mechanism of cocaine relaled stroke remains uncertaiD 
carotid vasospasm has been suggested as a potential mechanism. To test this 
hypothesis, we studied 13 pigs, eight weeks after bilateral carotid baJIooD 
angiop1asty (Smmx3cm). All swine were fed regular chow diet. Carotid angiography 
were performed during infusions of cocaine (1,3,10 mg/kg). Luminal diameter 01 
the normal reference segment (RS) and the angioplasty site (AS) were measured by 
digital calipen in both the right (R) and left (L) carotid (C). Angiography rcsulls an: 
expressed in cross·sectional area(CSA mm2). Data expressed (Mean±SE) 
Cocala. R •• ulll: RC, CSA in the RS segment decreased from 16±2 to 13±1 
with ImWJ<g; 10 11±2 with 3mWKg and to 7±1 with 10 mWJ<g (0) RC, CSA in 
the AS segnent decreased from l5±2 to 12±2 with I mWJ<g; to 11±2 with 3mJK, 
and to Sil with the IOmg/kg (0) Simillarly, the LC, CSA in the RS decreased from 
15±2 10 14±2 with ImWJ<g; IOI0±2 with 3mg/kg; and 10 7±1 with 10mg/ks 
(O).The LC. CSA in the AS segment decreased from 14±S to J3±2 with Img/Kg;UJ 
lIB with 3mg/kg and to Sil with 10 mg/kg(O). We did not observe any localized 
vasospams. (0 p value .0.001 baseline vs 10 mWJ<g dose) 
la vltra Results: Resting and peak isometric force development of isolated 
normal RS and AS ring segments were measured: 
Resting 60mM Histamine Acetylcholine 
Fm:e KCL (%cImnge) (%cImnge) 
(10 4 xN/m2) (10 4 xN/m2) 
Cocaine 
(%change) 
RS(n=I5) 7.S± l1±O.9 556±76 373±125 0 % 
AS(n=IS) 7.4 11±J.9 475±73 223±S9 0 % 
(There was no statistical difference in resting tension between RS and AS 
segments.) Resting force, KCL, Histamine and Acetylcholine produced simil81 
degrees of contractions in the normal reference segment and in the hyperpastic 
segment, whereas, cocaine, in concentrations up 10 3xlo-3M failed 10 produce 
contraction. Conclusion: 1)10 this model of vascular injury, cocaine produced a 
moderate generalized carotid vasoconstriction in vivo, 2) Since there was no 
response ill vitTO. the ill vivo effect was most likely mediated by neuro-humoral 
factors,rather than by a direct action of cocaine 011 vascular smooth muscle. 
794·6 3:15 
Medical Complications of Coc.!aine: Possible 
Relationship to Low Plasma Cholinesterase 
Enzyme. 
A. Om, S. Ellahham, J.P. Ornato, C. Picone, 
J. Theogaraj, G.P. Corretjer, G.W. vetrovec. 
Medical College of Virginia, Richmond. 
Despi te widespread cocaine use, the incidence 
of its reported complication is low. Cocaine 
is metabolized by plasma cholinesterase 
enzyme (PCE) and deficiency or low level of 
PCE is known to exist. To assess the 
possibility that low PCE is a factor in the 
development of cocaine- complications, PCE 
were measured in 3 groups. Group I-patients 
with cocaine-induced complications (n=14, age 
32±7 yrs, 8 had myocardial infarction, 2 had 
cardiomyopathy, 1 had intracranial bleed, 1 
had sudden death, 1 had CAD and 1 had 
seizure); Group II - chronic cocaine users 
wi thout documented complications (n=25, age 
37 ±10 yrs); and Group III non-cocaine users 
(n=14, age 31±2 yrs). The PCE level of all 
the groups is shown in Figure. Despite 
overlap, pts in Group 1 had a significantly 
lower PCE level than ottler groups (P<O. 05) • 
we conclude that 
persons with low PCE 
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rt-PA Prese"e5 Left Ventricular Function Better Than 
Streptokinase 24 Houl'S After Acute Myocardial Infarction 
George J Taylor for the Central Illinois Thrombolytic Therapy 
Study (CmS). Prairie Education & Research Cooperative, and 
So IL Univ, Springfield, IL 
CITTS was a blinded, randomized trial comparing rt-PA and 
STK in 253 patients (pts) treated 2.4±1 hrs after onset of MI; 
left ventricular (LV) function was the primary endpoint. We 
previously reported no difference in global LV ejection fraction 
(L VEF) measured 8 days after MI. Because of recent studies 
indicating a high rate of early reocclusion of the infarct artery 
after coronary thrombolysis, we now report results of 
angiography performed 19±10 hrs after MI. 
There was no difference in global or regional LV function in 
pts with inferior MI. LV angiograms could be analyzed in 90 pts 
with anterior MI. 
Results: Global LVEf was 45±12 with rt-PA and 39±13% 
with STK treatment (p < 0.03). The RAO image was divided into 
6 wedge-shaped segments for measurement of regional EF. 
Apical EF was similar with rt-PA and STK, but was better with 
rt-PA in anterolateral (18±24% vs 9±18%, p=.04), and distal 
inferior (35±22% vs 26±20%, p=O.07) segments. 
Conclusion: Despite small sample size, global and regional 
LVEF were higher in pts with anterior MI treated with rt-PA 
when measured within I day of coronary thrombolysis. We and 
others who have reported L VEF > 1 week after thrombolysis 
observed no difference when comparing the 2 drugs. We 
speculate that early reocclusion of infarct arteries may obscure 
clinically important differences between rt-PA and STK. 
795-2 2:15 
Reladoa JIetwftD Thrombolytic 1berapy, Coronary PateDcy aad Left 
Veatrlealar 1brombus iD Acute Myocardlallnfan:tloa 
Giuseppe Pizzetti, Giuseppina Belotti, Mauro Carlino, Stefano Gerosa, 
Alberto Margoaato, Sergio Cbiercbia. H S Raffaele, Milano, Italy. 
Previous studies report contr<m:rsial data about the effect of thrombolytic 
therapy (TL) on the incideDtC of LV thrombus (L VT) after acute myocardial 
infarction (MI). We studied 123 consecutive patients (pIS, age 57 yn.± 11) 
who presented with a first anterior MI and exlubited a proximal lAD Ie· 
sion/occlusion; 59 (group A) received i.v. TL (32 SI{, rI rTPA) and 64 (group 
B) did not. In a1l, technically adequate 2D Etbocardiograms were obtained 
within 3 weeks of CCU admission. The presence of L vr was related to the 
patency of the lAD (OP:opeo, CL:closed), presence of coUaterais (Coli: 
Rentrop's grade 2-3) when the vessel was occluded and oc:c:urrcnce of an early 
CK peak (eCK;s 12 hrs from the onset of the symptoms). Overa1l, the 
percent incidence of L vr was significantly lower in group A than in group B 
(26 vs 45, P - 0.04). The % incidence of L vr and the echocardiografic: 
asynergy score (SC) in the different subgroups are summarized below. 
CL CL.+CoII OP Op.eCK 
A(%) 57% 30% 14% 7% 
st. 19.±8 18.±3 16.±6 16.±7 
B(%) 58% rI% 35% 0% 
st. 20.±7 18..±7 lS.±7 12 (lpt) 
In conclusioo, in anterior MI, the incidence of L vr is lower in pts treated 
with TL especiaUy when vessel patency is achieved early. The presence of 
coUaterais seems to provide some protection against L vr formatioo, 
probably by limiting the extent of myocardial damage. The results suggest 
that in anterior MI the presence of L vr is inversely related to the extent of 
myocardial sa1vage achieved by reperfusion. 
795-3 
JACC Vol. 21, No.2 
February 1993:370A 
2:30 
Iffect of lar1y BDa1apri1 Therapy 00 Left Veotricular 
V01u.a. 10 Acute MYocardial Iof.rctioo 
Steven Schulman, Gary Geratenblith, Alan Guerci, Niaha 
Chandra, Lewis Becker, Cynthia Sui, Vicki Coombs, John 
Petronis, Harlan Weisman, Myron Weisfeldt. Johns Hopkins 
Medical Institution., Baltimore, MD and Columbia 
Preabyterian Hoapital, New York, NY 
In a double-blind, placebo (P) controlled trial 
evaluating intravenous (1 mq/2-3 hours) followed by oral 
(up to 20 mq) enalapril (I), 26 patients (PTS)presenting 
within 24 hour. of a first Q-wave myocardial infarction 
had pre-drug and one month gated blood pool scan •• 13/14 
I PTS and 11/12 P PTS received thrombolytics. Mean 
arterial presaure (± SI) waa aimilar between the two 
groupa at baseline (86.3 ± 2 (I), 91.9 ± 2 (Pl), 
predischarge (80.5 ± 2 (I), 83.7 ± 2 (Pl), and one 
month (92.9 ± 3 (I), 94.8 ± 4 (Pl). Pre-drug end 
diastolic volume (I!!DV) , end ayatolic volume (ISV) , 
cardiac output (CO),. and ejection fraction (IF) were 
similar in the two groups. The percentage change from 
baseline to one month in theae variables ia ahown in the 
table. 
IF CO IDV 
I: 19.6 ± 9'· -6.2 ± 10' -2.0 ± 6' 
I!!SV 
-8.4 ± 9\ 
P: 4.7 ± 6\ -14.5 ± 15' 13.4 ± 4'- 14.5 ± 8'-
'p < 0.05 for I vs P, 'p < 0.05 for baseline vs one 
month. Data expreased aa mean ± SI. 
When patienta were atratified by infarct location, the 
beneficial effect of I on cardiac volumes was limited to 
thoae patients with anterior infarctions. Therefore, I 
initiated within 24 hour. of an anterior Q-wave 
myocardial infarcti"n decreaaes cardiac volumea and 
increaaea ejection fraction without a change in mean 
arterial preaaure, probably reflecting beneficial 
effecta on left ventricular remodelling. 
795-4 2:45 
Enalaprillmpro.,. Sunim and Left Ventricular FunctIon In Paden .. 
not ReperfuIed After 'Ibrombolysil. 
-Giuseppe M.C. Rosano, @Francesco Romeo, -Eugenio Martuscelli, 
Cesare Bianco, Michele Comito, Michele Miceli, Francesco Miceli, Biagio 
Milano, Nicola Cardona, Corrado Colistra, Vito Rosano. Dept of 
Cardiology Vibo Valentia bospital 'G.Jazzolioo', @UniversityofCatania, 
·University of Roma. Italy 
The aim of the present study was to evaluate the effect of ACE inhibitor 
therapy with Enalapril in patients with acute myocardial infarction not 
reperfused after thrombolytic therapy. Eighty nine patients (pts) with acute 
myocardial infarction wbo did not sbow signs of reperfusion after 
thrombolytic therapy (administered within 3 bours from the onset of 
symptoms) were randomly assigned to treatment with Enalapril (Group A 
46 pts) or placebo (Group B 43 pts). The two groups were similar with 
regard to infarct size (evaluated enzymatically) and distribution of coronary 
lesions. All pts also received standard treatment with nitrates, beta•
blockers, and heparin. During hospitalisation 2 pts from Gr.A and 9 pts 
from Gr.B died of cardiac related events, p < 0.01. No deaths from 
haemorrhagic causes were observed in either group. At discharge 1 pts of 
Gr.A and 11 pts of Gr.B developed left ventricular aneurism (with 
echocardiography), p < 0.001. The mean fractional shortening was 
0.29±0.03 in Gr.A pts and 0.2aO.04 in Gr.B pts, p<O.OOl; moreover 
Gr. A pts had a significantly better regional wall motion compared with 
Gr.B pts. The Q wave score on the electrocardiogram at the time of the 
discharge was significantly higher in patients from Gr.B, p<O.OOI. 
In conclusion: ACE inhibitor therapy improves the short term survival and 
&lobi! and reaional left ventricular function in pta with myocardial 
infarction not recanalised after thrombolytic therapy. 
JACC Vol. 21, No.2 
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Effects of Early Enalapril Treatment on Left Ventricular Glo•
bal and Regional Wall Motion in Acute Myocardial Infarction 
Jens Berning, Steen Carstensen. Vemon Bonarjee, Magnus Edner. Dennis WT 
Nilsen. Kenneth Caidahl for !he CONSENSUS IT Multi-Echo Trial. Hospitals of 
Copenhagen and Hi1Ier0d. Demnark. Slavanger. Nmway, and Gothenburg and 
Stockholm. Sweden. 
The effects of early angioteosin-<:Ollverting-enzyme inhibition on LV fiulction 
after AMI are not fully characterized in man. We studied 428 patients (pts) ran•
domized within the double blind placebo (P) conttolled multicenter uial CON•
SENSUS IT, who received trealmCnt witb acute (<24 b) i. v. enalaprilat followed 
by 6 months of oral enaIapril (E) (up 10 20 mg daily). All pIS were subjected 10 
serial 20 echocardiograpby and investigated 2-S days. I and S.1 months (early 
termination of CONSENSUS m after onset of symplOms. Baseline characteristics 
did not differ berween groups.·L V regional wall motion was analysed and a 
global wall motion index (WMl) calculated by a single investigator within !he 
frame of a 16-segment model accounting fer hyperkinesia. Digitized loops of 
apical and cross sectional views were evaluated. Acceptable images were obtai•
ned in 401 pts (9S%) on 1 and in 348 pts (81 %) on at least 2 occasions. Inter•
observervariation berween paired observations of WMI was (mean±SO) -0.008 
to.17. A paraJlel improvement of WMI was seen from initial 10 final exami•
nation within botb the E and !he P groups Hl.06 and -O.OS. p<O.OI). In 216 pIS 
witb available echocardiographic biplane volume measurements. in whom E bad 
a beneficial effect on LV-volumes after 1 montb compared witb P, the improve•
ment of global wall motion index from initial 10 final examination was insignifi•
cantly larger in tbe E group than in the P group (0.05<p<O.10). No differences 
in changes of regional wall motion were observed berween tbe treaDnent groups. 
Thus. early angiotensin-converting-enzyme inhibition «24 h) witb enaIapril. as 
measured by echocardiography, appears 10 have a neutral effect on LV global 
and regional wall motion during the first S months following AMI in an unse1ec•
ted group of patients. 
795-6 3:15 
CAPTOPRIL BEFORE REPERFUSION IN ACUTE MYOCARDIAL INFARCTION: 
THE CAPTIN EXPERIENCE 
Judith S. Hochman, M.D., R. Edelstein, M.D., S. Palmeri, M.D., M. Sands, 
M.D., S. Siskind, M.D., M. Nanna, M.D., P. Hermany, M.D., M. Blumenthal, 
M.D., J. Eni, A.E. Weyman, M.D., R. Hahn, M.D., J. Strom, M.D., M. H. 
Picard, M.D., E. Sonnenblick, M.D., and T. LeJemtel, M.D. for the CAPTIN 
Study Group (NY, NY). 
CAPTIN is a unique study testing the hypothesis that captopril (CAP), 
initiated parenterally (IV) concomitantly with tissue plasminogen 
activator (TPA), will reduce LV dilation and reperfusion injury after acute 
anterior MI. LV volume and extent of wall motion abnormality were 
measured using serial 20 echocardiograms during the 3 month follow·up 
period. Blinded study drug ( 2 mg IV; CAP or placebo) was initiated 
during TPA infusion within 6 hours post·MI and was followed 15 minutes 
later by a 4 mg IV dose. Oral therapy (6.25 mg) began within 2 hrs and 
was titrated over 24 hrs to a maximum of 25 mg TID for 3 months. A total 
of 260 patients were randomized. In the first 24 hrs: 78% of patients 
also received IV nitroglycerine; blood pressur.e averaged 129/81 mmHg at 
baseline and decreased to 11]/70 at 24 hrs; only 1.9% of patients were 
withdrawn because of symptomatic hypotension; mean heart rate was 
not significantly changed. Total in-hospital mortality was 4.6%. Over 
the 3 months follow-up: delayed hypotension requiring withdrawal 
occurred in 3.6 % of patients (mean duration of therapy = 21 days); only 
1.2% of patients were withdrawn because of worsening angina 
(mean = 42.7 days). 
In conclusion: analysis of 
blinded data suggests that 
captopril is tolerated when 
initiated concomitantly 
with TPA. Safety and 
efficacy results, inc! uding 
echocardiographic volumes, 
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Bffect of Alterations in Left Ventricular 
Loading Conditions on the Timing and Magnitude 
of coronary Blood Flow During Systole 
Knut Bjornstad. Alex Neumann. Svend Aakhus. Liv 
Hatle. Kenneth M. Borow. univ Hosp. Trondheim. 
Norway. Rush Med CoIl & Univ of Chicago. IL 
371A 
LAD blood flow(Ql during LV systole is generally 
regarded as contributing :51/3 of Q-LADtotal. To 
study the relationship between Q-LAD and LV-Ao 
coupling. data were acquired with pre-calibrated 
Ao and LAD DOppler flowmeters and high fidelity 
Ao catheter at baseline(BL). during esmolol 
(~contractility) and with Ao snare (iafterload). 
LAD MV02 was measured. (*p<.05vSBL#2) 
m..u. ~ m...u ~ 
CO (L/min) '2.5 2.4 2.4 2.0* 
Mean Psyst (rnmHg) 99 94 89 109* 
Mean Pdiast (rnmHg) 87 81 82 83 
Q-LADtotal (ml/beat) 0.41 0.39 0.35 0.44* 
Q-LADsyst (ml/beat) 0.09 0.10 0.09 0.17* 
Q-LADdiast (ml/beat) 0.32 0.29 0.26 0.27 
Q-LADsyst/Q-LADtotal 22% 26% 26% 39%* 
MV02 (ml/min) 2.6 2.5 2.3 2.8* 
iQ-LADtotal tracked with imean Psyst and Q-LADsyst 
but not mean Pdiast and Q-LADdiast. On analysis of 
forward (f) and reflected(r) AOP waves. the 36 
rnmHg i in peak AoP with snare was due to 31rnmHg 
i in Pf and 5rnmHg i in Pro Thus. changes in the 
magnitude and timing of LV load alter Q-LADsyst . 
Isolated changes in Q-LADsyst can be an important 
mechanism for meeting raised LV metabolic needs. 
796·2 2:15 
EUect of Diabetes on Left Ventricular Systolic Function In the 
Dysfunctloual Left Veutrlcle 
Steven J. Lavine and Petar Prcevski. Wayne State University. Detroit, 
MI 
Althougb in tbe normal left ventricle, experimental diabetes mellitus 
(OM) induces LV systolic and diastolic dysfunction. the influence of 
OM and blood glucose control on LV systolic function in tbe 
dysfunctional left ventricle is unknown. We studied 7 mongrel dogs 
(1 S-2Skg) witb cbronic moderate global LV dysfunction induced by left 
main coronary microspbere embolization prior to and 3 and 6 months 
following the induction of OM using alloxan tetrahydrate. For tbe first 
3 months (poor control), fasting blood glucose (FBS) was maintained 
between 2S0 - 400 mgldl using insulin. For the second 3 montbs (good 
control), the FBS was maintained between 100-ISO mgldl using insulin. 
LV systolic function was evaluated using high fidelity aortic and LV 
pressure and echocardiography during methoxamine infusion (raised 
systolic pressure> SO mmHg). With the induction of LV dysfunction. 
the LV dilated 41%, LVEOP increased to IS ± 3 mmHG, and the echo 
sbort axis area ejection fraction was 27 ± 4% (normal> 40%) (all p < 
.05). After 3 months of OM (poor control), LV size furtber increased 
14%, LVEOP increased 3 mmHg, and the area ejection fraction was 22 
± S% (all p < .OS). The slope of end systolic pressure to end systolic 
dimension declined from S9 ± IlmgHg/cm to 4S ± 7mm Hg/cm (p < 
.OS). Similarly. plots of the velocity of circumferential fiber shortening 
to end systolic stress demonstrated downward and leftward shifts for 
eacb dog (reduced contractility). Following 3 months of good control 
(now 6 months of OM). LV size. area ejection fraction and L VEOP 
became similar to values obtained from cbronic moderate LV 
dysfunction pre-OM. The slope of end systolic pressure to end systolic 
dimension increased to 62 ± 9 mmHg/cm and tbe plots of tbe velocity 
of circumferential fiber sbortening to end systolic stress moved upward 
and rigbtward toward tbe pre-OM position in eacb dog. We conclude 
tbat poorly controlled OM (based on FBS) results in furtber 
deterioration of LV systolic function in tbe dysfunctional left ventricle. 
Second, blood glucose control appears to bave a modulating effect on 
LV systolic performance. 
372A ABSTRACTS 
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Diff.r.ntiation B.tw .. n Alt.ratlon. in R.gional 
Aft.rload (Wall Str.a.) and D.pr •••• d Contractility 
in Myoc.rdlal I.ch.mia: U •• of Finit. EI.ment Method 
Kenneth M. Borow, Alex Neumann, Knut Bjornstad, Arild Buland , 
Svend Aakhus, Liv Hatle. University of Chicago and Rush Medical 
College, Chicago IL, University HOSpitll, Trondheim, Norway 
In the ischemic LV, segments can have .j, systolic wall thickness with 
a larger than normal regional radius of curvature. In theory, since 
these factors impact importantly on regional fiber load [wall stress 
(0)), Ischemia can result in i regional aftertoad (AF) despite normal 
LV pressures. Similar to assessment of global LV function, there is 
an inverse relation between regional LV fiber load [end-systolic (es) 
oJ and wall thickening (ah). We hypothesized that J,.ah in ischemia 
reflects bIUb..j, regional contractility and a disadvantageous i in 
regional 0... To test this hypothesis, we developed an open chest beta•
blocked porcine model of LV ischemia using pre-calibrated LAD 
Doppler flowmeter, high fidelity LV pressure catheter and occluder 
around the LAD. Finite f , ..... 
element method was used to -". 
calculate regional 0 based I,· 
on 120 nodes (30 sectors) '2. 
from 20 echos in the mid- I 
eAfll 
equatorial plane. For aM a 1-
regions, data were acquired • 5~O--7~O--'-.-~11-.-'~3"':. ~'~5.--I17. 
at control (CTRL) and over End-8yIIoIc _ (kdyneoIcm2) 
a range of AF (Ao snare). Ischemia data were obtained at 50% J,. in 
LAD flow. The example is from an ischemic zone. CTRL and iAF 
formed a line showing effect of iload (aL) alone on thickening (ahJ. 
The deviation of the ischemia data below the line (ahc ) reflects .j, 
contractility after AF has been eliminated as a variable. Thus, in LV 
ischemia, it is now possible to assess the impact of bIUb. regional load 
and contractility on J.ah. This has implications for reperfusion 
therapy as well as analysis of acute and chronic LV remodeling. 
796·4 2:45 
Accuracy of Single", Dual Field Excitation of the Conductance Catheter 
to Detennlne Absolute Left Ventricular Volume and Contractllily 
Marc D. Feldman, Komathi Subbiah. Patrick Finnerty. Howard L. Haber. 
Antharvedl Anne. Thomas C. Skalak. 
University of Virginia. Charlottesville, VA 
Since dual field (OF) excitation increases the homogeneity of the electric field, 
we hypothesized tbat the OF catheter would be more accurate than the single 
field (SF) catheter in larger volumes (V). The conductance catheter (CC) has 
been shown to be accurate only in cylinders with maximum V of 90 ml. 
However, c1iuical application requires calibration in larger V with more 
physiologic shapes, and demonstration that the relation between CC and true 
volume (TV) is linear with slope ". The relation between CC and TV was 
analyzed in glass cylinders and prolate ellipsoids with V ranging from 10 to 400 
ml. Results are shown below. ... -'Mm' I 'M 1« :: 
, ," ... I" ... 
~1JA41 . , .......... . 
OF approaches the line of identity (ID) in cylinders, but still undrrestimates TV 
in ellip50ids. In larger V, the relation between CC and TV is nonlinear, 
yielding a variable... To determine the effects of this nonlinear relation on 
end-systolic elastance (E.,) in patients with different sile heans, Ee, was 
calculated in 16 patients (pis) with CC using constant and variable". Ee, was 
determined using left ventricular pressure-volume loops generated during beat•
by-beat load changes. 8 pts were normal (NL. end-diastolic volume 161 ±32 
ml) and 8 pts had congestive heart failure (CHF. end-diastolic volume 245 ± 45 
ml). There was a greater percent decrease in Eet in the CHF pIS between 
constant and variable .. (1.13 ±0.6S to 0.90±O.51 mmHg/ml. 20±9%) than 
in NLplS (4.93±1.33 t04.59±1.39 mmHg/ml, 7±4%, p<.OI). 
In conclUSion. OF is more accurate than SF in larger volumes. However, in 
more physiologic shapes the accuracy of OF is decreased. The accuracy of the 
CC decreases nonlinearly in volumes greater than 100 ml, affecting absolute 
determination of E .. to a greater extent in patients with larger hearts. 
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Acate PA Ocdusioa Alters LoagitudiDal WaH Curvature aad Regiooal VolUlDe 
Dlstributloa of the Rlgbt V..,tricle \a Closed'(best, CODSdOU8 Dop. 
Marc R. Moon, Abe DeAndaJr, Luis J. Castro, George T. Daughters, Srdjan D. 
Nikolic, Neil B. Ingels, O. Craig Miller. Stanford University, Stanford, CA. 
The study of regional R V function has been limited due to difficulties in 
accurately representing 3-D geometry of the RV and septum. To facilitate this 
analysis, we implanted 17 tantalum markers into the RV free wall (7) and septum 
(10) of 7 dogs, aIlowing evaluation of 3-D geometry and volume in 3 RV regions 
(inlet, sinus, outflow tract [RVOT)). Following chest closure, recovery from 
anesthesia, autonomic blockade, and atrial pacing, biplane cinefluoroscopic 
marker images and R V pressure were recorded during the control state (R VP 
28.6±4.7 mmHg) and during acute partial PA occlusion (RVP 50.4±1r.! 
mmHg). End-diastolic volume of each region (r-EOV) was ~~ulated and 
reported as a percent of total RV-EDV (r-EDV% z r-EDV / RV-EOV). To 
evaluate wall motion, meridional wall curvature (1 / radius of curvature) was 
determined for the septum and RV free wall (FW) using paraIleJ marker arrays 
oriented along the RV meridional axis (positive is concave towards LV). Septal•
FW dimension (SFW) was measured in all 3 regions. RESULTS (mean ± SO): 
~ ..BU.i!!J!J ...BY2l 
r-EDV (m1) Ctri 21.2±6.8 t 20.8± 6.5, 17.5 ± 8.7 t 
PA Oa: 25.0±8.7 24.5± 7.3 18.5± 8.9 
Ctri 36.8±8.2
t 
35.1± 5.2, 28.2± 8.7 
PA Oa: 37.5±8.0 36.2± 5.1 26.3± 8.7' 
r-EDV'lI> 
RV SFW(cm) Ctri 2.96±0.9 3.48± 0.5 t 2.67± 0.5, 
PA Oa: 3.11 ±0.9 3.72± 0.5 3.06± 0.5 
'p<.Ol, t p<.05vs. PA Oa: (paired t-test, Hotelling's T2 test) 
WaIl curvature of the RV FW decreased (wall flattening) with PA occlusion 
from .163±.1O to .139±.09 (p<.05; Wilcoxon signed-rank test); similarly the 
septum flattened as waIl curvature decreased from .206±.13 to .157±.14 (p<.02). 
CONCLUSIONS: With increased RV afterload, the RV FW and septum flatten 
with respect to the LV (~curvature); however, since RV SFW dimension 
increases in the inlet and sinus regions, there must be a relative shift of the mid 
septal wall towards the LV while the inlet portion of the R V FW shifts outward 
to accommodate increased RV volume. Simultaneously, a redistribution of 
volume occurs as blood is shifted from the RVOT (~EDV%) to the inlet and 
sinus regions (t EOV%). Therefore, regional RV and septal geometry (volume 
distribution, shape) are significantly influenced by changes in RV afterload. 
796·6 3:15 
Right Ventricular Remodeling Following Left Ventricular 
Anterior Wall Myocardial Infarction 
Ken Hirose, Nai H. Shu, Judd E. Reed, Bernard J. Gersh, 
John A. Rumberger, Mayo Clinic, Rochester, MN 
It has been well documented that the LV cavity progressively 
dilates in patients during the first year after an index anterior wall 
MI; however, despite significant LV remodeling little is known 
about concomitant adaptations, if any, in RV chamber volumes. 
To address this issue we used Cine CT to determine absolute 
LV and RVend-diastolic (EOV) and end-systolic (ESV) volumes 
in 14 patients without clinical CHF following a first transmural 
anterior wall MI. No patient was taking ACE inhibitors. Each 
patient completed serial imaging studies at hospital discharge 
(d/c), 6-weeks, 6-months and 1-year. Results are shown 
graphically below (mean.± SEM, * = P < .05 versus d/c). 
Conclusions: Umited but progressive RV remodeling occurs 
after anterior wall MI; however, its magnitude is much less than 
that seen concomitantly in the 
LV. There may be several 
reasons as to why this 
adaptation occurs in the RV. 
• but it is likely due in part to a 
composite of changes in 
segment length, wall thickness 
T' and compliance within and 
~' adjacent to the infarcted interventricular septum which 110 effect both the RV and lV. 
l--'--_-'-_-'-__ '-- Cardiac remodeling following 
die 1-.kL I-mo.. t-,.-. anterior MI is a global process. 
TYNI from infarction 
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Regulation of an MLC-2 Luclferase Transgene In an In Vivo 
Murine Model of Right Atrial and Ventricular Overload 
Howard A. Rockman, Kevin J. Lee, John Ross, Jr., Kenneth R. Chien, 
UCSD School of Medicine, AHA Bugher Foundation Center, LaJolla, CA 
Under normal conditions, the ventricular form of myosin light chain·2 
(vMLC·2) is expressed in the atria during development but expressed 
only in the ventricle in the normal adult. Although previous studies in 
some species have shown that vMLC·2 can be induced in the atria in 
response to hemodynamic overtoad, the mechanisms which regulate 
vMLC·2 geml expresssion in the atria are unknown. To address this 
issue we have developed a murine model of severe right atrial (RA) and 
right ventricular overload (RV) by banding of the pulmonary artery (PAB) 
and applied this model to transgenic mice harboring a 250bp rat cardiac 
vMLC·2 luciferase transgene. These mice have previously been shown 
to have restricted expression of the reporter gene to the ventricle with 
low levels in the atria. Under a dissecting microscope, adult mice were 
anesthetiZed and connected to a rodent ventilator. The pulmonary artery 
was isolated and PAB performed by tying a 7·0 nylon suture against a 26 
gauge needle which was tlien rapidly removed. Experiments were 
terminated at 2 to 7 weeks after PAB, and RA and RV free walls were 
dissected, weighed and frozen in liquid nitrogen for later analysis. 
Compared to other sham operated animals, chronic PAB resulted in a 
significant increase in RAIbody weight ratio (O.3atO.17 vs. 0.10±O.02 
rT19'g, p<O.Ol) and RVibody weight ratiO (1.48tO.51 vs. O.StO.19 rT19'g, 
p<O.Ol). RV Luciferase activity, corrected for protein concentration, was 
significantly increased in the RV following PAB (460.3±161.5 n-14 vs. 
193.7±17.6 na5 light units/"g protein, p<0.005). In contrast, no 
induction of the transgene was observed in the RA of banded animals 
compared to sham (5.7±11.5 n-14 vs. 7.a±S.9 n.5 light unitsl"g 
protein, p=ns). Thus, although the 250bp region of the vMLC·2 5' 
flanking region can confer low level induction of the luciferase reporter 
gene to the overtoaded ventricle, it is not sufficient for induction in the 
overloaded atria. This suggests that during hemodynamic overload 
distinct regulatory programs control gene expression in the atria and 
ventricle. 
797-2 2:15 
Selective Changes in Gene Programming Characterize the Transition From 
Hypertrophy to Failure in Aortic Banded Rats 
Ellen O. Weinberg, Beverly H. l.orell, Phillip E. Ray, Arthur M. Feldman, 
Beth Israel Hospital, Boston, MA, lohns Hopkins Medical Instirutions, 
Baltimore, MD 
Pressure overload hypertrophy is associated with a switch to a fetal 
pattern of gene expression. To assess whether this change persists during 
subsequent failure, we measured steady state levels of LV mRNAs in rats 
S wks (compensated hypertrophy· LVH) and 20 wks (Failing) after 
ascending aortic banding. In Failing vs l.VH hearts, LVIBW ratios were 
similar (4.2.:!:,0.1 vs 4.4.:!:,0.1) whereas LV systolic developed pressurelg 
LV was depressed (64.:!:,3 vs 99.:!:,S mmHg/g, p<O.OS). Steady levels of 
ANF, Ca" ·ATPase, and ,B·MHC mRNAs were assessed by quantitative PCR 
in LVH, Failing, and age.matched sham·operated controls (C): 
~ --!.Y!:L _C_ Failing 
ANF 6.4.:!:,1.0 36.0.:!:,3.1* 3.0.:!:,1.0 18.8.:!:,1.8* 
,B·MHC 4.2.:!:,0.3 8.9.:!:,1.l* 1.02.:!:,0.1 1.89.:!:,0.1 
Ca" ATPase 2.2.:!:,O.3 2.7.:!:,0.3(NS) 2.46.:!:,0.3 !.32.:!:,0.7' 
(Molecules mRNAll'g IOtal RNAx107, ·p<O.Ol vs age.matched C.J 
These changes in Ca" ·ATPase mRNA levels were contirrned by 
Northern blot analyses. RESULTS: 1) The fetal· hypertrophic gene 
program persists during the transition from LVH to failure. 2) In contrast 
to earlier reports, absolute levels of Ca" ·A TPase mRNA are unchanged by 
compemated hypertrophy; however, 3) Levels of Ca" ·ATPase mRNA are 
substantially decreased with the onset of decompensation, and do not 
parallel changes in the fetal hypertrophic gene program. 
ABSTRACTS 373A 
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Impaired Response of Atrial Natriuretic Peptide Secretion to Volume Loading 
in Acute RIght Ventricular Inr8l'dlon: Role ~ Coronary Reperfusion. 
Satosbi Yasuda. Hiroshi Nonogi. Sbunicbi Miyazaki, Yoicbi 0010. Alcira Itob, 
SalOsbi Daikoku and Kazoo Haze. National Cardiovascular Center. Osaka. Japan. 
To assess effects'of reperfusion lbelliPY (RP) on secreting atrial natriuretic peptide 
(ANP), lbe response to volume loading was investigated in 15 patients (pts) with 
aculC inferior myoc.udiaJ infarction. Teo pIS bad rigbt ventricular infarction CRVI) 
and the remainiog 5 pIS without RVI served as conll'Ols. 00 admission, all pIS with 
RVI underwent RP 10 lbe proximal rigbt coronary artery lesion involving its right 
atrial blllDcbes: 5 pIS with successful RP(sRI') and the remaining 5 pts with 
unsuccessful RP (/lRI'). Within 24 bours after the onset of infarction, a rapid 
inuavenous infusion of Dexuan was performed at a rate of 200mI I Smin. 
Hemodynamics and plasma ANP level were measured before and immediately after 
volume loading. Before volume loading. the plasma ANP level (sRP 49 .6±7 .0. /lRP 
47.0±3.6pg/ml) and rigbt auial mean pressure (RAm)(.RP S.7±2.S. /lRP 
S.3±2.1mmHg)were similar between sRP and /lRP. in collltVl, plasma ANP level 
(23.7±8.3pglml) and RAm (4.0±2.1mmHg) were lower (p<O.05) !ban !bose in sRP 
and /lRP. After vollDlle loading. 9(,increase in ANP was mucb smaller in pIS with 
/lRP !ban in those with sRP and colllrol in spite of a similar increase in RAm 
(Figure). ~ (9(,) 
Z 160' 
< .s 120 
J: 
" O~=;;:;.... ....... -:'-----'r----l 
D: Control 
.: sRP 
• : IIRP 
(mean±SD) 
o 50 .. J.c~5~rJ~ 250(9(,) 
Coorlusjog: The pressure·sensitive ANP secretion was atlCnuated in pIS without 
RP, reflecting bypoperfusion of rigbt atrium. These fUlding indicate an immediate 
recovery of rigbt atrial tissue from ischemic insult by successful RP, in wbicb ANP 
is synthesized and stored. This functional recovery of rigbt atrium by RP may 
contribute 10 reduce rigbt bean failure in RVI. 
797-4 2:45 
Ventricular Specification In Vitro Independent of the 
Primitive Heart Tube 
Wanda C. Miller-Hance, Sylvia M. Evans, Kenneth R. Chien. 
University of California, San Diego School of Medicine, La Jolla, CA 
The aspects of cardiogenesis, recapitulated during the in vitro 
differen1iation of embryonic stem (ES) cells and reminiscent of murine 
embryonic cardiac developmen1 have been investigated to provide 
insight into the signalling mechanisms which activate and control gene 
expression during heart formation and throughout development. To 
determine' whether upon differentiation of ES celis, a cardiac 
differentiation program ensues which is similar bo1h temporally and in 
terms of the sequence of muscle gene expression to that observed 
during earty murine development, studies were performed to detect the 
transcriptional and translational products of cardiac muscle markers. The 
kinetics of induction of endogenous muscle genes during ES cell 
differentiation, as investigated by reverse transcriptase - linked 
polymerase chain reaction and RNase protection studies, demonstrated 
the transcriptional regulation of the myosin light chain-2v (MLC-2v) and 
atrial natriuretic factor (Aj(jF) genes during embryoid body (EB) 
cardiogenesis. MLC-2v and ANF transcripts were initially expressed on 
day 8 of EB differen1iation. concomitan1 with the appearance of 
spontaneous contractile ac1Mty in localized regions of the EB's. mRNA 
levels correspondIng to these two genE were gradually up-regulated as 
the cultures increased in complexity (days 8 through 21). Translational 
products of these cardiac muscle markers were also detected by 
immunofluorescence studies in dispersed cells from beating EB's. 
Regional patterning of the ~be occurring at the earliest stages of 
cardiogenesis has been doCumen1ed by the restricted expression of the 
MLC-2v gene to thewntncular region of the heart tube prior to septation 
and the developmen1 of distinct cardiac chambers. The finding of a 
ventricular specific marker (MLC-2v) in this in vitro system provides 
evidence for cardiac regional spec\fjcation independen1 of positional 
cues contributed by the primitive heart tube. The demonstration of the 
expression of appropriate, developmental stage-specific muscle 
transcripts in differentiated ES cells, and particularly, of a ventricular cet\ 
type. provide further support for the role of this system as a model to 
study cardlogenesls and suggtlSts a promising approach in the 
inwstigation of the specification of the various cardiac cell types. 
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n. IDducibIe F_ 01 Nitric Oxide Syntbale ia Up-lleplated by EDcIotoxiII 
Tnalmellt 01 Culand c.rdiac Myocytes ia tile Rat. 
B. Ra.ltodripoz. Tbomu F. MieaIua, Bdprdo V. ArizIia, AIIUId Kumar, 
Joaeph B. Parrillo. RIIIh l'IeIbyteriIIl St. Luke'. Medic:al Ccater. Cbic:qo. IL 
0biHJl1f.! TzeaImfIIa with eadoIoxin hu '- abown to produce • decteue of 
myocantial COIIIracIility. A mediatoc of 8UCh effect may be Ditric oxide. Evi•
daa IIbDw. that iDbibitioll of Ditric oxide aynIhue with N-Melhyl-Afainiue CID 
IboIiIh the myocantiaI ~ effect of TIImoc Necroeia Factor. Recemly it 
hu Il1o '- abown that Ihae u iDductioIl of ICIi.vity of Ca H -iDdepeadent 
(iDducibIe) Ditric oxide aynIhue ia the myocardium IDd ill cultured cardiac 
myocytel trated with IIIIIotoxiD. Measuremoml of the mzymaIic ICIi.vity IDd 
direct IIIIIUUI'eJIaIl of Ditric oxide are cumbenome procedurea. Tbaefore ill Ibia 
IIUdy we IItempIed to demoaatnIe that up-reauIatioa of the 1_ for the induc•
ible form of Ditric oxide aynIhue occun aft« treaIDaIl with aIdotoxia. lIkJlJ:. 
__ V mtric:uIar myocytel from aewbom rail were ebtained IDd maintaiDed ill 
culture for 7 daya. Five culture plalel were liliiii u coalrolllDd S plalel wen 
trated with Buherlddtl tDIllipOpoly...:clwide It • dole of 1 1'8/ml for 30 
IIIim.-. ~y both ~ of cella 1DIIIerw...t extnctioll of lola! eyto•
plumic RNA. The RNA _ ~ purified ill oJiao-dT -<:eIIuJo. to obIaia 
polyadmyllled mRNA. Murine Mo\oaey Leukemia virus rev_ trmscriptue 
_ liliiii ill tum to aynt\IeIize eDNA. The eDNA from both ~ _ ampli-
fied with 3 diffORlll primer pain for the codinl regioo of the inducible Ditric 
oxide aynIhue .- vU the polymerase cbaia.-:tica. The primer sequeacea 
liliiii_ lNOS01POS tJIJIgCCCCfcgagCQJcggcagg; lNOS01NEG cagcagtagt•
tgacaarccaaggt; lNOS02POS gcctICCQtJCQQIggcaacatcagg; lNOS02NBG 
aggagggallttXMllJgaalagg; lNOS03POS cagatgcagatggau:catcaga; 
lNOS03NEG CCQgcaaggtcgatgcaauu:tg. llwIIIc. The eDNA of the inducible 
form of Ditric oxide aynIhue _ amplified from the aIdotoxia trated cullUreI 
but DOt from the coalroI cullUreI. CO!lclwioa: We demoaatnIe that the 
iucreued activity of the iDducib\e Ditric oxide aynIhue u due to up-nguIatioo of 
the 1_ codina for the Ibia eazyme wilhia 30 miDutes after eqJ06UR of the 
cuIIUreI to IIIIIotoxiD. The mecIwIiam of iDductioIl of Ibia .- requires furtbec 
llUdy IiaI:e it may be • coaIributory mecIwIiam of myocantial dep~OIl _ ill 
cultured cardiac myocytel. 
797·6 3:15 
Reciprocal Expression of Cytochrome Oxidase Genes 
. During Murine Myogenesls 
William J. Parsons. John M. Shellon, David J. Kessler. 
James A. Richardson. University of Texas Southwestern and VA 
Medical Centers. Dallas. TX 
The marked increase in aerobic capacity during myocyte 
differentiation is due in part to increases in the amount and 
activity of cytochrome c oxidase. Cytochrome oxidase deficiencies 
are the most common of the inherited respiratory chain defects. 
are frequently muscle-specific. and may progress rapidly (fatal 
infantile form) or resolve spontaneously (benign reversible form) 
during development. We employed in situ hybridization to examine 
the expression of the muscle·specific (COX Via-H) and non•
muscle-specific (COX Vla-L) genes encoding cytochrome oxidase 
subunit Via in the developing mouse. At day 8 in gestation. COX 
Vla·L was the predominantly expressed mRNA in embryonic 
hearts. while COX Vla-H was only weakly detectable. By gestational 
day 14. expression of both genes was prominent and uniformly 
distributed in cardiac tissue. while COX Vla·H was weakly 
detectable in skeletal myoblasts. At birth (day ~ 18) expression of 
both genes was prominent in skeletal as well as cardiac myocytes. 
COX Vla-H expression remained prominent postnatally, while COX 
Vla-L mRNA decreased to essentially undetectable levels in skeletal 
and cardiac muscle of adult mice. Of note, mRNA expression of 
another nuclear-encoded subunit of cytochrome oxidase, COX Vic, 
was prominent throughout development. These data indicate that 
reciprocal regulation of cytochrome oxidase genes occurs during 
murine myogenesis. The predominant expression of COX Vla-L in 
prOliferating myocytes early in gestation suggests that it encodes 
the ·fetal· isoform of subunit Via in striated muscle. while COX 
Vla-H encodes the principal isoform of subunit Via in terminally•
differentiated myocytes. The influence of this regulated response 
on isoform composition and function of the holoenzyme may underly 
certain mitochondrial myopathies which result from inherited 
deficiencies in cytochrome oxidase activity. 
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CURATIVE RADIOFREQUENCY (RF) CATHETER ABLATION OF ATRIAL 
TACHYCARDIA AND FLUTTER 
Michael D. Lesh, George F. Van Hare, Michael A. Kwasman, Melvin M. 
Scheinman, Harlan R. Grogin, Randall J. Lee, Laurence M. Epstein, Rolando 
Gonzales, Jerry C. Griffin 
University of California San Francisco, San Francisco, CA 
We examined the safety and efficacy of RF ablation in the atrium for atrial 
arrhythmias in 17 pts who had failed a mean of 2.8 drugs. DiagnoSiS was 
automatic atrial tachycardia (AA TI: 7; reentrant atrial tachycardia(RA TI: 
3; typical atrial flutter(Afl-TI: 6; and atypical atrial flutter (Afl-A): 1. For 
AAT(right:4, ieft:3), target sites had earliest activation, mean 47±4ms 
before p-wave. All pts with RAT had previous surgery for congential heart 
disease and reentry around a surgical scar. Sites for Afl-T ablation were 
based upon anatomic barriers in the floor of the rt atrium, either between 
the IVC and the tricuspid ring (3) or between the coronary sinus and tri•
cuspid ring (3) and mapping confirmed these sites to be in a zone of slow 
conduction TIle case of Afl-A had a site of early activation near the rt atrial 
appendage. At target sites, 2D-SOW of RF energy were delivered during 
tachycardia between the 4 or 5mm catheter tip and a skin patch. Procedure 
endpoint was inablility to re-induce tachycardia. 
S"5 fhebled ch rtf Ell RESULT: uccess = absence 0 t a at ta ~yca laat 0 ow up. 
Ox N Age range Tachy. Procedure Success FlU Compl 
(mean) CL(ms) time(min) N(%)' mos. ication 
AAT 7 13-67(32) 407±38 28008 6(86) 4±1.2 0 
RAT 3 7-17(11) 348±48 183±43 3(100) 5±2 0 
Afl-T 6 33-80(56) 211+7 209±28 5(83) 7.5±4 0 
AfI-A 1 30 210 250 0 - 0 
All pts 17 7·80(36) 300±25 220+-20 14(82) 5.3±1 0 
Of 5 successfully treated pts WIth Afl, 3 had recurrence 1 day to 5 mos post 
ablation; but all had successful repeat ablations. 
CONCLUSIONS 1)Ablation of automatic and reentrant atrial tachycardia 
and atrial flutter has a high success rate; 2)RF ablation in the atrium is not 
associated with complications; 3)repeat procedures may be required for long· 
term success in patients with atrial flutter. 
798-2 2:15 
Radiorrequency Ablation: a Promising Approach to the 
Treatment of Atrial Flutter 
Gilbert Kirkorian. Guillaume Canu. Georges Atallah. Enrique 
Moncada. Philippe Chevalier. Jean-Philippe Claudel. Claudio de 
Zuloaga. Paul Touboul. H6pital Cardiologique. Lyon. France 
Catheter ablation of atrial tissue using DC shocks may prevent recur•
rences of type I atrial flutter (AFl). Ablation usually concerns areas 
where fragmented electrical activity is recorded. Another approach has 
been proposed with. as a target, the area of atrial tissue lying between 
the inferior vena cava (lVC) and the tricuspid ring (TR). Using this 
method and radiofrequency current (RFC). we studied 6 patients (pts) 
aged 53 10 64 yrs. Every pt had suffered from recurrent episodes of 
type I AFl despite 2 10 5 antiarrhythmic drugs (mean: 4). At the time of 
electrophysiologic study. AFl was present in 4 pts and induced by 
electrical stimulation in 2. Careful atrial mapping during common AFl 
as well as transient entrainment confirmed that right atrium was part of 
the reentrant loop with a counterclockwise rotation of right atrial 
depolarization. In 3 pts RFC was first delivered 10 slow conduction 
areas in the postero-inferior part of the right atrium (6 to 15 
applications of 30 w during 30 s - 1 min) without any efficacy. RFC 
was then directed 10 the atrial isthmus between IVC and TR. whatever 
the morphology of local electrograms. In 3 additional pIS the new 
procedure was perfonned as first line therapy. Results: In I pt, AFl 
persisted despite 37 applications. In 5 pIS. AFI abruptly 
terminated:multiple atrial recordings demonstrated that conduction 
block and AFl termination occurred at the site of RFC application. 
Number of applications prior 10 termination ranged from 110 38 (mean 
12). AFl could no longer be induced despite agressive stimulation 
protocol. During a 4 months mean follow-up. no AFl episode recur•
red without antiarrhythmic medication in these 5 pts.Atrial fibrillation 
not previously documented was recorded in 1 pt. There was no 
complication. In conclusion. in this short series : l)RFC application 10 
the atrial isthmus between IVC and TR tenninates AFl in most pts. 
2)AFl tennination is related 10 conduction block at the site of RFC 
application.3)These results need 10 be confmned on a long tenn basis. 
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Microwave Ablation of Atrial Tachycardia Induced 
by Aconitine 
Tai Ho Rho, Makoto Ito, Harald P. Pride, Douglas P. 
Zipes. Krannert Institute of Cardiology, Indiana 
University School of Medicine, Indianapolis, IN 
We tested the efficacy of microwave frequency energy 
(HW) for ablating atrial tachycardia (AT) in 8 open•
chest dogs. AT was induced by direct application of 
aconitine crystals to the atrial surface or injection of 
aconitine solution (0.15 mg/ml) into the right or left 
atrial myocardium. Catheter ablation was attempted on 10 
ATs using continuous, unmodulated HW energy from a 915 
MHz frequency signal generator (Microwave Medical 
Systems, Littleton, MA) delivered 74.3 ± 87.1 sec after 
development of AT via a 7 Fr helical or whip antenna 
catheter (E.P. Technologies, Sunnyvale, CA). Successful 
ablation was defined as conversion of AT to sinus rhythm 
during delivery of HW energy and maintenance of sinus 
rhythm for more than 5 min. after termination of energy 
delivery. ~: ATs developed 255.7 ± 118.2 sec after 
topical application or injection of aconitine. Ten of 10 
ATs (100 %) were successfully ablated by 2.3 ± 1. 6 
(mean) applications of HW energy for each AT induced. 
Forward HW power level was 50.5 ± 8.1 watts, and the 
duration of energy application was 25.0 ± 27.6 sec. 
Sinus rhythm resumed 9.5 ± 9.2 sec after the onset of HW 
energy application. After follow up of 18.4 ± 13.9 min., 
6 ATs recurred, most likely due to migration of 
aconitine beyond the perimeter of the ablation lesion. 
Creation of a larger HW lesion eliminated the AT in 3/3 
dogs. Gross examination revealed 10 demarcated round or 
oval transmural lesions in the right or left atrium of 
diameter 4 - 12 mm. No perforation occurred. We conclude 
that delivery of MW successfully ablates aconitine•
induced ATs in dogs. 
798-4 2:45 
Junctional Tachycardia: A Useful Marker During 
Anatomically Guided AV Node Modification 
Ranjan K. Thakur. George J. Klein. Raymond Yee. H. William 
Stites. University Hospital, London, Ontario, Canada. 
Junctional tachycardia (JT) appears to be a response to 
atrioventricular node (AVN) injury and is seen during both 
AVN ablation and AVN modification. We hypothesized that 
JT heralding AVN block and that heralding AVN modification 
may have different characteristics that could be useful in 
preventing AV block. JT characteristics in 53 consecutive 
patients age 41.6 ± 16.5 years (mean ± SO) were examined 
after 59 AV node modifications sessions. Fifty-one patients 
had typical AVN tachycardia while 2 patients had atypical 
tachycardia. Fast pathway (FP) modification was attempted 
in 6 patients and slow pathway (SP) modification in 53. The 
patients underwent 15.3 ± 10 RF applications with a duration 
of 24 ± 9.7 seconds. JT was observed an average of 2.8 ± 
1.8 times per patient. 
JT was divided into 2 groups. In group 1. JT was followed by 
transient 20 or 30 AV block (n=5) or permaoE'nt 30 AV block 
(n=1). In group 2. sinus rhythm without AV block followed JT. 
Patients in group 1 had significantly faster JT rates (CL 363 ± 
44 versus CL 558 ± 116, P <1l001). In addition, JT in group 2 
had predominantly 1:1 VA conduction whereas group 1 
patients had predominantly VA block during JT (46/53 vs 216, 
I>< 0.05). 
We conclude that JT leading to AV block can be recognized 
by a faster junctional rate and ventriculoatrial block. This may 




TIme C_ ot lesion Maturation aa a Function ot Redlotrequency 
Pow.- and TIme: Correlation with Chenges in Impedance 
Kashef Mughal, David Krum, John Hare, Cynthia L.essHa, Miqdad Khan, 
Masood Akhtar, Boaz Avitali. Slnai-Samaritan Medical Center, Milwaukee, 
Wisconsin. 
The relationship between lesion size, radiofrequency (RF) power, and tissue 
impedance during radiofrequency ablation are not well defined. We 
monitored these parameters in 5 dogs using an analog to digital data conver•
sion system to record RF voltage, current and tissue impedance. RF lesiOns 
were created on the epicardial surface of the right and left ventricles with the 
chest cavity filled wtth saline. Lesion depth and lesion diameter along 2 axes 
were measured after la, 20, 30, 40, 60 and 90 seconds at 20,30, and 40 watts 
CNl of RF power. The mean results were correlated with tissue impedance. 
RESULTS: 
lOsee 20 see 30 see 40 see 60 see 90 sec 
Diameter, 20 W 5.1 5.9 6.5 6.1 5.8 5.4 
Diameter, 30 W 6.2 6.4 6.5 7.2 7.2 6.3 
Diameter40W 6485808381 NP 
Depth, 20 W 1.5 2.2 3.3 3.1 4.1 4.7 
Depth, 30 W 2.3 3.0 3.8 5.5 5.2 5.1 
Deoth 40W 30 59 56 55 68 NP 
IMPDrop,2OW 4.4 11.6 11.8 17.3 16.1 22.9 
IMPDrop,3OW 10.7 19.1 15.1 16.2 17.8 21.2 
IMPDrop,4OW 10.0 16.1 17.7 19.0 23.1 NO 
Diameters and depths are in mm, IMP drops are in ohms. 
At high RF power, explOsions occured causing tissue tearing and rapid 
impedance Increases, after which RF was stopped. This always occured 
before 90 sec at 40 W. Lesion diameter appeared to reach the maximum 
after 20 to 30 seconds, wh~e lesion depth penetrated more slowly, especially 
at lower power levels. Maximum lesion depths of 4.7 mm were obS9lVed at 
2OW, between 5.1 and 5.5 mm at 3OW, and 6.8 mm at 4OW. A gradual 
decrease in I MP during lesion formation was observed which correlated with 
lesion depth (r= 0.76, p=O.OOO4). 
CONCLUSIONS: Larger lesions are generated when using high power for a 
shan period of time then when lower power is used for a longer duration. 
Lesion diameter reaches a plateau quickly, while lesion depth penetrates more 
slowly. Once lesion depth reaches the maximum, relatively small changes In 
impedance are observed, indicating that the lesion has matured. 
798-6 3:15 
Delivery of an Irreversible Beta-Adrenergic Blocking 
Agent via the A-V Nodal Artery: A New Method of A-V 
Junction Ablation? 
Paul J. Wang, Josef Pitha, Saroja Bharati. Maurice Lev. Mark 
Aronovitz, Arun Gadhoke, N.A. Mark Estes m. New England 
Medical Center, Boston. MA, National Institute of Aging. Baltimore. 
MD. and the Hem Institue for Children, Christ Hospital and Medical 
Center, Oak Lawn. n.. 
Ideally. cardiac arrhythmias might be treated by selectively delivering 
agents pennanently altering tissue electtOphysiologically without 
destroying the tissue itself. Because iIudlm studies suggest that 
alkylating pindolol may have imversible beta-adrenergic effects, we 
hypothesized that the delivery of this agent via the A-V nodal artery 
might permanently block beta-receptors without destruction of the 
A-V node. In 7 closed-chest dogs. selective catheterization of the 
A-V nodal artery was demonstrated by transient A-V block with 1-3 
meg of acetylcholine, In 5 animals, 2.8-5.6 mg alkylating pindolol 
solubilized in·normal saline using cyclodextrin was injected into the 
A-V nodal artery followed by 4.2mg as a 30 min infusion. Of the 5 
treated animals, 2 had complete A-V block persisting at the time of 
follow-up 7 to 38 days later. Isoproterenol up to 100 meg per min 
failed to reverse the A-V block. Two animals had prolongation of 
A-V nodal refractory periods. In the remaining treated animal and 2 
control animals receiving cyclodextrin in normal saline alone, A-V 
nodal function remained nonnal Histologic examination revealed 
nearly complete destruction or marked fibrosis of the A-V node 
and/or its approaches in all 5 animals receiving alkylating pindolol. 
In contrast, inflammation in the approaches to the A-V node was seen 
in the control animals. 
These data are the first deIoonstration that a pharmacologic 
agent may be used to pennanently ablate the A-V conduction system 
We hypothesize that this agent was cytotoxic because of its alkylating 
side-group. Chemical modification of this agent may permit 
pennanent beta-adrenergic blockade without tissue destruction. 
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DIIedI_SI'ICl''''''''''' ...... c..Ociaw n. .. .u.an.aStplelllll 
~DmpiIIeNanal~"""" 
RL EiIaa', SE MartiII, D Care7, LS So:Imarby, M Wonby, m CIIu, SF 
IIonIwitz'O, RE ~ Carlyle Fru« BIt ClI'/Cnwfonl Loaa Bsp oIEU; 
Dpa 01 Mel! (CardioI)1Rad, EUSM, AtIIIIta, GA; Bed! IsneI Med CII', NY" 
T~ SESTAMIBI (MIBI) ...... Idled IrMa' diaribudoa u the time 01 
 1'IIiI .... y put' iadicator aJIowed III to aeparate the effedll 01 
......... LV dysfllllCtM. III. myocardilll blood flow (MBF) .. SPECT 
"perfuIio.' ..... in dop. A flow prOOe aad oed ..... ~ placed oa the 
LAD; IOIIOIIIicnIaIe ---1fIIIIeIIt8I wall shorteaiaa ("SWS). At peak 
MBr witII admaIiDe, ~ mCI MIBI ~ iJVeded without oedusioa (n-7). 
At 1 ... , ..... 51_ end-diutolic (ED) aad eackystoIic (ES) SPECT ..... 
(l1-bueUae) ~ KqUired to Idled 1lOI'IIIIII Mar diaributioa. Thea, the 
LAD _ oeduded to pruduce .-.... (Ab) .. SWS a1thovala IrMa' 
distriIIuIioa would not cbanJe. DuriDa totaJ ocdusioa, aad without reinied!og 
lIl.i1IWIDI. IIIOtba' pled SPECT IICIUl _ KqUired (Il). MaximaJ (DIU) 
couot pro'U. (CPs) wtft obtaiDed from sbori Dis sIic& The Ab region 
(LAD) _ clef'med u pixell with CIIUIYII (eta) < 60 .. 01_ in ES (Il) CPs, 
aad Ala naioB _ mapped oa CPs 01 otber __ The 1lOI'IIIIII (N1) mae _ 
nmote from LAD. Derect _may (DS)-(AIa dI+N1 dI); SZ=Derect size u 
"LV. 
DS(ES) DS(ED) SZ(ES) SZ(ED) 
11 14t' l.satl.M I.Sit"" it1 
Il It' 1.63±8.G3 '.nto." lltU 
p <0.001 <0.001 <O.OS <0.01 




1'IIUI, ......... LV dysfuadion I!lmc durina _ Il procIuts aleYere, !up 
cIelect oa _ n images ampancl to bueIine IICIUl 11. Ulllated images (n-1) 
aad ...... acquired rollowina il\jedion durina partial oedusion (no. 1) sbow 
IimiIar diff-. 11 III. n.. Condusioa: AbnormaJ segmental cootradion, 
,., _, can create cIeledll oa SPECT myocantial 'perfusion' imag. despite 
1lOI'IIIIII Mar u the time 01 ndionudicle il\jedion. 1'IIiI ..... e effect 01 
CUDU'IIdiIe dysfuadion may exert profound inllueaas oa lIIIIated SPECT 
myocardial 'perfusioa" imaa. KqUired cIiuicaIly, LI., cardiomyopathy, 
LBBB. c:Iauce ill cIelect betw-. ItnII aad nit, aad imaaiDI oI·stunned· lit 
"bibernatina· myOClll'di_ 
799·2 2:15 
QuantiticatloD or Myocardial Blood Flow CaD Be Obtained 
With Technetium·99m TeborollUne and Fast Dynamic SPECT 
ScanDlnR 
DonaJd C Lien. Luis I Amujo. Thomas Budinger. Abass Alavi. Division of 
Nuclear Medicine. Hospital of The University of Pennsylvania, 
Philadelphia, Pennsylvania. Lawrence Berkeley Laboratory, University of 
California, Berl<eley. California. 
Technetium-99m teboroxime is a novel myocardial perfusion imaging agent 
in that it has a high myocardial first pass exuaction and a rapid clearance. 
These kinetic characteristics and the availability of multi-headed SPECT 
scannen may allow measurement of both arterial and myocardial time•
activity curves; thus, ttacer kinetic modeling can be applied. The purpose of 
this study was 10 assess die feasibility of quantification of myocardial blood 
flow employing Tc-99m Ieboroxime and fast dynamic SPECT and correlate 
the results with values obtained by labeled microsphere techniques. Nine 
experiments were performed in five closed-chested dogs. Tc-99m 
teboroxime was injected inlnlvenously while gamma-labeled microspheres 
(Co-57. Sn-1l3. Nb-95) were administered simultaneously into the left 
ventricle during baseline and hyperemic conditions induced by various doses 
of dipyridamole (0.0625. 0.1250. or 0.1875 mg/kg/min) infusions. 
Dynamic SPECT imaging began immediately after each teboroxime 
injection and continued for 24 minuleS (36 scans of 10 seconds each 
followed by 40 scans of 30 seconds each). Filtered backprojection, using a 
Hamming filter (cutoff 0.4), was performed on the raw data to generate 
ttanS8lIiai tomographic slices. ROJ's were drawn over the LA and LV 
(arterial input function) and myocardium (tissue response). Time-activity 
curves were generated and fitted to a 2 compartment tracer kinetic model to 
calculale the washin (kl) and washout (k2) rate constants. Myocardial blood 
flow values measured by microspheres (MBFm) ranged from 0.4 10 2.9 
ml{mintgm. Values of both k1 and k2 correlated linearly with the 
myocardial blood flow values obtained by microspheres (kl .. 0.39 + 0.70 
MBFm. r .. 0.79. p .. 0.0001; k2 .. 0.06 + 0.42 MBFm. r = 0.82. p .. 
O'(lOOI). The higher k1 values compared to the k2 values are most likely 
due to high first-pass exuaction and partia1 retention of teboroxime by the 
myocardium. These results demonstrate that fast dynamic SPECT imaging 
of Tc-99m teboroxime can provide an non-invasive quantitative 
measurement of myocardial blood flow. 
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ComparhioD BetweeD 11-201 aDd Tc:·99JD. Sestamibi Uptake for 
Detec:tiDc Myoc:ardlal Viability iD a CaniDe Model of 
Subendoc:ardlallnfarclion aDd Residual Hip Grade Stenosis. 
David Ie. Glover, Mirta Ruiz, Juris P. Simanis, Vedat Sansoy, 
William H. Smith, Denny D. Watson, George A. Beller, University 
of Virginia, Charlottesville, VA. 
We compared Tc-99m sestamibi with n-201 for detecting viability 
when administered under conditions of subendocardial infarction and 
persistent low flow. Twelve dogs had partial LAD occlusion causing 
a 49±1% reduction in resting blood flow. The LAD was then 
totally occluded for 1 hr, followed by reperfusion through the 
stenosis. Sixty min after reperfusion, 1.0 mCi of n·201 was 
administered and initial gamma camera images were acquired. After 
2 hrs, repeat n-201 images were obtained to assess redistribution . 
Five min later, Tc-99m sestamibi (5.0 mCi) was administered and 
initial sestamibi images were acquired. A second set of sestamibi 
images was acquired 45 min later, after which the dogs were killed 
and gamma well counting was performed. Systolic thickening by 
ultrasonic crystals was 23±2% at baseline and fell to -12±3% 
(dyskinesis) at time of sestamibi administration. Infarct size 
averaged 7.5% of the LV. There was no difference in defect 
magnitude (LAD/LCX count ratios) on delayed n-201 images 
(0.74±0.03) and the Tc-99m sestamibi images obtained 5 min later 
(0.71±0.03). Similarly, the gamma well counter LADILCX ratio 
was 0.71±0.03 for n-201 compared to 0.68±0.03 for sestamibi. 
Thus, these data show that, in a model of sustained flow reduction, 
minimal necrosis, and profound ischemic dysfunction, the initial 
uptake of Tc·99m sestamibi produces a resting defect which has a 
similar magnitude as the delayed n·201 redistribution defect. 
Hence, Tc-99m sestamibi compares favorably with n-201 for the 
determination of myocardial viability under these conditions. 
799·4 2:45 
Teboroxi_ as a Marker of Reperfusion During Acute 
~otardial Infarction Independent of Viability 
Bernard J. Villegas, Louis I. Heller, Christopher P. 
Reinhardt, 5eth T. Dahlberg, John Wironen, Jeffrey A. 
Leppo. U Mass Medical Center, Worcester, MA 
During an acute HI, the scintigraphic determination of 
coronary artery patency illll1ediately following 
thrombolysis should assess regional blood flow and not 
be affected by the presence of infarcted tissue. 
Accordingly, we evaluated the myocardial distribution of 
teboroxime (tebo) and microspheres (M5) during an acute 
MI. The left circumflex artery was occluded in 12 
rabbits and ~Nb-1abe1ed M5 were injected to determine 
regional blood flow. After lh, 7 rabbits were reperfused 
(group A) while 5 rabbits remained occluded (group B). 
Two hours later, tebo and s'Cr-labe1ed M5 were injected. 
Infarct (INF) was identified by the absence of 
tripheny1tetrazo1ium'staining and accounted for 22tl0% 
of the left ventricle. INF flow was expressed as a ratio 
of INF to viable myocardial blood flow (see figure). At 
the time of sacrifice, INF flow in group A had increased 
from O.12tO.04 to O.55tO.16 (p<O.OOl) but did not change 
'.0 in group B. In both groups, 
~ 0 Reperfu.ion (Group A) myocardial tebo distribution 
'" E:§I Non-Reperfusion (Group B) was essentially equal to the 
§ OA flow at the time of its 
~ injection. Tebo had a direct ! 0.' linear relationship to INF 





(raO.Bl). We conclude that 
tebo uptake dllri ng an acute 
MI reflects blood flow and 
not viability. Tebo imaging 
following thrombolytic 
therapy may prove useful in 
determining coronary patency. 
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Arbutamlnl: A New Pharmacological Stress Agent for 
Potential Use With Thalllum-201 Scintigraphy 
3:00 
Albert J. Sinusas, Edouard Daher, OingXin Shi, Reginald Williams, 
Michael Singer, Michael White, Frans J. Th. Wackers, Bany L. Zare!. 
Yale Uriversi!y, New Haven, CT 
Arbutarrine(ARB) Is a new potent Inotropic drug developed as a potential 
phannacological stress agent. The effect of ARB on coronary flow (FL) is 
unknown and its use with perfusion scintigraphy for the detection of 
coronary artery disease is not estabfished. To evaluate ARB as a 
phannacologlcal stress agent, 7 open chest dogs with a -critical" (no 
hypererric response) left anterior descending coronary stenosiS (STEN) 
underwent graded ARB stress (20-80 ng/kglmin). Aortic and great cardiac 
vein blood was used to measure oxygen consumption (MV02 ml 
02lmlrV100gm). Endocardial (EN), and transmural (TM) flow was assessed 
with radiolabeled !Ticrospheres during baseline (BASE) and STEN, before 
and during ARB 40 and BO ng/kglmin stress. T1·201 was injected at peak 
stress. ARB was continued for 2 !Tin alter injection, and dogs sacrificed 20 
!Tin later. Postmortem Tl-201 tomographic images were acquired. Risk area 
(RA) was assessed by postmortem dual perfusion and was 29 ±3% LV mass. 
Hearts were cut into 96 segments for gamma well counting. Hemodynamics, 
MV02 and flow (% nonischemic(NI» in RA were: (' p < 0.05 vs BASE) 
BASE STEN ARB40 ARBSO 
HR(bpm) 112±3 114±2 170$' 166±5' 
AOP (11"I"R-ig) 116±:2 119±3 108±5' 89±5* 
CO (Vrrin) 2.210.1 2.5±0.2 3.3..+Q.4' 3.3±1.2 
MV02 787±71 828±53 1012±130 1134±172 
FLOW EN 92.3±2.9% BO.9±5.7%' 60.8-.+6.7%' 59.9±7.2%' 
1M 115.2±5.2% 102.7±5.9"1o' B7.9±5.80/o 91.0±3.9%' 
No peak ARB stress, flow in the NI area was increased (177.B ± 20.B % 
BASE). Relative EN Tl-201 activity in RA was depressed (67.3 ± 5.9 %NI). 
This T1·201 deficit (TO) correlated with the flow deficit (TO • 0.93FL + B, r s 
0.B6) at peak stress. Tomographic imaging revealed a defect in all dogs. 
Thus, ARB produces sufficient hemodynamic stress to create a relative 
flow deficit in the RA and a T1·201 perfusion defect in the presence of a 
relatively !Tild coronary stenosis. Therefore, arbutamine presents a new 
aHemative to pharmacological stress perfusion imaging. 
799-6 3:15 
Assessment of Myocardial ReperCu.sion lIUury by Tc:-99Jn 
Sestamibi Retention. 
David K. Glover, Mir1a Ruiz, Juris P. Simanis, Vedat Sansoy, 
William H. Smith, Denny D. Watson, George A. Beller, University 
of Virginia, Charlottesville, VA. 
Sestamibi uptake and retention are dependent on mitochondrial 
membrane potential and thus may be a sensitive marker of viability. 
We previously showed marked myocardial loss of sestamibi over 3 
hrs of reperfusion (RP) when the tracer was administered at 5 min 
of reflow. These dogs initially underwent 3.hrs of LAD occlusion 
(OCC). To determine if this loss was reflecting RP injury, we 
examined the time course of sestamibi release in 24 dogs preloaded 
at baseline with 8 mCi of sestamibi. Dogs then underwent 3 hrs of 
LAD OCC followed by either 4 min (Grp 1:n=6), 30 min (Grp 
2:n=9), or 180 min (Grp 3:n=9) of reflow. Gamma well counting 
data from segments in the ischemic region (OCC flow < 0.3) are 
shown below, expressed as isc:hemiclnonischemic (liN) ratios: 
--Flow (microspberes) - -- Sestamibi -
Grp Control acc RP 
1 1.04±.06 0.23±.07· 2.71±.66 O.72±.OS (4' RP) 
2 0.93±.04 0.19±.03· 1.07±.13 0.71±.03 (30' RP) 
3 0.98±.05 0.23±.04· 1.04±.14 O.SH.OS·· (180' RP) 
(Mean±SEM • ps.OOS vs baseline, •• p=.OO6 Grp 2 vs Grp 3) 
These data show that between 30 and 180 min of RP, there was 
significant loss of sestamibi from the RP zone. The IIN ratio fell 
from 0.71 to 0.52 with unchanged flow. Sestamibi activity was 
unchanged from 4 to 30 min of RP. These data, in a "flow•
independent' model, show that serial assessment of sestamibi activity 
may be useful for evaluating RP injury during acute myocardial 
infarction. Validation studies in patients appear warranted. 
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Double-BliDd Evaluadoll or the Safety ud EfrlCxy or NicardipiDe ia 
Patiellil witll Advaaced Cllronic CODgestive Heart Failure 
Jonothan Abrams, Michael R Bristow. Yu-Kun Cbiang, G. William Dec, 
George W. Dennisb ill, Linda Fenney. E. Michael Gilbert, Robert J. Hariman, 
Dale G. Renlund, J.D. Routh, Michael Ryan, Charles Steiner, Janet Strain, 
Andrew Wollf. Charles WUJ\Sj;b, Lawreace Yellen for the Nicardipine Heart 
Failure Study Group 
University ofUtab, SaIt Lake City. Utah 
Nicardipine (NIC) is a bigbly vasoselcctive dihydropyridine calcium antagonist 
that bas been evaluated in only small numbers of heart failure patients. In a 
muiti<enter placebcKontrolied clinical trial the safety and efficacy ofNIC in 
heart failure (HI') subjects were evaluated over four months of therapy in 73 
patients (36-87 yrs) with advanced (NYHA Class ill-IV) HF, resting ejection 
fraction (EF) $30%, and stable regimen of digoxin, diuretics. and long-acting 
nitrntes; ACE inhibitors were prohibited. Patients received either 30-mg 
nicardipine (39 dosed, 26 completed) or placebo (34 dosed. 23 completed). 
Primary efficacy variables obtjined at baseline and completionlwithdrawal 
included resting EF by MUGA. exercise treadmill (EIT) duration in all 
patients. and 6·minute walking distancc. The NIC group bad statistically 
significant increases from baseline to end of double-blind phase in resting EF 
and duration of EIT in patients limited by dyspnea or fatigue (p!>O.OS). and a 
trend toward improvement in the Err and 6-minute walking distance. relative 
to placebo group. Adverse events (AEs) occurred with about equal frequency on 
NIC (36/39, 92.3%) and placebo (30/34, 88.2%). No AEs related to NIC were 
severe or unexpected; two deaths occurred on placebo and none on NIC. - (~::~1 (~~=.!:l -!'"'l"'T. povol'" R EeclIorIFI"ICbon % 6 36 '28,0001 000 23, I 000 0035 
J:lunaoa olEIT 11'1 J*IenIa lWho 
=~~~-. nUl 17, <0001 .. .. 11.0197) 0037 
D.nbCIIO(En,aI~entI _ 107.04 23,0.006 5732 22.0051 om 
Six~14C _ft 16129 26,0.026 81.05 21.0391 0416 
I paired-t test for change from baseline 
Conclusion: Nicardipine appears to be a safe. efficacious choicc when a calcium 
antagonist is desired for patients with advanced left ventricular dysfunction. 
800-2 2:15 
Is There Any Indication for Oral 
Phosphodiesterase Inhibitor Today? 
Guillaume Jondeau. Olivier Dubourg. Gabriel Delorme. 
Frank Chikli. Caroline Dumas, Fran<;ois BoCk, Jean F 
Arnal. Laurence Kamoun, Jean P Bourdarias. Hopital A. 
Pare, 92100 Boulogne, France. 
We undertook a randomized. double blind. placebo•
controlled study to determine whether oral enoximone (E) 
300 mg daily, could help weaning off dobutamine (D) in 
patients (pts) with end-stage congestive heart failure 
(CHF) in whom previous weaning attempts were 
unsuccessful. Twenty-four D dependent CHF pts (age 
64±10 y.o.) receiving furosemide (n=23), ACE inhibitor 
(n=20). digoxin (n=3). amiodarone (n=16), and D ( 0=10 
mcg/kg/min) were randomized to receive either E (n=12) 
or placebo (P) (ll= 12). Basal clinical and 
echocardiographic parameters were similar in the 2 
groups. After 4 days of combined therapy (D+E or D+P), D 
was reduced by 50% every day, and discontinued on the 
7th day. Pts were followed for 1 month thereafter. 
number of patients P E p 
weaned off dobutamine 4 9 <0.05. 
who completed study 2 9 <0.05 
withdrawn for -CHF relapse 8 2 <0.05 
-other cause 1VT 1 Rash 
1 sepsis 
CONCLUSION: Oral Enoximone significantly increased 
the number of CHF patients who could be weaned off 
dobutamine, and decreased the incidence of CHF 




Are Low Serum Levels or Digoxin Efrecdve in Chronic 
Heart Failure? Evidence Challenging the Accepted 
Guidelines ror a Tberapeudc Serum Level or the Drug 
James B. Young, Mihai Gheorghiade, Milton Packer, Barry Uretsky, 
Heyward Hull on behalf of the PROVED and RADIANCE 
Investigators. Baylor College of Medicine, Houston, TX 
"Therapeutic" serum levels of digoxin in heart failure (CHF) have 
been defined by identifying drug levels that do not cause toxicity 
rather than by correlating drug levels with measures of efficacy. To 
address this deficiency, we compared the effects of digoxin (Dig) and 
placebo (Pbo) on exercise tolerance in 258 CHP pts enrolled in two 
randomized withdrawal trials. All pts had LV ejection fraction S; 35% 
and received diuretics ± converting-enzyme inhibitor. Digoxin doses 
were adjusted in an attempt to reach a "therapeutic" serum level (0.9 to 
2.0 nglml). PIS were then randomly assigned to continue digoxin 
(n=124) or to substitute placebo for digoxin (n=134) for 12 wks. 
Efficacy was assessed by tJ. in maximal treadmill exercise time (ExT): 
sc:!;et TreaIJnent Baseline Median A A ExT~? p grouo ExT in ExT(s) (Dhl-Pbo value 
0.5 - 0.9 Placebo 579 -13.0 +21.5 0.022 
(n = 67) Digoxin 540 +8.5 
> 0.9 - 1.2 Placebo 545 -45.5 +83.5 0.005 
(n=107) Digoxin 515 +38.0 
> 1.2 Placebo 423 -89.0 +86.0 0.019 
(n = 84) Digoxin 404 -3.0 
Digoxin was superior to placebo (all P < 0.05) regardless of the 
digoxin level achieved. Although pts with high levels had a somewhat 
greater tJ. in ExT than pts with low levels (p=NS), this may have been 
related to the fact that high levels were seen in pts with low ExT 
(presumably because digoxin clearance is .j. in severe CHF), and such 
pts usually show the greatest changes in ExT. 
These results suggest that high levels of digoxin may be unneces•
sary for efficacy in CHP. Additional studies to elucidate the dose•
response relations of digoxin in CHF are warranted. 
800-4 2:45 
Double-Blind, Placebo-Controlled study of 
Ibopaaine and Diqozin in Patients with Kild to 
Koderate Heart Failure: The Dutch lbopaaine 
Kulticenter Trial (DINT) 
Dirk J. van Veldhuisen. Arie J. Man in ·t Veld. Peter 
H.J.M. Dunselman. Dirk J.A. Lok. Henk J.M. Dohmen. J. 
Cees Poortermans. Adrie J.A.M. Withagen. W. Hans Pasteu•
ning. Jan Brouwer. K.I. Lie. for the DIMT Study Group. 
University Hospital Groningen. The Netherlands 
To evaluate the efficacy and safety of the novel 
dopamine agonist, ibopamine, and to compare this drug 
with digoxin, we studied 161 patients (pts) with mild to 
moderate congestive heart failure (CHF) (mean age 61 ± 8 
years, ejection fraction 29 ± 9 \, 75\ of pts CHF due to 
coronary artery disease. 85\ male). Pts were randomized 
to ibopamine (3x 100 mg; n-53), digoxin (lx 0.25 mg; 
n=55) or placebo (n=53). Background therapy consisted of 
0-80 mg furosemide (mean 27 ± 26 mg). Follow-up was 6 
months and assessment a were made at 1, 3 and 6 months. 
Of the 161 pts, 128 (80') pts completed the study. 
OVerall, exerci •• time was not significantly affected by 
either drug. In pts with a relatively preserved left 
ventricular function, ibopamine caused an increase in 
exercise time (p< 0.05), but digoxin did not. However, 
none of the pte on digoxin dropped out for progressive 
CHF, compared to 6 pts on ibopamine (p< 0.05) and 2 on 
placebo. Plasma norepinephrine progressively increased on 
placebo (at 6 months + 62 pg/ml; p- 0.02 vs. baseline), 
but decreased on both digoxin and ibopamine (at 6 months: 
-106 pg/ml, and -13 pg/ml. resp.) (both p< 0.05 vs. 
placebo). Aldosterone was unaffected, but renin was 
reduced by ibopamine and digoxin after 6 months (p< 0.05 
vs. placebo). Total mortality was similar (ibopamine:n=l; 
digoxin:n-2; placebo:n-3) and analYSis of ambulatory 
arrhythmias revealed no differences between the groups. 
In conclusion, digoxin and ibopamine favorably 
affect plaama norepinephrine and renin, even in mild to 
moderate CHr. In pts with the worst left ventricular 
function, more aubjects deteriorated on ibopamine than on 
digoxin. However, in pts with a relatively preserved left 
ventricular function, ibopamine. but not digoxin, had a 
beneficial effect on exercise time. 
800·5 
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Beta-Blocker Therapy and Congestive Hurt Fa.ure In the Cardllc 
Arrhythmil Supprellion Trill (CAST) , 
Harold L. Kennedy, Sidney Goldstein. Allan H. Barker. Maria M. Brooks, 
Melissa Huther, Donald S. Beanlanell, J. Thomas Bigger, 
Robert Bergstrand, and the CAST Investigators. 
Objactlve: The relationship of Beta-Blocker (BBI therapy to congestive 
hea" failure (CHFI morbidity and mortality wera examined in a non•
randomized analysis of aU 1735 CAST post-myocardial infarction patienta 
(ptal with an ejection frection 540" followed for 2.5 ye.,.. 
Background: A history (hxl of CHF was obtained It baseline in 
16"(282/17351 of pta, and 22"(6212821 of them were taking BB. Of 
the remaining 1453 pta without hx-CHF. 31 "(454114531 were taking 
SB. Compared to pta on no BB, pts with or without a hx-CHF receiving 
BB were younger, had higher EF, and less commonly recaived digitalis and 
vasodilators at ba.eline. 
Resulta: A Kaplan-Meier analysis stratified for level of EF and BB 
therapy showed BS treated pta sustained significantly (asl new episodes 
of CHF either with • hx-CHF (p-.0061 or without. hx-CHF (p-.0371. 
Kaplan-Meier analysis of all deathlcardiac arrest (O/CAI and arrhythmic 
deathlcardiac arrest (AO/CAI showed SS treated pta had the be.t survival 
regardless of treatment (active and placebol or hea" failure status at 
baseline. A Cox stepwise proportional hazards model cOnfirmed that BS 
therapy wal independently associated with longer survival to new or 
worsened CHF (RR-0.66; 95" CI .47 to .91; p-.0091. For all main 
study CAST pts with one year of follow-up (402 SB pta. 867 no BB ptsl. 
the relative risks for SB treated pta were: 
EFt'" I DICA AOICA CHF 
30-40 .71 .34 .78 
<30 .65 .48 .79 
Conclusions: BB therapy in CAST pta (active and placebol was 
associated with (11 significantly better survival from new or worsened 
CHF in pta with (p- .0061 or without (p - .0371 a hx-CHF and had an 
independent beneficial effect by Cox multivariate analysis, and (21 
improved survival from OICA and AO/CA in Pta with low EF (540%1. 
These data emphasize the associated benefit and safety of BB therapy in 
post-myocardial infarction pts with a hx-CHF andlor low EF (540%1. 
800·6 3:15 
A Cold Elnirooment ReduceI Exercise Capadty in Patients Witb 
ChronIc Heart Failure: Reversal by ACE Inhibition 
Martin Juneau, David Waters, Mich~e de Guise, Mark Smilovitcb, 
Laurent B6langer, Marie-Josq,he Rey, Lucie Lariv6e. Montreal Heart 
Institute, Montreal, Canada 
To investigate tbe effect of cold upon exercise capacity in pts witb 
compensated chronic heart failure, S pts, mean age 61 ± 6 years, witb 
NYHA class 2 or 3 dyspnea and ejection fractions <35" (mean 2S±6") 
underwent 4 exercise tests (modified Naughton protocol), 2 at ·S·C in a 
cold, chamber and 2 at 20·C witb tbe same equipment. Placebo (PI) or 
lisinopriJ 5 mglday X 3 days was given double-blind 12 hours before tests 
at each temperature. The test order was randomized and the endpoint of all 
tests was dyspnea. 
~ 
Exercise duration (sec) 4S2± 130 
Resting HR (bpm) • 81± 11 
Resting Syst BP (mmHg) 131 ± 19 
Resting Diast BP (mmHg) 78± 12 
HR at 3 min (bpm) 96± 16 
Syst BP at 3 min (mmHg) 138± 17 
Max HR (bpm) 118± IS 
Max Syst BP (mmHg) 150± 19 
Max RPP (xlo"') 17.6±3.1 





















Exercise duration witb placebo was reduced by 22" at -S·C compared to 
20·C (p<0.01), but improved by 17" witb lisinopriJ (p<0.01). This 
improvement was not due to HR and BP differences at rest, at submaximal 
(3 min) or at peak exercise, which were not statistically significant. At 
20·C (not shown in table), lisinopriJ did not improve exercise duration 
(4S6± 167 sec versus 452± 130 sec witb placebo, p=NS). 
Conclusion: In pts witb chronic heart failure, cold reduces exercise 
capacity. ACE inhibition mitigates tbis reduction at a dose tbat does not 
improve exercise tolerance at normal temperature. 
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Permanently Improved Fi~rinoly.i. at Long•
tera Follow-up Atter Jejunoileal Bypa •• 
surgery 
Torbjorn K. Nilsson, Anders Sylvan, Depart•
ments of Clinical Chemistry and Surgery, UmeA 
University Hospital, UmeA, Sweden 
Hypofibrinolysis, usually due to increased 
plasminoqen activator inhibitor (PAl) activi•
ty, is a new cardiovascular risk factor, 
especially common in obesity and states of 
insulin resistance. Hypofibrinolysis has 
proved to be very difficult to treat, both 
pharmacologically and non-pharmacologically. 
Our aim was to evaluate the long-term impact 
of jejuno-ileal bypass surgery (JIB) on the 
fibrinolytic system. 45 patients who had been 
subjected to JIB 14-20 years ago because of 
excessive overweight were compared to 10 
obese nontreated control subjects. The JIB 
group had lower PAl activity (8.4 vs. 32 
U/mL, p<O. 001), in addition to lower body 
mass index, fasting plasma insulin, triglyce•
rides and cholesterol. ThUS, previously obese 
subjects have normal PAl activity 14-20 years 
after JIB in contrast to extremely elevated 
PAl in untreated obesity: this may contribute 
to the reduced cardiovascular risk after JIB, 
which has recently been reported. 
We conclude that JIB is a treatment 
modality which permanently improves obesity•
related hypofibrinolysis. The clinical 
implications may be huge. 
801-2 2:15 
Failure of Nonpharmarologic Therapy to Improve Low-Density 
Lipoprotein Cholesterol in Hypertriglyceridemia 
Carll. Lavie, Richard V. Milani. Ochsner Heart and Vascular 
Institute, New Orleans, LA 
The importance of triglycerides (TO) as a coronary risk factor is 
being increasingly recognized. Although it is generally accepted 
that patients with hypertriglyccridemia have marked improvements 
in coronary risk factors, particularly lipids, with nonpharmacologic 
therapy, data to support this belief are lacking. We assessed data 
from two institutions before and after phase II cardiac rehabilitation 
and exercise training in 313 consecutive patients to determine the 
impact of obesity, age, sex, exercise capacity, and baseline lipids 
(particularly TG) on improvements in lipids. After 
nonphannacologic therapy, lipids significantly improved: LDL-C (-
3%, p=O.06), TG (-11%, p<1l.0001), HDL-C (+6%, p<1).OOOI), and 
LDL-C/HDL-C (-8.5%, p<O.OOOI). By univariable and 
multivariable analyses, corresponding dyslipidemic baseline values 
strongly predicted improvements in LDL-C (univariable r=O.46, 
p<O.OOOI; multivariable t-value 7.1, p<O.OOOI), HDL-C 
(univariable r=O.36, p<O.OOOI; multivariable t-value 4.8, p<1l.000l), 
TG (univariable r=O.33, p<O.OOOI; multivariable t value 6.0, 
p<O.OOOI), and LDL-C/HDL-C (univariable r=O.44, p<1l.000I; 
multivariable t value 8.6, p<1l.0001). However, lw! baseline TG 
was the strongest independent predictor of LDL-C reduction with 
vigorous nonpharmacologic intervention (t value 7.9, p<O.OOOI) 
and was a strong independent predictor of reduction in LDL•
C/HDL-C, (t value 6.1, p<1l.0001). Improvements in LDL-C (-4% 
vs +1%, p < 0.01) and LDL-C/HDL-C (-9% vs -5%, p=O.03) were 
significantly greater in 157 patients with TG < 150 mg/dl compared 
with 39 patients with TG ~ 250 mg/dl. Conclusions: 1) Although 
reductions in TO are related to high baseline TG values, high TO is 
associated with less significant reductions in both LDL-C and LDL•
C/HDL-C ratio. 2) Contrary to popular belief, patients with 
hypertriglyceridemia are more resistant to nonpharmacologic 
therapy and are more likely to require drug treatment to reduce 
LDL-C and LDL-C/HDL-C ratio. 
ABSTRACTS 
801·3 2:30 
The Prmous Use of Aspirin Inftuences the Clinical Manifestation and 
Semty 01 Acute Coronary Syndromes 
David Garcia-Dorado, Antonio Sambola, Maria P. Tomos, JWIII Oliveras, 
Jorge Soler, Pierre Thc!roux. Hospital General Universitari Vall d'Hebron, 
Barcelona, Spain aDd die Montreal Heart Institute, Montreal, Canada 
Aspirin preven11l eoronary eveDUl, but bow it affec1s the clinical 
manifestations of acute coronary syndromes is not known. For this purpose, 
we prospectively characterized a consecutive series of 501 patients admitted 
to tile CCU wid! regard to tile determinants of unstable angina (UA) or 
myocardial infarction (M1) wid! or wi1hout new Q waves. A standardized, 
detailed questionnaire served 10 determine risk factors, previous cardiac 
history aDd use of aspirin preceding tile event. 
By serial ECGs aDd enzyme determinations,tIIe CCU diagnosis was UA in 
273 patients aDd MI in 228. Among the 301 patieD11l not taking aspirin, the 
diagnosis was UA in 43" aDd MI in 57" (23" non-Q and n" Q wave); 
among tile 200 1aIdng aspirin,. n" bad U A and 28" bad MI (34" non-Q 
aDd 66" Q wave) (p<O.OOOI). The 159 patieDUI wi1hout previously known 
coronary disease showed tile same distribution of diagnoses: 30" bad UA 
aDd 70" bad MI (20" non-Q, SO" Q wave) among those wid!out previous 
aspirin use; 57" bad UA and 33" MI (66" non-Q and 33" Q wave) wid! 
aspirin (p=0.05). The multivariate analysis retained as independent 
predictors ofUA (rather than M1) use of aspirin (p<O.OI),less cigarette use 
(p<O.OI), previous effort angina (p<0.02), previous episodes of UA 
(p<0.02) and lower plasma cholesterol levels (p < 0.05). The only 
independent predictors of non-Q (rather than Q wave M1) were use of 
aspirin (p<0.001) and lower cholesterol levels (p<O.OS). 
Conclusion: Coronary eveDUI in chronic aspirin users, as compared 10 non•
users, are more likely 10 be unstable angina than myocardial infarction, wid! 
a shift of infarctions to tile non-Q type. These observations suggest that 
aspirin reduces tile severity of tile underlying disease process in acute 
coronary syndromes. 
801-4 2:45 
TREATMENT OF CORONARY DISEASE DID NOT IMPROVE LONGTERM 
SURVIV AL.INTERRELATION BE1WEEN CORONARY RISK FACTORS 
AND BASELINE CHARACTERISTICS. 
379A 
Kodangudi Ramanathan, FateD E1·Zeky, Frank Kroetz, Jay Sullivan, David Mirvis, 
James Crenshaw, Roger Vander Zwaag. Baptist Memorial Hospira1, University 
of Tennessee. Memphis, TN. 
The de(:ade of the seventies wilnesSed a majcr decline in cardiovascular mortality. 
The reasons underlying such a decline remain UJ\C1ear. The present study was 
undertaken in 13701 patienlS who underwent cardiac catheIerization between the 
years 1972-1982 and followed for 5 years with annual questionnaires. After 
excluding those without coronary disease and those with other forms of hean 
disease. the study population was divided into two cohorts based upon whether they 
were studied during the years 1972-77 (Cohort A) or years 19n-82 (Cohort B). 
The two cohorts were further divided into those who underwent Coronary bypass 
surgery and those who were treaIed medically. Long-1elD1 five year survival did not 
differ between the two cohorts irrespective of whether they were treaIed medically or 
surgically. 
COHORT A COHORT B P 
Medical Group 86.3" 86.9" NS 
Surgical Group 89.1" 89.4" NS 
Coronary risk factors Viz. cigarette smolcing and hyperlipidemia (serum cholesterol 
>240 mg/d1) declined significantly in Cohort B compared to Cohort A. 
Cohort A Cohort B P 
Medicine Surgery Medicine Surgery 
Smolcing 75.2" 80.2" 63.3%* 63.5%* <0.0001 
cholesterol 39.9% 49.6" 28.9" 30.6"* <0.0001 
However, adverse baseline characreristics associared with decreased survival in 
coronary disease including left ventricular dysfunction. advancing age and female 
sex was more frequent in Cohort B. 
Cohort A Cohort B P 
Medicine Surgery Medicine Surgery 
Females 25.5" 14.3% 29.4%* 18.4"* <0.05 
Age >65 yrs 8.8 " 10.5% 22.1 %* 26.2"* <0.0001 
EF <SO" 15.1 % 18.3% 20.8"* 20.3" <0.05 
Thus the benefit derived from improvement in risk factor profile is offset by 
increased complexity in baseline characteristics resulting in null benefit in 
long-renn survival following medical or surgical treatmenL 
380A ABSTRACTS 
801·5 3:00 
Failure of Response to HMG CoA Reductase Inhibitors in 
Patients With Familial Hypercholesterolemia Due to the 
"French Canadian" Mutation. 
Lina Karayan, Shiqiang Qiu, Robert Dufour, Ghislaine 
Roederer, Anne Minnich, Jean Davignon, Jacques Genest 
Jr. Montreal, Quebec, Canada 
The 10 kb deletion of the low density lipoprotein 
receptor (LDL-R) gene is the most common mutation 
causing familial hypercholesterolemia (FH) among subjects 
of french Canadian descent. The prevalence of non•
responders to maximal doses of 3-hydroxy-3-
methylglutaryl Coenzyme A (HMG CoAl reductase 
inhibitors (defined as < 15% decrease in LDL cholesterol 
from baseline values after dietary intervention) was 
ascertained in 1 05 patients heterozygous for the 10 kb 
deletion, after excluding first degree relatives, those on 
combined lipid-lowering therapy, and other lipid lowering 
agents. Lipoprotein cholesterol and apolipoprotein B levels 
were examined after a diet period (30% fat as calories), 
and after receiving HMG CoA reductase inhibitors as 
monotherapy for a minimum of 3 months. The results 
reveal that 68% of patients had more than a 30% 
decrease in LDL cholesterol levels, 23% had a decrease 
ran'ging between 15-30%, while 9.5% of patients failed to 
respond and some even showed an increase in their LDL 
cholesterol levels. This response was independent of age, 
gender, or baseline lipid values. Non-responders have 
severe, premature coronary artery disease. Haplotype 
analysis of the normal allele of the LDL-R did not reveal a 
difference between responders and non-responders, 
suggesting that a defect in the normal allele of the LDL-R 
may not be the cause of this phenomenon. This clinical 
observation provides a unique opportunity to examine 
single allele gene regulation of the LDL-R in man. 
801·6 3:15 
Clinical Features and Drug Therapy in Patients with 
Paroxysmal Atrial Fibrillation: Results from the CRAFT 
Multi-Center Registry 
Francis D, Murgatroyd. Nicholas p, Curzen·. Jehad Aldergathert , David E, 
Ward, A, John Camm, for the Controlled Randomized Atrial Fibrillation 
Trial Investigators, St George's Hospital Medical School, London, 
*Boumemouth General Hospital, tHemel Hempstead Hospital, England, 
Despite its prevalence, little is known regarding the epidemiology of 
paroxysmal atrial fibrillation (PAF) , Therefore, a register of clinical, 
echocardiographic, and therapeutic data on all patients with symptomatic 
PAF is kept by centres participating in the CRAFT studies, 
During the period April 1991-April 1992, 161 patients were seen who had 
suffered at least one episode of atrial fibrillation in the preceding six 
months: 94 men (58%), aged 64,5 (:tll,7) and 67 women, aged 57,0 
(:t14.3) (P<O.OOI). Symptom frequencies over two months were similar for 
the two sexes: 81 (50%) had more than 2 episodes, 46 (29%) had 1-2, and 
31 patients (19%) had none. Clinical history and examination were entirely 
nonnal in 52% of men and 37% of women (p=0,09). Echocardiographic 
data were available for 129 patients: the ratio of nonnal echo: minor 
abnonnality: significant abnonnality was 58%:25%:17% in men and 
35%:36%:27% in women (p=0.01). This difference was largely accounted 
for by the greater incidence of mitral valve prolapse in women. 
32 patients (20%) were taking prophylactic antithrombotic therapy at the 
time of the questionnaire. 90 (56%) were taking prophylactic 
antiarrhythmiC drugs: digoxin (20%), {j-blockers (10%), sotalol (7%), class 
lc drugs (6%), class la drugs (6%), amiodarone (4%), and verapamil 
(2%). 41 patients completed a questionnaire from which scores were 
derived for vagal and sympathetic tone at the onset of symptoms. The 
median vagal and adrenergic scores were, respectively, 6 (range 0-16) and 
3 (0-9). 
We conclude that PAF occurs at a lower age in men than in women, and 
usually in the absence of significant structural disease: this has 
implications for safe phannacotherapy. Most treatment is with drugs which 
have not been fonnally evaluated in this condition, and controlled trials of 
these agents are needed. Symptom onset tends to be associated more 
frequently with vagal activity than adrenergiC activity. 
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Core Pathology Lah Findings in 425 Patients 
Undergoing Directional Atherectomy (or a Primary 
Coronary Artery Stenosis and Relationship to 
Subsequent Outcome: The CAVEAT Study 
Jeffrey M. Isner. Marianne Kearney, Lisa G. Berdan, Gordon 
Keeler, Roben M. Califf, and Eric J, Topol for the CAVEAT 
Investigators. Tufts University School of Medicine, St. Elizabeth's 
Hospital, Boston, MA. 
CAVEAT (Coronary Angioplasty versus Excisional Atherectomy 
Trial) was designed to compare acute and long-term outcomes of 
10 12 pts in a randomized trial of conventional angioplasty (PTCA) 
vs, directional atherectomy (DA) for primary coronary anerial (CA) 
stenoses. Enrollment was completed as of 4/92. A total 500 pts 
were randomized to PTCA, while 512 were randomized to DA. Of 
the 512 pts randomized to DA, the excised DA specimen was 
re~eved £!om 425 pts and forwarded to a core laboratory for light 
tnlcroSCOPIC (LM) analysis. Each was graded semi-quantitatively (0 
to 3+) for adventitia, media, thrombus, calcium, foam cells, 
cholesterol clefts, and hypercellular foci ("primary proliferative"), 
The LM findings for these 425 specimens are summarized below: 
# Specjmens <};.=425) % of 425 Pts 
.l±1±~IQW 
Media 124 24 19 167 39% 
Adventitia 8 5 7 20 5% 
Thrombus 107 37 5 149 35% 
Calcium 103 28 6 137 32% 
Foam Cells 24 8 3 35 8% 
Cholesterol Clefts 13 1 0 14 3% 
Primary Proliferative 0 0 31 31 7% 
Following completion of 6 month angiographic follow-up 
(scheduled to be complete by 11/92), data will be unblinded to 
determine incidence of restenosis associated with PTCA and DA 
respectively. These correlative findings will establish the 
relationship between baseline lesion histopathology and 
angiographic evidence of restenosis. 
802·2 2:15 
Saphenous Vein Bypass Graft Pathology in Lesions 
Obtained by Directional Atherectomy Discloses Similar 
Characteristics for Primary and Restenotic Lesions 
Marianne Kearney. Guy Leclerc, Martin B. Leon, Christopher J, 
White, Ge~ffrey O. Hanzler, Gary J. Becker, Barry L. Sharaf, 
Amy Sullivan, Jeffrey M. Isner, Tufts Medical School, SI. 
Elizabeth's Hospital, Boston, MA 
Limited data has been previously published regarding the 
pathobiology of saphenous vein bypass grafts (SVBG) evaluated 
i~ vi,,:o. Accordingly, we studied. sp.ecimens obtained by 
directIOnal atherectomy from 33 pts With pnmary (20) or restenotic 
(13) SVBG lesions. Percent primary and restenotic specimens 
with adventitia (A), media (M), thrombus (T), calcific deposits 
(Ca), cholesterol clefts (CC), foam cells (FC), iron deposits (I), 
extent of extracellular matrix (EM), and hypercellularity (Cells) are 
shown below: 
Lesion type A M T Ca CC FC I EM Cells 
Primary (%) 5 40 60 15 0 5 25 15 25 
Restenosis (%) 0 23 54 23 15 15 40 15 31 
In marked contrast to findings previously observed by multiple 
investigators for coronary and peripheral aneries, the distribution 
of histologic fmdings did not differ significantly for primary vs 
restenotic lesions, including extent of cellularity, 
Identity of cells in each specimen was funher characterized by 
immunohistochemical stains to identify smooth muscle cells (HHF-
35), macrophages (Mac; HAM-56), and leukocytes ( L; LCA). For 
primary lesions, 48% were smooth muscle cells, 42% Mac, and 
10% L; for restenosis lesions, a similar distribution (35% smooth 
muscle cells, 47% Mac,18% L; p=NS vs primary SVBO lesions) 
was observed. 
Conclusion: unlike coronary restenosis, restenotic SVBO lesions 
resemble primary SVBO lesions in terms of plaque composition, 
including cell type. These qualitative and quantitative features of 
SVBO restenosis may account, in pan, for less predictable response 
of SVBO lesions to percutaneous revascularization. 
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802·3 2:30 
Use of Quantitative Polymerase Chain Reaction (PeR) to 
Analyze Gene Expression In Human Primary and 
Restenotlc Vascular Lesions Obtained by Directional 
Atherectomy 
Rai1 Koster, Ulrich Windstetter, James M. Gulizia, Sigrid Nikol, 
Berthold Holling 
Department of Internal Medicine I, University of Munich, and 
Max Planck Institute for Biochemistry, Martinsried, Federal 
Republic of Germany 
There is a widely recognized need to evaluate gene 
expression in human vascular plaque tissue. Recent 
contributions include the use of in situ hybridization on 
atherectomized tissue. This method provides qualitative 
rather than quantitative information about specific mRNA 
content of lesions. 'Conventional more quantitative 
approaches such as Northern blot analysis and nuclease 
protection mapping are not sensitive enough to evaluate 
mRNA levels in atherectomy specimens limited by low cell 
number or low copy number per cell. We applied the 
polymerase chain reaction to detect platelet'derived growth 
factor-A mRNA expression in 12 human lesions sampled 
percutaneously by directional atherectomy. Alter reverse 
transcription, specific amplification of the resulting cDNA was 
performed. This was successful with cDNA from less than 0.5 
IIg of total cellular RNA. To quantitate mRNA content of 
specimens, we coamplify cDNA copies of mRNA from lesions 
and from a synthetic reference RNA in the same reaction 
vessel. This method allows quantitation of mRNA in human 
primary and restenotic lesions and complements 
histochemical approaches and in situ hybridization of 
coronary and peripheral atherectomy specimens. 
802·4 2:45 
Deep Wall Resection by Directional Coronary 
Atherectomy 
James W. Vetter, Tomoaki Hinohara. Gregory C. Robertson, 
Matlhew R. Selmon. Bruce J. McAuley. Dennis J. Sheehan. 
Jacqueline H. Lee. Bruce A. Benedick, John B. Simpson. 
Sequoia Hospital and the Pacific Foundation for 
Cardiovascular Research, Redwood City. CA 
The purposes of this study were to evaluate angiographic 
and procedural factors associated with deep tissue resection 
by directional coronary atherectomy (DCA) and to evaluate 
the effects rt:steno~is. Clinical, procedural, angiographic 
and histologic findings were analyzed for 385 lesions in 
native coronary arteries treated by DCA. Media (Med) and 
adventitia (Adv) were excised in ~6.1 % and 19.6% of lesions 
respectively. Among 5 clinical, l~ angiographic and 8 
procedural factors, Med and Adv excision was associated with 
female gender. ostial 10<'ation. greater tissue weight, lower 
residual stenosis and iarger post DCA diameter. The 
relationship between residual stenosis and deep wall 











Follow-up angiography was available for 295 lesions. 
Follow-up stenosh (FU-ste), late loss (FU-Ioss), lesion 
diameter (FU-L!) and restenosis (RS: >50%) were related to 
Med or Ad\" exci~ion as follows: 
n H)-ste fU-LD FU-Ioss ~ 
Med absent 162 ~~.7% l.74mm .8~mm 39% 
Med present 133 ~5d% !.7!mm 93mm ±f% 
Advabsent 238 ~6.5% 1.69mm .82mm ~2% 
Ady present 57 39.0% 1 86mm QOmm 38% 
Deep wall rese<:tion was frequently observed with DCA. 
hU\\iever this did not influence the restenosis process. 
ABSTRACTS 
802·5 3:00 
COI'OIIIII'Y Smooth Muscle Cells in Culture after Directional AtberEdomy. Do 
they RelIed or Predict Rtsteoosis? 
Donald C. MICLeod. Victor A. UIIIIIIS, Marcel de Joag. Javier Eacaoed, Pim J. 
de Feyter. Patrick W. Serruya. Thoraxceoter. Rotterdam, the NeIberIaIIds. 
The bdlaviour of smoodIlIIIISCle ceIJs (SMC) cultured from directional coronary 
atherectomy (DCA) may differ for primary atherooclerotic (P) and resteootic (R) 
lesioos. In 67 paticots who hid DCA (67 lesioaa: 48 P, 19 R). we related the 
powtb of SMC ill cullure to (a) 1IOIItCO: P or R. and also to (b) resteooois at 6 
mootluo port-DCA. 
Methods. Tissue explaots were placecl ill culture. SMC outgrowth ill primary 
culture and the successful secoaduy culture (sustained passage) of SMC were 
documeo\j!Cj. For SMC ill secoaduy culture. powtb curves were coastructed and 
population doubling times derived. Coronary angiognms at DCA and at post-DCA 
control (6 mooths: all 67 pis) were quantitatively analysed off-line. 
Results. (a) Lesion type did not illfluence the outgrowth (n=28) or successful 
sustained passage (n= 7) of SMC (X' test) but R SMC showed accelerated growth 
in secondary culture with a shorter derived doubling time (bows; means and 95" 
CI given). These data are shown ill Table 1. 
Table 1. Outgrowth Sustained Doublillg time 
Primary ath. 18/48 3148 71 (62-83) 
Resleoolic 10/19 4119 52 (48-58) 
381A 
(b) Culture results In relallon tocategoncaI reslenOSIS 6 monthSposl-DCA (~50" 
diameter stenosis. n=20), diameter stenosis (") and loss in minimal luminal 
diameter (-e Mill. mm) are shOWD in Table 2. The groups did not differ 
significantly (X' test and Kruskal-Wallis test; medians and 95" CI given). 
Table 2. No growth Outgrowth Sustained 
ReQenosia 12139 8/28 217 
" stenosis 38 (27-46) 45 (34-54) 34 (18.01) 
-e Mill 0.8 (0.5-1.0) 0.4 (0.2-1.0) 0.3 (~.~.8) 
Conclusion. SMC from restenotlC lesiOns aemonsiiiiied iCCderated growth ill 
secondary culture. Otherwise, the success of primary and secondary SMC culture 
after DCA did not reflect or predict restenosis. 
802·6 3:15 
Arterial Response to Atherectomy-Induced I.vury in Atherosclerotic 
Rabbit Diac Arteries. 
Robert L. Wilensky. Innina Gradus-Pizlo. George E. Sandusky. Keith L. 
Marcb. David R. Hathaway. Krannert lnstilute of Cardiology. Indiana 
University School of Medicine. Indianapolis. IN 46202 
Although directed athe=tomy and angioplasty increase 1_ size by dif•
ferent methods. the subseq\ICDt restenosis rates are similar. The response to 
atherectomy and angioplasty-illduced injury were evaluated in contralateral 
arteries of 41 rabbits to compare the vascular response to intervention. 
Arteries were obtained at 7 times: prior to (n=6) or I (n-13), 3 (n= 10). 5 
(n=8). 7 (n=l1). 14 (n= 13) and 28 (n=7) days after illtervention. Arter•
ies were stained with hematoxylin/eosin and Gomori's trichrome. immuno•
histochemistry was performed using HHF-3S antibody to detect smooth 
muscle cells (SMC) and RAM-ll fo( activated macrophages. Angi""lasty 
caused iIItimai and medial dissections which filled with fibrin-rich thrombus 
while atherectomy led to. more focal. wedge-shaped lesion. occasionally 
extending into the adventiti •. .Inflammation and mural thrombus was ob•
served ill the areas of atbe=tomy-illduced debulking although distinct focal 
areas of inflammation were observed circumferentially. The artery was 
stretched with ateas of medial and adventitial necrosis. Uptake of the 
thymidine analog bromodeoxyuridine. indicating increased DNA synthesis. 
was noted primarily around the area of the atherectomy but was also seen in 
focal areas. circumferentially. By 7 days. smooth muscle cells hid migra\j!Cj 
into the mural thrombus repairing the injury but fillillg ill the area of ather•
ectomy-induced debu11cing. The neoilltimal composition was similar to that 
observed in the angioplasty side. The neointima was SM C-rich but by 14 
and 28 days increased extracellular matrix and connective tissue was ob•
served. In conclusion: I) Atherectomy leads to generalized stretching of 
the artery. but a more focal injuty without the intimal and medi.1 flaps 
observed ill angioplasty; 2) Mural thrombus fills the area of focal resection 
in the same manner that it fills dissection planes post-angioplasty; and 3) 
The mural thrombus and general inflammatory response leads to increased 
SMC proliferation ill areas of debu11cing but also in areas untouched by the 
CUlling blade. leading to a generalized intimal response and a restenotic 
lesion similar to that seen after angioplasty. 
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Imran Niazi, Olerie Tauro, Laura Rector, Robert 
stawicki, Saed Saed1, Lalanan Kamath, and w. ~ey 
Johnson; St. Mary's Hospital, Milwaukee, WI. 
2:00 
18 patients \.lIXlert.olent pacing of the right ventricular 
septun (RVS) and apex (RVA) to detennire which pacing 
site provided superior hemodynamics. '!here ~ 16 
males and 2 females, with a nean age of 67 ± 11 and 
left ventricular ejection fraction of 41 ± 18. Pacing 
was perfonned at a cycle length (CL) just sufficiently 
shorter than the intrinsic CL to cbtain constant 
ventricular capture (nean CL 728 :!: 14). During pacing 
at each site, nean arterial blood pressure (BPI and 
cardiac output (CO) ~ recorded. CO was detennined 
using an impedance cardiogra{il (SOOBA r-a:lical Systems, 
Milwaukee, WI). 'lhree readings 1Nere cbtained over 
7 minutes, and averaged'. The paced QRS duration (QRS-D) 
was measured. 
RVA RVS P Value 
BP (om hg) 93 ± 16 96 ± 19 .003 
CO (L/mtn) 2.8 ± 1.1 3.7 ± 1.5 .0001 
QRS-D (msec) 195 ± 25 175 ± 29 .02 
BP and CO 1Nere significantly greater during septal 
pacing. Also, QRS-D was significantly shorter during 
septal as cx:mpared to apical pacing. A shorter QRS-D 
suggests IlOre rapid, synchronous ventricular activation. 
'thus, the superior hem:Xlynamics with septal vs. apical 
pacing 1Nere probably due to IlOre synchronous and 
efficient ventricular contraction. 
<XNCUJSICN: IN septal pacing provides better 
hemodynamics than IN apical pacing in the soort term. 
Further studies are indicated to detennire whether 
the RVS is superior to the RVA as a site for pennanent 
pacing. 
803·2 2:15 
Permanent Right Ventricular Outflow Tract Pacing Improves 
Cardiac Output • Comparison With Apical Lead Placemeat 
Michael C. Giudici, Greta A. Thornburg, DiAnne L Buck, Stephen G. Alldredge. 
St. Luke's Regional Heart Center, Davenpon, Iowa 
Investigators have demonstrated an increase in cardiac output with right 
ventricular outflow tract (RVOT) temporary pacing compared with tbe right 
ventricular apex (RVA). Experience with permanent implants has not been 
reported to date. We measured aortic flow velocity and cardiac output from 
both the RVA and RVOT by transthoracic doppler echocardiography while 
pacing in steady state in 15 consecutive patients (8 female, 7 male), age 28-86 
ylo, requiring dual chamber or ventricular only permanent pacemakers. The 
study leads (CPI Model 4269 "Sweet Tip'') were left in the RVOT in 13 of 15 
patients. Patients served as their own controls. Data were analyzed using a 
students paired T test 
aVA aVOT Mean Increase ± SD 
Mean Aortic Velocity (MIsec) 102 1.11 .086 ± .057 P<0.001 
Mean Cardiac Output (LImin) /i(I} 6.57 .478 ± .470 P<O.Ol 
Mean Pacing Threshold (range) O.72V (0.3 - 1.3) 
Mean a Wave (range) 11.29mv (5.0- 20.2) 
There have been no complications or lead dislodgements at 3 months 
follow-up. 
Conclusions: 1) Pacing the RVOT improves cardiac output compared 
to RVA lead placement. 2) Sensing and pacing thresholds in the RVOT are 
similar to those usually found in the RVA 
This data may have important implications for pacing in patients with 
diminished left ventricular function and also in athletic individuals requiring 
permanent pacing. 
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Maximal Work Capacity In Patients With a Dnal Chamber Pacemaker: 
Does a Different Atrioventricular Delay Playa Role? 
Jurgen Frielingsdorf*, Andreas Gerber, Peter Dilr, Philipp Wagd~ Andrt 
Vuilliomenet, Franz W. Amann·, Osmund Bertel 
Medical C1inic, Cardiology Division, Triemli-Hospital, Zurich, ·Depanment 
of Internal Medicine, Cardiology Division, University Hospital, Zurich, 
Switzerland 
We studied the influence of an individually programmed atrioventricular 
(A V) delay between 100 to 250ms on physical work capacity in 12 patients 
(68±16 yean) with dual chamber pacemaken implanted for high degree 
AV-block. 
During radionuclide ventriculography at rest the 'optimal AV -delay" (A VI ) 
with the maximal achieved left ventricular ejection fraction (EF) and the 
most 'unfavourable A V -delay" (A V2) with the least achieved EF were 
established. The EF at rest with AV1 was Sl±14% and with AV2 was 
4S±lS% (p<0.001). Each pl\tient was randomly assigned to either AV•
delay and a spiroergometry was performed to determine maximum oxygen 
uptake (max. V02) for AV1 and AV2, that correlates best with work 
capacity, at a respiratory quotient of 1.1. The results were not differently for 
AV1 and AV2, respectively. 
maxV02 maxsystBP maxHR MET 
(m!lmi!!) (mmti&) (mill-l) 
AV1 1297±421 161±17m±12 129±21 6.4±2.1 
ns ns ns ns 
AV2 128S±365 155 ± 16172± 13 127±25 6.6±2.0 
Conclusion: The A V -delay significantly affects left ventricular ejection 
fraction at rest in patients with a dual chamber pacemaker. On the contrary 
an optimally and individually programmed AV -delay has no influence on 
physical work capacity. 
803·4 2:45 
Left Veatrlcular Rqloul Systolic: FUDCtioII AssocIated wltI! AtrIo-Veatrlcular 
Padac at Varlo ... Veatrlcular SI .. 
Abe DeAnda Jr~ Luis J. Castro, Marc R. Moon, Stephen C. Raybi11, George T. 
Daughters, Neil B. Ingels, D. Craig Miller. Department of Cardiothoracic 
Surgery, Stanford University School of Medicine, Stanford, CA 
Impairment of left ventricular (LV) g\obal systolic function with dyssyncbronous 
activation has been shown to be independent of endocardial ventricular pacing 
site. To investigate whether there are regional differeDCQ in LV systolic function 
associated with pacing site, LV regional dynamics were eumincd in dop being 
paced endocardially. 6 dop underwent placement of bipolar atrial pacing wires in 
the right atrium, and 2S tantalum markers were inserted into the LV and septal 
waH endocardium. After a 6 week recovery period, the dop were lightly sedated, 
complete autonomic blockade instituted, and transvenous endocardial RV and 
LV pacing catheters positioned. Biplane cincfluorosco\lic marker images were 
obtained during the control stale (atrial pacing, 120 min-i), and with endocardial 
A-V pacing at the RV outflow tract (A-RVO), and LV apex (A-LVA). The 2S 
subendocardial markers defined 8 planar areas in each of 3 circumfercntiallevels 
(basal, equatorial, and apical). Percent fractional area shortening (F AS) of cach 
area was calculated and norma1ized to a region on the LV anterior free wall. 
RESULTS: AI'W, LFW, PFW, SW denote anterior, lateral, posterior and septal 
wa11s, respectively. No significant diffcrences were seen in F AS in any of the 8 
equatorial regions, as well as the SFW and AFW apical regions. FAS from 
representative regions with significant differences are shown below (mean + SO, 
ANOVA with replication): -
.B!ll!9.o 2 Ak!II A:fM) A:J.YA 
AFW, Basalt 0.798:!:.16 0.832+.15 0.975+.24 
LFW, ~BasaI 0.949:!: . .34 0.827+ 24 0.935+.26 
PFW, 0.724+.29 0.721 +.20 0.824+ .41 
SW, Basal 0.861:;:21 0.828!.30 1.123+.42 
LFW, Aplcal~ l.lU+.31 0.925+.33 1.079+.32 
fFW, Aplcal.l 1.168+~ 1.032+.23 0.991+.27 
atrial vs. RVO, p < 0.1l5, atrial 'IS. LV A, P < 0.05 -
CONCLUSION:1) In the basal regions, FAS increased in the AFW, SW and 
PFW with A-LVA pacing, and only in the LFW with RVO pacing; 2) The 
equatorial region was unaffected by pacing, 3) In the apical region, LFW FAS 
decreased with A-LVA but increased with A-RVO pacing. 
lACC Vol. 21, No.2 
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Improved Aerobic Capacity with Single Lead Atrial 
Synchronous Pacing with a Rate Adaptive Sensor 
Chu-Pak £.au, Yau-Ting Tai, Sum-Kin Leung, John Li, Cheuk-Kit 
Wong, Wing-Hung Leung, Felsa Chung, Emily Au. 
Division of Cardiology, Department of Medicine, University of 
Hong Kong, Queen Mary Hospital, Hong Kong. 
Single chamber ventricular rate adaptive pacing (VVIR) improves 
exercise capacity over constant rate ventricular pacing. The role of 
additional atrioventricular (A V) synchrony by sensing floating atrial 
electrogram using a single pass ventricular lead with an activity 
sensor (Unity-VDDR, Intermedics Inc) was tested in 10 patients 
(pts) with complete A V block. Implantation of the lead was similar 
to a standard ventricular lead, and satisfactory P wave sensing was 
achieved in all pts. Double blinded paired treadmill exercise tests 
(VDDR and VVIR modes)' were performed at one month after 
implantation with collection of metabolic data. At anaerobic 
threshold (AT), VDDR mode resulted in an II % improvement in 
oxygen uptake (VOV over the VVIR mode (P<0.05). VDDR 
pacing yielded a 30% increase in work capacity (17.3±3.4 vs 
13.3±2.6W, P<0.05) and prolonged the time to AT by 15% 
(4.1±0.3 vs 3.4±0.3 min, P<O.Ol). Compared to the VVIR 
mode, VDDR pacing improved the heart rate (1l4±5 vs 92±2, 
P<0.02) and systolic blood pressure (164±8 vs 145±6 mmHg) 
(P < 0.02) at AT. There was no significant difference between the 
maximum exercise duration and V02 in the two modes. 
Conclusion: Although the addition of A V synchrony may not 
improve maximum exercise, aerobic capacity in the range of daily 
activities was significantly improved. The ability for P wave 
sensing with a single pass ventricular lead enhanced functional 
capacity over VVIR pacing without added complexity in the 
implantation. 
803-6 3:15 
Effect Of ContrllC1ion Sequence On Left Ven1riculer FunC1ion And 
Wall Mo1ion 
Chang Zong Cui, Jolene Fox, J. Stan Hill, G. Michael Vincent. 
Department of Medicine, LOS Hospital and Department of Medicine 
and Laser Institute, l!niversity of Utah Health Sciences Center, Salt 
Lake City, UT. 
Recent studies have suggested that left ventricular (LV) contraction 
sequence (CS) has a greater effect on hemodynamics than was 
previously recognized. Therefore, hemodynamic effects of LVCS 
were further evaluated. 
~:LVCS and atrioventricular CS were varied by pacing. 
Pacing modes (PM) used were right atrial (RAP) or right ventricular 
(RVP) in 8 dogs and RA-AV node sequential (ANSP) and RA-RV se•
Quential (AVSP) in 10 dogs. From LV right anterior oblique 
angiograms we measured radial grid lengths of walls: apical lAP), 
anterior lAW), inferior (lW), and basilar IBW). Stroke volume ISV), 
ejection fraction (Efl, cardiac output (CO), and cardiac index (CI), 
were calculated. Statistics: PM comparisons in same dog were by 
Wilcoxon test and in different dogs by Mann-Whitney test. 
BuY!t!: Parameters shown are reported as: Walls Imm), SVlml), 
EF(%), CO(Um), CI(CO/10kg). 
I 
Compansons a , 
significantly different. For RAP vs RVP all values were significantly 
different (P< .009) except IW. ANSP vs AVSP comparisons were 
all significantly different IP<.02) with AVSP always worse. 
Conclusions: AVSP and RVP resulted in significantly decreased LV 
function compared to the other pacing modes. This was due to LV 
segment motion abnormality. LVCS is an important determinant of 
hemodynamic performance and is as critical as AV synchrony. 
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Dobutamlne Stress Echocardiography Accurately Predicts 
Subsequent Cardiac Events In Women 
Alicia M. Williams, Pamela A. Marcovitz, Klaus P. Bergmann. 
David S. Bach, Victoria Shayna. William F. Armstrong. University 
of Michigan. Ann Arbor. MI. 
1be accuracy of routine cardiovascular stress testing for detcction of 
coronary disease in women is known to be less than in men. The 
prognostic significance of newly developed stress testing modalities 
such as dobutamine stress echocardiography (DSE) has not been 
previously Investigated. The purpose of this study was to investigate 
the prognostic value of DSE in 145 women (mean age 65) who 
underwent DSE between 1190 and HV90. Baseline clinical variables. 
including cardiac risk factors (eRF) and follow-up infonnation was 
obtained in 134 women followed for 14±3 months after DSE. 
Follow-up was obtained and tabulated for hard events (HE): 
myocardial infarction (Mn and cardiac death; and soft events (SE): 
revascuJarizalion , unstable angina and congestive heart failure. 
Study subjects were divided into 4 groups based on lheir response 
during DSE (I =normaI rest, normal stress, 2=normal rest, abnonnal 
stress, 3=stable wall motion abnonnality (WMA) at rest and stress, 
4=abnonnal rest with new or worsening stress-induced WMA). Of 
44 women wilh nonnal DSK none died of cardiac causes and there 
was I nonfatal MI (2%) (specificity=98%). Eight of 56 (14%) 
women with ischemiC DSE had HE and 20 (36%) had SE. Any 
isehemic response on DSE (Grp 2&4) predicted HE (p=.05) and SE 
(p=.02). Of lhe 11 pts with a HE. 10 (sensitivity:91 %) had an 
abnonnal DSE (grp 2,3.4) and 8 (73%) demonstrated ischemia (grp 
2.4). Neilher age nor any Single CRF or combination of CRF 
predicted HE or SE (p=NS). 
t 2 3 4 
~ 44 20 34 36 
No Event 38(86%) 11)(50%) 27(79%) 18(50%) 
HE 1(2%) 4(20%) 2(6%) 4(11%) 
SE 5(11%) 6(30%) 5(15%) 14(39%) 
We conclude lhat DSE identifies both a high risk and a low risk 




Incremental Value of Exercise and Dobutamine Echocardio•
graphy in Patients with Normal Exercise ECG compared with 
SPEer. 
Rainer Hoffmarm, Harald Lethen. Monika Weill, Frank A. 
Fiachskampf, Peter Hanrath, Med. Oinic I, Klinikum RWnI 
Aachen,FRG. 
Exercise ECG is still the first line non-invasive stress test for 
diagnosis of coronary artery disease, although other stress 
modalities are known to have a higher sensitivity. In this study, we 
investigated the incremental value of exercise echocardiography 
(EE) and dobutamine echocardiography (DE) as well as perfusion 
scintigraphy for CAD detection in patients (pts) with normal 
exercise ECG. 66 pts with suspected CAD underwent maximal 
exercise ECG, EE and DE, SPECf (n=55) and subsequently 
coronary angiography. Exercise ECG was found to be abnormal in 
27 pts, of whom 25 pts had CAD (luminal area stenosis > 70%). 
Of the 39 pts with normal exercise ECG 24 had CAD on coronary 
angiography (sensitivity 25/49=51% of exercise ECG). In pts with 
false negative exercise ECG, EE was positive in 15/24, DE in 
14/24 and SPECf in 15/18. Especially in one-vessel disease pts 
(n=29) exercise ECG had a low sensitivity (13/29;45%) with EE 
and DE as well as SPECf identifying additional pts (see table). 
Sensitivity for CAD detection in pts with neg exercise ECG but 
positive coronary angiogram: 
EE DE SPECf 
all pts 63% 59% 83% 
one-vessel pts 62% 69% 85% 
Conclusion: In patients with suspected CAD but negative exercise 
EeG, exercise and dobutamine echocardiogniphy yield substantial 
incremental information, supporting its use in a stepwise 
diagnostic approach to CAD, Its incremental value however, does 
not reach that of SPECf. 
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Inotropic Contractile Reserve During Dobutamine Stress 
Echocardiography Predicts Recovery of Regional Left 
Ventricular Function After Coronary Revascularization. 
Carlos O. Cigarroa, Christopher R. DeFilippi, M. Elizabeth Brickner, 
Arvella Peters, Luis O. Alvarez, Paul A. Orayburn. 
UT Southwestern and VA Medical Centers, Dallas, TX. 
This study was undertaken to determine whether dobutarnine stress 
echocardiography (DSE) could identify hibernating myocardium and 
predict recovery of left ventricular regional wall motion in pts under•
going coronary revascularization. We studied 58 consecutive pts with 
chronic multivessel CAD and depressed LV function (EF 32 ± 8%). 
Two pts declined to participate and 7 had technically difficult studies. 
Thus, 49 pts underwent DSE with graded infusions of 5, 10, 15, and 
20 11g/kg/min at 3 min intervals. All studies were read in blinded 
fashion using a quad screen display. Regional wall motion was 
assessed using a 16-segment model. Systolic wall thickening in each 
segment was graded as I-normal or hyperkinetic, 2-hypokinetic, 3-
akinetic, and 4-dyskinetic. Inotropic contractile reserve was defined 
improved thickening grade in at least 2 adjacent abnormal segments 
and ~ 20% improvement in regional wall motion score. By these 
criteria, DSE showed inotropic contractile reserve in 24 pts (49%). 
Inotropic contractile reserve was present in 73/184 (40%) akinetic 
segments but only 2/38 (5%) dyskinetic segments. Although cardiac 
mortality was significantly higher in pts without inotropic contractile 
reserve (28% vs 0%, p..o.017), all 7 deaths were in pts with apical 
dyskinesis, a rmding that was more frequent in pts without inotropic 
contractile reserve (10/25 vs 2/24, p=O.025). Follow-up 2D echo 
studies were obtained one month after coronary revascularization in 
25 pts who underwent successful PICA or CABO. In this group, 9 
of 11 pts with inotropic contractile reserve had improved wall motion 
after revascularization (hibernating myocardium), whereas 12 of 14 
pts without inotropic contractile reserve did not improve (p=O.OO3). 
Thus, the presence of inotropic contractile reserve on DSE predicts 
recovery of left ventricular regional wall motion after coronary 
revascularization. DSE may be useful in selecting pts with chronic 
CAD who will benefit from coronary revascularization. 
804-4 2:45 
Wall Thickening during Low Dose Dobutamine 
Echocardiography and Thallium Uptake Identifies Reversible 
DYsfunction after Myocardial Infarction 
Thomas Stoiber, Steven Smart, Robert Hellman, Kooroush Saeian, 
John Duchak, John Wynsen, Kiran Sagar. Medical College of 
Wisconsin, Milwaukee, Wisconsin. 
Inotropic stimulation and thallium uptake (fhU) may identify 
reversible dysfunction after acute myocardial infarction (MI). To 
compare the accuracy of dobutamine induced wall thickening (WT) 
and Th U for identifying reversible dysfunction, 27 patients (age 
59±10 yrs, 11 anterior MI, 14 treated with thrombolysis, and 15 Q 
wave MI) underwent dobutamine echocardiography (DE, baseline 
and 5-10 mcg/kg/min) and 4 hour SPECT thallium scintigraphy 
after resting injection of 3.5mCi at 5 ±2 days after MI. 
Echocardiograms were repeated 4 weeks later (follow-up). 
EchOcardiograms were analyzed according to the standard 16 
segment model and scoring system. Thallium scans were analyzed 
according to the same model for the presence or absence of ThU. 
Analysis was localized to the 9 infarction wne segments. Improved 
WT during DE and ThU in dysfunctional segments were the criteria 
for predicting reversible dysfunction or improved WT at follow-up. 
In the 27 patients, 235 segments were visualized on all studies. 
Abnormal WT was noted in 133 (57%) segments at baseline. Fifty•
six (42%) of the abnormal segments improved at follow-up and 77 
(58%) were unchanged. Improved WT during DE and ThU 
occurred in 72 and 83 (p = ns), respectively, of the abnormal 
segments. The sensitivity and specificity of improved WT during 
DE and ThU for reversible dysfunction were: 
WT(DE) ThU 
Sensitivity (%) 75* 57 
Specificity (%) 61 ** 34 
Accuracy (%) 67** 44 
*p<O.05 vs Th **p<0.01 vs ThU 
WT during DE was more sensitive, specific, and accurate than ThU 
during rest thallium scintigraphy for identifying reversible 
dysfunction (stunned myocardium) early after acute MI. 
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Correlation of Dobulamine Stress Echocardiography and Dobulamine 
Technelium-99m Seslamibi 
Sheila K. Heinle, Frank D. Tice, Gordon Keeler, John H. Toptine 
Salvador Borges-Neto, Michael Hanson, R. Edward Coleman, Joseph 
Kisslo. Duke University Medical Center, Durham, North Carolina 
Although dobutamine stress echocardiography (DSE) has been 
previously reported to accurately detect angiographically proven 
coronary artery disease, the correlation of this technique with nuclear 
perfusion imaging is unknown. In order to determine the correlation of 
DSE with dobutamine technetium-99m (Tc99m) sestamibi, 17 patients 
with known or suspected coronary artery disease were studied 
simultaneously by both teChniques. All patients underwent baseline 
echocardiographic and Tc99m sestamibi imaging prior to the 
dobutamine infusion which was increased every 3 minutes to a 
maximum dose of 40 micrograms/kilogram/minute. Standard 
parasternal long and short axis, apical 2 and 4 chamber views were 
digitally acquired at baseline and at low and peak infusion levels. 
Dobutamine Tc99m sestamibi stress images were obtained 30 minutes 
after the infusion. The DSE and dobutamine Tc99m sestamibi images 
were analyzed independently by observers who were blinded to the 
results of the comparison study. Overall. the concordance between DSE 
and dobutamine Tc99m sestamibi was 76% with a kappa coefficient of 
0.54. Of 5 patients with CAD by coronary angiography, DSE and 
Tc99m sestamibi were abnormal in 3 and 4 respectively. The 
concordance between DSE and dobutamine Tc99m sestamibi was 92% 
in 12 patients who achieved a peak HR 2: 120 versus 40% in 5 patients 










These data indicate that although there is good overall correlation 
between dobutamine stress echocardiography and dobutamine Tc99m 
sestamibi, a peak heart rate of at least 120 beats per minute is necessary 
to achieve excellent correlation. 
804·6 3:15 
Dobutamine Stress E1ectrucardiography: Detection of Coronary 
Disease in Patients with Normal Baseline Electrocardiograms 
Judy Foltz, Stephen G. Sawada, Thomas Ryan, Douglas S. Segar, Stephen 
N. Morris, Harvey Feigenbaum, Krannert Institute of Cardiology, 
Indiana University, Indianapolis, IN 
The value of the electrocardiogram (ECG) during dobutamine stress 
echocardiography (DSE) has been questioned. To determine the 
accuracy of the stress EeG during DSE, the records of over 1000 
patients who had DSE performed were reviewed. All patients ([pts], 
n =51,27 male, mean age 60 ± 12 years) with a normal baseline ECG, 
no history of myocardial infarction, not taking digitalis and who 
underwent cardiac catheterization were studied. The ECGs during 
dobutamine infusion were reviewed blindly and compared to coronary 
angiography. Significant coronary artery disease (CAD) was defined as 
a 2: 50% luminal narrowing in a major epicardial coronary artery. 
Criteria f or an abnormal stress ECG included 2 1 mm of horizontal or 
downsloping ST -segment depression or 21 mm ST segment elevation as 
measured 80 msec after the J point. There were 30 pts with CAD (21 
with multivesse1 disease) and 21 pts without CAD. The mean maximum 
heart rate and rate· pressure product during stress were 128 ± 14 bpm, 
18007 ± 3529 mmHg/min in the pts without CAD and 126 ± 19 bpm, 
19707 ± 4558 mmHg/min in pts with CAD, respectively (p = NS). 
There was no difference between the groups with regard to age, gender, 
or percent of pts who reached their target heart rate. B-hlocker therapy 
was more common among pts with CAD (19%) than those without (5%). 
The ECG was positive in 25 of 31 pts with CAD (81% sensitivity) and 
was negative in 14 of 20 without CAD (70% specificity). ST elevation 
developed in 4 pts (all with CAD) and ST depression in 28 pts (23 of 28 
with CAD). Both ST elevation and depression were found in 2 pts. Of 
the 6 false-negative stress ECGs, only one pt was taking a B-blocker. In 
conclusion: 1) in pts with a normal baseline ECG, dobutamine stress 
ECG is moderately sensitive for the detection of CAD, 2) ST segment 
elevation appears to be an excellent marker for the presence of 
significant CAD. 
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ELCA: Single Institution experience with 800 Lesions 
Sameer Mehta, James R. Margolis, Robert Trautwein, Barry Kramer, 
Jorge Bejarano. Miami Heart Institute, Miami Beach, Florida 
A large single group experience may minimize the learning curve 
associated with new procedures. During the past 3 yrs., three 
associated cardiologists using the same techniques have developed a 
large experience with Excimer Laser Coronary Angioplasty (ELCAI. 
812 lesions in 635 pts. were treated between Mar, 1989, and Aug, 
1992, using the AIS 30Snm Xenon Chloride Excimer Laser. Mean 
age was 64 ± 11 yrs; 78% were males; 64% percent had class 3 or 4 
angina. Vessel distribution included LAD 37%, LCX 23%, RCA 27%, 
SVG 11 %, LMT 2%. 85% of the lesions were stenoses, 15% were 
chronic total occlusions. 58 % were in middle and distal segments; 
43% were longer than 10mm, 12% longer than 20mm; 55% were 
eccentric; 41 % were calcified. 
The pulse width of the excimer laser was> 200 n sec., repetition 
rate 20 Hz and f1uences 35-65 mJ/mm2. The laser catheter sizes 
were 1.3, 1.6, 2.0 and 2.2mm. Procedure success, dofined as S50% 
final stenosis (with or without PTCAI, was achieved, in 780 lesions 
(96%1. Stand Alone ELCA «50% stenosis after ELCA and no 
adjunctive PTCAI was used in 23% of the lesions. For the various 
subgroups, success rates were as follows: total occlusions 96%, 
long lesions (>20mml 94%, SVG 97%, calcified lesions 94%, ostial 
lesions 95%. ELCA complications included: transient closure/spasm 
28 (3.5%1, abrupt occlusion 15 (1.9%1, dissection (lnciudes clinically 
insignificant dissectionsl 81 (10%1, perforation 5 (0.6%1, MI 9 
(1.1 %), emergency CABG 7 (0.8%1, death 3 (0.3%). 
Conclusions: (11 ELCA success and complication rates are 
comparable to PTCA. Complex lesions: aorto·ostial, long and 
calcified lesions, total occlusions and SVG may be treated more 
favorably with ELCA. (2) Compared to a Registry series, the large 
single institution experience may be more representative of the role of 
ELCA, 
938·69 
308 Excimer Laser Tissue Interaction 
Using a Modified Multi Fiber Catheter 
Jaap N.Hamburger, Geert H.Gijsbers, Rene L. 
Sprangers, Martin J.van Gernert, Arend 
J.Dunning, Academic Medical Center, 
Amsterdam, The Netherlands 
Light intensity distribution in tissue is 
related to fiber diameter. Therefore, we 
designed a mOdified multi fiber catheter 
(MFC) with a hOlilogeneous light distribution 
(HLD). The effects of the modified MFC in 
porcine aorta were compared with standard 
MFC's, containing 200 or 50 /.1m fibers, 
using a 308 nm pulsed XeCl excimer laser 
with energy densities of 30 and 60 mJ/mm2, 
and pulse frequencies of 5 and 20 Hz. We 
assessed crater depth, morphology, thermal 
and mechanical damage by light and electron 
microscopy. 
Results. The standard MFC's produced 
different clusters of separate craters 
according to MFC design: 12x200/.lm and 
200x50~m, respectively. Crater walls were 
ragged, showing extensive damage to 
surrounding endothelium. 
In contrast, the modified MFC produced 
single smooth craters. Craterdepth 
increased with a factor 4.9 and 
craterwidth, being determined by the 
modified MFC diameter, by a factor 2. No 
damage to surrounding endothelium was seen. 
Conclusion. HLD improves ablation efficacy 
and reduces damage to adjacent endothelium. 
ABSTRACTS 
938·70 
Exclmer Laser Angioplasty With Sequential Fiber 
Activation: Preliminary Analysis of a Novel Catheter 
Design. 
Kenneth Rosenfield. Lisa Wells. Kenneth Grace, Ann M. Pieczek, 
Robert M. Schainfeld, Douglas W. Losordo, K. Ramaswamy, 
Mukul Bhatnager, Jeffrey M. Isner. Tufts University School of 
Medicine, SI. Elizabeth's Hospital, Boston, MA. 
Dissections complicating excimer laser (ExL) angioplasty have been 
attributed primarily to acoustic trauma and secondarily to the lack of 
adequate egress route for vapor products. We investigated the use 
of a novel fiberoptic catheter (Multiplex™, Spectranetics, Colorado 
Springs) coupled to a 308nm ExL, employing a mechanism which 
activates the fibers in a sequential fashion, such that adjacent fibers 
are not activated simultaneously. The design of this option is 
intended to reduce acoustic trauma and augment egress time for 
gaseous byproducts. 
Accordingly, Multiplex ExL angioplasty was perfonned ill 28 
vessels (4 coronary and 24 peripheral) in 17 patients. For coronary 
arteries, the laser was operated at 50 mI/mm2 and 36Hz. Mean 
lesion length was 11.2mm. Mean # passes=1.8. Percent stenoses 
pre, post-laser. and pcst-PTCA were 92.8, 70.0, and 30.0. 
respectively'. In no case was there angiographic evidence of laser•
induced dissection. 
For peripheral arteries. the laser was operated at 5O-69mI/mm2. and 
a frequency of 36Hz. Mean lesion length was I03.2mm. Mean # 
p3SlieS= 1.3. Percent stenoses were reduced from 97.7 pre-laser, to 
57.5 post·laser, to 15.3 post-PTA or atherectomy. Angiographic 
evidence of laser-induced dissection was limited to 3 pts; all were 
angiographicaUy mild and clinically insignificant 
Conclusion: Preliminary experience with Multiplex ExL angioplasty 
suggests that it may be effective in reducing the incidence of 
angiographic andlor clinically significant dissections resulting from 




Successrul Directional Excimer Laser Coronary Angloplasty in Unravorable 
Lesion Morpbologies 
Kenneth D. Henson. Martin B. Leon. Augusto D. Pichard. Frank Litvack. David 
R. Holmes. Spencer B. King iii. Ziyad Ghazzal. Washington Hospital Center. 
Washington, D.C. 
Excimer laser coronary angioplasty using concentric over-the-wire laser catheters 
is less successful in bifurcation lesions and eccentric lesions on severe bends. due 
to a higher frequency of major dissections and perforations. To address this 
limitation. a new 1.8mm directional laser catheter (DLC) has been developed 
(Advanced Interventional Systems) with a protective tip extension lcm beyond an 
eccentric bundle of densely packed fibers. A proximal tuming knob rotates the 
eccentric fiber bundle for precise directional control. From the multicenter 
experience. of the 73 pallents treated using this new DLC. 21 lesions in 20 pts 
(27% of cohort) were both eccentric and either at a bifurcation (n=16) or on a 
severe (>45°) bend (0=5). Moderate or heavy calcification was present in 7 
lesions (33%) and lesion length averaged 7.1±4.6mm. The extended catheter tip 
was positioned across or within the eccentric lesion. the catheter was rotated to 
maximize fiber-tissue contact. followed by slow «lmm/second) antegrade 
advancement through the lesion (3 second puL<;e trains. average Ouence SSmJ/mm2 
at 20Hz) for single (65%) or multiple passes (35%). Pre-treatment % diameter 
stenosis (DS) was reduced from 84.4% to 49.9% after DLC treatment (p<.OOI). 
Adjunct PTCA to achieve optimal lumen dimensions was utilized in all but I 
patient resulting in funher % DS reduction to 22.2% (P<.OOJ). OvernII procedure 
success «50% fmal DS without in.hospital death. Q-wave MI. or urgent CABG) 
was 85%: 2 of 3 failures were due to inability of the catheter to negotiate proximal 
tonuosity and reach a lesion or to cross a lesion on a sharp bend. There were no 
deaths. perforations. or Q·wave Mis. Urgent CABG was required in I patient 
after abrupt closure. Dissections (major or minor) were noted in 5 patients 
leading to abrupt closure in 3. 
We conclude: From this preliminary clinical experience using a new excimer 
DLC in eccentric lesions at bifurcations or severe bends (I) catheter performance 
characteristics were favorable exhibiting exceilent directional control and high 
ablation efficiency. (2) procedure success was high (85%) and major 
complications were acceptable (5%). and (3) adjunct PTCA was required to 
achieve optimal angiographic results. Thus. DLC may expand clinical 
applications of laser angioplasty to lesion subsets previously contraindicated for 
concentric laser catheters, 
386A ABSTRACTS 
938-72 
Excimer Laser Angioplasty of Saphenous Vein Graft Lesions: 
Relation Between Lesion Type and Outcome 
John A. Bitll, David Yardley, James E. Tcheng, Jeffrey M. Isner, John A. 
Power, George S. Abela, Bradley Strauss, Timothy A. Sanborn, and the 
PELCA Registry. Brigham &: Women's Hospital, Boston, MA 
Commonly lumped together as a single lesion type, saphenous vein 
graft stenoses comprise a wide 5pe(trum of morphologies ranging from 
discrete stenoses to ulcerated lesions containing thrombus. To identify 
predictors of major complications and restenosis after excimer laser 
angioplasty of saphenous vein graft stenoses, we analyzed results in 302 
patients (age 66±9 yrs; 75% male) with multivariate logistic regression _ 
methods. Oinical success was achieved in 91 % of patients, as indicated 
by $50% residual stenosis and no in-hospital complication. Major 
complications (non-Q and Q wave MI, CABG, death) occurred in 5.3% of 
patients and were more likely in patients with long, ulcerated lesions: 
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Risk- of Miljor Complication(Odds Ratio and 95% Confidence Limit! 
Restenosis (defined as >50% stenosis) was observed in 45% of all 
treated saphenous vein sites at 6 month follow-up (64% angiographic 
compliance) but found in only 24% in large vein grafts ~.4 mm (odds 
ratio=0.19 [0.07, 0.51); p=O.007). 
This study, which defines the profile of risk of excimer laser angio•
plasty according to veln graft lesion type, shows that: 1) complications 
are more likely in long, ulcerated lesions, and 2) restenosis is lower in 
large grafts. The analysis provides a basis for comparing excimer laser 
angioRlasty with other treatments for saphenous vein graft lesions. 
938-73 
Combined Laser Plus Balloon Angioplasty Increases Restenosis Versus 
Balloon Angloplasty Alone In Rabbits. 
Michael Ragosta, S. David Gertz, Howard L. Haber, Lawrence W. Glmple. 
Eric R. Powers, John DeFrancisco, William C. Roberts, Ian J. Sarembock. 
University of Virginia, Charlottesville, VA 
Plaque debulking techniques such as laser angloplasty (LA) were 
developed to improve acute outcome and reduce restenosis when used with 
or without balloon angioplasty (BA). We hypothesized that combined LA 
plus BA would improve procedural gain and reduce restenosis compared to 
BA alone in a hypercholesterolemic rabbit model of focal femoral 
atherosclerosis. Rabbits were assigned to LA alone (Holmium:YAG infra-red 
laser [Eclipse 2100], 1.5 mOl catheter at 5 watts for 69±.47 pulses; n~ \3 
arteries), BA alone (2.5 mm balloon, 3 x 60 s 10 atm inflations; n-8 
arteries), or combined LA plus BA (n-lI arteries) and kept alive for 28 
days. Additional rabbits were sacrificed 2 hours after BA andlor LA for 
acute histopathology (LA alone, n -6 arteries; BA alone, n -12 arteries). 
All rabbits received a heparin bolus (150 U/kg) at the time of the procedure. 
By quantitative angiography, BA increased luminal diameter (LD. in 
mm) from 1.12 ±. 0.20 pre- to 1.58 ±. 0.12 \l?st-BA with reoarrowing to 
1.12 ± 0.18 at 28 days. Combined LA plus BA resulted in a similar 
increase in LD from 1.02 ± 0.13 pre- to 1.51 ± 0.20 post but greater 
renarrowing to 0.85 ± 0.32 at 28 days (p-O.04 versus BA alone). 
Quantitative histopathology at 28 days confirmed greater percent cross•
sectional area narrowing by plaque in arteries treated with LA pi us BA vel'Sus 
BA alone (64 ± 9% vs 56 ± 17%, respectively). LA alone increased LD 
from 1.03 ±. O.IS to 1.20 ± 0.18 which was significantly less than BA alone 
(p=O.OOI). In animals sacrificed 2 bours after their procedure, LA alone 
resulted in increased acute thrombosis by histopathology compared to BA 
alone (4/6 arteries vs 0112 arteries respectively, p-O.OOI). 
Thus, the addition of LA to BA failed to improve initial procedural 
gain compared to BA alone and resulted in greater restenosis. LA alone 
results in less initial gain and was associated with increased acute thrombosis. 
938·74 
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A New Technique For Reducing Pressure Pulse Phenomena 
During Coronary Excimer Laser Angioplasty 
James E. Tcheng, Harry R. Phillips, Lisa D. Wells, Robert A. 
Golobic, John A. Power, Lawrence I. Deckelbaum, and the 
PELCA Investigators. Duke Medical Center, Durham, NC. 
Several investigators have demonstrated that blood and 
radiogra!)hic contrast decrease transmission of 30Bnm excimer 
laser radiation and promote the formation of pressure pulses 
and microbubbles. This may increase the potential for intimal 
disruption, vessel dissection, and coronary perforation during 
excimer laser angioplasty (PELCA). 
We quantitated transmission and magnitude of pressure 
wave generation when normal saline (NS), lactated Ringer's 
solution (LR)' Fluosol", contrast media, or various admixtures 
of bovine blood and either NS or LR were subjected to 30Bnm 
radiation. Transmission of 30Bnm radiation through 1 mm of 
media was 100% through both NS and LR but was reduced to 
59% and 53% with a 10% solution of bovine blood in NS and 
LR respectively. The magnitude of the pressure pulse 
generated during pulsed irradiation (50mJ-mm2) was 9 times 
greater with a 10% bovine blood solution and 23 times greater 
in 100% bovine blood compared to NS or LR. 
Prompted by these findings, a novel "flush and bathe" 
technique was developed to infuse NS or LR during PELCA, 
To date, 16 consecutive pts have been treated with this 
technique, with 100% procedural and clinical success, 
qualitatively improved angiographic post-laser luminal 
appearance, and absence of major dissection, luminal 
disruption, vessel occlusion, or adventitial staining. 
Conclusion: While preliminary, these data suggest that 
infusion of NS or LR may reduce the incidence of laser-related 
dissection and perforation and improve procedural outcomes 
following PELCA. A prospective randomized trial should be 
performed to determine the true efficacy of this technique. 
938·75 
Excimer Laser Coronary Angioplasty of Saphenous Vein Grafts 
William J. Untereker. James R. Margolis. Oary S. Roubin. Igor F. 
Palacios. David R. Holmes. Spencer B. King III. J. David Ogilby. 
Elizabeth K. Han. Frank Litvack and ELCA Investigators. 
Philadelphia Hean Institute. Philadelphia. Pa. 
Excimer Laser Coronary Angioplasty (ELCA) was used to 
treat 603 saphenous vein graft (SYO) lesions in 506 patients (pts.) in 
the ELCA registry. There were 412 male and 94 female pts. with 
mean age 65 years (range 31-89). Three hundred ninety-seven 
patients (78%) were CCSF III or IV. Lesion location was proximal 
m 133. body in 407 and distal anastomosis in 63. Four hundred 
ninety-seven lesions (82%) were in SVO's ~3 yrs. old. Morphologic 
data is available for the last 161 lesions consecutively treated. For 
67 ulcerated or thrombotic graft lesions more than 3 years old the 
procedure success rate was 93%. 
Overall the procedure success rate was 554/603 (92%) and 
laser success rate was 522/603 (87%) - independent of lesion length 
which was 9.5mm (.5-80mm). Eighty-three percent of the 
procedures utilized adjunct balloon. Lesion severity was 85% (34-
100) pre laser. 45% (0-100) post laser and 22% (0-100) post•
balloon. In-hospital clinical complications listed hierarchically 
included: death 4 (0.8%). transmural myocardial infarction 13 (3%). 
CABO 5 (1%). PTCA 16 (3%) and non-transmural myocardial 
infarction 21 (4%). Anatomic complications included: perforation 
3. dissection 29. acute occlusion 29. thrombosis 22. and embolus 24. 
One hundred nine of the 389 successful pts. (28%) with 6 
month follow up have had adverse cardiac events (18 deaths. 12 Q•
wave MI, 20 CABO and 59 repeat intervention). One hundred 
ninety-seven (51 %) have angiographic follow up with restenosis 
rate 57%. Combined clinical and angiographic restenosis is47%. 
Conclusions: 1) ELCA (usually with balloon adjunct) can be 
perfonned with a high primary success rate in older. high risk 
SVO's. 2) Complications are relatively infrequent. 3) Restenosis 
remains a clinical problem. 4) Direct comparison to PTCA will 
require a randomized trial. 
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939·6 
Protection of Contractile Function and Na+/K+ATPase Activity: 
Comparison of Continuous Warm Blood or Crystalloid 
Cardioplegia and Intermittent Cold Crystalloid Cardioplegia 
Yumin Qiu, Manuel Galiiianes, Peter 5. Haddock, David J. Hearse. 
Cardiovascular Research, St. Thomas' Hospftal, London 5E1 7EH, UK. 
We compared protection of contractile function, Na+/K+ATPase activity (an index 
of myocardial ion exchange activity) and tissue high-energy phosphate content 
afforded by continuous warm blood cardioplegia (CWB, 37°C, 0.8mVminlg), 
continuous warm aystalloid cardioplegia (CWC, 37°C, O.8mVminlg) and 
conventionally used intermittent cold crystalloid cardioplegia (ICC, 51. Thomas' 
HospHal cardioplegia, 20°C, every 30min for 3min). Three groups of rat hearts 
(11=12) were preserved wHh each cardioplegic solution for 3h. Na+/K+ATPase 
actMty ().unol PVmg'min) was assessed in 6 hearts in each group at the end of 
the ischemic period. The remaining hearts were Langendorff reperfused wHh 
blood (from a support rat) for 50 min. The hearts were paced at 320 beats/min. 
Left ventricular developed pressure (LVDP) and end-diastolic pressure (L VEDP) 
(mmHg, at an intraventricular balloon volume of 0.18 ml), tissue ATP and 
creatine phosphate (CP) content ij.L moVg dry wi) were measured at the end of 
reperfusion period (see table, 'p<0.05 compared wHh controls). Aerobically 
blood·perfused hearts (n=6) served as controls. 
LVDP LVEDP N.+n(ATPasa AlP CP 
cwe 95.B±S.6, 12.S±2.4, O.O32±O.O15. 11.7±L2. 20.1±3.0 
CWC S5.6±3.6 23.2±3.2 O.O12±O.OO3 9.S±L1 22.3±3.7 
ICC 70.2±2.S· B.B±L2 O.O31±O.013 B.2±LO· 25.S±3.S 
Control 102.9±7.& S.S±L2 0.O30±O.OO8 20.S±1.2 29.6±2.5 
Conclusion: CWB provided the best preservation of systolic function whereas 
ICC the best protection of diastolic function. Na+/K+ATPase activity and tissue 
ATP and CP content were equally preserved by CWB and ICC. RelativetoCWB 
and ICC, CWC provided poorer myocardial protection in terms of contractile 
function and Na+/K'ATPase activity. 
939·7 
Supraventricular Tach7arrh7thaiaB After Corona•
r7 Arter7 B7paBB Suraer7. Nulticentre Trial. 
Daniel Fernandez Berges, Ricardo Rey, Ricaruo 
Iglesias, Alejandra Cortez, Claudio Pensa,Juan 
C. Palma, Omar Scapin, Jose Martinez Martinez 
on behalf of Mar Study. National Academy of Me•
dicine.Pombo Foundation.Buenos Aires.Argentina 
This study was designed to determine the vali•
dity of atenolol and diltiazem in different 
doses in the prophylaxis of supraventricular 
tachyarrhythmias (SVT) after coronary artery 
bypass grafting (CABG). 805 patients (pts) di•
vided into 4 comparable groups in 13 hospitals 
were included in a randomised prospective stu•
dy. Group A(GA) received 50 mg of atenolol 
daily in a single ~ose(n:190), Group B(GB)608R 
of diltiazem every b hours(n:189), Group C(GC) 
90 mg of diltiazem every 8 hours(n:207), Group 
D(GD) received no medication (n:219).Treatment 
was started 6 hours after surgery on all pts 
anti continued for 5 tiays except in exclutied 
cases. 136 pts (16.9%) developed SVT, atrial 
fibrillation being the most common arrhythmia 
(b8.7~). SVT ocurred as follows: GA(n:190)23 
SVT(12.1S), GB(n:189) 33 SVT(16.4%), GC(n:207) 
31 SVT(15.9~) and GD(n:219) 49 SVT(22.4%) 
P ( 0.05. 
Conclusions: There was a statistically signi•
ficant lower incidence of SV? in groups A, B 
and C than in control D. There were no statis•
tically significant differences between groups 
A,B and C. Atenolol and diltiazem are equally 
effective in lowering the incidence of SVT. 
ABSTRACTS 
939·8 
Right Coronary Artery Stenosis: An Independent Risk 
Factor for Atrial Fibrillation Following Coronary 
Artery Bypass Grafting 
Lisa A. Hendes, Philip J. Podrid, Gilbert P. Connelly, 
Patrice A. McKenney, Richard J. Shemin, Adrienne L. 
Cupples, Thomas J. Ryan, Ravin Davidoff. Boston 
University Medical Center, Boston, MA. 
Atrial fibrillation (AF) is a common dysrhythmia 
following coronary artery bypass grafting (CABG). 
Preliminary data suggests that right coronary artery 
(RCA) disease and inferior HI accompanied by RV 
dysfunction are associated with a higher incidence of 
AF. To further assess the contribution of high grade 
RCA disease to post-CABG AF, we prospectively studied 
144 consecutive first time CABG pts without prior 
history of atrial dysrhythmias. Thirty-seven of 
91 (41%) pts with> 70% proximal or mid-RCA stenosis 
had post-CABG AF as compared to 11 of 53 (21%) pts 
without RCA disease (p~0.02). The independent 
significance of RCA disease on AF was evaluated by 
multivariate analysis. 
AF NoAF p 
n 48 -9-6-
Male/Female 33/15 .64/32 NS 
Pre-CABG LVEF(%) 57.9+13.3 55.8+14.9 NS 
No. of Grafts 3.0+ 0.6 3.0+0.8 NS 
RCA disease 37 (77%) 54 (56%) 0.002 
Age (years) 70.0+8.8 62.9+10.5 0.0001 
ItCA disease and age were independent predictors of 
AF. Discontinuation of beta-blockers post-GABG was not 
an independent risk factor for AF. 
COlI:clusion: RCA stenosis requiring CABG is an indepen•
dent predictor of post-operative AF. Right sided 
dysfunction associated with RCA disease may predispose 
to post-CABG AF. 
939·9 
Intraoperative Cardiac Di,lention: Treatment With Short Term 
Cardiopulmonary Bypass Versus Inotropic R.esuscitation 
W. Morris Brown III l\1D, John L. Jay MD, John Parker Gott MD, 
Richard J. Mellitt MD, Pan-Chih ~m, Lynne MA Dorsey BSN MBA, 
Sara Kalzmark BS, Robert A. Guyton MD 
Intraoperative left ventricular (LV) distention is an infrequent hut 
potentially devastating clini"," problem. A canine model was used to study 
effects of treatment with cardiopulmonary bypass (CPB) ror LV 
decompression versus catecholamine infusion. Twenty dogs undenvent 
cardioplegic arrest for 30 minutes on CPB to simulate a clinic.al cardiac 
operation. The animals were instrumented with triaxial sonomicometry 
and high lidelity micromanomelry ror LV pressure· volume data. After 
tapering CPB, there was a ten minute period of controlled hypotension 
and unifonn LV distention with an intraventricular balloon. 6 animaL~ 
were treated with CPR for 30 minules (GnlUp CPB). 14 animals were 
trealed initially with an epinephrine infusion. At 10 minutes, 6 of 14 had 
persistently elevated LV end diastolic pressw·es (> 20mmHg) constituting 
failure of inotropic treatment and CPR WIL' reinstituted for 30 minutes 
(Group EPI-CPB). 8 of 14 tolerated treatment with a 30 minute 
epinephrine infusion (Group EPI). Maximum elastance and preload 
recruitable stroke work (PRSW) relationships were calculated from the 
pressure·volume data 60 and 90 minutes after the injury in the three 
groups. There were no significant differences between the three groups for 
ultimate contractile perfonnance. However, there wa.~ a significant 
increase in the unstressed diastolic LV volume (x intercept of PRSW) from 
haseline in the EPI-CPR group when compared to both the EPI and CPR 
groups at 60 and 90 minutes. (90 minute increase: EPI-CPB 27±6%, EPI 
7 ±2.8%, CPB 10.S±2.8% p= .015 ANOVA). This implies significant acute 
persistent dilatation of the LV. In this model of acute intrdoperalive left 
ventricular distention, initial resuscitafion with catecholamine inflllilion 
alone entailed risk ror jJersistent distention (6114) despite suhsequent 
treatment with CPB. Prompt institution or short tenn cardiopulmonary 
byplL"~ for resuscitation precluded persistent distention and allowed 




Enhanced Recovery of Ischemic Myocardium by 
Combining Percutaneous Bypass With Intra•
Aortic Balloon pump Support 
Harold Lazar, Patrick Treanor, XiMing Yang, 
Sam Rivers, Richard Shemin 
Boston University Medical Center, Boston, MA 
Although Percutaneous Bypass (PB) can support 
the failing myocardium, regional ischemic 
damage may occur. This study sought to 
determine if the addition of Intra-Aortic 
Balloon Pump (IASP) support to PB would result 
in more optimal salvage of ischemic 
myocardium. In 30 pigs, the 2nd and 3rd 
diagonal vessels were occluded with snares for 
Ii hours followed by i hour of cardioplegic 
arrest and 3 hours of reperfusion with the 
snares released. During the period of coronary 
occlUSion, 10 pigs were placed on PB, 10 pigs 
received PB + IASP support, and 10 pigs 
received no support (UNMODIFIED). Ischemic 
damage was assessed by Wall Motion Scores 
(WMS) (4-normal to -l=dyskinesia), changes in 
myocardial pH ( A pH) , and the Area of 
NecrOSis/Area of Risk (AN/AR). Results are 
Mean±SE; ·p<.OS from UNMODIFIED; 'p<.OS from 
PB. 
UNMODIFIED PB PB+IASP 
WMS 1.3+.3 1.4+.3 3.3+.2" 
,t,. pH .41+.13 .60+.10 .30+.2' 
AN/AR( ') 73±3 43±2* 2S+S*' 
We conclude that IASP support should be added 
to PB to obtain the most optimal results 
during surgical revascularization of acutely 
ischemic myocardium. 
939·11 
Impairment of Coronary Blood Flow by Dynamic Cardiomyoplasty 
Ernesto R. Soltero, Uoyd H. Michael, Donald H. Glaeser, Craig J. Hartley, 
Nan R. Earle, Gerald M. Lawrie, Baylor College of Medicine, Houston, Texas 
Qinical results of dynamic cardiomyoplasty bave been Inconsistent. One 
concern has been possibile compromise of coronary blood flow (CBP) by 
epicardial compression during skeletal muscle wrap stimulation. In this acute 
study the effects on coronary blood flow of two single cardlomyoplasty wrap 
configurations, left posterior (LPC) and right anterior (RAC), and a double 
cardiomyoplasty wrap configuration (DCM) were evaluated. In 13 dogs 
latissimus dorsi muscles (LDM) were mobilized bilaterally from the chest wall 
and transposed into the chest while preserving the neurovascular pedicle. The 
proximal portion of the left anterior descending (LAD) and circumflex (CFX) 
coronary arteries were dissected and pulsed Doppler flow probes were placed 
around the vessels. Alternating RAC and LPC configurations, followed by a 
DeM, were used in each dog. The SP1005 cardiomyostimulator was used for 
synchronous LDM bUrst stimulation at 2V and 30 Hz. Most dogs were paced 
at a 3:1 ratio. Control CBF values were obtained fonowing each wrap and 
compared, using paired t-tests, with values averaged over six or more pacing 
cycles. 
LAD flow (ml/min) 'CFX now (mllmtn) 
Wrap C.ontrol Paced %Diff Control Paced ~ 
RAC 5.7±2.S 4.2±2.4 -23±13" 7.2±3.4 6.1±3.3 -17±lst 
LPC 6.3±2.1 S.7±2.2 -ll:tUt 7.8±2.3 .7.1±2.3 -10±10t 
DCM 5.7±2.1 4.S±2.3 ·23:t24t 7.4±2.S 6.0:t2.9 -21:t25 * 
Values are mean :t SO. ·<O.OOOS, tp<O.OOS, *P<0.01. 
Conclusion: Reduction of CBF with pacing was observed almost exclusively 
during systOle, and although diastolic augmentation of CBF occurred, it did not 
compensate for the systolic decrease. In all configurations, CBF Is significantly 
decreased with stimulation of the cardiomyoplasty but especiany in RAC and 
DCM. 
939·12 
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Correlation of Electrophysiologic Activation Patterns to Tension 
Genellltion in Stimulated Latissimus Dorsi Muscle 
Edward Rhee, Anthony Fumary. James Elson, and Race Kao, Allegheny•
Singer Research Inst.. Pittsburgh, PA. 
Cardiomyoplasty. aortomyoplasty. and skeletal muscle neoventricJes utilize 
electrically stimulated latissimus dorsi muscles (tOM) for biomechanical 
circulatory assist. We h)'l'Othesized that the mechanism of the observed 
im,rease in contractile force evoked by nerve versus intramuscular stimulation 
(IMS) could be delineated by electro-physiologic mapping (EPM). A 
specially fabricated 56 lead RPM array and an isometric force tnmsducer were 
attached to 7 canine LOM in !lim. Trains of 6 single pulse, supramaximaI 
intensity stimuli were then given at a rate of 1 Hz through »aI1lneural, 
proximal IMS, middle IMS, and distal IMS electrodes. EPM revealed that 
stimulation through paraneural or proximal IMS resulted in predominantly 
homogenous orthodromic activation patterns with respect to the motor 
innervation of the thoracoclorsa1 nerve. Middle and distal IMS resulted in 
more heterogenous activation patterns characterized by multiple sites of initial 
activation and non.cJepolarization. Contraction profiles revealed greater peak 
tension. ,longer contraction dURtion, and greater tension x time product for 
paraneural and proximal IMS vs middle and distal !MS. 
Electrode Paraneural Pro" Middle Distal 
Peak Tens. 9.8 (2.9) 10 (2.4) 7.4 (3.2)* 3.9 (1.6)* N 
Tena.X time 2387 (1054) 2368 (776) 1665 (924)* 893 (418)* N X msec 
Duration 346 (74) 350 (52) 270 (97)* 174 (99)* msec 
mean +1- (S.D.) * = p < 0.05 
Statistical analysis of EPM data revealed paraneural and proximal IMS was 
associated with a greater number of active electrodes but with no statistically 
significant difference in the mean time of activation and degree of temporal 
dispersion of activation times. We conclude that the greater tension 
generation observed following »aI1lneuI1l1 or proximal IMS resulted from 
stimulation of a greater total number of myofibers rather than from a greater 
degree of temporal synchronization and summation. 
939·13 
Deleterious Effects of Percutaneous Cardiopulaonary 
aIPus to the Unvented Left Ventricle in Cardiac 
Arrest. 
Karl H_ Schol'Z, Jens P. Hering, Thous Schr6der, 
Markus Ferrari, Hans R_ Figulla, Herbert Bock, 
Heinrich Kreuzer, Gerhard Hellige. University of 
G6ttingen, FRG_ 
The efficiency of percutaneous cardiopulmonary 
support (pCPS) was analyzed during ventriCUlar 
fibrillation (Vl) in a standardized model in adult 
sheep (n=ll; aean b.w.:97 kg): aean aortic:: (IIAP) , 
left ventricular (LVP) and myocardial perfUSion 
pressures (KPP) as well as wall tension (VT), 
ayocardial oxygen consumption (KV02) and arterial 
coronary-venoul difference of lactate (Lac-1VD) were 
aeasured at control and during 1, 3, and 10 ainutes 
of VF with pCPS (mean flow-rate 4.5 l/ain): (aean of 
n-9) 
control l'VF 10'Vr 
!lAP (ulIg) 87 55 54 
LVP(ed) (uHg) (14) 22 31 
MPP (uHg) 73 32 22 
VT(ed) (dyn/ca2) (22.804) 16.750 28.835 
IIV02 (ml/ain*100g) 5.8 4.8 5.3 
Lac-1VD (II1II01/1) 0.18 0.12 -0.10 
Two animals showed Ipontaneoul aortic regurgi•
tation with deterioration of coronary perfusion. 
Despite lufficient heaodynamic support during pCPS 
in vr, our data ShOlf deleterious eUects to the 
ayocardium (ayocardial release of lactate), which 
are related to an increase in LVP and 'lIT and a 
sublequent decrease in KPP. These data indicate the 
naed of simultaneous left ventric::ular decompression 
using pCPS in cardiac arrest. 
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939·14 
Quantification ofLert Ventricular Function in Cardiomyoplasty Patients 
by Pressure-Volume Analysis. 
Elmo T van der Velde', Jan J Schreuder', Vincent van Ommen2, Francois 
DelaHayc', Gerard Finet', Luciano Bonandi', Roberto LoJ1lSso', Jan Baan', 
FrederiIc H van der Veen'. 'Umversity Hospital Leiden, The Netherlands; 
'Umversity Hospital Maastricht, The Netherlands; 'Hopitaux de Lyon, 
France; 'Ospedale Civile di Brescia, Italy. 
A new therapy for chromc heart failure patients is dynamiC 
cardiomyoplasty. However, quantification of ventricular function in patients 
after cardiomyoplasty surgery is difficult with routine methods. The 
conductance catheter (CC) allows for measuring ventricular volume and 
other volume derived variables (e.g. stroke volume) on a beat-to-beat basis. 
Moreover, the CC method enables one to study left ventricular (LV) 
pressure-volume (P-V) relations dynamically. In a European cooperative 
study, ventricular function is examined in patients during catheterization 6-
24 months after surgery. Sofar, 6 patients have been studied. LV volume 
was measured by conductance catheter , LV pressure by a 2F micro•
manometer catheter inside the lumen of the CC. Ventricular function was 
evaluated under various pacing protocols of the latissimus dorsi (LO) 
muscle: at different ratios, voltage settings and delays. The effect of the 1:2 
stimulus protocol of the LD muscle was clearly visible in the PV -diagram 
(figure). For quantitative analysis, end-systolic (ES) P and V, stroke 
volume, stroke work, ESP/ESV ratio and peak velocity of shortening from 
adjacent stimulated and non-stimulated heartbeats were studied. Paired t-test 
showed in 4 of 6 patients a NOV.7.1. 
sigDificant (p < O.OS) improvement 
in these variables. 
Conclusion The use of LV PV 
analysis to study ventricular function i 
in cardiomyoplasty patients is a ! 
promising tool to quantify the 
benefits of cardiomyoplasty surgery 
in hemodynamic terms. .~--------------------~ a. LW" "0 
939·15 
Cardiomyoplasty - The Oregon Experience 
Remant Trehan, Jeffrey S. Swanson, Anthony P. Furnary, 
Albert Starr 
The Heart Institute at St. Vincent Hospital, Portland, 
Oregon 
Twelve patients with end stage heart disease underwent 
cardiomyoplasty at our heart institute over the past 
twelve months. There were eight males and four 
females with an age range of 47 to 74 years (mean -
65.7 yrs.). Eleven patients had idiopathic and one 
had ischemic cardiomyopathy. In all patients, the 
left latissimus dorsi muscle was used to wrap the 
heart. No patient required a concomitant procedure. 
There were three operative and two late deaths. 
Follow up ranged from three to twelve months (mean 
5 + 3 months). There were two system failures related 
to-the cardiac sensing lead and the pulse generator, 
which were corrected. At six months of follow up, 
the NYHA class had improved from 3.0 to 1.9 + 0.4 SEM 
(p = 0.05). There was no significant increa;e in the 
left and right ventricular ejection fractions, end 
diastolic and end systolic volume indices or stroke 
volume index. Preoperative right ventricular ejection 
fraction, the minimum intraoperative cardiac index 
and LVSWI were predictors of survival on univariate 
analysis. 
In carefully selected patients, cardiomyoplasty 
improves functional capacity. Further long term 
studies are needed to determine its effect on survival. 
939·16 
ABSTRACTS 
Cardi()myoplasty Impairs Early·Post()perative 
Left Ventricular Systolic Function 
David T. George, William J. Corin, James D. Sink. William P. 
Santamore, Philadelphia Heart Institute, Philadelphia, PA 
Patients (PTS) with severe congestive heart failure (CHF) have a 
Significantly greater early postoperative mortality after 
cardiomyoplasty surgery than PTS with moderate CHF. This may 
be partly related to the current practice of minimally stimulating 
the latissiumus dorsi muscle (LDM) during the initial 4 
postoperative weeks. To investigate the possibility that the 
unstimulated LDM wrap depresses LV function, we measured LV 
hemodynamics, immediately after cardiomyoplasty surgery, in 7 
mongrel dogs instrumented by micromanometry and 
sonomicrometry. LV pressure (LVP) and short axis dimensions 
were measured before and after the LDM wrap. fI-adrenergic 
receptors were blocked with propranolol (1 mg/Kg, iv). Heart rate 
(HR). end-diastolic area (EDA), and end-diastolic pressure (EDP) 
were unchanged after the LDM wrap. In contrast, the wrap 
decreased peak LVP, peak LV dP/dt. and stroke work (SW). 
Variable Prewrap Postwrap 
HR (bpm~. 116.3 : 14.3 121.1 : 12.6 
EOA (em) 6.3: 1.1 6.0: 1.2 
EDP (mm Hg) 6.6: 1.5 7.2 :t"1.0 
LVP(mmHg) 105.4:7.0 88.1:6.0·, 
dP/dt (mm Hglsec) 1491.9: 165.2 1175.3:t 145.8 
Sw (mm Hg-cm2) 166.9 ± 24.5 107.9 ± 24.8* 
• p<O.OS compared with prewrap 
Conclusion: Cardiomyoplasty impairs LV systolic function in the 
immediate postoperative period. These data may partly explain 
the clinical obselVation that PTS with greater preoperative LV 
dysfum:tion have a significantly poorer postoperative outcome 
after the cardiomyoplasty procedure. 
939·17 
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streSS-Reinjection Thalliua-201 Scintigraphy: 
Prediction of Effect of Coronary Artery Bypass 
Grafting on Regional Myocardial Perfusion 
Aaf FM Kuijper, Menco G Niemeyer, Ed GM D'haene, 
Ernst Evan der Wall, Ernest KJ Pauwels. Merwede 
Hospital, Dordrecht and University Hospital, 
Leiden, The Netherlands 
Regional myocardial perfusion by planar 
thallium-201 (Tl) stress-reinjection without 
redistribution imaging was assessed in 26 
patients before (preOP) and after (postoP) 
coronary artery bypass grafting (CABG). At 
stress 75 MBq Tl was administered fOllowed by 
reinjection of 37 MBq Tl after 4 hours. On each 
set of preop and po stOP Tl images 15 segments 
were visually and quantitativelY analyzed 
(circumferential profiles). 
Of the 143 preOP imaging defects observed at 
stress, 113 showed reversible Tl uptake and 30 
persisted following reinjection. On the postop 
images, 97 (86%) of the 113· preOP reversible 
defects were already normal at stress, 9 (8%) 
improved after reinjection and 7 (6%) persisted. 
Of the 30 preOP persistent defects, 7 (23%) were 
normal on the postop stress images and 3 (10%) 
segments showed reversible Tl. uptake after 
reinjection. Twenty (67%) of preop persistent 
defects after reinjection persisted also po stop 
at stress and after reinjection. 
Conclusion: Tl stress-reinjection imaging 
accurately predicts success of CABG in 86% of 
segments with reversible Tl uptake, and failure 
of CABG in 67% of segments with persistent 
defects. 
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940-62 
High incidence or asymptomatic Ihrombosis of 
mitral mechanical prosthesis in the early post•
operative period: demonstration by systematic 
trans-eosopllalleal eellocard iOllraplly. 
C Malergue, P Maribas, P Vignon, J Temkine, 0 Bical, P 
Gueret . Paris, Limoges, France. 
To assess tbe incidence of asymptomatic early 
tbrombosis of mitral mechanical prostbesis, we 
performed systematic trans-tboracic (TTE) and trans· 
eosphageal (TEE) t:cbocardiograpby, 10 days after 
uncomplicated surgery in 212 const:cutive patients(pts) 
(mean agt: 50 yt:ars) with St Judt: Mt:dical (174), 
Bicarbon Sorin (30), Starr (5), Omnicarbon (I) and 
Medtronic Hall (2). 
Based on initial TTE, all pts had normal prosthesis 
function (mean pressure gradient within normal 
limits) and no thrombus was visible. In 34 pts (16%), 
TEE evidenced presence of a thrombus on the prosthesis 
with conservation of specific valve diastolic mobility 
and physiologic systolic regurgitant patterns in all 
cast:s. Wht:n compared witb tht: remaining 178 pts 
without thrombosis, no difference was found 
concerning incidence of atrial fibrillation, 
spo,ntaneous contrast, left ventricular function, 
anticoagulation parameters. In 22 patit:nts with small 
thromhus (like strands), no complications occured and 
thrombus disappeared or decreased in 15 pts rt:•
examined. On the contrary, uut uf 12 pts with large 
thrombus, S embolic events and S prosthetic 
obstructions occured despite adequate anticoagulation ( 
Heparin) and, 10 patit:nts wert: reuperated. 
This systematic prospective TEE study demonstrated the 
high incidence of thrombosis developed in the early 
post-operative period in pts with mechanical prosthesis 
Size of the thrombus may be important factor for 
therapeutic decision. 
940-63 
Can Transesophagea\ Echocardiography Identity the Etiology 
of Prosthetic Valve Obstruction? 
Cyril B. Tawa, Miguel A Quiiiones, William A Zoghbi, Baylor 
College of Medicine, Houston, Texas 
Although transthoracic Doppler echocardiography allows 
the detection of prosthetic valve obstruction, it remaIns limited 
in the identification of the cause of the stenosis. To determine 
the value of transesophageal echocardiography (TEE) in 
elucidating the etiology of prosthetic valve obstruction, we 
reviewed our experience in 18 patients (10 F, 8 M; mean age 56 
.±. 10 yr) with suspected valve obstruction by transthoracic echo•
Doppler, who had TEE and subsequently underwent valve 
exploration. There were 10 mitral valves (mean gradient 17.±. 6 
mmHg), 7 aortic (mean gradient 57 .±. 22 mmH~) and 1 
tricuspid (10 mmH~). Fourteen valves were mechamcal and 4 
biological. The etiology of valve obstruction included pannus 
formation in 7 patients, thrombus in 2, a combination of pannus 
and thrombus in 3; calcifications were the etiology of 
obstruction in 4, vegetation in 1 and a mycotic aneurysm in 1 
patient. The transthoracic study correctly identified the cause of 
obstruction in 4/4 biologic valves (calcifications) and in only 
1/14 mechanical valves; a tricuspid vegetation attached to the 
Tight ventricular side of the prosthesis. In contrast, TEE 
correctly identified 13 of the 18 causes of obstruction: 5/7 
pannus formation, 2/2 thrombus, 1/3 mixed pannus and 
thrombus, 4/4 calcifications and 1/1 mycotic aneurysm. TEE 
also allowed a better assessment of the restricted motion of the 
prosthesis. Of the 5 etiologies missed by TEE, 4 were pannus 
formation (one with thrombus) on mechanical aortic valves and 
1 was a tricuspid vegetation on the right ventricular side of the 
prosthesis. 
Thus, TEE is a valuable modality for the detection of 
mechanisms responsible for prosthetic valve obstruction and 
compliments the transthoracic approach in the overall 
evaluation of prosthetic valve obstruction. 
940-64 
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Color Doppler Proximal Isovelocity Surface Area Method for 
Calculation of Effective Orifice Area in Prosthetic Mitral Valves: In 
Yi!!:2 and Clinical Transesophageal Echo Studies -
Shiro Yamachika, Cheryl LReld, Devang Savanl, Margaret Knoil, Beverly 
Jamison, Julius M. Gardin. University of California Irvine, California 
Effective orifice area (EOA) is a key parameter in the assessment of 
prosthetic valves. Although the pressure half·time (f y) method Is used 
widely to estimate m~ral valve orifice area, this method is not always 
applicable-e.g. In cases of severe tachycardia or severe aortic 
regurgitation. The purpose of the current study was to investigate the 
proximal isovelocity surface area (PISA) method as a possible altemative 
approach for estimating effective orifice area In patients with mitral 
prosthetic valves (PV). Method: Using the PISA method to measure 
forward flow, EOA was estimated in.!!l Yi!rQ and clinical studies of three 
mechanical and tissue PV. Three valve types (Bjork·Shlley, St.Jude and 
porcine:I9-23 mm) were studied in an .!!l Yi!rQ pulsatUe flow system. 
Clinically. 10 pts with mitral PV were studied using transesophageal 
echocardiography (fEE). Lower PISA isovelocities, obtained by shifting the 
zerO-baseline (V <20 cm/sec) were used to produce fusion of separate, 
distinct PISAs in multioriflce PV into a larger single PISA. At higher 
veloc~ies, separate, distinct PISAs were visualized. Maximum (max) FR 
was calculated as 2"R" * V, where R is max blue-red aliasing PISA 
radius. EOA was calculated as maxFR/peak flow velocity by CW Doppler 
(CWO). In clinical studies, T y, was measured by CWO. ~ 1) la.Jd1rQ, 
calculated maxFR using fusion PISA correlated excellently with actual FR 
at V <20 cm/sec (r;0.94.Q.97, p<O.OOI). 2) Clinically, in 9 of 10 PIS, EOA 
calculated by PISA correlated well wtth that by T Yo method (r;079. 
p<O.Ol). 3) Separate, distinct PISAs were visualized using V>30 cm/sec 
in all mechanical valves. 4) In 1 of 10 pts, PISA was unmeasurable due to 
a markedly thickened, distorted porcine valve. Conclysion: Color Doppler 
PISA method provides an accurate estimate of effective orifice area and 
may be useful as an a1tematlve to the pressure half·time method for serial 
follow·up and detection of obstruction in patients with prosthetic mitral 
valves. 
940-65 
Biplane Transesophageallmaging Provides Complete Visualization of 
Human Allograft Conduits Placed for Reconstruction of the Right 
Ventricular Outflow Tract 
Paulo Golebiovski, Taher Elkadi, Valdir Moises, lilliam M. Valdes-Cruz, 
David J. Sahn. Oregon Health Sciences Univ, Portland, OR 
We reviewed intraoperative TEE imaging of surgical RVOT reCOnstruc. 
tions involving homograft conduits in 26 patients (plSl (age 5 mos-20 
yrs, WT.5.8 - 64 kgsl. The study group consisted of 18 pts with te•
tralogy of Fallot, 6 with double outlet RV, and 2 with transposition 
ima~ed during repair with RV to PA grafts (10 aortic homografts, 8 pul•
mOniC homograftsl between 17-23 mm in size. Conduit visualization 
was onlv partial in the transverse plane images in 9 Pts. Biplane imag•
ing provided complete conduit visualization from ventricular origin to 
PA insertion including proximal branch PAs despite differing conduit 
orientation. In 6 studies conduit size on the two planes differed sug. 
gesting elliptical conduit cross section and compression of the conduit 
after the chest was closed but continued low flow velocities verified 
that there was no major obstruction in these pts. As a baseline for 
normal conduit function smooth nonturbulent flows with several aliases 
were detectable on color Doppler flow maps with maximal velOCities 
(VELI from 1.1 to 1.9 m/sec. In 3 pts however distal PA stenosis at or 
just beyond the distal conduit insertion was documented bv TEE (all 
with VEL> 2.8m/sec.' and aSSOCiated with >40 mm Hg intraoperative 
gradients. All were surgically revised. Allografts universally and immedi•
ately showed neopulmonary valve regurgitation with the regurgitant 
signal extended proximally for a distance of 75-125"% of the annulus 
diameter and easilv recorded on spectral Doppler. Biplane visualization 
is required for complete intraoperative evaluation of conduit repairs. 
Our study defines normal patterns of conduit flow and conduit valve 
regurgitation. The quality of visualization we achieved should preclude 
the need for intraoperative epicardial echo studies of the RVOT, espe. 
cially in settings where biplane TEE probes suit;lble for smaller pts are 
available. 
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940·66 
Contribution of Right Atrial Contraction to Pulmonary 
Venous Flow PaHerns in the Adult Fontan Patient 
Ariane J. Morelli. John S. Child. Joseph K. Perloff. Roberta G. Williams. 
UCLA School of Medicine. Los Angeles. California 
In the norma! circulation. pulmonary venous flow (PVF) is chiefly 
Influenced by left atrlal-to-systemlc ventricular transport. To 
examine the effects of right atrial transport on systemic ventricular 
filling in a circulation In series with and without a subpulmonic 
ventricle. aduit patients with the Fontan operation served as a 
model. Methods' We prospectively used transesophageal 
echocardiography and spectral Doppler analysis to study 
pulmonary arterial flow (PAF). PVF. transmitral flow (EtA) and 
systemic ventricular-ejection fraction (EF) in 8 patients with a right 
atrial-pulmonary artery anastomosis (Group A). and in 5 patients 
with a right atrial-right ventricular anastomosis (Group B). Five 
patients in A had a single ventricle. Three patients in A and 5 
patients in B had tricuspid atresia. ~.e& was predominantly 
diastolic in 6/9 patients in whom it was measurable. In 3/9. PAF was 
codominant in systole and diastole. Right atrial contraction 
accentuated presystolic forward PAF in 8/9 patients and PAF was 
paSSive in early diastole in 7/9 patients. Forward M was dominant 
in diastole in 12/13. Presystolic forward PVF coincided with right 
atrial augmentation of PAF in 7/9. The findings were Similar in A and 
B. Only the mean velocity time integral differed between the two 
groups (4±3cm in A and 10±2 cm in B). The fJ..A?... 1.1 in all but 1 
patient. Mean EE was 42.7 ± 10.6 and did not differ between the 
two groups. Conclusion: Pulmonary venous flow was abnormally 
dominant in diastole in nearly all patients. SystOliC PVF was greater 
in B than in A suggesting an effect of the sub pulmonic ventricle. 
Presystolic forward PVF and PAF reflect a contribution of right atrial 
contraction to PVF regardless of the presence or absence of a 
subpulmonicventricle. Right heart dynamics appear to affect 
pulmonary venous flow patterns and left atrial filling in patients with 
Fontan physiology. 
940·67 
Transesophageal Echocardlography In Infective Endocarditis: 
Prognostic ImplicatIOns of Vegetation Size and Mobility 
Melda Meri\i, Ramon CasteI/o, Elizabeth O. Ofili, Jeanette A. St. 
Vrain, David K. Beato, Arthur J. Labovitz. Saint Louis UniverSity 
Medical Center, St. Louis, Missouri. 
The diagnostic value of echocardiography in pts with infective 
endocarditis (IE) by transesophageal approach is well known. 
However, recently published studies have offered conflicting 
viewpoints as to the prognostic implications of this technique to 
Identify high risk subgroup of pts with IE. The present study was 
therefore undertaken in 37 pIS whose vegetations (VEG) had been 
detected by transesophageal echo cardiography (TEE) and 
clinically diagnosed as IE, to investigate the prognostiC significance 
of morphological parameters of VEG. Morphological parameters 
analyzed included maximum length, width and planimetered area 
of VEG. Mobility characteristics were identified on the basis of ratio 
of neck to width (NIW) and maximal angle of displacement of long 
axis of VEG throughout the cycle (delta angle). Clinical outcome 
was analyzed by presence or absence of embolic events and 
mortality. 25 pts (66%) had embolic events. Size and mobility of 
VEG assessed by TEE were Significantly different in pIS who had 
embolic events as compared to those who did not. 
Embolic events were associated with longer (1.3±O.7 vs 0.7±0.2 
cm, p=O.002), wider (O.7±O.2 vs 0.4±O.1 em, p=O.0009) and larger 
(1.0±O.4 vs O.4±O.2 cm 2, p=O.0001) VEG. Moreover, in pts with 
embolic events, VEG were more mobile as assessed by NIW ratio 
(0.44±O.1 vs O.7±O.2, p=O.0001) and delta angle (70.2±16 vs 
12±11. p=O.0001). Mortality was also highly associated with more 
mobile VEG (delta angle = 80±13 vs 37±26, p=O.0001 and NIW 
ratio = O.41±O.2 vs O.6±O.2, p=O.01). In conclusion, size and 
mobility of VEG assessed by TEE are good predictors of poor out•
come in IE. Early examination with TEE in pts with IE may help to 
identify high risk pIS in whom earlier intervention may be indicated. 
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940-100 
INFLUENCE OF ANTIBIOTICS ON VEGETATION SIZE IN 
INFECTIVE ENDOCARDIDITS: A COMPARATIVE STUDY 
Sven Rohmann, Raimund Erbel, Harald Darius, Thomas 
Makowski, Susanne Mohr-Kahaly, JUrgen Meyer 
2nd Medical Clinic, University of Mainz, FRG 
Complications in infective endocarditis are more com•
mon in patients with echocardiographically discerni•
ble vegetations (VEG) and more likely when VEG are 
large (> 10 mm in diameter). To assess whether 
antibiotic treatment (ABT) has an influence on VEG 
size (VS), 184 patients with VEG attached to the aortic 
or mitral valves detected using transesophageal 
echo cardiography (TEE) were followed up. Each patient 
underwent the minimum of one consecutive TEE 
examination. The % change in VS (in mm±SEM) was 
calculated as VS at admission (AA) - VS at the end of 
ABT Ivs AA. According to whether associations of 
penicillin (n=Sl;PEN), ampicillin (n=40; AMP). 
vancomycin (n=26; VAN), cephalosporin (n=24;CEPH), or 
penicillase resistant drugs (n=28; PRO) were used, 
patients were grouped: ('·p<.05 paired t-test) 
PEN AIIP VAN CEPH PRD I VS AA 8.2±1.1 8.S±1.0 8. HO. 7 07,8±0.9 8.0±1.l I VS ABT 7. 8±1. 3 6.9±O.7 4.8±0.6 10.9±1.1 9.2±0.8 
change -4.9% -18.8%* -44.8%* +39.7%* +15.0% 
Incidences of embolism (E), abscess formation (A) 
and mortality (M) were noted in each treatment group: 
E: CEPR 33% > PRD 21% > PEN 20% > VAN 15%> AMP 5% 
A: VAN 15% > PRD 14% > AMP 8% > PEN 6% > CEPR 4% 
M: CEPR 9% > PEN 8% > AMP 5% > PRD 4% > VAN 0% 
Our data imply that different antibiotics have a 
different influence on VS; a reduction in vs during ABT 
is associated with a lower incidence of embolism and 
mortality. Thus, using TEE it gets possible to 
estimate the efficiacy of ABT by monitoring VS. 
940·101 
Atrial Septal Defect Area After Mitral Valvotomy: Proximal Flow 
Convergence Method Versus Two Dimensional Echocardlography. 
Oylmitr RiMo, Thomas RO Shaw, George R Sutherland. Western General 
Hospital, Edinburgh, UK. 
Atrial septal defects (ASO) created during mitral balloon valvotomy allow left 
to right shunting, the defects acting as restrictive orifices. To compare the 
area of residual ASO, determined by the flow convergence method (FC-A) 
with that calculated from two dimensional echocardiography (20-A), biplane 
transoesophageal echocardlography (TEE) was performed on 36 
consecutive patients after mitral valvotomy. Row convergence regions 
(FeR) were Imaged by colour flow mapping In both transverse (T) and 
longitudinal (L) planes. proximal to ASOs. Instantaneous flow rate (0) was 
calculated using a hemispheric model: 0= 2Trf'Vr, where Vr Is the velocity 
at radial distance r. The maximal velocity (Vm) of ASO shunt was obtained 
by pulsed Doppler. Hence, FC-A = OmjVm, where Om is maximal O. ASO 
diameter was measured in both planes and area ( 20-A) was calculated 
using formula of an ellipse. Oximetry Identllied shunting In 1 I patients 
(group 1) and no shunts in the other 25 patients (group 2). Shunt ratio In 
group I ranged from 1.2 to 2.2. TEE showed shunting In 33/36, and flow 
convergence regions in 31 /36 patients. 
FC-A (T)/mm2 FC·A (L)/mm2 20-A/mm2 
Gp I 22.1 ± 11.2 25.5 ± 12.9 22.6 ± 10.4 
Gp 2 4.4 ± 2.0 4.4 ± 2.2 4.1 ± 2.3 
The two methods showed very good agreement. 20-A vs FC-A: transverse 
plane, y = 0.99x + 0.31, r = 0.93, SEE; 4.48 mm', ~ < 0.001; longttudlnal 
plane, y ; O.84x + 1.01, r = 0.94, SEE = 3.91 mm , p < 0.001 . Group 1 
patients had significantly larger defects than Ihose In group 2 (p < 0.01). 
The flow convergence method. combined with TEE, Is a new technique that 
can easily be applied to estimate ASO size In the majority of patients after 
mttral valvotomy. It is likely to prove especially useful in the follow up of 
patients wtth signKicant shunting. 
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940-102 
Is Aortic Yalve Prolapse a Manifestation of Myxomatous Disease? 
Carol Duffy, Gerald I. Cohen, Allan Klein, Harry Lever, Ian Black, 
Emesto Salcedo, Delos Cosgrove, James Thomas, William Stewart. 
Cleveland Clinic Foundation, Cleveland OH USA 
Significant aortic regurgitation (AR) is only rarely seen in non-infected 
trileatlet aortic valves with prolapse (A VP) but the etiology of this has not 
been systematically examined. Therefore, we reviewed intraoperative 
echocardiographic (lOE) studies of21 patients (pts) (age mean=58.3, range 
6-73, 3F) with AVP who underwent aortic valve (AoY) replacement (n=9) 
or repair (n= 12) in 1987 to 1992. The 10E findings were corroborated 
with surgical (SURG) and pathologic (PATH) examination. ~: During 
IOE, prolapse (P) of 1 cusp was noted in 18 pts, of 2 cusps in 2 pts, and 
of 3 cusps in 1 pt. All had significant AR. A tom fenestration on surgical 
inspection was present in 1 pt with A VP on 10E. Another pt had evidence 
of a healed membranous ventricular septal defect by SURG and IOE. IOE 
failed to detect fenestrations (F) in 3 pts. Thirteen of 24 (54.2%) prolapsing 
leatlets by IOE involved the right coronary cusp (RCC), 5 of 24 (20.8%) 

















PATH findings were available in 15 pts and revealed myxomatous cbanges 
in 9, fibroplasia in 3, and in 1 pt each, fenestration, normal tissue, and 
aortitis. Nine pts (43%) had mitral valve prolapse and this was associated 
with myxomatous AoV PATH (5 pts) and with normal AoV PATH in I pt; 
in 3 pts AoV PATH was not available. Conclusjon: Aortic valve prolapse 
is accurately diagnosed by intraoperative echocardiography and is most 
often secondary to myxomatous disease. This may be a manifestation of 
more generalized myxomatous valvular disease. 
940-103 
Is Ecbocardiography Capable of Predicting the Type of Surgery in 
Mitral Regurgitation: Reconstruction or Replacement? 
Irene M. Hel\emans, Els G. Pieper, Johannes P.M. Harner, Wybren Jaar•
sma, Renee B.A. van den Brink, Cathinka H. Peels, Emile C. Cheriex, 
Henry A. van Swieten, Jan G.P. TIjssen and Cees A. Vioser, on behalf 
of ESMIR (Echocardiographic Selection of patients for MItral Recon•
struction), Interuniversity Cardiology Institute, Utrecht, the Netherlands. 
In a prospective study of 299 patients (pts) undergoing Mitral Valve 
surgery because of severe regurgitation we determined the predictive value 
of transthoracic (TfE) and transesophageal echocardiography (TEE), in 
relation to the initial surgical procedure: reconstruction (Rec) or 
replacement (Repl). Initially MY-Rec was performed in 172 pIS (58%) 
and MY-Repl in 127 pts. Agreement between echocardiography 
















In 41 patients, there wa~ disagreement between TTE+ TEE and surgery: 
14 of these had MV-Ree whilst in 11 MV-Repl was predicted, and in 3 
no operation. In 3 of these II pts however, secondary MY -Repl was ne•
cessary. 
In 27 pts MV-Repl was performed, of whom in 25 MY-Ree was prediL'led 
and in 2 no operation. 
Conclusion: 
. 1. Echocardiograpby is highly reliable in predicting the type of Mitral 
Valve surgery for Mitral regurgitation. 
2. No additional information is obtained by monoplane TEE. 
940-104 
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Pulmonary Yenous Flow Predicts Left Atrial Pre881l1'8 V Wave in 
the Presence of Altered Loading Conditions in Patients With 
Mitral Regurgitation 
Allan L. Klein, Fred Kahan, Robert M. Savage, Alexander S. Bailey, 
Gregory L. Pearce, William J. Stewart, Delos M. Cosgrove, James D. 
Thomas. Cleveland Clinic, Cleveland, Ohio 
Pulmonary venous (PV) flow has been used to assess the severity of 
mitral regurgitation (MR) and is related to left atrial pressure (LAP) 
filling waves. The ability of PV flow to predict left atrial pressure v 
waves in pts with MR with altered loading conditions has not been 
described. We studied 25 pts with 3+ or 4+ MR undergoing mitral valve 
repair surgery with simultaneous Doppler TEE of the PV and hemody•
namic monito~, including direct left atrial pressure. Patients were 
evaluated pre and post neosynephrine (NEO; n=6), nitroprusside (NP; 
n=7), saline (Sal; n=6), and nitroglycerin (Nitro; n=6) to change the 
mean arterial and left atrial pressure by 25%. Measurements included 
LAP v wave, PV peak systolic (S) and diastolic (D) velocities. 
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The Neo group showed the largest change in the peak PV D velocity 
(p=O.OO2) and left atrial pressure v wave (p=O.OO3). ' 
Conclusion: Changes in PV diastolic flow by Doppler TEE in the pres•
ence of altered loading conditions (especially with increased afterload, 
NEOl predict changes in the left atrial pressure v wave. 
940-105 
Systolic Reversal of Pulmonary Venous Flow: Is it Meaningful in 
Mitral Stenosis? 
Frank D. Tice, Sheila K. Heinle, J. Kevin Harrison, Thomas M. 
Basbore, Eric B. Lieberman, Katherine B. Kisslo, Joseph Kisslo. Duke 
University Medical Center, Durbam, North Carolina 
On the hypothesis that systolic reversal of pulmonary venous flow 
(PVF) might IlQ1 predict severe mitral regurgitation (MR) in mitral 
stenosis we investigated PVF velocity profiles of 20 mitral stenosis 
patients (PTS) with transesophageal echocardiography (TEE). Fourteen 
PTS were in normal sinus rhythm and 6 in atrial fibrillation or flutter. 
PVF velocities were recorded with pulsed Doppler imaging from the left 
upper pulmonary vein, 0.5 cm from the orifice. PVF measurements 
were made by an observer blinded to the clinical data. Cardiac 
catheterization data, including transseptal left atrial pressure, was 
obtained within 24 hours of the TEE for all PTS. All PTS had normal 
left ventricular function. By standard criteria, angiographic MR was 
found to be 0 in 6 PTS, I + in 10 PTS, and 2+ in 4 PTS. Systolic reversal 
of PVF was identified in 10 of 20 PTS_(50%). Two distinct patterns 
were observed. The first was "early" systolic reversal, occurring in all 
6 atrial fibrillation or flutter PTS and beginning an average of 58±15 
msec after the onset of the QRS complex. No relationship to MR 
severity or left atrial pressure was observed. Tbe second was "late" 
systolic reversal, observed in 4 PTS in normal sinus rhythm and 
beginning an average of 243±52 msec after the onset of ·the QRS 
complex; three had 1+ MR, and 1 had 2+ MR. PTS with this pattern 
bad significantly higher left atrial pressure than those without it (28±4 
vs 23±4 mm Hg; p=0.03). Neither pattern demonstrated a relationship 
with left atrial size or catheterization mitral valve area or mean mitral 
valve gradient. The average ratio of pulmonary venous systolic velocity 
integral/diastolic velocity integral was 0.98,0.54, and 0.53 for PTS with 
0, \+, and 2+ MR, respectively, indicating predominantly diastolic 
antegrade PVF. These data demonstrate that systolic reversal of PVF 
occurs commonly in PTS with mitral stenosis in the absence of severe 
MR. It instead is associated with a bigh prevalence of atrial fibrillation 
or flutter and elevated left atrial pressure. 
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941·92 
Comparison of Diagnostic Value of Dipyridamole and 
Dobutamine Stress Echocardiography in the Diagnosis of 
Coronary Artery Disease. 
Alessandro Boccanelli,Vito Piazza,Cesare Greco,Egidio 
Zanchi,Corrado Cecchetti. Divisione Cardiologia A, 
Ospedale San Camillo ,Rome. Italy. 
To compare the ability of dipyridamole(Di) and dobutamine 
(Do) stress echocardiography in detecting CAD.we studied 
83 pts:68 pts in the third week after a first AMI,15 pts 
with chest pain(6 pts without and 9 pts with previous 
AMI).The stress tests were performed the week before 
coronary angiography(CA) in two consecutive days.during 
pharmacological wash-out .Oi was injected in dose of 0.56 
mg/Kg in 4 minutes followed.if the test was negative.by 
a second dose of 0.28 mg/Kg in 2 minutes;Oo was infused 
in incremental doses of 5 meg/Kg/min in 5 minute stages 
to a peak dose of 40 meg/Kg/min or until an end-point was 
reached. The tests were considered positive when new wall 
motion abnormalities appeared.CAD was defined as ~ 70% 
lumen narrowing.Oi was positive in 48 pts(58%) and 
negative in 35 pts(42%);00 was positive in 57 pts(69%) 
and negative in 26 pts(3l%).At CA.14 pts(17%) had not 
significant CAD.40 pts(48%) had single vessel disease 
(SVD) and 29 pts(35%) had multivessel disease(MVD). 
Overall(OV) sensitivity(SE),specificity(SP).accuracy 
(ACC) were compared;SE in SVD pts was compared with SE 
in MVD pts. 
OV-SE OV-SP OV-ACC SVO-SE MVO-SE 
Oi -69 100 ,- 75 **60 - * - 82-., 
00 L83 100 nL85 __ 75_* -93--, 
* p < 0.05; ** p < 0.01 
We conclude that:l) Do has greater SE than Oi in 
detecting CAD.both in SVD and MVO pts;2) SE of 00 and 
Oi in MVD pts is higher than in SVD pts. 
941·93 
Induction of Hemodynamically Significant Left Ventricular 
Outflow Tract Obstruction In Hypertensive Hypertrophic 
Cardiomyopathy during Dobutamlne Stress Echocardiography 
Matthew J Sorrentino, Richard Marcus, Claudia Korcarz, Lynn 
Weinert, Jim Bednarz, Beth Balasia, Roberto Lang. University of 
Chicago, Chicago, IL. 
Hypertensive hypertrophic cardiomyopathy (HHC) is 
characterized by supranormal systolic performance and 
concentric left ventricular hypertrophy. Episodes of sudden 
hemodynamic decompensation reported in these patients (pts) 
have been attributed to diastolic dysfunction. Left ventricular 
outflow tract (LVOT) obstruction observed during dobutamine 
stress echocardiography (DBSE) raises the possibility of an 
additonal mechanism for the hemodynamic compromise. 
Accordingly, in 9 patients (pts) with HHC, LVOT gradients and 
cardiac output (CO) were measured during DBSE for suspected 
myocardial ischemia. Eight were female. Age was 66 ± 11 yrs. 
8/9 pts had no resting LVOT gradients; one had a trivial gradient. 
Mean values for LV mass index and shortening fraction were. 
169±43 g/m2 and 40.4±6.0%, respectively. No pt had 
ischemic ECG or echocardiographic changes during OBSE. All pts 
developed significant LVOT gradients during OBSE (peak LVOT 
gradient= 59±27 mmHg. range 36·108). The precipitation of 
this gradient was associated with 1) a fali below baseline of 
systolic blood pressure in 6/9 pts. 2) a decline in CO at peak 
Dobutamine infusion (mean 36 ± 10 Jl9/kg/min) in 4 pts 3) 
Significant symptoms in 7/9 Pts including chest pain in 4 pts 
despite no evidence for ischemia. CONCLUSION: Dobutamine 
stress echocardiography precipitates LVOT obstruction in certain 
pts with HHC. The development of LVOT obstruction with 
reductions in systolic blood pressure and CO may explain the 




I)(.bulamine stress Test in Patients With SJDdrome X: Comparison 
of Ecbocardiognpby With Tballi ... ·201 SPECT 
AI"LU A. Cubukcu, Peter J. Scott, Andrew N. Deaner, Penny J. 
Thorley, Jane Allen, Michael R. Rees, Gordon J. Williams. 
Killinllbeck Hospital, Leeds. U.K. 
Twenty one patients, aged 55+/-8, 8 men, with chest pain, exercise 
induced ST depression, but nonnal coronary angioaraphy 
(syndrome Xl underw~nt symptom-limited dobulamine stress test. 
Control group is consisted of eight nonnal subjects. Dobutamine 
wus illfused at incremental doses of 5 mea/Iq/min up to a 
muximwn of 10-"5 mq/kg/min, with continuous ll·lead ECG 
monitoring. A dose of 90 mBq thallium wllS illiected at peak dose 
followed by immediate SPECT imaging repealed three to four 
hours later. Ecbocardioaraphic studies, perfonned on 14 of the "1 
syndrome X patients, were recorded at rest and at the end of each 
stage. Left ventricular wnll motion WIIS evaluated for 11 sepnrate 
segments at each stage by two independent observers. New wall 
motion abnonnality indicated a positive echo study. 
~: Chest pain devdoped in 13121. and Sf depression was 
observed in four. No major side efl'ects occurred. Nonnal resting 
echocardingrams were obtained in all. Dobutamine stress 
echucurdiograpby was ntgative in 13 of 14 patients (113"). and WL~ 
positive in only one patient (7%). SPECT imaaing was within nonnal 
limits in 6 of "1 patients ("II"). Reversible defects were observed in 
Ism (71 %), three times more than the controlaroup where only 2 
of 8 subjects hud a positive thallium SPECT (25") (p<O.OS). 
Perfusion defects were observed in more than one territory in 13 of 
IS patients. 
In conclusion. in patients with syndrome X, phannacolollically 
induced stress with dohulamine rarely produce regional wall 
ahnonnalities on echocllrdiography, although perfusion defects were 
detected ill most of' them by SPECT imaging. 
941·95 
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Safety of Dobutamine Stress Echocardlography In Outpatients 
with Resting Left Ventricular Dysfunction 
Larry R. Handlin, D.O., Erik Petersen, Janet Nelson. Linda 1. Crouse, 
M.D., James L. Vacek. M.D .• Joan L. White, Georgia Dittmeier, 
Thomas L. Rosamond, M.D., Mid America Heart Institute and 
University of Missouri-Kansas City School of Medicine, Kansas City, 
Missouri 
We compared the safety of dobutamine stress echocardiography in 
outpatienls with and without impaired left ventricular function. Two 
groups were identified; Group I with a left ventricular ejection fraction 
(LVEF) > 40% (N = 184, mean LVEF = 55 ± 6.2%), and Group II 
with a LVEF < 40% (N = 64, mean LVEF = 29.3 ± 8.9%). There 
was no significant difference between Group I and Group II in 
reference to age (65 ± 11.1 vs 68 ± 12.0 years), maximum dobutamine 
infusion rate (31.6 ± 9.2 \'s 31.2 ± 9.5mcglkg/min), percent maximum 
heart rate achieved (79% ± 15.5 vs 75% ± 15.7). There were no 
significant differences between Group I and Group II in test related 
symptoms (55% vs 50%), complex ventricular ectopy (4% vs 5%), 
supraventricular tachycardia (12% vs 8%), induced hypotension (33% 
vs 39%) or adverse test termination criteria 40% vs 45% (i.e., 
induced wall motion abnormalities, complex ventricular ectopy, ECG 
changes, or patient intolerance) respectively. A trend toward more 
dobutamine induced complex ventricular ectopy occurred in patients 
with LVEF < 20% (15% vs 4% in Group I). No deaths occurred. 
Conclusions: Dobutamine echocardiography can be performed safely 
in outpatients with moderate left ventricular dysfunction. There 
appears to be an increase in test related complex ventricular ectopy in 
patients with left ventricular ejection fractions < 20%. 
394A ABSTRACTS 
941·96 
The Detection of Residual Ischemia and Stenosis 
in Patients with Old Myocardial Infarction using 
Dobutamine Stress Echocardiography 
Masaaki Takeuchi, Yasuhide Nakashima, Akio Kuroiwa. The 2nd 
Dept. of Int. Med. University of Occupational and Environmental 
Health, Kitakyushu, Japan. 
The assessment of residual stenosis and ischemia at the infarct zone 
(IZ) is important for subsequent management in patients (pts) with old 
myocardial infarction (OMI). To estimate the efficacy of dobutamine 
stress echocardiography (DSE) for this purpose. DSE results were 
compared with exercise T1201 SPECf or CAG fmdings in 44 pts with 
OMI. Dobutamine was infused incrementaJ.ly(3-30 mcg/kg/min) under 
2-D echo imaging. Wall motion score index (WMSI) at the IZ was 
calculated before and at peak dobutamine infusion, and the pts were 
divided into three groups according the change of WMSI. Exercise 
TI201 SPECf and CAG were performed following DSE. Significant 
stenosis of infarct related artery (IRA) was defmed as >50%. 
WMSI atIZ improved 
(N = 13) 
Residual ischemia(Tl) 8.3% 
IRA stenosis(CAG) 30.5±36.9% 






(N = 25) 
87.5%* 
89.3±20.7%>I< 
After classification on the basis of change in WMSI at the IZ, DSE 
demonstrated sensitivity of 90% and specificity of 91 %, in the detect•
ion of significant residual stenosis. 
Conclusion: (1) Worsened WMSI strongly suggests residual 
ischemia, and it is rarely caused by an alteration of loading condition. 
(2) Conversely, less ischemia and less marked stenosis of the IRA is 
associated with improved WMSI. (3) Unchanged WMSI suggests 
severe residual stenosis and sometimes indicates ischemia. It may 
reflect hibernating myocardium, but the prognostic significance of this 
finding should be determined by revascularization. 
941·97 
Evaluation of Myocardial Reperfusion and 
Subsequent Recovery of Segmental Dysfunction 
With Exercise Echocardiography (EE). 
Puthenparampu A Joseph, Killian Robinson, Peter A. Crean, Gerard 
G. Gearty, Michael 1. Walsh. 
Trinity cardiology, St. James's Hospital, Dublin, Ireland. 
The use of EE in the detection of improved segmental function 
following reperfusion of the myocardium in 32 patients (pts) who 
remained asymptomatic after angioplasty (PTCA) was evaluated. 
All had abnormal segmental wall motion (WM) and thickness in 
deseased coronary artery territories on EE before PTCA. 6 months 
following PTCA all underwent repeat EE. 28 of 32 (87.5%) had 
normal WM and thickness in the target vessel territories. On 
angiography, after 6 months, the PTCA site remained dilated in 29 
of 32 (90.6%) pts. The concordance of findings of EE with 
agiography was 96.6% (p<O.OOOI,k=0.826). To evaluate recovery 
time for abnormalities ofWM and thickness, 7 of the 32 underwent 
serial EE after 2 days and after 2,4 and 6 months. Although 
abnormalities of WM and thickness were no different to pre PTCA 
values 2 days following reperfusion, improvement became evident 
at 2 months (p=O.015). Only after 6 months was WM normal in the 
majority (p=0.015). 
Conclusion: EE is useful in the confirmation of arterial reperfusion 
in the long term, following PTCA. In spite of successful 
reperfusion, however, normalisation of ischaemic segmental 
myocardial dysfunction may not be immediate and factors other 
than relief of major epicardial coronary obstructions may play an 
important role. 
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942·98 
Echocardiographic Predictors of Nonrheumatic 
Atrial Fibrillation 
Sonya M Vaziri, Martin G Larson, Emelia J Benjamin, Daniel Levy, 
Framingham Heart Study, Framingham, MA 
Prospective evaluation of echocardiographic precursors of 
nonrheumatic atrial fibrillation (AF) has not been previously 
reported. Surviving members of the Framingham Heart Study who 
routinely underwent M-mode echocardiography were followed for 
the development of AF. The population at risk consisted of 753 men 
and 1171 women, ranging in age from 59 to 90 years (after 
excluding subjects with prior AF, technically inadequate 
echocardiograms, or mitral stenosis). During a mean follow-up of 
5.7 years, 109 subjects (5.7%) developed atrial fibrillation. After 
adjustment for age, sex and multiple clinical factors in a Cox model, 
left atrial (LA) size (hazard ratio per 5 mm increment, 1.27; 
P=0.OO5), ventricular septal wall thickness (hazard ratio per 2 mm, 
1.33; P=O.OO4), posterior left ventricular (LV) wall thickness 
(hazard ratio per 2 mm, 1.40; P=O.OI) and LV mass/height (hazard 
ratio per 40 g/m, 1.29; P=0.016) were significantly related to risk 
of nonrheumatic atrial fibrillation. Simultaneous consideration of all 
echocardiographic variables in a stepwise model demonstrated that 
left atrial size was the strongest predictor of AF risk. In subjects 
with LA size O!! 50 mm, 14.8% developed AF compared with 3.8% 
of subjects with LA size S40 mm (hazard ratio, 2.79; P=0.015). 
CONCLUSION: After comprehensive adjustment for various 
factors, left atrial dilatation and, to a lesser extent, increased left 
ventricular wall thicknesses· and mass identify patients at 
significantly increased risk for the development of nonrheumatic 
atrial fibrillation. 
942·99 
Interatrial Septal Aneurysm: 
Detection by Transthoracic Echocardi09raphy. 
Ming Hui Chen, Donato Mele, 
Arthur E Weyman, Pieter M Vandervoort. 
Massachusetts General Hospital, Boston, MA 
Interatrial septal aneurysms (IASA) have received 
recent attention because of reported association with 
increased incidence of embolic events. In this study we 
reviewed 55 consecutive patients (pts) who were 
prospectively identified between 1989 and 1992 to have an 
IASA of the fossa ovalis membrane by echocardiography. 
All patients have complete transthoracic 
echocardiographic and Doppler studies. The detection rate 
of IASA was 0.26%. The mean age of the pts was 53±29 
years (mean±SD, range: Iday-87y) with female/male ratio 
of 1.4/1. The total excursion of the IASA was 17±5 mm 
(mean±SD, range: 11-36mm). The majority 52/55 (95%) 
showed predominant protrusion into the right atrium and 
32/55 (58%) were mobile. In 29/55 (53%) shuntflow at the 
atrial level was identified by Doppler or contrast study. 
In none of the patients was thrombus seen in the 
aneurysm. Only 3/55 pts (5%) were referred because of 
potent i a 1 emboli c events (1 TIA, 1 eVA, 1 cerebral 
hemorhage) and 1 pt (2%) because of syncope. All three 
patients with cerebrovascular events had evidence of 
atri a 1 shunt fl ow by Doppler. Two of these 3 pts had 
other associated abnormal echocardiographic findings as 
a potential source of embolus. 
Conclusions: In our series we do not find the high 
prevalence of embolic events in pts with IASA reported in 
other studies. In the majority of pts in this study the 
presence of an IASA was an incidental finding. IASA of 
the fossa ovalis are identified at all ages and were even 
seen in newborns. Atrial shunt flow is present in >50% of 
pts with IASA. 
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942·106 
Routine Transthoracic Echocardiography Provides a Low 
Yield in Unselected Patients Vith Presumed Cerebral 
Ische.ia and Should be Abandoned: Review of 1064 Con-
secutive Cases 
Vedat Sansoy, John Dent, Sanjiv Kaul. 
Virginia, Charlottesville, Virginia 
Universi ty of 
At our institution, all patients with presumed cerebral 
ischemia undergo transthoracic echocardiography (TTE) as 
a part of their routine work-up to 'rule out cardiac 
source of embolus' (CSE). To determine the yield and thus, 
clinical utility of TTE in such patients, we evaluated 
1064 consecutive patients with presumed cerebral ischemia 
(773 had stroke, 259 had transient ischemic attack, and in 
32 ischemic injury was undefined). There were 552 (52%) 
men and 512 (48%) women with a mean age of 64 ± 15 yrs. 
Definite CSE was defined as unquestionable presence of LV 
or LA thrombus, vegetations or myxoma. Probable CSE was 
defined as the questionable presence of LV or LA thrombus, 
vegetations, or myxoma or the presence of atrial septal 
defect (ASD). Mitral valve prolapse and mitral annular 
calcification were not considered CSE. 
Definite CSE was noted in only 2.7% of all patients (all 
29 had LV thrombus and in all it was associ a ted wi th 
either regional or global LV dysfunction). Probable CSE 
was noted in 5.5% of cases (31 had questionable LV throm•
bus; 4 had questionable LA thrombus, 1 had questionable LA 
myxoma, 22 had questionable vegetations and 3 had ASD. 
Mitral valve prolapse was noted in 5.5% cases, an inci•
dence not different from that in the general popUlation. 
Mitral annular calcification was seen in 30.8% cases. 
Ve conclude that defini te CSE is seen in <3% of un•
selected patients with presumed cerebral ischemia. In all 
such cases, LV dysfunction was present. Because of the 
low yield for CSE and relatively high cost, TTE should be 
abandoned for the routine evaluation of unselected pa•
tients with known or suspected cerebral ischemia. 
942·107 
Size ADd Mobility Of Vegetations In Infective Endocardltls: PredIctive Role Of 
Transthoracic Echocanllography (TfE) In Embolic Events. 
S.De Castro, G.Migliau, P .santopadre, G.d'Amati°, D.Cartoni, P.Giannantoni, 
C.Santini. Dept. of Internal Medicine, "La Sapienza" University, Rome, ° Dept. 
of Experimental Medicine, L'Aquila University. Italy. 
Echocardiography has a well defined role in the diagnosis of infectious 
endocarditis. Controversial, though, is its role in predicting embolic events due to 
the presence of vegetations' during infectious endocarditis. Aim of our study was 
to evaluate the predictive role of 'ITE in embolic events by prederminated 
morphologic characteristic of vegetations: size and mobility. Between November 
1985 and June 1992 we studied 59 patients (43M and 16F, mean age 47.15 +1-
SD 1.95) with a clinical diagnosis of infectious endocarditis: 1:1 were studied 
retrospectively and 32 prospectively. Endocarditis was diagnosed as either 
'definite' or 'probable' according to Von Reyn's criteria. M-2D 
echocardiography was performed within the 5th day of hospitaIization. In the 
absence of standard criteria to define the 'mobility' of vegetations, we 
considered as 'mobile' those masses that were peduncolated (or prolapsing) or 
whose movement was asynchronous with the valvular leaflets. We grouped 
echocardiographically visible vegetations (49m sites; 68%) by size and mobility: 
35% were fixed and 65% were mobile; 25 were < lOmm (9 fIXed and 16 mobile) 
and 24 > 10mm (8 fIXed and 16 mobile). Systemic embolism occurred in 18 of 59 
patients (305%). The most common pathogen identified in those cases was 
Staphylococcus epidennidis. Embolization occurred in 88% of patients with 
obvious vegetations as opposed to 12% with undetected vegetations (p < 0.001). 
Vegetations > 10mm embolized in 60% of the cases, those < 10mm in 40% (p. 
NS). Embolization occurred in 18% of the cases with fixed vegetations and 50% 
with mobile vegetations (p. NS). Vegetations that were mobile and > 10mm 
were responsable for 75% of the episodes of embolization, those mobile and 
< 10mm were involved in only 18% of the cases (p < 0.005 ). Conclusion: The 
prescnce of echocardiograpbically detected vegetations was associated with 
systemic embolism in our patient group. ConverselY, no-correlation was found 
between size (> tOmm) and embolic events. Patients having mobile vegetations 
> 10mm constituted a subgroup with increased risk for embolic complications. 
ABSTRACTS 
942-108 
Cardiovascular Abnormalities by 
Echocardiography in Patients With Human 
Immunodeficiency Virus Infection: Influence 
of Race and Gender 
Jan Dixon Webber, Jannet F_ Lewis, Vinod Mody. 
Howard University, washington, D.C_ 
Cardiovascular abnormalities have been 
reported in human immunodeficiency virus 
(HIV) infection_ However, previous reports 
have largely been in white homosexual males. 
395A 
We reviewed records of 60 consecutive black pts 
with HIV infection referred for echocardiograms 
(echo). Ages ranged 18 to 61 years (mean 37); 
42% were women. Risk factors were intravenous 
drug abuse (34 pts, 57%), homosexuality (10), 
heterosexual activity (7), blood transfusion 
(3) and unknown (6)_ Of 60 pts, 27 (45%) had 
abnormal echo including abnormal left 
ventricular wall motion in 13 (10 global and 
3 segmental); pericardial effusion (10), 
valvular regurgitation (8), pulmonary 
hypertension (PHTN) (8) and vegetation (3). 
The number of abnormalities was similar in 
men (18/35) and women (9/25);p=NS_ Over a 
mean period of 44 months after HIV diagnosis, 
16 pts died, including 5 with dilated 
cardiomyopathy, PHTN (1), pericardial effusion 
(1) and vegetation (1). The presence of 
abnormal echo (8/16 deaths vs 19/44 survivors) 
or female gender (6/16 deaths vs 19/44 
survivors) did not influence survival: p=NS. 
In conclusion, cardiac abnormalities are very 
common (45%) in the black population studied. 
Also, women comprise a significant minority 
of pts (42%) and show similar cardiac 
involvement and prognosis. 
942·109 
Transthoracic Right Parasternal Doppler EChocardlographlc Measur. 
ment of Left·ta-Rlght Shunt Volume In Secundum Atrial Septal Defect 
Shinichi Minagoe, Junichi Yoshikawa, Klyoshi Yoshida. Takashl Akasaka, 
Kenjl Maeda, Tutomu Takagi, Masahiro Shakudo, Chuwa Tei 
Kobe General Hospnal, Kobe, Kagoshima Universny, Kagoshima, Japan 
It has been reported that transthoracic Doppler echocardlographic measurment 
of the left-to-righl (L-R) shunt volume In atrial septal defect (ASO) Is of limned 
value. To examine the accuracy of the right parasternal approach (RPA) for 
evaluating the L-R shunt volume in ASO, we performed color and pulsed Dop•
pler echocardiography from the RPA and measured the L-R shunt volume, and 
related n to Qp - Os and OpiOs (Op; pulmonary flow volume. Os; systemic flow 
volume) obtained by cardiac catheterization using oximetry and the Fick's 
method. There were 19 patients (pts) with a single secundum ASO (mean age: 
44 yrs) diagnosed by surgery or transesophageal color Doppler echocardlogra•
phy studied. L-R shunt volume was calculated as a product of the defect area, 
time velocny integral olthe L-R flow velocHy and heart rate. The area of the ASD 
was calculated assuming a defect as an ellipse by measuring the rnaxirnallon•
gnudinal (a) and transverse (b) L-R shunt jet widths of the color flow signals 
inside the defect by the longnudinal and transverse planes from the RPA, re•
spectively (p/4 x a x b). Time velocHy integralS of L-R shunt velocity were ob•
tained by placing the sample volume parallel to the shunt flow direction at the 
defect using pulSed Doppler echocardiography. Results: The calculated L-R 
shunt volume by Doppler echocardiography averaged by 3 consecutive cardiac 
cycles showed high correlations wHh Op - Os and Op/Os. 
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Dop"'" (Llrrin) Doppler (LImn) 
Conclusion: Transthoracic Doppler echocardiography from the right paraster-
num is an accurate method for measurement of net L-R shunt volume in adun 
patients wHh secundum ASD. 
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943·18 
Impaired Response to In Vitro Thrombolysis Induced by 
Radiographic Contrast Agents 
Dale P. Daly, David A. Tate, Nancy J. Gresalfi, Bruce J. Oberhardt and 
Gregory J. Dehmer, The University of North Carolina at Chapel Hill and 
Cardiovascular Diagnostics, Inc, Research Triangle Par1l, NC 
Blood clots embollzed Into the coronary arteries during catheterization 
have been reported to be particularty difficult to lyse with thrombolytic 
agents. Experimentally, clots fonned in the presence of radiographic 
contrast agents have been shown to have an altered fibrin mass/length 
ratiO which should render the fibrin resistant to fibrinolysis. We diredly 
tested the effed of contrast agents on the ability of tissue plasminogen 
adlvator (t·PA) to lyse thrombi fonned In vitro. Blood samples were 
colleded Into standard citrate tubes from 26 patients (14 men, 12 women) 
with various cerdlac diseases. An unmeasured drop of whole blood was 
edded to a dry chemistry test card containing paramagnetic perticles, 
thrombin, buffers and t·PA. The paramagnetic perticles were driven into 
motion by an ocslllating magnetic field. When clot fonnation occurs, 
motion of the peramagnetic particles is restricted; subsequently, at the 
time of lysis, motion of the particles increases. Analysis of motion of the 
clot·imbedded particles was deteded opticelly and used to define the lysis 
onset time (LOT). After baseline testing, iohexol or dlatrizoate were 
added to separate aliquots of blood to achieve a 4% by volume mixture of 
blood and contrast. These samples were tested using Identical techniques 
in the same analytiC system. Results of the LOT values are seen below: 
Mean Lysis Onset TIme (sec.) n = 26 
t·PA ~ Non-ionil ~ . 
1oo0lU 67 ± 9.3 129 ± 74.8 118 ± 50.2 
100 IU 291 ± 63.8 565 ± 265.8 • 751 ± 298.3 *# 
• = p< 0.01 compared with baseline; # = p<0.01 compared with nonionic 
Conclusions: In this In vitro test system, clot lysis with clinically relevant 
concentrations of t·PA was impaired by both IoniC and nonionic contrast 
agents. At the lower dose of t·PA tested, the lysiS onset time was longer 
for the ioniC contrast agent tested. These data agree with clinical 
observations and have important implications for anglographic procedures 
which are coupled with the administration oft·PA. 
943-22 
The Combined Infusion of rt-PA Improves the Thrombolytic 
Efficacy of Streptokinase 
Giovanni Melandri, Anna M, Traini, Maria L. Bacchi 
Reggiani, Angelo Branzi, Bruno Magnani. Institute of 
Cardiology, University of Bologna, Italy 
In this study 80 patients with AMI were randomly treated 
with either streptokinase 1.5 MU (SK) or SK plus rt-PA 
(50 mg) over 60'. All patients received full i.v. hepa•
rin from the outset and oral aspirin(325 mg). Reperfu•
sion was evaluated by continuous ST segment monitoring. 
CK-MB was checked 2-hourly over 16 hrs. Infarct vessel 
patency (IVP) and residual culprit lesion stenosis(CLS) 
were evaluated after 4+/-2 days in both groups. No dif•
ference was found between the groups in age, gender,du•
ration of symptoms,infarct site and ST segment elevation 
on admission. Results: 
SK SK + rt-PA p<., 
Reperfusion rate(%) 71 90 0.07 
Reperfusion time(min} 82+/-43 53+/-32 0.01 
IVP(%) 83 94 0.10 
CLS ~90%(%) 78 55 0.08 
Time to peak CK-MB(hrs) 10.7+/-4.2 8.1+/-2.9 0.003 
Blood transfusion(n) 1 1 NS 
Thus, the combined infusion of rt-PA and SK on top of 
heparin and aspirin yields quicker reperfusion and high 
patency rates and less residual culprit lesion stenosis 
compared with SK alone. 
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The Value of Rescue PTCA Following Unsuccessful 
Thrombolytic Therapy: A Report From TIMI 
George R. McKendail. Sandra Forman, George Sopko. Eugene 
Braunwald, David O. Williams and the TIMI Investigators. Rhode 
Island Hospital. Brown University. Providence. RI 
Percutaneous transluminal coronary angioplasty (PTCA) has been 
proposed as a rescue mechanism to achieve coronary reperfusion for 
patients (pts) with acute myocardial infarction (AMI) who fail to 
respond to thrombolytic therapy (TI). Although the feasibility of 
this approach has been well demonstrated. little data demonstrating 
the value of rescue PTCA are available. Thus we evaluated the 
outcome of 149 selected TIMI pts who did not achieve reperfusion 
following TT (Grade 0.1 now at 90 minutes) of whom 38 (according 
to protocol) were routinely assigned to rescue PTCA (RESCUE) and 
III pts to medical therapy alone (NO RESCUE). In the RESCUE 
pIS. PTCA was successful in 31 (82%). Both groups were similar in 
terms of age. baseline characteristics. initial heart rate and blood 
prcssure. Time to treatment from symptom onset to TT was less in 
RESCUE (3.3 vs. 4.7 hI'S. pdIOl). Clinical outcomes for the first 21 
days were: 












RESCUE In-38) p 
5 (13.2%) .26 
4(10.5%) .28 
o (O'()%) 
5 (13.2%) .65 
14 (36.8%) .99 
Ejection fraction at hospital discharge did not differ (NO RESCUE: 
47.7% vs. RESCUE: 49.3%, p>0.20). We conclude that rescue 
PTCA. although usually angiographically successful. docs not 
appear to improve the clinical outcome of AMI pts who fail to 
achieve reperfusion after TT. 
943-24 
Neither Atenolol nor Alinidine, Added to Thrombolytic: Therapy, 
Reduces the Incidence of Arrhythmias During the First 24 Hours 
of Acute Myocardial Infarction 
Hein HeidbUchel. Laurent Vanneste. Jeltje Tack. Axel Ballet, 
Hilaire De Geest, Frans Van de Werf. Department of Cardiology. 
University of Leuven, Belgium 
We investigated whether the BI·blocker atenolol (AT) or the brady•
cardiac agent alinidine (AL) could reduce the incidence of ar' 
rhythmias during the first 24 hours of myocardial infarction, treated 
with thrombolysis. In 244 patients with typical chest pain of less than 
5 hours duration, Holter-recording was started at the beginning of the 
administration of 100 mg aJteplase and full intravenous heparin· 
isation. In addition. the patients were randomly and double·blindly 
assigned to AT (5 to 10 mg IV. followed by 25 to 50 mg PO bid)(n = 
83), to AL (20 to 40 mg IV. followed by 20 to 40 mg PO tid)(n = 84). 
or to placebo (PL; n = 77). Clinical characteristics and mean effective 
recording time were similar for all three groups. Average heart rate 
was lower with AT and AL. compared to PL (66 and 69 vs 77 
beats/min. p < 0.000 I). There was no difference in the incidence of 
atrial fibrillation (overal mean was 2.5%), mean number of attial (AT 
8.4, AL 9.5, PL 9.4) or of ventticular premature beats per hour (AT 
28.9. AL 27.8. PL 19.1). Also the average number of runs of non· 
sustained ventticular tachycardia (VT) (AT 19.2; AL 18.4; PL 26.9) 
and the duration (AT 10.\; AL 10.8; PL 12.9 beats) or rate of the 
longest run (AT 152; AL 149; PL 156 beats/min) were not statist· 
ically different. The proportion of patients with accellerated idio•
ventticular rhythms (AT 80%; AL 70%; PL 64%) and the mean rate 
of this arrhythmia (AT 80;AL 80; PL 82 beats/min) were similar for 
all groups. There were 4 episodes of sustained VT and/or ventticular 
fibrillation in the AT·. 1 in the AL- and 3 in the PL·group. which was 
not statistically different. 
Conclusion: our data do not support the hypothesis that 8-blockers or 
specific bradycardiac agents, associated to thrombolytic therapy 
might reduce the incidence of arrhythmias during the early phase of 
acute myocardial infarction. 
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943·25 
The Use of Aortic Counterpulsation to Improve Sustained Coronary 
Artery Patency During Acute Myocardial Infarction: Results of a 
Randomized Trial 
E. Magnus Ohman. Barry S. George. Christopher J. Wh~e. Morton J. 
Kem. Paul A. GUrbel. Robert J. Freedman. Conor Lundergan. Joseph R. 
Hartmann. J. David Talley. George Taylor. William Knopf. Jeffrey D. 
Leimberger. Cheryl A. Cortright. Richard S. Stack. Robert M. Califf. for 
the Randomized IABP Study Group. Duke Univers~ Medical Cerner, 
Durham. North Carolina 
To evaluate the use of aortic cournerpulsation (IABP) to improve the 
sustained patency rate of the infarct-related artery (IRA) following 
restoration of coronary flow during acute cardiac catheterization (CA TH), 
we performed a rnuHicerner randomized clinical trial comparing IABP with 
standard therapy. Patierns (PIs) all had acute CATH performed w~hin 24 
hours of onset of symptoms and had coronary flow restored prior to 
randomization. PIs with cardiogenic shock. sustained hypotension. and 
severe peripheral vascular disease were excluded. PIs assigned to IABP 
had ~ inserted percutaneously and maintained for 48 hours while on 
heparin. PIs assigned 10 standard therapy were maintained on heparin for 
a minimum of 48 hours. PIs underwent repeal CATH 5 to 10 days later. 
Patency of IRA and global and regional left vernricular function were 
assessed. PIs were enrolled at a median (25th. 75th percernile) of 7.4 
(4.12) hours after onset of symptoms. w~h a median age of 55 (45.64). 
Of pts enrolled. 73% were males. 18% had diabetes. 5% had peripheral 
vascular disease. and 26% had a history of previous infarction. IRA was 
left anterior descending in 42%. right coronary in 45%. circumflex in 13%. 
Coronary flow was restored by PTCA in 76% and by irnracoronary 
thrombolytic therapy in 13%. TIM I grade flow at the end of procedure was 
3 in 90% and 2 in 9%. To date 168 pis have been enrolled. 
The trial will be completed by September 1992 w~h 180 patients 
enrolled, Primary endpoint is patency of the infarct-related artery during 
repeat cardiac catheterization. Secondary analysis will include 
assessment of left ventricular function and adverse clinical outcomes 
using a compos~e clinical endpoint. 
943·26 
Prouroklnase Achieves Rapid and Sustained Patency for Treatment 
of Acute Myocardial Infarction 
W. Douglas Weaver. Joseph K. Hartmann. p, Sudhakar Reddy. Jeffrey 
Anderson. for the Pro-UK Study Group. University of Washington. 
Seattle. WA 
A-74187. a recombinant glycosylated prourokinase (r-proUK). 
was used to treat 122 pts wnh AMI to evaluate the effect of both infusion 
duration (60- vs gO-minutes) and "priming' (using 250.000 iu of r-UK) on 
initial patency and extent of clot lysis. 
All pts received intravenous heparin. Those pts with patent 
coronary arteries at gO-minutes underwent a repeat 24-hour study to 
assess reocclusion. Coagulation parameters were measured during the 
period of the study. 
Regimen 
60 mg mono-therapy (n=45) 
80 mg mono·therapy (n=31) 
60 mg "primed" (n=26) 
All 6O-min infusions (n=39) 



















Only 1 of 64 pts (1.5%) restudied at 24 hours showed evidence of 
reocclusion. There was a 24% drop in fibrinogen using 60 mg pro-UK 
and a 38% drop using 80 mg pro-UK; normalization occurred by 18 and 
24 hours. respectively. 'Priming" had no effect on fibrinogenolysis. 
We conclude that glycosylated prourokinase resuHs in relatively 
rapid and sustained reperfusion at little loss in fibrin specificity; that 
combined treatment ('priming') using 250,000 iu in~ial bolus of r-UK failed 
to enhance the rate of lysis and that a 60-minute infusion duration 
resuHed in more rapid lysis than did the 90-minute infusion. Prourokinase 
appears to have similar innial lytic and coagulation effects as rt-PA, 
however for unclear reasons. exhibits far less reocclusion. 
ABSTRACTS 
943·27 
Combination Treatment in Acute Myocardial Infarction 
(AMI): rt·PA Bolus versus rt·PA Infusion in Combination with 
Prourokinase (PUK) 
Christoph Bode; Wolfgang Kasper, Semi Sen, Thomas Nordt, 
Stefan Hohnloser, Gunther Berg, Andre Gries, Markus Zabe~ 
Eberhard von Hodenberg, Karin Ludwig. Depts. of Cardiology, 
Universities of Heidelberg, Freiburg and Homburg, Germany 
PUK and rt-PA act synergistically in fibrinolysis in vitro and in 
vivo at appropriate dosages. To determine the efficacy, 
specificity and safety of either a 20 mg bolus of rt-PA (regimen 
I) or an mfusion of 20 mg rt-PA over 1 hour (regimen n), each 
in combination with a 1 hr infusion of 6.4 Mega IU PUK (FCE 
26177), 63 patients with first AMI were treated in a sequential 
study .design. Patients had to present within 4 hours after the 
onset of pain and did so at 149±64 and 150±65 minutes for the 
respective re~en. At 90 minutes, regimen I achieved patency 
in 90% (27/30; 70% TIMI-grade m) of infarct vessels and 
regimen II in 78% (25/32; 56% TIMI-grade m) as assessed by 
coronary angiography. At 24-36 hrs patency was 93% and 88%, 
respectively. Plasma parameters changed relative to 
pretreatment values: 
Fibrinogen Plasminogen Antiplasmin 
(min) 60 120 60 120 60 120 
Reg I (%) 59 61 51 47 26 26 
RegII (%) 48 51 42 49 25 55 
Five bleeding events requireing transfusions occurred in 
regimen I, including a liver rupture and a splenic rupture, 
whereas 4 pts in group II needed transfusions. None of the 
transfused pts died, however, there was one death in each 
group after reinfarction. 
Conclusion: Bolus rt-PA followed by PUK infusion appears to 
be highly effective and moderately specific and somewhat 
superior to a coinfusion regimen. The regimen is, however, 
apparently associated with an increased bleeding risk. A 
decrease of the rt-PA bolus dosage is therefore recommended. 
943·28 
397A 
Hemorrhagic Potential of Combined Intravenous Diltiazem 
and Tissue Plasminogen Activator Administration 
Richard Becker, Ronald Caputo, Steven 8all, Jeanne Corrao, 
Jack Ansell, Stephen Baker, Joel Gore. Thrombosis Center, 
University of Massachusetts Medical School, Worcester, MA. 
In TIMI II, use of calcium antagonists at study entry was 
associated with an increased incidence of intracerebral 
hemorrhage. Nhether this association was due to chance, 
underlying cerebrovascular disease, or an effect of 
calcium antagonists was not able to be determinedc 
Accordingly, the following study was performed: Blood 
loss (Bl) from standardized ear incisions was measured in 
6 groups of anesthetized New Zeland white rabbits: (1) 
Saline control, (2) diltiazem (20ug/kg/min x 60 min), (3) 
t-PA (lmg/kg over 60 min, 10% bolus), (4) diltiazem + t•
PA, (5) diltiazem (daily x 3 consecutive days), (6) dil•
tiazem (3d) + t-PA (given on day 3). Blood pressure was 
monitored continuously with an arterial catheter. 
Treatment Group !U........1..!! SO 
1 (n - 6) 75.4 53.8 
2 (n 11) 76.4 77.2 
3 (n 10) 78.7 115.8 
4 (n 5) 76.7 80.0 
5 (n 6) 380.8< 199.5 
6 (n 6) 278.5* 203.4 
A combination of t-PA and diltiazem (3 d) resulted in 
Significantly more 81 than t-PA alone, diltiaze"l.alone (60 
min), or t-PA plus diltiazem (60 min) (P~.003). 
Similarly, diltiazem alone (3 d) resulted in greater Bl 
than either agent alone or t-PA plus diltiazem (60 min) 
(P~.003). In this animal model, prolonged diltiazem 
exposure, with or without t-PA, was associated with in•
creased B1. The potential for chronic oral calcium 
antagonist use to increase hemorrhagic risk following t•
PA administration must be investigated further. 
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943-29 
Outcome of Rescue Angioplasty Following Failed Thrombolysis in 
Acute Myocardial Infarction 
The CORAM! Study Group. Hopital Bichat, Broussais, Cochin. Paris. 
France 
Failed thrombolysis for acute myocardial infarction (AMI) carries a poor 
prognosis. The effects of "rescue" angioplasty on patency and survival 
were tested in 44 consecutive patients (pIS) (40 males; age 53 ± II years) 
with AMI < 6 h, treated by thrombolysis 178 ± 93 mn after the onset of 
pain. Angiography of the infarct-related artery (IRA) was perfonned 83 ± 
18 ron later, and showed TIM! 0 or I patency of the IRA. AMI location 
was anterior in 23 pts, inferior in 22 pts. 
Angiographic success (TIMI 2 or 3, < 50% stenosis) was achieved in 
40/44 pts (91 %). Reperfusion was obtained 31 ± 24 mn after 
angiography and 298 ± 106 mn after chest pain. I pt had ventricular 
fibrillation upon reperfusion.There were 2 in-hospital deaths (hospital 
morta1ity 4.5 %), no surgery, I transfusion. Predischarge angiography 
was performed 6.8 ± 5 days after RA in 35{42 survivors and showed IRA 
patency in 31/35 pts (88%) and 3 asymptomatic reocclusions. I 
symptomatic reocclusion was treated by emergency angioplasty. At 
discharge, 6{42 pts were in congestive heart failure (CHF) NYHA class 3 
or 4. 
At 6 months follow-up in 100 % of the pts, there was no death, no re•
infarction. 4 pts were in CHF NYHA class 3 or 4. Repeat angiography 
was performed in 27 pts and showed 5 restenoses and 3 reocclusions. 
(combined rate: 29 %). 
Conclusion: rescue angioplasty after failed thrombolysis in AMI can be 
performed safely with a high success rate and appears to result in low 
morta1ity and morbidity at 6 months in this high-risk subset Restenosis 
and reocclusion rates appear acceptable. 
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944-30 
Mechanisms of Inducible Ventricular Tachycardia in the 
First Three Hours after Coronary Artery Occlusion in 
the Dog 
James B. Martins, Shlomo A. Ben-Haim, Thomas E. Rath. 
University of Iowa College of Medicine, Iowa City, IA 
Acute coronary artery occlusion (CAO) renders the 
ventricle markedly disorganized electrically. Our 
hypothesis was that ventricular tachycardia (VT) 
inducible in the first 3 hours after CAO would be 
polymorphic and have mUltiple origins. 
Three-dimensional mapping was performed by plaCing 
multipolar electrodes in the risk zone of the anterior 
descending coronary artery. An endocardial cathode at 
the base, adjacent to the risk zone was paced at CL-300 
msec with up to 4 premature extrastimuli every 30 min 
after CAO. < Purkinje relative refractory period (PRRP) 
and muscle RRP were measured inside the risk area and 
at the pacing site, resp. 
Of 9 dogs studied, 2 had no inducible VT, 7 had at 
least I episode of sustained monomorphic VT inducible 
and 5 of the latter also had polymorphic VT inducible. 
Successful induction protocols usually employed 
extrastimulus intervals < PRRP but > MRRP. Cycle 
lengths of monomorphic VT ranged from 90 to 290 msec; 
VT frequently originated from a focal endocardial site 
although transmural and epicardial reentry were also 
observed. In the same heart polymorphic VT was usually 
due to a different mechanism but arose repetitively 
from the same general area (within 2 cm2). Infarct 
size (7 to 20% of left ventricular mass) did not 
correlate with inducibility of VT. The same morphology 
and mechanism of VT was inducible serially in 4 of 4 
dogs without intervention. 
We conclude that acutely after CAO inducible sustained 
VT was remarkably organized, frequently monomorphic and 
well localized even when polymorphic. 
944-31 
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How Well Does Time-la-Peak Enzyme Concentration Predict 
Coronary Patency after Thrombolytic Therapy? 
Robert H. Christenson, E. Magnus Ohman, Show-Hong Duh, 
Kristina N. Sigmon, Kimberly A. Klinker, Robin T. Vollmer and 
Thomas C. Wall for the TAMI Study Group, Univ. of Maryland, 
Baltimore, MD & Duke Univ., Durham, NC 
To examine use of time-to-peak enzyme concentration as an 
indicator of coronary patency, we analyzed total creatine kinase (T•
CK), CK-MB and the MMJ & M~ tissue isoforms in serial blood 
samples from 207 MI pts, all of whom received thrombolytic 
therapy (TI) at a median (25th,75th percentile) of 162 (113, 226) 
mins after onset of symptoms. All pts had acute angiography at 142 
(96, 195) mins after IT; flow in the infarct related artery (IRA) was 
graded as either "OPEN", TIMI 2-3 (n=147), or "CLOSED", TIMI 
0-1 (n=6O). Curvefitting analysis and plots of Receiver Operator 
Curves showed the following: 
IRA Minutes from Syptoms Onset to Peak-Concentration 
Patency TCK CK-MB MM3 Mlh 
OPEN 487(364,600) 452(353-533) 363(262-431) 410(312-475) 
CLOSED 593(451,727) 515(392-632) 437(346-512) 491(381-595) 
P-value <0.01 <0.03 <0.005 <0.004 
Sensitivity 75% 75% 75% 75% 
Specificity 68 % 65 % 64 % 75 % 
Conclusion: Although time-to-peak differences between the OPEN 
and CLOSED groups for TCK, CK-MB, MMJ or ~ were all 
significant (P<0.05), use of these data for assessing coronary 
patency lacks adaquate sensitivity and specificity for clinical use. 
Thus, this approach should be used cautiously for care of pis and 
results from research studies using time-to-peak for classifing OPEN 
and CLOSED pts must be interpreted with discretion. 
944·32 
The Cholesterol Content of Cardiomyocytes Affects Their 
Tolerance to Anoxia 
E.M.Lars Bastiaanse, Lizet I.M. Van der Valk, Arnoud Van der Laarse. 
University Hospital, Leiden, The Netherlands. 
Little is known about the effects of increased plasma cholesterol levels 
on the tolerance of cardiomyocytes to ischemia. In this study we 
investigated whether an increased or decreased cholesterol content of 
neonatal rat cardiomyocytes affects the susceptibility to anoxia-induced 
cell injury. After modulating the cholesterol content of the cells with 
liposomes, the release of lactate dehydrogenase (LOH) during anoxic 
incubation was measured to assess cell necrosis. Cultures were 
preincubated for 5 h with cholesterol rich liposomes 
(cholesterol/phospholipid (CIPL)=2; to increase the cholesterol content), 
cholesterol poor liposomes (CIPL=0.5; control liposomes, to exclude 
any effect of liposome incubation per se), or cholesterol free liposomes 
(CIPL=O; to decrease the cholesterol content). The cholesterol content 
and time to half maximal LOH release (LOH 50%) were compared to the 
data obtained in control cultures (not preincubated with liposomes). 
C content ALDH 50% (min) 
treatment N (control = 100%) (treated-control) 
CIPL=2 6 152 ± 6.7 # 35 ± 4.0 # 
C/PL=O.5 4 98.3 ± 4.2 -1.8 ± 2.8 
C/PL=O 4 80.8 ± 5.3 # -39 ± 10 # 
Mean ± SEM # P<0.05 compared to control 
The results show that cellular cholesterol content is positively correlated 
to the tolerance of the cardiomyocytes to anoxia. These results could be 
of interest with respect to the tolerance of cardiomyocytes to ischemia in 
relation to plasma cholesterol levels. 
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944-33 
The Beneficial Effect of FluosoliJ to Reduce Myocardial 
Reperfusion Injury is Independent of its Oxygen Carrying 
Ability 
Joao V. Vitola, Thomas W. Rigsby, David A. Ingram, James B. 
Atkinson, John 1. Murray, Mervyn B. Forman. Vanderbilt 
University, Nashville, TN 
FluosoliJ is an emulsion of perfluorochemicals designed to 
improve oXYien delivery to tissues. We have previously shown 
that Fluosol significantly attenuates myocardial reperfusion 
injury in dogs, rabbits and human beings when administered with 
oxygen. Studies in vitro demonstrated sUPJlression of rabbit 
neutrophil activation by FluosolQ\l suggesting this might account 
for its activity in vivo. We, therefore, investigated ilie necessity 
of oxygen in mediating the beneficial effect of FluosollJ• New 
Zealand White rabbits underwent 30 mins of circumflex occlusion 
and 48 hrs of reperfusion and were randomly assigned to 3 
groups: saline (control; n=10), FluosoliJ (3OCc/kg; n=9), or 
oxygenated Fluosol® (30cc/kg + 100% oxygen for the first 5 hrs 
ofreJlCrfusion; n=l1). The drugs were administered during the 
first 60 mins of reperfusion. Serial hemodynamics were similar 
in all grou!>s throughout the protocol. The area of risk (AR) was 
defined WIth Monastral blue and the area of necrosis (AN) 
histologically with Masson's trichrome stain; LV = left 












Intravenous FluosoliJ , administered in the peri-reperfusion 
period, significantly enhances myocardial salvage. This 
beneficial effect of FluosolQ\l is independent of its oxygen carrying 
capacity. These observations confirm the in vitro data that the 
protective effects of FluosolQ\l are mediated primarily through its 
action on neutrophils. 
944-34 
Myocardial Protection During and After Repeated 
Coronary Artery occlusions With Fructose 1-6 
Diphosphate 
Jian-zhang Feng, Shu-lin Wu, Lingyl Lu, Angel Markov. 
Guangdong Cardiovascular Institute, Guangzhou, P. R. 
China and University of MiSSissippi, Jackson, MS 
Repeated coronary artery occlusions can not only 
depress ventricular function and cause malignant 
arrhythmias, but can also produce subcellular 
myocardial injury. As Fructose 1-6 Diphosphate (FOP) 
is reported to have substantial therapeutic effects on 
myocardial infarction - both in animals and humans - we 
investigated whether this agent might have similar 
salutary effects in intermittent myocardial ischemia. 
Dogs (n=36) were subjected to 10 min occlusions of LAD 
followed by 15 min of reperfusion for a total ischemic 
time of 100 min. Following baseline measurements, 27 
dogs were injected with 500 mg glucose in 0.9\ NaCl and 
9 with 500 mg of FDP and then given infusions of 2.5 
mg/kg/min of the respective solutions. During the 
ischemic episodes the LVSP and dp/dt did not change in 
the FDP group, whereas they were significantly 
depressed in the glucose group (P<O.Ol). The degree of 
the epicardial ST segment elevation (EST) was less and 
the number of ST elevations were fewer in the FDP group 
(P<O.OS). In the control group, 11 dogs fibrillated 
and 9 had VT, whereas no dog treated with FDP had VF 
nor VT (P<0.05). Following the 10th reperfusion, VF 
was inducible in 50\ of the controls with electrical 
stimulation, but in only 20\ of those treated with FDP. 
Myocardial necrosis was absent in both groups; however, 
electron microscopy revealed substantial mitochondrial 
injury in the glucose group (P<O.OS). It is concluded 
that FOP improved ventricular function, prevented 
occurrence of malignant arrhythmias and protected the 
myocardium from subcellular injury during and following 
intermittent coronary artery occlusion. The 
therapeutic effect of FDP is attributed to its proven 
ability to enhance energy production in ischemic 
myocardium by intervening in glycosis both as a 
metabolic regulator and high energy substrate. 
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944·35 
Protein Kinase C Activity and Ventricular Fibrillation In 
Myocardial Ischemia 
JOrgen Schreieck, Gert Richardt. Albert SchOmig. 
1. Med. Klinik Technische Universit!lt MOnchen, Munich, Germany 
Transmembrane calcium f1u:~ and calcium dependent processes are 
thought to be important factors in the genesis of arrhythmias caused by 
acute ischemia. In rat isolated perfused hearts, ventricular fibrillation (VF) 
was induced by occlusion of the left anterior descending coronary artery. 
Occurrence of VF (0/0) within 30 min of ischemia was closely related to 
calcium concentration of the perfusion buffer (see figure). To test the 
involvement of calcium dependent protein kinase C (PKC), PKC activity 
was etther stirrulated by the phorbol ester phorbol12'myristate 13·acetate 
(PMA) or suppressed by three structurally different PKC inhibitors: 
polymyxin B. staurosporin, and chremophor RH 40. In the presence of 0.8 
mM calcium, the addition of PMA (10 nM) increased the Incidence of VF. In 
the presence of 1.85 mM ~lcium, polymyxin B, staurosporin, and 
cremophor RH 40 suppressed VF in a concentration dependent manner 
with maximum inhibitory effect at the concentrations shown in the figure. 
Further increase of PKC inhibitor concentrations did not cause a more 
pronounced suppression of VF. 
100 1 calcium (nvnoVI) 
VF 0.5 0.6 1.85 
~j 0 ~ ~ 
n: 10 15 13 23 11 11 12 
o control E::l PMA (10 nM) D polymyxin B (10 \.1M) 
lSI staurosporin (100 nM) Ell cremophor RH 40 (100 \.1M) 
Conclusion: The data are in keeping with an involvement of PKC in 
the pathogenesis of VF in myocardial ischemia. The role of PKC, however, 
in ischemia· induced VF seems to be limited, since inhibition of PKC by 
high concentrations of various blockers reveals a maximum reduction of VF 
by only 40%. 
944·36 
Mechanism of Attenuatiuon of Beta-Adrenergic 
Stimulation in Ischemic Canine Purkinje Tissue 
David G. Cable, Thomas E. Rath, James II. Martins. 
University of Iowa College of Medicine, Iowa City, IA 
Beta-adrenoceptors (BAR) increase during the initial 8 
hours of coronary occlusion (CO). We reported a 2-fold 
augmentation of ischemic Purkinje relative refractory 
period (PRRP) shortening with norepinephrine (NE) 
infusion 30' after CO. However, PRRP shortening with 
NE was attenuated with continued ischemia of 1-3 hours. 
To evaluate mechanisms of this attenuation of presumed 
increased BAR with continued CO, we studied PRRP 
response to NE or forskolin in 26 anesthetized dogs 
after sinoaortic denervation and vagotomy. 
After theophylline pretreatment (5 mg(kg bolus and 
0.5 mgjkg/min IV with serum levels of 10·15 pgjml) , NE 
(1.6 pg/kgjmin) every 30' reproducibly shortened PRRP 
(12±1 (SEM) msec) in controls. Shortening of PRRP with 
NE was still augmented at 30' after CO (-22±6t, 
t-p<0.05 msec) but was attenuated 1-3 hrs after co 
(-12±lt msec). Forskolin shortened PRRP maximally 
(·9±lt msec) in normal dogs in a dose dependent manner 
(plateau at 15 pg(kg, IV bolus). 1,9 dideoxyforskolin. 
an analogue which does not stimulate adenylate cyclase, 
prolonged PRRP (5±lt msec). In dogs without CO, 
repeated forskolin (15 pg/kg) boluses every 30' 
reproducibly shortened PRRP (·8±lt msec) over a 3 hour 
period and CO did not alter this response to forskolin. 
We conclude: Attenuation of ischemic PRRP shortening 
with NE was not corrected by theophylline. Forskolin 
reproducibly shortened PRRP, consistent with adenylate 
cyclase activation. The latter was not altered by 
ischemia. Uncoupling of liAR from adenylate cyclase by 
ischemia most likely explains the attenuation of PRRP 
responses to BAR stimulation. 
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944-37 
The ReJatM: Importana: of Myocardial Energy Metabolism Compared with 
Ischemic Contnlclure in the Determination of Ischemic Injury in Isolated 
Pedused Rabbit Hearts 
Jean-Louis J. Vanoverschelde, Marc F. lanier, Steven R. Bergmann. 
Washington University, St. Louis, MO 
The mechanical effects of ischemic contracture may he important in the 
development of irreversible cell damage as they increase mechanical stress and 
restrict endocardial perfusion. To assess the relative importance of these effects 
compared with decreased energy supply in the development of irreversible injury, 
the effects of inhibiting ischemic contracture with 2,3-butanedione monoxime 
(BDM), an agent that disrupts excitation-contraction coupling, were delineated 
in paced, isovolumically contracting isolated rabbit hearts. Administration of 20 
mM BDM in 12 hearts SUbjected to 60 min of low flow ischemia prevented 
ischemic contracture (left ventricular end-diastolic pressure (L VEOP) of 12 ± 
3 versus 48 ± 14 mm Hg in 20 control hearts, p < 0.001), reduced membrane 
damage (creatine kinase (CK) release -54% versus controls, p < 0.05) and 
enhanced functional recovery during reperfusion (86 ± 10% of baseline 
developed pressure (OP) compared with 56 ± 23% in controls, p < 0.01). These 
effects were not related to improved microvascular patency, since venting the left 
ventricle in additional control hearts did not result in improved function during 
reperfusion. Although it would he tempting to conclude that 80M protected 
ischemic myocardium by preventing ischemic contracture, administration of 
BOM was also associated with reduced depletion of A TP perhaps related to 
diminished energy demand. To distinguish between the relative importance of 
inhibiting contracture from provision of adequate energy, the period of ischemia 
was extended from 60 to 120 min. After 120 min oJ ischemia, BOM still 
prevented ischemic contracture (L VEOP 10 ± 6 mm Hg) and preserved A TP 
stores but it did not prevent membrane damage (CK release: 670 ± 324 U/g dry 
weight) nor contractile failure during reperfusion (68 ± 7% of baseline OP). 
In contrast, increasing anaerobic glycolysis during ischemia by doubling glucose 
supply in the presence of BOM markedly decreased membrane damage (CK 
release: 169 ± 93 U/g dry weight, p < 0.05) and contractile failure during 
reperfusion (88 ± 7% recovery of baseline DP, p < 0.01). These results suggest 
that insufficient A TP production from anaerobic glycolysis (perhaps related to 
compartmentalization) is responsible for myocardial ischemic damage. 
Mechanical effects of ischemic contracture appear to play only a minor role. 
944-38 
Iron-Catalyzed Upld Peroxldation DurIng Reperfuslon Is Prevented By 
An Intracellular Hydroxyl Radical Scavenger 
Edward J. Lesnefsky and Jlan Yeo Oeveland VAMC and Case Western 
Reserve University, Oeveland, Ohio 
Direct demonstration of the mechanisms of iron-catalyzed reperfusion (R) 
injury has been lacking. Administration of catalytic amounts of exogenous 
Iron (5 uM) during eany R increases myocardial R injury and lipid 
peroxidation (LP), but only when the iron Is bound to a ligand that allows 
iron to enter the cell. Intracellular iron could increase LP etther by 
catalyzing Intracellular 'OH formation via the Fenton reaction from H20 2 
and '02'; or by direct iron redox-cycling involving myocardial lipids 
independent of OH. Dimethylthiourea (DMTU) is a cell permeable 
scavenger that blocks the former, but not the latter, mechanism. Buffer 
perfused rabbit hearts underwent 30 min of ischemia and 30 min R. Hearts 
received 5uM omadine-iron (N=8), a redox-active cell-permeable complex, 
from 27 min ischemia to 4 min R (cytosolic Iron 129±6 pmol/mg tissue). 
Addttlonal omadlne-iron hearts were pretreated wtth 2C mM DMTU (N=6. 
iron 120±", p=NS). Non-iron controls (N=9) received either saline 
vehicle or omadine alone (Iron 95±5, p<O.05). Recovery of developed 
pressure (%RECDP), tissue lipid peroxides (pmol/rng tissue), and creatine 
phosphokinase (CI<) release (IU/mln) were measured at 30 min R. Tissue 
lipid peroxides were directly measured by a glutathione peroxidase-based 
assay. Omadine-iron did not Increase LP or CK release in non-ischemic 
hearts. 
%RECDP Lipid Peroxides 
Non-iron 51 ±3 28.S±4.5 
Omadlne-iron 35±4# 52.0±5.0# 
DMTU om-Iron 48±5 _ 22.3±6.9 
#p<O.05.l!§ non-Iron controls and DMTU 




DMTU prevented the LP and R damage caused by intracellular iron. Thus, 
Intracellular Iron caused LP by reacting wtth oxygen radicals generated 
during R to form ·OH, which then Initiated LP. Decreased CK release in 
omadine-Iron hearts treated with DMTU suggests that 'OH-initiated LP 
caused membrane damage and myocyte injury. 
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945-50 
Does Dobutamine Prevent the Rise in Left Ventricular Filling 
Pressures Observed During Exercise after Heart 
Transplantation? 
Pascal J. Vantrimpont, Herbert Felice and Walter J. Paulus. 
Cardiovascular Center, Aalst, Belgium. 
The rise in left ventricular(L V) filling pressures(P) observed 
during exercise(Ex) after heart transplantation(Tx) is attributed 
to deficient sympathetic stimulation because of denervation or 
limited reinnervation. To evaluate if a is-adrenergic agonist could 
prevent this Ex-induced rise of LV filling P, serial supine bicycle 
Ex at an identical workload was performed in 8 Tx recipients in 
control(C) state and during continuous infusion of 
dobutamine(Dob; 3.0±0.5/tg/kg/min) at the time of left-right 
heart catheterization, 1 year after Tx. Dob infusion was titrated 
before Ex to achieve a heart rate(HR; beats/min), which 
matched HR at peak Ex of C run. LV peak systolic P(LVPSP; 
mmHg), LV enddiastolic P(LVEDP; mmHg), LV 
peak+dP/dt(mm Hg/s) and the time constant of LV P decay(T; 
ms) were derived from micro-tip LV P recordings at resteR), at 
peak Ex of C run(Ex), during Dob before Ex(Dob-R) and during 
Dob at peak Ex(Doh-Ex). 
R Ex Dob-R Dob-Ex 
HR 87±8 104±l2* 108±lH 122±16t 
LVPSP 138±14 159±20* 137±14 156±15 
LVEDP 16±5 2l±4* 6±3; 1l±5t 
LV+dP/dt 1374±172 1854±280* 218l±220; 2619±214t 
T 42±6 38±7 30±4* 27±5 
*;*;t=p<0_05 Ex vB.R; Dob-R vB.R; Dab-Ex VB_ Dob-R 
By improving LV+dP/dt and T, Dob lowers LVEDP before Ex 
and at peak Ex but fails to prevent the Ex-induced rise in 
LVEDP. Conclusion: During Ex after Tx, a is-adrenergic agonist 
reduces the level but not the rise of LV filling P. 
945-51 
Importance or the Progressive Changes in Left Ventricular Diastolic 
Chamber StilTness in Patients With Depressed Systolic Function 
Wataru Hayashida, Otristian van Eyll, Liviu Sto1eru, Michel F. Rousseau. 
Marvin A. Konstam, James E. Udelson, Jacques Melin, Hubert Pouleur. 
for the SOL VD Investigators. University of Louvain, Brussels, Belgium. 
To detennine the respective roles of systolic and diastolic function in the 
progression of LV dysfunction, LV cineangiographic data (+ Millar) and 
right ventricular (RY) volumes (radionuclide angio) were studied at 
baseline and 1 year after randomization to conventional therapy with 
placebo (n=12) or with enalapri1 (ENA, 10 mg bj.d., n=17) in 29 pts 
enrolled in the Prevention or Treabnent Anns of the "Studies of Left 
Ventricular Dysfunction". For the assessment of LV passive diastolic 
properties, LV pressure (P) and volume (V) data from minimum diastolic 
P to end-diastole were fitted (correlation coefficient ~ 0.90) to the 
equation of a simple elastic model (p=a.e8V +1), and the chamber stiffness 
constant 6 was obtained. After I year and despite comparable changes in 
heart rate, RV volumes, in LV isovolumic indices of inotropic state and 
in the end-systolic stress/end-systolic V relationship, LV end-diastolic and 
end-systolic V had increased in the placebo group (+7% and +8%, 
respectively) but decrea~ed in the ENA group (-6%** and "ll%**). 
However, in the placebo group, the stiffness constant 6 had decreased 
from O.048±O.028 to 0.035±O.021 mrl.m2 (p<0.05 vs baseline) whereas 
6 remained unchanged with ENA (0.043±O.020 to 0.046±0.028; NS). 
Further, the changes in 6 during follow-up were significantly different 
between groups (dPlacebo: -0.014±O.02I, AENA: 0.OO3±O.016 ml-l.m2,"). 
These data therefore suggest that an alteration in the passive physical 
properties of the LV chamber rather than an alteration in LV or RV 
systolic perfonnance underlies the progressive LV dilatatioTt. The data 
also suggest that the beneficial effects of enalapril in pts with systolic LV 
dysfunction are at least in part mediated through an action of that drug 
on the cellular mechanisms responsible for the relentless decrease in LV 
chamber stiffness. +p<O.05, **p<0.OO5 AENA vs M'lacebo 
JACC Vol. 21, No.2 
February 1993:401A 
945·52 
hUmatlon of Laft Ventricular Contractile Performance In 
Patients wHh Lone Atrial Fibrillation 
RyuheI Tanaka, Masaakl TomHa, Yoko Mlwa. Tomoyo Arao. Hlsashl Shlrakl. 
Kensaku Kagawa, Mlchlo Arakawa. Masato Yamaguchi. Hlroyukl Uemura. 
and Senrt Hirakawa 
GHu unlverlsity school of medicine. Glfu. Japan 
The slope of the end-systolic pressure volume relation (Emax) and 
the relation between end-systolic wall stress and Iogartthm of reciprocal 
of wall thickness (Klndex) have been employed as Indexes of LV 
contractile performance In laboratory animals, however. LV contractile 
performance in patients with lone atrial fibrillation (AF) has not been 
fully examined. Therefore the purpose of this study was to examine 
these Indexes In AF subjects without valvular disease. coronary 
artery disease and cardiomyopathy (n=8) and compare with those 
In normal human subjects ( eTR. n=8 ). Emax and Klndex were 
assessed using simultaneous echocardlography and catheterization 
by dlgRzlng the data at 5-ms Intervals. In eTR. transient occlUSion of 
the Inferior vena cava with a balloon-tipped catheter was employed 
to obtain beat to beat reduction In LV pressure and volume In serial 
5 beats. In AF,5 beats with different LV pressure were examined 
without occlusion of the Inferior vane cava. There was neither significant 
difference In LVEDV betwean eTR and AF (95:t6 vs 83,,7 ml) nor In 
LVESV between eTR and AF (33:1:2 vs 37%4 ml ). %FS=%Fractlonai 
shortening 
RESULTS %FS Emax r of Emax K1ndex rofKlndex 
AF 27,,3 2.1%0.3 0.94%0.03 4.3%0.9 0.9%0.09 
em 37+2' 2 3-tQ 5 0 95:tO 04 Ii 1+1 n 095%0 03 
, = P <0.05 vs AF mean :I: SEM 
In AF, Emax and Klndex were easily obtained without ocduslon of 
the Inferior vena cava. and relation Indexes ( r) by least square linear 
regreSSion analysis of Emax and K1ndex were as high as those In 
eTR. While %FS was significantly lower In AF than In eTR, there 
were no Significant differences In Emax and Kindex between AF 
and eTR, suggesting that LV contractile performance In lone AF is 
not reduced . 
945·53 
Efficacy of ventricular suction Durinq Rapid 
Fillinq in the Normal Human Heart 
Hans-Michael Steffen, Lars Kramer, Ralf 
MUller, Gerhard Wambach, Reinhard Griebenow 
Med. Klink II, University of Cologne, D 
Restoring forces and elastic recoil may be im•
portant during early diastolic LV filling. To 
investigate this possibility we studied the 
relation between wall motion and mitral inflow 
during rest and supine exercise in 30 healthy 
volunteers (age 26±3y). Usinq digitized M-mode 
(ME) and PW-Doppler (DE) echocardiograms the 
following parameters were determined: time from 
mitral valve opening to peak rate of posterior 
wall thinning (TPRW), acceleration time (AT), 
rapid wall thinning period (RTP). Mitral valve 
ME and DE modal velocity envelopes were matched 
to calculate rapid filling period (RFP) and 
rapid filling volume (RFV). Plasma levels of 
ANP were measured to estimate LA pressure. 
rest exercise 
TPRW (ms) 39±22 42±17 
AT (ms) 66±15 p < 005 74±12 
RTP (ms) 67±18 7l±19 
RFP (ms) 123±18 116±16 
RFV (ml) 39±8 p < .001 48±10 
During exercise RTP was shorter than AT in 16 
volunteers who also showed higher RFV (53±IO vs 
43±9 ml, P<.01) and lower ANP plasma levels at 
peak exercise (122±98 vs 210±137 pg/ml, p<.05). 
Conclusion: phase differences between wall 
motion and transmitral flow are present in the 
normal LV. Elastic recoil and restoring forces 
contribute to an augmented transmitral pressure 
gradient and hence increase early filling. 
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945·54 
Factors Influencinq Left Ventricular systolic 
Function in Morbid Obesity: Bffect of .eiqht 
Loss 
Martin A. Alpert, Charles R. Lambert, Clara V. 
Massey, Vaskar Mukerji. University of South 
Alabama College of Medicine, Mobile, Alabama 
To identify factors influencing left ventricu•
lar (LV) systolic function in morbidly obese 
patients and to assess the effect of weight 
loss on these factors and LV systolic function 
itself, we studied 39 non-hypertensive sub•
jects (6 males and 33 females, mean age 37±8 
years) whose actual body weight was ~twice 
their ideal Heart rate and blood pressure were 
measured and echocardiography was performed 
prior to and at the nadir of weight loss 
(133±8% to 39±7% overweight). Prior to weight 
loss LV fractional shortening correlated 
inversely with the LV internal dimension in 
diastole (LVIDd, r=O.61, p=O.OOl), LV end•
systOlic wall stress (LVESS, r=O.79, p=O.0001) 
and systolic blood pressure r=O.82, p=O.0001). 
The weight loss-induced change in LV fraction•
al shortening correlated directly with the 
pre-weight loss LVIDd (raO.58, p=O.OOl), LVESS 
(r=o.78, p-O.0001) and systolic blood pressure 
(r=o.72, p=O.OOOl), and inversely with pre•
weight loss LV fractional shortening (r-O.77, 
p=O.0001), the weight loss-induced changes in 
LVESS (r=O.81, p=O.0001), and systolic blood 
pressure (r=O.55, peO.0003). Thus, in morbid•
ly obese patients, LV loading conditions 
(particularly afterload-related indices) 
greatly influence pre-weight loss LV systolic 
function and the alterations in LV systolic 
function resulting from weight loss. 
945·55 
EFFECTS OF BODY WEIGHT LOSS ON LEFT VENTRICULAR FUNCTIO•
NAL AND STRUCTURAL PARAMETERS IN HEALTHY OBESE SUBJECTS. 
Salvatore Corrao, Rosario scaglione, Sabrina Arnone, Ma•
riagra"ia Cecala, Giuseppe Licata. 
Institute of Internal Medicine. Univerllity of Palermo, 
Italy. 
The aim of our research was to evaluate left ventri•
cle morpho-functional changes in healthy obese subjects, 
during controlled hypocaloric regimen. Up until now we 
have followed for four months eight healthy obese su•
bjects (3 m and 5 9, with average age of 37 ± 5 years 
and 8MI Over the 95 percentile (20-29 years class) ac•
cording to Emilia Romagna Obesity Study. All patients 
started a controlled hypocaloric diet. We carried out a 
standard m-mode, two-d~mensional and Doppler echocardio•
graphic examination before beginning hypoca10ric regimen 
and after a four months period. We calculated. bOd! mass 
index (BMI), waist-hip ratio (WHR), left ventr cular 
mass normalized to BSA and height (LVMI and LVM/H), 
stroke index (SI), cardiac index (CII, systemic vascular 
resistance normalized to BSA (SVRI=MBP/CI), left ventri•
cular ejection fraction (LVEF), some trans-mitral flow 
Doppler parameters as A/E ratio and the deceleration 
half-time normalized to R to R interval (DHT/RR). All 
values are reported as mean ± standard Deviation. 
RESULTS (heart rate (HR) and mean blood pressure (MBP) 
are also reported): 
BASELINE AT FOLLOW-UP P < 
BMI (Kg/m2) 35 + 5 32 + 5 0.0001 
:~R(b/m') 0'~5 ~ ~505 o.~~ i ~004 g:g~7 
MBP (mmHg) 2 99 + 12 96 + 8 ns 
LWlI (g/m I 10875 =±+ 2241 60 ± 19 0.02 
LVM/H (g/ml 71 ± 22 0.01 
EF (') 57 + 3 62 + 3 ns 
SI (ml/m2 1 41 + 9 38 ± 13 ns 
CI (mltm'/m2) 3241 + 813 2659 + 1148 ns 
SVRI (mmHg/l/m'/m21 33 + 11 943 _=++ 2141 ns 
A/E ratio (') 114 ± 14 0.01 
DHT/RR 193 ± 66 129 ± 32 0.03 
CONCLUSION. body weight loss consequent to controlled 
hypocaloric diet produces considerable left ventricle 
morpho-functional changes, as a net reduction of left 
ventricular mass and a substantial improvement of left 
ventricular diastolic filling. 
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945·56 
Prevalence and Hemodynamic Implications of a Patent Foramen Ovale In 
Pulmonary Hypertension 
Mark T. Nootens, Laurence A Berarducci, Elizabeth Kaufmann, Rajitha Goli•
Bijanki, Slephen Devries, Sluart Rich 
The University of Illinois at Chicago, Chicago, Illinois 
II is reported that a patent foramen ovale (PFO) is common in pis with 
primary pulmonary hypertension (PH) and is associated with better survival by 
allowing right-to-Ieft shunting which lowers RA pressure and increases cardiac 
output. For these reasons the creation of an atrial septostomy in pts with PH 
without a PFO has been suggested as palliative therapy. The prevalence of a 
PFO in PH and ils hemodynamic effects have not been defined. 47 pis with 
PH (33 with primary and 14 with secondary) were studied by transesophageal 
echo for a PFO. A PFO was present if saline contrast was seen crossing from 
RA to LA within 3 cardiac cycles. Baseline hemodynamies, exercise time (Ef) 
by treadmill and S~ were compared in the pis with (n = 13) and without 
(n=34) a PFO. 
PA(mmHg) RA(mmHg) <XWmiI) 
PFO 54.0.±.1l.0 9.1.±.6.2 4.0.±.13 
noPFO 54.5.±.17.2 95.±.5.6 45.±.1.6 
PVR(units) Sa02(%) ET(secs) 
PFO 13.6.±.6.7 84.±.7 311.±.211 
noPFO 1l.4.±.6.4 89.±.8 367.±.242 
The 2 groups were similar in aU aspects. Conclusions: 1) The prevalence of 
a PFO in PH (28%) is similar to normals. 2) A PFO appears to have 
negftgible effects on hemodynamics and exercise tolerance in pts with PH. The 
importance of a PFO in PH may have been overstated and requires further 
investigation. Whether it will substitute for an atrial septostomy in pis with PH 
is uncertain. 
945·57 
A New Method for the Estimation of Peak dP/dt 
Jonathan Rhodes, James E. Udelson, Marvin A. Konstam, 
Gerald R. Marx, Zlyad M. Hljazi, Stephen A. BoYa, David R. 
Fulton, Tufts New England Medical Center, Boston, MA 
Peak positive dP/dt is a good index of venticular performanc:e that is not 
influenced by aflerload, wall motion abnonnalnies or the variations in 
ventricular anatomy and morphology commonly encountered among 
patients wnh congennal heart disease. Unfortunately, the clinical utilny of 
peak dP/dt has been limned by the fact that ns measurement generally 
requires an intraventricular catheter. However, peak dP/dt usually occurs 
during isovolumelric contraction (IC), and the pressure rise during IC is 
almost linear. We therefore postulated that the ratio of the rise in pressure 
during IC. (i.e .• aortic diastolic pressure minus the systemic ventricular end 
diastolic pressure (VEOP» over the IC time would provide a good estimate 
of peak dP/dt that could be generated non·invasively. We used echoJ 
phonocardiography to measure the IC tima and a BP cuff to estimate aortic: 
diastolic pressure. VEOP was determined by 3 methods: 1) intraventricular 
catheter; 2) assumed veop = 10 ; and 3) assignmant of e normal or 
elevated value on the basis of the patient's clinical history. The three 
estimates of peak dP/dt thus generated were compared to simuHaneous 
measurements of peak dP/dt obtained wnh tip transducer or fluid filled 
intraventricular catheters during the catheterization of 22 patients age 1 
day - n years with congennal and/or acquired heart disease. Invasively 
measured peak dP/dt ranged from 428 to 2439 (mean 1626) mmHg/sec 
and correlated well wnh the indirect determinations: 
Method Slope Intercept r p SEE 
1 1.07 150mmHglsec .95 <.0001 155mmHglsec 
2 1.01 181mmHglsec .88 <.0001 233mmHglsec 
3 1.00 235mmHglsec .92 <.0001 192mmHglsec 
Conclusion: EchoJphonocardiography can be used, in conjunction wilh a 
BP cuff and indirect estimates of VEOP. to generate rapid. bedside 
estimates of peak dP/dt, without employing an intraventricular catheter. 
The assessment of ventricl!lar performance so provided may prove useful 
to clinicians caring for patients wnh a variety of cardiovascular disorders. 
945·58 
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Accurate Determination of Left Ventricular dP/dt 
Without the Use of a Micromanometer Tipped Catheter 
Ira S. Nash, John B. Newell, Theodore J. MacVeigh, Richard A. 
Schrenker, Marc J. Semigran, Michael A. Fifer, Massachusetts 
General Hospital and Harvard Medical School, Boston. MA 
The utility of left ventricular (LV) dP/dt has been limited by the 
need for micromanometer tipped catheters. We compared LV 
pressure waveforms and dP/dt from a micromanometer tipped 
catheter (M) with both a standard fluid filled catheter (F) and the 
same fluid filled catheter in parallel with a disposable damping 
element (Resonance OverShoot Eliminator. Viggo-Speclramed, R) in 
10 patients undergoing diagnostic left heart catheterization. R LV 
waveforms were more similar to M LV waveforms than were F LV 
waveforms (mean RMS difference 2.3 vs. 5.1 mmHg, p=.0002). 
Peak positive and negative R dP/dt were closer to M dP/dt values 
than were F dP/dt values (means in mmHg/sec, p<.OOOOS): 
F R M 
+dP/dt 1845 1275 1274 
-dP/dt 2085 1454 1370 
Linear regression analysis predicted that at the mean values listed, 
peak positive R dP/dt exceeds M dP/dt by 1 % (95% confidence 
bounds: -13% to +14%) and peak negative R dP/dt exceeds M dP/dt 
by 7% (95% confidence bounds -10% to +25%). 
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Conclusion: R dP/dt is a good approximation of M dP/dt and may be 
a practical substitute for certain applications. 
945·59 
Variation. In Right Atrial Pre.sure Waveforme 
During Inspiration: a Prospective Analyele of 235 
Patient •• 
Louis I. Heller, Bonnie H. Weiner. Peter S. Cohn, Michael N. Jolie. 
University of Massachusetts, Worcester MA. 
During normal inspiration (I), intrathoracic pressure decreases 
resulting in a corresponding decrease in mean right atrial 
pressure (RAP) and internal jugular venous pressure (IJP). To 
better understand this phenomenon, we prospectively studied 235 
consecutive patients referred for right heart catheterization. RAP 
was recorded (mean and phasic) during quiet respiration for 5 -
10 respiratory cycles. In 222 (94.5%) patients, the mean RAP 
during I decreased physiologically. Mean RAP remained flat in 12 
(5.1%) patients, and paradoxically increased in 1 (0.4%) 
patient Further analysis of the 222 patients demonstrating a 
decrease in mean RAP during I revealed 2 patterns. In 144 
(65.5%) patients the height of both the A and V waves decreased 
with I (Type 1). However in 78 (34.5%) of these patients the A 
and V waves did not decrease during I and the fall in mean RAP was 
due to a decrease in the troughs following the x and y descents 
(Type 2). Chi square analysis revealed a significant association 
between Type 2 response and the presence of right heart failure, 
left heart failure. and pulmonary hypertension (p<O.Ol). There 
was no significant association between the RAP type and the 
presence of valvular heart disease, prior cardiac surgery or 
coronary artery disease. This is the first study to demonstrate that 
there are 2 characteristic forms of mean RAP decrease during 
inspiration. Oespne a decrease in mean RAP. IJP may become 
more obvious during I when the height of the A and V waves do not 
fall: care should therefore be exercised at the bedside so as not to 
mistake Type 2 response with Kussmaul's sign. 
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945·60 
Ventricular Shape and Orthogonal Wall Stress Adaptations During the First 
Year Aller Anterior Wall Myocardial Infarction 
Nai H. Shu, Ken Hirose, 1 udd E. Reed, Bernard 1. Gersh, Thomas Behrcnbeck, 
John A. Rumberger, Mayo Clinic, Rochester, MN 
Prior studies have suggested that following anterior MI, as the LV chamber 
dilates (remodels), LV wall stresses increase. Concomitant with this, the LV 
assumes a more spherical shape; this appears to be progressive, at least during 
the first year. It has been speculated, in the absence of CHF, that the observed 
changes in overall LV shape after anterior MI represent an adaptive mechanism 
which facilitates normalization of LV wall stresses. However, characterization 
ofthe adaptive changes in LV orthogonal wall stresses (circumferential ["J and 
meridional [am]) and LV shape following anterior wall MI has not been clearly 
established. To address this issue serial Cine CT scans (hospital discharge (d/c), 
6-weeks, 6-months, 1-year) were analyzed in 14 patients following an index 
anterior MI. No patient had CHF or was taking ACE inhibitors during the 1-
year follow up. Global LV volumes, long·axis cavity length, and mid-LV short 
axis tomographic chamber volumes and muscle mass were quantified in all 
studies. A sphericity index (SI) was determined as the ratio of absolute LV end•
diastolic volume to the volume of a sphere with a diameter equal to the long-axis 
length. SJlatiaily averaged, mid-LV peak systolic orthogonal wall stresses ("m'"c' 
dynes/cm2) were estimated based upon local geometry (cavity volume, muscle 
mass, cavity length) and simultaneous peak cuff arterial pressure. Results are 
mean±SD; "=p<.05 vs. d/c, .=p< .05 vs. 6-weeks; repeated measures ANOVA. 















"m/"c O.44±.02 0.46±.01" O.46±.02" O.46±.02" 
Conclusions: SI and mid-LV mean meridional and circumferential wall stresses 
increase significantly during the first year after anterior MI; however, the ratio, 
"m/"c' remains relatively fIXed, especially after the first 6-weeks. Thus, changes 
ia LV shape after anterior MI, whereupon it becomes progressively more 
spherical, do not normalize "m and "c but may be a mechanism by which their 
relative ratio to one another remains unchanged during post-Ml LV remodeling. 
945·61 
Interstudy VarIability of Blood Flow and Coronary Flow 
Reserve Measurements UsIng PET and [N·13]Ammonla_ . 
Otto Muzik, Steve Sawada, Rob S. Beanlands, Edwin Wolfe, Gary D. 
Hutchins and Markus Schwaiger. The University of Michigan, Ann Arbor, MI. 
To study the reproducibility of [N-13)ammonia PET studies for the 
noninvasive quantification of myocardial flow and coronary flow reserve 
(CFR), we performed dynamic PET measurements in 6 patients wHh CAD 
(57±13yr) and in 6 age-matched normals at rest and after pharmacological 
vasodilation. All subjects returned for a follow-up resUstress study 
approximately 2 months later (2.2±0.3). There was no Change in clinical 
condition or medication In any of the subjects. Dynamic tissue and blood 
activity curves were obtained from short-axis images using a semi•
automated sampling routine which Includes a correction for patient motion. 
A standard three-compartment model was used to derive absolute regional 
flow estimates in 5 anatomical regions of the myocardium (LAT, SEP, ANT, 
INF and APX). Interobserver variability of flow measurements was tested for 
baseline studies (N=12) yielding a r-value of 0.96 with a variation of less 
than 10% for both rest and stress studies. The resuHs of serial PET flow 
measurements (mVl00gfmin) in 10 patients are shown below: 









(r) CFR (r) 
2.8 ±1.4 
(0.54) 2.8 ±1.6 (0.64) 
Regional flow measurements in 5 patients with CAD were highly 
reproducible with a r-value of 0.81 for rest, 0.90 for stress and 0.91 for CFR. 
Thus, regional myocardial blood flow can be quantified with low 
interobserver variability using a standardized analysis approach. The good 
reproducibility of flow measurements in patients with CAD indicates the 
unique feasibility of PET in combination wHh [N-13)ammonia to 
quantitatively assess regional progression or regression of coronary artery 
disease as well as the acute and chronic drug effects on coronary blood 
flow. 
946 Ventricular Arrhythmias 
Wednesday, March 17, 1993 
3:00 PM-5:00 PM 
Anaheim Convention Center 
HallD 
Presentation Hour: 4:00 PM-5:00 PM 
946·81 
ABSTRACTS 
Outcome of Patients Undergoing Subendocardial Resection 
Who Are "Mapped" Versus "Nonmapped" 
Sunil Nath. David E. Haines, Michael I. Barber, Irving L. Kron, 
Iohn P. DiMarco. University of Virginia, Charlottesville, VA 
403A 
In prior studies, 20-40% of patients undergoing subendocardial resection (SER) 
for sustained ventricular tachycardia (VT) could not be mapped intraoperatively 
because the VT was noninducible following the ventriculotomy. The manage•
ment of such patients has been controversial, and their long-term survival and 
functionat outcome has not been well characterl%Cd. A total of 113 patients with 
prior myocardial infarction underwent SER for VT over a 9-year period at our 
institution. Preoperative catheter mapping was not performed. A map-guided 
sequential SER and cryoablation was used in tbe 85 patients (75%) who had 
inducible VT (mapped) following the ventriculotomy, and a visually-guided 
extended SER only was used in the 28 patients (25%) who had no inducible VT 
(nonmapped). There were no significant differences between mapped and 
nonmapped patients in age (60 years vs 64 years). ejection fraction (31 % vs 
34%), % of patients taking amiodarone preoperatively (14% vs 14%), or 
myocardial infarction within 60 days prior to surgery (40% vs 53%). 
RESULTS: Outcome after surgery in both groups is shown below: 
Mapped Nonmapped 
(n-85) (n=28) 
VT at post-operative EP study 
or clinical VT II (14%) 
Operative mortality (30 day) 8 (9%). 
Total mortality (2 yr) 24 (30%) 
Sudden death mortality (2 yr) 4 (7%) 
Heart failure mortality (2 yr) 10 (15%) 
NYHA functional class 1/11 (2 yr) 29 (47%) 








CONCLUSION: Patients who arc nonmapped and undergo a visually-guided 
extended SER have a similar long-term survlvat and functional outcome compared 
to patients who are mapped and undergo a map-guided sequential SER. 
Intraoperative VT noninducibility does not preclude a favorable long-term result 
if a visually-guided extended SER technique is used. 
946·82 
Surface Electrocardiographic Localization of Right Ventricular 
Outflow Tract Tachycardia 
Randall J. Lee, Michael A. Kwasman, Harlan R. Grogin, Dwain Coggins, 
Melvin M. Scheinman, Michael D. Lesh. University of CaIWornia, San 
Francisco, San Fmncisco, CA 
Radiofreq uency (RF) catheter ablation is an effective treatment for right 
ventricular outflow tract (RVOn ventricular tachycardia (VT). 
Endocardial activation mapping and pace-mapping have been used to 
localize the VT focus. We studied 10 patients with successful RF 
ablation of their RVOT VT to determine the utility of the surface 
electrocardiogram (EKG) in localizing the VT focus. Pace-mapping at 
successful sites of RF ablation and baseline VT EKG's were assessed 
for precordial ORS transftion (first precordial lead with R>S) and limb 
lead morphology. The anatomic position of the successful RF ablation 
site was determined fluoroscopically in the RAO and LAO views. 
Anatomical areas were defined as either septal or lateral, and either 







Precordial Transition Lead (mean ± semI 
3.1±O.2 (N=6) 
4.3±O.2 (N=4) p<.005 
Lead AVL ORS Complex 
Positive(1/1) 
Negative (9/9) 
The other limb leads offered no additional 
value in localizing the focus. 
CONCLUSIONS: 1) The 12 lead EKG of the RVOT VT is useful in 
localizing its orgin. 2) The transition in the precordial leads helps 
determine whether the VT focus is at the level of the pulmonic valve 
versus lower at the level of the His. The earlier the transition in the 
precordial leads implies a more superior focus. 3) Lead AVL is helpful 
in determining whether the VT focus is septal versus lateral. 
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946·83 
Relationship Between Widening of Intracardiac 
Electrograms and Abnormality of TI·10l Myocardial 
Scintigraphy in Patients With Verapamil Sensitive 
Idiopathic Ventricular Tachycardia 
Kikuya Uno, Tohru Ohe, Shiro Kamakura, Naohiko Aihara, 
Takashi Kurita, Wataru Shimizu, Katsuro Shimomura, National 
Cardiovascular Center, Osaka, Japan 
To clarify the relationship between of intracardiac electrograms 
(EGs) and localized myocardial abnonnalities, electrophysiologic 
studies and Tl-201 myocardial scintigraphy (TI SPECT) were 
perfonned in 16 patients (pts) with verapamil sensitive idiopathic 
left ventricular tachycardia (VT). The origin of VT was determined 
by the earliest site of ventricular activation during VT. Endocardial 
mappings during sinus rhythm were recorded at 5 to 12 sites of LV 
including the sites of VT origins in all pts. A fragmented 
electrogram (frag EG) was defined as an electrogram lasting 100 
msec or longer, and a widening electrogram (wide EO) 70 msec or 
longer but less than lOOmsec. The representative planes of Tl 
SPECT images (short, long and transaxial) were devided into 22 
segments. The grade of hypoperfusion in each segment was 
classified and the focal hypoperfusion of each segment was 
evaluated semiquantitatively. Frag EGs were recorded in none of 
the pts. Twelve pts (75%) showed wide EGs. The VT origin 
showed wide EG in 10 of 12 pts (83%). Fourteen pts (88%) 
showed focal hyP?perfusion in Tl SPECT. The VT origin showed 
hypoperfusion m 13 of 14 pts (93%). The wide EGs corresponded 
to the hypoperfusion sites of Tl SPECT in 10 of 13 Pts (77%). 
In conclusion, 1) "Widening" electrograms are recorded in 
majority of patients with verapamil sensitive idiopathic ventricular 
tachycardia. 2) "Widening" electrograms are closely related to 
myocardial abnonnalities in Tl SPECT. 
946·84 
Localization of Early Ventricular Depolarization 
by Magnetocardiogram in Patients with WPW 
Syndrome and Ventricular Tachycardia 
Masahiro Nomura, Yutaka Nakaya, Ken Saito, 
Itsuro Tamura"', Masao Wada"', Satoshi Fujita"', Tsutomu Takae*, 
The University of Tokus him a, Tokushima and "'Osaka Gas Co. Ltd. 
Osaka. Japan 
The magnetocardiogram (MeG) is a newly-developed method to 
localize cardiac current source. To test the clinical accuracy in 
localizing the site of early ventricular depolarization by multichannel 
(7-channel) biomagnetic measuring system, the MCGs of 14 patients 
with WPW syndrome (WPW group) and 10 patients with ventricular 
tachycardia (VT group) were recorded in a rf-shielded room. The 
locations of early ventricular depolarization site were classified by 
body surface isopotential map and electrophysiological studies. 
Accessory pathways of WPW group were located at left free wall in 
11 patients and at right free wall in 3. Origin of VT were: right 
outflow tract 5, left apex 2, left posterior wall I, right apex 1. right 
anterior wall 1. The three-dimensional dipole locations (single 
moving dipole) were computed every 2 msec from the onset of the 
QRS waves by the least square method. These three-dimensional 
dipole locations were projected onto gated Magnetic Resonance 
Image in order to visualize the propagation of the calculated source in 
the ventricle. These results were compared to those obtained by body 
surface isopotential map. The deduced dipoles during early 
depolarization phase (up to 20msec) moved around 1-2cm in the 
ventricle. In 12 cases ofWPW group (86%) and 9 cases ofVT group 
(90%). the location of deduced current dipole at 20msec were in 
good agreement with the location of accessory pathway and origin of 
VT estimated by the body surface isopotential, cardiac surface 
mappings and electrophysiological studies. 
Conclusion: The MCG could detennine precisely three-dimensional 
location of current source non-invasively and might help treatment by 
catheter ablation in WPW syndrome and VT patients. 
946·85 
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Analysis of the degree of QRS fusion necessary for Its visual detection. 
Importance for the recognition of transient entrainment 
Jose Ormaetxe. Jesus Almendral. Agustin Pastor. JuliAn Villacastrn. 
Jesus Martlnez·Alday. TomAs Etxeberrla. Angel Arenal. Juan L. Delc4n. 
Hospnal G. Gregorio MaraMn. Madrid. Spain. 
Evidence for the reentrant nature of a tachycardia frequently requires the 
observation of transient entrainment (TE) during pacing. Fixed fUSion (F) 
is the hallmarl< for the demonstration of TE. The recognnion of F on the 
surface ECG is limned by the amount of myocardium to be depolarized in 
a different fashion and by the extend of the modnications on the ECG 
necessary to be recognized by the human eye. To study these factors. a 
·model" of fusion was created by the Introduction during a paced rhythm 
at ventricular site (VS) A. of late prematute impulses at a VS B 
immediately preceding the local electrogram at site B. but with a variable 
degree of prematurity. The minimum percentage of F for each QRS 
complex was established considering 100% F n both stimulation artnacts 
ocaJrred simuHaneously (completely fused ORS) and 0% F if the artifact 
at the second VS was simuHaneous with the local electrogram at that sne. 
We analyzed 352 ORS complexes in a blind manner in 20 patients. 
pacing at the right ventricular apex (RVA). outflow tract (OT) and left 
ventricle (LV) in a variety of configurations. 
V S % fUSion 0-10 10·20 20·30 30-40 >40 
RVAlOT % detect 25 33 66 78 100 
OT/RVA % detect 33 37 84 85 100 
RV AIL V % detect 25 18 25 93 83 
LV/RVA % detect 20 87 73 100 100 
TOTAL % detect 26 50 75 90 95 
ORS with %F up to 20% were better recognized when VS A was the LV 
than when it was a RV site (22 vs 56%. j)<.05). 
Conclusions: 1. Accurate detection of ventricular fusion can only be 
accomplished when more than 30% of the ORS is fused. 2. Minor 
degrees of ORS fUSion can easily be overlooked. MuHlpie pacing Sites 
andlor analysis of intracardiac electrograms may frequently be necessary 
for the recognition of TE. 3. F may be more difficult to recognize in 
ventricular tachycardia of RVorigin. 
946·86 
Blood Pressure Recovery During Initiation of Tacbycardia 
Jeffrey Goldberger. Jane Kruse. Frederick Ehlert. Roger Damle. Alan Kadish. 
Nonbwestem University Medical School. Chicago. Illinois. 
In order to evaluate the detenninants of blood pressure (BP) recovery during onset 
of taChycardia (T). we recorded mean BP following initiation of ventricular (VT•
squares; 1>=11. 8 males. age 56±17 yrs. ejection fraction 4O±21 'lb. 6 with CAD. 1 
with valvular disease. I with hypertrophic cardiomyopathy. and 3 with no 
structural bean disease) or supraventricular (SVT -diamonds; 1>=12. 9 males. age 
40±21 yrs. all nonnal ejection fractions) tachycardia for a 30 second period. 
sampled every 5 seconds. Following tennination of T. pacing was initiated from 
the right ventricular apex (R V A·circles) and subsequently the right ventricular 
outflow tract (RVOT-triangles) at the taChycardia cycle length for 30 seconds and 
BP was recorded. A linear regression model with repeated measures using Tulcey's 
adjustment was used to evaluate the effects of time and clinical variables (cycle 
length. bundle branch morphology. axis, and ejection fraction) on BP recovery. 
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RVA and RVOT pacing led to lower BP than VT (p<O.OOI). The rate of BP rise 
during VT was 0.37 mmHg/min versus 0.65 mmHg/min for SVT (p=O.OOI7). The 
rate of BP rise during RVA and RVOT pacing in pts with SVT did not differ from 
that during SVT. The rate of BP rise during RVA and RVOT pacing in pts with 
VT did not differ from that during VT. Only ejection fraction was (positively) 
correlated with rate of BP rise during VT (p<O.OOOI). Conclusions: I) BP 
recovery at the onset of tachycardia is dependent on ejection fraction and is 
independent of cycle lengm, tachycardia type (VT versus SVl) or ventricular site 
of origin of tachycardia 2) RV A and RVOT pacing tachycardias are associated 
with lower BP than VT, perhaps due to their right ventricular origin. 
JACC Vol. 21, No.2 
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946·87 
Value of the Clinical Hi.tory in Differentiating 
Vasodepressor Syncope fro. Syncope due to Ventricular 
Tachycardia or Heart Block 
Hugh Calkins, Yu Shyr, Howard Frumin, Anthony Schork, and 
Fred Morady University of Michigan Medical Center, Ann 
Arbor Michigan 
The purpose of this study was to determine if the 
clinical history i8 of value in differentiating three of 
the more common types of syncope: vasodepressor syncope, 
syncope due to atrioventricular block (AV block), and 
syncope due to ventricular tachycardia. Eighty patients 
who presented for evaluation of syncope and in whom a 
diagnosis of vasodepressor syncope (32 ptS) , ventricular 
tachycardia (32 pts) , or AV block (16 pts) was 
established based on the rhythm recorded during the event 
and following diagnostic testing participated in this 
study (51M, 29F, 58tl7 years). Each patient was 
interviewed using a standard questionaire designed to 
identify precipitating factors, and to identify and 
quantitate prodromal and recovery symptoms. A stepwise 
logistic regression analysis was used to identify which 
of the 20 signs and/or symptoms were most predictive of 
the cause of syncope. Results: The clinical history of 
patients with syncope due to ventricular tachycardia 
could not be differentiated statistically from that of 
patients with syncope due to AV block. The presence of 
post syncopal fatigue and diaphoresis prior to or 
following syncope were the two factors which best 
differentiated syncope due to AV block or ventricular 
tachycardia from vasodepressor syncope (84\ sensitivity, 
100\ specificity). Addition of the patients age and sex 
to this model increased the sensitivity of detecting 
syncope due to ventricular tachycardia or AV block to 
97\. Conclusions. The results of this study demonstrate 
that vasodepressor syncope can be differentiated from 
syncope due to AV block or ventricular tachycardia based 
on the patients clinical history. However, no clinical 
variable clearly distinguishes sync,ope due to ventricular 
tachycardia that due to AV block. 
946·88 
Magnetocardiographic Mapping of Patients with 
Ventricular Tachycardia (VT) or Ventricular 
Fibrillation (V F) and healthy volunteers 
lars Hennig, Michael Oef!, Martin Burghoff*, Roger 
Zimmermann", Rahul Agrawal, Rolf Schroder. 
Dept. of Cardiology, Klinikum Steglitz, Free University of 
Berlin; " Physikalisch Technische Bundesanstalt (PTB) 
Institut Berlin, Germany 
13 patients with history of sustained VT or VF and positive 
electrophysiological stimulation (inducible VT or VF) were 
included. In the control group 16 volunteers had no patho· 
logical findings in 24h-Holtermonitoring, echocardiography 
and stress-test. Electrocardiographic (Frank leads) and 
magnetocardiographic (36 channel system) potentials were 
measured synchronically in the Berliner magnetic shielded 
room (BMSR) with a Superconducting Quantum Interference 
Device (SQUID). The magnetocardiogram (MCG) records 
the magnetic field of the heart locally, which is produced by 
the current flow and is not disturbed by volume conductor 
effects. 
The control group showed no pathological findings 
regarding late potentials or the magnetic fields. 10 of 13 
VTNF patients showed late potentials (Simpson criteria), but 
in all of them changes in the magnetocardiographic mapping 
were detected. All these pathological variations can be 
allocated to certain defined channels, whereby a localisation 
of the origin of VTNF may be possible in the future. 
Conclusion: Magnetocardiographic mapping showed 
localized pathological findings in all high-risk patients with 




Mechanism of Ventricular Tachycardia Termination USinglntracoronary 
and Epicardial Ethanol Administration in the Post-Infarction Canine Heart 
John M. Fontaine, Mahlet Alula and Ajay Garg, Medical College 
Hospitals, Main Clinical Campus of the Medical College of Pennsylvania, 
Philadelphia, Pennsylvania 
Selective intracoronary (lC) ethanol (Etoh) administration has been 
utilized to treat refractory ventricular tachycardia (VT) in post-myocardial 
infarction patients with variable success. However, the mechanism of 
VT termination or arrhythmogenicity of IC Etoh is unknown. To address 
these issues, epicardial (E) activation maps (ART, mapping system) were 
performed during sinus rhythm (SR) and VT; and the VT mechanism 
analyzed in 11 mongrel dogs, 3 days post left anterior descending (LAD) 
artery ligation. The LAD was canulated using a 6F angiographic catheter 
and programmed ventricular stimulation was performed using standard 
extrastimulus technique. A custom-designed jacket with 108 bipolar 
electrode pairs with 2 mm interelectrode spacing was used. Etoh was 
administered during 3 studies. All induced VT during the baseline period 
was reentrant, demonstrated a figure 8 activation pattern and initiated 
in the border zone of the infarction. E application of Etoh to the border 
zone resulted in no significant delay in the total E activation time during 
SR but resulted in delay in activation at that site. Reentrant VT was not 
inducible in the peri-infarction border zone however in one dog a non•
reentrant VT could be induced at a distal site. IC Etoh produced global 
conduction delay during SR which prolonged the total E activation time 
(57 ms to 110 ms). In one dog a new reentrant VT was induced along 
a new border zone where E Etoh was administered. At the onset of VT 
an arc of functional conduction block along the border zone was noted, 
for the initiating beat, which was abolished after IC and E Etoh 
application. Induction of new VT was associated with a new arc of 
block. Conclusion: (1) Etoh prevents reentrant VT by modifying 
conduction along the border zone, (2) IC Etoh exerts a greater effect on 
total E activation than local E application, (3) Etoh modification of 
conduction along the border zone may produce a new reentrant circuit 
and (4) Histopathologic evaluation will be needed to study the direct 
toxic effect of Etoh on the heart. 
946·90 
Intra-Patient Variability in the Initiation of Ventricular Tachycardia 
By Analysis of Stored Ventricular Electrograms 
Marc Roelke, Hasan Garan, 8rian A. McGovern, Jeremy N. Ruskin. 
Massachusetts General Hospital, Boston, MA. 
The availability of implantable cardioverter-defibrillators 
(lCDs) capable of storing intracardiac ventricular electrograms provides 
the opportunity to analyze the characteristics of the initiation of 
ventricular tachycardia (VT) in an individual patient. 
We reviewed stored intracardiac ventricular electrograms (lCEG) 
from 61 patients with the Ventritex Cadence<l> lCD, programmed to store 
up to three 30 second recordings of ICEGs during an arrhythmic event. We 
included patients with 3 or more recordings containing VT episodes 
preceded by at least 10 beats and followed by at least 5 beats. VT was 
defined as a sudden change in the rate and ICEG morphology with a 
regular cycle length. A total of 73 episodes in 15 patients were reviewed 
(mean 4.9 events, range 3-10 episodes/patient). All patients had 
underlying coronary artery disease and a history of sustained 
monomorphic VT. For each patient, the number of premature 
depolarizations (PO) initiating VT and the morphology of the PO was 
compared to the ensuing VT. 
TIle initiation of VT was marked by single PDs in 36/73, by pairs 
in 9/73, and multiple PDs in 28/73 episodes. The morphology of single 
PDs was the same as that of the ensuing VT in 32/36 episodes. For pair 
and multiple (>=3) PDs, the morphology of one or more of the PDs was 
similar to VT in 20/37 episodes. The s.lmc number of PDs preceded VT for 
a given patient 67 to 100% of the time (mean 73%). A specific electrogram 
morphology (same or different as VT) preceded VT 57 to 100% of the time 
(mean 81%). 
We conclude that for an individual patient there is constancy in 
both the number and type of PDs which precede VT. 
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947-1 
Diastolic Flow Correlates of Optimum Atrloye.trlcular Delay (AVD) I. 
Subjects With Dual Cbulber Pacemaken 
Ramdas G Pli. Roy V Jutzy. Linda Feenstra, Alan Jacobson. Paul A 
Levine. VA Hospital and Loma Linda University, Loma Linda. CA. 
In patients with dual chamber pacemakers. the stroke volume 
depends upon on the programmed AVO and the optimum A VD is 
variable and is influenced by heart rate. Diastolic LV filling (DFP) 
consists of periods of passive filling. diastasis and atrial systole and 
theoretically. left ventricular (LV) filling may be optimized by 
strategically placing the atrial contraction during diastOle. economically 
using the DFP which in turn influences the stroke volume through 
Starling mechanism. This study was undertaken to characterize the 
optimum timing of atrial systole in terms of LV diastolic flow pattern. 
We studied 7 patients with dual chamber pacemakers and recorded 
echocardiograms with Doppler recordings from the mitral valve and LV 
outflow tract at A VD of 25 to 250 ms at 25 ms intervals at a heart rate of 
6O/mt or closest to this rate as possible. At each stage stroke volume was 
calculated to determine the optimum AVO which varied from 75 to 175 
ms (mean;tSd-132±31 ms). At optimum AVD, both the E and A waves of 
the transmitraI flow were partially fused eliminating diastasis with a 
fusion velocity of 27±14 cm/s which was 47±20% of the peak E wave 
velocity and 33±12% of peak A wave velocity. The stroke volume was 
lower when the E and A waves were not fused at shorter A VD despite 
longer DFP or fully fused at longer AVO which also shortened DFP. At 
optimum AVD the E/A ratio was 0.74±O.15 reflecting slight atrial 
predominance of LV filling. The optimum timing of atrial contraction 
was better defined in terms of interval between the onset of the A wave 
and LV ejection (LA-LV interval). The optimum LA-LV interval was 
18S±22 ms with a smaller coefficient of variation than optimum AVO. 
CONCLUSION: The optimum timing of atrial systole is better defined in 
terms of LA-LV interval and degree of fusion of E and A waves which 
reflects economic use of diastolic flow period for maximum LV filling. 
947-2 
Beta-blockers Modify T Wave Morphology in Long OT Syndrome. 
l.i...Z!!ruuL Katherine Timothy, Jolene Fox, G. Michael Vincent. 
Departments of Medicine, LOS Hospital/University of Utah Health 
Sciences Center, Salt Lake City, Utah. 
T wave changes and ventricular tachycardia (VT) occur in LOTS 
patients during exercise. Since beta-blockers suppress VT in LOTS, 
we examined the hypothesis that beta-blockers also modify T 
changes during exercise. 
Methods: ECGs on 8 LOTS and 6 
normal controls (N L) during bicycle 
exercise (EX) before and after IV 
infusion of Esmolol (Esm) were 
evaluated for T wave morphology, Talb 
ratio (diagram) and OTc. Talb and OTc 
during Esm were compared to those 
without using Pearson's correlation. 
Bm!!tt: At rest excercise 
baseline 9' IS' 
LQTS TeA 1.49±.34 1.19±.3S 1.00±.28 
mean (1.90±.341' (t.7S±.371 (1.60±.381 
± SO QT .51 ±.06 .53±.06 .SS±.06 
(.49±.051 (.49±.031 ('49±.041 
NL Tall 1.54±.21 1.27 ±.22 1.06±.19 
mean (1.S6±.ISI (1.31 ±.221 (1.10±.201 
± SO QT .42±.02 .41 ±.01 .41 ±.02 
(.42±.011 (.42±.021 (.42±.011 
arentheses mllicate valueS on Esmolol. 
recovery 
S' F P 
1.44±.24 235.44 <.0005 
(1.92±.361 
.S3±.05 7.69 <.001 
(.48±.031 
1.48 ±.20 6.5 <.0025 
(1.53 ±.171 
.42±.01 2.09 <.25 
(.42±.021 
During EX 6/8 LOTS and 0/6 NL had notchedlbifid T waves, 
abolished or reduced by Esm in 5/6 LOTS. 
Conclusions: Esm reduced terminal T enlargement (tTalb) and 
notchedlbifid T of LOTS. These changes are visible on ECG and 
may be markers of therapeutic efficacy. The similar unmedicated 
Talb of LOTS and NL indicates reduction of T down slope is not the 
cause of t OTc, and suggests afterdepolarizations with the same 
phase 3 slope as normal action potential as the cause. 
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Increased PAI-1 Activity in Patients With an 
Implanted Pacemaker Is Not Suppressed by 
Low Dose Aspirin 
Haruhiko Abe, Kazuo Takahara, Yasuhide Nakashima, 
Akio Kuroiwa. The 2nd Dept. of Internal Medicine, University 
of Occupational and Environmental Health, Japan 
To clarify the activity states of coagulation and fibrinolysis in 
patients with a permanent pacemaker, we studied 30 pati•
ents more than 4 month after operation. They were divided 
into a single pacemaker lead group (8, n=14) and a double 
lead group (0, n= 16). Prothrombin time, activated partial 
thromboplastin time, fibrinogen, antithrombin III, d-dimer, 
tissue-type plasminogen activator (t-PA) activity, plasmin•
ogen activator inhibitor type-1 (PAI-1) activity and platelet 
aggregation were measured and compared to those in an 
age-matched control group (C, n=7). The effects of low dose 
aspirin (81 mg/day) in the patients (n=15) were also studied 
2 weeks after administration. PAI-1 activity in groups 8 and 
o was significantly higher than that in the group C (53.5± 
36.5, 86.8±59.2 ng/ml vs. 19.4±7.2 ng/ml ; both P < 0.05). 
Platelet aggregation induced by collagen was slightly higher 
in groups 8 and 0 than group C. Other parameters were 
not significantly different. In the patients, low dose aspirin 
significantly suppressed collagen induced platelet aggrega•
tion (71.8±20.3% vs. 41.7±28.3 %; P < 0.005), but not PAI-
1 activity. t-PA activity was increased significantly by the low 
dose aspirin administration (3.94±1.85 nglml vs. 2.48±1.19 
ng/ml; P < 0.005). Thus, PAI-1 activity in patients with a per•
manent pacemaker is elevated, and the activity is not suppr•
essed by low dose aspirin unlike the platelet aggregation. 
947-4 
Nuclear Pacemaker : Long Term Clinical Results. 
A Follow-up Study of 325 Patients . 
Christophe Chauvel, *Thomas Lavergne, *Pierre Ducimetiere, 
Ariel Cohen, *Jacques Ollitrault, Jean "alty, *Louis Guize, * 
Broussais and Saint-Antoine University Hospitals, Paris, France. 
Radioisotopes have been proposed as a power source for 
pacemaker (PM) generators, because their longevity could avoid 
frequent generator replacements. Despite more than 3000 
implantations, few large series have been published about these 
devices. In order to assess the long term reliability and safety of a 
nuclear PM, we analyzed the follow-up of 325 patients implanted 
in our institution between 1970 and 1982 with a VVI nuclear 
generator (Medtronic 9000/9090), attached to epicardial leads. 
The popUlation involved 188 men and 137 women with a mean age 
of 39 ± 18 years (range 2 to 70). Eighty four percent of patients 
were implanted for various degree of A V block, 15% for sinus•
node dysfunction and 1 % for other indications. Two hundred and 
five (63%) patients were free of underlying cardiac disease. 
The mean follow-up duration was 12 ± 4 years (range 10 days to 
19 years). The actuarial survival of patient~ at 5, 10 and 19 years 
was 93%, 87% and 68% respectively. 
Complications related to the stimulation were observed in 115 
patients (26%) and required 122 reoperations. Lead dysfunction 
accounted for 82 (67%) of these reoperations, generator failure for 
11 (9%), and other causes for 29 (24%). The actuarial survival of 
leads at 19 years was 54%. Most of lead dysfunction occured after 
15 years of stimulation. No clinical complication related to the 
nuclear source was observed. 
In conclusion, this nuclear generator is safe and reliable in long•
term cardiac stimulation. In our popUlation, complications occured 
in 26% of patients, primarily related to lead dysfunction. 
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947-5 
Usefulness of the Valsalva Maneuver to Predict Atrial 
Sensitivity in Unipolar and Bipolar Pacemakers 
Dong-Wei Gao, Chu-Pak Lau, Yau-Ting Tai, Man-Oi Tang. 
Division of Cardiology, Department of Medicine, University of 
Hong Kong, Queen Mary Hospital, Hong Kong 
The variations of endocardial P wave amplitude (PWA) during 
daily activities were investigated in 12 patients with implanted 
bipolar pacemakers. The mean of 6 consecutive telemetered PWA 
in the unipolar (Uni) and bipolar (Bi) modes were compared: 
Mean PWA (in mY) Variations during Daily Activities 
Sitting Lying Standing Coughing Exercise 
Uni 3.31±1.43 3.55±1.l3 3.27±1.35 3.3o±1.26 3.42±1.43 
Bi 4.00±1.66 4.00±1.32 4.06±1.47 3.9O±1.40 4.11±1.36 
There is no significant difference between the changes in PWA in 
either Uni or Bi sensing during these activities (ANOV A), but a 
superior PW A was seen with Bi versus Uni during each activity 
(p < 0.01). The Valsalva maneuver was performed with an airway 
pressure of 40mmHg for l5s. PWA during the strain phase (Uni = 
4.14 ± 1.34mV, Bi = 4.46 ± 1.36mV, p < 0.01) were higher 
compared to those during sitting, but these (Uni = 3.13 ± 1.56mV, 
Bi = 3.55 ± 1.33m V) were reduced abruptly during the relaxation 
phase. This resulted in failure of P wave sensing in 2 patients 
whose pacemakers were programmed with two times sensitivity 
safety margin. 
Conclusion: Mean PW A varies substantially during daily activities. 
The Val salva maneuver resulted in the maximal changes in PWA 
and is a simple method to assess the adequacy of atrial sensing. 
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Evaluation of the Extent of Infarcted Myocardium 
Measured by Gd-DTPA Enhanced MR Imaging 
Yoshiaki Harada, Tetsuya Ebizawa, Masaaki Hirano, Keizo 
Furukawa, Hiroyuki Matsui, Hiroki Sugihara, Masao Nakagawa. 
Saiseikai Hospital and Kyoto Prefectural University of Medicine, 
Kyoto, Japan 
This study was designed to evaluate the usefulness of MR imag•
ing (MRI) for quantitative assessment of infarcted myocardium in 
patients with acute myocardial infarction (AMI). Gd-enhanced MRI 
using 1.5 T superconducting system with electrocardiographic•
gated spin echo sequence was performed in 27 consecutive 
patients with AMI a mean of 5 ± 3 days (range 1 to 13) after 
infarction. Dual isotope SPECT with .... Tc-pyrophosphate (PYP) 
and ""TI-CI was also performed in those patients. In dual 
SPECT images, ali 27 patients had PYP accumulation in the 
area of infarcted myocardium. In MRI, the infarcted myocardium 
was diagnosed as increased Signal intensity area in Gd-enhanced 
images in ali but one patients. The location of increased signal 
intensity area was consistent with those of PYP accumulation 
area in ali patients. Among left ventricular short axis images 
in both methods, identical four slices from base to apex were 
chosen and circumferential angles of the corresponding infarcted 
area were measured as the extent of myocardial infarction, 
respectively. There was a good correlation between the circum•
ferential angles measured by MRI and those of PYP (n=104 
slices, r=0.89). Except poor correlation of basal slices (r=0.33). 
there were also good correlations in the other three slices 
(upper mid-ventricle; r=0.92, lower mid-ventricle; r=O.84, apex; 
r=0.98). In conclusion, we have accurately diagnosed the location 
and extent of infarcted myocardium by using Gd-enhanced MRI. 
MRI is a promising method for quantitative evaluation of myo•
cardial infarction size in situ. 
ABSTRACTS 407A 
948-110 
Dobutamine Stress Cine·MRI Versus :I01Thallium Rein•
jection SPECT Imaging for Detection of Residual Post•
infarction Myocardial Viability. 
Christoph A. Nienaber, Ted Rochau, Tushar Chatterjee, Volkmar 
Nicolas. Division of Cardiology, University Hospital Eppendorf, 
Hamburg, FRO. 
In the attempt to compare dobutamine (DOB)-enhanced systolic wall 
thickening (SWT) with myocardial Tl-201 uptake for the detection of 
residual viability in akinetic myocardial segments, 28 patients (57±9 
yrs; 24M, 4F) were subjected to TI-201 reinjection imaging (Rl 
SPECT), cine-MRl and coronary/LV angiography. Regional SWT 
>20% with incremental doses of DOB (5-20 JIg/kg/min) and TI-201 
uptake of >20% at quantitative Rl SPECT was indicative of viable tis•
sue in hibernation. Short axis slices of both DOB-cine-MRI and Tl-
20lRl SPECT were matched and analyzed by experienced observers 
blinded to all clinical data. 
Results: Baseline cine-MR Incremental DOB-cine-MRI 
noSWT SWT>20% noSWT 
20lTI Rl + 18 (37) 18* (37)* -
uptake - 10(251 4(8) 8 (18) 
Parantheses denote number of segments, *p.a>.o5; 
Conclusion: I) Lack of SWT at rest is not indicative of nonviable tis•
sue. 2) Both DOB-enhanced SWT and TI-20luptake at Rl are compat•
ible with residual viability in post-infarction patients. 3) DOB en•
hanced SWT on cine-MRI appears to be more sensitive for myocar•
dial viability than regional TI-201 uptake at Rl-SPECT. 
948-111 
Atrial Volumes and Fmptying Fractions Measured by Magnetic 
Resonance Imaging in Patients with Myocanlial Infarction 
Raad H Mohiaddin, M Hasegawa, Richard Underwood, Donald B 
Longmore. Royal Brompton Hospital, London UK 
Magnetic resonance imaging (MRI) was used to measure atrial 
volumes and emptying fractions in healthy volunteers and in patients 
with myocardial infarction. Fourteen healthy volunteers (age 
mean±SD, 47:t13) and 14 patients (age 56±9) with previous 
myocardial infarction (MI) were studied. All patients were in a sinus 
rhythm, had competent cardiac valves and had no heart failure. Atrial 
(LA, RA) and ventricular (LV, RV) volumes were measured from a 
set of transverse spin echo images acquired at end ventricular systole 
(ESV) and diastole (EDV). Ventricular ejection fraction (EF%) 
(EDV-ESV)/EDV X 100 and atrial emptying fraction (EF%) (ESV•
EDV)/ESV X 100 were calculated. The results (mean±SD) are 
tabulated below: 
BOV (ml) ESV (ml) EF% 
LA RA LA RA LA RA 
Norm 36±11 35±12 62±16 74±15 42±09 52±13 
MI 72±26 50±20 97±31 77±19 25±12 38±13 
LV RV LV RV LV RV 
Norm 124±23 129±34 48±14 45±14 62±08 65±07 
MI 158±65 121±26 82±52 45±17 52±12 64±10 
In patients with MI, LA EDV and ESV were significantly higher 
(p<O.OOl), and EF was significantly lower (p<O.OOl) than in the 
control group. These findings reflect the abnonnal systolic and 
diastolic function of the LV which contn'bute to atrial filling and 
emptying respectively. Changes in atrial and ventricular volumes can 
be measured non-invasively with MRI. We have established nonnal 
ranges and have demonstrated abnonnalities in patients with MI. 
408A ABSTRACTS 
948-112 
Left Ventrieular VolUllle Measurement After Acute Anterior Myocardial 
Infarction: Comparative Aa:uracy of Two-dimensional Ecbocardiography, 
Radionuclide VentricuJography and Magnetic Resouance Imaging. 
Krystyna H. Darasz, J. Bayliss, Jennifer Keepn, S.R. Underwood, P.A. Poole•
Wilson, a.c. Sutton. Hemel Hempstead & Hillingdon Hospitals, National Heart 
& Lung Institute, London, U.K. 
Left ventricular (LV) volume is an important determinant of prognosis after 
myocardial infarction and therefore IICClIIlICy of measurement is essential. LV end•
diastolic volume index (L VEDVI) and end-systolic volume index (L VESVI) were 
measured in 70 asymptomatic patients after a first Q wave anterior myocardial 
infarction, wilhin 12 days of infarction and again after six monlhs. Patients had no 
evidence ofheart failure or myocardial ischaemia. LV volumes were calculated by 
two-dimensional echocardioglllphy (2DE) using the modified Simpson formula, and 
from radionuclide ventriculography (&NV) using the counts-based method of Links, 
both with and without correction for attenuation of radioisotope. Magnetic 
resonance imaging (MRI) was used to calculate LV volume by summation of the 
areas of multiple contiguous transverse IOmm slices acquired at end-diastole and 
end-systole. 
Results: Analysing all volumes from the initial and follow-up studies, and 
comparing 20E and RNV with MRI, the mean differences (sd) between the 





+10.4 (16.8) -25.1 (23.8) 







Conclusions: In measuring LV volume after myocardial infarction, 20E shows the 
closest agreement with MRI although 20E consistently overestimates volume 
compared with MR!. With standard RNV using volumes corrected for attenuation 
of isotope, agreement with MR! is poor. This is due to the error in estimaJing LV 
depth. If volumes are calculated witheus correction for attenuation, agreement with 
MR! is improved but absolute RNV volumes are smaller. Results of nOD-invasive 
LV volume measurement depend on the method used and are not interchangeable. 
MRI produces the most reliable results but in the clinical setting, 20E compares 
well. 
948-113 
Right Ventricular Volume Estimation With Cine MRI, 
a Comparative Study Between Simpson's Method and 
a New Modified Area-Length Method In Humans 
Takashi Sawachika, Toshlro Miura, Kazuhiro Katayama, Michihiro Kohno, 
Takashi Fujii, Nobuaki Tanaka, TsulomJ Ryotile, Hisanori Sakai, 
Masunori Matsuzaki. 
Yamaguchi UniversHy School of Medicine. Ube, Japan 
To quantHate right ventricular(RV) volumes easily using Cine MRI, we 
developed a new method called "modRied area- length method". To 
validate this method, we compared H to Ihe conventional Simpson's 
method. Magnetom 1.5T(Siemens) was used and 7 normal volunteers and 
25 patients wHh various RV sizes were imaged wHh ECG triggered gradient 
echO method(FISP, TR50ms, TE12ms, slice thickness 10mm). For 
Simpson's method transverse images of 12 sequential views which covers 
whole heart were acquired. For the modRied area-length method, two 
orthogonal views were imaged; one was the sagittal view which inclUdes 
AV outflow tract and the other was the coronal view defined from the 
sagittal image to cover the whole AV. From these images the areas(As, 
Ac)of AV and the longest distance between AV apex and pulmonary 
valve(Lmax) were detennined. By correlating RV volumes measured by 
Simpson's method to As' AclLmax, the AV volume could be estimated as 
follows; 
V=0.8S'As'Ac/Lmax-16.3. The correlation between the RV volume by 
Sil1llson's(Y-axis)and the new method (X-axis) was Y=I.03X+0.14, 
(r=O.971). Thus the modified area-length method demonstrated excellent 
accuracy to quantijate RV volume and the acquisHion time abbreviated to 
one fifth COl1llared wHh Simpson's method. This should be a highly 
promising method for routine clinical applicatiOn. 
948·114 
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Quantification of Mitral Regurgitation Using Velocity Encoded Cine 
Magnetic Resonance Imaging 
Naoya Fujita, Iaakko Haniala, Elyse Foster, Anne F. Chazouilleres, 
Andre J. Duerinckx, Margaret O'Sullivan, Hajime Sakuma, Oary R. 
Caputo, Charles B. Higgins. University of California, San Francisco, CA 
The capability ofvelocity encoded cine magnetic resonance 
imaging(VEC-MRI) to measure the regurgitant volumes (ROy) in 
patient with mitral regurgitation was evaluated. Using a I.S Tesla 
supereonducting magnet with VEC-MRI and Doppler echocardiography, 
we srudied 11 pts with isolated mitral regurgitation and 11 nonnal 
subjects. VEC-MR images were acquired in the double oblique planes of 
the ascending aorta I em below the innominate artery and at the level of 
mitral annulus in short axis plane of the left ventricle, with velocity 
encoding with the direction of the flow. Two independent obselVers 
measured the ascending aortic flow volume and left ventricular inflow 
volume, calculating RGV, as left ventricular inflow - aortic flow, and 
regurgitant fraction (RF). Using accepted criteria of color flow Doppler 
imaging and spectral analysis, the severity of mitral regurgitation was 
qualitatively graded as mild, moderate and severe; and compared to 
regurgitant fraction as detennined by VEC-MRI. In nonnal volunteer RF 
was I.6±I.l'lb. In mild, moderate and severe mitral regurgitation, RFs 
were 4.5±2.6, 22.9±9.6, and 46.8±8.2% respectively_ RF correlated well 
c.aq. .... bdw_ RJI' by VEe.MRI 





wi th thc echocardiographic severity of 
mitral regurgitation. InterobselVcr 
reproducibility for RF was excellent 
(r=O.98, SEE=3.83). We conclude that 
VEC-MRI reproducibly measures RGV 
and RF in patients with mitral regurgita•
tion and may be useful for monitoring the 
cffect of therapy on mitral regurgitation 
and for follow-up of patient with mitral 
regurgitation. 
Post-surgical follow-up in thoracic aortic dissection: 
TraDSesophageal echocardiography or magnetic reso•
nance imaging? 
Christoph A. Nienaber, Karoline Rottig, Dietmar Koschyk. Volkmar 
Nicolas. University Hospital Eppendorf, Divisions of Cardiology and 
Radiology, Hamburg, Oennany 
Twenty-three patients after surgical repair of a dissecting aneurysm of 
the thoracic aorta by use of various operative techniques were fol•
lowed-up by a dual imaging approach for a median of 2,8 years. All 
patients undelWcnt both serial transesophageal echocardiography 
(TEE) and magnetic resonance imaging (MRI) once per follow-up 
year. TEE was perfonned using a monoplane 5,0 MHz phased anay 
transducer; MRI was conducted using a 1.5 T whole body scanner and 
acquisition of TI -weighted spin echo sequences in axial, coronal and 
sagittal orientation and optional ECO-gated cine-MRI for the assess•
ment of aortic valve regurgitation and perfusion of true and false 
lumina. All images were interpreted in a blinded mode by experi•
enced readers: 
MRI TEE P 
Residual dissection 18/23 18/23 ns 
Origin of residual flap 15123 10123 <.05 
Thrombosis in false lumen 17/23 19/23 ns 
Intraaortic debris 1123 2123 ns 
Sidebranch dissection 4123 1123 ns 
Aortic regurgitation (mild/moderate) 5123 7123 ns 
Conclusion: (1) Both TEE and MR! are extremely useful non-inva•
sive imaging modalities for post-surgical FlU of thoracic aortic dis•
section since findings with prognostic impact were detected by TEE 
and MRI. (2) MRI may offer more detailed infonnation on the origin 
of a residual flap and possibly on side branch dissection. 
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948·116 
Assessment of Diastolic Function in Dilated Cardiomyopathy Using 
Cine Magnetic Resonance Imaging; Effect of Angiotensin Convert· 
ing Enzyme Inhibitor 
Naoya Fujita. Jaakko Hartiala, Margaret O·Sullivan. David Steiman. 
Kanu Chatterjee, William W. Parmley. Charles B. Higgins. 
University of California. San Francisco. CA 
This study examined the effects of a new angiotensin convening enzyme 
inhibitor, benazcpril. on the left ventricular diastolic function in 11 
patients with dilated cardiomyopathy without mitral regurgitation by cine 
magnetic resonance imaging (MRI) before and after the 12 week's 
treatment of 20 mg/day bcnazepril. Its effects on the peak filling rate/ 
end-diastolic volume (PFR/EDV). peak filling rate/end-systolic volume 
(pFR/ESV). first third (1/3) filling fraction. and time to PFR were 
measured from the time-volume curve of the left vcntricle derived from 
the cine magnctic resonance images. In addition. left ventricular ejection 
fraction (L VEp) was also measured. Benazepril induced significant 
increase in left ventricular PFR/EDV (1.22±O.45 to 1.84±O.61 l/sec). 
PFR/ESV (1.85±O.96to 3.40±1.92 1Isec). and I/3li1ling fraction (38±10 
to 43±10 %). Time to PFR was decreased (I92±44 to I62±34 msec) and 
LVEF was increased (32±9 to 40±13 %) significantly after the therapy. 
There was a strong correlation betwecn PFR/ESV and L YEF (r=O.89) 
and significant relationship between the change (t.) ofPFR/ESV and that 
of LVEF after the treatment (r=0.74). In 4 
:';'i:"~::=~';'.::::;;~:tp, other patients with rnilml regurgitation, 
.+--~--.----,...---I . 
948·117 
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benazepril did not improve diastolic 
parameters. Conclusion: These findings 
suggest that long term benazepril therapy 
in patient with dilated cardiomyopathy 
bas favorable effects on left ventricular 
diastolic function which are associ•
ated with improvement in systolic 
function . 
Improved Evaluation of DIastolic DysfunctIon from RestrIctive 
CardIomyopathy and ConstrIctive PerIcardItis usIng MRI wIth 
SVC·Flow MappIng. 
Richard D. White. Allan L. Klein. Carolyn W. VanDyke. Peter A. Hardy. 
Cleveland Clinic Foundation. Cleveland. OH. 
Detection of Diastolic [D) dysfunction. and differentiation between 
Restrictive Cardiomyopathy [RC] and Constrictive Pericarditis [CP) as the 
source. can be problematic. MRI w~h dynamic Velocity-MAPping [VMAP] 
of flow in the Superior Vena Cava [SVC] was used to study 16 cases of 
suspected 0 dysfunction and 4 healthy volunteers; both transaxlal VMAP 
MRlof mid-SVC flow and standard 4-chamber MRI (spin-echo & Cine) of 
perlcardlal anatomy and ventricular function were performed. VMAP SVC 
plots were analyzed for their SVC-flow patterns (normal: blphaslc. Systolic 
[S] > 0) and the ratios of peak-S-flow:peak-D-flow were calculated. 
Standard Images were qualitatively evaluated for evidence of early or late 
RC (variably impaired ventricular filling! no slgnHicant pertcardlal thickening) 
or CP (abrupt mld-Iate-D filling Impairment! corresponding significant 
pericardlal thickening). TransEsophageal Echo [TEE)-Doppler results 
provided confirmation (12 cases). Of .the 16 cases. 0 dysfunction (No 
slgnHlcant tricuspid regurgitation) was diagnosed by standard MRI in 10 
cases; RC (na 5). CP (n&4). and mixed (nal) appearances were 
differentiated (confirmed by TEE-Doppler In 8/8). In the 10 cases of proven 
o dysfunction. S:D peak-flow ratios (0.17-1.14; mean: 0.54) were 
significantly different (p< 0.01) from those (1.28-3.39; mean: 2.04) of the 
control group (4 volunteers & 2 rule-out cases). Compared to CP (0.17-
0.99; mean: 0.44) ratios. ratiOS for early RC (n=2) (0.45-0.99; mean: 0.72) 
and late RC (n-3) (0.17-0.36; mean: 0.26) were different. The remaining 4 
cases had milder myocardiaV pericardlal disease and Intermediate ratios 
(0.74-1.76; mean: 1.12). MRI wHh VMAP analysis of SVC-flow Is sensitive 
for noninvasive detection of 0 dysfunction and aids in the differentiation 
between RC. Including Hs various stages. and CP as the source. 
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948·118 
Usefulness of MagnetiC Resonance Imaging In Presurgical 
Planning of Heterotaxy Syndrome: Comparison with 
Echocardlography and Catheterization 
~. G. Wesley Vick III. Richard E. Wendt. Roxann Rokey. 
Baylor College of Medicine. Houston, Texas. 
Early palliative. corrective and transplant surgery for patients with 
heterotaxy syndrome (HS) requires accurate delineation of 
complex cardiac anatomy. Even with preoperative 
echocardlography (echo) and catheterization (cath), previously 
unsuspected anomalies may be discovered at the time of surgery. 
To determine the usefulness of magnetic resonance Imaging (MRI) 
in the preoperative evaluation of patients (pts) with HS and Its 
impact on surgical planning. we prospectively evaluated pulmonary 
artery anatomy, systemic and pulmonary veins, and atnal situs In 
10 pts (ages: 3 mo - 10) who also underwent echo and cath. 
.Bu.I.I.IUl: Surgical planning was altered In 7/10 pts because MRI 
provided additional data not evident on echo and cath. This 
Information included delineation of complex pulmonary venous 
connections in 5 pts. draina\le of inferior vena cava and atrial situs 
in 1 pt. and anatomy of peripheral branch pulmonary arteries In 1 
pI. MRI correctly identified pulmonary outflow tract obstruction and 
pulmonary atresia in the 7 and 2 pts who had these abnormalities. 
respectively. All systemic and pulmonary venous anomalies were 
correctly identified by MRI when compared to cath and echo: 
Bilatera SVC's in 6 pts. separate drainage of hepatic vein to the 
ipsilateral atrium in 3 pts, azygous continuation of IVC in 4 pts (all 
with polysplenia). unroofing of the coronary sinus in 6 pts. totally 
anomalous pulmonary venous connections to a systemic vein in 4 
pts (to a left innominate vein in 3. and to an hepatic vein In 1). and 
to the right atrium in 1 pt. Atrial situs was determined In all pts 
using MRI: Solitus In 8 and inversus In 2. Atrial appendage 
morphology was clearly defined In all pts as either right or left. In 6 
pts (all with asplenia) atrial appendage morphology proved 
essential for diagnosing atrial situs. 
Conclyslon: Magnetic resonance imaging provides surgically 
important information in a substantial number of patients with 
heterotaxy syndrome that is not readily available by 
echocardiography or catheterization. 
948·119 
Magnetic Resonance Imaging of Cardiac Iron Overload in 
Thalassemia: Detection of Iron Content and Association with 
Cardiac Complications. 
Peter Liu, Nancy Olivieri, Hugh Sullivan, Mark Henkelman. 
The Toronto Hospital & Hospital for Sick Children, University 
of Toronto, Canada. 
Heart failure is the life·limiting complication of transfusional 
iron overload; but early detection of cardiac iron is clinically 
difficult. Magnetic resonance imaging (MRI) is sensitive to 
tissue iron. but has not been used clinically to quantitate cardiac 
iron and to assess the risk of cardiac complications. To 
determine the clinical role of MRI in cardiac iron overload, we 
performed T 2 wei~hted spin echo and gradient echo MRI 
studies on S5 patients (pts) with transfusion dependent 
beta-thalassemia (thaI) major, 12 pts with non-transfusion 
dependent thaI intermedia, and 8 normals. Serum ferritin and 
cumulative iron load was calculated for all transfused patients. 
and the patient's clinical status was independently determined 
hy an experienced team. 
Patients with thalassemia intermedia had consistently lower 
iron deposition in the henrt compared to thalassemia major. 
Correlation between serum ferritin and myocardial T2 
r~laxation time constnnt was only moderate (r = 0.52). Twelve 
thai major pts had the most severe cardiac iron deposition on 
MRI, and also were the same pIS that had ail the cardiac 
complicntions. Logistic regression identified the MRI derived 
cardiac T2 to be the most powerful ~arameter that 
differentiated those with cardiac complicatIOns from those 
without. 
We conclude MRI can assess directly the presence of 
myocardial iron overload, and identify those at risk for cardiac 
complications. MRI may have an important and novel role in 
the diagnosis and management of iron overload 
cardiomyopathies in patients at risk. and may be used in the 
future to monitor therapy. 
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949·39 
Coexistence or Functioning 111- and I1radrenoceplolS on Sial Ie 
VeDtrlcular Myocytes from Failln, Human Heart. 
Federica del Monte, Alberto J Kaumann, Dylan G Wynne, Philip A 
Poole-Wilson, Sian E Harding. National Heart & Lung Institute. 
London U.K. 
Force of contraction can be increased through both II r adrenoceptors 
(PIAR) and 1l2AR in human heart. The liAR desensitlSation in failing 
human ventricle is predominantly attributable to responses mediated 
through the III AR, with the 1l2AR less affected. Subtype analysis in 
whole tissue is complicated by the presence of endothelial and smooth 
muscle cells in addition to the cardiac myocytes. We have investigated 
PAR subtypes using individual myocytes enzymatically isolated from 
failing and non-failing human ventricle. The contraction amplitude 
of electrically-stimulated cells (0.2 Hz) at 320C was measured from 
the video image. 300 nM CGP 20712A (CGP) was used to block PI 
AR, SO nM ICI 118,551 (ICI) to block Il~AR. Antagonist-induced 
concentration-ratios (CR) of (- )-epinephnne, obtained from the 
dose-response curves (drc), were estimated at a response equivalent to 
15% of the maximum response to high calcium (15-30 mM). In 21 of 
29 myocytes from 12 patients ICI produced a CR smaller than 10, 
when a CR of 100 would be expected for a completely 
P2AR-mediated response. This suggests that there is a contribution of 
both P2AR (Le. ICI-sensitive) and PI AR (Le. ICI-hyposensitive) in 
these cells. In 3 patients, further drc to (-)-epinephrine in the 
presence of both ICI and CGP caused additional CR of 30-300 
compared to ICI alone, consistent with this hypothesis. III AR and 
1l2AR subtypes can coexist and function on the same human 
ventricular myocyte. 
949-40 
F10sequlnan Produces a Positive Inotropic Effect on Mammalian 
Myocardium by Enhancing Sodium-Calclum Exchanga 
Lin Miao. Cynthia L. Perreault. and James P. Morgan. Harvard 
Medical School. Boston. MA 
Flosequinan (Fa) is a new arterial and venous dilator for the treat•
ment of heart failure that also has a positive inotropic effect (PIE) 
at high doses. The purpose of this study was to determine the 
mechanism of this PIE in ferret papillary muscles (n=9). Muscles 
from the RV were placed in physiologic solution containing 2.5 
mM Ca2+. stretched to the length at which peak isometric tension 
(PTI developed. and stimulated at 0.33 Hz; 30 0 C. A subgroup 
was loaded with the ICa2+); indicator aequorin. Over the range of 
doses from 10'· to 10" M. Fa produced a 161 ±9% increase in 
PT that was accompanied by a corresponding increase in [Ca2+)\. 
This PIE was not blocked by the addition to the perfusete of the 
Na+ channel blockers. procaine 0.6 M. or tetrodotoxin 10.e M. or 
by autonomic blockade with propranolol 6 x 10.7 M. phentolamine 
10'· M, or atropine. 2 pM. The Ca2+ channel blockers. verapamil 
100 pM and nifedipine 0.1 pM. did not selectively antagonize Fa 
com~,ared to eQuieffective doses of other vasodilators with posi•
tive inotropic effects. milrinone (MIL) and hydralazine (HYD). In 
contrast. the PIE of Fa. but not MIL or HYD. was potentiated by 
prior addition of digoxin 3 nM to raise intracellular Na + and 
enhance Na+/Ca2+ exchange. Moreover. antagonists of Na+/Ca2+ 
exchange. including cadmium 10 pM. amiloride 600 pM. and 
choline substitution for 113 Na in the perfusate. blocked the 
response to Fa but not HYD or MIL. These results indicate that 
(1) Fa, in contrast to MIL and HYD, produces a PIE by enhancing 
Na+/Ca>+ exchange in mammalian myocardium. and (2) has the 
potential to interact with other agonists such as digoxin that 
affect Na+ ICa2 + exchange by direct or indirect actions. 
949·41 
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THE EFFEcr OF ANGIOTENSIN-CONVEIn'ING ENZ\'ME INHIBmON 
ON TERMINAL EXCHANGE VESSELS IN DIABETIC CARDIOPATHY 
Klaus Addicks, Dirk Hoever, Alexander Hess, Dirk Happieb, Christian Boy, 
Peter ROsen·, Wilhelm Bloeb. 
Department of Anatomy, University of Cologne, ·Diabetes Researeb Institute, 
University of DUsseldorf, Germany 
Since recent data indicate that inhibitors of the angiotensin-converting enzyme 
can protect the heart in diabetes, it has been suggested that angiotensin II plays 
a significant role in the ebange from reduced adaptability to irreversible damage 
of the heart. This study is concerned with the effect of long term administration 
of the angioteosin-converting enzyme inhibitor Captopril on diabetic 
myocardium. Isolated hearts from spontaneous diabetic BB rats were perfused 
for 30 minutes and fJX&ted in situ with glutaraldehyde. Capillaries and cardiac 
muscle ceDs were investigated in papillary muscle by means of light microscopic 
morphometry and electron microscopy. At five months of diabetic state cardiac 
muscle ceDs of diabetic BB·rats showed striking alterations of subeellular 
components: myofilament loss, deterioration of myofilament bundles, ebanges 
of mitochondrial size and structure, accumulations of glycogen granules all over 
the cytoplasm. These changes were absent or less frequent in diabetic animals 
plus Captopril. Although coronary flow was reduced by 20% morphometry 
revealed a 30% increase io capillary diameter in the non treated diabetic 
BB rats. This dilatation of the capillary bed was significantly reduced in the 
Captopril treated group, whereas the coronary flow did not increase 
significantly. 
Conclusion: long term appliCation of Captopril in vivo appears to diminish the 
degree of pathologic changes in terminal exchange vcs.sels and carcliac muscle 
ceDs in diabetes. 
949-42 
CAPILLARY DIAMETER IN MYOCARDIUM OF 
THE SPONTANEOUS DIABETIC BB RAT 
Angiotensin Convening Enzyme Inhibitors Reduce Free Radical 
Generation During Post·lschemlc Reperfuslon of canine Myocardium: 
A Real-time Study by Electron Spin Resonance Spectroscopy. 
Mukesh K. Sharma, Garry R Buettner and Richard E. Kerber. 
Cardiovascular Center, Univers~y of Iowa, Iowa City, IA 
Recent In vitro experiments suggest that captopril may be cardioprotective 
against reperfuslon injury due to ~s free radical scavenging properties. 
Whether this Is an effect of angiotensin converting enzyme (ACEI inhibHion 
or the free radical scavenging property of captoprll's suWhydryl group 
remains controversial. We used measuremenl of ascorbylfree radical 
(AFRI by electron spin resonance spectroscopy (ESR), a real-time. in vivo 
quantitative method recantly developed In our laboratory, to study the 
eflect of captopril and enalaprilat (a nonsuHhydryl-containing ACE inhibitor) 
on free radical generation during post· ischemic myocardial reperfusion. 
Eighteen open-chest dogs underwenl 20 minutes of left anterior 
descending artery occlUSion and 30 minutes of reperfusion. Before 
occlusion, 7 dogs received captopril (3 mglkg. iv). 4 received enalaprilat 
(4 mg. lVI, while the remaining 7 received only saline as a placebo. AFR 
concentration in the great cardiac vein was measured continuously by 
ESR. 
RESULTS' (mean ± SO) 
o - placebo 
• -captopril 
~ z enalaprilat 
Pre-ooclusion AFR concentrations were similar in the 3 groups. During 
reperfusion, dogs that received either captopril or enalaprilat showed a 
sign~icantly lower rise in AFR compared to the placebo group. The peak 
rise In the placebo group was 38% compared to only 15.5% (P<0.03) and 
9.6% (P<O.OI) in the captopril and enalaprilat groups. Conclusjon' ACE 
Inhibitors markedly attenuate free radical production during myocardial 
reperfusion. Furthermore, the nonsulfhydryl.containing enalaprilat had an 
equally potent effect as the sulfhydryl-containing captopril. 
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950-43 
The Geometric Component of Starling's Law of the Heart in 
Conscious Do,s 
Michael P. Feneley, Jerzy Michniewicz, Mohanraj K Karunanithi, 
St. Vincent's Hospital, Sydney, NSW, Australia. 
Left; ventricular (LV) stroke work (SW) increases linearly with 
increased end-diastolic volume (EDV), a phenomenon attributed to 
the length·dependence of myocardial fiber force and shortening. For 
any fixed amount of fiber shortening, however, geometric 
considerations alone dictate that more stroke volume is displaced 
from a higher EDV, contributing to increased SW. This geometric 
component of the SW·EDV relation was quantified in 8 conscious, 
autonomically blocked dogs. LV volume was measured with a three· 
dimensional array of ultrasonic dimension transducers. LV 
transmural pressure was measured with micromanometers. EDV 
was varied by transient vena caval occlusion. SW was determined as 
the product of the mean developed ejection pressure and the 
measured stroke volume, while the geometric component of SW was 
determined as the product of the same pressure and the stroke 
volume calculated to be displaced from the same EDV when absolute 
shortening of all three LV dimensions was held constant at the level 
observed at the lowest EDV. Both total SW (r=0.99±0.01) and the 
geometric component of SW(r=0.96±0.06) were related to EDV in a 
highly linear manner (Figure). 
950-44 
The geometric component of SW accounted 
for 29 + 9% of the area under the SW·EDV 
relation~ ranging from 14% to 41% as a 
linear function of the extent of (constant) 
shortening (r=0.8) when shortening was 
normalized for differences in control EDV. 
The geometric component of Starling's Law 
is substantial in the normal canine heart. 
Time Varying Elastance of the Intact left AtriUM 
Brian D. Hoit, Vanfu Shao, Marjorie Gabel, Richard A. 
Walsh. University of Cincinnati Medical Center, 
Cincinnati, OH 
Contractile function of the ex vivo, isolated left 
atrium (LA) has been described by a time-varying 
elastance, but this atrial chamber property has not 
been shown in vivo. Accordingly, instantaneous LA 
pressure-volume (P-V) relations were studied in 7 
anesthetized, autonomically blocked, atrially paced (98 
± 11 bpm) dogs. LA volume was calculated from 
orthogonal sonomicrometer pairs using a cast validated 
formula. Data were collected during increases in LA 
pressure produced by a phenylephrine bolus (003 mg 
i.v.). Isochronal P-V pOints from 5 beats, 
representing a wide range of atrial pressures, were 
fitted by linear regression analysis and the time 
varying elastance (E(t» and volume axis intercept 
(VO(t» from atrial diastasis to end systole were 
calculated every 10 ms. There were time-dependent 
increases in E(t) and decreases in VOlt) during atrial 
contractionj maximum elastance (E •• x) occurred 35 ± 19 
ms before atrial end systole (minimum LA volume). Ea.x 
was not significantly different than the slopes of 
either the nonisochronal end systolic P-V relation 
(Ea.) or the nonisochronal maximum P/V relation 
(Eaaxpv): 1.48±.72, 1.15t.50 and 1.49±1.11 mHg/ml, 
respectively. E.ax was linearly related to both Ea.xpv 
(slope=1.5, r=.95, p=.OOI) and E •• (slope=0.7, r=.93, 
p=.003). We conclude: 1) in the intact heart, left 
atrial pump function may be approximated by time•
varyin9 elastance with time-dependent changes in both 
E(t) and VOlt) and 2) LA systolic P-V relations using 
either the nonisochronal maximum P/V ratio or end 
systole may be useful as an estimate of E •• x. 
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950-45 
Comparison of the Effects of Dobutamine vs Increased 
Afterload on Ventricular Performance and Energetics 
Paul Steendijk, Atsushi Mikuniya, Enno T van der Velde, Jan &an. 
Cardiology, Leiden University Hospital, Netherlands 
An increased slope andlor a leftward shift of the end-systolic 
pressure-volume relation (ESPVR) is associated with increased 
motropism. The pressure-volume area (PV A) has been proposed as a 
measure of total mechanical energy consisting of external work and 
potential energy stored at end~systole. The slope of th~ V02-PVA 
relation represents the effiCiency of chemomechamcal energy 
transduction, the intercept reflects ~e 02 cost of~ metabolism and 
excitation-contraction (E-C) coupling.We have previously shown that 
increased afterlOad (Aft) causes a leftward shift of the ESPVR 
suggesting increased inotropism. Presently we compared the effects 
of Aft and Dobutamine (Dob) on the ESPVR and on the PVA-V02 
relation. Seven dogs were instrumented with a microtip catheter for 
LV pressure, a conductance catheter for LV volume and Doppler 
probes for coronary flow. Paced data were acquired during control 
(Con), Dob (10 IIg1kg1min) and Aft (by partial aortic occlusion) at 4 
levels of mean aortic pressure, obtained by changing preload. 
Dog NoA 10 01." Dog No.4 10..... Dog No.4 
Poo(KP" Aft Co "'"' (100) 
Dob/! / n 
.. (01' 
a 500 1000 800 
Results: With both Dob and Aft, the ESPVR shifts leftwards and 
tends to be steeper, suggesting increased contractility, compared to 
Coo. Assuming constant 02 extraction, the V02-PVA relation shifts 
to a higher VOl intercept with Dob but is unaffected by Aft This 
indicates that basal metabolism andlor E-C coupling energy is 
increased with Dob as expected, but not affected by Aft despite the 
increased inotropy indicated by the ESPVR. 
950-46 
Effect or Vagal Stimulation on Left Ventricular Diastolic 
Penonnance 
Nicholaos P. Xenopoulos, Robert J. Applegate, The Bowman Gray 
School of Medicine, Winston-Salem, NC 
Stimulation of the vagus results in cardiac depression. It is now 
recognized that abnonnalities of LV diastolic function may be equally as 
important as LV systolic abnonnalities in contributing to cardiac 
depression. Although vagal stimulation depresses LV contraclile 
function its effects on LV diastolic function are unknown. Accordingly, 
we evaluated the effect of VS on phasic indexes of LV diastolic function 
and on the LV diastolic pressure.volume relation (LVDPVR). 
Anesthetized, open chest dogs (n=14), were instrumented to measure LV 
P, and V (conductance catheter). The cervical vagi were transected and 
stimulated at SV, 2Hz for 5 min, to decrease the HR 27±6% (lS8±21 to 
11S±lS bpm, p<O.OS). Hemodynamic data were obtained during steady 
state, and during transient vena cava occlusion at a constant heart rate 
before and during VS. VS did not alter the time constant of isovolumic 
relaxation 1:, (32±S to 32±3ms; p=NS), or the LV end·systolic pressure· 
1: relation during caval occlusion. Similarly, no change was noted in the 
LV diastolic chamher stiffness constant Kc (P=AeKcV) during VS 
(0.06S±0.07 to 0.042±O.025 mmHg/ml; p=NS). However, a Significant 
increase in the filling fraction at 1/3 and 1/2 of diastole, after VS, was 
noted (1O±6% to 14±7% at 1/3 and 32±10% to 38±12% at 1/2; p<0.05). 
We examined the mechanism for this increase by examining the relation 
of LAP and LVP. VS increased mean LAP by 30% and the LAP·LVP 
gradient integral by 105%. 
Conclusion: Vagal stimulation in the intact anesthetized animal has no 
significant lucitropic effects. However, it augments early LV diastolic 




~r ....... ral IIIt.rUl}'OCanial .re .. ure DJ.at.riINt.J.OIII It.a 
DepeD4ellGe 011 .reload, Aft.edoacl AIIcl CoIIt.rectUe atat.e 
Toahiyuki Maruyama, Marc T. SWartz, John Standeven, D. 
Glenn Pennington, St. Louia UniveraJ.ty Koapit.al, Saint 
Loul8, Hl8&ouri 
UnderatandJ.ng J.ntramyocarclial preaaure cliatribution ia 
iDperative for t.he explanation of pheaic coronary 
paduion. However, the effecta of load AIIcl inotropic 
atate on J.nt.ramyocardial pre.aure cliatribution have not 
been extenaively inveatigatad. Uai.ng 3-'r pre.aure 
t.ranaclucera, we directly .. aaurad int.ramyocardial 
preaaure in t.he anterJ.or wall ot t.he left ventricle in 10 
acute open-cheat.ed doga. Preaaurea were measurad 
aiDult.aneou81y in the al1bendocardiWII (BND), midwall (HID) 
and al1bapicardiWII (BPI I wit.h lett. vent.ricular pressure 
(LVPI. Decreased preload waa produced by Ive occlusion, 
increaaad preload by volUM, increased aft.erload by 
croa.clamping the aorta and increased cont.ractility by 
epinephrine. Syat.olic normalized intramyocardial 
preasure (divided by LVP) were tabulated. 
IN!) (t) MID (t) BPI (t) 
CoDt.rol 93+17 77+49 39+231+ 
Ive Occlu81oll llOj)9* 11S+52* 71+19*1+ 
Vol .... 93+14 66+21' 43+121+ 
Aortic Cro .. claap 8l±12* 6l±15*' 34+14*t+ 
lpJ.nephrJ.ne 100±lS 79±42 43±141+ 
c*p < 0.05 va. control, 'p < 0.05 vs. ~, +p < 0.05 va. 
HlQ.) These data indicate that intramyocardial pres.ure 
diatribution variea according to load and inotropic 
conditions. Intramyocardial pre. sure diatribution i. 
mo.t aiCJnificantly alt.ered durinCJ perioda of decreased 
preload when the int.ramyocardial pressure relationship 
becomes non-linear. The.e re.ult. are con.iatent with 
the theoretical prediction of intramyocardial pre •• ure 
distribution based on transmural aarcomere dynamic •• 
950·48 
Load Dependence in the Intact Heart 
Adelino F. Leite-Moreira and Thierry C. Gillebert 
University of Antwerp, Antwerp, Belgium 
To analyze load dependence in the intact heart and to 
differentiate between slowing and accelerating effects on relaxation, 
we induced load clamps by abruptly inflating an intraaortic balloon 
in 9 open-chest dogs. The clamps were timed during early, mid and 
very late ejection and compared to ~. Total early aortic 
occlusions (isometric) induced premature onset [time to peak -dP/dt 
(t.-dP,ms)] and marked slowing of both initial (peak -dP/dt,mmHg/s) 
and subsequent (Tau,ms) left ventricular pressure (L VP) fall. Partial 
~ aortic occlusions (.:lLVP=+10mmHg) induced delayed onset 
and slight slowing of overall L VP fall. Mid-ejection clamps 
(.:lL VP= + IOmmHg) induced premature onset, acceleration of initial 
L VP fall and deceleration of subsequent L VP fall: effect on initial 
and subsequent L VP fall therefore was distinct. Very late ejection 
clamps did not increase LVP, accelerated initial L VP fall and had 
minor effects on subsequent LVP fall. 
• p<O.01 CONTROl 110010, '8OMEmC EARLY MID VlRYLATE 
t ..... ~e2 " 17 12":t:3· 102" t: 1 • I." *" . 11410 " ~ . 
PEAK ·dP/dt ·~~17 ~ 481 ., .. " * 12· 1311" 10 10811 ",I' us. * 11· 
TAU 38 ~ 3 13." *'0· 10110 .. I • 121" * •• 10'" t: 2 • 
Initial and subsequent L VP fall responded quite differently to load 
clamps. Load-dependent acceleration of initial LVP fall with late 
clamps was presumably related to crossbridge (CB) disruption. Early 
onset of L VP fall and slowing of subsequent L VP fall occurred when 
a mismatch was induced between number of CB and load, such as 
in isometric and mid clamps. This was presumably related to 
increased stress on individual CB, which might delay inactivation. Of 
note, no intervention altered L VP fall at and after mitral opening. 
950-49 
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Blocking the Exercise Induced Tachycardia with a Selective 
Bradycardic Agent Results In a Blunted Inotropic Response in 
Conscious Dogs. 
Pascal Vantrimpont, Michel De Pauw, Dirk Vogelaers, Yvan 
Degrieck, Guy R. Heyndrickx, Dept. PhysioL Vnlv. Gent, 
Cardiovascular Center, Aalst, Belgium. 
In order to evaluate the role of tachycardia for the inotropic 
response during .exercise (Ex), dogs instrumented with left (L) 
ventricular (V) pressure (P) gauge, arterial (A) P catheters and atrial 
pacing electrodes were submitted to graded treadmill Ex in control 
conditions (Ex-I) after propranolol (Prop) (I mg/kg)(Ex-2), after 
selective bradycardic agent VLFS-49 (V) (0.4 mg/kg) (Ex-3), after 
Prop+pacing (Ex-4) and after V+pacing (Ex-5). Results 
(Mean±SEM) for heart rate (HR) (b/min) AP(mmHg) LV end (E) 
diastolic (D) P (mmHg) LVdP/dt (mmHg/sec).(Op<0.05 Ex vs Rest; 
·p<O.05 Ex-n vs Ex-I; Ip<O.05 Ex-4 vs Ex-2; ,,<0.05 Ex-S vs Ex-3). 
HR AP LVEDP LVdP/dt 
Rest l2l±6 90±6 9±1 2934±219 
Ex-1 206±9° 104±4° 17±lo S209±2S1 o 
Ex-2 l36±10o• 103±6° 20±lo. 3044±137°· 
Ex-3 lSO±So. 100±So 22±4°· 4S27±344°· 
Ex-4 207±llo, 1l0±So 14±lo, 3426±44°" 
Ex-S 2l0±so$ 10S±So 1l±4°' S846±S20o$ 
Ex after Prop and V was associated with a lower HR and LVdP/dt. 
Atrial pacing during Ex+Prop as to match HR of Ex-I increased but 
faiJed to normalize LVdP /dt. In contrast atrial pacing during Ex+ V 
normalized LVdP/dt. Thus, in the absence of /3-blockade full inotropic 
response during Ex depends on a concomitant increase in heart rate. 
950·76 
Right Ventricular Systolic Performance in a Porcine Model 
Rakesh Uppal, Damian Craig, Donald Glower, Hide Vtsunomiya, 
Ares Pasipoularides, David C. Sabiston Jr., Peter K, Smith. 
Duke University Medical Center, Durham, NC 
RV dysfunction is a limiting factor in heart and lung transplantation, 
con~enital heart disease, and high risk open heart surgery. 
Similarities in human and swine coronary anatomy' and pulmonary 
vasculature make the swine a useful model for studying human RV 
perfonnance. Indices of LV function are commonly applied to the 
RV, despite different geometry and load conditions. To validate 
these indices for the RV, RV and LV pressures were measured and 
dynamic chamber volumes were calculated using a shell subtraction 
method in 16 B-blocked pigs. Preload Recruitable Stroke Work 
(PRSW), Maximal End Systolic Elastance (Emax), dp/dt max vs 
EDV (dPMXV) and dp/dt min vs EDV (dPMNV) were calculated by 
linear regression and expressed as mean slope and x-intercept. The 
animals were atrially paced at 120,140,160 bpm, afterload was 
increased acutely to 150% of control by pulmonary artery (PA) 
constriction and inotropic state altered with dopamine at 
IOIlg/kg/min. Data were acquired during vena caval occlusion and 
lzed'AOA analYl uSing N V 
Pacing PABand Dopamine 
*11<0.05 120 160 CII Band Ctl tl!Y!l. 
PRSW 21.0 22.6 20.0 2Q.6 20.9 30.0' 
Emax 1.89 2.12' 1.81 2.33' 1.79 2.34' 
dPMXV 20.0 28.1' 18.3 14.7 22.1 45.3' 
dPMNY -14.6 -22.2' -13.1 -19.3' -12.3 '16.5' 
Conclusion: The slope of each index increased si~nificantly to reflect 
the change in inotropic state. There were no sigruficant changes in x•
intercept (unstressed chamber volume) for these indices, sug~esting 
an unchanged geometry. Ees, dPMXV and dPMNV were sensItive to 
chronotropic state and Ees and dPMNV were afterload dependent. 
PRSW was sensitive to changes in inotropic state independent of 
heart rate and afterload and thus the index of choice to measure RV 
systolic function in this model. 
JACC Vol. 21, No.2 
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950·77 
Validation of Rigbt Ventricular Geometric Modeling Based on 
Waveform Analysis of Pulmonary Arterial Pressure and Flow 
Cary H. Meyers MD, David S. Peterseim MD, Rakesh Uppal FRCS, 
A. Mark Jayawant BA, David C. Sabiston, Ir. MD, 
Peter K. Smith MD, and Peter Van Trigt MD 
Duke University Medical Center, Durham, NC 
Dimensional modeling of the right ventricle (RV) is based on post· 
mortem in vitro intracavitary balloon volume determinations as 
compared with dynamic in vivo calculations. However, variations in 
septal loading during the cardiac cycle cannot be accounted for using 
post·mortem validation strategies. This study compares RV power 
output (Wss) as determined by the geometry·dependent shell•
subtraction model to RV power (Wt) as calculated from Fourier 
analysis of pulmonary arterial (PA) pressure and flow waveforms. 
We propose that Wss and Wt should be equivalent to substantiate the 
assumptions defined in the shell-subtraction model. Eight dogs (25-
30 kg) were instrumented with ultrasonic dimension transducers in 
the major, minor, septal-left ventricular (LV) free wall, and septal•
RV free wall diameters. Micromanometers were placed in the RV, 
LV, PA, and left atrium (LA), and an ultrasonic flow probe was 
placed around the PA. Pressure-flow and pressure-dimension data 
were acquired under identical loading conditions and heart rate. 
Dimensional data were also obtained during transient preload 
variation to derive the load-independent stroke work-end diastolic 
volume (pRSW) relationship. 
co PRSW Vo r2 Wss Wt 
Vmin dynocm-2ol()3 ml mW mW 
1.2ib.05 26±4 14±2 0.962 60±5 63±5 
Wss and Wt were wlthm 5% of each other as calculated frOm enller 
dimensional or waveform data. Linearity of the RV PRSW 
relationship was also excellent. Based on this analysis, the shell 
subtraction model allows for a rate and load-independent analysis of 
RV function as validated by Wt which makes no assumptions 
concerning intracavitary RV geometry. 
950·79 
Right Ventricular Contraction in Consciol18 Dogs: Deviation 
from the Predictions of the Time-Varying Elastance Model 
Michael P. Feneley, Mohanrl\i K. Karunanithi, Jerzy Michniewicz, 
St. Vincent's Hospital, Sydney, NSW, Australia. 
The left ventricular (LV) instantaneous pressure (P)-volume (V) 
relation has been described by the time(t)-varying elastance formula 
P,=E. <V,-V), where E. is the instantaneous slope and V. is constant. 
Emax is the maximal slope at time Tmax. In 8 conscious, 
autonomically blocked dogs, right ventricular (RV) volume was 
measured with an array of ultrasonic dimension transducers and RV 
transmural pressure was recorded with micromanometers. The RV 
instantaneous P-V relationships were plotted at 20 ms intervals 
during vena caval occlusions performed (i) under control conditions, 
(ii) during pulmonary artery constriction (PAC), and (iii) after 
calcium infusion (15mg/kg). RV instantaneous P-V relationships 
(Figure) deviated significantly from the predictions of the time•
varying elastance model: (i) E, increased sharply in early systole, but 
changed little subsequently; (ii) V. was neither constant nor 
predictably time-dependent; (iii) Emax increased and/or V. at Tmax 
decreased with PAC, indicating afterload sensitivity (p<O.05); (iv) 
calcium did not significantly increase Emax or shorten Tmax, but V. 




















~ These results in the RV suggest that the apparent conformity of LV contraction to the time-varying elastance model does not reflect a fundamental cardiac muscle property. -:10 0 ~ 100 150 2IID co 3l1li "--.. ... -........ , 
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950·80 
LEFT VENTRICULAR PRESSURE DECAY RATE DURING 
ISOVOLUMIC RELAXA nON IS PRELOAD DEPENDENT. 
Michael Courtois; Carol I Mechem; Benico Barzilai, F.A.C.C.; Philip 
A Ludbrook, F.A.C.C. Washington Univ., St. Louis, Mo. 
Studies have shown that left ventricular (LV) isovolumic pressure 
decay rate, often employed as an indirect measure of myocardial 
relaxation, is inversely related to end-systolic volume (ESV). Other 
studies have indicated that isovolumic pressure decay rate is 
independent of preload. Because preload is thought to be a determinant 
of ESV, we examined this relationship using multiple regression 
analysis in 14 anesthetized closed-chest dogs at baseline and after 
volume loading (500-650 ml) by rapid infusion of either normal saline 
or whole blood. We measured LV and aortic pressures with 
micromanometers, and LV volume with contrast angiography. 
lsovolumic pressure decay rate index (Tl/2) was defined as the time 
needed for the pressure at peak -dP/dt to decay by half. The 
relationship between ESV and measures of its three purported major 
determinants [preload (end-diastolic volume, EDV); afterload (aortic 
diastolic pressure, AOdias); and contractility (peak LV pressure rdte 
change during isovolurnic contraction, dP/dtlJ. was highly significant: 
ESV - 0.38 EDV*** + (-0.005) dP/dt** + 0.10 AOdias* + 4.38 
(R=O.94***) 
In this group of animals TI/2 had a weak, but significant relationship 
with EDV (r = 0.53**). The strength of this relationship was increased 
significantly when the two remaining major determinants of ESV were 
included in a multiple regression analysis: 
TI/2 - 0.14 EDV** + (-0.005) dP/dt* + 0.17 AOdias* + 10.66 
(R=O.74***) 
These results demonstrate that, to the extent that preload is a 
determinant of ESV, Tl/2 is preload dependent. These observations 
also emphasize the complex interactions between measures of diastolic 
performance and factors that influence systolic performance. 
***p<O.OOI; **<0.01; *<0.05 
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951·120 
Decreased Fibrinolytic Activity In Coronary Disease 
Patients With a Positive Family History. 
William C Siegel, Michael Robbins, Charles S Greenberg, 
Salvatore V Pizzo. Deaconess Hospital, Harvard Medical 
School, Boston MA, and Duke University, Durham NC. 
The biologic mechanism through which family history (FH) 
of premature coronary disease increases coronary disease risk is 
unknown. We sought to determine whether family history is 
associated with increased fibrinogen or decreased fibrinolysis, 
two new risk factors for coronary disease. Fasting moming blood 
samples were obtained from 101 men with coronary disease 
before age 55, documented by MI or positive coronary 
angiogram. Fifty had a strong FH, and 50 had a negative FH, 
documented by a review of family members' medical histories 
and death certificates. For t-PA activity, blood samples were 
drawn pre- and post- venous occlusion to induce t-PA release. 
+ FH • FH P 
baseline t-PA activity, Iu/ml 0.05 0.08 ns 
induced t·PA activity, lulml 0.59 0.87 0.02 
plasminogen activator 18 16 ns 
inhibitor·1 activity, unitslml 
fibrinogen, mg/dl 315 309 ns 
lipoprotein (a), mg/dl 23 25 ns 
FH was associated with decreased tPA release in 
response to venous stasis. This decreased fibrinolytic activity 
may increase risk of coronary thrombosis, and thus may be a 




Ethnic Differences Among Myoeardiallnfarctiolll Patients in an 
Urban Coronary Intensive Care Unit 
Christine Joseph, Suzanne Havstad, Syed Jam. Mihai Gheorghiade. 
Henry Ford Hospital, Detroit, MI 
Ethnic differences in management of myocardial infarction (MI) have 
been reported. We examined ethnic disparities in disease 
management and prevalence of complications among 691 MI patienls 
(pis) discharged from the coronary care unit (CCU) between 6190 and 
10191. Thirty-eight percent of the pis were female, 40% were black. 
Mean age was 63.7 }'IS :I: 12.9. Pre-existing hypertension (74% vs 
54%, p<.OOI), diabetes (33% vs 24%, p=.02), and a history of heart 
failure (HF) (23% vs 15%, p=.OI) were more prevalent in black pis. 
While in CCU, black pis experienced more HF/shock (50% vs 38%, 
p<.OI) and renal failure (14% vs 9%, p=.06). Mean CPK for black 
pis was significantly higher (1401:1: 1518 lUlL vs 1102:1: 1369 lUlL, 
p = .02). Despite these trends, black pis had fewer revascularization 
procedures during this admission. Thrombolytic therapy was also less 












Differences persisted after adjustment for age and morbidity by logistic 
regression. Hypertension (p<.OOI) and high CPK (p<.OOI) were 
significantly associated with black ethnicity. Black pis received less 
thrombolytic therapy (p=.03) and fewer revascularization procedures 
(p=.OI) than white pis after adjusting for baseline differences. In 
summary, complications experienced by black MI pis are more 
common than that seen in white pis, yet black pts do not receive the 
same management. Further studies should explore management 
differences in the black population. 
951-122 
The Effect of Adiposity Upon Left Ventricular Structure and Function in 
Normotensive Ch~dren 
Kurt L. Pflieger, Frank A. Treiber, Harry Davis, Francis M. McCaffrey, R. 
Austin Raunikar, William B. Strong. Medical College of Georgia, 
Augusta, Georgia 
In both normotensive and hypertensive adults, adiposity is associated 
with left ventricular hypertrophy. Adiposity has been associated with 
increased resting blood pressure in childhood and adolescence. Little is 
known concerning the effect of adiposity upon left ventricular structure 
and function in normotensive children. Similarly, little is known 
concerning the relationship between adiposity and cardiac output, blood 
pressure and systemic vascular resistance in childhood. Sixty-nine 
normotensive children 8 to 13 years of age were studied. Overweight 
was defined as weight for height for age ~ 85th %ile. (Non-overweight: 
n=50, mean 39.6, range 19.6 - 75.5 kg; Overweight: n=19, mean 
61.7, range 29.5 - 85.7 kg). The effect of overweight on left ventricular 
dimensions and mass index as well as on systolic and diastolic function 
were measured. The overweight children had higher systolic (p < 
.0001) and diastolic blood pressures (p < .001), heart rates (p < .05), 
and systemic vascular resistance index (p < .001) and lower stroke 
volumes (p < .01) and cardiac index (p < .01) than the non-overweight 
children. Univariate analyses revealed that overweiGht children had 
greater left ventricular mass indexed by height'·7 (p < .01), left 
ventricular end diastolic diameter (p < .05), interventricular septal 
thickness (p < .01) and greater peak flow velocity (PFVA) during the 
atrial filling period (p < .05). There were no significant differences in 
other indices of systolic and diastolic characteristics between groups lall 
p's> .10). 
Conclusion: Adiposity effects changes in l V mass and end diastolic 
dimension. Adiposity also contributes to higher resting blood pressures 
and systemic vascular resistance in normotensive children and 
adolescents. Therefore, the deleterious effects of adiposity are manifest 
on the heart, even in chiidren. 
951-123 
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Intravascular Ultrasound Identifies Early 
Coronary Artery Disease in High Risk Fcuailies. 
Thomas Aversano, Lewis C. Becker, Diane M. 
Becker. Johns Hopkins Hospital, Baltimore, MD 
To determine if intravascular ultrasound (IVU) 
is more sensitive than conventional 
angiography in the detection of early coronary 
artery disease (CAD) in asymptomatic siblings 
(SIBS) of patients with documented coronary 
artery disease, 13 proximal coronary artery 
segments were studied in 8 SIBS. SIBS, known 
to be at high risk for developing future CAD 
events, had positive exercise tests and 2 or 
more CAD risk factors. Arteries examined by 
lVU were angiographically normal or near 
normal, with a maximum percent diameter 
stenosis of 10±8 % by computer-assisted 
quantitative angiography (QCA). Significant 
intimal thickening, averaging 0.6±O.3 rom, was 
detected by lVU in 11 of 13 segments. Maximum 
percent lumen area reduction by QCA was 18±14% 
and by IVU was 27±14% (P<.02). As shown in 
the figure, lVU detected 
' .. / .. . . 
, 
-.. ~ .. ". .- _.- - -.. -- "'--
a greater maximum~ .. 
lumen area reduction I 
in 8/13 arteries a " 
(solid line, y=x). We ~ 
conclude that in SIBS, ; i 
conventional:"j 
angiographyl· 
underestimates the ~ "II 
severity of existing" 
atherosclerosis. lVU .".l::,,--:----:,"", -::;; .. --:: .. :---;,;---!, 
may be a more U-TfIADO\jWO'UflEAflEiX.ICT!OM 
sensitive instrument for identifying and 
quantifying CAD in this high risk group. 
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Mitral Valve Repair in Patients with the Marlan Syndrome 
A. Marc Gillinov, Atul Hulyalkar, Duke Cameron, Peter Cho, 
Bruce Reitz, Reed Pyeritz, and Vincent Gott 
The Johns Hopkins Medical Institutions, Baltimore, MD 21287 
Optimal surgical treatment of mitral regurgitation (valve repair 
versus replacement) in the Marfan syndrome (MS) is controversial 
because the underlying connective tissue defect of MS theoretically 
might compromise repair durability. To examine the results of 
mitral repair, a retrospective review was undertaken of 160 MS pIS 
having cardiac surgical procedures between July 1984 and June 
1992. 33 pIS had mitral procedures, 25 of which were repairs. Of 
these 14 men and 11 women, mean age was 27 ± 2 yrs (range 4-
54 yrs); 6 pIS were less than 18 years of,age. 23 of the 25 pIS had 
concomitant aortic root replacement for root dilatation or aortic 
insufficiency. All 25 valve repairs included annuloplasty with 
prosthetic rings; 7 also required leaflet resection. There were no 
operative deaths. At mean follow-up of 31 ± 6 months, there 
were 2 late deaths due to arrhythmias; all survivors are NYHA 
Class I or II. Mitral regurgitation (MR) was significantly 
improved in all but one pt; mean preop MR grade was 3.24 ± .17 
and postop was 1.38 ± .23 (p < .0004). There have been no late 
repair failures and no pt has required late mitral replacement. 
These results demonstrate that (I) approximately 20% of Marfan 
syndrome pts undergoing cardiac surgery require a mitral valve 
procedure, (2) most can be treated by mitral repair rather than 
replacement, and (3) at mid-term followup, results of mitral repair 
in MS pts are good. 
JACC Vol. 21, No.2 
February 1993:415A 
805-2 4:15 
Long-term Results of Mitral Valve Repair in 251 Patients with 
Rheumatic Mitral Regurgitation or Mixed Mitral Valve 
Disease. Is this the Optimal Surgical Approach for the Young 
Rheumatic? 
Vania Sinovich. John Skoularigis. Mohammed R Essop. 
Thomas Wisenbaugh, Rashid Essop, Christian Rothlisberger, 
Daniel Skudicky. Pinhas Sareli. 
Baragwanath Hospital, Johannesburg, South Africa. 
We followed 251 out of 308 consecutive patients that underwent 
mitral valve repair between 1981 and 1989 (by 3 experienced 
surgeons) for symptomatic rheumatic milrnl valve disease (pure 
mitral regurgitation in 71 %. mixed disease in 29%), mean age 
18±9 years. Rheumatic activity was present clinically/serologically 
in 30% and macroscopically during surgery in 32%. Surgical 
techniques included insertion of a Carpentier ring (96%), chordal 
shortening (93%), leaflet resection (13%), chordal transposition 
(7%) and commissurotomy (34%). Operative (Op) mortality was 
2.6%. Mean follow up period was 4.9±3 (range l-ll) years. Post 
op 26% were in atrial fibrillation and 36% received 
anticoagulation therapy. Late mortality was 15%, resulting in a 
survival rate of 86% at 5 years and 83% at 10 years. Other 
complications included re-op in 27%, significant valve dysfunction 
(defined by echo Doppler) in an additional·17%, systemic 
embolism in 4%, and endocarditis in 4%. Surgical findings at 
reoperation included leaflet retraction and either chordal 
elongation or rupture resulting in leaflet prolapse. Event free rate 
from death, re-op, thromboembolism and endocarditis was 68% at 
5 years and 37% at 10 years. In conclusion, mitral valve repair in 
this young rheumatic population is associated with increased long 
term morbidity. While the mortality rate is high in the first 5 years, 
it appears to plateau until the 10 year post-op. The advisability of 
mitral repair in young patients with rheumatic disease, although 
desirable, is questionable. 
805-3 4:30 
Is a Very Low Level of Anticoagulation Adequate for Patients 
With St Jude Medical Prosthesis? 
Daniel Skudicky, Thomas Wisenbaugh, Mohammed R Essop, John 
Skoularigis, Christian Rothlisberger, Victor Strugo, Pinhas Sareli, 
Baragwanath Hospital, Johannesburg, South Africa. 
It is generally accepted that lowering the level of anticoagulation 
in pts with St Jude Medical prosthesis (SJMP) is relatively safe,but 
the optimal level has not been determined, as well as the necessary 
frequency of the determination of the anticoagulation level. Using 
a "blanket recommendation" target international normalized ratio 
(INR) of 2 to 2,5 we followed prospectively (mean follow up IS±9 
months, range 1-34) 165 pts (mean age 30±13 years) with 
rheumatic heart disease that underwent valve replacement with a 
SJMP (mitrals=91, aortics=40, double valves=34). Anticoagulation 
level was checked at 1,2,3 months after surgery and thereafter 3 
monthly or more frequent whenever clinically indicated. The 
median warfarin dose was 5,4±1,6 mg daily and dipyridamole was 
used also in 82% of the pts. The median INR (1116 samples) was 
2±!),7 «2 61 %, >3 16%). This level is significantly below the 
WHO reccomendation level of anticoagulation which is 3-4,5. 
While 23% of the patients were in atrial fibrillation (AF) at the 
first 3 months post surgery, following an aggressive 
pharmacological and electrical cardioversion protocol the rate of 
AF was reduced to 12%. There was no valve related mortality. Left 
ventricular dysfunction resulted in 3 deaths and 1 pt had a non 
cardiovascular death. There were no valve obstructions or strokes, 
I pt had a TIA (O,9%/pt year). 7 pts were lost of follow up. 
Clinically significant ring leaks were documented in 5 pts (2,5%/pt 
year) but none of them required reoperation. In conclusion: 1) The 
SJMP performed extremely well in this young group of rheumatic 
pts with a low rate of AF using very low level of warfarin 
anticoagulation combined with dipyridamole. 2) A median INR of 
2 is safe in these pts and can be determined at 3-monthly intervals, 
3) Left ventricular dysfunction rather than valve related 
complications is the leading cause of mortality in these pts. 
ABSTRACTS 415A 
805·4 4:45 
ObStruction of the Inferior Vena caval Orifice by Giant Left Atrium In P. 
tlents with MHral Valve Replacement 
Shlnichi Minagoe, Junichi Yoshikawa, Kiyoshi Yoshida, Takashi Akasaka, 
Kenp Maeda, Tutomu Takagi, Masahiro Shakudo, Chuwa Tel 
Kobe General Hospital, Kobe, Kagoshima University, Kagoshima, Japan 
We previously reported that the giant lelt atrium (LA) obstructs the venous re•
tum from the inferior vena cava (IVC) at the junction with the right atrium (IVC 
Orifice) by marked rightward displacement of the atrial septum In patients (pis) 
wijh mitral stenosis (MS) using Doppler echocardiography. To examine whether 
this feature persists alter successful mijral valve replacement (MVR), the maxi•
mum dimension of the IVC orWice (IVC-d) by two-dimensional echocardlogra•
phy and the maximumlVC orifice flow velocity (IVC-v) by pulsed Doppler 
echocardiography were measured in 42 pts with MVR (mean follow-up time; 5.4 
yrs, mean age 56 yrs) from a right parasternal longitudinal plane. IVC-d and 
IVC-v were also measured in 12 of 42 pts before and one month alter MVR. All 
the pts had atrial fibrillation (AF) and did not have severe tricuspid regurgitation. 
The control population (CTL) conSisted of18 subjects with AF alone (mean age 
49 yrs). Peak flow velocities in the superior vena cava (SVC-v) and hepatic vein 
(HV -v) were also obtained by pulsed Doppler echocardlography from the stan•
dard views. Results: Pis were divided into 2 groups (Grp) according to the LA 
dimension (LA-d) (Grp A; LA-d<65mm, Grp B; LA-d~65mm). 'p<.05 and 
"pdl vs. CTL and Grp A 
n LA-d IVC-d IVC-v (p) IVC-v (m) HV-v SVC-v 
(mm) (mm) (Cm/5) (cm/s) (cm/s) (cm/s) 
CTL 18 42±6 20±2 68±13 37±8 53±17 58±16 
Grp A 26 49±9 25±7 66±22 40±12 58±14 65±24 
Grp B 16 n+l0" 17±8' 106±33" 60±24" 54+22 68±15 
Peak (p) and mean (m) IVC-V5 were significantly greater and IVC-d was signifi•
cantly smaller than in the CTL and in Grp A, while there were no significant 
differences in SVC·v and HV-v among the 3 Grps. There were significant 
negative correlations between the IVC-d and the IVC-v (p) (r.-.55, y=e-o ..... _u , 
p<.OI) as well as the IVC-v (m) (r=-.55. y_ e-o""-<2, p<.OI) in these 42 pts and 
CTL The IVC-d and IVC-v (p) before (21±4mm and as±31 cm/s) and one 
month alter MVR (20±5 and 84±40, respectively) obtained in 12 pts showed no 
significant changes. Conclusion: The IVC orifice In pts with MS and the giant 
LA is obstructed even after successful MVR due to persistent displacement of 
the atrial septum toward the right atrium. 
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Coronary Balloon Occlusion During PTCA - Are Clinical and 
Electrocardiographic Parameters of Ischemia Reliable in 
Predicting Left Ventricular Dysfunction? 
A.Hartmann. F.D.Maul. H.Klepzig. M.Zimny. G.Hor. 
M.Kaltenbach. G.Kober. Depts. of Cardiology and Nuclear 
Medicine. J.W.Goethe-University • Frankfurt. Germany 
Balloon inflation during percutaneous transluminal 
angioplasty (PTCA) causes transient total occlusion of the 
coronary artery and temporary ischemia of the left ventricle. 
Angina pectoris and ST-segment changes are commonly 
chosen as parameters of left ventricular ischemia during PTCA. 
We evaluated left ventricular dysfunction during coronary 
occlusion of 60 secs. duration with a newly developed 
miniature non-imaging Csi scintillation probe. Blood pool 
labeling was performed with 550·740 MBq of technetium-
99m-pertechnetate. 
Parameters of left ventricular systolic (ejection fraction-EF) and 
diastolic function (peak filling rate·PFR) were correlated with 
the occurrence of angina pectoris and 5T-segment changes on 
the intra coronary ECG. 23 patients (age 57 ±8.6 years) with 
stenosis of > 75 % in luminal diameter in one of the three 
major coronary arteries were investigated. EF decreased 
significantly during PTCA from 50.3 ± 15% to 37.1 ± 10.9% 
(p<O.01). PFR decreased from 2.46 EDV/sec to 1.9±0.7 
EDV/sec (p<O.01). 
5T-segment elevations were observed from 2 to 30 mm in 
22/23 patients (mean 9 ± 8.7 mm). There was no correlation 
between 5T·segment changes and the decrease in EF 
(y~0.19X + 6.4. corr.coeff=0.3. p= 0.15) and PFR 
(y =0.03 X +0.23.corr coeff. = O.4.P = 0.05). Angina pectoris 
occurred in 13 patients. 10 patients were asymptomatic. 
In conclusion. transient coronary occlusion during PTCA 
impairs systolic and diastolic ieft ventricular function.. The 
occurrence of angina pectoris and 5T-segment changes on.the 
intracoronary ECG do not correlate with LV-dysfunction, 
416A ABSTRACTS 
806·2 
Immediate Assessment of Balloon Angioplasty 
Result Using Atrial Pacing Stress Test. 
4:15 
Avanindra Jain, Robert Chilton. The University of Texas 
Health Science Center, San Antonio, TX USA. 
Despite a high acute success rate of coronary balloon 
angioplasty (PTCA) many patients return early with 
recurrent symptoms. Intravascular ultrasound and 
angioscopy after PTCA have shown significant residual 
narrowing in many pts with adequately dilated vessels on 
arteriography. To determine if atrial pacing at the time of 
PTCA would provide information as to the functional status 
of the coronary artery, we performed atrial pacing before 
and after PTCA in 37 pts with single vessel disease. 
Intracoronary ECGs (IC-ECG), sensitive markers of 
ischemia, were recorded from myocardium distal to 
stenosis by attaching the angioplasty guide wire to the V1 
lead of the surface ECG. With pacing to a mean HR of 
136±17 bpm (100-150), 33 pts developed angina and 31 
pts (84%) had transient ST segment change on the IC•
ECG. After dilatation with a mean residual stenosis of 27% 
(5-50%) and pacing to a HR of 146±11 bpm (110-150) 4 
pts had angina but 12 pts had transient ST segment 
change on the IC-ECG. These data suggest that (1) atrial 
pacing with IC-ECG recording can be easily performed 
before and after PTCA in the cardiac catheterization lab, 
(2) pacing stress will induce ischemia in most patients 
(84%) before balloon angioplasty, and (3) despite 
arteriographically adequate dilatation, 32% of patients 
continue to have evidence of inducible ischemia 
immediately after PTCA suggesting inadequate dilatation. 
Follow up of these patients would provide information as to 
the predictive value of a positive pacing study after PTCA. 
806·3 4:30 
Stress 201 Thallium SPECT Underestimates the Extent of 
Myocardium Area at Risk After Myocardial Infarction 
Gerard Ethevenot, Pierre Olivier, Karl lsaaz, Laurent Hennequin, 
Gilles Karcher, Etienne Aliot. Hopital Central, University of 
Nancy, France 
Whether PTCA of the infarct-related artery is beneficial in 
patients after myocardial infarction (Ml) is still debated. PTCA is 
usually indicated if the presence of jeopardized but viable 
myocardium is demonstrated in the infarct zone. The injection of 
99mTc-MIBI during total occlusion of the vessel by angioplasty 
balloon inflation may provide an accurate estimate of the 
myocardium area at risk in these patients. In this study, we 
compared the extent of MI and ischemia measured by stress TJ-
201 to the extent of non perfused myocardium measured by 
MIBI injected after one minute inflation of PTCA balloon in the 
infarct-related artery. We studied 15 patients (age 60 ± 5.2 yrs) 
who had a residual stenosis (>70% diameter reduction) of the 
infarct-related artery at the angiogram with no lesions on the 
other vessels. Ten patients had anterior MI and LAD stenosis and 
5 pts had inferior MI and right coronary stenosis. Stress TJ-20l 
was performed the day before PTCA and MIBI SPECr 
performed one hour after PTCA. Stress TI-201 total defect score 
and MIBI total defect score were calculated using a 4 point 
system for each of 20 SPECT segments (0 = normal uptake; 1 = 
moderatly decreased; 2 = severely decreased ; 3 = no tracer 
uptake). A difference ~ 3 in the total score was considered as 
signifkant. Ten of the 15 patients had identical stress 201 
Thallium and MIBI defect scores (23 ± 5). In the 5 remaining 
patients, stress TI-201 defect score was lower (15 ± 8) than MIDI 
defect score (21 ± 4 ; P < 0.05). Conclusion: Our data suggest that 
stress Thallium-201 performed at 1 month after MI 
underestimates the extent of the myocardium area at risk in 30 % 
of the patients with severe stenosis of the infarct-related artery . 
JACC Vol. 21, No.2 
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806·4 4:45 
Residual Flow to the Infarct Zone. A Frequent Phenomenon 
and a Significant Determinant of Myocardial Salvage 
I. P. Clements, T. F. Christian, R. S. Schwartz, S. To 
Higano, R. J. Gibbons. Mayo Clinic, Rochester, MN 
Sixty patients with acute myocardial infarction under•
went early coronary arteriography followed by successful 
direct angioplasty of the infarct-related artery. 
Myocardium at risk (MYO.RISK) and final infarct size 
(INFARCT) were determined from the extent of severely 
reduced perfusion found, respectively, before angioplasty 
and at discharge using technetium-99m sestamibi SPECT 
imaging. The presence of residual flow to the infarct 
zone before angioplasty, as estimated by the sum of 
antegrade flow in the infarct-related artery by TIMI 
grade (0-3) and collateral flow to the infarct zone by 
Rentrop grade (0-3), was associated wtih a reduction in 
INFARCT and enhanced myocardial SALVAGE (MYO.RISK•
INFARCT) and SALVAGE INDEX (SALVAGE/MYO.RISK) after 
angioplasty. 
RESIDUAL INFARCT SALVAGE SALVAGE 
FLOW Pts %L V %L V INDEX o 11 29f24 llfl .40f. 38 
1 12 31t20 9t9 .32t.28 
2 15 lOtll 20tl6 • 68t. 34 
3 18 6t9 20tl7 .77t.30 
4 4 6t7 27t20 • 72t. 37 
p (ANOVA) .001 .06 .005 
Collateral grade, TIMI grade, and residual flow pre•
dicted INFARCT with r values of 0.38, 0.44, and 0.59 
respectively. 
Conclusion: In acute infarction, residual flow to the 
infarct zone, which is frequently present, is a signifi•
cant determinant of final infarct size and treatment 
efficacy after reperfusion. 
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Diastolic Function in Lymphocytic Myocarditis: Doppler•
Pathologic Correlation 
Karen B. James, Kamthorn Lee, Robert E. Hobbs, Gustavo 
Rincon, Corinne Bott-Silverman, Norman Ratliff, Allan L. Klein, 
Cleveland Clinic Foundation, Cleveland, Ohio 
Restrictive physiology has been demonstrated in the presence of 
dilated cardiomyopathy. However, there have been no studies 
relating restrictive physiology and pathology in terms of 
lymphocytic infiltration. We therefore performed pulsed Doppler 
echocardiography of left ventricular (LV) inflows in 25 consecutive 
heart failure pts with biopsy-proven lymphocytic myocarditis 
(LM). There were 18 men and 7 women with a mean age of 48.7 
± 13.5 years. LV function was moderately severe-severe in 85%, 
and normal in 15%. 
Peak early (E) velocity, late (A) velocity, deceleration time (01') 
and filling pattern were assessed. These values were compared 
with a control population (NLS) and are shown with means and 
standard deviations: 
~ A.!m!ro ElA. .IITfiml 
LM 82±35 38±22 2.6±1.2 151±53 
NLS 67 + 14 49 ± 12 1.5 ±.5 194 ± 30 
P .001 .001 .0001 .0001 
There were significant differences in parameters of diastolic 
function as shown. In particular, the mean DT in LM was 
significantly shorter than that of controls. There was a trend, 
though not statistically significant, of shorter DT with higher 
density of T lymphocytes on biopsy in LM (r=-.36, p=.07). 
Diastolic filling patterns were abnormal in 24/25 (96 %) of the pts 
with LM, revealing a restrictive pattern in 21, abnormal relaxation 
in 3, and a normal pattern in 1. Conclusion: LM is associated with 
diastolic dysfunction, generally of a restrictive pattern. This 
restrictive diastolic impairment may be, in part, related to the 
lymphocytic infiltration of the myocardium. 
JACC Vol. 21, No.2 
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807·2 4:15 
Prognostic Value of Doppler Transmltral Flow Patterns in 
Patients with Congestive Heart Failure 
Gong·Yuan Xie, Martin R. BerIt, Melanie D. Mattson, Stephen K. 
Souther, Barbara A. Cutshaw, Allison S. Herring, Mikel D. Smith, 
Anthony N. DeMaria. University of Kentucky, Lexington, KY 
Previous studies have indicated that Doppler transmittal flow 
pattems(TMF) are related to functional class and exercise capacity in 
patients(pts) with congestive hean failure(CHF). However, the 
prognostic significance of TMF is not known. Therefore, we 
analyzed the relation of TMF and mortality in 100 consecutive pts (76 
male, 24 female; age 60 ± 11 yrs) with CHF (EF<40%). At entry, 
NYHA classification, EF by RNA, and Doppler echo were 
performed in all pts. TMF was obtained from apical 4-chamber view 
at mitral annulus level. Measurements included early filling(E) and 
atrial(A) velocities, FJA ratio, and deceleration time of E (DT). The 
patients were subdivided into two groups according to TMF: 
Group 1(42 pts) had FJASI or FJA 1-2 with DT>I40 msec; 
Group 2(58 pts) had E/A'22 or FJA 1-2 with DTSI40 msec, 
indicative of restrictive physiology. Results: Of the 100 pts, 26 
(26%) died during a follow-up period of 16 ± 8 months. The 
accumulated mortality in Group 1 and 2 was 5% vs 19% (p<O.05) at 
1 yr and 5% vs 50% (p<O.OI) at 2 yrs (Log-rank test). Cox 
proportional hazards model analysis revealed that TMF was more 
significantly related to mortality in pts with CHF than other variables: 
EE NYHAClIysIID NYHACIIvsIVl TMFCGPlysGP2) 
X2: 2.97 1.71 3.59 6.99 
P: 0.08 0.19 0.05 0.008 
Conclusion: Left ventricular diastolic fl1ling patterns. as assessed by 
Doppler echo. are important predictors of mortality in pts with LV 
systolic dysfunction. 
807-3 4:30 
Reduced Exercise Capacity in Patients with Congestive Heart 
Failure is Related to Doppler Restrictive Left Ventricular 
Filling Pattern 
Zukai Chatti. Karl Isaaz, Faiez Zannad, Mohamed Ismail, Jean•
Fran~ois Bruntz. Etienne Aliot. Department of Cardiology, 
University of Nancy, France. 
Previous studies have shown that reduced exercise tolerance (ET) 
in patients with congestive heart failure (CHF) is not related to 
resting parameters of left ventricular (LV) systolic function. In 
the present study, we evaluated the relation of ET to resting 
diastolic function as assessed by Doppler LV filling pattern in 31 
patients with CHF (NYHA grade n in 11 pts, grade III in 20 pts; 
age: 56±9 yrs; 8 idiopathic dilated cardiomyopathy and 23 
ischemic heart disease; resting radionuclide ejection fraction EF: 
27± 6%). Early (E) and late (A) maximal diastolic filling 
velocities (em/sec). isovolumic relaxation time (IVRT, msec) and 
pressure half time (PHT, msec) were measured by Doppler 
echocardiography. ET was estimated as the percent of 
theoretical maximal rate of total body oxygen consumption (% 
V02max) (gas exchange analysis, CPX medical graphics). 
Patients were divided into two groups based on the level of % 
V02max (G 1>50%, n = 16 and 02 S; 50%. n=15 ). 
Results: *p< 0.05 
% V02max EF (%) E A EtA IVRT PHT 
01 69±17 27±7 73±28 6O±14 1.3±o.6 94±20 49±19 
02 35±7* 27±4 82±23 44±22* 2.3±1.2*110±33 4O±17 
An inverse linear relation was observed between % V02max and 
EtA (r = - 0.50, P = 0.004) and E velocity (r = - 0.36, p = 0.04) ; 
% V02max was linearly related to A maximal velocity (r=O.38, p 
= 0.04) and to PHT (r = 0.47. P = 0.008). No significant relation 
existed between %V02max and ejection fraction. Conclusion: 
Patients with CHF and resting Doppler restrictive filling pattern 
(high EtA ratio) have more severely reduced exercise tolerance. 
Doppler echocardiography may be a clinically useful method for 
follow-up studies of patients with congestive heart failure. 
ABSTRACTS 417A 
807·4 4:45 
Characterization of Abnormal L.ft Ventricular Filling In 
Hypertrophic Hearts Ullng a Novel Kinematic Model 
David Prewitt. Samuel A. WIckline and SAndor J. Kov4cs 
Jewish Hospttal at Washington University Medical Center, St. louis. MO. 
The parametrized diastolic filling (PDF) formalism provides a mathematical 
expression for the transmitral diastolic Doppler velocity profile (DVP) based 
on the motion of a damped simple harmonic oscillator (SHO). A major 
advantage Inherent in the use of the PDF fonnallsm as compared with other 
diastoliC Indices such as the E/A ratio Is that fundamental global 
cardiovascular kinematic properties can be extracted from the DVP. To 
detennlne the sensltlvity of the PDF approach for quantHlcatlon of diastolic 
dysfunction, 5 patients with known hypertenSive hypertrophy (LVH) and 5 
without (NM L) prospectively underwent Doppler echocardlography. The 
following parameters were obtained from the model: 1) k. the spring 
constant. 2) xc. the Initial spring stretch. and 3) Fa, the computed forca of 
atrial contraction. The kinematic dimensionless ratio kxo'Fa was COlT1)8red to 
the conventional EJA ratio. LVH was defined by a LV postertorwall thickness 
~ 1.1 cm by M-mode echo. All patients had normal LV systolic function as 
determined by 2-D echo short axis and apical four -chamber views and were 
In sinus rhythm. 
The PDF approach provides Doppler-derived indexes of diastoliC function 
that appear more sensitive than the conventional EJA ratio. in addition. novel 
kinematic aHrlbutes analogous to physiologic diastolic events can be 
extracted from the DVP. This Illustrates the potenUal clinical utulty of the PDF 
approach for assessment of diastOliC function using Doppler 
echocardiography In diverse groups of patients and suggests that new 
insights Into diastOlic function may be gained by application of the PDF 
method. 
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808-1 4:00 
Intra-cardiac echocardiograpy during radio-frequency ablation: a new and 
accurate method of anatomic localization. 
Edward Chu, Michael Chin, Peter J. Fitzgerald, Krishnankutty Sudhir, Paul 
Heidenreich, Nelson B. Schiller, Paul C. Yock, Michael D. Lesh. 
University of California, San Francisco, CA 
We studied the anatomic accuracy of real time intra-cardiac 
echocardiograpy (ICE) in localizing and monitoring radio-frequency (RF) 
catheter ablation. We used a 10 MHz 10 Fr. over the wire imaging catheter 
in 8 anesthetized mongrel dogs. In the first 5 dogs, imaging planes and an 
analysis of venous approach was performed. The interatrial septum, right 
pulmonary vessels, and atrial appendage were best visualized from the 
superior vena cava. From the inferior vena cava, the coronary sinus, right 
ventricular outflow tract, eustachian, tricuspid, pulmonary and aortic valves 
were best identified. Seventeen RF lesions were then made in 3 dogs using 
ICE guidance and 7 and 8 Fr. 4mm long the~mister tipped catheters. Lesions 
were made at specific anatomic landmarks, as judged by ICE, at 20-50 Watts 
for 30 seconds with monitoring of thermister tip-endocardial contact 
temperature and impedence. Power was adjusted to produce temperatures 
of 50-100 degrees C. 
Catheter-endocardial contact was identified in 16 of 17 ablations 
(94%). Five lesions (29%) were seen immediately after ablation and 
thrombus was noted during lesion formation in 3 (18%) at the catheter•
endocardial interface. During generation of 2 lesions, micro-cavitation was 
seen at the catheter tip immediately before a rapid impedence and 
temperature rise. 
After ablation, the excised heart was dissected for lesion location, 
width and depth. Lesions were identified in relation to anatomic landmarks. 
The mean lesion volume was 30 mm3. Six of 17 lesions (35%) were within 2 
mm, 14 (82%) were within 5 mm, and all were within 10 mm of expected 
ICE locatioI'). The lesions disparate from the expected location were 
associated with movement of the ablation catheter tip or failure to identify 
endocardial contact. 
Conclusion: ICE is a new method of accurately localizing RF 
ablation lesions and ensuring catheter-endocardial contact. Unanticipated 
findings by ICE incloded identifying thrombus and defining the time of 
rapid impedence and temperature rise during lesion formation. 
418A ABSTRACTS 
808·2 
A New Cltheter for Rapid Mapping of Atrial Arrhythmias During 
Percutaneous Cardiac Catheterization 
Kathy J. Jenkins, Steven D. Colan, J. Philp Saul, James E. Lock, 
Edward P. Walsh. Chldren's Hospital, Boston, MA 
4:15 
A new mapping catheter for simultaneous recording of electrical 
activity from 25 bipolar electrodes was ussd In the right atrium during 
catheterization In 19 sheep (19.5-50kg). The catheter consists of 25 
pairs of electrodes arrangsd In a 3·0 ellipsoidal anay, 5 pairs each on 5 
arms of a ftexlble basket. The baskat Is delivered via an 11 F sheath 
from the femoral vein Into the right atrial appendage. The sheath Is then 
withdrawn, allowing the baskat to open and fllthe atrium and the 
electrodes to contact the atrial waD. 
Cathater shape, electrode spacing and Introduction technlqus were 
rnodlflsd In responss to the resUts of experiments In the first 12 animals. 
In the 7 most recent experiments, the basket was successfully 
posltlonsd within the right atrium, with good electrical contact, within 5 
minutes In all animals. Bipolar recordings were made In sinus rhythm 
In all animals. Sustalnsd atrial reentry tachycardia was Inducsd by rapid 
burst pacing and Intentional right atrial air embolus (3O-5Occ) In 4 
animals. Fltersd (30-250 Hz) bipolar racordlngs from au 25 electrode 
pslrs and surfaca EKG were recordsd and digltlzsd at 1000Hz using 
custom software to construct an activation map which was 
superlmpossd on AP and lateral fluoroscopic Images of the open basket 
catheter. 
All 7 animals remainsd stable throughout the procsdure. Post-mortem 
evaluation revealsd minor superficial abrasion of the atrial wall In all 
animals. One had a small myocardial perforation of the atrial 
appendage without hemodynamic consequsnce. No other damage was 
observsd. 
Conclusion: Multlelectrode mapping of sinus rhythm and atrial 
tachycardia within the right atrium can be rapidly accompllshsd during a 
cardiac catheterization. This new system may ultimately assist In 
mapping complex atrial arrhythmias during transcatheter ablation 
procsdures. 
808·3 4:30 
A NEW CATHETER FOR MAPPING AND RADIO FREQUENCY 
ABLATION OF THE AV NODE AND RIGHT SIDED ACCESSORY 
PATHWAYS 
Boaz Avltall, John Hare, Mlqdad Khan, Davk:I Krum, Cynthia LessIIa, Sanjay 
Deshpande, Anwer Dhala. Silal Samaritan Msdical Center, MDwaukee, WI. 
Since the trlcuapld valve ring Is directly accessible to catheters Introducsd 
from the major veins, It provides the setting for the Introduction of a ring 
type structure which adapts to the valvular ring and contsins an array of 
recordlng/abiatlon electrodes. The most eIfectIve approach for tissue abla•
tion around the tricuspid ring would be to simultaneously map the tricuspid 
ring and apply RF enargy to the recording electrode which identifies the 
deslrsd area for ablation. We have deslgnsd, constructsd and testsd a 
deflectable ring catheter equlppsd with sixteen 4 mm long electrodes, 
spscsd 4 mm apart. The most distal portion of the catheter ring Is equlppsd 
with a small secondary loop. The catheter, Introducsd Into the right atrium 
from the femoral vein, Is capable of adapting to the shape of the tricuspid 
ring when opensd and Is also capable of rotating across the valve plane by 
a sepsrate deflection control. The smalier secondary loop Is anchored In 
the RV outflow and the proximal end Is anchorsd by the Inferior vena cava. 
Discrete perlvalvular atrial sequential lesions were producsd In 3 doge 
around the trlcuapld valve without the nesd to readjust the catheter. 
Simultsneous recording from the catheter electrodes consIatsd of atrial and 
ventricular electrograma which could be adjustsd by discrete vertical and 
rotational movement 01 the catheter and changing the deflection angle of 
the ring. Placing the catheter at the tricuspid ring poslllon requlrsd lillie 
manipulation and remalnsd stable throughout the procsdure. 
Conclusion' This new approach to tricuspid ring mapping and perlvalviJar 
tissue ablation will expsdlte ablation procsdures and rsduce rsdlatlon 
exposure. 
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808·4 4:45 
Catheter Ablation of Atrioventricular Junction in Dogs Uncler Direct 
Vision Using An Angioscope 
Chien-Suu Kuo, Osamu Fujimura, University of Kentucky, Laxington, KY 
We have designsd an engioscopic sYBtem(ANGIS) conSisting of a fiberoptic 
endoscope encased in a thin wall flexible tube with an inflatable balloon secur•
sd at the distal end. By placing ANGIS intracardially and inflating the balloon 
with 5-10 ml Baline, endocardiac structure can be visuelized without requiring 
saline flushing. We testsd ANGIS in 8 anesthetized closed chest dogs for: 1) 
positioning of abiation(AB) electrode(EL) in coronary sinus(CS) or its vicinity or 
AV nodal(N) area under direct vision, 2) visualization of lesion and/or coagulum 
lannation during radiofrequency(RF) energy(E) delivery, 3) correlation of ana•
tomic location of lesions produced by RF E as seen by ANGIS & at postmortem 
examination, 4) effects ofRF E delivery on AV conduction. ANGIS is introduced 
via femoral vein, AB EL via internal jugular or femoral vein. His potential is re•
cordsd by an EL placsd at aorlic root. In each dog, CS is easily located and 
clearly seen. AS EL is placed near the tip of ANGIS under fluoroscopic guid•
ance & then positioned inside CS or its vicinity under direct vision. RF E (38 w, 
30 B) is deliversd through the distal terminal(4 mm, unipoiar). AB EL is then 
pulled under direct vision, its tip and the lesion are examined by using ANGIS. 
The location of the lesions is recordsd by video tape and photograph. RF E is 
delivered 3-18(av. 9) times in each dog which produced first(1'), second(2') 
or transient third(3') degree AH block(B) when RF E is delivered at medial 
edge and no effect on AV conduction when RF E is delivered at lateral or su•
perior edge of CS. In 3 dogs, 3' AV B with slow escape preceded by normal, 
ailersd or no His potential is produced when RF E is deliversd at AVN area 2-5 
mm from where l' or 2' AH B is produced. Lesion and/or coagulum formation 
can be visualized during RF E delivery. The postmortem anatomic location of 
the lesions correlates well with that seen by ANGIS. We conclude that ANGIS 
can: 1) assist placing of EL in CS & AVN areas and fine positioning of EL tip, 
2) visualize lesion/coagulum formation during delivery of RF E, 3) examine the 
lesions and EL tip. ANGIS can be useful for catheter AS in AV junction. 
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Hirudin and Thrombolysis with Front-loaded Alteplase in 
Acute Myocardial Infarction: Results of a Pilot Study 
Karl-L. Neuhaus, Rainer v_ Essen, Ulrich Tebbe, Albrecht 
Vogt, H.-R. Michels, Karl·P. Appel, Andreas Jessel, 
Uwe Zeymer, Medical Clinic n, Kassel, PRO 
Hirudin, a specific thrombin inhibitor, compledy blocks fibrin for•
mation durin~ thrombolysis in the experimental animal In a pilot 
study recombmant hirudin was used as adjunctive therapy during 
thrombolysis with a front·loaded regimen of alteplase (100 mg in 
90 min) in 40 patients (32 men, 8 women, 33-73 years, mean 58 ) 
with acute myocardial infarction (AMI). 
Hirudin·therapy was initiated by a bolus of O.07mg/kg, followed 
by an infusion of 0. OS mg/kg for 48 hours. APTT was kept bet•
ween 1.5 and 25 times control Angiograms of the infarct related 
art~ (IRA) were performed at 30, 60 and 90 min, at the end of 
the htrUdin infusion and before discharge. 
PATENCY .lQm1n .2WWl i2III.1.n!.all lid 
n 39 39 38 40 32 
TIMI 0/1 48.5% 15.2% 8.0% 15.0% 9.5% 
TIMI 2 13.2% 23.3% 21.0% 5.0% 9.5% 
TIMI 3 38.3% 61.5% 71.0% 80.0% 81.~ 
TIMI 2/3 51.5% 84.8% 92.0% 85.0% 90.5% 
There was no very early reocclusion up to the 90 min an~e. Bet•
ween 90 min and 48 hours reocclusion of IRA occurred m 8 pat 
(20 % ), four of the latter bad bad PTCA at 90 min. In three cases 
there were clinical signs of reocclusion after completion of the 
hirudin·treatment, none of them bad an occluded IRA at the pre· 
discharge angie. 
During hirudin treatment there was no severe bleeding and only 9 
minor bleeding complications. The onlr in hospital death (2.5 %) 
was due to a late retroperitoneal bleedmg. 
CONCLUSION: Hirudin given as an adjunct to front-loaded alte•
plase in a low dose pilot regimen is at least as effective as be•
parin. There were no safety problems so far. Consequently, a se•
quiential incremental dose finding study has been started 
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809·2 4:15 
Blockade of Platelet GP Ib Receptors Delays Thrombosis and Enhances 
Thrombolysis 
Sheng-Kun Vao, Judy C. Ober, Leonard Garfinkel, James J. Ferguson, H. 
Vernon Anderson, Marian Gorecki, Amos Panet, L MaxlmUian Buja, James 
T. Wlllerson. Texas Heart Instnute and UT Medical School, Houston, TX and 
810-Tech General Ltd., Israel. 
Platelet aggregation plays an Important role In the development of 
coronary artery thrombosis and acute coronary artery disease syndromes. 
We tested the hypothesis that blockade of platelet membrane glycoprotein 
(GP) Ib receptors prevents acute coronary thrombus formation. ThromboSis 
was Induced In the left anterior descending coronary arteries of 21 dogs by 
applying electrical stimulation to the endothelium of the artery. Coronary 
blood flow velocny was monitored by a pulsed Doppler flow probe placed 
around the artery. Three hours after the occlusive thrombi formed, dogs In 
Group 1 (n = 7) received tissue-type plasminogen activator (t-PA, 80 IIQ/kg + 
8 IIQ/kg/minute, I.v.) and dogs In Group 2 (n=7) received t·PA and VCl, a 
binding domain 01 Von Wlllebrand Factor which blocks platelet GP Ib 
receptors (4 mg/kg + 2 mg/kg/hour,l.v.).ln Group 3 dogs (n = 7), Vel was 
administered 30 minutes before the electrical stimulation. Treatment with t·PA 
resulted In thrombolysis In 1 dog In Group I, 2 In Group 2, and 5 in Group 
3. Coronary rethrombosis occurred in all the 3 dogs In Groups 1 and 2 and 
In 4 of the 5 Group 3 dogs whhln 180 minutes after thrombolysis. The times 
to thrombosis, thrombolysis, and rethrombosis were as follows: 
Group 1 Group 2 Group 3 
Thrombosis Time (min) lS± 4 lS± 4 70± 10 .... 
Thrombolysis Time (min) 86± 4 73± 11 47± 12" 
Rethrombosls Time (min) 36 54± 22 114± 18 
Compared with Group 1 and 2, "p<0.05; ·"p<O.OI. 
Ex vivo platelet aggregation Induced by botrocitln, a Von Wiliebrand factor· 
dependent activator of platelet GP Ib receptor, was completely inhibhed by 
Vel treatment. Thus, blockade of platelet GP Ib receptors delays coronary 
thrombus formation and may enhance thrombolysis whh t·PA and delay 
reoccluslon in this experimental canine model. 
809·3 4:30 
Hirulol as Adjunctive Therapy to Streptokinase In Acute 
Myocardial Inrarction 
Rosa·Maria Lid6n, Pierre Thc!roux, Raoul Bonan, Jacques Lesp6rance, 
John MaragallOre, Burt Adelman, David Waters. Montreal Heart Institute, 
Montreal, Canada 
Hirulog, a synthetic 20 amino acid, hirudin-like peptide with specific 
antithrombin action, was compared to heparin as adjunctive therapy to 
streptokinase (SK) in 42 patients with acute MI without contraindications to 
therapy. The primary endpoint was TIMI grade 2·3 angiographic patency of 
the infarct·related artery; safety data were carefully collected prospectively. 
All pts received 325 mg of oral aspirin and in one hour, 1.5 million units 
of SK i. v. Randomization to Hirulog (0.5 mg/kglhr for 12 brs followed by 
0.1 mg/kglhr for 84 brs) or to heparin (1,000 unitslhr adjusted to maintain 
aPTf at 2x control) was double·blind with single-blind administration. 
Angiographic data were analyzed blindly. The distribution of age (mean 
57 years, range 25·77), sex (10 women) and infarct-related artery (LAD 13, 
circumflex 6, and RCA 23) were similar in the 2 treatment groups. 
Hirl!I!!& HmIIliD. 1l..1EiiIIg 
N=28 N=14 exacttes!l 
Angiographic patency: 
• 90 min: TIMI grade 2·3 
TIMI grade 3 
- 120 min: TIMI grade 2-3 










• Death I (3.6%) 2 (14%) 
• Bleeding: 13 (46%) 9 (64%) 
puncture sites 12 (43%) 6 (43%) 






The incidence of bleeding at puncture sites was identical in the 2 groups. 
The one systemic hemorrhage with Hirulog was gastrointestinal and the 
3 with heparin were intracranial, retroperitoneal and intrapericardia!. 
Thus, hirulog holds promise as adjunctive therapy to streptokinase: clot lysis 
occurs more rapidly with no apparent increase in bleeding complications. 
ABSTRACTS 
809·4 4:45 
Culprit Lesion Changes in Acute Myocardial Infarction: A TIMIS 
Comparison of Patients Treated with t·PA and Either Heparin or 
Hirudin. 
419A 
Darry L. Sharaf, Nicholas Miele, Paula Ferreira, George R. McKendaIl, and 
David O. Williams. Rhode Island Hospital, Drown University, Providence, 
RI 
The new antithrombin, hirudin, may further reduce coronary narrowing 
and prevent reocclusion following thrombolytic therapy in acute 
myocardial infarction (AMI). To assess these effects, we compared percent 
stenosis (PS), minimum luminal diameter (MLD), TIM! flow (TF), 
thrombus grade [TG (score 0·4)] and complex lesion (CL) features [ulcer 
score (0-2), irregular contour score (0-2)] in 155 patients (PIS) with AMI 
treated with t·PA and either heparin or hirudin. Serial coronary 
angiography was done at 90 min and 18·36 hr after treatment. 

















































90 min 42 48 35 NS 
18·36 hr 28 27 29 NS 
The reduction in PS, MLD and TG for all pts between 90 min and 18·36 hr 
was significant (p<.03). Also, resolution of CL features occurred more 
often in hirudin than In heparin pIS. Thus both hirudln and heparin 
therapies are associated with continued culprit lesion thrombolysiS after t•
PA but CL resolution is more common with hirudin. Further study is 
needed to determine the clinical significance of this difference. 
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PREDICTIVE VALUE OF DIPYRIDAMOLE THALLIUM EARLY 
AFTER MYOCARDIAL IMFACTION. 
Hehdi H. Hoshiri*, Mark E. Hands, Geoff Groom, 
Agatha Van der Schaaf, Joseph Hung. Cardiology, 
SCG Hospital, Perth, WA 6009. Australia. 
Dipyridamole thallium testing COT) is useful in 
detecting the presence of reversible myocardial 
ischaemia, an important prognostic indicator 
post myocardial infarction (MI). However, the 
predictive value of DT for multivessel disease 
(MVD) and clinical events (CE) in the EARLY 
post HI has yet to be clearly defined. We 
performed DT 3-5 days post-HI in 165 patients 
(pts) aged 59±10 years, excluding those with 
heart failure and unstable angina. All pts had 
planar imaging immediately after DT and 3-4 
hours later following reinjection of thallium-
201, without complication. All pts were 
followed for 3 months. Coronary angiography was 
performed in 117 pts, of whom 90 had reversible 
changes on DT (+DT). Of these, 40% had MVD and 
57% had CE (revascularisation, death, or MI). 
Remote changes on DT (R) were detected in 41/90 
pts, of whom 83% had MVD and 78% had CEo The 
sensitivity, specificity and the predictive 
values (PV) are' 
+DT R 
MVD CE MVD CE 
sensitivity 91% 93% 87% 58% 
specificity 32% 37% 86% 85% 
positive PV 46% 57% 83% 78% 
neqative PV 85% 85% 90% 70% 
Cone lusion: DT EARLY post-HI 1S sate, ana 
sensitive for MVD and CE, with remote changes 
being highly specific and predictive for MVD. 
420A ABSTRACTS 
810·2 4:15 
Is Intravenous Dipyridamole Coronary Hyperemia 
Reversal By Aminophylline Equivalent To Adenosine 
Cessation? Comparison Using Continuous Intracoronary 
Spectral Flow Velocity Measurements 
Bassam AI-Joundi, Morton l. Kern, Thomas Donohue, Richard Bach, 
Frank V. Aguirre, Bernard R. Chaitman, D. Douglas Miller. St. Louis 
University Medical Center, St. Louis, MO 
.Intravenous adenosine (ADEN) is an attractive pharmacologic stress 
agent for myocardial imaging due to the rapid reversal of its hyperemic 
effect upon infusion cessation. The time course of intravenous 
dipyridamle (DIPY)-induced coronary hyperemia reversal by amino•
phylline (AMINO) has not been precisely defined in man. Therefore, 
we measured intracoronary continuous spectral flow velocity using an 
0.018" Doppler flowire in 6 patients with angiographically normal 
arteries before and during intracoronary ADEN (12mcg) and after 
DIPY (0.56mg/kg IV over 4 min). AMINO (125mg IV) was given at 
the peak of DIPY effect. The half-time of the average peak flow 
velocity (APV) return to baseline (TI/2 in minutes) was obtained by 
curve fitting analysis of on-line post-ADEN and post-AMINO APV 
data. Coronary vasodilatory reserve (CVR) was computed as peak 
h):peremjalbasal flow velocity. 
Results %4DFVj %4 APY Reversal Tta CVR 
DlPY 72±29 139±74 0.6±O.I* 1.7±O.3 
ADEN 138±22 146±28 O.OI±O.OI 2.7±O.3 
p value 0.02 NS <0.001 0.01 
"Reversal by AMINO. %4=ehange from base; DFVi=diastolic flow 
velocity integral (cm/sec); APV-average peak velocity (cm/sec>. 
We conclude that, although reversal of ADEN effect occurs immediate•
ly, 50% reversal ofDlPY hyperemia is achieved ~l min after AMINO 
administration. In the setting of myocardial ischemia during pharmaco•
logic stress perfusion imaging, the clinical significance of this time 
difference between AMINO reversal of DIPY effect and ADEN 
infusion cessation is likely to be minimal. 
810·3 4:30 
Sestamlbl and Echocardlography Imaging with High and Low 
Dose Adenosine 
Y. Jeffrey Chen, Jasvir Uppal, Susan Curry, Mau M. Dugal, 
Lynn Jacobs, Michael Siegle, Julio F. Thbau. LAC + USC 
Medical Center, Los Angeles, California 
We prospectively studied 59 pts with suspected coronary 
artery disease (CAD) using adenosine (A) infusion at either low 
(140 rg/kg/min) or high (200 rg/kg/min) dose combined with 
simultaneous echocardiography (ECHO) and SPECI' imaging 
with sestamibi (MIBI), to assess their relative value. CAD was 
defined as ~ 70% stenosis and it was present in 63% of pts. 
Side effects were common in 18% of pts worsened with the 
highest dose, but only one pt required premature termination of 
the study. 
The sensitivity and specificity for detecting CAD was similar 
between MIBI (80% and 64%) and ECHO (80% and 83%, 
respectively). However, whereas the yield of MIBI was not 
affected by A dosage. ECHO sensitivity increased from 71 % to 
90% due to the greater detection of pts with single vessel 
disease with the highest dose (64% vs. 91%, respectively). The 
predictive value for detecting or excluding disease of the left 
arterior descending was similar between MIBI (79% and 84%) 
and ECHO (77% and 88%, respectively, p=NS). However, 
MIBI detected the presence of multivessel disease better than 
ECHO 14/19 (74%) vs. 7/19 (37%), respectively. 
Conclusion: A-MIBI and A-ECHO offer comparable 
diagnostic accuracy for detecting CAD and can be used 
interchangeably. However, A-MIBI may be preferable since it 
better identifies multivessel disease at A-dosage associated with 
fewer side effects. 
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810·4 4:45 
Adenosine, Dipyridamole and Exercise Yield Comparable Tc·99m 
Sestamlbl SPECT Images 
Carlo D. Santos-Ocampo, Steven D. Herman, Mark I. Travin, Carol Ewing 
Garber, Alan W. Ahlberg, Debra E. Messinger, Gary V. Heller. Memorial, 
Miriam and Roger Williams Hospitals, Brown University School of 
Medicine, pawtucket and Providence, Rhode Island 
To assess how the varying degrees of myocardial hyperemia induced by 
adenOSine (AD), dipyridamole (OP) and treadmill exercise (EX) affect 
Tc-99m sestamibi SPECT imaging characteristics, 19 subjects (10 
normal controls In Group A and 9 patients with documented coronary 
artery disease (CADI In Group B) underwent imaging at rest and after AD 
(0.84 mg/kg), DP (0.57 mgJkg) and EX. Total and background-corrected 
myocardial counts were obtained from unprocessed SPECT Images for 
both IJoupB. In Group B, circumferential count profiles using SO radii at 
6° intervals were generated to quantify the count deficit index 
(maximum-mean/maximum) and the defect nadir (maximum-minimuml 
maximum). In addition, a 20 segment, 0-3 point scoring system 
(maximum defect score-SO) was used to visually assess the stress deficit 
(stress score/SO), defect size (lfabnormal segmentsJ20) and % ischemia 
(stress-rest score/SO). 
AD Op EX P 
Total MC Group A 6486±723 
Group B 6439± 1403 
Corrected MC Group A 3754±500 
Group B 3355±998 
















Stress Deficit (%) 23±19 21±14 23±14 
Defect Size (%) 42±26 42±18 43±20 
0lp Ischemia 14±13 14±9 15±9 






Myocardial counts were not different between Groups A and B, and no 
differences were detected between AD, DP, and EX in myocardial 
counts or defect parameters. CONCLUSIONS: 1) There are no 
significant differences in myocardial uptake of sestamibi after AD, DP 
and EX in normal controls or patients with CAD. 2) AD, DP and EX 
produce sestamibi SPECT defects of equivalent size and intensity. 
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Eplmyocardial vs. Endomyocardial Biopsy In Perlmyocardltis 
Bernhard Maisch, Ute Sch6nian, Alfonso Bittinger*; Departments of 
Internal Medicine-Cardiology and "Pathology, Philipps-University, 
Marburg, FRG 
Sensitivity and specificity of endomyocardial biopsy (EMB) has been 
controversial in myocarditis depending on the sampling error, the 
number of biopsy specimens and the histological criteria. In 
perimyocarditis(PM: pericardia! effusion(PE) and segmental wall 
motion abnormality or cardiac dilatation after exclusion of coronary 
artery disease by coronary angiography we reexamined the sensitivity 
of EMB and analyzed the value of epimyocardial biopsy(ECB) targeted 
by pericardioscopy. Patients: 10 patients(7ma1e, 3 female, mean age: 
42,6+9.4 years) with PM and pericardia! effusions> 250 m1 underwent 
EMB and pericardiocentesis with perlcardioscopically ECB. Methods 
Included cineangiography, coronary angiography, left ventricular 
EMB, perlcardiocentesis and pericardioscopy with ECB, specimen 
analysis by light microscopicy or immunocytochemistry (>5 
lymphocytes/ granulocytes per high power field(hpf), 2 biopsies/pt), 
pericardial cytology and immtmohistochemistry. Results:AII 10 
patients had pericardial effusions rich in granulocytes and 
lymphocytes but no neoplastic cells. Histological and 
immunohistological data("P<O.OS): 
rarameter ECBI%posl EMBI%posl 
Cellular infiltrate in 1M (>5 /hpf) 60 20* 
Cellular infiltrate with anti-CD3(>5/hpf) 80 40* 
Immunocytochemistry: IgG-fixation 90 80 
IgM-fixation 60 50 
C3-fixation 50 40 
MHC class !-de novo expressjon 90 80 
Conclusion: ECB is superior to EMB in patients with clinically 
suspected perimyocarditis. Both methods, however, still suffer from a 
oonsiderable sampling error. Binding of IgG, IgA, IgM and C3 as well 
as MHC class I expression yielded comparable results indicative of an 
active immune process in perimyocarditis. 
lACC Vol. 21, No.2 
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Constrictive Pericarditis : Changes in the Etiologic 
Spectrum, Early and Late Postoperative Results 
Patrice Cacoub. Patrick Nataf. Alain Pavie. Richard Dorent. 
Pierre Godeau. Christian Cabrol. Iradj Gandjbakhch. CHU La 
Pitil~. Paris. FRANCE. 
The records of 85 patients (70 males. 15 females). aged 15 to 78 years 
(median 46 years). who underwent operation for constrictive pericarditis 
(CP) from 1979 Ihrough 1989. were reviewed. 
The duration of symptoms prior to diagnosis varied from one month to 
22 years (median 20 months). Preoperatively. patients were in NYHA 
class III or IV (72%). had right cardiac failure signs (88%) or anasarca 
(18%). On chest radiography. there were pericardial calcifications (40%) 
and heart enlargement (28%). Echocardiography revealed a pericardial 
thickening (62%). A dip-and·plateau pattern in the right ventricular 
waveform was found in 47/62 patients (76%). 
A specific etiologic factor was identified in only 37 patients : 
tuberculosis (12%). repeated acute pericarditis (9%), bemopericardium 
(9%). radiotberapy (5%). JX'Cvious cardiac surgery (4%), bacterial infection 
(2%). myocardial infarction (2%) and connective tissue disease (2%). In 48 
patients (56%), CP remained idiopathic. 
Subtotal pericardiectomy (from phrenic nerve to pbrenic nerve) was 
performed in 75 patients but extent of pericardiectomy was limited in 10 
patients. Operative mortality was 2.3% and 8.2% patients developed early 
non lethal complications. Probability of survival for patients dismissed 
alive from the hospital was 94% at 3 years, 87% a17 years and 76% at 12 
years. There were 4 non cardiac-related late deaths. Variables significantly 
influencing the mortality and morbidity after operation were age, longer 
duration of symptoms and higher intracardiac pressures prior to 
pericardiectomy. There was no reoperation for recurrent constriction. At 
the lime of the latest follow·up, all patients were in NYHA class I or II. 
Conclusion : • in last decade, tuberculous CP has declined in incidence 
whereas "new" etiologies such as repeated acute pericarditis, 
bemopericardium. radiotherapy or previous cardiac surgery have emerged 
•• subtotal pericardiectomy through median sternotomy is a safe and 




Long Terml'olIow·Up After Percutaneous BanOOR Perlcardlotomy 
for the Tn!atmeut of Effa8Ive PerIcudIal DIaeaae 
Andrew A. Zlsklnd. Cynthia C. Lemmon. James F. Gardner. Igor F. 
Palacios for the PBP Registry Investigators. University of 
Maryland. Baltimore. Maryland 
Percutaneous balloon pericardiotomy (PBP) may offer a non•
surgical alternative for the management of pericardlal effUSion. 
particularly for patients (pts) with advanced malignancy and 
limited survival. This Is the first long term follow-up report of pts 
treated with PBP In the multicenter registry. 
Between July 1987 andApTllI992. 62 pts (mean age 58±13years) 
underwent PBP using a 20 nun x 3 cm dilating balloon (Mansfield) 
Introduced over a gwdewtre via a percutaneous subxlphold 
approach. Ser:laI chest x-rays and echocard1ograms were obtained 
during a mean follow-up of 147±l23 days (range 4-530 days). Forty•
one pts presented with peTicardtal tamponade, 21 had large 
effUSions felt to be at Tlsk for the development of tamponade. 
Thirty-two had undergone pTior peTicardlocentesls. Fifty-three 
had a history of mallgnancy. 
PBP was successful In 56 pts (90%). Two pts were considered 
failures due to peTicardlal bleeding and underwent surgical 
windowing. Four pts had recurrence of pericardlal effusion (mean 
time to recurrence 30±38 days). Those 4 underwent surgical 
wlndowtng, but 3 again recurred. MInOr complications occurred In 
14 (23%). the most frequent being fever. No patient had documented 
bacteremia or positive pericardla1 fluid cultures. Following PBP. 
thoracentesis or chest tube placement was required In 32% of pts 
with pre-existing pleural effUSiOns vs. 9% of pts without pre•
existing pleural effusions. 
Forty-four of the 53 pta with a history of mallgnancy died 
compared with 1 of 9 with nonmallgnant disease. The mean 
survival for pts with a history of malignancy was 132±112 days. No 
procedure-related variables were found to Influence either survtval 
or freedom from recurrence (eg: # of sites dllated. visualization of 
free flUid exit. duration of catheter placement). 
Conclusion: Percutaneous balloon pericardiotomy successfully 
treats effusive pericardlal disease. This IS a partlcular advantage 
for patients with advanced malignancy and llmlted sUTVlval. 
ABSTRACTS 
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Evaluation of Colchicine Therapy in Recurrent 
Pericarditis 
Alain Millaire, Pascal de Groote. Eric 
Decoulx, Luc Goullard, Gerard Ducloux. 
H6pital Cardiologique, Lille, France 
Colchicine (C) has proved effective in 
ending corticoid therapy in steroid dependent 
recurrent pericarditis (RP). To assess the 
usefulness of C in RP before corticoids need 
to be used, 19 pts (10 male, 9 female, age 
46±7 years) with RP (2 episodes [El or more) 
were treated with C (1 mg daily) during 1 to 
27 months (mean=7.7). Before C, these pts had 
a total numb~r of 57 E of pericarditis 
(mean=3±.5 E/patient) despite the use of 
nonsteroidal antiinflammatory drugs. The mean 
interval time (IT) between the different E 
was 6.9±5.6 months. After C, no recurrence 
occurred in 14 out of the 19 pts (74%) during 
a follow-up of 25.5±7 months. In 4 out of the 
19 pts (21%), 5 recurrences occurred, 
resolved without requiring corticoids, the 
further recurrence- free follow-up was 15±9. 2 
months. Only one patient (5%) had mUltiple 
recurrences requiring corticoids. Tolerance 
was good except 2 cases of diarrhea and 1 
case of hypothyroidism due to an associated 
long-term antidiarrhea therapy (including 
iodin). The overall duration of the 
recurrence-free follow-up (21.9±6.2 months) 
was significantly different from the IT 
(p<.OI). In conclusion, colchicine offers a 
very good benefit/risk ratio in patients with 
recurrent pericarditis and could avoid the 
use of corticoids. 
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Neutrophil Deposition on Injured Vessel Wall: Effect of Shear 
Rate, Vessel Stenosis and Heparin 
Joseph Hung, Jules Y.T. Lam, Lucie L.-Lacoste, Yayhe Merhi. . 
Montreal Heart Institute, Montreal, Canada 
Neutrophils interacting with the injured vessel wall may modulate 
thrombus formation and vasomotor tone. Whether shear forces and 
stenosis influence neutrophil deposition on the injured vessel wall and 
whether neutrophil deposition is inhibited by heparin was examined 
by flowing arterial blood from normal pigs (n=6) over porcine aortic 
media (simulating deep vessel injury) placed in cylindrical flow 
chambers. The flow chambers were designed to examine laminar flow 
at shear rates of 425 and 3,360 sec" and turbulent flow with stenosis 
of 50% or 75% diameter. Indium'"-labelled neutrophil deposition on 
aortic media was studied before control and after 200 iulkg heparin. 
The following differences in neutrophil deposition (xlQl/cm2) were 
observed: 
Shear rate (sec") ~ 
ill lJQQ ~ 
Control 32.9±2.4 55.5±7.4t 57.8±8.5t 
Heparin 9.2±2.9* 9.4±3.5* l3.4±3.8* 
mean ± SEM; t p<0.05 vs shear rate 425; 




Thus neutrophil deposition on injured vessel wall is significantly 
increased by a high shear rate and by luminal stenosis. The turbulent 
flow associated with a 50% stenosis produces equivalent neutrophil 
deposition as a high laminar flow shear rate of 3,360 sec". Heparin 
inhibits neutrophil deposition at the shear rates and stenoses tested, 




Nucleotide Kodulation of Glibenclamide Binding 
and ATP-Sensitive Potassium Channel Blockade in 
Vascular Smooth Kuscle 
Richard J. Kovacs and Timothy D. Hodges. 
Department of Medical Research, Kethodist 
Hospital of Indiana, Indianaolis, IN 
ATP-sensitive potassium channels (K
A1P
) 
regulate membrane potential in vascu ar smooth 
muscle (VSK), and are the site of action of 
exogenous and endogenous vasodilators. 
Glibenclamide (Gli) blocks K T in VSH. High 
affinity binding sites for Gt1Phave been 
identified in VSK. We tested a hypothesis that 
nucleotides modulate binding of Gli to its 
receptor in VSK, and hence modulate Gli block 
of KATP ' Experiments were performed using VSK membranes from canine aorta. 125-1 labelled 
Gli was bound to VSK membranes in the presence 
and absence of ATP, APD, and ratios of ~P/ATP. 
Single channel measurements were made using VSH 
membranes incorporated into planar bilayers. 
ADP (lmK) increased Gli binding 4-fold (from 40 
± 12 to 161 ± 25 fmols/mq protein n=4 p<0.01). 
ATP had no effect on G1i binding. AOP (lmK) 
enhanced Gli (50 UK) block of KAT (redUCing 
p(open) from .12 ! .05 to .03 ± .02 n-S 
peO.Ol). ATP had no effect on Gli block. ADP 
had similar effects on Gli block in the 
presence of ATP, but effect was dependent on a 
ratio of ADP to ATP greater than 1. We conclude 
that ADP but not ATP modulates Gli block of 




Hypoxia-Induced Vasodilation of Isolated Rabbit Coronary 
Arteries - Neurogenic and Endothelial Mechanisms 
Peter Collins & Canwen Jiang 
National Heart & Lung Institute, London, UK. 
Coronary artery rings from adult male New Zealand white rabbits 
with, or without endothelium, were suspended in Krebs for 
measurement of isometric tension. Prostaglandin Flo< (PGFlo<' 31'M) 
precontracted endothelium-intact and -denuded coronary arteries by 
0.9±0.1 and 0.9±0.2 g respectively (n=8; P>0.05), in the 
presence of indomethacin (10 pM). Hypoxia induced by bubbling 
modified Krebs solution with 95% ~ and 5% CO2 instead of 95% 
O2 and 5% CO2, caused a transient relaxation of 38±35% and 
17±2% (P<O.05 in comparison with time-matched controls) in 
endothelium-intact and -denuded arteries respectively. Incubation 
with tetrodotoxin (1TX 3 and 10 I'M) for 20 minutes decreased 
relaxation to 31±3% (P<0.05) and 21±4% (P<O.OI) in 
endothelium-intact rings, and 14±2% (P>O.OS) and 1l±1% 
(P< 0.05) in endothelium-denuded rings. Atropine, propranolol and 
phentolamine (10 I'M) did not affect hypoxia-induced dilation. The 
relaxation was also reduced to 30±2% (P<0.05) and 16±2% 
(P<O.OI) by ~-monomethyl-L-arginine in endothelium-intact rings 
and restored by L-arginine (ImM) but not D-arginine. 
These results suggest that hypoxia-induced vasodilation is mediated 
by the release of endothelium-derived relaxing factor in isolated 
rabbit coronary arteries and also partially by a neurogenic 
mechanism, possibly by the activation of non-adrenergic and non•
cholinergic nerve endings. 
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Glibenclamide Inhibits Coronary Relaxation Induced by 
Calcitonin Gene-Related Peptide (CGRP) but not by Vasoactive 
Intestinal Polypeptide (VIP) 
Peter Collins & Canwen Jiang 
National Heart & Lung Institute, London, UK. 
It has been shown that CGRP and VIP relax cerebral arteries and 
that activation of ATP-sensitive K (K"TP) channels is involved in the 
CGRP-induced relaxation in these vessels. In this study, the role of 
K"TP channels in coronary artery relaxation induced by CGRP and 
VIP was assessed. Epicardial coronary artery rings from male adult 
New Zealand white rabbits were suspended in organ baths for the 
measurement of isometric tension. Prostaglandin Flo< (3 I'M) caused 
contraction by 0.SiO.03 and 0.9±0.02 g (mean±S.E.M., n=8) in 
endothelium-intact (E+) and -denuded (E-) rings. CGRP (0.001, 
0.01,0.1 and 1i'M> induced relaxation by HI %, 22±3%, 60±4% 
and 81±5% in E+ arteries, and 4±1%, 24±3%, S7±3% and 
82±3% in E- rings (P>0.05 between E+ and E-). Glibenclamide 
(I and 10 I'M), a specific inhibitor of K" TP channels, caused no 
further contraction in precontracted arteries. In E- rings, 
glibenciamide (I and 10 I'M) reduced the CGRP-induced relaxation 
to 3±1 %, 20±2%, 46±3% (P<O.OS) and 67±3% (P<0.05); and 
1±0.2%, 12±2% (P<O.OS), 33±4% (P<0.05) and 60±4% 
(P<O.OS). VIP (0.001, 0.01, 0.1 and 1 I'M) caused relaxation by 
3±1 %, 22±4%, 37±3% and 62±6% in E- rings. Glibenc1amide 
did not inhibit the VIP-induced relaxation (P>0.05). Apamin, an 
inhibitor of Ca ++ -activated K+ channels, did not affect the relaxation 
induced by CGRP or VIP. These results suggest that activation of 
K"TP channels partially mediates coronary artery relaxation induced 
by CGRP but not by VIP. 
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Eifert or Age and Gender on Pulmonary Hemodynamics 
D.W. Kitzman, M.J. Sullivan, P. A. Beere. and M. B. Higginbotham 
4:00 
Duke U. Medical C.enter, Durham, N.C. and Bowman Gray School of Medicine 
of Wake Forest University, Winston·SaIem, N.C. 
Pulmonary hypertension has important prognostic implications in elderly 
patients. H~, 3\-ailable data regarding pulmon3lY hemodynamics were 
derived from young male subjects and from patients referred for catheterization, 
who may not be \-alid normal controls. Therefore. we examined pulmo~' 
hemodynamics with right heart catheterization in 72 male (M) and 32 female (F) 
asymptomatic. healthy. unmedicated. normotensn-e community dwelling 
volunteerS. aged 20-76 years, who had normal screening spirometry, exercise 
radionuclide ventriculography, and ec:hocardiograpby. Measurements included: 
systolic. mean and wedge pulmonary artery pressure (SPAP. MPAP, and WP 
respectively), mean right atrial pressure (MRAP). and mean systemic arterial 
pressure (MAP) in mm Hg. Fick cardiac index (CI), in Uminlm2. pulmonary 
and systemic vascular resistance (PVR and SVR) in dynes s ern 5, and latio of 
PVR to SVR (V.Ratio). Mean ;!:S.D. and p \'BIue (pg) for M \'S. F, and regres•
sion coefficients (r) and p \-alue (Pa) for all subjects combined vs. age were: 
M F Pg r Pa 
SPAP 23.8±5.7 21.9::5.4 0.10 0.18 O.oJ 
MPAP 15.7±3.3 15.0:::3.1 0.30 0.04 0.37 
MRAP 6.5:':2.~ 5.1:,:1& 0.01 0.14 0.11 
WP 9.2±2.6 8.7±2.7 0.40 0.26 O.lKKIl 
MAP 96 94 0.31 o.~o 0.0001 
CI 3.3;!:O.9 3.6±1.0 0.30 .0.35 0.0001 
PVR 91±53 97±57 0.60 0.50 0.0001 
SVR 1288 1377 0.35 0.49 O'c)()Ol 
V. Ratio 0.68 0.68 0.93 0.28 0.002 
There were no gender differences noted except for slightly higher MRAP in M. 
With advancing age SP AP. WP and MAP increased significanlly, ,,-bile there 
was no change in MPAP and MRAP. With aging CI declined, and PVR. SVR 
and V. Ratio increased significantly. Thus. PVR and SVR increase progressh'ely 
,,1th normal aging independent of gender, and PVR increases out or proportion 
to SVR. These data indicate that normal aging is accompanied by significant 
changes in pulmonal)" hemodynamics, and may be useful in understaDding the 
pathopbysiology of pulmonary hypertension in the elderly. 
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The Association of High Serum Lp(a) Level and High Cholesterol 
to HDL-Cholesterol Ratio is the Best Predictor of Coronary 
Artery Disease (CAD) in Women 
B. Charles Solymoss, Michel Marcil, Eva Wesolowska, 
Jacques Lesperance, Lucien Campeau. Montreal Heart Institute, 
Montreal, Quebec 
Whereas CAD is the leading cause of death among women, its risk 
factors were less extensively studied than in men. We compared the 
relative importance of various risk factors of angiographicall y 
documented CAD in women younger than 60 years; patients post•
PTCA, with antilipemic treatment, acute MI or valve disease were 
excluded. Pts with intact coronary arteries were considered as 
controls (n=69) and those with > 25% stenosis as cases (n= 144). 
The lipids were measured with enzymatic methods, apolipoproteins 
AI and B with nephelometry and Lp(a) with RIA. There were 
significant differences between controls and cases by univariate 
analyses concerning age (48.2±7.8 vs 52.0±6.6 years) and all the 
lipids and apolipoproteins. The relative frequency of smoking was 
higher among cases and of estrogen replacement among controls, with 
no significant differences in the frequency of diabetes, hypertension 
or family history of CAD. In multivariate analysis, the following 
parameters were selected as independent risk factors of CAD (odds 
ratio and 95 % confidence intervals): the ratio of cholesterol (C) to 
HDL-C (1.74; l.47-2.04); Lp(a) (5.19; 2.04-13.18); age (Lll; 1.05-
1.17); estrogen replacement (0.55; 0.33-0.92). The odds ratios of 
CAD, based on combined tercile values of Lp(a) and C to HDL-C 
ratio, indicate the lowest risk (0.2;0.1-0.4) if both values are within 
the first tercile, a considerably high risk (4.2;1.3-13.3) if Lp(a) level 
is in the second and C to HDL-C ratio in the third tercile, but the 
highest risk (15.1 ;3.2-31.2) when both are in the third tercile. These 
data suggest a synergistic or mutual modulating influence of Lp(a) 
and the C to HDL-C ratio on CAD. 
813-3 4:30 
The Acute Vascular Effects of 178-Estradiol in 
Postmenopausal Women 
David M. Gilligan, Diane M. 8adar, Julio A. Panza, Arshed A. 
Quyyumi, Richard o. Cannon, 111. NHLBI, Bethesda, MD. 
Although estrogen replacement therapy may reduce cardiovascular 
events in post-menopausal women, little is known of the acute 
vascular effects of estrogen replacement in humans. Experimental 
studies suggest a variety of effects, including potentiation of 
endothelium-dependent vasodilation. 
We studied the effect of 17B-estradiol on the peripheral vascular 
responses to the endothelium-dependent vasodilator acetylcholine 
(Ach; 7.5, 15, 30/Lglmin) and to the endothelium-independent 
vasodilator sodium nitroprusside (SNP; 0.8, 1.6, 3.2 /Lg/min) in 8 
postmenopausal women, age 60±3 years (mean±SEM). Ach and 
SNP were infused into the brachial artery in conjunction with 
either 5% dextrose or estradiol (45 ng/min). Forearm blood flow 
(ml/minllOO ml. volume) was measured by strain gauge 
plethysmography. Estradiol infusion increased venous estradiol 
levels in the ipsilateral forearm from < 30 to 321± 129 pg/ml. 
Estradiol had minimal effect on resting blood flow (3.4±0.5 to 
2.6±0.4, p=0.12). However, estradiol enhanced the vasodilator 
response to Ach (p=0.036); peak flow increased from 14.0±4.5 
to 17.8±4.6. Estradiol also enhanced the vasodilator response to 
SNP (p=O.044); peak flow increased from 1O.5± 1.5 to 12.6±5.0. 
Thus, in postmenopausal women, estradiol does not cause direct 
vasodilation in the forearm but it does potentiate the endothelium•
dependent vasodilation of Ach and the endothelium-independent 
vasodilation of SNP, both cyclic GMP mediated responses. These 
effects may contribute to long-term cardiovascular benefit. 
ABSTRACTS 
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Improved Sensitivity of Seismocardiography Compared to 
Electrocardiography for the Diagnosis of Coronary Artery 
Disease During Exercise Stress Testing in Elderly Women 
Richard A Wilson, Virinderjit S Bamrah, Joseph Undsay Jr, 
Markus Schwaiger, Joel Morganroth 
Oregon Health Sciences University, Portland, OR 
423A 
Exercise electrocardiography (EeG) has been shown to be 
relatively insensitive for the diagnosis of coronary artery disease 
(CAD) in women. Seismocardiography (SCG) is a new technique 
in which an accelerometer is placed on the lower sternum before 
and immediately after exercise stress testing to record changes in 
the compression waves emanating from the heart due to changes 
in regional wall motion induced by ischemia. In a multicenter 
study comparing the diagnostic accuracy of ECG vs SCG, 33 
women underwent simultaneous ECG and SCG exercise treadmill 
testing. Coronary angiography was performed and CAD, defined 
as2 50% stenosis in a major coronary artery, was present in 21 
women and absent in 12. The sensitivity and specificity for the 
detection of CAD were compared for ECG and SCG for all 
women, for those women > 50 yrs and for those women > 60 yrs. 








ECG SCG ECG SCG 
24 81* 75 67 
28 78* 75 67 
36 93* 71 86 
In conclusion, SCG appears to improve the sensitivity of exercise 
testing in older women without the loss of specificity. 
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Evidence of an association of high blood insulin levels and Coronary 
Artery Disease. 
Paolo Spallarossa, Claudio Brunelli, Giorgio Ghigliotti, Davide Caruso, 
Renzo Cordera, Gabriella Andraghetti, Pasquale Lantieri, Manrico 
Balbi, Salvatore Caponnetto. Dept of Cardiology and DI.S.E.M., 
University of Genoa Italy. 
Aim of the study was to investigate the potential role of hyperinsulinemia 
as risk factor for coronary artery disease (CAD). We determined the 
blood levels of insulin after a 12 hour fast (F), and one (I) and two hours 
(II) after an oral 75gr glucose tolerance test in 76 patients with no 
history of diabetes. The value of peak insulin level was also recorded. 
Evidence of stenosis greater than 70% was considered discriminant 
between CAD+ and CAD- groups. Extent of CAD was assessed 
counting the number of vessels (NY) and coronary segments (NCS) with 
~ 70% stenosis, according the IS-segment coding system of the 
American Heart Association 
Insulin F 1* II Peak 
. CAD- 6.1+ 1.5 42.5±25.4 59.6+53.4 66.4+51.8 
CAD+ 8.3+5.1 62.0±37.6 69.2±56.5 84.7+55.1 -*p<O.O', Mann-Whitney test 
Spearmann Correlation Coefficents 
Insulin F I II Peak 
NV .207 .308** .lll .252" 
NCS .212 .275· .156 .254" 
Lijlids Cholesterol LDL HDL Trit!1vcerid. 
NV -.045 .019 -.164 .259" 
NCS -.037 .032 -.127 .226 
*p<O.05; **p<O.OI 
Our preliminary data document a positive association between insulin 
levels and angiographic evidence of CAD of at least similar magnitude of 
that exerted by major risk factors. 
424A ABSTRACTS 
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lDpict of cardiovascular Risk Factors in Diabetics. 
Malec Mokraoui, william Kannel. 
'!be Framingham Heart study, Framingham, Mass. 
4:15 
The relationship of Diabetes (OM) to cardiovascular 
disease (CVO) is not fully understood. To determine 
whether cardiovascular risk factors (RF) have a 
stronger impact on OM than non-OM, the Framingham 
cohort is analyzed after 36 years of follow-up • 
. The age-adjusted absolute and relative risks of 
developing CVO is higher in all DM compared to non-OM. 
There is even a greater risk in females (F) under 64 
compared to males (M) in the same age group (3.65 vs 
2.21 P< .001). This gender difference in risk 
disappears after the age of 65 (1.79 vs F 1.7 vs M 
p=NS). 
This increased risk in OM compares equally with the 
one associated with other RFs, except for ECG-LVH 
(whose associated risk is much higher), in all age and 
sex groups. 
Although there is a higher prevalence of RFs present 
in OM, and a variability in the risk associated with 
it (depending on the nUl!Der of RFs present) the risk 
of CVD is much higher in OM than in non-OM at any 
given level of RFs present. 
In addition, using bi- and multivariate logistic 
regression analysis, the age and RF-adjusted 
regression coefficient for the incidence of CVO are 
not any higher in DM than non-OM. 
Finally, the age-adjusted prevalence of OM has 
increased over the last 36 years. 
Conclusioo: 
1- OM is a rna jor and independent RF, and its 
prevalence continues to increase. 
2- The increased risk associated with it, cannot be 
explained entirely by the mere presence of other RFs 
nor by their greater impact on OM. 
814·3 4:30· 
Pre.ature Coronary Heart Disease: Predictive 
Value of Faaily History 
Thomas J. Starc, Peter F. Belamarich, Marc S. 
Jacobson, Robert Mahedo, Elizabeth R. De 
Oliveira e Silva, Christine L. Williams, Lori 
Mosca, Welton M. Gersony, Richard J. Deckel•
baum. D. Peds., Schneider Child Hosp, NY Med. 
Col., Rockefeller U., Columbia U., NY, NY. 
Family history is often used to identify chil•
dren at risk for premature coronary heart 
disease (PCHD). However, there are limited 
data verifying the strength of this associa•
tion. Parents of hypercholesterolemic children 
may be young, and PCHD may not have yet been 
expressed. Therefore we investigated the 
parent to grandparent PCHD relationship to 
assess the ability of a family history to iden•
tify those at risk. Data were reviewed from 4 
lipid centers. We studied 98 families of chil•
dren referred for hypercholesterolemia in which 
a parent had PCHD (5 55 years). PCHD occurred 
in 87 fathers and 11 mothers at a mean age of 
38 ± 7 years. Only 33% of families in which a 
parent had PCHD also reported PCHD in a related 
grandparent (95% CI, 24-42%). Hypercholester•
olemia was reported in 52/72(72%) of affected 
parents. Other risk factors were present in 
78% (95% CI, 62-82%) including smoking 72%, 
hypertension 39%, and diabetes 8%. In summary, 
in the majority of parents with PCHD (67%), 
their own parents did not have PCHD. PCHD was 
often associated with other risk factors in 
addition to hypercholesterolemia. Our data 
suggest that family history may be inadequate 
to identify all children at risk for PCHD. 
JACC Vol. 21, No.2 
February 1993:424A 
814·4 4:45 
Association Between Plasminogen Activator Inhibitor Antigen 
and Lipid Levels in the Framingham Offspring Population 
Geoffrey H. Totler, Patrice Sutherland, Ping Xu, lzabella Lipinska, 
Otavio Gebara, Murray Mittleman, Peter Wilson, Daniel Levy, James 
E. Muller, Institute for Prevention of Cardiovascular Disease, 
Deaconess Hospital and the Framingham Heart Study, Boston, MA 
There is increasing evidence that elevated plasminogen 
activator inhibitor (PAl) levels are associated with an increased risk 
of cardiovascular disease. An association has also been described 
between PAT and elevated lipid levels. In 179 subjects (51% male) 
enrolled in the Framingham Offspring Study, we determined the 
relationship between PAl antigen (measured by ELISA) and fasting 
triglycerides, total cholesterol (Chol), and HDL-Chol levels. 
Mean ~ S.E. Correlation with PAl p-value 
PAl cng/ml) 24 ~ I 1.0 
Triglycerides (mg/dl) 149 ~ 9 0.40 <0.001 
Total Chol (mgidl) 203 ~ 3 0.27 <0.001 
HDL-Chol (mg/dl) 51 ~ I -0.27 <0.001 
Age (yrs) 49 ~ J 0.17 <0.001 
Multivariate linear regression analysis, controlling for age and 
gender, indic~ted that both increased triglyceride (p<0.005) and 
decreased HDL·Chol (p<O 05) levels were independent predictors of 
higher PAL 
These data provide evidence supporting an association 
between prothrombolic hemostatic factors and unfavorable lipid 
values in determining cardiovascular risk. Lipid lowering therapy 
may, in part, exert its protective effect through a beneficial effect on 
hemostasis. 
815 Peripheral Vascular Procedures 
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4:00 PM-5:00 PM 
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815·1 4:00 
PRIMARY AND SECONDARY PATENCY OF STENTED PERIPHERAL 
ARTERIES. THREE YEAR FOLLOW-UP. A SINGLE CENTER 
EXPERIENCE. 
Michel Henry. Max Amor. Gerard Ethevenot. Isabelle Henry. Bernard 
Mentre. Mohamed Allaoul. Essey Clinic. Nancy. France. 
In order to assess the benefit of arterial Palmaz Ba"oon Expandable 
Stents (BEIS) in the treatment of peripheral vascular diseases. 256 
symptomatic pts (223 M. 33 F. mean age 63±O.72 y) received 345 BEIS. 
183 BEIS were placed in 148 iliac arteries and 162 BEIS in 108 femora•
popliteal arteries. Before procedure. 213 arteries were stenosed and 55 
were occluded. 74% of pts received one stent and 26% more than one 
stent. A" pis were under anticoagulant and aspirin for the first three 
months and aspirin alone thereafter. In this serie we had only one 
unsuccessful placement (technical success: 99.6%). The mean follow up 
period was 20±0.5 months (range: 1 to 38 months). 4 pts were lost for 
follow up. All eligible pts were submitted to an angiography control at 6 
months and were followed cfinica"y and by Doppler examination 
thereafter. The table below summarizes the main results concerning lesion 
length (L.lesion). stented leSion length (L.stent). true primary patency 
(Primary P.) and secondary patency (Second P.) rates at 36 months. The 
results are represented as mean ± S.D according to the location and type 
of lesion (stenosis. occlusion). 
ILIAC FEM.POP STENO. OCCLUS. 
n.Art 148 108 213 55 
L.lesion 3.37±3.03 4.06±3.50 2.69+..2.18 6.96±4.17 
em - NS - --p<0.001-
L.stent 3.71±1.50 4.30±2.57 3.62±1.55 5.07±2.93 
em - p<O.OO3- --p<0.001--
Primary P 91±5 72±7.5 91±4 53±10 
% --p<O.OI- --p<0.001-
Second.P 94±4 97±3 97±3 94±6 
% -NS- -NS-
Conclusion: Femora-popliteal stenting has a lower true primary patency 
than iliac stenting. but secondary patency does not differ statistically. 
Stented occlusions have significantly lower true primary patency than 
slented stenosis but do not differ in terms of secondary patency. 
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815·2 4:15 
Quantitative Analysis of Physiologic Low·Stress 
Angioplasty (PLOSA) Using Intravascular Ultrasound: 
RF ·Heated Balloon Permits Successful Augmentation of 
Luminal Patency at Low Inflation Pressures. 
Kenneth RQSenfield, Jenifer Kaufman, Emer Grall, Valerie Popkin, 
Jeffrey M. Isner. Tufts University School of Medicine, SI. 
Elizabeth's Hospital, Boston, MA. 
Previous studies have documented deleterious consequences 
associated with angioplasty (PTA) peformed using high-pressure 
inflations. The radiofrequency (RF)-heated PTA balloon developed 
for Physiologic Low-Stress Angioplasty (PLOSA) is intended to 
modify physical characteristics of atherosclerotic plaque at onset of 
inflations, and thereby permit PTA at inflations pressures of 2-5 
atm. We investigated PLOSA in 10 pts with peripheral arterial 
stenoses; quantified outcomes using intravascular ultrasound 
(IVUS); and compared findings to matched (for artery size, calcium, 
% stenosis) but otherwise consecutive series of 10 pts treated by 
conventional PTA. Balloon size employed was similar (p=NS) for 
both groups. Inflation pressures for PLOSA, however, were s5 atm 
in all 10 pts (m±SEM=4.7±O.3), and were significantly (p=O.0063) 
less than inflation pressures employed for non-PLOSA pts 
(10.8±1.8). In spite of lower inflation pressures employed with 
PLOSA, IVUS documented that luminal cross-sectional area (CSA) 
achieved with PLOSA was statistically equivalent to that achieved 
with conventional PTA: CSA =13.3±1.2mm2 for 6 SFAs post•
PLOSA, vs 8.2±0.lmm2 for 6 SFAs post-PTA (p=O.0525). 
Likewise, for 4 iliacs post-PLOSA, CSA=24.8±6.5mm2 vs 
26.1±3.2mm2 post-PTA (p=ns). Acute clinical outcomes were 
identical for both groups of pts. Conclusion: clinically satisfactory 
results - including luminal patency quantified by IVUS - can be 
achieved using low inflation pressure with RF-heated balloon. 
Whether such reduced inflation pressures will have favorable long•
term consequences (Le. less restenosis) remains to be determined. 
815·3 4:30 
Use of a Compressive Leverage Apparatus Versus Manual 
Pressure In Achieving Hemostasis After Invasive Procedures 
Steven L A1many, David R. Cragg, Scott Lazzara, Sylvia Puchrowicz. 
John Bodine, William W. O'Neill, Victoria Hollingsworth, Gerald C. 
Timmis, Cindy L Grincs. William Beaumont Hospital, Royal Oak, 
Michigan 
We performed a prospective systematic quality assurance analysis to 
compare the effectiveness of a compressive clamp device versus manual 
hold after femoral sheath removal. as well as to identify determinants of 
post procedure bleeding (> 2 gm Hb drop). Variables analyzed include 
age, sex, body surface area. sheath size and duration, length of hold 
required for hemostasis and person performing (MD, PA, RN). heparin, 
aspirin and lytic use. Outcomes analyzed included Hb drop (pre and 8 
hrs post), transfusion requirement and need for vascular surgical repair. 
Patients were contactcd by telephone to determine time required to 
return to normal activity and any late vascular complications. 
Results: To date 623 patients have been entered. Univariate 
predictors of > 2 gm Hb drop included aspirin use (21.6% versus 11.3%, 
p < 0.04), sheath size (7.7%, 17.4%, 24.7%, 33.3% for 6,7,8, 9F, P < 
0.0009), total heparin received (p < 0.0009), sheath duration (p < 
0.0001) and time required to achieve hemostasis (p < 0.0001). The 
clamp device and manual hold were equally effective in achieving 
hcmostasis although the clamp more frequently required crossover to 
manual pressure (34% versus 7%, p < 0.0001). Thcre were no 
differences between the two methods in regard to drop in Hh, need for 
transfusion, vascular surgical repair, and time required to return to 
normal activity. The clamp device was preferred by 61 % of patients who 
had a previous manual hold. In conclusion. bleeding complications 
increase with sheath size and duration as well as the use of adjunctive 
antiplatelet, anticoagulant and lytic agents, but does not appear to he 
affected by the type of compression performed after sheath removal. 
ABSTRACTS 
815·4 4:45 
Transfemoral rntraluminal Graft rmplantation 
for Abdominal Aortic Aneurysms. 
Juan C. Parodi, Hector D. Barone, Jorge A. 
Belardi. Instituto Cardiovascular de Buenos 
Aires. Buenos Aires. Argentina. 
425A 
This study reports on initial clinical trials 
exploring the feasibility of exclusion of an 
abdominal aortic aneurysm by placement of an 
intraluminal, stent anchored, Dacron prosthetic 
graft using retrograde cannulation of the 
common femoral artery under local or re~ional 
anesthesia. 
Previous animal experiments showed that when a 
balloon-expandable stent was sutured to the 
partially overlapping ends of a tubular Dacron 
graft, friction seals were created which fixed 
the ends of the graft to the vessel wall. This 
excludes the aneurysm from circulation and 
allows normal flow throu~h the graft lumen. 
Treatment in 16 patients, most of them with 
serious co-morbidities, is described. 
Primary success was obtained in 15 of the 16 
procedures attempted. One patient has to be 
submitted to standard surgical resection of the 
aneurysm because of a mispositioning of the 
proximal stent. One additional patient had to 
be operated upon after 18 months' of the initial 
procedure because of a dilatation of the distal 
aorta not covered by the stent-graft 
combination. Follow-up period ranged between 
two years and one week with and average of 14 
months. Mortality rate of the entire series 
was nil. 
816 Cardiac Pacing Clinical Studies 
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816·1 8:30 
Effects of Head-up Tilt on Carotid Sinus Massage Response in 
Patients With Syncope 
Ryszard B. Krol, Sanjeev Saksena, Theofilos Kolettis, Ramesh Raju. 
Eastern Heart Institute, Passaic, NI 
We examined effects of 60° head-up tilt on response to carotid sinus 
massage [CSM] in 31 patients with history of syncope. There were 
16 males and 15 females, mean age 56±14 yrs. 25 patients 
underwent complete electrophysiolo~ic study [EPS] prior to tilt. 
CSM was performed in suptne position and at the end of 60° head•
up tilt. Patients with normal tilt underwent also isoproterenol 
infusion during tilt starting with 1 mcg/min and increased 1 mcg 
every 5 min to maximum dose of 4 mcg/min. ~: EPS was 
normal in all 25 patients tested. 6 patients with no evidence of heart 
disease and normal signal averaged ECG underwent only tilt testing. 
Tilt with isoproterenol infusion was normal in 13 (41 %) of patients. 
Tilt test with isoproterenol infusion was positive in 10 (33%) 
patients. During supine CSM only 2 patients had symptomatic pause 
> 3 sec. CSM during tilt produced symptomatic pause in an 
additional 7 patients and symptomatic hypotension without 
significant change in heart rate in 2 patients. Both patients also had a 
vasodepressor response with tilt followed by isoproterenol infusion. 
In patients with positive CSM during tilt, the duration of ventricular 
pause increased from mean 2.3 sec (range 1.4 to 3.7) while supine, 
to a mean of 6.5 sec (range 3.2 to 15.0; p< .001) during the head-up 
tilt. Drug therapy alone was effective in 5 patients. 4 patients 
required permanent pacemaker implantation, with 2 of them needing 
concomitant drug therapy with symptom resolution on followup in 
all patients. Conclusions: CSM dunng head·up tilt provides useful 
diagnostic information independent of tilt and isoproterenol infusion 
in over 30% of patients with syncope and should be routinely 
performed during tilt testing. 
426A ABSTRACTS 
816·2 .8:45 
Temperature May Be An Ideal Sensor Por Rate 
Modulation In Patients With Posture-Related 
Syncope And Chronotropic Incompetence 
Igor Singer, Pam Peavler, Ben Johnson, Robin 
Sneed 
University of Louisville, Louisville, KY 
Postural syncope in chronotropically incompe•
tent (CI) patients (pts.) may occur due to 
failure of appropriate heart rate (HR) res•
ponse. CUrrently available sensors do not 
respond promptly or physiologically to change 
in posture and hence may not correct posture•
related syncope(PRS). We studied 7 CI pts with 
PRS with implanted circadia(R) (Intermedics, 
Inc.) dual chamber rate-adaptive pacemaker, 
which modulates HR in response to temperature 
(T) change. Response to head up tilt (HUT) and 
head down tilt (HOT) was tested. The data 
displayed first order autocorrelation and 
hence, an autoregressive piecewise direct 
regression model (Durbin-Watson) was used for 
data analysis. 
Results; T increased within 5-30 secs from 
36.78 ± 0.29 C· to 36.89 ± 0.28 C· to HUT 
(p = 0.0002), and paced HR increased from 54±3 
to 7l±8 PPM (p = 0.0003). In response to HOT, 
T and paced HR response occurred within 5-15 
secs, with T decrease of 9±8 PPM. Postural 
symptoms were corrected in all patients. In 
all pts. strong correlation to T, increase to 
HUT (positive), and T decrease to HOT (neg•
ative), was noted (p=O.OOl, R2=0.755 - 0.976). 
Conclusions; 1) Temperature may be an. ideal 
sensor for CI pts. wi th PRS, and 2) blood 
volume redistribution may be the mechanism of 
T change. 
816·3 9:00 
Electrocardiographic Evidence of Ischemia During 
Ventricular Pacing 
Steven A. Guidera, William G. Kussmaul, and John M. Miller 
University of Pennsylvania, Philadelphia, Pennsylvania 
In the presence of a paced ventricular rhythm, the ECG diagnosis 
of acute myocardial ischemia is problematic. We studied 13 
patients (pts) undergoing elective PTCA to determine if ECG 
evidence of known ischemia can be detected during ventricular 
pacing. A temporary transvenous pacing catheter was inserted and 
positioned in the right ventricular apex immediately prior to PTCA. 
ECGs were obtained in normal sinus rhythm (NSR) and during 
ventricular pacing at a rate of l00/minute prior to and during 
balloon inflation. Analyses of pairs of NSR and paced ECGs were 
performed in a blinded fashion by three observers to identify 
evidence of ischemia during balloon inflation. Ischemia during 
balloon inflation was defined as a > 1mm ST segment change in 2 
or more leads in an anatomic distribution (anterior, inferior or 
lateral) compared to baseline recordings obtained prior to balloon 
inflation. ECG changes were considered significant when noted in 
the same anatomic distribution by at least two of three observers. 
Results: ECG evidence of ischemia was present in 12 of 13 
(92%) pts during NSR and 10 of 13 (77%) pts during ventricular 
pacing. The pt lacking evidence of ischemia during NSR also had 
no ischemic ECG changes during ventricular pacing. Two pts with 
ECG evidence of ischemia during NSR did not meet criteria for 
ischemia during ventricular pacing. The 12·lead ECG was 
associated with a sensitivity of 83% (10/12), specificity of 100% 
(1/1), and overall predictive accuracy of 85% (11/13) for detecting 
evidence of ischemia during ventricular pacing. 
Conclusion: When compared to a baseline tracing, the 12-lead 
electrocardiogram in pts with ventricular pacemakers demonstrates 
evidence of acute myocardial ischemia. In contrast to the general 
axiom, ischemia·related ST·segment ECG changes can reliably be 
interpreted when compared to a baseline tracing. Further 
investigation to develop ECG criteria for ischemia in patients with 
ventricular pacemakers is warranted. 
816·4 
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The Need for Permanent l'acemaker Implantation Following Slow 
Atrioventricular Nodal and Accessory Pathway Radlofrequency Ablation 
Marc Roelke, Thomas G. Trouton, Sean S. Q'Nunain, Hasan Garan, 
J.Warren Harthorne, Jeremy N. Ruskin. Massachusetts General Hospital, 
Boston,MA. 
From 1/91 through 8/92, 187 transcatheter radiofrequency (RF) ablations 
for supraventricular tachycardia (SVT) were undertaken. These included 
53 procedures directed at the slow pathway for atrioventricular (A V) 
nodal re-entry lilchycardia in 46 patients and 134 procedures directed at 
accessory pnlhways (AP) in 121 patients with AV reentrant tachycardia. 
Dual chamber permanent pacemakers were subsequently implanted in 5 
patients (2.7%), following A V nodal modification (2) or AP ablation (3). 
In 3 patients ablation was undertaken in the region of the AV node. 
Patient 1 developed transient 2:1 A V block during successful slow 
pathway ablation following 15 applications of RF current (278 sec). The 
patient was discharged with 1:1 AV conduction but returned 5 weeks later 
with complete heart block (CHB). Patient 2 suffered transient fast 
pathway block during attempted slow pathway modification following 5 
applications of RF current (130 sec). She developed highly symptomatic 
first degree A V block with 'pscudopacema ker syndrome' documented by 
echocardiography. Patient 3 dl'veloped a prolonged HV interval 
(75m~'C) and transient junctional rhythm following 7 applications (70 sec) 
of RF current to a right anteroseptal AP. 
In the two remaining patients, pacemakers were implanted for 
unmasking underlying A V nodal disease following ablation of an 
antegradely conducting AP. Patient 4 developed LBBB and subsequent 
transient CHB following catheter manipulation in the left ventricle prior 
to ablation of a left lateral AP. At follow-up study, the HV interval was 
70 msec and infra-Hisian block developed with atrial stimulation. 
Patient 5. with preexcitation at baseline, manifested underlying AV 
dissociation following 5 applications of RF current to a left free wall AP. 
In conclusion. (1) the need for permanent pacemaker implantation 
following RFA rur SVT is not limited to attempts at fast pathway 
modification but Cdn occur infrequently (2.7%) following AP 0.6%) and 
slow pathway ablation 0.1 %), <Ind (2) the indications for permanent 
pacing are variable and not always predictable. 
816·5 9:30 
Ncnlinear Dynamics of ventricular Excitatioo. in Patients 
With Artificial Pacemakers 
Nadir Saoudi, Agustin castellanos, Brice retac, Robert J. 
Myerburg. 
Hopital Olarles Nicolle, Rauen Cedex, France and 
University of Miami School of Madicine, Miami, Florida 
The field of nonlinear dynamics offers new approaches to 
the analysis of electrq:hysiologic Iilenanena. Although 
these approaches have been applied to the human AV node, 
they have not been reported in the hwnan ventricle. 'rtIe 
present camnmication deals with the findings in 6 
patients with CCXlq)lete AV block occuring ..nile evaluating 
the ventricular capture capabilities of pacenaker spikes 
referred to as stimulus-response patterns. Because the 
latter recurred periodically, the patterns 'tlere referred 
to as stimulus-response locking (SRL). 'rtIe approach used 
by Cllialvo and Jalife in their microelectrode studies 
was followed. Thus, in Cases 1 and 2, SRL was analyzed by 
qradually decreasing the voltage (fran 1.5 to 0.5V) ..nile 
maintaining pulse duration (0. 5ms) and cycle lengths 
(1020 to 100Oms) constant. The SRL evolved fran 1:1 to 
various ratios of \'1enckebach (5;4; 4:3; and 3;2) to 2;1 
to 1 ;0. In cases 3-6, the cycle lengths ware decreased 
(in various cases) fran 1440 to 300ms ..nile keeping 
voltage (fran 7 to 0.5V) and pulse duration (fran 0.5 to 
o .25ms) constant. At decreasing cycle lengths, 1; 1 SRL 
progressed to 2;1, as in cases 1 and 2, rut with 5:3 SRL 
in between. However, progression fran 2:1 to 3:1 occurred 
with expected (5;2 and 7:3), as wall as with non-expected 
(10:4 and 11;4), SRL. 
In sumnary, SRL patterns in the hwnan ventricle: 
a) 'tlere different than at the AV node, and b) could 
either follow the Farey sequence or display irreqular 
dynamics rot previously reported in the Farey tree. 
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The Effects of Magnetic Resonance Flowmetry in Implantable 
l'ulse Generators 
Dennis Glascock, Eric Enger, Karen Rice, Sam Money, Lawrence Hollier, Douglas 
Gohn, Alton Ochsner Medical Foundation, New Orleans, LA 
The application of Magnetic Resonance Imaging (MRI) is limited in patients with 
implanted melallic devices. Specifically, elcctromagnetic interference of pacemaker 
function has been reported. Magnetic Resonance F10wmetry (MRF) provides a 
direct method of mcasuring limb blood flow, and can be accomplished with a much 
weaker magnetic tield thun MRI (0.1 Tesla vs. 1.5 T). Also, MRF utilizes 
continuous instead of pulsed wave radio frequency. This offers theoretic 
advantages, however, its effcct on implanted pacemakers has not been reported. 
The safety of utilizing MRF in the presence of a permanent pacemakc·r was 
assessed using in vitro testing with 8 separate pulse generators (pGs). The MRF 
utilized was a Metriflow Medical Systems AMF-IOO Blood Flow Scanner with a 
magnetic field of 0.1 Tcsla and continuous wave radio-frequency at a frequency of 4 
MHz. The PGs were connccted to a Medtronic 5309 i"acing System Analyzer, 
which produces a soon test load. PO output was assessed during testing as well as 
displayed on an oscilloscope. The POs were placed on the sliding carriage at a 
distance of 106 cm from the scanning field and subsequently advanced at 5 em 
intervals to a minimum distance of 38 cm. The following effects were observed: 
PO Program I Reed Progrnm Output 
mod~ I closure change change 
Conclusions: I) Reed switch closure occurred in 7 of 8 POs. 2) MRF resulted in 
no alteration in programmed values. 3) There were no changes in PO output during 
MRF scanning with the exception of a slight dCCCl'8se in pacing interval in I PO. 
4) MRF scanning docs not appear to have any significant effect on POs. 
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817-1 8:30 
Long Term Follow·up of Right Ventricular Function After 
Single Lung Transplant for Primary Pulmonary 
Hypertension 
Alan D. Waggoner, Victor G. Davila-Roman, Benico 8arzilai, Elbert 
Trulock, Paul Eisenberg, Washington University, SI. Louis, MO 
Single lung transplant (SL 1) is an alternative to medical therapy for 
treatment of primary pulmonary hypertension (pPH) or severe 
pulmonary hypertension (PH) due to atrial septal defects. We studied 
14 patients with serial two dimensional echo (2D) prior to (pre), early 
after SLT at a mean (± S.D.) of 59 ± 28 days and at late follow up 
(448 ± 286 days). Right ventricular (RV) end diastolic (ED) and 
systolic (ES) areas in cm2, percent (%) fractional area change (FAC) 
and ejection fraction (EF) by area length method were measured in 
apical 4 chamber view; RV ED wall thickness (WT) was derived from 
the subcostal view. Results are as follows: 
EDA (cm2) ESA (cm2) % FAC ~ 
pre 3r.l=:;.0;':'±""7~.2::-'---::2:".:5"=.2,,-!±.x.;6;':'.8:L-----.!1'=9¥±"'6"'---· 28 ± 8 
early 17.3 ± 6.0* 10.0 ± 3.9* 43 ± 9* 59 ± 11 * 
late 17.0 ± 4.6* 9.6 ± 3.8* 45 ± 10'" 60 ± 14'" 
('" p < 0.001 vs pre SL1) 
RV wall thickness was unchanged from pre transplant values at early 
follow-up (0.76 ±.I pre vs 0.73 ±.2 cm) but by late follow-up 
significantly decreased to 0.63 ± .10 cm (p = 0.006 compared to pre), 
There have been 2 post SLT deaths (1 sepsis, 1 bronchiolitis 
obliterans); the latter developed RV dysfunction. SLT in PPH results 
in early nonnalization of RV size and function as evaluated by 2D 
echo which persists in long·tenn follow up. RV hypertrophy 




The Immediate Effects of Lung Transplantation on Right 
Ventricular Size and Function: An Intraoperative Transesophageal 
Echocardlographlc Study 
William E. Katz, Thomas A. GaSior, Joseph J. Quinlan, Banley P. 
Griffith, John Gorcsan III. University of Pittsburgh, Pittsburgh PA 
427A 
Lurtg transplantation (L Tx) Is a viable treatment for pts with end-stage 
pulmonary disease. The Immediate effects of LTx on RV size and 
function have not previously been characterized. Accordingly, we 
prospectively studied 24 consecutive pts, aged 42± 10 yrs, under•
going L Tx by Intraoperative transesophageal echo (TEE). Twelve pts 
underwent unilateral L Tx and 12 underwent bilateral L Tx. TEE 4-
chamber Images were recorded Immediately before and Immediately 
after L Tx. PA systolic pressure (pAS) was al80 recorded before and 
after L Tx. The following TEE measurements were made by observers 
blinded to all other pt data: RV end-dlastollc area cm2 (RVD), RV 
end-systolic area cm2 (RVS), and RV fractional area change % (FAC) 
as an Index of RV funcllon. Pts were dMded Into 2 groups based on 
the presence of sevsre pulmonary hypenenslon (PH) prior to L Tx de•
fined as PA systolic pressure (pAS) > 75mmHg. Eight pts had severe 
PH (+PH), and 16 pts did not have severe PH (-PH). Mean±S.D. 
values are shown: (·p<0.001 + PH vs.-PH), (. ·p<0.005 Post VS. Pre). 
PAS mmHg RVD cm2 RVS cm2 FAC % 
+ PH {Pre 110±27' 25 ± 10' 18±9· 25±14 
Post 43± 18" 16±7" 11 ±7" 36±15 
• PH {Pre 39±7 11 ±4 7±3 38±8 
Post 36±6 10±3 5±2 45±17 
Conclusions: An Immediate Significant decrease In PAS and RV size 
with L Tx occured In pts with severe PH, while changes In RV funcllon 
were variable. These changes occured In pts with both unilateral and 
bilateral L Tx. No significant RV changes were seen In pts without 
severe PH. Immediate effects of LTx on RV size occur In pts with 
preoperative severe PH. 
817-3 
The Impact of Transesophageal Echocardlography on the 
Evaluation of Patients With Severa Pulmonary Hypertension 
for Lung Transplantallon 
Todd D. Edwards, Galal M. Ziady, Banley P. Griffith, 
9:00 
John Gorcsan III. University of Pittsburgh, Pittsburgh, Pennsylvania 
Lung transplantation (L Tx) Is a viable option for the treatment of pts 
with severe pulmonary hypenenslon. Informallon on cardiac and great 
vessel anatomy, In panlcular the presence on shunt lesions, may 
Influence surgical decisions related to L Tx. The superior ability of 
transesophageal echocardlography (TEE) to assess congenital heart 
disease and shunt lesions compared to transthoracic echo may there•
fore Impact on surgical therapy in pts undergoing L Tx. Accordingly, 
we performed TEE with color Doppler and microbubble contrast on 48 
consecullve pts, aged 36 ± 11 yrs, with severe pulmonary hyperten•
sion undergoing LTx evaluallon. All pts underwent cardiac catheterlza•
lion, transthoracic echocardlography, and radlonucllde 
ventriculography prior to TEE. The diagnoses prior to TEE were: 
primary pulmonary hypenenslon In 12, ventricular septal defect (VSD) 
In 12, patent ductus anerlosus In 3, atrioventricular canel defect In 3. 
secundum atrial septal defect (ASD) In 2, truncus anerlous In 2, sinus 
venosus ASD In 2, and other causes of secondary pulmonary hyper•
tension In 12. No compllcallons from TEE were observed In this 
group. TEE provided new Informallon which significantly altered 
therapy In 13 pts. (27%). New findings by TEE were: pulmonary artery 
thrombi In 3, unsuspected VSD In 2, double outlet right ventricle In 2, 
aonopulmonary window rather than patent ductus anerosus In 1, 
secundum ASD In 1, and an ASD was excluded In 1. On the basis of 
VSD anatomy by TEE, 2 pts were selected for VSD closure with L Tx 
and 1 pt was listed for hean-Iung transplantation. In conclusion, TEE 
can be safely performed In pts with severe pulmonary hypertension 
and can provide clinically Important Information which may alter 
therapy. TEE should be routinely considered In pts with severe pul· 
monary hypenenslon who are undergoing evaluation for L Tx. 
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817·4 9:15 
Nitric Oxide is an Effective PubnOD8J'Y Vasodilator in Cardiac Transplant 
Candidates witb PubnOD8J'Y Hypertension 
Marc J. Semi&J'llll, Barbara A Cockrill, Robert Kac:marek, B. Taylor Thompson, 
Warren A. Zapol, O. William Dec, aod Michael A. Fifer. Massachusetts 
General Hospital and Harvard Medical Scbool, Boston, MA 
Elevated pulmonary vaacuJar resistance (PVR) in cardiac IrallSplant recipients is 
a predictor of acute right ventricular failure aod increased mortality. Nitric 
oxide (NO), an endothelium derived relaxation factor, has been reported to act as 
a selective pulmonary vasodilator when inhaled and is rapidly bound to 
hemoglobin aod inactivated in the pulmonary circulation. In order to assess the 
effects of inhaled nitric oxide on PVR, systemic arterial pressure, and right 
ventricular performance, we studied 9 pts with chronic NYHA class III or IV 
heart failure (8 male, I female, age SO±2 yrs, LV ejection frsction 0.16±0.02, 
mean ± SEM) referred for cardiac transplantation. Measurements were taken at 
baseline, during 100% ~ aod NO inhalation (80 parts per million), and during 
intravenous nitroprusside titrated to a systolic arterial pressure of 90mmHg 
(NTP, dose: 183±S2 I'gfmin). Micromanometer RV end-diastolic pressure 
(RVEDP, mmHg), mean pulmonary artery pressure (PA), pulmonary capillary 
wedge pressure (PCWP), arterial pressure (MAP, mmHg), and pulmonary 
vascular resistsnce (PVR, dyne.sec/cmS) were: 
B.YE!2f fA ~ ~ l.YR 
Baseline 9±2 36±S 22±4 83±2 288±88 
lOOIil>~ 8±2 34±S 23±3 86±2 248±64 
NO + lOO%~ 6±1· 34±4 26±4· 89±3 IS2±40*# 
NTP 2±1·# 17±3*# 6±2·# 69±2*# 200±4S* 
(*P<O.OS vs. baseline, #p<O.OS vs. 100% O2 ) 
Cardiac output was unchanged on 100% ~, NO, or NTP. Arterial oxygen 
aaturation was unchanged on NO. Conclusions: (I) NO reduces pulmonary 
vascular resistance (2) Unlike NTP, the effectiveness of NO is not limited by 
systemic hypotension. (3) In cardiac transplant candidates, NO may be useful to 
identify pts with reversible pulmonary vasoconstriction, as well as to treat 
perioperative right ventricular failure. 
817·5 
Conversion of Muscle Enzymes Following Minced 
Transplantation in Experimental Cardiomyoplasty 
Donald Armstrong, Syde Taheri, Robert Klick, 
Browne, Steven Stadl er and Mi chae 1 Wil son. 





Free muscle transplantation shows promise as an adjunct 
to staged latissimus dorsi cardiomyoplasty and has 
potential for supportive therapy in extensive heart 
disease. The objective was to determine isoenzyme 
patterns in transplanted skeletal muscle following 
experimental I'll. In previous studies we demonstrated 
transplant vlabil ity using histological and histochemical 
techniques. In the present report, 100mg of tissue from 
normal rectus femoris, left ventricle and transplanted 
region in porcine and rabbit model s at 8 weeks post•
surgery were prepared and the supernate analyzed for 
tota 1 CK and LDH expres sed in IU Img wet wt 1m 1, the i r 
isoenzyme profiles in percent, cytochrome oxidase (COX) 
and cytochrome concentration, Total CK in rectus muscle 
was 38.4 and 53.3 for pig and rabbit respectively; 15.B 
and 16.6 for ventricular tissue and 15.2 and 12.6 in the 
transplant. Values for total LDH were 4.6 and 4.0 for 
rectus, 0.9 and 1.0 for ventricle and 0.9 and 0.8 for the 
transplant. Thus, in both species the change from 
Skeletal to cardiac values were reproducible, 
Electrophoresis revealed cardiac CK-2 and LDH-5 isoenzyme 
in the transplant, demonstrating biochemical conversion 
from the skeletal type profile. Trends in individual 
cytochrome concentration were observed between skeletal 
muscle and transplant. Lipid peroxide values in the 
transplant were similar to those of normal heart and 
rectus supporting viability of the tissues. These 
findings suggest that during recovery the enzymatic 
composition of CK, LDH and COX in skeletal muscle is 
transformed to one consistent with cardiac muscle. 
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817·6 9:45 
Does Cardiac Afferent Reinnervation Occur After Human Cardiac 
Transplantation? 
James Arrowood, Evelyne Goudreau, Anthony Minisi, Catherine 
Murphy, J.V. Nixon, G.W. Vetrovec, A Guerraty, P.K. Mohanty. Med 
Coil of VA. and V AMC, Richmond, VA 
Recent evidence suggests that efferent cardiac reinnervation may occur 
after cardiac transplantation (CT) in humans. We hypothesized that 
reinnervation of cardiac afferents may also occur. To test this 
hypothesis we observed the reflex response of the recipient sinus node 
(RSNR) in the remnant right atrium, which remains innervated after 
cr, to stimulation of ventricular chemosensOlY endings (afferent limb) 
by radiographic contrast (Bezold-Jarisch reflex) in cr patients early 
«2 yrs) and late (>4 yrs) after cr. Since coronary injection (CA) 
normally results in reflex bradycardia, a decrease in the RSNR would 
be expected if afferent reinnervation OCl:urs after cr and the afferent 
limb of the reflex is intact. Thus, mean arterial pressure (MAP), and 
RSNR in cr were measured and compared with normals during CA in 
the left (LCA) and right (RCA) coronary artery. Results (change from 
baseline ± SEM) (·p<O.OOOl cr vs. C): 











RSNR in cr increased rather than decreased with coronary injection 
despite significant and comparable decreases in MAP in all groups. HR 
in controls decreased as expected. These results suggest that afferents 
to ventricular chemosensory endings remain denervated even in the 
long term following cr. 
818 Mitral Balloon Valvuloplasty Results and 
Follow·up 
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818·1 8:30 
Percutaneous Balloon Versus Surgical Closed and Open Mitral 
Commissurotomy :Sho;1 and lOl1g Term Result. 
Mohamed Ben Farhat, Mokdad Ayari, Fethi Betbout, Faouzi Maatouk, 
Habib Gamra, Mourad Jarrar, Kamel Esseghairi, Ali Cheri!. 
Fattouma Bourguiba University Hospital, Monastir, Tunisia. 
In order to compare the results of open lOMC), Instrumental closed (CMC) 
and percutaneous balloon mitral commissurotomy (PMC), we randomised 
90 pis (30 pts in each group) with pure non calcific rheumatic MS (echo 
score <9'18). All pts underwent 20 echo and cathererization pre and 6 
months post any procedure, clinical, doppler and 20 echoevabations at 4 
years follow· up. 
Results: ", §,& (p<0.01) OMC vs CMC, CMC vs PMV, OMC vs PMC 


























0.88 ± 0.18 0.90 ± 
1.69 ± 0.39 2.18 1: 
23 ± 9 25 ± 
14 ± 5 IS ± 
0.93 ± 0.17 0.93 ± 
1.64 ± 0.31 § 2.2 ± 
1.51 ± 0.47§ 1.80 ± 
27%§ ° 0/0 27%§ 6,6% Restenosis 
Class 
1I1·IV 
pre 87 % 90% 90 % 
6mths ° % 10% 0 % 








There were no death, no thromboembolism in the 3 groups. Induced MR:!++ 
was higher in PMC group(13% Vs 6.8% in group I and ll,§ • & < 0,05) but 
surgery was not required At 4 yrs follow-up survival was t 00% in the 3 
groups, freedom from reintervention was 97%, 87% (" ,§< 0.05) and 
93% respectively. 
Conclysipns: OMC and PMC produce more effective and similar relief of 
mitral obstruction than CMC. Despite a somewhat smaller MVA. PMC 
achieves long term results as favorable as OMC: initial therapy would be 
PMC In pts with severe non calcific MS. 
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818·2 8:45 
Failures, Poor Results and Complications Using the 
Inoue Balloon for Mitral Valvotomy 
Ted Feldman, Howard C. Herrmann, John D. Carroll, 
Jeffrey M. Isner, Thomas M. Bashore, David Holmes, 
Gerald Dorros, Donald A. Rothbaum, Augusto Pichard, 
Larry S. Dean and the N. American Inoue Investigators. 
The University of Chicago, Chicago, IL 
Of 550 Inoue balloon mitral valvotomy (BMY) 
procedures, 417 (76%) were successful (area >1.5 cm2 
or >50% increase in area after BMY). 87 pts (16%) had 
insufficient increase in valve area without major 
complications. The valve could not be crossed by the 
catheter in 15 pts (2.7%). Major complications 
included ~3+MR post BMY (n-27/4.9%) , hospital death 
(n-4/0.7%) , pericardiocentesis (n-4/0.7%) and TIA 
(n-5/0.9%). Mitral valve replacement in the hospital 
was required in 13 pts (2.4%). There were no strokes. 
Balloon rupture or device failure did not occur. 
Success Major Failure to Small 







417 31 15 87 
5l±4 57±16 56±16 59±12* 
2.8+7 3.2±6* 2.9+6 2.9±7 
7.0±2.6 7.2±2.5 8.5±2.8 7.9±2.6* 
l3.6±5.9 l4.3±7.l lS.1±7.4 11.6±2* 
4.2±1.23.6±1.1* 3.8±1.3 3.7±9* 
*-p<.05 vs. successful/uncomplicated 
Pre BMY valve area was not associated with failure, 
poor result or complications. Advanced age, low 
gradient and higher echo score were found with smaller 
increase in area, while high NYHA class and lower C.O. 
were associated with complications. 
Conclusions: Inoue BMY can be accomplished without 
complications in over 90% of pts. Poor results are 
associated with high NYHA class, age, valve deformity, 
and lower C.O. 
818·3 9:00 
EffeeHveness and Complications of Retrograde Nontransseptal 
Balloon MUral Valwloplasty 
Christodoulos Stefanadls. Costas Stratos. Charalambos 
Vlachopoulos. loannls Kallikazaros. Fillppos Triposkiadis, Aris 
Androulakis. Athanasios Trikas. Pavlos Toutouzas. Athens University, 
Athens. Greece 
Retrograde nontransseptal balloon mitral valvuloplasty (RNBMV) is 
an established method developed In our institution for dilating 
stenotic mitral valves. To assess the effectiveness and 
complications of this method. data of the first consecutive 150 
patients. who underwent RNBMV for symptomatic mitral stenosis. 
were analysed. Mean age was 51 ± 11 years (range 25 to 70). One 
hundred and twenty patients were in NYHA functional class III or IV 
and 30 In class II. Thirty-nine patients had calcified valves and the 
mean score of the echocardlographlc grading of the mitral valve 
morphology was 8.9±2.2 (range 5 to 14). Single balloon technique 
was used in 146 cases (single conventional in 28. double-twin in 
118) and double blfemoral balloon technique in 4. After RNBMV. 
valve area was Increased from 0.94±0.23 to 2.16±0.54 cm2 
(p<O.OOl). Severe mitral regurgitation;;, Seller's grade 3+ occured 
in 6 patients (4%) necessitating urgent surgery In 2. one of which 
died after valve replacement (0.7%). and late surgery in 3. Femoral 
artery damage occured in 3 patients (2%). Other major complica•
tions such as cardiac perforation. cardiac tamponade or embalic 
events were not encountered. There were no severe or sustained 
arrhythmias necessitating special treatment. 
Conclusion: RNBMV compares favorably with the transseptal 
techniques In terms of effectiveness and complications. This 
nontransseptal technique of mitral valvuloplasty may allow for 
more patients to have balloon valvuloplasty who would otherwise 
not to be offered this procedure as many interventional 




PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY vS.OPEN MITRAL 
VALVE CDMISSUROTOMY. RESULTS OF A RANDOMIZED CLINICAL 
TRIAL 
Ronaldo Bueno, Paulo Andrade, Deborah Nercolini, Danton 
Loures, Edison Ribeiro,Liliam Blume,Paulo Rossi, Marcos 
Pereira, Miguel Chama. Curitiba.Pr, Brazil 
Open mitral valve comissurotomy (DMVC) was compared to 
percutaneous balloon mitral valvuloplasty (PBMV) in a 
prospective randomized' study of 40 patients with severe 
mitral stenosis. Patients randomized to PBMV (n=20) 
underwent valvuloplasty;patients randomized to OMVC 
(n=20) underwent surgery. The patient were analised pre 
and post-treatment by mean of functional class physical 
examination, EKG,Echocardiogram,and hemodinamics.Follow•
up examinations, were performed at 3-months (functional 
class and Echocardiogram). At baseline PBMV and OMVC, 
mitral valve gradient was 13,6 ± 4,2 versus 14,2 ± 6,3mmHg; 
mitral valve area, 1,V ± 0,2 versus 1,34;1 0,4cm",:re5IEtively. 
At post-treatment after PBMV, mitral valve gradient was 
6,4 ± 4,2 mmHg; and mitral valve area was 2,10 ± 0,6 cm" 
(both p 0,0001). At post-treatment after OMVC, mitral 
valve gradient was 5,m ± 0,7 mmHg; and mitral valve area 
was 2,58 ± 0,6 cm" (both p 0,0001). At 3-month follow•
up, PBMV, mitral valve gradient was 6,9 ± 0,41 mmHg; and 
mitral valve area was 2,m ± 0,6 em" (both p 0,0001). At 
3-month follow-up, OMVC, mitral valve gradient was 5,4 ± 
0,4 mmHg; and mitral valve area was 2,34 ;I 0,6 cm" • There was 
no difference between the groups at post-treatment or 3-
month follow-up. There was no death, severe mitral 
regurgitation or stroke. 
We conclude that PBMV and OMVC result in comparable 
hemodynamic improvement that is sustained through 
3-months of follow-up. 
818·5 9:30 
Three and One-half Year FoUow-up of. Randomized Trial Comparing 
Pertutaneous Balloon and Surgital Oosed Mitral Commissurotomy 
B.S. Raju, Zoltan G. Turi, Raghava Raju, Barbara Fromm, Shailender 
Singh, Peter Farkas, Joshua Wynne for the WSU·NIMS Valwloplasty Study 
Group. Nizam's Institute of Medical Sciences, Hyderabad, India and Wayne 
State University School of Medicine, Detroit, MI. 
We previously have reported the acute results and early (8 months) follow-up 
comparing 2 groups randomized prospectively to percutaneous balloon mitral 
commissurotomty (pBMC; n=20) or surgical closed commissurotomy (CMC; 
n=20). Data were analyzed by an investigator blinded to treatment 
assignment. At 3.5 years, 34 patients returned for follow-up; all underwent 
repeat cardiac catheterization, 2D echo, and exercise testing. There were no 
significant differences in hemodynamics, mitral valve morphology, exercise 
duration or functional status between the two groups. 
Mitral Valve Area (Fick;cm2) 
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Seven patients were judged to have recurrent stenosis severe enough to justify 
repeat commissurotomy (pBMC=3; CMC=4); all underwent successful 
baJloon valvuloplasty. No patient had an oxygen step-up or severe mitral 
regurgitation; there was one late non-cardiac death. Conclusion: 
Percutaneous balloon mitral commissurotomy and closed surgical 
commissurotomy have similar results through 3.5 years of follow-up. 
430A ABSTRACfS 
818·6 9:45 
The Contribution of Mitrdl Valve Resen'e Capacity to Sustained 
Symptomatic Improvement After Balloon ValvulotoRlv:lmplications 
for Restenosis • 
Tugrul Okay,Ubeydullah Deligontil.Oktay Sancaktar, Omer Kozan,Yelda 
Bll§aran, Baymdlr Medical Center ,Ankara, International Hospital,lstanbul 
Ko§uyolu Heart and Research Hospital, Istanbul, Turkey 
To detennine the effect of mitral balloon valvulotomy (MBV) on the 
mitral valve orifice variability, 29 pts (mean age32± 7 yrs) with mitral 
stenosis who had succesful MBV 13±2 months ago and 10 pIS (mean age 
33±9 yrs) with untreated mitral stenosis (MS) were studied 
hemodynamically before and after IV Dobutamine (D) infusion (initially 5 
Jlgrlkg per min.lltrated up to 25 Jlgr/kg per min.,as tolerated). 
Heart rate 



















145±18 I 99±34* 
1.2±O.2 1.3±O.3· 
-P<D.05, tP<D.O I, *P<D.<XXl I,· p",NS Baseline vs Dobutamine. 
The mitral valve area (MVA) in 7 pts in MRV Group (24% ),was ;;1.5cm2 
before D infusion, in 5 of these 7 pts who had no or minimal symptoms 
the MVA was increased significantly after D infusion (from 13±O.l to 
1.9±O.lcm2). The other two pts who were symptomatic, the MY A did not 
change after D infusion and redilatation were perfonned in both. 
Conclusion: The MVA increased significantly after D infusion in the 
group with MBV and didn't change in MS group, suggesting that 
commisural splitting by balloon dilatation increases the MVA reserve 
capacity. This may explain the known clinical discrepancy between the 
continued s~mptomatic improvement after MBV despite hemodynamic 
"restenosis' in some pts. 
819 Lipoproteins-Monocytes-Venel Wall 
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819·1 8:30 
Oxidized Low Density Lipoproteins (OxLDL) Inhibit 
Endothelium-Dependent Relaxation to Acetylcholine (ACh) in 
Isolated Rabbit Coronary Arteries 
Canwen Jiang, • Michael Jacobs, • Paul Kerr & Peter Collins. 
National Heart & Lung Institute and • Royal Free Hospital School of 
Medicine, UK. 
The effect of OxLDL on ACh-induced endothelium-dependent 
relaxation of isolated coronary arteries is not known. In the present 
study, the effect of OxLDL on ACh-induced endothelium-dependent 
relaxation of isolated rabbit coronary arteries was assessed. 
Epicardial coronary arteries from adult male New Zealand white 
rabbits were suspended in organ baths for the measurement of 
isometric tension. Native LDL were obtained from patients with 
coronary artery disease by discontinuous density gradient 
ultracentrifugation and OxLDL were prepared. The arteries were 
precontracted with prostaglandin Flao (PGFlao' 3"M). ACh (0.01, 
0,03, 0.1, 0.3 and 1 I'M) caused relaxation by 8.5±2.4% 
(mean±S.E.M., n=6), 30.2±7.1 %, 63.1±6.8%, 84.5±5.3% and 
90.2±5.2%, this relaxation was abolished by mechanical removal of 
the endothelium. Incubation for 30 mins with OxLDL (300 "glml) 
significantly reduced the relaxation to 1.0±1.0% (P<O.05 vs 
control), 9.4±3.8% (P<0.05), 24.5±5.6% (P<O.OI) and 
66.4±9.6% (P=0.058). The relaxation was partially reversed 30 
mins after washout. PGFlao·induced contraction (0.82±0.02 g) after 
OxLDL incubation was similar to that (0.84±0.04 g, P>O.05) in 
control conditions. Native-LDL (300 "glml) had no effect on the 
relaxation. These results suggest that OxLDL but not native-LDL 
inhibits endothelium-dependent relaxation to ACh in this coronary 
arterial preparation. 
819·2 
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Dietary Fish Oil Decreases Superoxide Radical 
Generation Without Affecting Nitric Oxide Synthase 
Activity: A Mechanism of Vasorelaxation 
Jerrv Bryant. Bai Chun Yang, Paulette Mehta, Tom G.P. Saldeen, 
Jawahar L. Mehta 
University of Florida and V AMC, Gainesville, FL and University of 
Uppsala, Uppsala, Sweden 
Dietary supplementation with fish oil has been shown to 
induce a state of vasore1axation. This has been attnouted in part to an 
increase in the activity of endothelium-derived relaxing factor 
(EDRF). EDRF, now identified to be nitric oxide (NO), is rapidly 
destroyed by superoxide radicals. To determine if ftsh oil feeding 
increases NO synthase enzyme activity or decreases superoxide 
radical formation or both, 16 Sprague Dawley rats were fed a diet 
supplemented with fish oil (20% of fat), 8 rats for 4 days and the 
other 8 rats for 4 weeks. Sixteen other rats from the same batch were 
fed an ordinary diet. After 4 days of fish oil feeding, tissue content 
oflong chain polynnsaturated fatty acids (PUFAs) and n·3 PUFAs 
increased by 109%, and n-6 PUFAs decreased 42% (all P<O.Ol). 
Neutrophils and aortas were halVested from both groups of rats. NO 
synthase activity in neutrophils and aortic rings was measured as 
conversion of3H-l-arginine to 3H-l-citrulline. Neutrophil superoxide 
radical formation was measured as conversion of ferricytochrome to 
ferrocytochrome upon stimulation with PMA (100 nglmI). The NO 
synthase activity in the aortic rings and neutrophils of control rats 
was 37±IO% and 13±3% (mean±SE), respectively (expressed as 
conversion oflH-l-arginine to 3H-I-citrulIine). NO synthase activity 
in aortic tissues and neutrophils of fish oil- fed rats was 36±9% and 
14±2%, respectively (P·NS vs control rats). Superoxide formation 
was 6.2±0.9 nmoVI06 cell!VI0 min in control rat neutrophils, but 
only 3.8±0.S nmoVI06 cell!V1O min in fish oil· fed rat neutrophils 
(P<O.OI). The reduction in superoxide fonnation was seen in aU fish 
oil· fed rats, whereas NO synthase was unaffected. The decreased 
formation of superoxide radicals after fish oil feeding may pennit 
longer half· life of NO resulting in pronounced EDRF activity. 
819·3 9:00 
Glycosylation of Human LDL Enhances Oxygen Free Radical•
Induced Peroxidation 
Claudio Napoli Giuseppe Ambrosio, Giuseppe Palumbo·, Carlo 
Duilio, Paola Chiarieno and Massimo Cliiariello. Division of 
Cardiology and *Dpt. of Cellular and Molecular Biology, 2nd School 
of Medicme, University of Naples, Italy. 
Posttranslational nonenzymatic glycosylation of low density 
Iipojlrotein (LDL) occurs in VIVO in diabetic patients. Glycosylateil 
LDL (glc LDr,.) isdel!l'llded by macrophages in pan PY. the classic LJ?L•
receptor and m pan l5y the scavenger receptor. This latter mecharusm 
may contribute to llie foonation of foam cells and acceleration of 
atherosclerosis in diabetes mellitus. Oxygen free radicals (ORs) could 
induce LDL peroxidation and subsequent formation of foam cells. 
Glycosylation may alter protein conformation. Thus, the aim of this 
study was to investigate whether glc LDL are more susceptible to 
pc;roxidative modification by ORs. Glc LDLwas gre.Rared incubatil!g 
LDL with 40 roM mucose in sterile phosphate- ufTer-EDTA I roM 
for 10 days at 37°(; and dialyzed against pliosphate-buffered saline at 
pH 7.4. Olc LDL obtained was 10·12%. Control LDL (c LDL) was 
similarly incubated with buffer but without glucose. After this 
preparation both forms of LDL were oxidized by CuS04 0511M for 20 hs at 37° C). Peroxidation was measured from malonyldihaldehyde 
(MDA; nmoles/mg of prot) p'roduction. Data are expresSed as mean ± 
SD. (*p< 0.01 vs controls; #p<O.05 vs cLDL+CuSO.). 
*# 
c:LDL gJc:LDL glucose cLDL glcLDL 
+CuS04 +CuS04 +CuS04 
These results show that human glc LDL are more susceptible 
than cLDL to OR-mediated lipid peroxidation in vitro. These data 
suggest that glycosylation of LDL in diabetic patients may contribute 
to progression of atherosclerosis by a dual mechanisml . involving direct uptake of glc LDL. and enhanced fonnation of oxiaized LDL. 
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Allograft Specific Adhesion of Cardiac Transplant Recipient 
Monocytes Enhances Trans-endothelial Migration. 
Alistair 1. Fyfe, Mahamad Navab, Linda L. Derner, Lynne W. 
Stevenson. UCLA Medical Center, Los Angeles, CA. 
We have recently documented a threefold increase in binding of 
cardiac transplant monocytes to arterial endothelium of their 
donor. We investigated the ability of this increased adhesion to 
translate into transendothelial migration into the tissue by 
constructing vascular smooth muscle cell I endothelial cell co•
cultures. Peripheral blood mononuclear cells (PBMC) from 
cardiac transplant recipients were labelled with a fluorescent label 
(Oil) then incubated for 15 minutes with donor-specific cocultures 
(n=4) or third party cocultures (n=20). Non-adherent cells were 
rinsed off and the incubation continued for one hour. Monocytes 
migrating to the sub-endothelial space were counted using 
fluorescence microscopy. 
Monocytes showed a 5-fold 1.4 
increase in migration into donor 112 
specific co-culture compared to I. 1 
third partycoculture 1.35 ±0.73 vs J1o.a 
0.26±O.13 cells/HPF, p<0.005. ·p<O.OCXI6 
Recognition and binding of 0.1 
recipient monocytes to donor _ 
derived endothelium translates into 
. 1:0,4_ 
increased mig! ation of monocytes Nof>.IIpocIIc {II-"" Spoc:IIc "'-'I 
into the sub endothelial space in co-culture. Enhanced allograft 
specific binding and trans-endothelial migration of monocytes 
invivo may relate to the development of rejection and transplant 
vasculopathy. 
819-5 9:30 
Effect of Lipoproteins of Patients With Type m Hyperlipoproteinemia on 
Endothelial Monolayer Penneability and Resistance 
Herman I.M.B. Schaefer, Bianca M. Van den Hoogen, Marinetle M.C. Kuijpers, 
lanneke M. Egas-Kenniphaas, Shuiping Zhao and Arnoud Van der Laarse. 
University Hospital, Leiden, The Netherlands. 
The aim of this study was to investigate the influence of serum lipoproteins from 
type III hyperlipoproteinemic patients and from normal individuals (n) on the 
permeability and resistance ofEA.hy 926 confluent cell cultures. The lipoproteins 
were isolated by density gradient ultracentrifugation. Permeability for cholesterol 
and albumin was calculated after measuring their concentrations in the lower 
compartment of a Boyden chamber. Confluent monolayers were incubated with 
0.25 mg proteinlml of very low-density lipoprotein (VLDL), intermediate-density 
lipoprotein (1OL) or low-density lipoprotein (LDL) for 2 h. Resistance was 
measured by applying an electrical field across the cell monolayer and was 
recorded in the first h after addition of lipoproteins. Results are presented as 
means ± SD (' p<0.05 vs "no addition"). 
Cholesterol Albumin 
penneability penneability 
Resistance coefficient coefficient 
(Ohm*cm') (nrn/s) (runls) 
---- ---- ---- -----
no addition l2.6±2.4 n.d. 1l2±12 
LDL" l2.2±2.1 2±0.4 \O9±38 
LDL.".m 11.6± 1.0 3±0.1 106±55 
IDL.".m 10.4±0.5 4O±0.I' 67±67 
VLDL.".m 8.9±0.4' 70±2' 8l0± 140' 
We conclude that VLDL"", DI and IDL.". '" increases the cholesterol penneability 
of the endothelial monolayer, and that VLDI..,,,,, III also affects the albumin 
permeability as a result of a decreased resistance of the monolayer. These 
findings support the concept that elevated levels of JI-VLDL (VLDL.". m) and 
IOL in plasma impair the barrier function of the vascular endothelial layer, 
thereby initiating atheroma development. 
ABSTRACTS 
819·6 9:45 
Heritability of the Quantitative Llpoprotein(a) Trait in 
Monozygotic Twin Pairs 
Elizabeth R. de Oliveira e Silva, Neal Azrolan, Jan L. 
Breslow. 
The Rockefeller University, New York, New York 
Plasma Iipoprotein(a) (Lp(a)) concentrations vary profoundly 
among individuals and are thought to be highly heritable. 
Elevated levels of Lp(a) are associated with a high risk for 
cardiovascular disease. 
In an attempt to define the genetic contribution to this 
atherogenic protein, we measured plasma Lp(a) levels on 12 
pairs of monozygotic twins who were admitted to The 
Rockefeller University Hospital for a metabolic study. Lp(a) 
was quantified in two separate plasma samples by a 
sandwich-type ELISA assay. Zygosity was determined by 
four highly informative DNA polymorphisms detected by 
PCR. Intra-pair analysis of Lp(a) levels by single linear 
regression revealed a strong and highly significant 
correlation (r=0.98, p=0.0001). T-Chol, HDL-C and LDL-C 
levels were also found to be highly correlated. However, 
there was only a weak association between Lp(a) levels and 
T-Chol (r=0.43, p=0.04) and HDL-C (r=0.49, p=0.01S). 
Our data suggest that variability in plasma Lp(a) 
concentrations are controlled mainly by genetic factors. 
These might involve determinants of apo(a) gene activity 
and/or apo(a) protein size. 
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Ventilatory Threshold Alterations Caused by Repeated 
Maximal Exercise Testing in Sedentary Men 
Barry A. Franklin, Ingrid Crause, Kim Bonzheim, Tom Berg, Pam 
Fisher, Donovan Bakalyar, Seymour Gordon, Gerald C. Timmis. 
William Beaumont Hospital, Royal Oak, Michigan 
Previous studies have shown that prolonged, moderate-intensity 
aerobic training can delay the onset of anaerobic metabolism during 
progressive exercise, increasing the ventilatory threshold (VT). To 
clarify the effectiveness of short bouts of incremental, high intensity 
exercise on the VT, we studied 22 sedentary men ( X ± SD age = 
31.5 ± 2.1 yrs) who were randomly assigned to a high intenSity (HI) 
training group (n=12), involving 18 successive (3/week) maximal 
exercise tests (Bruce protocol), or to a conventionally trained control 
(C) group (n=10), exercising for 50 minutes at 70-85% of maximal 
heart rate, 3 times a week for 6 weeks. Graded treadmill testing with 
direct measurement of respiratory gases was performed before 
(T, ) and immediately after (T 2) the physical conditioning program. 
The VT was determined by the break point in linearity when 
minute ventilation was plotted as a function of oxygen con•
sumption No,). Results (x ± SE) were: 
Exercise ...YQJmax (Limin) VT-VO:! (Umin) VT(~) 
leslin~ HI C HI C HI C 
T1 3.1 ± 0.2 3.3 ± 0.1 2.5 ± 0.2 2.5 ± 0.1 78 ± 2 76 ± 2 
T2 3.6 ± 0.1 3.6 ± 0.2 2.9 ± 0.1 2.8 ± 0.1 8O±1 80±2 
" 0.5 + OJ' 0.3 + 0 l' 0.4 ± 0 1* 0.3 ± 0.1* 2 ± 2 4 + 3 
V02max = maximal 02 upta~e; " = change from T,; 'p < 0.01 
From T, to T" absolute VO, max increase~ by 0.5 LJmin for HI and 
0.3 LJmin for C. Although absolute VT-VO, (LJmin) increase.d by 
0.4 LJmin and 0.3 LJmin for HI and C, respectively, VT% (VT-VO,! 
VD,max x 100) remained unchanged in both groups. Conclusion: 
Repeated short bouts of maximal exercise increase VT in a manner 




Detection of Anaerobic Threshold by Near Infrared 
Spectrometry of Working Muscle 
Masayuki Takahashi, Tetsuhiro Yamada, Kenichi Mhsunaml, Masahiko 
Kinoshita. Shiga University of MecflCal Science, Otsu, Shiga, Japan 
We aimed to determine anaerobic threshold (AT) by near infrared 
spectrometry (NlRS). Seven patients whh old myocardial intarction, six 
normal volunteers and seven athletes participated in this study. NIRS was 
performed in quadriceps muscle of subjects undergoing upright ramp 
ergometer exercise test. Oxy Hb-Mb was measured by calculation of 
absorbance measured by silicon photo diode by three laser diodes (ASOS, 
A830 and A780) that cross working muscle whh Shimadzu OM-I 00. AT 
was determined by abrupt decrease in Oxy Hb-Mb by NIRS, which 
accompanied with decreased pH by lactate production. Expired gas was 
analyzed simuHaneously to compared AT obtained by different 
methodology. Close correlation was observed between AT V02 
determined by NIRS(ATnirs V02) and gas analysis (ATgeV02) (r=0.99, 
p=O.OOOI), HR at AT(r=0.83, p=O.OOOI) and AT time (r=0.99, p=O.OOOI). 
In two cases more abrupt decrease in NIRS was observed at the end of 




ATgeV02 ATnirsV02 ATgeHR ATnirsHR 
(rr+kQtrlinl IrTt:1<gIn1n) Ibpml /lxlm) 








0.0003 0.0005 0.0011 
Statistics by ANOVA 
These results clearly indicate that NI RS is a reliable noninvasive method for 
determining anaerobic threshold. Isocapnic buffering interval can also be 
measured in some cases. 
820-3 9:00 
Physiologic Response at LV Function. Size, WaD Stress and ComacdIly 
Durlngl After ExercIse 
Thomas R. Kimball, Wayne A. Mays, Philip R. Khoury, Robert E. Maille, 
Randal P. Claytor. Children's Hospital Medical Center, Cincinnati, Ohio 
and Miami University, Oxford, Ohio 
Data on the responses of LV function and size to exercise are conflict•
ing. Addhionally, exercise changes in wall stress and contractility (CON) 
are unknown. Eleven normal adult males (23.5 ± 3.4 y.o.) had echo at 
rest; 25%, 50%, 75%, and 100% maximum oxygen consumption (MVO.); 
and immediately, 3 minutes, and 5 minutes post cycle ergornetry. LV 
shortening fraction (SF), dimension, wall stress, CON and heart rate were 
measured. CON was the difference between actual velocity of 
circumferential fiber shortening and predicted fiber shortening for the 
measured wall stress. Mean and SO data are summarized: 
LV Wall 
SF dimension Stress HR CON 
00 .(gnl ~!lw.!!!l. ~
Rest 30± 8 5.0±0.5 
25% MV02 34± 8 4.9±0.7 
50% MV02 42± 7 4.8±0.9 
75% MV02 44± 7 4.4±0.7 
l00%MV02 44±13* 4.0±0.9* 
IPE 38±11 4.3±0.8 
3" post exercise 37± 9 4.6±0.6 
5" post exercise 34± 8 4.8±0.5 
* p<O.OI vs 25% MV02 
5O±14 66± 5 .03±0.22 
48±15 100± 8 .07±0.22 
32±10 130±12 .31±0.16 
28± 8 167±13 .47±0.23 
27±11' 194±27* .49±0.40* 
28±15 139±17 .38±0.36 
32±15 11ft 9 .14±028 
34±11 + 109±12+ .O1±O.22 
+ p<O.OI vs rest 
SF and CON Increased, and LV size and wall stress decreased with 
Increasing exercise. Except for HR and wall stress, these changes 
normalized by S" following exercise. 
During exercise, Increased function is not due to Frank-Starling effect 
but rather to Increased contractility and decreased afterload. 
820-4 
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Role of EDRFIShear Rate in the Control of Blood Flow 
During Exercise 
Thomas H. Hintze, Weiqun Shen, Jie Wang and 
Maja Lundborg 
Department Physiology, New York Medical College, Valhalla, 
NY 10595 
Perhaps the largest increase blood flow and shear rate occur in 
the coronary and skeletal muscle circulations during exercise. 
Because the primary stimulus for the release of EDRF is shear 
rate, we decided to determine the role of EDRF in the acute 
response to exercise in conscious dogs, Dogs (N=8) were 
instrumented for the measurements of LV and arterial pressures 
(AP) and with a catheter in the left atrium for the injection of 
radioactive microspheres. Dogs (N=8) were trained to run on 
a treadmill at 10 MPH. Hemodynamics were recorded and 
microspheres injected before and during exercise, after nitro-L•
arginine (NLA) and during exercise. Heart rate and LV dP/dt 
increased similarly during exercise before and after NLA while 
LV and AP increased significantly more after NLA, Coronary 
vascular resistance fell by 32±13% before and 54±5,4% after 
NLA_ Resistance in the gut increased slightly during exercise 
and was not affected by NLA. Vascular resistance in the gracilis 
muscle feU during exercise however, the minimum resistance 
was 3 times (415±85 mmHglmllmin/gr) higher (p<0,05) 
during exercise after NLA then before (173±35 
mmHg/mllmin/gr). Thus the large increase in blood flow and 
shear rate appear to stimulate EDRF release from exercising 
skeletal muscle and contribute significantly to the fall in skeletal 
muscle and total peripheral resistance during exercise. 
820-5 9:30 
The Importance of the Frank-Starling Kechanism for 
Enhancing Cardiac Performance in Young Athletes 
Kichael H. Crawford, Ann Gateley, Robert Robergs, 
Angelique Foster, Daniel K. Stark, Thomas A, Chick, 
Scott Meskin, University of New Mexico, Albuquerque, 
New Mexico. 
Changes in LV size have been shown to accompany the 
increases in maximum oxygen consumption (uVOa) observed 
during exercise training of sedentary individuals. 
Little is known about the effects of retraining college 
athletes who have reduced and unsupervised training 
during the summer. Thus, we studied 10 college 
endurance athletes (4 swimmers, 3 runners, 3 skiers) 
who reduced their training during the summer. Maximum 
exercise respiratory gas analysis and resting 2D echo 
were measured before and after a supervised training 
prograa. LV end diastolic volume (EDV) ejection 
fraction (EF), and other variable are shown below 
before (pre) and after (post) training: 
HR LVEDV LV IF LV-lfASS 
beats/min m1' p/ma 
pre 5s±10 119±46 6s±6 38±12 
post 63±11 l30;t35 6s±4 36±7 






Despite no significant changes in mVOz and resting 
heart rate, LVEDV increased during training, but LV 
mass did not. Ve conclude that supervised increased 
exercise training in college athletes after several 
months of reduced training, largely results in 
increases in LVEDV without significant changes in LV 
mass or mVOa. Thus, utilization of the Frank-Starling 
mechanism for increasing cardiac performance is a rapid 
adaptation to competitive training in well conditioned 
young subjects. 
JACC Vol. 21, No.2 
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Basis for the Aerobic Impairment During Exercise in 
Patients Late Post Cardiac Transplantation 
Lizanne M. Bussi~res-Chafe, Peter W. Pflugfelder, Alan H. Menkis, 
Richard J. Novick, F. Neil McKenzie, Albert W. Taylor, William 1. 
Kostuk. University Hospital, London, Ontario, Canada. 
To evaluate the physiologic basis for suboptimal peak exercise 
oxygen consumption (V02 max) observed late post cardiac 
transplantion (CTP), the functional aerobic impairment (FAI) or 
deviation in V02 max observed relative to that predicted for age and 
sex [FAI=«V02 max predicted-V02 max observed) I V02 max 
predicted) x 100] was related to pre-, intra-, and post-operative 
factors in addition to maximal exercise test variables. Fifty-seven 
CTP recipients (mean age 49±10 yrs, 1 to 9 yrs post CTP) 
underwent maximal upright cycle cardiopulmonary exercise testing 
(peak respiratory exchange ratio= l.1S±O.08). Concomitant exercise 
central hemodynamics were obtained in 36 patients. 
V02 max was 21.8±6.S mllkg/min and FAI was 34±16%. FAI 
correlated (p<O.OI) positively with peak systemic vascular resistance 
(SVR max, r=.S7) and negatively with hemoglobin concentration 
(r=-.40), peak cardiac index (CI max, r=·.62), and peak systemic a-v 
02 difference (r=-.74). A weak correlation was demonstrated 
between F AI and the duration of cardiac disease (r=.30, IKO.OS) but 
not the etiology of heart failure. No correlation was seen between 
FAI and donor factors (donor age, weight, height and total ischemic 
time). Factors such as time since CTP, recipient age, and resting and 
exercise right and left ventricular filling pressures did not correlate 
with FAI. Of note, CI max was also strongly related to SVR max 
(r=-.83, p<O.OOOI). 
These results suggest that decreased exercise capacity observed in 
late CTP recipients is in part due to peripheral vascular non•
compliance (increased LV afterload) which may be the result of 
irreversible changes from long standing heart failure and/or 
cyclosporine effects on the peripheral vasculature. 
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Inhibition of Local Angiotensin II Action Prevents 
Myocardial Hypertrophy Due to Pressure Overload In Mice 
Scott P. Wachhorst. Howard A. Rockman. John Ross. Jr. UCSD School 
of Medicine. LaJolla. CA 
Recently angiotensin II (All) has been implicated as a local growth 
factor in the development of cardiac hypertrophy. However some 
studies using thoracic aortiC banding have failed to show prevention of 
cardiac hypertrophy wHh inhibition of angiotensin converting enzyme 
(ACE). suggesting that more than one pathway for the generation of All 
may exist In the heart, as demonstrated in some studies. To address this 
Issue we utilized an in vivo murine model Of pressure overload 
hypertrophy where the action of All was blocked by InhibHlon of ACE or 
with the specific AU type 1 receptor blocker. Losartan®. Under a 
dissecting microscope, 8 week old aduH mice (C57/B6) weighing 18-22g 
were anesthetized. intubated and connected to a rodent ventilator. The 
chest was opened and the transverse aorta isolated. Transverse aortic 
constriction was performed by tying a 7-0 nylon suture against a 27 
gauge needle. Following rapid removal of the needle. the chest was 
ciosed, animals were allowed to recover and given eHher no drug n-21, 
captopril (CPT) 2g1L n=17 or Losartan (L) 1.05 giL n-17 in the drinking 
water. Alter 7 days of aortic constriction. animals were anesthetized and 
both carotid arteries were cannulated wHh flame stretched PE-50 tubing 
and connected to modified P50 Statham transducers to measure the 
pressure gradient across the stenosis. The mean gradient across the 
stenOSis was similar for all 3 groups (54±35 mmHg for no drug. 61±34 
mmHg for CPT, and 68±44 mmHg for L; pans). Heartlbody weight ratio 
Increased signHlcantly in the no drug group compared to our previously 
reported sham operated animals (0.623±0.091 vs. 0.491±0.028 %, 
p<0.05). However, the increase In heart weight was inhibited in the 
presence of either CPT or L (Heartlbody weight ratio 0.542±0.091 % for 
CPT. 0.506±069 % for L; p<O.Of CPT or L vs. no drug; pans CPT vs. L). 
We conclude that, f) In response to pressure overload, AlI is an 
important local growth factor for the development of cardiac hypertrophy. 
2) Cardiac hypertrophy can be prevented by directly blocking the action 
of All, or by ACE inhibition indicating that in this murine model the major 




A Rapid Increase in Contractile Protein Synthesis Rate 
Occurs In Pressure Overload. but not In Volume Overload 
Takuroh Imamura. Paul McDermott. Masayoshi Nagatsu. Robart L. 
Kent. George Cooper IV. Blase A. Carabello. Medical University of 
SC. Gazes Research Inst. and the Ralph H. Johnson Department 
of Veterans Affairs Medical Center. Charleston. SC 
Severe pressure overload (POL) leads to greater hypertrophy than 
severe pure volume overload (VaLl. This finding could be due to 
a greater increase in the protein synthesis rate (KSI in POL or 
greater degradation rate in VOL. It is known that Ks increases 
acutely in POL. However it is unknown if Ks increases acutely 
with the pure VOL of acute severe mitral regurgitation (MRI. 
Accordingly. we compared Ks (%/day) in dogs with acute severe 
VOL due to MR (average regurgitant fraction 0.631 to Ks in dogs 
with acute POL produced by partial aortic balloon occlusion 
(average left ventricular [LV) pressure 170 mmHgl and to Ks in 
normals. Ks was measured by the rate of incorporation of (3H) 
leucine into myosin during a 6 hr constant infusion of (3H) leucine. 
Ks for the unoverloaded right ventricle (RVI served as an internal 
control. 
Model 
Control (n = 31 
VOL (n=3) 
POL (n=21 












t P < 0.05 vs. control by post ANOVA Student-Newman-Keuls test 
Conclusion: Based on this preliminary data. it appears that despite 
severe pure volume overload. Ks for contractile proteins does not 
increase acutely in contrast to pressure overload where Ks 
increases by 60%. These data help explain the differences in the 
amount of hypertrophy found in POL versus VOL. 
821·3 9:00 
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To.hiyuki Haruy_, Harc T. Swart., Lawr.nce R. KcBrid., 
D. Gl.M P.Minqton, St. Loui. Univ.r.ity, St. Louia, 
llia.ouri 
Mechanical load ia a .. jor det.rminant of cardiac 
.tructur. anc:l function. Howev.r, to dat., there have 
bean faw experimental .tudi.. which quantify the 
r.lation.hip between pr ••• ur. and 901_ in the 
,r.DOd.Ung proc.... U.ing a modified h.t.rotopic cardiac 
tran.plant rat mod.l and inbrad Lawi. rat. weighing 270 
to 320 9 (n - 18), we produced heart. with variou. 
loading condition. (pr ••• ura-vol_ loopa) by cr.ating a 
ehunt between the donor pulmonary art.ry and recipi.nt·. 
aorta and varying anaetomotic .i •• to alt.r 8V (17-252 
Ill/beat) and LV. (112-228 _g). 'l'wanty-.ight to thirty•
five dey. after tran.plantation, LVP, a.cending aortic 
flow (Doppler flow mater), HR and LV dimen.ion. (II mode 
and 2D echo) of grafted h.arte were mea.ur.d in .itu. 
Left ventricular weight (LVW) wa. mea.ured at .acrific •• 

















(R. regr ••• ion coeffici.nt, PVA. pr ••• ur. 901_ ar.a). 
Th ••• r •• ulta .upport the conc.pt that the h.art ia 
remodeled eo that .ach unit of myocardiwa generate. a 
con.tant .tr... and .horten. to a con.tant length at .nd 
.y.tol. with re.ultant con.tant mechanioal energy 
production. The mathelatical modal pradicted LVW and LV 
volume with .ignificant correlation coefficient. of 0.876 
and 0.725, re.pectively. We conclude that. (1) thia 
model i. .uitable for the quantitative .tudy for cardiac 
remodeling, (2) in non-failing heart. remodeling follow. 
the mechanical adaptation principle, (3) total mechanical 
work play. an important role in the remod.ling proc •••• 
434A ABSTRACTS 
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Two Dimensional Analysis of Regional Systolic Rigid 
Body Motion and Deformation In Left Ventricular 
Hypertrophy Using Magnetic Resonance Tlslue Tagging 
Feng Xie, Victor A. Ferrari, Linda C. Palmon, Barbara Tallant, Leon 
Axel, Nathaniel Relchek, University of Pennsylvania, Phlla., PA 
We have previously demonstrated reduced unidimensional 
circumferential segmental shortening In hypertensive left ventricular 
hypertrophy (LV H) using magnetic resonance imaging (MAl) with tissue 
tagging by Spatial Modulation of Magnetization. To characterize regional 
two-dImensional myocardial deformation and rigid body motion in LVH, we 
used MAl tissue tagging to study 14 patients with LVH ancIl0 normal (NL) 
subjects. Deformation and rigid body motion were analyzed in anterior, 
lateral, Inferior, and septal regions at the basal, mid, and apical short axis 
levels. Using a finite element analysis technique we measured the 
magMudes of the prlnlclpal strains, represented as the greatest systolic 
elongation (AI), corresponding to wall thickening in normals, and the 
greatest systolic shortening (A2). Both AI and A2 are ratios of end•
systolic to end-diastolic length, so that values greater than 1.0 reflect 
lengthening and values less than 1.0 reflect shortening. We also 
measured ~, the direction of AI relative to the radial direction, as well as 
translation (T) and rotation of the finite elements. All results were 
compared in corresponding regions. Pooled data for the two groups are 
shown below (mean ±S.E.): 
A1 t.z. 
NL 1.IB±O.OI O.74tO.004 
LVH 1.10±O.OI" O.BHO.003" 









Regional analyses showed comparable differences between NL and 
LVH. Thus, in LVH AI and T were slgnHicantly less than in normals, 
whereas A2 and p were increased. In normals, there were no regional 
differences in AI, A2, and p, but septal T was significantly decreased. 
Similar regional pattems were found In LVH. In conclusion, patients with 
L VH show a signHicant reduction In myocardial deformation and rigid body 
motion on both a global and regional basis. in addition, the orientation of 
prinCipal strains was slgnHicantly different, which may reflect differences in 
myocardial fiber orientation or cross-fiber shortening between normals and 
LVH palients. 
821·5 
In Vivo Assessment of Ventricular Function by Digital 
Contrast Angiography in the Mouse 
9:30 
Satoko Ono. Howard A. Aockman. Michael!. Miyamoto. Valmik Bhargava. 
Shiro Ono. John Ross. Jr. UCSD School of Medicine, LaJolla, CA 
Recent studies have documented the utility of transgenic mice to 
examine cardiac gene regulation. To assess in vivo cardiac function In 
the Intact mouse we have developed an angiographic technique of 
contrast ventriculography and applied it to a model of right ventricular 
(AV) overfoad produced by pulmonary artery banding (PAB). PAB was 
performed in anesthetized adult mice (20·30g) by tying the pulmonary 
artery against either a 25 gauge (moderate stenosiS) or 26 gauge (severe 
stenosis) needle which was then rapidly removed. 14 days after surgery 
angiographic images were acquired on videotape under fluoroscopy 
following injection of 120 III of contrast into the jugular vein In 300 RAO 
and 600 LAO projections. First pass RV and levophase left ventrlclular 
(LV) interlaced images were digitized and regions of interest (ROI) were 
defined over the RV, LV and background (BKG). Video-density curves 
were generated using field by field subtraction of RV and LV ROl's from 
the corresponding BKG .ROI. Ejection fraction (EF) was calculated from 
the maximal (end diastole) and minimal (end systole) values. Biventricular 
and LV end diastolic volumes (EDV) were obtained from traced biplane 
images using the area-length method after grid correction for 
magnification. RV EDV was calculated by subtracting LV EDV and 
calculated septal volume (weight/l.0S) from the biventricular EDV. 
RV EF RV EDV EDVIBW RV WTIBW 
RV V 
sham (n-ll) 2.9tO.7 
PAB 2Sg (nz7) 3.S±0.8· 
PAB 26g (0-6) 27±8··, 91±21 3.8±1.0· 1.3±0.4·· 
Data are mean±SD. WT =weight, BW=body weight. ·p<0.05, ··p<O.OOl 
vs. sham; #p<O.005 vs. PAB 2Sg. or PAB. Thus, compensatory 
hypertrophy, or marked RV failure due to lack of adequate compensation 
occurs with graded PAB. These initial measurements of In vivo cardiac 
function can now be used to assess the effect of gene manipulation on 
the transition from compensated hypertrophy to heart failure. 
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Left Ventricular Adaptation to Gradual Renal HypertenSion In 
Doge 
Thuan N. P. Nguyen, Antonio Carlos P. Chagas, Stanton A. Glantz, 
UniverSity of California San FranCiSCO, San Francisco, CA. 
Left ventricular (LV) pump function improves In the early development 
of pressure-overload hypertrophy. To determine whether increased 
beta-adrenergic stimulation, intrinsic contractility, wall mass or a 
combination of these factors is responsible for the improvements. 
and whether hypertrophy normalizes peak systolic wall stress, we 
induced pressure overload in eight Intact-chest dogs by gradual 
constriction of one renal artery and implanted radiopaque markers 
(for measuring dimensions) in the dogs' LV endocardium. We 
measured changes In hemodynamics, LV dimensions, Indices of 
contractility, and wall stress for 12 weeks. The measurements were 
performed before and after acute beta-blockade with propranolol. LV 
function improved over time in the unblocked state, indicated by 
Increased cardiac output, pressures. stroke work, and normalized 
Emu. Acute beta-blockade reduced stroke work, E ...... and dp/dt".. 
relative to the unblocked state, but all still increased Significantly over 
time. dp/dt.- and E ..... did not vary with increases in LV mass. but 
stroke work was borderline dependent on LV mass. These patterns 
of changes suggest that beta-adrenergic stimulation contributes to 
improved LV pump function. and that the remaining improvements 
may be due to both increased Intrinsic contractility and wall mass. 
LV systOliC wall stresses decreased significantly over time while end•
diastolic wall stress remained constant. These changes suggest that 
hypertrophy normalizes end-diastolic, not peak systolic wall stress. 
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Increased Circumrerential Stress in Ruptured Atherosclerotic 
Lesions: Implications ror the Mechanism or Plaque Rupture 
George C. Cheng, Howard M. Loree, Roger D. KamIn, Michael 
C. Fishbein, Richard T. Lee. Brigham and Women's Hospital, 
Boston, MA 
Although rupture of atherosclerotic plaque is considered to 
be the cause of most acute coronary syndromes, the mechanism 
of plaque rupture is controversial. To test the hypothesis that 
plaque rupture occurs at sites of high circumferential stress in 
the diseased vessel, the distribution of stress was analyzed in 12 
coronary artery lesions that caused lethal myocardial infarction 
and 12 stable control lesions. Finite element analysis using a 
CRA Y X·MP supercomputer was used to calculate the stress 
distributions at a mean intraluminal pressure of 110 mmHg. 
The maximum circumferential stress in plaques that ruptured 
was significantly higher than maximum stress in stable specimens 
(4090.±. 1250 mroHg vs 1450.±. 510 mmHg, p<0.OOO1). The 12 
ruptured lesions had a total of 31 regions of stress greater than 
2250 mmHg (mean, 2.6 .±. 1.4 high stress regions per lesion); 
only 1 of 12 control lesions had a single high stress region. In 
7 of 12 lethal lesions (58%), rupture occurred in the region of 
maximum circumferential stress; in ten of the 12 lethal lesions 
(83%), rupture occurred in a region where computed stress 
exceeded 2250 mmHg. 
Conclusion. These data support the hypothesis that 
concentrations of high circumferential stress in the 
atherosclerotic plaque play an important role in myocardial 
infarction. However, plaque rupture does not always occur at 
the region of highest stress, suggesting that local variations in 
plaque material properties contribute to plaque rupture. 
JACC Vol. 21, No.2 
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Pharmacological Triggering of Plaque Rupture and 
Arterial Thrombosis In an Atherosclerotic Rabbit Model 
Paulo D. Picon, Stephan E. Friedl, Biqlng Ye, Otavlo Gebara, Eric 
Johnstone, Janet M. Saxton, Micheline Federman, H. Thomas Nett, 
Geoffrey H. Toller, James E. Muller, George S. Abela. Institute for 
Prevention of Cardiovascular Disease, Cardiovascular Division, 
Deaconess Hospital, Harvard Medical School, Boston, MA 
Plaque rupture and thrombosis is now recognized as a cause of 
acute coronary syndromes. To study this process of disease onset, 
we utilized a modification of a rabbit model of plaque rupture and 
thrombosis. Fourteen NZW rabbits were made atherosclerotic by 
balloon debridement of aortic endothelium and a high (1%) 
cholesterol diet for 2 months, followed by 2 months of normal diet. 
Seven rabbits on normal diet served as controls. 
Triggering of plaque rupture and thrombosis was attempted 
using Intraperitoneal Russell Viper Venom (a proteolytic 
procoagulant) and Intravenous histamine (a vasoconstrictor In 
rabbits). After 48 hours, rabbits were sacrificed and aortas 
evaluated by gross examination, light, scanning, and transmission 
electron microscopy. Ten of 14 atherosclerotic rabbits had 
developed localized white fibrin-platelet rich thrombi. Only one of 
the control rabbits had a small platelet thrombus. Thrombus 







Thrombus area (cm2) 
1 0.02 
10 )psO.023 1.6S±17 )pS.0.014 
Histology showed necrosis and tears of the Intimal and elastic 
layers In ruptured plaques with fibrin-platelet thrombI. 
Conclusions: Plaque lysis and rupture with formation of platelet 
rich thrombi was triggered using proteolytic enzymes and a 
vasoconstrictor. This model opens new opportunities to Investigate 
the pathophysiology of the onset of acute Ischemic events. 
822·3 9:00 
Lsck of Immediate Benefit of Urokinase Prior to Angloplasty 
for Unstable Angina. A Double-Blind Randomized Study. 
Emmanuel Halne, Philip Urban, Vitali Verine, Vivek. K. Mehan, Pierre•
Andre Dorsaz, Bernhard Meier. Cardiology Center, Universily HOSpital, 
Geneva, Switzerland 
Eighly-three patients presenting with unstable angina and recent « 24 
hours) rest pain despite nitrates, aspirin and heparin were randomly 
assigned to receive an intravenous bolus dose of 1 ,000,000 IU 
Urokinase or a placebo before percutaneous Iransluminal coronary 
angioplasty (PTCA) in addition to 20,000 IU heparin and aspirin. Only 
patients (Pis) with eccentric lesions (Ls) and filling defects suggesting an 
intraluminal thrombus were included. 
Results Urokinase Placebo p 
Angiographic result 40 PtSl42 Ls 43 PtSl56 Ls 
- good 27 (64%) 41 (73%) NS 
- hazy appearance 5(12%) 6(11%) NS 
- dissection 8(19%) 9(16%) NS 
Site Complications 13 (31%) 6(11%) 0.02 
- tranSient occlusion 2(5%) 1 (2"10) NS 
- coronary spasm 3(7%) 1 (2%) NS 
- acute occlusion 7(17%) 4(7%) NS 
- bailout stenting 5 (12%) 2(4%) NS 
Angiographic success/Pis 34/40 (85%) 42/43 (97%) 0.04 
Angiographic succesSiLs 34/42 (81%) 47/56 (84%) NS 
Q-wave infarct 1 (2%) 1 (2"/.) NS 
Non Q-wave inlarct 4(10%) 1 (2%) NS 
UrgentCABG 1(2%) - NS 
Elective CABG 1 (2%) NS 
Puncture site complications 3(7%) 6(14%) NS 
Death 1 (2%) NS 
Clinical in-hosoital success 34/40'{85%) 41/43 (94%) 0.05 
Conclusion. In this ongoing series, intravenous Urokinase before 
PTCA did not provide any demonstrable clinical benefit. On the contrary, 
there is a trend towards increased cardiac complications (i.e., acute 
occlusion) but without bleeding problems. 
ABSTRACTS 
822·4 9:15 
Aetlntlon 01 Coa.ulatloa Perslat. Alter CUnleal 
Stabiliution in Unstable AJlllaa and Myoardlal IDfardlOD 
Piera A. Merlini, Kennet A. Bauer, Pier M. Mam1ucci, Luigi Olttona, 
Diego Ardissino, Dario Grauata, Marco Cattaneo, Carlo Belli and Robert 
D. Rosenberg. Ospedale Niauarda. A.Bianchi Bonomi Hemophili.· 
Thrombosis Center , Milano, Italy and Belll Israel Hospital, Harvard 
Medical Scbool,Bos1on, MA. 
Althougb activation of blood ooagulalion is frequendy observed in tile 
acute phase of unstable angina (UA) and myocardial infl1'Clion (MI),little 
is known about its evolution after tile acute phase. We measured plasma 
Icvels ofproduombin frapIent 1+2 (Fl+V and fibrinopeplidc A (FPA) 
(nwkers of prothrombin activation and duombin acdvity upon fibrinoFII 
teSpeCIively) at hospital admission (Admission) in a consecutive aeries of 
80 pta willl UA (Braunwald's Classification Class UI B) and in 32 pta 
willl acute myocardial infarction. DeterminatiOlll weft: repeated after 6 
months in 57 UA pIS and in 23 MI pta willl uneventful course. No 
;mtiduombotic treatment wu given befoft: Admission and, after hospital 
discharge, medical therapy wu standardized to aspirin, betabloken or 
diltiazem and nitrales. At follow·up all pts were symptom·free and no 
episodes of SilCDl ischemia were de1ected on Holter monitoring. Twelve 
healthy volunteers served u oonttols. Data (oM) ue expressed u median 
and 99'KI Confidence InIeml: 
AdmissiOll 6-month follow-up 
Fl+2 FPA Fl+2 FPA 
Unscable angina (57 pIS) 1.11'" 2.9" 1.28'" 1.1. 
99'KICl 0.92-1.26 1.8-4.1 1.09·1.69 1-1.5 
Myocardial infart:tion(23 pIS) 1.29'" 3'" 1.22'" 1.1. 
99'KI CI 0.n-2.1 1.3·6.1 0.71-1.67 0.6-1.5 
Conuols (12 subjects) 0.76 1.2 0.78 1 
99'KI CI 0.32-0.91 0.5-2.1 0.31-1 0.5-1.3 
"'p< 0_0001 VI Conttols; .p < 0.005 VI Admission 
Thus,in tile acute coronary syndromes of unstable angina and myocardial 
infarction, activation of coagWation persists beyond tile acute phase. 1be 
biochemical abnonnalitics fouDcl after clinical stabilization ue consistent 
with tile pIeSCIICe of a prethrombolic state. 
822·5 9:30 
Thrombin Activity and the Pathogenesi, .. r Refractory 
Ischemia in Unstable Angina 
Diego Ardissino, Gabriella Gamba, Sophie Testa, Alb..·no Rolla. Gloria 
Demicheli, Paolo Barberis, Paola Zanini, Carlo Montemartini, Division 
of Cardiology, IRCCS S_ MaLteo, Pavia- Italy_ 
Intennittent thrombus fonnation has been regarded as a possible 
pathogenetic mechanism for refractory ischemia in pts with the acute 
coronary syndromes of unstable angina and myocardial infarction_ 
Fibrinopcptide A (FPA ) is a reliable in vivo marker of thrombin 
generation and its plasma levels are elevated in pts with ongoing 
thrombosis. To evaluate whether increased FPA plasma levels may 
identify patients who develop refractory ischemia we studied 109 patients 
with unstable angina. AU pIS undeIWent 24-hour Holter monitoring at the 
end of which blood samples for FPA determinations were taken and 
coronary arteriography performed. All pts received standardized maximal 
medical therapy before FPA detenninations. The upper limit for normal 
FPA was 9.2 ng/ml (mean+2SD of the values determined in age and 
sClC-matchcd controls). SilCly-scven pIS (61 %) had abnormally elevated 
values of FPA and 42 (39%) had values within the normal range. Thirty•
three pts (30%) had at least I ischemic episode during the 24-hour Holter 
monitoring. The positive predictive value of abnonnal FPA plasma level 
for the prescncc of refractory ischemia was 35%_ Eighteen pIS had both 
symptomatic and asymptomatic ischemic episodes. 10 only asymptomatic 
and 5 only symptomatic_ No significant difference was observed 
between pts with normal and abnonnal FPA plasma levels with regard to 
the number of ischemic episodes (median/range) (Normal: 1.5/1-10 vs 
Abnormal: 2/1-60) and to the total duration of ischemia in minutes 
(Nonnal: 10/4-28 vs Abnormal: 9/2-133). Thus, thrombin activity 
assessed by means of FP A plasma determinations does not correlate with 





Plasma Levels or the Thrombin·Antithrombin III Complex to Monitor 
Respon.'Ie to Heparin Treatment in Unstable Angina 
Rosa-Maria Lid6n, Pierre Th6roux. Montreal Heart Institute, 
Montreal, Canada 
The facilitating effect of heparin upon the formation of the thrombin•
antithrombin III complex (T -A T) may be inhibited by circulating factors 
present in thrombotic states. To evaluate the usefulness of plasma T -AT 
levels to monitor heparin efficacy, 49 conaecutive patients hospitalized for 
unstable angina had T-AT determinations before, and daily during heparin 
administration (5,000 Unit bolus followed by an infusion at a rate of 1,000 
UIhr adjusted to maintain the activated partial thromboplastin time (aPTT) 
at 1.S-2x control). T -AT was measured using the sandwich technique and 
a commercially available kit (Diagnostica Stago, France). Recurrent angina 
and ischemia in hospital occurred in 22 patients and 27 remained symptom•
free. Heparin administration initially increased T-AT levels by 13.8%, from 
24.6 to 28.0 ng/ml in patients with recurrent iscbemia and similarly by 
9.5% from 23.3 to 25.5 nglml in controlled patients (p=NS). Subsequent 
daily levels ofT-AT decreased to 27.0,24.8,26.0,25.8 and 25.0 ngIml in 
recurrent ischemic patients (p=O.08 by the ANOVA model with repeated 
measures with time as covariance), whereas they increased to 24.6, 24.7, 
25.3, 28.1 and 28.4 in patients with no recurrent ischemia (p < 0.(01). 
These changes were accompanied by opposite trends in the amount of 
heparin needed to maintain aPTT in the therapeutic range, with significantly 
more additional boluses needed in patients with recurrent angina. 
Thus, heparin administration resulted in an early increase in T -A T levels in 
all patients; thereafter, these levels increased progressively in patients 
responsive to therapy but tended to decrease in patients with recurrent 
ischemia. The data may suggest a state of heparin resistance in unstable 
angina which progressively dissipates, except in patients with continuing 
ischemia. Sequential changes in T-AT levels may thus be of use to monitor 
disease activity in unstable angina. 
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823·1 8:30 
Beta-Blocker Usage Is Associated with 8 Reduction In the Post· 
Awakening Peak of Myocardial Infarction Onset. 
Murray A. Mittleman, Malcolm Maclure, Jane B. Sherwood, Geoffrey H. Toller, 
James E. Muller for the Onset Study Investigators. InstHute for the 
Prevention of Cardiovascular Disease, Cardiovascular Division, Deaconess 
HospHal, Harvard Medical School, Boston, MA. 
MI onset has been well-documented to occur more frequenlly in the 
first hours after awakening than at other times of day. The mechanism of this 
increase Is unknown, but, surges in catecholamines, which occur in 
association wHh waking and rising, have been postulated to play a role. 
Previous studies of the effecl of beta-blockers on the pattem of MI onset have 
been IimHed by small sample siZe and/or lack Of wake-time adjustment. 
In the ongoing NHLBI·sponsored MI Onset study we interviewed 885 
patients and asked them to report the time of symptom onset, their wake·time 
on the day of their MI, and their usage of beta blockers. We compared the 
Wake-time adjusted paftem of MI onset In the 181 subjects taking beta•
blockers prior to their MI to the pattem in the remainder of the patients. 
MI Onset Adjusted for Wake Time 
Patients not on beta·blockers Patients on beta·blockers 
:~ 
'., ... ·1 0 2 ••• 1011 ,. II II zo at ..... _-
8eta-blockade was associated wnn a markedly altered wake-time 
adjusted pattem of onset (Figures 1 and 2). Peak onset among patients not 
receiving beta-blockers occurred in the first 3 hours after awakening. Beta· 
blocker usage was associated wHh a statistically signHicant decrease (p<O.OI) 
in this early peak in MIs compared to non·users. 
This finding suggests that adrenergic stimuli are Important in 
producing the peak in MI onset following awakening, and that the 
pathophysiology of MI onset varies at different times of the day. 
823·2 
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8:45 
Seasonal Periodicity of Acute Myocardial Infarction and 
Association With Birthdays and Holidays 
Alan C. Wilson, Ting Cui, Nora M. Cosgrove, John B. Kostis. 
UMDNJ-Robert Wood Johnson Medical School, New 
Brunswick, NJ. 
Precipitating factors and triggering events of acute myocardial 
Infarction (AMI) are not well defined. Circadian rhythm with a 
peak In the morning and a weekly cycle with a peak on 
Monday have been described. Using a large database 
(118,955 records) for New Jersey AMI hospitalizations we 
Investigated seasonal fluctuations for the years 1986-90. The 
differences between the monthly expected and observed 
number of AMI were determined. Significantly more AMI than 
expected were recorded in winter than in summer (p=O.OOO 
by the x' test of goodness of fit). There was a 13% greater 
risk of AMI hospitalization In the peak month, January, than in 
July (R.R. 1.13; 95% C.l., 1.09-1.17). 
The association of AMI with birthdays and holidays 
(New Year, Easter, July 4th, thanksgiving and Christmas) was 
also examined. Birthdays showed a significant excess from 
expected AMI compared with days in the surrounding week 
(p=0.0003) while AMI admissions were consistently higher on 
the day after holidays (RR 1.27, 95% CI, 1.10-1.46, for 
combined data excepting Christmas and New Year). These 
patterns may be explained by physiologic, behavioral and 
environmental influences, such as alcohol, exercise, 
psychological and social "stress" ,cold and day length. There 
may be avoidance of entry to the hospital on the day of public 
holidays, whereas there is no such reluctance on birthdays. 
823·3 9:00 
Circadian and Seasonal Factors In the Pathogenesis of 
Acute Myocardial Infarction: The Influence of 
Environmental Temperature 
Bradley Marchant, Kulasegaram Ranjadayalan, Robert 
Stevenson, Paul Wilkinson, Adam D Timmis. 
London Chest Hospital, London, United Kingdom 
Seasonal rhythms have been demonstrated in ischemic heart 
disease with both winter and summer peaks occurring in 
different climates, but the influence of environmental 
temperature remains uncertain. 
We have analysed the seasonal variation of acute myocardial 
infarction (AMI) in 633 consecutive patients over 4 years in a 
temperate climate (London, UK) with reference to the 
influence of environmental temperature. The mean age of the 
patients was 62 years (range: 26 to 94) and 462 were male. 
There is a significant winter peak and summer trough in 
incidence of AMI, 30.5% of the total study group presenting 
in the 3 months from December to February. The data show 
a higher weekly rate of AMI on colder days (temperature 
<3.0°C = 4.60/week, ~15.0oC=2.36/week, p<O.OO1). 
To determine if the excess of AMI on colder days reflected a 
seasonal rather than a temperature effect, the winter months 
(October to March) and summer months (April to September) 
were considered separately. The rate of AMI in each of 5 
temperature bands for both summer and winter confirm a 
significantly higher rate of AMI on colder days for both 
seasons. (winter, p<O.02; summer, p<O.02). 
Thus AMI occurs more commonly on colder days in both 
summer and winter, indicating that environmental temperature 
may be an important variable in the pathogenesis of AMI. 
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Circadian Variation of Symptom Onset in Patients With 
Ischemic and Non-ischemic Chest Pain 
Arturo A. Alfaro. Catarina Kiefe. R. Phillip Dellinger. Peter R. Puleo. 
Baylor College of Medicine, Houston. Texas 
A circadian pattern has been well documen~ in ~ variety ~f isc~emic 
syndromes. These findings have been used to Imphca~ an en.ologlc role 
for physiologic factors that might cause or exacerbate Isc~e~a. and that 
follow a similar diurnal pattern. However. few studies mcluded a 
control population to evaluate the circadian variation of non~ardiac (NC) 
complaints. Accordingly. we pr~spectively ~orded the .tJ~e of c~est 
pain onset in 852 consecutive panents (pts) with myocardial mfarctJon. 
unstable angina (VA). and NC sy~ptoms .. Tim~ of sY'!lptom onset was 
grouped by 3 hour intervals. DiagnOSIs of mfarctJ?n was by MB 
creatine kinase. symptoms. and ECO. UA was diagnosed when 
symptoms suggested ischemia and coronary disease was documen~ ~y 
arteriography or stress testing. A Chi sql!are goodn~s~ of ~t S~IiSIiC 
was employed to test the null hypothesIs that vanatlOn m tJl!1e of 
symptom onset was not significant. 111 pts had MI; the maximum 
frequency of symptom onset. w~s between 0900 and .1200 (23 pts. 21 %; 
p<o.OO5). This pattern was hrruted to the 64 pts havmg Q-wave MI (15 
pts. 23%; p<O.OO5); among 47 pts with nonQ-wave MI there was no 
diurnal variation. 194 pts had UA; peak onset occurred between 0600 
and Q900 (40 pts. 21 %; p<O.OOI). Among 367 pts with NC pain. ~8 
(18.5%) had symptom onset betw~n 0600 and 0900 (p~.005). This 
distribution did not differ from that ill UA. Among 180 pts m whom the 
etiology of pain remained uncertain. no diurnal .pattern was pr.esent. 
Because the incidence of MI. UA. and NC pam all peaked m the 
morning hours the relative liklihood of MI in a pt with chest pain was 
not increased i~ this interval. However. the "rule-in rate" did manifest a 
circadian pattern. having a peak between 1500 and. l~OO. with 22% of 
pts with pain during this interval having ~I; ~he h~hhood of MI was 
69% greater in a pt having symptom onset m thiS penod .th~ th~ o~erall 
rate (P=O.03). Thus I)Noncardiac pain has a. di~al vanalion slm.dar to 
that of ischemic pain; 2)Althou~h ischeml~ IS !ll~.st co:n.~on 10 the 
morning. the liklihood that a pt ~Ith. chest pam will . rl!le m IS greatest 
in the late afternoon due to a low mCldence of NC pam m the afternoon. 
823-5 9:30 
Exertional Physical Activity is Associated vith 
Increased Acute RiSK of Myocardial Infarction 
Stefan N. Wil1ich. Hannelore Lowel, Michael Lewis, 
Ri chard Arntz Frauke Schubert, Rolf Schroder, TRIMM 
Study Group, 'Klinikum Steglitz, Free University of 
Berli n, Germany 
To determine whether onset of MI may be triggered by 
physical activity, 1082 consecutive pts (74t male, 
61+10 years) of a prospectively monitored population 
were interviewed within 2 weeks after MI. Controls were 
matched for age, gender, precinct, and timing of a 
control event. The pts had a relative risk (RR) of 2.0 
(1.2-3.3) of performi ng exerti ona 1 phys i ca 1 acti vi ti es 
(>6 METS) at onset of the event compared to control s 
(7.2 vs 3.6 t). The reported strenuous activities 
included yard work, carrying bags, lifting heavy 
objects, climbing staircases, jogging, bicycling, and 
aerobics. 
An additional comparison of the p~SI usual fre~uency.of 
exertional activity and the last time of actiVIty prIor 
to MI yielded a RR of 2.2 (1.5-3.3) of performing 
exertional physical activity within 1 hour before MI. 
Furthermore, the subgroups of pts usually exercising <4 
vs 24 times per week had a RR of 6.1 v~ 1.5 (p<O.OI? 
Conclusion: Exertional physical activIty is assOCIated 
with an increased risk of acute MI, particularly in pts 
exercising only infrequently. These findings should ~id 
in i dentifyi ng the tri ggeri ng mechani sms and i mprovi ng 
prevention of MI. 
ABSTRACTS 
823-6 9:45 
Coronary Blood Flow Can be Affected by Transcutaneous 
Electric Nerve Stimulation 
Anoop Chauhan, Paul A. Mullins, Ged Taylor, Michael C. Petch, Peter M. 
Scholield. Papworth Hospital. Cambridge, U.K. 
During the last decade transcutaneous electric nerve stimulation 
(TENS) has been shown to have a beneficial effect in the treatment of 
angina. However, the mechanism of action of TENS is not clear. We 
investigated 34 patients with chest pain and normal coronary arteries 
(Group 1) and 12 patients with heart transplants (Group 2) to study 
whether neurostimulation can increase coronary blood flow. The heart 
transplant patients were included in the study because their hearts are 
denervated. All anti-anginal drugs were stopped 48 hours before the 
study. A commercially available transcutaneous nerve stimulator 
(Compact Tens, Neurotechnics Ltd, U.K.) was used. Electrodes were 
placed 10·30 cm apart on the chest of the patient. The electrodes were 
connected to the stimulator and the stimulation was adjusted to a levet 
immediately below that producing pain (Pulse width 300 jJ. I sec, Pulse 
rate 150 p.p.s, 25·30 mAl. The level of stimulation was noted and the 
stimulator was then turned off. USing a standard femoral approach a 
Judkins-type 8F Doppler-tipped coronary catheter (Cordis Corp. Miami) 
was positioned in the lelt coronary ostium and resting coronary blood flow 
velocity (CBFV) was recorded. Heart rate, mean arterial and systolic blood 
pressure were also recorded. TENS treatment was then started. Five 
minutes later the measurements were repeated.There was no signHicant 
difference in heart rate (69 SEM 3.1 vis 69 SEM 3.3, p=NS) , systOlic 
pressure (130 mmHg SEM 21 v 132 SEM 5.1, p=NS), and mean arterial 
pressure (96 mmHg SEM 2.2 vis 96 SEM 3.0, p=NS) in Group 1 patients. 
The mean CBFV increased from 6.8 em/sec (SEM 0.71) before 
treatment to 10.5 cm/sec (SEM 0.98) after treatment [p <0.001, paired t•
Test). In Group 2, however, there was no significant difference in the 
mean CBFV (7.4 SEM 1.4 before vis 7.4 SEM 1.4 after). We conclude 
that TENS can increase coronary blood flow and it may do so by affecting 
the coronary vascular tone by neural mechanisms. 
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Impaired Endothelium-Dependent Vascular Relaxation in Patie~ts 
With Essential Hypertension: Intrinsic Endothelial Abnormahty 
or Specific Defect in the Response to Acetylcholine '1 
Julio A. Panza, Philip R. Casino, Crescence M. Kilcoyne, Arshed A. 
Quyyumi, Stephen E. Epstein. NHLBI, Bethesda, MarylarId. 
Patients with essential hypertension have a reduced response to the 
endothelium-dependent vasodilator acetylcholine (Ach). However, 
because previous studies invariably used Ach to test endothelial 
function, it is not known whether such impaired response is due to an 
intrinsic abnormality of the endothelium to respond to various stimuli, 
or whether this is due to a defect in the specific response to Ach. To 
address this issue, we studied the vasodilator responses to the 
endothelium-dependent agents Ach (7.5. 15, arid 30 /Lg/min) and 
substance P (Subs P; 1, 2, and 4 pmol/min), arid to the direct smooth 
muscle dilator sodium nitroprusside (SNP; 0.8, 1.6, arid 3.2 /Lg/min) 
in 8 hypertensive patients (6 male; age 50± 12 years) and 8 normal 
controls (4 male; age 49±9 years). Drugs were infused into the 
brachial artery, and forearm blood flow was measured by strain gauge 




Subs P 13.9±4 
SNP 9.3±2 





Hypertensive patients had a reduced vasodilator response to both Ach 
arid Subs P; however, the response to SNP was similar to th~t of 
controls. These findings indicate that the impaired endothehum•
dependent vasodilation of hypertensive patients is not due to a def~t 
isolated to the response to Ach, and suggest an intrinsic abnormality 
of the vascular endothelium in response to diverse stimuli. 
438A ABSTRACTS 
824·2 8:45 
Relation of ventricular and Vascular Hyper•
trophy to Basal and Ambulatory Blood Pressure 
Mary J. Roman, Joseph E. Schwartz, Thomas G. 
Pickering, Riccardo Pini, Richard B. Devereux. 
Cornell University, New York, New York 
We previously reported a strong relation of 
common carotid artery intima-media thickness 
(IMT) to basal systolic (S) blood pressure 
(BP). To determine whether ambulatory BP meas•
urements improve this relation in the manner 
observed with LV mass, 64 employed subjects (BP 
100-166/60/119 mmHg) underwent echocardiography 
with basal BP, carotid ultrasound and ambula•
tory BP recording. Carotid IMT was more closely 
related to basal SBP (r=.48, p<0.0001) than to 
work (r=.36) or non-work SBP (r=.39, both 
p<0.005) whereas the relation of LV mass to 
basal SBP (r=.33, p<0.01) was improved by 
examining work (r=.41, p<0.001) and non-work 
SBP (r=.44, p<0.0005). SBP variability (stan•
dard deviations of ambulatory recordings) bore 
no relation to LV mass but was related to 
carotid IMT (r=.48 for work and .43 for non•
work, both p<0.0005), independent of age and 
SBP. The 13 subjects with carotid atheroscler•
osis had significantly greater variability of 
systolic and diastolic BP (p<0.01) than the 51 
without plaque. 
Thus the relation of large artery wall 
thickness with BP level is not improved by 
consideration of ambulatory BP whereas that of 
LV mass is. Increased carotid IMT and athero•
sclerosis are both associated with ambulatory 
BP variability and may reflect impaired baro•
receptor sensitivity by arterial hypertrophy. 
824·3 9:00 
Combined wall thickening of carotid and femoral arteries 
without lumen diameter change in human hypertension. 
Jerome Gariepy. Marc Massonneau, Jaime Levenson. Alain Simon. Centre de 
Diagnostic. INSERM U 28, Hopital Broussais. Paris. France. 
~ : Geometrical remodeling of arteries chamcterizes hypenension and 
contributes to change resistive and capacitive functions of the arterial tree. In 
contrast with small aneries. two major components of vascular geometry. wall 
thickness and lumen diameter. have not yet been studied simultaneously in large 
arteries. 
~ : The thickness of intima·media complex (IMC) and lumen diameter 
(D) were measured by high· resolution B-mode Echography coupled with 
computer·assisted image analysis in common carotid (CA) and femoral (FA) 
arteries of 50 men. including 25 untreated hypenensives (HT) with diastolic 
blood pressure (DBP»95 mmHg and 25 normotensives (NT) with DBP<90 
mmHg. Synchronisation of ultrasonic images with the ECG allowed to obtain 
diastolic measurements of IMe and 0 with reproducibility of respectively 5 and 
6%. 
~: Means ± SD were compared between NT and HT. *:P<O.OOI. 
Age DBP IMCCA IMCFA DCA DFA 
(yrs) (mmHg) (mm) (mm) (mm) (mm) 
NT 47±8 78±7 O.51±O.06 O.53±O.1O 6.30±0.64 8.73±1.21 
HT 47±9 I03±6* O.63±O.IO* O.69±O.19* 6.49±0.55 8.88±O.96 
Moreover lMCCA and lMCF A correlated with DBP in the overall popUlation 
(r=O.60.r:O,45.P<O.OOI) while such correlations did not exist for diameter. 
Lastly in NT. but not in HT. !MCCA and IMCFA correlated with age (r:O,48. 
P<O.OO5. r:O.55. P<O.OI). 
Discussipn : Thus. carolid and femoral aneries of hypertensives have a wall 
thickenine without concomiltanl alteration in lumen diameter. The laller 
observati';-n suggests that despite the stretching effect of high blood pressure. 
these large arteries are less distensible. The lack of age·related thickening in 
hypertensives also indicates that hypertension probably overweights the natural 
effect of aging on anerial wall. The determination of such slructurJl anerial 
parameters using a non-invasive technique may represent a new 1001 to monitor 
in vivo the behaviour of large aneries changes during the natural history and 
treatment of human hypertension. 
824·4 
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Increased Prevalence of Renal Artery Stenosis 
in Hypertensive Patients With Multivessel 
Coronary Artery Disease 
Wjlljam C. Robbjns Gordon J. Azar ,Jr., Richard A. Davidson, 
Thomas J. Wargovich 
University of Horida , Gainesville, Horida 
The prevalence of renal artery stenosis (RAS) in the 
general hypertensive population is reported to be less than 
S%. However, the prevalence of RAS in populations with 
other arterial atherosclerotic disease, including coronary 
artery disease (CAD), is uncertain. In the present study, we 
prospectively evaluated the patency of renal arteries by 
digital subtraction abdominal aortography in 110 unselected 
hypertensive patients undergoing diagnostic cardiac 
catheterization for suspected CAD. The prevalence of 
significant RAS ( > than SO% narrowing) was analyzed by 
subgroups according to the extent of coronary disease found 
at catheterization. 
RFSULTS: CAD PATIENTS 
o vessels 34 
1 23 
2 or 3 S3 





Patients' age and sex did not differ significantly between the 
subgroups studied. 
Conclusion: These data demonstrate that the risk of RAS 
increases significantly in hypertensive patients who are 
found to have multivessel CAD. These data suggest that 
screening aortography may be warranted in this patient 
group. 
824·5 9:30 
Role of Insulin-Resistance in Cell Cation Exchange in 
Arterial Hypertension 
Giuseppe Andronico, MariaTeresa Mangano, Giuseppe Mule, 
Giuseppe Piazza, Domenico Lupo and Giovanni Cerasola. 
Hypertension Centre, University of Palermo, Italy. 
Most of hypertensive patients show hyperinsulinemia that 
reflects resistance to the actions of insulin. Insulin 
could modify the sensitivity of the vascular smooth 
muscle to vasoconstrictor agents by augmenting Na+IW 
exchange producing an increase of intracellular Na+ and 
Ca++ concentra~ions. To verify this hypotesis we deter•
mined insulin ~lasma levels, insulin sensitivity and 
sodium-lithium countertransport (Na,Li-CT), that corre•
spond to a mode of operation of the Na+IWexchanger , in 
26 male Ratients (mean age 47.3 ± 2.2 y, mean BMI 27.5 ± 
0.7 Kg/m~) with mild to moderat~ hypertension. After 2 
weeks without therapy and with a balanced s:andardized 
diet, we ob:ained from each patient a fasting venous 
sample to determine glucose, insulin and Na,Li-CT. 
Insulin was measured with a double antibody radioimmuno•
assay and tla,Li-CT with ~he method of Canessc: M. The in•
sulin sensitivity index (lSI) is expressed as fasting 
glucose/insulin ratio. 
Results: In our patients mean Na,Li-CT was 0.404 ± 0.03 
mmol/L/h and showed a positive correlation with fasting 
insulin (r=0.53 peO.Ol) and a negative correlation with 
the lSI (r= -0.43 peO.051. These relationship were inde•
pendent of Body Mass Index. 
Our results confirm that in hypertensives plasma insulin 
levels and insulin-resistance are linked to cation trans•
port system; insulin, in vascular muscle smooth cells of 
hypertensives, can favour an increase of intracellular 
cation content, that exaggerates vasoconstriction, and 
an increase of pHi, that stimulates cell growth. 
JACC Vol. 21, No.2 
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A non·invasive evaluation of compliance of medium·sized 
muscular arteries in hypertension 
Emmanuel Heron·, Jean-Louis Megnien*, Alain Simon·, Denis Chemla+, 
Jean-Claude Poumy++, Yves Lecaq>entier+, Jaime Levenson· 
• H6pital Broussais, INSERM U28. Paris. + Hopital Bicetre, Kremlin Bicetre, 
++ INSERM U275, Palaiseau, France 
~: We tried to determine the geometrical and elastic properties of the 
hand arteries which are classicaly investigated for vascular reactivity studies in 
human hypertension. 
~: Height untreated sustained essential hypertensive men (HT) and IO 
normotensive men (NT) of similar age (53±8 and 48±9 years) underwent 
measurements of finger blood pressure contour (Finapres), and radial artery 
diameter (D. pulsed Doppler). Hand vascular resistance (R) was calculated as the 
MBP/Q ratio. where MBP was the mean integrated pressure and Q was the mean 
radial artery blood flow (pulsed Doppler). Hand arterial compliance (C) was 
deduced by a first order "RC" model as the t/R ratio where t was the time 
constant of the exponential telediastolic decay of the pressure wave aUrOmaticaly 
calculated by a computer after digitization of the simultanous recordings of 
arterial pressure and flow. 
~: mean t SD.(a p<0.01; b p<O.OO!) 
MBP D Q R 't C 
mmHg em ml/mn mm Hg.sec/ml sec 1Q,3ml/mmHg 
Nr 91 0.319 16 511 2.30 5.79 
til to.03! tl3 ±282 ±0.64 t3.!2 
HT l27b 0.354a 19 440 2.55 6.07 
±17 ±0.022 t7 ±1l5 ±0.53 to.89 
Moreover positive correlations existed in the overall subjects between t and R 
(r=O.60; p<0.01) and between D and MBP (r= 
0.57; p<0.01). 
Copclusiop : At first, the validity of the model relationship: t=C.R • 
applied 10 the hand, was demonstrated by the t vs R correlation obtained in the 
study subjects. Secondly, Iikc the proximal larger arteries, the caliber of 
medium-sized arteries was found increased in chronic hypertension probably due 
to a stretching effect of distending blood pressure; In contrast, tbe compliance of 
such arteries was not impaired indicating that hypertension did nOi aiter, at least 
in basal conditions. the clastic propenies of peripheral muscular arteries 
distributed to the skin circulation. 
825 New Devices for Interventional Cardiology II 
Thursday, March 18, 1993 
8:30 AM-1O:00 AM 
Anaheim Convention Center 
B-4 
825·1 8:30 
IlEAT ACTIVATED RECOVERABLE TEMPORARY STENTS: 
IIISTOPATHOLOGIC AND ANGIOGRAPUIC OBSERVATIONS FOR 
IMI'LANTATIONS OF UP TO SIX WEEKS 
Mehran J. Khorsandi, Neal L. Eigter, Frank Lilvack, Ken N. Mahrer, 
James Forrester. Cedars-Sinai Medical Center, Los Angeles, CA 
Seventy-eight Heat Activated Recoverable Temporary Stent(HARTS) 
devices were percutaneously deployed in the LAD and LCx coronary 
arteries of 28 anesthetized dogs treated with ASA, dipyridamole, heparin 
and dextran. Using standard balloon angioplasty techniques, stents were 
expanded to diameters of 3.0-4.0 mm and left in-situ for periods of 30 min, 5 
hrs, 24 hrs, 72 hrs, I week and 6 weeks. To recover the HARTS devices a 3F 
catheter was coaxially placed through the stent. 3-5 cc of lactated Ringer's 
solution at 75-8(1JC resulted in thermoelastic collapse of the stent onto the 
catheter. 70 of 70(100%) stents were implanted for up to 1 week and 
recovered without difficulty. There was no embolization, migration, rupture 
or spasm associated with implantation or recovery. No angiographic 
evidence of dissection or thrombus formation was seen. At Six-week stents 
were not recoverable because of neointimal proliferation embedding the 
struts into the vessel Wall. Three classes of vascular injury were observed. 
Class 1- minor intimal injury was seen in 40(59%), Class II- microscopic 
platelet-fibrin thrombi and focal medial necrosis was seen in 23(33%). 
Class III or medial disruption wa~ observed in 7(11%), only when the ratio 
of balloon to vessel si7.e exceeded 1.4. There was a predilection for class" 
injury with implantations of more than 24 hours 16/24(78%). Scanning 
electron microscopy showed minimal platelet and fibrin deposition on 
stents implanted for 24-72 hours. 
Conclusions: The HARTS device can be reliably implanted and removed by 
conventional angioplasty techniques. Removal can be accomplished up to 
one week post implantation: At six weeks, neointimal proliferation 
precludes recovery. Histopathologic evaluation demonstrates the absence of 




Removable Self Expandable Nitinoil Coil Stent: Initial 
Report on In-Vitro, Canine and Human Experience. 
Rafael Beyar and Michel Henry. The University of Calgary, 
Canada and the Polyclinique D'Essey-les-Nancy, Nancy, 
France. 
Removal of an intravascular stent may be important in case 
of misplacement of the stent or other potential indications. We 
hypothesize that a self expandable Nitinoil stent (In-Stent) 
could be removed by retracting the stent as a straight wire into 
a catheter utilizing a special device. The stent is constructed 
as a coil with small balls at the proximal and distal ends. The 
retracting device is a wire loop within a special catheter, which 
is rotated in the artery opposite to the stent coil direction so as 
to catch the end of the stent, lock it and retract it into the 
removal catheter as a straight wire. The retracting device was 
tested in vitro with 20 stents (diameter 5-7 mm, length 40 mm) 
released in curved plastic tubes. In all cases the stent could be 
easily removed. In addition, 5 stents (diameter 6·8 mm, length 
40 mm) were released in ileac and aortic arteries of mongrel 
dogs under direct fluoroscopic vision, and removed as 
described above within 24 hours of insertion. At the end of 
the procedure, the arteries were excised and inspected. No 
macroscopic intimal tears or intimal damage could be seen. 
In 1 patient in which the stent was misplaced in an ileac artery 
below the stenosis, the stent was removed after 3 hours 
without sequela. Angiography following the stent retraction 
showed patent artery. Conclusion: removal of the vascular 




Short and Long-term Vascular Tissue Response to the Duke 
Bioabsorbable Stent. 
James P. Zidar, Roger S. Gammon, Gregory D. Chapman, Stephen C. 
Culp, Brigitta C_ Brott, Howard Clark, Robert P. Bauman, Bruce F. 
Waller, Harry R. Phillips, Richard S. Stack. St. Vincent's Hospital, 
Indianapolis, IN and Duke University, Durham, NC. 
Although metallic stents are currently used for post angioplasty 
acute closure and late restenosis, some concern exists over their permanent 
nature and aggressive need for anticoagulation to overcome subacute stent 
thrombosis. Initial experimental results have previously been reported for 
the Duke self-expanding stent composed of a specialized bioerodible poly•
L lactide(PLLA) polymer. To further analyze the vascular tissue response, 
our cumulative histologic results with long-term follow up are now 
reported. 
Eleven stents (4-6 mm x 17-22 mm) were pland in femoral 
arteries of eleven mongrel dogs via a catheter delivery system. Each stent 
was woven of eight polymeric strands into a diamond-braided pattern. 
Heparin (10,000 units) was given at deployment. Subsequent 
anticoagulation treaUnent consisted of daily aspirin alone. Angiographic 
and pathologic data were obtained at 2 br(n= 1), 2 days(n= 1), 4 
days(n=2), 1 wk(n=2), 2 wk(n=3), 12 wk(n=I), and 18 mo(n=I). 
Stent patency was present in 92% (10/11) vessels at follow up, with 
minimal arterial narrowing «25% residual stenosis) in the 10 patent 
stents. Loss of mechanical integrity and nearly complete degradation was 
seen at 18 months. 
Serial histologic examination noted preservation of the internal 
elastic lamina, minimal medial thinning around the stent struts, complete 
endothelialization within 2 weeks, and minimal thrombus formation. The 
tissue response was minimal at all time intervals observed from 2 hours to 
18 months. 
In conclusion, this bioabsorbable stent was hemocompatible and 




Physiological Low Stress Angioplasty at 60°C. Initial 
Results and 6 Month Follow·up. 
Serge Makowski, *Blaire O'Neill, Antoine Sarkis, Ezra Deutsch, 
Ray G McKay, Jack L Manin, Salvatore Battaglia, Gilles Bayet, 
Jean Uon Guermonprez. * Victoria General Hospital, Halifax, 
Canada. Broussais Hospital, Paris, France 
We have previously demonstrated in animals and human 
peripheral vessels that the simultaneous application of heat at 60 °C 
and low pressure during angioplasty results in improved stenosis 
reduction and less intimal damage than conventional PTCA. 
To evaluate the feasi bility of physiologic low stress angioplasty 
(PLOSA), 30 patients (pts) underwent thermal angioplasty at 
60°C. Heating was achieved through the application of 
radiofrequency energy to a modified noncompliant conventional 
angioplasty balloon. Twenty seven pts had de novo lesions and 3 
had restenotic lesions. Mean maximum pressure for these lesions 
was 3.7 ± 1.1 atmospheres (ATM). Mean heating time was 151 ± 
78 seconds. PLOSA was successful in 24/30 pts. A mean initial 
stenosis of 78.6 ± 9.84 % was reduced to 21.93 ± 10 (p<O.OOl). 
In 2 cases, PLOSA limited to 5 A TM was inadequate to dilate the 
lesion and conventional PTCA was used. Dissection occured in 2 
pts and required prolonged conventional balloon inflation, 
thrombosis and subacute occlusion each occured in 1 pI. Twenty•
four hour post-PLOSA angiograms performed in 11 pts did not 
show any elastic recoil; initial and 24 hour residual stenosis were 
respectively 24.54 ± 10.87 % and 29.72 ± 12 % (p=O.6). 
Allgiographic follow-up is available in 20/30 pts. Restenosis 
(defined as a 50% luminal diameter reduction) occured in 12/20 
pts. Samples of atheroma removed by atherectomy in 1 restenotic 
pt did not show any thenna! damage. 
This initial experience demonstrates the feasibility and safety of 
angioplasty with PLOSA at 60°C in human coronary arteries. 
There is no elastic recoil at 24 hours. However, further studies 
Wilh long term follow-up are needed to establish whether the 
restenosis rate is reduced by this technique. 
825·5 9:30 
Vascular Hemostasis Device (Vasoseal) in Patients Undergoing 
Coronary Stent Implantation 
Franz von Hoeh, Adnan Kastrali, Franz-Josef Neumann. Gert Richard, 
Wolfram Theiss, Allert SchOmig. I. Mad. Klinik 1U MOnchen, Germany 
Patients (pts) who are managed with coronary stenting need a strict antico•
agUlation regimen to maintain the patency of the stented vessel. This makes 
necessary a prolonged manual compression after arterial sheath removal 
and may expose the patient to local vascular complications. Sixty three pts 
und8lWent Palmaz-8chatz coronary stent implantation for treating large 0c•
clusive dissections after PTCA. During the procedure pts received 15000 U 
heparin and SOO mg. Aspirin intraveneously. In 33 pts the sheath was re•
moved from the femoral artery 2 hours after stent implantaiion. Heparin infu•
sion was discontinued until bleeding was controlled by external cofl1ll"8SSion. 
The time of extemal compression varied from 1 to 6 hours (Control group). 
In 30 pis the sheath was removed immediately after stent placement. Vaso•
seal. a bovina collagen plug, was iltlllanted and bleeding caesed after 3 • 5 
minutes of extemal comprassion (Vasoseal group). A pressure bandage 
was additionally used for 72 hours in all pis. On the first and third day after 
bandage removal all pis were controlled by color Doppler. 




local bleeding necessitating 
blood transfusion 
local colJ1)licetions requiring surgery 



















Conclusions: The use of vascular hemostasis device reduced the time of 
extemal manual compression and allowed continuous heparinization of the 
pts undergoing coronary stent placement. The incidence of local compfica•
tions was however not influenced by the application of Vasoseal. 
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Percutaneous Closure of False Aneurysms; an AHemative for SurgI•
cal Treatment 
Paul H.M.J. Vermeersch, Jef M.P.G. Emst. R. Melvyn Tjon Joe Gin, Egbert 
T. Bal, E. Gijs Mast, Maarten-Jan Sutlorp, Carl AP.L Ascoop. H.w. Thljs 
Plokker. St.Antonlus Hospital, Nieuwegeln, The Netherlands. 
A well known complication after arterial puncture Is the development of a 
false aneurysm. The risk of occurrence of this event Is higher In procedu•
res with a larger sheath and with a lower grade of hemostasis. Although 
the maJor~y of these aneurysms, especially the smaller ones, may close 
spontaneously by clotting, surgical treatment is often Indicated for the 
large- and the symptomatic ones. 
In order to facilitate the clotting process within the aneurysm it has been 
proposed to compress the entrance of the aneurysm guided by u~ra­
sound or by Introducing spring coils within the aneurysm. It has been our 
approach to use biodegradable collagen to facDitate clotting within the 
false aneurysm to achieve closure. Bovine biodegradable collagen is 
applied within the aneurysm percutaneously through an Introducing 
sheath. The shape and constHution of the collagen is such that embolisatl•
on into the arterial lumen is avoided. 
Since September 1991 we successfully closed 31 large false aneurysms 
(defined larger than 3 cm.); thirty were of the femoral artery and one of 
the left internal mammary artery. In 27 of the 31 patients the aneurysm 
occluded successfully w~hin 24 hours (87%). The only short term compli•
cation was a local Infection which needed surgical debridement. There 
were no signs of peripheral embollsatlon. At repeat color duplex scanning 
in all patients no abnormalities were seen. There were no long tenn 
clinical complications. 
We conclude that large false aneurysms occurring after arterial puncture 
can be obliterated effectively and safely with specially prepared biodegra•
dable collagen. 
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Exercise Echocardiography and SPECf for Detection of 
Restenosis 4 Months after PTCA; ImproVed Accuracy by 
Comparison with Test Results Acquired Directly after PTCA. 
Rainer Hoffmann, Harald Letheo, Eduard Kleinhans, Rainer 
Uebis, Frank A Flachskampf, Peter Hanrath, FACC,Med. Clinic 
I, RWIH Aachen, FRG 
Exercise echocardiography (EE) as well as perfusion scintigraphy 
was performed in 31 patients (pts) without prior Q wave infarction 
to evaluate functional improvement and detect restenosis after 
PTCA. For this purpose EE was performed 2 days prior to PTCA, 
2 weeks post PTCA and at control angiography (CA) 4 months 
post PTCA. In 24 pts CA and SPECf were performed. 
Angio~aPhically successful PTCA was achieved in 94% of pts 
(29/31 . In these patients average luminal area stenosis decreased 
from 6±.6% to 58±.11 %. CA showed significant restenosis in 
5/24 pts (21%). EE before PTCA was positive in 88%, continued 
to be poSItive in 31% of pts after PTCA and was positive in 42% 
at CA SPECf at the time of CA was positive in 47% of cases. 
Resulting sensitivity for detection of restenosis was high for EE 4 
months post PTCA, 100%, as well as SPECf 100%, specificity 
however was low, 65% and 53% respectively. Taking only a 
deterioration of EE results from 2 weekS to 4 months after PTCA 
as sign of restenosis resulted in increased specificity 90% and 
accuracy, 80% instead of 72%. Sensitivity however decreased to 
40%, indicating that some pts have had restenosis already 2 weeks 
post PTCA The early EE has a l'rognostic value since 60% of pts 
with restenosis had an early positIve EE. 
Conclusion: EE documents improvement in re~onal function 
after PTCA A significant 1,'roportion of pts contmues to have a 
positive EE even after anglOgraphically successful PTCA due to 
persistent ischemic regions or restenoSlS. Serial EE is a valuable 
tool in the follow up after PTCA, while single EE or SPEer lack 
specificity. Early positive EE is a sensitive prognostic marker of 
restenosis and deterioration between early and late post PTCA 
EE is highly specific for restenosis. 
JACC Vol. 21, No.2 
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826·2 8:45 
Dipyridamole Ecbocal"diographlc Test Early After 
Uncomplicated Acute Myocardial Infarction: lnbospital 
Prognostic Value 
Francesco Chiarella, Gianni Scarsi, Stefano Domenicucci, Paolo 
Bellotti, Pietro Bellone, LUigi Moroni, Gabriele Lupi, Carlo 
Vecchio - Cardiology Division, Ospedale Galliera, Genova, Italy. 
Early after an Acute Myocardial Infarction (AMI) it is important to 
discriminate patients at low from patients at high risk for 
predischarge cardiac events: those in the first group could be 
e)(c\uded from diagnostic invasive tests and discharged earlier. 
those in the second group should undergo further diagnostic 
invasive procedure and appropriate medical or surgical therapy. 
Dipyridamole Echocardiographic Test (DET) is a useful tool for 
predicting the extent of coronary artery disease after AMI; however, 
lillie is known about its value in the prognostic field. Aim of this 
prospective study was to evaluate the short term prognostic 
significance of DEf performed very early after uncomplicated AMI. 
DEf e2D-echo monitoring during dipyridamole infusion, up to 0.84 
mg/Kg over 10') was performed three days after AMI without any 
complication in 221 consecutive patients (189 male, age 57±9) with 
a 2D-Echo of good technical quality. All tests were videotaped, and 
the first 100 were reviewed by' two experienced blinded indep~ 
ndent observers (agreement in 94 cases, 6 cases resoil'ed by a third 
observer). DEf resulted positive in 126 patients (57%) and negative 
in 95 (43%). During the hospital stay, cardiac events (exitus, 
rcinfarction, angina requiring revascularization procedUre or 
medical treatment) oecurred in 39/221 patienL~: 36 of them had a 
positive and 3 a negative DET. Hence, test sensitivity was 92%, 
negative predictive value 97%, relative risk 9.05 (confidence 
intervals:2.9-28.5); the difference between positive and negative 
DEf versus events resulted highly significant (Jl<.0000009). 
In conclusion, DET performed very early after AMI makes it 
possible early identification of patients at low risk of inhospital 
cardiac events,potentially guiding inhospital menagcment strategies. 
826·3 9:00 
Prognostic Implications of a Nonnal Exercise Ecbocardlogram 
Linda 1. Crouse, James L. Vacek, Thomas L. Rosamond, Joan White, Gary D. 
Beauchamp, Paul H. Kramer, Mid Ameriea Cardiology A'isociates, Mid Ameriea 
Heart Institute, St. Luke's Hospital, Kansas City, Missouri 
Although exercise echocardiography (EE) has been shown to be a 
useful test for coronary insufficiency in a number of patient 
populations, the prognostic implications of a normal test are largely 
unknown. We assessed the clinical status of 172 pis at 1 and 5 yrs 
after a normal EE. There were 71 males (41%) and 101 females 
ranging in age from 16 to 83 (mean 56 ± 13) yrs. 15 pts had 
previously documented CAD by cath. Cineloop format digitized 
echocardiograms were acquired in 4 standard views at rest and 
following maximal symptom-limited treadmill exercise. A normal 
response consisted of hyperkinesis of each segment in each view. All 
studies were interpreted by a single observer. Clinical status was 
assessed by direct personal history, telephone interview, and/or mailed 
questionnaire. Events consisted of PTCA, MI, CABG, and death. 
The results are tabulated below. 
Follow-up Event-











If pIS with previously documented CAD are excluded from this 
analysis, event-free survival at 1 and 5 yrs was 100% and 99%, 
respectively. In conclusion, 1) a normal EE predicts a very low risk 
of cardiac events in tbe short and long term; 2) the benign prognostic 
implications of a normal EE strengthen the rde of this test as a 
screening tool for CAD. 
ABSTRACTS 
826·4 
Dobutamlne Stress Echocardlography Predicts Cardiac 
Complications Following Non Cardiac Surgery. 
Jennifer G. Nastelin, Pamela A. Marcovitz, David S. Bach, William F. 
Anns~g. University of Michigan, Ann Arbor, MI. 
Dobutamine stress echocardiography (DSE) is an accurate means for 
detflCting coronary artery disease and is independent of the patient's ability 
to exercise. As such, it may be an ideal method for evaluating patients 
with exercise limitations prior to noncardiac surgery. The purpose of thi" 
study was to evaluale the ahility of J)SE to predict cardiac complications 
following non cardiac surgery In a cohort of 73 patients. DS I:! was 
perfonned using a standard protocol and classified as nonnaI (normal at re~1, 
no inducible iscbemia). lixed (rest abnlllUl8llty, no inducible ischemia) or 
ischemic (new, additional or worsening wall motion abnormalities). 
Cardiac events were stratified as hard cventR (HE), Including cardiac death 
and nonfatal myocardial infarction (MI), or soft endpoinls (SE) of 
myocardial ischemia, unRtable angina, need for revlISCUlarizatiOll and 
arrhytbmia. The avcrngc 8lle was 65 y~ and 34 patients were maJc. Two 
or more traditional tis" factors were prescnt in 55 of 73 patients (75%) 
including 31142 with normal DSE (74%). 
DSE n Age Prior MI Angina HE SE None 
Normal 42 62 3/42 (7%) 8/42 (19%) 0 0 42· 
Ischemic 18 63 9/18 (50%)* 4/18 (22%) "2++ 7+ 9 
Hxed 13 68 7113 (54%)* 3/13 (23%) 2 10 
·P<.OO5, "'PdJOl, ++1'=.08 compared to normal. 
Non Q-wave MI occurred in 2 patient~ with fixed abnonnalllUcs; hoth had 
C01IlplicalCd Intra- or pIlSt-operative courses (one ruptured aortic aneurysm 
and one pheochromocytoma resection); There were no cardiac 
complications In the 41 palients with nonnaI DSE (sensltivlly 100%). We 
~"OIIcludc IbMt DSE is a highly sensitive and specifiC non-invasive technique 





The Prognostic Value of Rest and Stress 
Ecbocardiograpby Early After Uncomplicated Acute 
Myocardial Infarction: tbe First 995 Patients of the EPIC 
Study 
Patrizia Landi, Andres Orlandini, Franco Chiarella, Maria Grazia 
Sc1avo, Omelia Magaia, Giovanni Seveso, Leonardo Bolognese, 
Mario Previtali, Franca Margaria, Nicola Gandolfo, Stefano 
ChiarandA, Paola Rosse\li, Silva Severi. Eugenio Pieano, on behalf 
of the EPIC study group - subproject residual ischemia 
Left ventricular function at baseline and after stress are recognized 
prognostic markers, and both parameters can be easily obtained in 
one sitting by rest and high dose (up to 0,84 mg/kg over 10') 
dipyridamole echocardiograpby test (DET). Aim of this study was to 
assess the prognostic value of rest and dipyridamole 
echocardiography in predicting death early after first uncomplicated 
myocardial infarction. A total of 995 patients (age 56.3±9 years) 
performed a DET a mean of 10 days after acute myocardial infarction 
and were followed up for a mean of 14.6±10.2 months. There were 
39 deaths. Patients were stratified into 4 groups according to resting 
function (by the Wall Motion Score Index - WMSI - each segment 
ranging from I, nonnal, to 4, dyskinetic, in an 11 segment model) 
and presence of inducible ischemia, Event rate was lowest in 447 
patients with negative DET and resting WMSI <1.6 (10 deaths. 2%); 
intennediate in 110 patients with negative DET and resting WMSI > 
1.6 (3 deaths, 3%); higher in 346 pts with positive DET and resting 
WMSI < 1.6 (16 deaths, 5%); highest in 92 pts with positive DET 
and resting WMSl > 1.6 (10 deaths, 11%, p<.OI vs all other 
groups). Thus, rest and stress echocardiography provide an 
integrated panoramic view on left ventricular function at baseline and 
during stress, allowing an accurate stratification early after 





Preoperative Risk Assessment Prior to Major Vascular Surgery: A 
Prospective Trial Comparing Dipyridamole Thallium Scintigraphy 
and Dobutamine Stress Bchocardiography 
Gregory B. Clarke, Douglas S. Segar, Thomas Ryan, Stephen G. Sawada, 
Robert W. Burt, Vernon A. Vix, Judy Foltz, Harvey Feigenbaum, 
Krannert Institute of Cardiology, Indiana University School of Medicine, 
Indianapolis, IN 
seventy-six consecutive peripheral vascular surgery patients (pts) at 
Indiana University underwent both dobutamine stress echocardiography 
(DSE) and dipyridamole thallium scintigraphy (DTS) for preoperative 
cardiac risk assessment prior to high risk vascular surgery. Abnormal 
results were categorized as eilher fixed or induced. Patients were 
referred for cardiac catheterization (cath) prior to surgery at the 
discretion of the patient's physician. All studies were interpreted in a 
blinded fashion by experienced investigators. Patients were screened for 
events with serial cardiac enzymes, daily ECG, daily clinical evaluation, 
and a resting 2-D echocardiogram on the fifth postoperative day to 
assess for new resting wall motion abnormalities. The two tests were 
concordant in 53/76 pts (70%) for a normal vs abnormal result, but 
agreed in only 41/76 pts (54%) on the presence or absence of ischemia. 
There were 8 periopcrative cardiac events, including 2 fatal MI, 3 
nonfatal MI, 2 episodes of unstable angina, and 1 episode of CHF. DSE 
was abnormal in all 8 pts (4 fixed, 4 induced) with a cardiac event, while 
DTS correctly identified 7 of 8 (6 fixed, 1 induced). The negative 
predictive values of DSE and DTS were 100% and 94%, respectively. 
Twenty-four of 29 pts who underwent cath bad significant coronary 
artery disease (CAD) defined as ;;, 50% slenosis in a major vessel. DSE 
was abnormal in 21/24 pIs and DrS in 22/24 pts with CAD. In 5 pts 
without CAD at cath, DSE was normal in 3, DTS in none. Conclulions: 
1) perioperative events are predicted with similar accuracy using DSE 
and DTS; 2) both have high negative predictive value (100% and 94%, 
respectively) for perioperative cardiac events; 3) for determining a 
normal vs an abnormal result, concordance between the 2 tests was only 
modest (70%). 
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Discordant Results of Extradion Atberectomy in Old and YOIIIII Saphenous 
Vein GrafIlI: The NACI Experience 
AI .. E. Abdel_suid. SlepbeD G. Ellis, Patrick L. Whitlow, Micbul Sketch, 
WanJiD Yeh, Patrice-Deoivp Nickeoa, Raymond Mathews, Robert Salian, 
Martin Leon. Eric J. Topol and the NACI lnvestigatol1l 
The Cleveland Clinic Foundation. Cleveland, Ohio 
The role of exll1ll:tion atherectomy in revascularization of old (> 36 months) and 
YOWla (~36 months) saphenous vein pfts (SVG) was evaluated by analyzing all 
patients in the NACI regiatry treated with this device for SVG stenosis. There 
were 891esiOO8 in the old SVG """" & 15 lesiona in the yOWlg group (78 & 13 
patients. respectively). S-Iine characteristics inchlding EF. WlStable angina. 
multivesael diseue, and reuon for revlSCuiarization were similar in both groups. 
Lesion morphology showed more thrombwl-lSSOCiattd lesioDl (57% vs 27%; p< 
0.05), more _Iricity (74% vs 43%; p< 0.05), and more tortuosity (18% vs 
0"; pzNS) in the old SVG group. 70" of patients reached 6·month follow up. 
~ NEWSVG 
iii H!!!I!illl BllI!IIlIi 
Device Success 74% 8a 
Lesion Success 8U 93% 
Residual Stenosis 24.3" 12.1% p<0.05 
Hospital Slay (days) 6.7 4.4 
Q-MI 1% 0" 
CABO III all 
Death 8ll 0" 
Cumulative 6-Month EvOllts lPott-discham)· 
Repeal Revascularizatjon 22 II 33 II 
Angina 46" 56% 
MI Wll all 
Death 10" 0" 
Total <Death. MI CABO): 14" all 
IN CONCLUSION; These preliminary observatiOO8 from • multicenter 
compariSOll of eXlrllCtion atherectomy in old vs young SVG reveal different acute 
procedutaI reaults and complication rates. These results suggest that, like PTCA, 
IIdvanced SVG aae &Jor lesion morpholOlY are risk facton for acute and follow 
up complications. 
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Xecbani.. of Tran.lw.inal .xtraction Catb.ter 
(T.C) Atb.rectoay In D.generative Sapbenou. V.in 
Qraft.(SVQ). AD ADgio.copic Ob.ervational Study. 
Jeffrey W. Moses, Scott M. Lieberman, William D. Knopf, 
Christopher U. Cates, Thomas Glascock, Alexander 
Shaknovich, Cenap Undemir, Nancy Cohen. 
Lenox Hill Hospital, New York, New York 
St. Joseph's Hospital, Atlanta, Georgia. 
TEC atherectomy has been proposed as a treatment of 
choice for obstructed degenerated SVG. However its 
mechanism of action, & the utility of adjunctive device 
therapy have not been fully defined. To clarify these 
issues, 12 pts. undergoing TEC atherectomy of SVG were 
studied with coronary angioscopy (CA). CA was preformed 
prior to intervention (n=9), post TEC (n=12), and after 
adjunctive therapy (n=9) with either PTCA (n=5), or 
Directional Atherectomy (DCA), (n=4). 
Pre-TEC CA revealed a predominance of yellow atheroma 
in all lesions which wace friable in 55%. Thrombus was 
seen in 55% but was extensive (>2 quadrants) in only lIt 
(lpt). SmAll intimal flaps or dissections were seen in 
44%. Deep dissection was not observed. Post-TEC CA 
revealed marked diminution of atheroma but deep 
dissection was noted in 75% of pts.(p<.OOl vs. pre). 
Multiple intimal flaps were now present in 100% of 
pts.(p<.OOl vs. pre), 75% of which were totally or 
partially occlusive. 
After adjunctive therapy, occlusive flaps were no 
longer seen (p<.03 vs.post TEC), although a few AmAll 
dissections or flaps remained in most pts.(88%). Luminal 
appearance after DCA or PTCA adjunctive treatment was 
similar. 
COICLOSI9I· TEC atherectomy in SVG removes 
atheromatous plaque, however it results in severe intimal 
disruption, with the creation of deep dissections, and 
obstructive intimal flaps. Adjunctive modalities improve 
luminal patency and are virtually always required. 
952·66 
Complex Lesions witb Ulceration or Calcification Are Predictors of 
RestenOllis After Transluminal Extraction Atberectomy 
Joseph M. Sutton. Jeffrey B. Gitlin, Paul N. Casale, Patrick L. Whitlow, Eric 
J. Topol, Stephen G. Ellis for the US Coronary Transluminal Extraction 
Catheter (TEe) Investigaton 
The C1evel8lld Clinic Foundation, Cleveland. Obio 
To establisb determinants of late restenosis after TEC, follow-up 
angiograpbic data was obtained in 625 pIS undergoing TEe atherectomy of 
primary or restenotic lesions during acute MI or as an elective, alternate 
mterventional strategy. Restenosis was dermed by a >50% stenosis, or 
renarrowiog to within 20% of the original lesion at repeat angiography 
performed 7±2 months after the procedure. Restenosis occurred in 53% of 
pts, who had a limited net gain in luminal diameter of O.9±15%, compared 
with a 64±18% improvement in luminal diameter in pts without resteoosis. 
There were no distinguishing differences in restenotic vs. non·resteootic pIS 
with respect to age, sex, %stenosis treated, lesion length, graft v. native, 
primary v. resteootic lesions. diffuse disease, eccentricity, thrombus or total 
occlusion. Differences were noted in the following variables: 
BemJIueii(ll IlIIi BemJIllliia (Il II 
Target artery 332 (53) 293 (47) 
Native vessels 191 (54) 160(46) 
LM 10(71) 4(29) NS 
LAD 120 (45) 146 (55) 0.006 
LCx 95 (29) 65 (41) 0.08 
RCA 120 (59) 85 (41) NS 
Graft conduits 141 (51) 133 (49) 
LAD 40(41) 58 (59) 0.02 
LCx 60 (56) 48 (44) NS 
SS::A ~~ '~6l ll'~l tiS 
By stepwise. multivariate logistic regression analysis, only calcification 
(Odds Ratio (OR)=!.3; 95%CIoz!.04·!.60) and ulceration (OR=I.5; 
95%CIoz l.l-!.9) proved to be independent predictors for late restenosis. 
Thus, resteDOsis may be less common in nauve LAD and LCx arteries, or 
when addressing lesions within grafts supplying the LAD territory. Late 
resteoosis after TEe is predicted by lesion complexity or ulceration and 
calcification. 
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952·67 
Rotatioaal Atbenc:tomy Elrectlvely Treats Calcined Lesions 
Dory B. Altmann. Jeffrey J. Popma. Kenneth M. Kent. Lowell F. Satler. Augusto 
D. Pichard. Gary S. Mintz. Michael B. Keller. Martin B. Leon. Washington 
Hospital Center. Washington. D.C. 
Balloon PTCA is less effective in treating calcified coronary lesions due in part to 
reduced sttetch in rigid lesions. To examine the potential beneficial effect of 
fibrocalcific plaque ablation by rotational atherectomy in improving lesion 
compliance. we analyzed results in 675 lesions using quaJilalive morphologic and 
quantitative angiographic methods. Lesions were classified as having no/mild 
(27%). moderate (56%). or dense calcification (CA. 17%). Acute gain was 
defined as the increase in minimaJ luminal diameter (MLD). In 599 lesions (89%). 
adjunct balloon angioplasty was used: in these lesions. % sttelCh=[(mean balloon 
diameter· pre-MLD)/normal reference diameter] X 100 and % recoil = [(mean 
balloon diameter - post-MLD)/normal reference diameter] X 100. Procedural 
success was defmed as <50% final diameter stenosis and no death. Q-wave MI. or 
CABG. One year event-free survival was defined as freedom from death. CABG. 
Q-wave MI. or repeat PTCA. Baseline characteristics and angiographic and 
clinical outcome included: • 
Age 
LAD/proximal location (%) 
Acute gain (mm) 
Sttetch (%) 
Elastic recoil (%) 
Procedural success (%) 
Death/Q-wave MI/CABG (%) 





























We conclude tbat: I) the high procedural success rates (overall 95%) and 
infrequent major complications obtained with rotational atherectomy are not 
affected by the degree of CA. (2) -30% of patients have late cardiac events 
(including repeat PTCA) in the fllSt year of follow-up. and 3) after rotational 
atherectomy. sttetch and acute gain are now independent of CA. suggesting that 
fibrocalcific plaque ablation increases lesion compliance and permits more 
effective adjunct PTCA. 
952·68 
ROTATIONAL ATHERECTOMY OF LEFT MAIN 
CORONARY LESIONS: SUCCESS, COMPLICATIONS, AND 
RESTENOSIS 
Steven E. Jones. Patrick L. Whitlow, Simon Stertzer, Maurice 
Buchbinder, Lowell Saller 
Cleveland Clinic Foundation, Cleveland, Ohio 
Conventional balloon angioplasty of the left main coronary 
artery has been associated With suboptimal residual stenosis 
and procedural success, as well as a high restenosis rate. We 
examined the results of patients undergoing left main 
rotational atherectomy (Rotablator TM) by accessing a 
multicenter registry (Heart Technology, Inc.). Between 1988 
and 1992, 60 patients had rotational atherectomy of the left 
main, including 5 with "unprotected" left main lesions. Success 
was defined as a final lumen diameter of less than 50% with 
no major complications (CABG, Q-wave MI. death). 
Results: 
Success 57/60 95% 
Major Complications: 
CABG 3/60 5.0% 
Death' 2/60 3.3% 
Q·wave MI 0/60 0% 
'These 2 patients also included in CABG group 
The success rate of the 5 patients in the subgroup with 
"unprotected" left main lesions was 100% (5/5). 
Angiographic follow·up was available in 30 patients; the 
restenosis rate was 50% (15/30). One patient had sudden 
cardiac death 31 days following the procedure. 
Conclusion: Rotational atherectomy of the left main coronary 
artery can be performed with high success and reasonably low 




PERCUTANEOUS PERIPHERAL ROTATIONAL ABLATION. 
IMMEDIATE AND MID TERM RESULTS, SINGLE CENTER 
EXPERIENCE CONCERNING 146 LESIONS TREATED. 
Max Amor. Michel Henry. Gerartl Ethevenot. Isabelle Henry. Bemartl 
Mentra. Claude Amicabile. Essey Clinic, Nancy, France. 
In ortler to assess the role of percutaneous peripheral rotational ablation 
using Rotablator (PPRA), 95 symptomatic pts (58 M, 37 F, m. age : n ± 1 
y) (r : 50 - 90 y) having 148 peripheral vascular lesions (PVL)were treated 
by PPRA. 59% were below the knee and 41 % above. The run off status (n 
of distal leg art. involved) was as follows: 3:52 pts. 2:23 pts. 1 :14 pts, 0:8 
pts. The femoral lesions were significantly longer than those at other sites 
(5.27 ± 0.43 vs 2.97 ± 0.3 em) (p < 0.001). The mean length was 3.73 ± 
0.26 em (r: 1·20 em). Complementary PTA was significantly (p < 0.001) 
more frequent In femoro-popli1eal (32 PTAl48 Fem. 5 PTAl12 POp) than in 
distal leg lesions (10188 art.). 
Results: After PPRA alone (99 PVL) the stenosis % decreased from 81 
± 0.75 to 18 ± 1.1. The resi~ual stenosis was greater at femoral (26 ± 
2.3%) than at distal leg level (18 ± 1.2%) (p < 0.01). Complementary PTA 
(47 PVL) lowered residual stenosis from 44% to 13%. 52 complications 
(spasm, perforation, dissection, distal emboli, no reflow. others) were 
cured in 47 PVL. Thus our primary technical success per PVL was 97% 
and per pt 95%. The mean follow up period wes 11 ± 1 mths (r : 1 - 37 m). 
Among 78 pts having a follow up period :! 4 mths, 74 pts representing 115 
treated PVL underwent an angiography control (2 deaths, 2 lost for follow 
up). 87 lesions (78%) showed no restenosis and 28 lesions (34%) showed 
restenosis of 83 ± 2.4% (r : 50 • 100%). The restenosis rate was higher in 
femoral (12121 :36%) than in distal (15/58:21%) orpopli1eal arteries 
(1/8:12%). Restenosis was more frequent for PVL:! 7 em (87% vs 18%) (p 
< 0.001) at all sites. This result together with the complication rate would 
seem to indicate that lesions:! 8-7 em would be a limitation for PPRA. 
Conclusions : In our experience Percutaneous Peripheral Rotational 
Ablation has taken a pre-eminent posi1ion in the treatment of distal leg 
arteries. Our results lead us to broaden i1s indications to complex vascular 
lesions. The possibility of run off treatment should allow an improvement 
in the long term patency of PTA and bypass grafts. 
952·70 
Outcome or Lonl LesioDJ Treated With Hip Speed Rotational 
Ablation 
Mark Reisman, Barry Coben, David Warth, Joanna Fenner, Ian T. Goc:ka, 
Maurice Buchbinder, UCSD, San Diego, CA 
Long lesions tn:ated with conventional PTCA have been associated with 
low primary success and frequent complicatiOlll. We evaluated the usc of 
Rotational Ablation (PTCRA) in the treatment of long lesiOlll between 
15mm • 25mm. A tota1 of 1276 lesions were reported in the Rotablator 
Registry with 953 lesiOlll betweea I • IOmm (group I), 180 lesiOlll were 
II • 15mm (group 2) and 143 lesions were IS • 2Smm (group 3). When 
assessed for lesion morphology, group 3 differed significantly with Group 
I and Group 2 only with regard to calcification (40% VI. 43% VI. 5S% P 
= .009), and eccentricity (60% VI. 65% VI. 75% P = .001). The success, 
complications, and restenosis data arc reported below. 
Gt G2 G3 p 
Procedural Succeu "I., 
Burr Alone 86 84 83 ns 
BurrlBaJlooD 95 97 92 ns 
ComplicatioDl % 
NooQM! 4.0 5.5 6.2 os 
OM! 0.7 0 2.8 0.016 
CABG 2.6 1.1 1.4 os 
Death 0.6 0.6 2.1 os 
Angiographic FlU % 35 42 3J os 
Overall Restenosis% .. 46 53 57 os . -s-<,~ ___ .. )CIt-'_ "_-.3O%_ .. ~FIU 
Conclusion: Long lesiOlll can be effectively tn:ated with high speed 





Lesl Vascular Injury After Coronary Rotablatlon Comblnld With 
Low·Pressure Angloplasty? Investigation With Intrevascular 
Ultrasound 
DIetmar H. Koschyk, Wollram Terres, Peter Weber, Chunguang Chen, 
Christian W. Hamm. University Hosp~al Eppendorf, Medical Clinic, Dept 
of Cardiology, Hamburg, Germany 
Coronary balloon angioplasty (PTCA ) is frequently associated with ex•
tensive disruption of the vessel wall resuhing in acute complications. In 
contrast, rotablation (RA) abrases the plaque surface with Imle or no dis•
ruption but may leave a higher grade residual narrowing. We Investigated 
by intravascular uhrasound (IVUS), the effect of RA (max burr sizes 1,75 -
2,25 mm) followed by low pressure PTCA (S 4 atm) In 22 pts with type 8 
or C coronary lesions. The resuhs were compared w~h PTCA (n- 68) or 
RA (n- 27) alone. Results: IV US was superior to angiography in 
detecting vascular Injury, such as Intimal splmlng (Int-spl) or dissection 
(DIss), extending to the media and In verifying neolumlna (Neolum): 
PTCA RA RA+PTCA 
n- B8 n- 27 n- 22 
Int-spl 15(22%) 2(7%) 4(18 %) 
DIss ~9 (43%) 0 0 
Neolum 1(1%) 0 0 
PTCA following RA Improved stenOSiS diameter by 32 ± 14 % 
Conclysjons: Low pressure PTCA following RA improves stenoSiS 
diameter without additional major vascular Injury and with less disruption 
of the vessel than PTCA alone. The combination of PTCA and RA ap•
pears to provide a promising strategy In complicated lesions. 
952·72 
Surf_ luminal ChlflCteriatica Following Coronary Rotational 
AtherlCtomy (PTCRAI VI Balloon Angloplalty (PTCAI; Angloleople 
Ultresound • .,d Anglographle Evalultlon 
Theodore A.Baes. Paul S. Gilmore. Christopher J.Whlte. Youssef G. 
Chami. Barbara J.KIrcher. Suresh P. Jain. Donald A. Conetta. University 
of Florida Health Science Center. Jacksonville. FI. and Ochsner Clinic. New 
Orlean.. LA 
Surface luminal morphology following successful coronary intervention is 
examined in 66 patienta. 68 lesions. 35 lesions underwent successful 
PTCAA (Gp Al and 33 lesions underwent successful PTCA (Gp BI. All 
lesionl underwent post procedural anglographic assessment. In GP A.14 
lesionl underwent pre &: poat PTCRA angioscapie assessment and 21 
lesions had post procedural ultrasound examination (lVUSI. In GP B.20 
lesions underwent pre &: post procedural angioscopic evaluation and 1 3 
lesions had post PTCA IVUS.Gp A( 121351 had more restenosis lesions than 
Gp B (41331 (P< .051. Preinterventional angioscopy showed no differences 
in dissection (01. intimal hemorrhage (lHI. plaque fracture(PI.Fxl or 
smoothness(Sml comparing both groups. 
Post procedural angiographic analysis showed intimal tear to be present 
Gp A(5/35).Gp B (13/22) (P< .031. IVUS assessment showed intimal tear 
to be present Gp A(2/21) vs. Gp 8(5/131 (P=.0791. Angioscopic analysis 
























Conclysions: Surface luminal characteristics are quite different following 
PTCRA vs PTCA. These differences assessed angioscoplcally reveal 
smoother lumens and less plaque fracture post PTCRA. While Intimal 
dissection appears to be less common following rotational atherectomy, 
surface bruiSing is sean following both PTCRA and PTCA. 
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Is "Late LOllS" of "Early Galli" 1II CoronlfY Luminal Diameter Different 
Following Rotational Atbereetomy and Balloon Angloplasty? A Paired 
Quaatitathe Anglograpbk Study 
A. Michael Lincoff, Michael J. Cowley, Sue A. DeLuca. David DeBollis, Patrick L. 
Whitlow. The Cleveland Clinic Foundation. Cleveland, Ohio. 
"Late loss" (LL) of coronary minimal luminal diameter (MLD) leading to 
resteDosis may be proportional to the "early gain" (EO) following successful percu•
taneous revascularizalion. To determine whether this relationship Is Independent of 
the technique ofrevascularizatioD, EO and LL in patients simultaneously undergoing 
rotational atheterectomy (ROTO) and balloon angioplasty (PTCA) of differelll 
coronary lesions were measured. Among 59 pta treated with both ROTO and PTCA 
at two clinical centers, 26 pts have thus far undergone repeat angiography 181 ± 110 
d following the index procedure. Paired ROTO and PTCA lesions were comparable 
with respect to normal vessel diameter(2.65 vs 2.57 mm, p=NS) and initial MLD (0.72 
vs 0.71 mm, p=NS). although proximal vessel location (50% vs 32%. p=NS), LAD 
location (61 % vs 21 %, p..oJXl2), and high-risk characteristics (ACCIAHA 82 or C In 
71 % vs 54%, p .. NS) tended to be more frequent among ROTO lesions. 
Electronic digital caliper measurements were perfonned in 28 pairs of 
ROTOIPTCA lesions in the 26 pts to detennine EO (post-procedure MLD minus 
initial MLD), LL (post-procedure MLD minus followup MLD), Net Oain (NO) (EO 
minus LL), and MLD on followup angiogram 
(FMLD), expressed as mean (SO) in mm. 
ROTO Pi'CA P 
EG LlO(..Il) U)5(..I0) .06 
LL 0.68 (.69) 0..19(.68) NS 
LUEG 0..14 (.55) 0.54(.65) NS 
NG 0.6l(.71) 0.46(..18) .l4 
FMLD Ll5 (.68) U8 (..16) .23 








,U ~/ \ " 
, A ~ 
./' U 10 11 I U I 
/. "ROTO UJECI 
result in a larger lumen on foUowup than with '----------~ 
PTCA. However, the mean ratio LUEG is the same following ROTO and PTCA, and 
there is no consistent relationship between LUEG values for ROTOand PTCA lesions 
(see graph) in any individual patient. 
952·74 
Report or The Rotablator* Multicenter Registry: Experience 
in 1683 Patients 
Maurice Buchbinder, Robert IGppennan, Martin B. Leon, Patrick 
Whitlow, Simon Stertzer, UCSD. San Diego, CA, USA. 
To evaluate the effects of case experience on outcome and 
complications following Rotational Ablation (RA) we analyzed 
1683 patients with 2058 lesions entered in the Rotablator 
Multicenter Registry. Results from the first consectutive 1000 
patients were compared to the last 683 patients enrolled. 
Demographics and lesion characteristics were similar in the two 
groups. Results were as follows: 
(1.1000 1001·1683 p value 
Overall Soo;ess 95% 94% NS 
Success R alone '84% 83% NS 
Success Type A 96% 96% NS 
Success TypeB+C 96% 92% NS 
NonQMI 4.3% 5.7"10 NS 
I QMI 0.7"/. 1.6% NS 
UrgenlCABO 1.7"/. 2.8% NS 
Death 0.8% 1.0% NS 
Conclusions: a) RA is a safe and effective treatment modality in 
simple and more complex coronary lesions; b) RA appears to have 
a short learning curve since early experience is similar to late 
experience. 
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952·75 
Risk of High Speed R.otational Atbendomy in Bifun:atiOD Lesions: 
Patrick L Whidow, M.D., Michael Cowley, M.D., Theodore Bau, M.D., IUId 
David Warth, M.D., ClevelaDd CliDic FoundaliOll, ClevelaDd, Ohio. 
CorOllary bif\ucalioa lesions are a Type B characteristic for balloon angioplasty, 
IUId thus predict increased risk of failure and procedural complications. We have 
reported that Type B cbaracteristics do not predict failure or complications with the 
Rotablalor, even with multiple risk facton present in the SIU1le lesiOIl. To further 
analyze if bifurcatiOIl lesions represent an increased risk for the Rotablalor, aU 
patients who bad single lesioa Rotablalor procedures in the Hearl T ecImology 
Registry were analyzed. 
Group I coasisted of 272 patients with lesions at a bifurcatiOIl IUId Group II 
coasisted of 881 patients with lesions not at a bifurcatiOIl. Age and sex diatribution 
were equal between the Groupa. Group I bad 11 % right coronary artery lesions, 
61 % left anterior descendinS lesions, 22 % circumflex lesions IUId 6 % left main 
lesions. Group II bad 33 % riBbt coronary artery lesions, 45 % left anterior 
descendinS, 19% circumflex IUId 3% left main lesions. 
Procedutal success (1_ than 50% residual in the absence of major complications) 
was 95 % for Group I IUId 95 % for Group II. Acute occlusion occurred in 17 
(6.2%) of Group I lesiona IUId OIIIy 2S (2.8%) of GroupU lesiona, P=O.OO9. Post 
cardiac catheterizatiOIl laboratory clO6\lre occurred in 6 Group I lesions (2.2%) 
versus 12 Group II lesiona (1.4%) P=0.4. Compromise of a side branch occurred 
in 4 Group I lesiona (1.5%) versus 3 Group II lesions (0.3%) P=O.06. Major 
complications of emergency bypaas, Q wave myocardial infarction or death 
occurred in 13 Group I patients (4.8%) IUId 26 Group II patients, (2.9%), P=0.15. 
We conclude that bifurcatiOll lesiona lead to an increased risk of side branch 
compromiae IUId acute occlusiOIl syndrome with the Rotablator, thougb major 
complicationa IUId overall success rate may not be different than with lesions not 
at a bifurcatiOIl point. 
953 Pediatric Interventional Catheterization 
Thursday, March 18, 1993 
9:00 AM-ll:00 AM 
Anaheim Convention Center 
Hall D 
Presentation Hour: 9:00 AM-1O:00 AM 
953·8 
IIauJU of BaUooe Dilatiooa for Coa&eaital Mitral SIeDoIiI in Infaa .. 
Phillip Moon:, Philip 1. Spevak, 10hn F. KeaDe. Stanton B. Perry, lames E. Lock 
The Boston Children's Hospital, Boston Massacbusens 
We have dilated 17 mitral valves (MV) in 14 infants (S.8± 6.1 months, 5.8± 2.1 
kilograms) with congenital mitral stenosis. EiBbt nf 14 were less than 6 mo of age 
and 5 kg in weight All patients bad associated cardiac defects and were 
symptomati<: with congestive heart failure and/or failure to thrive at the time nf 
dilation. Mitral valve morphology (determined by 2-0 ecbocardiogram) included 
double orifice mitral valve with normal papillary muscles (2114), hypoplastic 
mitral valve with baJancecI chordal attachments to closely spaced symmetric 
papillary muscles (10/14), and hypoplastic mitral valve with unbaJancecI chordal 
attachments to asymmetric papillary muscles (2114). MV dilation was sua:essful (> 
25% reduction in peak traasmitral gradient) in 13114 initial attempts; balloon to 
annulus ratio was 0.6 to 1.4 (m=<l.9± 0.2) in sua:essful cases and 1.0 in the failure. 
Overall, initial MV dilation reduced the left atrial a wave to left ventricular end 
diastolic pressure gradient from 2U±9.S to 11.I±6.9 nunHg (p< .001) and the 
mean dopp\ertraasmitral gradient from 11.4±4.S to 7.7±3.3 mmHg (p<.ool). 
Mean mitral valve area increased from 0.6±O.3 to I.()± 0.4 cm21M!(n=9,P<.01). 
Complications nf the procedure included mitral regurgitation: mild(5/14), 
moderate (2114), and severe (1114), venous thrombosis (1/14), and cardiac arrest 
(1114). Three patients bad a second mitral valve dilation with larger balloons due 
to "restcnosis" 2 to 4 months after the initial dilation. Two nf three died during the 
second dilation due to LV perforation and balloon induced cardiac arrest. Short 
term follow-up shows one nf the twelve patients who survived the procedure died 3 
months after the procedure due to heart failure (DO attempt at redilatiOD or mitral 
va1ve replacement(MVR1 was made), and four required MVR \ to S weeks after 
the procedure because nfpersistent mitral stenosis (214) or combined mitral 
stenosis/mitral regurgitation (214). The remaining seven patients have had 
persistent symptomatic improvement at a mean follow up of \2.9±IO.9 
months(range 2 to 32 mol. Mean doppler transmitral gradient remains reduced in 
these patients (pre: 9.4, post: 6.3, follow up: 6.0 nunHg). In conclusion, procedure 
molbidity appears related to balloon size in small left hearts, however severe MR is 
rare. "Restcnosis" is common; however, redilation with larger balloons is 
hazardous. Independent of valve morphology, 50 'Y. of infants with congenital MS 
will derive significaat "Ions term" beDCfil 
ABSTRACTS 
953·9 
Long·term 95% Follow·up In One Centre on 261 
Rashklnd Patent Ductus Arteriosus Occlusion 
Procedures With 92% Overall Complete Occlusion 
MA Ali Khan, Saad AI Yousef, Charles E. Mullins, Riyadh, 
Saudi Arabia 
USing the Rashkind ductal occluder device, patent ductus 
arteriosus (PDA) closure was attempted in 228 infants, 
children and young adults between December 1987 and 
August 1992; male to female ratio was 1 :2.4. Patients ages 
ranged from 8 months to 45 years, median age of 5 years. 
34 were aged ~ 2 years. Patients weights ranged from 7.4 to 
69 kg mean of 18.8 ± 9.9. Successful device implantation 
was achieved in 252 procedures (97%). There were 9 
technical failures. Complications included 7 embolization to 
a pulmonary artery, 2 self-limited episodes of hemolysis and 
2 with induced supraventricular tachycardia. The device 
was retrieved in 3 patients by grabber and 4 by surgery. 
Follow-up included 2-0 echo and Doppler studies with color 
flow mapping. At 6 months follow-up, 20% (47/238) of 
patients had a small residual shunt. The incidence was 15% 
(32/209) in ducts with a narrowest diameter < 6 mm, and 
52% (15/29) in ducts ~ 6 mm. Successful implantation of a 
second occluder device was achieved in 33 patients who 
had residual shunt with continuous murmur at 6 months 
follow-up. Overall closure was 92% in patients seen 6 
months after initial or repeated implantation. Follow-up 
ranged 1 to 58 months with a mean of 38 months with no 
complications. This study confirms the efficacy of PDA 
closure with the Rashkind occluder, especially in patients 
with ductal diameter < 6 mm. 
953·10 
Long-Tenn Effects of Balloon Coarctation Angioplasty 
on Arterial Hypertension in Adolescents and Adults 
Rainer Schrader, Sabine Bahr, Martin Kaltenbach. 
University Hospital, Frankfurt a.M., Germany 
When surgical repair of aortic coarctation (CoA) is performed after 
the second decade, as much as 50 % of patients (P) may suffer from 
persistent hypertension. We studied the effects of balloon 
coarctation angioplasty on arterial blood pressure up to 6 years after 
the procedure. 28 P (8 females and 20 males) 14 to 54 years old 
(median, 25 years) underwent balloon angioplasty for native CoA. 
24/28 P (= 86 %) had systemic hypertension (> 140/90 mmHg). 
The diameter of the stenotic segment was 5.4 ± 2.3 (range, 2.0 -
12.3) mm and the peak pressure gradient was 62 ± 18 (range, 30 -
110) mmHg. 
Bal!oon angioplasty was successful in 28128 P. CoA-diameter 
increased to 11.6 ± 2.6 (.range, 7.0 - 15.5) mm and CoA-gradient 
decreased to 21 ± 13 (range, 0 - 50) mmHg. The residual gradient 
was <30 mmHg in 22128 P (= 79 %). Paradoxical hypertension 
was not observed. At hospital discharge, blood pressure was 
< 140/90 mmHg in 19/28 P (= 68 %). Clinical follow-up studies 
including invasive pressure measurements and aortography were 
performed in all P 6 months to 6 years later (total follow-up time, 
66 patient-years; average, 2.3 years). At latest follow-up, CoA•
diameter was 14.3 ± 3.0 (range, 9.0 - 20.4) mm and CoA-gradient 
was 15 ± 13 (range, 0 - 60) mmHg. The residual gradient was 
< 30 mmHg in 24128 P (= 86 %). Blood pressure was normal 
« 140/90 mmHg wilhout antihypertensive medication) in 22/28 P 
(= 79 %). In the 6 P with persistent hypertension the peak pressure 
gradients were 7, 13, 30, 30, 35, and 60 mmHg. 
Conclusion: bailoon coarctation angioplasty relieved arterial 
hypertension in 80 % of adolescent and adult patients with native 
CoA. Persistent hypertension was mostly due to a residual pressure 
gradient of ~30 mmHg. In comparison to the follow-up data of 
post-surgical patients normalization of blood pressure seems to 




Maintaininl Patenq of The Ductus Arteriosus With • New B81I_ 
Expandable Stent in • Newborn AnimaJ Model 
Ziyad M. Hijazi, Mark J. ArollOvilZ, Gerald R. MUlt, Barbara Romero, 
David R. FullOD. Tufts University School of MediciDe, Bostoa. MA. 
Maintainin, pateacy of the ductua Irteriooua (DA) in aewboma wilb ductal 
dependeat conaenital heart disease is aeceuuy until soqical intetvention. 
Therefore, we evaluated • newly devised balloon expandable stent 
specifically desiped for newborn babiea that couJd be pt.:ed at 
catheterization. The steal (3.5 mm x 1.6 em) wu mounted on • balloon 
catbeter aDd the enlire .ystem wu delivered Ihroup • SF sbeath. 14 
newborn pillell, a,. 12 days, median weiaht 3.6 X, (ran,. 2.7-4.3 XI), 
bad initial balloon dilatation of the DA. Immediate ansiolflPhy 
delllDllStrated 110 sianificanlleft 10 rilhl shunl. Initial llenl implantation wu 
successfully done in all pillelland confinned by ansioaraphic demonstration 
of sianificanlleft 10 righl shunl across the DA. Follow-up pateacy of the 
steal wu confirmed by color f\ow Doppler at weekly intetvals. In 3 Pillell 
Ibe llenl wu DOl patenl at initial follow up and autopsy reves1ed the steal 
wu DOl optimally placed in the DA. In the remaininl 11 the steal wu 
patent at. median follow up of 10 day. (ran,. 3-31 days), median weighl 
wu 6.1 Kg (range 3.6-9.5 KI). In 2 animals the steal wu suc:ceasfully re•
expanded wilb a larger balloon al 22 days and flow wu maintained for an 
additional 30 and 34 day. as demonstrated by color flow Doppler aDd 
ansiography. 
All pilS were sacrificed by 6 weeks after implantation It a median weilhl 
of 7.S XI aDd median follow up interval of 20 days. In S wilb Doppler 
evidence of patenl DA, the steal wu in optimal position extrudinllhrough 
the aortic and pulmonary ends of Ibe DA. In pigs wilb aarrowinl of the 
DA 116 weeks, histology reves1ed sianificanl proliferation of ductal lissue. 
This study delllOllSlralea that 1 balloon expandable steal can safely aDd 
effectively maintain pateacy of the DA in the aewbom animal model. This 
sleDl procedure may be applicable 10 neonates ohviatinl the need for early 
shunl sur,.ry, reducinS the propensity for pulmonary arteriaJ distortion that 
may occur wilb surlical shunts. 
953·12 
Percutaneous Closure of Very Sman Patent 
Ductus Arteriosus (PDA) by Occluding Spring 
Emboli 
John W. Moore, Robert L. Spicer, William C. Kirby. 
Children's Hospital and Health Center, San Diego, California 
and Walter Reed Army Medical Center, Washington, D.C. 
Existing percutaneous systems are often too large to close 
PDAs with smallest internal dimension less than 2.2 mm (7 
French). Five patients with very small PDAs were treated with 
occluding spring emboli. Patients were 6 to 21 months old 
(mean 12 months) and weighed 6.0 to n.s kg (mean 9.3 kg). 
PDA smallest internal dimension by color flow imaging studies 
ranged from 1.2 to 1.5 mm (mean 1.4 mm). Angiography 
confirmed PDA dimension in all cases. A 5 French Judkins 
right coronary catheter was used to deliver one Cook Occluding 
Spring Embolus (.038 inch-4cm-3mm) in each patient. In all 
five patients, the coil was successfully delivered with a loop in 
the main pulmonary artery and a loop in the aortic diverticulum 
of the PDA. In all patients, immediate post delivery 
angiography demonstrated total PDA occlusion. There were no 
complications. Fluoroscopy time ranged from 8 to 16 minutes 
(mean 12 minutes). Color flow imaging confirmed total PDA 
occlusion after the procedures. All procedures were 
accomplished as outpatient catheterizations. Follow up chest 
radiographs and color flow imaging studies 6 weeks to 17 
months later showed PDA occlusion and lack of coil migration. 
We conclude that use of occluding spring emboli for PDA 
closure is a safe and effective method to treat very small PDAs. 
953·13 
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Pers~ent Ductus Arteriosus iD Asymptomatic Adults•
Should it he Closed? 
Rainer Schrader, Martin Kaltenbach. 
University Hospital, Frankfurt a.M., Germany 
Today, a persistent ductus arteriosus (PDA) is considered an 
indication for surgical or non-surgical closure in almost all patients. 
We hypothetized that conservative treatment might be justified in 
asymptomatic adults with a small PDA. The data of 100 patients 
(73 females and 27 males) who had later undergone non-operative 
closure were retrospectively analyzed. The patients were 18 - 72 
years old (average, 42.3 years). Left- and right-heart catheterization 
as well as angiographic measurement of PDA-size had been 
performed in all patients. 
65 patients had cardiac symptoms (exertional dyspnea, n = 47; 
atrial fibrillation, n = 12; angina pectoris, n = 12; paroxysmal 
tachycardia, n = 8; NYHA class IV, n = 7; edema, n = 6; 
fatigue, n = 3). 35 patients were asymptomatic. 24 patients had 
arterial hypertension, 6 patients had a history of endocarditis 
(incidence, 11705 patient-years), and 4 patients had undergone 
unsuccessful surgical ligation of the ductus earlier. 
Symptomatic Asymptomatic p-value 
patients (n =65) patients (n =35) 
PDA-size (mm) 4.7 ± 1.4 4.8 ± 1.3 n.s. 
Qp/Qs 1.69 ± 0.45 1.S7 ± 0.32 n.s. 
MPAP* (mmHg) 22.1 ± 9.7 18.5 ± 5.1 <0.05 
Age (years) 48.4 ± 14.3 30.9 ± 11.2 <0.01 
(In the 6 patients with endocarditis the PDA-size ranged between 
4.5 and 7.0 mm) * mean pulmonary artery pressure. 
Conclusion: neither from the size of the ductus nor from the Qp/Qs 
ratio the development of cardiac symptoms or the risk of endocar•
ditis can be predicted. From these data it might be concluded that a 
patent ductus should be closed even in asymptomatic adults with 
small PDA and insignificant left-ta-right shunt. 
953·14 
Ale EDdOft8C1l1ar Steat. Uteful for Short-Term PllWatloa of 
Coadult 8tenom? 
A11son M Hayes. Davtd G Nykanen. Robert M Freedom. 
William G WI11lams. Lee N Benson. 
Hospital for SiCk Chlldren. Toronto. Canada. 
Right ventricular condUit obstructton may precipitate early 
replacement in pattents already COmmitted to multiple surgical 
procedures. To determine the efficacy of endovascular stents for 
short-term pail1atton in thIS setting. 11 iliac (P12/PS30) and I 
renal (1'204) Palmaz and Palmaz-Schatz stents were placed in the 
conduits of 10 ch1ldren (mean age 6.5 ± 4.7yrs). 2.2 ± 1.8yrs post•
surgical correction. 
Result.: Stents were implanted successfully in all pattents. The 
ratto of r1ght ventrtcular to systemic pressure was reduced from 
0.B1 ± 0.2 to 0.46 ± 0.11 (p:O.0007) and the mtntmmn outflow area 
Increased from 0.21 ± 0.08 to 0.61 ± 0.3 (p:O.OOI6) of that ccpected 
for BSA. Early condUit replacement was required in 2 pattents 
for severe residual obstruction (acheJved mlnImum outflow area 
0.26 ± 0.01. p=O.05). Re-dUatton for reSidual stenosIS 6 months 
after stent implantation wIIS necessary in I chJld. Despite an 
outflow area of 0.67 of expected. the Doppler gradient rematned 
hlgh and the conduit was subsequently replaced. 
Seven chlldren. B.7 ± 4.2 months following stent implantation 
have a reSidual Doppler gradient across the conduit of 29 ± 11 
mmHg. In these pattents freedom from reoperation is most 
strongly predicted by the right ventricular to systemic pressure 
ratio pre-stent (0.68 ± 0.13 compared with 1.10 ± 0.26. p=O.OOB) 
and the conduit Doppler gradient 4Bhl1l post procedure (29 ± 7 
compared with 72 ± 19 mmHg. P <0.00(1). The first 3 chJldren 
offered this therapeutic approach all required conduit 
replacement within 6 months of stent tmplantatton. 2 due to 
fallure to achetve an adequate outflow area. 
Coachilloa: Endovascular stent tmplantatton in the right 
ventrICular outflow tract achetves safe. effecttve. short-term 
palliation for conduit obstructton. 
lACC Vol. 21, No.2 
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953-15 
Effect of Ionic and Nonionic Radiographic Contrast 
Agents on Renal Function in Cyanotic: and Normal Dogs 
Ara K. Pridjian, Edward L. Bovc::, Roben H. Beekman, Flavian M. 
Lupinetti, University of Michigan, Ann Arbor, Michigan 
Renal dysfunction may follow administration of radiographic contrast 
agents. Although significant renal impairment is uncommon, this 
complication may be even less common when nonionic agents are 
used. While a small benefit from the use of nonionic contrast may be 
undetectable in individuals with normal physiology, such an 
advantage may be more pronounced in the presence of cyanosis. To 
test this hypothesis, six adult mongrel dogs underwent anastomosis 
of the inferior vena cava to the left atrium. This produced chronic 
cyanosis with a mean p02 of 48 mm Hg and a mean hematocrit of 
56%. Three to five months after preparation, these cyanotic dogs and 
five control dogs each received diatrizoate (ionic--I) or ioversol 
(nonionic-NI), 465 mg iodine/kg body weight, by intravenous bolus 
injection. Animals were not hydrated prior to contrast injection. One 
month later, each animal received the other agent. The order of 
administration was randomized. Renal function studies were 
performed precontrast and 60 minutes and 24 hours postcontrast and 
included serum creatinine (Cr) and creatinine clearance (CCr). 
Results (mean ± SEM): 
Precontmst 
~m 
Cyanotic-I 0.8 ± 0.1 46 ± 10 
Cyanotic-NI 0.8 ± 0.1 60 ± 15 
Control-I 0.8 ± 0.1 42 ± 3 
Control-NI 0.8 ± 0.1 52 ± 15 
60 Min Post 
~ m 
0.6±0.1 14O±47 
0.6 ± 0.1 96 ± 23 
0.9 ± 0.2 40 ±8 
0.6 ± 0.2 82 ± 26 
24 HrPost 
~ 
0.8 ± 0.0 
0.9 ± 0.1 
0.8 ± 0.2 
0.7 ± 0.0 
Neither agent adversely affected renal function in either the cyanotic 
or the normal group. We conclude that at doses that are commonly 
used in clinical practice, ionic contrast agents do not create a greater 
risk of renal injury than do nonionic agents in the presence of chronic 
cyanosis .. 
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954-62 
Transesophageal Echocardlograpblc Diagnosi. or 
Prollimal Coronary Artery Disease 
Rita F. Redberg, David Lim,Timothy Winslow, Gary Fazio.Peter 
J. Fitzgerald. Krisbna Sudbir. Mary Malloy. John Kane.Nelson 
B. Schiller. University of California. San Francisco. 
To evaluate the potential of transesophageal 
echocardiograpby (TEE) in diagnosis of coronary artery 
disease (CAD). we performed TEEs on 52 patients (ages 36-81) 
wbo bad recently undergone angiography (angio). A subset 
of these pts(ten) also had intracoronary imaging (ICI). 
Fourty pts underwent angio for suspected or known CAD and 
twelve as part of a study of pis with familial 
hypercholesterolemia. We used 2-0 and color flow Doppler 
(CFD) criteria for eacb coronary artery. TEE was read by a 
blinded observer who scored coronary calcification using a 
1-4 scale. weighted fo~ irregularities and shadowing. Grade 
3 and 4 calcification and/or aliasing of color flow Doppler 
was considered abnormal by TEE. Arteries were considered 
abnormal by angio if there was >c()% stenosis. ICI was 
performed in the LMCA and LAD and graded on a 1-4 scale 
for calcification and measured for presence of lumenal 
plaque. Results: We imaged 150/192 of coronary vessels by 
TEE. 88% of LMCA. 56% of LAD. 75% of LCX and 39% of RCA. 
CAD was correctly predicted by TEE in 87%of LMCA. 89% of 
LAD, 75% of LCX, and 71%of RCA lesions. Approximately 1.6, 
i.2,1.6 and Icm of LMCA, LAD. LCX and RCA. respectively, 
were imaged. Aliasing by CFD could precisely identify the 
site of stenosis. The most common source of discrepancy was 
the finding of calcification by TEE in an angiographically 
normal coronary artery. This accounted for all mismatches 
in the LMCA. In the pts also imaged by ICI. calcification by 
TEE in the LMCA had a stronger correlation(r=.78) to ICI 
findings than to angio stenosis. Conclusions: TEE can 
identify CAD ill most patients undergoing angio for a 
variety of reasons. TEE can identify areas of calcification 
not measured as stenosis on angio, and best seen by ICI. 
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954-63 
Detection and estimation of Stenosis of Proximal Left 
Anterior Descending Artery by Transesophageal Pulsed 
Doppler Echocardlography 
Satoshi Kibira, Hitoshi Murayama. Elsuko Fushimi. Gen Terui. 
Akira Nakagomi. Yoshinobu Ikeda, Takashi Saito, Wataru Sasaki. 
Hitoshi Matsuoka, Mamoru Miura. Second Department of Internal Medicine, 
Akita University and Akita Kumiai Hospital, Akita. Japan. 
To study the usefulness of transesophageal pulsed Doppler echocardi•
ography (pulsed Doppler TEE) for detection and estimation of stenosis of 
segment 6(AHA classffication). 43 patients with angiographical stenosis of 
segment 6 (stenosis group) and 46 patients without stenosis (control group) 
underwent pulsed Doppler TEE within 2 weeks after coronary angiography. 
In 74 % of stenosis group, more than twofold abrupt increase of diastolic 
flow velocity • or diastolic flow velocity of over 100cmls was observed in left 
anterior descending artery(LAC). These findings were not observed in any 
case of control group. 
The stenosis group was devided to 3 subgroups with 75, 90 or 99% sten•
osis, respectively, by the angiographicaJ estimation of segment 6 stenosis 
based on AHA criteria. The maximal flow velocity recorded in LAD, and also 
the ratio of flow velcity increase in LAD were compared between 3 subgroups. 
The maximal flow velocity in LAD was 102131.111 136, 171 157cm/sec in 
subgroup with 75%. 900/ •• 99% stenosis, respectively. The maximal velocity in 
subgroup with 99% stenosis was significantly higher than in the other sub•
groups, but there was no significant difference between subgroup with 75% 
stenosis and with 90% stenosis. The ratio of flow velocity increase in LAD was 
2.010.3. 2.811.0, 42 ± 1.6 in subgroup with 75%. 90%, 99% stenosis, re•
spectively. The difference in this ratio between these subgroups was signifi•
cant, and significant relationship was observed between the ratio of velocity 
increase in LAD and the severity of stenosis. The ratio of velocity increase in 
LAD seemed to be better index of severity of stenosis than the maximal flow 
velocity in LAD. 
We suppose pulsed Doppler TEE is clinically useful not only for detection 
of stenosis of segment 6 but also for estimation of this stenosis. 
954-96 
Transesophageal Doppler Echocardlographlc Evaluation of 
Coronary Row Reserve In Patients with a Stenotic Lesion In 
the Left Anterior Descending Coronary Artery 
Takashi Muro, Jlmichi Yoshikawa. Kiyoshi Yoshida, Takashl Akasaka, 
Masahiro Shakudo, Tsutomu Takagi. Kobe General Hospital, Kobe. Japan. 
To clarify the value of transesop/1ageal Doppler echocardiograpy (TEDE) in 
evaluating coronary flow reserve (CFR) in patients with a stenotic lesion in the 
left anterior descending coronary artery (LAD), we studied 37 consecutive 
patients with a stenotic lesion in the LAD. Coronary blood flow velocity was 
measured by TEDE in the proximal portion of the LAD. Maximal and mean 
diastolic blood flow velocities (DVm .. , DVmean) were measured both in 
baseline (B) condition and after dipyridamole (D) infusion (0.56 mg/kg in 4 
min). Indexes of CFR were expressed by D/B ratios of DVmax and DVmean 
(CFRmax, CFR_). Angiograms of each lesion were analyzed by quantita•
tive coronary angiography. 
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Optimal separation of values for CFR was seen at 2.5 in relation to 50% 
diameter stenoSiS. The sensitivity and specWicity of CFRmax was 88% and 
83%. respectively. and those of CFRmean was 84% and 92%, respectively. 
Conclusion: TEDE is a usefultechnicJ.te that is highly sensitive in detecting 
a stenotic lesion with more than 50% diameter stenosis in the LAD. 
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954·97 
Coronary Flow Dynamics Before and After Coronary 
Angioplasty: Noninvasive Analysis by Transesophageal 
Doppler 
Karl Isaaz, Jean F Bruntz, Gerard Ethevenot, Thiery Courtalon, 
Jean L Weber, Etienne Aliot. Hopital Central, CHRU de Nancy, 
University of Nancy I, France. 
Recent invasive studies using intracoronary Doppler catheters or 
Doppler guidewires have reported improved coronary flow (CF) 
dynamics following successful percutaneous transluminal coronary 
angioplasty (PTCA). Transesophageal Doppler (TED) permits to 
measure CF velocities (CFV) within the left anterior descending 
artery (LAD). In this study, we tested I) whether TED may detect 
CFV changes in patients undergoing PTCA for LAD stenosis and 2) 
whether this technique might help to evaluate noninvasively PTCA 
results. Fifteen patients undergoing angioplasty of the LAD were 
studied by TED before agd within 24 hours after PTCA. Peak 
diastolic and peak systolic CFV (Vd, Vs; cm/sec) were measured in 
the proximal part of the LAD with the use of pulsed Doppler guided 
by colour flow imaging. The degree of stenosis was measured by 
computerized quantitative coronary arteriography. CFV recording 
was successfully obtained by TED in 12/15 patients (80%). Peak 
Vd increased from 42±12 cm/sec before PTCA to 56±15 cm/sec 
after PTCA (p=O.OOOl) with an increase in the ratio Vd/Vs from 
1.7±O.5 pre- to 2A±O.7 post-PTCA (p=0.OOO4). A linear relation 
was found between the percent gain in Vd and the percent loss in the 
degree of stenosis (r = 0.83, p=O.OOOI). In one patient in whom 
PTCA was unsuccessful, TED showed no significant change in 
CFV. In one patient with restenosis at 2 months after the 
procedure, TED repeated at 2 months showed that CFV had 
returned to pre-PTCA values. Thus, in patients with LAD stenosis 
TED demonstrates improvement in CFV pattern following 
successful PTCA. This method may be useful for noninvasive 
evaluation of PTCA results in these patients. 
954·98 
Improved Transesophageal Echo Assessment of Proximal 
Coronary Stenosis Using Echo Contrast Enhancement 
Krishan K Aggarwal, Robert Gatewood, Navin C. Nanda, Reinhard 
Schlief. University of Alabama at Birmingham, Birmingham, 
Alabama 
We studied 10 pts (6 proximal coronary artery stenosis, 4 no 
proximal stenosis by angiography) to evaluate the potential clinical 
utility of intravenous injection of a saccharide based microbubble 
agent (capable of transpulmonary passage) in enhancing color flow 
in the coronary arteries during transesophageal echocardiography 
(TEE). The entire left main coronary artery (LMCA, 8-24mm), and 
variable lengths of proximal left anterior descending (LAD, 1-17mm) 
and proximal circumflex (CFX, 1-16mm) were imaged in all cases at 
baseline by 20 echo. However, color Doppler TEE revealed no or 
insignificant flow in these vessels. After an intravenous injection of 
lOco (300 mg/ml) of this agent, there was pronounced 
enhancement of color flow signals with complete filling of LMCA in 
all cases and of the visualized segments of the LAD and CFX In 
9/10 pts. Furthermore, color flow in the LAD and CFX was noted 
beyond the visualized segments in 9/10 cases; the additional 
lengths visualized ranged from 4-30mm (mean 7.9 mm) for LAD and 
3-20mm (mean 16.5mm) for CFX. Both flow acceleration and 
aliasing were seen at all sites of >50% stenosis diagnosed on the 
angiogram (3 proximal LAD and 3 proximal CFX); these were not 
seen at baseline but were noted only in the additional lengths of 
these vessels imaged after contrast injection. No flow acceleration 
or aliasing was noted in the nonstenotic segments. No adverse 
effects were associated with the use of this agent. Thus, this 
preliminary data suggests that this agent is safe and markedly 
enhances TEE color flow imaging of the coronary arteries and 
improves detection of stenosis in the proximal LAD and CFX 
vessels. 
954·99 
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Biplane fransesophageal Pacing Echocardiography in tha 
Detection of Coronary Artery Disease 
L. Parker Norris, Richard Stewart, Charlotte Hibner, 
Avanindra Jain, Miguel Zabalgoitia. The University of 
Texas Health Science Center, San Antonio, TX 
Noninvasive assessment of coronary artery disease 
(CAD) in patients unable to exercise has been limited by 
suboptimal transthoracic echo imaging or by adverse 
pharmacologic effects. Accordingly, we prospectively 
studied biplane transesophageal echocardiography and 
simultaneous transesophageal atrial pacing (TPE test) 
utilizing an octapolar pacing sheath attached to the 
transesophageal probe in 57 patients (5·2 men, 5 women; 
mean age 64±1l yrs) with suspected CAD who underwent 
coronary arteriography. LV echo images were divided into 
9 segments grouped according to coronary distribution. 
Wan motion was analyzed at rest and at peak pacing; new 
pacing-induced regional wall motion abnormalities were 
considered abnormal. 49/57 pts had significant disease 
(~70\ stenosis) in at least one major coronary artery. 
The success rate for both obtaining diagnostic echo 
images and achieving adequate pacing (~90\ of the age•
predicted heart rate) was 94\. All 8 patients without 
angiographic evidence of significant CAD had a normal 
result on the biplane TPE (100' specificity). 46/49 
patients with significant CAD had an abnormal result on 
the biplane TPE (94\ sensitivity). Seven more true + 
tests were detected by the transverse plane TPE but not 
by the longitudinal plane where only 1 additional true 
+ test was detected. 
In conclusion, TPE is a highly sensitive and 
specific technique for detecting CAD. The use of the 
transverse plane alone provided adequate imaging for 
diagnosis in all three coronary artery distributions. 
954·100 
Absence of Descending Aortic Atherosclerosis on 
Transeaophsgeal Echocardlography Indlcatea the 
Absence of Significant Coronary Stenosis 
David T. Unker, Rene F.J.M.Geuskens, Harald A. Oiij, Jos RTC. 
ROeland!. Thoraxcenter. Rotterdam. The Netheriands 
Adun patients undergoing non-coronary cardiac surgery often 
undergo pre-operative catheterization (CATH) purely to check for 
significant coronary stenoses. Since these patients usually undergo 
transesophageal echocardiography (TEE) as part of the pre-operative 
evaluation. we performed a study to see whether the absence of 
atherosclerosis in the thoracic aorta on TEE was predictive of absence 
of significant coronary stenoses at CATH. From 1989 to the present 
there were a total of 120 patients who had both TEE and coronary 
angiography within two months of each other, and complete 
recordings available for review. Forty -four had an good visualization of 
the descending thoraciC aorta, wh~e seven had poor TEE 
visualization. The rest had no recording of the descending aorta or 
arch. The TEE studies were scored for presence or absence of 
atherosclerosis, and the results compared to the CA TH reports for 














- 1 1 p=ns 
In cases where there was a good recording from the thoracic aorta, and 
there was no evidence for atherosclerosis, there was also no 
significant coronary lesion by angiography. Lack of thoracic aorta 
atherosclerosis appears to be a very strong predictor of lack of 
significant coronary stenosis. This may eliminate the need for coronary 
arteriography for a significant number of patients. 
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954-101 
Tbe Dimorpblc PatllolOlY 01 Sapbe.ou5 Vela Gralt Steao,": AD 
IntravBKUlar Ultr1lsouacl Study 
Keum S. PaIk. Gary S. Mintz. Fadi A. Malar. Augusto O. Pichard. Kenneth M. 
Kent. Lowell F. Saticr. Martin B. Leon. WashinglOfl Hospital Center. WashinglOfl. 
DC 
To better understand lesion characteristics in saphenous vein graft (SYG) disease. 
we studiedSS pis before and/or after transcatheter therapy (TCn using a 
comprehensive intrav~ular ultrasOund (iVUS) imaging system (25MHz nxating 
transducer. 3.9F monorail imaging sheath. motorized transducer pullback at 
O.Smm/sec. 2·0 and 3·0 display and quantificationl. SYG's were imaged from 
beyond !he largetlesion to !he aorto ostial junction (a length of SVG averaging 
7.I13.7cm): the number of lesion sites were cOl/nted: and the external elastic 
membrane (EEM) and plaque+media (P+M) cross· sectional areas (CSA) were 
me&liured at !he larget lesions and proximal reference sites. Mean SYG age was 
9.StS.1 years. SYG wall thickness (included in measurements of P+M eSA) 
averaged 0.7±O.2mm at both normal and abnormal. stenotic and nonstenotic areas 
in all SYG's: this was significantly thicker than that of 10 in 111ro freshly excised. 
pressurized. and imaged SVG·s,0.4±O.lmm. p<.OOI). SYG stenoses were either 
(1) detmerated (seen in larger SYG's): defmed as a bulky accumulation of soft. 
friable plaque containing craters (29%) and mobile elements (37%) with multiple 
lesion sites (averaging 2.8 per SYG) or diffuse disease and having target lesion 
site EEM enlargement (lesion site EEM-1.6 . prodmal reference site EEM) or (1) 
fibrotic (seen in smaller SYG's): defined as usually only I hour·glass·shaped 
narrowing involving all three SVG wail layers including the EEM (lesion site 
EEM.o.8· pro~imal reference site EEM) with Iirllt «2mm2) plaque accumulation 
superimposed on the e~pected increase in SVG wall thickness. 
Reference CSA (mm2) Lesion CSA (mml) 
EEM P+M EEM P+M 
degenerated (0-39) 17.7t4.9 9.B±4.7 28.4tI0.2 23 .6±II.1 
fibrotic ("",16) 12.1133 4.7±2.8 9.9±2.8 6.9±1.7 
We conclude: lVUS assessment of SYG stenoses shows a dimorphic appearance 
suggesting either SVG deteDeratloD (with a large plaque burden and either 
primary or compensatory SVG dilalation) or intrinsic/extrinsic fibrosis causing 
SVG constriction with minimal plaque accumulation and relative narrQwing of !he 
entire SVG. These findings may be important in selecting the proper mechanical 
or pharmacologic therapy for individual SVG stenOSes. 
954·102 
The llecbuls. of Paradoxical Vasocoutr Ictlon In Atherosclerotic 
HUUII Corooary Artery by lotracoroouy Injection of 
Acetylcholine: InvestlcatioD With Iotravasculu Ultrasound 
Yasuhiko Matsu-ura, Kazuhlko Hashi.ura.. Isao Mori. 
Ishlokal Yao Hospital. Yao. Osaka. Jap&ll 
To elucidate the llech&llis. of puadoxical vasoconstriction In 
atherosclerotic hua&ll coronuy uterles by Intracoronuy injec•
tion of acetylcholine (Ach). we used Intravasculu ultrasound 
to visualize tile coaponeots of the uterles. We exaaioed 7 
patients with Illd atherosclerotic coronary arteries (A). 5 with 
varlaDt ancina (V) aDd 8 noraal subjects (N). At 3 linute 
Iptervais. different doses of Ach (ACHI:25#«: ACH2:50#«: 
ACH3: 100#«. respectively) aDd ISDN (Sag) were injected into the 
LCA as a bolus. Half-doses of each were also Injected into the 
RCA. Luinal dl&lleter. lledial aDd Intlul thick.oess at both the 
lesion aDd at a site opposite the lesion. aDd ledial circufer•
eoce (IIC). used as &II indication of lledlal constriction. were 
leasured off a 33 inch video acnltor uslD( a leasurellent and 
aDalysls software. All atherosclerotic arteries constricted in 
direct proportion to the dose of Ach. In A. intiaal thickeniD( 
at the lesion site (ACH2.3: p<O.OI vs. control) &lid shorteniD( 
of IIC (ACH3: p<0.05) were slpific&llt. In V. each si«nificant 
value was acre severe thao in A. however. in addition to intiaal 
thickeniD( and shorteniD( of IIC. ledial thickening (ACHl. 2: 
p<O.OO at the lesion site was also seen. although with ACH3 
there was inverse .edlal thlnniD( (p<O.OS) . M opposed to A. 
Iotiul thlclreniD( at the opposite site (p<O. OO was also seeo. 
In)l' •• Inlaal chances with Ach was seen. but sipific&lltvasodi•
latioa was seen with ISDN (p<O. OI vs. control). 
Copcluslog: These results show that the ojor factor of para•
doxical vasoconstriction ia the atherosclerotic coronary artery 
by Ach Is due to paradoxical Intiol thickeniD( at the lesion 
site and In part due to lledlal constriction. In V. intiol 
thlckeniD( and aedial constriction were severe all around. 
ABSTRACfS 
954·103 
Comparlloa 01 Intravucular Ultruouad Images 01 Human Coronary 
Arterl. Obtained by Mechanical Rotatlnl and Syathetlc: Aperture Amy 
SystelDl • In Vitro and In Vivo O"'r .. lIo ... 
Shigeo Kawano. Masakazu Yamagishi. SaIOShi Nakalani. JUD Tamai, 
Akito Kawaguchi. Hiroyuki Hao. Cbi.kao YutaDi, Kunia Miyatake 
Naliooal Cardiovascular Center. Suita. Osaka. JAPAN 
Coronary artery morpbo!ogy bas heeD evaluated by intravascular ultrasound in 
which two different imaging systeIDS. aperture array (AA) and mecbanical 
rotaIiDg (MR). are DOW available. However. DO daIa exits regarding the possible 
difference of ultraSound images obtained by these tWo systems. Therefore. we 
performed histological correlalioo of 31 postmonem humao coronary segments 
with the images obtained by AA (3.S·SFr. 2OMHz. 32-64 elements. 
Eodosonics) and MR (4.3Fr. 30MHz. 1.800 rpm. CVIS). In histologically non•
sclerotic segments (n~5). ultrasound images by AA coosisted of thin intimal 
leading-edge. subintimal sonolucent zone and echogeoic outerlayer. By MR. 
these segments consisted of ~ low and outer high echogeoic layer. In the 
segments where the histology demonSlJ'8/Cd the thickened intima associated 
with fibrin cap and/or byaiinization (n-26). AA showed widening of subintimal 
sonolucent ZODe. Under these conditions. Iitlle aIternalioo was observed in the 
thickness of intimalleading-edge. In contrasl, by MR these were represented by 
increased thickness of inner layer. which became more ecbogenic. At the site of 
calcified atheromatous plaque by histology (n-4). both systems revealed dense 
byperecbogenic images associated with acoustic shadow. The thickness of 
intimal leading-edge plus subintimal sooolucent zone in AA images (0.4-1.3 
mm) correlated with that of imler layer in MR images (0.4-1.4mm) 
(Y~.99X+O.06. r-O.90). These valuea also well correlated with the 
histologically determined thickness of intima-media complex (0.3-1.3mm) 
(r-O.7S with AA and r-O.80 with MR). During catheterization. 12 
angiographicaiiy oormaI segmenlS were studied by AA and MR. There were 
thin intimal leading-edge and subintimal SODolucent zone by AA and soflly 
echogeoic inner layer by MR. These results indicate the dependency of 
ultrasound images of buman coronary artery on each device. AA or MR. We 
suggest that the thickness of intima-media ~omplex on ultrasOund images caD 
be a device-independent index for evaluating coronary artery atherosclerosis. 
954·104 
Thr-olmerlaion8l Intrftac:ular Ultruonlc Reconatructton of the 
o-ndlng ThoracIC Aorta 
John J. Ross Jr.. Arthur J. O' Adamo. Dean G. Karalls. Krishnaswamy 
Chandrasekaran. 
Hahnemann University, Philadelphia, PA 
To evaluate the feasibility and potential utility of three-dimensional (30) 
reconstruction of the descending thoraclc aorta (OTA), sequential 
transverse cross-sectional intravascular u~rasound (JVU) (12.5 MHz) 
images were obtained in 3 nonnaIs. 3 PIS with aortic dIsseCtion. and 3 PIS 
wkh layered thrombus and debris. Video images were digitized onto a 
512x482 matnx retaining 256 gray levels. Three-dimensional voIumes_ 
~ed using 'ANAl vze- software speciIIcalIy developed and validated 
for votumeIric analysis and prOC8&S8d and displayed maintaining lui gray 
scaie range as 30 projectlon Images on a Macintosh 1Ie1 computer. in 
vivo. validation Incorporating this technique 
.has prevtouSty . been reported by our 
laboratOl'f (AHA. March. 1991). 
BD!I.I1I: 1) 30 volumes generated from IVU 
of OTA demonstrated anatomical and 
geometrical details In multiple planes 
simultaneously not feasible by standard 
IVU: 2) surface display of the aortic lumen 
allowed easier recognition of the 
geornetrIcal changes in the lumen resulting 
from dissection and thrombus formation 
which correlaled well with angiography and 
pathoi0gicai specimen. . 
Conclusion: 1) three-dimensional intravascular ultrasound imaging of the 
descending thoracic aorta is possible from two-dimensional Intravascular 
Images: 2) three-dimensional volume rendered imaging 8Uowed 
visualization of morphology and geometry of the aorta in multiple planes 




Occult Atherosclerosis is Present at the Site of Focal 
Vasospasm in Angiographically Normal Coronary 
Arteries: Evidence from Intravascular Ultrasound 
Masakazu Yamagishi, Jun Tarnai, Satoshi Nakatani, Shigeo Kawano, 
Jun Koyama, Kenichi Kure, Steven E. Nissen, Kunio Miyatake. 
National Cardiovascular Center, Suita, Osaka, JAPAN and Cleveland 
Clinic Foundation, Ohio. 
The previous animal study in cholesterol-fed swine demonstrates that 
early atherosclerosis is invariably present at the site of focal coronary 
vasospasm. However, few clinical data exist demonstrating occult 
atherosclerosis at sites of vasospasm in angiographically normal 
coronary arteries. Therefore, we studied 21 patients using a 32-64 
element, 20 MHz, intravascular device, including 15 patients with 
ergonovine-induced focal vasospas~ and 6 without spasm. ~oc;:al . 
vasospasm (> 75% diameter reduenon) was provoked by IC IDJecnon 
of ergonovine (.01-.04 mg) in the left coronary in 5 patients and the 
right coronary in 10 patients-. Intravascular ultrasound was performed 
after relieving the vasospasm with 250-500 meg IC nitroglycerin. A~ 
all IS angiographically normal sites with focal spasm, atheroscleroSIS 
was present by ultrasound, defined as a significantly thickened 
subi11limal sonolucent zone (0.4'±O.12 mm) with or without thickened 
intimalleading-edge. Circumferential lesions were present in 13/15 
segments, and non-circumferential atherosclerosis in 2 segments. 
Additional infusion of nitroglycerin resulted in funher dilation these 
segments of 11/15 patients. In contrast, segments from control 
cases without focal spasm exhibited a thin intimalleading-edge 
(0.16±O.11 mm) and subintimal sonolucent zone (0.14±O.11 mm), 
although artery diameter reduced by 24± II % after ergonovine. 
These thickness values corresponded closely to previously reponed 
morphological findings in normal coronary segments. These results 
indicate that atherosclerosis is invariably present in patients with focal 
vasospasm, even in the absence of angiographic coronary disease. 
Existence of such atherosclerotic lesions can be related to the 
occurrence of focal vasospasm in clinical settings, although 
functional disintegration of these segments should funher be sought. 
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955·16 
Syndrome X Patients Have Abnormal Cardiac 
Nociception 
Anoop Chauhan, Paul A. Mullins, Ged Taylor, Suren 
Thuraisingham, Michael C. Petch, Peter M. Schofield. Papworth 
Hospital, Cambridge, U.K. 
The mechanism of chest pain in patients who present with chest 
pain, a positive exercise test and nonnal coronary arteries on 
angiography (SYNDROME X) is not clear. Syndrome X is a 
heterogenous disorder and the various proposed theories include 
abnormalities of coronary vasodilator reserve or myocardial 
metabolism in some patients whereas psychological, 
hyperventilation and oesophageal factors have been reponed in 
others. We studied the response of four groups of patients to right 
atrial instrumentation: 26 patients with Syndrome X (Group I), 26 
patients with mitral valve disease and normal coronary arteries 
(Group 2), 26 patients with mitral valve disease and coronary artery 
disease (Group 3), & 16 heart transplant patients (Group 4). All 
patients were premedicated with diazepam 10mg. A standard 
femoral approach was used and the catheters were introduced 
through vascular sheaths. The patients were instructed to report any 
chest pain during the catheter. A Gensini catheter was advanced to 
the right atrium through the femoral venous sheath. The catheter was 
then rotated rapidly and moved forward and backwards in the right 
atrium without warning the patient. In Group I (syndrome X) 
patients a 3.6 F intracoronary Doppler-tipped catheter (Schneider 
U.K.) was also positioned in the proximal left anterior descending 
coronary artery to measure coronary flow velocity. Twenty two 
patients out of 26 in Group I reported their usual chest pain during 
right atrial stimulation. There was no significant difference in the 
coronary flow velocity measured before (7.8 SO 5.2 cmlsee) and 
after (7.8 SO 5.2 cmlsee) the period of stimulation. Only 5 patients 
in Group 2, three patients in Group 3 and none in Group 4 reponed 
any chest pain on right atrial stimulation. We conclude that there may 
be abnormal cardiac nociception in Syndrome X patients . 
955·17 
JACC Vol. 21, No.2 
February 1993:450A 
Cardiac Autonomic De nervation During the Early 
Hours of Acute Myocardial Infarction 
Enrico Balli. Antonio Giomi, Gian Carlo Casolo*, Angelo Alfieri, 
Mauri:io Chiti. Federico Del CireTna. Coronary Care Unit. Del Ceppo 
Hospital, Pistoia and *Oinica Medica I, University of Rorence, Italy. 
Acute myocardial infarction (AMI) causes a variable derangement of 
autonomic function, related to the balance between triggering of cardiac 
reflexes, their inhibition (afferent denervation) and efferent denervation. 
Spectral analysis of heart period variability (HRV-SA) is a method to 
study the global autonomic outflow to the hean, to evaluate selectively 
vagal and sympathetic components and to quantify their balance. 
We studied cardiac autonomic changes in the early phase of evolving 
transmural AMI (rypical chest pain lasting >30' and ST elevation at the 
ECG), performing HRV-SA in 18 pts (14 M, age 67±8, r. 49-75) 6±.1 
hours from the onset of symptoms; 10 pts had an anterior, 8 an inferior 
AMI. No pts had previous AMI, heart failure or diabetes. No one had 
received beta-blockers or atropine. In the same environment we studied 
15 pts with unstable angina (UA, chest pain at rest and ST depression at 
the ECG) and 16 controls (C), age and sex matched. 
A Fast Fourier Transform method was used to detect the spectral 
components. Two major peaks were identified: Low-frequency (LF), 
centered at 0,04-0,15 Hz, and High·frequency (HF), synchronous with 
thr respiratory rate. LF/HF ratio and the global amplitude of the signal 
(total ?SO. 0.04-0,35 Hz) were computed: LF phenomena <0,04 Hz were 
not studied. Pts with AMI had a significantly lower total PSO count 
(458 msec21Hz vs VA 746, p<O,05 and C 1297. p<O,OI). Anterior AMI pts had 
a marked reduction in total PSO and vagal withdrawal with relative 
prevalence of LF signal (PSO 318. LF 132, HF 47, LF/HF 2.8, p<O.OI vs VA, 
p<O,OO5 vs C). Global autonomic and selective vagal activities were more 
preserved in inferior AMI (PSO 556. LF 93. HF 312. LF/HF 0,3, p<O,05vsVA. 
p<O.OlvsC). However, we observed individual variations from this pattern. 
Our data show a reduction of global autonomic activity in the early 
phase of evolving transmural AMI, more marked in anterior wall AMI. 
This may be related to functional efferent denervation, secondary to the 
development of an ischemic milieu and to direct ischemic damage to 
cardiac nerve axons and nerve endings. 
955·18 
Kole of CoronarJ Vasospasl in 1I10cardial Infarction lithout 
Sicnificant CoronarJ ArterJ Stenosis 
Hiroki Hizobe, Nitaro Shibata, Tetsuro Ueda, Saichi Rosoda. 
Yoshihiro Hi1tzaki, Sin-n Kasahara, Jumpei Nakano, Yukio KOlllatsu. 
Heart Institute of Japan, Tok10 lOlen's Hedical College, T0110, 
JAPAN 
It is ilPortant to find out the direct lechanisl of tile onset of 
1I10cardia! infarction (MIl. In HI without significant coronarr 
arter1 stenosis, vasospasl la1 plu role for the onset of HI. We 
evaluated the spasticitr of coronarr arteries in 16 cases of HI 
without significant «25~) coronarJ stenosis. HI was defined as 
t1Pica! chest pain, ECG findincs, and significant elevation of CPK•
MB in acute phase. There includes 13 lIale, 3 fellale, and lean age 
was 52. The location of HI was anterior in 10 cases and inferior in 
6. CoronarJ arteriograllS (CAG) .ere performed 2-3 weeks after the 
onset of HI. Nitrates, beta blockedes, and calciul antagonists 
.ere .ithdrawn at least 2 dan before CAG procedure. Vasospasm was 
induced using selective intracoronarJ injection of acetylcholine 
(25-100 J.lC to the left coronarJ arterJ: LCA, and 25-50 J.lg to the 
right: RCAl. Spas! positive for SPasl was defined as 90~< stenosis 
associated .ith chest pain or ECG changes. RESULT: Vasospasm was 
induced in 12 cases (75~; RCA in 10, left anterior descending 
arterJ (LAD) in 6, and left circumflex (LCX) in 6. The location of 
HI related arterJ and location of coronar1 spasl was coincide in 
4 cases (67X) of inferior HI and in 5 cases (50~ of anterior HI. 
Spas! was induced in 9 (90~ .i th the age of lore than -50, and in 3 
(50~ .ith the age of less than 50, .hich is significantl1 differ•
ent (P< 0.05). CONCLUSION: In HI patients without significant 
coronarJ arterJ stenosis, vasospas! was induced in 75 ~ of cases, 
in which vasospasl .as induced in HI related artery in 671 SpaSlil 
.as induced lore .i th the age <50. Vasospasl might be illPortant 
for the role of the onset of HI in lIan1 cases of HI without 
sicnificant organic coronan stenosis. 
JACC Vol. 21, No.2 
February 1993:451A 
955·22 
Balloon· Occlusive· Intravascular· Lysis· EnhallCed • RecanaUzation 
(B-O-I·L-E·R) of Thrombotic Saphenous Vein Graft Occlusions: 
A New Technique of Selective Intravascular Thrombolysis 
Ulrich W. Busch. Frieder Weingartner. Ulrich Renner. Franz 1. Neumann. 
Albert W. Schtlmig 1. Med. KllDik, Technische Unlversillil MUncheD, FRG 
Thrombotic: occlusions of saphenous vein grafts represent a therapeutic 
challenge. since systemic thrombolytic therapy appears to be less effective 
than In native vessels. and subselective application of the thrombolytic drug 
bears the risk of washing thrombotic material Into the aorta. We therefore 
investigated, whether selective thrombolytic therapy in occluded grafts 
could be Improved by proximal balloon occlusion of the graft and slow 
infusion of the thrombolytic agent via the inner lumen of the balloon 
catheter. This would avoid retrograde embolization and loss of the drug into 
the aorta, and Indeed would bee the thrombolytic agent into the thrombus. 
So far. we have followed this strategy In 6 patients (pis). 
Mean age of the pts was 62 years. 3 pts presented with unstable angina 
without evidence of new infarction. 2 pts had had a recent episode of chest 
pain and one presented with an acute infarction. After documentation of the 
occluded graft an angioplasty balloon catheter large enough to occlude the 
proximal portion of the vein graft was introducedFollowing withdrawal of 
the guide-wire an infusion of urokinase was started with a concentration of 
10.000 IU/mI at a rate of I mlImin. A first control Injection was performed 
after infusion of 100.000 IU. Depending upon the result. another 100-
200.000 IU were added, again with proximal balloon occlusion. The 
interventions were completed by angioplasty of remaining stenotic lesions. 
In 5/6 pts the grafts could be successfully reopened, while in one only a 
proximal portion of the occluded graft could be recanalized Attempted wire 
manipulation through the remaining occlUSion was unsuccessful. In no case 
there was angiographlc evidence of damage to the graft from overinflation 
with the thrombolytic infusion. 
Conclusion: BOll..ER appears to be a safe and highly effective modification 
of thrombolytic therapy in cases with thrombotic vein graft occlusions. 
955·23 
Percutaneous Insertion of Collagen Plugs IS In Adjunctive Therapy In 
Closing the Femoral Puncture Site aller Percutaneous Intra Aortic 
Balloon Pumping. 
Jef M.P.G. Erns\, R. Melvyn Tjon Joe Gin, Egbert T. Bal, E. Gljs Mas\, 
Maarten-Jan Suttorp, Paul H.M.J. Vermeersch, Carl A.P.L Ascoop. HW. 
Thijs Plokker. SlAntonlus Hospital, Nleuwegein, The Netherlands. 
Closure of the arterial puncture site after percutaneous intra aortic balloon 
pumping (IABP) usually demands a very long compression time because 
of the relatively large sheaths used. Therefore not frequently vascular 
surgery Is needed and often direct surgical closure of the vascular defect 
after removal of the IABP Is advised. Recendy we closed the puncture stte 
wtth biodegradable collagen plugs in 19 patients who had been treated 
wtth IABP for 2-8 days, for complicated acute myocardial Ischemia or 
perioperatively. The blunt tipped plugs are placed between the skin and 
the artery in order to avoid placement of the collagen material within the 
arterial lumen. The collagen in the puncture channel is considered to 
enhance formation of a firm qlot at the junction of collagen and blood. 
Before IASP removal Duplex scanning is performed to exclude thrombus 
distal of the balloon Insertion site. After additional manual compression 
hemostasis was achieved wtthin 3 minutes after removal of the sheath In 
all patients (mean 1.8 minutes). All patients were fully heparinized and no 
heparin antagonists were given. There were no signs of peripheral emboli•
sation. These results compare favourable with manual compression times 
in IABP patients, which ranged from 28 to 52 minutes (mean 41 minutes 
in the last 10 patients prior to the availability of the collagen plug. Long 
term results were evaluated with color duplex studies, which yielded 
excellent results, with two small false aneurysms, one resolved sponta•
neously and the other needed surgical repair. 
We concluded that the biodegradable collagen plug may be a great help 
to close the puncture site after IABP. 
ABSTRACTS 
955·24 
Double Umbrella Closure of Post· Myocardial Infarction 
Ventricular Septal Defects 
Michael J Landzberg. Stanton B Perry. John F Keane. Chris E 
Faherty. James E Lock. Children's Hosp., Boston, MA. 
Ventricular septal rupture is a rare but often fatal complication of 
acute myocardial infarction (AMP. despite medical/surgical 
intervention. Between 2/90 and 5/92 we attempted transcatheter 
closure (TeC) of ventricular septal defects (VSD's) complicating 
AMI using a Clamshell (C) occluder In 8 patients (PIS). age 52-
79. Five pts (pOST-MI) presented acutely. without surgical 
intervention--all required hemodynamic suppon and had 
multiorgan failure. Three other pIS survived surgical VSD repair 
but had significant postoperative residual defects (PORD's)-1 
required hemodynamic suppon. At catheterization. all pIS had 
pulmonary/systemic blood flow> 1.S. POST MI VSO's were 18-
20 mm diameter and were associated with a septal cavity (4) or 
marked septal thinning (1). PORD's were 8-19 mm diameter. C's 
were successfully implaIited in stable position in all pIS (1 pt 
received 2 devices)--moderate residual angiographic shunting was 
present in all. Procedural complications Included e retrieval (2) 
with tricuspid leaflet ruptUre/regurgitation (1), transfusion (3) and 
acute renal failure (1)--all occurred In pIS POST-MI. Survival In 
all POST-MI pIS was shon-term (1-90 days), while all pIS with 
PORO's are alive with both hemodynamic and symptomatic 
improvement (4-31 months). 
This elIperience suUests that Tee of post-MI VSO's, limited by 
available e technology, may provide long-term improvement for 
pts with post-operative VSO's, but currently offers httle long-term 
benefit in the acute management of unoperated pIS with 
hemodynamic compromise and mulitorgan failure. 
955·25 
451A 
Propbyt.dic LidocUae Iiw LodIal VCIIIricuIu Anbytbmiaa Followins AwIe 
MyocudiaIlnfarcticJa: II- v .... 48-Hour Infusioa 
Chantal Pharand, Eleanor O'Rangen!, Michael Ujhelyi, Jane Fisher, Linda Bosco, 
Moses Chow. Jeffrey K1ueer. Hartford Hospital, Hartford, CT and University of 
Connecticut, School. of Pharmacy and Medicine, Stom and Farmington, CT. 
Prophylactic lidocaine bas ~ shown to reduce the incidence of ventricular 
fibrillation (VF) after acute myocardial infarction (AMI), but its use remains 
controversial, as an increase in mortality bas been suggested wben lidocaine is 
administered to uncomplic:aled AMI patients. However, the GISSI group bas 
recently reported an increased mortality in uncomplic:aled AMI patients with VF. 
Since VF OCCIInI early after AMI and lidocaine related morbidity maybe a function 
of infusion duntion, we performed this double-blind, randomized study to compare 
the efficacy and toxicity of 8- and 48-hour lidocaine infusions after AMI. 
Methods: Patients presenting to our institution with S 6 hours of symptoms, ECG 
changes, and a history consistent with AMI were included. Those presenting with 
hypotension (systolic blood pressure S 90 mmHg), Killip class III or IV, recent 
VF or sustained ventricular tachycardia, or on other antiarrbythmics were 
excluded. After the loading dose, lidocaine, 1-3 mg/min (weight- and age•
adjusted), was infused for 8 bOIln!. Patients were tben randomized to placebo 
(Group I) or continued on a lidocaine (Group II) infusion for 40 boun!. 
Results: Of 264 patients meeting inclusion criteria, 175 were enrolled (87 in 
Group I, 88 in Group II); an additional 225 patients met ~ I exclusion criteria. 
Demographics were similar for both groups. Thrombolytics were administered in 
77.0% of Group I and 86.4% of Group II patients (p=0.268). VF did not occur 
in any patient, and only one patient experienced ventricular tachycardia (Group I). 
More Group II patients developed late (randomil.ltion phase) congestive heart 
failure (CHF) compared to Group I, 10.2% vs 2.3% (p=0.031). However, the 
incidence of CNS side effects, nausea/vomiting, and hypotensionlbradycardia was 
similar in both groups. Severe toxic effects requiring unblinding occurred 
infrequently, 5 in Group I and 6 in Group II. The in-hospital mortality rate was 
also similar in both groups, 3.4% and 2.2%. Of note, 28 patients were excluded 
due to VF, 13 of whom experienced VF in the ER or CCU and met no other 
criteria for exclusion. None of the 13 patients were prophylactically treated with 
lidocaine at the time of VF, and 2 (15.4%) died (unsucussfully resuscitated). 
Conclusion: Prophylactic lidocaine infusions, 8- or 48-hour, are equally effective 
in preventing VF. However. the i/lcidence of late CHF is greater in patients 
receiving longer lidocaine infusions. In view of the present results and the 
controven!Y concerning prophylactic lidocaine and increased mortality in AMI 
patients with primary VF, a randomized trial comparing short term lidocaine to 
placebo should be performed. 
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956·26 
LolIg 'ren! Oute_ after AIIgiopla.ty ill th. httillg of It.at 
AIIgiDa .eetoria 
W. Lae aail.y. Donald R. W.et.rh.u.en. aarry D. Rutherford. 
David R. McConahay. Warren Johneon. L.e V. Giorgi. Thoma. 
H. Shim.hack. Robert W. Ligon and G.offr.y O. Hartzler. 
Hid America Heart In.titut •• Kan.a. City. HO. 
Reet angina pectorie (RAP) ie an independ.nt predictor for 
increa.ed procedural mortality. We have analyzed the 
procedural re.ult. and long t.rm outcome. of 5001 patients 
pre.enting with RAP between 1980 and 1992. A control group 
(C) of 7220 patient. without RAP r.ferred for coronary 
angiopla.ty wa. employed for compari.on. 
~ w.... ~ 
Hal. 82' 70' <.0001 
Hean Age 59.9 65.6 <.001 
Diabete. 14' 20' <.0001 
Prior HI 50' 49\ NS 
Prior CABG 22\ 28' <.0001 
LYEP < 40 10' ln <.0001 
Procedural HI 1. 0' 1. " <.0001 
Procedural D •• th 0.5'. 1." <.0001 
Urg.nt CABO 1.n 1. 5' NS 
While individual l •• ion .ucc... rat.. were aimilar. 
ho.pital .tay. ware prolonged for RAP. Long term survival. 
event fr .. lurvival and fr.edom from revascularization were 
all adver.ely .ffected (' < 0.0001) by RAP. 
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Purther .ubgroup an.1Ylie rev •• led little difference in 
outcome. b.tween RAP and control. with .ingle ve.s.l 
di...... while p.ti.nt. with multiv •••• l di.ea •• 
demon.tr.ted even gre.ter di.parity in clinical 
char.ct.ri.tic. and outcome •• 
956·27 
Intermittent Urokinase Therapy In Symptomatic End•
Stage Coronary Artery Disease: 
M. Leschke. F. Schoebel. W. Mecklenbeck. B.E. Strauer. 
University of Duesseldorf 
In patients with endstage coronary artery disease (CAD) 
without a perspective to profit from further Interventional 
therapy ( PI'CA.ACBG ) and untractable angina pectoris 
Intermittent urokinase ( UK ) therapy was Introduced as an 
alternativ therapy.To test validity and effectiveness two 
groups were compared. group I (n=49.76% post ACBG ) 
received 3x500.000I.U.UK t.v. per week over 3 month vs. 
group II ( n=49.67% post ACBG ) with 3x50.000 I.U.UK i.v. 
per week over 3 month. Fibrinogen levels were reduced In 
group I by 34% from 370±87mg/dl (p<O.OOOI). In group II 
by 10% from 360±94 mg/d (p<O.05). Plasma v1scosity In 
group I was reduced signtflcanty by 7.1% from 1.4O±O.07 
mPas versus a decrease.of 2.2% from 1. 39±O. 11 mPas In 
group II. Global myocardial perfusion as evaluated by MIBI•
SPECT analysis Increased by 23% In group I. while it 
remained constant In group II. Daily Incidence of angina 
pectOris decreased In group I by 68°A> from lnitlally 
3.4±1. 7 / d versus a decrease by 37% In group II from 
Intlally 3.3±1.6 / d. The long term follow up (O-27months) 
showed a persistance of clinical therapy effects for 6.4±4.8 
months In the group I.There were no UK-related bleeding 
complications In both groups.The concept of Intermittent 
UK therapy In endstage CAD could demonstrate a dose•
dependent effect for i ) improvement of symptoms U ) an 
objective enhancement of myocardial perfusion by 
improved rheological blood properties and probably 
ftbrlnolysis of microthrombi. In addition. a long term effect 
could be demonstrated. Therefore.lntermittent UK therapy 
Is Indicated In therapy refractory symptomatic CAD as a 
new method of treatment. 
956·28 
JACC Vol. 21, No.2 
February 1993:452A 
PersIstent Activation of the Fibrinolytic System In Retractory Unstable 
An&ina 
InM WAnk' Keith Fox, Christopher Ludlam. 
Cardlovucular Research Unit, University of Ecllnbur&il, UK 
To assess the function of the fibrinolytic system in unstable angina (VA) 
we IDC8IIIJ'ed plasma levels of tissue plasminogen activator activity (t-PA 
act) and plasminogen activator Inhibitor type I activity (pAl act) in 22 
pa1iCDtI with refractory UA and in IS healthy age and sex matched 
COIIII'Ols. Based on clinical outcome during 9 weeks follow-up the patients 
were divided Into 3 groups: (1) those who developed AMI (n=6), (2) those 
who experienced recurrent angina ± PrCA/CABG (n-7. n=S) and (3) those 
who remained event-free (0=4). 
We demonstrated significant elevation of plasma t-PA act in 
patients with UA compared with controls (0.6O±O.07 vs 0.36±O.04 iU/ll1l, 
po:O.OO3 at presentation and 0.S9±O.09 iU/ll1l. p=O.03 at 9 weeks). The 
highest presentation t-PA act values were observed in a group with 
recurrent angina (0.6S±O.SS. po:O.OOS vs controls) and especially in a 
subgroup requiring PTCA/CABG (0.8O±O.OS III/ml. p=O.OOOI vs controls). 
Patients who developed AMI bad the lowest level of plasma t-PA act and 
this was significantly decreased compared with PTCA/CABG subgroup 
(0.46±O.07 iU/ll1l, p=O.OOI). PAl act levels were non-significantly elevated 
in UA ampared with controls (S.SS±l.27 vs 6.S4±1.62 iU/ll1l). 
We demonstrated chronic activation of the fibrinolytic system in 
patients with UA. despite a trend for elevated PAl act levels. This may 
represent secondary activatioo of the fibrinolytic system In response to a 
COl1Iinuing thrombotic process. Significantly decreased plasma t-PA act in 
pa1iCDtI who developed AMI compared to recurrent angina + intervention 
group may indicate inadequate endothelial aclivatioo in the presence of 
intI'IcoroIIary thrombus formatial. 
956·29 
Pro longed Treatment wi th Subcutaneous Hepari n improves 
the Prognosis of Subacute Phase of Unstable Angina. 
A Randomized Pilot Study. 
Stefano Reggiani, Giorgio Mattioli. 
Opt of Cardiology, University of Modena, Italy. 
The use of heparin by continuous or intermittent 
intravenous infusion has shown to be highly effective 
in acute phase of unstable angina (UA) in the prevention 
of myocardial infarction and cardiac death (CD); 
however, by design, in all study the therapy with 
heparin was continued for only S to 6 days. To investiga•
te if subcutaneous heparin (SH) 12500 UI/b.i.d. influences 
the subacute phase of pts with UA, we enrolled in 
a randomized trial 159 pts (112 M and 47 F) (74.2% 
in Class I! B and II! B of Braunwa1d's classification) 
of which 80 were allocated to conventional therapy 
(CT)( Ca-antagoni sts, nitrates, etc. ) and 79 were 
treated with CT +SH withi n 48 hrs of recovery. Basel i ne 
demographi c and angi ographi c aspects were s imil ar 
in 2 groups. The follow-up was 3 months and PTT was 
moni tored. AMI and CD were the primary end poi nts. 




CT n=80 CT+SH n=79 Risk reduct. p value 
17 (21.2%) 4 (5.0%) 76.4 % P (0.01 
10 (12.5%) 2 (2.5%) 80.0 % p< 0.05 
27(33.7%) 6(7.5%) 77.7% p<O.OOl 
No serious bleeding complication was observed in 
pts with SH. Our data suggest that therapy with SH 
is useful in long-term prognosis of pts with UA. 
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956-30 
Value cC ~ Qrd stiaJlatim in Pat1atta with Severe RatnIctxry 
Aqpnl AlctIris. 
GJerrlro ZUin, ~ Cazzin, *Michele Sic:olo, §GiEl!p!lOlo Plmto, 
Fnn:esco Di Pede, Eligio Piccolo. 
Di visicn of Cardiology, *ttclear Medicine Service, §Di visicn of 
Anesthesia; UIi:lerto 1° !bspital, r.ertre- Venice, Italy. 
The usefulness of cmt:i.rua.s spinal cxrd stinulaticn (SCS) was 
evallBted in 9 pts (a.t, rreEI"l ¥ 66 yrs) with severe argina refractory 
to q:>tiJral dng treatment ani aq;p.~ clocl.rrmted ITlJl tiple 
vessels disease rot &.Ii table fer revasc:ularizaticn. Ead1 pt recei vee! 
inplmt of ITlJl tipo1ar electrodes fer epidJral spinal electrical 
stinulaticn (rnn 7<124 MecItn:I1ic), am tn:Ier..e1t score questicrrei.re 
fer synptaIB (argina, dispx>ea, weakness) ani i..nc:remantal 
t281lS!!ElCP~ atrial pacirig with the detenninaticn of radicnclide 
ejecticn fracticn (EF) befcre the inplmt ani 6 nmths later. 
Results (rreEI"l values): befcre SCS at 6 nmthe 
argina 4.1 0.8* 
synpt.cm; score dispx>ea 2.7 0.5* 
weakness 2.2 0.1* 
baseline EF(%)/RPI'(x 1(0) 48.7/ll0 !1l.7/1ce 
9Ot:pn «).3/1!1l 43.7/141 
llO t:pn 34.3/2l3 34.0/165* 
13) t:pn 33.7/z:B 3l.7/aB" 
Recovery 48.7/112 48.7/100 
time to argina (m') 5.5 7.0 
HI'P=rate;:lres prod.ct; * p4).01 "at 6 nmths" VB "befcre SCS". 
In oc:rclusicn:1) SCS reclJce synptaIB ani inprove the <pility of life 
in pts with refractory argina; 2) the RPP falla signifiC!l1tly after 
SCS ~ pacing. These effects IIB,Y be associated with decreased 
synpathetic a::ti vi ty ciJe to the neurcsti.ITlJlaticn. 
956-31 
Effect or Gender, Race, and Age on the Natural mstory or Unstable 
Angina and Non-Q-wave MI: The T3 Registry 
Peter Stone, Neal Kleiman, Marvin Kronenberg, James Willerson, Marcus 
Williams, Mary Jane Prior, Bruce Thompson, Eugene Braunwald for the 
T3R Study Group, Brigham and Women's Hospital, Boston, MA 
The natural history of patients (pts) with unstable angina (VA) or non-Q•
wave Ml (nQMl), especially in women, blacks and the elderly, is the focus 
of the T3 Registry since these pts are considered to have been under•
represented in previous studies and to be at ~ risk of cardiac events. 
From 6214 pts identified with acute ischemic pain, 2040 were selected using 
stratified sampling techniques to obtain substantial numbers of women, 
blacks, and pts > 75 years of age. 
Rs: White Black 
Au;. :;;75 >75 :;;75 >75 
~ ...M....f.....M....f.. ...M..L...M....f.. 2 
N= 553 373' 183 261 186 303 24 60 
nQMl('JI,) 15 16 20 15 25 19 27 17 0.03 
CATH('JI,) 73 60 54 44 57 41 38 25 < .001 
MVD('JI,) 54 41 73 55 43 27 30 67 < .001 
DIMI (by 6-wk)('JI,) 6 5 11 11 6 4 8 8 .007 
D/MlIR (by 6-wk)('JI,) 26 28 44 45 22 17 32 28 < .001 
[MVD= multivessel CAD in those catheterized, D= death, Ml= 
myocardial infarction, R= recurrent ischemia) 
By logistic regression the independent characteristics of gender, race and age 
contributed to the group differences of catheterization and of MVD. 
Women, blacks, and younger pts had less severe CAD than their respective 
counterparts. By 6 weeks, younger pts had a decreased likelihood of D/Ml 
and D/MlIR (odds ratio [OR) 0.5, p<O.OOOI); blacks also had a decreased 
likelihood of D/MlIR (OR 0.6, p< 0.0001). A reduced incidence of cardiac 
events was not detected in women. Thus, blacks and younger pts exhibit less 
severe CAD and less frequent adverse events than whites and elderly pts. 
In this study women have less severe CAD than men, but manifest a similar 
incidence of adverse events. 
ABSTRACTS 453A 
956-32 
COIIIpIrison of nme Domain Ind Spec:trli Turbullnce Anllysll of Signal•
AYII'Iged Electrocardiogram for Idll1liflcltlon of Poll Inflirctlon Pltllnla 
It Rilk of Sudden D .. th 
PIoIr Kulakowski, OIusoIa Odemuylwa. Anne Staunton. Marek Malik, A. John 
Camm. SI. George's Hospital Medical School, London, UK 
Late potentials detected by the time domain analysis of the s1gnal-averaged 
ECG (SAECG) are established marker for predlctlon of arrhythmic events (AE) 
after MI. Spectral turbulence analysis (STA) Is a new frequency domain 
technique for SAECG analysis. Unlike other methods, STA examinee the 
whole ORS complex and not solely the final portion. The value of both 
techniques In identification of post Infarction patients at risk of AE was 
examined In 430 patients with acute MI wtthout bundle branch block who 
survived to discharge from hospital. 
RESULTS: During follow-up of 6-60 months 28 AE (12 sudden deaths and 18 
non-fatal 'IT {VF) occurred. The mean values of the time domain and STA 
Indices In catlents with and without AE are D esented below (mean +SOI: 
SAECG AnaIYII. NoAE AE p< 
nmeDomaln 
Total ORS (ms) 104±19 121±29 0.0001 
Low Amplitude Signals (ms) 27±15 38±28 0.001 
RMS Voltage~ast 40 ms of ORS ON) 42±24 31±29 0.02 
Spec:trli Turbulence 
Low Intersegment Correlation Ratio 71.9±5.8 73.3±8.2 NS 
Intersegment Correlation Mean 92.4±1.4 92.0±1.8 NS 
Intersegment Correlation SO 103.8±23 110.2±29 NS 
Spectral Entropy 13.8±3.7 15.4±4.3 0.05 
The receiver operator characteristic curves showed that for various levels of 
sensitivity the positive predictive accuracy of time domain analysis was 
significantly better than that of ST A. 
CONCLUSIONS: Time domain SAECG Is superior to STA for predicting 
events In postlnfarctlon patients without bundle branch block. Whether the 
combination of both techniques may Improve the predictive value of SAECG 
after MI remains to be established. 
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957·50 
Hew Predictors of Adverse Clinical Ootco.es: Angioscopic 
Analysis of COrooary Lesions 
Kyoichi Mizuno. Akira Miyamoto. Kimio Satomura. Bonpei 
Takase. Toshio Shibuya. Koh Arakawa. Kazushige Isojima. 
Akira Kurita. Haruo Nakamura_ 
National Defense Medical College. Saitama, Japan. 
The purpose of this study is to determine whether or not 
angioscopic descriptors are predictive of adverse short•
and long-term outcomes in patients with ischemic heart 
disease. 101 patients were followed for 4 years after 
percutaneous trans luminal coronary angioscopy. Among 
them, 44 patients underwent coronary angioscopy 
immediately after PTCA. Lesion morphology was classified 
into 4 patterns; (1) hemorrhage (n=6); (2) thrombus 
(n=50); (3) irregular surface (e.g., intimal flap. 
intimal split. ulceration) (n=32); (4) smooth plaque 
(n=37). Hemorrhage. thrombus or irregular surface was 
diagnosed by coronary arteriography in only 32 lesions 
(36%). An adverse outcome was defined as unstable angina 
(n=7). acute myocardial infarction (n=6). acute coronary 
occlusion (n=2). or sudden death (n=l). The association 
between lesion descriptors and patient outcome is as 
follows: 
anqioscopy adverse outcome 
hemorrhage 100% 
thrombus 75% 
irregular surface 31% 
smooth plaque 0% 










The presence of massive hemorrhage or thrombus. as 
detected by angioscopy. is aSSOCiated with a high 
proportion of adverse outcomes. In contrast. smooth 
plaque is strong predictor of non-adverse outcome. Thus. 
coronary angioscopy clearly can play a useful role in 
identifying patients likely to develop adverse outcomes_ 
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957-51 
Value of Intracoronary Venous Electrocardiograa to Detect 
Regional M1'ocardial Ischeaia During Coronary AngioplastJ 
:Co~ison With Lactate Metabolis. 
Takayoshi Adachi, Shinsuke Nanto, Masayoshi Mishima, 
Atsushi Hirayama, Kazuhisa Kodama. 
Osaka Police Hospital, Osaka, Japan 
Intracoronary EGG is proved to be more sensitive than 
standard EGG(12-EGG) in detecting myocardial ischemia 
during PTGA. It is hazardous, however, to insert the 
guidewire into the coronary artery other than during 
PTGA. Therefore, we developed the method of 
intracoronary venous EGG(icv-EGG). Studied were 28 
patients with effort angina. Unipolar icv-EGG was 
recorded from a guidewire in the anterior 
interventricular vein running parallel with LAD. ST shift 
in icv-EGG and 12-EGG during coronary angioplasty(PTGA) 
were measured. Aorto-coronary sinus differences of 
lactate extraction ratio(LER) as an index of myocardial 
ischemia were calculated. 
Results: Icv-EGG could be safely recorded. ST shift in 
icv-EGG correlated well with LER. When considered LER(O% 
as a gold standard of ischemia, and the criteria of ST 
elevation or depression>0.1mV for 12-EGG and that of ST 
elevation>0.1mV or ST depression>0.15mV for icv-EGG were 
used, the sensitivity and the specificity were as 
follows: 
12-EGG icv-EGG 
sensitivity 66%(12/18) 100%(18/18) 
specificity 90%(9/10) 90%(9/10) 
Gonclusion:These deta indicate that icv-EGG was safe and 
superior to 12-EGG in detecting regional myocardial 
ischemia as well as intra coronary EGG. 
957-52 
3-Dimensional Reconstruction of Intravascular Ultrasound in 
Coronary Stenoses of Borderline Significance 
David Zientek, Bruce Ennis, Philip R. Liebson, Eugene Urea:, Joseph 
E. Parrillo, Uoyd W. Klein, Rush Hean Institute, Chicago, IL 
We evaluated the role of 3-dimensional reconstruction (3DR) 
of serially acquired intravascular ultrasound (lVUS) images in the 
diagnostic evaluation of stenoses in which coronary angiography 
(ANG) demonstrated borderline severity or equivocal morphology. 
3DR was performed in 9 stenoses of 40-60% luminal diameter 
narrowing and/or a hazy appearance, possible filling defects, or 
marked eccentricity on ANG. IVUS was performed either separately 
or in conjunction with coronary intervention (balloon angioplasty or 
excimer laser). Quantitative and morphologic analysis of ANG and 
3DR were performed by investigators blinded to the other imaging 
technique. Quantitative ANG analysis was performed using previously 
validated computer software for videodensitometric analysis of vessel 
borders. Results: There was an excellent correlation between 
measurements of reference segment diameter (r=.94, p= < .(01) and 
cross sectional area (r= .93, p = < .(01) determined from quantitative 
ANG and 30R of the corresponding arterial segment, but diameter 
(r=.58, p=.13) and area (r=.42, p=.30) at the stenosis correlated 
only weakly. ANG revealed no dissection or thrombus in 4, possible 
thrombus in 2, dissection in 2, and ulcerated plaque in 1. 30R 
revealed 2 arteries with significant luminal obstruction by atheroma, 
2 with thrombus, 3 with dissection and 2 with ulcerated plaque. 
Conclusions: (1) 30R identified cases of atheromatous obstruction, 
dissection and ulceration not demonstrated by ANG, (2) dimensional 
measurements by 30R correlates closely with ANG in normal 
segments, and (3) 30R provides unique data concerning stenosis 
severity and composition of crucial clinical impact not obtainable by 
ANG. These flDdings are of great importance in evaluating the 
potential role of IVUS in patient management. 
957-53 
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Int:ima.l 'Ihlckening and Hespcnse to Coronary Vasodilators 
in Patients With Coronary Vasospasm:Study Fran Intra•
vascular Ultrasound. 
Mikihiro Kijima,Hiranichi HashiJroto,Shuichi Matsl.lOOto, 
Kiyohiro Ikeda,Yukio Maruyama. 
'lhe .un of this paper was to study the relationship 
between coroaru:y vessel wall pathoana1:al¥ by intra•
vascular ultrasound and response to coronary vasodilators 
in patients with coronary vasospasm.21 patients (25 spasm 
sites) were incl1.Dld in this study.AlI of them had 00 
significant fixed steooses nore than 50% in cli.arreter on 
corooary angiograms and reacted positive to an acetyl•
choline test (total or subtotal occlusion was induced). 
Scme of vasodilators were admi..nistered and the second 
acetylcholine test was perfoxmed in 9 of 21 patients. 
4 of 9 patients had negative response to the test with 
one of vasodilators(resporx3er) and 5 had positive in 
spite of adm.i.nistration of 3 different vasodilators (pcor 
responder).As a control,l3 patients with chest pain 
synd.rcJre(49 noospasrn sites) who had norna! coronary 
arteries and reacted negative to an acetylcholine test, 
were selected. We measured the following ~ pararreters 
by intravascular ultrasound.l) tlti.ckness of intima (in•
cluding media),2)echodensity;soft,fibrous,calcif1ed. 
Results:The mean thickness of intima was significantly 
higher in the spasm sites (l.lnm) than the oonspasm sites 
(0.3IIm) .Echodensity was soft in 80% Of spasm sites.en 
the contrary, intima echo was abscent in 37%, soft in 29%, 
and fibrous in 24% of oonspasm sites.The mean thickness 
of intima. was significantly higher in the pcor responder 
(l.5r;rn) than the responder (1.1irm) • 
ConclusiDn:Corooa.ry vasospasm tends to develop in 
lesion with soft and thick intima and the thickness of 
intima was higher in the poor responder than the 
responder. 
957-54 
Myocardial Bridging Analysed by ECG-triggered Intravascular 
Ultrasound 
Raimund Erbel, lunbo Ge, Hans I. Rupprecht, Giinter Gorge, 
liirgen Meyer. II. Medical Clinic, University Mainz, Germany 
The aim of our study was to evaluate the usefulness of 
intravascular ultrasound (IVUS) in comparison to angiography in 
patients (pts) with myocardial bridging (MB). Nine pts with unstable 
angina with angiographic signs (systolic milking effect) of MB were 
examined by IVUS with simultaneous ECG recording after coronary 
angiography. The IVUS probe could not pass the distal sites of the 
MB in 6 pts, only the proximal segments were analyzed. Good 
correlations of the lumen dimensions between IVUS and 
angiography were obtained in the normal segment (r=O.9S, 
SEE=O.30 mm for diameter and r=O.92, SEE=3.13 mm2 for area, 
both p<O.Ol). Systolic, eccentric compression of the MB segment 
was clearly visualized in all pts. Ouring diastole, ECG triggered 
analysis detected delayed relaxation of the compressed artery. 
Lumen area of the MB segments decreased from 9.0±2.l mm2 
(enddiastole) to 6.3±2.0 mm2 (endsystole) (p<O.OOl) and 
corresponding angiographic values were 6.3 ± 1.1 mm2 and 3.a 1.5 
mm2 (p<O.OOl). Three layer appearance of the vessel wall was 
imaged in normal segments, whereas only in 3/9 pts in MB 
segments. In 7 pts plaques were found proximal to MB but not 
within MB segments. 
Conclusion: IVUS can clearly identify MB by showing eccentric 
compression with delayed relaxation. MB segments seem to have 
less atherosclerosis compared to the other vessel segments. The 
reported coronary flow reserve decrease in pts with MB might be 
caused by the proximal atherosclerosis. 
lACC Vol. 21, No.2 
February 1993:455A 
957-55 
Coronary Arterial Remodeling Studied by Intravaswlar 
Uhrasound: A Retrospective Study 
Junbo Ge, Raimund Erbel, Giinter Gorge, Jose Zamorano, Arthur 
Scholte, Hans J. Rupprecht, Jiirgen Meyer. II. Medical Clinic, 
University Mainz, Germany 
The purpose of the study was to assess coronary arterial 
remodeling, a compensatory mechanism of obstructive coronary 
atherosclerosis. In 46 patients (pts) (36 M, 10 F, 5S.2±6.S years) 
with intravascular ultrasonic non-calcified atherosclerosis but 
without any interventions, the intravascular ultrasound (NUS) 
images of atherosclerotic segment (I), proximal normal segment (II), 
and distal normal segment (III) were analyzed. The vessel area 
(V A), luman area (LA), and plaque area (PA) were measured. A 
total of 92 atherosclerotic segments were analyzed. The percentage 
of stenosis ranged from 9.2-92.S% (34.1 ± 16.9). PA ranged from 
2 to 19.6 mm2 (6 3+36) 
I II III 
VA (mm2) 20.4±7.3 IS.7+7.3* 16.S+6.3# 
LA (mm2) 15.3±6.S 
PA (mm2) 6.3+3.6 
*p-=O.OlS, #p<@1 
V A increased in relation to PA (r==O.4I, p < 0.00 I). The difference 
between V A (I) and V A(ln correlated directly with the percentage 
of stenosis (r==0.49, p < 0.05) when the percentage of stenosis was 
less than 40%; however, closer correlation was obtained when the 
percentage of stenosis was less than 30% (r=O.66, p<0.005). 
Conclusion: Human coronary arteries enlarge in the presence of 
atherosclerosis. V A increases in relation to the percentage of 
stenosis until the stenosis exceeds 40%. Coronary arterial 
remodeling, previously observed by pathological study, can be 
evaluated by lVUS in vivo. 
957-56 
Doppler Guldewlre Flow Velocity Indica Measured Distal to Coronary 
8t_; RelatloMhlp to Quantitative Angiography Ind Thallium 
Sclntlgrephy. 
Yurl A. Deychak, Alan G. Wasserman, Jonalhan S. Reiner, Steve C. 
Rohrbeck, M8I1< A. Thompson, Conor F. Lundergan. Allan M. Ross, 
Jerome SegaL 
George Washington University Medical Center, Washington, DC 
New techniques to measure distal corona/y flow were used to 
characterize the physiology underlying thallium pertusion deficits. A 
Doppler guidewire was used to measure phasic coronary blood flow 
velocity distal to stenoses in 18 symptomatic patients with recent exercise 
or adenosine thallium scintlgrams. Quantitative angiography was used 
to determine % diameter stenosis (%OS) and minimal cross sectional 
area (MesA). Distal average peak velocity (APV) and diastolic to systolic 
velocity ratio (DSVR) were obtained in 17 vessels with angiographic 
stenoses 0/ intermediate severity (%OS from 55% to 85%) and a 
corresponding reversible thallium defect and in 11 control vessels with no 
stenosis or thallium defect. Coronary flow velocity r8S81Ve (CFR) was 
obtained using intracoronary adenosine as a hyperemic stimulus. 
Thallium normal (11) Ibnonn .. (17) (mean.SD) 
APV (ern/sec) 2"* 11 22t 11 (p=0.29) 
DSVR 1.93..58 1.540.61 (p=O.OS) 
CFR 2.30.4 1.30.4 (p< 0.01) 
%OS 66t8 
MCSA(1l1Iif) 0.530.26 
Distal CFR and DSVR were significantly different in vessels with stenoses 
and reversible thallium defects when compared to control vessels with no 
thallium defects. Using a normal CFR 0/ ~1.8 and DSVR ~1.7, 
concordance with thallium scintigraphy was 89'l(, for distal CFR and 71 % 
for distal DSVR. No vessel with a CFR 0/ < 1.7 had a normal thallium 
SCintigram. 10Q'l(, 0/ lesions with a reversible thallium defect had a MCSA 
0/ ~l.Omni, despite a mean %OS 0/ only 66%. 
Conclualon: Distal Doppler guidewire derived DSVR and CFR alone, or 
in combination w~h quant~ative angiography, are useful in predicting 




Medical and Surgical Therapy (or Left Main Coronary 
Artery Disease: Long Term CASS Experience 
Eugene A. Caracciolo, George C. Kaiser, Hartzell Schaff, Herman 
A. Taylor, George Sopko, Kathryn Davis, Bernard R. Chaitman, for 
the CASS Investigators, SL Louis, Missouri 
The 13 yr cwnulative survival of 1675 pts with left main (LM) 
coronary disease> 50% enrolled in the CASS registry was 32% for 
361 pts treated with medical therapy (MT) and 52% for 1314 pts who 
had coronary artery bypass grafting (CABG) (p<O.OOI). After 6.6 
yrs in the MT and 13.3 yrs in the CABG group, 50% of the 
respective popUlations were dead. Therapy (MT vs CABG),left 
ventricular score, congestive heart failure score, age, hypertension, 
and diabetes mellitus were selected from 14 baseline variables as 
independent predictors of survival by Cox regression analyses 
(p<O.OO 1). Separate analysis of the CABG group selected left 
ventricular score, congestive heart failure score, age, smoking, 
hypertension, and diabetes as independent predictors of outcome. 
CABG improved survival compared to MT in most pts with LM 
coronary disease stratified by left ventricular score, age, degree of 
LM stenoses and right coronary artery disease (RCA). However, no 
long-term survival benefit was present in 522 pts with a normal left 
ventricular score; the 13 yr survival rates were 57% and 61 % for MT 
and CABG, respectively (p=O.20). In 362 pts with a normal left 
ventricular score and concurrent RCA disease> 50%, there was no 
long-term survival benefit for MT vs CABG (p=O.42). In 243 pts 
with RCA disease < 50%, the median survival was 14.9 yrs in the 
MT group and 15.6 yrs in the CABG group. 
In conclusion, CABG improves survival in most pts with LM 
coronary disease. However, the atherosclerotic risk factors smoking, 
hypertension, and diabetes significantly reduce survival in the 
surgical group. Pts with LM coronary disease and norma1left 
ventricular function had similar long term survival regardless of the 
therapy received. Median survival for the surgical group was 16.2 
years; in the medical group, >50% of the pts are still alive at 15.S yrs. 
957-58 
Functional Assessment of Collateral Circulation In 
Patients During PTCA of Total Occlusions 
Helmut SchOhlen, Hanjorg Just, Andreas M. Zeiher 
Medizinische Klinik III, University of Freiburg, Germany 
In the presence of coronary collaterals, the pressure measured 
distally of an ocduding PTCA ballon (coronary wedge pressure) is 
dependent on the extent of collateral flow. We simultaneously 
assessed coronary wedge pressure and proximal aortic pressure 
in 12 patients undergoing PTCA of single vessel, chronic total 
occlusion (10 LAD, 2 RCA). Baseline measurements were taken 
60· after PTCA ballon inflation. After 90· of sympathetic 
stim.ulation (cold pressor test) the pressure gradient (between 
aortic and coronary wedge pressure) increased significantly 
compared to baseline measurements (50±15 ~ 70±19 mmHg; 
p<O.OOl), mainly due to a higher aortic pressure (97±19 ~ 
119±28 mmHg; p<O.OOl) whereas coronary wedge pressure was 
basically unchanged (49±14 ~ 50±20 mmHg; p=ns); moreover, 
coronary wedge pressure decreased in 3 patients by > 10%. This 
effect of sympathetic stimulation was blunted after selective a•
adrenergic blockade (2.5 mg phentolamine intracoronary) with a 
parallel increase of aortic and coronary wedge pressure, resulting 
In a basically unchanged pressure gradient (50±15 ~ 49±13 
mm~~; p=ns). Intracoronary nitroglycerin (0.25 mg) led to a 
Significant decrease of aortic pressure (97± 19 ~ 90±22 mmHg; 
p<0.01) but a small increase of coronary wedge pressure (49±14 
~ 51±14 mmHg; p=ns). This resulted in a significantly lower' 
pressure gradient (50±15~40±18mmHg; p<O.OOl). 
Conclusions: (1) Measurements of distal coronary wedge 
pressure and the gradient to aortic pressure enable a functional 
assessment of the collateral circulation. (2) Our results indicate 
that collateral function can be improved by nitrates, but it 
deteriorates during sympathetic stimulation. (3) This deterioration 
can be blocked by phentolamine, suggesting a-adrenergic control 




Death Following PTCA: Relationship Between Etiology 
and Baseline Characteristics: The NHLBI PTCA Registry 
David R. Holmes, Sheryl F. Kelsey, Michael B. Mock, Mayo Clinic, 
Rochester, MN 
There is limited infonnation on incidence, timing, associated factors 
and mode of death (0) in pIS who have previously undergone PfCA. 
In the 1985-86 NHLBI PfCA Registry there is 5 yr follow-up of 
2136 pIS with well characterized baseline coronary anatomy and LV 
function. PIs with infarct (MI) in 10 days prior to baseline PfCA 
were excluded. Mortal status was available for all pts and 0 details 
obtained from 0 certificates, autopsy or hospital records and family 
interviews. ~uring follow-up there were 209 D's (9.8%), 27% 
occwred in the first yr. Of 0, 53% were noncardiac, 17% sudden 
death (SO), 13% MI,9% were periprocedural and 8% were from 
CHF. Noncardiac 0 occwred later after initial PfCA than cardiac 0 
and in older pIS. The relationship between etiology of 0 and pt 
characteristics was: 
Ca'use or Death (%l 
Patient N 
characteristics Deaths 
1 vessel disease (VO) 71 

























Stable angina 87 6.9 12.6 14.9 55.2 10.0 
Unstable angina 110 17.3 5.5 20.0 50.0 7.3 
EruO% 106 11.3 6.6 12.3 61.3 8.5 
EF<SO% 41 12.2 14.6 24.4 41.5 7.3 
Conclusion: 1) For more than half of pts, 0 was noncardiac, 2) In pts 
with 1 VD, 0 was more apt to be noncardiac than cardiac, 3) In pIS 
with stable angina 0 was more apt to be from CHF vs unstable angina 
when 0 was more from MI (p=.07), 4) In pIS with decreased LV 
function, 0 is more apt to be cardiac related than noncardiac (p=.03). 
957-60 
Ie AngIna R .. 1Iy the Gold Standard to Tut InterventJona In 
lache.,.? 
Willem J. Remme. Dick Kruijssan, Hanno Krauss, Louis Bartels. 
Sticarw Foundation, Rotterdam, The NeIheIIands. 
For decades. the cIegrae of and time to angina during stress tasting 
have be«t used aa primary objectives to study inl8IVentions in ische•
mia, often in an uncontrolled fashion. As objectivity obviously is lacking 
and its reproducibility largely unknown. the latter was _Iuated in 68 
untreated pIS with > 70% left CAD during 2 identical. plac:ebcKontrolled 
abial pacing stress teals (Tl and 12. increments of 10 beIItsI2 min) with 
different intervall. SIucIies __ c:arried out in the morning, with the 
patient fasting and supine for 1-2 hours. Angina was scorad using a 
modifted Borg scale. Objective indices of pacing-induced ischemia in•
cluded 2:0.1 mV ST-depression from baseline and/or myocardial IadaIe 
production. Patients __ randomized in 5 groups depending on pacing 
int81V81 [15 (n,.,14). 30 (n=15). 45 (n=l2). 60 (n=14) and 70 (n=l3) 
min. reap.l. All groups __ comparable aa to demographic, clinical and 
angiographic data. Also. left ventricular systolic pressur8I and rate-pr88-
sure product at baseline __ comparable. wh..a they __ similar 
during T1 and T2 in each group. Average and individual values of objec> 
live indices of ischemia __ comparable and reproducible batMen T1 
and T2 with pacing inl8lVaIs of 2:45 min. but __ significantly less dur•
ing T2 with shorter intervals. indicating less ischemia. Although the latter 
was accompanied by angina in 64% and 47% (15 and 30 min. reap.), 
angina was also absent or significantly less in 50% (45 min). 50% (60 
min) and 62% (70 min) of pIS during T2. wheraas time to angina invaria•
bly was longer as compared to T1. Thus. compared with accepted 0b•
jective maIIIers of ischemia. angina is not reproducible during repetitive 
episodes of (pacing-induced) ischemia. even when long recovery per•
iods are allowed. A mar1<ed placebo-effect prohibits its usefulness to de•
fine the efficacy of interventions in ischemia. 
957·61 
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Impairment of Left Ventricular Function During Episodes of Silent 
and Symptomatic Myocardial Ischemia as Determined by Continuous 
Monitoring Using a Miniature - Scintillation Probe 
A.Hartmann, F.D.Maul. M.Zimny, G.Hor. M.Kaltenbach. Depts. of 
Cardiology and Nuclear Medicine, J.W.Goethe·University Medical 
Center, Frankfurt/Main, Germany 
Transluminal coronary angioplasty (PTCAI causes 
transient occlusion of the coronary artery and temporary ischemia of 
the left ventricle. Left ventricular dysfunction during silent and 
symptomatic episodes of myocardial ischemia during PTCA was 
evaluated continuously with a newly developed miniature, non' 
imaging scintillation probe. Parameters of left ventricular function 
were compared before and during balloon inflations of 60 sec. 
duration: ejection fraction (EFI. indices of end· systolic and end•
diastolic volumes (ESV,EDVI. peak ejection and peak filling rates 
(PER, PFRI. 13 patients (age S4±7.4 yearsl were symptomatic. 10 
patients (age 61 ± 8 years I were asymptomatic. 
Sl£mll!Qmgti~ Ililtien!s: 
before 49 35 68 2.7 
TCA ±14 ±lS ±17 ±0.8 
during 37" 47·· 73' 2.06" 
TCA ±9 ±17 ±17 ±0.S4 
aSl£ml!tQmali~ I!;!li!lnl~: 
before 52 27 52 2.9 
TCA ±17 ±20 ±27 ±0.8 
during 37" 35" 56' 2.16" 
TCA ±10 ±20 ±26 ±0.6 









Conciusion: Symptomatic and asymptomatic episodes of myocardial 
ischemia during PTCA cause similar impairment of systolic and 
diastolic left ventricular function. The degree of left ventricular 
dysfunction during PTCA cannot be assumed from clinical 
symptoms. 
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958-79 
Reaprasial of the Bfficacy of Adenosine for 
Termination of Bctopic Atrial Tachycardia. 
Hossein Shenasa, Ronald J Kanter, Hark E Hamer, Robert 
A Sorrentino, William E Sanders, Ruth A Greenfield, 
Richard L Page, J Marcus Wharton. Duke University 
Medical Center, Durham, North Carolina. 
It is generally thought that ectopiC atrial 
tachycardias (EAT) typically do not terminate with 
adenosine, though reported experience is limited. We 
reviewed the electrophYBioloqic .. tudies of patients 
(ptS) undergoing evaluation of supraventricular 
tachycardia (SVT) in the past two years and identified 
26 pt. who received 6-12 mg of intravenous adenosine 
after careful evaluation of the mechanism of their 
SVT and atrial mapping during diagnostic 
electrophysiological testing. Eight pta had structural 
heart disease (SHD) including one pt. with coronary 
artery disease. Sixteen pts had EAT (6 pts with SHD). 
and 11 had AV or AV nodal reciprocating tachycardia 
(RT). With adenosine administration, 13 of 16 cases of 
EAT (81\), and all 11 cases of RT (100\) converted to 
sinus rhythm within 5-25 seconds. Eight (89\) of the 
9 cases of EAT initially given a 6 mg dose of 
adenosine terminated. At any dose of adenosine high 
degree AV nodal block prior to termination occurred in 
only one pt. In pts with EAT, non-responders to 
adenosine were younger (21+9 VB 56+21 years, peO.021 
and all had SHD (100\ vs 23\, p<0.04I, when compared 
with pta responding to adenosine. 
We conclude that contrary to the reported 
experience of adenosine with EAT' 5, adenosine 
terminates these tachycardias in most cases, 
especially in older individuals without identifiable 
heart disease. Whether the presence of structural 
heart disease or age influence the mechanism of EAT 
and its response to adenosine remains uncertain. 
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February 1993:457 A 
958·80 
Intravanou. Adano.ine Revaale Intermittent 
Preezcitation by Direct .nd Indiract Iffect. 
on Acce •• ory Patbway Conduction. 
Nicholas J Morgan-Hughes, Michael J Griffith, Janet M 
McComb. Freeman Hospital, Newcastle upon Tyne, UK. 
Earlier studies have shown that adenosine induced 
AV nodal block can unmask 'latent' preexcitation in 
patients (pts) with accessory pathways. We examined 
responses to intravenous adenos ina in 6 pts with 
intermittent preexcitation but absent preexcitation at 
the time of study. Increasing doses of adenosine were 
injected until AV block or preexcitation occurred. 
Doses of up to 280 ~g/kg were given. 
No patient developed preexcitation due to delayed 
AV nodal conduction: however, in 3 pts prexcitation 
was seen early, coincident with the onset of AV nodal 
block. In these 3 pta. the P delta intervals seen with 
preexcited beats were less than the PR intervals seen 
in the resting state and the PP intervals proceeding 
preexcited beats were less than or equal to the PP 
intervals seen in the resting state. These findings 
suggest a direct effect of adenosine on accessory 
pathway conduction. In 4 pts preexcitation was seen 
during the secondary sinus tachycardia following AV 
block indicating enhanced accessory pathway conduction 
due to sympathetic activation. Intravenous propranolol 
(10 mg) was given to 1 patient who demonstrated both 
effects: S-adrenergic blockade failed to prevent early 
preexcitation but abolished late preexcitation related 
to sinus tachycardia. 
These data suggest that adenosine has two effects 
in pts with intermittent preexcitation: an immediate 
direct effect on accessory pathway conduction and a 
secondary indirect effect due to sympathetic 
activation. 
958·81 
Dose·Dependence of Adenosine's Suppressant Actions on 
Anterograde and Retrograde Conduction in Patients With A V 
Nodal Reentrant Tachycardia 
David Radzik, Mario Talajic, Denis Roy, Robert Lemery, John 
T.Y. Hii, Bernard Thibault, Richard Cartier, Stanley Nane!. Montreal 
Heart Institute, Montreal, Quebec, Canada 
Prior studies reporting that retrograde conduction in pts with 
atrioventricular nodal reentrant tachycardia (A VNRT) is not blocked 
by adenosine (AD) have been interpreted as indicating that this limb 
might be extranodal and therefore lack typical nodal physiology. To 
test the hypothesis that the lack of response of retrograde conduction 
to AD is a relative phenomenon, we studied the dose-dependent effects 
of AD in pts with AVNRT, end points being complete transient 
atrioventricular (A V) or ventriculoatrial (VA) block. Incremental doses 
(3,6,12,18,24 mg) of, AD were administered by bolus injection into 
the left subclavian vein during right ventricular (RV) pacing at a cycle 
length (CL) 30 rnsec longer' than the CL causing Wenckebach block 
(WBCL +30) in 17 consecutive pts with proven AVNRT. The same 
AD injection protocol was used in 10 pts during induced SVT and 
during RV pacing at the SVT CL, as well as in 7 controls during atrial 
and RV pacing at WBCL +30. AD caused transient VA block in the 
retrograde (fast) pathway at WBCL +30 in 16/17 pts with an AD EC,O 
of 5.5 mg. During SVT, block always occurred in the anterograde 
limb (slow pathway), with an EC,O of 1.8 mg of AD, vs 6.5 mg for 
VA block during RV pacing at the same CL (fast pathway), p=O.OI. 
In controls, anterograde and retrograde block occurred with an EC,O 
of 3.0 and 3.S mg respectively (NS). Conclusions: 1) The fast 
(retrograde) pathway shows a typical AV nodal response to AD; 2) 
both pathways in pIS with A VNRT appear to respond to AD differently 
from normal AV nodes, with the fast pathway showing reduced, and 
the slow pathway enhanced, sensitivity. Enhanced slow pathway 
sensitivity to AD may contribute to the drug's ability to terminate 
A VRT by causing antegrade block. 
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958·82 
Adlnolln .. Dlpendlnt ACCHaory Pethwllr COfI!IuctIon Following 
Succnaful Rldlofrequlncr Clu.t. AbIItIon: A Nlw 
Electrophyllologlc ActIon? 
Yaver BashIr, Spencer C Heald, Angela J Bygrave, Piotr KulakOYlSkI. 
A John Camm, David E Ward. St George's Hospital, London. UK. 
Adenollne Is Increasingly used to assess the 8UCCIII 01 radlofrequency (RF) 
catheter ablation of accessory pathways (APs), based on Its property 01 
Inhlbttlng AV nodal conduction with little direct effect on AP conduction apan 
from slight shonenlng of refractoriness. We deecrlbl a new phenomenom 01 
adenosine-Induced pre-excitatlon due to a direct action 01 adenosine on AP 
conduction following RF ablation. 81 pta with WPW syndrome and stable 
pre-excitatlon und8lWel1t successful RF ablation: there was no evidence of 
antegrade or retrograde AP conduction at follow-up EPS (2-8 weeks post. 
procedure). All pts received IV adenosine (O.I.().3mg/kg) during sinus 
rhythm. In 76/81 pts adenosine Induced transient AV block with no pre•
excitation. In 2/81 pts adenosine failed to Induce AV block or pre-excltatlon. 
In the remaining 3/81 pts, adenosine reproducibly Induced transient AV 
block ~ by pre-excitatlon. Pre-excitatlon persisted for > 60s In all 3 pts 
and > 180s In 2 pts. Adenosine-Induced pre-excltatlon was stUI demonstrable 
during atrial pacing at cycle lengths up to 400ma both before and aiter IV 
propranolol O.2mg/kg. However. In 2/3 pts with VA block, adenosine failed 
to restore 1: 1 VA conduction. None of these 3 pts exhibited any pre· 
excitation during ambulatory ECG monitoring or at follow·up visits (2-6 
months). 
Conclusions: (1) Adenoslne-dependent antegrade AP conduction may be 
observed In a few pts following apparantly successful RF ablation; (2) The 
phenomenon Involves a direct action on AP conduction and does .!!21 
represent latent pre-excitation; (3) The slow onset and delayed offset of the 
AP effect are strikingly different to the normal time-course of 
electrophysiologlc actions following IV adenosine; (4) Although the 
underlying mechanism Is unclear. It does not seem to depend on sinus 
bradycardia, reflex sympathetic stimulation or shonenlng of AP 
refractoriness. These observations suggest that the e1ectrophyslologlc 
actions of adenosine on accessory AV pethways may be more complex then 
previously thought. 
958·83 
U.. of Adenolloe to AlIna Immediltl Ind Long·term Succna 
Following Rldlofrequlncr Cltheter Ablltlon of Accnaory PlthWlYS 
Kirk W. Walker, Blair D. Halperin, Michael J. Silka, Jack Kron. Ronald 
p, Oliver, Charles G. Walance, John H. McAnulty. Oregon Health 
Sciences University, Portland, Oregon 
Accessory pathway (AP) conduction recurs In 5-10% of patients 
(PTS) following 'successful" radiofrequency catheter ablation (RFCA). 
We prospectively evaluated the use of adenosine (ADO) 12·18 mg 
before and alter RFCA to determine its utility for predicting immediate 
and long·term successful outcome. Forty two PTS were classified as 
having manifest preexcitatlon (7B%), Intermittent preexcitatlon (5%), 
or concealed AP conduction (17%) as determined by baseline 12 
lead electrocardiography, Prior to RFCA, ADO resulted in manifest 
preexcitation in 2/2 PTS with intermittent preexcitatlon, 1/7 PTS with 
a concealed pathway, and rJid not block AP conduction in any PT. 
All PTS had AP conduction eliminated by RFCA. ADO was given 
when all evidence of AP conduction remained absent for at least 30 
minutes. Follow·up was 20-74 weeks. 
ADO induced complete atrioventricular (AV) and ventriculoatrial rJA) 
block in 39 PTS; 1 PT had recurrence of preexcitatlon. Persistent AP 
conduction was revealed in 3 PTS; 2 of these PTS subsequently 
exhibited ADO induced AV and VA block alter further radiofrequency 
deliveries. Only 1/41 (2.5%) PTS with ADO induced AV and VA block 
at the end of the procedure had late recurrence of AP conduction. 
The 1 PT who revealed persistent AP conduction only with ADO 
demonstrated preexcitatlon on surface ECG 1 month alter RFCA. 
Conclusion: Use of ADO alter presumed 'successful" RFCA may 
reveal perSistent AP conduction which necessitates further radio•
frequency deliveries. Persistent evidence of AP conduction with ADO 
alter RFCA may idllntify those at risk for clinical rhythm recurrence. 
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959·84 
Vagal .ediated aeflexe. in the EValuation of 
SJDcope 
Sheldon L. Brownstein, Joyce Morris, Rueben 
Hernandez,Ron Oberhaus st. Vincent Medical 
Center, Toledo, Ohio 
Carotid massage (CM) and the tilt table 
(TT)are diagnostic tools for evaluating 
patients with syncope(S) and imply a vagal 
mediated reflex mechanism explain many (S) 
spells. Th.e purpose of our study was to 
determine whether carotid sinus 
hypersensitivity (CSH) predicts a positive (+) 
TT. We prospectively evaluated 101 patients 
(PTS) (age 10 - 88) for S. All PTS had CM to 
each carotid sinus. Positive responses were 
defined as:Vasodepressor (VD)=Fall of 30 mmHg 
systolic or 10 mmHg diastolic blood pressure, 
cardioinhibitory (CI»3 sec of asystole. After 
5 min a TT was done consisting of 10 min of 
t~lt at 800 an~ if negative (-) repeating 
w~th 2-4 mcg/m~n of Isuprel for 10 min.TT+ 
was defined as symptomatic hypotension and/or 
bradycardia. Group 1 (G-1) consisted of 27 PTS 
with CSH which accounted for 35% of the study 
population;22 (80%) of G-1 went on to be TT+. 
G-2 consisted of 51 PTS who were CSH(-) but 
TT+. * In comparing G-1 to G-2 : G-1 PTS were 
62±3 years of age (±SEM) vs 42±3 in G-2 
(*p<O. 0001). Coronary disease was more 
prevelent in G-l and mitral valve prolapse in 
G-2. Conclusions: 1. The prevalence of CSH in a 
patient population presenting with S is higher 
then previously reported. 2. PTS with CSH tend 
to be TT+ and TT is an important adjunct 
to the diagnosis of CSH. 
959·85 
Mechanisms of Syncope Induced by Head-up Tilt: 
Differences between two Groups of Vasovagal Syncope 
Koichi Mizumaki, Akira Fujiki, Masanao Tani, Mayumi Shimono, 
Toyama Medical & Pharmaceutical University, Toyama, Japan. 
To elucidate differences in mechanisms of vasovagal syncope 
(WS) between patients (pts) with WS induced by head-up tilt 
(Tilt) alone (T) and pts with WS by addition of isoproterenol 
(IP) to Tilt (1+ T), we evaluated changes in left ventricular (LV) 
end diastolic dimension (EDD), end systolic dimension (ESD) 
and fractional shortening (FS)(%) by echocardiography during 
Tilt (60·,10 minutes). Six T pts, 8 I+T pts and 14 control (C) 
without syncope were studied. The % change (%~) in EDD, 
ESD at 1 minutes before the end of Tilt compared to baseline 
and FS at 1 minutes before the end of Tilt are displayed below. 
(mean t SD) 
Tilt Tilt+IP 
%~DD %~SD FS %~EDD %~ESD FS 
T -33±5 -29±10 32±4 
I+T -17±10* - 8±5** 32±5 
C -14+8** -14+7** 33+7 
(* P<.Ol, ** P<.005 vs. T) 
During control Tilt, EDD and ESD decreased greater in T than 
in 1+ T and C. However, there is no significant difference in FS 
among 3 groups. During Tilt with IP, EDD and ESD decreased 
and FS increased greater than during control Tilt in both 
groups. There is no significant difference in %~EDD, %~ESD 
and FS between 1+ T and C. Conclusions: In T pts, an 
exaggerated decrease in LV volume is a primary cause of WS. 
Whereas in 1+ T pts, an increase in LV contractility in addition 
to a decrease in LV volume causes VVS, because LV 
mechanoreceptors may be more sensitive to these stimulations 
than those in C pts. 
959·86 
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Catecholamine Response In Patients Undergoing Tilt 
Table Test 
Arun Gadhoke, Simon Ho, Andrew Macaulay, Jose Zebede 
Ann Marie Conway, Arthur Comegno, N.A.Mark Estes m,' 
Paul 1. Wang, Mark Linzer. 
New England Medical Center, Boston, MA 
Neurally mediated syncope (SYN) has been hypothesized 
to be due. to exaggerated sympathetic output followed by 
abrupt WIthdraWal. To test this hypothesis we examined 
Epinephrine (EPI) and Norepinephrine (NE) levels in 16 
Patients (PTS) (10 Male, 6 Female, Age=48.2±19.3 years) 
during Head Up Tilt table testing (HUT). Ten PTS had a 
positive (POS) HUT without isoproterenol (ISO) and 6 PTS 
had a negative (NEG) test (3 with ISO). Baseline values 
were compared in the two groups (NE=421 ± 267 pcg/mi 
(POS) and 380 ± 299 pcg/mi (NEG), p = NS ; and 
EPI= 45 ± 21 pcg/mi (POS) and 58 ± 16 pcg/ml (NEG), 
p=NS ). Levels were drawn at 5 minute intervals. When 
comparing NE and EPI levels drawn before syncope to 
those drawn at or shonly after syncope, NE levels fell in 8 
of 10 PTS and EPI increased in 8 of 8 (2 were not 
measured). 
NE AND EPI LEVEl,S IN PIS WITH POS HUT 
BASELINE BEFORE SYN AFTER SYN 
(peg/mI) (pcg/mI) (pcg/ml) 
NE 421± 267 823± 418 621±320 
p=O.OO9 p= 0.02 
EPI 45± 21 52± 40 329±257 
p=O.22 p=O.02 
We conclude 1) NE levels show an initial rise with HUT 
and show an abrupt drop with SYN reflecting a withdrawal 
of sympathetic tone; and 2) EPI levels rise immediately after 
SYN suggesting an increased adrenal output .These data 
support the Bezold Jarisch reflex as the mechanism of 
neurally mediated SYN . 
959·87 
Reproducibility at a seven Day Interval 01 a Positive 
Passive Upright Tilt Test in Patients With Syncope. 
Jacques Mansourati, Benoit Maheu, Driss Boughaleb. LoiC Genet. Jean· 
Jacques Blanc. University hospital, Brest. France. 
P~ve ~t testing is now widely performed in pts with syncope. The 
alt~ of thIS study was to assess its reproducibility over seven days. 
ThIrteen. syncopal or presyncopal pts with a positive 60° footplate 
support tilt for up to 60 min were prospectively included in the study 
group. In all, a second tilt test was performed with the same protocol 
exactly a week later (same day, same hour). During the ftrst test the 
time between tilt and onset of symptoms (syncope or presyncope) was 
25 ± 11 min and in all the pts blood pressure was less than 88 mm of 
Hg associated in 5 cases with severe bradycardia (4 junctional rhythm) 
or asystole (1 case). A severe bradycardia was registered in 5 out of the 
6 pts (83 %) with syncope, but not in the 7 with presyncope (p < 0.02). 
The second tilt test was posi~ve in 8 pts (61.5 %). in 7 it ended in 
pres~cope (6 with presynco~ and 1 syncope during the ftrst test) and 
In 1 In syncope (syncope durmg the ftrst test). The likelihood of an 
initial test ending in presyncope, syncope. hypotension and 
hypotension with severe bradycardia being associated with a second test 
ending in the same events is respectively 86 %. 17 % (p = 0.05 when 
compared to 86 %), 75 % and 40 % (NS when compared to 75 %). In 
the 8 patients who were symptomatic in both tests. symptoms occured 
at a mean of 26 ± 16 min during the first test and 40 ± 13 min during 
the second (p < 0.03). 
It is concluded that passive tilt testing has a limited overall 
!'Cproducibility over the period of a week and is therefore probably 
InSufficient in assessing at an individual level the effect of treatment 
How~ver as !he reprodu~ibility is muc~ higher in pts with presyncope 
than In pts WIth syncope 11 may be poSSIble to evaluate treatment in this 
particular subgroup. 
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960·1 
Asymptomatic: Ventricular Arrhythmias Do Not Identify 
Patients with Severe Heart Failure at Risk for Sudden 
Death: Results of the PROMISE Trial. 
Barry M. Massie, Gary S. Francis, P. K. Tandon, Susan Anderson, 
Oavid OeMets, Milton Packer on behalf of the PROMISE 
Investigator!!. University of California, VA Medical Center, San 
Francisco, CA and Columbia University P & S, New York, NY. 
Previous studies have reached conflicting conclusions regarding 
the importance of ventricular arrhythmias (V A) in predicting sudden 
death (SO) in pts with heart failure (CHF), but these studies had few 
events and failed to classify these events blindly. To clarify this issue, 
we evaluated the predictive value of ventricular arrhythmias in 1080 
CHF pts in the PROMISE Trial who had Holter recordings before 
randomization (to placebo or milrinone). At the start of the study, 
60% of pts had frequent premature ventricular beats (PVBs > 301br), 
62% had non·sustained ventricular tachycardia (NSVT), and 10% had 
VT runs ~ 10 beats in length. Ouring follow·up (1-20 months), there 
were 139 SO and 290 cardiovascular deaths (CVO). All deaths were 
classified by a Mortality Committee without knowledge of Holter data 
By Cox proportional hazard analysis, both NSVT and VT ~ 10 
beats on the pretreatment Holter recording predicted the subsequent 
occurrence of CVO (P < 0.004 and P < 0.05), but neither arrhythmia 
predicted SO. Frequent VPBs failed to predict either CVO or SO. In 
contrast, several non-Holter variables were powerful predictors of 
both CVD and SO. Specifically, both CVD and SO were predicted by 
pretreatment values for LV ejection fraction (P < 0.<XXl1 for both CVO 
and SO), by the pretreatment NYHA class (P < 0.<XXl1 for CVO and 
P < 0.04 for SO), by presence of coronary artery disease (P < 0.003 
for CVO and P < 0.05 for SO) and by whether patients received 
milrinone or placebo (P < 0.07 for CVO and P < 0.001 for SO). 
These fmdings indicate that ventricular arrhythmias (regardless of 
frequency or complexity) do not predict SO in severe CHF. Thus, the 
fmding of asymptomatic NSVT on Holter (even VT ~ 10 beats) does 
not identify specific candidates for antiarrhythmic therapy. Clinical 
variables, not ventricular arrhythmias, are the best predictors of SO. 
960·2 
Noninvasive, Heart Rate Variability-Based Index Predicts 
Inducibility of Sustained Monomorphic Ventricular 
Tachycardia by Programmed Electrical Stimulation 
Tomas Vybiral, Caroline Knight, Kenneth Hess, Antonio 
PaCifico, Baylor College of Medicine, Houston, Texas 
Background: Sustained monomorphic ventricular tachy•
cardia (VT) induced during programmed electrical stimu•
lation (PES) identifies cardiac patients at high risk of 
sudden death. Since susceptibility to VT induction may 
vary dependent upon autonomic nervous system activity, 
we postulated that analysis of heart rate variability 
(HRV) may contribute to the noninvasive identification 
of high risk patients. 
Methods : Fi fty-three consecuti ve pati ents referred for 
evaluation of symptomatic VT underwent computerized 
analysis of short-term HRV prior to PES. The following 
five parameters of HRV·were calculated from a ten 
minute rhythm recording, obtained in the supine position 
at bedside: mean R-R interval and standard deviation, 
0.05-0.15 Hertz (l), 0.15-0.35 Hertz (H) spectral band 
power and the l/H power ratio. All patients underwent 
PES within 24 hours of HRV analysis. None were taking 
antiarrhythmic medications. 
Results: The diagnosis of coronary artery disease, age 
and left ventricular ejection fraction were univariate 
predictors of VT inducibility, but their individual and 
combined predictive accuracy was only 90 %. However, by 
including them with the five HRV parameters into a multi•
variate regression model complete separation of inducible 
(n=30) from non-inducible subjects was achieved. 
Conclusion : A multivariate HRV-based risk index was 
developed resulting in the noninvasive identification of 
presumably high-risk cardiac patients, who also are 
inducible for VT during PES. If confirmed, this analySis 
may significantly contribute to risk stratification. 
ABSTRACTS 
960·3 
Recovery Patterns Obtained From Continuous ST Segment Monitoring 
During Thrombolysis for Acute Myocardial Infarction are Good 
Predictors for Coronary Recanalization. 
Olivier Decoster, Jean Boland, Bnmo Pirenne, Paul Cheron, Jean Renkin, 
Jacques Col. University of Louvain Medical Sdlool, Brussels, Belgium. 
Significant ST segment elevation is highly predictive of total ooronary 
oo:iusion in the first hours of aarte myocardial infarction (AMI). To test 
its predictive value for myocardial reperfusion oontinuous ST monitoring 
was perfonned during 48 hours in 128 consecutive patients (pts) admitted 
for AMI of recent onset (S6 hours), with ST>-2 mm in ~ ECG leads and 
treated with 1.5 MU N streptadnase (SK). ST measurement at J+50 msec 
fran the ECG lead showing the highest elevation on admission was 
averaged from all nonna1 beats every 20 sec and its trend was 
cmtinuously reoorded (SirEcust, Siemens). Out of the 128 pts, 122 ST•
trends (959&) were available and read by 2 observers blinded from 
coronary angiography (ANGlO) perfonned within 24 hours. In 105 pts 
(869&), the ST reoovery pha,se was clearly identified, deaeasing from 
4.4z.3.1 to 1.2;tl.6mm within 7S±41 min (Pattern 1). Coronary patency at 
ANGlO (Timi grade 2 and 3) was 969&. In 9 pts (79&) a prolonged and/or 
unstable ST reoovery phase was observed (Pattern 2) but ooronary patency 
was oonfirmed at ANGlO in each case. In the remaining 8 pts (79&) the 
absence of ST reoovery within 5 hours of treatment (Pattern 3) predicted 
coronary artery oo:iusion at ANGlO. Sensitivity for Patterns 1+2 in 
predicting subsequent coronary patency was 969&, specificity 679& and the 
positive predictive value 969&. A negative predictive value of 1009& 
cmducted to aa:elerated catheterization (presence of Pattern 3). In 
cmdusion, reoovery patterns of ST segment using continuous ST 
monitoring during thrombolysis allowed the correct identification of 
myocardial reperfusion in 969& of pts with AMI and selected candidates 
for early medlanical recanalization. 
960·4 
Heart Rate Variability in Mild to Moderate Heart Failure: Relation 
between Time Domain and Frequency Domain Parameters 
Jan Brouwer, Dirk 1. van Veldhuisen, Arie J. Man in 't Veld, Jaap 
Haaksma, Kong 1. Lie, for the DIMT Study Group, University Hospi· 
tal, Groningen, The Netherlands. 
In the analysis of heart rate variability (HRV) time and frequency 
domain parameters are used. To 'study the relation between these 
parameters in patients with mild to moderate congestive heart failure 
(CHF) we analyzed 24 Hour Holter registrations of 69 patients (mean 
age IS(} ± 8 years, ejection fraction 29±9~) .. Backgro~nd ther3I!y 
consisted of furosemide 0-80 mg. HRV analysIS meluded time domalD 
parameters mean RR interval, SDNN, SDANN, SO, pNN50 and 
rMSSD. Spectral analysis was performed using a fast Fourier transfor•
mation algorithm, resulting in low frequency (LF, O.~.I~ Hz) and 
high frequency components (HF, 0.15 - 0.40 HI). LogarIthmIc transfor•
mation was applied to rMSSO, pNN50, and to the power of LF and 
HF. Also normalized values of LF and HF were calculated. 
Linear regression showed strong correlations (p < 0.00(1) between LF 
and SO (r '" 0.93) and between HF and resp. rMSSO and pNN50 
(resp. r '" 0.92 and r == 0.81). LF/HF ratio and the n?rmaliz~ ~alues 
of LF and HF showed significant but weaker correlations. W.thm the 
time domain parameters SONN showed strong correlations to SOANN 
(r==0.98), rMSSD was related to pNN50 (r"'0.7S). 
LnLowF _ LnH· hF __ 
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Conclusion: Strong correlations between time and frequency domain 
parameters exsist in patients with CHF as in patients after acute myocar· 
dial infarction. The broader presence of these correlations can be useful 




Diagnostic Performance of Signal Variance ECG for the 
Diagnosis of Ischemic Heart Disease • a Comparison to 
Exercise Stress Test as Related to Myocardial 
Scintigraphy 
Inger Hagerman. Marco Y1en, Olof Nyquist. Jacek Nowalc, Christer 
Sylven. Karolinska Institute at Depts of Medicine and elin 
Physiology. Huddinge Univ Hospital. Huddinge. Sweden. 
With signal variance ECG. resting ECG is monitored with 22 leads 
during 220 beats at 4 kHz. On the basis of the phase-bound 
variability. the electrical temporal signal variance is quantitated with 
a non-dimensional index (O-ISO). ~: 160 consequtive 
patients referred to exercise myocardial scintigraphy (SPECf) were 
investigated. With variance ECG diagnostic performance for 
ischemic bean disease was quantitated with increasing cut points and 
at exercise test by ST depressions of ~.I m V and ~.2 m V with or 
without chest pain. These indexes were related to perfusion defects 
atSPECf. 
~: Prevalence of abnOrmal SPECf was 0.S9. The ROC curves 
show that in this study group ST depressions alone or ST 
depressions combined with exertiooal chest pain did not diagnose 
better than chance. Variance ECG had a definite discriminant 
accuracy (p<O.OOOl). When variance ECG was combined with ST 
depressions at exercise test 96% of patients with reversible 
myocardial ischemia at SPEer were identified. Conclusions: 
Variance ECG has better diagnostic performance than exercise stress 
test for ischemic heart disease. When combined. these two tests 
identify the majority of patients with abnormal perfusion defects. 
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Reproducibility of Spectrli Turbulence Analysil of the Signal-Av_ged 
Electrocardiogram 
Plair Kulakowski, Olusola Odemuyiwa, Anne Staunton, A. John Camm, Marek 
Malik. Department of Cardiological Selenees. SI. George's Hospital Medical 
School, London, UK. 
Spectral turbulence analysis (STA) Is a new frequency domain technique 10/' 
slgnal-averaged ECG (SAECG) analysis which examines the whole CRS 
complex and not solely the terminal portion of the CRS. There Is growing 
evidence that reproducibNIty of other than STA frequency domain lechniquet 
Ia worse than thet of time domain analysis. This study cOI'npared the short•
term reproduclbNIty (3 recordings wHhln 25 min) of the STA (score and 
numerical values of 4 STA parameters: low Intersegment COI'reiatlon ratio, 
Intersegment COI'reiation mean, Intersegment COI'reletion SO, spectral 
entropy) wtth the standard time domain SAECG analysis and with other 
frequency domain technique - spectral temporal mapping of SAECG In 69 
subjects (15 healthy subjects, 22 patients wtth ventricular tachycardia without 
apparent heart disease, and il2 post Infarction patients with ventricular 
tachycardia). The reproducibUIty of numerical values of Individual Indices was 
assessed by COI'nputing the ratios between standard deviations of 
measurements In Individual subjects and standard deviations of d 
measurements. 
RESULTS: Consistent results (all 3 normal or all 3 abnormal) were achieved 
In 62 (90%) subjects using time domain analysiS and In 15 (22%) using 
spectral temporal mapping. The STA score (0 to 4) was consistent (the seme 
SCOI'8 In all 3 recordings) In 41 (59%) subjects. The score was > 2 or $ 2 
(reproduclbHIty of diagnosis) in all 3 recOl'dlngs In 62 (90%) subjects. 
ReproduclbKIty of STA Indices was Inferior to time domain variables (however, 
the difference reached statistical significance only lor Intersagment 
correlation SO, p • 0.01), but was superior to the reproducibility of the resUta 
Ii spectral temporal mapping (p • 0.001). 
CONCLUSION: ReproduclbHIty of the qualitative results of STA Is slmBar to 
that Ii the time domain analysis and significantly better than that 01 spectral 
temporal mapping of SAECG. Reproducibility of the numerical values of the 
STA Indices Is superior to the reproduelbNIty of the values of the normality 
factO/' of spectral temporal mapping and slightly but not significantly WOl14l 
than the reproduclbHIty of the time domain SAECG Indices. 
960·7 
lACC Vol. 21, No.2 
February 1993:460A 
Influence of Propranolol on Heart Rat. 
Variability in Patients With Long QT Syndr~ 
Thomas Eggeling, Hans-H. osterhues, Martin 
HOher, Vinzenz Hombach, University of Ulm, 
Ul., FR Germany 
spectral analysis of heart rate variability 
(HRV) during Holter Monitoring (HM) was 
determined in patients with the Long OT syn•
drome (LOTS) to evaluate the influence of 
Beta-Blocker therapy on HRV. 13 patients with 
LQTS (9 female, 4 male, mean age 20±4 years) 
and a history of ventricular tachycardia (VT) 
were studied without medication <baseline> 
and after taking propranolol <Prop> (160-240 
JIg/day) for 3 months. During therapy with 
Prop no episodes of VT occurred. HM tapes 
were analyzed for entire power spectrum, low 
frequency and high frequency content, and 
.ean RR-interval duration. 
DAlll1DI El:QR 11 
Spectral Analysis 
Entire spectrum 
0.01-1.0 Hz 92±12 ms 39±13 DIS <0.002 
Low frequency 
0.04-0.15 Hz 57±9 DIS 24±10 ms <0.001 
High frequency 
0.15-0.40 Hz 44±6 ms 13±5 DIS <0.002 
Mean RR-Interval 931± 997± 
92 DIS 155 ms n.s. 
Patients with LOTS showed significant dif•
ferent HRV before and after administration of 
Propranolol. Therefore, determination of HRV 
could be a new method to evaluate the anti•
arrhythmic efficacy of Prop in LQTS patients. 
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961·88 
Regional Rb-Bl Washout Assessed by PET Renec:ts the Severity and 
TIme Course or Myocardial IsdIem.ia·Reperrusion Injury 
Masazumi Arai. Jonathan M. Links. Hisato Takatsu. Lewis C. 
Becker. Johns Hopkins Medical Institutions. Baltimore. MD 
To determine whether Rb-82 washout is useful for assessing injury 
in acute myocardial ischemia-reperfusion. 7 dogs underwent 90 min 
coronary artery occlusion foUowed by 3 hr reperfusion (R). Serial 
Rb-82 studies were performed during Ischemia and at S min and O.S. 
I. 2. and 3 hr reperfusion. For each study. 20-S0 mCi Rb-82 was 
infused i. v. and 30 sec afterwards. one 30 sec and four 1-min 
images were acquired. Decay corrected myocardial activity was 
obtained from multiple regions of interest in each tomographic slice 
and washout was estimated as the difference in activity between the 
second and the next 2 I-min images. Washout (mean ± SEM %) in 











7.3± 1.9* 6.8±2.2* 
-3.8±0.9 -S.4±1.1 
*p<O.OS vs 5 min R (ANOVA) 
Mean washout over 3 hr reperfusion (WO) was greater in I-R than N 
(S.S4% activity JQu vs S.05% activity Din. p=O.OOl) and correlated 
with the severil)' of ischemia assessed by the ratio of ischemic 10 
normal zone Rb-82 activity during coronary occlusion (r=0.8S). WO 
was also strongly correlated with infarct size as a fraction of the zone 
at risk assessed from TIC stained postmortem myocardial slices 
(r=O.92). Thus. myocardial washout of Rb-82 assessed by PET 
imaging is increased in acute myo-cardial infarction and correlates with 
the severity of injury. Rb-82 PET may be useful for assessing residual 
myocardial viability in patients undergoing reperfusion early after 
infarction. 
JACC Vol. 21, No.2 
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961-89 
Recovery or Coronary Resistive Vessel Function Arter Myocardial 
Inrarction in Patients witb Single Vessel Disease 
Neal G. Uren. Tom Crake, David C. Lefroy, Ranil de Silva. Graham J. Davies, 
Attilio Maseri. Hammersmith Hospital. London. UK 
Recovery of myocardial blood flow (MBF) after thrombolysis for transmural 
myocardial infarction (MI) was investigated using positron emission tomography 
(PET) in 13 patients, mean age 62±H years. Patients received intravenous (iv) 
streptokinase (1.5 MU) 4.2±2.3 h after the onset of chest pain. Mean peak creatine 
kinase (CK) was 2733±1914 IUII. The infarct-related artery was the left anterior 
descending in 8 patients, the right coronary artery in 4, and left circumflex artery in 
I; the remaining arteries in all patients were angiographically normal. At coronary 
angiography 25±36 days post·MI. 2/13 infarct·related arteries were occluded. Basal 
and maximal regional MBF (in mVmin/g) were measured by 15 slice PET using 
H21S0 before and after iv dipyridamole (Dip). 0.5 mg/kg over 4 min. 8±3 days 
(PET!) and 6± I months (PETI) after MI. The regional coronary vasodilator 
response (CVR; maximal/basal MBF) was determined in the infarct region of 
interest (ROl) and in a remote RO! subtended by an angiographically normal artery. 
To assess the amount of viable myocardium in the infarct RO!, the regional 
perfusable tissue index (PTI) derived from the dynamic H21S0 scan (in ml of 
perfused tissue/ml of total tissue) was measured. Results were (mean±SD; • 
p<O.05 and •• p<0.01 vs. R. t p<0.05 vs. PET!): 
fEr BQl .llBsal..MB.f I2.iIl..MB.E. .-CYlL. -fIl 
I MI 0.8 I ±O.22· 0.9I±O.5I·· 1.12±O.51· 0.78±O.24· 
R l.lI±O.30 1.72±0.71 1.52±0.36 0.99±O.19 
2 MI 0.82±O.21· 1.20±0.45·· 1.42±O.37··t 0.83±O.l8· 
R 1.08±O.18 2.38±O.86t 2.19±O.69t 1.05±O.1O 
Correlations were shown between PTI in the infarct ROI and i) peak CK (R=..().54, 
p<0.05). and ii) CVR (R=O.59, p<0.05). The CVR in remote myocardium at 
PET! was significantly less than that of remote regions, subtended by a normal 
coronary artery, in 10 stable patients with single vessel coronary artery disease 
without MI. 2.90 ± 1.39 (p<0.05). In conclusjon the CVR is markedly decreased 
in regions remote from the site of infarction 8±3 days after MI. and within 6±1 
months returns towards normal values. This impairment of CVR is due to an acute 
altemtion. in resistive vessel function in remote myocardium after MI. 
961-90 
Mismatch between Perlusab Ie Tissue Density and Regional Myocardial 
Blood Flolw in Old Myocardial Infarction Detected by H%l5() and PET 
Hidehiro Iida, Akira Takahashi, Denis Agostini, Yoshikazu Tamura, 
Peter M Bloomfield, Yukihiko Ono, Akita Noken, Japan 
Functional images ot tissue traction (TF), which is introduce, as the 
traction ot non-scar tissue (normal, ischemic andlor hibernating tissues) per 
given volume element, and region.al myocardial blood flow (rMBF) have 
been calculated using ISO-labeled water (H2ISO) and dynamic pOSitron 
emi .. ion tomography (PET). Subjects consisted of 10 normal volunteers and 
14 patients with old myocardial infarction (OM I) in only the anterior wall 
region. Defect regions ot TF peCtct SI .. of TE and rMBE In OM! 
and rMBF were defined in Wall 
the OMI patients by Motion i 
comparing with the normal. . t 
values, and the detect size D)skl .. ", 
was measured as area lmm2] Akinesis 
on surtace of the blood pool . r 
o 
o 
according to the Hypoklnesls~_ 
3-dimensional surface ~




detect size of both TF and I 
rMBF increased as wall 0 10 20 30 40 SO 
motIon fuchon decreased Derect Size (em') 
(see Figure). It was also 
observed that detect in TF was often smaller than that in rMBF (mismatch 
between TF and rMBF). The experiments were also performed using the 
same protocol on 4 dogs with OMI, and demonstrated the validity of the 
concept of TF: (1) TF images agreed with the histological analysis 
(Elastica-Masson staining and capillary density measurement); (2) 
Calculated TF values agreed well with the perfusable tissue density 
which was obtained from the myocardial H215Q equilibrium distribution, 
taken at 10 min post injection of large bolus injection of H21SO 
("re-distribution" of exogenous water) (y=-0.041+1.073x, r=0.888). It has 
been concluded that regions ot TF and rMBF mismatch correspond to 
ischemic or hibernating myocardium, which may still be viable and 
benFlit trom revascclarization. 
ABSTRACTS 
961-91 
Quantification of the Extent and Severity of Perfusion Defects In 
Canine Myocardium by PET Polar Mapping 
Karl Sun, Marc De Groof, Herbert W. Hansen, Carl E. Selin, Heinrich 
R Schelbert, UCLA School of Medicine, Los Angeles, CA 
This study aimed to validate a new PET polar map approach for 
quantifying the extent and severity of myocardial perfusion defects. In 
24 experiments in 7 open chest dogs, the left anterior (n= 11) or 
circumflex (n=13) coronary artery was ligated sequentially from distal 
to proximal. Atter each successive occlusion, the resulting perfusion 
defect was imaged with N-13 ammonia (20 mCi) while 
radiomicrospheres (RM) were injected into the left atrium. The 
transaxial PET images were reoriented into short axis LV cuts 
including the apex. Polar maps were generated from circumferential 
activity profiles. RM activity was determined by well counting ot 
tissue samples after breadloafing the LV. A normal data base tor N-13 
ammonia polar maps was established in the 5 baseline studies and for 
RM in 8 open chest dogs at baseline. Myocardium with N-13 or RM 
activities less than I.S SO below the mean were defined as 
hypoperfused. Mean volume of each short axis cut was calculated from 
its cross-sectional area determined by profile fitting algorithms and its 
thickness. Weighting tactors for each short axis cut in the polar map, 
established from the normal data base, were applied to account tor the 
volume contribution of each crosssection to the entire LV myocardium. 
The extent (% of LV mass) and mean severity [!-(mean 
reduction/mean normal-l.S SO» of hypoperfused mass in the post•
mortem RM measurements ranged from 6-69% and 3-58%, resp. 
Extent of perfusion defects by PET and by RM correlated by 
y=0.9x+3.5, (r=O.94, p<.OOOl; SEE=6.8) and mean severity by y=l.1x-
2.7, (r=0.93, p<.OOOl; SEE=6.5). The results indicate that, provided 
appropriate thresholding and weighting factors are applied, the extent 
and severity of myocardial perfusion detects can be determined 
accurately from PET polar maps. 
961-110 
Study of Myocardial Distribution of -r"c-Sestamibi Witb Positron 
Emission Tomography: Comparison to Resting "N-Ammonia 
Charles K. Stone, Bradley T. Christian, Robert J. Nickles, Robert W. 
PyzaIski, Scott B. Perlman. Madison V AHlUW Hospital PET Center and 
Univenity of Wisconsin-Madison, Madison WI 
The clinical valiclation of tecbnetium-99m-labeUed radiopharmaceuticals 
currently requires the imaging of the invivo distribution of the compounds 
with planar or SPECT gamma camera technique. Positron emission 
tomography (PE'I) offen advantages over standard gamma camera 
techniques for this valiclation with higher spatial and temporal resolution 
and measured attenuation correction. To confirm these advantages, an 
initial feasibility study was performed in which S patients with coronary 
artery disease were imaged with PET using sestamibi labelled with the 
positron emitter "'-rc (balf-Iife of S3 m). Following transmission imaging, 
dynamic resting studies of the beart were performed with 25-30 mCi of 
"N-ammonia followed 1-2 h later by 3-4 mCi of "'-rc-sestamibi with 
analysis of the summed dynamic images performed. Qualitatively. the 
sestamibi images were sinillar to the "N -ammonia images with respect to 
myocardial delineation, with higher liver activity present in the sestamibi 
images. Quantification of infarct size was performed with region of interest 
analysis. Infarct was considered present in defects < 20% of maximal 
myocardial uptake. 10 the 3 patients with defects, infarct size in absolute 
terms by "'-rc-sestamibi PET was sinillar to "N-ammonia PET: 19± I 
venus 18± 1 g, (mean±SE), respectively. Total myocardial mass by 
"'-rc-sestamibi as a fraction of the "N-ammonia determination was also 
sinillar: 1.0±0.1. Thus, in this initial series of patients, qualitative and 
quantitative review of "'-rc-sestamibi rest PET images were similar to 
resting "N-ammonia myocardial studies, confirming the feasibility of 
performing clinical valiclation studies of tecbnetium-99m-labelled 




Decreased Myocardial Glucose Utilization in 
Myotonic Dystrophy 
Denis Duboc. Djillali Annane. Bernard Mazoyer. Pascal 
Merlet. Bruno Eymard. Marco Fiorelli. Philippe Gajdos. 
Fran~ois Guerin. Andre Syrota. 
Cardiologie. CHU Cochin. Reanimation medicale. CHU R. 
Poincare and SHFJ. CEA. Orsay. France. 
Myocardial metabolic rate for glucose (MMRGLc. 
Ilmol/min/g) was investigated with I 8 F - fl u 0 r 0-
deoxyglucose (FOG) and with PET in 9 myotonic pts 
(without left ventricular dysfunction) and 6 healthy 
volunteers. After an oral dose of 45g of glucose. all 
subjects underwent an intravenous bolus of 15-20 mCI of 
ISO labeled water. to assess myocardial blood flow (MBF). 
followed by an intravenous injection of 8-10 mCi of FOG. 
Parametric images of MMRGLc were generated from FDG 
studies. according to the model described by Choi et al. 
Blood samples were collected before FOG administration in 
all subjects in order to measure glycemia (GL. mmol/l). 
insulinemia (lns. UI/L). All parameters were compared 
between the 2 groups using the Mann-Withney non 
parametric test. GI and Ins were not different between 
the 2 groups. MBF was not significantly different 
between pts and volunteers. and MMRGLc was 
significantly lower in pts (0.36 ± 0.19 versus 0.86 ± 0.34. 
p= 0.01). These results suggest that in glucose loading 
condition. MMRGLc is reduced in pts with My D. Since 
MBF and left ventricular function are not impaired. the 
observed decreased MMRGLc may reflect a primary 
decrease in myocardial glucose utilization in Steinert 
muscular dystrophy. Similar findings were observed in 
brain using the same methodology. These in vivo results 
show that the glucose utilization abnormalities 
previously described in vitro in skeletal muscle are 
diffuse in this multi systemic disease. 
961·112 
Sustained Ventricular Tachycardia and Myocardial Blood 
Flow in Hypertrophic Cardiomyopathy 
Roberto Gistri, Franco Cecchi, Alberto Genovesi-Ebert, 
Piero A Salvadori, Paolo G Camid 
CNR Institute of Clinical Physiology, Pisa Cardiologia S 
Luca, Florence, Italy. 
To ascertain whether ventricular tachycardia (VT) in 
patients (pts) with hypertrophic cardiomyopathy (HCM) is 
related to abnormal myocardial blood flow (MBF, 
ml/min/g), regional MBF at baseline (BAS) and after i.v. 
dipyridamole (DIP, 0.56 mg/Kg over 4 mins) was 
measured in 12 HCM pts (mean age 44±11 yrs) with 
nitrogen·13-ammonia and dynamic positron emission 
tomography. Eleven pts had septal and one had lateral 
wall hypertrophy (thickest wall 22.5±5.00 mm; range 16·32 
mm). Six pts had at least 1 episode of VT during a 72 hour 
Holter monitoring (GROUP 1) while 6 had no evidence of 
VT (GROUP 2). 
GROUP 1 GROUP 2 12 
Free wall MBF·BAS 0.66±.17 O.86±.24 ns 
Septal MBF-BAS 0.8O±.17 1.27±.42 <.05 
Mean MBF-BAS 0.72±.15 1.04±.31 <.05 
Free Wall MBF·DIP 1.13±.37 1.8O±.67 =.05 
Septal MBF-DIP 1.16±.29 1.98±.37 <.01 
Mean MBF-DIP 1.15±.32 1.60±.33 <.01 
In conclusion, HCM pts with VT have a lower MBF at 
BAS and a more reduced flow response after DIP infusion 
than those without VT. These abnormalities may playa 
role in the pathogenesis of arrhythmias in pts with HCM. 
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Are the ae.ults of Exercise Thallium Testing Different in 
Hen and Vomen? 
Ira Yolmer, Kathleen McClain, Jaekyeong Heo, Valerie 
Yasserleben, Virginia Cave, Abdulmassih S. Iskandrian. 
Philadelphia Heart Institute, Presbyterian Medical 
Center, Philadelphia, PA. 
This study examined the results of exercise (Ex) ECG and 
thallium in women and men in relation to pretest 
probability of CAD. There were 1,035 men, and 594 women 
who underwent Symptom limited treadmill Ex testing with 
SPECT thallium- 201 imaging. More patients (pts) had 
abnormal thallium than SoT ~ (34\ vs. 19\, P < 0.001). 
SoT ~ was seen in 212 men (20%), and 98 women (16\, P < 
0.05). The thallium images were abnormal in 452 men 
(44\) , and 98 women (16\, P < 0.001). In women with 
negative Ex ECG, only 6\ had reversible thallium defects 
compared to 30% in men' (P < 0.0001). Men and women were 
divided into 3 groups each; group 1 with s 33'; group 2, 
34 to 66\; and group 3, 67 to 100\ pretest probability of 
CAD. SoT ~ was similar in men and women in each of the 
3 groups (12% vs. 13'; 15\ vs. 16%; and 2S\ vs. 21\, 
respectively, P:NS), but reversible thallium defects were 
more in men (17' vs. 8\, P < 0.02; 30\ vs. 17\, P < 
0.001; and 56\ vs. 30\, P < 0.001). In pts who had CAD 
by catheterization (N-235), there were no differences 
between men and women in the severity and extent of CAD. 
However, women had lower Ex time (6.4 vs. 8.7 min, P < 
0.0001), lower Ex heart rate (140 vs. 144, r < 0.001), 
and smaller body weight (156 vs. 183 Ibs., P < 0.001). 
Thus, women have less reversible thallium defects than 
men regardless of the pretest probability of CAD. This 
is unlikely due to differences in severity of CAD, but 
may be due to differences in Ex performance and heart 
size. Further, reversible defects are unusual in women 
with negative Ex ECG response. 
962·114 
Optt.al Tiaing of Stress Perfusion Iaaging in Predicting 
Early Restenosis Following Coronary Angioplasty 
Jose M. Dimen. Alan Y_ Meholick. John C. Corbe1li. 
William M. Morris. Yil1iam J. Breen Jr •• Alan M. Taylor 
II. Sen G. Rueda and Michael E. Merhige. State University 
of New York at Buffalo. Buffalo. NY 
False positive (F+) redistributing Thallium (TI) defects 
are often seen in patients studied shortly after PTCA. 
The purpose of this study was to determine the optimal 
timing of stress perfusion imaging for accurate detection 
of early restenosis. Accordingly. we determined the 
positive predictive value (+PV) of maximal stress/4 hour 
redistribution Tl SPECT imaging at varying time intervals 
up to 6 months following PTCA in 72 patients who 
subsequently underwent repeat coronary arteriography 
(ANGlO). Reinjection TI scintigraphy was performed when 
fixed 4 hour redistribution perfusion defects were seen. 
The angiographic restenbsis rate was 63% (59/94 PTCA 
sites). Of the 48 redistributing TI defects observed. 
9 were F+. with no restenosis at ANGlO (+PV-0.81). 
Improvement in +PV of imaging performed at:>/=3 weeks 
after PTCA was highly significant. compared with earlier 
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Conclusion: Redistributing TI defects reliably predict 
early restenosis 3 weeks or more after PTCA. 
JACC Vol. 21, No.2 
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962·115 
Silent Myocardial I.cheaia in a Black Diabetic 
population 
cynthia Crawford-Green and Celeste Brickler Hart 
Howard University, Washington, D.C. 
As 35% of patients (pts) undergoing coronary 
artery bypass grafting at our institution which 
serves a largely black inner city population have 
diabetes mellitus (OM), we performed a 
prospective clinical trial evaluating the utility 
of thallium scintigraphy in asymptomatic 
diabetics. Previous similar investigations have 
been largely limited to white males. We studied 
60 pts: 46 with OM, 14 men, mean age 44, 32 
women, mean age 47; 14 controls, 7 men, mean age 
51 and 7 women, mean age 45. All patients 
achieved at least 85% of the maximum predicted 
heart rate resp9nse. Abnormal thallium 
scintigrams (TS) and exercise electrocardiograms 
(ECG) were found in none of the control women, 
17% of the control men, and 23% of the diabetic 
men. The TS were abnormal in 29% of diabetic 
women; but, of those 90% had a normal ECG 
response. These data demonstrate 1. that black 
asymptomatic pts with OM frequently have 
objective evidence of inducible ischemia; 2. that 
thallium scintigraphy may be a useful diagnostic 
modality especially in women who overwhelmingly 
were found to have a normal ECG response to 
exercise despite perfusion abnormalities; and 3. 
development of coronary artery disease in black 
women appears to be dramatically influenced by 
OM. The longterm phase of this study likely will 
aid in determining if earlier disease detection 
will positively impact on the increased 
morbidity, surgical risk and mortality observed 
in the black patient. 
962·116 
Automatic Interpretation of Myocardial Planar Thallium 
Scintigrams Using Neural Networks 
Jacob Erel, Charles Rosenberg, Henri Atlan. 
Hadassah Medical Center, Jerusalem, Israel 
Planar Thallium stress study is a worldwide standard for 
evaluation of myocardial perfusion and coronary disease. 
Image interpretation is mainly based on subjective 
visual scoring, where computerized quantitative programs 
are considered supportive only. We integrated standard 
quantitative analysis (circumferencial profiles) with a 
special artificial intelligence program (radial basis 
function neural networks) to yield a fully automatic 
interpretation system. This neural network (NN) was 
chosen for its flexible ability to recognize complex 
patterns and learn from experience, unlike ordinary 
rule-based systems. A set of 100 consecutive new cases 
was tested for disease detection against cardiologist's 
scores. The overall accuracy of the system to identify 
stress or delayed phase defects was 89-90% when decision 
threshold was set for optimal performance according to a 
receiver operating characteristic (ROC) curve. 
localization of defects was more than 85% correct with 
accuracy of 100% for anterior wall defects. The 
sensitivity of the system to identify multiple defects 
was 94%. Classification into fixed or reversible defects 
generally failed, mainly due to insufficient reversible 
defects in the data set (58/900 regions), yet negative 
predictive values were 96 and 94% respectively. 
We conclude that our artificial NN system is already the 
first reliable automatic tool for interpretation of 
planar Thallium stress scintigrams, especially suitable 
for screening and risk stratification purposes. With 
some modifications the system may also be applied to 
other cardiac imaging techniques and combined with ECG 
and clinical data it has the potential to replace the 
human expert and enhance final clinical diagnosis. 
ABSTRACTS 
962·117 
Neural Network Recognition of Coronary Stenosis from Myocardial 
Perfusion Scln1lgraphs 
Lucy S. Goodenday, Krzysztof J. Cios and Inho Shin. Medical College of 
Ohio and Univen;ity of Toledo, Toledo, Ohio. 
In order to improve consistency of diagnosis and to extract as much 
objective data as possible from post-exercise myocardial perfusion images, 
an image-recogni~on neural network (IRNN) was developed to identify 
patterns typical for stenosis in each of the major epicardial coronary arteries. 
The IRNN consisted of 3 visual segments and 1 associative segment.Unpro•
cessed digitized images comprised the input data to the visual segments. 
Outputs of the visual segments are connected to the associative segment. 
The output of the associative segment represents a code which defines a 
scintigraph as showing stenosis of the left anterior descending (LAD) artery, 
no significant stenosis (NSS)in any vessel, single vessel stenosis (SS) or 
multiple stenoses (MS). A simulation was perlormed for 2 classifications: (1) 
multiple ven;us single vessel stenosis, and (2)LAO stenosis ven;us all other. 
In (1),30 cases (90 images) drawn at random served as the training 
data and 12 (36 images) as the testing data set. In order to reduce bias, 
simulations were repeated twic;e after rotating and re-randomizing the data 
Perlormance of the IRNN in recognizing MS versus SS was: 
Category MS SS NSS 
Leaming(90) 94%(85) 89%(80) 92%(83) 
Testing(36) 89%(32) 83%(30) 78%(28) 
Overall(126) 93%(117) 87%(110) 88%(111) 
In (2), patients identified as having MS were removed; SS and NSS 
patients were combined. The same procedure was followed as in (1). 
Perlormance of the IRNN in recognizing lAD distinct from all others was: 
Category LAD All Othen; 
Learning (54) 98% (53) 98% (53) 
Testing (21) 76% (16) 76% (16) 
Overall (75) 92% (69) 92% (69) 
Resuhs from a previously described expert system had 
demonstrated 94% accuracy in identifying LAD stenosis and 83% accuracy 
for other stenoses in 198 images. Thus, in a selected popUlation, an IRNN 
can perlorm as well as a supervised expert system. 
962·118 
Assignment of Perfusion Defects to Coronary Distributions in Exercise 
Tomographic Thallium Imaging: Impact of Collateral Flow 
Thomas P. Nobrega, Timothy F. Christian, Malcolm R Bell, 
Raymond J. Gibbons. Mayo Oinie, Rochester, Minnesota 
Although perfusion defects can be assigned to specific coronary 
distributions using tomographic imaging, there is an imperfect 
correspondence between findings on perfusion imaging and those on 
angiography. The purpose of this study was to detennine the frequency 
with which angiographica\ly visible collaterals were associated with 
perfusion defects in territories supplied by donor vessels. In a consecutive 
series of patients undergoing exercise thallium ,imaging and coronary 
angiography within 6 months of the exercise test, there were 27 patients 
with angiographic single-vessel right coronary artery disease (;~70% 
stenosis) and less than 50% stenosis in the left anterior descending (LAD), 
circumflex, or any of their major branches. Left to right (L->R) collaterals 
were graded as present or absent. Tomographic images were scored from 
11 segments using a five-point grading scale. Of 27 patients, 26 had 
significant fixed or reversible defects in the inferior and inferoseptal 
segments. Four segments in the anterior and anteroseptal walls at the 
base and mid ventricle (total of lOS segments) were assigned to the LAD 
territory. Redistribution was considered present if there was an 
improvement in perfusion grade from post exercise to delayed imaging. 
Eight patients had LAD redistribution; 7 of these 8 had L->R collaterals. 
Of the lOS LAD segments, 18 had redistribution; 17 of these 18 (94%) were 
associated with L->R collaterals. Collaterals were associated with 
significantly fewer of the remaining 90 LAD segments without 
redistribution (55, or 61 %, p=.OO6). Conclusion: The presence of perfusion 
defects in territories supplied by donor vessels without significant stenoses 
is associated with collaterals· in a very high percentage of patients. 
Collateral flow is one potential explanation for the presence of reversible 
perfusion defects in more than one coronary distribution in patients who 




Quantitative Exercise Followed by Rest Tc·99m-8estamlbl 
Slngl.Photon Tomography tor Detection and Vascular 
localization ot Coronary Artery Stenoses 
Mehmet Emin Korkmaz, John J. Mahmarian, Maria G. Koutelou, 
Mario S. Verani. Baylor College of Medicine, Houston, Texas 
A one-day rest/exercise protocol of perfusion imaging with Tc· 
99m sestamibi (MIBI) is often preferred, though an exercise/rest 
sequence is more practical. Accordingly, we investigated the 
diagnostic accuracy of an exercise/rest MISI tomographic 
imaging protocol in 53 pts (46 males, 7 females, mean age 
58::!: 12 yrs) who were referred for suspected coronary artery 
disease and also had subsequent coronary angiography. Most 
pts (70%) had no prior evidence of myocardial infarction. All pts 
performed symptom·limited treadmill exercise followed by 
Injection of 8-10 mCi Tc-99m MISI. Standard 180° rotational 
tomography was performed 1·11h hrs after exercise followed by 
an injection of 18-20 mCi. Tc·99m MISI at rest Tom09raphic 
imaging was repeated 1-2 hours later. The tomographiC Images 
were interpreted by both a visual M and a quantitative (a) 
method using computer-generated polar maps to determine the 
presence and location of coronary stenoses. The coronary 
angiograms were analyzed using electroniC calipers. Significant 
stenoses were defined as > 50%. 
The overall sensitivity for detecting pts with coronary 
artery disease was 86% by V and 92% by a analySis. Most pts 
(95% with single vessel and 87% with multivessel disease) were 
correctly identified by the a method. All pts with prior infarction 
were identified, as were 78% and 87% of pts without infarction 
by V and a tomography, respectively. The sensitivity for 
detecting all indMdual1y stenosed vessels was 71% by V and 
87% by a analysis (p=.05). Importantly, indMdual vessel 
specificity remained high by V (86%) ancf a (87%) analysis. 
Thus, quantitative Tc-99m MISI tomography using a more 
practical exercise/rest sequence appears to be both a highly 
sensitive and specific technique for detecting the presence and 
location of individual coronary stenoses. 
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963-33 
Inhibition of the Fibrinolytic Systa. in vivo by Insulin 
and by Proinsulin 
Thomas K. Nordt, Satoshi Fujii, Hirofumi Sawa, David J. 
Schneider, Burton E. Sobel. Washington University School 
of MediCine, St. lOUis, MO 
Causes of accelerated atherosclerosis in type II diabetes, 
a condition known to be associated with increased fasting 
concentrations in plasma of insulin and proinsulin, remain 
enigmatic. We found previously that both moieties induce 
synthesis of plasminogen activator inhibitor type-I (PAI•
l) in cells in vitro, thereby potentially exacerbating 
thrombosis and atherogenesis in vivo. This study was 
performed to determine whether insul in, proinsul in, or 
both directly induce accumulation of PAl-I in plasma in 
vivo. To simulate the hyperinsulinemia and proinsulinemia 
of type II diabetes, conscious rabbits (n • 19) were given 
Lv. infusions (1 hr) "Of insulin (1 IU/kg) or equimolar 
proinsulin (which is not converted to insulin in rabbits 
for at least 4 hr). Glucose was infused concomitantly to 
maintain euglycemia (verified by assays). Plasma PAl-I 
activity did not change in controls (n • 6). However, 
infusion of insulin incre.ased plasma PAl-I activity from 
5.4 t 1.9 (SO) to 19.5 t 5.9 arbitrary units (AU)/ml (p • 
0.002, n - 7). Proinsulin increased PAl-I from 5.8 t 2.0 
to 22.3 t 5.3 AU/ml (p - 0.002, n - 6). Increases were 
maximal with both agents within 3 hr and perSistent for 
approximately 6 hr. Values returned to baseline within 24 
hr. Inhibition of fibrinolytic activity in plasma was 
attributable to PAl-I protein as shown by reverse fibrin 
autography. Thus, both insulin and proinsulin directly in•
crease plasma PAl-I in vivo. These results indicate that 
the hyper(pro)insulinemia typical of type II diabetes is 
responsible for the inhibition of fibrinolysis seen in 
vivo, a phenomenon potentially exacerbating macrovascular 
disease. 
963·34 
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Lack of Supresslon of Thrombin Activity In Vivo: A 
Determinant of Failure of Recanalization 
Paul R. Eisenberg, Dana R. Abendschein, Richard C. Becker, Joseph 
Loscalzo, Burton E. Sobel, and the TIM I V tnvestigators, Washington 
University, St. Louis, MO 
We have shown previously that administration of fibrinolytic agents 
induces thrombin activity. Furthermore, angiographic studies 
indicate that the incidence of sustained coronal)' patency is increased 
when t-PA is ~iven with conjunctive intravenous heparin. To 
determine directly whether patency is limited by the extent of 
thrombin activity in patients treated with t-PA, plasma 
concentrations of fibrinopeptide A (FPA), a marker of thrombin 
activity, were measured as part of the TIMI V study. Patients 
presenting within 6 hr of the onset of symptoms were treated with a 
maximum of 100 mg t-PA over 90 min (weight·adjusted, front 
loaded) and randomized to !lither I.V. heparin (5,000 IU bolus plus 
1,000 IUlhr) or hirudin in doses ranging from 0.15 mg/kg bolus 
plus 0.05 mg/kglhr to 0.9 mg/kg bolus plus 0.3 mg/kglhr .. 
Coronary angiography was performed 90 min after initiation of t•
PA. Patency was defined as TIMI flow grade 2 or 3. Plasma 
concentrations of FPA decreased from 48 i 5 (SE) ng/ml before, to 
25 i 3 nglml 1 hr after t·PA. Plasma FPA was higher in the 26 
patients in whom coronary artery patency was not present after 90 
min, averaging 45 i 11 nglml compared with values in the 97 
patients with patent arteries averaging 19 i 2 nglml, p=0.009. 
Thus, failure of t-PA to achieve coronary artery patency after 90 
min is associated with insufficient inhibition of thrombin activity. 
Accordingly, measurements of FPA made as early as 90 min after 
initiation of therapy should prove useful in titrating conventional and 
novel antithrombins and ensuring the adequacy of inhibition of 
thrombin activity in patients treated with fibrin-selective 
plasminogen activators. 
963·35 
Glibenclaaide-Induced Coronary Vasoconstriction 
occurs by Membrane Depolarisation and 
Activation of voltage-Sensitive ca- Channels. 
Frederick Samaha, Frederick Heineman, Joni 
Taylor, and Robert S. Balaban. NHLBI, NIH, 
Bethesda, M.D. 
In vivo studies have recently demonstrated that 
infusion of glibenclamide (glib), a blocker of 
ATP-sensitive x+ (IK+ATP) channels, into the 
coronary vasculature of intact hearts causes 
vasoconstriction with myocardial ischemia. Thus 
it has been postulated that this IK+ATP channel 
is active in vivo, and sets basal coronary 
tone. It has been proposed that intracoronary 
glib inactivates the (IK+ATP) channel, thus 
causing membrane depolarization, influx of Ca"" 
through voltage-sensitive Ca- (ICa-) channels, 
and smooth muscle contraction. We used isolated 
rabbit hearts and in vivo dog hearts to test 
this proposed mechanism. We found that verapa•
mil, an ICa- channel blocker, prevented or 
reversed the vasoconstrictive effects of glib 
(p<.01) in the isolated hearts (n=14) and in 
vivo hearts (n=5). Nitroprusside, which causes 
vasodilation without affecting membrane potent•
ial or Ca- channels, had no effect on glib 
induced vasoconstriction. Raising the resting 
membrane potential by raising the extracellular 
x+ concentration from 20 mM to 35 mM inhibited 
the glib induced vasoconstriction by 50\ 
(p<.05). We conclude that coronary smooth 
muscle IK+ATP channels are active in vivo, and 
glib causes vasoconstriction by blocking these 
channels, causing membrane depolarization, and 
Ca- influx through ICa- channels. 
lACC Vol. 21, No.2 
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963·36 
Induction of Plas.in0gen Activator Inhibitor Type-lin the 
Vessel Walls by Thro.bosis in Vivo 
Hirofumi Sawa, Satoshi Fujii, Burton E. Sobel. 
Washington University, St. louis, Missouri 
Several specific links between thrombosis and atherogene•
sis have been recognized. Recently we found that the 
synthesis of plasminogen activator inhibitor type-l (PAI•
l) increases in cultured endothel fal and smooth muscle 
cells in vitro in response to thrombin and other constit•
uents of thrombi. Augmented synthes is of PAl -1 in the 
vessel wall may modify turnover of matrix and thereby 
exacerbate injury. Accordingly, we characterized the PAI•
l gene expression in vessels exposed to thrombi in the 
absence of an antecedent physical insult such as electri•
cal injury. Thrombosis was induced in the carotid arter•
ies from 12 rabbits with intraluminal surgical silk su•
ture. PAI-l mRNA and antigen were assayed by in situ hy•
bridization and immunocytochemistry after 1,2,4,6,8 or 10 
wk. Plasma PAI-I activity remained virtually constant 
(3.1 t 1.6 (SO) arbitrary units (AU)/ml at baseline, 3.6 
t 0.9 after 4 wk and 4.3 t 0.9 after 10 wk). In contrast, 
PAI-l gene expression increased in endothelium (positive 
for Factor VII I and thrombomodulin) juxtaposed to thrombi, 
in smooth muscle cells (positive for actin) adjacent to 
neointima, and macrophages (positive for RAM-ll) sur•
rounding suture material. Increases did not occur in 
contralateral control arteries or in arteries in sham•
operated controls. The increased vascular wall PAI-l gene 
expression was paralleled by co-localization of PAI-I 
protein. Our results indicate that locally increased 
expression of PAI-l in endothelium juxtaposed to thrombi 
may: (1) shift the balance between fibrinolysis and 
thrombosis toward thrombosis; and (2) predispose vessels 
to restenosis by altering vascular remodeling after inter•
ventions such as angioplasty in which local thrombosis can 
not be avoided. 
963·37 
Cocaine-Induced Increase In Macromolecular Permeability Across the 
Endothelium 
Frank D. Kolodgle, Patricia S. Wilson, Renu Virmanl. Armed Forces 
Institute of Pathology, Washington, D.C. 
Although clinical evidence suggests a strong association of cocaine abuse 
with myocardial ischemic syndromes, the underlying mechanisms remain 
poorly defined. Recent postmortem studies demonstrate histological 
evidence of accelerated atherosclerosis In subjects with a history of chronic 
cocaine abuse which may be a ~edlsposing factor for myocardial ischemia 
and infarction, To explore this relationship further, the effect of various 
concentrations of cocaine on confluent monolayers of human umbilical 
vein endothelial cell cultures (confirmed by scanning and transmission 
electron microscopy) was studied. The barrier function of endothelial cells 
was examined at various time Intervals using horseradish peroxidase 
(HRP) as a macromolecular tracer. Transendothellal cell electrical 
resistance (TEER) was examined prior to and after 10 minutes of cocaine 
exposure. 
~ 
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Cocaine significantly Increased the passage rate of peroxidase. Together 
with this Increase, a decrease In transendothellal cell resistance was 
observed. The effect of cocaine on endothelial permeaNlity was transient 
and maximal at 30 minutes. 
Conclusion: Acute exposure of endothelial cells to cocalne, Increases 
macromolecular transport. Cocaine-accelerated atherosclerosis may occur 




Virion-Sized Particles Infused by Double Balloon Catheter are Excluded 
From Muscular Layers of Elastic Arteries 
J Jack Rome, Moshe Y Flugelman, Kurt 0 Newman, Vafa Shayani, 
Andrew Farb, Renu Virmani, David A oichek, NHLBI, Bethesda MD. 
465A 
In vivo intra-arterial gene transfer has been demonstrated to occur but 
only at very low levels. We undertook the present study to determine to 
what degree this low efficiencv of gene transfer might be due to phys•
ical barriers of the vascular wall to particle penetration. The compart•
ment-producing double-balloon catheter (USCII was used to infuse 
particles sized 30 to 250nm (30 and 93nm fluorescent-labelled 
microspheres(MSI, and filtered india ink (In I)) as well as the 40 kD 
protein horseradish peroxidase (HRP, approximately 3nm) into the caro•
tids of 30 kg sheep. Infusion pressure was maintained at 150 to 400 
mmHG for 30 min followed by either pressure fixation in situ (lnl and 
HRP), or snap freezing (MS). Vessels were studied with and without 
prior injury by balloon angioplasty. Multiple microscopic sections from 
each vessel were reviewed, and the percentage of sections with 
penetration into the intima, media, and ad venti a was determined. 
~ Inl and MS were found in intima and adventitia, no significant 
medial penetration was seen. Extensive HRP reaction product was 
present through all vessel layers. Prior balloon injurv had no significant 
effect on these findings (see table). 
Infusate Balloon Number of Percent of Sections with Penetration: 
Injury Vessels Intima Media Adventitia 
Inl no 4 74 0 32 
Inl yes 6 68 3 23 
MS no 4 98 6 55 
MS yes 5 60 0 30 
Vehicle no 3 0 0 0 
HRP no 6 83 83 100 
HRP ves 3 100 100 100 
Vehiclp no 4 0 0 0 
Conclusions: (11 In this acute model, particles eqUivalent In size to 
most currently used vectors for gene transfer gain access to intimal and 
adventitial but not medial layers of elastic arteries. Adventitial access is 
most likely via vasa vasorum. (2) Prior balloon injury does not signi•
ficantly alter penetration. (3) These findings may have significant 
implications regarding the cellular targets of vascular gene therapy: 
963·39 
Low-Dose Sulfonylurea (Gllbenclamlde) Attenuates 
Coronary Vasodilatory Responses Mediated by AlP•
Dependent Potassium Channels 
Cornelius A. Davis III, Gopalakrishnan Srinivasan, James 
Black, Anuj Narang, John Min and Francis J. Klocke. 
Feinberg Cardiovascular Research Institute, Northwestern 
U. Medical School, Chicago, IL 
ATP-dependent potassium channels in coronary arteriolar 
smooth muscle are thought to be importantly involved in 
the vasodilatory responses to adenosine, increased 
metabolic activity, hypoxia and transient coronary 
occlusion. Although large doses of the sulfonylurea 
glibenclamide (e.g., 2 mg/kg) are known to attenuate 
these responses, effects of dosages Similar to those 
used clinically are unclear. Accordingly, responses of 
coronary flow to intracoronary adenosine infusion (Ado) 
have been assessed before and following 0.1·0.3 mg/kg 
glibenclamide (GB) given intravenously in seven paced 
heart blocked dogs. Dose-response curves were 
consistently shifted to the right by GB, with the dose of 
Ado needed to double resting flow increasing by 175 ± 
120 (SO)% (range 52-354%) at 0.3 mg/kg GB. 
Pressure·flow relationships obtained during prolonged 
post-pacing diastoles revealed that GB attenuated Ado•
induced reductions in zero-flow pressure as well as 
resistance. In addition, over the range of 60·150 bpm, 
coronary flow was reduced by 15·30% at any level of 
heart rate (or double product). We conclude that low 
doses of GB alter coronary vasodilatory responses and 
that ATP-dependent potassium channels affect coronary 
vascular tone on a tonic basis as well as during stress. 
466A ABSTRACTS 
963·40 
Inhibition of Experimental Thrombosis With Monoclonal 
Antibody Against Rabbit Tissue Factor 
Aruna Pawashe, Brian D. Guth, Thomas H. Muller, francesca 
Migliaccio, Michael D. Ezekowitz. Yale University School 
of Medicine, New Haven, CT and Dr. Karl Thomae GmbH, 
Biberach, Germany 
Tissue factor is the prime trigger of blood clotting 
mechanism which contributes towards thrombus formation. 
The goal of this study was to determine whether the 
inhibition of tissue factor in vivo would prevent 
thrombus formation in a rabbit model of recurrent 
arterial thrombosis. To test this hypothesis, we have 
produced a monoclonal antibody (AP-l) against rabbit 
tissue factor. This antibody is characterized for its 
ability to inhibit tissue factor activity in vitro. 
Immunohistochemical analysis revealed that AP-l 
specifically stains adv~ntitia of the blood vessels which 
are known to express tissue factor. To produce recurrent 
thrombosis in rabbit, the abdominal aorta was damaged 
acutely by balloon injury and the animal instrumented to 
measure aortic flow velocity and pressure. A stenosis at 
the site of injury was produced by external clamping 
which resulted in recurrent occlusive thrombosis. 
Following a control period of 20 minutes AP-l was 
injected intravenously and the occlusive frequency per 
hour determined. At a dose of 50ug/kg AP-l (n=2), there 
was no difference from control (23 vs 20). At 200ug/kg 
AP-1 (n=4), 1/4 rabbits had complete inhibition of 
thrombus formation. At 400ug/kg AP-l(n=2), total 
inhibition occured. 
Conclusion: From this preliminary study it appears that 
in vivo thrombosis can be inhibited using a monoclonal 
antibody against tissue factor. There is a dose response 
with no inhibition at 50ug/kg and complete inhibition at 
400ug/kg. 
963·41 
Persisting Cytomegalovirus· DNA in Endomyocardial Biopsies of 
Patients with Angina Pectoris and Normal Coronary Arteriograms 
Ute SchOnian, MarHes Crombach. Bernhard Maisch. Philipps-University. 
Dept. of Cardiology. Marlrurg. Oennany 
Angina pectoris without coronary stenosis 0CCUI8 in patients with • 
hypertensive heart disease, vasculitis or syndrome X. This is due to 
morphologic or functional changes of the endothelium and/or the 
vascular smooth muscle cells. These changes can be caused by 
inflammatory or proliferative stimuli e.g. by a persisting virus. We 
therefore examined endomyocardial biopsies of patients with chest pain 
but normal coronary arteries for the presence of cytomegalovirus (CMV)•
DNA by in-situ hybridization. In addition a vascular or cardiac 
autoimmune process W&'l assessed by the presence of antisarcolemmal 
(ASA) and antiendothelial (AEA) antibodies bound to the autologous 
biopsy specimen: 18 patients (14m/4f. 15 with a hypertrophic heart, 3 
without hypertrophy) were included in the study and compared to 32 
controls. 
Results: All patients hypertrophy no hypertrophy controls 
N positive 18 15 3 32 
CMV-DNA 7 4 3 4 
ASA (IgM) 10 8 2 0 
ASA (IgA) 10 8 2 0 
AEA (IgO) 18 15 3 3 
AEA (IgM) 11 8 3 0 
AEA (IgA) 9 7 2 0 
CMV-DNA could be assessed in 39% of patients with angina pectoris 
mainly in interstitial and endothelial cells. remarkably in all patients 
without hypertrophy and in 27% of patients with hypertrophy. Viral 
persistence may therefore account partly for their angina. 
Most striking W&'l the presence of IgM and IgA bound to endothelium 
and sarcolemma in contrast to controls in patients with and without 
hypertrophy. We therefore postulate that a virally triggered antibody 
mediated process in the smiill vessels may playa pathogenetic role. 
JACC Vol. 21, No.2 
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963·42 
Effect of L-Arginine on the Inhibition of Platelet 
Aggregation by Endotheliu.-Derived Relaxing Factor 
Jean G. Diodati, Nabeen Hussain, Nader Dakak, 
Richard O. Cannon III, Arshed A. Quyyumi, NHLBI, 
Bethesda, Maryland. 
We have previously reported that stimulation of 
endothelium-derived relaxing factor (EDRF) release with 
acetylcholine (Ach) inhibits in vivo platelet 
aggregation (PA) by 70% in normals, and that this effect 
is blunted in atherosclerosis (30% inhibition). To 
investigate whether L-Arginine (L·Arg), a substrate for 
nitric oxide synthesis, would correct the attenuated 
inhibition of PA, we studied II atherosclerotic pts 
using ex vivo whole blood impedance ~ggregometry in 
response to collagen 1-5 #g/ml at 37 C. Measurements 
were made from blood drawn simultaneously from the 
femoral artery and femoral vein at I) baseline with 
dextrose 5%, 2) after 2-min infusion of 145 #g/min 
acetylcholine (Ach) that is known to release EDRF, 3) 
after a 15 min recovery period, 4) after a 4-min 
infusion of L-Arg (160#M/min), and 5) after repeated 
infusion of Ach and L-Arg. L-Arg did not alter resting 
blood flow. Ach produced similar transient increases in 
flow with or without L-Arg (131±32% and 111±28%, 
respectively, p=ns). Ach produced a transient inhibition 
of PA (-25±lS%; p=0.03) in venous blood with no change 
in arterial PA. L-Arg produced inhibition of PA in 
venous blood (-30±14%; p=0.03) which was similar in 
magnitude to that observed with Ach, but without change 
in arterial PA. Combined administration of L-Arg and Arh 
did not further inhibit PA (-8±10%; p=ns compared to L•
Arg alone). Thus, the nitric oxide substrate inhibits in 
vivo platelet function, but it does not enhance the 
blunted inhibition of platelet aggregation with EDRF in 
atherosclerosis. 
963·43 
Saline 1.0±.0 1.0±.0 -1 -1:1::1 
NO 2xl(}8mol/min 1.1:1::.1 1.0±.0 %4 11:1::6 
2xl().7 1.1:1::.1 13:1::.1 5:t.7 19:t5t· 
2xl0-6 1.6:1::.2 2.0:t.3t l%4t 33:1::2t· 





Acetylcholine 2.7:1::.3 t 3.3:1::.4t 9:1::.4 28:t7t· 0:1::7 
Nitroglycerine 2.4:l::.6t 33:1::.8t 17:1::6 44:t8t 37:1::13t 
--=lIE; ~.05 VI .IDda; tp<.05 VI saIine 
Boluses of NO into the left main coronary caused stepwise increases in 
CBFV. Peak .1CBFV at SxIQ-6mol bolus (5.4:1::.1 peaklresting velocity) 
was similar to that caused by adenosine (4.4:1::.7). NO infusions did not 
change blood pressure or heart rate. Conclusions: Epicardial coronary 
dilation at the NO infusion site was observed at 1I1Oth the dose needed 
for microvascular dilation. NO infused in vivo at ~8xlO-6mol/min 
caused microvascular coronary dilation similar to Ach and boluses of 
~ 10-6 mol caused microvascular dilation similar to adenosine. 
Direct NO infusions may provide a tool for assessing the circulation. 
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963·44 
IntnvascuIar Ultrllouncl Rewais Sizeable. NeurGilenlcally MedUited Changel in 
Lqe C-.y v .... Cro..sec:tlonal Area 
JUie A. Kovach, John S. GoIkiener, Yi·Hwa Uu, Marian M. TIunher, Richard L Venier. 
Georgetown UniYInity School 01 Madcine, Washington, D.C. 
PnMclUI atudea 01 auIanonic neMlU8 system influences on coronary cIameter have been 
linited ~ !he use 01 piazDeIectric crystals ~ted on !he Y88S8i adventitia with 
intnNancUI .mriaIration 01 catecholamines and rooscariric agents. The reported effects 
on caIcUatad left ciraJnftex (lCx) coronary cross-sectional area (CSA) _less than 10%. 
In !lis sIuctt, WI damonaIrated major alterations in LCx CSA in response to vagotomy and 
stellate stinUation utilizing intravascular ultrasound (25 MHz rotating msciJcer witl1n a 
3.9F monorail sheath) to 8YOid !he possibility 01 pericoronary neMI damage. In 9 chloralose 
InISIhetizlld dogs, \I1ilateraI vagotomy (right in 3, left in 6 dogs) decraased LCx CSA from 
8.69±0.85 to 7.10±.0.81 rnrn2 or by 18.3%. Bilateral vagotomy (n-"'d) further decreased LCx 
CSA to 5.42±0.68 rnrn2 or by a total 0136.8% (p=.023). HR increased from 126.8±5.7 to 
133.9±5.1 ~ after lIlilaterai and to 155.0±10.5 ~ after bila1eral vagotomy (p=.03). 
Insignificant in SBP resulted in an IllChanged RPP. In 8 dogs, LCx CSA was 
measued alter biIataraI vagotomy ciJring stellate stimulation without RPP control and with 
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ConcIutIonI: Vagal influences on LCx CSA n neariy <bi*I those pI'6'IiousIy reported for 
inb?Moously acininistered muscariric agents. The two vagi swear to contribute ~Iy to 
maintairing LCx resting dlated tone. Vagotomy~nciJced coronary constriction occurs 
despite an increased HR suggesting a neurogenic and not metabolic basis. Increased LCx 
CSA cUing stellate stimulation is associated with increases in HR. BP, and RPP. When 
dstendng Pf'8SIU8 and RPP n controlled, increases in CSA do not 0CClJ' dJring stellate 
stiroolation. Thus, dstandng pressure plays a key role in !he vasodlatation prod.oced by 
stellate stinUation. 
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964·45 
Placebo Controlled Study of the Effects of Inhibition 
of Prostaglandin Synthesis with Indomethacin on 
Regional Blood flow In Congestive Heart Failure. 
Jonathan Townend, Christopher Lote. William Littler. Michael Davies. 
University of Birmingham, UK. 
Circulating prostaglandins are elevated in heart failure but their physiological 
role has not been studied in detail. We have investigated the effect of 
inibition of prostaglandin synthesis with indomethacin in a group of 12 
patients with severe (NYHA class III and IV) heart failure. Blood pressure 
(BP), cardiac output (CO) (Doppler measurement of aortic flow). renal blood 
flow (RBF) (calculated from renal plasma flow measured by para-amino 
hippurate clearance). glomerular filtration rate (GFR) (endogenous creatinine 
clearance), urinary sodium excretion, forearm and calf blood flow (venous 
occlusion plethysmography) were measured at baseline and at 1 and 2 
hours after a single. double blind. oral dose of indomethacin 50 mg or 
placebo. At 2 hours an intravenous infusion of exogenous prostaglandin 
E1 was administered for 1 hour and measurements repeated. 
Because of wide variation in baseline values changes from baseline rather 
than absolute values were compared between indomethacin and placebo 
groups. 
Indomethacin caused no change in BP but a fall in CO (mean change from 
baseline at 2 hours = -0.4 L. placebo = -+Q.3L, pc:(1.05); a fall in RBF (mean 
change from baseline at hour 2 = ·79m1. placebo = +51 mi. p<O.OI). a fall in 
GFR (mean change from baseline at hour 1 = ·15mlhnin, placebo = +15 
mllmin, p<O.02). a fall in unnary sodium excretion (mean change from 
baseline at hour 1 = ·9 umollmin. placebo = +8 umolhnin. pc:0.05) and a fall 
in calf blood flow (mean change from baseline at hour 2 = -0.2 mll100mlhnin. 
placebo = -+Q.1 mIl100mllmin. p<O.01).The change in forearm blood flow 
was not sigificantly different from placebo. Calculated systemic vascular 
resistance. renal vascular resistance and calf vascular resistance all 
increased from baseline after indomethacin in signdicant contrast to the 
placebo group. All changes were reversed after intravenous infusion of 
exogenous prostaglandin El 
Conclusion: prostagandins playa significant "counter· regulatory role' in 
heart failure. They are important in the maintenance of renal blood flow and 
function and also have a role in the regulation of limb muscte blood flow. 
ABSTRACTS 
964·46 
Flosequinan Attenuates The Adverse Renal Effects of 
Indomethacin In Patients With Heart Failure 
Stephen S. Gottlieb, Michael L. Fisher, Catherine Krichten, Richard 
D. Patten, Shawn Robinson, Michael Pressel. University of 
Maryland School of Medicine, Baltimore, MD. 
The systemic vasoconstrictor effects and direct renal actions of 
indomethacin (Indo) may cause important changes in both renal 
plasma flow (RPF) and glomerular filtration rate (GFR) in patients 
with congestive heart failure. Since flosequinan (Flo) is a vasodilator 
with the potential to oppose the vasoconstrictor actions of Indo, we 
sought to detennine if Flo limits the adverse renal consequences of 
Indo. We compared the renal effects of Indo (75 mg) both before 
and after 6 weeks of Flo therapy. Mean arterial pressure (MAP). 
GFR (by 99lllTc-DTPA urine accumulation, mVmin/1.73m2) & RPF 
(by 13lI-Hippuran serum disappearance, mil min/I.73m2) were 
assessed in 30 patients with severe CHF before any in.tervention 
(Pre), after a single dose of Indo, after 6 weeks of Flo, & after a dose 
of Indo following chronic Flo therapy (F1o-Indo),where" = p < 0.05 
v. Pre: 
Pre Indo Flo I'lo+Indo 
GFR 42 35 44 43 
RPF 247 228* 24K 270 
MAP 97 99 9~ 102 
Indo ncreased decreased RPF before F 0 admintstration, but i 
RPF after chronic administration of Flo (p < 0.05). Similarly, Indo 
decreased GFR initially, but did not change GFR after chronic Flo 
therapy. In contrast, indo had no significant impact upon MAP prior 
to Flo, but increased MAP after chronic Flo (p < 0.05). Chronic 
flosequinan therapy itself caused no change in GFR, RPF, or MAP. 
We conclude that flosequinan attenuates the adverse renal effects 
of indomethacin in patients with CHF. Even though indomethacin 
was more likely to cause systemic vasoconstriction after flosequinan 
therapy, the renal actions of indomethacin were probably limited by 
the changes in renal physiology resulting from flosequinan-induced 
improvements in cardiac perfonnance. 
964·47 
Tbe Renal Response to Dobutamine and Nitroprusside in Patients witb 
Cbronic Heart Failure during Frusemide Induced Diuresis. 
JM Good. G Frost. J Meek. P Law. M Gonzalez, CM OaIdey. JGF Cleland. 
Dept of Medicine (Cardiology) Royal Postgraduate Medical School. 
Hammersmith Haspilal. London UK. 
Both dobulallline and sodium nitroprusside (SNP) can improve haemodynamic 
status in heart failwe and raise renal blood flow but have opposite effects on 
renal perfusion presswe. The aim of the present study was to detennine 
whether increases in renal blood flow or perfusion pressure would enhance a 
frusemide-induced diuresis in chronic heart failwe (CHF). 
8 patients with CHF requiring diwetics were studied. Sodium intake was fIXed 
for three days prior to each study and medication was witheld on study days. 
Frusemide was given by hourly bolus in identical fashion on each of 3 study 
days. (mean tolal for the 4 houn was 19m9) to maintain a moderate. constant 
diuresis. PAH was infused to calculate renal plasma flow (ERPF). Patients 
voided urine hourly for 4 hours. During the 2nd and 3rd hours. vehicle (normal 
saline) was infused at 3Oml/hr (hen 60 ml/hr respectively (placebo) and 
dobulallline or SNP added in random. single-blind fashion on 2 of the 3 study 
periods. Dobulallline was infused at ll1g/kg/min during the 2nd hour then 
incremenlally up to 1OJ.Lg/kg/min. for the 3rd hour. SNP was infused at 0.2 
11g/kg/min for the 2nd hour then increased incremenlally up to O.6jlg/kg/min 
for the 3rd hour. Plasma and urine electrolytes were measured hourly and 
plasma saved for measurement of ANP. catecholamines and renin. ERPF 
increased from 174±39mVmin to 300:t9OmVmin during high dose dobulallline 
infusion (p<0.003). ERPF tended to rise during low-dose SNP but feU towards 
baseline during high-dose infusion. Mean arterial pressure did nOl change 
during dobulallline infusion. but fell (S7±9 to 7I±9mmHg) during the high 
dose infusion of SNP. Calculated renal vascular resistance fell with both 
agents. Urine volume during higher·dose infusions was greater with 
dobutamine compared to SNP (260±87; 19l±61 and 2l6±77ml for 
dobulallline. SNP and vehicle respectively. p<O.02) as was sodium output 
(21±10. 14±S. IS±7; p<0.03). Treatment that improves central 
haemodynamics and reduces renal vascular resistance may impair the response 




Does Digoxin Facilitate The Renal Response To 
Furosemide In Chronic Heart Failure? 
1M Good. E Sbarouni. G Frost. 1 Meek. CM Oakley. IGF 
Cleland. 
Dept of Medicine (Cardiology) Hammersmith Hospital. London 
UK. 
Digoxin improves quality of life and functional s~tus in patients 
with chronic heart failure (CHF). Withering originally described a 
diuretic effect of digoxin but no clinical trials to substantiate this 
observation have been perfonned this century. A diuretic as well as 
inotropic effect of digoxin could contribute to its clinical effects. 
8 patients with CHF treated with diuretics but not digoxin were 
studied. Sodium intake was fixed for 3 days prior to study. All 
medication was witheld on study days. Furosemide was given by 
hourly bolus in identical fashion on each of 2 study days (mean 
total for 4 hours was 19 mg) to maintain a constant. moderate 
diuresis. PAH was infused to calculate renal plasma flow. Patients 
voided urine hourly for 4 hrs. Digoxin 500llg or matching placebo 
was infused over 30 mins. after the first urine sample. Plasma and 
urinary electrolytes and plasma renin. atrial natriuretic peptide and 
catecholamines were measured hourly. Stroke volume (SV) was 
measured at 15 min intervals by thoracic bioimpedance (Bomed). 
There was no change in blood pressure or SV after digoxin but 
heart rate fell (71±10 to 68±11. p<0.04) during the final hour. 
Urine volume did not change (227±79 vs 207±82 and 247±74 vs 
228±82 and 258±88 vs 232±85mls during the 3 hrs following 
digoxin and placebo respectively. NS). Sodium and chloride 
excretion rose during the 2nd and 3rd hrs following digoxin 
administration (21iS vs 15±7mmol and 21±6 vs 16±8mmol. 
p<o.03 for sodium and 21 vs 13mmol and 19 vs 13mmol. p<O.OI 
for chloride excretion after digoxin and placebo respectively). 
Digoxin augments a furosemide induced natriuresis in patients 
with CHF. 
964·49 
D.pr .... d Ik.l.tal muscle prot.1n Iynthetlc rat. In cNonlc L.ft 
Ventricular Dysfunction 
Lindsay Morrison, Alastair Gibson, K.n Smith, Michael J. 
Renni •• The Cardiothoracic Centre, Liverpool, United Kingdom. 
Effort intolerance, muscl. weakness and muscle wasting 
commonly occur in advanced heart failure. We have 
investigated protein synthetic rates of Quadriceps muscle in 
vivo using stable isotope techniques. We studied 7 men with 
left ventricular dysfunction (NYHA liB), mean aged 58 years 
(46-68), mean w.ight 69 kg (60-75 kg), and compar.d the 
results to those from 25 control subjects (mean age 45 yrs (19-
82), mean weight 74 kg (53-105). L-(1-13C) leucine was infused 
after an overnight fast over a 7 hour period to achieve steady 
state plasma leucine labelling, following which a percutaneous 
biopsy was taken from Quadriceps muscle. Muscle protein 
synth.sis (k.) was calculated by comparing 13C leucine 
enrichment of muscle wit~ that of the plasma, measured using 
gas chromatography mass spectrometry. Muscle DNA 
concentration was significantly higher in cardiac patients 
(3.76:0.55pg per mg protein) relative to normal (2.04:8.89, 
p<0.01). Muscle protein synthesis (k.) was 0.033:0.010 % 
hr" (mean : SO) for cardiac patients, compared to 
0.045:0.015 for control subjects (p<0.01). Muscle RNA 
activity (ie protein synthetic rate per RNA) which gives an index 
of the efficiency of protein synthesis, was 0.08: 0.03 pg of 
protein.h·' of RNA in cardiac patients compared to 0.018: 0.08 
in control subjects (p< 0.05). 
Conclusion: In chronic left ventricular dysfunction, even in the 
absence of clinically overt muscle wasting, there is substantial 
depression (27%) of skeletal muscle protein synthesis. 
964·76 
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Skeletal Muscle Changes in Chronic Congestive Heart FaUure. 
10hn R. Minotti, Barry M. Massie, Prem Pil1ay, Lauren Wells, 
Gary Dudley. University of California. VA Med Center, San 
Francisco and Marshall University, Huntington, West Virginia 
Exercise tolerance is impaired in patients with congestive heart 
failure (CHF) and is proportional to the degree of skeletal muscle 
dysfunction. To determine if intrinsic muscle abnormalities are 
responsible for these changes, 2 biopsies obtained from the right 
vastus lateralis muscle of 14 CHF patients (pts) and 8 sedentary age 
and weight-matched controls (Con) were analyzed for muscle fiber 
type, fiber cross-sectional area (CSA) and capillary density (CpO). 
CHF pts had a lower proportion of slow twitch oxidative Type I 
fibers than Con (32±3 vs 45±5% p<0.05), and a trend toward a 
greater percentage of fast twitch glycolytic Type lib fibers (35 ±4 
vs 25 ±4 %). In contrast to the usual pattern of larger Type II than 
Type I fibers, which was' seen in the Con, the CSA of Type I 
fibers was larger than that of Type II fibers in CHF pts (6735±462 
vs 5245 ±4741'2; p < 0.05) and also tended to be larger than Type I 
fibers in Con (5830±450I'2). The ratio of CSA of Type II to Type 
I fibers, an index of relative fiber use, was lower in CHF 
(0.79±0.07vsl.05±0.08; p<0.05). Although the CSA of Type I 
fibers in CHF pts was larger, this hypertrophy was not accompanied 
by a commensurate increase in capillarization (CpO for the Type I 
fibers: 0.69±0.04 vs 0.79±0.04 capillaries per 1'2 for CHF vs Con. 
p < 0.05). These results suggest: 1) that a shift to faster muscle 
fibers occurs in CHF; 2) the larger CSA of the slow twitch fibers 
may serve to partially compensate for this transition, but is not 
accompanied by proportional increase in capillaries; and 3) the 
relative low proportion and poor capillary supply of Type I fibers 
could in part account for impaired oxidative metabolism and 
exercise intolerance in CHF. 
964-77 
Skeletal Muscle Changes After Enalapril in Patienu 
Witb Congestive Heart Failure 
Maria Schaufelberger, Gull Andersson, Bengt 0 Eriksson, Peter 
Held, Anna-Greta JOnsson, Karl Swedberg. Departments of 
Medicine and Pediatrics, Ostra Hospital, University of GOteborg. 
Sweden. 
Muscular fatigue in patients with CHF could partly be due to 
intrinsic factors in skeletal muscle. We have studied enzymes and 
glucose metabolism in skeletal muscle in patients with CHF 
before and after treatment with enalapril. Musclebiopsies were 
taken at rest with chonchotome from the vastus lateralis muscle in 
25 patients (mean age 67) with CHF (NYHA II-IV, EFS4O*) 
before and after three months treatment with enalapril. Biopsies 
were also taken from 10 age matched normal subjects. Muscle 
glucose (n=21) was si~candy lower in the patients compared 
with the nonnai subjects 1,63±O.67 mmol/l vs 2,45±1,15 mmol/l 
(p<O,02) whereas glycogen, glucose-6-phosphate, 
creatinephosphate, lactate and A TP showed no significant change. 
At baseline, no significant differences in the enzymes 
phosphorylase, lactate dehydrogenase, citrate synthetase and 3-
hydroxyacyl-CoA-dehydrogenase between the patients and 
controls were found. After treaanent with enalaprll lactate· 
dehydrogenase increased significandy 142±82 J.LmoVg/min va 
168±83IJ.1llOVg/min (p<O,04). 
Conclusion. Only small changes in skeletal muscle biochemistry 
could be demonstrated in these patients with CHF. Treatment with 
enaiapril increases lactatcdehydrogenase which is not previously 
reported. This observation indicate that skeletal muscle changes 
may be important during hean failure therapy. 
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964·78 
Long·term Dynamic Cardiomyoplasty in the Goat is Accompanied by 
Major Degenerative Changes in the Wrapped Lattissimus Dorsi 
Muscl •• 
Caroline Lucas, Frederik van der Veen, Elisa Kloosterman, Jo Habets. 
Hein Wellens. Dept. of Cardiology, Academic Hospital Maastricht. 
In recent years promising reports have appeared about long· term 
hemodynamic results of dynamic cardiomyoplasty IDC)' However, no 
information is available about long·term changes in the wrapped 
latissimus dorsi ILDI muscle. Therefore we evaluated extensively 
histological changes occurring in long-term wrapped and stimulated 
goat LD muscles. 
Methods: 24 goats underwent a DC procedure. Two weeks after 
operation stimulation of the wrapped latissimus dorsi ILDI muscle 
was started using 1 pulse synchronized to every other heart beat. 
Every two weeks the number of pulses was increased resulting in a 
burst of 6 pulses Iburst duration 185msec. burst freQ 30HzI syn· 
chronized to every cardiac contraction with a maximum of 100 LD 
contractions/min after ten weeks. After 3-8 months follow-up the 
animals were sacrificed. Subsequently the LD muscle·heart prepara· 
tus was evaluated histologically using R 11 D 1 0 for fibre-typing, 
alkaline phosphatase to demonstrate capillaries and hematoxilin·eosin 
staining. Results: In all goats the wrapped LD muscle was completely 
composed of type I muscle fibres contrary to the nonstimulated right 
LD muscle 127..±.7% type II. 22 goats demonstrated severe LD mus' 
cle destruction. arterial intimal hyperplasia and nerve damage conco' 
mitant with fatty cell infiltration. Furthermore there was no increase 
in capillary-to-fibre ratio. 
Conclusion: Dynamic cardiomyoplasty using burst stimulation with a 
maximum of 100 LD contractions/min results in complete LD muscle 
transformation but is unfortunately accompanied by major degenera· 
tive changes in the wrapped muscle destruction of major part of it. 
More research is necessary as to optimal surgical technique and LD 
muscle stimulation. 
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965·92 
Values of Pulmonary Venous Flow Velocity Patterns in 
Evaluating Participation of Left Ventricular Systolic and 
Diastolic Dysfunction as a Cause of Heart Failure 
Reiko Nagano, Tohru Masuyama, Jung·Myung Lee, Jun Tanouchi, 
Masatsugu Hori, Osaka University Medical Center, Osaka, Japan 
In hypertensive (HT) pts either systolic or diastolic dysfunction may 
independently evolve, progressing to different forms of heart failure 
(HF). It is important, from the treatment standpoint, to evaluate HF 
due primarily to systolic or to diastolic dysfunction in individual pts. 
To clarify whether the measurements of Doppler mitral andlor 
pulmonary venous flow velocity patterns provide valuable information 
in assessing primary cause of HF from the functional viewpoint, we 
studied 18 HT pts with HF and 43 HT pts without HF. Peak early 
diastolic filling velocity (E, em/s), peak filling velocity at atrial 
contraction (A, em/s), FJA ratio and isovolumic relaxation time (IRT, 
ms) were determined in mitral flow velocity patterns. Peak systolic 
forward flow velocity (S, el'tlls), peak diastolic forward flow velocity 
(D, em/s) and SID ratio were determined in pulmonary venous flow 
velocity patterns. End-systolic stress - fractional shortening relation 
was used to divide HT pts with HF into two subsets: 10 pts without 
systolic dysfunction (SDF) and 8 pts with SDF. Results are: 
Pts IRT E FJA S D SID 
HF(·) 88±26 51±13 .7±.2 61±IO 34± 7 1.8±.4 
HF(+),SDF(-) 62±21" 76±17* l.5±.4* 65±2l 64±16" l.O±.2" 
HF(+),SDF(+) 65±16 80±23" 1.5±.3* 38±13"t 67±17* .6±.4" 
Values are mean ± S.D., *p<.OI vs HF(·), tp<.OI vs HF(+),SDF(.) 
Any indexes of mitral flow velocity patterns and pulmonary venous D 
uniformly changed in pts with HF irrespective of the presence or 
absence of systolic dysfunction. On the other hand, pulmonary venous 
S decreased only in pts with HF due primarily to sy~tolic dysfunction. 
Conclusions: (I) Mitral flow velocity patterns uniformly changed in 
association with HF, and thus failed to imply HF is due primarily to 
systolic or diastolic dysfunction. (2) Analysis of pulmonary venous 
flow velocity patterns, in contrast to mitral flow velocity patterns, 
provides unique and useful information in evaluating whether HF is 
due primarily to systolic or to diastolic dysfunction in individual pts. 
ABSTRACTS 
965·93 
Sodium: A Modulator of Left Ventricular Hypertropby in 
Renal Hypertension. 
lean Luc Pasquit, Bernard lover. Guilhem du Cailar. Albert Mimran. Centte 
Hospitalier Universitaire. MontpeIIier. France. 
In order to assess the role of dietary sodium (Na+) with or without chloride 
(Cn on the development of hypertension and left ventricular hypertrophy (L VH). 
49 male Sprague-Dawley rats with 2K·IC hypertension (Clip) received one of the 
following diets for 4 weeks after clipping: normal sodium Chloride (NS : Na+ 
and cr 77 mmol/l drinking water). sodium citrate (CIT : Na+ 77 and CI' 0 
mmol/l) and low sodium chloride (LS : Na+ and CI' 0 mmol/l). Sham-<lperated 
rats were used as control (Sham). At the end of studies awake systolic arterial 
pressure (SAP. mm Hg) was measured and LVH was approached by heart weight 
and left ventricular weight (HWI and LVWI respectively. mg/g body weight). 
Cardiac index (CI. mVmin.kg) was estimated using 57 Co-labelled microspheres 
in anesthetized animals. Results were expressed as mean and standard error of the 
mean (SEM) and analyzed by a IWI>-factor analysis of variance. 
Diet NS CIT LS 
Group Clip Sham Clip Sham Clip Sham 
SAP 180±6* I32±2 183±1l* 129±2 163±3* 132±1 
CI 185±23 235±12 164±17 200±17 219±12 2I3±5 
HWI 3.8±0.3* 3.I±O.l 3.6±0.2* 3.1±0.1 3.1±0.1# 2.9±0.1 
LVWI 2.7±O.2* 2.I±O.1 2.6±O.I* 2.2±0.1 2.2±0.1# 2.0±0.1 
* p<O.05 clip vs sham; # p<O.05 vs corresponding NS groups 
SAP and CI were similar in all hypertensive animals regardless of the diet NS 
and CIT hypertensive rats showed identical L VH whereas no L VH occurred in 
LS despite a similar final awake pressure level. The anion linked to Na+ does 
not influence the effect of sodium on hypertension and L VH. whereas 
suppression of dietary sodium prevented L VH without affecting 
hypertension. These results indicate that sodium per se is a modulator of the LV 
response to hypertension in this model. 
965·94 
Cardiovascular Adaptation to Cyclosporine-Induced 
Hypertension in Cardiac Transplant Recipients 
Hector O. Ventura. Carl I. Lavie. Franz H. Messerli. Frank W. 
Smart, Dwight D. Stapleton. Ochsner Heart and Vascular Institute, 
New Orleans. LA 
Anerial hypertension is a frequent complication of cyclosporine 
therapy in heart transplant recipients. We studied cardiovascular 
adaptation to cyclosporine-induced hypertension by determining 
hemodynamic and echocardiographic indexes in 25 cardiac 
transplant recipients matched by mean arterial pressure (MAP). age, 
sex. height. and weight with 25 essential hypertensive patients; 25 
normotensive subjects matched by age. sex. and body habitus served 
as controls. Results (mean ± SEM): 
Essential 
NormoccnsiYe3 Hypertmsim 
MAP.mmHg 87±2 117±4" 
Stroke Volume Index. ml/m2 49 ± 7 40 ± 6 
Cardiac index,l.Im2 3.a 02 3.0 ± 0.1 
SVR.dynes·sec-cm-5 1280±19 1760±2D-
LV mass index. g/m 102 ± 8 126 ± 10'" 
EF. % 69 ± 5 65± 5 
Cardiac 
~
117 ± 4* 
29 ± 3*+ 
2.4 ±O.l*+ 
2037± 19* 
145 ± 3'+ 
58 ±4*+ 
"p < 0.01 vs nonnotensives; + p < 0.05 vs essential hypertension 
469A 
The results indicate that both established hypertension and cardiac 
transplant hypertension are associated with markedly increased 
systemic vascular resistance (SYR). However, after heart 
transplantation. hypertension is associated with a higher SVR 
(+15%. p=O.07). lower cardiac ind~x. stroke volume index. and 
stroke work (-25%; p<O.OI) compared with patients with established 
essential hypertension at the same level of MAP. The cardiac 
adaptation to cyclosporine-induced hypertension is associated with a 
greater increase in L Y mass index (concentric. LV hypertrophy) and 
impaired left ventricular systolic performance. The presence of 
cardiovascular adaptive changes in patients with cyclosporine· 
induced hypertension following cardiac transplantation may increase 
the morbidity and mortality of these patients. 
470A ABSTRACTS 
965-95 
Discrepancy between Systolic Elastance and Flow 
Generating Capacity of Concentric Hypertrophied Heart in 
Hypertensive Patients 
Makoto Suzuki,Mareomi Hamada, Takashi Ohtani,Mitsunori 
Abe,Hiroshi Matsuoka, Yuji Shigematsu, Tak-umi Sumimoto, 
Kunio Hiwada. Ehime University. Ehime, Japan. 
The power generation of the heart is composed of two major 
mechanical factors, which are the elastance and now generations. To 
evaluate the systolic elastance and now generating capacity of the 
concentric hypertrophied heart (CHH) in untreated hypertensive 
patients (!{f), 35 !{f and 27 matched normotensive subjects (N) were 
studied using pulsed Doppler, M-mode and two-dimensional 
echocardiography. !{f were divided into two groups, which had CHH 
(HT2;n=24) or not (!{fl;n=ll). In this study, peak stroke power 
(SP), end-systolic wall stress/end-systolic volume index ratio 
(WS/ESVI) and maximal ejection force (Fmax) were examined as the 
indexes of cardiac perfomante, elastance and now generation, 
respectively. WS/ESVI represents the maximal value of time-varying 
elastance, and Fmax renects the initial impulse, which generates large 
change in momentum of blood. According to Issaz (J Am Coli Cardiol 
1991 ;17: 112). Fma'( was calculated with the formula: F=pSava2 + 
d(pVkva)/dt where p is blood's density. Sa is cross-sectional area of 
the aortic anulus. va is instantaneous out now velocity. V is 
instantaneous left ventricular vol ume. and k is momentum coefficient 
on the basis of unsteady Bernoulli equation. 
mBP L VMI SP WS/ESVI Fmax 
(mmHg) (glm2) (xlO-4mW) (kdynem2/cm2ml) (kdyne) 
N 91±9 87±1l 6.3±1.1 2.23±O.71 44±7 
HT I 113±8* 87±8 8.4±1.2* 3.07±O.71 * 45±4 
HT 2 117±8* 131±18*, 7.8±1.6* 2.46±0.58 34±8*' 
*p<.OI vs.N, 'p<.OI vs.HTI mBP=mean blood pressure, LVMI=left 
ventricular ma~s index. 
Conclusion: the concentric hypertrophied heart in hypertensive patients 
was a well-preserved elastance generator, but a weak now generator. 
965-106 
Diastolic: Filling and Reversal of Left Ventric:ular Hypertrophy 
Federico Soria, Franz H. Messerli, Dagnovar Aristizabal, Edward D. 
. Frohlich. 
Ochsner Medical Institutions, New Orleans, Louisiana 
Reversal of L VH has been associated with increased ventricular 
filling (L VF). However, whether this reversal is due to a reduction 
in arterial pressure or to a reduction of L VH is unclear. We did a 
meta-analysis, pooling 17 individual studies that included a total of 
284 patients who were treated with beta-blockers (BB), ACE 
inhibitors (ACE-I), calcium antagonists (CA) or other drugs for an 
average of 6.3±3.5 months (mean ± standard deviation). Reduction 
of left ventricular mass (L VM) and reduction of mean arterial 
pressure (MAP), as well as increase in L VF were expressed as 
percentage of pretreatment values. L VF was assessed by either 
echocardiogram (Doppler or planirnetry) or radionuclide imaging. 
All 
BB ACE-I CA Studies 
Measures (% change from baselin-e-) --
LVM 9.6 16.8 13.6 12.7 
LVF 13.9 16.6 11.1 12.7 
MAP 13.6 17.9 10.8 14.5 
Regression Analysis (r values) 
LVMvsLYF +0.98"'''' +0.77 +0.75'" +0.75"''''''' 
MAPvsLYF -0.32 +0.39 +0.42 +0.31 
MAP vs LVM -0.43 +0.56 +0.14 +0.32 
"'p<O.05; "''''p<O.OI; ·"'·p<O.OOI 
In all treatment groups, the correlation between the change in L YF 
and the change in L VM was better than the one between the change 
in L VF and the change in MAP. We conclude that the increase in 
L VF after antihypertensive therapy depends predominantly on the 
reduction in L VH rather than on the fall in arterial pressure. 
965·107 
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Plasma Renin Activity and Left Ventricular Adaptation to 
Hypertension. 
Guilhem Du Cailar, Jean Ribstein, Jean C Macia, Alben Mimrnn. 
Lapeyrooie Hospital. University Montpellier,France 
The level of arterial pressure is not the sole determinant of cardiac 
adaptation to hypertension. In order to identify others factors (such 
as preload as well as neuro-humoral factors) we categorized by M•
mode echocardiography, 177 never treated patients with mild to 
moderate hypertension of short duration, according to values of end•
diastolic relative wall thickness (RWT) and left ventricular mass 
index (LVMI). Upper normal limits for LVMI and RWT was 
estimated as 2SD above mean values in 165 normal subjects. Mitral 
regurgitation was excluded in all patients by Dopplet 
echocardiography. Among hypertensive patients, LVMI and RWT 
were normal in 43% (group I), whereas 20% had increase RWT 
with normal L VMI "concentric remodeling" (group 2), 24% had 
concentric hypertrophy (increase both LVMI and RWT) (group 3) 
and 13% had increased LVMI with normal RWT (eccentric 
hypertrophy) (group 4). Results presented as rneans±SD. 
group 1 group 2 group 3 group 4 
n=77 n=35 n=43 n=22 
MAP nunHg 114±W 118±W 123±11 " 121±W" 
FS % 40±7 40±7 40±8 39±7 
CI Vmin/m2 3.4±O.9 2.2±O.7* 3±O.7* 4.6±1.4"'£ 
PRA nglml/h 2.07±2 1.93±1.3 1.69±1.7 1.08±O.9* 
MAP:mean artenal pressure, FS: fracttonal shortenmg, CI: cardiac 
index, PRA: plasma renin activity. ANOVA • P<O.05 versus group 
1. £ P<O.05 versus group 3. 
In addition the acute response after ACE-inhibition (Captopril 
50mg) of MAP was significantly attenuated in group 4 when 
compared with group I. 
Conclusion: these results suggest that the effect of arterial pressure 
on the heart may be modulated by volume overload (low PRA and 
high CI) in hypertensive patients with eccentric LV hypertrophy and 
normal LV function. 
965·108 
Aging and the Heaodyna.ic Response to Posture in 
Essential Hypertension 
Robert Fagard, Jan Staessen, Antoon Amery. Hypertension 
Unit, University of Leuven KUL, Leuven, Belgium. 
The effect of age on the hemodynamic response to a 
change in posture was studied in 110 untreated 16- to 
64-year old men with essential hypertension, in whom 
WHO stage III complications were excluded and who were 
alive and free of cardiovascular disease 7 years after 
the hemodynamic study. Brachial artery pressure was 
measured intraarterially, pulmonary capillary wedge 
pressure by use of a Swan-Ganz catheter and cardiac 
output by the direct 0 -Fick method. The change of 
systolic and diastolic 5rterial pressure, from 153 t 
24/83 t 16 (SD) mmHg after 30 min of supine rest to 156 
t 24 (P < 0.05) 1 92 t 16 (P < 0.001) mmHg after sitting 
for 10 min, was not significantly (P > 0.10) related to 
age. Heart rate (HR; + 9 b/min) and systemic vascular 
resistance (SVR; + 4.5 mmHg/l/min) increased 
significantly (P < 0.001) on sitting; cardiac output 
(CO; -1.7 l/min) , stroke volume (SV; -30 ml) and 
pulmonary capillary wedge pressure (Pc; -2.2 mmHg) fell 
(P < 0.001). Whereas the postural changes of HR (P < 
o. 01), CO (P < O. 001), SV (P < 0.001) and Pc (P = 0.06) 
were less pronounced in older than in younger subjects, 
the increase of SVR was not related to age (P > 0.10). 
The slopes of the postural changes of HR and of SVR 
differed significantly (P = 0.01). The results were not 
confounded by the level of blood pressure or weight. 
In conclusion, the increase of HR in response to the 
upright posture is impaired with aging, whereas the 
reflex control of the peripheral vasculature is 
preserved. The smaller postural falls of CO, SV and Pc 
in older subjects suggest less thoracic blood volume 
displacement to the lower parts of the body, possibly 
due to a lesser peripheral venous distensibility. 
JACC Vol. 21, No.2 
February 1993:471A 
965·109 
Are Moderately and Severely Hypertensive Voaen 
Misclassified and Overtreated? 
Joseph A. Diamond, Maria Ardeljan, Arlene Travis, Craig 
Vilkenfeld, Kevin L. Martin, Lawrence R. Krakoff, 
Robert A. Phillips. Mount Sinai School of Medicine, 
New York, New York. 
Criteria for diagnosing and treating moderate and 
severe hypertension has been derived from studies that 
often excluded women. In mild hypertension, a "whi te 
coat" response is more prevalent in women. Ve 
hypothesized that women with more severe forms of 
hypertension would demonstrate a similar pattern. Ve 
studied 22 asymptomatic and untreated patients with a 
diagnosis of moderate or severe hypertension based on 
at least 3 separate office visits with diastolic blood 
pressure (DBP) > 105 mm Bg. To determine 1£ a "whi te 
coat" response - was .present, 24 hr ambulatory BP 
recordings were obtained with a Space labs monitor. 
VOMEN (n=9) MEN (n=13) p value 
Age 46+12 50+8 NS 
Office SBP 175~16 178~20 NS 
24 hr SBP 158~11 172~21 <0.05 
Office - 24 hr SBP 17~12 6~13 <0.05 
Office DBP 111~11 118~7 NS 
24 hr DBP 103~12 112~10 NS 
Office - 24 DBP 8~4 6~8 NS 
Although office systolic-BP (SBP) was similar, women 
had a "white coat" response, and thus had significantly 
lower ambulatory systolic BP. Conclusion: Ambulatory 
BP characteristics may be inherently different in women 
and men with moderate and severe hypertension. Current 
strategies for treating women with moderate and severe 
hypertension may result in misdiagnosis and 
overtreatment, since they are predominantly based on 
results of studies which relied on men's office BP. 
965·120 
Do Late Potentials Predict Future Sudden Death in Hypertensive Patients7 
Lianmin Ma, John Turner, Udho Thadani 
University of Oklahoma, Oklahoma City, OK 
Late potentials (LP' 51 detected by signal averaged electrocardiogram 
(SAECGI have been associated with a higher incidence of future sudden 
death and malignant ventricular arrhythmias in survivors of an acute 
myocardial infarction. Abnormal SAECG' s characterized by prolonged ORS 
duration and higher prevalence of LP's have been reported in patients with 
uncomplicated hypertension who have left ventricular hypertrophy (LVHI. 
However, the prognostic value of LP's in hypertensive patients to predict 
future episodes of sudden death is not known. We recorded 
echocardiograms and SAECG's in 144 consecutive hypertensive patients 
without a previous history of myocardial -infarction or ventricular 
arrhythmias. Of these 144 patients, 103 patients have been followed for 
at least a period of one year (range 12 to 18 months) and form the basis 
of this report. Forty six patients had LVH and 57 patients had no LVH by 
the standard echocardiographic LV mass criteria. Nine patients had LP's 
as defined by SAECG ORS duration> 114 ms and RMS < 20 /Nor LAS 
>38 ms; 8 in the LVH group and one in no LVH group. At one year of 
follow-up, 2 patients had sudden death [one in the LVH and 1 in the no 
L VH groupl and both these patients did not have LP's. Conclusion: late 
potentials were more prevalent in hypertensive patients with L VH but did 




The Relation of Morning Rise in Blood Pressure (MR) to Pres•
sure Response to Exercise and Mental Stress 
Yasuko Suzuki, Iwao Kuwajima, Kenichi Milani, Kizuku 
Kuramoto, Tokyo, Japan 
Morning rise in blood pressure (MR) has been shown to be asso•
ciated with the occurrence of myocardial ischemic events and 
stroke. We monitored ambulatory blood pressure (BP) and physi•
cal activity in 47 hypertensives using ABPM 630 (Nippon-Cohlin, 
Ltd.) and ACfIVEfRACER, equipped with a 2-directional accel•
eration sensor (GMS Ltd, Tokyo) for detection of MR. To evaluate 
the relation of MR to the BP response to exercise and mental 
stress, handgrip and arithmetical tests were conducted. MR was 
defined as rise in BP ~ 50 mmHg during the early morning (4:00 
to 8:00 AM) compared with the lowest basal BP. MR was seen in 
21 patients (45 %) and showed 2 distinct patterns, in one of which 
BP rose steeply after waking-up (group 1: 13 patients) and in the 
other of which BP started to rise gradually durin2 sleep (group 2: 8 
pts.). 200 group \ 160 grou~2 : 
120 SBP : 
80~ 
40 DBP ACT: 
o 2 4 6 8 TIME 00 2 4 6 B TIME 
The mean age of group 1 was higher than that of group 2 (74 vs. 
60 years; p<O.05). BP reached its basal value earlier in group 2 
than in group 1 ( 5.8 vs. 4.8 hour before awakening). The BP value 
and number of activity counts in both groups were comparable. 
Although the pressor response to exercise of the two groups was 
similar, that to mental stress in group 1 was more augmented than 
that in group 2 (44125 vs. 27/11 mmHg). 
Conclusion: there are two types of MR, the mechanism of which 
may differ. MR which begins during sleep was more common in 
older pts. and to be related to mental stress, while that which 
begins immediately after awakening, was more common in 
younger pts. and possibly related with physical activity. 
965·122 
471A 
Left Ventricular Geometry Predicts Blood Pres•
sure Response to Diet in Hypertension 
Antonello Ganau, Mauro Pisano, Caterina Puddu, 
PierSergio Saba, Giuseppe Piga, Giuseppe Real•
di. Clinical Medicine, Sassari, Italy. 
We investigated whether left ventricular (LV) 
geometry predicts blood pressure (BP) response 
to non-pharmacological treatment in essential 
hypertension (H). Plasma renin activity (PRA), 
24-hour urinary sodium excretion (UNa), M-mode 
echocardiographic LV mass index (LVMI) and 
relative wall thickness (RWT) were assessed in 
74 untreated patients with mild to moderate 
H. Both LVMI and RWT were normal in 34 pa•
tients (group 1), whereas at least one of the 
two indices was increased in 40 (group 2). 
Patients were then recommended to reduce 
sodium intake and' lose body weight if over•
weighted. BP was measured at 2 weeks inter•
vals. After 2 months, 2S patients had diastol•
ic BP (DBP) S90 mmHg and continued diet, while 
49 patients had DBP >90 and needed drugs. BP 
before diet was similar in patients who re•
sponded to diet (lSO±lO/lOl±7) compared to 
those who remained hypertensive (lS4±lS/103± 
9). Forty-seven percent of patients with 
normal LV geometry (group 1) became normoten•
sive with diet, versus only 22% of those whit 
LV abnormalities (group 2) (p<O.02). When BP, 
body mass index, LV geometry, PRA and UNa at 
baseline were entered in a multiple regression 
analysis, only LV geometry was an independent 
predictor of BP response to diet (p<O.02). 
Conclusion: hypertensive patients wi~h normal 
LV geometry are more sensitive to non-pharma•
cological treatment than those with LV hyper•
trophy or concentric remodelling. 
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965·123 
Development of Left Ventricular Concentric Hypertrophy 
Associates with Impairment of Exercise Tolerance in Mi Id 
Hypertension. 
Nobutaka Doba. Toshlo Kushlro. Hlrofuml Tomlyama. Makoto 
Yamashita. Katsuo Kanmatsuse. Shigeakl Hlnohara. Nagao 
. KaJ Iwara. Telkyo University. Surugadal Nlhon Univ. 
Hosplpal. Life Planning Center. Ichihara. Japan 
·To evaluate the relation of evolution of different types 
of ventricular hypertrophy and exercise tolerance in mild 
hypertenSion. 77 middle aged mild hypertensive males aged 
46 .! 7years were followed-up without medication for 5 
years. At the beginning and the end of follow-up. 
symptoll-Ilmlted treadmill exercise test and 
echocardlography were performed. During the 5-year 
observation. casual blood pressure C140.!12194.!12' to 
139.!16/9Z,tl0mmHg) and blood pressure at peak exercise 
(frail 199.!23/94.!14 to aOl.!25/95.!13mmHg) did not change 
significantly. SystoliC functions (cardiac Index (CI). 
ejection fraction and mean velocity of circumferential 
shortening) did not change. but left ventricular mass 
Index(LVMI) (frail 107.!21 to 125.!28g/m2) and relative wall 
thickness (RWTl In diastole (from 0.39.!O.09 to 0.43,!O.IIJ 
Increased slgnlflcantly(p(O.OI). Among those showed 
develoPilent of concentric hypertrophy determined by the 
Increase of RWT(n=24). their treadmill time (TMTl and CI 
decreased significantly (719.!130 to 658.!115sec and 
2.8,!0.7 to 2.4.!0.6L/mln. respectively). However. among 
who showed evolution of eccentriC hypertrophy determined 
by decrease of RWT (n=20). their TMT did not change (from 
689,!137 to 659.!131sec) and CI Increased significantly 
(2.5.!1.0 to 2.9.!0.6L/mln). TMT correlated negatively with 
RWT. but It did not correlate with LVMI. 
Thus. development of concentric hypertrophy Is associated 
with Impairment of exercise tolerance In mi Id essential 
hypertenSion. 
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827·1 10:30 
Variability in Estimation of Total Ischemic Burden in 
Multicentre Studies 
AW Haider, IC Kaski and G Davies. Cardiology Department, RPMS 
Hammersmith Hospital, London, UK 
Total ischemic burden during daily life is routinely calculated using ST 
Holter monitoring. We conducted this study to examine the variability 
in detection and quantification of silent and painful myocardial ischemia 
on 24 hour Holter tapes in two participating cardiac centres. Twenty 
two male patients (mean age 52, range 40-73 years) with angina, 
positive exercise test and documented coronary artery disease 
participated in this study. All patients underwent 48 hour ST Holter 
monitoring, as a part of an ongoing drug trial in the participating 
centres. Tapes obtained were analysed for the presence of myocardial 
ischemia using visual scanning and ST segment trending, on a 
Marquette 8000 laser system in our centre (DC). An ischemic episode 
was defined as ~ Imm of flat or downsloping ST depression, lasting a 
minimum of 1 minute and separated from another episode by atleast 1 
minute. Each tape was reviewed by two experienced operators and for 
each episode the following parameters were measured: total number of 
ST episodes, duration of episode, magnitude of episode and ST 
integral. The same tapes were then analysed at the other participating 
centre (PC) using same hardware, software and analysis protocol 
without the knowledge of previous analysis. The results were as 
follows: 
No. ST episodes 





2.3 ± 4 
16±36 








STintegral -17±17 -53±17 p<0.05 
Thus if criteria are not rigorously adhered to, significantly different 
results on the presence and severity of total ischemic burden may be 
obtained, on analysing the same Holter tape in different cardiac centres. 
This may bear important implications for multicentre studies. 
827·2 
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10:45 
AutonomiC Nervous System Influences on T Wave 
MorphOlogy During Ambulatory Monitoring 
Usa R. Dunn, Brian Johnson, Steven D. Nelson. The Ohio State 
University, Columbus, Ohio 
T·wave inversion, usually the result of myocardial ischemia, 
metabolic abnormalities, or cerebral vascular accident, is known 
to occur in patients without organic heart disease. The purpose 
of this study was to determine if T ·wave inversions are 
associated with alterations in cardiac autonomic nervous system 
tone by examining the power spectrum of heart rate variability 
during ambulatory ECG monitoring. 
Thirty T -wave inversions were recorded from 17 patients (8 men 
and 9 women, mean age 33.7 :!: 7.3 yrs) without organic heart 
disease. Power spectral density analysis was performed just 
prior to and during T·wave inversion (5 min. sampling size). The 
mean power for sympathetic tone was 9.275 :!: 6.694 BPM' /HZ 
before vs. 16.449 :!: 11.632 BPM2/HZ during T-wave inversion 
(p<O.05). In contrast, parasympathetic tone did not change 
significantly during T-wave inversion (3.456 :!: 3.521 BPM2/HZ 
before vs. 3.534 :!: 4.299 BPM2/HZ during T-wave inversion, 
p=nonsignificant). Three of the 17 subjects experienced 
symptoms of palpitations, dizziness, or shortness of breath 
during T·wave inversion. 
Conclusion: T-wave inversions recorded during ambulatory 
monitoring in patients without heart disease are associated with 
augmentation in cardiac sympathetic tone, but without change 
in cardiac vagal tone. These data suggest that cardiac 
autonomic perturbations are able to influence T -wave 
morphology in the absence of myocardial ischemia. 
827·3 11:00 
QT c Interval: How Long Is Prolonged? Evaluation by a New Software Assisted 
Method of QT Measurement rrom 24-Hour Holter Recordlnp 
Janos Molnar, Frederick A Ehlert, Feng Zhang, Jerry S. Weiss, Alan H. 
Kadish, James E. Rosenthal, Northwestern University, Chicago, IL. 
Published upper limits of normal for the Bazen-corrected QT interval (QT.) 
may be too low and may not adequately reflect the true range of QT over 24 
hours. Therefore, we wished to assess the normal range of QT. over 24 hours. 
Since previously described methods of long-term QT measurement are based 
on a relatively small number of determinations, we developed a new method for 
continuous QT assessment. 16 healthy subjects (11 M, 5 F; age 59:1: 12) 
underwent 3-channel 24-hour Holter monitoring. For each subject, data were 
divided into 5 minute segments for analysis. For each segment, the software 
created an average QRST template and measured the average RR interval. QT 
onset and offset for each template QT were manually set by a single investi· 
gator. These QT and RR values were used to calculate the QT, for each 
segment. To compare this technique with standard QT. measurement, 
regression analysis was performed between computer assisted QT, and manual 
measurements (determined as the mean of 5 successive QT) in 5 subjects at 
their maximum, minimum and average heart rates. Results: 1) Software•
assisted QT. corresponded closely with manual QT C' the 2 measurements 
forming a line of identity (R=.95; p<O.OOOl). 2) Measurements (mean:l: SO, 
ms) of 4608 windoWs in the 16 subjects over 24 hours showed: RR interval: 850 
t 100; QT: 4<r1 t 21; QT.: 440:1: 14 (M 435:1: 13; F 449:1: 11). The average 
maximum QT. was 501 t 17 (range: 486-526); 10 subjects had maximum 
QT.> 500. The average range between minimum and maximum QT. was 113 t 
25. Conclusions: 1) This new computer-assisted technique provides the ability 
to assess continuously the QT, over 24 hours. The measurements correlate 
closely to manually measured values. 2) Continuous measurement of QT. over 
24 hours shows that (a) the range of values is larger than previously described 
and (b) the commonly accepted upper limit should be revised upward, as others 
have suggested. From our data, the 95% upper confidence limit of mean 24-
hour QT. was 448 ms (443 M; 458 F). However, even with these upper limits, 
the common occurrence of QT. > 500 ms in these normal subjects, uncovered by 
detailed examination of QT. over 24 hours, suggests that caution should be 
applied when categorizing a single clinically measured QT, as prolonged. 
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827·4 11:15 
T-wave "Humps': A Distinctive ECG Finding In Romano-Ward (RW) Long QT 
Syndrome (LQTS) Famllles 
Fumio Suzuki, Russell T. Steinman, Debra Frankovich, Paul Elko, Julie Fresard, 
John Baga, Timothy Lessmeier, Michael H. Lehmann. Harper HospitaljWayne 
State University, Detroit, MI and Marquette Electronics, Milwaukee. WI 
Proper clinical classification of asymptomatic blood relatives of RW-LOTS 
families, based on the classic OTc cutoff of .44 sec, is hampered by possible mild 
OTc prolongation in normals (false positives) and incomplete phenotypic 
penetrance of the abnormal gene (false negatives). We hypothesized that T· 
wave "humps" (1") near the apex or descending limb of an upright T ·wave may 
represent an EeG manifestation of the RW-LQTS genotype in some patients 
who do not have overt OTc prolongation. EeGs were examined from 12 RW•
LQTS families (188 blood relatives. 17% symptomatic). and OTc intervals were 
classified as short (s. .41 sec). borderlme (.42-.46 sec) or long (2..47 sec), as per 
Keating et all (Science 252:704. 1991). T' (2. 2 leads) was identified in all RW•
LOTS families, with the following overall prevalence: 
Prevalence of T' ~ 





Seven (54%) of the 13 blood relatives with T' and short or borderline OTc were 
asymptomatic.awl had a OTc oS. .44 sec. T' prevalence was not related to age 
(15 yr cutoll) or gender. Maximum amplitUde ofT' exceeded 1mm ordy among 
family members in the long OTc category. We then examined EeGs of 3394 
"normals" (by history and physical) with OTc oS. .46: Prevalence of T' was ordy 
1.6% (vs. 10% in RW-LOTS blood relatives with OTcoS..46; p < .0001) and, 
when present in normals, T' was found in lateral precordial or limb leads in 
53% (vs. 85% in blood relatives with T' and OTcoS..46; p <.04). 
Conclusions: 1) T' is readily demonstrated in families with RW-LQTS, and its 
prevalence among blood relatives progressively increases as OTc varies from 
short to long. (2) Even for OTc oS..46, prevalence of 1" in RW-LOTS blood 
relatives is 6 times more common than in the general population. (3) Thus, T' 
(especially in limb leads or lateral precordial leads) may merit consideration as 
an additional phenotypic marker - besides OTc - for determining RW-LOTS 
carrier status in asymptomatic blood relatives of affected patients. 
827·5 
Computer Assisted Validation of Ischemia In Holter ECGs 
Georg Schmidt, Petra Barthel, Barbara Parhofer, Kurt Ulm, 
Horst Herb, Heinz Kreuzberg, Albert SchOmlg. 
I. Medizinische K1inlk der Technischen Universili.\t Munchen, 
Zentrum fOr Nichtlineare Oynamik in der Kardiologle, Germany. 
11:30 
Analysis of the ST segment in Holter ECGs Is complicated by a high "sponta•
neous· variability of this parameter. The number of ischemic episodes, their 
length and their Intensity differ greatly from day to day, mainly because of 
differing work load levels. Hitherto, no criteria exist for vandation of Ischemia in 
Holter ECGs. A computer program developed in our Institution allows for 
classifying QRS complexes and their corresponding ST-T segments depen•
ding on heart rate In Holter tapes. 
In 10 untreated patients with exercise Induced ST depression, we analysed the 
Sf segments In all observed heart rate classes (Increment 10Imln). After visual 
confirmation of at least 50 beats In ead1 class, the ST segment levels and their 
slopes were measured 80 IllS after the J point. The means ± SO were compared 
by the Wilcoxon rsnk test. 
Comparing two control Honer tapes In each patient, the rate dependent ST 
depreSSions showed a good reproducibility without significant differences at 
comparable heart rstes. After anti-ischemic Intervention, the ST depression 
were observed only at signHicanUy higher heart rates (889 figure). In cases of 
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100 heart rate 13) 
These observations suggest that the new method could be suitable for 
validating the effects of anti-ischemic therapy using long-term ECG findings. 
ABSTRACTS 473A 
827-6 11:45 
The Relationship Between Nonsustalned Ventricular 
Tachycardia and Heart Rate Variability in Patients with 
Dilated Cardiomyopathy. 
Piotr Ponlkowski. Elena Cerquetanl, Christine O'Sullivan, Stamalls 
Adamopoulos, Giuseppe M.C.Rosano, Massimo Piepoli, Derek Gibson, 
Andrew J.S.Coats. National Heart & Lung Institute, Royal Brompton 
Hospital,London and John Radcliffe Hospital,Oxford,UK. 
The relationship between asymptomatic ventricular arrhythmias(VA) 
and sudden death in patients with dilated cardiomyopathy (OCM) 
remains controversial. Abnormalities in the autonomic control of the 
circulatory system in DCM may play an Important role in the genesis 
of VA as well as having possible prognostic importance in these pts. To 
assess autonomic nervous function in DCM we measured heart rate 
varlability(HRV) derived from 24h recordings by both:tlme-domaln 
(mean RR,SDRR,pNNSO,rMSSD) and frequency-domain measures 
(low and high frequency·LF,HF). We investigated 38 pts with DCM 
divided into 2 groups: 17pts with nonsustained ventricular 
tachycardia (NSVT +) on Holter monitoring and 21 pts without NSVT 
(NSVT.). There was no difference in age, ejection fraction and NYHA 
functional class between the two groups. 
BwlI.1a: NSyT· NSYT+ 
mean RR(msl 777+10Q 704±125 
SDRR(msl 104+39 78+34' 
rMSSD(msl 22+12 15±5' 
pNNSO(%1 S,3+7,1 1 5+1,9' 
LE(ms21 279+308 8S±110* 
HE(ms21 112+170 26±21' 
mean±SD are given, "p<O.OS NSVT· vs NSVT+. 
The analysis of circadian pattern of HRV revealed depressed 
day(10am·8pm) and night(I·Sam) values of HE and LE in pts with 
NSVT. 
Depressed HRV on 24h ECG recording may identify pts with DCM al 
risk of NSVT. Abnormalities in autonomic control of heart rate with 
preferential reduction of vagal tone may predispose some DCM pts to 
VA and possibly also to sudden cardiac death. 
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828·1 10:30 
Right Ventricular Outflow Muscle In Tetralogy of Fallot: 
Histologic and Immunohistochemical Monoclonal Antibody 
Analysis. 
Douglas Schneider. Carol M, Cottrill. William N, O'Connor. 
Robert Salley. University of Kentucky. Lexington. Kentucky. and 
Children's Hospital. Cincinnati, Ohio, 
Sections of fonnalin-fixed. paraffin-embedded, myectomy tissue 
obtained from the right ventricular outflow tract (RVOT) at the 
time of total surgical correction of tetralogy of Fallot (TOF) (n=32) 
(ages 3 mo-l3 yrs) were compared with age-matched tissue from 
the RVOT of nonnal control hearts (n=6) obtained at autopsy after 
non-cardiac death. 
Light microscopy of Hematoxylin and Eosin and Elastic 
Trichrome combination stained slides showed cardiomyocrte 
(CM) hypertrophy. extensive myofiber dismay. sinusoidal sitts. 
thick-walled coronary arteries and fibrosis within the myocardium 
of TOF tissue. Also, prominent lining cells and stellate cells (SC) 
within the thickened and hypercellular fibroelastic endocardium 
co-existed with focal neovascularization at the interface of 
myocardium and endocardium. Marked subendocardial zonal CM 
hyperreactivity consisting of binuc1eation without mitoses was 
seen in the TOF heart tissue but not in controls. 
Immunohistochemical studies were undertaken using antibodies 
to a variety of collular and extracellular matrix proteins. When 
compared to controls, TOF tissue showed a ~attern of upregulated 
expression within the endocardium and adjacent subendocardial 
myocardium. Decoration for Muscle Specific Actin. Vimentin • 
Desmin and Epidennal Growth Factor receptor highlighted the cell 
specificity and zonal nature of this tissue hyperreactivity, Laminin 
(a basement membrane protein) was abundant around endocardial 
SCs. subendocardial CMs and interface vessels in TOF tissue 
when compared to the remainder of the myocardium. 
Overall. changes in TOF were a¥e related with older patients 
showing less zonal myocardial reacuvity. These findings provide 
evidence for an ongoing complex remodelling of the RVOT 
muscle in TOF. 
474A ABSTRACfS 
828·2 10:45 
DiIIgnoIis of Viral Myocarditis in Fresh and Fixed Cardiac ..... By 
~ alliin Reaction (PCR' 
Jeffrey A. Towbin. Jiyuan Ni. Hua U. Kathryn Meura. Anthony Cola. 
Am.eta Martin. Steven Webber. F. Jay Frickar. Debra Keamey. Usa 
Griffin. Gail Demmler. Yao-Hua Zhang. Baylor College of Medicine. 
Houston. Texes. and Children's Hospital of Pittsburgh. Pennsylvania 
Virel myocarditis is a major cause of morbidity and mortality In chHdran 
and edults. The diagnosis classically depends on historical end physical 
exam criteria. echocardiographic evidence of ventricular dysfunction. II 
well II peripheral culture and serial antibody titer results. Right 
ventricular endomyocardial biopsy (RVEMB) typicany has low diagnostic 
sensitivity while autopsy has Improved diagnostic capability. but rarely is 
able to demonstrate the exact etiology. The purpose of this study was to 
enalyze the usefulness of PCR in the diagnosis of viral myocarditis from 
14B fresh end fixed cardiac tissue. The following specimens were 
analyzed for the presence of enterovirus (entero). cytomegalovirus (CMV). 
adenovirus (adeno). and herpes simplex (HSV): blood and cardiac tissue 
obtained at the time of RVEMB for myocarditis in 33 patients and for 
surveillence In 25 post-op cardiac transplant recipients. fresh frozen 
explanted cardiac tissue obtained from 44 patients transplented for dilated 
cardiomyopathy (DCMI. and 46 cardiac autopsy specimens with histologic 
evidence of myocarditis. PCR primers were designed using consensus 
and unlqua sequences of these viral genomes. Cardiac tissue from 10/33 
biopsies for myocarditis were positive for viral genomel3 entaro. 7 adenol 
while 9/44 explanted hearts with DCM were positive 12 entero. 7 edeno. 
and 6/25 post·transplant surveillance biopsies were positive (4 CMV. 2 
adeno). A high percentage of autopsy specimens (26/46) amplified viral 
g!lnome (10 entero. 12 adeno. 2 CMV. 2 HSVI PCR on ell concomitant 
blood samples for myocarditis were negative: 12 patients hed positive 
viral serology or cultures; all occurred in patients with positive PCR 
amplification. CONCLUSIONS: PCR 111 is valuable In the rapid diagnosis 
of viral myocarditis; (21 improves the accuracy/sensitivity of the diagnosis 
of myocarditis compared to standard culture/serologic methods; (3) is a 
useful adjunct to routine surveillance methods in post-operative transplant 
patients; (41 Is useful In the postmortem diagnosis of myocarditis: end (51 
demonstrates adenovirus to be an important agent causing myocarditis. 
828·3 11:00 
Effects of Chronic Rapid Right Atrial Pacing on HeIno•
dynanics and MyofibriIar ATPase ActIvity In Piglels 
Niels G. Glddins, Kim F. Duncan, Rablndranath Persad, 
Grant N, Pierce. Variety Children's Heart centre and 
University or Manitoba, Winnipeg, Canada. 
In order to characterize hemodynamic and associated sub•
cellular effects of chronic supraventricular tachycardia (SVT) 
in young animals, a model was developed using 2 week old 
piglets. 
Six animals underwent right atrial pacing at a rate of 2501min 
(-30% above normal) for a mean duration or 10 days, starting 
3-4 days after surgical placement of pressure monitoring 
lines, pulmonary artery (PA) flow probe, pacing wires, and LV 
cavity dimension crystals. Hemodynamic effects were com-
red with 5 simlla instrumented controls: 
PACED 3S%' 42% I 39%' * 
32% I 13% • "'%1 2H> I 9'Ib' 
III -~I increue from bUeiine * P<O.OS VI. controls 
LV tissue was harvested from 516 paced animals, all 5 instru•
mented controls, and 2 non-instrumented controls. Myofibrils 
were Isolated and myosin ca++ ATPase activity was then 
assayed. ATPase activity or myofibrils from the paced group 
was 33% less than that or the control groups (P<O.05). 
In conclusion, hemodynamic compromise in piglets following 
rapid right atrial pacing for 10 days is associated with a 
Significant depression of myosin Ca++ ATPase actiVity. This 
abnormal utilization of high energy phosphates by the cardiac 
contractile apparatus may contribute to the cardiomyopathic 
changes of longer durations of SVT. 
828-4 
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Late Evaluation of Left Ventricular Performance Following Rapid 
Two-Stage Arterial Switch Operation. 
Christine Boutin, Steven D Colan, Stephen P Sanders, Gil Wernovsky, 
Richard A Jonas, Aldo R Castaneda. Children's Hospital, Boston, MA. 
Banding of the pulmonary artery to Induce LV hypertrophy 
followed by arterial switch operation (ASO) wtthin 1·2 weeks (Rapid 2· 
stage ASO, 2S·ASO) has been used when a primary ASO (1S·ASO) is 
considered high risk due to subsystemiC LV pressure. Potential adverse 
myocardial effects of the 2-stage procedure were examined by comparing 
outcome In 18 pts 0.6 to 5 yrs (mean=2) after 2S·ASO with 33 pts 0.2 to 
7.5 yrs (mean=2.6) after lS·ASO. Regional wall motion was assessed 
using both centerline and floating center of mass algorilhms. Echo and 
pressure data were combined to obtain LV dimension, wall thickness, 
mass, fractional shortening (FS), rate-corrected mean veloclly of 
shortening (VCFc) , and end·systolic wall stress (ESS). Afterload-adjusted 
VCFc (stress.velocity index, SVI) was obtained as a load·independent 
index of contractility. In the 2S·ASO group, the magnitude and rate of LV 
mass accrual after PA banding was measured. RESULTS: No 
abnormaltties of regional wall motion were seen in either group. Systolic 
function (FS and VCFc) was significantly reduced in the 2S·ASO compared 
to both normal values and the 1 S·ASO group. The reduced systolic 
function was due to the combined effects of higher afterload (ESS) and 
lower contractility (SVI) in the 2S·ASO. Contractility below the limits of 
normal was seen in 25% of 2S·ASO compared with 3% of 1S·ASO, but 
symptomatic or progressive LV dysfunction was not observed. Thera was 
a significant inverse relation between peak rate of hypertrophy and 
contractility, that is, the fastest hypertrophy was associated with the lowest 
contractility. Lower LV ejection fraction before and especially after PA 
banding was relaled to depressed contractility on late exam. 
Myocardial contractility is lower alter the 2·stage ASO than after a 
single slage procedure, although severe or progressive dysfunction has 
not been seen. A very high peak rate of hypertrophy and severe LV 
dysfunction after banding predict a greater reduction in late contractility. 
828·5 11:30 
Myocardial Perfusion Abnormalities in 
chronic Xawasaki Syndrome: Lack of 
Correlation with ADgiographic coronary 
o!)struction. 
Masato Takahashi, John H. Miller, Wil!)ert 
Mason, Childrens Hospital Los Angeles, Los 
Angeles, CA 
coronary artery aneurysms (CAA) due to 
Kawasaki syndrome (KS) may progress to 
stenoses or thrombosis. Or it may regress to 
normal lumens. To determine whether 
m~ocardial ~erfusion scans (MPS) correlate 
wlth anglographic coronary artery 
obstructions, 14 MPS and coronary 
arteriograms in 13 patients (pts) were 
reviewed. The ages at MPS were 12.2 ± 2.0 
yrs. The interval from KS onset to MPS was 
9.2 ± 2.2 yrs. TI-201 (N=7) and Tc-99m 
sestaMIBI (N=7) studies were combined with 
treadmill stress test. SPECT image analysis 
was done in each case. 
Results: MPS on 6 pts with known coronary 
obstructions showed fixed or reversible 
hypoperfusion. Six of 8 pts without 
obstructions demonstrated hypoperfused 
segments. Two had persistent CAA, 3 had 
regressed CAA and 1 had normal coronary 
arteries. 
Conclusions: (1) MPS is a sensitive but non•
specific test for detection of obstruction 
in major coronary arteries. (2) Persistent 
or regressed CAA is associated with local 
hypoperfusion even in the absence of 
angiogra~hic stenosis or occlusion. 
Speculatlon: Fibrosis around CAA may cause 
local microvascular changes. 
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Geometric Modeling of the Neonatal Left Ventricle 
11:45 
Jeffrey Heinle, Andrew Lodge, James Mault, Elizabeth Whitaker, 
Ross UngerJeider. Department of Surgery, Duke University 
Medical Center, Durham, NC 
Load-independent dimensional analysis of neonatal myocardial 
function requires an assessment of left ventricular (LV) geometry 
to predict dynamic intracavitary volume. The purpose of this 
study was to determine the most appropriate geometric model for 
studying the neonatal heart. Eleven neonatal piglets (1 week old, 
1.5-2.5 kg) underwent median sternotomy for instrumentation of 
the LV with major and minor axis endocardial ultrasonic 
dimension transducers. Following initiation of total 
cardiopulmonary bypass, a natural skin balloon containing a 
micromanometer was introduced into the LV through the mitral 
valve and the annulus was sutured closed. With the LV beating 
and empty, 0.25 rnl increments of blood were infused into the 
balloon, and at each volume, LV endocardial dimensions were 
recorded and dimension data were used to calculate LV cavitary 
volume for cylindrical, prolate ellipsoid, and spherical models. 
The relationship between calculated and balloon volumes was 
highly linear for each model (r ~ .96). The slope and y-intercept 
(mean±SEM) of the regression line for each model are 
summarized in the table below. 
Parameter 1m er 
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829·1 10:30 
Clinical Features and Long Term Follow up of 99 Consecutive Patients 
with Syndrome X 
Giuseppe M.C. Rosano; Juan Carlos Kaski; Peter Collins; Attilio Maseri; 
Philip A. Poole-Wilson. National Heart & Lung Institute and 
Hammersmith Hospital, London, United Kingdom. 
The clinical features and the long term follow up of syndrome X (SX) have 
not been systematically investigated in a large and homogeneous patient 
population. To this end we studied 99 pts (78 women, 21 men; mean age 
54.9±7 years) with SX who were followed for a mean of 6.7±4 years. 
The mean age at the onset of chest pain was 48.5±8 yrs; 46 pts had a 
family history of CAD, 29 were cigarette smokers, 5 diabetic, and 9 
hyperlipidemic. Mean resting left ventricular ejection fraction (L YEF) was 
68±8% (range: 53-85%). Chest pain was exertional in 85% of pts but 
occurred also at rest in 42%. Chest pain lasted for <5 min in 21 pts, < 15 
min in 45 pts and > 15 min in 33 pts. Response to sublingual nitrates was 
poor in over 50% of patients. Transient myocardial ischemia was 
documented objectively in 32 % of pts by means of coronary sinus oxygen 
and/or pH monitoring, -myocardial lactate consumption, myocardial 
perfusion scintigraphy (SPECT) and positron emission tomography. All pts 
had positive exercise tests and 64 had transient ST depression on Holter 
monitoring. Serious arrhythmias were not observed. During follow up, no 
deaths or major cardiac events occurred. Mean L YEF remained unchanged 
but declined in I pt, 2 pts developed conduction abnormalities and 8 
systemic hypertension. Twenty-nine pts were hospitalized for a suspected 
MI (5 pts) or unstable angina (24 pts). Owing to chest pain 25 pts were 
severely limited and 7 abandoned work. Thus, Pts with SX are frequently 
women. The chest pain, which can be frequent and prolonged, seems to be 
cardiac but an ischaemic origin can only be demonstrated in a small 
proportion of pts. SX is not associated with cardiac mortality, or major 
coronary events and a decline of L YEP is a not a frequent event. 
ABSTRACTS 
829·2 10:45 
Abnormal Left Ventricular Diastolic FHling Dynamics in 
Syndrome X: Documentation by Doppler Measures During 
Isometric Exercise 
Katsufumi Mizushige, Hisashi Masugata*, Anthony N. 
DeMaria, Hisaki Morita*, Hirohide Matsuo*. University of 
California, San Diego, CA, *Kagawa Medical School, Japan 
475A 
Considerable controversy continues regarding the clinical 
significance of Syndrome X(X), defined as anginal chest pain, 
abnormal stress test, and normal coronary angiography. 
Although several studies have examined systolic function in X, 
few data are available regarding LV diastolic filling dynamics 
in this disorder. Therefore. we performed transmitral pulsed 
Doppler examinations at mitral annulus in apical view before 
(B) and dUling (Ex) isometric handgrip (50% maximal effort 
for one minute) in 14 pts with X. Results were compared to 
those in 12 normals (N), 13 pts with single vessel(S) and 7 pts 
with multivessel(M) CAD. Measurements included systolic BP 
(mmHg), HR (/min). early diastolic (E) and late atrial (A) 
inflow velocities (cm/sec), and % change of AlE ratio from 
baseline (% AlE). Results: 
Syst BP HR E A %AIE 
B fu B fu B fu B fu 
N 118 153 60 69 44 43 49 51 5 
X 141 168 61 75 49 37** 51 57** 52++ 
S 131 163 62 74 43 42 49 56** 18 
M 142 174 63 73 38 31'" 50 58** 45+ 
*, ** ,:p<0.05. p<O.OI, vs B; +.++:p<O.01,p<O.OOI vs Sand N 
Thus, as compared to normals. isometric exertion results in 
evidence of impaired relaxation by Doppler ( ~ E, tA, ~ %AIE) in 
pts with Syndrome X. The abnormal LV diastolic filling 
dynamics in X are similar to multivessel CAD. suggesting that 
X may produce diffuse prolongation of relaxation similar to 
myocardial ischemia. 
829·3 11:00 
Sympatho-Vagal Imbalance In Patients with Anginal Pain, Normal Coronary 
Arteries and Reversible ThaUium Abnormalities. 
Cinzia Cianfrocca, Alberico Borgbi, Francesco Pelliccia, Augusto Ruggeri, Paola 
Venturi and Raffaele Bugiardini. Inst. of Patologia Medica, University of 
Bologna, Bologna, Italy 
The clinical course of pts with anginal pain and angiograpbicaUy normal coronary 
aneries (NCA) may vary despite a similar clinical presentation. We investigated 
wbether dysregulation in autonomic nervous system and its regression could be a 
reason for variability of symptoms in a subset of 24 NCA pts (aged 45±12 yn) 
found to have STJ. and reversible tbaJliwn abnormalities during exercise. AU pts 
underwent 24 br-bolter monitoring (HM) at recruiunent (TI) and 12 months later 
(1'2). At n, all pts were symptomatic and exhibited ~1 episode of transient ST J. 
~.I5 mV) at HM. At 1'2, 10124 pts (Gr.A) still had evidence of symptomatic or 
asymptomatic ST J., the remaining 14124 pts (Gr.B) being free of symptoms and 
ST shifts. After excluding artifacts and ECG recordings during significant (~ 0.15 
m V) ST changes, HMs were analyzed and 4 measures of beart rate (HR) 
variability were assessed: SDANN index (standard deviation of the average RR 
intervals for all 5-min segments), SDNN index (mean of the standard deviations 
of RR intervals for all 5-min segments), rMSSD (root mean square successive RR 
difference) and pNN50 (percent of differences boltween adjacent RR intervals>50 
ms). SDANN and SDNN indexes are modulated by mixed vagal and sympathetic 
activity and reduction of their values is influenced by either decrease in vagal tone 
or increase in sympathetic outflow, while rMSSD and pNN50 are pure vagal 
signals. At n, both Gr.A and Gr.B pts exhibited similar SDANN (64±l7 vs 
61±1S ms), and SDNN (74±7 vs 71±9 ms) indexes. At T2, Gr. B but nol Gr. A 
pts showed a significant (p < 0.(01) increase in SDANN (+34±27 ms) and SDNN 
(+IS±5 ms) indexes. Time domain measures of parasympathetic activity were 
normal (rMSSD>15 ms: pNN50>0.75 ms) in all pts, either at n or 1'2. We 
conclude that in pts with anginal pain, NCA and reversible tballiwn abnormaJities: 
(I) time domain measures of HR variability reflecting mixed vagal and 
sympathetic signals vary with time, being consistently lower during the active 
phase of the disease than during periods of remission: (2) vagally-mediated 
measures of HR variability are persistently normal: (3) this suggests an increase in 
sympathetic nervous system activity as a possible means of ischemia. 
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829·4 11:15 
Long.Term Clinical Outcome of Patients with Angina Pectoris, 
Normal Coronary Anglograms Bnd Evidence of Myocardial 
ischemia. 
Alberico Borghi. Domenico 01 Clemente. Giovanni M. Puddu. Augusto 
Ruggeri and Raffaele Buglardlni. Inst. of Patologla Medica, University of 
Bologna,. Bologna. Italy 
TIle cause of anginal pain despite normal coronary anglograms (NCA) 
need not to be the same In all pts. This could account for a substantial 
difference In the clinical course of these pts despite similar clinical 
presentation. Accordingly we studied 28 pts with the above set of 
findings. All pts were followed for 4 to 6 yrs. Qlnical data and exercise 
stress testing (EST) were obtained when diagnosis was first established. 
and then at 6-month Intervals until the end of the follow·up (F). TI-201 
exercise myocardial scintigraphy (EMS) was performed In all pts at the 
enrollment and at the end of F. At baseline all pts showed a positive EST 
~.15 mV ST depression). Reversible thallium abnormalities were found 
in 10 pts (gr. I); the remaining 18 pts showed normal EMS Images (gr. 
2). During the F none of the pts experienced major coronary events 
neither developed left ventricular dysfunction or bundle branch block. 
Nine of the 10 gr. I pts showed complete resolution of chest pain starting 
6 to 24 months after baseline assessment. At the end of F all 9 pt.~ had 
normal EMS: of these. I stm had significant albeit painless ST 
depression. whereas 8 showed normal ECG response to exercise. 
Conversely. 16118 gr.2 pts complained anginal episodes at the end of F. 
EST was positive In 13 of these pts. EMS was still normal in all gr.2 pts. 
We conclude that: (1) the long-term clinical course ofpts with angina and 
NCA may be different in different pts; (2) long-lasting regression of 
symptoms and remission of the disease are common findings In those pts 
with objective signs of myocardial ischemia documented by positive 
EMS; (3) symptoms and EST remain substantially unchanged with time 
in the remaining pts showing normal EMS; (4) although a negative EMS 
does not necessarily exclude a cardiac origin of symptoms. Its positivity 
could allow the identification of a more homogeneous group of pts with 
an Implied different underlying cause of the disease. 
829·5 11:30 
symptom aDd Viscaral ADalqa.ic BaDafit of 
Imipramine in Patients with Chest Pain and 
Normal coronary ADqioqrams 
Richard O. Cannon III, Arshed A. Quyyumi. 
NHLBI, Bethesda, MD. 
We have previously demonstrated that patients 
(pts) with chest pain and normal coronary 
angiogram. (CPNCA) commonly have exaggerated 
cardiac sensitivity compared to pts with 
coronary artery disease, with their typical 
pain provoked by right ventricular pacing 
(RVP) in the absence of ischemia. In order to 
assess the impact of drugs used in chronic 
neuropathic pain syndromes, we compared 
imipramine 50 mg and clonidine .2 mg to 
placebo in a randomized trial in 30 CPNCA pts, 
with a one month placebo period (single-blind) 
for all pts followed by a one month treatment 
period (double-blind) on imipramine, clonidine 
or placebo (10 pts each group). RVP was 
repeated at the end of the second month 
treatment period. Patient symptom diaries 
showed that compared to the first month on 
placebo, imipramine-treated pts experienced a 
57±27% (mean ± S.D.) reduction in chest pain 
episodes (p=.05 by ANOVA) compared to a 21±72% 
reduction in chest pain for clonidine-treated 
pts, and a 29±104% increase in chest pain for 
placebo-treated pts. Only imipramine-treated 
pts demonstrated reduction in prevalence of CP 
provoked by RVP, from 80% off all medications 
to 20% on imipramine (p<.03). Thus, imipramine 
in relatively low doses tends to reduce chest 
pain frequency in pts with CPNCA, a response 
that may be a consequence of visceral 
analgesic effects of the drug. 
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Focal Hyperreactlvlty Induced by Intracoronary AcetylchOline 
In Patients with Chest Pain, Positive Exercise Test and Normal 
Coronary Anglograms; A Possible Mechanism? 
Hasson EI-Tamlml, Michael Mansour, Thomas J. Wargovlch, 
James A. Hili, Roger M. Mills, Eileen Handberg, James Kazakls, 
Christopher Nunn, Gordon J. Azar, Carl J. Pepine. University of 
Florida, Gainesville, FL 
The mechanism of Ischemia in patients with anglographlcally 
normal coronary arteries was Investigated during diagnostic 
coronary angiography In 13 male patlents(pts) with chest pain, 
positive exercise test (~1 mm horizontal or downsloplng ST 
segment depression) and normal coronary anglograms. All pts 
took no anti-anginal therapy for ~24 hrs. After baseline 
angiography, acetylchOline (ACh) was infused selectively Into 
the left coronary artery (l ml/min for 2 mlns) at concentrations 
from 10"6 to 1Q-4M Immediately followed by angiography after 
each dose. Nitroglycerin 200l1g Intracoronary was then given. 
Coronary lumen dlameters(mm) were measured by 
computerized angiography. Three patterns were observed In 
response to the maximal dose of ACh. Four pts showed 
generalized minimal constriction, 4 showed generolized 
minimal dilation and In 5 pts developed significant focal 
constriction In 9 sites with 35% to 73% diameter reduction. The 
mean minimal lumen diameter at these focal sites decreased 
from 1.53±O.01 mm at baseline to 0.78±O.08 mm (p<O.OOl) after 
maximal dose of ACh and dilated to 1. 78±O.1l mm (p<O.02) 
after nitroglycerin. 
Conclusion: In a subset of patients with chest pain and positive 
exercise tests who are found to have 'normal' coronary 
anglograms, ACh infusion causes focal sites of constriction. 
These sites of endothelial dysfunction may be responsible for 
the production of Ischemia under certain conditions. Further 
Investigation Is needed to establish the possible relationship 
between these focal areas and future cardiac events. 
830 Molecular Biology: Clinical Studies and Animal 
Models 
Thursday, March 18, 1993 
10:30 AM-Noon 
Anaheim Convention Center 
C-I 
830·1 10:30 
Molecular Cloning of a Nove' Human, Vascular-tleeue, cGMP•
InhlbHed Cyclic Nucleotide Pholphodleatera .. (eGl POE) 
Sasko KedBl!. Masato Taira. and Vincent C. Manganiello. NHLBI. 
NIH. Bethesda. MO 20892 
At least five malor POE gene families have been Identlfled. One, the 
cGl POE lamUy. plays an Important role In regulation r:A myocardial 
contractBlty. vascular tonus, platelet aggregation. and the 
antllpolytlc action r:A Insulin. We have recently cloned cONAs 
encoding four cGl POEs. two adlpocyte-speclflc types from rat and 
human adipose tissue cONA libraries. and two cardiovascular types 
from libraries derived from human cardiac muscle and rat adipose 
tissue (presumably from vascular elementa present In adipose 
tissue). AnalysIs of the four cGl POEs Indicated that rat and human 
adlpocyte and cardiovascular types are more closely related than 
are cGl POEs from different tissues In rat or human. Although aU 
four exhibit considerable homology In the putative catalytic domain. 
a sequence r:A 44 amino acids In this domain (a so-called 'addHlonai 
region· not found In other POE famlies) clearly distinguishes 
adlpocyte and cardiovascular-type cGI POEs. and thus may be 
usef~ In identifying other members of the cGl POE famDy. Using 
sequence information from upstream and downstream regions 
adjacent to the 'addltional region· of the four cloned cGl POE 
cONAs. degenerate oligonucleotides were synthesized and used for 
peR amplification of cGl POE from human aortic eDNA. A PCR 
product r:A the expected size (310 bp) was subcloned and 
sequenced. Nucleotide and deduced amino acid sequences of 
several Independent eDNA clones rBl!ealed a novel human. perhaps 
vascular tlssue-specHlc. cGl POE which has 82% and 96% 
nucleotide sequence and 92% and 96'!b amino acid sequence 
Identities with human cardiac and rat cardlov8SC~ar-type cGI PDEs. 
respectively. Northem blot analysis indicated that aortic cGl POE 
cONA hybridized with a poIy(A) + RNA species (-8.3 kb) from 
human heart. lung. and pancreas. Increasing understanding 0/ 
structure. function and tissue distribution of different cGI POEs may 
ultimately be useful In designing more speclllc and effective drug 
therapies for certain cardiovascular disease states. 
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Ident1lkatlon or Romano-Ward Type Long QT Syndrome (LQTS) Families 
That Are Not Unked to Chromosome 11p15 Markers 
R. Thomas Taggart, Shelley D. Smith, Debra Frankovich, Colleen O'Brien, Julie 
A. Fresard, Michael H. Lehmann. Wayne State University, Detroit, MI, and 
Boys Town National Research Hospital, Omaha, NE 
The recent reports by Keating et al of tight linkage of Romano-Ward LOTS to 
an HRASl polymorpbism, (Science 252:704, 1991; Am J Hum Genet 49:1335, 
1992) have provided evidence tbat this condition can result from a genetic 
abnormality localized to chromosome llp15. We investigated the universality 
of tbis rmding by analyzing 7 Romano-Ward LOTS families with respect to two 
DNA markers at llpl5: tbe HRASl variable-number tandem-repeat polymor•
phism detected by Southern blot analysis (MspI), and a closely linked tetranuc1e•
otide repeat polymorphism of tyrosine hydroxylase (TH) detected by polymerase 
chain reaction. As per Keating et al, family members were classified conserva•
tively as: Affected, corrected OTc 2. .45 sec with symptoms, or 2. .47 sec 
without symptoms; unaffected, OTc~ .41 sec; and uncertain dia[?lOSis, OTe .42-
.46 sec. 43% of affected members were symptomatic. A total of 193 DNA 
samples were analyzed with 5 to 27 (median 17) meiotic events per family. 
Families were scored for DNA markers and analyzed for linkage, assuming 90% 
penctrance for the LOTS heterozygote and a 0.001 gene frequency in the 
general population. Recombination was found between HRASl, and/or TH, 
and LOTS in 6/7 families; when affected individuals only were scored, 5 families 
still showed recombination. Total two-point WD scores (log of odds of 
linkage) with LOTS at 8=0.0 were -17.5 with HRAS1 and -21.3 with TH. 
Multipoint analysis significantly rejected linkage at or between the two markers 
in 4 of the families. Only 1 family had positive WD scores for this region, with 
a maximum WD of 0.540 at 9=0.0 with TH; this family was uninformative for 
HRASl. The total multipoint WD scores for all 7 families were ~34.2 at 
HRASl and -30.6 at TH, and remained strongly negative out 10 20cM either 
side of Ihe markers (WD scores=-2.04 aI8=.2O distal to HRAS1 and -1.9 al 
8=0.20 proximal to TH. These dala suggest that Romano-Ward LOTS may also 
be caused by a gene(s) outside the llpl5 region. 
830·3 11:00 
The lnherHed Genetic Defect 11 Expressed in Skeletal al well as cardiac 
Muscle In Patients with Hypertrophic cardlomyopathy_ 
Oun-Tao Yu, Jonah lfegwu, All J. Marian, Wnda L Bachlnski, M. Benjamin 
Perryman, Robert Roberts, Baylor College of Medicine, Houston, Texas. 
Famlial hypertrophic cardiomyopathy (FHCM) Is generally recognized as 
restricted to the heart. The recent documentation of mutations In beIa•
myosin heavy chain (IIMHC) gene, being responsible for this disease, at least 
In those famlles linked to chromosome 14, raises the possibHity of the 
disease being more systemic, since .8MHC, Is not only the predominant 
protein In the ventricles, but is also a predominant myosin In skeletal muscle. 
Thus, one would expect such mutations to be expressed In skeletal as well as 
cardiac muscles. Accordingly, skeletal and C8Idlac biopsIes were obtained 
from a patient with FHCM known to have the missense mutation In exon 13 of 
the .8MHC gene. A skeletal biopsy was also obtained from a normal 
individual. RNA was extracted by RNAzol method and cDNA synthesized 
using an antisense primer to exon 16. USing primers 10 exons 12 and 14, the 
encompassed exon 13 was amplified via polymerase chain reaction and the 
product digested with Ddel restriction endonuclease. Electrophoretic 
analysis of nennal skeletal muscle showed two fragments of 181 and 140 bp 
while cardiac and skeletal samples from affected showed four fragments of 
181 bp, 149 bp, 140 bp, and 32 bp, the laner due to the mutation In exon 13. 
Thus, the abnormality (mutation) in affected individuals is expressed in the 
mRNA of skeletal as well as cardiac muscle. This finding of the expression of 
the missense mutation in the mRNA in skeletal and cardiac muscles has 
important etiological and pathogenetic implications. It is of some concern 
that .8MHC Is the major myosin of the right and left cardiac ventricles, yet this 
disease is restricted primarily to the ventricular septum and left ventricle. 
Expression of the defect In skeletal muscle which appears to have normal 
function Is further perplexing in understanding how this mutation Induces the 
myriad of functional abnormalities seen in patients with HCM. Does this 
imply that the functional Impairment Is a manifestation of Interaction wtth 
cardiac hemodynamics? Does tt impair skeletal muscle function? 
Furthermore, skeletal muscle provides a readily accessible source of mRNA 
for expression studies and for purification of the .8MHC protein, which Is 
uttimately essential to unravel the molecular basis of this disorder. 
ABSTRACTS 477A 
830·4 11:15 
Effect of Nitric Oxide Synthetase Inhibition on Tumor Necrosis Factor 
Induced Myocardial CeU Depression In-Vitro 
Anand Kumar, Venkateswarlu Thota, Jeanne Olson, Eugene Uretz and 
Joseph E. Parrillo, Rush-Presbyterian-St. Luke's Medical Center, 
Chicago, Illinois 
Nitric oxide has been shown to mediate vascular smooth muscle 
relaxation in response to a variety of stimuli and may be involved in the 
vascular response to sepsis. We hypothesized that nitric oxide might 
mediate previously demonstrated TNF-induced myocardial cell depression 
and could play an important role in septic myocardial depression. Using 
an assay which employs a video system to track sepharose beads 
imbedded in the cell membranes of contracting in-vitro cardiomyocytes, 
the effect of N-methyl-arginine IN MAl, a competitive nitric oxide 
synthetase INOSI inhibitor, on TNF-mediated cardiomyocyte depression 
was assessed. In-vitro neonatal rat cardiomyocytes were incubated for 
30 minutes with 11 standard media 21 human recombinant TNF 11000 
U/mLI 3) TNF 11000 UlmLI + NMA 110 uMI or 41 TNF 11000 U/mL) + 
NMA 110uM) + L-arginine 150 mM) [the natural substrate of NOS). 
As seen in the figure, TNF 
causes significant depression of 
extent of myocardial 
contraction compared to 
controllp<.051. NMA causes 
reversal of this effect Ip < .011 
and the addition of L-arginine 
re-establishes it IP< .011. 
Similar results are obtained by 
assessing velocity of 
myocardial contraction. These 
data suggest that TNF•
mediated cardiomyocyte 
depression is a nitric oxide 
dependent process and that 
nitric oxide may play a role in 
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At Adenosine Receptors: Use of Interspecles Chimeras 
and Slte·Directed Mutagenesis to Investigate Determi•
nants of Ugand Affinity Differences Between Species 
Amy L. Tucker, Anna S. Robeva, Heidi E. Taylor and Joel 
Unden, Department of Internal Medicine (Cardiology), Uni•
versity of Virginia, Charlottesville, VA 22908 
The purpose of our study was to investigate determinants of 
the marked differences between species in the binding of 
ligands to At adenosine receptors. We have found that dif· 
ferences observed in brain membranes are preserved in 
recombinant receptors expressed in C08-1 cells. In order to 
determine which region(s) of the receptor are responsible for 
modified ligand binding we have engineered two splice sites 
into canine and bovine receptor cDNA's and subcloned 
these into the expression plasmid CLDN10B. All six possible 
interspecies chimeras were transiently expressed in COS·1 
cells using the DEAE dextran method. Binding to COS cell 
membranes was assessed with agonists and antagonists 
that distinguish well (> 50 fold) between canine and bovine 
receptors: bovine > canine ([3HJ8-cyclopentyl-1,3,-dipro· 
pylxanthine, N·0861 and R·N6·phenylisopropyladenosine; 
and canine > bovine (5' -N-ethylcarboxamidoadenosine and 
2-chloroadenosine. The species of the carboxy terminal por. 
tion of the chimeras was found to determine ligand binding 
affinities. Based on these findings we are mutating selected 
amino acids which differ between the two species to pinpoint 




Chloroquine Substantially Enhances Liporectin-Mediated Gene 
Tranrer in Cultured Porcine Coronary Arterial Smooth Muscle 
Cells 
James P. Finnigan, Wojciech Mazur, Robert Roberts, Albert E. Raizner, 
Brent A. French. Baylor College of Medicine, Houston, Texas 
Introduction: Initial experiments involving Lipofectin-mediated gene transfer into 
the arterial wall, in our laboratory and in the laboratories of others. have met with 
limited success. The low efficiency of existing gene transfer techniques and 
picogram quantities of recombinant reporter gene expression in vascular smooth 
muscle cells (VSMCs) currently preclude the development of somatic gene 
therapy directed against atherosclerosis and post-angioplasty restenosis. Porous 
balloon catheters have been employed successfully to deliver DNA-Lipofectin 
complexes into coronary arteries. The effectiveness of Lipofectin-mediated gene 
transfer is thought to result in part from the ability of the introduced DNA to 
bypass tbe degradative lysosomal enzymes that ordinarily impede effective nuclear 
DNA delivery. However, we have found that the addition of the lysosomal 
enzyme inhibitor chloroquine to the DNA-Lipofectin complex substantially 
increases the expression of reporter genes. 
~ 20,--------------, 
~ * p<O.Ol 
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~: VSMCs were obtained by 
enzymatic digestion of porcine coronary 
arteries and were cultured in DMEM plus 
10% FBS. Transfections were performed 
after the second passage; we used 1.67 ~g 
ofluciferase reporter vector (pRSVL) and 5 
~g of Lipofectin (BRL, Gaithersburg, MD) 
per 35mm culture dish. Aqueous 20mM 
chloroquine diphosphate was added to the 
DNA prior to the addition of Lipofectm. as 
indicated. The DNA-chloroquine-Lipofectin 
o 100 200 complexes were subsequently mixed in 
micrograms chloroquine/plate Opti-MEM I (BRL) and applied to the 
culture dishes which were !ben incubated 
for 16 hours. The plates were then washed with PBS and cultured in DMEM/FBS 
an additional 2 days until barvest. Luciferase activity was determined on a 
Monolight 2010 luminometer (ALL, San Diego, CA) calibrated with certified 
luciferase standards. ~: Chloroquine enhanced transfection efficiency in a 
dose-dependcnt fashion. At the higbest concentration tested, chloroquine increased 
transfection efficiency greater than 500-fold over transfected controls. This 
technique may also enhance Lipofectin-mediated direct gene transfer in vivo. 
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PnJgnosis of Atrial. Pibr:i.llat.i.m in Men. 
Manitdla Fbllow-up study (MFU3) 1948-1992 
10:30 
ArDrew D. Krahn, Jure Manfreda, RdJert B. Tate, Francis 
A. L. MatheWson, T. Etlward Olddy. University of ManitdJa, 
Wirmipeg, ManitdJa, canada 
'Ihe prognosis of atrial fibrillation (AF) was examined in 
the MFUS oohort of 3983 men followed for 44 years. AF was 
detected at a mean age of 65±9 years in 278 men. 
PnJgnosis of these cases (median follow-up 4.9 yrs) was 
ClCIJIlar9d to 1079 age-matd:led cxntrols (1:4) free of AF 
with respect to total and cardiovascular oortality, and 
develcpnent of isdlemic heart disease (nID) and stroke. 
Usin;} Cox's prqx>Itiooal hazards model to cxntrol for the 
effect of oanfc::Rll'dinJ cardiovascular variables, there was 
a 1.7 times risk for total m:xtality (P<0.00l) and a 2.4 
til!Ies risk for cardiovascular death (P<0.001) associated 
with AF. AF did rot in::rease risk for nan-cardiovascular 
IIOrtality or subsequent nID • 'Ihe risk for stroke was 4.0 
tilres greater in men with AF (p<0.OO1). AF increased the 
risk for total and cardiovascular oortality and stroke, 
J:ut did rot CCIIpXIID. the risk beyor¥1 the inieperrlent 
contribution of each iIDividual effect in the 1OOdel. In 
a separate analysis of men with previoos MI, AF did rot 
awear to be associated with total oortality. Men with 
lone AF (n=70) had a 3.2 fold increased risk of stroke 
(p<0.01), J:ut 00 excess in cardiovascular or total 
oortality, when ClCIJIlar9d to men free of AF with 00 
cc:m:n:bid oonditions. 
Atrial fibrillation :ilx::reases risk for stroke, 
cardiovascular and total oortality. The irxieperrlent 
effect of AF and c:atOrbidity on total and cardiovasc:ular 
oortality is additive. 'Ihe risk of stroke in lone AF is 
high canpared to healthy cxntrols. 
SUpported in part by the Heart and stroke Fourrlation of 
ManitdJa and the Stooy members. 
831·2 
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Prophylaxis or atrial fibrillation following cardioversion. 
A study comparing cibeDZoline to hydroquinidine. 
Paul Touboul, B~atrice Brembilla-Perrot, Samuel Levy, Henri 
Lardoux, Xavier Marchand, Ghlath Dayoub, Florence Scheck. 
Hopital Cardiologique, Lyon; CHU Brabois, Vandoeuvre; Hopital 
Nord, Marseille. France. 
Eighty seven patients (pts), 56 M 31 F, mean age 30, presenting with 
chronic atrial fibrillation (AP) were included in a multicenter, double 
blind, controlled trial. Aetiology was rheumatic in 22 pIS (25%) and 
non rheumatic in 65 pIS including 15 with lone AF. Age> 75, AF 
duration > 3 years, left atrial thrombosis andlor dilatation (> 70 
mm), left ventricular shortening fraction < 20% were exclusion 
criteria. Following successful defibrillation, the pIS were randomly 
allocated to 2 treaunent groups: oral cibenzoline 130 mg b.i.d (43 
pIS) or hydroquinidine 300 mg b.i.d (44 pts). Both groups were 
similar regarding history, clinical characteristics, ECG and 
echocardiography. Assessment using clinical examination, ECG, 
Holter monitoring was performed after 1 week, 1,3 and 6 months. 
The rate of AF recurrences was 34.9% on cibenzoline and 36.4% on 
hydroquinidine (NS). Most of the relapses (75%) occurred during 
the lrst month. In the cibenzoline group, ten additional pts left the 
trial because of dizziness (I), diarrhea (2), skin intolerance (1), 
marked QRS widening (2), runs of ventricular tachycardia 
suggesting proarrhythmia (2), poor compliance (2). In 5 
hydroquinidine pIS, diarrhea (I), skin reaction (2), suspected 
proarrhythmia (1), transient ischemic attack (1) led to interrupt the 
evaluation. There was one cardiac arrest on hydroquinidine in the 
setting of severe hypoglycemia. Effect of both drugs on heart rate, 
blood pressure, PR interval, QRS and QT duration was not 
statistically different. 
We conclude that cibenzoline is as effective as hydroquinidine in 
maintaining sinus rythm following conversion of chronic AF. 
Preferential use of either drug may be guided by individual factors 
including tolerance. 
831·3 11:00 
The Results of CRAFT-1: a Multi-Center, Double-Blind, 
Placebo-Controlled Crossover Study of Digoxin in 
Symptomatic Paroxysmal Atrial Fibrillation 
FranciS D. Murgatroyd, Sean O'Nunain. Sheila M. Gibson, Jan D. 
Poloniecki, David E. Ward, A. John Camm, for the Controlled Randomized 
Atrial Fibrillation Trial Investigators. St George's Hospital, London, 
England 
Patients with paroxysmal atrial fibrillation (PAF) are very frequently 
prescribed digoxin. However, its effects in this group have not been 
adequately documented. The CRAFT-1 trial was designed to evaluate 
these effects. 80 patients with symptomatic PAF were recruited from 10 
centers, and entered a one-month drug-free screening period with palient•
activated transtelephonic cardiac monitors. Patients who transmitted PAF 
were randomized into a double-blind, placebo-controlled crossover trial of 
digoxin. Digoxin dosing was initially based on estimated creatinine 
clearance and subsequently adjusted according to blood levels without loss 
of blind. Each monitoring period commenced when a satisfactory blood 
level was achieved after a 10adingIWashout phase, and continued for two 
months, or until two episodes of PAF were transmitted. 
35 patients (20 men, aged 33-81 and 15 women, aged 40-76) completed 
the double-blind phase. Daily digoxin doses during monitoring were 250JL9 
(n = 6), 375JL9 (n = 25), and 500 I'g (n = 4). The mean serum digoxin level 
was 1.0 (sd 0.2) ngll. 
The mean time to first attack increased on digoxin from 7.1 (sd 10.9) to 
13.3 (sd 18.8) days (p < 0.05). and the mean time to second attack 
increased from 18.2 (sd 17.2) to 25.6 (sd 21.4) days (p = 0.05). The mean 
heart rate during attacks decreased from 140.1 (sd 32.5) to 129.3 (sd 35.7) 
beats/minute (p < 0.05). No ventricular arrhythmias or significant pauses 
were recorded. 
We conclude that digoxin reduces the frequency of symptomatic attacks 
of paroxysmal atrial fibrillation, though by a small factor, and that the heart 
rate during symptomatic attacks is also reduced. It is unclear from these 
data whether the former effect is due to a true decrease in the frequency of 
atrial fibrillation episodes, or to diminished symptoms because of a 
reduced heart rate. 
JACC Vol. 21, No.2 
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Atrial Transport Function After the Maze Procedure for Atrial 
Arrhythmias: An Echo-Doppler Follow·up Study 
Allan L. Klein, Robert M. Savage, Yvette M. McQueen, John J. Schutzman, 
Richard A. Grimm, Brian L. Luvisi, Gerald I. Cohen, Lon W. Castle, James D. 
Thomas, WilliamJ. Stewart, Delos M. Cosgrove, Patrick M. McCarthy. 
Cleveland Clinic Foundation, Cleveland, OH 
The Maze procedure for atrial arrhythmias is designed to eliminate atrial 
fibrillation, restore sinus rhythm, and preserve atrial contraction. The echo•
Doppler evaluation of atrial transport function after this procedure has not heen 
well described. We studied 16 patients (11 males, mean age 49 years) with atrial 
fibrillation (mean duration 7 years) who underwent the Maze procedure, using 
Doppler TEE to document the return of atrial function at a mean follow-up time 
of 2.7 months. Measurements included mitral valve (MV) and tricuspid valve 
(TV) atrial (A) flow velocity (VEL), pulmonary vein (PV) and hepatic vein 
(HV) atrial reversal (AR) flow VEL. Four (25 %) of 16 pts had a Dobutamine 
TEE in follow-up to document atrial systole. 
Results: Seven pis (44 %) had no evidence of atrial contraction and were in a 
junctional rhythm or were atrial-ventricular paced at the time of follow-up (mean 
3.1 months). The other 9 pis (56%) showed evidence of atrial contraction at the 
time of follow-up (mean 2.4 months); 7 with spontaneous atrial contraction in 
follow-up and 2 during atrial pacing. These 9 pis had a mean MV A VEL of 34 
cm/sec, TV A VEL of 35 cm/sec, PV AR VEL of 26 em/sec, and HV AR 
VEL of 20 cm/sec. In 2 (22 %) of the 9 pis, the TV A wave was more prominent 
than the MV A wave. In 3 (33 %) of the 9 pis, Dobutamine TEE at low doses 
(5ug/kg/min) enhanced the mean MV· A wave to 40 cm/sec in patienls; and in 1 
pt with no apparent atrial contraction, enhanced the MV A wave to 33 cm/sec 
and the TV A wave to 30 em/sec. 
Conclusion: 1) Atrial transport function is preserved in 56% of pis at 3 months 
after the Maze procedure, as documented by Doppler transesophagea1 
echocardiography. 2) Right atrial systolic function is more preserved than left 
atrial function. 3) Dobutamine transesophageal echocardiography at low doses is 
useful in enhancing latent atrial contraction after the Maze procedure. 
831·5 11:30 
Increased Plasma Fibrinogen and Fibrin D-dlmer levels in 
Patients with Chronic Atrial Fibrillation :The Effects of 
Antithrombotlc Therapy 
Gregory Y. H. Up. "Ann Rumley, Francis G. Dunn and "Gordon D.O. Lowe. 
Department of CardIOlogy, Stobhill Hosp~al; and "University Department of 
Medicine, Royal Infirmary, Glasgow, Scotland, United Kingdom 
A prospective population-controlled study. was performed to determine 
possible associations between chronic atrial fibrillation (AF) and plasma 
fibrinogen or D-dimer levels and whether or not such levels are related to an 
enlarged atrium, impaired left ventricular function or to treatment with 
warfarin or aspirin. Fifty seven patients with established AF were studied, 
with 19 on no anti-thrombotic therapy (Group 1), 27 patients taking warfarin 
(including 2 on both aspirin and warfarin) (Group 2) and 11 taking aspirin 
therapy alone (Group 3). 
As a group, patients with AF had significantly higher levels of plasma 
fibrinogen when compared to population controls (point estimate of difference 
between medians (d.b.m.) 1.27 gA ; 95% c.L 1.01 to 1.55). There were no 
significant correlations between these coagulation parameters and atrial 
volume or left ventricular function. In Group 1, there was significant 
elevation of plasma fibrinogen (d.b.m. 1.66gA; 95%c.i. 1.2 to 2.18) and D•
dimer levels (d.b.m. 43 ng/ml; 95% c.L 13 to 198) when compared to 
population controls. In patients in Group 2, plasma fibrinogen was not 
significantly different compared to Group 1 (d.b.m. -0.68 gil ; 95% c.L -1.3 
to 0.07). However, there was a significant difference in plasma D-dimer 
levels between the two groups (d.b.m. -50 ng/ml, 95% c.i. -228.9 to -16.0). 
In Group 3, there was no signifICant differences in plasma fibrinogen (d.b.m. 
-0.33 gA ; 95% c.i. -1.13 to 0.51) and D-dimer levels (d.b.m. -29 nglml ; 95% 
c.L -268 to 14.0) when compared to Group 1. 
Conclusion - Plasma fibrinogen levels are significantly elevated in all 
patients with chronic atrial fibrillation. In patients without any antithrombotic 
therapy plasma D-dimer levels were significantly elevated suggesting 
increased intravascular thrombus formation. In patients on warfarin therapy 
there was a striking reduction in plasma D-dimer levels, suggesting that 
warfarin therapy is effective in redUCing thrombus formation. Atrial size or 
ventricular function did not appear to influence matters. 
ABSTRACTS 479A 
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The Relationship Between Baroreflex Sensitivity 
and Paroxysmal Atrial Fibrillation 
Iwao Yamaguchi, Tohru Kurihara, Hiroshi Maeda, 
Masae Eudoh, Keisuke Kuga, Yasuro Sugishita, 
University of Tsukuba, Tsukuba, Japan 
Paroxysmal atrial fibrillation (PAF) is known to 
occur both during increased vagal and/or sympathetic 
tone. However, limited data are available about the 
relationship between the baroreflex sensitivity (BRS) 
and atrial arrhythmias. In 58 patients with idiopathic 
PAF we measured BRS (ms/mmHg) (change in sinus interval 
resulting from change in systolic blood pressure) by 
intravenous bolus of 2.0 \lg/kg phenylephrine (Schwartz's 
method). In 16 patients PAF was documented during 
physical activity immediately after they awoke in the 
morning (group A). In 8 PAF occurred at rest or during 
sleeping at night (group B). In 20 PAF was related to 
physical exercise in daytime (group e), while in 14 
PAF occurred both at rest and during activity (Group D). 
Efficacy of B blockade nadolol (30 rog/day) for 
prevention of PAF occurrence was determined by the 
number of PAF episodes during 14 days loading period. 
Group ABe D 
N 16 8 20 14 
BRS (mean±SD) 2.3=1.1 10.911.9 6.2±2.4 6.9±3.2 
N of BRS <3.0 14(88%)* 0 2(10%) 2(14%) 
N of BRS >7.0 0 8(100%) 2(10%) 4(29%) 
N of patients with ~75% decrease of PAF episodes 
by nadolol 14(88%)* 0 11(55%) 2(14%) 
* ~ p<O.Ol compared to other groups 
In conclusion, measurement of BRS is useful to 
distinguish PAF patients with from without a disturbed 
or increased vagal tone and to choose the patient group 
in which a blockade is effective for prevention of PAF 
occurrence. 
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In Vivo Magnetic Resonance Spectroscopy Measurement 
of Deoxymyoglobin During Exercise in Heart Failure 
Donna M. Mancini, Liz Ann Bolinger, Hao U, Kar Wong, 
John R. Wilson, Britton Chance, John S. Leigh 
Hospital of the University of Pennsylvania, Philadelphia, PA 
Skeletal muscle metabolic abnormalities have been described in 
patients with heart failure (HF). These metabolic changes may be 
due to cellular hypoxia. Myoglobin, an {h binding protein which 
facilitates {h diffusion, can indirectly assess cellular hypoxia. 
Myoglobin content was measured in gastrocnemius biopsy speci•
mens from 16 HF and 9 nonnal subjects (NI) and was comparable 
(HF: 4.4±1.5; Nl: 4_O±Q.9 mg/gm; NS). In vivo measurement of 
deoxygenated myoglobin (Deoxy-Mb) was also performed using IH 
magnetic resonance spectroscopy (MRS) in 9 HF patients 
(EF=19±7%; V{h=14.4±5.4 ml/kg/min) and 5 Nl subjects. Calf 
plantarflexion was followed by 4 min of arterial occlusion. 31 P 
MRS was simultaneously recorded. At end exercise, inorganic 
phosphorus to phosphocreatine ratios were similar (HF: l.l±O.4; 
Nl: 1.2±0.6; NS). No Deoxy-Mb signals were observed at rest. 
At end exercise, 2 HF and 1 Nl subject had Deoxy-Mb signals. 
With arterial occlusion, Deoxy-Mb was seen in 86% of subjects. 
One minute IH spectra in a Nl and HF subject at rest (1), end exer•
cise (2), and follOwing arterial occlusion (3) are ~~ted below: 
'r-~~~~~-------
-~ 
In conclusion, significant cellular hypoxia assessed by Deoxy•
Mb signal usually does not occur during exercise in heart failure or 
normal subjects. The etiology of skeletal muscle metabolic 
abnormalities in patients with heart failure remains unclear. 
480A ABSTRACTS 
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Clinical Significance of Ammonia R!'sponse During Exercise in 
Patients With Congestive Heart Failure· Different Implicntion 
From Lactate Response 
KazuWde Ogino, Hideyuki Kitamurn, Shuichi Osaki, Ichiro Hisatome, HirO',ruki 
Miyakod.:!., Tai:;uhiko ~1J.i:;umoto, Noriyasu Noguchi, TOID Kinugawd, Hiroshi 
Kotake, Hiroto Mashiba. Tottori UniveISity, Yonago, Japan 
To evaluate the sigoificance of ammonia response during exen:ise, we mp.asurW 
blood ammonia, lactate and hypoxanthine (Hx) in 39 patients with congestive 
heart failure (CHF; l'o'YHA 1:14, II:14, m:ll) and in 12 nonnal conlrcIs during 
t.xercise. 
Ammonia threshold (AmT) were higher tlJan lactate threshold (LT) in both CHP 
(AmT-16.2:t2.3, LT-13.7±1.7ml/kgfrnin) and nonnal groups (AmT-19.3±6.I, 
LT-16.7±4.3mlfkgfmin)(p<O.05). AmT and maximum ammonia levels were 
significantly low in proportion to NYHA class (AmT;NYHA l-17.9±1.1, 
II-15.5±1.S, ill-15.0±2.7 m.lJkgJmin, maximum ammoniA;NYHA r-182±50, 
II-I05±IS, ill-71±15I'gJdl)(p<O.05, respectively). A significant cotreIatlon was 
noted between maximum ammunia and Hx levels (p<O.OOI)(Fig. I). 
Conclusion: (1) the inaease of ammonia level during exen:isc .... sults frOIn the 
activation of purine nucleotide cycle (Fig. 2), (2) AmT means the onset of "energy 
aisis' in skeletal muscles during exercise which is the different implication from 
the anaerobic threshold, (3) ammonia response during exen:isc is the new index 
for exercise capacity in ClIP. 
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Muscle Ergoreflex Role in Exertional Dyspnea in Chronic 
Heart Failure Patients 
Massimo Piepoli, Andrew L Clark, Maurizio Volterrani, Elena 
Cerquetani, Stamatis Adamopoulos, Loris Maj, Philip Poole-Wilson, 
Peter Sleight, Andrew JS Coats. Cardiac Department, John Radcliffe 
Hospital, Oxford, and National Heart & Lung Institute, London, U.K. 
In chronic heart failure (CHF) exertional dyspnea is a major symptom 
whose pathophysiological basis has not been characterized. Muscle 
ergoreceptors are unmyelinated and small myelinated nerve afferents 
sensitive to metabolic changes related to skeletal muscle work. Their 
role in the exertional dyspnea in CHF is unknown. Eight CHF patients 
(47·69 years, NYHA class II-III, EF=24.1%) were studied under 2 
different conditions: (a) isometric handgrip contractions (control), (b) 
handgrip contractions with a protocol previously showing to prolong 
ergoreflex activity (3 min ischemia at the end of exercise). Heart rate 
(HR, b/min), intra-arterial pressure (SAPIDAP, mmHg), minute 
ventilation (Ve, Vmin), peripheral resistance in a non-exercising limb 
by right leg strain gauge venous occlusion plethysmograph (R, 
mmHg/mI/1OOmg) were measured. At 3 min after exercise, results of 
recovery with ischemia were compared with control recovery 
(mean±SEM; *p<.Ol, tp<.OOl, control vs ischemia): 
Baseline Handgrip Recovery Recovery 
Rest Exercise Ischemia Control 
HR 76.S±1 92.5±3 SO.9±2 7S.6±3 
SAP 124.4±3 171.2±9 157.7±1l 127.0±8* 
DAP 76.5±1 99.7±3 91.3±5 77.6±3* 
Ve 6.8±.2 14.3±1 12.1±.S S.0±.5t 
R 47.S±4 90.5±12 93.8±13 58.8±12* 
The exercise-induced increases in ventilation, arterial pressures and 
peripheral resistance tend to persist during recovery when entrapment 
of the metabolites in the exercising ann is maintained. This suggests 
that specific muscle ergoreflex receptors stimulate vasoconstriction and 
increase in ventilation in CHF. This reflex could be the link between 
the abnormal metabolism of skeletal muscle and the heightened 
ventilatory drive observed in this syndrome. 
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Exertional Dyspnea in Heart Failure: Influence of the 
Level of Leg Muscle Activation on the Perception of 
Ventilation . 
John R. Wilson, Donna M. Mancini, Laura Farrell 
Hospital of the University of Pennsylvania, Philadelphia, PA 
Patients with heart failure and excessive ventilatory levels during 
treadmill exercise may not experience the sensation of dyspnea. To 
determine if the level of leg muscle activation influences the extent 
to which a patient perceives excessive ventilation, 32 patients with 
HF and ejection fractions <35% underwent maximum treadmill 
exercise (Naughton Protocol) with respiratory gas analysis (peak 
VOz=15±5 ml/min/kg), At each workload, patients were asked to 
rate the intensity of dyspnea (D) and fatigue (F) using the Borg 
Scale (6=none, 20=extreme1y severe). To quantify the perception 
of ventilation, Borg Scale measurements were correlated with VE in 
each patient. This relationship was always linear and was used to 
calculate the level of dyspnea experienced at a VE of 30 I.Jmin 
(Dyspnea Index), a normalized index of the perception of 
ventilation. This index averaged 13±3 but varied from 8 to 20. 
There was a significant relationship between the Dyspnea Index and 
the anaerobic threshold (r=O.49, p<O.01). In addition, the level of 
perceived dyspnea correlated closely with the level of perceiVed leg 
fatigue throughout exercise (r=0.90), suggesting a close 
relationship between the level of perceived leg muscle activation 
and the perception of ventilation. In contrast, there was no 
significant correlation between the Dyspnea Index and the slope of 
the VE to VC02 relation, a measure of the extent of intrinsic lung 
dysfunction. These findings suggest that the sensation of 
exertional dyspnea in patients with heart failure is modulated by the 
level of leg muscle activation. Treatments designed to reduce leg 
muscle activation in heart failure therefore might reduce the 
sensation of dyspnea even if the level of lung dysfunction remains 
unchanged. 
832·5 11:30 
Limb IIIld Respiratory Muscles Strength in Chronic: Heart Failure 
Cristina Opasich, Nicola Ambrosino, Guido Felicetti, Oreste Febo, Egidio Traversi, 
Franco Cobefli and Luigi Tavazzi. 
Fondazione Clinica del Lavoro IRCCS, Centro Medico di Montescano (Py), Italy 
The 111m of this study was to investigate limb ancfrespitatory musctes strength in 
clvonic heart failure (CHf). 
Population: 45 male CHF patients, 25 in NYHA Class" and 20 in NYHA Class 
III and 22 male post-MI patients without Jeflt ventricular dysfunction (L VEF 
> 50%) were studied. 
Methods: All patients underwent assessment of respiratory muscle strength by 
maximal inspiratory (MIl'! and expiratory (MEl'! pressures, of handgrip force and 
peak torque developed during isokinetic knee extension (EX) (quadriceps) and 
flexion (FX) (hamstring) at 1 20 0 • 
RauIt8: CliF patients. showed a significant reduction in aU, limb and respiratory 
muscles strer9lths compared to control patients. Moreover, NYHA Class III 
patients compared to those in NVHA Class II showed significantly reduced 
values of MlP, Handgrip, EX forces, as well as significantly reduced exercise 
tolerance in terms of METS and anaerobic thre8hoId level (An, while no 
significant differences were observed In L VEF, cardiac Index (CI) and pulmonary 
capillary wedge pressures(PCwp). Weak, but significant (p< .05) were the 
correlations between limb muscles and respiratory muscles strenghts. No 
correlations _e found between muscles forces and hemodymanic parameters. 
SIgnificant correlations (from p< .05 to p< .0001) were found among e-ase 
tolerance and limb muscles strength, but not betwes1 exen:lse tolerance and 




AGE LVEF CI PCWP METS 
51.±.7 58.±.6 S.9.±.0.7 
Sl.±.8 23.±.7 2.1.±.0.4 20.±.9 4.4.±.1.2* 
56.±.7 20.±.7 2.1.±.0.S 23.±.9 2.8.±.0.9 
MlP MEP HANDGRIP FX EX 
Post-Ml B4.5.±.5 94.±.4 1 OS.±.6 74.S.±.3 l17.B.±.5 
Class II 8B.±.6* llB.±.6 96.±.5* 4S.±.3 94.±.S * 






In lumm.-y:lIl1espiratory and skeletal muscles strengths are impainMlln CHF. 
2)lIespiratory and 8mb muscles strength reductions ere pBftially related to each 
other. 3) The degree of central hemodynamic impairment is not correlated with 
muscles forces. Conclusion: Decondltioning could be a major detenrinant of 
skeletal muscle but not of respiratory muscle weakness. 01her factors link limb 
and respiratory w~ in CHF. 
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Determinants of Peak Leg Blood Flow in Chronic Heart Failure : 
Relationship Between Leg Vascular Resistance, Muscle Wasting and 
Maximal Oxygen Uptake. 
Peter F. Ludman, Maurizio Volterrani, Andrew L Clark, John Swan, 
Andrew, J. Coats. Royal Brompton National Heart and Lung Hospital, 
London, UK 
Maximum leg muscle blood flow has been shown to be related to 
severity of chronic heart failure. To investigate whether this is due to 
a reduction in skeletal muscle mass or a true reduction in intrinsic flow, 
we assessed 13 patients with chronic stable heart failure. Their details 
were as follows: 11 male, age 76 to 46 yrs, maximum oxygen 
consumption range 8.6 to 23.5 mVmin/kg, ejection fraction 5 to 60 %. 
We measured the following parameters: a) skeletal muscle cross 
sectional area (CSA) in the thigh at mid femur level, by planimetry of 
an x-ray computed tomography scan, b) peak calf muscle blood flow by 
mercury-in-silastic strain gauge venous occlusion plethysmography 
(VOP), and c) maximum oxygen consumption (MV02) during treadmill 
exercise. The data were analysed by linear regression. 
We failed to show a correlation between peak leg blood flow 
and MV02, but skeletal muscle CSA was correlated with MV02 (r = 
0.56), and with peak leg blood flow (r = 0.61). 
These data imply that in non-oedcmatous stable treated chronic 
heart failure, the degree of muscle atrophy is a more important 
determinant of exercise capacity than is absolute peak leg blood flow. 
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833·1 10:30 
Increased Plaque Fibrosis and Calcification with Advancing Age In 
Coronary Artery Disease Patients: Evidence from Intrecoronary Ultresound 
Oalser Rasheed, John McS. Hodgson. University Hospitals of Oeveland and 
Case Western Reserve University, Cleveland, Ohio 
Older patients are an Increasingly Important group presenting with coronary 
artery disease. If lesion morphology varies from younger patients, treatment 
of these patients may require different strategies. Previous necropsy studies 
describing the composition of atherosclerotic coronary lesions reveal an 
increase In plaque fibrosis and calcification with advancing age; however, little 
data exist describing such findings In vivo. Intracoronary ultrasound (ICUS) 
allows definition of plaque morphology which correlates with histologic 
composition. We analyzed ICUS images obtained from sites of significant 
obstructive lesions (mean % area stenosis = 91 .5) In 127 coronary artery 
disease patients to determine the Influence of age on atherosclerotic plaque 
composition. Lesions were classHied as soft (S), fibrotic without calcHication 
(F), fibrotic with calcification (FC) or predominantly calcified (C). Data were 




S F FC C 
71% 12% 11% 6% 
48% 9% 15% 28% 
X2 = It.70 
P = 0.01 
We found an increased prevalence of fibrocaicHic lesions in thl! older age 
group. There was no significant difference between the two groups with 
respect to the prevalance of diabetes. hypertension, hypercholesterolemia or 
anginal type (stable vs unstable). We conclude that the prevalence of fibra•
calcific plaques In severely stenotic atherosclerotic coronary lesions Increases 
with advancing age. This difference In plaque morphology may be due to 
differences In the predominant mechanism of plaque formation (I.e. slow 
growth vs rupture/thrombosis). These findings may have Implications for the 
Interventlonal or medical treatment of older patients since different lesion 
subtypes may be expected to respond differently to therapy. 
ABSTRACTS 481A 
833·2 10:45 
Poorer Outcome and Less Aggressive Treatment for Acute Myocardial 
Infarction in the Elderly: Is There an age llias in Management? 
Sumit.~ D. Paul, Patrick T. O'Gara, John B. Newell, Gerardo Villarreal-Levy, A. J. 
Conrad Smith, Nicholas I. Kondo. Mart.~ Cararach, Laura Ferrer, Kim A. Eagle. 
Massachusetts General Hospital. Harvard Medical School, Boston, MA. 
To identify differences in clinic<~ features, management and outcome for acute 
myocardial infarction (MI) in the elderly, we studied 224 consecutive patients, 
identified prospectively, and admitted via Ute emergency room; obtaining data for 
history, ho;-pital course, and outcome by chart review. The differences between 98 
patients who were ~ 65 yrs (YOUNG). and 59 >75 yrs (OLD), by Fisher's test are: 
YOUNG (0=98) OLD (0=59) p·value 




History of CHF 
History of MI 
Family history 
Hypercholesterolemia 









59% < 0.01 
47% < 0,0] 
29% < 0.01 
40% < 0,0] 
20% < 0.01 
19% < om 
27% < om 
Thrombolysis (THROM) 32% 8% < om 
Catheterization (CATH) 77% 48% < om 
PTCA 17% 7% OJl9 
In-Hospital Death: 4% 17% < om 
In the OLD, 73% do not meet EKG criteria for THROM, and even in the 
remaining 27% with QW A YE. only 31 % got THROM versus 56% of the YOUNG 
with QW AYE (p=O.09). Furthermore, in the OLD, the mean duration of chest pain 
was significantly ionger in those who did not get THROM versus those who did (6.3 
vs 2.8 hours, p<O.04). 
Conclusions: The OLD have a substmtially greater risk of in-hospital monaJity. 
They also present with less chest pain, and more CHF. Since the OLD present later 
and predominantly with nan-Q wave infarcts, a majority do not meet the existing 
criteria for THROM. Thus, delayed, atypical. and non-Q wave presentation explain 
much of the observed differences in treatment. Further study is needed to detennine 
the reason far the differences in CA TH in the OLD. 
833·3 11:00 
Current Trends in the Treatment of Elderly Patients with 
Acute Myocardial Infarction 
Joel Gore, Richard Becker, Allen Tiefenbrunn, William 
French and Nisha Chandra For The National Registry of 
Myocardial Infarction (NRMI) Investigators, Worcester, MA. 
Patients >75 years of age with acute MI have been shown to 
benefit from thrombolytic therapy (TT). Further, due to 
the high absolute mortality in the elderly, even a small 
percent reduction translates into a large absolute 
benefit. To determine the impact of age in the treatment 
of acute MI, data from the NRMI registry were examined. 
47016 patients with MI did not receive TT and 19201 
received rt-PA. The following was observed: 
no TT rt-PA 
<65 65-75 >75 <65 65-75 7~ 
N (Total) 17509 15315 14192 12517 5484 1466 
Males (%) 73.3 59.4 44.0" 79 64 53.3" 
Age (mean) 54,0 70.6 82.4 53 69.9 80.2 
Time to Tx (hrs) 4.5 4.8 5.7" 
Excluded (%) 0.3 3.9 75.4-
Anterior MI (%) 26.9 29.1 32,5- 37,4 39.4 45.1" 
Bleeding (%) 0,4 0,6 0.5 1.1 3.0 5.7" 
Total stroke (\) 0,3 1.2 1.4" 
IV Heparin (% ) 62.7 52.8 38.5' 98.3 98.1 97,S 
Aspirin (\) 64,4 57.4 50.7' 81. 5 79,2 72.8-
I" PTCA (\) 4,6 2,7 1.2* 
Mortality (%) 6,6 13.8 23.1 2.9 8.1 18.4-
"p<.OOl comparing <65 and >75 groups 
Although the elderly represent a high risk group, they are 
frequently excluded from receiving TT based solely on age. 
Further, they less frequently are offered 1° PTCA, heparin 
or aspirin. The NRMI registry represents an important 




The Baseline Characteristics of the Older Patients in 
the NHLBI Bypass Angioplasty Revascularization 
Investigation (BARI) Study 
Michael B. Mock, Sheryl Kelsey, David R. Holmes Jr., 
Charles J. Mullany, George Sopko, BARI Investigators, 
Mayo Clinic, Rochester, MN 
BARI is a randomized trial comparing the long term risks 
and benefits of bypass surgery with coronary angioplasty 
in the treatment of multivessel coronary disease. Of 
the 1340 men, 30% are aged 65-74 and 5% > 75 years. Of 
the 489 women, 39% are aged 65-74 and 10% > 75 years. 
Major baseline characteristics of the randomized patients 
by age and sex are presented below. 
MEN WOMEN 
Years 
< 65 65-74 ;;: 75 < 65 65-74 ;;; 75 
Number randomized 871 408 61 250 192 47 
%Unstable angina 59% 63% 77% 65% 68% 77% 
%History of smoking 79% 74% 77% 67% 41% 17% 
%History of CHF 6% 7% 15% 11% 15% 20% 
Mean HDL chol (mg/dL) 37 36 42 43 41 46 
History hypertension 39% 49% 48% 64% 70% 81% 
Family history CAD 54% 43% 35% 54% 52% 36% 
5T seg depressed> 1 mm 2% 8% 14% 3% 8% 17% 
Negative T waves 31% 29% 36% 26% 33% 44% 
Myocardial jeopardy 62 61 60 61 65 68 
index (MJI) 
Among the elderly more p~tients were women. Overall 
more of the men were smokers and older women smoked the 
least. HUL cholesterol levels increased with age. Older 
patients had more congestive heart failure, resting ECG 
changes and a higher incidence of unstable angina. The 
oldest women had the most hypertension and resting ECG 
changes of negative T waves or depressed 5T segments and 
the highest MJI or territory of ischemic disease. 
833·5 11:30 
Acute Outcome and Long-term Follow-up of Elderly Patients with Non-Q•
Wave Myocardial Infarction Treated with Coronary Angioplasty 
Dwarka N Vemnrj, James L Vacek, Steven K. Rowe, Charles B. Porter, Randall 
E. Genton, Thomas L Rosamond, Paul H. Kramer, Linda I. Crouse, O. Wayne 
Robuck, Gary D. Beauchamp. Mid America Heart Institute and St. Luke's Hospital. 
Kansas City. Missouri 
The purpose of the study is to asses., the outcome of coronary angioplasty (PTCA) 
in elderly pts, with non-O myocardial infarction (NOM 1). 
We studied 136 consecutive elderly pts (age 70-91 yrs; mean 81 ± 10 yrs; 
58% male, 42% female) with NOMI who underwent YfCA before hospital 
discharge. The infarct related vessel was identified as LAD in 63 pts (46.3%). RCA 
in 36 (26.5%), LCX in 32 (23.6%), left main in 1 (0.7%) and saphenous vein graft 
in 4 pts (2.9%). Thirty pts (22.1%) had prior MI and 19 (14%) prior bypass 
surgery (CAnG). Ejection fraction (EF) is available in 124 pts (91.2%), of whom 
50 pts (40.3%) had EF s 40% and 74 pts (59.7%) ~ 40%. YfCA was successful 
in 128 pts (94.1%). There were no procedural deaths although 2 pts (1.5%) died 
prior to discharge. Two pts (1.5%) required emergency CAnG after failed PTCA, 
and 3 pts (2_2%) required CAnG prior to discharge. There were 6 deaths at 1 yr 
(survival 95.6%). At 2.3 ± 1.9 yr follow-up, there were 21 deaths (survival 
84.6%), 8 were cardiac (5.9%). Aogioplasty survival rates were similar for ejection 
fraction s 40% and ~ 40% (84%. 82.4%); p=NS. Three pts (2.2%) sustained a 
late non-fatal MI, and 8 pts (5.9%) underwent CABG at 1 yr and 7 pts (5.1%) at 
long-term follow-up. The 2.3 ± 1.9 yr event-free survival (without death, MI, and 
CABG) was 67_6%. Fifty-six pts (41.2%) were restudied for angina, MI, abnormal 
stress echo. persistent arrhythmia,; out of these. 46 pts (33.8%) showed restenosis. 
Repeat PTCA was performed in 16 pIS (11.8%), prior to discharge in 2 (1.5%), and 
after discharge in 14 (10.3%). At 2.3 ± 1.9 yr follow-up 97 pts (71.3%) were free 
of angina. 
CONCLUSIONS: 1) In elderly pts presenting with NOMI. revascularization with 
PTCA can be performed with • very high early success rate and few procedural 
complications; 2) There were no significant differences in long-term mortality when 
PTCA is applied to pts with EF s 40% or ~ 40% in the elderly NOMI population; 
3) This approach results in good early and mid-term (2.3 ± 1.9 yr) event-free 
survival. 
833·6 
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Outcome of Aged With Myocardial Infarction in the Lytic Era 
William Devlin, David R. Cragg, Marsha J. Jacks, Harold Z. Friedman, 
Cindy L. Grines, Gerald C. Timmis, William W. O'Neill William 
Beaumont Hospital, Royal Oak, Michigan 
Between July 1988 and July 1990, 1,123 consecutive acute myocardial 
infarction (AMI) cases hospitalized were reviewed. There were 326 
patients ?: 76 years old and 797 patients ~ 76. Demographic analysis of 
the two groups showed that the elderly had a higher proportion of 
females (56 vs 30%, P = < 0.01) less hypercholesterolemia (10 vs 27%, 
P = 0.01), more previous AMI (33 vs 28%, p = 0.07) and a higher 
incidence of bundle branch block (28 vs 13%, P < 0.01). Only 7% of 
elderly and 22% of young patients were considered eligible for lysis 
(p < 0.00(1), reperfusion (Iytics or PTCA) was used in 10 and 38% 
respectively, p < 0.001. Bleeding risk and nondiagnostic ECG were the 
commonest exclusions in the elderly. 
Lytic Exclusions Elderly (%) Young (%) p Value 
ECG non-<iiagnostic 42 33 0.003 
Late presentation 15 13 0.28 
Bleeding risk 32 17 0.0001 
Misc. exclusions 11 23 0.0001 
Although the elderly had a higher proportion of non-Q Mrs (54 vs 44%, 
P = 0.(03). incidence of congestive heart failure (47 vs 23%, P = 0.(01) 
and death (27 vs 10%, P = 0.(01) was greater. Causes of death were 
not significantly different: mechanical 51 vs 45%, arrhythmia 17 vs 17%, 
stroke 1 vs 2%, sepsis 8 and 7%, respiratory failure 6 vs 5%, and 
unassignable 15 vs 9%, respectively. In conclusion, despite aggressive 
attempts to treat elderly only 7% were lytic eligible even when age was 
not a contraindication. Increased mortality in the elderly was not due 
to multisystem failure but to impaired myocardial reseIVe, suggesting that 
mechanical repcrfusion strategies may improve prognosis. 
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834·1 10:30 
Evidence of Thrombin Production in the Presence of 
Conventional Anticoagulation Following Coronary 
Stenting 
Subodh K. Agrawal, Pradip K. Rustagi, Ming W. Liu, James A Hearn, 
Adam D. Cannon, Luc Bilodeau, Sriram S. lyer, Larry S. Dean, William A. 
Baxley, Gary S. Roubin. Division of Cardiovascular Disease, University of 
Alabama, Birmingham, Alabama 
Acute thrombosis limits the efficacy of metallic coronary stents. 
Prothrombin fragment 1+2 (Fl.2) is a peptide cleaved from prothrombin 
during thrombin generation. Enzyme-linked immunosorbent assays to 
measure Fl.2 have recently become available and may be used clinically 
to assess ongoing thrombin production. Fl.2 levels in anticoagulated 
patients are reported to be < 0.5 nM/L. We measured this mar1<er of 
thrombin production in 85 patients who underwent stenting for threatened 
or acute closure after coronary angioplasty. In these patients who received 
aspirin. dipyridamole. heparin and/or coumadin, the results of Fl.2 





























* mean ± standard error of the mean ** one way analySis of variance 
Fl.2 remained elevated for the first 2 days after stenting despite adequate 
conventional anticoagulation. 
Conclusion: These data suggest that for the first two days after stenting, 
conventional anticoagulation therapy is unable to inhibit thrombin 
generation. The role of prothrombin fragment 1 +2 measurements deserve 
further evaluation in the management of patients after metallic coronary 
stent placement. 
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A New Method for Arterial Drug Delivery Via Removable Stent 
Tom Lambert, Neal l. Elgler, James S. Forrester, Frank litvack 
Cedars-Sinal Medical Center, los Angeles, CA 
10:45 
This study's goal was to develop a method 01 delivering lipophilic drug 
Into the arterial wall from a removable stent and to measure vessel wall 
uptake and systemic distribution. A specialized polyurethane drug 
delivery coating which Incorporates and releases trttiated Forskolln (FSK), 
a lipophilic adenyiate cyclase activator was developed and applied to 3 
mm diameter Nitinol Heat Activated Removable Temporary Stents 
(HARTS). The balloon expandable stents were deployed in the right 
carotid arteries of 13 New Zealand WMe rabbns. Quantification was 
performed by scintillation counting. Resu~s: After 4 hours (6 rabb~s) 
FSK levels were measured in blood (BlD) and tissue samples from media 
(MED) and adventitia (ADV) adjacent to the stent, 1 em proximal (PST), 
1 cm dlst (DST), contralateral carotid artery, (CLA), and liver (UV). 
MED ADV PST DST LlV CLA BlD 
ug FSK/ 60* 48* 3.0* 6.0* 0.45 0.25 0.13 
gm tissue *p < 0.000001 (compared to CLA and BlD.) 
Release rate from the stent into blood averaged 3.7 ug/min and peak 
blood concentration was 14 + / - 4 ug%. Analysis of tissue 
concentrations near the stent suggest that diffusion of drug occurs in 
both radial and long~udinal direction from the stent. After 24 hour 
implant (3 rabbtts), media FSK was 4.9 ug/gm (p < .01 vs 4 hours). In 
four rabbits stents were percutaneously removed and adjacent media 
tissue levels were 1.2 ug/gm at 2 hrs. and 0.2 ug/g at 24 hrs following 
removal of the stent. ConClusion: These data suggest that a lipophilic 
drug can be loaded into a specialized coating on a removable stent. The 
drug can then be delivered whh high local arterial wall and low systemic 
concentrations and the stent subsequently removed. This system may 
be useful for evaluating effects of local drug delivery on restenosis. 
834-3 
Biodegradable Intracoronary Stents in Adult Dogs 
Takashl Susawa, Kaneto Shiraki*, Yasuhiko Shimizu. 
Research Center of Biomedical Engineeling, 
Kyoto University, Gunzc Ltd.*, Kyoto, Japan 
11:00 
Metallic permanent stents have been the treatment of choice in 
cases of aClite coronary closure and restenosis_ These prostheses, 
however, may induce late complications, such as late restenosis. 
coronarj aneurysm, and flexibility mismatch. In order to resolve 
these problems, we have recently developed a balloon-expandable 
intracoronary stent which is knitted from a biodegradable polymer, 
polyglycolic acid_ 
Stents were implanted in coronary arteries of J 5 dogs treated with 
intravenolls heparin (10,000 U), aspirin (500 mg) and low 
molecular weight dextran (10%; 250 ml). In 6 dogs, coronary 
angiography was repeated for 3 h after stent placement. The other 
9 dogs were sacrificed after 1 (n=4), 2 (n=4) and 8 weeks (n=1) 
for pathologic study. 
Alt the stents were successfully delivered to the desired coronary 
artery without migration, rupture or abrupt thrombosis. 
Angiography demonstrated vessel patency without stenosis over 
the 3 h period. The strutq of the stent locally depre~sed the arterial 
wall, and were covered with fresh ,hrombus at 3 h. Thromblls 
material on the stent was composed mainly of red blood cells and 
fibrin at I week. At 2 and 8 weeks, the neo-intima covering the 
stent was cellula., and the arterial wall was covered bv 
endothelium. The stent~ subsequently became fragile, and a 
foreign body reaction accompanied by stent degradation was 
observed around the stents at 1 and 2 weeks. The diameter of the 
polymer fibers was unchanged at I and 2 weeks, and had 
decreased to le&s than half of the primary diameter by 8 weeks. 
Therefore, this newly developed sten! can enlarge the coronary 
artery effectively, and degrades within the artery. As polymeric 
fibers can be modified to suppress thrombus formation for 
reduction of neo-intima thickness, biodegradable stents can be a 
llseful adjunctive device for coronary :mgiop\asty. 
ABSTRACTS 
834-4 11:15 
Neointimal Coverage of the Stents in Human 
Coronary Arteries Observed by Angioscopy 
Yasunori Ueda, Atsushi Hirayama, Takayoshi Adachi, 
Shinsuke Nanto, Kazuhisa Kodama. Cardiovascular 
Division, Osaka Police Hospital, Osaka, Japan 
To delineate the course of the neointimal coverage of the 
stents in human coronary arteries, 12 balloon-expandable 
Wiktor stents placed in the coronary arteries in 12 patients 
(pts) were observed by angioscopy soon after stenting, at 2 
weeks after, and at 3 months after. Anticoagulation therapy 
(intravenous heparin followed by coumadinization) and anti•
platelets therapy (aspirin 300mg/day and dipyridamole 
75mg/day) were performed during the study. Soon after 
stenting, the glittering stents were well embedded into the 
luminal wall in all pts. Even at 2 weeks, the stents were not 
covered at all by the neointimal layer in all pts, and showed 
the same appearance as they did soon after. At 3 months, 
the stents were almost completely covered by the neointimal 
layer in all pts. In 3 pts, the stent was covered by a thin 
transparent layer with a smooth surface; however in the rest 
of the pts, it was covered by a thick white layer with a cotton•
like surface appearance. Angioscopic completion of the 
neointimal coverage was found much later in this study than 
in the experimental observations in dogs; which 
demonstrated the coverage within a week. The findings in 
this study would suggest that the anticoagulation and anti•
platelets therapy after coronary stenting should be 
continued at least for 3 months. and the time to quit the 
therapy would better be determined from the angioscopic 
findings in each patient. 
834-5 11:30 
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In Vitro Thrombogenicity Analysis of a new Bioabsorbable, Balloon•
expandable, Endovasclilar Stent. 
James P. Zidar, S. Fazal Mohammad, Stephen C. Culp, Brigitta C, Brott, 
Harry R. Phillips, Richard S. Stack. University of Utah and Duke 
University, Durham, NC. 
Metallic stents are often used to treat acute arterial closure and 
restenosis following angioplasty, yet the risk of subacute stent thrombosis 
and the potential for long-term problems with permanent metallic implants 
remains significant. A new balloon-expandable stent made of a special 
bioerodible polymer of L-poly lactide (ACS, Inc.) has been developed to 
address these issues. 
To quantitatively determine the thrombogenic potential for this 
polymer, an jn-vitro analysis using fresh, heparinized bovine blood and 
Indium Ill-labeled platelets was performed using a conduit test chamber. 
The entire test system was submerged in a 37"C degree water bath. 
Anticoagulation level was carefully adjusted (3x nI aP'IT) to simulate in•
Yb!2 conditions. 
Three types of stents were submitted for analysis: uncoated 
polymer stents (PLLA), heparin-coated polymer stents (HPLLA) and 
slotted-tube stainless steel metallic stents (MET), Three experiments were 
performed on different batches of bovine blood, and the results were 
consistent throughout each separate run. Data are reported as mean 
percentage of labeled platelets C±.standard error) bound to the stent 
compared with the control MET stent. 
MET(n=3) PLLAfn=6) HPLLAfn=3) 
Mean 100% -p < .05- 33.9±8.1 % -p < .05- 2.0±1.I % 
HPLLA (3.7 mg) and the PLLA (15.0 mg) also developed less mean 
thrombus mass when compared with the MET stent (78.6 mg). 
In conclusion, this new polymeric stent shows reduced platelet 
adherence and reduced thrombogenicity compared to a stainless steel 




Increased and selective neointimal permeability, 
up to 12 weeks after successful stent implantation. 
HMM van Beusekom, WI van der Giessen, PW Serruys and 
PD Verdouw. Thoraxcenter, Erasmus University Rotterdam. 
Introduction. We have shown previously, that de-endothelialized 
porcine coronary arteries exhibit an increased permeability for 
angiotensin (ANG)-II (MW 1046), as indicated by an increased 
breakdown of ANG-II when compared to normal controls. Also 
stented coronary arteries show this increased ANG breakdown, which 
indicates a problem at the level of endothelial permeability. 
Objectives. To study the endothelial permeability after stenting by 
dye-exclusion testing (Bjorkerud, Atherosclerosis 1972;15:285). 
Methods. Both balloon-expandable (n= 11) and self-expandable stents 
(n =6) were implanted in porcine coronary arteries under quantitative 
angiographic guidance to prevent oversizing. At 4 to 12 weeks, the 
animals were catheterized for control angiography and Evans Blue 
infusion (EB). To assess the size of endothelial leakage, 500 ml EB in 
saline (MW 960) was infused into normal and stented coronary 
arteries in vivo after a saline wash and compared to EB-albumin 
complex (MW 70.(00) given intravenously. Thereafter, the coronary 
arteries were pressure-fixed for macro- and microscopic analysis. 
Results. Macroscopical analysis revealed penetration of EB into the 
vessel wall up to 12 weeks after stenting, specifically in the tissue 
covering the metal stent wires. When EB was coupled to albumin 
however no penetration was found at either time point. Microscopical 
analysis revealed that all stents were completely endothelialized, 
apparently without any missing cells. 
Conclusion. This study indicates that stenting decreases long-term 
endothelial integrity, but leakage is restricted to smaller molecules 
such as EB and ANG-II. The extent of endothelial leakage and the 
threshold of molecular size has to be determined by further study. 
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835-1 10:30 
Etiologies of Abrupt Occlusion After PTCA : Angloacoplc Morphology 
Suresh P. Jain, Christopher J. White, Tyrone J. Collins, Alvaro Escobar, 
Slephen R. Ramee, Ochsner Clinic, New Orleans, LA. 
We performed percutaneous coronary angioscopy in 10 patients 
following abrupt occlusion (AC) occurring immediately after 
balloon angioplasty (PTCA). All of the patients had failed to respond 
to the administration of intracoronary nitroglycerine. All of the 
patients were undergoing single vessel PTCA of a culprit lesion 
causing unstable angina. Although the angiographic characterstics 
of patients with a high risk of AC have been described, no data exists 
regarding angioscopic findings in this population. Lesion 
morphologies contributing to occlusion of the dilated lesion were 
observed and included the presence of intravascular thrombi 
(mural or ocdusive), and dissections (superficial or occlusive). 
Intravascular thrombi were observed at the site of the AC in 
9/10 patients and were occlusive in 2 patients. Fragmented plaque 
and tissue flaps secondary to dissection of the artery wan was seen 
in all 10 patients and were occlusive in 8/10. The primary cause 
of the abrupt occlusion was thrombus in 2 patients, and occlusive 
dissection in 8 patients. Seven of the occlusive dissections were 
associated with non-occlusive mural thrombi, and the 2 occlusive 
thrombi were associated with superficial (non-occlusive) 
dissections. One patient had evidence of an occlusive dissection 
without thrombus present. 
Conclusion: Angioscopy revealed the primary cause of AC by 
visualizing the vascular lumen of the occluded vessel. It is of 
interest that although the primary cause of AC was most often an 
occlusive dissection, non-occlusive intracoronary thrombi were 
associated with these dissections in all but one case. Angioscopy may 
allow the selection of specific therapy (thrombolysis, long balloon 
inflations, atherectomy, or stents) in cases of AC based upon the 
primary cause of the occlusion. 
835-2 
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Conservation of Plaque Mass: A Volumetric Intravascular Ultrasound 
Analysis of PatienlS before and after Percutaneous TranslumiDal Coronary 
Angioplasty 
Gary S. Mintz. Julie A. Kovach, Keum S. Park. Fadi A. Matar. AuguslO O. 
Pichrud. Kenneth M. Kent, Lowell F. Sader. Martin B. Leon. Washington Hospital 
Center. Washington. DC 
To bener understand arterial and plaque remodeling after percutaneous 
transluminal angioplasty (PTCA). we studied II patients (2 LAD. I LCX. 7 RCA. 
I SVG) using a comprehensive intravascular ultrasound (NUS) imaging system 
{25MHz rotating transducer. 3.9F monorail imaging sheath, motorized transducer 
pullback at O.5mm/sec. 2·0 and 3-D display and quantification I and a 
histologically validated method for measuring external elastic membrane (EEM), 
lumen. and plaque+media (p+M) volumes and cross-sectional areas (CSA). We 
analyzed an ISmm long segment centered at the narrowest pretreatment cross•
sectional area and compared it 10 that cross-section before and after PTCA. Eight 
lesion sites were calcified (mean arc 110'); 5 of these had dissections after PTCA. 
pre PTCA postP'fCA A P 
EEM volume (ce) O.36±O.96 0.40i0.SO 11±6% .0005 
CSA (mm2) IS.2±6.7 2O.I±6.5 12:±9% .0009 
Lumen volume (ee) O.l3±O.21 O.l7±O.22 26±21% .0007 
CSA (mm2) 1.4±O.6 5.2±1.4 282±I34% <.0001 
P+M volume (cc) 0.22±.39 0.22±O.40 O.3±O.5% NS 
CSA (mm2) 20.1±6.S 14.2±5.6 .15±5% .017 
IVUS showed arterial expansion (EEM post PTCA>EEM pre PTCA) in all, even 
in calcified lesions with dissection. However, axial inhomogeneity in expansion 
correlated inversely with tbe focal arc of calcification (1'=.029). Single slice NUS 
data showed lumen enlargement out of proportion to expansion erroneously 
suggesting plaque compression; this was explained by volumetric analysis which 
showed no change in P+M volume, but axial redistribution of plaque away from 
the narrowest CSA (p<.OOOJ. ANOVA). 
We conclude: Volumetric lVUS analysis shows that atherosclerotic 
plaque mass is conserved and redistributed, but not compressed following PTCA. 
All of the lumen volume increase is accounted for by arterial expansion which (I) 
occurs even with post-PTCA dissection. (2) depends on the interaction of plaque 
and vessel wall compliance. and (3) is modulated by axial variations in non•
compliant plaque elements. 
835-3 11:00 
Serial Intravaseular Ultrasound Studies Indicate tbat Cbronlc Recoil is an 
Important Mecbanism of Restenosis following Transcatbeter Tberapy 
Julie A. Kovach, Gary S. Mintz. Kenneth M. Kent. Augusto O. Pichard. LoweIl F. 
Satler, Jeffrey J. Popma. Martin B. Leon. Washington Hospital Center. 
Washington. DC 
Post-procedural minimal lumen diameter, chronic recoil. and intimal hyperplasia 
may all interact to cause late lumen narrowing resulting in restenosis. To evaluate 
the relative contributions of these factors to restenosis, we used a comprebensive 
intravascular ultrasound (IVUS) imaging system {25MHz rotating transducer. 
3.9F monorail imaging sheath, motorized puIlback at 0.5mm/sec. 2-D and 3-D 
display and quantification I 10 study 20 pIS (15 males, 5 females, ages 58± 12 years: 
I left main. 7 LAD. 2 LCX. 6 RCA. 2 SVG) immediately after and 4.1±2.4 
months following transcatheter therapy (TCT: 3 baUoon. 3 excimer laser 
angioplasty: 7 directional. 7 rotational atherectomy). Paired post-TCT and follow•
up image slices were analyzed; and external elastic membrane (EEM). lumen, and 
plaque+media (P+ M) cross-sectional areas (CSA). and % cross-sectional 
narrowing (CSN=P+M!EEM) measured; and their differences at follow-up (A) 
calculated. 
Restenosis (n-9) No Restenosis (n=11) P 
post· TCT lumen CSA 4.3±1.5 mm2 5.7±2.2 mm2 .er12 
post-TCf P+M CSA 16.8±3.5 mm2 16.2±5.9 mm2 NS 
AEEMCSA ·1.9±1.9mm2 ·1.5±O.9mm2 NS 
A lumen CSA ·2.8±1.6 mm2 .Q.6±O.9 mm2 .001 
A P+M CSA 0.9±2.3 mm2 .Q.9± 1.2 mm2 .02 
Arc of calcium 131±120' 50±72' .~ 
Post·TCf dissection 3 (33%) 1 (9%) NS 
Late lumen CSA loss averaged 65% in the restenotic lesions. Although P+M area 
increased (presumably reflecting the presence of intimal hyperplasia). this 
accounted for ollly 32% of late loss. More imponantly. a smaller post·procedural 
lumen CSA and chronic arterial recoil (averaging 7.5% of EEM CSA. but 44% of 
lumen CSA to cause 68% of late lumen loss) contributed significantly to 
restenosis. We conclude: (I) SeriallVUS studies provide unique insights into 
causative mechanisms of restenosis after TCT. (2) a larger post-TCT lumen CSA 
reduces restenosis frequency. and (3) chronic arterial recoil may have a greater 
influence on late lumen loss and restenosis than intimal hyperplasia. 
JACC Vol. 21, No.2 
February 1993:485A 
835-4 11:15 
Intravascular Ultrasound Assessment of PTCA Results: 
Insights into the Mechanisms of Balloon Angioplasty 
Anthony De Franco, E. Murat Tuzcu, Alaa Abdelmeguid, A Michael 
Lincoff, David Brown, Mark Bernardi, Stephen G. Ellis, Patrick L. 
Whitlow, Joseph M. Sutton, Paul N. Casale, Russel E. Raymond, 
Eric J. Topol, & Steven E. Nissen, Cleveland Clinic, Cleveland, OH 
Intravascular ultrasound can evaluate wall morphology following 
coronary balloon angioplasty providing the opportunity to evaluate, 
in vivo, the extent and mechanism of benefit from PTCA We 
examined 74 dilated lesions in 63 patients using one of several 
intravascular instruments. These included a new 30 MHz 3.5F 
mechanical system (Boston ScientifidHewlett-Packard), a 20 MHz 
3.5F or 5.5F multi-element array and a 20 MHz 3.5F combination 
device with both an imaging array and PTCA balloon (Endosonics). 
For each lesion, we imaged both the dilated and nearest angio•
graphically normal, non-dilated segment, and evaluated the extent, 
distribution, and morphology of plaque. At the PICA and reference 
segments, we measured the angiographic and ultrasound per-cent 
luminal area reduction and radius of curvature of the media. The 
residual stenosis following PTCA by angiography and ultrasound 
correlatcd poorly, 36% vs. 54%, r=0.39. At 9 of74lesions (12%). 
the PTCA site demonstrated an eccentric lesion with increased radius 
of curvature for the least diseased side of the vessel. suggesting that 
the mechanism of PTCA was primarily focal stretching of normal wall. 
At Iln4 PTCA sites (15%). concentric plaque was evident with an 
increased radius of curvature in comparison to the reference segment, 
indicating circumferential stretching. At 19n4 PTCA sites (26%). a 
concentric lesion (calcified in 15/19) showed cracks or splits demon•
strating that plaque fracture was the probable mechanism of benefit. At 
8 siles studied with the combined device. 3 showed evidence of plaque 
compression during serial balloon inflations. At 32174 PTCA sites 
(42%). distortion of anatomy precluded defmitive evaluation of PTCA 
mechanism. These data demonstrate at least 4 mechanisms of benefit 
by PTCA including plaque fracture. circumferential or focal stretching, 
and plaque compression. These altemative mechanisms may impact 
upon the long-term outcome following PTCA. particularly restenosis. 
835-5 11:30 
Mechanisms Of Balloon Angioplasty_ A Study Using A 
Combined Ball oon Oil atation Catheter And Ultrasound 
Imaging Device. 
Robert J. Siegel, Susan Kelly, Wolfgang Steffen, 
Robert Crowley, Jim Koger, Gerald Maurer, Michael C. 
Fishbein. Cedars-Sinai Medical Center, Los Angeles, 
CA. 
The mechanisms of balloon angioplasty (PTA) remain 
unresolved. To evaluate the effects of PTA in real 
time, we used a prototype ultrasound imaging (US) wire 
(0.36 in) within a PTA catheter to study 14 fresh 
(pressure di stended) human atherosclerotic arteries 
(ART). US was performed before, serially during 
balloon inflation (0-10 ATM) and after PTA. Histology 
was used to evaluate plaque composition [calcified, 
nm9; non-calcified ns 5] and the presence of dissection 
(n=9). Distensibility was assessed by the slope of the 
pressure-area curve. During PTA lumen area increased 
by 43% and the medial thickness decreased by 49%. 
Imaging during PTA revealed that as lumen area 
increases lumen eccentricity decreases (p<O.05), 
medi al thickness decreases (p<O.05), but pl aque 
thickness does not change. Recoil with a mean 46% 
reduction in the maximal lumen area occurs immediately 
after PTA balloon deflation. Both direct visualization 
by US and pressure area curves demonstrated that the 
predominant mechanism of dilatation was stretching in 
non-cal ci fied and di ssection in cal cified ART during 
PTA. 
Conclusion: Real-time ultrasound imaging through a PTA 
catheter duri ng ba 11 oon dil at at i on demonstrates: (I) 
progressive decreases in lumen eccentricity and medial 
thickness as the artery dilates; (2) frequent 
dissection; (3) no plaque compression; (4) immediate 
recoil, and (5) differences in PTA effects on 
different plaque types. 
ABSTRACTS 
835-6 11:45 
A Comparison of Angiography and Intravascular Ultrasound to 
Predict the Result of PTCA 
Junko Honye. Donald J. Mahon. Shigeru Nakamura. Tim Martinez. 
Jonathan M. Tobis 
University of CalHornia. Irvine. CA 
Angiographic appearance pre·PTCA was compared with plaque 
morphology post PTCA by Intravascular ultraSOUnd (IVUS) Imaging to 
determine ~ the pre·PTCA angiographlc appearance can predict the 
resutts of PTCA. Ninety·four lesions were classWied into 4 anglographlc 
patterns as 1) concentric; symmetric narrowing, 2) Type I eccentric; 
asymmetric stenosis with smooth borders and a broad neck. 3) Type II 
eccentric; asymmetric stenosis with a narrow base or Irregular borders, 
4) Multiple irregularities. Total occlusions were excluded. Plaque 
morphology (fracture. dissection and eccentricity) post PTCA was 
evaluated by IVUS imaging. 
Pre·:PTCA 
Angiographic Morphology 
Concentric (n = 18) 
Type I Eccentric (n =38) 
Type II Eccentric (n=23) 
Diffuse Irregular (n=15) 
IVUS Morphology 
Plaque Medial Eccentric 
~ Dissection ~ 
12 (67%) 10 (56%) 13 (72%) 
20 (53%) 13 (34%) 30 (79%) 
12 (52%) 5 (22%) 18 (78%) 
12 (80%)* 12(80%)* 11 (73%) 
The majority (60%) of successful angioplasties resulted In plaque 
fracture. The overall incidence of medial dissection was 43%. Most of 
the plaques(78%) were eccentric by IVUS but there was only 67% 
concordance with the angiographlc appearance of eccentricity. Except 
for the high incidence of dissection and fracture associated with an 
angiographic appearance of multiple irregularities (*p<O.OI), 
angiography does not predict the morphologic effect of balloon dilation 
on the atherosclerotic plaque. 
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Use of the Proximal Convergence Method to Quantitate Mitral Regurgitation 
in Patients with a I1aiI LeaI1et: Lessons from Fluid Dynamiw Modelling 
James D. Thomas. Kimerly A. Powell, Neil Greenberg. Pieter M. Vandervoort. 
William J. Stewart. Cleveland Clinic Foundation. Cleveland. OH 
The proximal convergence method is a promising approach to the 
quantification of mitral regurgitation (MR). but it may overestimate regurgitant flow 
in cases of severe MR when there is a flail leaflet. To investigate the reason for 
this and identify possible corrective actions, we performed finite difference 
turbulent flow numerical simulation on a I mm grid. modelling I) centrally-directed 
MR from incomplete MV closure; 2) eccentric MR from posterior leaflet prolapse; 
and 3) severe MR from posterior leaflet flail. Results: Flow rates (Q) ranged from 
230 to 447 cm'/sec. Assuming hemispheric convergence into a point-like orifice. 
the centrally-directed MR was most accurately estimated with an error AQ = 
0±8%. The prolapse and flail simulations revealed 2 distinct types of errors: 1) 
close to the orifice. Q was underestimated by 30 to 50% because the flow was 
directed eccentrically and the rull velocity could not be recorded by Dorpler; and 
2) far (> 1.3 cm) from the orifice, Q was progressively overestimated (by up to 
\ 00 %) due to the constraining effect of the posterior LV wall preventing the 
hemispheric spread of velocity assumed in the uncorrected proximal convergence 
method. Optimal estimation _______ ....-:="".,..;..,. __ '--__ 
of Q with leaflet flail was lEFT YE'11!lm L 
obtained when the orifice 
center was identified just Velocity Contours 
behind the anterior MV 
leaflet. Digitally output color 
flow maps from patients with 
central and eccentric MR 
LEFT AfRIUM 
correlated closely to these "::::=-__ =~eZ.... _________ _ 
simulations. supporting their 
clinical utility. Conclusions: \) Eccentrically directed MR is inherently less 
quantifiable than central MR when the proximal convergence method is used with 
assumption of hemispheric symmetry. 2) Selection of an adjusted orifice center and 
correction for isovelocity contour constraint by the ventricular wall yield more 




Is Proximal Accelerating Flow Calculation a Better Method 
for Estimating Severity of Mitral Regurgitation Than Color 
Doppler Jet Area 
Chunguang Chen, Dietmar Koschyk, Soeren Heik, Christian 
Hamm, Wolfram Kupper. University Hospital Hamburg, 
Hamburg, FRG 
Color Doppler jet area (JA) is widely used in 
routine c1 inica1 assessment of severity of mitral 
regurgitation (MR). Proximal convergent flow (PCF) 
cal cul at i on has been proposed as an accurate method for 
estimation of MR flow. To examine relative accuracy of 
these methods for estimating MR stroke volume (MR-V) and 
angiographic severity of MR, 56 patients were studied. 
Color Doppler JA (cm2), ratio of JA to left atrial area 
(JA/LA, %) and color Doppler PCF stroke volume (ml) were 
measured and compared with stroke MR-V (m1) and 
angiographic severity of MR (I-IV). Eccentrically directed 
MR jet clinging along atrial wall was defined as wall jet 
and central jet as free jet. Results: Correlation 
coefficients (r) between color Doppler parameters and 
angiogram or MR-RV (r) were: 
MR-V Angiographic MR severity 
JA 0.66 0.71 
JA/LA 0.68 0.70 
PCF volume 0.93 0.86 
Predictive accuracy for severe MR of 4+ was 82% using JA 
~ 12 cm2 and 93% using PCF stroke volume ~ 80 m1. Presence 
of wall jet significantly worsened both the correlation 
(r=0.45) and predictive accuracy (65%) by JA (p<0.05, 
each), while wall MR jet did not influence the correlation 
and the predictive accuracy by PCF (p=NS). Conclusions; 1) 
Proxima 1 convergent fl ow cal cul at i on is a more accurate 
method for estimating MR severity; 2) its accuracy is not 
altered by presence of wall MR jet and 3) this calculation 
should replace downstream jet area in assessing severity 
of MR, especially, in patients with eccentrically directed 
wall MR jet. 
836-3 11:00 
Proximal Jet Size by Doppler Color Flow Mapping Predicts the 
Severity of Mitral Regurgitation: Clinical Studies 
Donato Mele. Pieter M. Vandervoort, Igor F. Palacios. Robert E. 
Dinsmore. Arthur E. Weyman. Ehud Schwammenthal. J. Miguel 
Rivera. Jane E. Marshall. Ucia N. Mueller. Robert A. Levine. 
Mass. General Hospital. Boston. MA 
Recent studies have shown that many instrument and physiologic 
factors limit the ability of color Doppler jet area within the 
receiving chamber to predict the severity of regurgitation. In 
contrast. the proximal or initial dimensions and area of the jet as 
it emeiMs from the onhce have been shown to mcrease dIrectly 
WIth 0 ce sIZe. and to correlate well with the severity of aortic 
insufficiency. Only limited data. however. are available regarding 
the value of proximal jet size in mitral regurgitation (MR). and it 
has not been examined in short-axis views. The purpose of this 
study, therefore. was to evaluate the relation between proximal jet 
size and other measures of MR sevent . In 41 consecutive pt 
stu es. t e anteropostenor el tot e proximal jet as it 
emerges from the valve was measured in the parasternal long-axis 
view; proximal jet width and area were measured in the short-axis 
view at the same level. Results were compared with angiographic 
grade (1-3 +) delermined within 24 hrs in 33 studies. and to 
regurgitanl fraction (RF) by pulsed Doppler subtraction of aortic 
and mitral flows in 39. RESULTS: Proxirnaliet height. width 
and area correlated well with an io ra hlc ra e (r = 0.90. 0.95. 
. WIt mmlm over ap etween g ese dimensions 
also related well to Doppler RF: 
Dimension Regression Une r SEE 
Height y l.7x + .03 0:93 O.Tiern 
Width y = 3.9x - .22 0.94 0.23 ern 
Area y = 2.3x - .24 0.92 . 0.17 cm 
CONCLUSION: Proximal jet size agrees well with established 
measures of the seventy of mltrill regurgitation. It IS convemently 
avatl8ble WIth routme cliriiC8i scanmng and should be useful in 
evaluating patients with MR. 
836-4 
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Noninvasive Quantification of Regurgitant Orifice Diameter 
Based on Laminar Core Length: 111 Vitro Laser and 
Ultrasound Doppler Studies 
Arrnelle C. Burleson. Donato Mele. Ajit P. Yoganalhan. Robert 
A. Levine, Mass. General Hospital. Boston, MA and Georgia 
Institute of Technology. Atlanta, GA 
Regurgitant jets are characterized by an initial central high•
velocity or laminar core, where centerline velocity (CLVEL) is 
close to orifice velocity, and beyond which turbulence causes 
CLVEL to decay inversely with distance from the orifice. A linear 
relation has been proposed between this laminar core len~th (L) 
and the orifice diameter (D): L=-kD. where k is an empincal 
constant. If verified. this relation could allow us to assess 
regurgitant orifice D noninvasively from Doppler velocities. 
particularly for lower-velocity right-sided jets. The purpose of 
this study. therefore. was to determine whether this relation holds 
for h siolo . c ulsatile flow m VItro over a ran e of heart rates 
an on Ice ve OClties. u satl e ow was pumpe t roug 
C1rcu ar on ces mm) at 60-150 beats/min and peak VELs 
of 2-5 m/s. CLVELs were recorded by laser Doppler anemometry 
and pulsed Doppler ultrasound. and averaged in multiple beats. 
RESULTS: When L was measured from the orifice to the point 
where CLVEL fell to 85% of the orifice VEL, the estimated 
empirical constant k relaling Land D was 6.2 + 1.0. When this 
average value was used to calculate D as Uk, ffi'e magnitude of 
the error vs actual D was .J""+'Tmm (.4 + .2 mm for laser .. 6 
+ .4 mm for echo). related to the turbuleriffluctuations which 
cause CL VEL to decay following the core. These errors were 
smaller if L was taken to 85 % of orifice VEL than to 95 % or 
90% of it. Multiple linear regression analysis showed that HR 
(p>.3). peak VEL (p>.05) and actual D (p>.2) did not 
significantly affect k. CONCLUSION: Measuring the initial 
hi~h-velocity or laminar core length of free turbulent lets can 
al ow regurwtant orifice diameter to ·be Cillculated mdepenaent of 
HR and ontlce velocity. This could then be used to C8iCUlate area 
and regurgitant flow using the Doppler flow velocity integral. 
836-5 11:30 
Variables Affecting estimation of Regurgitant Volume by Doppler Color 
Flow Mapping of Regurgitant Jet Areas In Mitral Regurgitation: 
Investigations In an Animal Model with Quantifiable Mitral Ragurgltation 
Takahiro Shiota, Dag Teien, Izumi Yamada, Michael Jones, David J. Sahn. 
Oregon Health SCiences Univ, Portland, OR 
Doppler .color flow mapping has been used to quantify mitral regurgitation 
in many studies. The direct influence of the regurgitant volume (reg vol) 
on the maximal variance encoded jet area on color Doppler is, however, 
affected by many other hemodynamic and/or instrument factors. In this 
study we examined the influence of reg vol, peripheral resistance, left 
ventricular function, the v-wave pressure and jet velocity on the maximal 
color flow jet areas in an animal with quantifiable chronic mitral 
regurgitation. Six sheep with mitral regurgitation previously created 
surgically by inducing Chordal damage were examined bv epicardial 
echocardiography. Maximal jet velocity (V Ell from continuous wave 
Doppler and maximal regurgitant jet area were recorded using a Vingmed 
750 ultrasound system interfaced directly to transfer digital flow maps 
into a Macintosh computer. The scanner was used with a 5 MHz 
transducer and all other settings (Gain, Color Nyquist Umit, and Filter) 
were fixed. Electromagnetic flowmeters were positioned on the aorta and 
mitral ring and balanced against each other allowlng direct measurement 
of the reg vol. Ventricular and atrial pressures were recorded with 
manometer tipped catheters. Preload and lifterload were varied 
systematically resulting in 24 stable hemodynamic states. Simple linear 
regression between the reg vol and the maximal color jet area was only 
moderately good (r ~ 0.63, SEE 4.9 cc!beat). By stepwlse linear 
regression with color flow jet area as a dependent parameter compared to 
peak regurgitant flow rate (I/min.), LV fractional shortening, maximal jet 
velocity, and v-wave size, only contributions from peak regurgitant flow 
rate and max jet VEL reached significance level In determining color jet 
area (r = 0.75). Color flow jet area gives limited information regarding reg 
vol in mitral regurgitation and while peak systolic images reflect 
regurgitant flow rate other variables, especially driving VEL. influence 
regurgitant jet area so as to limit the quantitative applicability of this 
approach. 
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Difference of Dynamic Change in Mitral Regurgitant 
Orifice Area In Patients With and Without Combined 
Mitral Stenosis 
Hisaki Morita, Shiro Nozaki, Hidetoshi Fukada, Koichi 
Hirabayashi, Koji Ohmori, Hirohide Matsuo. Kagawa Medical 
School, Kagawa, Japan 
Mitral regurgitant orifice area (MROA) is a major 
hemodynamic determinant of mitral regurgitation (MR), 
however its dynamic change has not been 
clarified.Therefore, we employed an algorithm based on color 
Doppler"proximal isovelocity surface area (PISA)"method to 
calculate instantaneous MROA and elucidated its chage in 
pts with MR combined with (MRS, n=10) and without (MR, 
n=15) mitral stenosis (MS). The M-mode color Doppler beam 
was directed to the mitral regurgitant orifice from the apex 
and an instantaneous aliasing radius (r) of hemispherical 
PISA was meausred. Regurgitant flow rate (RFR) was 
calculated as 2 rdxV, where V is an aliasing velocity. 
Instantaneous MROA was obtained by dividing RFR by 
corresponding MR velocity measured by continuous-wave 
Doppler. Results : RFR showed a peak in mid-systole and 
increased by 32 to 55% than in the isovolumic contraction 
(lCT) and relaxation time (IRT) in pts with MRS, while it kept 
almost constant in pts with MR. Instantaneous MROA showed 
a maximum in ICT, gradually decreased to a minimum in mid•
systole, and increased in IRT. Maximum MROA ranged from 
0.50 to 1.25cm
2 
and 0.65 to 1.50cm 2, and reduced by 15 to 
48% (mean±SD,32±10%) and 58 to 80% (72±5%, 
p<O.OOI) in mid-systole in pts with MRS and MR, respectively. 
Conclusions : Instantaneous MROA shows a bi-phasic 
change throughout systole and is minimum in mid-systole. 
However, such change is substantially small in MR combined 
with MS. This fact may imply that the influence of left 
ventricular dimension on MR severity is lesser in MRS. 
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Multlplane Transesophageal Echocardiographic Study of the 
Left Ventricle: Improved Definition of Regional and Segmental 
Dysfunction and Complications In Ischemic Heart Disease 
Abraham Schneider, Notesa Pondlan, Steven Schwartz. Tsul-Lieh Hsu, 
and MarjOry Caldeira. Tufts - New England Med Center, Boston, MA. 
Mu~iplane transesophageal echocardiography (MPTEE) allows for an 
imaging beam to be steered through a 180' rotation and a spectrum of 
images to be obtained at each location. Thus, one may more precisely 
define regional anatomy and wall motion abnormaUties (WMA). We reviewed 
140 MPTEE studies with allention to the LV and, using appropriately 
sectioned canine hearts, examined the echo anatomic correlation of 
intermediate imaging planes unique to MPTEE. Transesophaqeal views: 
With rotation to 30·40', the post LV septum is on the left (l); WMA as· 
sociated with PDA disease may be seen. The anterolat wall is on the right 
(R) and the effect of diagonal art. stenoses may be observed. In pts with 
anatomically vertical hearts this rotation may be necessary to obtain a 4-
chamber view. At 130-150' the LV cavity is tangentially cut displaying the 
LVOT, basal septum and distal anterolat wall (R) and basal inf-postr wall 
and distal inf-Iat wall (L), thus territories from all three coronary arteries are 
seen. Transgastric views: The pap muscle level is best suited for surveying 
myocardial function; the levels of the MV apparatus usually provide fore•
shortened cuts of the LV. At 40-60' the apical septum (L) and basilar lateral 
wall (R) are seen. The LV ant and postr walls are seen over 80-1000, but 
the true apex is sometimes best visualized at 100'. The LVOT is seen at 
100-120', well oriented for Doppler sampling. This tangential view places the 
postero- and anteroseptal walls on the R and postero- and anterolat walls on 
the L. Results: MPTEE provided a comprehensive assessment of regional 
wall motion in all pts. WMA were observed in 45 pts. Intermediate axis 
images defined the extent of WMA's suggested by standard views (0',90'), 
providing a more quantitative assessment of myocardial dysfxn in 26 pts. 
Regions difficult to evaluate using standard planes were readily imaged in 
12 pts. This was particularly true of posterobasal (3 pts) and apical 
aneurysms (3 pts) with thrombus (4 pts). Serpiginous septal ruptures (3 pts) 
and pap muscle ruptures (3 pts) were dx'd with greater assurance and 
anatomic precision. ConclusIon: MPTEE offers improved spatial resolution 
and enhanced delineation of segmental LV pathology with unique, but easily 
obtained and reproducible imaging planes. Thus, MPTEE is of particular 
value in assessing pts with CAD in the OR and ICU settings. 
ABSTRACTS 
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A Newly Developed Transesophageal Echocardiography 
Probe with a Rotating Matrix Biplane Transducer 
Variomatrix: Its Inilial Clinical Experience. 
487A 
Ryozo Omoto Shunei Kyo, Makoto l'IIatsumura, Elina 
Yamada, Toshiyuki Matsunaka. 
Saitama Medical School, Saitama, Japan 
To combine the advantages of the rotating 
mechanism of multiplane transesophageal 
echocardiography (TEE) with the capability of 
providing simultaneous side-by-side matrix 
biplane imaging, a Variomatrix probe was newly 
developed. The first-step prototype 
Variomatrix transducer has a pediatric matrix 
with 24 x 24 phased arrays, because the adult 
matrix would demand a bigger tip housing. 
Without moving the probe shaft, the transducer 
can be rotated 180 degrees in clockwise or 
counterclockwise way by a handle knob. In each 
position, two orthogonal, real-time images can 
be continuouly displayed side by side in the 
screen. To evaluate its performance and 
clinical feasibility, we studied 14 patients (6 
ischemic heart diseases, 4 mitral prolapses, 
and 4 aortic aneurysms), From this preliminary 
study we found various advantages such as: (1) 
Within 6 cm depth, the penetration and 
resolution powers are sufficient. (2) 
Avoidance of excessive movement of the probe. 
(3) Easy manipulation to obtain the optimal 
planes. (4) Assessment of oblique planes that 
were not Viewed from the usual biplane probe 
manipulation. (5) Better understanding of the 
continuity of structures. In conclusion, a 
newly developed Variomatrix probe seems to have 
significant advantages in the future TEE 
technology with the improved sensitivity. 
837·3 11:00 
Munlplane Tran_phageal Echocardlography Increaaea Diagnostic 
CapabilHy Beyond Biplane Tranaeaophageal Echocardlography 
Krishnaswamy Chandrasekaran, Deirdre V. Walsh, John J. Ross Jr., Peter 
M. Ouch, Dean G. Karalis. Hahnemann University, Philadelphia, PA 
Multiplane transesophageal echocardiography (MPTEE) provides 
tomographic images over 0°-180", thereby overcoming the restriction 01 
limited imaging planes encountered even with biplane TEE and 
eliminates the need for extreme probe manipulation to obtain the 
necessary views. However, the clinical usefulness and diagnostic value 
01 MPTEE over biplane TEE is less certain. Hence the purpose 01 this 
study was to evaluate the diagnostic value and clinical usefulness of 
MPTEE compared to biplane TEE. We studied 48 pts (24 male, 24 
female) 01 18-83 years (mean 59 years) using a mechanical MPTEE 
probe. Indication for TEE: 9 source 01 embolus, 8 aortic stenosis, 7 
aortic dissection, 7 prosthetic vafve dysfunction, 7 congenital heart 
disease, 7 intracardiac masses and 3 others. In all patients, Initial 
comprehensive cardiac assessment was performed at 0° and goO similar 
to biplane imaging and then tomographic sections over 0°-'80° were 
obtained by gradual mechanical rotation of the plane. Echo information 
obtained from MPTEE was compared to biplane to determine whether 
additional information, 01 diagnostic or nondiagnostic value, was obtained 
over and above that provided by biplane TEE. 
Results: 1) additional information obtained but not of diagnostic 
importance in 31 of 48 (65%) pts; 2) additional diagnostic information 
obtained of Clinical importance in 10 01 48 (20%) pts. The clinically 
important data Include aortic vafve area and morphology in 4, location of 
aortic tear in 2, pulmonary thrombus in 2, myocardial contusion in I, and 
mitral cleft and ventricular septal defect in 1. 
Conclusion: 1) MPTEE allows more thorough visualization of cardiac 
structure and thereby enhances the confidence of TEE diagnosis; 2) 
additional clinically useful information provided by MPTEE in 20% of pis, 




Panoramic Transesophageal Echocardiography In the 
Evaluation of Cardiac, Pericardial, Paracardlac, Aortic 
and Thoracic Abnormalities - Experience In 100 Patients 
Michaela Kozakova. Carlo Palombo. Steven Schwartz. Tsui-Ueh Hsu. 
Alessandro Distante and Notesa Pandian. CNR Institute of Clinical 
Physiology. Piso. Italy and Tufts-New England Medical Center. 
Boston. Massachusetts. 
We have previously described the feasibmty of panoramic transesopha•
geal echocardiography (TEE) that yields imaging fields of not only 10 to 90 
degrees with a high frame rate but also wide-angle fields up to 270 degrees 
and a maximum depth of 24 cm. In this study, we explored the day-to-day 
clinical utility of panoramic TEE in a large group of patients (100 pts, age 17 
to 82 yrs) with a variety of cardiothoracic disorders. An annular array pano•
ramic TEE probe (Esaoate/Biosound) operating at 4 to 7 MHz frequency 
was employed, and the clinical utility of various sector sizes (up to 90 as in 
conventional TEE coupled with probe rotations Vs wide-angle sectors) was 
explored. We noted that small sectors at a frequency of 5 to 7 MHz frequen•
cy allowed us to obtain detailed images of cardiac pathology, while wide•
angle sectors at the lower frequency yielded panoramic views of the whole 
hean, ascending and descending thoracic aorta, mediastinum and other 
adjacent regions of the thorax. In the 100 pts, panoramic TEE assisted in 
the detection and delineation of the following abnonmalities: mitral chordal 
rupture, aortic and mitral stenosis, supravalvar pulmonic stenosis, LV clots, 
embolus in transit, aortic, mitral and tricuspid vegetations, regional and 
global LV and RV dysfunction. Importantly, panoramic TEE was useful in a 
better display of the whole LA and the clots within LA, tumor infi"ration of the 
pleura, pericardium and the heart, mediastinal hematomas, aortiC dissec•
tions, aortic aneurysms, cardiac lipomatosis and intra- and extra-cardiac 
tumors. We noted that panoramic viewing (compared to 90 degree or less 
angled sectors) allowed improvement in the display and delineation of such 
abnonmalities in 30% of cases. Panoramic TEE allowed comprehensive 
visualization (not easily available in conventional TEE probes) of the LA, RV 
and dilated LV, aortiC arch and other portions of the aorta, and mediastinal 
structures, without unnecessary probe rotation. Mild degree of intentional 
probe rotation allowed us to perlonm 360 degree circumferential tomogra•
phic reconstructions. Probe insertion and image acquisition were uncompli•
cated. WE conclude that panoramic TEE, besides serving as a conventional 
TEE tool, oilers certain unique advantages with cUnicai implications. 
837-5 11:30 
Assessment or Normal Rigbt Ventricular Kinesis by Means or 
Panoramic Transesopbageal Ecbocardiograpby 
Michaela Koz8kova, Carto Palombo, Cesare Benanti, Alessandro Distante, Antonio 
L'Abbate, C.N.R. Institute of Clinical Physiology, Pisa, Italy 
The assessment ofRV kinesis silll represents a difficult task for echocardiography. 
Aim of this study was to evaluate normal RV kinesis by means of wide-angle 
(270"), "panoramic". transesophageal echocardiography (TEE). To this purpose. RV 
recordings were obtained in 25 pts (M:F=16:9.mean age: 45.6±18.6 years) without 
any RV and LV abnormality. in ttansgastric short-axis view. by means of an 
annular anay panoramic probe (EsaotelBiosound). at three different levels according 
ID papillary muscles: apical (A). medium (M). upper (U)- Quantitative analysis of 
RV kinesis was provided off-line on digitized images (Mipron) in 3 consecutive 
beats. with each view divided inlD 12 segments (2 for inferior, 3 for lateral, 3 for 
anterior and 4 for septal waIl); percentage area changes (%AC) were calculated from 
peak systolic and peak diastolic areas for each segment both by "fixed" and "float" 
system. The variability of %AC between different segments of RV. in three 
consecutive cardiac beats in each view and in different pts was assessed by ANOVA. 
B&suI.ts: clearly defined RV cavity conlDurs were detected and analysed in 22 pts 
(88%) at M. in 13 pts (52%) at A and in 14 pts (56%) at U level. %AC variability 
was not significant between Ihree consecutive cycles at each plane, and significant 
(p<.OOI) between different pts, both wilh "fixed" and "float" system. particularly at 
M level. %AC values in "fixed" system were highest (range of mean values: 
59-77%) in anterolateral and lowest (range: 14-35%) in septal segments (p<.OOI) at 
all three levels. In "float" system. the %AC in various segments were more 
homogeneous and ranging from 54 to 63% at A level and M level (p=ns). while 
they were significantly lower (range:36-54%) at U level (p<.01). with persisting 
differences between anterolateral and septal segments (pc.OI). 
Conclusions: panoramic TEE. which allows to image all the RV in short-axis 
view, seems to represent a feasible and reliable method to study RV kinesis. 
especially at M level. Analysis by "float" system. minimizing the effects of 
passive movements of the heart within the chest, shows lower "horizontal" 
(between segments) variability. and can represent the system of choice to provide 
detailed informations on normal RV kinesis. With this method. RV exhibits almost 
concentric syslDlic contraction at M and A level (%AC about 60%). while %AC at 
U level are lower (about 40%) and show significant differences between anterolateral 
and septal segments. probably due to the peculiar anatomy of upper part of RV. 
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Benefit of Ii· or Multiplane Versus Monoplane TEE for the 
Assessment of Endocarcrdic Lesions 
Frank P. Job, Harald lethen, Stefanie Franke, Christian lehmann, Frank A. 
Flachskampf, Peler Hanrath (FAC.C.). Mad. Clinic I, RwrH Aachen; FRG 
T a assess the accuracy of diognosing endocarditis with differenl TEE 
modolities, we compared the monoplane (MO) approach with the bi 
(BI)- and multiplane (MU). In 21 patienls (pis) MU examination was 
perfonned systematically in three steps evaluating 00 (MO), 0" and 
90' (BI) with aditionallateral Retion of the choscope and optimized 
intermediate planes (MU). Maximal area (AI and maximal length (ll of 
vegetations and abscesses were determined. 19 vegetations (mean L .. 
1.4 ± 1.1 cm; mean A .. 0.9 ± 0.6 cm~ and 5 abscesses (mean L .. 
2.9 ± 1.1 cm; mean A • 3.6 ± 3.3 cm'" were found. With MO 2 
small vegetations (l .. 0.5 cm; A - 0.05 cm1 and l - 0.7 cm, A - 0.2 
c~ were missed. One was located at the aortic valve shadowed by a 
bioprothesis in mitral position and could also not be detected by BI. In 
two further cases neither by 81 nor by MO the site of attachment of the 
vegetations could precisely be determined, whereas MU allowed exael 
localization in all cases. Vegetation size did not differ significandy 
between BI and MU but underestimation occured in 15 of 23 cases 
with MO (mean underestimation of l .. 43 %, of A - 60 %). In the 9 
cases who underwent surgery TEE findings matched exactly 
intraoperative findings. 
Conclusion: Sensitivity for the detectionn of endocarditic lesions as 
well as accuracy in size assessment and localization of the lesions are 
improved by MU compared 10 MO and BI. Especially in case of 
small sized vegelotions or shadOWing caused by valve prothesis in 
mitral position MU provides substancial additional information. 
